VARIABLE,TYPE,NGENES,BETA,BETA_STD,SE,P,FULL_NAME,P_FDR
GOMF_POTASSIUM_ION_TRANSMEMB...,SET,156,0.35597,0.032675,0.075244,1.1261e-06,GOMF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.03295295325
HP_ABNORMAL_SECOND_TOE_MORPH...,SET,12,1.2771,0.03264,0.27619,1.8963e-06,HP_ABNORMAL_SECOND_TOE_MORPHOLOGY,0.03295295325
RODRIGUES_DCC_TARGETS_UP,SET,5,1.7345,0.028621,0.38294,2.977e-06,RODRIGUES_DCC_TARGETS_UP,0.034488545
GOMF_DNA_DNA_TETHERING_ACTIV...,SET,5,1.494,0.024653,0.33886,5.2244e-06,GOMF_DNA_DNA_TETHERING_ACTIVITY,0.0453935055
HP_ANTERIOR_OPEN_BITE_MALOCC...,SET,14,1.0335,0.028529,0.23901,7.6999e-06,HP_ANTERIOR_OPEN_BITE_MALOCCLUSION,0.04730329275
MIR17_3P,SET,121,0.33959,0.027479,0.078771,8.1663e-06,MIR17_3P,0.04730329275
GOBP_POSITIVE_REGULATION_OF_...216,SET,5,1.2354,0.020386,0.29241,1.2011e-05,GOBP_POSITIVE_REGULATION_OF_DNA_LIGATION,0.059634615
NIKOLSKY_BREAST_CANCER_1Q32_...,SET,13,1.4169,0.037691,0.34091,1.6261e-05,NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON,0.070643881875
MIR3919,SET,278,0.21787,0.026607,0.052889,1.9082e-05,MIR3919,0.0712603881818182
KEGG_MEDICUS_REFERENCE_CORE_...,SET,27,0.5248,0.020111,0.1286,2.2547e-05,KEGG_MEDICUS_REFERENCE_CORE_NER_REACTION,0.0712603881818182
ZNF354C_TARGET_GENES,SET,10,1.0308,0.024052,0.25261,2.2554e-05,ZNF354C_TARGET_GENES,0.0712603881818182
WP_INTERACTOME_OF_POLYCOMB_R...,SET,15,0.8124,0.023213,0.20188,2.8704e-05,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,0.0782655865384615
GOMF_POTASSIUM_CHANNEL_ACTIV...2,SET,122,0.34611,0.028121,0.086107,2.9275e-05,GOMF_POTASSIUM_CHANNEL_ACTIVITY,0.0782655865384615
GOMF_POLY_ADP_D_RIBOSE_BINDI...,SET,4,1.5138,0.022342,0.38036,3.4621e-05,GOMF_POLY_ADP_D_RIBOSE_BINDING,0.0859466325
GOMF_NUCLEOTIDASE_ACTIVITY,SET,13,0.86957,0.023132,0.22106,4.1999e-05,GOMF_NUCLEOTIDASE_ACTIVITY,0.0919769353125
GOMF_ADP_D_RIBOSE_MODIFICATI...,SET,4,1.4234,0.021008,0.36203,4.2343e-05,GOMF_ADP_D_RIBOSE_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.0919769353125
MIR384,SET,109,0.32149,0.024699,0.082696,5.0796e-05,MIR384,0.10178581
GOMF_SPHINGOSINE_N_ACYLTRANS...,SET,6,1.3766,0.024882,0.35491,5.2716e-05,GOMF_SPHINGOSINE_N_ACYLTRANSFERASE_ACTIVITY,0.10178581
ZNF548_TARGET_GENES,SET,45,0.53281,0.026347,0.13838,5.9203e-05,ZNF548_TARGET_GENES,0.10637289075
GSE6092_UNSTIM_VS_IFNG_STIM_...4,SET,179,0.22907,0.022509,0.059622,6.1213e-05,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP,0.10637289075
GCAAAAA_MIR129,SET,171,0.2444,0.023478,0.064439,7.4732e-05,GCAAAAA_MIR129,0.12368146
GOBP_REGULATION_OF_DNA_LIGAT...,SET,6,1.0381,0.018764,0.27462,7.8656e-05,GOBP_REGULATION_OF_DNA_LIGATION,0.12400130673913
GSE17301_CTRL_VS_48H_ACD3_AC...4,SET,175,0.23425,0.022762,0.062143,8.2061e-05,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP,0.12400130673913
MIR548AO_3P,SET,17,0.82349,0.025048,0.21952,8.822e-05,MIR548AO_3P,0.1277535875
GOBP_MYCOTOXIN_METABOLIC_PRO...,SET,7,1.2305,0.024024,0.33048,9.8591e-05,GOBP_MYCOTOXIN_METABOLIC_PROCESS,0.134635523076923
HP_RENAL_ATROPHY,SET,7,1.1597,0.022642,0.31193,0.00010072,HP_RENAL_ATROPHY,0.134635523076923
HP_OVERTUBULATED_LONG_BONES,SET,7,1.21,0.023624,0.32736,0.0001097,HP_OVERTUBULATED_LONG_BONES,0.141208277777778
GSE37301_COMMON_LYMPHOID_PRO...3,SET,170,0.24254,0.023232,0.065931,0.00011754,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,0.141752462068966
WP_IRINOTECAN_PATHWAY,SET,12,0.92465,0.023633,0.25146,0.00011828,WP_IRINOTECAN_PATHWAY,0.141752462068966
KEGG_MEDICUS_REFERENCE_WNT_S...3,SET,17,0.81316,0.024734,0.22255,0.00012952,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION,0.14949134516129
WP_TAMOXIFEN_METABOLISM,SET,21,0.73239,0.024757,0.20085,0.00013334,WP_TAMOXIFEN_METABOLISM,0.14949134516129
GSE19825_NAIVE_VS_DAY3_EFF_C...2,SET,177,0.24457,0.023898,0.067349,0.0001414,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP,0.15357365625
GOBP_REGULATION_OF_CELLULAR_...4,SET,310,0.17629,0.022714,0.049122,0.00016659,GOBP_REGULATION_OF_CELLULAR_COMPONENT_SIZE,0.17045838
MIR3157_3P,SET,35,0.55687,0.024292,0.15543,0.00017037,MIR3157_3P,0.17045838
MIR3619_5P,SET,255,0.18497,0.021648,0.051653,0.00017166,MIR3619_5P,0.17045838
GOBP_HYPOTHALAMUS_GONADOTROP...,SET,6,1.469,0.026552,0.41621,0.00020883,GOBP_HYPOTHALAMUS_GONADOTROPHIN_RELEASING_HORMONE_NEURON_DIFFERENTIATION,0.2016079625
CCTGCTG_MIR214,SET,218,0.19757,0.021402,0.056289,0.00022467,CCTGCTG_MIR214,0.211037995945946
GSE13306_TREG_VS_TCONV_LAMIN...1,SET,181,0.21555,0.021297,0.062116,0.00026069,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN,0.230898909574468
MIR214_3P,SET,222,0.19032,0.020802,0.055065,0.00027447,MIR214_3P,0.230898909574468
GSE22886_NAIVE_CD8_TCELL_VS_...4,SET,181,0.21205,0.020952,0.061361,0.00027494,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP,0.230898909574468
MIR154_5P,SET,61,0.39577,0.022776,0.11455,0.0002758,MIR154_5P,0.230898909574468
GOBP_ACTIVATION_OF_TRANSMEMB...,SET,6,1.1535,0.020849,0.33541,0.00029269,GOBP_ACTIVATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.230898909574468
HP_PHOTOSENSITIVE_MYOCLONIC_...,SET,7,1.1625,0.022696,0.33836,0.00029619,HP_PHOTOSENSITIVE_MYOCLONIC_SEIZURE,0.230898909574468
GTCTTCC_MIR7,SET,155,0.23999,0.021958,0.070109,0.00031034,GTCTTCC_MIR7,0.230898909574468
KEGG_MEDICUS_REFERENCE_ALTER...,SET,5,1.5179,0.025048,0.44355,0.00031123,KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN,0.230898909574468
GOBP_REPLICATION_BORN_DOUBLE...,SET,6,0.98345,0.017776,0.28739,0.00031154,GOBP_REPLICATION_BORN_DOUBLE_STRAND_BREAK_REPAIR_VIA_SISTER_CHROMATID_EXCHANGE,0.230898909574468
WP_ESTRADIOL_REGULATION_IN_P...,SET,5,1.3386,0.022088,0.39125,0.00031225,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,0.230898909574468
GOBP_REGULATION_OF_LIGASE_AC...,SET,5,1.0254,0.01692,0.30422,0.0003758,GOBP_REGULATION_OF_LIGASE_ACTIVITY,0.265265898113208
REACTOME_RND1_GTPASE_CYCLE,SET,41,0.44374,0.020947,0.13211,0.00039211,REACTOME_RND1_GTPASE_CYCLE,0.265265898113208
KEGG_MEDICUS_VARIANT_MUTATIO...21,SET,28,0.55088,0.021498,0.16429,0.00040041,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY,0.265265898113208
KEGG_MEDICUS_VARIANT_MUTATIO...85,SET,28,0.55088,0.021498,0.16429,0.00040041,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY,0.265265898113208
GSE3982_CTRL_VS_LPS_1H_NEUTR...2,SET,170,0.21541,0.020633,0.064272,0.00040266,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP,0.265265898113208
MIR6134,SET,122,0.26124,0.021226,0.077976,0.00040452,MIR6134,0.265265898113208
HP_PALPEBRAL_EDEMA,SET,37,0.47932,0.021497,0.14385,0.00043196,HP_PALPEBRAL_EDEMA,0.277338580909091
GOBP_NEGATIVE_REGULATION_OF_...641,SET,11,0.8951,0.021904,0.26899,0.00043889,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_COMPETITIVE_PROMOTER_BINDING,0.277338580909091
GOBP_ALKALOID_METABOLIC_PROC...,SET,7,1.0511,0.02052,0.31714,0.00046044,GOBP_ALKALOID_METABOLIC_PROCESS,0.285760575
GOBP_POSITIVE_REGULATION_OF_...670,SET,40,0.44153,0.020588,0.13348,0.00047091,GOBP_POSITIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,0.287131176315789
HP_APLASIA_OF_THE_NASAL_BONE,SET,5,1.6266,0.02684,0.49445,0.00050253,HP_APLASIA_OF_THE_NASAL_BONE,0.300023916666667
MIR339_3P,SET,6,1.1121,0.020102,0.33873,0.00051409,MIR339_3P,0.300023916666667
DARWICHE_SKIN_TUMOR_PROMOTER...1,SET,174,0.20927,0.020277,0.063815,0.00052115,DARWICHE_SKIN_TUMOR_PROMOTER_DN,0.300023916666667
GSE18893_CTRL_VS_TNF_TREATED...4,SET,182,0.19946,0.019761,0.060888,0.00052783,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP,0.300023916666667
KEGG_DRUG_METABOLISM_CYTOCHR...,SET,65,0.46926,0.027874,0.14345,0.00053636,KEGG_DRUG_METABOLISM_CYTOCHROME_P450,0.300023916666667
MIR761,SET,209,0.18569,0.019699,0.056831,0.00054385,MIR761,0.300023916666667
GSE19941_IL10_KO_VS_IL10_KO_...4,SET,181,0.21026,0.020774,0.064689,0.00057759,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_UP,0.310195717605634
GOBP_NEGATIVE_REGULATION_OF_...358,SET,8,1.0408,0.021722,0.3207,0.00058767,GOBP_NEGATIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.310195717605634
TRAYNOR_RETT_SYNDROM_UP,SET,36,0.55341,0.024483,0.17057,0.00058947,TRAYNOR_RETT_SYNDROM_UP,0.310195717605634
GSE17721_CTRL_VS_LPS_0.5H_BM...2,SET,179,0.20831,0.020469,0.06436,0.00060574,GSE17721_CTRL_VS_LPS_0.5H_BMDC_UP,0.310195717605634
GOBP_NEGATIVE_REGULATION_OF_...355,SET,9,0.95761,0.021198,0.29647,0.00062001,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,0.310195717605634
GOMF_INWARD_RECTIFIER_POTASS...,SET,26,0.61019,0.022947,0.18915,0.00062888,GOMF_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.310195717605634
MIR877_3P,SET,174,0.21281,0.02062,0.065976,0.00062959,MIR877_3P,0.310195717605634
GSE10422_WT_VS_BAFF_TRANSGEN...2,SET,157,0.21439,0.019742,0.066503,0.00063369,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP,0.310195717605634
GSE3039_ALPHABETA_CD8_TCELL_...1,SET,179,0.20078,0.019729,0.062477,0.00065655,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_DN,0.312719251923077
HP_COARSE_FACIAL_FEATURES,SET,191,0.19404,0.01969,0.06051,0.00067219,HP_COARSE_FACIAL_FEATURES,0.312719251923077
GOMF_ADENOSINE_3_5_BISPHOSPH...,SET,5,1.2402,0.020464,0.38696,0.00067673,GOMF_ADENOSINE_3_5_BISPHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.312719251923077
VALK_AML_CLUSTER_6,SET,32,0.46973,0.019595,0.14666,0.00068161,VALK_AML_CLUSTER_6,0.312719251923077
GOBP_EOSINOPHIL_MEDIATED_IMM...,SET,8,0.87575,0.018278,0.27371,0.00068946,GOBP_EOSINOPHIL_MEDIATED_IMMUNITY,0.312719251923077
GOMF_POTASSIUM_PROTON_ANTIPO...,SET,12,0.78755,0.020129,0.24639,0.00069721,GOMF_POTASSIUM_PROTON_ANTIPORTER_ACTIVITY,0.312719251923077
GSE3982_EOSINOPHIL_VS_TH1_UP,SET,178,0.20231,0.019824,0.063332,0.00070183,GSE3982_EOSINOPHIL_VS_TH1_UP,0.312719251923077
GOMF_VOLTAGE_GATED_POTASSIUM...1,SET,96,0.31391,0.022641,0.098685,0.00073517,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.32269209244186
GSE12392_WT_VS_IFNAR_KO_CD8A...1,SET,167,0.19944,0.018935,0.062779,0.00074574,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_DN,0.32269209244186
GOBP_PURINE_NUCLEOSIDE_MONOP...2,SET,10,0.9137,0.021319,0.28812,0.0007603,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.32269209244186
HP_ABNORMAL_MORPHOLOGY_OF_TH...2,SET,24,0.56016,0.020241,0.17678,0.00076705,HP_ABNORMAL_MORPHOLOGY_OF_THE_CHOROIDAL_VASCULATURE,0.32269209244186
GOBP_REGULATION_OF_RRNA_PROC...,SET,15,0.72061,0.02059,0.22769,0.00077707,GOBP_REGULATION_OF_RRNA_PROCESSING,0.32269209244186
REACTOME_WNT_LIGAND_BIOGENES...,SET,24,0.60075,0.021707,0.19017,0.000793,REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING,0.32269209244186
GNF2_SPI1,SET,34,0.47796,0.02055,0.15134,0.00079496,GNF2_SPI1,0.32269209244186
GOMF_OXIDOREDUCTASE_ACTIVITY...23,SET,42,0.48095,0.022978,0.15235,0.00079849,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_FLAVIN_OR_FLAVOPROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.32269209244186
MIR6736_5P,SET,42,0.39342,0.018796,0.12485,0.00081446,MIR6736_5P,0.323158309090909
chr16q22,SET,105,0.53977,0.040705,0.17137,0.00081824,chr16q22,0.323158309090909
FARMER_BREAST_CANCER_CLUSTER...8,SET,7,1.1021,0.021517,0.35034,0.0008294,FARMER_BREAST_CANCER_CLUSTER_8,0.323885359550562
HP_CHOROIDAL_NEOVASCULARIZAT...,SET,19,0.64985,0.020896,0.20703,0.00084902,HP_CHOROIDAL_NEOVASCULARIZATION,0.327277523076923
HP_YELLOW_BROWN_DISCOLORATIO...,SET,14,0.74511,0.020569,0.23758,0.00085692,HP_YELLOW_BROWN_DISCOLORATION_OF_THE_TEETH,0.327277523076923
KEGG_MEDICUS_PATHOGEN_SHIGEL...4,SET,13,0.72103,0.019181,0.23037,0.00087588,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAC_TO_ACTIN_SIGNALING_PATHWAY,0.330667943617021
FRANCO_BLOOD_SANOFI_PASTEUR_...4,SET,20,0.57267,0.018892,0.18327,0.00089124,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_POSITIVE,0.330667943617021
BREDEMEYER_RAG_SIGNALING_VIA...2,SET,46,0.42221,0.021108,0.13516,0.00089434,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,0.330667943617021
GOBP_EOSINOPHIL_ACTIVATION,SET,8,0.86533,0.01806,0.27771,0.00091836,GOBP_EOSINOPHIL_ACTIVATION,0.334805305670103
MODULE_261,SET,89,0.28616,0.019876,0.091961,0.0009315,MODULE_261,0.334805305670103
GOBP_HYPOTHALAMUS_CELL_MIGRA...,SET,6,1.2952,0.023411,0.41635,0.00093443,GOBP_HYPOTHALAMUS_CELL_MIGRATION,0.334805305670103
GSE19888_ADENOSINE_A3R_INH_V...6,SET,176,0.19955,0.019444,0.064262,0.00095224,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP,0.337705114285714
KEGG_MEDICUS_REFERENCE_WNT_S...4,SET,27,0.55004,0.021079,0.17748,0.00097181,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR,0.341164207575758
GSE2770_UNTREATED_VS_TGFB_AN...3,SET,175,0.19145,0.018603,0.062138,0.0010329,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.357288282178218
GSE29618_PDC_VS_MDC_UP,SET,173,0.20304,0.019617,0.065931,0.0010383,GSE29618_PDC_VS_MDC_UP,0.357288282178218
GOBP_OLIGODENDROCYTE_DIFFERE...,SET,104,0.27215,0.020425,0.088493,0.0010529,GOBP_OLIGODENDROCYTE_DIFFERENTIATION,0.358760191176471
GOBP_NEGATIVE_REGULATION_OF_...608,SET,26,0.53104,0.019971,0.17318,0.0010848,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,0.366041009708738
GOBP_OXIDATIVE_DEMETHYLATION,SET,10,0.82602,0.019274,0.26964,0.0010957,GOBP_OXIDATIVE_DEMETHYLATION,0.366163975961538
GOBP_NEGATIVE_REGULATION_OF_...38,SET,82,0.28166,0.018782,0.092118,0.0011172,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY,0.3697932
GOBP_SUBTELOMERIC_HETEROCHRO...,SET,6,0.95161,0.017201,0.31288,0.001179,GOBP_SUBTELOMERIC_HETEROCHROMATIN_FORMATION,0.384253878504673
GSE25088_IL4_VS_IL4_AND_ROSI...2,SET,183,0.19199,0.019073,0.063146,0.001183,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,0.384253878504673
GOMF_D1_DOPAMINE_RECEPTOR_BI...,SET,6,0.95742,0.017306,0.31527,0.001197,GOMF_D1_DOPAMINE_RECEPTOR_BINDING,0.38520125
GOCC_ARP2_3_PROTEIN_COMPLEX,SET,9,0.7857,0.017392,0.25946,0.0012317,GOCC_ARP2_3_PROTEIN_COMPLEX,0.392167905405405
KEGG_MEDICUS_REFERENCE_BLOCK...,SET,12,0.73178,0.018703,0.24185,0.0012419,KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2,0.392167905405405
GOBP_NEGATIVE_REGULATION_OF_...476,SET,7,1.1404,0.022264,0.37721,0.0012525,GOBP_NEGATIVE_REGULATION_OF_P38MAPK_CASCADE,0.392167905405405
GSE5589_LPS_VS_LPS_AND_IL10_...1,SET,176,0.1951,0.019011,0.064706,0.0012862,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_DN,0.399042276315789
GSE13522_WT_VS_IFNG_KO_SKING...1,SET,110,0.24657,0.019029,0.081863,0.0012994,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,0.399042276315789
GOBP_REGULATION_OF_EOSINOPHI...,SET,5,1.2265,0.020238,0.40749,0.0013089,GOBP_REGULATION_OF_EOSINOPHIL_MIGRATION,0.399042276315789
GOBP_REGULATION_OF_CENTROMER...2,SET,4,1.2332,0.018201,0.41021,0.0013245,GOBP_REGULATION_OF_CENTROMERIC_SISTER_CHROMATID_COHESION,0.400286934782609
GOBP_REGULATION_OF_NUCLEAR_C...,SET,12,0.68439,0.017492,0.22791,0.0013391,GOBP_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION,0.401210521551724
GOBP_REGULATION_OF_SMOOTHENE...,SET,79,0.27446,0.017966,0.091855,0.0014062,GOBP_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,0.417713512820513
GOBP_INTRACELLULAR_POTASSIUM...,SET,15,0.74299,0.02123,0.24941,0.001448,GOBP_INTRACELLULAR_POTASSIUM_ION_HOMEOSTASIS,0.426485084745763
MIR3622A_5P,SET,37,0.44848,0.020114,0.15083,0.0014746,MIR3622A_5P,0.430669941176471
HP_PERIVENTRICULAR_NODULAR_H...,SET,14,0.65509,0.018084,0.22064,0.0014959,HP_PERIVENTRICULAR_NODULAR_HETEROTOPIA,0.431019446280992
MODULE_58,SET,17,0.6761,0.020565,0.22779,0.0015006,MODULE_58,0.431019446280992
GOBP_NUCLEOSIDE_MONOPHOSPHAT...2,SET,18,0.63734,0.019947,0.21571,0.0015676,GOBP_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.445287841463415
HOEGERKORP_CD44_TARGETS_TEMP...1,SET,23,0.52099,0.018429,0.17643,0.0015759,HOEGERKORP_CD44_TARGETS_TEMPORAL_DN,0.445287841463415
REACTOME_UPTAKE_AND_FUNCTION...1,SET,11,0.84293,0.020628,0.2861,0.0016104,REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS,0.447764244827586
GSE11961_GERMINAL_CENTER_BCE...6,SET,179,0.18882,0.018554,0.064203,0.0016381,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,0.447764244827586
GOBP_IMP_CATABOLIC_PROCESS,SET,5,1.1561,0.019077,0.39319,0.0016413,GOBP_IMP_CATABOLIC_PROCESS,0.447764244827586
MIR4701_3P,SET,46,0.35468,0.017732,0.12068,0.0016482,MIR4701_3P,0.447764244827586
AIZARANI_LIVER_C31_KUPFFER_C...,SET,107,0.24652,0.018766,0.08391,0.0016544,AIZARANI_LIVER_C31_KUPFFER_CELLS_5,0.447764244827586
GOMF_AMIDE_TRANSMEMBRANE_TRA...,SET,34,0.44997,0.019347,0.15348,0.0016871,GOMF_AMIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.447764244827586
GOBP_FC_RECEPTOR_MEDIATED_ST...,SET,30,0.48842,0.019728,0.1667,0.0016976,GOBP_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.447764244827586
LXR_Q3,SET,73,0.28618,0.01801,0.09771,0.001703,LXR_Q3,0.447764244827586
KEGG_COMPLEMENT_AND_COAGULAT...,SET,61,0.36088,0.020768,0.12334,0.0017193,KEGG_COMPLEMENT_AND_COAGULATION_CASCADES,0.447764244827586
GOBP_EXIT_FROM_MITOSIS,SET,29,0.46256,0.01837,0.15817,0.0017272,GOBP_EXIT_FROM_MITOSIS,0.447764244827586
GSE17974_IL4_AND_ANTI_IL12_V...3,SET,168,0.20574,0.019591,0.070441,0.0017485,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN,0.447764244827586
GSE18893_CTRL_VS_TNF_TREATED...5,SET,171,0.18656,0.017922,0.06389,0.0017521,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN,0.447764244827586
GOBP_REGULATION_OF_CELL_SIZE,SET,156,0.20467,0.018787,0.070127,0.0017603,GOBP_REGULATION_OF_CELL_SIZE,0.447764244827586
WP_GLP1_IN_PANCREATIC_ISLET_...,SET,7,1.0916,0.021312,0.37475,0.0017927,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,0.447764244827586
HP_RECURRENT_URINARY_TRACT_I...,SET,143,0.20821,0.018304,0.071599,0.0018211,HP_RECURRENT_URINARY_TRACT_INFECTIONS,0.447764244827586
MODULE_113,SET,96,0.26307,0.018974,0.090551,0.0018375,MODULE_113,0.447764244827586
GOBP_ENDOCARDIAL_CELL_DIFFER...,SET,6,1.1813,0.021352,0.40662,0.0018379,GOBP_ENDOCARDIAL_CELL_DIFFERENTIATION,0.447764244827586
GOCC_NUCLEOTIDE_EXCISION_REP...,SET,11,0.58149,0.01423,0.20024,0.0018446,GOCC_NUCLEOTIDE_EXCISION_REPAIR_COMPLEX,0.447764244827586
LXR_DR4_Q3,SET,79,0.28766,0.01883,0.099065,0.0018459,LXR_DR4_Q3,0.447764244827586
FAN_EMBRYONIC_CTX_IN_3_INTER...,SET,5,1.1939,0.019701,0.41118,0.0018467,FAN_EMBRYONIC_CTX_IN_3_INTERNEURON,0.447764244827586
GOBP_POTASSIUM_ION_TRANSPORT,SET,227,0.17996,0.019887,0.062031,0.0018614,GOBP_POTASSIUM_ION_TRANSPORT,0.447764244827586
KEGG_MISMATCH_REPAIR,SET,22,0.48364,0.016733,0.16677,0.0018681,KEGG_MISMATCH_REPAIR,0.447764244827586
GOBP_REGULATION_OF_PROTEIN_A...2,SET,5,0.85331,0.014081,0.29575,0.0019578,GOBP_REGULATION_OF_PROTEIN_ADP_RIBOSYLATION,0.464653071428571
GOCC_LAMININ_COMPLEX,SET,9,0.8896,0.019692,0.30845,0.0019653,GOCC_LAMININ_COMPLEX,0.464653071428571
GOBP_RESPONSE_TO_OZONE,SET,5,1.2569,0.020741,0.43657,0.0019966,GOBP_RESPONSE_TO_OZONE,0.468863736486486
HP_ABNORMAL_AFFECT,SET,37,0.44363,0.019896,0.15436,0.0020285,HP_ABNORMAL_AFFECT,0.469010774509804
MODULE_182,SET,89,0.26284,0.018257,0.091456,0.0020293,MODULE_182,0.469010774509804
HP_UROGENITAL_SINUS_ANOMALY,SET,15,0.69481,0.019853,0.24199,0.0020469,HP_UROGENITAL_SINUS_ANOMALY,0.469010774509804
GSE5589_UNSTIM_VS_180MIN_LPS...3,SET,182,0.17662,0.017498,0.061566,0.0020629,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN,0.469010774509804
LIM_MAMMARY_LUMINAL_MATURE_UP,SET,97,0.26003,0.018852,0.090652,0.0020647,LIM_MAMMARY_LUMINAL_MATURE_UP,0.469010774509804
CGCAAAA_MIR450,SET,9,0.82368,0.018233,0.28831,0.0021414,CGCAAAA_MIR450,0.483275045454545
TORCHIA_TARGETS_OF_EWSR1_FLI...1,SET,291,0.15008,0.018745,0.052633,0.0021783,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,0.487394317307692
GOMF_DOPAMINE_RECEPTOR_BINDI...,SET,13,0.69771,0.01856,0.2448,0.0021877,GOMF_DOPAMINE_RECEPTOR_BINDING,0.487394317307692
MIR1262,SET,44,0.34881,0.017056,0.12252,0.0022088,MIR1262,0.488960789808917
GOBP_NEGATIVE_REGULATION_OF_...98,SET,3,1.6218,0.02073,0.57061,0.0022429,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,0.492152521875
GOBP_OPSONIZATION,SET,15,0.74162,0.02119,0.26112,0.0022574,GOBP_OPSONIZATION,0.492152521875
GOMF_TELETHONIN_BINDING,SET,7,1.0329,0.020165,0.36382,0.0022657,GOMF_TELETHONIN_BINDING,0.492152521875
MIR616_5P,SET,856,0.084727,0.017864,0.029893,0.0022984,MIR616_5P,0.496154608695652
MIR4787_5P,SET,6,1.0626,0.019207,0.37561,0.0023371,MIR4787_5P,0.499136899390244
GOMF_SOLUTE_POTASSIUM_ANTIPO...,SET,17,0.6178,0.018791,0.21847,0.0023456,GOMF_SOLUTE_POTASSIUM_ANTIPORTER_ACTIVITY,0.499136899390244
MIR373_5P,SET,852,0.084823,0.017844,0.030009,0.0023553,MIR373_5P,0.499136899390244
MODULE_97,SET,88,0.25855,0.017858,0.091612,0.0023876,MODULE_97,0.501644457831325
NEWMAN_ERCC6_TARGETS_UP,SET,23,0.6162,0.021797,0.21843,0.002396,NEWMAN_ERCC6_TARGETS_UP,0.501644457831325
HP_LOCALIZED_SKIN_LESION,SET,790,0.088437,0.017947,0.031415,0.0024408,HP_LOCALIZED_SKIN_LESION,0.503508068965517
MIR5001_3P,SET,139,0.19949,0.017293,0.070889,0.0024479,MIR5001_3P,0.503508068965517
KEGG_MEDICUS_PATHOGEN_ESCHER...1,SET,14,0.62244,0.017182,0.22122,0.0024512,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TCCP_TO_ACTIN_SIGNALING_PATHWAY,0.503508068965517
LFA1_Q6,SET,237,0.15757,0.017787,0.056075,0.0024803,LFA1_Q6,0.503508068965517
MIR545_5P,SET,286,0.14462,0.017909,0.051482,0.0024868,MIR545_5P,0.503508068965517
GOBP_NEGATIVE_REGULATION_OF_...431,SET,15,0.62611,0.01789,0.22318,0.0025151,GOBP_NEGATIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.503508068965517
WP_CREATINE_PATHWAY,SET,4,1.3617,0.020099,0.48548,0.0025188,WP_CREATINE_PATHWAY,0.503508068965517
MIR5193,SET,158,0.19553,0.018062,0.069716,0.0025208,MIR5193,0.503508068965517
ZFP3_TARGET_GENES,SET,286,0.14287,0.017693,0.051,0.0025465,ZFP3_TARGET_GENES,0.504520167613636
GOBP_MONOCYTE_CHEMOTAXIS,SET,47,0.37183,0.01879,0.13278,0.0025549,GOBP_MONOCYTE_CHEMOTAXIS,0.504520167613636
GOBP_NEGATIVE_REGULATION_OF_...129,SET,5,1.1542,0.019046,0.41246,0.0025711,GOBP_NEGATIVE_REGULATION_OF_CELL_VOLUME,0.504850737288136
HIPC_SIGNATURES_PROJECT_PBMC...1,SET,6,0.89657,0.016206,0.32061,0.0025858,HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_DOWN,0.504884713483146
MIR371B_5P,SET,856,0.083597,0.017626,0.02993,0.0026129,MIR371B_5P,0.507325918994413
MIR4672,SET,335,0.13348,0.017866,0.047831,0.0026329,MIR4672,0.507802836065574
GSE27786_LSK_VS_ERYTHROBLAST...2,SET,178,0.1748,0.017129,0.062704,0.0026564,GSE27786_LSK_VS_ERYTHROBLAST_UP,0.507802836065574
REACTOME_COMPLEMENT_CASCADE,SET,49,0.38387,0.019806,0.13778,0.0026699,REACTOME_COMPLEMENT_CASCADE,0.507802836065574
GOBP_POSITIVE_REGULATION_OF_...155,SET,136,0.21589,0.018513,0.0775,0.0026738,GOBP_POSITIVE_REGULATION_OF_CHEMOTAXIS,0.507802836065574
GOBP_REGULATION_OF_INOSITOL_...2,SET,15,0.68086,0.019454,0.24475,0.0027055,GOBP_REGULATION_OF_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.511030720108696
EVI1_02,SET,112,0.22842,0.017787,0.082294,0.0027577,EVI1_02,0.518074937837838
HP_LARGE_FLESHY_EARS,SET,13,0.70748,0.01882,0.25517,0.0027836,HP_LARGE_FLESHY_EARS,0.519513303191489
HP_APLASIA_OF_THE_PHALANGES_...,SET,8,0.82299,0.017176,0.29698,0.0027956,HP_APLASIA_OF_THE_PHALANGES_OF_THE_TOES,0.519513303191489
HP_ACUTE_CORONARY_SYNDROME,SET,101,0.25638,0.018964,0.092573,0.0028102,HP_ACUTE_CORONARY_SYNDROME,0.519513303191489
GOBP_ENDOSOMAL_TRANSPORT,SET,255,0.14204,0.016624,0.051339,0.0028342,GOBP_ENDOSOMAL_TRANSPORT,0.521177888888889
GOMF_NON_MEMBRANE_SPANNING_P...1,SET,43,0.4034,0.019501,0.14592,0.0028539,GOMF_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.5213068984375
GOMF_ADP_TRANSMEMBRANE_TRANS...,SET,9,0.83914,0.018575,0.3038,0.0028743,GOMF_ADP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.5213068984375
MIR518A_5P_MIR527,SET,237,0.16062,0.018132,0.058164,0.0028799,MIR518A_5P_MIR527,0.5213068984375
GOCC_MALE_PRONUCLEUS,SET,6,0.81418,0.014717,0.2954,0.0029266,GOCC_MALE_PRONUCLEUS,0.527015455958549
HP_ANTERIOR_PLAGIOCEPHALY,SET,5,1.1874,0.019594,0.43142,0.0029614,HP_ANTERIOR_PLAGIOCEPHALY,0.52751896039604
HP_PROGRESSIVE_EXTRAPYRAMIDA...,SET,8,0.83222,0.017369,0.30335,0.0030435,HP_PROGRESSIVE_EXTRAPYRAMIDAL_MOVEMENT_DISORDER,0.52751896039604
GOBP_RIBONUCLEOSIDE_MONOPHOS...2,SET,14,0.68363,0.018871,0.24925,0.0030493,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.52751896039604
MIR6840_3P,SET,154,0.18625,0.016987,0.067913,0.0030516,MIR6840_3P,0.52751896039604
GOBP_POSITIVE_REGULATION_OF_...5,SET,45,0.36075,0.017839,0.13154,0.003052,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,0.52751896039604
MIR1203,SET,4,1.1263,0.016623,0.4108,0.0030595,MIR1203,0.52751896039604
HP_ABNORMALITY_OF_THE_EPIPHY...2,SET,6,1.0161,0.018367,0.37067,0.0030622,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_FEET,0.52751896039604
GOBP_MULTIVESICULAR_BODY_ORG...,SET,32,0.38605,0.016104,0.14083,0.0030636,GOBP_MULTIVESICULAR_BODY_ORGANIZATION,0.52751896039604
DARWICHE_PAPILLOMA_RISK_LOW_...1,SET,152,0.18631,0.016882,0.067972,0.003066,DARWICHE_PAPILLOMA_RISK_LOW_DN,0.52751896039604
GOBP_VENTRICULAR_CARDIAC_MUS...4,SET,27,0.47754,0.018301,0.17436,0.0030866,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.528447206896552
HP_PERIORBITAL_EDEMA,SET,99,0.25032,0.018333,0.091455,0.0031026,HP_PERIORBITAL_EDEMA,0.528582661764706
SUZUKI_RESPONSE_TO_TSA,SET,15,0.6148,0.017567,0.22489,0.0031336,SUZUKI_RESPONSE_TO_TSA,0.528698257009346
GOBP_REGULATION_OF_LIPOPROTE...3,SET,19,0.54764,0.017609,0.20047,0.0031526,GOBP_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,0.528698257009346
MIR8088,SET,5,0.92974,0.015342,0.34054,0.0031681,MIR8088,0.528698257009346
MIR6507_5P,SET,306,0.14046,0.017983,0.051477,0.0031834,MIR6507_5P,0.528698257009346
GOBP_POINTED_END_ACTIN_FILAM...,SET,7,0.77873,0.015203,0.28569,0.0032105,GOBP_POINTED_END_ACTIN_FILAMENT_CAPPING,0.528698257009346
GSE2770_IL12_AND_TGFB_VS_IL4...1,SET,173,0.17278,0.016694,0.063444,0.003234,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.528698257009346
REACTOME_SODIUM_COUPLED_SULP...,SET,5,1.1711,0.019324,0.43012,0.0032408,REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS,0.528698257009346
MIR3152_3P,SET,76,0.26884,0.017262,0.098764,0.0032474,MIR3152_3P,0.528698257009346
GSE13306_LAMINA_PROPRIA_VS_S...1,SET,186,0.17559,0.017585,0.064518,0.0032518,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN,0.528698257009346
GGGCATT_MIR365,SET,100,0.23689,0.017436,0.087053,0.0032554,GGGCATT_MIR365,0.528698257009346
GOBP_REGULATION_OF_INTEGRIN_...2,SET,3,1.6029,0.020488,0.5896,0.0032816,GOBP_REGULATION_OF_INTEGRIN_BIOSYNTHETIC_PROCESS,0.530474455813953
GOCC_FEMALE_PRONUCLEUS,SET,8,0.73745,0.015391,0.27196,0.0033516,GOCC_FEMALE_PRONUCLEUS,0.536768171945701
WENG_POR_DOSAGE,SET,22,0.53533,0.018521,0.19748,0.0033587,WENG_POR_DOSAGE,0.536768171945701
WP_13Q1212_COPY_NUMBER_VARIA...,SET,31,0.44386,0.018224,0.16397,0.0033978,WP_13Q1212_COPY_NUMBER_VARIATION,0.536768171945701
HP_ELONGATED_SUPERIOR_CEREBE...,SET,10,0.70406,0.016428,0.26011,0.0034006,HP_ELONGATED_SUPERIOR_CEREBELLAR_PEDUNCLE,0.536768171945701
IRF2_01,SET,118,0.22091,0.017654,0.081617,0.0034018,IRF2_01,0.536768171945701
GSE36891_POLYIC_TLR3_VS_PAM_...1,SET,146,0.18927,0.016812,0.069957,0.0034132,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,0.536768171945701
REACTOME_MRNA_EDITING,SET,9,0.9036,0.020002,0.33436,0.0034446,REACTOME_MRNA_EDITING,0.539266094594595
GOBP_IMMUNE_COMPLEX_CLEARANCE,SET,5,1.2089,0.019948,0.44819,0.0034987,GOBP_IMMUNE_COMPLEX_CLEARANCE,0.539531384937239
GOBP_POSITIVE_REGULATION_OF_...354,SET,137,0.21185,0.018232,0.078629,0.0035308,GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,0.539531384937239
WANG_TARGETS_OF_MLL_CBP_FUSI...1,SET,38,0.38103,0.017318,0.14146,0.0035379,WANG_TARGETS_OF_MLL_CBP_FUSION_DN,0.539531384937239
WP_MECP2_AND_ASSOCIATED_RETT...,SET,67,0.30838,0.018596,0.1145,0.0035418,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,0.539531384937239
MIR3667_5P,SET,53,0.32483,0.017428,0.12069,0.0035618,MIR3667_5P,0.539531384937239
PBXIP1_TARGET_GENES,SET,196,0.16493,0.01695,0.061283,0.0035626,PBXIP1_TARGET_GENES,0.539531384937239
HP_INCREASED_MUSCLE_FATIGUAB...,SET,16,0.57411,0.016941,0.21338,0.0035698,HP_INCREASED_MUSCLE_FATIGUABILITY,0.539531384937239
NME2_TARGET_GENES,SET,53,0.32678,0.017533,0.12149,0.0035792,NME2_TARGET_GENES,0.539531384937239
GSE27786_LSK_VS_CD4_TCELL_UP,SET,172,0.17364,0.016729,0.06466,0.0036247,GSE27786_LSK_VS_CD4_TCELL_UP,0.539531384937239
GOMF_ESTROGEN_16_ALPHA_HYDRO...,SET,8,0.96144,0.020066,0.35805,0.0036278,GOMF_ESTROGEN_16_ALPHA_HYDROXYLASE_ACTIVITY,0.539531384937239
HP_ERUPTION_FAILURE,SET,16,0.58669,0.017313,0.21856,0.0036366,HP_ERUPTION_FAILURE,0.539531384937239
GOBP_NEGATIVE_REGULATION_OF_...154,SET,11,0.82492,0.020187,0.30732,0.0036377,GOBP_NEGATIVE_REGULATION_OF_COMPLEMENT_ACTIVATION,0.539531384937239
HEBERT_MATRISOME_TNBC_LUNG_M...2,SET,6,0.84999,0.015364,0.31689,0.00366,HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED,0.539531384937239
MODULE_130,SET,18,0.59671,0.018676,0.22254,0.0036693,MODULE_130,0.539531384937239
HESS_TARGETS_OF_HOXA9_AND_ME...1,SET,79,0.27354,0.017905,0.10206,0.0036829,HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,0.539531384937239
REACTOME_DUAL_INCISION_IN_GG...,SET,38,0.31975,0.014532,0.11941,0.0037092,REACTOME_DUAL_INCISION_IN_GG_NER,0.539531384937239
MIR520G_5P,SET,53,0.31779,0.01705,0.11868,0.0037102,MIR520G_5P,0.539531384937239
KEGG_RETINOL_METABOLISM,SET,60,0.38677,0.022075,0.14473,0.0037684,KEGG_RETINOL_METABOLISM,0.542305152439024
MIR505_3P,SET,98,0.22537,0.016422,0.08444,0.0038073,MIR505_3P,0.542305152439024
MIR3908,SET,106,0.2376,0.018002,0.08905,0.0038166,MIR3908,0.542305152439024
HP_ZONULAR_CATARACT,SET,47,0.33769,0.017065,0.12662,0.0038317,HP_ZONULAR_CATARACT,0.542305152439024
WP_COVID19_AND_ENDOTHELIAL_C...,SET,5,1.1429,0.018859,0.42857,0.0038325,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,0.542305152439024
GOCC_CHLORIDE_CHANNEL_COMPLEX,SET,49,0.37213,0.0192,0.13955,0.0038349,GOCC_CHLORIDE_CHANNEL_COMPLEX,0.542305152439024
MODULE_358,SET,71,0.27302,0.016946,0.1024,0.0038385,MODULE_358,0.542305152439024
GSE7460_FOXP3_MUT_VS_WT_ACT_...3,SET,184,0.16846,0.016781,0.063322,0.0039058,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN,0.546218958333333
GSE1460_CD4_THYMOCYTE_VS_THY...1,SET,174,0.17861,0.017306,0.067135,0.0039062,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,0.546218958333333
GOBP_REGULATION_OF_OPSONIZAT...,SET,10,0.85864,0.020035,0.32287,0.0039173,GOBP_REGULATION_OF_OPSONIZATION,0.546218958333333
HP_LIMITED_NECK_RANGE_OF_MOT...,SET,8,0.90938,0.018979,0.34232,0.0039513,HP_LIMITED_NECK_RANGE_OF_MOTION,0.546218958333333
HP_HIGH_FOREHEAD,SET,261,0.14036,0.016617,0.052852,0.0039597,HP_HIGH_FOREHEAD,0.546218958333333
GOMF_INTERLEUKIN_17_RECEPTOR...,SET,8,0.86656,0.018086,0.3263,0.0039605,GOMF_INTERLEUKIN_17_RECEPTOR_ACTIVITY,0.546218958333333
GOBP_NEURON_REMODELING,SET,15,0.66733,0.019068,0.25153,0.0039917,GOBP_NEURON_REMODELING,0.548345982213439
GOBP_NEGATIVE_REGULATION_OF_...91,SET,103,0.22017,0.016446,0.083101,0.0040345,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.552043494094488
GOBP_XENOBIOTIC_CATABOLIC_PR...,SET,23,0.46286,0.016373,0.17488,0.0040674,GOBP_XENOBIOTIC_CATABOLIC_PROCESS,0.554362694117647
ACCTGTTG_UNKNOWN,SET,144,0.19485,0.01719,0.073743,0.0041206,ACCTGTTG_UNKNOWN,0.558635912451362
HP_USUAL_INTERSTITIAL_PNEUMO...,SET,13,0.66369,0.017655,0.25126,0.0041309,HP_USUAL_INTERSTITIAL_PNEUMONIA,0.558635912451362
TGTTTAC_MIR30A5P_MIR30C_MIR3...,SET,530,0.10031,0.016796,0.03801,0.0041608,TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P,0.560498465116279
GSE14000_4H_VS_16H_LPS_DC_DN,SET,161,0.16868,0.015727,0.063994,0.0041996,GSE14000_4H_VS_16H_LPS_DC_DN,0.561489236842105
GSE12198_CTRL_VS_LOW_IL2_STI...2,SET,181,0.15951,0.01576,0.060531,0.0042087,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP,0.561489236842105
GSE42088_UNINF_VS_LEISHMANIA...5,SET,178,0.17193,0.016848,0.065268,0.0042197,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN,0.561489236842105
GOCC_POTASSIUM_CHANNEL_COMPL...,SET,99,0.24961,0.01828,0.094811,0.0042397,GOCC_POTASSIUM_CHANNEL_COMPLEX,0.561489236842105
GOMF_HISTONE_UBIQUITIN_LIGAS...,SET,10,0.68903,0.016077,0.26209,0.0042853,GOMF_HISTONE_UBIQUITIN_LIGASE_ACTIVITY,0.561489236842105
TANAKA_METHYLATED_IN_ESOPHAG...,SET,97,0.2731,0.019799,0.10389,0.0042884,TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,0.561489236842105
HP_ABNORMAL_HALLUX_MORPHOLOGY,SET,177,0.17262,0.016868,0.065676,0.0042938,HP_ABNORMAL_HALLUX_MORPHOLOGY,0.561489236842105
HP_DECREASED_CIRCULATING_COM...4,SET,3,1.5199,0.019428,0.57835,0.0042974,HP_DECREASED_CIRCULATING_COMPLEMENT_FACTOR_I_CONCENTRATION,0.561489236842105
HP_HYPERAMMONEMIA,SET,66,0.26068,0.015602,0.099262,0.0043211,HP_HYPERAMMONEMIA,0.562073813114754
GOBP_RESPONSE_TO_PARATHYROID...,SET,10,0.74213,0.017316,0.28281,0.0043467,GOBP_RESPONSE_TO_PARATHYROID_HORMONE,0.562073813114754
GOBP_POTASSIUM_ION_HOMEOSTAS...,SET,34,0.40656,0.01748,0.15511,0.0043853,GOBP_POTASSIUM_ION_HOMEOSTASIS,0.562073813114754
MIR296_3P,SET,28,0.41313,0.016122,0.15766,0.0043946,MIR296_3P,0.562073813114754
REACTOME_CA2_ACTIVATED_K_CHA...,SET,9,0.79458,0.017589,0.3042,0.0045047,REACTOME_CA2_ACTIVATED_K_CHANNELS,0.562073813114754
GOMF_CALCIUM_ACTIVATED_POTAS...,SET,13,0.68656,0.018264,0.26286,0.0045057,GOMF_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY,0.562073813114754
GOBP_HEMIDESMOSOME_ASSEMBLY,SET,6,1.0262,0.01855,0.39293,0.0045077,GOBP_HEMIDESMOSOME_ASSEMBLY,0.562073813114754
TRAVAGLINI_LUNG_CLASSICAL_MO...,SET,248,0.14589,0.016841,0.055872,0.0045171,TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL,0.562073813114754
NABA_SECRETED_FACTORS,SET,318,0.14495,0.018912,0.055542,0.0045335,NABA_SECRETED_FACTORS,0.562073813114754
GSE15750_WT_VS_TRAF6KO_DAY10...2,SET,175,0.16135,0.015678,0.061884,0.004567,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP,0.562073813114754
REACTOME_FCGR_ACTIVATION,SET,12,0.68584,0.017529,0.26316,0.0045815,REACTOME_FCGR_ACTIVATION,0.562073813114754
MIR30E_3P,SET,348,0.12039,0.016418,0.046197,0.0045844,MIR30E_3P,0.562073813114754
GOBP_MICROTUBULE_NUCLEATION_...,SET,5,0.98084,0.016185,0.3764,0.0045862,GOBP_MICROTUBULE_NUCLEATION_BY_MICROTUBULE_ORGANIZING_CENTER,0.562073813114754
MIR190B_5P,SET,104,0.22871,0.017165,0.087791,0.0045961,MIR190B_5P,0.562073813114754
MIR300,SET,406,0.1137,0.01672,0.043652,0.0046023,MIR300,0.562073813114754
GOBP_SINGLE_STRAND_BREAK_REP...,SET,11,0.59679,0.014604,0.22913,0.0046035,GOBP_SINGLE_STRAND_BREAK_REPAIR,0.562073813114754
GTAAGAT_MIR200A,SET,44,0.3434,0.016792,0.13192,0.0046239,GTAAGAT_MIR200A,0.562073813114754
GOBP_GLIOGENESIS,SET,325,0.12925,0.017044,0.049655,0.004625,GOBP_GLIOGENESIS,0.562073813114754
HP_OPTIC_DISC_COLOBOMA,SET,24,0.44178,0.015963,0.16973,0.0046261,HP_OPTIC_DISC_COLOBOMA,0.562073813114754
VANHARANTA_UTERINE_FIBROID_DN,SET,59,0.32364,0.018318,0.12438,0.004636,VANHARANTA_UTERINE_FIBROID_DN,0.562073813114754
GOBP_REGULATION_OF_MYOSIN_LI...,SET,7,0.75889,0.014816,0.29184,0.0046605,GOBP_REGULATION_OF_MYOSIN_LIGHT_CHAIN_PHOSPHATASE_ACTIVITY,0.562073813114754
REACTOME_POTASSIUM_CHANNELS,SET,102,0.2457,0.018264,0.094572,0.0046915,REACTOME_POTASSIUM_CHANNELS,0.562073813114754
GSE9988_LOW_LPS_VS_ANTI_TREM...2,SET,176,0.17013,0.016578,0.065506,0.0047044,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,0.562073813114754
GOBP_REGULATION_OF_OLIGODEND...,SET,46,0.38534,0.019265,0.14856,0.0047508,GOBP_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.562073813114754
GOBP_FOREGUT_MORPHOGENESIS,SET,10,0.73946,0.017254,0.28525,0.0047706,GOBP_FOREGUT_MORPHOGENESIS,0.562073813114754
GOBP_REGULATION_OF_DNA_DAMAG...3,SET,6,0.87595,0.015833,0.33792,0.0047724,GOBP_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR,0.562073813114754
GOBP_POSITIVE_REGULATION_OF_...264,SET,72,0.26383,0.01649,0.1018,0.0047789,GOBP_POSITIVE_REGULATION_OF_EXOCYTOSIS,0.562073813114754
GSE29618_PDC_VS_MDC_DAY7_FLU...2,SET,173,0.17468,0.016877,0.067423,0.0047916,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP,0.562073813114754
HP_ABNORMAL_VISUAL_ACCOMMODA...,SET,5,0.91777,0.015144,0.35427,0.0047943,HP_ABNORMAL_VISUAL_ACCOMMODATION,0.562073813114754
HP_GENERALIZED_HYPERTRICHOSIS,SET,8,0.80135,0.016725,0.30935,0.0047969,HP_GENERALIZED_HYPERTRICHOSIS,0.562073813114754
GOBP_DISRUPTION_OF_CELLULAR_...,SET,3,1.6374,0.02093,0.63246,0.0048168,GOBP_DISRUPTION_OF_CELLULAR_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM,0.562073813114754
MIR6874_5P,SET,35,0.39753,0.017341,0.15356,0.0048198,MIR6874_5P,0.562073813114754
DIRMEIER_LMP1_RESPONSE_LATE_...2,SET,53,0.31333,0.016811,0.12112,0.0048453,DIRMEIER_LMP1_RESPONSE_LATE_UP,0.562073813114754
FIGUEROA_AML_METHYLATION_CLU...14,SET,104,0.22678,0.017021,0.087709,0.0048638,FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,0.562073813114754
GSE36476_YOUNG_VS_OLD_DONOR_...1,SET,166,0.17348,0.016422,0.067179,0.0049096,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN,0.562073813114754
GOBP_MICROTUBULE_SEVERING,SET,9,0.66601,0.014743,0.25794,0.0049156,GOBP_MICROTUBULE_SEVERING,0.562073813114754
GOCC_NURF_COMPLEX,SET,5,0.84099,0.013877,0.32572,0.0049165,GOCC_NURF_COMPLEX,0.562073813114754
DESCARTES_FETAL_INTESTINE_IN...,SET,208,0.16106,0.017046,0.062383,0.0049196,DESCARTES_FETAL_INTESTINE_INTESTINAL_EPITHELIAL_CELLS,0.562073813114754
GOBP_ENDOCARDIUM_MORPHOGENES...,SET,6,1.0786,0.019496,0.41793,0.0049326,GOBP_ENDOCARDIUM_MORPHOGENESIS,0.562073813114754
HMGIY_Q6,SET,237,0.1532,0.017294,0.059435,0.0049782,HMGIY_Q6,0.564185726384365
GOCC_PRONUCLEUS,SET,12,0.60571,0.015481,0.23502,0.0049836,GOCC_PRONUCLEUS,0.564185726384365
GOBP_CONSTITUTIVE_HETEROCHRO...,SET,8,0.74372,0.015522,0.28939,0.0050902,GOBP_CONSTITUTIVE_HETEROCHROMATIN_FORMATION,0.569585671052632
GOBP_HYPOTHALAMUS_CELL_DIFFE...,SET,11,0.79573,0.019473,0.30975,0.0051044,GOBP_HYPOTHALAMUS_CELL_DIFFERENTIATION,0.569585671052632
HP_OSTEOLYSIS_INVOLVING_BONE...2,SET,20,0.50231,0.016571,0.19556,0.0051106,HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.569585671052632
IVANOVA_HEMATOPOIESIS_LATE_P...,SET,466,0.098484,0.01549,0.038409,0.0051768,IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR,0.569585671052632
HP_LIMITED_KNEE_EXTENSION,SET,17,0.57611,0.017523,0.22469,0.0051774,HP_LIMITED_KNEE_EXTENSION,0.569585671052632
MORF_UBE2N,SET,82,0.21875,0.014587,0.085319,0.0051799,MORF_UBE2N,0.569585671052632
CAGCTTT_MIR320,SET,220,0.15472,0.016836,0.060355,0.0051843,CAGCTTT_MIR320,0.569585671052632
HP_ASYMMETRY_OF_THE_THORAX,SET,6,0.84533,0.01528,0.3299,0.0052021,HP_ASYMMETRY_OF_THE_THORAX,0.569585671052632
HP_APLASIA_OF_THE_DISTAL_PHA...,SET,5,0.87221,0.014392,0.34068,0.0052345,HP_APLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,0.569585671052632
MIR30A_3P,SET,347,0.11834,0.016116,0.046233,0.0052429,MIR30A_3P,0.569585671052632
GOBP_POSITIVE_REGULATION_OF_...588,SET,15,0.63208,0.01806,0.24718,0.0052811,GOBP_POSITIVE_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,0.569585671052632
GOMF_HISTONE_H3K27_METHYLTRA...,SET,5,0.93792,0.015477,0.36683,0.005286,GOMF_HISTONE_H3K27_METHYLTRANSFERASE_ACTIVITY,0.569585671052632
HP_CHRONIC_GASTRITIS,SET,2,1.6139,0.016844,0.63148,0.0053026,HP_CHRONIC_GASTRITIS,0.569585671052632
GSE3982_BCELL_VS_TH1_UP,SET,163,0.17114,0.016055,0.066991,0.0053179,GSE3982_BCELL_VS_TH1_UP,0.569585671052632
GOBP_POSITIVE_REGULATION_OF_...97,SET,11,0.75006,0.018355,0.29385,0.0053513,GOBP_POSITIVE_REGULATION_OF_CATECHOLAMINE_SECRETION,0.569585671052632
HP_ABNORMAL_SOFT_PALATE_MORP...,SET,224,0.14139,0.015523,0.055423,0.0053719,HP_ABNORMAL_SOFT_PALATE_MORPHOLOGY,0.569585671052632
REACTOME_CHOLINE_CATABOLISM,SET,6,0.99141,0.01792,0.38887,0.0053984,REACTOME_CHOLINE_CATABOLISM,0.569585671052632
GOBP_GRANULOCYTE_ACTIVATION,SET,45,0.32252,0.015948,0.12651,0.0054004,GOBP_GRANULOCYTE_ACTIVATION,0.569585671052632
GOBP_REGULATION_OF_PROTEIN_P...1,SET,179,0.16116,0.015836,0.063243,0.0054175,GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION,0.569585671052632
GOMF_CGMP_BINDING,SET,15,0.57453,0.016416,0.2256,0.0054415,GOMF_CGMP_BINDING,0.569585671052632
GSE20366_CD103_POS_VS_CD103_...1,SET,178,0.16352,0.016023,0.06423,0.0054551,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN,0.569585671052632
RODRIGUES_NTN1_AND_DCC_TARGE...,SET,28,0.44051,0.01719,0.17308,0.0054675,RODRIGUES_NTN1_AND_DCC_TARGETS,0.569585671052632
TFIIA_Q6,SET,231,0.14744,0.016435,0.057944,0.0054751,TFIIA_Q6,0.569585671052632
GOMF_METAL_CATION_PROTON_ANT...,SET,23,0.45204,0.01599,0.17768,0.0054824,GOMF_METAL_CATION_PROTON_ANTIPORTER_ACTIVITY,0.569585671052632
GOBP_REGULATION_OF_COLLATERA...,SET,18,0.54777,0.017144,0.21542,0.0055034,GOBP_REGULATION_OF_COLLATERAL_SPROUTING,0.569585671052632
REACTOME_HDR_THROUGH_MMEJ_AL...,SET,11,0.60197,0.014731,0.23679,0.0055124,REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ,0.569585671052632
WP_SPHINGOLIPID_PATHWAY,SET,27,0.4333,0.016605,0.17054,0.0055346,WP_SPHINGOLIPID_PATHWAY,0.569585671052632
GOCC_I_BAND,SET,137,0.19379,0.016678,0.076274,0.0055361,GOCC_I_BAND,0.569585671052632
GOBP_COMPLEMENT_DEPENDENT_CY...,SET,13,0.6782,0.018041,0.26695,0.0055386,GOBP_COMPLEMENT_DEPENDENT_CYTOTOXICITY,0.569585671052632
KASLER_HDAC7_TARGETS_1_DN,SET,16,0.57953,0.017101,0.22812,0.0055389,KASLER_HDAC7_TARGETS_1_DN,0.569585671052632
GOBP_POSITIVE_REGULATION_OF_...175,SET,9,0.7261,0.016073,0.28605,0.0055728,GOBP_POSITIVE_REGULATION_OF_COLLATERAL_SPROUTING,0.569585671052632
GOMF_SPHINGOLIPID_BINDING,SET,25,0.43359,0.01599,0.17083,0.0055762,GOMF_SPHINGOLIPID_BINDING,0.569585671052632
GSE42021_TREG_PLN_VS_CD24LO_...2,SET,171,0.1648,0.015831,0.064969,0.0056008,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_UP,0.569585671052632
GOBP_POSITIVE_REGULATION_OF_...464,SET,5,0.95243,0.015716,0.37549,0.0056024,GOBP_POSITIVE_REGULATION_OF_MIRNA_PROCESSING,0.569585671052632
MIR10B_3P,SET,72,0.24768,0.015481,0.097653,0.0056049,MIR10B_3P,0.569585671052632
KEGG_RIBOFLAVIN_METABOLISM,SET,13,0.58414,0.015539,0.23042,0.0056251,KEGG_RIBOFLAVIN_METABOLISM,0.569971867346939
FINETTI_BREAST_CANCER_KINOME...1,SET,14,0.63223,0.017453,0.24978,0.0056892,FINETTI_BREAST_CANCER_KINOME_GREEN,0.571094553824363
HE_LIM_SUN_FETAL_LUNG_C2_PDC...,SET,132,0.19259,0.016272,0.076152,0.0057226,HE_LIM_SUN_FETAL_LUNG_C2_PDC_CELL,0.571094553824363
EPPERT_HSC_R,SET,107,0.21992,0.016741,0.086967,0.005727,EPPERT_HSC_R,0.571094553824363
RPA1_TARGET_GENES,SET,38,0.35293,0.016041,0.13958,0.0057304,RPA1_TARGET_GENES,0.571094553824363
HP_ABNORMAL_BRONCHOALVEOLAR_...,SET,14,0.66368,0.018321,0.26256,0.0057453,HP_ABNORMAL_BRONCHOALVEOLAR_LAVAGE_FLUID_MORPHOLOGY,0.571094553824363
KEGG_MEDICUS_REFERENCE_PURIN...2,SET,10,0.66099,0.015423,0.26166,0.0057708,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_HYPOXANTHINE_GUANINE_TO_IMP_GMP,0.571094553824363
GSE25123_CTRL_VS_ROSIGLITAZO...4,SET,176,0.17268,0.016826,0.068357,0.0057717,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,0.571094553824363
PID_GLYPICAN_1PATHWAY,SET,26,0.44556,0.016756,0.17644,0.0057852,PID_GLYPICAN_1PATHWAY,0.571094553824363
KEGG_MEDICUS_REFERENCE_ESTAB...,SET,5,0.84187,0.013892,0.33342,0.0057896,KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION,0.571094553824363
REACTOME_MRNA_EDITING_C_TO_U...,SET,7,0.96654,0.01887,0.38289,0.0058005,REACTOME_MRNA_EDITING_C_TO_U_CONVERSION,0.571094553824363
GOBP_REGULATION_OF_BRANCHING...5,SET,5,1.0765,0.017763,0.42675,0.0058302,GOBP_REGULATION_OF_BRANCHING_MORPHOGENESIS_OF_A_NERVE,0.572057509859155
GSE41176_WT_VS_TAK1_KO_ANTI_...7,SET,183,0.15636,0.015533,0.062004,0.0058432,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN,0.572057509859155
WP_FOXP3_IN_COVID19,SET,13,0.72072,0.019172,0.2863,0.0059164,WP_FOXP3_IN_COVID19,0.577596859550562
chr3q22,SET,54,0.58011,0.031416,0.23056,0.0059388,chr3q22,0.578159647058824
HP_AREFLEXIA_OF_UPPER_LIMBS,SET,7,0.9025,0.01762,0.35891,0.0059638,HP_AREFLEXIA_OF_UPPER_LIMBS,0.578971701117318
GOCC_ESCRT_COMPLEX,SET,29,0.38705,0.015371,0.1542,0.0060391,GOCC_ESCRT_COMPLEX,0.580568185135135
GOBP_REGULATION_OF_LEUKOCYTE...5,SET,41,0.33802,0.015956,0.13475,0.0060662,GOBP_REGULATION_OF_LEUKOCYTE_DEGRANULATION,0.580568185135135
MIR6720_5P,SET,123,0.18843,0.015372,0.075148,0.0060851,MIR6720_5P,0.580568185135135
GOBP_ADP_TRANSPORT,SET,10,0.70467,0.016442,0.28112,0.0060977,GOBP_ADP_TRANSPORT,0.580568185135135
WP_GENETIC_CAUSES_OF_PORTOSI...,SET,30,0.39866,0.016103,0.15905,0.0061,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,0.580568185135135
GOBP_REELIN_MEDIATED_SIGNALI...,SET,8,0.76821,0.016033,0.30652,0.0061059,GOBP_REELIN_MEDIATED_SIGNALING_PATHWAY,0.580568185135135
WU_HBX_TARGETS_3_DN,SET,13,0.63948,0.017011,0.25533,0.0061349,WU_HBX_TARGETS_3_DN,0.580568185135135
GSE21927_SPLENIC_C26GM_TUMOR...1,SET,162,0.16461,0.015395,0.065735,0.0061421,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_DN,0.580568185135135
GOBP_RETROGRADE_TRANSPORT_EN...,SET,88,0.2084,0.014394,0.083227,0.0061437,GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI,0.580568185135135
GOBP_ANTIBACTERIAL_HUMORAL_R...,SET,48,0.37953,0.019381,0.15165,0.0061677,GOBP_ANTIBACTERIAL_HUMORAL_RESPONSE,0.580568185135135
HP_ERYTHEMATOUS_PAPULE,SET,10,0.54828,0.012793,0.21908,0.0061682,HP_ERYTHEMATOUS_PAPULE,0.580568185135135
KEGG_HEDGEHOG_SIGNALING_PATH...,SET,54,0.30329,0.016425,0.12122,0.0061807,KEGG_HEDGEHOG_SIGNALING_PATHWAY,0.580568185135135
GOBP_POSITIVE_REGULATION_OF_...795,SET,70,0.27048,0.01667,0.10825,0.0062391,GOBP_POSITIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION,0.581998983050848
SREBP1_Q6,SET,233,0.13961,0.015629,0.055886,0.0062453,SREBP1_Q6,0.581998983050848
HP_APLASIA_INVOLVING_BONES_O...2,SET,13,0.61413,0.016337,0.24596,0.0062702,HP_APLASIA_INVOLVING_BONES_OF_THE_LOWER_LIMBS,0.581998983050848
GOBP_REGULATION_OF_INTEGRIN_...1,SET,17,0.5513,0.016769,0.22106,0.0063209,GOBP_REGULATION_OF_INTEGRIN_ACTIVATION,0.581998983050848
GSE22886_NAIVE_VS_MEMORY_TCE...2,SET,175,0.15692,0.015248,0.06296,0.0063482,GSE22886_NAIVE_VS_MEMORY_TCELL_UP,0.581998983050848
GCNF_01,SET,67,0.27351,0.016493,0.10978,0.0063663,GCNF_01,0.581998983050848
HP_PROMINENT_DIGIT_PAD,SET,35,0.36435,0.015894,0.14626,0.0063713,HP_PROMINENT_DIGIT_PAD,0.581998983050848
HP_POOR_GROSS_MOTOR_COORDINA...,SET,12,0.673,0.017201,0.27029,0.0063924,HP_POOR_GROSS_MOTOR_COORDINATION,0.581998983050848
KEGG_MEDICUS_REFERENCE_ARNO_...,SET,24,0.42051,0.015195,0.16897,0.0064144,KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,0.581998983050848
GOBP_POSITIVE_REGULATION_OF_...403,SET,21,0.44878,0.01517,0.18033,0.0064148,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION,0.581998983050848
WP_NUCLEOTIDE_EXCISION_REPAI...,SET,55,0.2399,0.013111,0.096468,0.0064484,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,0.581998983050848
GAGCCTG_MIR484,SET,96,0.21506,0.015511,0.086489,0.0064535,GAGCCTG_MIR484,0.581998983050848
MIKKELSEN_MEF_HCP_WITH_H3K27...,SET,557,0.10058,0.017251,0.040448,0.0064539,MIKKELSEN_MEF_HCP_WITH_H3K27ME3,0.581998983050848
GSE2770_UNTREATED_VS_ACT_CD4...3,SET,164,0.16848,0.015853,0.067763,0.006459,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN,0.581998983050848
REACTOME_TRANSCRIPTION_COUPL...,SET,73,0.2151,0.013537,0.086614,0.0065111,REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,0.581998983050848
GSE7852_TREG_VS_TCONV_FAT_DN,SET,183,0.15567,0.015465,0.062695,0.0065199,GSE7852_TREG_VS_TCONV_FAT_DN,0.581998983050848
GOBP_INTEGRIN_BIOSYNTHETIC_P...,SET,4,1.227,0.01811,0.49437,0.0065376,GOBP_INTEGRIN_BIOSYNTHETIC_PROCESS,0.581998983050848
GOBP_BRANCHING_INVOLVED_IN_S...,SET,22,0.47684,0.016497,0.1923,0.0065804,GOBP_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,0.581998983050848
GOBP_DEFENSE_RESPONSE_TO_GRA...1,SET,77,0.27828,0.017984,0.11229,0.0066058,GOBP_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM,0.581998983050848
GOBP_CELLULAR_RESPONSE_TO_L_...1,SET,6,0.87511,0.015818,0.3533,0.00663,GOBP_CELLULAR_RESPONSE_TO_L_GLUTAMATE,0.581998983050848
GOBP_NEGATIVE_REGULATION_OF_...353,SET,4,1.1765,0.017365,0.47506,0.0066366,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY,0.581998983050848
GOBP_PLASMA_CELL_DIFFERENTIA...,SET,9,0.69011,0.015276,0.27873,0.0066495,GOBP_PLASMA_CELL_DIFFERENTIATION,0.581998983050848
GOMF_POLYAMINE_TRANSMEMBRANE...,SET,10,0.76378,0.017821,0.30859,0.006665,GOMF_POLYAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.581998983050848
MIR6747_5P,SET,40,0.32514,0.01516,0.13154,0.0067258,MIR6747_5P,0.581998983050848
GSE5589_UNSTIM_VS_180MIN_LPS...4,SET,180,0.15609,0.01538,0.063165,0.0067395,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP,0.581998983050848
GOBP_REGULATION_OF_DNA_TEMPL...1,SET,47,0.29135,0.014723,0.11795,0.0067578,GOBP_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.581998983050848
GSE41867_NAIVE_VS_DAY8_LCMV_...6,SET,181,0.14817,0.01464,0.059993,0.0067647,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,0.581998983050848
GSE32986_GMCSF_AND_CURDLAN_L...1,SET,165,0.16784,0.01584,0.067958,0.0067655,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.581998983050848
HP_CLASS_III_OBESITY,SET,5,1.2394,0.020452,0.50186,0.0067665,HP_CLASS_III_OBESITY,0.581998983050848
GSE38697_LIGHT_ZONE_VS_DARK_...1,SET,113,0.20642,0.016145,0.083619,0.0067861,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,0.581998983050848
GOCC_COSTAMERE,SET,16,0.54892,0.016198,0.2224,0.0067959,GOCC_COSTAMERE,0.581998983050848
MODULE_334,SET,146,0.17406,0.015461,0.070523,0.006796,MODULE_334,0.581998983050848
KEGG_MEDICUS_REFERENCE_MISMA...,SET,26,0.3672,0.013809,0.14879,0.0068013,KEGG_MEDICUS_REFERENCE_MISMATCH_REPAIR,0.581998983050848
GSE9988_ANTI_TREM1_VS_LOW_LP...2,SET,174,0.16401,0.015892,0.066469,0.0068077,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP,0.581998983050848
GSE11057_NAIVE_VS_MEMORY_CD4...1,SET,174,0.1631,0.015803,0.066128,0.0068283,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN,0.581998983050848
CORONEL_RFX7_DIRECT_TARGETS_...,SET,39,0.31976,0.014723,0.12973,0.0068597,CORONEL_RFX7_DIRECT_TARGETS_UP,0.581998983050848
HOEK_PBMC_INACTIVATED_INFLUE...6,SET,14,0.56541,0.015608,0.22943,0.0068668,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP,0.581998983050848
WP_FATTY_ACID_OMEGAOXIDATION,SET,15,0.61546,0.017585,0.24977,0.0068724,WP_FATTY_ACID_OMEGAOXIDATION,0.581998983050848
GSE7852_TREG_VS_TCONV_DN,SET,178,0.16211,0.015885,0.065797,0.0068783,GSE7852_TREG_VS_TCONV_DN,0.581998983050848
GOMF_PHOSPHOLIPASE_ACTIVATOR...,SET,14,0.50701,0.013996,0.20579,0.006879,GOMF_PHOSPHOLIPASE_ACTIVATOR_ACTIVITY,0.581998983050848
GOBP_URONIC_ACID_METABOLIC_P...,SET,24,0.63193,0.022834,0.25665,0.006908,GOBP_URONIC_ACID_METABOLIC_PROCESS,0.581998983050848
GOBP_DORSAL_VENTRAL_PATTERN_...,SET,88,0.24697,0.017058,0.10031,0.0069109,GOBP_DORSAL_VENTRAL_PATTERN_FORMATION,0.581998983050848
GSE19888_ADENOSINE_A3R_INH_V...1,SET,179,0.15911,0.015634,0.064629,0.006916,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN,0.581998983050848
GOCC_PCG_PROTEIN_COMPLEX,SET,44,0.30577,0.014952,0.12449,0.0070246,GOCC_PCG_PROTEIN_COMPLEX,0.589001402877698
KEGG_MEDICUS_PATHOGEN_SHIGEL...7,SET,28,0.38775,0.015132,0.15794,0.0070476,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,0.589001402877698
GOBP_CELLULAR_RESPONSE_TO_HY...1,SET,63,0.26881,0.01572,0.10951,0.0070552,GOBP_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE,0.589001402877698
MODULE_120,SET,67,0.25481,0.015365,0.10383,0.007067,MODULE_120,0.589001402877698
AMBROSINI_FLAVOPIRIDOL_TREAT...,SET,99,0.20272,0.014846,0.082669,0.0071055,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,0.589930872315036
GOBP_REGULATION_OF_DEVELOPME...2,SET,13,0.63156,0.0168,0.25759,0.0071121,GOBP_REGULATION_OF_DEVELOPMENT_HETEROCHRONIC,0.589930872315036
GOBP_REGULATION_OF_COMPLEMEN...3,SET,9,0.85866,0.019007,0.35042,0.0071403,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY,0.590555645390071
HP_MACULAR_DRUSEN,SET,5,1.1221,0.018516,0.4583,0.0071781,HP_MACULAR_DRUSEN,0.590555645390071
GSE29164_DAY3_VS_DAY7_CD8_TC...2,SET,178,0.15154,0.014849,0.061901,0.0071858,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP,0.590555645390071
GOBP_CELLULAR_RESPONSE_TO_FO...,SET,9,0.82881,0.018347,0.33857,0.0071876,GOBP_CELLULAR_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE_STIMULUS,0.590555645390071
GOBP_POSITIVE_REGULATION_OF_...614,SET,178,0.15674,0.015359,0.064066,0.0072173,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.591597314858491
MIR4753_5P,SET,156,0.17405,0.015976,0.071223,0.0072744,MIR4753_5P,0.594874757647059
GOBP_UBIQUITIN_DEPENDENT_PRO...2,SET,34,0.33467,0.014389,0.13704,0.0073051,GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.595982982394366
GOBP_HEMATOPOIETIC_STEM_CELL...2,SET,19,0.49756,0.015999,0.204,0.0073687,GOBP_HEMATOPOIETIC_STEM_CELL_HOMEOSTASIS,0.599294993071594
HP_MACROGLOSSIA,SET,134,0.17851,0.015195,0.073231,0.0073974,HP_MACROGLOSSIA,0.599294993071594
HP_ATRESIA_OF_THE_EXTERNAL_A...,SET,45,0.29942,0.014806,0.12284,0.0073978,HP_ATRESIA_OF_THE_EXTERNAL_AUDITORY_CANAL,0.599294993071594
REACTOME_RAF_INDEPENDENT_MAP...,SET,22,0.4783,0.016548,0.19633,0.0074267,REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,0.599294993071594
MIR8062,SET,97,0.21105,0.0153,0.086649,0.0074375,MIR8062,0.599294993071594
HP_LATE_ONSET,SET,122,0.19171,0.015576,0.078745,0.0074594,HP_LATE_ONSET,0.599294993071594
MIR30D_3P,SET,350,0.11211,0.015332,0.046057,0.0074664,MIR30D_3P,0.599294993071594
MIR3664_5P,SET,69,0.25198,0.015419,0.10361,0.0075128,MIR3664_5P,0.599583398169336
GOMF_PHOSPHATIDYLINOSITOL_5_...,SET,18,0.48643,0.015224,0.20008,0.0075312,GOMF_PHOSPHATIDYLINOSITOL_5_PHOSPHATE_BINDING,0.599583398169336
CSR_LATE_UP.V1_DN,SET,130,0.19478,0.016333,0.080121,0.0075318,CSR_LATE_UP.V1_DN,0.599583398169336
GOBP_CELL_SURFACE_RECEPTOR_S...1,SET,7,0.88363,0.017251,0.36352,0.007539,GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT,0.599583398169336
HP_PENOSCROTAL_HYPOSPADIAS,SET,8,0.76622,0.015992,0.31535,0.0075593,HP_PENOSCROTAL_HYPOSPADIAS,0.59982527739726
REACTOME_MISMATCH_REPAIR,SET,15,0.47266,0.013505,0.19463,0.0075855,REACTOME_MISMATCH_REPAIR,0.599883156716418
GSE10239_KLRG1INT_VS_KLRG1HI...2,SET,183,0.14762,0.014665,0.060837,0.0076291,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.599883156716418
HP_APLASIA_HYPOPLASIA_OF_THE...66,SET,178,0.15264,0.014957,0.06297,0.0076809,HP_APLASIA_HYPOPLASIA_OF_THE_SKIN,0.599883156716418
GOBP_POSITIVE_REGULATION_OF_...672,SET,23,0.45517,0.016101,0.18781,0.0076886,GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.599883156716418
GOMF_KINESIN_BINDING,SET,39,0.31121,0.014329,0.12844,0.0077002,GOMF_KINESIN_BINDING,0.599883156716418
MODULE_279,SET,122,0.18863,0.015326,0.077855,0.0077049,MODULE_279,0.599883156716418
IBRAHIM_NRF3_UP,SET,5,0.97619,0.016108,0.40292,0.0077056,IBRAHIM_NRF3_UP,0.599883156716418
MIR9902,SET,259,0.13167,0.015528,0.054374,0.0077332,MIR9902,0.599883156716418
KEGG_MEDICUS_REFERENCE_ACTIV...2,SET,23,0.41441,0.014659,0.1713,0.0077823,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES,0.599883156716418
MIR190A_5P,SET,105,0.21134,0.015938,0.087366,0.0077855,MIR190A_5P,0.599883156716418
KDM1B_TARGET_GENES,SET,110,0.19414,0.014983,0.080289,0.0078087,KDM1B_TARGET_GENES,0.599883156716418
GAUTAM_EYE_CHOROID_SCLERA_MO...,SET,120,0.18888,0.015221,0.078126,0.0078148,GAUTAM_EYE_CHOROID_SCLERA_MONOCYTES,0.599883156716418
GOMF_VOLTAGE_GATED_POTASSIUM...3,SET,11,0.72174,0.017662,0.29871,0.0078476,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION,0.599883156716418
KEGG_MEDICUS_PATHOGEN_SALMON...8,SET,19,0.45371,0.014589,0.1878,0.0078546,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY,0.599883156716418
HP_FACIAL_EDEMA,SET,122,0.19878,0.016151,0.082283,0.0078558,HP_FACIAL_EDEMA,0.599883156716418
MIR7152_5P,SET,223,0.1437,0.015741,0.059484,0.0078572,MIR7152_5P,0.599883156716418
LHX4_TARGET_GENES,SET,5,0.84258,0.013904,0.34904,0.0078935,LHX4_TARGET_GENES,0.599883156716418
GOBP_REGULATION_OF_EARLY_END...,SET,16,0.55181,0.016284,0.22862,0.0079015,GOBP_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT,0.599883156716418
HP_THIN_SKIN,SET,83,0.21924,0.014708,0.090845,0.0079094,HP_THIN_SKIN,0.599883156716418
SIRNA_EIF4GI_UP,SET,84,0.21107,0.014245,0.087555,0.0079667,SIRNA_EIF4GI_UP,0.599883156716418
MIR4266,SET,74,0.23383,0.014816,0.097028,0.0079831,MIR4266,0.599883156716418
GOBP_REGULATION_OF_VENTRICUL...3,SET,22,0.45879,0.015873,0.19046,0.0080072,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.599883156716418
MIR1185_5P,SET,53,0.27802,0.014917,0.11542,0.0080099,MIR1185_5P,0.599883156716418
HP_SEVERE_EXPRESSIVE_LANGUAG...,SET,9,0.69166,0.015311,0.28715,0.0080109,HP_SEVERE_EXPRESSIVE_LANGUAGE_DELAY,0.599883156716418
IWANAGA_CARCINOGENESIS_BY_KR...1,SET,115,0.19737,0.015572,0.081969,0.0080287,IWANAGA_CARCINOGENESIS_BY_KRAS_DN,0.599883156716418
GLASS_IGF2BP1_CLIP_TARGETS_K...,SET,105,0.19269,0.014531,0.08005,0.0080438,GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,0.599883156716418
MIR6512_3P,SET,122,0.18135,0.014735,0.075346,0.0080493,MIR6512_3P,0.599883156716418
GOBP_NEGATIVE_REGULATION_OF_...493,SET,6,0.91992,0.016628,0.38223,0.0080531,GOBP_NEGATIVE_REGULATION_OF_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.599883156716418
HP_ABNORMALITY_OF_THE_TARSAL...,SET,113,0.19815,0.015498,0.082343,0.0080611,HP_ABNORMALITY_OF_THE_TARSAL_BONES,0.599883156716418
GOBP_REGULATION_OF_HEART_RAT...1,SET,39,0.36951,0.017013,0.15363,0.008088,GOBP_REGULATION_OF_HEART_RATE_BY_CARDIAC_CONDUCTION,0.599883156716418
MANNO_MIDBRAIN_NEUROTYPES_HO...2,SET,324,0.12454,0.016399,0.051788,0.0080951,MANNO_MIDBRAIN_NEUROTYPES_HOPC,0.599883156716418
HP_INTRAALVEOLAR_PHOSPHOLIPI...,SET,7,0.88554,0.017289,0.36849,0.0081316,HP_INTRAALVEOLAR_PHOSPHOLIPID_ACCUMULATION,0.600516222929936
GSE17721_CTRL_VS_LPS_1H_BMDC...2,SET,176,0.1502,0.014636,0.062508,0.0081382,GSE17721_CTRL_VS_LPS_1H_BMDC_UP,0.600516222929936
GSE21927_BALBC_VS_C57BL6_MON...3,SET,160,0.15737,0.014627,0.065577,0.0082096,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_DN,0.602959007368421
GOMF_N6_METHYLADENOSINE_CONT...,SET,11,0.63535,0.015548,0.26477,0.008211,GOMF_N6_METHYLADENOSINE_CONTAINING_RNA_READER_ACTIVITY,0.602959007368421
GOBP_POSITIVE_REGULATION_OF_...710,SET,33,0.36156,0.015316,0.15072,0.0082267,GOBP_POSITIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,0.602959007368421
HP_CYANOTIC_EPISODE,SET,7,0.8803,0.017186,0.36705,0.0082407,HP_CYANOTIC_EPISODE,0.602959007368421
HOWARD_MONOCYTE_INACT_MONOV_...2,SET,203,0.1566,0.016376,0.06537,0.0083022,HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.60413477348643
HP_BIFID_NASAL_TIP,SET,13,0.54135,0.014401,0.22603,0.0083141,HP_BIFID_NASAL_TIP,0.60413477348643
HP_ABNORMAL_UMBILICUS_MORPHO...,SET,265,0.1263,0.015064,0.052735,0.0083166,HP_ABNORMAL_UMBILICUS_MORPHOLOGY,0.60413477348643
MIR1277_5P,SET,820,0.075049,0.015503,0.031342,0.0083263,MIR1277_5P,0.60413477348643
GOBP_OVULATION_CYCLE,SET,71,0.25797,0.016012,0.10779,0.0083565,GOBP_OVULATION_CYCLE,0.605062828125
TRAVAGLINI_LUNG_ALVEOLAR_FIB...,SET,149,0.1847,0.016572,0.077226,0.0083903,TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL,0.605548899590164
GOMF_MITOGEN_ACTIVATED_PROTE...1,SET,29,0.38122,0.01514,0.15949,0.0084249,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING,0.605548899590164
HP_APLASIA_HYPOPLASIA_OF_THE...46,SET,7,0.97958,0.019125,0.40999,0.008446,HP_APLASIA_HYPOPLASIA_OF_THE_NASAL_BONE,0.605548899590164
KEGG_MEDICUS_REFERENCE_CITRA...2,SET,10,0.56834,0.013261,0.23796,0.008466,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_SECOND_CARBON_OXIDATION_2,0.605548899590164
GOBP_REGULATION_OF_RESPIRATO...2,SET,7,0.82387,0.016085,0.34499,0.0084726,GOBP_REGULATION_OF_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.605548899590164
MISIAK_ANAPLASTIC_THYROID_CA...2,SET,44,0.32523,0.015903,0.13622,0.0084876,MISIAK_ANAPLASTIC_THYROID_CARCINOMA_UP,0.605548899590164
GSE13522_CTRL_VS_T_CRUZI_Y_S...7,SET,128,0.17101,0.01423,0.071631,0.0084881,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_DN,0.605548899590164
E2F1_UP.V1_UP,SET,172,0.14682,0.014145,0.061512,0.0085026,E2F1_UP.V1_UP,0.605548899590164
HP_DEVIATION_OF_TOES,SET,103,0.20963,0.015658,0.087884,0.0085379,HP_DEVIATION_OF_TOES,0.605673257142857
GSE18893_CTRL_VS_TNF_TREATED...2,SET,179,0.14969,0.014709,0.062755,0.0085392,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP,0.605673257142857
GOBP_REGULATION_OF_PLASMA_CE...,SET,6,0.79257,0.014326,0.33244,0.0085657,GOBP_REGULATION_OF_PLASMA_CELL_DIFFERENTIATION,0.606315485743381
GOBP_KINETOCHORE_ASSEMBLY,SET,16,0.48631,0.014351,0.20408,0.0085915,GOBP_KINETOCHORE_ASSEMBLY,0.606905655487805
GSE11864_CSF1_VS_CSF1_IFNG_P...1,SET,173,0.14933,0.014427,0.062703,0.0086264,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.608134953346856
KEGG_DRUG_METABOLISM_OTHER_E...,SET,48,0.35496,0.018127,0.14921,0.0086874,KEGG_DRUG_METABOLISM_OTHER_ENZYMES,0.610360990909091
GOMF_VOLTAGE_GATED_MONOATOMI...1,SET,14,0.53208,0.014688,0.22369,0.0086931,GOMF_VOLTAGE_GATED_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.610360990909091
GAUSSMANN_MLL_AF4_FUSION_TAR...7,SET,10,0.67726,0.015802,0.28499,0.0087452,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN,0.611798552683897
GSE31082_DN_VS_CD4_SP_THYMOC...1,SET,180,0.14929,0.01471,0.062872,0.0087921,GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN,0.611798552683897
GOBP_NEGATIVE_REGULATION_OF_...598,SET,31,0.32,0.013139,0.1348,0.0088055,GOBP_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,0.611798552683897
GSE30083_SP2_VS_SP3_THYMOCYT...2,SET,185,0.16151,0.016131,0.068039,0.0088084,GSE30083_SP2_VS_SP3_THYMOCYTE_UP,0.611798552683897
GOBP_IMP_METABOLIC_PROCESS,SET,15,0.52437,0.014983,0.22101,0.0088351,GOBP_IMP_METABOLIC_PROCESS,0.611798552683897
GSE9988_LPS_VS_LPS_AND_ANTI_...2,SET,177,0.1535,0.014999,0.064694,0.0088358,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP,0.611798552683897
HOLLEMAN_DAUNORUBICIN_ALL_UP,SET,6,0.8487,0.015341,0.35781,0.0088525,HOLLEMAN_DAUNORUBICIN_ALL_UP,0.611798552683897
HP_APLASIA_HYPOPLASIA_OF_THE...54,SET,3,1.1756,0.015028,0.49566,0.0088544,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_5TH_TOE,0.611798552683897
GOMF_PURINE_RIBONUCLEOTIDE_T...,SET,20,0.49022,0.016172,0.20682,0.0088921,GOMF_PURINE_RIBONUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.613130401185771
HP_PULMONARY_CYST,SET,26,0.42711,0.016062,0.18026,0.0089122,HP_PULMONARY_CYST,0.613130401185771
GOBP_POSITIVE_REGULATION_OF_...359,SET,11,0.65541,0.016039,0.27668,0.0089266,GOBP_POSITIVE_REGULATION_OF_INTEGRIN_ACTIVATION,0.613130401185771
GOBP_IMMUNE_RESPONSE_REGULAT...2,SET,21,0.47279,0.015982,0.19971,0.008962,GOBP_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_PHAGOCYTOSIS,0.61351468996063
HP_RETINAL_FLECKS,SET,8,0.76533,0.015973,0.32331,0.0089675,HP_RETINAL_FLECKS,0.61351468996063
WP_NRF2ARE_REGULATION,SET,23,0.43586,0.015418,0.18421,0.0089952,WP_NRF2ARE_REGULATION,0.613746041176471
REACTOME_PARASITE_INFECTION,SET,56,0.26832,0.014797,0.11343,0.0090062,REACTOME_PARASITE_INFECTION,0.613746041176471
ATAGGAA_MIR202,SET,95,0.21518,0.015439,0.091058,0.0090677,ATAGGAA_MIR202,0.616727815068493
KATSANOU_ELAVL1_TARGETS_DN,SET,133,0.18258,0.015484,0.077303,0.0090982,KATSANOU_ELAVL1_TARGETS_DN,0.616887726653697
HP_METAMORPHOPSIA,SET,17,0.49961,0.015196,0.21161,0.0091174,HP_METAMORPHOPSIA,0.616887726653697
GOBP_NEGATIVE_REGULATION_OF_...499,SET,12,0.60721,0.015519,0.25721,0.0091233,GOBP_NEGATIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.616887726653697
HP_ANKLE_PAIN,SET,5,0.94264,0.015555,0.3998,0.0091976,HP_ANKLE_PAIN,0.620704054368932
MIR6742_5P,SET,40,0.31736,0.014798,0.13471,0.0092436,MIR6742_5P,0.621772317567568
GOBP_REGULATION_OF_GONAD_DEV...,SET,12,0.6469,0.016534,0.27461,0.0092499,GOBP_REGULATION_OF_GONAD_DEVELOPMENT,0.621772317567568
GSE1460_NAIVE_CD4_TCELL_CORD...1,SET,173,0.15184,0.01467,0.064475,0.0092671,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN,0.621772317567568
VALK_AML_WITH_CEBPA,SET,31,0.41015,0.01684,0.17428,0.009306,VALK_AML_WITH_CEBPA,0.622802916346154
GOBP_COMMON_MYELOID_PROGENIT...,SET,9,0.66106,0.014633,0.28095,0.0093183,GOBP_COMMON_MYELOID_PROGENITOR_CELL_PROLIFERATION,0.622802916346154
MIR3666,SET,353,0.10984,0.015084,0.046749,0.0094021,MIR3666,0.62719766890595
GOMF_TRNA_URIDINE_METHYLTRAN...,SET,3,0.90211,0.011531,0.38426,0.0094519,GOMF_TRNA_URIDINE_METHYLTRANSFERASE_ACTIVITY,0.629311847701149
MIR454_3P,SET,386,0.10432,0.014967,0.044454,0.0094739,MIR454_3P,0.629570543977055
ZNF530_TARGET_GENES,SET,23,0.4454,0.015755,0.18994,0.0095193,ZNF530_TARGET_GENES,0.631380289122137
AKT_UP_MTOR_DN.V1_DN,SET,173,0.15048,0.014539,0.064243,0.0095854,AKT_UP_MTOR_DN.V1_DN,0.633767261320755
HP_ABNORMAL_CILIARY_BODY_MOR...,SET,6,0.7616,0.013766,0.32541,0.0096363,HP_ABNORMAL_CILIARY_BODY_MORPHOLOGY,0.633767261320755
WP_MATRIX_METALLOPROTEINASES,SET,28,0.41645,0.016252,0.17794,0.0096367,WP_MATRIX_METALLOPROTEINASES,0.633767261320755
HP_CLEFT_ALA_NASI,SET,4,1.2028,0.017753,0.5141,0.0096561,HP_CLEFT_ALA_NASI,0.633767261320755
GOMF_PROTEIN_RNA_ADAPTOR_ACT...,SET,18,0.4805,0.015039,0.2054,0.0096638,GOMF_PROTEIN_RNA_ADAPTOR_ACTIVITY,0.633767261320755
NAKAYA_B_CELL_FLUMIST_AGE_18...1,SET,346,0.10725,0.014584,0.045846,0.0096647,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN,0.633767261320755
ACTWSNACTNY_UNKNOWN,SET,96,0.18908,0.013638,0.080858,0.0096875,ACTWSNACTNY_UNKNOWN,0.634066031073446
HP_OSTEOLYTIC_DEFECTS_OF_THE...,SET,5,0.80677,0.013313,0.3452,0.0097229,HP_OSTEOLYTIC_DEFECTS_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,0.635186822368421
GOBP_PROTEIN_POLYMERIZATION,SET,253,0.1248,0.014549,0.053464,0.0097978,GOBP_PROTEIN_POLYMERIZATION,0.638182298713235
REACTOME_MAPK1_ERK2_ACTIVATI...,SET,9,0.69681,0.015425,0.29862,0.0098175,REACTOME_MAPK1_ERK2_ACTIVATION,0.638182298713235
GOBP_REGULATION_OF_LOW_DENSI...,SET,15,0.53401,0.015258,0.22909,0.0098826,GOBP_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.638182298713235
GOBP_POSITIVE_REGULATION_OF_...366,SET,26,0.43175,0.016237,0.18529,0.0099055,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION,0.638182298713235
GOBP_POSITIVE_REGULATION_OF_...376,SET,58,0.27277,0.015308,0.1171,0.009927,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,0.638182298713235
HP_CROHN_S_DISEASE,SET,13,0.67644,0.017994,0.29041,0.0099291,HP_CROHN_S_DISEASE,0.638182298713235
TAKADA_GASTRIC_CANCER_COPY_N...1,SET,28,0.43766,0.017079,0.18793,0.0099381,TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,0.638182298713235
GOBP_NEUTRAL_LIPID_BIOSYNTHE...,SET,45,0.2861,0.014148,0.12286,0.0099444,GOBP_NEUTRAL_LIPID_BIOSYNTHETIC_PROCESS,0.638182298713235
MIR564,SET,14,0.56166,0.015504,0.24126,0.0099602,MIR564,0.638182298713235
GSE3982_MAC_VS_CENT_MEMORY_C...2,SET,179,0.14342,0.014093,0.061618,0.0099717,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP,0.638182298713235
GSE17721_LPS_VS_GARDIQUIMOD_...14,SET,177,0.14649,0.014314,0.062939,0.0099756,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_UP,0.638182298713235
GOBP_MEGAKARYOCYTE_DIFFERENT...,SET,47,0.30278,0.0153,0.13012,0.0099891,GOBP_MEGAKARYOCYTE_DIFFERENTIATION,0.638182298713235
chr15q11,SET,8,0.9601,0.020038,0.41318,0.010077,chr15q11,0.64261676146789
GSE6259_FLT3L_INDUCED_33D1_P...1,SET,176,0.14376,0.014009,0.061924,0.010132,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN,0.644352663043478
GOBP_NEGATIVE_REGULATION_OF_...107,SET,9,0.66892,0.014807,0.28829,0.010167,GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.644352663043478
TIEN_INTESTINE_PROBIOTICS_2H...1,SET,83,0.22474,0.015077,0.096875,0.01018,TIEN_INTESTINE_PROBIOTICS_2HR_DN,0.644352663043478
HP_ABNORMAL_CORNEAL_REFLEX,SET,11,0.54094,0.013237,0.23319,0.010184,HP_ABNORMAL_CORNEAL_REFLEX,0.644352663043478
GSE2770_TGFB_AND_IL4_ACT_VS_...6,SET,177,0.14368,0.01404,0.061954,0.010201,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,0.644352663043478
GOMF_3_KETO_STEROL_REDUCTASE...,SET,5,0.89637,0.014791,0.38665,0.010223,GOMF_3_KETO_STEROL_REDUCTASE_ACTIVITY,0.644352663043478
MIR297,SET,130,0.1805,0.015135,0.077872,0.010234,MIR297,0.644352663043478
MIR4437,SET,96,0.2036,0.014685,0.087873,0.010258,MIR4437,0.64469582278481
DESCARTES_FETAL_MUSCLE_MEGAK...,SET,195,0.13944,0.014295,0.06021,0.010286,DESCARTES_FETAL_MUSCLE_MEGAKARYOCYTES,0.645288682310469
MIR301A_3P,SET,352,0.10841,0.014867,0.046843,0.01033,MIR301A_3P,0.645842913669065
GOMF_INTERLEUKIN_6_RECEPTOR_...,SET,6,0.75107,0.013576,0.32454,0.010332,GOMF_INTERLEUKIN_6_RECEPTOR_BINDING,0.645842913669065
GOBP_BERGMANN_GLIAL_CELL_DIF...,SET,10,0.59986,0.013997,0.25938,0.010375,GOBP_BERGMANN_GLIAL_CELL_DIFFERENTIATION,0.647366472172352
GOBP_B_CELL_ACTIVATION_INVOL...,SET,75,0.22774,0.014527,0.098588,0.01045,GOBP_B_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.650877688172043
GOBP_REGULATION_OF_TELOMERE_...3,SET,19,0.42685,0.013725,0.18486,0.010477,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE_IN_RESPONSE_TO_DNA_DAMAGE,0.651392012522361
HP_HYPERLORDOSIS,SET,184,0.14676,0.014619,0.063636,0.010553,HP_HYPERLORDOSIS,0.653497574503311
GOBP_POSITIVE_REGULATION_OF_...288,SET,26,0.37992,0.014287,0.16479,0.010575,GOBP_POSITIVE_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY,0.653497574503311
GOBP_CHROMATIN_LOOPING,SET,10,0.57006,0.013301,0.24731,0.010588,GOBP_CHROMATIN_LOOPING,0.653497574503311
HP_LIMITATION_OF_KNEE_MOBILI...,SET,30,0.38079,0.015381,0.16524,0.010604,HP_LIMITATION_OF_KNEE_MOBILITY,0.653497574503311
GOBP_TONGUE_MORPHOGENESIS,SET,9,0.74322,0.016452,0.32269,0.010639,GOBP_TONGUE_MORPHOGENESIS,0.653497574503311
MIR149_5P,SET,133,0.16421,0.013926,0.071329,0.010668,MIR149_5P,0.653497574503311
GSE39820_CTRL_VS_TGFBETA3_IL...2,SET,177,0.14277,0.013951,0.062015,0.010668,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP,0.653497574503311
GOBP_MHC_CLASS_II_BIOSYNTHET...,SET,19,0.46082,0.014817,0.20025,0.010695,GOBP_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.653497574503311
GOMF_PROSTAGLANDIN_E_RECEPTO...,SET,5,1.0181,0.0168,0.44276,0.010743,GOMF_PROSTAGLANDIN_E_RECEPTOR_ACTIVITY,0.653497574503311
GOMF_OPSONIN_RECEPTOR_ACTIVI...,SET,4,1.1117,0.016408,0.48354,0.010758,GOMF_OPSONIN_RECEPTOR_ACTIVITY,0.653497574503311
MIR7977,SET,207,0.13736,0.014504,0.059752,0.010761,MIR7977,0.653497574503311
GOBP_REGULATION_OF_REGULATED...,SET,104,0.19283,0.014472,0.083908,0.010785,GOBP_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,0.653497574503311
MYLLYKANGAS_AMPLIFICATION_HO...18,SET,12,0.59028,0.015087,0.2569,0.010796,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8,0.653497574503311
HP_CRACKLES,SET,21,0.46706,0.015788,0.20338,0.010829,HP_CRACKLES,0.653497574503311
HP_AGENESIS_OF_CEREBELLAR_VE...,SET,16,0.44319,0.013078,0.19309,0.010866,HP_AGENESIS_OF_CEREBELLAR_VERMIS,0.653497574503311
DAZARD_RESPONSE_TO_UV_SCC_UP,SET,88,0.20358,0.014061,0.088746,0.010901,DAZARD_RESPONSE_TO_UV_SCC_UP,0.653497574503311
GSE3920_UNTREATED_VS_IFNG_TR...1,SET,174,0.14285,0.013841,0.062278,0.01091,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,0.653497574503311
HALLMARK_COMPLEMENT,SET,191,0.14806,0.015023,0.064558,0.010918,HALLMARK_COMPLEMENT,0.653497574503311
LIU_PROSTATE_CANCER_UP,SET,86,0.22358,0.015267,0.097545,0.010958,LIU_PROSTATE_CANCER_UP,0.653497574503311
HP_ABSENT_DISTAL_PHALANGES,SET,6,0.85133,0.015388,0.37145,0.010961,HP_ABSENT_DISTAL_PHALANGES,0.653497574503311
HP_CUTANEOUS_PHOTOSENSITIVITY,SET,94,0.19349,0.01381,0.084508,0.011027,HP_CUTANEOUS_PHOTOSENSITIVITY,0.653497574503311
HP_ABNORMAL_SWEAT_GLAND_MORP...,SET,18,0.49672,0.015546,0.217,0.011044,HP_ABNORMAL_SWEAT_GLAND_MORPHOLOGY,0.653497574503311
GSE13522_CTRL_VS_T_CRUZI_G_S...2,SET,185,0.14288,0.014271,0.06243,0.011055,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP,0.653497574503311
GOBP_ACTIN_POLYMERIZATION_OR...,SET,171,0.15101,0.014507,0.065986,0.011059,GOBP_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION,0.653497574503311
GSE40274_SATB1_VS_FOXP3_AND_...2,SET,155,0.15108,0.013823,0.066015,0.01106,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.653497574503311
GOBP_MITOTIC_RECOMBINATION,SET,24,0.34693,0.012536,0.1516,0.011063,GOBP_MITOTIC_RECOMBINATION,0.653497574503311
GSE17721_0.5H_VS_24H_LPS_BMD...1,SET,183,0.14075,0.013982,0.061547,0.01111,GSE17721_0.5H_VS_24H_LPS_BMDC_DN,0.653497574503311
GOBP_NEGATIVE_REGULATION_OF_...677,SET,5,0.95685,0.015789,0.41847,0.011117,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MIGRATION,0.653497574503311
CAO_BLOOD_FLUZONE_AGE_05_14Y...3,SET,7,0.71591,0.013977,0.31322,0.011144,CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_DN,0.653497574503311
HP_CONGENITAL_LOCALIZED_ABSE...,SET,9,0.62078,0.013742,0.27163,0.01115,HP_CONGENITAL_LOCALIZED_ABSENCE_OF_SKIN,0.653497574503311
ROVERSI_GLIOMA_COPY_NUMBER_UP,SET,80,0.27005,0.017788,0.11819,0.011167,ROVERSI_GLIOMA_COPY_NUMBER_UP,0.653497574503311
MODULE_39,SET,9,0.63267,0.014005,0.27691,0.01117,MODULE_39,0.653497574503311
GOBP_REGULATION_OF_DEPHOSPHO...,SET,92,0.19656,0.01388,0.086066,0.011197,GOBP_REGULATION_OF_DEPHOSPHORYLATION,0.653497574503311
HP_LIMB_TREMOR,SET,20,0.45739,0.015089,0.20031,0.011211,HP_LIMB_TREMOR,0.653497574503311
SWEET_KRAS_TARGETS_UP,SET,74,0.24998,0.015839,0.10949,0.011217,SWEET_KRAS_TARGETS_UP,0.653497574503311
E47_02,SET,222,0.13811,0.015095,0.060517,0.011247,E47_02,0.653497574503311
GOBP_NEGATIVE_REGULATION_OF_...567,SET,9,0.71577,0.015844,0.31369,0.011258,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,0.653497574503311
GSE39820_TGFBETA1_VS_TGFBETA...4,SET,184,0.13681,0.013627,0.059961,0.011263,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP,0.653497574503311
GOBP_REGULATION_OF_PROTEIN_D...3,SET,77,0.21287,0.013758,0.093319,0.011276,GOBP_REGULATION_OF_PROTEIN_DEPOLYMERIZATION,0.653497574503311
PEDERSEN_METASTASIS_BY_ERBB2...4,SET,11,0.6483,0.015865,0.28421,0.011278,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5,0.653497574503311
HP_INAPPROPRIATE_CRYING,SET,14,0.51501,0.014217,0.22586,0.011305,HP_INAPPROPRIATE_CRYING,0.653497574503311
GOBP_UV_PROTECTION,SET,11,0.50041,0.012246,0.21953,0.011327,GOBP_UV_PROTECTION,0.653497574503311
GOMF_HYDROLASE_ACTIVITY_ACTI...4,SET,32,0.3828,0.015968,0.16795,0.011335,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES,0.653497574503311
GOBP_REGULATION_OF_EXIT_FROM...,SET,16,0.48603,0.014342,0.21327,0.011342,GOBP_REGULATION_OF_EXIT_FROM_MITOSIS,0.653497574503311
GSE13738_RESTING_VS_TCR_ACTI...2,SET,155,0.15408,0.014098,0.067627,0.011357,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP,0.653497574503311
GOBP_TRICARBOXYLIC_ACID_TRAN...,SET,5,0.77745,0.012829,0.34143,0.011398,GOBP_TRICARBOXYLIC_ACID_TRANSPORT,0.65415103960396
HP_2_4_TOE_CUTANEOUS_SYNDACT...,SET,4,1.1814,0.017436,0.51887,0.011406,HP_2_4_TOE_CUTANEOUS_SYNDACTYLY,0.65415103960396
TIEN_INTESTINE_PROBIOTICS_6H...1,SET,159,0.15439,0.014306,0.067885,0.011482,TIEN_INTESTINE_PROBIOTICS_6HR_DN,0.657320344827586
RREB1_01,SET,191,0.14127,0.014334,0.062134,0.011501,RREB1_01,0.657320344827586
GOBP_SALIVARY_GLAND_DEVELOPM...,SET,36,0.33162,0.014671,0.14589,0.011518,GOBP_SALIVARY_GLAND_DEVELOPMENT,0.657320344827586
GSE18791_CTRL_VS_NEWCASTLE_V...4,SET,177,0.14004,0.013684,0.06164,0.011553,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP,0.657846274509804
GSE6092_IFNG_VS_IFNG_AND_B_B...2,SET,166,0.15462,0.014636,0.068082,0.011577,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,0.657846274509804
GOBP_NEGATIVE_REGULATION_OF_...104,SET,11,0.5073,0.012414,0.22339,0.011584,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.657846274509804
GOCC_PRESYNAPTIC_CYTOSKELETON,SET,10,0.60193,0.014045,0.26548,0.011692,GOCC_PRESYNAPTIC_CYTOSKELETON,0.66289634584013
WP_CONSTITUTIVE_ANDROSTANE_R...,SET,29,0.37629,0.014944,0.1661,0.011747,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,0.664929942996743
GOMF_CHROMATIN_DNA_BINDING,SET,95,0.19483,0.013979,0.086129,0.011852,GOMF_CHROMATIN_DNA_BINDING,0.669639286871961
MIR381_3P,SET,407,0.098281,0.014471,0.043462,0.011876,MIR381_3P,0.669639286871961
GOBP_INFLAMMATORY_CELL_APOPT...,SET,21,0.41699,0.014095,0.18443,0.011888,GOBP_INFLAMMATORY_CELL_APOPTOTIC_PROCESS,0.669639286871961
GOBP_ALLANTOIN_METABOLIC_PRO...,SET,9,0.70781,0.015668,0.31327,0.011934,GOBP_ALLANTOIN_METABOLIC_PROCESS,0.670011583601286
MIR301B_3P,SET,351,0.10593,0.014507,0.046892,0.011947,MIR301B_3P,0.670011583601286
GOBP_PHENYLPROPANOID_METABOL...,SET,7,0.81138,0.015841,0.35932,0.011975,GOBP_PHENYLPROPANOID_METABOLIC_PROCESS,0.670011583601286
GSE16385_MONOCYTE_VS_12H_IL4...1,SET,187,0.13022,0.013075,0.057677,0.011989,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN,0.670011583601286
HP_INTRACTABLE_DIARRHEA,SET,6,0.90698,0.016394,0.40174,0.011991,HP_INTRACTABLE_DIARRHEA,0.670011583601286
REACTOME_ALPHA_DEFENSINS,SET,6,0.93229,0.016852,0.41327,0.012045,REACTOME_ALPHA_DEFENSINS,0.671948595505618
HP_AMELOGENESIS_IMPERFECTA,SET,31,0.35743,0.014675,0.15857,0.0121,HP_AMELOGENESIS_IMPERFECTA,0.673614081469649
REACTOME_MISCELLANEOUS_SUBST...,SET,12,0.62171,0.01589,0.27588,0.012118,REACTOME_MISCELLANEOUS_SUBSTRATES,0.673614081469649
GOBP_POSITIVE_REGULATION_OF_...170,SET,16,0.51541,0.015209,0.22876,0.012133,GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM,0.673614081469649
MIR6809_3P,SET,504,0.090434,0.014777,0.040172,0.012193,MIR6809_3P,0.674578
BUSSLINGER_DUODENAL_LATE_IMM...,SET,164,0.15553,0.014634,0.069101,0.012207,BUSSLINGER_DUODENAL_LATE_IMMATURE_ENTEROCYTES,0.674578
GSE3982_MEMORY_CD4_TCELL_VS_...6,SET,172,0.1464,0.014105,0.065052,0.012212,GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP,0.674578
REACTOME_GLOBAL_GENOME_NUCLE...,SET,79,0.19149,0.012535,0.085105,0.012228,REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,0.674578
SMID_BREAST_CANCER_RELAPSE_I...3,SET,76,0.23303,0.014963,0.10364,0.012278,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,0.674803516483517
HP_PULVERULENT_CATARACT,SET,11,0.62389,0.015267,0.27765,0.012324,HP_PULVERULENT_CATARACT,0.674803516483517
GOBP_GLIAL_CELL_DIFFERENTIAT...,SET,247,0.12758,0.014699,0.056784,0.012332,GOBP_GLIAL_CELL_DIFFERENTIATION,0.674803516483517
GSE39110_UNTREATED_VS_IL2_TR...2,SET,182,0.14627,0.014492,0.06511,0.01234,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP,0.674803516483517
HP_PILL_ROLLING_TREMOR,SET,4,1.0866,0.016037,0.48367,0.012343,HP_PILL_ROLLING_TREMOR,0.674803516483517
GSE40443_INDUCED_VS_TOTAL_TR...1,SET,179,0.14348,0.014098,0.063888,0.012367,GSE40443_INDUCED_VS_TOTAL_TREG_DN,0.674803516483517
HP_ABNORMAL_PREIMPLANTATION_...,SET,6,0.65417,0.011825,0.2913,0.012368,HP_ABNORMAL_PREIMPLANTATION_EMBRYONIC_DEVELOPMENT,0.674803516483517
HP_HYPOPLASTIC_FINGERNAIL,SET,46,0.29464,0.014731,0.13141,0.012484,HP_HYPOPLASTIC_FINGERNAIL,0.677130696594427
GTTTGTT_MIR495,SET,228,0.13047,0.014449,0.058207,0.012507,GTTTGTT_MIR495,0.677130696594427
MIR6734_3P,SET,134,0.16497,0.014043,0.073611,0.012514,MIR6734_3P,0.677130696594427
GOMF_PHOSPHOPROTEIN_BINDING,SET,86,0.20348,0.013894,0.09083,0.012544,GOMF_PHOSPHOPROTEIN_BINDING,0.677130696594427
CYTAGCAAY_UNKNOWN,SET,135,0.16049,0.013712,0.071649,0.012553,CYTAGCAAY_UNKNOWN,0.677130696594427
PHF21A_TARGET_GENES,SET,224,0.12901,0.014164,0.057609,0.012571,PHF21A_TARGET_GENES,0.677130696594427
REACTOME_NUCLEOTIDE_EXCISION...,SET,103,0.16725,0.012492,0.074687,0.012573,REACTOME_NUCLEOTIDE_EXCISION_REPAIR,0.677130696594427
GOBP_MEMBRANE_REPOLARIZATION...3,SET,14,0.5799,0.016008,0.25901,0.012586,GOBP_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.677130696594427
GSE41867_DAY8_EFFECTOR_VS_DA...1,SET,178,0.14256,0.013969,0.063673,0.012586,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,0.677130696594427
GOCC_MONOATOMIC_ION_CHANNEL_...,SET,319,0.11838,0.015469,0.052923,0.012656,GOCC_MONOATOMIC_ION_CHANNEL_COMPLEX,0.678956087962963
REACTOME_TRANSCRIPTIONAL_REG...14,SET,12,0.59943,0.015321,0.268,0.012659,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_TESTIS_DIFFERENTIATION,0.678956087962963
WP_DENGUE2_INTERACTIONS_WITH...,SET,53,0.28815,0.01546,0.12895,0.01273,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.681358407692308
HP_ADRENOCORTICAL_ADENOMA,SET,9,0.7225,0.015993,0.32339,0.012743,HP_ADRENOCORTICAL_ADENOMA,0.681358407692308
WP_OVARIAN_INFERTILITY,SET,38,0.30399,0.013816,0.13626,0.012847,WP_OVARIAN_INFERTILITY,0.681484639175258
HP_ABNORMAL_UVULA_MORPHOLOGY,SET,168,0.14259,0.013578,0.063915,0.01285,HP_ABNORMAL_UVULA_MORPHOLOGY,0.681484639175258
REACTOME_RHO_GTPASES_ACTIVAT...10,SET,33,0.31391,0.013297,0.14071,0.012851,REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,0.681484639175258
KEGG_MEDICUS_PATHOGEN_ESCHER...6,SET,13,0.49126,0.013068,0.22025,0.012863,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_CDC42_SIGNALING_PATHWAY,0.681484639175258
GSE36078_WT_VS_IL1R_KO_LUNG_...5,SET,176,0.14213,0.013849,0.06377,0.012922,GSE36078_WT_VS_IL1R_KO_LUNG_DC_DN,0.681484639175258
KEGG_MEDICUS_PATHOGEN_SALMON...4,SET,29,0.34725,0.013791,0.15589,0.012963,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,0.681484639175258
GOBP_REGULATION_OF_ESTABLISH...5,SET,5,0.88706,0.014637,0.3984,0.012995,GOBP_REGULATION_OF_ESTABLISHMENT_OF_T_CELL_POLARITY,0.681484639175258
GOCC_BASAL_PART_OF_CELL,SET,297,0.11683,0.014739,0.052481,0.01301,GOCC_BASAL_PART_OF_CELL,0.681484639175258
MIR130A_3P,SET,356,0.10364,0.014291,0.046582,0.013052,MIR130A_3P,0.681484639175258
HP_UPPER_LIMB_POSTURAL_TREMOR,SET,10,0.68706,0.016031,0.30889,0.013071,HP_UPPER_LIMB_POSTURAL_TREMOR,0.681484639175258
MIR150_3P,SET,118,0.17246,0.013782,0.077557,0.01309,MIR150_3P,0.681484639175258
OSF2_Q6,SET,245,0.12533,0.014382,0.056365,0.013096,OSF2_Q6,0.681484639175258
ACATATC_MIR190,SET,54,0.28307,0.01533,0.12733,0.013112,ACATATC_MIR190,0.681484639175258
GSE36078_WT_VS_IL1R_KO_LUNG_...4,SET,181,0.14213,0.014043,0.063943,0.013121,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_UP,0.681484639175258
MODULE_480,SET,82,0.20346,0.013567,0.091548,0.013134,MODULE_480,0.681484639175258
GSE22886_UNSTIM_VS_STIM_MEMO...2,SET,177,0.14672,0.014337,0.066031,0.01315,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP,0.681484639175258
GOBP_POSITIVE_REGULATION_OF_...793,SET,104,0.19281,0.014471,0.086782,0.013155,GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.681484639175258
MODULE_349,SET,17,0.50069,0.015229,0.22538,0.013163,MODULE_349,0.681484639175258
GOBP_POSITIVE_REGULATION_OF_...605,SET,7,0.7764,0.015158,0.34953,0.013172,GOBP_POSITIVE_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,0.681484639175258
GOMF_ATP_GATED_ION_CHANNEL_A...,SET,9,0.63751,0.014112,0.28704,0.013183,GOMF_ATP_GATED_ION_CHANNEL_ACTIVITY,0.681484639175258
MIR5187_3P,SET,91,0.19056,0.013383,0.085812,0.013192,MIR5187_3P,0.681484639175258
GOBP_COMPLEMENT_RECEPTOR_MED...,SET,13,0.62001,0.016493,0.27925,0.013207,GOBP_COMPLEMENT_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.681484639175258
REACTOME_MUSCARINIC_ACETYLCH...,SET,5,0.9612,0.015861,0.43308,0.013235,REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS,0.681484639175258
MIR4421,SET,49,0.27645,0.014263,0.12463,0.01328,MIR4421,0.681484639175258
GOBP_REGULATION_OF_GLIAL_CEL...2,SET,74,0.25167,0.015946,0.11347,0.013283,GOBP_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.681484639175258
MIR3158_5P,SET,154,0.15062,0.013737,0.067917,0.013295,MIR3158_5P,0.681484639175258
HP_WIDE_MOUTH,SET,188,0.13711,0.013804,0.061838,0.013307,HP_WIDE_MOUTH,0.681484639175258
GOBP_ENDOCARDIUM_DEVELOPMENT,SET,12,0.64148,0.016395,0.28933,0.013313,GOBP_ENDOCARDIUM_DEVELOPMENT,0.681484639175258
MIR6859_3P,SET,33,0.33884,0.014353,0.15283,0.013314,MIR6859_3P,0.681484639175258
GOBP_PROTEIN_TRANSPORT_TO_VA...,SET,15,0.44935,0.012839,0.20282,0.013371,GOBP_PROTEIN_TRANSPORT_TO_VACUOLE_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.681651326086957
GOBP_REGULATION_OF_MALE_GONA...,SET,8,0.76537,0.015974,0.34563,0.013407,GOBP_REGULATION_OF_MALE_GONAD_DEVELOPMENT,0.681651326086957
MIR154_3P,SET,91,0.20098,0.014115,0.090817,0.013455,MIR154_3P,0.681651326086957
REACTOME_FATTY_ACIDS,SET,15,0.5628,0.016081,0.25436,0.013469,REACTOME_FATTY_ACIDS,0.681651326086957
HP_HERNIA,SET,500,0.085619,0.013936,0.038701,0.013478,HP_HERNIA,0.681651326086957
HP_NORMAL_INTERICTAL_EEG,SET,6,0.76211,0.013776,0.34448,0.013479,HP_NORMAL_INTERICTAL_EEG,0.681651326086957
GOMF_DELTA_CATENIN_BINDING,SET,9,0.68349,0.01513,0.30913,0.013525,GOMF_DELTA_CATENIN_BINDING,0.681651326086957
STK33_NOMO_DN,SET,233,0.12682,0.014197,0.057363,0.013529,STK33_NOMO_DN,0.681651326086957
GOBP_REGULATION_OF_PHOSPHATI...4,SET,5,0.6079,0.010031,0.27497,0.013531,GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION,0.681651326086957
GSE46606_IRF4MID_VS_WT_CD40L...3,SET,185,0.1326,0.013244,0.059977,0.013532,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.681651326086957
HP_BROAD_NAIL,SET,8,0.71204,0.014861,0.32208,0.013533,HP_BROAD_NAIL,0.681651326086957
GSE46242_TH1_VS_ANERGIC_TH1_...2,SET,168,0.14602,0.013905,0.066097,0.013586,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_UP,0.682556469329529
MIR4692,SET,202,0.13306,0.013881,0.060246,0.013608,MIR4692,0.682556469329529
HP_FUSED_CERVICAL_VERTEBRAE,SET,30,0.32975,0.013319,0.14931,0.013612,HP_FUSED_CERVICAL_VERTEBRAE,0.682556469329529
WP_VITAMIN_B6DEPENDENT_AND_R...,SET,6,0.74486,0.013464,0.33744,0.013649,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,0.682556469329529
MIR130B_3P,SET,358,0.10277,0.01421,0.046561,0.01366,MIR130B_3P,0.682556469329529
GOBP_EPITHELIAL_CELL_PROLIFE...3,SET,10,0.64447,0.015037,0.29203,0.01367,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,0.682556469329529
GOBP_REGULATION_OF_STRIATED_...1,SET,78,0.22326,0.014522,0.10125,0.013731,GOBP_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.682556469329529
GSE27786_BCELL_VS_MONO_MAC_UP,SET,170,0.14046,0.013454,0.063707,0.013742,GSE27786_BCELL_VS_MONO_MAC_UP,0.682556469329529
GOBP_REGULATION_OF_CHEMOTAXIS,SET,193,0.14431,0.014719,0.065458,0.013746,GOBP_REGULATION_OF_CHEMOTAXIS,0.682556469329529
GOCC_LUMENAL_SIDE_OF_ENDOPLA...,SET,29,0.35549,0.014118,0.16126,0.013755,GOCC_LUMENAL_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE,0.682556469329529
HP_ABNORMAL_ELECTROPHYSIOLOG...,SET,78,0.22022,0.014324,0.099915,0.013767,HP_ABNORMAL_ELECTROPHYSIOLOGY_OF_SINOATRIAL_NODE_ORIGIN,0.682556469329529
HP_DEVIATION_OF_THE_4TH_FING...,SET,8,0.72452,0.015121,0.32905,0.013846,HP_DEVIATION_OF_THE_4TH_FINGER,0.684171373937677
REACTOME_GAP_FILLING_DNA_REP...,SET,24,0.33176,0.011988,0.15071,0.013865,REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER,0.684171373937677
GOBP_GANGLIOSIDE_BIOSYNTHETI...2,SET,6,0.69932,0.012641,0.31776,0.013881,GOBP_GANGLIOSIDE_BIOSYNTHETIC_PROCESS_VIA_LACTOSYLCERAMIDE,0.684171373937677
GSE29618_PRE_VS_DAY7_POST_LA...2,SET,181,0.13613,0.01345,0.061867,0.013896,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP,0.684171373937677
GSE17721_CTRL_VS_LPS_24H_BMD...1,SET,184,0.13596,0.013543,0.061789,0.013898,GSE17721_CTRL_VS_LPS_24H_BMDC_DN,0.684171373937677
GOBP_LUNG_SACCULE_DEVELOPMENT,SET,10,0.60779,0.014181,0.27636,0.013935,GOBP_LUNG_SACCULE_DEVELOPMENT,0.68464404661017
GOMF_CERAMIDE_BINDING,SET,17,0.46833,0.014245,0.21298,0.013947,GOMF_CERAMIDE_BINDING,0.68464404661017
GOBP_POSITIVE_REGULATION_OF_...520,SET,5,0.89757,0.014811,0.40859,0.014025,GOBP_POSITIVE_REGULATION_OF_NECROPTOTIC_PROCESS,0.685562148594377
GOBP_UREA_TRANSMEMBRANE_TRAN...,SET,8,0.80396,0.016779,0.36639,0.014114,GOBP_UREA_TRANSMEMBRANE_TRANSPORT,0.685562148594377
GSE3982_MAC_VS_TH1_UP,SET,181,0.14418,0.014245,0.065738,0.014153,GSE3982_MAC_VS_TH1_UP,0.685562148594377
NABA_MATRISOME_ASSOCIATED,SET,698,0.081759,0.015636,0.037285,0.014168,NABA_MATRISOME_ASSOCIATED,0.685562148594377
GOBP_REGULATION_OF_PEPTIDYL_...1,SET,8,0.6896,0.014392,0.31455,0.014185,GOBP_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION,0.685562148594377
GOBP_ESTABLISHMENT_OF_EPITHE...1,SET,16,0.50077,0.014777,0.22845,0.014197,GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY,0.685562148594377
GOBP_CELLULAR_RESPONSE_TO_PA...,SET,8,0.69247,0.014452,0.31596,0.01421,GOBP_CELLULAR_RESPONSE_TO_PARATHYROID_HORMONE_STIMULUS,0.685562148594377
ATGTTTC_MIR494,SET,142,0.16019,0.014034,0.073107,0.014224,ATGTTTC_MIR494,0.685562148594377
HP_ABSENT_TOENAIL,SET,17,0.46908,0.014268,0.21409,0.01423,HP_ABSENT_TOENAIL,0.685562148594377
GSE3039_ALPHABETA_CD8_TCELL_...2,SET,178,0.13785,0.013508,0.062914,0.014231,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP,0.685562148594377
HP_HYPERMETRIC_SACCADES,SET,11,0.51046,0.012492,0.23312,0.01428,HP_HYPERMETRIC_SACCADES,0.685562148594377
GOCC_RETROMER_COMPLEX,SET,19,0.40143,0.012908,0.18342,0.01432,GOCC_RETROMER_COMPLEX,0.685562148594377
MIR2115_5P,SET,123,0.16678,0.013606,0.076215,0.01433,MIR2115_5P,0.685562148594377
GSE17301_IFNA2_VS_IFNA2_AND_...2,SET,183,0.13471,0.013383,0.061581,0.014358,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP,0.685562148594377
HP_TIBIAL_TORSION,SET,20,0.40321,0.013302,0.18445,0.014412,HP_TIBIAL_TORSION,0.685562148594377
GOMF_ASPARTIC_ENDOPEPTIDASE_...,SET,8,0.55191,0.011519,0.25249,0.014419,GOMF_ASPARTIC_ENDOPEPTIDASE_ACTIVITY_INTRAMEMBRANE_CLEAVING,0.685562148594377
GOBP_ESTABLISHMENT_OR_MAINTE...4,SET,22,0.40545,0.014027,0.18553,0.014439,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_MONOPOLAR_CELL_POLARITY,0.685562148594377
REACTOME_ASPIRIN_ADME,SET,41,0.35983,0.016986,0.1647,0.014461,REACTOME_ASPIRIN_ADME,0.685562148594377
GSE23308_CTRL_VS_CORTICOSTER...3,SET,185,0.13199,0.013183,0.060423,0.014472,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_UP,0.685562148594377
COLLIS_PRKDC_SUBSTRATES,SET,15,0.4761,0.013604,0.21796,0.014474,COLLIS_PRKDC_SUBSTRATES,0.685562148594377
GOMF_ARP2_3_COMPLEX_BINDING,SET,13,0.49493,0.013166,0.22662,0.014489,GOMF_ARP2_3_COMPLEX_BINDING,0.685562148594377
MALONEY_RESPONSE_TO_17AAG_DN,SET,66,0.21397,0.012807,0.097984,0.014497,MALONEY_RESPONSE_TO_17AAG_DN,0.685562148594377
GOBP_EMBRYONIC_BODY_MORPHOGE...,SET,10,0.56651,0.013218,0.25944,0.014503,GOBP_EMBRYONIC_BODY_MORPHOGENESIS,0.685562148594377
GOBP_MIRNA_MEDIATED_GENE_SIL...1,SET,18,0.44158,0.01382,0.20231,0.014538,GOBP_MIRNA_MEDIATED_GENE_SILENCING_BY_INHIBITION_OF_TRANSLATION,0.685562148594377
REACTOME_CIPROFLOXACIN_ADME,SET,5,0.867,0.014307,0.39723,0.014539,REACTOME_CIPROFLOXACIN_ADME,0.685562148594377
HP_HAMARTOMA_OF_TONGUE,SET,21,0.37151,0.012558,0.17026,0.014561,HP_HAMARTOMA_OF_TONGUE,0.685562148594377
GSE46606_UNSTIM_VS_CD40L_IL2...3,SET,171,0.14028,0.013476,0.064294,0.014564,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,0.685562148594377
HP_BIFID_UVULA,SET,139,0.15555,0.013484,0.071292,0.014566,HP_BIFID_UVULA,0.685562148594377
REACTOME_POTENTIAL_THERAPEUT...,SET,92,0.18988,0.013408,0.087036,0.014573,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,0.685562148594377
GCTCTTG_MIR335,SET,80,0.20161,0.01328,0.092425,0.014584,GCTCTTG_MIR335,0.685562148594377
GOBP_CELL_CYCLE_DNA_REPLICAT...1,SET,41,0.26945,0.01272,0.12358,0.014622,GOBP_CELL_CYCLE_DNA_REPLICATION,0.685562148594377
CHEN_LIVER_METABOLISM_QTL_CIS,SET,88,0.21624,0.014936,0.099196,0.014638,CHEN_LIVER_METABOLISM_QTL_CIS,0.685562148594377
HP_PSYCHOMOTOR_DETERIORATION,SET,19,0.44226,0.014221,0.20288,0.014639,HP_PSYCHOMOTOR_DETERIORATION,0.685562148594377
FAN_EMBRYONIC_CTX_BIG_GROUPS...6,SET,8,0.79336,0.016558,0.36398,0.014647,FAN_EMBRYONIC_CTX_BIG_GROUPS_INHIBITORY,0.685562148594377
GOBP_MATURE_B_CELL_DIFFERENT...2,SET,29,0.36706,0.014577,0.16845,0.014672,GOBP_MATURE_B_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE,0.685562148594377
MIR12132,SET,134,0.1564,0.013313,0.071799,0.014699,MIR12132,0.685562148594377
GOBP_NEGATIVE_REGULATION_OF_...578,SET,7,0.77038,0.01504,0.35369,0.014705,GOBP_NEGATIVE_REGULATION_OF_RUFFLE_ASSEMBLY,0.685562148594377
GOBP_REGULATION_OF_COMPLEMEN...2,SET,3,1.2169,0.015555,0.55882,0.014725,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY,0.685562148594377
GOBP_NEGATIVE_REGULATION_OF_...382,SET,9,0.66368,0.014691,0.30481,0.014735,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.685562148594377
GSE15735_CTRL_VS_HDAC_INHIBI...4,SET,177,0.14542,0.01421,0.066837,0.014793,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP,0.6872222
GOBP_NEGATIVE_REGULATION_OF_...224,SET,3,1.124,0.014367,0.51671,0.014813,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,0.6872222
HP_ABNORMALITY_OF_THE_UMBILI...,SET,62,0.23585,0.013683,0.10845,0.01483,HP_ABNORMALITY_OF_THE_UMBILICAL_CORD,0.6872222
OSMAN_BLOOD_CHAD63_KH_AGE_18...2,SET,1574,0.050595,0.014166,0.023275,0.014867,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP,0.68763274535809
GOMF_ADENYLYLTRANSFERASE_ACT...,SET,21,0.41401,0.013994,0.19052,0.014894,GOMF_ADENYLYLTRANSFERASE_ACTIVITY,0.68763274535809
TGCACGA_MIR517A_MIR517C,SET,17,0.43058,0.013097,0.1982,0.014918,TGCACGA_MIR517A_MIR517C,0.68763274535809
GAVISH_3CA_METAPROGRAM_EPITH...1,SET,48,0.29414,0.015021,0.1354,0.014918,GAVISH_3CA_METAPROGRAM_EPITHELIAL_ALVEOLAR,0.68763274535809
GSE28737_BCL6_HET_VS_BCL6_KO...2,SET,179,0.13485,0.01325,0.062103,0.014958,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP,0.688563298013245
GSE24972_MARGINAL_ZONE_BCELL...2,SET,181,0.13967,0.0138,0.064356,0.015,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_DN,0.688834953947368
HP_ABNORMAL_FINGERTIP_MORPHO...,SET,76,0.21775,0.013982,0.10035,0.01501,HP_ABNORMAL_FINGERTIP_MORPHOLOGY,0.688834953947368
GSE10273_HIGH_VS_LOW_IL7_TRE...2,SET,171,0.14126,0.013569,0.065119,0.01504,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP,0.688834953947368
GOBP_VERY_LOW_DENSITY_LIPOPR...2,SET,3,1.0788,0.013789,0.49735,0.015046,GOBP_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.688834953947368
GOBP_REGULATION_OF_ENDOSOME_...2,SET,9,0.62658,0.01387,0.28893,0.015063,GOBP_REGULATION_OF_ENDOSOME_SIZE,0.688834953947368
WP_SULINDAC_METABOLIC_PATHWAY,SET,5,0.92916,0.015332,0.42864,0.015099,WP_SULINDAC_METABOLIC_PATHWAY,0.689573909329829
GATA1_02,SET,218,0.13116,0.014207,0.060562,0.015174,GATA1_02,0.691415242146597
ATGAAGG_MIR205,SET,139,0.15324,0.013284,0.070764,0.015181,ATGAAGG_MIR205,0.691415242146597
GOBP_REGULATION_OF_MESENCHYM...3,SET,7,0.83119,0.016228,0.38391,0.015199,GOBP_REGULATION_OF_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS,0.691415242146597
LOPEZ_MESOTHELIOMA_SURVIVAL_...3,SET,7,0.71145,0.01389,0.32874,0.015232,LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP,0.691742467362924
REACTOME_FLT3_SIGNALING_THRO...,SET,6,0.72609,0.013125,0.33556,0.015246,REACTOME_FLT3_SIGNALING_THROUGH_SRC_FAMILY_KINASES,0.691742467362924
WANG_MLL_TARGETS,SET,273,0.11989,0.014511,0.055424,0.015271,WANG_MLL_TARGETS,0.691794254498715
DURAND_STROMA_S_UP,SET,261,0.12378,0.014654,0.057276,0.015351,DURAND_STROMA_S_UP,0.691794254498715
GOBP_POSITIVE_REGULATION_OF_...548,SET,6,0.65787,0.011891,0.30457,0.015392,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION,0.691794254498715
HP_SKELETAL_MUSCLE_HYPERTROP...,SET,184,0.13721,0.013668,0.06354,0.015415,HP_SKELETAL_MUSCLE_HYPERTROPHY,0.691794254498715
MIR4295,SET,353,0.10068,0.013826,0.046629,0.015425,MIR4295,0.691794254498715
GOBP_POSITIVE_REGULATION_OF_...843,SET,6,0.83176,0.015034,0.38527,0.015436,GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.691794254498715
GOBP_ANTIMICROBIAL_HUMORAL_R...,SET,127,0.19501,0.016163,0.090358,0.015464,GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE,0.691794254498715
GOBP_COMPLEMENT_ACTIVATION,SET,46,0.3127,0.015633,0.14489,0.015464,GOBP_COMPLEMENT_ACTIVATION,0.691794254498715
GOBP_REGULATION_OF_ENDOPLASM...2,SET,5,0.81866,0.013509,0.37937,0.015473,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION,0.691794254498715
HP_CUPPED_EAR,SET,57,0.23859,0.013274,0.11057,0.015473,HP_CUPPED_EAR,0.691794254498715
MODULE_180,SET,109,0.18869,0.014496,0.087439,0.015474,MODULE_180,0.691794254498715
GOBP_NEGATIVE_REGULATION_OF_...282,SET,10,0.72245,0.016857,0.33484,0.015486,GOBP_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.691794254498715
REACTOME_TRANS_GOLGI_NETWORK...,SET,65,0.21312,0.012659,0.098817,0.015519,REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,0.692328398734177
GOBP_CRANIOFACIAL_SUTURE_MOR...,SET,19,0.46277,0.01488,0.21469,0.015569,GOBP_CRANIOFACIAL_SUTURE_MORPHOGENESIS,0.692328398734177
GSE23308_WT_VS_MINERALCORTIC...3,SET,189,0.14111,0.014244,0.065486,0.015596,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_DN,0.692328398734177
MIKKELSEN_IPS_LCP_WITH_H3K27...,SET,10,0.54645,0.01275,0.25364,0.015611,MIKKELSEN_IPS_LCP_WITH_H3K27ME3,0.692328398734177
GOBP_AMELOGENESIS,SET,23,0.40215,0.014225,0.18673,0.01564,GOBP_AMELOGENESIS,0.692328398734177
GSE3720_VD1_VS_VD2_GAMMADELT...6,SET,177,0.14053,0.013732,0.065272,0.015665,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP,0.692328398734177
RAMPON_ENRICHED_LEARNING_ENV...1,SET,10,0.64029,0.01494,0.29744,0.015679,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN,0.692328398734177
SPIRA_SMOKERS_LUNG_CANCER_UP,SET,36,0.31423,0.013902,0.14598,0.015683,SPIRA_SMOKERS_LUNG_CANCER_UP,0.692328398734177
HP_SMALL_FORAMEN_MAGNUM,SET,11,0.48925,0.011973,0.2273,0.015687,HP_SMALL_FORAMEN_MAGNUM,0.692328398734177
WP_NUCLEOTIDE_EXCISION_REPAIR,SET,41,0.24263,0.011453,0.11276,0.015718,WP_NUCLEOTIDE_EXCISION_REPAIR,0.692328398734177
MIR196B_3P,SET,6,0.84276,0.015233,0.39167,0.015718,MIR196B_3P,0.692328398734177
chr8q11,SET,19,0.70107,0.022542,0.3259,0.015737,chr8q11,0.692328398734177
HP_INCISOR_MACRODONTIA,SET,15,0.51809,0.014803,0.24099,0.015792,HP_INCISOR_MACRODONTIA,0.693213049242424
MODULE_141,SET,14,0.56321,0.015547,0.262,0.015797,MODULE_141,0.693213049242424
GSE32255_UNSTIM_VS_4H_LPS_ST...2,SET,172,0.14295,0.013772,0.066542,0.015852,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP,0.69413701511335
GSE14308_NAIVE_CD4_TCELL_VS_...4,SET,177,0.13414,0.013108,0.062444,0.015858,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP,0.69413701511335
PURBEY_TARGETS_OF_CTBP1_NOT_...1,SET,352,0.098736,0.01354,0.046003,0.015932,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,0.696147889447236
TAXCREB_02,SET,25,0.37085,0.013676,0.17281,0.015944,TAXCREB_02,0.696147889447236
GOMF_NEUROTRANSMITTER_RECEPT...3,SET,12,0.57565,0.014713,0.26853,0.016036,GOMF_NEUROTRANSMITTER_RECEPTOR_REGULATOR_ACTIVITY,0.699286298619824
GOBP_MAINTENANCE_OF_CELL_POL...,SET,15,0.55425,0.015836,0.25868,0.016079,GOBP_MAINTENANCE_OF_CELL_POLARITY,0.6999657
WP_OXIDATION_BY_CYTOCHROME_P...,SET,61,0.26946,0.015507,0.12579,0.016096,WP_OXIDATION_BY_CYTOCHROME_P450,0.6999657
GOBP_INTERLEUKIN_2_MEDIATED_...,SET,8,0.75649,0.015789,0.35321,0.016112,GOBP_INTERLEUKIN_2_MEDIATED_SIGNALING_PATHWAY,0.6999657
GOBP_POSITIVE_REGULATION_OF_...578,SET,147,0.15872,0.014146,0.074245,0.016272,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,0.705283821695761
GOBP_NEGATIVE_REGULATION_OF_...391,SET,5,0.90602,0.01495,0.42382,0.016275,GOBP_NEGATIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.705283821695761
GOMF_MHC_CLASS_I_PROTEIN_BIN...,SET,15,0.47525,0.013579,0.22249,0.016343,GOMF_MHC_CLASS_I_PROTEIN_BINDING,0.707348648816936
GOMF_PROFILIN_BINDING,SET,10,0.58331,0.01361,0.27314,0.016365,GOMF_PROFILIN_BINDING,0.707419869402985
PID_INTEGRIN4_PATHWAY,SET,11,0.59816,0.014638,0.28017,0.016388,PID_INTEGRIN4_PATHWAY,0.707534086956522
GOBP_POLYAMINE_TRANSPORT,SET,16,0.45872,0.013536,0.21492,0.016413,GOBP_POLYAMINE_TRANSPORT,0.707632472118959
GOBP_RESPONSE_TO_HUMAN_CHORI...,SET,5,0.96937,0.015996,0.45426,0.016431,GOBP_RESPONSE_TO_HUMAN_CHORIONIC_GONADOTROPIN,0.707632472118959
GAZIN_EPIGENETIC_SILENCING_B...,SET,25,0.37313,0.01376,0.17495,0.01648,GAZIN_EPIGENETIC_SILENCING_BY_KRAS,0.708503658838072
GOBP_PHOSPHATIDYLINOSITOL_AC...,SET,6,0.85406,0.015438,0.40051,0.016492,GOBP_PHOSPHATIDYLINOSITOL_ACYL_CHAIN_REMODELING,0.708503658838072
GOBP_CELLULAR_RESPONSE_TO_GO...,SET,17,0.5074,0.015433,0.2381,0.016548,GOBP_CELLULAR_RESPONSE_TO_GONADOTROPIN_STIMULUS,0.709584821208385
HP_IMPAIRED_MYOCARDIAL_CONTR...,SET,8,0.69917,0.014592,0.32812,0.016558,HP_IMPAIRED_MYOCARDIAL_CONTRACTILITY,0.709584821208385
GSE43955_TH0_VS_TGFB_IL6_TH1...16,SET,184,0.13763,0.013709,0.064633,0.016619,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_UP,0.711002656826568
GOMF_DEOXYRIBONUCLEASE_I_ACT...,SET,4,0.95837,0.014145,0.45014,0.016632,GOMF_DEOXYRIBONUCLEASE_I_ACTIVITY,0.711002656826568
GOBP_CYTOPLASMIC_SEQUESTERIN...1,SET,4,0.83916,0.012386,0.39455,0.016721,GOBP_CYTOPLASMIC_SEQUESTERING_OF_NF_KAPPAB,0.711405852478839
GOBP_CELL_SUBSTRATE_JUNCTION...2,SET,100,0.18625,0.013708,0.087567,0.016722,GOBP_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.711405852478839
HP_LIMITED_KNEE_FLEXION,SET,4,0.91194,0.01346,0.42889,0.016746,HP_LIMITED_KNEE_FLEXION,0.711405852478839
WP_COMPLEMENT_AND_COAGULATIO...,SET,52,0.27636,0.014687,0.12998,0.016751,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.711405852478839
GOBP_POSITIVE_REGULATION_OF_...315,SET,8,0.75442,0.015745,0.35492,0.016776,GOBP_POSITIVE_REGULATION_OF_GONAD_DEVELOPMENT,0.711405852478839
HP_PERIODIC_PARALYSIS,SET,9,0.64113,0.014192,0.30167,0.016789,HP_PERIODIC_PARALYSIS,0.711405852478839
GOMF_NUCLEAR_VITAMIN_D_RECEP...,SET,13,0.45424,0.012083,0.2139,0.016858,GOMF_NUCLEAR_VITAMIN_D_RECEPTOR_BINDING,0.711405852478839
GSE21379_TFH_VS_NON_TFH_SAP_...1,SET,172,0.13917,0.013408,0.065554,0.016884,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN,0.711405852478839
WONG_PROTEASOME_GENE_MODULE,SET,47,0.23912,0.012083,0.11264,0.016893,WONG_PROTEASOME_GENE_MODULE,0.711405852478839
MIR1193,SET,32,0.31146,0.012992,0.14674,0.016904,MIR1193,0.711405852478839
GSE17721_CTRL_VS_POLYIC_4H_B...2,SET,183,0.12891,0.012806,0.060739,0.01691,GSE17721_CTRL_VS_POLYIC_4H_BMDC_UP,0.711405852478839
GOMF_ATP_TRANSMEMBRANE_TRANS...,SET,12,0.55539,0.014195,0.26169,0.016913,GOMF_ATP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.711405852478839
MIR487A_3P,SET,92,0.19189,0.01355,0.090423,0.016922,MIR487A_3P,0.711405852478839
MIR5571_5P,SET,149,0.15474,0.013884,0.072925,0.016928,MIR5571_5P,0.711405852478839
ZIC1_01,SET,234,0.11558,0.012966,0.054527,0.017022,ZIC1_01,0.71387857400722
SAFB2_TARGET_GENES,SET,614,0.074869,0.013461,0.035335,0.01706,SAFB2_TARGET_GENES,0.71387857400722
GSE9601_UNTREATED_VS_NFKB_IN...2,SET,145,0.15769,0.013959,0.07443,0.017066,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,0.71387857400722
GSE11961_GERMINAL_CENTER_BCE...1,SET,177,0.13542,0.013233,0.063919,0.017069,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.71387857400722
GOMF_LIPASE_ACTIVATOR_ACTIVI...,SET,18,0.40153,0.012567,0.1898,0.017201,GOMF_LIPASE_ACTIVATOR_ACTIVITY,0.716717942583732
HP_DYSTROPHIC_TOENAIL,SET,19,0.43491,0.013984,0.20559,0.017206,HP_DYSTROPHIC_TOENAIL,0.716717942583732
GSE3982_NEUTROPHIL_VS_EFF_ME...1,SET,181,0.12522,0.012372,0.0592,0.017213,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,0.716717942583732
TGIF_01,SET,229,0.12364,0.013722,0.058458,0.017223,TGIF_01,0.716717942583732
HP_GRAY_MATTER_HETEROTOPIA,SET,111,0.16096,0.012478,0.076121,0.01724,HP_GRAY_MATTER_HETEROTOPIA,0.716717942583732
REACTOME_CHOLESTEROL_BIOSYNT...,SET,24,0.32319,0.011678,0.15292,0.01729,REACTOME_CHOLESTEROL_BIOSYNTHESIS,0.717495823389022
CHENG_TAF7L_TARGETS,SET,4,0.82156,0.012126,0.38878,0.0173,CHENG_TAF7L_TARGETS,0.717495823389022
GOBP_POSITIVE_REGULATION_OF_...405,SET,141,0.15995,0.013964,0.075752,0.017373,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,0.719664618593564
MODULE_204,SET,79,0.19976,0.013076,0.094689,0.01745,MODULE_204,0.721176581450654
GSE16385_MONOCYTE_VS_12H_ROS...1,SET,175,0.13659,0.013272,0.064744,0.017451,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,0.721176581450654
GOMF_TRANSCRIPTION_REGULATOR...2,SET,1779,0.048076,0.014222,0.022814,0.017553,GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY,0.721216942823804
MIR125A_3P,SET,68,0.21964,0.013343,0.10424,0.017561,MIR125A_3P,0.721216942823804
ADCYAP1_TARGET_GENES,SET,7,0.59376,0.011592,0.28184,0.017577,ADCYAP1_TARGET_GENES,0.721216942823804
GOBP_MACROAUTOPHAGY,SET,325,0.097441,0.01285,0.046255,0.017583,GOBP_MACROAUTOPHAGY,0.721216942823804
KEGG_METABOLISM_OF_XENOBIOTI...,SET,65,0.3074,0.018259,0.14595,0.017604,KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450,0.721216942823804
REACTOME_ATTACHMENT_AND_ENTRY,SET,16,0.49716,0.014671,0.23619,0.017656,REACTOME_ATTACHMENT_AND_ENTRY,0.721216942823804
GSE44649_NAIVE_VS_ACTIVATED_...3,SET,176,0.13231,0.012893,0.06287,0.017671,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP,0.721216942823804
GSE17721_LPS_VS_GARDIQUIMOD_...3,SET,180,0.13013,0.012823,0.061837,0.017677,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_DN,0.721216942823804
GSE17721_CTRL_VS_GARDIQUIMOD...16,SET,179,0.1328,0.013049,0.063105,0.017681,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_UP,0.721216942823804
GOBP_NEGATIVE_REGULATION_OF_...345,SET,10,0.62205,0.014514,0.29566,0.017699,GOBP_NEGATIVE_REGULATION_OF_LIPASE_ACTIVITY,0.721216942823804
GOCC_TRICARBOXYLIC_ACID_CYCL...,SET,18,0.36745,0.0115,0.17468,0.017717,GOCC_TRICARBOXYLIC_ACID_CYCLE_HETEROMERIC_ENZYME_COMPLEX,0.721216942823804
GOBP_COMPLEMENT_ACTIVATION_A...,SET,14,0.50962,0.014068,0.24232,0.017734,GOBP_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY,0.721216942823804
GALLUZZI_PREVENT_MITOCHONDIA...,SET,14,0.51653,0.014259,0.24568,0.017764,GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,0.721216942823804
MIR663B,SET,28,0.32743,0.012778,0.15575,0.017771,MIR663B,0.721216942823804
MIR3190_5P,SET,110,0.16838,0.012994,0.080099,0.017779,MIR3190_5P,0.721216942823804
GSE9988_ANTI_TREM1_VS_VEHICL...1,SET,183,0.13024,0.012939,0.061962,0.017784,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN,0.721216942823804
GOBP_PURINE_DEOXYRIBONUCLEOS...2,SET,6,0.76334,0.013798,0.36338,0.017842,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.721497728323699
GSE15659_NAIVE_CD4_TCELL_VS_...2,SET,160,0.14112,0.013117,0.067181,0.017843,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP,0.721497728323699
GSE1925_CTRL_VS_24H_IFNG_STI...4,SET,176,0.13345,0.013004,0.063555,0.017882,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP,0.721497728323699
HP_SHAWL_SCROTUM,SET,18,0.42607,0.013335,0.20298,0.017914,HP_SHAWL_SCROTUM,0.721497728323699
REACTOME_TRANSCRIPTIONAL_REG...1,SET,31,0.29511,0.012117,0.14065,0.01795,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6,0.721497728323699
GOBP_LOOP_OF_HENLE_DEVELOPME...,SET,11,0.60665,0.014845,0.28913,0.01795,GOBP_LOOP_OF_HENLE_DEVELOPMENT,0.721497728323699
MIR4533,SET,303,0.10123,0.012898,0.048248,0.017953,MIR4533,0.721497728323699
GOBP_POSITIVE_REGULATION_OF_...222,SET,13,0.4875,0.012968,0.23236,0.017957,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.721497728323699
HP_THIN_LOWER_LIP_VERMILION,SET,5,0.88782,0.01465,0.42344,0.018017,HP_THIN_LOWER_LIP_VERMILION,0.723072557736721
MIR656_3P,SET,358,0.098774,0.013658,0.047132,0.018063,MIR656_3P,0.724082543252595
GSE3982_MAST_CELL_VS_BCELL_UP,SET,180,0.14021,0.013816,0.066921,0.018085,GSE3982_MAST_CELL_VS_BCELL_UP,0.724129233870968
GOBP_PLATELET_MORPHOGENESIS,SET,23,0.33341,0.011794,0.1592,0.018124,GOBP_PLATELET_MORPHOGENESIS,0.724741620689655
WP_SOMATIC_SEX_DETERMINATION,SET,13,0.52065,0.01385,0.24865,0.018142,WP_SOMATIC_SEX_DETERMINATION,0.724741620689655
GOBP_POSITIVE_REGULATION_OF_...302,SET,68,0.23733,0.014417,0.1134,0.018186,GOBP_POSITIVE_REGULATION_OF_GLIOGENESIS,0.725151915137615
HP_JOINT_STIFFNESS,SET,177,0.13521,0.013212,0.064608,0.018194,HP_JOINT_STIFFNESS,0.725151915137615
GOBP_FOREBRAIN_NEURON_DEVELO...,SET,21,0.4168,0.014089,0.19933,0.018273,GOBP_FOREBRAIN_NEURON_DEVELOPMENT,0.726924749199573
GOBP_DGMP_METABOLIC_PROCESS,SET,6,0.71632,0.012948,0.3432,0.018444,GOBP_DGMP_METABOLIC_PROCESS,0.726924749199573
chr2p15,SET,15,0.59471,0.016993,0.28494,0.018445,chr2p15,0.726924749199573
MODULE_486,SET,85,0.18555,0.012597,0.088946,0.01849,MODULE_486,0.726924749199573
AAAGACA_MIR511,SET,185,0.13313,0.013296,0.063823,0.018503,AAAGACA_MIR511,0.726924749199573
MIR6773_5P,SET,33,0.29199,0.012369,0.14,0.018513,MIR6773_5P,0.726924749199573
GSE43955_1H_VS_42H_ACT_CD4_T...2,SET,180,0.12844,0.012656,0.061611,0.018556,GSE43955_1H_VS_42H_ACT_CD4_TCELL_UP,0.726924749199573
HP_SOFT_SKIN,SET,40,0.29212,0.013621,0.14015,0.018576,HP_SOFT_SKIN,0.726924749199573
HP_ABSENT_SEPTUM_PELLUCIDUM,SET,54,0.24126,0.013066,0.1158,0.018612,HP_ABSENT_SEPTUM_PELLUCIDUM,0.726924749199573
GSE8835_HEALTHY_VS_CLL_CD8_T...1,SET,180,0.13512,0.013314,0.064856,0.018617,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN,0.726924749199573
WP_ECTODERM_DIFFERENTIATION,SET,121,0.17614,0.014253,0.084565,0.018638,WP_ECTODERM_DIFFERENTIATION,0.726924749199573
STAT5A_01,SET,227,0.12227,0.013512,0.058705,0.018641,STAT5A_01,0.726924749199573
REACTOME_GRB7_EVENTS_IN_ERBB...,SET,5,0.89356,0.014745,0.42913,0.018668,REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING,0.726924749199573
WP_ETHANOL_METABOLISM_PRODUC...,SET,9,0.63294,0.014011,0.30408,0.018701,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.726924749199573
GOBP_ENDOSOME_TRANSPORT_VIA_...,SET,39,0.26405,0.012158,0.12689,0.018723,GOBP_ENDOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.726924749199573
GOCC_SARCOLEMMA,SET,136,0.16142,0.013842,0.077601,0.018766,GOCC_SARCOLEMMA,0.726924749199573
MIR499B_5P,SET,86,0.19658,0.013423,0.094567,0.018828,MIR499B_5P,0.726924749199573
HP_BIRD_LIKE_FACIES,SET,13,0.43146,0.011477,0.20764,0.018865,HP_BIRD_LIKE_FACIES,0.726924749199573
HP_POSTERIOR_RIB_CUPPING,SET,4,0.90346,0.013335,0.43501,0.018914,HP_POSTERIOR_RIB_CUPPING,0.726924749199573
WP_RIBOFLAVIN_AND_COQ_DISORD...,SET,13,0.44418,0.011816,0.21395,0.018949,WP_RIBOFLAVIN_AND_COQ_DISORDERS,0.726924749199573
PRDM5_TARGET_GENES,SET,79,0.19968,0.01307,0.096191,0.018962,PRDM5_TARGET_GENES,0.726924749199573
KEGG_NUCLEOTIDE_EXCISION_REP...,SET,40,0.23518,0.010966,0.1133,0.018965,KEGG_NUCLEOTIDE_EXCISION_REPAIR,0.726924749199573
GOBP_NEGATIVE_REGULATION_OF_...585,SET,2,1.483,0.015478,0.71457,0.018987,GOBP_NEGATIVE_REGULATION_OF_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.726924749199573
MIR5186,SET,31,0.31206,0.012813,0.15038,0.018992,MIR5186,0.726924749199573
GOBP_NEGATIVE_REGULATION_OF_...561,SET,5,0.80756,0.013326,0.38924,0.019015,GOBP_NEGATIVE_REGULATION_OF_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.726924749199573
GOBP_REGULATION_OF_MYOTUBE_D...,SET,40,0.29919,0.013951,0.14423,0.019026,GOBP_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.726924749199573
GSE41867_NAIVE_VS_DAY30_LCMV...4,SET,170,0.14407,0.013799,0.069467,0.019051,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP,0.726924749199573
MIR6761_5P,SET,108,0.17545,0.013417,0.084601,0.019053,MIR6761_5P,0.726924749199573
EGR1_01,SET,240,0.11236,0.012763,0.054179,0.019054,EGR1_01,0.726924749199573
MIR6739_5P,SET,243,0.11456,0.013093,0.055246,0.019063,MIR6739_5P,0.726924749199573
GSE16385_MONOCYTE_VS_12H_ROS...5,SET,169,0.12682,0.012111,0.061174,0.019091,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,0.726924749199573
GAVISH_3CA_METAPROGRAM_EPITH...20,SET,48,0.25897,0.013225,0.12498,0.019132,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_3,0.726924749199573
GSE2770_UNTREATED_VS_ACT_CD4...5,SET,179,0.12877,0.012653,0.062149,0.019145,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN,0.726924749199573
HP_PREGNANCY_EXPOSURE,SET,5,0.779,0.012854,0.37599,0.019146,HP_PREGNANCY_EXPOSURE,0.726924749199573
GOBP_INOSITOL_TRISPHOSPHATE_...2,SET,10,0.61994,0.014465,0.29924,0.019153,GOBP_INOSITOL_TRISPHOSPHATE_METABOLIC_PROCESS,0.726924749199573
HP_LUMBAR_HYPERLORDOSIS,SET,82,0.19558,0.013042,0.094415,0.019161,HP_LUMBAR_HYPERLORDOSIS,0.726924749199573
GSE17721_PAM3CSK4_VS_CPG_4H_...1,SET,181,0.13518,0.013357,0.065258,0.019162,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_DN,0.726924749199573
GOBP_REGULATION_OF_COMPLEMEN...4,SET,11,0.61435,0.015034,0.2966,0.019172,GOBP_REGULATION_OF_COMPLEMENT_DEPENDENT_CYTOTOXICITY,0.726924749199573
HP_GENERALIZED_CEREBRAL_ATRO...,SET,11,0.51646,0.012638,0.24935,0.019176,HP_GENERALIZED_CEREBRAL_ATROPHY_HYPOPLASIA,0.726924749199573
GOBP_REGULATION_OF_STEM_CELL...1,SET,80,0.19688,0.012969,0.095072,0.019193,GOBP_REGULATION_OF_STEM_CELL_DIFFERENTIATION,0.726924749199573
HP_COMPLEX_FEBRILE_SEIZURE,SET,15,0.43386,0.012397,0.20952,0.0192,HP_COMPLEX_FEBRILE_SEIZURE,0.726924749199573
HP_RECURRENT_CUTANEOUS_FUNGA...,SET,53,0.24569,0.013182,0.11868,0.019224,HP_RECURRENT_CUTANEOUS_FUNGAL_INFECTIONS,0.726924749199573
HP_DECREASED_CORNEAL_REFLEX,SET,9,0.5087,0.011261,0.24584,0.019269,HP_DECREASED_CORNEAL_REFLEX,0.726924749199573
RAHMAN_TP53_TARGETS_PHOSPHOR...,SET,19,0.39115,0.012577,0.18918,0.019346,RAHMAN_TP53_TARGETS_PHOSPHORYLATED,0.726924749199573
HP_RETINAL_DYSPLASIA,SET,18,0.41079,0.012857,0.19868,0.019346,HP_RETINAL_DYSPLASIA,0.726924749199573
MIR570_3P,SET,686,0.069702,0.01322,0.033724,0.019384,MIR570_3P,0.726924749199573
GOMF_MONOATOMIC_ANION_CHANNE...,SET,88,0.2101,0.014511,0.10165,0.019384,GOMF_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.726924749199573
GSE6259_DEC205_POS_DC_VS_BCE...2,SET,139,0.16179,0.014025,0.078314,0.019425,GSE6259_DEC205_POS_DC_VS_BCELL_UP,0.726924749199573
GOBP_POSITIVE_REGULATION_OF_...675,SET,7,0.7147,0.013953,0.34598,0.019433,GOBP_POSITIVE_REGULATION_OF_RESPIRATORY_BURST,0.726924749199573
HP_INTERVERTEBRAL_DISK_DEGEN...,SET,6,0.76581,0.013842,0.37073,0.019437,HP_INTERVERTEBRAL_DISK_DEGENERATION,0.726924749199573
GOBP_INTRACELLULAR_MRNA_LOCA...,SET,15,0.4782,0.013664,0.23152,0.019446,GOBP_INTRACELLULAR_MRNA_LOCALIZATION,0.726924749199573
HP_PHIMOSIS,SET,9,0.52234,0.011563,0.2529,0.019451,HP_PHIMOSIS,0.726924749199573
GOBP_THROMBOPOIETIN_MEDIATED...,SET,5,0.75285,0.012423,0.36453,0.019458,GOBP_THROMBOPOIETIN_MEDIATED_SIGNALING_PATHWAY,0.726924749199573
GOBP_ACINAR_CELL_DIFFERENTIA...,SET,5,0.89314,0.014738,0.43251,0.019468,GOBP_ACINAR_CELL_DIFFERENTIATION,0.726924749199573
PGM3_TARGET_GENES,SET,214,0.11857,0.012727,0.057421,0.019475,PGM3_TARGET_GENES,0.726924749199573
JECHLINGER_EPITHELIAL_TO_MES...2,SET,65,0.23343,0.013865,0.11308,0.019499,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,0.726924749199573
MIR4685_3P,SET,117,0.16504,0.013134,0.079958,0.019512,MIR4685_3P,0.726924749199573
TSAI_RESPONSE_TO_RADIATION_T...,SET,28,0.37703,0.014713,0.18267,0.019516,TSAI_RESPONSE_TO_RADIATION_THERAPY,0.726924749199573
HP_MULTIPLE_PULMONARY_CYSTS,SET,18,0.4376,0.013696,0.21208,0.019545,HP_MULTIPLE_PULMONARY_CYSTS,0.726924749199573
GSE4142_PLASMA_CELL_VS_GC_BC...2,SET,180,0.12711,0.012525,0.061603,0.019545,GSE4142_PLASMA_CELL_VS_GC_BCELL_UP,0.726924749199573
REACTOME_BETA_OXIDATION_OF_L...,SET,5,0.78887,0.013017,0.38244,0.019576,REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA,0.726924749199573
GOBP_GERMINAL_CENTER_B_CELL_...,SET,8,0.77631,0.016202,0.37638,0.019584,GOBP_GERMINAL_CENTER_B_CELL_DIFFERENTIATION,0.726924749199573
TBX1_TARGET_GENES,SET,166,0.13387,0.012672,0.064911,0.019594,TBX1_TARGET_GENES,0.726924749199573
MIR3192_3P,SET,75,0.20664,0.013181,0.1002,0.019598,MIR3192_3P,0.726924749199573
GOBP_POSITIVE_REGULATION_OF_...55,SET,22,0.42908,0.014845,0.20806,0.019598,GOBP_POSITIVE_REGULATION_OF_BEHAVIOR,0.726924749199573
GOBP_EMBRYONIC_CAMERA_TYPE_E...2,SET,11,0.57991,0.014191,0.28136,0.019653,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_FORMATION,0.727981316067653
GOBP_NEGATIVE_REGULATION_OF_...459,SET,1305,0.050613,0.013006,0.024561,0.019672,GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.727981316067653
GOBP_INOSITOL_PHOSPHATE_BIOS...,SET,26,0.33559,0.012621,0.16299,0.019754,GOBP_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.727981316067653
GSE26290_WT_VS_PDK1_KO_ANTI_...1,SET,169,0.12561,0.011997,0.061015,0.019767,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,0.727981316067653
GCCNNNWTAAR_UNKNOWN,SET,132,0.15695,0.01326,0.076239,0.019773,GCCNNNWTAAR_UNKNOWN,0.727981316067653
GSE2197_CPG_DNA_VS_UNTREATED...2,SET,177,0.1317,0.012869,0.063982,0.019786,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP,0.727981316067653
HP_ABNORMAL_KNEE_PHYSIOLOGY,SET,78,0.20079,0.01306,0.097569,0.019806,HP_ABNORMAL_KNEE_PHYSIOLOGY,0.727981316067653
WHITFIELD_CELL_CYCLE_G1_S,SET,117,0.15599,0.012413,0.0758,0.019807,WHITFIELD_CELL_CYCLE_G1_S,0.727981316067653
GOBP_OPTIC_CUP_MORPHOGENESIS...,SET,7,0.7828,0.015283,0.38042,0.019815,GOBP_OPTIC_CUP_MORPHOGENESIS_INVOLVED_IN_CAMERA_TYPE_EYE_DEVELOPMENT,0.727981316067653
TTF1_Q6,SET,239,0.11734,0.013301,0.057062,0.019879,TTF1_Q6,0.729561399155227
MIR498_5P,SET,216,0.12519,0.013499,0.060899,0.019915,MIR498_5P,0.729565072992701
PRC2_EED_DN.V1_DN,SET,177,0.12387,0.012104,0.060283,0.019954,PRC2_EED_DN.V1_DN,0.729565072992701
HP_DECREASED_CIRCULATING_TOT...2,SET,8,0.68493,0.014295,0.33337,0.019968,HP_DECREASED_CIRCULATING_TOTAL_IGG,0.729565072992701
GOBP_DEOXYRIBONUCLEOSIDE_MON...2,SET,14,0.49781,0.013742,0.24242,0.020017,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.729565072992701
HP_HYPERPIGMENTED_HYPOPIGMEN...,SET,5,0.82053,0.01354,0.39965,0.020038,HP_HYPERPIGMENTED_HYPOPIGMENTED_MACULES,0.729565072992701
GSE32423_CTRL_VS_IL4_MEMORY_...2,SET,176,0.13347,0.013005,0.065013,0.020048,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP,0.729565072992701
HP_REDUCED_BLOOD_FOLATE_CONC...,SET,4,0.90312,0.01333,0.43995,0.020054,HP_REDUCED_BLOOD_FOLATE_CONCENTRATION,0.729565072992701
GOBP_ORGANIC_CATION_TRANSPORT,SET,108,0.18219,0.013933,0.088761,0.020063,GOBP_ORGANIC_CATION_TRANSPORT,0.729565072992701
GSE22935_WT_VS_MYD88_KO_MACR...5,SET,175,0.13224,0.01285,0.064444,0.020092,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_DN,0.729565072992701
HP_DIFFICULTY_WALKING,SET,277,0.1026,0.012507,0.050014,0.020125,HP_DIFFICULTY_WALKING,0.729565072992701
GOMF_CHROMATIN_INSULATOR_SEQ...,SET,4,0.72465,0.010695,0.35327,0.020129,GOMF_CHROMATIN_INSULATOR_SEQUENCE_BINDING,0.729565072992701
GOMF_HISTONE_H2A_UBIQUITIN_L...,SET,6,0.66975,0.012106,0.32652,0.020131,GOMF_HISTONE_H2A_UBIQUITIN_LIGASE_ACTIVITY,0.729565072992701
GSE16697_CD4_TCELL_VS_TFH_CD...1,SET,183,0.13016,0.012931,0.063476,0.020162,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_DN,0.72992740625
GSE17721_LPS_VS_GARDIQUIMOD_...7,SET,181,0.12658,0.012507,0.061807,0.020287,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN,0.733384523316062
GOBP_BRONCHUS_DEVELOPMENT,SET,11,0.60087,0.014704,0.29343,0.0203,GOBP_BRONCHUS_DEVELOPMENT,0.733384523316062
GOBP_TRANSEPITHELIAL_TRANSPO...,SET,35,0.32317,0.014097,0.15787,0.02033,GOBP_TRANSEPITHELIAL_TRANSPORT,0.733384523316062
GOMF_SINGLE_STRANDED_DNA_END...,SET,10,0.49577,0.011568,0.24221,0.020344,GOMF_SINGLE_STRANDED_DNA_ENDODEOXYRIBONUCLEASE_ACTIVITY,0.733384523316062
HP_MICROTIA_THIRD_DEGREE,SET,10,0.47492,0.011081,0.23207,0.020363,HP_MICROTIA_THIRD_DEGREE,0.733384523316062
HP_AORTIC_TORTUOSITY,SET,6,0.82725,0.014953,0.40451,0.02043,HP_AORTIC_TORTUOSITY,0.734441226804124
MIR548E_3P,SET,433,0.085649,0.012998,0.041892,0.020459,MIR548E_3P,0.734441226804124
WP_DNA_MISMATCH_REPAIR,SET,23,0.3228,0.011419,0.15791,0.020472,WP_DNA_MISMATCH_REPAIR,0.734441226804124
MIR3658,SET,734,0.067082,0.013143,0.032819,0.020485,MIR3658,0.734441226804124
GSE36888_STAT5_AB_KNOCKIN_VS...6,SET,175,0.12777,0.012416,0.06252,0.020498,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP,0.734441226804124
GSE45365_WT_VS_IFNAR_KO_BCEL...3,SET,150,0.13502,0.012155,0.066083,0.020525,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP,0.734651261585994
GSE1460_DP_VS_CD4_THYMOCYTE_...1,SET,189,0.1399,0.014122,0.068511,0.020582,GSE1460_DP_VS_CD4_THYMOCYTE_DN,0.735927302158273
REACTOME_ENDOSOMAL_SORTING_C...,SET,30,0.30107,0.012161,0.14747,0.020603,REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT,0.735927302158273
GOCC_EXON_EXON_JUNCTION_COMP...,SET,16,0.41635,0.012286,0.20406,0.020666,GOCC_EXON_EXON_JUNCTION_COMPLEX,0.737419743326489
MIR4291,SET,351,0.093225,0.012767,0.045715,0.020719,MIR4291,0.738552661538462
MALTA_CURATED_STEMNESS_MARKE...,SET,20,0.43093,0.014216,0.21139,0.020758,MALTA_CURATED_STEMNESS_MARKERS,0.738855015353122
GOCC_TUBULAR_ENDOSOME,SET,5,0.78997,0.013035,0.38758,0.02077,GOCC_TUBULAR_ENDOSOME,0.738855015353122
HP_ABNORMAL_HALLUX_PHALANX_M...,SET,37,0.27421,0.012298,0.1346,0.020819,HP_ABNORMAL_HALLUX_PHALANX_MORPHOLOGY,0.739840843558282
HP_MACRODONTIA_OF_PERMANENT_...,SET,12,0.53473,0.013667,0.26254,0.020843,HP_MACRODONTIA_OF_PERMANENT_MAXILLARY_CENTRAL_INCISOR,0.739937145045965
GOBP_REGULATION_OF_CARDIAC_M...6,SET,25,0.36472,0.01345,0.17914,0.020885,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.740671607142857
GOBP_CARDIAC_MUSCLE_CONTRACT...,SET,131,0.16139,0.013585,0.079309,0.020935,GOBP_CARDIAC_MUSCLE_CONTRACTION,0.741687996941896
MIKKELSEN_NPC_WITH_LCP_H3K27...,SET,7,0.63671,0.012431,0.31302,0.020979,MIKKELSEN_NPC_WITH_LCP_H3K27ME3,0.742017482197355
HP_MEGALOCORNEA,SET,42,0.29021,0.013865,0.14269,0.020987,HP_MEGALOCORNEA,0.742017482197355
SERVITJA_ISLET_HNF1A_TARGETS...1,SET,100,0.18123,0.013339,0.089189,0.021086,SERVITJA_ISLET_HNF1A_TARGETS_DN,0.743401788577154
GOBP_POSITIVE_REGULATION_OF_...400,SET,27,0.3602,0.013804,0.17728,0.021094,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.743401788577154
GOBP_POSITIVE_REGULATION_OF_...645,SET,81,0.19502,0.012925,0.096013,0.021127,GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,0.743401788577154
WP_SPHINGOLIPID_METABOLISM_I...1,SET,23,0.3836,0.013569,0.18886,0.021128,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,0.743401788577154
MIR5571_3P,SET,39,0.28797,0.013259,0.14181,0.021151,MIR5571_3P,0.743401788577154
GOMF_G_PROTEIN_COUPLED_ACETY...,SET,7,0.75027,0.014648,0.36959,0.021186,GOMF_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_ACTIVITY,0.743401788577154
HP_PROLONGED_QTC_INTERVAL,SET,28,0.35041,0.013675,0.17263,0.021193,HP_PROLONGED_QTC_INTERVAL,0.743401788577154
chr12q14,SET,32,0.47764,0.019925,0.23539,0.021227,chr12q14,0.743401788577154
GSE20366_CD103_POS_VS_NEG_TR...2,SET,179,0.13365,0.013133,0.065865,0.02123,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP,0.743401788577154
GSE14308_TH2_VS_NAIVE_CD4_TC...2,SET,175,0.12451,0.012099,0.061373,0.021246,GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP,0.743401788577154
HERNANDEZ_MITOTIC_ARREST_BY_...2,SET,23,0.40824,0.014441,0.2013,0.021286,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,0.743401788577154
KEGG_MEDICUS_REFERENCE_PURIN...1,SET,11,0.51364,0.012569,0.25334,0.021316,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_ADENINE_TO_AMP,0.743401788577154
GSE36891_UNSTIM_VS_POLYIC_TL...2,SET,141,0.15816,0.013808,0.078026,0.021339,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP,0.743401788577154
GOBP_REGULATION_OF_PROTEIN_D...2,SET,69,0.20532,0.012564,0.1013,0.021346,GOBP_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.743401788577154
GOBP_NEGATIVE_REGULATION_OF_...560,SET,6,0.72662,0.013134,0.3585,0.021347,GOBP_NEGATIVE_REGULATION_OF_RESPIRATORY_BURST,0.743401788577154
GOBP_TRACHEA_FORMATION,SET,7,0.76024,0.014842,0.37517,0.02137,GOBP_TRACHEA_FORMATION,0.743457807807808
GOMF_ALCOHOL_DEHYDROGENASE_N...2,SET,23,0.40739,0.014411,0.20109,0.021397,GOMF_ALCOHOL_DEHYDROGENASE_NADPPLUS_ACTIVITY,0.743652735
HP_RIGHT_VENTRICULAR_HYPERTR...,SET,25,0.3243,0.011959,0.16014,0.021436,HP_RIGHT_VENTRICULAR_HYPERTROPHY,0.744263916083916
DARWICHE_PAPILLOMA_PROGRESSI...,SET,72,0.20677,0.012924,0.10217,0.021499,DARWICHE_PAPILLOMA_PROGRESSION_RISK,0.745363207171315
GOBP_NEUROMUSCULAR_PROCESS_C...2,SET,16,0.42381,0.012506,0.20943,0.021512,GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE,0.745363207171315
HP_ABNORMAL_FUNDUS_AUTOFLUOR...,SET,26,0.38002,0.014291,0.18783,0.021532,HP_ABNORMAL_FUNDUS_AUTOFLUORESCENCE_IMAGING,0.745363207171315
DESCARTES_FETAL_STOMACH_MYEL...,SET,65,0.23265,0.013819,0.11502,0.021564,DESCARTES_FETAL_STOMACH_MYELOID_CELLS,0.745717713026445
GOMF_GLYCOSPHINGOLIPID_BINDI...,SET,10,0.56436,0.013168,0.27914,0.021606,GOMF_GLYCOSPHINGOLIPID_BINDING,0.745717713026445
KEGG_MEDICUS_PATHOGEN_ESCHER...5,SET,14,0.44181,0.012196,0.21859,0.021636,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPT_TO_RAC_SIGNALING_PATHWAY,0.745717713026445
GOBP_TRNA_WOBBLE_BASE_MODIFI...,SET,18,0.39205,0.01227,0.19405,0.02168,GOBP_TRNA_WOBBLE_BASE_MODIFICATION,0.745717713026445
GSE9988_ANTI_TREM1_AND_LPS_V...1,SET,185,0.12071,0.012057,0.059752,0.021689,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN,0.745717713026445
WP_NPHP1_DELETION_SYNDROME,SET,10,0.60014,0.014003,0.2971,0.021701,WP_NPHP1_DELETION_SYNDROME,0.745717713026445
REACTOME_VITAMIN_B5_PANTOTHE...,SET,19,0.37322,0.012001,0.18479,0.021716,REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM,0.745717713026445
HP_APLASIA_HYPOPLASIA_OF_THE...12,SET,66,0.20871,0.012492,0.10336,0.021733,HP_APLASIA_HYPOPLASIA_OF_THE_BREASTS,0.745717713026445
MIR4802_5P,SET,57,0.2377,0.013224,0.11774,0.021756,MIR4802_5P,0.745717713026445
GOMF_ANDROGEN_BINDING,SET,4,0.92408,0.013639,0.45807,0.021838,GOMF_ANDROGEN_BINDING,0.745717713026445
GSE36888_UNTREATED_VS_IL2_TR...4,SET,182,0.13241,0.013118,0.065639,0.021844,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_UP,0.745717713026445
MIR148B_3P,SET,313,0.10022,0.012975,0.049685,0.021846,MIR148B_3P,0.745717713026445
TIMOFEEVA_GROWTH_STRESS_VIA_...,SET,16,0.43702,0.012896,0.21667,0.021859,TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN,0.745717713026445
GOMF_SODIUM_PROTON_ANTIPORTE...,SET,13,0.46277,0.01231,0.22947,0.021873,GOMF_SODIUM_PROTON_ANTIPORTER_ACTIVITY,0.745717713026445
HP_PERIFOVEAL_RING_OF_HYPERA...,SET,15,0.48023,0.013722,0.23815,0.021878,HP_PERIFOVEAL_RING_OF_HYPERAUTOFLUORESCENCE,0.745717713026445
GOBP_REGULATION_OF_EXTENT_OF...,SET,83,0.19351,0.012982,0.095972,0.02189,GOBP_REGULATION_OF_EXTENT_OF_CELL_GROWTH,0.745717713026445
GOMF_G_PROTEIN_COUPLED_NEURO...,SET,12,0.55619,0.014216,0.27589,0.021907,GOMF_G_PROTEIN_COUPLED_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.745717713026445
GOMF_METAL_CATION_MONOATOMIC...,SET,39,0.27648,0.01273,0.13721,0.021962,GOMF_METAL_CATION_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,0.746062697560976
TSUDA_ALVEOLAR_SOFT_PART_SAR...,SET,10,0.58006,0.013534,0.28792,0.021978,TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,0.746062697560976
MIR5588_3P,SET,41,0.26561,0.012538,0.13186,0.021991,MIR5588_3P,0.746062697560976
GOBP_POSITIVE_REGULATION_OF_...490,SET,32,0.32134,0.013404,0.15954,0.022003,GOBP_POSITIVE_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,0.746062697560976
GSE46606_IRF4HIGH_VS_IRF4MID...4,SET,177,0.11995,0.011721,0.059578,0.02205,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.746572594936709
GOBP_TELOMERE_MAINTENANCE_VI...1,SET,14,0.3928,0.010843,0.19512,0.022061,GOBP_TELOMERE_MAINTENANCE_VIA_RECOMBINATION,0.746572594936709
GSE27786_LSK_VS_NKTCELL_UP,SET,174,0.12907,0.012506,0.064137,0.022099,GSE27786_LSK_VS_NKTCELL_UP,0.747131074902724
GOBP_DISTAL_TUBULE_DEVELOPME...,SET,11,0.58078,0.014212,0.2887,0.022133,GOBP_DISTAL_TUBULE_DEVELOPMENT,0.747266242718447
GOBP_RENAL_VESICLE_FORMATION,SET,8,0.65803,0.013733,0.32714,0.022146,GOBP_RENAL_VESICLE_FORMATION,0.747266242718447
GOBP_POSITIVE_REGULATION_OF_...742,SET,6,0.8113,0.014665,0.40359,0.022212,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC,0.748766304558681
HP_FOCAL_CLONIC_SEIZURE,SET,39,0.27656,0.012733,0.13764,0.02226,HP_FOCAL_CLONIC_SEIZURE,0.74965726744186
ATF3_Q6,SET,229,0.11608,0.012884,0.057786,0.022284,ATF3_Q6,0.749739031945789
MIR1843,SET,58,0.23465,0.013169,0.11688,0.022344,MIR1843,0.749829137931034
GOBP_NEUTROPHIL_HOMEOSTASIS,SET,19,0.42122,0.013544,0.20991,0.022401,GOBP_NEUTROPHIL_HOMEOSTASIS,0.749829137931034
QI_PBMC_ZOSTAVAX_AGE_50_75YO...4,SET,266,0.10737,0.01283,0.053511,0.02241,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE,0.749829137931034
GOMF_MAP_KINASE_TYROSINE_SER...,SET,11,0.56303,0.013778,0.28061,0.022411,GOMF_MAP_KINASE_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.749829137931034
HARALAMBIEVA_PBMC_TIV_AGE_50...3,SET,13,0.46587,0.012393,0.23233,0.022476,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_3DY_POSITIVE,0.749829137931034
GSE24142_EARLY_THYMIC_PROGEN...4,SET,179,0.13021,0.012795,0.064938,0.02248,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN,0.749829137931034
CAO_BLOOD_FLUZONE_AGE_05_14Y...5,SET,6,0.75942,0.013727,0.37878,0.022492,CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_DN,0.749829137931034
GSE16385_ROSIGLITAZONE_IL4_V...5,SET,182,0.12535,0.012418,0.062522,0.022498,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN,0.749829137931034
GSE27786_NKCELL_VS_MONO_MAC_...2,SET,178,0.1224,0.011994,0.061052,0.022499,GSE27786_NKCELL_VS_MONO_MAC_UP,0.749829137931034
GOBP_MATURE_B_CELL_DIFFERENT...1,SET,34,0.31384,0.013494,0.15655,0.022506,GOBP_MATURE_B_CELL_DIFFERENTIATION,0.749829137931034
GOBP_MIDBRAIN_DOPAMINERGIC_N...,SET,15,0.5183,0.014809,0.25859,0.022524,GOBP_MIDBRAIN_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.749829137931034
MIR6823_5P,SET,64,0.21199,0.012495,0.10586,0.022617,MIR6823_5P,0.752110668161435
MCGOWAN_RSP6_TARGETS_DN,SET,4,0.84239,0.012433,0.42087,0.022674,MCGOWAN_RSP6_TARGETS_DN,0.752110668161435
MIR34C_3P,SET,58,0.21376,0.011996,0.1068,0.022683,MIR34C_3P,0.752110668161435
GOBP_REGULATION_OF_MYELOID_L...2,SET,52,0.24148,0.012834,0.12071,0.022731,GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.752110668161435
HP_ABNORMAL_ELASTICITY_OF_SK...,SET,204,0.12014,0.012594,0.060104,0.022819,HP_ABNORMAL_ELASTICITY_OF_SKIN,0.752110668161435
GOBP_CYTOPLASMIC_SEQUESTERIN...2,SET,13,0.445,0.011838,0.22265,0.02283,GOBP_CYTOPLASMIC_SEQUESTERING_OF_PROTEIN,0.752110668161435
ERWIN_COHEN_BLOOD_VACCINE_TC...1,SET,6,0.69183,0.012505,0.34621,0.022848,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_DN,0.752110668161435
GOBP_LEUKOCYTE_CHEMOTAXIS,SET,219,0.12685,0.013772,0.063488,0.022862,GOBP_LEUKOCYTE_CHEMOTAXIS,0.752110668161435
HP_SCLERAL_STAPHYLOMA,SET,9,0.59318,0.013131,0.29701,0.02291,HP_SCLERAL_STAPHYLOMA,0.752110668161435
GOBP_PROTEIN_O_LINKED_FUCOSY...,SET,4,0.73608,0.010864,0.36862,0.022929,GOBP_PROTEIN_O_LINKED_FUCOSYLATION,0.752110668161435
MITSIADES_RESPONSE_TO_APLIDI...1,SET,229,0.11116,0.012338,0.055705,0.023001,MITSIADES_RESPONSE_TO_APLIDIN_DN,0.752110668161435
GSE360_CTRL_VS_T_GONDII_DC_UP,SET,177,0.12805,0.012512,0.064183,0.023026,GSE360_CTRL_VS_T_GONDII_DC_UP,0.752110668161435
HP_EPISODIC_HYPOKALEMIA,SET,4,0.9529,0.014064,0.47764,0.023029,HP_EPISODIC_HYPOKALEMIA,0.752110668161435
GSE40184_HEALTHY_VS_HCV_INFE...1,SET,187,0.12212,0.012262,0.061218,0.023039,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_DN,0.752110668161435
SHETH_LIVER_CANCER_VS_TXNIP_...3,SET,69,0.20339,0.012446,0.10198,0.02306,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,0.752110668161435
MIR152_3P,SET,314,0.098976,0.012833,0.049631,0.02307,MIR152_3P,0.752110668161435
GOBP_INHIBITION_OF_NEUROEPIT...,SET,6,0.70623,0.012766,0.35417,0.023082,GOBP_INHIBITION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.752110668161435
GOBP_NEGATIVE_REGULATION_OF_...83,SET,307,0.095252,0.012214,0.047772,0.023089,GOBP_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS,0.752110668161435
MIR513B_5P,SET,254,0.10942,0.012781,0.054879,0.023091,MIR513B_5P,0.752110668161435
GOBP_REGULATION_OF_GLIOGENES...,SET,101,0.18062,0.01336,0.090602,0.023109,GOBP_REGULATION_OF_GLIOGENESIS,0.752110668161435
MIR3151_5P,SET,48,0.22703,0.011593,0.11392,0.023142,MIR3151_5P,0.752110668161435
GOMF_GTPASE_ACTIVATING_PROTE...,SET,11,0.52224,0.01278,0.26206,0.023149,GOMF_GTPASE_ACTIVATING_PROTEIN_BINDING,0.752110668161435
GOMF_DNA_BINDING_TRANSCRIPTI...2,SET,1328,0.05486,0.014211,0.027539,0.023187,GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.752110668161435
GSE6674_CPG_VS_PL2_3_STIM_BC...1,SET,175,0.12727,0.012367,0.063903,0.023211,GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN,0.752110668161435
GOBP_EMBRYONIC_HEART_TUBE_LE...,SET,5,0.66718,0.011009,0.335,0.023216,GOBP_EMBRYONIC_HEART_TUBE_LEFT_RIGHT_PATTERN_FORMATION,0.752110668161435
GOBP_REGULATION_OF_PHOSPHOPR...,SET,38,0.26973,0.012259,0.13546,0.023239,GOBP_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,0.752110668161435
GOBP_MONOSACCHARIDE_TRANSMEM...,SET,110,0.16712,0.012897,0.083945,0.023258,GOBP_MONOSACCHARIDE_TRANSMEMBRANE_TRANSPORT,0.752110668161435
HP_VISUALLY_INDUCED_SEIZURE,SET,15,0.47221,0.013492,0.23719,0.023259,HP_VISUALLY_INDUCED_SEIZURE,0.752110668161435
GOBP_REGULATION_OF_LYSOSOME_...2,SET,4,0.84739,0.012507,0.42567,0.023264,GOBP_REGULATION_OF_LYSOSOME_SIZE,0.752110668161435
GOCC_BORC_COMPLEX,SET,4,0.84739,0.012507,0.42567,0.023264,GOCC_BORC_COMPLEX,0.752110668161435
ZNF169_TARGET_GENES,SET,35,0.27301,0.011909,0.13719,0.0233,ZNF169_TARGET_GENES,0.752110668161435
REACTOME_DUAL_INCISION_IN_TC...,SET,60,0.19147,0.010928,0.096245,0.023336,REACTOME_DUAL_INCISION_IN_TC_NER,0.752110668161435
GOBP_ERYTHROCYTE_MATURATION,SET,18,0.39176,0.012261,0.19697,0.023365,GOBP_ERYTHROCYTE_MATURATION,0.752110668161435
GOBP_REGULATION_OF_KIDNEY_SI...,SET,5,0.83279,0.013742,0.41874,0.02337,GOBP_REGULATION_OF_KIDNEY_SIZE,0.752110668161435
GOBP_POSITIVE_REGULATION_OF_...215,SET,5,0.73368,0.012107,0.36891,0.023372,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR,0.752110668161435
HP_ABNORMAL_LABIA_MORPHOLOGY,SET,72,0.20706,0.012942,0.10415,0.023409,HP_ABNORMAL_LABIA_MORPHOLOGY,0.752110668161435
HALLMARK_EPITHELIAL_MESENCHY...,SET,187,0.13775,0.013831,0.069318,0.02346,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.752110668161435
GOBP_TAXIS,SET,423,0.090286,0.013546,0.045454,0.023506,GOBP_TAXIS,0.752110668161435
GOBP_REGULATION_OF_OSTEOBLAS...1,SET,116,0.16849,0.013351,0.084832,0.023517,GOBP_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.752110668161435
HP_ABNORMALITY_OF_FOVEAL_PIG...,SET,5,0.93014,0.015348,0.46834,0.023521,HP_ABNORMALITY_OF_FOVEAL_PIGMENTATION,0.752110668161435
BIOCARTA_IRES_PATHWAY,SET,7,0.5767,0.011259,0.29038,0.023522,BIOCARTA_IRES_PATHWAY,0.752110668161435
GOMF_PHOSPHATIDYLINOSITOL_3_...7,SET,26,0.31274,0.011761,0.15748,0.023531,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_BINDING,0.752110668161435
HP_LOW_PLASMA_CITRULLINE,SET,5,0.65995,0.01089,0.33245,0.023574,HP_LOW_PLASMA_CITRULLINE,0.752110668161435
REACTOME_XENOBIOTICS,SET,23,0.41142,0.014553,0.20737,0.023634,REACTOME_XENOBIOTICS,0.752110668161435
GSE27786_LSK_VS_MONO_MAC_UP,SET,174,0.12379,0.011995,0.062404,0.023653,GSE27786_LSK_VS_MONO_MAC_UP,0.752110668161435
HP_SHORT_UMBILICAL_CORD,SET,6,0.74898,0.013538,0.37769,0.023689,HP_SHORT_UMBILICAL_CORD,0.752110668161435
HP_HIP_PAIN,SET,11,0.48002,0.011747,0.24209,0.023702,HP_HIP_PAIN,0.752110668161435
GOMF_AMINOPEPTIDASE_ACTIVITY,SET,36,0.29235,0.012934,0.14746,0.023718,GOMF_AMINOPEPTIDASE_ACTIVITY,0.752110668161435
HP_THICKENED_EARS,SET,11,0.51807,0.012678,0.26139,0.023749,HP_THICKENED_EARS,0.752110668161435
HP_DERMAL_ATROPHY,SET,90,0.17575,0.012275,0.088682,0.02376,HP_DERMAL_ATROPHY,0.752110668161435
GOBP_ENDOSOME_ORGANIZATION,SET,86,0.17415,0.011892,0.087893,0.02378,GOBP_ENDOSOME_ORGANIZATION,0.752110668161435
GOBP_RESPONSE_TO_THYROXINE,SET,4,0.97685,0.014418,0.49302,0.023783,GOBP_RESPONSE_TO_THYROXINE,0.752110668161435
LANDEMAINE_LUNG_METASTASIS,SET,20,0.43054,0.014203,0.21734,0.023806,LANDEMAINE_LUNG_METASTASIS,0.752110668161435
AP2_Q3,SET,230,0.11217,0.012477,0.05663,0.023813,AP2_Q3,0.752110668161435
GOBP_POSITIVE_REGULATION_OF_...23,SET,38,0.30283,0.013763,0.15288,0.023813,GOBP_POSITIVE_REGULATION_OF_AMINE_TRANSPORT,0.752110668161435
DESCARTES_MAIN_FETAL_SKELETA...,SET,134,0.14758,0.012562,0.074507,0.02382,DESCARTES_MAIN_FETAL_SKELETAL_MUSCLE_CELLS,0.752110668161435
GTTAAAG_MIR302B,SET,63,0.20916,0.012232,0.10566,0.02388,GTTAAAG_MIR302B,0.752110668161435
HP_PHOTOSENSITIVE_TONIC_CLON...,SET,12,0.53734,0.013734,0.27143,0.02388,HP_PHOTOSENSITIVE_TONIC_CLONIC_SEIZURE,0.752110668161435
HERNANDEZ_MITOTIC_ARREST_BY_...4,SET,53,0.23958,0.012854,0.12112,0.023968,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,0.752110668161435
GOBP_POSITIVE_REGULATION_OF_...146,SET,4,0.90126,0.013302,0.45568,0.023981,GOBP_POSITIVE_REGULATION_OF_CENTRIOLE_ELONGATION,0.752110668161435
GSE37533_PPARG2_FOXP3_VS_FOX...3,SET,175,0.12926,0.01256,0.065354,0.023983,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,0.752110668161435
HP_CHRONIC_ORAL_CANDIDIASIS,SET,26,0.32774,0.012325,0.16576,0.024013,HP_CHRONIC_ORAL_CANDIDIASIS,0.752110668161435
GSE29164_DAY3_VS_DAY7_CD8_TC...3,SET,183,0.12522,0.01244,0.063331,0.024014,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN,0.752110668161435
LMO2COM_02,SET,220,0.11688,0.012718,0.059112,0.024015,LMO2COM_02,0.752110668161435
GSE8515_CTRL_VS_IL1_4H_STIM_...1,SET,172,0.12593,0.012132,0.063699,0.024029,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN,0.752110668161435
GOBP_REGULATION_OF_LEUKOCYTE...7,SET,226,0.12076,0.013316,0.06109,0.024043,GOBP_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,0.752110668161435
MIR4793_3P,SET,68,0.21365,0.012979,0.10811,0.024075,MIR4793_3P,0.752110668161435
HP_POLYARTICULAR_ARTHROPATHY,SET,18,0.42205,0.013209,0.21358,0.024079,HP_POLYARTICULAR_ARTHROPATHY,0.752110668161435
GOBP_REGULATION_OF_SISTER_CH...1,SET,11,0.54357,0.013302,0.27513,0.024103,GOBP_REGULATION_OF_SISTER_CHROMATID_COHESION,0.752110668161435
GOBP_NUCLEOTIDE_BINDING_DOMA...,SET,26,0.33117,0.012454,0.16765,0.02412,GOBP_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.752110668161435
GOBP_REGULATION_OF_CAMP_MEDI...,SET,19,0.40632,0.013065,0.20571,0.024129,GOBP_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.752110668161435
GSE12003_4D_VS_8D_CULTURE_MI...1,SET,153,0.13707,0.012461,0.069462,0.024237,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_DN,0.753754685073339
GSE22611_UNSTIM_VS_6H_MDP_ST...1,SET,174,0.12808,0.01241,0.064917,0.024259,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.753754685073339
GOBP_DETECTION_OF_CELL_DENSI...,SET,8,0.55774,0.01164,0.28272,0.02427,GOBP_DETECTION_OF_CELL_DENSITY,0.753754685073339
CGTCTTA_MIR208,SET,8,0.61282,0.01279,0.31072,0.024298,CGTCTTA_MIR208,0.753754685073339
GOBP_NEUTROPHIL_APOPTOTIC_PR...,SET,7,0.74659,0.014576,0.3786,0.024312,GOBP_NEUTROPHIL_APOPTOTIC_PROCESS,0.753754685073339
GOBP_IP_10_PRODUCTION,SET,4,0.97137,0.014337,0.49276,0.024354,GOBP_IP_10_PRODUCTION,0.753754685073339
CTGAGCC_MIR24,SET,201,0.11699,0.012174,0.059353,0.024367,CTGAGCC_MIR24,0.753754685073339
HP_ROTARY_NYSTAGMUS,SET,21,0.37607,0.012712,0.19085,0.0244,HP_ROTARY_NYSTAGMUS,0.753754685073339
GSE2405_HEAT_KILLED_VS_LIVE_...4,SET,178,0.11903,0.011664,0.060414,0.024411,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,0.753754685073339
HP_DEVIATION_OF_THE_2ND_TOE,SET,5,0.88079,0.014534,0.44717,0.024443,HP_DEVIATION_OF_THE_2ND_TOE,0.753754685073339
MIR148A_3P,SET,315,0.09751,0.012663,0.04951,0.024456,MIR148A_3P,0.753754685073339
GOBP_REGULATION_OF_MITOTIC_R...,SET,6,0.56506,0.010214,0.28696,0.024477,GOBP_REGULATION_OF_MITOTIC_RECOMBINATION,0.753754685073339
GSE19772_CTRL_VS_HCMV_INF_MO...1,SET,184,0.1233,0.012282,0.062637,0.024511,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,0.753754685073339
MTOR_UP.V1_UP,SET,155,0.13355,0.01222,0.067849,0.02452,MTOR_UP.V1_UP,0.753754685073339
GOMF_CERAMIDE_1_PHOSPHATE_BI...,SET,5,0.70917,0.011702,0.36032,0.024532,GOMF_CERAMIDE_1_PHOSPHATE_BINDING,0.753754685073339
MCM2_TARGET_GENES,SET,75,0.1873,0.011947,0.095176,0.024546,MCM2_TARGET_GENES,0.753754685073339
CAHOY_ASTROGLIAL,SET,89,0.18763,0.013033,0.095397,0.024607,CAHOY_ASTROGLIAL,0.753754685073339
GSE16385_MONOCYTE_VS_12H_IFN...2,SET,183,0.1225,0.01217,0.062291,0.024621,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,0.753754685073339
GOBP_UV_DAMAGE_EXCISION_REPA...,SET,11,0.39639,0.0097001,0.20157,0.024625,GOBP_UV_DAMAGE_EXCISION_REPAIR,0.753754685073339
GOBP_PHOSPHOLIPID_DEPHOSPHOR...,SET,27,0.27916,0.010698,0.14197,0.024641,GOBP_PHOSPHOLIPID_DEPHOSPHORYLATION,0.753754685073339
HP_ELFIN_FACIES,SET,18,0.4291,0.01343,0.2183,0.024679,HP_ELFIN_FACIES,0.753754685073339
MIR4514,SET,162,0.13197,0.012342,0.067143,0.024686,MIR4514,0.753754685073339
MIR585_5P,SET,119,0.16186,0.012989,0.082402,0.02476,MIR585_5P,0.753754685073339
GSE29164_DAY3_VS_DAY7_CD8_TC...1,SET,187,0.12699,0.012751,0.064656,0.024767,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DN,0.753754685073339
HP_COMPLETE_ATRIOVENTRICULAR...,SET,16,0.38293,0.0113,0.19502,0.024798,HP_COMPLETE_ATRIOVENTRICULAR_CANAL_DEFECT,0.753754685073339
MIR338_5P,SET,428,0.084435,0.012741,0.043025,0.024863,MIR338_5P,0.753754685073339
GOBP_CARDIAC_CONDUCTION,SET,91,0.19163,0.013459,0.097659,0.024874,GOBP_CARDIAC_CONDUCTION,0.753754685073339
GOBP_REGULATION_OF_PROTEIN_C...4,SET,374,0.085338,0.012056,0.043516,0.024943,GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.753754685073339
LANDIS_ERBB2_BREAST_TUMORS_6...1,SET,36,0.30535,0.013509,0.15572,0.024956,LANDIS_ERBB2_BREAST_TUMORS_65_DN,0.753754685073339
GOBP_ION_CHANNEL_MODULATING_...,SET,8,0.65134,0.013594,0.33218,0.024959,GOBP_ION_CHANNEL_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.753754685073339
GSE11057_NAIVE_VS_EFF_MEMORY...1,SET,173,0.12943,0.012505,0.06601,0.02496,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,0.753754685073339
HIRSCH_CELLULAR_TRANSFORMATI...1,SET,91,0.17764,0.012476,0.090609,0.024979,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,0.753754685073339
GOBP_REGULATION_OF_CHAPERONE...,SET,8,0.54042,0.011279,0.27568,0.024987,GOBP_REGULATION_OF_CHAPERONE_MEDIATED_AUTOPHAGY,0.753754685073339
GSE30083_SP1_VS_SP3_THYMOCYT...1,SET,181,0.12559,0.012408,0.064074,0.025004,GSE30083_SP1_VS_SP3_THYMOCYTE_DN,0.753754685073339
REACTOME_SODIUM_PROTON_EXCHA...,SET,7,0.62681,0.012237,0.31985,0.025024,REACTOME_SODIUM_PROTON_EXCHANGERS,0.753754685073339
GOMF_PROTEIN_SERINE_THREONIN...1,SET,63,0.20819,0.012175,0.10623,0.025024,GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY,0.753754685073339
FINETTI_BREAST_CANCERS_KINOM...2,SET,15,0.43381,0.012395,0.22138,0.025031,FINETTI_BREAST_CANCERS_KINOME_GRAY,0.753754685073339
GOCC_ESC_E_Z_COMPLEX,SET,14,0.42893,0.01184,0.21893,0.025051,GOCC_ESC_E_Z_COMPLEX,0.753754685073339
GOBP_POTASSIUM_ION_IMPORT_AC...,SET,44,0.28294,0.013835,0.14443,0.025066,GOBP_POTASSIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.753754685073339
GOBP_REGULATION_OF_COMPLEMEN...1,SET,17,0.45969,0.013982,0.23467,0.025073,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION,0.753754685073339
MIR335_5P,SET,105,0.16696,0.01259,0.085245,0.02509,MIR335_5P,0.753754685073339
JIANG_VHL_TARGETS,SET,77,0.18528,0.011974,0.094621,0.025116,JIANG_VHL_TARGETS,0.753754685073339
GOBP_CELLULAR_GLUCURONIDATION,SET,19,0.65574,0.021085,0.33493,0.025131,GOBP_CELLULAR_GLUCURONIDATION,0.753754685073339
MIR411_5P,SET,44,0.24224,0.011845,0.12373,0.025136,MIR411_5P,0.753754685073339
MIR4530,SET,133,0.14627,0.012405,0.074737,0.025175,MIR4530,0.75427338362069
GOBP_PHOSPHATIDYLINOSITOL_DE...,SET,24,0.28713,0.010375,0.14675,0.025201,GOBP_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION,0.754402028423773
HP_ABNORMALITY_OF_THE_VERTEB...1,SET,1337,0.046454,0.012071,0.023757,0.025277,HP_ABNORMALITY_OF_THE_VERTEBRAL_COLUMN,0.755913779019777
GOCC_FASCIA_ADHERENS,SET,9,0.63275,0.014007,0.32365,0.025295,GOCC_FASCIA_ADHERENS,0.755913779019777
HP_DECREASED_CIRCULATING_TOT...1,SET,7,0.72174,0.014091,0.36945,0.025387,HP_DECREASED_CIRCULATING_TOTAL_IGA,0.758011327319588
FOXD2_TARGET_GENES,SET,993,0.052623,0.011903,0.026948,0.025432,FOXD2_TARGET_GENES,0.758703141630901
GOBP_POSITIVE_REGULATION_OF_...87,SET,9,0.66336,0.014684,0.33991,0.025503,GOBP_POSITIVE_REGULATION_OF_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.759904524421594
GCM_MSN,SET,23,0.33016,0.011679,0.1692,0.025516,GCM_MSN,0.759904524421594
AREB6_02,SET,236,0.11266,0.012692,0.057749,0.025541,AREB6_02,0.759997821061644
MIR4693_5P,SET,100,0.16788,0.012357,0.086068,0.025564,MIR4693_5P,0.760031497005988
GOBP_SYNAPTONEMAL_COMPLEX_OR...,SET,23,0.32132,0.011366,0.16477,0.025591,GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION,0.760183935897436
HP_MACULAR_HYPERPIGMENTATION,SET,6,0.79227,0.014321,0.40681,0.025745,HP_MACULAR_HYPERPIGMENTATION,0.762028034223706
GSE23321_CENTRAL_MEMORY_VS_N...2,SET,182,0.12157,0.012044,0.062426,0.025751,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.762028034223706
GSE360_HIGH_VS_LOW_DOSE_B_MA...2,SET,179,0.12332,0.012118,0.063332,0.025764,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP,0.762028034223706
GSE12001_MIR223_KO_VS_WT_NEU...2,SET,150,0.13672,0.012308,0.070215,0.025766,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_UP,0.762028034223706
GOBP_LATE_ENDOSOME_TO_VACUOL...1,SET,36,0.25997,0.011501,0.13356,0.025807,GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT,0.762028034223706
HP_UPPER_EYELID_EDEMA,SET,6,0.75158,0.013585,0.3862,0.02583,HP_UPPER_EYELID_EDEMA,0.762028034223706
GOBP_STEM_CELL_FATE_SPECIFIC...,SET,6,0.80843,0.014613,0.41544,0.025839,GOBP_STEM_CELL_FATE_SPECIFICATION,0.762028034223706
GOBP_KINETOCHORE_ORGANIZATION,SET,20,0.342,0.011282,0.17583,0.025891,GOBP_KINETOCHORE_ORGANIZATION,0.762028034223706
LIN_NPAS4_TARGETS_UP,SET,156,0.12893,0.011835,0.066322,0.02595,LIN_NPAS4_TARGETS_UP,0.762028034223706
HP_APLASIA_INVOLVING_BONES_O...1,SET,22,0.35855,0.012405,0.18443,0.025951,HP_APLASIA_INVOLVING_BONES_OF_THE_EXTREMITIES,0.762028034223706
GOBP_MONOACYLGLYCEROL_BIOSYN...,SET,7,0.64791,0.012649,0.33331,0.025963,GOBP_MONOACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.762028034223706
EN1_01,SET,98,0.1775,0.012934,0.091324,0.025976,EN1_01,0.762028034223706
HP_ABNORMALITY_OF_THUMB_PHAL...,SET,171,0.12352,0.011865,0.063569,0.026013,HP_ABNORMALITY_OF_THUMB_PHALANX,0.762028034223706
MIR223_5P,SET,138,0.14008,0.012099,0.07211,0.026043,MIR223_5P,0.762028034223706
GOMF_BENZODIAZEPINE_RECEPTOR...,SET,9,0.68024,0.015058,0.35022,0.026059,GOMF_BENZODIAZEPINE_RECEPTOR_ACTIVITY,0.762028034223706
KEGG_CIRCADIAN_RHYTHM_MAMMAL,SET,12,0.55125,0.014089,0.2839,0.026097,KEGG_CIRCADIAN_RHYTHM_MAMMAL,0.762028034223706
BYSTROEM_CORRELATED_WITH_IL5...1,SET,55,0.22643,0.012375,0.11665,0.026126,BYSTROEM_CORRELATED_WITH_IL5_DN,0.762028034223706
MIR431_5P,SET,49,0.22713,0.011719,0.11702,0.026137,MIR431_5P,0.762028034223706
MIR4443,SET,155,0.1358,0.012426,0.069971,0.026148,MIR4443,0.762028034223706
GOBP_DEMETHYLATION,SET,37,0.27605,0.01238,0.14223,0.026149,GOBP_DEMETHYLATION,0.762028034223706
DESCARTES_MAIN_FETAL_RETINAL...2,SET,43,0.26227,0.012678,0.13515,0.026165,DESCARTES_MAIN_FETAL_RETINAL_PROGENITORS_AND_MULLER_GLIA,0.762028034223706
HP_ABNORMALITY_OF_SKIN_PIGME...,SET,434,0.078419,0.011914,0.040418,0.026186,HP_ABNORMALITY_OF_SKIN_PIGMENTATION,0.762028034223706
GOBP_SKELETAL_MUSCLE_FIBER_D...,SET,11,0.54312,0.013291,0.27995,0.026195,GOBP_SKELETAL_MUSCLE_FIBER_DIFFERENTIATION,0.762028034223706
GOBP_REGULATION_OF_HELICASE_...,SET,9,0.48521,0.010741,0.25014,0.026211,GOBP_REGULATION_OF_HELICASE_ACTIVITY,0.762028034223706
SETD1A_TARGET_GENES,SET,1212,0.048756,0.012107,0.025139,0.026233,SETD1A_TARGET_GENES,0.762028034223706
GKCGCNNNNNNNTGAYG_UNKNOWN,SET,54,0.19882,0.010767,0.10252,0.026241,GKCGCNNNNNNNTGAYG_UNKNOWN,0.762028034223706
GSE22432_PDC_VS_TGFB1_TREATE...1,SET,176,0.12929,0.012598,0.066673,0.026248,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN,0.762028034223706
KEGG_MEDICUS_REFERENCE_TSC1_...,SET,11,0.46453,0.011367,0.23959,0.026267,KEGG_MEDICUS_REFERENCE_TSC1_2_MTORC1_SIGNALING_PATHWAY,0.762028034223706
MIR6875_3P,SET,361,0.089937,0.012487,0.04642,0.026353,MIR6875_3P,0.762485611246944
GOBP_POSITIVE_REGULATION_OF_...101,SET,10,0.62964,0.014691,0.325,0.02636,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.762485611246944
HP_OCULAR_PAIN,SET,20,0.38337,0.012647,0.19793,0.026384,HP_OCULAR_PAIN,0.762485611246944
GOBP_DNA_SYNTHESIS_INVOLVED_...,SET,38,0.226,0.010272,0.11669,0.026401,GOBP_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR,0.762485611246944
GOBP_REGULATION_OF_EXOCYTOSIS,SET,155,0.13618,0.012461,0.070357,0.026466,GOBP_REGULATION_OF_EXOCYTOSIS,0.762485611246944
GSE9988_ANTI_TREM1_VS_CTRL_T...2,SET,172,0.13719,0.013217,0.070885,0.026481,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP,0.762485611246944
HP_VELOPHARYNGEAL_INSUFFICIE...,SET,26,0.33255,0.012506,0.17183,0.026482,HP_VELOPHARYNGEAL_INSUFFICIENCY,0.762485611246944
WP_GDNFRET_SIGNALING_AXIS,SET,20,0.44147,0.014563,0.22813,0.026491,WP_GDNFRET_SIGNALING_AXIS,0.762485611246944
MIR548AZ_3P,SET,437,0.080699,0.012302,0.04171,0.026518,MIR548AZ_3P,0.762485611246944
DER_IFN_ALPHA_RESPONSE_UP,SET,72,0.19767,0.012355,0.1022,0.026558,DER_IFN_ALPHA_RESPONSE_UP,0.762485611246944
WP_WNT_SIGNALING_IN_KIDNEY_D...,SET,34,0.31184,0.013408,0.16123,0.026559,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,0.762485611246944
GSE15750_WT_VS_TRAF6KO_DAY10...1,SET,180,0.13012,0.012821,0.067308,0.026612,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN,0.762485611246944
HP_DEEP_PALMAR_CREASE,SET,28,0.30736,0.011995,0.159,0.02662,HP_DEEP_PALMAR_CREASE,0.762485611246944
NAKAMURA_LUNG_CANCER_DIFFERE...,SET,12,0.50024,0.012785,0.25888,0.026669,NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS,0.762485611246944
GOBP_IRES_DEPENDENT_VIRAL_TR...,SET,10,0.50361,0.011751,0.26066,0.026685,GOBP_IRES_DEPENDENT_VIRAL_TRANSLATIONAL_INITIATION,0.762485611246944
KEGG_MEDICUS_REFERENCE_TRANS...1,SET,11,0.485,0.011869,0.25105,0.026694,KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27,0.762485611246944
HP_2_3_FINGER_SYNDACTYLY,SET,9,0.62509,0.013837,0.32358,0.0267,HP_2_3_FINGER_SYNDACTYLY,0.762485611246944
GOBP_DIACYLGLYCEROL_METABOLI...,SET,25,0.32325,0.011921,0.16735,0.026713,GOBP_DIACYLGLYCEROL_METABOLIC_PROCESS,0.762485611246944
GSE22886_NAIVE_CD4_TCELL_VS_...5,SET,182,0.11461,0.011355,0.059347,0.026737,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN,0.762485611246944
GOBP_METANEPHRIC_TUBULE_FORM...,SET,6,0.72244,0.013059,0.37418,0.026766,GOBP_METANEPHRIC_TUBULE_FORMATION,0.762485611246944
REACTOME_BIOSYNTHESIS_OF_MAR...2,SET,6,0.64252,0.011614,0.33294,0.026822,REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS,0.762485611246944
GOCC_CELL_LEADING_EDGE,SET,399,0.083311,0.012148,0.043172,0.026828,GOCC_CELL_LEADING_EDGE,0.762485611246944
HP_ABNORMAL_LIGHT_AND_DARK_A...,SET,35,0.29679,0.012947,0.1538,0.02683,HP_ABNORMAL_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM,0.762485611246944
MIR2054,SET,148,0.14437,0.012911,0.07482,0.026835,MIR2054,0.762485611246944
GSE20152_SPHK1_KO_VS_WT_HTNF...2,SET,179,0.12378,0.012163,0.064147,0.026837,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_UP,0.762485611246944
GOBP_REGULATION_OF_ACTIN_FIL...4,SET,135,0.1421,0.012141,0.07366,0.026866,GOBP_REGULATION_OF_ACTIN_FILAMENT_LENGTH,0.762485611246944
MIR6830_5P,SET,163,0.13187,0.012371,0.068375,0.026892,MIR6830_5P,0.762485611246944
DESCARTES_FETAL_HEART_SCHWAN...,SET,47,0.25212,0.01274,0.13073,0.026906,DESCARTES_FETAL_HEART_SCHWANN_CELLS,0.762485611246944
CLIMENT_BREAST_CANCER_COPY_N...2,SET,23,0.37848,0.013388,0.19628,0.026919,CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,0.762485611246944
GSE18791_CTRL_VS_NEWCASTLE_V...12,SET,138,0.14108,0.012186,0.0732,0.026979,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP,0.762971146341463
HP_IRON_DEFICIENCY_ANEMIA,SET,27,0.3232,0.012386,0.1677,0.026986,HP_IRON_DEFICIENCY_ANEMIA,0.762971146341463
HP_PROMINENT_COCCYX,SET,5,0.84119,0.013881,0.43654,0.027002,HP_PROMINENT_COCCYX,0.762971146341463
GNF2_MLH1,SET,36,0.24664,0.010911,0.12804,0.027046,GNF2_MLH1,0.763227698863636
REACTOME_BIOSYNTHESIS_OF_MAR...1,SET,8,0.58044,0.012114,0.30136,0.027055,REACTOME_BIOSYNTHESIS_OF_MARESINS,0.763227698863636
GOBP_RESPONSE_TO_HYDROGEN_PE...,SET,89,0.17858,0.012404,0.092746,0.02709,GOBP_RESPONSE_TO_HYDROGEN_PEROXIDE,0.763595255474453
YATGNWAAT_OCT_C,SET,315,0.099014,0.012858,0.051466,0.027193,YATGNWAAT_OCT_C,0.764022355072464
GOBP_NEGATIVE_REGULATION_OF_...694,SET,16,0.44547,0.013145,0.23157,0.027203,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_PERMEABILITY,0.764022355072464
MIR5191,SET,27,0.33457,0.012821,0.17392,0.027205,MIR5191,0.764022355072464
GSE15330_MEGAKARYOCYTE_ERYTH...1,SET,174,0.12033,0.011659,0.062554,0.027209,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_DN,0.764022355072464
GOBP_OOGENESIS,SET,100,0.16424,0.012088,0.08541,0.027254,GOBP_OOGENESIS,0.764022355072464
GOBP_NEGATIVE_REGULATION_OF_...463,SET,14,0.54026,0.014914,0.28099,0.027266,GOBP_NEGATIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.764022355072464
GOBP_POSITIVE_REGULATION_OF_...267,SET,6,0.83332,0.015063,0.43346,0.027281,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.764022355072464
IBRAHIM_NRF1_DOWN,SET,127,0.14907,0.012356,0.077548,0.02729,IBRAHIM_NRF1_DOWN,0.764022355072464
GSE23321_EFFECTOR_MEMORY_VS_...1,SET,172,0.11491,0.01107,0.059782,0.027303,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.764022355072464
HP_FEMORAL_BOWING,SET,41,0.27488,0.012976,0.14304,0.027326,HP_FEMORAL_BOWING,0.764050788415125
GSE12845_IGD_NEG_BLOOD_VS_DA...2,SET,162,0.12981,0.01214,0.067595,0.027414,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.765895152733119
GOBP_RESPONSE_TO_LITHIUM_ION,SET,16,0.42411,0.012515,0.221,0.027499,GOBP_RESPONSE_TO_LITHIUM_ION,0.767036713483146
HP_BROAD_NASAL_TIP,SET,133,0.13755,0.011665,0.071676,0.027499,HP_BROAD_NASAL_TIP,0.767036713483146
GOCC_SITE_OF_DNA_DAMAGE,SET,110,0.13895,0.010723,0.072428,0.027535,GOCC_SITE_OF_DNA_DAMAGE,0.767042309486781
MIR6733_5P,SET,240,0.10645,0.012091,0.055501,0.027567,MIR6733_5P,0.767042309486781
GSE22611_MUTANT_NOD2_VS_CTRL...1,SET,160,0.12991,0.012075,0.067746,0.027587,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,0.767042309486781
MIR5683,SET,217,0.11501,0.01243,0.059987,0.027611,MIR5683,0.767042309486781
GSE22886_NEUTROPHIL_VS_DC_UP,SET,164,0.13571,0.012769,0.070806,0.027651,GSE22886_NEUTROPHIL_VS_DC_UP,0.767042309486781
GOBP_NEGATIVE_REGULATION_OF_...434,SET,124,0.15134,0.012396,0.078969,0.027664,GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.767042309486781
FIGUEROA_AML_METHYLATION_CLU...5,SET,35,0.2941,0.012829,0.15348,0.027677,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,0.767042309486781
HP_BROAD_HALLUX_PHALANX,SET,19,0.39919,0.012836,0.20851,0.027786,HP_BROAD_HALLUX_PHALANX,0.767042309486781
MODULE_175,SET,52,0.23517,0.012498,0.12284,0.027792,MODULE_175,0.767042309486781
GOBP_CELLULAR_RESPONSE_TO_LU...,SET,5,0.78191,0.012902,0.40845,0.027797,GOBP_CELLULAR_RESPONSE_TO_LUTEINIZING_HORMONE_STIMULUS,0.767042309486781
SCHLINGEMANN_SKIN_CARCINOGEN...2,SET,36,0.29065,0.012858,0.15185,0.027811,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP,0.767042309486781
GOBP_NEGATIVE_REGULATION_OF_...614,SET,7,0.71506,0.01396,0.37367,0.027843,GOBP_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.767042309486781
HOUSTIS_ROS,SET,34,0.30484,0.013107,0.15931,0.027852,HOUSTIS_ROS,0.767042309486781
HP_PUNCTATE_CATARACT,SET,14,0.44452,0.012271,0.23233,0.027861,HP_PUNCTATE_CATARACT,0.767042309486781
MIR4287,SET,115,0.15362,0.01212,0.080291,0.027866,MIR4287,0.767042309486781
GOMF_SCAFFOLD_PROTEIN_BINDING,SET,65,0.20483,0.012166,0.1071,0.02791,GOMF_SCAFFOLD_PROTEIN_BINDING,0.767042309486781
GOMF_PROTEIN_TYROSINE_SERINE...,SET,22,0.34117,0.011804,0.17841,0.027924,GOMF_PROTEIN_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.767042309486781
GOBP_FOREBRAIN_REGIONALIZATI...,SET,23,0.40027,0.014159,0.20936,0.027953,GOBP_FOREBRAIN_REGIONALIZATION,0.767042309486781
GOBP_REGULATION_OF_ANATOMICA...2,SET,444,0.080434,0.012357,0.042072,0.027959,GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE,0.767042309486781
HP_GASTROINTESTINAL_EOSINOPH...,SET,14,0.46414,0.012813,0.24284,0.027993,HP_GASTROINTESTINAL_EOSINOPHILIA,0.767042309486781
CARDOSO_RESPONSE_TO_GAMMA_RA...,SET,11,0.42443,0.010386,0.22211,0.028017,CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB,0.767042309486781
GOBP_EXOCRINE_SYSTEM_DEVELOP...,SET,48,0.24409,0.012465,0.12775,0.028028,GOBP_EXOCRINE_SYSTEM_DEVELOPMENT,0.767042309486781
MIR4763_5P,SET,54,0.21056,0.011403,0.1102,0.028032,MIR4763_5P,0.767042309486781
MATSUMIYA_PBMC_MODIFIED_VACC...1,SET,60,0.22431,0.012802,0.11743,0.028062,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_2DY_UP,0.767042309486781
chr2q21,SET,33,0.58303,0.024697,0.30542,0.028142,chr2q21,0.767042309486781
GOBP_VIRAL_BUDDING,SET,25,0.31243,0.011522,0.1637,0.028165,GOBP_VIRAL_BUDDING,0.767042309486781
GOBP_REGULATION_OF_LIPOPROTE...1,SET,10,0.527,0.012296,0.27617,0.028188,GOBP_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY,0.767042309486781
MIR6891_5P,SET,109,0.15618,0.011998,0.081865,0.028222,MIR6891_5P,0.767042309486781
MORI_EMU_MYC_LYMPHOMA_BY_ONS...1,SET,16,0.40147,0.011847,0.21049,0.028248,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,0.767042309486781
ZSCAN30_TARGET_GENES,SET,1380,0.046549,0.012273,0.024405,0.028248,ZSCAN30_TARGET_GENES,0.767042309486781
KEGG_MEDICUS_REFERENCE_FLCN_...,SET,13,0.4093,0.010888,0.21461,0.028259,KEGG_MEDICUS_REFERENCE_FLCN_MTORC1_SIGNALING_PATHWAY,0.767042309486781
GOMF_PYRIMIDINE_NUCLEOTIDE_B...,SET,5,0.6238,0.010293,0.3271,0.028264,GOMF_PYRIMIDINE_NUCLEOTIDE_BINDING,0.767042309486781
GOBP_NEGATIVE_REGULATION_OF_...480,SET,5,0.71033,0.011721,0.37248,0.028266,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION,0.767042309486781
FIGUEROA_AML_METHYLATION_CLU...8,SET,99,0.16969,0.012427,0.088988,0.028278,FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,0.767042309486781
KEGG_MEDICUS_ENV_FACTOR_META...3,SET,14,0.38831,0.010719,0.20365,0.028281,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY,0.767042309486781
HARALAMBIEVA_PBMC_M_M_R_II_A...3,SET,10,0.56401,0.01316,0.29591,0.028333,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_HIGH_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_DN,0.767042309486781
MIR6124,SET,410,0.080753,0.011933,0.042369,0.028337,MIR6124,0.767042309486781
GOBP_TYPE_II_INTERFERON_PROD...,SET,107,0.17035,0.012968,0.089389,0.028348,GOBP_TYPE_II_INTERFERON_PRODUCTION,0.767042309486781
HP_GINGIVAL_OVERGROWTH,SET,110,0.16254,0.012544,0.08531,0.028378,HP_GINGIVAL_OVERGROWTH,0.767042309486781
GSE5589_IL6_KO_VS_IL10_KO_LP...6,SET,184,0.11386,0.011342,0.05976,0.028382,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.767042309486781
FAN_EMBRYONIC_CTX_BIG_GROUPS...4,SET,43,0.26525,0.012822,0.13925,0.028405,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,0.767067424242424
NAGASHIMA_NRG1_SIGNALING_DN,SET,50,0.22918,0.011944,0.1204,0.028496,NAGASHIMA_NRG1_SIGNALING_DN,0.768546563227308
HP_OVARIAN_GONADOBLASTOMA,SET,9,0.5896,0.013051,0.30976,0.028504,HP_OVARIAN_GONADOBLASTOMA,0.768546563227308
MIR548AT_5P,SET,313,0.093388,0.01209,0.049082,0.028548,MIR548AT_5P,0.76913623255814
GSE21063_CTRL_VS_ANTI_IGM_ST...12,SET,173,0.12404,0.011984,0.065257,0.028676,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP,0.771426810810811
NIKOLSKY_BREAST_CANCER_10Q22...,SET,8,0.78033,0.016286,0.41058,0.028688,NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON,0.771426810810811
HP_DEVIATION_OF_THE_HALLUX,SET,75,0.19922,0.012707,0.10485,0.028727,HP_DEVIATION_OF_THE_HALLUX,0.771426810810811
GOBP_REGULATION_OF_BIOMINERA...,SET,89,0.18148,0.012605,0.095524,0.028739,GOBP_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.771426810810811
BMI1_DN_MEL18_DN.V1_UP,SET,135,0.15241,0.013022,0.080228,0.028744,BMI1_DN_MEL18_DN.V1_UP,0.771426810810811
GSE17974_IL4_AND_ANTI_IL12_V...17,SET,173,0.12721,0.01229,0.067014,0.028843,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN,0.773399236700077
REACTOME_PROCESSIVE_SYNTHESI...1,SET,19,0.34075,0.010956,0.17954,0.028862,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE,0.773399236700077
PRC2_SUZ12_UP.V1_UP,SET,165,0.12642,0.011931,0.066635,0.028912,PRC2_SUZ12_UP.V1_UP,0.773680011547344
GSE3982_MEMORY_CD4_TCELL_VS_...2,SET,172,0.12881,0.012409,0.067898,0.028917,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP,0.773680011547344
TUBG1_TARGET_GENES,SET,2,0.79445,0.0082917,0.41887,0.028945,TUBG1_TARGET_GENES,0.773833442307692
MIR3200_3P,SET,24,0.34405,0.012432,0.18145,0.028981,MIR3200_3P,0.774200349730976
HADDAD_T_LYMPHOCYTE_AND_NK_P...1,SET,59,0.22213,0.012573,0.11718,0.029014,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN,0.77437234075211
GSE18791_UNSTIM_VS_NEWCATSLE...2,SET,186,0.11532,0.011548,0.060842,0.029032,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP,0.77437234075211
GSE42021_TCONV_PLN_VS_TREG_P...2,SET,180,0.12154,0.011975,0.064139,0.029062,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_UP,0.774578075153374
GSE32423_IL7_VS_IL7_IL4_NAIV...1,SET,173,0.12304,0.011888,0.06495,0.029092,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN,0.774783494252874
HP_DEEP_PLANTAR_CREASES,SET,19,0.36925,0.011873,0.19502,0.029162,HP_DEEP_PLANTAR_CREASES,0.775501806282722
REACTOME_FORMATION_OF_DEFINI...,SET,14,0.4804,0.013261,0.2538,0.029199,REACTOME_FORMATION_OF_DEFINITIVE_ENDODERM,0.775501806282722
RAPA_EARLY_UP.V1_DN,SET,168,0.12036,0.011461,0.063607,0.029238,RAPA_EARLY_UP.V1_DN,0.775501806282722
GNF2_SMC1L1,SET,23,0.31676,0.011205,0.16741,0.029243,GNF2_SMC1L1,0.775501806282722
HP_TACTILE_HYPERSENSITIVITY,SET,5,0.66921,0.011043,0.3537,0.029252,HP_TACTILE_HYPERSENSITIVITY,0.775501806282722
GSE19888_ADENOSINE_A3R_ACT_V...5,SET,160,0.12224,0.011362,0.064615,0.02927,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN,0.775501806282722
HP_THICK_EYEBROW,SET,134,0.14055,0.011964,0.074333,0.029333,HP_THICK_EYEBROW,0.775501806282722
MIR4451,SET,132,0.1438,0.01215,0.076066,0.029353,MIR4451,0.775501806282722
GOBP_GALACTOSE_TRANSMEMBRANE...,SET,4,0.94283,0.013916,0.49882,0.029381,GOBP_GALACTOSE_TRANSMEMBRANE_TRANSPORT,0.775501806282722
GOCC_INO80_TYPE_COMPLEX,SET,27,0.28684,0.010992,0.15178,0.029402,GOCC_INO80_TYPE_COMPLEX,0.775501806282722
REACTOME_ACYL_CHAIN_REMODELI...1,SET,5,0.76863,0.012683,0.40684,0.029435,REACTOME_ACYL_CHAIN_REMODELING_OF_CL,0.775501806282722
REACTOME_THE_ACTIVATION_OF_A...,SET,8,0.54703,0.011417,0.28959,0.029456,REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES,0.775501806282722
GOBP_SMOOTHENED_SIGNALING_PA...1,SET,129,0.13825,0.011548,0.073199,0.029479,GOBP_SMOOTHENED_SIGNALING_PATHWAY,0.775501806282722
HP_ABNORMAL_MORPHOLOGY_OF_TH...5,SET,43,0.24662,0.011922,0.1306,0.029501,HP_ABNORMAL_MORPHOLOGY_OF_THE_LIMBIC_SYSTEM,0.775501806282722
WP_DNA_REPAIR_PATHWAYS_FULL_...,SET,109,0.1277,0.009811,0.067646,0.029532,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,0.775501806282722
GOBP_LATE_ENDOSOME_TO_VACUOL...2,SET,26,0.28962,0.010892,0.15342,0.029539,GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.775501806282722
REACTOME_MAPK3_ERK1_ACTIVATI...,SET,10,0.53578,0.012501,0.28384,0.029548,REACTOME_MAPK3_ERK1_ACTIVATION,0.775501806282722
GSE25123_CTRL_VS_ROSIGLITAZO...2,SET,183,0.115,0.011424,0.060926,0.029558,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.775501806282722
HP_EXCESSIVE_BLEEDING_FROM_S...,SET,5,0.76456,0.012616,0.40515,0.029579,HP_EXCESSIVE_BLEEDING_FROM_SUPERFICIAL_CUTS,0.775501806282722
GOBP_TRIGLYCERIDE_RICH_LIPOP...1,SET,4,0.88786,0.013104,0.47051,0.029588,GOBP_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_CLEARANCE,0.775501806282722
XU_RESPONSE_TO_TRETINOIN_UP,SET,13,0.48451,0.012889,0.25681,0.029612,XU_RESPONSE_TO_TRETINOIN_UP,0.775501806282722
HIF1_Q5,SET,227,0.10871,0.012013,0.057629,0.029634,HIF1_Q5,0.775501806282722
HP_ABNORMAL_PREPUTIUM_MORPHO...,SET,30,0.25739,0.010397,0.13648,0.02966,HP_ABNORMAL_PREPUTIUM_MORPHOLOGY,0.775501806282722
GOMF_HISTONE_H3K27ME2_H3K27M...,SET,2,0.98384,0.010268,0.52172,0.029671,GOMF_HISTONE_H3K27ME2_H3K27ME3_DEMETHYLASE_ACTIVITY,0.775501806282722
GOBP_REGULATION_OF_TUMOR_NEC...,SET,57,0.21482,0.011952,0.11396,0.029724,GOBP_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.775501806282722
GOBP_LEUKOCYTE_CHEMOTAXIS_IN...,SET,8,0.64213,0.013402,0.34071,0.029744,GOBP_LEUKOCYTE_CHEMOTAXIS_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.775501806282722
GOBP_POSITIVE_REGULATION_OF_...176,SET,4,0.93675,0.013826,0.49709,0.02976,GOBP_POSITIVE_REGULATION_OF_COMPLEMENT_ACTIVATION,0.775501806282722
GOBP_REGULATION_OF_PHOSPHATA...,SET,50,0.22437,0.011694,0.11907,0.029769,GOBP_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.775501806282722
GOBP_POSITIVE_REGULATION_OF_...191,SET,167,0.12685,0.012044,0.06732,0.02977,GOBP_POSITIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,0.775501806282722
PID_P38_ALPHA_BETA_PATHWAY,SET,29,0.31073,0.01234,0.16495,0.029807,PID_P38_ALPHA_BETA_PATHWAY,0.775501806282722
GOBP_POSITIVE_REGULATION_OF_...654,SET,5,0.75621,0.012478,0.4015,0.029827,GOBP_POSITIVE_REGULATION_OF_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.775501806282722
GOBP_NEGATIVE_REGULATION_OF_...41,SET,28,0.30863,0.012044,0.16387,0.029833,GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION,0.775501806282722
GOBP_RESPONSE_TO_FUNGUS,SET,54,0.23401,0.012673,0.12438,0.029962,GOBP_RESPONSE_TO_FUNGUS,0.777165338674435
GSE3982_DC_VS_NEUTROPHIL_DN,SET,171,0.12273,0.011789,0.06526,0.030024,GSE3982_DC_VS_NEUTROPHIL_DN,0.777165338674435
GSE45365_WT_VS_IFNAR_KO_CD8A...3,SET,186,0.1151,0.011527,0.061232,0.030079,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP,0.777165338674435
GOBP_SISTER_CHROMATID_COHESI...,SET,42,0.23968,0.011451,0.12752,0.030091,GOBP_SISTER_CHROMATID_COHESION,0.777165338674435
MIR766_3P,SET,142,0.13794,0.012084,0.07339,0.030097,MIR766_3P,0.777165338674435
NFY_C,SET,212,0.11214,0.011981,0.059674,0.030111,NFY_C,0.777165338674435
GOBP_REGULATION_OF_RELEASE_O...1,SET,41,0.25656,0.012111,0.13655,0.03014,GOBP_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.777165338674435
MIR6756_3P,SET,92,0.16137,0.011395,0.085887,0.030141,MIR6756_3P,0.777165338674435
GOMF_GLUCURONOSYLTRANSFERASE...,SET,31,0.375,0.015397,0.1996,0.030149,GOMF_GLUCURONOSYLTRANSFERASE_ACTIVITY,0.777165338674435
FIGUEROA_AML_METHYLATION_CLU...12,SET,127,0.14686,0.012172,0.078181,0.03017,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,0.777165338674435
GOBP_NEUROEPITHELIAL_CELL_DI...,SET,42,0.27571,0.013173,0.14682,0.030203,GOBP_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.777165338674435
GOMF_MEMBRANE_INSERTASE_ACTI...,SET,14,0.39956,0.01103,0.21281,0.030226,GOMF_MEMBRANE_INSERTASE_ACTIVITY,0.777165338674435
GSE22229_UNTREATED_VS_IMMUNO...1,SET,180,0.12541,0.012357,0.066794,0.030232,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN,0.777165338674435
GSE23114_PERITONEAL_CAVITY_B...1,SET,183,0.11608,0.011532,0.061841,0.030259,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN,0.777165338674435
GSE17721_LPS_VS_POLYIC_2H_BM...1,SET,190,0.11112,0.011246,0.059206,0.030279,GSE17721_LPS_VS_POLYIC_2H_BMDC_DN,0.777165338674435
GOBP_PEPTIDE_METABOLIC_PROCE...,SET,72,0.19878,0.012424,0.10593,0.030302,GOBP_PEPTIDE_METABOLIC_PROCESS,0.777165338674435
GSE369_PRE_VS_POST_IL6_INJEC...1,SET,176,0.11872,0.011568,0.0633,0.030371,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN,0.777165338674435
HP_EPISODIC_FLACCID_WEAKNESS,SET,5,0.79505,0.013119,0.42392,0.030372,HP_EPISODIC_FLACCID_WEAKNESS,0.777165338674435
HP_ABNORMALITY_OF_LIMB_BONE,SET,1523,0.042627,0.011758,0.022732,0.030391,HP_ABNORMALITY_OF_LIMB_BONE,0.777165338674435
GSE45365_NK_CELL_VS_CD8_TCEL...3,SET,183,0.12103,0.012024,0.064569,0.030438,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_UP,0.777165338674435
WP_H19_RBE2F1_AND_CDKBETACAT...,SET,13,0.4242,0.011284,0.22634,0.030459,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,0.777165338674435
GOMF_GTP_DEPENDENT_PROTEIN_B...,SET,20,0.38927,0.012842,0.20771,0.030469,GOMF_GTP_DEPENDENT_PROTEIN_BINDING,0.777165338674435
GOBP_STABILIZATION_OF_MEMBRA...,SET,17,0.43391,0.013198,0.23154,0.030475,GOBP_STABILIZATION_OF_MEMBRANE_POTENTIAL,0.777165338674435
MIR3679_5P,SET,70,0.18575,0.011448,0.099171,0.030544,MIR3679_5P,0.777165338674435
MIR548P,SET,541,0.07143,0.01208,0.038145,0.030569,MIR548P,0.777165338674435
CMYB_01,SET,232,0.10375,0.011589,0.055421,0.03061,CMYB_01,0.777165338674435
MIR5579_3P,SET,140,0.13717,0.011933,0.073285,0.03063,MIR5579_3P,0.777165338674435
LIU_IL13_PRIMING_MODEL,SET,15,0.43601,0.012458,0.23295,0.030632,LIU_IL13_PRIMING_MODEL,0.777165338674435
GOCC_CONTRACTILE_MUSCLE_FIBER,SET,237,0.10838,0.012234,0.057906,0.030639,GOCC_CONTRACTILE_MUSCLE_FIBER,0.777165338674435
GOBP_REGULATION_OF_HIGH_VOLT...,SET,8,0.63325,0.013216,0.33836,0.030645,GOBP_REGULATION_OF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.777165338674435
GOCC_PROTEIN_DNA_COMPLEX,SET,1227,0.04752,0.011868,0.025392,0.030651,GOCC_PROTEIN_DNA_COMPLEX,0.777165338674435
HP_NEONATAL_SEIZURE,SET,8,0.56473,0.011786,0.30177,0.030653,HP_NEONATAL_SEIZURE,0.777165338674435
GOBP_MYELOID_LEUKOCYTE_MIGRA...,SET,217,0.11952,0.012918,0.063871,0.030657,GOBP_MYELOID_LEUKOCYTE_MIGRATION,0.777165338674435
GSE5589_WT_VS_IL6_KO_LPS_STI...2,SET,119,0.14368,0.01153,0.076784,0.030669,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_UP,0.777165338674435
GOBP_VENTRICULAR_CARDIAC_MUS...1,SET,33,0.31309,0.013262,0.16734,0.030683,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.777165338674435
GSE40274_GATA1_VS_FOXP3_AND_...1,SET,181,0.12026,0.011882,0.064285,0.030702,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.777165338674435
GOBP_RESPONSE_TO_L_PHENYLALA...,SET,5,0.82508,0.013615,0.44125,0.030758,GOBP_RESPONSE_TO_L_PHENYLALANINE_DERIVATIVE,0.778016222707424
HP_TOE_SYNDACTYLY,SET,199,0.11165,0.011561,0.059743,0.030832,HP_TOE_SYNDACTYLY,0.779320843636364
GOBP_INTERLEUKIN_11_MEDIATED...,SET,6,0.68369,0.012358,0.36593,0.030866,GOBP_INTERLEUKIN_11_MEDIATED_SIGNALING_PATHWAY,0.779613248546512
GOCC_EXCITATORY_SYNAPSE,SET,57,0.22252,0.01238,0.11915,0.030917,GOCC_EXCITATORY_SYNAPSE,0.780334302832244
GSE43955_10H_VS_60H_ACT_CD4_...1,SET,182,0.12411,0.012296,0.066469,0.030944,GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN,0.780448998548621
HP_BREAST_HYPOPLASIA,SET,42,0.25259,0.012068,0.13533,0.030992,HP_BREAST_HYPOPLASIA,0.78049009051412
GOBP_ACTIVATION_OF_PROTEIN_K...3,SET,3,0.99945,0.012775,0.53547,0.030995,GOBP_ACTIVATION_OF_PROTEIN_KINASE_C_ACTIVITY,0.78049009051412
GSE27786_CD8_TCELL_VS_MONO_M...2,SET,171,0.11596,0.011139,0.062135,0.031013,GSE27786_CD8_TCELL_VS_MONO_MAC_UP,0.78049009051412
HP_ABNORMALLY_LAX_OR_HYPEREX...,SET,150,0.12966,0.011672,0.069495,0.031051,HP_ABNORMALLY_LAX_OR_HYPEREXTENSIBLE_SKIN,0.780880973227207
GOBP_ISOLEUCINE_TRANSPORT,SET,5,0.71546,0.011806,0.3837,0.031125,GOBP_ISOLEUCINE_TRANSPORT,0.78196238800578
STK33_DN,SET,237,0.10533,0.011891,0.056497,0.031139,STK33_DN,0.78196238800578
WP_HOSTPATHOGEN_INTERACTION_...3,SET,30,0.29713,0.012001,0.15946,0.031214,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,0.783040681818182
GSE17974_0H_VS_12H_IN_VITRO_...1,SET,176,0.11555,0.011259,0.062016,0.031227,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN,0.783040681818182
NPM1_TARGET_GENES,SET,280,0.093586,0.011469,0.05027,0.031333,NPM1_TARGET_GENES,0.784398612508986
GOBP_RESPIRATORY_BURST_INVOL...2,SET,9,0.54115,0.011979,0.29077,0.031373,GOBP_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.784398612508986
LEE_INTRATHYMIC_T_PROGENITOR,SET,17,0.40801,0.01241,0.21925,0.031384,LEE_INTRATHYMIC_T_PROGENITOR,0.784398612508986
GOBP_TELOMERE_MAINTENANCE_IN...,SET,30,0.2702,0.010914,0.14521,0.031392,GOBP_TELOMERE_MAINTENANCE_IN_RESPONSE_TO_DNA_DAMAGE,0.784398612508986
GCTNWTTGK_UNKNOWN,SET,279,0.099517,0.012175,0.05348,0.031394,GCTNWTTGK_UNKNOWN,0.784398612508986
MIR4536_3P,SET,19,0.37206,0.011963,0.20001,0.031435,MIR4536_3P,0.784594748743719
GOBP_AMACRINE_CELL_DIFFERENT...,SET,12,0.51506,0.013164,0.27691,0.031447,GOBP_AMACRINE_CELL_DIFFERENTIATION,0.784594748743719
GOBP_NEGATIVE_REGULATION_OF_...329,SET,12,0.40311,0.010303,0.21688,0.031545,GOBP_NEGATIVE_REGULATION_OF_JUN_KINASE_ACTIVITY,0.786475233142037
MIR616_3P,SET,41,0.26047,0.012295,0.14018,0.03159,MIR616_3P,0.786869099356683
GOBP_EOSINOPHIL_MIGRATION,SET,28,0.35477,0.013844,0.19098,0.031624,GOBP_EOSINOPHIL_MIGRATION,0.786869099356683
GSE22589_HEALTHY_VS_SIV_INFE...2,SET,177,0.11639,0.011373,0.062662,0.031638,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP,0.786869099356683
YAO_TEMPORAL_RESPONSE_TO_PRO...11,SET,52,0.20415,0.01085,0.10993,0.031652,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2,0.786869099356683
GSE39820_TGFBETA1_VS_TGFBETA...1,SET,183,0.11488,0.011412,0.061865,0.031674,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN,0.786869099356683
GSE22886_NEUTROPHIL_VS_MONOC...1,SET,176,0.11357,0.011066,0.061193,0.031742,GSE22886_NEUTROPHIL_VS_MONOCYTE_DN,0.787583644067797
OUILLETTE_CLL_13Q14_DELETION...2,SET,70,0.16828,0.010371,0.090679,0.031754,OUILLETTE_CLL_13Q14_DELETION_UP,0.787583644067797
GOBP_CELLULAR_RESPONSE_TO_AN...2,SET,11,0.50655,0.012396,0.27307,0.031804,GOBP_CELLULAR_RESPONSE_TO_ANTIBIOTIC,0.787583644067797
GSE22886_NAIVE_TCELL_VS_DC_UP,SET,178,0.11518,0.011287,0.062121,0.031865,GSE22886_NAIVE_TCELL_VS_DC_UP,0.787583644067797
ZSCAN26_TARGET_GENES,SET,4,0.8506,0.012554,0.45877,0.031873,ZSCAN26_TARGET_GENES,0.787583644067797
HP_PERIODIC_HYPOKALEMIC_PARE...,SET,7,0.63419,0.012382,0.34208,0.031883,HP_PERIODIC_HYPOKALEMIC_PARESIS,0.787583644067797
HP_ABNORMALITY_OF_THE_CALF,SET,272,0.097419,0.01177,0.052555,0.031901,HP_ABNORMALITY_OF_THE_CALF,0.787583644067797
GOMF_CCR5_CHEMOKINE_RECEPTOR...,SET,7,0.6593,0.012872,0.35569,0.031908,GOMF_CCR5_CHEMOKINE_RECEPTOR_BINDING,0.787583644067797
GSE16266_CTRL_VS_LPS_STIM_ME...2,SET,182,0.12419,0.012304,0.067016,0.031945,GSE16266_CTRL_VS_LPS_STIM_MEF_UP,0.787583644067797
GOBP_MONOATOMIC_ANION_TRANSP...,SET,159,0.13438,0.012452,0.072533,0.031973,GOBP_MONOATOMIC_ANION_TRANSPORT,0.787583644067797
GSE26351_UNSTIM_VS_BMP_PATHW...2,SET,173,0.11742,0.011345,0.063388,0.03199,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,0.787583644067797
GOBP_REGULATION_OF_ALDOSTERO...,SET,8,0.61875,0.012914,0.33402,0.031991,GOBP_REGULATION_OF_ALDOSTERONE_METABOLIC_PROCESS,0.787583644067797
GOMF_PHOSPHOLIPID_TRANSFER_A...,SET,20,0.3207,0.01058,0.17317,0.032028,GOMF_PHOSPHOLIPID_TRANSFER_ACTIVITY,0.787583644067797
HP_ABNORMAL_SHAPE_OF_THE_PAL...,SET,51,0.21327,0.011225,0.11517,0.032037,HP_ABNORMAL_SHAPE_OF_THE_PALPEBRAL_FISSURE,0.787583644067797
KEGG_HOMOLOGOUS_RECOMBINATION,SET,25,0.27504,0.010143,0.14857,0.032069,KEGG_HOMOLOGOUS_RECOMBINATION,0.787583644067797
GSE15930_STIM_VS_STIM_AND_IL...2,SET,179,0.11247,0.011052,0.060757,0.032079,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_UP,0.787583644067797
GOBP_REGULATION_OF_GLUCOCORT...1,SET,9,0.58645,0.012982,0.31681,0.032088,GOBP_REGULATION_OF_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS,0.787583644067797
MIR548AV_5P_MIR548K,SET,267,0.099838,0.011952,0.053953,0.032131,MIR548AV_5P_MIR548K,0.78804143864598
REACTOME_BETA_OXIDATION_OF_B...,SET,5,0.65999,0.010891,0.35672,0.032152,REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA,0.78804143864598
GOMF_HISTONE_H3K36_DEMETHYLA...,SET,7,0.53354,0.010417,0.28855,0.032232,GOMF_HISTONE_H3K36_DEMETHYLASE_ACTIVITY,0.789060876760563
GOBP_NUCLEOTIDE_TRANSMEMBRAN...,SET,28,0.32233,0.012579,0.17433,0.032239,GOBP_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT,0.789060876760563
MIR3176,SET,67,0.18045,0.010882,0.097617,0.032267,MIR3176,0.789190418719212
HP_VASCULITIS_BY_ANATOMICAL_...,SET,14,0.42672,0.01178,0.23097,0.032343,HP_VASCULITIS_BY_ANATOMICAL_SITE,0.790017271769663
GOBP_ENDOMEMBRANE_SYSTEM_ORG...,SET,531,0.068177,0.011426,0.036908,0.032367,GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION,0.790017271769663
GOBP_FLAVONOID_GLUCURONIDATI...,SET,5,1.2316,0.020323,0.66675,0.032369,GOBP_FLAVONOID_GLUCURONIDATION,0.790017271769663
SESTO_RESPONSE_TO_UV_C5,SET,46,0.242,0.012099,0.13114,0.032505,SESTO_RESPONSE_TO_UV_C5,0.792720661764706
GSE39110_DAY3_VS_DAY6_POST_I...2,SET,180,0.12093,0.011916,0.065551,0.03254,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP,0.792720661764706
REACTOME_PHASE_3_RAPID_REPOL...,SET,8,0.56574,0.011807,0.30673,0.032568,REACTOME_PHASE_3_RAPID_REPOLARISATION,0.792720661764706
GOCC_BASOLATERAL_PLASMA_MEMB...,SET,246,0.10666,0.012264,0.057828,0.032571,GOCC_BASOLATERAL_PLASMA_MEMBRANE,0.792720661764706
GOMF_OLFACTORY_RECEPTOR_BIND...,SET,6,0.71885,0.012994,0.39003,0.032669,GOMF_OLFACTORY_RECEPTOR_BINDING,0.794549401679496
GOBP_NEGATIVE_REGULATION_OF_...58,SET,13,0.51837,0.013789,0.28147,0.032771,GOBP_NEGATIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.796148288100209
GOBP_FIBROBLAST_ACTIVATION,SET,15,0.47064,0.013448,0.25569,0.032845,GOBP_FIBROBLAST_ACTIVATION,0.796148288100209
GOBP_XENOBIOTIC_TRANSPORT_AC...,SET,6,0.74067,0.013388,0.40245,0.032863,GOBP_XENOBIOTIC_TRANSPORT_ACROSS_BLOOD_BRAIN_BARRIER,0.796148288100209
GSE11961_FOLLICULAR_BCELL_VS...4,SET,177,0.11369,0.011109,0.061786,0.032891,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,0.796148288100209
GSE15624_3H_VS_6H_HALOFUGINO...2,SET,159,0.12417,0.011506,0.067491,0.032907,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.796148288100209
MIR6511A_3P_MIR6511B_3P,SET,55,0.20367,0.011131,0.11071,0.03291,MIR6511A_3P_MIR6511B_3P,0.796148288100209
MIR1257,SET,88,0.17531,0.012108,0.095289,0.032911,MIR1257,0.796148288100209
GOBP_CARDIAC_MUSCLE_CELL_MEM...,SET,36,0.27774,0.012287,0.15097,0.032918,GOBP_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.796148288100209
GOMF_POTASSIUM_ION_LEAK_CHAN...,SET,16,0.43666,0.012885,0.23747,0.03298,GOMF_POTASSIUM_ION_LEAK_CHANNEL_ACTIVITY,0.79668968446602
REACTOME_MITOCHONDRIAL_FATTY...2,SET,11,0.41845,0.01024,0.22765,0.033034,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS,0.79668968446602
GOCC_MMXD_COMPLEX,SET,3,0.78265,0.010004,0.4258,0.033036,GOCC_MMXD_COMPLEX,0.79668968446602
GNF2_JAK1,SET,30,0.27101,0.010946,0.14746,0.033053,GNF2_JAK1,0.79668968446602
MIR8058,SET,41,0.27349,0.01291,0.14882,0.033055,MIR8058,0.79668968446602
WP_FBXL10_ENHANCEMENT_OF_MAP...,SET,10,0.45156,0.010536,0.24585,0.033133,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,0.798016226611227
GOBP_BASIC_AMINO_ACID_TRANSP...,SET,20,0.36996,0.012205,0.20164,0.033277,GOBP_BASIC_AMINO_ACID_TRANSPORT,0.800877130524862
GOMF_SEQUENCE_SPECIFIC_DNA_B...,SET,1523,0.045532,0.012559,0.024824,0.033319,GOMF_SEQUENCE_SPECIFIC_DNA_BINDING,0.800877130524862
GSE1460_DP_THYMOCYTE_VS_THYM...1,SET,174,0.11391,0.011037,0.062115,0.033344,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,0.800877130524862
LEF1_Q6,SET,241,0.10759,0.012246,0.058677,0.033366,LEF1_Q6,0.800877130524862
GOMF_INOSITOL_POLYPHOSPHATE_...,SET,6,0.6114,0.011051,0.33345,0.033367,GOMF_INOSITOL_POLYPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.800877130524862
ZHAN_MULTIPLE_MYELOMA_CD2_DN,SET,44,0.23972,0.011722,0.13088,0.033511,ZHAN_MULTIPLE_MYELOMA_CD2_DN,0.802910949324324
GOBP_POSITIVE_REGULATION_OF_...299,SET,45,0.26784,0.013245,0.14623,0.033514,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.802910949324324
HP_TRACHEAL_CALCIFICATION,SET,3,0.9572,0.012235,0.52276,0.033554,HP_TRACHEAL_CALCIFICATION,0.802910949324324
GOBP_POSITIVE_REGULATION_OF_...419,SET,6,0.7695,0.013909,0.42045,0.033621,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_DEPRESSION,0.802910949324324
GOBP_VOLUNTARY_MUSCULOSKELET...,SET,7,0.52829,0.010314,0.28873,0.033655,GOBP_VOLUNTARY_MUSCULOSKELETAL_MOVEMENT,0.802910949324324
HP_TAPERED_DISTAL_PHALANGES_...,SET,6,0.76817,0.013885,0.41993,0.033685,HP_TAPERED_DISTAL_PHALANGES_OF_FINGER,0.802910949324324
GSE17580_UNINFECTED_VS_S_MAN...4,SET,186,0.11092,0.011108,0.060644,0.033701,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP,0.802910949324324
GOBP_RESPONSE_TO_INTERLEUKIN...7,SET,9,0.64733,0.014329,0.35396,0.033724,GOBP_RESPONSE_TO_INTERLEUKIN_2,0.802910949324324
HP_APHTHOUS_ULCER,SET,6,0.74113,0.013396,0.40526,0.033726,HP_APHTHOUS_ULCER,0.802910949324324
GOBP_REGULATION_OF_BONE_MINE...1,SET,70,0.19763,0.012181,0.10808,0.033743,GOBP_REGULATION_OF_BONE_MINERALIZATION,0.802910949324324
GOBP_ESTABLISHMENT_OR_MAINTE...1,SET,51,0.22965,0.012087,0.1256,0.033758,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_BIPOLAR_CELL_POLARITY,0.802910949324324
REACTOME_REELIN_SIGNALLING_P...,SET,4,0.89068,0.013146,0.48735,0.033814,REACTOME_REELIN_SIGNALLING_PATHWAY,0.802910949324324
GOBP_GLIAL_CELL_FATE_COMMITM...,SET,13,0.5032,0.013386,0.27534,0.033819,GOBP_GLIAL_CELL_FATE_COMMITMENT,0.802910949324324
GOBP_NAD_TRANSPORT,SET,5,0.75196,0.012408,0.41149,0.033827,GOBP_NAD_TRANSPORT,0.802910949324324
GOBP_MONOTERPENOID_METABOLIC...,SET,6,0.59213,0.010703,0.32413,0.033869,GOBP_MONOTERPENOID_METABOLIC_PROCESS,0.802910949324324
MIR553,SET,10,0.4642,0.010831,0.25416,0.033905,MIR553,0.802910949324324
HP_LATERAL_CLAVICLE_HOOK,SET,11,0.44675,0.010932,0.24464,0.033925,HP_LATERAL_CLAVICLE_HOOK,0.802910949324324
GOBP_METANEPHRIC_LOOP_OF_HEN...,SET,5,0.77725,0.012826,0.42571,0.033949,GOBP_METANEPHRIC_LOOP_OF_HENLE_DEVELOPMENT,0.802910949324324
HP_DOUBLE_AORTIC_ARCH,SET,5,0.69476,0.011464,0.38061,0.033981,HP_DOUBLE_AORTIC_ARCH,0.802910949324324
GSE13485_DAY7_VS_DAY21_YF17D...2,SET,183,0.11808,0.011731,0.064698,0.033996,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.802910949324324
GSE30083_SP1_VS_SP4_THYMOCYT...1,SET,189,0.11351,0.011458,0.062198,0.034007,GSE30083_SP1_VS_SP4_THYMOCYTE_DN,0.802910949324324
HP_SYNCOPE,SET,116,0.15414,0.012214,0.084469,0.034019,HP_SYNCOPE,0.802910949324324
MIR548BC,SET,433,0.076417,0.011597,0.041892,0.034074,MIR548BC,0.802910949324324
MIR548AR_3P,SET,512,0.07061,0.011626,0.038713,0.034089,MIR548AR_3P,0.802910949324324
GOBP_METANEPHRIC_RENAL_VESIC...,SET,14,0.49658,0.013708,0.27229,0.034104,GOBP_METANEPHRIC_RENAL_VESICLE_MORPHOGENESIS,0.802910949324324
GOMF_HEXOSE_TRANSMEMBRANE_TR...,SET,21,0.36979,0.0125,0.20277,0.034111,GOMF_HEXOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.802910949324324
GSE21546_ELK1_KO_VS_SAP1A_KO...2,SET,176,0.11051,0.010769,0.060608,0.034129,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.802910949324324
GAO_STOMACH_24W_C1_PROCRPOS_...,SET,37,0.22991,0.010311,0.12609,0.034136,GAO_STOMACH_24W_C1_PROCRPOS_MULTIPOTENT_PROGENITOR,0.802910949324324
MIR548F_3P,SET,434,0.076484,0.01162,0.041949,0.034142,MIR548F_3P,0.802910949324324
GSE37416_CTRL_VS_12H_F_TULAR...2,SET,169,0.12103,0.011559,0.066392,0.034164,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.802910949324324
GSE29949_CD8_NEG_DC_SPLEEN_V...6,SET,184,0.11455,0.01141,0.062842,0.034177,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,0.802910949324324
GOBP_CARDIAC_CELL_FATE_COMMI...,SET,12,0.52121,0.013321,0.28597,0.034191,GOBP_CARDIAC_CELL_FATE_COMMITMENT,0.802910949324324
HP_INTRAHEPATIC_BILIARY_ATRE...,SET,7,0.54612,0.010662,0.29976,0.034249,HP_INTRAHEPATIC_BILIARY_ATRESIA,0.803044389750506
GOBP_UBIQUITIN_DEPENDENT_END...,SET,7,0.57584,0.011242,0.31608,0.03425,GOBP_UBIQUITIN_DEPENDENT_ENDOCYTOSIS,0.803044389750506
PID_PDGFRB_PATHWAY,SET,124,0.14252,0.011674,0.078241,0.034266,PID_PDGFRB_PATHWAY,0.803044389750506
KANG_FLUOROURACIL_RESISTANCE...1,SET,16,0.39751,0.01173,0.21833,0.034334,KANG_FLUOROURACIL_RESISTANCE_DN,0.803364397711978
MIR19A_5P,SET,161,0.12949,0.012074,0.071125,0.034339,MIR19A_5P,0.803364397711978
GSE9946_IMMATURE_VS_PROSTAGL...2,SET,139,0.13288,0.011519,0.072992,0.034349,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,0.803364397711978
HP_ATOPIC_DERMATITIS,SET,35,0.27095,0.011819,0.14889,0.034406,HP_ATOPIC_DERMATITIS,0.804069345351044
GSE10240_CTRL_VS_IL22_STIM_P...1,SET,174,0.10976,0.010635,0.06036,0.034512,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.804069345351044
GOBP_POSITIVE_REGULATION_OF_...737,SET,5,0.74479,0.01229,0.40979,0.034578,GOBP_POSITIVE_REGULATION_OF_SULFUR_METABOLIC_PROCESS,0.804069345351044
NKX2_3_TARGET_GENES,SET,435,0.074791,0.011376,0.041155,0.034593,NKX2_3_TARGET_GENES,0.804069345351044
GOBP_ESTROGEN_METABOLIC_PROC...,SET,37,0.27502,0.012334,0.15135,0.034607,GOBP_ESTROGEN_METABOLIC_PROCESS,0.804069345351044
GOBP_STEM_CELL_FATE_COMMITME...,SET,10,0.57726,0.013469,0.31774,0.034634,GOBP_STEM_CELL_FATE_COMMITMENT,0.804069345351044
GOBP_ERBB3_SIGNALING_PATHWAY,SET,10,0.5082,0.011858,0.27975,0.034647,GOBP_ERBB3_SIGNALING_PATHWAY,0.804069345351044
MIR6873_5P,SET,93,0.16559,0.011756,0.091178,0.034685,MIR6873_5P,0.804069345351044
GSE7400_CTRL_VS_CSF3_IN_VIVO...2,SET,176,0.10971,0.01069,0.060415,0.034701,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP,0.804069345351044
ZNF239_TARGET_GENES,SET,32,0.28132,0.011735,0.15493,0.03471,ZNF239_TARGET_GENES,0.804069345351044
GOBP_POSITIVE_REGULATION_OF_...594,SET,12,0.51369,0.013129,0.28297,0.034743,GOBP_POSITIVE_REGULATION_OF_PLATELET_ACTIVATION,0.804069345351044
KEGG_MEDICUS_REFERENCE_BCR_P...1,SET,16,0.38139,0.011255,0.2101,0.034745,KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,0.804069345351044
GAUTAM_EYE_CORNEA_TGFBI_HIGH...,SET,102,0.15918,0.011832,0.087701,0.034771,GAUTAM_EYE_CORNEA_TGFBI_HIGH_EPITHELIAL_CELLS,0.804069345351044
RB_P107_DN.V1_DN,SET,110,0.13831,0.010674,0.076204,0.034774,RB_P107_DN.V1_DN,0.804069345351044
GOBP_REGULATION_OF_GASTRIC_A...,SET,6,0.59427,0.010742,0.32745,0.034784,GOBP_REGULATION_OF_GASTRIC_ACID_SECRETION,0.804069345351044
WP_POLYCYSTIC_KIDNEY_DISEASE...,SET,82,0.18014,0.012012,0.099261,0.034787,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,0.804069345351044
GOBP_ISOPENTENYL_DIPHOSPHATE...,SET,5,0.61133,0.010088,0.33694,0.03482,GOBP_ISOPENTENYL_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.804069345351044
LI_CISPLATIN_RESISTANCE_DN,SET,28,0.33069,0.012905,0.1823,0.034847,LI_CISPLATIN_RESISTANCE_DN,0.804069345351044
HP_PROMINENT_ANTITRAGUS,SET,6,0.62301,0.011261,0.34352,0.034878,HP_PROMINENT_ANTITRAGUS,0.804069345351044
GSE41867_NAIVE_VS_DAY8_LCMV_...4,SET,185,0.11005,0.010991,0.060692,0.034911,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.804069345351044
GOBP_REGULATION_OF_FC_RECEPT...,SET,10,0.50699,0.011829,0.27984,0.035022,GOBP_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.804069345351044
HP_BROAD_THUMB,SET,75,0.1811,0.011552,0.099965,0.035027,HP_BROAD_THUMB,0.804069345351044
GSE37533_PPARG1_FOXP3_VS_PPA...3,SET,173,0.11519,0.01113,0.063594,0.035049,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,0.804069345351044
chr8q21,SET,67,0.3452,0.020816,0.19057,0.035052,chr8q21,0.804069345351044
HP_BROAD_FEMORAL_NECK,SET,16,0.36993,0.010916,0.20431,0.035111,HP_BROAD_FEMORAL_NECK,0.804069345351044
GOMF_ACTININ_BINDING,SET,36,0.27215,0.01204,0.15031,0.035115,GOMF_ACTININ_BINDING,0.804069345351044
TAKEDA_TARGETS_OF_NUP98_HOXA...6,SET,168,0.1323,0.012598,0.073071,0.035116,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,0.804069345351044
GOBP_GLIAL_CELL_MIGRATION,SET,57,0.22726,0.012644,0.12554,0.03514,GOBP_GLIAL_CELL_MIGRATION,0.804069345351044
GSE6259_FLT3L_INDUCED_DEC205...3,SET,111,0.15465,0.011989,0.085435,0.035145,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN,0.804069345351044
BANDRES_RESPONSE_TO_CARMUSTI...5,SET,9,0.56235,0.012448,0.31073,0.035175,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN,0.804069345351044
GSE29949_MICROGLIA_VS_DC_BRA...1,SET,176,0.12036,0.011729,0.066515,0.035191,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.804069345351044
MYF6_TARGET_GENES,SET,13,0.42348,0.011265,0.23403,0.035198,MYF6_TARGET_GENES,0.804069345351044
AP2ALPHA_01,SET,221,0.10142,0.011061,0.056061,0.035225,AP2ALPHA_01,0.804069345351044
MIR595,SET,57,0.19458,0.010826,0.10756,0.035226,MIR595,0.804069345351044
GOBP_REGULATION_OF_VASCULAR_...6,SET,9,0.49281,0.010909,0.27243,0.035242,GOBP_REGULATION_OF_VASCULAR_WOUND_HEALING,0.804069345351044
MODULE_192,SET,99,0.15637,0.011452,0.086455,0.035255,MODULE_192,0.804069345351044
GOCC_CARBOXY_TERMINAL_DOMAIN...,SET,19,0.27196,0.0087448,0.15043,0.035315,GOCC_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX,0.804069345351044
GSE17721_POLYIC_VS_CPG_0.5H_...1,SET,178,0.11221,0.010996,0.062076,0.035336,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN,0.804069345351044
GSE3982_MAC_VS_BCELL_UP,SET,178,0.11426,0.011196,0.063231,0.035391,GSE3982_MAC_VS_BCELL_UP,0.804069345351044
HP_IMPAIRED_PAIN_SENSATION,SET,65,0.18799,0.011166,0.10404,0.035393,HP_IMPAIRED_PAIN_SENSATION,0.804069345351044
GSE27786_BCELL_VS_CD4_TCELL_...2,SET,180,0.11078,0.010916,0.061313,0.035401,GSE27786_BCELL_VS_CD4_TCELL_UP,0.804069345351044
HEBERT_MATRISOME_TNBC_LUNG_M...1,SET,20,0.36756,0.012125,0.20347,0.035432,HEBERT_MATRISOME_TNBC_LUNG_METASTASIS,0.804069345351044
ARID3B_TARGET_GENES,SET,114,0.1481,0.011635,0.081992,0.035443,ARID3B_TARGET_GENES,0.804069345351044
GOMF_PURINE_NUCLEOTIDE_TRANS...,SET,25,0.33132,0.012218,0.18349,0.035495,GOMF_PURINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.804069345351044
GSE24574_BCL6_LOW_TFH_VS_NAI...1,SET,171,0.12095,0.011618,0.066986,0.035502,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_DN,0.804069345351044
GOBP_DETERMINATION_OF_DORSAL...,SET,10,0.51334,0.011978,0.28444,0.035564,GOBP_DETERMINATION_OF_DORSAL_VENTRAL_ASYMMETRY,0.804069345351044
HP_FOCAL_HEAD_NODDING_AUTOMA...,SET,5,0.66369,0.010952,0.36779,0.035583,HP_FOCAL_HEAD_NODDING_AUTOMATISM_SEIZURE,0.804069345351044
GOBP_POSITIVE_REGULATION_OF_...40,SET,6,0.71425,0.01291,0.39582,0.035585,GOBP_POSITIVE_REGULATION_OF_ARTERY_MORPHOGENESIS,0.804069345351044
GOBP_REGULATION_OF_ARTERY_MO...,SET,6,0.71425,0.01291,0.39582,0.035585,GOBP_REGULATION_OF_ARTERY_MORPHOGENESIS,0.804069345351044
GOBP_SPERMINE_METABOLIC_PROC...,SET,4,0.70757,0.010443,0.39211,0.035585,GOBP_SPERMINE_METABOLIC_PROCESS,0.804069345351044
DESCARTES_FETAL_PANCREAS_ENS...1,SET,58,0.21457,0.012041,0.11893,0.035608,DESCARTES_FETAL_PANCREAS_ENS_GLIA,0.804069345351044
ACEVEDO_METHYLATED_IN_LIVER_...,SET,683,0.065731,0.01244,0.036446,0.035661,ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN,0.804069345351044
GOBP_PURINE_DEOXYRIBONUCLEOT...2,SET,10,0.48316,0.011273,0.26799,0.035709,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS,0.804069345351044
GOBP_HUMORAL_IMMUNE_RESPONSE,SET,231,0.11748,0.013095,0.065165,0.035717,GOBP_HUMORAL_IMMUNE_RESPONSE,0.804069345351044
MIR3165,SET,33,0.26263,0.011125,0.1457,0.035739,MIR3165,0.804069345351044
GOMF_ORGANIC_CATION_TRANSMEM...,SET,75,0.19099,0.012182,0.10598,0.035769,GOMF_ORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.804069345351044
GOBP_RENAL_VESICLE_DEVELOPME...,SET,18,0.41776,0.013075,0.23182,0.035773,GOBP_RENAL_VESICLE_DEVELOPMENT,0.804069345351044
ANDERSON_BLOOD_CN54GP140_ADJ...8,SET,28,0.2784,0.010864,0.15455,0.035834,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_7DY_UP,0.804069345351044
MIR4695_5P,SET,79,0.17021,0.011142,0.094517,0.03587,MIR4695_5P,0.804069345351044
HP_HAPPY_DEMEANOR,SET,23,0.3806,0.013463,0.21135,0.035878,HP_HAPPY_DEMEANOR,0.804069345351044
HP_PROMINENT_SUPERFICIAL_BLO...,SET,33,0.2579,0.010925,0.14323,0.035896,HP_PROMINENT_SUPERFICIAL_BLOOD_VESSELS,0.804069345351044
HP_EPICANTHUS_INVERSUS,SET,13,0.46859,0.012465,0.26026,0.035899,HP_EPICANTHUS_INVERSUS,0.804069345351044
GOMF_CCR3_CHEMOKINE_RECEPTOR...,SET,4,0.8162,0.012047,0.45339,0.035921,GOMF_CCR3_CHEMOKINE_RECEPTOR_BINDING,0.804069345351044
GSE411_100MIN_VS_400MIN_IL6_...2,SET,179,0.11089,0.010896,0.06161,0.035953,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_UP,0.804069345351044
GOMF_TORC2_COMPLEX_BINDING,SET,4,0.85318,0.012592,0.47405,0.035957,GOMF_TORC2_COMPLEX_BINDING,0.804069345351044
HP_ABNORMAL_NASAL_BONE_MORPH...,SET,9,0.60909,0.013483,0.33861,0.036036,HP_ABNORMAL_NASAL_BONE_MORPHOLOGY,0.804069345351044
MIR323A_5P,SET,39,0.22956,0.01057,0.12762,0.036039,MIR323A_5P,0.804069345351044
GOBP_CELL_VOLUME_HOMEOSTASIS,SET,34,0.26445,0.01137,0.14707,0.036084,GOBP_CELL_VOLUME_HOMEOSTASIS,0.804069345351044
GOBP_REGULATION_OF_REPRODUCT...,SET,187,0.1155,0.011597,0.06424,0.036108,GOBP_REGULATION_OF_REPRODUCTIVE_PROCESS,0.804069345351044
MIR922,SET,180,0.11043,0.010881,0.061446,0.036162,MIR922,0.804069345351044
MIR1252_3P,SET,270,0.097059,0.011684,0.054013,0.036178,MIR1252_3P,0.804069345351044
GSE40277_EOS_AND_LEF1_TRANSD...2,SET,175,0.11573,0.011245,0.064402,0.036178,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,0.804069345351044
GSE20715_WT_VS_TLR4_KO_LUNG_...1,SET,175,0.11188,0.010871,0.062273,0.036204,GSE20715_WT_VS_TLR4_KO_LUNG_DN,0.804069345351044
GOBP_REGULATION_OF_ACTION_PO...,SET,52,0.23351,0.01241,0.12998,0.036215,GOBP_REGULATION_OF_ACTION_POTENTIAL,0.804069345351044
HP_POIKILODERMA,SET,23,0.27994,0.0099024,0.15585,0.036244,HP_POIKILODERMA,0.804069345351044
GOMF_FRIZZLED_BINDING,SET,35,0.26861,0.011717,0.14958,0.036273,GOMF_FRIZZLED_BINDING,0.804069345351044
HP_TETRAPLEGIA,SET,31,0.26516,0.010887,0.14767,0.036291,HP_TETRAPLEGIA,0.804069345351044
HALLMARK_ANGIOGENESIS,SET,35,0.27501,0.011997,0.15317,0.036293,HALLMARK_ANGIOGENESIS,0.804069345351044
HP_EROSION_OF_ORAL_MUCOSA,SET,89,0.17257,0.011986,0.096125,0.036316,HP_EROSION_OF_ORAL_MUCOSA,0.804069345351044
GSE13887_HEALTHY_VS_LUPUS_RE...1,SET,114,0.14466,0.011364,0.080601,0.036355,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN,0.804069345351044
GSE17721_LPS_VS_CPG_8H_BMDC_...2,SET,186,0.1134,0.011356,0.063193,0.036375,GSE17721_LPS_VS_CPG_8H_BMDC_UP,0.804069345351044
MIR593_3P,SET,127,0.14211,0.011779,0.079197,0.036386,MIR593_3P,0.804069345351044
HP_DIFFUSE_CEREBRAL_ATROPHY,SET,45,0.22329,0.011042,0.12444,0.036388,HP_DIFFUSE_CEREBRAL_ATROPHY,0.804069345351044
HP_LONG_THUMB,SET,7,0.595,0.011616,0.33168,0.036423,HP_LONG_THUMB,0.804069345351044
chr22q12,SET,107,0.31654,0.024096,0.17648,0.036439,chr22q12,0.804069345351044
GOBP_HETEROPHILIC_CELL_CELL_...,SET,45,0.25969,0.012842,0.14479,0.036447,GOBP_HETEROPHILIC_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,0.804069345351044
NAKAYA_PBMC_FLUMIST_AGE_18_5...5,SET,10,0.56497,0.013182,0.31508,0.036486,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_DN,0.804069345351044
MATSUMIYA_BLOOD_MODIFIED_VAC...1,SET,9,0.52071,0.011527,0.2904,0.036488,MATSUMIYA_BLOOD_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_DN,0.804069345351044
MIR4722_3P,SET,79,0.17297,0.011322,0.096483,0.036512,MIR4722_3P,0.804069345351044
HP_GAIT_ATAXIA,SET,217,0.10276,0.011106,0.057323,0.03652,HP_GAIT_ATAXIA,0.804069345351044
MIR8054,SET,268,0.096218,0.01154,0.053674,0.036523,MIR8054,0.804069345351044
GSE22886_NAIVE_TCELL_VS_MONO...2,SET,177,0.11386,0.011126,0.063524,0.036541,GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP,0.804069345351044
WP_NICOTINE_METABOLISM_IN_LI...,SET,6,0.82033,0.014828,0.45775,0.036568,WP_NICOTINE_METABOLISM_IN_LIVER_CELLS,0.804069345351044
GOBP_NEGATIVE_REGULATION_OF_...281,SET,14,0.48947,0.013512,0.27314,0.036577,GOBP_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,0.804069345351044
GSE2770_IL12_AND_TGFB_ACT_VS...2,SET,174,0.11254,0.010904,0.062803,0.036577,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP,0.804069345351044
MIR6727_3P,SET,102,0.15195,0.011294,0.084824,0.036631,MIR6727_3P,0.80410132807571
GOBP_REGULATION_OF_PROTEIN_A...1,SET,17,0.33954,0.010328,0.18955,0.036632,GOBP_REGULATION_OF_PROTEIN_ACETYLATION,0.80410132807571
GSE19888_ADENOSINE_A3R_INH_P...3,SET,173,0.10854,0.010487,0.060607,0.036663,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,0.80410132807571
GOMF_PROTEIN_TYROSINE_THREON...,SET,9,0.59743,0.013225,0.33361,0.036671,GOMF_PROTEIN_TYROSINE_THREONINE_PHOSPHATASE_ACTIVITY,0.80410132807571
TATCTGG_MIR488,SET,58,0.20704,0.011619,0.11572,0.036801,TATCTGG_MIR488,0.805936140075377
ETS2_B,SET,256,0.09514,0.011156,0.053179,0.036811,ETS2_B,0.805936140075377
GOBP_COLLATERAL_SPROUTING,SET,25,0.31733,0.011702,0.17742,0.03685,GOBP_COLLATERAL_SPROUTING,0.805936140075377
KEGG_MEDICUS_REFERENCE_TIGHT...,SET,34,0.27291,0.011734,0.1526,0.036862,KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY,0.805936140075377
MCCOLLUM_GELDANAMYCIN_RESIST...2,SET,9,0.55803,0.012353,0.31207,0.036884,MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP,0.805936140075377
MIR561_3P,SET,437,0.07604,0.011591,0.042533,0.036913,MIR561_3P,0.805936140075377
JAZAERI_BREAST_CANCER_BRCA1_...2,SET,45,0.21424,0.010594,0.11984,0.036917,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,0.805936140075377
HP_GONADOBLASTOMA,SET,14,0.46042,0.01271,0.2578,0.03706,HP_GONADOBLASTOMA,0.806625315203956
HP_VERTICAL_NYSTAGMUS,SET,21,0.31752,0.010733,0.17781,0.037084,HP_VERTICAL_NYSTAGMUS,0.806625315203956
MADAN_DPPA4_TARGETS,SET,49,0.22113,0.011409,0.12384,0.037092,MADAN_DPPA4_TARGETS,0.806625315203956
GSE33424_CD161_HIGH_VS_NEG_C...1,SET,182,0.11288,0.011183,0.063223,0.03711,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN,0.806625315203956
GAVISH_3CA_METAPROGRAM_EPITH...5,SET,47,0.23507,0.011879,0.13168,0.037129,GAVISH_3CA_METAPROGRAM_EPITHELIAL_COLON_RELATED,0.806625315203956
GOBP_TRACHEA_MORPHOGENESIS,SET,11,0.51934,0.012709,0.29094,0.037138,GOBP_TRACHEA_MORPHOGENESIS,0.806625315203956
GOBP_NEGATIVE_REGULATION_OF_...540,SET,5,0.57815,0.0095401,0.3239,0.037142,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION,0.806625315203956
MODULE_139,SET,73,0.19088,0.012013,0.10694,0.037144,MODULE_139,0.806625315203956
ROZANOV_MMP14_TARGETS_DN,SET,30,0.30344,0.012257,0.17006,0.037198,ROZANOV_MMP14_TARGETS_DN,0.806625315203956
HP_ABNORMALITY_OF_THE_ADRENA...,SET,199,0.10899,0.011286,0.061086,0.037201,HP_ABNORMALITY_OF_THE_ADRENAL_GLANDS,0.806625315203956
GSE5542_IFNG_VS_IFNA_TREATED...2,SET,178,0.1091,0.010691,0.061176,0.037268,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,0.806625315203956
ASGHARZADEH_NEUROBLASTOMA_PO...,SET,37,0.24997,0.011211,0.14019,0.037293,ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN,0.806625315203956
GOBP_CORONARY_ARTERY_MORPHOG...,SET,8,0.59116,0.012338,0.33165,0.037345,GOBP_CORONARY_ARTERY_MORPHOGENESIS,0.806625315203956
HP_PRIMARY_GONADAL_INSUFFICI...,SET,15,0.40773,0.01165,0.22875,0.037351,HP_PRIMARY_GONADAL_INSUFFICIENCY,0.806625315203956
GOMF_VOLTAGE_GATED_MONOATOMI...2,SET,139,0.14371,0.012458,0.080637,0.037365,GOMF_VOLTAGE_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.806625315203956
GOBP_REGULATION_OF_ENDODERMA...,SET,6,0.73254,0.013241,0.41105,0.037373,GOBP_REGULATION_OF_ENDODERMAL_CELL_DIFFERENTIATION,0.806625315203956
GOBP_REGULATION_OF_NITRIC_OX...1,SET,6,0.67931,0.012279,0.38121,0.037384,GOBP_REGULATION_OF_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION,0.806625315203956
GOBP_NUCLEOTIDE_TRANSPORT,SET,44,0.2475,0.012102,0.13892,0.037414,GOBP_NUCLEOTIDE_TRANSPORT,0.806625315203956
GOBP_POSITIVE_REGULATION_OF_...417,SET,547,0.070251,0.011945,0.039432,0.037416,GOBP_POSITIVE_REGULATION_OF_LOCOMOTION,0.806625315203956
MIR1976,SET,79,0.17239,0.011285,0.096782,0.037445,MIR1976,0.806625315203956
HP_BILATERAL_SENSORINEURAL_H...,SET,60,0.19855,0.011333,0.11147,0.037446,HP_BILATERAL_SENSORINEURAL_HEARING_IMPAIRMENT,0.806625315203956
GOLDRATH_IMMUNE_MEMORY,SET,61,0.2092,0.012039,0.11749,0.037501,GOLDRATH_IMMUNE_MEMORY,0.806625315203956
GOBP_ODONTOBLAST_DIFFERENTIA...,SET,16,0.4303,0.012698,0.24167,0.037505,GOBP_ODONTOBLAST_DIFFERENTIATION,0.806625315203956
GOCC_BLOC_COMPLEX,SET,19,0.34707,0.01116,0.19494,0.037511,GOCC_BLOC_COMPLEX,0.806625315203956
GOBP_NEGATIVE_REGULATION_OF_...515,SET,5,0.73741,0.012168,0.41428,0.037549,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,0.806625315203956
GENTILE_UV_HIGH_DOSE_UP,SET,17,0.41374,0.012585,0.23245,0.037552,GENTILE_UV_HIGH_DOSE_UP,0.806625315203956
GOBP_DNA_LIGATION,SET,16,0.30578,0.0090233,0.17191,0.037648,GOBP_DNA_LIGATION,0.807014528360049
GOBP_GOLGI_VESICLE_BUDDING,SET,10,0.44456,0.010373,0.24993,0.03765,GOBP_GOLGI_VESICLE_BUDDING,0.807014528360049
GOBP_REGULATION_OF_STEROID_H...1,SET,15,0.43899,0.012543,0.2468,0.037651,GOBP_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.807014528360049
GOMF_AROMATASE_ACTIVITY,SET,25,0.3692,0.013615,0.20758,0.037663,GOMF_AROMATASE_ACTIVITY,0.807014528360049
IVANOVA_HEMATOPOIESIS_INTERM...,SET,123,0.13086,0.010675,0.073589,0.037689,IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,0.807074057301294
GOMF_NETRIN_RECEPTOR_ACTIVITY,SET,5,0.69153,0.011411,0.38919,0.037804,GOMF_NETRIN_RECEPTOR_ACTIVITY,0.808294065765212
YGCGYRCGC_UNKNOWN,SET,287,0.086483,0.010728,0.048676,0.037816,YGCGYRCGC_UNKNOWN,0.808294065765212
MISIAK_ANAPLASTIC_THYROID_CA...1,SET,17,0.42423,0.012904,0.23879,0.037826,MISIAK_ANAPLASTIC_THYROID_CARCINOMA_DN,0.808294065765212
GOBP_REGULATION_OF_MITOCHOND...16,SET,136,0.12964,0.011117,0.072977,0.037839,GOBP_REGULATION_OF_MITOCHONDRION_ORGANIZATION,0.808294065765212
REACTOME_GERM_LAYER_FORMATIO...,SET,15,0.40495,0.011571,0.228,0.037864,REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION,0.808331277641278
GOBP_POSITIVE_REGULATION_OF_...559,SET,28,0.33604,0.013114,0.18928,0.037931,GOBP_POSITIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.809036880733945
HP_COLPOCEPHALY,SET,28,0.28862,0.011263,0.16261,0.037966,HP_COLPOCEPHALY,0.809036880733945
GOCC_ZYMOGEN_GRANULE,SET,18,0.36243,0.011343,0.20423,0.037988,GOCC_ZYMOGEN_GRANULE,0.809036880733945
GOBP_POSITIVE_REGULATION_OF_...58,SET,48,0.22569,0.011525,0.1272,0.038015,GOBP_POSITIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.809036880733945
GSE2706_2H_VS_8H_R848_STIM_D...2,SET,172,0.1188,0.011445,0.06697,0.038045,GSE2706_2H_VS_8H_R848_STIM_DC_UP,0.809036880733945
ZA_UNIPROT_Q9UM89_UNREVIEWED...,SET,60,0.20592,0.011753,0.11609,0.038055,ZA_UNIPROT_Q9UM89_UNREVIEWED_GENES_TARGET_GENES,0.809036880733945
GSE16755_CTRL_VS_IFNA_TREATE...1,SET,174,0.11896,0.011527,0.067068,0.03806,GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN,0.809036880733945
GOBP_LAYER_FORMATION_IN_CERE...,SET,13,0.4668,0.012418,0.26324,0.038097,GOBP_LAYER_FORMATION_IN_CEREBRAL_CORTEX,0.809328383251834
SANA_TNF_SIGNALING_UP,SET,79,0.18258,0.011952,0.10301,0.038162,SANA_TNF_SIGNALING_UP,0.809713517283202
WP_NODLIKE_RECEPTOR_NLR_SIGN...,SET,7,0.54704,0.01068,0.30864,0.03817,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,0.809713517283202
MIR4529_3P,SET,43,0.23572,0.011395,0.13301,0.038191,MIR4529_3P,0.809713517283202
GOBP_TRANSLESION_SYNTHESIS,SET,24,0.25361,0.0091637,0.14316,0.038252,GOBP_TRANSLESION_SYNTHESIS,0.809713517283202
HP_ABNORMALITY_OF_MOUTH_SIZE,SET,373,0.07914,0.011166,0.044696,0.038319,HP_ABNORMALITY_OF_MOUTH_SIZE,0.809713517283202
GOMF_EXOPEPTIDASE_ACTIVITY,SET,95,0.16372,0.011747,0.09247,0.038327,GOMF_EXOPEPTIDASE_ACTIVITY,0.809713517283202
GSE41867_DAY15_EFFECTOR_VS_D...1,SET,182,0.10644,0.010545,0.060119,0.038333,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,0.809713517283202
MIR3934_3P,SET,90,0.1552,0.01084,0.087663,0.038339,MIR3934_3P,0.809713517283202
HP_POSTERIOR_STAPHYLOMA,SET,7,0.63843,0.012464,0.36071,0.03838,HP_POSTERIOR_STAPHYLOMA,0.809713517283202
GOMF_DEAMINASE_ACTIVITY,SET,29,0.31689,0.012585,0.17906,0.038394,GOMF_DEAMINASE_ACTIVITY,0.809713517283202
REACTOME_CYTOSOLIC_IRON_SULF...,SET,10,0.43096,0.010056,0.24354,0.038405,REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY,0.809713517283202
HP_CHEST_PAIN,SET,127,0.14118,0.011702,0.079784,0.038409,HP_CHEST_PAIN,0.809713517283202
GOMF_UREA_TRANSMEMBRANE_TRAN...,SET,7,0.68553,0.013384,0.38743,0.038418,GOMF_UREA_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.809713517283202
MENON_FETAL_KIDNEY_7_LOOPOF_...,SET,209,0.10248,0.010872,0.057941,0.038483,MENON_FETAL_KIDNEY_7_LOOPOF_HENLE_CELLS_DISTAL,0.810416711084191
HP_POSTPRANDIAL_HYPERGLYCEMIA,SET,7,0.61414,0.01199,0.34727,0.038498,HP_POSTPRANDIAL_HYPERGLYCEMIA,0.810416711084191
MIR378A_5P,SET,120,0.14233,0.01147,0.080508,0.038547,MIR378A_5P,0.81095
CUI_TCF21_TARGETS_2_UP,SET,390,0.078979,0.011389,0.044681,0.03857,CUI_TCF21_TARGETS_2_UP,0.81095
MORF_HDAC1,SET,225,0.093001,0.010233,0.052632,0.038623,MORF_HDAC1,0.811573376662636
GSE17974_IL4_AND_ANTI_IL12_V...9,SET,144,0.13338,0.011767,0.075513,0.038674,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN,0.812154
GSE17974_2H_VS_72H_UNTREATED...2,SET,174,0.11009,0.010667,0.062369,0.038784,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.812359266547406
MIR767_5P,SET,174,0.11651,0.011289,0.066008,0.038788,MIR767_5P,0.812359266547406
GSE28726_NAIVE_CD4_TCELL_VS_...3,SET,173,0.11636,0.011242,0.065934,0.038813,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN,0.812359266547406
GOBP_RESPONSE_TO_ACTINOMYCIN...,SET,5,0.64131,0.010582,0.36346,0.038835,GOBP_RESPONSE_TO_ACTINOMYCIN_D,0.812359266547406
GOCC_LAMELLIPODIUM,SET,187,0.10766,0.01081,0.061017,0.038843,GOCC_LAMELLIPODIUM,0.812359266547406
GOBP_TRANSEPITHELIAL_CHLORID...,SET,8,0.55158,0.011512,0.31268,0.03887,GOBP_TRANSEPITHELIAL_CHLORIDE_TRANSPORT,0.812359266547406
GOBP_GRANULOCYTE_CHEMOTAXIS,SET,118,0.15654,0.01251,0.08874,0.038876,GOBP_GRANULOCYTE_CHEMOTAXIS,0.812359266547406
WP_EBSTEINBARR_VIRUS_LMP1_SI...,SET,21,0.30733,0.010389,0.17426,0.038905,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,0.812359266547406
GOBP_NAD_TRANSMEMBRANE_TRANS...,SET,4,0.80343,0.011858,0.45579,0.038982,GOBP_NAD_TRANSMEMBRANE_TRANSPORT,0.812359266547406
GOMF_NAD_TRANSMEMBRANE_TRANS...,SET,4,0.80343,0.011858,0.45579,0.038982,GOMF_NAD_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.812359266547406
NAKAYA_PBMC_FLUAD_MALE_AGE_1...1,SET,36,0.26271,0.011622,0.14905,0.038991,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_ATIV_UP,0.812359266547406
MIR483_3P,SET,49,0.22159,0.011433,0.12574,0.039015,MIR483_3P,0.812359266547406
GRAHAM_CML_DIVIDING_VS_NORMA...2,SET,9,0.51355,0.011368,0.29147,0.039053,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP,0.812359266547406
GSE19198_CTRL_VS_IL21_TREATE...1,SET,182,0.11685,0.011577,0.066324,0.039059,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_DN,0.812359266547406
GSE4984_UNTREATED_VS_LPS_TRE...1,SET,156,0.11665,0.010708,0.066213,0.039063,GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN,0.812359266547406
HP_ABNORMALITY_OF_THE_PERIOR...,SET,229,0.10261,0.011388,0.058264,0.03912,HP_ABNORMALITY_OF_THE_PERIORBITAL_REGION,0.812359266547406
EBNA1BP2_TARGET_GENES,SET,290,0.089392,0.011146,0.050762,0.039127,EBNA1BP2_TARGET_GENES,0.812359266547406
GCCATNTTG_YY1_Q6,SET,385,0.074713,0.010706,0.042431,0.039143,GCCATNTTG_YY1_Q6,0.812359266547406
GOBP_REGULATION_OF_DNA_DIREC...,SET,9,0.46123,0.01021,0.26197,0.039162,GOBP_REGULATION_OF_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,0.812359266547406
MODULE_427,SET,99,0.14565,0.010667,0.082735,0.039179,MODULE_427,0.812359266547406
HP_2_3_TOE_SYNDACTYLY,SET,81,0.16742,0.011096,0.095103,0.039182,HP_2_3_TOE_SYNDACTYLY,0.812359266547406
CHARAFE_BREAST_CANCER_LUMINA...3,SET,425,0.078512,0.011807,0.044605,0.039198,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,0.812359266547406
MIR548A_3P,SET,431,0.073979,0.011202,0.04205,0.039271,MIR548A_3P,0.813387130512515
FAN_OVARY_CL13_MONOCYTE_MACR...,SET,411,0.075096,0.01111,0.04272,0.039393,FAN_OVARY_CL13_MONOCYTE_MACROPHAGE,0.814652353282975
GOMF_TROPOMYOSIN_BINDING,SET,14,0.386,0.010656,0.21961,0.039412,GOMF_TROPOMYOSIN_BINDING,0.814652353282975
HE_LIM_SUN_FETAL_LUNG_C4_ILC...1,SET,135,0.13837,0.011822,0.078742,0.039446,HE_LIM_SUN_FETAL_LUNG_C4_ILC2_CELL,0.814652353282975
GOBP_ASTRAL_MICROTUBULE_ORGA...,SET,10,0.54561,0.012731,0.31058,0.03949,GOBP_ASTRAL_MICROTUBULE_ORGANIZATION,0.814652353282975
HP_POSITIONAL_FOOT_DEFORMITY,SET,414,0.07524,0.011171,0.042835,0.039511,HP_POSITIONAL_FOOT_DEFORMITY,0.814652353282975
ZHONG_PFC_MAJOR_TYPES_INTERN...,SET,13,0.471,0.012529,0.26816,0.039521,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,0.814652353282975
GOBP_CYTOPLASMIC_SEQUESTERIN...3,SET,7,0.50949,0.009947,0.29009,0.039523,GOBP_CYTOPLASMIC_SEQUESTERING_OF_TRANSCRIPTION_FACTOR,0.814652353282975
GOBP_TOXIN_METABOLIC_PROCESS,SET,15,0.39432,0.011267,0.22452,0.039528,GOBP_TOXIN_METABOLIC_PROCESS,0.814652353282975
GUTIERREZ_MULTIPLE_MYELOMA_UP,SET,30,0.28015,0.011316,0.15957,0.039582,GUTIERREZ_MULTIPLE_MYELOMA_UP,0.814652353282975
GSE22103_UNSTIM_VS_GMCSF_AND...2,SET,185,0.10524,0.010511,0.059952,0.03961,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,0.814652353282975
GOCC_MISMATCH_REPAIR_COMPLEX,SET,7,0.49941,0.0097502,0.28454,0.039624,GOCC_MISMATCH_REPAIR_COMPLEX,0.814652353282975
GOBP_NEURAL_CREST_FORMATION,SET,15,0.42374,0.012107,0.24143,0.039627,GOBP_NEURAL_CREST_FORMATION,0.814652353282975
WP_ESTROGEN_METABOLISM_WP697,SET,14,0.46184,0.012749,0.26318,0.03965,WP_ESTROGEN_METABOLISM_WP697,0.814652353282975
ACTAYRNNNCCCR_UNKNOWN,SET,411,0.073809,0.01092,0.042104,0.039806,ACTAYRNNNCCCR_UNKNOWN,0.814652353282975
KEGG_MEDICUS_REFERENCE_MANNO...1,SET,3,0.88638,0.01133,0.50563,0.039809,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_FKTN_TO_LARGE,0.814652353282975
GSE360_L_MAJOR_VS_B_MALAYI_L...1,SET,178,0.11025,0.010803,0.06291,0.039858,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN,0.814652353282975
GOBP_POSITIVE_REGULATION_OF_...363,SET,36,0.2715,0.012011,0.15494,0.039873,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,0.814652353282975
HP_ABNORMAL_CEREBRAL_VEIN_MO...,SET,8,0.52921,0.011045,0.30203,0.039882,HP_ABNORMAL_CEREBRAL_VEIN_MORPHOLOGY,0.814652353282975
HP_PAROXYSMAL_DYSKINESIA,SET,15,0.37945,0.010842,0.21659,0.039899,HP_PAROXYSMAL_DYSKINESIA,0.814652353282975
MIR4277,SET,116,0.13946,0.011051,0.079617,0.039924,MIR4277,0.814652353282975
GOCC_PARASPECKLES,SET,7,0.49593,0.0096822,0.28314,0.039934,GOCC_PARASPECKLES,0.814652353282975
MIR659_5P,SET,25,0.30983,0.011426,0.17691,0.039954,MIR659_5P,0.814652353282975
FRASOR_TAMOXIFEN_RESPONSE_DN,SET,10,0.45135,0.010531,0.25775,0.03997,FRASOR_TAMOXIFEN_RESPONSE_DN,0.814652353282975
HP_ABNORMALITY_ON_PULMONARY_...,SET,167,0.11599,0.011013,0.06625,0.039995,HP_ABNORMALITY_ON_PULMONARY_FUNCTION_TESTING,0.814652353282975
HE_LIM_SUN_FETAL_LUNG_C2_NEU...,SET,58,0.21199,0.011897,0.12108,0.039998,HE_LIM_SUN_FETAL_LUNG_C2_NEUTROPHIL_CELL,0.814652353282975
MIR19B_1_5P_MIR19B_2_5P,SET,160,0.12474,0.011594,0.071266,0.040039,MIR19B_1_5P_MIR19B_2_5P,0.814652353282975
GOBP_INTERLEUKIN_17_PRODUCTI...,SET,37,0.27289,0.012239,0.15598,0.040103,GOBP_INTERLEUKIN_17_PRODUCTION,0.814652353282975
WALLACE_JAK2_TARGETS_UP,SET,19,0.29969,0.0096364,0.1713,0.040109,WALLACE_JAK2_TARGETS_UP,0.814652353282975
HP_INCREASED_CUP_TO_DISC_RAT...,SET,8,0.60488,0.012624,0.34576,0.040116,HP_INCREASED_CUP_TO_DISC_RATIO,0.814652353282975
GSE15215_CD2_POS_VS_NEG_PDC_...2,SET,181,0.11071,0.010939,0.063283,0.040118,GSE15215_CD2_POS_VS_NEG_PDC_UP,0.814652353282975
ZNF776_TARGET_GENES,SET,6,0.58976,0.01066,0.33714,0.040128,ZNF776_TARGET_GENES,0.814652353282975
MIR4308,SET,133,0.12979,0.011007,0.074207,0.040152,MIR4308,0.814652353282975
REACTOME_INTERLEUKIN_6_SIGNA...,SET,11,0.46322,0.011336,0.26486,0.040161,REACTOME_INTERLEUKIN_6_SIGNALING,0.814652353282975
HP_MACRODONTIA,SET,27,0.29494,0.011303,0.16865,0.040173,HP_MACRODONTIA,0.814652353282975
HP_OSTEOPENIA,SET,288,0.088043,0.010941,0.050346,0.040176,HP_OSTEOPENIA,0.814652353282975
HP_HEMIFACIAL_SPASM,SET,12,0.37884,0.0096825,0.21667,0.040204,HP_HEMIFACIAL_SPASM,0.814652353282975
GOCC_TRANSCRIPTION_FACTOR_TF...3,SET,11,0.35998,0.0088091,0.20589,0.040209,GOCC_TRANSCRIPTION_FACTOR_TFIIH_HOLO_COMPLEX,0.814652353282975
HP_OSTEOPOROSIS,SET,281,0.090781,0.011145,0.051934,0.040242,HP_OSTEOPOROSIS,0.814652353282975
MIR153_5P,SET,950,0.051581,0.011426,0.029521,0.040303,MIR153_5P,0.814652353282975
GOBP_MESENCHYMAL_STEM_CELL_D...,SET,11,0.49002,0.011991,0.2805,0.04033,GOBP_MESENCHYMAL_STEM_CELL_DIFFERENTIATION,0.814652353282975
BUSSLINGER_GASTRIC_TUFT_CELLS,SET,11,0.49777,0.012181,0.28494,0.040332,BUSSLINGER_GASTRIC_TUFT_CELLS,0.814652353282975
MIR6862_3P,SET,26,0.26846,0.010096,0.15367,0.040334,MIR6862_3P,0.814652353282975
GOBP_REGULATION_OF_DNA_REPLI...,SET,117,0.13579,0.010806,0.077736,0.04034,GOBP_REGULATION_OF_DNA_REPLICATION,0.814652353282975
HP_SINUS_TACHYCARDIA,SET,27,0.26853,0.010291,0.15375,0.04037,HP_SINUS_TACHYCARDIA,0.814784756097561
GOCC_PERINUCLEAR_ENDOPLASMIC...,SET,19,0.34768,0.011179,0.19911,0.040398,GOCC_PERINUCLEAR_ENDOPLASMIC_RETICULUM,0.814876662797446
GOMF_SH3_DOMAIN_BINDING,SET,111,0.1365,0.010582,0.078198,0.040448,GOMF_SH3_DOMAIN_BINDING,0.815411972157773
chr4p12,SET,15,0.70255,0.020074,0.40256,0.040482,chr4p12,0.815624295652174
MIR12113,SET,83,0.16911,0.011345,0.096962,0.040579,MIR12113,0.816581597222222
GOBP_REGULATION_OF_MORPHOGEN...2,SET,46,0.23984,0.011991,0.13753,0.040594,GOBP_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,0.816581597222222
GRUETZMANN_PANCREATIC_CANCER...1,SET,182,0.11172,0.011068,0.064063,0.0406,GRUETZMANN_PANCREATIC_CANCER_DN,0.816581597222222
GSE13738_TCR_VS_BYSTANDER_AC...2,SET,178,0.11094,0.010871,0.063651,0.040686,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,0.81704349595843
GOBP_TERMINAL_BUTTON_ORGANIZ...,SET,6,0.66415,0.012005,0.38108,0.040693,GOBP_TERMINAL_BUTTON_ORGANIZATION,0.81704349595843
WP_NCRNAS_INVOLVED_IN_STAT3_...,SET,13,0.44977,0.011964,0.25807,0.040694,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,0.81704349595843
LI_ESTROGENE_LATE_E2_RESPONS...1,SET,71,0.19291,0.011974,0.11071,0.040717,LI_ESTROGENE_LATE_E2_RESPONSE_DN,0.81704349595843
LIU_OVARIAN_CANCER_TUMORS_AN...1,SET,33,0.29492,0.012493,0.16932,0.040782,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN,0.817875597230237
MIR3127_3P,SET,95,0.14682,0.010535,0.084363,0.040906,MIR3127_3P,0.819550480161012
GOBP_CARDIAC_MUSCLE_CELL_ACT...1,SET,77,0.18609,0.012026,0.10696,0.040952,GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.819550480161012
GOMF_NUCLEOSIDE_BINDING,SET,8,0.53726,0.011213,0.30882,0.040962,GOMF_NUCLEOSIDE_BINDING,0.819550480161012
DARWICHE_SQUAMOUS_CELL_CARCI...1,SET,164,0.11414,0.010739,0.065608,0.040967,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,0.819550480161012
ISRE_01,SET,226,0.10227,0.011277,0.058796,0.040996,ISRE_01,0.819550480161012
GSE29618_PRE_VS_DAY7_FLU_VAC...3,SET,178,0.106,0.010386,0.060945,0.041007,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN,0.819550480161012
GOBP_CELLULAR_RESPONSE_TO_TE...2,SET,8,0.53094,0.011081,0.30535,0.041047,GOBP_CELLULAR_RESPONSE_TO_TESTOSTERONE_STIMULUS,0.819878439655172
GSE17721_LPS_VS_CPG_24H_BMDC...1,SET,190,0.10586,0.010714,0.060903,0.041093,GSE17721_LPS_VS_CPG_24H_BMDC_DN,0.820198083094556
ABDULRAHMAN_KIDNEY_CANCER_VH...,SET,13,0.40271,0.010713,0.23177,0.041153,ABDULRAHMAN_KIDNEY_CANCER_VHL_DN,0.820198083094556
GOBP_POSITIVE_REGULATION_OF_...822,SET,8,0.54989,0.011477,0.31651,0.041171,GOBP_POSITIVE_REGULATION_OF_UTERINE_SMOOTH_MUSCLE_CONTRACTION,0.820198083094556
GSE20366_EX_VIVO_VS_DEC205_C...4,SET,182,0.1098,0.010878,0.063203,0.041179,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP,0.820198083094556
GOBP_REGULATION_OF_ASTROCYTE...1,SET,5,0.75161,0.012402,0.43265,0.041181,GOBP_REGULATION_OF_ASTROCYTE_ACTIVATION,0.820198083094556
BUSSLINGER_DUODENAL_EARLY_IM...,SET,99,0.15231,0.011154,0.087751,0.041321,BUSSLINGER_DUODENAL_EARLY_IMMATURE_ENTEROCYTES,0.821525025641026
MIR5007_3P,SET,109,0.14702,0.011295,0.084727,0.041359,MIR5007_3P,0.821525025641026
GOBP_RESPONSE_TO_INTERLEUKIN...12,SET,5,0.77499,0.012788,0.44663,0.041363,GOBP_RESPONSE_TO_INTERLEUKIN_9,0.821525025641026
GOBP_REGULATION_OF_AMACRINE_...,SET,6,0.6498,0.011745,0.37451,0.041374,GOBP_REGULATION_OF_AMACRINE_CELL_DIFFERENTIATION,0.821525025641026
GOBP_REGULATION_OF_CELL_ADHE...2,SET,46,0.21861,0.010929,0.126,0.041381,GOBP_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.821525025641026
chr3p11,SET,7,0.83707,0.016342,0.48256,0.04141,chr3p11,0.821525025641026
GOCC_CYTOPLASMIC_SIDE_OF_END...2,SET,6,0.49492,0.008946,0.28532,0.041414,GOCC_CYTOPLASMIC_SIDE_OF_ENDOSOME_MEMBRANE,0.821525025641026
GOBP_UREA_TRANSPORT,SET,10,0.56746,0.013241,0.32723,0.041454,GOBP_UREA_TRANSPORT,0.821525025641026
GOBP_INTERLEUKIN_17A_MEDIATE...,SET,6,0.66676,0.012052,0.38456,0.041483,GOBP_INTERLEUKIN_17A_MEDIATED_SIGNALING_PATHWAY,0.821525025641026
BERENJENO_TRANSFORMED_BY_RHO...1,SET,354,0.079562,0.010941,0.045888,0.041484,BERENJENO_TRANSFORMED_BY_RHOA_DN,0.821525025641026
GOBP_ERYTHROCYTE_DEVELOPMENT,SET,38,0.23721,0.010781,0.13684,0.041508,GOBP_ERYTHROCYTE_DEVELOPMENT,0.821532198177677
MIR6843_3P,SET,82,0.17361,0.011577,0.10018,0.04155,MIR6843_3P,0.821895418326693
GOMF_GENERAL_TRANSCRIPTION_I...2,SET,50,0.20489,0.010678,0.11826,0.041597,GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING,0.822031304347826
HEB_Q6,SET,239,0.094541,0.010717,0.054576,0.041622,HEB_Q6,0.822031304347826
HP_PROLONGED_NEONATAL_JAUNDI...,SET,63,0.17971,0.010509,0.10376,0.041648,HP_PROLONGED_NEONATAL_JAUNDICE,0.822031304347826
GOBP_REGULATION_OF_LIPASE_AC...,SET,59,0.20447,0.011573,0.11807,0.04166,GOBP_REGULATION_OF_LIPASE_ACTIVITY,0.822031304347826
GOBP_REGULATION_OF_DENDRITE_...1,SET,89,0.16308,0.011328,0.094178,0.041676,GOBP_REGULATION_OF_DENDRITE_DEVELOPMENT,0.822031304347826
GOBP_POSITIVE_REGULATION_OF_...93,SET,29,0.30514,0.012118,0.17626,0.041721,GOBP_POSITIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,0.822031304347826
BOYLAN_MULTIPLE_MYELOMA_C_DN,SET,52,0.22552,0.011986,0.13031,0.041766,BOYLAN_MULTIPLE_MYELOMA_C_DN,0.822031304347826
REACTOME_REGULATION_OF_HMOX1...,SET,5,0.63673,0.010507,0.36793,0.041772,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,0.822031304347826
GOBP_REGULATION_OF_TESTOSTER...,SET,6,0.6656,0.012031,0.38463,0.041781,GOBP_REGULATION_OF_TESTOSTERONE_BIOSYNTHETIC_PROCESS,0.822031304347826
GOBP_RESPONSE_TO_PLATELET_DE...,SET,19,0.36269,0.011662,0.20968,0.041849,GOBP_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR,0.822031304347826
GSE5589_IL6_KO_VS_IL10_KO_LP...10,SET,175,0.10652,0.01035,0.061596,0.041882,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,0.822031304347826
GSE9006_HEALTHY_VS_TYPE_1_DI...5,SET,178,0.11977,0.011737,0.069259,0.041882,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN,0.822031304347826
GOBP_PURINE_NUCLEOTIDE_TRANS...,SET,38,0.25963,0.0118,0.15013,0.041884,GOBP_PURINE_NUCLEOTIDE_TRANSPORT,0.822031304347826
MODULE_138,SET,80,0.17128,0.011282,0.099048,0.041888,MODULE_138,0.822031304347826
GOBP_LATE_ENDOSOME_TO_LYSOSO...,SET,21,0.32625,0.011028,0.18869,0.041913,GOBP_LATE_ENDOSOME_TO_LYSOSOME_TRANSPORT,0.822057739841986
HP_PAPULE,SET,92,0.15202,0.010734,0.087945,0.041956,HP_PAPULE,0.822071338782413
GOBP_POSITIVE_REGULATION_OF_...679,SET,576,0.063524,0.011074,0.036752,0.041961,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,0.822071338782413
GSE13887_ACT_CD4_VS_NO_TREAT...2,SET,116,0.13977,0.011075,0.080884,0.041997,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP,0.822313090140845
HP_ARTERIAL_THROMBOSIS,SET,29,0.28467,0.011305,0.1648,0.04206,HP_ARTERIAL_THROMBOSIS,0.822991359032077
GOBP_POSITIVE_REGULATION_OF_...695,SET,297,0.08984,0.011334,0.052016,0.042079,GOBP_POSITIVE_REGULATION_OF_SECRETION,0.822991359032077
MIR5589_5P,SET,67,0.18259,0.011011,0.10575,0.042123,MIR5589_5P,0.823388562992126
REACTOME_RND3_GTPASE_CYCLE,SET,41,0.22667,0.0107,0.13131,0.042165,REACTOME_RND3_GTPASE_CYCLE,0.823746247892074
MIR1229_3P,SET,75,0.16279,0.010384,0.094322,0.042195,MIR1229_3P,0.82386922752809
GSE3720_LPS_VS_PMA_STIM_VD2_...1,SET,138,0.13051,0.011273,0.075714,0.042391,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,0.824214633406836
GOBP_NEGATIVE_REGULATION_OF_...249,SET,14,0.38826,0.010718,0.22527,0.042406,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_VIA_CHROMOSOMAL_CPG_ISLAND_METHYLATION,0.824214633406836
WP_RETT_SYNDROME,SET,41,0.23846,0.011257,0.13837,0.042416,WP_RETT_SYNDROME,0.824214633406836
HP_ABNORMALITY_OF_DENTAL_COL...,SET,31,0.26976,0.011076,0.15661,0.042495,HP_ABNORMALITY_OF_DENTAL_COLOR,0.824214633406836
HP_VERTEBRAL_SEGMENTATION_DE...,SET,131,0.12978,0.010924,0.075348,0.042504,HP_VERTEBRAL_SEGMENTATION_DEFECT,0.824214633406836
GSE42724_B1_BCELL_VS_PLASMAB...1,SET,180,0.10429,0.010276,0.060549,0.042508,GSE42724_B1_BCELL_VS_PLASMABLAST_DN,0.824214633406836
GOBP_NEGATIVE_REGULATION_OF_...158,SET,42,0.22318,0.010663,0.1296,0.042538,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.824214633406836
GOBP_APOPTOTIC_MITOCHONDRIAL...,SET,94,0.14965,0.010681,0.086904,0.042541,GOBP_APOPTOTIC_MITOCHONDRIAL_CHANGES,0.824214633406836
GUTIERREZ_WALDENSTROEMS_MACR...1,SET,8,0.59165,0.012348,0.34368,0.042587,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN,0.824214633406836
PID_HIF2PATHWAY,SET,30,0.25887,0.010456,0.15042,0.042642,PID_HIF2PATHWAY,0.824214633406836
GOBP_REGULATION_OF_SUPRAMOLE...,SET,335,0.079988,0.010706,0.04648,0.042643,GOBP_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION,0.824214633406836
KEGG_MEDICUS_REFERENCE_N_GLY...3,SET,5,0.56408,0.0093079,0.32781,0.042655,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG7_TO_ALG11,0.824214633406836
GOMF_MODIFIED_AMINO_ACID_TRA...,SET,30,0.2661,0.010748,0.15466,0.042676,GOMF_MODIFIED_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.824214633406836
PU1_Q6,SET,221,0.10332,0.011267,0.060056,0.042694,PU1_Q6,0.824214633406836
HP_DECREASED_LIGHT_AND_DARK_...,SET,14,0.40208,0.011099,0.23388,0.042801,HP_DECREASED_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM_AMPLITUDE,0.824214633406836
GOBP_REGULATION_OF_VERY_LOW_...1,SET,2,0.96349,0.010056,0.56046,0.042807,GOBP_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.824214633406836
GOBP_POSITIVE_REGULATION_OF_...29,SET,33,0.28121,0.011912,0.16358,0.042809,GOBP_POSITIVE_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS,0.824214633406836
GSE41867_DAY8_EFFECTOR_VS_DA...2,SET,174,0.10953,0.010613,0.063721,0.042822,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,0.824214633406836
chr3q21,SET,62,0.32073,0.018608,0.18659,0.042824,chr3q21,0.824214633406836
MODULE_238,SET,141,0.1282,0.011192,0.074585,0.042828,MODULE_238,0.824214633406836
GOBP_UTERINE_SMOOTH_MUSCLE_C...,SET,10,0.44317,0.010341,0.25791,0.042879,GOBP_UTERINE_SMOOTH_MUSCLE_CONTRACTION,0.824214633406836
AP2_Q6,SET,239,0.094287,0.010688,0.054879,0.042898,AP2_Q6,0.824214633406836
IK2_01,SET,235,0.098784,0.011105,0.057498,0.042902,IK2_01,0.824214633406836
MIR4762_3P,SET,242,0.096416,0.010997,0.05612,0.042904,MIR4762_3P,0.824214633406836
GOBP_SULFUR_COMPOUND_TRANSPO...,SET,60,0.19393,0.011069,0.11288,0.042904,GOBP_SULFUR_COMPOUND_TRANSPORT,0.824214633406836
KEGG_MATURITY_ONSET_DIABETES...,SET,25,0.32914,0.012138,0.19159,0.042911,KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,0.824214633406836
GSE46242_CTRL_VS_EGR2_DELETE...4,SET,168,0.10862,0.010343,0.063227,0.042918,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_UP,0.824214633406836
E2F_Q2,SET,170,0.11712,0.011218,0.068178,0.042926,E2F_Q2,0.824214633406836
GOBP_NEGATIVE_REGULATION_OF_...629,SET,8,0.40419,0.0084357,0.23532,0.042943,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_CAPPING,0.824214633406836
HP_URETHRAL_STRICTURE,SET,16,0.38655,0.011407,0.22505,0.042945,HP_URETHRAL_STRICTURE,0.824214633406836
MIR4796_5P,SET,89,0.16523,0.011477,0.096202,0.042948,MIR4796_5P,0.824214633406836
GOCC_ESCRT_I_COMPLEX,SET,12,0.41705,0.010659,0.24286,0.042975,GOCC_ESCRT_I_COMPLEX,0.824214633406836
GOBP_NEGATIVE_REGULATION_OF_...576,SET,72,0.1713,0.010707,0.099768,0.043001,GOBP_NEGATIVE_REGULATION_OF_RNA_CATABOLIC_PROCESS,0.824214633406836
HE_LIM_SUN_FETAL_LUNG_C4_TRE...,SET,36,0.28284,0.012513,0.16475,0.043019,HE_LIM_SUN_FETAL_LUNG_C4_TREG_CELL,0.824214633406836
HP_IMPAIRED_COLLAGEN_INDUCED...,SET,16,0.33819,0.0099799,0.19702,0.043043,HP_IMPAIRED_COLLAGEN_INDUCED_PLATELET_AGGREGATION,0.824220090909091
SCHUETZ_BREAST_CANCER_DUCTAL...2,SET,321,0.088757,0.011634,0.051717,0.04307,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,0.824282957048458
GOBP_EXTRACELLULAR_EXOSOME_A...,SET,7,0.59878,0.01169,0.34901,0.043123,GOBP_EXTRACELLULAR_EXOSOME_ASSEMBLY,0.824408481848185
GOBP_RIBONUCLEOSIDE_METABOLI...,SET,32,0.31827,0.013276,0.18551,0.043124,GOBP_RIBONUCLEOSIDE_METABOLIC_PROCESS,0.824408481848185
GOBP_REGULATION_OF_DNA_DAMAG...2,SET,33,0.2557,0.010831,0.14907,0.043156,GOBP_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.824566673996701
HP_ABNORMAL_SCROTUM_MORPHOLO...,SET,110,0.14669,0.011321,0.085538,0.04319,HP_ABNORMAL_SCROTUM_MORPHOLOGY,0.824762884615385
GGCNRNWCTTYS_UNKNOWN,SET,77,0.16369,0.010579,0.095497,0.043268,GGCNRNWCTTYS_UNKNOWN,0.825070010940919
HP_HYPOAUTOFLUORESCENT_RETIN...,SET,5,0.79205,0.01307,0.46213,0.043282,HP_HYPOAUTOFLUORESCENT_RETINAL_LESION,0.825070010940919
GSE21927_SPLEEN_VS_BONE_MARR...2,SET,168,0.11538,0.010987,0.06735,0.043348,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP,0.825070010940919
HP_GENERALIZED_HYPERPIGMENTA...,SET,37,0.23556,0.010565,0.13751,0.043358,HP_GENERALIZED_HYPERPIGMENTATION,0.825070010940919
KINSEY_TARGETS_OF_EWSR1_FLII...1,SET,299,0.088067,0.011147,0.051417,0.043384,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,0.825070010940919
DARWICHE_PAPILLOMA_RISK_HIGH...1,SET,163,0.11192,0.010499,0.065349,0.043394,DARWICHE_PAPILLOMA_RISK_HIGH_DN,0.825070010940919
HP_ENLARGED_INTERPHALANGEAL_...,SET,5,0.65847,0.010865,0.38447,0.043394,HP_ENLARGED_INTERPHALANGEAL_JOINTS,0.825070010940919
GOCC_MYELIN_SHEATH_ADAXONAL_...,SET,5,0.56039,0.0092471,0.3272,0.043396,GOCC_MYELIN_SHEATH_ADAXONAL_REGION,0.825070010940919
GSE36527_CD62L_HIGH_CD69_NEG...2,SET,180,0.10552,0.010398,0.061625,0.043423,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_UP,0.825131965554948
GOMF_PEPTIDE_ANTIGEN_BINDING,SET,32,0.29526,0.012317,0.17258,0.043564,GOMF_PEPTIDE_ANTIGEN_BINDING,0.82696400054615
GOBP_NUCLEAR_ENVELOPE_ORGANI...,SET,54,0.1951,0.010566,0.11404,0.043567,GOBP_NUCLEAR_ENVELOPE_ORGANIZATION,0.82696400054615
MIR6894_5P,SET,37,0.2294,0.010288,0.13413,0.043609,MIR6894_5P,0.827309385917031
MIR6816_5P,SET,19,0.35611,0.011451,0.20825,0.043638,MIR6816_5P,0.82740790507365
WP_OSTEOPONTIN_SIGNALING,SET,13,0.4132,0.010992,0.24168,0.043671,WP_OSTEOPONTIN_SIGNALING,0.827582118320611
HP_CUTANEOUS_ABSCESS,SET,23,0.30529,0.010799,0.17862,0.043719,HP_CUTANEOUS_ABSCESS,0.827683888888889
HP_DILATION_OF_VIRCHOW_ROBIN...,SET,13,0.41895,0.011145,0.24513,0.043724,HP_DILATION_OF_VIRCHOW_ROBIN_SPACES,0.827683888888889
GSE14000_UNSTIM_VS_16H_LPS_D...4,SET,169,0.10909,0.010419,0.063873,0.043833,GSE14000_UNSTIM_VS_16H_LPS_DC_UP,0.828882168117519
GOBP_GLIAL_CELL_FATE_SPECIFI...,SET,7,0.65616,0.01281,0.38419,0.043835,GOBP_GLIAL_CELL_FATE_SPECIFICATION,0.828882168117519
GSE7852_TREG_VS_TCONV_THYMUS...1,SET,178,0.10954,0.010734,0.064173,0.043917,GSE7852_TREG_VS_TCONV_THYMUS_DN,0.82970247148289
NAISHIRO_CTNNB1_TARGETS_WITH...,SET,8,0.59335,0.012384,0.34762,0.04393,NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF,0.82970247148289
GCM_CHUK,SET,69,0.1696,0.010378,0.099377,0.04395,GCM_CHUK,0.82970247148289
HP_REDUCED_NUMBER_OF_INTRAHE...,SET,5,0.71678,0.011828,0.4203,0.044069,HP_REDUCED_NUMBER_OF_INTRAHEPATIC_BILE_DUCTS,0.830139416531605
PID_NFKAPPAB_ATYPICAL_PATHWAY,SET,15,0.36043,0.010298,0.21137,0.04409,PID_NFKAPPAB_ATYPICAL_PATHWAY,0.830139416531605
CHIANG_LIVER_CANCER_SUBCLASS...6,SET,67,0.1846,0.011132,0.10827,0.044111,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP,0.830139416531605
GSE20366_EX_VIVO_VS_DEC205_C...3,SET,181,0.10884,0.010754,0.063841,0.044115,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP,0.830139416531605
GSE29614_DAY3_VS_DAY7_TIV_FL...2,SET,143,0.12967,0.0114,0.076081,0.044168,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,0.830139416531605
GOBP_POSITIVE_REGULATION_OF_...669,SET,51,0.21103,0.011107,0.12383,0.044183,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.830139416531605
REACTOME_PROSTANOID_LIGAND_R...,SET,9,0.54769,0.012124,0.32141,0.044196,REACTOME_PROSTANOID_LIGAND_RECEPTORS,0.830139416531605
MODULE_366,SET,29,0.2527,0.010036,0.1483,0.044198,MODULE_366,0.830139416531605
GOBP_PHAGOCYTOSIS_RECOGNITION,SET,27,0.31372,0.012022,0.18412,0.044205,GOBP_PHAGOCYTOSIS_RECOGNITION,0.830139416531605
MIR3153,SET,190,0.10802,0.010932,0.063397,0.044212,MIR3153,0.830139416531605
REACTOME_NEPHRON_DEVELOPMENT,SET,12,0.47364,0.012105,0.27807,0.044265,REACTOME_NEPHRON_DEVELOPMENT,0.830256269374666
REACTOME_BETA_OXIDATION_OF_O...,SET,5,0.65706,0.010842,0.3858,0.044283,REACTOME_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA,0.830256269374666
HUMMEL_BURKITTS_LYMPHOMA_DN,SET,14,0.43839,0.012102,0.25754,0.044368,HUMMEL_BURKITTS_LYMPHOMA_DN,0.830256269374666
GOBP_HYPOTHALAMUS_DEVELOPMENT,SET,25,0.32458,0.01197,0.19069,0.04437,GOBP_HYPOTHALAMUS_DEVELOPMENT,0.830256269374666
GOBP_CARDIAC_MUSCLE_CELL_ACT...2,SET,57,0.21845,0.012153,0.12842,0.044473,GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_CONTRACTION,0.830256269374666
GOBP_TOOTH_ERUPTION,SET,5,0.70258,0.011593,0.41318,0.044533,GOBP_TOOTH_ERUPTION,0.830256269374666
RADAEVA_RESPONSE_TO_IFNA1_DN,SET,10,0.54962,0.012824,0.32322,0.044535,RADAEVA_RESPONSE_TO_IFNA1_DN,0.830256269374666
GOBP_MESENCHYMAL_TO_EPITHELI...2,SET,11,0.52335,0.012807,0.30781,0.044554,GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS,0.830256269374666
GOBP_POSITIVE_REGULATION_OF_...772,SET,7,0.6023,0.011759,0.35429,0.044572,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NOTCH_RECEPTOR_TARGET,0.830256269374666
HP_GRANULOMATOSIS,SET,8,0.63958,0.013349,0.37626,0.044589,HP_GRANULOMATOSIS,0.830256269374666
GOBP_PODOSOME_ASSEMBLY,SET,21,0.32008,0.010819,0.18832,0.044603,GOBP_PODOSOME_ASSEMBLY,0.830256269374666
GSE41867_DAY6_EFFECTOR_VS_DA...2,SET,185,0.10817,0.010804,0.063642,0.044603,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,0.830256269374666
GOCC_PROTEIN_COMPLEX_INVOLVE...2,SET,5,0.60726,0.01002,0.35728,0.044605,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_CELL_ADHESION,0.830256269374666
GSE2706_2H_VS_8H_LPS_STIM_DC...1,SET,162,0.11512,0.010767,0.067736,0.044615,GSE2706_2H_VS_8H_LPS_STIM_DC_DN,0.830256269374666
GSE27241_WT_CTRL_VS_DIGOXIN_...1,SET,161,0.10948,0.010208,0.064419,0.044619,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,0.830256269374666
GOMF_PHOSPHATIDYLINOSITOL_4_...4,SET,27,0.27722,0.010624,0.16313,0.044631,GOMF_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_BINDING,0.830256269374666
WP_16P112_DISTAL_DELETION_SY...,SET,31,0.28804,0.011827,0.1695,0.044637,WP_16P112_DISTAL_DELETION_SYNDROME,0.830256269374666
GOBP_REGULATION_OF_DNA_STRAN...,SET,17,0.35648,0.010843,0.20982,0.044667,GOBP_REGULATION_OF_DNA_STRAND_ELONGATION,0.830256269374666
MIR4747_5P,SET,256,0.089973,0.01055,0.052965,0.044694,MIR4747_5P,0.830256269374666
CAO_BLOOD_FLUMIST_AGE_05_14Y...2,SET,7,0.51753,0.010104,0.30466,0.044696,CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_UP,0.830256269374666
MIR1468_3P,SET,589,0.062744,0.011057,0.036968,0.044832,MIR1468_3P,0.832232348242812
HOFFMAN_CLOCK_TARGETS_UP,SET,9,0.55448,0.012274,0.32689,0.044931,HOFFMAN_CLOCK_TARGETS_UP,0.832232348242812
GSE22432_MULTIPOTENT_PROGENI...4,SET,186,0.10572,0.010587,0.062332,0.044944,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_UP,0.832232348242812
GSE17721_CTRL_VS_GARDIQUIMOD...11,SET,179,0.10902,0.010712,0.064276,0.044948,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_DN,0.832232348242812
KEGG_TERPENOID_BACKBONE_BIOS...,SET,15,0.32624,0.0093216,0.19236,0.044952,KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS,0.832232348242812
RUTELLA_RESPONSE_TO_CSF2RB_A...1,SET,295,0.08794,0.011058,0.051855,0.044962,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,0.832232348242812
HP_ECTROPION_OF_LOWER_EYELIDS,SET,7,0.42567,0.0083104,0.25101,0.04497,HP_ECTROPION_OF_LOWER_EYELIDS,0.832232348242812
WP_GLUCURONIDATION,SET,24,0.42493,0.015354,0.25073,0.045065,WP_GLUCURONIDATION,0.832357464342314
HP_ACNE,SET,60,0.18676,0.010659,0.11022,0.0451,HP_ACNE,0.832357464342314
VANTVEER_BREAST_CANCER_METAS...2,SET,41,0.23558,0.01112,0.13903,0.045103,VANTVEER_BREAST_CANCER_METASTASIS_UP,0.832357464342314
GSE15930_NAIVE_VS_24H_IN_VIT...1,SET,189,0.097135,0.009805,0.057334,0.045124,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN,0.832357464342314
GSE11057_EFF_MEM_VS_CENT_MEM...1,SET,158,0.1148,0.010604,0.067803,0.045227,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN,0.832357464342314
GSE3982_DC_VS_CENT_MEMORY_CD...1,SET,165,0.11296,0.010661,0.066734,0.04527,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN,0.832357464342314
GOBP_RESPONSE_TO_SYMBIONT,SET,6,0.54641,0.0098768,0.32283,0.045275,GOBP_RESPONSE_TO_SYMBIONT,0.832357464342314
LHX2_TARGET_GENES,SET,1129,0.044323,0.010648,0.026188,0.045287,LHX2_TARGET_GENES,0.832357464342314
GOCC_POSTSYNAPTIC_SPECIALIZA...2,SET,19,0.32855,0.010564,0.19413,0.045293,GOCC_POSTSYNAPTIC_SPECIALIZATION_INTRACELLULAR_COMPONENT,0.832357464342314
GSE17721_LPS_VS_CPG_0.5H_BMD...1,SET,179,0.10619,0.010435,0.062748,0.045294,GSE17721_LPS_VS_CPG_0.5H_BMDC_DN,0.832357464342314
WP_SYNTHESIS_OF_CERAMIDES_AN...,SET,22,0.32954,0.011401,0.19473,0.045306,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,0.832357464342314
HP_BULBOUS_NOSE,SET,176,0.10916,0.010637,0.064507,0.045311,HP_BULBOUS_NOSE,0.832357464342314
GOBP_B_CELL_PROLIFERATION_IN...,SET,6,0.67534,0.012207,0.3991,0.045318,GOBP_B_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE,0.832357464342314
HP_INFANTILE_ONSET,SET,1171,0.043293,0.01058,0.025586,0.045326,HP_INFANTILE_ONSET,0.832357464342314
HP_TORSION_DYSTONIA,SET,7,0.49957,0.0097533,0.29526,0.045336,HP_TORSION_DYSTONIA,0.832357464342314
HP_FLAT_NASAL_ALAE,SET,8,0.38731,0.0080834,0.22906,0.045442,HP_FLAT_NASAL_ALAE,0.833760217391304
GOBP_ANOIKIS,SET,31,0.27029,0.011098,0.1599,0.045493,GOBP_ANOIKIS,0.833760217391304
MIR4694_3P,SET,281,0.089004,0.010927,0.052686,0.045586,MIR4694_3P,0.833760217391304
GSE19941_LPS_VS_LPS_AND_IL10...2,SET,161,0.1119,0.010433,0.066244,0.045605,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,0.833760217391304
BIOCARTA_FMLP_PATHWAY,SET,32,0.26237,0.010945,0.15536,0.045638,BIOCARTA_FMLP_PATHWAY,0.833760217391304
GOMF_METALLOPEPTIDASE_ACTIVI...,SET,173,0.11839,0.011439,0.070111,0.045649,GOMF_METALLOPEPTIDASE_ACTIVITY,0.833760217391304
GOMF_VOLTAGE_GATED_POTASSIUM...2,SET,14,0.43139,0.011909,0.25547,0.045652,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION,0.833760217391304
ALFANO_MYC_TARGETS,SET,223,0.095183,0.010427,0.056381,0.045692,ALFANO_MYC_TARGETS,0.833760217391304
GSE45365_CTRL_VS_MCMV_INFECT...2,SET,180,0.10688,0.010531,0.063314,0.045712,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP,0.833760217391304
GOBP_VENTRICULAR_SYSTEM_DEVE...,SET,30,0.25182,0.010171,0.1492,0.045732,GOBP_VENTRICULAR_SYSTEM_DEVELOPMENT,0.833760217391304
MIR605_3P,SET,233,0.096655,0.01082,0.057269,0.04574,MIR605_3P,0.833760217391304
GOBP_REGULATION_OF_EMBRYONIC...,SET,81,0.15543,0.010301,0.092105,0.045763,GOBP_REGULATION_OF_EMBRYONIC_DEVELOPMENT,0.833760217391304
HP_PULMONARY_INTERSTITIAL_HI...,SET,21,0.33805,0.011427,0.20032,0.045763,HP_PULMONARY_INTERSTITIAL_HIGH_RESOLUTION_COMPUTED_TOMOGRAPHY_ABNORMALITY,0.833760217391304
GOBP_POSITIVE_REGULATION_OF_...598,SET,11,0.46854,0.011466,0.27783,0.045862,GOBP_POSITIVE_REGULATION_OF_POST_TRANSCRIPTIONAL_GENE_SILENCING,0.833760217391304
HP_GAIT_IMBALANCE,SET,63,0.18417,0.01077,0.10921,0.045868,HP_GAIT_IMBALANCE,0.833760217391304
MIR6834_3P,SET,42,0.22268,0.010639,0.13206,0.045885,MIR6834_3P,0.833760217391304
GOBP_ACTIN_NUCLEATION,SET,45,0.20028,0.0099035,0.11878,0.045893,GOBP_ACTIN_NUCLEATION,0.833760217391304
GOBP_BONE_RESORPTION,SET,65,0.1899,0.01128,0.11263,0.04591,GOBP_BONE_RESORPTION,0.833760217391304
HP_ABNORMAL_SOCIAL_BEHAVIOR,SET,152,0.11624,0.010533,0.068963,0.045952,HP_ABNORMAL_SOCIAL_BEHAVIOR,0.833760217391304
BIOCARTA_CACAM_PATHWAY,SET,9,0.55362,0.012255,0.32846,0.045954,BIOCARTA_CACAM_PATHWAY,0.833760217391304
GOBP_POSITIVE_REGULATION_OF_...402,SET,89,0.16183,0.011241,0.096014,0.045955,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,0.833760217391304
GSE9988_LPS_VS_VEHICLE_TREAT...1,SET,183,0.10282,0.010215,0.061008,0.045964,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,0.833760217391304
ZWANG_EGF_INTERVAL_UP,SET,76,0.169,0.010851,0.10031,0.046016,ZWANG_EGF_INTERVAL_UP,0.833760217391304
GOBP_RETINAL_GANGLION_CELL_A...,SET,22,0.3433,0.011877,0.20378,0.046041,GOBP_RETINAL_GANGLION_CELL_AXON_GUIDANCE,0.833760217391304
KEGG_MEDICUS_REFERENCE_CREAT...,SET,7,0.51566,0.010067,0.30614,0.04606,KEGG_MEDICUS_REFERENCE_CREATINE_PATHWAY,0.833760217391304
VERHAAK_AML_WITH_NPM1_MUTATE...1,SET,224,0.10415,0.011434,0.061849,0.046104,VERHAAK_AML_WITH_NPM1_MUTATED_DN,0.833760217391304
GOMF_FOLIC_ACID_TRANSMEMBRAN...,SET,5,0.70338,0.011607,0.4177,0.046107,GOMF_FOLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.833760217391304
GOCC_BARR_BODY,SET,2,1.2075,0.012603,0.71724,0.046141,GOCC_BARR_BODY,0.833760217391304
GOBP_POSITIVE_REGULATION_OF_...92,SET,13,0.40375,0.01074,0.23984,0.046158,GOBP_POSITIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.833760217391304
REACTOME_PCNA_DEPENDENT_LONG...,SET,21,0.27387,0.0092573,0.16273,0.046198,REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,0.833760217391304
GSE26928_NAIVE_VS_EFF_MEMORY...1,SET,168,0.10662,0.010153,0.063388,0.046291,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,0.833760217391304
GOBP_CEREBRAL_CORTEX_TANGENT...,SET,5,0.73775,0.012174,0.43862,0.046294,GOBP_CEREBRAL_CORTEX_TANGENTIAL_MIGRATION,0.833760217391304
GOBP_NEGATIVE_REGULATION_OF_...341,SET,12,0.43894,0.011219,0.26097,0.046296,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION,0.833760217391304
HP_ABNORMALITY_OF_THE_ABDOMI...2,SET,467,0.067069,0.01056,0.039884,0.04633,HP_ABNORMALITY_OF_THE_ABDOMINAL_WALL,0.833760217391304
PID_S1P_META_PATHWAY,SET,21,0.32575,0.011011,0.19372,0.046339,PID_S1P_META_PATHWAY,0.833760217391304
HP_NEOPLASM_OF_THE_TONGUE,SET,42,0.20941,0.010005,0.12454,0.046341,HP_NEOPLASM_OF_THE_TONGUE,0.833760217391304
GSE10239_KLRG1INT_VS_KLRG1HI...1,SET,179,0.10908,0.010718,0.06487,0.046341,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.833760217391304
GOBP_POSITIVE_REGULATION_OF_...30,SET,4,0.54693,0.0080723,0.32526,0.046344,GOBP_POSITIVE_REGULATION_OF_ANOIKIS,0.833760217391304
MIR6828_5P,SET,159,0.11422,0.010584,0.067932,0.046348,MIR6828_5P,0.833760217391304
WP_ALTERED_GLYCOSYLATION_OF_...,SET,8,0.4534,0.0094627,0.26973,0.046398,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,0.834066171915333
GOCC_RNA_POLYMERASE_II_TRANS...2,SET,14,0.36069,0.0099569,0.21466,0.04646,GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REPRESSOR_COMPLEX,0.834066171915333
GAUTAM_EYE_CHOROID_SCLERA_AC...,SET,104,0.13264,0.009955,0.078942,0.046467,GAUTAM_EYE_CHOROID_SCLERA_ACTIVATED_T_CELLS,0.834066171915333
GSE7831_UNSTIM_VS_INFLUENZA_...3,SET,181,0.1062,0.010493,0.063214,0.046484,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN,0.834066171915333
GOBP_REGULATION_OF_STRIATED_...2,SET,87,0.15993,0.010983,0.095193,0.046485,GOBP_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,0.834066171915333
MIR1291,SET,97,0.14638,0.010612,0.087223,0.046664,MIR1291,0.83574606940874
REACTOME_ALTERNATIVE_COMPLEM...,SET,4,0.78493,0.011585,0.46777,0.046679,REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION,0.83574606940874
GOBP_REGULATION_OF_NUCLEOTID...1,SET,13,0.44338,0.011795,0.26423,0.046682,GOBP_REGULATION_OF_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.83574606940874
GSE5503_MLN_DC_VS_SPLEEN_DC_...2,SET,178,0.10914,0.010694,0.065061,0.046736,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.83574606940874
GOBP_NEPHRIC_DUCT_FORMATION,SET,5,0.73193,0.012078,0.43634,0.046738,GOBP_NEPHRIC_DUCT_FORMATION,0.83574606940874
GSE40666_UNTREATED_VS_IFNA_S...5,SET,181,0.10907,0.010777,0.065033,0.046765,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN,0.83574606940874
HP_ABNORMAL_DERMOEPIDERMAL_J...,SET,12,0.45587,0.011651,0.27182,0.04677,HP_ABNORMAL_DERMOEPIDERMAL_JUNCTION_MORPHOLOGY,0.83574606940874
GOBP_FEMALE_GAMETE_GENERATION,SET,145,0.11818,0.010462,0.070467,0.046771,GOBP_FEMALE_GAMETE_GENERATION,0.83574606940874
GOMF_SODIUM_INDEPENDENT_ORGA...,SET,16,0.42889,0.012656,0.25581,0.04682,GOMF_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.836191726618705
GOBP_HEMOSTASIS,SET,220,0.10299,0.011206,0.061436,0.04685,GOBP_HEMOSTASIS,0.83629553104156
GSE15624_CTRL_VS_6H_HALOFUGI...2,SET,123,0.13291,0.010843,0.079313,0.046896,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.83629553104156
GOBP_SODIUM_ION_IMPORT_ACROS...,SET,22,0.3081,0.010659,0.18385,0.046898,GOBP_SODIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.83629553104156
HP_POROKERATOSIS,SET,7,0.50136,0.0097883,0.29923,0.046926,HP_POROKERATOSIS,0.836365707692308
GOBP_TUMOR_NECROSIS_FACTOR_S...,SET,161,0.11801,0.011003,0.070466,0.046997,GOBP_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.836492354948805
GOBP_MULTIVESICULAR_BODY_SOR...,SET,45,0.20244,0.01001,0.1209,0.047028,GOBP_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.836492354948805
GOBP_REGULATION_OF_CDC42_PRO...,SET,7,0.62249,0.012153,0.37175,0.047028,GOBP_REGULATION_OF_CDC42_PROTEIN_SIGNAL_TRANSDUCTION,0.836492354948805
HP_ABNORMAL_RENAL_TUBULAR_LU...,SET,5,0.6907,0.011397,0.41258,0.047064,HP_ABNORMAL_RENAL_TUBULAR_LUMEN_MORPHOLOGY,0.836492354948805
GOBP_NEURAL_TUBE_PATTERNING,SET,29,0.28392,0.011276,0.16962,0.047087,GOBP_NEURAL_TUBE_PATTERNING,0.836492354948805
GOBP_NEGATIVE_REGULATION_OF_...616,SET,34,0.24873,0.010694,0.14865,0.047144,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.836492354948805
ZNF502_TARGET_GENES,SET,25,0.2677,0.0098722,0.15999,0.047153,ZNF502_TARGET_GENES,0.836492354948805
GSE2706_UNSTIM_VS_2H_LPS_DC_...2,SET,155,0.10641,0.0097361,0.063598,0.047161,GSE2706_UNSTIM_VS_2H_LPS_DC_UP,0.836492354948805
GAVIN_PDE3B_TARGETS,SET,20,0.32742,0.010801,0.19575,0.047202,GAVIN_PDE3B_TARGETS,0.836492354948805
GSE8921_3H_VS_24H_TLR1_2_STI...1,SET,184,0.10681,0.010639,0.063868,0.047241,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN,0.836492354948805
HP_PERMANENT_ATRIAL_FIBRILLA...,SET,9,0.50844,0.011255,0.30406,0.047254,HP_PERMANENT_ATRIAL_FIBRILLATION,0.836492354948805
ZNF416_TARGET_GENES,SET,4,0.63825,0.0094202,0.38182,0.04731,ZNF416_TARGET_GENES,0.836492354948805
TSUTSUMI_FBXW8_TARGETS,SET,9,0.45319,0.010032,0.27116,0.047339,TSUTSUMI_FBXW8_TARGETS,0.836492354948805
LIM_MAMMARY_STEM_CELL_UP,SET,429,0.073997,0.011179,0.044276,0.047342,LIM_MAMMARY_STEM_CELL_UP,0.836492354948805
MIR6790_3P,SET,4,0.89001,0.013136,0.53272,0.047399,MIR6790_3P,0.836492354948805
GOMF_CCR_CHEMOKINE_RECEPTOR_...,SET,38,0.28385,0.012901,0.16991,0.047415,GOMF_CCR_CHEMOKINE_RECEPTOR_BINDING,0.836492354948805
MIR590_5P,SET,118,0.13163,0.010519,0.078798,0.047421,MIR590_5P,0.836492354948805
HP_LIMITATION_OF_JOINT_MOBIL...,SET,370,0.075451,0.010603,0.045169,0.047427,HP_LIMITATION_OF_JOINT_MOBILITY,0.836492354948805
MIR3139,SET,54,0.19932,0.010795,0.11935,0.047455,MIR3139,0.836492354948805
HP_REDUCED_FORCED_EXPIRATORY...,SET,27,0.27457,0.010522,0.16447,0.04752,HP_REDUCED_FORCED_EXPIRATORY_VOLUME_IN_ONE_SECOND,0.836492354948805
MIR660_3P,SET,91,0.15007,0.01054,0.089897,0.047534,MIR660_3P,0.836492354948805
WP_BENZOAPYRENE_METABOLISM,SET,9,0.54774,0.012125,0.32819,0.04757,WP_BENZOAPYRENE_METABOLISM,0.836492354948805
GNF2_TNFSF10,SET,30,0.258,0.010421,0.15461,0.047589,GNF2_TNFSF10,0.836492354948805
MIR5196_5P,SET,267,0.086666,0.010376,0.051944,0.04762,MIR5196_5P,0.836492354948805
GSE41176_UNSTIM_VS_ANTI_IGM_...7,SET,175,0.10487,0.01019,0.062852,0.04762,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN,0.836492354948805
GOBP_POSITIVE_REGULATION_OF_...115,SET,20,0.3342,0.011025,0.20036,0.047669,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.836492354948805
GOMF_NUCLEOTIDE_RECEPTOR_ACT...,SET,17,0.41212,0.012535,0.2471,0.047685,GOMF_NUCLEOTIDE_RECEPTOR_ACTIVITY,0.836492354948805
HAY_BONE_MARROW_CD34_POS_LYM...,SET,7,0.61986,0.012102,0.37169,0.047697,HAY_BONE_MARROW_CD34_POS_LYMPHOID_UNK,0.836492354948805
GOBP_SEPTUM_PRIMUM_DEVELOPME...,SET,4,0.80819,0.011928,0.48464,0.047706,GOBP_SEPTUM_PRIMUM_DEVELOPMENT,0.836492354948805
GOBP_ESTABLISHMENT_OR_MAINTE...5,SET,11,0.50121,0.012265,0.30063,0.047746,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_TRANSMEMBRANE_ELECTROCHEMICAL_GRADIENT,0.836492354948805
HP_RIGHT_AORTIC_ARCH,SET,20,0.30999,0.010226,0.18595,0.04776,HP_RIGHT_AORTIC_ARCH,0.836492354948805
GOMF_RNA_POLYMERASE_II_GENER...2,SET,21,0.29062,0.0098238,0.17437,0.047793,GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING,0.836492354948805
WP_VALPROIC_ACID_PATHWAY,SET,11,0.42886,0.010495,0.25736,0.047828,WP_VALPROIC_ACID_PATHWAY,0.836492354948805
HP_CHRONIC_MYELOGENOUS_LEUKE...,SET,9,0.47831,0.010588,0.28707,0.047846,HP_CHRONIC_MYELOGENOUS_LEUKEMIA,0.836492354948805
GSE15659_NAIVE_VS_PTPRC_NEG_...2,SET,156,0.11012,0.010108,0.066099,0.047868,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP,0.836492354948805
MALIK_REPRESSED_BY_ESTROGEN,SET,13,0.42285,0.011248,0.25382,0.047875,MALIK_REPRESSED_BY_ESTROGEN,0.836492354948805
GOBP_POSITIVE_REGULATION_OF_...329,SET,6,0.54722,0.0098912,0.32849,0.047879,GOBP_POSITIVE_REGULATION_OF_HELICASE_ACTIVITY,0.836492354948805
CHAUHAN_RESPONSE_TO_METHOXYE...1,SET,83,0.15663,0.010508,0.094041,0.047911,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,0.836492354948805
WP_GENES_TARGETED_BY_MIRNAS_...,SET,11,0.47597,0.011647,0.2858,0.047925,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,0.836492354948805
REACTOME_N_GLYCAN_TRIMMING_A...,SET,5,0.77365,0.012766,0.46459,0.047944,REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI,0.836492354948805
HP_RESTRICTIVE_VENTILATORY_D...,SET,90,0.15407,0.010761,0.092534,0.047968,HP_RESTRICTIVE_VENTILATORY_DEFECT,0.836492354948805
GOBP_ARP2_3_COMPLEX_MEDIATED...,SET,33,0.22827,0.0096694,0.13713,0.047998,GOBP_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,0.836492354948805
GOCC_NUCLEAR_PROTEIN_CONTAIN...,SET,1120,0.041202,0.0098616,0.024751,0.047999,GOCC_NUCLEAR_PROTEIN_CONTAINING_COMPLEX,0.836492354948805
MIR580_3P,SET,190,0.10434,0.01056,0.062712,0.048079,MIR580_3P,0.836492354948805
KEGG_MEDICUS_REFERENCE_IL6_F...,SET,25,0.29238,0.010782,0.17582,0.048167,KEGG_MEDICUS_REFERENCE_IL6_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,0.836492354948805
GOBP_LOCOMOTION,SET,1124,0.046494,0.011147,0.027959,0.048173,GOBP_LOCOMOTION,0.836492354948805
GOBP_NEGATIVE_REGULATION_OF_...271,SET,5,0.65853,0.010867,0.39602,0.048178,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,0.836492354948805
MILI_PSEUDOPODIA_HAPTOTAXIS_...2,SET,452,0.065231,0.010109,0.039241,0.048231,MILI_PSEUDOPODIA_HAPTOTAXIS_UP,0.836492354948805
GOMF_ATP_DEPENDENT_ACTIVITY_...2,SET,71,0.15911,0.009876,0.095719,0.048236,GOMF_ATP_DEPENDENT_ACTIVITY_ACTING_ON_RNA,0.836492354948805
MIR6802_3P,SET,36,0.2281,0.010091,0.13723,0.04825,MIR6802_3P,0.836492354948805
MIR4798_3P,SET,10,0.38062,0.008881,0.22902,0.048268,MIR4798_3P,0.836492354948805
GOBP_PEPTIDYL_LYSINE_ACETYLA...,SET,22,0.26241,0.0090785,0.15793,0.048308,GOBP_PEPTIDYL_LYSINE_ACETYLATION,0.836492354948805
HP_DECREASED_CIRCULATING_COM...3,SET,3,0.87982,0.011246,0.52961,0.04834,HP_DECREASED_CIRCULATING_COMPLEMENT_FACTOR_B_CONCENTRATION,0.836492354948805
GOBP_TRANSDIFFERENTIATION,SET,7,0.63126,0.012324,0.38,0.048348,GOBP_TRANSDIFFERENTIATION,0.836492354948805
GOBP_REGULATION_OF_CARDIOBLA...,SET,5,0.74019,0.012214,0.44577,0.048418,GOBP_REGULATION_OF_CARDIOBLAST_DIFFERENTIATION,0.836492354948805
MIR6724_5P,SET,18,0.30858,0.0096579,0.18587,0.048445,MIR6724_5P,0.836492354948805
GSE42088_UNINF_VS_LEISHMANIA...8,SET,183,0.1108,0.011007,0.06674,0.048449,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP,0.836492354948805
GOBP_POSITIVE_REGULATION_OF_...631,SET,18,0.31534,0.0098692,0.19008,0.048571,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,0.836492354948805
HP_TOENAIL_DYSPLASIA,SET,15,0.40464,0.011562,0.24392,0.048577,HP_TOENAIL_DYSPLASIA,0.836492354948805
GOBP_POSITIVE_REGULATION_OF_...715,SET,30,0.28011,0.011314,0.16886,0.048583,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,0.836492354948805
GSE3982_MAST_CELL_VS_TH2_UP,SET,181,0.10741,0.010613,0.064766,0.048625,GSE3982_MAST_CELL_VS_TH2_UP,0.836492354948805
HP_SCARRING_ALOPECIA_OF_SCALP,SET,13,0.40233,0.010703,0.24263,0.048646,HP_SCARRING_ALOPECIA_OF_SCALP,0.836492354948805
GOCC_CYTOSKELETON_OF_PRESYNA...,SET,8,0.5536,0.011554,0.33387,0.048655,GOCC_CYTOSKELETON_OF_PRESYNAPTIC_ACTIVE_ZONE,0.836492354948805
GOBP_PROTEIN_CATABOLIC_PROCE...2,SET,21,0.31394,0.010612,0.18941,0.048719,GOBP_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,0.836492354948805
ZNF133_TARGET_GENES,SET,175,0.10582,0.010283,0.06385,0.04873,ZNF133_TARGET_GENES,0.836492354948805
GOBP_FC_GAMMA_RECEPTOR_SIGNA...,SET,31,0.28267,0.011606,0.17056,0.048734,GOBP_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY,0.836492354948805
ZNF513_TARGET_GENES,SET,614,0.058978,0.010604,0.035586,0.048737,ZNF513_TARGET_GENES,0.836492354948805
TAFAZZIN_TARGET_GENES,SET,367,0.074174,0.010382,0.044761,0.048756,TAFAZZIN_TARGET_GENES,0.836492354948805
GOBP_RESPONSE_TO_LECTIN,SET,20,0.35551,0.011728,0.21455,0.048765,GOBP_RESPONSE_TO_LECTIN,0.836492354948805
GOBP_ACTOMYOSIN_CONTRACTILE_...,SET,10,0.407,0.0094964,0.24562,0.048769,GOBP_ACTOMYOSIN_CONTRACTILE_RING_ORGANIZATION,0.836492354948805
MODULE_331,SET,69,0.1651,0.010103,0.099646,0.048784,MODULE_331,0.836492354948805
GOCC_H3_HISTONE_ACETYLTRANSF...,SET,8,0.51585,0.010766,0.3114,0.048815,GOCC_H3_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.836492354948805
CDC5L_TARGET_GENES,SET,225,0.093929,0.010335,0.056714,0.048851,CDC5L_TARGET_GENES,0.836492354948805
GSE3982_DC_VS_BASOPHIL_DN,SET,172,0.10703,0.010312,0.064627,0.048851,GSE3982_DC_VS_BASOPHIL_DN,0.836492354948805
GSE37532_TREG_VS_TCONV_CD4_T...2,SET,181,0.10087,0.009966,0.060913,0.04888,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_UP,0.836492354948805
HP_INTERPHALANGEAL_JOINT_ERO...,SET,7,0.55202,0.010777,0.33339,0.048895,HP_INTERPHALANGEAL_JOINT_EROSIONS,0.836492354948805
IVANOVA_HEMATOPOIESIS_STEM_C...2,SET,514,0.064291,0.010606,0.038829,0.048898,IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR,0.836492354948805
GOBP_LONG_TERM_MEMORY,SET,36,0.24672,0.010915,0.14904,0.048928,GOBP_LONG_TERM_MEMORY,0.836492354948805
WP_IL9_SIGNALING,SET,15,0.42317,0.012091,0.25566,0.04895,WP_IL9_SIGNALING,0.836492354948805
WP_8P231_COPY_NUMBER_VARIATI...,SET,51,0.25126,0.013225,0.15185,0.049004,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,0.836492354948805
GSE40666_UNTREATED_VS_IFNA_S...6,SET,153,0.11495,0.010451,0.069479,0.04902,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP,0.836492354948805
MIR5100,SET,84,0.15859,0.010703,0.095868,0.04905,MIR5100,0.836492354948805
GSE17721_PAM3CSK4_VS_GADIQUI...17,SET,183,0.10381,0.010313,0.062756,0.04905,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN,0.836492354948805
MIR573,SET,86,0.1531,0.010454,0.092557,0.049059,MIR573,0.836492354948805
VECCHI_GASTRIC_CANCER_EARLY_...1,SET,306,0.089822,0.0115,0.054304,0.049066,VECCHI_GASTRIC_CANCER_EARLY_DN,0.836492354948805
MIR365A_3P_MIR365B_3P,SET,106,0.13955,0.010573,0.084376,0.049087,MIR365A_3P_MIR365B_3P,0.836492354948805
LI_PBMC_MENACTRA_AGE_18_45YO...3,SET,25,0.28803,0.010622,0.17416,0.049094,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP,0.836492354948805
GOBP_POSITIVE_REGULATION_OF_...119,SET,6,0.54193,0.0097957,0.32769,0.049096,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.836492354948805
HP_ANDROGEN_INSUFFICIENCY,SET,3,0.78548,0.01004,0.47496,0.049096,HP_ANDROGEN_INSUFFICIENCY,0.836492354948805
MIR4687_3P,SET,76,0.16738,0.010747,0.10122,0.049123,MIR4687_3P,0.836492354948805
GOBP_MAINTENANCE_OF_APICAL_B...,SET,9,0.56124,0.012424,0.33967,0.049247,GOBP_MAINTENANCE_OF_APICAL_BASAL_CELL_POLARITY,0.836492354948805
SRPK2_TARGET_GENES,SET,47,0.20308,0.010262,0.12291,0.049249,SRPK2_TARGET_GENES,0.836492354948805
HP_NONTUBERCULOUS_MYCOBACTER...,SET,19,0.33395,0.010738,0.20212,0.049257,HP_NONTUBERCULOUS_MYCOBACTERIAL_PULMONARY_INFECTION,0.836492354948805
GOBP_HISTIDINE_METABOLIC_PRO...,SET,8,0.53237,0.011111,0.32225,0.049273,GOBP_HISTIDINE_METABOLIC_PROCESS,0.836492354948805
MORF_CUL1,SET,68,0.15768,0.0095791,0.095455,0.049283,MORF_CUL1,0.836492354948805
GOBP_REGULATION_OF_VASCULAR_...5,SET,44,0.2318,0.011335,0.14033,0.049296,GOBP_REGULATION_OF_VASCULAR_PERMEABILITY,0.836492354948805
GTCAGGA_MIR378,SET,50,0.19762,0.010299,0.11964,0.049298,GTCAGGA_MIR378,0.836492354948805
MIR6848_3P,SET,81,0.16644,0.011031,0.10077,0.049307,MIR6848_3P,0.836492354948805
GOMF_OXIDOREDUCTASE_ACTIVITY...5,SET,9,0.42895,0.0094952,0.25973,0.049325,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,0.836492354948805
HP_DECREASED_DLCO,SET,22,0.30607,0.010589,0.18537,0.049363,HP_DECREASED_DLCO,0.836492354948805
HP_ABNORMAL_AUDITORY_CANAL_M...,SET,76,0.1591,0.010216,0.096358,0.049364,HP_ABNORMAL_AUDITORY_CANAL_MORPHOLOGY,0.836492354948805
GOBP_DEFENSE_RESPONSE_TO_FUN...,SET,44,0.22633,0.011067,0.1371,0.049392,GOBP_DEFENSE_RESPONSE_TO_FUNGUS,0.836558947368421
GOMF_NADPLUS_PROTEIN_LYSINE_...,SET,5,0.65483,0.010805,0.39677,0.049438,GOMF_NADPLUS_PROTEIN_LYSINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.836675017039922
BOYLAN_MULTIPLE_MYELOMA_C_D_...1,SET,247,0.096714,0.011143,0.058603,0.049447,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,0.836675017039922
GOBP_CELLULAR_RESPONSE_TO_PU...,SET,13,0.3966,0.01055,0.24042,0.049518,GOBP_CELLULAR_RESPONSE_TO_PURINE_CONTAINING_COMPOUND,0.837159795918367
GOBP_POSITIVE_REGULATION_OF_...20,SET,24,0.33497,0.012104,0.20306,0.049524,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,0.837159795918367
GSE37301_PRO_BCELL_VS_CD4_TC...1,SET,150,0.11835,0.010654,0.071761,0.049565,GSE37301_PRO_BCELL_VS_CD4_TCELL_DN,0.837159795918367
chr11p15,SET,274,0.18931,0.022955,0.1148,0.049572,chr11p15,0.837159795918367
GOBP_CILIARY_NEUROTROPHIC_FA...,SET,5,0.68393,0.011286,0.41482,0.049609,GOBP_CILIARY_NEUROTROPHIC_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.837377753763963
GAUTAM_EYE_IRIS_CILIARY_BODY...11,SET,111,0.14109,0.010938,0.085599,0.04966,GAUTAM_EYE_IRIS_CILIARY_BODY_MONOCYTES,0.837789050847458
GOBP_POSITIVE_REGULATION_OF_...75,SET,13,0.3969,0.010558,0.24084,0.049689,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.837789050847458
HP_NEONATAL_ASPHYXIA,SET,12,0.40352,0.010313,0.24489,0.049711,HP_NEONATAL_ASPHYXIA,0.837789050847458
GOBP_ATP_TRANSPORT,SET,19,0.35558,0.011433,0.21583,0.049741,GOBP_ATP_TRANSPORT,0.837789050847458
GSE41867_NAIVE_VS_DAY15_LCMV...2,SET,179,0.099303,0.0097577,0.060288,0.049774,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.837789050847458
GOMF_METALLOEXOPEPTIDASE_ACT...,SET,63,0.19804,0.011582,0.12024,0.049778,GOMF_METALLOEXOPEPTIDASE_ACTIVITY,0.837789050847458
HP_RHEUMATOID_ARTHRITIS,SET,20,0.33065,0.010908,0.20079,0.049815,HP_RHEUMATOID_ARTHRITIS,0.837987271407837
GOMF_METALLOENDOPEPTIDASE_AC...,SET,102,0.14826,0.01102,0.090042,0.049838,GOMF_METALLOENDOPEPTIDASE_ACTIVITY,0.837987271407837
GOBP_POSITIVE_REGULATION_OF_...408,SET,47,0.21481,0.010855,0.13049,0.049878,GOBP_POSITIVE_REGULATION_OF_LIPASE_ACTIVITY,0.838254298839458
GOBP_REGULATION_OF_RUFFLE_AS...,SET,29,0.28254,0.011221,0.17167,0.049905,GOBP_REGULATION_OF_RUFFLE_ASSEMBLY,0.838302694538424
BONOME_OVARIAN_CANCER_SURVIV...2,SET,453,0.066557,0.010325,0.040458,0.049984,BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING,0.83875958313253
WP_MELATONIN_METABOLISM_AND_...,SET,30,0.26273,0.010612,0.15971,0.049987,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.83875958313253
GSE7852_LN_VS_THYMUS_TREG_UP,SET,182,0.10708,0.010609,0.065102,0.050015,GSE7852_LN_VS_THYMUS_TREG_UP,0.83875958313253
GOCC_METHYLTRANSFERASE_COMPL...,SET,92,0.13256,0.0093607,0.080604,0.050033,GOCC_METHYLTRANSFERASE_COMPLEX,0.83875958313253
GOBP_PLASMA_LIPOPROTEIN_PART...,SET,37,0.24616,0.01104,0.14971,0.050072,GOBP_PLASMA_LIPOPROTEIN_PARTICLE_CLEARANCE,0.83875958313253
GOBP_POSITIVE_REGULATION_OF_...617,SET,39,0.23204,0.010684,0.14113,0.050077,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.83875958313253
KAMIKUBO_MYELOID_MN1_NETWORK,SET,18,0.34736,0.010871,0.21131,0.050116,KAMIKUBO_MYELOID_MN1_NETWORK,0.839008468208092
MIR5687,SET,16,0.33831,0.0099834,0.2059,0.050192,MIR5687,0.839876244583534
HP_HIGHLY_ARCHED_EYEBROW,SET,177,0.10079,0.0098489,0.061362,0.050247,HP_HIGHLY_ARCHED_EYEBROW,0.840363118811881
GOBP_DENDRITIC_SPINE_MAINTEN...,SET,20,0.33946,0.011198,0.20676,0.050319,GOBP_DENDRITIC_SPINE_MAINTENANCE,0.840363118811881
WP_PHOTODYNAMIC_THERAPYINDUC...5,SET,25,0.28308,0.010439,0.17244,0.050343,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,0.840363118811881
GOMF_HISTONE_H4K12_ACETYLTRA...,SET,12,0.38882,0.0099377,0.23689,0.050372,GOMF_HISTONE_H4K12_ACETYLTRANSFERASE_ACTIVITY,0.840363118811881
WP_MEVALONATE_PATHWAY,SET,7,0.42613,0.0083195,0.25966,0.050397,WP_MEVALONATE_PATHWAY,0.840363118811881
RODRIGUES_THYROID_CARCINOMA_...4,SET,706,0.053154,0.010221,0.032398,0.050443,RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN,0.840363118811881
GOBP_INOSITOL_PHOSPHATE_META...,SET,38,0.22072,0.010032,0.13456,0.050479,GOBP_INOSITOL_PHOSPHATE_METABOLIC_PROCESS,0.840363118811881
WP_SARSCOV2_B117_VARIANT_ANT...,SET,7,0.51936,0.01014,0.31665,0.050495,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,0.840363118811881
SNF5_DN.V1_DN,SET,136,0.1294,0.011097,0.078901,0.050502,SNF5_DN.V1_DN,0.840363118811881
HP_CENTRAL_OPACIFICATION_OF_...,SET,21,0.3532,0.011939,0.21536,0.050503,HP_CENTRAL_OPACIFICATION_OF_THE_CORNEA,0.840363118811881
GOBP_REGULATION_OF_BASEMENT_...,SET,11,0.42878,0.010493,0.26157,0.050592,GOBP_REGULATION_OF_BASEMENT_MEMBRANE_ORGANIZATION,0.840363118811881
GOMF_STEROID_HYDROXYLASE_ACT...,SET,26,0.31396,0.011807,0.19154,0.050602,GOMF_STEROID_HYDROXYLASE_ACTIVITY,0.840363118811881
GOBP_POSITIVE_REGULATION_OF_...298,SET,11,0.4797,0.011739,0.29266,0.050608,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION_VIA_CHROMOSOMAL_CPG_ISLAND_DEMETHYLATION,0.840363118811881
HP_SWOLLEN_LIP,SET,6,0.66895,0.012092,0.40815,0.050618,HP_SWOLLEN_LIP,0.840363118811881
GSE21670_TGFB_VS_TGFB_AND_IL...2,SET,181,0.10488,0.010362,0.063989,0.050618,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,0.840363118811881
GSE37534_PIOGLITAZONE_VS_ROS...2,SET,174,0.099649,0.0096553,0.060813,0.050655,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,0.840363118811881
HP_CUTIS_LAXA,SET,110,0.13415,0.010353,0.081883,0.050686,HP_CUTIS_LAXA,0.840363118811881
HP_ABNORMALITY_OF_THE_PUBIC_...,SET,52,0.19139,0.010171,0.11682,0.050693,HP_ABNORMALITY_OF_THE_PUBIC_HAIR,0.840363118811881
GOMF_XMP_5_NUCLEOSIDASE_ACTI...,SET,5,0.75684,0.012489,0.46199,0.050697,GOMF_XMP_5_NUCLEOSIDASE_ACTIVITY,0.840363118811881
GOBP_RNA_STABILIZATION,SET,60,0.18172,0.010372,0.11095,0.050729,GOBP_RNA_STABILIZATION,0.840363118811881
GOMF_PROMOTER_ENHANCER_LOOP_...,SET,4,0.70718,0.010438,0.43183,0.050759,GOMF_PROMOTER_ENHANCER_LOOP_ANCHORING_ACTIVITY,0.840363118811881
HP_CLINODACTYLY_OF_THE_3RD_F...,SET,6,0.64509,0.01166,0.39413,0.050852,HP_CLINODACTYLY_OF_THE_3RD_FINGER,0.840363118811881
HP_ATYPICAL_ABSENCE_SEIZURE,SET,31,0.24621,0.010109,0.15043,0.050858,HP_ATYPICAL_ABSENCE_SEIZURE,0.840363118811881
GOBP_FLAVIN_CONTAINING_COMPO...,SET,6,0.55345,0.010004,0.33823,0.050895,GOBP_FLAVIN_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.840363118811881
GOBP_POSITIVE_REGULATION_OF_...609,SET,11,0.38143,0.009334,0.23322,0.050983,GOBP_POSITIVE_REGULATION_OF_PROTEIN_ACETYLATION,0.840363118811881
GOBP_EMBRYONIC_FORELIMB_MORP...,SET,32,0.27382,0.011422,0.16744,0.050995,GOBP_EMBRYONIC_FORELIMB_MORPHOGENESIS,0.840363118811881
GOBP_PROCESS_UTILIZING_AUTOP...,SET,541,0.058863,0.0099548,0.035994,0.050996,GOBP_PROCESS_UTILIZING_AUTOPHAGIC_MECHANISM,0.840363118811881
GOMF_MHC_CLASS_II_RECEPTOR_A...,SET,8,0.61505,0.012836,0.37611,0.051004,GOMF_MHC_CLASS_II_RECEPTOR_ACTIVITY,0.840363118811881
GSE22589_HEALTHY_VS_HIV_AND_...1,SET,171,0.10264,0.0098597,0.062765,0.051004,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN,0.840363118811881
GSE17974_CTRL_VS_ACT_IL4_AND...12,SET,155,0.11822,0.010816,0.072313,0.051058,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP,0.840363118811881
GOMF_LIGAND_GATED_MONOATOMIC...3,SET,15,0.39293,0.011227,0.24036,0.051062,GOMF_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY_INVOLVED_IN_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.840363118811881
GOBP_FOREBRAIN_NEURON_DIFFER...,SET,40,0.25115,0.011711,0.15365,0.051084,GOBP_FOREBRAIN_NEURON_DIFFERENTIATION,0.840363118811881
WUNDER_INFLAMMATORY_RESPONSE...2,SET,59,0.19005,0.010757,0.11629,0.051103,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,0.840363118811881
GOBP_POSITIVE_REGULATION_OF_...723,SET,21,0.30544,0.010325,0.18693,0.05114,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,0.840363118811881
ZNF660_TARGET_GENES,SET,598,0.058199,0.010332,0.035621,0.051153,ZNF660_TARGET_GENES,0.840363118811881
LINDGREN_BLADDER_CANCER_CLUS...4,SET,8,0.48183,0.010056,0.29493,0.051168,LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP,0.840363118811881
GOBP_FUNGIFORM_PAPILLA_DEVEL...,SET,5,0.6739,0.01112,0.4126,0.051211,GOBP_FUNGIFORM_PAPILLA_DEVELOPMENT,0.840363118811881
MURAKAMI_UV_RESPONSE_24HR,SET,20,0.29727,0.0098065,0.18201,0.051213,MURAKAMI_UV_RESPONSE_24HR,0.840363118811881
HP_THICK_VERMILION_BORDER,SET,226,0.090181,0.0099441,0.055225,0.051246,HP_THICK_VERMILION_BORDER,0.840363118811881
GOCC_INNER_KINETOCHORE,SET,14,0.33115,0.0091413,0.20279,0.051248,GOCC_INNER_KINETOCHORE,0.840363118811881
GOMF_LIGAND_GATED_MONOATOMIC...2,SET,132,0.12982,0.010968,0.0795,0.051251,GOMF_LIGAND_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.840363118811881
HP_EVERTED_LOWER_LIP_VERMILI...,SET,117,0.13397,0.010661,0.082043,0.051255,HP_EVERTED_LOWER_LIP_VERMILION,0.840363118811881
GOBP_POSITIVE_REGULATION_OF_...79,SET,28,0.28247,0.011023,0.173,0.051273,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.840363118811881
GOBP_NEGATIVE_REGULATION_OF_...575,SET,1109,0.043585,0.010384,0.026696,0.051285,GOBP_NEGATIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS,0.840363118811881
GSE39110_DAY3_VS_DAY6_POST_I...3,SET,178,0.10333,0.010126,0.063342,0.051415,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN,0.841614251412429
CALVET_IRINOTECAN_SENSITIVE_...2,SET,5,0.65258,0.010768,0.40005,0.051426,CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN,0.841614251412429
HP_BILATERAL_TONIC_CLONIC_SE...3,SET,41,0.23491,0.011089,0.14401,0.051434,HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_GENERALIZED_ONSET,0.841614251412429
GSE14308_TH17_VS_NAIVE_CD4_T...1,SET,182,0.1023,0.010136,0.062733,0.051478,GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN,0.841649161184211
GOMF_ROUNDABOUT_BINDING,SET,8,0.55083,0.011496,0.33782,0.051503,GOMF_ROUNDABOUT_BINDING,0.841649161184211
MIR509_3_5P,SET,140,0.1156,0.010057,0.070909,0.051529,MIR509_3_5P,0.841649161184211
HP_MACROCEPHALY_AT_BIRTH,SET,8,0.52322,0.01092,0.32094,0.051533,HP_MACROCEPHALY_AT_BIRTH,0.841649161184211
GOMF_HSP90_PROTEIN_BINDING,SET,38,0.22623,0.010282,0.13884,0.051621,GOMF_HSP90_PROTEIN_BINDING,0.841658590339062
MIR372_5P,SET,226,0.093346,0.010293,0.057319,0.051713,MIR372_5P,0.841658590339062
REACTOME_BUDDING_AND_MATURAT...,SET,27,0.25839,0.0099019,0.15867,0.051722,REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION,0.841658590339062
GOMF_NARROW_PORE_CHANNEL_ACT...,SET,19,0.35868,0.011533,0.22027,0.051736,GOMF_NARROW_PORE_CHANNEL_ACTIVITY,0.841658590339062
GSE10325_CD4_TCELL_VS_LUPUS_...2,SET,182,0.10072,0.0099786,0.061856,0.051743,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP,0.841658590339062
GOBP_LOBAR_BRONCHUS_DEVELOPM...,SET,6,0.64339,0.01163,0.39515,0.051749,GOBP_LOBAR_BRONCHUS_DEVELOPMENT,0.841658590339062
AACYNNNNTTCCS_UNKNOWN,SET,88,0.15236,0.010524,0.093579,0.051751,AACYNNNNTTCCS_UNKNOWN,0.841658590339062
GOMF_TRNA_CYTIDINE_5_METHYLT...,SET,5,0.53745,0.0088685,0.33009,0.051751,GOMF_TRNA_CYTIDINE_5_METHYLTRANSFERASE_ACTIVITY,0.841658590339062
GOMF_GLYCOLIPID_MANNOSYLTRAN...,SET,5,0.51153,0.0084408,0.3142,0.051771,GOMF_GLYCOLIPID_MANNOSYLTRANSFERASE_ACTIVITY,0.841658590339062
GOBP_POLYOL_METABOLIC_PROCESS,SET,95,0.14263,0.010234,0.087613,0.051779,GOBP_POLYOL_METABOLIC_PROCESS,0.841658590339062
CROONQUIST_NRAS_VS_STROMAL_S...2,SET,36,0.23042,0.010194,0.1416,0.051858,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,0.841658590339062
HP_ABNORMAL_SEX_DETERMINATION,SET,18,0.35477,0.011103,0.21805,0.051879,HP_ABNORMAL_SEX_DETERMINATION,0.841658590339062
ZNF7_TARGET_GENES,SET,679,0.055374,0.010451,0.034043,0.051924,ZNF7_TARGET_GENES,0.841658590339062
LEE_BMP2_TARGETS_UP,SET,698,0.055837,0.010679,0.034344,0.052006,LEE_BMP2_TARGETS_UP,0.841658590339062
GSE19825_NAIVE_VS_IL2RALOW_D...2,SET,180,0.10969,0.010809,0.067483,0.052036,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP,0.841658590339062
GSE41867_NAIVE_VS_DAY8_LCMV_...1,SET,180,0.099854,0.009839,0.061435,0.052051,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.841658590339062
BIOCARTA_STAT3_PATHWAY,SET,8,0.56413,0.011774,0.34709,0.052058,BIOCARTA_STAT3_PATHWAY,0.841658590339062
GSE25088_ROSIGLITAZONE_VS_IL...4,SET,165,0.10716,0.010114,0.065936,0.052062,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,0.841658590339062
GOMF_POSTSYNAPTIC_NEUROTRANS...,SET,67,0.18958,0.011432,0.11665,0.05207,GOMF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.841658590339062
HP_ABSENT_FINGERNAIL,SET,35,0.23965,0.010454,0.14747,0.052077,HP_ABSENT_FINGERNAIL,0.841658590339062
GSE34217_MIR17_92_OVEREXPRES...1,SET,126,0.12083,0.0099763,0.074357,0.052083,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_DN,0.841658590339062
FIGUEROA_AML_METHYLATION_CLU...2,SET,105,0.13836,0.010434,0.085143,0.052089,FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,0.841658590339062
MODULE_568,SET,62,0.17091,0.0099155,0.10519,0.052122,MODULE_568,0.841658590339062
KIM_ALL_DISORDERS_DURATION_C...1,SET,131,0.11247,0.0094667,0.069228,0.052133,KIM_ALL_DISORDERS_DURATION_CORR_DN,0.841658590339062
HP_SINGLE_LINEAGE_MYELODYSPL...,SET,5,0.57421,0.0094752,0.35346,0.052139,HP_SINGLE_LINEAGE_MYELODYSPLASIA,0.841658590339062
GSE23925_DARK_ZONE_VS_NAIVE_...1,SET,188,0.10182,0.010251,0.062686,0.052168,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN,0.841735766016713
FAN_OVARY_CL2_PUTATIVE_EARLY...,SET,82,0.16189,0.010796,0.099714,0.052242,FAN_OVARY_CL2_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_1,0.842538612529002
GSE22045_TREG_VS_TCONV_DN,SET,157,0.11001,0.01013,0.067781,0.052297,GSE22045_TREG_VS_TCONV_DN,0.842985743055556
GSE18893_CTRL_VS_TNF_TREATED...3,SET,178,0.098468,0.0096489,0.060691,0.052361,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN,0.842985743055556
GOBP_POSITIVE_REGULATION_OF_...534,SET,17,0.35899,0.010919,0.22129,0.052386,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION,0.842985743055556
HP_APLASIA_CUTIS_CONGENITA_O...2,SET,6,0.59932,0.010833,0.36944,0.052388,HP_APLASIA_CUTIS_CONGENITA_ON_TRUNK_OR_LIMBS,0.842985743055556
GOBP_POSITIVE_REGULATION_OF_...334,SET,5,0.67217,0.011091,0.41436,0.052391,GOBP_POSITIVE_REGULATION_OF_HEPATIC_STELLATE_CELL_ACTIVATION,0.842985743055556
GSE14908_RESTING_VS_HDM_STIM...4,SET,186,0.10164,0.010179,0.062687,0.05247,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP,0.843255144495413
REACTOME_SIGNAL_TRANSDUCTION...,SET,20,0.32057,0.010575,0.19773,0.052493,REACTOME_SIGNAL_TRANSDUCTION_BY_L1,0.843255144495413
GOBP_LEUKOCYTE_DEGRANULATION,SET,75,0.1616,0.010308,0.099708,0.052546,GOBP_LEUKOCYTE_DEGRANULATION,0.843255144495413
REACTOME_STAT5_ACTIVATION,SET,7,0.4575,0.008932,0.2823,0.052555,REACTOME_STAT5_ACTIVATION,0.843255144495413
GOBP_RESPONSE_TO_THYROID_HOR...,SET,22,0.32828,0.011357,0.20256,0.052556,GOBP_RESPONSE_TO_THYROID_HORMONE,0.843255144495413
GOCC_TORC2_COMPLEX,SET,9,0.45704,0.010117,0.28208,0.0526,GOCC_TORC2_COMPLEX,0.843255144495413
GOBP_PURINE_DEOXYRIBONUCLEOS...3,SET,11,0.42231,0.010334,0.26066,0.05261,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.843255144495413
HP_TALIPES_EQUINOVARUS,SET,347,0.075803,0.010323,0.046789,0.052615,HP_TALIPES_EQUINOVARUS,0.843255144495413
FAN_OVARY_CL18_B_LYMPHOCYTE,SET,382,0.06999,0.0099905,0.043204,0.052627,FAN_OVARY_CL18_B_LYMPHOCYTE,0.843255144495413
DESCARTES_FETAL_STOMACH_MUC1...,SET,81,0.16345,0.010833,0.10095,0.052712,DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS,0.843255144495413
GOBP_REGULATION_OF_MEMBRANE_...8,SET,420,0.073514,0.010991,0.045405,0.052726,GOBP_REGULATION_OF_MEMBRANE_POTENTIAL,0.843255144495413
MIR4666B,SET,111,0.14053,0.010894,0.086819,0.052772,MIR4666B,0.843255144495413
HP_ABNORMALITY_OF_THE_KNEE,SET,371,0.073467,0.010338,0.04539,0.052778,HP_ABNORMALITY_OF_THE_KNEE,0.843255144495413
WP_CHOLESTEROL_SYNTHESIS_DIS...,SET,17,0.30815,0.0093728,0.19042,0.052811,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,0.843255144495413
GOBP_URETER_DEVELOPMENT,SET,17,0.36047,0.010964,0.22276,0.052823,GOBP_URETER_DEVELOPMENT,0.843255144495413
REACTOME_FORMATION_OF_THE_AN...,SET,9,0.51555,0.011412,0.31862,0.052829,REACTOME_FORMATION_OF_THE_ANTERIOR_NEURAL_PLATE,0.843255144495413
HP_MACULAR_DYSTROPHY,SET,18,0.3416,0.010691,0.21113,0.052846,HP_MACULAR_DYSTROPHY,0.843255144495413
HP_ABNORMAL_LOWER_LIP_MORPHO...,SET,208,0.097761,0.010347,0.060432,0.052871,HP_ABNORMAL_LOWER_LIP_MORPHOLOGY,0.843255144495413
HOSHIDA_LIVER_CANCER_SURVIVA...1,SET,99,0.13641,0.0099902,0.084331,0.052891,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,0.843255144495413
GOCC_NLS_DEPENDENT_PROTEIN_N...,SET,10,0.39207,0.009148,0.24239,0.052893,GOCC_NLS_DEPENDENT_PROTEIN_NUCLEAR_IMPORT_COMPLEX,0.843255144495413
WP_ACQUIRED_PARTIAL_LIPODYST...,SET,10,0.43077,0.010051,0.26639,0.052942,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,0.843374565120428
HP_ABNORMAL_CALCIFICATION_OF...,SET,5,0.7081,0.011684,0.43803,0.052996,HP_ABNORMAL_CALCIFICATION_OF_THE_CARPAL_BONES,0.843374565120428
GSE4748_CTRL_VS_LPS_AND_CYAN...2,SET,180,0.1049,0.010336,0.064913,0.053055,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.843374565120428
GSE26343_UNSTIM_VS_LPS_STIM_...1,SET,182,0.099608,0.0098685,0.061657,0.053109,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.843374565120428
GOBP_NEGATIVE_REGULATION_OF_...33,SET,3,0.88693,0.011337,0.54907,0.053129,GOBP_NEGATIVE_REGULATION_OF_ASTROCYTE_ACTIVATION,0.843374565120428
GOBP_POSITIVE_REGULATION_OF_...53,SET,7,0.53981,0.010539,0.33426,0.05317,GOBP_POSITIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,0.843374565120428
GOBP_REGULATION_OF_VESICLE_S...,SET,15,0.36766,0.010505,0.22768,0.053187,GOBP_REGULATION_OF_VESICLE_SIZE,0.843374565120428
chr4q34,SET,19,0.55083,0.017712,0.34118,0.053218,chr4q34,0.843374565120428
MIR3657,SET,49,0.20298,0.010473,0.12573,0.053222,MIR3657,0.843374565120428
GOBP_SEX_CHROMOSOME_DOSAGE_C...,SET,13,0.371,0.0098692,0.2299,0.053296,GOBP_SEX_CHROMOSOME_DOSAGE_COMPENSATION,0.843374565120428
ACACTCC_MIR122A,SET,68,0.15777,0.0095845,0.097811,0.053376,ACACTCC_MIR122A,0.843374565120428
REACTOME_DECTIN_2_FAMILY,SET,19,0.33829,0.010878,0.20973,0.053383,REACTOME_DECTIN_2_FAMILY,0.843374565120428
REACTOME_SPECIFICATION_OF_TH...,SET,16,0.37212,0.010981,0.23072,0.053393,REACTOME_SPECIFICATION_OF_THE_NEURAL_PLATE_BORDER,0.843374565120428
GSE21546_WT_VS_SAP1A_KO_AND_...1,SET,181,0.10452,0.010327,0.064818,0.053436,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.843374565120428
GSE42088_UNINF_VS_LEISHMANIA...7,SET,169,0.10919,0.010428,0.067717,0.05344,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN,0.843374565120428
GSE9037_WT_VS_IRAK4_KO_BMDM_...2,SET,179,0.1017,0.0099933,0.063075,0.05345,GSE9037_WT_VS_IRAK4_KO_BMDM_UP,0.843374565120428
MIR4739,SET,127,0.12891,0.010685,0.079956,0.053466,MIR4739,0.843374565120428
FIGUEROA_AML_METHYLATION_CLU...6,SET,151,0.11619,0.010494,0.072082,0.053497,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,0.843374565120428
GOCC_PRESYNAPTIC_ACTIVE_ZONE...1,SET,16,0.36324,0.010719,0.22535,0.053498,GOCC_PRESYNAPTIC_ACTIVE_ZONE_CYTOPLASMIC_COMPONENT,0.843374565120428
GSE22886_NAIVE_CD4_TCELL_VS_...14,SET,172,0.10711,0.010319,0.066456,0.053516,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP,0.843374565120428
REACTOME_TRANSPORT_OF_ORGANI...,SET,10,0.5037,0.011753,0.31254,0.053527,REACTOME_TRANSPORT_OF_ORGANIC_ANIONS,0.843374565120428
HP_ABNORMAL_TOE_MORPHOLOGY,SET,627,0.055933,0.010159,0.034707,0.053535,HP_ABNORMAL_TOE_MORPHOLOGY,0.843374565120428
GOBP_TRICARBOXYLIC_ACID_CYCLE,SET,28,0.23292,0.0090897,0.14454,0.053547,GOBP_TRICARBOXYLIC_ACID_CYCLE,0.843374565120428
GOMF_VOLTAGE_GATED_CHANNEL_A...,SET,165,0.11759,0.011098,0.072991,0.05359,GOMF_VOLTAGE_GATED_CHANNEL_ACTIVITY,0.843374565120428
HEN1_02,SET,184,0.10027,0.0099885,0.062249,0.053615,HEN1_02,0.843374565120428
GSE9037_WT_VS_IRAK4_KO_BMDM_...1,SET,179,0.10216,0.010039,0.063422,0.053619,GSE9037_WT_VS_IRAK4_KO_BMDM_DN,0.843374565120428
HP_OCULOMOTOR_NERVE_PALSY,SET,27,0.25561,0.0097954,0.15872,0.053661,HP_OCULOMOTOR_NERVE_PALSY,0.843374565120428
MIR122B_5P,SET,195,0.09585,0.0098261,0.059526,0.053684,MIR122B_5P,0.843374565120428
HP_SPONDYLOEPIMETAPHYSEAL_DY...,SET,15,0.35155,0.010045,0.21835,0.053704,HP_SPONDYLOEPIMETAPHYSEAL_DYSPLASIA,0.843374565120428
GOCC_NUCLEOCYTOPLASMIC_TRANS...,SET,12,0.36178,0.0092465,0.22472,0.053716,GOCC_NUCLEOCYTOPLASMIC_TRANSPORT_COMPLEX,0.843374565120428
KAECH_NAIVE_VS_DAY15_EFF_CD8...1,SET,183,0.10441,0.010372,0.064874,0.05377,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN,0.843374565120428
GSE7768_OVA_ALONE_VS_OVA_WIT...3,SET,148,0.11166,0.0099852,0.06938,0.053774,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,0.843374565120428
MIR9903,SET,44,0.20904,0.010222,0.12989,0.053783,MIR9903,0.843374565120428
GOBP_GANGLIOSIDE_BIOSYNTHETI...1,SET,17,0.35721,0.010865,0.22209,0.053878,GOBP_GANGLIOSIDE_BIOSYNTHETIC_PROCESS,0.843374565120428
GOBP_RELEASE_OF_CYTOCHROME_C...,SET,52,0.19647,0.010441,0.12215,0.053887,GOBP_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.843374565120428
GOBP_MOLTING_CYCLE_PROCESS,SET,95,0.15683,0.011252,0.097509,0.05389,GOBP_MOLTING_CYCLE_PROCESS,0.843374565120428
GSE1925_CTRL_VS_3H_IFNG_STIM...2,SET,155,0.10991,0.010057,0.068338,0.05389,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,0.843374565120428
MORF_ETV3,SET,60,0.17871,0.0102,0.11112,0.053894,MORF_ETV3,0.843374565120428
GOBP_RHOMBOMERE_DEVELOPMENT,SET,7,0.66156,0.012916,0.41136,0.053899,GOBP_RHOMBOMERE_DEVELOPMENT,0.843374565120428
GOBP_REGULATION_OF_TRANSCRIP...3,SET,27,0.24696,0.0094638,0.15356,0.053908,GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.843374565120428
GSE2770_TGFB_AND_IL4_VS_IL4_...6,SET,162,0.103,0.0096327,0.064076,0.053989,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.843374565120428
HP_BROAD_PHALANGES_OF_THE_HA...,SET,94,0.14359,0.010248,0.089333,0.053998,HP_BROAD_PHALANGES_OF_THE_HAND,0.843374565120428
GOBP_COPI_COATED_VESICLE_BUD...,SET,6,0.45575,0.008238,0.28363,0.054049,GOBP_COPI_COATED_VESICLE_BUDDING,0.843374565120428
MIR4539,SET,67,0.17082,0.010301,0.10631,0.05405,MIR4539,0.843374565120428
GSE37301_PRO_BCELL_VS_CD4_TC...2,SET,155,0.11048,0.010109,0.068766,0.054077,GSE37301_PRO_BCELL_VS_CD4_TCELL_UP,0.843374565120428
HP_HYPOPLASTIC_FEMALE_EXTERN...,SET,55,0.18639,0.010187,0.11604,0.054113,HP_HYPOPLASTIC_FEMALE_EXTERNAL_GENITALIA,0.843374565120428
GOCC_GOLGI_CISTERNA_MEMBRANE,SET,74,0.16113,0.010209,0.10031,0.05412,GOCC_GOLGI_CISTERNA_MEMBRANE,0.843374565120428
MIR4293,SET,99,0.13937,0.010207,0.086774,0.054127,MIR4293,0.843374565120428
TAXCREB_01,SET,121,0.12396,0.010031,0.077181,0.054134,TAXCREB_01,0.843374565120428
GSE3982_CTRL_VS_LPS_4H_MAC_DN,SET,187,0.10413,0.010456,0.064836,0.054137,GSE3982_CTRL_VS_LPS_4H_MAC_DN,0.843374565120428
MIR5583_3P,SET,76,0.16593,0.010654,0.10333,0.054159,MIR5583_3P,0.843374565120428
MIR371A_5P,SET,159,0.10964,0.01016,0.068283,0.054176,MIR371A_5P,0.843374565120428
GOBP_REGULATION_OF_MEIOTIC_C...1,SET,63,0.17114,0.010008,0.10661,0.054221,GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.843374565120428
GOMF_CIS_REGULATORY_REGION_S...,SET,1111,0.046071,0.010985,0.028704,0.054249,GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.843374565120428
GOBP_POSITIVE_REGULATION_OF_...581,SET,24,0.29681,0.010725,0.18492,0.054254,GOBP_POSITIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.843374565120428
GOBP_SODIUM_INDEPENDENT_ORGA...,SET,15,0.438,0.012515,0.27294,0.054285,GOBP_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT,0.843374565120428
GOBP_TRIGLYCERIDE_BIOSYNTHET...,SET,37,0.21903,0.0098232,0.1365,0.0543,GOBP_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.843374565120428
ZNF2_TARGET_GENES,SET,940,0.045617,0.010055,0.028432,0.054317,ZNF2_TARGET_GENES,0.843374565120428
HP_PAROXYSMAL_BURSTS_OF_LAUG...,SET,9,0.43649,0.0096622,0.27215,0.054379,HP_PAROXYSMAL_BURSTS_OF_LAUGHTER,0.843374565120428
GOBP_POSITIVE_REGULATION_OF_...301,SET,19,0.32993,0.010609,0.20572,0.054388,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION,0.843374565120428
DESCARTES_MAIN_FETAL_SYMPATH...,SET,40,0.23129,0.010785,0.14423,0.054404,DESCARTES_MAIN_FETAL_SYMPATHOBLASTS,0.843374565120428
GSE3982_NEUTROPHIL_VS_BASOPH...2,SET,176,0.10159,0.0098988,0.063347,0.054405,GSE3982_NEUTROPHIL_VS_BASOPHIL_UP,0.843374565120428
GOCC_INTERCELLULAR_BRIDGE,SET,83,0.14204,0.009529,0.088594,0.054448,GOCC_INTERCELLULAR_BRIDGE,0.843664841729826
MIR6516_5P,SET,172,0.10423,0.010042,0.065054,0.054557,MIR6516_5P,0.844631645879733
HP_RECURRENT_BRONCHOPULMONAR...,SET,10,0.36228,0.008453,0.2261,0.054559,HP_RECURRENT_BRONCHOPULMONARY_INFECTIONS,0.844631645879733
HP_SPERMATOCYTE_MATURATION_A...,SET,3,0.84561,0.010809,0.52793,0.054616,HP_SPERMATOCYTE_MATURATION_ARREST,0.845132710280374
MIR548AH_5P,SET,321,0.079188,0.010379,0.049446,0.05464,MIR548AH_5P,0.845132710280374
JI_RESPONSE_TO_FSH_UP,SET,57,0.17429,0.0096965,0.10888,0.054722,JI_RESPONSE_TO_FSH_UP,0.845926500666963
HP_DECREASED_ACTIVITY_OF_MIT...3,SET,13,0.34185,0.0090936,0.21357,0.05474,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_II,0.845926500666963
GOBP_NETRIN_ACTIVATED_SIGNAL...,SET,8,0.50286,0.010495,0.31421,0.054766,GOBP_NETRIN_ACTIVATED_SIGNALING_PATHWAY,0.845952146666667
HP_HYPEREXTENSIBLE_SKIN,SET,60,0.17256,0.0098491,0.10787,0.054843,HP_HYPEREXTENSIBLE_SKIN,0.846679822852082
P53_DN.V2_UP,SET,132,0.12827,0.010838,0.080221,0.054921,P53_DN.V2_UP,0.846679822852082
JONES_TCOF1_TARGETS,SET,5,0.62288,0.010278,0.38956,0.054927,JONES_TCOF1_TARGETS,0.846679822852082
AIZARANI_LIVER_C17_HEPATOCYT...,SET,97,0.15191,0.011013,0.095015,0.054943,AIZARANI_LIVER_C17_HEPATOCYTES_3,0.846679822852082
HP_LARGE_FOREHEAD,SET,21,0.30389,0.010272,0.19009,0.054954,HP_LARGE_FOREHEAD,0.846679822852082
LEIN_PONS_MARKERS,SET,79,0.15733,0.010298,0.09843,0.054987,LEIN_PONS_MARKERS,0.846679822852082
GOBP_MESENCHYMAL_TO_EPITHELI...1,SET,18,0.37822,0.011837,0.23665,0.055007,GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION,0.846679822852082
GOBP_POSITIVE_REGULATION_OF_...78,SET,77,0.16323,0.010549,0.10213,0.055008,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.846679822852082
GTGCCTT_MIR506,SET,664,0.053603,0.010008,0.033556,0.055093,GTGCCTT_MIR506,0.846986033653846
ROZANOV_MMP14_TARGETS_SUBSET,SET,32,0.28165,0.011749,0.17637,0.055151,ROZANOV_MMP14_TARGETS_SUBSET,0.846986033653846
GOBP_CELL_CHEMOTAXIS,SET,290,0.0881,0.010985,0.055179,0.055184,GOBP_CELL_CHEMOTAXIS,0.846986033653846
GOBP_TETRAPYRROLE_CATABOLIC_...,SET,13,0.38888,0.010345,0.24359,0.055202,GOBP_TETRAPYRROLE_CATABOLIC_PROCESS,0.846986033653846
GOBP_DEPHOSPHORYLATION,SET,243,0.083975,0.0095972,0.052606,0.05522,GOBP_DEPHOSPHORYLATION,0.846986033653846
JINESH_BLEBBISHIELD_TO_IMMUN...2,SET,341,0.079075,0.010677,0.049539,0.055229,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,0.846986033653846
GUTIERREZ_WALDENSTROEMS_MACR...3,SET,10,0.46544,0.01086,0.2916,0.055237,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2,0.846986033653846
HP_LARGE_FOR_GESTATIONAL_AGE,SET,49,0.19542,0.010083,0.12247,0.055285,HP_LARGE_FOR_GESTATIONAL_AGE,0.846986033653846
GOMF_NUCLEOTIDE_TRANSMEMBRAN...,SET,29,0.27192,0.010799,0.17041,0.055291,GOMF_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.846986033653846
GSE6269_FLU_VS_STAPH_AUREUS_...2,SET,172,0.10004,0.0096382,0.062698,0.055293,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP,0.846986033653846
MIR6784_3P,SET,35,0.21618,0.0094304,0.13551,0.055332,MIR6784_3P,0.846986033653846
MIR4418,SET,118,0.12537,0.010019,0.078601,0.05536,MIR4418,0.846986033653846
MIR10398_3P,SET,5,0.64275,0.010606,0.40301,0.055379,MIR10398_3P,0.846986033653846
HP_GENERALIZED_ONSET_MOTOR_S...,SET,158,0.10973,0.010136,0.068847,0.055499,HP_GENERALIZED_ONSET_MOTOR_SEIZURE,0.846986033653846
GSE17721_LPS_VS_POLYIC_6H_BM...1,SET,178,0.10229,0.010023,0.064185,0.055522,GSE17721_LPS_VS_POLYIC_6H_BMDC_DN,0.846986033653846
GOBP_REGULATION_OF_CORTISOL_...,SET,7,0.55926,0.010919,0.35099,0.055544,GOBP_REGULATION_OF_CORTISOL_BIOSYNTHETIC_PROCESS,0.846986033653846
GSE21033_CTRL_VS_POLYIC_STIM...4,SET,174,0.10555,0.010227,0.066247,0.055563,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP,0.846986033653846
HP_CARDIAC_ARREST,SET,146,0.12083,0.010733,0.075858,0.055603,HP_CARDIAC_ARREST,0.846986033653846
GSE25123_CTRL_VS_IL4_STIM_PP...2,SET,179,0.097541,0.0095845,0.061238,0.055611,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_UP,0.846986033653846
GOBP_REGULATION_OF_ACTIN_FIL...5,SET,233,0.090937,0.01018,0.057096,0.055622,GOBP_REGULATION_OF_ACTIN_FILAMENT_ORGANIZATION,0.846986033653846
MIR4663,SET,61,0.17768,0.010225,0.11157,0.055639,MIR4663,0.846986033653846
ACAWNRNSRCGG_UNKNOWN,SET,57,0.18007,0.010018,0.11308,0.055652,ACAWNRNSRCGG_UNKNOWN,0.846986033653846
KEGG_MEDICUS_REFERENCE_TLR4_...,SET,9,0.42687,0.0094492,0.26809,0.055673,KEGG_MEDICUS_REFERENCE_TLR4_IRF3_7_SIGNALING_PATHWAY,0.846986033653846
GSE27786_LIN_NEG_VS_MONO_MAC...2,SET,181,0.095008,0.0093872,0.059672,0.055683,GSE27786_LIN_NEG_VS_MONO_MAC_UP,0.846986033653846
CAR_MYST2,SET,25,0.26442,0.009751,0.16609,0.0557,CAR_MYST2,0.846986033653846
GOBP_NEGATIVE_REGULATION_OF_...188,SET,31,0.22262,0.0091406,0.13985,0.055716,GOBP_NEGATIVE_REGULATION_OF_DNA_RECOMBINATION,0.846986033653846
GOMF_ALPHA_GLUCOSIDASE_ACTIV...,SET,7,0.52878,0.010324,0.33219,0.055723,GOMF_ALPHA_GLUCOSIDASE_ACTIVITY,0.846986033653846
GOBP_VESICLE_ORGANIZATION,SET,336,0.074105,0.0099334,0.046561,0.05575,GOBP_VESICLE_ORGANIZATION,0.846986033653846
HP_ABNORMALITY_OF_CHROMOSOME...1,SET,13,0.41085,0.010929,0.25815,0.055754,HP_ABNORMALITY_OF_CHROMOSOME_SEGREGATION,0.846986033653846
WINNEPENNINCKX_MELANOMA_META...1,SET,38,0.23257,0.01057,0.14613,0.055759,WINNEPENNINCKX_MELANOMA_METASTASIS_DN,0.846986033653846
WP_TRANSCRIPTIONAL_ACTIVATIO...,SET,15,0.3608,0.010309,0.22675,0.055794,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,0.847147431192661
GSE360_L_MAJOR_VS_B_MALAYI_L...2,SET,177,0.099654,0.0097379,0.062642,0.055831,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP,0.847339041484716
REACTOME_HIV_ELONGATION_ARRE...,SET,29,0.21709,0.0086216,0.13652,0.055899,REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY,0.848000761676124
MIR3616_5P,SET,84,0.14893,0.010051,0.093703,0.055994,MIR3616_5P,0.849034487570868
GOBP_CARDIOCYTE_DIFFERENTIAT...,SET,142,0.12035,0.010544,0.075731,0.056016,GOBP_CARDIOCYTE_DIFFERENTIATION,0.849034487570868
GOBP_INTERLEUKIN_10_PRODUCTI...,SET,51,0.20875,0.010987,0.13141,0.05609,GOBP_INTERLEUKIN_10_PRODUCTION,0.849553217239878
GOBP_STRIATED_MUSCLE_CONTRAC...,SET,173,0.10659,0.010299,0.067105,0.056104,GOBP_STRIATED_MUSCLE_CONTRACTION,0.849553217239878
HP_ORAL_ULCER,SET,57,0.18865,0.010496,0.11878,0.056131,HP_ORAL_ULCER,0.849553217239878
BIOCARTA_BARRESTIN_SRC_PATHW...,SET,16,0.37486,0.011062,0.23605,0.056148,BIOCARTA_BARRESTIN_SRC_PATHWAY,0.849553217239878
GOBP_REGULATION_OF_PROTEIN_C...2,SET,11,0.39095,0.0095669,0.2463,0.056235,GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,0.85049931462141
WP_GASTRIC_CANCER_NETWORK_2,SET,30,0.26068,0.010529,0.16432,0.056324,WP_GASTRIC_CANCER_NETWORK_2,0.851354009126467
BIOCARTA_TERT_PATHWAY,SET,8,0.43953,0.0091732,0.27707,0.056341,BIOCARTA_TERT_PATHWAY,0.851354009126467
GSE22886_NEUTROPHIL_VS_DC_DN,SET,177,0.098682,0.009643,0.062216,0.056365,GSE22886_NEUTROPHIL_VS_DC_DN,0.851354009126467
GSE26488_WT_VS_HDAC7_KO_DOUB...2,SET,159,0.11039,0.010229,0.069649,0.056494,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,0.852931785403997
HP_ABNORMAL_LONG_BONE_MORPHO...,SET,686,0.051782,0.0098211,0.032677,0.056527,HP_ABNORMAL_LONG_BONE_MORPHOLOGY,0.85305943768997
GSE32986_GMCSF_VS_GMCSF_AND_...4,SET,170,0.10457,0.010017,0.066002,0.05656,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.853186979166667
GOBP_OOCYTE_DIFFERENTIATION,SET,60,0.17562,0.010023,0.11089,0.056634,GOBP_OOCYTE_DIFFERENTIATION,0.853848662185603
HP_PAROXYSMAL_ATRIAL_FIBRILL...,SET,23,0.29823,0.01055,0.18833,0.056653,HP_PAROXYSMAL_ATRIAL_FIBRILLATION,0.853848662185603
GSE15930_NAIVE_VS_24H_IN_VIT...3,SET,188,0.092132,0.0092756,0.058235,0.056825,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.854085
SAMOLS_TARGETS_OF_KHSV_MIRNA...1,SET,47,0.21758,0.010995,0.13753,0.05683,SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,0.854085
GCM_RAD21,SET,32,0.21157,0.0088256,0.13374,0.056838,GCM_RAD21,0.854085
chr11q25,SET,13,0.64246,0.01709,0.40613,0.056846,chr11q25,0.854085
GOBP_OVULATION_FROM_OVARIAN_...,SET,9,0.47619,0.010541,0.30103,0.056846,GOBP_OVULATION_FROM_OVARIAN_FOLLICLE,0.854085
HP_IMPAIRED_GLUCOSE_TOLERANCE,SET,36,0.2416,0.010688,0.15273,0.056847,HP_IMPAIRED_GLUCOSE_TOLERANCE,0.854085
GOBP_CELL_KILLING,SET,204,0.10598,0.01111,0.067003,0.056865,GOBP_CELL_KILLING,0.854085
HP_ABNORMALITY_OF_CHORIORETI...,SET,12,0.42643,0.010899,0.26967,0.056915,HP_ABNORMALITY_OF_CHORIORETINAL_PIGMENTATION,0.854085
GOCC_ELONGATOR_HOLOENZYME_CO...,SET,5,0.65209,0.01076,0.41241,0.056928,GOCC_ELONGATOR_HOLOENZYME_COMPLEX,0.854085
GOBP_NEGATIVE_REGULATION_OF_...529,SET,5,0.45437,0.0074975,0.28737,0.056936,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MICROTUBULE,0.854085
MIR509_5P,SET,141,0.11169,0.0097506,0.07064,0.056939,MIR509_5P,0.854085
GSE24142_ADULT_VS_FETAL_DN3_...2,SET,179,0.10193,0.010016,0.064494,0.057004,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP,0.85419400862069
HP_STREAK_OVARY,SET,31,0.2364,0.0097063,0.14958,0.05701,HP_STREAK_OVARY,0.85419400862069
HP_ARACHNOID_HEMANGIOMATOSIS,SET,16,0.29489,0.0087019,0.18659,0.05702,HP_ARACHNOID_HEMANGIOMATOSIS,0.85419400862069
GSE11057_NAIVE_VS_CENT_MEMOR...1,SET,183,0.10322,0.010254,0.065321,0.057047,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,0.854230282205946
THAKAR_PBMC_INACTIVATED_INFL...6,SET,377,0.068902,0.0097721,0.043632,0.057159,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP,0.854733405309033
HP_HEPATIC_VEIN_THROMBOSIS,SET,9,0.43151,0.009552,0.27328,0.057175,HP_HEPATIC_VEIN_THROMBOSIS,0.854733405309033
MIR7856_5P,SET,363,0.072514,0.010095,0.045932,0.057211,MIR7856_5P,0.854733405309033
GOBP_REGULATION_OF_LIPOPROTE...2,SET,15,0.34095,0.0097421,0.21598,0.057218,GOBP_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS,0.854733405309033
GSE17721_CTRL_VS_POLYIC_6H_B...1,SET,189,0.10137,0.010233,0.064223,0.057235,GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN,0.854733405309033
REACTOME_BASE_EXCISION_REPAIR,SET,44,0.17658,0.0086345,0.11189,0.057269,REACTOME_BASE_EXCISION_REPAIR,0.854733405309033
GOMF_SUGAR_TRANSMEMBRANE_TRA...,SET,25,0.27926,0.010298,0.17696,0.05728,GOMF_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.854733405309033
HP_ANKLE_SWELLING,SET,12,0.42112,0.010763,0.26692,0.057326,HP_ANKLE_SWELLING,0.854733405309033
HP_ECLABION,SET,147,0.11521,0.010268,0.073032,0.057344,HP_ECLABION,0.854733405309033
GOBP_PLATELET_DEGRANULATION,SET,7,0.57482,0.011222,0.36446,0.057387,GOBP_PLATELET_DEGRANULATION,0.854733405309033
GOCC_SITE_OF_DOUBLE_STRAND_B...,SET,85,0.13129,0.0089132,0.08325,0.057394,GOCC_SITE_OF_DOUBLE_STRAND_BREAK,0.854733405309033
HP_ABNORMAL_FOOT_MORPHOLOGY,SET,1315,0.038851,0.010019,0.024643,0.057458,HP_ABNORMAL_FOOT_MORPHOLOGY,0.854733405309033
GAVISH_3CA_MALIGNANT_METAPRO...26,SET,43,0.2127,0.010282,0.13492,0.05746,GAVISH_3CA_MALIGNANT_METAPROGRAM_34_PLATELET_ACTIVATION,0.854733405309033
MIR1321,SET,124,0.12764,0.010455,0.081001,0.057543,MIR1321,0.854733405309033
GOBP_POSITIVE_REGULATION_OF_...435,SET,25,0.27943,0.010305,0.17738,0.057602,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_MIGRATION,0.854733405309033
KONDO_EZH2_TARGETS,SET,203,0.10018,0.010477,0.063628,0.057692,KONDO_EZH2_TARGETS,0.854733405309033
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...1,SET,12,0.48588,0.012418,0.30864,0.057721,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_CLASS_II_PROTEIN_COMPLEX,0.854733405309033
GOBP_NEGATIVE_REGULATION_OF_...468,SET,35,0.24603,0.010732,0.1563,0.057745,GOBP_NEGATIVE_REGULATION_OF_OSSIFICATION,0.854733405309033
GSE339_CD8POS_VS_CD4CD8DN_DC...3,SET,184,0.098964,0.0098579,0.062876,0.05776,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,0.854733405309033
REACTOME_RESOLUTION_OF_ABASI...,SET,37,0.18956,0.0085016,0.12049,0.057834,REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES,0.854733405309033
MIR181C_3P,SET,10,0.40656,0.0094861,0.2585,0.057896,MIR181C_3P,0.854733405309033
HP_HYPEREXTENSIBILITY_OF_THE...1,SET,21,0.31131,0.010523,0.19796,0.057914,HP_HYPEREXTENSIBILITY_OF_THE_FINGER_JOINTS,0.854733405309033
GSE32986_CURDLAN_HIGHDOSE_VS...2,SET,177,0.099415,0.0097146,0.06322,0.057924,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.854733405309033
CGGTGTG_MIR220,SET,5,0.62617,0.010333,0.39821,0.057931,CGGTGTG_MIR220,0.854733405309033
GOBP_CENTROMERIC_SISTER_CHRO...,SET,9,0.49577,0.010974,0.31531,0.057944,GOBP_CENTROMERIC_SISTER_CHROMATID_COHESION,0.854733405309033
HP_HYPERGLYCINURIA,SET,14,0.3832,0.010578,0.24376,0.057978,HP_HYPERGLYCINURIA,0.854733405309033
GOBP_GROWTH_INVOLVED_IN_HEAR...,SET,4,0.79539,0.01174,0.50599,0.057989,GOBP_GROWTH_INVOLVED_IN_HEART_MORPHOGENESIS,0.854733405309033
GOMF_PORIN_ACTIVITY,SET,5,0.61117,0.010085,0.38883,0.058007,GOMF_PORIN_ACTIVITY,0.854733405309033
MATZUK_MATERNAL_EFFECT,SET,7,0.50889,0.0099353,0.32386,0.05806,MATZUK_MATERNAL_EFFECT,0.854733405309033
ZNF680_TARGET_GENES,SET,614,0.054352,0.0097724,0.03459,0.058063,ZNF680_TARGET_GENES,0.854733405309033
GSE24671_BAKIMULC_VS_SENDAI_...1,SET,173,0.095957,0.0092711,0.061069,0.058065,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,0.854733405309033
GOBP_REGULATION_OF_DENDRITE_...3,SET,57,0.18029,0.01003,0.11475,0.058084,GOBP_REGULATION_OF_DENDRITE_MORPHOGENESIS,0.854733405309033
GOMF_DNA_POLYMERASE_BINDING,SET,19,0.24566,0.0078991,0.15638,0.058105,GOMF_DNA_POLYMERASE_BINDING,0.854733405309033
GOMF_VOLTAGE_GATED_CHLORIDE_...,SET,9,0.43105,0.0095419,0.27439,0.058106,GOMF_VOLTAGE_GATED_CHLORIDE_CHANNEL_ACTIVITY,0.854733405309033
GOBP_GLIAL_CELL_DEVELOPMENT,SET,126,0.12285,0.010143,0.078215,0.058132,GOBP_GLIAL_CELL_DEVELOPMENT,0.854733405309033
GSE32034_UNTREATED_VS_ROSIGL...4,SET,154,0.10712,0.0097698,0.068214,0.058179,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP,0.854733405309033
HP_UNILATERAL_PRIMARY_PULMON...,SET,3,0.71234,0.0091054,0.45365,0.058189,HP_UNILATERAL_PRIMARY_PULMONARY_DYSGENESIS,0.854733405309033
HP_ENLARGED_JOINTS,SET,12,0.36964,0.0094475,0.23543,0.058212,HP_ENLARGED_JOINTS,0.854733405309033
CHARAFE_BREAST_CANCER_BASAL_...1,SET,50,0.20702,0.010789,0.13191,0.058285,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,0.854733405309033
GOMF_OXIDIZED_DNA_BINDING,SET,11,0.39486,0.0096626,0.25167,0.058341,GOMF_OXIDIZED_DNA_BINDING,0.854733405309033
GOCC_DENDRITIC_TREE,SET,570,0.058738,0.010188,0.03744,0.05835,GOCC_DENDRITIC_TREE,0.854733405309033
GSE40274_FOXP3_VS_FOXP3_AND_...7,SET,174,0.10185,0.009869,0.064941,0.058401,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.854733405309033
GOBP_REGULATION_OF_PLATELET_...1,SET,50,0.2138,0.011143,0.13633,0.058421,GOBP_REGULATION_OF_PLATELET_ACTIVATION,0.854733405309033
MODULE_521,SET,35,0.25464,0.011108,0.16239,0.058435,MODULE_521,0.854733405309033
GSE30083_SP1_VS_SP3_THYMOCYT...2,SET,178,0.10555,0.010343,0.067309,0.058436,GSE30083_SP1_VS_SP3_THYMOCYTE_UP,0.854733405309033
MIR4777_5P,SET,101,0.13846,0.010242,0.0883,0.058438,MIR4777_5P,0.854733405309033
GOBP_RESPONSE_TO_ACTIVITY,SET,72,0.16562,0.010352,0.10562,0.058438,GOBP_RESPONSE_TO_ACTIVITY,0.854733405309033
GCM_TINF2,SET,38,0.1968,0.0089447,0.12551,0.058452,GCM_TINF2,0.854733405309033
GSE22935_UNSTIM_VS_24H_MBOVI...3,SET,181,0.099044,0.009786,0.063178,0.058485,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.854733405309033
GSE2706_LPS_VS_R848_AND_LPS_...2,SET,146,0.10734,0.0095341,0.068483,0.058527,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP,0.854733405309033
GSE2585_CTEC_VS_MTEC_THYMUS_...2,SET,176,0.1002,0.0097633,0.063935,0.058549,GSE2585_CTEC_VS_MTEC_THYMUS_UP,0.854733405309033
GOLDRATH_EFF_VS_MEMORY_CD8_T...1,SET,186,0.097398,0.009754,0.062152,0.058554,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN,0.854733405309033
BANP_TARGET_GENES,SET,612,0.053684,0.009637,0.034261,0.058576,BANP_TARGET_GENES,0.854733405309033
GSE24634_TEFF_VS_TCONV_DAY7_...1,SET,183,0.10341,0.010273,0.066008,0.058615,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN,0.854733405309033
GSE13306_TREG_VS_TCONV_DN,SET,186,0.094441,0.0094578,0.060288,0.058627,GSE13306_TREG_VS_TCONV_DN,0.854733405309033
GOBP_ALDEHYDE_BIOSYNTHETIC_P...,SET,17,0.3587,0.01091,0.22898,0.058628,GOBP_ALDEHYDE_BIOSYNTHETIC_PROCESS,0.854733405309033
GSE37301_RAG2_KO_VS_RAG2_AND...2,SET,181,0.099283,0.0098096,0.0634,0.058687,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP,0.854733405309033
GOBP_DEFENSE_RESPONSE_TO_GRA...2,SET,92,0.14914,0.010531,0.095241,0.058691,GOBP_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM,0.854733405309033
GOBP_CHLORIDE_TRANSPORT,SET,113,0.13441,0.010513,0.085845,0.058719,GOBP_CHLORIDE_TRANSPORT,0.854733405309033
GOMF_MANGANESE_ION_BINDING,SET,61,0.17688,0.010179,0.11299,0.058755,GOMF_MANGANESE_ION_BINDING,0.854733405309033
GOBP_NEPHRON_TUBULE_FORMATION,SET,18,0.36539,0.011436,0.23342,0.058756,GOBP_NEPHRON_TUBULE_FORMATION,0.854733405309033
GOBP_POSITIVE_REGULATION_OF_...394,SET,8,0.51517,0.010752,0.32917,0.058793,GOBP_POSITIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,0.854733405309033
SCHWAB_TARGETS_OF_BMYB_POLYM...1,SET,13,0.39603,0.010535,0.25306,0.058801,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN,0.854733405309033
FAN_EMBRYONIC_CTX_IN_4_INTER...,SET,8,0.53073,0.011077,0.33913,0.058804,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,0.854733405309033
HARALAMBIEVA_PBMC_FLUARIX_AG...8,SET,555,0.053175,0.009105,0.033985,0.058837,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE,0.854733405309033
MIR6864_5P,SET,77,0.15773,0.010194,0.10081,0.058852,MIR6864_5P,0.854733405309033
WP_CHOLESTEROL_METABOLISM,SET,66,0.1677,0.010037,0.10719,0.058858,WP_CHOLESTEROL_METABOLISM,0.854733405309033
MODULE_455,SET,36,0.21899,0.0096881,0.13998,0.058868,MODULE_455,0.854733405309033
TTGCACT_MIR130A_MIR301_MIR13...,SET,352,0.071598,0.0098188,0.04578,0.058923,TTGCACT_MIR130A_MIR301_MIR130B,0.854733405309033
WP_HOMOLOGOUS_RECOMBINATION,SET,12,0.31704,0.008103,0.20272,0.058928,WP_HOMOLOGOUS_RECOMBINATION,0.854733405309033
GOBP_NEGATIVE_REGULATION_OF_...52,SET,15,0.35301,0.010087,0.22577,0.058967,GOBP_NEGATIVE_REGULATION_OF_BONE_MINERALIZATION,0.854733405309033
GOMF_RNA_DIRECTED_DNA_POLYME...,SET,6,0.49567,0.0089596,0.31702,0.058972,GOMF_RNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,0.854733405309033
GOBP_SEX_DETERMINATION,SET,18,0.35133,0.010996,0.22473,0.058995,GOBP_SEX_DETERMINATION,0.854733405309033
GOBP_NEGATIVE_REGULATION_OF_...251,SET,24,0.31008,0.011204,0.19838,0.059022,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.854733405309033
GOCC_IMMUNOGLOBULIN_COMPLEX_...,SET,3,0.91912,0.011749,0.58812,0.059057,GOCC_IMMUNOGLOBULIN_COMPLEX_CIRCULATING,0.854733405309033
GOBP_BRANCHING_INVOLVED_IN_B...,SET,31,0.26205,0.010759,0.16771,0.05909,GOBP_BRANCHING_INVOLVED_IN_BLOOD_VESSEL_MORPHOGENESIS,0.854733405309033
HP_ABSENCE_OF_SECONDARY_SEX_...,SET,40,0.22646,0.010559,0.14496,0.059125,HP_ABSENCE_OF_SECONDARY_SEX_CHARACTERISTICS,0.854733405309033
HP_ENLARGED_KIDNEY,SET,41,0.20034,0.009457,0.12827,0.059173,HP_ENLARGED_KIDNEY,0.854733405309033
HP_ABNORMAL_EAR_MORPHOLOGY,SET,1420,0.036588,0.0097743,0.023429,0.059195,HP_ABNORMAL_EAR_MORPHOLOGY,0.854733405309033
REACTOME_HSF1_ACTIVATION,SET,28,0.2461,0.0096038,0.15764,0.05925,REACTOME_HSF1_ACTIVATION,0.854733405309033
GOMF_1_4_ALPHA_OLIGOGLUCAN_P...,SET,5,0.45042,0.0074324,0.28855,0.059273,GOMF_1_4_ALPHA_OLIGOGLUCAN_PHOSPHORYLASE_ACTIVITY,0.854733405309033
KRIEG_HYPOXIA_NOT_VIA_KDM3A,SET,663,0.053281,0.0099411,0.034138,0.0593,KRIEG_HYPOXIA_NOT_VIA_KDM3A,0.854733405309033
HP_ABNORMALITY_OF_BODY_MASS_...,SET,25,0.2861,0.010551,0.18331,0.059305,HP_ABNORMALITY_OF_BODY_MASS_INDEX,0.854733405309033
HP_LIP_TELANGIECTASIA,SET,5,0.58552,0.0096618,0.37529,0.059367,HP_LIP_TELANGIECTASIA,0.854733405309033
HP_RECURRENT_INTRAPULMONARY_...,SET,7,0.6421,0.012536,0.41155,0.059367,HP_RECURRENT_INTRAPULMONARY_HEMORRHAGE,0.854733405309033
HP_GASTROINTESTINAL_OBSTRUCT...,SET,85,0.14942,0.010144,0.095777,0.05938,HP_GASTROINTESTINAL_OBSTRUCTION,0.854733405309033
GSE15324_ELF4_KO_VS_WT_NAIVE...2,SET,181,0.098377,0.0097201,0.06306,0.059383,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP,0.854733405309033
GSE19888_ADENOSINE_A3R_INH_V...4,SET,184,0.10259,0.010219,0.065761,0.059384,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP,0.854733405309033
REACTOME_DEFENSINS,SET,32,0.32318,0.013481,0.20717,0.05939,REACTOME_DEFENSINS,0.854733405309033
HP_OSTEOMALACIA,SET,22,0.30633,0.010598,0.19641,0.05943,HP_OSTEOMALACIA,0.854733405309033
GOBP_REGULATION_OF_CARTILAGE...,SET,62,0.18143,0.010526,0.11633,0.059438,GOBP_REGULATION_OF_CARTILAGE_DEVELOPMENT,0.854733405309033
GOCC_MEDIATOR_COMPLEX,SET,34,0.21053,0.0090521,0.13502,0.059468,GOCC_MEDIATOR_COMPLEX,0.854733405309033
FAN_EMBRYONIC_CTX_EX_2_EXCIT...,SET,15,0.38596,0.011028,0.24752,0.059468,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,0.854733405309033
GOBP_PANCREAS_DEVELOPMENT,SET,74,0.16572,0.0105,0.10629,0.059487,GOBP_PANCREAS_DEVELOPMENT,0.854733405309033
GOBP_REGULATION_OF_PENTOSE_P...,SET,6,0.55296,0.009995,0.35466,0.059495,GOBP_REGULATION_OF_PENTOSE_PHOSPHATE_SHUNT,0.854733405309033
SCHAEFFER_PROSTATE_DEVELOPME...12,SET,33,0.21974,0.0093081,0.14098,0.059551,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,0.854733405309033
GSE17721_LPS_VS_PAM3CSK4_0.5...1,SET,174,0.098621,0.0095557,0.063303,0.059634,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN,0.854733405309033
GSE3982_CENT_MEMORY_CD4_TCEL...4,SET,169,0.10127,0.0096717,0.065006,0.059643,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP,0.854733405309033
GSE37301_MULTIPOTENT_PROGENI...5,SET,188,0.097099,0.0097756,0.062337,0.059669,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,0.854733405309033
HP_MITTEN_DEFORMITY,SET,9,0.472,0.010448,0.30305,0.059687,HP_MITTEN_DEFORMITY,0.854733405309033
REACTOME_DNA_DOUBLE_STRAND_B...1,SET,126,0.10743,0.0088695,0.068984,0.059708,REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,0.854733405309033
GOBP_GLUTATHIONE_TRANSPORT,SET,9,0.45871,0.010154,0.29455,0.059708,GOBP_GLUTATHIONE_TRANSPORT,0.854733405309033
FLORIO_HUMAN_NEOCORTEX,SET,28,0.27186,0.010609,0.17458,0.059719,FLORIO_HUMAN_NEOCORTEX,0.854733405309033
MIR5195_3P,SET,290,0.08028,0.01001,0.051594,0.059865,MIR5195_3P,0.854733405309033
GOBP_NODAL_SIGNALING_PATHWAY,SET,16,0.3632,0.010718,0.23357,0.059982,GOBP_NODAL_SIGNALING_PATHWAY,0.854733405309033
GSE34156_UNTREATED_VS_24H_NO...4,SET,150,0.10706,0.0096382,0.068916,0.060157,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_UP,0.854733405309033
REACTOME_LIGAND_RECEPTOR_INT...,SET,8,0.53169,0.011097,0.34226,0.060165,REACTOME_LIGAND_RECEPTOR_INTERACTIONS,0.854733405309033
GOBP_REGULATION_OF_MEGAKARYO...,SET,22,0.30152,0.010432,0.19411,0.060179,GOBP_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,0.854733405309033
JIANG_HYPOXIA_CANCER,SET,53,0.18355,0.0098482,0.11817,0.060193,JIANG_HYPOXIA_CANCER,0.854733405309033
KORKOLA_CHORIOCARCINOMA,SET,5,0.6597,0.010886,0.42474,0.060197,KORKOLA_CHORIOCARCINOMA,0.854733405309033
WANG_BARRETTS_ESOPHAGUS_AND_...1,SET,33,0.23533,0.0099686,0.15152,0.060199,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN,0.854733405309033
GOMF_COMPLEMENT_COMPONENT_C3...,SET,7,0.62231,0.012149,0.40068,0.060207,GOMF_COMPLEMENT_COMPONENT_C3B_BINDING,0.854733405309033
ZNF561_TARGET_GENES,SET,689,0.051441,0.0097768,0.033125,0.060232,ZNF561_TARGET_GENES,0.854733405309033
KEGG_MEDICUS_PATHOGEN_ESCHER...2,SET,17,0.29373,0.0089343,0.18915,0.060233,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY,0.854733405309033
GOBP_LYSOSOMAL_PROTEIN_CATAB...,SET,18,0.31353,0.0098126,0.20191,0.060241,GOBP_LYSOSOMAL_PROTEIN_CATABOLIC_PROCESS,0.854733405309033
GOBP_GLUTATHIONE_TRANSMEMBRA...,SET,8,0.47567,0.0099275,0.30639,0.060279,GOBP_GLUTATHIONE_TRANSMEMBRANE_TRANSPORT,0.854733405309033
LINDSTEDT_DENDRITIC_CELL_MAT...1,SET,61,0.17876,0.010287,0.11515,0.060284,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,0.854733405309033
CAAGGAT_MIR362,SET,59,0.1635,0.0092543,0.10533,0.0603,CAAGGAT_MIR362,0.854733405309033
GSE3039_NKT_CELL_VS_ALPHAALP...2,SET,185,0.1018,0.010168,0.065581,0.060309,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP,0.854733405309033
GOMF_NEUROLIGIN_FAMILY_PROTE...,SET,5,0.57805,0.0095384,0.37242,0.060323,GOMF_NEUROLIGIN_FAMILY_PROTEIN_BINDING,0.854733405309033
MIR4471,SET,68,0.15583,0.0094664,0.10041,0.060351,MIR4471,0.854733405309033
MIR6748_3P,SET,79,0.14884,0.009743,0.095924,0.060379,MIR6748_3P,0.854733405309033
GOCC_LATE_ENDOSOME_MEMBRANE,SET,153,0.10619,0.0096536,0.068436,0.060384,GOCC_LATE_ENDOSOME_MEMBRANE,0.854733405309033
GOBP_NUCLEAR_MEMBRANE_REASSE...,SET,25,0.26223,0.0096703,0.169,0.060388,GOBP_NUCLEAR_MEMBRANE_REASSEMBLY,0.854733405309033
REACTOME_METABOLISM_OF_FOLAT...,SET,16,0.29899,0.0088229,0.19271,0.060402,REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES,0.854733405309033
RIZKI_TUMOR_INVASIVENESS_3D_...1,SET,243,0.085828,0.009809,0.055332,0.060441,RIZKI_TUMOR_INVASIVENESS_3D_DN,0.854733405309033
MIR433_5P,SET,7,0.48698,0.0095074,0.31395,0.060443,MIR433_5P,0.854733405309033
HP_HYPOGLYCEMIC_COMA,SET,20,0.29888,0.0098596,0.19277,0.060523,HP_HYPOGLYCEMIC_COMA,0.854733405309033
GOBP_LEUKOCYTE_MEDIATED_IMMU...,SET,363,0.074314,0.010346,0.047939,0.060559,GOBP_LEUKOCYTE_MEDIATED_IMMUNITY,0.854733405309033
GOBP_SALIVA_SECRETION,SET,13,0.41044,0.010918,0.26478,0.060567,GOBP_SALIVA_SECRETION,0.854733405309033
HP_ABNORMAL_POSTERIOR_PITUIT...,SET,33,0.22039,0.0093357,0.1422,0.06059,HP_ABNORMAL_POSTERIOR_PITUITARY_MORPHOGENESIS,0.854733405309033
GOBP_DETECTION_OF_BIOTIC_STI...,SET,33,0.23745,0.010058,0.15321,0.060595,GOBP_DETECTION_OF_BIOTIC_STIMULUS,0.854733405309033
GOMF_IGG_BINDING,SET,10,0.48508,0.011318,0.31301,0.060608,GOMF_IGG_BINDING,0.854733405309033
GOBP_POSITIVE_REGULATION_OF_...476,SET,116,0.12039,0.0095399,0.0777,0.060645,GOBP_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,0.854733405309033
LI_ESTROGENE_MCF7_E2_RESPONS...2,SET,46,0.20877,0.010437,0.13474,0.060651,LI_ESTROGENE_MCF7_E2_RESPONSE_UP,0.854733405309033
GOBP_TELENCEPHALON_GLIAL_CEL...,SET,25,0.2877,0.01061,0.18569,0.060653,GOBP_TELENCEPHALON_GLIAL_CELL_MIGRATION,0.854733405309033
GOBP_ADENYLATE_CYCLASE_INHIB...2,SET,8,0.50595,0.01056,0.32655,0.060654,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,0.854733405309033
HP_BROAD_ALVEOLAR_RIDGES,SET,12,0.40758,0.010417,0.26307,0.060657,HP_BROAD_ALVEOLAR_RIDGES,0.854733405309033
GOBP_GLYCOLIPID_TRANSPORT,SET,8,0.45883,0.0095762,0.29616,0.060669,GOBP_GLYCOLIPID_TRANSPORT,0.854733405309033
MIR122_3P,SET,8,0.44276,0.0092407,0.28581,0.060682,MIR122_3P,0.854733405309033
GOMF_BASIC_AMINO_ACID_TRANSM...,SET,16,0.35392,0.010444,0.22846,0.060683,GOMF_BASIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.854733405309033
GOMF_RETINOIC_ACID_BINDING,SET,26,0.33638,0.01265,0.21719,0.060725,GOMF_RETINOIC_ACID_BINDING,0.854733405309033
HP_AMENORRHEA,SET,171,0.10101,0.0097035,0.065224,0.060737,HP_AMENORRHEA,0.854733405309033
GSE17974_1H_VS_72H_UNTREATED...1,SET,178,0.090501,0.0088682,0.058446,0.060766,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,0.854733405309033
YOKOE_CANCER_TESTIS_ANTIGENS,SET,33,0.21394,0.0090624,0.13818,0.060796,YOKOE_CANCER_TESTIS_ANTIGENS,0.854733405309033
HP_OPEN_BITE,SET,54,0.18514,0.010026,0.1196,0.060825,HP_OPEN_BITE,0.854733405309033
GSE30083_SP1_VS_SP2_THYMOCYT...2,SET,178,0.10027,0.009825,0.064775,0.060831,GSE30083_SP1_VS_SP2_THYMOCYTE_UP,0.854733405309033
HP_PARTIAL_ALBINISM,SET,9,0.49078,0.010864,0.3171,0.060853,HP_PARTIAL_ALBINISM,0.854733405309033
ATGTCAC_MIR489,SET,77,0.15751,0.010179,0.10177,0.06086,ATGTCAC_MIR489,0.854733405309033
GOCC_EARLY_PHAGOSOME,SET,12,0.38105,0.009739,0.24621,0.060862,GOCC_EARLY_PHAGOSOME,0.854733405309033
GOBP_POSITIVE_REGULATION_OF_...145,SET,31,0.23597,0.0096884,0.15249,0.060894,GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.854733405309033
GOBP_NEGATIVE_REGULATION_OF_...411,SET,83,0.13992,0.0093872,0.090433,0.060907,GOBP_NEGATIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,0.854733405309033
MIR4296,SET,65,0.17084,0.010147,0.11042,0.060924,MIR4296,0.854733405309033
BIOCARTA_ETC_PATHWAY,SET,7,0.42858,0.0083674,0.27709,0.060975,BIOCARTA_ETC_PATHWAY,0.854733405309033
HP_GASTROINTESTINAL_INFARCTI...,SET,13,0.38703,0.010295,0.25023,0.060983,HP_GASTROINTESTINAL_INFARCTIONS,0.854733405309033
GOMF_KINASE_ACTIVITY,SET,682,0.051083,0.0096613,0.033029,0.060986,GOMF_KINASE_ACTIVITY,0.854733405309033
CGTSACG_PAX3_B,SET,140,0.11482,0.0099883,0.074258,0.06104,CGTSACG_PAX3_B,0.854733405309033
GOBP_NEGATIVE_REGULATION_OF_...201,SET,33,0.25576,0.010834,0.16543,0.061053,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.854733405309033
GSE3720_LPS_VS_PMA_STIM_VD1_...2,SET,124,0.11782,0.0096506,0.076209,0.061055,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,0.854733405309033
WP_TYPE_I_INTERFERON_INDUCTI...,SET,28,0.24544,0.0095783,0.15878,0.061078,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,0.854733405309033
GOBP_MICTURITION,SET,8,0.47343,0.0098809,0.30626,0.061079,GOBP_MICTURITION,0.854733405309033
GOCC_CORVET_COMPLEX,SET,7,0.45116,0.0088082,0.29189,0.061103,GOCC_CORVET_COMPLEX,0.854733405309033
GOBP_POSITIVE_REGULATION_OF_...423,SET,4,0.63112,0.009315,0.4084,0.061138,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_ANERGY,0.854733405309033
HP_ELEVATED_BRONCHOALVEOLAR_...,SET,6,0.65908,0.011913,0.42673,0.061244,HP_ELEVATED_BRONCHOALVEOLAR_LAVAGE_FLUID_NEUTROPHIL_PROPORTION,0.854733405309033
GSE25123_CTRL_VS_IL4_STIM_MA...1,SET,174,0.10113,0.0097987,0.06551,0.061336,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN,0.854733405309033
GOBP_REGULATION_OF_EXTRACELL...1,SET,20,0.31365,0.010347,0.20319,0.061345,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,0.854733405309033
GOMF_DNA_REPLICATION_ORIGIN_...,SET,15,0.30287,0.0086539,0.19631,0.061449,GOMF_DNA_REPLICATION_ORIGIN_BINDING,0.854733405309033
GOBP_INTERLEUKIN_18_PRODUCTI...,SET,12,0.36112,0.0092298,0.23408,0.061453,GOBP_INTERLEUKIN_18_PRODUCTION,0.854733405309033
GOBP_REGULATION_OF_INTRINSIC...4,SET,15,0.31949,0.0091287,0.20709,0.061456,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR,0.854733405309033
GSE28737_BCL6_HET_VS_BCL6_KO...4,SET,184,0.10221,0.010182,0.066267,0.061488,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,0.854733405309033
HP_ORAL_MUCOSAL_BLISTERS,SET,13,0.38802,0.010322,0.25157,0.061501,HP_ORAL_MUCOSAL_BLISTERS,0.854733405309033
GOBP_DNA_STRAND_ELONGATION,SET,35,0.20624,0.0089968,0.13373,0.061516,GOBP_DNA_STRAND_ELONGATION,0.854733405309033
GSE21927_EL4_VS_MCA203_TUMOR...2,SET,149,0.11324,0.010161,0.073433,0.061529,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_UP,0.854733405309033
GSE17721_CTRL_VS_LPS_12H_BMD...1,SET,182,0.096955,0.0096057,0.062884,0.061568,GSE17721_CTRL_VS_LPS_12H_BMDC_DN,0.854733405309033
HP_APLASIA_CUTIS_CONGENITA_O...3,SET,7,0.46,0.0089806,0.29836,0.061574,HP_APLASIA_CUTIS_CONGENITA_OVER_THE_SCALP_VERTEX,0.854733405309033
WALLACE_PROSTATE_CANCER_RACE...1,SET,74,0.14947,0.0094708,0.096962,0.061599,WALLACE_PROSTATE_CANCER_RACE_DN,0.854733405309033
GOBP_METANEPHRIC_NEPHRON_MOR...,SET,24,0.30843,0.011145,0.20016,0.061681,GOBP_METANEPHRIC_NEPHRON_MORPHOGENESIS,0.854733405309033
GOBP_POSTSYNAPTIC_CYTOSKELET...,SET,17,0.34892,0.010613,0.22648,0.061713,GOBP_POSTSYNAPTIC_CYTOSKELETON_ORGANIZATION,0.854733405309033
GOMF_RIBOSOMAL_LARGE_SUBUNIT...,SET,12,0.35951,0.0091886,0.23336,0.061719,GOMF_RIBOSOMAL_LARGE_SUBUNIT_BINDING,0.854733405309033
GSE27241_WT_VS_RORGT_KO_TH17...2,SET,164,0.10344,0.0097326,0.06715,0.061744,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_DN,0.854733405309033
GOBP_STRESS_ACTIVATED_PROTEI...,SET,52,0.18056,0.0095962,0.11723,0.061755,GOBP_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.854733405309033
GAVISH_3CA_METAPROGRAM_CD4_T...5,SET,47,0.19741,0.0099757,0.12818,0.061778,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_INTERFERON,0.854733405309033
HP_ANGIOKERATOMA,SET,5,0.57311,0.0094569,0.37214,0.061784,HP_ANGIOKERATOMA,0.854733405309033
MODULE_399,SET,49,0.19762,0.010196,0.12832,0.061787,MODULE_399,0.854733405309033
GOBP_REGULATION_OF_CARBOHYDR...1,SET,88,0.14179,0.0097934,0.092075,0.061795,GOBP_REGULATION_OF_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,0.854733405309033
HP_ABNORMAL_NECK_PHYSIOLOGY,SET,29,0.25901,0.010286,0.1682,0.061797,HP_ABNORMAL_NECK_PHYSIOLOGY,0.854733405309033
BIOCARTA_CCR3_PATHWAY,SET,18,0.33637,0.010527,0.21846,0.061823,BIOCARTA_CCR3_PATHWAY,0.854733405309033
TTTTGAG_MIR373,SET,212,0.089848,0.0095994,0.058355,0.061827,TTTTGAG_MIR373,0.854733405309033
GSE21063_3H_VS_16H_ANTI_IGM_...4,SET,180,0.095146,0.0093751,0.061796,0.061828,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP,0.854733405309033
REACTOME_PLATELET_ADHESION_T...,SET,15,0.37383,0.010681,0.24282,0.061847,REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN,0.854733405309033
MIR125B_2_3P,SET,121,0.11691,0.0094605,0.075942,0.061847,MIR125B_2_3P,0.854733405309033
MIR589_3P,SET,229,0.090159,0.010007,0.058578,0.061894,MIR589_3P,0.854733405309033
HALLMARK_COAGULATION,SET,127,0.12844,0.010646,0.083467,0.061934,HALLMARK_COAGULATION,0.854733405309033
ELF1_Q6,SET,227,0.084856,0.0093773,0.055144,0.061935,ELF1_Q6,0.854733405309033
GSE14415_INDUCED_VS_NATURAL_...2,SET,130,0.11376,0.0095389,0.07395,0.061996,GSE14415_INDUCED_VS_NATURAL_TREG_UP,0.854733405309033
MISHRA_CARCINOMA_ASSOCIATED_...2,SET,22,0.30909,0.010694,0.20094,0.062007,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP,0.854733405309033
chr7q33,SET,24,0.37984,0.013725,0.24694,0.062012,chr7q33,0.854733405309033
OSADA_ASCL1_TARGETS_DN,SET,23,0.30795,0.010893,0.20024,0.062041,OSADA_ASCL1_TARGETS_DN,0.854733405309033
HP_RECURRENT_SKIN_INFECTIONS,SET,122,0.12067,0.0098042,0.078464,0.062049,HP_RECURRENT_SKIN_INFECTIONS,0.854733405309033
GSE13762_CTRL_VS_125_VITAMIN...4,SET,122,0.12929,0.010505,0.084073,0.062051,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP,0.854733405309033
MODULE_209,SET,81,0.15427,0.010224,0.10032,0.062069,MODULE_209,0.854733405309033
GSE14308_TH17_VS_NATURAL_TRE...2,SET,180,0.095787,0.0094382,0.062293,0.062072,GSE14308_TH17_VS_NATURAL_TREG_UP,0.854733405309033
HP_SMALL_EPIPHYSES,SET,20,0.31444,0.010373,0.20449,0.062073,HP_SMALL_EPIPHYSES,0.854733405309033
MIR382_3P,SET,91,0.14026,0.0098503,0.091251,0.062153,MIR382_3P,0.855349994061758
MIR4794,SET,88,0.1449,0.010008,0.094283,0.062167,MIR4794,0.855349994061758
LEIN_ASTROCYTE_MARKERS,SET,40,0.21228,0.0098983,0.13816,0.062213,LEIN_ASTROCYTE_MARKERS,0.855644168975069
GOBP_REGULATION_OF_NEUTROPHI...5,SET,5,0.6036,0.00996,0.393,0.062293,GOBP_REGULATION_OF_NEUTROPHIL_MEDIATED_CYTOTOXICITY,0.856135622775801
GSE29164_DAY3_VS_DAY7_CD8_TC...4,SET,181,0.095745,0.00946,0.062341,0.062298,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_UP,0.856135622775801
GOBP_RESPONSE_TO_EPINEPHRINE,SET,14,0.36386,0.010044,0.23695,0.062326,GOBP_RESPONSE_TO_EPINEPHRINE,0.85617816943128
HP_EXCESSIVE_SALIVATION,SET,106,0.12947,0.0098096,0.084329,0.062365,HP_EXCESSIVE_SALIVATION,0.85617816943128
HP_HYPERAUTOFLUORESCENT_MACU...,SET,11,0.45495,0.011133,0.29635,0.062375,HP_HYPERAUTOFLUORESCENT_MACULAR_LESION,0.85617816943128
TRAVAGLINI_LUNG_NONCLASSICAL...,SET,171,0.10628,0.01021,0.06925,0.062431,TRAVAGLINI_LUNG_NONCLASSICAL_MONOCYTE_CELL,0.856302875739645
GOBP_REGULATION_OF_LEUKOCYTE...8,SET,213,0.095374,0.010213,0.062146,0.062441,GOBP_REGULATION_OF_LEUKOCYTE_MIGRATION,0.856302875739645
MIR5003_5P,SET,177,0.1015,0.0099181,0.066143,0.062458,MIR5003_5P,0.856302875739645
HP_ABNORMAL_FINGERNAIL_MORPH...,SET,173,0.10041,0.0097014,0.06546,0.062532,HP_ABNORMAL_FINGERNAIL_MORPHOLOGY,0.856759077555817
GSE3982_EFF_MEMORY_CD4_TCELL...4,SET,173,0.10101,0.0097598,0.065871,0.062581,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP,0.856759077555817
REACTOME_ENERGY_DEPENDENT_RE...,SET,28,0.23785,0.0092821,0.1551,0.062583,REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK,0.856759077555817
REACTOME_FLT3_SIGNALING,SET,37,0.20953,0.0093972,0.13668,0.062646,REACTOME_FLT3_SIGNALING,0.856759077555817
GOBP_REGULATION_OF_CHONDROCY...2,SET,47,0.2083,0.010526,0.13592,0.062698,GOBP_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,0.856759077555817
MYLLYKANGAS_AMPLIFICATION_HO...14,SET,5,0.46264,0.0076341,0.30188,0.062704,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30,0.856759077555817
ZNF532_TARGET_GENES,SET,53,0.17779,0.0095391,0.11603,0.062727,ZNF532_TARGET_GENES,0.856759077555817
SASAI_TARGETS_OF_CXCR6_AND_P...1,SET,8,0.53449,0.011155,0.34883,0.062742,SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN,0.856759077555817
KEGG_MEDICUS_REFERENCE_EGF_E...1,SET,21,0.27189,0.0091907,0.17748,0.062778,KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY,0.856759077555817
PETRETTO_HEART_MASS_QTL_CIS_...2,SET,30,0.23626,0.0095431,0.15424,0.062801,PETRETTO_HEART_MASS_QTL_CIS_UP,0.856759077555817
GOBP_INTERLEUKIN_2_PRODUCTION,SET,60,0.18433,0.010521,0.12034,0.062808,GOBP_INTERLEUKIN_2_PRODUCTION,0.856759077555817
GSE4590_LARGE_PRE_BCELL_VS_V...2,SET,160,0.10795,0.010034,0.070482,0.062815,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,0.856759077555817
SALL4_TARGET_GENES,SET,1442,0.035709,0.0096069,0.023318,0.062842,SALL4_TARGET_GENES,0.856759077555817
MIR26B_3P,SET,95,0.13062,0.0093722,0.085304,0.062861,MIR26B_3P,0.856759077555817
PRAMOONJAGO_SOX4_TARGETS_DN,SET,46,0.18414,0.0092061,0.12029,0.062919,PRAMOONJAGO_SOX4_TARGETS_DN,0.856759077555817
chr1p33,SET,28,0.40055,0.015631,0.26166,0.06292,chr1p33,0.856759077555817
MURAKAMI_UV_RESPONSE_6HR_DN,SET,21,0.28303,0.009567,0.18489,0.062924,MURAKAMI_UV_RESPONSE_6HR_DN,0.856759077555817
GSE7568_IL4_VS_IL4_AND_TGFB_...1,SET,176,0.092923,0.0090547,0.060708,0.062935,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_DN,0.856759077555817
REACTOME_RHOBTB2_GTPASE_CYCLE,SET,22,0.25107,0.0086864,0.16408,0.06299,REACTOME_RHOBTB2_GTPASE_CYCLE,0.856968320297223
KEGG_MEDICUS_REFERENCE_IL2_F...,SET,20,0.33242,0.010966,0.21728,0.063024,KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,0.856968320297223
MIR6750_5P,SET,63,0.15689,0.0091748,0.10255,0.06303,MIR6750_5P,0.856968320297223
GOBP_REGULATION_OF_POTASSIUM...2,SET,4,0.74278,0.010963,0.48556,0.063049,GOBP_REGULATION_OF_POTASSIUM_ION_IMPORT,0.856968320297223
GSE2405_0H_VS_1.5H_A_PHAGOCY...2,SET,188,0.09847,0.0099136,0.064386,0.063097,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.857218707692308
GSE22886_NAIVE_TCELL_VS_NEUT...1,SET,173,0.10716,0.010353,0.070083,0.063136,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN,0.857218707692308
GOBP_METHYLGLYOXAL_METABOLIC...,SET,4,0.54138,0.0079904,0.35409,0.063152,GOBP_METHYLGLYOXAL_METABOLIC_PROCESS,0.857218707692308
GOCC_POSTSYNAPSE,SET,608,0.055634,0.0099556,0.036399,0.063207,GOCC_POSTSYNAPSE,0.857218707692308
CEBALLOS_TARGETS_OF_TP53_AND...2,SET,18,0.33537,0.010496,0.21942,0.063216,CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,0.857218707692308
HP_OSTEOLYSIS_INVOLVING_BONE...1,SET,11,0.42569,0.010417,0.27859,0.063263,HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_LOWER_LIMBS,0.857218707692308
HP_LOSS_OF_EYELASHES,SET,4,0.56442,0.0083306,0.36943,0.063286,HP_LOSS_OF_EYELASHES,0.857218707692308
HP_PROGRESSIVE_PSYCHOMOTOR_D...,SET,12,0.36019,0.0092059,0.23592,0.063423,HP_PROGRESSIVE_PSYCHOMOTOR_DETERIORATION,0.857218707692308
HP_REDUCED_FORCED_VITAL_CAPA...,SET,34,0.21236,0.0091307,0.13911,0.063437,HP_REDUCED_FORCED_VITAL_CAPACITY,0.857218707692308
MIR6772_3P,SET,66,0.15871,0.0094988,0.10396,0.06344,MIR6772_3P,0.857218707692308
MIR138_5P,SET,189,0.095649,0.0096549,0.062664,0.063467,MIR138_5P,0.857218707692308
GOMF_DOUBLE_STRANDED_RNA_ADE...,SET,6,0.59118,0.010686,0.38737,0.063498,GOMF_DOUBLE_STRANDED_RNA_ADENOSINE_DEAMINASE_ACTIVITY,0.857218707692308
GOBP_REGULATION_OF_OSSIFICAT...,SET,111,0.13014,0.010089,0.085283,0.063517,GOBP_REGULATION_OF_OSSIFICATION,0.857218707692308
GSE5589_WT_VS_IL6_KO_LPS_STI...3,SET,182,0.098641,0.0097727,0.064652,0.06355,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN,0.857218707692308
GSE7460_CTRL_VS_TGFB_TREATED...6,SET,177,0.098699,0.0096446,0.064694,0.063559,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP,0.857218707692308
GSE25123_ROSIGLITAZONE_VS_IL...4,SET,178,0.096195,0.0094261,0.063074,0.063626,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,0.857218707692308
chr4q26,SET,15,0.61328,0.017523,0.40213,0.063631,chr4q26,0.857218707692308
GOBP_REGULATION_OF_B_CELL_ME...,SET,52,0.18392,0.0097746,0.12061,0.063644,GOBP_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.857218707692308
GOCC_SWR1_COMPLEX,SET,13,0.31513,0.008383,0.20673,0.063719,GOCC_SWR1_COMPLEX,0.857218707692308
GOBP_REGULATION_OF_PEPTIDYL_...2,SET,10,0.37921,0.008848,0.24879,0.06374,GOBP_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION,0.857218707692308
GSE17301_ACD3_ACD28_VS_ACD3_...1,SET,183,0.094829,0.0094206,0.062217,0.063745,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN,0.857218707692308
GOBP_CORNEA_DEVELOPMENT_IN_C...,SET,12,0.45157,0.011542,0.29629,0.063752,GOBP_CORNEA_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.857218707692308
HP_THORACIC_KYPHOSCOLIOSIS,SET,24,0.24726,0.0089342,0.16226,0.063788,HP_THORACIC_KYPHOSCOLIOSIS,0.857218707692308
GOBP_MESENCHYMAL_CELL_APOPTO...,SET,15,0.39534,0.011296,0.25953,0.063854,GOBP_MESENCHYMAL_CELL_APOPTOTIC_PROCESS,0.857218707692308
GOBP_OLFACTORY_NERVE_DEVELOP...,SET,6,0.57576,0.010407,0.37803,0.063881,GOBP_OLFACTORY_NERVE_DEVELOPMENT,0.857218707692308
LOPEZ_EPITHELIOID_MESOTHELIO...,SET,15,0.32445,0.0092705,0.21309,0.063936,LOPEZ_EPITHELIOID_MESOTHELIOMA,0.857218707692308
HP_BREAST_APLASIA,SET,16,0.30661,0.0090478,0.2014,0.06396,HP_BREAST_APLASIA,0.857218707692308
HP_MULTIFOCAL_SEIZURES,SET,16,0.30771,0.0090803,0.20213,0.063967,HP_MULTIFOCAL_SEIZURES,0.857218707692308
DESCARTES_FETAL_ADRENAL_SCHW...,SET,108,0.13947,0.010666,0.091616,0.063967,DESCARTES_FETAL_ADRENAL_SCHWANN_CELLS,0.857218707692308
GOBP_NUCLEOLUS_ORGANIZATION,SET,14,0.31092,0.0085828,0.20423,0.063968,GOBP_NUCLEOLUS_ORGANIZATION,0.857218707692308
GSE40655_FOXO1_KO_VS_WT_NTRE...2,SET,178,0.09182,0.0089975,0.060315,0.063971,GSE40655_FOXO1_KO_VS_WT_NTREG_UP,0.857218707692308
GOCC_NUCLEAR_CHROMOSOME,SET,211,0.083491,0.0088994,0.054854,0.064004,GOCC_NUCLEAR_CHROMOSOME,0.857218707692308
GOMF_MONOATOMIC_ION_GATED_CH...,SET,30,0.25286,0.010214,0.16613,0.064008,GOMF_MONOATOMIC_ION_GATED_CHANNEL_ACTIVITY,0.857218707692308
GOBP_MITOCHONDRIAL_FRAGMENTA...,SET,10,0.45209,0.010549,0.29705,0.064024,GOBP_MITOCHONDRIAL_FRAGMENTATION_INVOLVED_IN_APOPTOTIC_PROCESS,0.857218707692308
DESCARTES_FETAL_CEREBRUM_MEG...,SET,313,0.07509,0.0097209,0.049345,0.064047,DESCARTES_FETAL_CEREBRUM_MEGAKARYOCYTES,0.857218707692308
GOBP_MITOCHONDRIAL_TRANSLATI...2,SET,5,0.50874,0.0083948,0.33432,0.06405,GOBP_MITOCHONDRIAL_TRANSLATIONAL_ELONGATION,0.857218707692308
WEINMANN_ADAPTATION_TO_HYPOX...2,SET,25,0.2905,0.010713,0.19093,0.064077,WEINMANN_ADAPTATION_TO_HYPOXIA_UP,0.857218707692308
GOBP_L_LYSINE_TRANSMEMBRANE_...,SET,6,0.59016,0.010668,0.38789,0.064079,GOBP_L_LYSINE_TRANSMEMBRANE_TRANSPORT,0.857218707692308
GOBP_ORNITHINE_TRANSPORT,SET,6,0.59016,0.010668,0.38789,0.064079,GOBP_ORNITHINE_TRANSPORT,0.857218707692308
GOMF_L_LYSINE_TRANSMEMBRANE_...,SET,6,0.59016,0.010668,0.38789,0.064079,GOMF_L_LYSINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.857218707692308
BROWN_MYELOID_CELL_DEVELOPME...1,SET,119,0.12092,0.0097041,0.07948,0.064087,BROWN_MYELOID_CELL_DEVELOPMENT_DN,0.857218707692308
GOBP_DICHOTOMOUS_SUBDIVISION...,SET,8,0.53116,0.011086,0.34919,0.064125,GOBP_DICHOTOMOUS_SUBDIVISION_OF_AN_EPITHELIAL_TERMINAL_UNIT,0.857218707692308
MIR5699_3P,SET,60,0.17417,0.0099411,0.11451,0.064128,MIR5699_3P,0.857218707692308
HP_ERYTHROMELALGIA,SET,7,0.4951,0.009666,0.32565,0.064224,HP_ERYTHROMELALGIA,0.857983233601841
MIR4671_3P,SET,191,0.095689,0.0097095,0.062953,0.064263,MIR4671_3P,0.857983233601841
CHAUHAN_RESPONSE_TO_METHOXYE...2,SET,41,0.1821,0.0085964,0.11983,0.064303,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,0.857983233601841
GOBP_DEVELOPMENT_OF_PRIMARY_...1,SET,101,0.13702,0.010136,0.090181,0.064335,GOBP_DEVELOPMENT_OF_PRIMARY_FEMALE_SEXUAL_CHARACTERISTICS,0.857983233601841
GOBP_REGULATION_OF_CARDIAC_M...2,SET,27,0.26855,0.010291,0.17675,0.064348,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.857983233601841
BUSSLINGER_ESOPHAGEAL_LATE_S...,SET,130,0.1244,0.010431,0.081879,0.06435,BUSSLINGER_ESOPHAGEAL_LATE_SUPRABASAL_CELLS,0.857983233601841
GOCC_BCL_2_FAMILY_PROTEIN_CO...,SET,10,0.44953,0.010489,0.29589,0.064358,GOCC_BCL_2_FAMILY_PROTEIN_COMPLEX,0.857983233601841
GOBP_REGULATION_OF_CARDIOCYT...,SET,25,0.26665,0.0098333,0.17557,0.064422,GOBP_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.858142229885058
GSE28737_WT_VS_BCL6_KO_FOLLI...1,SET,182,0.096671,0.0095776,0.063657,0.064437,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_DN,0.858142229885058
HP_THIRD_TRIMESTER_ONSET,SET,41,0.19405,0.0091603,0.12779,0.064444,HP_THIRD_TRIMESTER_ONSET,0.858142229885058
GOBP_REGULATION_OF_INTRINSIC...2,SET,28,0.24337,0.0094974,0.1604,0.064607,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.8597905510907
GOBP_POSITIVE_REGULATION_OF_...642,SET,682,0.051488,0.0097379,0.033939,0.064633,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.8597905510907
GOBP_MATURATION_OF_SSU_RRNA,SET,47,0.18863,0.0095319,0.12434,0.064642,GOBP_MATURATION_OF_SSU_RRNA,0.8597905510907
GSE7218_UNSTIM_VS_ANTIGEN_ST...4,SET,109,0.12336,0.0094774,0.081336,0.064681,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_UP,0.859893967889908
GSE19888_CTRL_VS_A3R_ACT_TRE...1,SET,178,0.095111,0.00932,0.062719,0.06471,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_DN,0.859893967889908
SP1_Q6,SET,235,0.082531,0.0092778,0.054427,0.064724,SP1_Q6,0.859893967889908
AMIT_EGF_RESPONSE_20_HELA,SET,10,0.44286,0.010333,0.29232,0.0649,AMIT_EGF_RESPONSE_20_HELA,0.860646319969743
IRF_Q6,SET,218,0.090412,0.0097937,0.059684,0.064914,IRF_Q6,0.860646319969743
GAVISH_3CA_METAPROGRAM_CD4_T...3,SET,43,0.20045,0.0096898,0.13235,0.06496,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_DYSFUNCTION,0.860646319969743
HP_SIDEROBLASTIC_ANEMIA,SET,32,0.20616,0.0085999,0.13616,0.065003,HP_SIDEROBLASTIC_ANEMIA,0.860646319969743
GOCC_MULTIVESICULAR_BODY_MEM...,SET,27,0.24945,0.0095596,0.16475,0.065006,GOCC_MULTIVESICULAR_BODY_MEMBRANE,0.860646319969743
chr6q26,SET,6,0.69852,0.012626,0.46135,0.065011,chr6q26,0.860646319969743
GSE3982_MAST_CELL_VS_MAC_UP,SET,175,0.096119,0.0093398,0.063494,0.065042,GSE3982_MAST_CELL_VS_MAC_UP,0.860646319969743
MORF_MYL3,SET,63,0.17097,0.0099984,0.11294,0.065046,MORF_MYL3,0.860646319969743
GOMF_TELOMERASE_ACTIVITY,SET,5,0.50617,0.0083523,0.33437,0.065047,GOMF_TELOMERASE_ACTIVITY,0.860646319969743
GOBP_GLOMERULAR_MESANGIUM_DE...,SET,16,0.36647,0.010814,0.24215,0.065097,GOBP_GLOMERULAR_MESANGIUM_DEVELOPMENT,0.860646319969743
GSE3920_IFNA_VS_IFNB_TREATED...1,SET,151,0.10549,0.0095274,0.069703,0.065105,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,0.860646319969743
GOBP_REGULATION_OF_CARDIAC_E...,SET,11,0.45398,0.011109,0.30005,0.065148,GOBP_REGULATION_OF_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.860646319969743
GOBP_REGULATION_OF_PEROXISOM...,SET,14,0.39603,0.010932,0.26179,0.065179,GOBP_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.860646319969743
BRF2_TARGET_GENES,SET,7,0.4313,0.0084204,0.28512,0.065185,BRF2_TARGET_GENES,0.860646319969743
GOBP_POSITIVE_REGULATION_OF_...582,SET,172,0.1061,0.010222,0.07014,0.065189,GOBP_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,0.860646319969743
GOBP_POTASSIUM_ION_EXPORT_AC...,SET,18,0.34344,0.010749,0.22712,0.065258,GOBP_POTASSIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.860646319969743
GOCC_ENDODEOXYRIBONUCLEASE_C...,SET,5,0.51432,0.0084868,0.34017,0.065283,GOCC_ENDODEOXYRIBONUCLEASE_COMPLEX,0.860646319969743
WP_SMALL_LIGAND_GPCRS,SET,18,0.34363,0.010755,0.2273,0.065305,WP_SMALL_LIGAND_GPCRS,0.860646319969743
GSE13522_CTRL_VS_T_CRUZI_Y_S...6,SET,184,0.097085,0.0096707,0.064225,0.065324,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP,0.860646319969743
GOCC_HISTONE_METHYLTRANSFERA...,SET,63,0.14831,0.008673,0.098119,0.065342,GOCC_HISTONE_METHYLTRANSFERASE_COMPLEX,0.860646319969743
HP_SHORT_PALPEBRAL_FISSURE,SET,107,0.12123,0.0092281,0.080215,0.065367,HP_SHORT_PALPEBRAL_FISSURE,0.860646319969743
GSE40685_NAIVE_CD4_TCELL_VS_...2,SET,186,0.093199,0.0093335,0.061671,0.065374,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_UP,0.860646319969743
PARK_TRETINOIN_RESPONSE,SET,11,0.43299,0.010596,0.28653,0.065387,PARK_TRETINOIN_RESPONSE,0.860646319969743
GOBP_STEROID_HORMONE_MEDIATE...,SET,122,0.11711,0.0095152,0.077517,0.065432,GOBP_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.860646319969743
GOBP_INTERLEUKIN_8_PRODUCTION,SET,77,0.15292,0.0098828,0.10122,0.065438,GOBP_INTERLEUKIN_8_PRODUCTION,0.860646319969743
WP_PTF1A_RELATED_REGULATORY_...,SET,11,0.44022,0.010773,0.29141,0.065447,WP_PTF1A_RELATED_REGULATORY_PATHWAY,0.860646319969743
GSE28726_NAIVE_CD4_TCELL_VS_...1,SET,184,0.096756,0.009638,0.064054,0.065463,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN,0.860646319969743
FULLER_PBMC_F_TULARENSIS_VAC...3,SET,37,0.21037,0.0094347,0.13928,0.065474,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_DN,0.860646319969743
HP_INCREASED_CIRCULATING_INT...3,SET,11,0.40776,0.0099785,0.27001,0.065509,HP_INCREASED_CIRCULATING_INTERLEUKIN_6_CONCENTRATION,0.860780829867675
GOBP_REGULATION_OF_ESTABLISH...6,SET,22,0.26015,0.0090005,0.17237,0.065626,GOBP_REGULATION_OF_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,0.861538125
GSE45365_BCELL_VS_CD8_TCELL_...1,SET,137,0.1117,0.0096138,0.074016,0.065634,GSE45365_BCELL_VS_CD8_TCELL_DN,0.861538125
REACTOME_OAS_ANTIVIRAL_RESPO...,SET,7,0.66052,0.012896,0.43768,0.065641,REACTOME_OAS_ANTIVIRAL_RESPONSE,0.861538125
HP_SHOULDER_DISLOCATION,SET,16,0.31248,0.0092212,0.20711,0.065685,HP_SHOULDER_DISLOCATION,0.861790175537939
GOBP_POSITIVE_REGULATION_OF_...66,SET,40,0.21089,0.0098334,0.13983,0.065768,GOBP_POSITIVE_REGULATION_OF_BONE_MINERALIZATION,0.862553524528302
GOBP_INTERMEDIATE_FILAMENT_O...,SET,71,0.21004,0.013037,0.1393,0.065813,GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION,0.862818112033195
GOMF_CARBOHYDRATE_TRANSMEMBR...,SET,36,0.23116,0.010226,0.15339,0.065908,GOMF_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.86338805274972
GSE36476_YOUNG_VS_OLD_DONOR_...3,SET,179,0.091643,0.0090051,0.060813,0.06592,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN,0.86338805274972
MIR3617_3P,SET,79,0.14776,0.009672,0.098085,0.065989,MIR3617_3P,0.86338805274972
ZHANG_BREAST_CANCER_PROGENIT...2,SET,397,0.063136,0.0091836,0.041913,0.065999,ZHANG_BREAST_CANCER_PROGENITORS_UP,0.86338805274972
ZNF486_TARGET_GENES,SET,160,0.10271,0.0095472,0.068192,0.066011,ZNF486_TARGET_GENES,0.86338805274972
GSE20727_CTRL_VS_ROS_INH_AND...2,SET,167,0.098175,0.009321,0.06519,0.066043,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,0.86338805274972
HP_RENAL_DYSPLASIA,SET,62,0.16631,0.0096489,0.11045,0.066078,HP_RENAL_DYSPLASIA,0.86338805274972
TRAVAGLINI_LUNG_FIBROMYOCYTE...,SET,21,0.32046,0.010832,0.21284,0.066086,TRAVAGLINI_LUNG_FIBROMYOCYTE_CELL,0.86338805274972
GOBP_OLIGODENDROCYTE_DEVELOP...,SET,44,0.19865,0.0097137,0.13198,0.066154,GOBP_OLIGODENDROCYTE_DEVELOPMENT,0.86338805274972
GOBP_POSITIVE_REGULATION_OF_...226,SET,6,0.59994,0.010844,0.3986,0.066155,GOBP_POSITIVE_REGULATION_OF_DOPAMINE_SECRETION,0.86338805274972
GOBP_OVULATION_CYCLE_PROCESS,SET,49,0.19953,0.010295,0.13258,0.066176,GOBP_OVULATION_CYCLE_PROCESS,0.86338805274972
MIR432_5P,SET,87,0.14229,0.0097723,0.094556,0.06619,MIR432_5P,0.86338805274972
TTTGCAG_MIR518A2,SET,188,0.095353,0.0095999,0.063375,0.066224,TTTGCAG_MIR518A2,0.86338805274972
GSE13485_CTRL_VS_DAY1_YF17D_...2,SET,179,0.087308,0.0085791,0.058031,0.066234,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP,0.86338805274972
GOBP_GENOMIC_IMPRINTING,SET,17,0.28592,0.0086968,0.19005,0.06624,GOBP_GENOMIC_IMPRINTING,0.86338805274972
KEGG_MEDICUS_REFERENCE_LONG_...,SET,17,0.26594,0.0080891,0.17681,0.066285,KEGG_MEDICUS_REFERENCE_LONG_PATCH_BER,0.86338805274972
MIR3202,SET,229,0.081958,0.0090965,0.0545,0.066322,MIR3202,0.86338805274972
HP_RECURRENT_VIRAL_INFECTIONS,SET,54,0.17974,0.0097339,0.11954,0.066349,HP_RECURRENT_VIRAL_INFECTIONS,0.86338805274972
GOBP_CELL_PROLIFERATION_INVO...1,SET,17,0.35453,0.010784,0.23582,0.066379,GOBP_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS,0.86338805274972
HP_COLDNESS,SET,2,1.0464,0.010921,0.69603,0.066389,HP_COLDNESS,0.86338805274972
HP_HAND_APRAXIA,SET,2,1.0464,0.010921,0.69603,0.066389,HP_HAND_APRAXIA,0.86338805274972
GOBP_HEPATIC_STELLATE_CELL_A...,SET,9,0.48865,0.010817,0.32507,0.066403,GOBP_HEPATIC_STELLATE_CELL_ACTIVATION,0.86338805274972
GSE32901_TH17_EMRICHED_VS_TH...1,SET,157,0.099388,0.0091518,0.066148,0.066492,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN,0.863402384328358
MORF_XRCC5,SET,210,0.080358,0.0085453,0.053485,0.066499,MORF_XRCC5,0.863402384328358
MEISSNER_BRAIN_HCP_WITH_H3_U...,SET,31,0.22824,0.0093713,0.15194,0.066537,MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED,0.863402384328358
GSE9988_ANTI_TREM1_VS_LPS_MO...2,SET,173,0.098739,0.0095399,0.065737,0.066554,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP,0.863402384328358
GSE7460_WT_VS_FOXP3_HET_ACT_...4,SET,183,0.094894,0.0094271,0.063178,0.066555,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP,0.863402384328358
GSE41867_NAIVE_VS_DAY6_LCMV_...4,SET,185,0.090328,0.0090219,0.060141,0.066564,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP,0.863402384328358
REACTOME_ACTIVATION_OF_MATRI...,SET,30,0.26923,0.010875,0.17927,0.066578,REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES,0.863402384328358
HP_ABNORMAL_CIRCULATING_CITR...,SET,10,0.40166,0.0093719,0.26749,0.066611,HP_ABNORMAL_CIRCULATING_CITRULLINE_CONCENTRATION,0.863508133159269
HP_BCGITIS,SET,10,0.43029,0.01004,0.28664,0.066669,HP_BCGITIS,0.863937768456376
GOBP_NEGATIVE_REGULATION_OF_...366,SET,31,0.2242,0.0092055,0.14939,0.066709,GOBP_NEGATIVE_REGULATION_OF_MACROAUTOPHAGY,0.864072726256983
WP_GENES_RELATED_TO_PRIMARY_...,SET,88,0.12618,0.0087155,0.08409,0.066741,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,0.864072726256983
HP_ABNORMAL_NASAL_TIP_MORPHO...,SET,324,0.070672,0.0093055,0.0471,0.066754,HP_ABNORMAL_NASAL_TIP_MORPHOLOGY,0.864072726256983
KEGG_MEDICUS_REFERENCE_ORGAN...1,SET,14,0.31599,0.0087229,0.21069,0.06684,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_INNER_KINETOCHORE,0.864863812360387
GSE21033_CTRL_VS_POLYIC_STIM...9,SET,147,0.10069,0.0089742,0.067154,0.066892,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN,0.865214536657983
HP_HYPOPLASTIC_ACETABULAE,SET,5,0.64013,0.010563,0.42706,0.066955,HP_HYPOPLASTIC_ACETABULAE,0.865514531424321
REACTOME_ACTIVATION_OF_C3_AN...,SET,4,0.65919,0.0097292,0.43979,0.066965,REACTOME_ACTIVATION_OF_C3_AND_C5,0.865514531424321
CHEOK_RESPONSE_TO_HD_MTX_DN,SET,19,0.25993,0.0083579,0.17347,0.067016,CHEOK_RESPONSE_TO_HD_MTX_DN,0.865851702602231
GOBP_REGULATION_OF_ALTERNATI...,SET,50,0.16719,0.0087136,0.11159,0.067045,GOBP_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME,0.865904487179487
GOBP_PEPTIDYL_THREONINE_DEPH...,SET,17,0.33295,0.010127,0.22235,0.067154,GOBP_PEPTIDYL_THREONINE_DEPHOSPHORYLATION,0.866144065974796
KEGG_MEDICUS_REFERENCE_BASE_...3,SET,9,0.3515,0.0077809,0.23478,0.067186,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_NEIL_GLYCOSYLASE,0.866144065974796
GOMF_DNA_BINDING_TRANSCRIPTI...4,SET,263,0.081273,0.0096577,0.054285,0.067186,GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY,0.866144065974796
GOBP_POSITIVE_REGULATION_OF_...147,SET,8,0.38226,0.0079781,0.25533,0.067188,GOBP_POSITIVE_REGULATION_OF_CENTRIOLE_REPLICATION,0.866144065974796
REACTOME_FORMATION_OF_XYLULO...,SET,5,0.59798,0.0098673,0.3995,0.06723,REACTOME_FORMATION_OF_XYLULOSE_5_PHOSPHATE,0.866144065974796
GOBP_GLUCURONATE_CATABOLIC_P...,SET,5,0.59798,0.0098673,0.3995,0.06723,GOBP_GLUCURONATE_CATABOLIC_PROCESS_TO_XYLULOSE_5_PHOSPHATE,0.866144065974796
GSE24292_WT_VS_PPARG_KO_MACR...1,SET,178,0.091892,0.0090045,0.061394,0.067238,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN,0.866144065974796
GOBP_REGULATION_OF_FATTY_ACI...2,SET,39,0.19355,0.0089115,0.12936,0.067311,GOBP_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.866212422279793
MIR3193,SET,7,0.45083,0.0088017,0.30134,0.067326,MIR3193,0.866212422279793
GOBP_REGULATION_OF_HIGH_DENS...,SET,4,0.61495,0.0090764,0.41108,0.067341,GOBP_REGULATION_OF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.866212422279793
MIR526B_5P,SET,94,0.13857,0.0098905,0.092633,0.067343,MIR526B_5P,0.866212422279793
GOMF_ACETYLCHOLINE_RECEPTOR_...1,SET,22,0.29292,0.010134,0.19593,0.067465,GOMF_ACETYLCHOLINE_RECEPTOR_ACTIVITY,0.867449878093831
KEGG_MEDICUS_REFERENCE_AUTOP...3,SET,5,0.68201,0.011254,0.4563,0.067509,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TRANS_SNARE,0.867449878093831
MIR342_3P,SET,111,0.12034,0.0093295,0.080521,0.067521,MIR342_3P,0.867449878093831
HP_DIFFICULTY_IN_TONGUE_MOVE...,SET,12,0.38781,0.0099119,0.25951,0.067543,HP_DIFFICULTY_IN_TONGUE_MOVEMENTS,0.867449878093831
GSE41978_KLRG1_HIGH_VS_LOW_E...2,SET,182,0.098409,0.0097498,0.065859,0.067564,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_UP,0.867449878093831
ZEILSTRA_CD44_TARGETS_DN,SET,9,0.41585,0.0092052,0.27834,0.067592,ZEILSTRA_CD44_TARGETS_DN,0.867488906942393
GOBP_POSITIVE_REGULATION_OF_...352,SET,44,0.18478,0.0090354,0.12372,0.067656,GOBP_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,0.867760893515107
HP_THICK_HAIR,SET,19,0.28348,0.0091152,0.18986,0.067713,HP_THICK_HAIR,0.867760893515107
GOBP_POSITIVE_REGULATION_OF_...690,SET,9,0.44905,0.0099403,0.30076,0.067722,GOBP_POSITIVE_REGULATION_OF_RRNA_PROCESSING,0.867760893515107
OUELLET_OVARIAN_CANCER_INVAS...1,SET,11,0.43731,0.010701,0.29294,0.067751,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,0.867760893515107
GOBP_LATERAL_VENTRICLE_DEVEL...,SET,12,0.35201,0.0089969,0.23582,0.067762,GOBP_LATERAL_VENTRICLE_DEVELOPMENT,0.867760893515107
MIR504_5P,SET,53,0.17359,0.0093139,0.11629,0.067763,MIR504_5P,0.867760893515107
HP_BACK_PAIN,SET,68,0.15273,0.0092783,0.10235,0.067821,HP_BACK_PAIN,0.867966456185567
GOCC_SARCOPLASMIC_RETICULUM,SET,73,0.14786,0.0093054,0.099087,0.067829,GOCC_SARCOPLASMIC_RETICULUM,0.867966456185567
CTCTAGA_MIR526C_MIR518F_MIR5...,SET,48,0.18795,0.0095981,0.12598,0.067868,CTCTAGA_MIR526C_MIR518F_MIR526A,0.868060230769231
GOBP_CARBOHYDRATE_TRANSPORT,SET,126,0.11773,0.0097196,0.078921,0.0679,GOBP_CARBOHYDRATE_TRANSPORT,0.868060230769231
MIR552_3P,SET,53,0.17194,0.009225,0.11529,0.067953,MIR552_3P,0.868060230769231
HEN1_01,SET,182,0.094706,0.0093829,0.063508,0.067957,HEN1_01,0.868060230769231
HP_DYSTROPHIC_FINGERNAILS,SET,25,0.24923,0.0091911,0.16716,0.067987,HP_DYSTROPHIC_FINGERNAILS,0.868060230769231
GOBP_TOLERANCE_INDUCTION_TO_...,SET,5,0.62414,0.010299,0.41862,0.067997,GOBP_TOLERANCE_INDUCTION_TO_SELF_ANTIGEN,0.868060230769231
MIR377_5P,SET,50,0.1819,0.0094803,0.12204,0.068046,MIR377_5P,0.868060230769231
GSE11864_UNTREATED_VS_CSF1_I...2,SET,163,0.098944,0.0092818,0.066381,0.068048,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP,0.868060230769231
HP_DECREASED_CERVICAL_SPINE_...2,SET,11,0.37498,0.0091763,0.25159,0.068062,HP_DECREASED_CERVICAL_SPINE_MOBILITY,0.868060230769231
HP_PROLONGED_QT_INTERVAL,SET,45,0.19912,0.0098464,0.13362,0.068099,HP_PROLONGED_QT_INTERVAL,0.868060230769231
GOBP_REGULATION_OF_LOCOMOTION,SET,960,0.044775,0.0099676,0.030049,0.068118,GOBP_REGULATION_OF_LOCOMOTION,0.868060230769231
GOBP_POSITIVE_REGULATION_OF_...514,SET,5,0.59694,0.0098502,0.40069,0.068149,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS,0.868060230769231
HP_EPISODIC_HYPERHIDROSIS,SET,25,0.23487,0.0086616,0.15767,0.068172,HP_EPISODIC_HYPERHIDROSIS,0.868060230769231
ZNF586_TARGET_GENES,SET,35,0.2084,0.0090908,0.13991,0.068186,ZNF586_TARGET_GENES,0.868060230769231
GSE36392_TYPE_2_MYELOID_VS_N...2,SET,182,0.093145,0.0092282,0.062553,0.068245,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,0.868214693094629
GOBP_CGMP_CATABOLIC_PROCESS,SET,5,0.60489,0.0099814,0.40626,0.068261,GOBP_CGMP_CATABOLIC_PROCESS,0.868214693094629
MODULE_371,SET,26,0.24963,0.0093879,0.16769,0.068297,MODULE_371,0.868214693094629
AP2_Q6_01,SET,247,0.080463,0.0092702,0.054059,0.068328,AP2_Q6_01,0.868214693094629
HP_REDUCED_TENDON_REFLEXES,SET,521,0.054787,0.0090977,0.036815,0.068362,HP_REDUCED_TENDON_REFLEXES,0.868214693094629
REACTOME_BETA_OXIDATION_OF_D...,SET,6,0.46316,0.0083718,0.31123,0.068364,REACTOME_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA,0.868214693094629
GOBP_INTRACELLULAR_CORTICOST...,SET,12,0.38274,0.0097823,0.2572,0.068373,GOBP_INTRACELLULAR_CORTICOSTEROID_RECEPTOR_SIGNALING_PATHWAY,0.868214693094629
GOMF_DYSTROGLYCAN_BINDING,SET,10,0.44666,0.010422,0.30022,0.068412,GOMF_DYSTROGLYCAN_BINDING,0.868392644265887
GSE24634_TEFF_VS_TCONV_DAY3_...2,SET,183,0.089788,0.0089198,0.06036,0.068446,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP,0.868469693877551
MIR5002_5P,SET,233,0.085186,0.0095359,0.05728,0.068493,MIR5002_5P,0.868469693877551
HP_PSYCHOTIC_EPISODES,SET,15,0.30269,0.0086488,0.20353,0.068494,HP_PSYCHOTIC_EPISODES,0.868469693877551
GSE3982_MAST_CELL_VS_EFF_MEM...1,SET,171,0.099359,0.0095446,0.066828,0.068545,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN,0.868469693877551
HP_ABNORMAL_REFLEX,SET,1088,0.03875,0.0091497,0.026064,0.068553,HP_ABNORMAL_REFLEX,0.868469693877551
GSE26928_EFF_MEM_VS_CENTR_ME...2,SET,164,0.10138,0.0095388,0.068193,0.068568,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP,0.868469693877551
GOMF_ALCOHOL_TRANSMEMBRANE_T...,SET,6,0.51162,0.0092479,0.34436,0.068687,GOMF_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.869406576839039
REACTOME_GLUCURONIDATION,SET,23,0.3857,0.013644,0.25962,0.068692,REACTOME_GLUCURONIDATION,0.869406576839039
KAAB_FAILED_HEART_ATRIUM_UP,SET,32,0.22523,0.0093951,0.15167,0.068788,KAAB_FAILED_HEART_ATRIUM_UP,0.869987564568934
HP_YELLOW_WHITE_LESIONS_OF_T...1,SET,16,0.331,0.0097674,0.22292,0.068808,HP_YELLOW_WHITE_LESIONS_OF_THE_MACULA,0.869987564568934
GOBP_NATURAL_KILLER_CELL_ACT...2,SET,29,0.27347,0.010861,0.18419,0.068813,GOBP_NATURAL_KILLER_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.869987564568934
GOBP_NEGATIVE_REGULATION_OF_...2,SET,40,0.18449,0.0086024,0.12436,0.068982,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,0.871753365419542
GOBP_MAINTENANCE_OF_LENS_TRA...,SET,7,0.56546,0.01104,0.38124,0.069015,GOBP_MAINTENANCE_OF_LENS_TRANSPARENCY,0.871753365419542
HOEK_T_CELL_2011_2012_TIV_AD...2,SET,8,0.45341,0.009463,0.30574,0.069048,HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_UP,0.871753365419542
GSE26928_CENTR_MEMORY_VS_CXC...2,SET,159,0.099083,0.0091811,0.066815,0.069053,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,0.871753365419542
HP_AXONAL_REGENERATION,SET,6,0.57851,0.010457,0.39017,0.069084,HP_AXONAL_REGENERATION,0.871828039215686
MIR1286,SET,80,0.14012,0.0092293,0.094526,0.069141,MIR1286,0.872178994920174
GSE17721_LPS_VS_PAM3CSK4_24H...2,SET,187,0.089637,0.0090006,0.060479,0.069162,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_UP,0.872178994920174
GSE22443_NAIVE_VS_ACT_AND_IL...1,SET,185,0.094375,0.009426,0.063696,0.069227,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN,0.872368091106291
GOMF_TRANSLATION_ELONGATION_...,SET,18,0.26928,0.0084278,0.18179,0.069279,GOMF_TRANSLATION_ELONGATION_FACTOR_ACTIVITY,0.872368091106291
GOMF_PHOSPHATIDYLINOSITOL_3_...5,SET,8,0.35494,0.0074078,0.23962,0.069281,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_3_PHOSPHATASE_ACTIVITY,0.872368091106291
HP_SELECTIVE_TOOTH_AGENESIS,SET,40,0.22674,0.010572,0.15311,0.069322,HP_SELECTIVE_TOOTH_AGENESIS,0.872368091106291
MORF_GMPS,SET,40,0.17673,0.0082406,0.11935,0.069337,MORF_GMPS,0.872368091106291
MIR4756_5P,SET,123,0.12046,0.009827,0.081356,0.06936,MIR4756_5P,0.872368091106291
KEGG_MEDICUS_REFERENCE_ARL8_...,SET,30,0.2307,0.0093186,0.15584,0.069396,KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,0.872368091106291
INSM2_TARGET_GENES,SET,747,0.046935,0.0092731,0.031708,0.069417,INSM2_TARGET_GENES,0.872368091106291
GOBP_MHC_CLASS_I_BIOSYNTHETI...,SET,8,0.53388,0.011142,0.36068,0.069418,GOBP_MHC_CLASS_I_BIOSYNTHETIC_PROCESS,0.872368091106291
QUEREC_MODEL_PBMC_YF_17D_VAC...1,SET,46,0.17919,0.0089585,0.12106,0.069428,QUEREC_MODEL_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_PREDICTIVE,0.872368091106291
REACTOME_EARLY_SARS_COV_2_IN...,SET,34,0.22318,0.0095957,0.15083,0.06949,REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS,0.872831568485725
BOYAULT_LIVER_CANCER_SUBCLAS...14,SET,26,0.29292,0.011016,0.19799,0.069519,BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,0.8728355409304
BLANCO_MELO_BETA_INTERFERON_...2,SET,337,0.075013,0.01007,0.05071,0.069543,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,0.8728355409304
HP_ABNORMAL_CORTICOSPINAL_TR...,SET,44,0.18588,0.0090892,0.12569,0.069592,HP_ABNORMAL_CORTICOSPINAL_TRACT_MORPHOLOGY,0.8728355409304
GOBP_GASTRIC_ACID_SECRETION,SET,13,0.36015,0.0095804,0.24354,0.069607,GOBP_GASTRIC_ACID_SECRETION,0.8728355409304
GOBP_NEGATIVE_REGULATION_OF_...379,SET,17,0.32087,0.0097599,0.21701,0.06963,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.8728355409304
HP_DIFFICULTY_CLIMBING_STAIRS,SET,58,0.16222,0.0091039,0.10972,0.069641,HP_DIFFICULTY_CLIMBING_STAIRS,0.8728355409304
GSE19888_CTRL_VS_T_CELL_MEMB...1,SET,186,0.092177,0.0092311,0.062356,0.069683,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN,0.873047103460706
GOBP_CELLULAR_RESPONSE_TO_BI...,SET,232,0.088564,0.0098929,0.059929,0.069737,GOBP_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS,0.873094176873199
HP_DYSGENESIS_OF_THE_HIPPOCA...,SET,15,0.30512,0.0087183,0.20647,0.069737,HP_DYSGENESIS_OF_THE_HIPPOCAMPUS,0.873094176873199
GSE2935_UV_INACTIVATED_VS_LI...1,SET,162,0.10426,0.0097504,0.070579,0.069825,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN,0.873190664347826
MIR6809_5P,SET,125,0.11461,0.0094247,0.077596,0.069852,MIR6809_5P,0.873190664347826
chr18q23,SET,15,0.50784,0.01451,0.34386,0.069862,chr18q23,0.873190664347826
GSE37416_CTRL_VS_6H_F_TULARE...2,SET,163,0.097202,0.0091184,0.065836,0.069922,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.873190664347826
WP_CAMKK2_PATHWAY,SET,32,0.2289,0.0095483,0.15509,0.069994,WP_CAMKK2_PATHWAY,0.873190664347826
GCM_ERBB2IP,SET,59,0.16047,0.0090828,0.10875,0.070034,GCM_ERBB2IP,0.873190664347826
GOBP_RESPONSE_TO_L_GLUTAMATE,SET,15,0.32671,0.009335,0.22143,0.070054,GOBP_RESPONSE_TO_L_GLUTAMATE,0.873190664347826
GOBP_POSITIVE_REGULATION_OF_...545,SET,14,0.38374,0.010593,0.26009,0.070063,GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.873190664347826
GOCC_GABA_RECEPTOR_COMPLEX,SET,18,0.37064,0.0116,0.25124,0.070081,GOCC_GABA_RECEPTOR_COMPLEX,0.873190664347826
GOCC_DERLIN_1_RETROTRANSLOCA...,SET,7,0.40552,0.0079171,0.27499,0.07016,GOCC_DERLIN_1_RETROTRANSLOCATION_COMPLEX,0.873190664347826
HP_PULMONARY_OPACITY,SET,22,0.28508,0.009863,0.19335,0.070191,HP_PULMONARY_OPACITY,0.873190664347826
MIR147B_5P,SET,285,0.07707,0.0095279,0.052272,0.070197,MIR147B_5P,0.873190664347826
TITF1_Q3,SET,214,0.087762,0.0094201,0.059529,0.070214,TITF1_Q3,0.873190664347826
REACTOME_PHOSPHORYLATION_OF_...2,SET,19,0.24807,0.0079765,0.1683,0.070257,REACTOME_PHOSPHORYLATION_OF_THE_APC_C,0.873190664347826
HP_MICROANGIOPATHIC_HEMOLYTI...,SET,9,0.44614,0.0098759,0.30269,0.070261,HP_MICROANGIOPATHIC_HEMOLYTIC_ANEMIA,0.873190664347826
MIR500A_5P,SET,140,0.10691,0.0093004,0.072576,0.070377,MIR500A_5P,0.873190664347826
HOXB7_TARGET_GENES,SET,24,0.25403,0.0091788,0.17247,0.070398,HOXB7_TARGET_GENES,0.873190664347826
HP_HYPEREXTENSIBILITY_OF_THE...2,SET,38,0.20173,0.0091683,0.13696,0.0704,HP_HYPEREXTENSIBILITY_OF_THE_KNEE,0.873190664347826
GOMF_HISTONE_DEACETYLASE_BIN...,SET,102,0.12532,0.0093156,0.085098,0.070424,GOMF_HISTONE_DEACETYLASE_BINDING,0.873190664347826
GOMF_ACETYLCHOLINE_RECEPTOR_...3,SET,7,0.56893,0.011107,0.38632,0.07043,GOMF_ACETYLCHOLINE_RECEPTOR_INHIBITOR_ACTIVITY,0.873190664347826
HP_CHOROIDEREMIA,SET,6,0.59288,0.010717,0.4026,0.070436,HP_CHOROIDEREMIA,0.873190664347826
GOBP_HEMATOPOIETIC_STEM_CELL...4,SET,5,0.53246,0.0087861,0.36157,0.070437,GOBP_HEMATOPOIETIC_STEM_CELL_MIGRATION_TO_BONE_MARROW,0.873190664347826
GSE42724_NAIVE_VS_MEMORY_BCE...2,SET,184,0.09083,0.0090477,0.061685,0.070453,GSE42724_NAIVE_VS_MEMORY_BCELL_UP,0.873190664347826
REACTOME_MITOPHAGY,SET,34,0.20594,0.0088547,0.13987,0.070466,REACTOME_MITOPHAGY,0.873190664347826
HP_DENTAL_MALOCCLUSION,SET,127,0.11544,0.0095686,0.078408,0.070474,HP_DENTAL_MALOCCLUSION,0.873190664347826
GOCC_PRESYNAPTIC_ACTIVE_ZONE...2,SET,30,0.24493,0.0098933,0.1664,0.070527,GOCC_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE,0.873190664347826
HP_ESOPHAGITIS,SET,33,0.2359,0.0099928,0.16027,0.070531,HP_ESOPHAGITIS,0.873190664347826
GOBP_POSITIVE_REGULATION_OF_...83,SET,7,0.46513,0.009081,0.31601,0.070536,GOBP_POSITIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.873190664347826
HP_FINGER_SYMPHALANGISM,SET,11,0.3995,0.0097762,0.27149,0.070589,HP_FINGER_SYMPHALANGISM,0.873190664347826
GSE22886_NAIVE_CD4_TCELL_VS_...1,SET,184,0.085319,0.0084987,0.05799,0.070619,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN,0.873190664347826
REACTOME_REGULATION_OF_CYTOS...,SET,7,0.46808,0.0091385,0.31815,0.07062,REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS,0.873190664347826
GOBP_SINOATRIAL_NODE_CELL_DE...,SET,5,0.65311,0.010777,0.44397,0.070644,GOBP_SINOATRIAL_NODE_CELL_DEVELOPMENT,0.873190664347826
HP_CHROMOSOMAL_BREAKAGE_INDU...2,SET,13,0.30986,0.0082426,0.21074,0.070747,HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_IONIZING_RADIATION,0.873190664347826
MIR12119,SET,173,0.092506,0.0089377,0.062918,0.070754,MIR12119,0.873190664347826
TESAR_ALK_TARGETS_EPISC_4D_UP,SET,5,0.58511,0.009655,0.39799,0.070769,TESAR_ALK_TARGETS_EPISC_4D_UP,0.873190664347826
SARTIPY_BLUNTED_BY_INSULIN_R...1,SET,17,0.33818,0.010286,0.23004,0.070779,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,0.873190664347826
GOMF_DELAYED_RECTIFIER_POTAS...,SET,27,0.28697,0.010997,0.19528,0.070854,GOMF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.873190664347826
GTACAGG_MIR486,SET,53,0.1671,0.0089656,0.11373,0.070883,GTACAGG_MIR486,0.873190664347826
GOBP_RUFFLE_ASSEMBLY,SET,42,0.2058,0.0098326,0.14009,0.07092,GOBP_RUFFLE_ASSEMBLY,0.873190664347826
GSE8621_UNSTIM_VS_LPS_STIM_M...1,SET,175,0.091323,0.0088738,0.062197,0.071021,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.873190664347826
GOBP_FUNGIFORM_PAPILLA_MORPH...,SET,4,0.71073,0.01049,0.48406,0.071022,GOBP_FUNGIFORM_PAPILLA_MORPHOGENESIS,0.873190664347826
GSE3982_EOSINOPHIL_VS_BASOPH...1,SET,177,0.092377,0.0090268,0.062924,0.071051,GSE3982_EOSINOPHIL_VS_BASOPHIL_DN,0.873190664347826
GOBP_REGULATION_OF_BEHAVIOR,SET,70,0.16634,0.010252,0.11332,0.071091,GOBP_REGULATION_OF_BEHAVIOR,0.873190664347826
GSE5589_IL6_KO_VS_IL10_KO_LP...1,SET,179,0.09421,0.0092573,0.064187,0.071097,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.873190664347826
GENTILE_UV_RESPONSE_CLUSTER_...4,SET,35,0.20527,0.0089543,0.13988,0.071138,GENTILE_UV_RESPONSE_CLUSTER_D5,0.873190664347826
MORF_CSNK1D,SET,65,0.14603,0.0086736,0.099517,0.071151,MORF_CSNK1D,0.873190664347826
CUI_DEVELOPING_HEART_RIGHT_A...,SET,36,0.21528,0.009524,0.14672,0.071156,CUI_DEVELOPING_HEART_RIGHT_ATRIAL_CARDIOMYOCYTE,0.873190664347826
GOBP_REGULATION_OF_HEPATIC_S...,SET,7,0.55653,0.010865,0.37931,0.071165,GOBP_REGULATION_OF_HEPATIC_STELLATE_CELL_ACTIVATION,0.873190664347826
HP_NEPHROCALCINOSIS,SET,86,0.14432,0.0098547,0.09837,0.071182,HP_NEPHROCALCINOSIS,0.873190664347826
GSE22432_UNTREATED_VS_TGFB1_...2,SET,186,0.091092,0.0091225,0.06209,0.071185,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_UP,0.873190664347826
GOBP_MONOATOMIC_ANION_HOMEOS...,SET,20,0.28191,0.0092997,0.19221,0.071243,GOBP_MONOATOMIC_ANION_HOMEOSTASIS,0.873190664347826
MIR3938,SET,68,0.14831,0.0090096,0.10112,0.071249,MIR3938,0.873190664347826
MIR6807_5P,SET,53,0.16205,0.0086946,0.11052,0.071302,MIR6807_5P,0.873190664347826
GSE39820_TGFBETA3_IL6_VS_TGF...2,SET,181,0.09305,0.0091938,0.063463,0.071302,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP,0.873190664347826
MIR4283,SET,185,0.091881,0.009177,0.06267,0.07132,MIR4283,0.873190664347826
GOBP_NEGATIVE_REGULATION_OF_...686,SET,15,0.31209,0.0089172,0.21288,0.071334,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,0.873190664347826
GOBP_LOW_DENSITY_LIPOPROTEIN...1,SET,27,0.25874,0.0099153,0.17653,0.071381,GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.873190664347826
MIR517A_3P_MIR517B_3P_MIR517...,SET,19,0.27925,0.0089792,0.19053,0.071384,MIR517A_3P_MIR517B_3P_MIR517C_3P,0.873190664347826
REACTOME_PTK6_REGULATES_PROT...,SET,5,0.61924,0.010218,0.42251,0.071386,REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING,0.873190664347826
GOBP_POSITIVE_REGULATION_OF_...808,SET,8,0.46421,0.0096884,0.31675,0.071392,GOBP_POSITIVE_REGULATION_OF_T_CELL_TOLERANCE_INDUCTION,0.873190664347826
GSE24081_CONTROLLER_VS_PROGR...2,SET,178,0.09839,0.0096413,0.06714,0.071408,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP,0.873190664347826
GSE1740_MCSF_VS_MCSF_AND_IFN...4,SET,184,0.089656,0.0089308,0.061192,0.071447,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP,0.873190664347826
YAMASHITA_LIVER_CANCER_WITH_...1,SET,14,0.31736,0.0087608,0.21665,0.071488,YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN,0.873190664347826
GOBP_EPITHELIAL_MESENCHYMAL_...,SET,5,0.68814,0.011355,0.46978,0.071496,GOBP_EPITHELIAL_MESENCHYMAL_CELL_SIGNALING,0.873190664347826
GOBP_HARD_PALATE_DEVELOPMENT,SET,8,0.55422,0.011567,0.37843,0.071534,GOBP_HARD_PALATE_DEVELOPMENT,0.873190664347826
GOBP_POSITIVE_REGULATION_OF_...460,SET,7,0.51657,0.010085,0.35278,0.07157,GOBP_POSITIVE_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,0.873190664347826
HP_ECTROPION,SET,58,0.14765,0.0082862,0.10085,0.071587,HP_ECTROPION,0.873190664347826
GOCC_INTERMEDIATE_FILAMENT_C...,SET,208,0.10713,0.011338,0.073182,0.071626,GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON,0.873190664347826
GSE9988_LOW_LPS_VS_ANTI_TREM...1,SET,171,0.09902,0.0095121,0.067663,0.071683,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,0.873190664347826
HP_MYOCLONIC_ABSENCE_SEIZURE,SET,14,0.34183,0.0094361,0.23358,0.071685,HP_MYOCLONIC_ABSENCE_SEIZURE,0.873190664347826
PID_RET_PATHWAY,SET,39,0.19945,0.009183,0.13629,0.071689,PID_RET_PATHWAY,0.873190664347826
GOBP_REGULATION_OF_PROSTAGLA...,SET,14,0.39733,0.010968,0.27152,0.071694,GOBP_REGULATION_OF_PROSTAGLANDIN_SECRETION,0.873190664347826
HP_LOSS_OF_CONSCIOUSNESS,SET,23,0.26822,0.0094878,0.1833,0.071701,HP_LOSS_OF_CONSCIOUSNESS,0.873190664347826
MIR4662A_5P,SET,81,0.14065,0.0093222,0.096129,0.071721,MIR4662A_5P,0.873190664347826
GSE16451_CTRL_VS_WEST_EQUINE...4,SET,181,0.089267,0.0088199,0.061014,0.071734,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.873190664347826
GOBP_ADENOSINE_TO_INOSINE_ED...,SET,6,0.56346,0.010185,0.38513,0.071739,GOBP_ADENOSINE_TO_INOSINE_EDITING,0.873190664347826
HOELZEL_NF1_TARGETS_DN,SET,99,0.14164,0.010373,0.096815,0.071745,HOELZEL_NF1_TARGETS_DN,0.873190664347826
HP_URINARY_BLADDER_SPHINCTER...,SET,28,0.21883,0.0085395,0.14958,0.071747,HP_URINARY_BLADDER_SPHINCTER_DYSFUNCTION,0.873190664347826
GOCC_INTEGRATOR_COMPLEX,SET,13,0.35202,0.0093642,0.24063,0.071759,GOCC_INTEGRATOR_COMPLEX,0.873190664347826
REACTOME_CHYLOMICRON_REMODEL...,SET,8,0.56962,0.011888,0.38945,0.071791,REACTOME_CHYLOMICRON_REMODELING,0.873190664347826
PURWIN_MEWO_SOX10_TARGETS,SET,82,0.14234,0.009492,0.097339,0.071833,PURWIN_MEWO_SOX10_TARGETS,0.873190664347826
GOMF_TRANSCRIPTION_COREGULAT...2,SET,105,0.12591,0.0094949,0.086104,0.071841,GOMF_TRANSCRIPTION_COREGULATOR_BINDING,0.873190664347826
LAKE_ADULT_KIDNEY_C4_PROXIMA...,SET,159,0.11012,0.010204,0.075322,0.071874,LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2,0.873190664347826
HP_REDUCED_CIRCULATING_PROLA...,SET,20,0.26967,0.0088962,0.18449,0.071918,HP_REDUCED_CIRCULATING_PROLACTIN_CONCENTRATION,0.873190664347826
GOCC_SPERM_ANNULUS,SET,2,0.99524,0.010387,0.68102,0.071961,GOCC_SPERM_ANNULUS,0.873190664347826
GOBP_CEREBRAL_CORTEX_GABAERG...2,SET,9,0.48568,0.010751,0.33237,0.071982,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DIFFERENTIATION,0.873190664347826
MIR4639_3P,SET,66,0.15784,0.0094473,0.10804,0.072021,MIR4639_3P,0.873190664347826
GSE3982_BCELL_VS_TH2_UP,SET,173,0.094173,0.0090987,0.064462,0.072029,GSE3982_BCELL_VS_TH2_UP,0.873190664347826
MIR6758_3P,SET,99,0.12802,0.0093758,0.087638,0.072047,MIR6758_3P,0.873190664347826
chr7p15,SET,40,0.33809,0.015764,0.23145,0.072049,chr7p15,0.873190664347826
HP_VERTEBRAL_FUSION,SET,63,0.15527,0.0090802,0.10631,0.072083,HP_VERTEBRAL_FUSION,0.873190664347826
MIR3922_3P,SET,89,0.12485,0.0086721,0.085515,0.072153,MIR3922_3P,0.873190664347826
MIR3609,SET,324,0.072015,0.0094824,0.049327,0.072159,MIR3609,0.873190664347826
HP_PROGRESSIVE_PULMONARY_FUN...,SET,13,0.3195,0.0084993,0.21887,0.07218,HP_PROGRESSIVE_PULMONARY_FUNCTION_IMPAIRMENT,0.873190664347826
GSE3982_MAC_VS_TH2_UP,SET,181,0.094672,0.009354,0.064864,0.072215,GSE3982_MAC_VS_TH2_UP,0.873190664347826
GSE37534_GW1929_VS_ROSIGLITA...2,SET,149,0.10013,0.0089845,0.068609,0.072225,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,0.873190664347826
REACTOME_ACTIVATION_OF_SMO,SET,17,0.30389,0.0092434,0.20822,0.072226,REACTOME_ACTIVATION_OF_SMO,0.873190664347826
GSE36078_UNTREATED_VS_AD5_T4...1,SET,181,0.094351,0.0093223,0.064648,0.072227,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_DN,0.873190664347826
WP_MAPK_AND_NFKB_SIGNALING_I...,SET,11,0.37778,0.0092448,0.25886,0.072232,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,0.873190664347826
GOBP_ONE_CARBON_COMPOUND_TRA...,SET,22,0.32278,0.011167,0.22126,0.072313,GOBP_ONE_CARBON_COMPOUND_TRANSPORT,0.873598394160584
GOCC_EUCHROMATIN,SET,49,0.17136,0.0088414,0.11747,0.072316,GOCC_EUCHROMATIN,0.873598394160584
HP_AORTIC_VALVE_CALCIFICATION,SET,8,0.48114,0.010042,0.32987,0.072349,HP_AORTIC_VALVE_CALCIFICATION,0.87369336170952
GSE6090_UNSTIM_VS_DC_SIGN_ST...2,SET,153,0.092378,0.0083982,0.063343,0.072377,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_UP,0.873727903786037
GSE27786_CD4_TCELL_VS_NEUTRO...2,SET,178,0.090544,0.0088724,0.062101,0.072429,GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP,0.873951979528105
HP_KINKED_BRAINSTEM,SET,4,0.57123,0.0084311,0.39187,0.072471,HP_KINKED_BRAINSTEM,0.873951979528105
HP_MENINGOENCEPHALOCELE,SET,4,0.57123,0.0084311,0.39187,0.072471,HP_MENINGOENCEPHALOCELE,0.873951979528105
GOBP_ADENOSINE_METABOLIC_PRO...,SET,9,0.49617,0.010983,0.34056,0.072579,GOBP_ADENOSINE_METABOLIC_PROCESS,0.874950796045786
HP_HYPOPLASIA_OF_THE_VAGINA,SET,13,0.37008,0.0098446,0.25408,0.072635,HP_HYPOPLASIA_OF_THE_VAGINA,0.875070508826584
GSE29618_LAIV_VS_TIV_FLU_VAC...6,SET,167,0.094258,0.0089491,0.064727,0.072674,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP,0.875070508826584
RIZ_ERYTHROID_DIFFERENTIATION,SET,74,0.13813,0.0087522,0.094865,0.072694,RIZ_ERYTHROID_DIFFERENTIATION,0.875070508826584
HP_RESPIRATORY_ALKALOSIS,SET,5,0.54783,0.0090398,0.3763,0.07273,HP_RESPIRATORY_ALKALOSIS,0.875070508826584
MANNE_COVID19_NONICU_VS_HEAL...1,SET,179,0.1011,0.0099338,0.069445,0.072739,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,0.875070508826584
GSE3691_IFN_PRODUCING_KILLER...3,SET,176,0.091466,0.0089127,0.062831,0.07274,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN,0.875070508826584
REACTOME_TP53_REGULATES_TRAN...6,SET,57,0.13658,0.0075984,0.093849,0.072805,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES,0.875402832929782
GOBP_INTERLEUKIN_3_MEDIATED_...,SET,6,0.59229,0.010706,0.40702,0.072818,GOBP_INTERLEUKIN_3_MEDIATED_SIGNALING_PATHWAY,0.875402832929782
WP_MULTIPLE_EPIPHYSEAL_DYSPL...,SET,6,0.55317,0.0099989,0.38025,0.072879,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,0.875590535776011
GSE46025_WT_VS_FOXO1_KO_KLRG...2,SET,166,0.093585,0.0088588,0.064332,0.072884,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_UP,0.875590535776011
GOCC_WEIBEL_PALADE_BODY,SET,5,0.56213,0.0092758,0.38654,0.072946,GOCC_WEIBEL_PALADE_BODY,0.876032560469938
GOBP_REGULATION_OF_RELEASE_O...2,SET,77,0.15059,0.0097322,0.10357,0.072988,GOBP_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,0.876234176165803
MIR6086,SET,49,0.17904,0.0092376,0.12316,0.073014,MIR6086,0.876243636049724
GSE37534_UNTREATED_VS_GW1929...1,SET,186,0.088615,0.0088744,0.060973,0.073074,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.876307942393929
HP_AXONAL_DEGENERATION_REGEN...,SET,9,0.38785,0.0085854,0.26687,0.073077,HP_AXONAL_DEGENERATION_REGENERATION,0.876307942393929
GSE19941_UNSTIM_VS_LPS_STIM_...3,SET,174,0.095524,0.0092557,0.065734,0.073095,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.876307942393929
HP_SUDDEN_DEATH,SET,123,0.12018,0.0098042,0.08274,0.073191,HP_SUDDEN_DEATH,0.877156277586207
GTAAACC_MIR2995P,SET,42,0.19463,0.0092989,0.13402,0.073221,GTAAACC_MIR2995P,0.877213324715615
GOBP_VIRION_ASSEMBLY,SET,33,0.20432,0.0086548,0.14072,0.073271,GOBP_VIRION_ASSEMBLY,0.877488975903614
GSE5589_UNSTIM_VS_45MIN_LPS_...6,SET,183,0.092707,0.0092098,0.063869,0.073328,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_UP,0.877488975903614
PID_ERBB1_INTERNALIZATION_PA...,SET,40,0.19328,0.0090124,0.13317,0.073338,PID_ERBB1_INTERNALIZATION_PATHWAY,0.877488975903614
GOBP_ENDOSOME_TO_LYSOSOME_TR...1,SET,68,0.15256,0.009268,0.10512,0.073345,GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT,0.877488975903614
YAO_TEMPORAL_RESPONSE_TO_PRO...3,SET,63,0.14881,0.0087025,0.10255,0.073384,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,0.877638472652219
GSE37605_NOD_VS_C57BL6_IRES_...1,SET,143,0.10362,0.0091096,0.071416,0.073408,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_DN,0.877638472652219
GOBP_SYNAPTIC_TRANSMISSION_C...,SET,31,0.23354,0.0095887,0.16104,0.073516,GOBP_SYNAPTIC_TRANSMISSION_CHOLINERGIC,0.87777552523172
MOREIRA_RESPONSE_TO_TSA_UP,SET,25,0.24671,0.0090979,0.17013,0.073518,MOREIRA_RESPONSE_TO_TSA_UP,0.87777552523172
REACTOME_TRANSPORT_OF_FATTY_...,SET,8,0.4192,0.0087489,0.28908,0.073526,REACTOME_TRANSPORT_OF_FATTY_ACIDS,0.87777552523172
GOBP_REGULATION_OF_BRANCHING...1,SET,6,0.56858,0.010277,0.39211,0.07353,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS,0.87777552523172
DESCARTES_FETAL_EYE_VASCULAR...,SET,81,0.15033,0.0099634,0.10368,0.073548,DESCARTES_FETAL_EYE_VASCULAR_ENDOTHELIAL_CELLS,0.87777552523172
GSE7852_TREG_VS_TCONV_LN_DN,SET,182,0.097317,0.0096416,0.067126,0.073571,GSE7852_TREG_VS_TCONV_LN_DN,0.87777552523172
GSE4590_SMALL_VS_LARGE_PRE_B...2,SET,164,0.096082,0.0090407,0.066294,0.07363,GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP,0.877814043209877
GOBP_EXTRACELLULAR_REGULATIO...,SET,12,0.39424,0.010076,0.27201,0.073632,GOBP_EXTRACELLULAR_REGULATION_OF_SIGNAL_TRANSDUCTION,0.877814043209877
LIN_TUMOR_ESCAPE_FROM_IMMUNE...,SET,17,0.31652,0.0096275,0.21841,0.07365,LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,0.877814043209877
GSE10856_CTRL_VS_TNFRSF6B_IN...1,SET,164,0.093482,0.008796,0.064531,0.073728,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN,0.87844245457662
REACTOME_SIGNALING_BY_CYTOSO...,SET,17,0.34158,0.01039,0.23597,0.07388,REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS,0.879951816312543
WRN_TARGET_GENES,SET,10,0.35989,0.0083972,0.24866,0.073917,WRN_TARGET_GENES,0.880075155821918
KEGG_MEDICUS_VARIANT_MUTATIO...42,SET,5,0.4518,0.0074553,0.31221,0.073941,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_II,0.880075155821918
MODULE_109,SET,35,0.22751,0.0099247,0.15726,0.073992,MODULE_109,0.880380677850051
MIR6818_5P,SET,100,0.12632,0.0092976,0.087329,0.074031,MIR6818_5P,0.880543259753593
VALK_AML_CLUSTER_7,SET,25,0.25423,0.0093754,0.17582,0.074104,VALK_AML_CLUSTER_7,0.88057857727738
MANNO_MIDBRAIN_NEUROTYPES_HR...4,SET,296,0.077727,0.0097898,0.05377,0.074163,MANNO_MIDBRAIN_NEUROTYPES_HRGL2C,0.88057857727738
GOBP_REGULATION_OF_ER_TO_GOL...,SET,10,0.3569,0.0083274,0.24692,0.074183,GOBP_REGULATION_OF_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.88057857727738
CUI_TCF21_TARGETS_UP,SET,35,0.22697,0.0099011,0.15704,0.074189,CUI_TCF21_TARGETS_UP,0.88057857727738
DER_IFN_BETA_RESPONSE_UP,SET,98,0.1271,0.0092616,0.087944,0.074205,DER_IFN_BETA_RESPONSE_UP,0.88057857727738
REACTOME_PYRIMIDINE_CATABOLI...,SET,12,0.37094,0.0094807,0.25669,0.074227,REACTOME_PYRIMIDINE_CATABOLISM,0.88057857727738
HP_APLASIA_CUTIS_CONGENITA,SET,37,0.20305,0.0091065,0.14052,0.074238,HP_APLASIA_CUTIS_CONGENITA,0.88057857727738
GOBP_ICOSANOID_METABOLIC_PRO...,SET,110,0.12197,0.0094132,0.084419,0.074261,GOBP_ICOSANOID_METABOLIC_PROCESS,0.88057857727738
FAN_EMBRYONIC_CTX_NSC_1,SET,16,0.34228,0.0101,0.2369,0.074262,FAN_EMBRYONIC_CTX_NSC_1,0.88057857727738
GOMF_PYRUVATE_DEHYDROGENASE_...2,SET,5,0.56189,0.0092717,0.38897,0.0743,GOMF_PYRUVATE_DEHYDROGENASE_ACETYL_TRANSFERRING_PHOSPHATASE_ACTIVITY,0.880728683492497
GOBP_POSITIVE_REGULATION_OF_...174,SET,22,0.28423,0.0098334,0.19682,0.074361,GOBP_POSITIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.881065186567164
GOMF_LIGAND_GATED_CHANNEL_AC...,SET,177,0.10103,0.009872,0.06998,0.074428,GOMF_LIGAND_GATED_CHANNEL_ACTIVITY,0.881065186567164
REACTOME_DISINHIBITION_OF_SN...,SET,5,0.49087,0.0080999,0.34007,0.074459,REACTOME_DISINHIBITION_OF_SNARE_FORMATION,0.881065186567164
ATGTAGC_MIR221_MIR222,SET,130,0.11734,0.0098394,0.0813,0.074474,ATGTAGC_MIR221_MIR222,0.881065186567164
DESCARTES_FETAL_THYMUS_VASCU...,SET,112,0.12921,0.010061,0.089545,0.074525,DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS,0.881065186567164
REACTOME_SYNTHESIS_OF_PIPS_A...2,SET,5,0.59357,0.0097946,0.41142,0.074557,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE,0.881065186567164
HP_THIN_VERMILION_BORDER,SET,346,0.066145,0.0089948,0.045848,0.074561,HP_THIN_VERMILION_BORDER,0.881065186567164
REACTOME_PHASE_I_FUNCTIONALI...,SET,99,0.13997,0.010251,0.097022,0.074565,REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,0.881065186567164
HP_VENTRICULAR_FIBRILLATION,SET,52,0.17719,0.0094171,0.12284,0.074599,HP_VENTRICULAR_FIBRILLATION,0.881065186567164
TCGATGG_MIR213,SET,5,0.49872,0.0082294,0.34581,0.074638,TCGATGG_MIR213,0.881065186567164
chr5q11,SET,34,0.36271,0.015595,0.25157,0.074691,chr5q11,0.881065186567164
GOBP_MYELOID_LEUKOCYTE_MEDIA...,SET,107,0.12123,0.0092286,0.084092,0.074703,GOBP_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.881065186567164
GOBP_POSITIVE_REGULATION_OF_...566,SET,62,0.16586,0.0096228,0.11506,0.074718,GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.881065186567164
HP_ABNORMALITY_OF_THE_PROXIM...2,SET,7,0.44315,0.0086518,0.30742,0.074729,HP_ABNORMALITY_OF_THE_PROXIMAL_PHALANX_OF_THE_THUMB,0.881065186567164
MIR3126_3P,SET,43,0.18577,0.0089801,0.12887,0.07473,MIR3126_3P,0.881065186567164
REACTOME_NEGATIVE_REGULATION...1,SET,10,0.40601,0.0094735,0.28166,0.074734,REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS,0.881065186567164
OHASHI_AURKB_TARGETS,SET,7,0.46915,0.0091593,0.32552,0.074767,OHASHI_AURKB_TARGETS,0.881155335707019
GOBP_MONOCYTE_CHEMOTACTIC_PR...,SET,18,0.34178,0.010697,0.23721,0.074829,GOBP_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,0.88134300304878
HP_SINUS_BRADYCARDIA,SET,30,0.23749,0.0095927,0.16485,0.074853,HP_SINUS_BRADYCARDIA,0.88134300304878
GSE37533_PPARG2_FOXP3_VS_FOX...4,SET,175,0.092764,0.0090137,0.064393,0.074859,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,0.88134300304878
MODULE_264,SET,10,0.37665,0.0087884,0.2615,0.074895,MODULE_264,0.881468244158483
MIR633,SET,128,0.1074,0.0089365,0.074574,0.074922,MIR633,0.881487511848341
GOBP_REGULATION_OF_MESENCHYM...2,SET,10,0.41867,0.0097688,0.29086,0.075025,GOBP_REGULATION_OF_MESENCHYMAL_STEM_CELL_DIFFERENTIATION,0.882400634517766
GOCC_EMC_COMPLEX,SET,8,0.40823,0.0085201,0.28371,0.075097,GOCC_EMC_COMPLEX,0.882920392289483
GOBP_REGULATION_OF_MICROGLIA...,SET,17,0.3059,0.0093045,0.21262,0.07512,GOBP_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,0.882920392289483
GOBP_REGULATION_OF_AXON_EXTE...2,SET,15,0.32876,0.0093938,0.22863,0.075228,GOBP_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,0.883796792580101
EPPERT_PROGENITOR,SET,124,0.10842,0.0088807,0.075413,0.075266,EPPERT_PROGENITOR,0.883796792580101
GOBP_CELLULAR_RESPONSE_TO_TY...,SET,91,0.13137,0.0092262,0.091384,0.075288,GOBP_CELLULAR_RESPONSE_TO_TYPE_II_INTERFERON,0.883796792580101
GOBP_POSITIVE_REGULATION_OF_...272,SET,9,0.40445,0.0089529,0.28138,0.075315,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,0.883796792580101
MIR548AJ_5P_MIR548G_5P_MIR54...,SET,446,0.060831,0.0093656,0.042325,0.075334,MIR548AJ_5P_MIR548G_5P_MIR548X_5P,0.883796792580101
WP_COMPLEMENT_SYSTEM,SET,89,0.14156,0.0098327,0.098504,0.075351,WP_COMPLEMENT_SYSTEM,0.883796792580101
HP_HYPERNATREMIA,SET,8,0.47498,0.0099132,0.33057,0.075387,HP_HYPERNATREMIA,0.883796792580101
AMIT_SERUM_RESPONSE_60_MCF10A,SET,54,0.19321,0.010463,0.13447,0.075398,AMIT_SERUM_RESPONSE_60_MCF10A,0.883796792580101
PID_INSULIN_GLUCOSE_PATHWAY,SET,26,0.2369,0.0089089,0.16492,0.075443,PID_INSULIN_GLUCOSE_PATHWAY,0.884026117666891
CACTTTG_MIR520G_MIR520H,SET,215,0.085992,0.0092514,0.059889,0.07553,CACTTTG_MIR520G_MIR520H,0.884649323232323
REACTOME_CGMP_EFFECTS,SET,15,0.34558,0.0098742,0.24073,0.075573,REACTOME_CGMP_EFFECTS,0.884649323232323
SCHLOSSER_MYC_TARGETS_REPRES...,SET,140,0.097646,0.0084946,0.06802,0.075575,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,0.884649323232323
GSE3982_NEUTROPHIL_VS_BCELL_...2,SET,168,0.099857,0.0095088,0.069568,0.075598,GSE3982_NEUTROPHIL_VS_BCELL_UP,0.884649323232323
HP_WIDOW_S_PEAK,SET,14,0.32872,0.0090742,0.2291,0.075681,HP_WIDOW_S_PEAK,0.884861135678392
GOMF_ATP_ACTIVATED_INWARD_RE...,SET,6,0.61703,0.011153,0.43009,0.075703,GOMF_ATP_ACTIVATED_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.884861135678392
GOBP_REGULATION_OF_SULFUR_ME...,SET,12,0.39256,0.010033,0.27365,0.075721,GOBP_REGULATION_OF_SULFUR_METABOLIC_PROCESS,0.884861135678392
GOMF_CYCLIC_NUCLEOTIDE_BINDI...,SET,36,0.21016,0.0092972,0.1465,0.075721,GOMF_CYCLIC_NUCLEOTIDE_BINDING,0.884861135678392
GSE40274_CTRL_VS_FOXP3_AND_H...2,SET,187,0.088473,0.0088837,0.061709,0.075836,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.884861135678392
GSE9006_HEALTHY_VS_TYPE_1_DI...6,SET,169,0.092211,0.0088065,0.064322,0.075854,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP,0.884861135678392
HP_ORTHOSTATIC_HYPOTENSION_D...,SET,15,0.35569,0.010163,0.24814,0.075874,HP_ORTHOSTATIC_HYPOTENSION_DUE_TO_AUTONOMIC_DYSFUNCTION,0.884861135678392
GOBP_CORTICAL_CYTOSKELETON_O...,SET,51,0.16225,0.0085398,0.1132,0.075889,GOBP_CORTICAL_CYTOSKELETON_ORGANIZATION,0.884861135678392
HE_LIM_SUN_FETAL_LUNG_C1_LAT...1,SET,22,0.30437,0.01053,0.21237,0.075912,HE_LIM_SUN_FETAL_LUNG_C1_LATE_AIRWAY_PROGENITOR_CELL,0.884861135678392
chr11q12,SET,178,0.21137,0.020712,0.14749,0.075923,chr11q12,0.884861135678392
REACTOME_CYTOCHROME_P450_ARR...,SET,63,0.17707,0.010355,0.12357,0.075946,REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE,0.884861135678392
DESCARTES_MAIN_FETAL_ELF3_AG...,SET,127,0.10043,0.0083239,0.070086,0.075952,DESCARTES_MAIN_FETAL_ELF3_AGBL2_POSITIVE_CELLS,0.884861135678392
GOCC_MHC_CLASS_II_PROTEIN_CO...,SET,13,0.42073,0.011192,0.29365,0.075973,GOCC_MHC_CLASS_II_PROTEIN_COMPLEX,0.884861135678392
GOCC_CHROMOSOME_TELOMERIC_RE...1,SET,134,0.098767,0.0084074,0.068941,0.075991,GOCC_CHROMOSOME_TELOMERIC_REGION,0.884861135678392
GOMF_2_ACYLGLYCEROL_O_ACYLTR...,SET,6,0.53152,0.0096075,0.37102,0.075998,GOMF_2_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,0.884861135678392
GOBP_REGULATION_OF_VERY_LOW_...2,SET,5,0.66679,0.011003,0.46555,0.076042,GOBP_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,0.885076929002009
ZNF214_TARGET_GENES,SET,12,0.36908,0.0094331,0.25778,0.076117,ZNF214_TARGET_GENES,0.885642457372116
GOBP_REGULATION_OF_NATURAL_K...6,SET,12,0.4031,0.010303,0.28159,0.076147,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION,0.885642457372116
ALPHACP1_01,SET,224,0.083668,0.0091855,0.058454,0.076174,ALPHACP1_01,0.885642457372116
KEGG_MEDICUS_REFERENCE_ISOLE...,SET,9,0.41101,0.0090981,0.2872,0.076212,KEGG_MEDICUS_REFERENCE_ISOLEUCINE_DEGRADATION,0.885642457372116
NCX_01,SET,160,0.098692,0.0091733,0.068965,0.076218,NCX_01,0.885642457372116
GOBP_POSITIVE_REGULATION_OF_...674,SET,85,0.13985,0.0094943,0.097754,0.076273,GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,0.885700925492816
GSE37301_HEMATOPOIETIC_STEM_...3,SET,186,0.09515,0.0095288,0.066508,0.076274,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_DN,0.885700925492816
HP_GLOBAL_BRAIN_ATROPHY,SET,58,0.15898,0.0089217,0.11116,0.076351,HP_GLOBAL_BRAIN_ATROPHY,0.886090093457944
GOBP_CHOLINE_METABOLIC_PROCE...,SET,6,0.5617,0.010153,0.39279,0.076366,GOBP_CHOLINE_METABOLIC_PROCESS,0.886090093457944
GOMF_CHLORIDE_CHANNEL_ACTIVI...,SET,72,0.16078,0.010049,0.11245,0.076384,GOMF_CHLORIDE_CHANNEL_ACTIVITY,0.886090093457944
GOBP_PROSTATE_GLAND_GROWTH,SET,10,0.46751,0.010908,0.32704,0.076434,GOBP_PROSTATE_GLAND_GROWTH,0.886096050350117
GSE33513_TCF7_KO_VS_HET_EARL...2,SET,178,0.097545,0.0095584,0.068238,0.076443,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP,0.886096050350117
HP_ABNORMAL_ORAL_MUCOSA_MORP...,SET,336,0.070313,0.009425,0.049193,0.076461,HP_ABNORMAL_ORAL_MUCOSA_MORPHOLOGY,0.886096050350117
GOBP_METANEPHRIC_NEPHRON_DEV...,SET,40,0.22413,0.010451,0.15685,0.076511,GOBP_METANEPHRIC_NEPHRON_DEVELOPMENT,0.88614320754717
GOBP_POLYOL_BIOSYNTHETIC_PRO...,SET,58,0.15539,0.0087203,0.10875,0.076533,GOBP_POLYOL_BIOSYNTHETIC_PROCESS,0.88614320754717
MODULE_277,SET,47,0.16344,0.0082593,0.1144,0.076562,MODULE_277,0.88614320754717
GSE9037_CTRL_VS_LPS_4H_STIM_...4,SET,173,0.091722,0.008862,0.064207,0.076578,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP,0.88614320754717
GOMF_SECONDARY_ACTIVE_TRANSM...,SET,274,0.076158,0.0092345,0.053319,0.076605,GOMF_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.88614320754717
GOCC_CATION_CHANNEL_COMPLEX,SET,195,0.09563,0.0098035,0.066961,0.076633,GOCC_CATION_CHANNEL_COMPLEX,0.88614320754717
GOBP_NEGATIVE_REGULATION_OF_...236,SET,5,0.63346,0.010453,0.44358,0.076646,GOBP_NEGATIVE_REGULATION_OF_FEEDING_BEHAVIOR,0.88614320754717
WP_TRANSCRIPTION_FACTOR_REGU...,SET,21,0.31229,0.010556,0.21875,0.076709,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,0.88614320754717
HP_MORNING_GLORY_ANOMALY,SET,6,0.57498,0.010393,0.40278,0.076721,HP_MORNING_GLORY_ANOMALY,0.88614320754717
KEGG_MEDICUS_REFERENCE_GATOR...,SET,13,0.31965,0.0085031,0.22393,0.076734,KEGG_MEDICUS_REFERENCE_GATOR1_MTORC1_SIGNALING_PATHWAY,0.88614320754717
GOBP_NEGATIVE_REGULATION_OF_...342,SET,67,0.16233,0.0097886,0.11373,0.076756,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,0.88614320754717
GOBP_CENTRIOLE_ELONGATION,SET,7,0.43675,0.0085269,0.30614,0.07685,GOBP_CENTRIOLE_ELONGATION,0.88614320754717
LU_TUMOR_ANGIOGENESIS_UP,SET,25,0.26034,0.0096007,0.18249,0.076857,LU_TUMOR_ANGIOGENESIS_UP,0.88614320754717
HP_SECONDARY_GROWTH_HORMONE_...,SET,15,0.28231,0.0080665,0.19791,0.076872,HP_SECONDARY_GROWTH_HORMONE_DEFICIENCY,0.88614320754717
GSE40666_UNTREATED_VS_IFNA_S...3,SET,177,0.087752,0.0085749,0.061526,0.076907,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_DN,0.88614320754717
GSE13485_DAY3_VS_DAY7_YF17D_...1,SET,175,0.094561,0.0091884,0.066302,0.07691,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN,0.88614320754717
GOBP_POSITIVE_REGULATION_OF_...160,SET,20,0.29718,0.0098037,0.20839,0.076935,GOBP_POSITIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,0.88614320754717
BIOCARTA_ION_PATHWAY,SET,5,0.52367,0.0086411,0.36722,0.076938,BIOCARTA_ION_PATHWAY,0.88614320754717
GSE42021_CD24LO_TREG_VS_CD24...2,SET,184,0.092534,0.0092175,0.064896,0.076961,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP,0.88614320754717
GOCC_NUCLEAR_REPLICATION_FORK,SET,39,0.18615,0.0085709,0.13056,0.076978,GOCC_NUCLEAR_REPLICATION_FORK,0.88614320754717
KEGG_MEDICUS_REFERENCE_CHOLE...,SET,11,0.34694,0.00849,0.24337,0.077002,KEGG_MEDICUS_REFERENCE_CHOLESTEROL_BIOSYNTHESIS,0.88614320754717
LAKE_ADULT_KIDNEY_C21_COLLEC...,SET,98,0.13378,0.0097486,0.093855,0.077026,LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B,0.88614320754717
GOBP_ENAMEL_MINERALIZATION,SET,18,0.29746,0.0093098,0.20879,0.077133,GOBP_ENAMEL_MINERALIZATION,0.886760747617483
HP_HYPERAUTOFLUORESCENT_RETI...,SET,14,0.37506,0.010353,0.26341,0.077254,HP_HYPERAUTOFLUORESCENT_RETINAL_LESION,0.886760747617483
ANDERSON_BLOOD_CN54GP140_ADJ...2,SET,63,0.15636,0.0091437,0.10982,0.077269,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_UP,0.886760747617483
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...3,SET,17,0.33291,0.010126,0.23383,0.077272,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_PROTEIN_COMPLEX,0.886760747617483
GOBP_NEGATIVE_REGULATION_OF_...620,SET,8,0.43508,0.0090805,0.30561,0.077286,GOBP_NEGATIVE_REGULATION_OF_SYNAPSE_ASSEMBLY,0.886760747617483
HAHTOLA_MYCOSIS_FUNGOIDES_DN,SET,13,0.35199,0.0093634,0.24726,0.077298,HAHTOLA_MYCOSIS_FUNGOIDES_DN,0.886760747617483
GOBP_TRIGLYCERIDE_RICH_LIPOP...2,SET,10,0.43697,0.010196,0.30696,0.0773,GOBP_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_REMODELING,0.886760747617483
MEL18_DN.V1_UP,SET,133,0.11314,0.0095954,0.079506,0.077364,MEL18_DN.V1_UP,0.886760747617483
GOMF_MAP_KINASE_SCAFFOLD_ACT...,SET,12,0.35822,0.0091556,0.25176,0.077394,GOMF_MAP_KINASE_SCAFFOLD_ACTIVITY,0.886760747617483
chr3q29,SET,43,0.35437,0.017131,0.24906,0.077398,chr3q29,0.886760747617483
WP_LEUCINE_ISOLEUCINE_AND_VA...,SET,22,0.26845,0.0092876,0.18869,0.077422,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,0.886760747617483
GOBP_NEGATIVE_REGULATION_OF_...517,SET,70,0.13708,0.0084482,0.096382,0.077491,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.886760747617483
GSE3039_CD4_TCELL_VS_ALPHAAL...1,SET,178,0.092938,0.009107,0.065348,0.077494,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_DN,0.886760747617483
GOBP_REGULATION_OF_RYANODINE...,SET,20,0.31526,0.0104,0.22171,0.077525,GOBP_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.886760747617483
GOBP_REGULATION_OF_MUSCLE_CO...,SET,154,0.10288,0.009383,0.072359,0.077555,GOBP_REGULATION_OF_MUSCLE_CONTRACTION,0.886760747617483
IL21_UP.V1_DN,SET,157,0.10266,0.0094529,0.07221,0.077572,IL21_UP.V1_DN,0.886760747617483
GOBP_NEGATIVE_REGULATION_OF_...40,SET,44,0.18855,0.0092195,0.13263,0.077576,GOBP_NEGATIVE_REGULATION_OF_AXONOGENESIS,0.886760747617483
GOBP_MEIOTIC_DNA_DOUBLE_STRA...,SET,5,0.64285,0.010608,0.4522,0.077579,GOBP_MEIOTIC_DNA_DOUBLE_STRAND_BREAK_FORMATION,0.886760747617483
GOBP_CELLULAR_RESPONSE_TO_LI...2,SET,557,0.054729,0.0093873,0.038499,0.077588,GOBP_CELLULAR_RESPONSE_TO_LIPID,0.886760747617483
GOMF_GABA_A_RECEPTOR_ACTIVITY,SET,16,0.38038,0.011225,0.26763,0.077627,GOMF_GABA_A_RECEPTOR_ACTIVITY,0.886760747617483
REACTOME_ROLE_OF_ABL_IN_ROBO...,SET,8,0.49756,0.010384,0.35008,0.077628,REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING,0.886760747617483
MIR374B_3P,SET,128,0.11223,0.0093388,0.078971,0.077641,MIR374B_3P,0.886760747617483
GSE14308_INDUCED_VS_NATURAL_...1,SET,182,0.089051,0.0088226,0.062682,0.077715,GSE14308_INDUCED_VS_NATURAL_TREG_DN,0.887314331471748
GOBP_REGULATION_OF_T_CELL_EX...,SET,5,0.55345,0.0091326,0.38971,0.077787,GOBP_REGULATION_OF_T_CELL_EXTRAVASATION,0.887758626066973
GSE27786_ERYTHROBLAST_VS_NEU...2,SET,178,0.090799,0.0088974,0.063941,0.077805,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_UP,0.887758626066973
HP_TORSADE_DE_POINTES,SET,24,0.25896,0.0093571,0.18243,0.07788,HP_TORSADE_DE_POINTES,0.887963062255541
GSE40666_WT_VS_STAT1_KO_CD8_...1,SET,181,0.089343,0.0088274,0.062972,0.077994,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_DN,0.887963062255541
HE_LIM_SUN_FETAL_LUNG_C0_MES...2,SET,265,0.076398,0.0091124,0.05385,0.078,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL,0.887963062255541
GSE7768_OVA_WITH_LPS_VS_OVA_...1,SET,154,0.09636,0.0087885,0.067931,0.078033,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,0.887963062255541
HP_CONTINUOUS_SPIKE_AND_WAVE...,SET,8,0.46243,0.0096512,0.32602,0.078048,HP_CONTINUOUS_SPIKE_AND_WAVES_DURING_SLOW_SLEEP,0.887963062255541
BIOCARTA_PRC2_PATHWAY,SET,12,0.39328,0.010052,0.27731,0.078075,BIOCARTA_PRC2_PATHWAY,0.887963062255541
STAT5B_01,SET,223,0.08346,0.0091425,0.058855,0.078095,STAT5B_01,0.887963062255541
GOBP_DIACYLGLYCEROL_BIOSYNTH...,SET,9,0.40862,0.0090454,0.28826,0.078168,GOBP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.887963062255541
WP_RANKLRANK_SIGNALING,SET,53,0.16694,0.0089569,0.11777,0.078175,WP_RANKLRANK_SIGNALING,0.887963062255541
GSE37301_RAG2_KO_VS_RAG2_AND...1,SET,182,0.088134,0.0087318,0.062197,0.078249,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_DN,0.887963062255541
KEGG_MEDICUS_PATHOGEN_EBV_LM...3,SET,5,0.57552,0.0094968,0.40619,0.078267,KEGG_MEDICUS_PATHOGEN_EBV_LMP2A_TO_PI3K_SIGNALING_PATHWAY,0.887963062255541
GOMF_DEATH_DOMAIN_BINDING,SET,10,0.42109,0.0098251,0.2972,0.078274,GOMF_DEATH_DOMAIN_BINDING,0.887963062255541
HP_REDUCED_SOCIAL_RECIPROCITY,SET,52,0.15935,0.0084687,0.11248,0.078296,HP_REDUCED_SOCIAL_RECIPROCITY,0.887963062255541
MIR7151_5P,SET,42,0.19261,0.0092021,0.13596,0.0783,MIR7151_5P,0.887963062255541
BIOCARTA_REELIN_PATHWAY,SET,7,0.50025,0.0097666,0.35313,0.078302,BIOCARTA_REELIN_PATHWAY,0.887963062255541
ZNF785_TARGET_GENES,SET,55,0.15998,0.0087433,0.11293,0.07831,ZNF785_TARGET_GENES,0.887963062255541
GOMF_ENDOPEPTIDASE_ACTIVITY,SET,362,0.0679,0.0094403,0.047937,0.078332,GOMF_ENDOPEPTIDASE_ACTIVITY,0.887963062255541
HP_GONADAL_DYSGENESIS,SET,28,0.20719,0.0080855,0.14628,0.078342,HP_GONADAL_DYSGENESIS,0.887963062255541
MIR3976,SET,104,0.11876,0.0089133,0.083854,0.078359,MIR3976,0.887963062255541
GOBP_PURINE_RIBONUCLEOSIDE_M...,SET,19,0.32892,0.010576,0.23227,0.078382,GOBP_PURINE_RIBONUCLEOSIDE_METABOLIC_PROCESS,0.887963062255541
GOBP_URETER_MORPHOGENESIS,SET,7,0.44861,0.0087584,0.31679,0.078382,GOBP_URETER_MORPHOGENESIS,0.887963062255541
GOBP_LIPID_MODIFICATION,SET,168,0.091597,0.0087223,0.064684,0.078385,GOBP_LIPID_MODIFICATION,0.887963062255541
GOBP_FOREBRAIN_GENERATION_OF...,SET,50,0.19144,0.0099773,0.13521,0.078419,GOBP_FOREBRAIN_GENERATION_OF_NEURONS,0.888046269944643
GOBP_NEURONAL_SIGNAL_TRANSDU...,SET,6,0.583,0.010538,0.41186,0.078463,GOBP_NEURONAL_SIGNAL_TRANSDUCTION,0.888046269944643
GOBP_REGULATION_OF_KETONE_BI...,SET,19,0.28275,0.0090917,0.19975,0.078469,GOBP_REGULATION_OF_KETONE_BIOSYNTHETIC_PROCESS,0.888046269944643
MIR4666A_3P,SET,502,0.057511,0.0093794,0.040639,0.078516,MIR4666A_3P,0.88828892578125
GOCC_SUPRAMOLECULAR_POLYMER,SET,924,0.042245,0.0092361,0.029858,0.078562,GOCC_SUPRAMOLECULAR_POLYMER,0.8883378
KEGG_MEDICUS_REFERENCE_CHOND...,SET,7,0.47482,0.0092701,0.33565,0.078593,KEGG_MEDICUS_REFERENCE_CHONDROITIN_SULFATE_BIOSYNTHESIS,0.8883378
GSE40277_GATA1_AND_SATB1_TRA...2,SET,181,0.088662,0.0087601,0.062675,0.078597,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,0.8883378
GSE26669_CTRL_VS_COSTIM_BLOC...3,SET,179,0.08695,0.0085439,0.061489,0.078678,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN,0.88841978730261
LE_NEURONAL_DIFFERENTIATION_...2,SET,17,0.28252,0.0085934,0.1998,0.078684,LE_NEURONAL_DIFFERENTIATION_UP,0.88841978730261
GOBP_ENDODERMAL_CELL_FATE_SP...,SET,7,0.48931,0.0095529,0.34615,0.078756,GOBP_ENDODERMAL_CELL_FATE_SPECIFICATION,0.88841978730261
HP_HYPOPLASTIC_LABIA_MINORA,SET,28,0.23241,0.0090695,0.16441,0.078756,HP_HYPOPLASTIC_LABIA_MINORA,0.88841978730261
WP_ANTIVIRAL_AND_ANTIINFLAMM...,SET,26,0.24784,0.0093205,0.17539,0.078828,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,0.88841978730261
GRE_C,SET,112,0.11725,0.0091302,0.082985,0.07885,GRE_C,0.88841978730261
GOBP_NATURAL_KILLER_CELL_MED...2,SET,75,0.15356,0.0097953,0.1087,0.07887,GOBP_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.88841978730261
HAY_BONE_MARROW_CD34_POS_PRE...2,SET,96,0.1336,0.0096356,0.094568,0.078879,HAY_BONE_MARROW_CD34_POS_PRE_PC,0.88841978730261
MODULE_396,SET,9,0.44379,0.0098238,0.31424,0.078944,MODULE_396,0.88841978730261
MIR8063,SET,362,0.063966,0.0088934,0.045294,0.078946,MIR8063,0.88841978730261
HOEK_MYELOID_DENDRITIC_CELL_...4,SET,3,0.85587,0.01094,0.60606,0.078956,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_UP,0.88841978730261
GSE41978_WT_VS_ID2_KO_KLRG1_...2,SET,187,0.090129,0.00905,0.063828,0.078974,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.88841978730261
GOCC_PROCENTRIOLE_REPLICATIO...,SET,6,0.37485,0.0067756,0.2656,0.079082,GOCC_PROCENTRIOLE_REPLICATION_COMPLEX,0.88841978730261
HP_ABNORMAL_CURVATURE_OF_THE...,SET,1027,0.037892,0.008708,0.026851,0.079102,HP_ABNORMAL_CURVATURE_OF_THE_VERTEBRAL_COLUMN,0.88841978730261
GOBP_NUCLEOTIDE_BINDING_OLIG...2,SET,16,0.31957,0.0094304,0.22647,0.07912,GOBP_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY,0.88841978730261
KEGG_BASE_EXCISION_REPAIR,SET,32,0.18487,0.0077116,0.13105,0.079175,KEGG_BASE_EXCISION_REPAIR,0.88841978730261
WP_MAMMALIAN_DISORDER_OF_SEX...,SET,24,0.26391,0.009536,0.18709,0.079184,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,0.88841978730261
HOSHIDA_LIVER_CANCER_LATE_RE...1,SET,63,0.15432,0.0090249,0.1094,0.079192,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,0.88841978730261
REACTOME_ACETYLCHOLINE_REGUL...,SET,10,0.41487,0.0096802,0.29416,0.079226,REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION,0.88841978730261
RPS14_DN.V1_UP,SET,180,0.095829,0.0094424,0.06795,0.079236,RPS14_DN.V1_UP,0.88841978730261
GOBP_REGULATION_OF_TOLL_LIKE...1,SET,11,0.39302,0.0096176,0.27869,0.07924,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.88841978730261
GOBP_ASTROCYTE_DIFFERENTIATI...,SET,79,0.14429,0.0094452,0.10232,0.079256,GOBP_ASTROCYTE_DIFFERENTIATION,0.88841978730261
E2F1_Q4,SET,222,0.081614,0.0089205,0.057882,0.079278,E2F1_Q4,0.88841978730261
GSE17721_LPS_VS_PAM3CSK4_4H_...2,SET,189,0.088079,0.0088909,0.062467,0.079278,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP,0.88841978730261
GOBP_POSITIVE_REGULATION_OF_...584,SET,37,0.21079,0.0094538,0.1495,0.079286,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,0.88841978730261
GSE29164_CD8_TCELL_VS_CD8_TC...3,SET,162,0.096618,0.0090361,0.068526,0.079287,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,0.88841978730261
HP_LARGE_PLACENTA,SET,6,0.54355,0.009825,0.38555,0.079304,HP_LARGE_PLACENTA,0.88841978730261
HP_COGNITIVE_DISTORTION,SET,29,0.22857,0.0090774,0.16214,0.07932,HP_COGNITIVE_DISTORTION,0.88841978730261
GOBP_NEGATIVE_REGULATION_OF_...241,SET,3,0.7982,0.010203,0.56635,0.079372,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_PRODUCTION,0.888528857418732
HARALAMBIEVA_PBMC_FLUARIX_AG...5,SET,11,0.33914,0.008299,0.24068,0.079411,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_SIG_DIAB_OF_THE_YNG_NEGATIVE,0.888528857418732
IRF7_01,SET,224,0.084533,0.0092805,0.059991,0.079412,IRF7_01,0.888528857418732
GOMF_SERINE_TYPE_ENDOPEPTIDA...,SET,92,0.14735,0.010405,0.10458,0.079432,GOMF_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.888528857418732
GOBP_TRIPEPTIDE_TRANSPORT,SET,11,0.38415,0.0094005,0.27276,0.07952,GOBP_TRIPEPTIDE_TRANSPORT,0.889153407848183
GOBP_OVULATION,SET,16,0.33468,0.0098762,0.23766,0.079539,GOBP_OVULATION,0.889153407848183
GOBP_MEMBRANE_PROTEIN_INTRAC...,SET,12,0.30815,0.0078758,0.2189,0.079612,GOBP_MEMBRANE_PROTEIN_INTRACELLULAR_DOMAIN_PROTEOLYSIS,0.88968329903537
REACTOME_RAB_REGULATION_OF_T...,SET,111,0.10921,0.0084667,0.077601,0.079666,REACTOME_RAB_REGULATION_OF_TRAFFICKING,0.889790102105935
GSE6875_TCONV_VS_FOXP3_KO_TR...1,SET,177,0.087528,0.008553,0.062201,0.079697,GSE6875_TCONV_VS_FOXP3_KO_TREG_DN,0.889790102105935
GOMF_INTRACELLULARLY_CGMP_AC...,SET,6,0.50416,0.009113,0.35833,0.079729,GOMF_INTRACELLULARLY_CGMP_ACTIVATED_CATION_CHANNEL_ACTIVITY,0.889790102105935
GOBP_NEGATIVE_REGULATION_OF_...270,SET,14,0.34407,0.0094981,0.24462,0.079783,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,0.889790102105935
HP_SKIN_DIMPLE,SET,102,0.1264,0.0093956,0.089874,0.07981,HP_SKIN_DIMPLE,0.889790102105935
MIR6073,SET,95,0.12186,0.0087432,0.08665,0.079826,MIR6073,0.889790102105935
GOMF_PHOSPHATASE_ACTIVITY,SET,231,0.07567,0.0084346,0.053814,0.07985,GOMF_PHOSPHATASE_ACTIVITY,0.889790102105935
GOBP_REGULATION_OF_PROTEIN_A...4,SET,4,0.63988,0.0094442,0.4551,0.079868,GOBP_REGULATION_OF_PROTEIN_AUTOUBIQUITINATION,0.889790102105935
GOCC_UNCONVENTIONAL_MYOSIN_C...,SET,9,0.42681,0.009448,0.30359,0.079886,GOCC_UNCONVENTIONAL_MYOSIN_COMPLEX,0.889790102105935
PPARA_02,SET,124,0.10342,0.0084705,0.073559,0.07989,PPARA_02,0.889790102105935
KEGG_MEDICUS_REFERENCE_LEUCI...,SET,7,0.44586,0.0087047,0.31721,0.079935,KEGG_MEDICUS_REFERENCE_LEUCINE_DEGRADATION,0.889790102105935
chr1p31,SET,77,0.26325,0.017014,0.18732,0.079964,chr1p31,0.889790102105935
TSENG_ADIPOGENIC_POTENTIAL_DN,SET,38,0.21488,0.0097662,0.15291,0.079983,TSENG_ADIPOGENIC_POTENTIAL_DN,0.889790102105935
TGCACTG_MIR148A_MIR152_MIR14...,SET,270,0.074758,0.0089993,0.053202,0.079995,TGCACTG_MIR148A_MIR152_MIR148B,0.889790102105935
HP_CRANIAL_NERVE_PARALYSIS,SET,258,0.075183,0.00885,0.053516,0.080038,HP_CRANIAL_NERVE_PARALYSIS,0.889790102105935
MYLLYKANGAS_AMPLIFICATION_HO...4,SET,18,0.2571,0.0080467,0.18303,0.08006,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17,0.889790102105935
GSE36888_UNTREATED_VS_IL2_TR...7,SET,179,0.096705,0.0095024,0.068849,0.080081,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_DN,0.889790102105935
REACTOME_VITAMIN_B2_RIBOFLAV...,SET,7,0.46828,0.0091424,0.33349,0.080143,REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM,0.889790102105935
HP_ELEVATED_CIRCULATING_LUTE...,SET,35,0.1996,0.008707,0.14215,0.080152,HP_ELEVATED_CIRCULATING_LUTEINIZING_HORMONE_LEVEL,0.889790102105935
HP_URETERAL_OBSTRUCTION,SET,34,0.20901,0.0089864,0.14887,0.08017,HP_URETERAL_OBSTRUCTION,0.889790102105935
GOBP_MEDIUM_CHAIN_FATTY_ACID...3,SET,15,0.28927,0.0082653,0.20607,0.080201,GOBP_MEDIUM_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.889790102105935
GOMF_HISTONE_ACETYLTRANSFERA...,SET,23,0.26082,0.0092262,0.18581,0.080216,GOMF_HISTONE_ACETYLTRANSFERASE_BINDING,0.889790102105935
REACTOME_PHASE_4_RESTING_MEM...,SET,19,0.31002,0.0099684,0.22088,0.080232,REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL,0.889790102105935
GOBP_POSITIVE_REGULATION_OF_...583,SET,5,0.58921,0.0097226,0.4198,0.080236,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY,0.889790102105935
REACTOME_INTERLEUKIN_9_SIGNA...,SET,7,0.57962,0.011316,0.4131,0.080305,REACTOME_INTERLEUKIN_9_SIGNALING,0.890271220095694
HP_SUPERNUMERARY_MAXILLARY_I...,SET,3,0.81348,0.010398,0.57999,0.080379,HP_SUPERNUMERARY_MAXILLARY_INCISOR,0.890627332695985
HP_ABNORMAL_RESPONSE_TO_GLUC...,SET,4,0.64193,0.0094746,0.45773,0.080402,HP_ABNORMAL_RESPONSE_TO_GLUCAGON_STIMULATION_TEST,0.890627332695985
WP_2Q112_COPY_NUMBER_VARIATI...,SET,32,0.27812,0.011601,0.19832,0.080414,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,0.890627332695985
GSE32034_UNTREATED_VS_ROSIGL...2,SET,178,0.091641,0.0089799,0.065357,0.080442,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP,0.890653618986939
MIR493_5P,SET,431,0.061071,0.0092471,0.043574,0.080533,MIR493_5P,0.890663201335878
GOMF_POLYSACCHARIDE_BINDING,SET,21,0.27536,0.009308,0.19647,0.080533,GOMF_POLYSACCHARIDE_BINDING,0.890663201335878
ALX4_01,SET,15,0.33456,0.0095595,0.23873,0.080553,ALX4_01,0.890663201335878
GOCC_AXONEMAL_B_TUBULE_INNER...,SET,5,0.45398,0.0074912,0.32395,0.080559,GOCC_AXONEMAL_B_TUBULE_INNER_SHEATH,0.890663201335878
GOBP_REGULATION_OF_RESPIRATO...1,SET,16,0.31251,0.009222,0.22302,0.080571,GOBP_REGULATION_OF_RESPIRATORY_BURST,0.890663201335878
GOBP_RESPIRATORY_BURST_INVOL...1,SET,14,0.33854,0.0093454,0.24166,0.08063,GOBP_RESPIRATORY_BURST_INVOLVED_IN_DEFENSE_RESPONSE,0.89103200317965
GOBP_MAGNESIUM_ION_TRANSPORT,SET,14,0.32385,0.0089397,0.23123,0.080686,GOBP_MAGNESIUM_ION_TRANSPORT,0.891119961977186
GOCC_NEURON_SPINE,SET,167,0.096273,0.0091404,0.068761,0.080748,GOCC_NEURON_SPINE,0.891119961977186
HP_FINGER_SWELLING,SET,4,0.78417,0.011574,0.56017,0.080784,HP_FINGER_SWELLING,0.891119961977186
GSE13522_CTRL_VS_T_CRUZI_Y_S...4,SET,121,0.10213,0.0082638,0.072958,0.080798,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_UP,0.891119961977186
chr17q11,SET,76,0.29885,0.019189,0.21353,0.080831,chr17q11,0.891119961977186
GOBP_EPITHELIAL_CELL_DIFFERE...3,SET,10,0.42917,0.010014,0.30673,0.080891,GOBP_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,0.891119961977186
REACTOME_REMOVAL_OF_AMINOTER...,SET,8,0.44888,0.0093685,0.32083,0.080895,REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS,0.891119961977186
GOBP_MEMBRANE_REPOLARIZATION,SET,48,0.18627,0.0095123,0.13313,0.080895,GOBP_MEMBRANE_REPOLARIZATION,0.891119961977186
GOBP_SUCCINATE_TRANSMEMBRANE...,SET,6,0.50733,0.0091702,0.36262,0.080909,GOBP_SUCCINATE_TRANSMEMBRANE_TRANSPORT,0.891119961977186
GOMF_SUCCINATE_TRANSMEMBRANE...,SET,6,0.50733,0.0091702,0.36262,0.080909,GOMF_SUCCINATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.891119961977186
HP_PREAXIAL_FOOT_POLYDACTYLY,SET,16,0.29264,0.0086356,0.20918,0.08092,HP_PREAXIAL_FOOT_POLYDACTYLY,0.891119961977186
GOBP_REGULATION_OF_TRIGLYCER...1,SET,18,0.2561,0.0080152,0.18311,0.080976,GOBP_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.891307872744539
GSE15330_LYMPHOID_MULTIPOTEN...1,SET,181,0.086119,0.0085089,0.061582,0.081001,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.891307872744539
HP_SHORT_4TH_METACARPAL,SET,10,0.40813,0.0095228,0.29187,0.081014,HP_SHORT_4TH_METACARPAL,0.891307872744539
GOBP_REGULATION_OF_OVARIAN_F...,SET,6,0.44934,0.008122,0.3214,0.081055,GOBP_REGULATION_OF_OVARIAN_FOLLICLE_DEVELOPMENT,0.891476748417722
MIR629_5P,SET,102,0.12254,0.0091088,0.087675,0.081114,MIR629_5P,0.891843426130971
GOBP_CORNIFIED_ENVELOPE_ASSE...,SET,6,0.43779,0.0079133,0.31339,0.081223,GOBP_CORNIFIED_ENVELOPE_ASSEMBLY,0.892008419640038
GOBP_POSITIVE_REGULATION_OF_...445,SET,26,0.2458,0.0092436,0.17596,0.081228,GOBP_POSITIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.892008419640038
WP_KCNQ2RELATED_EPILEPSIES,SET,19,0.28437,0.0091436,0.20357,0.081231,WP_KCNQ2RELATED_EPILEPSIES,0.892008419640038
GOBP_ENDOTHELIAL_CELL_CHEMOT...,SET,26,0.25376,0.009543,0.18167,0.081242,GOBP_ENDOTHELIAL_CELL_CHEMOTAXIS,0.892008419640038
GOCC_NEURON_PROJECTION_MEMBR...,SET,56,0.16419,0.0090547,0.11757,0.081273,GOCC_NEURON_PROJECTION_MEMBRANE,0.892008419640038
REACTOME_INTERLEUKIN_6_FAMIL...,SET,24,0.23989,0.0086682,0.17178,0.081283,REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,0.892008419640038
GSE17721_0.5H_VS_8H_POLYIC_B...2,SET,183,0.082633,0.008209,0.059177,0.081311,GSE17721_0.5H_VS_8H_POLYIC_BMDC_UP,0.892034029356061
GSE45365_NK_CELL_VS_BCELL_DN,SET,127,0.11044,0.0091538,0.079105,0.081351,GSE45365_NK_CELL_VS_BCELL_DN,0.892191229094352
TESAR_ALK_TARGETS_EPISC_3D_UP,SET,5,0.55552,0.0091666,0.39803,0.081415,TESAR_ALK_TARGETS_EPISC_3D_UP,0.892582052980132
GOBP_PROTEIN_LOCALIZATION_TO...30,SET,17,0.23514,0.0071522,0.1685,0.081438,GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE,0.892582052980132
SHEPARD_BMYB_MORPHOLINO_UP,SET,198,0.081445,0.0084126,0.058378,0.081498,SHEPARD_BMYB_MORPHOLINO_UP,0.892794296703297
HP_ABNORMAL_MORPHOLOGY_OF_TH...3,SET,25,0.20516,0.0075659,0.14709,0.081539,HP_ABNORMAL_MORPHOLOGY_OF_THE_CONJUNCTIVAL_VASCULATURE,0.892794296703297
GOBP_TRIPEPTIDE_TRANSMEMBRAN...,SET,10,0.39334,0.0091777,0.28207,0.0816,GOBP_TRIPEPTIDE_TRANSMEMBRANE_TRANSPORT,0.892794296703297
GSE37416_0H_VS_48H_F_TULAREN...2,SET,177,0.088969,0.0086938,0.063809,0.081623,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.892794296703297
GOMF_K48_LINKED_DEUBIQUITINA...,SET,10,0.35117,0.0081938,0.25189,0.08165,GOMF_K48_LINKED_DEUBIQUITINASE_ACTIVITY,0.892794296703297
HP_ABNORMALITY_OF_THE_CRUS_O...,SET,10,0.38946,0.0090872,0.2794,0.081678,HP_ABNORMALITY_OF_THE_CRUS_OF_THE_HELIX,0.892794296703297
GOBP_NEGATIVE_REGULATION_OF_...392,SET,6,0.52523,0.0094939,0.37681,0.081682,GOBP_NEGATIVE_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,0.892794296703297
HP_ABSENT_VAS_DEFERENS,SET,19,0.29259,0.0094079,0.20995,0.081727,HP_ABSENT_VAS_DEFERENS,0.892794296703297
WP_NCRNAS_INVOLVED_IN_WNT_SI...,SET,82,0.13954,0.0093054,0.10015,0.081768,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,0.892794296703297
HP_ABNORMAL_GASTRIC_MUCOSA_M...,SET,39,0.20116,0.0092618,0.14437,0.081768,HP_ABNORMAL_GASTRIC_MUCOSA_MORPHOLOGY,0.892794296703297
HP_MICROTIA_FIRST_DEGREE,SET,4,0.69379,0.01024,0.49796,0.081781,HP_MICROTIA_FIRST_DEGREE,0.892794296703297
GSE12392_WT_VS_IFNB_KO_CD8A_...4,SET,176,0.086273,0.0084067,0.061926,0.081793,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_UP,0.892794296703297
MANNE_COVID19_COMBINED_COHOR...1,SET,196,0.093216,0.0095802,0.066916,0.081815,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,0.892794296703297
HOWARD_T_CELL_INACT_MONOV_IN...,SET,40,0.19512,0.0090982,0.14007,0.081817,HOWARD_T_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.892794296703297
chr8q23,SET,16,0.52266,0.015423,0.37531,0.081876,chr8q23,0.893157683615819
VALK_AML_CLUSTER_2,SET,26,0.2607,0.0098042,0.18724,0.081922,VALK_AML_CLUSTER_2,0.893376898047722
HOXA1_TARGET_GENES,SET,955,0.039003,0.0086613,0.028025,0.082015,HOXA1_TARGET_GENES,0.893376898047722
GSE29164_UNTREATED_VS_CD8_TC...6,SET,175,0.08586,0.0083429,0.061698,0.082027,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_UP,0.893376898047722
HP_DOWNTURNED_CORNERS_OF_MOU...,SET,150,0.097929,0.0088158,0.070376,0.082046,HP_DOWNTURNED_CORNERS_OF_MOUTH,0.893376898047722
GOMF_GLUCOSE_SODIUM_SYMPORTE...,SET,7,0.46824,0.0091416,0.33652,0.082059,GOMF_GLUCOSE_SODIUM_SYMPORTER_ACTIVITY,0.893376898047722
GOCC_FLEMMING_BODY,SET,34,0.19813,0.0085188,0.14242,0.0821,GOCC_FLEMMING_BODY,0.893376898047722
PICCALUGA_ANGIOIMMUNOBLASTIC...1,SET,117,0.11547,0.0091891,0.083018,0.08213,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,0.893376898047722
GOCC_MITOCHONDRIA_ASSOCIATED...,SET,18,0.27121,0.0084881,0.19501,0.082166,GOCC_MITOCHONDRIA_ASSOCIATED_ENDOPLASMIC_RETICULUM_MEMBRANE_CONTACT_SITE,0.893376898047722
PIONTEK_PKD1_TARGETS_DN,SET,15,0.2949,0.0084262,0.21208,0.082197,PIONTEK_PKD1_TARGETS_DN,0.893376898047722
GOBP_BODY_MORPHOGENESIS,SET,45,0.18003,0.0089025,0.12949,0.082223,GOBP_BODY_MORPHOGENESIS,0.893376898047722
GSE17721_CTRL_VS_POLYIC_8H_B...2,SET,177,0.083921,0.0082005,0.060362,0.08223,GSE17721_CTRL_VS_POLYIC_8H_BMDC_UP,0.893376898047722
GSE17721_LPS_VS_POLYIC_1H_BM...1,SET,178,0.085448,0.008373,0.061475,0.082279,GSE17721_LPS_VS_POLYIC_1H_BMDC_DN,0.893376898047722
HP_UNILATERAL_RENAL_HYPOPLAS...,SET,4,0.6058,0.0089413,0.4359,0.082308,HP_UNILATERAL_RENAL_HYPOPLASIA,0.893376898047722
HP_SCLEROTIC_VERTEBRAL_ENDPL...,SET,5,0.60251,0.009942,0.43362,0.082353,HP_SCLEROTIC_VERTEBRAL_ENDPLATES,0.893376898047722
REN_ALVEOLAR_RHABDOMYOSARCOM...2,SET,93,0.13275,0.0094248,0.09555,0.082369,REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,0.893376898047722
GOCC_TRANSCRIPTION_FACTOR_TF...2,SET,30,0.18096,0.0073094,0.13027,0.082402,GOCC_TRANSCRIPTION_FACTOR_TFIID_COMPLEX,0.893376898047722
GSE22935_WT_VS_MYD88_KO_MACR...1,SET,186,0.088532,0.0088661,0.063737,0.082424,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN,0.893376898047722
GSE45881_CXCR6HI_VS_CXCR1LO_...2,SET,168,0.086064,0.0081954,0.061962,0.082427,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP,0.893376898047722
KEGG_PRION_DISEASES,SET,33,0.22168,0.0093904,0.1596,0.08243,KEGG_PRION_DISEASES,0.893376898047722
HP_ABNORMALITY_OF_JAW_MUSCLES,SET,26,0.23348,0.0087803,0.1681,0.08244,HP_ABNORMALITY_OF_JAW_MUSCLES,0.893376898047722
GOBP_REGULATION_OF_LEUKOCYTE...4,SET,115,0.1177,0.0092865,0.084747,0.082448,GOBP_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,0.893376898047722
NAKAMURA_BRONCHIAL_AND_BRONC...,SET,5,0.55136,0.0090981,0.39713,0.08252,NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA,0.893376898047722
SPZ1_01,SET,216,0.080429,0.0086727,0.057937,0.082544,SPZ1_01,0.893376898047722
GOBP_B_CELL_DIFFERENTIATION,SET,139,0.1078,0.0093443,0.077673,0.082605,GOBP_B_CELL_DIFFERENTIATION,0.893376898047722
HP_APLASIA_HYPOPLASIA_OF_THE...72,SET,23,0.25329,0.0089597,0.18253,0.082636,HP_APLASIA_HYPOPLASIA_OF_THE_THYROID_GLAND,0.893376898047722
SENGUPTA_NASOPHARYNGEAL_CARC...1,SET,293,0.06993,0.0087638,0.050399,0.082647,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,0.893376898047722
GSE9509_LPS_VS_LPS_AND_IL10_...6,SET,168,0.090893,0.0086551,0.065512,0.082665,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_UP,0.893376898047722
GOBP_MALE_SEX_DETERMINATION,SET,11,0.4013,0.0098203,0.28925,0.082668,GOBP_MALE_SEX_DETERMINATION,0.893376898047722
GOBP_REGULATION_OF_MEMBRANE_...10,SET,33,0.21981,0.009311,0.15844,0.082677,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION,0.893376898047722
GOMF_INTRONIC_TRANSCRIPTION_...,SET,11,0.38815,0.0094985,0.27981,0.082696,GOMF_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.893376898047722
GOBP_REGULATION_OF_MACROPHAG...7,SET,42,0.18771,0.0089679,0.13536,0.082767,GOBP_REGULATION_OF_MACROPHAGE_MIGRATION,0.893376898047722
HP_SUBMUCOUS_CLEFT_PALATE,SET,70,0.13732,0.0084634,0.099039,0.082802,HP_SUBMUCOUS_CLEFT_PALATE,0.893376898047722
LANG_MYB_FAMILY_TARGETS,SET,28,0.21986,0.0085798,0.15857,0.082804,LANG_MYB_FAMILY_TARGETS,0.893376898047722
HP_CRANIAL_NERVE_COMPRESSION,SET,49,0.1617,0.0083431,0.11663,0.082815,HP_CRANIAL_NERVE_COMPRESSION,0.893376898047722
MORF_MYST2,SET,60,0.13977,0.0079773,0.10083,0.082861,MORF_MYST2,0.893376898047722
GOBP_NLS_BEARING_PROTEIN_IMP...,SET,18,0.27885,0.0087275,0.20118,0.082871,GOBP_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS,0.893376898047722
HP_ABNORMAL_TOE_PHALANX_MORP...,SET,113,0.11032,0.0086288,0.079601,0.082892,HP_ABNORMAL_TOE_PHALANX_MORPHOLOGY,0.893376898047722
CDPCR1_01,SET,117,0.1175,0.0093508,0.084796,0.082922,CDPCR1_01,0.893376898047722
GOBP_REGULATION_OF_PROTEIN_O...,SET,5,0.55596,0.0091739,0.40124,0.082945,GOBP_REGULATION_OF_PROTEIN_OLIGOMERIZATION,0.893376898047722
HALMOS_CEBPA_TARGETS_DN,SET,40,0.2116,0.0098663,0.15271,0.082946,HALMOS_CEBPA_TARGETS_DN,0.893376898047722
GOBP_INOSITOL_TRISPHOSPHATE_...1,SET,6,0.50206,0.009075,0.36235,0.08295,GOBP_INOSITOL_TRISPHOSPHATE_BIOSYNTHETIC_PROCESS,0.893376898047722
HP_HYPERINSULINEMIC_HYPOGLYC...,SET,25,0.24199,0.0089238,0.17471,0.083019,HP_HYPERINSULINEMIC_HYPOGLYCEMIA,0.893788824799506
GOMF_CARBOXY_LYASE_ACTIVITY,SET,32,0.20861,0.0087019,0.15069,0.083132,GOMF_CARBOXY_LYASE_ACTIVITY,0.893788824799506
GOMF_CHLORIDE_ION_BINDING,SET,9,0.44154,0.0097741,0.31895,0.083135,GOMF_CHLORIDE_ION_BINDING,0.893788824799506
LEE_NEURAL_CREST_STEM_CELL_DN,SET,103,0.12599,0.009411,0.091014,0.083136,LEE_NEURAL_CREST_STEM_CELL_DN,0.893788824799506
GOMF_LIGASE_ACTIVITY,SET,123,0.1013,0.008264,0.073181,0.083151,GOMF_LIGASE_ACTIVITY,0.893788824799506
GOMF_MEMBRANE_POTENTIAL_DRIV...,SET,5,0.62715,0.010349,0.45311,0.083172,GOMF_MEMBRANE_POTENTIAL_DRIVEN_UNIPORTER_ACTIVITY,0.893788824799506
GOMF_THREONINE_TYPE_ENDOPEPT...,SET,9,0.38994,0.0086317,0.28184,0.083256,GOMF_THREONINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.893788824799506
GOBP_SPECIFICATION_OF_SYMMET...,SET,131,0.10276,0.0086496,0.074282,0.083281,GOBP_SPECIFICATION_OF_SYMMETRY,0.893788824799506
GOBP_MITOCHONDRION_ENDOPLASM...,SET,7,0.42392,0.0082763,0.30644,0.083282,GOBP_MITOCHONDRION_ENDOPLASMIC_RETICULUM_MEMBRANE_TETHERING,0.893788824799506
MIR4680_3P,SET,228,0.078871,0.0087349,0.057023,0.083321,MIR4680_3P,0.893788824799506
GSE17721_CPG_VS_GARDIQUIMOD_...1,SET,186,0.087007,0.0087134,0.06291,0.083336,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN,0.893788824799506
REACTOME_NEGATIVE_REGULATION...8,SET,19,0.27515,0.0088473,0.19898,0.083364,REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,0.893788824799506
GSE7852_THYMUS_VS_FAT_TREG_UP,SET,188,0.0818,0.0082354,0.059155,0.083372,GSE7852_THYMUS_VS_FAT_TREG_UP,0.893788824799506
GOBP_BASE_CONVERSION_OR_SUBS...,SET,16,0.36288,0.010708,0.26242,0.083373,GOBP_BASE_CONVERSION_OR_SUBSTITUTION_EDITING,0.893788824799506
GAVIN_FOXP3_TARGETS_CLUSTER_...1,SET,72,0.14205,0.0088787,0.10273,0.083374,GAVIN_FOXP3_TARGETS_CLUSTER_P2,0.893788824799506
GSE17721_12H_VS_24H_LPS_BMDC...2,SET,190,0.085807,0.0086841,0.062077,0.083453,GSE17721_12H_VS_24H_LPS_BMDC_UP,0.894359856614246
GOBP_POSITIVE_REGULATION_OF_...459,SET,6,0.56375,0.01019,0.40797,0.083518,GOBP_POSITIVE_REGULATION_OF_MHC_CLASS_I_BIOSYNTHETIC_PROCESS,0.894395373889059
GOCC_BLOC_1_COMPLEX,SET,14,0.3165,0.008737,0.22905,0.083524,GOCC_BLOC_1_COMPLEX,0.894395373889059
HP_ELEVATED_LACTATE_PYRUVATE...,SET,18,0.25266,0.0079076,0.18292,0.083603,HP_ELEVATED_LACTATE_PYRUVATE_RATIO,0.894395373889059
WP_IL7_SIGNALING,SET,24,0.26819,0.0096905,0.19419,0.083641,WP_IL7_SIGNALING,0.894395373889059
GOBP_POSITIVE_REGULATION_OF_...140,SET,5,0.63133,0.010418,0.45719,0.083665,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS,0.894395373889059
HP_CORONARY_ARTERY_ANEURYSM,SET,7,0.54218,0.010585,0.39264,0.083673,HP_CORONARY_ARTERY_ANEURYSM,0.894395373889059
WHN_B,SET,228,0.07867,0.0087126,0.056999,0.083771,WHN_B,0.894395373889059
HP_ABNORMALITY_OF_SALIVATION,SET,178,0.0908,0.0088975,0.065793,0.083791,HP_ABNORMALITY_OF_SALIVATION,0.894395373889059
HP_RHINORRHEA,SET,7,0.39461,0.0077042,0.28595,0.083802,HP_RHINORRHEA,0.894395373889059
GOBP_LONG_TERM_SYNAPTIC_DEPR...,SET,30,0.24263,0.0098003,0.17584,0.083825,GOBP_LONG_TERM_SYNAPTIC_DEPRESSION,0.894395373889059
MIR423_5P,SET,124,0.099296,0.0081331,0.071962,0.083827,MIR423_5P,0.894395373889059
HP_ABDUCENS_PALSY,SET,9,0.41836,0.0092608,0.30319,0.083828,HP_ABDUCENS_PALSY,0.894395373889059
VETTER_TARGETS_OF_PRKCA_AND_...1,SET,16,0.31566,0.0093148,0.22878,0.08384,VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN,0.894395373889059
REACTOME_HCMV_LATE_EVENTS,SET,51,0.15362,0.0080857,0.11136,0.083889,REACTOME_HCMV_LATE_EVENTS,0.894395373889059
GSE25088_WT_VS_STAT6_KO_MACR...1,SET,181,0.088546,0.0087487,0.064191,0.083893,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN,0.894395373889059
GOCC_PHAGOCYTIC_VESICLE_MEMB...,SET,67,0.14477,0.0087298,0.10495,0.083895,GOCC_PHAGOCYTIC_VESICLE_MEMBRANE,0.894395373889059
GOMF_KERATIN_FILAMENT_BINDING,SET,6,0.43777,0.007913,0.3174,0.083921,GOMF_KERATIN_FILAMENT_BINDING,0.894395373889059
MIR10400_3P_MIR4674,SET,33,0.19931,0.0084429,0.14451,0.083925,MIR10400_3P_MIR4674,0.894395373889059
PURBEY_TARGETS_OF_CTBP1_NOT_...2,SET,262,0.071536,0.0084848,0.051873,0.083948,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,0.894395373889059
GOBP_SINOATRIAL_NODE_CELL_DI...,SET,6,0.55804,0.010087,0.4047,0.083971,GOBP_SINOATRIAL_NODE_CELL_DIFFERENTIATION,0.894395373889059
MIR4646_5P,SET,133,0.10133,0.0085936,0.073506,0.084027,MIR4646_5P,0.894717642463235
GOMF_PHOSPHATIDYLINOSITOL_BI...2,SET,98,0.1184,0.0086278,0.085944,0.084159,GOMF_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_BINDING,0.894964599880561
GSE37301_LYMPHOID_PRIMED_MPP...7,SET,168,0.091044,0.0086695,0.066086,0.084163,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_DN,0.894964599880561
HP_LENS_SUBLUXATION,SET,13,0.34169,0.0090894,0.24807,0.084201,HP_LENS_SUBLUXATION,0.894964599880561
HP_EMG_CHRONIC_DENERVATION_S...,SET,25,0.22011,0.0081173,0.15982,0.084226,HP_EMG_CHRONIC_DENERVATION_SIGNS,0.894964599880561
HP_PROTRUDING_EAR,SET,168,0.08935,0.0085083,0.064886,0.084258,HP_PROTRUDING_EAR,0.894964599880561
GOBP_REGULATION_OF_SALIVA_SE...,SET,7,0.58443,0.01141,0.42442,0.084262,GOBP_REGULATION_OF_SALIVA_SECRETION,0.894964599880561
GOBP_PYRIMIDINE_NUCLEOSIDE_M...3,SET,8,0.42078,0.0087821,0.30575,0.084386,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.894964599880561
HP_APLASIA_HYPOPLASIA_OF_THE...73,SET,27,0.23593,0.0090412,0.17144,0.084392,HP_APLASIA_HYPOPLASIA_OF_THE_TIBIA,0.894964599880561
GSE13484_12H_VS_3H_YF17D_VAC...2,SET,174,0.088406,0.008566,0.064263,0.084467,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,0.894964599880561
GOBP_NEGATIVE_REGULATION_OF_...648,SET,89,0.12516,0.0086934,0.090992,0.084497,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,0.894964599880561
REACTOME_TBC_RABGAPS,SET,40,0.16596,0.0077383,0.12069,0.084555,REACTOME_TBC_RABGAPS,0.894964599880561
GOCC_CYTOPLASMIC_SIDE_OF_LYS...,SET,9,0.36483,0.0080759,0.26532,0.084565,GOCC_CYTOPLASMIC_SIDE_OF_LYSOSOMAL_MEMBRANE,0.894964599880561
HP_CHRONIC_HEPATIC_FAILURE,SET,14,0.29957,0.0082697,0.21788,0.084584,HP_CHRONIC_HEPATIC_FAILURE,0.894964599880561
HP_ABNORMAL_EYELASH_MORPHOLO...,SET,250,0.07427,0.0086078,0.054022,0.084607,HP_ABNORMAL_EYELASH_MORPHOLOGY,0.894964599880561
chr6p12,SET,59,0.28998,0.016413,0.21097,0.084645,chr6p12,0.894964599880561
BIOCARTA_PEPI_PATHWAY,SET,8,0.44692,0.0093276,0.32519,0.084673,BIOCARTA_PEPI_PATHWAY,0.894964599880561
REACTOME_DNA_REPAIR,SET,264,0.064661,0.0076982,0.047062,0.084735,REACTOME_DNA_REPAIR,0.894964599880561
HP_BROAD_FACE,SET,15,0.31265,0.0089334,0.22757,0.084753,HP_BROAD_FACE,0.894964599880561
GOBP_BRANCHING_MORPHOGENESIS...2,SET,10,0.41729,0.0097365,0.30379,0.08479,GOBP_BRANCHING_MORPHOGENESIS_OF_A_NERVE,0.894964599880561
GOCC_CELL_BODY_MEMBRANE,SET,32,0.23675,0.0098757,0.17237,0.084807,GOCC_CELL_BODY_MEMBRANE,0.894964599880561
GOBERT_OLIGODENDROCYTE_DIFFE...2,SET,525,0.050223,0.0083709,0.03657,0.08483,GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP,0.894964599880561
MIR5681B,SET,48,0.16706,0.0085314,0.12167,0.084867,MIR5681B,0.894964599880561
HP_DOWNBEAT_NYSTAGMUS,SET,7,0.43473,0.0084874,0.31663,0.084885,HP_DOWNBEAT_NYSTAGMUS,0.894964599880561
HP_INTRAHEPATIC_BILE_DUCT_DI...,SET,3,0.71141,0.0090935,0.51817,0.084897,HP_INTRAHEPATIC_BILE_DUCT_DILATATION,0.894964599880561
ZHOU_PANCREATIC_ENDOCRINE_PR...,SET,12,0.38222,0.009769,0.2784,0.084901,ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR,0.894964599880561
HP_CORONAL_CRANIOSYNOSTOSIS,SET,26,0.2135,0.0080292,0.15554,0.084942,HP_CORONAL_CRANIOSYNOSTOSIS,0.894964599880561
SESTO_RESPONSE_TO_UV_C8,SET,66,0.15601,0.0093375,0.11366,0.084952,SESTO_RESPONSE_TO_UV_C8,0.894964599880561
MIR6507_3P,SET,112,0.10857,0.0084542,0.079104,0.084965,MIR6507_3P,0.894964599880561
GOBP_CHAPERONE_MEDIATED_AUTO...,SET,14,0.29178,0.0080546,0.2126,0.084967,GOBP_CHAPERONE_MEDIATED_AUTOPHAGY,0.894964599880561
YAO_TEMPORAL_RESPONSE_TO_PRO...8,SET,28,0.22083,0.0086179,0.1609,0.084968,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15,0.894964599880561
GROSS_HIF1A_TARGETS_UP,SET,7,0.52662,0.010281,0.38374,0.084988,GROSS_HIF1A_TARGETS_UP,0.894964599880561
GSE15750_WT_VS_TRAF6KO_DAY6_...1,SET,185,0.087469,0.0087363,0.063751,0.085033,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN,0.894964599880561
GSE20484_MCSG_VS_CXCL4_MONOC...1,SET,174,0.088482,0.0085733,0.064506,0.085089,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN,0.894964599880561
HP_HYPOARGININEMIA,SET,6,0.40329,0.0072898,0.29403,0.085105,HP_HYPOARGININEMIA,0.894964599880561
HOWARD_DENDRITIC_CELL_INACT_...2,SET,140,0.10682,0.0092931,0.077893,0.085129,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.894964599880561
HP_BROAD_PALM,SET,24,0.23432,0.0084669,0.17087,0.085134,HP_BROAD_PALM,0.894964599880561
GSE18791_CTRL_VS_NEWCASTLE_V...6,SET,176,0.085336,0.0083154,0.062235,0.085165,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP,0.894964599880561
HP_ABNORMAL_RENAL_CORTEX_MOR...,SET,200,0.084006,0.0087204,0.061265,0.085167,HP_ABNORMAL_RENAL_CORTEX_MORPHOLOGY,0.894964599880561
VETTER_TARGETS_OF_PRKCA_AND_...2,SET,16,0.29672,0.008756,0.2164,0.085174,VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,0.894964599880561
HP_ABNORMALITY_OF_THE_CALCAN...,SET,31,0.23635,0.0097042,0.1724,0.085199,HP_ABNORMALITY_OF_THE_CALCANEUS,0.894964599880561
GSE12963_UNINF_VS_ENV_AND_NE...4,SET,127,0.10509,0.0087106,0.076657,0.085207,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP,0.894964599880561
HAHTOLA_SEZARY_SYNDROM_UP,SET,83,0.12726,0.0085374,0.092831,0.08522,HAHTOLA_SEZARY_SYNDROM_UP,0.894964599880561
AP2GAMMA_01,SET,232,0.076199,0.0085118,0.055592,0.085245,AP2GAMMA_01,0.894964599880561
HP_HYPOTHALAMIC_HAMARTOMA,SET,14,0.27523,0.0075976,0.20083,0.085281,HP_HYPOTHALAMIC_HAMARTOMA,0.894964599880561
PID_SHP2_PATHWAY,SET,55,0.16624,0.0090854,0.12133,0.085336,PID_SHP2_PATHWAY,0.894964599880561
HP_DEVIATION_OF_THE_3RD_FING...,SET,10,0.3829,0.0089342,0.27952,0.085378,HP_DEVIATION_OF_THE_3RD_FINGER,0.894964599880561
GOBP_BRANCHED_CHAIN_AMINO_AC...4,SET,13,0.3347,0.0089036,0.24436,0.085398,GOBP_BRANCHED_CHAIN_AMINO_ACID_TRANSPORT,0.894964599880561
HP_ABNORMALITY_OF_THROMBOCYT...,SET,425,0.057655,0.0086702,0.042101,0.085438,HP_ABNORMALITY_OF_THROMBOCYTES,0.894964599880561
GOBP_CELL_PROJECTION_ASSEMBLY,SET,537,0.050988,0.0085921,0.037234,0.085447,GOBP_CELL_PROJECTION_ASSEMBLY,0.894964599880561
GOMF_MONOATOMIC_ANION_TRANSM...,SET,131,0.1092,0.0091913,0.079746,0.085462,GOMF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.894964599880561
MURARO_PANCREAS_EPSILON_CELL,SET,42,0.18886,0.0090231,0.13793,0.085477,MURARO_PANCREAS_EPSILON_CELL,0.894964599880561
GOBP_MEGAKARYOCYTE_DEVELOPME...,SET,20,0.27779,0.009164,0.20289,0.085481,GOBP_MEGAKARYOCYTE_DEVELOPMENT,0.894964599880561
HP_MYELOMENINGOCELE,SET,20,0.28316,0.0093412,0.20682,0.085493,HP_MYELOMENINGOCELE,0.894964599880561
MIR323B_3P,SET,56,0.15389,0.0084863,0.11242,0.085522,MIR323B_3P,0.894964599880561
NAKAMURA_ALVEOLAR_EPITHELIUM,SET,5,0.54623,0.0090134,0.39903,0.085526,NAKAMURA_ALVEOLAR_EPITHELIUM,0.894964599880561
GSE5542_IFNA_VS_IFNA_AND_IFN...3,SET,173,0.083788,0.0080954,0.061214,0.085545,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.894964599880561
HP_ABNORMAL_DISTAL_PHALANX_M...,SET,146,0.097845,0.008691,0.071497,0.085583,HP_ABNORMAL_DISTAL_PHALANX_MORPHOLOGY_OF_FINGER,0.894964599880561
GOMF_FIBROBLAST_GROWTH_FACTO...1,SET,23,0.2457,0.0086914,0.17957,0.085618,GOMF_FIBROBLAST_GROWTH_FACTOR_BINDING,0.894964599880561
DESCARTES_MAIN_FETAL_ENS_GLIA,SET,11,0.34836,0.0085246,0.25459,0.085621,DESCARTES_MAIN_FETAL_ENS_GLIA,0.894964599880561
BANDRES_RESPONSE_TO_CARMUSTI...1,SET,31,0.21106,0.0086656,0.15425,0.085628,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,0.894964599880561
GOCC_9PLUS2_MOTILE_CILIUM,SET,158,0.092262,0.0085224,0.067445,0.085673,GOCC_9PLUS2_MOTILE_CILIUM,0.894964599880561
GOMF_DNA_BINDING_TRANSCRIPTI...1,SET,442,0.058156,0.0089145,0.042518,0.0857,GOMF_DNA_BINDING_TRANSCRIPTION_ACTIVATOR_ACTIVITY,0.894964599880561
GOMF_ACID_PHOSPHATASE_ACTIVI...,SET,6,0.44425,0.0080301,0.32483,0.085718,GOMF_ACID_PHOSPHATASE_ACTIVITY,0.894964599880561
WP_LIPID_PARTICLES_COMPOSITI...,SET,8,0.45121,0.009417,0.32993,0.085729,WP_LIPID_PARTICLES_COMPOSITION,0.894964599880561
MIR4427,SET,211,0.082698,0.0088148,0.060471,0.085734,MIR4427,0.894964599880561
HP_SHORT_1ST_METACARPAL,SET,21,0.26008,0.0087915,0.19024,0.085795,HP_SHORT_1ST_METACARPAL,0.894964599880561
GSE33425_CD8_ALPHAALPHA_VS_A...2,SET,186,0.084298,0.0084421,0.061671,0.085838,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,0.894964599880561
REACTOME_FGFR1_MUTANT_RECEPT...,SET,30,0.23855,0.0096353,0.17453,0.085848,REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,0.894964599880561
MIR3134,SET,59,0.15172,0.0085875,0.11104,0.085916,MIR3134,0.894964599880561
FISCHER_G1_S_CELL_CYCLE,SET,172,0.088434,0.0085198,0.064726,0.085932,FISCHER_G1_S_CELL_CYCLE,0.894964599880561
GOCC_MULTIVESICULAR_BODY,SET,60,0.15827,0.0090335,0.11584,0.08594,GOCC_MULTIVESICULAR_BODY,0.894964599880561
GNF2_ITGB2,SET,51,0.16223,0.008539,0.11878,0.086,GNF2_ITGB2,0.894964599880561
GOBP_PRIMARY_ALCOHOL_BIOSYNT...,SET,14,0.34014,0.0093896,0.24907,0.086033,GOBP_PRIMARY_ALCOHOL_BIOSYNTHETIC_PROCESS,0.894964599880561
LIM_MAMMARY_LUMINAL_MATURE_DN,SET,89,0.13494,0.0093724,0.09881,0.086041,LIM_MAMMARY_LUMINAL_MATURE_DN,0.894964599880561
GOBP_SPINAL_CORD_PATTERNING,SET,18,0.28374,0.0088804,0.20779,0.086054,GOBP_SPINAL_CORD_PATTERNING,0.894964599880561
GOBP_MEMBRANE_REPOLARIZATION...1,SET,26,0.25682,0.0096583,0.18809,0.086061,GOBP_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL,0.894964599880561
TBK1.DN.48HRS_DN,SET,46,0.17225,0.0086114,0.12615,0.086066,TBK1.DN.48HRS_DN,0.894964599880561
REACTOME_PHOSPHORYLATION_OF_...1,SET,6,0.38484,0.0069561,0.28192,0.086129,REACTOME_PHOSPHORYLATION_OF_EMI1,0.894964599880561
REACTOME_OTHER_INTERLEUKIN_S...,SET,24,0.24388,0.0088121,0.1787,0.086173,REACTOME_OTHER_INTERLEUKIN_SIGNALING,0.894964599880561
GOBP_REGULATION_OF_MITOCHOND...4,SET,5,0.53305,0.008796,0.39065,0.086206,GOBP_REGULATION_OF_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE,0.894964599880561
HP_ABNORMAL_QT_INTERVAL,SET,55,0.16572,0.0090573,0.12146,0.08623,HP_ABNORMAL_QT_INTERVAL,0.894964599880561
HP_DECREASED_DISTAL_SENSORY_...,SET,9,0.4189,0.0092728,0.30703,0.086233,HP_DECREASED_DISTAL_SENSORY_NERVE_ACTION_POTENTIAL,0.894964599880561
GOBP_COMPLEMENT_ACTIVATION_C...,SET,29,0.24523,0.0097389,0.17974,0.086236,GOBP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY,0.894964599880561
MIR5189_3P,SET,51,0.15957,0.0083986,0.11695,0.086237,MIR5189_3P,0.894964599880561
MIR1287_5P,SET,58,0.14642,0.0082173,0.10732,0.086239,MIR1287_5P,0.894964599880561
HP_TOE_CLINODACTYLY,SET,24,0.23725,0.0085726,0.17397,0.086334,HP_TOE_CLINODACTYLY,0.895355987470167
GSE16451_CTRL_VS_WEST_EQUINE...1,SET,177,0.084295,0.0082371,0.061816,0.086349,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.895355987470167
HP_HYPOPARATHYROIDISM,SET,28,0.22249,0.0086827,0.16317,0.086354,HP_HYPOPARATHYROIDISM,0.895355987470167
YAATNANRNNNCAG_UNKNOWN,SET,61,0.15049,0.0086607,0.11041,0.086436,YAATNANRNNNCAG_UNKNOWN,0.8955936829559
GOBP_ENDOCARDIAL_CUSHION_FUS...,SET,4,0.70748,0.010442,0.51906,0.086448,GOBP_ENDOCARDIAL_CUSHION_FUSION,0.8955936829559
GSE19923_WT_VS_HEB_KO_DP_THY...2,SET,183,0.087661,0.0087085,0.064317,0.086459,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP,0.8955936829559
MIR4318,SET,100,0.11801,0.0086863,0.086596,0.08648,MIR4318,0.8955936829559
GOMF_PHOSPHATIDYLINOSITOL_3_...8,SET,11,0.27585,0.0067504,0.20247,0.08654,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.895948078641644
HP_DEFECTIVE_DNA_REPAIR_AFTE...,SET,10,0.27941,0.0065195,0.20519,0.086653,HP_DEFECTIVE_DNA_REPAIR_AFTER_ULTRAVIOLET_RADIATION_DAMAGE,0.896408841320865
KEGG_MEDICUS_VARIANT_MUTATIO...72,SET,5,0.52099,0.008597,0.38263,0.08667,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ERBB4_TO_NRG_ERBB4_PI3K_SIGNALING_PATHWAY,0.896408841320865
GOBP_AUTOPHAGOSOME_MEMBRANE_...,SET,7,0.41763,0.0081534,0.30674,0.086687,GOBP_AUTOPHAGOSOME_MEMBRANE_DOCKING,0.896408841320865
GOBP_CLEARANCE_OF_FOREIGN_IN...,SET,6,0.65953,0.011921,0.48451,0.086727,GOBP_CLEARANCE_OF_FOREIGN_INTRACELLULAR_NUCLEIC_ACIDS,0.896408841320865
GOBP_PEPTIDE_CATABOLIC_PROCE...,SET,19,0.28329,0.0091091,0.20816,0.086771,GOBP_PEPTIDE_CATABOLIC_PROCESS,0.896408841320865
GSE7852_LN_VS_FAT_TREG_UP,SET,181,0.082022,0.0081041,0.060277,0.086805,GSE7852_LN_VS_FAT_TREG_UP,0.896408841320865
REACTOME_BETA_OXIDATION_OF_H...,SET,5,0.51034,0.0084211,0.37512,0.08685,REACTOME_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA,0.896408841320865
VDR_Q6,SET,235,0.077639,0.0087278,0.057072,0.086866,VDR_Q6,0.896408841320865
GOBP_POSTSYNAPTIC_MEMBRANE_A...,SET,7,0.47355,0.0092453,0.34815,0.086893,GOBP_POSTSYNAPTIC_MEMBRANE_ASSEMBLY,0.896408841320865
chr10q25,SET,51,0.27896,0.014683,0.20515,0.086959,chr10q25,0.896408841320865
MIR5003_3P,SET,293,0.069269,0.008681,0.050945,0.086971,MIR5003_3P,0.896408841320865
MODULE_471,SET,9,0.40265,0.008913,0.29613,0.086973,MODULE_471,0.896408841320865
HP_INCREASED_CIRCULATING_IGE...,SET,39,0.18639,0.0085817,0.13711,0.087022,HP_INCREASED_CIRCULATING_IGE_LEVEL,0.896408841320865
GSE360_L_DONOVANI_VS_T_GONDI...1,SET,169,0.089167,0.0085158,0.06561,0.087074,GSE360_L_DONOVANI_VS_T_GONDII_DC_DN,0.896408841320865
GSE8921_UNSTIM_0H_VS_TLR1_2_...1,SET,185,0.085571,0.0085467,0.062964,0.087076,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN,0.896408841320865
GOBP_MOLTING_CYCLE,SET,114,0.12019,0.0094421,0.088442,0.08708,GOBP_MOLTING_CYCLE,0.896408841320865
HP_ANGULATED_MUSCLE_FIBERS,SET,5,0.4915,0.0081103,0.36171,0.087109,HP_ANGULATED_MUSCLE_FIBERS,0.896408841320865
HP_KETOACIDOSIS,SET,35,0.20188,0.0088066,0.14858,0.087119,HP_KETOACIDOSIS,0.896408841320865
HP_LIMITATION_OF_MOVEMENT_AT...,SET,5,0.58959,0.0097288,0.43393,0.087129,HP_LIMITATION_OF_MOVEMENT_AT_ANKLES,0.896408841320865
HP_JUVENILE_RHEUMATOID_ARTHR...,SET,5,0.50819,0.0083858,0.37405,0.087141,HP_JUVENILE_RHEUMATOID_ARTHRITIS,0.896408841320865
WP_ENTEROCYTE_CHOLESTEROL_ME...,SET,34,0.18562,0.0079809,0.13666,0.087202,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,0.896408841320865
MIR1248,SET,120,0.1123,0.0090497,0.082709,0.087277,MIR1248,0.896408841320865
HAHTOLA_SEZARY_SYNDROM_DN,SET,38,0.1923,0.0087399,0.14164,0.087288,HAHTOLA_SEZARY_SYNDROM_DN,0.896408841320865
GOBP_SENSORY_PERCEPTION_OF_T...3,SET,5,0.51042,0.0084225,0.37595,0.087294,GOBP_SENSORY_PERCEPTION_OF_TOUCH,0.896408841320865
ATCMNTCCGY_UNKNOWN,SET,47,0.16204,0.0081883,0.11937,0.087334,ATCMNTCCGY_UNKNOWN,0.896408841320865
GNF2_MBD4,SET,22,0.23771,0.008224,0.17514,0.087361,GNF2_MBD4,0.896408841320865
GOCC_CLEAVAGE_FURROW,SET,50,0.16026,0.0083523,0.11808,0.087373,GOCC_CLEAVAGE_FURROW,0.896408841320865
GOBP_STRESS_GRANULE_ASSEMBLY,SET,32,0.20443,0.0085278,0.15068,0.087438,GOBP_STRESS_GRANULE_ASSEMBLY,0.896408841320865
GNF2_SERPINI2,SET,21,0.2916,0.0098568,0.21495,0.087468,GNF2_SERPINI2,0.896408841320865
GSE11961_MARGINAL_ZONE_BCELL...7,SET,175,0.090955,0.008838,0.067053,0.087483,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_DN,0.896408841320865
GOBP_FEMALE_SEX_DIFFERENTIAT...,SET,116,0.11487,0.0091023,0.08469,0.087499,GOBP_FEMALE_SEX_DIFFERENTIATION,0.896408841320865
HP_ABNORMAL_FOOT_BONE_OSSIFI...,SET,9,0.37786,0.0083643,0.27861,0.087522,HP_ABNORMAL_FOOT_BONE_OSSIFICATION,0.896408841320865
GSE17721_LPS_VS_CPG_24H_BMDC...2,SET,180,0.08486,0.0083616,0.062575,0.087537,GSE17721_LPS_VS_CPG_24H_BMDC_UP,0.896408841320865
chr9q21,SET,57,0.23672,0.01317,0.17456,0.087544,chr9q21,0.896408841320865
WP_IL17_SIGNALING,SET,30,0.21972,0.0088747,0.16205,0.087582,WP_IL17_SIGNALING,0.896408841320865
GOMF_ANTIPORTER_ACTIVITY,SET,126,0.10002,0.0082576,0.073772,0.087595,GOMF_ANTIPORTER_ACTIVITY,0.896408841320865
HP_METAPHYSEAL_SPURS,SET,7,0.44002,0.0085906,0.32463,0.087646,HP_METAPHYSEAL_SPURS,0.896408841320865
HP_PLACENTAL_ABRUPTION,SET,4,0.69504,0.010258,0.51292,0.087707,HP_PLACENTAL_ABRUPTION,0.896408841320865
GCAAGAC_MIR431,SET,43,0.18541,0.008963,0.13685,0.087744,GCAAGAC_MIR431,0.896408841320865
GOBP_POSITIVE_REGULATION_OF_...345,SET,6,0.52682,0.0095227,0.38885,0.087746,GOBP_POSITIVE_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,0.896408841320865
GSE2770_TGFB_AND_IL4_VS_TGFB...2,SET,139,0.10116,0.0087693,0.074674,0.087761,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.896408841320865
GSE37301_LYMPHOID_PRIMED_MPP...3,SET,189,0.087367,0.0088189,0.064503,0.087804,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN,0.896408841320865
GOBP_XENOBIOTIC_GLUCURONIDAT...,SET,6,0.58965,0.010658,0.43536,0.087814,GOBP_XENOBIOTIC_GLUCURONIDATION,0.896408841320865
KEGG_MEDICUS_REFERENCE_VALIN...,SET,8,0.42664,0.0089043,0.31507,0.087859,KEGG_MEDICUS_REFERENCE_VALINE_DEGRADATION,0.896408841320865
GOBP_NEUTRAL_LIPID_METABOLIC...,SET,119,0.10633,0.0085333,0.078528,0.087865,GOBP_NEUTRAL_LIPID_METABOLIC_PROCESS,0.896408841320865
PHESSE_TARGETS_OF_APC_AND_MB...2,SET,15,0.3292,0.0094061,0.24313,0.087876,PHESSE_TARGETS_OF_APC_AND_MBD2_UP,0.896408841320865
BIOCARTA_BIOPEPTIDES_PATHWAY,SET,28,0.2293,0.0089481,0.16936,0.087896,BIOCARTA_BIOPEPTIDES_PATHWAY,0.896408841320865
GOBP_POSITIVE_REGULATION_OF_...458,SET,14,0.30824,0.0085089,0.22776,0.087984,GOBP_POSITIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.896408841320865
GOBP_GERM_CELL_PROLIFERATION,SET,10,0.33166,0.0077387,0.24508,0.087989,GOBP_GERM_CELL_PROLIFERATION,0.896408841320865
HP_PITUITARY_HYPOTHYROIDISM,SET,35,0.1949,0.0085019,0.14403,0.088006,HP_PITUITARY_HYPOTHYROIDISM,0.896408841320865
MIR3184_5P,SET,120,0.098741,0.0079571,0.072971,0.088012,MIR3184_5P,0.896408841320865
GOBP_CIRCADIAN_SLEEP_WAKE_CY...1,SET,22,0.27386,0.0094746,0.2024,0.088031,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE,0.896408841320865
GSE9946_MATURE_STIMULATORY_V...4,SET,120,0.10507,0.0084671,0.077657,0.088036,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,0.896408841320865
HP_SHORT_COLUMELLA,SET,24,0.22759,0.0082236,0.16821,0.088039,HP_SHORT_COLUMELLA,0.896408841320865
HP_LOW_ALKALINE_PHOSPHATASE,SET,10,0.38514,0.0089863,0.28467,0.088049,HP_LOW_ALKALINE_PHOSPHATASE,0.896408841320865
RHEIN_ALL_GLUCOCORTICOID_THE...1,SET,324,0.063829,0.0084045,0.047179,0.088052,RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,0.896408841320865
GOBP_SODIUM_ION_TRANSPORT,SET,232,0.082362,0.0092002,0.060882,0.088067,GOBP_SODIUM_ION_TRANSPORT,0.896408841320865
GOCC_TRAPPIII_PROTEIN_COMPLEX,SET,10,0.34352,0.0080153,0.25399,0.088118,GOCC_TRAPPIII_PROTEIN_COMPLEX,0.896408841320865
GOBP_REGULATION_OF_MONOCYTE_...1,SET,25,0.23925,0.008823,0.1769,0.088124,GOBP_REGULATION_OF_MONOCYTE_CHEMOTAXIS,0.896408841320865
REACTOME_RESOLUTION_OF_AP_SI...,SET,24,0.20617,0.0074497,0.15247,0.088158,REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY,0.896408841320865
HP_ABNORMAL_LIP_MORPHOLOGY,SET,1049,0.036671,0.0085118,0.02712,0.088167,HP_ABNORMAL_LIP_MORPHOLOGY,0.896408841320865
GSE45365_CTRL_VS_MCMV_INFECT...1,SET,172,0.085484,0.0082356,0.063231,0.088209,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN,0.896408841320865
GOBP_L_LEUCINE_TRANSPORT,SET,10,0.37862,0.0088344,0.28008,0.088219,GOBP_L_LEUCINE_TRANSPORT,0.896408841320865
GSE13306_RA_VS_UNTREATED_MEM...2,SET,189,0.084387,0.0085182,0.062434,0.088258,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP,0.896408841320865
GOCC_MICROTUBULE_END,SET,33,0.21735,0.0092067,0.16081,0.088261,GOCC_MICROTUBULE_END,0.896408841320865
RICKMAN_HEAD_AND_NECK_CANCER...5,SET,75,0.14369,0.0091655,0.10633,0.088297,RICKMAN_HEAD_AND_NECK_CANCER_E,0.896453660922897
HP_PROSTATITIS,SET,6,0.59909,0.010829,0.44336,0.088317,HP_PROSTATITIS,0.896453660922897
GSE14308_TH1_VS_INDUCED_TREG...1,SET,176,0.082682,0.0080568,0.061202,0.088362,GSE14308_TH1_VS_INDUCED_TREG_DN,0.896596369962308
GAO_STOMACH_24W_C2_TFF2POS_M...,SET,6,0.45507,0.0082256,0.33688,0.088386,GAO_STOMACH_24W_C2_TFF2POS_MULTIPOTENT_PROGENITOR,0.896596369962308
GSE22432_MULTIPOTENT_VS_COMM...4,SET,178,0.081509,0.0079871,0.060358,0.08845,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP,0.896596369962308
E2F1_UP.V1_DN,SET,176,0.086276,0.008407,0.063901,0.088494,E2F1_UP.V1_DN,0.896596369962308
GSE37605_C57BL6_VS_NOD_FOXP3...2,SET,148,0.098341,0.0087941,0.072847,0.088524,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_UP,0.896596369962308
GSE15735_CTRL_VS_HDAC_INHIBI...1,SET,185,0.084453,0.008435,0.062569,0.088556,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN,0.896596369962308
GOBP_BASEMENT_MEMBRANE_ORGAN...,SET,37,0.20311,0.0091093,0.15051,0.088596,GOBP_BASEMENT_MEMBRANE_ORGANIZATION,0.896596369962308
MIR3619_3P,SET,49,0.1938,0.0099991,0.14363,0.088634,MIR3619_3P,0.896596369962308
MIR770_5P,SET,93,0.12164,0.0086356,0.090164,0.088666,MIR770_5P,0.896596369962308
GOBP_MITOCHONDRIAL_ELECTRON_...3,SET,5,0.43143,0.007119,0.31982,0.088679,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_SUCCINATE_TO_UBIQUINONE,0.896596369962308
GOBP_POSITIVE_REGULATION_OF_...693,SET,5,0.52065,0.0085914,0.38603,0.08872,GOBP_POSITIVE_REGULATION_OF_SARCOMERE_ORGANIZATION,0.896596369962308
HP_ABNORMAL_MAGNESIUM_CONCEN...,SET,31,0.22535,0.0092525,0.16709,0.088725,HP_ABNORMAL_MAGNESIUM_CONCENTRATION,0.896596369962308
GOBP_REGULATION_OF_MYELOID_C...2,SET,186,0.088958,0.0089088,0.06597,0.088763,GOBP_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.896596369962308
GOMF_EXTRACELLULAR_MATRIX_PR...,SET,6,0.54468,0.0098454,0.40394,0.088771,GOMF_EXTRACELLULAR_MATRIX_PROTEIN_BINDING,0.896596369962308
HP_FUNCTIONAL_MOTOR_DEFICIT,SET,450,0.053646,0.0082955,0.039785,0.088772,HP_FUNCTIONAL_MOTOR_DEFICIT,0.896596369962308
HP_STEATORRHEA,SET,61,0.15623,0.0089908,0.11591,0.088851,HP_STEATORRHEA,0.896596369962308
GOCC_UBIQUINONE_BIOSYNTHESIS...,SET,6,0.38736,0.0070018,0.28738,0.088855,GOCC_UBIQUINONE_BIOSYNTHESIS_COMPLEX,0.896596369962308
MIR877_5P,SET,75,0.13475,0.0085949,0.099971,0.088863,MIR877_5P,0.896596369962308
WENG_POR_TARGETS_LIVER_UP,SET,41,0.18422,0.0086962,0.13668,0.08887,WENG_POR_TARGETS_LIVER_UP,0.896596369962308
GOBP_LIPID_HYDROXYLATION,SET,7,0.52324,0.010215,0.38823,0.088877,GOBP_LIPID_HYDROXYLATION,0.896596369962308
GSE17721_0.5H_VS_12H_CPG_BMD...2,SET,181,0.084891,0.0083876,0.062997,0.088911,GSE17721_0.5H_VS_12H_CPG_BMDC_UP,0.896596369962308
SP1_Q4_01,SET,231,0.074334,0.0082857,0.055163,0.088913,SP1_Q4_01,0.896596369962308
WP_PREIMPLANTATION_EMBRYO,SET,54,0.1627,0.0088111,0.12075,0.088932,WP_PREIMPLANTATION_EMBRYO,0.896596369962308
GSE17721_0.5H_VS_24H_LPS_BMD...2,SET,182,0.085552,0.008476,0.063506,0.088975,GSE17721_0.5H_VS_24H_LPS_BMDC_UP,0.896596369962308
GOBP_CHEMICAL_SYNAPTIC_TRANS...,SET,104,0.1184,0.008886,0.087886,0.088976,GOBP_CHEMICAL_SYNAPTIC_TRANSMISSION_POSTSYNAPTIC,0.896596369962308
GSE40274_CTRL_VS_FOXP3_AND_P...1,SET,148,0.092207,0.0082457,0.068461,0.08902,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.896779739130435
MORF_RAD23A,SET,303,0.061193,0.0077965,0.045441,0.089056,MORF_RAD23A,0.896882434077079
HP_VITREOUS_HEMORRHAGE,SET,16,0.27622,0.0081512,0.20517,0.089108,HP_VITREOUS_HEMORRHAGE,0.896928543717429
GSE30083_SP3_VS_SP4_THYMOCYT...1,SET,181,0.090253,0.0089173,0.067041,0.089123,GSE30083_SP3_VS_SP4_THYMOCYTE_DN,0.896928543717429
GOBP_CELL_FATE_COMMITMENT,SET,268,0.077391,0.0092822,0.057491,0.089138,GOBP_CELL_FATE_COMMITMENT,0.896928543717429
GOBP_KIDNEY_MORPHOGENESIS,SET,92,0.13209,0.0093276,0.098181,0.089256,GOBP_KIDNEY_MORPHOGENESIS,0.897458927125506
GOBP_POSITIVE_REGULATION_OF_...367,SET,8,0.35736,0.0074584,0.26562,0.089261,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_18_PRODUCTION,0.897458927125506
GOBP_POSITIVE_REGULATION_OF_...303,SET,7,0.48962,0.0095591,0.36396,0.089278,GOBP_POSITIVE_REGULATION_OF_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION,0.897458927125506
GOBP_NEGATIVE_REGULATION_OF_...643,SET,809,0.042122,0.0086454,0.031314,0.089294,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.897458927125506
PARK_TRETINOIN_RESPONSE_AND_...2,SET,20,0.28504,0.0094032,0.21196,0.08935,PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,0.897487952586207
JIANG_HYPOXIA_NORMAL,SET,189,0.080949,0.0081712,0.060207,0.0894,JIANG_HYPOXIA_NORMAL,0.897487952586207
GSE411_WT_VS_SOCS3_KO_MACROP...5,SET,184,0.089046,0.00887,0.066231,0.089407,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP,0.897487952586207
GOBP_POSITIVE_REGULATION_OF_...565,SET,50,0.16403,0.0085486,0.122,0.08941,GOBP_POSITIVE_REGULATION_OF_OSSIFICATION,0.897487952586207
GOBP_ATP_EXPORT,SET,6,0.55219,0.0099812,0.41082,0.089462,GOBP_ATP_EXPORT,0.897487952586207
HAY_BONE_MARROW_CD34_POS_MKP,SET,54,0.17281,0.0093584,0.12859,0.089511,HAY_BONE_MARROW_CD34_POS_MKP,0.897487952586207
GOBP_POSITIVE_REGULATION_OF_...527,SET,14,0.32892,0.0090799,0.24477,0.089517,GOBP_POSITIVE_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,0.897487952586207
GOBP_ERBB2_SIGNALING_PATHWAY,SET,23,0.25387,0.0089804,0.18896,0.089555,GOBP_ERBB2_SIGNALING_PATHWAY,0.897487952586207
HP_RECURRENT_ACUTE_RESPIRATO...,SET,11,0.32526,0.0079594,0.24209,0.089557,HP_RECURRENT_ACUTE_RESPIRATORY_TRACT_INFECTION,0.897487952586207
MIR510_5P,SET,59,0.14569,0.0082461,0.10848,0.089639,MIR510_5P,0.897487952586207
GOMF_3_HYDROXYACYL_COA_DEHYD...2,SET,5,0.5371,0.0088628,0.39992,0.089639,GOMF_3_HYDROXYACYL_COA_DEHYDROGENASE_ACTIVITY,0.897487952586207
GOBP_RIBONUCLEOSIDE_CATABOLI...,SET,18,0.34023,0.010648,0.25333,0.089643,GOBP_RIBONUCLEOSIDE_CATABOLIC_PROCESS,0.897487952586207
BRUNEAU_HEART_GREAT_VESSELS_...,SET,8,0.40271,0.0084049,0.29988,0.08966,BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS,0.897487952586207
HP_UNUSUAL_FUNGAL_INFECTION,SET,103,0.11678,0.0087224,0.086994,0.089751,HP_UNUSUAL_FUNGAL_INFECTION,0.897487952586207
HP_PORTAL_VEIN_THROMBOSIS,SET,11,0.3544,0.0086726,0.26403,0.089762,HP_PORTAL_VEIN_THROMBOSIS,0.897487952586207
IIZUKA_LIVER_CANCER_EARLY_RE...,SET,11,0.36973,0.0090478,0.27548,0.089784,IIZUKA_LIVER_CANCER_EARLY_RECURRENCE,0.897487952586207
HP_SHORT_TIBIA,SET,23,0.24375,0.0086222,0.18162,0.089791,HP_SHORT_TIBIA,0.897487952586207
HP_DELAYED_SOMATOSENSORY_CEN...,SET,3,0.68721,0.0087842,0.51208,0.089807,HP_DELAYED_SOMATOSENSORY_CENTRAL_CONDUCTION_TIME,0.897487952586207
GSE33424_CD161_HIGH_VS_INT_C...1,SET,184,0.083541,0.0083216,0.06226,0.089839,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN,0.897487952586207
HP_CAPILLARY_FRAGILITY,SET,6,0.48246,0.0087207,0.35957,0.089847,HP_CAPILLARY_FRAGILITY,0.897487952586207
GOBP_RNA_POLYMERASE_II_PREIN...,SET,52,0.14551,0.0077331,0.10845,0.089856,GOBP_RNA_POLYMERASE_II_PREINITIATION_COMPLEX_ASSEMBLY,0.897487952586207
GSE43863_TH1_VS_TFH_EFFECTOR...2,SET,187,0.085463,0.0085815,0.0637,0.089865,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_UP,0.897487952586207
GSE22229_RENAL_TRANSPLANT_IM...2,SET,185,0.081995,0.0081896,0.06113,0.089916,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_UP,0.897671144457209
REACTOME_HOMOLOGY_DIRECTED_R...,SET,96,0.10401,0.0075015,0.077548,0.089935,REACTOME_HOMOLOGY_DIRECTED_REPAIR,0.897671144457209
HP_ABNORMAL_UPPER_MOTOR_NEUR...,SET,14,0.27209,0.0075109,0.20297,0.090048,HP_ABNORMAL_UPPER_MOTOR_NEURON_MORPHOLOGY,0.898303028128588
KEGG_MEDICUS_PATHOGEN_HIV_NE...,SET,12,0.3133,0.0080075,0.23372,0.09005,KEGG_MEDICUS_PATHOGEN_HIV_NEF_TO_TNF_NFKB_SIGNALING_PATHWAY,0.898303028128588
HP_ABNORMAL_PLEURA_MORPHOLOGY,SET,168,0.093728,0.0089251,0.069935,0.090096,HP_ABNORMAL_PLEURA_MORPHOLOGY,0.898378886181193
HE_LIM_SUN_FETAL_LUNG_C2_PRO...2,SET,44,0.17066,0.0083448,0.12735,0.090124,HE_LIM_SUN_FETAL_LUNG_C2_PROMYELOCYTE_LIKE_CELL,0.898378886181193
MEISSNER_BRAIN_HCP_WITH_H3K2...,SET,251,0.080689,0.0093702,0.060218,0.090141,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,0.898378886181193
PHONG_TNF_RESPONSE_VIA_P38_P...,SET,155,0.10094,0.0092362,0.075342,0.090161,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,0.898378886181193
HP_ABNORMAL_RESPONSE_TO_INSU...,SET,8,0.43183,0.0090127,0.32248,0.090276,HP_ABNORMAL_RESPONSE_TO_INSULIN_TOLERANCE_TEST,0.898525636518288
GSE6674_CPG_VS_PL2_3_STIM_BC...2,SET,171,0.081343,0.007814,0.060744,0.090276,GSE6674_CPG_VS_PL2_3_STIM_BCELL_UP,0.898525636518288
GSE32986_GMCSF_VS_GMCSF_AND_...1,SET,167,0.091247,0.0086632,0.068149,0.090306,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.898525636518288
HP_EEG_WITH_CENTROTEMPORAL_E...,SET,3,0.73445,0.009388,0.54857,0.09032,HP_EEG_WITH_CENTROTEMPORAL_EPILEPTIFORM_DISCHARGES,0.898525636518288
GOBP_CELLULAR_MODIFIED_AMINO...1,SET,42,0.17759,0.0084844,0.13264,0.090325,GOBP_CELLULAR_MODIFIED_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.898525636518288
DESCARTES_FETAL_HEART_EPICAR...,SET,90,0.1285,0.0089753,0.095994,0.090352,DESCARTES_FETAL_HEART_EPICARDIAL_FAT_CELLS,0.898525636518288
GOBP_REGULATION_OF_B_CELL_DI...,SET,31,0.21081,0.0086555,0.15752,0.090408,GOBP_REGULATION_OF_B_CELL_DIFFERENTIATION,0.898525636518288
GSE39820_CTRL_VS_IL1B_IL6_IL...1,SET,185,0.086496,0.0086391,0.064639,0.090435,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN,0.898525636518288
GSE23321_CENTRAL_VS_EFFECTOR...1,SET,178,0.084671,0.0082969,0.06328,0.090449,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,0.898525636518288
GCACTTT_MIR175P_MIR20A_MIR10...,SET,545,0.049727,0.0084399,0.037166,0.09046,GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D,0.898525636518288
REACTOME_EICOSANOIDS,SET,12,0.39984,0.010219,0.29889,0.090498,REACTOME_EICOSANOIDS,0.898525636518288
GOBP_PROTEIN_MATURATION_BY_P...,SET,6,0.44186,0.0079869,0.33031,0.090506,GOBP_PROTEIN_MATURATION_BY_PROTEIN_FOLDING,0.898525636518288
MIKKELSEN_NPC_HCP_WITH_H3K4M...,SET,202,0.089434,0.0093296,0.06687,0.09055,MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.898525636518288
GOMF_CARBOHYDRATE_PHOSPHATAS...,SET,8,0.38831,0.0081042,0.29048,0.090655,GOMF_CARBOHYDRATE_PHOSPHATASE_ACTIVITY,0.898525636518288
GOBP_REGULATION_OF_CYTOSKELE...,SET,463,0.053223,0.008345,0.039817,0.090673,GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION,0.898525636518288
GOBP_REGULATION_OF_IMMUNOGLO...,SET,62,0.1392,0.0080756,0.10414,0.090683,GOBP_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,0.898525636518288
WP_SEROTONIN_AND_ANXIETYRELA...,SET,12,0.39009,0.0099702,0.29187,0.090698,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,0.898525636518288
GOBP_PERIPHERAL_NERVOUS_SYST...2,SET,8,0.48072,0.010033,0.3597,0.090714,GOBP_PERIPHERAL_NERVOUS_SYSTEM_AXON_REGENERATION,0.898525636518288
GSE7831_CPG_VS_INFLUENZA_STI...3,SET,177,0.082148,0.0080273,0.061484,0.090768,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_DN,0.898525636518288
ZNF454_TARGET_GENES,SET,11,0.36374,0.0089011,0.27226,0.090782,ZNF454_TARGET_GENES,0.898525636518288
chr2p13,SET,81,0.29457,0.019524,0.22051,0.090804,chr2p13,0.898525636518288
GSE3039_ALPHABETA_CD8_TCELL_...4,SET,180,0.08506,0.0083813,0.063701,0.090897,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP,0.898525636518288
GAUTAM_EYE_CORNEA_CONJUNCTIV...,SET,92,0.12125,0.0085618,0.090805,0.090906,GAUTAM_EYE_CORNEA_CONJUNCTIVAL_CELLS,0.898525636518288
chr8p23,SET,42,0.31283,0.014946,0.23431,0.090929,chr8p23,0.898525636518288
MIR539_5P,SET,341,0.064039,0.0086464,0.047971,0.090955,MIR539_5P,0.898525636518288
GOMF_PROTEIN_CONTAINING_COMP...2,SET,15,0.29136,0.008325,0.21829,0.090986,GOMF_PROTEIN_CONTAINING_COMPLEX_DESTABILIZING_ACTIVITY,0.898525636518288
GOBP_MONOCARBOXYLIC_ACID_BIO...,SET,202,0.082538,0.0086102,0.061839,0.09099,GOBP_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS,0.898525636518288
KEGG_MEDICUS_REFERENCE_N_GLY...1,SET,16,0.29255,0.0086329,0.21919,0.091002,KEGG_MEDICUS_REFERENCE_N_GLYCAN_BIOSYNTHESIS,0.898525636518288
HP_MICROLISSENCEPHALY,SET,5,0.54654,0.0090185,0.40959,0.091051,HP_MICROLISSENCEPHALY,0.898525636518288
HP_PRECOCIOUS_ATHEROSCLEROSIS,SET,12,0.36607,0.0093562,0.27435,0.091056,HP_PRECOCIOUS_ATHEROSCLEROSIS,0.898525636518288
HP_CLOSED_NEURAL_TUBE_DEFECT,SET,67,0.14446,0.0087111,0.10828,0.091092,HP_CLOSED_NEURAL_TUBE_DEFECT,0.898525636518288
REACTOME_LAMININ_INTERACTIONS,SET,28,0.23142,0.009031,0.17348,0.091117,REACTOME_LAMININ_INTERACTIONS,0.898525636518288
WANG_THOC1_TARGETS_UP,SET,5,0.54952,0.0090678,0.41202,0.091154,WANG_THOC1_TARGETS_UP,0.898525636518288
GSE36888_STAT5_AB_KNOCKIN_VS...2,SET,182,0.082797,0.0082031,0.06208,0.091156,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP,0.898525636518288
REACTOME_ACTIVATED_NTRK3_SIG...1,SET,6,0.51556,0.0093191,0.38657,0.09116,REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K,0.898525636518288
KEGG_MEDICUS_VARIANT_LOSS_OF...3,SET,6,0.42066,0.0076037,0.31543,0.091173,KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY,0.898525636518288
GSE27241_WT_VS_RORGT_KO_TH17...3,SET,166,0.084832,0.0080302,0.063611,0.091175,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP,0.898525636518288
FARMER_BREAST_CANCER_CLUSTER...4,SET,18,0.29764,0.0093153,0.22319,0.091179,FARMER_BREAST_CANCER_CLUSTER_4,0.898525636518288
MYCMAX_B,SET,245,0.073808,0.0084695,0.055347,0.091184,MYCMAX_B,0.898525636518288
MIR4749_5P,SET,4,0.58959,0.0087021,0.44219,0.091215,MIR4749_5P,0.898576339285714
HP_ABNORMAL_CIRCULATING_LEPT...,SET,12,0.3353,0.0085697,0.2515,0.091243,HP_ABNORMAL_CIRCULATING_LEPTIN_CONCENTRATION,0.898597468121281
GOMF_DENEDDYLASE_ACTIVITY,SET,6,0.39084,0.0070647,0.29325,0.09131,GOMF_DENEDDYLASE_ACTIVITY,0.899002563739377
GOBP_MAST_CELL_CYTOKINE_PROD...,SET,6,0.51884,0.0093784,0.38943,0.091385,GOBP_MAST_CELL_CYTOKINE_PRODUCTION,0.899486172472387
GOBP_CENTROMERE_COMPLEX_ASSE...,SET,26,0.20064,0.0075453,0.15062,0.091423,GOBP_CENTROMERE_COMPLEX_ASSEMBLY,0.89960542610419
GSE17721_CTRL_VS_GARDIQUIMOD...3,SET,184,0.083596,0.0083271,0.062771,0.09148,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN,0.899857607837609
GOMF_SPHINGOLIPID_TRANSFER_A...,SET,7,0.3958,0.0077274,0.29732,0.091564,GOMF_SPHINGOLIPID_TRANSFER_ACTIVITY,0.899857607837609
GOBP_TOLL_LIKE_RECEPTOR_2_SI...,SET,16,0.30138,0.0088936,0.22644,0.091611,GOBP_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.899857607837609
HP_CONICAL_TOOTH,SET,49,0.17836,0.0092022,0.13401,0.091618,HP_CONICAL_TOOTH,0.899857607837609
NAKAYA_PBMC_FLUMIST_AGE_18_5...7,SET,1366,0.030702,0.0080572,0.023071,0.091641,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP,0.899857607837609
HAY_BONE_MARROW_CD34_POS_CLP,SET,7,0.50699,0.0098982,0.38112,0.091725,HAY_BONE_MARROW_CD34_POS_CLP,0.899857607837609
ROZANOV_MMP14_TARGETS_UP,SET,242,0.077148,0.0087991,0.057999,0.09174,ROZANOV_MMP14_TARGETS_UP,0.899857607837609
HP_WRIST_FLEXION_CONTRACTURE,SET,33,0.22083,0.0093543,0.16602,0.091747,HP_WRIST_FLEXION_CONTRACTURE,0.899857607837609
ATF_01,SET,240,0.075826,0.008613,0.057009,0.091756,ATF_01,0.899857607837609
RODRIGUES_THYROID_CARCINOMA_...3,SET,73,0.14994,0.0094363,0.11274,0.09177,RODRIGUES_THYROID_CARCINOMA_DN,0.899857607837609
GOBP_LENS_FIBER_CELL_DEVELOP...,SET,14,0.3188,0.0088003,0.2397,0.091772,GOBP_LENS_FIBER_CELL_DEVELOPMENT,0.899857607837609
GOMF_BETA_GALACTOSIDE_CMP_AL...,SET,7,0.37241,0.0072707,0.28004,0.091791,GOMF_BETA_GALACTOSIDE_CMP_ALPHA_2_3_SIALYLTRANSFERASE_ACTIVITY,0.899857607837609
GOCC_MICROTUBULE_PLUS_END,SET,24,0.24099,0.0087079,0.18124,0.091822,GOCC_MICROTUBULE_PLUS_END,0.899857607837609
GOBP_CELL_ADHESION_MEDIATED_...,SET,82,0.12872,0.0085839,0.096812,0.091827,GOBP_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.899857607837609
GOBP_POSITIVE_REGULATION_OF_...798,SET,61,0.15073,0.0086741,0.11337,0.091837,GOBP_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.899857607837609
GOBP_ESTROUS_CYCLE,SET,16,0.27748,0.0081881,0.20878,0.091923,GOBP_ESTROUS_CYCLE,0.900084562604807
WP_LNCRNA_IN_CANONICAL_WNT_S...,SET,89,0.127,0.0088211,0.095568,0.091954,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,0.900084562604807
GOBP_MYELOID_CELL_DIFFERENTI...,SET,392,0.060042,0.0086795,0.045193,0.092004,GOBP_MYELOID_CELL_DIFFERENTIATION,0.900084562604807
TGANNYRGCA_TCF11MAFG_01,SET,269,0.069923,0.008402,0.052641,0.092048,TGANNYRGCA_TCF11MAFG_01,0.900084562604807
GOBP_REGULATION_OF_SARCOMERE...,SET,8,0.4004,0.0083567,0.30144,0.09205,GOBP_REGULATION_OF_SARCOMERE_ORGANIZATION,0.900084562604807
HEIDENBLAD_AMPLICON_8Q24_UP,SET,35,0.17128,0.0074718,0.12896,0.092069,HEIDENBLAD_AMPLICON_8Q24_UP,0.900084562604807
MIR4536_5P,SET,41,0.17449,0.0082368,0.13138,0.092084,MIR4536_5P,0.900084562604807
GSE2128_CTRL_VS_MIMETOPE_NEG...2,SET,158,0.092982,0.0085889,0.070024,0.09212,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_UP,0.900084562604807
GSE3039_CD4_TCELL_VS_NKT_CEL...2,SET,182,0.079001,0.007827,0.059515,0.092192,GSE3039_CD4_TCELL_VS_NKT_CELL_UP,0.900084562604807
GOMF_MYOSIN_II_BINDING,SET,11,0.32908,0.0080528,0.24795,0.092229,GOMF_MYOSIN_II_BINDING,0.900084562604807
MIR6828_3P,SET,107,0.1109,0.008442,0.083568,0.092252,MIR6828_3P,0.900084562604807
GOBP_NEGATIVE_REGULATION_OF_...137,SET,6,0.43581,0.0078776,0.32845,0.092284,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY,0.900084562604807
GSE3203_INFLUENZA_INF_VS_IFN...1,SET,172,0.086891,0.0083711,0.065485,0.092284,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_DN,0.900084562604807
HP_REDUCED_MUSCLE_FIBER_ALPH...,SET,8,0.3952,0.0082481,0.29789,0.092316,HP_REDUCED_MUSCLE_FIBER_ALPHA_DYSTROGLYCAN,0.900084562604807
MIR10527_5P,SET,531,0.052757,0.0088419,0.039767,0.092319,MIR10527_5P,0.900084562604807
WHITE_NEUROBLASTOMA_WITH_1P3...,SET,19,0.36655,0.011786,0.27635,0.09236,WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION,0.900084562604807
HP_HIPPOCAMPAL_ATROPHY,SET,5,0.52219,0.0086168,0.39378,0.092412,HP_HIPPOCAMPAL_ATROPHY,0.900084562604807
HP_DISPROPORTIONATE_SHORT_TR...,SET,24,0.22535,0.0081426,0.16993,0.092413,HP_DISPROPORTIONATE_SHORT_TRUNK_SHORT_STATURE,0.900084562604807
GSE1112_OT1_VS_HY_CD8AB_THYM...1,SET,177,0.082665,0.0080778,0.062352,0.092464,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_DN,0.900084562604807
WP_BASE_EXCISION_REPAIR,SET,30,0.17639,0.0071248,0.13307,0.092497,WP_BASE_EXCISION_REPAIR,0.900084562604807
GOBP_TRIGLYCERIDE_CATABOLIC_...,SET,26,0.24583,0.0092449,0.18549,0.092546,GOBP_TRIGLYCERIDE_CATABOLIC_PROCESS,0.900084562604807
MIR6748_5P,SET,59,0.15019,0.0085008,0.11334,0.09257,MIR6748_5P,0.900084562604807
MIR6793_5P,SET,56,0.15673,0.0086432,0.11828,0.092576,MIR6793_5P,0.900084562604807
GSE6259_FLT3L_INDUCED_DEC205...5,SET,161,0.091486,0.0085299,0.069044,0.092586,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN,0.900084562604807
GSE25088_WT_VS_STAT6_KO_MACR...6,SET,180,0.083479,0.0082255,0.063001,0.092588,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,0.900084562604807
GOBP_G_PROTEIN_COUPLED_PURIN...1,SET,10,0.46366,0.010819,0.34994,0.092601,GOBP_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY,0.900084562604807
GOMF_G_PROTEIN_COUPLED_PURIN...,SET,10,0.46366,0.010819,0.34994,0.092601,GOMF_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_ACTIVITY,0.900084562604807
WEBER_METHYLATED_IN_COLON_CA...,SET,18,0.28764,0.0090025,0.21712,0.092622,WEBER_METHYLATED_IN_COLON_CANCER,0.900084562604807
KONDO_HYPOXIA,SET,6,0.46481,0.0084017,0.35087,0.092638,KONDO_HYPOXIA,0.900084562604807
GSE2706_UNSTIM_VS_8H_R848_DC...2,SET,172,0.086445,0.0083281,0.065259,0.092653,GSE2706_UNSTIM_VS_8H_R848_DC_UP,0.900084562604807
MIR5006_3P,SET,334,0.064906,0.0086748,0.049001,0.092663,MIR5006_3P,0.900084562604807
MODULE_532,SET,366,0.059583,0.0083287,0.044998,0.09274,MODULE_532,0.900384132980206
HP_RED_EYE,SET,99,0.11302,0.0082769,0.085366,0.092777,HP_RED_EYE,0.900384132980206
GOMF_FILAMIN_BINDING,SET,12,0.34675,0.0088624,0.262,0.09285,GOMF_FILAMIN_BINDING,0.900384132980206
GOBP_PATTERN_SPECIFICATION_P...,SET,433,0.059466,0.0090244,0.044938,0.092879,GOBP_PATTERN_SPECIFICATION_PROCESS,0.900384132980206
REACTOME_TANDEM_PORE_DOMAIN_...,SET,12,0.35486,0.0090696,0.26817,0.092889,REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS,0.900384132980206
REACTOME_RELEASE_OF_HH_NP_FR...,SET,8,0.37837,0.0078969,0.28597,0.092906,REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL,0.900384132980206
HP_BARREL_SHAPED_CHEST,SET,20,0.26087,0.0086058,0.19718,0.092922,HP_BARREL_SHAPED_CHEST,0.900384132980206
KRAS.KIDNEY_UP.V1_DN,SET,121,0.10997,0.0088989,0.083124,0.092922,KRAS.KIDNEY_UP.V1_DN,0.900384132980206
GOBP_POSITIVE_REGULATION_OF_...610,SET,21,0.24922,0.0084243,0.18838,0.092927,GOBP_POSITIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,0.900384132980206
HP_CYSTIC_RENAL_DYSPLASIA,SET,8,0.38635,0.0080633,0.29208,0.092966,HP_CYSTIC_RENAL_DYSPLASIA,0.900467817195326
GOBP_REGULATION_OF_ENAMEL_MI...,SET,7,0.45144,0.0088136,0.34134,0.093004,GOBP_REGULATION_OF_ENAMEL_MINERALIZATION,0.900467817195326
GOBP_REGULATION_OF_CELL_KILL...,SET,106,0.12308,0.0093251,0.093071,0.09303,GOBP_REGULATION_OF_CELL_KILLING,0.900467817195326
GOCC_POLYMERIC_CYTOSKELETAL_...,SET,687,0.045435,0.0086234,0.034362,0.093052,GOCC_POLYMERIC_CYTOSKELETAL_FIBER,0.900467817195326
GOBP_LONG_CHAIN_FATTY_ACID_C...,SET,8,0.40464,0.0084451,0.30605,0.093073,GOBP_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.900467817195326
GSE26928_NAIVE_VS_CENT_MEMOR...1,SET,170,0.083741,0.0080211,0.063344,0.093092,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,0.900467817195326
GROSS_ELK3_TARGETS_DN,SET,32,0.21185,0.008837,0.16026,0.093117,GROSS_ELK3_TARGETS_DN,0.900467817195326
GOCC_GAMMA_DELTA_T_CELL_RECE...,SET,3,0.65891,0.0084224,0.49856,0.093156,GOCC_GAMMA_DELTA_T_CELL_RECEPTOR_COMPLEX,0.900594375521558
GSE15930_NAIVE_VS_24H_IN_VIT...5,SET,189,0.075993,0.0076709,0.057516,0.093219,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN,0.900952821190211
GOMF_PHOSPHOLIPID_SCRAMBLASE...,SET,15,0.32032,0.0091525,0.24251,0.093289,GOMF_PHOSPHOLIPID_SCRAMBLASE_ACTIVITY,0.901004066666667
GSE17974_CTRL_VS_ACT_IL4_AND...18,SET,172,0.087794,0.0084581,0.066479,0.093321,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP,0.901004066666667
HE_LIM_SUN_FETAL_LUNG_C0_ACT...,SET,520,0.05103,0.0084659,0.038641,0.093321,HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL,0.901004066666667
LIEN_BREAST_CARCINOMA_METAPL...1,SET,32,0.2211,0.0092232,0.16743,0.093328,LIEN_BREAST_CARCINOMA_METAPLASTIC,0.901004066666667
VAN_DEN_BIGGELAAR_PBMC_PREVN...2,SET,4,0.58501,0.0086344,0.44306,0.093362,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_DN,0.901082007775618
GSE6259_FLT3L_INDUCED_33D1_P...6,SET,134,0.098497,0.0083844,0.074614,0.093411,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_UP,0.901304637701277
GOBP_B_CELL_CHEMOTAXIS,SET,8,0.46734,0.0097536,0.3542,0.093525,GOBP_B_CELL_CHEMOTAXIS,0.901610478693968
REACTOME_MATERNAL_TO_ZYGOTIC...,SET,58,0.14776,0.0082922,0.11201,0.093557,REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT,0.901610478693968
GOBP_REGULATION_OF_PROTEIN_E...2,SET,34,0.18836,0.0080988,0.14279,0.093561,GOBP_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.901610478693968
IYENGAR_RESPONSE_TO_ADIPOCYT...,SET,10,0.4067,0.0094895,0.30835,0.0936,IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS,0.901610478693968
BENPORATH_ES_CORE_NINE_CORRE...,SET,94,0.11856,0.0084622,0.089893,0.093604,BENPORATH_ES_CORE_NINE_CORRELATED,0.901610478693968
VICENT_METASTASIS_UP,SET,13,0.31786,0.0084556,0.241,0.093604,VICENT_METASTASIS_UP,0.901610478693968
GSE17721_PAM3CSK4_VS_GADIQUI...13,SET,181,0.081724,0.0080747,0.061972,0.093638,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN,0.901610478693968
BIOCARTA_EIF_PATHWAY,SET,13,0.28485,0.0075775,0.21603,0.093666,BIOCARTA_EIF_PATHWAY,0.901610478693968
AML_Q6,SET,238,0.073883,0.0083578,0.05604,0.093691,AML_Q6,0.901610478693968
HP_APLASIA_HYPOPLASIA_OF_THE...13,SET,18,0.29567,0.0092537,0.22429,0.093723,HP_APLASIA_HYPOPLASIA_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS,0.901610478693968
GOBP_HINDBRAIN_TANGENTIAL_CE...,SET,5,0.47862,0.0078977,0.36311,0.09374,GOBP_HINDBRAIN_TANGENTIAL_CELL_MIGRATION,0.901610478693968
MIR4733_3P,SET,66,0.13442,0.0080451,0.10198,0.093754,MIR4733_3P,0.901610478693968
GOBP_AUTOPHAGOSOME_MATURATION,SET,60,0.13431,0.0076659,0.10197,0.093893,GOBP_AUTOPHAGOSOME_MATURATION,0.901979113504557
KEGG_MEDICUS_PATHOGEN_HTLV_1...2,SET,6,0.54897,0.0099229,0.41683,0.093927,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY,0.901979113504557
HP_INCREASED_SENSITIVITY_TO_...,SET,12,0.29329,0.007496,0.2227,0.093931,HP_INCREASED_SENSITIVITY_TO_IONIZING_RADIATION,0.901979113504557
REACTOME_DISEASES_OF_MISMATC...,SET,5,0.4202,0.0069337,0.31906,0.093932,REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR,0.901979113504557
HAY_BONE_MARROW_CD34_POS_PRE...1,SET,80,0.13602,0.0089596,0.1033,0.093963,HAY_BONE_MARROW_CD34_POS_PRE_B,0.901979113504557
NAGY_STAGA_COMPONENTS_HUMAN,SET,13,0.26489,0.0070464,0.20116,0.093965,NAGY_STAGA_COMPONENTS_HUMAN,0.901979113504557
GSE8621_LPS_PRIMED_UNSTIM_VS...2,SET,175,0.082164,0.0079838,0.0624,0.093974,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,0.901979113504557
VALK_AML_CLUSTER_4,SET,25,0.23984,0.0088446,0.18225,0.094097,VALK_AML_CLUSTER_4,0.902477387001872
GOBP_REGULATION_OF_NUCLEOTID...2,SET,9,0.4222,0.0093458,0.32086,0.094127,GOBP_REGULATION_OF_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY,0.902477387001872
LIM_MAMMARY_LUMINAL_PROGENIT...1,SET,14,0.33393,0.0092181,0.25379,0.094134,LIM_MAMMARY_LUMINAL_PROGENITOR_DN,0.902477387001872
GOMF_ACID_AMINO_ACID_LIGASE_...,SET,22,0.24801,0.0085803,0.18858,0.094244,GOMF_ACID_AMINO_ACID_LIGASE_ACTIVITY,0.902477387001872
GOBP_NEGATIVE_REGULATION_OF_...658,SET,5,0.50247,0.0082914,0.3821,0.094258,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,0.902477387001872
GOBP_REGULATION_OF_MEIOTIC_N...,SET,32,0.20704,0.0086365,0.15744,0.09426,GOBP_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.902477387001872
ZHAN_V1_LATE_DIFFERENTIATION...2,SET,31,0.19505,0.0080085,0.14833,0.094265,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,0.902477387001872
GOBP_INTRACELLULAR_PHOSPHATE...,SET,9,0.44713,0.0098978,0.34014,0.09434,GOBP_INTRACELLULAR_PHOSPHATE_ION_HOMEOSTASIS,0.902477387001872
REACTOME_RET_SIGNALING,SET,40,0.17605,0.0082088,0.13393,0.094347,REACTOME_RET_SIGNALING,0.902477387001872
GOMF_ADENYL_NUCLEOTIDE_BINDI...,SET,1501,0.029995,0.0082187,0.022819,0.094357,GOMF_ADENYL_NUCLEOTIDE_BINDING,0.902477387001872
GOCC_B_CELL_RECEPTOR_COMPLEX,SET,5,0.48969,0.0080804,0.37255,0.094361,GOCC_B_CELL_RECEPTOR_COMPLEX,0.902477387001872
GSE16450_CTRL_VS_IFNA_6H_STI...1,SET,157,0.090102,0.0082967,0.068553,0.094374,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.902477387001872
GSE22886_CD4_TCELL_VS_BCELL_...2,SET,183,0.080614,0.0080085,0.061343,0.094405,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP,0.902477387001872
HP_ABNORMALITY_OF_THE_GLENOI...,SET,6,0.4799,0.0086745,0.36523,0.094437,HP_ABNORMALITY_OF_THE_GLENOID_FOSSA,0.902477387001872
CASORELLI_APL_SECONDARY_VS_D...,SET,34,0.20078,0.0086326,0.15282,0.094455,CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP,0.902477387001872
GOBP_DEFENSE_RESPONSE_TO_BAC...,SET,273,0.076006,0.0091995,0.057882,0.094579,GOBP_DEFENSE_RESPONSE_TO_BACTERIUM,0.902477387001872
GOCC_CTF18_RFC_LIKE_COMPLEX,SET,8,0.37263,0.007777,0.28377,0.09458,GOCC_CTF18_RFC_LIKE_COMPLEX,0.902477387001872
GOBP_CALCIUM_ION_REGULATED_E...2,SET,21,0.24552,0.0082991,0.18702,0.094633,GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS_OF_NEUROTRANSMITTER,0.902477387001872
MIR4755_5P,SET,333,0.064398,0.0085943,0.049061,0.094664,MIR4755_5P,0.902477387001872
HP_MONOCYTOSIS,SET,15,0.28069,0.0080201,0.21388,0.094707,HP_MONOCYTOSIS,0.902477387001872
HP_COMMON_ATRIUM,SET,8,0.40197,0.0083893,0.30633,0.094736,HP_COMMON_ATRIUM,0.902477387001872
GSE24671_CTRL_VS_SENDAI_VIRU...1,SET,177,0.079716,0.0077896,0.06075,0.094737,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,0.902477387001872
GOBP_NEGATIVE_REGULATION_OF_...39,SET,7,0.43518,0.0084961,0.33165,0.09474,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.902477387001872
GOBP_POSITIVE_REGULATION_OF_...105,SET,459,0.053285,0.0083196,0.040622,0.094816,GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS,0.902477387001872
GOBP_NEURON_MATURATION,SET,46,0.16987,0.0084926,0.12951,0.094824,GOBP_NEURON_MATURATION,0.902477387001872
FONTAINE_PAPILLARY_THYROID_C...2,SET,61,0.1496,0.0086091,0.11407,0.094851,FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,0.902477387001872
MIR6890_3P,SET,82,0.12732,0.0084901,0.097081,0.094859,MIR6890_3P,0.902477387001872
AIGNER_ZEB1_TARGETS,SET,33,0.21369,0.0090518,0.16295,0.094871,AIGNER_ZEB1_TARGETS,0.902477387001872
MIR340_3P,SET,44,0.16435,0.0080366,0.12535,0.094915,MIR340_3P,0.902477387001872
GSE6259_BCELL_VS_CD8_TCELL_DN,SET,168,0.090029,0.0085729,0.068685,0.094981,GSE6259_BCELL_VS_CD8_TCELL_DN,0.902477387001872
GSE36888_STAT5_AB_KNOCKIN_VS...4,SET,169,0.088713,0.0084725,0.067694,0.095022,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP,0.902477387001872
VANTVEER_BREAST_CANCER_BRCA1...1,SET,37,0.18492,0.0082933,0.14111,0.095033,VANTVEER_BREAST_CANCER_BRCA1_DN,0.902477387001872
MIR6826_5P,SET,34,0.18663,0.0080241,0.14244,0.095068,MIR6826_5P,0.902477387001872
GOBP_CARDIAC_MUSCLE_CELL_CON...,SET,78,0.13564,0.0088229,0.10354,0.095084,GOBP_CARDIAC_MUSCLE_CELL_CONTRACTION,0.902477387001872
MODULE_206,SET,144,0.09197,0.0081135,0.07021,0.095117,MODULE_206,0.902477387001872
GSE26495_NAIVE_VS_PD1LOW_CD8...2,SET,153,0.093478,0.0084982,0.071362,0.095122,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP,0.902477387001872
GSE8621_UNSTIM_VS_LPS_PRIMED...4,SET,176,0.083702,0.0081562,0.063901,0.095129,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_UP,0.902477387001872
GOBP_BUNDLE_OF_HIS_CELL_TO_P...1,SET,15,0.34882,0.0099669,0.26638,0.095192,GOBP_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_COMMUNICATION,0.902477387001872
MODULE_301,SET,136,0.098881,0.0084792,0.075523,0.095227,MODULE_301,0.902477387001872
GOMF_L_ORNITHINE_TRANSMEMBRA...,SET,4,0.68127,0.010055,0.52041,0.095255,GOMF_L_ORNITHINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.902477387001872
GOBP_POSITIVE_REGULATION_OF_...763,SET,6,0.4845,0.0087576,0.37011,0.095262,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.902477387001872
ENGELMANN_CANCER_PROGENITORS...2,SET,46,0.17591,0.0087943,0.13438,0.095277,ENGELMANN_CANCER_PROGENITORS_UP,0.902477387001872
GOBP_INORGANIC_ANION_TRANSPO...,SET,159,0.094367,0.0087442,0.072096,0.09529,GOBP_INORGANIC_ANION_TRANSPORT,0.902477387001872
WANG_METHYLATED_IN_BREAST_CA...,SET,34,0.20602,0.0088582,0.15744,0.095351,WANG_METHYLATED_IN_BREAST_CANCER,0.902477387001872
GOBP_PROTEIN_LOCALIZATION_TO...19,SET,7,0.37418,0.0073053,0.28599,0.095385,GOBP_PROTEIN_LOCALIZATION_TO_CYTOPLASMIC_STRESS_GRANULE,0.902477387001872
GSE18804_SPLEEN_MACROPHAGE_V...4,SET,182,0.083601,0.0082827,0.063902,0.0954,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP,0.902477387001872
GOBP_RNA_DECAPPING,SET,17,0.28763,0.0087486,0.21988,0.095427,GOBP_RNA_DECAPPING,0.902477387001872
GOMF_DIACYLGLYCEROL_O_ACYLTR...,SET,5,0.54422,0.0089802,0.41608,0.095451,GOMF_DIACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,0.902477387001872
WP_CHRONIC_HYPERGLYCEMIA_IMP...,SET,43,0.19125,0.009245,0.14623,0.095467,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.902477387001872
MORF_THRA,SET,46,0.17366,0.0086818,0.13282,0.095542,MORF_THRA,0.902477387001872
GOBP_REGULATION_OF_DIGESTIVE...,SET,38,0.18376,0.008352,0.14055,0.095543,GOBP_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,0.902477387001872
HP_OPTIC_NERVE_COMPRESSION,SET,14,0.30645,0.0084596,0.23447,0.095612,HP_OPTIC_NERVE_COMPRESSION,0.902477387001872
GSE14350_IL2RB_KO_VS_WT_TREG...1,SET,181,0.083986,0.0082981,0.064258,0.095615,GSE14350_IL2RB_KO_VS_WT_TREG_DN,0.902477387001872
IVANOV_MUTATED_IN_COLON_CANC...,SET,13,0.26391,0.0070203,0.20205,0.095758,IVANOV_MUTATED_IN_COLON_CANCER,0.902477387001872
GOMF_PROLINE_SODIUM_SYMPORTE...,SET,5,0.61857,0.010207,0.47358,0.095758,GOMF_PROLINE_SODIUM_SYMPORTER_ACTIVITY,0.902477387001872
GSE30962_ACUTE_VS_CHRONIC_LC...2,SET,176,0.083493,0.0081359,0.063981,0.095959,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP,0.902477387001872
GOBP_NEGATIVE_REGULATION_OF_...589,SET,27,0.21654,0.0082984,0.16595,0.09597,GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.902477387001872
GOCC_GPI_ANCHOR_TRANSAMIDASE...,SET,5,0.4062,0.0067028,0.31132,0.095996,GOCC_GPI_ANCHOR_TRANSAMIDASE_COMPLEX,0.902477387001872
HP_PALMAR_TELANGIECTASIA,SET,7,0.44492,0.0086864,0.34101,0.096,HP_PALMAR_TELANGIECTASIA,0.902477387001872
GSE26669_CD4_VS_CD8_TCELL_IN...2,SET,181,0.082046,0.0081065,0.062885,0.096008,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP,0.902477387001872
GOBP_NEGATIVE_REGULATION_OF_...404,SET,5,0.58821,0.009706,0.45093,0.096051,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,0.902477387001872
REACTOME_VOLTAGE_GATED_POTAS...,SET,42,0.19556,0.0093433,0.14994,0.096071,REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS,0.902477387001872
MIR4694_5P,SET,34,0.19852,0.0085356,0.15221,0.096073,MIR4694_5P,0.902477387001872
HP_COUGH,SET,135,0.098612,0.0084253,0.075612,0.096094,HP_COUGH,0.902477387001872
GSE17721_CTRL_VS_PAM3CSK4_4H...1,SET,187,0.080497,0.0080829,0.061723,0.096095,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN,0.902477387001872
REACTOME_KIDNEY_DEVELOPMENT,SET,42,0.19601,0.0093647,0.1503,0.09611,REACTOME_KIDNEY_DEVELOPMENT,0.902477387001872
TAKEDA_TARGETS_OF_NUP98_HOXA...9,SET,176,0.090784,0.0088463,0.069627,0.096147,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,0.902477387001872
GOBP_POSITIVE_REGULATION_OF_...769,SET,1151,0.034067,0.0082584,0.026129,0.09616,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.902477387001872
GSE3720_UNSTIM_VS_PMA_STIM_V...3,SET,173,0.081928,0.0079157,0.062848,0.096195,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,0.902477387001872
ZHANG_GATA6_TARGETS_DN,SET,61,0.14821,0.0085293,0.11371,0.096216,ZHANG_GATA6_TARGETS_DN,0.902477387001872
GOBP_L_LEUCINE_CATABOLIC_PRO...,SET,6,0.44099,0.0079712,0.33837,0.09625,GOBP_L_LEUCINE_CATABOLIC_PROCESS,0.902477387001872
VANLOO_SP3_TARGETS_DN,SET,83,0.11448,0.0076802,0.087848,0.096268,VANLOO_SP3_TARGETS_DN,0.902477387001872
MIR3923,SET,45,0.16627,0.0082219,0.12761,0.096297,MIR3923,0.902477387001872
HP_RECURRENT_GASTROENTERITIS,SET,12,0.30926,0.0079041,0.23735,0.096304,HP_RECURRENT_GASTROENTERITIS,0.902477387001872
GOBP_CYCLIC_NUCLEOTIDE_TRANS...,SET,11,0.36146,0.0088453,0.27742,0.096305,GOBP_CYCLIC_NUCLEOTIDE_TRANSPORT,0.902477387001872
GOBP_CELLULAR_RESPONSE_TO_TH...,SET,12,0.38198,0.0097628,0.29317,0.096312,GOBP_CELLULAR_RESPONSE_TO_THYROID_HORMONE_STIMULUS,0.902477387001872
GSE3982_NKCELL_VS_TH2_UP,SET,171,0.088352,0.0084873,0.067816,0.096326,GSE3982_NKCELL_VS_TH2_UP,0.902477387001872
GOBP_INTEGRIN_ACTIVATION,SET,26,0.22753,0.0085567,0.17466,0.096339,GOBP_INTEGRIN_ACTIVATION,0.902477387001872
GSE25088_WT_VS_STAT6_KO_MACR...3,SET,176,0.081814,0.0079722,0.062805,0.096351,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP,0.902477387001872
HP_ANKYLOBLEPHARON,SET,13,0.26558,0.0070648,0.2039,0.096385,HP_ANKYLOBLEPHARON,0.902477387001872
FEKIR_HEPARG_SPHERE_VS_HEPAR...2,SET,95,0.1192,0.0085523,0.09152,0.096398,FEKIR_HEPARG_SPHERE_VS_HEPARG_UP,0.902477387001872
GOBP_MEMORY,SET,117,0.10495,0.0083519,0.080597,0.096435,GOBP_MEMORY,0.902477387001872
WP_TYROBP_CAUSAL_NETWORK_IN_...,SET,56,0.15634,0.0086217,0.12007,0.096455,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,0.902477387001872
HP_HYPOREFLEXIA_OF_LOWER_LIM...,SET,33,0.19707,0.008348,0.15136,0.096463,HP_HYPOREFLEXIA_OF_LOWER_LIMBS,0.902477387001872
HP_PROTEIN_AVOIDANCE,SET,5,0.49475,0.0081639,0.38004,0.096498,HP_PROTEIN_AVOIDANCE,0.902477387001872
HP_MYOPIC_ASTIGMATISM,SET,6,0.44109,0.007973,0.33886,0.096516,HP_MYOPIC_ASTIGMATISM,0.902477387001872
chr4q27,SET,14,0.44146,0.012186,0.33917,0.096541,chr4q27,0.902477387001872
GSE17721_0.5H_VS_24H_CPG_BMD...1,SET,188,0.085303,0.0085881,0.065547,0.096568,GSE17721_0.5H_VS_24H_CPG_BMDC_DN,0.902477387001872
CUI_DEVELOPING_HEART_ENDOCAR...,SET,50,0.17286,0.0090087,0.13282,0.096569,CUI_DEVELOPING_HEART_ENDOCARDIAL_CELL,0.902477387001872
GSE4748_CTRL_VS_CYANOBACTERI...2,SET,181,0.080736,0.0079771,0.06204,0.096578,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_UP,0.902477387001872
MIR6807_3P,SET,128,0.097977,0.0081526,0.075308,0.096633,MIR6807_3P,0.902477387001872
GSE44955_MCSF_VS_MCSF_AND_IL...1,SET,180,0.081383,0.0080189,0.062554,0.096637,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN,0.902477387001872
KEGG_MEDICUS_REFERENCE_HOMOL...1,SET,31,0.16971,0.0069679,0.13045,0.096656,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION,0.902477387001872
GSE11924_TFH_VS_TH2_CD4_TCEL...1,SET,176,0.081338,0.0079258,0.062531,0.096678,GSE11924_TFH_VS_TH2_CD4_TCELL_DN,0.902477387001872
GOBP_ANTIGEN_PROCESSING_AND_...7,SET,8,0.34169,0.0071314,0.26273,0.096718,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,0.902477387001872
GSE3920_IFNA_VS_IFNG_TREATED...4,SET,161,0.08585,0.0080044,0.066012,0.096719,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP,0.902477387001872
GOMF_CCR1_CHEMOKINE_RECEPTOR...,SET,5,0.50959,0.0084087,0.39192,0.096767,GOMF_CCR1_CHEMOKINE_RECEPTOR_BINDING,0.902477387001872
HP_STEROID_RESISTANT_NEPHROT...,SET,14,0.25944,0.0071618,0.19957,0.096812,HP_STEROID_RESISTANT_NEPHROTIC_SYNDROME,0.902477387001872
GOBP_NEUTROPHIL_CHEMOTAXIS,SET,78,0.14014,0.0091151,0.1078,0.096814,GOBP_NEUTROPHIL_CHEMOTAXIS,0.902477387001872
HP_FEMALE_EXTERNAL_GENITALIA...,SET,14,0.31683,0.008746,0.24375,0.096837,HP_FEMALE_EXTERNAL_GENITALIA_IN_INDIVIDUAL_WITH_46_XY_KARYOTYPE,0.902477387001872
GOMF_VASCULAR_ENDOTHELIAL_GR...3,SET,7,0.50968,0.0099506,0.39213,0.09685,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_ACTIVITY,0.902477387001872
GOBP_NEGATIVE_REGULATION_OF_...555,SET,21,0.25588,0.0086493,0.19687,0.096852,GOBP_NEGATIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,0.902477387001872
EVI1_05,SET,161,0.090702,0.0084567,0.069789,0.096868,EVI1_05,0.902477387001872
GSE23568_ID3_TRANSDUCED_VS_I...1,SET,182,0.083036,0.0082267,0.063891,0.096869,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN,0.902477387001872
GOCC_CATALYTIC_STEP_1_SPLICE...,SET,10,0.32342,0.0075464,0.24887,0.096882,GOCC_CATALYTIC_STEP_1_SPLICEOSOME,0.902477387001872
GSE12198_CTRL_VS_LOW_IL2_STI...1,SET,191,0.077523,0.0078662,0.059655,0.096891,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_DN,0.902477387001872
GCM_FANCL,SET,21,0.21396,0.0072324,0.16466,0.096918,GCM_FANCL,0.902477387001872
GSE9988_ANTI_TREM1_VS_CTRL_T...1,SET,188,0.078906,0.0079441,0.060733,0.096939,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN,0.902477387001872
GOBP_ERROR_FREE_TRANSLESION_...,SET,5,0.34223,0.0056472,0.26345,0.09697,GOBP_ERROR_FREE_TRANSLESION_SYNTHESIS,0.902477387001872
TGTTTGY_HNF3_Q6,SET,650,0.045909,0.0084843,0.035342,0.096983,TGTTTGY_HNF3_Q6,0.902477387001872
GSE16522_ANTI_CD3CD28_STIM_V...4,SET,173,0.083326,0.0080507,0.064148,0.096987,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP,0.902477387001872
BARHL1_TARGET_GENES,SET,1038,0.034669,0.0080074,0.026694,0.097018,BARHL1_TARGET_GENES,0.902477387001872
MIR4462,SET,13,0.25104,0.0066781,0.1933,0.097033,MIR4462,0.902477387001872
HP_OPPORTUNISTIC_BACTERIAL_I...,SET,22,0.24942,0.0086293,0.19206,0.097039,HP_OPPORTUNISTIC_BACTERIAL_INFECTION,0.902477387001872
PID_SYNDECAN_2_PATHWAY,SET,31,0.203,0.0083349,0.15633,0.097058,PID_SYNDECAN_2_PATHWAY,0.902477387001872
KEGG_MEDICUS_REFERENCE_MEVAL...,SET,12,0.27308,0.0069796,0.21032,0.097076,KEGG_MEDICUS_REFERENCE_MEVALONATE_PATHWAY,0.902477387001872
GOBP_POSITIVE_REGULATION_OF_...7,SET,7,0.46494,0.0090773,0.35809,0.097085,GOBP_POSITIVE_REGULATION_OF_ACTION_POTENTIAL,0.902477387001872
GOCC_IMMUNOGLOBULIN_COMPLEX,SET,10,0.37359,0.0087169,0.28774,0.09709,GOCC_IMMUNOGLOBULIN_COMPLEX,0.902477387001872
MODULE_188,SET,118,0.10521,0.0084081,0.081069,0.097185,MODULE_188,0.903118897058824
GOBP_PROTECTION_FROM_NON_HOM...,SET,9,0.31187,0.0069035,0.24045,0.097323,GOBP_PROTECTION_FROM_NON_HOMOLOGOUS_END_JOINING_AT_TELOMERE,0.903796913020278
GOBP_REGULATION_OF_ODONTOBLA...,SET,10,0.40639,0.0094822,0.31333,0.097328,GOBP_REGULATION_OF_ODONTOBLAST_DIFFERENTIATION,0.903796913020278
TSANG_PBMC_FLUVIRIN_PANDEMRI...,SET,65,0.14434,0.0085737,0.1113,0.097343,TSANG_PBMC_FLUVIRIN_PANDEMRIX_ADULT_CORR_WITH_CELL_FREQ_CD27HI_CD38HI_CD20_NEG_PLASMABLASTS_AND_CD38PLUS_OF_IGD_CD27PLUS_MEM_B_CELLS_7DY_POSITIVE,0.903796913020278
RFX1_01,SET,224,0.073968,0.0081206,0.057045,0.097384,RFX1_01,0.903796913020278
MIR12122,SET,193,0.081137,0.0082754,0.062589,0.097436,MIR12122,0.903796913020278
HP_EEG_WITH_MULTIFOCAL_SLOW_...,SET,49,0.15752,0.008127,0.12152,0.097455,HP_EEG_WITH_MULTIFOCAL_SLOW_ACTIVITY,0.903796913020278
TURJANSKI_MAPK7_TARGETS,SET,7,0.46402,0.0090592,0.35798,0.097461,TURJANSKI_MAPK7_TARGETS,0.903796913020278
HP_ABNORMAL_MUSCLE_FIBER_PRO...,SET,25,0.22686,0.0083661,0.17502,0.097466,HP_ABNORMAL_MUSCLE_FIBER_PROTEIN_EXPRESSION,0.903796913020278
HP_ABNORMAL_ENDOCARDIUM_MORP...,SET,54,0.15794,0.0085536,0.12188,0.097513,HP_ABNORMAL_ENDOCARDIUM_MORPHOLOGY,0.903805951239009
GOBP_NEUTROPHIL_MEDIATED_IMM...,SET,37,0.18142,0.0081363,0.14003,0.097579,GOBP_NEUTROPHIL_MEDIATED_IMMUNITY,0.903805951239009
GOBP_REGULATION_OF_HEART_MOR...,SET,8,0.49714,0.010376,0.38375,0.097585,GOBP_REGULATION_OF_HEART_MORPHOGENESIS,0.903805951239009
GOBP_FATTY_ACID_HOMEOSTASIS,SET,14,0.27996,0.0077281,0.21611,0.097594,GOBP_FATTY_ACID_HOMEOSTASIS,0.903805951239009
GSE37301_CD4_TCELL_VS_GRANUL...1,SET,170,0.088041,0.0084329,0.067964,0.097597,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.903805951239009
GOMF_MONOOXYGENASE_ACTIVITY,SET,100,0.12589,0.0092659,0.097211,0.097668,GOMF_MONOOXYGENASE_ACTIVITY,0.903944524886878
GCM_SMARCC1,SET,32,0.18393,0.0076725,0.14203,0.097671,GCM_SMARCC1,0.903944524886878
GSE13411_NAIVE_BCELL_VS_PLAS...2,SET,169,0.085532,0.0081686,0.066055,0.097693,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP,0.903944524886878
GOBP_REGULATION_OF_RESPONSE_...9,SET,27,0.22226,0.0085175,0.17167,0.097716,GOBP_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,0.903944524886878
GOBP_INTRACELLULAR_TRIGLYCER...,SET,9,0.34161,0.0075619,0.26388,0.097744,GOBP_INTRACELLULAR_TRIGLYCERIDE_HOMEOSTASIS,0.903962937732837
GSE360_CTRL_VS_L_DONOVANI_MA...1,SET,175,0.082392,0.008006,0.06366,0.097796,GSE360_CTRL_VS_L_DONOVANI_MAC_DN,0.904101160287081
GOBP_POSITIVE_REGULATION_OF_...230,SET,8,0.41228,0.0086047,0.31862,0.097849,GOBP_POSITIVE_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT,0.904101160287081
HP_RETINAL_ATROPHY,SET,91,0.11449,0.0080405,0.088479,0.097852,HP_RETINAL_ATROPHY,0.904101160287081
ELK1_01,SET,253,0.069187,0.008066,0.053472,0.097863,ELK1_01,0.904101160287081
GOBP_REGULATION_OF_AXON_EXTE...1,SET,68,0.13503,0.0082026,0.10438,0.097902,GOBP_REGULATION_OF_AXON_EXTENSION,0.904221102843476
GSE41176_UNSTIM_VS_ANTI_IGM_...3,SET,180,0.0824,0.0081191,0.063706,0.09794,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN,0.904331748140276
GSE3039_NKT_CELL_VS_B1_BCELL...1,SET,173,0.086302,0.0083383,0.066738,0.09799,GSE3039_NKT_CELL_VS_B1_BCELL_DN,0.904364389857369
GSE15624_3H_VS_6H_HALOFUGINO...1,SET,135,0.097192,0.0083039,0.07517,0.098019,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,0.904364389857369
MISSIAGLIA_REGULATED_BY_METH...2,SET,109,0.11149,0.008565,0.086235,0.098045,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,0.904364389857369
HP_ABNORMAL_LOWER_LIMB_BONE_...,SET,671,0.043127,0.0080931,0.033366,0.098094,HP_ABNORMAL_LOWER_LIMB_BONE_MORPHOLOGY,0.904364389857369
GAVISH_3CA_MALIGNANT_METAPRO...27,SET,46,0.18026,0.009012,0.13948,0.098127,GAVISH_3CA_MALIGNANT_METAPROGRAM_35_HEMATO_RELATED_1,0.904364389857369
MODULE_429,SET,14,0.29231,0.0080691,0.22621,0.098148,MODULE_429,0.904364389857369
GSE1740_MCSF_VS_MCSF_AND_IFN...1,SET,172,0.082473,0.0079455,0.063828,0.098168,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN,0.904364389857369
BIDUS_METASTASIS_UP,SET,186,0.07711,0.0077222,0.059692,0.098223,BIDUS_METASTASIS_UP,0.904364389857369
HP_SHORT_MANDIBULAR_RAMI,SET,6,0.46042,0.0083224,0.35642,0.098225,HP_SHORT_MANDIBULAR_RAMI,0.904364389857369
MIR152_5P,SET,74,0.13382,0.0084792,0.1036,0.098244,MIR152_5P,0.904364389857369
MIR4803,SET,411,0.056931,0.0084224,0.04409,0.098317,MIR4803,0.904364389857369
HE_LIM_SUN_FETAL_LUNG_C7_COL...,SET,65,0.15083,0.0089593,0.11682,0.098328,HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL,0.904364389857369
GSE21670_UNTREATED_VS_TGFB_T...4,SET,181,0.079123,0.0078176,0.061283,0.098343,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP,0.904364389857369
GOMF_LIGASE_ACTIVITY_FORMING...3,SET,22,0.21174,0.0073257,0.16403,0.098386,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS,0.904364389857369
GOBP_FATTY_ACID_BIOSYNTHETIC...,SET,145,0.092569,0.0081943,0.071714,0.098393,GOBP_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.904364389857369
MIR7107_3P,SET,49,0.15934,0.0082212,0.12345,0.098403,MIR7107_3P,0.904364389857369
HP_HYPOTHALAMIC_HYPOTHYROIDI...,SET,12,0.28897,0.0073857,0.2239,0.098429,HP_HYPOTHALAMIC_HYPOTHYROIDISM,0.904364389857369
MAHAJAN_RESPONSE_TO_IL1A_UP,SET,73,0.13856,0.0087202,0.10737,0.098445,MAHAJAN_RESPONSE_TO_IL1A_UP,0.904364389857369
NAKAYA_PBMC_FLUARIX_FLUVIRIN...8,SET,134,0.095309,0.0081131,0.073866,0.098482,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_POSITIVE,0.904364389857369
MODULE_439,SET,20,0.23065,0.0076089,0.17877,0.098498,MODULE_439,0.904364389857369
GOBP_PROTEIN_SIDE_CHAIN_DEGL...,SET,5,0.49235,0.0081243,0.38161,0.098503,GOBP_PROTEIN_SIDE_CHAIN_DEGLUTAMYLATION,0.904364389857369
GOBP_RESPONSE_TO_CELL_CYCLE_...,SET,7,0.39419,0.0076959,0.30555,0.098516,GOBP_RESPONSE_TO_CELL_CYCLE_CHECKPOINT_SIGNALING,0.904364389857369
GSE23308_WT_VS_MINERALCORTIC...2,SET,175,0.08166,0.0079348,0.063309,0.098556,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_UP,0.904382352164731
CP2_01,SET,238,0.071656,0.0081058,0.055556,0.09857,CP2_01,0.904382352164731
MODULE_491,SET,68,0.1312,0.00797,0.10174,0.098615,MODULE_491,0.904556433095804
IIZUKA_LIVER_CANCER_PROGRESS...1,SET,23,0.207,0.0073224,0.16057,0.098676,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN,0.904858480611976
KEGG_MEDICUS_VARIANT_LRP6_OV...,SET,43,0.17944,0.0086743,0.1392,0.0987,KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,0.904858480611976
TUOMISTO_TUMOR_SUPPRESSION_B...2,SET,17,0.2957,0.0089942,0.22946,0.098764,TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP,0.904948072162233
GOBP_MYELOID_CELL_APOPTOTIC_...,SET,36,0.18072,0.0079949,0.14027,0.098816,GOBP_MYELOID_CELL_APOPTOTIC_PROCESS,0.904948072162233
GOBP_RESPONSE_TO_TYPE_II_INT...,SET,112,0.10804,0.0084126,0.083855,0.098819,GOBP_RESPONSE_TO_TYPE_II_INTERFERON,0.904948072162233
GOCC_APICAL_DENDRITE,SET,16,0.27771,0.0081949,0.21556,0.098825,GOCC_APICAL_DENDRITE,0.904948072162233
GSE20727_ROS_INH_VS_ROS_INH_...1,SET,149,0.095103,0.008533,0.073827,0.098848,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,0.904948072162233
KEGG_MEDICUS_PATHOGEN_HTLV_1...9,SET,5,0.58526,0.0096574,0.45436,0.098866,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_TNF_JNK_SIGNALING_PATHWAY,0.904948072162233
GOBP_MOTOR_NEURON_MIGRATION,SET,12,0.37754,0.0096495,0.29319,0.098929,GOBP_MOTOR_NEURON_MIGRATION,0.905248425414365
GOBP_REGULATION_OF_GERM_CELL...,SET,7,0.36883,0.0072009,0.28647,0.098966,GOBP_REGULATION_OF_GERM_CELL_PROLIFERATION,0.905248425414365
CHYLA_CBFA2T3_TARGETS_UP,SET,346,0.062081,0.0084421,0.04822,0.09898,CHYLA_CBFA2T3_TARGETS_UP,0.905248425414365
GOBP_T_TUBULE_ORGANIZATION,SET,6,0.41114,0.0074317,0.31938,0.099003,GOBP_T_TUBULE_ORGANIZATION,0.905248425414365
VALK_AML_CLUSTER_1,SET,26,0.24101,0.0090636,0.18725,0.09904,VALK_AML_CLUSTER_1,0.905346747241198
KREPPEL_CD99_TARGETS_DN,SET,7,0.43434,0.0084797,0.33754,0.099094,KREPPEL_CD99_TARGETS_DN,0.905346747241198
HP_CAROTID_ARTERY_TORTUOSITY,SET,4,0.58902,0.0086935,0.45777,0.099109,HP_CAROTID_ARTERY_TORTUOSITY,0.905346747241198
WP_DNA_REPLICATION,SET,40,0.15676,0.0073092,0.12184,0.099132,WP_DNA_REPLICATION,0.905346747241198
MIR421,SET,160,0.087317,0.008116,0.067872,0.099144,MIR421,0.905346747241198
WEBER_METHYLATED_HCP_IN_SPER...2,SET,16,0.25202,0.0074368,0.19596,0.099222,WEBER_METHYLATED_HCP_IN_SPERM_UP,0.905610523897059
CONRAD_GERMLINE_STEM_CELL,SET,8,0.36498,0.0076173,0.2838,0.099225,CONRAD_GERMLINE_STEM_CELL,0.905610523897059
GOMF_MUSCLE_ALPHA_ACTININ_BI...,SET,15,0.30495,0.0087134,0.23718,0.099271,GOMF_MUSCLE_ALPHA_ACTININ_BINDING,0.905617041699449
GOBP_NEGATIVE_REGULATION_OF_...195,SET,17,0.23944,0.007283,0.18623,0.099282,GOBP_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,0.905617041699449
GSE20152_SPHK1_KO_VS_HTNFA_O...1,SET,177,0.078809,0.0077009,0.061307,0.09932,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN,0.905617041699449
GSE3982_CTRL_VS_IGE_STIM_MAS...1,SET,180,0.080549,0.0079368,0.06267,0.099354,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN,0.905617041699449
REACTOME_IRS_ACTIVATION,SET,5,0.58815,0.0097052,0.45761,0.099356,REACTOME_IRS_ACTIVATION,0.905617041699449
MYLLYKANGAS_AMPLIFICATION_HO...3,SET,9,0.40546,0.0089754,0.31551,0.099384,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16,0.905634745673833
GSE22432_MULTIPOTENT_PROGENI...3,SET,177,0.076382,0.0074638,0.059485,0.09957,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_DN,0.907089114719749
HP_AVASCULAR_NECROSIS,SET,83,0.12361,0.0082928,0.096289,0.099622,HP_AVASCULAR_NECROSIS,0.907089114719749
HP_HYPERACTIVE_DEEP_TENDON_R...,SET,22,0.23924,0.008277,0.18638,0.099647,HP_HYPERACTIVE_DEEP_TENDON_REFLEXES,0.907089114719749
HP_TEMPERATURE_INSTABILITY,SET,34,0.19474,0.0083729,0.15171,0.099648,HP_TEMPERATURE_INSTABILITY,0.907089114719749
GSE2770_TGFB_AND_IL4_VS_IL12...2,SET,172,0.080932,0.007797,0.063069,0.099716,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.907284593251373
LIU_IL13_MEMORY_MODEL_DN,SET,4,0.4817,0.0071096,0.37539,0.099724,LIU_IL13_MEMORY_MODEL_DN,0.907284593251373
GSE17721_CTRL_VS_LPS_4H_BMDC...2,SET,185,0.077701,0.0077607,0.060567,0.099774,GSE17721_CTRL_VS_LPS_4H_BMDC_UP,0.907284593251373
REACTOME_FCGR3A_MEDIATED_IL1...,SET,37,0.1895,0.0084989,0.14772,0.099781,REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,0.907284593251373
AAACCAC_MIR140,SET,98,0.11238,0.0081893,0.087613,0.0998,AAACCAC_MIR140,0.907284593251373
KEGG_MEDICUS_VARIANT_MUTATIO...33,SET,13,0.31979,0.0085069,0.24941,0.099892,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM,0.907883488493724
chr4q35,SET,36,0.32183,0.014238,0.25108,0.099967,chr4q35,0.908043621635746
HP_INTRAMUSCULAR_HEMATOMA,SET,7,0.45033,0.008792,0.35135,0.09998,HP_INTRAMUSCULAR_HEMATOMA,0.908043621635746
GOBP_ATTACHMENT_OF_GPI_ANCHO...,SET,6,0.36134,0.0065314,0.28193,0.099988,GOBP_ATTACHMENT_OF_GPI_ANCHOR_TO_PROTEIN,0.908043621635746
GOBP_PROPRIOCEPTION,SET,4,0.60616,0.0089466,0.47301,0.10002,GOBP_PROPRIOCEPTION,0.908096943573668
GOBP_NEGATIVE_REGULATION_OF_...289,SET,181,0.083228,0.0082232,0.064957,0.10006,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE,0.908111589663273
HP_FLARED_ILIAC_WING,SET,16,0.26854,0.0079244,0.20962,0.10009,HP_FLARED_ILIAC_WING,0.908111589663273
GSE16385_UNTREATED_VS_12H_RO...6,SET,142,0.096813,0.0084816,0.075574,0.1001,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,0.908111589663273
GSE14000_UNSTIM_VS_4H_LPS_DC...1,SET,179,0.086473,0.008497,0.067515,0.10014,GSE14000_UNSTIM_VS_4H_LPS_DC_DN,0.908225403435711
GSE22886_IGM_MEMORY_BCELL_VS...3,SET,177,0.082208,0.0080331,0.064198,0.10019,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,0.908225403435711
HP_ABNORMALITY_OF_CORNEAL_SI...,SET,145,0.092469,0.0081856,0.072218,0.10021,HP_ABNORMALITY_OF_CORNEAL_SIZE,0.908225403435711
HP_ABNORMAL_MACROPHAGE_MORPH...,SET,41,0.19367,0.0091424,0.15127,0.10022,HP_ABNORMAL_MACROPHAGE_MORPHOLOGY,0.908225403435711
BIOCARTA_RECK_PATHWAY,SET,8,0.39126,0.0081659,0.30569,0.10029,BIOCARTA_RECK_PATHWAY,0.908225403435711
GOBP_NITRIC_OXIDE_TRANSPORT,SET,3,0.77207,0.0098689,0.60334,0.10034,GOBP_NITRIC_OXIDE_TRANSPORT,0.908225403435711
GSE15324_NAIVE_VS_ACTIVATED_...2,SET,171,0.081663,0.0078447,0.063823,0.10037,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,0.908225403435711
GSE6674_UNSTIM_VS_ANTI_IGM_A...2,SET,185,0.077455,0.0077361,0.060539,0.10038,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,0.908225403435711
GOBP_POSITIVE_REGULATION_OF_...813,SET,18,0.27677,0.0086621,0.21633,0.10039,GOBP_POSITIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.908225403435711
GOMF_UBIQUITIN_CONJUGATING_E...,SET,28,0.20977,0.008186,0.16397,0.1004,GOMF_UBIQUITIN_CONJUGATING_ENZYME_BINDING,0.908225403435711
GSE6269_E_COLI_VS_STAPH_AURE...1,SET,162,0.086558,0.0080952,0.06766,0.1004,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN,0.908225403435711
MIR4796_3P,SET,224,0.074804,0.0082124,0.058482,0.10044,MIR4796_3P,0.908254365904366
GOMF_PHOSPHATIDYLCHOLINE_BIN...,SET,27,0.22259,0.0085302,0.17405,0.10047,GOMF_PHOSPHATIDYLCHOLINE_BINDING,0.908254365904366
HP_IMPAIRED_RISTOCETIN_INDUC...,SET,8,0.40805,0.0085162,0.31913,0.10052,HP_IMPAIRED_RISTOCETIN_INDUCED_PLATELET_AGGREGATION,0.908254365904366
MIR4440,SET,5,0.57857,0.0095471,0.4525,0.10053,MIR4440,0.908254365904366
ER_Q6_01,SET,239,0.071179,0.0080685,0.055673,0.10054,ER_Q6_01,0.908254365904366
LEE_CALORIE_RESTRICTION_MUSC...1,SET,40,0.15399,0.0071802,0.12045,0.10056,LEE_CALORIE_RESTRICTION_MUSCLE_DN,0.908254365904366
REACTOME_TERMINATION_OF_TRAN...,SET,30,0.1777,0.0071777,0.13903,0.10061,REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS,0.908469875292284
GAVIN_FOXP3_TARGETS_CLUSTER_...2,SET,147,0.091434,0.0081491,0.071551,0.10065,GAVIN_FOXP3_TARGETS_CLUSTER_P3,0.90857437694704
GOBP_CARDIAC_MUSCLE_CELL_DIF...,SET,112,0.10732,0.0083572,0.084,0.10069,GOBP_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.90857437694704
MIR4320,SET,48,0.16638,0.0084967,0.13023,0.1007,MIR4320,0.90857437694704
NABA_BASEMENT_MEMBRANES,SET,37,0.19905,0.0089272,0.15587,0.1008,NABA_BASEMENT_MEMBRANES,0.909080706521739
HP_ABNORMALITY_OF_THE_TONGUE...,SET,3,0.51171,0.0065409,0.40075,0.10083,HP_ABNORMALITY_OF_THE_TONGUE_MUSCLE,0.909080706521739
SCHERER_PBMC_APSV_WETVAX_AGE...7,SET,20,0.25552,0.0084293,0.20015,0.10087,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_5_TO_7DY_DN,0.909080706521739
GOMF_GABA_RECEPTOR_ACTIVITY,SET,19,0.3108,0.0099935,0.24355,0.10096,GOMF_GABA_RECEPTOR_ACTIVITY,0.909080706521739
GOBP_POSITIVE_REGULATION_OF_...252,SET,56,0.16277,0.008976,0.12756,0.10098,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.909080706521739
WP_CHOLESTASIS,SET,19,0.27961,0.0089905,0.21916,0.10102,WP_CHOLESTASIS,0.909080706521739
GOBP_ISOPRENOID_METABOLIC_PR...,SET,129,0.10108,0.0084437,0.079229,0.10102,GOBP_ISOPRENOID_METABOLIC_PROCESS,0.909080706521739
GSE41978_WT_VS_ID2_KO_KLRG1_...1,SET,190,0.082623,0.0083619,0.064766,0.10104,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.909080706521739
ANDERSEN_CHOLANGIOCARCINOMA_...1,SET,58,0.15114,0.0084817,0.11848,0.10105,ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,0.909080706521739
GSE9988_ANTI_TREM1_VS_LPS_MO...1,SET,176,0.086374,0.0084165,0.067711,0.10105,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN,0.909080706521739
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...7,SET,90,0.11642,0.0081316,0.091267,0.10105,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN,0.909080706521739
GOCC_SARCOPLASM,SET,92,0.11304,0.0079821,0.088622,0.10107,GOCC_SARCOPLASM,0.909080706521739
HP_FACIAL_TELANGIECTASIA,SET,15,0.24864,0.0071044,0.19503,0.10119,HP_FACIAL_TELANGIECTASIA,0.909924566623545
REACTOME_NETRIN_1_SIGNALING,SET,42,0.17064,0.0081524,0.13388,0.10124,REACTOME_NETRIN_1_SIGNALING,0.910138696326953
GOBP_EMBRYONIC_HINDLIMB_MORP...,SET,27,0.24343,0.0093286,0.19115,0.10143,GOBP_EMBRYONIC_HINDLIMB_MORPHOGENESIS,0.910715535483871
CBX7_TARGET_GENES,SET,726,0.04177,0.0081407,0.032804,0.10146,CBX7_TARGET_GENES,0.910715535483871
HP_DELAYED_ABILITY_TO_WALK,SET,253,0.067471,0.007866,0.052993,0.10148,HP_DELAYED_ABILITY_TO_WALK,0.910715535483871
GSE17721_0.5H_VS_4H_GARDIQUI...1,SET,185,0.079793,0.0079697,0.06267,0.10148,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_DN,0.910715535483871
GOBP_POSITIVE_REGULATION_OF_...443,SET,12,0.32623,0.0083379,0.25624,0.10149,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_DEGRANULATION,0.910715535483871
HP_HEMIPARESIS,SET,79,0.12675,0.0082969,0.099568,0.10152,HP_HEMIPARESIS,0.910715535483871
GOBP_CELL_ADHESION_INVOLVED_...,SET,7,0.49705,0.009704,0.39048,0.10153,GOBP_CELL_ADHESION_INVOLVED_IN_HEART_MORPHOGENESIS,0.910715535483871
HP_PROMINENT_CALCANEUS,SET,9,0.37984,0.0084082,0.2984,0.10153,HP_PROMINENT_CALCANEUS,0.910715535483871
HP_PERIANAL_ABSCESS,SET,8,0.42075,0.0087813,0.33054,0.10154,HP_PERIANAL_ABSCESS,0.910715535483871
GOCC_NEUROFILAMENT,SET,10,0.39971,0.0093265,0.31408,0.10158,GOCC_NEUROFILAMENT,0.91075280638517
GSE411_WT_VS_SOCS3_KO_MACROP...2,SET,183,0.07593,0.0075431,0.059673,0.10162,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_DN,0.91075280638517
HP_ALVEOLAR_RHABDOMYOSARCOMA,SET,5,0.56329,0.0092949,0.44286,0.10171,HP_ALVEOLAR_RHABDOMYOSARCOMA,0.91075280638517
GSE9988_ANTI_TREM1_VS_VEHICL...2,SET,166,0.091849,0.0086945,0.072212,0.10171,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP,0.91075280638517
GGGYGTGNY_UNKNOWN,SET,598,0.044693,0.0079339,0.03514,0.10172,GGGYGTGNY_UNKNOWN,0.91075280638517
KEGG_MEDICUS_REFERENCE_OKAZA...,SET,11,0.28813,0.0070508,0.22657,0.10175,KEGG_MEDICUS_REFERENCE_OKAZAKI_FRAGMENT_MATURATION,0.91075280638517
HP_FUSION_OF_THE_CEREBELLAR_...,SET,5,0.43026,0.0070998,0.33834,0.10175,HP_FUSION_OF_THE_CEREBELLAR_HEMISPHERES,0.91075280638517
HP_APLASIA_HYPOPLASIA_OF_THE...32,SET,4,0.56525,0.0083428,0.44451,0.10176,HP_APLASIA_HYPOPLASIA_OF_THE_FALLOPIAN_TUBE,0.91075280638517
HP_UNDERDEVELOPED_SUPRAORBIT...,SET,55,0.15351,0.0083896,0.12073,0.10178,HP_UNDERDEVELOPED_SUPRAORBITAL_RIDGES,0.91075280638517
GSE9037_CTRL_VS_LPS_1H_STIM_...3,SET,174,0.083258,0.0080671,0.065502,0.10186,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN,0.911115692307692
GOCC_9PLUS0_MOTILE_CILIUM,SET,4,0.44602,0.006583,0.35102,0.10194,GOCC_9PLUS0_MOTILE_CILIUM,0.911115692307692
HP_ABNORMAL_CARDIAC_EXERCISE...,SET,19,0.25864,0.0083165,0.20357,0.10195,HP_ABNORMAL_CARDIAC_EXERCISE_STRESS_TEST,0.911115692307692
GOBP_POSTSYNAPTIC_MODULATION...,SET,26,0.21648,0.0081411,0.17046,0.10205,GOBP_POSTSYNAPTIC_MODULATION_OF_CHEMICAL_SYNAPTIC_TRANSMISSION,0.911115692307692
GOMF_PROTEIN_SERINE_THREONIN...2,SET,392,0.054663,0.007902,0.043041,0.10205,GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.911115692307692
GOBP_PROTEIN_NITROSYLATION,SET,13,0.32282,0.0085876,0.25423,0.10208,GOBP_PROTEIN_NITROSYLATION,0.911115692307692
MIR5581_3P,SET,117,0.10022,0.0079756,0.078932,0.1021,MIR5581_3P,0.911115692307692
ZSCAN4_TARGET_GENES,SET,1097,0.034297,0.0081296,0.027011,0.1021,ZSCAN4_TARGET_GENES,0.911115692307692
GSE28737_BCL6_HET_VS_BCL6_KO...1,SET,183,0.080456,0.0079928,0.063364,0.1021,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN,0.911115692307692
GOBP_NEURAL_CREST_CELL_FATE_...,SET,6,0.52432,0.0094773,0.41301,0.10214,GOBP_NEURAL_CREST_CELL_FATE_COMMITMENT,0.911115692307692
GSE22886_IGG_IGA_MEMORY_BCEL...4,SET,178,0.081004,0.0079376,0.063813,0.10216,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,0.911115692307692
HP_ENAMEL_HYPOMINERALIZATION,SET,8,0.38489,0.0080329,0.30322,0.10217,HP_ENAMEL_HYPOMINERALIZATION,0.911115692307692
GSE5463_CTRL_VS_DEXAMETHASON...1,SET,177,0.085427,0.0083477,0.067308,0.10219,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN,0.911115692307692
GSE34156_UNTREATED_VS_6H_NOD...2,SET,149,0.089797,0.008057,0.070757,0.10221,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.911115692307692
SUPT20H_TARGET_GENES,SET,1112,0.032753,0.0078131,0.02581,0.10222,SUPT20H_TARGET_GENES,0.911115692307692
GOMF_GATED_CHANNEL_ACTIVITY,SET,301,0.068753,0.0087311,0.054182,0.10224,GOMF_GATED_CHANNEL_ACTIVITY,0.911115692307692
HP_DECREASED_EOSINOPHIL_COUNT,SET,8,0.40475,0.0084475,0.31901,0.10227,HP_DECREASED_EOSINOPHIL_COUNT,0.911149410407588
GOBP_RESPIRATORY_BURST,SET,30,0.20795,0.0083995,0.16394,0.10232,GOBP_RESPIRATORY_BURST,0.911216794773251
GOBP_NEURON_PROJECTION_EXTEN...2,SET,19,0.26339,0.0084691,0.20765,0.10233,GOBP_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE,0.911216794773251
GOBP_L_METHIONINE_SALVAGE_FR...,SET,5,0.55612,0.0091766,0.43849,0.10236,GOBP_L_METHIONINE_SALVAGE_FROM_METHYLTHIOADENOSINE,0.911250461065574
HP_ABNORMAL_TALUS_MORPHOLOGY,SET,61,0.13273,0.0076382,0.10469,0.10244,HP_ABNORMAL_TALUS_MORPHOLOGY,0.91130791357709
REACTOME_CHYLOMICRON_CLEARAN...,SET,4,0.60715,0.0089612,0.47896,0.10247,REACTOME_CHYLOMICRON_CLEARANCE,0.91130791357709
WP_S1P_RECEPTOR_SIGNAL_TRANS...,SET,25,0.21455,0.0079122,0.16925,0.10247,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,0.91130791357709
HP_DEEPLY_SET_EYE,SET,216,0.072835,0.0078538,0.057461,0.10249,HP_DEEPLY_SET_EYE,0.91130791357709
HP_TRIANGULAR_MOUTH,SET,19,0.22025,0.0070821,0.17377,0.1025,HP_TRIANGULAR_MOUTH,0.91130791357709
MIR8071,SET,31,0.18528,0.0076071,0.14621,0.10255,MIR8071,0.91130791357709
GOMF_ATP_DEPENDENT_DNA_DAMAG...,SET,16,0.22224,0.0065582,0.17538,0.10255,GOMF_ATP_DEPENDENT_DNA_DAMAGE_SENSOR_ACTIVITY,0.91130791357709
MIR452_5P,SET,197,0.07623,0.0078543,0.060167,0.10259,MIR452_5P,0.911430329754601
GSE15330_HSC_VS_LYMPHOID_PRI...2,SET,177,0.080206,0.0078375,0.06332,0.10264,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_DN,0.911504042067917
HP_PERINEAL_FISTULA,SET,12,0.30314,0.0077479,0.23936,0.10268,HP_PERINEAL_FISTULA,0.911504042067917
GSE6269_HEALTHY_VS_STAPH_PNE...2,SET,165,0.080645,0.0076111,0.063681,0.10269,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP,0.911504042067917
BLANCO_MELO_COVID19_SARS_COV...12,SET,139,0.09732,0.0084362,0.076868,0.10276,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,0.911504042067917
GSE37301_MULTIPOTENT_PROGENI...1,SET,176,0.078972,0.0076953,0.062379,0.10276,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN,0.911504042067917
GOBP_REGULATION_OF_HEART_RATE,SET,96,0.12084,0.0087156,0.09546,0.10279,GOBP_REGULATION_OF_HEART_RATE,0.911504042067917
REACTOME_HEME_DEGRADATION,SET,15,0.29056,0.0083021,0.22954,0.1028,REACTOME_HEME_DEGRADATION,0.911504042067917
DUTERTRE_ESTRADIOL_RESPONSE_...1,SET,475,0.053615,0.008512,0.042362,0.10283,DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN,0.911504042067917
KEGG_MEDICUS_REFERENCE_BCR_B...,SET,14,0.31254,0.0086278,0.24703,0.10291,KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY,0.911504042067917
GOMF_NEUREGULIN_BINDING,SET,5,0.50994,0.0084145,0.40309,0.10293,GOMF_NEUREGULIN_BINDING,0.911504042067917
GR_Q6,SET,234,0.072501,0.008133,0.057312,0.10294,GR_Q6,0.911504042067917
MIR887_3P,SET,5,0.49559,0.0081777,0.39185,0.10299,MIR887_3P,0.911504042067917
HP_TRISMUS,SET,13,0.26955,0.0071705,0.21315,0.10301,HP_TRISMUS,0.911504042067917
GOBP_REGULATION_OF_ASTROCYTE...2,SET,27,0.23141,0.0088681,0.18308,0.10313,GOBP_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,0.911504042067917
REACTOME_MYOGENESIS,SET,28,0.22699,0.0088582,0.17961,0.10316,REACTOME_MYOGENESIS,0.911504042067917
HP_ABNORMAL_SIZE_OF_THE_DENT...,SET,14,0.32167,0.0088796,0.25452,0.10316,HP_ABNORMAL_SIZE_OF_THE_DENTAL_ROOT,0.911504042067917
REACTOME_CHROMATIN_MODIFICAT...,SET,7,0.40665,0.0079391,0.32178,0.10317,REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT,0.911504042067917
HP_ABNORMAL_CEREBRAL_VASCULA...,SET,307,0.062492,0.0080134,0.049452,0.10318,HP_ABNORMAL_CEREBRAL_VASCULAR_MORPHOLOGY,0.911504042067917
GOCC_SEX_CHROMATIN,SET,4,0.47446,0.0070028,0.37548,0.10319,GOCC_SEX_CHROMATIN,0.911504042067917
MORF_TERF2IP,SET,109,0.095625,0.0073465,0.075688,0.10323,MORF_TERF2IP,0.911504042067917
WP_NRF2_PATHWAY,SET,133,0.10302,0.0087371,0.081584,0.10334,WP_NRF2_PATHWAY,0.911504042067917
GOBP_TISSUE_HOMEOSTASIS,SET,247,0.07341,0.0084577,0.058134,0.10334,GOBP_TISSUE_HOMEOSTASIS,0.911504042067917
DING_LUNG_CANCER_MUTATED_FRE...,SET,12,0.283,0.007233,0.22411,0.10335,DING_LUNG_CANCER_MUTATED_FREQUENTLY,0.911504042067917
MODULE_63,SET,197,0.084768,0.008734,0.067133,0.10336,MODULE_63,0.911504042067917
HP_ABNORMAL_LARGE_INTESTINE_...2,SET,52,0.15075,0.0080117,0.11939,0.10336,HP_ABNORMAL_LARGE_INTESTINE_PHYSIOLOGY,0.911504042067917
REACTOME_SYNTHESIS_OF_GDP_MA...,SET,5,0.38458,0.0063461,0.30461,0.10338,REACTOME_SYNTHESIS_OF_GDP_MANNOSE,0.911504042067917
REACTOME_SYNTHESIS_OF_LEUKOT...,SET,21,0.26803,0.0090601,0.21232,0.10341,REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX,0.911504042067917
GSE21033_1H_VS_12H_POLYIC_ST...2,SET,166,0.084685,0.0080164,0.067086,0.10342,GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP,0.911504042067917
MIR6502_3P,SET,50,0.15256,0.0079511,0.12087,0.10344,MIR6502_3P,0.911504042067917
GSE1791_CTRL_VS_NEUROMEDINU_...3,SET,141,0.094001,0.0082065,0.074477,0.10346,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN,0.911504042067917
KEGG_MEDICUS_ENV_FACTOR_BENZ...,SET,11,0.37492,0.0091747,0.29708,0.10348,KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM,0.911504042067917
GOBP_REGULATION_OF_SMOOTH_MU...1,SET,6,0.43478,0.007859,0.34452,0.10348,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CELL_CHEMOTAXIS,0.911504042067917
MIR548AD_3P,SET,23,0.22788,0.0080609,0.18058,0.10349,MIR548AD_3P,0.911504042067917
HP_SKIN_PIT,SET,62,0.13868,0.0080454,0.10989,0.10349,HP_SKIN_PIT,0.911504042067917
GOBP_CELLULAR_RESPONSE_TO_CA...2,SET,10,0.33179,0.0077417,0.26302,0.10357,GOBP_CELLULAR_RESPONSE_TO_CAFFEINE,0.911779691061028
BRUINS_UVC_RESPONSE_LATE,SET,1032,0.033437,0.0077019,0.026507,0.10358,BRUINS_UVC_RESPONSE_LATE,0.911779691061028
HP_LATE_ONSET_PROXIMAL_MUSCL...,SET,6,0.45103,0.0081526,0.35758,0.1036,HP_LATE_ONSET_PROXIMAL_MUSCLE_WEAKNESS,0.911779691061028
GOMF_CARBONYL_REDUCTASE_NADP...,SET,9,0.39796,0.0088093,0.31558,0.10365,GOMF_CARBONYL_REDUCTASE_NADPH_ACTIVITY,0.911988797468354
HP_IMPAIRED_ARACHIDONIC_ACID...,SET,7,0.40658,0.0079379,0.32252,0.10373,HP_IMPAIRED_ARACHIDONIC_ACID_INDUCED_PLATELET_AGGREGATION,0.912198285858331
REACTOME_ANTIMICROBIAL_PEPTI...,SET,74,0.1555,0.0098525,0.12336,0.10376,REACTOME_ANTIMICROBIAL_PEPTIDES,0.912198285858331
HP_ABSENT_TESTIS,SET,24,0.19334,0.006986,0.15342,0.10381,HP_ABSENT_TESTIS,0.912198285858331
MIR6893_3P,SET,86,0.11874,0.0081078,0.094233,0.10383,MIR6893_3P,0.912198285858331
HP_ENLARGED_NARIS,SET,5,0.49241,0.0081253,0.39079,0.10384,HP_ENLARGED_NARIS,0.912198285858331
HP_TRACHEOESOPHAGEAL_FISTULA,SET,82,0.11717,0.0078132,0.093003,0.10388,HP_TRACHEOESOPHAGEAL_FISTULA,0.912198285858331
HP_SUBEPIDERMAL_BLISTERING,SET,11,0.3374,0.0082565,0.26783,0.10389,HP_SUBEPIDERMAL_BLISTERING,0.912198285858331
GSE43955_TH0_VS_TGFB_IL6_TH1...12,SET,176,0.082738,0.0080622,0.065679,0.10389,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_UP,0.912198285858331
HP_ABNORMAL_COCCYX_MORPHOLOGY,SET,8,0.44006,0.0091843,0.34937,0.10392,HP_ABNORMAL_COCCYX_MORPHOLOGY,0.912198285858331
GSE27786_CD4_VS_CD8_TCELL_UP,SET,188,0.077389,0.0077913,0.061449,0.10395,GSE27786_CD4_VS_CD8_TCELL_UP,0.912198285858331
GOBP_CELLULAR_HOMEOSTASIS,SET,746,0.041104,0.0081159,0.032642,0.10398,GOBP_CELLULAR_HOMEOSTASIS,0.912198285858331
REACTOME_RECEPTOR_MEDIATED_M...,SET,10,0.32687,0.0076268,0.25961,0.10401,REACTOME_RECEPTOR_MEDIATED_MITOPHAGY,0.912198285858331
GOBP_ESCRT_COMPLEX_DISASSEMB...,SET,10,0.29553,0.0068956,0.23473,0.10402,GOBP_ESCRT_COMPLEX_DISASSEMBLY,0.912198285858331
REACTOME_SIGNALING_BY_RETINO...,SET,40,0.1775,0.0082765,0.14104,0.10411,REACTOME_SIGNALING_BY_RETINOIC_ACID,0.912198285858331
GOBP_RESPONSE_TO_ATP,SET,31,0.20433,0.0083896,0.16236,0.10411,GOBP_RESPONSE_TO_ATP,0.912198285858331
GOBP_SENSORY_PERCEPTION_OF_P...,SET,73,0.13378,0.0084191,0.1063,0.10412,GOBP_SENSORY_PERCEPTION_OF_PAIN,0.912198285858331
GSE31082_DN_VS_CD8_SP_THYMOC...1,SET,188,0.077955,0.0078483,0.061945,0.10412,GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN,0.912198285858331
GOMF_SIGNALING_RECEPTOR_REGU...,SET,489,0.053912,0.0086808,0.042845,0.10415,GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY,0.912231161794355
MIR6787_5P,SET,24,0.23034,0.0083229,0.1831,0.10421,MIR6787_5P,0.912526719576719
GSE40274_CTRL_VS_FOXP3_AND_G...2,SET,125,0.099287,0.0081649,0.078957,0.1043,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.912657727158319
GOBP_L_HISTIDINE_TRANSMEMBRA...,SET,4,0.58887,0.0086914,0.46832,0.10431,GOBP_L_HISTIDINE_TRANSMEMBRANE_TRANSPORT,0.912657727158319
REACTOME_GLI_PROTEINS_BIND_P...,SET,7,0.42282,0.0082549,0.33629,0.10433,REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION,0.912657727158319
HP_WADDLING_GAIT,SET,116,0.099787,0.007907,0.079365,0.10433,HP_WADDLING_GAIT,0.912657727158319
HP_DIFFUSE_WHITE_MATTER_ABNO...,SET,29,0.19129,0.0075968,0.15217,0.10437,HP_DIFFUSE_WHITE_MATTER_ABNORMALITIES,0.912750596421471
GOBP_C21_STEROID_HORMONE_BIO...,SET,19,0.27054,0.0086992,0.21526,0.10442,GOBP_C21_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.912750596421471
GOCC_SARCOPLASMIC_RETICULUM_...2,SET,42,0.16374,0.0078231,0.13034,0.10452,GOCC_SARCOPLASMIC_RETICULUM_MEMBRANE,0.912750596421471
KEGG_MEDICUS_VARIANT_FZD7_OV...,SET,36,0.18522,0.0081943,0.14746,0.10454,KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,0.912750596421471
BIOCARTA_CXCR4_PATHWAY,SET,19,0.25483,0.0081938,0.20288,0.10455,BIOCARTA_CXCR4_PATHWAY,0.912750596421471
GOMF_PURINE_NUCLEOTIDE_BINDI...,SET,1797,0.026411,0.0078484,0.021028,0.10457,GOMF_PURINE_NUCLEOTIDE_BINDING,0.912750596421471
GOBP_DETECTION_OF_MOLECULE_O...,SET,12,0.34375,0.0087856,0.27373,0.10461,GOBP_DETECTION_OF_MOLECULE_OF_BACTERIAL_ORIGIN,0.912750596421471
HP_ABNORMAL_INCISOR_MORPHOLO...,SET,55,0.15483,0.0084622,0.12331,0.10463,HP_ABNORMAL_INCISOR_MORPHOLOGY,0.912750596421471
CDC73_TARGET_GENES,SET,479,0.047326,0.0075442,0.037697,0.10467,CDC73_TARGET_GENES,0.912750596421471
HP_ABNORMAL_ENDOMETRIUM_MORP...,SET,28,0.18173,0.007092,0.14477,0.10469,HP_ABNORMAL_ENDOMETRIUM_MORPHOLOGY,0.912750596421471
ACAWYAAAG_UNKNOWN,SET,91,0.11907,0.0083625,0.094878,0.10475,ACAWYAAAG_UNKNOWN,0.912750596421471
GSE7768_OVA_ALONE_VS_OVA_WIT...4,SET,164,0.081276,0.0076476,0.064765,0.10476,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,0.912750596421471
MIR7854_3P,SET,99,0.10659,0.0078066,0.084951,0.10479,MIR7854_3P,0.912750596421471
REACTOME_NITRIC_OXIDE_STIMUL...,SET,19,0.27401,0.0088106,0.21844,0.10485,REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE,0.912750596421471
GOMF_COMPLEMENT_RECEPTOR_ACT...,SET,10,0.43615,0.010177,0.34769,0.10485,GOMF_COMPLEMENT_RECEPTOR_ACTIVITY,0.912750596421471
KEGG_MEDICUS_VARIANT_MUTATIO...50,SET,6,0.47268,0.008544,0.37682,0.10486,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM,0.912750596421471
REACTOME_CONVERSION_FROM_APC...,SET,19,0.22356,0.0071885,0.17825,0.10489,REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE,0.912750596421471
HP_CHIN_WITH_HORIZONTAL_CREA...,SET,8,0.43134,0.0090024,0.34394,0.10491,HP_CHIN_WITH_HORIZONTAL_CREASE,0.912750596421471
GSE3982_BASOPHIL_VS_EFF_MEMO...1,SET,172,0.080115,0.0077183,0.063882,0.10491,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,0.912750596421471
GOBP_GALACTOSE_METABOLIC_PRO...,SET,9,0.34381,0.0076107,0.27418,0.10493,GOBP_GALACTOSE_METABOLIC_PROCESS,0.912750596421471
GOLDRATH_HOMEOSTATIC_PROLIFE...,SET,134,0.090806,0.0077297,0.072424,0.10496,GOLDRATH_HOMEOSTATIC_PROLIFERATION,0.912750596421471
REACTOME_TNF_SIGNALING,SET,51,0.14319,0.0075365,0.11421,0.10497,REACTOME_TNF_SIGNALING,0.912750596421471
HP_THORACIC_PLATYSPONDYLY,SET,6,0.39249,0.0070945,0.31315,0.10504,HP_THORACIC_PLATYSPONDYLY,0.912750596421471
GOBP_HINDBRAIN_MATURATION,SET,5,0.4878,0.0080492,0.38921,0.10506,GOBP_HINDBRAIN_MATURATION,0.912750596421471
MIR4695_3P,SET,70,0.1339,0.0082522,0.10685,0.10509,MIR4695_3P,0.912750596421471
MODULE_385,SET,27,0.23243,0.008907,0.18552,0.10514,MODULE_385,0.912750596421471
MIR4314,SET,121,0.096088,0.0077752,0.07671,0.10518,MIR4314,0.912750596421471
HP_GENERALIZED_MYOCLONIC_SEI...,SET,114,0.10099,0.0079336,0.080623,0.10518,HP_GENERALIZED_MYOCLONIC_SEIZURE,0.912750596421471
REACTOME_SYNTHESIS_OF_ACTIVE...,SET,26,0.21357,0.0080315,0.17056,0.10527,REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES,0.912750596421471
GOBP_CAMP_MEDIATED_SIGNALING,SET,53,0.15416,0.0082713,0.12312,0.10528,GOBP_CAMP_MEDIATED_SIGNALING,0.912750596421471
GOBP_CELLULAR_RESPONSE_TO_FA...,SET,32,0.20517,0.0085586,0.16387,0.10529,GOBP_CELLULAR_RESPONSE_TO_FATTY_ACID,0.912750596421471
GOBP_PHOSPHATIDYLINOSITOL_3_...1,SET,275,0.067852,0.0082421,0.05422,0.1054,GOBP_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,0.912750596421471
GOBP_WATER_TRANSPORT,SET,25,0.24695,0.0091068,0.19734,0.1054,GOBP_WATER_TRANSPORT,0.912750596421471
GSE22935_24H_VS_48H_MBOVIS_B...2,SET,178,0.079173,0.0077582,0.06327,0.10541,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.912750596421471
WEBER_METHYLATED_LCP_IN_FIBR...1,SET,9,0.38108,0.0084357,0.30455,0.10542,WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN,0.912750596421471
MIR5089_3P,SET,62,0.13518,0.0078425,0.10804,0.10545,MIR5089_3P,0.912750596421471
GOBP_POSITIVE_REGULATION_OF_...446,SET,17,0.28403,0.0086392,0.22702,0.10545,GOBP_POSITIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.912750596421471
WP_WNT_SIGNALING_WP428,SET,109,0.10736,0.008248,0.085816,0.10547,WP_WNT_SIGNALING_WP428,0.912750596421471
MARSON_FOXP3_TARGETS_STIMULA...2,SET,29,0.21591,0.0085746,0.17261,0.1055,MARSON_FOXP3_TARGETS_STIMULATED_UP,0.912750596421471
XU_GH1_EXOGENOUS_TARGETS_UP,SET,48,0.15443,0.0078862,0.12346,0.1055,XU_GH1_EXOGENOUS_TARGETS_UP,0.912750596421471
GOCC_MITOCHONDRIAL_CRISTA_JU...,SET,4,0.54005,0.0079709,0.43175,0.1055,GOCC_MITOCHONDRIAL_CRISTA_JUNCTION,0.912750596421471
HP_TRANSPOSITION_OF_THE_GREA...,SET,68,0.12819,0.0077872,0.1025,0.10555,HP_TRANSPOSITION_OF_THE_GREAT_ARTERIES,0.912750596421471
GOBP_NUCLEAR_MEMBRANE_ORGANI...,SET,44,0.15804,0.0077278,0.12637,0.10556,GOBP_NUCLEAR_MEMBRANE_ORGANIZATION,0.912750596421471
chr10q22,SET,85,0.23538,0.015979,0.18823,0.10557,chr10q22,0.912750596421471
GOBP_LAMELLIPODIUM_ASSEMBLY,SET,61,0.14167,0.0081531,0.1133,0.10557,GOBP_LAMELLIPODIUM_ASSEMBLY,0.912750596421471
HP_GLOMERULAR_SCLEROSIS,SET,78,0.11676,0.0075944,0.093392,0.10562,HP_GLOMERULAR_SCLEROSIS,0.912750596421471
SATO_SILENCED_BY_METHYLATION...1,SET,368,0.059149,0.0082902,0.047314,0.10563,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,0.912750596421471
GOBP_GLIAL_CELL_PROLIFERATION,SET,52,0.15282,0.008122,0.12226,0.10567,GOBP_GLIAL_CELL_PROLIFERATION,0.912750596421471
GOBP_EMBRYONIC_DIGIT_MORPHOG...,SET,53,0.16361,0.0087782,0.1309,0.10568,GOBP_EMBRYONIC_DIGIT_MORPHOGENESIS,0.912750596421471
GOBP_POSITIVE_REGULATION_OF_...759,SET,6,0.4469,0.008078,0.35756,0.10568,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.912750596421471
HP_ACUTE_RHABDOMYOLYSIS,SET,5,0.44808,0.0073939,0.3585,0.10568,HP_ACUTE_RHABDOMYOLYSIS,0.912750596421471
GSE37301_HEMATOPOIETIC_STEM_...1,SET,118,0.10378,0.0082935,0.083074,0.1058,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_DN,0.913403527272727
PID_ANTHRAX_PATHWAY,SET,17,0.2625,0.0079843,0.21016,0.10584,PID_ANTHRAX_PATHWAY,0.913403527272727
VERNELL_RETINOBLASTOMA_PATHW...2,SET,68,0.12459,0.0075685,0.099786,0.10592,VERNELL_RETINOBLASTOMA_PATHWAY_UP,0.913403527272727
GOMF_ATP_HYDROLYSIS_ACTIVITY,SET,381,0.053197,0.0075837,0.04261,0.10594,GOMF_ATP_HYDROLYSIS_ACTIVITY,0.913403527272727
GOBP_REGULATION_OF_POSTSYNAP...7,SET,134,0.099405,0.0084617,0.079642,0.106,GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL,0.913403527272727
DER_IFN_GAMMA_RESPONSE_UP,SET,67,0.13479,0.0081282,0.10802,0.10605,DER_IFN_GAMMA_RESPONSE_UP,0.913403527272727
MIR4714_5P,SET,93,0.11134,0.0079047,0.089225,0.10605,MIR4714_5P,0.913403527272727
GSE45365_HEALTHY_VS_MCMV_INF...6,SET,154,0.08157,0.0074396,0.065377,0.10608,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP,0.913403527272727
GSE5099_MONOCYTE_VS_CLASSICA...2,SET,174,0.078441,0.0076004,0.06287,0.10609,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP,0.913403527272727
REACTOME_CREATINE_METABOLISM,SET,10,0.33834,0.0078946,0.27121,0.10611,REACTOME_CREATINE_METABOLISM,0.913403527272727
HP_ABNORMALITY_OF_LOWER_LIMB...,SET,639,0.042841,0.0078524,0.034344,0.10613,HP_ABNORMALITY_OF_LOWER_LIMB_JOINT,0.913403527272727
WP_TCA_CYCLE_AKA_KREBS_OR_CI...,SET,17,0.2188,0.0066553,0.17542,0.10614,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,0.913403527272727
KEGG_MEDICUS_REFERENCE_CYTOK...,SET,42,0.17973,0.0085867,0.1441,0.10617,KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY,0.913403527272727
MIR4329,SET,70,0.13128,0.0080908,0.10527,0.1062,MIR4329,0.913403527272727
GSE6259_DEC205_POS_DC_VS_CD4...1,SET,181,0.076039,0.007513,0.060977,0.1062,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_DN,0.913403527272727
GSE36888_UNTREATED_VS_IL2_TR...2,SET,168,0.087169,0.0083005,0.069935,0.10631,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_UP,0.913403527272727
MIR6867_3P,SET,105,0.10369,0.0078192,0.083189,0.10632,MIR6867_3P,0.913403527272727
GOBP_REGULATION_OF_SYNAPTIC_...14,SET,3,0.64273,0.0082156,0.51567,0.10632,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_TRANSPORT,0.913403527272727
GOBP_VACUOLAR_LOCALIZATION,SET,75,0.12538,0.0079975,0.1006,0.10633,GOBP_VACUOLAR_LOCALIZATION,0.913403527272727
HP_HYPOGLYCEMIC_SEIZURES,SET,23,0.2391,0.0084579,0.19186,0.10635,HP_HYPOGLYCEMIC_SEIZURES,0.913403527272727
GSE3565_DUSP1_VS_WT_SPLENOCY...2,SET,146,0.093631,0.0083167,0.075144,0.10638,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_DN,0.913403527272727
TESAR_ALK_TARGETS_HUMAN_ES_5...2,SET,4,0.56381,0.0083215,0.45257,0.10643,TESAR_ALK_TARGETS_HUMAN_ES_5D_UP,0.913403527272727
REACTOME_MATURATION_OF_SARS_...3,SET,5,0.42734,0.0070516,0.34304,0.10643,REACTOME_MATURATION_OF_SARS_COV_2_SPIKE_PROTEIN,0.913403527272727
GOMF_OXYGEN_SENSOR_ACTIVITY,SET,5,0.37856,0.0062466,0.30387,0.10643,GOMF_OXYGEN_SENSOR_ACTIVITY,0.913403527272727
GOBP_T_CELL_SELECTION,SET,57,0.15641,0.0087022,0.12559,0.10649,GOBP_T_CELL_SELECTION,0.913403527272727
chr13q21,SET,11,0.517,0.012652,0.41517,0.10652,chr13q21,0.913403527272727
ERWIN_COHEN_PBMC_TC_83_AGE_1...1,SET,36,0.21319,0.0094314,0.1712,0.10652,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,0.913403527272727
MIR645,SET,35,0.17408,0.0075936,0.1398,0.10654,MIR645,0.913403527272727
HP_URETERAL_STENOSIS,SET,29,0.19721,0.0078318,0.15838,0.10654,HP_URETERAL_STENOSIS,0.913403527272727
GSE15330_WT_VS_IKAROS_KO_LYM...1,SET,179,0.075469,0.0074157,0.06063,0.10662,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN,0.913403527272727
GOBP_NEGATIVE_REGULATION_OF_...388,SET,7,0.46713,0.0091199,0.37535,0.10667,GOBP_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,0.913403527272727
MIR2861,SET,82,0.13821,0.0092162,0.11106,0.10668,MIR2861,0.913403527272727
REACTOME_TRANSCRIPTIONAL_REG...10,SET,38,0.16834,0.0076512,0.13531,0.10673,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,0.913403527272727
HP_DYSGENESIS_OF_THE_CEREBEL...,SET,7,0.36717,0.0071685,0.29514,0.10674,HP_DYSGENESIS_OF_THE_CEREBELLAR_VERMIS,0.913403527272727
MORF_KDR,SET,82,0.1238,0.0082553,0.099511,0.10675,MORF_KDR,0.913403527272727
GSE7509_UNSTIM_VS_FCGRIIB_ST...3,SET,150,0.082595,0.0074354,0.066402,0.10678,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN,0.913403527272727
GOMF_OXIDOREDUCTASE_ACTIVITY...7,SET,11,0.30493,0.007462,0.24519,0.10682,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS,0.913403527272727
GOBP_CARDIAC_MUSCLE_CELL_FAT...,SET,7,0.46398,0.0090584,0.37318,0.10689,GOBP_CARDIAC_MUSCLE_CELL_FATE_COMMITMENT,0.913403527272727
BIOCARTA_IL6_PATHWAY,SET,20,0.24161,0.0079704,0.19439,0.10696,BIOCARTA_IL6_PATHWAY,0.913403527272727
HP_PARAPLEGIA,SET,126,0.095594,0.0078924,0.076915,0.10697,HP_PARAPLEGIA,0.913403527272727
HP_BLEPHAROCHALASIS,SET,6,0.48066,0.0086883,0.3868,0.107,HP_BLEPHAROCHALASIS,0.913403527272727
GSE40273_EOS_KO_VS_WT_TREG_DN,SET,187,0.077159,0.0077477,0.062093,0.10701,GSE40273_EOS_KO_VS_WT_TREG_DN,0.913403527272727
GSE9650_NAIVE_VS_MEMORY_CD8_...1,SET,181,0.08096,0.0079992,0.065163,0.10705,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.913403527272727
chr2p12,SET,13,0.43366,0.011536,0.34907,0.10707,chr2p12,0.913403527272727
GSE3982_MAST_CELL_VS_DC_UP,SET,161,0.082402,0.0076829,0.066363,0.10718,GSE3982_MAST_CELL_VS_DC_UP,0.913403527272727
GSE5589_LPS_VS_LPS_AND_IL10_...8,SET,179,0.078748,0.007738,0.063418,0.10718,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP,0.913403527272727
GOBP_ALDEHYDE_CATABOLIC_PROC...,SET,13,0.28115,0.0074789,0.22652,0.10728,GOBP_ALDEHYDE_CATABOLIC_PROCESS,0.913403527272727
MIR4698,SET,572,0.046358,0.0080544,0.037353,0.1073,MIR4698,0.913403527272727
HP_CHROMOSOME_BREAKAGE,SET,36,0.15948,0.0070555,0.12854,0.10736,HP_CHROMOSOME_BREAKAGE,0.913403527272727
GAUSSMANN_MLL_AF4_FUSION_TAR...14,SET,219,0.073944,0.008028,0.059599,0.10737,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,0.913403527272727
KEGG_MEDICUS_REFERENCE_CA2_C...2,SET,12,0.29395,0.007513,0.23696,0.1074,KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY,0.913403527272727
REACTOME_NEUREXINS_AND_NEURO...,SET,51,0.15561,0.0081905,0.12544,0.1074,REACTOME_NEUREXINS_AND_NEUROLIGINS,0.913403527272727
ZNF592_TARGET_GENES,SET,1471,0.028439,0.0077211,0.022926,0.1074,ZNF592_TARGET_GENES,0.913403527272727
GSE43863_DAY6_EFF_VS_DAY150_...2,SET,177,0.082685,0.0080798,0.066657,0.10741,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP,0.913403527272727
GOBP_REGULATION_OF_FEAR_RESP...,SET,8,0.43123,0.009,0.34765,0.10742,GOBP_REGULATION_OF_FEAR_RESPONSE,0.913403527272727
MODULE_131,SET,31,0.20722,0.0085082,0.16707,0.10743,MODULE_131,0.913403527272727
GSE17721_LPS_VS_PAM3CSK4_12H...2,SET,188,0.077465,0.007799,0.062455,0.10743,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_UP,0.913403527272727
CCCNNNNNNAAGWT_UNKNOWN,SET,93,0.10846,0.0077003,0.087449,0.10744,CCCNNNNNNAAGWT_UNKNOWN,0.913403527272727
HP_SPASTIC_PARAPLEGIA,SET,95,0.10828,0.0077694,0.087315,0.10747,HP_SPASTIC_PARAPLEGIA,0.913403527272727
GOBP_APOPTOTIC_PROCESS_INVOL...2,SET,4,0.6578,0.0097088,0.53051,0.10751,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_HEART_MORPHOGENESIS,0.913403527272727
MIR6753_3P,SET,50,0.15198,0.0079208,0.12258,0.10753,MIR6753_3P,0.913403527272727
GOMF_GANGLIOSIDE_BINDING,SET,5,0.54085,0.0089246,0.43638,0.10761,GOMF_GANGLIOSIDE_BINDING,0.913403527272727
WIKMAN_ASBESTOS_LUNG_CANCER_...1,SET,28,0.19441,0.0075866,0.15688,0.10764,WIKMAN_ASBESTOS_LUNG_CANCER_DN,0.913403527272727
SESTO_RESPONSE_TO_UV_C7,SET,64,0.13849,0.0081628,0.11176,0.10765,SESTO_RESPONSE_TO_UV_C7,0.913403527272727
GOBP_NEGATIVE_REGULATION_OF_...586,SET,3,0.72548,0.0092734,0.58565,0.10772,GOBP_NEGATIVE_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY,0.913403527272727
MODULE_150,SET,12,0.26479,0.0067677,0.21376,0.10773,MODULE_150,0.913403527272727
HP_CHRONIC_CONSTIPATION,SET,90,0.11403,0.0079644,0.092056,0.10774,HP_CHRONIC_CONSTIPATION,0.913403527272727
KEGG_MEDICUS_ENV_FACTOR_NNK_...5,SET,5,0.54741,0.009033,0.44203,0.10779,KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS,0.913403527272727
GOBP_FOLATE_TRANSMEMBRANE_TR...,SET,5,0.5305,0.0087539,0.42837,0.10779,GOBP_FOLATE_TRANSMEMBRANE_TRANSPORT,0.913403527272727
GOCC_OXOGLUTARATE_DEHYDROGEN...,SET,11,0.27559,0.006744,0.22262,0.10787,GOCC_OXOGLUTARATE_DEHYDROGENASE_COMPLEX,0.913403527272727
MIR3199,SET,41,0.16239,0.0076656,0.13118,0.10789,MIR3199,0.913403527272727
GOBP_OLIGOPEPTIDE_TRANSPORT,SET,18,0.25364,0.0079384,0.2049,0.10789,GOBP_OLIGOPEPTIDE_TRANSPORT,0.913403527272727
HP_ABNORMAL_T_WAVE,SET,35,0.18453,0.0080494,0.14907,0.10789,HP_ABNORMAL_T_WAVE,0.913403527272727
GOBP_KETONE_BIOSYNTHETIC_PRO...,SET,42,0.16029,0.007658,0.12951,0.10793,GOBP_KETONE_BIOSYNTHETIC_PROCESS,0.913403527272727
HP_ABNORMALITIES_OF_PLACENTA...,SET,103,0.10754,0.0080327,0.086891,0.10793,HP_ABNORMALITIES_OF_PLACENTA_OR_UMBILICAL_CORD,0.913403527272727
GOBP_REGULATION_OF_PH,SET,95,0.10988,0.0078842,0.088794,0.10795,GOBP_REGULATION_OF_PH,0.913403527272727
GSE18804_SPLEEN_MACROPHAGE_V...3,SET,174,0.082651,0.0080083,0.066787,0.10795,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN,0.913403527272727
GCM_SMO,SET,58,0.13218,0.0074181,0.10681,0.10796,GCM_SMO,0.913403527272727
GRAHAM_CML_DIVIDING_VS_NORMA...3,SET,77,0.1312,0.0084789,0.10602,0.10797,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,0.913403527272727
GOBP_POSITIVE_REGULATION_OF_...275,SET,13,0.29974,0.0079735,0.24224,0.10799,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_OXIDATION,0.913403527272727
REACTOME_SIGNALING_BY_MAPK_M...,SET,6,0.49177,0.0088891,0.39748,0.10801,REACTOME_SIGNALING_BY_MAPK_MUTANTS,0.913403527272727
GOBP_NEGATIVE_REGULATION_OF_...213,SET,6,0.43595,0.00788,0.35247,0.10808,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,0.913403527272727
GOBP_POSITIVE_REGULATION_OF_...120,SET,300,0.062615,0.0079387,0.050631,0.10811,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE,0.913403527272727
GSE13306_RA_VS_UNTREATED_TCO...2,SET,183,0.076734,0.007623,0.062054,0.10813,GSE13306_RA_VS_UNTREATED_TCONV_UP,0.913403527272727
GOBP_SKELETAL_MUSCLE_SATELLI...4,SET,16,0.23333,0.0068855,0.18873,0.10817,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_PROLIFERATION,0.913403527272727
GOMF_DIPEPTIDYL_PEPTIDASE_AC...,SET,12,0.29925,0.0076484,0.24205,0.10818,GOMF_DIPEPTIDYL_PEPTIDASE_ACTIVITY,0.913403527272727
GSE27786_BCELL_VS_NEUTROPHIL...2,SET,183,0.072171,0.0071697,0.058383,0.10821,GSE27786_BCELL_VS_NEUTROPHIL_UP,0.913403527272727
GOMF_TBP_CLASS_PROTEIN_BINDI...,SET,23,0.2279,0.0080616,0.1844,0.10825,GOMF_TBP_CLASS_PROTEIN_BINDING,0.913403527272727
GOBP_GRANULOCYTE_MIGRATION,SET,140,0.10021,0.0087181,0.081097,0.10828,GOBP_GRANULOCYTE_MIGRATION,0.913403527272727
GOCC_CILIARY_TRANSITION_FIBER,SET,8,0.36243,0.0075642,0.29329,0.10828,GOCC_CILIARY_TRANSITION_FIBER,0.913403527272727
HP_ABNORMAL_URETER_PHYSIOLOGY,SET,213,0.072617,0.0077765,0.058775,0.10833,HP_ABNORMAL_URETER_PHYSIOLOGY,0.913403527272727
GSE1460_DP_THYMOCYTE_VS_NAIV...3,SET,173,0.083912,0.0081074,0.067917,0.10833,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,0.913403527272727
GOBP_RESPONSE_TO_2_3_7_8_TET...,SET,5,0.57357,0.0094646,0.46426,0.10834,GOBP_RESPONSE_TO_2_3_7_8_TETRACHLORODIBENZODIOXINE,0.913403527272727
MIR1322,SET,68,0.1468,0.0089176,0.11882,0.10835,MIR1322,0.913403527272727
GOMF_ICOSANOID_RECEPTOR_ACTI...,SET,14,0.29617,0.0081758,0.23974,0.10835,GOMF_ICOSANOID_RECEPTOR_ACTIVITY,0.913403527272727
HP_PROXIMAL_MUSCLE_WEAKNESS,SET,219,0.072071,0.0078246,0.058338,0.10835,HP_PROXIMAL_MUSCLE_WEAKNESS,0.913403527272727
KEGG_MEDICUS_REFERENCE_RIG_I...1,SET,20,0.26267,0.008665,0.21265,0.10838,KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY,0.913403527272727
KEGG_PROXIMAL_TUBULE_BICARBO...,SET,21,0.2402,0.0081193,0.19446,0.10839,KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION,0.913403527272727
HP_HEPATIC_NECROSIS,SET,13,0.27398,0.0072882,0.22182,0.1084,HP_HEPATIC_NECROSIS,0.913403527272727
GOBP_ORGANELLE_ASSEMBLY,SET,914,0.034606,0.007527,0.02802,0.10841,GOBP_ORGANELLE_ASSEMBLY,0.913403527272727
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...8,SET,72,0.12909,0.0080684,0.10452,0.10841,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE,0.913403527272727
GOBP_POSITIVE_REGULATION_OF_...713,SET,36,0.19226,0.0085055,0.15572,0.1085,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,0.913940256907416
ROSS_AML_WITH_CBFB_MYH11_FUS...,SET,45,0.16685,0.0082506,0.13518,0.10855,ROSS_AML_WITH_CBFB_MYH11_FUSION,0.91400261627907
GOBP_NUCLEUS_ORGANIZATION,SET,132,0.089413,0.0075545,0.072443,0.10856,GOBP_NUCLEUS_ORGANIZATION,0.91400261627907
GSE19401_RETINOIC_ACID_VS_RE...2,SET,176,0.081717,0.0079628,0.066234,0.10865,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,0.914538810850085
HP_ABNORMAL_ALVEOLAR_RIDGE_M...,SET,38,0.16513,0.007505,0.13386,0.10869,HP_ABNORMAL_ALVEOLAR_RIDGE_MORPHOLOGY,0.914653983050847
HP_SUPRAVENTRICULAR_ARRHYTHM...,SET,111,0.10902,0.0084513,0.088405,0.10877,HP_SUPRAVENTRICULAR_ARRHYTHMIA,0.914884160212972
GSE9037_WT_VS_IRAK4_KO_LPS_4...1,SET,187,0.078124,0.0078446,0.063353,0.10877,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN,0.914884160212972
SRF_Q4,SET,202,0.076693,0.0080005,0.062245,0.10896,SRF_Q4,0.915483526490066
GOBP_REGULATION_OF_RETROGRAD...2,SET,5,0.46215,0.0076259,0.37509,0.10896,GOBP_REGULATION_OF_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI,0.915483526490066
KLEIN_PRIMARY_EFFUSION_LYMPH...1,SET,50,0.16066,0.0083733,0.13041,0.10899,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,0.915483526490066
HP_DEVIATION_OF_THE_5TH_TOE,SET,16,0.26533,0.0078296,0.21539,0.10901,HP_DEVIATION_OF_THE_5TH_TOE,0.915483526490066
HP_ABNORMAL_TARSAL_OSSIFICAT...,SET,8,0.36775,0.0076753,0.29859,0.10906,HP_ABNORMAL_TARSAL_OSSIFICATION,0.915483526490066
GOCC_HAUS_COMPLEX,SET,7,0.32107,0.0062683,0.26072,0.10909,GOCC_HAUS_COMPLEX,0.915483526490066
NABA_MATRISOME,SET,950,0.039321,0.0087103,0.031936,0.10912,NABA_MATRISOME,0.915483526490066
MIR892C_3P,SET,189,0.075478,0.0076189,0.061325,0.10921,MIR892C_3P,0.915483526490066
NR1H4_TARGET_GENES,SET,328,0.059095,0.0078281,0.048016,0.10922,NR1H4_TARGET_GENES,0.915483526490066
GOBP_REGULATION_OF_CARDIAC_M...8,SET,68,0.13295,0.0080766,0.10804,0.10924,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,0.915483526490066
HP_PLETHORA,SET,12,0.32718,0.0083621,0.26586,0.10924,HP_PLETHORA,0.915483526490066
GOBP_PIGMENT_GRANULE_LOCALIZ...,SET,23,0.22175,0.0078442,0.1802,0.10925,GOBP_PIGMENT_GRANULE_LOCALIZATION,0.915483526490066
WP_PATHOGENESIS_OF_SARSCOV2_...,SET,18,0.2847,0.0089104,0.23137,0.10926,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,0.915483526490066
HOWLIN_CITED1_TARGETS_2_UP,SET,16,0.25393,0.0074933,0.20639,0.10929,HOWLIN_CITED1_TARGETS_2_UP,0.915483526490066
REACTOME_REGULATION_OF_CDH11...1,SET,10,0.3545,0.0082716,0.28817,0.10932,REACTOME_REGULATION_OF_CDH11_FUNCTION,0.915483526490066
GOBP_REGULATION_OF_SKELETAL_...9,SET,11,0.30273,0.0074082,0.24609,0.10933,GOBP_REGULATION_OF_SKELETAL_MUSCLE_SATELLITE_CELL_PROLIFERATION,0.915483526490066
GOMF_PROTEIN_KINASE_A_REGULA...,SET,24,0.1986,0.0071762,0.16151,0.10942,GOMF_PROTEIN_KINASE_A_REGULATORY_SUBUNIT_BINDING,0.915483526490066
WP_PTDINS45P2_IN_CYTOKINESIS...,SET,9,0.33943,0.0075137,0.27606,0.10944,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,0.915483526490066
HP_LEUKOPENIA,SET,129,0.090391,0.0075505,0.07352,0.10945,HP_LEUKOPENIA,0.915483526490066
GOMF_RNA_POLYMERASE_II_INTRO...,SET,8,0.39733,0.0082927,0.32318,0.10946,GOMF_RNA_POLYMERASE_II_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.915483526490066
KEGG_BASAL_TRANSCRIPTION_FAC...,SET,31,0.1678,0.0068897,0.13649,0.10947,KEGG_BASAL_TRANSCRIPTION_FACTORS,0.915483526490066
KIM_GLIS2_TARGETS_UP,SET,81,0.128,0.0084837,0.10412,0.10948,KIM_GLIS2_TARGETS_UP,0.915483526490066
GSE20151_CTRL_VS_FUSOBACT_NU...2,SET,178,0.076999,0.0075451,0.062634,0.10948,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP,0.915483526490066
HE_LIM_SUN_FETAL_LUNG_C2_DC1...,SET,291,0.063313,0.0079078,0.051516,0.10954,HE_LIM_SUN_FETAL_LUNG_C2_DC1_CELL,0.915483526490066
LEIN_LOCALIZED_TO_PROXIMAL_D...,SET,31,0.18052,0.007412,0.14692,0.10959,LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES,0.915483526490066
GOBP_NEGATIVE_REGULATION_OF_...328,SET,34,0.17379,0.007472,0.14146,0.10963,GOBP_NEGATIVE_REGULATION_OF_JNK_CASCADE,0.915483526490066
GOBP_NEGATIVE_REGULATION_OF_...652,SET,137,0.092951,0.0079997,0.075658,0.10963,GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.915483526490066
HP_ABNORMAL_PROLACTIN_LEVEL,SET,26,0.2069,0.0077808,0.16846,0.10969,HP_ABNORMAL_PROLACTIN_LEVEL,0.915483526490066
GOMF_NADPLUS_PROTEIN_ASPARTA...,SET,5,0.46159,0.0076168,0.37598,0.10979,GOMF_NADPLUS_PROTEIN_ASPARTATE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.915483526490066
HP_HYPOPLASTIC_DERMOEPIDERMA...,SET,7,0.44456,0.0086793,0.36215,0.10981,HP_HYPOPLASTIC_DERMOEPIDERMAL_HEMIDESMOSOMES,0.915483526490066
GOBP_CELLULAR_RESPONSE_TO_ZI...,SET,20,0.2797,0.009227,0.22786,0.10982,GOBP_CELLULAR_RESPONSE_TO_ZINC_ION,0.915483526490066
GOMF_G_PROTEIN_COUPLED_RECEP...2,SET,254,0.071164,0.0083127,0.057989,0.10988,GOMF_G_PROTEIN_COUPLED_RECEPTOR_BINDING,0.915483526490066
GSE17186_CD21LOW_VS_CD21HIGH...3,SET,184,0.079531,0.0079222,0.064826,0.10995,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,0.915483526490066
GOCC_INTERCHROMATIN_GRANULE,SET,5,0.46921,0.0077426,0.38248,0.10996,GOCC_INTERCHROMATIN_GRANULE,0.915483526490066
GOBP_ORGANIC_HYDROXY_COMPOUN...1,SET,224,0.071357,0.007834,0.058171,0.10998,GOBP_ORGANIC_HYDROXY_COMPOUND_BIOSYNTHETIC_PROCESS,0.915483526490066
HP_PANCREATIC_ISLET_CELL_HYP...,SET,10,0.38985,0.0090963,0.31781,0.10998,HP_PANCREATIC_ISLET_CELL_HYPERPLASIA,0.915483526490066
REACTOME_RHO_GTPASE_CYCLE,SET,412,0.051848,0.0076796,0.04227,0.11,REACTOME_RHO_GTPASE_CYCLE,0.915483526490066
GOBP_EPITHELIAL_FLUID_TRANSP...,SET,12,0.32251,0.0082428,0.26296,0.11002,GOBP_EPITHELIAL_FLUID_TRANSPORT,0.915483526490066
GSE40274_FOXP3_VS_FOXP3_AND_...8,SET,176,0.082113,0.0080014,0.066963,0.11006,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.915483526490066
GOBP_LONG_CHAIN_FATTY_ACID_B...,SET,25,0.2237,0.0082495,0.18244,0.11007,GOBP_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.915483526490066
HP_NARROW_PALM,SET,13,0.33751,0.0089781,0.27524,0.11007,HP_NARROW_PALM,0.915483526490066
GSE22103_UNSTIM_VS_LPS_STIM_...1,SET,177,0.078945,0.0077142,0.06439,0.1101,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN,0.915483526490066
chr21q22,SET,149,0.17838,0.016005,0.14551,0.11012,chr21q22,0.915483526490066
REACTOME_METHIONINE_SALVAGE_...,SET,6,0.49621,0.0089693,0.40476,0.11012,REACTOME_METHIONINE_SALVAGE_PATHWAY,0.915483526490066
MIR3117_3P,SET,30,0.19701,0.0079576,0.16076,0.11019,MIR3117_3P,0.915483526490066
chr2q34,SET,15,0.48677,0.013908,0.39723,0.11022,chr2q34,0.915483526490066
HP_ABNORMAL_POSTERIOR_SEGMEN...,SET,41,0.17912,0.0084553,0.14618,0.11024,HP_ABNORMAL_POSTERIOR_SEGMENT_IMAGING,0.915483526490066
GOBP_L_ARGININE_TRANSMEMBRAN...,SET,13,0.3339,0.0088823,0.27252,0.11025,GOBP_L_ARGININE_TRANSMEMBRANE_TRANSPORT,0.915483526490066
WP_FAMILIAL_HYPERLIPIDEMIA_T...1,SET,16,0.27758,0.0081913,0.22659,0.11028,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,0.915483526490066
HP_OPTIC_NEUROPATHY,SET,46,0.14513,0.0072555,0.11847,0.11029,HP_OPTIC_NEUROPATHY,0.915483526490066
GOMF_OXIDOREDUCTASE_ACTIVITY...37,SET,25,0.21485,0.0079232,0.17539,0.1103,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS,0.915483526490066
WP_GROWTH_FACTORS_AND_HORMON...,SET,26,0.20805,0.0078241,0.16992,0.11041,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,0.915483526490066
GOCC_CUL4_RING_E3_UBIQUITIN_...,SET,31,0.17954,0.0073715,0.14663,0.11041,GOCC_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.915483526490066
chr5q23,SET,35,0.28008,0.012218,0.22876,0.11042,chr5q23,0.915483526490066
MIR3925_5P,SET,141,0.088812,0.0077534,0.072543,0.11043,MIR3925_5P,0.915483526490066
KAPOSI_LIVER_CANCER_MET_DN,SET,5,0.50971,0.0084108,0.41637,0.11045,KAPOSI_LIVER_CANCER_MET_DN,0.915483526490066
GOCC_DENDRITIC_SPINE_MEMBRANE,SET,14,0.28554,0.0078823,0.23325,0.11045,GOCC_DENDRITIC_SPINE_MEMBRANE,0.915483526490066
GOBP_REGULATION_OF_INFLAMMAT...1,SET,357,0.058126,0.0080265,0.047484,0.11046,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE,0.915483526490066
GSE46606_IRF4HIGH_VS_WT_CD40...1,SET,185,0.077726,0.0077632,0.063493,0.11046,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.915483526490066
GOBP_POSITIVE_REGULATION_OF_...204,SET,49,0.15284,0.0078855,0.12492,0.11059,GOBP_POSITIVE_REGULATION_OF_DEPHOSPHORYLATION,0.915483526490066
REACTOME_DOWNREGULATION_OF_S...,SET,28,0.20691,0.0080745,0.16914,0.11061,REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,0.915483526490066
MODULE_252,SET,227,0.066139,0.007309,0.054069,0.11063,MODULE_252,0.915483526490066
GOMF_TRANSPORTER_ACTIVITY,SET,1107,0.033556,0.0079879,0.027434,0.11064,GOMF_TRANSPORTER_ACTIVITY,0.915483526490066
MIR670_3P,SET,268,0.064554,0.0077426,0.052782,0.11066,MIR670_3P,0.915483526490066
ABBUD_LIF_SIGNALING_1_DN,SET,21,0.24853,0.0084008,0.20326,0.11073,ABBUD_LIF_SIGNALING_1_DN,0.915483526490066
CREIGHTON_ENDOCRINE_THERAPY_...1,SET,445,0.051662,0.0079452,0.042251,0.11073,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1,0.915483526490066
MIR4317,SET,88,0.11016,0.0076089,0.090097,0.11073,MIR4317,0.915483526490066
GOMF_MYOSIN_LIGHT_CHAIN_BIND...,SET,8,0.33407,0.0069722,0.27322,0.11073,GOMF_MYOSIN_LIGHT_CHAIN_BINDING,0.915483526490066
MIR1304_5P,SET,121,0.09358,0.0075723,0.076546,0.11076,MIR1304_5P,0.915483526490066
GSE45365_CD8A_DC_VS_CD11B_DC...2,SET,167,0.081861,0.0077721,0.066959,0.11076,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN,0.915483526490066
GAVISH_3CA_METAPROGRAM_FIBRO...15,SET,44,0.18303,0.00895,0.14972,0.11077,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM,0.915483526490066
GOBP_PROTEIN_IMPORT,SET,8,0.40874,0.0085307,0.33437,0.11078,GOBP_PROTEIN_IMPORT,0.915483526490066
GSE21063_WT_VS_NFATC1_KO_16H...2,SET,175,0.076235,0.0074076,0.062363,0.11078,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_UP,0.915483526490066
HP_THORACIC_AORTA_CALCIFICAT...,SET,5,0.51696,0.0085304,0.42305,0.11086,HP_THORACIC_AORTA_CALCIFICATION,0.915483526490066
GAUTAM_EYE_IRIS_CILIARY_BODY...12,SET,104,0.1058,0.0079409,0.086587,0.11087,GAUTAM_EYE_IRIS_CILIARY_BODY_PIGMENTED_CILIARY_BODY_CELLS,0.915483526490066
GOBP_NEGATIVE_REGULATION_OF_...191,SET,10,0.29006,0.006768,0.23744,0.11094,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.915483526490066
MIR3646,SET,771,0.039116,0.0078461,0.032023,0.11096,MIR3646,0.915483526490066
HP_BITEMPORAL_HEMIANOPIA,SET,16,0.23434,0.0069152,0.1919,0.11103,HP_BITEMPORAL_HEMIANOPIA,0.915483526490066
MANNO_MIDBRAIN_NEUROTYPES_HR...1,SET,316,0.062785,0.0081661,0.05142,0.11105,MANNO_MIDBRAIN_NEUROTYPES_HRGL1,0.915483526490066
FOURATI_BLOOD_TWINRIX_AGE_25...1,SET,598,0.04359,0.0077382,0.035706,0.11109,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN,0.915483526490066
MIKKELSEN_ES_LCP_WITH_H3K27M...,SET,12,0.31423,0.0080313,0.25743,0.11112,MIKKELSEN_ES_LCP_WITH_H3K27ME3,0.915483526490066
GOBP_CELLULAR_CATABOLIC_PROC...,SET,1032,0.033087,0.0076211,0.027107,0.11113,GOBP_CELLULAR_CATABOLIC_PROCESS,0.915483526490066
GOBP_REGULATION_OF_PROTEIN_C...5,SET,110,0.096203,0.0074245,0.078816,0.11113,GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.915483526490066
KEGG_MEDICUS_REFERENCE_FANCO...,SET,12,0.25568,0.0065348,0.20951,0.11117,KEGG_MEDICUS_REFERENCE_FANCONI_ANEMIA_PATHWAY,0.915483526490066
GOBP_CELL_CELL_ADHESION_MEDI...1,SET,48,0.15837,0.0080876,0.12978,0.11117,GOBP_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.915483526490066
GOCC_MRE11_COMPLEX,SET,3,0.54218,0.0069304,0.44442,0.11124,GOCC_MRE11_COMPLEX,0.915483526490066
HOLLEMAN_ASPARAGINASE_RESIST...3,SET,12,0.27371,0.0069955,0.22439,0.11128,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN,0.915483526490066
HP_ABNORMAL_TIBIA_MORPHOLOGY,SET,90,0.11215,0.0078335,0.091959,0.11131,HP_ABNORMAL_TIBIA_MORPHOLOGY,0.915483526490066
WP_FATTY_ACIDS_AND_LIPOPROTE...,SET,355,0.056355,0.0077606,0.046211,0.11133,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,0.915483526490066
KEGG_MEDICUS_REFERENCE_MACHR...,SET,18,0.25245,0.007901,0.20701,0.11134,KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY,0.915483526490066
WP_PROGERIAASSOCIATED_LIPODY...,SET,21,0.22742,0.0076875,0.18649,0.11134,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,0.915483526490066
GOBP_ISOTYPE_SWITCHING_TO_IG...2,SET,15,0.26799,0.0076574,0.21977,0.11135,GOBP_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES,0.915483526490066
HP_ABNORMAL_NUMBER_OF_DENSE_...,SET,7,0.38565,0.0075292,0.31627,0.11136,HP_ABNORMAL_NUMBER_OF_DENSE_GRANULES,0.915483526490066
HP_FEEDING_DIFFICULTIES,SET,1009,0.032658,0.0074429,0.026782,0.11136,HP_FEEDING_DIFFICULTIES,0.915483526490066
KEGG_MEDICUS_REFERENCE_RAD51...,SET,10,0.28701,0.0066969,0.23539,0.11137,KEGG_MEDICUS_REFERENCE_RAD51_DSDNA_DESTABILIZATION,0.915483526490066
GOMF_L_ARGININE_TRANSMEMBRAN...,SET,11,0.36345,0.008894,0.29807,0.11137,GOMF_L_ARGININE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.915483526490066
HP_SHORT_PHALANX_OF_THE_THUMB,SET,29,0.20092,0.0079794,0.16484,0.11144,HP_SHORT_PHALANX_OF_THE_THUMB,0.915603721644613
HP_EXERCISE_INDUCED_MUSCLE_F...,SET,9,0.33886,0.007501,0.27801,0.11146,HP_EXERCISE_INDUCED_MUSCLE_FATIGUE,0.915603721644613
BIOCARTA_DICER_PATHWAY,SET,5,0.49822,0.0082212,0.40882,0.11149,BIOCARTA_DICER_PATHWAY,0.915603721644613
GOMF_HISTONE_H3K14_ACETYLTRA...,SET,9,0.35122,0.0077746,0.28819,0.11149,GOMF_HISTONE_H3K14_ACETYLTRANSFERASE_ACTIVITY,0.915603721644613
GOMF_NUCLEAR_THYROID_HORMONE...,SET,27,0.18876,0.0072336,0.15493,0.11155,GOMF_NUCLEAR_THYROID_HORMONE_RECEPTOR_BINDING,0.915745819555976
GOMF_CO_SMAD_BINDING,SET,9,0.39553,0.0087555,0.32465,0.11156,GOMF_CO_SMAD_BINDING,0.915745819555976
DESCARTES_FETAL_PLACENTA_VAS...,SET,85,0.12519,0.0084988,0.10282,0.1117,DESCARTES_FETAL_PLACENTA_VASCULAR_ENDOTHELIAL_CELLS,0.916654943502825
HP_EXTRAHEPATIC_CHOLESTASIS,SET,10,0.31366,0.0073185,0.25768,0.11177,HP_EXTRAHEPATIC_CHOLESTASIS,0.916654943502825
WP_SLEEP_REGULATION,SET,38,0.18874,0.0085782,0.15508,0.11179,WP_SLEEP_REGULATION,0.916654943502825
TTTGTAG_MIR520D,SET,311,0.060873,0.0078556,0.050022,0.11182,TTTGTAG_MIR520D,0.916654943502825
MIR4483,SET,85,0.11856,0.0080489,0.097428,0.11183,MIR4483,0.916654943502825
HP_RECURRENT_HAEMOPHILUS_INF...,SET,22,0.24117,0.0083438,0.1982,0.11185,HP_RECURRENT_HAEMOPHILUS_INFLUENZAE_INFECTIONS,0.916654943502825
SCHMIDT_POR_TARGETS_IN_LIMB_...2,SET,26,0.1857,0.0069837,0.15264,0.11189,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP,0.916654943502825
GSE18791_CTRL_VS_NEWCASTLE_V...10,SET,186,0.071162,0.0071266,0.058507,0.11194,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP,0.916654943502825
MORF_PDPK1,SET,65,0.12484,0.0074155,0.10264,0.11195,MORF_PDPK1,0.916654943502825
AAGTCCA_MIR422B_MIR422A,SET,63,0.12686,0.0074185,0.10431,0.11198,AAGTCCA_MIR422B_MIR422A,0.916654943502825
GOBP_ACTION_POTENTIAL,SET,158,0.091591,0.0084605,0.075328,0.11202,GOBP_ACTION_POTENTIAL,0.916654943502825
GOBP_RENAL_SODIUM_ION_ABSORP...,SET,12,0.33237,0.0084948,0.27335,0.11202,GOBP_RENAL_SODIUM_ION_ABSORPTION,0.916654943502825
GOBP_REGULATION_OF_CALCIUM_I...2,SET,29,0.19285,0.0076589,0.15861,0.11203,GOBP_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.916654943502825
GOBP_IMMUNOGLOBULIN_PRODUCTI...2,SET,47,0.146,0.0073779,0.12009,0.11204,GOBP_IMMUNOGLOBULIN_PRODUCTION_INVOLVED_IN_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE,0.916654943502825
GSE6875_TCONV_VS_TREG_DN,SET,186,0.07842,0.0078534,0.064529,0.11214,GSE6875_TCONV_VS_TREG_DN,0.916907374735356
HP_ATROPHY_DEGENERATION_INVO...2,SET,34,0.18172,0.007813,0.14954,0.11215,HP_ATROPHY_DEGENERATION_INVOLVING_THE_CORTICOSPINAL_TRACTS,0.916907374735356
GSE36078_WT_VS_IL1R_KO_LUNG_...2,SET,182,0.078778,0.0078048,0.064826,0.11215,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_UP,0.916907374735356
HP_VASCULITIS_IN_THE_SKIN,SET,7,0.36659,0.0071571,0.30173,0.1122,HP_VASCULITIS_IN_THE_SKIN,0.917055098684211
GSE2770_TGFB_AND_IL4_VS_TGFB...4,SET,171,0.072667,0.0069805,0.059818,0.11223,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.917055098684211
GOMF_CYCLIC_NUCLEOTIDE_ACTIV...,SET,10,0.34235,0.0079881,0.28186,0.11226,GOMF_CYCLIC_NUCLEOTIDE_ACTIVATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.917055098684211
chr1q25,SET,73,0.25043,0.015761,0.2062,0.11228,chr1q25,0.917055098684211
HP_ABNORMAL_CONNECTION_OF_TH...,SET,234,0.068105,0.00764,0.05608,0.1123,HP_ABNORMAL_CONNECTION_OF_THE_CARDIAC_SEGMENTS,0.917055098684211
DESCARTES_MAIN_FETAL_MESANGI...,SET,16,0.2893,0.0085371,0.23827,0.11235,DESCARTES_MAIN_FETAL_MESANGIAL_CELLS,0.917247885835095
MORF_ACP1,SET,198,0.068961,0.0071231,0.056812,0.11241,MORF_ACP1,0.917522205260686
BIOCARTA_NUCLEARRS_PATHWAY,SET,34,0.18361,0.0078946,0.1513,0.11246,BIOCARTA_NUCLEARRS_PATHWAY,0.917658944041208
GSE21379_TFH_VS_NON_TFH_SAP_...2,SET,179,0.07526,0.0073952,0.062049,0.11259,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP,0.917658944041208
GSE2770_UNTREATED_VS_IL12_TR...2,SET,176,0.077767,0.0075778,0.064117,0.11259,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.917658944041208
REACTOME_REPLACEMENT_OF_PROT...,SET,6,0.45044,0.0081419,0.37139,0.1126,REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS,0.917658944041208
GSE27786_LSK_VS_BCELL_UP,SET,175,0.076817,0.0074642,0.063342,0.11263,GSE27786_LSK_VS_BCELL_UP,0.917658944041208
GSE12392_IFNAR_KO_VS_IFNB_KO...2,SET,177,0.077215,0.0075453,0.063676,0.11265,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP,0.917658944041208
GOCC_KATANIN_COMPLEX,SET,5,0.45108,0.0074433,0.37202,0.11267,GOCC_KATANIN_COMPLEX,0.917658944041208
GOBP_SARCOPLASMIC_RETICULUM_...,SET,38,0.16689,0.0075849,0.13765,0.11269,GOBP_SARCOPLASMIC_RETICULUM_CALCIUM_ION_TRANSPORT,0.917658944041208
GOBP_POSITIVE_REGULATION_OF_...504,SET,9,0.37094,0.0082112,0.30599,0.11272,GOBP_POSITIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,0.917658944041208
GOBP_MYELOID_CELL_HOMEOSTASIS,SET,163,0.081348,0.0076312,0.067116,0.11275,GOBP_MYELOID_CELL_HOMEOSTASIS,0.917658944041208
GSE37605_TREG_VS_TCONV_C57BL...3,SET,136,0.085114,0.0072987,0.070221,0.11275,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_DN,0.917658944041208
GOBP_NEGATIVE_REGULATION_OF_...223,SET,30,0.20384,0.0082334,0.16818,0.11276,GOBP_NEGATIVE_REGULATION_OF_EXOCYTOSIS,0.917658944041208
MIR379_3P_MIR411_3P,SET,173,0.081266,0.0078517,0.067054,0.11277,MIR379_3P_MIR411_3P,0.917658944041208
WP_CHOLESTEROL_BIOSYNTHESIS_...1,SET,14,0.24594,0.006789,0.20298,0.11284,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,0.917898867351705
HP_ABNORMAL_COLUMELLA_MORPHO...,SET,78,0.11395,0.007412,0.094072,0.11289,HP_ABNORMAL_COLUMELLA_MORPHOLOGY,0.917898867351705
HP_GASTRIC_ULCER,SET,5,0.43073,0.0071075,0.35564,0.11293,HP_GASTRIC_ULCER,0.917898867351705
MIR4511,SET,139,0.089352,0.0077455,0.073778,0.11294,MIR4511,0.917898867351705
GOBP_CARBOHYDRATE_DERIVATIVE...4,SET,88,0.1136,0.0078465,0.093803,0.11294,GOBP_CARBOHYDRATE_DERIVATIVE_TRANSPORT,0.917898867351705
GNF2_S100A4,SET,44,0.15724,0.0076885,0.12986,0.11299,GNF2_S100A4,0.917898867351705
HP_IMPAIRED_CORTISOL_RESPONS...,SET,5,0.51682,0.0085281,0.4269,0.11302,HP_IMPAIRED_CORTISOL_RESPONSE_TO_INSULIN_STIMULATION_TEST,0.917898867351705
GOBP_REGULATION_OF_CATABOLIC...,SET,914,0.034512,0.0075066,0.02851,0.11304,GOBP_REGULATION_OF_CATABOLIC_PROCESS,0.917898867351705
GOBP_MAST_CELL_DIFFERENTIATI...,SET,6,0.48226,0.0087171,0.39843,0.11307,GOBP_MAST_CELL_DIFFERENTIATION,0.917898867351705
BROWNE_HCMV_INFECTION_6HR_UP,SET,57,0.13891,0.0077282,0.11477,0.11309,BROWNE_HCMV_INFECTION_6HR_UP,0.917898867351705
HP_ABNORMAL_TOENAIL_MORPHOLO...,SET,152,0.083523,0.0075685,0.06901,0.11309,HP_ABNORMAL_TOENAIL_MORPHOLOGY,0.917898867351705
GOMF_MHC_CLASS_I_RECEPTOR_AC...,SET,10,0.43189,0.010077,0.35693,0.11314,GOMF_MHC_CLASS_I_RECEPTOR_ACTIVITY,0.917917536704731
GOBP_OLIGOSACCHARIDE_LIPID_I...,SET,20,0.20328,0.0067061,0.16803,0.11318,GOBP_OLIGOSACCHARIDE_LIPID_INTERMEDIATE_BIOSYNTHETIC_PROCESS,0.917917536704731
HP_LOW_BACK_PAIN,SET,13,0.28556,0.0075962,0.23608,0.11322,HP_LOW_BACK_PAIN,0.917917536704731
GAO_LARGE_INTESTINE_ADULT_CF...,SET,22,0.2335,0.0080783,0.19304,0.11323,GAO_LARGE_INTESTINE_ADULT_CF_GOBLET_CELL_SUBTYPE_1,0.917917536704731
GOCC_MEMBRANE_PROTEIN_COMPLEX,SET,1152,0.031935,0.0077448,0.026404,0.11324,GOCC_MEMBRANE_PROTEIN_COMPLEX,0.917917536704731
TAANNYSGCG_UNKNOWN,SET,73,0.1233,0.0077599,0.10197,0.1133,TAANNYSGCG_UNKNOWN,0.917917536704731
GOCC_AMPHISOME,SET,13,0.28243,0.0075131,0.23358,0.11331,GOCC_AMPHISOME,0.917917536704731
MIR211_3P,SET,75,0.11797,0.007525,0.097574,0.11333,MIR211_3P,0.917917536704731
GOBP_GLOMERULAR_MESANGIAL_CE...2,SET,12,0.34756,0.0088831,0.28746,0.11333,GOBP_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION,0.917917536704731
CREB3L4_TARGET_GENES,SET,1158,0.030585,0.0074353,0.025307,0.11343,CREB3L4_TARGET_GENES,0.918513431966449
GAO_LARGE_INTESTINE_24W_C1_D...,SET,93,0.11713,0.0083154,0.09696,0.11353,GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR,0.918958094905792
GSE36476_YOUNG_VS_OLD_DONOR_...5,SET,173,0.079995,0.0077289,0.066225,0.11355,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN,0.918958094905792
GSE17721_PAM3CSK4_VS_CPG_8H_...1,SET,183,0.075575,0.0075079,0.062579,0.11359,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_DN,0.918958094905792
GENTILE_RESPONSE_CLUSTER_D3,SET,51,0.14273,0.0075127,0.11821,0.11363,GENTILE_RESPONSE_CLUSTER_D3,0.918958094905792
GGCAGTG_MIR3243P,SET,87,0.10832,0.0074394,0.089712,0.11363,GGCAGTG_MIR3243P,0.918958094905792
KEGG_MEDICUS_PATHOGEN_HIV_GP...2,SET,17,0.24157,0.0073478,0.20008,0.11366,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN,0.918958094905792
GOCC_CUL4A_RING_E3_UBIQUITIN...,SET,12,0.29179,0.0074577,0.24169,0.11367,GOCC_CUL4A_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.918958094905792
LI_CYTIDINE_ANALOGS_CYCTOTOX...,SET,14,0.26021,0.0071831,0.21558,0.11372,LI_CYTIDINE_ANALOGS_CYCTOTOXICITY,0.919125139470014
GOMF_C_ACETYLTRANSFERASE_ACT...,SET,7,0.34719,0.0067782,0.28768,0.11375,GOMF_C_ACETYLTRANSFERASE_ACTIVITY,0.919125139470014
SMID_BREAST_CANCER_RELAPSE_I...2,SET,87,0.11714,0.0080447,0.097065,0.11377,SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,0.919125139470014
GOBP_CELLULAR_RESPONSE_TO_AL...2,SET,16,0.27418,0.008091,0.22724,0.11381,GOBP_CELLULAR_RESPONSE_TO_ALDEHYDE,0.919234615384615
GOBP_GANGLION_DEVELOPMENT,SET,16,0.28995,0.0085562,0.24035,0.11385,GOBP_GANGLION_DEVELOPMENT,0.919344040427509
MIR1227_3P,SET,67,0.12885,0.0077696,0.10682,0.11388,MIR1227_3P,0.919372682926829
HP_FLATTENED_FEMORAL_HEAD,SET,6,0.3763,0.0068018,0.31209,0.11397,HP_FLATTENED_FEMORAL_HEAD,0.919463639526792
LI_DCP2_BOUND_MRNA,SET,78,0.10611,0.0069018,0.088012,0.11399,LI_DCP2_BOUND_MRNA,0.919463639526792
GCM_NUMA1,SET,51,0.12956,0.0068191,0.10746,0.114,GCM_NUMA1,0.919463639526792
REACTOME_NEGATIVE_REGULATION...6,SET,14,0.25672,0.0070866,0.21297,0.11403,REACTOME_NEGATIVE_REGULATION_OF_FLT3,0.919463639526792
HOLLEMAN_DAUNORUBICIN_B_ALL_...1,SET,12,0.27299,0.0069771,0.22648,0.11404,HOLLEMAN_DAUNORUBICIN_B_ALL_DN,0.919463639526792
HOWARD_MONOCYTE_INACT_MONOV_...1,SET,35,0.18796,0.0081991,0.15594,0.11405,HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.919463639526792
GOBP_GLUCAN_BIOSYNTHETIC_PRO...,SET,40,0.15874,0.0074018,0.13173,0.1141,GOBP_GLUCAN_BIOSYNTHETIC_PROCESS,0.919520762810109
HP_ALLERGY,SET,35,0.18138,0.007912,0.15052,0.11411,HP_ALLERGY,0.919520762810109
NAKAYA_MYELOID_DENDRITIC_CEL...3,SET,247,0.062793,0.0072345,0.052133,0.11421,NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN,0.919980556199305
KHETCHOUMIAN_TRIM24_TARGETS_...2,SET,44,0.16431,0.0080346,0.13642,0.11422,KHETCHOUMIAN_TRIM24_TARGETS_UP,0.919980556199305
GAVIN_FOXP3_TARGETS_CLUSTER_...3,SET,92,0.11536,0.0081462,0.095797,0.11426,GAVIN_FOXP3_TARGETS_CLUSTER_P4,0.920037387074357
MIR4637,SET,51,0.14677,0.0077254,0.12189,0.11428,MIR4637,0.920037387074357
GOBP_COLLAGEN_CATABOLIC_PROC...,SET,39,0.18703,0.0086113,0.15535,0.11432,GOBP_COLLAGEN_CATABOLIC_PROCESS,0.920146271421955
REACTOME_CYP2E1_REACTIONS,SET,11,0.34097,0.008344,0.28335,0.11443,REACTOME_CYP2E1_REACTIONS,0.920794353158991
GOMF_OLIGOSACCHARIDE_BINDING,SET,17,0.28214,0.0085817,0.2345,0.11447,GOMF_OLIGOSACCHARIDE_BINDING,0.920794353158991
ZHANG_INTERFERON_RESPONSE,SET,23,0.24309,0.0085988,0.20205,0.11448,ZHANG_INTERFERON_RESPONSE,0.920794353158991
HP_SPASTIC_GAIT,SET,69,0.12496,0.0076464,0.10388,0.11452,HP_SPASTIC_GAIT,0.920850728660652
WAKABAYASHI_ADIPOGENESIS_PPA...2,SET,598,0.042821,0.0076015,0.035601,0.11454,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D,0.920850728660652
GOBP_POSITIVE_REGULATION_OF_...39,SET,7,0.37192,0.0072612,0.30927,0.11458,GOBP_POSITIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,0.920959273820537
GOMF_DNA_CLAMP_LOADER_ACTIVI...,SET,9,0.32642,0.0072258,0.27167,0.11478,GOMF_DNA_CLAMP_LOADER_ACTIVITY,0.922353502890173
LIU_BREAST_CANCER,SET,25,0.20133,0.0074246,0.16759,0.11482,LIU_BREAST_CANCER,0.922461650485437
MIR6514_5P,SET,47,0.15605,0.007886,0.12993,0.11487,MIR6514_5P,0.922526077934056
AATGTGA_MIR23A_MIR23B,SET,381,0.053339,0.0076039,0.04442,0.11492,AATGTGA_MIR23A_MIR23B,0.922526077934056
GOBP_POSITIVE_REGULATION_OF_...268,SET,28,0.19136,0.0074676,0.15936,0.11492,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,0.922526077934056
MATZUK_LUTEAL_GENES,SET,8,0.36878,0.0076968,0.30721,0.11499,MATZUK_LUTEAL_GENES,0.922526077934056
WP_TLR4_SIGNALING_AND_TOLERA...,SET,26,0.19284,0.007252,0.16068,0.11505,WP_TLR4_SIGNALING_AND_TOLERANCE,0.922526077934056
MIR4652_3P,SET,290,0.062567,0.0078014,0.052135,0.11506,MIR4652_3P,0.922526077934056
GOBP_NOREPINEPHRINE_UPTAKE,SET,8,0.44445,0.0092759,0.37039,0.11509,GOBP_NOREPINEPHRINE_UPTAKE,0.922526077934056
MIR4286,SET,79,0.11114,0.0072751,0.092628,0.1151,MIR4286,0.922526077934056
GOBP_RANDOM_INACTIVATION_OF_...,SET,6,0.4046,0.0073134,0.33721,0.1151,GOBP_RANDOM_INACTIVATION_OF_X_CHROMOSOME,0.922526077934056
GSE28726_ACT_CD4_TCELL_VS_AC...4,SET,183,0.07466,0.0074169,0.062223,0.1151,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP,0.922526077934056
REACTOME_NFE2L2_REGULATING_M...,SET,8,0.38676,0.0080719,0.32235,0.11512,REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES,0.922526077934056
MANNO_MIDBRAIN_NEUROTYPES_HDA,SET,435,0.054149,0.0082359,0.045141,0.11516,MANNO_MIDBRAIN_NEUROTYPES_HDA,0.922633886583679
GSE3982_DC_VS_BASOPHIL_UP,SET,182,0.076321,0.0075614,0.063642,0.11523,GSE3982_DC_VS_BASOPHIL_UP,0.92266533973919
MIR642B_5P,SET,70,0.12291,0.0075749,0.10249,0.11524,MIR642B_5P,0.92266533973919
DESCARTES_FETAL_PLACENTA_SYN...,SET,51,0.15143,0.0079706,0.12629,0.11525,DESCARTES_FETAL_PLACENTA_SYNCYTIOTROPHOBLASTS_AND_VILLOUS_CYTOTROPHOBLASTS,0.92266533973919
GSE8921_UNSTIM_VS_TLR1_2_STI...8,SET,189,0.074547,0.0075249,0.062181,0.11529,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP,0.92266533973919
AGTCTTA_MIR499,SET,68,0.1222,0.0074235,0.10193,0.1153,AGTCTTA_MIR499,0.92266533973919
MODULE_205,SET,276,0.063305,0.0077036,0.05281,0.11533,MODULE_205,0.92266533973919
HP_OPPORTUNISTIC_INFECTION,SET,43,0.16143,0.0078037,0.13471,0.11539,HP_OPPORTUNISTIC_INFECTION,0.92266533973919
CUI_DEVELOPING_HEART_C1_5TH_...,SET,73,0.12115,0.0076245,0.1011,0.11541,CUI_DEVELOPING_HEART_C1_5TH_WEEK_CARDIAC_CELLS,0.92266533973919
GOBP_POSTREPLICATION_REPAIR,SET,32,0.15545,0.0064844,0.12975,0.11545,GOBP_POSTREPLICATION_REPAIR,0.92266533973919
MIR6858_5P,SET,56,0.13909,0.0076704,0.1161,0.11546,MIR6858_5P,0.92266533973919
GOBP_NEGATIVE_REGULATION_OF_...685,SET,9,0.35446,0.0078464,0.2959,0.11549,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,0.92266533973919
GOBP_PURINE_DEOXYRIBONUCLEOT...3,SET,16,0.25483,0.0075197,0.21275,0.11551,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,0.92266533973919
GOBP_PHOSPHATE_ION_HOMEOSTAS...,SET,19,0.27639,0.0088873,0.23083,0.11559,GOBP_PHOSPHATE_ION_HOMEOSTASIS,0.92266533973919
HP_CERVICAL_C2_C3_VERTEBRAL_...,SET,11,0.30756,0.0075264,0.25693,0.11565,HP_CERVICAL_C2_C3_VERTEBRAL_FUSION,0.92266533973919
GOBP_POSITIVE_REGULATION_OF_...832,SET,15,0.30201,0.0086294,0.25232,0.11567,GOBP_POSITIVE_REGULATION_OF_VASCULAR_PERMEABILITY,0.92266533973919
GSE29164_DAY3_VS_DAY7_UNTREA...1,SET,175,0.077783,0.0075581,0.064984,0.11567,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN,0.92266533973919
HP_INTERMITTENT_THROMBOCYTOP...,SET,4,0.55317,0.0081645,0.46221,0.1157,HP_INTERMITTENT_THROMBOCYTOPENIA,0.92266533973919
HP_PYRIDOXINE_RESPONSIVE_SID...,SET,22,0.19036,0.0065857,0.15906,0.11571,HP_PYRIDOXINE_RESPONSIVE_SIDEROBLASTIC_ANEMIA,0.92266533973919
HP_SYNOVIAL_LINING_HYPERPLAS...,SET,8,0.38817,0.0081013,0.32437,0.11572,HP_SYNOVIAL_LINING_HYPERPLASIA,0.92266533973919
MIR504_3P,SET,130,0.086062,0.0072165,0.071923,0.11574,MIR504_3P,0.92266533973919
GOBP_REGULATION_OF_CARDIAC_M...11,SET,5,0.57616,0.0095072,0.48149,0.11574,GOBP_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,0.92266533973919
HP_DISPROPORTIONATE_SHORT_LI...,SET,96,0.10759,0.0077599,0.089924,0.11577,HP_DISPROPORTIONATE_SHORT_LIMB_SHORT_STATURE,0.92266533973919
HP_DECREASED_THALAMIC_VOLUME,SET,9,0.32603,0.0072171,0.27256,0.11582,HP_DECREASED_THALAMIC_VOLUME,0.92266533973919
HP_SHOULDER_GIRDLE_MUSCLE_AT...,SET,13,0.29942,0.007965,0.25037,0.11587,HP_SHOULDER_GIRDLE_MUSCLE_ATROPHY,0.92266533973919
GOBP_ELASTIN_CATABOLIC_PROCE...,SET,4,0.59716,0.0088137,0.49941,0.11591,GOBP_ELASTIN_CATABOLIC_PROCESS,0.92266533973919
GSE33424_CD161_INT_VS_NEG_CD...1,SET,181,0.075107,0.0074209,0.062815,0.11592,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN,0.92266533973919
HP_ABNORMAL_CIRCULATING_LEUC...,SET,4,0.49435,0.0072964,0.41349,0.11594,HP_ABNORMAL_CIRCULATING_LEUCINE_CONCENTRATION,0.92266533973919
HOEK_MYELOID_DENDRITIC_CELL_...6,SET,20,0.26457,0.0087279,0.22129,0.11594,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_UP,0.92266533973919
GOBP_ANTERIOR_POSTERIOR_AXON...,SET,7,0.44147,0.008619,0.36931,0.11597,GOBP_ANTERIOR_POSTERIOR_AXON_GUIDANCE,0.92266533973919
TACAATC_MIR508,SET,58,0.1391,0.007806,0.11637,0.116,TACAATC_MIR508,0.92266533973919
MIR489_3P,SET,69,0.12823,0.0078463,0.10728,0.11601,MIR489_3P,0.92266533973919
HP_ALOPECIA_OF_SCALP,SET,37,0.16576,0.0074342,0.1387,0.11603,HP_ALOPECIA_OF_SCALP,0.92266533973919
GSE2585_AIRE_KO_VS_WT_CD80_H...2,SET,182,0.073678,0.0072995,0.061652,0.11604,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP,0.92266533973919
GAVISH_3CA_METAPROGRAM_CD8_T...7,SET,48,0.15338,0.0078325,0.12837,0.11609,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_INTERFERON,0.922851772644099
GOBP_REGULATION_OF_HYDROLASE...,SET,641,0.043406,0.007968,0.036343,0.11618,GOBP_REGULATION_OF_HYDROLASE_ACTIVITY,0.923356025611708
BIOCARTA_WNT_LRP6_PATHWAY,SET,6,0.46149,0.0083418,0.38657,0.11628,BIOCARTA_WNT_LRP6_PATHWAY,0.923757581639644
UNTERMAN_IPF_VS_CTRL_CD8T_DN,SET,2,0.83219,0.0086857,0.69718,0.11631,UNTERMAN_IPF_VS_CTRL_CD8T_DN,0.923757581639644
HP_ABNORMAL_TUBULAR_BASEMENT...,SET,5,0.41684,0.0068783,0.34924,0.11633,HP_ABNORMAL_TUBULAR_BASEMENT_MEMBRANE_MORPHOLOGY,0.923757581639644
MIR4676_3P,SET,189,0.073345,0.0074036,0.06146,0.11637,MIR4676_3P,0.923757581639644
chr22q13,SET,177,0.15227,0.01488,0.1276,0.11638,chr22q13,0.923757581639644
CC2D1A_TARGET_GENES,SET,1191,0.030677,0.0075561,0.025708,0.11639,CC2D1A_TARGET_GENES,0.923757581639644
GOBP_NEUTROPHIL_CLEARANCE,SET,6,0.47408,0.0085693,0.39741,0.11645,GOBP_NEUTROPHIL_CLEARANCE,0.924022773972603
TET1_TARGET_GENES,SET,1072,0.031708,0.0074351,0.026583,0.11648,TET1_TARGET_GENES,0.924049851632047
GOCC_GOLGI_LUMEN,SET,88,0.11459,0.0079144,0.096083,0.11653,GOCC_GOLGI_LUMEN,0.92423554313099
MIR149_3P,SET,396,0.051398,0.007467,0.043125,0.11667,MIR149_3P,0.924923779653285
GOMF_HEMOGLOBIN_BINDING,SET,8,0.42914,0.0089565,0.36006,0.11667,GOMF_HEMOGLOBIN_BINDING,0.924923779653285
GOBP_NEGATIVE_REGULATION_OF_...695,SET,4,0.5517,0.0081428,0.46299,0.11671,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_WOUND_HEALING,0.925029885974914
BIOCARTA_LIS1_PATHWAY,SET,18,0.22069,0.0069071,0.18525,0.11677,BIOCARTA_LIS1_PATHWAY,0.925294425444596
GOBP_B_CELL_APOPTOTIC_PROCESS,SET,24,0.21907,0.0079159,0.18398,0.11689,GOBP_B_CELL_APOPTOTIC_PROCESS,0.92540801405577
HP_BOWING_OF_THE_LEGS,SET,217,0.070079,0.0075739,0.058855,0.11689,HP_BOWING_OF_THE_LEGS,0.92540801405577
HP_SMALL_SCROTUM,SET,51,0.15102,0.0079489,0.12687,0.11697,HP_SMALL_SCROTUM,0.92540801405577
MODULE_46,SET,367,0.059565,0.0083373,0.050043,0.11698,MODULE_46,0.92540801405577
GOBP_REGULATION_OF_MICROTUBU...8,SET,85,0.1071,0.0072708,0.090007,0.11705,GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,0.92540801405577
GSE44732_UNSTIM_VS_IL27_STIM...2,SET,175,0.07636,0.0074198,0.064172,0.11705,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP,0.92540801405577
GOBP_METANEPHROS_MORPHOGENES...,SET,30,0.21458,0.0086673,0.18034,0.11706,GOBP_METANEPHROS_MORPHOGENESIS,0.92540801405577
GOBP_POLYOL_TRANSMEMBRANE_TR...,SET,10,0.36244,0.0084567,0.30473,0.11716,GOBP_POLYOL_TRANSMEMBRANE_TRANSPORT,0.92540801405577
BIOCARTA_SPPA_PATHWAY,SET,16,0.27962,0.0082514,0.23513,0.11718,BIOCARTA_SPPA_PATHWAY,0.92540801405577
GOBP_LYMPHOCYTE_ANERGY,SET,7,0.39715,0.0077537,0.33397,0.11719,GOBP_LYMPHOCYTE_ANERGY,0.92540801405577
GSE5589_UNSTIM_VS_45MIN_LPS_...2,SET,182,0.073639,0.0072957,0.061927,0.1172,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,0.92540801405577
GOBP_SOMATOTROPIN_SECRETING_...,SET,5,0.53287,0.008793,0.44819,0.11724,GOBP_SOMATOTROPIN_SECRETING_CELL_DIFFERENTIATION,0.92540801405577
KEGG_MEDICUS_REFERENCE_MDA5_...,SET,21,0.24166,0.0081687,0.20327,0.11726,KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY,0.92540801405577
GOMF_L_AMINO_ACID_TRANSMEMBR...,SET,62,0.13524,0.0078464,0.11376,0.11726,GOMF_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.92540801405577
GOBP_SECONDARY_METABOLIC_PRO...,SET,55,0.14915,0.0081513,0.12547,0.11728,GOBP_SECONDARY_METABOLIC_PROCESS,0.92540801405577
KEGG_MEDICUS_REFERENCE_GLYCO...3,SET,5,0.4632,0.0076433,0.38971,0.11731,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_,0.92540801405577
KEGG_MEDICUS_VARIANT_AMPLIFI...11,SET,6,0.35162,0.0063557,0.29583,0.11731,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_REPRESSION,0.92540801405577
TCCATTKW_UNKNOWN,SET,217,0.070057,0.0075716,0.058951,0.11735,TCCATTKW_UNKNOWN,0.92540801405577
HP_RECURRENT_GRAM_NEGATIVE_B...,SET,32,0.19329,0.0080631,0.16266,0.11735,HP_RECURRENT_GRAM_NEGATIVE_BACTERIAL_INFECTIONS,0.92540801405577
GOBP_REGULATION_OF_CRISTAE_F...,SET,5,0.4866,0.0080295,0.4095,0.11737,GOBP_REGULATION_OF_CRISTAE_FORMATION,0.92540801405577
GOBP_ECTODERMAL_PLACODE_DEVE...,SET,12,0.29008,0.0074141,0.24415,0.1174,GOBP_ECTODERMAL_PLACODE_DEVELOPMENT,0.92540801405577
GOBP_REGULATION_OF_ASYMMETRI...,SET,5,0.48206,0.0079545,0.40572,0.1174,GOBP_REGULATION_OF_ASYMMETRIC_CELL_DIVISION,0.92540801405577
GOMF_CARBOXYLESTERASE_ACTIVI...,SET,6,0.44593,0.0080604,0.37539,0.11744,GOMF_CARBOXYLESTERASE_ACTIVITY,0.92540801405577
PAF1_TARGET_GENES,SET,55,0.1421,0.0077662,0.11963,0.11745,PAF1_TARGET_GENES,0.92540801405577
GOMF_CHONDROITIN_SULFATE_BIN...,SET,9,0.37228,0.0082408,0.3134,0.11745,GOMF_CHONDROITIN_SULFATE_BINDING,0.92540801405577
GOBP_REGULATION_OF_RESTING_M...,SET,10,0.32615,0.00761,0.27469,0.11756,GOBP_REGULATION_OF_RESTING_MEMBRANE_POTENTIAL,0.926064777878513
MIR4779,SET,132,0.087209,0.0073683,0.07348,0.11765,MIR4779,0.926563732154997
AAGCAAT_MIR137,SET,198,0.076234,0.0078744,0.064253,0.11772,AAGCAAT_MIR137,0.9267737599094
MIR5689,SET,137,0.089599,0.0077112,0.075519,0.11773,MIR5689,0.9267737599094
GSE9960_HEALTHY_VS_GRAM_NEG_...2,SET,148,0.083152,0.0074359,0.070097,0.11777,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,0.926878702445652
GOMF_ORGANIC_ANION_TRANSMEMB...,SET,253,0.065508,0.007637,0.055236,0.11783,GOMF_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.927114596062458
HP_PROMINENT_CRUS_OF_HELIX,SET,5,0.50527,0.0083375,0.42611,0.11787,HP_PROMINENT_CRUS_OF_HELIX,0.927114596062458
DESCARTES_FETAL_SPLEEN_MYELO...,SET,110,0.10883,0.0083987,0.091783,0.11788,DESCARTES_FETAL_SPLEEN_MYELOID_CELLS,0.927114596062458
MIR6868_3P,SET,241,0.068896,0.0078418,0.058128,0.11797,MIR6868_3P,0.927506881355932
REACTOME_IRF3_MEDIATED_ACTIV...,SET,5,0.39044,0.0064427,0.32951,0.11803,REACTOME_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN,0.927506881355932
HP_LARYNGEAL_STRIDOR,SET,4,0.54336,0.0080198,0.45858,0.11804,HP_LARYNGEAL_STRIDOR,0.927506881355932
GOBP_REGULATION_OF_HYDROGEN_...1,SET,7,0.41484,0.0080991,0.35018,0.11808,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS,0.927506881355932
HP_ABNORMAL_PERISTALSIS,SET,21,0.22043,0.0074509,0.18606,0.11808,HP_ABNORMAL_PERISTALSIS,0.927506881355932
MIR23A_5P,SET,30,0.19086,0.0077092,0.16111,0.11809,MIR23A_5P,0.927506881355932
GAVISH_3CA_METAPROGRAM_CD8_T...12,SET,47,0.14333,0.007243,0.12101,0.11812,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_2,0.92753289652056
HP_SYNKINESIS,SET,28,0.20189,0.0078787,0.1705,0.11819,HP_SYNKINESIS,0.927820359078591
GOBP_NUCLEOBASE_CATABOLIC_PR...,SET,10,0.34097,0.0079558,0.28797,0.11821,GOBP_NUCLEOBASE_CATABOLIC_PROCESS,0.927820359078591
REACTOME_COMPLEX_III_ASSEMBLY,SET,22,0.20316,0.0070288,0.17162,0.11826,REACTOME_COMPLEX_III_ASSEMBLY,0.928003228719801
GOBP_REGULATION_OF_LAMELLIPO...1,SET,32,0.18414,0.0076813,0.15561,0.11834,GOBP_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.92829028436019
MIR6816_3P,SET,31,0.17212,0.0070671,0.14546,0.11835,MIR6816_3P,0.92829028436019
GOMF_CARBOHYDRATE_KINASE_ACT...,SET,20,0.20078,0.0066234,0.16972,0.11842,GOMF_CARBOHYDRATE_KINASE_ACTIVITY,0.928340836339044
GOBP_ACTIVATION_OF_PROTEIN_K...1,SET,75,0.11937,0.0076142,0.10091,0.11843,GOBP_ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY,0.928340836339044
ZNF236_TARGET_GENES,SET,212,0.068341,0.0073015,0.057775,0.11844,ZNF236_TARGET_GENES,0.928340836339044
ARGGGTTAA_UNKNOWN,SET,111,0.10132,0.0078544,0.085671,0.11849,ARGGGTTAA_UNKNOWN,0.928340836339044
GOBP_ACTIVATION_OF_PROTEIN_K...2,SET,21,0.23865,0.0080669,0.2018,0.11849,GOBP_ACTIVATION_OF_PROTEIN_KINASE_B_ACTIVITY,0.928340836339044
GOCC_LATERAL_ELEMENT,SET,13,0.24087,0.0064074,0.20374,0.11857,GOCC_LATERAL_ELEMENT,0.928384850863422
MIR212_5P,SET,86,0.10634,0.0072614,0.089961,0.11859,MIR212_5P,0.928384850863422
GOMF_MOLECULAR_CARRIER_ACTIV...,SET,84,0.10454,0.0070554,0.088455,0.11864,GOMF_MOLECULAR_CARRIER_ACTIVITY,0.928384850863422
GOBP_RAP_PROTEIN_SIGNAL_TRAN...,SET,12,0.31483,0.0080466,0.26645,0.11869,GOBP_RAP_PROTEIN_SIGNAL_TRANSDUCTION,0.928384850863422
GSE16450_IMMATURE_VS_MATURE_...3,SET,177,0.07607,0.0074333,0.064383,0.11871,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.928384850863422
GOBP_AMIDE_TRANSPORT,SET,295,0.060801,0.0076452,0.051462,0.11872,GOBP_AMIDE_TRANSPORT,0.928384850863422
GOBP_REGULATION_OF_CELL_SUBS...2,SET,65,0.12939,0.0076856,0.10953,0.11874,GOBP_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.928384850863422
HP_PAIN_IN_HEAD_AND_NECK_REG...,SET,40,0.16106,0.0075099,0.13634,0.11874,HP_PAIN_IN_HEAD_AND_NECK_REGION,0.928384850863422
WP_15Q11Q13_COPY_NUMBER_VARI...,SET,48,0.14963,0.007641,0.1267,0.11881,WP_15Q11Q13_COPY_NUMBER_VARIATION,0.928384850863422
GOBP_POSITIVE_REGULATION_OF_...761,SET,13,0.27009,0.0071847,0.22869,0.11881,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.928384850863422
GSE29618_PRE_VS_DAY7_FLU_VAC...1,SET,175,0.073679,0.0071593,0.062403,0.11887,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN,0.928384850863422
GSE6259_CD4_TCELL_VS_CD8_TCE...1,SET,165,0.07644,0.0072142,0.064747,0.11889,GSE6259_CD4_TCELL_VS_CD8_TCELL_DN,0.928384850863422
TAATGTG_MIR323,SET,148,0.083532,0.0074699,0.070765,0.11893,TAATGTG_MIR323,0.928384850863422
GSE11057_CD4_CENT_MEM_VS_PBM...2,SET,178,0.075669,0.0074148,0.064108,0.11894,GSE11057_CD4_CENT_MEM_VS_PBMC_UP,0.928384850863422
GOBP_DEFINITIVE_HEMOPOIESIS,SET,18,0.26802,0.0083884,0.22708,0.11895,GOBP_DEFINITIVE_HEMOPOIESIS,0.928384850863422
GSE1432_CTRL_VS_IFNG_1H_MICR...2,SET,170,0.074204,0.0071075,0.062874,0.11897,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.928384850863422
REACTOME_CREB3_FACTORS_ACTIV...,SET,8,0.31753,0.006627,0.26916,0.11907,REACTOME_CREB3_FACTORS_ACTIVATE_GENES,0.928384850863422
GOBP_REGULATION_OF_MAST_CELL...4,SET,25,0.2172,0.0080097,0.18412,0.11908,GOBP_REGULATION_OF_MAST_CELL_DEGRANULATION,0.928384850863422
MIR3663_5P,SET,49,0.14598,0.0075317,0.12376,0.11909,MIR3663_5P,0.928384850863422
GOMF_CHLORIDE_CHANNEL_INHIBI...,SET,7,0.34564,0.006748,0.29302,0.11909,GOMF_CHLORIDE_CHANNEL_INHIBITOR_ACTIVITY,0.928384850863422
GSE2770_TGFB_AND_IL4_VS_IL12...1,SET,182,0.076753,0.0076043,0.06507,0.1191,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.928384850863422
GOBP_INTRACELLULAR_TRANSPORT...,SET,10,0.32927,0.0076828,0.27916,0.11911,GOBP_INTRACELLULAR_TRANSPORT_OF_VIRUS,0.928384850863422
GSE13738_RESTING_VS_BYSTANDE...2,SET,152,0.081111,0.0073499,0.068767,0.11911,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,0.928384850863422
MIR4728_3P,SET,99,0.106,0.0077634,0.089904,0.11919,MIR4728_3P,0.928460559910414
GOBP_AMP_CATABOLIC_PROCESS,SET,5,0.4899,0.0080839,0.41551,0.1192,GOBP_AMP_CATABOLIC_PROCESS,0.928460559910414
GOCC_DNA_REPLICATION_FACTOR_...1,SET,12,0.27533,0.0070371,0.23355,0.11923,GOCC_DNA_REPLICATION_FACTOR_A_COMPLEX,0.928460559910414
HP_STEREOTYPICAL_HAND_WRINGI...,SET,20,0.24261,0.0080035,0.20582,0.11925,HP_STEREOTYPICAL_HAND_WRINGING,0.928460559910414
HP_CEREBRAL_HEMORRHAGE,SET,63,0.12064,0.0070552,0.10235,0.11927,HP_CEREBRAL_HEMORRHAGE,0.928460559910414
HP_MENINGOCELE,SET,53,0.14346,0.0076973,0.12172,0.11928,HP_MENINGOCELE,0.928460559910414
BURTON_ADIPOGENESIS_10,SET,26,0.18959,0.00713,0.16089,0.11933,BURTON_ADIPOGENESIS_10,0.928583500669344
HP_EPIDIDYMITIS,SET,3,0.62498,0.0079887,0.53055,0.11941,HP_EPIDIDYMITIS,0.928583500669344
CTR9_TARGET_GENES,SET,46,0.13674,0.0068364,0.11611,0.11946,CTR9_TARGET_GENES,0.928583500669344
MIR6834_5P,SET,53,0.13949,0.0074843,0.11845,0.11948,MIR6834_5P,0.928583500669344
GOMF_MICROTUBULE_PLUS_END_BI...,SET,21,0.21829,0.0073787,0.18537,0.11949,GOMF_MICROTUBULE_PLUS_END_BINDING,0.928583500669344
HP_OPEN_OPERCULUM,SET,6,0.46987,0.0084932,0.39901,0.11949,HP_OPEN_OPERCULUM,0.928583500669344
GOBP_REGULATION_OF_ISOMERASE...,SET,7,0.37446,0.0073106,0.31802,0.11952,GOBP_REGULATION_OF_ISOMERASE_ACTIVITY,0.928583500669344
HP_RENAL_CORTICAL_MICROCYSTS,SET,4,0.47679,0.0070371,0.40499,0.11955,HP_RENAL_CORTICAL_MICROCYSTS,0.928583500669344
HP_GENERALIZED_ABNORMALITY_O...,SET,944,0.033228,0.0073386,0.028227,0.11957,HP_GENERALIZED_ABNORMALITY_OF_SKIN,0.928583500669344
DOANE_BREAST_CANCER_CLASSES_...2,SET,66,0.12951,0.0077514,0.11003,0.11959,DOANE_BREAST_CANCER_CLASSES_UP,0.928583500669344
GSE14908_ATOPIC_VS_NONATOPIC...3,SET,180,0.070025,0.0068998,0.059495,0.11961,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_DN,0.928583500669344
HP_ABNORMALITY_OF_LOWER_EYEL...,SET,5,0.4502,0.0074288,0.38262,0.11968,HP_ABNORMALITY_OF_LOWER_EYELASHES,0.928583500669344
HOXA4_Q2,SET,243,0.06834,0.0078104,0.058083,0.11969,HOXA4_Q2,0.928583500669344
GAUTAM_EYE_CHOROID_SCLERA_ME...,SET,136,0.082832,0.007103,0.070406,0.11971,GAUTAM_EYE_CHOROID_SCLERA_MELANOCYTES,0.928583500669344
GSE26290_CTRL_VS_AKT_INHIBIT...2,SET,174,0.079583,0.0077111,0.06765,0.11973,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,0.928583500669344
ONO_FOXP3_TARGETS_UP,SET,21,0.25092,0.0084819,0.21331,0.11974,ONO_FOXP3_TARGETS_UP,0.928583500669344
GOMF_MICROTUBULE_SEVERING_AT...,SET,9,0.33372,0.0073873,0.28371,0.11975,GOMF_MICROTUBULE_SEVERING_ATPASE_ACTIVITY,0.928583500669344
MIR507,SET,241,0.065449,0.0074495,0.055648,0.11978,MIR507,0.928608944902967
GOBP_DENDRITE_MORPHOGENESIS,SET,131,0.0898,0.0075587,0.076371,0.11984,GOBP_DENDRITE_MORPHOGENESIS,0.9287372909699
GOMF_LIGAND_GATED_MONOATOMIC...1,SET,42,0.17868,0.0085369,0.15197,0.11985,GOMF_LIGAND_GATED_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.9287372909699
OKAWA_NEUROBLASTOMA_1P36_31_...,SET,22,0.33005,0.011419,0.28087,0.11999,OKAWA_NEUROBLASTOMA_1P36_31_DELETION,0.92914848518601
MIR4322,SET,35,0.18903,0.0082457,0.16086,0.11999,MIR4322,0.92914848518601
HP_DECREASED_SKULL_OSSIFICAT...,SET,38,0.16266,0.0073926,0.13842,0.11999,HP_DECREASED_SKULL_OSSIFICATION,0.92914848518601
GSE22886_DC_VS_MONOCYTE_DN,SET,180,0.076245,0.0075127,0.064891,0.12001,GSE22886_DC_VS_MONOCYTE_DN,0.92914848518601
MIR12125,SET,101,0.10262,0.007591,0.087383,0.12012,MIR12125,0.929497771124418
GOCC_GLYCOPROTEIN_COMPLEX,SET,21,0.2289,0.0077373,0.19492,0.12015,GOCC_GLYCOPROTEIN_COMPLEX,0.929497771124418
HP_ABNORMAL_CIRCULATING_ANTI...,SET,8,0.31151,0.0065014,0.2653,0.12017,HP_ABNORMAL_CIRCULATING_ANTIMULLERIAN_HORMONE_CONCENTRATION,0.929497771124418
HP_LOW_SELF_ESTEEM,SET,10,0.37291,0.0087011,0.31765,0.12021,HP_LOW_SELF_ESTEEM,0.929497771124418
GOBP_SMOOTH_MUSCLE_CELL_MIGR...,SET,67,0.13526,0.0081562,0.11524,0.12027,GOBP_SMOOTH_MUSCLE_CELL_MIGRATION,0.929497771124418
MYLLYKANGAS_AMPLIFICATION_HO...11,SET,9,0.3412,0.0075529,0.29073,0.12029,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25,0.929497771124418
GOBP_POSITIVE_REGULATION_OF_...833,SET,4,0.4171,0.0061562,0.35546,0.12033,GOBP_POSITIVE_REGULATION_OF_VASCULAR_WOUND_HEALING,0.929497771124418
GOMF_CYSTEINE_TYPE_ENDOPEPTI...7,SET,18,0.2387,0.0074709,0.20345,0.12035,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.929497771124418
GOBP_REGULATION_OF_PROTEIN_M...2,SET,1098,0.031416,0.0074499,0.026781,0.12039,GOBP_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.929497771124418
GOMF_PROTEIN_LYSINE_DEACETYL...,SET,21,0.21046,0.0071139,0.17941,0.1204,GOMF_PROTEIN_LYSINE_DEACETYLASE_ACTIVITY,0.929497771124418
MODULE_509,SET,12,0.27478,0.0070231,0.23427,0.12042,MODULE_509,0.929497771124418
MIR1205,SET,160,0.079344,0.0073749,0.067648,0.12043,MIR1205,0.929497771124418
CUI_TCF21_TARGETS_DN,SET,30,0.21347,0.0086223,0.18203,0.12047,CUI_TCF21_TARGETS_DN,0.929497771124418
GOMF_HISTONE_DECROTONYLASE_A...,SET,4,0.45772,0.0067556,0.39032,0.12047,GOMF_HISTONE_DECROTONYLASE_ACTIVITY,0.929497771124418
HP_UNILATERAL_CLEFT_PALATE,SET,18,0.26127,0.008177,0.22282,0.1205,HP_UNILATERAL_CLEFT_PALATE,0.929497771124418
GSE34515_CD16_NEG_VS_POS_MON...1,SET,163,0.076664,0.0071917,0.06539,0.12052,GSE34515_CD16_NEG_VS_POS_MONOCYTE_DN,0.929497771124418
MORF_RAD54L,SET,91,0.098021,0.0068841,0.08361,0.12054,MORF_RAD54L,0.929497771124418
GSE46606_IRF4_KO_VS_WT_UNSTI...2,SET,186,0.071334,0.0071438,0.060848,0.12054,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP,0.929497771124418
GOBP_REGULATION_OF_PLATELET_...5,SET,22,0.21688,0.0075033,0.18503,0.12058,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.929497771124418
HP_HYPERPIGMENTATION_OF_THE_...2,SET,289,0.056491,0.0070319,0.048197,0.12059,HP_HYPERPIGMENTATION_OF_THE_SKIN,0.929497771124418
GOMF_JUN_KINASE_KINASE_KINAS...,SET,9,0.35963,0.0079609,0.30693,0.12066,GOMF_JUN_KINASE_KINASE_KINASE_ACTIVITY,0.92983110864745
WANG_LMO4_TARGETS_UP,SET,310,0.056432,0.007271,0.04817,0.1207,WANG_LMO4_TARGETS_UP,0.929933163378408
MIR6835_3P,SET,414,0.05232,0.0077679,0.044679,0.1208,MIR6835_3P,0.92998100088574
GSE16385_ROSIGLITAZONE_IL4_V...3,SET,188,0.072029,0.0072517,0.061508,0.1208,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN,0.92998100088574
NAKAJIMA_EOSINOPHIL,SET,22,0.24436,0.0084542,0.20868,0.12081,NAKAJIMA_EOSINOPHIL,0.92998100088574
SCHMIDT_POR_TARGETS_IN_LIMB_...1,SET,8,0.3833,0.0079998,0.32736,0.12083,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN,0.92998100088574
GOCC_NUCLEOID,SET,41,0.14154,0.0066814,0.12088,0.12084,GOCC_NUCLEOID,0.92998100088574
GOMF_HYDROPEROXY_ICOSATETRAE...,SET,7,0.41535,0.0081089,0.35478,0.12087,GOMF_HYDROPEROXY_ICOSATETRAENOATE_DEHYDRATASE_ACTIVITY,0.930005944210759
GOBP_POSITIVE_REGULATION_OF_...762,SET,3,0.72217,0.0092311,0.61695,0.1209,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.930030876494024
GOBP_SMOOTHENED_SIGNALING_PA...2,SET,5,0.46232,0.0076288,0.39508,0.12097,GOBP_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING,0.930234491150443
GSE15735_2H_VS_12H_HDAC_INHI...2,SET,188,0.076234,0.007675,0.065149,0.12098,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP,0.930234491150443
HP_ABNORMAL_SERUM_BILE_ACID_...,SET,25,0.21178,0.0078099,0.18106,0.12108,HP_ABNORMAL_SERUM_BILE_ACID_CONCENTRATION,0.930797478433975
HP_WEAK_EXTRAOCULAR_MUSCLES,SET,12,0.26098,0.0066704,0.2232,0.12115,HP_WEAK_EXTRAOCULAR_MUSCLES,0.931019701986755
chr1p35,SET,77,0.22478,0.014527,0.19228,0.1212,chr1p35,0.931019701986755
GOMF_NEUROTRANSMITTER_RECEPT...2,SET,52,0.15625,0.0083041,0.13365,0.1212,GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY_INVOLVED_IN_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL,0.931019701986755
HP_ABNORMAL_PITUITARY_GLAND_...,SET,304,0.057048,0.0072801,0.048814,0.12128,HP_ABNORMAL_PITUITARY_GLAND_MORPHOLOGY,0.931019701986755
BIOCARTA_GPCR_PATHWAY,SET,28,0.19966,0.0077917,0.17087,0.1213,BIOCARTA_GPCR_PATHWAY,0.931019701986755
GOBP_DEVELOPMENTAL_INDUCTION,SET,30,0.1985,0.0080178,0.16989,0.12132,GOBP_DEVELOPMENTAL_INDUCTION,0.931019701986755
GOBP_POSITIVE_REGULATION_OF_...74,SET,20,0.20825,0.0068699,0.17823,0.12132,GOBP_POSITIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,0.931019701986755
GSE3982_EOSINOPHIL_VS_DC_UP,SET,173,0.077403,0.0074784,0.06625,0.12134,GSE3982_EOSINOPHIL_VS_DC_UP,0.931019701986755
HOWARD_NEUTROPHIL_INACT_MONO...4,SET,113,0.098247,0.0076843,0.084095,0.12135,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.931019701986755
HP_GINGIVAL_FIBROMATOSIS,SET,22,0.21932,0.0075877,0.18782,0.12147,HP_GINGIVAL_FIBROMATOSIS,0.931262634822804
GOBP_NEGATIVE_REGULATION_OF_...472,SET,31,0.1993,0.008183,0.17074,0.12156,GOBP_NEGATIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.931262634822804
GOBP_DEVELOPMENTAL_GROWTH_IN...,SET,211,0.072413,0.0077185,0.062047,0.1216,GOBP_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS,0.931262634822804
GOBP_PURINERGIC_NUCLEOTIDE_R...,SET,27,0.21706,0.0083182,0.18599,0.12161,GOBP_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY,0.931262634822804
GOCC_PROTEIN_LIPID_COMPLEX,SET,33,0.19049,0.0080693,0.16325,0.12164,GOCC_PROTEIN_LIPID_COMPLEX,0.931262634822804
GOMF_ACID_THIOL_LIGASE_ACTIV...,SET,29,0.17985,0.0071426,0.15415,0.12167,GOMF_ACID_THIOL_LIGASE_ACTIVITY,0.931262634822804
RIZ_ERYTHROID_DIFFERENTIATIO...6,SET,25,0.22045,0.0081296,0.18896,0.12168,RIZ_ERYTHROID_DIFFERENTIATION_HEMGN,0.931262634822804
GOBP_REGULATION_OF_STRESS_AC...,SET,36,0.16449,0.0072772,0.141,0.12169,GOBP_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.931262634822804
GOMF_ICOSANOID_BINDING,SET,7,0.39252,0.0076633,0.33646,0.12169,GOMF_ICOSANOID_BINDING,0.931262634822804
GSE26928_EFF_MEM_VS_CENTR_ME...1,SET,146,0.08439,0.0074958,0.072336,0.12169,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN,0.931262634822804
WP_MEVALONATE_ARM_OF_CHOLEST...,SET,13,0.23262,0.0061879,0.19942,0.12172,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,0.931262634822804
PGF_UP.V1_UP,SET,167,0.078683,0.0074704,0.067455,0.12172,PGF_UP.V1_UP,0.931262634822804
HP_SILVER_GRAY_HAIR,SET,6,0.41683,0.0075344,0.35735,0.12173,HP_SILVER_GRAY_HAIR,0.931262634822804
SAENZ_DETOX_PATHWAY_AND_CARC...,SET,14,0.2651,0.0073181,0.22737,0.12183,SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN,0.931357615384615
KEGG_CITRATE_CYCLE_TCA_CYCLE,SET,27,0.16746,0.0064175,0.14365,0.12187,KEGG_CITRATE_CYCLE_TCA_CYCLE,0.931357615384615
ZHAN_MULTIPLE_MYELOMA_DN,SET,35,0.18438,0.008043,0.15817,0.12188,ZHAN_MULTIPLE_MYELOMA_DN,0.931357615384615
GOBP_ALPHA_KETOGLUTARATE_TRA...,SET,7,0.37501,0.0073214,0.32173,0.1219,GOBP_ALPHA_KETOGLUTARATE_TRANSPORT,0.931357615384615
GOBP_RESPONSE_TO_HEPARIN,SET,6,0.49758,0.008994,0.42689,0.1219,GOBP_RESPONSE_TO_HEPARIN,0.931357615384615
REACTOME_METABOLIC_DISORDERS...,SET,32,0.18447,0.0076951,0.15827,0.12191,REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES,0.931357615384615
HP_CYANOSIS,SET,100,0.10156,0.0074753,0.087145,0.12193,HP_CYANOSIS,0.931357615384615
GOBP_REGULATION_OF_PHOSPHOLI...4,SET,32,0.19233,0.0080227,0.16505,0.12196,GOBP_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY,0.931382069874753
GSE30962_ACUTE_VS_CHRONIC_LC...4,SET,180,0.074688,0.0073593,0.064106,0.122,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP,0.931482864674868
REACTOME_GLUTATHIONE_CONJUGA...,SET,32,0.2003,0.0083555,0.17198,0.12208,REACTOME_GLUTATHIONE_CONJUGATION,0.931836956521739
WP_TOLLLIKE_RECEPTOR_SIGNALI...2,SET,26,0.18416,0.0069258,0.15814,0.1221,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,0.931836956521739
HP_WRIST_HYPERMOBILITY,SET,7,0.42836,0.008363,0.36793,0.12217,HP_WRIST_HYPERMOBILITY,0.931961885425812
GSE7460_CTRL_VS_TGFB_TREATED...4,SET,192,0.069581,0.0070786,0.059766,0.12217,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP,0.931961885425812
GSE21670_UNTREATED_VS_TGFB_I...4,SET,180,0.072965,0.0071895,0.062683,0.12221,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.932058980263158
HP_ATRIAL_FLUTTER,SET,17,0.26529,0.0080692,0.22793,0.12224,HP_ATRIAL_FLUTTER,0.932058980263158
MIR615_3P,SET,6,0.39559,0.0071505,0.33996,0.12229,MIR615_3P,0.932058980263158
GOMF_VITAMIN_TRANSMEMBRANE_T...,SET,33,0.17575,0.0074446,0.15103,0.12229,GOMF_VITAMIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.932058980263158
STAEGE_EWING_FAMILY_TUMOR,SET,24,0.23288,0.0084147,0.20016,0.12233,STAEGE_EWING_FAMILY_TUMOR,0.932131689677844
GOBP_POSITIVE_REGULATION_OF_...383,SET,5,0.47007,0.0077568,0.40411,0.12237,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.932131689677844
HP_MOON_FACIES,SET,12,0.2837,0.0072509,0.24389,0.12238,HP_MOON_FACIES,0.932131689677844
GOBP_LYSOSOMAL_TRANSPORT,SET,126,0.087789,0.007248,0.075484,0.12242,GOBP_LYSOSOMAL_TRANSPORT,0.932232055214724
GSE24210_IL35_TREATED_VS_UNT...1,SET,182,0.074924,0.007423,0.064434,0.12246,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN,0.932304587256405
GOBP_CEREBELLAR_GRANULAR_LAY...1,SET,12,0.30893,0.0078958,0.26571,0.12249,GOBP_CEREBELLAR_GRANULAR_LAYER_DEVELOPMENT,0.932304587256405
GOBP_DE_NOVO_CENTRIOLE_ASSEM...2,SET,4,0.39314,0.0058025,0.33817,0.12251,GOBP_DE_NOVO_CENTRIOLE_ASSEMBLY_INVOLVED_IN_MULTI_CILIATED_EPITHELIAL_CELL_DIFFERENTIATION,0.932304587256405
GOBP_REGULATION_OF_OSTEOCLAS...2,SET,65,0.13889,0.0082496,0.11952,0.12261,GOBP_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.932657156927118
GSE1925_CTRL_VS_IFNG_PRIMED_...4,SET,156,0.076431,0.0070156,0.065771,0.12261,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP,0.932657156927118
MORF_BECN1,SET,96,0.09269,0.0066853,0.07978,0.12266,MORF_BECN1,0.932781316998469
GOCC_FHF_COMPLEX,SET,4,0.42486,0.0062706,0.36571,0.12268,GOCC_FHF_COMPLEX,0.932781316998469
GOBP_VACUOLAR_TRANSPORT,SET,161,0.076532,0.0071356,0.065909,0.12279,GOBP_VACUOLAR_TRANSPORT,0.933205168269231
MIR623,SET,107,0.095366,0.0072595,0.082131,0.1228,MIR623,0.933205168269231
ZHONG_PFC_MAJOR_TYPES_EXCITA...,SET,8,0.34894,0.0072827,0.30056,0.12283,ZHONG_PFC_MAJOR_TYPES_EXCITATORY_NEURON,0.933205168269231
GOBP_APOLIPOPROTEIN_A_I_MEDI...,SET,5,0.45765,0.0075518,0.39422,0.12285,GOBP_APOLIPOPROTEIN_A_I_MEDIATED_SIGNALING_PATHWAY,0.933205168269231
MIR548N,SET,554,0.043613,0.0074612,0.037572,0.12287,MIR548N,0.933205168269231
GSE15330_HSC_VS_LYMPHOID_PRI...1,SET,164,0.079736,0.0075026,0.068699,0.1229,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,0.933229080183526
GSE25123_CTRL_VS_IL4_AND_ROS...2,SET,186,0.071684,0.0071789,0.061786,0.12299,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.933604290393013
GSE7459_UNTREATED_VS_IL6_TRE...1,SET,125,0.091938,0.0075606,0.079253,0.12302,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_DN,0.933604290393013
GOBP_ACTIVIN_RECEPTOR_SIGNAL...,SET,44,0.16088,0.0078669,0.13869,0.12303,GOBP_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.933604290393013
ZHOU_PANCREATIC_BETA_CELL,SET,11,0.3457,0.0084596,0.29806,0.12307,ZHOU_PANCREATIC_BETA_CELL,0.933651887821912
DESCARTES_FETAL_EYE_SKELETAL...,SET,132,0.088336,0.0074636,0.076172,0.12309,DESCARTES_FETAL_EYE_SKELETAL_MUSCLE_CELLS,0.933651887821912
GSE17721_LPS_VS_POLYIC_0.5H_...1,SET,182,0.071201,0.0070542,0.061418,0.12318,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_DN,0.93367117313563
HP_SLENDER_LONG_BONE,SET,46,0.13012,0.0065054,0.11225,0.12319,HP_SLENDER_LONG_BONE,0.93367117313563
GOBP_POSITIVE_REGULATION_OF_...125,SET,239,0.065115,0.0073811,0.056175,0.1232,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS,0.93367117313563
GOBP_VESICLE_MEDIATED_TRANSP...2,SET,44,0.15183,0.0074244,0.13098,0.1232,GOBP_VESICLE_MEDIATED_TRANSPORT_BETWEEN_ENDOSOMAL_COMPARTMENTS,0.93367117313563
GOBP_POSITIVE_REGULATION_OF_...200,SET,35,0.16585,0.0072346,0.14309,0.12323,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,0.933694931327665
KEGG_MEDICUS_REFERENCE_CXCR4...3,SET,21,0.20886,0.0070601,0.18024,0.12327,KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,0.933794431124673
ZHENG_IL22_SIGNALING_DN,SET,34,0.17551,0.0075462,0.15151,0.12335,ZHENG_IL22_SIGNALING_DN,0.933813567073171
KYNG_ENVIRONMENTAL_STRESS_RE...3,SET,33,0.17706,0.0075001,0.15285,0.12337,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,0.933813567073171
GOBP_REGULATION_OF_CARDIAC_M...10,SET,18,0.23377,0.0073165,0.20182,0.12337,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION,0.933813567073171
GSE10325_BCELL_VS_MYELOID_DN,SET,182,0.075544,0.0074845,0.065222,0.12338,GSE10325_BCELL_VS_MYELOID_DN,0.933813567073171
HP_HEMOPTYSIS,SET,81,0.12232,0.0081073,0.10566,0.12351,HP_HEMOPTYSIS,0.934437630548303
GSE7219_WT_VS_NIK_NFKB2_KO_D...1,SET,158,0.080577,0.007443,0.069605,0.12352,GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN,0.934437630548303
KEGG_TOLL_LIKE_RECEPTOR_SIGN...,SET,95,0.1082,0.0077632,0.093479,0.12355,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.934437630548303
HP_VASCULAR_SKIN_ABNORMALITY,SET,513,0.043628,0.0071904,0.037696,0.12357,HP_VASCULAR_SKIN_ABNORMALITY,0.934437630548303
GOMF_C_X_C_CHEMOKINE_BINDING,SET,4,0.4987,0.0073605,0.43094,0.1236,GOMF_C_X_C_CHEMOKINE_BINDING,0.934461170328475
MIR6892_5P,SET,84,0.10657,0.0071925,0.092118,0.12366,MIR6892_5P,0.934711461505002
HP_DECREASED_CIRCULATING_AND...,SET,62,0.12975,0.0075274,0.11219,0.12374,HP_DECREASED_CIRCULATING_ANDROGEN_CONCENTRATION,0.93479482423981
GNF2_NPM1,SET,65,0.10628,0.0063129,0.091914,0.12379,GNF2_NPM1,0.93479482423981
WP_MEASLES_VIRUS_INFECTION,SET,123,0.096106,0.0078403,0.083121,0.1238,WP_MEASLES_VIRUS_INFECTION,0.93479482423981
MODY_HIPPOCAMPUS_POSTNATAL,SET,52,0.13317,0.0070777,0.11521,0.12386,MODY_HIPPOCAMPUS_POSTNATAL,0.93479482423981
HP_ANTERIOR_UVEITIS,SET,15,0.2739,0.0078262,0.23696,0.12387,HP_ANTERIOR_UVEITIS,0.93479482423981
GOMF_DYNEIN_LIGHT_INTERMEDIA...,SET,28,0.1732,0.0067591,0.14987,0.12391,GOMF_DYNEIN_LIGHT_INTERMEDIATE_CHAIN_BINDING,0.93479482423981
GSE36392_MAC_VS_NEUTROPHIL_I...2,SET,186,0.070315,0.0070418,0.060848,0.12393,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,0.93479482423981
GOMF_TRNA_CYTIDINE_METHYLTRA...,SET,9,0.30092,0.0066611,0.26047,0.124,GOMF_TRNA_CYTIDINE_METHYLTRANSFERASE_ACTIVITY,0.93479482423981
GOBP_RESPONSE_TO_HEPATOCYTE_...,SET,17,0.26124,0.0079461,0.22618,0.12405,GOBP_RESPONSE_TO_HEPATOCYTE_GROWTH_FACTOR,0.93479482423981
GOCC_MON1_CCZ1_COMPLEX,SET,4,0.49957,0.0073734,0.43263,0.12411,GOCC_MON1_CCZ1_COMPLEX,0.93479482423981
GSE45365_CD8A_DC_VS_CD11B_DC...4,SET,151,0.081194,0.0073334,0.070317,0.12412,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP,0.93479482423981
REACTOME_UBIQUINOL_BIOSYNTHE...,SET,10,0.28002,0.0065337,0.24254,0.12415,REACTOME_UBIQUINOL_BIOSYNTHESIS,0.93479482423981
MODULE_310,SET,19,0.246,0.0079101,0.21309,0.12416,MODULE_310,0.93479482423981
GOBP_NEGATIVE_REGULATION_OF_...405,SET,5,0.50622,0.0083532,0.43849,0.12416,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS,0.93479482423981
GNF2_HAT1,SET,45,0.13471,0.0066611,0.11669,0.12419,GNF2_HAT1,0.93479482423981
GOBP_MARGINAL_ZONE_B_CELL_DI...,SET,7,0.37582,0.0073372,0.32559,0.1242,GOBP_MARGINAL_ZONE_B_CELL_DIFFERENTIATION,0.93479482423981
REACTOME_INTERLEUKIN_2_SIGNA...,SET,11,0.32722,0.0080075,0.2835,0.12421,REACTOME_INTERLEUKIN_2_SIGNALING,0.93479482423981
GGGNRMNNYCAT_UNKNOWN,SET,74,0.11287,0.0071516,0.097791,0.12422,GGGNRMNNYCAT_UNKNOWN,0.93479482423981
GOBP_PEPTIDOGLYCAN_METABOLIC...,SET,6,0.42094,0.0076086,0.36471,0.12422,GOBP_PEPTIDOGLYCAN_METABOLIC_PROCESS,0.93479482423981
HP_PROMINENT_UMBILICUS,SET,5,0.4946,0.0081615,0.42854,0.12422,HP_PROMINENT_UMBILICUS,0.93479482423981
GOBP_POSITIVE_REGULATION_OF_...137,SET,32,0.16968,0.0070779,0.14711,0.12439,GOBP_POSITIVE_REGULATION_OF_CELL_MORPHOGENESIS,0.93479482423981
GOMF_GALACTOSIDASE_ACTIVITY,SET,6,0.39538,0.0071467,0.34281,0.12439,GOMF_GALACTOSIDASE_ACTIVITY,0.93479482423981
PID_GMCSF_PATHWAY,SET,35,0.16938,0.0073886,0.14686,0.1244,PID_GMCSF_PATHWAY,0.93479482423981
GOMF_LIGASE_ACTIVITY_FORMING...4,SET,38,0.14689,0.006676,0.12736,0.1244,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_SULFUR_BONDS,0.93479482423981
GOBP_MITOTIC_NUCLEAR_MEMBRAN...2,SET,10,0.28653,0.0066857,0.24846,0.12441,GOBP_MITOTIC_NUCLEAR_MEMBRANE_ORGANIZATION,0.93479482423981
GOBP_REGULATION_OF_COLLAGEN_...2,SET,32,0.19016,0.0079325,0.16492,0.12445,GOBP_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.93479482423981
HP_ABNORMALITY_OF_THE_OUTER_...,SET,1117,0.030104,0.0071963,0.026111,0.12448,HP_ABNORMALITY_OF_THE_OUTER_EAR,0.93479482423981
GOBP_AGGRESOME_ASSEMBLY,SET,4,0.47178,0.0069632,0.40928,0.12452,GOBP_AGGRESOME_ASSEMBLY,0.93479482423981
TSENG_IRS1_TARGETS_UP,SET,94,0.10335,0.0073762,0.089662,0.12454,TSENG_IRS1_TARGETS_UP,0.93479482423981
GCM_TPR,SET,29,0.1609,0.0063901,0.13962,0.12457,GCM_TPR,0.93479482423981
TAGHAVI_NEOPLASTIC_TRANSFORM...,SET,11,0.27545,0.0067405,0.23901,0.12458,TAGHAVI_NEOPLASTIC_TRANSFORMATION,0.93479482423981
GOBP_STRESS_GRANULE_DISASSEM...,SET,7,0.32567,0.0063581,0.28261,0.12459,GOBP_STRESS_GRANULE_DISASSEMBLY,0.93479482423981
GSE22611_NOD2_VS_MUTANT_NOD2...1,SET,158,0.076575,0.0070733,0.06645,0.12459,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.93479482423981
GOBP_EXTRACELLULAR_MATRIX_CO...,SET,13,0.31714,0.0084363,0.27528,0.12466,GOBP_EXTRACELLULAR_MATRIX_CONSTITUENT_SECRETION,0.93479482423981
GSE12198_LOW_IL2_STIM_NK_CEL...1,SET,189,0.071097,0.0071766,0.061717,0.12467,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN,0.93479482423981
GOBP_EPITHELIAL_TO_MESENCHYM...1,SET,164,0.080956,0.0076175,0.070278,0.12468,GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.93479482423981
SANSOM_APC_MYC_TARGETS,SET,223,0.063809,0.0069898,0.055398,0.1247,SANSOM_APC_MYC_TARGETS,0.93479482423981
GSE339_EX_VIVO_VS_IN_CULTURE...4,SET,185,0.070251,0.0070166,0.060992,0.12471,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP,0.93479482423981
HP_INEFFECTIVE_ESOPHAGEAL_PE...,SET,14,0.26086,0.0072009,0.22648,0.12472,HP_INEFFECTIVE_ESOPHAGEAL_PERISTALSIS,0.93479482423981
MIR1228_3P,SET,70,0.12128,0.0074745,0.10531,0.12475,MIR1228_3P,0.934802550032279
MIR3137,SET,47,0.15268,0.0077154,0.13264,0.12485,MIR3137,0.934802550032279
REACTOME_PHASE_2_PLATEAU_PHA...,SET,14,0.2748,0.0075859,0.23875,0.12487,REACTOME_PHASE_2_PLATEAU_PHASE,0.934802550032279
GOMF_CYTOKINE_ACTIVITY,SET,217,0.078394,0.0084726,0.068115,0.12489,GOMF_CYTOKINE_ACTIVITY,0.934802550032279
GSE2770_UNTREATED_VS_IL4_TRE...6,SET,187,0.069176,0.0069461,0.060106,0.12489,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.934802550032279
HP_PES_CAVUS,SET,252,0.062152,0.0072317,0.05401,0.12492,HP_PES_CAVUS,0.934802550032279
GSE6681_DELETED_FOXP3_VS_WT_...1,SET,176,0.073457,0.0071579,0.063834,0.12493,GSE6681_DELETED_FOXP3_VS_WT_TREG_DN,0.934802550032279
ZNF362_TARGET_GENES,SET,488,0.044315,0.0071286,0.038512,0.12494,ZNF362_TARGET_GENES,0.934802550032279
MIR145_5P,SET,285,0.059796,0.0073923,0.051972,0.12497,MIR145_5P,0.934802550032279
GOCC_HOPS_COMPLEX,SET,14,0.23841,0.0065814,0.20724,0.12499,GOCC_HOPS_COMPLEX,0.934802550032279
GOBP_NEGATIVE_REGULATION_OF_...112,SET,242,0.0668,0.0076189,0.058082,0.12506,GOBP_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT,0.935091005802708
GOBP_IMMUNOGLOBULIN_PRODUCTI...1,SET,91,0.096558,0.0067814,0.083967,0.12509,GOBP_IMMUNOGLOBULIN_PRODUCTION,0.935091005802708
HP_DECREASED_BODY_MASS_INDEX,SET,20,0.2347,0.0077424,0.20415,0.12515,HP_DECREASED_BODY_MASS_INDEX,0.935091005802708
PGBD5_TARGET_GENES,SET,14,0.28639,0.0079057,0.24913,0.12517,PGBD5_TARGET_GENES,0.935091005802708
GSE21063_3H_VS_16H_ANTI_IGM_...1,SET,168,0.070847,0.0067464,0.061633,0.12518,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN,0.935091005802708
GOCC_INO80_COMPLEX,SET,16,0.24746,0.0073022,0.21528,0.12519,GOCC_INO80_COMPLEX,0.935091005802708
GOCC_CELL_CORTEX_REGION,SET,34,0.17313,0.007444,0.15065,0.12523,GOCC_CELL_CORTEX_REGION,0.935188794585303
GOBP_RELEASE_OF_SEQUESTERED_...,SET,34,0.1716,0.0073782,0.14934,0.12526,GOBP_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_ENDOPLASMIC_RETICULUM,0.935211879699248
GOBP_NEGATIVE_REGULATION_OF_...187,SET,107,0.090279,0.0068722,0.078587,0.12533,GOBP_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,0.935533537371134
GOBP_CYTOKINE_PRODUCTION_INV...2,SET,57,0.12681,0.0070553,0.11042,0.12539,GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.935780427313721
HP_COMPULSIVE_BEHAVIORS,SET,137,0.084614,0.0072822,0.073683,0.12542,HP_COMPULSIVE_BEHAVIORS,0.935803370545298
MIR4777_3P,SET,61,0.12127,0.0069789,0.10563,0.12547,MIR4777_3P,0.935975499034127
KEGG_MEDICUS_REFERENCE_TLR1_...,SET,18,0.22478,0.0070349,0.19583,0.12553,KEGG_MEDICUS_REFERENCE_TLR1_2_4_NFKB_SIGNALING_PATHWAY,0.936222135193133
DAZARD_UV_RESPONSE_CLUSTER_G2,SET,25,0.21269,0.0078435,0.18535,0.12559,DAZARD_UV_RESPONSE_CLUSTER_G2,0.936311738293778
TGCCAAR_NF1_Q6,SET,639,0.040653,0.0074515,0.035431,0.12562,TGCCAAR_NF1_Q6,0.936311738293778
GOBP_POSITIVE_REGULATION_OF_...488,SET,87,0.10936,0.0075105,0.095321,0.12564,GOBP_POSITIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,0.936311738293778
KEGG_MEDICUS_REFERENCE_INACT...,SET,6,0.31912,0.0057683,0.27819,0.12567,KEGG_MEDICUS_REFERENCE_INACTIVATION_OF_CONDENSIN_I,0.936311738293778
GOBP_CYCLIC_GMP_AMP_TRANSMEM...,SET,8,0.36947,0.0077111,0.32213,0.1257,GOBP_CYCLIC_GMP_AMP_TRANSMEMBRANE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.936311738293778
GOBP_BIOMINERAL_TISSUE_DEVEL...,SET,161,0.082029,0.0076481,0.071545,0.12579,GOBP_BIOMINERAL_TISSUE_DEVELOPMENT,0.936311738293778
MODULE_285,SET,41,0.14264,0.0067335,0.12443,0.12583,MODULE_285,0.936311738293778
GOCC_MITOCHONDRIAL_PERMEABIL...,SET,6,0.41452,0.0074927,0.36163,0.12585,GOCC_MITOCHONDRIAL_PERMEABILITY_TRANSITION_PORE_COMPLEX,0.936311738293778
KEGG_MEDICUS_REFERENCE_ACTIV...1,SET,16,0.22768,0.0067185,0.19867,0.12591,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119,0.936311738293778
REACTOME_CLASS_B_2_SECRETIN_...,SET,90,0.11399,0.0079615,0.09947,0.12592,REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,0.936311738293778
GOBP_POSITIVE_REGULATION_OF_...424,SET,17,0.25518,0.0077617,0.22269,0.12593,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.936311738293778
TGFB_UP.V1_UP,SET,176,0.079676,0.0077638,0.069533,0.12593,TGFB_UP.V1_UP,0.936311738293778
DESCARTES_FETAL_EYE_BIPOLAR_...,SET,19,0.26024,0.008368,0.22712,0.12593,DESCARTES_FETAL_EYE_BIPOLAR_CELLS,0.936311738293778
GSE3720_VD1_VS_VD2_GAMMADELT...2,SET,171,0.075251,0.0072288,0.065675,0.12595,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP,0.936311738293778
HP_CEREBRAL_VENOUS_THROMBOSIS,SET,8,0.30407,0.0063461,0.26541,0.12598,HP_CEREBRAL_VENOUS_THROMBOSIS,0.936311738293778
GOBP_FOREBRAIN_DEVELOPMENT,SET,380,0.05302,0.0075488,0.046284,0.126,GOBP_FOREBRAIN_DEVELOPMENT,0.936311738293778
HP_VERTIGO,SET,136,0.088179,0.0075615,0.076974,0.126,HP_VERTIGO,0.936311738293778
GNF2_ANP32B,SET,34,0.15357,0.0066029,0.13416,0.12618,GNF2_ANP32B,0.936537973745501
GOCC_ALPHA_KETOACID_DEHYDROG...,SET,15,0.22455,0.0064161,0.19617,0.12618,GOCC_ALPHA_KETOACID_DEHYDROGENASE_COMPLEX,0.936537973745501
GOCC_GOLGI_CISTERNA,SET,96,0.10156,0.0073253,0.088727,0.12618,GOCC_GOLGI_CISTERNA,0.936537973745501
GOMF_GLUCOSIDASE_ACTIVITY,SET,13,0.26881,0.0071506,0.23486,0.1262,GOMF_GLUCOSIDASE_ACTIVITY,0.936537973745501
MODULE_430,SET,52,0.13231,0.007032,0.11562,0.12623,MODULE_430,0.936537973745501
HP_SPONTANEOUS_RECURRENT_EPI...,SET,13,0.29395,0.0078195,0.25689,0.12627,HP_SPONTANEOUS_RECURRENT_EPISTAXIS,0.936537973745501
GOBP_POLARIZED_EPITHELIAL_CE...,SET,24,0.21482,0.007762,0.18775,0.12628,GOBP_POLARIZED_EPITHELIAL_CELL_DIFFERENTIATION,0.936537973745501
HP_DECREASED_CERVICAL_SPINE_...1,SET,5,0.45503,0.0075085,0.39771,0.12629,HP_DECREASED_CERVICAL_SPINE_FLEXION_DUE_TO_CONTRACTURES_OF_POSTERIOR_CERVICAL_MUSCLES,0.936537973745501
CASTELLANO_NRAS_TARGETS_UP,SET,67,0.12836,0.0077406,0.11221,0.12633,CASTELLANO_NRAS_TARGETS_UP,0.936537973745501
P300_01,SET,223,0.067113,0.0073518,0.058687,0.12641,P300_01,0.936537973745501
GOMF_DYNACTIN_BINDING,SET,11,0.27651,0.0067664,0.2418,0.12641,GOMF_DYNACTIN_BINDING,0.936537973745501
BUSSLINGER_GASTRIC_MATURE_PI...,SET,208,0.071903,0.0076101,0.062877,0.12641,BUSSLINGER_GASTRIC_MATURE_PIT_CELLS,0.936537973745501
HP_RECURRENT_OTITIS_MEDIA,SET,172,0.077328,0.0074498,0.067623,0.12642,HP_RECURRENT_OTITIS_MEDIA,0.936537973745501
WEBER_METHYLATED_LCP_IN_SPER...1,SET,6,0.41304,0.007466,0.36123,0.12644,WEBER_METHYLATED_LCP_IN_SPERM_DN,0.936537973745501
GSE15330_HSC_VS_GRANULOCYTE_...4,SET,185,0.068149,0.0068066,0.059607,0.12646,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.936537973745501
MIR1283,SET,435,0.049153,0.0074761,0.042998,0.1265,MIR1283,0.936537973745501
HP_THENAR_MUSCLE_WEAKNESS,SET,4,0.52186,0.0077024,0.45665,0.12656,HP_THENAR_MUSCLE_WEAKNESS,0.936537973745501
GSE19888_ADENOSINE_A3R_INH_V...7,SET,176,0.073562,0.0071681,0.064383,0.12662,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,0.936537973745501
WP_INHIBITION_OF_EXOSOME_BIO...,SET,17,0.22143,0.0067351,0.19381,0.12663,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,0.936537973745501
GOMF_TRANSCRIPTION_REGULATOR...1,SET,5,0.49391,0.0081501,0.43242,0.12669,GOMF_TRANSCRIPTION_REGULATOR_ACTIVATOR_ACTIVITY,0.936537973745501
GSE29618_PRE_VS_DAY7_POST_TI...2,SET,168,0.081154,0.0077278,0.07106,0.12673,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP,0.936537973745501
GOMF_PASSIVE_TRANSMEMBRANE_T...,SET,453,0.050827,0.007885,0.044512,0.12676,GOMF_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.936537973745501
GSE5589_LPS_VS_LPS_AND_IL10_...6,SET,184,0.069624,0.0069354,0.060972,0.12676,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP,0.936537973745501
GSE17721_0.5H_VS_8H_POLYIC_B...1,SET,184,0.072911,0.0072627,0.063854,0.12677,GSE17721_0.5H_VS_8H_POLYIC_BMDC_DN,0.936537973745501
GSE12484_HEALTHY_VS_PERIDONT...2,SET,120,0.092586,0.007461,0.081108,0.12684,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP,0.936537973745501
HP_ANAL_FISTULA,SET,7,0.35054,0.0068436,0.30715,0.12689,HP_ANAL_FISTULA,0.936537973745501
GOCC_X_CHROMOSOME,SET,6,0.44488,0.0080415,0.38984,0.12691,GOCC_X_CHROMOSOME,0.936537973745501
GOBP_SKIN_DEVELOPMENT,SET,301,0.064197,0.0081526,0.056259,0.12692,GOBP_SKIN_DEVELOPMENT,0.936537973745501
GSE25123_CTRL_VS_ROSIGLITAZO...3,SET,178,0.073707,0.0072226,0.064593,0.12692,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,0.936537973745501
GOBP_T_CELL_MEDIATED_IMMUNE_...,SET,11,0.30949,0.0075736,0.27125,0.12695,GOBP_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.936537973745501
HP_SYNOSTOSIS_OF_CARPAL_BONES,SET,23,0.22444,0.0079392,0.19671,0.12695,HP_SYNOSTOSIS_OF_CARPAL_BONES,0.936537973745501
GSE43955_TH0_VS_TGFB_IL6_TH1...3,SET,182,0.073329,0.007265,0.064276,0.12698,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN,0.936537973745501
GOBP_SULFUR_AMINO_ACID_METAB...,SET,30,0.18904,0.0076357,0.16572,0.127,GOBP_SULFUR_AMINO_ACID_METABOLIC_PROCESS,0.936537973745501
GOBP_PHOTOTRANSDUCTION_VISIB...,SET,16,0.24504,0.0072309,0.21482,0.12701,GOBP_PHOTOTRANSDUCTION_VISIBLE_LIGHT,0.936537973745501
GOBP_NUCLEOBASE_CONTAINING_C...,SET,207,0.064194,0.006778,0.056279,0.12702,GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,0.936537973745501
HP_PARANOIA,SET,20,0.21177,0.0069859,0.18569,0.12706,HP_PARANOIA,0.936537973745501
GNF2_CDH3,SET,26,0.20146,0.0075762,0.17668,0.12711,GNF2_CDH3,0.936537973745501
HP_INCREASED_NUMBER_OF_SKIN_...,SET,6,0.35349,0.0063896,0.31003,0.12711,HP_INCREASED_NUMBER_OF_SKIN_FOLDS,0.936537973745501
GOBP_PURINE_CONTAINING_COMPO...3,SET,14,0.2794,0.0077129,0.24506,0.12712,GOBP_PURINE_CONTAINING_COMPOUND_SALVAGE,0.936537973745501
MIR4725_5P,SET,52,0.13372,0.0071065,0.11729,0.12714,MIR4725_5P,0.936537973745501
GOMF_FATZ_BINDING,SET,5,0.44016,0.0072631,0.3861,0.12715,GOMF_FATZ_BINDING,0.936537973745501
GOBP_VENTRICULAR_SEPTUM_MORP...,SET,40,0.17962,0.0083752,0.15759,0.12719,GOBP_VENTRICULAR_SEPTUM_MORPHOGENESIS,0.936537973745501
MIR3916,SET,202,0.067403,0.0070313,0.059148,0.12724,MIR3916,0.936537973745501
ZNF19_TARGET_GENES,SET,10,0.28185,0.0065763,0.24735,0.12726,ZNF19_TARGET_GENES,0.936537973745501
HP_EARLY_YOUNG_ADULT_ONSET,SET,57,0.12659,0.0070426,0.11109,0.12726,HP_EARLY_YOUNG_ADULT_ONSET,0.936537973745501
HP_WIDE_PUBIC_SYMPHYSIS,SET,7,0.4209,0.0082174,0.3694,0.12727,HP_WIDE_PUBIC_SYMPHYSIS,0.936537973745501
WEST_ADRENOCORTICAL_TUMOR_UP,SET,280,0.057812,0.0070851,0.050749,0.12732,WEST_ADRENOCORTICAL_TUMOR_UP,0.936707578323455
HP_SOFT_DOUGHY_SKIN,SET,12,0.30335,0.0077533,0.26635,0.12737,HP_SOFT_DOUGHY_SKIN,0.936730697135636
MIR136_5P,SET,102,0.098459,0.0073187,0.086475,0.12745,MIR136_5P,0.936730697135636
GACAGGG_MIR339,SET,63,0.11943,0.0069842,0.10491,0.12748,GACAGGG_MIR339,0.936730697135636
BURTON_ADIPOGENESIS_1,SET,28,0.19564,0.0076349,0.17187,0.12749,BURTON_ADIPOGENESIS_1,0.936730697135636
GOBP_MEDIUM_CHAIN_FATTY_ACID...2,SET,5,0.38713,0.0063881,0.34009,0.1275,GOBP_MEDIUM_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.936730697135636
HP_ABNORMAL_TEMPER_TANTRUMS,SET,29,0.17641,0.007006,0.15501,0.12756,HP_ABNORMAL_TEMPER_TANTRUMS,0.936730697135636
GOBP_POSITIVE_REGULATION_OF_...131,SET,4,0.54543,0.0080503,0.47929,0.12757,GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,0.936730697135636
MIR936,SET,127,0.085932,0.0071226,0.07552,0.12759,MIR936,0.936730697135636
CHAMP1_TARGET_GENES,SET,145,0.080457,0.0071222,0.070725,0.12765,CHAMP1_TARGET_GENES,0.936730697135636
GOMF_L_HISTIDINE_TRANSMEMBRA...,SET,3,0.6017,0.0076912,0.52896,0.12767,GOMF_L_HISTIDINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.936730697135636
MIR6894_3P,SET,62,0.12329,0.007153,0.1084,0.1277,MIR6894_3P,0.936730697135636
GOMF_GLUTATHIONE_DISULFIDE_O...,SET,5,0.49181,0.0081155,0.43241,0.1277,GOMF_GLUTATHIONE_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,0.936730697135636
GOBP_EPITHELIAL_CELL_CELL_AD...,SET,16,0.25484,0.0075202,0.22408,0.12772,GOBP_EPITHELIAL_CELL_CELL_ADHESION,0.936730697135636
KEGG_MEDICUS_REFERENCE_CA2_E...1,SET,12,0.29499,0.0075395,0.2594,0.12773,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL,0.936730697135636
GOBP_MACROPHAGE_APOPTOTIC_PR...,SET,12,0.25172,0.0064335,0.22135,0.12773,GOBP_MACROPHAGE_APOPTOTIC_PROCESS,0.936730697135636
REACTOME_SODIUM_COUPLED_PHOS...,SET,5,0.48489,0.0080012,0.42647,0.12778,REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS,0.936730697135636
GOBP_RESPONSE_TO_CAFFEINE,SET,14,0.25311,0.006987,0.22264,0.12781,GOBP_RESPONSE_TO_CAFFEINE,0.936730697135636
HP_ABNORMAL_MUSCLE_FIBER_MER...,SET,4,0.47385,0.0069937,0.41685,0.12784,HP_ABNORMAL_MUSCLE_FIBER_MEROSIN_EXPRESSION,0.936730697135636
MIR141_5P,SET,91,0.10273,0.0072145,0.090399,0.12791,MIR141_5P,0.936730697135636
HE_LIM_SUN_FETAL_LUNG_C7_MFN...,SET,17,0.24418,0.007427,0.21487,0.12791,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,0.936730697135636
GSE15330_GRANULOCYTE_MONOCYT...1,SET,184,0.070289,0.0070016,0.061862,0.12794,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_DN,0.936730697135636
GOBP_ADAPTIVE_IMMUNE_RESPONSE,SET,425,0.051732,0.0077795,0.045536,0.12797,GOBP_ADAPTIVE_IMMUNE_RESPONSE,0.936730697135636
GOBP_REGULATION_OF_CELL_CELL...3,SET,11,0.27934,0.0068357,0.24588,0.12797,GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.936730697135636
HP_COMPLETE_DUPLICATION_OF_P...,SET,11,0.27652,0.0067668,0.2434,0.12797,HP_COMPLETE_DUPLICATION_OF_PHALANX_OF_HAND,0.936730697135636
GOBP_POSITIVE_REGULATION_OF_...353,SET,18,0.23172,0.0072523,0.20405,0.12807,GOBP_POSITIVE_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,0.937092911153119
HP_APLASIA_HYPOPLASIA_OF_THE...69,SET,6,0.40007,0.0072315,0.35243,0.12816,HP_APLASIA_HYPOPLASIA_OF_THE_SWEAT_GLANDS,0.937092911153119
MORF_RAD21,SET,158,0.068914,0.0063657,0.060716,0.12819,MORF_RAD21,0.937092911153119
GOBP_OLEFINIC_COMPOUND_BIOSY...,SET,26,0.20014,0.0075265,0.17633,0.12819,GOBP_OLEFINIC_COMPOUND_BIOSYNTHETIC_PROCESS,0.937092911153119
MIR492,SET,23,0.20016,0.0070802,0.17636,0.12821,MIR492,0.937092911153119
GOCC_BASAL_CORTEX,SET,5,0.43612,0.0071965,0.38432,0.12824,GOCC_BASAL_CORTEX,0.937092911153119
HP_HYPOPLASTIC_LABIA_MAJORA,SET,34,0.15915,0.0068428,0.14025,0.12825,HP_HYPOPLASTIC_LABIA_MAJORA,0.937092911153119
GOBP_PORPHYRIN_CONTAINING_CO...,SET,48,0.13415,0.0068507,0.11823,0.12826,GOBP_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.937092911153119
GSE14308_TH17_VS_INDUCED_TRE...1,SET,186,0.066869,0.0066967,0.058937,0.12828,GSE14308_TH17_VS_INDUCED_TREG_DN,0.937092911153119
GOBP_MYELOID_CELL_DEVELOPMENT,SET,80,0.11276,0.0074276,0.099401,0.12832,GOBP_MYELOID_CELL_DEVELOPMENT,0.937092911153119
GOBP_CATECHOL_CONTAINING_COM...1,SET,20,0.23705,0.0078199,0.20897,0.12833,GOBP_CATECHOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.937092911153119
GSE1925_CTRL_VS_3H_IFNG_STIM...3,SET,177,0.07793,0.0076151,0.068705,0.12835,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN,0.937092911153119
GSE4590_PRE_BCELL_VS_VPREB_P...1,SET,147,0.07515,0.0066978,0.066259,0.12837,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.937092911153119
GOBP_NEGATIVE_REGULATION_OF_...424,SET,76,0.12076,0.0077539,0.10652,0.12847,GOBP_NEGATIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.937219869174162
MANNO_MIDBRAIN_NEUROTYPES_HP...2,SET,263,0.060333,0.0071695,0.053242,0.12858,MANNO_MIDBRAIN_NEUROTYPES_HPROGBP,0.937219869174162
BOYAULT_LIVER_CANCER_SUBCLAS...4,SET,38,0.152,0.0069081,0.13418,0.12866,BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP,0.937219869174162
GOBP_PRIMITIVE_HEMOPOIESIS,SET,8,0.37345,0.0077942,0.32972,0.12869,GOBP_PRIMITIVE_HEMOPOIESIS,0.937219869174162
GOBP_REGULATION_OF_GLUCONEOG...,SET,43,0.14496,0.0070075,0.12799,0.1287,GOBP_REGULATION_OF_GLUCONEOGENESIS,0.937219869174162
HP_PES_VALGUS,SET,48,0.14553,0.0074317,0.1285,0.12871,HP_PES_VALGUS,0.937219869174162
GSE3720_LPS_VS_PMA_STIM_VD2_...2,SET,118,0.088847,0.0071002,0.078449,0.12871,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,0.937219869174162
GOBP_PROTEIN_DEPHOSPHORYLATI...,SET,187,0.068342,0.0068624,0.060346,0.12872,GOBP_PROTEIN_DEPHOSPHORYLATION,0.937219869174162
GOMF_THIOREDOXIN_DISULFIDE_R...,SET,6,0.39479,0.007136,0.34867,0.12876,GOMF_THIOREDOXIN_DISULFIDE_REDUCTASE_NADPH_ACTIVITY,0.937219869174162
JNK_DN.V1_UP,SET,161,0.07886,0.0073527,0.069658,0.1288,JNK_DN.V1_UP,0.937219869174162
HOLLEMAN_ASPARAGINASE_RESIST...2,SET,21,0.2062,0.0069702,0.18215,0.12881,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,0.937219869174162
GOMF_ISOPRENOID_BINDING,SET,42,0.17618,0.0084174,0.15564,0.12883,GOMF_ISOPRENOID_BINDING,0.937219869174162
HP_FATIGUE,SET,445,0.048511,0.0074607,0.042862,0.12887,HP_FATIGUE,0.937219869174162
REACTOME_BACTERIAL_INFECTION...,SET,67,0.11736,0.0070773,0.10371,0.1289,REACTOME_BACTERIAL_INFECTION_PATHWAYS,0.937219869174162
GOBP_POSITIVE_REGULATION_OF_...734,SET,41,0.16214,0.0076537,0.14328,0.1289,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.937219869174162
GOBP_CELL_FATE_SPECIFICATION,SET,101,0.10248,0.0075802,0.090569,0.12893,GOBP_CELL_FATE_SPECIFICATION,0.937219869174162
GOBP_LUTEOLYSIS,SET,6,0.46512,0.0084074,0.4112,0.12901,GOBP_LUTEOLYSIS,0.937219869174162
GSE5589_LPS_VS_LPS_AND_IL10_...4,SET,177,0.072539,0.0070883,0.064147,0.12907,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP,0.937219869174162
REACTOME_REGULATION_OF_CDH11...3,SET,9,0.34131,0.0075553,0.30184,0.12908,REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS,0.937219869174162
HP_ABNORMAL_CELLULAR_PHENOTY...,SET,573,0.039322,0.0068378,0.03478,0.12912,HP_ABNORMAL_CELLULAR_PHENOTYPE,0.937219869174162
GNF2_BUB3,SET,26,0.16434,0.0061802,0.14536,0.12914,GNF2_BUB3,0.937219869174162
GOBP_LAMELLIPODIUM_ORGANIZAT...,SET,79,0.10974,0.0071836,0.097081,0.12916,GOBP_LAMELLIPODIUM_ORGANIZATION,0.937219869174162
GSE34156_UNTREATED_VS_6H_NOD...4,SET,159,0.076226,0.0070631,0.067433,0.12917,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP,0.937219869174162
GSE43957_UNTREATED_VS_NACL_T...1,SET,181,0.070621,0.0069776,0.062484,0.1292,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,0.937219869174162
HP_ABSENT_SPEECH,SET,364,0.049809,0.0069438,0.04408,0.12925,HP_ABSENT_SPEECH,0.937219869174162
GOBP_REGULATION_OF_FEEDING_B...,SET,25,0.21821,0.008047,0.19315,0.1293,GOBP_REGULATION_OF_FEEDING_BEHAVIOR,0.937219869174162
MORF_REV3L,SET,55,0.12191,0.0066626,0.10795,0.1294,MORF_REV3L,0.937219869174162
GOMF_PROSTANOID_RECEPTOR_ACT...,SET,11,0.33048,0.0080872,0.29266,0.12941,GOMF_PROSTANOID_RECEPTOR_ACTIVITY,0.937219869174162
GSE4142_PLASMA_CELL_VS_GC_BC...1,SET,177,0.071609,0.0069974,0.063419,0.12943,GSE4142_PLASMA_CELL_VS_GC_BCELL_DN,0.937219869174162
GSE8835_HEALTHY_VS_CLL_CD4_T...2,SET,176,0.073633,0.0071751,0.065216,0.12944,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP,0.937219869174162
GOBP_RESPONSE_TO_REDOX_STATE,SET,12,0.28371,0.0072512,0.25132,0.12948,GOBP_RESPONSE_TO_REDOX_STATE,0.937219869174162
REACTOME_CARNITINE_METABOLISM,SET,13,0.26127,0.0069501,0.23158,0.12962,REACTOME_CARNITINE_METABOLISM,0.937219869174162
MIR1284,SET,214,0.068354,0.0073369,0.060604,0.12969,MIR1284,0.937219869174162
MOSERLE_IFNA_RESPONSE,SET,30,0.20884,0.0084354,0.1852,0.12975,MOSERLE_IFNA_RESPONSE,0.937219869174162
MIR7156_5P,SET,126,0.088956,0.0073444,0.078889,0.12975,MIR7156_5P,0.937219869174162
GOBP_T_CELL_TOLERANCE_INDUCT...,SET,14,0.28449,0.0078534,0.25231,0.12976,GOBP_T_CELL_TOLERANCE_INDUCTION,0.937219869174162
JIANG_MELANOMA_TRM9_CD8,SET,459,0.045506,0.007105,0.04036,0.12977,JIANG_MELANOMA_TRM9_CD8,0.937219869174162
HP_INTERVERTEBRAL_SPACE_NARR...,SET,6,0.39611,0.0071599,0.35136,0.12981,HP_INTERVERTEBRAL_SPACE_NARROWING,0.937219869174162
GSE17721_POLYIC_VS_GARDIQUIM...6,SET,186,0.070182,0.0070284,0.062257,0.12982,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP,0.937219869174162
GSE40274_CTRL_VS_FOXP3_AND_E...1,SET,148,0.076734,0.006862,0.068079,0.12985,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.937219869174162
ZHENG_FOXP3_TARGETS_DN,SET,6,0.39468,0.007134,0.35024,0.1299,ZHENG_FOXP3_TARGETS_DN,0.937219869174162
HP_RECURRENT_INFECTION_OF_TH...,SET,35,0.16598,0.0072402,0.14729,0.12991,HP_RECURRENT_INFECTION_OF_THE_GASTROINTESTINAL_TRACT,0.937219869174162
HP_ABNORMALITY_OF_SOMATOSENS...,SET,14,0.25764,0.0071122,0.22865,0.12992,HP_ABNORMALITY_OF_SOMATOSENSORY_EVOKED_POTENTIALS,0.937219869174162
GOBP_FOCAL_ADHESION_ASSEMBLY,SET,82,0.10657,0.0071068,0.094597,0.12996,GOBP_FOCAL_ADHESION_ASSEMBLY,0.937219869174162
GNF2_TNFRSF1B,SET,58,0.12948,0.0072666,0.11494,0.12997,GNF2_TNFRSF1B,0.937219869174162
AGUIRRE_PANCREATIC_CANCER_CO...2,SET,271,0.062363,0.0075209,0.055363,0.13,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,0.937219869174162
HP_SUPRAVENTRICULAR_TACHYCAR...,SET,51,0.14932,0.0078593,0.13258,0.13004,HP_SUPRAVENTRICULAR_TACHYCARDIA,0.937219869174162
HP_ABNORMAL_RENAL_CORPUSCLE_...,SET,164,0.076284,0.0071779,0.067744,0.13008,HP_ABNORMAL_RENAL_CORPUSCLE_MORPHOLOGY,0.937219869174162
GOBP_WATER_SOLUBLE_VITAMIN_B...,SET,11,0.29241,0.0071557,0.2597,0.13009,GOBP_WATER_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS,0.937219869174162
WP_INTRACELLULAR_TRAFFICKING...,SET,27,0.18983,0.0072748,0.16859,0.1301,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,0.937219869174162
GOBP_REGULATION_OF_EPITHELIA...4,SET,212,0.069739,0.0074509,0.061954,0.13017,GOBP_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,0.937219869174162
GNF2_HCK,SET,86,0.10874,0.007425,0.096617,0.1302,GNF2_HCK,0.937219869174162
GSE31082_DP_VS_CD4_SP_THYMOC...2,SET,171,0.070808,0.006802,0.062918,0.13022,GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP,0.937219869174162
MORF_PCNA,SET,71,0.10352,0.0064252,0.091994,0.13024,MORF_PCNA,0.937219869174162
OZANNE_AP1_TARGETS_UP,SET,14,0.24383,0.006731,0.21669,0.13025,OZANNE_AP1_TARGETS_UP,0.937219869174162
GSE44649_NAIVE_VS_ACTIVATED_...1,SET,176,0.070476,0.0068674,0.062636,0.13026,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,0.937219869174162
GSE7568_IL4_VS_IL4_AND_DEXAM...2,SET,149,0.073998,0.0066394,0.065767,0.13027,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP,0.937219869174162
CAR_WBSCR22,SET,32,0.15676,0.0065389,0.13936,0.13033,CAR_WBSCR22,0.937219869174162
GOBP_NEUTROPHIL_DIFFERENTIAT...,SET,11,0.29835,0.007301,0.26525,0.13035,GOBP_NEUTROPHIL_DIFFERENTIATION,0.937219869174162
GOBP_PRODUCTION_OF_MOLECULAR...1,SET,84,0.10366,0.0069957,0.092157,0.13035,GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.937219869174162
MIR4434,SET,148,0.079607,0.0071189,0.070785,0.13038,MIR4434,0.937219869174162
GOBP_REGULATION_OF_MULTICELL...1,SET,1270,0.028944,0.0073447,0.025738,0.1304,GOBP_REGULATION_OF_MULTICELLULAR_ORGANISMAL_DEVELOPMENT,0.937219869174162
HP_EMBRYONAL_RENAL_NEOPLASM,SET,41,0.17061,0.008054,0.15172,0.1304,HP_EMBRYONAL_RENAL_NEOPLASM,0.937219869174162
HP_BRADYCARDIA,SET,90,0.10422,0.0072797,0.092699,0.13045,HP_BRADYCARDIA,0.937219869174162
MATTHEWS_SKIN_CARCINOGENESIS...,SET,17,0.24013,0.0073038,0.21359,0.13046,MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN,0.937219869174162
GOBP_LEUKOCYTE_ACTIVATION_IN...,SET,48,0.14878,0.007598,0.13234,0.13046,GOBP_LEUKOCYTE_ACTIVATION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.937219869174162
GOBP_NEGATIVE_REGULATION_OF_...335,SET,5,0.42258,0.006973,0.37591,0.13048,GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.937219869174162
GOBP_NEGATIVE_REGULATION_OF_...498,SET,11,0.31337,0.0076685,0.27876,0.13048,GOBP_NEGATIVE_REGULATION_OF_PLATELET_AGGREGATION,0.937219869174162
GSE25146_UNSTIM_VS_HELIOBACT...1,SET,148,0.076818,0.0068695,0.068339,0.1305,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN,0.937219869174162
CAIRO_LIVER_DEVELOPMENT_DN,SET,203,0.069088,0.0072247,0.061467,0.13052,CAIRO_LIVER_DEVELOPMENT_DN,0.937219869174162
HP_ARTHRALGIA,SET,178,0.075445,0.0073928,0.067127,0.13053,HP_ARTHRALGIA,0.937219869174162
FREAC3_01,SET,232,0.067259,0.0075131,0.059848,0.13055,FREAC3_01,0.937219869174162
GSE21927_SPLENIC_VS_TUMOR_MO...2,SET,163,0.074787,0.0070157,0.066561,0.1306,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_UP,0.937219869174162
HP_ABNORMAL_SELLA_TURCICA_MO...,SET,37,0.1485,0.0066601,0.1322,0.13065,HP_ABNORMAL_SELLA_TURCICA_MORPHOLOGY,0.937219869174162
MIR624_5P,SET,97,0.098411,0.0071345,0.087616,0.13068,MIR624_5P,0.937219869174162
GOBP_ANTIGEN_PROCESSING_AND_...10,SET,64,0.13589,0.0080095,0.12098,0.13069,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN,0.937219869174162
KEGG_MEDICUS_PATHOGEN_HIV_GP...4,SET,13,0.25618,0.0068148,0.2281,0.13071,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_TNF_NFKB_SIGNALING_PATHWAY,0.937219869174162
DESCARTES_FETAL_EYE_PDE11A_F...,SET,16,0.27581,0.0081389,0.24562,0.13075,DESCARTES_FETAL_EYE_PDE11A_FAM19A2_POSITIVE_CELLS,0.937219869174162
GSE3039_ALPHAALPHA_CD8_TCELL...3,SET,181,0.073483,0.0072604,0.065442,0.13076,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_DN,0.937219869174162
GOBP_REGULATION_OF_SYNAPTIC_...2,SET,193,0.070174,0.0071572,0.062508,0.1308,GOBP_REGULATION_OF_SYNAPTIC_PLASTICITY,0.937219869174162
WEIGEL_OXIDATIVE_STRESS_BY_T...,SET,35,0.15664,0.0068331,0.13956,0.13084,WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2,0.937219869174162
GOCC_NUCLEAR_UBIQUITIN_LIGAS...,SET,42,0.13717,0.0065537,0.12221,0.13084,GOCC_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX,0.937219869174162
GSE6259_33D1_POS_DC_VS_CD8_T...1,SET,112,0.091423,0.0071191,0.081456,0.13086,GSE6259_33D1_POS_DC_VS_CD8_TCELL_DN,0.937219869174162
HP_ABNORMAL_SPERMATOGENESIS,SET,134,0.080574,0.0068587,0.071795,0.13088,HP_ABNORMAL_SPERMATOGENESIS,0.937219869174162
GOBP_ALDITOL_METABOLIC_PROCE...,SET,21,0.21661,0.0073221,0.19305,0.13092,GOBP_ALDITOL_METABOLIC_PROCESS,0.937219869174162
GSE11961_MEMORY_BCELL_DAY7_V...5,SET,181,0.067904,0.0067092,0.060522,0.13095,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,0.937219869174162
MIR4261,SET,387,0.05042,0.007243,0.044957,0.13104,MIR4261,0.937219869174162
GSE34156_NOD2_LIGAND_VS_NOD2...2,SET,155,0.079324,0.007258,0.070734,0.13106,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,0.937219869174162
GOBP_NATURAL_KILLER_CELL_PRO...,SET,14,0.29145,0.0080455,0.25991,0.13108,GOBP_NATURAL_KILLER_CELL_PROLIFERATION,0.937219869174162
GOBP_REGULATION_OF_AUTOPHAGY...1,SET,39,0.15295,0.007042,0.13641,0.13111,GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.937219869174162
chr3q24,SET,15,0.38132,0.010895,0.3402,0.13118,chr3q24,0.937219869174162
RFX7_TARGET_GENES,SET,402,0.047003,0.0068789,0.041935,0.13118,RFX7_TARGET_GENES,0.937219869174162
HP_ABSENT_HAIR,SET,55,0.13702,0.0074888,0.12225,0.13118,HP_ABSENT_HAIR,0.937219869174162
GOBP_REGULATION_OF_THYROID_H...,SET,7,0.38213,0.0074605,0.34095,0.1312,GOBP_REGULATION_OF_THYROID_HORMONE_GENERATION,0.937219869174162
HP_CEREBRAL_CORTICAL_ATROPHY,SET,276,0.056715,0.0069016,0.050605,0.13121,HP_CEREBRAL_CORTICAL_ATROPHY,0.937219869174162
GOBP_ROUNDABOUT_SIGNALING_PA...,SET,5,0.47567,0.0078491,0.42444,0.13122,GOBP_ROUNDABOUT_SIGNALING_PATHWAY,0.937219869174162
HP_BAND_KERATOPATHY,SET,14,0.29705,0.0082,0.26507,0.13123,HP_BAND_KERATOPATHY,0.937219869174162
chr5q21,SET,14,0.38728,0.010691,0.34564,0.13126,chr5q21,0.937219869174162
WP_PRION_DISEASE_PATHWAY,SET,31,0.17531,0.0071978,0.15646,0.13126,WP_PRION_DISEASE_PATHWAY,0.937219869174162
GSE24972_MARGINAL_ZONE_BCELL...4,SET,171,0.074301,0.0071375,0.066313,0.13127,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP,0.937219869174162
CAFFAREL_RESPONSE_TO_THC_24H...4,SET,29,0.15444,0.0061335,0.13786,0.1313,CAFFAREL_RESPONSE_TO_THC_24HR_5_UP,0.937219869174162
BEGUM_TARGETS_OF_PAX3_FOXO1_...3,SET,54,0.14334,0.0077629,0.12796,0.13131,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,0.937219869174162
GGARNTKYCCA_UNKNOWN,SET,70,0.12248,0.0075486,0.10934,0.13132,GGARNTKYCCA_UNKNOWN,0.937219869174162
WANG_METASTASIS_OF_BREAST_CA...1,SET,13,0.25271,0.0067225,0.22561,0.13134,WANG_METASTASIS_OF_BREAST_CANCER,0.937219869174162
REACTOME_EICOSANOID_LIGAND_B...,SET,14,0.26664,0.0073606,0.23811,0.1314,REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS,0.937219869174162
HP_OBSESSIVE_COMPULSIVE_TRAIT,SET,36,0.16154,0.0071465,0.14426,0.13141,HP_OBSESSIVE_COMPULSIVE_TRAIT,0.937219869174162
HP_ABNORMAL_RESPONSE_TO_SOCI...,SET,61,0.12832,0.0073848,0.11461,0.13143,HP_ABNORMAL_RESPONSE_TO_SOCIAL_NORMS,0.937219869174162
MODULE_101,SET,10,0.34332,0.0080107,0.30665,0.13145,MODULE_101,0.937219869174162
GOBP_RENAL_SYSTEM_VASCULATUR...1,SET,31,0.19496,0.0080047,0.17415,0.13148,GOBP_RENAL_SYSTEM_VASCULATURE_DEVELOPMENT,0.937219869174162
GOBP_PINOCYTOSIS,SET,20,0.20021,0.0066046,0.17886,0.1315,GOBP_PINOCYTOSIS,0.937219869174162
GOCC_EARLY_ENDOSOME_MEMBRANE,SET,175,0.070013,0.0068031,0.062549,0.13151,GOCC_EARLY_ENDOSOME_MEMBRANE,0.937219869174162
MIR7705,SET,45,0.14131,0.0069878,0.12627,0.13155,MIR7705,0.937219869174162
GOBP_POSITIVE_REGULATION_OF_...835,SET,11,0.29241,0.0071557,0.26129,0.13156,GOBP_POSITIVE_REGULATION_OF_VASCULOGENESIS,0.937219869174162
GSE46606_IRF4_KO_VS_WT_UNSTI...1,SET,181,0.076254,0.0075342,0.068159,0.13163,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_DN,0.937219869174162
RB_P130_DN.V1_DN,SET,119,0.085673,0.0068754,0.076598,0.13169,RB_P130_DN.V1_DN,0.937219869174162
KEGG_MEDICUS_REFERENCE_HORMO...,SET,17,0.26097,0.0079379,0.23335,0.13171,KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY,0.937219869174162
HP_CHRONIC_PAIN,SET,6,0.34313,0.0062022,0.30685,0.13175,HP_CHRONIC_PAIN,0.937219869174162
GSE24210_IL35_TREATED_VS_RES...2,SET,178,0.074574,0.0073075,0.066695,0.13176,GSE24210_IL35_TREATED_VS_RESTING_TREG_UP,0.937219869174162
MIR378G,SET,79,0.10728,0.0070225,0.095949,0.13177,MIR378G,0.937219869174162
KYNG_ENVIRONMENTAL_STRESS_RE...5,SET,28,0.17053,0.0066547,0.15254,0.1318,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS,0.937219869174162
REACTOME_METABOLISM_OF_VITAM...,SET,183,0.070477,0.0070014,0.063048,0.13183,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,0.937219869174162
GOMF_DINUCLEOTIDE_PHOSPHATAS...,SET,7,0.42491,0.0082956,0.38013,0.13184,GOMF_DINUCLEOTIDE_PHOSPHATASE_ACTIVITY,0.937219869174162
GNF2_ITGAL,SET,51,0.1393,0.0073322,0.12463,0.13185,GNF2_ITGAL,0.937219869174162
GSE2770_TGFB_AND_IL4_VS_IL4_...2,SET,183,0.069355,0.0068899,0.06205,0.13185,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.937219869174162
MIR6513_5P,SET,88,0.10276,0.0070974,0.091938,0.13186,MIR6513_5P,0.937219869174162
HP_ABNORMAL_FETAL_CARDIOVASC...,SET,46,0.13493,0.006746,0.12073,0.13186,HP_ABNORMAL_FETAL_CARDIOVASCULAR_MORPHOLOGY,0.937219869174162
HECKER_IFNB1_TARGETS,SET,88,0.11443,0.0079036,0.10239,0.13188,HECKER_IFNB1_TARGETS,0.937219869174162
BYSTRYKH_HEMATOPOIESIS_STEM_...3,SET,7,0.34672,0.0067691,0.31024,0.13189,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3,0.937219869174162
GOMF_AMP_ACTIVATED_PROTEIN_K...,SET,8,0.33097,0.0069077,0.29619,0.13191,GOMF_AMP_ACTIVATED_PROTEIN_KINASE_ACTIVITY,0.937219869174162
REACTOME_INHIBITION_OF_THE_P...,SET,20,0.19868,0.0065543,0.1778,0.13192,REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS,0.937219869174162
MODULE_333,SET,27,0.16241,0.0062241,0.14535,0.13192,MODULE_333,0.937219869174162
MIR4717_3P,SET,71,0.11555,0.0071719,0.10344,0.132,MIR4717_3P,0.937596566523605
GOBP_GLYCOSYL_COMPOUND_CATAB...,SET,31,0.19522,0.0080154,0.1748,0.13205,GOBP_GLYCOSYL_COMPOUND_CATABOLIC_PROCESS,0.93763948927477
MIR6732_3P,SET,87,0.097329,0.0066843,0.087155,0.13206,MIR6732_3P,0.93763948927477
MIR1231,SET,48,0.1428,0.0072926,0.12791,0.13212,MIR1231,0.937768047337278
HP_HEMORRHAGE_OF_THE_EYE,SET,45,0.14525,0.0071823,0.1301,0.13214,HP_HEMORRHAGE_OF_THE_EYE,0.937768047337278
REACTOME_ATTACHMENT_OF_GPI_A...,SET,7,0.30363,0.0059278,0.272,0.13216,REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR,0.937768047337278
KEGG_MEDICUS_VARIANT_MUTATIO...35,SET,8,0.33565,0.0070052,0.30077,0.13223,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006,0.937768047337278
GOBP_SUCCINATE_METABOLIC_PRO...,SET,7,0.40164,0.0078414,0.35991,0.13223,GOBP_SUCCINATE_METABOLIC_PROCESS,0.937768047337278
HP_TALIPES_CALCANEOVALGUS,SET,13,0.24936,0.0066332,0.22345,0.13224,HP_TALIPES_CALCANEOVALGUS,0.937768047337278
HE_LIM_SUN_FETAL_LUNG_C2_DC3...,SET,6,0.37908,0.006852,0.33976,0.13228,HE_LIM_SUN_FETAL_LUNG_C2_DC3_CELL,0.937804097024052
MODULE_107,SET,73,0.11832,0.0074461,0.10606,0.1323,MODULE_107,0.937804097024052
FIRESTEIN_CTNNB1_PATHWAY,SET,26,0.18861,0.0070931,0.1691,0.13235,FIRESTEIN_CTNNB1_PATHWAY,0.937804097024052
HP_ABNORMALITY_OF_THE_CURVAT...,SET,305,0.054242,0.0069332,0.048634,0.13237,HP_ABNORMALITY_OF_THE_CURVATURE_OF_THE_CORNEA,0.937804097024052
RAMJAUN_APOPTOSIS_BY_TGFB1_V...2,SET,6,0.41441,0.0074907,0.37159,0.13238,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP,0.937804097024052
DUNNE_TARGETS_OF_AML1_MTG8_F...2,SET,49,0.14321,0.007389,0.12844,0.13244,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,0.93799356846473
GARGALOVIC_RESPONSE_TO_OXIDI...19,SET,13,0.29994,0.0079788,0.2691,0.13251,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN,0.93799356846473
MOREAUX_B_LYMPHOCYTE_MATURAT...2,SET,72,0.1189,0.0074317,0.10672,0.13262,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,0.93799356846473
GSE40274_CTRL_VS_FOXP3_AND_G...1,SET,135,0.081074,0.0069268,0.072782,0.13266,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.93799356846473
HP_NEOPLASM_OF_THE_GALLBLADD...,SET,6,0.40179,0.0072627,0.36076,0.1327,HP_NEOPLASM_OF_THE_GALLBLADDER,0.93799356846473
GOBP_GLOMERULAR_ENDOTHELIUM_...,SET,4,0.57768,0.0085263,0.51871,0.13272,GOBP_GLOMERULAR_ENDOTHELIUM_DEVELOPMENT,0.93799356846473
GOBP_REGULATION_OF_MACROPHAG...3,SET,27,0.18079,0.0069284,0.16239,0.13278,GOBP_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.93799356846473
REACTOME_TRANSLESION_SYNTHES...3,SET,36,0.13829,0.006118,0.12425,0.13286,REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE,0.93799356846473
GOBP_NEGATIVE_REGULATION_OF_...311,SET,26,0.20044,0.0075379,0.1801,0.13288,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,0.93799356846473
GSE17974_0H_VS_4H_IN_VITRO_A...2,SET,168,0.074581,0.0071019,0.067017,0.13289,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP,0.93799356846473
HP_ABNORMAL_LDL_CHOLESTEROL_...,SET,41,0.15498,0.0073161,0.13933,0.13301,HP_ABNORMAL_LDL_CHOLESTEROL_CONCENTRATION,0.93799356846473
GOMF_RNA_POLYMERASE_II_CORE_...,SET,15,0.24874,0.0071071,0.22363,0.13302,GOMF_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,0.93799356846473
GSE18791_UNSTIM_VS_NEWCATSLE...5,SET,159,0.074692,0.006921,0.067157,0.13303,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN,0.93799356846473
GOBP_CARDIAC_PACEMAKER_CELL_...2,SET,11,0.31808,0.0077839,0.28602,0.13305,GOBP_CARDIAC_PACEMAKER_CELL_DIFFERENTIATION,0.93799356846473
GOBP_REGULATION_OF_LUTEINIZI...,SET,7,0.41124,0.0080287,0.36978,0.13305,GOBP_REGULATION_OF_LUTEINIZING_HORMONE_SECRETION,0.93799356846473
HP_AUTISTIC_BEHAVIOR,SET,499,0.043219,0.0070279,0.038868,0.13309,HP_AUTISTIC_BEHAVIOR,0.93799356846473
HP_ABNORMAL_CIRCULATING_OSTE...,SET,8,0.35409,0.00739,0.31845,0.1331,HP_ABNORMAL_CIRCULATING_OSTEOCALCIN_LEVEL,0.93799356846473
GOBP_ANAGEN,SET,5,0.48292,0.0079688,0.43438,0.13313,GOBP_ANAGEN,0.93799356846473
KATSANOU_ELAVL1_TARGETS_UP,SET,154,0.083362,0.007603,0.074992,0.13316,KATSANOU_ELAVL1_TARGETS_UP,0.93799356846473
GOMF_ORGANIC_HYDROXY_COMPOUN...,SET,52,0.1406,0.0074726,0.12649,0.13317,GOMF_ORGANIC_HYDROXY_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.93799356846473
GOBP_REGULATION_OF_UBIQUITIN...3,SET,35,0.15374,0.0067067,0.13833,0.13319,GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,0.93799356846473
GSE26290_WT_VS_PDK1_KO_ANTI_...2,SET,169,0.074248,0.007091,0.066812,0.13323,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,0.93799356846473
MIR4265,SET,36,0.17659,0.0078124,0.15892,0.13325,MIR4265,0.93799356846473
GOBP_POSITIVE_REGULATION_OF_...54,SET,5,0.4306,0.0071054,0.3876,0.1333,GOBP_POSITIVE_REGULATION_OF_BASEMENT_MEMBRANE_ASSEMBLY_INVOLVED_IN_EMBRYONIC_BODY_MORPHOGENESIS,0.93799356846473
HOEK_B_CELL_2011_2012_TIV_AD...4,SET,6,0.41962,0.0075849,0.37777,0.13334,HOEK_B_CELL_2011_2012_TIV_ADULT_7DY_DN,0.93799356846473
GOBP_REGULATION_OF_MITOCHOND...1,SET,6,0.36116,0.0065282,0.32524,0.13341,GOBP_REGULATION_OF_MITOCHONDRIAL_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT,0.93799356846473
GOBP_THIAMINE_TRANSPORT,SET,8,0.36358,0.0075883,0.32745,0.13343,GOBP_THIAMINE_TRANSPORT,0.93799356846473
GOBP_PROTEIN_CONTAINING_COMP...2,SET,231,0.059465,0.0066283,0.053564,0.13347,GOBP_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.93799356846473
GSE32034_LY6C_HIGH_VS_LOW_RO...1,SET,182,0.072077,0.007141,0.064927,0.13348,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_DN,0.93799356846473
GOBP_FORELIMB_MORPHOGENESIS,SET,38,0.16943,0.0077004,0.15266,0.13355,GOBP_FORELIMB_MORPHOGENESIS,0.93799356846473
GSE17721_POLYIC_VS_PAM3CSK4_...2,SET,180,0.071658,0.0070607,0.064575,0.13357,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_UP,0.93799356846473
HP_ABNORMAL_NUMBER_OF_GRANUL...,SET,9,0.32157,0.0071183,0.28986,0.13364,HP_ABNORMAL_NUMBER_OF_GRANULOCYTE_PRECURSORS,0.93799356846473
HP_STARING_GAZE,SET,20,0.19978,0.0065904,0.18011,0.13367,HP_STARING_GAZE,0.93799356846473
GOBP_REGULATION_OF_SKELETAL_...7,SET,4,0.50076,0.0073909,0.45161,0.13376,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION_BY_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION,0.93799356846473
TRAVAGLINI_LUNG_SIGNALING_AL...,SET,67,0.12463,0.0075156,0.1124,0.13377,TRAVAGLINI_LUNG_SIGNALING_ALVEOLAR_EPITHELIAL_TYPE_2_CELL,0.93799356846473
MIR6869_5P,SET,37,0.14944,0.0067024,0.1348,0.13381,MIR6869_5P,0.93799356846473
GSE30962_PRIMARY_VS_SECONDAR...4,SET,180,0.067487,0.0066497,0.060878,0.13382,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP,0.93799356846473
ZHONG_PFC_C9_ORG_OTHER,SET,71,0.1256,0.0077961,0.11333,0.13387,ZHONG_PFC_C9_ORG_OTHER,0.93799356846473
GOBP_TONGUE_DEVELOPMENT,SET,19,0.24777,0.007967,0.22357,0.13388,GOBP_TONGUE_DEVELOPMENT,0.93799356846473
WARTERS_IR_RESPONSE_5GY,SET,44,0.13136,0.0064232,0.11855,0.13393,WARTERS_IR_RESPONSE_5GY,0.93799356846473
GSE43955_TH0_VS_TGFB_IL6_TH1...10,SET,181,0.069126,0.0068299,0.062386,0.13393,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_UP,0.93799356846473
CTAGGAA_MIR384,SET,56,0.12447,0.0068638,0.11234,0.13395,CTAGGAA_MIR384,0.93799356846473
NR1D1_TARGET_GENES,SET,88,0.096644,0.0066751,0.087227,0.13395,NR1D1_TARGET_GENES,0.93799356846473
GOBP_REGULATION_OF_CHEMOKINE...,SET,9,0.31659,0.007008,0.28575,0.13396,GOBP_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY,0.93799356846473
GSE19825_NAIVE_VS_IL2RAHIGH_...1,SET,179,0.067018,0.0065853,0.060491,0.13396,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN,0.93799356846473
GOCC_TRAPPII_PROTEIN_COMPLEX,SET,9,0.29782,0.0065926,0.26888,0.13402,GOCC_TRAPPII_PROTEIN_COMPLEX,0.93799356846473
GOBP_PROTEIN_LOCALIZATION_TO...20,SET,59,0.11064,0.0062624,0.099897,0.13403,GOBP_PROTEIN_LOCALIZATION_TO_CYTOSKELETON,0.93799356846473
GOCC_SCAR_COMPLEX,SET,11,0.28255,0.0069143,0.25512,0.13404,GOCC_SCAR_COMPLEX,0.93799356846473
GSE17721_PAM3CSK4_VS_GADIQUI...10,SET,184,0.070442,0.0070168,0.063603,0.13404,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP,0.93799356846473
GOBP_REGULATION_OF_ISOTYPE_S...1,SET,30,0.16513,0.00667,0.14911,0.13405,GOBP_REGULATION_OF_ISOTYPE_SWITCHING,0.93799356846473
KEGG_MEDICUS_VARIANT_MUTATIO...31,SET,19,0.22495,0.0072331,0.20315,0.13409,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY,0.93799356846473
GOBP_NEGATIVE_REGULATION_OF_...700,SET,26,0.20361,0.0076569,0.18393,0.13417,GOBP_NEGATIVE_REGULATION_OF_VIRAL_LIFE_CYCLE,0.93799356846473
HP_PELVIC_KIDNEY,SET,30,0.17489,0.0070641,0.158,0.13417,HP_PELVIC_KIDNEY,0.93799356846473
OLF1_01,SET,242,0.061264,0.0069875,0.055356,0.13421,OLF1_01,0.93799356846473
HP_EMG_POSITIVE_SHARP_WAVES,SET,9,0.34545,0.0076469,0.31218,0.13425,HP_EMG_POSITIVE_SHARP_WAVES,0.93799356846473
CUI_DEVELOPING_HEART_TRABECU...1,SET,161,0.076897,0.0071697,0.069496,0.13426,CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE,0.93799356846473
GSE43955_1H_VS_20H_ACT_CD4_T...3,SET,187,0.073658,0.0073961,0.066583,0.13432,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.93799356846473
GOCC_NUCLEAR_STRESS_GRANULE,SET,6,0.33431,0.0060429,0.30224,0.13434,GOCC_NUCLEAR_STRESS_GRANULE,0.93799356846473
MIR3125,SET,220,0.063179,0.0068747,0.057125,0.13438,MIR3125,0.93799356846473
HP_THROMBOEMBOLIC_STROKE,SET,69,0.12003,0.0073447,0.10854,0.1344,HP_THROMBOEMBOLIC_STROKE,0.93799356846473
GSE43955_1H_VS_20H_ACT_CD4_T...4,SET,184,0.069879,0.0069607,0.063194,0.13442,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.93799356846473
GOBP_RESPONSE_TO_HYDROPEROXI...,SET,19,0.2265,0.0072829,0.20484,0.13443,GOBP_RESPONSE_TO_HYDROPEROXIDE,0.93799356846473
GOBP_POSITIVE_REGULATION_OF_...575,SET,6,0.33867,0.0061217,0.30631,0.13444,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION,0.93799356846473
GOMF_THREONINE_TYPE_PEPTIDAS...,SET,16,0.23998,0.0070815,0.21705,0.13445,GOMF_THREONINE_TYPE_PEPTIDASE_ACTIVITY,0.93799356846473
MIR6882_5P,SET,154,0.076659,0.0069917,0.069341,0.13447,MIR6882_5P,0.93799356846473
ROZANOV_MMP14_CORRELATED,SET,10,0.32405,0.007561,0.29314,0.13449,ROZANOV_MMP14_CORRELATED,0.93799356846473
GSE20727_CTRL_VS_DNFB_ALLERG...1,SET,165,0.07271,0.0068622,0.065779,0.13451,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_DN,0.93799356846473
JIANG_HYPOXIA_VIA_VHL,SET,17,0.22107,0.0067241,0.20003,0.13455,JIANG_HYPOXIA_VIA_VHL,0.93799356846473
HWANG_PROSTATE_CANCER_MARKERS,SET,25,0.18701,0.0068964,0.16925,0.13461,HWANG_PROSTATE_CANCER_MARKERS,0.93799356846473
BUSSLINGER_GASTRIC_IMMUNE_CE...,SET,1342,0.026692,0.0069481,0.02416,0.13463,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.93799356846473
MIR4270,SET,164,0.073471,0.0069131,0.066509,0.13466,MIR4270,0.93799356846473
HP_ECTOPIC_KIDNEY,SET,72,0.1139,0.0071189,0.10311,0.13466,HP_ECTOPIC_KIDNEY,0.93799356846473
REACTOME_ERYTHROCYTES_TAKE_U...1,SET,11,0.29599,0.0072433,0.26798,0.13469,REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN,0.93799356846473
HP_GENERALIZED_ONSET_SEIZURE,SET,277,0.056664,0.0069077,0.051305,0.1347,HP_GENERALIZED_ONSET_SEIZURE,0.93799356846473
GUTIERREZ_CHRONIC_LYMPHOCYTI...2,SET,11,0.30818,0.0075415,0.27905,0.13472,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,0.93799356846473
HOEGERKORP_CD44_TARGETS_DIRE...2,SET,24,0.19693,0.0071159,0.17836,0.13477,HOEGERKORP_CD44_TARGETS_DIRECT_UP,0.93799356846473
KYNG_DNA_DAMAGE_BY_4NQO,SET,33,0.15385,0.0065169,0.13934,0.13477,KYNG_DNA_DAMAGE_BY_4NQO,0.93799356846473
HP_ABNORMALITY_OF_VITAMIN_K_...,SET,13,0.28111,0.007478,0.25459,0.13477,HP_ABNORMALITY_OF_VITAMIN_K_METABOLISM,0.93799356846473
GOBP_NEGATIVE_REGULATION_OF_...234,SET,48,0.15054,0.0076875,0.13635,0.13479,GOBP_NEGATIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.93799356846473
FOXM1_01,SET,226,0.064783,0.0071436,0.058684,0.13482,FOXM1_01,0.93799356846473
GOBP_CALCINEURIN_MEDIATED_SI...,SET,47,0.13575,0.0068601,0.12299,0.13485,GOBP_CALCINEURIN_MEDIATED_SIGNALING,0.93799356846473
GOBP_MEIOTIC_CELL_CYCLE_CHEC...,SET,9,0.34268,0.0075857,0.31048,0.13486,GOBP_MEIOTIC_CELL_CYCLE_CHECKPOINT_SIGNALING,0.93799356846473
MIR219B_5P,SET,41,0.13988,0.0066033,0.12674,0.13487,MIR219B_5P,0.93799356846473
HP_CONGENITAL_MALFORMATION_O...1,SET,454,0.044545,0.0069179,0.040361,0.13488,HP_CONGENITAL_MALFORMATION_OF_THE_GREAT_ARTERIES,0.93799356846473
GSE17301_ACD3_ACD28_VS_ACD3_...3,SET,183,0.072796,0.0072317,0.065963,0.1349,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN,0.93799356846473
HP_MACULAR_ATROPHY,SET,39,0.15348,0.0070668,0.13909,0.13491,HP_MACULAR_ATROPHY,0.93799356846473
WP_IL3_SIGNALING,SET,46,0.14476,0.0072374,0.1312,0.13494,WP_IL3_SIGNALING,0.93799356846473
GOCC_INTRACELLULAR_CYCLIC_NU...,SET,5,0.42112,0.006949,0.38172,0.13497,GOCC_INTRACELLULAR_CYCLIC_NUCLEOTIDE_ACTIVATED_CATION_CHANNEL_COMPLEX,0.93799356846473
GSE17301_IFNA2_VS_IFNA2_AND_...1,SET,182,0.073683,0.0073,0.066788,0.13497,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN,0.93799356846473
GOBP_VACUOLE_FUSION,SET,12,0.26408,0.0067494,0.23945,0.13506,GOBP_VACUOLE_FUSION,0.93799356846473
GSE31082_DN_VS_CD8_SP_THYMOC...2,SET,176,0.06749,0.0065764,0.061208,0.1351,GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP,0.93799356846473
GOBP_MUSCLE_CELL_FATE_COMMIT...,SET,16,0.28166,0.0083117,0.25546,0.13511,GOBP_MUSCLE_CELL_FATE_COMMITMENT,0.93799356846473
GOBP_REGULATION_OF_MICROTUBU...5,SET,25,0.17914,0.0066064,0.16248,0.13511,GOBP_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION,0.93799356846473
MIR3196,SET,19,0.23148,0.0074431,0.20996,0.13513,MIR3196,0.93799356846473
MIR574_5P,SET,77,0.10519,0.0067979,0.095406,0.13513,MIR574_5P,0.93799356846473
GOBP_FEMALE_MEIOSIS_CHROMOSO...,SET,6,0.34561,0.0062471,0.31348,0.13513,GOBP_FEMALE_MEIOSIS_CHROMOSOME_SEGREGATION,0.93799356846473
GOBP_NEUROTRANSMITTER_RECEPT...4,SET,9,0.33696,0.007459,0.30569,0.13517,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_ENDOSOME_TO_POSTSYNAPTIC_MEMBRANE,0.93799356846473
REACTOME_PI_3K_CASCADE_FGFR1,SET,21,0.21383,0.007228,0.19399,0.13518,REACTOME_PI_3K_CASCADE_FGFR1,0.93799356846473
HIF1_Q3,SET,211,0.065995,0.0070344,0.059875,0.13519,HIF1_Q3,0.93799356846473
HP_CRYPTOPHTHALMOS,SET,5,0.50309,0.0083016,0.45647,0.13521,HP_CRYPTOPHTHALMOS,0.93799356846473
GOBP_CELLULAR_PIGMENTATION,SET,59,0.12509,0.0070802,0.1135,0.13522,GOBP_CELLULAR_PIGMENTATION,0.93799356846473
GOMF_3_5_RNA_HELICASE_ACTIVI...,SET,5,0.45288,0.007473,0.41098,0.13525,GOMF_3_5_RNA_HELICASE_ACTIVITY,0.93799356846473
ZNF488_TARGET_GENES,SET,25,0.18439,0.0067997,0.16738,0.13533,ZNF488_TARGET_GENES,0.93799356846473
ZHENG_IL22_SIGNALING_UP,SET,53,0.13818,0.007414,0.12545,0.13535,ZHENG_IL22_SIGNALING_UP,0.93799356846473
HOEK_PBMC_INACTIVATED_INFLUE...3,SET,10,0.3178,0.0074151,0.28856,0.13539,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_3DY_DN,0.93799356846473
GSE27859_DC_VS_CD11C_INT_F48...1,SET,143,0.073944,0.0065007,0.067167,0.13548,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,0.93799356846473
SHEPARD_CRASH_AND_BURN_MUTAN...1,SET,179,0.071368,0.0070128,0.064831,0.13549,SHEPARD_CRASH_AND_BURN_MUTANT_DN,0.93799356846473
MORF_RPA2,SET,174,0.066945,0.0064866,0.060815,0.1355,MORF_RPA2,0.93799356846473
GOBP_DEVELOPMENT_OF_SECONDAR...2,SET,9,0.3594,0.0079558,0.32649,0.1355,GOBP_DEVELOPMENT_OF_SECONDARY_SEXUAL_CHARACTERISTICS,0.93799356846473
HP_ERYTHEMATOUS_PLAQUE,SET,13,0.23392,0.0062227,0.2125,0.1355,HP_ERYTHEMATOUS_PLAQUE,0.93799356846473
XU_HGF_TARGETS_INDUCED_BY_AK...2,SET,13,0.28109,0.0074774,0.25538,0.13553,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP,0.93799356846473
GOBP_INTERLEUKIN_4_MEDIATED_...,SET,9,0.2988,0.0066143,0.27147,0.13553,GOBP_INTERLEUKIN_4_MEDIATED_SIGNALING_PATHWAY,0.93799356846473
MIR1237_3P,SET,120,0.089608,0.007221,0.081418,0.13555,MIR1237_3P,0.93799356846473
MODULE_350,SET,54,0.12205,0.0066097,0.11095,0.13566,MODULE_350,0.93799356846473
GOBP_RIBOFLAVIN_METABOLIC_PR...,SET,5,0.42677,0.0070422,0.38798,0.13568,GOBP_RIBOFLAVIN_METABOLIC_PROCESS,0.93799356846473
HP_IMPAIRED_ADP_INDUCED_PLAT...,SET,18,0.21984,0.0068804,0.19986,0.13568,HP_IMPAIRED_ADP_INDUCED_PLATELET_AGGREGATION,0.93799356846473
NFXL1_TARGET_GENES,SET,340,0.052384,0.0070626,0.047629,0.13571,NFXL1_TARGET_GENES,0.93799356846473
GOBP_REGULATION_OF_GLUCAGON_...,SET,8,0.31401,0.0065536,0.2856,0.13579,GOBP_REGULATION_OF_GLUCAGON_SECRETION,0.93799356846473
GAGCCAG_MIR149,SET,130,0.078036,0.0065435,0.070979,0.1358,GAGCCAG_MIR149,0.93799356846473
MIR10395_5P,SET,66,0.11845,0.0070896,0.10774,0.13581,MIR10395_5P,0.93799356846473
GOBP_POSITIVE_REGULATION_OF_...499,SET,66,0.1185,0.0070921,0.10781,0.13587,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,0.93799356846473
TTANWNANTGGM_UNKNOWN,SET,55,0.13382,0.0073139,0.12178,0.13592,TTANWNANTGGM_UNKNOWN,0.93799356846473
GOBP_ATRIAL_SEPTUM_MORPHOGEN...,SET,13,0.29416,0.007825,0.2677,0.13593,GOBP_ATRIAL_SEPTUM_MORPHOGENESIS,0.93799356846473
MODULE_395,SET,12,0.26222,0.006702,0.23866,0.13595,MODULE_395,0.93799356846473
HP_HEPATIC_CALCIFICATION,SET,5,0.44969,0.0074203,0.40928,0.13595,HP_HEPATIC_CALCIFICATION,0.93799356846473
GOBP_NEGATIVE_REGULATION_OF_...173,SET,6,0.38444,0.006949,0.34991,0.13596,GOBP_NEGATIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS,0.93799356846473
GOMF_ORGANIC_ACID_TRANSMEMBR...,SET,174,0.073341,0.0071062,0.066758,0.13598,GOMF_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.93799356846473
GOBP_DENDRITE_DEVELOPMENT,SET,218,0.065003,0.0070413,0.059172,0.13599,GOBP_DENDRITE_DEVELOPMENT,0.93799356846473
GOBP_PURINE_NUCLEOSIDE_METAB...,SET,24,0.22421,0.0081015,0.20411,0.13601,GOBP_PURINE_NUCLEOSIDE_METABOLIC_PROCESS,0.93799356846473
HP_INTRA_ORAL_HYPERPIGMENTAT...,SET,7,0.37489,0.0073192,0.34134,0.13604,HP_INTRA_ORAL_HYPERPIGMENTATION,0.93799356846473
REACTOME_ASSEMBLY_OF_THE_HIV...,SET,15,0.23803,0.0068011,0.21673,0.13605,REACTOME_ASSEMBLY_OF_THE_HIV_VIRION,0.93799356846473
GOBP_PROTEIN_FOLDING_IN_ENDO...,SET,10,0.27547,0.0064274,0.25085,0.13608,GOBP_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM,0.93799356846473
GSE37301_HEMATOPOIETIC_STEM_...6,SET,149,0.075874,0.0068078,0.069094,0.13608,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP,0.93799356846473
GSE21670_TGFB_VS_TGFB_AND_IL...4,SET,180,0.069283,0.0068267,0.063101,0.13612,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.93799356846473
REACTOME_INACTIVATION_OF_CSF...,SET,22,0.23477,0.0081223,0.2139,0.1362,REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,0.93799356846473
REACTOME_CYTOSOLIC_TRNA_AMIN...,SET,6,0.29964,0.0054162,0.27301,0.13621,REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,0.93799356846473
REACTOME_COMMON_PATHWAY_OF_F...,SET,21,0.23677,0.0080034,0.21573,0.13622,REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION,0.93799356846473
GOMF_GLUTATHIONE_TRANSMEMBRA...,SET,7,0.35164,0.0068651,0.32045,0.13626,GOMF_GLUTATHIONE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.93799356846473
HP_ABNORMAL_FACIAL_SHAPE,SET,937,0.031184,0.006863,0.028419,0.13626,HP_ABNORMAL_FACIAL_SHAPE,0.93799356846473
GUILLAUMOND_KLF10_TARGETS_UP,SET,48,0.13639,0.0069652,0.12431,0.13628,GUILLAUMOND_KLF10_TARGETS_UP,0.93799356846473
GOBP_REGULATION_OF_DNA_TOPOI...,SET,5,0.3938,0.0064982,0.35896,0.13631,GOBP_REGULATION_OF_DNA_TOPOISOMERASE_ATP_HYDROLYZING_ACTIVITY,0.93799356846473
GCM_DFFA,SET,116,0.080992,0.0064177,0.073831,0.13633,GCM_DFFA,0.93799356846473
GSE25677_R848_VS_MPL_AND_R84...2,SET,134,0.07991,0.0068022,0.072847,0.13634,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_UP,0.93799356846473
HP_ADULT_ONSET,SET,776,0.034149,0.0068709,0.031137,0.13639,HP_ADULT_ONSET,0.93799356846473
BERNARD_PPAPDC1B_TARGETS_UP,SET,34,0.16151,0.0069443,0.14728,0.1364,BERNARD_PPAPDC1B_TARGETS_UP,0.93799356846473
HP_BILATERAL_CRYPTORCHIDISM,SET,43,0.13256,0.0064078,0.12089,0.13644,HP_BILATERAL_CRYPTORCHIDISM,0.93799356846473
GSE16697_CD4_TCELL_VS_TFH_CD...2,SET,179,0.071727,0.007048,0.065426,0.13648,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_UP,0.93799356846473
DESCARTES_MAIN_FETAL_CHROMAF...,SET,15,0.2248,0.0064232,0.20507,0.1365,DESCARTES_MAIN_FETAL_CHROMAFFIN_CELLS,0.93799356846473
GOBP_PROTEIN_ACETYLATION,SET,49,0.12618,0.0065101,0.11513,0.13655,GOBP_PROTEIN_ACETYLATION,0.93799356846473
HP_OOCYTE_ARREST_AT_METAPHAS...,SET,5,0.42984,0.0070928,0.3922,0.13655,HP_OOCYTE_ARREST_AT_METAPHASE_I,0.93799356846473
chr1q32,SET,139,0.17022,0.014755,0.15532,0.13656,chr1q32,0.93799356846473
HE_LIM_SUN_FETAL_LUNG_C2_ADC...1,SET,151,0.080244,0.0072476,0.07322,0.13656,HE_LIM_SUN_FETAL_LUNG_C2_ADC_1_CELL,0.93799356846473
GOBP_POSITIVE_REGULATION_OF_...558,SET,8,0.38699,0.0080768,0.35313,0.13657,GOBP_POSITIVE_REGULATION_OF_ODONTOGENESIS,0.93799356846473
MIR21_5P,SET,133,0.082928,0.0070329,0.075677,0.13659,MIR21_5P,0.93799356846473
HP_LONG_EYELASHES,SET,115,0.083814,0.0066128,0.076486,0.13659,HP_LONG_EYELASHES,0.93799356846473
GAVISH_3CA_METAPROGRAM_MACRO...12,SET,48,0.14846,0.0075812,0.1355,0.13662,GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP,0.938014243382062
REACTOME_SYNTHESIS_OF_PIPS_A...5,SET,48,0.12701,0.0064861,0.11594,0.13666,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,0.938103555204424
REACTOME_INITIAL_TRIGGERING_...,SET,17,0.2691,0.0081851,0.24569,0.1367,REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT,0.93816546585077
GSE43863_DAY6_EFF_VS_DAY150_...4,SET,184,0.070024,0.0069752,0.063942,0.13674,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP,0.93816546585077
REACTOME_HIV_LIFE_CYCLE,SET,138,0.071049,0.0061369,0.06488,0.13675,REACTOME_HIV_LIFE_CYCLE,0.93816546585077
GOBP_P_BODY_ASSEMBLY,SET,21,0.19807,0.0066954,0.18091,0.1368,GOBP_P_BODY_ASSEMBLY,0.938323268206039
HP_LONG_THORAX,SET,6,0.3807,0.0068814,0.34784,0.13688,HP_LONG_THORAX,0.938501558492799
HP_PAROXYSMAL_DYSTONIA,SET,20,0.20586,0.0067911,0.18809,0.13688,HP_PAROXYSMAL_DYSTONIA,0.938501558492799
ONDER_CDH1_TARGETS_1_UP,SET,122,0.085709,0.0069638,0.078346,0.13699,ONDER_CDH1_TARGETS_1_UP,0.93907050295858
GSE36891_POLYIC_TLR3_VS_PAM_...2,SET,140,0.084813,0.0073782,0.077545,0.13704,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,0.939228002366397
KAMIKUBO_MYELOID_CEBPA_NETWO...,SET,27,0.19662,0.0075348,0.17979,0.13707,KAMIKUBO_MYELOID_CEBPA_NETWORK,0.939248393138801
GOBP_LEUKOCYTE_ADHESION_TO_A...,SET,5,0.46737,0.007712,0.42766,0.13724,GOBP_LEUKOCYTE_ADHESION_TO_ARTERIAL_ENDOTHELIAL_CELL,0.939897872759504
FONTAINE_FOLLICULAR_THYROID_...2,SET,70,0.10832,0.0066759,0.099121,0.13725,FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,0.939897872759504
GOBP_REGULATION_OF_FEMALE_GO...,SET,7,0.38868,0.0075883,0.35569,0.13726,GOBP_REGULATION_OF_FEMALE_GONAD_DEVELOPMENT,0.939897872759504
MIKKELSEN_MCV6_LCP_WITH_H3K4...,SET,146,0.079892,0.0070963,0.073121,0.13729,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,0.939897872759504
GOBP_REGULATION_OF_OXIDATIVE...1,SET,19,0.20313,0.0065315,0.18592,0.1373,GOBP_REGULATION_OF_OXIDATIVE_PHOSPHORYLATION,0.939897872759504
GOBP_UMP_CATABOLIC_PROCESS,SET,5,0.42542,0.0070199,0.38944,0.13734,GOBP_UMP_CATABOLIC_PROCESS,0.939938334317779
GSE41978_WT_VS_BIM_KO_KLRG1_...1,SET,178,0.070445,0.0069029,0.064494,0.13736,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.939938334317779
MIR335_3P,SET,786,0.035292,0.0071444,0.032324,0.13747,MIR335_3P,0.939991179941003
GOBP_ERROR_PRONE_TRANSLESION...,SET,12,0.22421,0.0057306,0.20538,0.13749,GOBP_ERROR_PRONE_TRANSLESION_SYNTHESIS,0.939991179941003
REACTOME_RHOT1_GTPASE_CYCLE,SET,5,0.36888,0.006087,0.33793,0.13751,REACTOME_RHOT1_GTPASE_CYCLE,0.939991179941003
REACTOME_RECOGNITION_OF_DNA_...,SET,28,0.16511,0.0064432,0.15126,0.13752,REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX,0.939991179941003
HAY_BONE_MARROW_CD34_POS_HSC,SET,96,0.10167,0.0073331,0.093144,0.13752,HAY_BONE_MARROW_CD34_POS_HSC,0.939991179941003
GSE17721_POLYIC_VS_GARDIQUIM...4,SET,181,0.067675,0.0066866,0.062001,0.13753,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_UP,0.939991179941003
chr19q13,SET,714,0.085491,0.016529,0.078357,0.13763,chr19q13,0.94048970703893
HP_UNICORONAL_SYNOSTOSIS,SET,7,0.41245,0.0080525,0.37813,0.13769,HP_UNICORONAL_SYNOSTOSIS,0.940598172169811
MIR548L,SET,334,0.052283,0.0069877,0.047934,0.1377,MIR548L,0.940598172169811
GOBP_MITOCHONDRIAL_MEMBRANE_...,SET,98,0.090212,0.0065736,0.082727,0.13776,GOBP_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,0.94082310866575
GOBP_CDP_DIACYLGLYCEROL_BIOS...,SET,11,0.3075,0.0075249,0.28212,0.13787,GOBP_CDP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.940914743967039
HP_NUCLEAR_CATARACT,SET,25,0.18731,0.0069077,0.17186,0.13788,HP_NUCLEAR_CATARACT,0.940914743967039
HP_TRICUSPID_STENOSIS,SET,6,0.4131,0.0074671,0.37902,0.13788,HP_TRICUSPID_STENOSIS,0.940914743967039
RICKMAN_TUMOR_DIFFERENTIATED...2,SET,111,0.087964,0.0068193,0.080729,0.13795,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,0.940914743967039
GSE22611_NOD2_TRANSDUCED_VS_...2,SET,166,0.074176,0.0070216,0.068078,0.13796,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP,0.940914743967039
MODULE_404,SET,25,0.20592,0.0075938,0.18901,0.13799,MODULE_404,0.940914743967039
GOBP_NEGATIVE_REGULATION_OF_...144,SET,3,0.61969,0.0079211,0.56882,0.13799,GOBP_NEGATIVE_REGULATION_OF_CHONDROCYTE_PROLIFERATION,0.940914743967039
GSE339_CD4POS_VS_CD4CD8DN_DC...1,SET,179,0.069677,0.0068466,0.063958,0.13799,GSE339_CD4POS_VS_CD4CD8DN_DC_DN,0.940914743967039
MODULE_432,SET,13,0.23724,0.0063109,0.21781,0.13804,MODULE_432,0.941071047469596
GOBP_LONG_TERM_SYNAPTIC_POTE...,SET,88,0.1017,0.0070245,0.093403,0.13812,GOBP_LONG_TERM_SYNAPTIC_POTENTIATION,0.941097154312537
GOBP_EPIGENETIC_PROGRAMMING_...2,SET,28,0.16831,0.0065684,0.15461,0.13816,GOBP_EPIGENETIC_PROGRAMMING_OF_GENE_EXPRESSION,0.941097154312537
GOBP_NEGATIVE_REGULATION_OF_...497,SET,17,0.25216,0.0076699,0.23163,0.13817,GOBP_NEGATIVE_REGULATION_OF_PLATELET_ACTIVATION,0.941097154312537
GOBP_MONOCYTE_EXTRAVASATION,SET,9,0.33918,0.0075081,0.31161,0.1382,GOBP_MONOCYTE_EXTRAVASATION,0.941097154312537
GOMF_C_ACYLTRANSFERASE_ACTIV...,SET,19,0.21038,0.0067646,0.1933,0.13822,GOMF_C_ACYLTRANSFERASE_ACTIVITY,0.941097154312537
MIR6870_3P,SET,42,0.13776,0.0065817,0.12658,0.13823,MIR6870_3P,0.941097154312537
GOMF_DICARBOXYLIC_ACID_TRANS...,SET,30,0.16647,0.0067238,0.15296,0.13824,GOMF_DICARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.941097154312537
HP_ABNORMAL_SUPERIOR_CEREBEL...,SET,12,0.24979,0.0063843,0.22956,0.13828,HP_ABNORMAL_SUPERIOR_CEREBELLAR_PEDUNCLE_MORPHOLOGY,0.941097154312537
MIR6746_5P,SET,5,0.44865,0.0074032,0.41236,0.1383,MIR6746_5P,0.941097154312537
MIR6506_3P,SET,5,0.35886,0.0059215,0.32989,0.13835,MIR6506_3P,0.941097154312537
GOBP_REGULATION_OF_PLATELET_...3,SET,5,0.43494,0.0071771,0.39989,0.13838,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_ALPHA_SIGNALING_PATHWAY,0.941097154312537
GOBP_POSITIVE_REGULATION_OF_...278,SET,5,0.44377,0.0073227,0.40802,0.13839,GOBP_POSITIVE_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.941097154312537
GSE12198_NK_VS_NK_ACT_EXPANS...2,SET,182,0.071858,0.0071192,0.066073,0.1384,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP,0.941097154312537
PID_AVB3_OPN_PATHWAY,SET,31,0.18086,0.0074258,0.16632,0.13843,PID_AVB3_OPN_PATHWAY,0.941097154312537
GAJATE_RESPONSE_TO_TRABECTED...2,SET,59,0.12768,0.0072266,0.11742,0.13845,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,0.941097154312537
GOBP_POSITIVE_REGULATION_OF_...732,SET,7,0.29644,0.0057874,0.27275,0.13856,GOBP_POSITIVE_REGULATION_OF_STRESS_GRANULE_ASSEMBLY,0.941660696128275
HP_FRAGILE_SKIN,SET,34,0.16707,0.0071832,0.15375,0.1386,HP_FRAGILE_SKIN,0.941748387096774
GOBP_HEMATOPOIETIC_STEM_CELL...1,SET,36,0.15524,0.0068677,0.14288,0.13863,GOBP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,0.941768109851446
GOBP_ORGAN_OR_TISSUE_SPECIFI...,SET,26,0.20646,0.0077643,0.19005,0.13867,GOBP_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE,0.941855745554036
GNF2_DENR,SET,46,0.12427,0.006213,0.11444,0.13876,GNF2_DENR,0.942098808361008
KAECH_NAIVE_VS_MEMORY_CD8_TC...1,SET,184,0.070742,0.0070467,0.065142,0.13876,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.942098808361008
HP_BLEPHARITIS,SET,42,0.13114,0.0062652,0.12079,0.13883,HP_BLEPHARITIS,0.942109476869022
GOBP_NEGATIVE_REGULATION_OF_...74,SET,125,0.088179,0.0072514,0.081229,0.13884,GOBP_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,0.942109476869022
QI_PLASMACYTOMA_UP,SET,245,0.061876,0.0071002,0.057002,0.13886,QI_PLASMACYTOMA_UP,0.942109476869022
GSE2770_UNTREATED_VS_TGFB_AN...5,SET,178,0.067712,0.0066351,0.062381,0.13887,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.942109476869022
GSE27896_HDAC6_KO_VS_WT_TREG...1,SET,150,0.074356,0.0066938,0.06852,0.13893,GSE27896_HDAC6_KO_VS_WT_TREG_DN,0.942198499317872
HOEK_PBMC_INACTIVATED_INFLUE...4,SET,6,0.36551,0.0066069,0.33687,0.13896,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_3DY_UP,0.942198499317872
MODULE_500,SET,28,0.17209,0.0067158,0.15861,0.13897,MODULE_500,0.942198499317872
MIR1179,SET,108,0.088756,0.0067876,0.081822,0.13902,MIR1179,0.942198499317872
MIR3180_MIR3180_3P,SET,20,0.21958,0.0072437,0.20245,0.13905,MIR3180_MIR3180_3P,0.942198499317872
GOBP_REGULATION_OF_LYMPHOCYT...5,SET,170,0.07721,0.0073955,0.071197,0.13909,GOBP_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,0.942198499317872
HP_INFECTION_FOLLOWING_LIVE_...,SET,20,0.21557,0.0071113,0.19879,0.1391,HP_INFECTION_FOLLOWING_LIVE_VACCINATION,0.942198499317872
HP_OSTEOCHONDRITIS_DISSECANS,SET,7,0.37054,0.0072342,0.3417,0.1391,HP_OSTEOCHONDRITIS_DISSECANS,0.942198499317872
GOBP_REGULATION_OF_PROTEIN_L...1,SET,10,0.26986,0.0062967,0.24895,0.13918,GOBP_REGULATION_OF_PROTEIN_LIPIDATION,0.942373056691993
GOBP_RESPONSE_TO_NEMATODE,SET,7,0.37961,0.0074113,0.35019,0.13918,GOBP_RESPONSE_TO_NEMATODE,0.942373056691993
MIR3166,SET,103,0.095803,0.0071559,0.08839,0.13922,MIR3166,0.942460284378652
GOBP_POSITIVE_REGULATION_OF_...643,SET,4,0.5211,0.0076912,0.48093,0.13929,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MONOUBIQUITINATION,0.942538283378747
HP_BLOCK_VERTEBRAE,SET,5,0.44534,0.0073487,0.411,0.13929,HP_BLOCK_VERTEBRAE,0.942538283378747
HP_PREMATURELY_AGED_APPEARAN...,SET,156,0.072064,0.0066148,0.066518,0.13933,HP_PREMATURELY_AGED_APPEARANCE,0.942538283378747
ZHAN_MULTIPLE_MYELOMA_LB_DN,SET,35,0.15676,0.0068384,0.14471,0.13934,ZHAN_MULTIPLE_MYELOMA_LB_DN,0.942538283378747
SUMO1_TARGET_GENES,SET,803,0.033418,0.0068347,0.030855,0.13939,SUMO1_TARGET_GENES,0.942577237354086
GSE6259_FLT3L_INDUCED_DEC205...4,SET,147,0.070823,0.0063121,0.065392,0.1394,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP,0.942577237354086
MODULE_485,SET,49,0.12692,0.0065485,0.11724,0.1395,MODULE_485,0.942886522753792
GOBP_PYRIMIDINE_NUCLEOBASE_C...,SET,8,0.34283,0.0071551,0.31667,0.1395,GOBP_PYRIMIDINE_NUCLEOBASE_CATABOLIC_PROCESS,0.942886522753792
GOBP_PROTEIN_LOCALIZATION_TO...13,SET,21,0.20601,0.0069638,0.19041,0.13965,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_CENTROMERIC_REGION,0.943253667054715
KENNY_CTNNB1_TARGETS_UP,SET,47,0.13699,0.0069224,0.12662,0.13966,KENNY_CTNNB1_TARGETS_UP,0.943253667054715
HP_CONCAVE_NAIL,SET,11,0.25604,0.0062655,0.23675,0.13975,HP_CONCAVE_NAIL,0.943253667054715
GSE25087_FETAL_VS_ADULT_TREG...1,SET,157,0.074042,0.0068179,0.068467,0.13976,GSE25087_FETAL_VS_ADULT_TREG_DN,0.943253667054715
GOBP_IRE1_MEDIATED_UNFOLDED_...,SET,20,0.21332,0.0070372,0.19727,0.13977,GOBP_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.943253667054715
PAX_Q6,SET,227,0.065256,0.0072114,0.060353,0.1398,PAX_Q6,0.943253667054715
GARGALOVIC_RESPONSE_TO_OXIDI...14,SET,25,0.1811,0.0066784,0.16749,0.13981,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,0.943253667054715
GOBP_RIBOSOMAL_SUBUNIT_EXPOR...,SET,15,0.24449,0.0069857,0.22613,0.13981,GOBP_RIBOSOMAL_SUBUNIT_EXPORT_FROM_NUCLEUS,0.943253667054715
HP_UVEAL_MELANOMA,SET,8,0.28417,0.0059308,0.26284,0.13982,HP_UVEAL_MELANOMA,0.943253667054715
GOBP_RESPONSE_TO_ARSENIC_CON...,SET,30,0.1651,0.0066686,0.15273,0.13986,GOBP_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE,0.943253667054715
HP_SEA_BLUE_HISTIOCYTOSIS,SET,4,0.5987,0.0088365,0.55388,0.13987,HP_SEA_BLUE_HISTIOCYTOSIS,0.943253667054715
GNF2_DEK,SET,51,0.11672,0.0061435,0.10799,0.13988,GNF2_DEK,0.943253667054715
GOBP_REGULATION_OF_SIGNAL_TR...,SET,95,0.093863,0.0067347,0.086867,0.13996,GOBP_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.943302019713954
GOBP_POSITIVE_REGULATION_OF_...213,SET,4,0.38966,0.0057511,0.36071,0.14002,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_CHECKPOINT,0.943302019713954
DURANTE_ADULT_OLFACTORY_NEUR...7,SET,31,0.18035,0.0074049,0.16699,0.14007,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_GLOBOSE_BASAL_CELLS,0.943302019713954
TAKEDA_TARGETS_OF_NUP98_HOXA...5,SET,28,0.18658,0.007281,0.17279,0.14012,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,0.943302019713954
DESCARTES_MAIN_FETAL_ASTROCY...,SET,33,0.17257,0.0073099,0.15981,0.14012,DESCARTES_MAIN_FETAL_ASTROCYTES,0.943302019713954
HP_ABNORMAL_VESTIBULO_OCULAR...,SET,7,0.34934,0.0068202,0.32355,0.14015,HP_ABNORMAL_VESTIBULO_OCULAR_REFLEX,0.943302019713954
GOMF_PHOSPHATIDYLINOSITOL_3_...13,SET,10,0.29013,0.0067696,0.26874,0.14017,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY,0.943302019713954
HP_POSTERIOR_PLAGIOCEPHALY,SET,7,0.35635,0.0069571,0.33009,0.14018,HP_POSTERIOR_PLAGIOCEPHALY,0.943302019713954
ACAACCT_MIR453,SET,36,0.15115,0.0066869,0.14002,0.1402,ACAACCT_MIR453,0.943302019713954
LE_SKI_TARGETS_UP,SET,17,0.24052,0.0073158,0.22284,0.14022,LE_SKI_TARGETS_UP,0.943302019713954
MIR122B_3P,SET,124,0.08626,0.0070654,0.079931,0.14026,MIR122B_3P,0.943302019713954
GOBP_NEGATIVE_REGULATION_OF_...364,SET,57,0.13244,0.0073683,0.12273,0.14027,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,0.943302019713954
REACTOME_ACTIVATION_OF_NOXA_...,SET,5,0.46867,0.0077335,0.43437,0.14031,REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA,0.943302019713954
HP_ABNORMAL_CORNEA_MORPHOLOGY,SET,639,0.036897,0.0067629,0.034198,0.14032,HP_ABNORMAL_CORNEA_MORPHOLOGY,0.943302019713954
AMIT_SERUM_RESPONSE_40_MCF10A,SET,29,0.19328,0.007676,0.17915,0.14033,AMIT_SERUM_RESPONSE_40_MCF10A,0.943302019713954
GOBP_CYTOSOLIC_TRANSPORT,SET,123,0.077395,0.0063138,0.071746,0.14036,GOBP_CYTOSOLIC_TRANSPORT,0.943302019713954
REACTOME_OPSINS,SET,7,0.32512,0.0063474,0.30141,0.14038,REACTOME_OPSINS,0.943302019713954
MODULE_135,SET,25,0.2028,0.0074787,0.18805,0.14043,MODULE_135,0.943302019713954
GOBP_AMMONIUM_TRANSMEMBRANE_...,SET,13,0.26877,0.0071495,0.24922,0.14043,GOBP_AMMONIUM_TRANSMEMBRANE_TRANSPORT,0.943302019713954
GOMF_TRANSMEMBRANE_RECEPTOR_...7,SET,17,0.22758,0.0069222,0.21103,0.14043,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ADAPTOR_ACTIVITY,0.943302019713954
HP_HEMIATROPHY,SET,4,0.42355,0.0062514,0.39286,0.14049,HP_HEMIATROPHY,0.943426723971412
GU_PDEF_TARGETS_UP,SET,68,0.12571,0.0076365,0.11661,0.14053,GU_PDEF_TARGETS_UP,0.943426723971412
PID_LIS1_PATHWAY,SET,27,0.16736,0.0064137,0.15525,0.14053,PID_LIS1_PATHWAY,0.943426723971412
PID_FCER1_PATHWAY,SET,56,0.11894,0.0065592,0.11036,0.14057,PID_FCER1_PATHWAY,0.943513006952491
GSE26495_PD1HIGH_VS_PD1LOW_C...2,SET,166,0.071313,0.0067505,0.066176,0.14061,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP,0.943599256613246
HP_HYPOREFLEXIA,SET,349,0.04799,0.0065536,0.044551,0.14071,HP_HYPOREFLEXIA,0.943694326719322
GOBP_PEPTIDYL_LYSINE_DIMETHY...,SET,4,0.48079,0.0070961,0.44637,0.14072,GOBP_PEPTIDYL_LYSINE_DIMETHYLATION,0.943694326719322
BOYLAN_MULTIPLE_MYELOMA_C_CL...1,SET,27,0.20462,0.0078413,0.19,0.14076,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,0.943694326719322
GSE3982_MAST_CELL_VS_TH1_DN,SET,172,0.069687,0.0067137,0.06471,0.14077,GSE3982_MAST_CELL_VS_TH1_DN,0.943694326719322
STTTCRNTTT_IRF_Q6,SET,174,0.073166,0.0070893,0.06795,0.1408,STTTCRNTTT_IRF_Q6,0.943694326719322
GOBP_NEGATIVE_REGULATION_OF_...323,SET,19,0.2155,0.0069293,0.20016,0.14083,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.943694326719322
HP_ABNORMAL_CELLULAR_COMPOSI...,SET,8,0.37803,0.0078898,0.35116,0.14085,HP_ABNORMAL_CELLULAR_COMPOSITION_OF_BRONCHOALVEOLAR_FLUID,0.943694326719322
GOBP_POSITIVE_REGULATION_OF_...89,SET,8,0.30978,0.0064653,0.28776,0.14086,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.943694326719322
GSE22025_PROGESTERONE_VS_TGF...2,SET,177,0.06902,0.0067444,0.06412,0.14088,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.943694326719322
DESCARTES_FETAL_SPLEEN_STC2_...,SET,10,0.31417,0.0073305,0.2919,0.14091,DESCARTES_FETAL_SPLEEN_STC2_TLX1_POSITIVE_CELLS,0.943694326719322
HP_SPARSE_EYELASHES,SET,61,0.11917,0.006858,0.11074,0.14094,HP_SPARSE_EYELASHES,0.943694326719322
GNF2_MSH2,SET,26,0.15741,0.0059196,0.14628,0.14095,GNF2_MSH2,0.943694326719322
GSE27786_LSK_VS_NKCELL_UP,SET,177,0.066001,0.0064494,0.061346,0.141,GSE27786_LSK_VS_NKCELL_UP,0.943732437897169
GOCC_CYTOPLASMIC_SIDE_OF_END...1,SET,18,0.18844,0.0058976,0.17516,0.14101,GOCC_CYTOPLASMIC_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE,0.943732437897169
GSE23114_PERITONEAL_CAVITY_B...3,SET,178,0.069804,0.0068401,0.064913,0.14112,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP,0.943749865771812
MIR4496,SET,268,0.059864,0.00718,0.055679,0.14116,MIR4496,0.943749865771812
GOMF_IMMUNE_RECEPTOR_ACTIVITY,SET,131,0.094488,0.0079532,0.087901,0.14121,GOMF_IMMUNE_RECEPTOR_ACTIVITY,0.943749865771812
GOBP_WOUND_HEALING,SET,398,0.048327,0.0070382,0.044963,0.14123,GOBP_WOUND_HEALING,0.943749865771812
BAKER_HEMATOPOIESIS_STAT3_TA...,SET,14,0.26563,0.0073326,0.24714,0.14124,BAKER_HEMATOPOIESIS_STAT3_TARGETS,0.943749865771812
GOBP_POSITIVE_REGULATION_OF_...221,SET,40,0.14042,0.0065476,0.13065,0.14124,GOBP_POSITIVE_REGULATION_OF_DNA_REPLICATION,0.943749865771812
GOCC_T_CELL_RECEPTOR_COMPLEX,SET,15,0.26074,0.0074502,0.24265,0.14129,GOCC_T_CELL_RECEPTOR_COMPLEX,0.943749865771812
MEF2D_TARGET_GENES,SET,474,0.042649,0.006764,0.039691,0.1413,MEF2D_TARGET_GENES,0.943749865771812
GOBP_REGULATION_OF_GOLGI_TO_...,SET,8,0.3106,0.0064824,0.2891,0.14133,GOBP_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.943749865771812
MORF_UBE2A,SET,39,0.13577,0.006251,0.12639,0.14138,MORF_UBE2A,0.943749865771812
GSE29618_PRE_VS_DAY7_POST_TI...6,SET,166,0.069992,0.0066255,0.065176,0.14144,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP,0.943749865771812
REACTOME_RNA_POLYMERASE_I_TR...1,SET,45,0.12069,0.005968,0.11239,0.14145,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,0.943749865771812
DESCARTES_FETAL_HEART_SATB2_...,SET,84,0.11702,0.0078976,0.10898,0.14146,DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS,0.943749865771812
GOBP_DRINKING_BEHAVIOR,SET,8,0.37952,0.0079208,0.35349,0.1415,GOBP_DRINKING_BEHAVIOR,0.943749865771812
GSE40443_INDUCED_VS_TOTAL_TR...2,SET,180,0.068162,0.0067163,0.063493,0.14152,GSE40443_INDUCED_VS_TOTAL_TREG_UP,0.943749865771812
PTPRA_TARGET_GENES,SET,94,0.094108,0.0067168,0.087675,0.14156,PTPRA_TARGET_GENES,0.943749865771812
GOBP_REGULATION_OF_UBIQUITIN...2,SET,18,0.20332,0.0063634,0.18942,0.14156,GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,0.943749865771812
FOXF2_TARGET_GENES,SET,7,0.32762,0.0063962,0.30523,0.14157,FOXF2_TARGET_GENES,0.943749865771812
GOBP_AMINO_ACID_ACTIVATION,SET,26,0.15829,0.0059526,0.14748,0.14158,GOBP_AMINO_ACID_ACTIVATION,0.943749865771812
REACTOME_ASSEMBLY_OF_THE_ORC...,SET,9,0.23789,0.005266,0.22166,0.1416,REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION,0.943749865771812
WP_KREBS_CYCLE_DISORDERS,SET,13,0.26672,0.0070952,0.24854,0.14161,WP_KREBS_CYCLE_DISORDERS,0.943749865771812
GOBP_SKELETAL_MUSCLE_TISSUE_...2,SET,36,0.16194,0.0071642,0.15091,0.14161,GOBP_SKELETAL_MUSCLE_TISSUE_REGENERATION,0.943749865771812
VALK_AML_CLUSTER_12,SET,24,0.18059,0.0065252,0.1683,0.14164,VALK_AML_CLUSTER_12,0.943768826687116
GOBP_REGULATION_OF_SKELETAL_...3,SET,18,0.2047,0.0064066,0.19081,0.14169,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,0.943796954606397
GOBP_RESPONSE_TO_LEUKEMIA_IN...,SET,92,0.10239,0.0072302,0.095447,0.1417,GOBP_RESPONSE_TO_LEUKEMIA_INHIBITORY_FACTOR,0.943796954606397
HP_FACIAL_HYPERTRICHOSIS,SET,174,0.068537,0.0066408,0.063899,0.14174,HP_FACIAL_HYPERTRICHOSIS,0.943796954606397
MOOTHA_TCA,SET,14,0.2083,0.00575,0.19422,0.14176,MOOTHA_TCA,0.943796954606397
WP_TARGET_OF_RAPAMYCIN_SIGNA...,SET,35,0.15871,0.0069235,0.148,0.14178,WP_TARGET_OF_RAPAMYCIN_SIGNALING,0.943796954606397
GOCC_DEUTEROSOME,SET,5,0.30343,0.005007,0.28303,0.14185,GOCC_DEUTEROSOME,0.944042481849446
MIR23B_5P,SET,43,0.14637,0.0070754,0.13655,0.14189,MIR23B_5P,0.944042481849446
HP_ANAL_ATRESIA,SET,111,0.085017,0.0065908,0.079316,0.1419,HP_ANAL_ATRESIA,0.944042481849446
GOBP_POSITIVE_REGULATION_OF_...305,SET,17,0.21746,0.0066143,0.20296,0.142,GOBP_POSITIVE_REGULATION_OF_GLUCONEOGENESIS,0.944042481849446
KEGG_MEDICUS_REFERENCE_TELOM...1,SET,3,0.39924,0.0051032,0.37265,0.14201,KEGG_MEDICUS_REFERENCE_TELOMERASE_RNA_MATURATION,0.944042481849446
MARTIN_NFKB_TARGETS_DN,SET,10,0.26736,0.0062382,0.24956,0.14202,MARTIN_NFKB_TARGETS_DN,0.944042481849446
AP3_Q6,SET,228,0.064924,0.0071903,0.060613,0.14206,AP3_Q6,0.944042481849446
GOBP_OOCYTE_MATURATION,SET,30,0.17081,0.0068991,0.15947,0.14208,GOBP_OOCYTE_MATURATION,0.944042481849446
GSE1460_INTRATHYMIC_T_PROGEN...10,SET,176,0.066733,0.0065026,0.062313,0.14211,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP,0.944042481849446
GOBP_REGULATION_OF_XENOPHAGY,SET,9,0.26737,0.0059186,0.24968,0.14212,GOBP_REGULATION_OF_XENOPHAGY,0.944042481849446
DESCARTES_MAIN_FETAL_PDE1C_A...,SET,238,0.055759,0.0063075,0.052068,0.14212,DESCARTES_MAIN_FETAL_PDE1C_ACSM3_POSITIVE_CELLS,0.944042481849446
MIR200B_5P,SET,95,0.089925,0.0064521,0.083985,0.14215,MIR200B_5P,0.944042481849446
DESCARTES_MAIN_FETAL_HEMATOP...,SET,38,0.13697,0.006225,0.12793,0.14217,DESCARTES_MAIN_FETAL_HEMATOPOIETIC_STEM_CELLS,0.944042481849446
GOBP_VASCULAR_TRANSPORT,SET,81,0.11236,0.0074467,0.10499,0.14229,GOBP_VASCULAR_TRANSPORT,0.944316838487973
GSE18791_CTRL_VS_NEWCASTLE_V...20,SET,180,0.063246,0.0062318,0.059103,0.14229,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP,0.944316838487973
KEGG_MEDICUS_PATHOGEN_HIV_VP...1,SET,5,0.48572,0.0080149,0.45395,0.14232,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY,0.944316838487973
GSE360_L_DONOVANI_VS_T_GONDI...2,SET,183,0.069309,0.0068854,0.064775,0.14232,GSE360_L_DONOVANI_VS_T_GONDII_DC_UP,0.944316838487973
GSE27786_BCELL_VS_CD4_TCELL_...1,SET,177,0.06964,0.006805,0.065112,0.14242,GSE27786_BCELL_VS_CD4_TCELL_DN,0.944413728622439
HP_ABNORMAL_FETAL_PULMONARY_...,SET,8,0.33995,0.0070951,0.31788,0.14244,HP_ABNORMAL_FETAL_PULMONARY_MORPHOLOGY,0.944413728622439
HP_SACCADIC_SMOOTH_PURSUIT,SET,21,0.18646,0.0063028,0.17437,0.14246,HP_SACCADIC_SMOOTH_PURSUIT,0.944413728622439
HP_LOSS_OF_VOICE,SET,6,0.33963,0.0061389,0.31773,0.14256,HP_LOSS_OF_VOICE,0.944413728622439
GOBP_INTEGRIN_MEDIATED_SIGNA...,SET,102,0.095686,0.0071125,0.089533,0.14261,GOBP_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,0.944413728622439
KEGG_MEDICUS_PATHOGEN_HCMV_U...6,SET,19,0.20682,0.0066502,0.19353,0.14262,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,0.944413728622439
chr6q22,SET,54,0.23165,0.012545,0.21678,0.14263,chr6q22,0.944413728622439
MIR612,SET,97,0.089238,0.0064696,0.083514,0.14264,MIR612,0.944413728622439
GOBP_CYTOKINETIC_PROCESS,SET,46,0.13028,0.006513,0.12192,0.14265,GOBP_CYTOKINETIC_PROCESS,0.944413728622439
GOBP_POSITIVE_REGULATION_OF_...517,SET,5,0.46327,0.0076444,0.4336,0.14268,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.944413728622439
GCM_MYCL1,SET,23,0.17706,0.0062634,0.16575,0.14271,GCM_MYCL1,0.944413728622439
GOBP_REGULATION_OF_MICROTUBU...6,SET,16,0.2022,0.0059667,0.18932,0.14277,GOBP_REGULATION_OF_MICROTUBULE_NUCLEATION,0.944413728622439
MIR1288_3P,SET,36,0.15638,0.0069183,0.14643,0.14278,MIR1288_3P,0.944413728622439
KEGG_MEDICUS_REFERENCE_GNRH_...,SET,20,0.2063,0.0068056,0.19321,0.14282,KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY,0.944413728622439
DESCARTES_MAIN_FETAL_EXTRAVI...,SET,97,0.097611,0.0070765,0.091433,0.14287,DESCARTES_MAIN_FETAL_EXTRAVILLOUS_TROPHOBLASTS,0.944413728622439
MODULE_172,SET,89,0.10232,0.0071071,0.095873,0.14293,MODULE_172,0.944413728622439
LAKE_ADULT_KIDNEY_C15_CONNEC...,SET,156,0.080599,0.0073982,0.075539,0.143,LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE,0.944413728622439
HP_DECREASED_FERTILITY_IN_FE...,SET,87,0.094062,0.00646,0.088169,0.14303,HP_DECREASED_FERTILITY_IN_FEMALES,0.944413728622439
GOBP_CELLULAR_RESPONSE_TO_MI...,SET,12,0.30136,0.0077022,0.28251,0.14306,GOBP_CELLULAR_RESPONSE_TO_MINERALOCORTICOID_STIMULUS,0.944413728622439
IK1_01,SET,250,0.058822,0.0068174,0.055147,0.14307,IK1_01,0.944413728622439
GOBP_POSITIVE_REGULATION_OF_...758,SET,10,0.30905,0.0072111,0.28976,0.14309,GOBP_POSITIVE_REGULATION_OF_TOLERANCE_INDUCTION,0.944413728622439
GOBP_CEREBRAL_CORTEX_CELL_MI...,SET,42,0.14373,0.0068667,0.13479,0.14315,GOBP_CEREBRAL_CORTEX_CELL_MIGRATION,0.944413728622439
GOBP_HEART_FIELD_SPECIFICATI...,SET,17,0.27047,0.0082267,0.25367,0.14317,GOBP_HEART_FIELD_SPECIFICATION,0.944413728622439
GOCC_HOST_CELLULAR_COMPONENT,SET,9,0.30054,0.0066527,0.28189,0.14319,GOCC_HOST_CELLULAR_COMPONENT,0.944413728622439
REACTOME_LGI_ADAM_INTERACTIO...,SET,14,0.24914,0.0068775,0.2338,0.14331,REACTOME_LGI_ADAM_INTERACTIONS,0.944413728622439
KYNG_WERNER_SYNDROM_UP,SET,11,0.26582,0.0065049,0.2496,0.14345,KYNG_WERNER_SYNDROM_UP,0.944413728622439
GOBP_C4_DICARBOXYLATE_TRANSP...,SET,28,0.17339,0.0067664,0.16281,0.14345,GOBP_C4_DICARBOXYLATE_TRANSPORT,0.944413728622439
MIR548BB_3P,SET,541,0.039781,0.0067278,0.037356,0.14346,MIR548BB_3P,0.944413728622439
GOBP_BEHAVIORAL_RESPONSE_TO_...3,SET,8,0.36796,0.0076796,0.34556,0.14348,GOBP_BEHAVIORAL_RESPONSE_TO_NICOTINE,0.944413728622439
GSE45739_NRAS_KO_VS_WT_UNSTI...1,SET,169,0.071007,0.0067815,0.066686,0.14349,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN,0.944413728622439
HP_ABNORMALITY_OF_BONE_MINER...,SET,572,0.03859,0.0067048,0.036243,0.1435,HP_ABNORMALITY_OF_BONE_MINERAL_DENSITY,0.944413728622439
GOBP_ABSCISSION,SET,5,0.34168,0.005638,0.32092,0.14352,GOBP_ABSCISSION,0.944413728622439
HP_NONIMMUNE_HYDROPS_FETALIS,SET,58,0.1126,0.0063193,0.10576,0.14352,HP_NONIMMUNE_HYDROPS_FETALIS,0.944413728622439
WNT_UP.V1_DN,SET,160,0.077343,0.007189,0.072652,0.14354,WNT_UP.V1_DN,0.944413728622439
MATSUMIYA_PBMC_MODIFIED_VACC...3,SET,10,0.31814,0.0074231,0.29889,0.14358,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_LOW_VS_HIGH_RESPONDERS_2DY_GO_T_CELL_ACTIV_AND_CO_STIM_UP,0.944413728622439
GSE13484_3H_UNSTIM_VS_YF17D_...1,SET,184,0.070272,0.0069999,0.066025,0.1436,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,0.944413728622439
AIZARANI_LIVER_C2_KUPFFER_CE...,SET,178,0.072801,0.0071337,0.068406,0.14361,AIZARANI_LIVER_C2_KUPFFER_CELLS_1,0.944413728622439
WP_LUNG_FIBROSIS,SET,59,0.13107,0.0074183,0.1232,0.14371,WP_LUNG_FIBROSIS,0.944413728622439
HP_SHORT_FOURTH_METATARSAL,SET,15,0.22435,0.0064103,0.21089,0.14371,HP_SHORT_FOURTH_METATARSAL,0.944413728622439
HP_DECEREBRATE_RIGIDITY,SET,5,0.41389,0.0068296,0.38915,0.14377,HP_DECEREBRATE_RIGIDITY,0.944413728622439
GOBP_NEGATIVE_REGULATION_OF_...559,SET,68,0.11394,0.0069214,0.10713,0.14378,GOBP_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,0.944413728622439
GOBP_POSITIVE_REGULATION_OF_...44,SET,37,0.1434,0.0064315,0.13484,0.14378,GOBP_POSITIVE_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,0.944413728622439
GSE1460_INTRATHYMIC_T_PROGEN...8,SET,184,0.064806,0.0064555,0.060958,0.14387,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,0.944413728622439
GOBP_REGULATION_OF_RELEASE_O...3,SET,27,0.18287,0.0070081,0.17203,0.14389,GOBP_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM,0.944413728622439
GOBP_TORC2_SIGNALING,SET,10,0.30191,0.0070444,0.28404,0.14392,GOBP_TORC2_SIGNALING,0.944413728622439
DESCARTES_FETAL_MUSCLE_SCHWA...,SET,101,0.10047,0.0074317,0.094528,0.14393,DESCARTES_FETAL_MUSCLE_SCHWANN_CELLS,0.944413728622439
GCM_CSNK1A1,SET,35,0.13533,0.0059033,0.12733,0.14394,GCM_CSNK1A1,0.944413728622439
HP_RIGHT_AORTIC_ARCH_WITH_MI...,SET,5,0.37109,0.0061234,0.34915,0.14394,HP_RIGHT_AORTIC_ARCH_WITH_MIRROR_IMAGE_BRANCHING,0.944413728622439
DESCARTES_FETAL_ADRENAL_VASC...,SET,110,0.092365,0.0071283,0.086907,0.14394,DESCARTES_FETAL_ADRENAL_VASCULAR_ENDOTHELIAL_CELLS,0.944413728622439
HU_GENOTOXIC_DAMAGE_24HR,SET,31,0.15001,0.0061592,0.14118,0.144,HU_GENOTOXIC_DAMAGE_24HR,0.944413728622439
HP_PETERS_ANOMALY,SET,18,0.22103,0.0069176,0.20802,0.14401,HP_PETERS_ANOMALY,0.944413728622439
YAO_TEMPORAL_RESPONSE_TO_PRO...13,SET,15,0.22902,0.0065439,0.21557,0.14403,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4,0.944413728622439
HP_BULIMIA,SET,5,0.5225,0.0086219,0.49181,0.14403,HP_BULIMIA,0.944413728622439
HP_DECREASED_LYMPHOCYTE_PROL...2,SET,27,0.18673,0.0071561,0.1758,0.14408,HP_DECREASED_LYMPHOCYTE_PROLIFERATION_IN_RESPONSE_TO_MITOGEN,0.944413728622439
GSE8621_UNSTIM_VS_LPS_PRIMED...2,SET,179,0.067275,0.0066105,0.063341,0.1441,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,0.944413728622439
HP_STENOSIS_OF_THE_EXTERNAL_...,SET,32,0.16782,0.0070005,0.15801,0.14411,HP_STENOSIS_OF_THE_EXTERNAL_AUDITORY_CANAL,0.944413728622439
TCTGATC_MIR383,SET,46,0.13672,0.0068353,0.12874,0.14413,TCTGATC_MIR383,0.944413728622439
HP_ABNORMAL_UPPER_LIMB_BONE_...,SET,398,0.046401,0.0067577,0.043695,0.14414,HP_ABNORMAL_UPPER_LIMB_BONE_MORPHOLOGY,0.944413728622439
PER1_TARGET_GENES,SET,21,0.19514,0.0065964,0.18378,0.14417,PER1_TARGET_GENES,0.944413728622439
HP_CRANIOFACIAL_DYSOSTOSIS,SET,8,0.3004,0.0062696,0.28293,0.14418,HP_CRANIOFACIAL_DYSOSTOSIS,0.944413728622439
GOCC_ORIGIN_RECOGNITION_COMP...,SET,8,0.2472,0.0051592,0.23286,0.14423,GOCC_ORIGIN_RECOGNITION_COMPLEX,0.944413728622439
chr4p16,SET,93,0.18577,0.013189,0.17502,0.14426,chr4p16,0.944413728622439
GOCC_RDNA_HETEROCHROMATIN,SET,3,0.40386,0.0051623,0.38052,0.14428,GOCC_RDNA_HETEROCHROMATIN,0.944413728622439
GOMF_IMMUNOGLOBULIN_RECEPTOR...2,SET,9,0.33644,0.0074474,0.317,0.14428,GOMF_IMMUNOGLOBULIN_RECEPTOR_BINDING,0.944413728622439
GOBP_REGULATION_OF_NATURAL_K...5,SET,49,0.14175,0.0073135,0.13357,0.1443,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.944413728622439
HP_HEAT_INTOLERANCE,SET,19,0.19911,0.0064024,0.18765,0.14433,HP_HEAT_INTOLERANCE,0.944413728622439
GOMF_CHONDROITIN_SULFOTRANSF...,SET,5,0.38774,0.0063982,0.36545,0.14435,GOMF_CHONDROITIN_SULFOTRANSFERASE_ACTIVITY,0.944413728622439
OCT1_05,SET,222,0.065646,0.0071752,0.061875,0.14436,OCT1_05,0.944413728622439
GSE17721_POLYIC_VS_CPG_12H_B...2,SET,178,0.069154,0.0067764,0.065181,0.14436,GSE17721_POLYIC_VS_CPG_12H_BMDC_UP,0.944413728622439
chr6q21,SET,46,0.23516,0.011757,0.22168,0.14439,chr6q21,0.944413728622439
HP_OSTEOARTHRITIS_OF_THE_SMA...,SET,4,0.42718,0.0063049,0.40278,0.14445,HP_OSTEOARTHRITIS_OF_THE_SMALL_JOINTS_OF_THE_HAND,0.944413728622439
KEGG_BASAL_CELL_CARCINOMA,SET,53,0.12984,0.0069662,0.12243,0.14447,KEGG_BASAL_CELL_CARCINOMA,0.944413728622439
HP_CLAW_HAND_DEFORMITY,SET,8,0.33588,0.00701,0.31672,0.14447,HP_CLAW_HAND_DEFORMITY,0.944413728622439
HP_EPISODIC_METABOLIC_ACIDOS...,SET,4,0.50777,0.0074944,0.47882,0.14447,HP_EPISODIC_METABOLIC_ACIDOSIS,0.944413728622439
GOBP_GLUCOSE_IMPORT_ACROSS_P...,SET,4,0.50992,0.0075261,0.48085,0.14448,GOBP_GLUCOSE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.944413728622439
REACTOME_PROTEIN_UBIQUITINAT...,SET,57,0.11593,0.0064497,0.10934,0.14452,REACTOME_PROTEIN_UBIQUITINATION,0.944413728622439
HP_TESTICULAR_DYSGENESIS,SET,10,0.31525,0.0073558,0.29734,0.14452,HP_TESTICULAR_DYSGENESIS,0.944413728622439
GOMF_KINASE_ACTIVATOR_ACTIVI...,SET,130,0.07877,0.0066051,0.0743,0.14454,GOMF_KINASE_ACTIVATOR_ACTIVITY,0.944413728622439
HP_ABNORMAL_MALE_REPRODUCTIV...,SET,283,0.053431,0.0065826,0.050398,0.14454,HP_ABNORMAL_MALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,0.944413728622439
HP_ADRENAL_INSUFFICIENCY,SET,93,0.093824,0.006661,0.088511,0.14457,HP_ADRENAL_INSUFFICIENCY,0.944413728622439
GSE19941_LPS_VS_LPS_AND_IL10...4,SET,183,0.068062,0.0067615,0.064207,0.14457,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.944413728622439
MIR675_3P,SET,56,0.12537,0.0069139,0.11828,0.14459,MIR675_3P,0.944413728622439
GSE9988_ANTI_TREM1_AND_LPS_V...3,SET,186,0.065354,0.0065449,0.061657,0.14459,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN,0.944413728622439
NAGY_TFTC_COMPONENTS_HUMAN,SET,17,0.17903,0.0054454,0.16896,0.14467,NAGY_TFTC_COMPONENTS_HUMAN,0.944758709131905
GOBP_CARDIOLIPIN_ACYL_CHAIN_...,SET,5,0.50999,0.0084154,0.48166,0.14485,GOBP_CARDIOLIPIN_ACYL_CHAIN_REMODELING,0.945276077586207
GSE3039_B2_VS_B1_BCELL_DN,SET,180,0.062955,0.0062032,0.059488,0.14497,GSE3039_B2_VS_B1_BCELL_DN,0.945276077586207
HP_INFERTILITY,SET,248,0.05669,0.0065444,0.053569,0.14498,HP_INFERTILITY,0.945276077586207
MATTIOLI_MULTIPLE_MYELOMA_SU...,SET,10,0.28664,0.0066882,0.27088,0.14499,MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS,0.945276077586207
GSE18791_CTRL_VS_NEWCASTLE_V...1,SET,170,0.073247,0.0070159,0.069219,0.14499,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN,0.945276077586207
MIR7975,SET,37,0.15018,0.0067352,0.14196,0.14506,MIR7975,0.945276077586207
ZNF843_TARGET_GENES,SET,675,0.03597,0.0067694,0.034004,0.14507,ZNF843_TARGET_GENES,0.945276077586207
HP_ABSENT_FACIAL_HAIR,SET,33,0.16881,0.0071506,0.15957,0.14507,HP_ABSENT_FACIAL_HAIR,0.945276077586207
HP_BROAD_FINGER,SET,113,0.084814,0.0066337,0.080184,0.14509,HP_BROAD_FINGER,0.945276077586207
HP_REDUCED_CEREBRAL_WHITE_MA...,SET,31,0.16965,0.0069655,0.16039,0.1451,HP_REDUCED_CEREBRAL_WHITE_MATTER_VOLUME,0.945276077586207
GOBP_PARASYMPATHETIC_NERVOUS...,SET,17,0.24427,0.0074298,0.23095,0.14511,GOBP_PARASYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,0.945276077586207
GOBP_REGULATION_OF_SKELETAL_...4,SET,14,0.23697,0.0065415,0.22405,0.14511,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.945276077586207
HP_ABNORMAL_NASAL_SKELETON_M...,SET,11,0.32488,0.0079501,0.30717,0.14512,HP_ABNORMAL_NASAL_SKELETON_MORPHOLOGY,0.945276077586207
GOMF_AMYLASE_ACTIVITY,SET,2,0.68799,0.0071806,0.65053,0.14513,GOMF_AMYLASE_ACTIVITY,0.945276077586207
KIM_MYC_AMPLIFICATION_TARGET...1,SET,87,0.10249,0.0070388,0.09696,0.14525,KIM_MYC_AMPLIFICATION_TARGETS_DN,0.945375014031805
GOCC_ISWI_TYPE_COMPLEX,SET,12,0.23227,0.0059366,0.21975,0.14527,GOCC_ISWI_TYPE_COMPLEX,0.945375014031805
GSE9988_ANTI_TREM1_VS_ANTI_T...2,SET,181,0.063712,0.006295,0.06028,0.14528,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,0.945375014031805
GAVISH_3CA_METAPROGRAM_ENDOT...12,SET,47,0.14123,0.0071369,0.13363,0.14529,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_INTERFERON,0.945375014031805
GOBP_NUCLEOTIDE_BINDING_OLIG...1,SET,7,0.33995,0.006637,0.32167,0.1453,GOBP_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_1_SIGNALING_PATHWAY,0.945375014031805
GOBP_NEGATIVE_REGULATION_OF_...230,SET,17,0.19915,0.0060575,0.18848,0.14535,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.945375014031805
GOMF_PHOSPHATIDYLINOSITOL_3_...2,SET,6,0.3148,0.0056902,0.29795,0.14536,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.945375014031805
GOBP_MULTICELLULAR_ORGANISMA...5,SET,58,0.11704,0.0065684,0.11078,0.14537,GOBP_MULTICELLULAR_ORGANISMAL_MOVEMENT,0.945375014031805
HP_LIMB_ATAXIA,SET,82,0.095828,0.0063902,0.090707,0.14539,HP_LIMB_ATAXIA,0.945375014031805
GSE14908_RESTING_VS_HDM_STIM...1,SET,185,0.066439,0.0066358,0.062914,0.14549,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN,0.945780095273678
GOBP_NEGATIVE_REGULATION_OF_...252,SET,5,0.45915,0.0075765,0.43486,0.14552,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_MIGRATION,0.945780095273678
GOBP_HORMONE_MEDIATED_SIGNAL...,SET,178,0.068349,0.0066975,0.064743,0.14556,GOBP_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.945780095273678
HP_IMPACTED_TOOTH,SET,6,0.40404,0.0073033,0.38277,0.14559,HP_IMPACTED_TOOTH,0.945780095273678
HP_PECTUS_CARINATUM,SET,158,0.069885,0.0064554,0.066215,0.14562,HP_PECTUS_CARINATUM,0.945780095273678
ERWIN_COHEN_BLOOD_VACCINE_TC...4,SET,71,0.11206,0.0069553,0.10618,0.14563,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_UP,0.945780095273678
HP_GENERALIZED_HYPERREFLEXIA,SET,10,0.235,0.0054832,0.22268,0.14565,HP_GENERALIZED_HYPERREFLEXIA,0.945780095273678
FONTAINE_FOLLICULAR_THYROID_...1,SET,62,0.11803,0.0068475,0.11185,0.14567,FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,0.945780095273678
GSE360_CTRL_VS_L_DONOVANI_MA...2,SET,183,0.064754,0.0064329,0.061398,0.14579,GSE360_CTRL_VS_L_DONOVANI_MAC_UP,0.946223693054518
MIKKELSEN_MCV6_HCP_WITH_H3K2...,SET,412,0.049035,0.0072629,0.046494,0.1458,MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,0.946223693054518
GOBP_TUMOR_NECROSIS_FACTOR_M...,SET,104,0.090754,0.0068114,0.086057,0.14582,GOBP_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.946223693054518
HP_ABNORMAL_JEJUNUM_MORPHOLO...,SET,9,0.2967,0.0065677,0.28143,0.1459,HP_ABNORMAL_JEJUNUM_MORPHOLOGY,0.946360494402985
GOBP_REGULATION_OF_PRESYNAPT...2,SET,28,0.18951,0.0073954,0.17977,0.14592,GOBP_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.946360494402985
HP_SPARSE_MEDIAL_EYEBROW,SET,5,0.36944,0.0060962,0.35051,0.14594,HP_SPARSE_MEDIAL_EYEBROW,0.946360494402985
GOBP_POSITIVE_REGULATION_OF_...430,SET,25,0.18957,0.0069909,0.17986,0.14595,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_ACTIVATION,0.946360494402985
GOBP_REGULATION_OF_KIDNEY_DE...,SET,31,0.18157,0.0074551,0.17234,0.14604,GOBP_REGULATION_OF_KIDNEY_DEVELOPMENT,0.946608773074772
HP_OXYCEPHALY,SET,7,0.32941,0.0064312,0.31267,0.14605,HP_OXYCEPHALY,0.946608773074772
HP_LOBULATED_TONGUE,SET,15,0.20336,0.0058105,0.19304,0.14607,HP_LOBULATED_TONGUE,0.946608773074772
HP_ABNORMAL_LIVER_PARENCHYMA...,SET,10,0.27119,0.0063277,0.25758,0.14621,HP_ABNORMAL_LIVER_PARENCHYMA_MORPHOLOGY,0.947162823858341
GSE16385_ROSIGLITAZONE_IL4_V...4,SET,178,0.067424,0.0066069,0.064039,0.14621,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP,0.947162823858341
GSE39820_CTRL_VS_IL1B_IL6_CD...1,SET,182,0.069251,0.006861,0.06579,0.14627,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN,0.947282124930284
GOBP_REGULATION_OF_NATURAL_K...4,SET,8,0.33938,0.0070831,0.32252,0.14634,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.947282124930284
HP_ENLARGED_THORAX,SET,57,0.1155,0.0064257,0.10976,0.14635,HP_ENLARGED_THORAX,0.947282124930284
HP_NEVUS,SET,153,0.071471,0.0064975,0.067931,0.14638,HP_NEVUS,0.947282124930284
NAKAYA_PLASMACYTOID_DENDRITI...2,SET,186,0.065706,0.0065802,0.062465,0.14643,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.947282124930284
GOBP_POSITIVE_REGULATION_OF_...731,SET,49,0.13275,0.0068494,0.12623,0.14648,GOBP_POSITIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY,0.947282124930284
MORF_PSMC2,SET,101,0.080104,0.0059252,0.076173,0.1465,MORF_PSMC2,0.947282124930284
GSE37416_CTRL_VS_24H_F_TULAR...1,SET,176,0.064508,0.0062858,0.061345,0.14651,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.947282124930284
REACTOME_BIOTIN_TRANSPORT_AN...,SET,10,0.25996,0.0060655,0.24722,0.14652,REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM,0.947282124930284
BIOCARTA_HDAC_PATHWAY,SET,25,0.18732,0.0069077,0.17817,0.14655,BIOCARTA_HDAC_PATHWAY,0.947282124930284
GARGALOVIC_RESPONSE_TO_OXIDI...11,SET,8,0.38113,0.0079545,0.36258,0.1466,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN,0.947282124930284
BIOCARTA_TCAPOPTOSIS_PATHWAY,SET,9,0.32203,0.0071285,0.30635,0.1466,BIOCARTA_TCAPOPTOSIS_PATHWAY,0.947282124930284
MIR6855_5P,SET,60,0.11196,0.0063903,0.10651,0.1466,MIR6855_5P,0.947282124930284
FUJIWARA_PARK2_HEPATOCYTE_PR...2,SET,12,0.29778,0.0076109,0.2833,0.14661,FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP,0.947282124930284
HP_COLD_INDUCED_MUSCLE_CRAMPS,SET,6,0.38864,0.0070248,0.37006,0.14682,HP_COLD_INDUCED_MUSCLE_CRAMPS,0.948433082497213
BENPORATH_MYC_TARGETS_WITH_E...,SET,200,0.062705,0.0065092,0.059721,0.14687,BENPORATH_MYC_TARGETS_WITH_EBOX,0.948433082497213
GAO_LARGE_INTESTINE_ADULT_CE...,SET,287,0.054041,0.006704,0.051469,0.14687,GAO_LARGE_INTESTINE_ADULT_CE_OLFM4HIGH_STEM_CELL,0.948433082497213
ZNF92_TARGET_GENES,SET,1104,0.028284,0.0067243,0.026942,0.14691,ZNF92_TARGET_GENES,0.948515149544864
GOBP_NEGATIVE_REGULATION_OF_...313,SET,7,0.37208,0.0072642,0.35456,0.147,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION,0.948890224656517
REACTOME_UPTAKE_AND_ACTIONS_...,SET,28,0.17203,0.0067134,0.16396,0.14704,REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,0.948890224656517
MIR548O_3P,SET,250,0.058747,0.0068087,0.055991,0.14705,MIR548O_3P,0.948890224656517
REACTOME_SIGNALING_BY_FGFR1_...,SET,37,0.1555,0.0069741,0.14823,0.14708,REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,0.948907629478374
HP_ABNORMALITY_OF_PREMOLAR,SET,12,0.29021,0.0074173,0.27668,0.14712,HP_ABNORMALITY_OF_PREMOLAR,0.948989532293987
GOMF_CHLORIDE_TRANSMEMBRANE_...,SET,107,0.093111,0.0070878,0.088794,0.14718,GOMF_CHLORIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.949175477293791
HP_ABNORMALITY_OF_THE_AXILLA...,SET,51,0.13101,0.0068958,0.12496,0.14723,HP_ABNORMALITY_OF_THE_AXILLARY_HAIR,0.949175477293791
GOBP_CYSTEINE_METABOLIC_PROC...,SET,10,0.30322,0.0070749,0.28929,0.14729,GOBP_CYSTEINE_METABOLIC_PROCESS,0.949175477293791
HP_ABNORMALLY_LARGE_GLOBE,SET,39,0.15043,0.0069261,0.14353,0.14731,HP_ABNORMALLY_LARGE_GLOBE,0.949175477293791
GOBP_POSITIVE_REGULATION_OF_...110,SET,24,0.18429,0.0066592,0.17585,0.14733,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.949175477293791
GOBP_REGULATION_OF_MONOCYTE_...3,SET,6,0.385,0.006959,0.36737,0.14733,GOBP_REGULATION_OF_MONOCYTE_EXTRAVASATION,0.949175477293791
GSE31082_DP_VS_CD4_SP_THYMOC...1,SET,176,0.066958,0.0065246,0.063896,0.14734,GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN,0.949175477293791
GOBP_NEGATIVE_REGULATION_OF_...288,SET,117,0.088447,0.0070384,0.08442,0.14739,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,0.949274513618677
GOBP_NEGATIVE_REGULATION_OF_...425,SET,49,0.14169,0.0073106,0.13525,0.14741,GOBP_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.949274513618677
RANKIN_ANGIOGENIC_TARGETS_OF...1,SET,8,0.37431,0.007812,0.35738,0.14748,RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN,0.949549351611708
GOBP_REGULATION_OF_TOLL_LIKE...4,SET,4,0.55421,0.0081799,0.52939,0.14758,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.949828484175458
HP_WIDE_INTERMAMILLARY_DISTA...,SET,103,0.086,0.0064237,0.082165,0.14763,HP_WIDE_INTERMAMILLARY_DISTANCE,0.949828484175458
HP_T_WAVE_INVERSION,SET,5,0.38,0.0062704,0.36307,0.14764,HP_T_WAVE_INVERSION,0.949828484175458
ZNF667_TARGET_GENES,SET,120,0.080098,0.0064547,0.076531,0.14765,ZNF667_TARGET_GENES,0.949828484175458
GSE4590_PRE_BCELL_VS_SMALL_P...1,SET,109,0.084252,0.0064728,0.080504,0.14766,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN,0.949828484175458
HP_PARAPLEGIA_PARAPARESIS,SET,181,0.064605,0.0063832,0.061764,0.14779,HP_PARAPLEGIA_PARAPARESIS,0.950265732519423
BIOCARTA_NKCELLS_PATHWAY,SET,18,0.2153,0.0067382,0.20584,0.1478,BIOCARTA_NKCELLS_PATHWAY,0.950265732519423
GOBP_NON_LYTIC_VIRAL_RELEASE,SET,14,0.23306,0.0064337,0.22283,0.14781,GOBP_NON_LYTIC_VIRAL_RELEASE,0.950265732519423
HP_REDUCED_C_PEPTIDE_LEVEL,SET,7,0.36294,0.0070857,0.34705,0.14784,HP_REDUCED_C_PEPTIDE_LEVEL,0.950282818568522
TAKAO_RESPONSE_TO_UVB_RADIAT...2,SET,71,0.098959,0.0061423,0.094665,0.14793,TAKAO_RESPONSE_TO_UVB_RADIATION_UP,0.950484510919435
ARID5B_TARGET_GENES,SET,724,0.033302,0.0064818,0.031857,0.14794,ARID5B_TARGET_GENES,0.950484510919435
GOMF_HELICASE_ACTIVITY,SET,142,0.071271,0.0062439,0.068224,0.1481,GOMF_HELICASE_ACTIVITY,0.950484510919435
WP_VITAMIN_D_IN_INFLAMMATORY...,SET,20,0.20096,0.0066295,0.19243,0.14817,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,0.950484510919435
GOBP_INTERLEUKIN_27_MEDIATED...,SET,7,0.36404,0.0071073,0.34871,0.14825,GOBP_INTERLEUKIN_27_MEDIATED_SIGNALING_PATHWAY,0.950484510919435
AACGGTT_MIR451,SET,9,0.32499,0.0071941,0.31131,0.14826,AACGGTT_MIR451,0.950484510919435
GSE14908_RESTING_VS_HDM_STIM...2,SET,177,0.06317,0.0061728,0.060513,0.14827,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP,0.950484510919435
ZHAN_MULTIPLE_MYELOMA_UP,SET,47,0.11744,0.0059347,0.11253,0.14832,ZHAN_MULTIPLE_MYELOMA_UP,0.950484510919435
GOCC_CIA_COMPLEX,SET,2,0.52058,0.0054333,0.4988,0.14833,GOCC_CIA_COMPLEX,0.950484510919435
GOBP_MEMBRANE_DEPOLARIZATION...3,SET,21,0.22209,0.0075073,0.21282,0.14835,GOBP_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.950484510919435
GSE8835_HEALTHY_VS_CLL_CD4_T...1,SET,174,0.067186,0.0065098,0.064403,0.14843,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN,0.950484510919435
GSE9988_LPS_VS_LPS_AND_ANTI_...1,SET,170,0.070751,0.0067768,0.067819,0.14843,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN,0.950484510919435
GOBP_REGULATION_OF_CARDIAC_M...9,SET,23,0.18474,0.0065349,0.1771,0.14846,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING,0.950484510919435
HP_CUPPED_RIBS,SET,23,0.1846,0.0065299,0.17697,0.14846,HP_CUPPED_RIBS,0.950484510919435
HP_ABNORMAL_EUSTACHIAN_TUBE_...,SET,4,0.57995,0.0085598,0.55601,0.14847,HP_ABNORMAL_EUSTACHIAN_TUBE_MORPHOLOGY,0.950484510919435
GSE23568_CTRL_TRANSDUCED_VS_...2,SET,185,0.068069,0.0067987,0.06526,0.14847,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP,0.950484510919435
WP_INSULIN_SIGNALING_IN_ADIP...1,SET,8,0.34053,0.0071071,0.32662,0.14857,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,0.950484510919435
WP_INSULIN_SIGNALING_IN_ADIP...2,SET,8,0.34053,0.0071071,0.32662,0.14857,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,0.950484510919435
GOBP_WATER_SOLUBLE_VITAMIN_M...,SET,58,0.11269,0.0063241,0.10808,0.14857,GOBP_WATER_SOLUBLE_VITAMIN_METABOLIC_PROCESS,0.950484510919435
MIR4269,SET,189,0.065742,0.0066361,0.063061,0.14859,MIR4269,0.950484510919435
HP_ABNORMALITY_OF_THE_MUSCUL...4,SET,12,0.26586,0.0067949,0.25502,0.1486,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_ARM,0.950484510919435
BROWN_MYELOID_CELL_DEVELOPME...2,SET,147,0.077562,0.0069127,0.074404,0.14861,BROWN_MYELOID_CELL_DEVELOPMENT_UP,0.950484510919435
LAKE_ADULT_KIDNEY_C29_UNKNOW...,SET,77,0.11433,0.0073892,0.10968,0.14861,LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2,0.950484510919435
CORRE_MULTIPLE_MYELOMA_DN,SET,52,0.13272,0.0070535,0.12733,0.14864,CORRE_MULTIPLE_MYELOMA_DN,0.950484510919435
CDP_02,SET,96,0.096039,0.0069268,0.092141,0.14864,CDP_02,0.950484510919435
GOBP_POSITIVE_REGULATION_OF_...680,SET,10,0.28325,0.0066091,0.27175,0.14864,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,0.950484510919435
GOCC_IGA_IMMUNOGLOBULIN_COMP...1,SET,2,0.67011,0.006994,0.64292,0.14865,GOCC_IGA_IMMUNOGLOBULIN_COMPLEX,0.950484510919435
GOCC_IGA_IMMUNOGLOBULIN_COMP...2,SET,2,0.67011,0.006994,0.64292,0.14865,GOCC_IGA_IMMUNOGLOBULIN_COMPLEX_CIRCULATING,0.950484510919435
GOCC_ACTIN_FILAMENT,SET,105,0.089385,0.0067406,0.085801,0.14877,GOCC_ACTIN_FILAMENT,0.950484510919435
MIR3085_3P,SET,132,0.076254,0.0064427,0.073209,0.14881,MIR3085_3P,0.950484510919435
HP_ATROPHY_DEGENERATION_AFFE...1,SET,36,0.15378,0.006803,0.14765,0.14883,HP_ATROPHY_DEGENERATION_AFFECTING_THE_BRAINSTEM,0.950484510919435
HP_ABNORMAL_FIFTH_TOE_MORPHO...,SET,83,0.095549,0.0064101,0.091745,0.14884,HP_ABNORMAL_FIFTH_TOE_MORPHOLOGY,0.950484510919435
MIR495_5P,SET,62,0.11463,0.0066504,0.11008,0.14887,MIR495_5P,0.950484510919435
GOBP_CLEAVAGE_FURROW_FORMATI...,SET,7,0.38002,0.0074192,0.36495,0.14888,GOBP_CLEAVAGE_FURROW_FORMATION,0.950484510919435
ZIC3_01,SET,235,0.05901,0.0066336,0.056679,0.14892,ZIC3_01,0.950484510919435
MORF_DEK,SET,237,0.053424,0.0060309,0.051314,0.14892,MORF_DEK,0.950484510919435
GOBP_OLFACTORY_BEHAVIOR,SET,11,0.30169,0.0073826,0.28979,0.14893,GOBP_OLFACTORY_BEHAVIOR,0.950484510919435
HP_TOOTH_MALPOSITION,SET,349,0.048248,0.0065888,0.046346,0.14894,HP_TOOTH_MALPOSITION,0.950484510919435
BLANCO_MELO_COVID19_SARS_COV...6,SET,70,0.11349,0.0069947,0.10903,0.14897,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP,0.950484510919435
GOCC_MHC_PROTEIN_COMPLEX,SET,21,0.23557,0.0079628,0.22632,0.14897,GOCC_MHC_PROTEIN_COMPLEX,0.950484510919435
HP_CYSTOID_MACULAR_EDEMA,SET,19,0.20735,0.0066672,0.19923,0.149,HP_CYSTOID_MACULAR_EDEMA,0.950484510919435
GSE43863_NAIVE_VS_TFH_CD4_EF...1,SET,149,0.075372,0.0067627,0.072426,0.14902,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_DN,0.950484510919435
GSE41867_MEMORY_VS_EXHAUSTED...2,SET,186,0.065816,0.0065912,0.063258,0.14908,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP,0.950662720102715
GOMF_CYCLOHYDROLASE_ACTIVITY,SET,5,0.4155,0.0068562,0.39941,0.14911,GOMF_CYCLOHYDROLASE_ACTIVITY,0.950662720102715
WP_ESTROGEN_RECEPTOR_PATHWAY,SET,13,0.26908,0.0071579,0.25868,0.14913,WP_ESTROGEN_RECEPTOR_PATHWAY,0.950662720102715
NERF_Q2,SET,228,0.058684,0.0064992,0.056422,0.14916,NERF_Q2,0.950679589216945
MIR1250_3P,SET,457,0.043234,0.006736,0.041573,0.14919,MIR1250_3P,0.950694459681843
GSE6259_33D1_POS_DC_VS_BCELL...1,SET,133,0.076386,0.0064781,0.073471,0.14925,GSE6259_33D1_POS_DC_VS_BCELL_DN,0.950694459681843
HP_DECREASED_AMPLITUDE_OF_SE...,SET,24,0.18408,0.0066514,0.17711,0.14933,HP_DECREASED_AMPLITUDE_OF_SENSORY_ACTION_POTENTIALS,0.950694459681843
MIR367_3P,SET,385,0.046762,0.0067005,0.044995,0.14935,MIR367_3P,0.950694459681843
GOBP_REGULATION_OF_MACROPHAG...2,SET,9,0.26808,0.0059342,0.25798,0.14938,GOBP_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS,0.950694459681843
LOPEZ_MBD_TARGETS_IMPRINTED_...,SET,3,0.41238,0.0052712,0.39693,0.14943,LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED,0.950694459681843
GOBP_ACTIVATION_OF_JANUS_KIN...,SET,13,0.24871,0.006616,0.23941,0.14944,GOBP_ACTIVATION_OF_JANUS_KINASE_ACTIVITY,0.950694459681843
CAGGTCC_MIR492,SET,54,0.11513,0.0062351,0.11083,0.14946,CAGGTCC_MIR492,0.950694459681843
MIR548AC,SET,545,0.038653,0.0065604,0.037213,0.14948,MIR548AC,0.950694459681843
GOBP_REGULATION_OF_MORPHOGEN...1,SET,59,0.12433,0.0070368,0.11971,0.14951,GOBP_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,0.950694459681843
WP_CHOLESTEROL_BIOSYNTHESIS_...3,SET,5,0.36235,0.0059792,0.34895,0.14954,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,0.950694459681843
GOBP_HEMATOPOIETIC_STEM_CELL...3,SET,9,0.30372,0.0067231,0.29249,0.14955,GOBP_HEMATOPOIETIC_STEM_CELL_MIGRATION,0.950694459681843
MIR6127,SET,185,0.065552,0.0065472,0.063132,0.14957,MIR6127,0.950694459681843
GOMF_MECHANOSENSITIVE_MONOAT...1,SET,5,0.37117,0.0061247,0.35749,0.14958,GOMF_MECHANOSENSITIVE_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.950694459681843
GOBP_REGULATION_OF_CELLULAR_...3,SET,897,0.030322,0.0065367,0.029205,0.14959,GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS,0.950694459681843
GOBP_CILIUM_ORGANIZATION,SET,369,0.044649,0.0062662,0.043007,0.1496,GOBP_CILIUM_ORGANIZATION,0.950694459681843
HP_UNCONTROLLED_EYE_MOVEMENTS,SET,8,0.37681,0.0078642,0.36318,0.14975,HP_UNCONTROLLED_EYE_MOVEMENTS,0.951269687557098
GOBP_REGULATION_OF_CELL_DIFF...,SET,1405,0.025353,0.0067401,0.024439,0.14978,GOBP_REGULATION_OF_CELL_DIFFERENTIATION,0.951269687557098
HP_FUNCTIONAL_INTESTINAL_OBS...,SET,10,0.26598,0.0062062,0.25639,0.14978,HP_FUNCTIONAL_INTESTINAL_OBSTRUCTION,0.951269687557098
GOBP_PROTEIN_PEPTIDYL_PROLYL...,SET,17,0.20481,0.0062296,0.19744,0.1498,GOBP_PROTEIN_PEPTIDYL_PROLYL_ISOMERIZATION,0.951269687557098
GOBP_PANTOTHENATE_METABOLIC_...,SET,7,0.34165,0.0066701,0.3294,0.14983,GOBP_PANTOTHENATE_METABOLIC_PROCESS,0.951286381074169
QIU_PBMC_HEPTATITIS_B_SURFAC...3,SET,7,0.35641,0.0069583,0.34375,0.14992,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_28DY_DN,0.951419709959869
BILD_SRC_ONCOGENIC_SIGNATURE,SET,55,0.11189,0.0061149,0.10793,0.14995,BILD_SRC_ONCOGENIC_SIGNATURE,0.951419709959869
REACTOME_POSTMITOTIC_NUCLEAR...,SET,26,0.16356,0.0061511,0.15777,0.14995,REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION,0.951419709959869
GOBP_REGULATION_OF_DNA_DAMAG...1,SET,18,0.1862,0.0058277,0.17964,0.14998,GOBP_REGULATION_OF_DNA_DAMAGE_CHECKPOINT,0.951419709959869
MODULE_465,SET,13,0.23901,0.0063581,0.23063,0.15002,MODULE_465,0.951419709959869
GOMF_DNA_INSERTION_OR_DELETI...,SET,6,0.29299,0.0052959,0.28271,0.15003,GOMF_DNA_INSERTION_OR_DELETION_BINDING,0.951419709959869
GOBP_SINOATRIAL_NODE_DEVELOP...,SET,12,0.2973,0.0075987,0.28692,0.15006,GOBP_SINOATRIAL_NODE_DEVELOPMENT,0.951419709959869
GSE5589_IL6_KO_VS_IL10_KO_LP...4,SET,181,0.067674,0.0066864,0.065311,0.15007,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.951419709959869
MATZUK_SPERMATOGONIA,SET,25,0.1856,0.0068445,0.17926,0.15026,MATZUK_SPERMATOGONIA,0.95166105664488
GOBP_INOSINE_METABOLIC_PROCE...,SET,4,0.53425,0.0078852,0.51606,0.15028,GOBP_INOSINE_METABOLIC_PROCESS,0.95166105664488
GOBP_PIGMENT_GRANULE_ORGANIZ...,SET,36,0.15252,0.0067474,0.14736,0.15034,GOBP_PIGMENT_GRANULE_ORGANIZATION,0.95166105664488
HP_FETAL_PLEURAL_EFFUSION,SET,5,0.39199,0.0064682,0.37875,0.15035,HP_FETAL_PLEURAL_EFFUSION,0.95166105664488
HP_SHORT_FACE,SET,17,0.23192,0.0070541,0.22408,0.15035,HP_SHORT_FACE,0.95166105664488
GOBP_NEGATIVE_REGULATION_OF_...272,SET,3,0.64045,0.0081865,0.61894,0.1504,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,0.95166105664488
GOMF_EXTRACELLULARLY_ATP_GAT...,SET,7,0.36139,0.0070555,0.34925,0.1504,GOMF_EXTRACELLULARLY_ATP_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.95166105664488
HP_MECHANICAL_ILEUS,SET,21,0.20856,0.0070499,0.20158,0.15042,HP_MECHANICAL_ILEUS,0.95166105664488
KORKOLA_YOLK_SAC_TUMOR,SET,53,0.12882,0.0069115,0.12451,0.15045,KORKOLA_YOLK_SAC_TUMOR,0.95166105664488
GOMF_INOSITOL_TETRAKISPHOSPH...1,SET,5,0.41235,0.0068042,0.39858,0.15045,GOMF_INOSITOL_TETRAKISPHOSPHATE_KINASE_ACTIVITY,0.95166105664488
MIR6774_3P,SET,5,0.47588,0.0078525,0.46002,0.15047,MIR6774_3P,0.95166105664488
GSE22886_NAIVE_TCELL_VS_NEUT...2,SET,175,0.063802,0.0061996,0.061683,0.15049,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP,0.95166105664488
GOBP_PEPTIDYL_GLUTAMIC_ACID_...,SET,25,0.17704,0.0065286,0.1712,0.15055,GOBP_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION,0.95166105664488
BIOCARTA_CALCINEURIN_PATHWAY,SET,18,0.20476,0.0064084,0.19801,0.15056,BIOCARTA_CALCINEURIN_PATHWAY,0.95166105664488
GOBP_GASTRULATION_WITH_MOUTH...,SET,23,0.17118,0.0060551,0.16556,0.1506,GOBP_GASTRULATION_WITH_MOUTH_FORMING_SECOND,0.95166105664488
GOBP_REGULATION_OF_POTASSIUM...1,SET,7,0.34777,0.0067897,0.33641,0.15063,GOBP_REGULATION_OF_POTASSIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.95166105664488
NIKOLSKY_BREAST_CANCER_21Q22...,SET,15,0.387,0.011058,0.37443,0.15067,NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON,0.95166105664488
GOBP_CARBOHYDRATE_PHOSPHORYL...,SET,21,0.16917,0.0057185,0.16368,0.15067,GOBP_CARBOHYDRATE_PHOSPHORYLATION,0.95166105664488
HP_DISPROPORTIONATE_SHORT_ST...,SET,119,0.082091,0.0065878,0.079428,0.15069,HP_DISPROPORTIONATE_SHORT_STATURE,0.95166105664488
RYTGCNWTGGNR_UNKNOWN,SET,100,0.090105,0.0066321,0.087186,0.1507,RYTGCNWTGGNR_UNKNOWN,0.95166105664488
GOBP_XYLULOSE_5_PHOSPHATE_ME...,SET,6,0.3793,0.006856,0.36702,0.1507,GOBP_XYLULOSE_5_PHOSPHATE_METABOLIC_PROCESS,0.95166105664488
GOBP_RESPONSE_TO_FOLLICLE_ST...,SET,15,0.25881,0.0073951,0.25049,0.15075,GOBP_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE,0.95166105664488
HP_FUNCTIONAL_ABNORMALITY_OF...1,SET,228,0.057702,0.0063904,0.055853,0.15078,HP_FUNCTIONAL_ABNORMALITY_OF_MALE_INTERNAL_GENITALIA,0.95166105664488
GSE22886_NAIVE_CD4_TCELL_VS_...6,SET,179,0.064802,0.0063676,0.062725,0.15078,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP,0.95166105664488
HP_ABNORMAL_LABIA_MINORA_MOR...,SET,34,0.15797,0.0067919,0.15292,0.15082,HP_ABNORMAL_LABIA_MINORA_MORPHOLOGY,0.95166105664488
GSE19401_PAM2CSK4_VS_RETINOI...3,SET,175,0.065066,0.0063224,0.062989,0.15082,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,0.95166105664488
RICKMAN_TUMOR_DIFFERENTIATED...6,SET,212,0.058588,0.0062596,0.056726,0.15085,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,0.951677573062262
HP_FASTING_HYPERINSULINEMIA,SET,9,0.30752,0.0068072,0.29785,0.15093,HP_FASTING_HYPERINSULINEMIA,0.9520094646098
HP_MALFORMATION_OF_THE_HEPAT...,SET,8,0.25514,0.0053249,0.24719,0.151,HP_MALFORMATION_OF_THE_HEPATIC_DUCTAL_PLATE,0.952168459724238
HP_TORTUOUS_CEREBRAL_ARTERIES,SET,5,0.3551,0.0058596,0.34404,0.15101,HP_TORTUOUS_CEREBRAL_ARTERIES,0.952168459724238
HP_ABNORMAL_PIGMENTATION_OF_...,SET,35,0.15498,0.0067604,0.15021,0.1511,HP_ABNORMAL_PIGMENTATION_OF_THE_ORAL_MUCOSA,0.9522769515721
GOBP_NOREPINEPHRINE_TRANSPORT,SET,23,0.21182,0.0074927,0.20536,0.15117,GOBP_NOREPINEPHRINE_TRANSPORT,0.9522769515721
GSE16451_IMMATURE_VS_MATURE_...1,SET,180,0.062957,0.0062034,0.061045,0.1512,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.9522769515721
HP_ABNORMALITY_OF_THE_DENTIT...,SET,875,0.030387,0.006474,0.029476,0.1513,HP_ABNORMALITY_OF_THE_DENTITION,0.9522769515721
REACTOME_ABACAVIR_TRANSMEMBR...,SET,5,0.46501,0.0076732,0.4511,0.15132,REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT,0.9522769515721
MIR11400,SET,8,0.27744,0.0057903,0.26915,0.15133,MIR11400,0.9522769515721
SIPA1_TARGET_GENES,SET,102,0.086634,0.0064397,0.084078,0.15142,SIPA1_TARGET_GENES,0.9522769515721
GOBP_REGULATION_OF_NEUROGENE...,SET,346,0.049465,0.0067265,0.048005,0.15142,GOBP_REGULATION_OF_NEUROGENESIS,0.9522769515721
GOMF_FATTY_ACYL_COA_SYNTHASE...,SET,6,0.39641,0.0071654,0.38473,0.15143,GOMF_FATTY_ACYL_COA_SYNTHASE_ACTIVITY,0.9522769515721
HE_LIM_SUN_FETAL_LUNG_C1_PUL...1,SET,202,0.067307,0.0070214,0.065326,0.15143,HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NEUROENDOCRINE_CELL,0.9522769515721
GOBP_RESPONSE_TO_REACTIVE_OX...,SET,179,0.067917,0.0066736,0.065926,0.15146,GOBP_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,0.9522769515721
MIR605_5P,SET,125,0.08265,0.0067968,0.080228,0.15147,MIR605_5P,0.9522769515721
HP_CARDIAC_VALVE_CALCIFICATI...,SET,11,0.30013,0.0073446,0.29135,0.15148,HP_CARDIAC_VALVE_CALCIFICATION,0.9522769515721
HP_ABNORMAL_BRAINSTEM_WHITE_...,SET,15,0.21873,0.0062497,0.21235,0.15151,HP_ABNORMAL_BRAINSTEM_WHITE_MATTER_MORPHOLOGY,0.9522769515721
HP_MALAR_PROMINENCE,SET,5,0.37223,0.0061422,0.36142,0.15153,HP_MALAR_PROMINENCE,0.9522769515721
GSE17721_CTRL_VS_CPG_24H_BMD...2,SET,180,0.064021,0.0063082,0.06216,0.15153,GSE17721_CTRL_VS_CPG_24H_BMDC_UP,0.9522769515721
GOBP_MITOCHONDRIAL_TRANSPORT,SET,163,0.066011,0.0061925,0.064099,0.15155,GOBP_MITOCHONDRIAL_TRANSPORT,0.9522769515721
WP_PREGNANE_X_RECEPTOR_PATHW...,SET,31,0.17788,0.0073033,0.17274,0.15157,WP_PREGNANE_X_RECEPTOR_PATHWAY,0.9522769515721
HP_TACHYCARDIA,SET,134,0.079759,0.0067894,0.077453,0.15157,HP_TACHYCARDIA,0.9522769515721
HP_STOMATOCYTOSIS,SET,12,0.27049,0.0069133,0.26273,0.15162,HP_STOMATOCYTOSIS,0.9522769515721
E47_01,SET,233,0.058015,0.0064943,0.056353,0.15163,E47_01,0.9522769515721
HP_PROFOUND_SENSORINEURAL_HE...,SET,9,0.31057,0.0068747,0.30167,0.15163,HP_PROFOUND_SENSORINEURAL_HEARING_IMPAIRMENT,0.9522769515721
CTGCAGY_UNKNOWN,SET,678,0.035154,0.00663,0.034157,0.1517,CTGCAGY_UNKNOWN,0.952497940751445
GAUSSMANN_MLL_AF4_FUSION_TAR...12,SET,166,0.072503,0.0068632,0.070453,0.15172,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,0.952497940751445
GSE12505_WT_VS_E2_2_HET_PDC_...2,SET,119,0.081675,0.0065545,0.079375,0.15175,GSE12505_WT_VS_E2_2_HET_PDC_UP,0.95251422250316
ROESSLER_LIVER_CANCER_METAST...2,SET,100,0.084863,0.0062463,0.082485,0.15179,ROESSLER_LIVER_CANCER_METASTASIS_UP,0.952546768369742
GOCC_SMOOTH_ENDOPLASMIC_RETI...2,SET,7,0.38211,0.00746,0.37144,0.15181,GOCC_SMOOTH_ENDOPLASMIC_RETICULUM_MEMBRANE,0.952546768369742
GSE21063_3H_VS_16H_ANTI_IGM_...2,SET,179,0.06789,0.0066711,0.06602,0.1519,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP,0.952597827262892
GOMF_DAMAGED_DNA_BINDING,SET,71,0.089627,0.0055631,0.087161,0.15191,GOMF_DAMAGED_DNA_BINDING,0.952597827262892
HP_MALE_HYPOGONADISM,SET,38,0.14549,0.0066127,0.14149,0.15191,HP_MALE_HYPOGONADISM,0.952597827262892
GSE29618_PRE_VS_DAY7_FLU_VAC...2,SET,176,0.067233,0.0065514,0.065396,0.15196,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP,0.952597827262892
HP_SPARSE_EYEBROW,SET,121,0.077949,0.0063075,0.075828,0.15199,HP_SPARSE_EYEBROW,0.952597827262892
GSE44649_WT_VS_MIR155_KO_ACT...2,SET,189,0.064463,0.0065071,0.062712,0.152,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP,0.952597827262892
GSE28408_LY6G_POS_VS_NEG_DC_...2,SET,175,0.065361,0.006351,0.063588,0.15201,GSE28408_LY6G_POS_VS_NEG_DC_UP,0.952597827262892
GOBP_DEVELOPMENTAL_CELL_GROW...,SET,198,0.064648,0.0066776,0.062941,0.15219,GOBP_DEVELOPMENTAL_CELL_GROWTH,0.953553893996755
PANGAS_TUMOR_SUPPRESSION_BY_...2,SET,118,0.083795,0.0066965,0.081597,0.15223,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,0.953586006487655
GOBP_POSITIVE_REGULATION_OF_...787,SET,12,0.22396,0.005724,0.2181,0.15225,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.953586006487655
HP_MIDDLE_AGE_ONSET,SET,219,0.060384,0.0065558,0.058822,0.15232,HP_MIDDLE_AGE_ONSET,0.953587574284171
GSE20727_H2O2_VS_ROS_INHIBIT...1,SET,174,0.067301,0.006521,0.065564,0.15234,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN,0.953587574284171
chr15q25,SET,58,0.1904,0.010685,0.1855,0.15236,chr15q25,0.953587574284171
LMO2COM_01,SET,241,0.059468,0.0067688,0.05794,0.15236,LMO2COM_01,0.953587574284171
BIOCARTA_DSP_PATHWAY,SET,8,0.36165,0.0075479,0.35239,0.15239,BIOCARTA_DSP_PATHWAY,0.953603610010803
NAKAMURA_CANCER_MICROENVIRON...2,SET,23,0.19784,0.0069982,0.1928,0.15243,NAKAMURA_CANCER_MICROENVIRONMENT_UP,0.953682205220522
MIR4633_3P_MIR6500_5P,SET,32,0.15204,0.0063424,0.14821,0.15249,MIR4633_3P_MIR6500_5P,0.953855289672544
HP_BEAKING_OF_VERTEBRAL_BODI...,SET,25,0.17152,0.0063253,0.16723,0.15253,HP_BEAKING_OF_VERTEBRAL_BODIES,0.953855289672544
SCHLESINGER_METHYLATED_IN_CO...,SET,10,0.30696,0.0071624,0.2993,0.15254,SCHLESINGER_METHYLATED_IN_COLON_CANCER,0.953855289672544
GOBP_STEM_CELL_PROLIFERATION,SET,107,0.088027,0.0067008,0.085837,0.15257,GOBP_STEM_CELL_PROLIFERATION,0.953871262817053
GOBP_POSITIVE_REGULATION_OF_...706,SET,5,0.38502,0.0063532,0.37556,0.15265,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION,0.954108985637343
REACTOME_SARS_COV_2_MODULATE...1,SET,11,0.23681,0.0057951,0.23105,0.1527,REACTOME_SARS_COV_2_MODULATES_AUTOPHAGY,0.954108985637343
KEGG_MEDICUS_REFERENCE_HYDRO...,SET,8,0.30805,0.0064293,0.3006,0.15274,KEGG_MEDICUS_REFERENCE_HYDROLYSIS_OF_SPHINGOMYELIN,0.954108985637343
GOBP_ANTIMICROBIAL_HUMORAL_I...,SET,90,0.1089,0.0076065,0.10628,0.15277,GOBP_ANTIMICROBIAL_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_ANTIMICROBIAL_PEPTIDE,0.954108985637343
GOBP_MITOTIC_DNA_REPLICATION...,SET,11,0.22636,0.0055393,0.22091,0.15277,GOBP_MITOTIC_DNA_REPLICATION_CHECKPOINT_SIGNALING,0.954108985637343
GOCC_THO_COMPLEX,SET,5,0.36074,0.0059527,0.3522,0.15287,GOCC_THO_COMPLEX,0.954108985637343
HP_JOINT_CONTRACTURE_OF_THE_...2,SET,14,0.23784,0.0065656,0.23223,0.15289,HP_JOINT_CONTRACTURE_OF_THE_5TH_FINGER,0.954108985637343
HP_ABNORMAL_CIRCULATING_BRAN...,SET,8,0.30729,0.0064133,0.30006,0.1529,HP_ABNORMAL_CIRCULATING_BRANCHED_CHAIN_AMINO_ACID_CONCENTRATION,0.954108985637343
GSE37301_MULTIPOTENT_PROGENI...10,SET,178,0.066317,0.0064984,0.064755,0.1529,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP,0.954108985637343
GOBP_MEIOTIC_ATTACHMENT_OF_T...,SET,2,0.48434,0.0050551,0.47297,0.15291,GOBP_MEIOTIC_ATTACHMENT_OF_TELOMERE_TO_NUCLEAR_ENVELOPE,0.954108985637343
GOMF_EXTRACELLULAR_LIGAND_GA...,SET,67,0.11905,0.007179,0.11626,0.15291,GOMF_EXTRACELLULAR_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.954108985637343
REACTOME_RAB_GEFS_EXCHANGE_G...,SET,82,0.095613,0.0063759,0.093385,0.15296,REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,0.954249649973075
GOBP_POSITIVE_REGULATION_OF_...487,SET,5,0.40383,0.0066637,0.39455,0.15303,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_EXTRAVASATION,0.954344755244755
MARIADASON_RESPONSE_TO_BUTYR...3,SET,9,0.30064,0.0066551,0.29375,0.15305,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8,0.954344755244755
REACTOME_METABOLISM_OF_WATER...,SET,120,0.078386,0.0063167,0.076598,0.15308,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,0.954344755244755
GOBP_REGULATION_OF_CELL_CELL...2,SET,19,0.18922,0.0060842,0.18491,0.15309,GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.954344755244755
GOBP_REGULATION_OF_NEURON_MA...,SET,8,0.32292,0.0067395,0.31562,0.15313,GOBP_REGULATION_OF_NEURON_MATURATION,0.954344755244755
GSE5542_UNTREATED_VS_IFNA_TR...3,SET,171,0.065163,0.0062597,0.063692,0.15314,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,0.954344755244755
REACTOME_ACTIVATION_OF_THE_T...,SET,11,0.27678,0.0067732,0.27064,0.15324,REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS,0.954405846344926
GOBP_SMOOTH_MUSCLE_CELL_CHEM...,SET,8,0.3166,0.0066076,0.3096,0.15325,GOBP_SMOOTH_MUSCLE_CELL_CHEMOTAXIS,0.954405846344926
GSE16522_MEMORY_VS_NAIVE_CD8...2,SET,170,0.06337,0.0060698,0.062,0.15337,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.954405846344926
MIR4315,SET,3,0.49153,0.006283,0.48091,0.15338,MIR4315,0.954405846344926
GOMF_SH2_DOMAIN_BINDING,SET,39,0.15054,0.0069311,0.14728,0.15338,GOMF_SH2_DOMAIN_BINDING,0.954405846344926
MIR6851_3P,SET,53,0.11592,0.0062194,0.11342,0.15339,MIR6851_3P,0.954405846344926
HP_PROXIMAL_SYMPHALANGISM_OF...,SET,5,0.43441,0.0071683,0.42518,0.15346,HP_PROXIMAL_SYMPHALANGISM_OF_HANDS,0.954405846344926
KYNG_RESPONSE_TO_H2O2_VIA_ER...1,SET,17,0.21892,0.0066588,0.21433,0.15353,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,0.954405846344926
WP_LACTATE_SHUTTLE_IN_GLIAL_...,SET,12,0.27403,0.0070039,0.26832,0.15357,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,0.954405846344926
HP_ABNORMALITY_OF_THE_ORBITA...,SET,1409,0.023893,0.0063603,0.023396,0.15357,HP_ABNORMALITY_OF_THE_ORBITAL_REGION,0.954405846344926
GSE17301_CTRL_VS_48H_ACD3_AC...5,SET,177,0.06749,0.0065949,0.066096,0.15361,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN,0.954405846344926
FORTSCHEGGER_PHF8_TARGETS_DN,SET,684,0.033825,0.0064063,0.033132,0.15366,FORTSCHEGGER_PHF8_TARGETS_DN,0.954405846344926
GOBP_LIVER_REGENERATION,SET,30,0.15173,0.0061286,0.14863,0.15367,GOBP_LIVER_REGENERATION,0.954405846344926
GSE21546_ELK1_KO_VS_SAP1A_KO...4,SET,172,0.064222,0.0061871,0.062914,0.15369,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.954405846344926
GOBP_BRAIN_DERIVED_NEUROTROP...,SET,6,0.40448,0.0073113,0.3963,0.15372,GOBP_BRAIN_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.954405846344926
HP_ABNORMALITY_OF_SECONDARY_...,SET,70,0.10468,0.0064517,0.10257,0.15374,HP_ABNORMALITY_OF_SECONDARY_SEXUAL_HAIR,0.954405846344926
PEDERSEN_METASTASIS_BY_ERBB2...1,SET,44,0.13263,0.0064854,0.12997,0.15375,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,0.954405846344926
GSE369_PRE_VS_POST_IL6_INJEC...5,SET,184,0.061052,0.0060814,0.059827,0.15376,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN,0.954405846344926
GOBP_RESPONSE_TO_BACTERIUM,SET,611,0.038851,0.0069688,0.038073,0.15377,GOBP_RESPONSE_TO_BACTERIUM,0.954405846344926
GOMF_OXIDATIVE_PHOSPHORYLATI...,SET,4,0.42001,0.0061991,0.41165,0.1538,GOMF_OXIDATIVE_PHOSPHORYLATION_UNCOUPLER_ACTIVITY,0.954405846344926
HP_PRENATAL_DEATH,SET,61,0.11678,0.0067205,0.11446,0.15381,HP_PRENATAL_DEATH,0.954405846344926
MIR21_3P,SET,122,0.082976,0.0067418,0.081336,0.15383,MIR21_3P,0.954405846344926
GSE15330_LYMPHOID_MULTIPOTEN...10,SET,182,0.063748,0.0063158,0.062499,0.15388,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_UP,0.954405846344926
GOMF_PROTEIN_GLUTAMIC_ACID_L...,SET,9,0.31113,0.0068873,0.30507,0.1539,GOMF_PROTEIN_GLUTAMIC_ACID_LIGASE_ACTIVITY,0.954405846344926
PURBEY_TARGETS_OF_CTBP1_AND_...1,SET,150,0.069412,0.0062486,0.068063,0.15391,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,0.954405846344926
GOBP_POSITIVE_REGULATION_OF_...688,SET,1682,0.022176,0.0063975,0.021745,0.15392,GOBP_POSITIVE_REGULATION_OF_RNA_METABOLIC_PROCESS,0.954405846344926
GOBP_POSITIVE_REGULATION_OF_...396,SET,23,0.1811,0.0064062,0.1776,0.15393,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.954405846344926
HP_ABNORMALITY_OF_VENOUS_PHY...,SET,11,0.27668,0.0067707,0.27135,0.15395,HP_ABNORMALITY_OF_VENOUS_PHYSIOLOGY,0.954405846344926
GOBP_PURINE_RIBONUCLEOSIDE_C...,SET,5,0.48349,0.007978,0.47417,0.15396,GOBP_PURINE_RIBONUCLEOSIDE_CATABOLIC_PROCESS,0.954405846344926
KEGG_MEDICUS_REFERENCE_TNF_N...,SET,14,0.22285,0.0061518,0.21859,0.15399,KEGG_MEDICUS_REFERENCE_TNF_NFKB_SIGNALING_PATHWAY,0.954405846344926
HP_ALOPECIA_TOTALIS,SET,13,0.27432,0.0072972,0.26914,0.15406,HP_ALOPECIA_TOTALIS,0.954405846344926
FOXJ2_TARGET_GENES,SET,439,0.041651,0.0063633,0.040869,0.15408,FOXJ2_TARGET_GENES,0.954405846344926
GSE17721_12H_VS_24H_GARDIQUI...2,SET,177,0.066175,0.0064665,0.064936,0.15409,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_UP,0.954405846344926
GOMF_O_PALMITOYLTRANSFERASE_...,SET,5,0.3697,0.0061004,0.36281,0.15411,GOMF_O_PALMITOYLTRANSFERASE_ACTIVITY,0.954405846344926
MIR4648,SET,37,0.13288,0.0059595,0.13042,0.15415,MIR4648,0.954405846344926
GOBP_CARDIAC_VENTRICLE_FORMA...,SET,7,0.38937,0.0076019,0.38218,0.15415,GOBP_CARDIAC_VENTRICLE_FORMATION,0.954405846344926
MIR324_3P,SET,71,0.10121,0.0062822,0.099371,0.15422,MIR324_3P,0.954405846344926
HP_ABNORMALITY_OF_THE_HYPOTH...1,SET,360,0.045206,0.0062681,0.044392,0.15427,HP_ABNORMALITY_OF_THE_HYPOTHALAMUS_PITUITARY_AXIS,0.954405846344926
chr17q12,SET,86,0.19686,0.013442,0.19335,0.15432,chr17q12,0.954405846344926
KEGG_NICOTINATE_AND_NICOTINA...,SET,24,0.19216,0.0069433,0.18874,0.15433,KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM,0.954405846344926
GSE22886_UNSTIM_VS_IL2_STIM_...2,SET,168,0.063755,0.006071,0.062628,0.15434,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP,0.954405846344926
HP_ELEVATED_URINARY_3_HYDROX...,SET,5,0.40779,0.006729,0.40063,0.15438,HP_ELEVATED_URINARY_3_HYDROXYBUTYRIC_ACID,0.954405846344926
MIR3686,SET,294,0.051885,0.0065132,0.050978,0.1544,MIR3686,0.954405846344926
GOBP_NEGATIVE_REGULATION_OF_...635,SET,6,0.39496,0.0071391,0.38808,0.15441,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.954405846344926
HU_GENOTOXIN_ACTION_DIRECT_V...1,SET,45,0.12624,0.0062423,0.12405,0.15444,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,0.954405846344926
GINESTIER_BREAST_CANCER_ZNF2...1,SET,303,0.046584,0.0059351,0.045785,0.15448,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,0.954405846344926
GSE24142_ADULT_VS_FETAL_EARL...2,SET,183,0.065946,0.0065513,0.064839,0.15456,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP,0.954405846344926
GOBP_SPERMIDINE_METABOLIC_PR...,SET,6,0.32389,0.0058544,0.31845,0.15457,GOBP_SPERMIDINE_METABOLIC_PROCESS,0.954405846344926
MIR6743_5P,SET,35,0.13652,0.0059553,0.13424,0.15458,MIR6743_5P,0.954405846344926
GSE411_UNSTIM_VS_100MIN_IL6_...3,SET,186,0.065682,0.0065778,0.064586,0.15459,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,0.954405846344926
GOMF_SULFUR_COMPOUND_TRANSME...,SET,59,0.11324,0.0064092,0.11135,0.1546,GOMF_SULFUR_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.954405846344926
GSE13738_TCR_VS_BYSTANDER_AC...1,SET,169,0.067362,0.0064333,0.06624,0.1546,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,0.954405846344926
HP_CONGENITAL_ONSET,SET,951,0.028821,0.0063877,0.028346,0.15464,HP_CONGENITAL_ONSET,0.954405846344926
GSE2770_IL4_ACT_VS_ACT_CD4_T...4,SET,178,0.06457,0.0063272,0.063508,0.15465,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,0.954405846344926
GOBP_REGULATION_OF_HEMATOPOI...3,SET,14,0.23366,0.0064503,0.2299,0.15473,GOBP_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,0.954405846344926
GOBP_RESPONSE_TO_INACTIVITY,SET,12,0.26909,0.0068776,0.26476,0.15473,GOBP_RESPONSE_TO_INACTIVITY,0.954405846344926
GOBP_CORTISOL_BIOSYNTHETIC_P...,SET,10,0.32078,0.0074847,0.31564,0.15476,GOBP_CORTISOL_BIOSYNTHETIC_PROCESS,0.954405846344926
GSE23502_BM_VS_COLON_TUMOR_M...2,SET,184,0.069009,0.0068741,0.067905,0.15476,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,0.954405846344926
MIR3158_3P,SET,35,0.14038,0.0061237,0.13814,0.15477,MIR3158_3P,0.954405846344926
GSE11386_NAIVE_VS_MEMORY_BCE...1,SET,144,0.073613,0.006494,0.072449,0.15481,GSE11386_NAIVE_VS_MEMORY_BCELL_DN,0.954483155934007
GOBP_REGULATION_OF_GLIAL_CEL...3,SET,18,0.22999,0.007198,0.22638,0.15484,GOBP_REGULATION_OF_GLIAL_CELL_MIGRATION,0.954498793898546
GSE32423_CTRL_VS_IL7_IL4_MEM...2,SET,182,0.06504,0.0064437,0.064029,0.15487,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,0.954514426316723
HP_SPLANCHNIC_VEIN_THROMBOSIS,SET,22,0.19451,0.0067295,0.19152,0.15491,HP_SPLANCHNIC_VEIN_THROMBOSIS,0.954591675531915
HP_SCHISTOCYTOSIS,SET,10,0.26842,0.0062631,0.26434,0.15496,HP_SCHISTOCYTOSIS,0.95473050877504
MIR3170,SET,46,0.12142,0.0060703,0.11965,0.15511,MIR3170,0.955315975544923
GOMF_PROTEIN_KINASE_ACTIVITY,SET,534,0.038319,0.0064396,0.03776,0.15511,GOMF_PROTEIN_KINASE_ACTIVITY,0.955315975544923
HP_SUBRETINAL_FLUID,SET,9,0.31711,0.0070197,0.3126,0.15519,HP_SUBRETINAL_FLUID,0.955517055084746
GOBP_MONONUCLEAR_CELL_MIGRAT...,SET,203,0.064631,0.0067587,0.063726,0.15525,GOBP_MONONUCLEAR_CELL_MIGRATION,0.955517055084746
GOBP_SPECIFICATION_OF_ANIMAL...,SET,35,0.16723,0.0072951,0.16491,0.15528,GOBP_SPECIFICATION_OF_ANIMAL_ORGAN_IDENTITY,0.955517055084746
GOCC_MIB_COMPLEX,SET,9,0.27073,0.0059929,0.26699,0.1553,GOCC_MIB_COMPLEX,0.955517055084746
SRPK1_TARGET_GENES,SET,304,0.048738,0.0062196,0.048083,0.15539,SRPK1_TARGET_GENES,0.955517055084746
WP_NUCLEAR_RECEPTORS_IN_LIPI...,SET,33,0.15518,0.0065734,0.15311,0.15541,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,0.955517055084746
MIR7113_5P,SET,136,0.074276,0.0063693,0.073309,0.15549,MIR7113_5P,0.955517055084746
GSE22935_24H_VS_48H_MBOVIS_B...3,SET,178,0.066974,0.0065628,0.066107,0.15551,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.955517055084746
YTAAYNGCT_UNKNOWN,SET,130,0.082026,0.0068781,0.080967,0.15552,YTAAYNGCT_UNKNOWN,0.955517055084746
HP_ABNORMAL_SERUM_ESTRADIOL,SET,59,0.10947,0.0061958,0.10806,0.15553,HP_ABNORMAL_SERUM_ESTRADIOL,0.955517055084746
GOBP_SKELETAL_MUSCLE_CONTRAC...,SET,43,0.12902,0.0062368,0.12738,0.15558,GOBP_SKELETAL_MUSCLE_CONTRACTION,0.955517055084746
GOBP_ANAPHASE_PROMOTING_COMP...,SET,22,0.16478,0.0057009,0.16271,0.1556,GOBP_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS,0.955517055084746
BUSSLINGER_DUODENAL_IMMUNE_C...,SET,822,0.030769,0.0063633,0.030386,0.15563,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.955517055084746
HP_ISOMERISM,SET,4,0.43939,0.0064852,0.43399,0.15567,HP_ISOMERISM,0.955517055084746
GOBP_AXON_EXTENSION,SET,93,0.091292,0.0064812,0.090175,0.15568,GOBP_AXON_EXTENSION,0.955517055084746
HP_MYOPIA,SET,364,0.045593,0.0063561,0.045035,0.15568,HP_MYOPIA,0.955517055084746
GOBP_NONRIBOSOMAL_PEPTIDE_BI...,SET,17,0.22275,0.0067752,0.22004,0.1557,GOBP_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS,0.955517055084746
HP_UPSLANTED_PALPEBRAL_FISSU...,SET,270,0.050452,0.0060734,0.049838,0.1557,HP_UPSLANTED_PALPEBRAL_FISSURE,0.955517055084746
REACTOME_NEGATIVE_FEEDBACK_R...,SET,6,0.35548,0.0064255,0.35118,0.15572,REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY,0.955517055084746
GOCC_PRERIBOSOME_SMALL_SUBUN...,SET,14,0.21186,0.0058484,0.2093,0.15572,GOCC_PRERIBOSOME_SMALL_SUBUNIT_PRECURSOR,0.955517055084746
GOMF_CCR2_CHEMOKINE_RECEPTOR...,SET,5,0.43811,0.0072293,0.43282,0.15572,GOMF_CCR2_CHEMOKINE_RECEPTOR_BINDING,0.955517055084746
GOBP_NEGATIVE_REGULATION_OF_...255,SET,5,0.45193,0.0074574,0.44654,0.15576,GOBP_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS,0.955547811507236
GOBP_CIRCADIAN_SLEEP_WAKE_CY...3,SET,16,0.23579,0.0069581,0.233,0.15578,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP,0.955547811507236
REACTOME_SIGNAL_REGULATORY_P...,SET,14,0.24521,0.006769,0.24249,0.15596,REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS,0.956252697461213
WP_LET7_INHIBITION_OF_ES_CEL...,SET,6,0.37606,0.0067975,0.3719,0.15597,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,0.956252697461213
P53_DN.V2_DN,SET,134,0.074999,0.0063841,0.074188,0.15603,P53_DN.V2_DN,0.956252697461213
GSE17721_0.5H_VS_24H_GARDIQU...2,SET,172,0.062429,0.0060145,0.061754,0.15603,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_UP,0.956252697461213
GOCC_EXTRINSIC_COMPONENT_OF_...3,SET,6,0.31711,0.005732,0.3137,0.15604,GOCC_EXTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE,0.956252697461213
GOBP_PROTEIN_INSERTION_INTO_...2,SET,9,0.27053,0.0059886,0.26764,0.15606,GOBP_PROTEIN_INSERTION_INTO_ER_MEMBRANE_BY_STOP_TRANSFER_MEMBRANE_ANCHOR_SEQUENCE,0.956252697461213
HP_ABNORMALITY_OF_THE_PALPEB...,SET,738,0.03184,0.0062543,0.031513,0.15617,HP_ABNORMALITY_OF_THE_PALPEBRAL_FISSURES,0.956359191759112
REACTOME_HISTIDINE_CATABOLISM,SET,7,0.34766,0.0067875,0.34411,0.15618,REACTOME_HISTIDINE_CATABOLISM,0.956359191759112
HP_REDUCED_PANCREATIC_BETA_C...,SET,7,0.38245,0.0074666,0.37855,0.15618,HP_REDUCED_PANCREATIC_BETA_CELLS,0.956359191759112
GOBP_ODONTOGENESIS_OF_DENTIN...,SET,87,0.10173,0.0069868,0.10071,0.15621,GOBP_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH,0.956359191759112
MORF_NF1,SET,160,0.067643,0.0062874,0.066963,0.15622,MORF_NF1,0.956359191759112
GOBP_POSITIVE_REGULATION_OF_...2,SET,11,0.26407,0.0064621,0.26148,0.15627,GOBP_POSITIVE_REGULATION_OF_ACROSOME_REACTION,0.956359191759112
HP_OLIGOMENORRHEA,SET,37,0.13886,0.0062277,0.13749,0.15627,HP_OLIGOMENORRHEA,0.956359191759112
HP_SMALL_INTESTINAL_STENOSIS,SET,27,0.14896,0.0057083,0.14751,0.15631,HP_SMALL_INTESTINAL_STENOSIS,0.956435572183099
GOBP_HAIR_FOLLICLE_MATURATION,SET,15,0.23988,0.006854,0.2376,0.15636,GOBP_HAIR_FOLLICLE_MATURATION,0.956573103326879
WP_CHOLESTEROL_METABOLISM_WI...,SET,44,0.12263,0.0059964,0.12151,0.15645,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,0.956585933660934
GOBP_EMBRYONIC_SKELETAL_JOIN...1,SET,14,0.25734,0.0071038,0.255,0.15646,GOBP_EMBRYONIC_SKELETAL_JOINT_DEVELOPMENT,0.956585933660934
GOBP_REGULATION_OF_NERVOUS_S...1,SET,417,0.044283,0.0065979,0.043887,0.15649,GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.956585933660934
DESCARTES_MAIN_FETAL_METANEP...,SET,25,0.20365,0.0075101,0.20187,0.15654,DESCARTES_MAIN_FETAL_METANEPHRIC_CELLS,0.956585933660934
GOBP_NUCLEOBASE_CONTAINING_S...2,SET,28,0.1927,0.0075199,0.19104,0.15657,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_CATABOLIC_PROCESS,0.956585933660934
MIR4696,SET,91,0.091394,0.0064187,0.09062,0.1566,MIR4696,0.956585933660934
GOMF_AROMATIC_AMINO_ACID_TRA...,SET,8,0.30601,0.0063867,0.30342,0.1566,GOMF_AROMATIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.956585933660934
MYAATNNNNNNNGGC_UNKNOWN,SET,103,0.085743,0.0064044,0.085026,0.15663,MYAATNNNNNNNGGC_UNKNOWN,0.956585933660934
MIF1_01,SET,163,0.068486,0.0064246,0.067914,0.15664,MIF1_01,0.956585933660934
GSE6269_E_COLI_VS_STREP_PNEU...1,SET,153,0.07094,0.0064492,0.070351,0.15665,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN,0.956585933660934
ZSCAN18_TARGET_GENES,SET,33,0.15277,0.0064713,0.15154,0.1567,ZSCAN18_TARGET_GENES,0.956585933660934
GOBP_RESPONSE_TO_WATER_DEPRI...,SET,5,0.33558,0.0055375,0.3329,0.15672,GOBP_RESPONSE_TO_WATER_DEPRIVATION,0.956585933660934
HP_POOR_WOUND_HEALING,SET,40,0.13988,0.0065221,0.13877,0.15674,HP_POOR_WOUND_HEALING,0.956585933660934
ZHAN_MULTIPLE_MYELOMA_MF_UP,SET,40,0.13652,0.0063656,0.13546,0.15677,ZHAN_MULTIPLE_MYELOMA_MF_UP,0.956585933660934
MIR299_5P,SET,134,0.077496,0.0065967,0.076911,0.15683,MIR299_5P,0.956585933660934
GNF2_MATK,SET,23,0.17465,0.0061781,0.17333,0.15683,GNF2_MATK,0.956585933660934
GOBP_REGULATION_OF_ANOIKIS,SET,22,0.18688,0.0064656,0.18548,0.15683,GOBP_REGULATION_OF_ANOIKIS,0.956585933660934
GOBP_SECRETION_OF_LYSOSOMAL_...,SET,6,0.3034,0.0054841,0.30125,0.15694,GOBP_SECRETION_OF_LYSOSOMAL_ENZYMES,0.957088910335146
GOBP_FLUID_TRANSPORT,SET,35,0.16443,0.0071726,0.16331,0.15701,GOBP_FLUID_TRANSPORT,0.957133926692389
REACTOME_FORMATION_OF_INCISI...,SET,38,0.1201,0.0054586,0.11929,0.15703,REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER,0.957133926692389
GOMF_UNMETHYLATED_CPG_BINDING,SET,9,0.25317,0.0056042,0.25147,0.15703,GOMF_UNMETHYLATED_CPG_BINDING,0.957133926692389
HP_PALPITATIONS,SET,102,0.089409,0.006646,0.08884,0.15712,HP_PALPITATIONS,0.957254784437434
FAN_EMBRYONIC_CTX_OLIG,SET,671,0.034577,0.0064886,0.034357,0.15712,FAN_EMBRYONIC_CTX_OLIG,0.957254784437434
MIR6887_3P,SET,176,0.067176,0.0065459,0.066761,0.15716,MIR6887_3P,0.957254784437434
GOBP_REGULATION_OF_AUTOPHAGY,SET,333,0.046709,0.0062336,0.046421,0.15716,GOBP_REGULATION_OF_AUTOPHAGY,0.957254784437434
GOBP_NEGATIVE_REGULATION_OF_...422,SET,9,0.27765,0.006146,0.27598,0.1572,GOBP_NEGATIVE_REGULATION_OF_MYELINATION,0.957284705676244
GOBP_CYTIDINE_METABOLIC_PROC...,SET,11,0.34366,0.0084098,0.34162,0.15722,GOBP_CYTIDINE_METABOLIC_PROCESS,0.957284705676244
GOBP_POSITIVE_REGULATION_OF_...321,SET,183,0.068336,0.0067887,0.067977,0.15739,GOBP_POSITIVE_REGULATION_OF_GTPASE_ACTIVITY,0.95781209156037
GGTGAAG_MIR412,SET,54,0.11736,0.0063558,0.11676,0.15741,GGTGAAG_MIR412,0.95781209156037
MORF_PAPSS1,SET,97,0.083902,0.0060827,0.083484,0.15745,MORF_PAPSS1,0.95781209156037
DESCARTES_MAIN_FETAL_CORNEAL...,SET,219,0.057414,0.0062334,0.057134,0.15748,DESCARTES_MAIN_FETAL_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS,0.95781209156037
HP_ABNORMAL_TONGUE_MORPHOLOGY,SET,333,0.047199,0.0062989,0.046973,0.1575,HP_ABNORMAL_TONGUE_MORPHOLOGY,0.95781209156037
GOCC_GLUTAMATERGIC_SYNAPSE,SET,389,0.044511,0.0064104,0.044302,0.15752,GOCC_GLUTAMATERGIC_SYNAPSE,0.95781209156037
HP_CERVICAL_SPINAL_CORD_ATRO...,SET,5,0.40433,0.0066718,0.40246,0.15754,HP_CERVICAL_SPINAL_CORD_ATROPHY,0.95781209156037
chr11q21,SET,28,0.26932,0.01051,0.26817,0.15762,chr11q21,0.95781209156037
GOBP_POSITIVE_REGULATION_OF_...312,SET,24,0.16999,0.0061422,0.16927,0.15765,GOBP_POSITIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,0.95781209156037
HP_ABNORMAL_FETAL_CENTRAL_NE...,SET,5,0.38415,0.0063389,0.38254,0.15765,HP_ABNORMAL_FETAL_CENTRAL_NERVOUS_SYSTEM_MORPHOLOGY,0.95781209156037
HP_SHORTENED_PR_INTERVAL,SET,6,0.34839,0.0062974,0.34694,0.15765,HP_SHORTENED_PR_INTERVAL,0.95781209156037
GOBP_REGULATION_OF_MUSCLE_CE...,SET,132,0.075482,0.0063775,0.075172,0.15767,GOBP_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,0.95781209156037
POMEROY_MEDULLOBLASTOMA_DESM...2,SET,56,0.11362,0.0062659,0.11317,0.15769,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,0.95781209156037
MIR548H_3P_MIR548Z,SET,547,0.037304,0.0063426,0.037156,0.1577,MIR548H_3P_MIR548Z,0.95781209156037
GOMF_PHOTORECEPTOR_ACTIVITY,SET,13,0.2422,0.0064429,0.24127,0.15772,GOMF_PHOTORECEPTOR_ACTIVITY,0.95781209156037
GSE43955_10H_VS_60H_ACT_CD4_...3,SET,184,0.065755,0.0065499,0.065559,0.15794,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.958410125370016
GOBP_NEGATIVE_REGULATION_OF_...427,SET,23,0.18687,0.0066104,0.18633,0.15795,GOBP_NEGATIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,0.958410125370016
GSE5589_WT_VS_IL10_KO_LPS_AN...6,SET,177,0.064368,0.0062899,0.064187,0.15798,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.958410125370016
GOBP_REGULATION_OF_ACROSOME_...,SET,18,0.2048,0.0064098,0.20424,0.158,GOBP_REGULATION_OF_ACROSOME_REACTION,0.958410125370016
GSE16450_CTRL_VS_IFNA_12H_ST...2,SET,172,0.066878,0.006443,0.066697,0.158,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.958410125370016
GSE7460_CTRL_VS_FOXP3_OVEREX...2,SET,171,0.064552,0.006201,0.064378,0.15801,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP,0.958410125370016
KCCGNSWTTT_UNKNOWN,SET,96,0.082108,0.005922,0.081897,0.15804,KCCGNSWTTT_UNKNOWN,0.958410125370016
CAFFAREL_RESPONSE_TO_THC_24H...2,SET,8,0.27678,0.0057765,0.27618,0.15814,CAFFAREL_RESPONSE_TO_THC_24HR_3_UP,0.958410125370016
HP_ENTHESITIS,SET,10,0.31621,0.0073781,0.31557,0.15817,HP_ENTHESITIS,0.958410125370016
GNF2_STAT6,SET,73,0.097046,0.0061074,0.096863,0.15821,GNF2_STAT6,0.958410125370016
HP_APLASIA_HYPOPLASIA_OF_THE...56,SET,200,0.06186,0.0064215,0.061751,0.15824,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_HAND,0.958410125370016
GSE46606_DAY1_VS_DAY3_CD40L_...1,SET,175,0.062996,0.0061212,0.062893,0.15827,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_DN,0.958410125370016
PID_HNF3A_PATHWAY,SET,42,0.13607,0.006501,0.13586,0.15829,PID_HNF3A_PATHWAY,0.958410125370016
BENPORATH_ES_WITH_H3K27ME3,SET,1000,0.03127,0.0070967,0.031223,0.1583,BENPORATH_ES_WITH_H3K27ME3,0.958410125370016
MZF1_02,SET,220,0.058092,0.0063211,0.058011,0.15833,MZF1_02,0.958410125370016
GSE36888_UNTREATED_VS_IL2_TR...1,SET,181,0.064298,0.0063529,0.06421,0.15833,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_DN,0.958410125370016
HP_DECREASED_CIRCULATING_PAR...,SET,10,0.29793,0.0069515,0.29755,0.15835,HP_DECREASED_CIRCULATING_PARATHYROID_HORMONE_LEVEL,0.958410125370016
GOMF_HISTONE_DEACETYLASE_REG...,SET,5,0.44654,0.0073684,0.446,0.15837,GOMF_HISTONE_DEACETYLASE_REGULATOR_ACTIVITY,0.958410125370016
GSE14415_ACT_VS_CTRL_NATURAL...2,SET,157,0.065499,0.0060312,0.06542,0.15837,GSE14415_ACT_VS_CTRL_NATURAL_TREG_UP,0.958410125370016
GSE18791_CTRL_VS_NEWCASTLE_V...2,SET,178,0.059444,0.0058249,0.059372,0.15837,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP,0.958410125370016
REACTOME_FORMATION_OF_TC_NER...,SET,48,0.10923,0.0055779,0.10913,0.15844,REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX,0.958529232643118
WEI_MYCN_TARGETS_WITH_E_BOX,SET,722,0.031416,0.0061065,0.031393,0.15848,WEI_MYCN_TARGETS_WITH_E_BOX,0.958529232643118
WP_THYMIC_STROMAL_LYMPHOPOIE...,SET,44,0.13752,0.0067247,0.13743,0.1585,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,0.958529232643118
GOCC_DYSTROPHIN_ASSOCIATED_G...,SET,17,0.21111,0.0064212,0.21097,0.1585,GOCC_DYSTROPHIN_ASSOCIATED_GLYCOPROTEIN_COMPLEX,0.958529232643118
GSE46606_DAY1_VS_DAY3_CD40L_...3,SET,177,0.064325,0.0062857,0.064327,0.15867,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN,0.958820964106121
KEGG_AMINOACYL_TRNA_BIOSYNTH...,SET,22,0.16692,0.0057748,0.16694,0.1587,KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,0.958820964106121
GOBP_REGULATION_OF_NADP_META...,SET,8,0.31866,0.0066508,0.31873,0.15871,GOBP_REGULATION_OF_NADP_METABOLIC_PROCESS,0.958820964106121
GOMF_UBIQUITIN_LIKE_PROTEIN_...3,SET,34,0.14086,0.0060565,0.14089,0.15872,GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_BINDING,0.958820964106121
GSE21360_NAIVE_VS_QUATERNARY...2,SET,188,0.062039,0.0062459,0.062055,0.15873,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.958820964106121
REACTOME_PDH_COMPLEX_SYNTHES...,SET,4,0.42763,0.0063116,0.42781,0.15876,REACTOME_PDH_COMPLEX_SYNTHESIZES_ACETYL_COA_FROM_PYR,0.958820964106121
GOMF_PYRUVATE_DEHYDROGENASE_...3,SET,4,0.42763,0.0063116,0.42781,0.15876,GOMF_PYRUVATE_DEHYDROGENASE_ACTIVITY,0.958820964106121
GOMF_PHOSPHATASE_BINDING,SET,176,0.063544,0.0061919,0.063588,0.15883,GOMF_PHOSPHATASE_BINDING,0.958820964106121
HP_PROGRESSIVE_FLEXION_CONTR...,SET,6,0.42151,0.0076191,0.42184,0.15885,HP_PROGRESSIVE_FLEXION_CONTRACTURES,0.958820964106121
GSE7596_AKT_TRANSD_VS_CTRL_C...2,SET,147,0.069447,0.0061895,0.069506,0.15887,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP,0.958820964106121
TGCAAAC_MIR452,SET,86,0.094148,0.0064287,0.094236,0.15889,TGCAAAC_MIR452,0.958820964106121
POU2AF1_TARGET_GENES,SET,664,0.033652,0.0062831,0.033689,0.15893,POU2AF1_TARGET_GENES,0.958820964106121
MODULE_169,SET,89,0.098771,0.0068605,0.098885,0.15894,MODULE_169,0.958820964106121
BIOCARTA_IFNA_PATHWAY,SET,9,0.2828,0.0062602,0.28315,0.15896,BIOCARTA_IFNA_PATHWAY,0.958820964106121
RUTELLA_RESPONSE_TO_HGF_VS_C...2,SET,371,0.046569,0.006553,0.046629,0.15897,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,0.958820964106121
TATTATA_MIR374,SET,265,0.056451,0.0067333,0.056531,0.159,TATTATA_MIR374,0.958820964106121
DAZARD_UV_RESPONSE_CLUSTER_G6,SET,135,0.075322,0.0064353,0.07544,0.15904,DAZARD_UV_RESPONSE_CLUSTER_G6,0.958820964106121
GOBP_REGULATION_OF_APOPTOTIC...2,SET,9,0.28728,0.0063592,0.28776,0.15907,GOBP_REGULATION_OF_APOPTOTIC_DNA_FRAGMENTATION,0.958820964106121
GOCC_CYTOSOLIC_REGION,SET,19,0.19182,0.0061677,0.19215,0.15908,GOCC_CYTOSOLIC_REGION,0.958820964106121
LINSLEY_MIR16_TARGETS,SET,193,0.059178,0.0060358,0.059286,0.1591,LINSLEY_MIR16_TARGETS,0.958820964106121
KEGG_MEDICUS_VARIANT_HRAS_OV...,SET,9,0.29733,0.0065817,0.29794,0.15916,KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY,0.958970514820593
GOBP_REGULATION_OF_SENSORY_P...,SET,13,0.24417,0.0064952,0.24469,0.15918,GOBP_REGULATION_OF_SENSORY_PERCEPTION,0.958970514820593
MIR6516_3P,SET,126,0.07785,0.0064274,0.078041,0.15926,MIR6516_3P,0.959119961878357
GSE39820_CTRL_VS_TGFBETA3_IL...1,SET,182,0.062563,0.0061984,0.062717,0.15926,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN,0.959119961878357
GOMF_MITOGEN_ACTIVATED_PROTE...4,SET,7,0.35967,0.0070219,0.36063,0.15931,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_P38_BINDING,0.959230793157076
FAN_EMBRYONIC_CTX_EX_1_EXCIT...,SET,5,0.35556,0.0058671,0.35655,0.15934,FAN_EMBRYONIC_CTX_EX_1_EXCITATORY_NEURON,0.959230793157076
PID_TELOMERASE_PATHWAY,SET,64,0.10609,0.0062532,0.10644,0.15945,PID_TELOMERASE_PATHWAY,0.959230793157076
GAVISH_3CA_METAPROGRAM_CD8_T...4,SET,46,0.12931,0.0064646,0.12973,0.15946,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_DYSFUNCTION,0.959230793157076
GOBP_PROTEIN_POLYGLUTAMYLATI...,SET,11,0.2789,0.0068249,0.27985,0.15949,GOBP_PROTEIN_POLYGLUTAMYLATION,0.959230793157076
GSE21546_UNSTIM_VS_ANTI_CD3_...8,SET,175,0.065748,0.0063886,0.065976,0.1595,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_UP,0.959230793157076
HP_SMALL_CEREBRAL_CORTEX,SET,8,0.31438,0.0065614,0.31551,0.15953,HP_SMALL_CEREBRAL_CORTEX,0.959230793157076
HP_EPIDURAL_HEMORRHAGE,SET,5,0.48695,0.0080352,0.48874,0.15955,HP_EPIDURAL_HEMORRHAGE,0.959230793157076
GOBP_REGULATION_OF_PROTEIN_U...,SET,165,0.066322,0.0062593,0.066572,0.15957,GOBP_REGULATION_OF_PROTEIN_UBIQUITINATION,0.959230793157076
GOBP_RESPONSE_TO_PURINE_CONT...,SET,136,0.074499,0.0063884,0.07478,0.15957,GOBP_RESPONSE_TO_PURINE_CONTAINING_COMPOUND,0.959230793157076
FXR_IR1_Q6,SET,105,0.086471,0.0065209,0.086811,0.15961,FXR_IR1_Q6,0.959230793157076
LENAOUR_DENDRITIC_CELL_MATUR...2,SET,108,0.089807,0.006868,0.090171,0.15964,LENAOUR_DENDRITIC_CELL_MATURATION_UP,0.959230793157076
MIR642A_5P,SET,82,0.096071,0.0064064,0.096461,0.15964,MIR642A_5P,0.959230793157076
HOWARD_PBMC_INACT_MONOV_INFL...2,SET,333,0.050855,0.0067868,0.051067,0.15967,HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP,0.959230793157076
GSE1460_INTRATHYMIC_T_PROGEN...6,SET,178,0.060831,0.0059608,0.061092,0.1597,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,0.959230793157076
GOBP_MEMBRANE_HYPERPOLARIZAT...,SET,11,0.25238,0.0061759,0.25348,0.15972,GOBP_MEMBRANE_HYPERPOLARIZATION,0.959230793157076
MIR5582_5P,SET,357,0.046823,0.0064658,0.047057,0.15987,MIR5582_5P,0.959662836671271
HP_PYODERMA_GANGRENOSUM,SET,11,0.27955,0.0068409,0.28096,0.15988,HP_PYODERMA_GANGRENOSUM,0.959662836671271
GOBP_REGULATION_OF_PROTEIN_K...2,SET,12,0.25561,0.0065329,0.25691,0.15989,GOBP_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.959662836671271
chr6q14,SET,36,0.21715,0.0096068,0.21828,0.15991,chr6q14,0.959662836671271
REACTOME_LEISHMANIA_INFECTION,SET,152,0.068918,0.0062451,0.06928,0.15993,REACTOME_LEISHMANIA_INFECTION,0.959662836671271
GOBP_NEGATIVE_REGULATION_OF_...295,SET,26,0.16724,0.0062894,0.16814,0.15996,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.95967716209218
GOBP_CELL_MIGRATION_INVOLVED...1,SET,13,0.23367,0.0062161,0.23505,0.16009,GOBP_CELL_MIGRATION_INVOLVED_IN_GASTRULATION,0.960185591026747
CHANGOLKAR_H2AFY_TARGETS_DN,SET,35,0.13313,0.0058074,0.13392,0.1601,CHANGOLKAR_H2AFY_TARGETS_DN,0.960185591026747
TSENG_IRS1_TARGETS_DN,SET,112,0.085768,0.0066787,0.086348,0.16029,TSENG_IRS1_TARGETS_DN,0.960552989317712
BOYAULT_LIVER_CANCER_SUBCLAS...15,SET,19,0.20749,0.0066716,0.20889,0.1603,BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN,0.960552989317712
HP_ABNORMAL_SWEAT_HOMEOSTASIS,SET,28,0.17505,0.006831,0.17628,0.16036,HP_ABNORMAL_SWEAT_HOMEOSTASIS,0.960552989317712
PLASARI_TGFB1_TARGETS_10HR_UP,SET,186,0.067815,0.0067914,0.068296,0.16037,PLASARI_TGFB1_TARGETS_10HR_UP,0.960552989317712
MORI_EMU_MYC_LYMPHOMA_BY_ONS...2,SET,104,0.080043,0.0060075,0.080617,0.16039,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,0.960552989317712
GOBP_POSITIVE_REGULATION_OF_...124,SET,103,0.082102,0.0061325,0.082694,0.1604,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,0.960552989317712
HP_DIAPHRAGMATIC_EVENTRATION,SET,18,0.18588,0.0058175,0.18721,0.1604,HP_DIAPHRAGMATIC_EVENTRATION,0.960552989317712
BIOCARTA_PGC1A_PATHWAY,SET,15,0.21918,0.0062625,0.22077,0.16041,BIOCARTA_PGC1A_PATHWAY,0.960552989317712
MIR4738_3P,SET,163,0.068322,0.0064092,0.068817,0.16041,MIR4738_3P,0.960552989317712
WENDT_COHESIN_TARGETS_UP,SET,31,0.15953,0.0065499,0.16072,0.16047,WENDT_COHESIN_TARGETS_UP,0.960687418412916
GOBP_MULTICELLULAR_ORGANISMA...3,SET,24,0.16892,0.0061036,0.17022,0.16052,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_IRON_ION_HOMEOSTASIS,0.960687418412916
PODAR_RESPONSE_TO_ADAPHOSTIN...2,SET,127,0.081179,0.0067286,0.081833,0.1606,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,0.960687418412916
GOBP_GALACTOSE_CATABOLIC_PRO...1,SET,6,0.33833,0.0061155,0.34106,0.16061,GOBP_GALACTOSE_CATABOLIC_PROCESS,0.960687418412916
GOBP_POSITIVE_REGULATION_OF_...107,SET,15,0.22116,0.0063192,0.22295,0.16061,GOBP_POSITIVE_REGULATION_OF_CELLULAR_EXTRAVASATION,0.960687418412916
GSE17721_LPS_VS_PAM3CSK4_6H_...2,SET,186,0.061077,0.0061166,0.06157,0.16061,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_UP,0.960687418412916
GOBP_REGULATION_OF_FAT_CELL_...2,SET,10,0.30392,0.0070914,0.30646,0.16068,GOBP_REGULATION_OF_FAT_CELL_PROLIFERATION,0.960687418412916
GSE360_L_DONOVANI_VS_M_TUBER...3,SET,188,0.062912,0.0063338,0.063459,0.16076,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN,0.960687418412916
GSE22611_NOD2_TRANSD_VS_CTRL...3,SET,178,0.065848,0.0064524,0.06643,0.16079,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN,0.960687418412916
ATF_B,SET,174,0.065625,0.0063586,0.066211,0.16081,ATF_B,0.960687418412916
GOBP_NEGATIVE_REGULATION_OF_...172,SET,7,0.32329,0.0063117,0.32619,0.16082,GOBP_NEGATIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,0.960687418412916
GOBP_MITOCHONDRIAL_OUTER_MEM...,SET,26,0.15687,0.0058993,0.15828,0.16083,GOBP_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION,0.960687418412916
GOBP_REGULATION_OF_TORC2_SIG...,SET,4,0.40885,0.0060344,0.41255,0.16084,GOBP_REGULATION_OF_TORC2_SIGNALING,0.960687418412916
GOBP_NEGATIVE_REGULATION_OF_...552,SET,5,0.39722,0.0065545,0.40082,0.16085,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_RECYCLING,0.960687418412916
GOBP_VIRAL_RELEASE_FROM_HOST...,SET,28,0.15187,0.0059265,0.15325,0.16085,GOBP_VIRAL_RELEASE_FROM_HOST_CELL,0.960687418412916
MIR597_5P,SET,72,0.10056,0.0062854,0.10149,0.16089,MIR597_5P,0.960687418412916
MIR130B_5P,SET,175,0.066402,0.0064522,0.067027,0.16093,MIR130B_5P,0.960687418412916
GOCC_EUKARYOTIC_TRANSLATION_...4,SET,7,0.30736,0.0060008,0.31026,0.16093,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX_EIF3M,0.960687418412916
ZHAN_VARIABLE_EARLY_DIFFEREN...1,SET,27,0.14598,0.0055943,0.14739,0.16098,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,0.960715564903846
GSE42724_MEMORY_BCELL_VS_PLA...1,SET,175,0.061084,0.0059355,0.061674,0.16099,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN,0.960715564903846
GOBP_UBIQUITIN_INDEPENDENT_P...,SET,5,0.39153,0.0064607,0.3954,0.16104,GOBP_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.960719419222203
GOMF_CARNITINE_TRANSMEMBRANE...,SET,5,0.50369,0.0083114,0.5087,0.16106,GOMF_CARNITINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.960719419222203
HP_INFLAMMATORY_ABNORMALITY_...,SET,188,0.062304,0.0062726,0.062934,0.16109,HP_INFLAMMATORY_ABNORMALITY_OF_THE_EYE,0.960719419222203
GSE40274_FOXP3_VS_FOXP3_AND_...12,SET,176,0.065423,0.006375,0.066087,0.16111,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.960719419222203
AIZARANI_LIVER_C25_KUPFFER_C...,SET,158,0.072968,0.0067402,0.073731,0.16118,AIZARANI_LIVER_C25_KUPFFER_CELLS_4,0.960719419222203
GOBP_LIGAND_GATED_ION_CHANNE...,SET,30,0.17006,0.0068689,0.17184,0.16119,GOBP_LIGAND_GATED_ION_CHANNEL_SIGNALING_PATHWAY,0.960719419222203
GAL_LEUKEMIC_STEM_CELL_UP,SET,110,0.082023,0.0063301,0.082896,0.16122,GAL_LEUKEMIC_STEM_CELL_UP,0.960719419222203
GOBP_REGULATION_OF_PLATELET_...2,SET,29,0.17578,0.006981,0.17769,0.16127,GOBP_REGULATION_OF_PLATELET_AGGREGATION,0.960719419222203
GOCC_CORTICAL_CYTOSKELETON,SET,103,0.082061,0.0061295,0.082956,0.16128,GOCC_CORTICAL_CYTOSKELETON,0.960719419222203
GSE17721_PAM3CSK4_VS_CPG_16H...2,SET,177,0.062669,0.0061239,0.063361,0.16132,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP,0.960719419222203
GSE33425_CD161_HIGH_VS_INT_C...1,SET,178,0.063937,0.0062652,0.06465,0.16134,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN,0.960719419222203
GOBP_COLLAGEN_METABOLIC_PROC...,SET,90,0.0981,0.0068519,0.099195,0.16135,GOBP_COLLAGEN_METABOLIC_PROCESS,0.960719419222203
HP_TALIPES_EQUINOVALGUS,SET,13,0.20376,0.0054203,0.20603,0.16135,HP_TALIPES_EQUINOVALGUS,0.960719419222203
MIR2467_3P,SET,139,0.069422,0.0060178,0.070206,0.16138,MIR2467_3P,0.96073345323741
PAX6_01,SET,86,0.091963,0.0062796,0.093068,0.16155,PAX6_01,0.961166985645933
MIR363_3P,SET,384,0.0445,0.0063683,0.045035,0.16156,MIR363_3P,0.961166985645933
MIR548D_3P,SET,547,0.036729,0.0062448,0.037179,0.16161,MIR548D_3P,0.961166985645933
MODULE_53,SET,360,0.045026,0.0062431,0.045581,0.16163,MODULE_53,0.961166985645933
GOBP_REGULATION_OF_SKELETAL_...5,SET,16,0.20394,0.006018,0.20647,0.16165,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION,0.961166985645933
GOMF_PHOSPHATE_ION_BINDING,SET,8,0.32571,0.0067978,0.3298,0.16168,GOMF_PHOSPHATE_ION_BINDING,0.961166985645933
HP_SANDAL_GAP,SET,87,0.092281,0.0063376,0.09346,0.16173,HP_SANDAL_GAP,0.961166985645933
MIR6165,SET,111,0.077383,0.005999,0.078377,0.16175,MIR6165,0.961166985645933
GNF2_SERPINB5,SET,27,0.17199,0.0065912,0.1742,0.16175,GNF2_SERPINB5,0.961166985645933
GSE42088_UNINF_VS_LEISHMANIA...6,SET,183,0.063861,0.0063442,0.064687,0.16177,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP,0.961166985645933
KEGG_MEDICUS_REFERENCE_IL10_...,SET,13,0.2786,0.0074111,0.28221,0.16178,KEGG_MEDICUS_REFERENCE_IL10_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,0.961166985645933
GOBP_THYROID_HORMONE_MEDIATE...,SET,7,0.3561,0.0069522,0.36075,0.1618,GOBP_THYROID_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.961166985645933
MODULE_247,SET,35,0.15655,0.0068289,0.1586,0.16182,MODULE_247,0.961166985645933
TBPL1_TARGET_GENES,SET,135,0.073519,0.0062814,0.074492,0.16184,TBPL1_TARGET_GENES,0.961166985645933
HP_SEVERE_SHORT_LIMB_DWARFISM,SET,5,0.4171,0.0068825,0.42279,0.16194,HP_SEVERE_SHORT_LIMB_DWARFISM,0.96159656586366
HAY_BONE_MARROW_PLATELET,SET,217,0.058575,0.0063306,0.059388,0.162,HAY_BONE_MARROW_PLATELET,0.961742971818958
REACTOME_REGULATION_OF_TBK1_...1,SET,13,0.25767,0.0068544,0.26127,0.16202,REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7,0.961742971818958
GOBP_TAIL_ANCHORED_MEMBRANE_...,SET,12,0.211,0.0053929,0.21404,0.16212,GOBP_TAIL_ANCHORED_MEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE,0.962172233606557
GOBP_ANIMAL_ORGAN_REGENERATI...,SET,61,0.10906,0.006276,0.11065,0.16217,GOBP_ANIMAL_ORGAN_REGENERATION,0.962213440860215
GSE11961_GERMINAL_CENTER_BCE...3,SET,184,0.064192,0.0063943,0.065135,0.16219,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,0.962213440860215
GOBP_REGULATION_OF_BROWN_FAT...,SET,22,0.1826,0.0063175,0.1853,0.16221,GOBP_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,0.962213440860215
GSE7460_FOXP3_MUT_VS_WT_ACT_...1,SET,184,0.062295,0.0062052,0.063223,0.16224,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN,0.962227167235495
HP_RECURRENT_PAROXYSMAL_HEAD...,SET,18,0.17823,0.0055783,0.18098,0.16235,HP_RECURRENT_PAROXYSMAL_HEADACHE,0.962715278962634
GOBP_PROTEIN_EXPORT_FROM_NUC...,SET,58,0.10345,0.0058058,0.10511,0.1625,GOBP_PROTEIN_EXPORT_FROM_NUCLEUS,0.963440378710338
PID_ALPHA_SYNUCLEIN_PATHWAY,SET,30,0.15866,0.0064084,0.16125,0.16258,PID_ALPHA_SYNUCLEIN_PATHWAY,0.963580598159509
GOCC_NUCLEAR_RNA_EXPORT_FACT...,SET,2,0.46535,0.0048569,0.47297,0.16259,GOCC_NUCLEAR_RNA_EXPORT_FACTOR_COMPLEX,0.963580598159509
WP_IRONSULFUR_CLUSTER_BIOGEN...,SET,13,0.25295,0.0067289,0.25711,0.16261,WP_IRONSULFUR_CLUSTER_BIOGENESIS,0.963580598159509
HP_CONICAL_INCISOR,SET,34,0.15814,0.0067995,0.16077,0.16264,HP_CONICAL_INCISOR,0.963580598159509
GOMF_ACETYLGALACTOSAMINYLTRA...,SET,32,0.16508,0.0068864,0.16784,0.16267,GOMF_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,0.963580598159509
MIR3124_3P,SET,204,0.058752,0.0061589,0.059739,0.16269,MIR3124_3P,0.963580598159509
GOBP_POSITIVE_REGULATION_OF_...535,SET,22,0.19055,0.0065924,0.19383,0.16279,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,0.963798594787941
HP_INTERSTITIAL_PNEUMONITIS,SET,15,0.22665,0.006476,0.23057,0.16281,HP_INTERSTITIAL_PNEUMONITIS,0.963798594787941
HP_SUPERNUMERARY_TOOTH,SET,44,0.13232,0.0064701,0.13461,0.16281,HP_SUPERNUMERARY_TOOTH,0.963798594787941
WP_FLUOROPYRIMIDINE_ACTIVITY,SET,33,0.14181,0.0060071,0.14438,0.16301,WP_FLUOROPYRIMIDINE_ACTIVITY,0.964680485106383
GOBP_REGULATION_OF_VESICLE_M...,SET,464,0.039724,0.006235,0.040451,0.16305,GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT,0.964680485106383
FERRANDO_T_ALL_WITH_MLL_ENL_...2,SET,77,0.09914,0.0064072,0.10096,0.16306,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,0.964680485106383
GOBP_GLIAL_CELL_ACTIVATION,SET,53,0.1233,0.0066156,0.12557,0.16307,GOBP_GLIAL_CELL_ACTIVATION,0.964680485106383
MIR548AA_MIR548AP_3P_MIR548T...,SET,505,0.038126,0.0062359,0.038835,0.16312,MIR548AA_MIR548AP_3P_MIR548T_3P,0.964779406260633
GSE17974_CTRL_VS_ACT_IL4_AND...2,SET,131,0.069994,0.0058915,0.071307,0.16316,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP,0.964779406260633
GOBP_NEGATIVE_REGULATION_OF_...394,SET,33,0.1427,0.0060448,0.14539,0.16317,GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,0.964779406260633
GOBP_CARBOHYDRATE_IMPORT_ACR...,SET,5,0.42691,0.0070445,0.43508,0.16325,GOBP_CARBOHYDRATE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.965088237795544
GOBP_TANGENTIAL_MIGRATION_FR...,SET,7,0.33495,0.0065394,0.34146,0.16331,GOBP_TANGENTIAL_MIGRATION_FROM_THE_SUBVENTRICULAR_ZONE_TO_THE_OLFACTORY_BULB,0.96527875
NR2E3_TARGET_GENES,SET,8,0.33877,0.0070704,0.34538,0.16334,NR2E3_TARGET_GENES,0.965291906138412
AIZARANI_LIVER_C18_NK_NKT_CE...,SET,110,0.08499,0.0065591,0.086664,0.16338,AIZARANI_LIVER_C18_NK_NKT_CELLS_5,0.965364144848691
GSE41176_WT_VS_TAK1_KO_UNSTI...2,SET,178,0.063433,0.0062158,0.064692,0.16342,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_UP,0.965416666666667
GOBP_PROSTATE_GLAND_DEVELOPM...,SET,47,0.13903,0.0070258,0.14181,0.16345,GOBP_PROSTATE_GLAND_DEVELOPMENT,0.965416666666667
GOBP_CARDIAC_RIGHT_VENTRICLE...,SET,19,0.21811,0.0070131,0.22251,0.1635,GOBP_CARDIAC_RIGHT_VENTRICLE_MORPHOGENESIS,0.965416666666667
HP_ABNORMALITY_OF_CRANIAL_SU...,SET,338,0.045211,0.0060779,0.046125,0.1635,HP_ABNORMALITY_OF_CRANIAL_SUTURES,0.965416666666667
HP_EXUDATIVE_RETINAL_DETACHM...,SET,5,0.45699,0.0075408,0.4664,0.16359,HP_EXUDATIVE_RETINAL_DETACHMENT,0.965429765943012
HP_HYPERREFLEXIA,SET,706,0.031196,0.0059989,0.031841,0.16362,HP_HYPERREFLEXIA,0.965429765943012
GOBP_NEGATIVE_REGULATION_OF_...334,SET,3,0.55732,0.0071239,0.56895,0.16366,GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.965429765943012
RIZ_ERYTHROID_DIFFERENTIATIO...5,SET,36,0.15561,0.0068843,0.15887,0.16367,RIZ_ERYTHROID_DIFFERENTIATION_HBZ,0.965429765943012
GOMF_OXIDOREDUCTASE_ACTIVITY...38,SET,15,0.20781,0.0059378,0.21217,0.16368,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,0.965429765943012
GOBP_REGULATION_OF_MITOCHOND...8,SET,48,0.11527,0.0058867,0.1177,0.16369,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY,0.965429765943012
HP_THICK_LOWER_LIP_VERMILION,SET,115,0.078381,0.0061842,0.080031,0.1637,HP_THICK_LOWER_LIP_VERMILION,0.965429765943012
HP_GAIT_DISTURBANCE,SET,1052,0.026312,0.0061156,0.026872,0.16376,HP_GAIT_DISTURBANCE,0.965429765943012
CUI_DEVELOPING_HEART_5TH_WEE...2,SET,64,0.11051,0.0065135,0.11286,0.16376,CUI_DEVELOPING_HEART_5TH_WEEK_VENTRICULAR_CARDIOMYOCYTE,0.965429765943012
GOBP_ENDOSOMAL_VESICLE_FUSION,SET,15,0.19914,0.0056901,0.2034,0.16378,GOBP_ENDOSOMAL_VESICLE_FUSION,0.965429765943012
HP_BRAIN_STEM_COMPRESSION,SET,14,0.20832,0.0057506,0.21281,0.16382,HP_BRAIN_STEM_COMPRESSION,0.965501797524165
GOBP_TELOMERE_TETHERING_AT_N...,SET,3,0.41297,0.0052787,0.42191,0.16385,GOBP_TELOMERE_TETHERING_AT_NUCLEAR_PERIPHERY,0.96551487792472
LET_7I_3P,SET,5,0.37214,0.0061407,0.38031,0.16392,LET_7I_3P,0.965756843977639
AKT_UP.V1_UP,SET,149,0.06939,0.006226,0.070924,0.16395,AKT_UP.V1_UP,0.965756843977639
GOBP_ORGANELLE_INHERITANCE,SET,15,0.19183,0.005481,0.19612,0.16401,GOBP_ORGANELLE_INHERITANCE,0.965756843977639
GOBP_NEGATIVE_REGULATION_OF_...435,SET,14,0.22671,0.0062582,0.23178,0.16402,GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,0.965756843977639
HP_ABNORMAL_PLATELET_AGGREGA...,SET,39,0.1332,0.0061331,0.13619,0.16403,HP_ABNORMAL_PLATELET_AGGREGATION,0.965756843977639
BIOCARTA_EICOSANOID_PATHWAY,SET,21,0.20439,0.0069088,0.20902,0.16409,BIOCARTA_EICOSANOID_PATHWAY,0.965841744284505
DAZARD_RESPONSE_TO_UV_NHEK_DN,SET,283,0.050583,0.0062318,0.051733,0.1641,DAZARD_RESPONSE_TO_UV_NHEK_DN,0.965841744284505
STK33_SKM_DN,SET,239,0.055905,0.0063371,0.057192,0.16417,STK33_SKM_DN,0.965866379746835
HE_LIM_SUN_FETAL_LUNG_C1_SMG...2,SET,650,0.034136,0.0063086,0.03493,0.16422,HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL,0.965866379746835
HP_SYNDACTYLY,SET,346,0.044815,0.0060942,0.045866,0.16427,HP_SYNDACTYLY,0.965866379746835
REACTOME_CDH11_HOMOTYPIC_AND...,SET,7,0.33913,0.0066209,0.34714,0.16431,REACTOME_CDH11_HOMOTYPIC_AND_HETEROTYPIC_INTERACTIONS,0.965866379746835
GOCC_PRC1_COMPLEX,SET,17,0.20258,0.0061618,0.20737,0.16432,GOCC_PRC1_COMPLEX,0.965866379746835
HP_ABNORMALITY_OF_THE_ACOUST...,SET,4,0.44517,0.0065704,0.45571,0.16432,HP_ABNORMALITY_OF_THE_ACOUSTIC_REFLEX,0.965866379746835
HP_ABNORMAL_MIDDLE_EAR_REFLE...,SET,4,0.44517,0.0065704,0.45571,0.16432,HP_ABNORMAL_MIDDLE_EAR_REFLEXES,0.965866379746835
RIZKI_TUMOR_INVASIVENESS_2D_...1,SET,52,0.11574,0.0061511,0.11852,0.1644,RIZKI_TUMOR_INVASIVENESS_2D_DN,0.965866379746835
GOMF_SUMO_BINDING,SET,16,0.19274,0.0056875,0.19737,0.16441,GOMF_SUMO_BINDING,0.965866379746835
GOCC_HETEROCHROMATIN,SET,69,0.097484,0.0059653,0.099841,0.16444,GOCC_HETEROCHROMATIN,0.965866379746835
HP_PATCHY_CHANGES_OF_BONE_MI...,SET,5,0.39122,0.0064556,0.40068,0.16444,HP_PATCHY_CHANGES_OF_BONE_MINERAL_DENSITY,0.965866379746835
GOBP_MICROGLIAL_CELL_MIGRATI...,SET,8,0.32824,0.0068505,0.33629,0.16452,GOBP_MICROGLIAL_CELL_MIGRATION,0.965866379746835
HP_MUSCLE_FLACCIDITY,SET,13,0.25634,0.0068189,0.26262,0.16452,HP_MUSCLE_FLACCIDITY,0.965866379746835
BROWNE_HCMV_INFECTION_20HR_UP,SET,213,0.056905,0.0060939,0.058303,0.16454,BROWNE_HCMV_INFECTION_20HR_UP,0.965866379746835
GSE19198_1H_VS_24H_IL21_TREA...1,SET,182,0.063592,0.0063003,0.065163,0.16457,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN,0.965866379746835
GSE10273_HIGH_IL7_VS_HIGH_IL...1,SET,174,0.062426,0.0060486,0.063976,0.1646,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,0.965866379746835
GOMF_MAGNESIUM_ION_TRANSMEMB...,SET,13,0.23117,0.0061494,0.23693,0.16462,GOMF_MAGNESIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.965866379746835
HP_IMPAIRED_DISTAL_VIBRATION...,SET,47,0.11805,0.0059653,0.121,0.16465,HP_IMPAIRED_DISTAL_VIBRATION_SENSATION,0.965866379746835
GOBP_CELLULAR_ALDEHYDE_METAB...,SET,74,0.098729,0.0062556,0.10121,0.16466,GOBP_CELLULAR_ALDEHYDE_METABOLIC_PROCESS,0.965866379746835
HP_SCAPULOPERONEAL_AMYOTROPHY,SET,5,0.37609,0.0062059,0.38553,0.16466,HP_SCAPULOPERONEAL_AMYOTROPHY,0.965866379746835
PASTURAL_RIZ1_TARGETS_UP,SET,8,0.26455,0.0055213,0.27123,0.1647,PASTURAL_RIZ1_TARGETS_UP,0.965937985150186
GSE17721_POLYIC_VS_CPG_8H_BM...2,SET,180,0.060018,0.0059138,0.061564,0.16482,GSE17721_POLYIC_VS_CPG_8H_BMDC_UP,0.966158543983822
HP_EQUINUS_CALCANEUS,SET,8,0.33261,0.0069418,0.34126,0.16487,HP_EQUINUS_CALCANEUS,0.966158543983822
MIR6768_3P,SET,127,0.076356,0.0063288,0.078347,0.16489,MIR6768_3P,0.966158543983822
GOCC_HEMIDESMOSOME,SET,7,0.35809,0.006991,0.36742,0.16489,GOCC_HEMIDESMOSOME,0.966158543983822
GOBP_INTERNAL_PEPTIDYL_LYSIN...,SET,8,0.24117,0.0050335,0.24748,0.1649,GOBP_INTERNAL_PEPTIDYL_LYSINE_ACETYLATION,0.966158543983822
GOBP_PLATELET_DERIVED_GROWTH...1,SET,7,0.34672,0.0067691,0.35586,0.16495,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_ALPHA_SIGNALING_PATHWAY,0.966158543983822
DESCARTES_MAIN_FETAL_EPICARD...,SET,38,0.15226,0.0069202,0.15627,0.16495,DESCARTES_MAIN_FETAL_EPICARDIAL_FAT_CELLS,0.966158543983822
NIKOLSKY_BREAST_CANCER_16Q24...,SET,50,0.20674,0.010775,0.2122,0.16496,NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON,0.966158543983822
ERWIN_COHEN_PBMC_TC_83_AGE_1...2,SET,14,0.23426,0.0064668,0.24048,0.16499,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_DN,0.966171432181971
GOBP_RESPONSE_TO_ZINC_ION_ST...,SET,8,0.26692,0.0055709,0.27409,0.16507,GOBP_RESPONSE_TO_ZINC_ION_STARVATION,0.966313228662101
MIR557,SET,204,0.058913,0.0061757,0.060506,0.16512,MIR557,0.966313228662101
CAO_BLOOD_FLUMIST_AGE_05_14Y...4,SET,3,0.46753,0.0059762,0.48018,0.16512,CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_UP,0.966313228662101
HP_AZOOSPERMIA,SET,105,0.078575,0.0059255,0.080707,0.16514,HP_AZOOSPERMIA,0.966313228662101
GOBP_REGULATION_OF_RESPONSE_...12,SET,20,0.19746,0.0065141,0.20289,0.16522,GOBP_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,0.966313228662101
GOCC_AGGRESOME,SET,30,0.14852,0.005999,0.15265,0.16529,GOCC_AGGRESOME,0.966313228662101
HP_PROGRESSIVE_SPASTIC_PARAP...2,SET,26,0.15809,0.0059451,0.16251,0.16534,HP_PROGRESSIVE_SPASTIC_PARAPLEGIA,0.966313228662101
GOBP_ALCOHOL_BIOSYNTHETIC_PR...,SET,125,0.072715,0.0059798,0.074782,0.16544,GOBP_ALCOHOL_BIOSYNTHETIC_PROCESS,0.966313228662101
GOBP_BILE_ACID_BIOSYNTHETIC_...,SET,36,0.14268,0.0063123,0.14678,0.1655,GOBP_BILE_ACID_BIOSYNTHETIC_PROCESS,0.966313228662101
MIR3187_5P,SET,109,0.076532,0.0058797,0.078732,0.16552,MIR3187_5P,0.966313228662101
GOBP_INTRACELLULAR_ESTROGEN_...,SET,45,0.11642,0.0057567,0.11978,0.16555,GOBP_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,0.966313228662101
GOBP_GRANULOCYTE_DIFFERENTIA...,SET,38,0.13868,0.0063027,0.1427,0.16558,GOBP_GRANULOCYTE_DIFFERENTIATION,0.966313228662101
MIR216B_5P,SET,85,0.093332,0.006336,0.096048,0.1656,MIR216B_5P,0.966313228662101
GOBP_RETROGRADE_TRANS_SYNAPT...2,SET,5,0.42027,0.0069349,0.43257,0.16564,GOBP_RETROGRADE_TRANS_SYNAPTIC_SIGNALING_BY_LIPID,0.966313228662101
GOBP_EXOCRINE_PANCREAS_DEVEL...,SET,7,0.35726,0.0069749,0.36774,0.16566,GOBP_EXOCRINE_PANCREAS_DEVELOPMENT,0.966313228662101
GOMF_METALLOAMINOPEPTIDASE_A...,SET,23,0.18894,0.0066835,0.19453,0.16571,GOMF_METALLOAMINOPEPTIDASE_ACTIVITY,0.966313228662101
PID_S1P_S1P1_PATHWAY,SET,21,0.17786,0.0060122,0.18313,0.16572,PID_S1P_S1P1_PATHWAY,0.966313228662101
GOMF_ACTIVE_TRANSMEMBRANE_TR...,SET,421,0.040819,0.0061102,0.04204,0.16579,GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.966313228662101
GSE13411_IGM_VS_SWITCHED_MEM...2,SET,173,0.064846,0.0062653,0.066788,0.1658,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP,0.966313228662101
GOBP_RESPONSE_TO_GONADOTROPI...,SET,5,0.34626,0.0057137,0.35665,0.16581,GOBP_RESPONSE_TO_GONADOTROPIN_RELEASING_HORMONE,0.966313228662101
WP_PHASE_I_BIOTRANSFORMATION...,SET,8,0.35792,0.00747,0.36872,0.16585,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,0.966313228662101
WP_MIRNA_TARGETS_IN_ECM_AND_...,SET,22,0.19618,0.0067872,0.20212,0.16587,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,0.966313228662101
GOBP_REGULATION_OF_MODIFICAT...1,SET,4,0.45252,0.006679,0.46628,0.1659,GOBP_REGULATION_OF_MODIFICATION_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.966313228662101
HP_POSTERIOR_PITUITARY_DYSGE...,SET,22,0.17568,0.0060781,0.18102,0.1659,HP_POSTERIOR_PITUITARY_DYSGENESIS,0.966313228662101
GSE9988_ANTI_TREM1_VS_LOW_LP...1,SET,174,0.066266,0.0064207,0.068289,0.16594,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN,0.966313228662101
MIR512_3P,SET,94,0.085535,0.006105,0.088156,0.16596,MIR512_3P,0.966313228662101
GSE45739_NRAS_KO_VS_WT_UNSTI...2,SET,177,0.062235,0.0060814,0.064142,0.16596,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_UP,0.966313228662101
HP_ABNORMAL_MEAN_CORPUSCULAR...1,SET,16,0.19657,0.0058006,0.20261,0.16599,HP_ABNORMAL_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,0.966313228662101
GSE15930_NAIVE_VS_72H_IN_VIT...7,SET,188,0.057254,0.0057642,0.059024,0.16602,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN,0.966313228662101
MIR6079,SET,135,0.072957,0.0062333,0.075214,0.16603,MIR6079,0.966313228662101
chr7q11,SET,71,0.19151,0.011887,0.19744,0.16604,chr7q11,0.966313228662101
MOTAMED_RESPONSE_TO_ANDROGEN...2,SET,4,0.4901,0.0072336,0.5053,0.16605,MOTAMED_RESPONSE_TO_ANDROGEN_UP,0.966313228662101
HP_SMALL_NAIL,SET,157,0.06573,0.0060526,0.067772,0.16606,HP_SMALL_NAIL,0.966313228662101
GOCC_LAMIN_FILAMENT,SET,5,0.35214,0.0058108,0.36319,0.16613,GOCC_LAMIN_FILAMENT,0.966313228662101
GAVISH_3CA_METAPROGRAM_ENDOT...14,SET,46,0.13847,0.0069229,0.14283,0.16616,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING,0.966313228662101
DOANE_BREAST_CANCER_CLASSES_...1,SET,32,0.16408,0.0068443,0.16926,0.16618,DOANE_BREAST_CANCER_CLASSES_DN,0.966313228662101
HP_SPARSE_AXILLARY_HAIR,SET,42,0.13428,0.0064152,0.13852,0.16618,HP_SPARSE_AXILLARY_HAIR,0.966313228662101
REACTOME_CELLULAR_SENESCENCE,SET,123,0.073391,0.0059872,0.075718,0.16621,REACTOME_CELLULAR_SENESCENCE,0.966313228662101
GOBP_POSITIVE_REGULATION_OF_...73,SET,8,0.28523,0.0059529,0.29427,0.16622,GOBP_POSITIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.966313228662101
GOMF_UBIQUITIN_PROTEIN_TRANS...2,SET,12,0.25624,0.0065492,0.26437,0.16622,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_INHIBITOR_ACTIVITY,0.966313228662101
GOBP_FOLIC_ACID_CONTAINING_C...2,SET,5,0.32702,0.0053961,0.33744,0.16625,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.966313228662101
GOCC_CILIARY_TIP,SET,40,0.12287,0.005729,0.12679,0.16627,GOCC_CILIARY_TIP,0.966313228662101
GSE2585_CD80_HIGH_VS_LOW_MTE...1,SET,171,0.06373,0.0061221,0.065778,0.16631,GSE2585_CD80_HIGH_VS_LOW_MTEC_DN,0.966313228662101
GOBP_EPIDIDYMIS_DEVELOPMENT,SET,3,0.57058,0.0072933,0.58894,0.16633,GOBP_EPIDIDYMIS_DEVELOPMENT,0.966313228662101
GOBP_FOREBRAIN_CELL_MIGRATION,SET,59,0.1136,0.0064295,0.11727,0.16635,GOBP_FOREBRAIN_CELL_MIGRATION,0.966313228662101
GOBP_REGULATION_OF_MEMBRANE_...3,SET,4,0.47337,0.0069867,0.48869,0.16636,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.966313228662101
REACTOME_NGF_INDEPENDANT_TRK...,SET,5,0.40457,0.0066758,0.41767,0.16637,REACTOME_NGF_INDEPENDANT_TRKA_ACTIVATION,0.966313228662101
GOBP_NEGATIVE_REGULATION_OF_...297,SET,83,0.089541,0.0060071,0.092445,0.16638,GOBP_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE,0.966313228662101
YAMASHITA_METHYLATED_IN_PROS...,SET,59,0.11561,0.0065436,0.11937,0.16639,YAMASHITA_METHYLATED_IN_PROSTATE_CANCER,0.966313228662101
URS_ADIPOCYTE_DIFFERENTIATIO...2,SET,64,0.10106,0.0059569,0.10435,0.16641,URS_ADIPOCYTE_DIFFERENTIATION_UP,0.966313228662101
MIR6074,SET,249,0.054841,0.0063435,0.056638,0.16646,MIR6074,0.966313228662101
HP_DIAPHRAGMATIC_PARALYSIS,SET,6,0.34428,0.0062231,0.35556,0.16646,HP_DIAPHRAGMATIC_PARALYSIS,0.966313228662101
chr3p12,SET,7,0.43563,0.008505,0.45004,0.16653,chr3p12,0.966534149950674
GSE13485_PRE_VS_POST_YF17D_V...2,SET,167,0.063703,0.0060482,0.065858,0.16671,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP,0.966534149950674
NAKAYA_PBMC_FLUMIST_AGE_18_5...2,SET,30,0.1472,0.0059456,0.15219,0.16673,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_IFN_SUBSET_UP,0.966534149950674
HP_BONE_MARROW_MATURATION_AR...,SET,6,0.34395,0.0062172,0.35563,0.16674,HP_BONE_MARROW_MATURATION_ARREST,0.966534149950674
GOCC_LIPOPOLYSACCHARIDE_RECE...,SET,5,0.32852,0.005421,0.3397,0.16675,GOCC_LIPOPOLYSACCHARIDE_RECEPTOR_COMPLEX,0.966534149950674
chr18p11,SET,63,0.20372,0.011913,0.21067,0.16678,chr18p11,0.966534149950674
GOMF_TRIPEPTIDE_TRANSMEMBRAN...,SET,9,0.28324,0.0062698,0.29293,0.1668,GOMF_TRIPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.966534149950674
HP_CANDIDA_ESOPHAGITIS,SET,5,0.37164,0.0061325,0.38439,0.16682,HP_CANDIDA_ESOPHAGITIS,0.966534149950674
GOBP_NEGATIVE_REGULATION_OF_...190,SET,22,0.17418,0.006026,0.18017,0.16685,GOBP_NEGATIVE_REGULATION_OF_DNA_REPLICATION,0.966534149950674
GOBP_CARDIOBLAST_DIFFERENTIA...,SET,16,0.23879,0.0070465,0.24702,0.16686,GOBP_CARDIOBLAST_DIFFERENTIATION,0.966534149950674
GOBP_POSITIVE_REGULATION_OF_...134,SET,55,0.11452,0.006259,0.1185,0.16692,GOBP_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION,0.966534149950674
GSE36888_UNTREATED_VS_IL2_TR...10,SET,177,0.061148,0.0059752,0.063278,0.16695,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_UP,0.966534149950674
GSE22886_CTRL_VS_LPS_24H_DC_...1,SET,176,0.064847,0.0063189,0.067119,0.16699,GSE22886_CTRL_VS_LPS_24H_DC_DN,0.966534149950674
GOBP_ALPHA_BETA_T_CELL_PROLI...,SET,42,0.1418,0.0067746,0.14679,0.16704,GOBP_ALPHA_BETA_T_CELL_PROLIFERATION,0.966534149950674
HANN_RESISTANCE_TO_BCL2_INHI...1,SET,40,0.1463,0.0068214,0.15147,0.16708,HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN,0.966534149950674
HP_ABNORMAL_BLOOD_MONOVALENT...,SET,140,0.072587,0.0063146,0.075182,0.16716,HP_ABNORMAL_BLOOD_MONOVALENT_INORGANIC_CATION_CONCENTRATION,0.966534149950674
NAKAYA_MYELOID_DENDRITIC_CEL...2,SET,355,0.042816,0.0058961,0.044347,0.16716,NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.966534149950674
GSE35685_CD34POS_CD38NEG_VS_...1,SET,188,0.059905,0.0060311,0.062049,0.16717,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN,0.966534149950674
GOMF_MINUS_END_DIRECTED_MICR...,SET,17,0.18933,0.0057588,0.19613,0.16719,GOMF_MINUS_END_DIRECTED_MICROTUBULE_MOTOR_ACTIVITY,0.966534149950674
GOBP_CRD_MEDIATED_MRNA_STABI...,SET,11,0.24384,0.0059671,0.25261,0.1672,GOBP_CRD_MEDIATED_MRNA_STABILIZATION,0.966534149950674
GOBP_RESPONSE_TO_CORTISOL,SET,6,0.38369,0.0069353,0.39749,0.16721,GOBP_RESPONSE_TO_CORTISOL,0.966534149950674
GOBP_HINDLIMB_MORPHOGENESIS,SET,34,0.16304,0.0070099,0.16892,0.16723,GOBP_HINDLIMB_MORPHOGENESIS,0.966534149950674
HP_ABNORMAL_OOCYTE_MORPHOLOGY,SET,6,0.33156,0.0059932,0.34352,0.16723,HP_ABNORMAL_OOCYTE_MORPHOLOGY,0.966534149950674
HP_ULNAR_DEVIATION_OF_THE_2N...,SET,7,0.30525,0.0059595,0.31642,0.16735,HP_ULNAR_DEVIATION_OF_THE_2ND_FINGER,0.966534149950674
GOBP_REGULATION_OF_ATP_DEPEN...,SET,58,0.10587,0.0059416,0.10976,0.16737,GOBP_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,0.966534149950674
GOMF_CARBOHYDRATE_MONOATOMIC...,SET,16,0.21193,0.0062537,0.21969,0.16737,GOMF_CARBOHYDRATE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.966534149950674
GOBP_VIRAL_TRANSLATION,SET,18,0.18756,0.0058702,0.19446,0.1674,GOBP_VIRAL_TRANSLATION,0.966534149950674
GOBP_EMBRYONIC_DIGESTIVE_TRA...1,SET,33,0.16453,0.0069693,0.17059,0.16741,GOBP_EMBRYONIC_DIGESTIVE_TRACT_DEVELOPMENT,0.966534149950674
HP_HYPERTRICHOSIS,SET,234,0.052843,0.0059279,0.054789,0.16741,HP_HYPERTRICHOSIS,0.966534149950674
GOBP_VITAMIN_D3_METABOLIC_PR...,SET,7,0.27792,0.005426,0.28819,0.16744,GOBP_VITAMIN_D3_METABOLIC_PROCESS,0.966534149950674
MIR3692_5P,SET,128,0.072545,0.0060364,0.075249,0.16751,MIR3692_5P,0.966534149950674
GOBP_MEMBRANE_FISSION,SET,44,0.11868,0.0058032,0.1231,0.16751,GOBP_MEMBRANE_FISSION,0.966534149950674
GOCC_PORE_COMPLEX,SET,22,0.18324,0.0063394,0.19007,0.16751,GOCC_PORE_COMPLEX,0.966534149950674
KEGG_MEDICUS_REFERENCE_PRL_J...,SET,5,0.50549,0.0083411,0.52436,0.16753,KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY,0.966534149950674
GSE19941_LPS_VS_LPS_AND_IL10...1,SET,137,0.073891,0.0063594,0.076655,0.16754,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.966534149950674
GOCC_SPINDLE_MIDZONE,SET,35,0.13659,0.0059585,0.14181,0.16772,GOCC_SPINDLE_MIDZONE,0.966534149950674
GOBP_CERAMIDE_1_PHOSPHATE_TR...,SET,5,0.32041,0.0052871,0.33267,0.16774,GOBP_CERAMIDE_1_PHOSPHATE_TRANSPORT,0.966534149950674
GOBP_HYPERSENSITIVITY,SET,15,0.23993,0.0068556,0.24911,0.16774,GOBP_HYPERSENSITIVITY,0.966534149950674
GOMF_CERAMIDE_1_PHOSPHATE_TR...,SET,5,0.32041,0.0052871,0.33267,0.16774,GOMF_CERAMIDE_1_PHOSPHATE_TRANSFER_ACTIVITY,0.966534149950674
HP_ABNORMAL_DENTIN_MORPHOLOGY,SET,21,0.17531,0.0059259,0.18202,0.16774,HP_ABNORMAL_DENTIN_MORPHOLOGY,0.966534149950674
MAINA_VHL_TARGETS_DN,SET,14,0.25041,0.0069126,0.26,0.16775,MAINA_VHL_TARGETS_DN,0.966534149950674
GSE33425_CD161_HIGH_VS_INT_C...2,SET,186,0.059345,0.0059431,0.061616,0.16775,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP,0.966534149950674
HP_PERIVENTRICULAR_WHITE_MAT...,SET,29,0.15512,0.0061605,0.16107,0.16776,HP_PERIVENTRICULAR_WHITE_MATTER_HYPERINTENSITIES,0.966534149950674
GOMF_CARBOXYPEPTIDASE_ACTIVI...,SET,42,0.13271,0.0063404,0.13784,0.16783,GOMF_CARBOXYPEPTIDASE_ACTIVITY,0.966534149950674
GOMF_SERINE_HYDROLASE_ACTIVI...,SET,182,0.066925,0.0066305,0.069512,0.16783,GOMF_SERINE_HYDROLASE_ACTIVITY,0.966534149950674
GOBP_PROTEIN_UFMYLATION,SET,6,0.31775,0.0057435,0.33011,0.1679,GOBP_PROTEIN_UFMYLATION,0.966534149950674
MIR1285_5P,SET,60,0.11179,0.0063803,0.11614,0.16791,MIR1285_5P,0.966534149950674
HP_PAPILLOMA,SET,46,0.11257,0.0056278,0.11696,0.16791,HP_PAPILLOMA,0.966534149950674
GSE18893_TCONV_VS_TREG_2H_CU...2,SET,174,0.06113,0.0059231,0.063512,0.16791,GSE18893_TCONV_VS_TREG_2H_CULTURE_UP,0.966534149950674
XU_GH1_EXOGENOUS_TARGETS_DN,SET,90,0.086195,0.0060204,0.089574,0.16796,XU_GH1_EXOGENOUS_TARGETS_DN,0.966534149950674
MIR1537_5P,SET,109,0.07961,0.0061161,0.082744,0.168,MIR1537_5P,0.966534149950674
REACTOME_PD_1_SIGNALING,SET,18,0.21631,0.00677,0.22485,0.16803,REACTOME_PD_1_SIGNALING,0.966534149950674
GSE11057_NAIVE_VS_MEMORY_CD4...2,SET,158,0.068538,0.0063309,0.071295,0.1682,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP,0.966534149950674
REACTOME_PURINE_CATABOLISM,SET,17,0.2105,0.0064026,0.21901,0.16825,REACTOME_PURINE_CATABOLISM,0.966534149950674
GSE14308_TH2_VS_TH17_UP,SET,184,0.060471,0.0060236,0.062923,0.16827,GSE14308_TH2_VS_TH17_UP,0.966534149950674
GOBP_NEGATIVE_REGULATION_OF_...218,SET,8,0.28046,0.0058535,0.2919,0.16833,GOBP_NEGATIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,0.966534149950674
GSE32901_TH17_EMRICHED_VS_TH...2,SET,102,0.083139,0.0061799,0.086532,0.16833,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_UP,0.966534149950674
HP_EPISODIC_PAIN,SET,38,0.12972,0.0058957,0.13503,0.16837,HP_EPISODIC_PAIN,0.966534149950674
AMIT_EGF_RESPONSE_480_MCF10A,SET,42,0.13013,0.0062171,0.13547,0.16838,AMIT_EGF_RESPONSE_480_MCF10A,0.966534149950674
GOBP_CORTICAL_ACTIN_CYTOSKEL...,SET,42,0.11828,0.005651,0.12315,0.16841,GOBP_CORTICAL_ACTIN_CYTOSKELETON_ORGANIZATION,0.966534149950674
GOBP_CELLULAR_RESPONSE_TO_MO...,SET,209,0.060609,0.0064301,0.063109,0.16844,GOBP_CELLULAR_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN,0.966534149950674
ASXL2_TARGET_GENES,SET,38,0.13359,0.0060718,0.13911,0.16845,ASXL2_TARGET_GENES,0.966534149950674
DESCARTES_FETAL_ADRENAL_MEGA...,SET,86,0.089979,0.0061441,0.093697,0.16845,DESCARTES_FETAL_ADRENAL_MEGAKARYOCYTES,0.966534149950674
HP_PERONEAL_MUSCLE_WEAKNESS,SET,8,0.30778,0.0064236,0.32057,0.16851,HP_PERONEAL_MUSCLE_WEAKNESS,0.966534149950674
BARRIER_CANCER_RELAPSE_NORMA...2,SET,29,0.14916,0.0059237,0.15536,0.16852,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,0.966534149950674
GNF2_ELAC2,SET,40,0.11834,0.0055177,0.12326,0.16853,GNF2_ELAC2,0.966534149950674
GOBP_MODULATION_OF_EXCITATOR...,SET,46,0.12707,0.0063526,0.13236,0.16854,GOBP_MODULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,0.966534149950674
GOBP_PROTEIN_POLYUFMYLATION,SET,5,0.33687,0.0055588,0.35101,0.1686,GOBP_PROTEIN_POLYUFMYLATION,0.966534149950674
BIOCARTA_CTCF_PATHWAY,SET,24,0.18659,0.0067423,0.19443,0.16861,BIOCARTA_CTCF_PATHWAY,0.966534149950674
POU6F1_01,SET,211,0.061411,0.0065458,0.063993,0.16862,POU6F1_01,0.966534149950674
REACTOME_THE_FATTY_ACID_CYCL...,SET,4,0.38753,0.0057197,0.40389,0.16866,REACTOME_THE_FATTY_ACID_CYCLING_MODEL,0.966534149950674
REACTOME_TGFBR3_EXPRESSION,SET,25,0.1771,0.006531,0.18462,0.16872,REACTOME_TGFBR3_EXPRESSION,0.966534149950674
GOBP_AGGRESSIVE_BEHAVIOR,SET,8,0.34534,0.0072076,0.36002,0.16873,GOBP_AGGRESSIVE_BEHAVIOR,0.966534149950674
GOBP_REGULATION_OF_GLIAL_CEL...4,SET,36,0.13641,0.0060345,0.14221,0.16874,GOBP_REGULATION_OF_GLIAL_CELL_PROLIFERATION,0.966534149950674
MODULE_312,SET,46,0.11981,0.0059899,0.12491,0.16875,MODULE_312,0.966534149950674
GOBP_NEGATIVE_REGULATION_OF_...153,SET,9,0.31407,0.0069523,0.32748,0.16877,GOBP_NEGATIVE_REGULATION_OF_COLLATERAL_SPROUTING,0.966534149950674
GOBP_SLEEP,SET,21,0.19654,0.0066435,0.20493,0.16877,GOBP_SLEEP,0.966534149950674
MIR6889_3P,SET,100,0.084362,0.0062094,0.087975,0.1688,MIR6889_3P,0.966534149950674
GOBP_REGULATION_OF_PODOSOME_...,SET,13,0.22667,0.0060297,0.23638,0.16881,GOBP_REGULATION_OF_PODOSOME_ASSEMBLY,0.966534149950674
GOCC_MICOS_COMPLEX,SET,5,0.3415,0.0056351,0.35616,0.16883,GOCC_MICOS_COMPLEX,0.966534149950674
MORF_AP3D1,SET,119,0.067074,0.0053827,0.069971,0.16889,MORF_AP3D1,0.966534149950674
GSE17974_0H_VS_6H_IN_VITRO_A...1,SET,178,0.057585,0.0056428,0.060078,0.16891,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN,0.966534149950674
HP_ECHOGENIC_FETAL_BOWEL,SET,5,0.3501,0.005777,0.3653,0.16894,HP_ECHOGENIC_FETAL_BOWEL,0.966534149950674
GOBP_REGULATION_OF_MEMBRANE_...12,SET,4,0.44476,0.0065644,0.46413,0.16897,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.966534149950674
GOBP_REGULATION_OF_MEMBRANE_...13,SET,4,0.44476,0.0065644,0.46413,0.16897,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.966534149950674
MIR4673,SET,129,0.072458,0.0060525,0.07562,0.16899,MIR4673,0.966534149950674
GSE10273_HIGH_IL7_VS_HIGH_IL...2,SET,182,0.060516,0.0059956,0.063156,0.16899,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,0.966534149950674
HP_ANTERIOR_PITUITARY_HYPOPL...,SET,32,0.14937,0.006231,0.1559,0.169,HP_ANTERIOR_PITUITARY_HYPOPLASIA,0.966534149950674
GOBP_ARACHIDONIC_ACID_METABO...,SET,55,0.11604,0.0063418,0.12112,0.16903,GOBP_ARACHIDONIC_ACID_METABOLIC_PROCESS,0.966534149950674
BERENJENO_ROCK_SIGNALING_NOT...2,SET,28,0.15449,0.0060289,0.16127,0.16905,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,0.966534149950674
MIR452_3P,SET,118,0.080803,0.0064574,0.08436,0.16908,MIR452_3P,0.966534149950674
GOBP_NEGATIVE_REGULATION_OF_...384,SET,18,0.18251,0.0057121,0.19054,0.16908,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PERMEABILITY,0.966534149950674
GOBP_CELL_MIGRATION_INVOLVED...3,SET,6,0.41367,0.0074772,0.43196,0.16912,GOBP_CELL_MIGRATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.966534149950674
HE_LIM_SUN_FETAL_LUNG_C4_CD8...,SET,46,0.12306,0.0061525,0.1285,0.16912,HE_LIM_SUN_FETAL_LUNG_C4_CD8_T_CELL,0.966534149950674
GOBP_LEUKOCYTE_MEDIATED_CYTO...,SET,133,0.079824,0.0067697,0.08336,0.16914,GOBP_LEUKOCYTE_MEDIATED_CYTOTOXICITY,0.966534149950674
GOMF_ANKYRIN_REPEAT_BINDING,SET,6,0.28731,0.0051933,0.30008,0.16918,GOMF_ANKYRIN_REPEAT_BINDING,0.966603797468354
HOEK_B_CELL_2011_2012_TIV_AD...3,SET,30,0.15072,0.006088,0.15746,0.16923,HOEK_B_CELL_2011_2012_TIV_ADULT_3DY_UP,0.966730547337278
GOBP_EPITHELIAL_CELL_DIFFERE...1,SET,681,0.035118,0.0066372,0.036701,0.16932,GOBP_EPITHELIAL_CELL_DIFFERENTIATION,0.966907045491871
GSE15930_STIM_VS_STIM_AND_IL...3,SET,189,0.064066,0.0064669,0.066964,0.16936,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_DN,0.966907045491871
MIR892C_5P,SET,252,0.053482,0.0062229,0.055909,0.16939,MIR892C_5P,0.966907045491871
GOBP_ACUTE_INFLAMMATORY_RESP...1,SET,99,0.089207,0.0065332,0.093258,0.1694,GOBP_ACUTE_INFLAMMATORY_RESPONSE,0.966907045491871
GSE7831_UNSTIM_VS_INFLUENZA_...2,SET,179,0.058576,0.0057558,0.061235,0.1694,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_UP,0.966907045491871
chr3q26,SET,61,0.20541,0.011821,0.21479,0.16946,chr3q26,0.967013810930576
HARALAMBIEVA_PBMC_M_M_R_II_A...6,SET,40,0.14262,0.0066499,0.14914,0.16948,HARALAMBIEVA_PBMC_M_M_R_II_AGE_13_16YO_STIMULATED_VS_UNSTIMULATED_3_TO_7YR_POST_TOP_DEG_UP,0.967013810930576
MIR6814_5P,SET,100,0.079275,0.005835,0.08292,0.16953,MIR6814_5P,0.967013810930576
GOMF_TRANSFERASE_ACTIVITY_TR...4,SET,822,0.028411,0.0058757,0.029717,0.16953,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS,0.967013810930576
IKEDA_MIR133_TARGETS_UP,SET,40,0.12605,0.0058776,0.13189,0.1696,IKEDA_MIR133_TARGETS_UP,0.967254348539547
MONNIER_POSTRADIATION_TUMOR_...1,SET,335,0.04487,0.0060057,0.046956,0.16965,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,0.967380762920427
REACTOME_IKK_COMPLEX_RECRUIT...,SET,21,0.17695,0.0059813,0.18521,0.1697,REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,0.967422480747174
GSE2585_CD80_HIGH_VS_LOW_MTE...2,SET,179,0.062876,0.0061784,0.065817,0.16972,GSE2585_CD80_HIGH_VS_LOW_MTEC_UP,0.967422480747174
HMG20B_TARGET_GENES,SET,1493,0.022289,0.0060925,0.023335,0.16975,HMG20B_TARGET_GENES,0.967422480747174
GOBP_OLFACTORY_BULB_INTERNEU...1,SET,7,0.35898,0.0070085,0.37588,0.16978,GOBP_OLFACTORY_BULB_INTERNEURON_DEVELOPMENT,0.967422480747174
GOBP_RESPONSE_TO_COLD,SET,42,0.12135,0.0057976,0.12707,0.16981,GOBP_RESPONSE_TO_COLD,0.967422480747174
GOBP_FC_RECEPTOR_SIGNALING_P...,SET,53,0.12018,0.0064483,0.12588,0.16985,GOBP_FC_RECEPTOR_SIGNALING_PATHWAY,0.967422480747174
HP_OSTEOCHONDROSIS,SET,12,0.2504,0.0063999,0.26228,0.16987,HP_OSTEOCHONDROSIS,0.967422480747174
GOBP_PROTEIN_PROCESSING_INVO...,SET,7,0.31656,0.0061803,0.3316,0.16988,GOBP_PROTEIN_PROCESSING_INVOLVED_IN_PROTEIN_TARGETING_TO_MITOCHONDRION,0.967422480747174
GAVISH_3CA_METAPROGRAM_ENDOT...2,SET,47,0.12985,0.0065618,0.13605,0.16994,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_COAGULATION,0.967431833796826
WP_INITIATION_OF_TRANSCRIPTI...,SET,31,0.13645,0.0056025,0.14303,0.17005,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,0.967431833796826
REACTOME_REGULATION_OF_SIGNA...1,SET,21,0.19419,0.0065641,0.20357,0.17007,REACTOME_REGULATION_OF_SIGNALING_BY_CBL,0.967431833796826
GCM_USP6,SET,67,0.091014,0.0054883,0.095416,0.17008,GCM_USP6,0.967431833796826
GOCC_NUCLEAR_ENVELOPE,SET,450,0.038017,0.0058787,0.039856,0.17008,GOCC_NUCLEAR_ENVELOPE,0.967431833796826
HP_LEG_MUSCLE_STIFFNESS,SET,14,0.20052,0.0055352,0.21021,0.17008,HP_LEG_MUSCLE_STIFFNESS,0.967431833796826
GOBP_SEQUESTERING_OF_EXTRACE...,SET,10,0.30116,0.0070269,0.31578,0.17012,GOBP_SEQUESTERING_OF_EXTRACELLULAR_LIGAND_FROM_RECEPTOR,0.967431833796826
MIR204_3P,SET,128,0.07175,0.0059703,0.07524,0.17014,MIR204_3P,0.967431833796826
KEGG_MEDICUS_REFERENCE_HEDGE...3,SET,9,0.28724,0.0063583,0.30122,0.17016,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR,0.967431833796826
GOBP_CELL_SURFACE_RECEPTOR_P...3,SET,6,0.31204,0.0056404,0.32724,0.17016,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_PHOSPHATASE_SIGNALING_PATHWAY,0.967431833796826
GSE17721_CTRL_VS_LPS_1H_BMDC...1,SET,181,0.062153,0.006141,0.0652,0.17023,GSE17721_CTRL_VS_LPS_1H_BMDC_DN,0.967481020107896
HP_SHOULDER_PAIN,SET,6,0.39654,0.0071676,0.41602,0.17026,HP_SHOULDER_PAIN,0.967481020107896
ABBUD_LIF_SIGNALING_2_UP,SET,13,0.24263,0.0064542,0.25456,0.17027,ABBUD_LIF_SIGNALING_2_UP,0.967481020107896
GOMF_ADENOSINE_DEAMINASE_ACT...,SET,12,0.24131,0.0061675,0.25319,0.17028,GOMF_ADENOSINE_DEAMINASE_ACTIVITY,0.967481020107896
JACKSON_DNMT1_TARGETS_DN,SET,20,0.2052,0.0067694,0.21535,0.17034,JACKSON_DNMT1_TARGETS_DN,0.967663729977117
GOBP_EMBRYONIC_EYE_MORPHOGEN...,SET,34,0.15319,0.0065866,0.16087,0.17049,GOBP_EMBRYONIC_EYE_MORPHOGENESIS,0.9679764
GSE20198_IL12_VS_IL12_IL18_T...2,SET,175,0.058821,0.0057156,0.061772,0.1705,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,0.9679764
KEGG_MEDICUS_REFERENCE_AUTOP...6,SET,16,0.18733,0.0055279,0.19676,0.17054,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_MTORC1_PI3KC3_C1,0.9679764
REACTOME_SPHINGOLIPID_DE_NOV...,SET,36,0.1395,0.0061716,0.14654,0.17056,REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS,0.9679764
GSE41867_NAIVE_VS_DAY15_LCMV...1,SET,178,0.059569,0.0058372,0.062574,0.17056,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.9679764
ACEVEDO_NORMAL_TISSUE_ADJACE...1,SET,320,0.044554,0.0058309,0.046804,0.17057,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,0.9679764
HP_IMPAIRED_VIBRATORY_SENSAT...,SET,113,0.07333,0.0057354,0.077038,0.17059,HP_IMPAIRED_VIBRATORY_SENSATION,0.9679764
CREB_02,SET,232,0.053086,0.0059299,0.055786,0.17066,CREB_02,0.968126387075718
GSE21063_CTRL_VS_ANTI_IGM_ST...11,SET,174,0.05789,0.0056091,0.06084,0.17068,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN,0.968126387075718
GOBP_POSITIVE_REGULATION_OF_...770,SET,17,0.19035,0.0057897,0.20007,0.1707,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.968126387075718
GOBP_REGULATION_OF_GLOMERULU...,SET,4,0.46954,0.0069301,0.49361,0.17075,GOBP_REGULATION_OF_GLOMERULUS_DEVELOPMENT,0.968199282686665
GOBP_L_GLUTAMINE_IMPORT_ACRO...,SET,4,0.42882,0.0063292,0.45084,0.17077,GOBP_L_GLUTAMINE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.968199282686665
MIR330_3P,SET,307,0.049593,0.0063593,0.05215,0.17082,MIR330_3P,0.968199282686665
HP_SHORT_NOSE,SET,276,0.048893,0.0059497,0.051423,0.17086,HP_SHORT_NOSE,0.968199282686665
GOMF_CALCIUM_INDEPENDENT_PHO...,SET,9,0.26639,0.0058968,0.28019,0.17088,GOMF_CALCIUM_INDEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY,0.968199282686665
GSE12366_GC_BCELL_VS_PLASMA_...1,SET,162,0.06293,0.0058854,0.066192,0.17088,GSE12366_GC_BCELL_VS_PLASMA_CELL_DN,0.968199282686665
MANN_RESPONSE_TO_AMIFOSTINE_...1,SET,9,0.2393,0.0052972,0.25183,0.171,MANN_RESPONSE_TO_AMIFOSTINE_DN,0.968575468469936
GSE24142_ADULT_VS_FETAL_DN2_...2,SET,186,0.062685,0.0062776,0.065975,0.17103,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP,0.968575468469936
DESCARTES_FETAL_PANCREAS_DUC...,SET,96,0.090119,0.0064998,0.094849,0.17103,DESCARTES_FETAL_PANCREAS_DUCTAL_CELLS,0.968575468469936
KEGG_MEDICUS_REFERENCE_DNA_R...2,SET,17,0.17931,0.0054539,0.18882,0.17115,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_TERMINATION,0.968838078175896
HP_PERICARDITIS,SET,33,0.15119,0.0064042,0.15921,0.17116,HP_PERICARDITIS,0.968838078175896
HP_SECOND_TRIMESTER_ONSET,SET,41,0.12559,0.0059288,0.13226,0.17116,HP_SECOND_TRIMESTER_ONSET,0.968838078175896
NFY_01,SET,230,0.055044,0.0061224,0.057978,0.17122,NFY_01,0.969019882755252
chr20q11,SET,118,0.19017,0.015198,0.20034,0.17125,chr20q11,0.969031870726148
DESCARTES_FETAL_LIVER_VASCUL...,SET,102,0.087669,0.0065166,0.092373,0.1713,DESCARTES_FETAL_LIVER_VASCULAR_ENDOTHELIAL_CELLS,0.969059155960319
HP_ABNORMAL_PAROTID_GLAND_MO...,SET,8,0.29013,0.0060552,0.30577,0.17135,HP_ABNORMAL_PAROTID_GLAND_MORPHOLOGY,0.969059155960319
GOBP_MYD88_DEPENDENT_TOLL_LI...,SET,18,0.16679,0.0052202,0.1758,0.17137,GOBP_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.969059155960319
GSE17186_CD21LOW_VS_CD21HIGH...1,SET,175,0.059562,0.0057876,0.062776,0.17137,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,0.969059155960319
EBAUER_MYOGENIC_TARGETS_OF_P...,SET,43,0.12697,0.006138,0.13384,0.1714,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,0.969059155960319
DESCARTES_FETAL_LUNG_VASCULA...,SET,43,0.13516,0.0065335,0.14249,0.17144,DESCARTES_FETAL_LUNG_VASCULAR_ENDOTHELIAL_CELLS,0.969059155960319
CTTTGA_LEF1_Q2,SET,1088,0.02678,0.0063232,0.028234,0.17145,CTTTGA_LEF1_Q2,0.969059155960319
REACTOME_ARYL_HYDROCARBON_RE...,SET,6,0.26812,0.0048464,0.28278,0.17154,REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING,0.969410195121951
MANNO_MIDBRAIN_NEUROTYPES_HN...4,SET,413,0.043539,0.0064565,0.045935,0.17161,MANNO_MIDBRAIN_NEUROTYPES_HNBML5,0.969648114127784
GOBP_L_LEUCINE_METABOLIC_PRO...,SET,8,0.28321,0.0059107,0.29892,0.17171,GOBP_L_LEUCINE_METABOLIC_PROCESS,0.969977887896019
GSE8621_LPS_STIM_VS_LPS_PRIM...2,SET,185,0.060746,0.0060672,0.06413,0.17177,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,0.969977887896019
NIKOLSKY_BREAST_CANCER_19P13...,SET,5,0.55372,0.0091369,0.5846,0.17178,NIKOLSKY_BREAST_CANCER_19P13_AMPLICON,0.969977887896019
HP_ABNORMALITY_OF_FACIAL_SOF...,SET,458,0.038421,0.0059925,0.040563,0.17178,HP_ABNORMALITY_OF_FACIAL_SOFT_TISSUE,0.969977887896019
GOBP_ACTIVATION_OF_PHOSPHOLI...,SET,21,0.19226,0.0064987,0.20304,0.17185,GOBP_ACTIVATION_OF_PHOSPHOLIPASE_C_ACTIVITY,0.970215521442495
GNF2_TST,SET,99,0.081531,0.0059711,0.08613,0.17193,GNF2_TST,0.970509525743057
GOBP_AMMONIUM_ION_METABOLIC_...,SET,22,0.19477,0.0067383,0.20585,0.17204,GOBP_AMMONIUM_ION_METABOLIC_PROCESS,0.970546763990268
LIANG_SILENCED_BY_METHYLATIO...1,SET,45,0.12751,0.0063055,0.13481,0.1721,LIANG_SILENCED_BY_METHYLATION_2,0.970546763990268
MIR6791_5P,SET,152,0.065414,0.0059276,0.069163,0.17213,MIR6791_5P,0.970546763990268
GOBP_NEGATIVE_REGULATION_OF_...550,SET,15,0.20004,0.0057156,0.2115,0.17213,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION,0.970546763990268
HP_ABNORMAL_FEMALE_MEIOSIS,SET,6,0.33544,0.0060633,0.35466,0.17213,HP_ABNORMAL_FEMALE_MEIOSIS,0.970546763990268
KEGG_MEDICUS_REFERENCE_REGUL...14,SET,8,0.23381,0.0048797,0.24721,0.17214,KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA,0.970546763990268
MIR1236_3P,SET,170,0.062353,0.0059724,0.065933,0.17216,MIR1236_3P,0.970546763990268
MIR200A_5P,SET,96,0.079169,0.0057101,0.083715,0.17216,MIR200A_5P,0.970546763990268
GOBP_POSITIVE_REGULATION_OF_...113,SET,343,0.046174,0.0062522,0.048839,0.17223,GOBP_POSITIVE_REGULATION_OF_CELL_ACTIVATION,0.970574307916464
REACTOME_DEFECTS_IN_BIOTIN_B...,SET,8,0.2844,0.0059355,0.30083,0.17224,REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM,0.970574307916464
GSE9946_IMMATURE_VS_MATURE_S...2,SET,124,0.068103,0.0055782,0.072046,0.17227,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP,0.970574307916464
GOBP_CEREBRAL_CORTEX_RADIALL...,SET,33,0.14379,0.0060908,0.15214,0.17232,GOBP_CEREBRAL_CORTEX_RADIALLY_ORIENTED_CELL_MIGRATION,0.970574307916464
HP_ABNORMAL_MONOCYTE_COUNT,SET,20,0.18332,0.0060474,0.19405,0.17241,HP_ABNORMAL_MONOCYTE_COUNT,0.970574307916464
HP_INCREASED_ENDOMYSIAL_CONN...,SET,27,0.15857,0.0060767,0.16785,0.17241,HP_INCREASED_ENDOMYSIAL_CONNECTIVE_TISSUE,0.970574307916464
GSE40273_GATA1_KO_VS_WT_TREG...1,SET,183,0.059888,0.0059494,0.063392,0.17241,GSE40273_GATA1_KO_VS_WT_TREG_DN,0.970574307916464
ZHENG_CORD_BLOOD_C10_MULTILY...,SET,81,0.093216,0.0061782,0.098684,0.17244,ZHENG_CORD_BLOOD_C10_MULTILYMPHOID_PROGENITOR,0.970574307916464
GSE2405_HEAT_KILLED_LYSATE_V...1,SET,182,0.060704,0.0060142,0.064268,0.17245,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,0.970574307916464
PETROVA_PROX1_TARGETS_DN,SET,55,0.11147,0.006092,0.11803,0.17248,PETROVA_PROX1_TARGETS_DN,0.970574307916464
HP_AGENESIS_OF_CORPUS_CALLOS...,SET,301,0.045188,0.0057385,0.047847,0.17248,HP_AGENESIS_OF_CORPUS_CALLOSUM,0.970574307916464
KEGG_MEDICUS_PATHOGEN_EBV_LM...1,SET,10,0.24752,0.0057753,0.2621,0.1725,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_NFKB_SIGNALING_PATHWAY,0.970574307916464
GOBP_PHOTOTRANSDUCTION,SET,40,0.13231,0.0061695,0.14013,0.17253,GOBP_PHOTOTRANSDUCTION,0.97058597442538
TURJANSKI_MAPK1_AND_MAPK2_TA...,SET,11,0.27455,0.0067184,0.29079,0.17256,TURJANSKI_MAPK1_AND_MAPK2_TARGETS,0.970597637158116
GOMF_HYDROLASE_ACTIVITY_ACTI...1,SET,716,0.030525,0.0059097,0.032343,0.17264,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES,0.970789637599094
GOBP_ISOPRENOID_BIOSYNTHETIC...,SET,28,0.14934,0.005828,0.15824,0.17265,GOBP_ISOPRENOID_BIOSYNTHETIC_PROCESS,0.970789637599094
REACTOME_FRUCTOSE_CATABOLISM,SET,5,0.28463,0.0046966,0.30164,0.1727,REACTOME_FRUCTOSE_CATABOLISM,0.97086909267346
MIR6758_5P,SET,99,0.080729,0.0059124,0.085563,0.17272,MIR6758_5P,0.97086909267346
GAUSSMANN_MLL_AF4_FUSION_TAR...10,SET,90,0.090328,0.0063091,0.095766,0.17279,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP,0.971004688763137
SUNG_METASTASIS_STROMA_DN,SET,51,0.11421,0.0060114,0.12109,0.1728,SUNG_METASTASIS_STROMA_DN,0.971004688763137
GOBP_REGULATION_OF_PHOSPHATE...,SET,7,0.32461,0.0063376,0.34421,0.17283,GOBP_REGULATION_OF_PHOSPHATE_TRANSPORT,0.971016270611057
MIR5089_5P,SET,103,0.078211,0.0058419,0.082955,0.1729,MIR5089_5P,0.971163305865245
HP_EOSINOPHILIC_INFILTRATION...,SET,10,0.29078,0.0067847,0.30846,0.17293,HP_EOSINOPHILIC_INFILTRATION_OF_THE_ESOPHAGUS,0.971163305865245
ZHONG_RESPONSE_TO_AZACITIDIN...1,SET,58,0.098552,0.0055307,0.10455,0.17294,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,0.971163305865245
GSE19401_NAIVE_VS_IMMUNIZED_...1,SET,181,0.060581,0.0059857,0.064287,0.17301,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN,0.971374772400575
GOBP_NEGATIVE_REGULATION_OF_...63,SET,4,0.47425,0.0069996,0.50349,0.17313,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.971374772400575
GOBP_B_CELL_MEDIATED_IMMUNITY,SET,117,0.076823,0.0061134,0.081572,0.17316,GOBP_B_CELL_MEDIATED_IMMUNITY,0.971374772400575
CAO_BLOOD_FLUZONE_AGE_05_14Y...7,SET,6,0.32586,0.0058902,0.34619,0.17328,CAO_BLOOD_FLUZONE_AGE_05_14YO_CORRELATED_WITH_H3N1_HI_TITER_1DY_POSITIVE,0.971374772400575
CHESLER_BRAIN_HIGHEST_GENETI...,SET,36,0.13964,0.0061776,0.1484,0.17337,CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE,0.971374772400575
JOSEPH_RESPONSE_TO_SODIUM_BU...1,SET,57,0.11007,0.0061237,0.11697,0.17337,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,0.971374772400575
HP_CHRONIC_LEUKEMIA,SET,23,0.16737,0.0059205,0.17788,0.17337,HP_CHRONIC_LEUKEMIA,0.971374772400575
MIR4650_3P,SET,119,0.076693,0.0061546,0.081516,0.1734,MIR4650_3P,0.971374772400575
GOMF_LIGASE_ACTIVITY_FORMING...1,SET,7,0.29898,0.005837,0.31779,0.17341,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_CARBON_BONDS,0.971374772400575
HP_OTOSCLEROSIS,SET,6,0.36001,0.0065074,0.38268,0.17342,HP_OTOSCLEROSIS,0.971374772400575
GOBP_DUMP_METABOLIC_PROCESS,SET,7,0.32417,0.0063289,0.34462,0.17344,GOBP_DUMP_METABOLIC_PROCESS,0.971374772400575
GSE29614_CTRL_VS_DAY3_TIV_FL...1,SET,138,0.072449,0.0062578,0.077032,0.17349,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN,0.971374772400575
UNTERMAN_IPF_VS_CTRL_NK_CELL...1,SET,8,0.32059,0.0066909,0.3409,0.17351,UNTERMAN_IPF_VS_CTRL_NK_CELL_DN,0.971374772400575
GOCC_EGG_COAT,SET,5,0.32018,0.0052834,0.34057,0.17358,GOCC_EGG_COAT,0.971374772400575
HP_LIMB_UNDERGROWTH,SET,220,0.053423,0.0058131,0.056825,0.17358,HP_LIMB_UNDERGROWTH,0.971374772400575
HP_METAPHYSEAL_IRREGULARITY,SET,44,0.12334,0.0060311,0.13119,0.17358,HP_METAPHYSEAL_IRREGULARITY,0.971374772400575
PATEL_SKIN_OF_BODY_ZOSTAVAX_...2,SET,33,0.14231,0.0060283,0.15139,0.1736,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_DN,0.971374772400575
MIR556_3P,SET,129,0.070464,0.005886,0.074967,0.17363,MIR556_3P,0.971374772400575
TEF_Q6,SET,235,0.055765,0.0062688,0.059334,0.17365,TEF_Q6,0.971374772400575
MIR6879_3P,SET,41,0.12567,0.0059323,0.13376,0.17375,MIR6879_3P,0.971374772400575
GOCC_FICOLIN_1_RICH_GRANULE_...2,SET,52,0.11164,0.0059331,0.11883,0.17375,GOCC_FICOLIN_1_RICH_GRANULE_MEMBRANE,0.971374772400575
GOMF_HYDRO_LYASE_ACTIVITY,SET,52,0.1157,0.0061491,0.12319,0.17382,GOMF_HYDRO_LYASE_ACTIVITY,0.971374772400575
AP4_Q6_01,SET,233,0.052507,0.0058777,0.055914,0.17385,AP4_Q6_01,0.971374772400575
GOBP_REGULATION_OF_INFLAMMAT...2,SET,39,0.12843,0.0059132,0.13677,0.17386,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.971374772400575
GSE7348_LPS_VS_TOLERIZED_AND...1,SET,157,0.061846,0.0056949,0.06587,0.17389,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,0.971374772400575
REACTOME_FATTY_ACIDS_BOUND_T...,SET,8,0.3032,0.006328,0.323,0.17395,REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION,0.971374772400575
HP_ABNORMAL_THOUGHT_PATTERN,SET,63,0.099061,0.0057931,0.10553,0.17395,HP_ABNORMAL_THOUGHT_PATTERN,0.971374772400575
HP_CHOANAL_ATRESIA,SET,107,0.074651,0.0056826,0.079536,0.17398,HP_CHOANAL_ATRESIA,0.971374772400575
HP_DIGITAL_FLEXOR_TENOSYNOVI...,SET,7,0.31233,0.0060977,0.33283,0.17402,HP_DIGITAL_FLEXOR_TENOSYNOVITIS,0.971374772400575
BIOCARTA_IL10_PATHWAY,SET,13,0.23791,0.0063289,0.25354,0.17403,BIOCARTA_IL10_PATHWAY,0.971374772400575
GOBP_CELL_FATE_DETERMINATION,SET,40,0.14206,0.0066241,0.1514,0.17404,GOBP_CELL_FATE_DETERMINATION,0.971374772400575
HP_SHORT_TELOMERE_LENGTH,SET,14,0.20557,0.0056746,0.21912,0.17409,HP_SHORT_TELOMERE_LENGTH,0.971374772400575
GOBP_IMP_SALVAGE,SET,4,0.41913,0.0061861,0.4468,0.17411,GOBP_IMP_SALVAGE,0.971374772400575
GOBP_REGULATION_OF_LONG_TERM...2,SET,12,0.27693,0.007078,0.29529,0.17417,GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_DEPRESSION,0.971374772400575
GOBP_CELLULAR_DETOXIFICATION...,SET,9,0.272,0.0060211,0.29005,0.17418,GOBP_CELLULAR_DETOXIFICATION_OF_ALDEHYDE,0.971374772400575
GSE39820_CTRL_VS_TGFBETA1_IL...1,SET,183,0.058594,0.0058209,0.062492,0.17422,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN,0.971374772400575
HP_CHOROIDAL_HEMANGIOMA,SET,5,0.31837,0.0052535,0.33964,0.17429,HP_CHOROIDAL_HEMANGIOMA,0.971374772400575
GOCC_AP_TYPE_MEMBRANE_COAT_A...,SET,39,0.12416,0.0057168,0.13248,0.17432,GOCC_AP_TYPE_MEMBRANE_COAT_ADAPTOR_COMPLEX,0.971374772400575
MIR30A_5P,SET,709,0.031453,0.0060607,0.033565,0.17437,MIR30A_5P,0.971374772400575
MIR30D_5P,SET,709,0.031453,0.0060607,0.033565,0.17437,MIR30D_5P,0.971374772400575
MIR30E_5P,SET,709,0.031453,0.0060607,0.033565,0.17437,MIR30E_5P,0.971374772400575
MODULE_267,SET,14,0.20624,0.0056933,0.22009,0.17437,MODULE_267,0.971374772400575
GOBP_NEUTRAL_LIPID_CATABOLIC...,SET,36,0.13823,0.0061153,0.14751,0.17437,GOBP_NEUTRAL_LIPID_CATABOLIC_PROCESS,0.971374772400575
HP_RECURRENT_THROMBOPHLEBITIS,SET,6,0.27953,0.0050526,0.29831,0.17437,HP_RECURRENT_THROMBOPHLEBITIS,0.971374772400575
BASSO_CD40_SIGNALING_UP,SET,95,0.086212,0.0061858,0.092012,0.17439,BASSO_CD40_SIGNALING_UP,0.971374772400575
GSE20727_DNFB_ALLERGEN_VS_RO...2,SET,163,0.064776,0.0060765,0.069136,0.1744,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,0.971374772400575
HP_ABNORMAL_INTERNAL_GENITAL...,SET,467,0.037299,0.0058729,0.039812,0.17441,HP_ABNORMAL_INTERNAL_GENITALIA,0.971374772400575
HP_ABNORMALITY_OF_MASSETER_M...,SET,5,0.36195,0.0059725,0.38636,0.17443,HP_ABNORMALITY_OF_MASSETER_MUSCLE,0.971374772400575
MODULE_528,SET,10,0.26694,0.0062284,0.28494,0.17444,MODULE_528,0.971374772400575
MORF_PRDX3,SET,72,0.088751,0.0055472,0.094766,0.17451,MORF_PRDX3,0.971374772400575
JAIN_NFKB_SIGNALING,SET,68,0.092139,0.0055973,0.098391,0.17453,JAIN_NFKB_SIGNALING,0.971374772400575
GOBP_NUCLEAR_EXPORT,SET,153,0.058877,0.0053526,0.062875,0.17453,GOBP_NUCLEAR_EXPORT,0.971374772400575
MODULE_281,SET,28,0.144,0.0056195,0.15379,0.17456,MODULE_281,0.971374772400575
GOCC_SERINE_TYPE_PEPTIDASE_C...,SET,13,0.27244,0.0072473,0.29097,0.17457,GOCC_SERINE_TYPE_PEPTIDASE_COMPLEX,0.971374772400575
GSE11057_NAIVE_VS_CENT_MEMOR...2,SET,153,0.06496,0.0059055,0.069379,0.17457,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,0.971374772400575
ONDER_CDH1_TARGETS_3_UP,SET,15,0.22391,0.0063978,0.23916,0.17459,ONDER_CDH1_TARGETS_3_UP,0.971374772400575
GSE16451_IMMATURE_VS_MATURE_...2,SET,181,0.060414,0.0059692,0.064535,0.17461,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.971374772400575
HP_RENAL_TUBULAR_ATROPHY,SET,18,0.18232,0.0057061,0.19477,0.17462,HP_RENAL_TUBULAR_ATROPHY,0.971374772400575
MIR501_3P_MIR502_3P,SET,65,0.10702,0.006357,0.11434,0.17464,MIR501_3P_MIR502_3P,0.971374772400575
GSE45365_WT_VS_IFNAR_KO_CD8A...4,SET,174,0.061107,0.0059209,0.065289,0.17466,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_UP,0.971374772400575
GOBP_ERBB_SIGNALING_PATHWAY,SET,121,0.072794,0.0058904,0.077801,0.17473,GOBP_ERBB_SIGNALING_PATHWAY,0.971374772400575
GTCTACC_MIR379,SET,22,0.19,0.0065734,0.20307,0.17474,GTCTACC_MIR379,0.971374772400575
GSE17721_CTRL_VS_CPG_4H_BMDC...1,SET,179,0.058408,0.0057393,0.062433,0.17476,GSE17721_CTRL_VS_CPG_4H_BMDC_DN,0.971374772400575
GOBP_MEIOTIC_CYTOKINESIS,SET,7,0.29113,0.0056838,0.31125,0.17481,GOBP_MEIOTIC_CYTOKINESIS,0.971374772400575
HP_ABNORMAL_FORAMEN_MAGNUM_M...,SET,16,0.18158,0.0053583,0.19415,0.17483,HP_ABNORMAL_FORAMEN_MAGNUM_MORPHOLOGY,0.971374772400575
GOBP_REGULATION_OF_B_CELL_RE...,SET,21,0.1759,0.005946,0.18815,0.17492,GOBP_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.971374772400575
HP_ABNORMAL_FALLOPIAN_TUBE_M...,SET,21,0.16081,0.0054358,0.17201,0.17493,HP_ABNORMAL_FALLOPIAN_TUBE_MORPHOLOGY,0.971374772400575
GOBP_PROTEIN_DEPOLYMERIZATION,SET,108,0.07325,0.0056018,0.078354,0.17494,GOBP_PROTEIN_DEPOLYMERIZATION,0.971374772400575
GOBP_REGULATION_OF_T_CELL_ME...2,SET,10,0.26309,0.0061386,0.28144,0.17495,GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.971374772400575
GOBP_REGULATION_OF_PHOSPHOLI...2,SET,45,0.12711,0.0062857,0.13598,0.17496,GOBP_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,0.971374772400575
MIR4486,SET,34,0.1268,0.0054517,0.13565,0.17497,MIR4486,0.971374772400575
GOBP_ORGANIC_ACID_BIOSYNTHET...,SET,301,0.047099,0.0059813,0.050392,0.17499,GOBP_ORGANIC_ACID_BIOSYNTHETIC_PROCESS,0.971374772400575
TAGAACC_MIR182,SET,34,0.13917,0.0059838,0.14892,0.17502,TAGAACC_MIR182,0.9713861545832
HP_VASCULITIS,SET,65,0.10508,0.0062413,0.11249,0.17513,HP_VASCULITIS,0.971669532368379
HP_APLASIA_HYPOPLASIA_OF_THE...11,SET,80,0.088948,0.005859,0.095238,0.17517,HP_APLASIA_HYPOPLASIA_OF_THE_BRAINSTEM,0.971669532368379
GSE20198_IL12_VS_IFNA_TREATE...1,SET,179,0.059697,0.005866,0.063923,0.17519,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,0.971669532368379
HP_INCREASED_T_CELL_COUNT,SET,4,0.44274,0.0065346,0.47418,0.17524,HP_INCREASED_T_CELL_COUNT,0.971669532368379
GSE16385_ROSIGLITAZONE_IFNG_...2,SET,185,0.059416,0.0059344,0.063645,0.17527,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,0.971669532368379
NKX25_01,SET,109,0.079713,0.006124,0.0854,0.17531,NKX25_01,0.971669532368379
BIOCARTA_EXTRINSIC_PATHWAY,SET,13,0.24193,0.0064358,0.25921,0.17533,BIOCARTA_EXTRINSIC_PATHWAY,0.971669532368379
MIR4635,SET,120,0.073759,0.0059438,0.079028,0.17533,MIR4635,0.971669532368379
GOMF_SIGNALING_RECEPTOR_INHI...,SET,27,0.15247,0.0058429,0.16338,0.17536,GOMF_SIGNALING_RECEPTOR_INHIBITOR_ACTIVITY,0.971669532368379
GOMF_ALPHA_ACTININ_BINDING,SET,28,0.16046,0.006262,0.17196,0.17538,GOMF_ALPHA_ACTININ_BINDING,0.971669532368379
KEGG_MEDICUS_PATHOGEN_HPV_E6...1,SET,12,0.23815,0.0060868,0.25532,0.17547,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380,0.971669532368379
GOBP_INTERMEMBRANE_LIPID_TRA...,SET,28,0.14248,0.0055604,0.15277,0.1755,GOBP_INTERMEMBRANE_LIPID_TRANSFER,0.971669532368379
GOBP_RESPONSE_TO_L_ASCORBIC_...,SET,5,0.4026,0.0066434,0.43166,0.1755,GOBP_RESPONSE_TO_L_ASCORBIC_ACID,0.971669532368379
GSE15930_STIM_VS_STIM_AND_TR...1,SET,177,0.057231,0.0055925,0.061362,0.1755,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN,0.971669532368379
GOBP_LEUKOCYTE_MIGRATION,SET,369,0.045339,0.006363,0.048613,0.17551,GOBP_LEUKOCYTE_MIGRATION,0.971669532368379
GOBP_GLUTAMINE_TRANSPORT,SET,9,0.29623,0.0065574,0.31765,0.17553,GOBP_GLUTAMINE_TRANSPORT,0.971669532368379
GOBP_MUSCLE_STRUCTURE_DEVELO...,SET,639,0.03293,0.0060358,0.035322,0.1756,GOBP_MUSCLE_STRUCTURE_DEVELOPMENT,0.971669532368379
MODULE_459,SET,389,0.040977,0.0059013,0.043955,0.17561,MODULE_459,0.971669532368379
GOCC_CEREBELLAR_MOSSY_FIBER,SET,7,0.31324,0.0061156,0.33606,0.17564,GOCC_CEREBELLAR_MOSSY_FIBER,0.971669532368379
GOMF_TRANSFERRIN_RECEPTOR_BI...,SET,9,0.24237,0.0053652,0.26001,0.17564,GOMF_TRANSFERRIN_RECEPTOR_BINDING,0.971669532368379
MIR6860,SET,102,0.075752,0.0056308,0.081294,0.17572,MIR6860,0.971669532368379
HP_ABNORMAL_HAIRSHAFT_MORPHO...,SET,25,0.1508,0.005561,0.16183,0.17572,HP_ABNORMAL_HAIRSHAFT_MORPHOLOGY,0.971669532368379
MIR4445_3P,SET,9,0.27282,0.0060391,0.2928,0.17574,MIR4445_3P,0.971669532368379
CCAGGGG_MIR331,SET,83,0.081297,0.0054541,0.087262,0.17577,CCAGGGG_MIR331,0.971669532368379
GOBP_LOCALIZATION_OF_CELL,SET,5,0.34929,0.0057636,0.37493,0.17577,GOBP_LOCALIZATION_OF_CELL,0.971669532368379
GOMF_RNA_POLYMERASE_II_GENER...1,SET,35,0.11749,0.0051251,0.12614,0.17583,GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.971846636450382
GOBP_ORGANOPHOSPHATE_ESTER_T...,SET,141,0.068994,0.0060233,0.074095,0.17589,GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT,0.972023684210526
HP_INCREASED_MEGAKARYOCYTE_C...,SET,7,0.28354,0.0055357,0.30457,0.17594,HP_INCREASED_MEGAKARYOCYTE_COUNT,0.972135009532888
GOBP_MESENCHYMAL_CELL_PROLIF...2,SET,6,0.37675,0.0068099,0.40475,0.17598,GOBP_MESENCHYMAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_DEVELOPMENT,0.972135009532888
GOMF_OUTWARD_RECTIFIER_POTAS...,SET,26,0.17379,0.0065358,0.18672,0.176,GOMF_OUTWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.972135009532888
GOBP_REGULATION_OF_BODY_FLUI...,SET,351,0.045504,0.0062317,0.048897,0.17603,GOBP_REGULATION_OF_BODY_FLUID_LEVELS,0.972135009532888
SCHERER_PBMC_APSV_WETVAX_AGE...6,SET,263,0.051826,0.0061585,0.055695,0.17605,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_UP,0.972135009532888
CREB_Q3,SET,238,0.05167,0.005845,0.055535,0.17609,CREB_Q3,0.972157409466328
GSE9006_TYPE_1_DIABETES_AT_D...2,SET,182,0.056242,0.0055721,0.060455,0.17611,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP,0.972157409466328
GOCC_AXONEMAL_OUTER_DOUBLET,SET,14,0.21103,0.0058253,0.22688,0.17616,GOCC_AXONEMAL_OUTER_DOUBLET,0.972278989995236
GSE11961_FOLLICULAR_BCELL_VS...8,SET,180,0.059808,0.0058931,0.064344,0.17632,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_UP,0.973007557954906
AGCYRWTTC_UNKNOWN,SET,107,0.077613,0.005908,0.083551,0.17647,AGCYRWTTC_UNKNOWN,0.973490728476821
KEGG_CYTOSOLIC_DNA_SENSING_P...,SET,45,0.11927,0.0058977,0.12841,0.1765,KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,0.973490728476821
REACTOME_NF_KB_ACTIVATION_TH...,SET,11,0.24112,0.0059005,0.2597,0.1766,REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10,0.973490728476821
HP_ENCEPHALOCELE,SET,110,0.074747,0.0057687,0.080512,0.17661,HP_ENCEPHALOCELE,0.973490728476821
GOBP_RESPONSE_TO_XENOBIOTIC_...,SET,417,0.04121,0.00614,0.044392,0.17663,GOBP_RESPONSE_TO_XENOBIOTIC_STIMULUS,0.973490728476821
GOBP_BRADYKININ_CATABOLIC_PR...,SET,7,0.32704,0.006385,0.35246,0.17674,GOBP_BRADYKININ_CATABOLIC_PROCESS,0.973490728476821
GOBP_POSITIVE_REGULATION_OF_...806,SET,93,0.091364,0.0064864,0.098486,0.17679,GOBP_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION,0.973490728476821
TFIII_Q6,SET,201,0.057934,0.0060288,0.062452,0.1768,TFIII_Q6,0.973490728476821
HP_PRIMARY_CONGENITAL_GLAUCO...,SET,6,0.33296,0.0060185,0.35897,0.17683,HP_PRIMARY_CONGENITAL_GLAUCOMA,0.973490728476821
GOBP_IMMUNE_EFFECTOR_PROCESS,SET,580,0.035325,0.0061788,0.038092,0.17688,GOBP_IMMUNE_EFFECTOR_PROCESS,0.973490728476821
GOBP_NEGATIVE_REGULATION_OF_...138,SET,21,0.19054,0.0064407,0.20554,0.17697,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_PRODUCTION,0.973490728476821
GSE29164_UNTREATED_VS_CD8_TC...5,SET,182,0.059557,0.0059006,0.064249,0.17697,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN,0.973490728476821
GOBP_SARCOMERE_ORGANIZATION,SET,50,0.11401,0.0059419,0.12299,0.17698,GOBP_SARCOMERE_ORGANIZATION,0.973490728476821
GSE12366_PLASMA_CELL_VS_NAIV...2,SET,165,0.062448,0.0058937,0.067368,0.17698,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP,0.973490728476821
GOBP_INTESTINAL_EPITHELIAL_S...,SET,7,0.33218,0.0064853,0.35839,0.177,GOBP_INTESTINAL_EPITHELIAL_STRUCTURE_MAINTENANCE,0.973490728476821
KEGG_MEDICUS_PATHOGEN_HBV_HB...2,SET,5,0.40136,0.0066229,0.43315,0.17707,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_ERK_SIGNALING_PATHWAY,0.973490728476821
GOMF_LYSOPHOSPHOLIPID_ACYLTR...,SET,18,0.20348,0.0063685,0.21961,0.17709,GOMF_LYSOPHOSPHOLIPID_ACYLTRANSFERASE_ACTIVITY,0.973490728476821
GOCC_DESMOSOME,SET,26,0.17199,0.0064681,0.18565,0.17711,GOCC_DESMOSOME,0.973490728476821
HP_ABNORMAL_BOWMAN_CAPSULE_M...,SET,9,0.25717,0.0056928,0.2776,0.17712,HP_ABNORMAL_BOWMAN_CAPSULE_MORPHOLOGY,0.973490728476821
HP_PROMINENT_EYELASHES,SET,14,0.20071,0.0055406,0.21666,0.17712,HP_PROMINENT_EYELASHES,0.973490728476821
HP_ACUTE_OTITIS_MEDIA,SET,5,0.3961,0.0065362,0.42759,0.17714,HP_ACUTE_OTITIS_MEDIA,0.973490728476821
HP_INCREASED_CIRCULATING_HEM...,SET,12,0.23577,0.0060258,0.25453,0.17715,HP_INCREASED_CIRCULATING_HEMOGLOBIN_CONCENTRATION,0.973490728476821
HP_ABNORMALITY_OF_INTRACRANI...,SET,82,0.083496,0.0055678,0.090157,0.1772,HP_ABNORMALITY_OF_INTRACRANIAL_PRESSURE,0.973490728476821
GOCC_MITOTIC_SPINDLE_MICROTU...,SET,13,0.17463,0.0046455,0.18857,0.17721,GOCC_MITOTIC_SPINDLE_MICROTUBULE,0.973490728476821
MIR6126,SET,106,0.075677,0.0057339,0.081731,0.17725,MIR6126,0.973490728476821
HP_RADIAL_DEVIATION_OF_THE_2...,SET,6,0.35437,0.0064055,0.38279,0.17729,HP_RADIAL_DEVIATION_OF_THE_2ND_FINGER,0.973490728476821
GOBP_ENSHEATHMENT_OF_NEURONS,SET,148,0.066461,0.0059433,0.071795,0.1773,GOBP_ENSHEATHMENT_OF_NEURONS,0.973490728476821
GOCC_SAGA_TYPE_COMPLEX,SET,33,0.11612,0.0049187,0.12545,0.17733,GOCC_SAGA_TYPE_COMPLEX,0.973490728476821
SOBOLEV_PBMC_PANDEMRIX_AGE_1...3,SET,28,0.15541,0.0060649,0.16793,0.17736,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_CORRELATED_WITH_AGE_1DY_POSITIVE,0.973490728476821
E2F_Q3_01,SET,209,0.054046,0.0057337,0.058405,0.1774,E2F_Q3_01,0.973490728476821
GSE32423_MEMORY_VS_NAIVE_CD8...6,SET,184,0.059752,0.005952,0.064586,0.17745,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.973490728476821
REACTOME_ABACAVIR_ADME,SET,9,0.31093,0.0068829,0.3361,0.17746,REACTOME_ABACAVIR_ADME,0.973490728476821
GSE17974_2H_VS_72H_UNTREATED...1,SET,164,0.057548,0.0054149,0.062208,0.17746,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,0.973490728476821
SCHLOSSER_SERUM_RESPONSE_UP,SET,116,0.073951,0.0058598,0.07994,0.17747,SCHLOSSER_SERUM_RESPONSE_UP,0.973490728476821
GOBP_REGULATION_OF_MICROTUBU...3,SET,7,0.26245,0.0051238,0.28371,0.17748,GOBP_REGULATION_OF_MICROTUBULE_BINDING,0.973490728476821
WP_SARS_CORONAVIRUS_AND_INNA...,SET,26,0.17241,0.0064837,0.18639,0.1775,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,0.973490728476821
HP_ABNORMALITY_OF_DENTAL_STR...,SET,315,0.044084,0.0057249,0.047666,0.17753,HP_ABNORMALITY_OF_DENTAL_STRUCTURE,0.973490728476821
GRAESSMANN_APOPTOSIS_BY_DOXO...1,SET,1594,0.020348,0.0057297,0.022004,0.17756,GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN,0.973490728476821
HP_DECREASED_LYMPHOCYTE_PROL...1,SET,9,0.29602,0.0065527,0.32011,0.17756,HP_DECREASED_LYMPHOCYTE_PROLIFERATION_IN_RESPONSE_TO_ANTI_CD3,0.973490728476821
LMTK3_TARGET_GENES,SET,426,0.039188,0.0058999,0.042385,0.1776,LMTK3_TARGET_GENES,0.973490728476821
BOYLAN_MULTIPLE_MYELOMA_D_UP,SET,82,0.089674,0.0059798,0.096991,0.17761,BOYLAN_MULTIPLE_MYELOMA_D_UP,0.973490728476821
MIR302F,SET,167,0.062403,0.0059247,0.067499,0.17762,MIR302F,0.973490728476821
GOBP_COMMISSURAL_NEURON_AXON...,SET,13,0.23646,0.0062901,0.25578,0.17763,GOBP_COMMISSURAL_NEURON_AXON_GUIDANCE,0.973490728476821
PITX1_TARGET_GENES,SET,290,0.045156,0.0056304,0.048848,0.17764,PITX1_TARGET_GENES,0.973490728476821
WP_COVID19_THROMBOSIS_AND_AN...,SET,7,0.38814,0.0075777,0.42,0.17772,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,0.97362209962169
GOBP_IODIDE_TRANSPORT,SET,9,0.23804,0.0052693,0.25758,0.17772,GOBP_IODIDE_TRANSPORT,0.97362209962169
HP_HYPERINTENSITY_OF_CEREBRA...,SET,72,0.096791,0.0060497,0.10477,0.1778,HP_HYPERINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI,0.973665595463138
MIR1293,SET,55,0.11297,0.0061744,0.12231,0.17783,MIR1293,0.973665595463138
KYNG_ENVIRONMENTAL_STRESS_RE...4,SET,29,0.14528,0.0057698,0.15729,0.17784,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,0.973665595463138
GSE19923_WT_VS_E2A_KO_DP_THY...2,SET,181,0.059266,0.0058557,0.064164,0.17784,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_UP,0.973665595463138
GSE34156_TLR1_TLR2_LIGAND_VS...4,SET,184,0.062782,0.0062538,0.06798,0.17787,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,0.973676460859978
GSE22589_HEALTHY_VS_HIV_AND_...2,SET,182,0.054631,0.0054125,0.059167,0.17792,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP,0.973796787401575
GOBP_INTRACELLULAR_RECEPTOR_...,SET,335,0.043088,0.0057672,0.046675,0.17797,GOBP_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY,0.973850400943396
MIR6754_5P,SET,111,0.074578,0.0057815,0.080811,0.17805,MIR6754_5P,0.973850400943396
HP_ABNORMAL_CAPILLARY_PHYSIO...,SET,8,0.29257,0.0061062,0.31706,0.17807,HP_ABNORMAL_CAPILLARY_PHYSIOLOGY,0.973850400943396
HP_PANHYPOGAMMAGLOBULINEMIA,SET,16,0.18999,0.0056065,0.2059,0.17808,HP_PANHYPOGAMMAGLOBULINEMIA,0.973850400943396
MIR193A_5P,SET,36,0.13377,0.0059178,0.14497,0.17809,MIR193A_5P,0.973850400943396
GOBP_ACTIN_FILAMENT_DEPOLYME...,SET,54,0.10131,0.0054867,0.10982,0.17813,GOBP_ACTIN_FILAMENT_DEPOLYMERIZATION,0.973850400943396
GOBP_NEGATIVE_REGULATION_OF_...277,SET,13,0.2411,0.0064136,0.26139,0.17817,GOBP_NEGATIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,0.973850400943396
HP_PALATE_FISTULA,SET,12,0.26589,0.0067957,0.28826,0.17817,HP_PALATE_FISTULA,0.973850400943396
GOBP_RELAXATION_OF_MUSCLE,SET,31,0.14742,0.0060527,0.15985,0.17821,GOBP_RELAXATION_OF_MUSCLE,0.973850400943396
HP_MELANOMA,SET,74,0.083417,0.0052854,0.090451,0.17821,HP_MELANOMA,0.973850400943396
GOBP_NEGATIVE_REGULATION_OF_...426,SET,10,0.27342,0.0063797,0.29661,0.17831,GOBP_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.974002867693275
GOBP_POSITIVE_REGULATION_OF_...633,SET,6,0.30599,0.0055309,0.33192,0.17831,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CILIUM,0.974002867693275
GOBP_STRIATED_MUSCLE_CELL_DI...,SET,281,0.049079,0.0060254,0.053247,0.17834,GOBP_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.974002867693275
GOMF_GUANYL_RIBONUCLEOTIDE_B...,SET,342,0.043299,0.0058545,0.046978,0.17835,GOMF_GUANYL_RIBONUCLEOTIDE_BINDING,0.974002867693275
GOBP_POSITIVE_REGULATION_OF_...81,SET,13,0.23776,0.0063247,0.25802,0.17841,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,0.974045987751256
GSE43955_1H_VS_60H_ACT_CD4_T...3,SET,185,0.06001,0.0059938,0.065137,0.17845,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.974045987751256
SREBP_Q3,SET,229,0.052108,0.0057834,0.056564,0.17847,SREBP_Q3,0.974045987751256
HP_RECURRENT_ASPERGILLUS_INF...,SET,22,0.17602,0.0060899,0.19107,0.17847,HP_RECURRENT_ASPERGILLUS_INFECTIONS,0.974045987751256
GOMF_INTERMEDIATE_FILAMENT_B...,SET,10,0.23862,0.0055678,0.25908,0.17852,GOMF_INTERMEDIATE_FILAMENT_BINDING,0.97416589731512
HE_LIM_SUN_FETAL_LUNG_C5_LAT...,SET,25,0.17072,0.0062957,0.18538,0.17855,HE_LIM_SUN_FETAL_LUNG_C5_LATE_PRO_B_CELL,0.974176648351648
GOBP_REGULATION_OF_CATECHOLA...1,SET,15,0.20833,0.0059527,0.22631,0.17864,GOBP_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS,0.974437723564481
HP_PREMATURE_LOSS_OF_TEETH,SET,53,0.11122,0.0059673,0.12084,0.1787,HP_PREMATURE_LOSS_OF_TEETH,0.974437723564481
GSE1791_CTRL_VS_NEUROMEDINU_...8,SET,175,0.059129,0.0057455,0.064246,0.1787,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_UP,0.974437723564481
MARTORIATI_MDM4_TARGETS_FETA...1,SET,466,0.036266,0.0057043,0.039407,0.17871,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN,0.974437723564481
KEGG_MEDICUS_REFERENCE_BASE_...1,SET,8,0.23036,0.0048078,0.25045,0.17885,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_BIFUNCTIONAL_GLYCOSYLASE,0.974796816684962
MIR5692B_MIR5692C,SET,373,0.04324,0.0061006,0.047013,0.17886,MIR5692B_MIR5692C,0.974796816684962
GOBP_MITOTIC_SISTER_CHROMATI...1,SET,21,0.1673,0.0056552,0.1819,0.17886,GOBP_MITOTIC_SISTER_CHROMATID_COHESION,0.974796816684962
HP_ANEMIA_OF_INADEQUATE_PROD...,SET,174,0.058056,0.0056253,0.063138,0.17892,HP_ANEMIA_OF_INADEQUATE_PRODUCTION,0.974970931326435
HP_SHORTENED_QT_INTERVAL,SET,13,0.24009,0.0063866,0.26113,0.17895,HP_SHORTENED_QT_INTERVAL,0.974981540993886
MIR7150,SET,121,0.069387,0.0056146,0.075479,0.17898,MIR7150,0.974992147335423
GSE40277_EOS_AND_LEF1_TRANSD...3,SET,181,0.059026,0.005832,0.064243,0.17911,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN,0.975403318722605
DESCARTES_FETAL_ADRENAL_SLC2...,SET,32,0.1421,0.0059275,0.15472,0.17921,DESCARTES_FETAL_ADRENAL_SLC26A4_PAEP_POSITIVE_CELLS,0.975403318722605
GOMF_PHOSPHOTRANSFERASE_ACTI...1,SET,21,0.16559,0.0055975,0.18031,0.17922,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_FOR_OTHER_SUBSTITUTED_PHOSPHATE_GROUPS,0.975403318722605
MIR548F_5P,SET,446,0.038692,0.0059571,0.042135,0.17924,MIR548F_5P,0.975403318722605
GOMF_CO_RECEPTOR_BINDING,SET,13,0.20888,0.0055564,0.22747,0.17925,GOMF_CO_RECEPTOR_BINDING,0.975403318722605
COULOUARN_TEMPORAL_TGFB1_SIG...2,SET,101,0.078701,0.0058215,0.085711,0.17926,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,0.975403318722605
REACTOME_ABERRANT_REGULATION...1,SET,19,0.15541,0.0049971,0.16926,0.17927,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_EXIT_IN_CANCER_DUE_TO_RB1_DEFECTS,0.975403318722605
PID_PI3KCI_PATHWAY,SET,47,0.11553,0.0058381,0.12583,0.17928,PID_PI3KCI_PATHWAY,0.975403318722605
MODULE_318,SET,27,0.13601,0.0052121,0.14816,0.17933,MODULE_318,0.975522640475818
MENSE_HYPOXIA_UP,SET,89,0.081946,0.0056919,0.089298,0.1794,MENSE_HYPOXIA_UP,0.975750704225352
HP_ABNORMAL_NEPHRON_MORPHOLO...,SET,219,0.053841,0.0058455,0.058689,0.17947,HP_ABNORMAL_NEPHRON_MORPHOLOGY,0.975880381727159
GOCC_LUMENAL_SIDE_OF_MEMBRANE,SET,38,0.12901,0.0058633,0.14063,0.17948,GOCC_LUMENAL_SIDE_OF_MEMBRANE,0.975880381727159
GSE10240_IL22_VS_IL17_STIM_P...1,SET,174,0.057206,0.0055428,0.06238,0.17956,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.975905218408736
HP_ABNORMAL_CIRCULATING_ADRE...,SET,42,0.1209,0.0057763,0.13185,0.17958,HP_ABNORMAL_CIRCULATING_ADRENOCORTICOTROPIN_CONCENTRATION,0.975905218408736
HALLMARK_PROTEIN_SECRETION,SET,85,0.082987,0.0056338,0.090499,0.17958,HALLMARK_PROTEIN_SECRETION,0.975905218408736
GOBP_ATRIAL_SEPTUM_DEVELOPME...,SET,21,0.19421,0.0065647,0.21183,0.17963,GOBP_ATRIAL_SEPTUM_DEVELOPMENT,0.975905218408736
GOBP_PROTEIN_DEGLUTAMYLATION,SET,7,0.29533,0.0057658,0.32218,0.17967,GOBP_PROTEIN_DEGLUTAMYLATION,0.975905218408736
GSE36826_WT_VS_IL1R_KO_SKIN_...3,SET,179,0.054715,0.0053765,0.059694,0.17968,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_UP,0.975905218408736
KEGG_MEDICUS_REFERENCE_GENE_...,SET,26,0.15517,0.0058356,0.16933,0.17973,KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119,0.975905218408736
YGACNNYACAR_UNKNOWN,SET,83,0.085813,0.005757,0.093644,0.17974,YGACNNYACAR_UNKNOWN,0.975905218408736
RICKMAN_METASTASIS_DN,SET,243,0.050519,0.0057737,0.055137,0.17977,RICKMAN_METASTASIS_DN,0.975905218408736
HP_ANONYCHIA,SET,60,0.10543,0.0060176,0.11509,0.17981,HP_ANONYCHIA,0.975905218408736
LEF1_Q2,SET,212,0.056577,0.0060446,0.061772,0.17987,LEF1_Q2,0.975905218408736
GOBP_INTERLEUKIN_17_MEDIATED...,SET,11,0.25868,0.0063303,0.28244,0.17987,GOBP_INTERLEUKIN_17_MEDIATED_SIGNALING_PATHWAY,0.975905218408736
HP_OVOTESTIS,SET,3,0.46868,0.0059909,0.51177,0.17989,HP_OVOTESTIS,0.975905218408736
CIITA_TARGET_GENES,SET,972,0.025306,0.0056667,0.027634,0.1799,CIITA_TARGET_GENES,0.975905218408736
NFY_Q6_01,SET,230,0.051422,0.0057196,0.056155,0.17991,NFY_Q6_01,0.975905218408736
GOBP_DIACYLGLYCEROL_CATABOLI...,SET,5,0.36048,0.0059483,0.39376,0.17998,GOBP_DIACYLGLYCEROL_CATABOLIC_PROCESS,0.975905218408736
GOBP_NUCLEOTIDE_EXCISION_REP...2,SET,6,0.23842,0.0043096,0.26043,0.17998,GOBP_NUCLEOTIDE_EXCISION_REPAIR_DNA_GAP_FILLING,0.975905218408736
GOBP_CARDIAC_ATRIUM_MORPHOGE...,SET,26,0.17457,0.0065648,0.19069,0.17999,GOBP_CARDIAC_ATRIUM_MORPHOGENESIS,0.975905218408736
GOBP_REGULATION_OF_DNA_RECOM...,SET,112,0.06886,0.0053621,0.07524,0.18005,GOBP_REGULATION_OF_DNA_RECOMBINATION,0.976078263921385
GSE41978_KLRG1_HIGH_VS_LOW_E...1,SET,179,0.056827,0.0055839,0.062103,0.18009,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_DN,0.976099025417121
GSE5542_IFNG_VS_IFNA_AND_IFN...1,SET,182,0.057267,0.0056737,0.062589,0.18011,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.976099025417121
GSE23308_WT_VS_MINERALCORTIC...1,SET,174,0.059274,0.0057433,0.064792,0.18014,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_DN,0.976109401309635
GOMF_NOTCH_BINDING,SET,22,0.15651,0.0054148,0.1711,0.18017,GOMF_NOTCH_BINDING,0.976119773967264
GOCC_SUPRAMOLECULAR_COMPLEX,SET,1253,0.0231,0.0058255,0.025268,0.18031,GOCC_SUPRAMOLECULAR_COMPLEX,0.976187546641791
NAKAYA_MONOCYTE_FLUARIX_FLUV...2,SET,74,0.090714,0.0057478,0.099228,0.18031,NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.976187546641791
OCT_Q6,SET,217,0.056477,0.0061039,0.061779,0.18032,OCT_Q6,0.976187546641791
DESCARTES_MAIN_FETAL_INHIBIT...2,SET,4,0.47663,0.0070348,0.52139,0.18032,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,0.976187546641791
MIR4645_5P,SET,103,0.077471,0.0057866,0.084748,0.18033,MIR4645_5P,0.976187546641791
DESCARTES_MAIN_FETAL_MEGAKAR...,SET,155,0.064457,0.0058976,0.070525,0.18038,DESCARTES_MAIN_FETAL_MEGAKARYOCYTES,0.976187546641791
HP_FOCAL_AWARE_SEIZURE,SET,26,0.15748,0.0059221,0.17232,0.1804,HP_FOCAL_AWARE_SEIZURE,0.976187546641791
REACTOME_ACETYLCHOLINE_INHIB...,SET,5,0.41252,0.0068071,0.45144,0.18042,REACTOME_ACETYLCHOLINE_INHIBITS_CONTRACTION_OF_OUTER_HAIR_CELLS,0.976187546641791
GRATIAS_RETINOBLASTOMA_16Q24,SET,17,0.23881,0.0072639,0.2614,0.18047,GRATIAS_RETINOBLASTOMA_16Q24,0.976187546641791
GOMF_INTRAMOLECULAR_PHOSPHOT...,SET,10,0.22319,0.0052076,0.24432,0.18049,GOMF_INTRAMOLECULAR_PHOSPHOTRANSFERASE_ACTIVITY,0.976187546641791
GSE42088_UNINF_VS_LEISHMANIA...4,SET,184,0.059912,0.005968,0.065594,0.18053,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP,0.976187546641791
MODULE_159,SET,69,0.088222,0.0053985,0.096601,0.18056,MODULE_159,0.976187546641791
GSE17721_4_VS_24H_GARDIQUIMO...1,SET,177,0.057132,0.0055828,0.062569,0.1806,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN,0.976187546641791
GOBP_MITOCHONDRIAL_ADP_TRANS...,SET,3,0.39714,0.0050764,0.43497,0.18062,GOBP_MITOCHONDRIAL_ADP_TRANSMEMBRANE_TRANSPORT,0.976187546641791
HP_CUTANEOUS_SYNDACTYLY,SET,64,0.096699,0.0056995,0.10591,0.18063,HP_CUTANEOUS_SYNDACTYLY,0.976187546641791
LI_CYTIDINE_ANALOG_PATHWAY,SET,17,0.19472,0.0059226,0.21328,0.18064,LI_CYTIDINE_ANALOG_PATHWAY,0.976187546641791
GSE11057_CD4_EFF_MEM_VS_PBMC...2,SET,175,0.057381,0.0055756,0.062856,0.18066,GSE11057_CD4_EFF_MEM_VS_PBMC_UP,0.976187546641791
GSE27670_CTRL_VS_LMP1_TRANSD...1,SET,183,0.057715,0.0057336,0.063242,0.18073,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN,0.976218531468531
GOBP_REGULATION_OF_CELL_FATE...2,SET,23,0.16335,0.0057784,0.17901,0.18075,GOBP_REGULATION_OF_CELL_FATE_SPECIFICATION,0.976218531468531
HP_MICROCYTIC_ANEMIA,SET,37,0.13309,0.0059688,0.14585,0.18075,HP_MICROCYTIC_ANEMIA,0.976218531468531
KEGG_MEDICUS_PATHOGEN_SARS_C...1,SET,6,0.38563,0.0069704,0.42265,0.18078,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_N_TO_LECTIN_PATHWAY_OF_COAGULATION_CASCADE,0.976228853325047
DESCARTES_FETAL_INTESTINE_EN...1,SET,46,0.12496,0.0062472,0.13701,0.18087,DESCARTES_FETAL_INTESTINE_ENS_GLIA,0.976519408201305
GOBP_VASCULAR_WOUND_HEALING,SET,18,0.1909,0.0059746,0.20932,0.18089,GOBP_VASCULAR_WOUND_HEALING,0.976519408201305
HP_ABNORMAL_ESOPHAGUS_MORPHO...,SET,207,0.055123,0.0058203,0.060449,0.18092,HP_ABNORMAL_ESOPHAGUS_MORPHOLOGY,0.97652967852151
GOMF_GABA_RECEPTOR_BINDING,SET,16,0.18546,0.0054727,0.20345,0.18101,GOMF_GABA_RECEPTOR_BINDING,0.976749235048679
GOBP_INTERNEURON_MIGRATION,SET,13,0.25715,0.0068406,0.28214,0.18104,GOBP_INTERNEURON_MIGRATION,0.976749235048679
GOBP_EMBRYONIC_APPENDAGE_MOR...,SET,116,0.079893,0.0063307,0.08768,0.1811,GOBP_EMBRYONIC_APPENDAGE_MORPHOGENESIS,0.976749235048679
HP_REDUNDANT_SKIN,SET,79,0.089967,0.0058891,0.098772,0.18119,HP_REDUNDANT_SKIN,0.976749235048679
GOBP_NEGATIVE_REGULATION_OF_...594,SET,5,0.33797,0.0055769,0.37108,0.18121,GOBP_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.976749235048679
GOBP_OLIGODENDROCYTE_PROGENI...,SET,8,0.30744,0.0064165,0.33758,0.18123,GOBP_OLIGODENDROCYTE_PROGENITOR_PROLIFERATION,0.976749235048679
GOBP_ROSTROCAUDAL_NEURAL_TUB...,SET,8,0.29114,0.0060763,0.31971,0.18125,GOBP_ROSTROCAUDAL_NEURAL_TUBE_PATTERNING,0.976749235048679
HP_ACRAL_ULCERATION,SET,8,0.27303,0.0056983,0.29983,0.18126,HP_ACRAL_ULCERATION,0.976749235048679
GSE40274_CTRL_VS_FOXP3_AND_X...1,SET,133,0.069795,0.0059191,0.076651,0.18127,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.976749235048679
WP_HEPATOCYTE_GROWTH_FACTOR_...,SET,33,0.13894,0.0058854,0.15261,0.18131,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,0.976749235048679
GOBP_PROTEOGLYCAN_BIOSYNTHET...,SET,63,0.10136,0.0059278,0.11134,0.18131,GOBP_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.976749235048679
REACTOME_GAMMA_CARBOXYLATION...2,SET,9,0.26652,0.0058998,0.29282,0.18137,REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS,0.976749235048679
GOBP_MITOCHONDRIAL_CALCIUM_I...2,SET,20,0.19413,0.0064041,0.2133,0.18139,GOBP_MITOCHONDRIAL_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.976749235048679
HP_REDUCED_SYSTOLIC_FUNCTION,SET,21,0.17735,0.0059948,0.1949,0.18143,HP_REDUCED_SYSTOLIC_FUNCTION,0.976749235048679
GSE22886_NAIVE_VS_MEMORY_TCE...1,SET,183,0.057178,0.0056802,0.062844,0.18146,GSE22886_NAIVE_VS_MEMORY_TCELL_DN,0.976749235048679
GOCC_EUKARYOTIC_TRANSLATION_...5,SET,13,0.20248,0.0053862,0.22257,0.18149,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_4F_COMPLEX,0.976749235048679
MIR455_5P,SET,82,0.086496,0.0057679,0.095093,0.18152,MIR455_5P,0.976749235048679
AZARE_NEOPLASTIC_TRANSFORMAT...2,SET,116,0.077169,0.0061148,0.084864,0.1816,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,0.976749235048679
REACTOME_BRANCHED_CHAIN_AMIN...,SET,20,0.16915,0.0055801,0.18607,0.18166,REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM,0.976749235048679
MIR3675_3P,SET,78,0.093296,0.0060684,0.10263,0.18166,MIR3675_3P,0.976749235048679
GOCC_HISTONE_DEACETYLASE_COM...,SET,73,0.085406,0.0053749,0.093955,0.18168,GOCC_HISTONE_DEACETYLASE_COMPLEX,0.976749235048679
GOBP_ERBB2_ERBB4_SIGNALING_P...,SET,5,0.36259,0.0059832,0.39896,0.18172,GOBP_ERBB2_ERBB4_SIGNALING_PATHWAY,0.976749235048679
TRAVAGLINI_LUNG_CILIATED_CELL,SET,952,0.025232,0.005595,0.027763,0.18172,TRAVAGLINI_LUNG_CILIATED_CELL,0.976749235048679
GOBP_CGAS_STING_SIGNALING_PA...,SET,15,0.17638,0.0050396,0.19412,0.18178,GOBP_CGAS_STING_SIGNALING_PATHWAY,0.976749235048679
GOBP_PEPTIDE_MODIFICATION,SET,5,0.36699,0.0060557,0.40393,0.1818,GOBP_PEPTIDE_MODIFICATION,0.976749235048679
GOBP_PRIMITIVE_ERYTHROCYTE_D...,SET,4,0.45561,0.0067246,0.5015,0.18181,GOBP_PRIMITIVE_ERYTHROCYTE_DIFFERENTIATION,0.976749235048679
MODULE_106,SET,14,0.22981,0.0063439,0.25297,0.18183,MODULE_106,0.976749235048679
GUENTHER_GROWTH_SPHERICAL_VS...2,SET,20,0.19696,0.0064976,0.21683,0.18184,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP,0.976749235048679
HP_SHORT_PHILTRUM,SET,213,0.053079,0.0056841,0.058432,0.18184,HP_SHORT_PHILTRUM,0.976749235048679
HP_FLANK_PAIN,SET,14,0.20005,0.0055223,0.22023,0.18185,HP_FLANK_PAIN,0.976749235048679
GOBP_NEGATIVE_REGULATION_OF_...659,SET,11,0.23235,0.0056859,0.2558,0.18186,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.976749235048679
HP_STILLBIRTH,SET,28,0.15053,0.0058742,0.16572,0.18186,HP_STILLBIRTH,0.976749235048679
CETS1P54_01,SET,250,0.046851,0.00543,0.05159,0.18191,CETS1P54_01,0.97682328904681
MODULE_275,SET,15,0.21487,0.0061394,0.23663,0.18193,MODULE_275,0.97682328904681
HP_BUPHTHALMOS,SET,24,0.1762,0.0063669,0.19413,0.18203,HP_BUPHTHALMOS,0.976865470506699
GTGACTT_MIR224,SET,139,0.063521,0.0055063,0.069986,0.18205,GTGACTT_MIR224,0.976865470506699
SOX15_TARGET_GENES,SET,3,0.44074,0.0056337,0.4857,0.1821,SOX15_TARGET_GENES,0.976865470506699
GSE2770_TGFB_AND_IL4_VS_TGFB...1,SET,166,0.05905,0.0055897,0.065086,0.18214,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.976865470506699
MIR1245A,SET,34,0.14406,0.0061939,0.15881,0.18218,MIR1245A,0.976865470506699
MIR205_5P,SET,201,0.05508,0.0057318,0.060723,0.18219,MIR205_5P,0.976865470506699
GSE15659_TREG_VS_TCONV_UP,SET,149,0.063804,0.0057248,0.070343,0.1822,GSE15659_TREG_VS_TCONV_UP,0.976865470506699
GOBP_REGULATION_OF_CATALYTIC...,SET,1226,0.023534,0.0058752,0.025951,0.18224,GOBP_REGULATION_OF_CATALYTIC_ACTIVITY,0.976865470506699
SHIN_B_CELL_LYMPHOMA_CLUSTER...8,SET,17,0.2139,0.0065062,0.23593,0.1823,SHIN_B_CELL_LYMPHOMA_CLUSTER_9,0.976865470506699
AHR_Q5,SET,195,0.056152,0.0057564,0.06194,0.18233,AHR_Q5,0.976865470506699
GOCC_SAGA_COMPLEX,SET,21,0.1418,0.0047933,0.15645,0.18238,GOCC_SAGA_COMPLEX,0.976865470506699
REACTOME_POLYMERASE_SWITCHIN...,SET,24,0.1422,0.0051383,0.15692,0.18242,REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE,0.976865470506699
HP_ABSCESS,SET,61,0.10183,0.0058599,0.11237,0.18242,HP_ABSCESS,0.976865470506699
HP_HYPOPLASTIC_VERTEBRAL_BOD...,SET,17,0.19545,0.005945,0.21569,0.18242,HP_HYPOPLASTIC_VERTEBRAL_BODIES,0.976865470506699
REACTOME_TRNA_AMINOACYLATION,SET,24,0.14122,0.0051029,0.15586,0.18245,REACTOME_TRNA_AMINOACYLATION,0.976865470506699
GOBP_REGULATION_OF_MATRIX_ME...,SET,5,0.41254,0.0068073,0.45534,0.18247,GOBP_REGULATION_OF_MATRIX_METALLOPEPTIDASE_SECRETION,0.976865470506699
HOWARD_NK_CELL_INACT_MONOV_I...1,SET,19,0.17764,0.0057119,0.19607,0.18247,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.976865470506699
GCM_CSNK1D,SET,29,0.13704,0.0054426,0.15127,0.18248,GCM_CSNK1D,0.976865470506699
GOBP_NEGATIVE_REGULATION_OF_...395,SET,27,0.15557,0.0059616,0.17172,0.18249,GOBP_NEGATIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS,0.976865470506699
GOBP_MUSCLE_CELL_DIFFERENTIA...,SET,376,0.041173,0.0058318,0.04545,0.1825,GOBP_MUSCLE_CELL_DIFFERENTIATION,0.976865470506699
GOCC_TRANSPORTER_COMPLEX,SET,428,0.039482,0.0059579,0.043596,0.18257,GOCC_TRANSPORTER_COMPLEX,0.977089675084694
HP_ABNORMAL_PANCREAS_SIZE,SET,33,0.14009,0.0059341,0.15472,0.18263,HP_ABNORMAL_PANCREAS_SIZE,0.977260300230947
HP_PROLONGED_BLEEDING_TIME,SET,46,0.1165,0.0058243,0.12871,0.1827,HP_PROLONGED_BLEEDING_TIME,0.977484375
MORF_CNTN1,SET,91,0.078509,0.0055138,0.086763,0.18277,MORF_CNTN1,0.977708380791134
GOBP_EPITHELIAL_TUBE_BRANCHI...,SET,30,0.15227,0.0061504,0.16832,0.18283,GOBP_EPITHELIAL_TUBE_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS,0.977737730202578
chr4q25,SET,28,0.24727,0.0096496,0.27339,0.18288,chr4q25,0.977737730202578
KEGG_PANTOTHENATE_AND_COA_BI...,SET,16,0.19832,0.0058524,0.21929,0.1829,KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS,0.977737730202578
GSE5589_WT_VS_IL6_KO_LPS_AND...5,SET,178,0.058816,0.0057634,0.065046,0.18294,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.977737730202578
GHANDHI_DIRECT_IRRADIATION_DN,SET,32,0.15176,0.0063305,0.16784,0.18296,GHANDHI_DIRECT_IRRADIATION_DN,0.977737730202578
GSE37532_WT_VS_PPARG_KO_LN_T...4,SET,156,0.059285,0.0054418,0.065571,0.18297,GSE37532_WT_VS_PPARG_KO_LN_TREG_UP,0.977737730202578
HP_NEOPLASM_OF_THE_ORAL_CAVI...,SET,63,0.09193,0.0053761,0.10169,0.18301,HP_NEOPLASM_OF_THE_ORAL_CAVITY,0.977737730202578
HP_PROPTOSIS,SET,257,0.047725,0.0056071,0.052808,0.18307,HP_PROPTOSIS,0.977737730202578
HP_SEPTO_OPTIC_DYSPLASIA,SET,18,0.19856,0.0062146,0.21974,0.1831,HP_SEPTO_OPTIC_DYSPLASIA,0.977737730202578
REACTOME_GOLGI_ASSOCIATED_VE...,SET,50,0.10549,0.0054979,0.11675,0.18312,REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,0.977737730202578
GOBP_PROTON_TRANSMEMBRANE_TR...,SET,118,0.071028,0.0056762,0.078617,0.18315,GOBP_PROTON_TRANSMEMBRANE_TRANSPORT,0.977737730202578
MIR139_3P,SET,14,0.22781,0.0062887,0.25224,0.18323,MIR139_3P,0.977737730202578
GOCC_PICLN_SM_PROTEIN_COMPLEX,SET,6,0.25412,0.0045933,0.28139,0.18325,GOCC_PICLN_SM_PROTEIN_COMPLEX,0.977737730202578
HOEK_NK_CELL_2011_2012_TIV_A...3,SET,13,0.23102,0.0061455,0.25584,0.18327,HOEK_NK_CELL_2011_2012_TIV_ADULT_7DY_UP,0.977737730202578
GOBP_ENDOTHELIAL_CELL_APOPTO...,SET,55,0.11153,0.0060954,0.12351,0.18328,GOBP_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.977737730202578
GOBP_REGULATION_OF_CALCIUM_I...6,SET,153,0.064829,0.0058936,0.071796,0.18328,GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.977737730202578
GOBP_LIPID_PHOSPHORYLATION,SET,10,0.23136,0.0053982,0.25624,0.1833,GOBP_LIPID_PHOSPHORYLATION,0.977737730202578
GOMF_ATP_DEPENDENT_DIACYLGLY...,SET,10,0.23136,0.0053982,0.25624,0.1833,GOMF_ATP_DEPENDENT_DIACYLGLYCEROL_KINASE_ACTIVITY,0.977737730202578
HP_TRANSIENT_NEUTROPENIA,SET,7,0.24436,0.0047707,0.27066,0.18331,HP_TRANSIENT_NEUTROPENIA,0.977737730202578
PID_S1P_S1P2_PATHWAY,SET,23,0.16779,0.0059355,0.1859,0.18337,PID_S1P_S1P2_PATHWAY,0.977763371559633
GSE6259_FLT3L_INDUCED_DEC205...2,SET,138,0.066262,0.0057234,0.073429,0.18343,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP,0.977763371559633
HE_LIM_SUN_FETAL_LUNG_C1_AT1...,SET,37,0.13413,0.0060156,0.14866,0.18346,HE_LIM_SUN_FETAL_LUNG_C1_AT1_CELL,0.977763371559633
REACTOME_RHOBTB_GTPASE_CYCLE,SET,34,0.12091,0.0051985,0.13401,0.18348,REACTOME_RHOBTB_GTPASE_CYCLE,0.977763371559633
MIR708_5P,SET,43,0.11841,0.0057242,0.13125,0.18348,MIR708_5P,0.977763371559633
HP_CLINODACTYLY_OF_THE_2ND_F...,SET,8,0.31628,0.006601,0.35057,0.18349,HP_CLINODACTYLY_OF_THE_2ND_FINGER,0.977763371559633
WP_DISORDERS_OF_GALACTOSE_ME...,SET,12,0.21552,0.0055084,0.23894,0.18353,WP_DISORDERS_OF_GALACTOSE_METABOLISM,0.977763371559633
GOBP_POSITIVE_REGULATION_OF_...265,SET,15,0.18566,0.0053048,0.20587,0.18358,GOBP_POSITIVE_REGULATION_OF_EXOSOMAL_SECRETION,0.977763371559633
MIR6529_3P,SET,80,0.09096,0.0059915,0.10088,0.18363,MIR6529_3P,0.977763371559633
HP_NARROW_NOSE,SET,21,0.17047,0.0057622,0.18909,0.18366,HP_NARROW_NOSE,0.977763371559633
REACTOME_MITOCHONDRIAL_FATTY...3,SET,6,0.31441,0.0056831,0.34879,0.18369,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS,0.977763371559633
GCM_NCAM1,SET,115,0.071556,0.0056457,0.079402,0.18375,GCM_NCAM1,0.977763371559633
GOBP_LYMPHOCYTE_AGGREGATION,SET,4,0.42072,0.0062096,0.46686,0.18375,GOBP_LYMPHOCYTE_AGGREGATION,0.977763371559633
REACTOME_GASTRULATION,SET,118,0.068892,0.0055055,0.076461,0.1838,REACTOME_GASTRULATION,0.977763371559633
HP_HYPOTHALAMIC_GONADOTROPIN...,SET,20,0.19119,0.0063071,0.2122,0.1838,HP_HYPOTHALAMIC_GONADOTROPIN_RELEASING_HORMONE_DEFICIENCY,0.977763371559633
VANOEVELEN_MYOGENESIS_SIN3A_...,SET,207,0.050038,0.0052834,0.055549,0.18386,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,0.977763371559633
SANA_RESPONSE_TO_IFNG_DN,SET,79,0.088544,0.0057959,0.098315,0.1839,SANA_RESPONSE_TO_IFNG_DN,0.977763371559633
HP_INCREASED_OVERBITE,SET,8,0.286,0.005969,0.31758,0.18392,HP_INCREASED_OVERBITE,0.977763371559633
WANG_BARRETTS_ESOPHAGUS_UP,SET,50,0.11929,0.0062173,0.13248,0.18393,WANG_BARRETTS_ESOPHAGUS_UP,0.977763371559633
HP_POOR_MOTOR_COORDINATION,SET,77,0.087723,0.0056693,0.097432,0.18397,HP_POOR_MOTOR_COORDINATION,0.977763371559633
HE_LIM_SUN_FETAL_LUNG_C3_PRI...,SET,100,0.077426,0.0056989,0.085993,0.18397,HE_LIM_SUN_FETAL_LUNG_C3_PRIMITIVE_ERYTHROCYTE,0.977763371559633
HP_HELICOBACTER_PYLORI_INFEC...,SET,4,0.41003,0.0060517,0.45542,0.18398,HP_HELICOBACTER_PYLORI_INFECTION,0.977763371559633
MIR8052,SET,40,0.12046,0.0056167,0.1338,0.18399,MIR8052,0.977763371559633
GSE24634_TREG_VS_TCONV_POST_...8,SET,177,0.054994,0.0053738,0.061084,0.18399,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP,0.977763371559633
HP_RHIZOMELIA,SET,59,0.1026,0.0058071,0.11399,0.18404,HP_RHIZOMELIA,0.977879559700352
HP_DRUSEN,SET,25,0.1657,0.0061107,0.18416,0.18412,HP_DRUSEN,0.978155090186487
DUTERTRE_ESTRADIOL_RESPONSE_...3,SET,86,0.091359,0.0062383,0.10156,0.18419,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,0.978377418615314
HEBERT_MATRISOME_TNBC_BRAIN_...1,SET,23,0.17534,0.0062025,0.19503,0.18432,HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS,0.97848448564048
AMIT_EGF_RESPONSE_480_HELA,SET,154,0.064094,0.0058457,0.071298,0.18434,AMIT_EGF_RESPONSE_480_HELA,0.97848448564048
GOBP_ANTIBACTERIAL_INNATE_IM...,SET,8,0.28162,0.0058776,0.31329,0.18436,GOBP_ANTIBACTERIAL_INNATE_IMMUNE_RESPONSE,0.97848448564048
HP_HOODED_EYELID,SET,6,0.28706,0.0051887,0.31936,0.18437,HP_HOODED_EYELID,0.97848448564048
REACTOME_MUSCLE_CONTRACTION,SET,194,0.057647,0.0058946,0.064142,0.1844,REACTOME_MUSCLE_CONTRACTION,0.97848448564048
PEREZ_TP63_TARGETS,SET,309,0.04643,0.0059728,0.051672,0.18445,PEREZ_TP63_TARGETS,0.97848448564048
MIR4273,SET,94,0.08018,0.0057227,0.089245,0.18449,MIR4273,0.97848448564048
GOBP_AMINE_BIOSYNTHETIC_PROC...,SET,35,0.12802,0.0055844,0.14252,0.18453,GOBP_AMINE_BIOSYNTHETIC_PROCESS,0.97848448564048
GOBP_LEUKOCYTE_AGGREGATION,SET,12,0.25327,0.0064733,0.28196,0.18453,GOBP_LEUKOCYTE_AGGREGATION,0.97848448564048
MIR634,SET,83,0.081624,0.005476,0.090894,0.18459,MIR634,0.97848448564048
GOBP_RETINOL_METABOLIC_PROCE...,SET,50,0.121,0.006306,0.13474,0.1846,GOBP_RETINOL_METABOLIC_PROCESS,0.97848448564048
GAGACTG_MIR452,SET,88,0.078326,0.0054099,0.087264,0.18471,GAGACTG_MIR452,0.97848448564048
LAKE_ADULT_KIDNEY_C25_ENDOTH...,SET,37,0.14521,0.0065126,0.16178,0.18471,LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED,0.97848448564048
HP_RECURRENT_NEISSERIAL_INFE...,SET,7,0.29652,0.005789,0.33038,0.18473,HP_RECURRENT_NEISSERIAL_INFECTIONS,0.97848448564048
REACTOME_TRNA_MODIFICATION_I...2,SET,38,0.10993,0.0049962,0.12249,0.18474,REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,0.97848448564048
GSE43863_TFH_VS_LY6C_INT_CXC...4,SET,184,0.058896,0.0058668,0.065632,0.18477,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,0.97848448564048
BIOCARTA_PAR1_PATHWAY,SET,19,0.20252,0.0065119,0.2257,0.18479,BIOCARTA_PAR1_PATHWAY,0.97848448564048
PID_S1P_S1P3_PATHWAY,SET,29,0.15172,0.0060253,0.16911,0.18482,PID_S1P_S1P3_PATHWAY,0.97848448564048
HP_SKULL_ASYMMETRY,SET,7,0.30406,0.0059363,0.33891,0.18482,HP_SKULL_ASYMMETRY,0.97848448564048
HP_SLANTING_OF_THE_PALPEBRAL...,SET,622,0.03053,0.0055236,0.03403,0.18483,HP_SLANTING_OF_THE_PALPEBRAL_FISSURE,0.97848448564048
MODULE_525,SET,58,0.10003,0.0056139,0.11152,0.18486,MODULE_525,0.97848448564048
GOBP_NEGATIVE_REGULATION_OF_...667,SET,22,0.16785,0.0058071,0.18714,0.18489,GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.97848448564048
PID_RAC1_PATHWAY,SET,51,0.1072,0.0056421,0.11956,0.18499,PID_RAC1_PATHWAY,0.97848448564048
HE_LIM_SUN_FETAL_LUNG_C4_TH1...,SET,15,0.21715,0.0062047,0.24221,0.18499,HE_LIM_SUN_FETAL_LUNG_C4_TH17_CELL,0.97848448564048
GOBP_NEGATIVE_REGULATION_OF_...42,SET,8,0.28258,0.0058976,0.31525,0.18504,GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,0.97848448564048
GOBP_PURINE_NUCLEOSIDE_CATAB...,SET,7,0.3448,0.0067316,0.38467,0.18504,GOBP_PURINE_NUCLEOSIDE_CATABOLIC_PROCESS,0.97848448564048
GOBP_MINERALOCORTICOID_BIOSY...,SET,12,0.25962,0.0066356,0.28968,0.18507,GOBP_MINERALOCORTICOID_BIOSYNTHETIC_PROCESS,0.97848448564048
KEGG_MEDICUS_VARIANT_FUS_DDI...,SET,5,0.37876,0.00625,0.42268,0.18511,KEGG_MEDICUS_VARIANT_FUS_DDIT3_FUSION_TO_NFKB_MEDIATED_TRANSCRIPTION,0.97848448564048
HP_THYROID_DYSGENESIS,SET,7,0.34207,0.0066783,0.38178,0.18513,HP_THYROID_DYSGENESIS,0.97848448564048
CDX1_TARGET_GENES,SET,35,0.13078,0.0057048,0.14598,0.18517,CDX1_TARGET_GENES,0.97848448564048
GOBP_RESPONSE_TO_STEROL,SET,32,0.14266,0.0059511,0.15925,0.18517,GOBP_RESPONSE_TO_STEROL,0.97848448564048
GOBP_MONOCARBOXYLIC_ACID_MET...,SET,587,0.032901,0.0057884,0.036728,0.18519,GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS,0.97848448564048
GOCC_PRESYNAPTIC_ACTIVE_ZONE,SET,73,0.093831,0.0059052,0.10476,0.18521,GOCC_PRESYNAPTIC_ACTIVE_ZONE,0.97848448564048
GOBP_CELLULAR_RESPONSE_TO_EP...,SET,11,0.23584,0.0057712,0.26331,0.18522,GOBP_CELLULAR_RESPONSE_TO_EPINEPHRINE_STIMULUS,0.97848448564048
GOBP_TRACHEA_DEVELOPMENT,SET,18,0.19773,0.0061884,0.22076,0.18522,GOBP_TRACHEA_DEVELOPMENT,0.97848448564048
HP_EMG_AXONAL_ABNORMALITY,SET,14,0.21729,0.0059981,0.24263,0.18526,HP_EMG_AXONAL_ABNORMALITY,0.97848448564048
HP_FOCAL_TONIC_SEIZURE,SET,28,0.15063,0.0058783,0.16822,0.18528,HP_FOCAL_TONIC_SEIZURE,0.97848448564048
HP_TRIPHALANGEAL_THUMB,SET,64,0.089264,0.0052613,0.099688,0.18528,HP_TRIPHALANGEAL_THUMB,0.97848448564048
GSE12392_CD8A_POS_VS_NEG_SPL...4,SET,188,0.053758,0.0054122,0.060069,0.18541,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_UP,0.979022265268915
GOBP_PROTEIN_DNA_COMPLEX_ASS...,SET,147,0.058321,0.0051979,0.065189,0.18549,GOBP_PROTEIN_DNA_COMPLEX_ASSEMBLY,0.979031740306582
GOCC_CHOLINERGIC_SYNAPSE,SET,10,0.27702,0.0064638,0.30965,0.1855,GOCC_CHOLINERGIC_SYNAPSE,0.979031740306582
PID_FRA_PATHWAY,SET,35,0.13792,0.0060162,0.15425,0.18563,PID_FRA_PATHWAY,0.979031740306582
HP_ALKALOSIS,SET,29,0.14189,0.0056351,0.15873,0.18569,HP_ALKALOSIS,0.979031740306582
SCHAEFFER_PROSTATE_DEVELOPME...7,SET,9,0.2404,0.0053214,0.26895,0.18572,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN,0.979031740306582
MIR4717_5P,SET,94,0.080162,0.0057214,0.089718,0.1858,MIR4717_5P,0.979031740306582
GOBP_NATURAL_KILLER_CELL_DIF...,SET,24,0.16246,0.0058701,0.18187,0.18586,GOBP_NATURAL_KILLER_CELL_DIFFERENTIATION,0.979031740306582
HOEK_NK_CELL_2011_2012_TIV_3...,SET,208,0.056844,0.0060163,0.063644,0.18589,HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN,0.979031740306582
GOBP_REGULATION_OF_INTESTINA...1,SET,11,0.23199,0.005677,0.25975,0.1859,GOBP_REGULATION_OF_INTESTINAL_ABSORPTION,0.979031740306582
DESCARTES_FETAL_PLACENTA_MEG...,SET,156,0.062619,0.0057479,0.070122,0.18593,DESCARTES_FETAL_PLACENTA_MEGAKARYOCYTES,0.979031740306582
GOBP_COLLECTING_DUCT_DEVELOP...,SET,15,0.23094,0.0065987,0.25862,0.18594,GOBP_COLLECTING_DUCT_DEVELOPMENT,0.979031740306582
GOMF_PHOSPHOLIPID_TRANSPORTE...,SET,58,0.10154,0.0056986,0.11371,0.18594,GOMF_PHOSPHOLIPID_TRANSPORTER_ACTIVITY,0.979031740306582
GSE13738_RESTING_VS_TCR_ACTI...1,SET,178,0.05744,0.0056285,0.064334,0.18598,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN,0.979031740306582
GOBP_POSITIVE_REGULATION_OF_...560,SET,8,0.32194,0.0067191,0.3607,0.18606,GOBP_POSITIVE_REGULATION_OF_OPSONIZATION,0.979031740306582
GOBP_MEMBRANE_RAFT_LOCALIZAT...,SET,6,0.29314,0.0052986,0.32853,0.18613,GOBP_MEMBRANE_RAFT_LOCALIZATION,0.979031740306582
GOBP_AMINE_CATABOLIC_PROCESS,SET,14,0.22969,0.0063405,0.25748,0.18619,GOBP_AMINE_CATABOLIC_PROCESS,0.979031740306582
GSE21033_CTRL_VS_POLYIC_STIM...3,SET,175,0.057214,0.0055594,0.064139,0.18619,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_DN,0.979031740306582
HP_PERIPHERAL_CYANOSIS,SET,31,0.1349,0.0055387,0.15123,0.1862,HP_PERIPHERAL_CYANOSIS,0.979031740306582
GOCC_MLL3_4_COMPLEX,SET,10,0.21532,0.005024,0.24144,0.18625,GOCC_MLL3_4_COMPLEX,0.979031740306582
GOBP_POSITIVE_REGULATION_OF_...415,SET,10,0.25905,0.0060444,0.29052,0.18629,GOBP_POSITIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,0.979031740306582
CHENG_IMPRINTED_BY_ESTRADIOL,SET,98,0.082093,0.0059819,0.092072,0.18631,CHENG_IMPRINTED_BY_ESTRADIOL,0.979031740306582
GOBP_ATRIOVENTRICULAR_CANAL_...,SET,13,0.22675,0.0060319,0.25432,0.18631,GOBP_ATRIOVENTRICULAR_CANAL_DEVELOPMENT,0.979031740306582
MIR28_5P,SET,42,0.11855,0.0056638,0.13297,0.18633,MIR28_5P,0.979031740306582
HP_LOW_1_MINUTE_APGAR_SCORE,SET,6,0.38112,0.0068889,0.42753,0.18635,HP_LOW_1_MINUTE_APGAR_SCORE,0.979031740306582
GOMF_PROTEIN_SERINE_KINASE_A...,SET,334,0.041857,0.0055943,0.046957,0.18636,GOMF_PROTEIN_SERINE_KINASE_ACTIVITY,0.979031740306582
GOBP_HEART_VALVE_FORMATION,SET,15,0.21905,0.006259,0.24579,0.18641,GOBP_HEART_VALVE_FORMATION,0.979031740306582
HP_SMALL_PLACENTA,SET,9,0.28737,0.0063612,0.32245,0.18642,HP_SMALL_PLACENTA,0.979031740306582
GOBP_IMMUNE_RESPONSE_TO_TUMO...,SET,24,0.16768,0.0060589,0.18817,0.18643,GOBP_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.979031740306582
HP_TITUBATION,SET,29,0.14229,0.0056507,0.15968,0.18645,HP_TITUBATION,0.979031740306582
GOBP_SECRETORY_GRANULE_ORGAN...,SET,61,0.098416,0.0056637,0.11045,0.18646,GOBP_SECRETORY_GRANULE_ORGANIZATION,0.979031740306582
GSE7460_TREG_VS_TCONV_ACT_DN,SET,173,0.059818,0.0057795,0.067138,0.18648,GSE7460_TREG_VS_TCONV_ACT_DN,0.979031740306582
HP_AMINOACIDURIA,SET,123,0.067177,0.0054803,0.075412,0.18652,HP_AMINOACIDURIA,0.979031740306582
GOBP_REGULATION_OF_EPITHELIA...3,SET,14,0.23854,0.0065847,0.2678,0.18654,GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.979031740306582
HP_MACULAR_SCAR,SET,5,0.37033,0.0061109,0.41575,0.18654,HP_MACULAR_SCAR,0.979031740306582
KEGG_MEDICUS_VARIANT_AMPLIFI...10,SET,6,0.30271,0.0054717,0.33993,0.1866,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_ACTIVATION,0.979031740306582
AREB6_03,SET,242,0.050756,0.005789,0.056997,0.1866,AREB6_03,0.979031740306582
REACTOME_CLATHRIN_MEDIATED_E...,SET,134,0.065761,0.0055978,0.073866,0.18667,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,0.979031740306582
MIR7850_5P,SET,110,0.072907,0.0056266,0.0819,0.18669,MIR7850_5P,0.979031740306582
MIR4712_5P,SET,92,0.082065,0.005795,0.092193,0.1867,MIR4712_5P,0.979031740306582
MODULE_378,SET,393,0.038902,0.0056306,0.043703,0.1867,MODULE_378,0.979031740306582
GOBP_NUCLEOTIDE_SUGAR_TRANSM...,SET,12,0.20779,0.0053108,0.23344,0.1867,GOBP_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORT,0.979031740306582
GOBP_DCMP_CATABOLIC_PROCESS,SET,6,0.32329,0.0058437,0.3632,0.18671,GOBP_DCMP_CATABOLIC_PROCESS,0.979031740306582
HP_FATIGUABLE_WEAKNESS_OF_PR...,SET,21,0.16611,0.0056149,0.18666,0.18676,HP_FATIGUABLE_WEAKNESS_OF_PROXIMAL_LIMB_MUSCLES,0.979031740306582
GOBP_COENZYME_A_METABOLIC_PR...,SET,18,0.16425,0.0051405,0.18458,0.18678,GOBP_COENZYME_A_METABOLIC_PROCESS,0.979031740306582
GOBP_REGULATION_OF_EXOSOMAL_...,SET,18,0.1734,0.0054269,0.19486,0.18678,GOBP_REGULATION_OF_EXOSOMAL_SECRETION,0.979031740306582
GOCC_SWI_SNF_SUPERFAMILY_TYP...,SET,88,0.074884,0.0051722,0.084156,0.18679,GOCC_SWI_SNF_SUPERFAMILY_TYPE_COMPLEX,0.979031740306582
ICHIBA_GRAFT_VERSUS_HOST_DIS...1,SET,51,0.11296,0.0059456,0.12696,0.18681,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,0.979031740306582
MIR3972,SET,62,0.09562,0.0055475,0.1075,0.18688,MIR3972,0.979031740306582
HP_ARTERIA_LUSORIA,SET,6,0.36044,0.0065152,0.40524,0.18688,HP_ARTERIA_LUSORIA,0.979031740306582
GOBP_NEGATIVE_REGULATION_OF_...657,SET,3,0.42226,0.0053975,0.4748,0.18692,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.979031740306582
GOBP_HIGH_DENSITY_LIPOPROTEI...2,SET,9,0.26112,0.0057803,0.29364,0.18694,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.979031740306582
HP_FOCAL_HEMICLONIC_SEIZURE,SET,23,0.17394,0.006153,0.19561,0.18695,HP_FOCAL_HEMICLONIC_SEIZURE,0.979031740306582
GOBP_MONOATOMIC_ION_HOMEOSTA...,SET,560,0.033944,0.0058373,0.038182,0.18701,GOBP_MONOATOMIC_ION_HOMEOSTASIS,0.979031740306582
GOBP_DIENCEPHALON_DEVELOPMENT,SET,71,0.10129,0.0062867,0.114,0.18715,GOBP_DIENCEPHALON_DEVELOPMENT,0.979031740306582
GSE15271_CXCR4_POS_VS_NEG_GC...2,SET,158,0.056105,0.0051825,0.063149,0.18715,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_UP,0.979031740306582
REACTOME_NUCLEAR_ENVELOPE_NE...,SET,71,0.087799,0.0054496,0.098826,0.18716,REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY,0.979031740306582
HP_IMPAIRED_HORIZONTAL_SMOOT...,SET,7,0.26955,0.0052624,0.30343,0.18718,HP_IMPAIRED_HORIZONTAL_SMOOTH_PURSUIT,0.979031740306582
HP_ABNORMALITY_OF_THE_SUPRAO...,SET,87,0.08428,0.0057882,0.094878,0.18719,HP_ABNORMALITY_OF_THE_SUPRAORBITAL_RIDGES,0.979031740306582
GOMF_DNA_DAMAGE_SENSOR_ACTIV...,SET,20,0.14105,0.004653,0.1588,0.18722,GOMF_DNA_DAMAGE_SENSOR_ACTIVITY,0.979031740306582
KEGG_MEDICUS_VARIANT_MUTATIO...34,SET,11,0.23834,0.0058324,0.26835,0.18723,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004,0.979031740306582
GOCC_NUCLEAR_INCLUSION_BODY,SET,11,0.19831,0.0048528,0.22329,0.18724,GOCC_NUCLEAR_INCLUSION_BODY,0.979031740306582
GOMF_IMMUNOGLOBULIN_BINDING,SET,25,0.16349,0.0060291,0.18411,0.18727,GOMF_IMMUNOGLOBULIN_BINDING,0.979031740306582
HP_WEAKNESS_OF_FACIAL_MUSCUL...,SET,210,0.051899,0.0055189,0.058448,0.18729,HP_WEAKNESS_OF_FACIAL_MUSCULATURE,0.979031740306582
PID_HEDGEHOG_2PATHWAY,SET,21,0.16674,0.0056362,0.18779,0.1873,PID_HEDGEHOG_2PATHWAY,0.979031740306582
GOMF_DOUBLE_STRANDED_RNA_BIN...,SET,69,0.084741,0.0051855,0.09544,0.18731,GOMF_DOUBLE_STRANDED_RNA_BINDING,0.979031740306582
GRAHAM_CML_QUIESCENT_VS_NORM...2,SET,49,0.12083,0.0062342,0.13611,0.18735,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,0.979031740306582
TERT_TARGET_GENES,SET,71,0.094457,0.0058628,0.1064,0.18735,TERT_TARGET_GENES,0.979031740306582
GOBP_CRISTAE_FORMATION,SET,15,0.20327,0.0058081,0.229,0.18737,GOBP_CRISTAE_FORMATION,0.979031740306582
GOBP_POSITIVE_REGULATION_OF_...199,SET,6,0.29563,0.0053437,0.33309,0.1874,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,0.979031740306582
GOBP_EMBRYONIC_CAMERA_TYPE_E...1,SET,37,0.13452,0.0060331,0.15159,0.18743,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT,0.979031740306582
GOBP_NEGATIVE_REGULATION_OF_...527,SET,6,0.29202,0.0052784,0.32907,0.18744,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.979031740306582
GSE22611_MUTANT_NOD2_VS_CTRL...2,SET,176,0.056467,0.0055023,0.063631,0.18744,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,0.979031740306582
REACTOME_ZBP1_DAI_MEDIATED_I...,SET,20,0.15786,0.0052075,0.17791,0.18747,REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,0.979041299774606
REACTOME_CARDIAC_CONDUCTION,SET,125,0.072252,0.0059416,0.081457,0.18755,REACTOME_CARDIAC_CONDUCTION,0.979311936598558
GAUTAM_EYE_IRIS_CILIARY_BODY...6,SET,68,0.087896,0.0053396,0.099126,0.18762,GAUTAM_EYE_IRIS_CILIARY_BODY_CYTOTOXIC_T_CELLS,0.979359480558475
GOBP_POSITIVE_REGULATION_OF_...484,SET,13,0.24715,0.0065744,0.27875,0.18765,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,0.979359480558475
IIZUKA_LIVER_CANCER_PROGRESS...5,SET,15,0.19288,0.005511,0.21756,0.18767,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN,0.979359480558475
ZNF197_TARGET_GENES,SET,503,0.033836,0.0055235,0.038171,0.1877,ZNF197_TARGET_GENES,0.979359480558475
HP_CEREBRAL_CORTICAL_HEMIATR...,SET,5,0.33316,0.0054975,0.37584,0.1877,HP_CEREBRAL_CORTICAL_HEMIATROPHY,0.979359480558475
GOBP_NEUTROPHIL_MEDIATED_KIL...1,SET,7,0.35397,0.0069106,0.39938,0.18774,GOBP_NEUTROPHIL_MEDIATED_KILLING_OF_GRAM_NEGATIVE_BACTERIUM,0.979421149804863
SMID_BREAST_CANCER_RELAPSE_I...8,SET,21,0.17902,0.0060513,0.20206,0.18782,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP,0.979555684961421
GOMF_OLIGOPEPTIDE_TRANSMEMBR...,SET,14,0.21105,0.005826,0.23824,0.18785,GOMF_OLIGOPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.979555684961421
AGGCACT_MIR5153P,SET,80,0.087304,0.0057507,0.098576,0.18791,AGGCACT_MIR5153P,0.979555684961421
GSE17721_PAM3CSK4_VS_GADIQUI...7,SET,177,0.05544,0.0054174,0.062606,0.18794,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_DN,0.979555684961421
GOBP_CHEMICAL_HOMEOSTASIS,SET,934,0.026252,0.0057687,0.029652,0.188,GOBP_CHEMICAL_HOMEOSTASIS,0.979555684961421
GSE41978_WT_VS_BIM_KO_KLRG1_...2,SET,184,0.053959,0.005375,0.06095,0.188,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.979555684961421
MODULE_160,SET,2,0.48659,0.0050786,0.54971,0.18803,MODULE_160,0.979555684961421
GOMF_NUCLEOCYTOPLASMIC_CARRI...,SET,30,0.12418,0.0050157,0.1403,0.18806,GOMF_NUCLEOCYTOPLASMIC_CARRIER_ACTIVITY,0.979555684961421
REACTOME_NECTIN_NECL_TRANS_H...,SET,3,0.48573,0.0062088,0.54886,0.18809,REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION,0.979555684961421
HAHTOLA_MYCOSIS_FUNGOIDES_SK...1,SET,26,0.15387,0.0057865,0.17392,0.18817,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN,0.979555684961421
GINESTIER_BREAST_CANCER_20Q1...1,SET,157,0.055514,0.0051118,0.062769,0.18824,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,0.979555684961421
JEON_SMAD6_TARGETS_UP,SET,23,0.18341,0.0064879,0.20742,0.18829,JEON_SMAD6_TARGETS_UP,0.979555684961421
GOBP_GONADAL_MESODERM_DEVELO...,SET,2,0.57782,0.0060307,0.65348,0.1883,GOBP_GONADAL_MESODERM_DEVELOPMENT,0.979555684961421
GOBP_REGULATION_OF_MACROAUTO...,SET,166,0.058255,0.0055145,0.065897,0.18834,GOBP_REGULATION_OF_MACROAUTOPHAGY,0.979555684961421
HP_ABNORMAL_MALE_INTERNAL_GE...,SET,69,0.09497,0.0058114,0.10743,0.18834,HP_ABNORMAL_MALE_INTERNAL_GENITALIA_MORPHOLOGY,0.979555684961421
HP_ABNORMAL_PULSE,SET,5,0.30845,0.0050898,0.349,0.1884,HP_ABNORMAL_PULSE,0.979555684961421
HP_BROAD_TOE,SET,72,0.087896,0.0054937,0.099453,0.18841,HP_BROAD_TOE,0.979555684961421
GOBP_NEGATIVE_REGULATION_OF_...304,SET,7,0.31652,0.0061795,0.35821,0.18846,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION,0.979555684961421
GOCC_PEPTIDASE_INHIBITOR_COM...,SET,11,0.23709,0.0058019,0.26832,0.18846,GOCC_PEPTIDASE_INHIBITOR_COMPLEX,0.979555684961421
GOMF_LIPOPOLYSACCHARIDE_BIND...,SET,36,0.12945,0.0057268,0.14651,0.18847,GOMF_LIPOPOLYSACCHARIDE_BINDING,0.979555684961421
GOBP_CENTRAL_NERVOUS_SYSTEM_...2,SET,6,0.32268,0.0058326,0.3653,0.18853,GOBP_CENTRAL_NERVOUS_SYSTEM_MATURATION,0.979555684961421
GSE5589_LPS_VS_LPS_AND_IL10_...2,SET,181,0.057075,0.0056393,0.064627,0.18859,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_UP,0.979555684961421
HP_CONGENITAL_HEMOLYTIC_ANEM...,SET,8,0.25611,0.0053453,0.29004,0.18862,HP_CONGENITAL_HEMOLYTIC_ANEMIA,0.979555684961421
BIOCARTA_ARAP_PATHWAY,SET,17,0.16228,0.0049359,0.18379,0.18864,BIOCARTA_ARAP_PATHWAY,0.979555684961421
GOMF_PROTEIN_KINASE_B_BINDING,SET,10,0.20794,0.0048517,0.23551,0.18864,GOMF_PROTEIN_KINASE_B_BINDING,0.979555684961421
GOBP_POSITIVE_REGULATION_OF_...300,SET,11,0.25446,0.0062269,0.28835,0.18877,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_MIGRATION,0.979555684961421
KEGG_PATHOGENIC_ESCHERICHIA_...,SET,53,0.1036,0.0055587,0.11741,0.18878,KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,0.979555684961421
WP_PATHOGENIC_ESCHERICHIA_CO...,SET,53,0.1036,0.0055587,0.11741,0.18878,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,0.979555684961421
GSE22886_NAIVE_CD8_TCELL_VS_...8,SET,173,0.054728,0.0052877,0.062022,0.18878,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP,0.979555684961421
GOBP_COLLATERAL_SPROUTING_IN...,SET,4,0.39654,0.0058526,0.44941,0.1888,GOBP_COLLATERAL_SPROUTING_IN_ABSENCE_OF_INJURY,0.979555684961421
KEGG_MEDICUS_REFERENCE_BMP_S...2,SET,14,0.22089,0.0060975,0.25036,0.18882,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY_BMP_ANTAGONIST,0.979555684961421
GSE10239_NAIVE_VS_MEMORY_CD8...2,SET,184,0.053537,0.0053329,0.060683,0.18883,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP,0.979555684961421
chr4q12,SET,33,0.24235,0.010266,0.27474,0.18886,chr4q12,0.979555684961421
HP_ADRENAL_HYPOPLASIA,SET,28,0.14229,0.0055526,0.16133,0.1889,HP_ADRENAL_HYPOPLASIA,0.979555684961421
HP_ABNORMAL_SCROTAL_RUGATION,SET,4,0.43384,0.0064032,0.49199,0.18895,HP_ABNORMAL_SCROTAL_RUGATION,0.979555684961421
REACTOME_APOBEC3G_MEDIATED_R...,SET,5,0.31688,0.0052288,0.35944,0.189,REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION,0.979555684961421
GOMF_SPHINGOSINE_1_PHOSPHATE...2,SET,8,0.28501,0.0059483,0.32333,0.18904,GOMF_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_ACTIVITY,0.979555684961421
FUJIWARA_PARK2_IN_LIVER_CANC...1,SET,5,0.36825,0.0060766,0.41782,0.18906,FUJIWARA_PARK2_IN_LIVER_CANCER_DN,0.979555684961421
MIR6741_3P,SET,5,0.32913,0.005431,0.37344,0.18907,MIR6741_3P,0.979555684961421
GOBP_MODIFIED_AMINO_ACID_TRA...,SET,38,0.12984,0.0059014,0.14733,0.18909,GOBP_MODIFIED_AMINO_ACID_TRANSPORT,0.979555684961421
GOBP_BUNDLE_OF_HIS_CELL_TO_P...2,SET,7,0.34047,0.0066472,0.38641,0.18913,GOBP_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_SIGNALING,0.979555684961421
GSE9650_NAIVE_VS_EXHAUSTED_C...2,SET,182,0.052679,0.0052191,0.059789,0.18914,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP,0.979555684961421
TORCHIA_TARGETS_OF_EWSR1_FLI...2,SET,19,0.18656,0.0059987,0.21176,0.18917,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN,0.979555684961421
HP_KNEE_OSTEOARTHRITIS,SET,14,0.22323,0.0061623,0.2534,0.18918,HP_KNEE_OSTEOARTHRITIS,0.979555684961421
KEGG_MEDICUS_REFERENCE_ANTIG...1,SET,11,0.26821,0.0065633,0.30454,0.18925,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES,0.979555684961421
HP_ABNORMAL_CENTRAL_SENSORY_...,SET,12,0.19699,0.0050349,0.22373,0.1893,HP_ABNORMAL_CENTRAL_SENSORY_FUNCTION,0.979555684961421
GSE2770_IL12_ACT_VS_ACT_CD4_...2,SET,167,0.059469,0.0056461,0.06755,0.18933,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP,0.979555684961421
HP_ABNORMAL_EYELID_MORPHOLOGY,SET,1179,0.022359,0.0054813,0.025399,0.18935,HP_ABNORMAL_EYELID_MORPHOLOGY,0.979555684961421
LEE_TARGETS_OF_PTCH1_AND_SUF...2,SET,51,0.10616,0.0055875,0.12059,0.18936,LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,0.979555684961421
GOMF_INHIBITORY_MHC_CLASS_I_...,SET,8,0.37315,0.007788,0.42392,0.18937,GOMF_INHIBITORY_MHC_CLASS_I_RECEPTOR_ACTIVITY,0.979555684961421
MIR10394_5P,SET,162,0.058901,0.0055086,0.066916,0.18938,MIR10394_5P,0.979555684961421
GSE13411_NAIVE_VS_SWITCHED_M...2,SET,174,0.057085,0.0055312,0.064855,0.18938,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP,0.979555684961421
WP_ENDODERM_DIFFERENTIATION,SET,130,0.068947,0.0057813,0.07834,0.18941,WP_ENDODERM_DIFFERENTIATION,0.979555684961421
REACTOME_SPHINGOLIPID_CATABO...,SET,9,0.2343,0.0051864,0.26626,0.18945,REACTOME_SPHINGOLIPID_CATABOLISM,0.979555684961421
HP_NYSTAGMUS_INDUCED_HEAD_NO...,SET,15,0.22289,0.0063685,0.2533,0.18946,HP_NYSTAGMUS_INDUCED_HEAD_NODDING,0.979555684961421
HP_DELAYED_PROXIMAL_FEMORAL_...,SET,16,0.19009,0.0056094,0.21608,0.18951,HP_DELAYED_PROXIMAL_FEMORAL_EPIPHYSEAL_OSSIFICATION,0.979555684961421
HP_LUPUS_ANTICOAGULANT,SET,4,0.41862,0.0061786,0.4761,0.18964,HP_LUPUS_ANTICOAGULANT,0.979555684961421
HP_TELANGIECTASIA_OF_THE_SKIN,SET,70,0.081244,0.0050073,0.092403,0.18964,HP_TELANGIECTASIA_OF_THE_SKIN,0.979555684961421
MIR653_3P,SET,121,0.067406,0.0054543,0.076666,0.18965,MIR653_3P,0.979555684961421
DESCARTES_FETAL_CEREBRUM_LIM...,SET,22,0.1766,0.0061097,0.20088,0.18967,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,0.979555684961421
REACTOME_ERYTHROPOIETIN_ACTI...4,SET,7,0.35593,0.0069489,0.4049,0.18969,REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5,0.979555684961421
GOBP_ANTIGEN_PROCESSING_AND_...1,SET,104,0.081603,0.0061246,0.092841,0.18972,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION,0.979555684961421
GOBP_SKELETAL_MUSCLE_CELL_PR...,SET,23,0.14842,0.0052503,0.16891,0.18978,GOBP_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.979555684961421
GOCC_REPLICATION_FORK,SET,69,0.084956,0.0051986,0.09668,0.18978,GOCC_REPLICATION_FORK,0.979555684961421
DESCARTES_FETAL_LIVER_STELLA...,SET,122,0.077437,0.0062917,0.088127,0.18979,DESCARTES_FETAL_LIVER_STELLATE_CELLS,0.979555684961421
KEGG_MEDICUS_VARIANT_MUTATIO...18,SET,17,0.16903,0.0051412,0.19238,0.18981,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKACA_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.979555684961421
GOCC_SEX_CHROMOSOME,SET,26,0.1359,0.0051109,0.15472,0.18988,GOCC_SEX_CHROMOSOME,0.979555684961421
MIKKELSEN_MEF_LCP_WITH_H3K27...,SET,61,0.104,0.0059847,0.11847,0.19002,MIKKELSEN_MEF_LCP_WITH_H3K27ME3,0.979555684961421
MIR4292,SET,143,0.062284,0.0054756,0.070953,0.19003,MIR4292,0.979555684961421
MIR1264,SET,109,0.069859,0.005367,0.079598,0.19007,MIR1264,0.979555684961421
GOBP_MELANOCYTE_PROLIFERATION,SET,5,0.35151,0.0058003,0.40059,0.19012,GOBP_MELANOCYTE_PROLIFERATION,0.979555684961421
GSE411_UNSTIM_VS_100MIN_IL6_...1,SET,186,0.053333,0.0053411,0.060787,0.19015,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN,0.979555684961421
GOBP_SYMPATHETIC_GANGLION_DE...,SET,9,0.28942,0.0064066,0.32992,0.19019,GOBP_SYMPATHETIC_GANGLION_DEVELOPMENT,0.979555684961421
GSE22140_GERMFREE_VS_SPF_ART...1,SET,175,0.056243,0.0054651,0.064115,0.19019,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN,0.979555684961421
MIR5691_MIR6805_3P,SET,144,0.064829,0.0057191,0.073907,0.1902,MIR5691_MIR6805_3P,0.979555684961421
GOBP_RESPONSE_TO_ANTIBIOTIC,SET,36,0.12328,0.0054539,0.14056,0.19023,GOBP_RESPONSE_TO_ANTIBIOTIC,0.979555684961421
ETF_Q6,SET,111,0.072804,0.005644,0.08304,0.19032,ETF_Q6,0.979555684961421
PYEON_CANCER_HEAD_AND_NECK_V...2,SET,157,0.060102,0.0055343,0.068564,0.19036,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,0.979555684961421
GOMF_TRNA_METHYLTRANSFERASE_...,SET,30,0.11801,0.0047666,0.13464,0.19039,GOMF_TRNA_METHYLTRANSFERASE_ACTIVITY,0.979555684961421
WENG_POR_TARGETS_GLOBAL_UP,SET,18,0.16187,0.0050662,0.1847,0.19041,WENG_POR_TARGETS_GLOBAL_UP,0.979555684961421
REACTOME_UREA_CYCLE,SET,9,0.23975,0.0053072,0.27366,0.1905,REACTOME_UREA_CYCLE,0.979555684961421
chr9p24,SET,33,0.21572,0.0091377,0.2463,0.19057,chr9p24,0.979555684961421
WP_ANGIOTENSIN_II_RECEPTOR_T...,SET,25,0.15655,0.0057734,0.17875,0.19057,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,0.979555684961421
OCT1_Q5_01,SET,224,0.053437,0.0058667,0.061028,0.19062,OCT1_Q5_01,0.979555684961421
GOBP_SYMPATHETIC_NERVOUS_SYS...,SET,21,0.18757,0.0063404,0.21428,0.19069,GOBP_SYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,0.979555684961421
HP_SPLIT_NAIL,SET,4,0.28112,0.0041492,0.32114,0.19069,HP_SPLIT_NAIL,0.979555684961421
HP_TIGER_TAIL_BANDING,SET,4,0.28112,0.0041492,0.32114,0.19069,HP_TIGER_TAIL_BANDING,0.979555684961421
GOMF_PHOSPHOTYROSINE_RESIDUE...,SET,45,0.11348,0.0056114,0.12965,0.19072,GOMF_PHOSPHOTYROSINE_RESIDUE_BINDING,0.979555684961421
GSE13485_DAY1_VS_DAY3_YF17D_...1,SET,182,0.053424,0.0052929,0.06104,0.19073,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN,0.979555684961421
GOBP_GUANINE_NUCLEOTIDE_TRAN...,SET,11,0.24457,0.0059848,0.27944,0.19074,GOBP_GUANINE_NUCLEOTIDE_TRANSPORT,0.979555684961421
GOMF_HEPARAN_SULFATE_GLUCOSA...,SET,7,0.3401,0.0066399,0.3886,0.19074,GOMF_HEPARAN_SULFATE_GLUCOSAMINE_3_SULFOTRANSFERASE_1_ACTIVITY,0.979555684961421
ZF5_01,SET,226,0.049972,0.0055103,0.0571,0.19075,ZF5_01,0.979555684961421
HSF4_TARGET_GENES,SET,5,0.31312,0.0051668,0.3578,0.19076,HSF4_TARGET_GENES,0.979555684961421
GOBP_POSITIVE_REGULATION_OF_...840,SET,22,0.15469,0.0053518,0.17677,0.19076,GOBP_POSITIVE_REGULATION_OF_VIRAL_LIFE_CYCLE,0.979555684961421
HP_CELLULITIS,SET,44,0.11587,0.0056659,0.13243,0.1908,HP_CELLULITIS,0.979555684961421
GSE1460_CORD_VS_ADULT_BLOOD_...2,SET,165,0.056937,0.0053736,0.065076,0.19081,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP,0.979555684961421
GSE39110_UNTREATED_VS_IL2_TR...4,SET,182,0.056732,0.0056207,0.064848,0.19083,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP,0.979555684961421
TEAD2_TARGET_GENES,SET,1171,0.022564,0.005514,0.0258,0.19091,TEAD2_TARGET_GENES,0.979555684961421
POMEROY_MEDULLOBLASTOMA_DESM...1,SET,52,0.10934,0.0058108,0.12504,0.19095,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,0.979555684961421
GOCC_TORC1_COMPLEX,SET,6,0.24459,0.0044211,0.27977,0.19099,GOCC_TORC1_COMPLEX,0.979555684961421
WP_APOE_AND_MIR146_IN_INFLAM...,SET,6,0.30486,0.0055105,0.34874,0.19102,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.979555684961421
MIR6815_5P,SET,54,0.10153,0.0054984,0.11615,0.19103,MIR6815_5P,0.979555684961421
CACCAGC_MIR138,SET,208,0.053446,0.0056566,0.061141,0.19103,CACCAGC_MIR138,0.979555684961421
PID_SYNDECAN_4_PATHWAY,SET,31,0.13947,0.0057265,0.15961,0.19111,PID_SYNDECAN_4_PATHWAY,0.979555684961421
HP_DECREASED_SERUM_LEPTIN,SET,11,0.2316,0.0056675,0.26504,0.19111,HP_DECREASED_SERUM_LEPTIN,0.979555684961421
HP_VESTIBULAR_HYPOFUNCTION,SET,15,0.21187,0.0060537,0.24249,0.19115,HP_VESTIBULAR_HYPOFUNCTION,0.979555684961421
HP_SCLEROSING_CHOLANGITIS,SET,10,0.26715,0.0062335,0.30586,0.19122,HP_SCLEROSING_CHOLANGITIS,0.979555684961421
MIR3682_3P,SET,72,0.090325,0.0056456,0.10342,0.19123,MIR3682_3P,0.979555684961421
BAUS_TFF2_TARGETS_UP,SET,30,0.13894,0.0056121,0.15909,0.19124,BAUS_TFF2_TARGETS_UP,0.979555684961421
HP_ABNORMALITY_OF_THE_CERVIC...,SET,375,0.038185,0.0054016,0.043723,0.19124,HP_ABNORMALITY_OF_THE_CERVICAL_SPINE,0.979555684961421
MENON_FETAL_KIDNEY_5_PROXIMA...,SET,88,0.081917,0.005658,0.093806,0.19127,MENON_FETAL_KIDNEY_5_PROXIMAL_TUBULE_CELLS,0.979555684961421
GOBP_NEGATIVE_REGULATION_OF_...72,SET,9,0.26622,0.005893,0.3049,0.1913,GOBP_NEGATIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.979555684961421
MIR6895_5P,SET,38,0.12398,0.005635,0.14206,0.1914,MIR6895_5P,0.979555684961421
GOBP_LIPID_GLYCOSYLATION,SET,11,0.23016,0.0056322,0.26372,0.19141,GOBP_LIPID_GLYCOSYLATION,0.979555684961421
GSE11864_CSF1_IFNG_VS_CSF1_I...2,SET,174,0.056532,0.0054775,0.064774,0.19141,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.979555684961421
GOCC_TIM22_MITOCHONDRIAL_IMP...,SET,6,0.29179,0.0052742,0.33442,0.19147,GOCC_TIM22_MITOCHONDRIAL_IMPORT_INNER_MEMBRANE_INSERTION_COMPLEX,0.979555684961421
MIR5703,SET,150,0.061355,0.0055234,0.070327,0.19149,MIR5703,0.979555684961421
REACTOME_DRUG_ADME,SET,101,0.085699,0.0063391,0.098232,0.1915,REACTOME_DRUG_ADME,0.979555684961421
SAUL_SEN_MAYO,SET,123,0.077748,0.0063426,0.089148,0.19157,SAUL_SEN_MAYO,0.979555684961421
PEREZ_TP53_AND_TP63_TARGETS,SET,178,0.059084,0.0057896,0.067755,0.1916,PEREZ_TP53_AND_TP63_TARGETS,0.979555684961421
GOBP_MITOTIC_DNA_REPLICATION,SET,15,0.1703,0.0048659,0.19536,0.19169,GOBP_MITOTIC_DNA_REPLICATION,0.979555684961421
ZHAN_MULTIPLE_MYELOMA_CD1_VS...2,SET,60,0.10338,0.0059003,0.11861,0.19172,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP,0.979555684961421
HP_ABNORMAL_CIRCULATING_CERU...,SET,10,0.24094,0.0056218,0.27646,0.19174,HP_ABNORMAL_CIRCULATING_CERULOPLASMIN_CONCENTRATION,0.979555684961421
ZNF433_TARGET_GENES,SET,46,0.10531,0.0052647,0.12086,0.19179,ZNF433_TARGET_GENES,0.979555684961421
GOBP_REGULATION_OF_SYNAPTIC_...3,SET,8,0.26347,0.0054989,0.30243,0.19183,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC,0.979555684961421
REACTOME_HIV_TRANSCRIPTION_E...,SET,38,0.10114,0.0045966,0.11609,0.19184,REACTOME_HIV_TRANSCRIPTION_ELONGATION,0.979555684961421
DESCARTES_FETAL_EYE_MICROGLIA,SET,127,0.068115,0.0056458,0.078188,0.19184,DESCARTES_FETAL_EYE_MICROGLIA,0.979555684961421
HP_RENAL_MAGNESIUM_WASTING,SET,7,0.27898,0.0054466,0.32025,0.19185,HP_RENAL_MAGNESIUM_WASTING,0.979555684961421
HP_SYMPTOMATIC_SEIZURES,SET,35,0.13441,0.0058634,0.1543,0.19185,HP_SYMPTOMATIC_SEIZURES,0.979555684961421
GSE36888_STAT5_AB_KNOCKIN_VS...1,SET,177,0.057122,0.0055818,0.065573,0.19185,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN,0.979555684961421
MATZUK_CUMULUS_EXPANSION,SET,8,0.30999,0.0064696,0.35586,0.19186,MATZUK_CUMULUS_EXPANSION,0.979555684961421
GSE30083_SP1_VS_SP2_THYMOCYT...1,SET,184,0.056436,0.0056217,0.064788,0.19186,GSE30083_SP1_VS_SP2_THYMOCYTE_DN,0.979555684961421
GOBP_EMBRYONIC_CAMERA_TYPE_E...3,SET,26,0.15833,0.0059544,0.18178,0.19188,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_MORPHOGENESIS,0.979555684961421
GOBP_PLATELET_ACTIVATING_FAC...,SET,8,0.26347,0.0054988,0.30255,0.19193,GOBP_PLATELET_ACTIVATING_FACTOR_METABOLIC_PROCESS,0.979555684961421
MIR10A_3P,SET,20,0.16808,0.0055448,0.19303,0.19194,MIR10A_3P,0.979555684961421
GOBP_REGULATION_OF_NEURON_DI...,SET,176,0.06109,0.0059528,0.070162,0.19196,GOBP_REGULATION_OF_NEURON_DIFFERENTIATION,0.979555684961421
PID_AMB2_NEUTROPHILS_PATHWAY,SET,40,0.12283,0.0057272,0.14108,0.19198,PID_AMB2_NEUTROPHILS_PATHWAY,0.979555684961421
GOBP_IMP_BIOSYNTHETIC_PROCESS,SET,10,0.23265,0.0054285,0.26723,0.19198,GOBP_IMP_BIOSYNTHETIC_PROCESS,0.979555684961421
HP_ONION_BULB_FORMATION,SET,27,0.14232,0.0054542,0.16348,0.19199,HP_ONION_BULB_FORMATION,0.979555684961421
GOBP_ECTODERMAL_CELL_DIFFERE...,SET,5,0.39932,0.0065893,0.45869,0.192,GOBP_ECTODERMAL_CELL_DIFFERENTIATION,0.979555684961421
GOBP_REGULATION_OF_WOUND_HEA...2,SET,10,0.23751,0.0055418,0.27282,0.192,GOBP_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,0.979555684961421
GOBP_REGULATION_OF_GLUCOSE_T...,SET,70,0.092198,0.0056823,0.10592,0.19203,GOBP_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,0.979555684961421
GOCC_TOM_COMPLEX,SET,5,0.30466,0.0050272,0.35003,0.19206,GOCC_TOM_COMPLEX,0.979555684961421
GOBP_REGULATION_OF_WOUND_HEA...1,SET,125,0.069905,0.0057486,0.080345,0.19214,GOBP_REGULATION_OF_WOUND_HEALING,0.979555684961421
MIR571,SET,61,0.096207,0.0055365,0.11058,0.19216,MIR571,0.979555684961421
MIR6856_5P,SET,93,0.076884,0.0054584,0.088373,0.19216,MIR6856_5P,0.979555684961421
HP_LACTICACIDURIA,SET,20,0.17099,0.0056407,0.19655,0.19217,HP_LACTICACIDURIA,0.979555684961421
HP_HYPOLIPIDEMIA,SET,10,0.23306,0.0054379,0.26791,0.19218,HP_HYPOLIPIDEMIA,0.979555684961421
HP_ABNORMAL_CARDIAC_TEST,SET,24,0.16014,0.0057863,0.18409,0.19219,HP_ABNORMAL_CARDIAC_TEST,0.979555684961421
GOBP_POSITIVE_REGULATION_OF_...3,SET,57,0.10034,0.0055825,0.11538,0.19225,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.979555684961421
GOMF_INTRACELLULARLY_CAMP_AC...,SET,8,0.26484,0.0055275,0.30454,0.19225,GOMF_INTRACELLULARLY_CAMP_ACTIVATED_CATION_CHANNEL_ACTIVITY,0.979555684961421
SCHERER_PBMC_YF_VAX_AGE_18_4...1,SET,221,0.049159,0.0053611,0.056556,0.19237,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN,0.979555684961421
GOMF_CALMODULIN_DEPENDENT_PR...2,SET,5,0.26308,0.004341,0.30272,0.19242,GOMF_CALMODULIN_DEPENDENT_PROTEIN_PHOSPHATASE_ACTIVITY,0.979555684961421
REACTOME_TP53_REGULATES_TRAN...1,SET,20,0.16631,0.0054865,0.19141,0.19246,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN,0.979555684961421
MIR4668_5P,SET,425,0.036696,0.0055185,0.042237,0.19248,MIR4668_5P,0.979555684961421
HP_AGENESIS_OF_MAXILLARY_INC...,SET,15,0.20289,0.0057971,0.23354,0.1925,HP_AGENESIS_OF_MAXILLARY_INCISOR,0.979555684961421
GOBP_POSITIVE_REGULATION_OF_...618,SET,15,0.20549,0.0058715,0.23655,0.19251,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION,0.979555684961421
NICK_RESPONSE_TO_PROC_TREATM...2,SET,4,0.37099,0.0054756,0.42713,0.19255,NICK_RESPONSE_TO_PROC_TREATMENT_UP,0.979555684961421
GOMF_XENOBIOTIC_TRANSMEMBRAN...,SET,32,0.14178,0.0059143,0.16326,0.19258,GOMF_XENOBIOTIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.979555684961421
HP_PALMOPLANTAR_BLISTERING,SET,11,0.23346,0.005713,0.26885,0.1926,HP_PALMOPLANTAR_BLISTERING,0.979555684961421
GOBP_MAGNESIUM_ION_HOMEOSTAS...,SET,10,0.23537,0.0054918,0.27106,0.19262,GOBP_MAGNESIUM_ION_HOMEOSTASIS,0.979555684961421
GOBP_SIGNAL_COMPLEX_ASSEMBLY,SET,8,0.24275,0.0050664,0.27957,0.19262,GOBP_SIGNAL_COMPLEX_ASSEMBLY,0.979555684961421
GSE17721_CTRL_VS_PAM3CSK4_6H...2,SET,178,0.056466,0.0055331,0.065039,0.19265,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_UP,0.979555684961421
GOBP_LYMPHOCYTE_MEDIATED_IMM...,SET,267,0.049396,0.0059137,0.056897,0.19266,GOBP_LYMPHOCYTE_MEDIATED_IMMUNITY,0.979555684961421
GOBP_POSITIVE_REGULATION_OF_...202,SET,17,0.18953,0.005765,0.21838,0.19272,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,0.979555684961421
KEGG_MEDICUS_VARIANT_EML4_AL...1,SET,5,0.44224,0.0072975,0.50966,0.19278,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY,0.979555684961421
MIR6778_5P,SET,97,0.072375,0.005247,0.08341,0.19278,MIR6778_5P,0.979555684961421
HP_PURPURA,SET,116,0.07203,0.0057076,0.083016,0.1928,HP_PURPURA,0.979555684961421
REACTOME_CRISTAE_FORMATION,SET,9,0.22794,0.0050458,0.26273,0.19282,REACTOME_CRISTAE_FORMATION,0.979555684961421
HP_ABNORMALITY_OF_PAIN_SENSA...,SET,90,0.077188,0.0053913,0.088975,0.19283,HP_ABNORMALITY_OF_PAIN_SENSATION,0.979555684961421
RIZ_ERYTHROID_DIFFERENTIATIO...3,SET,24,0.16075,0.0058084,0.18531,0.19285,RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2,0.979555684961421
TONKS_TARGETS_OF_RUNX1_RUNX1...10,SET,7,0.30292,0.0059139,0.34923,0.19287,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN,0.979555684961421
GOMF_SIGNALING_RECEPTOR_COMP...,SET,51,0.10187,0.0053621,0.11746,0.1929,GOMF_SIGNALING_RECEPTOR_COMPLEX_ADAPTOR_ACTIVITY,0.979555684961421
HP_HYPOPIGMENTATION_OF_THE_S...,SET,179,0.053236,0.0052311,0.061385,0.19291,HP_HYPOPIGMENTATION_OF_THE_SKIN,0.979555684961421
HP_ABNORMAL_ULNAR_METAPHYSIS...,SET,10,0.28045,0.0065436,0.32342,0.19294,HP_ABNORMAL_ULNAR_METAPHYSIS_MORPHOLOGY,0.979555684961421
GSE42021_CD24INT_VS_CD24LOW_...2,SET,181,0.056469,0.0055794,0.065122,0.19294,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_UP,0.979555684961421
MIR6888_5P,SET,45,0.1207,0.0059685,0.13921,0.19296,MIR6888_5P,0.979555684961421
MIR12124,SET,289,0.043544,0.0054203,0.050224,0.19298,MIR12124,0.979555684961421
MIR450B_5P,SET,421,0.037388,0.0055965,0.043123,0.19298,MIR450B_5P,0.979555684961421
GOMF_NUCLEAR_STEROID_RECEPTO...,SET,25,0.1557,0.0057417,0.17961,0.19301,GOMF_NUCLEAR_STEROID_RECEPTOR_ACTIVITY,0.979555684961421
GOMF_G_QUADRUPLEX_RNA_BINDING,SET,6,0.29362,0.0053074,0.33882,0.19308,GOMF_G_QUADRUPLEX_RNA_BINDING,0.979555684961421
GOBP_REGULATION_OF_TOOTH_MIN...,SET,10,0.24253,0.0056589,0.2799,0.19312,GOBP_REGULATION_OF_TOOTH_MINERALIZATION,0.979555684961421
GOBP_POSITIVE_REGULATION_OF_...347,SET,5,0.3003,0.0049553,0.34659,0.19313,GOBP_POSITIVE_REGULATION_OF_HYPERSENSITIVITY,0.979555684961421
GSE7852_LN_VS_FAT_TCONV_UP,SET,180,0.052955,0.0052178,0.061132,0.19319,GSE7852_LN_VS_FAT_TCONV_UP,0.979555684961421
GOBP_MEMBRANE_PROTEIN_ECTODO...,SET,45,0.10562,0.0052228,0.12194,0.1932,GOBP_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.979555684961421
GOMF_NUCLEAR_IMPORT_SIGNAL_R...,SET,19,0.14833,0.0047694,0.17125,0.19321,GOMF_NUCLEAR_IMPORT_SIGNAL_RECEPTOR_ACTIVITY,0.979555684961421
CAGGTA_AREB6_01,SET,684,0.029458,0.0055792,0.034014,0.19323,CAGGTA_AREB6_01,0.979555684961421
HP_BUDD_CHIARI_SYNDROME,SET,7,0.30213,0.0058985,0.34885,0.19323,HP_BUDD_CHIARI_SYNDROME,0.979555684961421
ATACTGT_MIR144,SET,181,0.056269,0.0055597,0.064975,0.19325,ATACTGT_MIR144,0.979555684961421
KEGG_MEDICUS_REFERENCE_ATR_S...,SET,11,0.19998,0.0048936,0.23094,0.19327,KEGG_MEDICUS_REFERENCE_ATR_SIGNALING,0.979555684961421
ZNF626_TARGET_GENES,SET,12,0.20194,0.0051612,0.2332,0.19327,ZNF626_TARGET_GENES,0.979555684961421
ZNF584_TARGET_GENES,SET,284,0.044064,0.0054381,0.050892,0.19329,ZNF584_TARGET_GENES,0.979555684961421
HP_SWAN_NECK_LIKE_DEFORMITIE...,SET,8,0.28283,0.0059028,0.32665,0.1933,HP_SWAN_NECK_LIKE_DEFORMITIES_OF_THE_FINGERS,0.979555684961421
REACTOME_REGULATION_OF_TP53_...2,SET,28,0.13874,0.0054143,0.16025,0.19331,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION,0.979555684961421
GOBP_REGULATION_OF_AUTOPHAGO...1,SET,43,0.10762,0.0052023,0.12431,0.19332,GOBP_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,0.979555684961421
GOMF_DYNEIN_INTERMEDIATE_CHA...,SET,31,0.12708,0.0052175,0.14684,0.19341,GOMF_DYNEIN_INTERMEDIATE_CHAIN_BINDING,0.979555684961421
MODULE_389,SET,196,0.05206,0.0053505,0.060164,0.19344,MODULE_389,0.979555684961421
REACTOME_FORMATION_OF_FIBRIN...,SET,36,0.13979,0.0061841,0.16157,0.19348,REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE,0.979555684961421
MIR9718,SET,95,0.080081,0.0057458,0.092564,0.19349,MIR9718,0.979555684961421
GOBP_SNARE_COMPLEX_ASSEMBLY,SET,21,0.15098,0.0051035,0.17453,0.19351,GOBP_SNARE_COMPLEX_ASSEMBLY,0.979555684961421
HP_OLIGOZOOSPERMIA,SET,43,0.10601,0.0051247,0.12256,0.19353,HP_OLIGOZOOSPERMIA,0.979555684961421
GOBP_CELL_ACTIVATION_INVOLVE...,SET,278,0.046445,0.005672,0.0537,0.19355,GOBP_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.979555684961421
BIOCARTA_HER2_PATHWAY,SET,23,0.15464,0.0054702,0.1788,0.19356,BIOCARTA_HER2_PATHWAY,0.979555684961421
GOBP_POSITIVE_REGULATION_OF_...68,SET,14,0.19832,0.0054745,0.22932,0.19358,GOBP_POSITIVE_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,0.979555684961421
HP_ABNORMAL_4TH_METACARPAL_M...,SET,14,0.21766,0.0060085,0.25169,0.19358,HP_ABNORMAL_4TH_METACARPAL_MORPHOLOGY,0.979555684961421
GOCC_T_TUBULE,SET,52,0.10986,0.0058388,0.12705,0.19359,GOCC_T_TUBULE,0.979555684961421
GOCC_SERINE_TYPE_ENDOPEPTIDA...,SET,11,0.2769,0.0067761,0.32022,0.1936,GOCC_SERINE_TYPE_ENDOPEPTIDASE_COMPLEX,0.979555684961421
GOBP_THELARCHE,SET,4,0.429,0.0063318,0.49622,0.19365,GOBP_THELARCHE,0.979666048034935
GARY_CD5_TARGETS_UP,SET,415,0.035665,0.0053014,0.041272,0.19376,GARY_CD5_TARGETS_UP,0.979892342667437
HP_ABNORMAL_BLOOD_GAS_LEVEL,SET,44,0.11715,0.0057286,0.13558,0.19378,HP_ABNORMAL_BLOOD_GAS_LEVEL,0.979892342667437
BIOCARTA_IL2_PATHWAY,SET,20,0.17629,0.0058157,0.20409,0.19385,BIOCARTA_IL2_PATHWAY,0.979892342667437
GOBP_TYROSINE_PHOSPHORYLATIO...,SET,74,0.08866,0.0056177,0.10264,0.19386,GOBP_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.979892342667437
STAMBOLSKY_TARGETS_OF_MUTATE...1,SET,47,0.11037,0.0055775,0.12783,0.19395,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,0.979892342667437
HP_ABNORMAL_PALATE_MORPHOLOGY,SET,991,0.023712,0.0053586,0.027462,0.19395,HP_ABNORMAL_PALATE_MORPHOLOGY,0.979892342667437
GSE39556_CD8A_DC_VS_NK_CELL_...4,SET,182,0.055847,0.005533,0.064683,0.19397,GSE39556_CD8A_DC_VS_NK_CELL_UP,0.979892342667437
FAN_OVARY_CL3_MATURE_CUMULUS...,SET,200,0.053237,0.0055263,0.06166,0.19397,FAN_OVARY_CL3_MATURE_CUMULUS_GRANULOSA_CELL_1,0.979892342667437
chr19p13,SET,517,0.074461,0.012318,0.086249,0.19398,chr19p13,0.979892342667437
MORF_TPR,SET,131,0.060002,0.0050505,0.069512,0.19402,MORF_TPR,0.979892342667437
REACTOME_PI3K_EVENTS_IN_ERBB...2,SET,10,0.24541,0.0057262,0.28434,0.19404,REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING,0.979892342667437
GOBP_DEOXYRIBONUCLEOSIDE_MON...3,SET,24,0.14994,0.0054179,0.17375,0.19408,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.979892342667437
GOBP_REGULATION_OF_ACTIVIN_R...,SET,26,0.14885,0.0055979,0.1725,0.1941,GOBP_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.979892342667437
REACTOME_AFLATOXIN_ACTIVATIO...,SET,18,0.18086,0.0056604,0.20968,0.1942,REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION,0.979892342667437
HP_PERIVENTRICULAR_HETEROTOP...,SET,37,0.11404,0.0051144,0.13221,0.19421,HP_PERIVENTRICULAR_HETEROTOPIA,0.979892342667437
GOMF_CALCIUM_DEPENDENT_PROTE...1,SET,74,0.097409,0.006172,0.11294,0.19422,GOMF_CALCIUM_DEPENDENT_PROTEIN_BINDING,0.979892342667437
GNF2_TTK,SET,39,0.10774,0.0049606,0.12493,0.19424,GNF2_TTK,0.979892342667437
HP_RENAL_CORTICOMEDULLARY_CY...,SET,8,0.25317,0.0052838,0.29356,0.19424,HP_RENAL_CORTICOMEDULLARY_CYSTS,0.979892342667437
GOBP_METALLO_SULFUR_CLUSTER_...,SET,21,0.16271,0.0054999,0.18869,0.19427,GOBP_METALLO_SULFUR_CLUSTER_ASSEMBLY,0.979892342667437
HP_FATIGABLE_WEAKNESS_OF_SKE...,SET,42,0.1102,0.0052648,0.12779,0.19427,HP_FATIGABLE_WEAKNESS_OF_SKELETAL_MUSCLES,0.979892342667437
GOBP_GALACTOSE_CATABOLIC_PRO...2,SET,5,0.31493,0.0051967,0.36529,0.19431,GOBP_GALACTOSE_CATABOLIC_PROCESS_VIA_UDP_GALACTOSE,0.979892342667437
GOCC_PERICILIARY_MEMBRANE_CO...,SET,4,0.35348,0.0052172,0.41007,0.19435,GOCC_PERICILIARY_MEMBRANE_COMPARTMENT,0.979892342667437
GOBP_VENOUS_BLOOD_VESSEL_DEV...,SET,16,0.19553,0.0057698,0.22685,0.19437,GOBP_VENOUS_BLOOD_VESSEL_DEVELOPMENT,0.979892342667437
HP_DEGENERATION_OF_THE_LATER...,SET,19,0.15967,0.0051339,0.18525,0.19438,HP_DEGENERATION_OF_THE_LATERAL_CORTICOSPINAL_TRACTS,0.979892342667437
REACTOME_APEX1_INDEPENDENT_R...,SET,7,0.2117,0.004133,0.24569,0.19445,REACTOME_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY,0.979892342667437
GOBP_REGULATION_OF_MITOTIC_S...2,SET,22,0.13695,0.004738,0.159,0.19454,GOBP_REGULATION_OF_MITOTIC_SPINDLE_ASSEMBLY,0.979892342667437
HP_ABNORMAL_SYNAPTIC_TRANSMI...,SET,111,0.070706,0.0054814,0.082092,0.19454,HP_ABNORMAL_SYNAPTIC_TRANSMISSION_AT_THE_NEUROMUSCULAR_JUNCTION,0.979892342667437
GOBP_POSITIVE_REGULATION_OF_...24,SET,22,0.17075,0.0059074,0.19826,0.19456,GOBP_POSITIVE_REGULATION_OF_AMINO_ACID_TRANSPORT,0.979892342667437
GSE46606_UNSTIM_VS_CD40L_IL2...4,SET,178,0.053818,0.0052737,0.0625,0.1946,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,0.979892342667437
GSE7460_CTRL_VS_FOXP3_OVEREX...3,SET,173,0.055512,0.0053634,0.064467,0.1946,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN,0.979892342667437
GOBP_VENTRICULAR_SEPTUM_DEVE...,SET,70,0.09413,0.0058014,0.10934,0.19466,GOBP_VENTRICULAR_SEPTUM_DEVELOPMENT,0.979892342667437
HP_TOOTH_ABSCESS,SET,6,0.34043,0.0061535,0.39554,0.19471,HP_TOOTH_ABSCESS,0.979892342667437
HAY_BONE_MARROW_MONOCYTE,SET,195,0.054102,0.0055463,0.062873,0.19476,HAY_BONE_MARROW_MONOCYTE,0.979892342667437
BOWIE_RESPONSE_TO_EXTRACELLU...,SET,17,0.17195,0.0052301,0.19986,0.19481,BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX,0.979892342667437
GSE14415_TCONV_VS_FOXP3_KO_I...2,SET,151,0.059343,0.0053598,0.068984,0.19483,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP,0.979892342667437
HP_CEREBELLAR_DYSPLASIA,SET,18,0.17911,0.0056058,0.20821,0.19484,HP_CEREBELLAR_DYSPLASIA,0.979892342667437
HP_POST_PARTUM_HEMORRHAGE,SET,13,0.22003,0.0058532,0.2558,0.19486,HP_POST_PARTUM_HEMORRHAGE,0.979892342667437
MIR1252_5P,SET,294,0.043318,0.0054378,0.050365,0.19488,MIR1252_5P,0.979892342667437
GOCC_REPLISOME,SET,22,0.14355,0.0049664,0.1669,0.19488,GOCC_REPLISOME,0.979892342667437
CTTTGCA_MIR527,SET,215,0.051272,0.005516,0.059622,0.19491,CTTTGCA_MIR527,0.979892342667437
ERWIN_COHEN_BLOOD_VACCINE_TC...3,SET,5,0.32565,0.0053736,0.37876,0.19496,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_DN,0.979892342667437
HP_PROMINENT_METOPIC_RIDGE,SET,57,0.098284,0.005468,0.11432,0.19497,HP_PROMINENT_METOPIC_RIDGE,0.979892342667437
DESCARTES_MAIN_FETAL_MICROGL...,SET,121,0.069897,0.0056559,0.081306,0.19499,DESCARTES_MAIN_FETAL_MICROGLIA,0.979892342667437
GOBP_ANTIFUNGAL_HUMORAL_RESP...,SET,4,0.40337,0.0059536,0.46926,0.19501,GOBP_ANTIFUNGAL_HUMORAL_RESPONSE,0.979892342667437
GSE44649_WT_VS_MIR155_KO_NAI...1,SET,188,0.057221,0.0057609,0.066568,0.19501,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_DN,0.979892342667437
GOBP_POSITIVE_REGULATION_OF_...141,SET,9,0.27552,0.0060991,0.32055,0.19503,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.979892342667437
VALK_AML_WITH_EVI1,SET,22,0.17482,0.0060483,0.2034,0.19504,VALK_AML_WITH_EVI1,0.979892342667437
DESCARTES_MAIN_FETAL_STC2_TL...,SET,16,0.20001,0.0059022,0.23277,0.1951,DESCARTES_MAIN_FETAL_STC2_TLX1_POSITIVE_CELLS,0.979892342667437
KEGG_MEDICUS_VARIANT_DUPLICA...1,SET,4,0.48321,0.0071319,0.56253,0.19518,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY,0.979892342667437
HELLER_HDAC_TARGETS_SILENCED...1,SET,257,0.047332,0.0055609,0.055105,0.19519,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,0.979892342667437
MIR4713_3P,SET,37,0.11884,0.0053299,0.13835,0.19519,MIR4713_3P,0.979892342667437
GOBP_NEGATIVE_REGULATION_OF_...707,SET,156,0.061801,0.0056727,0.071957,0.19522,GOBP_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,0.979892342667437
MIYAGAWA_TARGETS_OF_EWSR1_ET...1,SET,204,0.057929,0.0060726,0.067453,0.19523,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,0.979892342667437
GOBP_POSITIVE_REGULATION_OF_...764,SET,6,0.3185,0.005757,0.3709,0.19525,GOBP_POSITIVE_REGULATION_OF_TOOTH_MINERALIZATION,0.979892342667437
HP_HYPERCHLOREMIC_ACIDOSIS,SET,13,0.20475,0.0054467,0.23846,0.19527,HP_HYPERCHLOREMIC_ACIDOSIS,0.979892342667437
MIR6865_5P,SET,55,0.098931,0.0054069,0.11522,0.19529,MIR6865_5P,0.979892342667437
GOBP_MESENCHYMAL_EPITHELIAL_...,SET,9,0.2762,0.0061139,0.32175,0.19533,GOBP_MESENCHYMAL_EPITHELIAL_CELL_SIGNALING,0.979892342667437
GSE10273_HIGH_VS_LOW_IL7_TRE...1,SET,175,0.054941,0.0053385,0.063999,0.19533,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN,0.979892342667437
KEGG_MEDICUS_REFERENCE_DEUBI...,SET,21,0.15636,0.0052852,0.1822,0.19541,KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119,0.980152193678741
REACTOME_RNA_POLYMERASE_I_TR...2,SET,42,0.099866,0.0047713,0.11641,0.19548,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION,0.980361818181818
GSE10211_UV_INACT_SENDAI_VS_...1,SET,140,0.062287,0.0054186,0.072618,0.19552,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_DN,0.980420949357957
GSE46606_IRF4HIGH_VS_IRF4MID...1,SET,178,0.056094,0.0054967,0.06542,0.1956,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.980524873864783
HP_ERYTHEMA_NODOSUM,SET,7,0.31109,0.0060735,0.36282,0.19561,HP_ERYTHEMA_NODOSUM,0.980524873864783
GOBP_FRUCTOSE_TRANSMEMBRANE_...,SET,9,0.24141,0.0053439,0.28162,0.19567,GOBP_FRUCTOSE_TRANSMEMBRANE_TRANSPORT,0.980524873864783
GOBP_POSITIVE_REGULATION_OF_...346,SET,412,0.038504,0.0057031,0.044919,0.19568,GOBP_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY,0.980524873864783
GSE17721_LPS_VS_GARDIQUIMOD_...16,SET,187,0.053409,0.0053629,0.062314,0.1957,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP,0.980524873864783
GSE13485_DAY1_VS_DAY21_YF17D...2,SET,160,0.05565,0.0051726,0.064929,0.19571,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.980524873864783
GOBP_RESPONSE_TO_IRON_II_ION,SET,6,0.31342,0.0056653,0.36581,0.19579,GOBP_RESPONSE_TO_IRON_II_ION,0.980782198877536
HP_HYPERGALACTOSEMIA,SET,6,0.30083,0.0054377,0.3512,0.19585,HP_HYPERGALACTOSEMIA,0.980782198877536
GSE360_CTRL_VS_B_MALAYI_HIGH...3,SET,189,0.051804,0.0052292,0.060489,0.19589,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN,0.980782198877536
HP_ABNORMAL_MUSCLE_FIBER_ALP...,SET,9,0.24513,0.0054263,0.28625,0.1959,HP_ABNORMAL_MUSCLE_FIBER_ALPHA_DYSTROGLYCAN,0.980782198877536
DURCHDEWALD_SKIN_CARCINOGENE...1,SET,242,0.048677,0.0055518,0.056851,0.19595,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,0.980782198877536
HP_CHORIORETINAL_HYPOPIGMENT...,SET,10,0.25025,0.0058391,0.2923,0.19597,HP_CHORIORETINAL_HYPOPIGMENTATION,0.980782198877536
HP_PERINUCLEAR_ANTINEUTROPHI...,SET,6,0.2685,0.0048533,0.31364,0.19599,HP_PERINUCLEAR_ANTINEUTROPHIL_ANTIBODY_POSITIVITY,0.980782198877536
GOBP_RENAL_ABSORPTION,SET,33,0.14114,0.0059786,0.1649,0.19603,GOBP_RENAL_ABSORPTION,0.980782198877536
KEGG_MEDICUS_VARIANT_OLIGOME...,SET,13,0.19152,0.0050946,0.22378,0.19605,KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.980782198877536
GSE15624_CTRL_VS_3H_HALOFUGI...1,SET,144,0.05693,0.0050223,0.066525,0.19607,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_DN,0.980782198877536
GOMF_ACYLGLYCEROL_O_ACYLTRAN...,SET,24,0.15636,0.0056498,0.18272,0.19609,GOMF_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,0.980782198877536
MIR4433B_3P,SET,28,0.1375,0.0053659,0.1607,0.1961,MIR4433B_3P,0.980782198877536
GOBP_TRNA_MODIFICATION,SET,83,0.072561,0.0048679,0.084817,0.19614,GOBP_TRNA_MODIFICATION,0.980841107913669
HP_WORMIAN_BONES,SET,53,0.097445,0.0052282,0.11394,0.19623,HP_WORMIAN_BONES,0.98115
ZNF354B_TARGET_GENES,SET,161,0.057081,0.005322,0.066758,0.19627,ZNF354B_TARGET_GENES,0.981208839182969
RORA2_01,SET,134,0.063825,0.005433,0.07466,0.19632,RORA2_01,0.981217919655667
GSE39382_IL3_VS_IL3_IL33_TRE...2,SET,182,0.052913,0.0052423,0.061907,0.19636,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_UP,0.981217919655667
HP_AGENESIS_OF_INCISOR,SET,31,0.14392,0.0059091,0.1684,0.19638,HP_AGENESIS_OF_INCISOR,0.981217919655667
HP_ABNORMAL_CORNEAL_EPITHELI...,SET,95,0.073128,0.0052469,0.085575,0.19641,HP_ABNORMAL_CORNEAL_EPITHELIUM_MORPHOLOGY,0.981217919655667
GOBP_DETECTION_OF_MUSCLE_STR...,SET,7,0.29771,0.0058124,0.3484,0.19642,GOBP_DETECTION_OF_MUSCLE_STRETCH,0.981217919655667
REACTOME_REGULATION_OF_ENDOG...4,SET,9,0.23147,0.0051239,0.27097,0.1965,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX,0.981217919655667
GOBP_POSITIVE_REGULATION_OF_...410,SET,24,0.15541,0.0056153,0.18194,0.19652,GOBP_POSITIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,0.981217919655667
FEVR_CTNNB1_TARGETS_DN,SET,504,0.032206,0.0052625,0.037713,0.19657,FEVR_CTNNB1_TARGETS_DN,0.981217919655667
GOBP_PIGMENT_CATABOLIC_PROCE...,SET,11,0.23137,0.0056619,0.27097,0.1966,GOBP_PIGMENT_CATABOLIC_PROCESS,0.981217919655667
GOBP_SPERMIDINE_TRANSPORT,SET,5,0.39255,0.0064775,0.45991,0.19668,GOBP_SPERMIDINE_TRANSPORT,0.981217919655667
GOBP_HOMEOSTATIC_PROCESS,SET,1566,0.019855,0.0055461,0.023262,0.19669,GOBP_HOMEOSTATIC_PROCESS,0.981217919655667
GSE43863_NAIVE_VS_LY6C_LOW_C...1,SET,172,0.053839,0.0051869,0.063082,0.1967,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_DN,0.981217919655667
HP_TRIANGULAR_SHAPED_PHALANG...,SET,7,0.31785,0.0062055,0.37244,0.19672,HP_TRIANGULAR_SHAPED_PHALANGES_OF_THE_HAND,0.981217919655667
KAPOSI_LIVER_CANCER_MET_UP,SET,18,0.15623,0.0048897,0.18308,0.19674,KAPOSI_LIVER_CANCER_MET_UP,0.981217919655667
GOBP_MITOCHONDRIAL_TRANSMEMB...,SET,89,0.073293,0.0050908,0.0859,0.19677,GOBP_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT,0.981217919655667
WU_HBX_TARGETS_2_DN,SET,14,0.20715,0.0057183,0.24279,0.19678,WU_HBX_TARGETS_2_DN,0.981217919655667
WP_PI3KAKTMTOR_VITAMIN_D3_SI...,SET,20,0.17385,0.0057351,0.20376,0.19678,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,0.981217919655667
GSE13522_CTRL_VS_T_CRUZI_Y_S...3,SET,117,0.069367,0.0055201,0.081301,0.19678,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_DN,0.981217919655667
MODULE_71,SET,19,0.18628,0.0059896,0.21841,0.19687,MODULE_71,0.981525871467508
GAVISH_3CA_METAPROGRAM_FIBRO...5,SET,43,0.10114,0.0048891,0.11863,0.19696,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4,0.981833734939759
GSE3720_VD1_VS_VD2_GAMMADELT...4,SET,172,0.054977,0.0052965,0.0645,0.19701,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP,0.98190101089762
PIAS4_TARGET_GENES,SET,49,0.10579,0.0054584,0.12413,0.19703,PIAS4_TARGET_GENES,0.98190101089762
WP_UREA_CYCLE_AND_METABOLISM...,SET,18,0.16283,0.0050962,0.19109,0.19708,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,0.981918427465596
HOLLERN_SQUAMOUS_BREAST_TUMOR,SET,169,0.06198,0.0059194,0.072738,0.19709,HOLLERN_SQUAMOUS_BREAST_TUMOR,0.981918427465596
HP_ASYMMETRIC_SEPTAL_HYPERTR...,SET,13,0.2186,0.0058152,0.2566,0.19713,HP_ASYMMETRIC_SEPTAL_HYPERTROPHY,0.981976945678658
GOBP_POSITIVE_REGULATION_OF_...280,SET,9,0.25553,0.0056565,0.30001,0.19719,GOBP_POSITIVE_REGULATION_OF_FEEDING_BEHAVIOR,0.981987993986254
GOBP_POSITIVE_REGULATION_OF_...387,SET,11,0.23194,0.0056757,0.27236,0.19723,GOBP_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES,0.981987993986254
KEGG_MEDICUS_PATHOGEN_ARSENI...,SET,6,0.23774,0.0042973,0.27919,0.19725,KEGG_MEDICUS_PATHOGEN_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_II,0.981987993986254
THRAP3_TARGET_GENES,SET,19,0.18279,0.0058776,0.21469,0.19727,THRAP3_TARGET_GENES,0.981987993986254
LU_EZH2_TARGETS_UP,SET,253,0.043208,0.0050373,0.050754,0.1973,LU_EZH2_TARGETS_UP,0.981987993986254
DUNNE_TARGETS_OF_AML1_MTG8_F...1,SET,17,0.18142,0.0055181,0.21311,0.19731,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,0.981987993986254
ZHAN_EARLY_DIFFERENTIATION_G...2,SET,7,0.27901,0.0054472,0.32778,0.19733,ZHAN_EARLY_DIFFERENTIATION_GENES_UP,0.981987993986254
GOBP_PROTEIN_KINASE_C_SIGNAL...,SET,35,0.12784,0.0055766,0.15027,0.19746,GOBP_PROTEIN_KINASE_C_SIGNALING,0.982331815582559
GSE360_LOW_DOSE_B_MALAYI_VS_...3,SET,181,0.052692,0.0052062,0.061945,0.19749,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,0.982331815582559
GOBP_LUNG_ALVEOLUS_DEVELOPME...,SET,51,0.10896,0.0057349,0.12812,0.19754,GOBP_LUNG_ALVEOLUS_DEVELOPMENT,0.982331815582559
LU_IL4_SIGNALING,SET,86,0.076876,0.0052494,0.090402,0.19756,LU_IL4_SIGNALING,0.982331815582559
ZHENG_RESPONSE_TO_ARSENITE_DN,SET,11,0.20598,0.0050406,0.24225,0.19759,ZHENG_RESPONSE_TO_ARSENITE_DN,0.982331815582559
HP_MORNING_MYOCLONIC_JERKS,SET,10,0.25638,0.0059822,0.30154,0.1976,HP_MORNING_MYOCLONIC_JERKS,0.982331815582559
MIR6879_5P,SET,99,0.074385,0.0054477,0.087522,0.1977,MIR6879_5P,0.982331815582559
HOEK_PBMC_INACTIVATED_INFLUE...1,SET,8,0.21616,0.0045115,0.25434,0.1977,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_DN,0.982331815582559
GOBP_MEMBRANE_DEPOLARIZATION,SET,85,0.085698,0.0058178,0.10084,0.19771,GOBP_MEMBRANE_DEPOLARIZATION,0.982331815582559
GOCC_BASAL_DENDRITE,SET,6,0.33558,0.0060659,0.39487,0.19771,GOCC_BASAL_DENDRITE,0.982331815582559
HP_STEREOTYPIC_WHOLE_BODY_MO...,SET,8,0.22771,0.0047524,0.26794,0.19771,HP_STEREOTYPIC_WHOLE_BODY_MOVEMENTS,0.982331815582559
KEGG_STEROID_BIOSYNTHESIS,SET,15,0.18208,0.0052027,0.21438,0.19785,KEGG_STEROID_BIOSYNTHESIS,0.982796098327855
HP_HYPOPLASIA_OF_OLFACTORY_T...,SET,8,0.20695,0.0043191,0.24366,0.19786,HP_HYPOPLASIA_OF_OLFACTORY_TRACT,0.982796098327855
PID_NETRIN_PATHWAY,SET,32,0.12993,0.00542,0.153,0.19789,PID_NETRIN_PATHWAY,0.982804651328951
GOBP_NEGATIVE_REGULATION_OF_...621,SET,11,0.22778,0.0055739,0.26827,0.19793,GOBP_NEGATIVE_REGULATION_OF_SYNAPSE_ORGANIZATION,0.982862858979854
DESCARTES_FETAL_CEREBRUM_INH...,SET,32,0.15278,0.006373,0.17999,0.198,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,0.98307
HP_ABNORMAL_CONJUNCTIVA_MORP...,SET,150,0.058289,0.0052473,0.06869,0.19806,HP_ABNORMAL_CONJUNCTIVA_MORPHOLOGY,0.983084135231317
HP_CLINODACTYLY_OF_THE_5TH_T...,SET,13,0.20367,0.005418,0.24005,0.19809,HP_CLINODACTYLY_OF_THE_5TH_TOE,0.983084135231317
GOBP_NEUROGENESIS,SET,1593,0.019677,0.005539,0.023196,0.19815,GOBP_NEUROGENESIS,0.983084135231317
GOBP_NEGATIVE_REGULATION_OF_...377,SET,5,0.37945,0.0062613,0.44736,0.19817,GOBP_NEGATIVE_REGULATION_OF_MAST_CELL_DEGRANULATION,0.983084135231317
GOCC_AZUROPHIL_GRANULE_LUMEN,SET,81,0.080268,0.00532,0.094655,0.19822,GOCC_AZUROPHIL_GRANULE_LUMEN,0.983084135231317
GOMF_CADHERIN_BINDING_INVOLV...,SET,18,0.19351,0.0060565,0.22822,0.19825,GOMF_CADHERIN_BINDING_INVOLVED_IN_CELL_CELL_ADHESION,0.983084135231317
BRUINS_UVC_RESPONSE_MIDDLE,SET,92,0.071214,0.0050287,0.083991,0.19826,BRUINS_UVC_RESPONSE_MIDDLE,0.983084135231317
HP_OVERFRIENDLINESS,SET,23,0.17708,0.0062639,0.20886,0.19827,HP_OVERFRIENDLINESS,0.983084135231317
GOBP_SPINAL_CORD_MOTOR_NEURO...1,SET,9,0.24803,0.0054904,0.29258,0.1983,GOBP_SPINAL_CORD_MOTOR_NEURON_CELL_FATE_SPECIFICATION,0.983084135231317
REACTOME_REGULATION_OF_BETA_...,SET,41,0.11789,0.0055649,0.13907,0.19832,REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT,0.983084135231317
BIOCARTA_FXR_PATHWAY,SET,7,0.28089,0.0054839,0.33138,0.19833,BIOCARTA_FXR_PATHWAY,0.983084135231317
REACTOME_LISTERIA_MONOCYTOGE...,SET,18,0.16839,0.0052701,0.19871,0.19839,REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS,0.983084135231317
HE_LIM_SUN_FETAL_LUNG_C1_PRO...1,SET,176,0.060125,0.0058588,0.070951,0.19839,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_BASAL_CELL,0.983084135231317
GOBP_POSITIVE_REGULATION_OF_...549,SET,59,0.10002,0.005661,0.11803,0.1984,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_DIVISION,0.983084135231317
HP_PILI_TORTI,SET,12,0.22192,0.0056719,0.262,0.1985,HP_PILI_TORTI,0.983084135231317
GSE14415_ACT_VS_CTRL_NATURAL...1,SET,157,0.057753,0.005318,0.068195,0.19854,GSE14415_ACT_VS_CTRL_NATURAL_TREG_DN,0.983084135231317
GOBP_PEPTIDYL_SERINE_AUTOPHO...,SET,8,0.23644,0.0049347,0.27923,0.19857,GOBP_PEPTIDYL_SERINE_AUTOPHOSPHORYLATION,0.983084135231317
GSE17721_PAM3CSK4_VS_GADIQUI...16,SET,179,0.051438,0.0050544,0.060746,0.19857,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_UP,0.983084135231317
NKX61_01,SET,215,0.053177,0.005721,0.062807,0.19859,NKX61_01,0.983084135231317
GOMF_PHOSPHATIDYLINOSITOL_3_...11,SET,4,0.30615,0.0045186,0.3616,0.1986,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_INHIBITOR_ACTIVITY,0.983084135231317
GOBP_ANTIGEN_PROCESSING_AND_...6,SET,36,0.13026,0.0057628,0.15392,0.19869,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN,0.983084135231317
GOBP_ORGANIC_ACID_TRANSMEMBR...,SET,139,0.062572,0.005424,0.073934,0.19869,GOBP_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORT,0.983084135231317
KORKOLA_CORRELATED_WITH_POU5...,SET,25,0.15153,0.0055881,0.17905,0.1987,KORKOLA_CORRELATED_WITH_POU5F1,0.983084135231317
MIR1295B_3P,SET,18,0.1916,0.0059965,0.2264,0.1987,MIR1295B_3P,0.983084135231317
GOMF_CYSTEINE_TYPE_ENDOPEPTI...8,SET,37,0.11832,0.0053064,0.13981,0.19871,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_REGULATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.983084135231317
GOBP_TYPE_II_HYPERSENSITIVITY,SET,8,0.30862,0.0064412,0.36485,0.19881,GOBP_TYPE_II_HYPERSENSITIVITY,0.983438877028181
MOOTHA_ROS,SET,7,0.30314,0.0059183,0.35841,0.19884,MOOTHA_ROS,0.983447303258859
GOBP_CRANIAL_GANGLION_DEVELO...,SET,4,0.39884,0.0058867,0.4718,0.19896,GOBP_CRANIAL_GANGLION_DEVELOPMENT,0.983900796812749
MIR374A_3P,SET,128,0.06505,0.0054128,0.07697,0.19903,MIR374A_3P,0.983983639078498
GOBP_REGULATION_OF_MACROPHAG...6,SET,5,0.346,0.0057095,0.40946,0.19905,GOBP_REGULATION_OF_MACROPHAGE_FUSION,0.983983639078498
GOBP_RESPONSE_TO_MUSCLE_INAC...,SET,9,0.25726,0.0056946,0.30448,0.19909,GOBP_RESPONSE_TO_MUSCLE_INACTIVITY,0.983983639078498
HP_PERIAURICULAR_SKIN_PITS,SET,48,0.11164,0.005701,0.13213,0.19909,HP_PERIAURICULAR_SKIN_PITS,0.983983639078498
GOBP_POSITIVE_REGULATION_OF_...562,SET,472,0.033439,0.0052925,0.039588,0.19915,GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION,0.984000319874893
GOBP_POSITIVE_REGULATION_OF_...673,SET,42,0.12266,0.0058605,0.14522,0.19915,GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,0.984000319874893
MIR548AL,SET,10,0.23826,0.0055593,0.28212,0.19919,MIR548AL,0.984016991188175
REACTOME_CELL_SURFACE_INTERA...,SET,131,0.070228,0.0059113,0.083161,0.19921,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,0.984016991188175
WP_EFFECT_OF_PROGERIN_ON_GEN...,SET,20,0.14772,0.0048733,0.17499,0.19929,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,0.984272268011937
KIM_LIVER_CANCER_POOR_SURVIV...1,SET,41,0.11032,0.0052077,0.13074,0.1994,KIM_LIVER_CANCER_POOR_SURVIVAL_DN,0.984495008508225
GOBP_DNA_DAMAGE_RESPONSE_SIG...1,SET,66,0.089048,0.0053297,0.10556,0.19946,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.984495008508225
GOCC_TRANSCRIPTION_ELONGATIO...,SET,45,0.098235,0.0048576,0.11646,0.19949,GOCC_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX,0.984495008508225
MOROSETTI_FACIOSCAPULOHUMERA...1,SET,12,0.21252,0.0054318,0.252,0.19953,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN,0.984495008508225
GROSS_HYPOXIA_VIA_HIF1A_ONLY,SET,8,0.28181,0.0058817,0.3343,0.19962,GROSS_HYPOXIA_VIA_HIF1A_ONLY,0.984495008508225
WP_TCA_CYCLE_AND_DEFICIENCY_...,SET,15,0.17507,0.0050022,0.20768,0.19963,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,0.984495008508225
GOBP_ELASTIN_METABOLIC_PROCE...,SET,7,0.31649,0.0061789,0.37544,0.19963,GOBP_ELASTIN_METABOLIC_PROCESS,0.984495008508225
GOBP_MAINTENANCE_OF_PROTEIN_...5,SET,7,0.32159,0.0062785,0.38151,0.19963,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_EXTRACELLULAR_REGION,0.984495008508225
WEBER_METHYLATED_HCP_IN_FIBR...1,SET,38,0.1108,0.005036,0.13147,0.19967,WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN,0.984495008508225
MIR4495,SET,435,0.035927,0.0054645,0.042628,0.19967,MIR4495,0.984495008508225
GSE2826_XID_VS_BTK_KO_BCELL_...1,SET,185,0.054022,0.0053957,0.064106,0.1997,GSE2826_XID_VS_BTK_KO_BCELL_DN,0.984495008508225
GOBP_REGULATION_OF_RECEPTOR_...8,SET,100,0.076198,0.0056085,0.090422,0.19971,GOBP_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.984495008508225
GROSS_HYPOXIA_VIA_ELK3_ONLY_...2,SET,30,0.14538,0.0058722,0.17256,0.19976,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,0.984495008508225
MIR4667_3P,SET,117,0.066616,0.0053012,0.079069,0.19976,MIR4667_3P,0.984495008508225
GOBP_POSTSYNAPTIC_DENSITY_PR...,SET,10,0.24253,0.005659,0.28787,0.19976,GOBP_POSTSYNAPTIC_DENSITY_PROTEIN_95_CLUSTERING,0.984495008508225
MEBARKI_HCC_PROGENITOR_WNT_D...1,SET,54,0.10142,0.0054923,0.12042,0.19985,MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD,0.984603868674195
GOMF_LIPID_TRANSFER_ACTIVITY,SET,49,0.10427,0.0053796,0.12383,0.19989,GOMF_LIPID_TRANSFER_ACTIVITY,0.984603868674195
GSE9316_CD4_TCELL_BALBC_VS_T...1,SET,180,0.055787,0.0054969,0.066271,0.19996,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN,0.984603868674195
ZHONG_PFC_C6_DLX5_GAD1_GAD2_...,SET,13,0.21728,0.0057799,0.25814,0.19998,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.984603868674195
HP_SKIN_VESICLE,SET,24,0.1328,0.0047986,0.15779,0.2,HP_SKIN_VESICLE,0.984603868674195
DORSAM_HOXA9_TARGETS_UP,SET,35,0.12423,0.0054194,0.14763,0.20003,DORSAM_HOXA9_TARGETS_UP,0.984603868674195
chr3p25,SET,79,0.18031,0.011803,0.21428,0.20004,chr3p25,0.984603868674195
MIR4713_5P,SET,140,0.06095,0.0053023,0.072463,0.20015,MIR4713_5P,0.984603868674195
HP_EMG_NEUROPATHIC_CHANGES,SET,48,0.098273,0.0050185,0.11686,0.20018,HP_EMG_NEUROPATHIC_CHANGES,0.984603868674195
HP_PROFOUND_HEARING_IMPAIRME...,SET,10,0.24119,0.0056276,0.2868,0.20019,HP_PROFOUND_HEARING_IMPAIRMENT,0.984603868674195
GSE22611_UNSTIM_VS_2H_MDP_ST...2,SET,177,0.052513,0.0051314,0.062444,0.20019,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.984603868674195
GSE14699_NAIVE_VS_ACT_CD8_TC...2,SET,174,0.056324,0.0054574,0.066998,0.20027,GSE14699_NAIVE_VS_ACT_CD8_TCELL_UP,0.984603868674195
GOBP_PROTEIN_RNA_COMPLEX_DIS...,SET,10,0.20579,0.0048017,0.2449,0.20038,GOBP_PROTEIN_RNA_COMPLEX_DISASSEMBLY,0.984603868674195
GOBP_TUBE_LUMEN_CAVITATION,SET,4,0.40229,0.0059376,0.47878,0.20039,GOBP_TUBE_LUMEN_CAVITATION,0.984603868674195
REACTOME_NR1H2_NR1H3_REGULAT...2,SET,9,0.21444,0.004747,0.25525,0.20042,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS,0.984603868674195
LAKE_ADULT_KIDNEY_C17_COLLEC...,SET,225,0.051427,0.0056584,0.061217,0.20044,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.984603868674195
GOMF_PROTEIN_TYROSINE_KINASE...2,SET,140,0.065815,0.0057255,0.07835,0.20046,GOMF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.984603868674195
HE_LIM_SUN_FETAL_LUNG_C5_DEL...,SET,3,0.39016,0.0049872,0.46456,0.2005,HE_LIM_SUN_FETAL_LUNG_C5_DELTA_SMALL_PRE_B_CELL,0.984603868674195
MIR219A_2_3P,SET,64,0.088116,0.0051936,0.10495,0.20056,MIR219A_2_3P,0.984603868674195
OVSYANNIKOVA_PBMC_FLUARIX_AG...3,SET,17,0.1636,0.0049762,0.19484,0.20056,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN,0.984603868674195
MIR6133,SET,169,0.055252,0.0052768,0.065819,0.20061,MIR6133,0.984603868674195
HP_ABNORMAL_LARYNX_PHYSIOLOGY,SET,43,0.10773,0.0052077,0.12834,0.20063,HP_ABNORMAL_LARYNX_PHYSIOLOGY,0.984603868674195
GTTRYCATRR_UNKNOWN,SET,156,0.057382,0.0052671,0.068366,0.20065,GTTRYCATRR_UNKNOWN,0.984603868674195
GSE30971_2H_VS_4H_LPS_STIM_M...1,SET,152,0.060924,0.0055207,0.072591,0.20066,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_DN,0.984603868674195
GSE16385_IL4_VS_ROSIGLITAZON...2,SET,174,0.052693,0.0051056,0.062789,0.20068,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.984603868674195
XU_RESPONSE_TO_TRETINOIN_DN,SET,10,0.2408,0.0056185,0.28697,0.20071,XU_RESPONSE_TO_TRETINOIN_DN,0.984603868674195
PID_INTEGRIN1_PATHWAY,SET,63,0.099905,0.0058425,0.11906,0.20071,PID_INTEGRIN1_PATHWAY,0.984603868674195
GOCC_DYSTROGLYCAN_COMPLEX,SET,7,0.28078,0.0054818,0.33464,0.20072,GOCC_DYSTROGLYCAN_COMPLEX,0.984603868674195
GOBP_INTRACELLULAR_SODIUM_IO...,SET,22,0.17993,0.0062249,0.21445,0.20074,GOBP_INTRACELLULAR_SODIUM_ION_HOMEOSTASIS,0.984603868674195
REACTOME_REACTIONS_SPECIFIC_...,SET,10,0.24136,0.0056316,0.28777,0.20082,REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY,0.984603868674195
REACTOME_RHOU_GTPASE_CYCLE,SET,37,0.11543,0.0051769,0.13763,0.20082,REACTOME_RHOU_GTPASE_CYCLE,0.984603868674195
GSE9946_IMMATURE_VS_LISTERIA...1,SET,112,0.067833,0.0052822,0.080885,0.20084,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_DN,0.984603868674195
TFEB_TARGET_GENES,SET,1068,0.022685,0.0053101,0.027051,0.20085,TFEB_TARGET_GENES,0.984603868674195
GSE25677_MPL_VS_R848_STIM_BC...2,SET,161,0.059463,0.0055441,0.070914,0.20087,GSE25677_MPL_VS_R848_STIM_BCELL_UP,0.984603868674195
MIR4731_3P,SET,203,0.053545,0.0055993,0.063872,0.20093,MIR4731_3P,0.984603868674195
PID_VEGF_VEGFR_PATHWAY,SET,9,0.26713,0.0059133,0.31873,0.20099,PID_VEGF_VEGFR_PATHWAY,0.984603868674195
GOMF_DNA_ENDONUCLEASE_ACTIVI...1,SET,38,0.10968,0.0049849,0.13089,0.20103,GOMF_DNA_ENDONUCLEASE_ACTIVITY,0.984603868674195
GOCC_CHROMOSOMAL_REGION,SET,340,0.037104,0.0050026,0.044284,0.20105,GOCC_CHROMOSOMAL_REGION,0.984603868674195
GOMF_AMMONIUM_TRANSMEMBRANE_...,SET,12,0.2161,0.0055232,0.25791,0.20105,GOMF_AMMONIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.984603868674195
HP_ENTROPION,SET,20,0.14013,0.0046228,0.16727,0.20109,HP_ENTROPION,0.984603868674195
HP_DECREASED_LDL_CHOLESTEROL...,SET,13,0.19442,0.0051719,0.23213,0.20114,HP_DECREASED_LDL_CHOLESTEROL_CONCENTRATION,0.984603868674195
REACTOME_PURINE_SALVAGE,SET,12,0.21496,0.005494,0.25666,0.20116,REACTOME_PURINE_SALVAGE,0.984603868674195
GTCGATC_MIR3695P,SET,4,0.3412,0.0050359,0.40747,0.2012,GTCGATC_MIR3695P,0.984603868674195
GOBP_REGULATION_OF_CARDIAC_M...4,SET,16,0.17332,0.0051147,0.20701,0.20122,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.984603868674195
GOMF_NEDD8_TRANSFERASE_ACTIV...,SET,7,0.23804,0.0046474,0.28433,0.20124,GOMF_NEDD8_TRANSFERASE_ACTIVITY,0.984603868674195
HP_INCREASED_BODY_MASS_INDEX,SET,4,0.37196,0.00549,0.44428,0.20124,HP_INCREASED_BODY_MASS_INDEX,0.984603868674195
GOBP_POSITIVE_REGULATION_OF_...671,SET,20,0.17407,0.0057424,0.20797,0.2013,GOBP_POSITIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION,0.984603868674195
GOMF_BICARBONATE_MONOATOMIC_...,SET,12,0.19899,0.0050858,0.23774,0.2013,GOMF_BICARBONATE_MONOATOMIC_ANION_ANTIPORTER_ACTIVITY,0.984603868674195
GSE40274_FOXP3_VS_FOXP3_AND_...4,SET,183,0.055356,0.0054992,0.066138,0.20131,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.984603868674195
PID_LKB1_PATHWAY,SET,45,0.1071,0.0052962,0.12798,0.20133,PID_LKB1_PATHWAY,0.984603868674195
BIOCARTA_MRP_PATHWAY,SET,6,0.33289,0.0060172,0.39779,0.20134,BIOCARTA_MRP_PATHWAY,0.984603868674195
MODULE_239,SET,109,0.068283,0.0052459,0.081598,0.20135,MODULE_239,0.984603868674195
GOBP_INTEGRATED_STRESS_RESPO...,SET,44,0.10955,0.0053568,0.13094,0.20141,GOBP_INTEGRATED_STRESS_RESPONSE_SIGNALING,0.984603868674195
BUSSLINGER_GASTRIC_CHIEF_CEL...,SET,51,0.10633,0.0055965,0.1271,0.20142,BUSSLINGER_GASTRIC_CHIEF_CELLS,0.984603868674195
WP_COMPLEMENT_ACTIVATION,SET,17,0.19312,0.0058742,0.23086,0.20143,WP_COMPLEMENT_ACTIVATION,0.984603868674195
GSE28726_NAIVE_VS_ACTIVATED_...4,SET,176,0.053136,0.0051777,0.063519,0.20143,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP,0.984603868674195
KRASNOSELSKAYA_ILF3_TARGETS_...1,SET,43,0.10746,0.0051945,0.12847,0.20146,KRASNOSELSKAYA_ILF3_TARGETS_DN,0.984603868674195
HP_DELAYED_BRAINSTEM_AUDITOR...,SET,3,0.45306,0.0057912,0.54203,0.20162,HP_DELAYED_BRAINSTEM_AUDITORY_EVOKED_RESPONSE_CONDUCTION_TIME,0.984603868674195
MIR6732_5P,SET,25,0.14237,0.0052502,0.17033,0.20163,MIR6732_5P,0.984603868674195
MIR4278,SET,31,0.1297,0.0053253,0.15524,0.20172,MIR4278,0.984603868674195
HP_SLOWLY_PROGRESSIVE,SET,141,0.058996,0.0051505,0.070612,0.20172,HP_SLOWLY_PROGRESSIVE,0.984603868674195
GOBP_NEGATIVE_REGULATION_OF_...220,SET,7,0.22717,0.0044351,0.27191,0.20174,GOBP_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.984603868674195
GOBP_PROGESTERONE_BIOSYNTHET...,SET,5,0.30268,0.0049945,0.3623,0.20175,GOBP_PROGESTERONE_BIOSYNTHETIC_PROCESS,0.984603868674195
GOBP_REGULATION_OF_ERYTHROCY...,SET,42,0.10946,0.0052298,0.13103,0.20175,GOBP_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,0.984603868674195
GSE33425_CD161_INT_VS_NEG_CD...1,SET,190,0.052435,0.0053068,0.062779,0.2018,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN,0.984603868674195
MODULE_145,SET,95,0.07559,0.0054236,0.090509,0.20182,MODULE_145,0.984603868674195
GSE10240_IL22_VS_IL22_AND_IL...1,SET,187,0.05129,0.0051502,0.06142,0.20184,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.984603868674195
GOBP_NEGATIVE_REGULATION_OF_...159,SET,5,0.28354,0.0046787,0.33958,0.20187,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.984603868674195
GOBP_PULMONARY_VALVE_MORPHOG...,SET,20,0.18661,0.0061561,0.2235,0.20187,GOBP_PULMONARY_VALVE_MORPHOGENESIS,0.984603868674195
GNF2_TDG,SET,33,0.11119,0.0047099,0.13318,0.2019,GNF2_TDG,0.984603868674195
REACTOME_APOPTOTIC_CLEAVAGE_...2,SET,11,0.24537,0.0060046,0.29394,0.20193,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS,0.984603868674195
GOBP_NUCLEOSIDE_BISPHOSPHATE...1,SET,51,0.098384,0.0051784,0.11787,0.20196,GOBP_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS,0.984603868674195
GOBP_POSITIVE_REGULATION_OF_...95,SET,769,0.027084,0.0054259,0.032449,0.20196,GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY,0.984603868674195
REACTOME_PURINERGIC_SIGNALIN...,SET,23,0.1427,0.0050478,0.17098,0.20198,REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,0.984603868674195
CEBP_Q2,SET,205,0.05124,0.0053843,0.061396,0.20199,CEBP_Q2,0.984603868674195
LOPEZ_MESOTHELIOMA_SURVIVAL_...4,SET,12,0.19834,0.0050694,0.23767,0.202,LOPEZ_MESOTHELIOMA_SURVIVAL_UP,0.984603868674195
HEY2_TARGET_GENES,SET,54,0.097334,0.0052712,0.11664,0.202,HEY2_TARGET_GENES,0.984603868674195
GOBP_DENDRITE_ARBORIZATION,SET,11,0.21338,0.0052217,0.25573,0.20204,GOBP_DENDRITE_ARBORIZATION,0.984603868674195
GOBP_POSITIVE_REGULATION_OF_...214,SET,16,0.1672,0.0049341,0.20046,0.20211,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.984603868674195
BRUNEAU_SEPTATION_ATRIAL,SET,5,0.36333,0.0059954,0.43567,0.20216,BRUNEAU_SEPTATION_ATRIAL,0.984603868674195
HP_SPONTANEOUS_HEMATOMAS,SET,18,0.19858,0.0062149,0.23812,0.20217,HP_SPONTANEOUS_HEMATOMAS,0.984603868674195
GOMF_HISTONE_DEUBIQUITINASE_...,SET,7,0.20104,0.0039249,0.2411,0.2022,GOMF_HISTONE_DEUBIQUITINASE_ACTIVITY,0.984603868674195
HP_INCREASED_MEAN_CORPUSCULA...,SET,11,0.189,0.0046251,0.22667,0.2022,HP_INCREASED_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,0.984603868674195
GOBP_CALCIUM_ION_REGULATED_E...1,SET,62,0.091725,0.0053215,0.11002,0.20222,GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS,0.984603868674195
DACOSTA_LOW_DOSE_UV_RESPONSE...2,SET,11,0.22742,0.0055651,0.27278,0.20223,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP,0.984603868674195
HP_DELAYED_ABILITY_TO_CRAWL,SET,8,0.20744,0.0043295,0.24882,0.20223,HP_DELAYED_ABILITY_TO_CRAWL,0.984603868674195
FERRARI_RESPONSE_TO_FENRETIN...2,SET,20,0.18481,0.0060965,0.22175,0.20231,FERRARI_RESPONSE_TO_FENRETINIDE_UP,0.984603868674195
GOBP_NEGATIVE_REGULATION_OF_...46,SET,24,0.14888,0.0053797,0.17865,0.20231,GOBP_NEGATIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.984603868674195
MIR4707_5P,SET,9,0.23162,0.0051273,0.27795,0.20233,MIR4707_5P,0.984603868674195
HP_ABNORMALITY_OF_AMINO_ACID...,SET,7,0.2577,0.0050311,0.30926,0.20235,HP_ABNORMALITY_OF_AMINO_ACID_METABOLISM,0.984603868674195
GOMF_OXIDOREDUCTASE_ACTIVITY...8,SET,5,0.27466,0.0045321,0.32968,0.2024,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS_DISULFIDE_AS_ACCEPTOR,0.984603868674195
HP_ABNORMAL_BRANCHING_PATTER...,SET,26,0.13891,0.0052238,0.16674,0.20241,HP_ABNORMAL_BRANCHING_PATTERN_OF_THE_AORTIC_ARCH,0.984603868674195
GOBP_REGULATION_OF_BRANCHING...3,SET,9,0.2417,0.0053504,0.29016,0.20243,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,0.984603868674195
BROWNE_HCMV_INFECTION_24HR_DN,SET,131,0.062271,0.0052415,0.074768,0.20247,BROWNE_HCMV_INFECTION_24HR_DN,0.984603868674195
GSE26343_UNSTIM_VS_LPS_STIM_...3,SET,186,0.054124,0.0054203,0.06502,0.20259,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN,0.984603868674195
HP_ABNORMALITY_OF_THE_METOPI...,SET,80,0.078175,0.0051494,0.093916,0.2026,HP_ABNORMALITY_OF_THE_METOPIC_SUTURE,0.984603868674195
GOBP_B_CELL_RECEPTOR_SIGNALI...,SET,58,0.097247,0.0054575,0.11684,0.20261,GOBP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.984603868674195
GSE36888_UNTREATED_VS_IL2_TR...8,SET,169,0.054345,0.0051902,0.065294,0.20262,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP,0.984603868674195
LINDSTEDT_DENDRITIC_CELL_MAT...4,SET,60,0.095785,0.005467,0.11509,0.20263,LINDSTEDT_DENDRITIC_CELL_MATURATION_D,0.984603868674195
GOBP_CYTOSOL_TO_ENDOPLASMIC_...,SET,4,0.32832,0.0048458,0.39452,0.20265,GOBP_CYTOSOL_TO_ENDOPLASMIC_RETICULUM_TRANSPORT,0.984603868674195
GSE36078_UNTREATED_VS_AD5_IN...4,SET,185,0.053941,0.0053875,0.064822,0.20267,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP,0.984603868674195
GSE37416_CTRL_VS_3H_F_TULARE...2,SET,168,0.051637,0.0049171,0.062062,0.2027,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.984603868674195
BIOCARTA_MHC_PATHWAY,SET,10,0.27276,0.0063643,0.32795,0.20279,BIOCARTA_MHC_PATHWAY,0.984603868674195
GSE360_DC_VS_MAC_DN,SET,171,0.054092,0.0051962,0.065042,0.20281,GSE360_DC_VS_MAC_DN,0.984603868674195
LUND_SILENCED_BY_METHYLATION,SET,14,0.17937,0.0049516,0.2157,0.20282,LUND_SILENCED_BY_METHYLATION,0.984603868674195
HNF4_01_B,SET,233,0.044644,0.0049975,0.053689,0.20284,HNF4_01_B,0.984603868674195
GOBP_REGULATION_OF_NEUTROPHI...2,SET,29,0.14871,0.005906,0.17886,0.20286,GOBP_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS,0.984603868674195
HP_PROLONGED_BLEEDING_AFTER_...2,SET,16,0.20688,0.0061048,0.24886,0.20291,HP_PROLONGED_BLEEDING_AFTER_SURGERY,0.984603868674195
GOCC_CHECKPOINT_CLAMP_COMPLEX,SET,5,0.31236,0.0051543,0.37581,0.20295,GOCC_CHECKPOINT_CLAMP_COMPLEX,0.984603868674195
ZFP36L1_TARGET_GENES,SET,47,0.10317,0.0052136,0.12413,0.20296,ZFP36L1_TARGET_GENES,0.984603868674195
BAKKER_FOXO3_TARGETS_UP,SET,51,0.099892,0.0052577,0.1202,0.20299,BAKKER_FOXO3_TARGETS_UP,0.984603868674195
GSE3039_CD4_TCELL_VS_NKT_CEL...1,SET,180,0.04991,0.0049178,0.060062,0.203,GSE3039_CD4_TCELL_VS_NKT_CELL_DN,0.984603868674195
GOBP_MONOATOMIC_ION_TRANSMEM...,SET,904,0.025535,0.0055252,0.030731,0.20301,GOBP_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.984603868674195
CEBP_Q3,SET,218,0.051827,0.0056141,0.062379,0.20304,CEBP_Q3,0.984603868674195
REACTOME_BIOLOGICAL_OXIDATIO...,SET,204,0.057838,0.006063,0.069622,0.20306,REACTOME_BIOLOGICAL_OXIDATIONS,0.984603868674195
CEBPE_TARGET_GENES,SET,25,0.16906,0.0062344,0.20355,0.20312,CEBPE_TARGET_GENES,0.984603868674195
GSE37532_VISCERAL_ADIPOSE_TI...2,SET,148,0.055717,0.0049825,0.067087,0.20313,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_UP,0.984603868674195
GSE29949_DC_BRAIN_VS_MONOCYT...2,SET,176,0.052431,0.005109,0.063132,0.20314,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.984603868674195
GOBP_PLATELET_DENSE_GRANULE_...,SET,24,0.14665,0.005299,0.1766,0.20316,GOBP_PLATELET_DENSE_GRANULE_ORGANIZATION,0.984603868674195
SIRT3_TARGET_GENES,SET,38,0.10989,0.0049944,0.13236,0.2032,SIRT3_TARGET_GENES,0.984603868674195
REACTOME_AMPK_INHIBITS_CHREB...,SET,8,0.26378,0.0055052,0.31772,0.20321,REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY,0.984603868674195
HP_BROAD_CLAVICLES,SET,10,0.24047,0.0056109,0.28971,0.20327,HP_BROAD_CLAVICLES,0.984757297184277
REACTOME_DEFECTIVE_F9_ACTIVA...,SET,5,0.38182,0.0063004,0.46023,0.20338,REACTOME_DEFECTIVE_F9_ACTIVATION,0.984805675487465
GSE17974_IL4_AND_ANTI_IL12_V...4,SET,167,0.056234,0.005339,0.067784,0.20339,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP,0.984805675487465
GOBP_POSITIVE_REGULATION_OF_...248,SET,140,0.063651,0.0055372,0.07673,0.2034,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,0.984805675487465
HP_DISTAL_RENAL_TUBULAR_ACID...,SET,6,0.30082,0.0054374,0.36262,0.2034,HP_DISTAL_RENAL_TUBULAR_ACIDOSIS,0.984805675487465
MIR4778_3P,SET,230,0.049492,0.0055048,0.05967,0.20344,MIR4778_3P,0.984805675487465
HP_GLOMUS_JUGULAR_TUMOR,SET,5,0.25949,0.0042818,0.31286,0.20345,HP_GLOMUS_JUGULAR_TUMOR,0.984805675487465
GOBP_ACTIN_MEDIATED_CELL_CON...,SET,106,0.072654,0.0055048,0.087632,0.20353,GOBP_ACTIN_MEDIATED_CELL_CONTRACTION,0.984918567251462
GOCC_MICROTUBULE_MINUS_END,SET,6,0.37854,0.0068423,0.45656,0.20353,GOCC_MICROTUBULE_MINUS_END,0.984918567251462
HP_POSTERIOR_BLEPHARITIS,SET,5,0.28676,0.0047318,0.34592,0.20357,HP_POSTERIOR_BLEPHARITIS,0.98497498955868
REACTOME_DEPOSITION_OF_NEW_C...,SET,23,0.14559,0.0051502,0.1757,0.20366,REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE,0.985071181375956
REACTOME_P38MAPK_EVENTS,SET,13,0.21175,0.005633,0.25559,0.2037,REACTOME_P38MAPK_EVENTS,0.985071181375956
GOBP_BLOOD_VESSEL_MATURATION,SET,8,0.26361,0.0055017,0.3182,0.20372,GOBP_BLOOD_VESSEL_MATURATION,0.985071181375956
HP_DECREASED_CIRCULATING_CER...,SET,8,0.25117,0.0052421,0.30327,0.20378,HP_DECREASED_CIRCULATING_CERULOPLASMIN_CONCENTRATION,0.985071181375956
LI_PBMC_MENACTRA_AGE_18_45YO...5,SET,30,0.1366,0.0055175,0.16494,0.2038,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP,0.985071181375956
PID_CIRCADIAN_PATHWAY,SET,13,0.20514,0.0054571,0.24774,0.20382,PID_CIRCADIAN_PATHWAY,0.985071181375956
HP_ABNORMAL_CIRCULATING_CALC...,SET,46,0.10423,0.0052108,0.12587,0.20383,HP_ABNORMAL_CIRCULATING_CALCIUM_PHOSPHATE_REGULATING_HORMONE_CONCENTRATION,0.985071181375956
GOBP_HYDROGEN_PEROXIDE_BIOSY...,SET,14,0.20656,0.005702,0.24949,0.20386,GOBP_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS,0.985071181375956
MIKKELSEN_ES_LCP_WITH_H3K4ME...,SET,7,0.27303,0.0053305,0.32979,0.20387,MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3,0.985071181375956
YAGI_AML_RELAPSE_PROGNOSIS,SET,33,0.12904,0.0054661,0.15589,0.20391,YAGI_AML_RELAPSE_PROGNOSIS,0.985071181375956
HP_ABNORMAL_PLATELET_VOLUME,SET,25,0.14164,0.0052232,0.17112,0.20393,HP_ABNORMAL_PLATELET_VOLUME,0.985071181375956
HP_SLOW_DECREASE_IN_VISUAL_A...,SET,24,0.13719,0.0049571,0.16575,0.20393,HP_SLOW_DECREASE_IN_VISUAL_ACUITY,0.985071181375956
BIOCARTA_ASBCELL_PATHWAY,SET,10,0.25079,0.0058517,0.30306,0.20398,BIOCARTA_ASBCELL_PATHWAY,0.985175778210117
GOBP_NEGATIVE_REGULATION_OF_...412,SET,20,0.13987,0.0046141,0.16905,0.20401,GOBP_NEGATIVE_REGULATION_OF_MRNA_PROCESSING,0.985183764068362
MIR2278,SET,95,0.071255,0.0051126,0.086148,0.20409,MIR2278,0.985424635568513
HP_NEONATAL_HYPOTONIA,SET,169,0.053689,0.0051275,0.064929,0.20416,HP_NEONATAL_HYPOTONIA,0.985424635568513
GOBP_CELLULAR_MODIFIED_AMINO...3,SET,175,0.053182,0.0051677,0.064326,0.20419,GOBP_CELLULAR_MODIFIED_AMINO_ACID_METABOLIC_PROCESS,0.985424635568513
LIAO_METASTASIS,SET,476,0.032153,0.0051099,0.038893,0.2042,LIAO_METASTASIS,0.985424635568513
GOBP_NEPHRON_MORPHOGENESIS,SET,75,0.089087,0.0056826,0.10776,0.20421,GOBP_NEPHRON_MORPHOGENESIS,0.985424635568513
GOBP_NEUROTRANSMITTER_RECEPT...6,SET,15,0.1886,0.0053889,0.22816,0.20423,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_TO_PLASMA_MEMBRANE,0.985424635568513
GSE14769_UNSTIM_VS_20MIN_LPS...1,SET,183,0.05219,0.0051848,0.063144,0.20426,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN,0.98543257912271
MIR8076,SET,116,0.062914,0.0049853,0.076152,0.20436,MIR8076,0.985689612822648
GOBP_REGULATION_OF_ENDOTHELI...4,SET,153,0.0599,0.0054456,0.072506,0.20437,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,0.985689612822648
GSE42021_CD24HI_VS_CD24LOW_T...4,SET,171,0.052891,0.0050808,0.064042,0.20444,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_UP,0.985809737827715
GOMF_INOSITOL_1_4_5_TRISPHOS...1,SET,6,0.24856,0.0044929,0.30102,0.20448,GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.985809737827715
GSE43260_BTLA_POS_VS_NEG_INT...1,SET,173,0.053332,0.0051528,0.064586,0.20448,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN,0.985809737827715
GSE26495_NAIVE_VS_PD1HIGH_CD...2,SET,151,0.059596,0.0053827,0.072186,0.20453,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP,0.985897310784586
KEGG_MEDICUS_REFERENCE_BILE_...,SET,14,0.19515,0.005387,0.23641,0.20457,KEGG_MEDICUS_REFERENCE_BILE_ACID_BIOSYNTHESIS,0.985897310784586
HOFFMAN_CLOCK_TARGETS_DN,SET,10,0.20933,0.0048842,0.25362,0.20459,HOFFMAN_CLOCK_TARGETS_DN,0.985897310784586
GOCC_ANCHORING_JUNCTION,SET,837,0.025426,0.005304,0.030812,0.20463,GOCC_ANCHORING_JUNCTION,0.985897310784586
HP_TYPE_II_LISSENCEPHALY,SET,12,0.1994,0.0050965,0.24165,0.20464,HP_TYPE_II_LISSENCEPHALY,0.985897310784586
GOBP_POSITIVE_REGULATION_OF_...692,SET,9,0.27293,0.0060416,0.33086,0.20472,GOBP_POSITIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.985936618645242
PLASARI_TGFB1_TARGETS_1HR_DN,SET,4,0.4089,0.0060352,0.49573,0.20473,PLASARI_TGFB1_TARGETS_1HR_DN,0.985936618645242
GAUSSMANN_MLL_AF4_FUSION_TAR...1,SET,90,0.079841,0.0055765,0.096798,0.20474,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,0.985936618645242
GOBP_PEPTIDE_BIOSYNTHETIC_PR...,SET,25,0.15432,0.0056909,0.18713,0.20479,GOBP_PEPTIDE_BIOSYNTHETIC_PROCESS,0.985936618645242
GOBP_TOLERANCE_INDUCTION,SET,27,0.15111,0.0057909,0.18324,0.20479,GOBP_TOLERANCE_INDUCTION,0.985936618645242
HP_RECURRENT_STAPHYLOCOCCAL_...,SET,32,0.12946,0.0054004,0.15706,0.2049,HP_RECURRENT_STAPHYLOCOCCAL_INFECTIONS,0.986170130944176
GOBP_RESPONSE_TO_INTERLEUKIN...6,SET,12,0.22982,0.0058739,0.27886,0.20494,GOBP_RESPONSE_TO_INTERLEUKIN_18,0.986170130944176
GSE27786_LSK_VS_CD4_TCELL_DN,SET,177,0.052879,0.0051672,0.064168,0.20496,GSE27786_LSK_VS_CD4_TCELL_DN,0.986170130944176
GOMF_EXTRACELLULAR_MATRIX_BI...,SET,60,0.096199,0.0054907,0.11676,0.205,GOMF_EXTRACELLULAR_MATRIX_BINDING,0.986170130944176
GOBP_DEHYDROASCORBIC_ACID_TR...,SET,7,0.24644,0.0048112,0.29913,0.20502,GOBP_DEHYDROASCORBIC_ACID_TRANSPORT,0.986170130944176
GOCC_RNA_POLYMERASE_II_HOLOE...,SET,67,0.076557,0.0046166,0.09293,0.20503,GOCC_RNA_POLYMERASE_II_HOLOENZYME,0.986170130944176
HP_PELVIC_GIRDLE_AMYOTROPHY,SET,3,0.30726,0.0039275,0.37311,0.20512,HP_PELVIC_GIRDLE_AMYOTROPHY,0.986170130944176
GOMF_PEROXIREDOXIN_ACTIVITY,SET,6,0.25642,0.0046349,0.31142,0.20515,GOMF_PEROXIREDOXIN_ACTIVITY,0.986170130944176
MODULE_65,SET,7,0.26541,0.0051817,0.32238,0.20518,MODULE_65,0.986170130944176
GOBP_REGULATION_OF_TOLERANCE...,SET,17,0.19095,0.005808,0.23195,0.20519,GOBP_REGULATION_OF_TOLERANCE_INDUCTION,0.986170130944176
KEGG_MEDICUS_VARIANT_DELETED...,SET,9,0.23475,0.0051964,0.28516,0.2052,KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX,0.986170130944176
SCHRAETS_MLL_TARGETS_DN,SET,32,0.13882,0.0057907,0.16866,0.20523,SCHRAETS_MLL_TARGETS_DN,0.986170130944176
GOBP_SIGNAL_TRANSDUCTION_BY_...,SET,158,0.055655,0.0051409,0.067622,0.20525,GOBP_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.986170130944176
ICHIBA_GRAFT_VERSUS_HOST_DIS...3,SET,41,0.11544,0.0054494,0.14029,0.2053,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN,0.986170130944176
MIR655_5P,SET,75,0.08569,0.0054659,0.10414,0.2053,MIR655_5P,0.986170130944176
GOBP_PENETRATION_OF_ZONA_PEL...,SET,9,0.24228,0.0053631,0.2946,0.20543,GOBP_PENETRATION_OF_ZONA_PELLUCIDA,0.986170130944176
HP_HYPOGONADOTROPIC_HYPOGONA...,SET,146,0.058606,0.0052056,0.071264,0.20544,HP_HYPOGONADOTROPIC_HYPOGONADISM,0.986170130944176
HP_ABNORMAL_ERYTHROCYTE_PHYS...,SET,15,0.18574,0.0053073,0.2259,0.20548,HP_ABNORMAL_ERYTHROCYTE_PHYSIOLOGY,0.986170130944176
GSE46606_DAY1_VS_DAY3_CD40L_...6,SET,176,0.053918,0.005254,0.065594,0.20554,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP,0.986170130944176
GSE27786_BCELL_VS_NKCELL_DN,SET,183,0.051201,0.0050865,0.06229,0.20555,GSE27786_BCELL_VS_NKCELL_DN,0.986170130944176
GOMF_CHROMO_SHADOW_DOMAIN_BI...,SET,5,0.27227,0.0044928,0.33127,0.20557,GOMF_CHROMO_SHADOW_DOMAIN_BINDING,0.986170130944176
HP_LICHENIFICATION,SET,15,0.1789,0.0051117,0.21768,0.20558,HP_LICHENIFICATION,0.986170130944176
MIR1267,SET,70,0.084704,0.0052205,0.10307,0.20559,MIR1267,0.986170130944176
GSE22935_UNSTIM_VS_24H_MBOVI...4,SET,191,0.049414,0.005014,0.060126,0.20559,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.986170130944176
GOBP_SYNAPTIC_ASSEMBLY_AT_NE...,SET,8,0.28072,0.0058589,0.34161,0.20561,GOBP_SYNAPTIC_ASSEMBLY_AT_NEUROMUSCULAR_JUNCTION,0.986170130944176
GOBP_INDUCTION_OF_BACTERIAL_...,SET,5,0.38721,0.0063894,0.47128,0.20565,GOBP_INDUCTION_OF_BACTERIAL_AGGLUTINATION,0.986170130944176
GOCC_MLL1_2_COMPLEX,SET,29,0.11355,0.0045093,0.1382,0.20565,GOCC_MLL1_2_COMPLEX,0.986170130944176
HP_DIFFICULTY_RUNNING,SET,47,0.10288,0.0051987,0.12523,0.2057,HP_DIFFICULTY_RUNNING,0.986170130944176
HOWARD_DENDRITIC_CELL_INACT_...1,SET,39,0.11892,0.0054752,0.14481,0.20577,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.986170130944176
REACTOME_PREVENTION_OF_PHAGO...,SET,8,0.25272,0.0052744,0.30775,0.20578,REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION,0.986170130944176
MIR4718,SET,97,0.077959,0.0056518,0.094949,0.20581,MIR4718,0.986170130944176
GOBP_LYMPHOCYTE_ACTIVATION_I...,SET,192,0.053255,0.0054177,0.064859,0.20581,GOBP_LYMPHOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.986170130944176
GSE14000_4H_VS_16H_LPS_DC_TR...2,SET,170,0.054969,0.0052651,0.06695,0.20582,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP,0.986170130944176
GOBP_HEMATOPOIETIC_STEM_CELL...5,SET,31,0.12696,0.0052128,0.15464,0.20583,GOBP_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,0.986170130944176
GOBP_POSITIVE_REGULATION_OF_...821,SET,12,0.22075,0.0056421,0.2689,0.20584,GOBP_POSITIVE_REGULATION_OF_URINE_VOLUME,0.986170130944176
GSE6259_33D1_POS_VS_DEC205_P...1,SET,156,0.057231,0.0052532,0.069719,0.20586,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_DN,0.986170130944176
HP_ABSENT_EYEBROW,SET,31,0.13875,0.0056968,0.16906,0.20591,HP_ABSENT_EYEBROW,0.986273711411246
GOBP_ATRIAL_CARDIAC_MUSCLE_T...1,SET,20,0.1824,0.0060172,0.22231,0.20597,GOBP_ATRIAL_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,0.986425155022737
GSE43955_TGFB_IL6_VS_TGFB_IL...2,SET,185,0.049474,0.0049414,0.060321,0.20606,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,0.986720212179664
GSE18791_CTRL_VS_NEWCASTLE_V...14,SET,165,0.053616,0.0050602,0.065417,0.20623,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP,0.987362235772358
HP_DISTICHIASIS,SET,8,0.24407,0.0050938,0.29798,0.20638,HP_DISTICHIASIS,0.987362235772358
ERWIN_COHEN_PBMC_TC_83_AGE_1...4,SET,31,0.14346,0.0058903,0.17516,0.20639,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,0.987362235772358
MIR12131,SET,154,0.057149,0.0052123,0.069783,0.20641,MIR12131,0.987362235772358
GOBP_REGULATION_OF_GTPASE_AC...,SET,245,0.047847,0.0054904,0.058431,0.20644,GOBP_REGULATION_OF_GTPASE_ACTIVITY,0.987362235772358
GSE17186_NAIVE_VS_CD21LOW_TR...2,SET,175,0.051171,0.0049723,0.06249,0.20644,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP,0.987362235772358
HP_ABNORMALITY_OF_EXOCRINE_P...,SET,66,0.086449,0.0051741,0.1056,0.2065,HP_ABNORMALITY_OF_EXOCRINE_PANCREAS_PHYSIOLOGY,0.987362235772358
GOBP_SERINE_TRANSPORT,SET,9,0.22922,0.005074,0.28008,0.20656,GOBP_SERINE_TRANSPORT,0.987362235772358
WP_MITOCHONDRIAL_COMPLEX_III...,SET,15,0.16005,0.0045731,0.19559,0.2066,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,0.987362235772358
GOBP_RELAXATION_OF_CARDIAC_M...,SET,17,0.17879,0.0054381,0.2185,0.20662,GOBP_RELAXATION_OF_CARDIAC_MUSCLE,0.987362235772358
GOBP_REGULATION_OF_NON_CANON...2,SET,26,0.14187,0.0053352,0.17339,0.20663,GOBP_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.987362235772358
REACTOME_INTERLEUKIN_27_SIGN...,SET,11,0.22354,0.0054703,0.27325,0.20666,REACTOME_INTERLEUKIN_27_SIGNALING,0.987362235772358
MIR122_5P,SET,82,0.073875,0.0049263,0.090313,0.20669,MIR122_5P,0.987362235772358
GOCC_CUL2_RING_UBIQUITIN_LIG...,SET,20,0.15648,0.0051622,0.1913,0.20669,GOCC_CUL2_RING_UBIQUITIN_LIGASE_COMPLEX,0.987362235772358
MIR4769_5P,SET,39,0.10925,0.0050302,0.13357,0.2067,MIR4769_5P,0.987362235772358
AP2REP_01,SET,156,0.057509,0.0052788,0.070329,0.20676,AP2REP_01,0.987362235772358
KEGG_MEDICUS_ENV_FACTOR_PHIP...,SET,3,0.44674,0.0057104,0.54642,0.20681,KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS,0.987362235772358
GOBP_RESPONSE_TO_OXYGEN_GLUC...,SET,9,0.22675,0.0050193,0.27739,0.20685,GOBP_RESPONSE_TO_OXYGEN_GLUCOSE_DEPRIVATION,0.987362235772358
GOBP_NEGATIVE_REGULATION_OF_...542,SET,63,0.089916,0.0052583,0.11001,0.20688,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_UBIQUITINATION,0.987362235772358
HP_ABNORMAL_CIRCULATING_ORNI...,SET,5,0.29309,0.0048363,0.35868,0.20693,HP_ABNORMAL_CIRCULATING_ORNITHINE_CONCENTRATION,0.987362235772358
HP_FEMALE_HYPOGONADISM,SET,28,0.13406,0.0052316,0.16406,0.20693,HP_FEMALE_HYPOGONADISM,0.987362235772358
GOCC_MICROTUBULE_ORGANIZING_...2,SET,10,0.21552,0.0050287,0.26377,0.20695,GOCC_MICROTUBULE_ORGANIZING_CENTER_ATTACHMENT_SITE,0.987362235772358
HP_ATLANTOAXIAL_INSTABILITY,SET,5,0.30698,0.0050654,0.37573,0.20696,HP_ATLANTOAXIAL_INSTABILITY,0.987362235772358
GOBP_CELL_REDOX_HOMEOSTASIS,SET,34,0.12003,0.005161,0.14693,0.20698,GOBP_CELL_REDOX_HOMEOSTASIS,0.987362235772358
GOBP_GLUTATHIONE_METABOLIC_P...,SET,46,0.10964,0.0054812,0.1342,0.20698,GOBP_GLUTATHIONE_METABOLIC_PROCESS,0.987362235772358
GOBP_SULFUR_COMPOUND_METABOL...,SET,291,0.042348,0.0052892,0.051855,0.20707,GOBP_SULFUR_COMPOUND_METABOLIC_PROCESS,0.987362235772358
HOLLEMAN_ASPARAGINASE_RESIST...1,SET,22,0.12721,0.0044011,0.15579,0.20709,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN,0.987362235772358
MIR6871_5P,SET,51,0.11042,0.005812,0.13524,0.20711,MIR6871_5P,0.987362235772358
REACTOME_RSV_HOST_INTERACTIO...,SET,84,0.077166,0.0052078,0.094536,0.20718,REACTOME_RSV_HOST_INTERACTIONS,0.987362235772358
GOMF_NUCLEOSOME_BINDING,SET,52,0.092084,0.0048939,0.11283,0.20721,GOMF_NUCLEOSOME_BINDING,0.987362235772358
GOBP_REGULATION_OF_ALCOHOL_B...,SET,44,0.10912,0.0053357,0.13371,0.20724,GOBP_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,0.987362235772358
GOBP_NEGATIVE_REGULATION_OF_...708,SET,69,0.08905,0.0054491,0.10913,0.20726,GOBP_NEGATIVE_REGULATION_OF_WOUND_HEALING,0.987362235772358
GOBP_POSITIVE_REGULATION_OF_...508,SET,19,0.14828,0.0047678,0.18173,0.20728,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.987362235772358
GOCC_MITOTIC_SPINDLE,SET,167,0.050478,0.0047925,0.061895,0.20739,GOCC_MITOTIC_SPINDLE,0.987362235772358
HP_GASTROINTESTINAL_ULCER,SET,46,0.10991,0.0054951,0.13478,0.20739,HP_GASTROINTESTINAL_ULCER,0.987362235772358
HP_PAINLESS_FRACTURES_DUE_TO...,SET,7,0.24521,0.0047872,0.30073,0.20744,HP_PAINLESS_FRACTURES_DUE_TO_INJURY,0.987362235772358
GOBP_OPTIC_NERVE_MORPHOGENES...,SET,6,0.3226,0.0058312,0.39576,0.2075,GOBP_OPTIC_NERVE_MORPHOGENESIS,0.987362235772358
KEGG_MEDICUS_VARIANT_MUTATIO...46,SET,7,0.31716,0.0061921,0.3891,0.20751,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_REST_MEDIATED_TRANSCRIPTIONAL_REPRESSION,0.987362235772358
KEGG_MEDICUS_VARIANT_AML1_ET...,SET,5,0.27833,0.0045928,0.3415,0.20753,KEGG_MEDICUS_VARIANT_AML1_ETO_FUSION_TO_PU.1_MEDIATED_TRANSCRIPTION,0.987362235772358
GOMF_TRANSCRIPTION_FACTOR_BI...,SET,553,0.030219,0.0051653,0.037078,0.20753,GOMF_TRANSCRIPTION_FACTOR_BINDING,0.987362235772358
HP_INTELLECTUAL_DISABILITY_P...2,SET,31,0.11097,0.0045563,0.13616,0.20754,HP_INTELLECTUAL_DISABILITY_PROGRESSIVE,0.987362235772358
MIR3928_5P,SET,94,0.071982,0.0051376,0.08833,0.20757,MIR3928_5P,0.987362235772358
GSE339_EX_VIVO_VS_IN_CULTURE...3,SET,180,0.052004,0.0051241,0.063816,0.20757,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN,0.987362235772358
GOBP_POSITIVE_REGULATION_OF_...12,SET,116,0.067937,0.0053832,0.083374,0.20759,GOBP_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,0.987362235772358
HP_ABNORMALITY_OF_THE_HYPOTH...2,SET,7,0.27055,0.0052821,0.33208,0.20762,HP_ABNORMALITY_OF_THE_HYPOTHENAR_EMINENCE,0.987362235772358
GOBP_NEGATIVE_REGULATION_OF_...501,SET,75,0.082715,0.0052761,0.10153,0.20763,GOBP_NEGATIVE_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.987362235772358
GOMF_ACIDIC_AMINO_ACID_TRANS...,SET,18,0.17134,0.0053625,0.21032,0.20764,GOMF_ACIDIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.987362235772358
CERVERA_SDHB_TARGETS_1_DN,SET,34,0.12633,0.0054317,0.15512,0.20771,CERVERA_SDHB_TARGETS_1_DN,0.987362235772358
MODULE_226,SET,27,0.12583,0.0048219,0.1545,0.20772,MODULE_226,0.987362235772358
HP_CEREBELLAR_CORTICAL_ATROP...,SET,5,0.30916,0.0051015,0.37964,0.20773,HP_CEREBELLAR_CORTICAL_ATROPHY,0.987362235772358
GOMF_L_GLUTAMATE_TRANSMEMBRA...,SET,14,0.19108,0.0052747,0.23469,0.20778,GOMF_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.987362235772358
CREB3_TARGET_GENES,SET,388,0.035142,0.0050547,0.043175,0.20784,CREB3_TARGET_GENES,0.987362235772358
BUSSLINGER_GASTRIC_OXYNTIC_E...,SET,74,0.088463,0.0056052,0.10869,0.20786,BUSSLINGER_GASTRIC_OXYNTIC_ENTEROCHROMAFFIN_LIKE_CELLS,0.987362235772358
GOBP_REGULATION_OF_SKELETAL_...12,SET,7,0.26573,0.0051879,0.3265,0.20787,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION,0.987362235772358
HP_PERIPAPILLARY_CHORIORETIN...,SET,5,0.34053,0.0056191,0.41841,0.20787,HP_PERIPAPILLARY_CHORIORETINAL_ATROPHY,0.987362235772358
GCGCCTT_MIR525_MIR524,SET,15,0.17326,0.0049506,0.21291,0.20789,GCGCCTT_MIR525_MIR524,0.987362235772358
GOCC_ENDOLYSOSOME_MEMBRANE,SET,17,0.16883,0.0051353,0.20747,0.2079,GOCC_ENDOLYSOSOME_MEMBRANE,0.987362235772358
GOBP_REGULATION_OF_MEMBRANE_...2,SET,5,0.36103,0.0059575,0.44374,0.20794,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL,0.987362235772358
HAHTOLA_CTCL_PATHOGENESIS,SET,15,0.19191,0.0054834,0.23592,0.20798,HAHTOLA_CTCL_PATHOGENESIS,0.987362235772358
GOBP_POSITIVE_REGULATION_OF_...526,SET,226,0.048521,0.0053503,0.059677,0.2081,GOBP_POSITIVE_REGULATION_OF_NEUROGENESIS,0.987362235772358
LEI_MYB_TARGETS,SET,297,0.041398,0.0052228,0.050922,0.20813,LEI_MYB_TARGETS,0.987362235772358
KEGG_MEDICUS_REFERENCE_WNT_S...5,SET,44,0.11172,0.0054631,0.13744,0.20814,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY,0.987362235772358
MIR8059,SET,55,0.09322,0.0050948,0.11468,0.20814,MIR8059,0.987362235772358
HP_ABNORMAL_SACCADIC_EYE_MOV...,SET,84,0.073551,0.0049639,0.090485,0.20816,HP_ABNORMAL_SACCADIC_EYE_MOVEMENTS,0.987362235772358
BIOCARTA_ERBB3_PATHWAY,SET,5,0.3643,0.0060114,0.44823,0.20819,BIOCARTA_ERBB3_PATHWAY,0.987362235772358
MIR34B_3P,SET,98,0.066633,0.0048554,0.081992,0.20821,MIR34B_3P,0.987362235772358
REACTOME_NETRIN_MEDIATED_REP...,SET,8,0.2454,0.0051216,0.302,0.20823,REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS,0.987362235772358
MIR3128,SET,114,0.065115,0.0051153,0.080137,0.20824,MIR3128,0.987362235772358
GSE10325_CD4_TCELL_VS_BCELL_...2,SET,175,0.053555,0.0052039,0.065909,0.20824,GSE10325_CD4_TCELL_VS_BCELL_UP,0.987362235772358
HOSHIDA_LIVER_CANCER_SUBCLAS...2,SET,108,0.063915,0.0048879,0.078668,0.20827,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,0.987362235772358
GOBP_REGULATION_OF_PROTEIN_K...5,SET,18,0.17429,0.0054549,0.21453,0.20828,GOBP_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING,0.987362235772358
GOCC_DENDRITIC_SPINE_HEAD,SET,7,0.28285,0.0055222,0.34815,0.20828,GOCC_DENDRITIC_SPINE_HEAD,0.987362235772358
GSE26928_EFF_MEMORY_VS_CXCR5...2,SET,163,0.053959,0.0050619,0.066421,0.20829,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,0.987362235772358
KEGG_ASCORBATE_AND_ALDARATE_...,SET,23,0.18989,0.0067171,0.23375,0.2083,KEGG_ASCORBATE_AND_ALDARATE_METABOLISM,0.987362235772358
GSE32423_MEMORY_VS_NAIVE_CD8...1,SET,176,0.053043,0.0051687,0.065304,0.20833,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.987362235772358
GOCC_MIGRASOME,SET,5,0.24929,0.0041136,0.30702,0.20841,GOCC_MIGRASOME,0.987362235772358
GOBP_GLOMERULAR_MESANGIAL_CE...1,SET,4,0.36796,0.0054309,0.45328,0.20846,GOBP_GLOMERULAR_MESANGIAL_CELL_DEVELOPMENT,0.987362235772358
HP_DECREASED_SERUM_CREATININE,SET,4,0.3699,0.0054596,0.45572,0.20849,HP_DECREASED_SERUM_CREATININE,0.987362235772358
MODULE_104,SET,314,0.039364,0.0051039,0.048529,0.20865,MODULE_104,0.987362235772358
GOMF_ARACHIDONIC_ACID_MONOOX...,SET,18,0.19105,0.0059793,0.23554,0.20866,GOMF_ARACHIDONIC_ACID_MONOOXYGENASE_ACTIVITY,0.987362235772358
GTGTGAG_MIR342,SET,56,0.092035,0.0050754,0.11349,0.2087,GTGTGAG_MIR342,0.987362235772358
MIR6872_3P,SET,61,0.089643,0.0051587,0.11057,0.20877,MIR6872_3P,0.987362235772358
WP_17Q12_COPY_NUMBER_VARIATI...,SET,84,0.14628,0.0098721,0.18046,0.20881,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,0.987362235772358
HP_BROAD_NECK,SET,21,0.14085,0.004761,0.17378,0.20883,HP_BROAD_NECK,0.987362235772358
MIR620,SET,69,0.087757,0.00537,0.10829,0.20886,MIR620,0.987362235772358
GSE2770_IL12_VS_IL4_TREATED_...6,SET,182,0.04974,0.004928,0.061382,0.20888,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.987362235772358
KEGG_MEDICUS_REFERENCE_EGF_E...4,SET,16,0.16586,0.0048945,0.20473,0.20893,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,0.987362235772358
GOBP_CELLULAR_RESPONSE_TO_UV...1,SET,10,0.25956,0.0060563,0.3204,0.20895,GOBP_CELLULAR_RESPONSE_TO_UV_A,0.987362235772358
PEREZ_TP53_TARGETS,SET,1025,0.022453,0.0051551,0.027719,0.20897,PEREZ_TP53_TARGETS,0.987362235772358
HP_ARTHROPATHY,SET,41,0.11345,0.0053553,0.14005,0.20897,HP_ARTHROPATHY,0.987362235772358
KEGG_MEDICUS_REFERENCE_ITGA_...4,SET,22,0.15783,0.0054604,0.19485,0.20898,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,0.987362235772358
GOBP_POSITIVE_REGULATION_OF_...470,SET,34,0.11406,0.0049039,0.14083,0.209,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY,0.987362235772358
GOBP_RUFFLE_ORGANIZATION,SET,53,0.10004,0.0053674,0.12352,0.20901,GOBP_RUFFLE_ORGANIZATION,0.987362235772358
MIR555,SET,39,0.12228,0.0056299,0.15101,0.20905,MIR555,0.987362235772358
MIR6071,SET,155,0.055287,0.0050587,0.068279,0.20906,MIR6071,0.987362235772358
HP_ABNORMAL_CLAVICLE_MORPHOL...,SET,94,0.069608,0.0049682,0.085972,0.20907,HP_ABNORMAL_CLAVICLE_MORPHOLOGY,0.987362235772358
GSE411_UNSTIM_VS_400MIN_IL6_...2,SET,183,0.050465,0.0050134,0.062328,0.20907,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_UP,0.987362235772358
GOBP_NEGATIVE_REGULATION_OF_...116,SET,151,0.056841,0.0051338,0.070205,0.20908,GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH,0.987362235772358
GOBP_CD4_POSITIVE_ALPHA_BETA...4,SET,19,0.17872,0.0057465,0.22074,0.20909,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.987362235772358
GOBP_METENCEPHALON_DEVELOPME...,SET,101,0.070224,0.0051944,0.08677,0.20917,GOBP_METENCEPHALON_DEVELOPMENT,0.987362235772358
NF1_Q6,SET,240,0.046753,0.0053107,0.057773,0.20919,NF1_Q6,0.987362235772358
GOBP_ALTERNATIVE_MRNA_SPLICI...,SET,67,0.077473,0.0046718,0.095737,0.2092,GOBP_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME,0.987362235772358
GOBP_CARDIAC_PACEMAKER_CELL_...1,SET,9,0.25206,0.0055797,0.31157,0.20926,GOBP_CARDIAC_PACEMAKER_CELL_DEVELOPMENT,0.987362235772358
WANG_LMO4_TARGETS_DN,SET,319,0.037196,0.0048604,0.045984,0.20929,WANG_LMO4_TARGETS_DN,0.987362235772358
GOBP_MITOCHONDRIAL_RIBOSOME_...,SET,11,0.19908,0.0048718,0.24615,0.20932,GOBP_MITOCHONDRIAL_RIBOSOME_ASSEMBLY,0.987362235772358
PURWIN_A375_MEWO_COMMON_SOX1...,SET,25,0.14316,0.0052795,0.17701,0.20933,PURWIN_A375_MEWO_COMMON_SOX10_TARGETS,0.987362235772358
GSE25123_IL4_VS_IL4_AND_ROSI...4,SET,124,0.059642,0.0048852,0.073747,0.20934,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,0.987362235772358
GSE17721_POLYIC_VS_GARDIQUIM...3,SET,182,0.04848,0.0048031,0.059951,0.20936,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_DN,0.987362235772358
chr2p25,SET,45,0.1776,0.008782,0.21969,0.20944,chr2p25,0.987362235772358
GOBP_PYRIMIDINE_NUCLEOSIDE_C...,SET,15,0.22756,0.0065022,0.28151,0.20945,GOBP_PYRIMIDINE_NUCLEOSIDE_CATABOLIC_PROCESS,0.987362235772358
GSE360_CTRL_VS_B_MALAYI_LOW_...2,SET,180,0.052733,0.005196,0.065236,0.20945,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP,0.987362235772358
MIR6830_3P,SET,191,0.054579,0.0055381,0.067521,0.20946,MIR6830_3P,0.987362235772358
GOCC_EARP_COMPLEX,SET,3,0.35905,0.0045895,0.44422,0.20947,GOCC_EARP_COMPLEX,0.987362235772358
GSE41867_DAY6_EFFECTOR_VS_DA...1,SET,181,0.049126,0.0048539,0.060785,0.20949,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,0.987362235772358
MIR32_5P,SET,433,0.034288,0.0052034,0.042427,0.2095,MIR32_5P,0.987362235772358
GSE14308_TH1_VS_NAIVE_CD4_TC...1,SET,176,0.051457,0.0050141,0.063673,0.20951,GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN,0.987362235772358
GOMF_L_LEUCINE_TRANSMEMBRANE...,SET,6,0.29053,0.0052516,0.35957,0.20955,GOMF_L_LEUCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.987362235772358
CHICAS_RB1_TARGETS_CONFLUENT,SET,500,0.032843,0.0053459,0.040649,0.20956,CHICAS_RB1_TARGETS_CONFLUENT,0.987362235772358
REACTOME_HIV_TRANSCRIPTION_I...,SET,43,0.090576,0.0043785,0.11213,0.20962,REACTOME_HIV_TRANSCRIPTION_INITIATION,0.987362235772358
GOBP_POSITIVE_REGULATION_OF_...399,SET,23,0.14722,0.0052078,0.18227,0.20963,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.987362235772358
HP_ABNORMAL_COCHLEA_MORPHOLO...,SET,27,0.12926,0.0049534,0.16004,0.20965,HP_ABNORMAL_COCHLEA_MORPHOLOGY,0.987362235772358
BMI1_DN_MEL18_DN.V1_DN,SET,129,0.066027,0.0055153,0.081754,0.20966,BMI1_DN_MEL18_DN.V1_DN,0.987362235772358
HP_METAPHYSEAL_STRIATIONS,SET,11,0.22548,0.0055178,0.27933,0.20978,HP_METAPHYSEAL_STRIATIONS,0.98742738336714
GOBP_ANATOMICAL_STRUCTURE_MA...,SET,247,0.045952,0.0052942,0.056929,0.20979,GOBP_ANATOMICAL_STRUCTURE_MATURATION,0.98742738336714
GSE19198_CTRL_VS_IL21_TREATE...5,SET,176,0.05297,0.0051615,0.065628,0.2098,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN,0.98742738336714
GOMF_NUCLEOBASE_CONTAINING_C...2,SET,52,0.09904,0.0052636,0.12271,0.20981,GOMF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.98742738336714
HP_ABNORMALITY_OF_DNA_REPAIR,SET,14,0.13956,0.0038526,0.17294,0.20984,HP_ABNORMALITY_OF_DNA_REPAIR,0.98742738336714
HELLEBREKERS_SILENCED_DURING...,SET,71,0.08766,0.005441,0.10865,0.20989,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,0.98742738336714
GSE15330_GRANULOCYTE_MONOCYT...2,SET,177,0.04919,0.0048067,0.060972,0.2099,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_UP,0.98742738336714
GSE5455_HEALTHY_VS_TUMOR_BEA...2,SET,176,0.052178,0.0050844,0.064681,0.20993,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_UP,0.98742738336714
GOBP_ENDONUCLEOLYTIC_CLEAVAG...1,SET,7,0.24842,0.00485,0.308,0.20996,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_IN_5_ETS_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.98742738336714
PETROVA_PROX1_TARGETS_UP,SET,25,0.13247,0.0048851,0.16429,0.21003,PETROVA_PROX1_TARGETS_UP,0.98742738336714
KEGG_MEDICUS_REFERENCE_GLYCO...2,SET,8,0.21214,0.0044275,0.26311,0.21004,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION,0.98742738336714
GSE25123_CTRL_VS_IL4_STIM_MA...2,SET,177,0.051163,0.0049995,0.063459,0.21006,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_UP,0.98742738336714
HOEK_MONOCYTE_2011_2012_TIV_...4,SET,2,0.60428,0.0063069,0.74952,0.21006,HOEK_MONOCYTE_2011_2012_TIV_ADULT_3DY_UP,0.98742738336714
HUANG_GATA2_TARGETS_DN,SET,66,0.085511,0.005118,0.10607,0.21008,HUANG_GATA2_TARGETS_DN,0.98742738336714
REACTOME_SARS_COV_INFECTIONS,SET,378,0.035205,0.0049994,0.043674,0.2101,REACTOME_SARS_COV_INFECTIONS,0.98742738336714
GOBP_POSITIVE_REGULATION_OF_...82,SET,56,0.095943,0.0052909,0.11904,0.21013,GOBP_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,0.987434849918875
GSE6092_UNSTIM_VS_IFNG_STIM_...1,SET,177,0.052827,0.0051621,0.065566,0.21021,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,0.987464695945946
HP_AREFLEXIA,SET,271,0.041111,0.004958,0.051028,0.21022,HP_AREFLEXIA,0.987464695945946
GOBP_POSITIVE_REGULATION_OF_...848,SET,5,0.31214,0.0051507,0.38747,0.21024,GOBP_POSITIVE_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,0.987464695945946
GSE2706_LPS_VS_R848_AND_LPS_...1,SET,128,0.06341,0.0052763,0.078714,0.21025,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN,0.987464695945946
HP_ABNORMAL_SACROILIAC_JOINT...,SET,6,0.33913,0.00613,0.42111,0.21032,HP_ABNORMAL_SACROILIAC_JOINT_MORPHOLOGY,0.987487059300284
GOMF_SINGLE_STRANDED_DNA_HEL...,SET,23,0.13135,0.0046465,0.16312,0.21034,GOMF_SINGLE_STRANDED_DNA_HELICASE_ACTIVITY,0.987487059300284
GOMF_TRANSCRIPTION_COACTIVAT...2,SET,40,0.11626,0.005421,0.14438,0.21034,GOMF_TRANSCRIPTION_COACTIVATOR_BINDING,0.987487059300284
GOBP_REGULATION_OF_MITOCHOND...9,SET,36,0.10798,0.0047771,0.13412,0.21039,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.987588391410049
THRA_TARGET_GENES,SET,66,0.080277,0.0048047,0.099742,0.21046,THRA_TARGET_GENES,0.987650189035917
HP_HIGH_PITCHED_CRY,SET,5,0.27624,0.0045583,0.34322,0.21046,HP_HIGH_PITCHED_CRY,0.987650189035917
PRDM12_TARGET_GENES,SET,93,0.06868,0.0048759,0.085369,0.21055,PRDM12_TARGET_GENES,0.987687295911483
OKUMURA_INFLAMMATORY_RESPONS...,SET,156,0.055805,0.0051223,0.06937,0.21058,OKUMURA_INFLAMMATORY_RESPONSE_LPS,0.987687295911483
GOCC_RNAI_EFFECTOR_COMPLEX,SET,15,0.17732,0.0050665,0.22043,0.21058,GOCC_RNAI_EFFECTOR_COMPLEX,0.987687295911483
GOBP_PROTEIN_LOCALIZATION_TO...41,SET,6,0.25374,0.0045865,0.31548,0.21061,GOBP_PROTEIN_LOCALIZATION_TO_PERINUCLEAR_REGION_OF_CYTOPLASM,0.987687295911483
HP_SEVERE_PHOTOSENSITIVITY,SET,5,0.24209,0.0039947,0.30098,0.21061,HP_SEVERE_PHOTOSENSITIVITY,0.987687295911483
KORKOLA_CHORIOCARCINOMA_DN,SET,8,0.28367,0.0059204,0.35274,0.21065,KORKOLA_CHORIOCARCINOMA_DN,0.987741601457097
MODULE_501,SET,15,0.18363,0.0052468,0.22839,0.2107,MODULE_501,0.987759019241048
GOBP_POSITIVE_REGULATION_OF_...442,SET,5,0.29296,0.0048341,0.36448,0.21077,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_CHEMOTAXIS,0.987759019241048
GOBP_IMMATURE_T_CELL_PROLIFE...,SET,11,0.2223,0.00544,0.27658,0.21078,GOBP_IMMATURE_T_CELL_PROLIFERATION,0.987759019241048
GOBP_REGULATION_OF_DENDRITIC...6,SET,41,0.11339,0.0053526,0.14109,0.2108,GOBP_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,0.987759019241048
HP_ABNORMALITY_OF_JOINT_MOBI...,SET,1163,0.020394,0.0049679,0.025377,0.2108,HP_ABNORMALITY_OF_JOINT_MOBILITY,0.987759019241048
REACTOME_NS1_MEDIATED_EFFECT...,SET,39,0.10133,0.0046654,0.12611,0.21085,REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS,0.987759019241048
MIR6806_3P,SET,94,0.070804,0.0050535,0.088156,0.21094,MIR6806_3P,0.987759019241048
GSE24142_EARLY_THYMIC_PROGEN...5,SET,186,0.052989,0.0053066,0.065985,0.21098,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP,0.987759019241048
MIR626,SET,51,0.10418,0.0054836,0.12975,0.21101,MIR626,0.987759019241048
GOBP_NEGATIVE_REGULATION_OF_...639,SET,43,0.10106,0.0048854,0.12588,0.21103,GOBP_NEGATIVE_REGULATION_OF_TORC1_SIGNALING,0.987759019241048
MANNO_MIDBRAIN_NEUROTYPES_HP...4,SET,298,0.040397,0.0051049,0.050315,0.21103,MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM,0.987759019241048
GOBP_REGULATION_OF_JNK_CASCA...,SET,131,0.060555,0.005097,0.075438,0.21108,GOBP_REGULATION_OF_JNK_CASCADE,0.987759019241048
GSE13485_CTRL_VS_DAY21_YF17D...2,SET,177,0.048289,0.0047187,0.060161,0.21109,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.987759019241048
HP_ABNORMAL_CIRCULATING_HORM...,SET,434,0.033402,0.0050747,0.041618,0.21111,HP_ABNORMAL_CIRCULATING_HORMONE_CONCENTRATION,0.987759019241048
GOCC_NEUROFIBRILLARY_TANGLE,SET,5,0.3926,0.0064783,0.48921,0.21113,GOCC_NEUROFIBRILLARY_TANGLE,0.987759019241048
GOMF_G_PROTEIN_ACTIVITY,SET,46,0.09853,0.0049259,0.12279,0.21115,GOMF_G_PROTEIN_ACTIVITY,0.987759019241048
HP_ABNORMAL_CIRCULATING_SEX_...,SET,108,0.066118,0.0050564,0.082397,0.21116,HP_ABNORMAL_CIRCULATING_SEX_HORMONE_CONCENTRATION,0.987759019241048
HP_APLASIA_HYPOPLASIA_OF_THE...5,SET,3,0.4735,0.0060525,0.5901,0.21117,HP_APLASIA_HYPOPLASIA_OF_THE_3RD_METACARPAL,0.987759019241048
HP_ABNORMAL_REPRODUCTIVE_SYS...,SET,1236,0.019975,0.0050056,0.024899,0.21121,HP_ABNORMAL_REPRODUCTIVE_SYSTEM_MORPHOLOGY,0.987759019241048
GOBP_REGULATION_OF_INTRACELL...1,SET,29,0.12395,0.0049225,0.15456,0.21129,GOBP_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,0.987759019241048
GATA_Q6,SET,177,0.054419,0.0053177,0.067864,0.21131,GATA_Q6,0.987759019241048
DUAN_PRDM5_TARGETS,SET,65,0.092225,0.005478,0.11501,0.21132,DUAN_PRDM5_TARGETS,0.987759019241048
ZSCAN21_TARGET_GENES,SET,393,0.034022,0.0049243,0.042434,0.21135,ZSCAN21_TARGET_GENES,0.987759019241048
REACTOME_CELLULAR_HEXOSE_TRA...,SET,18,0.16644,0.0052093,0.20761,0.21137,REACTOME_CELLULAR_HEXOSE_TRANSPORT,0.987759019241048
HP_LOW_SET_NIPPLES,SET,6,0.23856,0.0043122,0.29757,0.21137,HP_LOW_SET_NIPPLES,0.987759019241048
DESCARTES_MAIN_FETAL_GANGLIO...,SET,19,0.17917,0.0057612,0.22365,0.21153,DESCARTES_MAIN_FETAL_GANGLION_CELLS,0.987759019241048
LAIHO_COLORECTAL_CANCER_SERR...1,SET,67,0.083602,0.0050413,0.10437,0.21156,LAIHO_COLORECTAL_CANCER_SERRATED_DN,0.987759019241048
GSE16450_CTRL_VS_IFNA_6H_STI...3,SET,176,0.049636,0.0048367,0.061966,0.21157,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,0.987759019241048
HSF1_01,SET,246,0.044298,0.0050934,0.055315,0.21162,HSF1_01,0.987759019241048
GOBP_SIGNAL_TRANSDUCTION_INV...,SET,23,0.15444,0.005463,0.19285,0.21162,GOBP_SIGNAL_TRANSDUCTION_INVOLVED_IN_REGULATION_OF_GENE_EXPRESSION,0.987759019241048
HP_FRONTAL_CORTICAL_ATROPHY,SET,10,0.22046,0.005144,0.27529,0.21162,HP_FRONTAL_CORTICAL_ATROPHY,0.987759019241048
WP_MIRNA_BIOGENESIS,SET,6,0.26918,0.0048657,0.33617,0.21165,WP_MIRNA_BIOGENESIS,0.987759019241048
GOBP_POSITIVE_REGULATION_OF_...431,SET,18,0.16339,0.0051137,0.20406,0.21166,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.987759019241048
HP_RELATIVE_MACROCEPHALY,SET,52,0.093834,0.0049869,0.1172,0.21168,HP_RELATIVE_MACROCEPHALY,0.987759019241048
GSE17580_TREG_VS_TEFF_DN,SET,189,0.049835,0.0050304,0.062248,0.21169,GSE17580_TREG_VS_TEFF_DN,0.987759019241048
GOBP_MUSCLE_SYSTEM_PROCESS,SET,411,0.035613,0.0052687,0.044495,0.21175,GOBP_MUSCLE_SYSTEM_PROCESS,0.987759019241048
GSE37301_COMMON_LYMPHOID_PRO...5,SET,177,0.049594,0.0048462,0.061963,0.21175,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_DN,0.987759019241048
GOCC_ASYMMETRIC_GLUTAMATERGI...,SET,13,0.20418,0.0054315,0.25526,0.21189,GOCC_ASYMMETRIC_GLUTAMATERGIC_EXCITATORY_SYNAPSE,0.987759019241048
GOBP_REGULATION_OF_CELLULAR_...6,SET,121,0.062893,0.0050892,0.07863,0.2119,GOBP_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS,0.987759019241048
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...3,SET,913,0.023821,0.0051785,0.029783,0.21191,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP,0.987759019241048
JINESH_BLEBBISHIELD_TO_IMMUN...1,SET,342,0.039978,0.0054055,0.049996,0.21197,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,0.987759019241048
HE_LIM_SUN_FETAL_LUNG_C2_APO...1,SET,11,0.21007,0.0051407,0.26272,0.21198,HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M1_MACROPHAGE_CELL,0.987759019241048
GOMF_STEROID_HORMONE_BINDING,SET,6,0.31726,0.0057346,0.39682,0.21201,GOMF_STEROID_HORMONE_BINDING,0.987759019241048
GOBP_POSITIVE_REGULATION_OF_...372,SET,33,0.13396,0.0056747,0.16758,0.21203,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,0.987759019241048
CHEN_HOXA5_TARGETS_9HR_UP,SET,205,0.048797,0.0051276,0.06105,0.21207,CHEN_HOXA5_TARGETS_9HR_UP,0.987759019241048
GOBP_EPOXYGENASE_P450_PATHWAY,SET,18,0.19087,0.0059739,0.23883,0.21209,GOBP_EPOXYGENASE_P450_PATHWAY,0.987759019241048
GSE3565_CTRL_VS_LPS_INJECTED...2,SET,166,0.056517,0.0053499,0.07073,0.21213,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP,0.987759019241048
DHIMAN_PBMC_ATTENUVAX_AGE_15...2,SET,44,0.10325,0.0050489,0.12924,0.21216,DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_SUBQ_7_OR_14DY_UP,0.987759019241048
MIR6783_3P,SET,185,0.050127,0.0050066,0.062747,0.21219,MIR6783_3P,0.987759019241048
GOBP_INNATE_IMMUNE_RESPONSE_...2,SET,12,0.22892,0.0058509,0.28659,0.21222,GOBP_INNATE_IMMUNE_RESPONSE_IN_MUCOSA,0.987759019241048
MIR3180_5P,SET,288,0.040859,0.0050773,0.051157,0.21224,MIR3180_5P,0.987759019241048
KORKOLA_EMBRYONAL_CARCINOMA_...1,SET,9,0.26894,0.0059532,0.33676,0.21226,KORKOLA_EMBRYONAL_CARCINOMA_DN,0.987759019241048
PID_VEGFR1_2_PATHWAY,SET,68,0.080661,0.0049001,0.10102,0.2123,PID_VEGFR1_2_PATHWAY,0.987759019241048
GOBP_REGENERATION,SET,180,0.052919,0.0052143,0.066276,0.21231,GOBP_REGENERATION,0.987759019241048
GOBP_DOUBLE_STRAND_BREAK_REP...3,SET,8,0.19834,0.0041395,0.24842,0.21232,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_ALTERNATIVE_NONHOMOLOGOUS_END_JOINING,0.987759019241048
GOBP_SNRNA_PROCESSING,SET,22,0.13608,0.0047078,0.17046,0.21236,GOBP_SNRNA_PROCESSING,0.987759019241048
chr15q21,SET,78,0.13847,0.0090065,0.17347,0.21238,chr15q21,0.987759019241048
GOCC_TRANSCRIPTION_REPRESSOR...,SET,72,0.082443,0.005153,0.10329,0.21239,GOCC_TRANSCRIPTION_REPRESSOR_COMPLEX,0.987759019241048
MORF_EI24,SET,118,0.059908,0.0047875,0.075076,0.21245,MORF_EI24,0.987759019241048
GSE6674_UNSTIM_VS_CPG_STIM_B...1,SET,145,0.055939,0.0049518,0.070107,0.21247,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN,0.987759019241048
GOBP_HEMOPOIESIS,SET,878,0.024407,0.0052084,0.030593,0.2125,GOBP_HEMOPOIESIS,0.987759019241048
GOBP_BRUSH_BORDER_ASSEMBLY,SET,8,0.21531,0.0044938,0.26992,0.21253,GOBP_BRUSH_BORDER_ASSEMBLY,0.987759019241048
DESCARTES_FETAL_CEREBELLUM_V...,SET,506,0.033361,0.0054618,0.041828,0.21256,DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS,0.987759019241048
GOBP_ENDOSOME_TO_LYSOSOME_TR...2,SET,17,0.15555,0.0047313,0.19505,0.21259,GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.987759019241048
HP_INCREASED_INTRAMYOCELLULA...,SET,18,0.17008,0.0053231,0.21327,0.21259,HP_INCREASED_INTRAMYOCELLULAR_LIPID_DROPLETS,0.987759019241048
ZNF30_TARGET_GENES,SET,1184,0.020067,0.0049291,0.025164,0.2126,ZNF30_TARGET_GENES,0.987759019241048
GOCC_MYELIN_SHEATH,SET,41,0.1046,0.0049376,0.13117,0.21262,GOCC_MYELIN_SHEATH,0.987759019241048
KEGG_ALDOSTERONE_REGULATED_S...,SET,39,0.12165,0.005601,0.15256,0.21263,KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,0.987759019241048
GOBP_MEMBRANE_REPOLARIZATION...2,SET,5,0.34407,0.0056775,0.43155,0.21265,GOBP_MEMBRANE_REPOLARIZATION_DURING_ATRIAL_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.987759019241048
REACTOME_INFECTIOUS_DISEASE,SET,888,0.022331,0.0047911,0.028011,0.21267,REACTOME_INFECTIOUS_DISEASE,0.987759019241048
HE_LIM_SUN_FETAL_LUNG_C1_PRO...2,SET,96,0.078683,0.005675,0.098706,0.21269,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_1_CELL,0.987759019241048
HP_ABNORMALITY_OF_FIBRINOLYS...,SET,4,0.26193,0.0038659,0.3286,0.2127,HP_ABNORMALITY_OF_FIBRINOLYSIS,0.987759019241048
GSE43956_WT_VS_SGK1_KO_TH17_...2,SET,183,0.050829,0.0050495,0.063792,0.21279,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_UP,0.987964099826505
GOBP_POLYAMINE_BIOSYNTHETIC_...,SET,12,0.16914,0.0043229,0.21229,0.21281,GOBP_POLYAMINE_BIOSYNTHETIC_PROCESS,0.987964099826505
TAKEDA_TARGETS_OF_NUP98_HOXA...2,SET,171,0.058125,0.0055836,0.072977,0.21288,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,0.987964099826505
chr16q24,SET,72,0.16161,0.010101,0.20291,0.2129,chr16q24,0.987964099826505
GSE27786_LSK_VS_CD8_TCELL_DN,SET,182,0.049028,0.0048574,0.061573,0.21294,GSE27786_LSK_VS_CD8_TCELL_DN,0.987964099826505
GOBP_RESPONSE_TO_STILBENOID,SET,7,0.32031,0.0062535,0.40226,0.21295,GOBP_RESPONSE_TO_STILBENOID,0.987964099826505
PAX4_01,SET,247,0.042992,0.0049531,0.053999,0.21298,PAX4_01,0.987964099826505
BIOCARTA_NDKDYNAMIN_PATHWAY,SET,17,0.16575,0.0050414,0.2082,0.213,BIOCARTA_NDKDYNAMIN_PATHWAY,0.987964099826505
GOBP_DEVELOPMENT_OF_SECONDAR...1,SET,6,0.31215,0.0056424,0.39212,0.213,GOBP_DEVELOPMENT_OF_SECONDARY_FEMALE_SEXUAL_CHARACTERISTICS,0.987964099826505
MIR7_5P,SET,241,0.045081,0.0051313,0.056663,0.21314,MIR7_5P,0.988225070028011
GSE33425_CD8_ALPHAALPHA_VS_A...1,SET,182,0.049592,0.0049133,0.062334,0.21314,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,0.988225070028011
HP_CARIOUS_TEETH,SET,147,0.056819,0.005064,0.071424,0.21316,HP_CARIOUS_TEETH,0.988225070028011
HP_ABNORMAL_CIRCULATING_IGE_...,SET,44,0.10211,0.0049929,0.12836,0.21317,HP_ABNORMAL_CIRCULATING_IGE_LEVEL,0.988225070028011
HP_SPLENIC_INFARCTION,SET,6,0.29945,0.0054128,0.37656,0.21324,HP_SPLENIC_INFARCTION,0.988332277637018
GSE23114_PERITONEAL_CAVITY_B...2,SET,175,0.051572,0.0050112,0.064855,0.21325,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_DN,0.988332277637018
GSE19923_WT_VS_HEB_KO_DP_THY...1,SET,180,0.049291,0.0048568,0.061994,0.21328,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_DN,0.98833952
MIR3614_5P,SET,64,0.088813,0.0052348,0.11172,0.21333,MIR3614_5P,0.988361235505798
MIR5684,SET,35,0.11999,0.0052341,0.15096,0.21336,MIR5684,0.988361235505798
SCGGAAGY_ELK1_02,SET,1125,0.02028,0.0048642,0.025517,0.21337,SCGGAAGY_ELK1_02,0.988361235505798
ELVIDGE_HIF1A_AND_HIF2A_TARG...1,SET,94,0.072661,0.0051861,0.091445,0.21343,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,0.988507416044776
GOBP_DICARBOXYLIC_ACID_TRANS...,SET,99,0.071803,0.0052587,0.09038,0.21347,GOBP_DICARBOXYLIC_ACID_TRANSPORT,0.988543467838594
STOSSI_RESPONSE_TO_ESTRADIOL,SET,37,0.12618,0.005659,0.15886,0.21352,STOSSI_RESPONSE_TO_ESTRADIOL,0.988543467838594
REACTOME_AUTOPHAGY,SET,144,0.054768,0.0048315,0.068962,0.21355,REACTOME_AUTOPHAGY,0.988543467838594
GSE3920_UNTREATED_VS_IFNB_TR...1,SET,157,0.053406,0.0049177,0.06725,0.21356,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,0.988543467838594
HP_PEG_SHAPED_MAXILLARY_LATE...,SET,24,0.15633,0.0056488,0.19687,0.21358,HP_PEG_SHAPED_MAXILLARY_LATERAL_INCISORS,0.988543467838594
MODULE_317,SET,396,0.034561,0.0050209,0.043529,0.21361,MODULE_317,0.988550672436751
GOBP_POSITIVE_REGULATION_OF_...208,SET,13,0.18128,0.0048223,0.22836,0.21365,GOBP_POSITIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,0.988565075878594
MIR4790_3P,SET,77,0.076151,0.0049215,0.095935,0.21367,MIR4790_3P,0.988565075878594
GOBP_MALONYL_COA_METABOLIC_P...,SET,6,0.2848,0.0051479,0.35886,0.21372,GOBP_MALONYL_COA_METABOLIC_PROCESS,0.988579471652915
HP_DECREASED_CALVARIAL_OSSIF...,SET,17,0.17137,0.0052125,0.21595,0.21373,HP_DECREASED_CALVARIAL_OSSIFICATION,0.988579471652915
WP_CODEINE_AND_MORPHINE_META...,SET,14,0.18139,0.0050072,0.22863,0.21379,WP_CODEINE_AND_MORPHINE_METABOLISM,0.988722217790188
ATOH8_TARGET_GENES,SET,38,0.11184,0.0050829,0.14099,0.21384,ATOH8_TARGET_GENES,0.988722217790188
GOMF_GLUTAMATE_GATED_CALCIUM...,SET,7,0.27906,0.0054482,0.35188,0.21388,GOMF_GLUTAMATE_GATED_CALCIUM_ION_CHANNEL_ACTIVITY,0.988722217790188
MIR4653_5P,SET,137,0.059463,0.0051177,0.075,0.21394,MIR4653_5P,0.988722217790188
GOBP_NEGATIVE_REGULATION_OF_...511,SET,6,0.25793,0.0046623,0.32533,0.21394,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_ACETYLATION,0.988722217790188
GOCC_LATERAL_PLASMA_MEMBRANE,SET,65,0.086765,0.0051537,0.10944,0.21395,GOCC_LATERAL_PLASMA_MEMBRANE,0.988722217790188
GUO_HEX_TARGETS_UP,SET,72,0.081698,0.0051064,0.10306,0.21396,GUO_HEX_TARGETS_UP,0.988722217790188
GOBP_MONOACYLGLYCEROL_METABO...,SET,14,0.16699,0.0046096,0.21069,0.21402,GOBP_MONOACYLGLYCEROL_METABOLIC_PROCESS,0.988868000531773
GOMF_PEPTIDOGLYCAN_IMMUNE_RE...,SET,5,0.34416,0.0056791,0.43468,0.21426,GOMF_PEPTIDOGLYCAN_IMMUNE_RECEPTOR_ACTIVITY,0.989471941824944
GOBP_POSITIVE_REGULATION_OF_...80,SET,107,0.068188,0.0051906,0.086131,0.21428,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,0.989471941824944
HP_CENTRAL_Y_SHAPED_METACARP...,SET,8,0.19048,0.0039754,0.24062,0.2143,HP_CENTRAL_Y_SHAPED_METACARPAL,0.989471941824944
GOBP_BASEMENT_MEMBRANE_ASSEM...,SET,9,0.24003,0.0053133,0.30324,0.21432,GOBP_BASEMENT_MEMBRANE_ASSEMBLY,0.989471941824944
CAO_BLOOD_FLUZONE_AGE_05_14Y...4,SET,7,0.26349,0.0051442,0.33289,0.21432,CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_UP,0.989471941824944
GSE11864_UNTREATED_VS_CSF1_I...3,SET,164,0.050738,0.0047741,0.064104,0.21434,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.989471941824944
GOMF_TRNA_SPECIFIC_ADENOSINE...,SET,8,0.24771,0.0051699,0.31299,0.21435,GOMF_TRNA_SPECIFIC_ADENOSINE_DEAMINASE_ACTIVITY,0.989471941824944
GOCC_NASCENT_POLYPEPTIDE_ASS...,SET,4,0.29791,0.004397,0.37654,0.21443,GOCC_NASCENT_POLYPEPTIDE_ASSOCIATED_COMPLEX,0.989606536164565
GOBP_LEUKOTRIENE_METABOLIC_P...,SET,29,0.13369,0.0053095,0.169,0.21446,GOBP_LEUKOTRIENE_METABOLIC_PROCESS,0.989606536164565
GOCC_CLOCK_BMAL_TRANSCRIPTIO...,SET,2,0.67401,0.0070347,0.85211,0.21448,GOCC_CLOCK_BMAL_TRANSCRIPTION_COMPLEX,0.989606536164565
GOBP_RESPONSE_TO_SELENIUM_ION,SET,5,0.2632,0.0043432,0.33279,0.21451,GOBP_RESPONSE_TO_SELENIUM_ION,0.989606536164565
CHUANG_OXIDATIVE_STRESS_RESP...1,SET,10,0.17851,0.0041652,0.22572,0.21453,CHUANG_OXIDATIVE_STRESS_RESPONSE_DN,0.989606536164565
GOBP_POSITIVE_REGULATION_OF_...475,SET,7,0.27401,0.0053496,0.34653,0.21455,GOBP_POSITIVE_REGULATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,0.989606536164565
GSE8868_SPLEEN_VS_INTESTINE_...2,SET,175,0.049463,0.0048063,0.062573,0.21463,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP,0.989805061695635
GSE36078_UNTREATED_VS_AD5_IN...3,SET,175,0.050207,0.0048785,0.063519,0.21465,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_DN,0.989805061695635
GOBP_POSITIVE_REGULATION_OF_...572,SET,61,0.086104,0.0049551,0.10897,0.21472,GOBP_POSITIVE_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.989893172477794
GOBP_REGULATION_OF_CELLULAR_...16,SET,17,0.17254,0.0052482,0.21843,0.21479,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,0.989893172477794
GOCC_ALPHA_BETA_T_CELL_RECEP...,SET,4,0.34748,0.0051286,0.43988,0.21479,GOCC_ALPHA_BETA_T_CELL_RECEPTOR_COMPLEX,0.989893172477794
GOBP_ENDODERM_DEVELOPMENT,SET,80,0.080448,0.0052991,0.10185,0.2148,GOBP_ENDODERM_DEVELOPMENT,0.989893172477794
AAAYWAACM_HFH4_01,SET,224,0.047516,0.0052165,0.060166,0.21484,AAAYWAACM_HFH4_01,0.989893172477794
GOBP_NEGATIVE_REGULATION_OF_...569,SET,8,0.26352,0.0054999,0.33367,0.21484,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,0.989893172477794
GSE13547_CTRL_VS_ANTI_IGM_ST...5,SET,141,0.058932,0.0051449,0.074631,0.21487,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN,0.989900165694592
GSE11961_FOLLICULAR_BCELL_VS...9,SET,179,0.04959,0.0048728,0.062848,0.21505,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_DN,0.989985348468849
MIR2113,SET,234,0.045409,0.0050939,0.057557,0.21508,MIR2113,0.989985348468849
GOMF_PROTEINASE_ACTIVATED_RE...,SET,5,0.36558,0.0060325,0.46341,0.21509,GOMF_PROTEINASE_ACTIVATED_RECEPTOR_ACTIVITY,0.989985348468849
GOBP_GERMINAL_CENTER_FORMATI...,SET,13,0.19022,0.0050602,0.24114,0.21511,GOBP_GERMINAL_CENTER_FORMATION,0.989985348468849
WP_FAMILIAL_PARTIAL_LIPODYST...,SET,30,0.12805,0.0051721,0.16236,0.21516,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,0.989985348468849
WP_TOLLLIKE_RECEPTOR_SIGNALI...1,SET,95,0.074236,0.0053265,0.094136,0.21518,WP_TOLLLIKE_RECEPTOR_SIGNALING,0.989985348468849
HP_MOTTLED_PIGMENTATION,SET,8,0.2569,0.0053618,0.32577,0.21518,HP_MOTTLED_PIGMENTATION,0.989985348468849
GSE10239_NAIVE_VS_KLRG1HIGH_...2,SET,187,0.048896,0.0049097,0.06201,0.2152,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.989985348468849
LIN_SILENCED_BY_TUMOR_MICROE...,SET,96,0.0753,0.005431,0.095531,0.21529,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,0.989985348468849
GOBP_ERBB4_ERBB4_SIGNALING_P...,SET,6,0.28583,0.0051666,0.36265,0.2153,GOBP_ERBB4_ERBB4_SIGNALING_PATHWAY,0.989985348468849
EBAUER_TARGETS_OF_PAX3_FOXO1...2,SET,172,0.05336,0.0051407,0.067703,0.21531,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,0.989985348468849
GOBP_NEUTROPHIL_MEDIATED_CYT...,SET,15,0.19677,0.0056224,0.2497,0.21534,GOBP_NEUTROPHIL_MEDIATED_CYTOTOXICITY,0.989985348468849
GSE8621_UNSTIM_VS_LPS_STIM_M...2,SET,182,0.049945,0.0049482,0.063379,0.21534,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,0.989985348468849
MIR30B_5P_MIR30C_5P,SET,713,0.026357,0.0050924,0.033449,0.21536,MIR30B_5P_MIR30C_5P,0.989985348468849
GOBP_REGULATION_OF_TRANSMEMB...2,SET,420,0.035076,0.0052443,0.044513,0.21536,GOBP_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,0.989985348468849
GOCC_ANKYRIN_1_COMPLEX,SET,8,0.26361,0.0055017,0.33459,0.21539,GOCC_ANKYRIN_1_COMPLEX,0.989985348468849
GSE29615_CTRL_VS_LAIV_FLU_VA...2,SET,175,0.052722,0.005123,0.066917,0.21539,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP,0.989985348468849
GOBP_POSITIVE_REGULATION_OF_...783,SET,185,0.052023,0.005196,0.066048,0.21545,GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,0.989985348468849
KEGG_MEDICUS_REFERENCE_MEMBR...,SET,9,0.21418,0.0047412,0.27199,0.21551,KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY,0.989985348468849
GOBP_POSITIVE_REGULATION_OF_...217,SET,271,0.039422,0.0047543,0.050063,0.21551,GOBP_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,0.989985348468849
GSE13547_WT_VS_ZFX_KO_BCELL_...2,SET,123,0.065538,0.0053465,0.08324,0.21555,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP,0.989985348468849
HP_ABNORMAL_VENTRICULAR_AXIS,SET,5,0.33739,0.0055673,0.4286,0.21559,HP_ABNORMAL_VENTRICULAR_AXIS,0.989985348468849
MIR6753_5P,SET,20,0.15476,0.0051054,0.19663,0.21562,MIR6753_5P,0.989985348468849
GOBP_NEURON_PROJECTION_EXTEN...1,SET,148,0.056793,0.0050788,0.072158,0.21563,GOBP_NEURON_PROJECTION_EXTENSION,0.989985348468849
GOBP_SPHINGOID_BIOSYNTHETIC_...,SET,13,0.19614,0.0052175,0.24923,0.21566,GOBP_SPHINGOID_BIOSYNTHETIC_PROCESS,0.989985348468849
MIR1251_5P,SET,23,0.12691,0.0044892,0.16129,0.21569,MIR1251_5P,0.989985348468849
CCATCCA_MIR432,SET,50,0.094056,0.0049019,0.11956,0.21574,CCATCCA_MIR432,0.989985348468849
GSE16385_ROSIGLITAZONE_IL4_V...1,SET,169,0.054185,0.0051748,0.06888,0.21575,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN,0.989985348468849
GOBP_POSITIVE_REGULATION_OF_...247,SET,6,0.3261,0.0058945,0.41458,0.21576,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.989985348468849
MODULE_397,SET,110,0.061723,0.0047635,0.07847,0.21577,MODULE_397,0.989985348468849
KEGG_MEDICUS_PATHOGEN_HCMV_U...5,SET,13,0.19634,0.0052228,0.24964,0.2158,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY,0.989985348468849
GOBP_OVIDUCT_DEVELOPMENT,SET,6,0.2864,0.0051769,0.36416,0.2158,GOBP_OVIDUCT_DEVELOPMENT,0.989985348468849
GSE40274_XBP1_VS_FOXP3_AND_X...1,SET,180,0.047671,0.0046972,0.060627,0.21585,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.990065927977839
REACTOME_INTERLEUKIN_12_FAMI...,SET,53,0.088816,0.0047653,0.11297,0.21588,REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,0.990065927977839
CHANDRAN_METASTASIS_TOP50_DN,SET,35,0.1171,0.0051083,0.14897,0.21592,CHANDRAN_METASTASIS_TOP50_DN,0.990065927977839
GOBP_GRANULOCYTE_COLONY_STIM...2,SET,5,0.27706,0.0045717,0.3525,0.21595,GOBP_GRANULOCYTE_COLONY_STIMULATING_FACTOR_SIGNALING_PATHWAY,0.990065927977839
FIGUEROA_AML_METHYLATION_CLU...10,SET,12,0.19151,0.0048948,0.24368,0.21596,FIGUEROA_AML_METHYLATION_CLUSTER_5_UP,0.990065927977839
GOMF_FRUCTOSE_TRANSMEMBRANE_...,SET,8,0.23541,0.0049132,0.29966,0.21606,GOMF_FRUCTOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.990308960833443
HP_DECREASED_PROPORTION_OF_N...,SET,3,0.4511,0.0057662,0.57425,0.21607,HP_DECREASED_PROPORTION_OF_NAIVE_T_CELLS,0.990308960833443
GOMF_RECEPTOR_TYROSINE_KINAS...,SET,75,0.074427,0.0047474,0.094779,0.21615,GOMF_RECEPTOR_TYROSINE_KINASE_BINDING,0.990544996044304
chr7q31,SET,58,0.16377,0.0091905,0.20861,0.21622,chr7q31,0.990684613357924
GOBP_REGULATION_OF_AEROBIC_R...,SET,27,0.1233,0.0047251,0.15707,0.21624,GOBP_REGULATION_OF_AEROBIC_RESPIRATION,0.990684613357924
REACTOME_VEGF_LIGAND_RECEPTO...,SET,7,0.28029,0.0054721,0.35715,0.2163,REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS,0.990684613357924
HP_ABNORMAL_INTRAHEPATIC_BIL...,SET,28,0.13159,0.0051352,0.16768,0.2163,HP_ABNORMAL_INTRAHEPATIC_BILE_DUCT_MORPHOLOGY,0.990684613357924
MULLIGHAN_NPM1_MUTATED_SIGNA...1,SET,110,0.060783,0.004691,0.077471,0.21635,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,0.990684613357924
GOBP_REGULATION_OF_CELLULAR_...20,SET,41,0.10196,0.0048132,0.12997,0.21638,GOBP_REGULATION_OF_CELLULAR_SENESCENCE,0.990684613357924
GSE16450_CTRL_VS_IFNA_12H_ST...4,SET,180,0.049569,0.0048842,0.063185,0.21638,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,0.990684613357924
ZNF302_TARGET_GENES,SET,4,0.26475,0.0039076,0.33755,0.21643,ZNF302_TARGET_GENES,0.990783015015806
GOBP_NEGATIVE_REGULATION_OF_...610,SET,23,0.15615,0.0055237,0.19913,0.21648,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,0.990810327804107
MIR92B_3P,SET,431,0.033338,0.0050479,0.042521,0.21651,MIR92B_3P,0.990810327804107
MIR9500,SET,145,0.054615,0.0048346,0.069668,0.21654,MIR9500,0.990810327804107
MIR6515_3P,SET,199,0.047718,0.0049411,0.060871,0.21655,MIR6515_3P,0.990810327804107
CHEBOTAEV_GR_TARGETS_DN,SET,109,0.068485,0.0052614,0.087378,0.21659,CHEBOTAEV_GR_TARGETS_DN,0.990855193014706
GOBP_PLASMA_MEMBRANE_REPAIR,SET,27,0.12714,0.0048723,0.16225,0.21664,GOBP_PLASMA_MEMBRANE_REPAIR,0.990855193014706
GOBP_CALMODULIN_DEPENDENT_KI...,SET,12,0.19604,0.0050104,0.25027,0.21673,GOBP_CALMODULIN_DEPENDENT_KINASE_SIGNALING_PATHWAY,0.990855193014706
MIR3135B,SET,97,0.06814,0.00494,0.086998,0.21675,MIR3135B,0.990855193014706
GOBP_PHENOL_CONTAINING_COMPO...1,SET,44,0.10901,0.0053304,0.13918,0.21676,GOBP_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.990855193014706
WANG_LSD1_TARGETS_UP,SET,21,0.15982,0.0054024,0.20408,0.21677,WANG_LSD1_TARGETS_UP,0.990855193014706
HP_MENORRHAGIA,SET,34,0.11991,0.0051557,0.15311,0.21677,HP_MENORRHAGIA,0.990855193014706
GSE21927_SPLENIC_C26GM_TUMOR...2,SET,151,0.052411,0.0047338,0.066965,0.21692,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_UP,0.990855193014706
GSE17721_POLYIC_VS_PAM3CSK4_...6,SET,187,0.047406,0.0047602,0.060575,0.21693,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP,0.990855193014706
MIR3188,SET,72,0.076631,0.0047897,0.097945,0.217,MIR3188,0.990855193014706
MIR4463,SET,75,0.075859,0.0048388,0.09696,0.217,MIR4463,0.990855193014706
HP_PROMINENT_NOSE,SET,86,0.068603,0.0046845,0.087688,0.21701,HP_PROMINENT_NOSE,0.990855193014706
REACTOME_PECAM1_INTERACTIONS,SET,11,0.19162,0.0046891,0.24493,0.21702,REACTOME_PECAM1_INTERACTIONS,0.990855193014706
TGTATGA_MIR4853P,SET,146,0.056089,0.0049821,0.071696,0.21702,TGTATGA_MIR4853P,0.990855193014706
HP_LANGUAGE_IMPAIRMENT,SET,987,0.021595,0.0048707,0.027613,0.21709,HP_LANGUAGE_IMPAIRMENT,0.990855193014706
HP_APLASIA_OF_THE_MIDDLE_PHA...,SET,7,0.24026,0.0046906,0.30721,0.2171,HP_APLASIA_OF_THE_MIDDLE_PHALANX_OF_THE_HAND,0.990855193014706
GSE7852_LN_VS_THYMUS_TREG_DN,SET,179,0.050251,0.0049378,0.064257,0.2171,GSE7852_LN_VS_THYMUS_TREG_DN,0.990855193014706
MIR6859_5P,SET,189,0.04784,0.0048291,0.061177,0.21711,MIR6859_5P,0.990855193014706
GOCC_TRANSCRIPTION_FACTOR_TF...1,SET,5,0.26113,0.004309,0.33392,0.21711,GOCC_TRANSCRIPTION_FACTOR_TFIIA_COMPLEX,0.990855193014706
MIR380_5P,SET,42,0.1105,0.0052793,0.14131,0.21713,MIR380_5P,0.990855193014706
HP_ABNORMAL_SEVENTH_CRANIAL_...,SET,167,0.050512,0.0047958,0.064607,0.21716,HP_ABNORMAL_SEVENTH_CRANIAL_PHYSIOLOGY,0.990861992910595
KEGG_MEDICUS_VARIANT_EWSR1_W...,SET,5,0.3235,0.0053381,0.41408,0.21733,KEGG_MEDICUS_VARIANT_EWSR1_WT1_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.990865915345302
HP_PAPILLEDEMA,SET,26,0.12847,0.0048315,0.16444,0.21733,HP_PAPILLEDEMA,0.990865915345302
GOBP_REGULATION_OF_JUN_KINAS...,SET,39,0.10412,0.0047939,0.13328,0.21735,GOBP_REGULATION_OF_JUN_KINASE_ACTIVITY,0.990865915345302
GSE360_L_DONOVANI_VS_B_MALAY...8,SET,185,0.050188,0.0050127,0.064253,0.21738,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.990865915345302
GSE9006_1MONTH_VS_4MONTH_POS...1,SET,169,0.052693,0.0050324,0.06746,0.21738,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN,0.990865915345302
GOBP_REGULATION_OF_HOMOTYPIC...,SET,36,0.12254,0.005421,0.15692,0.21744,GOBP_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,0.990865915345302
GOBP_PYRIMIDINE_NUCLEOBASE_M...,SET,20,0.14512,0.0047872,0.18584,0.21745,GOBP_PYRIMIDINE_NUCLEOBASE_METABOLIC_PROCESS,0.990865915345302
GOBP_POSITIVE_REGULATION_OF_...600,SET,32,0.12429,0.0051848,0.15919,0.21746,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,0.990865915345302
MIR548AO_5P_MIR548AX,SET,152,0.054893,0.0049741,0.070311,0.21749,MIR548AO_5P_MIR548AX,0.990865915345302
HUANG_FOXA2_TARGETS_DN,SET,35,0.11758,0.0051291,0.15061,0.2175,HUANG_FOXA2_TARGETS_DN,0.990865915345302
GOBP_SYNAPTIC_VESICLE_DOCKING,SET,9,0.21952,0.0048594,0.28124,0.21754,GOBP_SYNAPTIC_VESICLE_DOCKING,0.990865915345302
KEGG_MEDICUS_REFERENCE_ELECT...2,SET,10,0.18018,0.0042042,0.23085,0.21755,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_III,0.990865915345302
GSE2405_S_AUREUS_VS_A_PHAGOC...1,SET,189,0.045511,0.004594,0.058312,0.21756,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN,0.990865915345302
GSE37532_VISCERAL_ADIPOSE_TI...3,SET,120,0.058813,0.0047394,0.075353,0.21756,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN,0.990865915345302
FOXD3_TARGET_GENES,SET,29,0.12898,0.0051224,0.16529,0.2176,FOXD3_TARGET_GENES,0.990918238993711
REACTOME_PINK1_PRKN_MEDIATED...,SET,28,0.11932,0.0046565,0.15298,0.21771,REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY,0.99098044834308
GSE26343_WT_VS_NFAT5_KO_MACR...1,SET,186,0.050567,0.0050641,0.064833,0.21771,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN,0.99098044834308
GOBP_FOLIC_ACID_METABOLIC_PR...,SET,13,0.15959,0.0042453,0.2047,0.21782,GOBP_FOLIC_ACID_METABOLIC_PROCESS,0.99098044834308
GSE26488_WT_VS_VP16_TRANSGEN...2,SET,181,0.050707,0.00501,0.065062,0.21789,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,0.99098044834308
HP_AGAMMAGLOBULINEMIA,SET,19,0.16179,0.0052023,0.20763,0.21792,HP_AGAMMAGLOBULINEMIA,0.99098044834308
PID_ATR_PATHWAY,SET,38,0.097497,0.0044312,0.12512,0.21794,PID_ATR_PATHWAY,0.99098044834308
MIR6735_5P,SET,92,0.069967,0.0049407,0.089815,0.21799,MIR6735_5P,0.99098044834308
GSE21063_CTRL_VS_ANTI_IGM_ST...7,SET,175,0.049204,0.0047811,0.063166,0.21801,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN,0.99098044834308
GOMF_PROTEIN_KINASE_A_BINDING,SET,49,0.092294,0.0047619,0.11852,0.21808,GOMF_PROTEIN_KINASE_A_BINDING,0.99098044834308
GOMF_MISMATCHED_DNA_BINDING,SET,14,0.14324,0.0039542,0.18399,0.21813,GOMF_MISMATCHED_DNA_BINDING,0.99098044834308
GSE43955_1H_VS_60H_ACT_CD4_T...2,SET,184,0.049045,0.0048854,0.063006,0.21817,GSE43955_1H_VS_60H_ACT_CD4_TCELL_UP,0.99098044834308
ARHGAP35_TARGET_GENES,SET,87,0.069922,0.0048021,0.089831,0.21818,ARHGAP35_TARGET_GENES,0.99098044834308
GOBP_NEGATIVE_REGULATION_OF_...387,SET,10,0.24814,0.0057897,0.31883,0.21821,GOBP_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_APOPTOTIC_PROCESS,0.99098044834308
E2A_Q2,SET,220,0.044146,0.0048037,0.056725,0.21822,E2A_Q2,0.99098044834308
PID_EPHRINB_REV_PATHWAY,SET,29,0.12965,0.0051487,0.16661,0.21825,PID_EPHRINB_REV_PATHWAY,0.99098044834308
GSE13173_UNTREATED_VS_IL12_T...2,SET,113,0.063524,0.0049685,0.081649,0.21829,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP,0.99098044834308
GOBP_NORADRENERGIC_NEURON_DI...,SET,9,0.2793,0.0061826,0.35907,0.21834,GOBP_NORADRENERGIC_NEURON_DIFFERENTIATION,0.99098044834308
GOBP_REGULATION_OF_ACTIVATIO...,SET,8,0.24752,0.0051659,0.31821,0.21834,GOBP_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY,0.99098044834308
GSE22033_UNTREATED_VS_ROSIGL...1,SET,176,0.05038,0.0049092,0.064773,0.21835,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN,0.99098044834308
HP_MONOTONIC_SPEECH,SET,8,0.27237,0.0056845,0.3502,0.21837,HP_MONOTONIC_SPEECH,0.99098044834308
PETROVA_ENDOTHELIUM_LYMPHATI...1,SET,154,0.05697,0.0051959,0.073255,0.21838,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,0.99098044834308
GOBP_POSITIVE_REGULATION_OF_...589,SET,633,0.02781,0.0050743,0.03576,0.21838,GOBP_POSITIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,0.99098044834308
GOBP_GABAERGIC_NEURON_DIFFER...,SET,18,0.18334,0.0057381,0.23578,0.21841,GOBP_GABAERGIC_NEURON_DIFFERENTIATION,0.99098044834308
GSE46606_IRF4HIGH_VS_IRF4MID...3,SET,181,0.050907,0.0050298,0.065481,0.21846,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.99098044834308
GSE35685_CD34POS_CD10NEG_CD6...1,SET,190,0.049846,0.0050447,0.064126,0.21849,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN,0.99098044834308
GOBP_NEURON_PROJECTION_ORGAN...,SET,85,0.073299,0.0049761,0.094302,0.2185,GOBP_NEURON_PROJECTION_ORGANIZATION,0.99098044834308
GOBP_ORGAN_INDUCTION,SET,20,0.16705,0.0055108,0.21492,0.2185,GOBP_ORGAN_INDUCTION,0.99098044834308
GOCC_CYCLIN_CDK_POSITIVE_TRA...,SET,8,0.17112,0.0035715,0.22028,0.21863,GOCC_CYCLIN_CDK_POSITIVE_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX,0.99098044834308
GOMF_STAT_FAMILY_PROTEIN_BIN...,SET,10,0.20591,0.0048045,0.26505,0.21863,GOMF_STAT_FAMILY_PROTEIN_BINDING,0.99098044834308
HP_ABSENT_FOVEAL_REFLEX,SET,14,0.18381,0.0050739,0.23661,0.21863,HP_ABSENT_FOVEAL_REFLEX,0.99098044834308
RHEIN_ALL_GLUCOCORTICOID_THE...2,SET,67,0.083382,0.0050281,0.10734,0.21865,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,0.99098044834308
GAVISH_3CA_MALIGNANT_METAPRO...32,SET,40,0.093767,0.0043722,0.12071,0.21865,GAVISH_3CA_MALIGNANT_METAPROGRAM_3_CELL_CYLCE_HMG_RICH,0.99098044834308
MYOCD_TARGET_GENES,SET,1134,0.02049,0.0049327,0.026384,0.2187,MYOCD_TARGET_GENES,0.99098044834308
WU_HBX_TARGETS_3_UP,SET,18,0.16585,0.0051908,0.21358,0.21872,WU_HBX_TARGETS_3_UP,0.99098044834308
HP_CHRONIC_LYMPHOCYTIC_MENIN...,SET,5,0.32809,0.0054138,0.42253,0.21874,HP_CHRONIC_LYMPHOCYTIC_MENINGITIS,0.99098044834308
GOMF_SUPEROXIDE_GENERATING_N...1,SET,7,0.26935,0.0052587,0.34691,0.21875,GOMF_SUPEROXIDE_GENERATING_NADPH_OXIDASE_ACTIVATOR_ACTIVITY,0.99098044834308
GARGALOVIC_RESPONSE_TO_OXIDI...20,SET,10,0.23145,0.0054003,0.29813,0.21878,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,0.99098044834308
LUI_THYROID_CANCER_CLUSTER_4,SET,10,0.24605,0.005741,0.31698,0.21881,LUI_THYROID_CANCER_CLUSTER_4,0.99098044834308
GOBP_CERAMIDE_BIOSYNTHETIC_P...,SET,66,0.084342,0.005048,0.10869,0.21888,GOBP_CERAMIDE_BIOSYNTHETIC_PROCESS,0.99098044834308
GOCC_FEMALE_GERM_CELL_NUCLEUS,SET,14,0.18214,0.005028,0.23472,0.21888,GOCC_FEMALE_GERM_CELL_NUCLEUS,0.99098044834308
KORKOLA_SEMINOMA_DN,SET,8,0.28643,0.0059781,0.36914,0.2189,KORKOLA_SEMINOMA_DN,0.99098044834308
KEGG_MEDICUS_REFERENCE_LECTI...1,SET,10,0.26484,0.0061794,0.34134,0.21892,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_FIBRINOGEN_TO_FIBRIN,0.99098044834308
MORF_EIF4E,SET,79,0.0709,0.004641,0.091397,0.21896,MORF_EIF4E,0.99098044834308
GOBP_BRANCHED_CHAIN_AMINO_AC...2,SET,21,0.13947,0.0047144,0.1798,0.21897,GOBP_BRANCHED_CHAIN_AMINO_ACID_CATABOLIC_PROCESS,0.99098044834308
GOBP_REGULATION_OF_FAT_CELL_...1,SET,121,0.065063,0.0052647,0.083885,0.21899,GOBP_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.99098044834308
QUINTENS_EMBRYONIC_BRAIN_RES...,SET,73,0.077787,0.0048954,0.1003,0.21901,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,0.99098044834308
GOCC_SYNAPTONEMAL_STRUCTURE,SET,34,0.10019,0.0043076,0.12918,0.21901,GOCC_SYNAPTONEMAL_STRUCTURE,0.99098044834308
GSE29618_BCELL_VS_PDC_DN,SET,177,0.051764,0.0050582,0.066758,0.21906,GSE29618_BCELL_VS_PDC_DN,0.99098044834308
KEGG_MEDICUS_REFERENCE_HEDGE...1,SET,14,0.17069,0.0047119,0.22016,0.21908,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY,0.99098044834308
GOBP_REGULATION_OF_CALCINEUR...,SET,40,0.10061,0.0046913,0.12977,0.21909,GOBP_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,0.99098044834308
BRN2_01,SET,210,0.047242,0.0050237,0.060955,0.21917,BRN2_01,0.99098044834308
HP_ABNORMALITY_OF_FACIAL_MUS...,SET,291,0.038558,0.004816,0.049751,0.21917,HP_ABNORMALITY_OF_FACIAL_MUSCULATURE,0.99098044834308
GOBP_ACTIVATION_OF_GTPASE_AC...,SET,81,0.075118,0.0049787,0.096941,0.21921,GOBP_ACTIVATION_OF_GTPASE_ACTIVITY,0.99098044834308
GOBP_REGULATION_OF_GLYCOPROT...,SET,44,0.10037,0.0049077,0.12954,0.21924,GOBP_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,0.99098044834308
REACTOME_TELOMERE_C_STRAND_L...,SET,32,0.10612,0.0044265,0.13699,0.21928,REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS,0.99098044834308
KEGG_MEDICUS_REFERENCE_ITGA_...3,SET,22,0.15158,0.0052442,0.19571,0.21932,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY,0.99098044834308
GSE41176_UNSTIM_VS_ANTI_IGM_...14,SET,179,0.048251,0.0047413,0.062303,0.21933,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP,0.99098044834308
GOBP_SYNAPTIC_VESICLE_CYTOSK...,SET,18,0.15755,0.0049308,0.20345,0.21936,GOBP_SYNAPTIC_VESICLE_CYTOSKELETAL_TRANSPORT,0.99098044834308
MIR1250_5P,SET,6,0.24203,0.0043748,0.31256,0.21937,MIR1250_5P,0.99098044834308
TGTGTGA_MIR377,SET,182,0.048096,0.004765,0.06212,0.2194,TGTGTGA_MIR377,0.99098044834308
GOBP_REGULATION_OF_INTRACELL...5,SET,61,0.083837,0.0048247,0.10828,0.2194,GOBP_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.99098044834308
GOBP_REGULATION_OF_MICROTUBU...2,SET,235,0.041014,0.0046106,0.052976,0.21941,GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS,0.99098044834308
GSE360_DC_VS_MAC_UP,SET,178,0.049622,0.0048625,0.064095,0.21941,GSE360_DC_VS_MAC_UP,0.99098044834308
GOBP_POSITIVE_REGULATION_OF_...6,SET,13,0.18516,0.0049255,0.23936,0.2196,GOBP_POSITIVE_REGULATION_OF_ACTIN_NUCLEATION,0.991626029621931
GOBP_MYELOID_LEUKOCYTE_DIFFE...,SET,218,0.04845,0.0052483,0.062636,0.21961,GOBP_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.991626029621931
REACTOME_REGULATION_OF_NPAS4...1,SET,13,0.19267,0.0051252,0.24915,0.21968,REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION,0.991698845355475
GSE17974_0.5H_VS_72H_UNTREAT...1,SET,172,0.046512,0.004481,0.060156,0.21971,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,0.991698845355475
GOBP_CARDIOLIPIN_BIOSYNTHETI...,SET,7,0.26287,0.005132,0.34001,0.21973,GOBP_CARDIOLIPIN_BIOSYNTHETIC_PROCESS,0.991698845355475
HP_ILEUS,SET,29,0.12862,0.0051082,0.16641,0.21978,HP_ILEUS,0.991698845355475
GSE41867_NAIVE_VS_DAY15_LCMV...6,SET,183,0.046868,0.004656,0.060637,0.21979,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_UP,0.991698845355475
ZNF407_TARGET_GENES,SET,1551,0.017476,0.0048605,0.022616,0.21984,ZNF407_TARGET_GENES,0.991698845355475
GOBP_CEREBELLAR_CORTEX_DEVEL...,SET,46,0.097023,0.0048506,0.12557,0.21986,GOBP_CEREBELLAR_CORTEX_DEVELOPMENT,0.991698845355475
HP_RETINAL_VASCULAR_TORTUOSI...,SET,38,0.11236,0.0051067,0.14542,0.21986,HP_RETINAL_VASCULAR_TORTUOSITY,0.991698845355475
MORF_PRKAR1A,SET,125,0.054497,0.0044816,0.070544,0.21991,MORF_PRKAR1A,0.991698845355475
MIR4756_3P,SET,106,0.064212,0.0048652,0.083132,0.21994,MIR4756_3P,0.991698845355475
GSE21360_NAIVE_VS_TERTIARY_M...2,SET,168,0.049917,0.0047533,0.064624,0.21994,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_UP,0.991698845355475
HP_HYPEREXTENSIBILITY_AT_ELB...,SET,6,0.27348,0.0049434,0.35415,0.22,HP_HYPEREXTENSIBILITY_AT_ELBOW,0.991840705668699
chr6q15,SET,23,0.2458,0.0086948,0.31835,0.22003,chr6q15,0.991847295719844
GOBP_MULTINUCLEAR_OSTEOCLAST...,SET,8,0.25252,0.0052703,0.32735,0.22024,GOBP_MULTINUCLEAR_OSTEOCLAST_DIFFERENTIATION,0.992665179613539
GOMF_ACTIN_BINDING,SET,400,0.033522,0.004894,0.043462,0.22028,GOMF_ACTIN_BINDING,0.992716727178423
GSE17721_LPS_VS_GARDIQUIMOD_...11,SET,190,0.046572,0.0047134,0.060411,0.22038,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_DN,0.993
HP_ABNORMAL_DENSE_GRANULES,SET,9,0.21774,0.0048199,0.28246,0.2204,HP_ABNORMAL_DENSE_GRANULES,0.993
GOBP_REGULATION_OF_CENTROSOM...,SET,52,0.086757,0.0046108,0.11256,0.22044,GOBP_REGULATION_OF_CENTROSOME_CYCLE,0.993051484121841
GOBP_CARBOHYDRATE_BIOSYNTHET...,SET,186,0.047955,0.0048025,0.06224,0.22051,GOBP_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,0.9931544123364
REACTOME_EXTRINSIC_PATHWAY_O...,SET,4,0.39295,0.0057997,0.51003,0.22052,REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,0.9931544123364
HP_MULTIPLE_ENCHONDROMATOSIS,SET,10,0.20254,0.0047258,0.26296,0.22059,HP_MULTIPLE_ENCHONDROMATOSIS,0.993340949727909
GAVISH_3CA_MALIGNANT_METAPRO...37,SET,37,0.11088,0.0049728,0.14399,0.22065,GAVISH_3CA_MALIGNANT_METAPROGRAM_7_STRESS_IN_VITRO,0.993366491841492
CHICAS_RB1_TARGETS_LOW_SERUM,SET,74,0.075978,0.0048141,0.098694,0.2207,CHICAS_RB1_TARGETS_LOW_SERUM,0.993366491841492
SAMOLS_TARGETS_OF_KHSV_MIRNA...2,SET,8,0.25513,0.0053247,0.3314,0.2207,SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP,0.993366491841492
HP_AORTIC_VALVE_STENOSIS,SET,51,0.095604,0.0050321,0.12419,0.22071,HP_AORTIC_VALVE_STENOSIS,0.993366491841492
HP_ABNORMAL_FULL_FIELD_ELECT...,SET,55,0.095609,0.0052253,0.12421,0.22074,HP_ABNORMAL_FULL_FIELD_ELECTRORETINOGRAM,0.993372873235789
GOCC_TRANS_GOLGI_NETWORK_TRA...1,SET,35,0.11072,0.00483,0.14389,0.2208,GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE,0.993514241325738
GOMF_ARYLSULFATASE_ACTIVITY,SET,9,0.23774,0.0052626,0.30902,0.22085,GOMF_ARYLSULFATASE_ACTIVITY,0.993608377402296
GSE45365_NK_CELL_VS_CD11B_DC...1,SET,184,0.050233,0.0050038,0.065309,0.2209,GSE45365_NK_CELL_VS_CD11B_DC_DN,0.993608377402296
GSE39556_UNTREATED_VS_3H_POL...3,SET,179,0.050213,0.004934,0.065287,0.22092,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN,0.993608377402296
MIR219A_1_3P,SET,55,0.088918,0.0048597,0.11562,0.22094,MIR219A_1_3P,0.993608377402296
KEGG_MEDICUS_REFERENCE_TYPE_...3,SET,20,0.17905,0.0059067,0.23292,0.22103,KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,0.993608377402296
REACTOME_REGULATION_OF_GENE_...2,SET,21,0.15412,0.0052098,0.20054,0.22109,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS,0.993608377402296
BACH1_01,SET,238,0.044271,0.005008,0.057606,0.2211,BACH1_01,0.993608377402296
GOMF_PEPTIDASE_ACTIVITY,SET,534,0.029669,0.004986,0.038616,0.22116,GOMF_PEPTIDASE_ACTIVITY,0.993608377402296
MIR320A_5P,SET,98,0.069241,0.0050455,0.090131,0.22118,MIR320A_5P,0.993608377402296
GOMF_METALLOCHAPERONE_ACTIVI...,SET,12,0.16991,0.0043425,0.22116,0.22118,GOMF_METALLOCHAPERONE_ACTIVITY,0.993608377402296
UNTERMAN_PROGRESSIVE_VS_STAB...5,SET,8,0.25821,0.005389,0.33619,0.22124,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_NK_CELL_DN,0.993608377402296
REACTOME_CD28_DEPENDENT_PI3K...,SET,22,0.15127,0.0052334,0.19699,0.22128,REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING,0.993608377402296
DESCARTES_MAIN_FETAL_INTESTI...,SET,69,0.080414,0.0049207,0.10473,0.2213,DESCARTES_MAIN_FETAL_INTESTINAL_EPITHELIAL_CELLS,0.993608377402296
MIR1233_5P,SET,94,0.065244,0.0046567,0.084991,0.22135,MIR1233_5P,0.993608377402296
GOBP_CARBOHYDRATE_HOMEOSTASIS,SET,229,0.04426,0.0049124,0.057656,0.22135,GOBP_CARBOHYDRATE_HOMEOSTASIS,0.993608377402296
MIR4474_5P,SET,44,0.10316,0.0050444,0.13439,0.22136,MIR4474_5P,0.993608377402296
GOBP_ACETATE_ESTER_TRANSPORT,SET,9,0.22052,0.0048815,0.28731,0.22139,GOBP_ACETATE_ESTER_TRANSPORT,0.993608377402296
HP_RECURRENT_BACTERIAL_INFEC...,SET,184,0.049888,0.0049694,0.064999,0.22139,HP_RECURRENT_BACTERIAL_INFECTIONS,0.993608377402296
GSE369_PRE_VS_POST_IL6_INJEC...4,SET,177,0.051166,0.0049998,0.066675,0.22143,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP,0.993608377402296
GOMF_LACTATE_TRANSMEMBRANE_T...,SET,6,0.30595,0.0055302,0.39879,0.22148,GOMF_LACTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.993608377402296
GOBP_NEGATIVE_REGULATION_OF_...216,SET,28,0.12636,0.0049311,0.16472,0.2215,GOBP_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,0.993608377402296
HP_ABNORMAL_BLOOD_POTASSIUM_...,SET,105,0.06638,0.0050058,0.086532,0.22151,HP_ABNORMAL_BLOOD_POTASSIUM_CONCENTRATION,0.993608377402296
MIR92A_3P,SET,434,0.032431,0.0049271,0.042283,0.22155,MIR92A_3P,0.993608377402296
GOBP_ERBB4_SIGNALING_PATHWAY,SET,9,0.22112,0.0048948,0.28832,0.22157,GOBP_ERBB4_SIGNALING_PATHWAY,0.993608377402296
MODULE_316,SET,63,0.089147,0.0052134,0.11625,0.22159,MODULE_316,0.993608377402296
GOBP_CELL_COMMUNICATION_INVO...,SET,55,0.099583,0.0054425,0.12986,0.22159,GOBP_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION,0.993608377402296
GOBP_REGULATION_OF_DNA_DEMET...,SET,4,0.3178,0.0046906,0.4145,0.22163,GOBP_REGULATION_OF_DNA_DEMETHYLATION,0.993608377402296
GOCC_ATPASE_COMPLEX,SET,117,0.057966,0.0046128,0.075601,0.22163,GOCC_ATPASE_COMPLEX,0.993608377402296
GOCC_SEC61_TRANSLOCON_COMPLEX,SET,4,0.32241,0.0047585,0.42054,0.22165,GOCC_SEC61_TRANSLOCON_COMPLEX,0.993608377402296
HP_ABNORMALITY_OF_CONNECTIVE...,SET,1351,0.018424,0.0048105,0.024045,0.22178,HP_ABNORMALITY_OF_CONNECTIVE_TISSUE,0.994061963664476
GOBP_SODIUM_ION_EXPORT_ACROS...,SET,15,0.1943,0.0055519,0.25364,0.22182,GOBP_SODIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.994061963664476
REACTOME_SUPPRESSION_OF_APOP...,SET,7,0.23212,0.0045317,0.30304,0.22185,REACTOME_SUPPRESSION_OF_APOPTOSIS,0.994061963664476
PAL_PRMT5_TARGETS_UP,SET,186,0.04689,0.0046958,0.061237,0.22193,PAL_PRMT5_TARGETS_UP,0.994061963664476
GOBP_REGULATION_OF_SOMATIC_S...,SET,11,0.20805,0.0050912,0.27173,0.22194,GOBP_REGULATION_OF_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.994061963664476
GOBP_POSITIVE_T_CELL_SELECTI...,SET,44,0.10899,0.0053295,0.14235,0.22195,GOBP_POSITIVE_T_CELL_SELECTION,0.994061963664476
BUSSLINGER_DUODENAL_K_CELLS,SET,17,0.16761,0.005098,0.21891,0.22196,BUSSLINGER_DUODENAL_K_CELLS,0.994061963664476
GSE360_T_GONDII_VS_M_TUBERCU...1,SET,184,0.049575,0.0049383,0.064757,0.22198,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN,0.994061963664476
GSE28737_WT_VS_BCL6_KO_MARGI...1,SET,174,0.048694,0.0047181,0.06365,0.22213,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,0.99454077388617
GOBP_NEGATIVE_REGULATION_OF_...701,SET,85,0.077226,0.0052427,0.10096,0.22217,GOBP_NEGATIVE_REGULATION_OF_VIRAL_PROCESS,0.99454077388617
PASQUALUCCI_LYMPHOMA_BY_GC_S...2,SET,262,0.041965,0.0049774,0.054875,0.22222,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,0.99454077388617
WP_ESTROGEN_METABOLISM_WP5276,SET,23,0.14328,0.0050682,0.18735,0.22222,WP_ESTROGEN_METABOLISM_WP5276,0.99454077388617
MIR144_5P,SET,47,0.094198,0.0047601,0.12318,0.22223,MIR144_5P,0.99454077388617
GSE9601_UNTREATED_VS_NFKB_IN...1,SET,162,0.050628,0.0047349,0.066228,0.22231,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,0.994770702974121
GOBP_PURINE_CONTAINING_COMPO...4,SET,37,0.11621,0.0052117,0.15207,0.22238,GOBP_PURINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT,0.99495583161689
WU_HBX_TARGETS_1_UP,SET,13,0.18766,0.0049921,0.2456,0.22241,WU_HBX_TARGETS_1_UP,0.994961970652594
KEGG_MEDICUS_ENV_FACTOR_NNK_...1,SET,9,0.19221,0.0042548,0.25161,0.22247,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_CHRNA7_E2F_SIGNALING_PATHWAY,0.995102297297297
HP_POOR_FINE_MOTOR_COORDINAT...,SET,64,0.08209,0.0048385,0.10749,0.22254,HP_POOR_FINE_MOTOR_COORDINATION,0.995287311800283
CHANDRAN_METASTASIS_DN,SET,288,0.040088,0.0049816,0.052509,0.2226,CHANDRAN_METASTASIS_DN,0.995344210729448
MIR516A_5P,SET,6,0.26073,0.0047128,0.34153,0.22261,MIR516A_5P,0.995344210729448
GOBP_RESPONSE_TO_ODORANT,SET,5,0.31545,0.0052054,0.41337,0.2227,GOBP_RESPONSE_TO_ODORANT,0.995392847962987
HE_LIM_SUN_FETAL_LUNG_C0_ALV...,SET,7,0.28999,0.0056615,0.38,0.2227,HE_LIM_SUN_FETAL_LUNG_C0_ALVEOLAR_FIBROBLAST,0.995392847962987
HP_ABNORMAL_NASAL_MORPHOLOGY,SET,1289,0.018514,0.0047305,0.024269,0.22277,HP_ABNORMAL_NASAL_MORPHOLOGY,0.995392847962987
GOBP_CELLULAR_RESPONSE_TO_AL...3,SET,7,0.28031,0.0054726,0.36745,0.22278,GOBP_CELLULAR_RESPONSE_TO_ALDOSTERONE,0.995392847962987
LI_ESTROGENE_MID_E2_RESPONSE...2,SET,14,0.18421,0.0050851,0.24148,0.22279,LI_ESTROGENE_MID_E2_RESPONSE_UP,0.995392847962987
E2F_Q3,SET,196,0.044593,0.004583,0.058462,0.2228,E2F_Q3,0.995392847962987
MIR6822_5P,SET,64,0.077798,0.0045855,0.102,0.22283,MIR6822_5P,0.995392847962987
GSE37605_TREG_VS_TCONV_NOD_F...2,SET,133,0.058823,0.0049886,0.077133,0.22285,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP,0.995392847962987
GOBP_POSITIVE_REGULATION_OF_...31,SET,5,0.33053,0.0054541,0.43358,0.22294,GOBP_POSITIVE_REGULATION_OF_ANTIBACTERIAL_PEPTIDE_PRODUCTION,0.995538956700501
GSE25088_CTRL_VS_IL4_AND_ROS...1,SET,170,0.05002,0.0047911,0.065617,0.22294,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.995538956700501
HP_PLEURITIS,SET,26,0.14233,0.0053527,0.18677,0.22301,HP_PLEURITIS,0.995557108913434
HP_BROAD_LONG_BONES,SET,128,0.058393,0.0048588,0.076627,0.22302,HP_BROAD_LONG_BONES,0.995557108913434
WP_BIOTIN_METABOLISM_INCLUDI...,SET,9,0.21722,0.0048084,0.28505,0.22303,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,0.995557108913434
GOBP_GAMMA_AMINOBUTYRIC_ACID...3,SET,8,0.25434,0.0053083,0.33382,0.22306,GOBP_GAMMA_AMINOBUTYRIC_ACID_METABOLIC_PROCESS,0.995563156542956
GOBP_POSITIVE_REGULATION_OF_...375,SET,88,0.069594,0.0048068,0.091357,0.2231,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,0.995613828967642
GSE8921_UNSTIM_VS_TLR1_2_STI...2,SET,183,0.049269,0.0048945,0.06469,0.22315,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP,0.995709108999872
MORF_BMPR2,SET,47,0.10266,0.0051878,0.13483,0.22321,MORF_BMPR2,0.995801023464803
ZNF34_TARGET_GENES,SET,213,0.04365,0.0046745,0.05734,0.22326,ZNF34_TARGET_GENES,0.995801023464803
KEGG_MEDICUS_REFERENCE_LYSOS...,SET,10,0.19217,0.0044839,0.25251,0.22332,KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE,0.995801023464803
MIR584_5P,SET,79,0.073911,0.0048381,0.097119,0.22332,MIR584_5P,0.995801023464803
GOBP_NEUROMUSCULAR_PROCESS,SET,153,0.05351,0.0048647,0.070321,0.22335,GOBP_NEUROMUSCULAR_PROCESS,0.995801023464803
TESAR_ALK_AND_JAK_TARGETS_MO...2,SET,4,0.32899,0.0048557,0.43241,0.22339,TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP,0.995801023464803
GOCC_PERICENTRIC_HETEROCHROM...,SET,27,0.12459,0.0047745,0.16385,0.22351,GOCC_PERICENTRIC_HETEROCHROMATIN,0.995801023464803
HP_LIMB_GIRDLE_MUSCLE_ATROPHY,SET,31,0.11627,0.004774,0.15292,0.22352,HP_LIMB_GIRDLE_MUSCLE_ATROPHY,0.995801023464803
REACTOME_DISEASES_ASSOCIATED...3,SET,19,0.13246,0.0042592,0.17422,0.22354,REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS,0.995801023464803
KEGG_MEDICUS_PATHOGEN_HCMV_U...2,SET,6,0.26817,0.0048473,0.35276,0.22357,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,0.995801023464803
GOMF_ALL_TRANS_RETINOL_DEHYD...,SET,13,0.18973,0.0050471,0.24958,0.22357,GOMF_ALL_TRANS_RETINOL_DEHYDROGENASE_NADPPLUS_ACTIVITY,0.995801023464803
GOBP_ADULT_LOCOMOTORY_BEHAVI...,SET,79,0.075174,0.0049207,0.098898,0.2236,GOBP_ADULT_LOCOMOTORY_BEHAVIOR,0.995801023464803
WANG_IMMORTALIZED_BY_HOXA9_A...1,SET,24,0.14665,0.0052991,0.19295,0.22361,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,0.995801023464803
GOBP_REGULATION_OF_DNA_TEMPL...3,SET,94,0.062899,0.0044893,0.082769,0.22365,GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,0.995801023464803
HP_TAPERED_FINGER,SET,111,0.059065,0.0045789,0.077726,0.22366,HP_TAPERED_FINGER,0.995801023464803
GOBP_DTMP_METABOLIC_PROCESS,SET,6,0.2227,0.0040255,0.29318,0.22375,GOBP_DTMP_METABOLIC_PROCESS,0.995801023464803
GSE42088_2H_VS_24H_LEISHMANI...1,SET,173,0.048058,0.0046432,0.063271,0.22377,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN,0.995801023464803
MIR3126_5P,SET,59,0.083507,0.0047265,0.10997,0.22381,MIR3126_5P,0.995801023464803
GOBP_RENAL_WATER_ABSORPTION,SET,6,0.2977,0.0053811,0.39206,0.22383,GOBP_RENAL_WATER_ABSORPTION,0.995801023464803
GOBP_LYTIC_VACUOLE_ORGANIZAT...,SET,98,0.066262,0.0048284,0.087266,0.22384,GOBP_LYTIC_VACUOLE_ORGANIZATION,0.995801023464803
MIR7109_3P,SET,60,0.078578,0.0044849,0.10349,0.22385,MIR7109_3P,0.995801023464803
HP_LAGOPHTHALMOS,SET,12,0.16974,0.0043383,0.22358,0.22387,HP_LAGOPHTHALMOS,0.995801023464803
HP_EEG_WITH_FRONTAL_EPILEPTI...,SET,5,0.34237,0.0056494,0.45105,0.22392,HP_EEG_WITH_FRONTAL_EPILEPTIFORM_DISCHARGES,0.995801023464803
ATACCTC_MIR202,SET,168,0.05024,0.004784,0.066192,0.22393,ATACCTC_MIR202,0.995801023464803
DR4_Q2,SET,226,0.04334,0.0047791,0.057101,0.22393,DR4_Q2,0.995801023464803
GSE29164_UNTREATED_VS_CD8_TC...3,SET,181,0.04836,0.0047781,0.063746,0.22404,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,0.995801023464803
GSE27786_BCELL_VS_NKTCELL_DN,SET,178,0.049057,0.0048071,0.064682,0.2241,GSE27786_BCELL_VS_NKTCELL_DN,0.995801023464803
GOBP_GLUCOSE_IMPORT,SET,68,0.081091,0.0049262,0.10693,0.22412,GOBP_GLUCOSE_IMPORT,0.995801023464803
GOBP_MITOCHONDRIAL_CALCIUM_I...1,SET,21,0.14652,0.0049527,0.19327,0.22419,GOBP_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS,0.995801023464803
GOMF_R_SMAD_BINDING,SET,25,0.13584,0.0050094,0.1792,0.22422,GOMF_R_SMAD_BINDING,0.995801023464803
GOMF_3_5_DNA_HELICASE_ACTIVI...,SET,14,0.1637,0.0045188,0.21598,0.22425,GOMF_3_5_DNA_HELICASE_ACTIVITY,0.995801023464803
HP_CESSATION_OF_HEAD_GROWTH,SET,6,0.28087,0.0050768,0.3706,0.22427,HP_CESSATION_OF_HEAD_GROWTH,0.995801023464803
GOBP_OVARIAN_FOLLICLE_DEVELO...,SET,55,0.090861,0.0049659,0.1199,0.22428,GOBP_OVARIAN_FOLLICLE_DEVELOPMENT,0.995801023464803
GSE2585_AIRE_KO_VS_WT_CD80_L...2,SET,165,0.051444,0.0048552,0.067909,0.22437,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP,0.995801023464803
GOBP_SKELETAL_MUSCLE_CELL_DI...,SET,72,0.076628,0.0047895,0.10116,0.22439,GOBP_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,0.995801023464803
OCT1_03,SET,206,0.046246,0.0048713,0.061085,0.2245,OCT1_03,0.995801023464803
GSE40666_WT_VS_STAT4_KO_CD8_...3,SET,187,0.046828,0.0047021,0.061885,0.22462,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.995801023464803
HP_ABNORMAL_ODONTOID_TISSUE_...,SET,207,0.045102,0.0047622,0.059607,0.22463,HP_ABNORMAL_ODONTOID_TISSUE_MORPHOLOGY,0.995801023464803
REACTOME_TNFR1_INDUCED_PROAP...,SET,23,0.13464,0.0047626,0.17796,0.22466,REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING,0.995801023464803
GOBP_FUCOSYLATION,SET,16,0.16411,0.0048428,0.21692,0.22466,GOBP_FUCOSYLATION,0.995801023464803
REACTOME_TRAF3_DEPENDENT_IRF...,SET,14,0.16859,0.0046539,0.22289,0.22472,REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY,0.995801023464803
REACTOME_COENZYME_A_BIOSYNTH...,SET,7,0.21799,0.0042558,0.28822,0.22473,REACTOME_COENZYME_A_BIOSYNTHESIS,0.995801023464803
HP_OLIGOHYDRAMNIOS,SET,166,0.049042,0.0046423,0.064844,0.22474,HP_OLIGOHYDRAMNIOS,0.995801023464803
HP_ABNORMAL_ATRIOVENTRICULAR...1,SET,87,0.07177,0.004929,0.094929,0.22482,HP_ABNORMAL_ATRIOVENTRICULAR_CONDUCTION,0.995801023464803
KEGG_LINOLEIC_ACID_METABOLISM,SET,29,0.1411,0.0056037,0.18664,0.22483,KEGG_LINOLEIC_ACID_METABOLISM,0.995801023464803
DACOSTA_UV_RESPONSE_VIA_ERCC...8,SET,22,0.1336,0.0046222,0.17676,0.22488,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP,0.995801023464803
HP_ABNORMAL_CAROTID_ARTERY_M...,SET,83,0.071334,0.0047857,0.094396,0.22492,HP_ABNORMAL_CAROTID_ARTERY_MORPHOLOGY,0.995801023464803
REACTOME_E3_UBIQUITIN_LIGASE...,SET,39,0.098901,0.0045536,0.13088,0.22494,REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS,0.995801023464803
GOMF_LIPASE_BINDING,SET,6,0.28961,0.0052348,0.38331,0.22497,GOMF_LIPASE_BINDING,0.995801023464803
GOBP_MACROPHAGE_FUSION,SET,6,0.28531,0.0051572,0.37768,0.225,GOBP_MACROPHAGE_FUSION,0.995801023464803
GOCC_TERMINAL_BOUTON,SET,43,0.10339,0.0049981,0.13692,0.22509,GOCC_TERMINAL_BOUTON,0.995801023464803
GSE11924_TFH_VS_TH1_CD4_TCEL...1,SET,174,0.048267,0.0046768,0.063926,0.22512,GSE11924_TFH_VS_TH1_CD4_TCELL_DN,0.995801023464803
GSE37319_WT_VS_RC3H1_KO_CD44...1,SET,122,0.059737,0.0048536,0.07913,0.22515,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_DN,0.995801023464803
GOBP_POSITIVE_REGULATION_OF_...106,SET,1023,0.020973,0.004811,0.027784,0.22517,GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION,0.995801023464803
HP_AORTIC_REGURGITATION,SET,89,0.070319,0.0048843,0.093154,0.22517,HP_AORTIC_REGURGITATION,0.995801023464803
GOMF_UBIQUINONE_BINDING,SET,5,0.22293,0.0036786,0.29534,0.22518,GOMF_UBIQUINONE_BINDING,0.995801023464803
PTEN_DN.V2_DN,SET,119,0.060954,0.0048916,0.080754,0.22519,PTEN_DN.V2_DN,0.995801023464803
REACTOME_INTEGRATION_OF_PROV...,SET,9,0.18234,0.0040364,0.2416,0.22521,REACTOME_INTEGRATION_OF_PROVIRUS,0.995801023464803
GOMF_ADENYLATE_KINASE_ACTIVI...,SET,9,0.22352,0.004948,0.29617,0.22521,GOMF_ADENYLATE_KINASE_ACTIVITY,0.995801023464803
MIR2681_5P,SET,146,0.053761,0.0047753,0.071235,0.22522,MIR2681_5P,0.995801023464803
GSE40274_CTRL_VS_FOXP3_AND_L...1,SET,147,0.052203,0.0046526,0.069171,0.22522,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.995801023464803
GSE27786_NEUTROPHIL_VS_MONO_...2,SET,176,0.048251,0.0047017,0.063937,0.22523,GSE27786_NEUTROPHIL_VS_MONO_MAC_UP,0.995801023464803
MIR4501,SET,73,0.074218,0.0046708,0.098371,0.22529,MIR4501,0.995801023464803
MIR4309,SET,40,0.097082,0.0045267,0.12874,0.2254,MIR4309,0.995801023464803
HP_TETRALOGY_OF_FALLOT,SET,156,0.051998,0.0047729,0.068955,0.22541,HP_TETRALOGY_OF_FALLOT,0.995801023464803
MIR5195_5P,SET,18,0.14958,0.0046814,0.19839,0.22544,MIR5195_5P,0.995801023464803
GOCC_ENDOPLASMIC_RETICULUM_T...1,SET,24,0.12833,0.0046371,0.17025,0.22549,GOCC_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK,0.995801023464803
HP_AGENESIS_OF_LATERAL_INCIS...,SET,23,0.14625,0.0051736,0.19402,0.22549,HP_AGENESIS_OF_LATERAL_INCISOR,0.995801023464803
HP_MYOCLONIC_STATUS_EPILEPTI...,SET,5,0.31195,0.0051475,0.41393,0.22554,HP_MYOCLONIC_STATUS_EPILEPTICUS,0.995801023464803
GSE42021_TCONV_PLN_VS_CD24LO...1,SET,179,0.048408,0.0047567,0.064247,0.22559,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_DN,0.995801023464803
GOBP_ACYLGLYCEROL_HOMEOSTASIS,SET,35,0.10915,0.0047613,0.14488,0.22561,GOBP_ACYLGLYCEROL_HOMEOSTASIS,0.995801023464803
HP_NARROW_MOUTH,SET,208,0.045222,0.0047863,0.060037,0.22566,HP_NARROW_MOUTH,0.995801023464803
KEGG_MEDICUS_VARIANT_MUTATIO...74,SET,7,0.23548,0.0045974,0.31265,0.22568,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_OPTN_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,0.995801023464803
ZHANG_ADIPOGENESIS_BY_BMP7,SET,14,0.17098,0.0047199,0.22708,0.22575,ZHANG_ADIPOGENESIS_BY_BMP7,0.995801023464803
AACWWCAANK_UNKNOWN,SET,132,0.057958,0.0048969,0.076993,0.2258,AACWWCAANK_UNKNOWN,0.995801023464803
GOCC_LATE_ENDOSOME,SET,278,0.03898,0.0047603,0.051782,0.2258,GOCC_LATE_ENDOSOME,0.995801023464803
REACTOME_TRAFFICKING_AND_PRO...,SET,11,0.20396,0.0049911,0.27096,0.22581,REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR,0.995801023464803
MIR664A_3P,SET,359,0.035033,0.0048508,0.046541,0.22581,MIR664A_3P,0.995801023464803
GOBP_NEGATIVE_REGULATION_OF_...150,SET,51,0.096365,0.0050721,0.12803,0.22583,GOBP_NEGATIVE_REGULATION_OF_COAGULATION,0.995801023464803
MIR3162_5P,SET,67,0.075594,0.0045584,0.10044,0.22584,MIR3162_5P,0.995801023464803
GOBP_PURINE_NUCLEOSIDE_MONOP...3,SET,38,0.10611,0.0048225,0.14099,0.22585,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.995801023464803
GOBP_MYOBLAST_DIFFERENTIATION,SET,108,0.061511,0.004704,0.081766,0.22595,GOBP_MYOBLAST_DIFFERENTIATION,0.995801023464803
GOBP_REGULATION_OF_AMINE_MET...,SET,27,0.12711,0.0048712,0.16897,0.22595,GOBP_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.995801023464803
GOBP_ENTRY_OF_BACTERIUM_INTO...,SET,9,0.20525,0.0045435,0.27287,0.22597,GOBP_ENTRY_OF_BACTERIUM_INTO_HOST_CELL,0.995801023464803
GSE23114_WT_VS_SLE2C1_MOUSE_...2,SET,169,0.048187,0.0046021,0.064061,0.22597,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_UP,0.995801023464803
HP_CENTRAL_HYPOTHYROIDISM,SET,63,0.084304,0.0049302,0.11209,0.22599,HP_CENTRAL_HYPOTHYROIDISM,0.995801023464803
BOYLAN_MULTIPLE_MYELOMA_C_UP,SET,44,0.099827,0.0048814,0.13275,0.22604,BOYLAN_MULTIPLE_MYELOMA_C_UP,0.995801023464803
GOBP_SPLICEOSOMAL_CONFORMATI...,SET,4,0.337,0.004974,0.44815,0.22604,GOBP_SPLICEOSOMAL_CONFORMATIONAL_CHANGES_TO_GENERATE_CATALYTIC_CONFORMATION,0.995801023464803
GOBP_RESPONSE_TO_LUTEINIZING...,SET,7,0.24897,0.0048608,0.33125,0.22614,GOBP_RESPONSE_TO_LUTEINIZING_HORMONE,0.995801023464803
GOBP_CELL_RECOGNITION,SET,152,0.05607,0.0050808,0.074605,0.22616,GOBP_CELL_RECOGNITION,0.995801023464803
HP_INCREASED_C_PEPTIDE_LEVEL,SET,13,0.20146,0.0053591,0.26806,0.22617,HP_INCREASED_C_PEPTIDE_LEVEL,0.995801023464803
GOCC_LATERAL_PART_OF_CELL,SET,5,0.32053,0.0052891,0.42685,0.22636,GOCC_LATERAL_PART_OF_CELL,0.995801023464803
REACTOME_ROBO_RECEPTORS_BIND...,SET,9,0.18999,0.0042057,0.25303,0.22637,REACTOME_ROBO_RECEPTORS_BIND_AKAP5,0.995801023464803
GOBP_REGULATION_OF_CELL_JUNC...,SET,198,0.048979,0.0050591,0.06523,0.22637,GOBP_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,0.995801023464803
HP_HYPOPITUITARISM,SET,159,0.051407,0.0047634,0.068465,0.22638,HP_HYPOPITUITARISM,0.995801023464803
GOBP_NEGATIVE_REGULATION_OF_...239,SET,13,0.16739,0.0044528,0.22296,0.2264,GOBP_NEGATIVE_REGULATION_OF_FIBRINOLYSIS,0.995801023464803
HP_ABNORMAL_HEPATIC_ECHOGENI...,SET,7,0.26367,0.0051476,0.35126,0.22644,HP_ABNORMAL_HEPATIC_ECHOGENICITY,0.995801023464803
KEGG_MEDICUS_REFERENCE_RIG_I...2,SET,17,0.19006,0.0057809,0.25322,0.22646,KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY,0.995801023464803
GOMF_JUN_KINASE_BINDING,SET,11,0.19912,0.0048726,0.26529,0.22646,GOMF_JUN_KINASE_BINDING,0.995801023464803
chr12p12,SET,49,0.16441,0.0084825,0.21905,0.22647,chr12p12,0.995801023464803
LIEN_BREAST_CARCINOMA_METAPL...2,SET,104,0.063295,0.0047505,0.084331,0.22647,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,0.995801023464803
chr8p21,SET,79,0.14461,0.0094658,0.19268,0.22648,chr8p21,0.995801023464803
STAT5A_02,SET,124,0.059505,0.004874,0.079299,0.22652,STAT5A_02,0.995801023464803
MODULE_300,SET,33,0.11362,0.0048128,0.15142,0.22654,MODULE_300,0.995801023464803
GOMF_RISC_COMPLEX_BINDING,SET,4,0.28004,0.0041332,0.37324,0.22655,GOMF_RISC_COMPLEX_BINDING,0.995801023464803
REACTOME_MRNA_DECAY_BY_5_TO_...,SET,15,0.16186,0.0046248,0.21578,0.2266,REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE,0.995801023464803
WP_BIOSYNTHESIS_AND_TURNOVER...,SET,8,0.23002,0.0048007,0.30667,0.22661,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,0.995801023464803
GOBP_CELLULAR_RESPONSE_TO_IN...3,SET,196,0.048292,0.0049632,0.064383,0.22661,GOBP_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE,0.995801023464803
MIR1285_3P,SET,151,0.050218,0.0045357,0.066957,0.22663,MIR1285_3P,0.995801023464803
GOCC_AXONEMAL_DYNEIN_COMPLEX,SET,18,0.13641,0.0042694,0.18192,0.22667,GOCC_AXONEMAL_DYNEIN_COMPLEX,0.995801023464803
MIR4668_3P,SET,277,0.038968,0.0047504,0.05197,0.22669,MIR4668_3P,0.995801023464803
MIR8083,SET,49,0.092013,0.0047474,0.12273,0.22671,MIR8083,0.995801023464803
KEGG_VALINE_LEUCINE_AND_ISOL...1,SET,6,0.25457,0.0046015,0.33956,0.22672,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS,0.995801023464803
HP_CONGENITAL_FINGER_FLEXION...,SET,11,0.21179,0.0051829,0.2825,0.22672,HP_CONGENITAL_FINGER_FLEXION_CONTRACTURES,0.995801023464803
HP_OCCIPITAL_CORTICAL_ATROPHY,SET,5,0.36986,0.0061031,0.49348,0.22678,HP_OCCIPITAL_CORTICAL_ATROPHY,0.995801023464803
GSE17974_CTRL_VS_ACT_IL4_AND...10,SET,167,0.050755,0.0048188,0.067724,0.2268,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP,0.995801023464803
GOCC_ENDOSOME,SET,961,0.021143,0.0047091,0.028219,0.22686,GOCC_ENDOSOME,0.995801023464803
GOBP_PYRAMIDAL_NEURON_DEVELO...,SET,9,0.21947,0.0048583,0.293,0.22692,GOBP_PYRAMIDAL_NEURON_DEVELOPMENT,0.995801023464803
RAMJAUN_APOPTOSIS_BY_TGFB1_V...1,SET,8,0.24298,0.0050712,0.32444,0.22695,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN,0.995801023464803
MIR9898,SET,52,0.087669,0.0046593,0.11706,0.22696,MIR9898,0.995801023464803
HP_UTERINE_RUPTURE,SET,8,0.26708,0.0055741,0.35664,0.22697,HP_UTERINE_RUPTURE,0.995801023464803
HP_RENAL_SALT_WASTING,SET,20,0.1581,0.0052157,0.21113,0.22698,HP_RENAL_SALT_WASTING,0.995801023464803
HORIUCHI_WTAP_TARGETS_UP,SET,269,0.041227,0.0049538,0.055058,0.227,HORIUCHI_WTAP_TARGETS_UP,0.995801023464803
RAGHAVACHARI_PLATELET_SPECIF...,SET,60,0.08744,0.0049907,0.11679,0.22703,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,0.995801023464803
IGLV5_37_TARGET_GENES,SET,473,0.031076,0.0049235,0.041511,0.22705,IGLV5_37_TARGET_GENES,0.995801023464803
GOBP_INORGANIC_ANION_TRANSME...,SET,120,0.062171,0.00501,0.083051,0.22706,GOBP_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORT,0.995801023464803
GSE19198_6H_VS_24H_IL21_TREA...2,SET,178,0.050115,0.0049107,0.066946,0.22706,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_UP,0.995801023464803
GOBP_NADPH_REGENERATION,SET,21,0.14717,0.0049749,0.1967,0.22717,GOBP_NADPH_REGENERATION,0.995801023464803
GOBP_RESPONSE_TO_OSMOTIC_STR...,SET,78,0.072873,0.00474,0.097398,0.22717,GOBP_RESPONSE_TO_OSMOTIC_STRESS,0.995801023464803
HP_NON_MENDELIAN_INHERITANCE,SET,86,0.075276,0.0051401,0.10062,0.2272,HP_NON_MENDELIAN_INHERITANCE,0.995801023464803
SOBOLEV_PBMC_PANDEMRIX_AGE_1...2,SET,32,0.12693,0.0052947,0.16967,0.22721,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_7DY_DN,0.995801023464803
HP_GIANT_CELL_HEPATITIS,SET,5,0.29494,0.0048668,0.39428,0.22722,HP_GIANT_CELL_HEPATITIS,0.995801023464803
GOBP_REGULATION_OF_CALCIUM_I...7,SET,57,0.088194,0.0049067,0.11791,0.22725,GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.995801023464803
GOMF_BRANCHED_CHAIN_AMINO_AC...,SET,9,0.21855,0.0048378,0.29221,0.22726,GOMF_BRANCHED_CHAIN_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.995801023464803
GSE14908_RESTING_VS_HDM_STIM...3,SET,177,0.047385,0.0046304,0.063366,0.22729,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN,0.995801023464803
TURJANSKI_MAPK8_AND_MAPK9_TA...,SET,7,0.23523,0.0045924,0.31466,0.22737,TURJANSKI_MAPK8_AND_MAPK9_TARGETS,0.995801023464803
GOMF_ACYLTRANSFERASE_ACTIVIT...2,SET,199,0.044024,0.0045586,0.058903,0.22742,GOMF_ACYLTRANSFERASE_ACTIVITY_TRANSFERRING_GROUPS_OTHER_THAN_AMINO_ACYL_GROUPS,0.995801023464803
GOBP_EPITHELIAL_CELL_PROLIFE...2,SET,10,0.23604,0.0055076,0.31584,0.22743,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,0.995801023464803
GOBP_REGULATION_OF_RESPONSE_...10,SET,10,0.20032,0.004674,0.26808,0.22747,GOBP_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,0.995801023464803
GAUTAM_EYE_IRIS_CILIARY_BODY...3,SET,316,0.034759,0.0045209,0.046518,0.22747,GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_ENDOTHELIAL_CELLS,0.995801023464803
GOMF_RETINAL_BINDING,SET,17,0.1613,0.0049061,0.21587,0.22748,GOMF_RETINAL_BINDING,0.995801023464803
HP_ABNORMAL_FOVEAL_MORPHOLOG...,SET,6,0.27739,0.0050141,0.37129,0.2275,HP_ABNORMAL_FOVEAL_MORPHOLOGY_ON_MACULAR_OCT,0.995801023464803
GOBP_POSITIVE_REGULATION_OF_...274,SET,33,0.11412,0.0048342,0.15282,0.22761,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,0.995801023464803
SFMBT1_TARGET_GENES,SET,1308,0.018373,0.0047264,0.024611,0.22767,SFMBT1_TARGET_GENES,0.995801023464803
BIOCARTA_CD40_PATHWAY,SET,12,0.18766,0.0047962,0.25144,0.22774,BIOCARTA_CD40_PATHWAY,0.995801023464803
GSE15659_NAIVE_CD4_TCELL_VS_...4,SET,160,0.048429,0.0045015,0.064904,0.22779,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,0.995801023464803
MIR6747_3P,SET,105,0.06399,0.0048256,0.085762,0.2278,MIR6747_3P,0.995801023464803
GSE41978_ID2_KO_VS_BIM_KO_KL...2,SET,186,0.048508,0.0048579,0.065023,0.22783,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.995801023464803
HP_ABNORMAL_CIRCULATING_ARGI...,SET,8,0.1981,0.0041345,0.26555,0.22784,HP_ABNORMAL_CIRCULATING_ARGININE_CONCENTRATION,0.995801023464803
GSE411_WT_VS_SOCS3_KO_MACROP...3,SET,186,0.04382,0.0043884,0.058741,0.22784,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_UP,0.995801023464803
GOBP_LOBAR_BRONCHUS_EPITHELI...,SET,5,0.32379,0.0053429,0.43408,0.22786,GOBP_LOBAR_BRONCHUS_EPITHELIUM_DEVELOPMENT,0.995801023464803
HP_Y_SHAPED_METACARPALS,SET,12,0.15844,0.0040495,0.21243,0.22789,HP_Y_SHAPED_METACARPALS,0.995801023464803
GOMF_ALPHA_1_4_GLUCOSIDASE_A...,SET,5,0.30094,0.0049658,0.4035,0.2279,GOMF_ALPHA_1_4_GLUCOSIDASE_ACTIVITY,0.995801023464803
HP_REDUCED_NATURAL_KILLER_CE...2,SET,24,0.12799,0.0046249,0.17162,0.2279,HP_REDUCED_NATURAL_KILLER_CELL_COUNT,0.995801023464803
REACTOME_FGFR1_LIGAND_BINDIN...,SET,17,0.17976,0.0054678,0.24106,0.22792,REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION,0.995801023464803
CREL_01,SET,240,0.042105,0.0047827,0.056478,0.22799,CREL_01,0.995801023464803
GOBP_DNA_ALKYLATION_REPAIR,SET,11,0.17076,0.0041786,0.22908,0.22801,GOBP_DNA_ALKYLATION_REPAIR,0.995801023464803
GOBP_ICOSANOID_BIOSYNTHETIC_...,SET,50,0.089603,0.0046698,0.1202,0.22801,GOBP_ICOSANOID_BIOSYNTHETIC_PROCESS,0.995801023464803
HP_NEONATAL_INSULIN_DEPENDEN...,SET,20,0.14699,0.0048489,0.19718,0.22801,HP_NEONATAL_INSULIN_DEPENDENT_DIABETES_MELLITUS,0.995801023464803
GOBP_NEGATIVE_REGULATION_OF_...534,SET,68,0.074376,0.0045182,0.099784,0.22803,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,0.995801023464803
MIR25_3P,SET,379,0.033796,0.0048055,0.045345,0.22805,MIR25_3P,0.995801023464803
GAUSSMANN_MLL_AF4_FUSION_TAR...9,SET,17,0.16996,0.0051697,0.22808,0.22808,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,0.995801023464803
GSE17721_LPS_VS_POLYIC_16H_B...1,SET,190,0.04758,0.0048154,0.063856,0.2281,GSE17721_LPS_VS_POLYIC_16H_BMDC_DN,0.995801023464803
GOCC_TOR_COMPLEX,SET,12,0.17018,0.0043494,0.22839,0.22811,GOCC_TOR_COMPLEX,0.995801023464803
HP_ABNORMALITY_OF_THE_PHALAN...2,SET,3,0.38663,0.004942,0.51893,0.22813,HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_3RD_TOE,0.995801023464803
GSE8621_UNSTIM_VS_LPS_PRIMED...3,SET,179,0.044843,0.0044064,0.060196,0.22815,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_DN,0.995801023464803
RANKIN_ANGIOGENIC_TARGETS_OF...2,SET,5,0.33284,0.0054922,0.44695,0.22823,RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP,0.995801023464803
HE_LIM_SUN_FETAL_LUNG_C6_DEU...,SET,190,0.043535,0.004406,0.05846,0.22824,HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL,0.995801023464803
MURARO_PANCREAS_ENDOTHELIAL_...,SET,337,0.037884,0.0050855,0.050874,0.22825,MURARO_PANCREAS_ENDOTHELIAL_CELL,0.995801023464803
GOCC_INSULIN_RESPONSIVE_COMP...,SET,7,0.22115,0.0043175,0.29699,0.22826,GOCC_INSULIN_RESPONSIVE_COMPARTMENT,0.995801023464803
GOMF_K63_LINKED_DEUBIQUITINA...,SET,11,0.17705,0.0043325,0.23778,0.22826,GOMF_K63_LINKED_DEUBIQUITINASE_ACTIVITY,0.995801023464803
KEGG_MEDICUS_REFERENCE_PLASM...,SET,8,0.24132,0.0050365,0.32411,0.22827,KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA,0.995801023464803
SHEPARD_BMYB_MORPHOLINO_DN,SET,187,0.046423,0.0046614,0.062352,0.22828,SHEPARD_BMYB_MORPHOLINO_DN,0.995801023464803
GOBP_DE_NOVO_CENTRIOLE_ASSEM...1,SET,5,0.22879,0.0037753,0.30741,0.22836,GOBP_DE_NOVO_CENTRIOLE_ASSEMBLY,0.995801023464803
GOBP_TERPENOID_METABOLIC_PRO...,SET,96,0.072634,0.0052387,0.097591,0.22836,GOBP_TERPENOID_METABOLIC_PROCESS,0.995801023464803
GSE22140_HEALTHY_VS_ARTHRITI...3,SET,183,0.045521,0.0045222,0.061171,0.22839,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN,0.995801023464803
GOBP_CELLULAR_RESPONSE_TO_GL...3,SET,43,0.093615,0.0045254,0.12581,0.22841,GOBP_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION,0.995801023464803
GOBP_MITOCHONDRIAL_DEPOLARIZ...,SET,21,0.1467,0.0049589,0.19718,0.22844,GOBP_MITOCHONDRIAL_DEPOLARIZATION,0.995801023464803
GOBP_MUSCLE_CELL_MIGRATION,SET,80,0.076605,0.0050459,0.10297,0.22846,GOBP_MUSCLE_CELL_MIGRATION,0.995801023464803
GSE2706_2H_VS_8H_R848_STIM_D...1,SET,166,0.04971,0.0047056,0.066822,0.22847,GSE2706_2H_VS_8H_R848_STIM_DC_DN,0.995801023464803
GOBP_CELL_MATURATION,SET,188,0.048437,0.0048765,0.065135,0.22855,GOBP_CELL_MATURATION,0.995801023464803
GOBP_SODIUM_DEPENDENT_PHOSPH...,SET,12,0.20445,0.0052254,0.27493,0.22855,GOBP_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT,0.995801023464803
GSE3982_MAST_CELL_VS_BASOPHI...1,SET,172,0.048186,0.0046422,0.064799,0.22856,GSE3982_MAST_CELL_VS_BASOPHIL_DN,0.995801023464803
SHEPARD_CRASH_AND_BURN_MUTAN...2,SET,187,0.047445,0.004764,0.063839,0.22868,SHEPARD_CRASH_AND_BURN_MUTANT_UP,0.995801023464803
GOBP_POSITIVE_REGULATION_OF_...316,SET,24,0.14179,0.0051233,0.19084,0.22875,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,0.995801023464803
HP_MYOCLONIC_SEIZURE,SET,210,0.04323,0.0045971,0.058184,0.22875,HP_MYOCLONIC_SEIZURE,0.995801023464803
GSE17721_CTRL_VS_LPS_2H_BMDC...2,SET,184,0.043986,0.0043815,0.059211,0.22878,GSE17721_CTRL_VS_LPS_2H_BMDC_UP,0.995801023464803
MIR6740_3P,SET,146,0.052713,0.0046822,0.070971,0.22883,MIR6740_3P,0.995801023464803
MIR6130,SET,164,0.049866,0.0046921,0.067146,0.22885,MIR6130,0.995801023464803
REACTOME_NEGATIVE_REGULATORS...,SET,32,0.11579,0.0048301,0.15592,0.22887,REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,0.995801023464803
GOMF_PHOSPHATIDYLINOSITOL_4_...1,SET,9,0.17244,0.0038171,0.23221,0.22887,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.995801023464803
GOMF_PHOSPHATIDYLINOSITOL_4_...3,SET,9,0.17244,0.0038171,0.23221,0.22887,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.995801023464803
GSE39022_LN_VS_SPLEEN_DC_UP,SET,180,0.046189,0.0045512,0.062201,0.22887,GSE39022_LN_VS_SPLEEN_DC_UP,0.995801023464803
GOMF_ADENYLATE_CYCLASE_BINDI...,SET,12,0.19545,0.0049955,0.26325,0.22891,GOMF_ADENYLATE_CYCLASE_BINDING,0.995801023464803
AIZARANI_LIVER_C23_KUPFFER_C...,SET,196,0.047547,0.0048866,0.064054,0.22896,AIZARANI_LIVER_C23_KUPFFER_CELLS_3,0.995801023464803
REACTOME_P75NTR_REGULATES_AX...,SET,9,0.23756,0.0052587,0.32005,0.22897,REACTOME_P75NTR_REGULATES_AXONOGENESIS,0.995801023464803
GOBP_PROTEIN_CONTAINING_COMP...3,SET,177,0.047571,0.0046485,0.064092,0.22898,GOBP_PROTEIN_CONTAINING_COMPLEX_LOCALIZATION,0.995801023464803
GSE9988_LPS_VS_CTRL_TREATED_...1,SET,189,0.043399,0.0043807,0.058478,0.22901,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN,0.995801023464803
HP_DECREASED_FERTILITY,SET,312,0.035157,0.0045441,0.047378,0.22903,HP_DECREASED_FERTILITY,0.995801023464803
PID_FOXO_PATHWAY,SET,47,0.093775,0.0047388,0.12638,0.22904,PID_FOXO_PATHWAY,0.995801023464803
GSE42021_CD24HI_VS_CD24LOW_T...3,SET,183,0.048572,0.0048253,0.06546,0.22904,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN,0.995801023464803
AKT_UP.V1_DN,SET,178,0.048808,0.0047827,0.065793,0.2291,AKT_UP.V1_DN,0.995801023464803
GOBP_REGULATION_OF_BLOOD_BRA...,SET,9,0.25192,0.0055765,0.33965,0.22914,GOBP_REGULATION_OF_BLOOD_BRAIN_BARRIER_PERMEABILITY,0.995801023464803
GOBP_RESPONSE_TO_UV,SET,141,0.051733,0.0045164,0.069751,0.22915,GOBP_RESPONSE_TO_UV,0.995801023464803
HE_LIM_SUN_FETAL_LUNG_C2_PRE...,SET,507,0.027773,0.0045513,0.037451,0.22917,HE_LIM_SUN_FETAL_LUNG_C2_PRE_PDC_DC5_CELL,0.995801023464803
GOBP_RENAL_SODIUM_ION_TRANSP...,SET,14,0.18904,0.0052185,0.25492,0.22918,GOBP_RENAL_SODIUM_ION_TRANSPORT,0.995801023464803
GSE18893_TCONV_VS_TREG_24H_T...2,SET,175,0.044822,0.0043553,0.060445,0.22919,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_UP,0.995801023464803
GSE15930_NAIVE_VS_48H_IN_VIT...5,SET,178,0.044412,0.004352,0.059896,0.2292,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.995801023464803
GOCC_ENDOCYTIC_VESICLE,SET,314,0.037634,0.0048797,0.050766,0.22925,GOCC_ENDOCYTIC_VESICLE,0.995801023464803
REACTOME_INTRINSIC_PATHWAY_O...,SET,20,0.15026,0.0049569,0.20274,0.22931,REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,0.995801023464803
GSE23321_CD8_STEM_CELL_MEMOR...5,SET,178,0.046489,0.0045555,0.06273,0.22932,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.995801023464803
CCTGAGT_MIR510,SET,35,0.10544,0.0045996,0.14228,0.22933,CCTGAGT_MIR510,0.995801023464803
HP_ELEVATED_URINARY_NOREPINE...,SET,18,0.13392,0.0041913,0.18071,0.22933,HP_ELEVATED_URINARY_NOREPINEPHRINE_LEVEL,0.995801023464803
HP_ABNORMAL_ENDOCRINE_MORPHO...,SET,101,0.063717,0.0047131,0.085984,0.22934,HP_ABNORMAL_ENDOCRINE_MORPHOLOGY,0.995801023464803
REACTOME_SLC_MEDIATED_TRANSM...,SET,235,0.043068,0.0048415,0.058124,0.22936,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,0.995801023464803
WP_FOXA2_PATHWAY,SET,21,0.14593,0.0049328,0.19698,0.2294,WP_FOXA2_PATHWAY,0.995801023464803
GOBP_MINERALOCORTICOID_METAB...,SET,14,0.20011,0.005524,0.27018,0.22946,GOBP_MINERALOCORTICOID_METABOLIC_PROCESS,0.995801023464803
GOBP_RESPONSE_TO_ORGANOPHOSP...,SET,123,0.058166,0.0047452,0.078543,0.22948,GOBP_RESPONSE_TO_ORGANOPHOSPHORUS,0.995801023464803
GOBP_POSITIVE_REGULATION_OF_...438,SET,5,0.31436,0.0051873,0.42454,0.22951,GOBP_POSITIVE_REGULATION_OF_MAPKKK_CASCADE_BY_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.995801023464803
GSE14000_TRANSLATED_RNA_VS_M...4,SET,174,0.044716,0.0043327,0.060388,0.22951,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP,0.995801023464803
REACTOME_GENERATION_OF_SECON...,SET,27,0.12983,0.0049753,0.17534,0.22952,REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES,0.995801023464803
WP_ATR_SIGNALING,SET,11,0.16668,0.0040789,0.22514,0.22955,WP_ATR_SIGNALING,0.995801023464803
GSE4984_UNTREATED_VS_GALECTI...2,SET,169,0.048981,0.0046779,0.066162,0.22956,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP,0.995801023464803
GSE21063_WT_VS_NFATC1_KO_8H_...1,SET,180,0.046186,0.0045509,0.062416,0.22966,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN,0.995943504795118
GOBP_GLYCOLYTIC_PROCESS_THRO...1,SET,19,0.1313,0.0042219,0.17745,0.22967,GOBP_GLYCOLYTIC_PROCESS_THROUGH_FRUCTOSE_6_PHOSPHATE,0.995943504795118
SCHAEFFER_PROSTATE_DEVELOPME...10,SET,6,0.2785,0.005034,0.37649,0.22974,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP,0.995943504795118
KEGG_MEDICUS_PATHOGEN_SALMON...2,SET,24,0.12737,0.0046022,0.1722,0.22977,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,0.995943504795118
GOBP_SMALL_MOLECULE_BIOSYNTH...,SET,536,0.027471,0.004625,0.037143,0.22977,GOBP_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS,0.995943504795118
MIR5688,SET,715,0.024709,0.0047805,0.033417,0.22983,MIR5688,0.995943504795118
HP_ABNORMALITY_OF_SKULL_OSSI...,SET,46,0.092887,0.0046438,0.12563,0.22984,HP_ABNORMALITY_OF_SKULL_OSSIFICATION,0.995943504795118
GSE42724_NAIVE_BCELL_VS_PLAS...2,SET,181,0.047791,0.0047219,0.064644,0.22987,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP,0.995943504795118
GOBP_MACROPINOCYTOSIS,SET,8,0.22865,0.0047721,0.30932,0.2299,GOBP_MACROPINOCYTOSIS,0.995943504795118
HP_DECREASED_CIRCULATING_ACT...,SET,28,0.11608,0.0045301,0.15708,0.22996,HP_DECREASED_CIRCULATING_ACTH_CONCENTRATION,0.995943504795118
FUJII_YBX1_TARGETS_UP,SET,36,0.10546,0.0046654,0.14272,0.22998,FUJII_YBX1_TARGETS_UP,0.995943504795118
ACTGTGA_MIR27A_MIR27B,SET,435,0.031003,0.0047155,0.041961,0.23,ACTGTGA_MIR27A_MIR27B,0.995943504795118
GOCC_EUKARYOTIC_TRANSLATION_...3,SET,13,0.15463,0.0041134,0.20929,0.23001,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX,0.995943504795118
REACTOME_LATE_ENDOSOMAL_MICR...,SET,32,0.11229,0.0046839,0.15199,0.23003,REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY,0.995943504795118
HP_ABNORMALITY_OF_CARTILAGE_...,SET,14,0.17702,0.0048865,0.23964,0.23005,HP_ABNORMALITY_OF_CARTILAGE_OF_EXTERNAL_EAR,0.995943504795118
GOMF_UDP_XYLOSYLTRANSFERASE_...,SET,6,0.21538,0.0038932,0.29162,0.23008,GOMF_UDP_XYLOSYLTRANSFERASE_ACTIVITY,0.995943504795118
GSE17721_CTRL_VS_CPG_8H_BMDC...1,SET,187,0.045393,0.004558,0.061458,0.23008,GSE17721_CTRL_VS_CPG_8H_BMDC_DN,0.995943504795118
GOBP_NOREPINEPHRINE_SECRETION,SET,14,0.1875,0.0051758,0.25395,0.23016,GOBP_NOREPINEPHRINE_SECRETION,0.995972572815534
GOBP_CELLULAR_RESPONSE_TO_MA...3,SET,9,0.20107,0.0044509,0.27236,0.23018,GOBP_CELLULAR_RESPONSE_TO_MANGANESE_ION,0.995972572815534
GOMF_C4_DICARBOXYLATE_TRANSM...,SET,15,0.16044,0.0045842,0.21733,0.23019,GOMF_C4_DICARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.995972572815534
WP_LIVER_X_RECEPTOR_PATHWAY,SET,10,0.20794,0.0048518,0.28169,0.23021,WP_LIVER_X_RECEPTOR_PATHWAY,0.995972572815534
GOBP_MYELIN_ASSEMBLY,SET,23,0.13396,0.0047385,0.18149,0.23023,GOBP_MYELIN_ASSEMBLY,0.995972572815534
HP_INCREASED_CIRCULATING_ANT...,SET,93,0.067335,0.0047804,0.091242,0.23027,HP_INCREASED_CIRCULATING_ANTIBODY_LEVEL,0.996021636589919
KONG_E2F1_TARGETS,SET,8,0.20435,0.0042649,0.27704,0.23037,KONG_E2F1_TARGETS,0.99616875466534
KLEIN_PRIMARY_EFFUSION_LYMPH...2,SET,46,0.087517,0.0043753,0.11865,0.23039,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,0.99616875466534
MIR548V,SET,124,0.05692,0.0046622,0.077171,0.23039,MIR548V,0.99616875466534
HP_APLASIA_HYPOPLASIA_OF_THE...45,SET,219,0.042141,0.0045751,0.057196,0.23063,HP_APLASIA_HYPOPLASIA_OF_THE_NAILS,0.996998160805269
GSE24972_MARGINAL_ZONE_BCELL...1,SET,178,0.047493,0.0046538,0.064469,0.23066,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_DN,0.996998160805269
GSE17721_CPG_VS_GARDIQUIMOD_...9,SET,177,0.047884,0.0046791,0.065003,0.23067,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_DN,0.996998160805269
GOBP_HEART_TRABECULA_FORMATI...,SET,15,0.17983,0.0051383,0.24416,0.2307,GOBP_HEART_TRABECULA_FORMATION,0.996998160805269
GOBP_NEGATIVE_REGULATION_OF_...577,SET,23,0.11763,0.0041609,0.15976,0.23078,GOBP_NEGATIVE_REGULATION_OF_RNA_SPLICING,0.996998160805269
HOLLEMAN_PREDNISOLONE_RESIST...1,SET,11,0.18576,0.0045457,0.2523,0.23079,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN,0.996998160805269
GOBP_DETECTION_OF_EXTERNAL_B...,SET,23,0.13844,0.0048972,0.18804,0.2308,GOBP_DETECTION_OF_EXTERNAL_BIOTIC_STIMULUS,0.996998160805269
GSE14769_UNSTIM_VS_60MIN_LPS...2,SET,179,0.044603,0.0043828,0.060591,0.23083,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP,0.996998160805269
GOMF_SEQUENCE_SPECIFIC_SINGL...,SET,12,0.16152,0.0041283,0.21943,0.23084,GOMF_SEQUENCE_SPECIFIC_SINGLE_STRANDED_DNA_BINDING,0.996998160805269
GOBP_POSITIVE_CHEMOTAXIS,SET,60,0.086017,0.0049095,0.11689,0.23091,GOBP_POSITIVE_CHEMOTAXIS,0.997052683563176
GOMF_GLIAL_CELL_DERIVED_NEUR...,SET,5,0.30817,0.0050851,0.41878,0.23091,GOMF_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_ACTIVITY,0.997052683563176
GNF2_ICAM3,SET,34,0.10416,0.0044784,0.14158,0.23096,GNF2_ICAM3,0.997112835320417
TAKEDA_TARGETS_OF_NUP98_HOXA...8,SET,77,0.072312,0.0046734,0.098305,0.23099,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP,0.997112835320417
GOBP_OLIGOPEPTIDE_IMPORT_ACR...,SET,5,0.307,0.0050659,0.41739,0.23101,GOBP_OLIGOPEPTIDE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.997112835320417
GOMF_DNA_HELICASE_ACTIVITY,SET,55,0.079617,0.0043513,0.10826,0.23105,GOMF_DNA_HELICASE_ACTIVITY,0.997161647833106
MIR4709_5P,SET,94,0.068507,0.0048896,0.09317,0.23108,MIR4709_5P,0.997165702069649
GSE27786_NKCELL_VS_ERYTHROBL...2,SET,181,0.046301,0.0045747,0.06298,0.23113,GSE27786_NKCELL_VS_ERYTHROBLAST_UP,0.997165702069649
REACTOME_REGULATION_OF_GENE_...4,SET,5,0.31932,0.0052691,0.43444,0.23117,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS,0.997165702069649
GSE25123_WT_VS_PPARG_KO_MACR...6,SET,149,0.052303,0.0046928,0.071185,0.23125,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,0.997165702069649
GOBP_CELL_DIFFERENTIATION_IN...3,SET,21,0.15931,0.005385,0.21683,0.23126,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,0.997165702069649
GOBP_SULFUR_COMPOUND_BIOSYNT...,SET,155,0.052349,0.0047898,0.071255,0.23128,GOBP_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS,0.997165702069649
CHEN_METABOLIC_SYNDROM_NETWO...,SET,1122,0.019717,0.0047231,0.026842,0.23131,CHEN_METABOLIC_SYNDROM_NETWORK,0.997165702069649
GSE17721_LPS_VS_POLYIC_8H_BM...1,SET,177,0.046309,0.0045252,0.063043,0.23131,GSE17721_LPS_VS_POLYIC_8H_BMDC_DN,0.997165702069649
REACTOME_PKA_MEDIATED_PHOSPH...2,SET,4,0.28456,0.0042,0.38752,0.23138,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS,0.997165702069649
GOBP_REGULATION_OF_INTESTINA...2,SET,9,0.21911,0.0048502,0.29846,0.23144,GOBP_REGULATION_OF_INTESTINAL_LIPID_ABSORPTION,0.997165702069649
HP_DECREASED_NASAL_NITRIC_OX...,SET,24,0.12585,0.0045473,0.17143,0.23144,HP_DECREASED_NASAL_NITRIC_OXIDE,0.997165702069649
GSE21927_UNTREATED_VS_GMCSF_...3,SET,153,0.050978,0.0046345,0.069445,0.23145,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_DN,0.997165702069649
WP_PPAR_SIGNALING,SET,66,0.078054,0.0046717,0.10634,0.23148,WP_PPAR_SIGNALING,0.997165702069649
GSE19888_NO_PRETREAT_VS_ADEN...2,SET,176,0.045425,0.0044263,0.06189,0.23149,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_UP,0.997165702069649
HP_MIXED_HYPO_AND_HYPERPIGME...,SET,10,0.16373,0.0038204,0.2231,0.2315,HP_MIXED_HYPO_AND_HYPERPIGMENTATION_OF_THE_SKIN,0.997165702069649
GSE37301_MULTIPOTENT_PROGENI...2,SET,148,0.053894,0.0048195,0.073434,0.23151,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_UP,0.997165702069649
GOBP_NEGATIVE_REGULATION_OF_...675,SET,5,0.34328,0.0056644,0.46785,0.23156,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.997257472118959
GOBP_ACTIN_FILAMENT_BASED_MO...,SET,130,0.057512,0.0048225,0.078413,0.23165,GOBP_ACTIN_FILAMENT_BASED_MOVEMENT,0.997339777777778
HP_OPEN_NEURAL_TUBE_DEFECT,SET,134,0.053614,0.0045638,0.073113,0.23169,HP_OPEN_NEURAL_TUBE_DEFECT,0.997339777777778
NAKAYA_PBMC_IMUVAC_MALE_AGE_...,SET,38,0.10254,0.0046606,0.13984,0.23169,NAKAYA_PBMC_IMUVAC_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0DY_PREIMM_TIV_UP,0.997339777777778
HP_NEUTROPHILIA,SET,21,0.14671,0.0049593,0.20017,0.2318,HP_NEUTROPHILIA,0.997339777777778
GOCC_OUTER_DYNEIN_ARM,SET,10,0.19321,0.0045081,0.26365,0.23184,GOCC_OUTER_DYNEIN_ARM,0.997339777777778
DACH1_TARGET_GENES,SET,742,0.022967,0.0045231,0.031342,0.23185,DACH1_TARGET_GENES,0.997339777777778
GOBP_CELLULAR_RESPONSE_TO_AR...,SET,16,0.15482,0.0045687,0.21134,0.23192,GOBP_CELLULAR_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE,0.997339777777778
HOX13_01,SET,42,0.099802,0.0047682,0.13628,0.232,HOX13_01,0.997339777777778
GSE5589_UNSTIM_VS_180MIN_LPS...1,SET,184,0.043912,0.0043741,0.059968,0.23201,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,0.997339777777778
KEGG_MEDICUS_REFERENCE_DNA_E...,SET,13,0.15608,0.0041518,0.21315,0.23202,KEGG_MEDICUS_REFERENCE_DNA_END_RESECTION_AND_RPA_LOADING,0.997339777777778
GOBP_REGULATION_OF_PROTEIN_B...,SET,111,0.057505,0.004458,0.078536,0.23202,GOBP_REGULATION_OF_PROTEIN_BINDING,0.997339777777778
KEGG_MEDICUS_REFERENCE_SEROT...,SET,3,0.38955,0.0049794,0.53212,0.23206,KEGG_MEDICUS_REFERENCE_SEROTONIN_METABOLISM,0.997339777777778
HP_ABNORMAL_OCCIPITAL_BONE_M...,SET,103,0.058233,0.0043496,0.079553,0.23209,HP_ABNORMAL_OCCIPITAL_BONE_MORPHOLOGY,0.997339777777778
HALLMARK_WNT_BETA_CATENIN_SI...,SET,41,0.097831,0.0046182,0.13366,0.2321,HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.997339777777778
MORI_PRE_BI_LYMPHOCYTE_DN,SET,71,0.074225,0.0046071,0.10142,0.23212,MORI_PRE_BI_LYMPHOCYTE_DN,0.997339777777778
GSE21033_CTRL_VS_POLYIC_STIM...6,SET,142,0.053861,0.0047187,0.07359,0.23212,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP,0.997339777777778
GOMF_SULFURIC_ESTER_HYDROLAS...,SET,11,0.20562,0.0050317,0.28102,0.23218,GOMF_SULFURIC_ESTER_HYDROLASE_ACTIVITY,0.997339777777778
GOBP_LUTEINIZING_HORMONE_SEC...,SET,11,0.21167,0.0051797,0.28932,0.23221,GOBP_LUTEINIZING_HORMONE_SECRETION,0.997339777777778
GOBP_POSITIVE_REGULATION_OF_...127,SET,807,0.023509,0.0048195,0.032138,0.23224,GOBP_POSITIVE_REGULATION_OF_CELL_DIFFERENTIATION,0.997339777777778
GOCC_CLATHRIN_ADAPTOR_COMPLEX,SET,25,0.12169,0.0044875,0.16635,0.23224,GOCC_CLATHRIN_ADAPTOR_COMPLEX,0.997339777777778
KEGG_RIG_I_LIKE_RECEPTOR_SIG...,SET,61,0.085674,0.0049304,0.11713,0.23226,KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.997339777777778
GOBP_FATTY_ACID_BETA_OXIDATI...1,SET,70,0.0717,0.004419,0.098028,0.23226,GOBP_FATTY_ACID_BETA_OXIDATION,0.997339777777778
GOBP_MUSCLE_CONTRACTION,SET,328,0.036207,0.0047963,0.049509,0.23229,GOBP_MUSCLE_CONTRACTION,0.997339777777778
GALLUZZI_PERMEABILIZE_MITOCH...,SET,39,0.10966,0.005049,0.14997,0.23233,GALLUZZI_PERMEABILIZE_MITOCHONDRIA,0.997339777777778
HP_PERIORBITAL_WRINKLES,SET,4,0.34617,0.0051092,0.47341,0.23233,HP_PERIORBITAL_WRINKLES,0.997339777777778
WYAAANNRNNNGCG_UNKNOWN,SET,63,0.080416,0.0047028,0.10998,0.23234,WYAAANNRNNNGCG_UNKNOWN,0.997339777777778
GOBP_INTERMEDIATE_FILAMENT_B...1,SET,92,0.07838,0.0055347,0.10722,0.23238,GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS,0.997339777777778
HP_ANAL_STENOSIS,SET,30,0.12449,0.0050284,0.1703,0.23239,HP_ANAL_STENOSIS,0.997339777777778
BOHN_PRIMARY_IMMUNODEFICIENC...2,SET,44,0.10071,0.0049246,0.13779,0.23243,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP,0.997339777777778
GOBP_CARDIOBLAST_PROLIFERATI...,SET,9,0.23282,0.0051538,0.31856,0.23244,GOBP_CARDIOBLAST_PROLIFERATION,0.997339777777778
chr2p11,SET,44,0.20664,0.010104,0.2829,0.23257,chr2p11,0.99750864463013
REACTOME_N_GLYCAN_ANTENNAE_E...2,SET,26,0.13206,0.0049663,0.18083,0.23261,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI,0.99750864463013
GSE39152_SPLEEN_CD103_NEG_VS...2,SET,187,0.044788,0.0044973,0.061331,0.23262,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_UP,0.99750864463013
GSE3982_DC_VS_TH1_UP,SET,186,0.046788,0.0046856,0.064076,0.23264,GSE3982_DC_VS_TH1_UP,0.99750864463013
HP_ANKYLOGLOSSIA,SET,23,0.12555,0.0044411,0.17195,0.23266,HP_ANKYLOGLOSSIA,0.99750864463013
HP_NARROW_FOREHEAD,SET,150,0.04952,0.004458,0.067846,0.23273,HP_NARROW_FOREHEAD,0.99750864463013
chr1p22,SET,59,0.15407,0.0087203,0.21109,0.23274,chr1p22,0.99750864463013
MIR6847_5P,SET,136,0.052728,0.0045215,0.072254,0.23277,MIR6847_5P,0.99750864463013
KEGG_MEDICUS_PATHOGEN_KSHV_V...2,SET,5,0.25102,0.0041421,0.34403,0.23281,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_NFKB_SIGNALING_PATHWAY,0.99750864463013
HP_IRIDOCYCLITIS,SET,10,0.21511,0.0050191,0.29483,0.23282,HP_IRIDOCYCLITIS,0.99750864463013
HP_SHORT_PROXIMAL_PHALANX_OF...,SET,7,0.23863,0.0046588,0.32712,0.23285,HP_SHORT_PROXIMAL_PHALANX_OF_FINGER,0.99750864463013
FLECHNER_PBL_KIDNEY_TRANSPLA...4,SET,57,0.082718,0.0046021,0.1134,0.23287,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,0.99750864463013
GOBP_SEQUESTERING_OF_CALCIUM...,SET,126,0.057398,0.0047388,0.078697,0.2329,GOBP_SEQUESTERING_OF_CALCIUM_ION,0.99750864463013
HP_ABNORMAL_SHARPEY_FIBER_MO...,SET,31,0.12717,0.0052214,0.17437,0.23291,HP_ABNORMAL_SHARPEY_FIBER_MORPHOLOGY,0.99750864463013
HP_PERSISTENT_HEAD_LAG,SET,25,0.1133,0.0041783,0.15535,0.23291,HP_PERSISTENT_HEAD_LAG,0.99750864463013
HP_RECURRENT_TONSILLITIS,SET,12,0.19708,0.0050371,0.27026,0.23294,HP_RECURRENT_TONSILLITIS,0.99750864463013
UNTERMAN_IPF_VS_CTRL_DC_DN,SET,6,0.30078,0.0054367,0.41254,0.23298,UNTERMAN_IPF_VS_CTRL_DC_DN,0.99750864463013
BREDEMEYER_RAG_SIGNALING_NOT...2,SET,59,0.08391,0.0047493,0.11517,0.23314,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,0.99750864463013
HP_THIN_UPPER_LIP_VERMILION,SET,263,0.038133,0.0045314,0.052345,0.23316,HP_THIN_UPPER_LIP_VERMILION,0.99750864463013
KEGG_MEDICUS_VARIANT_MUTATIO...22,SET,5,0.2933,0.0048398,0.40264,0.23317,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_USP8_TO_EGFR_ERK_ACTH_SIGNALING_PATHWAY,0.99750864463013
HP_MOTOR_AXONAL_NEUROPATHY,SET,34,0.09497,0.0040833,0.1304,0.23322,HP_MOTOR_AXONAL_NEUROPATHY,0.99750864463013
SEIDEN_MET_SIGNALING,SET,18,0.13729,0.0042969,0.18857,0.23329,SEIDEN_MET_SIGNALING,0.99750864463013
ZNF410_TARGET_GENES,SET,488,0.028,0.0045041,0.03846,0.2333,ZNF410_TARGET_GENES,0.99750864463013
ZNF830_TARGET_GENES,SET,235,0.04066,0.0045708,0.055852,0.23331,ZNF830_TARGET_GENES,0.99750864463013
REACTOME_ERCC6_CSB_AND_EHMT2...,SET,15,0.15032,0.0042951,0.20649,0.23332,REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION,0.99750864463013
CROONQUIST_NRAS_SIGNALING_UP,SET,32,0.1187,0.0049513,0.16308,0.23336,CROONQUIST_NRAS_SIGNALING_UP,0.99750864463013
GOBP_POSITIVE_REGULATION_OF_...232,SET,4,0.31532,0.0046539,0.43329,0.2334,GOBP_POSITIVE_REGULATION_OF_ENAMEL_MINERALIZATION,0.99750864463013
FAN_EMBRYONIC_CTX_BRAIN_EFFE...,SET,116,0.060285,0.0047769,0.082849,0.23342,FAN_EMBRYONIC_CTX_BRAIN_EFFECTOR_T_CELL,0.99750864463013
REACTOME_INLB_MEDIATED_ENTRY...,SET,13,0.17374,0.0046218,0.23881,0.23345,REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL,0.99750864463013
THEODOROU_MAMMARY_TUMORIGENE...,SET,27,0.13269,0.0050849,0.18239,0.23347,THEODOROU_MAMMARY_TUMORIGENESIS,0.99750864463013
GSE33424_CD161_HIGH_VS_NEG_C...2,SET,189,0.04656,0.0046999,0.064001,0.23347,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP,0.99750864463013
BIOCARTA_LEPTIN_PATHWAY,SET,11,0.18371,0.0044957,0.25254,0.23348,BIOCARTA_LEPTIN_PATHWAY,0.99750864463013
GOBP_POSITIVE_REGULATION_OF_...51,SET,68,0.078105,0.0047447,0.10737,0.23348,GOBP_POSITIVE_REGULATION_OF_AXONOGENESIS,0.99750864463013
SEMBA_FHIT_TARGETS_DN,SET,9,0.18635,0.004125,0.25618,0.2335,SEMBA_FHIT_TARGETS_DN,0.99750864463013
GOBP_MATURATION_OF_SSU_RRNA_...,SET,30,0.11085,0.0044776,0.15241,0.23351,GOBP_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.99750864463013
ERWIN_COHEN_BLOOD_TC_83_AGE_...,SET,108,0.063009,0.0048186,0.086634,0.23352,ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP,0.99750864463013
MIR520G_3P_MIR520H,SET,182,0.045428,0.0045007,0.062469,0.23355,MIR520G_3P_MIR520H,0.99750864463013
MIR1180_5P,SET,34,0.10465,0.0044995,0.14392,0.23357,MIR1180_5P,0.99750864463013
GSE18791_CTRL_VS_NEWCASTLE_V...13,SET,142,0.053461,0.0046836,0.073541,0.23363,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN,0.997642296350903
GOCC_MITOCHONDRIAL_RESPIRATO...,SET,12,0.16174,0.0041339,0.22268,0.23382,GOCC_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III,0.997851632703167
GOBP_SEBACEOUS_GLAND_DEVELOP...,SET,10,0.21657,0.0050533,0.29819,0.23384,GOBP_SEBACEOUS_GLAND_DEVELOPMENT,0.997851632703167
GOMF_LIPID_TRANSPORTER_ACTIV...,SET,156,0.052096,0.0047819,0.071731,0.23384,GOMF_LIPID_TRANSPORTER_ACTIVITY,0.997851632703167
WP_AUTOSOMAL_RECESSIVE_OSTEO...,SET,11,0.18659,0.0045661,0.25694,0.23386,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,0.997851632703167
GOBP_REGULATION_OF_CELLULAR_...14,SET,6,0.29694,0.0053673,0.40891,0.23387,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS,0.997851632703167
GSE37301_HEMATOPOIETIC_STEM_...4,SET,174,0.047363,0.0045892,0.065224,0.23387,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_UP,0.997851632703167
WAMUNYOKOLI_OVARIAN_CANCER_G...2,SET,125,0.057647,0.0047406,0.079386,0.23388,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,0.997851632703167
GOBP_DEOXYRIBONUCLEOSIDE_CAT...,SET,6,0.29951,0.0054138,0.41262,0.23396,GOBP_DEOXYRIBONUCLEOSIDE_CATABOLIC_PROCESS,0.997893288020391
MIR4759,SET,46,0.089289,0.004464,0.12303,0.234,MIR4759,0.997893288020391
ANDERSON_BLOOD_CN54GP140_ADJ...5,SET,53,0.081164,0.0043547,0.11183,0.234,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_DN,0.997893288020391
GAUSSMANN_MLL_AF4_FUSION_TAR...2,SET,165,0.051013,0.0048145,0.070315,0.23408,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,0.997893288020391
GOBP_CELLULAR_RESPONSE_TO_ST...2,SET,193,0.0458,0.0046712,0.06317,0.23422,GOBP_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS,0.997893288020391
GOBP_TYPE_I_PNEUMOCYTE_DIFFE...,SET,8,0.25628,0.0053488,0.35347,0.23422,GOBP_TYPE_I_PNEUMOCYTE_DIFFERENTIATION,0.997893288020391
GOCC_TERTIARY_GRANULE_MEMBRA...,SET,63,0.077779,0.0045486,0.10731,0.23429,GOCC_TERTIARY_GRANULE_MEMBRANE,0.997893288020391
GOBP_CELLULAR_RESPONSE_TO_FR...,SET,5,0.24222,0.0039969,0.33427,0.23434,GOBP_CELLULAR_RESPONSE_TO_FRUCTOSE_STIMULUS,0.997893288020391
MA_RAT_AGING_UP,SET,96,0.066138,0.0047702,0.091286,0.23438,MA_RAT_AGING_UP,0.997893288020391
PSIP1_TARGET_GENES,SET,547,0.026174,0.0044502,0.036131,0.23441,PSIP1_TARGET_GENES,0.997893288020391
HP_ABNORMALITY_OF_THE_INCISOR,SET,93,0.065216,0.00463,0.090025,0.23441,HP_ABNORMALITY_OF_THE_INCISOR,0.997893288020391
MIR2355_5P,SET,118,0.053987,0.0043144,0.074536,0.23444,MIR2355_5P,0.997893288020391
HP_OCULAR_ANTERIOR_SEGMENT_D...,SET,273,0.037403,0.0045271,0.051638,0.23444,HP_OCULAR_ANTERIOR_SEGMENT_DYSGENESIS,0.997893288020391
QIU_PBMC_HEPTATITIS_B_SURFAC...2,SET,7,0.27066,0.0052841,0.37368,0.23445,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0_TO_35DY_JOINTLY_UP,0.997893288020391
chr3p24,SET,30,0.19897,0.0080367,0.27478,0.23451,chr3p24,0.997893288020391
GSE14415_INDUCED_TREG_VS_FAI...1,SET,168,0.049277,0.0046923,0.068069,0.23456,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN,0.997893288020391
GSE21063_WT_VS_NFATC1_KO_8H_...2,SET,179,0.043675,0.0042916,0.060363,0.23468,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP,0.997893288020391
KYNG_RESPONSE_TO_H2O2_VIA_ER...2,SET,39,0.095321,0.0043888,0.13175,0.23469,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,0.997893288020391
VECCHI_GASTRIC_CANCER_ADVANC...1,SET,132,0.05379,0.0045448,0.074357,0.23472,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,0.997893288020391
HP_APLASIA_HYPOPLASIA_OF_THE...58,SET,26,0.12883,0.0048448,0.1781,0.23474,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_TOES,0.997893288020391
HP_HYPERTROPHIC_CARDIOMYOPAT...,SET,243,0.038699,0.0044228,0.053511,0.23478,HP_HYPERTROPHIC_CARDIOMYOPATHY,0.997893288020391
GSE37532_WT_VS_PPARG_KO_VISC...3,SET,180,0.047452,0.0046756,0.065612,0.23478,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN,0.997893288020391
MIR200A_3P,SET,366,0.033874,0.004735,0.04684,0.23479,MIR200A_3P,0.997893288020391
HP_HIGH_OUTPUT_CONGESTIVE_HE...,SET,6,0.24991,0.0045172,0.3456,0.23481,HP_HIGH_OUTPUT_CONGESTIVE_HEART_FAILURE,0.997893288020391
GOBP_POSITIVE_REGULATION_OF_...386,SET,22,0.12626,0.0043683,0.17462,0.23482,GOBP_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING,0.997893288020391
KEGG_GALACTOSE_METABOLISM,SET,24,0.12013,0.0043406,0.1662,0.23491,KEGG_GALACTOSE_METABOLISM,0.997893288020391
GOBP_PROSTANOID_METABOLIC_PR...,SET,45,0.093497,0.0046234,0.12936,0.23492,GOBP_PROSTANOID_METABOLIC_PROCESS,0.997893288020391
HP_ABNORMAL_LABIA_MAJORA_MOR...,SET,40,0.093629,0.0043657,0.12955,0.23493,HP_ABNORMAL_LABIA_MAJORA_MORPHOLOGY,0.997893288020391
KEGG_MEDICUS_REFERENCE_COHES...4,SET,6,0.26538,0.0047968,0.36721,0.23494,KEGG_MEDICUS_REFERENCE_COHESIN_LOADING,0.997893288020391
GOBP_PHOSPHATIDYLGLYCEROL_ME...,SET,32,0.11829,0.0049343,0.16368,0.23494,GOBP_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS,0.997893288020391
GOCC_INCLUSION_BODY,SET,66,0.072956,0.0043665,0.10096,0.23496,GOCC_INCLUSION_BODY,0.997893288020391
DIAZ_CHRONIC_MYELOGENOUS_LEU...2,SET,1272,0.01726,0.004383,0.023886,0.23497,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP,0.997893288020391
GOMF_ALDOSE_REDUCTASE_NADPH_...,SET,12,0.23126,0.0059108,0.32012,0.23502,GOMF_ALDOSE_REDUCTASE_NADPH_ACTIVITY,0.997893288020391
GOCC_FANCONI_ANAEMIA_NUCLEAR...,SET,7,0.20666,0.0040348,0.28615,0.23509,GOCC_FANCONI_ANAEMIA_NUCLEAR_COMPLEX,0.997893288020391
ERWIN_COHEN_BLOOD_VACCINE_TC...2,SET,26,0.12752,0.0047956,0.17657,0.23509,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_DN,0.997893288020391
GOBP_NEGATIVE_REGULATION_OF_...478,SET,112,0.063721,0.0049619,0.088239,0.23511,GOBP_NEGATIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,0.997893288020391
GOBP_CELLULAR_RESPONSE_TO_CA...3,SET,69,0.078488,0.0048028,0.1087,0.23514,GOBP_CELLULAR_RESPONSE_TO_CALCIUM_ION,0.997893288020391
AP4_Q5,SET,235,0.040234,0.0045229,0.055733,0.23518,AP4_Q5,0.997893288020391
HP_CEREBRAL_HAMARTOMA,SET,18,0.13263,0.0041511,0.18374,0.2352,HP_CEREBRAL_HAMARTOMA,0.997893288020391
ODONNELL_TARGETS_OF_MYC_AND_...2,SET,68,0.075768,0.0046028,0.10498,0.23523,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,0.997893288020391
WP_EXTRACELLULAR_VESICLES_IN...,SET,19,0.16303,0.005242,0.22588,0.23523,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,0.997893288020391
GSE27786_CD4_TCELL_VS_NKTCEL...1,SET,184,0.044299,0.0044127,0.061379,0.23524,GSE27786_CD4_TCELL_VS_NKTCELL_DN,0.997893288020391
WP_HDAC6_INTERACTIONS_IN_THE...,SET,105,0.058433,0.0044065,0.080971,0.23526,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,0.997893288020391
HP_BILATERAL_TONIC_CLONIC_SE...2,SET,47,0.082088,0.0041482,0.11375,0.23526,HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_FOCAL_ONSET,0.997893288020391
GOBP_REGULATION_OF_B_CELL_AP...,SET,18,0.1509,0.0047228,0.20913,0.23529,GOBP_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS,0.997893288020391
GOMF_GLUCURONOSYL_N_ACETYLGA...,SET,6,0.2573,0.0046508,0.35662,0.23531,GOMF_GLUCURONOSYL_N_ACETYLGALACTOSAMINYL_PROTEOGLYCAN_4_BETA_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,0.997893288020391
REACTOME_PI_METABOLISM,SET,77,0.066942,0.0043263,0.092799,0.23535,REACTOME_PI_METABOLISM,0.997893288020391
MIR186_5P,SET,507,0.028212,0.0046232,0.039115,0.23538,MIR186_5P,0.997893288020391
GOBP_PROTEIN_LOCALIZATION_TO...46,SET,39,0.10185,0.0046892,0.14123,0.23542,GOBP_PROTEIN_LOCALIZATION_TO_POSTSYNAPSE,0.997893288020391
MIR4716_5P,SET,107,0.059737,0.0045473,0.082842,0.23543,MIR4716_5P,0.997893288020391
GOBP_REGULATION_OF_NEUROMUSC...,SET,7,0.2457,0.0047968,0.34073,0.23543,GOBP_REGULATION_OF_NEUROMUSCULAR_JUNCTION_DEVELOPMENT,0.997893288020391
GSE11961_PLASMA_CELL_DAY7_VS...2,SET,179,0.045216,0.0044431,0.062725,0.2355,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.997893288020391
HP_ABNORMAL_DELAYED_HYPERSEN...,SET,10,0.20608,0.0048084,0.28589,0.23551,HP_ABNORMAL_DELAYED_HYPERSENSITIVITY_SKIN_TEST,0.997893288020391
HP_URETHROVESICAL_OCCLUSION,SET,10,0.18781,0.0043821,0.26055,0.23552,HP_URETHROVESICAL_OCCLUSION,0.997893288020391
GSE19401_PAM2CSK4_VS_RETINOI...2,SET,170,0.046516,0.0044555,0.064548,0.23557,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,0.997893288020391
HP_EPILEPTIC_ENCEPHALOPATHY,SET,105,0.060851,0.0045889,0.084445,0.23558,HP_EPILEPTIC_ENCEPHALOPATHY,0.997893288020391
GOBP_SOMATIC_DIVERSIFICATION...3,SET,55,0.075765,0.0041408,0.10515,0.2356,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS,0.997893288020391
HP_PSEUDOEPIPHYSES_OF_THE_PH...,SET,5,0.30925,0.0051029,0.42919,0.2356,HP_PSEUDOEPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,0.997893288020391
HUANG_DASATINIB_SENSITIVITY_...,SET,75,0.080051,0.0051062,0.1111,0.23561,HUANG_DASATINIB_SENSITIVITY_UP,0.997893288020391
MODULE_243,SET,71,0.073098,0.0045371,0.10146,0.23563,MODULE_243,0.997893288020391
KEGG_GLYCOSAMINOGLYCAN_BIOSY...1,SET,21,0.12913,0.0043649,0.17925,0.23565,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,0.997893288020391
ZHU_CMV_8_HR_UP,SET,39,0.10399,0.004788,0.14439,0.23571,ZHU_CMV_8_HR_UP,0.997893288020391
HP_KNEE_PAIN,SET,15,0.17891,0.005112,0.24844,0.23573,HP_KNEE_PAIN,0.997893288020391
GOBP_POSITIVE_REGULATION_OF_...224,SET,66,0.070461,0.0042172,0.097854,0.23575,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.997893288020391
DESCARTES_MAIN_FETAL_BRONCHI...,SET,34,0.11971,0.0051469,0.16629,0.23581,DESCARTES_MAIN_FETAL_BRONCHIOLAR_AND_ALVEOLAR_EPITHELIAL_CELLS,0.997893288020391
GOBP_CELL_FATE_SPECIFICATION...,SET,7,0.23634,0.0046142,0.32833,0.23582,GOBP_CELL_FATE_SPECIFICATION_INVOLVED_IN_PATTERN_SPECIFICATION,0.997893288020391
WANG_THOC1_TARGETS_DN,SET,16,0.16728,0.0049364,0.23248,0.2359,WANG_THOC1_TARGETS_DN,0.997893288020391
HE_LIM_SUN_FETAL_LUNG_C4_NKT...2,SET,8,0.22485,0.0046929,0.3125,0.23591,HE_LIM_SUN_FETAL_LUNG_C4_NKT2_CELL,0.997893288020391
GSE37301_HEMATOPOIETIC_STEM_...9,SET,151,0.048593,0.0043889,0.067535,0.23592,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_DN,0.997893288020391
GSE3920_UNTREATED_VS_IFNG_TR...2,SET,136,0.053254,0.0045666,0.074048,0.23602,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.997893288020391
HAY_BONE_MARROW_DENDRITIC_CE...,SET,167,0.049703,0.0047189,0.069121,0.23606,HAY_BONE_MARROW_DENDRITIC_CELL,0.997893288020391
MORF_BUB3,SET,242,0.036527,0.004166,0.050803,0.23608,MORF_BUB3,0.997893288020391
GOBP_REGULATION_OF_STEM_CELL...4,SET,79,0.0731,0.004785,0.10167,0.23608,GOBP_REGULATION_OF_STEM_CELL_PROLIFERATION,0.997893288020391
TURASHVILI_BREAST_DUCTAL_CAR...4,SET,71,0.072944,0.0045276,0.10146,0.23609,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,0.997893288020391
HP_ABNORMAL_FEMORAL_HEAD_MOR...,SET,87,0.066487,0.0045662,0.09251,0.23617,HP_ABNORMAL_FEMORAL_HEAD_MORPHOLOGY,0.997893288020391
HP_SEVERE_FAILURE_TO_THRIVE,SET,16,0.16059,0.0047389,0.22348,0.2362,HP_SEVERE_FAILURE_TO_THRIVE,0.997893288020391
GOBP_REGULATION_OF_CELL_DEVE...,SET,764,0.02344,0.0046813,0.032625,0.23623,GOBP_REGULATION_OF_CELL_DEVELOPMENT,0.997893288020391
GOMF_CHLORIDE_CHANNEL_REGULA...,SET,13,0.16199,0.0043092,0.22548,0.23625,GOMF_CHLORIDE_CHANNEL_REGULATOR_ACTIVITY,0.997893288020391
KEGG_STARCH_AND_SUCROSE_META...,SET,45,0.10224,0.0050557,0.14232,0.23627,KEGG_STARCH_AND_SUCROSE_METABOLISM,0.997893288020391
REACTOME_MITOCHONDRIAL_FATTY...1,SET,35,0.1003,0.0043754,0.13965,0.23632,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION,0.997893288020391
MIR551A_MIR551B_3P,SET,5,0.31033,0.0051208,0.43215,0.23635,MIR551A_MIR551B_3P,0.997893288020391
GOBP_BILE_ACID_METABOLIC_PRO...,SET,49,0.093268,0.0048121,0.12989,0.23636,GOBP_BILE_ACID_METABOLIC_PROCESS,0.997893288020391
GOBP_REGULATION_OF_GLUCOCORT...2,SET,11,0.19051,0.004662,0.26535,0.2364,GOBP_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS,0.997893288020391
WP_P53_TRANSCRIPTIONAL_GENE_...,SET,89,0.062136,0.0043159,0.086555,0.23642,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,0.997893288020391
GSE14308_TH17_VS_INDUCED_TRE...2,SET,178,0.043654,0.0042777,0.060815,0.23644,GSE14308_TH17_VS_INDUCED_TREG_UP,0.997893288020391
GOBP_NEGATIVE_REGULATION_OF_...151,SET,44,0.086926,0.0042505,0.12111,0.23647,GOBP_NEGATIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS,0.997893288020391
HP_NEUROFIBROMA,SET,19,0.12777,0.0041082,0.17802,0.23648,HP_NEUROFIBROMA,0.997893288020391
GSE20715_0H_VS_6H_OZONE_TLR4...2,SET,178,0.045366,0.0044454,0.063212,0.23648,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP,0.997893288020391
DESCARTES_FETAL_HEART_CLC_IL...,SET,17,0.15949,0.0048511,0.22224,0.23649,DESCARTES_FETAL_HEART_CLC_IL5RA_POSITIVE_CELLS,0.997893288020391
SMARCA1_TARGET_GENES,SET,98,0.061326,0.0044687,0.085457,0.2365,SMARCA1_TARGET_GENES,0.997893288020391
TACGGGT_MIR99A_MIR100_MIR99B,SET,23,0.13592,0.0048081,0.18944,0.23654,TACGGGT_MIR99A_MIR100_MIR99B,0.997893288020391
HP_GINGIVAL_RECESSION,SET,5,0.26596,0.0043886,0.37067,0.23654,HP_GINGIVAL_RECESSION,0.997893288020391
JU_AGING_TERC_TARGETS_UP,SET,6,0.25659,0.0046381,0.35765,0.23656,JU_AGING_TERC_TARGETS_UP,0.997893288020391
HALLMARK_INFLAMMATORY_RESPON...,SET,190,0.048311,0.0048893,0.067347,0.23659,HALLMARK_INFLAMMATORY_RESPONSE,0.997898719660194
HP_ALVEOLAR_RIDGE_OVERGROWTH,SET,11,0.17892,0.0043783,0.24947,0.23664,HP_ALVEOLAR_RIDGE_OVERGROWTH,0.997988496541682
GOBP_ANTIGEN_PROCESSING_AND_...11,SET,36,0.11013,0.0048722,0.1536,0.23668,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,0.997999332767196
GOBP_REGULATION_OF_MEMBRANE_...4,SET,15,0.18033,0.0051527,0.25152,0.2367,GOBP_REGULATION_OF_MEMBRANE_INVAGINATION,0.997999332767196
HP_PLEURAL_EFFUSION,SET,78,0.071098,0.0046245,0.099191,0.23676,HP_PLEURAL_EFFUSION,0.998131222707423
WP_DISORDERS_OF_FOLATE_METAB...,SET,19,0.12824,0.0041235,0.17897,0.23683,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,0.9981481794068
HP_SUICIDAL_IDEATION,SET,21,0.1274,0.0043064,0.17781,0.23685,HP_SUICIDAL_IDEATION,0.9981481794068
RODRIGUES_THYROID_CARCINOMA_...5,SET,586,0.024915,0.0043799,0.034787,0.23693,RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP,0.9981481794068
GSE37301_PRO_BCELL_VS_GRANUL...1,SET,161,0.048291,0.0045025,0.067452,0.23702,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.9981481794068
GOTTWEIN_TARGETS_OF_KSHV_MIR...,SET,59,0.080233,0.0045411,0.11207,0.23703,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,0.9981481794068
MIR4323,SET,37,0.1001,0.0044895,0.13985,0.23706,MIR4323,0.9981481794068
PILON_KLF1_TARGETS_UP,SET,439,0.030245,0.0046209,0.042261,0.2371,PILON_KLF1_TARGETS_UP,0.9981481794068
HP_HYPERMOBILITY_OF_INTERPHA...,SET,5,0.28507,0.004704,0.39834,0.2371,HP_HYPERMOBILITY_OF_INTERPHALANGEAL_JOINTS,0.9981481794068
GOBP_POSITIVE_REGULATION_OF_...485,SET,19,0.14161,0.0045535,0.1979,0.23713,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS,0.9981481794068
CDC5_01,SET,228,0.043487,0.0048162,0.060793,0.23721,CDC5_01,0.9981481794068
GOBP_GROWTH_HORMONE_RECEPTOR...,SET,10,0.23862,0.0055677,0.33368,0.23728,GOBP_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT,0.9981481794068
KEGG_MEDICUS_VARIANT_CYP11B1...,SET,31,0.10848,0.0044538,0.15171,0.2373,KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.9981481794068
GOBP_MAINTENANCE_OF_LOCATION,SET,310,0.035876,0.0046225,0.050175,0.2373,GOBP_MAINTENANCE_OF_LOCATION,0.9981481794068
GSE17721_LPS_VS_GARDIQUIMOD_...15,SET,180,0.043642,0.0043002,0.061037,0.23731,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_DN,0.9981481794068
HP_DEVIATION_OF_THE_2ND_FING...,SET,19,0.14602,0.004695,0.20424,0.23734,HP_DEVIATION_OF_THE_2ND_FINGER,0.9981481794068
GOMF_ODORANT_BINDING,SET,95,0.085839,0.006159,0.12008,0.23735,GOMF_ODORANT_BINDING,0.9981481794068
GSE17721_CTRL_VS_LPS_6H_BMDC...1,SET,184,0.04479,0.0044616,0.062662,0.23738,GSE17721_CTRL_VS_LPS_6H_BMDC_DN,0.9981481794068
KEGG_MEDICUS_REFERENCE_TRANS...2,SET,28,0.099513,0.0038834,0.13932,0.23754,KEGG_MEDICUS_REFERENCE_TRANSCRIPTION_COUPLED_NER,0.9981481794068
HP_RECURRENT_PROTOZOAN_INFEC...,SET,5,0.30983,0.0051126,0.43389,0.23759,HP_RECURRENT_PROTOZOAN_INFECTIONS,0.9981481794068
MIR146A_3P,SET,197,0.044433,0.0045781,0.062227,0.2376,MIR146A_3P,0.9981481794068
MIR6782_3P,SET,79,0.06917,0.0045278,0.096875,0.23761,MIR6782_3P,0.9981481794068
GOBP_NEGATIVE_REGULATION_OF_...202,SET,4,0.34843,0.0051427,0.48799,0.23761,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,0.9981481794068
MIR4433A_3P,SET,53,0.079817,0.0042825,0.11179,0.23762,MIR4433A_3P,0.9981481794068
STAT1_03,SET,239,0.039488,0.0044762,0.055306,0.23762,STAT1_03,0.9981481794068
HP_ATRIAL_FIBRILLATION,SET,79,0.07596,0.0049722,0.1064,0.23766,HP_ATRIAL_FIBRILLATION,0.9981481794068
GSE13485_DAY1_VS_DAY7_YF17D_...1,SET,180,0.045508,0.0044841,0.063749,0.23766,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN,0.9981481794068
GSE21380_NON_TFH_VS_TFH_CD4_...1,SET,180,0.04645,0.0045768,0.065067,0.23766,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN,0.9981481794068
GSE25087_TREG_VS_TCONV_FETUS...1,SET,162,0.047439,0.0044367,0.066453,0.23766,GSE25087_TREG_VS_TCONV_FETUS_DN,0.9981481794068
MIR6760_5P,SET,105,0.059637,0.0044973,0.083548,0.23768,MIR6760_5P,0.9981481794068
HP_OVOID_VERTEBRAL_BODIES,SET,34,0.10891,0.0046828,0.1526,0.23771,HP_OVOID_VERTEBRAL_BODIES,0.9981481794068
MIR6504_5P,SET,128,0.053115,0.0044197,0.074444,0.23778,MIR6504_5P,0.9981481794068
GOBP_STRIATED_MUSCLE_CELL_PR...,SET,67,0.078251,0.0047187,0.10968,0.2378,GOBP_STRIATED_MUSCLE_CELL_PROLIFERATION,0.9981481794068
GOCC_EXTERNAL_SIDE_OF_APICAL...,SET,6,0.26133,0.0047237,0.36637,0.23784,GOCC_EXTERNAL_SIDE_OF_APICAL_PLASMA_MEMBRANE,0.9981481794068
GOMF_TRANSCRIPTION_ELONGATIO...,SET,7,0.24275,0.0047394,0.34038,0.23787,GOMF_TRANSCRIPTION_ELONGATION_FACTOR_ACTIVITY,0.9981481794068
HP_ABNORMAL_CRANIAL_NERVE_MO...,SET,71,0.07206,0.0044727,0.10105,0.23789,HP_ABNORMAL_CRANIAL_NERVE_MORPHOLOGY,0.9981481794068
SOBOLEV_PBMC_PANDEMRIX_AGE_1...1,SET,15,0.16686,0.0047677,0.23399,0.2379,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP,0.9981481794068
GOBP_REGULATION_OF_TRANSCRIP...1,SET,8,0.17979,0.0037524,0.25215,0.23791,GOBP_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE,0.9981481794068
WP_EMBRYONIC_STEM_CELL_PLURI...,SET,108,0.063332,0.0048433,0.08883,0.23794,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,0.9981481794068
GSE16385_MONOCYTE_VS_12H_IFN...1,SET,174,0.047378,0.0045907,0.066456,0.23795,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,0.9981481794068
HE_LIM_SUN_FETAL_LUNG_C7_SCH...,SET,214,0.040989,0.0043997,0.0575,0.23797,HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL,0.9981481794068
IK3_01,SET,199,0.044996,0.0046593,0.063124,0.23798,IK3_01,0.9981481794068
GSE7460_TCONV_VS_TREG_LN_UP,SET,184,0.046985,0.0046802,0.065915,0.23799,GSE7460_TCONV_VS_TREG_LN_UP,0.9981481794068
HE_LIM_SUN_FETAL_LUNG_C2_HSC...1,SET,1384,0.016443,0.0043413,0.023073,0.23803,HE_LIM_SUN_FETAL_LUNG_C2_HSC_CELL,0.9981481794068
HP_SPARSE_LATERAL_EYEBROW,SET,30,0.10863,0.0043877,0.15246,0.23809,HP_SPARSE_LATERAL_EYEBROW,0.9981481794068
HP_YOUNG_ADULT_ONSET,SET,512,0.026844,0.0044201,0.037678,0.23809,HP_YOUNG_ADULT_ONSET,0.9981481794068
GOBP_ANTIGEN_PROCESSING_AND_...5,SET,45,0.10159,0.0050237,0.14262,0.23813,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_ANTIGEN,0.9981481794068
GSE16385_UNTREATED_VS_12H_RO...2,SET,183,0.045707,0.0045407,0.064174,0.23816,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,0.9981481794068
HP_3_4_FINGER_SYNDACTYLY,SET,10,0.21376,0.0049876,0.30013,0.23817,HP_3_4_FINGER_SYNDACTYLY,0.9981481794068
GOBP_DNA_TEMPLATED_DNA_REPLI...1,SET,154,0.046019,0.0041971,0.064617,0.23818,GOBP_DNA_TEMPLATED_DNA_REPLICATION,0.9981481794068
MIR8078,SET,28,0.11457,0.0044711,0.16089,0.2382,MIR8078,0.9981481794068
PAX7_TARGET_GENES,SET,514,0.027054,0.0044631,0.038003,0.23827,PAX7_TARGET_GENES,0.998227574990965
GOMF_GUANINE_NUCLEOTIDE_TRAN...,SET,5,0.31856,0.0052565,0.44754,0.2383,GOMF_GUANINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.998227574990965
GOBP_CELLULAR_LIPID_METABOLI...,SET,921,0.02085,0.0045514,0.029296,0.23833,GOBP_CELLULAR_LIPID_METABOLIC_PROCESS,0.998227574990965
GOBP_CRANIAL_NERVE_STRUCTURA...,SET,10,0.22523,0.0052553,0.31652,0.23837,GOBP_CRANIAL_NERVE_STRUCTURAL_ORGANIZATION,0.998227574990965
GOBP_NEGATIVE_REGULATION_OF_...393,SET,13,0.16842,0.0044802,0.23669,0.23838,GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION,0.998227574990965
WANG_TARGETS_OF_MLL_CBP_FUSI...2,SET,43,0.091956,0.0044452,0.12925,0.2384,WANG_TARGETS_OF_MLL_CBP_FUSION_UP,0.998227574990965
GSE17721_POLYIC_VS_PAM3CSK4_...14,SET,180,0.044862,0.0044204,0.06306,0.23842,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_UP,0.998227574990965
GSE8685_IL2_ACT_IL2_STARVED_...2,SET,181,0.043421,0.0042902,0.061052,0.23848,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,0.998317509025271
GNF2_MYD88,SET,54,0.08258,0.0044722,0.11614,0.23853,GNF2_MYD88,0.998317509025271
GOBP_REGULATION_OF_MESONEPHR...,SET,4,0.31474,0.0046454,0.44273,0.23857,GOBP_REGULATION_OF_MESONEPHROS_DEVELOPMENT,0.998317509025271
REACTOME_SYNTHESIS_OF_BILE_A...2,SET,13,0.19636,0.0052233,0.27625,0.23861,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL,0.998317509025271
OISHI_CHOLANGIOMA_STEM_CELL_...2,SET,324,0.032099,0.0042266,0.045162,0.23862,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,0.998317509025271
GSE46606_UNSTIM_VS_CD40L_IL2...7,SET,180,0.046023,0.0045348,0.064753,0.23863,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,0.998317509025271
MORF_GNB1,SET,273,0.035258,0.0042675,0.049615,0.23866,MORF_GNB1,0.998317509025271
HP_ONYCHOMYCOSIS,SET,20,0.14523,0.004791,0.2044,0.23869,HP_ONYCHOMYCOSIS,0.998317509025271
WP_SCFA_AND_SKELETAL_MUSCLE_...,SET,6,0.2491,0.0045027,0.3506,0.2387,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,0.998317509025271
HP_HBS_HEMOGLOBIN,SET,5,0.29186,0.0048161,0.41096,0.2388,HP_HBS_HEMOGLOBIN,0.998531173798709
DIRMEIER_LMP1_RESPONSE_EARLY,SET,59,0.082649,0.0046779,0.11643,0.2389,DIRMEIER_LMP1_RESPONSE_EARLY,0.998531173798709
HP_HITCHHIKER_THUMB,SET,6,0.20279,0.0036655,0.28571,0.23893,HP_HITCHHIKER_THUMB,0.998531173798709
HP_OLIGODONTIA,SET,52,0.082164,0.0043667,0.1158,0.23899,HP_OLIGODONTIA,0.998531173798709
MIR4436B_5P,SET,121,0.058519,0.0047352,0.082478,0.23901,MIR4436B_5P,0.998531173798709
GSE29949_MICROGLIA_BRAIN_VS_...3,SET,182,0.047269,0.0046831,0.066622,0.23901,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.998531173798709
CHOI_ATL_CHRONIC_VS_ACUTE_DN,SET,17,0.14772,0.0044931,0.20821,0.23902,CHOI_ATL_CHRONIC_VS_ACUTE_DN,0.998531173798709
MORF_USP5,SET,46,0.079264,0.0039628,0.11179,0.23915,MORF_USP5,0.998531173798709
GSE43863_LY6C_INT_CXCR5POS_V...2,SET,181,0.047885,0.0047312,0.06754,0.23917,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.998531173798709
KANG_GLIS3_TARGETS,SET,34,0.1168,0.0050221,0.16477,0.2392,KANG_GLIS3_TARGETS,0.998531173798709
GSE3720_UNSTIM_VS_LPS_STIM_V...1,SET,130,0.056127,0.0047064,0.079177,0.2392,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN,0.998531173798709
GOBP_MRNA_METHYLGUANOSINE_CA...,SET,14,0.16688,0.0046067,0.23548,0.23926,GOBP_MRNA_METHYLGUANOSINE_CAP_DECAPPING,0.998531173798709
KEGG_MEDICUS_REFERENCE_CGAS_...,SET,13,0.21353,0.0056801,0.30131,0.23927,KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY,0.998531173798709
XU_HGF_TARGETS_INDUCED_BY_AK...3,SET,15,0.15701,0.0044863,0.22157,0.23928,XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,0.998531173798709
GSE17721_CTRL_VS_PAM3CSK4_4H...2,SET,182,0.04311,0.0042711,0.060837,0.23929,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_UP,0.998531173798709
GOBP_REGULATION_OF_PROTEIN_L...8,SET,10,0.17552,0.0040955,0.24775,0.23933,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CILIUM,0.998531173798709
GOMF_TRANSPORTER_ACTIVATOR_A...,SET,7,0.22941,0.0044788,0.32387,0.23937,GOMF_TRANSPORTER_ACTIVATOR_ACTIVITY,0.998531173798709
LAKE_ADULT_KIDNEY_C11_THIN_A...,SET,158,0.050191,0.0046362,0.070868,0.23941,LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB,0.998531173798709
HP_NEOPLASM_OF_THE_EYE,SET,47,0.075644,0.0038226,0.10682,0.23943,HP_NEOPLASM_OF_THE_EYE,0.998531173798709
OISHI_CHOLANGIOMA_STEM_CELL_...1,SET,253,0.04034,0.0047029,0.056971,0.23945,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,0.998531173798709
GSE27291_0H_VS_6H_STIM_GAMMA...2,SET,152,0.048656,0.004409,0.068724,0.23948,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_UP,0.998531173798709
chr2q24,SET,48,0.17291,0.0088299,0.24429,0.23954,chr2q24,0.998531173798709
GOBP_POSITIVE_REGULATION_OF_...427,SET,39,0.10109,0.0046545,0.14283,0.23955,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION,0.998531173798709
GSE5542_UNTREATED_VS_IFNG_TR...2,SET,184,0.045519,0.0045342,0.064332,0.23961,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.998531173798709
GNF2_TYK2,SET,28,0.10435,0.0040722,0.14748,0.23962,GNF2_TYK2,0.998531173798709
GENTILE_UV_RESPONSE_CLUSTER_...3,SET,52,0.083101,0.0044165,0.11746,0.23963,GENTILE_UV_RESPONSE_CLUSTER_D4,0.998531173798709
DAVIES_MULTIPLE_MYELOMA_VS_M...1,SET,23,0.13799,0.0048811,0.19506,0.23967,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,0.998531173798709
MIR4294,SET,69,0.075883,0.0046434,0.1073,0.23972,MIR4294,0.998531173798709
HP_APLASIA_HYPOPLASIA_OF_THE...16,SET,9,0.21238,0.0047012,0.30032,0.23974,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBRAL_WHITE_MATTER,0.998531173798709
HP_CEREBRAL_WHITE_MATTER_HYP...,SET,9,0.21238,0.0047012,0.30032,0.23974,HP_CEREBRAL_WHITE_MATTER_HYPOPLASIA,0.998531173798709
HP_HYPOCALCIURIA,SET,9,0.23136,0.0051214,0.32721,0.23977,HP_HYPOCALCIURIA,0.998531173798709
MARTIN_VIRAL_GPCR_SIGNALING_...1,SET,47,0.086128,0.0043523,0.12182,0.23978,MARTIN_VIRAL_GPCR_SIGNALING_DN,0.998531173798709
GOMF_UBIQUINOL_CYTOCHROME_C_...,SET,5,0.21442,0.0035381,0.30334,0.23983,GOMF_UBIQUINOL_CYTOCHROME_C_REDUCTASE_ACTIVITY,0.998531173798709
GOBP_SUCCINYL_COA_CATABOLIC_...,SET,6,0.24674,0.00446,0.3491,0.23986,GOBP_SUCCINYL_COA_CATABOLIC_PROCESS,0.998531173798709
GOBP_DORSAL_VENTRAL_NEURAL_T...,SET,16,0.1536,0.0045325,0.21735,0.23989,GOBP_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING,0.998531173798709
GOMF_GLUTATHIONE_TRANSFERASE...,SET,23,0.15234,0.0053888,0.21558,0.23989,GOMF_GLUTATHIONE_TRANSFERASE_ACTIVITY,0.998531173798709
GOCC_CYTOPLASMIC_STRESS_GRAN...,SET,83,0.062445,0.0041893,0.088384,0.23994,GOCC_CYTOPLASMIC_STRESS_GRANULE,0.998531173798709
GSE360_L_DONOVANI_VS_B_MALAY...1,SET,177,0.04511,0.004408,0.06386,0.23998,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.998531173798709
GOMF_DISACCHARIDE_BINDING,SET,5,0.2522,0.0041616,0.35716,0.24006,GOMF_DISACCHARIDE_BINDING,0.998531173798709
GOMF_EXCITATORY_EXTRACELLULA...,SET,34,0.11365,0.0048866,0.16097,0.24009,GOMF_EXCITATORY_EXTRACELLULAR_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.998531173798709
GOBP_NOSE_DEVELOPMENT,SET,15,0.16909,0.0048315,0.23951,0.2401,GOBP_NOSE_DEVELOPMENT,0.998531173798709
WEBER_METHYLATED_HCP_IN_FIBR...2,SET,6,0.25871,0.0046763,0.36648,0.24012,WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP,0.998531173798709
GSE25846_IL10_POS_VS_NEG_CD8...1,SET,176,0.043208,0.0042103,0.061207,0.24012,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_DN,0.998531173798709
GOCC_CYTOPLASMIC_REGION,SET,251,0.036947,0.0042906,0.052351,0.24017,GOCC_CYTOPLASMIC_REGION,0.998531173798709
MIR767_3P,SET,115,0.061032,0.0048154,0.086489,0.2402,MIR767_3P,0.998531173798709
MIR2117,SET,112,0.056448,0.0043956,0.079996,0.24021,MIR2117,0.998531173798709
GOBP_CELLULAR_RESPONSE_TO_ES...1,SET,36,0.10655,0.0047139,0.15101,0.24022,GOBP_CELLULAR_RESPONSE_TO_ESTRADIOL_STIMULUS,0.998531173798709
GSE3039_CD4_TCELL_VS_ALPHABE...2,SET,174,0.046149,0.0044715,0.065411,0.24025,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_UP,0.998531173798709
GSE2585_AIRE_KO_VS_WT_CD80_L...1,SET,192,0.043064,0.004381,0.061047,0.24028,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN,0.998531173798709
GCM_PRKAG1,SET,44,0.08415,0.0041148,0.1193,0.24029,GCM_PRKAG1,0.998531173798709
GOBP_POSITIVE_REGULATION_OF_...554,SET,7,0.25086,0.0048976,0.35567,0.24032,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.998531173798709
WP_RETINOBLASTOMA_GENE_IN_CA...,SET,81,0.062553,0.0041459,0.088703,0.24035,WP_RETINOBLASTOMA_GENE_IN_CANCER,0.998531173798709
HP_DYSPLASIA_OF_THE_FEMORAL_...,SET,5,0.26534,0.0043783,0.37625,0.24035,HP_DYSPLASIA_OF_THE_FEMORAL_HEAD,0.998531173798709
HP_ULNAR_CLAW,SET,9,0.22327,0.0049424,0.31661,0.24035,HP_ULNAR_CLAW,0.998531173798709
GOBP_DETERMINATION_OF_LEFT_R...,SET,10,0.21253,0.004959,0.30139,0.24036,GOBP_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY_IN_LATERAL_MESODERM,0.998531173798709
GOBP_NEGATIVE_REGULATION_OF_...82,SET,26,0.1248,0.0046932,0.17698,0.24036,GOBP_NEGATIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,0.998531173798709
KYNG_RESPONSE_TO_H2O2,SET,64,0.074261,0.004377,0.10534,0.24041,KYNG_RESPONSE_TO_H2O2,0.998558145363409
GOBP_CARDIAC_MUSCLE_CELL_CAR...,SET,7,0.26952,0.0052619,0.38237,0.24045,GOBP_CARDIAC_MUSCLE_CELL_CARDIAC_MUSCLE_CELL_ADHESION,0.998558145363409
GAVISH_3CA_METAPROGRAM_EPITH...10,SET,48,0.09954,0.0050832,0.14124,0.24048,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN,0.998558145363409
MIR5586_5P,SET,74,0.074436,0.0047164,0.10563,0.2405,MIR5586_5P,0.998558145363409
GOBP_SUPPRESSION_OF_VIRAL_RE...,SET,14,0.1712,0.0047261,0.24296,0.24052,GOBP_SUPPRESSION_OF_VIRAL_RELEASE_BY_HOST,0.998558145363409
GOBP_TYPE_II_PNEUMOCYTE_DIFF...,SET,6,0.23989,0.0043361,0.34055,0.24059,GOBP_TYPE_II_PNEUMOCYTE_DIFFERENTIATION,0.998558145363409
GOBP_LONG_CHAIN_FATTY_ACID_M...,SET,102,0.061739,0.0045892,0.087673,0.24066,GOBP_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.998558145363409
KEGG_GLYCEROLIPID_METABOLISM,SET,41,0.095537,0.0045099,0.1357,0.24071,KEGG_GLYCEROLIPID_METABOLISM,0.998558145363409
GOBP_INTERNAL_PROTEIN_AMINO_...,SET,10,0.16172,0.0037734,0.2297,0.24071,GOBP_INTERNAL_PROTEIN_AMINO_ACID_ACETYLATION,0.998558145363409
GSE20366_TREG_VS_NAIVE_CD4_T...3,SET,179,0.04601,0.004521,0.065355,0.24072,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN,0.998558145363409
GSE34515_CD16_NEG_VS_POS_MON...2,SET,181,0.045407,0.0044864,0.064499,0.24072,GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP,0.998558145363409
GLINSKY_CANCER_DEATH_UP,SET,5,0.23426,0.0038656,0.33277,0.24073,GLINSKY_CANCER_DEATH_UP,0.998558145363409
HP_INCREASED_FECAL_PORPHYRIN,SET,4,0.27536,0.0040642,0.39116,0.24074,HP_INCREASED_FECAL_PORPHYRIN,0.998558145363409
GOBP_RETINOIC_ACID_METABOLIC...,SET,33,0.1237,0.0052399,0.17585,0.2409,GOBP_RETINOIC_ACID_METABOLIC_PROCESS,0.998988564781675
GSE21360_NAIVE_VS_SECONDARY_...1,SET,156,0.049249,0.0045206,0.070018,0.24091,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN,0.998988564781675
GOBP_NEGATIVE_REGULATION_OF_...579,SET,9,0.22585,0.0049993,0.3211,0.24093,GOBP_NEGATIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.998988564781675
HP_FRONTOTEMPORAL_DEMENTIA,SET,50,0.083214,0.0043369,0.11833,0.24097,HP_FRONTOTEMPORAL_DEMENTIA,0.999035232017178
HP_IMPAIRED_PROPRIOCEPTION,SET,136,0.049654,0.0042579,0.070654,0.24111,HP_IMPAIRED_PROPRIOCEPTION,0.999066692444973
GOMF_ATPASE_COUPLED_TRANSMEM...,SET,91,0.066064,0.0046398,0.094027,0.24115,GOMF_ATPASE_COUPLED_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.999066692444973
HP_ABNORMAL_DELIVERY,SET,87,0.063921,0.0043899,0.090973,0.24115,HP_ABNORMAL_DELIVERY,0.999066692444973
REACTOME_ISG15_ANTIVIRAL_MEC...,SET,70,0.06868,0.0042329,0.097758,0.24117,REACTOME_ISG15_ANTIVIRAL_MECHANISM,0.999066692444973
GOBP_RESPONSE_TO_MOLECULE_OF...2,SET,4,0.31551,0.0046568,0.44911,0.24118,GOBP_RESPONSE_TO_MOLECULE_OF_FUNGAL_ORIGIN,0.999066692444973
GOBP_POSITIVE_REGULATION_OF_...529,SET,85,0.07283,0.0049443,0.10368,0.24119,GOBP_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION,0.999066692444973
GOBP_POSITIVE_REGULATION_OF_...729,SET,4,0.32862,0.0048503,0.468,0.24129,GOBP_POSITIVE_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,0.999066692444973
GOBP_PROSTANOID_BIOSYNTHETIC...,SET,27,0.11456,0.00439,0.16315,0.24129,GOBP_PROSTANOID_BIOSYNTHETIC_PROCESS,0.999066692444973
HP_DECREASED_SPECIFIC_PNEUMO...,SET,7,0.24151,0.0047151,0.34396,0.2413,HP_DECREASED_SPECIFIC_PNEUMOCOCCAL_ANTIBODY_LEVEL,0.999066692444973
GOCC_VACUOLE,SET,773,0.021903,0.0043988,0.031201,0.24134,GOCC_VACUOLE,0.999066692444973
MEBARKI_HCC_PROGENITOR_WNT_DN,SET,72,0.074496,0.0046562,0.10614,0.24138,MEBARKI_HCC_PROGENITOR_WNT_DN,0.999066692444973
GOBP_REGULATION_OF_HUMORAL_I...2,SET,17,0.17165,0.0052209,0.24455,0.24138,GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.999066692444973
HP_ABSENCE_OF_PUBERTAL_DEVEL...,SET,30,0.11786,0.0047607,0.16793,0.24139,HP_ABSENCE_OF_PUBERTAL_DEVELOPMENT,0.999066692444973
HP_APLASIA_HYPOPLASIA_OF_THE...78,SET,27,0.1029,0.0039433,0.14667,0.24149,HP_APLASIA_HYPOPLASIA_OF_THE_UVULA,0.999066692444973
HP_TESSIER_CLEFT,SET,17,0.13936,0.0042388,0.19865,0.24149,HP_TESSIER_CLEFT,0.999066692444973
KEGG_MEDICUS_REFERENCE_LECTI...3,SET,9,0.21624,0.0047868,0.30827,0.24151,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,0.999066692444973
GCM_DLG1,SET,69,0.06758,0.0041353,0.096352,0.24154,GCM_DLG1,0.999066692444973
CEBPA_01,SET,223,0.041996,0.0046004,0.059879,0.24155,CEBPA_01,0.999066692444973
GOMF_GLYCEROL_CHANNEL_ACTIVI...,SET,5,0.31671,0.0052261,0.45162,0.24157,GOMF_GLYCEROL_CHANNEL_ACTIVITY,0.999066692444973
HP_ABNORMALITY_OF_THE_ACHILL...,SET,50,0.085873,0.0044755,0.12245,0.24157,HP_ABNORMALITY_OF_THE_ACHILLES_TENDON,0.999066692444973
HP_BONE_MARROW_FOAM_CELLS,SET,5,0.34589,0.0057076,0.4933,0.2416,HP_BONE_MARROW_FOAM_CELLS,0.999066692444973
OLSSON_E2F3_TARGETS_UP,SET,22,0.14419,0.0049886,0.20565,0.24161,OLSSON_E2F3_TARGETS_UP,0.999066692444973
REACTOME_RAP1_SIGNALLING,SET,16,0.14755,0.0043541,0.2105,0.24167,REACTOME_RAP1_SIGNALLING,0.999092604042806
GSE17721_LPS_VS_CPG_6H_BMDC_...1,SET,180,0.044463,0.0043811,0.063439,0.24169,GSE17721_LPS_VS_CPG_6H_BMDC_DN,0.999092604042806
GOBP_CARDIAC_SEPTUM_MORPHOGE...,SET,68,0.083744,0.0050874,0.1195,0.24172,GOBP_CARDIAC_SEPTUM_MORPHOGENESIS,0.999092604042806
GOMF_PROTEIN_DEMETHYLASE_ACT...,SET,24,0.10763,0.0038889,0.15359,0.24174,GOMF_PROTEIN_DEMETHYLASE_ACTIVITY,0.999092604042806
GSE31082_DP_VS_CD8_SP_THYMOC...1,SET,179,0.04457,0.0043795,0.063611,0.24176,GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN,0.999092604042806
CAR_TNFRSF25,SET,28,0.11408,0.004452,0.16285,0.2418,CAR_TNFRSF25,0.999139103554869
HP_SHORT_CHIN,SET,56,0.080988,0.0044662,0.11564,0.24185,HP_SHORT_CHIN,0.99921141142925
GOBP_POSITIVE_REGULATION_OF_...697,SET,8,0.23533,0.0049115,0.33608,0.2419,GOBP_POSITIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.99921141142925
GOBP_CENTRAL_NERVOUS_SYSTEM_...6,SET,76,0.074943,0.004812,0.10703,0.24191,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT,0.99921141142925
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SET,49,0.087714,0.0045256,0.12529,0.24195,SMIRNOV_RESPONSE_TO_IR_2HR_UP,0.99921141142925
WP_CARDIOMYOCYTE_SIGNALING_C...,SET,31,0.1087,0.0044631,0.1553,0.24199,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,0.99921141142925
GOBP_POSITIVE_REGULATION_OF_...625,SET,230,0.040538,0.004509,0.057917,0.24199,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY,0.99921141142925
GOBP_MUSCLE_ORGAN_MORPHOGENE...,SET,76,0.076668,0.0049228,0.10957,0.24206,GOBP_MUSCLE_ORGAN_MORPHOGENESIS,0.999304293859128
GSE1791_CTRL_VS_NEUROMEDINU_...7,SET,175,0.044578,0.0043316,0.063711,0.24207,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN,0.999304293859128
GOBP_REGULATION_OF_LEUKOCYTE...1,SET,4,0.32824,0.0048446,0.46918,0.2421,GOBP_REGULATION_OF_LEUKOCYTE_ADHESION_TO_ARTERIAL_ENDOTHELIAL_CELL,0.999309441805226
HP_SYMPHALANGISM_OF_MIDDLE_P...2,SET,5,0.26166,0.0043177,0.37409,0.24213,HP_SYMPHALANGISM_OF_MIDDLE_PHALANX_OF_FINGER,0.999314588528678
HP_POSTURAL_TREMOR,SET,53,0.080628,0.004326,0.11529,0.24217,HP_POSTURAL_TREMOR,0.999324878309391
GSE3982_EOSINOPHIL_VS_BASOPH...2,SET,172,0.046485,0.0044784,0.066474,0.24219,GSE3982_EOSINOPHIL_VS_BASOPHIL_UP,0.999324878309391
GOBP_REGULATION_OF_SKELETAL_...6,SET,7,0.22184,0.004331,0.31732,0.24225,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING,0.999402081850534
GSE21033_CTRL_VS_POLYIC_STIM...8,SET,179,0.04224,0.0041506,0.060425,0.24227,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_UP,0.999402081850534
GOBP_REGULATION_OF_DELAYED_R...,SET,15,0.16703,0.0047725,0.239,0.24232,GOBP_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.999402081850534
GSE26488_WT_VS_HDAC7_DELTAP_...2,SET,184,0.046411,0.004623,0.066411,0.24233,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_UP,0.999402081850534
GOBP_NEGATIVE_REGULATION_OF_...113,SET,581,0.026376,0.0046175,0.037752,0.24238,GOBP_NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION,0.999402081850534
KEGG_MEDICUS_ENV_FACTOR_PARA...,SET,5,0.30319,0.005003,0.43399,0.2424,KEGG_MEDICUS_ENV_FACTOR_PARAQUAT_TO_FAS_JNK_SIGNALING_PATHWAY,0.999402081850534
FRANCO_BLOOD_SANOFI_PASTEUR_...1,SET,14,0.17177,0.0047418,0.24589,0.24241,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_0DY_NEGATIVE,0.999402081850534
GOBP_POSITIVE_REGULATION_OF_...47,SET,18,0.14233,0.0044546,0.2038,0.24248,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,0.999436870355078
GOBP_NATURAL_KILLER_CELL_DEG...,SET,10,0.18417,0.0042972,0.26376,0.24252,GOBP_NATURAL_KILLER_CELL_DEGRANULATION,0.999436870355078
GOBP_TISSUE_REGENERATION,SET,69,0.075616,0.0046271,0.10832,0.24256,GOBP_TISSUE_REGENERATION,0.999436870355078
GSE15767_MED_VS_SCS_MAC_LN_DN,SET,180,0.043571,0.0042932,0.062414,0.24256,GSE15767_MED_VS_SCS_MAC_LN_DN,0.999436870355078
HP_HIP_FLEXOR_WEAKNESS,SET,15,0.14532,0.0041522,0.20829,0.2427,HP_HIP_FLEXOR_WEAKNESS,0.999436870355078
KAMMINGA_EZH2_TARGETS,SET,40,0.08861,0.0041317,0.12705,0.24277,KAMMINGA_EZH2_TARGETS,0.999436870355078
GREENBAUM_E2A_TARGETS_DN,SET,17,0.14471,0.0044015,0.20756,0.24285,GREENBAUM_E2A_TARGETS_DN,0.999436870355078
PID_S1P_S1P4_PATHWAY,SET,14,0.15425,0.004258,0.22125,0.24285,PID_S1P_S1P4_PATHWAY,0.999436870355078
GOBP_NEGATIVE_REGULATION_OF_...440,SET,68,0.078377,0.0047613,0.11245,0.24291,GOBP_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION,0.999436870355078
REACTOME_CALCINEURIN_ACTIVAT...,SET,9,0.18148,0.0040173,0.26042,0.24294,REACTOME_CALCINEURIN_ACTIVATES_NFAT,0.999436870355078
chr3p14,SET,47,0.18018,0.009105,0.25856,0.24295,chr3p14,0.999436870355078
WP_REGULATION_OF_APOPTOSIS_B...,SET,24,0.11907,0.0043024,0.17092,0.24301,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,0.999436870355078
MIR5585_3P,SET,77,0.068783,0.0044453,0.098734,0.24301,MIR5585_3P,0.999436870355078
GOBP_CELL_MIGRATION_INVOLVED...4,SET,5,0.33359,0.0055047,0.47898,0.24307,GOBP_CELL_MIGRATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,0.999436870355078
GOBP_REGULATION_OF_MAP_KINAS...,SET,122,0.055602,0.0045177,0.079844,0.2431,GOBP_REGULATION_OF_MAP_KINASE_ACTIVITY,0.999436870355078
GOMF_ACTIVIN_BINDING,SET,11,0.17856,0.0043697,0.25642,0.2431,GOMF_ACTIVIN_BINDING,0.999436870355078
MIR4751,SET,31,0.10592,0.0043488,0.15212,0.24313,MIR4751,0.999436870355078
GOMF_LONG_CHAIN_FATTY_ACID_B...,SET,16,0.14062,0.0041496,0.20196,0.24313,GOMF_LONG_CHAIN_FATTY_ACID_BINDING,0.999436870355078
E2F1DP1RB_01,SET,208,0.041213,0.0043619,0.059195,0.24315,E2F1DP1RB_01,0.999436870355078
GOBP_NEGATIVE_REGULATION_OF_...698,SET,22,0.13614,0.0047102,0.19557,0.24317,GOBP_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL,0.999436870355078
MIR574_3P,SET,5,0.28659,0.004729,0.41172,0.2432,MIR574_3P,0.999436870355078
GOMF_MONOATOMIC_ION_TRANSMEM...,SET,687,0.023892,0.0045347,0.034325,0.2432,GOMF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.999436870355078
HE_LIM_SUN_FETAL_LUNG_C2_MYE...,SET,15,0.17218,0.0049197,0.24742,0.24325,HE_LIM_SUN_FETAL_LUNG_C2_MYELOCYTE_LIKE_CELL,0.999436870355078
GOCC_VESICLE_TETHERING_COMPL...,SET,62,0.073051,0.0042381,0.10498,0.24326,GOCC_VESICLE_TETHERING_COMPLEX,0.999436870355078
GOBP_POSITIVE_REGULATION_OF_...225,SET,5,0.34104,0.0056276,0.49022,0.24331,GOBP_POSITIVE_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.999436870355078
GSE19923_WT_VS_E2A_KO_DP_THY...1,SET,176,0.044068,0.0042942,0.063344,0.24331,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_DN,0.999436870355078
REACTOME_SYNTHESIS_OF_WYBUTO...,SET,6,0.20219,0.0036547,0.29069,0.24335,REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE,0.999436870355078
GOBP_PEROXISOME_PROLIFERATOR...,SET,22,0.14435,0.0049941,0.20756,0.24339,GOBP_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.999436870355078
HP_NEONATAL_HYPOGLYCEMIA,SET,42,0.091401,0.0043668,0.13143,0.2434,HP_NEONATAL_HYPOGLYCEMIA,0.999436870355078
KRCTCNNNNMANAGC_UNKNOWN,SET,14,0.16524,0.0045613,0.23765,0.24344,KRCTCNNNNMANAGC_UNKNOWN,0.999436870355078
MODULE_229,SET,27,0.1097,0.0042041,0.15779,0.24345,MODULE_229,0.999436870355078
GOBP_SUBSTRATE_INDEPENDENT_T...,SET,9,0.23337,0.0051659,0.33569,0.24347,GOBP_SUBSTRATE_INDEPENDENT_TELENCEPHALIC_TANGENTIAL_MIGRATION,0.999436870355078
GOMF_GALACTOSIDE_BINDING,SET,5,0.30857,0.0050917,0.44391,0.2435,GOMF_GALACTOSIDE_BINDING,0.999436870355078
HP_PLAGIOCEPHALY,SET,134,0.051391,0.0043746,0.073941,0.24352,HP_PLAGIOCEPHALY,0.999436870355078
HP_BICORNUATE_UTERUS,SET,48,0.082929,0.0042349,0.11932,0.24353,HP_BICORNUATE_UTERUS,0.999436870355078
GSE40225_WT_VS_RIP_B7X_DIABE...2,SET,167,0.044307,0.0042066,0.06375,0.24353,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP,0.999436870355078
MIR3921,SET,135,0.05246,0.0044821,0.075485,0.24354,MIR3921,0.999436870355078
GSE7568_IL4_TGFB_DEXAMETHASO...1,SET,160,0.044909,0.0041743,0.06462,0.24354,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_DN,0.999436870355078
HP_SUBGLOTTIC_STENOSIS,SET,14,0.15975,0.0044098,0.22993,0.2436,HP_SUBGLOTTIC_STENOSIS,0.999436870355078
KEGG_MEDICUS_PATHOGEN_ESCHER...8,SET,4,0.27414,0.0040461,0.39458,0.24361,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_TIR_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,0.999436870355078
HP_EAR_PAIN,SET,15,0.14284,0.0040814,0.20561,0.24361,HP_EAR_PAIN,0.999436870355078
BIOCARTA_BLYMPHOCYTE_PATHWAY,SET,10,0.21699,0.005063,0.31243,0.24368,BIOCARTA_BLYMPHOCYTE_PATHWAY,0.999436870355078
MORF_EIF4A2,SET,128,0.049682,0.004134,0.071539,0.2437,MORF_EIF4A2,0.999436870355078
HP_ELLIPTOCYTOSIS,SET,8,0.19795,0.0041313,0.28506,0.24372,HP_ELLIPTOCYTOSIS,0.999436870355078
WP_CYTOSOLIC_DNASENSING_PATH...,SET,62,0.075505,0.0043805,0.10875,0.24375,WP_CYTOSOLIC_DNASENSING_PATHWAY,0.999436870355078
MIR3064_5P,SET,133,0.050956,0.0043215,0.073394,0.24376,MIR3064_5P,0.999436870355078
WP_4HYDROXYTAMOXIFEN_DEXAMET...,SET,25,0.12867,0.004745,0.18534,0.24377,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,0.999436870355078
MIR6799_5P,SET,131,0.050433,0.004245,0.072659,0.24381,MIR6799_5P,0.999482961783439
HP_ABNORMALITY_OF_THE_FEMALE...,SET,504,0.026431,0.0043189,0.038087,0.24386,HP_ABNORMALITY_OF_THE_FEMALE_GENITALIA,0.999570031843378
HP_ABNORMAL_PLACENTA_MORPHOL...,SET,33,0.11463,0.0048556,0.16526,0.24396,HP_ABNORMAL_PLACENTA_MORPHOLOGY,0.999826070038911
GOBP_POSITIVE_REGULATION_OF_...480,SET,17,0.12552,0.0038178,0.18097,0.24398,GOBP_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION,0.999826070038911
HP_WIDELY_SPACED_TEETH,SET,103,0.057657,0.0043066,0.083206,0.24418,HP_WIDELY_SPACED_TEETH,0.999954841167507
HP_EMG_IMPAIRED_NEUROMUSCULA...,SET,34,0.10228,0.0043977,0.14767,0.24427,HP_EMG_IMPAIRED_NEUROMUSCULAR_TRANSMISSION,0.999954841167507
GOBP_NEGATIVE_REGULATION_OF_...285,SET,171,0.047496,0.0045625,0.068585,0.24431,GOBP_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY,0.999954841167507
MIR5584_5P,SET,229,0.039675,0.0044035,0.0573,0.24434,MIR5584_5P,0.999954841167507
GOMF_AMP_BINDING,SET,15,0.1368,0.0039088,0.19758,0.24435,GOMF_AMP_BINDING,0.999954841167507
KEGG_MEDICUS_REFERENCE_BETA_...2,SET,10,0.1834,0.0042793,0.26489,0.24436,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS,0.999954841167507
MIR6844,SET,306,0.034505,0.0044176,0.049837,0.24436,MIR6844,0.999954841167507
MIR3683,SET,5,0.26382,0.0043533,0.38109,0.24439,MIR3683,0.999954841167507
MIR4654,SET,51,0.080898,0.004258,0.11688,0.24442,MIR4654,0.999954841167507
GSE19888_ADENOSINE_A3R_INH_V...5,SET,177,0.046894,0.0045823,0.06775,0.24442,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN,0.999954841167507
HOFMANN_CELL_LYMPHOMA_DN,SET,37,0.094306,0.0042295,0.13627,0.24446,HOFMANN_CELL_LYMPHOMA_DN,0.999954841167507
HP_MACULAR_DEGENERATION,SET,87,0.062871,0.0043179,0.090852,0.24447,HP_MACULAR_DEGENERATION,0.999954841167507
GSE41867_NAIVE_VS_DAY6_LCMV_...2,SET,177,0.044202,0.0043193,0.063876,0.24447,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.999954841167507
MIR3680_3P,SET,491,0.028901,0.0046629,0.041768,0.24449,MIR3680_3P,0.999954841167507
GSE3982_EOSINOPHIL_VS_DC_DN,SET,184,0.043411,0.0043242,0.062778,0.24463,GSE3982_EOSINOPHIL_VS_DC_DN,0.999954841167507
GOBP_REGULATION_OF_CYTOPLASM...1,SET,7,0.22084,0.0043115,0.31937,0.24464,GOBP_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY,0.999954841167507
GOCC_MEIOTIC_COHESIN_COMPLEX,SET,6,0.22902,0.0041396,0.3312,0.24464,GOCC_MEIOTIC_COHESIN_COMPLEX,0.999954841167507
RYTTCCTG_ETS2_B,SET,1007,0.019568,0.0044555,0.028304,0.24468,RYTTCCTG_ETS2_B,0.999954841167507
HP_NAIL_DYSPLASIA,SET,140,0.050636,0.0044051,0.073272,0.24476,HP_NAIL_DYSPLASIA,0.999954841167507
HP_CHORDEE,SET,13,0.16837,0.0044789,0.24379,0.2449,HP_CHORDEE,0.999954841167507
HP_REFLEX_SEIZURE,SET,19,0.1386,0.0044567,0.2007,0.24491,HP_REFLEX_SEIZURE,0.999954841167507
CREIGHTON_ENDOCRINE_THERAPY_...2,SET,366,0.029593,0.0041366,0.042853,0.24492,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,0.999954841167507
GOBP_RESPONSE_TO_STIMULUS_IN...,SET,13,0.16708,0.0044446,0.24196,0.24493,GOBP_RESPONSE_TO_STIMULUS_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION,0.999954841167507
GSE43955_10H_VS_30H_ACT_CD4_...2,SET,183,0.044443,0.0044151,0.064361,0.24494,GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP,0.999954841167507
HP_TONGUE_THRUSTING,SET,13,0.15659,0.0041654,0.22677,0.24495,HP_TONGUE_THRUSTING,0.999954841167507
MIR329_5P,SET,124,0.051308,0.0042025,0.074311,0.24496,MIR329_5P,0.999954841167507
MIR32_3P,SET,306,0.034742,0.0044479,0.050321,0.24498,MIR32_3P,0.999954841167507
GOBP_POSITIVE_REGULATION_OF_...590,SET,564,0.02615,0.0045125,0.037881,0.245,GOBP_POSITIVE_REGULATION_OF_PHOSPHORYLATION,0.999954841167507
GSE17721_POLYIC_VS_CPG_1H_BM...2,SET,188,0.041153,0.0041432,0.059615,0.245,GSE17721_POLYIC_VS_CPG_1H_BMDC_UP,0.999954841167507
GOCC_HIGH_DENSITY_LIPOPROTEI...,SET,21,0.13984,0.0047271,0.2026,0.24502,GOCC_HIGH_DENSITY_LIPOPROTEIN_PARTICLE,0.999954841167507
HP_ASTIGMATISM,SET,196,0.041069,0.0042208,0.059501,0.24503,HP_ASTIGMATISM,0.999954841167507
HP_EPIDERMAL_NEVUS,SET,11,0.16775,0.004105,0.24306,0.24505,HP_EPIDERMAL_NEVUS,0.999954841167507
HP_GLANDULAR_HYPOSPADIAS,SET,4,0.28833,0.0042556,0.41789,0.24511,HP_GLANDULAR_HYPOSPADIAS,0.999954841167507
HP_ABNORMALITY_OF_THE_WRIST,SET,147,0.051001,0.0045455,0.073935,0.24516,HP_ABNORMALITY_OF_THE_WRIST,0.999954841167507
HP_IRREGULAR_CAPITAL_FEMORAL...,SET,4,0.26957,0.0039787,0.3909,0.24522,HP_IRREGULAR_CAPITAL_FEMORAL_EPIPHYSIS,0.999954841167507
WP_DNA_IRDAMAGE_AND_CELLULAR...,SET,74,0.058875,0.0037304,0.085382,0.24524,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,0.999954841167507
PID_INTEGRIN3_PATHWAY,SET,39,0.10771,0.004959,0.15621,0.24525,PID_INTEGRIN3_PATHWAY,0.999954841167507
GOBP_NEGATIVE_REGULATION_OF_...538,SET,7,0.22147,0.0043239,0.32119,0.24525,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SUMOYLATION,0.999954841167507
GOCC_PHAGOCYTIC_VESICLE,SET,126,0.052625,0.0043448,0.076325,0.24526,GOCC_PHAGOCYTIC_VESICLE,0.999954841167507
REACTOME_REGULATION_OF_NPAS4...2,SET,5,0.28007,0.0046215,0.40622,0.24527,REACTOME_REGULATION_OF_NPAS4_GENE_TRANSCRIPTION,0.999954841167507
GSE27786_LIN_NEG_VS_NKTCELL_...2,SET,179,0.040997,0.0040284,0.059464,0.24528,GSE27786_LIN_NEG_VS_NKTCELL_UP,0.999954841167507
GOMF_CYTIDYLYLTRANSFERASE_AC...,SET,8,0.21747,0.0045389,0.31551,0.24533,GOMF_CYTIDYLYLTRANSFERASE_ACTIVITY,0.999954841167507
TGTYNNNNNRGCARM_UNKNOWN,SET,79,0.067319,0.0044066,0.097682,0.24536,TGTYNNNNNRGCARM_UNKNOWN,0.999954841167507
GOBP_MEMBRANOUS_SEPTUM_MORPH...,SET,6,0.29466,0.0053261,0.42763,0.2454,GOBP_MEMBRANOUS_SEPTUM_MORPHOGENESIS,0.999954841167507
GOBP_SYNAPSE_PRUNING,SET,14,0.18844,0.0052018,0.27348,0.2454,GOBP_SYNAPSE_PRUNING,0.999954841167507
GOBP_TRUNK_SEGMENTATION,SET,5,0.27981,0.0046172,0.40608,0.2454,GOBP_TRUNK_SEGMENTATION,0.999954841167507
DITTMER_PTHLH_TARGETS_UP,SET,104,0.059637,0.0044759,0.086553,0.24541,DITTMER_PTHLH_TARGETS_UP,0.999954841167507
HP_LOWER_LIMB_PAIN,SET,37,0.10105,0.0045318,0.14665,0.24541,HP_LOWER_LIMB_PAIN,0.999954841167507
FINETTI_BREAST_CANCERS_KINOM...1,SET,20,0.12683,0.0041839,0.1841,0.24545,FINETTI_BREAST_CANCERS_KINOME_BLUE,0.999954841167507
GSE1460_NAIVE_CD4_TCELL_CORD...2,SET,162,0.044081,0.0041226,0.063988,0.24545,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP,0.999954841167507
KEGG_MEDICUS_REFERENCE_GHRHR...,SET,28,0.10937,0.0042682,0.15881,0.2455,KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY,0.999959139344262
GSE5455_EX_VIVO_VS_POST_24H_...2,SET,183,0.042077,0.0041801,0.0611,0.24552,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_UP,0.999959139344262
HP_TETANY,SET,21,0.1338,0.0045227,0.19433,0.24557,HP_TETANY,0.999959139344262
GSE24634_NAIVE_CD4_TCELL_VS_...8,SET,181,0.041865,0.0041365,0.060811,0.24559,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP,0.999959139344262
HP_ABNORMAL_METACARPOPHALANG...,SET,19,0.14656,0.0047127,0.21295,0.24565,HP_ABNORMAL_METACARPOPHALANGEAL_JOINT_MORPHOLOGY,0.999959139344262
HP_GEOGRAPHIC_ATROPHY,SET,4,0.28859,0.0042595,0.41935,0.24567,HP_GEOGRAPHIC_ATROPHY,0.999959139344262
STEIN_ESRRA_TARGETS_RESPONSI...2,SET,26,0.11732,0.0044119,0.17048,0.24568,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,0.999959139344262
ZSCAN2_TARGET_GENES,SET,674,0.023572,0.0044329,0.034257,0.2457,ZSCAN2_TARGET_GENES,0.999959139344262
HEIDENBLAD_AMPLIFIED_IN_BONE...,SET,7,0.25591,0.0049962,0.37192,0.24571,HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER,0.999959139344262
GOBP_REGULATION_OF_LAMELLIPO...3,SET,43,0.090662,0.0043827,0.13183,0.24582,GOBP_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.99999
MODULE_186,SET,19,0.14515,0.0046671,0.21107,0.24584,MODULE_186,0.99999
BECKER_TAMOXIFEN_RESISTANCE_...1,SET,49,0.087814,0.0045307,0.12773,0.24589,BECKER_TAMOXIFEN_RESISTANCE_DN,0.99999
REACTOME_INTERLEUKIN_35_SIGN...,SET,12,0.18505,0.0047295,0.26916,0.24589,REACTOME_INTERLEUKIN_35_SIGNALLING,0.99999
HP_ABNORMAL_FINGER_PHALANX_M...,SET,578,0.024643,0.0043033,0.035849,0.24592,HP_ABNORMAL_FINGER_PHALANX_MORPHOLOGY,0.99999
GOMF_COA_LIGASE_ACTIVITY,SET,25,0.11438,0.004218,0.16646,0.246,GOMF_COA_LIGASE_ACTIVITY,0.99999
GOMF_POLY_A_SPECIFIC_RIBONUC...,SET,12,0.16577,0.0042368,0.24125,0.24601,GOMF_POLY_A_SPECIFIC_RIBONUCLEASE_ACTIVITY,0.99999
chr10p14,SET,15,0.24224,0.0069216,0.3526,0.24604,chr10p14,0.99999
HP_POSTTERM_PREGNANCY,SET,5,0.32772,0.0054078,0.47703,0.24604,HP_POSTTERM_PREGNANCY,0.99999
MEIS1BHOXA9_01,SET,127,0.05641,0.0046756,0.082121,0.24607,MEIS1BHOXA9_01,0.99999
GSE15733_BM_VS_SPLEEN_MEMORY...2,SET,175,0.045106,0.0043829,0.06571,0.24622,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP,0.99999
HP_HYPOKALEMIA,SET,74,0.071577,0.0045352,0.10428,0.24624,HP_HYPOKALEMIA,0.99999
GOBP_CARDIAC_VENTRICLE_DEVEL...,SET,121,0.057645,0.0046645,0.083999,0.24628,GOBP_CARDIAC_VENTRICLE_DEVELOPMENT,0.99999
GOBP_VITAMIN_TRANSMEMBRANE_T...,SET,20,0.12923,0.0042632,0.18831,0.24628,GOBP_VITAMIN_TRANSMEMBRANE_TRANSPORT,0.99999
MIR500A_3P,SET,71,0.073336,0.0045519,0.10689,0.24634,MIR500A_3P,0.99999
GOBP_REGULATION_OF_EPITHELIA...1,SET,97,0.062209,0.00451,0.090681,0.24636,GOBP_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.99999
HP_CHRONIC_NEUTROPENIA,SET,9,0.1752,0.0038783,0.2555,0.24645,HP_CHRONIC_NEUTROPENIA,0.99999
HP_PARTIAL_ABSENCE_OF_SPECIF...1,SET,6,0.25921,0.0046854,0.37818,0.24654,HP_PARTIAL_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_TETANUS_VACCINE,0.99999
GSE2770_TGFB_AND_IL4_VS_IL4_...3,SET,174,0.044894,0.00435,0.065507,0.24657,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.99999
FAN_OVARY_CL15_SMALL_ANTRAL_...,SET,552,0.025418,0.0043407,0.037093,0.2466,FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL,0.99999
SERVITJA_LIVER_HNF1A_TARGETS...2,SET,132,0.052614,0.0044454,0.076791,0.24663,SERVITJA_LIVER_HNF1A_TARGETS_UP,0.99999
GSE411_WT_VS_SOCS3_KO_MACROP...4,SET,182,0.04199,0.0041601,0.061286,0.24663,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_DN,0.99999
GOBP_CORONARY_VASCULATURE_DE...,SET,45,0.089322,0.0044169,0.13038,0.24666,GOBP_CORONARY_VASCULATURE_DEVELOPMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...430,SET,5,0.22046,0.0036378,0.32189,0.24671,GOBP_NEGATIVE_REGULATION_OF_MYOSIN_LIGHT_CHAIN_PHOSPHATASE_ACTIVITY,0.99999
GOMF_CENTROMERIC_DNA_BINDING,SET,6,0.26037,0.0047063,0.38017,0.24672,GOMF_CENTROMERIC_DNA_BINDING,0.99999
GOBP_GLYCOPROTEIN_BIOSYNTHET...,SET,289,0.035502,0.0044192,0.05184,0.24673,GOBP_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS,0.99999
MORF_BMI1,SET,74,0.064639,0.0040956,0.094396,0.24675,MORF_BMI1,0.99999
GOCC_MITOCHONDRIAL_SMALL_RIB...,SET,31,0.096934,0.0039799,0.14159,0.24679,GOCC_MITOCHONDRIAL_SMALL_RIBOSOMAL_SUBUNIT,0.99999
GOBP_GLUCAN_METABOLIC_PROCESS,SET,74,0.066537,0.0042159,0.097188,0.2468,GOBP_GLUCAN_METABOLIC_PROCESS,0.99999
HP_INCREASED_LDL_CHOLESTEROL...,SET,30,0.11582,0.0046782,0.16919,0.24681,HP_INCREASED_LDL_CHOLESTEROL_CONCENTRATION,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...16,SET,176,0.042496,0.004141,0.062077,0.24681,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP,0.99999
MIR3941,SET,303,0.033886,0.0043174,0.04951,0.24685,MIR3941,0.99999
HP_ABNORMAL_FORM_OF_THE_VERT...,SET,307,0.0333,0.0042701,0.048654,0.24686,HP_ABNORMAL_FORM_OF_THE_VERTEBRAL_BODIES,0.99999
GSE10325_BCELL_VS_LUPUS_BCEL...1,SET,186,0.043713,0.0043777,0.063876,0.24688,GSE10325_BCELL_VS_LUPUS_BCELL_DN,0.99999
HP_SUBRETINAL_DEPOSITS,SET,6,0.27405,0.0049537,0.40049,0.2469,HP_SUBRETINAL_DEPOSITS,0.99999
BUCKANOVICH_T_LYMPHOCYTE_HOM...2,SET,18,0.1451,0.0045413,0.21209,0.24694,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...417,SET,57,0.078131,0.0043468,0.11422,0.24697,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,0.99999
MATZUK_SPERMATID_DIFFERENTIA...,SET,35,0.10563,0.0046077,0.15443,0.247,MATZUK_SPERMATID_DIFFERENTIATION,0.99999
MIR514A_3P_MIR514B_3P,SET,101,0.057433,0.0042483,0.083971,0.247,MIR514A_3P_MIR514B_3P,0.99999
LEE_EARLY_T_LYMPHOCYTE_UP,SET,95,0.06129,0.0043976,0.089627,0.24704,LEE_EARLY_T_LYMPHOCYTE_UP,0.99999
GOBP_MOTOR_LEARNING,SET,8,0.2235,0.0046646,0.32685,0.24706,GOBP_MOTOR_LEARNING,0.99999
DESCARTES_MAIN_FETAL_NEUROEN...,SET,27,0.12021,0.0046068,0.17581,0.24707,DESCARTES_MAIN_FETAL_NEUROENDOCRINE_CELLS,0.99999
chr14q23,SET,53,0.15578,0.008358,0.22784,0.24708,chr14q23,0.99999
HP_RECURRENT_APHTHOUS_STOMAT...,SET,44,0.093805,0.0045869,0.1372,0.24709,HP_RECURRENT_APHTHOUS_STOMATITIS,0.99999
GOCC_ENDOLYSOSOME_LUMEN,SET,5,0.30352,0.0050083,0.4441,0.24717,GOCC_ENDOLYSOSOME_LUMEN,0.99999
GOBP_REGULATION_OF_NEUROINFL...,SET,33,0.10902,0.0046179,0.15954,0.2472,GOBP_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,0.99999
MIR4776_5P,SET,44,0.08501,0.0041568,0.12442,0.24723,MIR4776_5P,0.99999
HP_SKIN_EROSION,SET,26,0.1081,0.0040652,0.15822,0.24724,HP_SKIN_EROSION,0.99999
REACTOME_ARACHIDONIC_ACID_ME...,SET,56,0.083163,0.0045862,0.12177,0.24732,REACTOME_ARACHIDONIC_ACID_METABOLISM,0.99999
PAX6_TARGET_GENES,SET,692,0.022902,0.0043618,0.033533,0.24732,PAX6_TARGET_GENES,0.99999
GSE41867_NAIVE_VS_EFFECTOR_C...1,SET,182,0.040165,0.0039793,0.058817,0.24735,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,0.99999
HP_DECREASED_CIRCULATING_BET...,SET,5,0.27958,0.0046134,0.40949,0.24738,HP_DECREASED_CIRCULATING_BETA_2_MICROGLOBULIN_LEVEL,0.99999
GOBP_AMYLOID_BETA_CLEARANCE_...1,SET,8,0.22935,0.0047868,0.33604,0.24746,GOBP_AMYLOID_BETA_CLEARANCE_BY_CELLULAR_CATABOLIC_PROCESS,0.99999
WONG_ENDMETRIUM_CANCER_DN,SET,69,0.075135,0.0045977,0.11009,0.24748,WONG_ENDMETRIUM_CANCER_DN,0.99999
GOMF_UBIQUITIN_LIKE_PROTEIN_...2,SET,36,0.096307,0.0042606,0.14113,0.24749,GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY,0.99999
WP_METAPATHWAY_BIOTRANSFORMA...,SET,173,0.051826,0.0050073,0.075954,0.24752,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,0.99999
FIGUEROA_AML_METHYLATION_CLU...4,SET,47,0.087043,0.0043986,0.12757,0.24753,FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,0.99999
HP_ANKYLOSIS,SET,16,0.16192,0.004778,0.23733,0.24754,HP_ANKYLOSIS,0.99999
MIR12118,SET,90,0.061209,0.0042752,0.089731,0.24758,MIR12118,0.99999
MODULE_408,SET,18,0.14484,0.0045332,0.21236,0.24761,MODULE_408,0.99999
GOBP_POSITIVE_REGULATION_OF_...304,SET,3,0.37943,0.00485,0.55638,0.24764,GOBP_POSITIVE_REGULATION_OF_GLOMERULUS_DEVELOPMENT,0.99999
ZHAN_VARIABLE_EARLY_DIFFEREN...2,SET,17,0.14466,0.0044,0.21214,0.24766,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP,0.99999
GOBP_POSTSYNAPTIC_MEMBRANE_O...,SET,35,0.10048,0.004383,0.14735,0.24766,GOBP_POSTSYNAPTIC_MEMBRANE_ORGANIZATION,0.99999
HP_DECREASED_PROPORTION_OF_C...2,SET,8,0.19859,0.0041447,0.29125,0.24767,HP_DECREASED_PROPORTION_OF_CD8_POSITIVE_T_CELLS,0.99999
REACTOME_CHROMOSOME_MAINTENA...,SET,83,0.059551,0.0039951,0.087341,0.24768,REACTOME_CHROMOSOME_MAINTENANCE,0.99999
GOBP_AMIDE_CATABOLIC_PROCESS,SET,16,0.14238,0.0042016,0.20884,0.2477,GOBP_AMIDE_CATABOLIC_PROCESS,0.99999
HP_PERIPHERAL_VISUAL_FIELD_L...,SET,92,0.060508,0.0042727,0.088795,0.2478,HP_PERIPHERAL_VISUAL_FIELD_LOSS,0.99999
ZHONG_PFC_C1_ASTROCYTE,SET,26,0.11154,0.0041948,0.16374,0.24787,ZHONG_PFC_C1_ASTROCYTE,0.99999
GSE7509_UNSTIM_VS_FCGRIIB_ST...1,SET,159,0.047327,0.0043854,0.06949,0.24792,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN,0.99999
GOCC_TRAPP_COMPLEX,SET,14,0.15708,0.0043363,0.23068,0.24795,GOCC_TRAPP_COMPLEX,0.99999
DESCARTES_FETAL_CEREBRUM_EXC...,SET,13,0.1824,0.004852,0.26789,0.24798,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...17,SET,46,0.088412,0.0044201,0.12988,0.24803,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,0.99999
REACTOME_TRANSCRIPTIONAL_ACT...2,SET,48,0.082325,0.0042041,0.12096,0.24806,REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,0.99999
GSE17721_4H_VS_24H_POLYIC_BM...2,SET,179,0.043956,0.0043192,0.064617,0.24818,GSE17721_4H_VS_24H_POLYIC_BMDC_UP,0.99999
HP_DENTAL_ENAMEL_PITS,SET,8,0.23758,0.0049585,0.34928,0.24819,HP_DENTAL_ENAMEL_PITS,0.99999
AIZARANI_LIVER_C10_MVECS_1,SET,244,0.041783,0.0047849,0.061436,0.24822,AIZARANI_LIVER_C10_MVECS_1,0.99999
HP_HYPOCHROMIC_ANEMIA,SET,51,0.082858,0.0043612,0.12183,0.24823,HP_HYPOCHROMIC_ANEMIA,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...43,SET,21,0.13726,0.0046398,0.20188,0.24828,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANX_OF_THE_5TH_FINGER,0.99999
GOBP_CEREBRAL_CORTEX_GABAERG...1,SET,5,0.28139,0.0046433,0.41387,0.24829,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DEVELOPMENT,0.99999
HP_ABNORMALITY_OF_ADRENAL_PH...,SET,131,0.051588,0.0043423,0.075883,0.24831,HP_ABNORMALITY_OF_ADRENAL_PHYSIOLOGY,0.99999
HP_GYNECOMASTIA,SET,91,0.061874,0.0043455,0.091014,0.24831,HP_GYNECOMASTIA,0.99999
GOBP_RESPONSE_TO_INTERLEUKIN...9,SET,35,0.098162,0.004282,0.14441,0.24834,GOBP_RESPONSE_TO_INTERLEUKIN_4,0.99999
GSE41867_NAIVE_VS_DAY30_LCMV...2,SET,182,0.04035,0.0039976,0.059364,0.24835,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP,0.99999
DOANE_RESPONSE_TO_ANDROGEN_UP,SET,162,0.044651,0.0041759,0.065694,0.24836,DOANE_RESPONSE_TO_ANDROGEN_UP,0.99999
BASAKI_YBX1_TARGETS_DN,SET,350,0.032198,0.0044033,0.047383,0.2484,BASAKI_YBX1_TARGETS_DN,0.99999
GSE35825_UNTREATED_VS_IFNG_S...1,SET,167,0.043587,0.0041383,0.064154,0.24844,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN,0.99999
WP_LDL_INFLUENCE_ON_CD14_AND...,SET,22,0.12897,0.0044618,0.18987,0.2485,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,0.99999
HP_BILATERAL_MICROPHTHALMOS,SET,19,0.12424,0.0039947,0.18291,0.2485,HP_BILATERAL_MICROPHTHALMOS,0.99999
HP_PULMONARY_ARTERY_STENOSIS,SET,66,0.073747,0.0044139,0.10859,0.24852,HP_PULMONARY_ARTERY_STENOSIS,0.99999
PID_ERBB_NETWORK_PATHWAY,SET,15,0.15154,0.0043299,0.22323,0.24863,PID_ERBB_NETWORK_PATHWAY,0.99999
GOMF_IGG_RECEPTOR_ACTIVITY,SET,6,0.30837,0.005574,0.45433,0.24866,GOMF_IGG_RECEPTOR_ACTIVITY,0.99999
SILIGAN_TARGETS_OF_EWS_FLI1_...2,SET,15,0.15312,0.0043751,0.22561,0.24867,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP,0.99999
RASHI_RESPONSE_TO_IONIZING_R...3,SET,43,0.083382,0.0040308,0.12288,0.24871,RASHI_RESPONSE_TO_IONIZING_RADIATION_3,0.99999
GOBP_INNATE_IMMUNE_RESPONSE,SET,845,0.020971,0.0043943,0.030904,0.24871,GOBP_INNATE_IMMUNE_RESPONSE,0.99999
RYAN_MANTLE_CELL_LYMPHOMA_NO...,SET,143,0.053268,0.004683,0.078507,0.24873,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,0.99999
MIR6832_5P,SET,74,0.069295,0.0043906,0.10214,0.24876,MIR6832_5P,0.99999
MORI_IMMATURE_B_LYMPHOCYTE_UP,SET,46,0.088747,0.0044369,0.13084,0.24879,MORI_IMMATURE_B_LYMPHOCYTE_UP,0.99999
MIR606,SET,87,0.062229,0.0042737,0.09176,0.24884,MIR606,0.99999
MARSHALL_VIRAL_INFECTION_RES...1,SET,26,0.114,0.0042872,0.16814,0.24889,MARSHALL_VIRAL_INFECTION_RESPONSE_DN,0.99999
WP_WARBURG_EFFECT_MODULATED_...,SET,24,0.1233,0.0044551,0.18186,0.2489,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,0.99999
DESCARTES_FETAL_LUNG_MESOTHE...,SET,83,0.069415,0.0046569,0.10239,0.24891,DESCARTES_FETAL_LUNG_MESOTHELIAL_CELLS,0.99999
LAKE_ADULT_KIDNEY_C16_COLLEC...,SET,124,0.057619,0.0047195,0.085006,0.24895,LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX,0.99999
MIR4653_3P,SET,47,0.086369,0.0043645,0.12745,0.249,MIR4653_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...688,SET,3,0.38814,0.0049613,0.57285,0.24903,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
GOCC_LSM1_7_PAT1_COMPLEX,SET,5,0.22103,0.0036472,0.32625,0.24905,GOCC_LSM1_7_PAT1_COMPLEX,0.99999
CAGTGTT_MIR141_MIR200A,SET,288,0.034571,0.0042959,0.051034,0.24908,CAGTGTT_MIR141_MIR200A,0.99999
SMIRNOV_RESPONSE_TO_IR_2HR_DN,SET,51,0.08346,0.0043929,0.12324,0.24914,SMIRNOV_RESPONSE_TO_IR_2HR_DN,0.99999
GOBP_INTRACELLULAR_DISTRIBUT...,SET,7,0.23861,0.0046585,0.35234,0.24914,GOBP_INTRACELLULAR_DISTRIBUTION_OF_MITOCHONDRIA,0.99999
FULLER_PBMC_F_TULARENSIS_VAC...2,SET,7,0.21409,0.0041798,0.31626,0.24922,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_336HR_SUSTAINED_UP,0.99999
GSE40274_XBP1_VS_FOXP3_AND_X...2,SET,177,0.04372,0.0042722,0.064586,0.24923,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GSE24026_PD1_LIGATION_VS_CTR...1,SET,182,0.04255,0.0042156,0.062894,0.24935,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN,0.99999
HOXD1_TARGET_GENES,SET,56,0.073474,0.0040519,0.10862,0.24938,HOXD1_TARGET_GENES,0.99999
HP_ABNORMAL_ANTITRAGUS_MORPH...,SET,10,0.18821,0.0043915,0.27825,0.2494,HP_ABNORMAL_ANTITRAGUS_MORPHOLOGY,0.99999
MORF_SART1,SET,58,0.068637,0.0038519,0.1015,0.24945,MORF_SART1,0.99999
GOBP_PHOSPHATIDYLGLYCEROL_BI...,SET,9,0.20854,0.0046162,0.30839,0.24946,GOBP_PHOSPHATIDYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.99999
GOMF_ALDO_KETO_REDUCTASE_NAD...,SET,29,0.11876,0.0047164,0.17568,0.24952,GOMF_ALDO_KETO_REDUCTASE_NADPH_ACTIVITY,0.99999
GSE20727_ROS_INH_VS_ROS_INH_...2,SET,177,0.044562,0.0043545,0.06592,0.24952,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,0.99999
HP_PROGRESSIVE_SPASTIC_QUADR...,SET,11,0.18359,0.0044927,0.27159,0.24953,HP_PROGRESSIVE_SPASTIC_QUADRIPLEGIA,0.99999
HP_ELEVATED_CIRCULATING_FOLL...,SET,46,0.083497,0.0041744,0.12353,0.24954,HP_ELEVATED_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_LEVEL,0.99999
HP_ABNORMAL_PELVIC_GIRDLE_BO...,SET,548,0.025008,0.0042557,0.037001,0.24957,HP_ABNORMAL_PELVIC_GIRDLE_BONE_MORPHOLOGY,0.99999
GSE45365_NK_CELL_VS_CD11B_DC...4,SET,176,0.043659,0.0042543,0.064617,0.24963,GSE45365_NK_CELL_VS_CD11B_DC_UP,0.99999
GOBP_MORPHOGENESIS_OF_EMBRYO...,SET,144,0.049189,0.0043394,0.072812,0.24966,GOBP_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM,0.99999
GSE24634_TEFF_VS_TCONV_DAY5_...1,SET,174,0.043387,0.0042039,0.06426,0.24979,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN,0.99999
HERNANDEZ_MITOTIC_ARREST_BY_...1,SET,35,0.10686,0.0046614,0.15828,0.2498,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,0.99999
GSE37532_VISCERAL_ADIPOSE_TI...4,SET,156,0.042968,0.0039441,0.063648,0.24981,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_UP,0.99999
GSE12392_WT_VS_IFNB_KO_CD8A_...3,SET,183,0.043417,0.0043132,0.064319,0.24983,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_DN,0.99999
GSE40277_GATA1_AND_SATB1_TRA...1,SET,180,0.043583,0.0042944,0.064573,0.24986,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,0.99999
GSE17186_NAIVE_VS_CD21HIGH_T...4,SET,177,0.043722,0.0042724,0.064785,0.24988,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,0.99999
GOBP_RESPONSE_TO_DISACCHARIDE,SET,8,0.19132,0.003993,0.2835,0.24989,GOBP_RESPONSE_TO_DISACCHARIDE,0.99999
HP_ABSENCE_OF_STOMACH_BUBBLE...,SET,5,0.26912,0.0044408,0.39888,0.24994,HP_ABSENCE_OF_STOMACH_BUBBLE_ON_FETAL_SONOGRAPHY,0.99999
SAKAI_TUMOR_INFILTRATING_MON...2,SET,26,0.11464,0.0043112,0.16993,0.24996,SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP,0.99999
MIR4442,SET,4,0.29443,0.0043456,0.43649,0.24999,MIR4442,0.99999
KEGG_MEDICUS_REFERENCE_ORGAN...2,SET,16,0.14903,0.0043978,0.22097,0.25002,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_OUTER_KINETOCHORE,0.99999
REACTOME_VXPX_CARGO_TARGETIN...,SET,20,0.12154,0.0040095,0.18021,0.25002,REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM,0.99999
HP_MATERNAL_HYPERTENSION,SET,7,0.23533,0.0045943,0.34898,0.25005,HP_MATERNAL_HYPERTENSION,0.99999
GOCC_GATOR2_COMPLEX,SET,8,0.18198,0.0037981,0.26997,0.25013,GOCC_GATOR2_COMPLEX,0.99999
GOBP_NEGATIVE_REGULATION_OF_...628,SET,9,0.20594,0.0045587,0.30557,0.25018,GOBP_NEGATIVE_REGULATION_OF_TELOMERASE_ACTIVITY,0.99999
GSE3203_INFLUENZA_INF_VS_IFN...2,SET,184,0.043688,0.0043519,0.064832,0.2502,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP,0.99999
CLASPER_LYMPHATIC_VESSELS_DU...1,SET,32,0.11267,0.0046999,0.1672,0.25021,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,0.99999
HP_KERATOCONJUNCTIVITIS,SET,43,0.088683,0.004287,0.13161,0.25021,HP_KERATOCONJUNCTIVITIS,0.99999
REACTOME_FORMATION_OF_LATERA...,SET,5,0.27847,0.0045951,0.41332,0.25024,REACTOME_FORMATION_OF_LATERAL_PLATE_MESODERM,0.99999
SANSOM_APC_TARGETS_UP,SET,120,0.055115,0.0044414,0.08181,0.25026,SANSOM_APC_TARGETS_UP,0.99999
GOBP_OUTFLOW_TRACT_SEPTUM_MO...,SET,26,0.13147,0.0049443,0.19518,0.25028,GOBP_OUTFLOW_TRACT_SEPTUM_MORPHOGENESIS,0.99999
HAY_BONE_MARROW_EOSINOPHIL,SET,41,0.093517,0.0044145,0.13883,0.25028,HAY_BONE_MARROW_EOSINOPHIL,0.99999
GOMF_SPHINGOLIPID_TRANSPORTE...,SET,18,0.13656,0.0042741,0.20276,0.25031,GOMF_SPHINGOLIPID_TRANSPORTER_ACTIVITY,0.99999
HP_ABNORMAL_VASCULAR_MORPHOL...,SET,1014,0.018684,0.0042681,0.027744,0.25034,HP_ABNORMAL_VASCULAR_MORPHOLOGY,0.99999
KANG_DOXORUBICIN_RESISTANCE_...2,SET,49,0.078041,0.0040265,0.11591,0.25039,KANG_DOXORUBICIN_RESISTANCE_UP,0.99999
GOBP_ADHERENS_JUNCTION_ASSEM...,SET,13,0.15988,0.0042531,0.23747,0.25039,GOBP_ADHERENS_JUNCTION_ASSEMBLY,0.99999
MIR425_5P,SET,78,0.065904,0.0042867,0.097892,0.2504,MIR425_5P,0.99999
GOBP_CEREBRAL_CORTEX_REGIONA...,SET,7,0.26765,0.0052254,0.39755,0.2504,GOBP_CEREBRAL_CORTEX_REGIONALIZATION,0.99999
GOBP_REGULATION_OF_MICROTUBU...7,SET,56,0.075521,0.0041647,0.11218,0.25041,GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION,0.99999
IVANOVA_HEMATOPOIESIS_STEM_C...1,SET,179,0.045109,0.0044325,0.067009,0.25042,IVANOVA_HEMATOPOIESIS_STEM_CELL,0.99999
NUYTTEN_NIPP1_TARGETS_UP,SET,665,0.02243,0.004191,0.033321,0.25043,NUYTTEN_NIPP1_TARGETS_UP,0.99999
GSE2770_IL12_AND_TGFB_VS_IL4...2,SET,179,0.042213,0.004148,0.062714,0.25044,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
GSE2770_UNTREATED_VS_TGFB_AN...9,SET,184,0.04263,0.0042464,0.063333,0.25044,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.99999
GOMF_PHOSPHATIDYLINOSITOL_3_...9,SET,6,0.27035,0.0048867,0.40166,0.25045,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVATOR_ACTIVITY,0.99999
GSE12003_MIR223_KO_VS_WT_BM_...1,SET,187,0.043109,0.0043287,0.064055,0.25048,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN,0.99999
GOBP_C21_STEROID_HORMONE_MET...,SET,35,0.10879,0.0047458,0.16171,0.25054,GOBP_C21_STEROID_HORMONE_METABOLIC_PROCESS,0.99999
HP_EXCESSIVE_WRINKLED_SKIN,SET,36,0.09452,0.0041815,0.1405,0.25055,HP_EXCESSIVE_WRINKLED_SKIN,0.99999
GOBP_CEREBELLAR_GRANULAR_LAY...3,SET,8,0.25542,0.0053308,0.37966,0.25056,GOBP_CEREBELLAR_GRANULAR_LAYER_MORPHOGENESIS,0.99999
HP_PULMONARY_HEMORRHAGE,SET,29,0.11369,0.0045149,0.16899,0.25056,HP_PULMONARY_HEMORRHAGE,0.99999
GOMF_DEMETHYLASE_ACTIVITY,SET,33,0.089078,0.0037733,0.13242,0.25058,GOMF_DEMETHYLASE_ACTIVITY,0.99999
GOMF_ATP_DEPENDENT_PROTEIN_D...,SET,6,0.22986,0.0041548,0.34172,0.25059,GOMF_ATP_DEPENDENT_PROTEIN_DISAGGREGASE_ACTIVITY,0.99999
EGR_Q6,SET,248,0.036252,0.004185,0.053911,0.25066,EGR_Q6,0.99999
GOBP_REGULATION_OF_CILIUM_DE...,SET,27,0.11529,0.004418,0.17146,0.25068,GOBP_REGULATION_OF_CILIUM_DEPENDENT_CELL_MOTILITY,0.99999
HP_NARROW_FOOT,SET,4,0.30128,0.0044467,0.44809,0.25068,HP_NARROW_FOOT,0.99999
LINDSTEDT_DENDRITIC_CELL_MAT...2,SET,44,0.097905,0.0047874,0.14567,0.25076,LINDSTEDT_DENDRITIC_CELL_MATURATION_B,0.99999
GOBP_NEGATIVE_REGULATION_OF_...254,SET,39,0.094007,0.0043283,0.13989,0.25079,GOBP_NEGATIVE_REGULATION_OF_GLIOGENESIS,0.99999
HP_CLONUS,SET,98,0.058172,0.0042389,0.086564,0.25079,HP_CLONUS,0.99999
REACTOME_INTERACTIONS_OF_VPR...,SET,33,0.091993,0.0038968,0.13693,0.25085,REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS,0.99999
MIR6082,SET,15,0.14636,0.0041818,0.21796,0.25096,MIR6082,0.99999
ZNF704_TARGET_GENES,SET,61,0.072618,0.004179,0.10815,0.25097,ZNF704_TARGET_GENES,0.99999
GOMF_P_TYPE_TRANSMEMBRANE_TR...,SET,22,0.11896,0.0041156,0.17717,0.25097,GOMF_P_TYPE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_TEMPORAL_OPTIC_DISC_PALLOR,SET,7,0.22346,0.0043627,0.33287,0.25101,HP_TEMPORAL_OPTIC_DISC_PALLOR,0.99999
GOBP_MYOFIBROBLAST_DIFFERENT...,SET,10,0.16102,0.0037572,0.23991,0.25105,GOBP_MYOFIBROBLAST_DIFFERENTIATION,0.99999
GOMF_PHOSPHATIDYLINOSITOL_3_...10,SET,24,0.12157,0.0043928,0.18126,0.25121,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_BINDING,0.99999
HP_LIVEDO,SET,6,0.20097,0.0036326,0.29965,0.25122,HP_LIVEDO,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...10,SET,171,0.042781,0.0041096,0.063805,0.25128,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP,0.99999
REACTOME_PARACETAMOL_ADME,SET,25,0.12757,0.0047046,0.19035,0.25137,REACTOME_PARACETAMOL_ADME,0.99999
CAMPS_COLON_CANCER_COPY_NUMB...2,SET,81,0.07269,0.0048177,0.10852,0.25149,CAMPS_COLON_CANCER_COPY_NUMBER_UP,0.99999
REACTOME_PROCESSING_OF_CAPPE...2,SET,255,0.032314,0.0037819,0.048242,0.25149,REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,0.99999
GOBP_REGULATION_OF_MEMBRANE_...11,SET,7,0.23856,0.0046574,0.35617,0.2515,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL,0.99999
GOBP_EXPORT_FROM_CELL,SET,833,0.020796,0.0043282,0.031054,0.25154,GOBP_EXPORT_FROM_CELL,0.99999
GOBP_PLATELET_ACTIVATION,SET,130,0.054074,0.0045343,0.080794,0.25166,GOBP_PLATELET_ACTIVATION,0.99999
GOBP_REGULATION_OF_BRANCHING...4,SET,17,0.15181,0.0046175,0.22687,0.2517,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...166,SET,27,0.097841,0.0037495,0.14622,0.25171,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,0.99999
GOBP_SODIUM_ION_TRANSMEMBRAN...,SET,177,0.046645,0.004558,0.069708,0.25171,GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,0.99999
chr2p16,SET,35,0.16353,0.0071334,0.24444,0.25176,chr2p16,0.99999
GSE21379_WT_VS_SAP_KO_TFH_CD...1,SET,178,0.043443,0.004257,0.064943,0.25177,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN,0.99999
HP_METOPIC_SYNOSTOSIS,SET,23,0.10409,0.0036819,0.1556,0.25178,HP_METOPIC_SYNOSTOSIS,0.99999
GOBP_REGULATION_OF_IMMUNE_EF...,SET,356,0.032173,0.0044367,0.048106,0.25182,GOBP_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,0.99999
GOBP_PEPTIDYL_TYROSINE_MODIF...,SET,247,0.038258,0.0044078,0.057207,0.25183,GOBP_PEPTIDYL_TYROSINE_MODIFICATION,0.99999
MIR4303,SET,212,0.039915,0.0042645,0.059691,0.25185,MIR4303,0.99999
GOMF_DEACETYLASE_ACTIVITY,SET,35,0.095827,0.0041802,0.14331,0.25185,GOMF_DEACETYLASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...193,SET,450,0.027513,0.0042545,0.041155,0.2519,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE,0.99999
WP_TGIF_DISRUPTION_OF_SHH_SI...,SET,9,0.20088,0.0044466,0.30054,0.25194,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,0.99999
GOBP_REGULATION_OF_RESPONSE_...2,SET,158,0.04508,0.0041642,0.067456,0.25198,GOBP_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,0.99999
GOBP_ENDOCRINE_PANCREAS_DEVE...,SET,42,0.095947,0.004584,0.1436,0.25202,GOBP_ENDOCRINE_PANCREAS_DEVELOPMENT,0.99999
GOMF_INORGANIC_ANION_TRANSME...,SET,146,0.05005,0.0044456,0.074909,0.25203,GOMF_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_HYDROXYPROLINEMIA,SET,5,0.31783,0.0052446,0.47572,0.25204,HP_HYDROXYPROLINEMIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...378,SET,5,0.25991,0.0042888,0.38906,0.25206,GOBP_NEGATIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,0.99999
TSUNODA_CISPLATIN_RESISTANCE...1,SET,43,0.091447,0.0044206,0.13691,0.2521,TSUNODA_CISPLATIN_RESISTANCE_DN,0.99999
GOBP_FATTY_ACID_METABOLIC_PR...,SET,365,0.030755,0.0042932,0.046066,0.25219,GOBP_FATTY_ACID_METABOLIC_PROCESS,0.99999
GOMF_QUATERNARY_AMMONIUM_GRO...1,SET,35,0.10166,0.0044345,0.15228,0.25221,GOMF_QUATERNARY_AMMONIUM_GROUP_BINDING,0.99999
HP_MALNUTRITION,SET,41,0.093836,0.0044296,0.14056,0.25221,HP_MALNUTRITION,0.99999
REACTOME_TRANSLESION_SYNTHES...1,SET,17,0.1216,0.0036987,0.18217,0.25222,REACTOME_TRANSLESION_SYNTHESIS_BY_POLH,0.99999
MIR9899,SET,4,0.26619,0.0039288,0.39876,0.25222,MIR9899,0.99999
GOBP_TRNA_METHYLATION,SET,36,0.084374,0.0037327,0.12641,0.25225,GOBP_TRNA_METHYLATION,0.99999
GOMF_GUANYL_NUCLEOTIDE_EXCHA...,SET,215,0.038452,0.0041368,0.057618,0.25227,GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,0.99999
GOMF_BILE_ACID_BINDING,SET,10,0.20443,0.0047701,0.30633,0.25228,GOMF_BILE_ACID_BINDING,0.99999
HP_ABNORMAL_NIPPLE_MORPHOLOGY,SET,209,0.038087,0.0040407,0.057084,0.25232,HP_ABNORMAL_NIPPLE_MORPHOLOGY,0.99999
GOBP_CELLULAR_RESPONSE_TO_TO...2,SET,115,0.055256,0.0043596,0.082827,0.25235,GOBP_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE,0.99999
GOMF_MHC_PROTEIN_BINDING,SET,26,0.11635,0.0043755,0.17441,0.25236,GOMF_MHC_PROTEIN_BINDING,0.99999
HP_EYELID_MYOCLONIA_SEIZURE,SET,7,0.18932,0.0036962,0.28394,0.25246,HP_EYELID_MYOCLONIA_SEIZURE,0.99999
DESCARTES_MAIN_FETAL_VASCULA...,SET,40,0.094756,0.0044183,0.14211,0.25246,DESCARTES_MAIN_FETAL_VASCULAR_ENDOTHELIAL_CELLS,0.99999
GOBP_FOLIC_ACID_TRANSPORT,SET,10,0.20502,0.0047837,0.30751,0.25248,GOBP_FOLIC_ACID_TRANSPORT,0.99999
GOBP_ENDOTHELIAL_CELL_FATE_C...,SET,8,0.22918,0.0047831,0.34376,0.25249,GOBP_ENDOTHELIAL_CELL_FATE_COMMITMENT,0.99999
GSE37336_LY6C_POS_VS_NEG_NAI...1,SET,140,0.048973,0.0042604,0.073474,0.25254,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...487,SET,53,0.076922,0.0041272,0.11542,0.25257,GOBP_NEGATIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,0.99999
GOBP_OSTEOCLAST_DIFFERENTIAT...,SET,100,0.064254,0.0047294,0.096416,0.25257,GOBP_OSTEOCLAST_DIFFERENTIATION,0.99999
HP_ELEVATED_MATERNAL_CIRCULA...,SET,4,0.32404,0.0047827,0.48628,0.25259,HP_ELEVATED_MATERNAL_CIRCULATING_ALPHA_FETOPROTEIN_CONCENTRATION,0.99999
GOMF_MAP_KINASE_PHOSPHATASE_...,SET,13,0.16456,0.0043776,0.24697,0.2526,GOMF_MAP_KINASE_PHOSPHATASE_ACTIVITY,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...14,SET,185,0.041816,0.0041765,0.062755,0.2526,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_LAT...2,SET,98,0.062916,0.0045846,0.094432,0.25263,HE_LIM_SUN_FETAL_LUNG_C1_LATE_BASAL_CELL,0.99999
GOBP_MICROGLIAL_CELL_MEDIATE...,SET,5,0.25116,0.0041444,0.37702,0.25266,GOBP_MICROGLIAL_CELL_MEDIATED_CYTOTOXICITY,0.99999
MODULE_257,SET,153,0.042712,0.003883,0.06412,0.25267,MODULE_257,0.99999
HP_ABNORMAL_SPUTUM,SET,119,0.055138,0.0044249,0.082777,0.25268,HP_ABNORMAL_SPUTUM,0.99999
GSE11864_CSF1_VS_CSF1_PAM3CY...1,SET,166,0.044449,0.0042076,0.066735,0.25269,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN,0.99999
GOBP_FRUCTOSE_2_6_BISPHOSPHA...,SET,4,0.23931,0.0035321,0.35931,0.2527,GOBP_FRUCTOSE_2_6_BISPHOSPHATE_METABOLIC_PROCESS,0.99999
GOMF_FRUCTOSE_2_6_BISPHOSPHA...,SET,4,0.23931,0.0035321,0.35931,0.2527,GOMF_FRUCTOSE_2_6_BISPHOSPHATE_2_PHOSPHATASE_ACTIVITY,0.99999
REACTOME_TRANSCRIPTION_OF_TH...,SET,62,0.060824,0.0035288,0.091339,0.25274,REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME,0.99999
GOMF_OSMOSENSOR_ACTIVITY,SET,5,0.28176,0.0046494,0.42322,0.25278,GOMF_OSMOSENSOR_ACTIVITY,0.99999
STONER_ESOPHAGEAL_CARCINOGEN...2,SET,31,0.099684,0.0040929,0.14976,0.25283,STONER_ESOPHAGEAL_CARCINOGENESIS_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...119,SET,29,0.10728,0.0042605,0.16117,0.25283,GOBP_NEGATIVE_REGULATION_OF_CELL_KILLING,0.99999
GSE4142_GC_BCELL_VS_MEMORY_B...1,SET,179,0.04088,0.004017,0.061418,0.25284,GSE4142_GC_BCELL_VS_MEMORY_BCELL_DN,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...2,SET,51,0.080098,0.0042159,0.12034,0.25285,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS,0.99999
WP_ADIPOGENESIS,SET,125,0.054468,0.0044792,0.081844,0.25287,WP_ADIPOGENESIS,0.99999
GSE16385_IFNG_TNF_VS_IL4_STI...1,SET,150,0.044797,0.0040327,0.067314,0.25287,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,0.99999
HP_RHEUMATOID_FACTOR_POSITIVE,SET,18,0.13978,0.0043748,0.21008,0.25291,HP_RHEUMATOID_FACTOR_POSITIVE,0.99999
GOMF_PHOSPHATIDYLCHOLINE_TRA...1,SET,5,0.2514,0.0041484,0.37789,0.25294,GOMF_PHOSPHATIDYLCHOLINE_TRANSFER_ACTIVITY,0.99999
GOBP_INTRACELLULAR_MONOATOMI...,SET,10,0.19572,0.0045667,0.2942,0.25295,GOBP_INTRACELLULAR_MONOATOMIC_ANION_HOMEOSTASIS,0.99999
MODULE_125,SET,42,0.083696,0.0039987,0.12582,0.25297,MODULE_125,0.99999
MODULE_321,SET,107,0.058411,0.0044464,0.087866,0.2531,MODULE_321,0.99999
MODULE_543,SET,14,0.15908,0.0043914,0.23938,0.25317,MODULE_543,0.99999
GSE5679_PPARG_LIGAND_ROSIGLI...3,SET,181,0.04151,0.0041014,0.062483,0.25324,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,0.99999
HP_DEVELOPMENTAL_GLAUCOMA,SET,64,0.071546,0.004217,0.10771,0.25328,HP_DEVELOPMENTAL_GLAUCOMA,0.99999
MIR4515,SET,38,0.096574,0.0043893,0.1454,0.25329,MIR4515,0.99999
HP_LATE_YOUNG_ADULT_ONSET,SET,42,0.085287,0.0040747,0.12843,0.25332,HP_LATE_YOUNG_ADULT_ONSET,0.99999
GNF2_CEBPA,SET,60,0.075281,0.0042967,0.11337,0.25335,GNF2_CEBPA,0.99999
GOBP_DNA_INTEGRATION,SET,7,0.1728,0.0033736,0.26028,0.25339,GOBP_DNA_INTEGRATION,0.99999
REACTOME_IMMUNOREGULATORY_IN...,SET,114,0.060246,0.0047328,0.090753,0.2534,REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,0.99999
GOMF_AMINE_TRANSMEMBRANE_TRA...,SET,6,0.26166,0.0047297,0.39448,0.25357,GOMF_AMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MIR320A_3P_MIR320B_MIR320C_M...,SET,276,0.036634,0.004458,0.055269,0.25372,MIR320A_3P_MIR320B_MIR320C_MIR320D,0.99999
REACTOME_M_DECAY_DEGRADATION...,SET,31,0.10043,0.0041236,0.15153,0.25373,REACTOME_M_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_MATERNALLY_STORED_FACTORS,0.99999
OSWALD_HEMATOPOIETIC_STEM_CE...1,SET,241,0.036175,0.0041175,0.05458,0.25374,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,0.99999
MIR2110,SET,159,0.043707,0.0040499,0.065964,0.2538,MIR2110,0.99999
HP_PATCHY_ALOPECIA,SET,19,0.14799,0.0047585,0.22339,0.25384,HP_PATCHY_ALOPECIA,0.99999
MIR505_5P,SET,50,0.077478,0.0040379,0.11696,0.25385,MIR505_5P,0.99999
GENTILE_UV_LOW_DOSE_DN,SET,59,0.080694,0.0045672,0.12183,0.25387,GENTILE_UV_LOW_DOSE_DN,0.99999
GOCC_PODOSOME,SET,33,0.099338,0.0042079,0.14998,0.25387,GOCC_PODOSOME,0.99999
HOEBEKE_LYMPHOID_STEM_CELL_DN,SET,82,0.064858,0.004325,0.097932,0.2539,HOEBEKE_LYMPHOID_STEM_CELL_DN,0.99999
GOMF_ACYL_COA_BINDING,SET,18,0.13211,0.0041349,0.19949,0.2539,GOMF_ACYL_COA_BINDING,0.99999
GOBP_MAINTENANCE_OF_PROTEIN_...3,SET,81,0.062347,0.0041322,0.094148,0.25392,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION,0.99999
HP_UPPER_EYELID_COLOBOMA,SET,9,0.19623,0.0043438,0.29638,0.25396,HP_UPPER_EYELID_COLOBOMA,0.99999
SANA_RESPONSE_TO_IFNG_UP,SET,68,0.069126,0.0041993,0.10442,0.25399,SANA_RESPONSE_TO_IFNG_UP,0.99999
chr5q15,SET,19,0.19052,0.0061262,0.28781,0.254,chr5q15,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...52,SET,30,0.10237,0.0041348,0.15468,0.25405,HP_APLASIA_HYPOPLASIA_OF_THE_PATELLA,0.99999
MIR4728_5P,SET,516,0.025059,0.0041417,0.037877,0.25412,MIR4728_5P,0.99999
HP_FOCAL_AUTOMATISM_SEIZURE,SET,12,0.15948,0.0040761,0.24105,0.25412,HP_FOCAL_AUTOMATISM_SEIZURE,0.99999
GSE14308_TH1_VS_TH17_DN,SET,176,0.04091,0.0039864,0.061838,0.25413,GSE14308_TH1_VS_TH17_DN,0.99999
TURASHVILI_BREAST_CARCINOMA_...2,SET,21,0.13255,0.0044805,0.20038,0.25415,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP,0.99999
GOBP_CELLULAR_KETONE_METABOL...,SET,196,0.040859,0.0041992,0.061792,0.25424,GOBP_CELLULAR_KETONE_METABOLIC_PROCESS,0.99999
CHEN_LUNG_CANCER_SURVIVAL,SET,24,0.11237,0.0040602,0.17,0.25432,CHEN_LUNG_CANCER_SURVIVAL,0.99999
GSE6674_ANTI_IGM_VS_PL2_3_ST...2,SET,178,0.039899,0.0039097,0.060371,0.25434,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_UP,0.99999
KEGG_MEDICUS_REFERENCE_COHES...1,SET,4,0.24837,0.0036657,0.37585,0.25437,KEGG_MEDICUS_REFERENCE_COHESIN_ACETYLATION,0.99999
HP_VENTRICULAR_ARRHYTHMIA,SET,188,0.042015,0.00423,0.063625,0.25452,HP_VENTRICULAR_ARRHYTHMIA,0.99999
GSE13493_DP_VS_CD8POS_THYMOC...1,SET,180,0.040991,0.004039,0.062083,0.25455,GSE13493_DP_VS_CD8POS_THYMOCYTE_DN,0.99999
GOBP_EPIDERMAL_CELL_FATE_SPE...,SET,5,0.27186,0.004486,0.41178,0.25457,GOBP_EPIDERMAL_CELL_FATE_SPECIFICATION,0.99999
GSE17721_0.5H_VS_12H_LPS_BMD...1,SET,184,0.040713,0.0040554,0.061673,0.25459,GSE17721_0.5H_VS_12H_LPS_BMDC_DN,0.99999
GSE34515_CD16_POS_MONOCYTE_V...2,SET,188,0.041381,0.0041661,0.062691,0.2546,GSE34515_CD16_POS_MONOCYTE_VS_DC_UP,0.99999
HP_INTRINSIC_HAND_MUSCLE_ATR...,SET,24,0.11958,0.004321,0.18117,0.25461,HP_INTRINSIC_HAND_MUSCLE_ATROPHY,0.99999
BLANCO_MELO_SARS_COV_1_INFEC...1,SET,9,0.18916,0.0041873,0.28662,0.25464,BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_DN,0.99999
POU3F2_02,SET,228,0.03835,0.0042472,0.058109,0.25465,POU3F2_02,0.99999
HP_EPIBLEPHARON,SET,6,0.21854,0.0039502,0.33114,0.25465,HP_EPIBLEPHARON,0.99999
MIR4661_5P,SET,36,0.089006,0.0039376,0.13488,0.25467,MIR4661_5P,0.99999
RP58_01,SET,191,0.042482,0.0043106,0.064392,0.25471,RP58_01,0.99999
MIR3942_3P,SET,299,0.033312,0.0042166,0.050513,0.2548,MIR3942_3P,0.99999
chr10q26,SET,91,0.11376,0.0079895,0.17261,0.25493,chr10q26,0.99999
GOBP_RNA_MODIFICATION,SET,145,0.042889,0.0037966,0.065085,0.25496,GOBP_RNA_MODIFICATION,0.99999
GOBP_RESPONSE_TO_CHEMOKINE,SET,91,0.069864,0.0049066,0.10608,0.25508,GOBP_RESPONSE_TO_CHEMOKINE,0.99999
WP_TNFRELATED_WEAK_INDUCER_O...,SET,41,0.087258,0.0041191,0.1325,0.25509,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.99999
GOMF_THIOREDOXIN_DEPENDENT_P...,SET,4,0.25996,0.0038369,0.39473,0.25509,GOMF_THIOREDOXIN_DEPENDENT_PEROXIREDOXIN_ACTIVITY,0.99999
HALLMARK_DNA_REPAIR,SET,136,0.04348,0.0037284,0.066029,0.25511,HALLMARK_DNA_REPAIR,0.99999
FAC1_01,SET,189,0.043401,0.0043809,0.065921,0.25515,FAC1_01,0.99999
GOBP_CELLULAR_RESPONSE_TO_CH...2,SET,17,0.14021,0.0042646,0.213,0.2552,GOBP_CELLULAR_RESPONSE_TO_CHOLESTEROL,0.99999
GSE41867_DAY15_EFFECTOR_VS_D...4,SET,177,0.04273,0.0041755,0.064926,0.25523,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,0.99999
HAHTOLA_MYCOSIS_FUNGOIDES_UP,SET,14,0.15743,0.004346,0.23922,0.25524,HAHTOLA_MYCOSIS_FUNGOIDES_UP,0.99999
GSE4142_NAIVE_VS_MEMORY_BCEL...2,SET,184,0.042937,0.004277,0.065258,0.25529,GSE4142_NAIVE_VS_MEMORY_BCELL_UP,0.99999
HP_ABNORMAL_PLACENTAL_SIZE,SET,14,0.16922,0.0046714,0.25726,0.25534,HP_ABNORMAL_PLACENTAL_SIZE,0.99999
GOBP_MONOUBIQUITINATED_PROTE...,SET,8,0.18113,0.0037803,0.27538,0.25536,GOBP_MONOUBIQUITINATED_PROTEIN_DEUBIQUITINATION,0.99999
WP_MACROPHAGESTIMULATING_PRO...,SET,104,0.059789,0.0044873,0.090905,0.25537,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,0.99999
GOBP_PROTEIN_MATURATION_BY_I...,SET,11,0.1698,0.0041553,0.25818,0.25537,GOBP_PROTEIN_MATURATION_BY_IRON_SULFUR_CLUSTER_TRANSFER,0.99999
SMID_BREAST_CANCER_RELAPSE_I...6,SET,6,0.25106,0.004538,0.38194,0.25549,SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP,0.99999
CARM1_TARGET_GENES,SET,8,0.21196,0.0044237,0.32245,0.25549,CARM1_TARGET_GENES,0.99999
GOMF_PROTEIN_ARGININE_OMEGA_...1,SET,7,0.22104,0.0043154,0.33641,0.25558,GOMF_PROTEIN_ARGININE_OMEGA_N_ASYMMETRIC_METHYLTRANSFERASE_ACTIVITY,0.99999
GOBP_CAMKK_AMPK_SIGNALING_CA...,SET,9,0.19277,0.0042672,0.29348,0.25565,GOBP_CAMKK_AMPK_SIGNALING_CASCADE,0.99999
GOMF_GLYCOLIPID_BINDING,SET,28,0.10418,0.0040657,0.15863,0.25566,GOMF_GLYCOLIPID_BINDING,0.99999
GSE23568_ID3_KO_VS_WT_CD8_TC...1,SET,185,0.041858,0.0041807,0.063748,0.25572,GSE23568_ID3_KO_VS_WT_CD8_TCELL_DN,0.99999
REACTOME_REGULATION_OF_TLR_B...,SET,20,0.1478,0.0048756,0.22514,0.25577,REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND,0.99999
GSE32533_WT_VS_MIR17_OVEREXP...1,SET,174,0.044475,0.0043093,0.067756,0.25579,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,0.99999
HP_ABNORMAL_HYPOTHALAMUS_MOR...,SET,19,0.1175,0.0037783,0.17903,0.2558,HP_ABNORMAL_HYPOTHALAMUS_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...7,SET,16,0.15986,0.0047173,0.24363,0.25587,GOBP_NEGATIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_NUCLEOSIDE_MONOPHOSPHAT...4,SET,11,0.1609,0.0039374,0.24522,0.25587,GOBP_NUCLEOSIDE_MONOPHOSPHATE_PHOSPHORYLATION,0.99999
MIR4272,SET,180,0.041237,0.0040632,0.062849,0.25588,MIR4272,0.99999
GOBP_PRIMITIVE_STREAK_FORMAT...,SET,8,0.21453,0.0044774,0.32709,0.25595,GOBP_PRIMITIVE_STREAK_FORMATION,0.99999
HP_HYPOPLASIA_OF_THE_BLADDER,SET,5,0.24503,0.0040432,0.37357,0.25595,HP_HYPOPLASIA_OF_THE_BLADDER,0.99999
LEE_METASTASIS_AND_ALTERNATI...1,SET,44,0.085485,0.0041801,0.13035,0.25598,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN,0.99999
GOBP_ERYTHROCYTE_HOMEOSTASIS,SET,133,0.04816,0.0040843,0.073456,0.25603,GOBP_ERYTHROCYTE_HOMEOSTASIS,0.99999
GOBP_GLYCOSIDE_TRANSPORT,SET,5,0.26336,0.0043457,0.40173,0.25606,GOBP_GLYCOSIDE_TRANSPORT,0.99999
GOBP_TRANSCRIPTION_COUPLED_N...,SET,10,0.16418,0.0038307,0.25057,0.25617,GOBP_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR,0.99999
GOBP_TOR_SIGNALING,SET,146,0.044806,0.0039799,0.068388,0.25618,GOBP_TOR_SIGNALING,0.99999
GOBP_NEURON_MIGRATION,SET,166,0.046267,0.0043797,0.070623,0.25619,GOBP_NEURON_MIGRATION,0.99999
BYSTROEM_CORRELATED_WITH_IL5...2,SET,38,0.087304,0.0039679,0.13327,0.25621,BYSTROEM_CORRELATED_WITH_IL5_UP,0.99999
HP_FIRST_DEGREE_ATRIOVENTRIC...,SET,42,0.092092,0.0043998,0.1406,0.25624,HP_FIRST_DEGREE_ATRIOVENTRICULAR_BLOCK,0.99999
REACTOME_SYNTHESIS_OF_PIPS_A...4,SET,10,0.142,0.0033133,0.21683,0.25627,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE,0.99999
MIR1468_5P,SET,14,0.14277,0.0039413,0.21807,0.25633,MIR1468_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...530,SET,15,0.13208,0.003774,0.20175,0.25634,GOBP_POSITIVE_REGULATION_OF_NEURON_MIGRATION,0.99999
GOBP_UNSATURATED_FATTY_ACID_...2,SET,104,0.057436,0.0043108,0.087731,0.25634,GOBP_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS,0.99999
GOMF_SIALYLTRANSFERASE_ACTIV...,SET,21,0.12942,0.0043748,0.19776,0.25642,GOMF_SIALYLTRANSFERASE_ACTIVITY,0.99999
GOBP_RENAL_WATER_HOMEOSTASIS,SET,24,0.12708,0.0045917,0.19421,0.25645,GOBP_RENAL_WATER_HOMEOSTASIS,0.99999
GOBP_REPRODUCTIVE_SYSTEM_DEV...,SET,284,0.035012,0.0043209,0.053509,0.25646,GOBP_REPRODUCTIVE_SYSTEM_DEVELOPMENT,0.99999
GOMF_L_GLUTAMINE_TRANSMEMBRA...,SET,8,0.21751,0.0045396,0.33252,0.25652,GOMF_L_GLUTAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
ATTCTTT_MIR186,SET,241,0.037438,0.0042613,0.057242,0.25655,ATTCTTT_MIR186,0.99999
PID_MAPK_TRK_PATHWAY,SET,33,0.10283,0.004356,0.15731,0.25665,PID_MAPK_TRK_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_NOD_N...,SET,8,0.17145,0.0035782,0.26228,0.25666,KEGG_MEDICUS_REFERENCE_NOD_NFKB_SIGNALING_PATHWAY,0.99999
HP_PROGRESSIVE_PTOSIS,SET,4,0.24571,0.0036265,0.37594,0.2567,HP_PROGRESSIVE_PTOSIS,0.99999
KEGG_GLYCOSYLPHOSPHATIDYLINO...,SET,24,0.10329,0.0037321,0.15807,0.25675,KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS,0.99999
REACTOME_ACTIVATION_OF_IRF3_...,SET,17,0.12388,0.0037681,0.18964,0.2568,REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_IKBKE,0.99999
MIR8060,SET,91,0.058944,0.0041397,0.090231,0.2568,MIR8060,0.99999
WINTER_HYPOXIA_UP,SET,87,0.058018,0.0039845,0.088815,0.25681,WINTER_HYPOXIA_UP,0.99999
HP_ABNORMAL_VESTIBULAR_FUNCT...,SET,193,0.041849,0.0042683,0.06407,0.25683,HP_ABNORMAL_VESTIBULAR_FUNCTION,0.99999
GOMF_CARD_DOMAIN_BINDING,SET,15,0.13863,0.0039612,0.2123,0.25688,GOMF_CARD_DOMAIN_BINDING,0.99999
REACTOME_PROTEIN_LIPOYLATION,SET,10,0.14809,0.0034553,0.22683,0.25693,REACTOME_PROTEIN_LIPOYLATION,0.99999
TERAMOTO_OPN_TARGETS_CLUSTER...3,SET,13,0.13598,0.0036173,0.2083,0.25694,TERAMOTO_OPN_TARGETS_CLUSTER_4,0.99999
GOMF_PROTEIN_CARRIER_CHAPERO...,SET,31,0.09611,0.0039461,0.14724,0.25696,GOMF_PROTEIN_CARRIER_CHAPERONE,0.99999
REACTOME_RHOB_GTPASE_CYCLE,SET,65,0.069158,0.0041079,0.10596,0.25698,REACTOME_RHOB_GTPASE_CYCLE,0.99999
GOCC_GLYCOPROTEIN_IB_IX_V_CO...,SET,4,0.33246,0.0049069,0.50941,0.257,GOCC_GLYCOPROTEIN_IB_IX_V_COMPLEX,0.99999
HJURP_TARGET_GENES,SET,27,0.10202,0.0039098,0.15636,0.25704,HJURP_TARGET_GENES,0.99999
REACTOME_2_LTR_CIRCLE_FORMAT...,SET,7,0.19049,0.0037189,0.29194,0.25705,REACTOME_2_LTR_CIRCLE_FORMATION,0.99999
HP_PREMATURE_LOSS_OF_PERMANE...,SET,7,0.24192,0.0047231,0.37086,0.2571,HP_PREMATURE_LOSS_OF_PERMANENT_TEETH,0.99999
ELVIDGE_HYPOXIA_BY_DMOG_UP,SET,122,0.054619,0.0044377,0.083734,0.25711,ELVIDGE_HYPOXIA_BY_DMOG_UP,0.99999
GSE32986_CURDLAN_LOWDOSE_VS_...4,SET,179,0.040509,0.0039805,0.062113,0.25714,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.99999
HP_DYSPAREUNIA,SET,34,0.10221,0.0043947,0.15679,0.25724,HP_DYSPAREUNIA,0.99999
GOBP_REGULATION_OF_GRANULOCY...1,SET,47,0.087054,0.0043992,0.13355,0.25726,GOBP_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,0.99999
GOCC_U2AF_COMPLEX,SET,3,0.31073,0.0039719,0.47676,0.25728,GOCC_U2AF_COMPLEX,0.99999
OVSYANNIKOVA_PBMC_FLUARIX_AG...6,SET,29,0.095688,0.0038001,0.14685,0.25733,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_UP,0.99999
HP_ERYTHEMA,SET,106,0.05409,0.0040983,0.083025,0.25737,HP_ERYTHEMA,0.99999
KEGG_MEDICUS_REFERENCE_ITGA_...1,SET,25,0.11946,0.0044054,0.18338,0.25739,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY,0.99999
HP_MUSCLE_FIBER_TUBULAR_INCL...,SET,7,0.2082,0.0040647,0.31962,0.2574,HP_MUSCLE_FIBER_TUBULAR_INCLUSIONS,0.99999
chr2q23,SET,21,0.19701,0.0066593,0.3025,0.25744,chr2q23,0.99999
MIR4690_5P,SET,68,0.070594,0.0042885,0.1084,0.25745,MIR4690_5P,0.99999
MIR4474_3P,SET,79,0.06563,0.004296,0.10079,0.25747,MIR4474_3P,0.99999
GGGNNTTTCC_NFKB_Q6_01,SET,124,0.051298,0.0042017,0.078775,0.25747,GGGNNTTTCC_NFKB_Q6_01,0.99999
HP_ENDOCARDIAL_FIBROSIS,SET,6,0.24439,0.0044175,0.37532,0.25748,HP_ENDOCARDIAL_FIBROSIS,0.99999
HP_ABNORMAL_HYPOTHALAMUS_PHY...,SET,49,0.082537,0.0042585,0.12677,0.25749,HP_ABNORMAL_HYPOTHALAMUS_PHYSIOLOGY,0.99999
GSE4984_UNTREATED_VS_VEHICLE...2,SET,136,0.047732,0.0040931,0.07331,0.2575,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP,0.99999
GSE29618_LAIV_VS_TIV_FLU_VAC...1,SET,170,0.041113,0.003938,0.063156,0.25754,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN,0.99999
MATZUK_STEROIDOGENESIS,SET,6,0.25954,0.0046914,0.39873,0.25755,MATZUK_STEROIDOGENESIS,0.99999
GOBP_CARDIAC_CHAMBER_FORMATI...,SET,11,0.19815,0.004849,0.30448,0.2576,GOBP_CARDIAC_CHAMBER_FORMATION,0.99999
HP_MICROCORNEA,SET,111,0.052457,0.0040667,0.08061,0.25761,HP_MICROCORNEA,0.99999
MIR6715B_5P,SET,199,0.039582,0.0040986,0.060828,0.25762,MIR6715B_5P,0.99999
REACTOME_RHOBTB1_GTPASE_CYCLE,SET,22,0.10584,0.0036616,0.16268,0.25766,REACTOME_RHOBTB1_GTPASE_CYCLE,0.99999
GOCC_ENDOCYTIC_VESICLE_LUMEN,SET,20,0.12368,0.0040801,0.19011,0.25766,GOCC_ENDOCYTIC_VESICLE_LUMEN,0.99999
GOBP_MALE_MATING_BEHAVIOR,SET,7,0.2493,0.0048672,0.38321,0.25767,GOBP_MALE_MATING_BEHAVIOR,0.99999
HP_HYPERLIPOPROTEINEMIA,SET,36,0.098771,0.0043696,0.15183,0.25768,HP_HYPERLIPOPROTEINEMIA,0.99999
JONES_OVARY_T_CELL,SET,83,0.066995,0.0044945,0.10299,0.25769,JONES_OVARY_T_CELL,0.99999
TRAVAGLINI_LUNG_MESOTHELIAL_...,SET,579,0.023814,0.0041619,0.036609,0.25769,TRAVAGLINI_LUNG_MESOTHELIAL_CELL,0.99999
TTANTCA_UNKNOWN,SET,839,0.020724,0.0043281,0.031865,0.25773,TTANTCA_UNKNOWN,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_NON...,SET,16,0.1369,0.0040399,0.2105,0.25773,HE_LIM_SUN_FETAL_LUNG_C2_NON_CLASSICAL_MONOCYTE,0.99999
GOBP_REGULATION_OF_ORGANELLE...2,SET,1094,0.017178,0.0040665,0.026413,0.25774,GOBP_REGULATION_OF_ORGANELLE_ORGANIZATION,0.99999
GOBP_MALATE_METABOLIC_PROCESS,SET,9,0.19177,0.004245,0.29494,0.25778,GOBP_MALATE_METABOLIC_PROCESS,0.99999
GATTGGY_NFY_Q6_01,SET,1023,0.017978,0.0041239,0.027653,0.25781,GATTGGY_NFY_Q6_01,0.99999
GOBP_REGULATION_OF_SYNAPSE_A...,SET,105,0.060018,0.004526,0.092348,0.25788,GOBP_REGULATION_OF_SYNAPSE_ASSEMBLY,0.99999
GOMF_RETINOIC_ACID_4_HYDROXY...,SET,10,0.19758,0.00461,0.304,0.25788,GOMF_RETINOIC_ACID_4_HYDROXYLASE_ACTIVITY,0.99999
GCM_CASP2,SET,26,0.10243,0.0038522,0.15762,0.25789,GCM_CASP2,0.99999
GSE5455_HEALTHY_VS_TUMOR_BEA...4,SET,178,0.041914,0.0041072,0.064507,0.25793,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_UP,0.99999
GOBP_PROSTATE_GLAND_MORPHOGE...,SET,26,0.12664,0.0047626,0.19491,0.25794,GOBP_PROSTATE_GLAND_MORPHOGENESIS,0.99999
BIOCARTA_CDMAC_PATHWAY,SET,16,0.14973,0.0044185,0.23046,0.25795,BIOCARTA_CDMAC_PATHWAY,0.99999
GOCC_LSM2_8_COMPLEX,SET,7,0.19785,0.0038627,0.30465,0.25803,GOCC_LSM2_8_COMPLEX,0.99999
GOCC_NUCLEAR_ENVELOPE_LUMEN,SET,10,0.18733,0.004371,0.28846,0.25804,GOCC_NUCLEAR_ENVELOPE_LUMEN,0.99999
GGATCCG_MIR127,SET,9,0.2158,0.0047771,0.33232,0.25805,GGATCCG_MIR127,0.99999
HP_CUTANEOUS_MELANOMA,SET,19,0.11041,0.00355,0.17002,0.25805,HP_CUTANEOUS_MELANOMA,0.99999
GOBP_HOMEOSTASIS_OF_NUMBER_O...2,SET,33,0.10253,0.0043433,0.15795,0.25812,GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS_WITHIN_A_TISSUE,0.99999
WP_THYROID_HORMONES_PRODUCTI...,SET,90,0.059818,0.004178,0.092171,0.25818,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,0.99999
BRACHAT_RESPONSE_TO_CISPLATIN,SET,20,0.12546,0.0041386,0.19338,0.25825,BRACHAT_RESPONSE_TO_CISPLATIN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...485,SET,19,0.13338,0.0042887,0.20561,0.25827,GOBP_NEGATIVE_REGULATION_OF_PHAGOCYTOSIS,0.99999
GOBP_PURINE_DEOXYRIBONUCLEOS...1,SET,5,0.29284,0.0048321,0.45143,0.25827,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...48,SET,43,0.081595,0.0039443,0.12579,0.25828,HP_APLASIA_HYPOPLASIA_OF_THE_NIPPLES,0.99999
GOBP_NATURAL_KILLER_CELL_CHE...,SET,10,0.19592,0.0045713,0.30204,0.25829,GOBP_NATURAL_KILLER_CELL_CHEMOTAXIS,0.99999
GOBP_REGULATION_OF_ICOSANOID...,SET,21,0.13243,0.0044764,0.20417,0.25829,GOBP_REGULATION_OF_ICOSANOID_SECRETION,0.99999
GOBP_DNA_STRAND_INVASION,SET,6,0.18499,0.0033438,0.28526,0.25834,GOBP_DNA_STRAND_INVASION,0.99999
GSE1460_CD4_THYMOCYTE_VS_NAI...2,SET,182,0.042348,0.0041956,0.065307,0.25835,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,0.99999
HP_ABNORMAL_CIRCULATING_C_PE...,SET,26,0.11707,0.0044026,0.1806,0.25843,HP_ABNORMAL_CIRCULATING_C_PEPTIDE_CONCENTRATION,0.99999
GNF2_FGR,SET,30,0.10001,0.0040397,0.15431,0.25846,GNF2_FGR,0.99999
GOMF_SIGNALING_RECEPTOR_BIND...,SET,1324,0.016589,0.0042915,0.0256,0.25849,GOMF_SIGNALING_RECEPTOR_BINDING,0.99999
GSE40274_CTRL_VS_XBP1_TRANSD...1,SET,148,0.04284,0.003831,0.066123,0.25853,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
IRF1_01,SET,225,0.038722,0.0042605,0.059774,0.25856,IRF1_01,0.99999
MIR4429,SET,275,0.035852,0.004355,0.055348,0.25858,MIR4429,0.99999
HP_HYPERECHOGENIC_PANCREAS,SET,4,0.26783,0.003953,0.4136,0.25864,HP_HYPERECHOGENIC_PANCREAS,0.99999
GOBP_CARDIAC_ATRIUM_DEVELOPM...,SET,34,0.10799,0.0046433,0.16679,0.25866,GOBP_CARDIAC_ATRIUM_DEVELOPMENT,0.99999
HP_LAMBDOIDAL_CRANIOSYNOSTOS...,SET,15,0.13025,0.0037215,0.20116,0.25867,HP_LAMBDOIDAL_CRANIOSYNOSTOSIS,0.99999
PARK_OSTEOBLAST_DIFFERENTIAT...2,SET,12,0.17785,0.0045456,0.27476,0.25873,PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP,0.99999
MIR7855_5P,SET,70,0.070082,0.0043193,0.10829,0.25876,MIR7855_5P,0.99999
GOMF_METALLODIPEPTIDASE_ACTI...,SET,8,0.21192,0.0044229,0.32753,0.25881,GOMF_METALLODIPEPTIDASE_ACTIVITY,0.99999
GOCC_DENDRITE_MEMBRANE,SET,37,0.092695,0.0041573,0.14328,0.25883,GOCC_DENDRITE_MEMBRANE,0.99999
GOMF_CYTIDINE_DEAMINASE_ACTI...,SET,10,0.23257,0.0054265,0.35953,0.25886,GOMF_CYTIDINE_DEAMINASE_ACTIVITY,0.99999
GSE17186_NAIVE_VS_CD21HIGH_T...1,SET,178,0.041069,0.0040243,0.063489,0.25886,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,0.99999
MIR6876_3P,SET,49,0.086035,0.0044389,0.13301,0.25887,MIR6876_3P,0.99999
KIM_MYCN_AMPLIFICATION_TARGE...1,SET,98,0.056567,0.0041219,0.087464,0.2589,KIM_MYCN_AMPLIFICATION_TARGETS_DN,0.99999
YNTTTNNNANGCARM_UNKNOWN,SET,63,0.076493,0.0044734,0.11831,0.25896,YNTTTNNNANGCARM_UNKNOWN,0.99999
GSE2770_UNTREATED_VS_ACT_CD4...4,SET,171,0.040661,0.003906,0.062888,0.25896,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_UP,0.99999
GSE42021_CD24INT_VS_CD24LOW_...1,SET,175,0.043228,0.0042004,0.066858,0.25896,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN,0.99999
GOBP_CYCLIC_NUCLEOTIDE_CATAB...,SET,14,0.15073,0.0041608,0.23317,0.25901,GOBP_CYCLIC_NUCLEOTIDE_CATABOLIC_PROCESS,0.99999
GSE2770_TGFB_AND_IL4_ACT_VS_...3,SET,179,0.041409,0.004069,0.064063,0.25902,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,0.99999
HP_ESODEVIATION,SET,200,0.038061,0.003951,0.058902,0.25909,HP_ESODEVIATION,0.99999
ATCTTGC_MIR31,SET,70,0.064957,0.0040034,0.10053,0.2591,ATCTTGC_MIR31,0.99999
MIR6854_3P,SET,10,0.20291,0.0047346,0.31413,0.25916,MIR6854_3P,0.99999
THAKAR_PBMC_INACTIVATED_INFL...1,SET,56,0.072229,0.0039832,0.11187,0.25925,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_DN,0.99999
REACTOME_APC_CDC20_MEDIATED_...,SET,24,0.10949,0.0039561,0.1696,0.25929,REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A,0.99999
GOBP_REGULATION_OF_MEMBRANE_...1,SET,41,0.095079,0.0044883,0.14736,0.2594,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION,0.99999
GSE20366_CD103_KLRG1_DP_VS_D...1,SET,173,0.041496,0.0040092,0.064314,0.2594,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN,0.99999
DESCARTES_FETAL_PLACENTA_MYE...,SET,125,0.053037,0.0043615,0.082202,0.2594,DESCARTES_FETAL_PLACENTA_MYELOID_CELLS,0.99999
REACTOME_TRIF_MEDIATED_PROGR...,SET,9,0.19439,0.0043031,0.30132,0.25942,REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH,0.99999
MODULE_207,SET,207,0.038798,0.0040966,0.060142,0.25943,MODULE_207,0.99999
GOBP_NEGATIVE_REGULATION_OF_...120,SET,32,0.10482,0.0043726,0.16249,0.25943,GOBP_NEGATIVE_REGULATION_OF_CELL_MATRIX_ADHESION,0.99999
MIR4633_5P,SET,38,0.091705,0.004168,0.14217,0.25946,MIR4633_5P,0.99999
REACTOME_SPERM_MOTILITY_AND_...,SET,9,0.17064,0.0037774,0.26462,0.25951,REACTOME_SPERM_MOTILITY_AND_TAXES,0.99999
PUJANA_BREAST_CANCER_LIT_INT...,SET,91,0.051988,0.0036512,0.080627,0.25953,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_CD1...,SET,16,0.16534,0.0048792,0.25646,0.25956,HE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL,0.99999
ASTIER_INTEGRIN_SIGNALING,SET,54,0.08,0.0043324,0.12409,0.25957,ASTIER_INTEGRIN_SIGNALING,0.99999
HP_PYELONEPHRITIS,SET,20,0.11961,0.0039459,0.1856,0.25964,HP_PYELONEPHRITIS,0.99999
GCM_PTPRD,SET,53,0.075652,0.004059,0.11739,0.25965,GCM_PTPRD,0.99999
HP_IMPULSIVITY,SET,128,0.049536,0.0041219,0.076868,0.25965,HP_IMPULSIVITY,0.99999
WP_MITOCHONDRIAL_IMMUNE_RESP...,SET,23,0.11136,0.0039391,0.17281,0.25967,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,0.99999
GOBP_POSTSYNAPSE_ORGANIZATION,SET,180,0.042549,0.0041925,0.066033,0.25968,GOBP_POSTSYNAPSE_ORGANIZATION,0.99999
ATF2_UP.V1_UP,SET,171,0.042621,0.0040943,0.066159,0.25972,ATF2_UP.V1_UP,0.99999
HP_ABNORMAL_CIRCULATING_INSU...,SET,144,0.0469,0.0041374,0.072808,0.25974,HP_ABNORMAL_CIRCULATING_INSULIN_CONCENTRATION,0.99999
GOBP_SYNAPTIC_VESICLE_RECYCL...2,SET,4,0.24129,0.0035613,0.37464,0.25977,GOBP_SYNAPTIC_VESICLE_RECYCLING_VIA_ENDOSOME,0.99999
GOBP_DIGESTIVE_SYSTEM_PROCESS,SET,102,0.057177,0.0042501,0.08879,0.25981,GOBP_DIGESTIVE_SYSTEM_PROCESS,0.99999
HP_PERSISTENCE_OF_PRIMARY_TE...,SET,22,0.11162,0.0038617,0.17334,0.25982,HP_PERSISTENCE_OF_PRIMARY_TEETH,0.99999
HP_OCCIPITAL_ENCEPHALOCELE,SET,36,0.09182,0.0040621,0.14261,0.25984,HP_OCCIPITAL_ENCEPHALOCELE,0.99999
MTOR_UP.N4.V1_UP,SET,175,0.04124,0.0040072,0.064055,0.25985,MTOR_UP.N4.V1_UP,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...10,SET,14,0.13186,0.0036401,0.20483,0.25986,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24,0.99999
GSE17301_CTRL_VS_48H_ACD3_AC...6,SET,176,0.039948,0.0038927,0.062087,0.25998,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_UP,0.99999
GOBP_REGULATION_OF_MYOFIBROB...,SET,6,0.18127,0.0032766,0.28182,0.26005,GOBP_REGULATION_OF_MYOFIBROBLAST_DIFFERENTIATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...337,SET,3,0.307,0.0039242,0.47739,0.26009,GOBP_POSITIVE_REGULATION_OF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
MIR1260A_MIR1260B,SET,97,0.055351,0.0040128,0.086103,0.26016,MIR1260A_MIR1260B,0.99999
MEL18_DN.V1_DN,SET,134,0.053254,0.0045331,0.082853,0.2602,MEL18_DN.V1_DN,0.99999
BUSSLINGER_DUODENAL_PANETH_C...,SET,15,0.16846,0.0048134,0.2621,0.2602,BUSSLINGER_DUODENAL_PANETH_CELLS,0.99999
REACTOME_TRANSCRIPTIONAL_REG...15,SET,79,0.059465,0.0038925,0.092578,0.26034,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...360,SET,11,0.16947,0.0041472,0.26386,0.26034,GOBP_POSITIVE_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,0.99999
GOCC_ADHERENS_JUNCTION,SET,170,0.0445,0.0042623,0.069292,0.26038,GOCC_ADHERENS_JUNCTION,0.99999
GOCC_TRANSCRIPTION_EXPORT_CO...1,SET,10,0.13602,0.0031738,0.21184,0.26041,GOCC_TRANSCRIPTION_EXPORT_COMPLEX,0.99999
HP_ATTACHED_EARLOBE,SET,6,0.23715,0.0042867,0.36936,0.26042,HP_ATTACHED_EARLOBE,0.99999
GOCC_SPHERICAL_HIGH_DENSITY_...,SET,7,0.21255,0.0041497,0.33111,0.26046,GOCC_SPHERICAL_HIGH_DENSITY_LIPOPROTEIN_PARTICLE,0.99999
MIR598_5P,SET,4,0.28505,0.0042072,0.44406,0.26047,MIR598_5P,0.99999
PID_DNA_PK_PATHWAY,SET,16,0.11334,0.0033446,0.17664,0.26056,PID_DNA_PK_PATHWAY,0.99999
WP_CLOCKCONTROLLED_AUTOPHAGY...,SET,77,0.066134,0.0042741,0.10308,0.26057,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.99999
WP_SUPPRESSION_OF_HMGB1MEDIA...,SET,8,0.18875,0.0039394,0.29421,0.26059,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,0.99999
GOBP_TELENCEPHALON_REGIONALI...,SET,13,0.18928,0.005035,0.29507,0.26061,GOBP_TELENCEPHALON_REGIONALIZATION,0.99999
DESCARTES_FETAL_CEREBRUM_VAS...,SET,436,0.028764,0.0043799,0.044845,0.26063,DESCARTES_FETAL_CEREBRUM_VASCULAR_ENDOTHELIAL_CELLS,0.99999
GOBP_RESPONSE_TO_MOLECULE_OF...1,SET,326,0.032559,0.0043001,0.050766,0.26065,GOBP_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN,0.99999
MODULE_9,SET,112,0.051334,0.0039973,0.080049,0.26067,MODULE_9,0.99999
GSE2770_IL12_VS_TGFB_AND_IL1...2,SET,114,0.052413,0.0041175,0.081746,0.26071,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
HP_COARCTATION_OF_AORTA,SET,128,0.047868,0.0039831,0.074665,0.26073,HP_COARCTATION_OF_AORTA,0.99999
REACTOME_FREE_FATTY_ACID_REC...,SET,4,0.32632,0.0048163,0.50916,0.2608,REACTOME_FREE_FATTY_ACID_RECEPTORS,0.99999
HALLMARK_CHOLESTEROL_HOMEOST...,SET,69,0.064274,0.0039331,0.10029,0.26081,HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.99999
chr9p21,SET,42,0.14487,0.0069216,0.22609,0.26083,chr9p21,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...9,SET,71,0.070614,0.0043829,0.11021,0.26085,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,0.99999
REACTOME_LECTIN_PATHWAY_OF_C...,SET,8,0.22245,0.0046427,0.34723,0.26088,REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION,0.99999
GSE13522_CTRL_VS_T_CRUZI_Y_S...1,SET,179,0.041556,0.0040833,0.064863,0.26088,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN,0.99999
HANSON_HRAS_SIGNALING_VIA_NF...,SET,21,0.12316,0.0041629,0.19224,0.26089,HANSON_HRAS_SIGNALING_VIA_NFKB,0.99999
GOBP_CELLULAR_RESPONSE_TO_OS...,SET,51,0.07709,0.0040576,0.12034,0.26089,GOBP_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS,0.99999
MIR202_5P,SET,103,0.054715,0.0040869,0.085425,0.26093,MIR202_5P,0.99999
HP_ABNORMAL_SYSTEMIC_ARTERIA...,SET,470,0.025517,0.0040302,0.039842,0.26094,HP_ABNORMAL_SYSTEMIC_ARTERIAL_MORPHOLOGY,0.99999
NAKAMURA_METASTASIS_MODEL_UP,SET,39,0.080572,0.0037097,0.12582,0.26097,NAKAMURA_METASTASIS_MODEL_UP,0.99999
HP_BROAD_PHILTRUM,SET,42,0.082417,0.0039376,0.12871,0.26098,HP_BROAD_PHILTRUM,0.99999
MIR4768_3P,SET,174,0.040189,0.003894,0.062763,0.26099,MIR4768_3P,0.99999
KEGG_MEDICUS_REFERENCE_C9ORF...,SET,8,0.19516,0.0040732,0.3048,0.261,KEGG_MEDICUS_REFERENCE_C9ORF72_MEDIATED_AUTOPHAGY_INITIATION,0.99999
MIR9900,SET,40,0.087461,0.0040781,0.13666,0.26109,MIR9900,0.99999
GOCC_EARLY_ENDOSOME,SET,399,0.027134,0.0039565,0.042398,0.2611,GOCC_EARLY_ENDOSOME,0.99999
GOBP_T_HELPER_CELL_LINEAGE_C...,SET,23,0.12801,0.0045282,0.20004,0.26111,GOBP_T_HELPER_CELL_LINEAGE_COMMITMENT,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...8,SET,161,0.043683,0.0040729,0.068271,0.26114,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,0.99999
FAN_EMBRYONIC_CTX_BRAIN_B_CE...,SET,84,0.064364,0.0043438,0.1006,0.26116,FAN_EMBRYONIC_CTX_BRAIN_B_CELL,0.99999
REACTOME_ERYTHROPOIETIN_ACTI...2,SET,7,0.21468,0.0041913,0.33559,0.26119,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG,0.99999
REACTOME_PROLONGED_ERK_ACTIV...,SET,14,0.15167,0.0041868,0.23711,0.26121,REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS,0.99999
AZARE_STAT3_TARGETS,SET,23,0.11296,0.0039957,0.17662,0.26124,AZARE_STAT3_TARGETS,0.99999
HP_VENOUS_MALFORMATION,SET,11,0.16154,0.003953,0.25258,0.26124,HP_VENOUS_MALFORMATION,0.99999
GOBP_TRIGLYCERIDE_METABOLIC_...,SET,93,0.057992,0.0041172,0.090702,0.26129,GOBP_TRIGLYCERIDE_METABOLIC_PROCESS,0.99999
GOBP_PROPIONATE_METABOLIC_PR...,SET,4,0.26874,0.0039665,0.42037,0.26132,GOBP_PROPIONATE_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_TOLL_LIKE...2,SET,14,0.13765,0.0037997,0.21541,0.26142,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.99999
BIOCARTA_ERYTH_PATHWAY,SET,15,0.15901,0.0045435,0.24887,0.26144,BIOCARTA_ERYTH_PATHWAY,0.99999
GOBP_PHOSPHATIDYLCHOLINE_CAT...,SET,15,0.14428,0.0041226,0.22583,0.26145,GOBP_PHOSPHATIDYLCHOLINE_CATABOLIC_PROCESS,0.99999
GOBP_VIRAL_PROTEIN_PROCESSING,SET,31,0.095474,0.00392,0.14946,0.26148,GOBP_VIRAL_PROTEIN_PROCESSING,0.99999
HP_CUTANEOUS_ANERGY,SET,6,0.24136,0.0043628,0.37822,0.26169,HP_CUTANEOUS_ANERGY,0.99999
GOBP_EMBRYONIC_BRAIN_DEVELOP...,SET,15,0.1533,0.0043803,0.24024,0.2617,GOBP_EMBRYONIC_BRAIN_DEVELOPMENT,0.99999
TARTE_PLASMA_CELL_VS_B_LYMPH...1,SET,34,0.10125,0.0043533,0.15874,0.26179,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN,0.99999
TTGCCAA_MIR182,SET,298,0.033468,0.0042293,0.052473,0.2618,TTGCCAA_MIR182,0.99999
GSE9878_CTRL_VS_EBF_TRANSDUC...2,SET,189,0.040031,0.0040408,0.062772,0.26183,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP,0.99999
GOBP_OLEFINIC_COMPOUND_METAB...,SET,154,0.047597,0.0043411,0.074642,0.26185,GOBP_OLEFINIC_COMPOUND_METABOLIC_PROCESS,0.99999
GOBP_CEREBELLAR_PURKINJE_CEL...1,SET,23,0.10893,0.0038532,0.17085,0.26189,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT,0.99999
GOBP_C_TERMINAL_PROTEIN_AMIN...,SET,16,0.13567,0.0040034,0.21287,0.26196,GOBP_C_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION,0.99999
HOEK_PBMC_INACTIVATED_INFLUE...2,SET,2,0.35705,0.0037266,0.56027,0.26197,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_UP,0.99999
LIN_MELANOMA_COPY_NUMBER_DN,SET,38,0.088983,0.0040443,0.13965,0.262,LIN_MELANOMA_COPY_NUMBER_DN,0.99999
GSE20198_IL12_IL18_VS_IFNA_T...2,SET,186,0.038223,0.0038279,0.059985,0.262,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...8,SET,184,0.041251,0.004109,0.064741,0.26201,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN,0.99999
GOMF_STEROID_BINDING,SET,102,0.056611,0.004208,0.088858,0.26204,GOMF_STEROID_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...744,SET,33,0.10435,0.0044202,0.16381,0.26207,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,0.99999
MIR4475,SET,58,0.071197,0.0039955,0.11179,0.2621,MIR4475,0.99999
GOBP_ESTABLISHMENT_OR_MAINTE...2,SET,211,0.038749,0.0041303,0.060857,0.26215,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,0.99999
HP_IMPAIRMENT_OF_ACTIVITIES_...,SET,170,0.041611,0.0039857,0.06535,0.26215,HP_IMPAIRMENT_OF_ACTIVITIES_OF_DAILY_LIVING,0.99999
GSE37416_0H_VS_3H_F_TULARENS...1,SET,182,0.039889,0.003952,0.062645,0.26215,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
HP_LARYNGOTRACHEOMALACIA,SET,7,0.20977,0.0040955,0.32951,0.26219,HP_LARYNGOTRACHEOMALACIA,0.99999
GOMF_INOSITOL_TRISPHOSPHATE_...,SET,12,0.14006,0.0035796,0.22001,0.2622,GOMF_INOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.99999
GSE5542_IFNA_VS_IFNA_AND_IFN...4,SET,176,0.03896,0.0037964,0.061214,0.26224,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.99999
GOBP_CELL_MOTILITY,SET,1577,0.014967,0.0041941,0.023528,0.26234,GOBP_CELL_MOTILITY,0.99999
REACTOME_BMAL1_CLOCK_NPAS2_A...,SET,23,0.1227,0.0043402,0.19289,0.26236,REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION,0.99999
GSE29618_MONOCYTE_VS_PDC_DN,SET,170,0.042066,0.0040293,0.066131,0.26236,GSE29618_MONOCYTE_VS_PDC_DN,0.99999
GSE3994_WT_VS_PAC1_KO_ACTIVA...1,SET,189,0.040416,0.0040796,0.063551,0.26241,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN,0.99999
GOBP_PEPTIDYL_LYSINE_MONOMET...,SET,7,0.17863,0.0034874,0.2809,0.26242,GOBP_PEPTIDYL_LYSINE_MONOMETHYLATION,0.99999
GSE37532_WT_VS_PPARG_KO_LN_T...3,SET,107,0.055622,0.004234,0.087508,0.26252,GSE37532_WT_VS_PPARG_KO_LN_TREG_DN,0.99999
GOBP_RIBOSOMAL_LARGE_SUBUNIT...3,SET,7,0.20031,0.0039107,0.31517,0.26254,GOBP_RIBOSOMAL_LARGE_SUBUNIT_EXPORT_FROM_NUCLEUS,0.99999
CARRILLOREIXACH_HEPATOBLASTO...3,SET,156,0.047271,0.004339,0.074386,0.26256,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP,0.99999
GOBP_EXOCYTOSIS,SET,322,0.030236,0.0039691,0.04759,0.26261,GOBP_EXOCYTOSIS,0.99999
GOMF_ATPASE_COUPLED_INORGANI...,SET,10,0.18302,0.0042705,0.28811,0.26264,GOMF_ATPASE_COUPLED_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE36826_WT_VS_IL1R_KO_SKIN_...2,SET,176,0.042624,0.0041534,0.067117,0.2627,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN,0.99999
GOMF_PROTEIN_TYROSINE_KINASE...3,SET,117,0.049759,0.0039597,0.078357,0.26271,GOMF_PROTEIN_TYROSINE_KINASE_BINDING,0.99999
HP_MINICORE_MYOPATHY,SET,8,0.18825,0.003929,0.29645,0.26271,HP_MINICORE_MYOPATHY,0.99999
GOBP_REGULATION_OF_ENTRY_OF_...,SET,7,0.19818,0.0038691,0.31214,0.26275,GOBP_REGULATION_OF_ENTRY_OF_BACTERIUM_INTO_HOST_CELL,0.99999
HP_MIXED_DEMYELINATING_AND_A...,SET,3,0.3019,0.0038591,0.47555,0.26277,HP_MIXED_DEMYELINATING_AND_AXONAL_POLYNEUROPATHY,0.99999
GOBP_POSITIVE_REGULATION_OF_...389,SET,89,0.058698,0.0040771,0.092467,0.26279,GOBP_POSITIVE_REGULATION_OF_JNK_CASCADE,0.99999
GOBP_REGULATION_OF_AXON_GUID...,SET,11,0.18956,0.0046388,0.29864,0.2628,GOBP_REGULATION_OF_AXON_GUIDANCE,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...57,SET,38,0.08684,0.0039468,0.13682,0.26281,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_THUMB,0.99999
GOBP_POSITIVE_REGULATION_OF_...11,SET,7,0.18413,0.0035947,0.29014,0.26285,GOBP_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...24,SET,27,0.10449,0.0040043,0.16466,0.26286,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,0.99999
HP_CRANIOFACIAL_DISPROPORTION,SET,6,0.21463,0.0038795,0.33828,0.26289,HP_CRANIOFACIAL_DISPROPORTION,0.99999
GOBP_LIPOPOLYSACCHARIDE_MEDI...,SET,54,0.076779,0.004158,0.12102,0.2629,GOBP_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,0.99999
HALLMARK_XENOBIOTIC_METABOLI...,SET,192,0.040107,0.0040802,0.063219,0.26291,HALLMARK_XENOBIOTIC_METABOLISM,0.99999
GOBP_SYNAPTIC_VESICLE_BUDDING,SET,12,0.15123,0.0038652,0.23846,0.26298,GOBP_SYNAPTIC_VESICLE_BUDDING,0.99999
LI_PBMC_MENOMUNE_A_C_Y_W_135...1,SET,16,0.14794,0.0043656,0.23329,0.263,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_DN,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...4,SET,10,0.16123,0.0037619,0.25433,0.26307,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_NAD_P_AS_ACCEPTOR,0.99999
GOBP_NEGATIVE_REGULATION_OF_...62,SET,7,0.22232,0.0043404,0.35075,0.26309,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.99999
HP_PREMATURE_CORONARY_ARTERY...,SET,18,0.14397,0.0045059,0.22714,0.2631,HP_PREMATURE_CORONARY_ARTERY_ATHEROSCLEROSIS,0.99999
BIOCARTA_EDG1_PATHWAY,SET,22,0.12171,0.0042108,0.19214,0.26322,BIOCARTA_EDG1_PATHWAY,0.99999
GOBP_VENOUS_BLOOD_VESSEL_MOR...,SET,9,0.19688,0.0043581,0.3108,0.26322,GOBP_VENOUS_BLOOD_VESSEL_MORPHOGENESIS,0.99999
GOBP_PHOSPHOLIPID_TRANSPORT,SET,92,0.057093,0.0040315,0.090165,0.2633,GOBP_PHOSPHOLIPID_TRANSPORT,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...10,SET,51,0.08339,0.0043892,0.1317,0.26331,BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN,0.99999
REACTOME_ADIPOGENESIS,SET,104,0.051367,0.0038553,0.081136,0.26334,REACTOME_ADIPOGENESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...624,SET,7,0.21046,0.0041089,0.33243,0.26334,GOBP_POSITIVE_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.99999
GSE3720_UNSTIM_VS_LPS_STIM_V...2,SET,176,0.040711,0.003967,0.064326,0.26341,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP,0.99999
HP_LOW_ANTERIOR_HAIRLINE,SET,130,0.045961,0.003854,0.072627,0.26342,HP_LOW_ANTERIOR_HAIRLINE,0.99999
GSE45365_NK_CELL_VS_BCELL_UP,SET,186,0.039772,0.003983,0.062849,0.26343,GSE45365_NK_CELL_VS_BCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...157,SET,55,0.073747,0.0040305,0.11657,0.26348,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.99999
GOMF_THYROID_HORMONE_TRANSME...,SET,7,0.21373,0.0041728,0.33782,0.26348,GOMF_THYROID_HORMONE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_CELLULAR_RESPONSE_TO_IR...,SET,7,0.19793,0.0038643,0.31293,0.26353,GOBP_CELLULAR_RESPONSE_TO_IRON_ION,0.99999
GSE3982_DC_VS_BCELL_UP,SET,183,0.041248,0.0040977,0.065215,0.26354,GSE3982_DC_VS_BCELL_UP,0.99999
MIR6730_5P,SET,120,0.048588,0.0039155,0.076826,0.26355,MIR6730_5P,0.99999
REACTOME_CDC6_ASSOCIATION_WI...,SET,8,0.15834,0.0033047,0.2504,0.26358,REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX,0.99999
MIR96_3P,SET,65,0.064819,0.0038501,0.10251,0.26359,MIR96_3P,0.99999
MIR3677_3P,SET,5,0.25982,0.0042872,0.41094,0.26362,MIR3677_3P,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...2,SET,47,0.084633,0.0042768,0.13388,0.26365,GAVISH_3CA_METAPROGRAM_MACROPHAGES_INTERFERON,0.99999
GOMF_VIRION_BINDING,SET,9,0.19322,0.0042772,0.30566,0.26365,GOMF_VIRION_BINDING,0.99999
HP_U_SHAPED_UPPER_LIP_VERMIL...,SET,6,0.17621,0.0031852,0.27879,0.26368,HP_U_SHAPED_UPPER_LIP_VERMILION,0.99999
BIOCARTA_CTL_PATHWAY,SET,13,0.16174,0.0043026,0.25591,0.26369,BIOCARTA_CTL_PATHWAY,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...25,SET,7,0.23736,0.0046341,0.37569,0.26376,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...84,SET,8,0.20226,0.0042213,0.32019,0.2638,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,0.99999
GOMF_ESTROGEN_2_HYDROXYLASE_...,SET,5,0.28037,0.0046265,0.44394,0.26384,GOMF_ESTROGEN_2_HYDROXYLASE_ACTIVITY,0.99999
HP_PNEUMOTHORAX,SET,72,0.068684,0.004293,0.10879,0.26391,HP_PNEUMOTHORAX,0.99999
HP_KERATITIS,SET,70,0.062673,0.0038626,0.099284,0.26394,HP_KERATITIS,0.99999
GSE14769_20MIN_VS_360MIN_LPS...2,SET,177,0.038427,0.003755,0.060881,0.26396,GSE14769_20MIN_VS_360MIN_LPS_BMDM_UP,0.99999
HARALAMBIEVA_PBMC_FLUARIX_AG...2,SET,404,0.026134,0.003834,0.041403,0.26396,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_POSITIVE,0.99999
CUX1_TARGET_GENES,SET,662,0.021245,0.0039609,0.03367,0.26403,CUX1_TARGET_GENES,0.99999
GSE37533_PPARG1_FOXP3_VS_FOX...2,SET,188,0.037772,0.0038028,0.059874,0.26407,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...846,SET,8,0.21872,0.0045648,0.34677,0.26411,GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,0.99999
GOBP_REGULATION_OF_CELLULAR_...2,SET,413,0.026495,0.0039291,0.042012,0.26414,GOBP_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.99999
HP_THINNING_OF_DESCEMET_MEMB...,SET,6,0.26108,0.0047191,0.414,0.26415,HP_THINNING_OF_DESCEMET_MEMBRANE,0.99999
CHIBA_RESPONSE_TO_TSA_DN,SET,20,0.12375,0.0040824,0.19625,0.26416,CHIBA_RESPONSE_TO_TSA_DN,0.99999
GOBP_RESPONSE_TO_LIPOTEICHOI...,SET,10,0.17261,0.0040275,0.27375,0.26417,GOBP_RESPONSE_TO_LIPOTEICHOIC_ACID,0.99999
GOMF_VOLTAGE_GATED_SODIUM_CH...2,SET,5,0.27669,0.0045657,0.43882,0.26418,GOMF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.99999
GOBP_MUSCLE_CELL_DEVELOPMENT,SET,185,0.040402,0.0040353,0.064092,0.26423,GOBP_MUSCLE_CELL_DEVELOPMENT,0.99999
GOCC_STRIATED_MUSCLE_THIN_FI...,SET,21,0.11773,0.0039795,0.18677,0.26425,GOCC_STRIATED_MUSCLE_THIN_FILAMENT,0.99999
MIR6833_5P,SET,119,0.049573,0.0039783,0.07866,0.26428,MIR6833_5P,0.99999
MIR6883_5P,SET,372,0.027954,0.0039387,0.044358,0.26429,MIR6883_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...391,SET,4,0.27137,0.0040053,0.43063,0.26429,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_APOPTOTIC_PROCESS,0.99999
MIR4276,SET,243,0.034911,0.0039898,0.0554,0.2643,MIR4276,0.99999
GSE3400_UNTREATED_VS_IFNB_TR...2,SET,167,0.041312,0.0039222,0.06556,0.26431,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_UP,0.99999
MIR3668,SET,95,0.054299,0.003896,0.086181,0.26433,MIR3668,0.99999
GSE46606_IRF4_KO_VS_WT_CD40L...2,SET,170,0.043055,0.004124,0.06837,0.26444,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_UP,0.99999
GSE30083_SP2_VS_SP3_THYMOCYT...1,SET,183,0.040769,0.0040502,0.064762,0.26451,GSE30083_SP2_VS_SP3_THYMOCYTE_DN,0.99999
GOMF_ATPASE_COUPLED_MONOATOM...,SET,49,0.079342,0.0040936,0.12605,0.26452,GOMF_ATPASE_COUPLED_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
chr4q24,SET,24,0.21185,0.0076547,0.33657,0.26454,chr4q24,0.99999
MAGRANGEAS_MULTIPLE_MYELOMA_...2,SET,16,0.13927,0.0041098,0.22128,0.26455,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP,0.99999
GOBP_ENDOTHELIN_RECEPTOR_SIG...,SET,10,0.18829,0.0043934,0.29928,0.26463,GOBP_ENDOTHELIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
STAT_01,SET,233,0.035817,0.0040094,0.056932,0.26464,STAT_01,0.99999
MIR1261,SET,76,0.060521,0.003886,0.096203,0.26465,MIR1261,0.99999
GSE24081_CONTROLLER_VS_PROGR...1,SET,173,0.042339,0.0040907,0.067311,0.26468,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN,0.99999
GOBP_NEUTROPHIL_MIGRATION,SET,96,0.060764,0.0043826,0.096614,0.2647,GOBP_NEUTROPHIL_MIGRATION,0.99999
GSE13522_CTRL_VS_T_CRUZI_BRA...1,SET,181,0.041007,0.0040517,0.065235,0.26481,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN,0.99999
VALK_AML_CLUSTER_15,SET,28,0.10975,0.0042829,0.1746,0.26482,VALK_AML_CLUSTER_15,0.99999
chr5q14,SET,46,0.13238,0.0066181,0.2107,0.26492,chr5q14,0.99999
MIR487A_5P,SET,94,0.053461,0.0038157,0.085108,0.26496,MIR487A_5P,0.99999
MIR487B_5P,SET,94,0.053461,0.0038157,0.085108,0.26496,MIR487B_5P,0.99999
GSE15139_GMCSF_TREATED_VS_UN...2,SET,180,0.038817,0.0038248,0.0618,0.26497,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP,0.99999
MODULE_164,SET,58,0.075217,0.0042211,0.11976,0.26498,MODULE_164,0.99999
GOCC_METHYLOSOME,SET,13,0.13617,0.0036224,0.21682,0.26499,GOCC_METHYLOSOME,0.99999
DESCARTES_FETAL_MUSCLE_SKELE...,SET,181,0.041108,0.0040616,0.065453,0.26499,DESCARTES_FETAL_MUSCLE_SKELETAL_MUSCLE_CELLS,0.99999
GREB1_TARGET_GENES,SET,682,0.021177,0.0040052,0.033722,0.26501,GREB1_TARGET_GENES,0.99999
HP_ONYCHOLYSIS,SET,20,0.12233,0.0040355,0.1948,0.26501,HP_ONYCHOLYSIS,0.99999
GOBP_OMEGA_HYDROXYLASE_P450_...,SET,11,0.17858,0.0043701,0.28441,0.26504,GOBP_OMEGA_HYDROXYLASE_P450_PATHWAY,0.99999
GOCC_CASPASE_COMPLEX,SET,10,0.15208,0.0035484,0.24221,0.26505,GOCC_CASPASE_COMPLEX,0.99999
GOBP_NEGATIVE_REGULATION_OF_...530,SET,35,0.091396,0.0039869,0.14562,0.26513,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.99999
GSE2770_TGFB_AND_IL4_VS_IL12...4,SET,173,0.0398,0.0038454,0.06342,0.26515,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.99999
GSE3982_MAC_VS_NEUTROPHIL_LP...2,SET,173,0.039813,0.0038466,0.063448,0.26517,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP,0.99999
CERIBELLI_PROMOTERS_INACTIVE...,SET,30,0.10367,0.0041876,0.16524,0.26519,CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY,0.99999
GOBP_MONOCARBOXYLIC_ACID_CAT...,SET,125,0.047323,0.0038916,0.075421,0.26519,GOBP_MONOCARBOXYLIC_ACID_CATABOLIC_PROCESS,0.99999
GSE23321_CD8_STEM_CELL_MEMOR...4,SET,177,0.039181,0.0038287,0.06245,0.2652,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,0.99999
RUTELLA_RESPONSE_TO_HGF_UP,SET,377,0.029014,0.004115,0.046253,0.26523,RUTELLA_RESPONSE_TO_HGF_UP,0.99999
HP_SPARSE_OR_ABSENT_EYELASHES,SET,80,0.062008,0.0040844,0.098847,0.26523,HP_SPARSE_OR_ABSENT_EYELASHES,0.99999
HELLER_SILENCED_BY_METHYLATI...1,SET,100,0.05801,0.0042698,0.092496,0.26528,HELLER_SILENCED_BY_METHYLATION_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...500,SET,46,0.082027,0.0041009,0.13082,0.26533,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CONTRACTION,0.99999
HP_PULMONARY_ARTERY_HYPOPLAS...,SET,8,0.21693,0.0045275,0.34599,0.26534,HP_PULMONARY_ARTERY_HYPOPLASIA,0.99999
GOBP_DICARBOXYLIC_ACID_METAB...,SET,89,0.055799,0.0038757,0.088999,0.26535,GOBP_DICARBOXYLIC_ACID_METABOLIC_PROCESS,0.99999
GSE21546_WT_VS_ELK1_KO_DP_TH...2,SET,183,0.03929,0.0039032,0.062668,0.26535,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP,0.99999
HP_OVERRIDING_AORTA,SET,21,0.13522,0.0045709,0.21576,0.26542,HP_OVERRIDING_AORTA,0.99999
GOCC_PARALLEL_FIBER_TO_PURKI...,SET,17,0.12929,0.0039327,0.20633,0.26546,GOCC_PARALLEL_FIBER_TO_PURKINJE_CELL_SYNAPSE,0.99999
KEGG_MEDICUS_REFERENCE_TLR2_...,SET,25,0.11522,0.0042492,0.18395,0.26554,KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY,0.99999
GOMF_NAD_DEPENDENT_HISTONE_D...,SET,5,0.22543,0.0037199,0.35999,0.26559,GOMF_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY,0.99999
GOCC_AZUROPHIL_GRANULE,SET,139,0.044631,0.0038689,0.071277,0.26561,GOCC_AZUROPHIL_GRANULE,0.99999
GRAESSMANN_APOPTOSIS_BY_DOXO...2,SET,1054,0.016885,0.0039281,0.026981,0.26572,GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP,0.99999
SANSOM_WNT_PATHWAY_REQUIRE_M...,SET,60,0.074976,0.0042793,0.11983,0.26577,SANSOM_WNT_PATHWAY_REQUIRE_MYC,0.99999
HP_ABNORMAL_BLOOD_SODIUM_CON...,SET,63,0.072749,0.0042544,0.11628,0.26578,HP_ABNORMAL_BLOOD_SODIUM_CONCENTRATION,0.99999
GOMF_3_CHLOROALLYL_ALDEHYDE_...,SET,5,0.20748,0.0034237,0.33178,0.26587,GOMF_3_CHLOROALLYL_ALDEHYDE_DEHYDROGENASE_ACTIVITY,0.99999
HP_THROMBOCYTOSIS,SET,55,0.069665,0.0038074,0.11143,0.26592,HP_THROMBOCYTOSIS,0.99999
KEGG_MEDICUS_REFERENCE_TRANS...4,SET,5,0.25344,0.004182,0.40541,0.26595,KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM,0.99999
GOMF_L_SERINE_TRANSMEMBRANE_...,SET,8,0.19025,0.0039707,0.30435,0.26595,GOMF_L_SERINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_REGULATION_OF_NON_CANON...1,SET,87,0.057028,0.0039165,0.091239,0.26598,GOBP_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.99999
WANG_RESPONSE_TO_BEXAROTENE_...2,SET,31,0.0899,0.0036911,0.14384,0.26599,WANG_RESPONSE_TO_BEXAROTENE_UP,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HR...3,SET,385,0.029301,0.0041985,0.046883,0.266,MANNO_MIDBRAIN_NEUROTYPES_HRGL2B,0.99999
REACTOME_FREE_FATTY_ACIDS_RE...,SET,10,0.18545,0.0043271,0.29675,0.26601,REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION,0.99999
GOBP_REGULATION_OF_RESPONSE_...11,SET,1248,0.015515,0.0039054,0.024827,0.26601,GOBP_REGULATION_OF_RESPONSE_TO_STRESS,0.99999
chr1q22,SET,43,0.1348,0.0065165,0.21572,0.26602,chr1q22,0.99999
GOBP_TRANSCRIPTION_BY_RNA_PO...1,SET,58,0.06343,0.0035597,0.1015,0.26602,GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.99999
GSE45837_WT_VS_GFI1_KO_PDC_UP,SET,164,0.040689,0.0038286,0.065117,0.26604,GSE45837_WT_VS_GFI1_KO_PDC_UP,0.99999
SCHERER_PBMC_APSV_WETVAX_AGE...2,SET,57,0.074097,0.0041224,0.11863,0.26612,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_2_TO_4DY_UP,0.99999
VOIGT_PBMC_FLUARIX_AGE_50_74...,SET,18,0.13508,0.0042277,0.21631,0.26616,VOIGT_PBMC_FLUARIX_AGE_50_74YO_FEMALES_VS_MALES_0DY_TO_28D_UP,0.99999
HMX1_01,SET,39,0.088061,0.0040545,0.14102,0.26617,HMX1_01,0.99999
KEGG_MEDICUS_REFERENCE_HOMOL...2,SET,12,0.13983,0.003574,0.22394,0.26618,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION_IN_ICLR,0.99999
GOBP_NEGATIVE_REGULATION_OF_...664,SET,15,0.15075,0.0043073,0.24142,0.26618,GOBP_NEGATIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,0.99999
GOBP_TOOTH_MINERALIZATION,SET,28,0.10655,0.0041581,0.17067,0.26621,GOBP_TOOTH_MINERALIZATION,0.99999
GOMF_PROTEIN_DOMAIN_SPECIFIC...,SET,599,0.021697,0.0038548,0.034756,0.26623,GOMF_PROTEIN_DOMAIN_SPECIFIC_BINDING,0.99999
KIM_MYCL1_AMPLIFICATION_TARG...2,SET,12,0.173,0.0044215,0.27714,0.26624,KIM_MYCL1_AMPLIFICATION_TARGETS_UP,0.99999
GOBP_LEUKOTRIENE_SIGNALING_P...,SET,4,0.24342,0.0035927,0.39,0.26627,GOBP_LEUKOTRIENE_SIGNALING_PATHWAY,0.99999
GOMF_INTERLEUKIN_2_RECEPTOR_...,SET,5,0.22859,0.003772,0.36639,0.26635,GOMF_INTERLEUKIN_2_RECEPTOR_BINDING,0.99999
GSE11961_MEMORY_BCELL_DAY7_V...6,SET,180,0.040156,0.0039567,0.064363,0.26635,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.99999
ROSS_AML_OF_FAB_M7_TYPE,SET,61,0.069606,0.0040057,0.11158,0.26638,ROSS_AML_OF_FAB_M7_TYPE,0.99999
DORN_ADENOVIRUS_INFECTION_12...2,SET,23,0.10466,0.0037024,0.16782,0.26642,DORN_ADENOVIRUS_INFECTION_12HR_UP,0.99999
HP_VEIN_OF_GALEN_ANEURYSMAL_...,SET,5,0.2316,0.0038217,0.37134,0.26642,HP_VEIN_OF_GALEN_ANEURYSMAL_MALFORMATION,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...15,SET,174,0.043571,0.0042217,0.06986,0.26642,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN,0.99999
GOBP_NATURAL_KILLER_CELL_MED...1,SET,9,0.19151,0.0042393,0.30721,0.26652,GOBP_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.99999
MENON_FETAL_KIDNEY_1_EMBRYON...,SET,83,0.056749,0.0038072,0.091032,0.26652,MENON_FETAL_KIDNEY_1_EMBRYONIC_RED_BLOOD_CELLS,0.99999
GOMF_POLYOL_TRANSMEMBRANE_TR...,SET,11,0.19276,0.0047171,0.30923,0.26653,GOMF_POLYOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_LOW_GRADE_FEVER,SET,11,0.17514,0.0042859,0.28099,0.26655,HP_LOW_GRADE_FEVER,0.99999
GOBP_CEREBROSPINAL_FLUID_CIR...,SET,9,0.18834,0.0041692,0.30222,0.26658,GOBP_CEREBROSPINAL_FLUID_CIRCULATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...235,SET,9,0.15644,0.0034629,0.25114,0.26667,GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOBP_DITERPENOID_METABOLIC_P...,SET,86,0.064162,0.0043812,0.10303,0.26672,GOBP_DITERPENOID_METABOLIC_PROCESS,0.99999
ZHONG_PFC_C3_PROX1_CCK_POS_I...,SET,10,0.20549,0.0047947,0.32997,0.26673,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,0.99999
OSWALD_HEMATOPOIETIC_STEM_CE...2,SET,208,0.038463,0.0040709,0.061767,0.26674,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,0.99999
GOCC_CONDENSED_NUCLEAR_CHROM...,SET,70,0.057908,0.003569,0.093004,0.26677,GOCC_CONDENSED_NUCLEAR_CHROMOSOME,0.99999
GOBP_PROTEIN_K11_LINKED_UBIQ...,SET,31,0.089761,0.0036854,0.14417,0.26678,GOBP_PROTEIN_K11_LINKED_UBIQUITINATION,0.99999
GSE42021_TREG_VS_TCONV_PLN_DN,SET,179,0.039884,0.0039191,0.064064,0.26679,GSE42021_TREG_VS_TCONV_PLN_DN,0.99999
GSE22432_CDC_VS_COMMON_DC_PR...2,SET,175,0.040549,0.0039401,0.065143,0.26682,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP,0.99999
GOBP_ACETYLCHOLINE_SECRETION,SET,5,0.23564,0.0038883,0.37866,0.26687,GOBP_ACETYLCHOLINE_SECRETION,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...42,SET,5,0.20473,0.0033783,0.32904,0.2669,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANGES_OF_THE_TOES,0.99999
GOBP_LACTATE_METABOLIC_PROCE...,SET,16,0.13047,0.00385,0.20969,0.26691,GOBP_LACTATE_METABOLIC_PROCESS,0.99999
GOMF_SUMO_LIGASE_ACTIVITY,SET,12,0.16271,0.0041585,0.26155,0.26695,GOMF_SUMO_LIGASE_ACTIVITY,0.99999
GSE45365_NK_CELL_VS_CD8_TCEL...2,SET,169,0.042174,0.0040278,0.067796,0.26695,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_DN,0.99999
GOBP_G_PROTEIN_COUPLED_ACETY...,SET,20,0.13201,0.004355,0.21223,0.26696,GOBP_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,0.99999
BANDRES_RESPONSE_TO_CARMUSTI...3,SET,148,0.044639,0.0039919,0.071765,0.26697,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,0.99999
HP_ABNORMALITY_THIGH_MUSCULA...,SET,15,0.14569,0.0041627,0.23437,0.2671,HP_ABNORMALITY_THIGH_MUSCULATURE_MORPHOLOGY,0.99999
HP_ESOPHAGEAL_ULCERATION,SET,7,0.19862,0.0038776,0.31959,0.26715,HP_ESOPHAGEAL_ULCERATION,0.99999
WP_PHOTODYNAMIC_THERAPYINDUC...2,SET,34,0.09262,0.0039822,0.14908,0.26721,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,0.99999
MODULE_214,SET,26,0.11151,0.0041935,0.17949,0.26722,MODULE_214,0.99999
GSE13411_NAIVE_VS_IGM_MEMORY...1,SET,183,0.038595,0.0038341,0.062129,0.26724,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN,0.99999
GOMF_ASPARTIC_TYPE_PEPTIDASE...,SET,25,0.10086,0.0037193,0.16241,0.2673,GOMF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY,0.99999
GOBP_STRIATED_MUSCLE_TISSUE_...,SET,239,0.036756,0.0041665,0.059189,0.26731,GOBP_STRIATED_MUSCLE_TISSUE_DEVELOPMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...429,SET,4,0.18838,0.0027803,0.30337,0.26733,GOBP_NEGATIVE_REGULATION_OF_MYOFIBROBLAST_DIFFERENTIATION,0.99999
GOBP_MAINTENANCE_OF_PROTEIN_...6,SET,5,0.25449,0.0041994,0.40993,0.26737,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_MITOCHONDRION,0.99999
HP_FOCAL_SEGMENTAL_GLOMERULO...,SET,51,0.073236,0.0038547,0.11798,0.26738,HP_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS,0.99999
KEGG_MEDICUS_REFERENCE_KERAT...,SET,5,0.25317,0.0041776,0.40791,0.26742,KEGG_MEDICUS_REFERENCE_KERATAN_SULFATE_DEGRADATION,0.99999
CRX_DN.V1_UP,SET,120,0.047463,0.0038248,0.076488,0.26746,CRX_DN.V1_UP,0.99999
KALMA_E2F1_TARGETS,SET,11,0.13747,0.0033642,0.22165,0.26755,KALMA_E2F1_TARGETS,0.99999
GSE12845_IGD_NEG_BLOOD_VS_NA...1,SET,182,0.038563,0.0038206,0.062174,0.26755,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...306,SET,3,0.35254,0.0045063,0.5684,0.26756,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_18_PRODUCTION,0.99999
GOBP_REGULATION_OF_MICROTUBU...1,SET,47,0.080349,0.0040603,0.12959,0.26763,GOBP_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT,0.99999
MANNE_COVID19_NONICU_VS_HEAL...2,SET,129,0.045749,0.0038215,0.073811,0.26769,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,0.99999
GOBP_TRANSCRIPTION_PREINITIA...,SET,64,0.060772,0.003582,0.098047,0.26769,GOBP_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY,0.99999
HP_FOCAL_AUTONOMIC_SEIZURE,SET,11,0.15286,0.0037408,0.24665,0.26771,HP_FOCAL_AUTONOMIC_SEIZURE,0.99999
MIR8485,SET,922,0.018104,0.0039541,0.029212,0.26772,MIR8485,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...4,SET,188,0.038249,0.0038508,0.061746,0.26781,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...611,SET,46,0.078001,0.0038996,0.12595,0.26786,GOBP_POSITIVE_REGULATION_OF_PROTEIN_BINDING,0.99999
GOMF_CYTOCHROME_B5_REDUCTASE...,SET,6,0.19727,0.0035657,0.31856,0.26788,GOMF_CYTOCHROME_B5_REDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H,0.99999
MIR1269A_MIR1269B,SET,48,0.097549,0.0049815,0.15753,0.26789,MIR1269A_MIR1269B,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...23,SET,16,0.12844,0.0037902,0.20744,0.2679,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...545,SET,4,0.28133,0.0041523,0.45437,0.26791,GOBP_NEGATIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
HP_METAPHYSEAL_DYSPLASIA,SET,31,0.094777,0.0038914,0.15309,0.26793,HP_METAPHYSEAL_DYSPLASIA,0.99999
GOBP_L_LEUCINE_IMPORT_ACROSS...,SET,5,0.2372,0.0039141,0.38317,0.26795,GOBP_L_LEUCINE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GOBP_AXONAL_FASCICULATION,SET,20,0.1323,0.0043643,0.21375,0.26798,GOBP_AXONAL_FASCICULATION,0.99999
GOBP_SNRNA_3_END_PROCESSING,SET,18,0.11337,0.0035482,0.1832,0.26802,GOBP_SNRNA_3_END_PROCESSING,0.99999
GOBP_POSITIVE_REGULATION_OF_...627,SET,9,0.195,0.0043165,0.31514,0.26804,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING,0.99999
GSE23114_WT_VS_SLE2C1_MOUSE_...3,SET,181,0.038994,0.0038528,0.063036,0.26809,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN,0.99999
HP_ACNE_INVERSA,SET,11,0.13255,0.0032436,0.21428,0.26811,HP_ACNE_INVERSA,0.99999
GSE32423_IL7_VS_IL7_IL4_NAIV...2,SET,172,0.041369,0.0039855,0.066884,0.26812,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP,0.99999
REACTOME_DNA_DAMAGE_BYPASS,SET,44,0.070535,0.003449,0.11407,0.26817,REACTOME_DNA_DAMAGE_BYPASS,0.99999
HP_INSOMNIA,SET,62,0.06926,0.0040182,0.11202,0.26819,HP_INSOMNIA,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...4,SET,22,0.11893,0.0041147,0.19238,0.26822,GOCC_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE,0.99999
GOBP_MEMBRANE_DISASSEMBLY,SET,12,0.14969,0.0038259,0.24214,0.26823,GOBP_MEMBRANE_DISASSEMBLY,0.99999
GOBP_POSITIVE_REGULATION_OF_...561,SET,83,0.056318,0.0037783,0.091158,0.26835,GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,0.99999
MIR4476,SET,202,0.03771,0.0039338,0.061045,0.26838,MIR4476,0.99999
GOBP_RESPONSE_TO_STARVATION,SET,191,0.038649,0.0039217,0.062578,0.26842,GOBP_RESPONSE_TO_STARVATION,0.99999
ZHENG_CORD_BLOOD_C8_PUTATIVE...,SET,74,0.063904,0.0040491,0.10349,0.26846,ZHENG_CORD_BLOOD_C8_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_2,0.99999
MODULE_563,SET,13,0.14264,0.0037945,0.23103,0.26848,MODULE_563,0.99999
MIR503_3P,SET,36,0.093931,0.0041555,0.15214,0.2685,MIR503_3P,0.99999
GSE7831_UNSTIM_VS_CPG_STIM_P...2,SET,180,0.039796,0.0039212,0.064462,0.26851,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP,0.99999
AAGCACT_MIR520F,SET,219,0.035902,0.0038978,0.058158,0.26852,AAGCACT_MIR520F,0.99999
TTGCWCAAY_CEBPB_02,SET,60,0.070095,0.0040008,0.11356,0.26854,TTGCWCAAY_CEBPB_02,0.99999
GSE29618_BCELL_VS_PDC_DAY7_F...1,SET,181,0.040695,0.0040208,0.065954,0.26861,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN,0.99999
GOBP_DNA_TEMPLATED_DNA_REPLI...2,SET,54,0.067484,0.0036546,0.1094,0.26866,GOBP_DNA_TEMPLATED_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY,0.99999
GOBP_CORONARY_VASCULATURE_MO...,SET,17,0.13656,0.0041536,0.22139,0.26869,GOBP_CORONARY_VASCULATURE_MORPHOGENESIS,0.99999
MIR4510,SET,166,0.041217,0.0039016,0.066837,0.26873,MIR4510,0.99999
LINDGREN_BLADDER_CANCER_WITH...,SET,103,0.053104,0.0039666,0.086133,0.26877,LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,0.99999
YU_MYC_TARGETS_DN,SET,50,0.074347,0.0038747,0.12059,0.26878,YU_MYC_TARGETS_DN,0.99999
GSE17721_PAM3CSK4_VS_CPG_16H...1,SET,176,0.039755,0.0038738,0.064494,0.26882,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_DN,0.99999
KEGG_MEDICUS_REFERENCE_NRG_E...,SET,11,0.15428,0.0037753,0.25032,0.26884,KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_FETAL_GASTROINTE...,SET,17,0.13441,0.0040882,0.21811,0.26888,HP_ABNORMAL_FETAL_GASTROINTESTINAL_SYSTEM_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...690,SET,10,0.20843,0.0048632,0.33824,0.26889,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,0.99999
KEGG_MEDICUS_REFERENCE_DNA_D...,SET,6,0.22931,0.0041449,0.37228,0.26896,KEGG_MEDICUS_REFERENCE_DNA_DEGRADATION_BY_EXTRACELLULAR_ENDOLYSOSOMAL_DNASE,0.99999
HP_VENTRICULAR_SEPTAL_HYPERT...,SET,12,0.13986,0.0035747,0.22707,0.26897,HP_VENTRICULAR_SEPTAL_HYPERTROPHY,0.99999
GSE3982_NEUTROPHIL_VS_NKCELL...2,SET,179,0.039053,0.0038375,0.063418,0.26902,GSE3982_NEUTROPHIL_VS_NKCELL_UP,0.99999
GOBP_NUCLEOSIDE_METABOLIC_PR...,SET,50,0.084967,0.0044282,0.13799,0.26903,GOBP_NUCLEOSIDE_METABOLIC_PROCESS,0.99999
GSE27786_NKCELL_VS_NEUTROPHI...2,SET,184,0.038063,0.0037915,0.061823,0.26906,GSE27786_NKCELL_VS_NEUTROPHIL_UP,0.99999
GOBP_CYTOLYSIS,SET,6,0.29107,0.0052613,0.47285,0.26909,GOBP_CYTOLYSIS,0.99999
HP_PREDOMINANTLY_LOWER_LIMB_...,SET,8,0.18817,0.0039273,0.3057,0.2691,HP_PREDOMINANTLY_LOWER_LIMB_LYMPHEDEMA,0.99999
HP_SUPRAVALVULAR_AORTIC_STEN...,SET,26,0.11916,0.0044811,0.19359,0.26911,HP_SUPRAVALVULAR_AORTIC_STENOSIS,0.99999
MORF_RBM8A,SET,77,0.059338,0.0038349,0.096413,0.26913,MORF_RBM8A,0.99999
GSE18281_PERIMEDULLARY_CORTI...3,SET,156,0.042221,0.0038755,0.068641,0.26925,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,0.99999
GSE5542_UNTREATED_VS_IFNA_TR...4,SET,172,0.041733,0.0040206,0.067852,0.26926,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,0.99999
ZNF774_TARGET_GENES,SET,19,0.11344,0.0036476,0.18449,0.26932,ZNF774_TARGET_GENES,0.99999
HP_ANISOMETROPIA,SET,4,0.22426,0.0033099,0.3648,0.26937,HP_ANISOMETROPIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...699,SET,51,0.080515,0.0042378,0.13103,0.26945,GOBP_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,0.99999
MIR3689A_5P_MIR3689B_5P_MIR3...,SET,110,0.051231,0.0039538,0.083426,0.26958,MIR3689A_5P_MIR3689B_5P_MIR3689E_MIR3689F,0.99999
REACTOME_HDR_THROUGH_HOMOLOG...,SET,64,0.05869,0.0034593,0.095583,0.2696,REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,0.99999
MIR192_3P,SET,95,0.055739,0.0039993,0.090777,0.2696,MIR192_3P,0.99999
GSE24142_DN2_VS_DN3_THYMOCYT...6,SET,184,0.039178,0.0039026,0.063816,0.26963,GSE24142_DN2_VS_DN3_THYMOCYTE_UP,0.99999
HP_LIP_PIT,SET,9,0.18563,0.0041092,0.30251,0.26973,HP_LIP_PIT,0.99999
HP_LEFT_VENTRICULAR_DIASTOLI...,SET,7,0.19848,0.0038749,0.32346,0.26974,HP_LEFT_VENTRICULAR_DIASTOLIC_DYSFUNCTION,0.99999
GOBP_ANTIFUNGAL_INNATE_IMMUN...,SET,14,0.13069,0.0036078,0.21301,0.26975,GOBP_ANTIFUNGAL_INNATE_IMMUNE_RESPONSE,0.99999
GOBP_METANEPHRIC_TUBULE_MORP...,SET,10,0.17917,0.0041804,0.29201,0.26976,GOBP_METANEPHRIC_TUBULE_MORPHOGENESIS,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...15,SET,178,0.039042,0.0038257,0.063648,0.26981,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN,0.99999
MIR378E,SET,37,0.082216,0.0036873,0.13407,0.26987,MIR378E,0.99999
HP_EEG_WITH_SPIKE_WAVE_COMPL...2,SET,8,0.21592,0.0045065,0.35217,0.2699,HP_EEG_WITH_SPIKE_WAVE_COMPLEXES_2_5_3_5_HZ,0.99999
HP_METAPHYSEAL_WIDENING,SET,89,0.054538,0.0037882,0.08895,0.2699,HP_METAPHYSEAL_WIDENING,0.99999
GOBP_REGULATION_OF_SNARE_COM...,SET,13,0.14003,0.003725,0.22851,0.27,GOBP_REGULATION_OF_SNARE_COMPLEX_ASSEMBLY,0.99999
ZSCAN5DP_TARGET_GENES,SET,1192,0.015715,0.0038723,0.025646,0.27002,ZSCAN5DP_TARGET_GENES,0.99999
GOBP_POSITIVE_REGULATION_OF_...362,SET,33,0.084216,0.0035674,0.13747,0.27006,GOBP_POSITIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION,0.99999
IPF1_Q4,SET,216,0.037473,0.0040407,0.061172,0.27008,IPF1_Q4,0.99999
GOBP_SECONDARY_HEART_FIELD_S...,SET,11,0.18745,0.004587,0.30604,0.27011,GOBP_SECONDARY_HEART_FIELD_SPECIFICATION,0.99999
HP_TYPE_1_MUSCLE_FIBER_PREDO...,SET,60,0.064486,0.0036806,0.10531,0.27016,HP_TYPE_1_MUSCLE_FIBER_PREDOMINANCE,0.99999
GSE45365_NK_CELL_VS_BCELL_MC...2,SET,181,0.039155,0.0038687,0.063947,0.27017,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_UP,0.99999
ZBTB12_TARGET_GENES,SET,1036,0.016552,0.0038195,0.027044,0.27026,ZBTB12_TARGET_GENES,0.99999
HP_BRANCHIAL_ANOMALY,SET,16,0.12145,0.0035838,0.19844,0.27027,HP_BRANCHIAL_ANOMALY,0.99999
GSE25890_CTRL_VS_IL33_IL7_TR...2,SET,179,0.039021,0.0038343,0.063777,0.27033,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_UP,0.99999
PKCA_DN.V1_UP,SET,143,0.04368,0.0038401,0.071409,0.27037,PKCA_DN.V1_UP,0.99999
GOBP_NEURON_PROJECTION_ARBOR...,SET,32,0.090007,0.0037546,0.14716,0.27039,GOBP_NEURON_PROJECTION_ARBORIZATION,0.99999
HP_RETINAL_ARTERIOLAR_TORTUO...,SET,27,0.10952,0.0041969,0.17906,0.2704,HP_RETINAL_ARTERIOLAR_TORTUOSITY,0.99999
GSE5542_UNTREATED_VS_IFNG_TR...4,SET,171,0.040048,0.0038471,0.065492,0.27044,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.99999
REACTOME_SYNTHESIS_OF_IP2_IP...,SET,13,0.12084,0.0032144,0.19761,0.27045,REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL,0.99999
GSE14026_TH1_VS_TH17_DN,SET,179,0.038342,0.0037676,0.062711,0.27047,GSE14026_TH1_VS_TH17_DN,0.99999
GOBP_REGULATION_OF_LYSOSOMAL...,SET,27,0.1004,0.0038477,0.16423,0.27049,GOBP_REGULATION_OF_LYSOSOMAL_LUMEN_PH,0.99999
HP_FOCAL_MOTOR_SEIZURE,SET,100,0.053271,0.0039209,0.087141,0.2705,HP_FOCAL_MOTOR_SEIZURE,0.99999
REACTOME_TRANSPORT_OF_INORGA...,SET,103,0.053956,0.0040302,0.088289,0.27056,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,0.99999
HP_SCOTOMA,SET,69,0.064048,0.0039192,0.1048,0.27056,HP_SCOTOMA,0.99999
GSE42021_TREG_PLN_VS_CD24INT...1,SET,184,0.039936,0.0039781,0.065348,0.27056,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN,0.99999
HP_UNUSUAL_INFECTION,SET,917,0.017814,0.0038807,0.029178,0.27076,HP_UNUSUAL_INFECTION,0.99999
BURTON_ADIPOGENESIS_6,SET,174,0.038283,0.0037094,0.062728,0.27083,BURTON_ADIPOGENESIS_6,0.99999
GOMF_DEHYDROASCORBIC_ACID_TR...,SET,6,0.19594,0.0035417,0.32113,0.27088,GOMF_DEHYDROASCORBIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MODULE_48,SET,293,0.030935,0.0038768,0.050709,0.27092,MODULE_48,0.99999
COATES_MACROPHAGE_M1_VS_M2_UP,SET,80,0.061617,0.0040587,0.10101,0.27093,COATES_MACROPHAGE_M1_VS_M2_UP,0.99999
WP_GASTRIC_ACID_PRODUCTION,SET,8,0.20489,0.0042762,0.33588,0.27093,WP_GASTRIC_ACID_PRODUCTION,0.99999
GSE10325_CD4_TCELL_VS_MYELOI...2,SET,179,0.039779,0.0039087,0.065232,0.271,GSE10325_CD4_TCELL_VS_MYELOID_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...740,SET,10,0.15579,0.003635,0.25563,0.27112,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_PLASTICITY,0.99999
HP_NEONATAL_OMPHALITIS,SET,10,0.18315,0.0042734,0.30056,0.27115,HP_NEONATAL_OMPHALITIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...516,SET,25,0.116,0.0042778,0.19042,0.27121,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,0.99999
GSE37532_WT_VS_PPARG_KO_VISC...1,SET,180,0.037837,0.0037282,0.062114,0.27122,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN,0.99999
GSE41867_DAY6_EFFECTOR_VS_DA...4,SET,183,0.038576,0.0038323,0.06334,0.27125,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,0.99999
GSE7460_TCONV_VS_TREG_THYMUS...2,SET,182,0.038623,0.0038265,0.063448,0.27136,GSE7460_TCONV_VS_TREG_THYMUS_UP,0.99999
CAO_BLOOD_FLUMIST_AGE_05_14Y...6,SET,7,0.2024,0.0039515,0.3325,0.27136,CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_UP,0.99999
GSE1740_UNSTIM_VS_IFNA_STIMU...3,SET,166,0.040059,0.0037921,0.065812,0.27137,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN,0.99999
GSE13522_CTRL_VS_T_CRUZI_BRA...2,SET,130,0.047584,0.00399,0.078182,0.27139,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP,0.99999
HP_EXCESSIVE_SHYNESS,SET,8,0.15649,0.0032661,0.25714,0.2714,HP_EXCESSIVE_SHYNESS,0.99999
MIR552_5P,SET,175,0.040075,0.003894,0.065858,0.27143,MIR552_5P,0.99999
MORF_PPP2R5E,SET,72,0.055346,0.0034593,0.090957,0.27144,MORF_PPP2R5E,0.99999
FONTAINE_THYROID_TUMOR_UNCER...1,SET,26,0.10708,0.0040268,0.17603,0.27151,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN,0.99999
MORF_CCNF,SET,72,0.056131,0.0035084,0.092283,0.27151,MORF_CCNF,0.99999
HP_DECREASED_URINARY_POTASSI...,SET,4,0.27908,0.0041191,0.45889,0.27154,HP_DECREASED_URINARY_POTASSIUM,0.99999
GOCC_MICROBODY_MEMBRANE,SET,57,0.066419,0.0036952,0.10923,0.27157,GOCC_MICROBODY_MEMBRANE,0.99999
GOBP_REGULATION_OF_ADAPTIVE_...,SET,191,0.040084,0.0040673,0.065924,0.27159,GOBP_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,0.99999
PID_MYC_ACTIV_PATHWAY,SET,77,0.059036,0.0038154,0.097102,0.2716,PID_MYC_ACTIV_PATHWAY,0.99999
REACTOME_PI3K_EVENTS_IN_ERBB...1,SET,16,0.13432,0.0039637,0.22093,0.27161,REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,0.99999
GOBP_POSITIVE_REGULATION_OF_...616,SET,6,0.1962,0.0035465,0.32272,0.27161,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEACETYLATION,0.99999
SNAPC4_TARGET_GENES,SET,60,0.065043,0.0037124,0.10703,0.2717,SNAPC4_TARGET_GENES,0.99999
MIR5009_5P,SET,56,0.075102,0.0041416,0.12359,0.27171,MIR5009_5P,0.99999
GSE15624_CTRL_VS_3H_HALOFUGI...2,SET,147,0.042402,0.0037791,0.069788,0.27173,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.99999
TRAVAGLINI_LUNG_ALVEOLAR_EPI...1,SET,363,0.029257,0.0040732,0.048156,0.27175,TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL,0.99999
WP_HEART_DEVELOPMENT,SET,42,0.09002,0.0043008,0.14818,0.27176,WP_HEART_DEVELOPMENT,0.99999
GOBP_KERATINOCYTE_DEVELOPMENT,SET,13,0.15768,0.0041946,0.25964,0.27183,GOBP_KERATINOCYTE_DEVELOPMENT,0.99999
HP_REDUNDANT_NECK_SKIN,SET,28,0.093009,0.0036296,0.15316,0.27184,HP_REDUNDANT_NECK_SKIN,0.99999
KIM_RESPONSE_TO_TSA_AND_DECI...1,SET,8,0.16342,0.0034106,0.26916,0.27189,KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN,0.99999
MIR1973,SET,6,0.22214,0.0040153,0.36592,0.2719,MIR1973,0.99999
DESCARTES_FETAL_SPLEEN_MEGAK...,SET,88,0.05746,0.0039687,0.094662,0.27193,DESCARTES_FETAL_SPLEEN_MEGAKARYOCYTES,0.99999
MIR551B_5P,SET,451,0.025773,0.0039897,0.042468,0.27197,MIR551B_5P,0.99999
MIR4727_5P,SET,103,0.053661,0.0040081,0.088427,0.27198,MIR4727_5P,0.99999
GSE37301_MULTIPOTENT_PROGENI...12,SET,182,0.037558,0.0037211,0.061899,0.27201,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,0.99999
TFAM_TARGET_GENES,SET,2,0.3785,0.0039504,0.62417,0.27213,TFAM_TARGET_GENES,0.99999
GOMF_SPHINGOSINE_1_PHOSPHATE...1,SET,2,0.39365,0.0041085,0.64923,0.27215,GOMF_SPHINGOSINE_1_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.99999
GOMF_UDP_GLYCOSYLTRANSFERASE...,SET,132,0.050024,0.0042265,0.082515,0.27218,GOMF_UDP_GLYCOSYLTRANSFERASE_ACTIVITY,0.99999
GSE21927_BALBC_VS_C57BL6_MON...1,SET,148,0.042253,0.0037785,0.069699,0.27219,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_DN,0.99999
GOBP_APPENDAGE_MORPHOGENESIS,SET,139,0.048306,0.0041874,0.079698,0.27222,GOBP_APPENDAGE_MORPHOGENESIS,0.99999
GOBP_POST_EMBRYONIC_CAMERA_T...,SET,8,0.20886,0.004359,0.34457,0.27222,GOBP_POST_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT,0.99999
GSE19401_PAM2CSK4_VS_RETINOI...4,SET,179,0.037983,0.0037323,0.062664,0.27222,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,0.99999
GSE24210_TCONV_VS_TREG_UP,SET,184,0.037896,0.0037748,0.062521,0.27222,GSE24210_TCONV_VS_TREG_UP,0.99999
HP_JOINT_HYPERMOBILITY,SET,476,0.023677,0.0037628,0.039068,0.27224,HP_JOINT_HYPERMOBILITY,0.99999
HP_AGENESIS_OF_CENTRAL_INCIS...,SET,13,0.15579,0.0041443,0.25707,0.27225,HP_AGENESIS_OF_CENTRAL_INCISOR,0.99999
GOBP_MESENCHYMAL_STEM_CELL_M...,SET,6,0.25107,0.0045383,0.41451,0.27236,GOBP_MESENCHYMAL_STEM_CELL_MAINTENANCE_INVOLVED_IN_NEPHRON_MORPHOGENESIS,0.99999
HP_PREMATURE_PUBARCHE,SET,13,0.15949,0.0042428,0.2634,0.27242,HP_PREMATURE_PUBARCHE,0.99999
BYSTRYKH_HEMATOPOIESIS_STEM_...1,SET,64,0.059543,0.0035095,0.09835,0.27245,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS,0.99999
HP_BUTTERFLY_VERTEBRAE,SET,16,0.13151,0.0038807,0.21722,0.27246,HP_BUTTERFLY_VERTEBRAE,0.99999
GOMF_TFIID_CLASS_TRANSCRIPTI...,SET,10,0.16529,0.0038566,0.27306,0.27249,GOMF_TFIID_CLASS_TRANSCRIPTION_FACTOR_COMPLEX_BINDING,0.99999
GOBP_EMBRYONIC_SKELETAL_JOIN...2,SET,10,0.18525,0.0043224,0.30618,0.27258,GOBP_EMBRYONIC_SKELETAL_JOINT_MORPHOGENESIS,0.99999
HAY_BONE_MARROW_PRO_B,SET,255,0.03124,0.0036562,0.051632,0.27258,HAY_BONE_MARROW_PRO_B,0.99999
GOBP_CARDIAC_NEURAL_CREST_CE...2,SET,15,0.15542,0.0044409,0.2571,0.27275,GOBP_CARDIAC_NEURAL_CREST_CELL_DIFFERENTIATION_INVOLVED_IN_HEART_DEVELOPMENT,0.99999
MIR4737,SET,4,0.2603,0.0038419,0.4307,0.2728,MIR4737,0.99999
LI_PBMC_MENOMUNE_A_C_Y_W_135...2,SET,27,0.10785,0.0041331,0.17854,0.2729,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_UP,0.99999
MSX1_01,SET,158,0.044614,0.004121,0.073858,0.27291,MSX1_01,0.99999
REACTOME_GENE_AND_PROTEIN_EX...,SET,35,0.080964,0.0035318,0.13405,0.27293,REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,0.99999
GOBP_MAINTENANCE_OF_GASTROIN...,SET,21,0.12811,0.0043304,0.21214,0.27296,GOBP_MAINTENANCE_OF_GASTROINTESTINAL_EPITHELIUM,0.99999
GOBP_CARDIOLIPIN_METABOLIC_P...,SET,13,0.16124,0.0042891,0.26709,0.27303,GOBP_CARDIOLIPIN_METABOLIC_PROCESS,0.99999
MIR1204,SET,6,0.21774,0.0039357,0.36071,0.27305,MIR1204,0.99999
HP_DISTURBANCE_OF_FACIAL_EXP...,SET,40,0.082227,0.003834,0.13622,0.27305,HP_DISTURBANCE_OF_FACIAL_EXPRESSION,0.99999
GATA4_Q3,SET,224,0.036318,0.0039872,0.060178,0.27309,GATA4_Q3,0.99999
ODONNELL_TFRC_TARGETS_UP,SET,329,0.028849,0.0038273,0.047807,0.27311,ODONNELL_TFRC_TARGETS_UP,0.99999
GOBP_INTERLEUKIN_18_MEDIATED...,SET,10,0.18141,0.0042328,0.30062,0.27311,GOBP_INTERLEUKIN_18_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_RESPONSE_TO_FUNGICIDE,SET,7,0.17409,0.0033989,0.28857,0.27316,GOBP_RESPONSE_TO_FUNGICIDE,0.99999
GOCC_GOLGI_STACK,SET,125,0.045579,0.0037482,0.075552,0.27317,GOCC_GOLGI_STACK,0.99999
MIR4999_5P,SET,81,0.05759,0.003817,0.095475,0.27319,MIR4999_5P,0.99999
HP_ABNORMALITY_OF_COORDINATI...,SET,1040,0.016085,0.0037183,0.026667,0.27321,HP_ABNORMALITY_OF_COORDINATION,0.99999
REACTOME_IKBA_VARIANT_LEADS_...,SET,6,0.19235,0.0034769,0.31893,0.27322,REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID,0.99999
GOBP_POSITIVE_REGULATION_OF_...441,SET,5,0.2225,0.0036715,0.36903,0.27328,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION,0.99999
MODULE_392,SET,14,0.13771,0.0038015,0.22848,0.27335,MODULE_392,0.99999
GOCC_PROTEIN_COMPLEX_INVOLVE...1,SET,55,0.072607,0.0039682,0.1205,0.27341,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_ADHESION,0.99999
GOBP_OUTFLOW_TRACT_MORPHOGEN...,SET,75,0.068525,0.004371,0.11376,0.27348,GOBP_OUTFLOW_TRACT_MORPHOGENESIS,0.99999
REACTOME_SYNTHESIS_OF_PROSTA...,SET,14,0.13206,0.0036454,0.21925,0.27349,REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX,0.99999
BILANGES_SERUM_SENSITIVE_VIA...2,SET,24,0.10272,0.0037116,0.1706,0.27355,BILANGES_SERUM_SENSITIVE_VIA_TSC2,0.99999
GOBP_PROTEIN_AUTOPHOSPHORYLA...,SET,175,0.040508,0.0039361,0.067278,0.27356,GOBP_PROTEIN_AUTOPHOSPHORYLATION,0.99999
MIR6895_3P,SET,85,0.056906,0.0038632,0.094548,0.27363,MIR6895_3P,0.99999
HP_HYPOREFLEXIA_OF_UPPER_LIM...,SET,7,0.2231,0.0043557,0.37072,0.27365,HP_HYPOREFLEXIA_OF_UPPER_LIMBS,0.99999
NAKAYA_PBMC_FLUMIST_AGE_18_5...6,SET,31,0.092304,0.0037898,0.15338,0.27366,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_UP,0.99999
HP_ABSENT_PATELLAR_REFLEXES,SET,11,0.16385,0.0040096,0.27228,0.27367,HP_ABSENT_PATELLAR_REFLEXES,0.99999
REACTOME_INTERLEUKIN_36_PATH...,SET,7,0.28771,0.0056171,0.47816,0.27369,REACTOME_INTERLEUKIN_36_PATHWAY,0.99999
MATSUMIYA_PBMC_MODIFIED_VACC...4,SET,81,0.057521,0.0038124,0.095611,0.27372,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_MVA85A_6HR_UP,0.99999
MIR1226_5P,SET,40,0.079233,0.0036944,0.13175,0.2738,MIR1226_5P,0.99999
HU_FETAL_RETINA_RGC,SET,393,0.026759,0.0038731,0.044496,0.2738,HU_FETAL_RETINA_RGC,0.99999
KEGG_MEDICUS_REFERENCE_RELN_...,SET,15,0.13671,0.0039062,0.22743,0.27389,KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY,0.99999
HP_PREMATURE_ARTERIOSCLEROSIS,SET,8,0.21453,0.0044773,0.35692,0.27391,HP_PREMATURE_ARTERIOSCLEROSIS,0.99999
BONOME_OVARIAN_CANCER_POOR_S...1,SET,19,0.10415,0.0033489,0.1733,0.27393,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN,0.99999
GOBP_REGULATION_OF_TRANSCRIP...2,SET,39,0.073277,0.0033739,0.12197,0.27399,GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.99999
MODULE_62,SET,67,0.053596,0.0032319,0.089228,0.27403,MODULE_62,0.99999
GOBP_POSITIVE_REGULATION_OF_...579,SET,9,0.20541,0.0045469,0.34197,0.27404,GOBP_POSITIVE_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.99999
DESCARTES_MAIN_FETAL_OLIGODE...,SET,40,0.089472,0.0041718,0.14895,0.27404,DESCARTES_MAIN_FETAL_OLIGODENDROCYTES,0.99999
GOBP_URINARY_TRACT_SMOOTH_MU...,SET,9,0.18444,0.0040827,0.30711,0.27407,GOBP_URINARY_TRACT_SMOOTH_MUSCLE_CONTRACTION,0.99999
GOBP_CRANIAL_NERVE_MORPHOGEN...,SET,29,0.10572,0.0041986,0.17604,0.27408,GOBP_CRANIAL_NERVE_MORPHOGENESIS,0.99999
VALK_AML_CLUSTER_10,SET,28,0.10402,0.0040595,0.17324,0.27411,VALK_AML_CLUSTER_10,0.99999
DBP_TARGET_GENES,SET,1180,0.015369,0.0037692,0.025601,0.27414,DBP_TARGET_GENES,0.99999
GCM_DENR,SET,49,0.067189,0.0034666,0.11192,0.27415,GCM_DENR,0.99999
HP_PROMINENT_EAR_HELIX,SET,6,0.22809,0.0041229,0.37997,0.27416,HP_PROMINENT_EAR_HELIX,0.99999
HP_METAPHYSEAL_CUPPING,SET,14,0.14177,0.0039135,0.23618,0.27417,HP_METAPHYSEAL_CUPPING,0.99999
GOBP_RESPONSE_TO_MUSCLE_STRE...,SET,24,0.1062,0.0038375,0.17699,0.27424,GOBP_RESPONSE_TO_MUSCLE_STRETCH,0.99999
GOMF_TAP_BINDING,SET,7,0.208,0.0040608,0.34663,0.27424,GOMF_TAP_BINDING,0.99999
DCA_UP.V1_UP,SET,161,0.042329,0.0039466,0.070551,0.27426,DCA_UP.V1_UP,0.99999
HP_HYPOPLASIA_OF_THE_UTERUS,SET,47,0.077104,0.0038963,0.12855,0.27432,HP_HYPOPLASIA_OF_THE_UTERUS,0.99999
REACTOME_REGULATION_OF_PTEN_...1,SET,57,0.065692,0.0036548,0.10952,0.27433,REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION,0.99999
MIR6804_5P,SET,66,0.062146,0.0037196,0.10361,0.27433,MIR6804_5P,0.99999
HP_FOOT_ACROOSTEOLYSIS,SET,7,0.1982,0.0038696,0.33057,0.2744,HP_FOOT_ACROOSTEOLYSIS,0.99999
WANG_SMARCE1_TARGETS_DN,SET,322,0.02927,0.0038424,0.04883,0.27444,WANG_SMARCE1_TARGETS_DN,0.99999
GOBP_ASTROCYTE_DEVELOPMENT,SET,40,0.086289,0.0040235,0.14394,0.27444,GOBP_ASTROCYTE_DEVELOPMENT,0.99999
GOBP_COMMON_BILE_DUCT_DEVELO...,SET,5,0.23989,0.0039584,0.40019,0.27445,GOBP_COMMON_BILE_DUCT_DEVELOPMENT,0.99999
GOBP_AMINO_ACID_BETAINE_META...,SET,16,0.12897,0.0038059,0.21524,0.27452,GOBP_AMINO_ACID_BETAINE_METABOLIC_PROCESS,0.99999
GOBP_G1_TO_G0_TRANSITION,SET,18,0.11282,0.003531,0.18834,0.27458,GOBP_G1_TO_G0_TRANSITION,0.99999
GOBP_POSITIVE_REGULATION_OF_...10,SET,26,0.10459,0.0039333,0.17461,0.27459,GOBP_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,0.99999
HOEK_MONOCYTE_2011_2012_TIV_...5,SET,9,0.20011,0.0044297,0.33407,0.27459,HOEK_MONOCYTE_2011_2012_TIV_ADULT_7DY_DN,0.99999
WP_HIJACK_OF_UBIQUITINATION_...,SET,6,0.17768,0.0032117,0.29665,0.27461,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,0.99999
GSE14415_FOXP3_KO_NATURAL_TR...2,SET,153,0.041547,0.0037771,0.069373,0.27462,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP,0.99999
MSX1_TARGET_GENES,SET,167,0.040168,0.0038137,0.067086,0.27467,MSX1_TARGET_GENES,0.99999
GOBP_POSITIVE_REGULATION_OF_...187,SET,26,0.10363,0.003897,0.17311,0.27472,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.99999
GSE5503_LIVER_DC_VS_SPLEEN_D...2,SET,182,0.038454,0.0038098,0.064242,0.27473,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.99999
GSE40666_WT_VS_STAT1_KO_CD8_...2,SET,181,0.039291,0.0038821,0.065645,0.27474,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP,0.99999
GSE23984_CTRL_VS_HYPOCALEMIC...2,SET,176,0.037197,0.0036246,0.062148,0.27475,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...127,SET,53,0.073944,0.0039674,0.12355,0.27476,GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,0.99999
HP_ABNORMALITY_OF_THE_FOREHE...,SET,1026,0.016053,0.0036876,0.026837,0.27486,HP_ABNORMALITY_OF_THE_FOREHEAD,0.99999
BLUM_RESPONSE_TO_SALIRASIB_UP,SET,219,0.033849,0.0036749,0.056595,0.2749,BLUM_RESPONSE_TO_SALIRASIB_UP,0.99999
GOBP_MITOTIC_G2_M_TRANSITION...,SET,46,0.066558,0.0033275,0.11129,0.2749,GOBP_MITOTIC_G2_M_TRANSITION_CHECKPOINT,0.99999
GOBP_CARDIAC_MUSCLE_CELL_MYO...,SET,11,0.17643,0.0043174,0.29506,0.27494,GOBP_CARDIAC_MUSCLE_CELL_MYOBLAST_DIFFERENTIATION,0.99999
BIOCARTA_CCR5_PATHWAY,SET,17,0.13647,0.0041509,0.22828,0.27498,BIOCARTA_CCR5_PATHWAY,0.99999
WP_ONCOSTATIN_M_SIGNALING,SET,63,0.070702,0.0041347,0.11832,0.27508,WP_ONCOSTATIN_M_SIGNALING,0.99999
GOBP_ENDOPLASMIC_RETICULUM_T...3,SET,5,0.22594,0.0037283,0.37815,0.27509,GOBP_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_FORMATION,0.99999
CHASSOT_SKIN_WOUND,SET,9,0.19606,0.00434,0.32816,0.27511,CHASSOT_SKIN_WOUND,0.99999
GOBP_MRNA_TRANSPORT,SET,112,0.043849,0.0034145,0.073399,0.27512,GOBP_MRNA_TRANSPORT,0.99999
REACTOME_IONOTROPIC_ACTIVITY...,SET,9,0.18155,0.0040188,0.30391,0.27513,REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS,0.99999
GSE37532_TREG_VS_TCONV_PPARG...1,SET,180,0.036433,0.0035899,0.061001,0.27517,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_DN,0.99999
GOBP_CENTRAL_NERVOUS_SYSTEM_...1,SET,931,0.017677,0.0038787,0.029608,0.27524,GOBP_CENTRAL_NERVOUS_SYSTEM_DEVELOPMENT,0.99999
GSE26351_WNT_VS_BMP_PATHWAY_...1,SET,176,0.03714,0.003619,0.062231,0.27532,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,0.99999
GSE22935_WT_VS_MYD88_KO_MACR...8,SET,181,0.039027,0.003856,0.065394,0.27533,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...16,SET,6,0.21844,0.0039485,0.36609,0.27536,GOBP_POSITIVE_REGULATION_OF_AGGREPHAGY,0.99999
GOMF_POTASSIUM_CHLORIDE_SYMP...,SET,9,0.15638,0.0034616,0.26212,0.2754,GOMF_POTASSIUM_CHLORIDE_SYMPORTER_ACTIVITY,0.99999
NIKOLSKY_BREAST_CANCER_15Q26...,SET,17,0.18887,0.0057448,0.31663,0.27542,NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON,0.99999
GSE20715_WT_VS_TLR4_KO_6H_OZ...1,SET,177,0.038765,0.003788,0.06499,0.27543,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN,0.99999
GOBP_DNA_DEMETHYLATION,SET,18,0.14069,0.0044034,0.2359,0.27545,GOBP_DNA_DEMETHYLATION,0.99999
BIOCARTA_FEEDER_PATHWAY,SET,8,0.14724,0.003073,0.247,0.27555,BIOCARTA_FEEDER_PATHWAY,0.99999
TRAVAGLINI_LUNG_OLR1_CLASSIC...,SET,652,0.021188,0.0039216,0.035547,0.27557,TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL,0.99999
MIR302B_5P,SET,187,0.037655,0.003781,0.063193,0.27563,MIR302B_5P,0.99999
GSE22443_NAIVE_VS_ACT_AND_IL...3,SET,185,0.038279,0.0038232,0.064245,0.27565,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN,0.99999
CAIRO_LIVER_DEVELOPMENT_UP,SET,145,0.043151,0.0038198,0.072436,0.27569,CAIRO_LIVER_DEVELOPMENT_UP,0.99999
HP_PROGRESSIVE_VISUAL_FIELD_...,SET,13,0.14232,0.003786,0.23894,0.27571,HP_PROGRESSIVE_VISUAL_FIELD_DEFECTS,0.99999
GSE5589_WT_VS_IL10_KO_LPS_AN...3,SET,183,0.037325,0.0037079,0.062662,0.27571,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.99999
REACTOME_FORMATION_OF_THE_NE...,SET,17,0.13943,0.0042409,0.23409,0.27572,REACTOME_FORMATION_OF_THE_NEPHRIC_DUCT,0.99999
GOCC_TRNA_METHYLTRANSFERASE_...,SET,6,0.1702,0.0030765,0.28586,0.27579,GOCC_TRNA_METHYLTRANSFERASE_COMPLEX,0.99999
GOBP_NEGATIVE_REGULATION_OF_...324,SET,28,0.096819,0.0037783,0.16262,0.2758,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...522,SET,4,0.26102,0.0038525,0.43846,0.27582,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.99999
GSE29164_UNTREATED_VS_CD8_TC...8,SET,187,0.037571,0.0037726,0.063147,0.27593,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_UP,0.99999
GOCC_AP_2_ADAPTOR_COMPLEX,SET,11,0.15788,0.0038634,0.26537,0.27595,GOCC_AP_2_ADAPTOR_COMPLEX,0.99999
GOMF_TRANSCRIPTION_COREGULAT...1,SET,451,0.022989,0.0035587,0.038642,0.27595,GOMF_TRANSCRIPTION_COREGULATOR_ACTIVITY,0.99999
GSE1448_CTRL_VS_ANTI_VBETA5_...2,SET,187,0.037764,0.003792,0.063477,0.27595,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...73,SET,52,0.069642,0.0037012,0.11707,0.27596,GOBP_NEGATIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.99999
MIR1912_5P,SET,73,0.061729,0.0038848,0.10377,0.27597,MIR1912_5P,0.99999
HP_ABNORMAL_BLEEDING,SET,497,0.023141,0.0037557,0.038903,0.27598,HP_ABNORMAL_BLEEDING,0.99999
GOBP_REGULATION_OF_ARP2_3_CO...,SET,18,0.1064,0.00333,0.17892,0.27604,GOBP_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,0.99999
SENGUPTA_NASOPHARYNGEAL_CARC...3,SET,146,0.045516,0.0040429,0.076562,0.27609,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,0.99999
GOBP_REGULATION_OF_BINDING_O...,SET,5,0.20292,0.0033485,0.34141,0.27613,GOBP_REGULATION_OF_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA,0.99999
GOBP_POSITIVE_REGULATION_OF_...641,SET,1110,0.015898,0.0037892,0.02675,0.27615,GOBP_POSITIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...341,SET,14,0.13998,0.0038642,0.23554,0.27616,GOBP_POSITIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_ACTIN_FIL...2,SET,341,0.028069,0.0037899,0.047251,0.27624,GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS,0.99999
GSE3982_BCELL_VS_NKCELL_DN,SET,171,0.040376,0.0038786,0.067969,0.27625,GSE3982_BCELL_VS_NKCELL_DN,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...12,SET,13,0.1535,0.0040833,0.25844,0.27628,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3,0.99999
MIR33A_3P,SET,393,0.025763,0.003729,0.043384,0.27631,MIR33A_3P,0.99999
CTIP_DN.V1_UP,SET,115,0.049067,0.0038713,0.082625,0.27631,CTIP_DN.V1_UP,0.99999
GOBP_RECEPTOR_LOCALIZATION_T...2,SET,56,0.07057,0.0038917,0.11887,0.27637,GOBP_RECEPTOR_LOCALIZATION_TO_SYNAPSE,0.99999
MIR5591_3P,SET,41,0.079022,0.0037303,0.13314,0.27641,MIR5591_3P,0.99999
KEGG_VALINE_LEUCINE_AND_ISOL...2,SET,42,0.076837,0.003671,0.12946,0.27642,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...36,SET,11,0.14128,0.0034574,0.23806,0.27643,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,0.99999
HP_HOARSE_CRY,SET,14,0.14747,0.0040709,0.24848,0.27643,HP_HOARSE_CRY,0.99999
KEGG_MEDICUS_REFERENCE_PYRIN...,SET,4,0.22116,0.0032642,0.37268,0.27645,KEGG_MEDICUS_REFERENCE_PYRIN_INFLAMMASOME_SIGNALING_PATHWAY,0.99999
GSE9960_GRAM_NEG_VS_GRAM_NEG...2,SET,151,0.041047,0.0037074,0.069179,0.27648,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,0.99999
MIR676_5P,SET,141,0.04433,0.0038701,0.074731,0.27653,MIR676_5P,0.99999
LI_INDUCED_T_TO_NATURAL_KILL...2,SET,287,0.030645,0.0038017,0.051671,0.27656,LI_INDUCED_T_TO_NATURAL_KILLER_UP,0.99999
MODULE_200,SET,27,0.11438,0.0043832,0.19285,0.27656,MODULE_200,0.99999
MIR6799_3P,SET,106,0.05244,0.0039733,0.08842,0.27657,MIR6799_3P,0.99999
HP_HEMOGLOBINURIA,SET,8,0.17166,0.0035826,0.28943,0.27657,HP_HEMOGLOBINURIA,0.99999
GSE23321_CD8_STEM_CELL_MEMOR...2,SET,174,0.039806,0.0038569,0.067119,0.27657,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP,0.99999
GOBP_OLFACTORY_LOBE_DEVELOPM...,SET,36,0.096649,0.0042757,0.163,0.27662,GOBP_OLFACTORY_LOBE_DEVELOPMENT,0.99999
MIR6776_3P,SET,57,0.070156,0.0039031,0.11835,0.27666,MIR6776_3P,0.99999
GOBP_MEMBRANE_FUSION_INVOLVE...,SET,4,0.29032,0.0042849,0.48976,0.27667,GOBP_MEMBRANE_FUSION_INVOLVED_IN_VIRAL_ENTRY_INTO_HOST_CELL,0.99999
LIU_SOX4_TARGETS_UP,SET,126,0.047109,0.0038894,0.079511,0.27677,LIU_SOX4_TARGETS_UP,0.99999
MIR576_5P,SET,313,0.029575,0.0038287,0.049921,0.27678,MIR576_5P,0.99999
GOBP_SPLICEOSOMAL_SNRNP_ASSE...,SET,36,0.072558,0.0032099,0.12247,0.27678,GOBP_SPLICEOSOMAL_SNRNP_ASSEMBLY,0.99999
GOBP_MANNOSE_METABOLIC_PROCE...,SET,9,0.1508,0.0033382,0.25469,0.27689,GOBP_MANNOSE_METABOLIC_PROCESS,0.99999
MIR548AV_3P,SET,162,0.040343,0.003773,0.068138,0.2769,MIR548AV_3P,0.99999
MODULE_311,SET,16,0.13468,0.0039743,0.22751,0.27693,MODULE_311,0.99999
GOBP_NEGATIVE_REGULATION_OF_...163,SET,23,0.098738,0.0034927,0.16681,0.27695,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.99999
GOBP_FORMATION_OF_CYTOPLASMI...,SET,13,0.12892,0.0034294,0.21782,0.27698,GOBP_FORMATION_OF_CYTOPLASMIC_TRANSLATION_INITIATION_COMPLEX,0.99999
HP_SHIELD_CHEST,SET,14,0.1264,0.0034893,0.21359,0.277,HP_SHIELD_CHEST,0.99999
GOBP_REGULATION_OF_MEMBRANE_...7,SET,61,0.063372,0.0036469,0.10714,0.27711,GOBP_REGULATION_OF_MEMBRANE_PERMEABILITY,0.99999
HP_ABNORMAL_PROPORTION_OF_NA...,SET,4,0.29026,0.0042841,0.49076,0.27711,HP_ABNORMAL_PROPORTION_OF_NAIVE_T_CELLS,0.99999
HP_SEGMENTAL_PERIPHERAL_DEMY...,SET,10,0.16232,0.0037873,0.27443,0.27711,HP_SEGMENTAL_PERIPHERAL_DEMYELINATION_REMYELINATION,0.99999
BARRIER_CANCER_RELAPSE_TUMOR...2,SET,15,0.12891,0.0036834,0.218,0.27715,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP,0.99999
GOBP_INTERLEUKIN_6_PRODUCTION,SET,136,0.04428,0.0037971,0.074891,0.27718,GOBP_INTERLEUKIN_6_PRODUCTION,0.99999
HIRSCH_CELLULAR_TRANSFORMATI...2,SET,227,0.034314,0.003792,0.058067,0.27728,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,0.99999
BIOCARTA_EEA1_PATHWAY,SET,7,0.18323,0.0035772,0.31006,0.27728,BIOCARTA_EEA1_PATHWAY,0.99999
MIR6782_5P,SET,37,0.08175,0.0036664,0.13834,0.27728,MIR6782_5P,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...18,SET,69,0.059348,0.0036316,0.10049,0.2774,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,0.99999
GOBP_NEGATIVE_REGULATION_OF_...93,SET,8,0.1958,0.0040866,0.33153,0.2774,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_EXTRAVASATION,0.99999
WP_VITAMIN_K_METABOLISM_AND_...,SET,12,0.13471,0.0034429,0.2281,0.27741,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,0.99999
GOCC_CATION_TRANSPORTING_ATP...,SET,18,0.13147,0.0041148,0.22267,0.27745,GOCC_CATION_TRANSPORTING_ATPASE_COMPLEX,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...2,SET,184,0.036597,0.0036455,0.062008,0.27753,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP,0.99999
HP_RETICULAR_HYPERPIGMENTATI...,SET,9,0.15043,0.00333,0.25489,0.27754,HP_RETICULAR_HYPERPIGMENTATION,0.99999
GSE22501_PERIPHERAL_BLOOD_VS...2,SET,178,0.039305,0.0038515,0.066602,0.27755,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP,0.99999
chr9q33,SET,74,0.12769,0.0080909,0.2164,0.27757,chr9q33,0.99999
YY1_02,SET,228,0.032226,0.003569,0.054616,0.27758,YY1_02,0.99999
ZBTB49_TARGET_GENES,SET,7,0.16104,0.0031441,0.27298,0.27762,ZBTB49_TARGET_GENES,0.99999
GOBP_CORTISOL_METABOLIC_PROC...,SET,12,0.15919,0.0040686,0.26986,0.27764,GOBP_CORTISOL_METABOLIC_PROCESS,0.99999
HP_TENDON_XANTHOMATOSIS,SET,14,0.15722,0.0043399,0.26656,0.27767,HP_TENDON_XANTHOMATOSIS,0.99999
GOBP_PYRIMIDINE_CONTAINING_C...2,SET,41,0.086163,0.0040674,0.14612,0.2777,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.99999
MODULE_254,SET,59,0.06574,0.0037209,0.11151,0.27774,MODULE_254,0.99999
GOBP_CALCIUM_MEDIATED_SIGNAL...,SET,214,0.036361,0.0039029,0.06168,0.27776,GOBP_CALCIUM_MEDIATED_SIGNALING,0.99999
GOBP_RENAL_WATER_TRANSPORT,SET,9,0.19035,0.0042136,0.3229,0.27777,GOBP_RENAL_WATER_TRANSPORT,0.99999
GOBP_MONOATOMIC_ION_TRANSPORT,SET,1104,0.01651,0.0039251,0.028011,0.27779,GOBP_MONOATOMIC_ION_TRANSPORT,0.99999
MIR4478,SET,162,0.03913,0.0036596,0.066389,0.2778,MIR4478,0.99999
GOCC_PRESYNAPTIC_CYTOSOL,SET,12,0.14803,0.0037835,0.2512,0.27783,GOCC_PRESYNAPTIC_CYTOSOL,0.99999
REACTOME_LAGGING_STRAND_SYNT...,SET,19,0.10282,0.0033062,0.17455,0.2779,REACTOME_LAGGING_STRAND_SYNTHESIS,0.99999
TAATAAT_MIR126,SET,201,0.038779,0.0040355,0.065833,0.27792,TAATAAT_MIR126,0.99999
MORF_CAMK4,SET,253,0.032531,0.0037926,0.05523,0.27793,MORF_CAMK4,0.99999
BOYERINAS_ONCOFETAL_TARGETS_...,SET,10,0.17308,0.0040385,0.29387,0.27794,BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1,0.99999
GOBP_POSITIVE_REGULATION_OF_...792,SET,12,0.13759,0.0035166,0.23372,0.27803,GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...653,SET,90,0.052222,0.0036475,0.088724,0.27807,GOBP_POSITIVE_REGULATION_OF_PROTEIN_UBIQUITINATION,0.99999
GSE5099_CLASSICAL_M1_VS_ALTE...1,SET,146,0.041107,0.0036513,0.069839,0.27807,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN,0.99999
HP_MILD_SHORT_STATURE,SET,18,0.13113,0.0041042,0.22281,0.27808,HP_MILD_SHORT_STATURE,0.99999
GSE7596_AKT_TRANSD_VS_CTRL_C...1,SET,109,0.049537,0.0038057,0.084169,0.27809,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_DN,0.99999
GSE46606_IRF4MID_VS_WT_CD40L...2,SET,171,0.036996,0.0035539,0.062911,0.27825,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.99999
HP_LACK_OF_T_CELL_FUNCTION,SET,7,0.21194,0.0041378,0.36048,0.27829,HP_LACK_OF_T_CELL_FUNCTION,0.99999
GSE20727_H2O2_VS_ROS_INHIBIT...2,SET,173,0.03745,0.0036183,0.06371,0.27833,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP,0.99999
LU_TUMOR_VASCULATURE_DN,SET,8,0.16002,0.0033398,0.27224,0.27834,LU_TUMOR_VASCULATURE_DN,0.99999
GOBP_MYOBLAST_FATE_COMMITMENT,SET,6,0.23459,0.0042403,0.39927,0.27842,GOBP_MYOBLAST_FATE_COMMITMENT,0.99999
HP_PEPTIC_ULCER,SET,34,0.094312,0.004055,0.16054,0.27844,HP_PEPTIC_ULCER,0.99999
GOMF_ANAPHASE_PROMOTING_COMP...,SET,9,0.14253,0.003155,0.24263,0.27846,GOMF_ANAPHASE_PROMOTING_COMPLEX_BINDING,0.99999
HOEK_MYELOID_DENDRITIC_CELL_...1,SET,5,0.22956,0.0037879,0.3908,0.27847,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_1DY_DN,0.99999
GOBP_ATF6_MEDIATED_UNFOLDED_...,SET,8,0.1617,0.0033748,0.2753,0.27848,GOBP_ATF6_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.99999
MIR3618,SET,88,0.055608,0.0038408,0.094681,0.2785,MIR3618,0.99999
GSE12707_AT16L1_HYPOMORPH_VS...2,SET,111,0.050481,0.0039134,0.085962,0.27852,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_UP,0.99999
HP_INTERRUPTED_AORTIC_ARCH,SET,18,0.12789,0.0040027,0.21779,0.27853,HP_INTERRUPTED_AORTIC_ARCH,0.99999
MEIS1_01,SET,225,0.033791,0.0037179,0.05756,0.27859,MEIS1_01,0.99999
MIR3714,SET,404,0.025481,0.0037381,0.043407,0.2786,MIR3714,0.99999
HP_ABNORMAL_NUMBER_OF_TEETH,SET,356,0.026711,0.0036834,0.04551,0.27863,HP_ABNORMAL_NUMBER_OF_TEETH,0.99999
GOCC_EPSILON_DNA_POLYMERASE_...,SET,5,0.18803,0.0031027,0.32037,0.27864,GOCC_EPSILON_DNA_POLYMERASE_COMPLEX,0.99999
GOMF_PHOSPHATIDYLINOSITOL_3_...12,SET,11,0.14214,0.0034784,0.2422,0.27864,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATORY_SUBUNIT_BINDING,0.99999
HP_PURE_RED_CELL_APLASIA,SET,25,0.094871,0.0034986,0.16165,0.27865,HP_PURE_RED_CELL_APLASIA,0.99999
GSE24671_CTRL_VS_BAKIMULC_IN...2,SET,180,0.037342,0.0036795,0.063638,0.27867,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...15,SET,12,0.13905,0.003554,0.23699,0.27869,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_OXYGEN_AS_ACCEPTOR,0.99999
MIR371A_3P,SET,9,0.18169,0.0040218,0.30973,0.27874,MIR371A_3P,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...86,SET,27,0.094397,0.0036175,0.16094,0.27876,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.99999
LOPEZ_TRANSLATION_VIA_FN1_SI...,SET,34,0.090975,0.0039115,0.15511,0.27877,LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,0.99999
ZERBINI_RESPONSE_TO_SULINDAC...2,SET,9,0.20008,0.0044291,0.34136,0.27889,ZERBINI_RESPONSE_TO_SULINDAC_UP,0.99999
MIR6878_5P,SET,197,0.037275,0.0038406,0.063601,0.27891,MIR6878_5P,0.99999
GSE21927_SPLEEN_VS_TUMOR_MON...4,SET,156,0.040228,0.0036925,0.068652,0.27895,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_UP,0.99999
WP_PURINE_METABOLISM_AND_REL...,SET,20,0.11445,0.0037754,0.19532,0.27896,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,0.99999
GRAESSMANN_RESPONSE_TO_MC_AN...2,SET,565,0.02116,0.0036546,0.036113,0.27897,GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...19,SET,46,0.079567,0.0039779,0.13582,0.279,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_2,0.99999
GOBP_BONE_REMODELING,SET,89,0.056495,0.0039241,0.096446,0.27902,GOBP_BONE_REMODELING,0.99999
REACTOME_MEIOSIS,SET,56,0.060962,0.0033618,0.10409,0.27905,REACTOME_MEIOSIS,0.99999
REACTOME_MIRO_GTPASE_CYCLE,SET,8,0.15556,0.0032467,0.26565,0.27908,REACTOME_MIRO_GTPASE_CYCLE,0.99999
chr11p14,SET,21,0.18337,0.0061984,0.31323,0.27914,chr11p14,0.99999
REACTOME_SIGNALING_BY_CSF3_G...,SET,27,0.1023,0.0039204,0.17479,0.27918,REACTOME_SIGNALING_BY_CSF3_G_CSF,0.99999
GOCC_MULTIVESICULAR_BODY_INT...,SET,5,0.26006,0.0042914,0.44452,0.27926,GOCC_MULTIVESICULAR_BODY_INTERNAL_VESICLE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...298,SET,7,0.19729,0.0038517,0.33725,0.27928,GOBP_NEGATIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...143,SET,21,0.11831,0.0039991,0.20225,0.27929,GOBP_NEGATIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,0.99999
HP_ABNORMAL_ANATOMIC_LOCATIO...,SET,127,0.042089,0.0034886,0.071951,0.27929,HP_ABNORMAL_ANATOMIC_LOCATION_OF_THE_HEART,0.99999
HP_ABNORMAL_RENAL_MEDULLA_MO...,SET,57,0.064691,0.0035991,0.1106,0.2793,HP_ABNORMAL_RENAL_MEDULLA_MORPHOLOGY,0.99999
REACTOME_NR1H2_NR1H3_REGULAT...5,SET,5,0.18399,0.003036,0.31457,0.27931,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE,0.99999
GSE15330_MEGAKARYOCYTE_ERYTH...4,SET,175,0.037349,0.0036291,0.063854,0.27931,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.99999
LIU_LIVER_CANCER,SET,29,0.089294,0.0035462,0.15268,0.27933,LIU_LIVER_CANCER,0.99999
GOBP_REGULATION_OF_RECEPTOR_...6,SET,105,0.04894,0.0036906,0.083693,0.27936,GOBP_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.99999
GSE42021_CD24HI_VS_CD24INT_T...3,SET,182,0.03874,0.0038381,0.066253,0.27937,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN,0.99999
GSE8685_IL2_STARVED_VS_IL2_A...2,SET,183,0.036791,0.0036549,0.062923,0.27938,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP,0.99999
E2F1_Q4_01,SET,202,0.03506,0.0036574,0.059967,0.27939,E2F1_Q4_01,0.99999
HP_MACROTIA,SET,219,0.033526,0.0036399,0.057363,0.27946,HP_MACROTIA,0.99999
WP_PHYSIOLOGICAL_AND_PATHOLO...,SET,24,0.10855,0.0039224,0.18575,0.27948,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,0.99999
WP_GPCRS_CLASS_B_SECRETINLIKE,SET,22,0.11938,0.0041304,0.2043,0.27949,WP_GPCRS_CLASS_B_SECRETINLIKE,0.99999
HP_PRIMARY_AMENORRHEA,SET,108,0.048713,0.0037253,0.083384,0.27954,HP_PRIMARY_AMENORRHEA,0.99999
GOBP_REGULATION_OF_RESPONSE_...14,SET,160,0.041435,0.0038513,0.070933,0.27957,GOBP_REGULATION_OF_RESPONSE_TO_WOUNDING,0.99999
GSE22229_UNTREATED_VS_IMMUNO...2,SET,171,0.039152,0.003761,0.067035,0.2796,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP,0.99999
GSE5099_UNSTIM_VS_MCSF_TREAT...3,SET,173,0.037554,0.0036284,0.064302,0.2796,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN,0.99999
GOBP_METANEPHRIC_MESENCHYMAL...,SET,5,0.26035,0.004296,0.44584,0.27963,GOBP_METANEPHRIC_MESENCHYMAL_CELL_DIFFERENTIATION,0.99999
REACTOME_G1_S_SPECIFIC_TRANS...,SET,28,0.086052,0.0033581,0.1474,0.27968,REACTOME_G1_S_SPECIFIC_TRANSCRIPTION,0.99999
REACTOME_ALPHA_OXIDATION_OF_...,SET,6,0.1856,0.0033549,0.31795,0.2797,REACTOME_ALPHA_OXIDATION_OF_PHYTANATE,0.99999
GSE557_CIITA_KO_VS_I_AB_KO_D...2,SET,180,0.036472,0.0035937,0.062479,0.2797,GSE557_CIITA_KO_VS_I_AB_KO_DC_UP,0.99999
TURJANSKI_MAPK14_TARGETS,SET,9,0.17339,0.0038382,0.29708,0.27973,TURJANSKI_MAPK14_TARGETS,0.99999
HP_FEMALE_SEXUAL_DYSFUNCTION,SET,61,0.065686,0.0037801,0.1126,0.27983,HP_FEMALE_SEXUAL_DYSFUNCTION,0.99999
WANG_RESPONSE_TO_FORSKOLIN_UP,SET,22,0.10764,0.0037241,0.18454,0.27985,WANG_RESPONSE_TO_FORSKOLIN_UP,0.99999
GOBP_REGULATION_OF_NODAL_SIG...,SET,7,0.22269,0.0043477,0.3819,0.27991,GOBP_REGULATION_OF_NODAL_SIGNALING_PATHWAY,0.99999
PAX3_TARGET_GENES,SET,1195,0.015394,0.0037976,0.026402,0.27993,PAX3_TARGET_GENES,0.99999
GOMF_ATPASE_INHIBITOR_ACTIVI...,SET,4,0.23404,0.0034542,0.40142,0.27995,GOMF_ATPASE_INHIBITOR_ACTIVITY,0.99999
HP_UPPER_LIMB_MUSCLE_WEAKNESS,SET,131,0.044378,0.0037354,0.07613,0.27997,HP_UPPER_LIMB_MUSCLE_WEAKNESS,0.99999
BIOCARTA_KREB_PATHWAY,SET,8,0.17053,0.0035592,0.29268,0.28006,BIOCARTA_KREB_PATHWAY,0.99999
GOBP_REGULATION_OF_MAST_CELL...1,SET,16,0.13233,0.0039049,0.22712,0.28007,GOBP_REGULATION_OF_MAST_CELL_ACTIVATION,0.99999
GSE2770_IL4_ACT_VS_ACT_CD4_T...5,SET,173,0.035985,0.0034767,0.061779,0.28013,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,0.99999
GOBP_REGULATION_OF_ATPASE_CO...,SET,5,0.17599,0.002904,0.30223,0.28018,GOBP_REGULATION_OF_ATPASE_COUPLED_CALCIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_RESPONSE_TO_SORBITOL,SET,6,0.21919,0.003962,0.37641,0.28018,GOBP_RESPONSE_TO_SORBITOL,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...1,SET,5,0.23116,0.0038144,0.39699,0.2802,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY,0.99999
GOMF_DIHYDROPYRIMIDINASE_ACT...,SET,6,0.21635,0.0039106,0.37156,0.2802,GOMF_DIHYDROPYRIMIDINASE_ACTIVITY,0.99999
GSE16385_MONOCYTE_VS_12H_ROS...3,SET,187,0.035395,0.0035541,0.060797,0.28023,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,0.99999
ZNF766_TARGET_GENES,SET,932,0.016496,0.0036213,0.028337,0.28024,ZNF766_TARGET_GENES,0.99999
EVI1_03,SET,54,0.068595,0.0037148,0.11783,0.28024,EVI1_03,0.99999
KEGG_MEDICUS_ENV_FACTOR_META...2,SET,9,0.1944,0.0043034,0.33402,0.28028,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY,0.99999
HP_LOW_APGAR_SCORE,SET,9,0.1846,0.0040864,0.31718,0.28028,HP_LOW_APGAR_SCORE,0.99999
GOMF_HEXOSAMINIDASE_ACTIVITY,SET,12,0.14348,0.0036671,0.24653,0.28029,GOMF_HEXOSAMINIDASE_ACTIVITY,0.99999
SOBOLEV_PBMC_PANDEMRIX_AGE_1...6,SET,5,0.26129,0.0043116,0.44896,0.28029,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_LOW_VS_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_0DY_DN,0.99999
REACTOME_SYNTHESIS_OF_PI,SET,5,0.21627,0.0035688,0.37173,0.28035,REACTOME_SYNTHESIS_OF_PI,0.99999
GOMF_EFFLUX_TRANSMEMBRANE_TR...,SET,15,0.13816,0.0039477,0.2375,0.28037,GOMF_EFFLUX_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_PAIN_INSENSITIVITY,SET,26,0.093489,0.0035158,0.16073,0.28041,HP_PAIN_INSENSITIVITY,0.99999
GSE2585_CD80_HIGH_VS_LOW_AIR...1,SET,183,0.03773,0.0037483,0.06487,0.28041,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN,0.99999
HP_ABNORMAL_SIZE_OF_THE_PALP...,SET,259,0.030611,0.0036102,0.052642,0.28046,HP_ABNORMAL_SIZE_OF_THE_PALPEBRAL_FISSURES,0.99999
ZHAN_LATE_DIFFERENTIATION_GE...2,SET,29,0.096838,0.0038458,0.16654,0.28047,ZHAN_LATE_DIFFERENTIATION_GENES_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...184,SET,46,0.077161,0.0038576,0.13271,0.28047,GOBP_POSITIVE_REGULATION_OF_CYTOKINESIS,0.99999
REACTOME_RELAXIN_RECEPTORS,SET,7,0.21821,0.0042602,0.37534,0.2805,REACTOME_RELAXIN_RECEPTORS,0.99999
WP_APOPTOSIS_MODULATION_AND_...,SET,84,0.055132,0.0037208,0.094846,0.28053,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.99999
MIR4499,SET,103,0.05051,0.0037728,0.086902,0.28055,MIR4499,0.99999
GCM_DDX5,SET,59,0.060554,0.0034274,0.10421,0.28059,GCM_DDX5,0.99999
HP_INTERRUPTED_INFERIOR_VENA...,SET,5,0.20018,0.0033032,0.34451,0.2806,HP_INTERRUPTED_INFERIOR_VENA_CAVA_WITH_AZYGOUS_CONTINUATION,0.99999
MODULE_210,SET,26,0.10653,0.0040062,0.18338,0.28065,MODULE_210,0.99999
GOBP_ADENOHYPOPHYSIS_DEVELOP...,SET,16,0.13798,0.0040716,0.23753,0.28066,GOBP_ADENOHYPOPHYSIS_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_RESPONSE_...5,SET,983,0.016614,0.0037401,0.028602,0.28067,GOBP_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,0.99999
GOBP_CD8_POSITIVE_ALPHA_BETA...3,SET,7,0.19249,0.0037581,0.33146,0.28071,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...50,SET,15,0.12719,0.0036343,0.21904,0.28073,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.99999
HP_EQUINOVARUS_DEFORMITY,SET,13,0.15414,0.0041004,0.26546,0.28074,HP_EQUINOVARUS_DEFORMITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...303,SET,17,0.11911,0.0036229,0.20517,0.28077,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,0.99999
KEGG_MEDICUS_PATHOGEN_HPV_E6...2,SET,12,0.14752,0.0037705,0.25416,0.28082,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381,0.99999
GOBP_ADULT_BEHAVIOR,SET,141,0.043632,0.0038092,0.075182,0.28084,GOBP_ADULT_BEHAVIOR,0.99999
GOBP_REGULATION_OF_CELL_CYCL...1,SET,41,0.069796,0.0032948,0.12027,0.28086,GOBP_REGULATION_OF_CELL_CYCLE_CHECKPOINT,0.99999
GOBP_PYRIMIDINE_DEOXYRIBONUC...2,SET,11,0.14228,0.0034818,0.24525,0.28091,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.99999
PID_AR_NONGENOMIC_PATHWAY,SET,30,0.085763,0.0034641,0.14784,0.28092,PID_AR_NONGENOMIC_PATHWAY,0.99999
HP_SYMPHALANGISM_OF_MIDDLE_P...1,SET,4,0.27887,0.004116,0.48076,0.28094,HP_SYMPHALANGISM_OF_MIDDLE_PHALANX_OF_5TH_FINGER,0.99999
GOBP_AXON_MIDLINE_CHOICE_POI...,SET,5,0.28268,0.0046645,0.48744,0.28099,GOBP_AXON_MIDLINE_CHOICE_POINT_RECOGNITION,0.99999
GOBP_REGULATION_OF_AUTOPHAGY...2,SET,10,0.17245,0.0040237,0.29739,0.281,GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,0.99999
YAGI_AML_FAB_MARKERS,SET,179,0.037676,0.0037021,0.064979,0.28102,YAGI_AML_FAB_MARKERS,0.99999
HP_ABNORMALITY_OF_HUMORAL_IM...,SET,280,0.029875,0.0036613,0.051524,0.28102,HP_ABNORMALITY_OF_HUMORAL_IMMUNITY,0.99999
GOBP_REGULATION_OF_VIRAL_PRO...,SET,154,0.042258,0.0038541,0.072883,0.28103,GOBP_REGULATION_OF_VIRAL_PROCESS,0.99999
HP_ABNORMAL_AORTIC_MORPHOLOGY,SET,350,0.026662,0.0036461,0.046005,0.28111,HP_ABNORMAL_AORTIC_MORPHOLOGY,0.99999
BENPORATH_NOS_TARGETS,SET,160,0.041547,0.0038618,0.071696,0.28113,BENPORATH_NOS_TARGETS,0.99999
GOBP_REGULATION_OF_HYPERSENS...,SET,9,0.16636,0.0036825,0.28709,0.28114,GOBP_REGULATION_OF_HYPERSENSITIVITY,0.99999
GOBP_REGULATION_OF_ANIMAL_OR...1,SET,26,0.11103,0.0041754,0.19166,0.2812,GOBP_REGULATION_OF_ANIMAL_ORGAN_FORMATION,0.99999
MIR4436A,SET,77,0.05955,0.0038486,0.10284,0.28129,MIR4436A,0.99999
GOBP_NEGATIVE_REGULATION_OF_...551,SET,28,0.091028,0.0035523,0.15723,0.28132,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.99999
GOBP_UTERUS_DEVELOPMENT,SET,25,0.1034,0.0038131,0.17861,0.28133,GOBP_UTERUS_DEVELOPMENT,0.99999
GOCC_OXIDOREDUCTASE_COMPLEX,SET,102,0.043489,0.0032326,0.075129,0.28135,GOCC_OXIDOREDUCTASE_COMPLEX,0.99999
HP_ABNORMAL_CIRCULATING_AMYL...,SET,6,0.19437,0.0035133,0.33577,0.28135,HP_ABNORMAL_CIRCULATING_AMYLASE_CONCENTRATION,0.99999
CAGCTG_AP4_Q5,SET,1354,0.014238,0.0037214,0.024602,0.28138,CAGCTG_AP4_Q5,0.99999
REACTOME_CELL_EXTRACELLULAR_...,SET,16,0.12883,0.0038017,0.22263,0.28141,REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,0.99999
GOBP_POSITIVE_REGULATION_OF_...482,SET,132,0.046048,0.0038906,0.079576,0.28141,GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.99999
GSE369_PRE_VS_POST_IL6_INJEC...3,SET,193,0.035998,0.0036716,0.062208,0.28141,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN,0.99999
GOBP_FOREBRAIN_DORSAL_VENTRA...,SET,7,0.22087,0.0043121,0.38178,0.28146,GOBP_FOREBRAIN_DORSAL_VENTRAL_PATTERN_FORMATION,0.99999
HP_RAYNAUD_PHENOMENON,SET,41,0.079978,0.0037754,0.13826,0.28148,HP_RAYNAUD_PHENOMENON,0.99999
AKL_HTLV1_INFECTION_UP,SET,24,0.092791,0.0033529,0.16049,0.28158,AKL_HTLV1_INFECTION_UP,0.99999
GOMF_FOUR_WAY_JUNCTION_HELIC...,SET,6,0.23134,0.0041816,0.40018,0.28161,GOMF_FOUR_WAY_JUNCTION_HELICASE_ACTIVITY,0.99999
BENPORATH_ES_2,SET,32,0.082493,0.0034411,0.14271,0.28163,BENPORATH_ES_2,0.99999
HP_NARROW_NARIS,SET,8,0.16696,0.0034847,0.28887,0.28164,HP_NARROW_NARIS,0.99999
ROETH_TERT_TARGETS_DN,SET,9,0.17013,0.0037661,0.29438,0.28166,ROETH_TERT_TARGETS_DN,0.99999
MORF_HAT1,SET,153,0.036255,0.0032959,0.062735,0.28167,MORF_HAT1,0.99999
GOBP_DIGESTION,SET,127,0.047248,0.0039162,0.081755,0.28167,GOBP_DIGESTION,0.99999
HP_ABNORMALITY_OF_MACULAR_PI...,SET,35,0.092843,0.00405,0.16067,0.28169,HP_ABNORMALITY_OF_MACULAR_PIGMENTATION,0.99999
WP_TH17_CELL_DIFFERENTIATION...,SET,67,0.065238,0.003934,0.11291,0.2817,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...14,SET,181,0.034257,0.0033847,0.059299,0.28174,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP,0.99999
GSE41867_DAY6_VS_DAY8_LCMV_C...2,SET,179,0.036187,0.0035558,0.06264,0.28174,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.99999
REACTOME_GLUCAGON_TYPE_LIGAN...,SET,33,0.092629,0.0039238,0.16035,0.28175,REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS,0.99999
GSE6269_HEALTHY_VS_STAPH_AUR...1,SET,145,0.041069,0.0036355,0.071133,0.28185,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN,0.99999
DEMAGALHAES_AGING_UP,SET,48,0.072111,0.0036825,0.12493,0.28191,DEMAGALHAES_AGING_UP,0.99999
REACTOME_SYNTHESIS_OF_16_20_...,SET,9,0.17383,0.003848,0.30118,0.28192,REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE,0.99999
REACTOME_PROCESSIVE_SYNTHESI...2,SET,14,0.11431,0.0031556,0.19811,0.28196,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND,0.99999
HP_ABNORMAL_BONE_STRUCTURE,SET,737,0.018461,0.0036239,0.031999,0.282,HP_ABNORMAL_BONE_STRUCTURE,0.99999
NR1I2_TARGET_GENES,SET,270,0.029463,0.0035468,0.051085,0.28206,NR1I2_TARGET_GENES,0.99999
GSE1925_3H_VS_24H_IFNG_STIM_...3,SET,180,0.035313,0.0034795,0.061236,0.28208,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN,0.99999
REACTOME_REGULATION_OF_COMMI...,SET,10,0.18061,0.0042141,0.3132,0.28209,REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO,0.99999
GOBP_UBIQUINONE_METABOLIC_PR...,SET,16,0.10866,0.0032066,0.18848,0.28213,GOBP_UBIQUINONE_METABOLIC_PROCESS,0.99999
MIR1279,SET,167,0.039683,0.0037676,0.068838,0.28215,MIR1279,0.99999
LAKE_ADULT_KIDNEY_C3_PROXIMA...,SET,194,0.038298,0.0039161,0.066436,0.28216,LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2,0.99999
GOCC_PYRUVATE_DEHYDROGENASE_...,SET,5,0.21964,0.0036242,0.38104,0.28217,GOCC_PYRUVATE_DEHYDROGENASE_COMPLEX,0.99999
HP_RENAL_AMYLOIDOSIS,SET,11,0.15451,0.0037809,0.26804,0.28217,HP_RENAL_AMYLOIDOSIS,0.99999
REACTOME_SPHINGOLIPID_METABO...,SET,95,0.051787,0.0037157,0.089857,0.2822,REACTOME_SPHINGOLIPID_METABOLISM,0.99999
GOCC_GAP_JUNCTION,SET,27,0.10869,0.0041654,0.1886,0.2822,GOCC_GAP_JUNCTION,0.99999
MIR1324,SET,107,0.049355,0.003757,0.085642,0.28221,MIR1324,0.99999
DESERT_EXTRACELLULAR_MATRIX_...,SET,19,0.12195,0.0039211,0.21163,0.28223,DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.99999
MARTENS_TRETINOIN_RESPONSE_DN,SET,683,0.018684,0.0035362,0.032424,0.28223,MARTENS_TRETINOIN_RESPONSE_DN,0.99999
BLANCO_MELO_MERS_COV_INFECTI...1,SET,30,0.094813,0.0038297,0.16454,0.28224,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_DN,0.99999
GSE22601_DOUBLE_POSITIVE_VS_...4,SET,186,0.03743,0.0037485,0.064963,0.28225,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.99999
GSE360_L_DONOVANI_VS_B_MALAY...5,SET,181,0.0359,0.0035471,0.062306,0.28225,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN,0.99999
GOBP_REGULATION_OF_T_HELPER_...5,SET,31,0.099416,0.0040819,0.17259,0.2823,GOBP_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.99999
MIR4423_3P,SET,116,0.046998,0.003724,0.081594,0.28231,MIR4423_3P,0.99999
HP_SMALL_FACE,SET,112,0.047255,0.0036797,0.082052,0.28234,HP_SMALL_FACE,0.99999
HP_ABNORMALITY_OF_THE_OVARY,SET,216,0.032858,0.0035431,0.057059,0.28236,HP_ABNORMALITY_OF_THE_OVARY,0.99999
KTGGYRSGAA_UNKNOWN,SET,68,0.058165,0.0035334,0.10102,0.28239,KTGGYRSGAA_UNKNOWN,0.99999
GSE17721_CTRL_VS_POLYIC_12H_...2,SET,178,0.034849,0.0034148,0.060527,0.28239,GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP,0.99999
GOBP_NEGATIVE_REGULATION_BY_...1,SET,8,0.16902,0.0035276,0.29358,0.2824,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,0.99999
MATTIOLI_MULTIPLE_MYELOMA_WI...,SET,31,0.094423,0.0038769,0.16401,0.28241,MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,0.99999
MIR498_3P,SET,196,0.035477,0.0036461,0.061635,0.28245,MIR498_3P,0.99999
GSE26890_CXCR1_NEG_VS_POS_EF...1,SET,176,0.034675,0.0033788,0.060253,0.28249,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN,0.99999
ARP1_01,SET,142,0.040582,0.0035553,0.070525,0.28251,ARP1_01,0.99999
GSE21927_UNTREATED_VS_GMCSF_...4,SET,154,0.039065,0.0035629,0.06789,0.28251,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_UP,0.99999
GOBP_VAGINA_DEVELOPMENT,SET,10,0.17586,0.0041034,0.30573,0.28258,GOBP_VAGINA_DEVELOPMENT,0.99999
GSE22886_IL2_VS_IL15_STIM_NK...1,SET,166,0.03633,0.003439,0.06316,0.28258,GSE22886_IL2_VS_IL15_STIM_NKCELL_DN,0.99999
GOBP_REGULATION_OF_CORTICOTR...,SET,4,0.26104,0.0038528,0.45388,0.28261,GOBP_REGULATION_OF_CORTICOTROPIN_SECRETION,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MYL...,SET,110,0.05128,0.0039576,0.089195,0.28268,HE_LIM_SUN_FETAL_LUNG_C0_MYL4_POS_SMC_CELL,0.99999
GOBP_POSITIVE_REGULATION_OF_...518,SET,31,0.10035,0.0041203,0.17459,0.28273,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.99999
PID_ERBB2_ERBB3_PATHWAY,SET,44,0.072004,0.0035209,0.1253,0.28277,PID_ERBB2_ERBB3_PATHWAY,0.99999
GOCC_CORE_MEDIATOR_COMPLEX,SET,25,0.08912,0.0032865,0.1551,0.28278,GOCC_CORE_MEDIATOR_COMPLEX,0.99999
GSE14000_UNSTIM_VS_4H_LPS_DC...2,SET,178,0.038939,0.0038156,0.067764,0.28278,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN,0.99999
LEI_HOXC8_TARGETS_DN,SET,17,0.11955,0.0036362,0.20806,0.28279,LEI_HOXC8_TARGETS_DN,0.99999
HP_UNDETECTABLE_LIGHT_AND_DA...,SET,13,0.15015,0.0039943,0.26132,0.28279,HP_UNDETECTABLE_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM,0.99999
MORF_AATF,SET,197,0.032052,0.0033024,0.055793,0.28282,MORF_AATF,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...17,SET,43,0.071587,0.0034606,0.12461,0.28283,HP_APLASIA_HYPOPLASIA_OF_THE_CLAVICLES,0.99999
GOMF_SUPEROXIDE_GENERATING_N...2,SET,7,0.19557,0.0038182,0.34063,0.28294,GOMF_SUPEROXIDE_GENERATING_NAD_P_H_OXIDASE_ACTIVITY,0.99999
GSE360_CTRL_VS_T_GONDII_MAC_...2,SET,180,0.03555,0.0035029,0.061955,0.28305,GSE360_CTRL_VS_T_GONDII_MAC_UP,0.99999
E2F_Q4,SET,212,0.033071,0.0035333,0.057655,0.28312,E2F_Q4,0.99999
chr2p21,SET,35,0.15202,0.0066313,0.26508,0.28316,chr2p21,0.99999
REACTOME_INTERLEUKIN_20_FAMI...,SET,26,0.10443,0.0039273,0.18212,0.28319,REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING,0.99999
HP_ATRIOVENTRICULAR_CANAL_DE...,SET,52,0.063924,0.0033973,0.11149,0.2832,HP_ATRIOVENTRICULAR_CANAL_DEFECT,0.99999
GOBP_CHONDROITIN_SULFATE_PRO...1,SET,23,0.10039,0.0035512,0.1751,0.28322,GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.99999
BIOCARTA_PRION_PATHWAY,SET,12,0.13384,0.0034208,0.23346,0.28323,BIOCARTA_PRION_PATHWAY,0.99999
RLF_TARGET_GENES,SET,268,0.030376,0.0036433,0.052987,0.28323,RLF_TARGET_GENES,0.99999
MODULE_401,SET,15,0.14467,0.0041335,0.2524,0.28327,MODULE_401,0.99999
GOBP_RESPONSE_TO_TRANSFORMIN...,SET,255,0.03201,0.0037464,0.055867,0.28334,GOBP_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA,0.99999
SIMBULAN_UV_RESPONSE_NORMAL_...1,SET,33,0.091457,0.0038741,0.15965,0.28337,SIMBULAN_UV_RESPONSE_NORMAL_DN,0.99999
GOMF_SUMO_POLYMER_BINDING,SET,5,0.21054,0.0034742,0.36755,0.28339,GOMF_SUMO_POLYMER_BINDING,0.99999
GSE5589_LPS_VS_LPS_AND_IL10_...11,SET,185,0.035667,0.0035624,0.062303,0.2835,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.99999
GOBP_GOLGI_DISASSEMBLY,SET,6,0.17999,0.0032534,0.31455,0.28359,GOBP_GOLGI_DISASSEMBLY,0.99999
GSE3982_EFF_MEMORY_VS_CENT_M...1,SET,172,0.036601,0.0035261,0.06399,0.28367,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN,0.99999
GSE17721_CTRL_VS_POLYIC_0.5H...2,SET,180,0.035996,0.0035468,0.062935,0.28368,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_UP,0.99999
GOBP_MEIOTIC_CHROMOSOME_COND...,SET,6,0.1607,0.0029047,0.28097,0.28369,GOBP_MEIOTIC_CHROMOSOME_CONDENSATION,0.99999
HALLMARK_FATTY_ACID_METABOLI...,SET,145,0.039461,0.0034932,0.06902,0.28375,HALLMARK_FATTY_ACID_METABOLISM,0.99999
chr6p22,SET,103,0.080901,0.0060428,0.14151,0.28377,chr6p22,0.99999
GSE37301_GRANULOCYTE_MONOCYT...1,SET,182,0.03462,0.0034299,0.060627,0.28399,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,0.99999
GCM_RAB10,SET,162,0.036385,0.0034028,0.063719,0.284,GCM_RAB10,0.99999
GOBP_CYTOPLASMIC_TRANSLATION...1,SET,4,0.19947,0.0029441,0.34935,0.28401,GOBP_CYTOPLASMIC_TRANSLATIONAL_ELONGATION,0.99999
GSE35825_IFNA_VS_IFNG_STIM_M...1,SET,178,0.035328,0.0034618,0.061874,0.28402,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN,0.99999
REACTOME_MISCELLANEOUS_TRANS...,SET,21,0.11116,0.0037575,0.19471,0.28403,REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...16,SET,180,0.036752,0.0036213,0.064372,0.28403,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP,0.99999
GSE37534_GW1929_VS_ROSIGLITA...1,SET,146,0.038825,0.0034486,0.068012,0.28405,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,0.99999
GSE9960_HEALTHY_VS_SEPSIS_PB...1,SET,139,0.042676,0.0036994,0.074762,0.28406,GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN,0.99999
GOBP_REGULATION_OF_RNA_POLYM...2,SET,6,0.19938,0.003604,0.34939,0.28412,GOBP_REGULATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY,0.99999
GOBP_10_FORMYLTETRAHYDROFOLA...,SET,5,0.22295,0.0036789,0.39074,0.28414,GOBP_10_FORMYLTETRAHYDROFOLATE_METABOLIC_PROCESS,0.99999
GSE339_CD4POS_VS_CD4CD8DN_DC...2,SET,189,0.035349,0.0035682,0.061956,0.28416,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,0.99999
KEGG_MEDICUS_REFERENCE_TLR3_...2,SET,16,0.15073,0.0044479,0.26422,0.28419,KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY,0.99999
HP_VASCULAR_TORTUOSITY,SET,21,0.10338,0.0034945,0.18123,0.28419,HP_VASCULAR_TORTUOSITY,0.99999
GSE22432_MULTIPOTENT_PROGENI...1,SET,183,0.035344,0.0035112,0.06198,0.28426,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_DN,0.99999
GENTLES_LEUKEMIC_STEM_CELL_DN,SET,16,0.12606,0.0037201,0.22112,0.28431,GENTLES_LEUKEMIC_STEM_CELL_DN,0.99999
HP_HYPOGLYCEMIA,SET,230,0.032215,0.0035832,0.056513,0.28433,HP_HYPOGLYCEMIA,0.99999
GOBP_URINARY_BLADDER_SMOOTH_...,SET,7,0.19554,0.0038176,0.34317,0.2844,GOBP_URINARY_BLADDER_SMOOTH_MUSCLE_CONTRACTION,0.99999
GSE4748_CTRL_VS_LPS_STIM_DC_...2,SET,183,0.037681,0.0037433,0.066137,0.28443,GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP,0.99999
SANSOM_APC_TARGETS,SET,191,0.035293,0.0035811,0.061954,0.28445,SANSOM_APC_TARGETS,0.99999
WP_CANONICAL_NFKB_PATHWAY,SET,7,0.17352,0.0033876,0.30459,0.28445,WP_CANONICAL_NFKB_PATHWAY,0.99999
ATAAGCT_MIR21,SET,111,0.046379,0.0035955,0.081457,0.28456,ATAAGCT_MIR21,0.99999
GSE3203_UNTREATED_VS_IFNB_TR...1,SET,186,0.037226,0.0037281,0.065405,0.28462,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN,0.99999
HP_CEPHALOHEMATOMA,SET,9,0.17387,0.0038487,0.30551,0.28465,HP_CEPHALOHEMATOMA,0.99999
REACTOME_HIV_INFECTION,SET,215,0.029921,0.003219,0.05258,0.28466,REACTOME_HIV_INFECTION,0.99999
GOBP_GLUTAMATE_SECRETION,SET,28,0.10457,0.0040807,0.18376,0.28466,GOBP_GLUTAMATE_SECRETION,0.99999
HP_PERITONEAL_ABSCESS,SET,11,0.14465,0.0035398,0.25421,0.28467,HP_PERITONEAL_ABSCESS,0.99999
HP_CUTANEOUS_FINGER_SYNDACTY...,SET,30,0.094488,0.0038165,0.16607,0.2847,HP_CUTANEOUS_FINGER_SYNDACTYLY,0.99999
GSE15324_ELF4_KO_VS_WT_ACTIV...2,SET,180,0.034341,0.0033837,0.060373,0.28475,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP,0.99999
REACTOME_EXTENSION_OF_TELOME...,SET,48,0.064735,0.0033058,0.11381,0.28476,REACTOME_EXTENSION_OF_TELOMERES,0.99999
MIR378A_3P_MIR378C_MIR378D_M...,SET,38,0.075647,0.0034381,0.133,0.28476,MIR378A_3P_MIR378C_MIR378D_MIR378I,0.99999
GOBP_B_CELL_ACTIVATION,SET,244,0.032469,0.0037183,0.057109,0.28484,GOBP_B_CELL_ACTIVATION,0.99999
GSE24634_TREG_VS_TCONV_POST_...6,SET,179,0.034968,0.0034361,0.061524,0.2849,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...21,SET,108,0.047385,0.0036237,0.083376,0.28491,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,0.99999
GOMF_ALPHA_N_ACETYLGALACTOSA...,SET,6,0.24427,0.0044154,0.42988,0.28494,GOMF_ALPHA_N_ACETYLGALACTOSAMINIDE_ALPHA_2_6_SIALYLTRANSFERASE_ACTIVITY,0.99999
RUVBL2_TARGET_GENES,SET,28,0.088172,0.0034409,0.15525,0.28504,RUVBL2_TARGET_GENES,0.99999
GOMF_G_PROTEIN_BETA_SUBUNIT_...,SET,21,0.11744,0.0039697,0.20679,0.28505,GOMF_G_PROTEIN_BETA_SUBUNIT_BINDING,0.99999
GSE21033_3H_VS_12H_POLYIC_ST...1,SET,122,0.045614,0.0037061,0.080333,0.28508,GSE21033_3H_VS_12H_POLYIC_STIM_DC_DN,0.99999
MIR1914_3P,SET,23,0.10651,0.0037678,0.1876,0.28509,MIR1914_3P,0.99999
GOBP_LUNG_ASSOCIATED_MESENCH...,SET,9,0.18096,0.0040058,0.31875,0.28511,GOBP_LUNG_ASSOCIATED_MESENCHYME_DEVELOPMENT,0.99999
MIR510_3P,SET,337,0.027144,0.0036438,0.047821,0.28515,MIR510_3P,0.99999
MIR1911_5P,SET,24,0.092588,0.0033455,0.16313,0.28516,MIR1911_5P,0.99999
KEGG_DNA_REPLICATION,SET,34,0.074385,0.0031982,0.13108,0.28519,KEGG_DNA_REPLICATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...62,SET,50,0.071157,0.0037085,0.12539,0.28519,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,0.99999
NIKOLSKY_BREAST_CANCER_12Q24...,SET,14,0.25146,0.0069416,0.44324,0.28525,NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON,0.99999
MARSON_FOXP3_TARGETS_UP,SET,61,0.06637,0.0038194,0.117,0.28527,MARSON_FOXP3_TARGETS_UP,0.99999
HP_HYPERTROPHIC_NERVE_CHANGES,SET,6,0.23443,0.0042375,0.41326,0.28527,HP_HYPERTROPHIC_NERVE_CHANGES,0.99999
MORF_SMC1L1,SET,54,0.058152,0.0031493,0.10252,0.28529,MORF_SMC1L1,0.99999
GOBP_NEGATIVE_REGULATION_OF_...179,SET,82,0.056977,0.0037995,0.10045,0.28529,GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,0.99999
BYSTRYKH_HEMATOPOIESIS_STEM_...2,SET,142,0.040408,0.0035401,0.071256,0.28533,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,0.99999
RAMJAUN_APOPTOSIS_BY_TGFB1_V...4,SET,10,0.15362,0.0035844,0.27092,0.28535,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP,0.99999
GOBP_CELL_SURFACE_RECEPTOR_S...2,SET,166,0.040048,0.0037909,0.07063,0.28536,GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.99999
KEGG_MEDICUS_PATHOGEN_YERSIN...2,SET,6,0.22002,0.003977,0.38814,0.28541,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,0.99999
GOCC_GERM_CELL_NUCLEUS,SET,62,0.058021,0.0033662,0.1024,0.28549,GOCC_GERM_CELL_NUCLEUS,0.99999
MORF_CTBP1,SET,155,0.035071,0.003209,0.061919,0.28556,MORF_CTBP1,0.99999
GGGATGC_MIR3245P,SET,42,0.072215,0.0034502,0.1275,0.28557,GGGATGC_MIR3245P,0.99999
WP_QUERCETIN_AND_NFKB_AP1_IN...,SET,15,0.13413,0.0038325,0.23687,0.28561,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.99999
GOBP_GAMMA_AMINOBUTYRIC_ACID...1,SET,6,0.22266,0.0040248,0.39328,0.28564,GOBP_GAMMA_AMINOBUTYRIC_ACID_BIOSYNTHETIC_PROCESS,0.99999
MIR548J_3P,SET,717,0.018564,0.0035965,0.03279,0.28565,MIR548J_3P,0.99999
GOBP_PHAGOSOME_MATURATION,SET,28,0.098612,0.0038483,0.17419,0.28566,GOBP_PHAGOSOME_MATURATION,0.99999
DESCARTES_FETAL_EYE_ASTROCYT...,SET,28,0.10372,0.0040477,0.18323,0.28567,DESCARTES_FETAL_EYE_ASTROCYTES,0.99999
GOCC_JUNCTIONAL_SARCOPLASMIC...,SET,9,0.18566,0.0041097,0.32799,0.28568,GOCC_JUNCTIONAL_SARCOPLASMIC_RETICULUM_MEMBRANE,0.99999
GOBP_REGULATION_OF_PHOSPHOLI...9,SET,14,0.12639,0.0034891,0.22332,0.28571,GOBP_REGULATION_OF_PHOSPHOLIPID_TRANSPORT,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...23,SET,45,0.080188,0.0039652,0.1417,0.28574,GAVISH_3CA_METAPROGRAM_EPITHELIAL_STRESS,0.99999
ZNF426_TARGET_GENES,SET,121,0.042061,0.0034035,0.074337,0.28576,ZNF426_TARGET_GENES,0.99999
GOCC_SET1C_COMPASS_COMPLEX,SET,14,0.12833,0.0035424,0.2268,0.28577,GOCC_SET1C_COMPASS_COMPLEX,0.99999
GSE9509_10MIN_VS_30MIN_LPS_A...1,SET,142,0.041507,0.0036364,0.073363,0.28578,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.99999
KEGG_MEDICUS_REFERENCE_NON_H...,SET,13,0.10756,0.0028614,0.19016,0.28582,KEGG_MEDICUS_REFERENCE_NON_HOMOLOGOUS_END_JOINING,0.99999
MIR4761_3P,SET,46,0.072841,0.0036416,0.12878,0.28583,MIR4761_3P,0.99999
GR_01,SET,183,0.036425,0.0036186,0.064417,0.28588,GR_01,0.99999
GOBP_REGULATION_OF_MYELOID_L...1,SET,116,0.048439,0.0038382,0.085661,0.28588,GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.99999
GOBP_RETINAL_BIPOLAR_NEURON_...,SET,7,0.18795,0.0036694,0.33245,0.28592,GOBP_RETINAL_BIPOLAR_NEURON_DIFFERENTIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...209,SET,59,0.066533,0.0037658,0.11769,0.28593,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.99999
GOBP_PHOSPHOLIPASE_C_ACTIVAT...2,SET,8,0.19747,0.0041213,0.34931,0.28593,GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE5589_IL6_KO_VS_IL10_KO_LP...7,SET,183,0.036202,0.0035964,0.064056,0.28599,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,0.99999
GSE22103_UNSTIM_VS_GMCSF_AND...1,SET,188,0.033774,0.0034003,0.059767,0.286,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,0.99999
GOBP_ADULT_HEART_DEVELOPMENT,SET,13,0.14777,0.003931,0.26155,0.28604,GOBP_ADULT_HEART_DEVELOPMENT,0.99999
GOBP_HOMOPHILIC_CELL_ADHESIO...,SET,157,0.051251,0.0047193,0.090752,0.28613,GOBP_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,0.99999
HP_CLINODACTYLY,SET,492,0.021528,0.0034768,0.038121,0.28613,HP_CLINODACTYLY,0.99999
GSE19772_HCMV_INFL_VS_HCMV_I...2,SET,187,0.035158,0.0035303,0.062276,0.28619,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,0.99999
REACTOME_POLYMERASE_SWITCHING,SET,13,0.12035,0.0032016,0.2133,0.2863,REACTOME_POLYMERASE_SWITCHING,0.99999
GSE17186_NAIVE_VS_CD21HIGH_T...2,SET,176,0.034707,0.003382,0.061519,0.28632,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,0.99999
GOMF_E_BOX_BINDING,SET,52,0.077599,0.0041241,0.13759,0.28638,GOMF_E_BOX_BINDING,0.99999
MIR548E_5P,SET,659,0.019483,0.0036245,0.034546,0.28639,MIR548E_5P,0.99999
GOMF_HISTONE_H4K5_ACETYLTRAN...,SET,11,0.14102,0.0034509,0.25005,0.2864,GOMF_HISTONE_H4K5_ACETYLTRANSFERASE_ACTIVITY,0.99999
GOBP_ENDODERMAL_CELL_FATE_CO...,SET,14,0.13763,0.0037993,0.24412,0.28646,GOBP_ENDODERMAL_CELL_FATE_COMMITMENT,0.99999
REACTOME_POST_TRANSLATIONAL_...1,SET,87,0.053345,0.0036636,0.09464,0.2865,REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,0.99999
GOBP_RESPONSE_TO_CAMP,SET,83,0.053152,0.0035658,0.0943,0.2865,GOBP_RESPONSE_TO_CAMP,0.99999
GOBP_GOLGI_ORGANIZATION,SET,136,0.039691,0.0034035,0.070431,0.28654,GOBP_GOLGI_ORGANIZATION,0.99999
MIR6810_3P,SET,69,0.059135,0.0036186,0.10496,0.28658,MIR6810_3P,0.99999
HP_EMG_DECREMENTAL_RESPONSE_...,SET,28,0.090747,0.0035413,0.16111,0.28663,HP_EMG_DECREMENTAL_RESPONSE_OF_COMPOUND_MUSCLE_ACTION_POTENTIAL_TO_REPETITIVE_NERVE_STIMULATION,0.99999
GOBP_SCHWANN_CELL_MIGRATION,SET,5,0.24929,0.0041135,0.44259,0.28664,GOBP_SCHWANN_CELL_MIGRATION,0.99999
GSE12366_GC_VS_NAIVE_BCELL_DN,SET,171,0.037791,0.0036303,0.067109,0.28668,GSE12366_GC_VS_NAIVE_BCELL_DN,0.99999
HP_MYELIN_OUTFOLDINGS,SET,7,0.17861,0.0034871,0.31721,0.28669,HP_MYELIN_OUTFOLDINGS,0.99999
GOBP_NITROGEN_UTILIZATION,SET,5,0.21576,0.0035603,0.38324,0.28672,GOBP_NITROGEN_UTILIZATION,0.99999
PID_MYC_PATHWAY,SET,25,0.091831,0.0033865,0.16322,0.28685,PID_MYC_PATHWAY,0.99999
GSE11961_FOLLICULAR_BCELL_VS...6,SET,180,0.036045,0.0035516,0.064071,0.28687,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_UP,0.99999
MODULE_158,SET,41,0.071463,0.0033735,0.12705,0.28689,MODULE_158,0.99999
GSE2128_C57BL6_VS_NOD_THYMOC...2,SET,181,0.036231,0.0035798,0.064414,0.2869,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_DN,0.99999
GOBP_ALCOHOL_METABOLIC_PROCE...,SET,332,0.026783,0.0035691,0.04762,0.28691,GOBP_ALCOHOL_METABOLIC_PROCESS,0.99999
REACTOME_INTERLEUKIN_21_SIGN...,SET,9,0.19417,0.0042981,0.34528,0.28694,REACTOME_INTERLEUKIN_21_SIGNALING,0.99999
GOCC_TRNA_SPLICING_LIGASE_CO...,SET,7,0.18621,0.0036355,0.33113,0.28694,GOCC_TRNA_SPLICING_LIGASE_COMPLEX,0.99999
HP_KETOTIC_HYPOGLYCEMIA,SET,12,0.14828,0.0037898,0.2637,0.28696,HP_KETOTIC_HYPOGLYCEMIA,0.99999
GSE3565_DUSP1_VS_WT_SPLENOCY...4,SET,148,0.042852,0.0038321,0.076208,0.28696,GSE3565_DUSP1_VS_WT_SPLENOCYTES_UP,0.99999
GSE6269_HEALTHY_VS_STAPH_AUR...2,SET,154,0.037631,0.0034321,0.066925,0.28697,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP,0.99999
GOBP_DEADENYLATION_DEPENDENT...,SET,10,0.16329,0.00381,0.29044,0.28699,GOBP_DEADENYLATION_DEPENDENT_DECAPPING_OF_NUCLEAR_TRANSCRIBED_MRNA,0.99999
KEGG_MEDICUS_REFERENCE_IFN_R...,SET,28,0.1061,0.0041406,0.18874,0.28701,KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...667,SET,50,0.069964,0.0036463,0.12449,0.28705,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.99999
GOBP_VITAMIN_A_METABOLIC_PRO...,SET,8,0.18766,0.0039166,0.33401,0.28712,GOBP_VITAMIN_A_METABOLIC_PROCESS,0.99999
GOCC_SPERM_MIDPIECE,SET,50,0.069382,0.003616,0.12349,0.28712,GOCC_SPERM_MIDPIECE,0.99999
GOMF_WATER_TRANSMEMBRANE_TRA...,SET,17,0.13861,0.004216,0.24674,0.28714,GOMF_WATER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_ABNORMAL_UMBILICAL_STUMP_...,SET,8,0.19134,0.0039934,0.34061,0.28715,HP_ABNORMAL_UMBILICAL_STUMP_BLEEDING,0.99999
HP_MATURITY_ONSET_DIABETES_O...,SET,19,0.11824,0.003802,0.2105,0.28716,HP_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,0.99999
GSE29949_CD8_POS_DC_SPLEEN_V...4,SET,171,0.036899,0.0035446,0.065693,0.28717,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,0.99999
GOBP_PYRUVATE_FAMILY_AMINO_A...1,SET,10,0.14939,0.0034857,0.266,0.28719,GOBP_PYRUVATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,0.99999
GOMF_NADPLUS_PROTEIN_ARGININ...,SET,6,0.20471,0.0037002,0.36449,0.28719,GOMF_NADPLUS_PROTEIN_ARGININE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...18,SET,179,0.035418,0.0034802,0.063065,0.28719,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_UP,0.99999
KEGG_MEDICUS_REFERENCE_LECTI...2,SET,8,0.1917,0.004001,0.34141,0.28723,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN,0.99999
GSE18281_MEDULLARY_THYMOCYTE...2,SET,163,0.036776,0.0034499,0.065506,0.28726,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_UP,0.99999
MIR6129,SET,170,0.037093,0.0035529,0.06609,0.28732,MIR6129,0.99999
MORF_SNRP70,SET,59,0.054276,0.003072,0.096708,0.28732,MORF_SNRP70,0.99999
GOCC_OUTER_MITOCHONDRIAL_MEM...,SET,17,0.10741,0.003267,0.19137,0.28732,GOCC_OUTER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX,0.99999
REACTOME_RIP_MEDIATED_NFKB_A...,SET,16,0.11632,0.0034326,0.20729,0.28735,REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,0.99999
GOBP_CELL_FATE_COMMITMENT_IN...2,SET,11,0.15642,0.0038278,0.27876,0.28735,GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_PATTERN_SPECIFICATION,0.99999
GOCC_SPINDLE,SET,386,0.023386,0.0033553,0.041682,0.28738,GOCC_SPINDLE,0.99999
WP_METHYLATION_PATHWAYS,SET,9,0.17292,0.0038277,0.30821,0.28739,WP_METHYLATION_PATHWAYS,0.99999
HP_WIDE_NASAL_RIDGE,SET,8,0.13612,0.0028409,0.24263,0.2874,HP_WIDE_NASAL_RIDGE,0.99999
MORF_ANP32B,SET,178,0.033249,0.003258,0.059272,0.28742,MORF_ANP32B,0.99999
GOBP_AMELOBLAST_DIFFERENTIAT...,SET,5,0.26051,0.0042987,0.46445,0.28744,GOBP_AMELOBLAST_DIFFERENTIATION,0.99999
TCCCRNNRTGC_UNKNOWN,SET,189,0.033871,0.003419,0.060401,0.28748,TCCCRNNRTGC_UNKNOWN,0.99999
GSE46606_DAY1_VS_DAY3_CD40L_...5,SET,180,0.035194,0.0034678,0.062769,0.28751,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN,0.99999
BARX1_TARGET_GENES,SET,1024,0.015164,0.0034802,0.027054,0.28756,BARX1_TARGET_GENES,0.99999
REACTOME_PI_3K_CASCADE_FGFR2,SET,22,0.10775,0.0037278,0.19227,0.28761,REACTOME_PI_3K_CASCADE_FGFR2,0.99999
MIR548AH_3P_MIR548AM_3P,SET,715,0.018385,0.003557,0.032817,0.28766,MIR548AH_3P_MIR548AM_3P,0.99999
MODULE_95,SET,485,0.022435,0.0035981,0.040054,0.2877,MODULE_95,0.99999
BLANCO_MELO_COVID19_SARS_COV...7,SET,16,0.1215,0.0035854,0.21693,0.28771,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_DN,0.99999
GOBP_STOMACH_DEVELOPMENT,SET,5,0.24083,0.0039739,0.43004,0.28774,GOBP_STOMACH_DEVELOPMENT,0.99999
MODULE_163,SET,489,0.022352,0.0035992,0.039925,0.28779,MODULE_163,0.99999
CHEN_LVAD_SUPPORT_OF_FAILING...2,SET,88,0.052915,0.0036548,0.094518,0.2878,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,0.99999
GSE36392_TYPE_2_MYELOID_VS_E...2,SET,177,0.034809,0.0034014,0.062178,0.2878,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP,0.99999
JACKSON_DNMT1_TARGETS_UP,SET,80,0.055556,0.0036594,0.099246,0.28782,JACKSON_DNMT1_TARGETS_UP,0.99999
GOBP_MITOCHONDRIAL_FISSION,SET,37,0.079298,0.0035564,0.14166,0.28782,GOBP_MITOCHONDRIAL_FISSION,0.99999
GSE22886_NAIVE_VS_IGG_IGA_ME...1,SET,173,0.036984,0.0035733,0.066083,0.28786,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN,0.99999
chr8p12,SET,22,0.19001,0.0065737,0.33953,0.28787,chr8p12,0.99999
GOBP_POSITIVE_REGULATION_OF_...478,SET,43,0.076835,0.0037142,0.13734,0.28793,GOBP_POSITIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,0.99999
HP_ALLERGIC_RHINITIS,SET,10,0.13877,0.0032379,0.24818,0.28803,HP_ALLERGIC_RHINITIS,0.99999
HP_HYPERTELORISM,SET,721,0.017974,0.0034914,0.032146,0.28803,HP_HYPERTELORISM,0.99999
GSE4535_BM_DERIVED_DC_VS_FOL...2,SET,178,0.036972,0.0036229,0.066138,0.28808,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_UP,0.99999
NFKAPPAB65_01,SET,228,0.032197,0.0035657,0.057632,0.2882,NFKAPPAB65_01,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_EAR...,SET,592,0.019374,0.0034226,0.03468,0.2882,HE_LIM_SUN_FETAL_LUNG_C3_EARLY_CAP_CELL,0.99999
GOBP_MONOATOMIC_CATION_TRANS...1,SET,750,0.018533,0.0036686,0.03318,0.28824,GOBP_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORT,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...43,SET,11,0.12408,0.0030364,0.22216,0.28825,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_III,0.99999
BIOCARTA_INSULIN_PATHWAY,SET,20,0.10355,0.003416,0.18543,0.28828,BIOCARTA_INSULIN_PATHWAY,0.99999
GNF2_CBFB,SET,28,0.084554,0.0032997,0.15143,0.2883,GNF2_CBFB,0.99999
REACTOME_PROTON_COUPLED_MONO...,SET,6,0.21721,0.0039262,0.38919,0.28839,REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT,0.99999
MIR192_5P,SET,32,0.082956,0.0034604,0.14864,0.28839,MIR192_5P,0.99999
BRUINS_UVC_RESPONSE_VIA_TP53...3,SET,85,0.052755,0.0035814,0.094531,0.2884,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,0.99999
MIR4750_3P,SET,36,0.075171,0.0033255,0.13476,0.28849,MIR4750_3P,0.99999
REACTOME_MRNA_SPLICING,SET,191,0.030911,0.0031365,0.055418,0.2885,REACTOME_MRNA_SPLICING,0.99999
HP_SLEEP_WAKE_CYCLE_DISTURBA...,SET,35,0.085,0.0037079,0.1524,0.28851,HP_SLEEP_WAKE_CYCLE_DISTURBANCE,0.99999
HP_ACQUIRED_ABNORMAL_HAIR_PA...,SET,34,0.087189,0.0037487,0.15637,0.28857,HP_ACQUIRED_ABNORMAL_HAIR_PATTERN,0.99999
HP_HYPERKINETIC_MOVEMENTS,SET,35,0.082918,0.0036171,0.14871,0.28857,HP_HYPERKINETIC_MOVEMENTS,0.99999
REACTOME_TRAFFICKING_OF_GLUR...,SET,15,0.13074,0.0037357,0.2345,0.28859,REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS,0.99999
GOMF_SMAD_BINDING,SET,74,0.059663,0.0037804,0.10702,0.2886,GOMF_SMAD_BINDING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...284,SET,5,0.22802,0.0037626,0.40904,0.28861,GOBP_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,0.99999
MIR450B_3P,SET,42,0.071446,0.0034134,0.12818,0.28864,MIR450B_3P,0.99999
GSE28726_ACT_CD4_TCELL_VS_AC...1,SET,177,0.035862,0.0035044,0.064346,0.28865,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN,0.99999
GNF2_PA2G4,SET,75,0.048565,0.0030978,0.087152,0.28868,GNF2_PA2G4,0.99999
REACTOME_TACHYKININ_RECEPTOR...,SET,5,0.21953,0.0036224,0.39409,0.28875,REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS,0.99999
GOBP_ATTACHMENT_OF_MITOTIC_S...,SET,25,0.090672,0.0033437,0.16287,0.28886,GOBP_ATTACHMENT_OF_MITOTIC_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.99999
RODRIGUES_THYROID_CARCINOMA_...1,SET,468,0.022339,0.003521,0.04013,0.28888,RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN,0.99999
GOBP_MAMMALIAN_OOGENESIS_STA...,SET,12,0.15002,0.0038344,0.26966,0.28899,GOBP_MAMMALIAN_OOGENESIS_STAGE,0.99999
MIR4700_3P,SET,86,0.052915,0.0036132,0.095115,0.289,MIR4700_3P,0.99999
GSE45365_CD8A_DC_VS_CD11B_DC...1,SET,173,0.035851,0.0034639,0.064446,0.28901,GSE45365_CD8A_DC_VS_CD11B_DC_DN,0.99999
GOBP_REGULATION_OF_SECONDARY...2,SET,15,0.13258,0.0037883,0.2385,0.28914,GOBP_REGULATION_OF_SECONDARY_METABOLIC_PROCESS,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...3,SET,14,0.14665,0.0040484,0.26395,0.28924,BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN,0.99999
REPIN1_TARGET_GENES,SET,5,0.23882,0.0039408,0.42986,0.28925,REPIN1_TARGET_GENES,0.99999
PHONG_TNF_RESPONSE_VIA_P38_C...,SET,213,0.03259,0.00349,0.058668,0.28928,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,0.99999
HP_PROTRUDING_TONGUE,SET,38,0.07804,0.0035469,0.14059,0.28941,HP_PROTRUDING_TONGUE,0.99999
MARTORIATI_MDM4_TARGETS_FETA...2,SET,210,0.032696,0.003477,0.058929,0.28951,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,0.99999
HP_ABNORMAL_LEFT_ATRIUM_MORP...,SET,22,0.10441,0.0036121,0.18818,0.28951,HP_ABNORMAL_LEFT_ATRIUM_MORPHOLOGY,0.99999
MODULE_248,SET,117,0.044795,0.0035647,0.080772,0.28959,MODULE_248,0.99999
GSE17721_CTRL_VS_PAM3CSK4_0....1,SET,181,0.034919,0.0034501,0.062964,0.28959,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_DN,0.99999
GSE1460_CD4_THYMOCYTE_VS_NAI...3,SET,176,0.035493,0.0034585,0.06404,0.28971,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,0.99999
GOCC_MICROTUBULE,SET,416,0.022584,0.003361,0.040751,0.28972,GOCC_MICROTUBULE,0.99999
GOBP_REGULATION_OF_HEART_CON...,SET,190,0.037277,0.0037726,0.067267,0.28974,GOBP_REGULATION_OF_HEART_CONTRACTION,0.99999
WP_MRNA_PROTEIN_AND_METABOLI...,SET,7,0.17815,0.003478,0.32151,0.28976,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,0.99999
HP_HYDROURETER,SET,65,0.059018,0.0035056,0.10654,0.28981,HP_HYDROURETER,0.99999
REACTOME_MITOCHONDRIAL_PROTE...2,SET,53,0.05834,0.0031302,0.10533,0.28983,REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT,0.99999
WEBER_METHYLATED_LCP_IN_SPER...2,SET,14,0.13063,0.0036059,0.23596,0.28994,WEBER_METHYLATED_LCP_IN_SPERM_UP,0.99999
REACTOME_BIOSYNTHESIS_OF_SPE...,SET,19,0.11539,0.0037102,0.20847,0.28996,REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS,0.99999
GOBP_REGULATION_OF_PRODUCTIO...,SET,171,0.037054,0.0035595,0.06696,0.29,GOBP_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.99999
GOBP_RIBOSOMAL_LARGE_SUBUNIT...2,SET,60,0.057079,0.0032579,0.10316,0.29002,GOBP_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS,0.99999
GOBP_POLYAMINE_METABOLIC_PRO...,SET,15,0.10867,0.0031051,0.19645,0.29007,GOBP_POLYAMINE_METABOLIC_PROCESS,0.99999
GOMF_METAL_ION_TRANSMEMBRANE...,SET,426,0.02423,0.0036479,0.043817,0.29014,GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...38,SET,10,0.14777,0.0034478,0.26721,0.29014,HP_APLASIA_HYPOPLASIA_OF_THE_INNER_EAR,0.99999
MIR1270,SET,72,0.057671,0.0036046,0.10431,0.29018,MIR1270,0.99999
GSE26030_TH1_VS_TH17_DAY5_PO...1,SET,182,0.035736,0.0035405,0.064636,0.29018,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN,0.99999
MODULE_198,SET,289,0.026338,0.0032785,0.047645,0.2902,MODULE_198,0.99999
GSE18281_SUBCAPSULAR_CORTICA...3,SET,172,0.03654,0.0035203,0.066108,0.29023,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,0.99999
GOBP_PHOSPHAGEN_METABOLIC_PR...,SET,5,0.18597,0.0030687,0.33648,0.29024,GOBP_PHOSPHAGEN_METABOLIC_PROCESS,0.99999
MIR563,SET,30,0.089772,0.003626,0.16244,0.29026,MIR563,0.99999
GSE27786_LSK_VS_NEUTROPHIL_UP,SET,172,0.034117,0.0032868,0.061735,0.29026,GSE27786_LSK_VS_NEUTROPHIL_UP,0.99999
HP_TRANSIENT_NEONATAL_DIABET...,SET,15,0.12996,0.0037133,0.23519,0.29028,HP_TRANSIENT_NEONATAL_DIABETES_MELLITUS,0.99999
HP_DECREASED_PATELLAR_REFLEX,SET,9,0.15748,0.0034861,0.28509,0.29034,HP_DECREASED_PATELLAR_REFLEX,0.99999
SCHLOSSER_MYC_AND_SERUM_RESP...,SET,30,0.084901,0.0034293,0.1537,0.29035,SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY,0.99999
HP_ABNORMAL_CIRCULATING_VITA...3,SET,19,0.10949,0.0035206,0.19828,0.29041,HP_ABNORMAL_CIRCULATING_VITAMIN_E_CONCENTRATION,0.99999
HP_ABNORMALITY_OF_THE_BREAST,SET,393,0.022992,0.0033278,0.041639,0.29042,HP_ABNORMALITY_OF_THE_BREAST,0.99999
YAGI_AML_WITH_T_9_11_TRANSLO...,SET,115,0.045218,0.0035676,0.081896,0.29043,YAGI_AML_WITH_T_9_11_TRANSLOCATION,0.99999
MIR4482_3P,SET,427,0.02369,0.0035708,0.042917,0.29048,MIR4482_3P,0.99999
GOBP_REGULATION_OF_AGGREPHAGY,SET,7,0.17661,0.003448,0.31995,0.29048,GOBP_REGULATION_OF_AGGREPHAGY,0.99999
GOBP_VASCULAR_ASSOCIATED_SMO...4,SET,26,0.11233,0.0042245,0.20355,0.29052,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,0.99999
GOBP_CELLULAR_RESPONSE_TO_LI...1,SET,106,0.043704,0.0033113,0.079222,0.29059,GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS,0.99999
HP_PALMAR_PITS,SET,8,0.12468,0.0026021,0.22603,0.29061,HP_PALMAR_PITS,0.99999
MIR3162_3P,SET,20,0.11013,0.0036331,0.19967,0.29063,MIR3162_3P,0.99999
HP_TEMPOROMANDIBULAR_JOINT_A...,SET,4,0.21893,0.0032313,0.39693,0.29063,HP_TEMPOROMANDIBULAR_JOINT_ANKYLOSIS,0.99999
MIKKELSEN_IPS_LCP_WITH_H3K4M...2,SET,5,0.25399,0.0041911,0.46069,0.29071,MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3,0.99999
KEGG_MEDICUS_REFERENCE_PRE_I...,SET,27,0.080751,0.0030946,0.14653,0.29079,KEGG_MEDICUS_REFERENCE_PRE_IC_FORMATION,0.99999
HP_FRONTOTEMPORAL_CEREBRAL_A...,SET,14,0.12043,0.0033245,0.21855,0.29081,HP_FRONTOTEMPORAL_CEREBRAL_ATROPHY,0.99999
HP_ABNORMALITY_OF_SKIN_PHYSI...,SET,504,0.021479,0.0035097,0.038994,0.29088,HP_ABNORMALITY_OF_SKIN_PHYSIOLOGY,0.99999
MORF_FANCG,SET,156,0.036289,0.003331,0.065899,0.29093,MORF_FANCG,0.99999
GOBP_CEREBRAL_CORTEX_GABAERG...3,SET,4,0.26142,0.0038585,0.47472,0.29093,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_MIGRATION,0.99999
GSE13522_CTRL_VS_T_CRUZI_Y_S...5,SET,183,0.035849,0.0035613,0.065098,0.29093,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_DN,0.99999
GSE27859_MACROPHAGE_VS_CD11C...4,SET,153,0.038873,0.0035339,0.070601,0.29096,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP,0.99999
FRIDMAN_SENESCENCE_DN,SET,11,0.13272,0.0032479,0.2411,0.29099,FRIDMAN_SENESCENCE_DN,0.99999
HP_INFANTILE_MUSCULAR_HYPOTO...,SET,177,0.035638,0.0034825,0.064754,0.29104,HP_INFANTILE_MUSCULAR_HYPOTONIA,0.99999
RODWELL_AGING_KIDNEY_DN,SET,124,0.043953,0.0036001,0.079882,0.29108,RODWELL_AGING_KIDNEY_DN,0.99999
GOBP_MEMBRANE_DEPOLARIZATION...2,SET,5,0.24255,0.0040024,0.44114,0.29122,GOBP_MEMBRANE_DEPOLARIZATION_DURING_AV_NODE_CELL_ACTION_POTENTIAL,0.99999
HP_RETINAL_DEGENERATION,SET,260,0.02883,0.0034066,0.052449,0.29127,HP_RETINAL_DEGENERATION,0.99999
GOBP_FACIAL_NERVE_MORPHOGENE...,SET,9,0.18188,0.0040262,0.33099,0.29133,GOBP_FACIAL_NERVE_MORPHOGENESIS,0.99999
GSE24142_ADULT_VS_FETAL_DN3_...1,SET,181,0.036131,0.0035699,0.065752,0.29133,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN,0.99999
SMITH_TERT_TARGETS_DN,SET,83,0.054114,0.0036304,0.098493,0.29136,SMITH_TERT_TARGETS_DN,0.99999
MODULE_174,SET,89,0.053585,0.003722,0.097542,0.29138,MODULE_174,0.99999
GOMF_L_LACTATE_DEHYDROGENASE...,SET,5,0.28034,0.0046259,0.51043,0.29143,GOMF_L_LACTATE_DEHYDROGENASE_ACTIVITY,0.99999
HP_ABNORMALITY_OF_PROTHROMBIN,SET,47,0.073,0.003689,0.13293,0.29146,HP_ABNORMALITY_OF_PROTHROMBIN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...523,SET,6,0.18561,0.003355,0.33808,0.2915,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY_BY_REGULATION_OF_PROTEIN_PHOSPHORYLATION,0.99999
GOBP_APOPTOTIC_CHROMOSOME_CO...,SET,6,0.19452,0.003516,0.35436,0.29153,GOBP_APOPTOTIC_CHROMOSOME_CONDENSATION,0.99999
GSE7218_IGM_VS_IGG_SIGNAL_TH...2,SET,176,0.033711,0.0032849,0.061415,0.29154,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP,0.99999
SIG_REGULATION_OF_THE_ACTIN_...,SET,30,0.082807,0.0033447,0.15089,0.29158,SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,0.99999
GSE46606_IRF4_KO_VS_WT_CD40L...3,SET,169,0.035238,0.0033654,0.06421,0.29158,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN,0.99999
NIKOLSKY_BREAST_CANCER_1Q21_...,SET,34,0.11652,0.00501,0.21239,0.29163,NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON,0.99999
SUZUKI_RESPONSE_TO_TSA_AND_D...2,SET,15,0.12994,0.0037129,0.23688,0.29166,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B,0.99999
HP_INAPPROPRIATE_ANTIDIURETI...,SET,8,0.16365,0.0034155,0.29846,0.29174,HP_INAPPROPRIATE_ANTIDIURETIC_HORMONE_SECRETION,0.99999
MIR664A_5P,SET,65,0.060035,0.003566,0.10951,0.29178,MIR664A_5P,0.99999
MIR1245B_5P,SET,53,0.061896,0.0033209,0.11292,0.2918,MIR1245B_5P,0.99999
WP_SEROTONIN_HTR1_GROUP_AND_...,SET,36,0.085832,0.0037972,0.15662,0.29184,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,0.99999
GOMF_RNA_POLYMERASE_II_ACTIV...,SET,9,0.1315,0.0029108,0.23995,0.29184,GOMF_RNA_POLYMERASE_II_ACTIVITY,0.99999
BIOCARTA_ALTERNATIVE_PATHWAY,SET,8,0.16774,0.0035009,0.3061,0.29185,BIOCARTA_ALTERNATIVE_PATHWAY,0.99999
TGATTTRY_GFI1_01,SET,263,0.031275,0.0037164,0.057071,0.29185,TGATTTRY_GFI1_01,0.99999
GOBP_NATURAL_KILLER_CELL_ACT...1,SET,89,0.053257,0.0036991,0.097182,0.29185,GOBP_NATURAL_KILLER_CELL_ACTIVATION,0.99999
BIOCARTA_P35ALZHEIMERS_PATHW...,SET,8,0.18267,0.0038125,0.33336,0.29186,BIOCARTA_P35ALZHEIMERS_PATHWAY,0.99999
GOBP_REGULATION_OF_MICROTUBU...4,SET,148,0.035832,0.0032043,0.065399,0.29188,GOBP_REGULATION_OF_MICROTUBULE_CYTOSKELETON_ORGANIZATION,0.99999
MODULE_202,SET,26,0.099583,0.003745,0.18176,0.29189,MODULE_202,0.99999
GOBP_NEGATIVE_REGULATION_OF_...248,SET,128,0.040262,0.0033502,0.073493,0.2919,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,0.99999
MIR4795_5P,SET,62,0.060901,0.0035332,0.11119,0.29194,MIR4795_5P,0.99999
HP_FOOD_ALLERGY,SET,15,0.1263,0.0036087,0.23062,0.29197,HP_FOOD_ALLERGY,0.99999
HP_COXA_VARA,SET,58,0.06044,0.0033918,0.11038,0.292,HP_COXA_VARA,0.99999
GOMF_MONOCARBOXYLIC_ACID_BIN...,SET,82,0.056431,0.003763,0.10306,0.29201,GOMF_MONOCARBOXYLIC_ACID_BINDING,0.99999
GSE19401_PLN_VS_PEYERS_PATCH...2,SET,171,0.035264,0.0033875,0.064404,0.29201,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_UP,0.99999
UROSEVIC_RESPONSE_TO_IMIQUIM...,SET,18,0.1125,0.003521,0.20552,0.29206,UROSEVIC_RESPONSE_TO_IMIQUIMOD,0.99999
GOBP_POSITIVE_REGULATION_OF_...42,SET,12,0.15297,0.0039097,0.27948,0.29207,GOBP_POSITIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,0.99999
HP_UNUSUAL_SKIN_INFECTION,SET,7,0.15348,0.0029964,0.28043,0.29209,HP_UNUSUAL_SKIN_INFECTION,0.99999
REACTOME_PYROPTOSIS,SET,26,0.10052,0.0037804,0.18375,0.29217,REACTOME_PYROPTOSIS,0.99999
GOBP_REGULATION_OF_AXONOGENE...,SET,125,0.043437,0.0035721,0.079434,0.29225,GOBP_REGULATION_OF_AXONOGENESIS,0.99999
GOBP_PROTEIN_K63_LINKED_DEUB...,SET,21,0.099037,0.0033477,0.18117,0.29232,GOBP_PROTEIN_K63_LINKED_DEUBIQUITINATION,0.99999
WP_CARDIAC_PROGENITOR_DIFFER...,SET,50,0.073519,0.0038316,0.13451,0.29233,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,0.99999
GSE17186_MEMORY_VS_CD21LOW_T...1,SET,178,0.034401,0.0033709,0.062943,0.29235,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN,0.99999
GOMF_CORE_PROMOTER_SEQUENCE_...,SET,35,0.077929,0.0033994,0.1426,0.29237,GOMF_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,0.99999
E2F_Q4_01,SET,211,0.031275,0.0033337,0.057251,0.29244,E2F_Q4_01,0.99999
WP_PHOSPHOINOSITIDES_METABOL...,SET,43,0.066831,0.0032307,0.12237,0.29249,WP_PHOSPHOINOSITIDES_METABOLISM,0.99999
GOBP_REGULATION_OF_GERMINAL_...,SET,8,0.18272,0.0038135,0.33457,0.29249,GOBP_REGULATION_OF_GERMINAL_CENTER_FORMATION,0.99999
PID_CXCR4_PATHWAY,SET,95,0.048267,0.0034632,0.088394,0.29252,PID_CXCR4_PATHWAY,0.99999
GSE5099_MONOCYTE_VS_ALTERNAT...2,SET,143,0.038605,0.003394,0.070701,0.29252,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_UP,0.99999
GOBP_PROSTAGLANDIN_SECRETION,SET,18,0.1317,0.004122,0.24122,0.29254,GOBP_PROSTAGLANDIN_SECRETION,0.99999
PARK_HSC_VS_MULTIPOTENT_PROG...1,SET,14,0.12427,0.0034305,0.22763,0.29256,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,0.99999
GOCC_INTERCELLULAR_CANALICUL...,SET,6,0.21796,0.0039397,0.39923,0.29256,GOCC_INTERCELLULAR_CANALICULUS,0.99999
GOBP_SERTOLI_CELL_DIFFERENTI...,SET,17,0.10955,0.003332,0.20067,0.29257,GOBP_SERTOLI_CELL_DIFFERENTIATION,0.99999
MCCABE_HOXC6_TARGETS_DN,SET,18,0.11381,0.0035621,0.20852,0.2926,MCCABE_HOXC6_TARGETS_DN,0.99999
LINDVALL_IMMORTALIZED_BY_TER...2,SET,59,0.066714,0.003776,0.12225,0.29263,LINDVALL_IMMORTALIZED_BY_TERT_UP,0.99999
HP_RENAL_STEATOSIS,SET,9,0.18258,0.0040416,0.33466,0.29268,HP_RENAL_STEATOSIS,0.99999
GSE28726_NAIVE_VS_ACTIVATED_...2,SET,173,0.036631,0.0035392,0.067149,0.2927,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP,0.99999
KEGG_ASTHMA,SET,25,0.10445,0.0038519,0.19149,0.29272,KEGG_ASTHMA,0.99999
REACTOME_IL_6_TYPE_CYTOKINE_...,SET,17,0.11303,0.003438,0.20727,0.29277,REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,0.99999
GSE30083_SP2_VS_SP4_THYMOCYT...1,SET,186,0.034705,0.0034756,0.063659,0.29282,GSE30083_SP2_VS_SP4_THYMOCYTE_DN,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...67,SET,83,0.04942,0.0033155,0.090661,0.29284,HP_APLASIA_HYPOPLASIA_OF_THE_SPLEEN,0.99999
CASTELLANO_HRAS_AND_NRAS_TAR...1,SET,7,0.18339,0.0035805,0.33649,0.29287,CASTELLANO_HRAS_AND_NRAS_TARGETS_DN,0.99999
GSE24726_WT_VS_E2_2_KO_PDC_D...2,SET,175,0.035171,0.0034175,0.064529,0.29287,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN,0.99999
GSE14000_UNSTIM_VS_16H_LPS_D...3,SET,180,0.034719,0.003421,0.063705,0.29288,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP,0.99999
GSE3982_BASOPHIL_VS_TH1_UP,SET,179,0.03413,0.0033537,0.06263,0.2929,GSE3982_BASOPHIL_VS_TH1_UP,0.99999
HP_ABNORMAL_PLATELET_FUNCTION,SET,58,0.059477,0.0033378,0.10915,0.29291,HP_ABNORMAL_PLATELET_FUNCTION,0.99999
GOBP_PERK_MEDIATED_UNFOLDED_...,SET,20,0.1054,0.0034771,0.19344,0.29292,GOBP_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.99999
GOBP_RESPONSE_TO_OXIDATIVE_S...,SET,356,0.02513,0.0034654,0.046132,0.29297,GOBP_RESPONSE_TO_OXIDATIVE_STRESS,0.99999
GOBP_DEOXYRIBONUCLEOTIDE_CAT...,SET,28,0.088561,0.003456,0.16263,0.29303,GOBP_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS,0.99999
GSE10240_CTRL_VS_IL22_STIM_P...2,SET,182,0.035682,0.0035351,0.065531,0.29305,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.99999
GOMF_LYSOPHOSPHATIDIC_ACID_P...,SET,2,0.40909,0.0042697,0.75149,0.2931,GOMF_LYSOPHOSPHATIDIC_ACID_PHOSPHATASE_ACTIVITY,0.99999
HP_ABNORMAL_SPERM_HEAD_MORPH...,SET,26,0.096559,0.0036313,0.1774,0.29312,HP_ABNORMAL_SPERM_HEAD_MORPHOLOGY,0.99999
HP_CALCIFICATION_OF_THE_AORTA,SET,21,0.10782,0.0036444,0.19813,0.29316,HP_CALCIFICATION_OF_THE_AORTA,0.99999
MIR6813_5P,SET,36,0.070002,0.0030969,0.12868,0.29323,MIR6813_5P,0.99999
WP_TCELL_RECEPTOR_SIGNALING,SET,87,0.050717,0.0034831,0.093253,0.29327,WP_TCELL_RECEPTOR_SIGNALING,0.99999
GSE37301_MULTIPOTENT_PROGENI...11,SET,184,0.03298,0.0032851,0.060638,0.29327,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,0.99999
MODULE_211,SET,11,0.17313,0.0042367,0.31836,0.29328,MODULE_211,0.99999
RAF_UP.V1_UP,SET,176,0.038212,0.0037235,0.070284,0.29333,RAF_UP.V1_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...258,SET,17,0.1154,0.0035102,0.21228,0.29335,GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,0.99999
HP_ABNORMALITY_OF_CANINE,SET,16,0.12344,0.0036425,0.22706,0.29335,HP_ABNORMALITY_OF_CANINE,0.99999
GARCIA_PINERES_PBMC_HPV_16_L...7,SET,122,0.043612,0.0035435,0.080233,0.29337,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN,0.99999
GOBP_REGULATION_OF_TRANSCRIP...4,SET,11,0.12,0.0029364,0.22077,0.29339,GOBP_REGULATION_OF_TRANSCRIPTION_OF_NUCLEOLAR_LARGE_RRNA_BY_RNA_POLYMERASE_I,0.99999
ISHIKAWA_STING_SIGNALING,SET,10,0.13802,0.0032204,0.25396,0.29341,ISHIKAWA_STING_SIGNALING,0.99999
MIR4520_5P,SET,6,0.20572,0.0037186,0.37859,0.29343,MIR4520_5P,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...4,SET,48,0.074253,0.0037918,0.13665,0.29343,GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2,0.99999
HP_ABNORMAL_CIRCULATING_FOLL...,SET,77,0.051995,0.0033603,0.09571,0.29348,HP_ABNORMAL_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_CONCENTRATION,0.99999
HP_HYPOAMYLASEMIA,SET,4,0.2025,0.0029888,0.37277,0.29349,HP_HYPOAMYLASEMIA,0.99999
MIR548Q,SET,43,0.067935,0.003284,0.12508,0.29353,MIR548Q,0.99999
KEGG_PENTOSE_AND_GLUCURONATE...,SET,26,0.11997,0.0045116,0.22093,0.29356,KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS,0.99999
GSE9960_HEALTHY_VS_GRAM_POS_...1,SET,166,0.036837,0.0034871,0.067843,0.29357,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN,0.99999
GOBP_REGULATION_OF_CILIUM_MO...,SET,36,0.081373,0.0035999,0.14989,0.29361,GOBP_REGULATION_OF_CILIUM_MOVEMENT,0.99999
MIR630,SET,71,0.055287,0.0034316,0.10188,0.29368,MIR630,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...19,SET,164,0.037587,0.0035367,0.069265,0.29369,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN,0.99999
DELACROIX_RARG_BOUND_MEF,SET,345,0.026013,0.0035324,0.047958,0.29377,DELACROIX_RARG_BOUND_MEF,0.99999
TGGAAA_NFAT_Q4_01,SET,1694,0.012213,0.0035347,0.022519,0.29379,TGGAAA_NFAT_Q4_01,0.99999
BIOCARTA_AKAP13_PATHWAY,SET,11,0.14536,0.0035572,0.26811,0.29385,BIOCARTA_AKAP13_PATHWAY,0.99999
HP_DEVIATION_OF_THE_HAND_OR_...,SET,478,0.021158,0.0033694,0.039027,0.29386,HP_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,0.99999
GOBP_POSITIVE_REGULATION_OF_...803,SET,4,0.20179,0.0029783,0.37224,0.29388,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.99999
HP_SEMILOBAR_HOLOPROSENCEPHA...,SET,7,0.17662,0.0034482,0.32587,0.29392,HP_SEMILOBAR_HOLOPROSENCEPHALY,0.99999
JI_CARCINOGENESIS_BY_KRAS_AN...2,SET,12,0.13028,0.0033297,0.24039,0.29394,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP,0.99999
HP_CHOLESTEATOMA,SET,10,0.14757,0.0034432,0.27235,0.29397,HP_CHOLESTEATOMA,0.99999
KEGG_MEDICUS_REFERENCE_RAC_C...,SET,9,0.14692,0.0032523,0.27128,0.29405,KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY,0.99999
MIR508_5P,SET,86,0.050731,0.0034641,0.093688,0.29409,MIR508_5P,0.99999
GSE27786_NKCELL_VS_ERYTHROBL...1,SET,185,0.033027,0.0032988,0.061048,0.29425,GSE27786_NKCELL_VS_ERYTHROBLAST_DN,0.99999
MORF_PTPN9,SET,51,0.060951,0.0032081,0.11267,0.29427,MORF_PTPN9,0.99999
GOBP_DORSAL_ROOT_GANGLION_DE...,SET,7,0.20598,0.0040213,0.38086,0.29432,GOBP_DORSAL_ROOT_GANGLION_DEVELOPMENT,0.99999
GOBP_PURINE_NUCLEOSIDE_BIOSY...,SET,9,0.1715,0.0037965,0.31712,0.29432,GOBP_PURINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_LUNG_SECRETORY_CELL_DIF...,SET,11,0.14571,0.0035657,0.26946,0.29434,GOBP_LUNG_SECRETORY_CELL_DIFFERENTIATION,0.99999
GOBP_METANEPHROS_DEVELOPMENT,SET,86,0.056432,0.0038534,0.10438,0.29438,GOBP_METANEPHROS_DEVELOPMENT,0.99999
BIOCARTA_IL22BP_PATHWAY,SET,9,0.19794,0.0043816,0.36615,0.2944,BIOCARTA_IL22BP_PATHWAY,0.99999
GOBP_TRANS_SYNAPTIC_SIGNALIN...2,SET,7,0.20191,0.0039419,0.37354,0.29442,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_LIPID,0.99999
HP_INAPPROPRIATE_LAUGHTER,SET,27,0.088916,0.0034075,0.16453,0.29446,HP_INAPPROPRIATE_LAUGHTER,0.99999
GOBP_POSITIVE_REGULATION_OF_...143,SET,10,0.1426,0.0033273,0.26394,0.2945,GOBP_POSITIVE_REGULATION_OF_CELL_SIZE,0.99999
REACTOME_TRANSPORT_OF_VITAMI...,SET,38,0.074845,0.0034017,0.13855,0.29453,REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES,0.99999
GOCC_SHELTERIN_COMPLEX,SET,6,0.16939,0.0030618,0.31356,0.29453,GOCC_SHELTERIN_COMPLEX,0.99999
KIM_GLIS2_TARGETS_DN,SET,6,0.18094,0.0032706,0.33497,0.29455,KIM_GLIS2_TARGETS_DN,0.99999
MACAEVA_PBMC_RESPONSE_TO_IR,SET,90,0.047956,0.0033496,0.088783,0.29455,MACAEVA_PBMC_RESPONSE_TO_IR,0.99999
GOCC_CLATHRIN_COAT_OF_COATED...,SET,18,0.10565,0.0033067,0.1956,0.29455,GOCC_CLATHRIN_COAT_OF_COATED_PIT,0.99999
KEGG_MEDICUS_VARIANT_NOTCH_O...,SET,16,0.12159,0.0035881,0.22516,0.2946,KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY,0.99999
GOBP_CELLULAR_RESPONSE_TO_OR...1,SET,483,0.022028,0.0035257,0.040795,0.29462,GOBP_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND,0.99999
GOBP_POSITIVE_REGULATION_OF_...279,SET,6,0.22552,0.0040764,0.41793,0.29474,GOBP_POSITIVE_REGULATION_OF_FEAR_RESPONSE,0.99999
GOBP_REACTIVE_OXYGEN_SPECIES...2,SET,201,0.033816,0.003519,0.062695,0.29482,GOBP_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,0.99999
GOBP_THREONINE_METABOLIC_PRO...,SET,4,0.23775,0.003509,0.44078,0.29482,GOBP_THREONINE_METABOLIC_PROCESS,0.99999
MIR6757_5P,SET,53,0.061751,0.0033131,0.1145,0.29483,MIR6757_5P,0.99999
GOMF_PHOSPHORIC_ESTER_HYDROL...,SET,318,0.025069,0.0032708,0.046488,0.29485,GOMF_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY,0.99999
GSE7764_NKCELL_VS_SPLENOCYTE...1,SET,189,0.033363,0.0033678,0.061869,0.29486,GSE7764_NKCELL_VS_SPLENOCYTE_DN,0.99999
WARTERS_RESPONSE_TO_IR_SKIN,SET,70,0.053338,0.0032873,0.098923,0.29488,WARTERS_RESPONSE_TO_IR_SKIN,0.99999
AP4_Q6,SET,199,0.032676,0.0033836,0.060601,0.29488,AP4_Q6,0.99999
MIR361_5P,SET,152,0.038205,0.003462,0.070874,0.29493,MIR361_5P,0.99999
GOBP_REGULATION_OF_PROTEIN_C...1,SET,317,0.02556,0.0033297,0.047445,0.29504,GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.99999
GATA1_03,SET,218,0.031966,0.0034627,0.059351,0.29509,GATA1_03,0.99999
GOBP_VITAMIN_B6_METABOLIC_PR...,SET,5,0.21091,0.0034803,0.39165,0.29511,GOBP_VITAMIN_B6_METABOLIC_PROCESS,0.99999
BIOCARTA_PARKIN_PATHWAY,SET,7,0.17188,0.0033556,0.31921,0.29514,BIOCARTA_PARKIN_PATHWAY,0.99999
GOBP_ESTABLISHMENT_OF_LYMPHO...,SET,15,0.12013,0.0034325,0.22312,0.29515,GOBP_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY,0.99999
HP_FRECKLING,SET,46,0.060521,0.0030257,0.11243,0.29519,HP_FRECKLING,0.99999
REACTOME_FOXO_MEDIATED_TRANS...4,SET,28,0.092178,0.0035972,0.17125,0.2952,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...221,SET,9,0.16059,0.0035548,0.29834,0.2952,GOBP_NEGATIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,0.99999
HP_NIGHT_SWEATS,SET,10,0.15508,0.0036186,0.28817,0.29523,HP_NIGHT_SWEATS,0.99999
GOBP_REGULATION_OF_MONONUCLE...,SET,130,0.041806,0.0035056,0.077732,0.29535,GOBP_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,0.99999
GOMF_MISFOLDED_PROTEIN_BINDI...,SET,15,0.10573,0.003021,0.19658,0.29535,GOMF_MISFOLDED_PROTEIN_BINDING,0.99999
REACTOME_MINERALOCORTICOID_B...,SET,6,0.20532,0.0037113,0.38182,0.29538,REACTOME_MINERALOCORTICOID_BIOSYNTHESIS,0.99999
GOBP_SODIUM_ION_HOMEOSTASIS,SET,46,0.076745,0.0038368,0.14272,0.29539,GOBP_SODIUM_ION_HOMEOSTASIS,0.99999
GOCC_CELL_SUBSTRATE_JUNCTION,SET,411,0.022843,0.0033794,0.042482,0.29539,GOCC_CELL_SUBSTRATE_JUNCTION,0.99999
GOBP_DISTAL_CONVOLUTED_TUBUL...,SET,4,0.26962,0.0039794,0.5015,0.29542,GOBP_DISTAL_CONVOLUTED_TUBULE_DEVELOPMENT,0.99999
GOBP_PROTEIN_AUTO_ADP_RIBOSY...,SET,11,0.1473,0.0036046,0.27399,0.29542,GOBP_PROTEIN_AUTO_ADP_RIBOSYLATION,0.99999
MIR31_5P,SET,129,0.041014,0.003426,0.076299,0.29545,MIR31_5P,0.99999
GOCC_CLATHRIN_COATED_PIT,SET,73,0.051771,0.0032581,0.096317,0.29546,GOCC_CLATHRIN_COATED_PIT,0.99999
MIR6848_5P,SET,70,0.05575,0.003436,0.10372,0.29547,MIR6848_5P,0.99999
GOBP_EXTERNAL_ENCAPSULATING_...,SET,306,0.027945,0.0035776,0.052009,0.29553,GOBP_EXTERNAL_ENCAPSULATING_STRUCTURE_ORGANIZATION,0.99999
MIR29B_2_5P,SET,199,0.032855,0.0034021,0.061151,0.29554,MIR29B_2_5P,0.99999
GOBP_REGULATION_OF_DOUBLE_ST...2,SET,68,0.050844,0.0030887,0.09463,0.29554,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,0.99999
WESTON_VEGFA_TARGETS_12HR,SET,21,0.10956,0.0037035,0.20394,0.29555,WESTON_VEGFA_TARGETS_12HR,0.99999
HP_RIMMED_VACUOLES,SET,38,0.069827,0.0031736,0.12998,0.29557,HP_RIMMED_VACUOLES,0.99999
MIR6749_3P,SET,100,0.047719,0.0035123,0.088846,0.2956,MIR6749_3P,0.99999
SP1_Q6_01,SET,229,0.029248,0.0032462,0.054475,0.29567,SP1_Q6_01,0.99999
GSE15750_DAY6_VS_DAY10_EFF_C...2,SET,179,0.032853,0.0032282,0.0612,0.2957,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP,0.99999
GOBP_FACIAL_NERVE_STRUCTURAL...,SET,8,0.188,0.0039237,0.35034,0.29577,GOBP_FACIAL_NERVE_STRUCTURAL_ORGANIZATION,0.99999
GOBP_INTRACELLULAR_PH_ELEVAT...,SET,7,0.17127,0.0033438,0.31917,0.29577,GOBP_INTRACELLULAR_PH_ELEVATION,0.99999
OZEN_MIR125B1_TARGETS,SET,22,0.098791,0.0034179,0.18417,0.29584,OZEN_MIR125B1_TARGETS,0.99999
GOBP_ER_OVERLOAD_RESPONSE,SET,10,0.17073,0.0039837,0.31829,0.29584,GOBP_ER_OVERLOAD_RESPONSE,0.99999
SUNG_METASTASIS_STROMA_UP,SET,102,0.047254,0.0035125,0.088099,0.29586,SUNG_METASTASIS_STROMA_UP,0.99999
HP_ABNORMAL_ILEUM_MORPHOLOGY,SET,33,0.074793,0.0031682,0.13945,0.29586,HP_ABNORMAL_ILEUM_MORPHOLOGY,0.99999
GOMF_HEXOSYLTRANSFERASE_ACTI...,SET,184,0.036214,0.0036073,0.067523,0.29587,GOMF_HEXOSYLTRANSFERASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...451,SET,26,0.091958,0.0034582,0.1715,0.29592,GOBP_NEGATIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.99999
GSE26928_NAIVE_VS_EFF_MEMORY...2,SET,156,0.036858,0.0033832,0.068759,0.29596,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
HP_ABNORMAL_VERTEBRAL_MORPHO...,SET,421,0.022213,0.003325,0.041444,0.29599,HP_ABNORMAL_VERTEBRAL_MORPHOLOGY,0.99999
GSE14350_IL2RB_KO_VS_WT_TREG...2,SET,183,0.03359,0.003337,0.062673,0.296,GSE14350_IL2RB_KO_VS_WT_TREG_UP,0.99999
GSE22601_DOUBLE_NEGATIVE_VS_...8,SET,172,0.032712,0.0031514,0.061051,0.29605,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP,0.99999
GOMF_URIDYLYLTRANSFERASE_ACT...,SET,5,0.17247,0.0028459,0.32202,0.29613,GOMF_URIDYLYLTRANSFERASE_ACTIVITY,0.99999
HP_FRACTURES_OF_THE_LONG_BON...,SET,12,0.11443,0.0029246,0.21367,0.29615,HP_FRACTURES_OF_THE_LONG_BONES,0.99999
HP_HOLOPROSENCEPHALY,SET,69,0.052904,0.0032373,0.098815,0.29619,HP_HOLOPROSENCEPHALY,0.99999
GTGTTGA_MIR505,SET,89,0.049214,0.0034183,0.091923,0.2962,GTGTTGA_MIR505,0.99999
GOBP_CHROMOSOME_ATTACHMENT_T...,SET,4,0.20028,0.0029561,0.37415,0.29622,GOBP_CHROMOSOME_ATTACHMENT_TO_THE_NUCLEAR_ENVELOPE,0.99999
MIR6510_5P,SET,78,0.050756,0.0033014,0.094825,0.29624,MIR6510_5P,0.99999
GSE5099_CLASSICAL_M1_VS_ALTE...2,SET,178,0.034868,0.0034167,0.065141,0.29624,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP,0.99999
GOBP_RENAL_SYSTEM_DEVELOPMENT,SET,315,0.028236,0.0036669,0.052757,0.29625,GOBP_RENAL_SYSTEM_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_MYOBLAST_...1,SET,70,0.055421,0.0034157,0.10357,0.29629,GOBP_REGULATION_OF_MYOBLAST_DIFFERENTIATION,0.99999
GOBP_XMP_METABOLIC_PROCESS,SET,7,0.16684,0.0032572,0.3118,0.2963,GOBP_XMP_METABOLIC_PROCESS,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...18,SET,11,0.13914,0.003405,0.26005,0.2963,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PLASMA_CELLS,0.99999
GOBP_XENOBIOTIC_METABOLIC_PR...,SET,120,0.046499,0.0037471,0.086916,0.29633,GOBP_XENOBIOTIC_METABOLIC_PROCESS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...1,SET,28,0.08446,0.003296,0.1579,0.29636,HP_APLASIA_HYPOPLASIA_OF_THE_1ST_METACARPAL,0.99999
DESCARTES_FETAL_STOMACH_PDE1...,SET,20,0.11262,0.0037151,0.21054,0.29636,DESCARTES_FETAL_STOMACH_PDE1C_ACSM3_POSITIVE_CELLS,0.99999
FOSTER_TOLERANT_MACROPHAGE_DN,SET,382,0.024772,0.0035361,0.046328,0.29643,FOSTER_TOLERANT_MACROPHAGE_DN,0.99999
KAYO_CALORIE_RESTRICTION_MUS...2,SET,89,0.04799,0.0033333,0.089749,0.29643,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,0.99999
GSE360_L_MAJOR_VS_T_GONDII_M...2,SET,178,0.034925,0.0034223,0.065335,0.29649,GSE360_L_MAJOR_VS_T_GONDII_MAC_UP,0.99999
PAPASPYRIDONOS_UNSTABLE_ATER...2,SET,51,0.066449,0.0034975,0.12435,0.29655,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,0.99999
KEGG_MEDICUS_REFERENCE_GLUCO...,SET,5,0.18582,0.0030662,0.34781,0.29659,KEGG_MEDICUS_REFERENCE_GLUCONEOGENESIS,0.99999
GSE24210_IL35_TREATED_VS_RES...1,SET,181,0.035938,0.0035509,0.06727,0.29659,GSE24210_IL35_TREATED_VS_RESTING_TREG_DN,0.99999
HP_PAROTITIS,SET,4,0.24815,0.0036626,0.46462,0.29664,HP_PAROTITIS,0.99999
TRAVAGLINI_LUNG_MACROPHAGE_C...,SET,189,0.036274,0.0036616,0.067915,0.29664,TRAVAGLINI_LUNG_MACROPHAGE_CELL,0.99999
WP_FAMILIAL_HYPERLIPIDEMIA_T...5,SET,14,0.12808,0.0035355,0.23981,0.29665,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,0.99999
HP_ABNORMALITY_OF_CHROMOSOME...2,SET,49,0.058601,0.0030235,0.10979,0.29675,HP_ABNORMALITY_OF_CHROMOSOME_STABILITY,0.99999
REACTOME_INTERLEUKIN_12_SIGN...,SET,43,0.065426,0.0031628,0.12259,0.29678,REACTOME_INTERLEUKIN_12_SIGNALING,0.99999
MIR6827_3P,SET,72,0.052735,0.0032961,0.098828,0.29681,MIR6827_3P,0.99999
GOMF_NAD_P_H_OXIDASE_H2O2_FO...,SET,8,0.14933,0.0031166,0.27985,0.29681,GOMF_NAD_P_H_OXIDASE_H2O2_FORMING_ACTIVITY,0.99999
GOMF_RETINAL_DEHYDROGENASE_A...,SET,9,0.18653,0.004129,0.34957,0.29681,GOMF_RETINAL_DEHYDROGENASE_ACTIVITY,0.99999
GOBP_GLUTAMATERGIC_NEURON_DI...,SET,15,0.13427,0.0038364,0.25168,0.29686,GOBP_GLUTAMATERGIC_NEURON_DIFFERENTIATION,0.99999
TTCYNRGAA_STAT5B_01,SET,300,0.026867,0.0034064,0.050368,0.29688,TTCYNRGAA_STAT5B_01,0.99999
GOBP_CARTILAGE_MORPHOGENESIS,SET,9,0.17571,0.0038896,0.32947,0.29691,GOBP_CARTILAGE_MORPHOGENESIS,0.99999
GOBP_REGULATION_OF_WNT_SIGNA...1,SET,301,0.027785,0.0035285,0.052103,0.29693,GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY,0.99999
GSE3982_MAC_VS_CENT_MEMORY_C...1,SET,167,0.034423,0.0032682,0.064552,0.29693,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN,0.99999
HP_LARGE_SELLA_TURCICA,SET,14,0.11629,0.0032101,0.21809,0.29695,HP_LARGE_SELLA_TURCICA,0.99999
MIR3059_5P,SET,274,0.027637,0.0033512,0.051843,0.29699,MIR3059_5P,0.99999
AAGCCAT_MIR135A_MIR135B,SET,306,0.026331,0.0033711,0.049405,0.29703,AAGCCAT_MIR135A_MIR135B,0.99999
GOBP_PROTEIN_HEXAMERIZATION,SET,8,0.16441,0.0034314,0.30854,0.29706,GOBP_PROTEIN_HEXAMERIZATION,0.99999
GOBP_RESPONSE_TO_WOUNDING,SET,529,0.020894,0.0034953,0.039216,0.29709,GOBP_RESPONSE_TO_WOUNDING,0.99999
HP_CRANIOSYNOSTOSIS,SET,162,0.034586,0.0032346,0.064918,0.2971,HP_CRANIOSYNOSTOSIS,0.99999
REACTOME_MITOCHONDRIAL_UNCOU...,SET,6,0.18512,0.0033461,0.34749,0.29711,REACTOME_MITOCHONDRIAL_UNCOUPLING,0.99999
GOMF_PHOSPHORYLATION_DEPENDE...,SET,8,0.17423,0.0036363,0.32718,0.29719,GOMF_PHOSPHORYLATION_DEPENDENT_PROTEIN_BINDING,0.99999
DESCARTES_MAIN_FETAL_SCHWANN...,SET,37,0.076388,0.0034259,0.14346,0.2972,DESCARTES_MAIN_FETAL_SCHWANN_CELLS,0.99999
GCGNNANTTCC_UNKNOWN,SET,115,0.040399,0.0031874,0.075878,0.29722,GCGNNANTTCC_UNKNOWN,0.99999
FORTSCHEGGER_PHF8_TARGETS_UP,SET,230,0.03041,0.0033824,0.057122,0.29724,FORTSCHEGGER_PHF8_TARGETS_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...294,SET,149,0.038824,0.0034834,0.072932,0.29725,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,0.99999
AACTTT_UNKNOWN,SET,1694,0.012262,0.0035489,0.023037,0.29727,AACTTT_UNKNOWN,0.99999
GOMF_GROWTH_HORMONE_RECEPTOR...,SET,8,0.17851,0.0037256,0.33542,0.2973,GOMF_GROWTH_HORMONE_RECEPTOR_BINDING,0.99999
HP_FACIAL_TICS,SET,14,0.12363,0.0034128,0.23232,0.29731,HP_FACIAL_TICS,0.99999
DESCARTES_FETAL_LUNG_MEGAKAR...,SET,133,0.041182,0.0034926,0.077396,0.29733,DESCARTES_FETAL_LUNG_MEGAKARYOCYTES,0.99999
MIR5000_3P,SET,89,0.050025,0.0034747,0.094019,0.29734,MIR5000_3P,0.99999
GOBP_CELL_CYCLE_DNA_REPLICAT...2,SET,4,0.21569,0.0031834,0.40557,0.29743,GOBP_CELL_CYCLE_DNA_REPLICATION_INITIATION,0.99999
GOBP_CHROMOSOME_ORGANIZATION...,SET,55,0.053219,0.0029086,0.10008,0.29744,GOBP_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE,0.99999
GSE32986_CURDLAN_HIGHDOSE_VS...1,SET,185,0.035181,0.0035139,0.066157,0.29744,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.99999
MIR24_3P,SET,246,0.028733,0.0033038,0.054035,0.29745,MIR24_3P,0.99999
JAK2_DN.V1_UP,SET,158,0.039779,0.0036744,0.074806,0.29745,JAK2_DN.V1_UP,0.99999
GSE17721_0.5H_VS_4H_POLYIC_B...2,SET,182,0.031788,0.0031494,0.059792,0.29749,GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP,0.99999
HP_REDUCED_SPERM_MOTILITY,SET,58,0.057572,0.0032309,0.10832,0.29753,HP_REDUCED_SPERM_MOTILITY,0.99999
GOBP_TELOMERE_MAINTENANCE_VI...2,SET,9,0.14208,0.003145,0.26739,0.29759,GOBP_TELOMERE_MAINTENANCE_VIA_SEMI_CONSERVATIVE_REPLICATION,0.99999
HP_SIMPLIFIED_GYRAL_PATTERN,SET,78,0.048904,0.003181,0.09205,0.29761,HP_SIMPLIFIED_GYRAL_PATTERN,0.99999
chr14q11,SET,91,0.092157,0.0064723,0.17359,0.29776,chr14q11,0.99999
GSE2770_TGFB_AND_IL4_ACT_VS_...4,SET,184,0.032289,0.0032163,0.060827,0.29777,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,0.99999
GOBP_NUCLEOSIDE_BISPHOSPHATE...3,SET,111,0.043199,0.0033489,0.081399,0.29781,GOBP_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS,0.99999
HP_FATIGABLE_WEAKNESS_OF_RES...,SET,57,0.059576,0.0033145,0.11226,0.29781,HP_FATIGABLE_WEAKNESS_OF_RESPIRATORY_MUSCLES,0.99999
HP_ABNORMALITY_OF_THE_ANUS,SET,197,0.032166,0.0033142,0.06062,0.29784,HP_ABNORMALITY_OF_THE_ANUS,0.99999
REACTOME_CD28_CO_STIMULATION,SET,32,0.084494,0.0035246,0.15925,0.29786,REACTOME_CD28_CO_STIMULATION,0.99999
GOMF_ABC_TYPE_TRANSPORTER_AC...,SET,46,0.072436,0.0036214,0.13653,0.29787,GOMF_ABC_TYPE_TRANSPORTER_ACTIVITY,0.99999
GOBP_RESPONSE_TO_MUSCLE_ACTI...,SET,24,0.1021,0.0036891,0.19251,0.29794,GOBP_RESPONSE_TO_MUSCLE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...445,SET,7,0.15864,0.0030971,0.29915,0.29796,GOBP_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,0.99999
GOBP_REGULATION_OF_MACROPHAG...1,SET,54,0.064714,0.0035047,0.12204,0.29797,GOBP_REGULATION_OF_MACROPHAGE_ACTIVATION,0.99999
DESCARTES_FETAL_SPLEEN_AFP_A...,SET,170,0.036773,0.0035223,0.06937,0.29802,DESCARTES_FETAL_SPLEEN_AFP_ALB_POSITIVE_CELLS,0.99999
KEGG_MEDICUS_PATHOGEN_HBV_HB...1,SET,13,0.11654,0.0031,0.21986,0.29804,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION,0.99999
RYTGCNNRGNAAC_MIF1_01,SET,78,0.052123,0.0033903,0.098367,0.2981,RYTGCNNRGNAAC_MIF1_01,0.99999
STARK_BRAIN_22Q11_DELETION,SET,10,0.14408,0.0033617,0.27204,0.2982,STARK_BRAIN_22Q11_DELETION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...646,SET,6,0.20499,0.0037053,0.38719,0.29826,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,0.99999
GSE22886_NAIVE_BCELL_VS_NEUT...1,SET,178,0.035678,0.003496,0.067425,0.29836,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN,0.99999
GOBP_REGULATION_OF_ORGANELLE...1,SET,231,0.028639,0.0031922,0.054127,0.29837,GOBP_REGULATION_OF_ORGANELLE_ASSEMBLY,0.99999
MIR4264,SET,97,0.04706,0.0034117,0.088961,0.29841,MIR4264,0.99999
MIR7112_3P,SET,87,0.050886,0.0034947,0.096199,0.29842,MIR7112_3P,0.99999
HP_ACRAL_BLISTERING,SET,9,0.14988,0.0033177,0.28334,0.29842,HP_ACRAL_BLISTERING,0.99999
HP_DIFFUSE_MESANGIAL_SCLEROS...,SET,38,0.072276,0.0032849,0.1367,0.2985,HP_DIFFUSE_MESANGIAL_SCLEROSIS,0.99999
TENEDINI_MEGAKARYOCYTE_MARKE...,SET,60,0.061016,0.0034826,0.11541,0.29851,TENEDINI_MEGAKARYOCYTE_MARKERS,0.99999
GOBP_NEURAL_TUBE_DEVELOPMENT,SET,151,0.037329,0.0033715,0.070609,0.29852,GOBP_NEURAL_TUBE_DEVELOPMENT,0.99999
GOBP_AEROBIC_RESPIRATION,SET,147,0.034118,0.0030408,0.06456,0.29859,GOBP_AEROBIC_RESPIRATION,0.99999
HP_JUVENILE_ASEPTIC_NECROSIS,SET,41,0.0721,0.0034035,0.13644,0.29861,HP_JUVENILE_ASEPTIC_NECROSIS,0.99999
BIOCARTA_MTOR_PATHWAY,SET,21,0.1006,0.0034006,0.19039,0.29862,BIOCARTA_MTOR_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...122,SET,54,0.061576,0.0033347,0.11656,0.29865,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,0.99999
TANG_SENESCENCE_TP53_TARGETS...2,SET,31,0.081371,0.003341,0.15403,0.29866,TANG_SENESCENCE_TP53_TARGETS_UP,0.99999
HP_NEONATAL_BREATHING_DYSREG...,SET,5,0.17744,0.0029279,0.3359,0.29866,HP_NEONATAL_BREATHING_DYSREGULATION,0.99999
REACTOME_SYNTHESIS_OF_EPOXY_...,SET,8,0.1626,0.0033937,0.30791,0.29872,REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET,0.99999
MIR6839_3P,SET,146,0.038854,0.0034512,0.073585,0.29875,MIR6839_3P,0.99999
GRAHAM_CML_QUIESCENT_VS_CML_...2,SET,23,0.11366,0.0040205,0.21527,0.29876,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,0.99999
GOMF_ENOYL_COA_HYDRATASE_ACT...,SET,11,0.15568,0.0038097,0.29508,0.2989,GOMF_ENOYL_COA_HYDRATASE_ACTIVITY,0.99999
HAY_BONE_MARROW_NK_CELLS,SET,323,0.025812,0.0033936,0.048939,0.29895,HAY_BONE_MARROW_NK_CELLS,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_MID...,SET,237,0.031897,0.0036007,0.060478,0.29896,HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL,0.99999
GOBP_REGULATION_OF_INTRINSIC...3,SET,35,0.074244,0.0032387,0.14079,0.29898,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.99999
HP_BROAD_COLUMELLA,SET,12,0.12308,0.0031458,0.23344,0.29901,HP_BROAD_COLUMELLA,0.99999
chr16q21,SET,37,0.139,0.0062341,0.26368,0.29904,chr16q21,0.99999
KRASNOSELSKAYA_ILF3_TARGETS_...2,SET,36,0.081649,0.0036121,0.15488,0.29904,KRASNOSELSKAYA_ILF3_TARGETS_UP,0.99999
GOBP_CYTIDINE_TO_URIDINE_EDI...,SET,10,0.18899,0.0044096,0.3585,0.29904,GOBP_CYTIDINE_TO_URIDINE_EDITING,0.99999
GOMF_THIOL_OXIDASE_ACTIVITY,SET,4,0.18644,0.0027518,0.35369,0.29905,GOMF_THIOL_OXIDASE_ACTIVITY,0.99999
HP_DUANE_ANOMALY,SET,22,0.099994,0.0034595,0.18974,0.2991,HP_DUANE_ANOMALY,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...1,SET,5,0.21407,0.0035324,0.4064,0.29919,GOBP_REGULATION_OF_SYNAPTIC_ASSEMBLY_AT_NEUROMUSCULAR_JUNCTION,0.99999
GOBP_ANIMAL_ORGAN_FORMATION,SET,64,0.06176,0.0036402,0.11726,0.29921,GOBP_ANIMAL_ORGAN_FORMATION,0.99999
GOBP_MAINTENANCE_OF_LOCATION...,SET,209,0.031533,0.0033453,0.05987,0.29921,GOBP_MAINTENANCE_OF_LOCATION_IN_CELL,0.99999
GOBP_REGULATION_OF_MUSCLE_SY...,SET,215,0.032697,0.0035177,0.062112,0.2993,GOBP_REGULATION_OF_MUSCLE_SYSTEM_PROCESS,0.99999
MIKKELSEN_NPC_HCP_WITH_H3K27...,SET,330,0.028033,0.0037245,0.05326,0.29933,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,0.99999
GOBP_ASTROCYTE_CELL_MIGRATION,SET,9,0.1617,0.0035794,0.30724,0.29934,GOBP_ASTROCYTE_CELL_MIGRATION,0.99999
MIR7106_3P,SET,37,0.077489,0.0034753,0.14728,0.2994,MIR7106_3P,0.99999
REACTOME_NR1H2_NR1H3_REGULAT...3,SET,5,0.1612,0.00266,0.3064,0.29941,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE,0.99999
LANDIS_ERBB2_BREAST_PRENEOPL...1,SET,56,0.062281,0.0034346,0.11839,0.29942,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...519,SET,10,0.16161,0.0037709,0.30721,0.29942,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION,0.99999
MIR3156_5P,SET,61,0.063345,0.0036454,0.12041,0.29943,MIR3156_5P,0.99999
MIR4766_5P,SET,293,0.026731,0.00335,0.050818,0.29944,MIR4766_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...139,SET,319,0.025852,0.0033781,0.049146,0.29944,GOBP_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.99999
BCAT.100_UP.V1_UP,SET,45,0.076737,0.0037946,0.14597,0.29955,BCAT.100_UP.V1_UP,0.99999
GOMF_IODIDE_TRANSMEMBRANE_TR...,SET,5,0.17919,0.0029569,0.34091,0.29957,GOMF_IODIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...6,SET,187,0.033118,0.0033255,0.063013,0.29959,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_UP,0.99999
GOBP_REGULATION_OF_RECEPTOR_...4,SET,61,0.05817,0.0033476,0.1107,0.29964,GOBP_REGULATION_OF_RECEPTOR_INTERNALIZATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...799,SET,14,0.125,0.0034505,0.2379,0.29965,GOBP_POSITIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.99999
GSE19888_CTRL_VS_T_CELL_MEMB...2,SET,184,0.031375,0.0031253,0.059718,0.29966,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP,0.99999
GSE5099_UNSTIM_VS_MCSF_TREAT...2,SET,177,0.032879,0.0032128,0.062582,0.29967,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_UP,0.99999
GOBP_CRANIAL_NERVE_FORMATION,SET,10,0.17302,0.0040369,0.32952,0.29978,GOBP_CRANIAL_NERVE_FORMATION,0.99999
HP_DELAYED_ERUPTION_OF_PERMA...,SET,32,0.079637,0.003322,0.15171,0.29981,HP_DELAYED_ERUPTION_OF_PERMANENT_TEETH,0.99999
GOBP_DNA_CATABOLIC_PROCESS,SET,27,0.083062,0.0031831,0.15826,0.29985,GOBP_DNA_CATABOLIC_PROCESS,0.99999
HP_MANDIBULAR_PROGNATHIA,SET,174,0.032862,0.0031841,0.062615,0.29986,HP_MANDIBULAR_PROGNATHIA,0.99999
GSE4590_PRE_BCELL_VS_LARGE_P...2,SET,142,0.040413,0.0035405,0.077035,0.29993,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP,0.99999
GOMF_N_ACETYLGLUCOSAMINE_6_O...,SET,6,0.19559,0.0035354,0.37286,0.29995,GOMF_N_ACETYLGLUCOSAMINE_6_O_SULFOTRANSFERASE_ACTIVITY,0.99999
GSE8835_CD4_VS_CD8_TCELL_CLL...2,SET,189,0.034232,0.0034554,0.06527,0.29998,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP,0.99999
HP_3_4_TOE_SYNDACTYLY,SET,6,0.19529,0.0035299,0.37261,0.30011,HP_3_4_TOE_SYNDACTYLY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...572,SET,8,0.15707,0.0032782,0.29974,0.30013,GOBP_NEGATIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.99999
WP_ARYLAMINE_METABOLISM,SET,6,0.24101,0.0043565,0.46008,0.30019,WP_ARYLAMINE_METABOLISM,0.99999
GOBP_CELL_CELL_ADHESION_MEDI...2,SET,17,0.10889,0.003312,0.20787,0.30021,GOBP_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.99999
HP_TRANSIENT_GLOBAL_AMNESIA,SET,20,0.096384,0.0031796,0.18409,0.30029,HP_TRANSIENT_GLOBAL_AMNESIA,0.99999
MIR3614_3P,SET,58,0.057802,0.0032438,0.11043,0.30034,MIR3614_3P,0.99999
HP_PULMONARY_INSUFFICIENCY,SET,24,0.094416,0.0034116,0.18041,0.30037,HP_PULMONARY_INSUFFICIENCY,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...83,SET,8,0.16578,0.0034599,0.31685,0.30042,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_CEREBRAL_CORTEX_...,SET,676,0.017288,0.0032558,0.033051,0.30047,HP_ABNORMAL_CEREBRAL_CORTEX_MORPHOLOGY,0.99999
REACTOME_THE_NLRP3_INFLAMMAS...,SET,14,0.11632,0.0032111,0.2224,0.30048,REACTOME_THE_NLRP3_INFLAMMASOME,0.99999
GOBP_HEART_PROCESS,SET,240,0.031222,0.0035465,0.059701,0.3005,GOBP_HEART_PROCESS,0.99999
MIR3198,SET,42,0.066089,0.0031575,0.12644,0.3006,MIR3198,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...22,SET,13,0.12377,0.0032924,0.23681,0.30062,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,0.99999
GOMF_HEMOGLOBIN_ALPHA_BINDING,SET,4,0.31207,0.004606,0.5972,0.30064,GOMF_HEMOGLOBIN_ALPHA_BINDING,0.99999
GOBP_LYMPHANGIOGENESIS,SET,17,0.11002,0.0033466,0.2106,0.30068,GOBP_LYMPHANGIOGENESIS,0.99999
GOBP_MAINTENANCE_OF_PROTEIN_...2,SET,42,0.064399,0.0030768,0.12326,0.30068,GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE,0.99999
KEGG_GLUTATHIONE_METABOLISM,SET,45,0.073104,0.0036149,0.13995,0.30072,KEGG_GLUTATHIONE_METABOLISM,0.99999
GOMF_ACTIVIN_RECEPTOR_ACTIVI...2,SET,5,0.25036,0.0041311,0.47931,0.30073,GOMF_ACTIVIN_RECEPTOR_ACTIVITY_TYPE_I,0.99999
MIR937_5P,SET,50,0.065873,0.0034331,0.12614,0.30077,MIR937_5P,0.99999
GOMF_POLY_A_RNA_POLYMERASE_A...,SET,5,0.21498,0.0035474,0.41172,0.30079,GOMF_POLY_A_RNA_POLYMERASE_ACTIVITY,0.99999
GSE23321_CENTRAL_VS_EFFECTOR...2,SET,181,0.033497,0.0033097,0.064153,0.30079,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,0.99999
GSE23114_PERITONEAL_CAVITY_B...4,SET,164,0.034936,0.0032873,0.066912,0.3008,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_UP,0.99999
GOBP_REGULATION_OF_CELL_PROL...1,SET,15,0.12867,0.0036764,0.24645,0.30081,GOBP_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.99999
GSE42021_TCONV_PLN_VS_CD24LO...2,SET,181,0.032498,0.0032109,0.062247,0.30081,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_UP,0.99999
GOBP_ATRIAL_CARDIAC_MUSCLE_T...2,SET,5,0.23048,0.0038032,0.44162,0.30087,GOBP_ATRIAL_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,0.99999
GOCC_TRANSLATION_PREINITIATI...,SET,15,0.10617,0.0030337,0.20343,0.30087,GOCC_TRANSLATION_PREINITIATION_COMPLEX,0.99999
GOBP_REGULATION_OF_PRIMARY_M...,SET,5,0.2248,0.0037094,0.43091,0.30095,GOBP_REGULATION_OF_PRIMARY_MIRNA_PROCESSING,0.99999
GOMF_MRNA_BINDING,SET,304,0.02371,0.0030257,0.045448,0.30095,GOMF_MRNA_BINDING,0.99999
WP_IL10_ANTIINFLAMMATORY_SIG...,SET,12,0.12463,0.0031853,0.23891,0.30096,WP_IL10_ANTIINFLAMMATORY_SIGNALING,0.99999
MORF_G22P1,SET,152,0.033083,0.0029979,0.063428,0.30098,MORF_G22P1,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...19,SET,178,0.034963,0.003426,0.067034,0.30099,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN,0.99999
GOCC_GOLGI_CIS_CISTERNA,SET,15,0.10787,0.0030823,0.20688,0.30104,GOCC_GOLGI_CIS_CISTERNA,0.99999
WP_MICRORNA_NETWORK_ASSOCIAT...,SET,4,0.24578,0.0036275,0.4715,0.3011,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,0.99999
METTL14_TARGET_GENES,SET,109,0.042819,0.0032896,0.082168,0.30115,METTL14_TARGET_GENES,0.99999
ZNF697_TARGET_GENES,SET,121,0.03871,0.0031323,0.074285,0.30115,ZNF697_TARGET_GENES,0.99999
GSE2405_HEAT_KILLED_VS_LIVE_...3,SET,183,0.033549,0.0033329,0.064379,0.30115,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,0.99999
HP_ABNORMALITY_OF_MOUTH_SHAPE,SET,240,0.028875,0.0032799,0.055428,0.30121,HP_ABNORMALITY_OF_MOUTH_SHAPE,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_ADV...,SET,62,0.060037,0.0034831,0.11528,0.30126,HE_LIM_SUN_FETAL_LUNG_C0_ADVENTITIAL_FIBROBLAST,0.99999
REACTOME_ERYTHROPOIETIN_ACTI...1,SET,12,0.14618,0.0037361,0.28071,0.30128,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,0.99999
GSE339_EX_VIVO_VS_IN_CULTURE...1,SET,180,0.032478,0.0032002,0.062382,0.30131,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN,0.99999
MODULE_433,SET,59,0.066503,0.003764,0.12774,0.30132,MODULE_433,0.99999
GOBP_NEGATIVE_REGULATION_OF_...535,SET,6,0.18993,0.003433,0.36488,0.30135,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,0.99999
HP_BIFID_NOSE,SET,11,0.13457,0.003293,0.25863,0.30142,HP_BIFID_NOSE,0.99999
UNTERMAN_IPF_VS_CTRL_TREG_CE...1,SET,16,0.12963,0.0038251,0.24917,0.30146,UNTERMAN_IPF_VS_CTRL_TREG_CELL_DN,0.99999
HP_ABNORMAL_FACIAL_SKELETON_...,SET,1162,0.013276,0.0032326,0.025524,0.30149,HP_ABNORMAL_FACIAL_SKELETON_MORPHOLOGY,0.99999
MIR6509_5P,SET,88,0.048401,0.003343,0.09307,0.30152,MIR6509_5P,0.99999
HP_OPTIC_DISC_DRUSEN,SET,12,0.13592,0.0034739,0.26138,0.30153,HP_OPTIC_DISC_DRUSEN,0.99999
MIR3140_3P,SET,207,0.032172,0.0033969,0.061871,0.30154,MIR3140_3P,0.99999
REACTOME_N_GLYCAN_ANTENNAE_E...1,SET,15,0.12591,0.0035975,0.24219,0.30158,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION,0.99999
GOBP_FAT_CELL_PROLIFERATION,SET,15,0.12823,0.0036638,0.24665,0.30158,GOBP_FAT_CELL_PROLIFERATION,0.99999
HADDAD_T_LYMPHOCYTE_AND_NK_P...2,SET,73,0.057523,0.0036201,0.11066,0.3016,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,0.99999
MIR378F,SET,36,0.070309,0.0031104,0.13536,0.30174,MIR378F,0.99999
GOMF_VOLUME_SENSITIVE_ANION_...,SET,9,0.1642,0.0036348,0.31617,0.30176,GOMF_VOLUME_SENSITIVE_ANION_CHANNEL_ACTIVITY,0.99999
GSE11961_MARGINAL_ZONE_BCELL...10,SET,185,0.032303,0.0032264,0.062202,0.30177,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_UP,0.99999
MIR4763_3P,SET,228,0.02984,0.0033047,0.057462,0.30178,MIR4763_3P,0.99999
REACTOME_VASOPRESSIN_LIKE_RE...,SET,5,0.23977,0.0039565,0.46195,0.30187,REACTOME_VASOPRESSIN_LIKE_RECEPTORS,0.99999
HP_ATROPHIC_SCARS,SET,33,0.07995,0.0033867,0.15405,0.30189,HP_ATROPHIC_SCARS,0.99999
HP_BROAD_FOOT,SET,26,0.092164,0.003466,0.17759,0.30189,HP_BROAD_FOOT,0.99999
KAZMIN_PBMC_P_FALCIPARUM_RTS...2,SET,6,0.17489,0.0031612,0.33699,0.3019,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_POSITIVE,0.99999
MIR4647_MIR4662B,SET,77,0.050805,0.0032834,0.097921,0.30194,MIR4647_MIR4662B,0.99999
BIOCARTA_CASPASE_PATHWAY,SET,21,0.096403,0.0032587,0.18583,0.30196,BIOCARTA_CASPASE_PATHWAY,0.99999
GSE27786_LIN_NEG_VS_CD4_TCEL...2,SET,180,0.031725,0.003126,0.06117,0.30201,GSE27786_LIN_NEG_VS_CD4_TCELL_UP,0.99999
GOMF_N_ACYLTRANSFERASE_ACTIV...,SET,79,0.048321,0.003163,0.093227,0.30212,GOMF_N_ACYLTRANSFERASE_ACTIVITY,0.99999
GSE17721_PAM3CSK4_VS_CPG_24H...1,SET,182,0.032024,0.0031727,0.061789,0.30214,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_DN,0.99999
YY1_Q6,SET,221,0.029804,0.0032503,0.057516,0.30217,YY1_Q6,0.99999
MIR92A_1_5P,SET,40,0.070738,0.0032983,0.13654,0.30221,MIR92A_1_5P,0.99999
GSE339_CD4POS_VS_CD8POS_DC_DN,SET,185,0.03211,0.0032071,0.061985,0.30222,GSE339_CD4POS_VS_CD8POS_DC_DN,0.99999
HP_ABNORMALITY_OF_GLOBE_LOCA...,SET,965,0.014428,0.0032199,0.027853,0.30223,HP_ABNORMALITY_OF_GLOBE_LOCATION,0.99999
GOBP_RESPONSE_TO_NICOTINE,SET,51,0.06973,0.0036702,0.13471,0.30236,GOBP_RESPONSE_TO_NICOTINE,0.99999
HP_PRIMARY_MICROCEPHALY,SET,67,0.050546,0.003048,0.097664,0.30239,HP_PRIMARY_MICROCEPHALY,0.99999
MIR6791_3P,SET,76,0.052135,0.0033475,0.10076,0.30243,MIR6791_3P,0.99999
REACTOME_APC_C_CDC20_MEDIATE...,SET,22,0.087046,0.0030115,0.16832,0.30253,REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B,0.99999
WP_CANNABINOID_RECEPTOR_SIGN...,SET,29,0.08535,0.0033896,0.16506,0.30255,WP_CANNABINOID_RECEPTOR_SIGNALING,0.99999
GOMF_GLYCOSYLTRANSFERASE_ACT...,SET,254,0.029218,0.0034129,0.056548,0.30269,GOMF_GLYCOSYLTRANSFERASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...746,SET,6,0.19071,0.0034471,0.36911,0.3027,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_FUSION_TO_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE,0.99999
MIR1255B_2_3P,SET,78,0.047275,0.003075,0.091505,0.30271,MIR1255B_2_3P,0.99999
MIR3173_3P,SET,90,0.045227,0.0031589,0.087546,0.30272,MIR3173_3P,0.99999
OVOL3_TARGET_GENES,SET,391,0.021912,0.0031636,0.042416,0.30272,OVOL3_TARGET_GENES,0.99999
HP_ABNORMAL_1ST_METACARPAL_M...,SET,31,0.07809,0.0032062,0.15125,0.30282,HP_ABNORMAL_1ST_METACARPAL_MORPHOLOGY,0.99999
GOBP_SPINAL_CORD_DEVELOPMENT,SET,93,0.049829,0.0035376,0.096515,0.30283,GOBP_SPINAL_CORD_DEVELOPMENT,0.99999
HP_LONG_NOSE,SET,32,0.074898,0.0031243,0.14509,0.30285,HP_LONG_NOSE,0.99999
AIYAR_COBRA1_TARGETS_UP,SET,36,0.077641,0.0034348,0.15041,0.30286,AIYAR_COBRA1_TARGETS_UP,0.99999
REACTOME_CLASS_I_MHC_MEDIATE...,SET,353,0.022758,0.0031253,0.044092,0.30288,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,0.99999
GARCIA_PINERES_PBMC_HPV_16_L...3,SET,256,0.028111,0.0032964,0.054465,0.30288,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN,0.99999
GOBP_FARNESYL_DIPHOSPHATE_ME...,SET,5,0.17135,0.0028275,0.33206,0.30292,GOBP_FARNESYL_DIPHOSPHATE_METABOLIC_PROCESS,0.99999
GOMF_PHOSPHATIDYLINOSITOL_3_...6,SET,5,0.15333,0.0025301,0.29713,0.30292,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.99999
HOFFMANN_IMMATURE_TO_MATURE_...1,SET,43,0.071494,0.0034561,0.13856,0.30294,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN,0.99999
MYC_Q2,SET,180,0.033784,0.0033289,0.065481,0.30295,MYC_Q2,0.99999
GOBP_MIDGUT_DEVELOPMENT,SET,11,0.1568,0.0038372,0.30395,0.30297,GOBP_MIDGUT_DEVELOPMENT,0.99999
DESCARTES_FETAL_INTESTINE_ER...,SET,132,0.039416,0.0033302,0.076427,0.30303,DESCARTES_FETAL_INTESTINE_ERYTHROBLASTS,0.99999
GSE17721_LPS_VS_PAM3CSK4_2H_...2,SET,184,0.034254,0.0034121,0.066439,0.30308,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_UP,0.99999
LIEN_BREAST_CARCINOMA_METAPL...3,SET,73,0.056509,0.0035563,0.10962,0.3031,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...63,SET,27,0.076171,0.002919,0.14779,0.30314,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT,0.99999
HP_CHROMOSOMAL_BREAKAGE_INDU...1,SET,16,0.095777,0.0028263,0.18583,0.30314,HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_CROSSLINKING_AGENTS,0.99999
HP_PARTIAL_ATRIOVENTRICULAR_...,SET,5,0.18059,0.0029799,0.35045,0.30317,HP_PARTIAL_ATRIOVENTRICULAR_CANAL_DEFECT,0.99999
GOBP_REGULATION_OF_ACUTE_INF...2,SET,13,0.12341,0.003283,0.23952,0.30319,GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.99999
VEGF_A_UP.V1_DN,SET,181,0.031265,0.0030891,0.060683,0.3032,VEGF_A_UP.V1_DN,0.99999
GSE15330_HSC_VS_GRANULOCYTE_...2,SET,173,0.03229,0.0031198,0.062689,0.30325,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_RE...2,SET,136,0.038744,0.0033224,0.075226,0.30327,GOBP_CELLULAR_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,0.99999
GSE37533_UNTREATED_VS_PIOGLI...1,SET,150,0.035026,0.0031531,0.068015,0.30329,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_DN,0.99999
HALLMARK_E2F_TARGETS,SET,188,0.029659,0.002986,0.057599,0.30331,HALLMARK_E2F_TARGETS,0.99999
KYNG_DNA_DAMAGE_BY_4NQO_OR_G...,SET,15,0.11094,0.0031699,0.21549,0.30334,KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION,0.99999
GSE13887_ACT_CD4_VS_NO_TREAT...1,SET,119,0.042338,0.0033977,0.082251,0.30337,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_DN,0.99999
SCIBETTA_KDM5B_TARGETS_DN,SET,75,0.050394,0.0032145,0.097924,0.30341,SCIBETTA_KDM5B_TARGETS_DN,0.99999
HP_GONADOTROPIN_DEFICIENCY,SET,8,0.17544,0.0036615,0.34092,0.30342,HP_GONADOTROPIN_DEFICIENCY,0.99999
GOCC_NUCLEAR_MEMBRANE,SET,282,0.025827,0.0031764,0.050193,0.30343,GOCC_NUCLEAR_MEMBRANE,0.99999
LEF1_UP.V1_UP,SET,173,0.035484,0.0034284,0.06896,0.30343,LEF1_UP.V1_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...166,SET,135,0.037314,0.0031881,0.072535,0.30348,GOBP_NEGATIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,0.99999
HP_FREQUENT_TEMPER_TANTRUMS,SET,8,0.15283,0.0031896,0.29715,0.30352,HP_FREQUENT_TEMPER_TANTRUMS,0.99999
GOBP_POSITIVE_REGULATION_OF_...479,SET,6,0.15538,0.0028086,0.30213,0.30353,GOBP_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION,0.99999
REACTOME_CRMPS_IN_SEMA3A_SIG...,SET,15,0.12316,0.0035191,0.2395,0.30355,REACTOME_CRMPS_IN_SEMA3A_SIGNALING,0.99999
HP_NASOGASTRIC_TUBE_FEEDING_...,SET,34,0.074012,0.0031822,0.14395,0.30358,HP_NASOGASTRIC_TUBE_FEEDING_IN_INFANCY,0.99999
WP_ARYL_HYDROCARBON_RECEPTOR...2,SET,45,0.066038,0.0032655,0.1285,0.30366,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,0.99999
GSE11884_WT_VS_FURIN_KO_NAIV...2,SET,121,0.041029,0.0033199,0.079846,0.30368,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_UP,0.99999
GSE46242_CTRL_VS_EGR2_DELETE...1,SET,167,0.034867,0.0033103,0.067856,0.30369,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_DN,0.99999
TCOF1_TARGET_GENES,SET,12,0.1301,0.0033252,0.25338,0.30382,TCOF1_TARGET_GENES,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...9,SET,40,0.069901,0.0032593,0.13618,0.30387,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_2,0.99999
GNF2_MSN,SET,20,0.094464,0.0031162,0.18403,0.30387,GNF2_MSN,0.99999
REACTOME_RNA_POLYMERASE_I_TR...3,SET,26,0.072982,0.0027446,0.14219,0.30388,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION,0.99999
ZNF140_TARGET_GENES,SET,551,0.01849,0.0031549,0.036027,0.3039,ZNF140_TARGET_GENES,0.99999
MIR219B_3P,SET,54,0.063591,0.0034438,0.12392,0.30393,MIR219B_3P,0.99999
GOMF_PLATELET_DERIVED_GROWTH...2,SET,13,0.13945,0.0037095,0.27176,0.30393,GOMF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BINDING,0.99999
GOMF_METALLOCARBOXYPEPTIDASE...,SET,29,0.091016,0.0036146,0.17741,0.30397,GOMF_METALLOCARBOXYPEPTIDASE_ACTIVITY,0.99999
MIR488_3P,SET,168,0.033579,0.0031975,0.065456,0.30398,MIR488_3P,0.99999
HP_MULTIPLE_EPIPHYSEAL_DYSPL...,SET,8,0.1471,0.0030701,0.2868,0.30401,HP_MULTIPLE_EPIPHYSEAL_DYSPLASIA,0.99999
REACTOME_NR1H2_AND_NR1H3_MED...,SET,42,0.068672,0.0032809,0.13389,0.30402,REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,0.99999
MIR6875_5P,SET,62,0.055082,0.0031957,0.10745,0.30411,MIR6875_5P,0.99999
GOBP_REGULATION_OF_CILIUM_BE...2,SET,9,0.14256,0.0031558,0.27814,0.30413,GOBP_REGULATION_OF_CILIUM_BEAT_FREQUENCY_INVOLVED_IN_CILIARY_MOTILITY,0.99999
HP_ABNORMAL_PLATELET_GRANULES,SET,12,0.11679,0.002985,0.22787,0.30414,HP_ABNORMAL_PLATELET_GRANULES,0.99999
HALLMARK_MITOTIC_SPINDLE,SET,187,0.030531,0.0030657,0.05958,0.30417,HALLMARK_MITOTIC_SPINDLE,0.99999
PETRETTO_BLOOD_PRESSURE_DN,SET,7,0.17635,0.0034428,0.34433,0.30428,PETRETTO_BLOOD_PRESSURE_DN,0.99999
RAMASWAMY_METASTASIS_DN,SET,51,0.061653,0.003245,0.12039,0.3043,RAMASWAMY_METASTASIS_DN,0.99999
MIR544B,SET,191,0.031161,0.0031618,0.06087,0.30436,MIR544B,0.99999
GOBP_LUNG_MORPHOGENESIS,SET,54,0.064503,0.0034932,0.12601,0.30437,GOBP_LUNG_MORPHOGENESIS,0.99999
REACTOME_ASSEMBLY_OF_ACTIVE_...,SET,16,0.12063,0.0035596,0.23568,0.30439,REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,0.99999
GOCC_CRD_MEDIATED_MRNA_STABI...,SET,6,0.15962,0.0028852,0.31193,0.30443,GOCC_CRD_MEDIATED_MRNA_STABILITY_COMPLEX,0.99999
GSE5589_WT_VS_IL10_KO_LPS_ST...4,SET,179,0.031871,0.0031317,0.062299,0.30447,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,0.99999
MIR3691_3P,SET,59,0.052077,0.0029476,0.10182,0.30452,MIR3691_3P,0.99999
GOBP_RESPONSE_TO_ELECTRICAL_...,SET,41,0.070398,0.0033232,0.13765,0.30452,GOBP_RESPONSE_TO_ELECTRICAL_STIMULUS,0.99999
MIR3171,SET,73,0.047873,0.0030129,0.09366,0.30463,MIR3171,0.99999
HP_RECURRENT_KLEBSIELLA_INFE...,SET,4,0.25571,0.0037741,0.50028,0.30463,HP_RECURRENT_KLEBSIELLA_INFECTIONS,0.99999
GSE37533_PPARG1_FOXP3_VS_FOX...3,SET,189,0.032469,0.0032775,0.063552,0.30471,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,0.99999
GOBP_HUMORAL_IMMUNE_RESPONSE...,SET,41,0.075964,0.0035859,0.14872,0.30476,GOBP_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.99999
HP_INCREASED_RED_BLOOD_CELL_...,SET,5,0.18824,0.0031062,0.36857,0.30477,HP_INCREASED_RED_BLOOD_CELL_MASS,0.99999
GRAESSMANN_RESPONSE_TO_MC_AN...1,SET,696,0.01628,0.0031093,0.031883,0.30481,GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN,0.99999
HP_DEFORMED_SELLA_TURCICA,SET,18,0.09142,0.0028612,0.1791,0.30487,HP_DEFORMED_SELLA_TURCICA,0.99999
HP_RENAL_PHOSPHATE_WASTING,SET,11,0.14523,0.003554,0.28454,0.30489,HP_RENAL_PHOSPHATE_WASTING,0.99999
GOBP_PROTEASOME_ASSEMBLY,SET,11,0.12439,0.003044,0.24393,0.30505,GOBP_PROTEASOME_ASSEMBLY,0.99999
GOBP_NEURON_CELLULAR_HOMEOST...,SET,58,0.056988,0.0031981,0.11178,0.3051,GOBP_NEURON_CELLULAR_HOMEOSTASIS,0.99999
GOBP_OSTEOCLAST_FUSION,SET,6,0.19094,0.0034513,0.37455,0.30511,GOBP_OSTEOCLAST_FUSION,0.99999
MIR18B_3P,SET,46,0.063266,0.0031629,0.12411,0.30512,MIR18B_3P,0.99999
GOBP_LEUKOTRIENE_CATABOLIC_P...,SET,6,0.17585,0.0031786,0.34499,0.30512,GOBP_LEUKOTRIENE_CATABOLIC_PROCESS,0.99999
GSE29164_CD8_TCELL_VS_CD8_TC...2,SET,175,0.032007,0.00311,0.062789,0.30512,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...118,SET,28,0.082834,0.0032326,0.16256,0.30518,GOBP_NEGATIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,0.99999
MA_MYELOID_DIFFERENTIATION_UP,SET,37,0.070991,0.0031838,0.13935,0.30522,MA_MYELOID_DIFFERENTIATION_UP,0.99999
GOBP_PERICYTE_CELL_DIFFERENT...,SET,10,0.14559,0.003397,0.28582,0.30525,GOBP_PERICYTE_CELL_DIFFERENTIATION,0.99999
TERAMOTO_OPN_TARGETS_CLUSTER...6,SET,17,0.10748,0.0032691,0.2111,0.30533,TERAMOTO_OPN_TARGETS_CLUSTER_7,0.99999
GSE9988_LOW_LPS_VS_CTRL_TREA...1,SET,187,0.030573,0.0030699,0.060083,0.30543,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN,0.99999
HP_LABIAL_HYPERTROPHY,SET,7,0.19005,0.0037104,0.37355,0.30546,HP_LABIAL_HYPERTROPHY,0.99999
HP_J_SHAPED_SELLA_TURCICA,SET,12,0.12087,0.0030893,0.23761,0.30548,HP_J_SHAPED_SELLA_TURCICA,0.99999
GOBP_HISTAMINE_METABOLIC_PRO...,SET,6,0.21534,0.0038924,0.42335,0.3055,GOBP_HISTAMINE_METABOLIC_PROCESS,0.99999
LAU_APOPTOSIS_CDKN2A_UP,SET,55,0.055415,0.0030286,0.10896,0.30552,LAU_APOPTOSIS_CDKN2A_UP,0.99999
GOCC_TELOMERASE_HOLOENZYME_C...,SET,19,0.090608,0.0029135,0.17816,0.30553,GOCC_TELOMERASE_HOLOENZYME_COMPLEX,0.99999
MIR601,SET,34,0.076169,0.0032749,0.14979,0.30555,MIR601,0.99999
GOBP_POSITIVE_REGULATION_OF_...253,SET,7,0.15929,0.0031098,0.31327,0.30556,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_TUBE_FORMATION,0.99999
NAKAMURA_CANCER_MICROENVIRON...1,SET,40,0.062742,0.0029255,0.12342,0.30561,NAKAMURA_CANCER_MICROENVIRONMENT_DN,0.99999
REACTOME_NUCLEOTIDE_CATABOLI...,SET,35,0.074211,0.0032372,0.14598,0.30561,REACTOME_NUCLEOTIDE_CATABOLISM,0.99999
HP_ABNORMAL_LYMPHATIC_VESSEL...,SET,16,0.11032,0.0032555,0.21702,0.30561,HP_ABNORMAL_LYMPHATIC_VESSEL_MORPHOLOGY,0.99999
HALLMARK_PANCREAS_BETA_CELLS,SET,38,0.079744,0.0036243,0.15696,0.30572,HALLMARK_PANCREAS_BETA_CELLS,0.99999
REACTOME_IRS_MEDIATED_SIGNAL...,SET,47,0.064445,0.0032566,0.12686,0.30573,REACTOME_IRS_MEDIATED_SIGNALLING,0.99999
JAEGER_METASTASIS_DN,SET,236,0.030011,0.0033808,0.059089,0.30577,JAEGER_METASTASIS_DN,0.99999
WP_CATABOLISM_OF_SKELETAL_MU...,SET,38,0.071037,0.0032286,0.13989,0.30579,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,0.99999
GOBP_NOREPINEPHRINE_BIOSYNTH...,SET,6,0.20551,0.0037147,0.40468,0.30579,GOBP_NOREPINEPHRINE_BIOSYNTHETIC_PROCESS,0.99999
NAKAYA_PBMC_FLUARIX_FLUVIRIN...4,SET,488,0.018844,0.0030313,0.037113,0.30582,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.99999
HP_POLYURIA,SET,35,0.07613,0.003321,0.14997,0.30586,HP_POLYURIA,0.99999
GSE23925_LIGHT_ZONE_VS_NAIVE...2,SET,181,0.033634,0.0033232,0.066257,0.30586,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...290,SET,43,0.065118,0.0031479,0.1283,0.30589,GOBP_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE,0.99999
GOBP_FREE_UBIQUITIN_CHAIN_PO...,SET,8,0.16236,0.0033885,0.31993,0.30591,GOBP_FREE_UBIQUITIN_CHAIN_POLYMERIZATION,0.99999
HP_ABNORMAL_DIAPHYSIS_MORPHO...,SET,296,0.025361,0.0031942,0.049975,0.30591,HP_ABNORMAL_DIAPHYSIS_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...756,SET,5,0.19549,0.0032257,0.38522,0.30592,GOBP_POSITIVE_REGULATION_OF_THYROID_HORMONE_GENERATION,0.99999
GTATGAT_MIR154_MIR487,SET,64,0.055532,0.0032731,0.10945,0.30595,GTATGAT_MIR154_MIR487,0.99999
GOBP_RHYTHMIC_BEHAVIOR,SET,46,0.071748,0.003587,0.14143,0.30597,GOBP_RHYTHMIC_BEHAVIOR,0.99999
HP_GASTROINTESTINAL_ARTERIOV...,SET,4,0.26718,0.0039434,0.52667,0.30597,HP_GASTROINTESTINAL_ARTERIOVENOUS_MALFORMATION,0.99999
ZNF223_TARGET_GENES,SET,257,0.026688,0.0031355,0.052641,0.30608,ZNF223_TARGET_GENES,0.99999
chr1q23,SET,130,0.079755,0.0066877,0.15736,0.30614,chr1q23,0.99999
HP_NEURAL_TUBE_DEFECT,SET,271,0.02607,0.003144,0.051443,0.30616,HP_NEURAL_TUBE_DEFECT,0.99999
GOBP_PLUS_END_DIRECTED_ORGAN...,SET,7,0.16212,0.0031652,0.31995,0.30618,GOBP_PLUS_END_DIRECTED_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,0.99999
FAN_EMBRYONIC_CTX_IN_5_INTER...,SET,5,0.2321,0.0038299,0.45811,0.3062,FAN_EMBRYONIC_CTX_IN_5_INTERNEURON,0.99999
GOBP_HIPPOCAMPAL_NEURON_APOP...,SET,6,0.20222,0.0036552,0.39914,0.30621,GOBP_HIPPOCAMPAL_NEURON_APOPTOTIC_PROCESS,0.99999
GOBP_FORMATE_METABOLIC_PROCE...,SET,6,0.19717,0.003564,0.38927,0.30625,GOBP_FORMATE_METABOLIC_PROCESS,0.99999
GOMF_PEPTIDOGLYCAN_MURALYTIC...,SET,13,0.13308,0.0035401,0.26273,0.30625,GOMF_PEPTIDOGLYCAN_MURALYTIC_ACTIVITY,0.99999
GOBP_LEUKOCYTE_HOMEOSTASIS,SET,101,0.044722,0.0033081,0.088316,0.30629,GOBP_LEUKOCYTE_HOMEOSTASIS,0.99999
HP_PITUITARY_CORTICOTROPIC_C...,SET,11,0.13024,0.0031871,0.25721,0.3063,HP_PITUITARY_CORTICOTROPIC_CELL_ADENOMA,0.99999
REACTOME_GP1B_IX_V_ACTIVATIO...,SET,11,0.14882,0.0036418,0.29391,0.30631,REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING,0.99999
GOBP_T_HELPER_17_TYPE_IMMUNE...,SET,45,0.06913,0.0034184,0.13653,0.30631,GOBP_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.99999
BROWNE_HCMV_INFECTION_2HR_UP,SET,33,0.083623,0.0035423,0.16517,0.30633,BROWNE_HCMV_INFECTION_2HR_UP,0.99999
MIR548AJ_3P_MIR548X_3P,SET,835,0.015466,0.0032226,0.030555,0.30637,MIR548AJ_3P_MIR548X_3P,0.99999
GSE37301_MULTIPOTENT_PROGENI...7,SET,169,0.034242,0.0032703,0.067669,0.30642,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN,0.99999
GOBP_THYMIC_T_CELL_SELECTION,SET,24,0.096084,0.0034719,0.18989,0.30643,GOBP_THYMIC_T_CELL_SELECTION,0.99999
HP_EYELID_MYOCLONUS,SET,9,0.14958,0.0033112,0.29563,0.30644,HP_EYELID_MYOCLONUS,0.99999
GOMF_PROTEIN_CARBOXYL_O_METH...,SET,6,0.16464,0.002976,0.32542,0.30645,GOMF_PROTEIN_CARBOXYL_O_METHYLTRANSFERASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_GLUCOCORT...3,SET,5,0.22033,0.0036357,0.43553,0.30647,GOBP_REGULATION_OF_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY,0.99999
CTCNANGTGNY_UNKNOWN,SET,74,0.04895,0.0031015,0.096782,0.30651,CTCNANGTGNY_UNKNOWN,0.99999
MIR6800_3P,SET,27,0.083554,0.003202,0.16522,0.30653,MIR6800_3P,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...14,SET,44,0.069511,0.003399,0.13747,0.30655,GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_1,0.99999
HP_CHORIOCAPILLARIS_ATROPHY,SET,8,0.15035,0.003138,0.29733,0.30655,HP_CHORIOCAPILLARIS_ATROPHY,0.99999
GSE8515_CTRL_VS_IL6_4H_STIM_...2,SET,179,0.031465,0.0030918,0.062235,0.30658,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP,0.99999
REACTOME_MEIOTIC_SYNAPSIS,SET,31,0.072326,0.0029696,0.14309,0.30662,REACTOME_MEIOTIC_SYNAPSIS,0.99999
GOBP_REGULATION_OF_GASTRULAT...,SET,15,0.10814,0.0030899,0.21397,0.30664,GOBP_REGULATION_OF_GASTRULATION,0.99999
GSE23321_CENTRAL_MEMORY_VS_N...1,SET,180,0.032885,0.0032403,0.065071,0.30665,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.99999
MIR7161_3P,SET,77,0.05153,0.0033303,0.10198,0.30668,MIR7161_3P,0.99999
MIR4755_3P,SET,133,0.037675,0.0031952,0.074564,0.30669,MIR4755_3P,0.99999
MIR6881_5P,SET,48,0.063278,0.0032314,0.12529,0.30676,MIR6881_5P,0.99999
APPIERTO_RESPONSE_TO_FENRETI...1,SET,43,0.062966,0.0030438,0.12468,0.30677,APPIERTO_RESPONSE_TO_FENRETINIDE_DN,0.99999
REACTOME_PROTEIN_METHYLATION,SET,14,0.12001,0.0033129,0.23763,0.30677,REACTOME_PROTEIN_METHYLATION,0.99999
HP_SMALL_ANTERIOR_FONTANELLE,SET,6,0.16956,0.003065,0.33593,0.30687,HP_SMALL_ANTERIOR_FONTANELLE,0.99999
HP_FLATTENED_EPIPHYSIS,SET,22,0.088554,0.0030637,0.17551,0.30694,HP_FLATTENED_EPIPHYSIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...580,SET,5,0.20198,0.0033328,0.40034,0.30695,GOBP_NEGATIVE_REGULATION_OF_SATELLITE_CELL_DIFFERENTIATION,0.99999
GOMF_ACETYLCHOLINE_BINDING,SET,10,0.1334,0.0031126,0.26441,0.30695,GOMF_ACETYLCHOLINE_BINDING,0.99999
HP_JOINT_SWELLING,SET,46,0.0672,0.0033596,0.13319,0.30695,HP_JOINT_SWELLING,0.99999
MORF_CD8A,SET,111,0.043805,0.0033959,0.086944,0.30719,MORF_CD8A,0.99999
FISCHER_DREAM_TARGETS,SET,860,0.014282,0.003018,0.028349,0.3072,FISCHER_DREAM_TARGETS,0.99999
GOCC_ENDOSOME_MEMBRANE,SET,518,0.019007,0.0031474,0.037751,0.30732,GOCC_ENDOSOME_MEMBRANE,0.99999
BIOCARTA_BBCELL_PATHWAY,SET,6,0.20304,0.0036701,0.4033,0.30733,BIOCARTA_BBCELL_PATHWAY,0.99999
GOBP_REGULATION_OF_DNA_BIOSY...,SET,111,0.039507,0.0030627,0.078489,0.30736,GOBP_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,0.99999
GOBP_PRIMARY_AMINO_COMPOUND_...1,SET,6,0.14502,0.0026214,0.28813,0.30737,GOBP_PRIMARY_AMINO_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
chr4q28,SET,19,0.15758,0.0050667,0.31311,0.30739,chr4q28,0.99999
GAURNIER_PSMD4_TARGETS,SET,63,0.060731,0.0035516,0.12068,0.3074,GAURNIER_PSMD4_TARGETS,0.99999
REACTOME_RNA_POLYMERASE_I_PR...,SET,27,0.069261,0.0026542,0.13768,0.30747,REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE,0.99999
chr7p11,SET,14,0.17092,0.0047182,0.3398,0.30748,chr7p11,0.99999
MIR141_3P,SET,369,0.023471,0.0032939,0.046668,0.30751,MIR141_3P,0.99999
MIR6836_3P,SET,53,0.059897,0.0032137,0.1191,0.30751,MIR6836_3P,0.99999
MIR181A_2_3P,SET,99,0.044484,0.0032578,0.088493,0.3076,MIR181A_2_3P,0.99999
GOBP_MULTICELLULAR_ORGANISMA...6,SET,819,0.015157,0.0031292,0.030157,0.30762,GOBP_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_PROCESS,0.99999
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...2,SET,6,0.16143,0.0029179,0.32118,0.30762,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_CLASS_I_PROTEIN_COMPLEX,0.99999
GAZDA_DIAMOND_BLACKFAN_ANEMI...6,SET,36,0.075173,0.0033256,0.14958,0.30764,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,0.99999
GOCC_ENDOPLASMIC_RETICULUM_Q...,SET,15,0.11065,0.0031617,0.22029,0.30773,GOCC_ENDOPLASMIC_RETICULUM_QUALITY_CONTROL_COMPARTMENT,0.99999
KEGG_MEDICUS_REFERENCE_ACTH_...,SET,32,0.075791,0.0031616,0.15089,0.30774,KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY,0.99999
GSE22886_TH1_VS_TH2_12H_ACT_...2,SET,180,0.031119,0.0030662,0.061954,0.30774,GSE22886_TH1_VS_TH2_12H_ACT_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_SPP...,SET,44,0.067191,0.0032855,0.13378,0.30775,HE_LIM_SUN_FETAL_LUNG_C2_SPP1_POS_MACROPHAGE_CELL,0.99999
GOBP_INTERKINETIC_NUCLEAR_MI...,SET,5,0.20801,0.0034324,0.41428,0.3078,GOBP_INTERKINETIC_NUCLEAR_MIGRATION,0.99999
HP_ABNORMAL_CALVARIA_MORPHOL...,SET,859,0.01469,0.0031025,0.029258,0.3078,HP_ABNORMAL_CALVARIA_MORPHOLOGY,0.99999
HP_STEROETYPIC_UPPER_EXTREMI...,SET,43,0.064678,0.0031266,0.12882,0.30781,HP_STEROETYPIC_UPPER_EXTREMITY_MOVEMENTS,0.99999
HP_ABNORMAL_THORAX_MORPHOLOGY,SET,783,0.015542,0.0031406,0.030968,0.30788,HP_ABNORMAL_THORAX_MORPHOLOGY,0.99999
GOBP_APOPTOTIC_DNA_FRAGMENTA...,SET,18,0.10267,0.0032132,0.20457,0.30789,GOBP_APOPTOTIC_DNA_FRAGMENTATION,0.99999
BAE_BRCA1_TARGETS_UP,SET,60,0.055932,0.0031924,0.11146,0.30791,BAE_BRCA1_TARGETS_UP,0.99999
WP_PPARALPHA_PATHWAY,SET,26,0.088802,0.0033395,0.17697,0.30791,WP_PPARALPHA_PATHWAY,0.99999
PR_Q2,SET,238,0.028857,0.0032643,0.057529,0.30798,PR_Q2,0.99999
HP_DECREASED_MEAN_CORPUSCULA...1,SET,5,0.22671,0.003741,0.45202,0.30799,HP_DECREASED_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,0.99999
GOMF_TITIN_BINDING,SET,13,0.11467,0.0030503,0.22865,0.30801,GOMF_TITIN_BINDING,0.99999
HP_RENAL_FIBROSIS,SET,15,0.11011,0.0031461,0.21956,0.30802,HP_RENAL_FIBROSIS,0.99999
KEGG_MEDICUS_REFERENCE_GLYCO...1,SET,5,0.17367,0.0028657,0.34639,0.30806,KEGG_MEDICUS_REFERENCE_GLYCOGEN_BIOSYNTHESIS,0.99999
HP_DECREASED_CIRCULATING_PRE...,SET,4,0.24325,0.0035902,0.48532,0.30811,HP_DECREASED_CIRCULATING_PREALBUMIN_CONCENTRATION,0.99999
GOBP_NUCLEOSIDE_BISPHOSPHATE...2,SET,11,0.12853,0.0031454,0.25645,0.30812,GOBP_NUCLEOSIDE_BISPHOSPHATE_CATABOLIC_PROCESS,0.99999
BIOCARTA_HCMV_PATHWAY,SET,17,0.10379,0.0031569,0.20712,0.30815,BIOCARTA_HCMV_PATHWAY,0.99999
GOBP_RESPONSE_TO_FATTY_ACID,SET,54,0.064876,0.0035134,0.12946,0.30815,GOBP_RESPONSE_TO_FATTY_ACID,0.99999
SIGMAR1_TARGET_GENES,SET,9,0.13915,0.0030803,0.27773,0.30818,SIGMAR1_TARGET_GENES,0.99999
HP_ABNORMAL_URINARY_ELECTROL...,SET,104,0.043604,0.0032726,0.08706,0.30824,HP_ABNORMAL_URINARY_ELECTROLYTE_CONCENTRATION,0.99999
GOBP_RESPONSE_TO_INTERLEUKIN...4,SET,11,0.14828,0.0036286,0.29608,0.30825,GOBP_RESPONSE_TO_INTERLEUKIN_15,0.99999
GOBP_NEUROTRANSMITTER_RECEPT...3,SET,24,0.093648,0.0033838,0.187,0.30827,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT,0.99999
HP_GENERALIZED_ICHTHYOSIS,SET,4,0.19483,0.0028756,0.38919,0.30832,HP_GENERALIZED_ICHTHYOSIS,0.99999
FOX_Q2,SET,191,0.032056,0.0032527,0.064048,0.30836,FOX_Q2,0.99999
GSE42021_TCONV_PLN_VS_CD24IN...1,SET,183,0.030862,0.0030659,0.06166,0.30836,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_DN,0.99999
GOLDRATH_NAIVE_VS_MEMORY_CD8...1,SET,183,0.032566,0.0032352,0.065067,0.30837,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.99999
GOMF_UNIPORTER_ACTIVITY,SET,9,0.17023,0.0037682,0.34014,0.30838,GOMF_UNIPORTER_ACTIVITY,0.99999
GSE17721_POLYIC_VS_CPG_4H_BM...1,SET,184,0.031359,0.0031237,0.062666,0.30839,GSE17721_POLYIC_VS_CPG_4H_BMDC_DN,0.99999
LU_TUMOR_VASCULATURE_UP,SET,27,0.087433,0.0033506,0.17472,0.3084,LU_TUMOR_VASCULATURE_UP,0.99999
BIOCARTA_PKC_PATHWAY,SET,7,0.18187,0.0035506,0.36346,0.30841,BIOCARTA_PKC_PATHWAY,0.99999
HP_SPLIT_FOOT,SET,6,0.16141,0.0029177,0.32259,0.30841,HP_SPLIT_FOOT,0.99999
BYSTRYKH_HEMATOPOIESIS_STEM_...9,SET,26,0.087319,0.0032838,0.1746,0.3085,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS,0.99999
HP_LOW_SET_EARS,SET,768,0.015583,0.0031199,0.031159,0.3085,HP_LOW_SET_EARS,0.99999
HP_THIN_NAIL,SET,13,0.11749,0.0031254,0.23494,0.30851,HP_THIN_NAIL,0.99999
GNF2_BUB1B,SET,49,0.053704,0.0027709,0.10739,0.30852,GNF2_BUB1B,0.99999
HP_ELEVATED_SYSTOLIC_BLOOD_P...,SET,13,0.12287,0.0032685,0.24579,0.30858,HP_ELEVATED_SYSTOLIC_BLOOD_PRESSURE,0.99999
GNF2_RAP1B,SET,32,0.074771,0.003119,0.14961,0.30862,GNF2_RAP1B,0.99999
TARTE_PLASMA_CELL_VS_PLASMAB...2,SET,350,0.024374,0.0033332,0.048773,0.30864,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,0.99999
HP_PARACENTRAL_SCOTOMA,SET,7,0.15843,0.003093,0.3171,0.30868,HP_PARACENTRAL_SCOTOMA,0.99999
HP_ENLARGED_METAPHYSES,SET,5,0.18386,0.0030338,0.36803,0.30869,HP_ENLARGED_METAPHYSES,0.99999
GOBP_DEVELOPMENTAL_PROCESS_I...,SET,868,0.014743,0.003129,0.029513,0.3087,GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION,0.99999
PAX4_04,SET,195,0.03229,0.0033102,0.064641,0.30871,PAX4_04,0.99999
MODULE_99,SET,325,0.025866,0.003411,0.051805,0.30879,MODULE_99,0.99999
YRCCAKNNGNCGC_UNKNOWN,SET,60,0.056348,0.0032161,0.11289,0.30885,YRCCAKNNGNCGC_UNKNOWN,0.99999
HP_POSTAXIAL_HAND_POLYDACTYLY,SET,78,0.046233,0.0030072,0.092662,0.30891,HP_POSTAXIAL_HAND_POLYDACTYLY,0.99999
REACTOME_INWARDLY_RECTIFYING...,SET,35,0.082133,0.0035828,0.16464,0.30894,REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,0.99999
GOBP_AMPA_GLUTAMATE_RECEPTOR...,SET,9,0.15115,0.003346,0.30305,0.30897,GOBP_AMPA_GLUTAMATE_RECEPTOR_CLUSTERING,0.99999
GOBP_PROSTATE_GLANDULAR_ACIN...1,SET,10,0.14227,0.0033196,0.28532,0.30902,GOBP_PROSTATE_GLANDULAR_ACINUS_DEVELOPMENT,0.99999
GOBP_NEUTROPHIL_ACTIVATION_I...,SET,20,0.095217,0.0031411,0.191,0.30906,GOBP_NEUTROPHIL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
GOBP_REGULATION_OF_VASCULOGE...,SET,15,0.1154,0.0032972,0.23156,0.30913,GOBP_REGULATION_OF_VASCULOGENESIS,0.99999
MIR6855_3P,SET,45,0.06203,0.0030673,0.12449,0.30915,MIR6855_3P,0.99999
GOBP_PROTEIN_UNFOLDING,SET,5,0.16275,0.0026856,0.32666,0.30916,GOBP_PROTEIN_UNFOLDING,0.99999
GOBP_NEUROENDOCRINE_CELL_DIF...,SET,16,0.12636,0.0037287,0.25362,0.30917,GOBP_NEUROENDOCRINE_CELL_DIFFERENTIATION,0.99999
IRF1_Q6,SET,247,0.027626,0.0031828,0.055458,0.30919,IRF1_Q6,0.99999
CTGYNNCTYTAA_UNKNOWN,SET,81,0.049459,0.003278,0.099328,0.30927,CTGYNNCTYTAA_UNKNOWN,0.99999
REACTOME_ERBB2_ACTIVATES_PTK...,SET,13,0.12176,0.0032389,0.24463,0.30934,REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING,0.99999
GOBP_POSITIVE_REGULATION_OF_...33,SET,25,0.086665,0.003196,0.17412,0.30934,GOBP_POSITIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.99999
KEGG_HUNTINGTONS_DISEASE,SET,153,0.031263,0.0028422,0.062814,0.30935,KEGG_HUNTINGTONS_DISEASE,0.99999
GOMF_NUCLEOSIDE_DIPHOSPHATE_...1,SET,17,0.099391,0.0030231,0.1998,0.30944,GOMF_NUCLEOSIDE_DIPHOSPHATE_KINASE_ACTIVITY,0.99999
HP_BRISK_REFLEXES,SET,99,0.039871,0.0029201,0.080152,0.30944,HP_BRISK_REFLEXES,0.99999
GOBP_POSITIVE_THYMIC_T_CELL_...,SET,15,0.11953,0.0034154,0.24035,0.30948,GOBP_POSITIVE_THYMIC_T_CELL_SELECTION,0.99999
GOBP_LIMB_JOINT_MORPHOGENESIS,SET,7,0.16984,0.0033159,0.34152,0.30949,GOBP_LIMB_JOINT_MORPHOGENESIS,0.99999
GSE39152_BRAIN_VS_SPLEEN_CD1...1,SET,186,0.030685,0.003073,0.061716,0.30953,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN,0.99999
MIR4436B_3P,SET,97,0.043728,0.0031702,0.087968,0.30956,MIR4436B_3P,0.99999
GSE14413_UNSTIM_VS_IFNB_STIM...6,SET,123,0.038563,0.003146,0.077602,0.30962,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_UP,0.99999
REACTOME_BETA_DEFENSINS,SET,26,0.11912,0.0044799,0.23977,0.30966,REACTOME_BETA_DEFENSINS,0.99999
GOBP_POSITIVE_REGULATION_OF_...696,SET,13,0.12718,0.0033832,0.25599,0.30966,GOBP_POSITIVE_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION,0.99999
GRADE_COLON_AND_RECTAL_CANCE...2,SET,256,0.025297,0.0029664,0.05093,0.3097,GRADE_COLON_AND_RECTAL_CANCER_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...34,SET,12,0.13183,0.0033693,0.26542,0.30971,GOBP_NEGATIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,0.99999
GSE20198_UNTREATED_VS_IL12_I...1,SET,176,0.030021,0.0029253,0.060445,0.30972,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,0.99999
GOBP_CELL_PROJECTION_ORGANIZ...,SET,1455,0.011799,0.0031874,0.023759,0.30973,GOBP_CELL_PROJECTION_ORGANIZATION,0.99999
DESCARTES_MAIN_FETAL_THYMIC_...,SET,139,0.036054,0.0031253,0.072604,0.30974,DESCARTES_MAIN_FETAL_THYMIC_EPITHELIAL_CELLS,0.99999
GOBP_TORC1_SIGNALING,SET,92,0.042829,0.0030243,0.086248,0.30975,GOBP_TORC1_SIGNALING,0.99999
TERAO_AOX4_TARGETS_SKIN_DN,SET,17,0.10677,0.0032476,0.21506,0.30978,TERAO_AOX4_TARGETS_SKIN_DN,0.99999
MIR203B_3P,SET,88,0.047261,0.0032643,0.095206,0.3098,MIR203B_3P,0.99999
HP_TISSUE_ISCHEMIA,SET,108,0.043899,0.0033572,0.088431,0.3098,HP_TISSUE_ISCHEMIA,0.99999
AACTGGA_MIR145,SET,216,0.028393,0.0030616,0.057213,0.30986,AACTGGA_MIR145,0.99999
HP_MEDULLOBLASTOMA,SET,18,0.096264,0.0030128,0.19398,0.30986,HP_MEDULLOBLASTOMA,0.99999
WP_MITOCHONDRIAL_GENE_EXPRES...,SET,18,0.10103,0.003162,0.20365,0.30991,WP_MITOCHONDRIAL_GENE_EXPRESSION,0.99999
HP_COLOBOMA,SET,207,0.029575,0.0031228,0.059644,0.31,HP_COLOBOMA,0.99999
MORF_ESR1,SET,159,0.033029,0.0030605,0.066632,0.31006,MORF_ESR1,0.99999
MIR3160_3P,SET,66,0.052796,0.00316,0.10656,0.31013,MIR3160_3P,0.99999
GOBP_INTRINSIC_APOPTOTIC_SIG...5,SET,58,0.052862,0.0029666,0.10669,0.31014,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.99999
GOBP_ANTERIOR_POSTERIOR_AXIS...,SET,51,0.063443,0.0033393,0.12807,0.31017,GOBP_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION,0.99999
GOBP_RESPONSE_TO_MACROPHAGE_...,SET,16,0.12115,0.003575,0.24458,0.31019,GOBP_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR,0.99999
REACTOME_PI_3K_CASCADE_FGFR4,SET,19,0.099469,0.0031984,0.20083,0.3102,REACTOME_PI_3K_CASCADE_FGFR4,0.99999
GOBP_POSITIVE_REGULATION_OF_...338,SET,12,0.15535,0.0039705,0.31373,0.31024,GOBP_POSITIVE_REGULATION_OF_HIPPO_SIGNALING,0.99999
GOBP_OLFACTORY_BULB_INTERNEU...2,SET,12,0.14304,0.0036558,0.28896,0.3103,GOBP_OLFACTORY_BULB_INTERNEURON_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_MRNA_CATA...,SET,170,0.031894,0.0030549,0.064444,0.31033,GOBP_REGULATION_OF_MRNA_CATABOLIC_PROCESS,0.99999
HP_MUCOPOLYSACCHARIDURIA,SET,19,0.091812,0.0029522,0.18564,0.31045,HP_MUCOPOLYSACCHARIDURIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...126,SET,8,0.15048,0.0031406,0.30428,0.31046,GOBP_NEGATIVE_REGULATION_OF_CELL_SIZE,0.99999
GSE28726_NAIVE_CD4_TCELL_VS_...4,SET,183,0.030148,0.002995,0.060989,0.31054,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP,0.99999
GSE37533_UNTREATED_VS_PIOGLI...2,SET,149,0.033874,0.0030393,0.068529,0.31055,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_UP,0.99999
REACTOME_MALATE_ASPARTATE_SH...,SET,9,0.12673,0.0028052,0.25642,0.31058,REACTOME_MALATE_ASPARTATE_SHUTTLE,0.99999
HP_SKIN_PLAQUE,SET,41,0.066211,0.0031255,0.13398,0.31059,HP_SKIN_PLAQUE,0.99999
GOBP_RHYTHMIC_PROCESS,SET,280,0.026587,0.0032584,0.053816,0.31064,GOBP_RHYTHMIC_PROCESS,0.99999
GOBP_CARDIAC_CELL_DEVELOPMENT,SET,82,0.049015,0.0032685,0.099222,0.31066,GOBP_CARDIAC_CELL_DEVELOPMENT,0.99999
GOBP_RESPONSE_TO_INTERLEUKIN...11,SET,14,0.10521,0.0029042,0.213,0.31068,GOBP_RESPONSE_TO_INTERLEUKIN_7,0.99999
GOBP_THYROID_HORMONE_GENERAT...,SET,22,0.094669,0.0032752,0.19168,0.3107,GOBP_THYROID_HORMONE_GENERATION,0.99999
GOMF_PROTEASOME_BINDING,SET,16,0.092467,0.0027286,0.18723,0.3107,GOMF_PROTEASOME_BINDING,0.99999
BIOCARTA_THELPER_PATHWAY,SET,12,0.13708,0.0035036,0.2776,0.31072,BIOCARTA_THELPER_PATHWAY,0.99999
GOBP_MITOTIC_CHROMOSOME_COND...,SET,17,0.087079,0.0026486,0.17637,0.31075,GOBP_MITOTIC_CHROMOSOME_CONDENSATION,0.99999
HP_MENINGITIS,SET,65,0.055112,0.0032736,0.11171,0.31088,HP_MENINGITIS,0.99999
PID_FAS_PATHWAY,SET,36,0.074969,0.0033166,0.15196,0.31089,PID_FAS_PATHWAY,0.99999
QI_PBMC_ZOSTAVAX_AGE_50_75YO...6,SET,224,0.028707,0.0031516,0.058199,0.31092,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_POSITIVE,0.99999
HP_LARYNGEAL_CLEFT,SET,6,0.21887,0.0039563,0.44386,0.31097,HP_LARYNGEAL_CLEFT,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...10,SET,13,0.12236,0.0032551,0.24819,0.311,HP_APLASIA_HYPOPLASIA_OF_THE_BLADDER,0.99999
MIR4699_3P,SET,440,0.020961,0.003206,0.042542,0.31111,MIR4699_3P,0.99999
MODULE_136,SET,447,0.019793,0.0030506,0.040189,0.31119,MODULE_136,0.99999
BASSO_CD40_SIGNALING_DN,SET,64,0.053991,0.0031823,0.10967,0.31125,BASSO_CD40_SIGNALING_DN,0.99999
GOBP_LEYDIG_CELL_DIFFERENTIA...,SET,9,0.14807,0.0032777,0.30078,0.31126,GOBP_LEYDIG_CELL_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_VENTRICUL...1,SET,12,0.14211,0.0036321,0.28876,0.31131,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.99999
CTTTAAR_UNKNOWN,SET,878,0.015047,0.003211,0.030582,0.31136,CTTTAAR_UNKNOWN,0.99999
GOMF_PROTEIN_KINASE_A_CATALY...,SET,14,0.11468,0.0031657,0.23312,0.31139,GOMF_PROTEIN_KINASE_A_CATALYTIC_SUBUNIT_BINDING,0.99999
MARKEY_RB1_ACUTE_LOF_UP,SET,215,0.027802,0.0029911,0.056538,0.31145,MARKEY_RB1_ACUTE_LOF_UP,0.99999
MIR4726_3P,SET,65,0.053447,0.0031747,0.10869,0.31145,MIR4726_3P,0.99999
GSE22432_UNTREATED_VS_TGFB1_...1,SET,174,0.030893,0.0029933,0.062821,0.31145,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_DN,0.99999
GSE6674_PL2_3_VS_ANTI_IGM_AN...2,SET,178,0.030679,0.0030063,0.062395,0.31147,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,0.99999
BIOCARTA_CREM_PATHWAY,SET,6,0.19824,0.0035833,0.40321,0.31148,BIOCARTA_CREM_PATHWAY,0.99999
MIR921,SET,57,0.059551,0.0033131,0.12114,0.31151,MIR921,0.99999
GSE2706_LPS_VS_R848_AND_LPS_...4,SET,166,0.032253,0.0030531,0.065618,0.31153,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP,0.99999
GSE5503_PLN_DC_VS_SPLEEN_DC_...1,SET,181,0.03021,0.0029848,0.061476,0.31157,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.99999
GOBP_SULFATE_TRANSPORT,SET,16,0.10645,0.0031412,0.21663,0.31158,GOBP_SULFATE_TRANSPORT,0.99999
HP_INCREASED_CIRCULATING_GON...,SET,75,0.046563,0.0029701,0.094774,0.31161,HP_INCREASED_CIRCULATING_GONADOTROPIN_LEVEL,0.99999
MIR934,SET,73,0.049629,0.0031233,0.10105,0.31167,MIR934,0.99999
HP_SCLERODERMA,SET,11,0.12604,0.0030843,0.25669,0.31171,HP_SCLERODERMA,0.99999
GOCC_GOLGI_APPARATUS_SUBCOMP...,SET,330,0.022494,0.0029886,0.045818,0.31174,GOCC_GOLGI_APPARATUS_SUBCOMPARTMENT,0.99999
GSE17580_TREG_VS_TEFF_S_MANS...1,SET,176,0.032403,0.0031575,0.066007,0.31175,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN,0.99999
GSE28237_EARLY_VS_LATE_GC_BC...2,SET,183,0.032222,0.0032011,0.065649,0.31178,GSE28237_EARLY_VS_LATE_GC_BCELL_UP,0.99999
GOBP_INTERCELLULAR_TRANSPORT,SET,10,0.14507,0.0033848,0.29562,0.31182,GOBP_INTERCELLULAR_TRANSPORT,0.99999
HP_RETINAL_VEIN_OCCLUSION,SET,6,0.16998,0.0030725,0.34655,0.31189,HP_RETINAL_VEIN_OCCLUSION,0.99999
FOXO4_01,SET,229,0.029364,0.0032591,0.059887,0.31196,FOXO4_01,0.99999
GOBP_BIOLOGICAL_PHASE,SET,11,0.13247,0.0032417,0.27023,0.31199,GOBP_BIOLOGICAL_PHASE,0.99999
HP_LYMPH_NODE_HYPOPLASIA,SET,3,0.2624,0.0033541,0.53543,0.31204,HP_LYMPH_NODE_HYPOPLASIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...24,SET,6,0.18153,0.0032812,0.3705,0.31208,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS,0.99999
GOBP_PHOSPHOLIPID_EFFLUX,SET,11,0.13545,0.0033147,0.27652,0.31212,GOBP_PHOSPHOLIPID_EFFLUX,0.99999
GOBP_POSITIVE_REGULATION_OF_...343,SET,20,0.10359,0.0034173,0.21147,0.31212,GOBP_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,0.99999
KEGG_STEROID_HORMONE_BIOSYNT...,SET,52,0.070002,0.0037203,0.14292,0.31214,KEGG_STEROID_HORMONE_BIOSYNTHESIS,0.99999
HNF1_Q6,SET,233,0.029872,0.003344,0.060994,0.31215,HNF1_Q6,0.99999
GSE11057_EFF_MEM_VS_CENT_MEM...2,SET,169,0.033493,0.0031987,0.068387,0.31215,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP,0.99999
GOCC_MPP7_DLG1_LIN7_COMPLEX,SET,5,0.21694,0.0035798,0.44323,0.31226,GOCC_MPP7_DLG1_LIN7_COMPLEX,0.99999
GOBP_FATTY_ACID_CATABOLIC_PR...,SET,101,0.04014,0.0029692,0.082018,0.31228,GOBP_FATTY_ACID_CATABOLIC_PROCESS,0.99999
GOMF_RRNA_ADENINE_METHYLTRAN...,SET,7,0.12285,0.0023984,0.25101,0.31228,GOMF_RRNA_ADENINE_METHYLTRANSFERASE_ACTIVITY,0.99999
REACTOME_CELLULAR_RESPONSE_T...2,SET,95,0.040002,0.0028702,0.081798,0.31241,REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,0.99999
MIR4490,SET,95,0.042514,0.0030504,0.086955,0.31245,MIR4490,0.99999
MATTIOLI_MGUS_VS_MULTIPLE_MY...,SET,13,0.11592,0.0030836,0.23714,0.31249,MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA,0.99999
MIR3659,SET,73,0.049427,0.0031106,0.10114,0.31253,MIR3659,0.99999
GSE25123_WT_VS_PPARG_KO_MACR...3,SET,161,0.032773,0.0030556,0.067084,0.31259,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_UP,0.99999
GSE24492_LYVE_NEG_VS_POS_MAC...2,SET,168,0.030906,0.002943,0.063271,0.31261,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_UP,0.99999
KEGG_PPAR_SIGNALING_PATHWAY,SET,67,0.051863,0.0031274,0.10619,0.31263,KEGG_PPAR_SIGNALING_PATHWAY,0.99999
GOBP_BASOLATERAL_PROTEIN_SEC...,SET,5,0.17018,0.0028081,0.34845,0.31264,GOBP_BASOLATERAL_PROTEIN_SECRETION,0.99999
GSE22033_UNTREATED_VS_MRL24_...1,SET,176,0.031993,0.0031175,0.065509,0.31265,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN,0.99999
GOBP_REGULATION_OF_MYELINATI...,SET,44,0.063121,0.0030865,0.12927,0.31268,GOBP_REGULATION_OF_MYELINATION,0.99999
AIZARANI_LIVER_C30_HEPATOCYT...,SET,369,0.0216,0.0030315,0.044243,0.3127,AIZARANI_LIVER_C30_HEPATOCYTES_4,0.99999
HP_CALF_MUSCLE_HYPERTROPHY,SET,42,0.06805,0.0032512,0.13941,0.31273,HP_CALF_MUSCLE_HYPERTROPHY,0.99999
GOMF_DOLICHYL_PHOSPHATE_MANN...,SET,8,0.12998,0.0027128,0.26631,0.31274,GOMF_DOLICHYL_PHOSPHATE_MANNOSE_PROTEIN_MANNOSYLTRANSFERASE_ACTIVITY,0.99999
GOCC_OMEGASOME,SET,4,0.17544,0.0025894,0.35946,0.31276,GOCC_OMEGASOME,0.99999
GOBP_RESPONSE_TO_TUMOR_NECRO...,SET,213,0.029328,0.0031407,0.060118,0.31283,GOBP_RESPONSE_TO_TUMOR_NECROSIS_FACTOR,0.99999
AKL_HTLV1_INFECTION_DN,SET,61,0.055226,0.0031781,0.11321,0.31284,AKL_HTLV1_INFECTION_DN,0.99999
GOBP_INNER_CELL_MASS_CELL_DI...,SET,8,0.18086,0.0037747,0.37081,0.31287,GOBP_INNER_CELL_MASS_CELL_DIFFERENTIATION,0.99999
HP_ABNORMAL_SPERM_MOTILITY,SET,93,0.042569,0.0030221,0.087327,0.31297,HP_ABNORMAL_SPERM_MOTILITY,0.99999
HP_ABNORMAL_RIGHT_VENTRICLE_...,SET,61,0.054376,0.0031292,0.11155,0.31298,HP_ABNORMAL_RIGHT_VENTRICLE_MORPHOLOGY,0.99999
MIR6835_5P,SET,30,0.072359,0.0029227,0.14847,0.313,MIR6835_5P,0.99999
HP_FIRST_DORSAL_INTEROSSEI_M...,SET,7,0.16257,0.003174,0.3336,0.31301,HP_FIRST_DORSAL_INTEROSSEI_MUSCLE_WEAKNESS,0.99999
GOCC_U5_SNRNP,SET,19,0.086087,0.0027681,0.17665,0.31302,GOCC_U5_SNRNP,0.99999
DORN_ADENOVIRUS_INFECTION_48...1,SET,37,0.064218,0.0028801,0.13179,0.31303,DORN_ADENOVIRUS_INFECTION_48HR_DN,0.99999
REACTOME_TGFBR3_REGULATES_TG...,SET,8,0.15491,0.003233,0.31791,0.31303,REACTOME_TGFBR3_REGULATES_TGF_BETA_SIGNALING,0.99999
GSE21670_STAT3_KO_VS_WT_CD4_...2,SET,175,0.033413,0.0032467,0.068578,0.31305,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN,0.99999
GSE36009_UNSTIM_VS_LPS_STIM_...1,SET,180,0.029912,0.0029473,0.061395,0.31306,GSE36009_UNSTIM_VS_LPS_STIM_DC_DN,0.99999
GOBP_HINDBRAIN_MORPHOGENESIS,SET,40,0.067491,0.003147,0.13861,0.31316,GOBP_HINDBRAIN_MORPHOGENESIS,0.99999
MODULE_197,SET,169,0.032912,0.0031432,0.067598,0.31318,MODULE_197,0.99999
GOBP_REGULATION_OF_RIBOSOME_...,SET,6,0.16138,0.0029171,0.33148,0.31318,GOBP_REGULATION_OF_RIBOSOME_BIOGENESIS,0.99999
GSE4748_CYANOBACTERIUM_LPSLI...1,SET,159,0.033989,0.0031494,0.06985,0.31328,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,0.99999
MIR764,SET,46,0.054556,0.0027275,0.11213,0.3133,MIR764,0.99999
GOMF_CYCLIC_NUCLEOTIDE_DEPEN...,SET,7,0.13947,0.0027229,0.28683,0.31341,GOMF_CYCLIC_NUCLEOTIDE_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.99999
HP_NECK_PAIN,SET,5,0.19879,0.0032802,0.40893,0.31345,HP_NECK_PAIN,0.99999
GOBP_POSITIVE_REGULATION_OF_...602,SET,39,0.070808,0.0032602,0.14567,0.31346,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,0.99999
REACTOME_BASIGIN_INTERACTIONS,SET,24,0.089729,0.0032422,0.18463,0.31349,REACTOME_BASIGIN_INTERACTIONS,0.99999
GOCC_SPERM_PLASMA_MEMBRANE,SET,14,0.10213,0.0028192,0.21016,0.3135,GOCC_SPERM_PLASMA_MEMBRANE,0.99999
BARRIER_COLON_CANCER_RECURRE...1,SET,16,0.10247,0.0030239,0.21088,0.31351,BARRIER_COLON_CANCER_RECURRENCE_DN,0.99999
MIR2115_3P,SET,215,0.029103,0.0031311,0.059902,0.31354,MIR2115_3P,0.99999
GSE14000_4H_VS_16H_LPS_DC_UP,SET,165,0.032571,0.0030739,0.067037,0.31354,GSE14000_4H_VS_16H_LPS_DC_UP,0.99999
HP_FURROWED_TONGUE,SET,38,0.060201,0.0027361,0.12393,0.31357,HP_FURROWED_TONGUE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...590,SET,34,0.074544,0.0032051,0.15348,0.3136,GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,0.99999
HP_RING_SCOTOMA,SET,5,0.1783,0.0029421,0.3671,0.3136,HP_RING_SCOTOMA,0.99999
HP_PROMINENT_OCCIPUT,SET,50,0.054587,0.0028449,0.1124,0.31361,HP_PROMINENT_OCCIPUT,0.99999
MIR4513,SET,46,0.060084,0.0030038,0.12375,0.31365,MIR4513,0.99999
REACTOME_ACTIVATION_OF_ATR_I...,SET,37,0.060538,0.002715,0.12473,0.31372,REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,0.99999
MIR10522_5P,SET,215,0.028684,0.003086,0.059131,0.31381,MIR10522_5P,0.99999
HP_HYPOINSULINEMIA,SET,21,0.096913,0.0032759,0.19979,0.31382,HP_HYPOINSULINEMIA,0.99999
GSE19941_UNSTIM_VS_LPS_STIM_...1,SET,177,0.031298,0.0030584,0.064536,0.31385,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN,0.99999
ZNF777_TARGET_GENES,SET,53,0.058516,0.0031396,0.12066,0.31386,ZNF777_TARGET_GENES,0.99999
GOBP_FATTY_ACYL_COA_CATABOLI...,SET,5,0.16705,0.0027565,0.34456,0.31391,GOBP_FATTY_ACYL_COA_CATABOLIC_PROCESS,0.99999
GOCC_MRNA_CLEAVAGE_AND_POLYA...,SET,17,0.09207,0.0028004,0.18991,0.31391,GOCC_MRNA_CLEAVAGE_AND_POLYADENYLATION_SPECIFICITY_FACTOR_COMPLEX,0.99999
MIR3928_3P,SET,84,0.04316,0.0029128,0.089034,0.31393,MIR3928_3P,0.99999
GSE17721_CTRL_VS_PAM3CSK4_12...1,SET,185,0.030544,0.0030507,0.063018,0.31395,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_DN,0.99999
REACTOME_MECP2_REGULATES_TRA...1,SET,4,0.25275,0.0037304,0.52151,0.31397,REACTOME_MECP2_REGULATES_TRANSCRIPTION_FACTORS,0.99999
GOMF_MANNOSIDASE_ACTIVITY,SET,15,0.11198,0.0031997,0.23106,0.31397,GOMF_MANNOSIDASE_ACTIVITY,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...5,SET,50,0.061906,0.0032263,0.12777,0.31402,GAVISH_3CA_METAPROGRAM_B_CELLS_INTERFERON,0.99999
GSE3982_DC_VS_MAC_DN,SET,178,0.031856,0.0031216,0.065758,0.31404,GSE3982_DC_VS_MAC_DN,0.99999
HP_ABNORMALITY_OF_THE_FONTAN...,SET,407,0.020322,0.0029921,0.041959,0.31408,HP_ABNORMALITY_OF_THE_FONTANELLES_OR_CRANIAL_SUTURES,0.99999
GSE24814_STAT5_KO_VS_WT_PRE_...2,SET,175,0.033156,0.0032217,0.068463,0.31409,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...571,SET,91,0.045841,0.0032195,0.094675,0.31413,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,0.99999
GENTILE_UV_RESPONSE_CLUSTER_...8,SET,24,0.087037,0.0031449,0.17982,0.31419,GENTILE_UV_RESPONSE_CLUSTER_D9,0.99999
REACTOME_OXIDATIVE_STRESS_IN...,SET,61,0.05607,0.0032267,0.11585,0.31421,REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,0.99999
MIR3689A_3P_MIR3689B_3P_MIR3...,SET,153,0.032899,0.0029909,0.067988,0.31423,MIR3689A_3P_MIR3689B_3P_MIR3689C,0.99999
MIR4503,SET,248,0.026915,0.0031071,0.055623,0.31424,MIR4503,0.99999
GOBP_THYROID_HORMONE_TRANSPO...,SET,10,0.13396,0.0031258,0.27696,0.31431,GOBP_THYROID_HORMONE_TRANSPORT,0.99999
HP_HYPOPLASTIC_SPLEEN,SET,8,0.1553,0.0032412,0.3211,0.31432,HP_HYPOPLASTIC_SPLEEN,0.99999
GOBP_TRANSITION_BETWEEN_FAST...,SET,7,0.14782,0.0028859,0.30583,0.31443,GOBP_TRANSITION_BETWEEN_FAST_AND_SLOW_FIBER,0.99999
WP_IMATINIB_AND_CHRONIC_MYEL...,SET,19,0.10262,0.0032996,0.21234,0.31446,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,0.99999
MORF_EIF3S6,SET,113,0.035839,0.0028031,0.074177,0.3145,MORF_EIF3S6,0.99999
HP_HEPATIC_CYSTS,SET,23,0.080614,0.0028516,0.16687,0.31452,HP_HEPATIC_CYSTS,0.99999
AP1_Q2,SET,242,0.027052,0.0030854,0.056013,0.31457,AP1_Q2,0.99999
YU_MYC_TARGETS_UP,SET,41,0.063653,0.0030048,0.13181,0.31458,YU_MYC_TARGETS_UP,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...6,SET,70,0.052861,0.003258,0.10948,0.3146,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,0.99999
MIR6846_5P,SET,70,0.049109,0.0030267,0.10171,0.31461,MIR6846_5P,0.99999
REACTOME_METABOLISM_OF_FAT_S...,SET,43,0.067205,0.0032487,0.13921,0.31464,REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,0.99999
GSE36888_UNTREATED_VS_IL2_TR...12,SET,167,0.033846,0.0032134,0.070112,0.31464,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_UP,0.99999
WP_TYPE_2_PAPILLARY_RENAL_CE...,SET,31,0.074193,0.0030462,0.15369,0.31465,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,0.99999
GOBP_UBIQUITIN_DEPENDENT_GLY...,SET,7,0.16471,0.0032158,0.34121,0.31465,GOBP_UBIQUITIN_DEPENDENT_GLYCOPROTEIN_ERAD_PATHWAY,0.99999
GOMF_MANNOSYL_OLIGOSACCHARID...1,SET,7,0.16471,0.0032158,0.34121,0.31465,GOMF_MANNOSYL_OLIGOSACCHARIDE_1_2_ALPHA_MANNOSIDASE_ACTIVITY,0.99999
GOBP_GLUCOCORTICOID_BIOSYNTH...,SET,16,0.11635,0.0034335,0.24108,0.31468,GOBP_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS,0.99999
GOCC_CLATHRIN_COAT,SET,48,0.057542,0.0029385,0.11926,0.31472,GOCC_CLATHRIN_COAT,0.99999
GOBP_RETROGRADE_TRANSPORT_VE...,SET,9,0.1519,0.0033626,0.31484,0.31474,GOBP_RETROGRADE_TRANSPORT_VESICLE_RECYCLING_WITHIN_GOLGI,0.99999
GSE9650_NAIVE_VS_EFF_CD8_TCE...2,SET,182,0.030327,0.0030046,0.062884,0.31481,GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP,0.99999
BUSSLINGER_DUODENAL_TUFT_CEL...,SET,70,0.054583,0.003364,0.11325,0.31492,BUSSLINGER_DUODENAL_TUFT_CELLS,0.99999
GOBP_CD4_POSITIVE_OR_CD8_POS...,SET,29,0.085567,0.0033982,0.1776,0.31497,GOBP_CD4_POSITIVE_OR_CD8_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT,0.99999
GSE7509_DC_VS_MONOCYTE_DN,SET,185,0.030379,0.0030343,0.063054,0.31498,GSE7509_DC_VS_MONOCYTE_DN,0.99999
GOCC_DEATH_INDUCING_SIGNALIN...,SET,9,0.14899,0.0032981,0.30937,0.31505,GOCC_DEATH_INDUCING_SIGNALING_COMPLEX,0.99999
BIOCARTA_AMI_PATHWAY,SET,18,0.10658,0.0033357,0.22132,0.31506,BIOCARTA_AMI_PATHWAY,0.99999
GSE3982_BASOPHIL_VS_CENT_MEM...2,SET,176,0.030656,0.0029872,0.063677,0.31511,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,0.99999
ZHENG_FOXP3_TARGETS_IN_THYMU...1,SET,12,0.12327,0.0031507,0.25608,0.31513,ZHENG_FOXP3_TARGETS_IN_THYMUS_DN,0.99999
GOCC_OUTER_MEMBRANE,SET,207,0.027882,0.0029439,0.057921,0.31513,GOCC_OUTER_MEMBRANE,0.99999
REACTOME_DETOXIFICATION_OF_R...,SET,33,0.069638,0.0029499,0.1447,0.31517,REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES,0.99999
WP_FOLLICLE_STIMULATING_HORM...,SET,26,0.084906,0.003193,0.17642,0.31517,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,0.99999
GSE2770_UNTREATED_VS_TGFB_AN...4,SET,175,0.029776,0.0028933,0.061875,0.31518,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.99999
GSE21670_TGFB_VS_IL6_TREATED...2,SET,177,0.030461,0.0029766,0.063303,0.31519,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP,0.99999
GOCC_ENDOPLASMIC_RETICULUM_P...3,SET,111,0.037687,0.0029216,0.078342,0.31524,GOCC_ENDOPLASMIC_RETICULUM_PROTEIN_CONTAINING_COMPLEX,0.99999
TOOKER_GEMCITABINE_RESISTANC...2,SET,73,0.049084,0.0030891,0.10205,0.31527,TOOKER_GEMCITABINE_RESISTANCE_UP,0.99999
GOMF_MELANOCORTIN_RECEPTOR_B...,SET,5,0.17867,0.0029482,0.37154,0.3153,GOMF_MELANOCORTIN_RECEPTOR_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...790,SET,19,0.087517,0.0028141,0.18215,0.31545,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.99999
GOBP_SIALYLATION,SET,10,0.13367,0.003119,0.27827,0.31548,GOBP_SIALYLATION,0.99999
HP_CONGENITAL_MALFORMATION_O...2,SET,76,0.048076,0.0030869,0.10014,0.31558,HP_CONGENITAL_MALFORMATION_OF_THE_RIGHT_HEART,0.99999
GOBP_NEGATIVE_REGULATION_OF_...287,SET,4,0.19859,0.002931,0.41366,0.31559,GOBP_NEGATIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION,0.99999
WP_GLP1_SECRETION_FROM_INTES...,SET,5,0.21515,0.0035503,0.44836,0.31566,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,0.99999
GOMF_ACROSIN_BINDING,SET,5,0.17161,0.0028318,0.35773,0.31571,GOMF_ACROSIN_BINDING,0.99999
ZNF514_TARGET_GENES,SET,7,0.15886,0.0031015,0.33121,0.31575,ZNF514_TARGET_GENES,0.99999
WP_UNFOLDED_PROTEIN_RESPONSE,SET,22,0.089452,0.0030948,0.18653,0.31577,WP_UNFOLDED_PROTEIN_RESPONSE,0.99999
ZIM3_TARGET_GENES,SET,799,0.014344,0.0029266,0.02991,0.31577,ZIM3_TARGET_GENES,0.99999
HP_MUSCLE_WEAKNESS,SET,912,0.013741,0.0029857,0.028668,0.31586,HP_MUSCLE_WEAKNESS,0.99999
GOBP_NEUROTRANSMITTER_RECEPT...2,SET,22,0.09102,0.003149,0.1899,0.31587,GOBP_NEUROTRANSMITTER_RECEPTOR_LOCALIZATION_TO_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,0.99999
GOBP_VASCULOGENESIS,SET,79,0.048586,0.0031804,0.10139,0.3159,GOBP_VASCULOGENESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...236,SET,13,0.12445,0.0033104,0.25972,0.31592,GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.99999
GOBP_TYPE_II_INTERFERON_MEDI...,SET,26,0.078506,0.0029523,0.16393,0.31601,GOBP_TYPE_II_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.99999
GOMF_NODAL_BINDING,SET,2,0.33242,0.0034695,0.69417,0.31602,GOMF_NODAL_BINDING,0.99999
WP_EXRNA_MECHANISM_OF_ACTION...,SET,6,0.15841,0.0028634,0.33084,0.31604,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,0.99999
GSE41867_LCMV_ARMSTRONG_VS_C...5,SET,178,0.029655,0.0029059,0.061949,0.31608,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...449,SET,38,0.064327,0.0029236,0.13444,0.31615,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PERMEABILITY,0.99999
GSE3982_EFF_MEMORY_CD4_TCELL...1,SET,172,0.03111,0.0029972,0.065016,0.31615,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN,0.99999
HP_ABNORMALITY_OF_THE_ANTERI...1,SET,6,0.14685,0.0026544,0.30702,0.31622,HP_ABNORMALITY_OF_THE_ANTERIOR_COMMISSURE,0.99999
GOBP_ACTIN_POLYMERIZATION_DE...,SET,7,0.15405,0.0030077,0.32215,0.31625,GOBP_ACTIN_POLYMERIZATION_DEPENDENT_CELL_MOTILITY,0.99999
RASHI_RESPONSE_TO_IONIZING_R...2,SET,116,0.039797,0.0031535,0.083227,0.31626,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,0.99999
GOBP_PRODUCTION_OF_MOLECULAR...2,SET,205,0.028715,0.0030174,0.060048,0.31626,GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.99999
STAT6_01,SET,238,0.027939,0.0031605,0.058433,0.31628,STAT6_01,0.99999
USF_02,SET,237,0.026552,0.0029974,0.055533,0.31628,USF_02,0.99999
FAN_EMBRYONIC_CTX_IN_6_INTER...,SET,4,0.23155,0.0034176,0.4843,0.31628,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...15,SET,83,0.043621,0.0029264,0.091237,0.31629,GAUTAM_EYE_IRIS_CILIARY_BODY_SCHWANN_CELLS,0.99999
HP_ACANTHOLYSIS,SET,10,0.13014,0.0030364,0.27227,0.31634,HP_ACANTHOLYSIS,0.99999
BIOCARTA_ERBB4_PATHWAY,SET,7,0.14437,0.0028185,0.30206,0.31635,BIOCARTA_ERBB4_PATHWAY,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...75,SET,8,0.13139,0.0027422,0.27494,0.31637,HP_APLASIA_HYPOPLASIA_OF_THE_TRAGUS,0.99999
KEGG_MELANOGENESIS,SET,98,0.043227,0.0031499,0.090459,0.31638,KEGG_MELANOGENESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...242,SET,96,0.043819,0.0031605,0.091734,0.31644,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,0.99999
MIR8079,SET,30,0.082529,0.0033335,0.1728,0.31647,MIR8079,0.99999
HP_CLITORAL_HYPOPLASIA,SET,26,0.078293,0.0029444,0.16395,0.31649,HP_CLITORAL_HYPOPLASIA,0.99999
MIR6775_3P,SET,69,0.048671,0.0029783,0.10192,0.3165,MIR6775_3P,0.99999
GOBP_HYALOID_VASCULAR_PLEXUS...,SET,7,0.17652,0.0034463,0.36977,0.31655,GOBP_HYALOID_VASCULAR_PLEXUS_REGRESSION,0.99999
GOMF_PHOSPHATIDYLINOSITOL_TR...1,SET,10,0.11505,0.0026844,0.241,0.31655,GOMF_PHOSPHATIDYLINOSITOL_TRANSFER_ACTIVITY,0.99999
WP_SOMITOGENESIS_IN_THE_CONT...,SET,9,0.13728,0.0030388,0.28765,0.3166,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,0.99999
GSE17721_LPS_VS_CPG_12H_BMDC...1,SET,177,0.030463,0.0029768,0.063833,0.3166,GSE17721_LPS_VS_CPG_12H_BMDC_DN,0.99999
MIR519D_5P,SET,220,0.027033,0.0029416,0.056658,0.31664,MIR519D_5P,0.99999
JNK_DN.V1_DN,SET,167,0.033539,0.0031843,0.070309,0.31667,JNK_DN.V1_DN,0.99999
REACTOME_CONDENSATION_OF_PRO...1,SET,11,0.10276,0.0025147,0.21543,0.31668,REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES,0.99999
HP_APLASIA_INVOLVING_BONES_O...3,SET,15,0.10227,0.0029223,0.21442,0.31669,HP_APLASIA_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.99999
BIOCARTA_NTHI_PATHWAY,SET,23,0.09108,0.0032218,0.19099,0.31672,BIOCARTA_NTHI_PATHWAY,0.99999
HP_LACUNAR_STROKE,SET,6,0.15472,0.0027967,0.32458,0.3168,HP_LACUNAR_STROKE,0.99999
TTCYRGAA_UNKNOWN,SET,300,0.023818,0.0030198,0.049972,0.31681,TTCYRGAA_UNKNOWN,0.99999
GOBP_MATURE_CONVENTIONAL_DEN...,SET,5,0.21062,0.0034754,0.44209,0.31689,GOBP_MATURE_CONVENTIONAL_DENDRITIC_CELL_DIFFERENTIATION,0.99999
MARTORIATI_MDM4_TARGETS_NEUR...1,SET,147,0.03602,0.0032103,0.075623,0.31693,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,0.99999
VALK_AML_WITH_FLT3_ITD,SET,36,0.070189,0.0031051,0.14737,0.31694,VALK_AML_WITH_FLT3_ITD,0.99999
GOCC_CILIARY_BASE,SET,35,0.067601,0.0029489,0.14194,0.31694,GOCC_CILIARY_BASE,0.99999
HP_FOAM_CELLS,SET,11,0.13971,0.0034189,0.29338,0.31696,HP_FOAM_CELLS,0.99999
GOBP_REGULATION_OF_ACUTE_INF...1,SET,44,0.065053,0.003181,0.13667,0.31704,GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,0.99999
HP_ABNORMAL_ACETABULUM_MORPH...,SET,84,0.044111,0.002977,0.092675,0.31705,HP_ABNORMAL_ACETABULUM_MORPHOLOGY,0.99999
GSE40655_FOXO1_KO_VS_WT_NTRE...1,SET,169,0.029516,0.0028189,0.062019,0.31707,GSE40655_FOXO1_KO_VS_WT_NTREG_DN,0.99999
GOMF_CHEMOKINE_RECEPTOR_BIND...,SET,60,0.062694,0.0035783,0.13176,0.3171,GOMF_CHEMOKINE_RECEPTOR_BINDING,0.99999
MIR4661_3P,SET,29,0.071638,0.002845,0.15058,0.31713,MIR4661_3P,0.99999
HP_MYELOPATHY,SET,13,0.11286,0.0030023,0.23733,0.3172,HP_MYELOPATHY,0.99999
GSE16266_CTRL_VS_HEATSHOCK_A...1,SET,186,0.029342,0.0029385,0.061705,0.31721,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,0.99999
HP_SHORTENING_OF_ALL_MIDDLE_...,SET,6,0.17926,0.0032402,0.37699,0.31722,HP_SHORTENING_OF_ALL_MIDDLE_PHALANGES_OF_THE_FINGERS,0.99999
WP_SARSCOV2_ALTERING_ANGIOGE...,SET,4,0.24583,0.0036283,0.51713,0.31726,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,0.99999
MIR422A,SET,37,0.063808,0.0028617,0.13426,0.3173,MIR422A,0.99999
REACTOME_PHOSPHOLIPASE_C_MED...1,SET,16,0.11196,0.003304,0.23561,0.31732,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1,0.99999
WP_IL26_SIGNALING,SET,44,0.067748,0.0033127,0.14257,0.31733,WP_IL26_SIGNALING,0.99999
HOEK_B_CELL_2011_2012_TIV_AD...5,SET,33,0.07434,0.003149,0.15645,0.31734,HOEK_B_CELL_2011_2012_TIV_ADULT_7DY_UP,0.99999
GOBP_ENERGY_RESERVE_METABOLI...,SET,85,0.044031,0.0029892,0.092672,0.31735,GOBP_ENERGY_RESERVE_METABOLIC_PROCESS,0.99999
MIR4524B_3P,SET,65,0.054514,0.003238,0.11476,0.31739,MIR4524B_3P,0.99999
REACTOME_AMINO_ACID_TRANSPOR...,SET,30,0.079985,0.0032307,0.1684,0.3174,REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE,0.99999
TCF11_01,SET,225,0.027675,0.003045,0.058286,0.31746,TCF11_01,0.99999
WP_ENDOCHONDRAL_OSSIFICATION,SET,63,0.05647,0.0033024,0.11894,0.31748,WP_ENDOCHONDRAL_OSSIFICATION,0.99999
WP_ENDOCHONDRAL_OSSIFICATION...,SET,63,0.05647,0.0033024,0.11894,0.31748,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,0.99999
HP_PLATYSPONDYLY,SET,108,0.039235,0.0030005,0.082643,0.31748,HP_PLATYSPONDYLY,0.99999
GOMF_MHC_CLASS_II_PROTEIN_CO...,SET,23,0.0904,0.0031978,0.19042,0.31749,GOMF_MHC_CLASS_II_PROTEIN_COMPLEX_BINDING,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...45,SET,5,0.20174,0.0033289,0.42503,0.31752,GOBP_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE_RAFT,0.99999
DESCARTES_FETAL_PLACENTA_EXT...,SET,60,0.056291,0.0032129,0.11863,0.31757,DESCARTES_FETAL_PLACENTA_EXTRAVILLOUS_TROPHOBLASTS,0.99999
CARRILLOREIXACH_HEPATOBLASTO...2,SET,18,0.097498,0.0030514,0.20549,0.31759,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPERMETHYLATED_AND_DN,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...1,SET,45,0.060454,0.0029894,0.12742,0.3176,BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN,0.99999
HP_MISCARRIAGE,SET,32,0.076909,0.0032082,0.16211,0.3176,HP_MISCARRIAGE,0.99999
MODULE_68,SET,26,0.088058,0.0033116,0.18563,0.31762,MODULE_68,0.99999
GOBP_MATERNAL_PROCESS_INVOLV...2,SET,5,0.16511,0.0027244,0.34812,0.31765,GOBP_MATERNAL_PROCESS_INVOLVED_IN_PARTURITION,0.99999
GSE26351_WNT_VS_BMP_PATHWAY_...2,SET,182,0.029901,0.0029624,0.063043,0.31765,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...603,SET,121,0.037187,0.0030091,0.078413,0.31767,GOBP_POSITIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.99999
GOBP_REGULATION_OF_NERVOUS_S...2,SET,107,0.041187,0.0031353,0.086861,0.31769,GOBP_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,0.99999
HP_ABNORMAL_CIRCULATING_ANDR...1,SET,89,0.044094,0.0030627,0.093007,0.31772,HP_ABNORMAL_CIRCULATING_ANDROGEN_LEVEL,0.99999
HP_LARGE_HANDS,SET,29,0.068294,0.0027122,0.14406,0.31772,HP_LARGE_HANDS,0.99999
HP_POIKILOCYTOSIS,SET,49,0.05727,0.0029548,0.12087,0.31782,HP_POIKILOCYTOSIS,0.99999
HP_ABNORMAL_SIZE_OF_PITUITAR...,SET,27,0.076436,0.0029292,0.1614,0.3179,HP_ABNORMAL_SIZE_OF_PITUITARY_GLAND,0.99999
MIR3606_5P,SET,141,0.034782,0.0030365,0.073447,0.31791,MIR3606_5P,0.99999
REACTOME_CASPASE_ACTIVATION_...3,SET,25,0.084237,0.0031064,0.17793,0.31796,REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY,0.99999
HP_LOSS_OF_SPEECH,SET,45,0.060285,0.0029811,0.12738,0.31801,HP_LOSS_OF_SPEECH,0.99999
GOBP_5_PHOSPHORIBOSE_1_DIPHO...,SET,4,0.17979,0.0026536,0.37994,0.31804,GOBP_5_PHOSPHORIBOSE_1_DIPHOSPHATE_METABOLIC_PROCESS,0.99999
MIR933,SET,6,0.18621,0.0033659,0.39365,0.3181,MIR933,0.99999
chr7p22,SET,67,0.1046,0.0063075,0.22116,0.31812,chr7p22,0.99999
GSE28130_ACTIVATED_VS_INDUCE...2,SET,175,0.03139,0.0030501,0.066385,0.31817,GSE28130_ACTIVATED_VS_INDUCEED_TREG_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...291,SET,10,0.12984,0.0030295,0.27464,0.31819,GOBP_NEGATIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,0.99999
KEGG_MEDICUS_PATHOGEN_EBV_LM...2,SET,5,0.18626,0.0030736,0.394,0.3182,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_PI3K_SIGNALING_PATHWAY,0.99999
MIR7703,SET,101,0.040858,0.0030222,0.08645,0.31825,MIR7703,0.99999
HP_VENTRICULAR_TACHYCARDIA,SET,62,0.054177,0.0031431,0.1147,0.31835,HP_VENTRICULAR_TACHYCARDIA,0.99999
GOMF_NUCLEAR_LOCALIZATION_SE...,SET,23,0.083183,0.0029425,0.1762,0.31843,GOMF_NUCLEAR_LOCALIZATION_SEQUENCE_BINDING,0.99999
GOBP_PHOSPHATIDIC_ACID_METAB...,SET,35,0.071683,0.003127,0.15187,0.31846,GOBP_PHOSPHATIDIC_ACID_METABOLIC_PROCESS,0.99999
CTIP_DN.V1_DN,SET,114,0.039697,0.0031185,0.084104,0.31847,CTIP_DN.V1_DN,0.99999
OCT1_B,SET,225,0.028818,0.0031708,0.061073,0.31851,OCT1_B,0.99999
REACTOME_DEFECTS_OF_PLATELET...,SET,8,0.15609,0.0032578,0.33083,0.31853,REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN,0.99999
MIR1292_5P,SET,15,0.10198,0.0029138,0.21616,0.31855,MIR1292_5P,0.99999
LY_AGING_MIDDLE_DN,SET,15,0.091861,0.0026247,0.19473,0.31856,LY_AGING_MIDDLE_DN,0.99999
GOCC_NEURONAL_DENSE_CORE_VES...2,SET,5,0.20707,0.0034169,0.43894,0.31856,GOCC_NEURONAL_DENSE_CORE_VESICLE_MEMBRANE,0.99999
HOEK_NEUTROPHIL_2011_2012_TI...4,SET,7,0.18538,0.0036192,0.39303,0.31859,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_3DY_UP,0.99999
HOEK_NEUTROPHIL_2011_2012_TI...2,SET,28,0.089254,0.0034831,0.18926,0.31862,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_UP,0.99999
GOMF_INSULIN_BINDING,SET,5,0.16644,0.0027464,0.3531,0.31869,GOMF_INSULIN_BINDING,0.99999
GSE21379_TFH_VS_NON_TFH_CD4_...2,SET,178,0.030334,0.0029724,0.064361,0.31871,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP,0.99999
MIR3934_5P,SET,55,0.054618,0.0029851,0.11592,0.31876,MIR3934_5P,0.99999
BILD_HRAS_ONCOGENIC_SIGNATURE,SET,229,0.028818,0.0031984,0.061171,0.31879,BILD_HRAS_ONCOGENIC_SIGNATURE,0.99999
GSE24142_EARLY_THYMIC_PROGEN...2,SET,183,0.0315,0.0031294,0.066884,0.31883,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP,0.99999
GOBP_REGULATION_OF_LONG_TERM...3,SET,45,0.062,0.0030658,0.13164,0.31884,GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,0.99999
HP_BLISTERING_BY_HISTOLOGICA...,SET,13,0.1094,0.0029103,0.23235,0.31888,HP_BLISTERING_BY_HISTOLOGICAL_LOCATION,0.99999
ZHAN_MULTIPLE_MYELOMA_CD1_UP,SET,40,0.067374,0.0031415,0.14318,0.31899,ZHAN_MULTIPLE_MYELOMA_CD1_UP,0.99999
HP_CYSTIC_LIVER_DISEASE,SET,40,0.058084,0.0027083,0.12344,0.31899,HP_CYSTIC_LIVER_DISEASE,0.99999
GOBP_RENAL_TUBULE_DEVELOPMENT,SET,96,0.045163,0.0032573,0.096007,0.31903,GOBP_RENAL_TUBULE_DEVELOPMENT,0.99999
chr20p13,SET,78,0.093304,0.0060689,0.19835,0.31904,chr20p13,0.99999
GSE14308_TH2_VS_INDUCED_TREG...1,SET,180,0.028394,0.0027978,0.060374,0.31907,GSE14308_TH2_VS_INDUCED_TREG_DN,0.99999
WP_PLURIPOTENT_STEM_CELL_DIF...,SET,46,0.065151,0.0032572,0.13855,0.3191,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,0.99999
BIOCARTA_CELL2CELL_PATHWAY,SET,12,0.11804,0.0030169,0.2511,0.31915,BIOCARTA_CELL2CELL_PATHWAY,0.99999
GOBP_GLYCEROL_TRANSMEMBRANE_...,SET,7,0.18078,0.0035294,0.38463,0.31918,GOBP_GLYCEROL_TRANSMEMBRANE_TRANSPORT,0.99999
GOMF_GLYCEROL_TRANSMEMBRANE_...,SET,7,0.18078,0.0035294,0.38463,0.31918,GOMF_GLYCEROL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
REACTOME_INTERLEUKIN_3_INTER...,SET,43,0.064481,0.0031171,0.13721,0.3192,REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,0.99999
GOBP_POSITIVE_REGULATION_OF_...838,SET,3,0.21646,0.0027669,0.46068,0.31923,GOBP_POSITIVE_REGULATION_OF_VESICLE_TRANSPORT_ALONG_MICROTUBULE,0.99999
WP_IL11_SIGNALING,SET,41,0.064513,0.0030454,0.13733,0.31927,WP_IL11_SIGNALING,0.99999
GOBP_SYNAPTIC_TRANSMISSION_G...2,SET,98,0.042799,0.0031187,0.091111,0.31927,GOBP_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,0.99999
GSE22886_DAY1_VS_DAY7_MONOCY...1,SET,176,0.029175,0.0028429,0.062112,0.31928,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN,0.99999
MIR4666A_5P,SET,226,0.027451,0.003027,0.058461,0.31934,MIR4666A_5P,0.99999
GOCC_FLOTILLIN_COMPLEX,SET,9,0.13375,0.0029607,0.28491,0.31937,GOCC_FLOTILLIN_COMPLEX,0.99999
GSE32164_ALTERNATIVELY_ACT_M...2,SET,178,0.029327,0.0028737,0.062477,0.3194,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP,0.99999
GOBP_DICARBOXYLIC_ACID_CATAB...,SET,17,0.093701,0.0028501,0.19971,0.31947,GOBP_DICARBOXYLIC_ACID_CATABOLIC_PROCESS,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...5,SET,176,0.029201,0.0028454,0.062238,0.31947,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN,0.99999
MIR7112_5P,SET,7,0.1441,0.0028133,0.30722,0.31952,MIR7112_5P,0.99999
HP_ABNORMAL_NASAL_MUCOSA_MOR...,SET,69,0.048243,0.0029521,0.10289,0.31958,HP_ABNORMAL_NASAL_MUCOSA_MORPHOLOGY,0.99999
GOBP_LUNG_VASCULATURE_DEVELO...,SET,9,0.14309,0.0031676,0.30528,0.31963,GOBP_LUNG_VASCULATURE_DEVELOPMENT,0.99999
GOBP_SEQUESTERING_OF_METAL_I...,SET,9,0.13737,0.0030409,0.29309,0.31964,GOBP_SEQUESTERING_OF_METAL_ION,0.99999
REACTOME_NEF_MEDIATED_CD4_DO...,SET,9,0.13077,0.0028948,0.27913,0.31971,REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION,0.99999
GOBP_LEUKOCYTE_MIGRATION_INV...,SET,19,0.096778,0.0031118,0.20657,0.31972,GOBP_LEUKOCYTE_MIGRATION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.99999
GOMF_MONOATOMIC_CATION_CHANN...,SET,302,0.02512,0.0031952,0.053619,0.31972,GOMF_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.99999
HP_ABNORMALITY_OF_THE_COSTOC...,SET,17,0.10534,0.0032042,0.22487,0.31973,HP_ABNORMALITY_OF_THE_COSTOCHONDRAL_JUNCTION,0.99999
GOBP_SEQUESTERING_OF_BMP_IN_...,SET,4,0.23469,0.003464,0.5011,0.31977,GOBP_SEQUESTERING_OF_BMP_IN_EXTRACELLULAR_MATRIX,0.99999
HP_RESPIRATORY_PARALYSIS,SET,7,0.16956,0.0033104,0.36206,0.31978,HP_RESPIRATORY_PARALYSIS,0.99999
chr15q15,SET,86,0.09334,0.0063736,0.19934,0.31981,chr15q15,0.99999
MORF_DMPK,SET,153,0.033103,0.0030094,0.070697,0.31981,MORF_DMPK,0.99999
GOBP_CGMP_METABOLIC_PROCESS,SET,13,0.11756,0.0031273,0.25108,0.31981,GOBP_CGMP_METABOLIC_PROCESS,0.99999
PID_INTEGRIN_CS_PATHWAY,SET,25,0.087501,0.0032268,0.18693,0.31986,PID_INTEGRIN_CS_PATHWAY,0.99999
TGASTMAGC_NFE2_01,SET,172,0.030422,0.0029309,0.064993,0.31986,TGASTMAGC_NFE2_01,0.99999
GOBP_DETERMINATION_OF_ADULT_...,SET,31,0.0722,0.0029644,0.15425,0.31987,GOBP_DETERMINATION_OF_ADULT_LIFESPAN,0.99999
GOMF_CYTOSKELETAL_PROTEIN_BI...,SET,909,0.013479,0.0029241,0.028798,0.31988,GOMF_CYTOSKELETAL_PROTEIN_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...425,SET,19,0.092732,0.0029817,0.1982,0.31994,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS,0.99999
WELCSH_BRCA1_TARGETS_DN,SET,125,0.033205,0.0027306,0.070982,0.31997,WELCSH_BRCA1_TARGETS_DN,0.99999
GSE3982_MAC_VS_EFF_MEMORY_CD...1,SET,173,0.030408,0.0029379,0.065022,0.32002,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN,0.99999
KEGG_MEDICUS_REFERENCE_BETA_...1,SET,11,0.11814,0.002891,0.25265,0.32003,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...789,SET,7,0.14601,0.0028507,0.31226,0.32004,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_LIPASE_ACTIVITY,0.99999
HP_INTELLECTUAL_DISABILITY_M...1,SET,289,0.023504,0.0029257,0.050269,0.32005,HP_INTELLECTUAL_DISABILITY_MILD,0.99999
GOBP_BONE_MINERALIZATION,SET,113,0.039597,0.003097,0.0847,0.32008,GOBP_BONE_MINERALIZATION,0.99999
HP_TRUNCAL_TITUBATION,SET,7,0.15776,0.00308,0.3375,0.3201,HP_TRUNCAL_TITUBATION,0.99999
GSE13485_DAY1_VS_DAY21_YF17D...1,SET,165,0.02893,0.0027303,0.061891,0.3201,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.99999
MIR6505_5P,SET,187,0.029661,0.0029783,0.063479,0.32016,MIR6505_5P,0.99999
HP_NARROW_ILIAC_WING,SET,8,0.128,0.0026715,0.27397,0.32018,HP_NARROW_ILIAC_WING,0.99999
HP_KNEE_CONTRACTURE,SET,98,0.041554,0.003028,0.088951,0.3202,HP_KNEE_CONTRACTURE,0.99999
HP_CORTICAL_SCLEROSIS,SET,5,0.18019,0.0029734,0.38575,0.32021,HP_CORTICAL_SCLEROSIS,0.99999
AIZARANI_LIVER_C14_HEPATOCYT...,SET,208,0.030043,0.0031797,0.064337,0.32027,AIZARANI_LIVER_C14_HEPATOCYTES_2,0.99999
GSE18804_BRAIN_VS_COLON_TUMO...2,SET,144,0.035529,0.0031343,0.076093,0.32028,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP,0.99999
KAAB_HEART_ATRIUM_VS_VENTRIC...1,SET,240,0.025529,0.0028999,0.05468,0.32029,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,0.99999
HP_BONE_FRACTURE,SET,21,0.078527,0.0026544,0.16821,0.32031,HP_BONE_FRACTURE,0.99999
BUSSLINGER_DUODENAL_BCHE_CEL...,SET,39,0.068124,0.0031366,0.14594,0.32033,BUSSLINGER_DUODENAL_BCHE_CELLS,0.99999
GOBP_LATE_ENDOSOME_TO_GOLGI_...,SET,3,0.20331,0.0025988,0.43562,0.32035,GOBP_LATE_ENDOSOME_TO_GOLGI_TRANSPORT,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...13,SET,179,0.028474,0.0027979,0.06102,0.32038,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.99999
GOBP_REGULATION_OF_FIBRINOLY...,SET,18,0.091752,0.0028716,0.19665,0.3204,GOBP_REGULATION_OF_FIBRINOLYSIS,0.99999
HP_MALE_SEXUAL_DYSFUNCTION,SET,78,0.045644,0.0029689,0.097827,0.3204,HP_MALE_SEXUAL_DYSFUNCTION,0.99999
GOMF_MALATE_DEHYDROGENASE_AC...,SET,8,0.14318,0.0029882,0.307,0.32047,GOMF_MALATE_DEHYDROGENASE_ACTIVITY,0.99999
MIR3151_3P,SET,39,0.059664,0.0027471,0.12793,0.32048,MIR3151_3P,0.99999
GOBP_CELLULAR_RESPONSE_TO_MA...1,SET,13,0.12949,0.0034446,0.27768,0.3205,GOBP_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS,0.99999
HP_AORTIC_ATHEROSCLEROTIC_LE...,SET,8,0.16443,0.0034319,0.35267,0.32052,HP_AORTIC_ATHEROSCLEROTIC_LESION,0.99999
HP_ABNORMALITY_OF_THE_NECK,SET,611,0.016102,0.0028883,0.03455,0.32059,HP_ABNORMALITY_OF_THE_NECK,0.99999
KYNG_NORMAL_AGING_DN,SET,16,0.1009,0.0029776,0.21653,0.32061,KYNG_NORMAL_AGING_DN,0.99999
GNF2_CKS2,SET,49,0.05269,0.0027185,0.11307,0.32061,GNF2_CKS2,0.99999
GOCC_CENTRAL_ELEMENT,SET,7,0.14193,0.0027709,0.30458,0.32062,GOCC_CENTRAL_ELEMENT,0.99999
HP_DOLICHOCEPHALY,SET,196,0.027896,0.002867,0.059871,0.32064,HP_DOLICHOCEPHALY,0.99999
MIR6777_3P,SET,45,0.059332,0.0029339,0.12736,0.32065,MIR6777_3P,0.99999
HP_ABNORMALITY_OF_THE_DIAPHR...,SET,101,0.039061,0.0028893,0.083855,0.32068,HP_ABNORMALITY_OF_THE_DIAPHRAGM,0.99999
HP_ABNORMAL_ILIAC_WING_MORPH...,SET,53,0.054511,0.0029247,0.11703,0.32069,HP_ABNORMAL_ILIAC_WING_MORPHOLOGY,0.99999
GOCC_ANAPHASE_PROMOTING_COMP...,SET,21,0.077888,0.0026328,0.16726,0.32072,GOCC_ANAPHASE_PROMOTING_COMPLEX,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...73,SET,14,0.10672,0.0029459,0.22918,0.32074,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOCC_U6_SNRNP,SET,8,0.12306,0.0025684,0.26438,0.32079,GOCC_U6_SNRNP,0.99999
HP_ARM_DYSTONIA,SET,12,0.10459,0.0026731,0.22478,0.32086,HP_ARM_DYSTONIA,0.99999
GSE33425_CD161_INT_VS_NEG_CD...2,SET,187,0.029333,0.0029454,0.06311,0.32104,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP,0.99999
MIR9851_5P,SET,103,0.038322,0.0028624,0.082458,0.32106,MIR9851_5P,0.99999
GOBP_RAB_PROTEIN_SIGNAL_TRAN...,SET,17,0.090455,0.0027513,0.19465,0.32107,GOBP_RAB_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...23,SET,48,0.061366,0.0031338,0.13208,0.32111,GAVISH_3CA_MALIGNANT_METAPROGRAM_31_ALVEOLAR,0.99999
GOBP_DNA_STRAND_ELONGATION_I...,SET,14,0.089057,0.0024584,0.19176,0.32118,GOBP_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION,0.99999
MEK_UP.V1_DN,SET,162,0.031858,0.0029795,0.068598,0.32118,MEK_UP.V1_DN,0.99999
GOBP_MODIFICATION_OF_POSTSYN...1,SET,10,0.12718,0.0029675,0.27388,0.3212,GOBP_MODIFICATION_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.99999
GOMF_OPSONIN_BINDING,SET,16,0.10581,0.0031225,0.22787,0.3212,GOMF_OPSONIN_BINDING,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...4,SET,8,0.12,0.0025045,0.25844,0.32121,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC,0.99999
TGCTGAY_UNKNOWN,SET,483,0.018694,0.002992,0.04031,0.32142,TGCTGAY_UNKNOWN,0.99999
GOCC_PHAGOCYTIC_CUP,SET,26,0.077948,0.0029314,0.16811,0.32144,GOCC_PHAGOCYTIC_CUP,0.99999
GOBP_REGULATION_OF_HEMATOPOI...2,SET,17,0.090764,0.0027607,0.1958,0.32148,GOBP_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,0.99999
HP_DYSARTHRIA,SET,537,0.016667,0.0028085,0.035961,0.32152,HP_DYSARTHRIA,0.99999
SOUCEK_MYC_TARGETS,SET,10,0.13409,0.0031288,0.2894,0.32156,SOUCEK_MYC_TARGETS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...437,SET,11,0.1281,0.0031347,0.27651,0.32159,GOBP_NEGATIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION,0.99999
HP_POLYCYTHEMIA,SET,22,0.085723,0.0029657,0.18505,0.3216,HP_POLYCYTHEMIA,0.99999
MIR6817_5P,SET,98,0.040773,0.0029711,0.088025,0.32161,MIR6817_5P,0.99999
CEBPB_02,SET,237,0.02644,0.0029847,0.057085,0.32163,CEBPB_02,0.99999
GOBP_REGULATION_OF_MITOPHAGY,SET,33,0.069914,0.0029616,0.15096,0.32164,GOBP_REGULATION_OF_MITOPHAGY,0.99999
MIR4790_5P,SET,13,0.10839,0.0028834,0.23412,0.3217,MIR4790_5P,0.99999
GOBP_DIPEPTIDE_TRANSMEMBRANE...,SET,8,0.13854,0.0028915,0.29932,0.32174,GOBP_DIPEPTIDE_TRANSMEMBRANE_TRANSPORT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...406,SET,7,0.17156,0.0033495,0.37067,0.32174,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_CALCIUM_M...,SET,92,0.042345,0.0029902,0.091486,0.32174,GOBP_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,0.99999
FU_INTERACT_WITH_ALKBH8,SET,13,0.089717,0.0023866,0.19391,0.3218,FU_INTERACT_WITH_ALKBH8,0.99999
GSE26156_DOUBLE_POSITIVE_VS_...1,SET,184,0.027761,0.0027654,0.060003,0.3218,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.99999
BIOCARTA_RHODOPSIN_PATHWAY,SET,8,0.13522,0.0028222,0.29228,0.32181,BIOCARTA_RHODOPSIN_PATHWAY,0.99999
GOBP_REGULATION_OF_GOLGI_ORG...,SET,15,0.10246,0.0029277,0.22152,0.32185,GOBP_REGULATION_OF_GOLGI_ORGANIZATION,0.99999
HP_PALMOPLANTAR_ERYTHEMA,SET,5,0.21522,0.0035514,0.46547,0.32191,HP_PALMOPLANTAR_ERYTHEMA,0.99999
GOBP_OXYGEN_METABOLIC_PROCESS,SET,6,0.15623,0.002824,0.33794,0.32193,GOBP_OXYGEN_METABOLIC_PROCESS,0.99999
GSE28737_FOLLICULAR_VS_MARGI...4,SET,185,0.027246,0.0027213,0.058932,0.32193,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_UP,0.99999
GSE10325_LUPUS_CD4_TCELL_VS_...2,SET,175,0.031335,0.0030448,0.067783,0.32194,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP,0.99999
GSE39820_TGFBETA1_IL6_VS_TGF...2,SET,185,0.028565,0.002853,0.061791,0.32194,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP,0.99999
GSE11057_PBMC_VS_MEM_CD4_TCE...1,SET,164,0.030868,0.0029045,0.066775,0.32195,GSE11057_PBMC_VS_MEM_CD4_TCELL_DN,0.99999
MIR628_3P,SET,66,0.045978,0.0027519,0.099474,0.32197,MIR628_3P,0.99999
GOBP_PEPTIDYL_LYSINE_METHYLA...,SET,14,0.099327,0.0027419,0.2149,0.32197,GOBP_PEPTIDYL_LYSINE_METHYLATION,0.99999
GSE21546_WT_VS_SAP1A_KO_AND_...2,SET,164,0.031611,0.0029744,0.068395,0.32198,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.99999
GOBP_EXTRACELLULAR_MATRIX_AS...,SET,43,0.063342,0.003062,0.13708,0.32202,GOBP_EXTRACELLULAR_MATRIX_ASSEMBLY,0.99999
GOCC_PRECATALYTIC_SPLICEOSOME,SET,48,0.049389,0.0025221,0.10694,0.32211,GOCC_PRECATALYTIC_SPLICEOSOME,0.99999
HP_ABNORMAL_NUMBER_OF_INCISO...,SET,51,0.057371,0.0030197,0.12423,0.32212,HP_ABNORMAL_NUMBER_OF_INCISORS,0.99999
HP_FETAL_ONSET,SET,170,0.029111,0.0027884,0.063048,0.32214,HP_FETAL_ONSET,0.99999
GOBP_REGULATION_OF_POSTSYNAP...8,SET,5,0.20056,0.0033095,0.43446,0.32217,GOBP_REGULATION_OF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.99999
GOBP_SIGNAL_TRANSDUCTION_IN_...2,SET,170,0.028733,0.0027521,0.062242,0.32218,GOBP_SIGNAL_TRANSDUCTION_IN_RESPONSE_TO_DNA_DAMAGE,0.99999
GOBP_MICROTUBULE_NUCLEATION,SET,41,0.056969,0.0026893,0.12343,0.3222,GOBP_MICROTUBULE_NUCLEATION,0.99999
GOBP_RESPONSE_TO_HYDROXYUREA,SET,9,0.11498,0.0025453,0.24911,0.3222,GOBP_RESPONSE_TO_HYDROXYUREA,0.99999
GSE25123_CTRL_VS_IL4_AND_ROS...4,SET,177,0.03033,0.0029638,0.065723,0.32223,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,0.99999
GOBP_IMMUNOLOGICAL_MEMORY_FO...,SET,13,0.12865,0.0034221,0.27878,0.32224,GOBP_IMMUNOLOGICAL_MEMORY_FORMATION_PROCESS,0.99999
GGCACTT_MIR519E,SET,109,0.037846,0.0029075,0.082031,0.32227,GGCACTT_MIR519E,0.99999
GOBP_REGULATION_OF_URINE_VOL...,SET,19,0.099119,0.0031871,0.21492,0.32233,GOBP_REGULATION_OF_URINE_VOLUME,0.99999
HP_DIAPHRAGMATIC_WEAKNESS,SET,16,0.10433,0.0030787,0.22621,0.32233,HP_DIAPHRAGMATIC_WEAKNESS,0.99999
GSE5542_IFNG_VS_IFNA_AND_IFN...3,SET,174,0.0293,0.002839,0.063555,0.3224,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.99999
GOBP_PROTEIN_LIPID_COMPLEX_A...,SET,26,0.075122,0.0028251,0.16299,0.32243,GOBP_PROTEIN_LIPID_COMPLEX_ASSEMBLY,0.99999
GSE25123_WT_VS_PPARG_KO_MACR...5,SET,178,0.029644,0.0029048,0.064329,0.32247,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_UP,0.99999
GSE11864_CSF1_VS_CSF1_PAM3CY...2,SET,166,0.029978,0.0028378,0.065058,0.32248,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP,0.99999
HE_PTEN_TARGETS_UP,SET,18,0.089998,0.0028167,0.19541,0.32256,HE_PTEN_TARGETS_UP,0.99999
GOBP_ACTIN_MODIFICATION,SET,4,0.18463,0.002725,0.4009,0.32257,GOBP_ACTIN_MODIFICATION,0.99999
GOBP_SYNAPTIC_VESICLE_PRIMING,SET,19,0.07922,0.0025473,0.17202,0.32257,GOBP_SYNAPTIC_VESICLE_PRIMING,0.99999
GSE17721_0.5H_VS_24H_PAM3CSK...1,SET,186,0.028134,0.0028175,0.061114,0.32263,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_DN,0.99999
GSE5589_WT_VS_IL6_KO_LPS_AND...1,SET,134,0.033292,0.0028339,0.072317,0.32263,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...8,SET,44,0.065062,0.0031814,0.14137,0.32268,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_MEMORY_NAIVE_1,0.99999
GOBP_SPINDLE_MIDZONE_ASSEMBLY,SET,13,0.10355,0.0027546,0.22503,0.3227,GOBP_SPINDLE_MIDZONE_ASSEMBLY,0.99999
chr12q12,SET,24,0.14548,0.0052567,0.3162,0.32273,chr12q12,0.99999
GOBP_NEGATIVE_REGULATION_OF_...44,SET,4,0.15721,0.0023204,0.34191,0.32283,GOBP_NEGATIVE_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,0.99999
GOBP_ANGIOGENESIS_INVOLVED_I...2,SET,27,0.080111,0.00307,0.17425,0.32285,GOBP_ANGIOGENESIS_INVOLVED_IN_WOUND_HEALING,0.99999
HP_ABNORMAL_PERIAURICULAR_RE...,SET,95,0.041229,0.0029582,0.089687,0.32287,HP_ABNORMAL_PERIAURICULAR_REGION_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_VOLTAGE_G...2,SET,6,0.17461,0.0031563,0.37994,0.32291,GOBP_REGULATION_OF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_TETHE...,SET,9,0.12495,0.002766,0.27198,0.32297,KEGG_MEDICUS_REFERENCE_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,0.99999
MODULE_75,SET,368,0.022959,0.0032179,0.05,0.32305,MODULE_75,0.99999
GOBP_POSITIVE_REGULATION_OF_...457,SET,14,0.088739,0.0024496,0.19325,0.32305,GOBP_POSITIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE,0.99999
HP_PATENT_DUCTUS_ARTERIOSUS,SET,334,0.021472,0.0028698,0.046767,0.32307,HP_PATENT_DUCTUS_ARTERIOSUS,0.99999
VALK_AML_CLUSTER_8,SET,22,0.08665,0.0029978,0.18873,0.32308,VALK_AML_CLUSTER_8,0.99999
GOBP_PREASSEMBLY_OF_GPI_ANCH...,SET,7,0.1379,0.0026922,0.30041,0.32311,GOBP_PREASSEMBLY_OF_GPI_ANCHOR_IN_ER_MEMBRANE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...178,SET,29,0.066583,0.0026443,0.14523,0.32332,GOBP_NEGATIVE_REGULATION_OF_DEPHOSPHORYLATION,0.99999
CHEN_LVAD_SUPPORT_OF_FAILING...1,SET,42,0.066202,0.0031629,0.14449,0.32341,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,0.99999
MIR548AE_3P_MIR548AQ_3P,SET,720,0.014998,0.0029114,0.032734,0.32341,MIR548AE_3P_MIR548AQ_3P,0.99999
HP_RETROCEREBELLAR_CYST,SET,7,0.13499,0.0026355,0.29462,0.32341,HP_RETROCEREBELLAR_CYST,0.99999
GOBP_ORGANIC_HYDROXY_COMPOUN...3,SET,511,0.017921,0.0029481,0.039117,0.32343,GOBP_ORGANIC_HYDROXY_COMPOUND_METABOLIC_PROCESS,0.99999
HP_GASTROINTESTINAL_HEMORRHA...,SET,154,0.032221,0.0029387,0.070329,0.32343,HP_GASTROINTESTINAL_HEMORRHAGE,0.99999
LANDIS_ERBB2_BREAST_TUMORS_3...1,SET,141,0.034694,0.0030289,0.075755,0.32349,LANDIS_ERBB2_BREAST_TUMORS_324_DN,0.99999
HP_DECREASED_CIRCULATING_ALD...,SET,18,0.099497,0.003114,0.21728,0.32351,HP_DECREASED_CIRCULATING_ALDOSTERONE_LEVEL,0.99999
GOBP_NEGATIVE_REGULATION_OF_...261,SET,14,0.11048,0.0030498,0.24129,0.32353,GOBP_NEGATIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,0.99999
HP_INCREASED_WAIST_TO_HIP_RA...,SET,36,0.071387,0.0031581,0.156,0.32362,HP_INCREASED_WAIST_TO_HIP_RATIO,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...2,SET,185,0.02794,0.0027906,0.061076,0.32367,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...266,SET,14,0.111,0.0030641,0.24266,0.32368,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,0.99999
HP_ABNORMAL_JOINT_MORPHOLOGY,SET,1067,0.012211,0.002857,0.026695,0.32369,HP_ABNORMAL_JOINT_MORPHOLOGY,0.99999
GOBP_LEUKOCYTE_PROLIFERATION,SET,323,0.023334,0.0030678,0.051032,0.32375,GOBP_LEUKOCYTE_PROLIFERATION,0.99999
GOBP_TRIF_DEPENDENT_TOLL_LIK...,SET,11,0.11081,0.0027115,0.24235,0.32376,GOBP_TRIF_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE14308_TH2_VS_NATURAL_TREG...2,SET,168,0.028655,0.0027286,0.062675,0.32377,GSE14308_TH2_VS_NATURAL_TREG_UP,0.99999
WP_PYRIMIDINE_METABOLISM_AND...,SET,19,0.088771,0.0028544,0.19418,0.32378,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,0.99999
GOBP_LEARNED_VOCALIZATION_BE...,SET,10,0.13824,0.0032256,0.3024,0.32378,GOBP_LEARNED_VOCALIZATION_BEHAVIOR_OR_VOCAL_LEARNING,0.99999
ZBTB5_TARGET_GENES,SET,395,0.020242,0.002937,0.044291,0.32383,ZBTB5_TARGET_GENES,0.99999
HP_HEMOLYTIC_UREMIC_SYNDROME,SET,14,0.1132,0.0031248,0.24772,0.32385,HP_HEMOLYTIC_UREMIC_SYNDROME,0.99999
GSE9650_NAIVE_VS_EXHAUSTED_C...1,SET,176,0.030739,0.0029953,0.067276,0.32387,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN,0.99999
HP_PALMAR_HYPERHIDROSIS,SET,15,0.1092,0.0031201,0.239,0.32388,HP_PALMAR_HYPERHIDROSIS,0.99999
REACTOME_INSULIN_RECEPTOR_SI...,SET,53,0.054612,0.0029301,0.11962,0.324,REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,0.99999
HP_ABNORMAL_UPPER_LIP_MORPHO...,SET,814,0.013912,0.0028639,0.030472,0.324,HP_ABNORMAL_UPPER_LIP_MORPHOLOGY,0.99999
GOBP_HOMEOSTASIS_OF_NUMBER_O...1,SET,295,0.023116,0.0029066,0.050636,0.32401,GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS,0.99999
GOMF_PROTEIN_TYROSINE_PHOSPH...,SET,89,0.041025,0.0028496,0.08988,0.32404,GOMF_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY,0.99999
BRUINS_UVC_RESPONSE_VIA_TP53...1,SET,815,0.014049,0.0028937,0.030799,0.32414,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A,0.99999
REACTOME_SIGNALING_BY_VEGF,SET,101,0.039639,0.0029321,0.086931,0.3242,REACTOME_SIGNALING_BY_VEGF,0.99999
GOCC_RADIAL_SPOKE_HEAD,SET,5,0.17364,0.0028653,0.38093,0.32426,GOCC_RADIAL_SPOKE_HEAD,0.99999
GOBP_PHOSPHOLIPASE_C_ACTIVAT...1,SET,8,0.16409,0.0034246,0.36006,0.3243,GOBP_PHOSPHOLIPASE_C_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_PAROXYSMAL_VENTRICULAR_TA...,SET,26,0.07953,0.0029908,0.17452,0.3243,HP_PAROXYSMAL_VENTRICULAR_TACHYCARDIA,0.99999
GOBP_HEART_TRABECULA_MORPHOG...,SET,31,0.078691,0.0032309,0.17284,0.32445,GOBP_HEART_TRABECULA_MORPHOGENESIS,0.99999
GSE33374_CD8_ALPHAALPHA_VS_A...2,SET,186,0.028702,0.0028744,0.063068,0.32452,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_ST...3,SET,22,0.086997,0.0030098,0.19117,0.32453,GOBP_CELLULAR_RESPONSE_TO_STEROL,0.99999
KEGG_MEDICUS_REFERENCE_LHCGR...,SET,16,0.10302,0.00304,0.22642,0.32456,KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY,0.99999
REACTOME_SIGNALING_BY_NTRKS,SET,132,0.034382,0.002905,0.075582,0.32459,REACTOME_SIGNALING_BY_NTRKS,0.99999
GSE26669_CTRL_VS_COSTIM_BLOC...4,SET,184,0.027579,0.0027472,0.060626,0.32459,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP,0.99999
GOBP_JNK_CASCADE,SET,159,0.031146,0.002886,0.068518,0.32471,GOBP_JNK_CASCADE,0.99999
HP_RENAL_INTERSTITIAL_FIBROS...,SET,6,0.13733,0.0024824,0.30217,0.32474,HP_RENAL_INTERSTITIAL_FIBROSIS,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...17,SET,44,0.066854,0.003269,0.14715,0.3248,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II,0.99999
GEORGES_CELL_CYCLE_MIR192_TA...,SET,58,0.048392,0.0027158,0.10652,0.32481,GEORGES_CELL_CYCLE_MIR192_TARGETS,0.99999
DESCARTES_FETAL_KIDNEY_METAN...,SET,110,0.040867,0.0031539,0.089991,0.32487,DESCARTES_FETAL_KIDNEY_METANEPHRIC_CELLS,0.99999
NABA_ECM_AFFILIATED,SET,151,0.036229,0.0032722,0.079798,0.32491,NABA_ECM_AFFILIATED,0.99999
GOBP_RESPONSE_TO_DSRNA,SET,49,0.059459,0.0030678,0.13096,0.32491,GOBP_RESPONSE_TO_DSRNA,0.99999
GSE11864_UNTREATED_VS_CSF1_I...5,SET,163,0.029309,0.0027494,0.064565,0.32494,GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN,0.99999
HP_HYPERPITUITARISM,SET,110,0.035442,0.0027353,0.078087,0.32496,HP_HYPERPITUITARISM,0.99999
GOMF_COLLAGEN_BINDING,SET,67,0.049235,0.0029689,0.10849,0.32498,GOMF_COLLAGEN_BINDING,0.99999
GSE13306_TREG_VS_TCONV_LAMIN...2,SET,182,0.029686,0.0029411,0.065429,0.32502,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP,0.99999
GOBP_EXTRACELLULAR_VESICLE_B...,SET,24,0.07683,0.0027761,0.1694,0.32508,GOBP_EXTRACELLULAR_VESICLE_BIOGENESIS,0.99999
GSE3982_MEMORY_CD4_TCELL_VS_...4,SET,168,0.029966,0.0028535,0.06608,0.3251,GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP,0.99999
GOBP_REGULATION_OF_FLAGELLAT...,SET,18,0.098935,0.0030964,0.21818,0.32511,GOBP_REGULATION_OF_FLAGELLATED_SPERM_MOTILITY,0.99999
HP_HYPERREFLEXIA_IN_UPPER_LI...,SET,25,0.07347,0.0027094,0.16208,0.32517,HP_HYPERREFLEXIA_IN_UPPER_LIMBS,0.99999
DESCARTES_MAIN_FETAL_SYNCYTI...,SET,64,0.052214,0.0030776,0.11519,0.32517,DESCARTES_MAIN_FETAL_SYNCYTIOTROPHOBLASTS_AND_VILLOUS_CYTOTROPHOBLASTS,0.99999
GOBP_ONE_CARBON_METABOLIC_PR...,SET,36,0.064496,0.0028533,0.1423,0.32519,GOBP_ONE_CARBON_METABOLIC_PROCESS,0.99999
SS18_SSX1_FUSION_UNIPROT_Q8I...,SET,311,0.023331,0.0030108,0.051478,0.3252,SS18_SSX1_FUSION_UNIPROT_Q8IZH1_UNREVIEWED_TARGET_GENES,0.99999
HE_PTEN_TARGETS_DN,SET,7,0.16705,0.0032614,0.36865,0.32523,HE_PTEN_TARGETS_DN,0.99999
GOBP_CARDIAC_MUSCLE_TISSUE_M...,SET,58,0.056299,0.0031595,0.12425,0.32524,GOBP_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,0.99999
HP_CHILDHOOD_ONSET,SET,774,0.014029,0.0028193,0.030967,0.32526,HP_CHILDHOOD_ONSET,0.99999
GSE28726_NAIVE_VS_ACTIVATED_...5,SET,177,0.029738,0.0029059,0.06566,0.32531,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_DN,0.99999
NFMUE1_Q6,SET,217,0.025676,0.0027751,0.056696,0.32532,NFMUE1_Q6,0.99999
GOBP_NEGATIVE_REGULATION_OF_...31,SET,213,0.026637,0.0028525,0.058828,0.32535,GOBP_NEGATIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOCC_INTERCALATED_DISC,SET,50,0.058488,0.0030482,0.12924,0.32543,GOCC_INTERCALATED_DISC,0.99999
BLANCO_MELO_HUMAN_PARAINFLUE...1,SET,100,0.039377,0.0028983,0.087024,0.32547,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN,0.99999
REACTOME_LONG_TERM_POTENTIAT...,SET,22,0.091182,0.0031546,0.20164,0.32556,REACTOME_LONG_TERM_POTENTIATION,0.99999
GOBP_EMBRYONIC_HEART_TUBE_DE...,SET,82,0.043643,0.0029103,0.096533,0.3256,GOBP_EMBRYONIC_HEART_TUBE_DEVELOPMENT,0.99999
HP_ABNORMALITY_OF_VON_WILLEB...,SET,12,0.10964,0.0028022,0.24269,0.32573,HP_ABNORMALITY_OF_VON_WILLEBRAND_FACTOR,0.99999
CALVET_IRINOTECAN_SENSITIVE_...1,SET,4,0.16106,0.0023772,0.35669,0.3258,CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP,0.99999
HP_MISSING_RIBS,SET,60,0.048645,0.0027765,0.10773,0.3258,HP_MISSING_RIBS,0.99999
BROWNE_HCMV_INFECTION_12HR_UP,SET,100,0.039535,0.0029099,0.08757,0.32583,BROWNE_HCMV_INFECTION_12HR_UP,0.99999
UDAYAKUMAR_MED1_TARGETS_DN,SET,212,0.026612,0.0028432,0.058956,0.32586,UDAYAKUMAR_MED1_TARGETS_DN,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...4,SET,175,0.027787,0.0027,0.061565,0.32587,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP,0.99999
IKEDA_MIR133_TARGETS_DN,SET,6,0.1957,0.0035374,0.43369,0.32591,IKEDA_MIR133_TARGETS_DN,0.99999
MIR370_3P,SET,88,0.041089,0.002838,0.091081,0.32595,MIR370_3P,0.99999
GSE26928_NAIVE_VS_CENT_MEMOR...2,SET,162,0.029862,0.0027928,0.066195,0.32596,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,0.99999
GOBP_CALCIUM_IMPORT_INTO_THE...,SET,14,0.11031,0.0030451,0.24463,0.32602,GOBP_CALCIUM_IMPORT_INTO_THE_MITOCHONDRION,0.99999
GSE17322_CD103_POS_VS_CD11B_...2,SET,176,0.029148,0.0028403,0.064644,0.32603,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_UP,0.99999
AMIT_EGF_RESPONSE_240_HELA,SET,55,0.053073,0.0029006,0.11771,0.32604,AMIT_EGF_RESPONSE_240_HELA,0.99999
REACTOME_ACTIVATION_OF_TRKA_...,SET,6,0.17467,0.0031572,0.38745,0.32606,REACTOME_ACTIVATION_OF_TRKA_RECEPTORS,0.99999
MIR4705,SET,111,0.037853,0.0029345,0.083964,0.32606,MIR4705,0.99999
MIR7978,SET,78,0.042456,0.0027615,0.094172,0.32606,MIR7978,0.99999
GSE27859_MACROPHAGE_VS_CD11C...1,SET,168,0.028637,0.002727,0.063537,0.3261,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,0.99999
GOBP_REGULATION_OF_DENDRITIC...4,SET,52,0.054616,0.0029026,0.12119,0.32612,GOBP_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,0.99999
MORF_IKBKG,SET,121,0.03313,0.0026808,0.073518,0.32613,MORF_IKBKG,0.99999
GOBP_CELLULAR_RESPONSE_TO_ATP,SET,16,0.099942,0.0029492,0.22186,0.32618,GOBP_CELLULAR_RESPONSE_TO_ATP,0.99999
WP_KLEEFSTRA_SYNDROME,SET,26,0.074863,0.0028154,0.16619,0.32619,WP_KLEEFSTRA_SYNDROME,0.99999
GSE6269_FLU_VS_E_COLI_INF_PB...2,SET,147,0.030311,0.0027014,0.067291,0.3262,GSE6269_FLU_VS_E_COLI_INF_PBMC_UP,0.99999
CHIARADONNA_NEOPLASTIC_TRANS...4,SET,53,0.05385,0.0028892,0.11961,0.32628,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,0.99999
JECHLINGER_EPITHELIAL_TO_MES...1,SET,59,0.052225,0.0029559,0.116,0.32628,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,0.99999
HP_NEPHROGENIC_DIABETES_INSI...,SET,7,0.1516,0.0029597,0.33674,0.32629,HP_NEPHROGENIC_DIABETES_INSIPIDUS,0.99999
DLX6_TARGET_GENES,SET,450,0.01759,0.00272,0.039075,0.3263,DLX6_TARGET_GENES,0.99999
HP_UPPER_MOTOR_NEURON_DYSFUN...,SET,1034,0.012021,0.0027715,0.026707,0.32632,HP_UPPER_MOTOR_NEURON_DYSFUNCTION,0.99999
GOMF_UNFOLDED_PROTEIN_BINDING,SET,107,0.033487,0.0025491,0.074448,0.32643,GOMF_UNFOLDED_PROTEIN_BINDING,0.99999
WP_DEREGULATION_OF_RAB_AND_R...,SET,14,0.094918,0.0026202,0.21104,0.32645,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,0.99999
HP_ABNORMAL_CIRCLE_OF_WILLIS...,SET,6,0.16321,0.0029502,0.36291,0.32646,HP_ABNORMAL_CIRCLE_OF_WILLIS_MORPHOLOGY,0.99999
HP_SEX_REVERSAL,SET,11,0.13019,0.0031859,0.28951,0.32647,HP_SEX_REVERSAL,0.99999
KEGG_MEDICUS_REFERENCE_PROK_...,SET,9,0.13673,0.0030267,0.30409,0.32648,KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,0.99999
MIR6742_3P,SET,94,0.03823,0.0027286,0.085046,0.32653,MIR6742_3P,0.99999
CASTELLANO_HRAS_AND_NRAS_TAR...2,SET,5,0.1591,0.0026253,0.35403,0.32657,CASTELLANO_HRAS_AND_NRAS_TARGETS_UP,0.99999
REACTOME_RAC3_GTPASE_CYCLE,SET,82,0.044823,0.002989,0.099762,0.32661,REACTOME_RAC3_GTPASE_CYCLE,0.99999
GSE17721_CTRL_VS_POLYIC_2H_B...2,SET,177,0.028265,0.002762,0.062913,0.32662,GSE17721_CTRL_VS_POLYIC_2H_BMDC_UP,0.99999
GSE37416_CTRL_VS_0H_F_TULARE...1,SET,133,0.033969,0.0028808,0.075621,0.32665,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
MATZUK_FERTILIZATION,SET,7,0.1434,0.0027996,0.31926,0.32666,MATZUK_FERTILIZATION,0.99999
HP_JOINT_HEMORRHAGE,SET,14,0.11316,0.0031238,0.25199,0.32669,HP_JOINT_HEMORRHAGE,0.99999
FEKIR_HEPARG_SIDE_POP_VS_HEP...1,SET,77,0.04334,0.002801,0.096514,0.3267,FEKIR_HEPARG_SIDE_POP_VS_HEPARG_DN,0.99999
XIE_ST_HSC_S1PR3_OE_UP,SET,175,0.032192,0.0031281,0.071699,0.32672,XIE_ST_HSC_S1PR3_OE_UP,0.99999
MIR7162_3P,SET,201,0.027417,0.0028531,0.061074,0.32675,MIR7162_3P,0.99999
GOBP_ANDROGEN_RECEPTOR_SIGNA...,SET,43,0.05717,0.0027636,0.12738,0.32678,GOBP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,0.99999
XU_RESPONSE_TO_TRETINOIN_AND...2,SET,14,0.11607,0.0032041,0.25862,0.32679,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP,0.99999
BENPORATH_CYCLING_GENES,SET,589,0.015533,0.0027374,0.034619,0.32683,BENPORATH_CYCLING_GENES,0.99999
MYOD_Q6,SET,227,0.025581,0.0028269,0.05701,0.32683,MYOD_Q6,0.99999
GOBP_POSITIVE_REGULATION_OF_...398,SET,30,0.069399,0.0028031,0.1547,0.32687,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...3,SET,7,0.15011,0.0029306,0.33474,0.32692,GOBP_PROTEIN_LOCALIZATION_TO_BASOLATERAL_PLASMA_MEMBRANE,0.99999
GOMF_TPR_DOMAIN_BINDING,SET,7,0.12152,0.0023725,0.27097,0.32692,GOMF_TPR_DOMAIN_BINDING,0.99999
WP_PURINE_METABOLISM,SET,10,0.13272,0.0030968,0.29608,0.32698,WP_PURINE_METABOLISM,0.99999
GOBP_REGULATION_OF_PHAGOCYTO...,SET,90,0.044363,0.0030985,0.098995,0.32703,GOBP_REGULATION_OF_PHAGOCYTOSIS,0.99999
GOCC_ORGANELLE_ENVELOPE_LUMEN,SET,83,0.04209,0.0028237,0.093957,0.32709,GOCC_ORGANELLE_ENVELOPE_LUMEN,0.99999
HP_URINARY_INCONTINENCE,SET,134,0.032889,0.0027996,0.073439,0.32714,HP_URINARY_INCONTINENCE,0.99999
HP_ABNORMAL_ANKLE_PHYSIOLOGY,SET,54,0.052622,0.0028498,0.11756,0.32721,HP_ABNORMAL_ANKLE_PHYSIOLOGY,0.99999
MIKKELSEN_PLURIPOTENT_STATE_...2,SET,8,0.12915,0.0026954,0.28856,0.32724,MIKKELSEN_PLURIPOTENT_STATE_UP,0.99999
GOBP_CHONDROCYTE_HYPERTROPHY,SET,6,0.19152,0.0034619,0.42793,0.32724,GOBP_CHONDROCYTE_HYPERTROPHY,0.99999
GSE3982_MAC_VS_BASOPHIL_UP,SET,181,0.028016,0.0027681,0.062607,0.32726,GSE3982_MAC_VS_BASOPHIL_UP,0.99999
GOMF_GLYCINE_N_ACYLTRANSFERA...,SET,4,0.26465,0.0039061,0.59151,0.32729,GOMF_GLYCINE_N_ACYLTRANSFERASE_ACTIVITY,0.99999
GSE43955_1H_VS_10H_ACT_CD4_T...4,SET,173,0.029656,0.0028652,0.066289,0.32731,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.99999
GAO_ESOPHAGUS_25W_C2_KRT6BPO...,SET,66,0.049548,0.0029655,0.11077,0.32733,GAO_ESOPHAGUS_25W_C2_KRT6BPOS_SECRETORY_PROGENITOR_CELLS,0.99999
GOBP_POSITIVE_REGULATION_OF_...538,SET,27,0.081987,0.0031419,0.18335,0.32738,GOBP_POSITIVE_REGULATION_OF_NEUTROPHIL_MIGRATION,0.99999
REACTOME_POST_TRANSCRIPTIONA...,SET,7,0.15838,0.003092,0.35419,0.32739,REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS,0.99999
GSE7509_FCGRIIB_VS_TNFA_IL1B...2,SET,157,0.028551,0.0026291,0.063859,0.3274,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...7,SET,4,0.22695,0.0033496,0.50765,0.32742,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_VASOPRESSIN,0.99999
GOBP_CELL_MIGRATION_INVOLVED...2,SET,19,0.10157,0.003266,0.22724,0.32744,GOBP_CELL_MIGRATION_INVOLVED_IN_HEART_DEVELOPMENT,0.99999
GSE3982_EOSINOPHIL_VS_MAST_C...2,SET,178,0.029007,0.0028424,0.06489,0.32744,GSE3982_EOSINOPHIL_VS_MAST_CELL_UP,0.99999
GOMF_NEUROPEPTIDE_Y_RECEPTOR...,SET,8,0.16739,0.0034935,0.37463,0.32751,GOMF_NEUROPEPTIDE_Y_RECEPTOR_ACTIVITY,0.99999
GOMF_COMPLEMENT_BINDING,SET,20,0.090261,0.0029776,0.20207,0.32755,GOMF_COMPLEMENT_BINDING,0.99999
GSE22589_HEALTHY_VS_HIV_INFE...1,SET,183,0.02853,0.0028342,0.063895,0.32762,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN,0.99999
WP_ALPHA_6_BETA_4_SIGNALING,SET,33,0.068531,0.002903,0.15351,0.32765,WP_ALPHA_6_BETA_4_SIGNALING,0.99999
REACTOME_NUCLEAR_SIGNALING_B...,SET,30,0.068246,0.0027566,0.15299,0.32777,REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,0.99999
REACTOME_STAT5_ACTIVATION_DO...,SET,10,0.11472,0.0026768,0.25719,0.32778,REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,0.99999
HP_FETAL_PERICARDIAL_EFFUSION,SET,6,0.13957,0.0025229,0.3129,0.32778,HP_FETAL_PERICARDIAL_EFFUSION,0.99999
GSE17721_LPS_VS_CPG_8H_BMDC_...1,SET,167,0.028674,0.0027223,0.064282,0.32778,GSE17721_LPS_VS_CPG_8H_BMDC_DN,0.99999
REACTOME_PROPIONYL_COA_CATAB...,SET,4,0.21245,0.0031357,0.47637,0.32781,REACTOME_PROPIONYL_COA_CATABOLISM,0.99999
HP_SEBORRHEIC_DERMATITIS,SET,22,0.079462,0.0027491,0.17823,0.32786,HP_SEBORRHEIC_DERMATITIS,0.99999
GOBP_MEMBRANE_BIOGENESIS,SET,60,0.048627,0.0027754,0.1091,0.3279,GOBP_MEMBRANE_BIOGENESIS,0.99999
GOCC_LEADING_EDGE_MEMBRANE,SET,170,0.029318,0.0028082,0.065793,0.32794,GOCC_LEADING_EDGE_MEMBRANE,0.99999
CUI_DEVELOPING_HEART_C4_ENDO...,SET,135,0.036134,0.0030873,0.08109,0.32794,CUI_DEVELOPING_HEART_C4_ENDOTHELIAL_CELL,0.99999
MIR3155A_MIR3155B,SET,71,0.044632,0.0027703,0.10019,0.32798,MIR3155A_MIR3155B,0.99999
REACTOME_DISEASES_ASSOCIATED...5,SET,9,0.15494,0.0034298,0.34796,0.32806,REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM,0.99999
GSE23505_IL6_IL1_VS_IL6_IL1_...3,SET,169,0.026713,0.0025512,0.059995,0.32807,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,0.99999
GOBP_HEPATOCYTE_DIFFERENTIAT...,SET,13,0.11116,0.0029571,0.24968,0.32808,GOBP_HEPATOCYTE_DIFFERENTIATION,0.99999
HP_INCREASED_THETA_FREQUENCY...,SET,10,0.12789,0.0029841,0.28734,0.32813,HP_INCREASED_THETA_FREQUENCY_ACTIVITY_IN_EEG,0.99999
REACTOME_POSITIVE_EPIGENETIC...,SET,42,0.053922,0.0025762,0.12116,0.32815,REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,0.99999
MORF_ERH,SET,97,0.035242,0.002555,0.079206,0.32818,MORF_ERH,0.99999
HP_HYPERPLASIA_OF_MIDFACE,SET,4,0.23426,0.0034576,0.52651,0.32819,HP_HYPERPLASIA_OF_MIDFACE,0.99999
GSE20366_CD103_POS_VS_NEG_TR...1,SET,177,0.028175,0.0027532,0.063343,0.32824,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN,0.99999
GSE26030_TH1_VS_TH17_DAY5_PO...2,SET,183,0.028029,0.0027844,0.063017,0.32824,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP,0.99999
MIR217_5P,SET,170,0.029046,0.0027822,0.065348,0.32835,MIR217_5P,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...6,SET,4,0.21393,0.0031575,0.48143,0.32839,HP_APLASIA_HYPOPLASIA_OF_THE_4TH_FINGER,0.99999
WP_AMINO_ACID_METABOLISM_IN_...,SET,7,0.14535,0.0028376,0.32713,0.32841,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.99999
WP_HEDGEHOG_SIGNALING_WP4249,SET,41,0.060093,0.0028367,0.13525,0.32842,WP_HEDGEHOG_SIGNALING_WP4249,0.99999
GSE15624_CTRL_VS_6H_HALOFUGI...1,SET,142,0.029804,0.0026111,0.067084,0.32842,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,0.99999
WP_PRIMARY_FOCAL_SEGMENTAL_G...,SET,70,0.046792,0.0028839,0.10533,0.32843,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,0.99999
GOBP_ESTABLISHMENT_OR_MAINTE...3,SET,7,0.14641,0.0028583,0.32966,0.32848,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CYTOSKELETON_POLARITY,0.99999
AFP1_Q6,SET,237,0.026508,0.0029924,0.059691,0.32849,AFP1_Q6,0.99999
ITO_PTTG1_TARGETS_DN,SET,9,0.12765,0.0028258,0.28756,0.32855,ITO_PTTG1_TARGETS_DN,0.99999
GOBP_HAIR_FOLLICLE_PLACODE_F...,SET,4,0.17065,0.0025187,0.38442,0.32855,GOBP_HAIR_FOLLICLE_PLACODE_FORMATION,0.99999
CTCCAAG_MIR432,SET,74,0.043236,0.0027395,0.097414,0.32858,CTCCAAG_MIR432,0.99999
GOBP_POSITIVE_REGULATION_OF_...340,SET,8,0.14266,0.0029774,0.32156,0.32865,GOBP_POSITIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,0.99999
ALONSO_METASTASIS_DN,SET,23,0.082804,0.0029291,0.18665,0.32866,ALONSO_METASTASIS_DN,0.99999
GSE29164_UNTREATED_VS_CD8_TC...4,SET,172,0.028563,0.0027517,0.064393,0.32868,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,0.99999
GOBP_RRNA_METHYLATION,SET,17,0.076289,0.0023204,0.17205,0.32873,GOBP_RRNA_METHYLATION,0.99999
GSE14308_INDUCED_VS_NATURAL_...2,SET,177,0.027083,0.0026464,0.061102,0.3288,GSE14308_INDUCED_VS_NATURAL_TREG_UP,0.99999
GSE6090_UNSTIM_VS_DC_SIGN_ST...1,SET,128,0.03532,0.002939,0.079694,0.32882,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_DN,0.99999
MODULE_255,SET,405,0.019048,0.0027978,0.042987,0.32885,MODULE_255,0.99999
GSE19401_UNSTIM_VS_RETINOIC_...3,SET,168,0.029047,0.002766,0.065567,0.32888,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,0.99999
HP_URETHRAL_ATRESIA,SET,22,0.07513,0.0025993,0.1696,0.32889,HP_URETHRAL_ATRESIA,0.99999
REACTOME_HORMONE_LIGAND_BIND...,SET,12,0.10935,0.002795,0.24694,0.32894,REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS,0.99999
GOBP_CALCIUM_ION_TRANSPORT_I...,SET,28,0.078429,0.0030606,0.17711,0.32895,GOBP_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,0.99999
GOBP_POSITIVE_REGULATION_OF_...69,SET,74,0.04381,0.0027758,0.098952,0.32898,GOBP_POSITIVE_REGULATION_OF_B_CELL_ACTIVATION,0.99999
HP_JERKY_OCULAR_PURSUIT_MOVE...,SET,8,0.11473,0.0023946,0.25916,0.32899,HP_JERKY_OCULAR_PURSUIT_MOVEMENTS,0.99999
MIR6845_3P,SET,124,0.035037,0.0028698,0.079198,0.3291,MIR6845_3P,0.99999
GOMF_NUCLEOSOMAL_DNA_BINDING,SET,24,0.077236,0.0027908,0.17458,0.3291,GOMF_NUCLEOSOMAL_DNA_BINDING,0.99999
HP_MULTIFOCAL_EPILEPTIFORM_D...,SET,66,0.048209,0.0028854,0.10898,0.32911,HP_MULTIFOCAL_EPILEPTIFORM_DISCHARGES,0.99999
KEGG_MEDICUS_REFERENCE_FSHR_...,SET,16,0.10057,0.0029676,0.2274,0.32916,KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY,0.99999
GOBP_METANEPHRIC_TUBULE_DEVE...,SET,23,0.088878,0.0031439,0.20102,0.3292,GOBP_METANEPHRIC_TUBULE_DEVELOPMENT,0.99999
MIR374C_3P,SET,47,0.059104,0.0029868,0.13371,0.32923,MIR374C_3P,0.99999
WP_REGULATORY_CIRCUITS_OF_ST...,SET,72,0.049225,0.0030767,0.11137,0.32924,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,0.99999
HP_ABNORMAL_CIRCULATING_CREA...2,SET,49,0.053245,0.0027472,0.12046,0.32924,HP_ABNORMAL_CIRCULATING_CREATININE_CONCENTRATION,0.99999
GOBP_CELLULAR_COMPONENT_ASSE...,SET,130,0.032969,0.0027645,0.07464,0.32935,GOBP_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...11,SET,44,0.056349,0.0027554,0.12759,0.32937,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CELL_CYCLE,0.99999
MODULE_26,SET,187,0.027541,0.0027655,0.06237,0.3294,MODULE_26,0.99999
KEGG_MEDICUS_REFERENCE_EARLY...,SET,8,0.12574,0.0026244,0.28485,0.32945,KEGG_MEDICUS_REFERENCE_EARLY_ENDOSOMAL_FUSION,0.99999
MODULE_179,SET,420,0.018647,0.002788,0.042241,0.32945,MODULE_179,0.99999
REACTOME_SARS_COV_2_ACTIVATE...,SET,111,0.035763,0.0027725,0.081049,0.32952,REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,0.99999
AIZARANI_LIVER_C34_MHC_II_PO...,SET,118,0.036664,0.00293,0.08315,0.32963,AIZARANI_LIVER_C34_MHC_II_POS_B_CELLS,0.99999
GOBP_BRONCHIOLE_DEVELOPMENT,SET,6,0.1699,0.003071,0.38535,0.32965,GOBP_BRONCHIOLE_DEVELOPMENT,0.99999
HP_PROGRESSIVE_SPASTIC_PARAP...1,SET,5,0.1661,0.0027408,0.37677,0.32966,HP_PROGRESSIVE_SPASTIC_PARAPARESIS,0.99999
GSE27786_LIN_NEG_VS_CD4_TCEL...1,SET,181,0.027301,0.0026974,0.061933,0.32968,GSE27786_LIN_NEG_VS_CD4_TCELL_DN,0.99999
GSE32423_IL7_VS_IL4_MEMORY_C...2,SET,182,0.026707,0.002646,0.060587,0.32968,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP,0.99999
GNF2_XRCC5,SET,65,0.042258,0.0025101,0.095872,0.32969,GNF2_XRCC5,0.99999
KEGG_MEDICUS_PATHOGEN_SHIGEL...1,SET,6,0.17921,0.0032394,0.40664,0.32971,KEGG_MEDICUS_PATHOGEN_SHIGELLA_FIMA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,0.99999
MIR508_3P,SET,94,0.040081,0.0028607,0.090949,0.32972,MIR508_3P,0.99999
MORF_RAB11A,SET,51,0.045911,0.0024165,0.10426,0.32985,MORF_RAB11A,0.99999
HP_ABNORMALITY_OF_MUSCLE_SIZE,SET,635,0.015077,0.0027552,0.034244,0.32987,HP_ABNORMALITY_OF_MUSCLE_SIZE,0.99999
GOBP_REGULATION_OF_HEMOGLOBI...,SET,8,0.13353,0.0027868,0.30335,0.32991,GOBP_REGULATION_OF_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,0.99999
VERHAAK_GLIOBLASTOMA_PRONEUR...,SET,149,0.032027,0.0028736,0.072808,0.33001,VERHAAK_GLIOBLASTOMA_PRONEURAL,0.99999
REACTOME_REGULATION_OF_GENE_...3,SET,8,0.15444,0.0032232,0.35109,0.33001,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS,0.99999
TCCAGAG_MIR518C,SET,137,0.035098,0.0030207,0.079822,0.33008,TCCAGAG_MIR518C,0.99999
REACTOME_SIGNALING_BY_TGF_BE...2,SET,8,0.14291,0.0029826,0.32506,0.33011,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER,0.99999
GOBP_TRNA_THIO_MODIFICATION,SET,5,0.16906,0.0027897,0.38467,0.33015,GOBP_TRNA_THIO_MODIFICATION,0.99999
GOBP_FUSED_ANTRUM_STAGE,SET,6,0.16977,0.0030686,0.38648,0.33024,GOBP_FUSED_ANTRUM_STAGE,0.99999
DESCARTES_FETAL_MUSCLE_MYELO...,SET,106,0.03866,0.0029292,0.08801,0.33024,DESCARTES_FETAL_MUSCLE_MYELOID_CELLS,0.99999
MIR30B_3P,SET,154,0.029803,0.0027182,0.067855,0.33026,MIR30B_3P,0.99999
GOCC_CHROMATIN_SILENCING_COM...,SET,12,0.092043,0.0023525,0.20959,0.33028,GOCC_CHROMATIN_SILENCING_COMPLEX,0.99999
REACTOME_REGULATION_OF_INSUL...1,SET,115,0.038432,0.0030322,0.08752,0.33029,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,0.99999
GOBP_DEVELOPMENT_OF_PRIMARY_...2,SET,213,0.026933,0.0028842,0.061334,0.33029,GOBP_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS,0.99999
GOCC_MALE_GERM_CELL_NUCLEUS,SET,48,0.049708,0.0025384,0.1133,0.33043,GOCC_MALE_GERM_CELL_NUCLEUS,0.99999
WP_OVERLAP_BETWEEN_SIGNAL_TR...,SET,51,0.052865,0.0027825,0.12051,0.33045,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,0.99999
HP_NUMEROUS_PIGMENTED_FRECKL...,SET,7,0.12379,0.0024168,0.28238,0.33056,HP_NUMEROUS_PIGMENTED_FRECKLES,0.99999
MIR28_3P,SET,46,0.050472,0.0025233,0.11522,0.33068,MIR28_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...642,SET,7,0.10964,0.0021405,0.25034,0.33071,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.99999
FLECHNER_PBL_KIDNEY_TRANSPLA...1,SET,37,0.061935,0.0027777,0.14144,0.33074,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,0.99999
GNF2_MCL1,SET,49,0.052579,0.0027128,0.1201,0.33077,GNF2_MCL1,0.99999
MIR4693_3P,SET,56,0.049887,0.0027511,0.11399,0.33082,MIR4693_3P,0.99999
GSE30971_WBP7_HET_VS_KO_MACR...1,SET,184,0.030245,0.0030127,0.069105,0.33082,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN,0.99999
MIR4659A_3P_MIR4659B_3P,SET,609,0.015712,0.0028138,0.03592,0.33091,MIR4659A_3P_MIR4659B_3P,0.99999
GOBP_EXOCYST_LOCALIZATION,SET,5,0.16808,0.0027735,0.38436,0.33095,GOBP_EXOCYST_LOCALIZATION,0.99999
HP_PERIPHERAL_PULMONARY_ARTE...,SET,30,0.071072,0.0028707,0.16253,0.33096,HP_PERIPHERAL_PULMONARY_ARTERY_STENOSIS,0.99999
GOBP_AMEBOIDAL_TYPE_CELL_MIG...,SET,401,0.019806,0.002895,0.045301,0.33098,GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION,0.99999
HP_INCREASED_HEPATOCELLULAR_...,SET,3,0.18695,0.0023896,0.42783,0.33107,HP_INCREASED_HEPATOCELLULAR_LIPID_DROPLETS,0.99999
GOBP_REGULATION_OF_RELAXATIO...2,SET,13,0.11181,0.0029744,0.2559,0.33108,GOBP_REGULATION_OF_RELAXATION_OF_MUSCLE,0.99999
HP_PRELINGUAL_SENSORINEURAL_...,SET,11,0.12185,0.0029818,0.27887,0.33108,HP_PRELINGUAL_SENSORINEURAL_HEARING_IMPAIRMENT,0.99999
HP_HAMARTOMA,SET,61,0.044779,0.0025769,0.10249,0.33109,HP_HAMARTOMA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...186,SET,12,0.11405,0.0029149,0.26111,0.33114,GOBP_NEGATIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...49,SET,100,0.036517,0.0026878,0.083607,0.33114,HP_APLASIA_HYPOPLASIA_OF_THE_OPTIC_NERVE,0.99999
ANDERSON_BLOOD_CN54GP140_ADJ...4,SET,25,0.073671,0.0027168,0.16867,0.33114,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_UP,0.99999
LOPES_METHYLATED_IN_COLON_CA...2,SET,27,0.081906,0.0031388,0.18759,0.33119,LOPES_METHYLATED_IN_COLON_CANCER_UP,0.99999
MIR8068,SET,353,0.020641,0.0028345,0.047276,0.3312,MIR8068,0.99999
NPAT_TARGET_GENES,SET,190,0.026813,0.0027136,0.06143,0.33125,NPAT_TARGET_GENES,0.99999
CACGTTT_MIR302A,SET,29,0.069539,0.0027617,0.15935,0.33128,CACGTTT_MIR302A,0.99999
GSE5589_WT_VS_IL6_KO_LPS_AND...2,SET,91,0.039972,0.0028072,0.091639,0.33135,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.99999
WP_MITOCHONDRIAL_BETAOXIDATI...,SET,8,0.13816,0.0028834,0.31684,0.3314,WP_MITOCHONDRIAL_BETAOXIDATION,0.99999
HP_ABNORMAL_PROPORTION_OF_CL...,SET,17,0.10504,0.0031949,0.24106,0.33152,HP_ABNORMAL_PROPORTION_OF_CLASS_SWITCHED_MEMORY_B_CELLS,0.99999
chr2q33,SET,74,0.078036,0.0049445,0.17915,0.33157,chr2q33,0.99999
GSE7831_UNSTIM_VS_CPG_STIM_P...3,SET,178,0.027672,0.0027115,0.063548,0.33162,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_DN,0.99999
GOBP_NEURONAL_ACTION_POTENTI...1,SET,33,0.069261,0.0029339,0.15907,0.33164,GOBP_NEURONAL_ACTION_POTENTIAL,0.99999
MILI_PSEUDOPODIA,SET,41,0.05475,0.0025845,0.12576,0.33165,MILI_PSEUDOPODIA,0.99999
REACTOME_SIGNALLING_TO_ERKS,SET,34,0.064577,0.0027765,0.14833,0.33166,REACTOME_SIGNALLING_TO_ERKS,0.99999
HP_ABNORMAL_CIRCULATING_MONO...,SET,66,0.045825,0.0027427,0.10529,0.3317,HP_ABNORMAL_CIRCULATING_MONOCARBOXYLIC_ACID_CONCENTRATION,0.99999
MIR3159,SET,84,0.042712,0.0028826,0.098167,0.33175,MIR3159,0.99999
WP_MAMMARY_GLAND_DEVELOPMENT...2,SET,10,0.13019,0.0030378,0.29929,0.33178,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,0.99999
LAKE_ADULT_KIDNEY_C20_COLLEC...,SET,139,0.033523,0.002906,0.077066,0.33178,LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX,0.99999
GOMF_2_ACYLGLYCEROL_3_PHOSPH...,SET,8,0.14614,0.00305,0.33617,0.33189,GOMF_2_ACYLGLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY,0.99999
REACTOME_PASSIVE_TRANSPORT_B...,SET,12,0.12894,0.0032956,0.29671,0.33194,REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS,0.99999
HP_ABNORMAL_PLATELET_MEMBRAN...,SET,6,0.15527,0.0028066,0.35736,0.33197,HP_ABNORMAL_PLATELET_MEMBRANE_PROTEIN_EXPRESSION,0.99999
GSE45365_CD8A_DC_VS_CD11B_DC...5,SET,149,0.030967,0.0027785,0.071274,0.33198,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP,0.99999
GOMF_ACETYL_COA_C_ACYLTRANSF...,SET,7,0.12747,0.0024887,0.2935,0.33203,GOMF_ACETYL_COA_C_ACYLTRANSFERASE_ACTIVITY,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...7,SET,171,0.031377,0.0030141,0.072245,0.33203,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN,0.99999
MIR302C_5P,SET,524,0.017061,0.002841,0.039288,0.33206,MIR302C_5P,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...16,SET,186,0.027717,0.0027758,0.063834,0.33207,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP,0.99999
GOBP_BRANCH_ELONGATION_INVOL...,SET,5,0.19383,0.0031984,0.4466,0.33214,GOBP_BRANCH_ELONGATION_INVOLVED_IN_MAMMARY_GLAND_DUCT_BRANCHING,0.99999
GOBP_RESPONSE_TO_ACID_CHEMIC...,SET,119,0.034793,0.0027921,0.080171,0.33215,GOBP_RESPONSE_TO_ACID_CHEMICAL,0.99999
GSE40274_CTRL_VS_FOXP3_TRANS...1,SET,182,0.028445,0.0028182,0.065544,0.33215,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
GOMF_11_CIS_RETINAL_BINDING,SET,7,0.14681,0.0028661,0.33836,0.3322,GOMF_11_CIS_RETINAL_BINDING,0.99999
GOCC_AXONEMAL_MICROTUBULE,SET,26,0.067437,0.0025361,0.15544,0.33221,GOCC_AXONEMAL_MICROTUBULE,0.99999
ZNF274_TARGET_GENES,SET,743,0.01371,0.0027018,0.031618,0.33229,ZNF274_TARGET_GENES,0.99999
GSE8835_HEALTHY_VS_CLL_CD8_T...2,SET,183,0.027431,0.002725,0.063261,0.33229,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP,0.99999
MIR5007_5P,SET,53,0.051989,0.0027894,0.11997,0.33238,MIR5007_5P,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_BAS...,SET,100,0.039195,0.0028849,0.090443,0.33238,HE_LIM_SUN_FETAL_LUNG_C2_BASOPHIL_CELL,0.99999
GOMF_VOLTAGE_GATED_CALCIUM_C...2,SET,5,0.18773,0.0030977,0.43321,0.33239,GOMF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.99999
REACTOME_ACTIVATION_OF_GENE_...,SET,41,0.052531,0.0024797,0.12126,0.33244,REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,0.99999
GSE3982_EOSINOPHIL_VS_CENT_M...2,SET,180,0.027902,0.0027493,0.064414,0.33245,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,0.99999
WP_NANOMATERIALINDUCED_INFLA...,SET,5,0.15717,0.0025934,0.36288,0.33247,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,0.99999
LET_7A_2_3P,SET,265,0.023052,0.0027495,0.053223,0.33247,LET_7A_2_3P,0.99999
LET_7G_3P,SET,265,0.023052,0.0027495,0.053223,0.33247,LET_7G_3P,0.99999
KEGG_MEDICUS_PATHOGEN_ESCHER...7,SET,4,0.18264,0.0026957,0.42178,0.3325,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...414,SET,12,0.12806,0.0032731,0.29577,0.33252,GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,0.99999
GSE32986_GMCSF_VS_GMCSF_AND_...2,SET,182,0.027482,0.0027227,0.063504,0.3326,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.99999
GOBP_GLUCOSE_IMPORT_IN_RESPO...,SET,5,0.15594,0.0025732,0.36039,0.33262,GOBP_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS,0.99999
GSE369_IFNG_KO_VS_WT_LIVER_UP,SET,179,0.027249,0.0026775,0.062982,0.33264,GSE369_IFNG_KO_VS_WT_LIVER_UP,0.99999
GSE40273_XBP1_KO_VS_WT_TREG_...1,SET,184,0.027452,0.0027346,0.063455,0.33265,GSE40273_XBP1_KO_VS_WT_TREG_DN,0.99999
RODWELL_AGING_KIDNEY_NO_BLOO...1,SET,127,0.03431,0.0028438,0.079324,0.33268,RODWELL_AGING_KIDNEY_NO_BLOOD_DN,0.99999
HP_WOLFF_PARKINSON_WHITE_SYN...,SET,15,0.090193,0.0025771,0.2086,0.33274,HP_WOLFF_PARKINSON_WHITE_SYNDROME,0.99999
GOBP_HEART_FORMATION,SET,31,0.075725,0.0031091,0.17515,0.33275,GOBP_HEART_FORMATION,0.99999
GOBP_SYNAPTIC_VESICLE_TRANSP...,SET,40,0.057443,0.0026784,0.13288,0.33277,GOBP_SYNAPTIC_VESICLE_TRANSPORT,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...1,SET,180,0.027381,0.0026979,0.063372,0.33285,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_DN,0.99999
WP_AFFECTED_PATHWAYS_IN_DUCH...,SET,67,0.048496,0.0029244,0.11225,0.33286,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,0.99999
GOBP_METANEPHRIC_S_SHAPED_BO...,SET,5,0.2003,0.0033052,0.46362,0.33286,GOBP_METANEPHRIC_S_SHAPED_BODY_MORPHOGENESIS,0.99999
GOCC_CONDENSED_CHROMOSOME,SET,250,0.022191,0.0025719,0.051373,0.33289,GOCC_CONDENSED_CHROMOSOME,0.99999
HP_SNORING,SET,6,0.15127,0.0027342,0.35029,0.33293,HP_SNORING,0.99999
MIR1238_3P,SET,30,0.065635,0.0026511,0.152,0.33294,MIR1238_3P,0.99999
GSE46606_IRF4MID_VS_WT_CD40L...4,SET,190,0.027224,0.0027552,0.063081,0.33303,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.99999
GOBP_AMIDE_BIOSYNTHETIC_PROC...,SET,144,0.031768,0.0028025,0.073613,0.33304,GOBP_AMIDE_BIOSYNTHETIC_PROCESS,0.99999
HP_GENERALIZED_HYPERKERATOSIS,SET,13,0.091369,0.0024306,0.21182,0.33311,HP_GENERALIZED_HYPERKERATOSIS,0.99999
GOBP_MITOCHONDRIAL_ELECTRON_...4,SET,12,0.095198,0.0024331,0.22076,0.33315,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_UBIQUINOL_TO_CYTOCHROME_C,0.99999
HP_BRUXISM,SET,29,0.068882,0.0027356,0.15973,0.33315,HP_BRUXISM,0.99999
GSE3982_MAST_CELL_VS_TH2_DN,SET,181,0.026149,0.0025836,0.060644,0.33317,GSE3982_MAST_CELL_VS_TH2_DN,0.99999
REACTOME_RHO_GTPASES_ACTIVAT...4,SET,11,0.099478,0.0024343,0.23089,0.33329,REACTOME_RHO_GTPASES_ACTIVATE_KTN1,0.99999
GOBP_MEMBRANE_ORGANIZATION,SET,721,0.013914,0.0027028,0.032298,0.3333,GOBP_MEMBRANE_ORGANIZATION,0.99999
GOBP_NEURON_FATE_COMMITMENT,SET,67,0.051422,0.0031008,0.11936,0.33331,GOBP_NEURON_FATE_COMMITMENT,0.99999
GSE26495_NAIVE_VS_PD1HIGH_CD...1,SET,181,0.02843,0.002809,0.066011,0.33335,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...518,SET,25,0.066823,0.0024643,0.15517,0.33336,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.99999
GSE22886_IGG_IGA_MEMORY_BCEL...3,SET,176,0.027483,0.002678,0.063819,0.33337,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,0.99999
HUANG_DASATINIB_RESISTANCE_DN,SET,66,0.049316,0.0029516,0.11456,0.33343,HUANG_DASATINIB_RESISTANCE_DN,0.99999
GSE11961_FOLLICULAR_BCELL_VS...2,SET,186,0.025563,0.00256,0.059384,0.33343,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.99999
GSE15767_MED_VS_SCS_MAC_LN_UP,SET,176,0.02946,0.0028707,0.068435,0.33343,GSE15767_MED_VS_SCS_MAC_LN_UP,0.99999
GSE6259_FLT3L_INDUCED_33D1_P...4,SET,159,0.02912,0.0026983,0.067649,0.33343,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_UP,0.99999
HP_SUPERNUMERARY_NIPPLE,SET,46,0.052593,0.0026294,0.12218,0.33344,HP_SUPERNUMERARY_NIPPLE,0.99999
GSE9006_TYPE_1_VS_TYPE_2_DIA...2,SET,180,0.02518,0.002481,0.058524,0.33351,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,0.99999
BEGUM_TARGETS_OF_PAX3_FOXO1_...1,SET,7,0.16432,0.0032081,0.38199,0.33354,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3,0.99999
GSE25088_ROSIGLITAZONE_VS_IL...2,SET,180,0.027018,0.0026622,0.06281,0.33355,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,0.99999
HP_DECREASED_FERTILITY_IN_MA...,SET,183,0.026327,0.0026154,0.06121,0.33356,HP_DECREASED_FERTILITY_IN_MALES,0.99999
MIR6780A_5P,SET,203,0.025172,0.0026323,0.058544,0.33361,MIR6780A_5P,0.99999
RHODES_UNDIFFERENTIATED_CANC...,SET,64,0.044035,0.0025955,0.10242,0.33362,RHODES_UNDIFFERENTIATED_CANCER,0.99999
GOCC_CBM_COMPLEX,SET,5,0.15441,0.002548,0.35914,0.33362,GOCC_CBM_COMPLEX,0.99999
GOBP_REGULATION_OF_POSTSYNAP...6,SET,83,0.040692,0.0027299,0.094696,0.33371,GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_NEUROTRANSMITTER_RECEPTOR_LEVELS,0.99999
HP_BREECH_PRESENTATION,SET,49,0.051752,0.0026702,0.12045,0.33372,HP_BREECH_PRESENTATION,0.99999
GSE23505_IL6_IL1_VS_IL6_IL1_...1,SET,184,0.02765,0.0027542,0.064365,0.33376,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,0.99999
GOBP_DNA_UNWINDING_INVOLVED_...,SET,20,0.079679,0.0026285,0.18551,0.33378,GOBP_DNA_UNWINDING_INVOLVED_IN_DNA_REPLICATION,0.99999
GSE28726_NAIVE_VS_ACTIVATED_...3,SET,187,0.02692,0.0027031,0.062695,0.33383,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN,0.99999
SMITH_LIVER_CANCER,SET,45,0.056116,0.0027749,0.13077,0.33392,SMITH_LIVER_CANCER,0.99999
HP_ABNORMAL_NUMBER_OF_ERYTHR...,SET,42,0.052898,0.0025273,0.1233,0.33396,HP_ABNORMAL_NUMBER_OF_ERYTHROID_PRECURSORS,0.99999
HP_GRANULAR_MACULAR_APPEARAN...,SET,8,0.14359,0.0029967,0.33487,0.33404,HP_GRANULAR_MACULAR_APPEARANCE,0.99999
HP_OVARIAN_NEOPLASM,SET,73,0.040505,0.0025491,0.094472,0.33405,HP_OVARIAN_NEOPLASM,0.99999
SKIL_TARGET_GENES,SET,1478,0.010194,0.0027735,0.023776,0.33406,SKIL_TARGET_GENES,0.99999
MIR301A_5P,SET,75,0.042306,0.0026986,0.098705,0.3341,MIR301A_5P,0.99999
MIR301B_5P,SET,75,0.042306,0.0026986,0.098705,0.3341,MIR301B_5P,0.99999
GOBP_PHAGOLYSOSOME_ASSEMBLY,SET,17,0.096993,0.0029502,0.22632,0.33412,GOBP_PHAGOLYSOSOME_ASSEMBLY,0.99999
GSE2197_IMMUNOSUPPRESSIVE_DN...1,SET,178,0.026578,0.0026044,0.062047,0.3342,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN,0.99999
HP_LONG_NECK,SET,3,0.17033,0.0021772,0.3977,0.33422,HP_LONG_NECK,0.99999
GOMF_SMALL_MOLECULE_SENSOR_A...,SET,44,0.050295,0.0024594,0.11747,0.33427,GOMF_SMALL_MOLECULE_SENSOR_ACTIVITY,0.99999
HP_AXILLARY_PTERYGIUM,SET,9,0.12757,0.0028239,0.29799,0.33429,HP_AXILLARY_PTERYGIUM,0.99999
MIR6085,SET,35,0.055573,0.0024242,0.12982,0.3343,MIR6085,0.99999
HP_ABNORMAL_CIRCULATING_COPP...,SET,11,0.10816,0.0026467,0.25267,0.33431,HP_ABNORMAL_CIRCULATING_COPPER_CONCENTRATION,0.99999
GSE17301_CTRL_VS_48H_ACD3_AC...3,SET,186,0.026136,0.0026174,0.061084,0.33437,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN,0.99999
WALLACE_PROSTATE_CANCER_DN,SET,5,0.18632,0.0030744,0.43551,0.3344,WALLACE_PROSTATE_CANCER_DN,0.99999
GCM_DEAF1,SET,24,0.069177,0.0024996,0.16172,0.33442,GCM_DEAF1,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...76,SET,55,0.047555,0.002599,0.11117,0.33442,HP_APLASIA_HYPOPLASIA_OF_THE_ULNA,0.99999
REACTOME_RND2_GTPASE_CYCLE,SET,40,0.054038,0.0025197,0.12636,0.33445,REACTOME_RND2_GTPASE_CYCLE,0.99999
CHESLER_BRAIN_QTL_TRANS,SET,6,0.15939,0.002881,0.37286,0.33452,CHESLER_BRAIN_QTL_TRANS,0.99999
KEGG_MEDICUS_REFERENCE_CASR_...,SET,7,0.1389,0.0027118,0.32504,0.33457,KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY,0.99999
WP_RIOK1_AND_RIOK2_IN_EGFR_A...,SET,15,0.09831,0.002809,0.23005,0.33457,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,0.99999
PAX5_01,SET,138,0.031906,0.0027558,0.074661,0.33457,PAX5_01,0.99999
GOBP_NEGATIVE_REGULATION_OF_...709,SET,5,0.16413,0.0027083,0.38419,0.33462,GOBP_NEGATIVE_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,0.99999
GOBP_POSITIVE_REGULATION_OF_...211,SET,68,0.041999,0.0025514,0.098334,0.33465,GOBP_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,0.99999
RACCACAR_AML_Q6,SET,240,0.023707,0.0026928,0.055509,0.33466,RACCACAR_AML_Q6,0.99999
GOMF_BETA_GALACTOSIDASE_ACTI...,SET,5,0.17658,0.0029138,0.41352,0.33469,GOMF_BETA_GALACTOSIDASE_ACTIVITY,0.99999
GSE23695_CD57_POS_VS_NEG_NK_...2,SET,185,0.025325,0.0025294,0.059311,0.3347,GSE23695_CD57_POS_VS_NEG_NK_CELL_UP,0.99999
REACTOME_FORMATION_OF_THE_UR...,SET,19,0.098099,0.0031543,0.22976,0.33471,REACTOME_FORMATION_OF_THE_URETERIC_BUD,0.99999
HP_PITUITARY_DWARFISM,SET,9,0.13217,0.0029258,0.30966,0.33475,HP_PITUITARY_DWARFISM,0.99999
HP_SPARSE_BODY_HAIR,SET,57,0.05199,0.0028925,0.12185,0.33481,HP_SPARSE_BODY_HAIR,0.99999
GOBP_BLOOD_VESSEL_ENDOTHELIA...1,SET,11,0.1196,0.0029268,0.28037,0.33484,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_DIFFERENTIATION,0.99999
GOBP_MICROGLIA_DIFFERENTIATI...,SET,11,0.11747,0.0028747,0.27552,0.33492,GOBP_MICROGLIA_DIFFERENTIATION,0.99999
HP_DOWNSLANTED_PALPEBRAL_FIS...,SET,428,0.017696,0.0026703,0.041534,0.33504,HP_DOWNSLANTED_PALPEBRAL_FISSURES,0.99999
TERAMOTO_OPN_TARGETS_CLUSTER...1,SET,13,0.098918,0.0026314,0.23224,0.33508,TERAMOTO_OPN_TARGETS_CLUSTER_1,0.99999
GOBP_CALCIUM_ION_TRANSMEMBRA...3,SET,17,0.097148,0.0029549,0.22812,0.3351,GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT_VIA_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL,0.99999
GOBP_NUCLEAR_TRANSCRIBED_MRN...5,SET,29,0.066239,0.0026306,0.15555,0.33512,GOBP_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING,0.99999
HAY_BONE_MARROW_CD34_POS_EO_...,SET,15,0.10393,0.0029695,0.24405,0.33512,HAY_BONE_MARROW_CD34_POS_EO_B_MAST,0.99999
RICKMAN_TUMOR_DIFFERENTIATED...5,SET,356,0.019863,0.002739,0.046661,0.33517,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,0.99999
DHIMAN_PBMC_ATTENUVAX_AGE_15...1,SET,17,0.091801,0.0027923,0.21566,0.33518,DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_SUBQ_7_OR_14DY_DN,0.99999
GOBP_ENDOTHELIAL_CELL_MIGRAT...,SET,202,0.026986,0.0028151,0.063408,0.33521,GOBP_ENDOTHELIAL_CELL_MIGRATION,0.99999
WP_ENDOPLASMIC_RETICULUM_STR...,SET,44,0.054444,0.0026622,0.12797,0.33526,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.99999
GOBP_DNA_REPLICATION_CHECKPO...,SET,20,0.069902,0.002306,0.16431,0.33527,GOBP_DNA_REPLICATION_CHECKPOINT_SIGNALING,0.99999
GOBP_POSITIVE_REGULATION_OF_...309,SET,11,0.12242,0.0029958,0.28777,0.33527,GOBP_POSITIVE_REGULATION_OF_GLUTAMATE_SECRETION,0.99999
HOLLEMAN_DAUNORUBICIN_B_ALL_...2,SET,10,0.11698,0.0027295,0.27507,0.33532,HOLLEMAN_DAUNORUBICIN_B_ALL_UP,0.99999
HP_NEOPLASM_BY_HISTOLOGY,SET,331,0.019687,0.0026196,0.046295,0.33533,HP_NEOPLASM_BY_HISTOLOGY,0.99999
REACTOME_DIGESTION,SET,17,0.10284,0.0031279,0.24198,0.33543,REACTOME_DIGESTION,0.99999
HP_FLAT_OCCIPUT,SET,52,0.048394,0.002572,0.11389,0.33544,HP_FLAT_OCCIPUT,0.99999
HP_EEG_WITH_FRONTAL_FOCAL_SP...,SET,4,0.22843,0.0033715,0.53766,0.33547,HP_EEG_WITH_FRONTAL_FOCAL_SPIKES,0.99999
GOBP_PROTEIN_REFOLDING,SET,24,0.068427,0.0024725,0.16107,0.33548,GOBP_PROTEIN_REFOLDING,0.99999
HP_DECREASED_HEAD_CIRCUMFERE...,SET,1163,0.010638,0.0025914,0.025047,0.33552,HP_DECREASED_HEAD_CIRCUMFERENCE,0.99999
GOBP_RETICULOPHAGY,SET,17,0.085674,0.0026059,0.20183,0.33561,GOBP_RETICULOPHAGY,0.99999
GOBP_MAINTENANCE_OF_DNA_REPE...,SET,7,0.14495,0.0028299,0.34151,0.33563,GOBP_MAINTENANCE_OF_DNA_REPEAT_ELEMENTS,0.99999
GSE21380_TFH_VS_GERMINAL_CEN...1,SET,179,0.02626,0.0025803,0.06188,0.33565,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,0.99999
GOMF_ALPHA_TUBULIN_BINDING,SET,35,0.058292,0.0025428,0.13737,0.33566,GOMF_ALPHA_TUBULIN_BINDING,0.99999
chr17q21,SET,271,0.04806,0.005796,0.11328,0.33569,chr17q21,0.99999
GOCC_PEPTIDASE_COMPLEX,SET,115,0.030633,0.0024169,0.072219,0.33572,GOCC_PEPTIDASE_COMPLEX,0.99999
GOBP_ALDITOL_BIOSYNTHETIC_PR...,SET,5,0.15553,0.0025663,0.36675,0.33576,GOBP_ALDITOL_BIOSYNTHETIC_PROCESS,0.99999
HP_ELEVATED_CIRCULATING_GLUT...,SET,6,0.15231,0.0027531,0.35915,0.33576,HP_ELEVATED_CIRCULATING_GLUTARIC_ACID_CONCENTRATION,0.99999
GSE37301_PRO_BCELL_VS_GRANUL...2,SET,132,0.032497,0.0027457,0.076633,0.33576,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.99999
GSE9509_10MIN_VS_30MIN_LPS_S...2,SET,174,0.026599,0.0025773,0.062722,0.33576,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_UP,0.99999
HP_OBSTRUCTIVE_SLEEP_APNEA,SET,72,0.044175,0.0027611,0.10419,0.33579,HP_OBSTRUCTIVE_SLEEP_APNEA,0.99999
HP_INCREASED_URINARY_NON_PRO...,SET,31,0.070918,0.0029118,0.16737,0.33588,HP_INCREASED_URINARY_NON_PROTEINOGENIC_AMINO_ACID_LEVEL,0.99999
HP_ABNORMAL_ORAL_GLUCOSE_TOL...,SET,15,0.099257,0.0028361,0.23434,0.33594,HP_ABNORMAL_ORAL_GLUCOSE_TOLERANCE,0.99999
MIR6770_5P,SET,170,0.028301,0.0027108,0.066821,0.33595,MIR6770_5P,0.99999
MIR744_5P,SET,10,0.10804,0.0025209,0.25514,0.33598,MIR744_5P,0.99999
GOBP_PROTEIN_TRANSPORT_INTO_...,SET,4,0.19569,0.0028883,0.46211,0.33598,GOBP_PROTEIN_TRANSPORT_INTO_MEMBRANE_RAFT,0.99999
MIR874_3P,SET,49,0.050003,0.0025799,0.11808,0.33599,MIR874_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...369,SET,7,0.12198,0.0023815,0.28818,0.33604,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.99999
HNF4_01,SET,244,0.022412,0.0025666,0.052949,0.33605,HNF4_01,0.99999
HP_PANIC_ATTACK,SET,49,0.048876,0.0025218,0.11549,0.33607,HP_PANIC_ATTACK,0.99999
GOBP_STRIATED_MUSCLE_CELL_DE...,SET,77,0.04134,0.0026717,0.097684,0.33608,GOBP_STRIATED_MUSCLE_CELL_DEVELOPMENT,0.99999
GSE32423_CTRL_VS_IL7_MEMORY_...1,SET,174,0.028194,0.0027318,0.06663,0.3361,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN,0.99999
GSE18804_SPLEEN_MACROPHAGE_V...5,SET,173,0.028021,0.0027073,0.066267,0.33621,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN,0.99999
GOBP_RNA_SECONDARY_STRUCTURE...,SET,8,0.11344,0.0023676,0.2683,0.33622,GOBP_RNA_SECONDARY_STRUCTURE_UNWINDING,0.99999
GOMF_LONG_CHAIN_FATTY_ACID_T...,SET,15,0.090454,0.0025846,0.21393,0.33622,GOMF_LONG_CHAIN_FATTY_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_CITRULLINE_BIOSYNTHETIC...,SET,4,0.15613,0.0023044,0.36933,0.33624,GOBP_CITRULLINE_BIOSYNTHETIC_PROCESS,0.99999
chr10q11,SET,45,0.092475,0.0045729,0.21882,0.33629,chr10q11,0.99999
BERTUCCI_MEDULLARY_VS_DUCTAL...2,SET,171,0.028552,0.0027427,0.06756,0.33629,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,0.99999
GOMF_PYRUVATE_DEHYDROGENASE_...1,SET,4,0.16654,0.002458,0.39412,0.33631,GOMF_PYRUVATE_DEHYDROGENASE_ACETYL_TRANSFERRING_KINASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...71,SET,34,0.061239,0.002633,0.14495,0.33634,GOBP_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.99999
PID_ECADHERIN_NASCENT_AJ_PAT...,SET,38,0.059904,0.0027226,0.1418,0.33635,PID_ECADHERIN_NASCENT_AJ_PATHWAY,0.99999
MIR665,SET,122,0.031156,0.0025314,0.073748,0.33635,MIR665,0.99999
GOBP_REGULATION_OF_TETRAPYRR...,SET,7,0.14959,0.0029206,0.35412,0.33636,GOBP_REGULATION_OF_TETRAPYRROLE_METABOLIC_PROCESS,0.99999
HP_ABNORMAL_TRACHEAL_MORPHOL...,SET,150,0.029021,0.0026126,0.068747,0.33646,HP_ABNORMAL_TRACHEAL_MORPHOLOGY,0.99999
PID_ERBB4_PATHWAY,SET,38,0.058604,0.0026635,0.13885,0.33649,PID_ERBB4_PATHWAY,0.99999
GOBP_REGULATION_OF_BLOOD_VOL...,SET,5,0.19049,0.0031433,0.45138,0.33651,GOBP_REGULATION_OF_BLOOD_VOLUME_BY_RENIN_ANGIOTENSIN,0.99999
GOMF_ARYL_HYDROCARBON_RECEPT...,SET,7,0.1064,0.0020772,0.25216,0.33654,GOMF_ARYL_HYDROCARBON_RECEPTOR_BINDING,0.99999
GSE26928_NAIVE_VS_CXCR5_POS_...2,SET,155,0.027764,0.0025404,0.065803,0.33654,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_LE...3,SET,10,0.10503,0.0024507,0.24896,0.33656,GOBP_CELLULAR_RESPONSE_TO_LEUCINE_STARVATION,0.99999
HP_ABNORMAL_PLACENTAL_MEMBRA...,SET,13,0.10725,0.002853,0.25423,0.33656,HP_ABNORMAL_PLACENTAL_MEMBRANE_MORPHOLOGY,0.99999
GOBP_ENDOTHELIAL_CELL_MATRIX...,SET,6,0.17152,0.0031004,0.40671,0.33661,GOBP_ENDOTHELIAL_CELL_MATRIX_ADHESION,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...8,SET,181,0.025656,0.0025349,0.060839,0.33662,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP,0.99999
REACTOME_ANTIGEN_PRESENTATIO...,SET,28,0.069785,0.0027233,0.16557,0.33671,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.99999
PETRETTO_HEART_MASS_QTL_CIS_...1,SET,24,0.069988,0.0025289,0.16612,0.33676,PETRETTO_HEART_MASS_QTL_CIS_DN,0.99999
HP_LARGE_POSTERIOR_FONTANELLE,SET,17,0.091204,0.0027741,0.21648,0.33677,HP_LARGE_POSTERIOR_FONTANELLE,0.99999
GSE43863_DAY6_EFF_VS_DAY150_...6,SET,179,0.028082,0.0027594,0.066662,0.33679,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP,0.99999
GOBP_AROMATIC_AMINO_ACID_TRA...,SET,9,0.12233,0.0027078,0.2905,0.33685,GOBP_AROMATIC_AMINO_ACID_TRANSPORT,0.99999
GOMF_UBIQUITIN_LIGASE_INHIBI...,SET,9,0.13076,0.0028946,0.31056,0.33686,GOMF_UBIQUITIN_LIGASE_INHIBITOR_ACTIVITY,0.99999
GOMF_FATTY_ACID_BINDING,SET,44,0.054858,0.0026825,0.13032,0.3369,GOMF_FATTY_ACID_BINDING,0.99999
WEST_ADRENOCORTICAL_TUMOR_MA...1,SET,18,0.093489,0.002926,0.22218,0.33696,WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN,0.99999
MIYAGAWA_TARGETS_OF_EWSR1_ET...2,SET,239,0.025751,0.002919,0.061213,0.337,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,0.99999
REACTOME_AKT_PHOSPHORYLATES_...2,SET,9,0.11294,0.0025001,0.2685,0.33701,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS,0.99999
HP_RETINAL_DYSTROPHY,SET,310,0.020274,0.0026123,0.048202,0.33702,HP_RETINAL_DYSTROPHY,0.99999
GOBP_TETRAHYDROFOLATE_INTERC...,SET,9,0.10362,0.0022938,0.24644,0.33707,GOBP_TETRAHYDROFOLATE_INTERCONVERSION,0.99999
GOBP_REACTIVE_OXYGEN_SPECIES...1,SET,45,0.052798,0.0026108,0.12565,0.33717,GOBP_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,0.99999
FAN_EMBRYONIC_CTX_BIG_GROUPS...2,SET,131,0.03291,0.0027701,0.078332,0.3372,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,0.99999
GOBP_XENOPHAGY,SET,14,0.091544,0.0025271,0.21797,0.33725,GOBP_XENOPHAGY,0.99999
HP_GENERALIZED_CLONIC_SEIZURE,SET,28,0.070344,0.0027451,0.16753,0.33728,HP_GENERALIZED_CLONIC_SEIZURE,0.99999
GAANYNYGACNY_UNKNOWN,SET,65,0.04479,0.0026605,0.10671,0.33734,GAANYNYGACNY_UNKNOWN,0.99999
GOCC_ATAC_COMPLEX,SET,12,0.092696,0.0023692,0.22087,0.33736,GOCC_ATAC_COMPLEX,0.99999
REACTOME_TERMINATION_OF_O_GL...,SET,21,0.08103,0.002739,0.19308,0.33737,REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS,0.99999
GSE37301_COMMON_LYMPHOID_PRO...6,SET,177,0.027317,0.0026694,0.065115,0.33742,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP,0.99999
NABA_MATRISOME_PRIMARY_METAS...,SET,54,0.054402,0.0029462,0.12971,0.33746,NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR,0.99999
GOBP_CELLULAR_COMPONENT_DISA...1,SET,481,0.016193,0.0025866,0.038616,0.33749,GOBP_CELLULAR_COMPONENT_DISASSEMBLY,0.99999
GOBP_RESPONSE_TO_INDOLE_3_ME...,SET,6,0.14807,0.0026765,0.35313,0.33749,GOBP_RESPONSE_TO_INDOLE_3_METHANOL,0.99999
GNF2_BNIP2,SET,32,0.058372,0.0024349,0.13925,0.33755,GNF2_BNIP2,0.99999
GOCC_AP_3_ADAPTOR_COMPLEX,SET,11,0.10343,0.0025312,0.24681,0.33758,GOCC_AP_3_ADAPTOR_COMPLEX,0.99999
WHITESIDE_CISPLATIN_RESISTAN...1,SET,12,0.095085,0.0024302,0.22689,0.33759,WHITESIDE_CISPLATIN_RESISTANCE_DN,0.99999
GOBP_ENDOTHELIUM_DEVELOPMENT,SET,129,0.03369,0.0028142,0.080466,0.33772,GOBP_ENDOTHELIUM_DEVELOPMENT,0.99999
PTEN_DN.V1_UP,SET,162,0.029358,0.0027457,0.07012,0.33773,PTEN_DN.V1_UP,0.99999
GNF2_APEX1,SET,77,0.037764,0.0024406,0.090213,0.33775,GNF2_APEX1,0.99999
PCGF1_TARGET_GENES,SET,456,0.017246,0.002684,0.041219,0.33783,PCGF1_TARGET_GENES,0.99999
REACTOME_SIGNALING_BY_NUCLEA...,SET,225,0.024598,0.0027065,0.058816,0.33789,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,0.99999
GOMF_IMPORTIN_ALPHA_FAMILY_P...,SET,9,0.10186,0.0022547,0.24353,0.33789,GOMF_IMPORTIN_ALPHA_FAMILY_PROTEIN_BINDING,0.99999
HP_PERIVENTRICULAR_CYSTS,SET,12,0.10829,0.0027676,0.25893,0.3379,HP_PERIVENTRICULAR_CYSTS,0.99999
GOBP_HINDGUT_DEVELOPMENT,SET,8,0.15381,0.00321,0.36779,0.33791,GOBP_HINDGUT_DEVELOPMENT,0.99999
GOMF_DNA_POLYMERASE_ACTIVITY,SET,27,0.053556,0.0020524,0.12809,0.33793,GOMF_DNA_POLYMERASE_ACTIVITY,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...12,SET,171,0.027004,0.0025941,0.064583,0.33793,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP,0.99999
KOINUMA_COLON_CANCER_MSI_UP,SET,16,0.087919,0.0025944,0.21029,0.33795,KOINUMA_COLON_CANCER_MSI_UP,0.99999
WP_STATIN_INHIBITION_OF_CHOL...,SET,26,0.075372,0.0028345,0.18034,0.338,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,0.99999
SMID_BREAST_CANCER_ERBB2_UP,SET,127,0.031945,0.0026478,0.076463,0.33806,SMID_BREAST_CANCER_ERBB2_UP,0.99999
MTF1_Q4,SET,221,0.024634,0.0026866,0.058977,0.33809,MTF1_Q4,0.99999
GOBP_RECOGNITION_OF_APOPTOTI...,SET,7,0.14309,0.0027935,0.34262,0.33811,GOBP_RECOGNITION_OF_APOPTOTIC_CELL,0.99999
MIR7_2_3P,SET,591,0.015632,0.0027593,0.037439,0.33814,MIR7_2_3P,0.99999
GOCC_CILIARY_TRANSITION_ZONE,SET,65,0.041602,0.0024711,0.099667,0.33819,GOCC_CILIARY_TRANSITION_ZONE,0.99999
GSE21927_SPLENIC_VS_TUMOR_MO...1,SET,178,0.025479,0.0024966,0.061048,0.33821,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN,0.99999
GSE339_CD4POS_VS_CD8POS_DC_I...1,SET,180,0.025474,0.00251,0.06106,0.33827,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN,0.99999
MARKEY_RB1_CHRONIC_LOF_UP,SET,106,0.034972,0.0026497,0.083883,0.33838,MARKEY_RB1_CHRONIC_LOF_UP,0.99999
REACTOME_HEME_SIGNALING,SET,45,0.055842,0.0027614,0.13395,0.33839,REACTOME_HEME_SIGNALING,0.99999
GOBP_METANEPHRIC_EPITHELIUM_...,SET,27,0.077272,0.0029612,0.18536,0.33839,GOBP_METANEPHRIC_EPITHELIUM_DEVELOPMENT,0.99999
GSE1460_NAIVE_CD4_TCELL_ADUL...1,SET,182,0.026244,0.0026001,0.062972,0.33843,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN,0.99999
PEART_HDAC_PROLIFERATION_CLU...2,SET,51,0.049941,0.0026286,0.11988,0.33849,PEART_HDAC_PROLIFERATION_CLUSTER_UP,0.99999
HP_PROXIMAL_TUBULOPATHY,SET,35,0.053747,0.0023446,0.12903,0.33851,HP_PROXIMAL_TUBULOPATHY,0.99999
REACTOME_POU5F1_OCT4_SOX2_NA...2,SET,9,0.13098,0.0028993,0.31465,0.33861,REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION,0.99999
GSE22601_IMMATURE_CD4_SINGLE...3,SET,184,0.027188,0.0027082,0.065312,0.33861,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.99999
BIOCARTA_MAL_PATHWAY,SET,19,0.078548,0.0025257,0.18871,0.33862,BIOCARTA_MAL_PATHWAY,0.99999
HP_VARICOSE_VEINS,SET,29,0.066637,0.0026464,0.16012,0.33865,HP_VARICOSE_VEINS,0.99999
GSE40441_NRP1_POS_INDUCED_TR...2,SET,184,0.027343,0.0027237,0.065704,0.33865,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_UP,0.99999
MIR1298_3P,SET,41,0.056284,0.0026569,0.13527,0.33868,MIR1298_3P,0.99999
GOMF_VERY_LONG_CHAIN_FATTY_A...,SET,9,0.11258,0.0024921,0.27059,0.33869,GOMF_VERY_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,0.99999
HP_ABNORMALITY_OF_THE_MUSCUL...3,SET,89,0.038121,0.0026478,0.09163,0.3387,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LOWER_LIMBS,0.99999
GOBP_POSITIVE_REGULATION_OF_...245,SET,32,0.064317,0.0026829,0.15467,0.33877,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.99999
MIR8070,SET,116,0.03528,0.0027956,0.084868,0.33882,MIR8070,0.99999
GOMF_INTRAMOLECULAR_OXIDORED...1,SET,51,0.048747,0.0025657,0.11728,0.33884,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY,0.99999
GOBP_AUTOPHAGIC_CELL_DEATH,SET,9,0.12183,0.0026969,0.29316,0.33886,GOBP_AUTOPHAGIC_CELL_DEATH,0.99999
PBX1_01,SET,233,0.024508,0.0027434,0.058976,0.33887,PBX1_01,0.99999
HP_ABNORMALITY_OF_THE_TEMPOR...,SET,18,0.090476,0.0028317,0.21773,0.33887,HP_ABNORMALITY_OF_THE_TEMPOROMANDIBULAR_JOINT,0.99999
REACTOME_FORMATION_OF_THE_PO...,SET,9,0.12954,0.0028675,0.31181,0.33891,REACTOME_FORMATION_OF_THE_POSTERIOR_NEURAL_PLATE,0.99999
SCHAEFFER_SOX9_TARGETS_IN_PR...1,SET,44,0.058359,0.0028536,0.14051,0.33895,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,0.99999
MIR4327,SET,74,0.046248,0.0029303,0.11135,0.33895,MIR4327,0.99999
MIR550A_3P,SET,70,0.044444,0.0027392,0.10703,0.33898,MIR550A_3P,0.99999
WP_SPHINGOLIPID_METABOLISM_O...,SET,23,0.081515,0.0028835,0.19633,0.339,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,0.99999
GOBP_REGULATION_OF_ANAPHASE_...,SET,5,0.13248,0.0021861,0.31924,0.33908,GOBP_REGULATION_OF_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_DNA_TEMPL...2,SET,15,0.089589,0.0025598,0.21592,0.3391,GOBP_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION_INITIATION,0.99999
HP_ABNORMAL_CIRCULATING_THYR...1,SET,20,0.083578,0.0027571,0.20143,0.3391,HP_ABNORMAL_CIRCULATING_THYROGLOBULIN_CONCENTRATION,0.99999
GOBP_PROXIMAL_DISTAL_PATTERN...1,SET,34,0.07057,0.0030342,0.1701,0.33912,GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION,0.99999
BOWIE_RESPONSE_TO_TAMOXIFEN,SET,18,0.080394,0.0025161,0.19381,0.33914,BOWIE_RESPONSE_TO_TAMOXIFEN,0.99999
GOBP_REGULATION_OF_EXTRACELL...4,SET,61,0.047057,0.002708,0.11346,0.33917,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,0.99999
GOBP_COENZYME_A_BIOSYNTHETIC...,SET,10,0.10346,0.0024141,0.24963,0.33926,GOBP_COENZYME_A_BIOSYNTHETIC_PROCESS,0.99999
MIR34A_3P,SET,64,0.045387,0.0026752,0.10954,0.33932,MIR34A_3P,0.99999
GSE27786_LSK_VS_BCELL_DN,SET,182,0.026207,0.0025964,0.06325,0.33932,GSE27786_LSK_VS_BCELL_DN,0.99999
MIR4330,SET,82,0.038631,0.0025761,0.093248,0.33934,MIR4330,0.99999
AP1_01,SET,235,0.023571,0.0026497,0.056901,0.33935,AP1_01,0.99999
HP_ABNORMAL_MITOCHONDRIAL_SH...,SET,10,0.10521,0.0024547,0.25398,0.33936,HP_ABNORMAL_MITOCHONDRIAL_SHAPE,0.99999
ENGELMANN_CANCER_PROGENITORS...1,SET,58,0.049205,0.0027613,0.11881,0.33939,ENGELMANN_CANCER_PROGENITORS_DN,0.99999
GAO_SMALL_INTESTINE_24W_C3_E...,SET,41,0.051676,0.0024394,0.12482,0.33944,GAO_SMALL_INTESTINE_24W_C3_ENTEROCYTE_PROGENITOR_SUBTYPE_1,0.99999
GOBP_REGULATION_OF_NEUTROPHI...6,SET,37,0.065097,0.0029195,0.15731,0.33951,GOBP_REGULATION_OF_NEUTROPHIL_MIGRATION,0.99999
GARCIA_TARGETS_OF_FLI1_AND_D...1,SET,148,0.027714,0.0024783,0.067023,0.33962,GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...2,SET,183,0.026635,0.002646,0.064419,0.33964,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.99999
IIZUKA_LIVER_CANCER_PROGRESS...4,SET,23,0.071687,0.0025358,0.17341,0.33966,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...593,SET,6,0.15376,0.0027793,0.37196,0.33967,GOBP_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOBP_NUCLEAR_TRANSPORT,SET,306,0.019108,0.0024464,0.04624,0.33972,GOBP_NUCLEAR_TRANSPORT,0.99999
DESCARTES_FETAL_HEART_MYELOI...,SET,104,0.03664,0.0027499,0.08867,0.33973,DESCARTES_FETAL_HEART_MYELOID_CELLS,0.99999
HP_UNEXPLAINED_FEVERS,SET,18,0.083289,0.0026067,0.20164,0.33978,HP_UNEXPLAINED_FEVERS,0.99999
MANNE_COVID19_ICU_VS_HEALTHY...2,SET,117,0.032047,0.0025502,0.077591,0.3398,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,0.99999
MODULE_132,SET,13,0.10821,0.0028785,0.262,0.3398,MODULE_132,0.99999
chr18q12,SET,43,0.099331,0.0048017,0.24052,0.33981,chr18q12,0.99999
MIR1912_3P,SET,80,0.038693,0.0025487,0.093704,0.33983,MIR1912_3P,0.99999
MIR5581_5P,SET,67,0.043372,0.0026154,0.10509,0.33991,MIR5581_5P,0.99999
MIR199A_3P_MIR199B_3P,SET,145,0.029149,0.0025803,0.070645,0.33995,MIR199A_3P_MIR199B_3P,0.99999
GOBP_LEUKOTRIENE_BIOSYNTHETI...,SET,16,0.096422,0.0028453,0.23371,0.33996,GOBP_LEUKOTRIENE_BIOSYNTHETIC_PROCESS,0.99999
REACTOME_SYNTHESIS_OF_DOLICH...,SET,5,0.16262,0.0026833,0.39434,0.34003,REACTOME_SYNTHESIS_OF_DOLICHYL_PHOSPHATE,0.99999
GSE6259_33D1_POS_DC_VS_CD4_T...2,SET,161,0.027704,0.0025831,0.067195,0.34006,GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP,0.99999
HOLLERN_MICROACINAR_BREAST_T...2,SET,40,0.058224,0.0027148,0.14126,0.3401,HOLLERN_MICROACINAR_BREAST_TUMOR_UP,0.99999
RGTTAMWNATT_HNF1_01,SET,65,0.047133,0.0027996,0.11435,0.3401,RGTTAMWNATT_HNF1_01,0.99999
HP_PERIORBITAL_FULLNESS,SET,34,0.055613,0.0023911,0.13492,0.3401,HP_PERIORBITAL_FULLNESS,0.99999
HP_ABNORMAL_BLOOD_ZINC_CONCE...,SET,6,0.14275,0.0025804,0.34641,0.34014,HP_ABNORMAL_BLOOD_ZINC_CONCENTRATION,0.99999
GSE23505_UNTREATED_VS_4DAY_I...3,SET,184,0.024763,0.0024667,0.060093,0.34014,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,0.99999
SRF_Q6,SET,228,0.024374,0.0026994,0.059158,0.34017,SRF_Q6,0.99999
GOBP_VASCULOGENESIS_INVOLVED...,SET,4,0.21117,0.0031167,0.51268,0.34021,GOBP_VASCULOGENESIS_INVOLVED_IN_CORONARY_VASCULAR_MORPHOGENESIS,0.99999
GOBP_MULTI_CILIATED_EPITHELI...,SET,8,0.113,0.0023584,0.27441,0.34025,GOBP_MULTI_CILIATED_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
WP_AMINO_ACID_TRANSPORT_DEFE...,SET,8,0.12207,0.0025476,0.29644,0.34026,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,0.99999
GOBP_DOUBLE_STRAND_BREAK_REP...8,SET,8,0.089931,0.0018769,0.21853,0.34035,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_SYNTHESIS_DEPENDENT_STRAND_ANNEALING,0.99999
HP_MYOCLONIC_SPASMS,SET,29,0.063815,0.0025343,0.15507,0.34035,HP_MYOCLONIC_SPASMS,0.99999
REACTOME_METABOLISM_OF_PORPH...,SET,26,0.069183,0.0026018,0.16825,0.34047,REACTOME_METABOLISM_OF_PORPHYRINS,0.99999
MARZEC_IL2_SIGNALING_DN,SET,36,0.056448,0.0024972,0.13739,0.34058,MARZEC_IL2_SIGNALING_DN,0.99999
SOX9_B1,SET,213,0.025001,0.0026774,0.060847,0.34058,SOX9_B1,0.99999
GSE42724_B1_BCELL_VS_PLASMAB...2,SET,184,0.02467,0.0024574,0.06008,0.34068,GSE42724_B1_BCELL_VS_PLASMABLAST_UP,0.99999
KEGG_ADIPOCYTOKINE_SIGNALING...,SET,63,0.044625,0.0026097,0.10869,0.34069,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,0.99999
HP_TEMPORAL_CORTICAL_ATROPHY,SET,17,0.085272,0.0025937,0.20769,0.34069,HP_TEMPORAL_CORTICAL_ATROPHY,0.99999
GOMF_ABC_TYPE_GLUTATHIONE_S_...,SET,8,0.13314,0.0027787,0.32439,0.34075,GOMF_ABC_TYPE_GLUTATHIONE_S_CONJUGATE_TRANSPORTER_ACTIVITY,0.99999
HP_MATERNAL_AUTOIMMUNE_DISEA...,SET,14,0.095871,0.0026465,0.23359,0.34075,HP_MATERNAL_AUTOIMMUNE_DISEASE,0.99999
GOMF_ALKANE_1_MONOOXYGENASE_...,SET,5,0.16702,0.0027561,0.40699,0.34076,GOMF_ALKANE_1_MONOOXYGENASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...263,SET,4,0.15794,0.0023311,0.38495,0.3408,GOBP_POSITIVE_REGULATION_OF_EXIT_FROM_MITOSIS,0.99999
MENON_FETAL_KIDNEY_0_CAP_MES...,SET,73,0.039425,0.0024811,0.096124,0.34085,MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS,0.99999
MIR4325,SET,244,0.023166,0.002653,0.056491,0.34087,MIR4325,0.99999
ZNF507_TARGET_GENES,SET,510,0.015237,0.0025041,0.037156,0.34087,ZNF507_TARGET_GENES,0.99999
GOBP_RADIAL_GLIA_GUIDED_PYRA...,SET,6,0.1535,0.0027746,0.37434,0.34089,GOBP_RADIAL_GLIA_GUIDED_PYRAMIDAL_NEURON_MIGRATION,0.99999
GCM_MAP1B,SET,62,0.044825,0.0026005,0.10932,0.3409,GCM_MAP1B,0.99999
GCM_RAF1,SET,37,0.051647,0.0023163,0.12597,0.34091,GCM_RAF1,0.99999
MIR376C_3P,SET,138,0.029447,0.0025435,0.071834,0.34093,MIR376C_3P,0.99999
GOBP_MAINTENANCE_OF_CENTROSO...,SET,5,0.12454,0.002055,0.30388,0.34097,GOBP_MAINTENANCE_OF_CENTROSOME_LOCATION,0.99999
HP_INTEROSSEUS_MUSCLE_ATROPHY,SET,4,0.14459,0.002134,0.35284,0.34098,HP_INTEROSSEUS_MUSCLE_ATROPHY,0.99999
GOBP_REGULATION_OF_HYDROGEN_...3,SET,17,0.085452,0.0025992,0.20859,0.34103,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,0.99999
HP_HYPOPIGMENTED_SKIN_PATCHES,SET,105,0.03194,0.0024086,0.077966,0.34103,HP_HYPOPIGMENTED_SKIN_PATCHES,0.99999
REACTOME_RECOGNITION_AND_ASS...,SET,10,0.10193,0.0023784,0.24901,0.34114,REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE,0.99999
HP_WEAKNESS_DUE_TO_UPPER_MOT...,SET,426,0.016971,0.002555,0.041464,0.34117,HP_WEAKNESS_DUE_TO_UPPER_MOTOR_NEURON_DYSFUNCTION,0.99999
HP_ABNORMAL_BRONCHUS_PHYSIOL...,SET,20,0.073993,0.0024409,0.18084,0.34121,HP_ABNORMAL_BRONCHUS_PHYSIOLOGY,0.99999
HP_INCREASED_HEMATOCRIT,SET,9,0.12047,0.0026669,0.29446,0.34122,HP_INCREASED_HEMATOCRIT,0.99999
GSE22886_UNSTIM_VS_IL15_STIM...2,SET,171,0.025937,0.0024916,0.063398,0.34123,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP,0.99999
GOBP_RISC_COMPLEX_ASSEMBLY,SET,10,0.10706,0.0024981,0.26171,0.34124,GOBP_RISC_COMPLEX_ASSEMBLY,0.99999
KEGG_MEDICUS_ENV_FACTOR_TCDD...,SET,19,0.098302,0.0031608,0.24031,0.34125,KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY,0.99999
HP_ABNORMALITY_OF_KREBS_CYCL...,SET,8,0.12323,0.0025719,0.30126,0.34126,HP_ABNORMALITY_OF_KREBS_CYCLE_METABOLISM,0.99999
GOBP_PROTEIN_DELIPIDATION,SET,4,0.15271,0.0022539,0.37339,0.34128,GOBP_PROTEIN_DELIPIDATION,0.99999
KEGG_MEDICUS_REFERENCE_CX3CR...,SET,17,0.088341,0.002687,0.21602,0.34129,KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY,0.99999
GSE14413_UNSTIM_VS_IFNB_STIM...3,SET,124,0.029859,0.0024457,0.073026,0.34132,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_DN,0.99999
REACTOME_OVARIAN_TUMOR_DOMAI...,SET,34,0.057953,0.0024917,0.14176,0.34134,REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,0.99999
HP_ABNORMAL_TRAGUS_MORPHOLOGY,SET,11,0.099031,0.0024234,0.24232,0.34139,HP_ABNORMAL_TRAGUS_MORPHOLOGY,0.99999
GOBP_PURINE_RIBONUCLEOSIDE_S...,SET,6,0.1581,0.0028578,0.38695,0.34143,GOBP_PURINE_RIBONUCLEOSIDE_SALVAGE,0.99999
GSE22886_CD4_TCELL_VS_BCELL_...1,SET,170,0.027281,0.0026131,0.066775,0.34144,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN,0.99999
VARELA_ZMPSTE24_TARGETS_DN,SET,35,0.060466,0.0026377,0.14802,0.34146,VARELA_ZMPSTE24_TARGETS_DN,0.99999
MIR3129_5P,SET,144,0.02886,0.002546,0.070668,0.3415,MIR3129_5P,0.99999
HASLINGER_B_CLL_WITH_MUTATED...,SET,16,0.093355,0.0027548,0.22864,0.34153,HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,0.99999
GSE14350_TREG_VS_TEFF_IN_IL2...2,SET,183,0.024745,0.0024582,0.060607,0.34153,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP,0.99999
HP_ABNORMALITY_OF_UPPER_LIP_...,SET,387,0.017761,0.0025514,0.043504,0.34154,HP_ABNORMALITY_OF_UPPER_LIP_VERMILLION,0.99999
GOBP_SNRNA_TRANSCRIPTION_BY_...1,SET,16,0.077495,0.0022868,0.18986,0.34157,GOBP_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.99999
HP_EXTERNAL_GENITAL_HYPOPLAS...,SET,436,0.016718,0.0025456,0.040979,0.34166,HP_EXTERNAL_GENITAL_HYPOPLASIA,0.99999
P53_DN.V1_DN,SET,177,0.02779,0.0027156,0.068128,0.34167,P53_DN.V1_DN,0.99999
GOMF_1_ALKYL_2_ACETYLGLYCERO...,SET,8,0.10707,0.0022347,0.26253,0.3417,GOMF_1_ALKYL_2_ACETYLGLYCEROPHOSPHOCHOLINE_ESTERASE_ACTIVITY,0.99999
ZHONG_PFC_C3_MICROGLIA,SET,431,0.017414,0.0026367,0.042708,0.34174,ZHONG_PFC_C3_MICROGLIA,0.99999
LI_PBMC_MENACTRA_AGE_18_45YO...6,SET,25,0.07791,0.0028731,0.19114,0.34179,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_NEGATIVE,0.99999
WP_TGFB_SMAD_SIGNALING,SET,11,0.12449,0.0030465,0.30547,0.3418,WP_TGFB_SMAD_SIGNALING,0.99999
GOBP_MELANOSOME_ASSEMBLY,SET,18,0.081968,0.0025654,0.20115,0.34182,GOBP_MELANOSOME_ASSEMBLY,0.99999
GOCC_MANCHETTE,SET,20,0.0765,0.0025236,0.18788,0.34194,GOCC_MANCHETTE,0.99999
MIR520D_3P,SET,303,0.020109,0.0025621,0.049394,0.34196,MIR520D_3P,0.99999
GOBP_CRANIAL_SUTURE_MORPHOGE...,SET,9,0.13135,0.0029076,0.32278,0.34203,GOBP_CRANIAL_SUTURE_MORPHOGENESIS,0.99999
DAIRKEE_CANCER_PRONE_RESPONS...1,SET,50,0.044751,0.0023323,0.11001,0.34208,DAIRKEE_CANCER_PRONE_RESPONSE_BPA,0.99999
CAO_BLOOD_FLUMIST_AGE_05_14Y...1,SET,8,0.11797,0.0024621,0.29005,0.34211,CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_DN,0.99999
MIR3200_5P,SET,58,0.045627,0.0025606,0.1122,0.34213,MIR3200_5P,0.99999
KEGG_MEDICUS_REFERENCE_TNF_J...,SET,16,0.090427,0.0026684,0.2224,0.34216,KEGG_MEDICUS_REFERENCE_TNF_JNK_SIGNALING_PATHWAY,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...11,SET,40,0.05413,0.002524,0.13316,0.34218,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1,0.99999
DESCARTES_FETAL_EYE_SMOOTH_M...,SET,53,0.047681,0.0025583,0.11732,0.34222,DESCARTES_FETAL_EYE_SMOOTH_MUSCLE_CELLS,0.99999
SUZUKI_RESPONSE_TO_TSA_AND_D...1,SET,20,0.085611,0.0028242,0.21073,0.34228,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,0.99999
KEGG_MEDICUS_REFERENCE_GLOBA...,SET,16,0.068199,0.0020125,0.16788,0.34229,KEGG_MEDICUS_REFERENCE_GLOBAL_GENOME_NER,0.99999
MODULE_181,SET,270,0.02147,0.0025845,0.052866,0.34233,MODULE_181,0.99999
SCIAN_INVERSED_TARGETS_OF_TP...2,SET,9,0.12113,0.0026814,0.29829,0.34234,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP,0.99999
REACTOME_TRANSLESION_SYNTHES...2,SET,16,0.077356,0.0022827,0.1905,0.34235,REACTOME_TRANSLESION_SYNTHESIS_BY_POLK,0.99999
GOBP_POSITIVE_REGULATION_OF_...587,SET,5,0.15618,0.0025771,0.38465,0.34236,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_TRANSLOCATION,0.99999
REACTOME_INTERLEUKIN_2_FAMIL...,SET,39,0.062725,0.002888,0.15458,0.34245,REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,0.99999
GOBP_REGULATION_OF_DENDRITIC...3,SET,14,0.099392,0.0027437,0.24495,0.34246,GOBP_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,0.99999
MAYBURD_RESPONSE_TO_L663536_...1,SET,51,0.046278,0.0024358,0.11406,0.34247,MAYBURD_RESPONSE_TO_L663536_DN,0.99999
GOBP_REGULATION_OF_MRNA_SPLI...,SET,97,0.031862,0.0023099,0.07854,0.34249,GOBP_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME,0.99999
GOBP_CARDIAC_NEURAL_CREST_CE...1,SET,12,0.1184,0.0030262,0.29191,0.34252,GOBP_CARDIAC_NEURAL_CREST_CELL_DEVELOPMENT_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS,0.99999
HP_ABNORMALITY_OF_THE_EPIPHY...1,SET,5,0.15844,0.0026145,0.39063,0.34252,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_DISTAL_PHALANX_OF_FINGER,0.99999
REACTOME_NUCLEAR_ENVELOPE_BR...,SET,50,0.046283,0.0024121,0.11412,0.34253,REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN,0.99999
GSE19888_ADENOSINE_A3R_INH_P...4,SET,186,0.026467,0.0026506,0.065262,0.34254,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,0.99999
HP_ABNORMAL_ANTERIOR_EYE_SEG...,SET,1152,0.010566,0.0025625,0.026064,0.3426,HP_ABNORMAL_ANTERIOR_EYE_SEGMENT_MORPHOLOGY,0.99999
HP_FUNDUS_ATROPHY,SET,3,0.26947,0.0034444,0.66476,0.34261,HP_FUNDUS_ATROPHY,0.99999
GOBP_QUINONE_METABOLIC_PROCE...,SET,21,0.068643,0.0023203,0.16936,0.34263,GOBP_QUINONE_METABOLIC_PROCESS,0.99999
REACTOME_TNFR1_INDUCED_NF_KA...,SET,27,0.06631,0.0025411,0.16363,0.34265,REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY,0.99999
VECCHI_GASTRIC_CANCER_ADVANC...2,SET,154,0.0308,0.0028091,0.076076,0.34279,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,0.99999
GOBP_ELECTRON_TRANSPORT_CHAIN,SET,107,0.030127,0.0022933,0.074413,0.34279,GOBP_ELECTRON_TRANSPORT_CHAIN,0.99999
KEGG_MEDICUS_PATHOGEN_SHIGEL...5,SET,4,0.17268,0.0025486,0.42653,0.3428,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAH7.8_TO_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY,0.99999
GOBP_PATTERN_SPECIFICATION_I...,SET,8,0.15051,0.0031412,0.37187,0.34284,GOBP_PATTERN_SPECIFICATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.99999
HP_ABNORMAL_SEPTUM_PELLUCIDU...,SET,92,0.03553,0.0025089,0.087797,0.34286,HP_ABNORMAL_SEPTUM_PELLUCIDUM_MORPHOLOGY,0.99999
HP_SPEECH_ARTICULATION_DIFFI...,SET,29,0.072307,0.0028716,0.17871,0.34288,HP_SPEECH_ARTICULATION_DIFFICULTIES,0.99999
GOBP_POSITIVE_REGULATION_OF_...621,SET,19,0.075345,0.0024227,0.18634,0.34298,GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.99999
ZNF282_TARGET_GENES,SET,851,0.012121,0.0025484,0.029983,0.34301,ZNF282_TARGET_GENES,0.99999
GSE2405_HEAT_KILLED_VS_LIVE_...1,SET,173,0.025632,0.0024764,0.063404,0.34301,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,0.99999
HP_THROMBOPHLEBITIS,SET,10,0.099532,0.0023224,0.24625,0.34304,HP_THROMBOPHLEBITIS,0.99999
MIR4781_5P,SET,5,0.16648,0.0027472,0.41195,0.34306,MIR4781_5P,0.99999
chr14q31,SET,15,0.14783,0.0042238,0.36587,0.3431,chr14q31,0.99999
GOMF_HEAT_SHOCK_PROTEIN_BIND...,SET,119,0.031365,0.002517,0.077644,0.34312,GOMF_HEAT_SHOCK_PROTEIN_BINDING,0.99999
HP_FATTY_REPLACEMENT_OF_SKEL...,SET,33,0.054286,0.0022995,0.13441,0.34315,HP_FATTY_REPLACEMENT_OF_SKELETAL_MUSCLE,0.99999
GSE9037_CTRL_VS_LPS_1H_STIM_...2,SET,173,0.025554,0.0024689,0.063282,0.34318,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP,0.99999
GSE17186_CD21LOW_VS_CD21HIGH...2,SET,184,0.02468,0.0024584,0.061135,0.34322,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,0.99999
GOMF_PROTEIN_HETERODIMERIZAT...,SET,232,0.023056,0.0025754,0.057122,0.34325,GOMF_PROTEIN_HETERODIMERIZATION_ACTIVITY,0.99999
HP_PANCREATIC_PSEUDOCYST,SET,4,0.19298,0.0028482,0.4783,0.34331,HP_PANCREATIC_PSEUDOCYST,0.99999
INGRAM_SHH_TARGETS_DN,SET,57,0.046369,0.0025797,0.11495,0.34334,INGRAM_SHH_TARGETS_DN,0.99999
MIR1273H_5P,SET,176,0.025577,0.0024923,0.063432,0.3434,MIR1273H_5P,0.99999
HP_BRONCHIAL_WALL_THICKENING,SET,6,0.17339,0.003134,0.43022,0.34347,HP_BRONCHIAL_WALL_THICKENING,0.99999
BIDUS_METASTASIS_DN,SET,131,0.03015,0.0025378,0.074838,0.34352,BIDUS_METASTASIS_DN,0.99999
GOBP_REGULATION_OF_SMOOTH_MU...3,SET,56,0.048631,0.0026818,0.12074,0.34356,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,0.99999
GSE6259_BCELL_VS_CD4_TCELL_DN,SET,166,0.026342,0.0024935,0.065416,0.34359,GSE6259_BCELL_VS_CD4_TCELL_DN,0.99999
WP_FAMILIAL_HYPERLIPIDEMIA_T...2,SET,16,0.088139,0.0026009,0.21889,0.3436,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,0.99999
HP_SCHIZENCEPHALY,SET,9,0.1228,0.0027182,0.30497,0.3436,HP_SCHIZENCEPHALY,0.99999
GOMF_ATP_DEPENDENT_ACTIVITY,SET,533,0.014631,0.0024565,0.03635,0.34366,GOMF_ATP_DEPENDENT_ACTIVITY,0.99999
GOBP_EPINEPHRINE_TRANSPORT,SET,11,0.11894,0.0029105,0.29565,0.34374,GOBP_EPINEPHRINE_TRANSPORT,0.99999
GOBP_INORGANIC_ION_IMPORT_AC...,SET,113,0.034464,0.0026956,0.085678,0.34375,GOBP_INORGANIC_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GOBP_EXCITATORY_CHEMICAL_SYN...,SET,10,0.1198,0.0027952,0.29782,0.34376,GOBP_EXCITATORY_CHEMICAL_SYNAPTIC_TRANSMISSION,0.99999
GOBP_POSITIVE_REGULATION_OF_...350,SET,666,0.013787,0.0025778,0.034279,0.34378,GOBP_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE,0.99999
MIR892A,SET,117,0.033892,0.002697,0.084289,0.34381,MIR892A,0.99999
GOBP_MITOCHONDRIAL_PROTEIN_P...,SET,12,0.096721,0.002472,0.24058,0.34383,GOBP_MITOCHONDRIAL_PROTEIN_PROCESSING,0.99999
KEGG_FATTY_ACID_METABOLISM,SET,41,0.053101,0.0025067,0.1321,0.34385,KEGG_FATTY_ACID_METABOLISM,0.99999
GOMF_5ALPHA_ANDROSTANE_3BETA...,SET,6,0.16118,0.0029135,0.40096,0.34385,GOMF_5ALPHA_ANDROSTANE_3BETA_17BETA_DIOL_DEHYDROGENASE_ACTIVITY,0.99999
GOCC_NEURON_PROJECTION_CYTOP...,SET,83,0.036918,0.0024767,0.091854,0.34387,GOCC_NEURON_PROJECTION_CYTOPLASM,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_DEF...2,SET,23,0.070575,0.0024965,0.17563,0.3439,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROCYTE,0.99999
HP_ABNORMAL_CARDIOMYOCYTE_MO...,SET,15,0.083852,0.0023959,0.2087,0.34392,HP_ABNORMAL_CARDIOMYOCYTE_MORPHOLOGY,0.99999
HP_ESOPHORIA,SET,5,0.13877,0.0022899,0.34543,0.34394,HP_ESOPHORIA,0.99999
KEGG_MEDICUS_REFERENCE_TYPE_...2,SET,20,0.087089,0.002873,0.21693,0.34404,KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_THYRO...,SET,8,0.11613,0.0024237,0.28929,0.34406,KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY,0.99999
MIR4632_5P,SET,91,0.036127,0.0025373,0.090028,0.34411,MIR4632_5P,0.99999
HP_PREMATURE_SKIN_WRINKLING,SET,61,0.043639,0.0025113,0.10875,0.34411,HP_PREMATURE_SKIN_WRINKLING,0.99999
GSE3720_UNSTIM_VS_PMA_STIM_V...2,SET,158,0.026205,0.0024206,0.065321,0.34415,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,0.99999
DARWICHE_PAPILLOMA_RISK_HIGH...2,SET,137,0.02947,0.0025363,0.073473,0.34417,DARWICHE_PAPILLOMA_RISK_HIGH_UP,0.99999
HP_PELVIC_GIRDLE_MUSCLE_WEAK...,SET,42,0.051841,0.0024768,0.12924,0.34417,HP_PELVIC_GIRDLE_MUSCLE_WEAKNESS,0.99999
KOHOUTEK_CCNT1_TARGETS,SET,47,0.053178,0.0026873,0.13259,0.34419,KOHOUTEK_CCNT1_TARGETS,0.99999
GOBP_INTERLEUKIN_21_PRODUCTI...,SET,2,0.27748,0.0028961,0.69193,0.3442,GOBP_INTERLEUKIN_21_PRODUCTION,0.99999
GOMF_ABC_TYPE_XENOBIOTIC_TRA...,SET,14,0.10132,0.002797,0.25266,0.3442,GOMF_ABC_TYPE_XENOBIOTIC_TRANSPORTER_ACTIVITY,0.99999
GSE2585_THYMIC_MACROPHAGE_VS...2,SET,173,0.025951,0.0025073,0.064738,0.34426,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_UP,0.99999
GOMF_PROTEIN_ARGININE_OMEGA_...2,SET,5,0.14751,0.0024341,0.36806,0.34429,GOMF_PROTEIN_ARGININE_OMEGA_N_MONOMETHYLTRANSFERASE_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_NALP1...,SET,4,0.15024,0.0022174,0.37489,0.34431,KEGG_MEDICUS_REFERENCE_NALP12_INFLAMMASOME_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_FINGER_MORPHOLOGY,SET,1056,0.010714,0.0024947,0.026736,0.34431,HP_ABNORMAL_FINGER_MORPHOLOGY,0.99999
REACTOME_LYSOSOME_VESICLE_BI...,SET,32,0.058631,0.0024457,0.14634,0.34434,REACTOME_LYSOSOME_VESICLE_BIOGENESIS,0.99999
ZHAN_MULTIPLE_MYELOMA_HP_DN,SET,38,0.055535,0.002524,0.13862,0.34436,ZHAN_MULTIPLE_MYELOMA_HP_DN,0.99999
GSE17974_2.5H_VS_72H_IL4_AND...2,SET,178,0.024865,0.0024366,0.062079,0.34438,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,0.99999
GSE16450_IMMATURE_VS_MATURE_...1,SET,180,0.024505,0.0024146,0.061185,0.34439,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.99999
HP_PORTAL_INFLAMMATION,SET,4,0.20297,0.0029957,0.50688,0.34443,HP_PORTAL_INFLAMMATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...139,SET,42,0.05484,0.00262,0.13698,0.34445,GOBP_NEGATIVE_REGULATION_OF_CHEMOTAXIS,0.99999
BIOCARTA_RANKL_PATHWAY,SET,14,0.099848,0.0027563,0.24942,0.34446,BIOCARTA_RANKL_PATHWAY,0.99999
MIR6829_5P,SET,89,0.036432,0.0025305,0.091035,0.34451,MIR6829_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...65,SET,5,0.12236,0.0020191,0.30594,0.3446,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
IL21_UP.V1_UP,SET,166,0.026905,0.0025468,0.067273,0.3446,IL21_UP.V1_UP,0.99999
GOBP_PANCREATIC_JUICE_SECRET...,SET,11,0.099744,0.0024409,0.24946,0.34464,GOBP_PANCREATIC_JUICE_SECRETION,0.99999
HP_METATARSUS_ADDUCTUS,SET,44,0.051341,0.0025105,0.12841,0.34464,HP_METATARSUS_ADDUCTUS,0.99999
GOCC_EUKARYOTIC_48S_PREINITI...,SET,13,0.086716,0.0023068,0.21689,0.34465,GOCC_EUKARYOTIC_48S_PREINITIATION_COMPLEX,0.99999
MIKKELSEN_DEDIFFERENTIATED_S...2,SET,6,0.14729,0.0026623,0.36842,0.34466,MIKKELSEN_DEDIFFERENTIATED_STATE_UP,0.99999
GSE360_CTRL_VS_L_DONOVANI_DC...1,SET,180,0.026392,0.0026005,0.066026,0.34468,GSE360_CTRL_VS_L_DONOVANI_DC_DN,0.99999
HP_SAGITTAL_CRANIOSYNOSTOSIS,SET,23,0.064868,0.0022946,0.16229,0.34469,HP_SAGITTAL_CRANIOSYNOSTOSIS,0.99999
GOBP_L_ASCORBIC_ACID_METABOL...,SET,9,0.11761,0.0026034,0.29425,0.3447,GOBP_L_ASCORBIC_ACID_METABOLIC_PROCESS,0.99999
GOBP_CELLULAR_RESPONSE_TO_UV,SET,81,0.036324,0.0024075,0.090888,0.34471,GOBP_CELLULAR_RESPONSE_TO_UV,0.99999
REACTOME_CD209_DC_SIGN_SIGNA...,SET,19,0.077932,0.0025058,0.19502,0.34472,REACTOME_CD209_DC_SIGN_SIGNALING,0.99999
HP_FEMALE_INFERTILITY,SET,69,0.039283,0.0024038,0.098331,0.34476,HP_FEMALE_INFERTILITY,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...8,SET,45,0.060881,0.0030105,0.15241,0.34479,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_7,0.99999
DESCARTES_FETAL_PANCREAS_STR...,SET,16,0.092907,0.0027416,0.23272,0.34487,DESCARTES_FETAL_PANCREAS_STROMAL_CELLS,0.99999
HP_ABNORMAL_RIB_CAGE_MORPHOL...,SET,339,0.018874,0.002541,0.04729,0.34491,HP_ABNORMAL_RIB_CAGE_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_VACUOLE_O...,SET,54,0.044767,0.0024244,0.11218,0.34492,GOBP_REGULATION_OF_VACUOLE_ORGANIZATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...818,SET,9,0.098369,0.0021775,0.24654,0.34495,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,0.99999
HP_CLUBBING_OF_FINGERS,SET,37,0.058747,0.0026347,0.14725,0.34496,HP_CLUBBING_OF_FINGERS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...432,SET,10,0.10376,0.0024209,0.26015,0.34501,GOBP_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,0.99999
GSE2770_IL12_AND_TGFB_ACT_VS...6,SET,171,0.026231,0.0025198,0.06577,0.34501,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP,0.99999
HP_ABNORMAL_GRANULOCYTOPOIET...,SET,14,0.093126,0.0025707,0.23352,0.34502,HP_ABNORMAL_GRANULOCYTOPOIETIC_CELL_MORPHOLOGY,0.99999
PTEN_DN.V2_UP,SET,126,0.032741,0.0027032,0.082122,0.34506,PTEN_DN.V2_UP,0.99999
GSE20500_CTRL_VS_RARA_ANTAGO...1,SET,180,0.023931,0.002358,0.060025,0.34507,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,0.99999
MIR516B_5P,SET,114,0.030474,0.002394,0.076446,0.34508,MIR516B_5P,0.99999
GOBP_INTRACELLULAR_GLUCOSE_H...,SET,142,0.028864,0.0025287,0.072419,0.34511,GOBP_INTRACELLULAR_GLUCOSE_HOMEOSTASIS,0.99999
GOBP_REGULATION_OF_EPITHELIA...7,SET,100,0.036713,0.0027022,0.092115,0.34511,GOBP_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.99999
REACTOME_DISSOLUTION_OF_FIBR...,SET,13,0.1039,0.0027639,0.26072,0.34513,REACTOME_DISSOLUTION_OF_FIBRIN_CLOT,0.99999
GOBP_CYTOKINE_MEDIATED_SIGNA...,SET,472,0.017,0.0026906,0.042668,0.34516,GOBP_CYTOKINE_MEDIATED_SIGNALING_PATHWAY,0.99999
GSE3982_CTRL_VS_IGE_STIM_MAS...2,SET,183,0.024773,0.002461,0.062192,0.3452,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP,0.99999
GSE8921_UNSTIM_VS_TLR1_2_STI...7,SET,178,0.024744,0.0024246,0.062127,0.34522,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN,0.99999
GOBP_CENP_A_CONTAINING_CHROM...,SET,9,0.10472,0.0023181,0.26336,0.34546,GOBP_CENP_A_CONTAINING_CHROMATIN_ASSEMBLY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...35,SET,16,0.08354,0.0024652,0.21011,0.34547,GOBP_NEGATIVE_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,0.99999
GSE12392_IFNAR_KO_VS_IFNB_KO...1,SET,185,0.026002,0.002597,0.065423,0.34553,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_DN,0.99999
ISHIDA_TARGETS_OF_SYT_SSX_FU...,SET,6,0.15426,0.0027884,0.38819,0.34554,ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS,0.99999
GOBP_POSITIVE_REGULATION_OF_...335,SET,10,0.10162,0.0023711,0.25571,0.34554,GOBP_POSITIVE_REGULATION_OF_HEPATOCYTE_PROLIFERATION,0.99999
MARIADASON_REGULATED_BY_HIST...2,SET,55,0.045267,0.002474,0.11395,0.34559,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...31,SET,41,0.051814,0.0024459,0.13043,0.34559,HP_APLASIA_HYPOPLASIA_OF_THE_EYELID,0.99999
PHONG_TNF_TARGETS_UP,SET,61,0.050408,0.0029009,0.1269,0.3456,PHONG_TNF_TARGETS_UP,0.99999
GOBP_TETRAHYDROFOLATE_METABO...,SET,17,0.073597,0.0022386,0.18545,0.34574,GOBP_TETRAHYDROFOLATE_METABOLIC_PROCESS,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...9,SET,19,0.076711,0.0024666,0.19332,0.34576,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,0.99999
GOCC_TETRASPANIN_ENRICHED_MI...,SET,10,0.11054,0.0025792,0.2786,0.34577,GOCC_TETRASPANIN_ENRICHED_MICRODOMAIN,0.99999
KEGG_MEDICUS_REFERENCE_DNA_R...1,SET,24,0.061773,0.0022321,0.15572,0.3458,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_LICENSING,0.99999
GOBP_RECEPTOR_MEDIATED_VIRIO...,SET,5,0.17889,0.0029518,0.45117,0.34587,GOBP_RECEPTOR_MEDIATED_VIRION_ATTACHMENT_TO_HOST_CELL,0.99999
GOCC_NUCLEOSOME,SET,37,0.054161,0.0024291,0.1366,0.34587,GOCC_NUCLEOSOME,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...2,SET,183,0.026711,0.0026536,0.067369,0.34587,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_UP,0.99999
ONGUSAHA_BRCA1_TARGETS_UP,SET,10,0.11954,0.0027891,0.30149,0.34588,ONGUSAHA_BRCA1_TARGETS_UP,0.99999
HP_EPISODIC_VOMITING,SET,37,0.049384,0.0022148,0.12459,0.34592,HP_EPISODIC_VOMITING,0.99999
GOBP_MACROPHAGE_CHEMOTAXIS,SET,39,0.052379,0.0024117,0.13216,0.34593,GOBP_MACROPHAGE_CHEMOTAXIS,0.99999
HARALAMBIEVA_PBMC_FLUARIX_AG...6,SET,14,0.10776,0.0029746,0.27187,0.34593,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_SIG_DIAB_OF_THE_YNG_POSITIVE,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_S10...,SET,32,0.061855,0.0025802,0.15607,0.34594,HE_LIM_SUN_FETAL_LUNG_C2_S100A12_HI_CLASSICAL_MONOCYTE,0.99999
GSE34205_HEALTHY_VS_RSV_INF_...2,SET,168,0.025528,0.0024309,0.064426,0.34597,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...3,SET,16,0.080572,0.0023776,0.20338,0.346,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN,0.99999
DESCARTES_MAIN_FETAL_SATELLI...,SET,44,0.049893,0.0024397,0.12595,0.346,DESCARTES_MAIN_FETAL_SATELLITE_CELLS,0.99999
GSE42021_TCONV_PLN_VS_CD24HI...1,SET,181,0.025583,0.0025277,0.064601,0.34605,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN,0.99999
ELVIDGE_HIF1A_TARGETS_DN,SET,81,0.038479,0.0025503,0.097208,0.34612,ELVIDGE_HIF1A_TARGETS_DN,0.99999
WONG_MITOCHONDRIA_GENE_MODULE,SET,190,0.022582,0.0022854,0.057065,0.34616,WONG_MITOCHONDRIA_GENE_MODULE,0.99999
GOBP_REGULATION_OF_CALCIUM_I...9,SET,18,0.085171,0.0026656,0.21532,0.34622,GOBP_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,0.99999
HP_CORNEAL_STROMAL_EDEMA,SET,11,0.11485,0.0028104,0.29036,0.34623,HP_CORNEAL_STROMAL_EDEMA,0.99999
HP_PYODERMA,SET,4,0.20299,0.002996,0.51353,0.34632,HP_PYODERMA,0.99999
GSE2770_IL12_VS_IL4_TREATED_...1,SET,151,0.028095,0.0025375,0.071083,0.34633,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.99999
GSE37301_HEMATOPOIETIC_STEM_...11,SET,149,0.026188,0.0023497,0.066255,0.34633,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_DN,0.99999
ELVIDGE_HIF1A_AND_HIF2A_TARG...2,SET,37,0.053112,0.002382,0.13438,0.34634,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP,0.99999
MIR7160_5P,SET,171,0.026222,0.0025189,0.066378,0.34641,MIR7160_5P,0.99999
GOBP_SOMATIC_STEM_CELL_POPUL...,SET,61,0.045044,0.0025922,0.11403,0.34641,GOBP_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.99999
HP_CHOROID_PLEXUS_CYST,SET,10,0.11645,0.0027172,0.2948,0.34641,HP_CHOROID_PLEXUS_CYST,0.99999
MIR7843_5P,SET,86,0.036116,0.0024661,0.091432,0.34642,MIR7843_5P,0.99999
MIR1202,SET,67,0.039915,0.002407,0.10105,0.34643,MIR1202,0.99999
GSE9988_ANTI_TREM1_AND_LPS_V...4,SET,162,0.028749,0.0026887,0.072796,0.34645,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP,0.99999
HP_RED_GREEN_DYSCHROMATOPSIA,SET,8,0.11365,0.0023719,0.2878,0.34646,HP_RED_GREEN_DYSCHROMATOPSIA,0.99999
ZNF791_TARGET_GENES,SET,41,0.049704,0.0023463,0.12587,0.34647,ZNF791_TARGET_GENES,0.99999
GSE2706_UNSTIM_VS_8H_R848_DC...1,SET,174,0.027853,0.0026987,0.070542,0.34648,GSE2706_UNSTIM_VS_8H_R848_DC_DN,0.99999
GOCC_SARCOPLASMIC_RETICULUM_...1,SET,9,0.11091,0.002455,0.28096,0.34652,GOCC_SARCOPLASMIC_RETICULUM_LUMEN,0.99999
HP_JUVENILE_ONSET,SET,597,0.01376,0.0024407,0.034859,0.34652,HP_JUVENILE_ONSET,0.99999
GOBP_CATECHOLAMINE_SECRETION,SET,46,0.05313,0.0026562,0.13465,0.34657,GOBP_CATECHOLAMINE_SECRETION,0.99999
GSE2405_0H_VS_9H_A_PHAGOCYTO...2,SET,176,0.024554,0.0023926,0.062227,0.34658,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.99999
HP_EXPRESSIVE_LANGUAGE_DELAY,SET,50,0.04662,0.0024297,0.11816,0.3466,HP_EXPRESSIVE_LANGUAGE_DELAY,0.99999
LIU_PROSTATE_CANCER_DN,SET,435,0.017316,0.0026337,0.043898,0.34662,LIU_PROSTATE_CANCER_DN,0.99999
REACTOME_MTOR_SIGNALLING,SET,40,0.051557,0.002404,0.1308,0.34673,REACTOME_MTOR_SIGNALLING,0.99999
MIR6867_5P,SET,773,0.012908,0.0025924,0.032747,0.34673,MIR6867_5P,0.99999
GOBP_INNER_EAR_RECEPTOR_CELL...2,SET,4,0.18313,0.0027029,0.46462,0.34674,GOBP_INNER_EAR_RECEPTOR_CELL_FATE_COMMITMENT,0.99999
GSE23308_CTRL_VS_CORTICOSTER...1,SET,186,0.024711,0.0024747,0.062694,0.34674,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN,0.99999
HP_4_5_FINGER_SYNDACTYLY,SET,5,0.17439,0.0028776,0.44269,0.34682,HP_4_5_FINGER_SYNDACTYLY,0.99999
HP_BULL_S_EYE_MACULOPATHY,SET,9,0.12575,0.0027836,0.31928,0.34685,HP_BULL_S_EYE_MACULOPATHY,0.99999
GOBP_ADHESION_OF_SYMBIONT_TO...2,SET,8,0.1374,0.0028676,0.34891,0.34687,GOBP_ADHESION_OF_SYMBIONT_TO_HOST_CELL,0.99999
HP_HIP_OSTEOARTHRITIS,SET,17,0.09275,0.0028211,0.23557,0.34689,HP_HIP_OSTEOARTHRITIS,0.99999
HP_TRICEPS_WEAKNESS,SET,17,0.077704,0.0023635,0.19739,0.34692,HP_TRICEPS_WEAKNESS,0.99999
MIR4531,SET,302,0.019979,0.0025414,0.050758,0.34693,MIR4531,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...4,SET,162,0.027303,0.0025534,0.06937,0.34695,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP,0.99999
MORF_HDAC2,SET,248,0.020026,0.0023118,0.050893,0.34698,MORF_HDAC2,0.99999
GOMF_BILE_ACID_TRANSMEMBRANE...,SET,20,0.077184,0.0025462,0.19621,0.34703,GOMF_BILE_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MIR4740_3P,SET,7,0.13188,0.0025748,0.33531,0.34704,MIR4740_3P,0.99999
HP_ABNORMAL_GASTROINTESTINAL...1,SET,87,0.035859,0.0024627,0.09117,0.34704,HP_ABNORMAL_GASTROINTESTINAL_MOTILITY,0.99999
WP_RESISTIN_AS_A_REGULATOR_O...,SET,32,0.058442,0.0024379,0.14861,0.34707,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.99999
GSE29618_PRE_VS_DAY7_POST_TI...8,SET,176,0.025342,0.0024694,0.064442,0.34707,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP,0.99999
WP_7Q1123_DISTAL_COPY_NUMBER...,SET,21,0.081605,0.0027584,0.20753,0.34708,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,0.99999
GOMF_IMMUNOGLOBULIN_RECEPTOR...1,SET,12,0.11848,0.0030282,0.30133,0.34709,GOMF_IMMUNOGLOBULIN_RECEPTOR_ACTIVITY,0.99999
HP_RECURRENT_HYPOGLYCEMIA,SET,21,0.079445,0.0026855,0.20221,0.34721,HP_RECURRENT_HYPOGLYCEMIA,0.99999
GOCC_CYTOPLASMIC_SIDE_OF_ROU...,SET,4,0.14021,0.0020694,0.3569,0.34722,GOCC_CYTOPLASMIC_SIDE_OF_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE,0.99999
HELLER_HDAC_TARGETS_UP,SET,251,0.021292,0.0024726,0.054204,0.34723,HELLER_HDAC_TARGETS_UP,0.99999
WP_T_CELL_MODULATION_IN_PANC...,SET,43,0.053666,0.0025942,0.13665,0.34726,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,0.99999
ZNF23_TARGET_GENES,SET,13,0.090544,0.0024086,0.23056,0.34727,ZNF23_TARGET_GENES,0.99999
REACTOME_DEUBIQUITINATION,SET,217,0.021205,0.0022917,0.054003,0.34729,REACTOME_DEUBIQUITINATION,0.99999
GSE29949_CD8_NEG_DC_SPLEEN_V...3,SET,179,0.025209,0.0024771,0.064204,0.34729,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN,0.99999
GSE37301_LYMPHOID_PRIMED_MPP...10,SET,185,0.02375,0.0023721,0.060483,0.34729,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP,0.99999
HP_POSTERIOR_UVEITIS,SET,5,0.16143,0.0026638,0.41119,0.34731,HP_POSTERIOR_UVEITIS,0.99999
JAATINEN_HEMATOPOIETIC_STEM_...2,SET,274,0.02152,0.0026094,0.054822,0.34733,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...630,SET,31,0.055033,0.0022595,0.1402,0.34734,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE,0.99999
GSE44649_WT_VS_MIR155_KO_NAI...2,SET,184,0.025329,0.0025231,0.064528,0.34734,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP,0.99999
HP_FULMINANT_HEPATIC_FAILURE,SET,5,0.13245,0.0021856,0.33747,0.34735,HP_FULMINANT_HEPATIC_FAILURE,0.99999
GOBP_POSITIVE_REGULATION_OF_...284,SET,8,0.11997,0.0025038,0.30572,0.34738,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_ELEVATED_CIRCULATING_CATE...,SET,12,0.098116,0.0025077,0.25012,0.34743,HP_ELEVATED_CIRCULATING_CATECHOLAMINE_LEVEL,0.99999
GOCC_TRANS_GOLGI_NETWORK_TRA...2,SET,18,0.073989,0.0023157,0.18865,0.34746,GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE_MEMBRANE,0.99999
GOBP_ADRENAL_GLAND_DEVELOPME...,SET,26,0.074285,0.0027936,0.18943,0.34747,GOBP_ADRENAL_GLAND_DEVELOPMENT,0.99999
chr1q21,SET,161,0.053104,0.0049512,0.13542,0.34748,chr1q21,0.99999
GSE17721_CTRL_VS_CPG_2H_BMDC...1,SET,189,0.025173,0.002541,0.064207,0.34751,GSE17721_CTRL_VS_CPG_2H_BMDC_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...17,SET,24,0.070618,0.0025517,0.18015,0.34753,GOBP_POSITIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...709,SET,126,0.030926,0.0025533,0.078902,0.34755,GOBP_POSITIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,0.99999
chr9q31,SET,55,0.08012,0.0043788,0.20449,0.3476,chr9q31,0.99999
GSE3039_ALPHAALPHA_CD8_TCELL...4,SET,180,0.025367,0.0024995,0.064755,0.34763,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP,0.99999
REACTOME_DNA_DAMAGE_REVERSAL,SET,8,0.12139,0.0025336,0.30992,0.34765,REACTOME_DNA_DAMAGE_REVERSAL,0.99999
GSE5679_CTRL_VS_RARA_AGONIST...1,SET,180,0.024178,0.0023824,0.06174,0.34767,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN,0.99999
GOBP_TELOMERE_ORGANIZATION,SET,147,0.025538,0.0022761,0.065217,0.34768,GOBP_TELOMERE_ORGANIZATION,0.99999
HP_ABNORMALITY_OF_THE_SPINOC...,SET,10,0.1068,0.0024919,0.2728,0.34772,HP_ABNORMALITY_OF_THE_SPINOCEREBELLAR_TRACTS,0.99999
HP_EPISODIC_HYPERTENSION,SET,5,0.13679,0.0022572,0.3494,0.34772,HP_EPISODIC_HYPERTENSION,0.99999
GOMF_SODIUM_PHOSPHATE_SYMPOR...,SET,13,0.11106,0.0029543,0.28372,0.34774,GOMF_SODIUM_PHOSPHATE_SYMPORTER_ACTIVITY,0.99999
HP_HYPOGONADISM,SET,377,0.017143,0.0024314,0.043806,0.34777,HP_HYPOGONADISM,0.99999
MIR5088_5P,SET,33,0.058993,0.0024989,0.15075,0.34778,MIR5088_5P,0.99999
GOBP_RETINAL_CONE_CELL_DIFFE...,SET,13,0.1008,0.0026814,0.25762,0.3478,GOBP_RETINAL_CONE_CELL_DIFFERENTIATION,0.99999
GSE26928_EFF_MEMORY_VS_CXCR5...1,SET,164,0.025815,0.002429,0.065976,0.3478,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,0.99999
KYNG_ENVIRONMENTAL_STRESS_RE...1,SET,16,0.08721,0.0025735,0.2229,0.34781,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN,0.99999
HP_PHOCOMELIA,SET,7,0.13335,0.0026034,0.34083,0.34781,HP_PHOCOMELIA,0.99999
SINGH_KRAS_DEPENDENCY_SIGNAT...,SET,19,0.080889,0.0026009,0.20688,0.3479,SINGH_KRAS_DEPENDENCY_SIGNATURE,0.99999
GSE22432_PDC_VS_TGFB1_TREATE...2,SET,168,0.024536,0.0023364,0.062754,0.3479,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_UP,0.99999
WP_CANCER_IMMUNOTHERAPY_BY_C...,SET,12,0.10066,0.0025727,0.25751,0.34794,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...444,SET,5,0.12846,0.0021197,0.32882,0.34803,GOBP_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION,0.99999
HP_ABNORMAL_VASCULAR_PHYSIOL...,SET,285,0.020245,0.0025028,0.051824,0.34803,HP_ABNORMAL_VASCULAR_PHYSIOLOGY,0.99999
GSE21033_3H_VS_24H_POLYIC_ST...1,SET,108,0.03005,0.0022981,0.076931,0.34804,GSE21033_3H_VS_24H_POLYIC_STIM_DC_DN,0.99999
GSE6259_DEC205_POS_DC_VS_CD8...2,SET,168,0.024761,0.0023578,0.063396,0.34806,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_UP,0.99999
MORF_MAP2K2,SET,116,0.028859,0.0022868,0.073906,0.34809,MORF_MAP2K2,0.99999
HAN_SATB1_TARGETS_UP,SET,387,0.017869,0.002567,0.045769,0.34811,HAN_SATB1_TARGETS_UP,0.99999
GOMF_ALL_TRANS_RETINAL_BINDI...,SET,5,0.15347,0.0025325,0.39313,0.34813,GOMF_ALL_TRANS_RETINAL_BINDING,0.99999
GSE37533_UNTREATED_VS_PIOGLI...5,SET,144,0.026878,0.0023711,0.068894,0.34822,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_DN,0.99999
GSE19825_NAIVE_VS_DAY3_EFF_C...1,SET,181,0.023186,0.0022909,0.05944,0.34824,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_DN,0.99999
IIZUKA_LIVER_CANCER_PROGRESS...7,SET,8,0.1109,0.0023146,0.28439,0.34828,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN,0.99999
BIOCARTA_COMP_PATHWAY,SET,15,0.094615,0.0027034,0.24262,0.34828,BIOCARTA_COMP_PATHWAY,0.99999
REACTOME_ORGANIC_CATION_TRAN...,SET,10,0.12343,0.0028801,0.31657,0.34831,REACTOME_ORGANIC_CATION_TRANSPORT,0.99999
GOBP_T_HELPER_1_TYPE_IMMUNE_...,SET,45,0.055513,0.0027451,0.14244,0.34837,GOBP_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...3,SET,20,0.083945,0.0027693,0.21539,0.34837,GOMF_STRUCTURAL_CONSTITUENT_OF_EYE_LENS,0.99999
GOMF_NEUROTROPHIN_RECEPTOR_A...,SET,5,0.16106,0.0026576,0.41332,0.34839,GOMF_NEUROTROPHIN_RECEPTOR_ACTIVITY,0.99999
HP_ABNORMALITY_OF_THE_VASCUL...,SET,336,0.018183,0.0024374,0.046666,0.3484,HP_ABNORMALITY_OF_THE_VASCULATURE_OF_THE_EYE,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...59,SET,11,0.09965,0.0024386,0.25587,0.34847,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY,0.99999
chr6q12,SET,5,0.23629,0.0038991,0.60718,0.34858,chr6q12,0.99999
FOURATI_BLOOD_TWINRIX_AGE_65...3,SET,4,0.15779,0.0023289,0.40547,0.34858,FOURATI_BLOOD_TWINRIX_AGE_65_83YO_POOR_RESPONDERS_VS_RESPONDERS_0DY_NETWORK_INFERENCE_UP,0.99999
GSE6092_UNSTIM_VS_IFNG_STIM_...3,SET,173,0.025173,0.0024322,0.064709,0.34863,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN,0.99999
GOMF_GTPASE_ACTIVITY,SET,287,0.020134,0.0024977,0.05177,0.34867,GOMF_GTPASE_ACTIVITY,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...8,SET,44,0.053542,0.0026181,0.13772,0.34873,GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1,0.99999
MIR378B,SET,37,0.052157,0.0023392,0.13418,0.34875,MIR378B,0.99999
GOBP_PHAGOCYTOSIS,SET,221,0.023644,0.0025785,0.060833,0.34876,GOBP_PHAGOCYTOSIS,0.99999
SMID_BREAST_CANCER_RELAPSE_I...7,SET,37,0.056088,0.0025155,0.14433,0.34878,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,0.99999
GNF2_CASP1,SET,102,0.033616,0.0024988,0.086498,0.34878,GNF2_CASP1,0.99999
GOBP_CARBON_DIOXIDE_TRANSPORT,SET,12,0.11673,0.0029833,0.30035,0.34878,GOBP_CARBON_DIOXIDE_TRANSPORT,0.99999
MIR8066,SET,142,0.027941,0.0024479,0.071907,0.3488,MIR8066,0.99999
GOCC_CELL_PROJECTION_MEMBRANE,SET,330,0.018151,0.0024116,0.046715,0.34881,GOCC_CELL_PROJECTION_MEMBRANE,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...49,SET,17,0.079272,0.0024112,0.2041,0.34887,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM,0.99999
GOBP_EQUILIBRIOCEPTION,SET,8,0.13848,0.0028901,0.35657,0.34888,GOBP_EQUILIBRIOCEPTION,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...1,SET,16,0.083905,0.002476,0.2161,0.34891,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN,0.99999
HELLER_HDAC_TARGETS_DN,SET,266,0.021165,0.0025292,0.054529,0.34896,HELLER_HDAC_TARGETS_DN,0.99999
REACTOME_FCGAMMA_RECEPTOR_FC...,SET,81,0.036077,0.0023911,0.092979,0.34901,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,0.99999
MIR484,SET,81,0.03661,0.0024265,0.094356,0.34901,MIR484,0.99999
HP_INCREASED_HEPATIC_GLYCOGE...,SET,11,0.10904,0.0026684,0.28105,0.34901,HP_INCREASED_HEPATIC_GLYCOGEN_CONTENT,0.99999
KEGG_INTESTINAL_IMMUNE_NETWO...,SET,40,0.0571,0.0026625,0.14719,0.34904,KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...197,SET,63,0.040153,0.0023481,0.10352,0.34906,GOBP_NEGATIVE_REGULATION_OF_ENDOCYTOSIS,0.99999
HP_FLUSHING,SET,45,0.047857,0.0023665,0.12339,0.34906,HP_FLUSHING,0.99999
GSE17721_0.5H_VS_12H_PAM3CSK...1,SET,184,0.023317,0.0023226,0.060121,0.34907,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_DN,0.99999
GOBP_CELL_MORPHOGENESIS_INVO...,SET,534,0.015274,0.0025668,0.039398,0.34913,GOBP_CELL_MORPHOGENESIS_INVOLVED_IN_NEURON_DIFFERENTIATION,0.99999
HP_PTERYGIUM,SET,45,0.047321,0.00234,0.1221,0.34917,HP_PTERYGIUM,0.99999
GOBP_REGULATION_OF_EPITHELIA...8,SET,6,0.15391,0.0027819,0.39719,0.3492,GOBP_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION,0.99999
GSE45365_BCELL_VS_CD8_TCELL_...2,SET,149,0.028124,0.0025234,0.072578,0.3492,GSE45365_BCELL_VS_CD8_TCELL_UP,0.99999
NABA_ECM_REGULATORS,SET,229,0.024463,0.0027151,0.06314,0.34922,NABA_ECM_REGULATORS,0.99999
HP_HYPOTENSION,SET,103,0.034935,0.0026094,0.090169,0.34922,HP_HYPOTENSION,0.99999
GOBP_DENDRITIC_CELL_DIFFEREN...,SET,45,0.053359,0.0026386,0.13777,0.34927,GOBP_DENDRITIC_CELL_DIFFERENTIATION,0.99999
MIR4423_5P,SET,26,0.062865,0.0023642,0.16234,0.34929,MIR4423_5P,0.99999
HP_ILEAL_ATRESIA,SET,4,0.17774,0.0026234,0.45905,0.34931,HP_ILEAL_ATRESIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...429,SET,79,0.036573,0.002394,0.094548,0.34945,GOBP_POSITIVE_REGULATION_OF_MACROAUTOPHAGY,0.99999
WILLIAMS_ESR1_TARGETS_DN,SET,6,0.1316,0.0023787,0.34033,0.3495,WILLIAMS_ESR1_TARGETS_DN,0.99999
TFCP2_TARGET_GENES,SET,76,0.037321,0.0023963,0.096539,0.34953,TFCP2_TARGET_GENES,0.99999
VANTVEER_BREAST_CANCER_BRCA1...2,SET,31,0.056134,0.0023048,0.14524,0.34957,VANTVEER_BREAST_CANCER_BRCA1_UP,0.99999
GOMF_OXIDATIVE_RNA_DEMETHYLA...,SET,5,0.13822,0.0022807,0.35763,0.34957,GOMF_OXIDATIVE_RNA_DEMETHYLASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_DOUBLE_ST...3,SET,18,0.073621,0.0023042,0.19052,0.3496,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.99999
GOBP_DE_NOVO_AMP_BIOSYNTHETI...,SET,6,0.12879,0.002328,0.33343,0.34965,GOBP_DE_NOVO_AMP_BIOSYNTHETIC_PROCESS,0.99999
DACOSTA_ERCC3_ALLELE_XPCS_VS...1,SET,31,0.058278,0.0023928,0.1509,0.34968,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,0.99999
HP_FAILURE_OF_ERUPTION_OF_PE...,SET,5,0.16881,0.0027856,0.4372,0.3497,HP_FAILURE_OF_ERUPTION_OF_PERMANENT_TEETH,0.99999
GSE13887_RESTING_VS_ACT_CD4_...1,SET,116,0.029609,0.0023462,0.076711,0.34976,GSE13887_RESTING_VS_ACT_CD4_TCELL_DN,0.99999
HELLER_HDAC_TARGETS_SILENCED...2,SET,370,0.017982,0.002527,0.046595,0.34978,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,0.99999
MIR6854_5P,SET,66,0.04057,0.0024282,0.10515,0.34981,MIR6854_5P,0.99999
GOBP_BRANCHED_CHAIN_AMINO_AC...3,SET,27,0.06327,0.0024246,0.16403,0.34985,GOBP_BRANCHED_CHAIN_AMINO_ACID_METABOLIC_PROCESS,0.99999
GSE27786_LIN_NEG_VS_CD8_TCEL...1,SET,185,0.023828,0.0023799,0.061802,0.34992,GSE27786_LIN_NEG_VS_CD8_TCELL_DN,0.99999
GOCC_TRIGLYCERIDE_RICH_PLASM...,SET,14,0.10067,0.002779,0.26114,0.34993,GOCC_TRIGLYCERIDE_RICH_PLASMA_LIPOPROTEIN_PARTICLE,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_MID...2,SET,136,0.031275,0.0026818,0.081123,0.34993,HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL,0.99999
HP_PSEUDOBULBAR_SIGNS,SET,28,0.061387,0.0023956,0.15935,0.35003,HP_PSEUDOBULBAR_SIGNS,0.99999
GOBP_REGULATION_OF_MACROPHAG...5,SET,23,0.071324,0.002523,0.18518,0.35006,GOBP_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,0.99999
GOBP_NUCLEAR_TRANSCRIBED_MRN...3,SET,6,0.12982,0.0023465,0.33714,0.3501,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_INDEPENDENT_DECAY,0.99999
GABP_B,SET,239,0.020616,0.002337,0.053552,0.35013,GABP_B,0.99999
GOMF_MITOGEN_ACTIVATED_PROTE...3,SET,16,0.075686,0.0022334,0.19664,0.35016,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_KINASE_BINDING,0.99999
GSE4590_PRE_BCELL_VS_LARGE_P...1,SET,147,0.025576,0.0022795,0.066448,0.35016,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN,0.99999
GSE14769_UNSTIM_VS_20MIN_LPS...2,SET,174,0.024928,0.0024154,0.064783,0.35019,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP,0.99999
ZNF740_TARGET_GENES,SET,1189,0.0098627,0.0024274,0.025635,0.35022,ZNF740_TARGET_GENES,0.99999
WP_10Q1121Q1123_COPY_NUMBER_...,SET,55,0.04434,0.0024233,0.11526,0.35023,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...2,SET,5,0.1299,0.0021435,0.33772,0.35025,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.99999
MODULE_323,SET,52,0.040564,0.0021558,0.10547,0.35027,MODULE_323,0.99999
GSE360_DC_VS_MAC_B_MALAYI_LO...2,SET,177,0.023924,0.0023378,0.062205,0.35027,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP,0.99999
HP_MYELOPROLIFERATIVE_DISORD...,SET,15,0.091351,0.0026102,0.2376,0.35032,HP_MYELOPROLIFERATIVE_DISORDER,0.99999
HP_OPPORTUNISTIC_FUNGAL_INFE...,SET,13,0.089222,0.0023734,0.23211,0.35035,HP_OPPORTUNISTIC_FUNGAL_INFECTION,0.99999
HUTTMANN_B_CLL_POOR_SURVIVAL...2,SET,240,0.021575,0.0024507,0.056146,0.35039,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,0.99999
GOBP_MEIOTIC_CELL_CYCLE_PROC...1,SET,189,0.022294,0.0022504,0.058046,0.35046,GOBP_MEIOTIC_CELL_CYCLE_PROCESS,0.99999
HP_PSORIASIFORM_DERMATITIS,SET,28,0.069353,0.0027064,0.18061,0.3505,HP_PSORIASIFORM_DERMATITIS,0.99999
KEGG_MEDICUS_REFERENCE_TLR5_...,SET,15,0.083412,0.0023833,0.2173,0.35054,KEGG_MEDICUS_REFERENCE_TLR5_NFKB_SIGNALING_PATHWAY,0.99999
MIR628_5P,SET,75,0.03985,0.0025419,0.10383,0.35056,MIR628_5P,0.99999
GOBP_AMINO_ACID_TRANSMEMBRAN...,SET,94,0.035827,0.0025571,0.093346,0.35056,GOBP_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,0.99999
GOMF_PRIMARY_MIRNA_BINDING,SET,9,0.10289,0.0022777,0.26809,0.35056,GOMF_PRIMARY_MIRNA_BINDING,0.99999
BIOCARTA_FIBRINOLYSIS_PATHWAY,SET,12,0.11308,0.00289,0.29465,0.35058,BIOCARTA_FIBRINOLYSIS_PATHWAY,0.99999
GOMF_FUCOSE_BINDING,SET,8,0.12438,0.002596,0.32413,0.35058,GOMF_FUCOSE_BINDING,0.99999
GSE14308_TH2_VS_NAIVE_CD4_TC...1,SET,178,0.023129,0.0022664,0.060288,0.35062,GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...9,SET,162,0.026119,0.0024427,0.068077,0.35062,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN,0.99999
GSE22886_CTRL_VS_LPS_24H_DC_...2,SET,178,0.023127,0.0022662,0.060294,0.35065,GSE22886_CTRL_VS_LPS_24H_DC_UP,0.99999
GSE5589_LPS_AND_IL10_VS_LPS_...5,SET,184,0.024536,0.002444,0.06399,0.3507,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.99999
REACTOME_ORGANIC_ANION_TRANS...2,SET,12,0.093491,0.0023895,0.24386,0.35072,REACTOME_ORGANIC_ANION_TRANSPORTERS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...13,SET,4,0.17454,0.0025761,0.45525,0.35072,GOBP_NEGATIVE_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.99999
GOMF_PROTEIN_SERINE_THREONIN...7,SET,42,0.051272,0.0024496,0.13378,0.35077,GOMF_PROTEIN_SERINE_THREONINE_TYROSINE_KINASE_ACTIVITY,0.99999
BIOCARTA_ARENRF2_PATHWAY,SET,20,0.080301,0.002649,0.20961,0.35083,BIOCARTA_ARENRF2_PATHWAY,0.99999
BIOCARTA_TOB1_PATHWAY,SET,19,0.080692,0.0025946,0.21065,0.35084,BIOCARTA_TOB1_PATHWAY,0.99999
HP_TALIPES_VALGUS,SET,17,0.084026,0.0025558,0.21937,0.35085,HP_TALIPES_VALGUS,0.99999
GSE10240_CTRL_VS_IL17_AND_IL...1,SET,190,0.023078,0.0023356,0.060251,0.35085,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.99999
CHEMELLO_SOLEUS_VS_EDL_MYOFI...2,SET,16,0.080699,0.0023814,0.21073,0.35088,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP,0.99999
GOCC_PERICHROMATIN_FIBRILS,SET,6,0.12462,0.0022526,0.32544,0.35089,GOCC_PERICHROMATIN_FIBRILS,0.99999
GOBP_EPIGENETIC_REGULATION_O...,SET,210,0.021943,0.0023334,0.057348,0.351,GOBP_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,0.99999
HP_FINGER_CLINODACTYLY,SET,387,0.01655,0.0023775,0.043257,0.35101,HP_FINGER_CLINODACTYLY,0.99999
MUNSHI_MULTIPLE_MYELOMA_DN,SET,9,0.10439,0.0023108,0.27287,0.35102,MUNSHI_MULTIPLE_MYELOMA_DN,0.99999
GOBP_SYNAPTIC_TRANSMISSION_G...3,SET,5,0.1593,0.0026286,0.41659,0.35109,GOBP_SYNAPTIC_TRANSMISSION_GLYCINERGIC,0.99999
RUTELLA_RESPONSE_TO_HGF_DN,SET,217,0.022806,0.0024648,0.059652,0.35112,RUTELLA_RESPONSE_TO_HGF_DN,0.99999
PID_CD40_PATHWAY,SET,30,0.063195,0.0025526,0.16531,0.35113,PID_CD40_PATHWAY,0.99999
GOBP_REGULATION_OF_GLUCOSE_M...,SET,88,0.035555,0.0024558,0.093006,0.35113,GOBP_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,0.99999
HP_IMMOTILE_SPERM,SET,14,0.090326,0.0024934,0.23632,0.35115,HP_IMMOTILE_SPERM,0.99999
GOCC_MRNA_EDITING_COMPLEX,SET,5,0.15069,0.0024865,0.39447,0.35123,GOCC_MRNA_EDITING_COMPLEX,0.99999
GOBP_HEMOGLOBIN_METABOLIC_PR...,SET,17,0.080576,0.0024508,0.21096,0.35125,GOBP_HEMOGLOBIN_METABOLIC_PROCESS,0.99999
HP_HYPOSMIA,SET,49,0.046857,0.0024176,0.12276,0.35134,HP_HYPOSMIA,0.99999
GSE34515_CD16_NEG_MONOCYTE_V...2,SET,180,0.024856,0.0024492,0.065122,0.35135,GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP,0.99999
GOBP_PROSTAGLANDIN_TRANSPORT,SET,29,0.069297,0.0027521,0.18158,0.35137,GOBP_PROSTAGLANDIN_TRANSPORT,0.99999
GNF2_CD97,SET,36,0.058972,0.0026089,0.15455,0.35139,GNF2_CD97,0.99999
GOBP_L_ALPHA_AMINO_ACID_TRAN...,SET,66,0.041854,0.0025051,0.1097,0.35141,GOBP_L_ALPHA_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,0.99999
GOBP_INTRINSIC_APOPTOTIC_SIG...2,SET,74,0.037056,0.0023479,0.097153,0.35145,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.99999
MIR663A,SET,17,0.082906,0.0025217,0.21737,0.35146,MIR663A,0.99999
GOBP_DOPAMINERGIC_NEURON_AXO...,SET,6,0.13395,0.0024213,0.35125,0.35147,GOBP_DOPAMINERGIC_NEURON_AXON_GUIDANCE,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...17,SET,8,0.1255,0.0026193,0.32928,0.35155,KEGG_MEDICUS_VARIANT_AMPLIFIED_REL_TO_TRANSCRIPTION,0.99999
GOBP_CYCLOOXYGENASE_PATHWAY,SET,9,0.10531,0.0023311,0.2763,0.35155,GOBP_CYCLOOXYGENASE_PATHWAY,0.99999
HP_THORACIC_SCOLIOSIS,SET,54,0.042372,0.0022947,0.11117,0.35155,HP_THORACIC_SCOLIOSIS,0.99999
CROONQUIST_STROMAL_STIMULATI...2,SET,49,0.05171,0.0026679,0.13568,0.35156,CROONQUIST_STROMAL_STIMULATION_UP,0.99999
HP_ABSENT_CIRCULATING_B_CELLS,SET,6,0.14279,0.002581,0.37472,0.35158,HP_ABSENT_CIRCULATING_B_CELLS,0.99999
ACOSTA_PROLIFERATION_INDEPEN...1,SET,105,0.032859,0.0024779,0.086243,0.3516,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,0.99999
GSE5589_UNSTIM_VS_180MIN_LPS...2,SET,183,0.023304,0.0023151,0.061162,0.3516,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...2,SET,9,0.11827,0.0026181,0.31044,0.35161,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15,0.99999
GOBP_LIMB_BUD_FORMATION,SET,9,0.11688,0.0025873,0.3068,0.35161,GOBP_LIMB_BUD_FORMATION,0.99999
GOBP_MONOAMINE_TRANSPORT,SET,72,0.040888,0.0025556,0.10732,0.35161,GOBP_MONOAMINE_TRANSPORT,0.99999
HP_ORTHOSTATIC_HYPOTENSION,SET,38,0.056522,0.0025689,0.14835,0.35161,HP_ORTHOSTATIC_HYPOTENSION,0.99999
GSE12392_CD8A_POS_VS_NEG_SPL...2,SET,189,0.023136,0.0023353,0.060732,0.35162,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP,0.99999
MIR106A_3P,SET,99,0.034698,0.0025412,0.091185,0.35178,MIR106A_3P,0.99999
GOMF_TOLL_LIKE_RECEPTOR_4_BI...,SET,5,0.13851,0.0022855,0.364,0.35179,GOMF_TOLL_LIKE_RECEPTOR_4_BINDING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...184,SET,30,0.058979,0.0023823,0.15501,0.3518,GOBP_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMAL_RESPONSE_TO_ENDO...,SET,130,0.02863,0.0024007,0.075317,0.35193,HP_ABNORMAL_RESPONSE_TO_ENDOCRINE_STIMULATION_TEST,0.99999
MIR520A_3P,SET,304,0.018742,0.0023918,0.049336,0.35201,MIR520A_3P,0.99999
KEGG_MEDICUS_REFERENCE_COPI_...,SET,23,0.058324,0.0020631,0.15357,0.35205,KEGG_MEDICUS_REFERENCE_COPI_VESICLE_FORMATION,0.99999
REACTOME_RESPIRATORY_SYNCYTI...1,SET,106,0.031359,0.002376,0.082573,0.35206,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,0.99999
ACTGCAG_MIR173P,SET,95,0.033167,0.0023798,0.087366,0.35211,ACTGCAG_MIR173P,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_FGF...,SET,45,0.049261,0.0024359,0.12977,0.35212,HE_LIM_SUN_FETAL_LUNG_C7_FGFBP2_POS_NEURAL_PROGENITOR_CELL,0.99999
KEGG_MEDICUS_REFERENCE_DOUBL...1,SET,4,0.13703,0.0020225,0.36109,0.35216,KEGG_MEDICUS_REFERENCE_DOUBLE_HOLLIDAY_JUNCTION_RESOLUTION,0.99999
GOBP_SUPRAMOLECULAR_FIBER_OR...,SET,775,0.012169,0.0024469,0.032064,0.35216,GOBP_SUPRAMOLECULAR_FIBER_ORGANIZATION,0.99999
HP_APLASIA_CUTIS_CONGENITA_O...1,SET,19,0.071641,0.0023036,0.18878,0.35216,HP_APLASIA_CUTIS_CONGENITA_OF_SCALP,0.99999
ONKEN_UVEAL_MELANOMA_UP,SET,718,0.01256,0.0024348,0.033105,0.3522,ONKEN_UVEAL_MELANOMA_UP,0.99999
GSE15330_LYMPHOID_MULTIPOTEN...6,SET,164,0.026603,0.0025032,0.070134,0.35223,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,0.99999
GSE360_L_DONOVANI_VS_L_MAJOR...3,SET,176,0.024114,0.0023497,0.063571,0.35223,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN,0.99999
GSE31082_DP_VS_CD8_SP_THYMOC...2,SET,180,0.022995,0.0022658,0.060638,0.35227,GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP,0.99999
HP_BICORONAL_SYNOSTOSIS,SET,9,0.097655,0.0021617,0.25754,0.35228,HP_BICORONAL_SYNOSTOSIS,0.99999
GOMF_FOLIC_ACID_BINDING,SET,12,0.093548,0.002391,0.24673,0.35229,GOMF_FOLIC_ACID_BINDING,0.99999
PETRETTO_BLOOD_PRESSURE_UP,SET,11,0.094645,0.0023161,0.24968,0.35232,PETRETTO_BLOOD_PRESSURE_UP,0.99999
MIR4688,SET,44,0.045805,0.0022398,0.12089,0.35238,MIR4688,0.99999
HP_CNS_HYPOMYELINATION,SET,79,0.034479,0.0022569,0.091015,0.35241,HP_CNS_HYPOMYELINATION,0.99999
TRAVAGLINI_LUNG_PROXIMAL_CIL...,SET,1476,0.0085703,0.0023304,0.022629,0.35244,TRAVAGLINI_LUNG_PROXIMAL_CILIATED_CELL,0.99999
HP_AXIAL_MUSCLE_WEAKNESS,SET,39,0.050995,0.0023479,0.13476,0.35256,HP_AXIAL_MUSCLE_WEAKNESS,0.99999
GSE20715_WT_VS_TLR4_KO_24H_O...2,SET,179,0.024232,0.0023811,0.064061,0.35262,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP,0.99999
GOBP_REGULATION_OF_MITOCHOND...5,SET,27,0.061049,0.0023395,0.16141,0.35263,GOBP_REGULATION_OF_MITOCHONDRIAL_FISSION,0.99999
GOBP_REGULATION_OF_PLASMA_LI...,SET,72,0.039429,0.0024644,0.10424,0.35263,GOBP_REGULATION_OF_PLASMA_LIPOPROTEIN_PARTICLE_LEVELS,0.99999
GOBP_POSITIVE_REGULATION_OF_...597,SET,10,0.1027,0.0023963,0.2717,0.35272,GOBP_POSITIVE_REGULATION_OF_PODOSOME_ASSEMBLY,0.99999
GOBP_MYOTUBE_CELL_DEVELOPMENT,SET,37,0.054518,0.0024451,0.14424,0.35273,GOBP_MYOTUBE_CELL_DEVELOPMENT,0.99999
GOCC_SPINDLE_POLE_CENTROSOME,SET,11,0.092557,0.002265,0.2449,0.35274,GOCC_SPINDLE_POLE_CENTROSOME,0.99999
MIR524_3P_MIR525_3P,SET,11,0.099961,0.0024462,0.26453,0.35276,MIR524_3P_MIR525_3P,0.99999
GOBP_TETRAPYRROLE_METABOLIC_...,SET,57,0.04135,0.0023005,0.10946,0.3528,GOBP_TETRAPYRROLE_METABOLIC_PROCESS,0.99999
GSE22886_TH1_VS_TH2_48H_ACT_...1,SET,182,0.024438,0.0024212,0.064692,0.35281,GSE22886_TH1_VS_TH2_48H_ACT_DN,0.99999
GSE16385_IFNG_TNF_VS_IL4_STI...2,SET,174,0.023896,0.0023154,0.063269,0.35283,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,0.99999
MIR596,SET,29,0.060466,0.0024014,0.16011,0.35285,MIR596,0.99999
SINGH_NFE2L2_TARGETS,SET,13,0.097255,0.0025871,0.25756,0.35287,SINGH_NFE2L2_TARGETS,0.99999
GOBP_LEUKOTRIENE_TRANSPORT,SET,7,0.12999,0.0025379,0.34449,0.35296,GOBP_LEUKOTRIENE_TRANSPORT,0.99999
GOCC_NUCLEAR_SPECK,SET,374,0.015807,0.0022331,0.041896,0.35298,GOCC_NUCLEAR_SPECK,0.99999
GOMF_THIOLESTER_HYDROLASE_AC...,SET,40,0.048527,0.0022627,0.12865,0.35301,GOMF_THIOLESTER_HYDROLASE_ACTIVITY,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HN...5,SET,197,0.024211,0.0024946,0.064195,0.35303,MANNO_MIDBRAIN_NEUROTYPES_HNPROG,0.99999
DARWICHE_SQUAMOUS_CELL_CARCI...2,SET,136,0.027601,0.0023668,0.073197,0.35306,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,0.99999
GOBP_EPIDERMIS_DEVELOPMENT,SET,356,0.019144,0.0026399,0.050769,0.35306,GOBP_EPIDERMIS_DEVELOPMENT,0.99999
BIOCARTA_BARR_MAPK_PATHWAY,SET,13,0.1001,0.0026627,0.26548,0.35307,BIOCARTA_BARR_MAPK_PATHWAY,0.99999
GSE5099_MONOCYTE_VS_CLASSICA...1,SET,177,0.023605,0.0023066,0.062606,0.35307,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN,0.99999
GSE19888_CTRL_VS_A3R_ACTIVAT...2,SET,179,0.021868,0.0021488,0.058013,0.35311,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP,0.99999
HP_CLEFT_PALATE,SET,510,0.014302,0.0023505,0.037949,0.35313,HP_CLEFT_PALATE,0.99999
GOBP_REGULATION_OF_PROTEIN_L...9,SET,12,0.093503,0.0023898,0.24813,0.35315,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_ENDOSOME,0.99999
LAKE_ADULT_KIDNEY_C14_DISTAL...,SET,179,0.02689,0.0026422,0.071401,0.35324,LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE,0.99999
CASTELLANO_HRAS_TARGETS_DN,SET,4,0.15143,0.002235,0.40216,0.35326,CASTELLANO_HRAS_TARGETS_DN,0.99999
GOBP_EMBRYONIC_HEMOPOIESIS,SET,23,0.069092,0.002444,0.1835,0.35326,GOBP_EMBRYONIC_HEMOPOIESIS,0.99999
SEITZ_NEOPLASTIC_TRANSFORMAT...2,SET,67,0.04387,0.0026455,0.11652,0.35327,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,0.99999
GOBP_REGULATION_OF_TOLL_LIKE...5,SET,11,0.10414,0.0025485,0.27666,0.3533,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.99999
MIR501_5P,SET,126,0.029051,0.0023985,0.077185,0.35332,MIR501_5P,0.99999
GSE3982_EOSINOPHIL_VS_MAC_DN,SET,177,0.023884,0.0023339,0.063456,0.35332,GSE3982_EOSINOPHIL_VS_MAC_DN,0.99999
GOBP_INTERFERON_MEDIATED_SIG...,SET,98,0.034322,0.002501,0.091204,0.35334,GOBP_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...741,SET,152,0.027295,0.0024734,0.072544,0.35337,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,0.99999
GOBP_SKELETAL_MUSCLE_SATELLI...2,SET,11,0.092641,0.002267,0.24626,0.35339,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_DIFFERENTIATION,0.99999
GAUCHER_PBMC_YF_VAX_STAMARIL...9,SET,31,0.054524,0.0022387,0.14496,0.35341,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_DN,0.99999
AFFAR_YY1_TARGETS_DN,SET,236,0.021302,0.0023997,0.056638,0.35342,AFFAR_YY1_TARGETS_DN,0.99999
HP_ABNORMAL_CIRCULATING_GLUT...1,SET,11,0.083818,0.0020511,0.2229,0.35345,HP_ABNORMAL_CIRCULATING_GLUTAMINE_CONCENTRATION,0.99999
TTTNNANAGCYR_UNKNOWN,SET,79,0.038157,0.0024977,0.10148,0.35346,TTTNNANAGCYR_UNKNOWN,0.99999
REACTOME_CASPASE_ACTIVATION_...1,SET,16,0.083473,0.0024632,0.22202,0.35347,REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND,0.99999
GSE7218_UNSTIM_VS_ANTIGEN_ST...3,SET,104,0.030927,0.0023212,0.082256,0.35347,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_DN,0.99999
GOBP_REGULATION_OF_T_CELL_CO...,SET,4,0.17934,0.002647,0.47733,0.35357,GOBP_REGULATION_OF_T_CELL_COSTIMULATION,0.99999
GSE32901_TH1_VS_TH17_ENRICHE...2,SET,160,0.025179,0.0023404,0.067016,0.35357,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP,0.99999
SHEPARD_BMYB_TARGETS,SET,71,0.037695,0.0023397,0.10039,0.35365,SHEPARD_BMYB_TARGETS,0.99999
PID_NECTIN_PATHWAY,SET,26,0.066018,0.0024827,0.17581,0.35365,PID_NECTIN_PATHWAY,0.99999
REACTOME_SIGNALING_BY_NOTCH1...3,SET,7,0.11086,0.0021644,0.29525,0.35365,REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT,0.99999
MIR650,SET,108,0.030608,0.0023407,0.081512,0.35365,MIR650,0.99999
MORF_TNFRSF6,SET,146,0.027558,0.0024478,0.073398,0.35366,MORF_TNFRSF6,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...44,SET,5,0.15446,0.0025488,0.41142,0.35367,HP_APLASIA_HYPOPLASIA_OF_THE_MUSCULATURE_OF_THE_PELVIS,0.99999
BIOCARTA_FLUMAZENIL_PATHWAY,SET,8,0.1223,0.0025526,0.32592,0.35373,BIOCARTA_FLUMAZENIL_PATHWAY,0.99999
HP_REDUCED_PROGRESSIVE_SPERM...,SET,15,0.07245,0.0020701,0.19313,0.35378,HP_REDUCED_PROGRESSIVE_SPERM_MOTILITY,0.99999
REACTOME_FGFRL1_MODULATION_O...,SET,13,0.1009,0.002684,0.26898,0.35379,REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING,0.99999
GOBP_VOCALIZATION_BEHAVIOR,SET,15,0.090928,0.0025981,0.24243,0.35381,GOBP_VOCALIZATION_BEHAVIOR,0.99999
MIR1296_5P,SET,26,0.064248,0.0024161,0.17131,0.35382,MIR1296_5P,0.99999
MIR511_5P,SET,291,0.01905,0.0023793,0.050795,0.35382,MIR511_5P,0.99999
GOBP_FLAVONE_METABOLIC_PROCE...,SET,6,0.12277,0.0022191,0.32736,0.35382,GOBP_FLAVONE_METABOLIC_PROCESS,0.99999
WIKMAN_ASBESTOS_LUNG_CANCER_...2,SET,15,0.080911,0.0023119,0.21579,0.35385,WIKMAN_ASBESTOS_LUNG_CANCER_UP,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...11,SET,36,0.052198,0.0023092,0.13923,0.35387,GOBP_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.99999
HASINA_NOL7_TARGETS_DN,SET,13,0.095771,0.0025477,0.2555,0.35389,HASINA_NOL7_TARGETS_DN,0.99999
GOBP_KERATINOCYTE_APOPTOTIC_...,SET,7,0.12351,0.0024113,0.32952,0.3539,GOBP_KERATINOCYTE_APOPTOTIC_PROCESS,0.99999
GOBP_REGULATION_OF_VOLTAGE_G...1,SET,21,0.074085,0.0025042,0.19765,0.3539,GOBP_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.99999
MORF_PSMF1,SET,159,0.024343,0.0022556,0.064971,0.35396,MORF_PSMF1,0.99999
HP_MILIA,SET,16,0.085947,0.0025362,0.2294,0.35396,HP_MILIA,0.99999
HP_PILI_CANALICULI,SET,5,0.16641,0.002746,0.44419,0.35397,HP_PILI_CANALICULI,0.99999
REACTOME_HIGHLY_CALCIUM_PERM...1,SET,9,0.13311,0.0029466,0.35536,0.35399,REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS,0.99999
GSE24634_IL4_VS_CTRL_TREATED...8,SET,177,0.023313,0.0022781,0.062253,0.35402,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP,0.99999
GOBP_LIMBIC_SYSTEM_DEVELOPME...,SET,118,0.030953,0.0024736,0.082686,0.35407,GOBP_LIMBIC_SYSTEM_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_NEURON_PR...1,SET,14,0.084597,0.0023353,0.22597,0.35407,GOBP_REGULATION_OF_NEURON_PROJECTION_ARBORIZATION,0.99999
HU_FETAL_RETINA_MICROGLIA,SET,338,0.018236,0.0024515,0.048718,0.35409,HU_FETAL_RETINA_MICROGLIA,0.99999
GOMF_CAMP_BINDING,SET,23,0.069423,0.0024557,0.1855,0.35411,GOMF_CAMP_BINDING,0.99999
DLX2_TARGET_GENES,SET,217,0.022369,0.0024175,0.059787,0.35415,DLX2_TARGET_GENES,0.99999
GOMF_INOSITOL_PHOSPHATE_KINA...,SET,11,0.082405,0.0020165,0.22038,0.35423,GOMF_INOSITOL_PHOSPHATE_KINASE_ACTIVITY,0.99999
GOBP_MYOTUBE_DIFFERENTIATION,SET,117,0.030931,0.0024614,0.082743,0.35427,GOBP_MYOTUBE_DIFFERENTIATION,0.99999
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...9,SET,65,0.035797,0.0021263,0.095772,0.35429,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE,0.99999
GSE37301_HEMATOPOIETIC_STEM_...8,SET,165,0.024673,0.0023285,0.066017,0.35431,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP,0.99999
HP_SPASTIC_DIPLEGIA,SET,29,0.060231,0.002392,0.16119,0.35433,HP_SPASTIC_DIPLEGIA,0.99999
PPARGC1A_TARGET_GENES,SET,79,0.034564,0.0022625,0.092509,0.35434,PPARGC1A_TARGET_GENES,0.99999
ZNF175_TARGET_GENES,SET,627,0.012729,0.0023119,0.034118,0.35454,ZNF175_TARGET_GENES,0.99999
MODULE_456,SET,102,0.032366,0.0024059,0.086769,0.35457,MODULE_456,0.99999
GOMF_POLY_ADP_D_RIBOSE_MODIF...,SET,2,0.23482,0.0024508,0.6298,0.35463,GOMF_POLY_ADP_D_RIBOSE_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.99999
SU_PANCREAS,SET,39,0.050433,0.0023221,0.1353,0.35467,SU_PANCREAS,0.99999
GOBP_TRANSMEMBRANE_TRANSPORT,SET,1409,0.0091895,0.0024462,0.024654,0.35467,GOBP_TRANSMEMBRANE_TRANSPORT,0.99999
GOMF_CYCLASE_ACTIVATOR_ACTIV...,SET,11,0.10635,0.0026025,0.28531,0.35467,GOMF_CYCLASE_ACTIVATOR_ACTIVITY,0.99999
GSE43863_TH1_VS_LY6C_LOW_CXC...1,SET,184,0.022998,0.0022908,0.061698,0.35467,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,0.99999
GOLUB_ALL_VS_AML_UP,SET,24,0.064822,0.0023423,0.17397,0.35473,GOLUB_ALL_VS_AML_UP,0.99999
GSE27241_WT_CTRL_VS_DIGOXIN_...2,SET,161,0.025899,0.0024148,0.069523,0.35475,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,0.99999
GSE22196_HEALTHY_VS_OBESE_MO...1,SET,182,0.023602,0.0023383,0.063358,0.35476,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN,0.99999
GOBP_CELLULAR_METABOLIC_COMP...,SET,30,0.062741,0.0025342,0.16843,0.35477,GOBP_CELLULAR_METABOLIC_COMPOUND_SALVAGE,0.99999
GSE15330_HSC_VS_GRANULOCYTE_...3,SET,173,0.024639,0.0023806,0.066184,0.35484,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,0.99999
HP_RENAL_ANGIOMYOLIPOMA,SET,5,0.12916,0.0021313,0.34702,0.35487,HP_RENAL_ANGIOMYOLIPOMA,0.99999
GOBP_POSITIVE_REGULATION_OF_...703,SET,8,0.12949,0.0027025,0.34826,0.35502,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT,0.99999
MIR4516,SET,271,0.019446,0.0023451,0.052312,0.35505,MIR4516,0.99999
MIR5590_5P,SET,106,0.030774,0.0023316,0.082791,0.35506,MIR5590_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...223,SET,57,0.038453,0.0021393,0.10348,0.3551,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,0.99999
HP_SYNOSTOSIS_OF_JOINTS,SET,171,0.024906,0.0023925,0.067034,0.35512,HP_SYNOSTOSIS_OF_JOINTS,0.99999
GOBP_ORGANELLE_MEMBRANE_FUSI...,SET,114,0.029015,0.0022793,0.078101,0.35513,GOBP_ORGANELLE_MEMBRANE_FUSION,0.99999
GOCC_COHESIN_COMPLEX,SET,8,0.11334,0.0023656,0.30508,0.35513,GOCC_COHESIN_COMPLEX,0.99999
GSE17721_0.5H_VS_4H_GARDIQUI...2,SET,172,0.023006,0.0022164,0.061941,0.35516,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_UP,0.99999
GOMF_O_ACYLTRANSFERASE_ACTIV...,SET,47,0.047067,0.0023784,0.12674,0.35518,GOMF_O_ACYLTRANSFERASE_ACTIVITY,0.99999
GOBP_MULTICELLULAR_ORGANISMA...4,SET,33,0.062029,0.0026275,0.16708,0.35523,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_WATER_HOMEOSTASIS,0.99999
HP_FACIAL_DIPLEGIA,SET,39,0.048563,0.002236,0.13085,0.35527,HP_FACIAL_DIPLEGIA,0.99999
HP_HYPOKETOTIC_HYPOGLYCEMIA,SET,14,0.08371,0.0023108,0.22562,0.35531,HP_HYPOKETOTIC_HYPOGLYCEMIA,0.99999
MIR6801_3P,SET,48,0.047129,0.0024067,0.12703,0.35532,MIR6801_3P,0.99999
HP_ABNORMAL_LEUKOCYTE_PHYSIO...,SET,263,0.01963,0.0023326,0.052912,0.35533,HP_ABNORMAL_LEUKOCYTE_PHYSIOLOGY,0.99999
HP_EYELID_COLOBOMA,SET,34,0.052263,0.0022471,0.14088,0.35533,HP_EYELID_COLOBOMA,0.99999
FOURNIER_ACINAR_DEVELOPMENT_...2,SET,18,0.083861,0.0026246,0.2261,0.35536,FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,0.99999
MANNE_COVID19_COMBINED_COHOR...2,SET,161,0.024771,0.0023096,0.066798,0.35538,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,0.99999
HP_ABNORMAL_HEAD_MOVEMENTS,SET,33,0.055324,0.0023435,0.14919,0.35538,HP_ABNORMAL_HEAD_MOVEMENTS,0.99999
GOBP_HEMATOPOIETIC_PROGENITO...,SET,128,0.028693,0.0023876,0.077401,0.35543,GOBP_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,0.99999
GOCC_BASEMENT_MEMBRANE,SET,85,0.036853,0.0025019,0.099437,0.35546,GOCC_BASEMENT_MEMBRANE,0.99999
HP_DECREASED_ACTIVITY_OF_MIT...4,SET,41,0.046058,0.0021742,0.1243,0.3555,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_III,0.99999
HP_PULP_CALCIFICATION,SET,7,0.14107,0.0027542,0.38078,0.35551,HP_PULP_CALCIFICATION,0.99999
HP_MYDRIASIS,SET,16,0.079878,0.0023571,0.21566,0.35555,HP_MYDRIASIS,0.99999
GSE17721_LPS_VS_CPG_6H_BMDC_...2,SET,175,0.023838,0.0023163,0.064357,0.35555,GSE17721_LPS_VS_CPG_6H_BMDC_UP,0.99999
GSE17721_LPS_VS_POLYIC_24H_B...1,SET,178,0.023349,0.002288,0.06306,0.3556,GSE17721_LPS_VS_POLYIC_24H_BMDC_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_MU...,SET,8,0.094099,0.0019639,0.25418,0.35562,GOBP_CELLULAR_RESPONSE_TO_MURAMYL_DIPEPTIDE,0.99999
GOBP_RESPONSE_TO_PEPTIDOGLYC...,SET,11,0.093277,0.0022826,0.25197,0.35562,GOBP_RESPONSE_TO_PEPTIDOGLYCAN,0.99999
HP_VENTRICULAR_HYPERTROPHY,SET,138,0.025582,0.0022096,0.069103,0.35562,HP_VENTRICULAR_HYPERTROPHY,0.99999
GOBP_REGULATION_OF_GLUCOSE_I...,SET,52,0.045496,0.0024179,0.12291,0.35564,GOBP_REGULATION_OF_GLUCOSE_IMPORT,0.99999
GOBP_NAD_BIOSYNTHESIS_VIA_NI...,SET,9,0.10897,0.0024123,0.29444,0.35565,GOBP_NAD_BIOSYNTHESIS_VIA_NICOTINAMIDE_RIBOSIDE_SALVAGE_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...3,SET,54,0.041017,0.0022213,0.11083,0.35565,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,0.99999
GTTNYYNNGGTNA_UNKNOWN,SET,80,0.035061,0.0023095,0.094746,0.35567,GTTNYYNNGGTNA_UNKNOWN,0.99999
GOMF_POTASSIUM_ION_BINDING,SET,13,0.089304,0.0023756,0.24136,0.3557,GOMF_POTASSIUM_ION_BINDING,0.99999
MARTINEZ_RESPONSE_TO_TRABECT...2,SET,254,0.018716,0.0021862,0.050591,0.35571,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...196,SET,14,0.095219,0.0026285,0.25738,0.35571,GOBP_POSITIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,0.99999
HAND1E47_01,SET,245,0.02129,0.0024431,0.057574,0.35577,HAND1E47_01,0.99999
GOCC_NUCLEAR_CYCLIN_DEPENDEN...,SET,13,0.067037,0.0017833,0.18136,0.35583,GOCC_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,0.99999
GOMF_MOLECULAR_ADAPTOR_ACTIV...,SET,1031,0.0097791,0.0022515,0.026468,0.35589,GOMF_MOLECULAR_ADAPTOR_ACTIVITY,0.99999
GSE37416_CTRL_VS_48H_F_TULAR...1,SET,167,0.022796,0.0021643,0.061697,0.35589,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
HP_ABNORMALITY_OF_THE_DISTAL...1,SET,22,0.070657,0.0024445,0.19129,0.35593,HP_ABNORMALITY_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,0.99999
GOBP_PROTEIN_DEUBIQUITINATIO...,SET,5,0.14242,0.0023501,0.38568,0.35596,GOBP_PROTEIN_DEUBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
MIR4704_3P,SET,124,0.029051,0.0023795,0.078704,0.35603,MIR4704_3P,0.99999
GSE9988_LOW_LPS_VS_VEHICLE_T...1,SET,182,0.022631,0.0022421,0.061314,0.35603,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...532,SET,144,0.026948,0.0023773,0.073027,0.35606,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,0.99999
GSE11961_FOLLICULAR_BCELL_VS...11,SET,185,0.022612,0.0022585,0.06129,0.35609,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN,0.99999
KEGG_MEDICUS_REFERENCE_CA2_P...2,SET,14,0.084451,0.0023313,0.22894,0.35611,KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY,0.99999
BIOCARTA_IL17_PATHWAY,SET,15,0.092096,0.0026314,0.24971,0.35614,BIOCARTA_IL17_PATHWAY,0.99999
GSE24726_WT_VS_E2_2_KO_PDC_DN,SET,180,0.022835,0.00225,0.061922,0.35615,GSE24726_WT_VS_E2_2_KO_PDC_DN,0.99999
GOMF_GTPASE_BINDING,SET,283,0.018336,0.0022589,0.049743,0.35621,GOMF_GTPASE_BINDING,0.99999
GSE37605_TREG_VS_TCONV_C57BL...1,SET,158,0.025686,0.0023726,0.069685,0.35622,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_DN,0.99999
MCGARVEY_SILENCED_BY_METHYLA...,SET,41,0.053989,0.0025486,0.14648,0.35623,MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER,0.99999
GOMF_HISTONE_H3_ACETYLTRANSF...,SET,15,0.078962,0.0022562,0.21424,0.35623,GOMF_HISTONE_H3_ACETYLTRANSFERASE_ACTIVITY,0.99999
HP_ABNORMALITY_OF_REPRODUCTI...,SET,755,0.011594,0.0023023,0.031462,0.35625,HP_ABNORMALITY_OF_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,0.99999
HP_CHRONIC_AXONAL_NEUROPATHY,SET,7,0.13822,0.0026986,0.37515,0.35627,HP_CHRONIC_AXONAL_NEUROPATHY,0.99999
GSE24634_TEFF_VS_TCONV_DAY10...1,SET,185,0.023785,0.0023757,0.064562,0.35628,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN,0.99999
AP1_Q2_01,SET,247,0.020475,0.002359,0.055608,0.35636,AP1_Q2_01,0.99999
GSE23568_ID3_TRANSDUCED_VS_I...2,SET,187,0.022887,0.0022981,0.062175,0.3564,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP,0.99999
WP_AMINO_ACID_METABOLISM_PAT...,SET,6,0.1345,0.0024312,0.36546,0.35643,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,0.99999
BIOCARTA_PLATELETAPP_PATHWAY,SET,11,0.1111,0.0027187,0.30208,0.35652,BIOCARTA_PLATELETAPP_PATHWAY,0.99999
HP_BILIARY_TRACT_NEOPLASM,SET,15,0.082515,0.0023577,0.22436,0.35652,HP_BILIARY_TRACT_NEOPLASM,0.99999
HP_HIGH_PALATE,SET,672,0.012088,0.00227,0.032886,0.3566,HP_HIGH_PALATE,0.99999
ACAACTT_MIR382,SET,62,0.038973,0.0022611,0.10605,0.35662,ACAACTT_MIR382,0.99999
GOBP_MICROTUBULE_DEPOLYMERIZ...,SET,41,0.047709,0.0022521,0.12985,0.35665,GOBP_MICROTUBULE_DEPOLYMERIZATION,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...3,SET,23,0.056867,0.0020116,0.15479,0.35667,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME,0.99999
GSE10273_LOW_IL7_VS_HIGH_IL7...1,SET,178,0.022694,0.0022238,0.061795,0.35672,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,0.99999
GSE3982_EOSINOPHIL_VS_EFF_ME...1,SET,171,0.02341,0.0022488,0.063746,0.35672,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,0.99999
LIM_MAMMARY_LUMINAL_PROGENIT...2,SET,57,0.043074,0.0023964,0.11742,0.35688,LIM_MAMMARY_LUMINAL_PROGENITOR_UP,0.99999
WP_ARACHIDONATE_EPOXYGENASE_...,SET,7,0.10833,0.0021149,0.29538,0.35691,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,0.99999
GSE19772_HCMV_INFL_VS_HCMV_I...1,SET,181,0.022776,0.0022504,0.062143,0.35699,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,0.99999
GSE2770_TGFB_AND_IL4_VS_TGFB...6,SET,177,0.023494,0.0022958,0.064115,0.35702,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.99999
GSE16385_UNTREATED_VS_12H_IL...1,SET,171,0.023818,0.002288,0.065044,0.35712,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN,0.99999
GSE22601_IMMATURE_CD4_SINGLE...4,SET,184,0.023503,0.0023412,0.064184,0.35712,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.99999
GOBP_DENDRITIC_TRANSPORT,SET,12,0.090888,0.002323,0.24823,0.35713,GOBP_DENDRITIC_TRANSPORT,0.99999
MIR6876_5P,SET,204,0.02215,0.002322,0.060513,0.35717,MIR6876_5P,0.99999
GSE7460_TCONV_VS_TREG_LN_DN,SET,181,0.024195,0.0023906,0.066125,0.35722,GSE7460_TCONV_VS_TREG_LN_DN,0.99999
GSE25123_IL4_VS_IL4_AND_ROSI...1,SET,177,0.022775,0.0022255,0.062252,0.35724,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.99999
GOMF_PHOSPHATIDYLINOSITOL_MO...,SET,11,0.079815,0.0019532,0.2182,0.35726,GOMF_PHOSPHATIDYLINOSITOL_MONOPHOSPHATE_PHOSPHATASE_ACTIVITY,0.99999
HP_ONYCHOGRYPOSIS_OF_TOENAILS,SET,7,0.12044,0.0023515,0.32925,0.35726,HP_ONYCHOGRYPOSIS_OF_TOENAILS,0.99999
HP_CEREBRAL_HYPOMYELINATION,SET,25,0.055545,0.0020483,0.15186,0.35728,HP_CEREBRAL_HYPOMYELINATION,0.99999
MIR4730,SET,6,0.14764,0.0026687,0.40371,0.35729,MIR4730,0.99999
GSE17974_1.5H_VS_72H_IL4_AND...2,SET,172,0.024515,0.0023617,0.067056,0.35734,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,0.99999
GOBP_RENAL_FILTRATION,SET,27,0.06809,0.0026093,0.18636,0.35742,GOBP_RENAL_FILTRATION,0.99999
KEGG_MEDICUS_REFERENCE_NOTCH...1,SET,9,0.11378,0.0025186,0.31159,0.3575,KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION,0.99999
GOMF_PHOSPHATIDYLINOSITOL_3_...4,SET,25,0.060937,0.0022472,0.16689,0.35751,GOMF_PHOSPHATIDYLINOSITOL_3_4_BISPHOSPHATE_BINDING,0.99999
SHAFFER_IRF4_TARGETS_IN_PLAS...,SET,65,0.041471,0.0024633,0.11361,0.35755,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_SMG...1,SET,347,0.018171,0.0024745,0.049784,0.35756,HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL,0.99999
MIR302D_5P,SET,183,0.023338,0.0023184,0.06395,0.35758,MIR302D_5P,0.99999
FAN_EMBRYONIC_CTX_BRAIN_MYEL...,SET,121,0.030234,0.0024465,0.082859,0.3576,FAN_EMBRYONIC_CTX_BRAIN_MYELOID,0.99999
MIR3660,SET,96,0.032749,0.002362,0.089774,0.35764,MIR3660,0.99999
JINESH_BLEBBISHIELD_TRANSFOR...1,SET,247,0.019697,0.0022693,0.054037,0.35774,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,0.99999
WP_2Q37_COPY_NUMBER_VARIATIO...,SET,124,0.036839,0.0030174,0.10108,0.35776,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GSE18281_SUBCAPSULAR_VS_PERI...2,SET,182,0.022993,0.0022781,0.063094,0.35777,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP,0.99999
MIR361_3P,SET,81,0.034805,0.0023068,0.095525,0.3578,MIR361_3P,0.99999
GOBP_DETECTION_OF_OTHER_ORGA...,SET,17,0.079486,0.0024177,0.21817,0.35781,GOBP_DETECTION_OF_OTHER_ORGANISM,0.99999
GSE32986_UNSTIM_VS_GMCSF_AND...2,SET,180,0.022277,0.002195,0.061147,0.35781,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.99999
GSE27786_CD4_TCELL_VS_NKCELL...2,SET,183,0.022565,0.0022417,0.061941,0.35782,GSE27786_CD4_TCELL_VS_NKCELL_UP,0.99999
CHEN_ETV5_TARGETS_SERTOLI,SET,24,0.068997,0.0024931,0.18942,0.35783,CHEN_ETV5_TARGETS_SERTOLI,0.99999
BARIS_THYROID_CANCER_DN,SET,52,0.041855,0.0022244,0.11491,0.35785,BARIS_THYROID_CANCER_DN,0.99999
HP_OPTIC_DISC_HYPOPLASIA,SET,16,0.082505,0.0024347,0.22655,0.35786,HP_OPTIC_DISC_HYPOPLASIA,0.99999
HP_REDUCED_DELAYED_HYPERSENS...,SET,4,0.15901,0.0023469,0.43663,0.35787,HP_REDUCED_DELAYED_HYPERSENSITIVITY,0.99999
GSE6269_FLU_VS_STREP_PNEUMO_...2,SET,162,0.024312,0.0022738,0.066784,0.35791,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP,0.99999
RUAN_RESPONSE_TO_TROGLITAZON...2,SET,24,0.07237,0.002615,0.19893,0.35801,RUAN_RESPONSE_TO_TROGLITAZONE_UP,0.99999
GOBP_ALKANESULFONATE_TRANSME...,SET,8,0.12506,0.0026101,0.34377,0.35801,GOBP_ALKANESULFONATE_TRANSMEMBRANE_TRANSPORT,0.99999
MIR609,SET,30,0.056053,0.0022641,0.15414,0.35806,MIR609,0.99999
GOBP_REGULATION_OF_MODIFICAT...3,SET,12,0.086433,0.0022091,0.23774,0.3581,GOBP_REGULATION_OF_MODIFICATION_OF_SYNAPTIC_STRUCTURE,0.99999
HOLLMANN_APOPTOSIS_VIA_CD40_...2,SET,184,0.023343,0.0023252,0.064217,0.35812,HOLLMANN_APOPTOSIS_VIA_CD40_UP,0.99999
CHOW_RASSF1_TARGETS_UP,SET,22,0.059742,0.0020669,0.16439,0.35815,CHOW_RASSF1_TARGETS_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_MID...,SET,50,0.046365,0.0024164,0.1276,0.35817,HE_LIM_SUN_FETAL_LUNG_C3_MID_CAP_CELL,0.99999
TSAI_DNAJB4_TARGETS_UP,SET,12,0.09045,0.0023118,0.24899,0.3582,TSAI_DNAJB4_TARGETS_UP,0.99999
OLSSON_E2F3_TARGETS_DN,SET,33,0.058169,0.002464,0.16016,0.35823,OLSSON_E2F3_TARGETS_DN,0.99999
GOMF_ALDEHYDE_DEHYDROGENASE_...,SET,17,0.074045,0.0022522,0.20387,0.35823,GOMF_ALDEHYDE_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,0.99999
MIR643,SET,58,0.040093,0.00225,0.1104,0.35824,MIR643,0.99999
HP_INTERMITTENT_CLAUDICATION,SET,8,0.10676,0.0022283,0.29397,0.35824,HP_INTERMITTENT_CLAUDICATION,0.99999
CARRILLOREIXACH_MRS3_VS_LOWE...1,SET,144,0.028008,0.0024708,0.077127,0.35825,CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN,0.99999
HP_ABNORMAL_HEAD_BLOOD_VESSE...,SET,64,0.041365,0.0024381,0.11391,0.35826,HP_ABNORMAL_HEAD_BLOOD_VESSEL_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_POLYAMINE...,SET,5,0.11312,0.0018666,0.31164,0.35831,GOBP_REGULATION_OF_POLYAMINE_TRANSMEMBRANE_TRANSPORT,0.99999
GOMF_ORNITHINE_DECARBOXYLASE...,SET,5,0.11312,0.0018666,0.31164,0.35831,GOMF_ORNITHINE_DECARBOXYLASE_REGULATOR_ACTIVITY,0.99999
GSE3982_BASOPHIL_VS_TH2_DN,SET,179,0.022747,0.0022352,0.062673,0.35832,GSE3982_BASOPHIL_VS_TH2_DN,0.99999
MEBARKI_HCC_PROGENITOR_WNT_D...2,SET,25,0.070122,0.0025859,0.19324,0.35835,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...3,SET,169,0.024506,0.0023405,0.067536,0.35835,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN,0.99999
MARTINELLI_IMMATURE_NEUTROPH...2,SET,8,0.12759,0.0026629,0.35167,0.35838,MARTINELLI_IMMATURE_NEUTROPHIL_UP,0.99999
REACTOME_SENESCENCE_ASSOCIAT...,SET,49,0.044636,0.002303,0.12313,0.35848,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,0.99999
WP_SENESCENCEASSOCIATED_SECR...,SET,49,0.044636,0.002303,0.12313,0.35848,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,0.99999
GOBP_REGULATION_OF_SODIUM_DE...,SET,5,0.14661,0.0024192,0.40453,0.35852,GOBP_REGULATION_OF_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT,0.99999
GOBP_SERTOLI_CELL_DEVELOPMENT,SET,12,0.085508,0.0021855,0.23607,0.3586,GOBP_SERTOLI_CELL_DEVELOPMENT,0.99999
MODULE_241,SET,69,0.039969,0.0024458,0.11041,0.35868,MODULE_241,0.99999
GOBP_REGULATION_OF_IMMUNE_SY...,SET,1404,0.0088139,0.0023424,0.024352,0.3587,GOBP_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,0.99999
GOMF_RETINOL_BINDING,SET,14,0.087158,0.002406,0.24085,0.35872,GOMF_RETINOL_BINDING,0.99999
JINESH_BLEBBISHIELD_TRANSFOR...2,SET,154,0.026959,0.0024588,0.074577,0.35887,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,0.99999
REACTOME_RHOV_GTPASE_CYCLE,SET,36,0.050359,0.0022279,0.13932,0.35888,REACTOME_RHOV_GTPASE_CYCLE,0.99999
GOBP_REGULATION_OF_TOLL_LIKE...3,SET,28,0.058407,0.0022793,0.16158,0.35888,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.99999
GOBP_PROTEIN_DEMETHYLATION,SET,8,0.088305,0.001843,0.24436,0.35891,GOBP_PROTEIN_DEMETHYLATION,0.99999
HP_MILD_MICROCEPHALY,SET,17,0.074354,0.0022616,0.20576,0.35892,HP_MILD_MICROCEPHALY,0.99999
GSE43957_UNTREATED_VS_NACL_T...2,SET,181,0.022351,0.0022084,0.061852,0.35892,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,0.99999
GOBP_OLIGOSACCHARIDE_BIOSYNT...,SET,29,0.061926,0.0024593,0.1714,0.35894,GOBP_OLIGOSACCHARIDE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_COMPLEMENT_ACTIVATION_L...,SET,10,0.10792,0.0025181,0.29884,0.359,GOBP_COMPLEMENT_ACTIVATION_LECTIN_PATHWAY,0.99999
GOMF_NADPH_OXIDASE_H202_FORM...,SET,5,0.12629,0.0020838,0.34974,0.35902,GOMF_NADPH_OXIDASE_H202_FORMING_ACTIVITY,0.99999
GOBP_REGULATION_OF_SPINDLE_A...,SET,32,0.048197,0.0020105,0.13354,0.35908,GOBP_REGULATION_OF_SPINDLE_ASSEMBLY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...687,SET,4,0.17162,0.002533,0.47579,0.35916,GOBP_NEGATIVE_REGULATION_OF_URINE_VOLUME,0.99999
GOBP_REGULATION_OF_NATURAL_K...2,SET,8,0.11993,0.002503,0.3326,0.35921,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS,0.99999
HP_DECREASED_PROPORTION_OF_C...1,SET,9,0.10595,0.0023454,0.29395,0.35926,HP_DECREASED_PROPORTION_OF_CD3_POSITIVE_T_CELLS,0.99999
MIR466,SET,372,0.016015,0.0022565,0.044434,0.35927,MIR466,0.99999
MIR6829_3P,SET,77,0.036116,0.0023341,0.10022,0.35928,MIR6829_3P,0.99999
GSE5503_LIVER_DC_VS_MLN_DC_A...2,SET,179,0.023057,0.0022657,0.063985,0.35929,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.99999
GOMF_CORECEPTOR_ACTIVITY,SET,52,0.045396,0.0024126,0.12599,0.35931,GOMF_CORECEPTOR_ACTIVITY,0.99999
HP_ABSENT_TIBIA,SET,5,0.15809,0.0026086,0.43893,0.35937,HP_ABSENT_TIBIA,0.99999
GOMF_NEUROTRANSMITTER_RECEPT...1,SET,90,0.036165,0.002526,0.10046,0.35943,GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_II_BL...,SET,7,0.13211,0.0025793,0.36707,0.35946,KEGG_MEDICUS_REFERENCE_II_BLOOD_GROUP_ANTIGEN_BIOSYNTHESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...691,SET,13,0.087437,0.002326,0.24296,0.35947,GOBP_POSITIVE_REGULATION_OF_RUFFLE_ASSEMBLY,0.99999
MIR4644,SET,273,0.019079,0.0023093,0.053021,0.35949,MIR4644,0.99999
GSE14415_TCONV_VS_FOXP3_KO_I...1,SET,159,0.023673,0.0021936,0.065885,0.35968,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN,0.99999
HP_DECREASED_CIRCULATING_VIT...2,SET,31,0.051806,0.0021271,0.1442,0.3597,HP_DECREASED_CIRCULATING_VITAMIN_D_CONCENTRATION,0.99999
NRF2_01,SET,249,0.018044,0.0020871,0.050233,0.35972,NRF2_01,0.99999
GSE23505_IL6_IL1_IL23_VS_IL6...1,SET,179,0.021998,0.0021616,0.061258,0.35976,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,0.99999
GSE6674_UNSTIM_VS_ANTI_IGM_S...1,SET,117,0.02907,0.0023134,0.080987,0.35982,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_DN,0.99999
MORF_PPP2CA,SET,117,0.02569,0.0020443,0.071581,0.35984,MORF_PPP2CA,0.99999
GSE11864_UNTREATED_VS_CSF1_P...2,SET,164,0.023253,0.0021879,0.064806,0.35987,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP,0.99999
REACTOME_SARS_COV_1_ACTIVATE...,SET,34,0.05274,0.0022676,0.147,0.35989,REACTOME_SARS_COV_1_ACTIVATES_MODULATES_INNATE_IMMUNE_RESPONSES,0.99999
HP_CALF_MUSCLE_PSEUDOHYPERTR...,SET,15,0.079956,0.0022846,0.22287,0.35989,HP_CALF_MUSCLE_PSEUDOHYPERTROPHY,0.99999
GSE9960_GRAM_POS_VS_GRAM_NEG...1,SET,173,0.024465,0.0023638,0.068207,0.35992,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,0.99999
GSE11924_TH1_VS_TH2_CD4_TCEL...1,SET,178,0.023233,0.0022766,0.064782,0.35994,GSE11924_TH1_VS_TH2_CD4_TCELL_DN,0.99999
WEBER_METHYLATED_LCP_IN_FIBR...2,SET,11,0.091659,0.002243,0.25562,0.35996,WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP,0.99999
BROWNE_HCMV_INFECTION_4HR_UP,SET,47,0.04666,0.0023579,0.13014,0.35998,BROWNE_HCMV_INFECTION_4HR_UP,0.99999
HP_NARROW_NASAL_BRIDGE,SET,41,0.051015,0.0024082,0.14234,0.36002,HP_NARROW_NASAL_BRIDGE,0.99999
GSE29949_MICROGLIA_BRAIN_VS_...2,SET,179,0.023115,0.0022713,0.06453,0.3601,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.99999
GSE17721_4_VS_24H_CPG_BMDC_DN,SET,176,0.022107,0.0021542,0.061721,0.36011,GSE17721_4_VS_24H_CPG_BMDC_DN,0.99999
MORF_CASP2,SET,89,0.031334,0.0021764,0.087501,0.36014,MORF_CASP2,0.99999
GOBP_AMYLOID_PRECURSOR_PROTE...1,SET,13,0.082387,0.0021916,0.2301,0.36016,GOBP_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS,0.99999
MIR5002_3P,SET,41,0.046813,0.0022099,0.13078,0.36019,MIR5002_3P,0.99999
LEIN_OLIGODENDROCYTE_MARKERS,SET,72,0.037674,0.0023547,0.10528,0.36022,LEIN_OLIGODENDROCYTE_MARKERS,0.99999
GOBP_MODIFICATION_OF_SYNAPTI...,SET,26,0.059135,0.0022239,0.16531,0.36028,GOBP_MODIFICATION_OF_SYNAPTIC_STRUCTURE,0.99999
GOBP_POSITIVE_REGULATION_OF_...501,SET,25,0.069323,0.0025565,0.1939,0.36035,GOBP_POSITIVE_REGULATION_OF_MUSCLE_HYPERTROPHY,0.99999
RELA_DN.V1_DN,SET,119,0.029865,0.0023967,0.083587,0.36044,RELA_DN.V1_DN,0.99999
MIR3160_5P,SET,188,0.023059,0.0023215,0.064555,0.36047,MIR3160_5P,0.99999
MIR3927_3P,SET,94,0.031734,0.0022649,0.088836,0.36047,MIR3927_3P,0.99999
GOBP_PH_REDUCTION,SET,6,0.14045,0.0025387,0.39327,0.3605,GOBP_PH_REDUCTION,0.99999
GOMF_MANNOSYL_OLIGOSACCHARID...2,SET,9,0.10669,0.0023617,0.29879,0.36052,GOMF_MANNOSYL_OLIGOSACCHARIDE_MANNOSIDASE_ACTIVITY,0.99999
MIKKELSEN_IPS_ICP_WITH_H3K27...,SET,54,0.042039,0.0022767,0.11774,0.36053,MIKKELSEN_IPS_ICP_WITH_H3K27ME3,0.99999
GOBP_POLAR_BODY_EXTRUSION_AF...,SET,4,0.14229,0.0021001,0.39861,0.36056,GOBP_POLAR_BODY_EXTRUSION_AFTER_MEIOTIC_DIVISIONS,0.99999
HAY_BONE_MARROW_CD34_POS_MEP,SET,8,0.11289,0.002356,0.31626,0.36057,HAY_BONE_MARROW_CD34_POS_MEP,0.99999
GOBP_MEDIUM_CHAIN_FATTY_ACYL...,SET,6,0.12171,0.0022,0.34131,0.3607,GOBP_MEDIUM_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS,0.99999
MIR4255,SET,155,0.025503,0.0023335,0.071547,0.36075,MIR4255,0.99999
MIR373_3P,SET,295,0.017869,0.0022469,0.050151,0.36081,MIR373_3P,0.99999
GOCC_BRCA1_C_COMPLEX,SET,5,0.12665,0.0020898,0.35558,0.36086,GOCC_BRCA1_C_COMPLEX,0.99999
GOBP_NEGATIVE_REGULATION_OF_...273,SET,107,0.032012,0.0024369,0.089886,0.36087,GOBP_NEGATIVE_REGULATION_OF_HEMOPOIESIS,0.99999
HP_BUNDLE_BRANCH_BLOCK,SET,68,0.036803,0.0022357,0.10335,0.36088,HP_BUNDLE_BRANCH_BLOCK,0.99999
WP_MIRNA_ROLE_IN_IMMUNE_RESP...,SET,32,0.054814,0.0022865,0.15394,0.3609,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.99999
HP_CAUDAL_APPENDAGE,SET,6,0.14598,0.0026387,0.40999,0.3609,HP_CAUDAL_APPENDAGE,0.99999
NCOA6_TARGET_GENES,SET,275,0.019064,0.0023157,0.053558,0.36094,NCOA6_TARGET_GENES,0.99999
STEINER_ERYTHROCYTE_MEMBRANE...,SET,14,0.077097,0.0021282,0.2166,0.36095,STEINER_ERYTHROCYTE_MEMBRANE_GENES,0.99999
GOBP_HORMONE_TRANSPORT,SET,304,0.018091,0.0023087,0.050841,0.36098,GOBP_HORMONE_TRANSPORT,0.99999
REACTOME_TRIGLYCERIDE_BIOSYN...,SET,12,0.094793,0.0024228,0.26652,0.36104,REACTOME_TRIGLYCERIDE_BIOSYNTHESIS,0.99999
GOCC_CELL_DIVISION_SITE,SET,58,0.038406,0.0021553,0.10803,0.36111,GOCC_CELL_DIVISION_SITE,0.99999
GATA3_01,SET,219,0.021246,0.0023066,0.059808,0.36121,GATA3_01,0.99999
GOBP_GAMETE_GENERATION,SET,675,0.01155,0.0021736,0.032517,0.36123,GOBP_GAMETE_GENERATION,0.99999
HP_PREMATURE_ADRENARCHE,SET,10,0.1081,0.0025223,0.30436,0.36123,HP_PREMATURE_ADRENARCHE,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...9,SET,189,0.022602,0.0022815,0.063635,0.36123,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,0.99999
HP_HYPOPLASIA_OF_THE_ZYGOMAT...,SET,37,0.051978,0.0023311,0.14638,0.36126,HP_HYPOPLASIA_OF_THE_ZYGOMATIC_BONE,0.99999
GOBP_ASPARTATE_TRANSMEMBRANE...,SET,20,0.067509,0.002227,0.19013,0.36127,GOBP_ASPARTATE_TRANSMEMBRANE_TRANSPORT,0.99999
REACTOME_FRS_MEDIATED_FGFR1_...,SET,23,0.06397,0.0022628,0.18017,0.36128,REACTOME_FRS_MEDIATED_FGFR1_SIGNALING,0.99999
HP_ABNORMAL_FLASH_VISUAL_EVO...,SET,13,0.08496,0.00226,0.2394,0.36134,HP_ABNORMAL_FLASH_VISUAL_EVOKED_POTENTIALS,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...2,SET,184,0.02285,0.0022761,0.064404,0.36137,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_UP,0.99999
HP_INCREASED_CIRCULATING_PRO...,SET,26,0.055286,0.0020791,0.15586,0.3614,HP_INCREASED_CIRCULATING_PROLACTIN_CONCENTRATION,0.99999
GOCC_MITOCHONDRIAL_INTERMEMB...,SET,5,0.11542,0.0019046,0.3254,0.36141,GOCC_MITOCHONDRIAL_INTERMEMBRANE_SPACE_PROTEIN_TRANSPORTER_COMPLEX,0.99999
GSE17721_0.5H_VS_24H_POLYIC_...2,SET,183,0.021894,0.002175,0.061731,0.36142,GSE17721_0.5H_VS_24H_POLYIC_BMDC_UP,0.99999
GSE31622_WT_VS_KLF3_KO_BCELL...2,SET,178,0.022636,0.0022181,0.063847,0.36147,GSE31622_WT_VS_KLF3_KO_BCELL_UP,0.99999
MPHOSPH8_TARGET_GENES,SET,7,0.12372,0.0024154,0.3491,0.36153,MPHOSPH8_TARGET_GENES,0.99999
LEE_AGING_CEREBELLUM_DN,SET,66,0.039393,0.0023577,0.11119,0.36156,LEE_AGING_CEREBELLUM_DN,0.99999
GOBP_REGULATION_OF_SECONDARY...1,SET,8,0.11815,0.0024659,0.3335,0.36157,GOBP_REGULATION_OF_SECONDARY_HEART_FIELD_CARDIOBLAST_PROLIFERATION,0.99999
WAGNER_APO2_SENSITIVITY,SET,25,0.068167,0.0025138,0.19244,0.36159,WAGNER_APO2_SENSITIVITY,0.99999
RIZ_ERYTHROID_DIFFERENTIATIO...2,SET,38,0.050014,0.0022731,0.14127,0.36166,RIZ_ERYTHROID_DIFFERENTIATION_6HR,0.99999
MIR4290,SET,62,0.035809,0.0020775,0.10117,0.36169,MIR4290,0.99999
GOBP_RESPONSE_TO_TYPE_I_INTE...,SET,79,0.0362,0.0023696,0.10228,0.3617,GOBP_RESPONSE_TO_TYPE_I_INTERFERON,0.99999
GOMF_EPIDERMAL_GROWTH_FACTOR...,SET,33,0.054809,0.0023217,0.15487,0.3617,GOMF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_BINDING,0.99999
REACTOME_PURINE_RIBONUCLEOSI...,SET,9,0.099488,0.0022023,0.28125,0.36177,REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS,0.99999
MIR5010_3P,SET,269,0.018894,0.0022702,0.053429,0.36181,MIR5010_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...133,SET,11,0.080682,0.0019744,0.22816,0.36182,GOBP_NEGATIVE_REGULATION_OF_CGAS_STING_SIGNALING_PATHWAY,0.99999
GSE3982_BCELL_VS_EFF_MEMORY_...2,SET,171,0.022547,0.0021659,0.063768,0.36183,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
GSE25085_FETAL_LIVER_VS_ADUL...2,SET,166,0.021847,0.0020681,0.061833,0.36192,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,0.99999
MIR4297,SET,161,0.02426,0.002262,0.068682,0.36196,MIR4297,0.99999
GSE27786_LIN_NEG_VS_BCELL_UP,SET,185,0.022033,0.0022006,0.062381,0.36197,GSE27786_LIN_NEG_VS_BCELL_UP,0.99999
MIR1245B_3P,SET,129,0.026346,0.0022007,0.074599,0.36199,MIR1245B_3P,0.99999
HP_ABNORMAL_MUSCULOSKELETAL_...,SET,1455,0.0081234,0.0021945,0.023009,0.36203,HP_ABNORMAL_MUSCULOSKELETAL_PHYSIOLOGY,0.99999
GSE6259_33D1_POS_DC_VS_CD4_T...1,SET,163,0.023409,0.002196,0.066307,0.36203,GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN,0.99999
MIR219A_5P,SET,141,0.025499,0.0022261,0.072237,0.36205,MIR219A_5P,0.99999
IRF5_TARGET_GENES,SET,654,0.011816,0.0021902,0.033477,0.36206,IRF5_TARGET_GENES,0.99999
HP_ERECTILE_DYSFUNCTION,SET,60,0.039584,0.0022593,0.1122,0.36213,HP_ERECTILE_DYSFUNCTION,0.99999
MIR3688_3P,SET,368,0.016048,0.0022492,0.045494,0.36214,MIR3688_3P,0.99999
HP_ABNORMALITY_OF_THE_GINGIVA,SET,211,0.021502,0.0022919,0.060958,0.36215,HP_ABNORMALITY_OF_THE_GINGIVA,0.99999
GSE37301_CD4_TCELL_VS_RAG2_K...2,SET,146,0.025956,0.0023055,0.073602,0.36218,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_UP,0.99999
HP_DELAYED_CLOSURE_OF_THE_AN...,SET,29,0.053937,0.002142,0.15298,0.36221,HP_DELAYED_CLOSURE_OF_THE_ANTERIOR_FONTANELLE,0.99999
HP_PHOTOPSIA,SET,90,0.031454,0.0021969,0.089225,0.36223,HP_PHOTOPSIA,0.99999
GAVISH_3CA_METAPROGRAM_CD4_T...9,SET,43,0.049416,0.0023888,0.14023,0.36228,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_T_REG,0.99999
HAN_SATB1_TARGETS_DN,SET,346,0.016875,0.0022948,0.047906,0.36232,HAN_SATB1_TARGETS_DN,0.99999
MIR12126,SET,34,0.05486,0.0023588,0.15575,0.36234,MIR12126,0.99999
GOBP_REGULATION_OF_MONOATOMI...3,SET,302,0.018577,0.002363,0.052743,0.36234,GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.99999
VISALA_RESPONSE_TO_HEAT_SHOC...1,SET,12,0.079187,0.0020239,0.22493,0.3624,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN,0.99999
REACTOME_DNA_REPLICATION_PRE...,SET,94,0.027065,0.0019317,0.076877,0.3624,REACTOME_DNA_REPLICATION_PRE_INITIATION,0.99999
GNF2_RFC3,SET,39,0.042437,0.0019539,0.12055,0.36241,GNF2_RFC3,0.99999
HP_ULCERATIVE_COLITIS,SET,13,0.087757,0.0023345,0.24931,0.36242,HP_ULCERATIVE_COLITIS,0.99999
GOBP_PIGMENT_METABOLIC_PROCE...,SET,72,0.035858,0.0022412,0.10193,0.3625,GOBP_PIGMENT_METABOLIC_PROCESS,0.99999
GSE17580_UNINFECTED_VS_S_MAN...2,SET,186,0.021842,0.0021874,0.062087,0.3625,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP,0.99999
GSE36476_YOUNG_VS_OLD_DONOR_...8,SET,167,0.023258,0.0022082,0.06612,0.36251,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP,0.99999
MIR6883_3P,SET,50,0.044736,0.0023315,0.12718,0.36252,MIR6883_3P,0.99999
SCHRAETS_MLL_TARGETS_UP,SET,29,0.062794,0.0024938,0.17854,0.36253,SCHRAETS_MLL_TARGETS_UP,0.99999
HP_FOOD_INTOLERANCE,SET,9,0.089242,0.0019755,0.25373,0.36253,HP_FOOD_INTOLERANCE,0.99999
MIR302E,SET,444,0.014492,0.0022263,0.041229,0.36261,MIR302E,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...7,SET,29,0.055408,0.0022005,0.15766,0.36263,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.99999
MIR8077,SET,61,0.04084,0.0023503,0.11621,0.36263,MIR8077,0.99999
GOBP_REGULATION_OF_TRIGLYCER...2,SET,12,0.090042,0.0023013,0.25626,0.36266,GOBP_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,0.99999
GOBP_DORSAL_VENTRAL_AXIS_SPE...,SET,14,0.090221,0.0024905,0.25684,0.36269,GOBP_DORSAL_VENTRAL_AXIS_SPECIFICATION,0.99999
CCCACAT_MIR2993P,SET,48,0.04074,0.0020804,0.11603,0.36275,CCCACAT_MIR2993P,0.99999
GSE22601_CD4_SINGLE_POSITIVE...2,SET,181,0.02079,0.0020541,0.059231,0.3628,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.99999
GOBP_PYRUVATE_FAMILY_AMINO_A...2,SET,12,0.086164,0.0022022,0.2455,0.36281,GOBP_PYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.99999
PID_IL6_7_PATHWAY,SET,43,0.047922,0.0023166,0.13656,0.36283,PID_IL6_7_PATHWAY,0.99999
HP_BROAD_FOREHEAD,SET,167,0.023122,0.0021953,0.065897,0.36284,HP_BROAD_FOREHEAD,0.99999
GOMF_PHOSPHATIDIC_ACID_TRANS...,SET,5,0.1364,0.0022508,0.38876,0.36285,GOMF_PHOSPHATIDIC_ACID_TRANSFER_ACTIVITY,0.99999
AGCACTT_MIR93_MIR302A_MIR302...,SET,318,0.017024,0.0022212,0.048551,0.36293,AGCACTT_MIR93_MIR302A_MIR302B_MIR302C_MIR302D_MIR372_MIR373_MIR520E_MIR520A_MIR526B_MIR520B_MIR520C_MIR520D,0.99999
GOBP_REGULATION_OF_CELLULAR_...5,SET,37,0.051783,0.0023224,0.14771,0.36295,GOBP_REGULATION_OF_CELLULAR_EXTRAVASATION,0.99999
GOCC_P_BODY,SET,93,0.030607,0.0021729,0.087304,0.36295,GOCC_P_BODY,0.99999
DESCARTES_FETAL_HEART_ERYTHR...,SET,242,0.018083,0.0020624,0.051604,0.36302,DESCARTES_FETAL_HEART_ERYTHROBLASTS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...269,SET,10,0.089542,0.0020893,0.25567,0.36309,GOBP_NEGATIVE_REGULATION_OF_HEART_RATE,0.99999
REACTOME_FGFR2_LIGAND_BINDIN...,SET,19,0.081868,0.0026324,0.23387,0.36315,REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION,0.99999
DESCARTES_MAIN_FETAL_UNIPOLA...,SET,22,0.068361,0.0023651,0.19534,0.36318,DESCARTES_MAIN_FETAL_UNIPOLAR_BRUSH_CELLS,0.99999
GOMF_MORPHOGEN_ACTIVITY,SET,6,0.13013,0.0023521,0.37191,0.36321,GOMF_MORPHOGEN_ACTIVITY,0.99999
GOBP_ENUCLEATE_ERYTHROCYTE_D...1,SET,5,0.14919,0.0024618,0.42663,0.36329,GOBP_ENUCLEATE_ERYTHROCYTE_DEVELOPMENT,0.99999
REACTOME_FICOLINS_BIND_TO_RE...,SET,5,0.14944,0.002466,0.42753,0.36334,REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE,0.99999
HP_HEPATIC_FAILURE,SET,133,0.025424,0.0021562,0.072745,0.36336,HP_HEPATIC_FAILURE,0.99999
GOBP_DETECTION_OF_VISIBLE_LI...,SET,43,0.045739,0.0022111,0.13088,0.36337,GOBP_DETECTION_OF_VISIBLE_LIGHT,0.99999
MIR16_1_3P,SET,173,0.022415,0.0021656,0.064142,0.36338,MIR16_1_3P,0.99999
IKEDA_MIR1_TARGETS_UP,SET,53,0.042477,0.002279,0.12158,0.36341,IKEDA_MIR1_TARGETS_UP,0.99999
REACTOME_GLUTATHIONE_SYNTHES...,SET,12,0.08774,0.0022425,0.25132,0.3635,REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING,0.99999
WP_OSX_AND_MIRNAS_IN_TOOTH_D...,SET,15,0.08291,0.002369,0.23749,0.36351,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,0.99999
GSE5503_LIVER_DC_VS_PLN_DC_A...1,SET,176,0.0214,0.0020852,0.061304,0.36352,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.99999
MIR8073,SET,76,0.034129,0.0021914,0.097782,0.36354,MIR8073,0.99999
FAN_EMBRYONIC_CTX_IN_2_INTER...,SET,7,0.11362,0.0022183,0.32578,0.36364,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,0.99999
EVI1_06,SET,19,0.067024,0.0021551,0.19224,0.36368,EVI1_06,0.99999
WIERENGA_STAT5A_TARGETS_GROU...1,SET,117,0.028186,0.002243,0.080872,0.36373,WIERENGA_STAT5A_TARGETS_GROUP1,0.99999
REACTOME_RHOD_GTPASE_CYCLE,SET,48,0.045398,0.0023183,0.13026,0.36373,REACTOME_RHOD_GTPASE_CYCLE,0.99999
chr5q12,SET,26,0.1132,0.004257,0.32486,0.36375,chr5q12,0.99999
BCL6B_TARGET_GENES,SET,129,0.026614,0.0022231,0.076378,0.36375,BCL6B_TARGET_GENES,0.99999
GOBP_ACYL_COA_METABOLIC_PROC...,SET,85,0.032408,0.0022001,0.093004,0.36375,GOBP_ACYL_COA_METABOLIC_PROCESS,0.99999
MIR4484,SET,31,0.054018,0.0022179,0.15505,0.36377,MIR4484,0.99999
GOCC_PML_BODY,SET,99,0.029093,0.0021307,0.083502,0.36377,GOCC_PML_BODY,0.99999
HP_ABNORMAL_HEART_SOUND,SET,39,0.050046,0.0023042,0.14374,0.36386,HP_ABNORMAL_HEART_SOUND,0.99999
DESCARTES_FETAL_LIVER_MEGAKA...,SET,113,0.029421,0.0023011,0.084506,0.36387,DESCARTES_FETAL_LIVER_MEGAKARYOCYTES,0.99999
GSE4142_NAIVE_VS_MEMORY_BCEL...1,SET,189,0.021477,0.002168,0.061709,0.36391,GSE4142_NAIVE_VS_MEMORY_BCELL_DN,0.99999
GOBP_ESTABLISHMENT_OF_EPITHE...2,SET,32,0.056236,0.0023458,0.16159,0.36392,GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY,0.99999
HP_GENU_VALGUM,SET,139,0.025691,0.002227,0.073826,0.36392,HP_GENU_VALGUM,0.99999
GOMF_CHEMOATTRACTANT_ACTIVITY,SET,32,0.054799,0.0022859,0.15753,0.36397,GOMF_CHEMOATTRACTANT_ACTIVITY,0.99999
KEGG_HEMATOPOIETIC_CELL_LINE...,SET,80,0.036904,0.0024308,0.10614,0.36404,KEGG_HEMATOPOIETIC_CELL_LINEAGE,0.99999
HINATA_NFKB_IMMU_INF,SET,15,0.087532,0.002501,0.25178,0.36405,HINATA_NFKB_IMMU_INF,0.99999
GSE2770_IL12_AND_TGFB_VS_IL4...4,SET,182,0.021705,0.0021504,0.06244,0.36407,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.99999
GOMF_PEPTIDOGLYCAN_BINDING,SET,18,0.078269,0.0024496,0.22519,0.36408,GOMF_PEPTIDOGLYCAN_BINDING,0.99999
LANDIS_BREAST_CANCER_PROGRES...1,SET,68,0.039061,0.0023729,0.11244,0.36415,LANDIS_BREAST_CANCER_PROGRESSION_DN,0.99999
GSE45365_WT_VS_IFNAR_KO_CD11...2,SET,151,0.025272,0.0022826,0.072764,0.36418,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN,0.99999
GOZGIT_ESR1_TARGETS_DN,SET,656,0.012636,0.0023455,0.036384,0.36419,GOZGIT_ESR1_TARGETS_DN,0.99999
GOBP_HEAD_MORPHOGENESIS,SET,35,0.051913,0.0022645,0.14953,0.36424,GOBP_HEAD_MORPHOGENESIS,0.99999
HP_INCREASED_LAXITY_OF_FINGE...,SET,5,0.15425,0.0025454,0.44433,0.36424,HP_INCREASED_LAXITY_OF_FINGERS,0.99999
GOBP_LYMPHOCYTE_APOPTOTIC_PR...,SET,77,0.034904,0.0022558,0.10063,0.36435,GOBP_LYMPHOCYTE_APOPTOTIC_PROCESS,0.99999
WOTTON_RUNX_TARGETS_UP,SET,18,0.068959,0.0021583,0.1989,0.36441,WOTTON_RUNX_TARGETS_UP,0.99999
GOBP_DE_NOVO_PYRIMIDINE_NUCL...,SET,6,0.11208,0.0020259,0.32333,0.36443,GOBP_DE_NOVO_PYRIMIDINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMAL_SUBCLAVIAN_ARTER...,SET,10,0.10206,0.0023814,0.2945,0.36446,HP_ABNORMAL_SUBCLAVIAN_ARTERY_MORPHOLOGY,0.99999
GOBP_DOPAMINE_BIOSYNTHETIC_P...,SET,12,0.09134,0.0023345,0.26363,0.36449,GOBP_DOPAMINE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_SHORT_CHAIN_FATTY_ACID_...1,SET,7,0.12057,0.0023538,0.34796,0.36449,GOBP_SHORT_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.99999
GOBP_STEM_CELL_DIFFERENTIATI...,SET,229,0.020288,0.0022517,0.058599,0.36459,GOBP_STEM_CELL_DIFFERENTIATION,0.99999
GOMF_ATPASE_ACTIVATOR_ACTIVI...,SET,24,0.057568,0.0020801,0.1663,0.36461,GOMF_ATPASE_ACTIVATOR_ACTIVITY,0.99999
GOBP_CENTRAL_NERVOUS_SYSTEM_...8,SET,27,0.062324,0.0023884,0.18008,0.36464,GOBP_CENTRAL_NERVOUS_SYSTEM_PROJECTION_NEURON_AXONOGENESIS,0.99999
MIR6770_3P,SET,4,0.13394,0.0019768,0.38708,0.36466,MIR6770_3P,0.99999
HP_SKIN_RASH,SET,147,0.025416,0.0022652,0.073507,0.36476,HP_SKIN_RASH,0.99999
BLANCO_MELO_COVID19_SARS_COV...10,SET,132,0.027172,0.0022958,0.078633,0.36484,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...169,SET,13,0.09026,0.002401,0.26139,0.36493,GOBP_POSITIVE_REGULATION_OF_CILIUM_MOVEMENT,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_INT...,SET,353,0.017019,0.0023372,0.049287,0.36493,HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL,0.99999
HP_EUNUCHOID_HABITUS,SET,21,0.069132,0.0023368,0.20023,0.36495,HP_EUNUCHOID_HABITUS,0.99999
PARK_HSC_MARKERS,SET,41,0.046852,0.0022117,0.13571,0.36496,PARK_HSC_MARKERS,0.99999
HP_ADRENOCORTICOTROPIC_HORMO...2,SET,4,0.13591,0.002006,0.394,0.36507,HP_ADRENOCORTICOTROPIC_HORMONE_EXCESS,0.99999
PID_P73PATHWAY,SET,76,0.031029,0.0019923,0.08998,0.36511,PID_P73PATHWAY,0.99999
GOBP_TYROSINE_CATABOLIC_PROC...,SET,6,0.12737,0.0023022,0.36936,0.36511,GOBP_TYROSINE_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_LIPID_CAT...,SET,57,0.039942,0.0022222,0.11584,0.36512,GOBP_REGULATION_OF_LIPID_CATABOLIC_PROCESS,0.99999
GOCC_ORGANELLE_ENVELOPE,SET,1108,0.0088375,0.0021046,0.025634,0.36514,GOCC_ORGANELLE_ENVELOPE,0.99999
AIZARANI_LIVER_C4_EPCAM_POS_...,SET,178,0.023679,0.0023203,0.068721,0.36521,AIZARANI_LIVER_C4_EPCAM_POS_BILE_DUCT_CELLS_1,0.99999
REACTOME_ACTIVATION_OF_PUMA_...,SET,9,0.10701,0.0023688,0.31061,0.36523,REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA,0.99999
HP_URETHRAL_STENOSIS,SET,49,0.044476,0.0022947,0.1291,0.36523,HP_URETHRAL_STENOSIS,0.99999
NAKAYA_PBMC_FLUMIST_AGE_18_5...4,SET,764,0.010768,0.0021504,0.031282,0.36534,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN,0.99999
HP_CERVICAL_NEOPLASM,SET,6,0.14047,0.0025391,0.4081,0.36535,HP_CERVICAL_NEOPLASM,0.99999
GENTILE_UV_HIGH_DOSE_DN,SET,269,0.018001,0.002163,0.052304,0.36537,GENTILE_UV_HIGH_DOSE_DN,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...13,SET,22,0.059661,0.0020641,0.17351,0.36548,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING,0.99999
GSE21670_TGFB_VS_TGFB_AND_IL...1,SET,175,0.021245,0.0020644,0.061815,0.36554,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,0.99999
REACTOME_ANTIGEN_PROCESSING_...1,SET,97,0.027916,0.0020238,0.081227,0.36555,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,0.99999
GSE2405_0H_VS_9H_A_PHAGOCYTO...1,SET,182,0.020673,0.0020481,0.060191,0.36563,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.99999
HP_STATUS_EPILEPTICUS,SET,182,0.021959,0.0021756,0.063967,0.36569,HP_STATUS_EPILEPTICUS,0.99999
GOMF_2_OXOGLUTARATE_DEPENDEN...,SET,52,0.036616,0.001946,0.10669,0.36573,GOMF_2_OXOGLUTARATE_DEPENDENT_DIOXYGENASE_ACTIVITY,0.99999
GSE22589_HIV_VS_HIV_AND_SIV_...1,SET,181,0.020771,0.0020522,0.060529,0.36574,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN,0.99999
HP_MULTIPLE_IMPACTED_TEETH,SET,4,0.16591,0.0024487,0.4837,0.3658,HP_MULTIPLE_IMPACTED_TEETH,0.99999
HP_ESOPHAGEAL_CARCINOMA,SET,13,0.083478,0.0022206,0.24346,0.36584,HP_ESOPHAGEAL_CARCINOMA,0.99999
SCHEIDEREIT_IKK_INTERACTING_...,SET,52,0.040666,0.0021613,0.11864,0.36589,SCHEIDEREIT_IKK_INTERACTING_PROTEINS,0.99999
HP_INCREASED_CIRCULATING_ACT...,SET,14,0.079441,0.002193,0.23181,0.36592,HP_INCREASED_CIRCULATING_ACTH_LEVEL,0.99999
MIR6744_5P,SET,42,0.047783,0.0022829,0.13945,0.36593,MIR6744_5P,0.99999
MIR600,SET,129,0.02747,0.0022946,0.080187,0.36596,MIR600,0.99999
BIOCARTA_NOS1_PATHWAY,SET,21,0.066158,0.0022363,0.19313,0.36597,BIOCARTA_NOS1_PATHWAY,0.99999
GSE22886_IGG_IGA_MEMORY_BCEL...1,SET,170,0.021829,0.0020908,0.063726,0.36598,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,0.99999
AP1FJ_Q2,SET,248,0.01915,0.0022107,0.055913,0.36599,AP1FJ_Q2,0.99999
HP_ABNORMAL_PYRAMIDAL_TRACT_...,SET,61,0.037901,0.0021811,0.11068,0.36601,HP_ABNORMAL_PYRAMIDAL_TRACT_MORPHOLOGY,0.99999
HP_SPEECH_APRAXIA,SET,28,0.053172,0.002075,0.15527,0.36601,HP_SPEECH_APRAXIA,0.99999
MIR1913,SET,138,0.023841,0.0020593,0.069633,0.36603,MIR1913,0.99999
WP_GENES_ASSOCIATED_WITH_THE...,SET,17,0.076779,0.0023353,0.22434,0.36609,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,0.99999
HP_HEMANGIOBLASTOMA,SET,18,0.060887,0.0019056,0.17795,0.36611,HP_HEMANGIOBLASTOMA,0.99999
LIAN_LIPA_TARGETS_6M,SET,65,0.039531,0.0023481,0.1156,0.36619,LIAN_LIPA_TARGETS_6M,0.99999
GSE1432_CTRL_VS_IFNG_6H_MICR...2,SET,183,0.020771,0.0020635,0.060741,0.36619,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,0.99999
AR_01,SET,142,0.024282,0.0021273,0.071015,0.3662,AR_01,0.99999
GSE2706_UNSTIM_VS_2H_LPS_AND...1,SET,169,0.02419,0.0023103,0.070746,0.3662,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN,0.99999
HP_2_3_TOE_CUTANEOUS_SYNDACT...,SET,13,0.084073,0.0022365,0.24589,0.36621,HP_2_3_TOE_CUTANEOUS_SYNDACTYLY,0.99999
HP_HEMIVERTEBRAE,SET,47,0.041165,0.0020802,0.12044,0.36625,HP_HEMIVERTEBRAE,0.99999
GSE41867_NAIVE_VS_DAY8_LCMV_...2,SET,179,0.021255,0.0020885,0.062204,0.36629,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.99999
GSE3982_DC_VS_NKCELL_DN,SET,166,0.022518,0.0021316,0.065912,0.36631,GSE3982_DC_VS_NKCELL_DN,0.99999
JEPSEN_SMRT_TARGETS,SET,29,0.05534,0.0021978,0.16201,0.36633,JEPSEN_SMRT_TARGETS,0.99999
E2F_Q6,SET,209,0.019819,0.0021026,0.058028,0.36635,E2F_Q6,0.99999
HP_BIRTH_LENGTH_LESS_THAN_3R...,SET,13,0.069594,0.0018513,0.2038,0.36637,HP_BIRTH_LENGTH_LESS_THAN_3RD_PERCENTILE,0.99999
GOBP_IRON_COORDINATION_ENTIT...,SET,11,0.089753,0.0021964,0.26293,0.36642,GOBP_IRON_COORDINATION_ENTITY_TRANSPORT,0.99999
MIR4519,SET,73,0.033514,0.0021092,0.098224,0.36648,MIR4519,0.99999
HP_IRREGULAR_HYPERPIGMENTATI...,SET,211,0.019057,0.0020313,0.055856,0.36649,HP_IRREGULAR_HYPERPIGMENTATION,0.99999
GOBP_REGULATION_OF_CATION_CH...,SET,86,0.034034,0.0023239,0.099843,0.3666,GOBP_REGULATION_OF_CATION_CHANNEL_ACTIVITY,0.99999
KRIGE_AMINO_ACID_DEPRIVATION,SET,24,0.067091,0.0024242,0.19684,0.36661,KRIGE_AMINO_ACID_DEPRIVATION,0.99999
REACTOME_MITOCHONDRIAL_TRNA_...,SET,18,0.064724,0.0020257,0.18997,0.36666,REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION,0.99999
REACTOME_HEDGEHOG_ON_STATE,SET,82,0.029328,0.0019557,0.086098,0.36669,REACTOME_HEDGEHOG_ON_STATE,0.99999
GOBP_LYSOSOMAL_MEMBRANE_ORGA...,SET,15,0.07736,0.0022104,0.22716,0.36672,GOBP_LYSOSOMAL_MEMBRANE_ORGANIZATION,0.99999
GOMF_CELL_ADHESIVE_PROTEIN_B...,SET,5,0.15636,0.0025801,0.45915,0.36673,GOMF_CELL_ADHESIVE_PROTEIN_BINDING_INVOLVED_IN_BUNDLE_OF_HIS_CELL_PURKINJE_MYOCYTE_COMMUNICATION,0.99999
WP_NOTCH1_REGULATION_OF_ENDO...,SET,16,0.080912,0.0023877,0.23764,0.36675,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,0.99999
SHETH_LIVER_CANCER_VS_TXNIP_...6,SET,51,0.042652,0.002245,0.12531,0.36679,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6,0.99999
NIKOLSKY_BREAST_CANCER_17Q11...,SET,119,0.045164,0.0036244,0.13271,0.36681,NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,0.99999
GOBP_OLIGODENDROCYTE_APOPTOT...,SET,5,0.14608,0.0024104,0.42924,0.36681,GOBP_OLIGODENDROCYTE_APOPTOTIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...547,SET,41,0.050301,0.0023745,0.14782,0.36682,GOBP_POSITIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,0.99999
GOBP_CARNITINE_TRANSPORT,SET,7,0.14454,0.0028219,0.42485,0.36685,GOBP_CARNITINE_TRANSPORT,0.99999
GOBP_REGULATION_OF_TRIGLYCER...3,SET,37,0.047391,0.0021254,0.13932,0.36687,GOBP_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.99999
GOCC_NODE_OF_RANVIER,SET,16,0.079468,0.002345,0.23365,0.36689,GOCC_NODE_OF_RANVIER,0.99999
GOCC_ACETYLCHOLINE_GATED_CHA...,SET,16,0.078211,0.002308,0.2301,0.36697,GOCC_ACETYLCHOLINE_GATED_CHANNEL_COMPLEX,0.99999
HP_DERMATOLOGICAL_MANIFESTAT...,SET,301,0.016746,0.0021266,0.049274,0.36699,HP_DERMATOLOGICAL_MANIFESTATIONS_OF_SYSTEMIC_DISORDERS,0.99999
GOBP_CELLULAR_RESPONSE_TO_CA...1,SET,33,0.059883,0.0025366,0.17623,0.36701,GOBP_CELLULAR_RESPONSE_TO_CADMIUM_ION,0.99999
GOBP_TOLL_LIKE_RECEPTOR_8_SI...,SET,2,0.24614,0.0025689,0.72446,0.36702,GOBP_TOLL_LIKE_RECEPTOR_8_SIGNALING_PATHWAY,0.99999
HUPER_BREAST_BASAL_VS_LUMINA...2,SET,51,0.044483,0.0023413,0.13094,0.36704,HUPER_BREAST_BASAL_VS_LUMINAL_UP,0.99999
RIZ_ERYTHROID_DIFFERENTIATIO...4,SET,39,0.044916,0.0020681,0.13226,0.36708,RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...6,SET,43,0.044911,0.002171,0.13228,0.36711,GAVISH_3CA_METAPROGRAM_B_CELLS_MEMORY,0.99999
DOANE_BREAST_CANCER_ESR1_UP,SET,102,0.030802,0.0022896,0.090733,0.36713,DOANE_BREAST_CANCER_ESR1_UP,0.99999
KEGG_ABC_TRANSPORTERS,SET,42,0.048923,0.0023374,0.14424,0.36724,KEGG_ABC_TRANSPORTERS,0.99999
GSE37301_MULTIPOTENT_PROGENI...6,SET,180,0.021696,0.0021378,0.063979,0.36726,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...12,SET,4,0.16633,0.002455,0.4906,0.36729,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS_OXYGEN_AS_ACCEPTOR,0.99999
GOCC_FILOPODIUM_MEMBRANE,SET,16,0.074584,0.0022009,0.22,0.3673,GOCC_FILOPODIUM_MEMBRANE,0.99999
GOBP_POSITIVE_REGULATION_OF_...608,SET,69,0.034337,0.0021011,0.10148,0.36754,GOBP_POSITIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_SKIN_EPIDERMIS_DEVELOPM...,SET,127,0.028167,0.0023346,0.0833,0.36763,GOBP_SKIN_EPIDERMIS_DEVELOPMENT,0.99999
HP_ABNORMALITY_OF_REFRACTION,SET,600,0.011919,0.0021193,0.035266,0.36769,HP_ABNORMALITY_OF_REFRACTION,0.99999
GSE22886_NAIVE_BCELL_VS_BLOO...2,SET,174,0.021675,0.0021002,0.064141,0.36771,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP,0.99999
HP_MANDIBULAR_APLASIA,SET,10,0.082388,0.0019224,0.24383,0.36772,HP_MANDIBULAR_APLASIA,0.99999
GOBP_MUSCLE_ATROPHY,SET,11,0.083055,0.0020324,0.24587,0.36776,GOBP_MUSCLE_ATROPHY,0.99999
GSE41867_DAY6_VS_DAY15_LCMV_...1,SET,169,0.021677,0.0020703,0.064201,0.36782,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...24,SET,25,0.055872,0.0020604,0.16556,0.36789,GOBP_PROTEIN_LOCALIZATION_TO_ENDOSOME,0.99999
GOMF_PHOSPHATIDYLINOSITOL_PH...2,SET,12,0.070551,0.0018032,0.20907,0.36789,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.99999
WP_BARDETBIEDL_SYNDROME,SET,76,0.031677,0.0020339,0.0939,0.36793,WP_BARDETBIEDL_SYNDROME,0.99999
GOBP_NEGATIVE_REGULATION_OF_...101,SET,21,0.060902,0.0020586,0.18054,0.36794,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_SENESCENCE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...259,SET,5,0.14512,0.0023946,0.43035,0.36798,GOBP_NEGATIVE_REGULATION_OF_GLUTAMATE_SECRETION,0.99999
GOMF_UBIQUITIN_LIKE_MODIFIER...,SET,9,0.076488,0.0016931,0.22682,0.36798,GOMF_UBIQUITIN_LIKE_MODIFIER_ACTIVATING_ENZYME_ACTIVITY,0.99999
BIOCARTA_CTLA4_PATHWAY,SET,17,0.071421,0.0021724,0.21184,0.368,BIOCARTA_CTLA4_PATHWAY,0.99999
MIR6779_5P,SET,158,0.022726,0.0020992,0.067403,0.368,MIR6779_5P,0.99999
GSE36826_NORMAL_VS_STAPH_AUR...4,SET,175,0.020885,0.0020293,0.061952,0.36802,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP,0.99999
GSE17721_CTRL_VS_POLYIC_0.5H...1,SET,187,0.020461,0.0020546,0.060721,0.36807,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_DN,0.99999
GSE41978_ID2_KO_AND_BIM_KO_V...1,SET,177,0.021986,0.0021484,0.065252,0.36808,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.99999
JONES_OVARY_OOCYTE,SET,64,0.036004,0.0021221,0.10685,0.36808,JONES_OVARY_OOCYTE,0.99999
GOBP_HAIR_CYCLE_PHASE,SET,9,0.099745,0.002208,0.29609,0.36811,GOBP_HAIR_CYCLE_PHASE,0.99999
GOMF_CYTOKINE_RECEPTOR_ACTIV...,SET,87,0.035048,0.002407,0.10406,0.36813,GOMF_CYTOKINE_RECEPTOR_ACTIVITY,0.99999
GOMF_ERBB_3_CLASS_RECEPTOR_B...,SET,5,0.12978,0.0021415,0.38531,0.36813,GOMF_ERBB_3_CLASS_RECEPTOR_BINDING,0.99999
HP_HIATUS_HERNIA,SET,32,0.049529,0.0020661,0.14706,0.36813,HP_HIATUS_HERNIA,0.99999
MATZUK_EARLY_ANTRAL_FOLLICLE,SET,12,0.093248,0.0023833,0.27688,0.36814,MATZUK_EARLY_ANTRAL_FOLLICLE,0.99999
GSE17721_LPS_VS_POLYIC_0.5H_...2,SET,181,0.02057,0.0020324,0.061088,0.36816,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_UP,0.99999
GOMF_CYCLIN_DEPENDENT_PROTEI...2,SET,14,0.068205,0.0018828,0.20257,0.36817,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY,0.99999
IKEDA_MIR30_TARGETS_DN,SET,22,0.05948,0.0020578,0.17671,0.36821,IKEDA_MIR30_TARGETS_DN,0.99999
OUYANG_PROSTATE_CANCER_PROGR...1,SET,20,0.065618,0.0021646,0.19509,0.3683,OUYANG_PROSTATE_CANCER_PROGRESSION_DN,0.99999
REACTOME_SIGNALING_BY_ACTIVIN,SET,16,0.073423,0.0021667,0.21828,0.3683,REACTOME_SIGNALING_BY_ACTIVIN,0.99999
AMIT_EGF_RESPONSE_40_HELA,SET,40,0.048893,0.0022798,0.14544,0.36837,AMIT_EGF_RESPONSE_40_HELA,0.99999
GSE22935_WT_VS_MYD88_KO_MACR...2,SET,188,0.020876,0.0021017,0.062097,0.36837,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP,0.99999
GOBP_BARBED_END_ACTIN_FILAME...,SET,21,0.059014,0.0019948,0.17559,0.36841,GOBP_BARBED_END_ACTIN_FILAMENT_CAPPING,0.99999
GOBP_MAINTENANCE_OF_PROTEIN_...7,SET,24,0.054149,0.0019566,0.16112,0.36841,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_NUCLEUS,0.99999
HP_THORACIC_AORTIC_ANEURYSM,SET,108,0.028636,0.0021899,0.085207,0.36841,HP_THORACIC_AORTIC_ANEURYSM,0.99999
ANDERSON_BLOOD_CN54GP140_ADJ...6,SET,31,0.051021,0.0020948,0.15184,0.36843,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_UP,0.99999
HP_URETHRAL_OBSTRUCTION,SET,60,0.038757,0.0022121,0.11535,0.36844,HP_URETHRAL_OBSTRUCTION,0.99999
GOBP_EMBRYONIC_DIGESTIVE_TRA...2,SET,17,0.080196,0.0024393,0.23873,0.36846,GOBP_EMBRYONIC_DIGESTIVE_TRACT_MORPHOGENESIS,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...9,SET,17,0.06599,0.0020072,0.19643,0.36846,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_ENDOCYTOSIS,0.99999
GOBP_REGULATION_OF_SERINE_TY...,SET,5,0.1433,0.0023646,0.42673,0.36851,GOBP_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY,0.99999
HP_SIMPLE_EAR,SET,19,0.067565,0.0021725,0.20133,0.36859,HP_SIMPLE_EAR,0.99999
GOBP_REGULATION_OF_MRNA_PROC...,SET,117,0.024131,0.0019203,0.071953,0.36868,GOBP_REGULATION_OF_MRNA_PROCESSING,0.99999
HP_DACRYOCYSTITIS,SET,7,0.1091,0.00213,0.32556,0.36877,HP_DACRYOCYSTITIS,0.99999
HP_SEROSITIS,SET,88,0.03141,0.0021694,0.093726,0.36877,HP_SEROSITIS,0.99999
HP_CLUBBING_OF_TOES,SET,28,0.049898,0.0019472,0.1489,0.36878,HP_CLUBBING_OF_TOES,0.99999
GSE20366_TREG_VS_TCONV_UP,SET,179,0.022173,0.0021787,0.06617,0.36878,GSE20366_TREG_VS_TCONV_UP,0.99999
GHO_ATF5_TARGETS_UP,SET,12,0.093109,0.0023797,0.27792,0.36881,GHO_ATF5_TARGETS_UP,0.99999
WP_NEOVASCULARIZATION_PROCES...,SET,36,0.053892,0.0023842,0.16089,0.36883,WP_NEOVASCULARIZATION_PROCESSES,0.99999
EHLERS_ANEUPLOIDY_DN,SET,10,0.099272,0.0023163,0.2964,0.36884,EHLERS_ANEUPLOIDY_DN,0.99999
HP_MECKEL_DIVERTICULUM,SET,25,0.051227,0.0018891,0.15298,0.36887,HP_MECKEL_DIVERTICULUM,0.99999
HUMMERICH_BENIGN_SKIN_TUMOR_...2,SET,15,0.080219,0.0022921,0.23961,0.3689,HUMMERICH_BENIGN_SKIN_TUMOR_UP,0.99999
GOBP_POST_TRANSCRIPTIONAL_RE...,SET,465,0.01323,0.0020788,0.03953,0.36893,GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION,0.99999
GOCC_NUCLEAR_PORE_OUTER_RING,SET,10,0.077852,0.0018165,0.23262,0.36894,GOCC_NUCLEAR_PORE_OUTER_RING,0.99999
GOBP_ANDROGEN_METABOLIC_PROC...,SET,28,0.057528,0.002245,0.17193,0.36897,GOBP_ANDROGEN_METABOLIC_PROCESS,0.99999
ZNF558_TARGET_GENES,SET,225,0.018609,0.0020475,0.055723,0.36921,ZNF558_TARGET_GENES,0.99999
YIH_RESPONSE_TO_ARSENITE_C1,SET,21,0.05886,0.0019896,0.17631,0.36925,YIH_RESPONSE_TO_ARSENITE_C1,0.99999
SOX3_TARGET_GENES,SET,413,0.014487,0.0021483,0.043402,0.36928,SOX3_TARGET_GENES,0.99999
MIR4753_3P,SET,513,0.013111,0.0021609,0.039294,0.36932,MIR4753_3P,0.99999
GOBP_MESENCHYMAL_CELL_DIFFER...2,SET,6,0.13776,0.00249,0.41286,0.36932,GOBP_MESENCHYMAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.99999
GAO_LARGE_INTESTINE_24W_C7_G...,SET,16,0.074112,0.002187,0.22218,0.36936,GAO_LARGE_INTESTINE_24W_C7_GOBLET_PROGENITOR,0.99999
GOBP_NEGATIVE_REGULATION_OF_...110,SET,59,0.033616,0.0019026,0.10083,0.36942,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.99999
GSE32533_WT_VS_MIR17_KO_ACT_...2,SET,178,0.021819,0.0021381,0.065447,0.36942,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP,0.99999
MIR4638_5P,SET,5,0.11805,0.001948,0.35412,0.36943,MIR4638_5P,0.99999
HP_EEG_WITH_PHOTOPAROXYSMAL_...,SET,15,0.079416,0.0022691,0.23828,0.36946,HP_EEG_WITH_PHOTOPAROXYSMAL_RESPONSE,0.99999
HP_ABNORMAL_BRAINSTEM_MORPHO...,SET,249,0.017506,0.0020249,0.052542,0.3695,HP_ABNORMAL_BRAINSTEM_MORPHOLOGY,0.99999
GSE26488_HDAC7_KO_VS_VP16_TR...1,SET,186,0.021274,0.0021305,0.063857,0.36952,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,0.99999
KIM_BIPOLAR_DISORDER_OLIGODE...1,SET,81,0.032037,0.0021234,0.096182,0.36954,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,0.99999
KEGG_MEDICUS_REFERENCE_ANGII...,SET,7,0.1218,0.0023779,0.3657,0.36955,KEGG_MEDICUS_REFERENCE_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,0.99999
GSE24671_BAKIMULC_VS_SENDAI_...2,SET,182,0.019817,0.0019634,0.05951,0.36956,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,0.99999
HERNANDEZ_ABERRANT_MITOSIS_B...2,SET,65,0.036845,0.0021885,0.11064,0.36957,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...443,SET,16,0.0757,0.0022338,0.22736,0.36959,GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION,0.99999
GSE31082_DN_VS_CD4_SP_THYMOC...2,SET,172,0.020224,0.0019484,0.060787,0.36968,GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP,0.99999
GOMF_SODIUM_ION_TRANSMEMBRAN...,SET,156,0.02414,0.0022158,0.072575,0.36971,GOMF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_FEMORAL_HERNIA,SET,17,0.072609,0.0022085,0.21834,0.36974,HP_FEMORAL_HERNIA,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...5,SET,178,0.021449,0.0021017,0.064499,0.36974,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_DN,0.99999
GNF2_LYN,SET,23,0.061029,0.0021588,0.18354,0.36975,GNF2_LYN,0.99999
PID_REELIN_PATHWAY,SET,28,0.05668,0.0022119,0.17054,0.36982,PID_REELIN_PATHWAY,0.99999
REACTOME_INTERLEUKIN_37_SIGN...,SET,19,0.056792,0.0018261,0.17113,0.37,REACTOME_INTERLEUKIN_37_SIGNALING,0.99999
WP_GABA_RECEPTOR_SIGNALING,SET,28,0.061046,0.0023823,0.18399,0.37002,WP_GABA_RECEPTOR_SIGNALING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...607,SET,12,0.0871,0.0022261,0.26252,0.37003,GOBP_NEGATIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS,0.99999
GOBP_MYELOID_LEUKOCYTE_ACTIV...,SET,223,0.020026,0.0021937,0.060399,0.37011,GOBP_MYELOID_LEUKOCYTE_ACTIVATION,0.99999
GOMF_P_TYPE_POTASSIUM_TRANSM...,SET,8,0.11659,0.0024334,0.35172,0.37014,GOMF_P_TYPE_POTASSIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_SPOTTY_HYPOPIGMENTATION,SET,7,0.11088,0.0021648,0.33465,0.3702,HP_SPOTTY_HYPOPIGMENTATION,0.99999
HP_HYPERSPLENISM,SET,20,0.067409,0.0022237,0.20346,0.37021,HP_HYPERSPLENISM,0.99999
HP_ANTERIOR_RIB_CUPPING,SET,15,0.071936,0.0020554,0.21716,0.37023,HP_ANTERIOR_RIB_CUPPING,0.99999
PID_HIF1A_PATHWAY,SET,15,0.065426,0.0018694,0.19779,0.37041,PID_HIF1A_PATHWAY,0.99999
MIR3622B_5P,SET,46,0.0413,0.0020648,0.12488,0.37043,MIR3622B_5P,0.99999
GOBP_REGULATION_OF_FATTY_ACI...3,SET,80,0.031577,0.00208,0.095522,0.37048,GOBP_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,0.99999
MIR3117_5P,SET,54,0.037652,0.0020391,0.11391,0.3705,MIR3117_5P,0.99999
ARNT_01,SET,238,0.018733,0.0021191,0.056675,0.3705,ARNT_01,0.99999
REACTOME_TELOMERE_MAINTENANCE,SET,61,0.033101,0.0019049,0.10015,0.37051,REACTOME_TELOMERE_MAINTENANCE,0.99999
MIR4769_3P,SET,97,0.029218,0.0021182,0.088423,0.37054,MIR4769_3P,0.99999
HP_AMBIGUOUS_GENITALIA,SET,109,0.026785,0.0020578,0.081082,0.37057,HP_AMBIGUOUS_GENITALIA,0.99999
REACTOME_MAP2K_AND_MAPK_ACTI...,SET,38,0.046018,0.0020915,0.13931,0.37058,REACTOME_MAP2K_AND_MAPK_ACTIVATION,0.99999
HP_ABNORMAL_BLOOD_FOLATE_CON...,SET,10,0.088527,0.0020656,0.26835,0.37074,HP_ABNORMAL_BLOOD_FOLATE_CONCENTRATION,0.99999
GOMF_BH_DOMAIN_BINDING,SET,10,0.091929,0.002145,0.27887,0.37084,GOMF_BH_DOMAIN_BINDING,0.99999
WP_NEUROTRANSMITTER_DISORDERS,SET,9,0.098861,0.0021884,0.30014,0.37093,WP_NEUROTRANSMITTER_DISORDERS,0.99999
MIR577,SET,300,0.016476,0.002089,0.050024,0.37094,MIR577,0.99999
HP_HYPERPIGMENTATION_IN_SUN_...,SET,7,0.088689,0.0017315,0.2693,0.37095,HP_HYPERPIGMENTATION_IN_SUN_EXPOSED_AREAS,0.99999
GOBP_GLUTAMATE_METABOLIC_PRO...,SET,32,0.050466,0.0021052,0.15327,0.37098,GOBP_GLUTAMATE_METABOLIC_PROCESS,0.99999
GOMF_LIPOPOLYSACCHARIDE_IMMU...,SET,6,0.11363,0.002054,0.34512,0.37098,GOMF_LIPOPOLYSACCHARIDE_IMMUNE_RECEPTOR_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_CXCL1...,SET,18,0.066882,0.0020932,0.20318,0.37101,KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY,0.99999
BENPORATH_EED_TARGETS,SET,903,0.010797,0.002335,0.032802,0.37102,BENPORATH_EED_TARGETS,0.99999
GAUTAM_EYE_CORNEA_CYTOTOXIC_...,SET,124,0.024982,0.0020462,0.075943,0.3711,GAUTAM_EYE_CORNEA_CYTOTOXIC_T_CELLS,0.99999
GOBP_KERATINOCYTE_DIFFERENTI...,SET,161,0.026492,0.00247,0.080547,0.37112,GOBP_KERATINOCYTE_DIFFERENTIATION,0.99999
TRAVAGLINI_LUNG_VEIN_CELL,SET,37,0.050124,0.002248,0.15254,0.37123,TRAVAGLINI_LUNG_VEIN_CELL,0.99999
HP_RETROBULBAR_OPTIC_NEURITIS,SET,15,0.080834,0.0023097,0.24605,0.37126,HP_RETROBULBAR_OPTIC_NEURITIS,0.99999
KEGG_MEDICUS_REFERENCE_TNFSF...,SET,5,0.1468,0.0024223,0.4469,0.37128,KEGG_MEDICUS_REFERENCE_TNFSF10_RIPK1_3_SIGNALING_PATHWAY,0.99999
GSE17721_0.5H_VS_8H_CPG_BMDC...2,SET,188,0.020024,0.0020159,0.060997,0.37135,GSE17721_0.5H_VS_8H_CPG_BMDC_UP,0.99999
GOCC_MEIOTIC_SPINDLE,SET,12,0.086278,0.0022051,0.26288,0.37138,GOCC_MEIOTIC_SPINDLE,0.99999
GOBP_REGULATION_OF_PROTEASOM...2,SET,113,0.025662,0.0020071,0.078193,0.37139,GOBP_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
HP_ABNORMAL_ISOHEMAGGLUTININ...,SET,7,0.11905,0.0023242,0.36277,0.3714,HP_ABNORMAL_ISOHEMAGGLUTININ_LEVEL,0.99999
HP_ABNORMAL_VENOUS_MORPHOLOGY,SET,136,0.02416,0.0020718,0.073627,0.3714,HP_ABNORMAL_VENOUS_MORPHOLOGY,0.99999
GSE21927_UNTREATED_VS_GMCSF_...2,SET,166,0.022234,0.0021047,0.067756,0.3714,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,0.99999
HP_RETICULOCYTOSIS,SET,41,0.043212,0.0020398,0.13179,0.3715,HP_RETICULOCYTOSIS,0.99999
GOBP_SPINAL_CORD_MOTOR_NEURO...2,SET,27,0.056956,0.0021827,0.17372,0.37151,GOBP_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION,0.99999
SATO_SILENCED_EPIGENETICALLY...,SET,39,0.045153,0.0020789,0.13779,0.37157,SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,0.99999
MIR185_5P,SET,266,0.017612,0.0021045,0.053746,0.37158,MIR185_5P,0.99999
GTF3A_TARGET_GENES,SET,12,0.082836,0.0021172,0.2528,0.37158,GTF3A_TARGET_GENES,0.99999
GOCC_MOTILE_CILIUM,SET,229,0.018297,0.0020308,0.055847,0.3716,GOCC_MOTILE_CILIUM,0.99999
GSE32901_NAIVE_VS_TH17_ENRIC...2,SET,137,0.023565,0.0020281,0.071924,0.3716,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP,0.99999
GOBP_INFLAMMATORY_RESPONSE,SET,778,0.010803,0.0021763,0.032984,0.37164,GOBP_INFLAMMATORY_RESPONSE,0.99999
TURASHVILI_BREAST_NORMAL_DUC...1,SET,5,0.12231,0.0020182,0.37363,0.3717,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...78,SET,9,0.10488,0.0023217,0.32041,0.37171,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.99999
GSE13547_WT_VS_ZFX_KO_BCELL_...3,SET,148,0.022407,0.0020037,0.068495,0.37179,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_DN,0.99999
ZHONG_PFC_MAJOR_TYPES_MICROG...,SET,389,0.014928,0.0021498,0.045637,0.3718,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,0.99999
GOMF_INORGANIC_MOLECULAR_ENT...,SET,659,0.011466,0.0021331,0.035066,0.37184,GOMF_INORGANIC_MOLECULAR_ENTITY_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE12366_NAIVE_VS_MEMORY_BCE...2,SET,162,0.022426,0.0020973,0.068606,0.37188,GSE12366_NAIVE_VS_MEMORY_BCELL_UP,0.99999
GSE26023_PHD3_KO_VS_WT_NEUTR...2,SET,171,0.021355,0.0020514,0.065331,0.37188,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_UP,0.99999
MARSON_BOUND_BY_FOXP3_UNSTIM...,SET,1068,0.0090958,0.0021291,0.027841,0.37195,MARSON_BOUND_BY_FOXP3_UNSTIMULATED,0.99999
MIR215_5P,SET,34,0.047472,0.0020411,0.14537,0.372,MIR215_5P,0.99999
HP_LOW_HANGING_COLUMELLA,SET,43,0.04146,0.0020042,0.127,0.37204,HP_LOW_HANGING_COLUMELLA,0.99999
REACTOME_EARLY_PHASE_OF_HIV_...,SET,14,0.067097,0.0018522,0.20554,0.37205,REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE,0.99999
MIR598_3P,SET,10,0.094303,0.0022004,0.28891,0.37206,MIR598_3P,0.99999
HP_ANTI_ACETYLCHOLINE_RECEPT...,SET,21,0.059249,0.0020028,0.18158,0.3721,HP_ANTI_ACETYLCHOLINE_RECEPTOR_ANTIBODY_POSITIVITY,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_PCP...,SET,48,0.043683,0.0022308,0.13389,0.37211,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,0.99999
GNF2_PTPN6,SET,41,0.043339,0.0020458,0.13286,0.37214,GNF2_PTPN6,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...26,SET,186,0.01957,0.0019598,0.059992,0.37214,HP_APLASIA_HYPOPLASIA_OF_THE_EAR,0.99999
HP_CHOLESTATIC_LIVER_DISEASE,SET,16,0.074101,0.0021867,0.22721,0.37217,HP_CHOLESTATIC_LIVER_DISEASE,0.99999
HP_ABNORMAL_OPTIC_NERVE_MORP...,SET,753,0.010105,0.002004,0.030987,0.37218,HP_ABNORMAL_OPTIC_NERVE_MORPHOLOGY,0.99999
GSE13522_WT_VS_IFNAR_KO_SKIN...4,SET,177,0.021145,0.0020662,0.064872,0.37223,GSE13522_WT_VS_IFNAR_KO_SKIN_UP,0.99999
BRUNEAU_SEPTATION_VENTRICULAR,SET,10,0.081781,0.0019082,0.25098,0.37227,BRUNEAU_SEPTATION_VENTRICULAR,0.99999
GOBP_NORADRENERGIC_NEURON_DE...,SET,4,0.16495,0.0024345,0.50646,0.37233,GOBP_NORADRENERGIC_NEURON_DEVELOPMENT,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...3,SET,154,0.023081,0.0021051,0.070921,0.37242,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN,0.99999
MIR1282,SET,10,0.090082,0.0021019,0.27686,0.37245,MIR1282,0.99999
KEGG_LYSOSOME,SET,113,0.025567,0.0019997,0.078615,0.37251,KEGG_LYSOSOME,0.99999
HP_DECREASED_CIRCULATING_CAR...,SET,22,0.056204,0.0019445,0.17282,0.37251,HP_DECREASED_CIRCULATING_CARNITINE_CONCENTRATION,0.99999
GOBP_RESPONSE_TO_TESTOSTERONE,SET,39,0.044781,0.0020618,0.13771,0.37253,GOBP_RESPONSE_TO_TESTOSTERONE,0.99999
KEGG_ALLOGRAFT_REJECTION,SET,32,0.05581,0.0023281,0.17172,0.37259,KEGG_ALLOGRAFT_REJECTION,0.99999
REACTOME_GLYCOGEN_BREAKDOWN_...,SET,11,0.070223,0.0017184,0.21614,0.37263,REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS,0.99999
BOYLAN_MULTIPLE_MYELOMA_PCA3...1,SET,63,0.035606,0.0020822,0.10963,0.37268,BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,0.99999
GOBP_REGULATION_OF_CALCIUM_I...1,SET,5,0.13256,0.0021873,0.40828,0.37272,GOBP_REGULATION_OF_CALCIUM_IMPORT_INTO_THE_MITOCHONDRION,0.99999
ZHENG_CORD_BLOOD_C6_HSC_MULT...,SET,81,0.033678,0.0022321,0.10378,0.37278,ZHENG_CORD_BLOOD_C6_HSC_MULTIPOTENT_PROGENITOR,0.99999
GSE16385_ROSIGLITAZONE_VS_UN...2,SET,178,0.021932,0.0021491,0.067608,0.37282,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP,0.99999
PID_TAP63_PATHWAY,SET,53,0.037044,0.0019875,0.11423,0.37286,PID_TAP63_PATHWAY,0.99999
MIR18A_3P,SET,82,0.029555,0.0019708,0.091132,0.37286,MIR18A_3P,0.99999
GOBP_REGULATION_OF_TOLL_SIGN...,SET,5,0.12502,0.002063,0.38561,0.37289,GOBP_REGULATION_OF_TOLL_SIGNALING_PATHWAY,0.99999
HP_SHALLOW_ANTERIOR_CHAMBER,SET,17,0.070274,0.0021375,0.21677,0.3729,HP_SHALLOW_ANTERIOR_CHAMBER,0.99999
GSE8921_UNSTIM_VS_TLR1_2_STI...1,SET,179,0.020806,0.0020444,0.064197,0.37294,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN,0.99999
GSE24574_BCL6_HIGH_VS_LOW_TF...1,SET,181,0.019966,0.0019727,0.061619,0.37296,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_DN,0.99999
MIR4683,SET,47,0.042966,0.0021712,0.13261,0.37297,MIR4683,0.99999
GOBP_POSITIVE_REGULATION_OF_...368,SET,6,0.14072,0.0025437,0.43441,0.37299,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION,0.99999
GOMF_MYOSIN_HEAVY_CHAIN_BIND...,SET,13,0.074208,0.001974,0.22911,0.37301,GOMF_MYOSIN_HEAVY_CHAIN_BINDING,0.99999
CAHOY_OLIGODENDROCUTIC,SET,88,0.029735,0.0020538,0.091804,0.37301,CAHOY_OLIGODENDROCUTIC,0.99999
FULCHER_INFLAMMATORY_RESPONS...1,SET,404,0.014349,0.002105,0.044351,0.37315,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,0.99999
GOBP_REGULATION_OF_PANCREATI...,SET,7,0.093947,0.0018342,0.29048,0.37319,GOBP_REGULATION_OF_PANCREATIC_JUICE_SECRETION,0.99999
GOCC_FC_RECEPTOR_COMPLEX,SET,5,0.14064,0.0023208,0.43521,0.37329,GOCC_FC_RECEPTOR_COMPLEX,0.99999
TONG_INTERACT_WITH_PTTG1,SET,51,0.035586,0.0018731,0.11013,0.3733,TONG_INTERACT_WITH_PTTG1,0.99999
GOBP_P38MAPK_CASCADE,SET,53,0.040885,0.0021936,0.12659,0.37336,GOBP_P38MAPK_CASCADE,0.99999
GOBP_PROTEIN_K63_LINKED_UBIQ...,SET,64,0.034102,0.00201,0.10561,0.37338,GOBP_PROTEIN_K63_LINKED_UBIQUITINATION,0.99999
GOBP_CHEMOKINE_PRODUCTION,SET,90,0.031213,0.0021801,0.09668,0.37341,GOBP_CHEMOKINE_PRODUCTION,0.99999
HP_HYPOPLASTIC_NASAL_BRIDGE,SET,5,0.11848,0.001955,0.36705,0.37343,HP_HYPOPLASTIC_NASAL_BRIDGE,0.99999
GOMF_THIAMINE_TRANSMEMBRANE_...,SET,7,0.11234,0.0021933,0.34811,0.37346,GOMF_THIAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MIR888_3P,SET,105,0.026953,0.0020326,0.083528,0.37347,MIR888_3P,0.99999
OVSYANNIKOVA_PBMC_FLUARIX_AG...7,SET,6,0.11207,0.0020257,0.3473,0.37347,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_DN,0.99999
HP_MYELOFIBROSIS,SET,11,0.077088,0.0018864,0.23892,0.37348,HP_MYELOFIBROSIS,0.99999
GOBP_URETERIC_BUD_FORMATION,SET,5,0.14223,0.002347,0.44096,0.37352,GOBP_URETERIC_BUD_FORMATION,0.99999
GOCC_ATG1_ULK1_KINASE_COMPLEX,SET,9,0.098309,0.0021762,0.30482,0.37353,GOCC_ATG1_ULK1_KINASE_COMPLEX,0.99999
MIR4485_5P,SET,7,0.10504,0.0020508,0.32595,0.37363,MIR4485_5P,0.99999
GOBP_INTERLEUKIN_12_PRODUCTI...,SET,61,0.036773,0.0021162,0.11418,0.3737,GOBP_INTERLEUKIN_12_PRODUCTION,0.99999
GOMF_CARBOHYDRATE_DERIVATIVE...,SET,54,0.039258,0.002126,0.12189,0.3737,GOMF_CARBOHYDRATE_DERIVATIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_BLEEDING_WITH_MINOR_OR_NO...,SET,7,0.111,0.0021672,0.34473,0.37373,HP_BLEEDING_WITH_MINOR_OR_NO_TRAUMA,0.99999
HP_NEURONAL_LOSS_IN_THE_CERE...,SET,12,0.076583,0.0019574,0.23796,0.37379,HP_NEURONAL_LOSS_IN_THE_CEREBRAL_CORTEX,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...6,SET,180,0.022315,0.0021988,0.069352,0.37382,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP,0.99999
GSE11367_CTRL_VS_IL17_TREATE...1,SET,101,0.029183,0.0021586,0.09074,0.37388,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_DN,0.99999
KEGG_MEDICUS_PATHOGEN_SALMON...3,SET,8,0.090821,0.0018955,0.28244,0.3739,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,0.99999
GOBP_POSITIVE_REGULATION_OF_...108,SET,5,0.1217,0.0020082,0.37859,0.37393,GOBP_POSITIVE_REGULATION_OF_CELLULAR_PH_REDUCTION,0.99999
GOMF_LIPOPEPTIDE_BINDING,SET,10,0.12578,0.0029348,0.39131,0.37394,GOMF_LIPOPEPTIDE_BINDING,0.99999
GSE5589_UNSTIM_VS_45MIN_LPS_...1,SET,181,0.019902,0.0019664,0.061921,0.37395,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,0.99999
MIR6878_3P,SET,59,0.036455,0.0020634,0.11344,0.37397,MIR6878_3P,0.99999
REACTOME_RESPIRATORY_SYNCYTI...2,SET,21,0.063608,0.0021501,0.19798,0.374,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY,0.99999
GOBP_REGULATION_OF_EATING_BE...,SET,7,0.12063,0.0023551,0.37548,0.374,GOBP_REGULATION_OF_EATING_BEHAVIOR,0.99999
ZNF577_TARGET_GENES,SET,380,0.014274,0.0020323,0.044436,0.37402,ZNF577_TARGET_GENES,0.99999
HP_TURRICEPHALY,SET,42,0.041095,0.0019634,0.12808,0.37416,HP_TURRICEPHALY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...68,SET,4,0.14003,0.0020667,0.43657,0.3742,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT_VIA_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL,0.99999
TRAVAGLINI_LUNG_CD8_MEMORY_E...,SET,26,0.053933,0.0020283,0.16818,0.37422,TRAVAGLINI_LUNG_CD8_MEMORY_EFFECTOR_T_CELL,0.99999
MARTENS_TRETINOIN_RESPONSE_UP,SET,752,0.011145,0.0022089,0.034759,0.37425,MARTENS_TRETINOIN_RESPONSE_UP,0.99999
TRAVAGLINI_LUNG_ADVENTITIAL_...,SET,279,0.018137,0.0022188,0.056592,0.3743,TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL,0.99999
GCM_VAV1,SET,40,0.039679,0.0018501,0.12382,0.37431,GCM_VAV1,0.99999
REACTOME_GLYCOSPHINGOLIPID_T...,SET,8,0.088261,0.0018421,0.27543,0.37432,REACTOME_GLYCOSPHINGOLIPID_TRANSPORT,0.99999
GOMF_PROTEIN_SERINE_THREONIN...6,SET,11,0.075879,0.0018568,0.23696,0.3744,GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_INHIBITOR_ACTIVITY,0.99999
GOBP_DEOXYRIBONUCLEOTIDE_MET...,SET,42,0.041907,0.0020022,0.1309,0.37443,GOBP_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...606,SET,4,0.15973,0.0023575,0.49896,0.37444,GOBP_NEGATIVE_REGULATION_OF_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.99999
GOMF_TRANSITION_METAL_ION_BI...,SET,1008,0.0090201,0.0020548,0.028177,0.37444,GOMF_TRANSITION_METAL_ION_BINDING,0.99999
RASHI_RESPONSE_TO_IONIZING_R...4,SET,45,0.040523,0.0020038,0.12664,0.3745,RASHI_RESPONSE_TO_IONIZING_RADIATION_4,0.99999
HP_ANAL_FISSURE,SET,4,0.11339,0.0016735,0.35443,0.37452,HP_ANAL_FISSURE,0.99999
KEGG_MEDICUS_REFERENCE_GLUTA...,SET,11,0.081922,0.0020047,0.25615,0.37455,KEGG_MEDICUS_REFERENCE_GLUTATHIONE_BIOSYNTHESIS,0.99999
GSE8921_UNSTIM_VS_TLR1_2_STI...6,SET,186,0.019325,0.0019353,0.060423,0.37455,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP,0.99999
GSE21927_SPLEEN_C57BL6_VS_4T...2,SET,182,0.019433,0.0019253,0.060771,0.37457,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP,0.99999
GOMF_TRANSMEMBRANE_TRANSPORT...,SET,125,0.02578,0.0021201,0.080641,0.3746,GOMF_TRANSMEMBRANE_TRANSPORTER_BINDING,0.99999
BOYLAN_MULTIPLE_MYELOMA_PCA1...2,SET,98,0.029525,0.0021515,0.092391,0.37465,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,0.99999
GSE20366_TREG_VS_NAIVE_CD4_T...4,SET,184,0.021004,0.0020923,0.065726,0.37465,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN,0.99999
REACTOME_INITIATION_OF_NUCLE...,SET,18,0.061523,0.0019255,0.19253,0.37466,REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION,0.99999
HP_ABNORMAL_AORTIC_VALVE_MOR...,SET,151,0.022399,0.0020231,0.070159,0.37476,HP_ABNORMAL_AORTIC_VALVE_MORPHOLOGY,0.99999
GOBP_PROTEIN_N_LINKED_GLYCOS...2,SET,23,0.056935,0.002014,0.17835,0.37477,GOBP_PROTEIN_N_LINKED_GLYCOSYLATION_VIA_ASPARAGINE,0.99999
BIOCARTA_MCM_PATHWAY,SET,18,0.060108,0.0018812,0.18832,0.37479,BIOCARTA_MCM_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...574,SET,106,0.026828,0.0020327,0.084046,0.37479,GOBP_POSITIVE_REGULATION_OF_PEPTIDE_SECRETION,0.99999
HP_THUMB_CONTRACTURE,SET,4,0.16235,0.0023962,0.50865,0.3748,HP_THUMB_CONTRACTURE,0.99999
GOMF_ACTIVE_MONOATOMIC_ION_T...,SET,261,0.016621,0.0019677,0.052092,0.37484,GOMF_ACTIVE_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_ELBOW_CONTRACTURE,SET,98,0.028601,0.0020841,0.089677,0.37489,HP_ELBOW_CONTRACTURE,0.99999
REACTOME_TRANSPORT_OF_MATURE...2,SET,74,0.028253,0.0017901,0.088643,0.37497,REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,0.99999
GOBP_RESPONSE_TO_EPIDERMAL_G...,SET,42,0.041307,0.0019735,0.12961,0.37498,GOBP_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR,0.99999
HP_CATAPLEXY,SET,10,0.087797,0.0020486,0.27551,0.37499,HP_CATAPLEXY,0.99999
HP_GENU_VARUM,SET,54,0.03723,0.0020162,0.11685,0.37502,HP_GENU_VARUM,0.99999
GOBP_TISSUE_MIGRATION,SET,294,0.016822,0.0021117,0.052808,0.37504,GOBP_TISSUE_MIGRATION,0.99999
GSE6674_CPG_VS_CPG_AND_ANTI_...2,SET,176,0.019269,0.0018777,0.0605,0.37505,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP,0.99999
ZNF585B_TARGET_GENES,SET,96,0.028259,0.0020382,0.088789,0.37514,ZNF585B_TARGET_GENES,0.99999
HP_SHORT_NAIL,SET,13,0.072773,0.0019359,0.22871,0.37517,HP_SHORT_NAIL,0.99999
GOBP_POSITIVE_REGULATION_OF_...687,SET,5,0.11571,0.0019093,0.3638,0.37523,GOBP_POSITIVE_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS,0.99999
GSE17721_CTRL_VS_CPG_12H_BMD...2,SET,183,0.0201,0.0019968,0.063199,0.37523,GSE17721_CTRL_VS_CPG_12H_BMDC_UP,0.99999
GOBP_VENTRAL_MIDLINE_DEVELOP...,SET,6,0.12153,0.0021967,0.38219,0.37525,GOBP_VENTRAL_MIDLINE_DEVELOPMENT,0.99999
GSE1925_CTRL_VS_IFNG_PRIMED_...6,SET,189,0.020634,0.0020828,0.064898,0.37527,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_UP,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...5,SET,103,0.028278,0.0021122,0.088978,0.37532,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_DENDRITIC_CELLS,0.99999
HP_ABNORMAL_AORTIC_VALVE_PHY...,SET,148,0.023314,0.0020849,0.073376,0.37535,HP_ABNORMAL_AORTIC_VALVE_PHYSIOLOGY,0.99999
GSE11961_FOLLICULAR_BCELL_VS...1,SET,180,0.020075,0.001978,0.063191,0.37537,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.99999
GOCC_VACUOLAR_LUMEN,SET,160,0.02168,0.0020152,0.068255,0.37538,GOCC_VACUOLAR_LUMEN,0.99999
GOBP_REGULATION_OF_B_CELL_AC...,SET,116,0.025657,0.002033,0.080782,0.3754,GOBP_REGULATION_OF_B_CELL_ACTIVATION,0.99999
PID_ARF6_DOWNSTREAM_PATHWAY,SET,15,0.074497,0.0021286,0.23463,0.37543,PID_ARF6_DOWNSTREAM_PATHWAY,0.99999
HP_ABNORMAL_SALIVARY_GLAND_M...,SET,27,0.051259,0.0019644,0.16144,0.37543,HP_ABNORMAL_SALIVARY_GLAND_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...700,SET,28,0.050979,0.0019894,0.16059,0.37546,GOBP_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.99999
FONTAINE_THYROID_TUMOR_UNCER...2,SET,33,0.049005,0.0020759,0.15461,0.37564,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...77,SET,9,0.075923,0.0016806,0.23954,0.37564,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GOBP_REGULATION_OF_MITOCHOND...3,SET,6,0.10264,0.0018552,0.32391,0.37567,GOBP_REGULATION_OF_MITOCHONDRIAL_DNA_METABOLIC_PROCESS,0.99999
MIR1255A_MIR1255B_5P,SET,65,0.03308,0.0019649,0.1044,0.37568,MIR1255A_MIR1255B_5P,0.99999
HATADA_METHYLATED_IN_LUNG_CA...1,SET,31,0.05199,0.0021346,0.16413,0.37571,HATADA_METHYLATED_IN_LUNG_CANCER_DN,0.99999
HP_ANIRIDIA,SET,41,0.042833,0.0020219,0.13522,0.37571,HP_ANIRIDIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...465,SET,312,0.015057,0.0019462,0.047601,0.37588,GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ORGANIZATION,0.99999
GOBP_TISSUE_REMODELING,SET,166,0.022273,0.0021084,0.070413,0.37588,GOBP_TISSUE_REMODELING,0.99999
GOBP_RESPONSE_TO_WATER,SET,13,0.073313,0.0019502,0.23177,0.37589,GOBP_RESPONSE_TO_WATER,0.99999
AHRARNT_02,SET,14,0.071361,0.0019699,0.2257,0.37593,AHRARNT_02,0.99999
REACTOME_NUCLEAR_RECEPTOR_TR...,SET,50,0.039637,0.0020658,0.12546,0.37603,REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,0.99999
GSE17721_0.5H_VS_12H_PAM3CSK...2,SET,182,0.019756,0.0019573,0.062545,0.37605,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_UP,0.99999
GOBP_NUCLEAR_PORE_LOCALIZATI...,SET,5,0.12993,0.002144,0.41141,0.37607,GOBP_NUCLEAR_PORE_LOCALIZATION,0.99999
GSE10325_MYELOID_VS_LUPUS_MY...1,SET,185,0.020204,0.002018,0.063977,0.37608,GSE10325_MYELOID_VS_LUPUS_MYELOID_DN,0.99999
PID_AJDISS_2PATHWAY,SET,46,0.042571,0.0021283,0.13482,0.37609,PID_AJDISS_2PATHWAY,0.99999
GCM_UBE2N,SET,141,0.022071,0.0019268,0.069903,0.3761,GCM_UBE2N,0.99999
GOBP_CLUSTERING_OF_VOLTAGE_G...,SET,6,0.11181,0.002021,0.35448,0.37623,GOBP_CLUSTERING_OF_VOLTAGE_GATED_SODIUM_CHANNELS,0.99999
GOMF_OPSIN_BINDING,SET,4,0.15368,0.0022682,0.48774,0.37635,GOMF_OPSIN_BINDING,0.99999
GOBP_RESPONSE_TO_VITAMIN_A,SET,15,0.074293,0.0021228,0.23581,0.37636,GOBP_RESPONSE_TO_VITAMIN_A,0.99999
GOBP_L_PROLINE_BIOSYNTHETIC_...,SET,5,0.11794,0.0019461,0.37464,0.37646,GOBP_L_PROLINE_BIOSYNTHETIC_PROCESS,0.99999
HP_FLARED_NOSTRILS,SET,6,0.11216,0.0020273,0.35628,0.37646,HP_FLARED_NOSTRILS,0.99999
GOBP_POSITIVE_REGULATION_OF_...34,SET,7,0.1176,0.002296,0.3737,0.3765,GOBP_POSITIVE_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE,0.99999
MANNE_COVID19_ICU_VS_HEALTHY...1,SET,134,0.025221,0.0021469,0.08019,0.37657,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...8,SET,14,0.065675,0.001813,0.20882,0.37657,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP,0.99999
MIR3145_3P,SET,206,0.018746,0.0019746,0.059638,0.37664,MIR3145_3P,0.99999
MCBRYAN_PUBERTAL_BREAST_4_5W...1,SET,170,0.021247,0.0020351,0.067624,0.37669,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,0.99999
MIR3671,SET,571,0.011737,0.0020376,0.037363,0.37671,MIR3671,0.99999
GOBP_CENTRAL_NERVOUS_SYSTEM_...7,SET,163,0.023417,0.0021967,0.074552,0.37672,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION,0.99999
GOMF_GLYCERALDEHYDE_3_PHOSPH...,SET,7,0.092205,0.0018001,0.29354,0.37672,GOMF_GLYCERALDEHYDE_3_PHOSPHATE_DEHYDROGENASE_NADPLUS_NON_PHOSPHORYLATING_ACTIVITY,0.99999
GYORFFY_MITOXANTRONE_RESISTA...,SET,32,0.051949,0.002167,0.16543,0.37675,GYORFFY_MITOXANTRONE_RESISTANCE,0.99999
MIR5093,SET,221,0.018232,0.0019883,0.058063,0.37676,MIR5093,0.99999
HP_APLASIA_HYPOPLASIA_OF_FAC...,SET,50,0.038609,0.0020122,0.12296,0.37676,HP_APLASIA_HYPOPLASIA_OF_FACIAL_BONES,0.99999
GSE20754_WT_VS_TCF1_KO_MEMOR...2,SET,187,0.018577,0.0018654,0.059167,0.37677,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_UP,0.99999
TAKEDA_TARGETS_OF_NUP98_HOXA...3,SET,111,0.027296,0.0021161,0.086953,0.37679,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,0.99999
HP_JERKY_HEAD_MOVEMENTS,SET,11,0.084675,0.0020721,0.26976,0.3768,HP_JERKY_HEAD_MOVEMENTS,0.99999
GSE8921_UNSTIM_VS_TLR1_2_STI...4,SET,177,0.020922,0.0020445,0.066654,0.3768,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP,0.99999
REACTOME_RUNX3_REGULATES_NOT...,SET,13,0.071452,0.0019007,0.22765,0.37681,REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING,0.99999
MIR889_5P,SET,110,0.025296,0.0019522,0.080602,0.37682,MIR889_5P,0.99999
HP_SMOOTH_TONGUE,SET,5,0.13461,0.0022213,0.42892,0.37682,HP_SMOOTH_TONGUE,0.99999
GOBP_CORTICOSPINAL_TRACT_MOR...,SET,8,0.10728,0.0022391,0.34186,0.37683,GOBP_CORTICOSPINAL_TRACT_MORPHOGENESIS,0.99999
HP_INCREASED_FEMALE_LIBIDO,SET,18,0.067873,0.0021243,0.21627,0.37683,HP_INCREASED_FEMALE_LIBIDO,0.99999
GOCC_FIBRILLAR_CENTER,SET,134,0.021489,0.0018292,0.068483,0.37684,GOCC_FIBRILLAR_CENTER,0.99999
HP_SPORADIC,SET,86,0.029668,0.0020259,0.094559,0.37686,HP_SPORADIC,0.99999
MIR6888_3P,SET,87,0.02959,0.0020322,0.094332,0.37688,MIR6888_3P,0.99999
GOBP_N_GLYCAN_PROCESSING,SET,17,0.066863,0.0020338,0.21315,0.37688,GOBP_N_GLYCAN_PROCESSING,0.99999
GSE28726_ACT_CD4_TCELL_VS_AC...2,SET,188,0.018992,0.001912,0.06055,0.37689,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP,0.99999
OSMAN_BLADDER_CANCER_DN,SET,353,0.013733,0.0018859,0.043806,0.37696,OSMAN_BLADDER_CANCER_DN,0.99999
GOBP_ORGANONITROGEN_COMPOUND...2,SET,1305,0.007577,0.0019471,0.024171,0.37696,GOBP_ORGANONITROGEN_COMPOUND_CATABOLIC_PROCESS,0.99999
GSE16385_IFNG_TNF_VS_IL4_STI...4,SET,184,0.019916,0.0019839,0.063532,0.37696,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,0.99999
GOBP_DAMP_METABOLIC_PROCESS,SET,7,0.10796,0.0021078,0.3445,0.377,GOBP_DAMP_METABOLIC_PROCESS,0.99999
MIR619_5P,SET,130,0.023822,0.0019976,0.076043,0.37704,MIR619_5P,0.99999
HP_ABNORMAL_LYMPH_NODE_MORPH...,SET,227,0.018737,0.0020706,0.059814,0.37705,HP_ABNORMAL_LYMPH_NODE_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...438,SET,12,0.085308,0.0021804,0.27236,0.37706,GOBP_NEGATIVE_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,0.99999
GOBP_HORMONE_MEDIATED_APOPTO...,SET,5,0.13119,0.0021647,0.41888,0.37707,GOBP_HORMONE_MEDIATED_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GSE8685_IL2_ACT_IL2_STARVED_...4,SET,161,0.021716,0.0020247,0.06936,0.37711,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,0.99999
GSE23398_WT_VS_IL2_KO_CD4_TC...2,SET,180,0.019735,0.0019446,0.063042,0.37712,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...206,SET,24,0.054728,0.0019775,0.17488,0.37717,GOBP_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...368,SET,6,0.096468,0.0017437,0.3085,0.37726,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS,0.99999
GSE21360_TERTIARY_VS_QUATERN...1,SET,161,0.022131,0.0020634,0.07079,0.37728,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...12,SET,35,0.052044,0.0022703,0.16648,0.37729,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MONOCYTES,0.99999
GSE24726_WT_VS_E2_2_KO_PDC_D...3,SET,177,0.019114,0.0018678,0.061149,0.3773,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_UP,0.99999
GOMF_MONOATOMIC_CATION_TRANS...,SET,580,0.011527,0.0020163,0.036885,0.37733,GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE27786_CD8_TCELL_VS_NKTCEL...2,SET,176,0.019291,0.0018797,0.06173,0.37733,GSE27786_CD8_TCELL_VS_NKTCELL_UP,0.99999
ZNF134_TARGET_GENES,SET,843,0.0091812,0.0019217,0.029394,0.37739,ZNF134_TARGET_GENES,0.99999
HP_ABNORMAL_CIRCULATING_FREE...1,SET,9,0.082202,0.0018196,0.26317,0.37739,HP_ABNORMAL_CIRCULATING_FREE_FATTY_ACID_CONCENTRATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...373,SET,23,0.059573,0.0021073,0.19075,0.3774,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,0.99999
KEGG_FC_GAMMA_R_MEDIATED_PHA...,SET,90,0.029,0.0020255,0.092878,0.37743,KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,0.99999
GOBP_OXIDATIVE_PHOSPHORYLATI...,SET,105,0.023163,0.0017468,0.074188,0.37744,GOBP_OXIDATIVE_PHOSPHORYLATION,0.99999
GOMF_PROTEIN_PHOSPHORYLATED_...,SET,57,0.036161,0.0020118,0.11585,0.37748,GOMF_PROTEIN_PHOSPHORYLATED_AMINO_ACID_BINDING,0.99999
GOCC_PARANODE_REGION_OF_AXON,SET,12,0.079734,0.0020379,0.25549,0.37749,GOCC_PARANODE_REGION_OF_AXON,0.99999
GOCC_ENDOPLASMIC_RETICULUM_L...,SET,284,0.016546,0.002042,0.053021,0.3775,GOCC_ENDOPLASMIC_RETICULUM_LUMEN,0.99999
REACTOME_TRNA_MODIFICATION_I...1,SET,7,0.085813,0.0016753,0.27507,0.37753,REACTOME_TRNA_MODIFICATION_IN_THE_MITOCHONDRION,0.99999
GSE37301_HEMATOPOIETIC_STEM_...10,SET,185,0.019718,0.0019694,0.063204,0.37753,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP,0.99999
WP_POSTCOVID_NEUROINFLAMMATI...,SET,20,0.065964,0.0021761,0.21148,0.37755,WP_POSTCOVID_NEUROINFLAMMATION,0.99999
LEONARD_HYPOXIA,SET,38,0.042626,0.0019373,0.13674,0.37762,LEONARD_HYPOXIA,0.99999
HP_CALCIUM_NEPHROLITHIASIS,SET,18,0.059237,0.001854,0.19011,0.37767,HP_CALCIUM_NEPHROLITHIASIS,0.99999
GOBP_REGULATED_EXOCYTOSIS,SET,210,0.018339,0.0019501,0.058859,0.37769,GOBP_REGULATED_EXOCYTOSIS,0.99999
HP_ABNORMALITY_OF_THE_DORSAL...,SET,5,0.097083,0.001602,0.31163,0.3777,HP_ABNORMALITY_OF_THE_DORSAL_COLUMN_OF_THE_SPINAL_CORD,0.99999
MIR1273H_3P,SET,88,0.029251,0.0020204,0.093912,0.37772,MIR1273H_3P,0.99999
WP_NOVEL_INTRACELLULAR_COMPO...,SET,54,0.035697,0.0019332,0.11464,0.37775,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,0.99999
GSE38681_WT_VS_LYL1_KO_LYMPH...2,SET,178,0.019168,0.0018782,0.061568,0.37778,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,0.99999
chr20q13,SET,207,0.041774,0.0044107,0.13419,0.37779,chr20q13,0.99999
GOMF_N_ACYLSPHINGOSINE_AMIDO...,SET,7,0.11673,0.0022789,0.37496,0.37779,GOMF_N_ACYLSPHINGOSINE_AMIDOHYDROLASE_ACTIVITY,0.99999
HP_ECTOPIC_THYROID,SET,5,0.14123,0.0023305,0.45369,0.37779,HP_ECTOPIC_THYROID,0.99999
HP_LOBAR_HOLOPROSENCEPHALY,SET,23,0.050204,0.0017759,0.16132,0.37782,HP_LOBAR_HOLOPROSENCEPHALY,0.99999
GOBP_DISACCHARIDE_METABOLIC_...,SET,11,0.083139,0.0020345,0.2672,0.37785,GOBP_DISACCHARIDE_METABOLIC_PROCESS,0.99999
GSE3982_MAC_VS_TH1_DN,SET,180,0.018971,0.0018693,0.060996,0.37789,GSE3982_MAC_VS_TH1_DN,0.99999
LAKE_ADULT_KIDNEY_C22_ENDOTH...,SET,135,0.024608,0.0021025,0.079131,0.37791,LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES,0.99999
HP_INTESTINAL_ATRESIA,SET,56,0.036799,0.0020294,0.11839,0.37796,HP_INTESTINAL_ATRESIA,0.99999
NAGY_PCAF_COMPONENTS_HUMAN,SET,9,0.0825,0.0018262,0.26547,0.37799,NAGY_PCAF_COMPONENTS_HUMAN,0.99999
KEGG_TYPE_I_DIABETES_MELLITUS,SET,39,0.047592,0.0021913,0.1532,0.37803,KEGG_TYPE_I_DIABETES_MELLITUS,0.99999
GOBP_REGULATION_OF_NEUTROPHI...3,SET,8,0.092317,0.0019267,0.29717,0.37804,GOBP_REGULATION_OF_NEUTROPHIL_DEGRANULATION,0.99999
RGAANNTTC_HSF1_01,SET,406,0.013472,0.0019811,0.04337,0.37805,RGAANNTTC_HSF1_01,0.99999
GOBP_NEGATIVE_REGULATION_OF_...19,SET,5,0.11503,0.0018982,0.37034,0.37805,GOBP_NEGATIVE_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.99999
GSE17974_0H_VS_6H_IN_VITRO_A...2,SET,162,0.021313,0.0019932,0.068632,0.37808,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP,0.99999
MIR10523_5P,SET,216,0.018597,0.0020053,0.059903,0.37811,MIR10523_5P,0.99999
MIR5572,SET,70,0.031941,0.0019686,0.10288,0.37811,MIR5572,0.99999
MIR7114_3P,SET,42,0.041186,0.0019677,0.13277,0.3782,MIR7114_3P,0.99999
GOMF_LNCRNA_BINDING,SET,17,0.058451,0.0017779,0.18843,0.37821,GOMF_LNCRNA_BINDING,0.99999
BILANGES_SERUM_RESPONSE_TRAN...,SET,29,0.048697,0.0019339,0.157,0.37822,BILANGES_SERUM_RESPONSE_TRANSLATION,0.99999
TTCNRGNNNNTTC_HSF_Q6,SET,137,0.022527,0.0019388,0.072632,0.37822,TTCNRGNNNNTTC_HSF_Q6,0.99999
GOBP_REGULATION_OF_MONOATOMI...1,SET,6,0.12509,0.0022611,0.40334,0.37823,GOBP_REGULATION_OF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORT,0.99999
HP_ABNORMAL_TEMPORAL_LOBE_MO...,SET,125,0.024009,0.0019744,0.077416,0.37823,HP_ABNORMAL_TEMPORAL_LOBE_MORPHOLOGY,0.99999
HP_LEFT_VENTRICULAR_OUTFLOW_...,SET,8,0.10769,0.0022476,0.34742,0.37829,HP_LEFT_VENTRICULAR_OUTFLOW_TRACT_OBSTRUCTION,0.99999
HP_PSEUDOHYPOALDOSTERONISM,SET,6,0.11764,0.0021265,0.37964,0.37833,HP_PSEUDOHYPOALDOSTERONISM,0.99999
WP_FOLATEALCOHOL_AND_CANCER_...,SET,8,0.097851,0.0020422,0.31585,0.37836,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,0.99999
ZC3H11A_TARGET_GENES,SET,745,0.0098942,0.0019523,0.031942,0.37837,ZC3H11A_TARGET_GENES,0.99999
GOBP_ORGANIC_ACID_METABOLIC_...,SET,855,0.0094104,0.001983,0.030382,0.37838,GOBP_ORGANIC_ACID_METABOLIC_PROCESS,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...5,SET,90,0.027376,0.0019121,0.088417,0.37843,HP_APLASIA_HYPOPLASIA_INVOLVING_FOREARM_BONES,0.99999
GSE26488_CTRL_VS_PEPTIDE_INJ...2,SET,188,0.020223,0.002036,0.065316,0.37843,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...11,SET,184,0.019023,0.0018949,0.061459,0.37846,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_DN,0.99999
CHIARADONNA_NEOPLASTIC_TRANS...5,SET,130,0.023925,0.0020062,0.077362,0.37856,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,0.99999
HP_APLASIA_HYPOPLASIA_AFFECT...2,SET,127,0.023113,0.0019158,0.074733,0.37856,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_ANTERIOR_SEGMENT_OF_THE_EYE,0.99999
GOMF_GALACTOSYLCERAMIDASE_AC...,SET,4,0.12557,0.0018534,0.40607,0.37857,GOMF_GALACTOSYLCERAMIDASE_ACTIVITY,0.99999
HP_ABNORMAL_PERIVENTRICULAR_...,SET,116,0.023658,0.0018747,0.076504,0.37857,HP_ABNORMAL_PERIVENTRICULAR_WHITE_MATTER_MORPHOLOGY,0.99999
GOBP_MODULATION_OF_MICROTUBU...,SET,4,0.12553,0.0018528,0.40603,0.3786,GOBP_MODULATION_OF_MICROTUBULE_CYTOSKELETON_INVOLVED_IN_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION,0.99999
MIR4662A_3P,SET,63,0.032883,0.001923,0.10641,0.37865,MIR4662A_3P,0.99999
CDX2_Q5,SET,232,0.01922,0.002147,0.062194,0.37865,CDX2_Q5,0.99999
GOBP_VESICLE_FUSION_TO_PLASM...,SET,23,0.054216,0.0019178,0.17545,0.37866,GOBP_VESICLE_FUSION_TO_PLASMA_MEMBRANE,0.99999
GOBP_VIRAL_TRANSLATIONAL_TER...,SET,5,0.10632,0.0017544,0.3442,0.3787,GOBP_VIRAL_TRANSLATIONAL_TERMINATION_REINITIATION,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_TH...9,SET,6,0.096175,0.0017384,0.31159,0.37879,HP_ABNORMAL_MORPHOLOGY_OF_THE_PROXIMAL_PHALANX_OF_THE_HALLUX,0.99999
HP_OPEN_ANGLE_GLAUCOMA,SET,12,0.085109,0.0021753,0.27572,0.37879,HP_OPEN_ANGLE_GLAUCOMA,0.99999
MODULE_151,SET,274,0.015119,0.0018332,0.049038,0.37893,MODULE_151,0.99999
FRASOR_RESPONSE_TO_ESTRADIOL...1,SET,69,0.033447,0.0020467,0.10861,0.37906,FRASOR_RESPONSE_TO_ESTRADIOL_DN,0.99999
GOBP_REGULATION_OF_ATRIAL_CA...1,SET,9,0.1046,0.0023154,0.33978,0.37911,GOBP_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION,0.99999
GSE32423_CTRL_VS_IL4_MEMORY_...1,SET,178,0.019145,0.001876,0.06221,0.37914,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN,0.99999
GOBP_CDP_CHOLINE_PATHWAY,SET,6,0.096014,0.0017355,0.31217,0.37921,GOBP_CDP_CHOLINE_PATHWAY,0.99999
GSE7568_CTRL_VS_24H_TGFB_TRE...1,SET,180,0.020539,0.0020238,0.066787,0.37922,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,0.99999
MIR541_5P,SET,113,0.02487,0.0019452,0.080893,0.37925,MIR541_5P,0.99999
GOMF_TYPE_1_FIBROBLAST_GROWT...,SET,5,0.12796,0.0021114,0.41641,0.37931,GOMF_TYPE_1_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,0.99999
HP_HEMATOCHEZIA,SET,20,0.062058,0.0020472,0.20197,0.37932,HP_HEMATOCHEZIA,0.99999
BIOCARTA_STEM_PATHWAY,SET,15,0.072188,0.0020626,0.23505,0.37938,BIOCARTA_STEM_PATHWAY,0.99999
HP_C1_C2_VERTEBRAL_ABNORMALI...,SET,7,0.096278,0.0018797,0.31354,0.3794,HP_C1_C2_VERTEBRAL_ABNORMALITY,0.99999
RAY_TARGETS_OF_P210_BCR_ABL_...1,SET,15,0.070714,0.0020205,0.2304,0.37945,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN,0.99999
HP_ABNORMALITY_OF_THE_PLANTA...,SET,159,0.021931,0.0020321,0.071451,0.37945,HP_ABNORMALITY_OF_THE_PLANTAR_SKIN_OF_FOOT,0.99999
GSE22140_HEALTHY_VS_ARTHRITI...1,SET,188,0.019915,0.002005,0.064882,0.37945,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN,0.99999
SA_MMP_CYTOKINE_CONNECTION,SET,15,0.074652,0.002133,0.24325,0.37946,SA_MMP_CYTOKINE_CONNECTION,0.99999
GSE22886_NAIVE_BCELL_VS_BM_P...1,SET,182,0.019348,0.0019169,0.063084,0.37953,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN,0.99999
GOBP_MESONEPHRIC_TUBULE_MORP...,SET,62,0.036119,0.0020955,0.11789,0.37966,GOBP_MESONEPHRIC_TUBULE_MORPHOGENESIS,0.99999
GOBP_REGULATION_OF_NATURAL_K...1,SET,38,0.045141,0.0020517,0.14734,0.37966,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,0.99999
HU_GENOTOXIC_DAMAGE_4HR,SET,34,0.042083,0.0018094,0.13741,0.3797,HU_GENOTOXIC_DAMAGE_4HR,0.99999
OUYANG_PROSTATE_CANCER_PROGR...2,SET,18,0.06352,0.001988,0.20745,0.37973,OUYANG_PROSTATE_CANCER_PROGRESSION_UP,0.99999
BIOCARTA_DREAM_PATHWAY,SET,13,0.087034,0.0023152,0.28424,0.37973,BIOCARTA_DREAM_PATHWAY,0.99999
GSE7509_UNSTIM_VS_FCGRIIB_ST...4,SET,150,0.01971,0.0017743,0.064396,0.37978,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_UP,0.99999
HP_XEROSTOMIA,SET,52,0.03675,0.0019531,0.12008,0.37979,HP_XEROSTOMIA,0.99999
WP_MIRNAS_INVOLVED_IN_DNA_DA...,SET,14,0.06764,0.0018672,0.22108,0.37982,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,0.99999
GOBP_GOLGI_LOCALIZATION,SET,12,0.070278,0.0017962,0.22975,0.37984,GOBP_GOLGI_LOCALIZATION,0.99999
GOBP_MITOCHONDRIAL_PROTEIN_C...,SET,9,0.078091,0.0017286,0.25535,0.37987,GOBP_MITOCHONDRIAL_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...552,SET,6,0.10205,0.0018445,0.33368,0.37987,GOBP_POSITIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,0.99999
HP_PES_PLANUS,SET,310,0.014818,0.0019093,0.048463,0.37989,HP_PES_PLANUS,0.99999
GOBP_REGULATION_OF_HUMORAL_I...1,SET,40,0.045555,0.0021241,0.14912,0.38,GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,0.99999
GOBP_LEUKOCYTE_APOPTOTIC_PRO...,SET,111,0.025455,0.0019734,0.083342,0.38002,GOBP_LEUKOCYTE_APOPTOTIC_PROCESS,0.99999
GOBP_ASTROCYTE_ACTIVATION,SET,23,0.059699,0.0021118,0.19547,0.38003,GOBP_ASTROCYTE_ACTIVATION,0.99999
GSE27786_LSK_VS_NEUTROPHIL_DN,SET,180,0.019235,0.0018952,0.062983,0.38004,GSE27786_LSK_VS_NEUTROPHIL_DN,0.99999
HP_ABNORMAL_OSSIFICATION_INV...,SET,23,0.054425,0.0019252,0.17825,0.38006,HP_ABNORMAL_OSSIFICATION_INVOLVING_THE_FEMORAL_HEAD_AND_NECK,0.99999
WP_ENERGY_METABOLISM,SET,47,0.037007,0.0018701,0.12121,0.38007,WP_ENERGY_METABOLISM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...168,SET,234,0.017425,0.0019547,0.057072,0.38007,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE,0.99999
GOMF_NUCLEAR_EXPORT_SIGNAL_R...,SET,11,0.074489,0.0018228,0.24403,0.38009,GOMF_NUCLEAR_EXPORT_SIGNAL_RECEPTOR_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...540,SET,36,0.046377,0.0020517,0.15196,0.38011,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,0.99999
GSE13485_DAY3_VS_DAY21_YF17D...2,SET,176,0.01877,0.001829,0.061502,0.38011,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.99999
HOEK_B_CELL_2011_2012_TIV_AD...1,SET,5,0.12857,0.0021216,0.42159,0.38019,HOEK_B_CELL_2011_2012_TIV_ADULT_1DY_UP,0.99999
GSE7852_TREG_VS_TCONV_LN_UP,SET,177,0.019854,0.0019401,0.065109,0.38021,GSE7852_TREG_VS_TCONV_LN_UP,0.99999
HP_BRACHYTURRICEPHALY,SET,8,0.097239,0.0020295,0.31891,0.38022,HP_BRACHYTURRICEPHALY,0.99999
GSE43863_NAIVE_VS_MEMORY_LY6...2,SET,174,0.019827,0.0019211,0.065025,0.38022,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_UP,0.99999
HP_SENSORY_SEEKING,SET,24,0.053308,0.0019262,0.17484,0.38023,HP_SENSORY_SEEKING,0.99999
chr22q11,SET,98,0.049486,0.003606,0.16243,0.38031,chr22q11,0.99999
HP_BRITTLE_HAIR,SET,41,0.038179,0.0018023,0.12531,0.38031,HP_BRITTLE_HAIR,0.99999
KEGG_MEDICUS_PATHOGEN_HTLV_1...8,SET,5,0.1232,0.0020329,0.40443,0.38033,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SRF_MEDIATED_TRANSCRIPTION,0.99999
LYF1_01,SET,238,0.017515,0.0019814,0.057516,0.38036,LYF1_01,0.99999
HP_ABNORMAL_CIRCULATING_INTE...3,SET,31,0.050986,0.0020934,0.16744,0.38037,HP_ABNORMAL_CIRCULATING_INTERLEUKIN_CONCENTRATION,0.99999
GOCC_SPLICEOSOMAL_TRI_SNRNP_...,SET,36,0.037157,0.0016438,0.12204,0.38039,GOCC_SPLICEOSOMAL_TRI_SNRNP_COMPLEX,0.99999
REACTOME_LIPOPHAGY,SET,9,0.088413,0.0019571,0.29048,0.38042,REACTOME_LIPOPHAGY,0.99999
GOBP_INFLAMMATORY_RESPONSE_T...2,SET,24,0.057225,0.0020677,0.18804,0.38044,GOBP_INFLAMMATORY_RESPONSE_TO_WOUNDING,0.99999
GOCC_CHROMOSOME_CENTROMERIC_...2,SET,219,0.016891,0.0018339,0.055517,0.38047,GOCC_CHROMOSOME_CENTROMERIC_REGION,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...23,SET,28,0.056094,0.002189,0.18437,0.38047,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_SECRETORY_CELLS,0.99999
KEGG_MEDICUS_PATHOGEN_HCMV_U...1,SET,26,0.049901,0.0018766,0.16414,0.38056,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...7,SET,163,0.021436,0.0020109,0.070514,0.38056,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN,0.99999
HP_EPIDERMOID_CYST,SET,15,0.061561,0.001759,0.20272,0.38069,HP_EPIDERMOID_CYST,0.99999
GSE37416_0H_VS_24H_F_TULAREN...1,SET,177,0.019366,0.0018924,0.063778,0.3807,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_UV...3,SET,4,0.11123,0.0016417,0.36652,0.38076,GOBP_CELLULAR_RESPONSE_TO_UV_C,0.99999
GOBP_CELLULAR_LIPID_CATABOLI...,SET,220,0.017526,0.0019071,0.057776,0.38081,GOBP_CELLULAR_LIPID_CATABOLIC_PROCESS,0.99999
GARCIA_TARGETS_OF_FLI1_AND_D...2,SET,46,0.034316,0.0017156,0.11318,0.38087,GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,0.99999
LEE_LIVER_CANCER_HEPATOBLAST,SET,15,0.07466,0.0021333,0.24636,0.38093,LEE_LIVER_CANCER_HEPATOBLAST,0.99999
HP_RIDGED_NAIL,SET,20,0.051863,0.0017109,0.17114,0.38093,HP_RIDGED_NAIL,0.99999
GOBP_POSITIVE_REGULATION_OF_...622,SET,7,0.0877,0.0017122,0.28944,0.38095,GOBP_POSITIVE_REGULATION_OF_PROTEIN_GLYCOSYLATION,0.99999
HP_DIABETIC_KETOACIDOSIS,SET,19,0.063931,0.0020557,0.21103,0.38097,HP_DIABETIC_KETOACIDOSIS,0.99999
GSE9960_HEALTHY_VS_GRAM_NEG_...3,SET,175,0.019768,0.0019209,0.065276,0.38101,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_DN,0.99999
PID_TRKR_PATHWAY,SET,60,0.033372,0.0019047,0.11025,0.38107,PID_TRKR_PATHWAY,0.99999
WP_RUBINSTEINTAYBI_SYNDROME_1,SET,14,0.072771,0.0020088,0.24043,0.38107,WP_RUBINSTEINTAYBI_SYNDROME_1,0.99999
DELYS_THYROID_CANCER_DN,SET,213,0.019341,0.0020712,0.063912,0.38109,DELYS_THYROID_CANCER_DN,0.99999
GSE41867_NAIVE_VS_DAY15_LCMV...5,SET,177,0.018435,0.0018015,0.060917,0.38109,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN,0.99999
HP_PECTUS_EXCAVATUM,SET,263,0.015644,0.001859,0.051707,0.38112,HP_PECTUS_EXCAVATUM,0.99999
chr2q12,SET,24,0.08932,0.0032274,0.29525,0.38113,chr2q12,0.99999
GOBP_POSITIVE_REGULATION_OF_...811,SET,18,0.062711,0.0019627,0.2073,0.38113,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.99999
GAUCHER_PBMC_YF_VAX_STAMARIL...6,SET,26,0.054195,0.0020381,0.17915,0.38114,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_UP,0.99999
GSE36888_UNTREATED_VS_IL2_TR...6,SET,171,0.020441,0.0019636,0.067611,0.3812,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_UP,0.99999
GOBP_RHODOPSIN_MEDIATED_SIGN...,SET,10,0.077171,0.0018006,0.25527,0.38121,GOBP_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY,0.99999
TAKEDA_TARGETS_OF_NUP98_HOXA...7,SET,42,0.042401,0.0020258,0.14029,0.38124,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,0.99999
MIR6785_5P,SET,469,0.012006,0.0018944,0.039738,0.38128,MIR6785_5P,0.99999
HP_HYPOPLASTIC_NIPPLES,SET,31,0.043597,0.00179,0.1443,0.38128,HP_HYPOPLASTIC_NIPPLES,0.99999
MIR124_3P,SET,691,0.01016,0.0019336,0.03363,0.38129,MIR124_3P,0.99999
LE_EGR2_TARGETS_UP,SET,103,0.025021,0.0018689,0.082852,0.38133,LE_EGR2_TARGETS_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...331,SET,8,0.083434,0.0017413,0.27651,0.38143,GOBP_POSITIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,0.99999
SQSTM1_TARGET_GENES,SET,30,0.044932,0.0018149,0.14893,0.38144,SQSTM1_TARGET_GENES,0.99999
BILD_E2F3_ONCOGENIC_SIGNATURE,SET,223,0.017473,0.001914,0.057928,0.38147,BILD_E2F3_ONCOGENIC_SIGNATURE,0.99999
MODULE_412,SET,13,0.080772,0.0021487,0.26778,0.38147,MODULE_412,0.99999
GOBP_CYTOPLASMIC_MICROTUBULE...,SET,58,0.033327,0.0018703,0.11052,0.3815,GOBP_CYTOPLASMIC_MICROTUBULE_ORGANIZATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MES...1,SET,264,0.016915,0.0020137,0.056091,0.3815,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_1_CELL,0.99999
HP_HETEROTROPIA,SET,234,0.016507,0.0018517,0.05475,0.38152,HP_HETEROTROPIA,0.99999
GSE22886_TCELL_VS_BCELL_NAIV...1,SET,167,0.020807,0.0019754,0.06902,0.38153,GSE22886_TCELL_VS_BCELL_NAIVE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...94,SET,8,0.088932,0.0018561,0.29506,0.38156,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPIRATION,0.99999
HP_RECTAL_PROLAPSE,SET,49,0.039606,0.0020435,0.13145,0.38159,HP_RECTAL_PROLAPSE,0.99999
DESCARTES_FETAL_THYMUS_ANTIG...,SET,152,0.022532,0.0020417,0.074784,0.3816,DESCARTES_FETAL_THYMUS_ANTIGEN_PRESENTING_CELLS,0.99999
FLETCHER_PBMC_BCG_10W_INFANT...2,SET,119,0.026692,0.0021421,0.08865,0.38167,FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_UP,0.99999
MYOGENIN_Q6,SET,245,0.016398,0.0018817,0.054463,0.38168,MYOGENIN_Q6,0.99999
GSE27786_CD4_VS_CD8_TCELL_DN,SET,175,0.019368,0.001882,0.064339,0.3817,GSE27786_CD4_VS_CD8_TCELL_DN,0.99999
GOCC_DYNEIN_COMPLEX,SET,43,0.035984,0.0017395,0.11955,0.38171,GOCC_DYNEIN_COMPLEX,0.99999
HP_APLASTIC_HYPOPLASTIC_TOEN...,SET,105,0.024777,0.0018684,0.082312,0.38171,HP_APLASTIC_HYPOPLASTIC_TOENAIL,0.99999
THEILGAARD_NEUTROPHIL_AT_SKI...2,SET,73,0.031969,0.0020119,0.10625,0.38175,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,0.99999
GSE21360_NAIVE_VS_SECONDARY_...2,SET,172,0.020506,0.0019755,0.068157,0.38176,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP,0.99999
GSE20151_CTRL_VS_FUSOBACT_NU...1,SET,174,0.018827,0.0018242,0.062613,0.38183,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN,0.99999
GOBP_REGULATION_OF_FERTILIZA...,SET,16,0.065912,0.001945,0.21923,0.38184,GOBP_REGULATION_OF_FERTILIZATION,0.99999
GOBP_S_SHAPED_BODY_MORPHOGEN...,SET,7,0.11932,0.0023295,0.3969,0.38185,GOBP_S_SHAPED_BODY_MORPHOGENESIS,0.99999
GOBP_GLYCEROLIPID_CATABOLIC_...,SET,62,0.033877,0.0019654,0.1127,0.38187,GOBP_GLYCEROLIPID_CATABOLIC_PROCESS,0.99999
REACTOME_REGULATION_OF_NFE2L...,SET,8,0.095949,0.0020025,0.31956,0.382,REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION,0.99999
GOBP_RESPONSE_TO_ACETYLCHOLI...,SET,44,0.041964,0.002052,0.13978,0.38201,GOBP_RESPONSE_TO_ACETYLCHOLINE,0.99999
MIR31_3P,SET,51,0.036446,0.0019183,0.12147,0.38208,MIR31_3P,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...10,SET,187,0.017875,0.0017948,0.059579,0.38209,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,0.99999
HP_INTELLECTUAL_DISABILITY_P...1,SET,87,0.026023,0.0017872,0.086789,0.38215,HP_INTELLECTUAL_DISABILITY_PROFOUND,0.99999
GOBP_COPULATION,SET,19,0.062188,0.0019996,0.20751,0.38221,GOBP_COPULATION,0.99999
MIKKELSEN_NPC_ICP_WITH_H3K27...,SET,11,0.091166,0.0022309,0.30428,0.38224,MIKKELSEN_NPC_ICP_WITH_H3K27ME3,0.99999
WP_EV_RELEASE_FROM_CARDIAC_C...,SET,7,0.11156,0.002178,0.37235,0.38224,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,0.99999
GSE15324_ELF4_KO_VS_WT_NAIVE...1,SET,175,0.019891,0.0019328,0.066386,0.38224,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN,0.99999
GSE360_L_MAJOR_VS_B_MALAYI_H...4,SET,181,0.019627,0.0019392,0.065507,0.38224,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.99999
ALCALAY_AML_BY_NPM1_LOCALIZA...2,SET,123,0.023898,0.0019496,0.07979,0.38227,ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...375,SET,41,0.040737,0.001923,0.13607,0.38233,GOBP_NEGATIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,0.99999
HP_IMPAIRED_TANDEM_GAIT,SET,9,0.096441,0.0021348,0.32231,0.38239,HP_IMPAIRED_TANDEM_GAIT,0.99999
DESCARTES_MAIN_FETAL_PARIETA...,SET,92,0.025952,0.0018326,0.086752,0.38241,DESCARTES_MAIN_FETAL_PARIETAL_AND_CHIEF_CELLS,0.99999
GOBP_MRNA_3_SPLICE_SITE_RECO...,SET,6,0.10357,0.001872,0.34625,0.38243,GOBP_MRNA_3_SPLICE_SITE_RECOGNITION,0.99999
GR_Q6_01,SET,247,0.016694,0.0019234,0.055856,0.38252,GR_Q6_01,0.99999
GOBP_REGULATION_OF_SYNAPSE_S...2,SET,230,0.017837,0.001984,0.059694,0.38254,GOBP_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY,0.99999
GSE17721_LPS_VS_CPG_4H_BMDC_...1,SET,171,0.018773,0.0018034,0.062833,0.38255,GSE17721_LPS_VS_CPG_4H_BMDC_DN,0.99999
GOBP_DENTINOGENESIS,SET,6,0.117,0.0021149,0.39184,0.38263,GOBP_DENTINOGENESIS,0.99999
MIR7158_3P,SET,57,0.035318,0.0019649,0.1183,0.38264,MIR7158_3P,0.99999
DIRMEIER_LMP1_RESPONSE_LATE_...1,SET,25,0.05175,0.0019084,0.17338,0.38267,DIRMEIER_LMP1_RESPONSE_LATE_DN,0.99999
HP_EPISPADIAS,SET,25,0.047298,0.0017442,0.15847,0.38268,HP_EPISPADIAS,0.99999
GOBP_ACUTE_INFLAMMATORY_RESP...2,SET,23,0.058276,0.0020614,0.19527,0.38269,GOBP_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.99999
HP_AUTOAMPUTATION_OF_DIGITS,SET,13,0.068688,0.0018272,0.23017,0.38269,HP_AUTOAMPUTATION_OF_DIGITS,0.99999
GOBP_CEREBRAL_CORTEX_NEURON_...,SET,22,0.061862,0.0021402,0.20732,0.3827,GOBP_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION,0.99999
BIOCARTA_TCRA_PATHWAY,SET,10,0.087041,0.0020309,0.2918,0.38274,BIOCARTA_TCRA_PATHWAY,0.99999
HP_ABNORMALITY_OF_HAND_JOINT...,SET,43,0.039947,0.0019311,0.13413,0.38292,HP_ABNORMALITY_OF_HAND_JOINT_MOBILITY,0.99999
FLECHNER_PBL_KIDNEY_TRANSPLA...3,SET,50,0.034142,0.0017794,0.11465,0.38294,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,0.99999
WEIGEL_OXIDATIVE_STRESS_RESP...,SET,32,0.044412,0.0018526,0.14919,0.38297,WEIGEL_OXIDATIVE_STRESS_RESPONSE,0.99999
BAUS_TFF2_TARGETS_DN,SET,11,0.07976,0.0019518,0.26798,0.38299,BAUS_TFF2_TARGETS_DN,0.99999
GOBP_ESTABLISHMENT_OF_MITOCH...1,SET,27,0.051144,0.0019599,0.17191,0.38304,GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...307,SET,39,0.041613,0.001916,0.13987,0.38304,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,0.99999
HP_ENLARGEMENT_OF_THE_COSTOC...,SET,8,0.094929,0.0019812,0.31917,0.38307,HP_ENLARGEMENT_OF_THE_COSTOCHONDRAL_JUNCTION,0.99999
MIR6501_3P,SET,132,0.022564,0.0019064,0.075922,0.38316,MIR6501_3P,0.99999
HP_FAILURE_TO_THRIVE,SET,956,0.0083527,0.0018558,0.028112,0.38319,HP_FAILURE_TO_THRIVE,0.99999
REACTOME_FRUCTOSE_METABOLISM,SET,7,0.081594,0.001593,0.27475,0.38324,REACTOME_FRUCTOSE_METABOLISM,0.99999
MODULE_298,SET,26,0.054513,0.0020501,0.1836,0.38327,MODULE_298,0.99999
GOCC_PROTEASE_INHIBITOR_COMP...,SET,8,0.10176,0.0021238,0.34276,0.38328,GOCC_PROTEASE_INHIBITOR_COMPLEX,0.99999
GOBP_THIOESTER_BIOSYNTHETIC_...,SET,41,0.040087,0.0018923,0.13507,0.38332,GOBP_THIOESTER_BIOSYNTHETIC_PROCESS,0.99999
GOBP_LENS_DEVELOPMENT_IN_CAM...,SET,79,0.031402,0.0020555,0.10591,0.38343,GOBP_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.99999
GOBP_POSITIVE_REGULATION_OF_...767,SET,6,0.091641,0.0016565,0.30909,0.38343,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE,0.99999
GSE5503_LIVER_DC_VS_SPLEEN_D...1,SET,173,0.018143,0.0017529,0.06121,0.38346,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.99999
PID_REG_GR_PATHWAY,SET,80,0.028372,0.0018688,0.095755,0.3835,PID_REG_GR_PATHWAY,0.99999
EPPERT_CE_HSC_LSC,SET,36,0.047181,0.0020873,0.15929,0.38354,EPPERT_CE_HSC_LSC,0.99999
HP_ADVANCED_ERUPTION_OF_TEETH,SET,37,0.040487,0.0018158,0.1367,0.38355,HP_ADVANCED_ERUPTION_OF_TEETH,0.99999
HP_SUBVALVULAR_AORTIC_STENOS...,SET,21,0.058373,0.0019731,0.19713,0.38357,HP_SUBVALVULAR_AORTIC_STENOSIS,0.99999
MIR1298_5P,SET,40,0.038007,0.0017722,0.12845,0.38366,MIR1298_5P,0.99999
HP_DIFFUSE_CEREBELLAR_ATROPHY,SET,15,0.058006,0.0016574,0.19622,0.38376,HP_DIFFUSE_CEREBELLAR_ATROPHY,0.99999
MIR7849_3P,SET,105,0.025813,0.0019466,0.087382,0.38385,MIR7849_3P,0.99999
AREB6_01,SET,247,0.016389,0.0018881,0.055501,0.38389,AREB6_01,0.99999
HP_POSTAXIAL_POLYDACTYLY,SET,123,0.02233,0.0018216,0.07563,0.3839,HP_POSTAXIAL_POLYDACTYLY,0.99999
HP_HYPERORALITY,SET,15,0.067354,0.0019245,0.22813,0.38391,HP_HYPERORALITY,0.99999
DESCARTES_FETAL_KIDNEY_MYELO...,SET,151,0.02188,0.0019762,0.074176,0.38401,DESCARTES_FETAL_KIDNEY_MYELOID_CELLS,0.99999
DACOSTA_UV_RESPONSE_VIA_ERCC...4,SET,78,0.028295,0.0018404,0.096008,0.38411,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,0.99999
LI_ESTROGENE_NON_MCF7_T47D_E...2,SET,15,0.059868,0.0017106,0.20314,0.38411,LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_UP,0.99999
MODULE_44,SET,290,0.015664,0.0019532,0.053163,0.38414,MODULE_44,0.99999
GOBP_AUTOCRINE_SIGNALING,SET,7,0.10778,0.0021042,0.36591,0.38417,GOBP_AUTOCRINE_SIGNALING,0.99999
HP_SCAPHOCEPHALY,SET,38,0.040681,0.001849,0.13816,0.38421,HP_SCAPHOCEPHALY,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...21,SET,15,0.069034,0.0019725,0.23468,0.38432,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_EPITHELIAL_CELLS,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...6,SET,22,0.049195,0.001702,0.16726,0.38434,GOMF_STRUCTURAL_CONSTITUENT_OF_NUCLEAR_PORE,0.99999
GOBP_PRENYLATION,SET,10,0.077461,0.0018074,0.2634,0.38435,GOBP_PRENYLATION,0.99999
NIKOLSKY_BREAST_CANCER_17Q21...,SET,305,0.024728,0.0031608,0.084112,0.38438,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,0.99999
HP_ABNORMAL_BASOPHIL_MORPHOL...,SET,8,0.098492,0.0020556,0.33501,0.38438,HP_ABNORMAL_BASOPHIL_MORPHOLOGY,0.99999
GOBP_MEMBRANE_FUSION,SET,166,0.019505,0.0018463,0.066358,0.38441,GOBP_MEMBRANE_FUSION,0.99999
NABA_MATRISOME_HIGHLY_METAST...1,SET,37,0.040006,0.0017942,0.13622,0.3845,NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER,0.99999
GOBP_UROGENITAL_SYSTEM_DEVEL...,SET,64,0.035703,0.0021044,0.12157,0.3845,GOBP_UROGENITAL_SYSTEM_DEVELOPMENT,0.99999
KAECH_DAY8_EFF_VS_MEMORY_CD8...1,SET,184,0.018559,0.0018487,0.063199,0.38451,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN,0.99999
HP_ANTEVERTED_EARS,SET,10,0.085903,0.0020044,0.29264,0.38455,HP_ANTEVERTED_EARS,0.99999
HP_ABNORMAL_GLOMERULAR_MESAN...,SET,44,0.037375,0.0018276,0.12739,0.38461,HP_ABNORMAL_GLOMERULAR_MESANGIUM_MORPHOLOGY,0.99999
EHRLICH_ICF_SYNDROM_UP,SET,9,0.084284,0.0018657,0.28738,0.38465,EHRLICH_ICF_SYNDROM_UP,0.99999
GOCC_INTRACILIARY_TRANSPORT_...2,SET,8,0.077224,0.0016117,0.26335,0.38467,GOCC_INTRACILIARY_TRANSPORT_PARTICLE_A,0.99999
GOCC_FACIT_COLLAGEN_TRIMER,SET,6,0.11677,0.0021107,0.39846,0.38474,GOCC_FACIT_COLLAGEN_TRIMER,0.99999
PASQUALUCCI_LYMPHOMA_BY_GC_S...1,SET,156,0.020962,0.0019241,0.071557,0.38479,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,0.99999
GOMF_TETRAPYRROLE_BINDING,SET,135,0.023441,0.0020027,0.080034,0.38481,GOMF_TETRAPYRROLE_BINDING,0.99999
GGTGTGT_MIR329,SET,103,0.026992,0.0020161,0.092173,0.38483,GGTGTGT_MIR329,0.99999
GOBP_RRNA_5_END_PROCESSING,SET,5,0.10469,0.0017275,0.35757,0.38484,GOBP_RRNA_5_END_PROCESSING,0.99999
FOXF1_TARGET_GENES,SET,5,0.11294,0.0018637,0.38587,0.38488,FOXF1_TARGET_GENES,0.99999
GSE17721_LPS_VS_CPG_0.5H_BMD...2,SET,177,0.018133,0.0017719,0.061955,0.38489,GSE17721_LPS_VS_CPG_0.5H_BMDC_UP,0.99999
GSE19198_6H_VS_24H_IL21_TREA...1,SET,177,0.018957,0.0018524,0.064786,0.38492,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN,0.99999
GOBP_ENDOCRINE_SYSTEM_DEVELO...,SET,130,0.024047,0.0020164,0.082233,0.38498,GOBP_ENDOCRINE_SYSTEM_DEVELOPMENT,0.99999
GOBP_PHAGOSOME_LYSOSOME_FUSI...,SET,13,0.073725,0.0019612,0.25211,0.38498,GOBP_PHAGOSOME_LYSOSOME_FUSION,0.99999
REACTOME_CHYLOMICRON_ASSEMBLY,SET,8,0.088924,0.0018559,0.3043,0.38506,REACTOME_CHYLOMICRON_ASSEMBLY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...548,SET,36,0.041922,0.0018546,0.14352,0.38511,GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,0.99999
HP_LEFT_TO_RIGHT_SHUNT,SET,10,0.089124,0.0020795,0.30512,0.38511,HP_LEFT_TO_RIGHT_SHUNT,0.99999
GSE27859_MACROPHAGE_VS_DC_DN,SET,170,0.019241,0.001843,0.065882,0.38512,GSE27859_MACROPHAGE_VS_DC_DN,0.99999
BIOCARTA_AKAP95_PATHWAY,SET,11,0.06795,0.0016628,0.23271,0.38515,BIOCARTA_AKAP95_PATHWAY,0.99999
HP_HYPOPLASTIC_HIPPOCAMPUS,SET,16,0.062424,0.0018421,0.21379,0.38515,HP_HYPOPLASTIC_HIPPOCAMPUS,0.99999
GOMF_WIDE_PORE_CHANNEL_ACTIV...,SET,30,0.051053,0.0020621,0.17491,0.38519,GOMF_WIDE_PORE_CHANNEL_ACTIVITY,0.99999
MIR6776_5P,SET,83,0.026652,0.001788,0.09135,0.38524,MIR6776_5P,0.99999
GOCC_NUCLEAR_PORE,SET,87,0.025286,0.0017366,0.086736,0.38532,GOCC_NUCLEAR_PORE,0.99999
GOBP_T_CELL_CHEMOTAXIS,SET,24,0.053069,0.0019176,0.18212,0.38537,GOBP_T_CELL_CHEMOTAXIS,0.99999
GOBP_NEUROMUSCULAR_PROCESS_C...1,SET,50,0.038262,0.0019941,0.13135,0.38541,GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE,0.99999
FOURNIER_ACINAR_DEVELOPMENT_...1,SET,6,0.1138,0.0020571,0.39071,0.38542,FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN,0.99999
MIR6514_3P,SET,67,0.03008,0.0018139,0.10327,0.38542,MIR6514_3P,0.99999
GOBP_VIRAL_GENOME_REPLICATION,SET,117,0.023851,0.001898,0.081892,0.38543,GOBP_VIRAL_GENOME_REPLICATION,0.99999
BIOCARTA_TPO_PATHWAY,SET,24,0.052419,0.0018941,0.18003,0.38546,BIOCARTA_TPO_PATHWAY,0.99999
GOBP_REGULATION_OF_RNA_SPLIC...,SET,161,0.018028,0.0016809,0.06194,0.3855,GOBP_REGULATION_OF_RNA_SPLICING,0.99999
HP_ABNORMALITY_OF_THE_TONSILS,SET,29,0.046926,0.0018636,0.16131,0.38556,HP_ABNORMALITY_OF_THE_TONSILS,0.99999
HP_SUDDEN_LOSS_OF_VISUAL_ACU...,SET,5,0.10251,0.0016916,0.35242,0.38557,HP_SUDDEN_LOSS_OF_VISUAL_ACUITY,0.99999
HP_CARDIORESPIRATORY_ARREST,SET,10,0.08546,0.001994,0.29386,0.3856,HP_CARDIORESPIRATORY_ARREST,0.99999
GOMF_INORGANIC_DIPHOSPHATE_P...,SET,4,0.14236,0.0021012,0.48966,0.38563,GOMF_INORGANIC_DIPHOSPHATE_PHOSPHATASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...4,SET,9,0.086209,0.0019083,0.29657,0.38565,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,0.99999
HP_GALACTOSURIA,SET,4,0.11584,0.0017097,0.39853,0.38565,HP_GALACTOSURIA,0.99999
BILANGES_RAPAMYCIN_SENSITIVE...2,SET,59,0.030387,0.0017199,0.10457,0.38568,BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,0.99999
GOBP_POST_EMBRYONIC_EYE_MORP...,SET,7,0.1037,0.0020246,0.35686,0.38568,GOBP_POST_EMBRYONIC_EYE_MORPHOGENESIS,0.99999
HP_ABNORMALITY_OF_THE_TONGUE,SET,409,0.012323,0.0018187,0.042452,0.3858,HP_ABNORMALITY_OF_THE_TONGUE,0.99999
GOMF_PHOSPHATIDYLINOSITOL_4_...2,SET,75,0.029051,0.0018531,0.10012,0.38585,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_BINDING,0.99999
GOBP_MULTICELLULAR_ORGANISMA...1,SET,75,0.029957,0.0019109,0.10329,0.38589,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_CHEMICAL_HOMEOSTASIS,0.99999
DASU_IL6_SIGNALING_SCAR_UP,SET,30,0.045171,0.0018245,0.15575,0.3859,DASU_IL6_SIGNALING_SCAR_UP,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...6,SET,39,0.037824,0.0017415,0.13042,0.3859,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP,0.99999
HP_INCREASED_BODY_WEIGHT,SET,424,0.012292,0.0018464,0.04239,0.38592,HP_INCREASED_BODY_WEIGHT,0.99999
HP_ONYCHOGRYPOSIS,SET,27,0.048827,0.0018712,0.16866,0.3861,HP_ONYCHOGRYPOSIS,0.99999
GSE41978_ID2_KO_VS_ID2_KO_AN...2,SET,175,0.019984,0.0019418,0.069057,0.38615,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.99999
GSE29615_CTRL_VS_DAY3_LAIV_I...2,SET,175,0.018798,0.0018265,0.064985,0.38619,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP,0.99999
GSE24634_NAIVE_CD4_TCELL_VS_...3,SET,182,0.017424,0.0017263,0.060245,0.38621,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN,0.99999
GSE17721_0.5H_VS_24H_POLYIC_...1,SET,183,0.017592,0.0017476,0.060869,0.38629,GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN,0.99999
GOMF_MOLECULAR_FUNCTION_ACTI...,SET,1018,0.0082879,0.0018968,0.028682,0.38631,GOMF_MOLECULAR_FUNCTION_ACTIVATOR_ACTIVITY,0.99999
GOBP_ENDOPLASMIC_RETICULUM_O...,SET,84,0.025999,0.0017546,0.090022,0.38637,GOBP_ENDOPLASMIC_RETICULUM_ORGANIZATION,0.99999
FREDERICK_PRKCI_TARGETS,SET,9,0.082444,0.001825,0.2856,0.38642,FREDERICK_PRKCI_TARGETS,0.99999
GOBP_ER_NUCLEUS_SIGNALING_PA...,SET,44,0.036988,0.0018086,0.12815,0.38643,GOBP_ER_NUCLEUS_SIGNALING_PATHWAY,0.99999
GSE29949_CD8_POS_DC_SPLEEN_V...1,SET,172,0.019043,0.0018346,0.065989,0.38645,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN,0.99999
ZHOU_PANCREATIC_EXOCRINE_PRO...,SET,11,0.084556,0.0020692,0.29312,0.38649,ZHOU_PANCREATIC_EXOCRINE_PROGENITOR,0.99999
GSE29618_PRE_VS_DAY7_POST_TI...3,SET,177,0.01752,0.001712,0.060739,0.38651,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN,0.99999
GOBP_SECONDARY_METABOLITE_BI...,SET,24,0.053593,0.0019365,0.18582,0.38652,GOBP_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,0.99999
chr1p12,SET,16,0.1044,0.0030807,0.36221,0.38659,chr1p12,0.99999
WOO_LIVER_CANCER_RECURRENCE_...1,SET,74,0.029473,0.0018674,0.10226,0.38659,WOO_LIVER_CANCER_RECURRENCE_DN,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...8,SET,19,0.062239,0.0020013,0.21602,0.38663,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PTP,0.99999
GSE5589_WT_VS_IL6_KO_LPS_AND...4,SET,175,0.018229,0.0017713,0.063287,0.38666,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.99999
chr14q24,SET,107,0.049164,0.0037424,0.17094,0.38683,chr14q24,0.99999
REACTOME_CASPASE_ACTIVATION_...2,SET,9,0.085522,0.0018931,0.29736,0.38683,REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND,0.99999
GSE5589_UNSTIM_VS_45MIN_LPS_...3,SET,178,0.017564,0.0017211,0.061113,0.3869,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_DN,0.99999
GNF2_RRM1,SET,85,0.024691,0.0016762,0.085936,0.38693,GNF2_RRM1,0.99999
MIR4639_5P,SET,86,0.028434,0.0019416,0.098971,0.38694,MIR4639_5P,0.99999
MORF_SOD1,SET,243,0.014503,0.0016575,0.050484,0.38695,MORF_SOD1,0.99999
GOBP_REGULATION_OF_DNA_METAB...,SET,447,0.011227,0.0017304,0.039081,0.38696,GOBP_REGULATION_OF_DNA_METABOLIC_PROCESS,0.99999
HP_SENSORY_AXONAL_NEUROPATHY,SET,36,0.039488,0.001747,0.13749,0.38697,HP_SENSORY_AXONAL_NEUROPATHY,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...3,SET,181,0.018058,0.0017842,0.062916,0.38705,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN,0.99999
GSE19772_CTRL_VS_HCMV_INF_MO...2,SET,168,0.018215,0.0017345,0.063479,0.38708,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,0.99999
GOBP_GLYCEROL_ETHER_METABOLI...,SET,19,0.058604,0.0018844,0.20426,0.38709,GOBP_GLYCEROL_ETHER_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_METAPHASE...,SET,14,0.066254,0.0018289,0.23097,0.38711,GOBP_REGULATION_OF_METAPHASE_PLATE_CONGRESSION,0.99999
GOBP_CELLULAR_RESPONSE_TO_CA...4,SET,49,0.036153,0.0018653,0.12612,0.38719,GOBP_CELLULAR_RESPONSE_TO_CAMP,0.99999
GSE6875_TCONV_VS_TREG_UP,SET,180,0.018332,0.0018063,0.063951,0.38719,GSE6875_TCONV_VS_TREG_UP,0.99999
ESC_J1_UP_EARLY.V1_DN,SET,153,0.0201,0.0018273,0.070128,0.3872,ESC_J1_UP_EARLY.V1_DN,0.99999
GOBP_ANTERIOR_COMMISSURE_MOR...,SET,7,0.10803,0.0021091,0.37699,0.38723,GOBP_ANTERIOR_COMMISSURE_MORPHOGENESIS,0.99999
GOBP_REGULATION_OF_CELLULAR_...1,SET,12,0.069071,0.0017654,0.24104,0.38723,GOBP_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS,0.99999
MORF_STK17A,SET,158,0.019542,0.0018051,0.068202,0.38724,MORF_STK17A,0.99999
HP_ABNORMAL_BRAIN_FDG_POSITR...,SET,22,0.048978,0.0016945,0.17094,0.38724,HP_ABNORMAL_BRAIN_FDG_POSITRON_EMISSION_TOMOGRAPHY,0.99999
GSE17721_CTRL_VS_PAM3CSK4_24...2,SET,185,0.018242,0.001822,0.063711,0.38732,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_UP,0.99999
BIOCARTA_BCR_PATHWAY,SET,31,0.04382,0.0017992,0.15314,0.38738,BIOCARTA_BCR_PATHWAY,0.99999
NUTT_GBM_VS_AO_GLIOMA_UP,SET,41,0.040238,0.0018994,0.14067,0.38742,NUTT_GBM_VS_AO_GLIOMA_UP,0.99999
HP_NEPHRITIS,SET,113,0.023462,0.001835,0.082064,0.38748,HP_NEPHRITIS,0.99999
GSE26727_WT_VS_KLF2_KO_LPS_S...1,SET,189,0.017617,0.0017783,0.061634,0.3875,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_DN,0.99999
MIR3611,SET,135,0.021014,0.0017954,0.073537,0.38753,MIR3611,0.99999
GOCC_HAPTOGLOBIN_HEMOGLOBIN_...,SET,7,0.11363,0.0022185,0.39775,0.38756,GOCC_HAPTOGLOBIN_HEMOGLOBIN_COMPLEX,0.99999
HP_ABNORMALITY_OF_NEURONAL_M...,SET,424,0.01169,0.0017559,0.040933,0.3876,HP_ABNORMALITY_OF_NEURONAL_MIGRATION,0.99999
HP_ABNORMALITY_OF_COMPLEMENT...,SET,49,0.036776,0.0018975,0.12892,0.38772,HP_ABNORMALITY_OF_COMPLEMENT_SYSTEM,0.99999
GOBP_REGULATION_OF_ENDOTHELI...1,SET,19,0.062608,0.0020131,0.21965,0.38781,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,0.99999
GOBP_FACE_MORPHOGENESIS,SET,30,0.046804,0.0018905,0.16427,0.38786,GOBP_FACE_MORPHOGENESIS,0.99999
GOBP_SYNAPTIC_VESICLE_LOCALI...,SET,53,0.03342,0.0017931,0.11731,0.38787,GOBP_SYNAPTIC_VESICLE_LOCALIZATION,0.99999
GSE9960_GRAM_NEG_VS_GRAM_POS...1,SET,179,0.017714,0.0017406,0.062192,0.38789,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN,0.99999
HP_HEAD_TITUBATION,SET,18,0.055878,0.0017489,0.19619,0.3879,HP_HEAD_TITUBATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...261,SET,31,0.045724,0.0018773,0.16061,0.38794,GOBP_POSITIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,0.99999
HP_SKIN_ULCER,SET,122,0.022726,0.0018464,0.079828,0.38795,HP_SKIN_ULCER,0.99999
GSE39820_CTRL_VS_TGFBETA1_IL...4,SET,172,0.018159,0.0017495,0.063805,0.38798,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP,0.99999
GOBP_REGULATION_OF_NEURON_PR...2,SET,402,0.012657,0.0018523,0.044484,0.38801,GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,0.99999
BHATI_G2M_ARREST_BY_2METHOXY...2,SET,107,0.023301,0.0017737,0.081904,0.38802,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,0.99999
BIOCARTA_STATHMIN_PATHWAY,SET,20,0.055802,0.0018408,0.19621,0.38805,BIOCARTA_STATHMIN_PATHWAY,0.99999
LIANG_SILENCED_BY_METHYLATIO...2,SET,9,0.081194,0.0017973,0.28558,0.38809,LIANG_SILENCED_BY_METHYLATION_DN,0.99999
GSE24634_IL4_VS_CTRL_TREATED...5,SET,183,0.018858,0.0018734,0.06634,0.38811,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN,0.99999
GOBP_ATP_SYNTHESIS_COUPLED_E...,SET,81,0.023662,0.0015683,0.083311,0.3882,GOBP_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT,0.99999
HP_ABNORMAL_FOVEAL_MORPHOLOGY,SET,45,0.039628,0.0019596,0.13954,0.38821,HP_ABNORMAL_FOVEAL_MORPHOLOGY,0.99999
GSE3982_NEUTROPHIL_VS_TH1_UP,SET,171,0.018944,0.0018198,0.066723,0.38824,GSE3982_NEUTROPHIL_VS_TH1_UP,0.99999
GOBP_SKIN_MORPHOGENESIS,SET,13,0.065756,0.0017492,0.23174,0.38831,GOBP_SKIN_MORPHOGENESIS,0.99999
GOBP_AMINE_TRANSPORT,SET,90,0.027745,0.0019379,0.09782,0.38835,GOBP_AMINE_TRANSPORT,0.99999
WP_OVERVIEW_OF_PROINFLAMMATO...,SET,121,0.026785,0.0021674,0.094467,0.38838,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,0.99999
MIR582_3P,SET,83,0.027172,0.0018229,0.095858,0.38841,MIR582_3P,0.99999
WEBER_METHYLATED_HCP_IN_SPER...1,SET,28,0.045251,0.0017659,0.15968,0.38844,WEBER_METHYLATED_HCP_IN_SPERM_DN,0.99999
MEISSNER_NPC_HCP_WITH_H3K4ME...2,SET,140,0.02183,0.0018991,0.077041,0.38845,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.99999
MODULE_293,SET,10,0.087687,0.002046,0.31011,0.38868,MODULE_293,0.99999
NAKAYA_MONOCYTE_FLUMIST_AGE_...1,SET,237,0.0154,0.0017385,0.054482,0.38872,NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN,0.99999
REACTOME_DEX_H_BOX_HELICASES...,SET,7,0.08223,0.0016054,0.29098,0.38875,REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION,0.99999
HP_RETINAL_THINNING,SET,28,0.046383,0.0018101,0.16415,0.38876,HP_RETINAL_THINNING,0.99999
WAMUNYOKOLI_OVARIAN_CANCER_L...2,SET,254,0.015377,0.0017962,0.054423,0.38877,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,0.99999
HP_FLAT_CORNEA,SET,19,0.062234,0.0020011,0.22031,0.38879,HP_FLAT_CORNEA,0.99999
GOBP_REGULATION_OF_MACROPHAG...8,SET,6,0.1077,0.0019468,0.38137,0.38882,GOBP_REGULATION_OF_MACROPHAGE_PROLIFERATION,0.99999
WP_FAMILIAL_HYPERLIPIDEMIA_T...3,SET,12,0.074726,0.0019099,0.26503,0.38899,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,0.99999
GOBP_REGULATION_OF_TRANS_SYN...,SET,446,0.011955,0.0018406,0.0424,0.38899,GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING,0.99999
GOBP_RESPONSE_TO_FRUCTOSE,SET,10,0.064336,0.0015012,0.22818,0.38899,GOBP_RESPONSE_TO_FRUCTOSE,0.99999
GAVIN_IL2_RESPONSIVE_FOXP3_T...1,SET,5,0.10525,0.0017368,0.37332,0.389,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN,0.99999
KEGG_GLYCOSAMINOGLYCAN_DEGRA...,SET,20,0.056661,0.0018692,0.20098,0.389,KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,0.99999
KEGG_HYPERTROPHIC_CARDIOMYOP...,SET,79,0.028984,0.0018972,0.10282,0.38902,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,0.99999
REACTOME_HIGHLY_CALCIUM_PERM...2,SET,11,0.087613,0.002144,0.31093,0.38906,REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,0.99999
GARCIA_PINERES_PBMC_HPV_16_L...8,SET,237,0.016803,0.0018969,0.059662,0.38911,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_UP,0.99999
KEGG_MEDICUS_ENV_FACTOR_NNK_...4,SET,18,0.058636,0.0018352,0.20834,0.38919,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOBP_ESTABLISHMENT_OF_LEFT_R...,SET,5,0.087413,0.0014424,0.31065,0.38921,GOBP_ESTABLISHMENT_OF_LEFT_RIGHT_ASYMMETRY,0.99999
CHEBOTAEV_GR_TARGETS_UP,SET,76,0.029424,0.0018893,0.10458,0.38922,CHEBOTAEV_GR_TARGETS_UP,0.99999
GOBP_VASODILATION,SET,44,0.040856,0.0019978,0.14521,0.38922,GOBP_VASODILATION,0.99999
GSE3982_BCELL_VS_CENT_MEMORY...2,SET,177,0.017932,0.0017523,0.063744,0.38924,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP,0.99999
GSE41867_DAY6_VS_DAY15_LCMV_...2,SET,161,0.020791,0.0019385,0.073944,0.38929,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.99999
GOMF_NUCLEOTIDE_SUGAR_TRANSM...,SET,12,0.067229,0.0017183,0.23935,0.3894,GOMF_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
SOBOLEV_PBMC_PANDEMRIX_AGE_1...5,SET,9,0.085483,0.0018923,0.30446,0.38944,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_TRANSIENT_UP,0.99999
GSE29618_MONOCYTE_VS_PDC_DAY...1,SET,174,0.018127,0.0017564,0.064566,0.38945,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...99,SET,4,0.12854,0.0018972,0.45791,0.38947,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,0.99999
GOBP_LIVER_MORPHOGENESIS,SET,25,0.048602,0.0017923,0.17324,0.38953,GOBP_LIVER_MORPHOGENESIS,0.99999
GOBP_NAIL_DEVELOPMENT,SET,11,0.081568,0.0019961,0.2908,0.38955,GOBP_NAIL_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...219,SET,65,0.029475,0.0017508,0.1051,0.38957,GOBP_POSITIVE_REGULATION_OF_DNA_RECOMBINATION,0.99999
GOMF_C_C_CHEMOKINE_BINDING,SET,22,0.059518,0.0020592,0.21224,0.38958,GOMF_C_C_CHEMOKINE_BINDING,0.99999
REACTOME_HDACS_DEACETYLATE_H...,SET,29,0.042246,0.0016778,0.15067,0.38959,REACTOME_HDACS_DEACETYLATE_HISTONES,0.99999
HP_SMALL_JOINT_HYPERMOBILTY,SET,52,0.03404,0.0018091,0.12142,0.38961,HP_SMALL_JOINT_HYPERMOBILTY,0.99999
MYB_Q3,SET,233,0.015501,0.0017352,0.055299,0.38962,MYB_Q3,0.99999
GOBP_REGULATION_OF_HEMOPOIES...,SET,384,0.01278,0.001829,0.045609,0.38966,GOBP_REGULATION_OF_HEMOPOIESIS,0.99999
GOBP_SNRNA_TRANSCRIPTION_BY_...2,SET,9,0.070354,0.0015574,0.2511,0.38967,GOBP_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.99999
WALLACE_PROSTATE_CANCER_UP,SET,18,0.059506,0.0018624,0.2124,0.38968,WALLACE_PROSTATE_CANCER_UP,0.99999
GOBP_BILE_ACID_AND_BILE_SALT...,SET,29,0.045297,0.0017989,0.16169,0.38969,GOBP_BILE_ACID_AND_BILE_SALT_TRANSPORT,0.99999
GOBP_NEPHRON_DEVELOPMENT,SET,150,0.021243,0.0019124,0.075859,0.38973,GOBP_NEPHRON_DEVELOPMENT,0.99999
HP_CHOLANGIOCARCINOMA,SET,8,0.086414,0.0018035,0.30859,0.38973,HP_CHOLANGIOCARCINOMA,0.99999
GOBP_L_PROLINE_TRANSMEMBRANE...,SET,3,0.14144,0.0018079,0.50526,0.38977,GOBP_L_PROLINE_TRANSMEMBRANE_TRANSPORT,0.99999
REACTOME_SIGNALING_BY_SCF_KIT,SET,42,0.038333,0.0018314,0.13702,0.38983,REACTOME_SIGNALING_BY_SCF_KIT,0.99999
ONO_AML1_TARGETS_DN,SET,37,0.044177,0.0019813,0.158,0.3899,ONO_AML1_TARGETS_DN,0.99999
GOCC_CELL_CELL_CONTACT_ZONE,SET,68,0.030247,0.0018375,0.10818,0.3899,GOCC_CELL_CELL_CONTACT_ZONE,0.99999
HP_JAW_HYPERREFLEXIA,SET,39,0.036384,0.0016752,0.13015,0.38991,HP_JAW_HYPERREFLEXIA,0.99999
GOMF_MAGNESIUM_ION_BINDING,SET,209,0.01631,0.0017304,0.058359,0.38994,GOMF_MAGNESIUM_ION_BINDING,0.99999
HP_ABNORMAL_CIRCULATING_SERI...1,SET,5,0.1085,0.0017904,0.38835,0.38997,HP_ABNORMAL_CIRCULATING_SERINE_CONCENTRATION,0.99999
REACTOME_NEF_MEDIATES_DOWN_M...,SET,20,0.050888,0.0016787,0.18219,0.39001,REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...12,SET,95,0.023289,0.001671,0.083403,0.39003,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME,0.99999
GOBP_EMBRYONIC_SKELETAL_SYST...1,SET,121,0.024868,0.0020123,0.08913,0.39012,GOBP_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT,0.99999
LAMB3_TARGET_GENES,SET,5,0.10371,0.0017114,0.37194,0.39018,LAMB3_TARGET_GENES,0.99999
GSE45365_NK_CELL_VS_CD8_TCEL...1,SET,144,0.020988,0.0018515,0.075315,0.39025,GSE45365_NK_CELL_VS_CD8_TCELL_DN,0.99999
GSE45365_WT_VS_IFNAR_KO_CD11...3,SET,167,0.017695,0.00168,0.063516,0.39028,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_UP,0.99999
HP_CEREBRAL_DYSMYELINATION,SET,12,0.060391,0.0015435,0.21691,0.39035,HP_CEREBRAL_DYSMYELINATION,0.99999
MODULE_519,SET,15,0.064151,0.001833,0.23049,0.39038,MODULE_519,0.99999
HP_POSTERIOR_FOSSA_CYST,SET,15,0.06334,0.0018098,0.22756,0.39038,HP_POSTERIOR_FOSSA_CYST,0.99999
KEGG_MEDICUS_VARIANT_LOSS_OF...4,SET,12,0.075991,0.0019422,0.27305,0.39039,KEGG_MEDICUS_VARIANT_LOSS_OF_VHL_TO_HIF_1_SIGNALING_PATHWAY,0.99999
DESCARTES_FETAL_INTESTINE_ST...,SET,33,0.047863,0.0020275,0.17197,0.39039,DESCARTES_FETAL_INTESTINE_STROMAL_CELLS,0.99999
GOBP_MRNA_CIS_SPLICING_VIA_S...,SET,26,0.041419,0.0015576,0.14901,0.39053,GOBP_MRNA_CIS_SPLICING_VIA_SPLICEOSOME,0.99999
GOBP_SERTOLI_CELL_PROLIFERAT...,SET,5,0.091789,0.0015146,0.33049,0.39061,GOBP_SERTOLI_CELL_PROLIFERATION,0.99999
HP_HIGH_MYOPIA,SET,76,0.027798,0.0017849,0.10009,0.39061,HP_HIGH_MYOPIA,0.99999
GSE360_CTRL_VS_L_MAJOR_DC_DN,SET,181,0.018451,0.001823,0.066455,0.39065,GSE360_CTRL_VS_L_MAJOR_DC_DN,0.99999
GOBP_VESICLE_TETHERING_TO_GO...,SET,5,0.11304,0.0018653,0.40728,0.39068,GOBP_VESICLE_TETHERING_TO_GOLGI,0.99999
HP_DECREASED_CIRCULATING_FRE...1,SET,5,0.087664,0.0014466,0.31611,0.39077,HP_DECREASED_CIRCULATING_FREE_T3,0.99999
GSE14000_TRANSLATED_RNA_VS_M...3,SET,152,0.018871,0.00171,0.068053,0.39077,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN,0.99999
HP_ACETABULAR_SPURS,SET,5,0.11091,0.0018302,0.40004,0.39079,HP_ACETABULAR_SPURS,0.99999
MORF_PTPN11,SET,93,0.022562,0.0016018,0.081386,0.39081,MORF_PTPN11,0.99999
GOMF_NUCLEAR_RECEPTOR_BINDING,SET,126,0.020671,0.0017067,0.07457,0.39081,GOMF_NUCLEAR_RECEPTOR_BINDING,0.99999
HP_CEREBELLAR_VERMIS_ATROPHY,SET,49,0.032836,0.0016941,0.11846,0.39082,HP_CEREBELLAR_VERMIS_ATROPHY,0.99999
GOBP_DOUBLE_STRAND_BREAK_REP...6,SET,58,0.027304,0.0015323,0.098524,0.39084,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.99999
MIR4801,SET,242,0.015968,0.0018213,0.057628,0.39085,MIR4801,0.99999
MIR4789_3P,SET,305,0.014001,0.0017896,0.050528,0.39086,MIR4789_3P,0.99999
MEF2_04,SET,23,0.04997,0.0017676,0.18037,0.39088,MEF2_04,0.99999
MIR7_1_3P,SET,593,0.010339,0.001828,0.037346,0.39095,MIR7_1_3P,0.99999
GOBP_CELLULAR_RESPONSE_TO_RA...,SET,161,0.017618,0.0016427,0.063637,0.39095,GOBP_CELLULAR_RESPONSE_TO_RADIATION,0.99999
GOMF_GLUCOSE_BINDING,SET,9,0.08447,0.0018698,0.30532,0.39102,GOMF_GLUCOSE_BINDING,0.99999
GSE12845_IGD_NEG_BLOOD_VS_DA...1,SET,182,0.016404,0.0016252,0.059299,0.39103,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.99999
RAY_TARGETS_OF_P210_BCR_ABL_...2,SET,12,0.078667,0.0020106,0.28449,0.39108,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP,0.99999
MODULE_379,SET,178,0.017803,0.0017445,0.06444,0.39117,MODULE_379,0.99999
PID_IL2_1PATHWAY,SET,54,0.03423,0.0018537,0.12393,0.39119,PID_IL2_1PATHWAY,0.99999
GSE26669_CD4_VS_CD8_TCELL_IN...4,SET,184,0.017412,0.0017345,0.063038,0.39119,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP,0.99999
GSE39152_CD103_NEG_VS_POS_ME...2,SET,185,0.017772,0.001775,0.064338,0.39119,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP,0.99999
WP_REGULATION_OF_ACTIN_CYTOS...,SET,140,0.021301,0.001853,0.077127,0.39121,WP_REGULATION_OF_ACTIN_CYTOSKELETON,0.99999
STN1_TARGET_GENES,SET,8,0.087026,0.0018163,0.31515,0.39122,STN1_TARGET_GENES,0.99999
GSE21033_1H_VS_24H_POLYIC_ST...1,SET,152,0.018877,0.0017106,0.068364,0.39123,GSE21033_1H_VS_24H_POLYIC_STIM_DC_DN,0.99999
DORN_ADENOVIRUS_INFECTION_32...1,SET,36,0.037506,0.0016593,0.13586,0.39125,DORN_ADENOVIRUS_INFECTION_32HR_DN,0.99999
MIR3975,SET,46,0.034337,0.0017167,0.12441,0.39128,MIR3975,0.99999
GOBP_POSITIVE_REGULATION_OF_...212,SET,5,0.093369,0.0015407,0.33832,0.39128,GOBP_POSITIVE_REGULATION_OF_DNA_CATABOLIC_PROCESS,0.99999
GOBP_ENDOCARDIAL_CUSHION_DEV...,SET,52,0.037893,0.0020139,0.13732,0.3913,GOBP_ENDOCARDIAL_CUSHION_DEVELOPMENT,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...9,SET,184,0.017645,0.0017577,0.063945,0.3913,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN,0.99999
GSE42021_TCONV_PLN_VS_CD24IN...2,SET,177,0.017843,0.0017436,0.064679,0.39133,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP,0.99999
GSE11961_MEMORY_BCELL_DAY7_V...3,SET,179,0.017806,0.0017496,0.064553,0.39134,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_DN,0.99999
HP_HYPERNATRIURIA,SET,9,0.088061,0.0019493,0.3195,0.39142,HP_HYPERNATRIURIA,0.99999
GREGORY_SYNTHETIC_LETHAL_WIT...,SET,128,0.020429,0.0016999,0.074137,0.39145,GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,0.99999
GOMF_OXALATE_TRANSMEMBRANE_T...,SET,9,0.077072,0.0017061,0.27971,0.39145,GOMF_OXALATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
KEGG_MEDICUS_VARIANT_BCR_ABL...2,SET,13,0.064543,0.0017169,0.23426,0.39146,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
MIR6857_3P,SET,68,0.030449,0.0018497,0.11053,0.39147,MIR6857_3P,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...13,SET,164,0.017709,0.0016663,0.064303,0.39151,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
KEGG_ENDOCYTOSIS,SET,174,0.018089,0.0017527,0.06572,0.39157,KEGG_ENDOCYTOSIS,0.99999
KEGG_PROPANOATE_METABOLISM,SET,31,0.042756,0.0017555,0.15537,0.39159,KEGG_PROPANOATE_METABOLISM,0.99999
HP_PATENT_DUCTUS_ARTERIOSUS_...,SET,5,0.09994,0.0016491,0.36329,0.39162,HP_PATENT_DUCTUS_ARTERIOSUS_AFTER_BIRTH_AT_TERM,0.99999
HP_PREMATURE_ATRIAL_CONTRACT...,SET,6,0.11675,0.0021104,0.42452,0.39165,HP_PREMATURE_ATRIAL_CONTRACTIONS,0.99999
HP_VENOUS_THROMBOSIS,SET,74,0.029296,0.0018562,0.10655,0.39168,HP_VENOUS_THROMBOSIS,0.99999
GOMF_ADP_PHOSPHATASE_ACTIVITY,SET,6,0.074335,0.0013436,0.27046,0.39172,GOMF_ADP_PHOSPHATASE_ACTIVITY,0.99999
MIR378H,SET,39,0.03554,0.0016363,0.12934,0.39175,MIR378H,0.99999
MIR3944_5P,SET,103,0.022837,0.0017058,0.083143,0.39179,MIR3944_5P,0.99999
HP_BROAD_FIRST_METATARSAL,SET,5,0.11114,0.001834,0.40472,0.39181,HP_BROAD_FIRST_METATARSAL,0.99999
GOBP_REGULATION_OF_LIPOPOLYS...,SET,27,0.045923,0.0017599,0.16732,0.39186,GOBP_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,0.99999
DNMT3A_TARGET_GENES,SET,489,0.010751,0.0017312,0.039179,0.39189,DNMT3A_TARGET_GENES,0.99999
GOCC_LATE_ENDOSOME_LUMEN,SET,7,0.092843,0.0018126,0.33842,0.39191,GOCC_LATE_ENDOSOME_LUMEN,0.99999
GSE27786_LIN_NEG_VS_CD8_TCEL...2,SET,179,0.016693,0.0016403,0.060855,0.39193,GSE27786_LIN_NEG_VS_CD8_TCELL_UP,0.99999
GOBP_TRNA_PROCESSING,SET,119,0.019421,0.0015586,0.070874,0.39203,GOBP_TRNA_PROCESSING,0.99999
NIKOLSKY_MUTATED_AND_AMPLIFI...,SET,87,0.02445,0.0016792,0.089256,0.39207,NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...11,SET,31,0.04683,0.0019227,0.17096,0.39208,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,0.99999
REACTOME_ANCHORING_OF_THE_BA...,SET,91,0.022039,0.0015478,0.080462,0.39208,REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,0.99999
GOBP_PROTEIN_INSERTION_INTO_...7,SET,13,0.061208,0.0016282,0.22357,0.39213,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_OUTER_MEMBRANE,0.99999
GSE34156_UNTREATED_VS_24H_TL...2,SET,148,0.019834,0.0017736,0.072473,0.39217,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.99999
HP_INTELLECTUAL_DISABILITY_S...,SET,312,0.01306,0.0016881,0.047733,0.39219,HP_INTELLECTUAL_DISABILITY_SEVERE,0.99999
GOBP_EPIDERMAL_GROWTH_FACTOR...,SET,101,0.02307,0.0017065,0.084354,0.39224,GOBP_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_RECURRENT_ABSCESS_FORMATI...,SET,16,0.068311,0.0020158,0.24976,0.39224,HP_RECURRENT_ABSCESS_FORMATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...260,SET,6,0.085737,0.0015497,0.31353,0.39225,GOBP_NEGATIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,0.99999
HP_IRIS_COLOBOMA,SET,150,0.019078,0.0017175,0.069775,0.39226,HP_IRIS_COLOBOMA,0.99999
GOBP_MODULATION_BY_HOST_OF_V...3,SET,3,0.14058,0.001797,0.51415,0.39227,GOBP_MODULATION_BY_HOST_OF_VIRAL_RNA_GENOME_REPLICATION,0.99999
HP_ABNORMAL_5TH_FINGER_MORPH...,SET,435,0.011058,0.001682,0.040446,0.39227,HP_ABNORMAL_5TH_FINGER_MORPHOLOGY,0.99999
GSE15735_CTRL_VS_HDAC_INHIBI...3,SET,178,0.017971,0.001761,0.065739,0.39229,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN,0.99999
GOBP_ODONTOGENESIS,SET,122,0.023519,0.0019109,0.086046,0.3923,GOBP_ODONTOGENESIS,0.99999
GSE21380_NON_TFH_VS_GERMINAL...2,SET,176,0.017901,0.0017443,0.065511,0.39233,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,0.99999
REACTOME_SUMOYLATION_OF_RNA_...,SET,44,0.033513,0.0016387,0.1227,0.39237,REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...25,SET,349,0.012888,0.00176,0.047197,0.3924,GOBP_PROTEIN_LOCALIZATION_TO_EXTRACELLULAR_REGION,0.99999
GSE3982_MAST_CELL_VS_NKCELL_...1,SET,179,0.017736,0.0017428,0.064957,0.39241,GSE3982_MAST_CELL_VS_NKCELL_DN,0.99999
MODULE_562,SET,20,0.059963,0.0019781,0.21965,0.39243,MODULE_562,0.99999
WHITFIELD_CELL_CYCLE_S,SET,128,0.020171,0.0016784,0.073902,0.39245,WHITFIELD_CELL_CYCLE_S,0.99999
HAY_BONE_MARROW_CD34_POS_LMPP,SET,6,0.10959,0.0019809,0.40159,0.39247,HAY_BONE_MARROW_CD34_POS_LMPP,0.99999
GSE5589_LPS_VS_LPS_AND_IL10_...10,SET,180,0.017556,0.0017298,0.064367,0.39253,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.99999
HP_TIBIALIS_ANTERIOR_MUSCLE_...,SET,4,0.12508,0.0018461,0.45864,0.39254,HP_TIBIALIS_ANTERIOR_MUSCLE_ATROPHY,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...5,SET,6,0.11143,0.0020141,0.4087,0.39257,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_PAI,0.99999
REACTOME_DEFECTIVE_CSF2RB_CA...,SET,7,0.10817,0.0021118,0.39694,0.39262,REACTOME_DEFECTIVE_CSF2RB_CAUSES_SMDP5,0.99999
HP_ABNORMAL_METACARPAL_MORPH...,SET,196,0.017045,0.0017518,0.062561,0.39264,HP_ABNORMAL_METACARPAL_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...154,SET,67,0.030293,0.0018267,0.11123,0.39268,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_PRODUCTION,0.99999
WANG_SMARCE1_TARGETS_UP,SET,258,0.015904,0.0018721,0.058406,0.3927,WANG_SMARCE1_TARGETS_UP,0.99999
GOBP_REGULATION_OF_DNA_TEMPL...4,SET,79,0.024819,0.0016246,0.091207,0.39277,GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.99999
HP_TIBIAL_BOWING,SET,33,0.041943,0.0017767,0.15429,0.39287,HP_TIBIAL_BOWING,0.99999
HP_ABNORMAL_CELL_MORPHOLOGY,SET,42,0.033535,0.0016022,0.12337,0.39288,HP_ABNORMAL_CELL_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_ACTIN_NUC...,SET,27,0.040334,0.0015457,0.14844,0.39292,GOBP_REGULATION_OF_ACTIN_NUCLEATION,0.99999
HP_PROGRESSIVE_NIGHT_BLINDNE...,SET,85,0.025099,0.0017039,0.092374,0.39292,HP_PROGRESSIVE_NIGHT_BLINDNESS,0.99999
WP_BIOMARKERS_FOR_PYRIMIDINE...,SET,15,0.058113,0.0016605,0.2139,0.39293,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,0.99999
GOBP_INNER_MITOCHONDRIAL_MEM...,SET,35,0.037298,0.001627,0.13737,0.393,GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,0.99999
BURTON_ADIPOGENESIS_PEAK_AT_...1,SET,59,0.030949,0.0017517,0.11406,0.39307,BURTON_ADIPOGENESIS_PEAK_AT_0HR,0.99999
GOBP_RESPONSE_TO_CYTOKINE,SET,857,0.0084828,0.0017895,0.031264,0.39307,GOBP_RESPONSE_TO_CYTOKINE,0.99999
HP_RECURRENT_CORNEAL_EROSIONS,SET,11,0.073813,0.0018063,0.27216,0.39311,HP_RECURRENT_CORNEAL_EROSIONS,0.99999
GOBP_REGULATION_OF_MRNA_META...,SET,271,0.013462,0.0016235,0.049644,0.39313,GOBP_REGULATION_OF_MRNA_METABOLIC_PROCESS,0.99999
HP_ABNORMAL_CIRCULATING_GONA...,SET,110,0.021631,0.0016694,0.079766,0.39313,HP_ABNORMAL_CIRCULATING_GONADOTROPIN_CONCENTRATION,0.99999
REACTOME_SIGNALING_BY_LEPTIN,SET,11,0.083383,0.0020405,0.30768,0.39319,REACTOME_SIGNALING_BY_LEPTIN,0.99999
GOMF_LYSOZYME_ACTIVITY,SET,9,0.081305,0.0017998,0.30001,0.3932,GOMF_LYSOZYME_ACTIVITY,0.99999
DOUGLAS_BMI1_TARGETS_DN,SET,293,0.01359,0.0017031,0.050224,0.39336,DOUGLAS_BMI1_TARGETS_DN,0.99999
HP_PROXIMAL_RENAL_TUBULAR_AC...,SET,10,0.070191,0.0016378,0.25948,0.39339,HP_PROXIMAL_RENAL_TUBULAR_ACIDOSIS,0.99999
KEGG_MEDICUS_REFERENCE_IGF_I...1,SET,13,0.066952,0.001781,0.24773,0.39348,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...271,SET,12,0.070332,0.0017976,0.26031,0.39351,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,0.99999
GOBP_MAMMARY_GLAND_EPITHELIA...1,SET,17,0.061898,0.0018827,0.22921,0.39356,GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
MAP2K1_TARGET_GENES,SET,5,0.093741,0.0015468,0.34726,0.3936,MAP2K1_TARGET_GENES,0.99999
GSE3691_IFN_PRODUCING_KILLER...1,SET,177,0.017229,0.0016836,0.063825,0.39361,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...21,SET,12,0.070471,0.0018011,0.26118,0.39365,GOBP_PROTEIN_LOCALIZATION_TO_EARLY_ENDOSOME,0.99999
HP_MITRAL_VALVE_PROLAPSE,SET,103,0.023045,0.0017213,0.085518,0.39378,HP_MITRAL_VALVE_PROLAPSE,0.99999
GOBP_T_CELL_PROLIFERATION,SET,195,0.017626,0.0018069,0.06542,0.3938,GOBP_T_CELL_PROLIFERATION,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...12,SET,4,0.12935,0.0019092,0.48037,0.39386,GOMF_STRUCTURAL_CONSTITUENT_OF_TOOTH_ENAMEL,0.99999
GSE22589_HIV_VS_HIV_AND_SIV_...2,SET,180,0.01696,0.0016712,0.06299,0.39387,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_UP,0.99999
GOBP_TELOMERASE_HOLOENZYME_C...,SET,6,0.070424,0.001273,0.26171,0.39393,GOBP_TELOMERASE_HOLOENZYME_COMPLEX_ASSEMBLY,0.99999
MARTORIATI_MDM4_TARGETS_NEUR...2,SET,149,0.019079,0.0017119,0.070943,0.39399,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,0.99999
GSE2770_UNTREATED_VS_TGFB_AN...7,SET,181,0.01705,0.0016847,0.063444,0.39406,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.99999
GSE360_L_DONOVANI_VS_B_MALAY...6,SET,177,0.018167,0.0017752,0.067615,0.39409,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP,0.99999
GOMF_ZINC_ION_BINDING,SET,757,0.008536,0.0016973,0.031781,0.39412,GOMF_ZINC_ION_BINDING,0.99999
ZHONG_PFC_C7_SST_LHX6_POS_PU...,SET,13,0.068378,0.001819,0.25476,0.3942,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.99999
GOBP_MYOBLAST_PROLIFERATION,SET,24,0.046494,0.00168,0.17325,0.39421,GOBP_MYOBLAST_PROLIFERATION,0.99999
HP_INCREASED_MUSCLE_LIPID_CO...,SET,33,0.04094,0.0017342,0.15256,0.39421,HP_INCREASED_MUSCLE_LIPID_CONTENT,0.99999
GSE26488_HDAC7_KO_VS_VP16_TR...2,SET,157,0.018708,0.0017227,0.06971,0.39421,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,0.99999
GOBP_LEUKOTRIENE_B4_METABOLI...,SET,5,0.10288,0.0016976,0.38347,0.39424,GOBP_LEUKOTRIENE_B4_METABOLIC_PROCESS,0.99999
GOBP_PROTEIN_K48_LINKED_UBIQ...,SET,94,0.023199,0.0016558,0.086487,0.39426,GOBP_PROTEIN_K48_LINKED_UBIQUITINATION,0.99999
GOMF_INITIATOR_METHIONYL_AMI...,SET,4,0.11974,0.0017673,0.44638,0.39426,GOMF_INITIATOR_METHIONYL_AMINOPEPTIDASE_ACTIVITY,0.99999
GOMF_CYSTEINE_TYPE_ENDOPEPTI...5,SET,5,0.10407,0.0017174,0.38847,0.39439,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,0.99999
GOBP_REGULATION_OF_BIOLOGICA...,SET,59,0.031581,0.0017875,0.11793,0.39442,GOBP_REGULATION_OF_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...296,SET,1056,0.0074023,0.0017235,0.027649,0.39446,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION,0.99999
KUMAMOTO_RESPONSE_TO_NUTLIN_...1,SET,9,0.064067,0.0014182,0.23932,0.39447,KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN,0.99999
GOCC_CORTICAL_GRANULE,SET,6,0.089796,0.0016231,0.33545,0.39447,GOCC_CORTICAL_GRANULE,0.99999
GOMF_GTPASE_ACTIVATOR_ACTIVI...,SET,240,0.014935,0.0016964,0.055791,0.39447,GOMF_GTPASE_ACTIVATOR_ACTIVITY,0.99999
GOCC_ORGANELLE_MEMBRANE_CONT...,SET,39,0.035372,0.0016286,0.13217,0.39449,GOCC_ORGANELLE_MEMBRANE_CONTACT_SITE,0.99999
HP_ADRENAL_HYPERPLASIA,SET,23,0.050603,0.00179,0.1892,0.39456,HP_ADRENAL_HYPERPLASIA,0.99999
HP_ANTENATAL_ONSET,SET,215,0.015293,0.0016453,0.057187,0.39457,HP_ANTENATAL_ONSET,0.99999
CLAUS_PGR_POSITIVE_MENINGIOM...1,SET,12,0.077025,0.0019686,0.28812,0.39461,CLAUS_PGR_POSITIVE_MENINGIOMA_DN,0.99999
HP_INSULIN_RESISTANT_DIABETE...,SET,38,0.038643,0.0017563,0.14456,0.39461,HP_INSULIN_RESISTANT_DIABETES_MELLITUS,0.99999
chr2q13,SET,14,0.086319,0.0023828,0.32296,0.39463,chr2q13,0.99999
GOMF_AMINO_ACID_MONOATOMIC_C...1,SET,4,0.094785,0.001399,0.35465,0.39464,GOMF_AMINO_ACID_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,0.99999
HP_ABNORMAL_JAW_MORPHOLOGY,SET,987,0.0073489,0.0016576,0.027497,0.39464,HP_ABNORMAL_JAW_MORPHOLOGY,0.99999
HP_ARRHINENCEPHALY,SET,30,0.038153,0.0015411,0.1428,0.39467,HP_ARRHINENCEPHALY,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_HMO...,SET,22,0.050534,0.0017483,0.18922,0.39471,HE_LIM_SUN_FETAL_LUNG_C3_HMOX1_POS_PRIMITIVE_ERYTHROBLAST,0.99999
HP_ALOPECIA_UNIVERSALIS,SET,11,0.076702,0.001877,0.28723,0.39472,HP_ALOPECIA_UNIVERSALIS,0.99999
KEGG_MEDICUS_REFERENCE_RETRO...,SET,42,0.033748,0.0016124,0.12643,0.39476,KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT,0.99999
GSE17721_POLYIC_VS_CPG_6H_BM...1,SET,183,0.016189,0.0016082,0.060671,0.3948,GSE17721_POLYIC_VS_CPG_6H_BMDC_DN,0.99999
GSE2706_2H_VS_8H_LPS_STIM_DC...2,SET,178,0.017336,0.0016988,0.065008,0.39486,GSE2706_2H_VS_8H_LPS_STIM_DC_UP,0.99999
GOMF_DEAD_H_BOX_RNA_HELICASE...,SET,8,0.091179,0.001903,0.34194,0.39487,GOMF_DEAD_H_BOX_RNA_HELICASE_BINDING,0.99999
REACTOME_DEFECTIVE_EXT2_CAUS...,SET,12,0.07542,0.0019276,0.28295,0.39491,REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2,0.99999
HP_ABNORMAL_CIRCULATING_C_RE...,SET,59,0.030299,0.0017149,0.11367,0.39491,HP_ABNORMAL_CIRCULATING_C_REACTIVE_PROTEIN_CONCENTRATION,0.99999
SETLUR_PROSTATE_CANCER_TMPRS...2,SET,66,0.027664,0.0016557,0.1038,0.39492,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,0.99999
GOCC_VOLTAGE_GATED_SODIUM_CH...,SET,14,0.06987,0.0019287,0.26224,0.39495,GOCC_VOLTAGE_GATED_SODIUM_CHANNEL_COMPLEX,0.99999
GOBP_NEGATIVE_REGULATION_OF_...314,SET,43,0.036372,0.0017583,0.13654,0.39498,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,0.99999
CACTGCC_MIR34A_MIR34C_MIR449,SET,258,0.013739,0.0016173,0.05159,0.395,CACTGCC_MIR34A_MIR34C_MIR449,0.99999
GOBP_NEGATIVE_REGULATION_OF_...611,SET,6,0.10791,0.0019505,0.40536,0.39504,GOBP_NEGATIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.99999
GSE5679_RARA_AGONIST_AM580_V...1,SET,181,0.017405,0.0017197,0.065394,0.39506,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN,0.99999
GSE21927_UNTREATED_VS_GMCSF_...1,SET,163,0.018033,0.0016917,0.067763,0.39507,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,0.99999
GSE29618_LAIV_VS_TIV_FLU_VAC...3,SET,170,0.01775,0.0017002,0.066699,0.39508,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...318,SET,14,0.062749,0.0017322,0.23587,0.39511,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,0.99999
GSE9316_CD4_TCELL_BALBC_VS_T...2,SET,178,0.016889,0.0016549,0.063494,0.39512,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...497,SET,4,0.13344,0.0019695,0.50195,0.39518,GOBP_POSITIVE_REGULATION_OF_MUSCLE_ADAPTATION,0.99999
GSE35435_RESTING_VS_IL4_TREA...2,SET,175,0.016541,0.0016073,0.062228,0.39519,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...51,SET,52,0.033312,0.0017704,0.12537,0.39523,GOBP_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,0.99999
HP_DECREASED_ACTIVITY_OF_MIT...1,SET,8,0.06947,0.0014499,0.26152,0.39526,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_ATP_SYNTHASE_COMPLEX,0.99999
HP_CIGARETTE_PAPER_SCARS,SET,10,0.077815,0.0018157,0.293,0.39528,HP_CIGARETTE_PAPER_SCARS,0.99999
GOMF_AMIDINE_LYASE_ACTIVITY,SET,7,0.089618,0.0017497,0.3375,0.3953,GOMF_AMIDINE_LYASE_ACTIVITY,0.99999
HP_EXERCISE_INDUCED_MYALGIA,SET,31,0.037963,0.0015587,0.14297,0.39531,HP_EXERCISE_INDUCED_MYALGIA,0.99999
MARCHINI_TRABECTEDIN_RESISTA...2,SET,16,0.057778,0.001705,0.21781,0.39541,MARCHINI_TRABECTEDIN_RESISTANCE_UP,0.99999
GOBP_REGULATION_OF_CYSTEINE_...3,SET,11,0.063888,0.0015634,0.24095,0.39545,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_VARIANT_TRK_FUS...,SET,10,0.070041,0.0016343,0.26426,0.39549,KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
WP_NEUROINFLAMMATION,SET,11,0.078348,0.0019173,0.2956,0.39549,WP_NEUROINFLAMMATION,0.99999
GSE9037_CTRL_VS_LPS_1H_STIM_...1,SET,176,0.017256,0.0016815,0.065115,0.3955,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN,0.99999
HP_RESTLESS_LEGS,SET,22,0.047533,0.0016445,0.17941,0.39553,HP_RESTLESS_LEGS,0.99999
WP_NUCLEAR_RECEPTORS_METAPAT...,SET,300,0.014103,0.0017881,0.053255,0.39557,WP_NUCLEAR_RECEPTORS_METAPATHWAY,0.99999
DESCARTES_MAIN_FETAL_ISLET_E...,SET,51,0.033772,0.0017776,0.12752,0.39557,DESCARTES_MAIN_FETAL_ISLET_ENDOCRINE_CELLS,0.99999
MIR3133,SET,447,0.011103,0.0017114,0.041934,0.39559,MIR3133,0.99999
GOBP_BRANCHING_INVOLVED_IN_P...,SET,12,0.073855,0.0018876,0.27899,0.39561,GOBP_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS,0.99999
PYEON_HPV_POSITIVE_TUMORS_UP,SET,81,0.024066,0.0015951,0.090938,0.39564,PYEON_HPV_POSITIVE_TUMORS_UP,0.99999
HP_ABNORMAL_MITRAL_VALVE_PHY...,SET,151,0.018886,0.0017058,0.071375,0.39566,HP_ABNORMAL_MITRAL_VALVE_PHYSIOLOGY,0.99999
GOMF_METHYL_CPG_BINDING,SET,25,0.046298,0.0017074,0.17499,0.39567,GOMF_METHYL_CPG_BINDING,0.99999
MIR608,SET,195,0.016926,0.0017352,0.063983,0.39568,MIR608,0.99999
GENTILE_UV_RESPONSE_CLUSTER_...7,SET,36,0.038916,0.0017216,0.14712,0.39569,GENTILE_UV_RESPONSE_CLUSTER_D8,0.99999
HP_HYPERACUSIS,SET,23,0.048856,0.0017282,0.18477,0.39573,HP_HYPERACUSIS,0.99999
GOBP_B_CELL_HOMEOSTASIS,SET,30,0.043538,0.0017586,0.16468,0.39575,GOBP_B_CELL_HOMEOSTASIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...215,SET,7,0.094829,0.0018514,0.35871,0.39575,GOBP_NEGATIVE_REGULATION_OF_ERAD_PATHWAY,0.99999
HP_ABNORMALITY_OF_THE_SUBUNG...,SET,11,0.063337,0.0015499,0.23959,0.39576,HP_ABNORMALITY_OF_THE_SUBUNGUAL_REGION,0.99999
GSE3720_UNSTIM_VS_PMA_STIM_V...1,SET,112,0.022074,0.0017189,0.083515,0.39577,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,0.99999
DESCARTES_FETAL_SPLEEN_VASCU...,SET,41,0.03922,0.0018514,0.14838,0.39577,DESCARTES_FETAL_SPLEEN_VASCULAR_ENDOTHELIAL_CELLS,0.99999
MODULE_153,SET,31,0.040863,0.0016778,0.1547,0.39584,MODULE_153,0.99999
REACTOME_DEADENYLATION_DEPEN...,SET,49,0.030474,0.0015723,0.11541,0.39587,REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...819,SET,18,0.049542,0.0015505,0.18768,0.3959,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...10,SET,179,0.015972,0.0015694,0.060505,0.3959,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP,0.99999
MIR10396A_5P,SET,8,0.076142,0.0015891,0.28851,0.39592,MIR10396A_5P,0.99999
HP_VITRITIS,SET,2,0.11133,0.001162,0.42196,0.39595,HP_VITRITIS,0.99999
WP_CALORIC_RESTRICTION_AND_A...,SET,8,0.081566,0.0017023,0.30919,0.39597,WP_CALORIC_RESTRICTION_AND_AGING,0.99999
MIR6837_3P,SET,101,0.022513,0.0016653,0.085467,0.39612,MIR6837_3P,0.99999
GSE3982_CTRL_VS_LPS_48H_DC_DN,SET,180,0.017696,0.0017436,0.067214,0.39617,GSE3982_CTRL_VS_LPS_48H_DC_DN,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_PUL...2,SET,270,0.014617,0.0017595,0.055517,0.39617,HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL,0.99999
HP_POLYSPLENIA,SET,49,0.030203,0.0015583,0.1149,0.39633,HP_POLYSPLENIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...461,SET,6,0.087665,0.0015846,0.33356,0.39635,GOBP_POSITIVE_REGULATION_OF_MICROTUBULE_NUCLEATION,0.99999
HP_AORTOPULMONARY_COLLATERAL...,SET,14,0.065785,0.001816,0.25032,0.39635,HP_AORTOPULMONARY_COLLATERAL_ARTERIES,0.99999
HP_FATIGABLE_WEAKNESS_OF_SWA...,SET,37,0.035729,0.0016024,0.13599,0.39638,HP_FATIGABLE_WEAKNESS_OF_SWALLOWING_MUSCLES,0.99999
KEGG_MEDICUS_REFERENCE_AVP_V...,SET,9,0.078132,0.0017295,0.29743,0.39639,KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_URINE_MAGNESIUM_...,SET,9,0.076754,0.001699,0.29245,0.39649,HP_ABNORMAL_URINE_MAGNESIUM_CONCENTRATION,0.99999
MCCLUNG_DELTA_FOSB_TARGETS_8...,SET,45,0.032559,0.00161,0.12407,0.3965,MCCLUNG_DELTA_FOSB_TARGETS_8WK,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_LAT...1,SET,103,0.02412,0.0018016,0.091937,0.39653,HE_LIM_SUN_FETAL_LUNG_C0_LATE_AIRWAY_SMC_CELL,0.99999
GSE26488_CTRL_VS_PEPTIDE_INJ...4,SET,148,0.018578,0.0016614,0.070831,0.39655,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_UP,0.99999
GSE3337_CTRL_VS_16H_IFNG_IN_...2,SET,179,0.017217,0.0016918,0.065681,0.39661,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP,0.99999
GOMF_SIRNA_BINDING,SET,7,0.078285,0.0015284,0.29867,0.39662,GOMF_SIRNA_BINDING,0.99999
MIR190B_3P,SET,124,0.02006,0.0016431,0.076559,0.39665,MIR190B_3P,0.99999
GOBP_PHOSPHATIDYLCHOLINE_ACY...,SET,13,0.062849,0.0016719,0.23985,0.39665,GOBP_PHOSPHATIDYLCHOLINE_ACYL_CHAIN_REMODELING,0.99999
GSE25085_FETAL_LIVER_VS_FETA...1,SET,183,0.017456,0.0017341,0.066617,0.39665,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN,0.99999
GOBP_REGULATION_OF_SYSTEM_PR...,SET,509,0.010707,0.0017579,0.040871,0.39668,GOBP_REGULATION_OF_SYSTEM_PROCESS,0.99999
MARKEY_RB1_ACUTE_LOF_DN,SET,211,0.016127,0.001719,0.061592,0.39672,MARKEY_RB1_ACUTE_LOF_DN,0.99999
MORF_FLT1,SET,116,0.02143,0.0016981,0.081856,0.39674,MORF_FLT1,0.99999
GSE19941_UNSTIM_VS_LPS_AND_I...4,SET,157,0.018027,0.0016599,0.068957,0.39689,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.99999
LASTOWSKA_COAMPLIFIED_WITH_M...,SET,35,0.048303,0.0021071,0.18493,0.39697,LASTOWSKA_COAMPLIFIED_WITH_MYCN,0.99999
GOBP_SPHINGOID_METABOLIC_PRO...,SET,18,0.05626,0.0017608,0.21538,0.39697,GOBP_SPHINGOID_METABOLIC_PROCESS,0.99999
GOMF_SULFATE_BINDING,SET,4,0.1253,0.0018494,0.47973,0.39697,GOMF_SULFATE_BINDING,0.99999
CADWELL_ATG16L1_TARGETS_UP,SET,93,0.024158,0.0017151,0.092497,0.39698,CADWELL_ATG16L1_TARGETS_UP,0.99999
BIOCARTA_BOTULIN_PATHWAY,SET,5,0.11035,0.0018208,0.4226,0.397,BIOCARTA_BOTULIN_PATHWAY,0.99999
GSE14415_ACT_TCONV_VS_ACT_NA...2,SET,158,0.018067,0.0016688,0.069211,0.39703,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP,0.99999
REACTOME_PHASE_II_CONJUGATIO...,SET,99,0.026268,0.0019238,0.10068,0.39709,REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,0.99999
MEISSNER_NPC_HCP_WITH_H3K27M...,SET,76,0.028976,0.0018605,0.11109,0.39712,MEISSNER_NPC_HCP_WITH_H3K27ME3,0.99999
GSE369_SOCS3_KO_VS_WT_LIVER_...3,SET,187,0.015834,0.0015899,0.060794,0.39726,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_UP,0.99999
GOBP_ENDODERM_FORMATION,SET,56,0.031192,0.0017201,0.11982,0.39731,GOBP_ENDODERM_FORMATION,0.99999
GOBP_REGULATION_OF_CELLULAR_...17,SET,460,0.010059,0.0015722,0.03865,0.39733,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_STRESS,0.99999
GOBP_AMMONIUM_HOMEOSTASIS,SET,5,0.12428,0.0020508,0.47761,0.39735,GOBP_AMMONIUM_HOMEOSTASIS,0.99999
MIR1268A_MIR1268B,SET,7,0.091119,0.0017789,0.35035,0.3974,MIR1268A_MIR1268B,0.99999
NEUROG3_TARGET_GENES,SET,15,0.055014,0.0015719,0.21154,0.39741,NEUROG3_TARGET_GENES,0.99999
GOBP_PARALLEL_ACTIN_FILAMENT...,SET,7,0.090749,0.0017717,0.34895,0.39741,GOBP_PARALLEL_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.99999
GOMF_PENTOSYLTRANSFERASE_ACT...,SET,47,0.031631,0.0015984,0.12166,0.39743,GOMF_PENTOSYLTRANSFERASE_ACTIVITY,0.99999
HP_ABNORMALITY_OF_THE_ANKLE,SET,159,0.018016,0.0016694,0.069364,0.39754,HP_ABNORMALITY_OF_THE_ANKLE,0.99999
MIR3115,SET,33,0.035538,0.0015054,0.13693,0.39761,MIR3115,0.99999
HP_DECREASED_CIRCULATING_COR...,SET,32,0.037792,0.0015764,0.14563,0.39763,HP_DECREASED_CIRCULATING_CORTISOL_LEVEL,0.99999
GOBP_CARBOHYDRATE_MEDIATED_S...,SET,11,0.064489,0.0015781,0.24863,0.39767,GOBP_CARBOHYDRATE_MEDIATED_SIGNALING,0.99999
GSE5099_UNSTIM_VS_MCSF_TREAT...4,SET,175,0.015674,0.001523,0.060443,0.3977,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP,0.99999
HP_SUBCORTICAL_CEREBRAL_ATRO...,SET,25,0.046004,0.0016965,0.17747,0.39773,HP_SUBCORTICAL_CEREBRAL_ATROPHY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...505,SET,43,0.03659,0.0017688,0.14123,0.39779,GOBP_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.99999
MODULE_13,SET,470,0.010246,0.0016184,0.039566,0.39783,MODULE_13,0.99999
GU_PDEF_TARGETS_DN,SET,37,0.040651,0.0018231,0.15705,0.39788,GU_PDEF_TARGETS_DN,0.99999
WP_AFLATOXIN_B1_METABOLISM,SET,6,0.097247,0.0017578,0.3757,0.39788,WP_AFLATOXIN_B1_METABOLISM,0.99999
HP_ABNORMALITY_OF_THE_VERTEB...2,SET,35,0.0401,0.0017492,0.15497,0.39791,HP_ABNORMALITY_OF_THE_VERTEBRAL_ENDPLATES,0.99999
HP_DISTAL_SYMPHALANGISM,SET,6,0.077666,0.0014039,0.30014,0.39791,HP_DISTAL_SYMPHALANGISM,0.99999
WP_MARKERS_OF_KIDNEY_CELL_LI...,SET,57,0.0323,0.001797,0.12489,0.39796,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,0.99999
HP_INFLEXIBLE_ADHERENCE_TO_R...,SET,2,0.1733,0.0018088,0.67008,0.39796,HP_INFLEXIBLE_ADHERENCE_TO_ROUTINES,0.99999
GOCC_DENDRITE_CYTOPLASM,SET,26,0.039964,0.0015029,0.15455,0.39798,GOCC_DENDRITE_CYTOPLASM,0.99999
HP_RENAL_MALROTATION,SET,6,0.093421,0.0016886,0.36137,0.398,HP_RENAL_MALROTATION,0.99999
HP_PANCREATIC_CYSTS,SET,33,0.035306,0.0014956,0.13659,0.39802,HP_PANCREATIC_CYSTS,0.99999
MAPK3_TARGET_GENES,SET,69,0.02591,0.0015855,0.10026,0.39804,MAPK3_TARGET_GENES,0.99999
HP_ABNORMAL_BLOOD_VESSEL_MOR...,SET,854,0.0077906,0.0016407,0.030149,0.39805,HP_ABNORMAL_BLOOD_VESSEL_MORPHOLOGY,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_ASP...,SET,105,0.022792,0.0017188,0.088203,0.39805,HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE,0.99999
RCGCANGCGY_NRF1_Q6,SET,852,0.0073767,0.0015518,0.028552,0.39806,RCGCANGCGY_NRF1_Q6,0.99999
GOBP_CELLULAR_RESPONSE_TO_CA...5,SET,137,0.018884,0.0016252,0.073145,0.39814,GOBP_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS,0.99999
KENNEDY_PBMC_DRYVAX_AGE_18_4...,SET,31,0.039507,0.0016221,0.15306,0.39816,KENNEDY_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_DN,0.99999
HP_CONCAVE_NASAL_RIDGE,SET,21,0.052184,0.001764,0.2022,0.39817,HP_CONCAVE_NASAL_RIDGE,0.99999
GSE37301_LYMPHOID_PRIMED_MPP...9,SET,170,0.016928,0.0016215,0.065601,0.39819,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN,0.99999
GOMF_C3HC4_TYPE_RING_FINGER_...,SET,6,0.084559,0.0015284,0.32787,0.39824,GOMF_C3HC4_TYPE_RING_FINGER_DOMAIN_BINDING,0.99999
MENON_FETAL_KIDNEY_9_ENDOTHE...,SET,91,0.025945,0.0018221,0.1006,0.39824,MENON_FETAL_KIDNEY_9_ENDOTHELIAL_CELLS,0.99999
GOBP_CELLULAR_DEFENSE_RESPON...,SET,47,0.033657,0.0017008,0.13055,0.39828,GOBP_CELLULAR_DEFENSE_RESPONSE,0.99999
GOBP_REGULATION_OF_RELAXATIO...1,SET,6,0.090141,0.0016293,0.34966,0.39828,GOBP_REGULATION_OF_RELAXATION_OF_CARDIAC_MUSCLE,0.99999
HP_CERVICAL_SUBLUXATION,SET,8,0.076912,0.0016052,0.29833,0.39828,HP_CERVICAL_SUBLUXATION,0.99999
AP4_01,SET,235,0.014757,0.0016589,0.057268,0.39833,AP4_01,0.99999
GOBP_SEROTONIN_TRANSPORT,SET,20,0.055058,0.0018163,0.21383,0.3984,GOBP_SEROTONIN_TRANSPORT,0.99999
MIR3667_3P,SET,136,0.01952,0.0016738,0.07584,0.39844,MIR3667_3P,0.99999
FLECHNER_PBL_KIDNEY_TRANSPLA...2,SET,137,0.017853,0.0015365,0.069413,0.39851,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,0.99999
GSE13522_WT_VS_IFNAR_KO_SKIN...1,SET,178,0.016244,0.0015918,0.063175,0.39854,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,0.99999
HP_LYMPHANGIECTASIS,SET,10,0.072063,0.0016814,0.2803,0.39855,HP_LYMPHANGIECTASIS,0.99999
KOINUMA_COLON_CANCER_MSI_DN,SET,8,0.083057,0.0017335,0.32315,0.39858,KOINUMA_COLON_CANCER_MSI_DN,0.99999
GSE15735_CTRL_VS_HDAC_INHIBI...2,SET,178,0.015967,0.0015646,0.062145,0.39861,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_UP,0.99999
GSE7460_TREG_VS_TCONV_ACT_WI...1,SET,179,0.016102,0.0015822,0.062663,0.39861,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN,0.99999
WEINBERGER_BLOOD_TWINRIX_AGE...2,SET,7,0.090862,0.0017739,0.3536,0.39861,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_HIGH_ANTI_HBS_CONC_AT_WEEK_30_PRIMARY_VACC_1DY_POSITIVE,0.99999
GOBP_POSITIVE_REGULATION_OF_...220,SET,118,0.019802,0.0015825,0.077081,0.39863,GOBP_POSITIVE_REGULATION_OF_DNA_REPAIR,0.99999
FOXR2_TARGET_GENES,SET,168,0.016636,0.0015841,0.064771,0.39865,FOXR2_TARGET_GENES,0.99999
MODULE_448,SET,40,0.032274,0.0015048,0.12567,0.39866,MODULE_448,0.99999
MIR676_3P,SET,47,0.031816,0.0016078,0.1239,0.39867,MIR676_3P,0.99999
SANA_TNF_SIGNALING_DN,SET,74,0.026997,0.0017106,0.10514,0.39868,SANA_TNF_SIGNALING_DN,0.99999
REACTOME_INACTIVATION_OF_CDC...,SET,8,0.080518,0.0016805,0.31366,0.3987,REACTOME_INACTIVATION_OF_CDC42_AND_RAC1,0.99999
GOBP_ATRIOVENTRICULAR_VALVE_...2,SET,8,0.087236,0.0018207,0.33992,0.39873,GOBP_ATRIOVENTRICULAR_VALVE_FORMATION,0.99999
GSE17721_CTRL_VS_CPG_0.5H_BM...2,SET,184,0.015919,0.0015858,0.06207,0.39879,GSE17721_CTRL_VS_CPG_0.5H_BMDC_UP,0.99999
SMAD3_Q6,SET,213,0.015501,0.00166,0.060446,0.39881,SMAD3_Q6,0.99999
STONER_ESOPHAGEAL_CARCINOGEN...1,SET,6,0.084393,0.0015254,0.32915,0.39882,STONER_ESOPHAGEAL_CARCINOGENESIS_DN,0.99999
HP_HYPERKALEMIA,SET,35,0.037948,0.0016554,0.14804,0.39884,HP_HYPERKALEMIA,0.99999
GSE40666_WT_VS_STAT4_KO_CD8_...2,SET,147,0.019,0.0016934,0.074119,0.39884,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_UP,0.99999
HP_HYPOMELANOTIC_MACULE,SET,8,0.074622,0.0015574,0.29121,0.39888,HP_HYPOMELANOTIC_MACULE,0.99999
GOMF_RNA_POLYMERASE_I_ACTIVI...,SET,9,0.062208,0.001377,0.24283,0.39891,GOMF_RNA_POLYMERASE_I_ACTIVITY,0.99999
GOBP_CELL_GROWTH,SET,427,0.010856,0.0016362,0.042392,0.39895,GOBP_CELL_GROWTH,0.99999
HP_THIN_RIBS,SET,46,0.032857,0.0016427,0.12832,0.39896,HP_THIN_RIBS,0.99999
GOBP_REGULATION_OF_CARDIAC_M...3,SET,7,0.071888,0.0014035,0.28087,0.399,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_REGULATION_OF_CONTRACTION,0.99999
GSE40184_HEALTHY_VS_HCV_INFE...2,SET,178,0.01605,0.0015728,0.062731,0.39903,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP,0.99999
GSE2405_0H_VS_12H_A_PHAGOCYT...1,SET,178,0.016423,0.0016092,0.064195,0.39905,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.99999
GSE5142_CTRL_VS_HTERT_TRANSD...1,SET,176,0.016484,0.0016063,0.064455,0.39908,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN,0.99999
GSE45365_NK_CELL_VS_CD8A_DC_...2,SET,161,0.017089,0.0015933,0.066846,0.39911,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN,0.99999
GOBP_CHROMOSOME_MOVEMENT_TOW...,SET,7,0.080911,0.0015796,0.31663,0.39916,GOBP_CHROMOSOME_MOVEMENT_TOWARDS_SPINDLE_POLE,0.99999
WP_TCA_CYCLE_NUTRIENT_USE_AN...,SET,5,0.10662,0.0017593,0.41728,0.39917,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...14,SET,189,0.015644,0.0015792,0.061268,0.39923,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_UP,0.99999
BENNETT_SYSTEMIC_LUPUS_ERYTH...,SET,25,0.048042,0.0017717,0.18827,0.3993,BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,0.99999
HP_AORTIC_ARCH_ANEURYSM,SET,37,0.039778,0.001784,0.15589,0.3993,HP_AORTIC_ARCH_ANEURYSM,0.99999
HP_INVOLUNTARY_VOCALIZATION,SET,42,0.033301,0.001591,0.13053,0.39932,HP_INVOLUNTARY_VOCALIZATION,0.99999
MIR12114,SET,37,0.035348,0.0015853,0.13857,0.39933,MIR12114,0.99999
GOMF_CIS_TRANS_ISOMERASE_ACT...,SET,37,0.032756,0.0014691,0.12842,0.39934,GOMF_CIS_TRANS_ISOMERASE_ACTIVITY,0.99999
NUYTTEN_EZH2_TARGETS_DN,SET,908,0.007014,0.0015208,0.027507,0.39937,NUYTTEN_EZH2_TARGETS_DN,0.99999
GOCC_RISC_LOADING_COMPLEX,SET,8,0.072293,0.0015088,0.28352,0.39937,GOCC_RISC_LOADING_COMPLEX,0.99999
HP_ABNORMAL_DUODENUM_MORPHOL...,SET,81,0.02384,0.0015801,0.0935,0.39937,HP_ABNORMAL_DUODENUM_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...361,SET,20,0.041369,0.0013647,0.16228,0.39939,GOBP_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,0.99999
HP_HALLUX_VARUS,SET,5,0.10815,0.0017846,0.42427,0.3994,HP_HALLUX_VARUS,0.99999
TGACGTCA_ATF3_Q6,SET,210,0.015397,0.0016374,0.060412,0.39941,TGACGTCA_ATF3_Q6,0.99999
GOMF_TYPE_I_INTERFERON_RECEP...,SET,13,0.092086,0.0024496,0.36165,0.39951,GOMF_TYPE_I_INTERFERON_RECEPTOR_BINDING,0.99999
AGGGCCA_MIR328,SET,68,0.026196,0.0015914,0.10294,0.39956,AGGGCCA_MIR328,0.99999
GOBP_GENERATION_OF_NEURONS,SET,1370,0.0063502,0.0016688,0.024961,0.39959,GOBP_GENERATION_OF_NEURONS,0.99999
HP_STIFF_SKIN,SET,6,0.096252,0.0017398,0.37844,0.39962,HP_STIFF_SKIN,0.99999
BOYLAN_MULTIPLE_MYELOMA_PCA1...1,SET,8,0.083478,0.0017422,0.32841,0.39968,BOYLAN_MULTIPLE_MYELOMA_PCA1_DN,0.99999
REACTOME_RUNX3_REGULATES_BCL...,SET,5,0.11155,0.0018407,0.43892,0.39969,REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION,0.99999
GOMF_ACETYLCHOLINE_GATED_MON...,SET,16,0.058035,0.0017126,0.22836,0.39969,GOMF_ACETYLCHOLINE_GATED_MONOATOMIC_CATION_SELECTIVE_CHANNEL_ACTIVITY,0.99999
NR4A2_TARGET_GENES,SET,4,0.12027,0.0017751,0.47363,0.39978,NR4A2_TARGET_GENES,0.99999
PID_IL12_STAT4_PATHWAY,SET,32,0.039761,0.0016586,0.15663,0.39981,PID_IL12_STAT4_PATHWAY,0.99999
ZHENG_GLIOBLASTOMA_PLASTICIT...2,SET,227,0.014955,0.0016527,0.058982,0.39992,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,0.99999
GSE22432_MULTIPOTENT_VS_COMM...1,SET,187,0.015503,0.0015567,0.061165,0.39995,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN,0.99999
GSE12845_IGD_POS_VS_NEG_BLOO...2,SET,169,0.01615,0.0015424,0.06372,0.39996,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP,0.99999
GOBP_ORGANELLE_DISASSEMBLY,SET,153,0.016758,0.0015235,0.066124,0.39997,GOBP_ORGANELLE_DISASSEMBLY,0.99999
GSE4590_SMALL_VS_VPREB_POS_L...2,SET,149,0.017399,0.0015611,0.068667,0.39999,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,0.99999
GOBP_LACTATE_TRANSMEMBRANE_T...,SET,8,0.085319,0.0017807,0.33696,0.40006,GOBP_LACTATE_TRANSMEMBRANE_TRANSPORT,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...6,SET,172,0.016827,0.0016211,0.066565,0.40022,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP,0.99999
GOBP_PEPTIDYL_TYROSINE_DEPHO...1,SET,27,0.040511,0.0015525,0.16032,0.40026,GOBP_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION,0.99999
GOMF_NEUTRAL_L_AMINO_ACID_TR...,SET,40,0.03598,0.0016777,0.14243,0.40028,GOMF_NEUTRAL_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
NKX2_5_TARGET_GENES,SET,1228,0.0064471,0.0016107,0.025535,0.40033,NKX2_5_TARGET_GENES,0.99999
PID_FOXM1_PATHWAY,SET,39,0.033637,0.0015487,0.13328,0.40038,PID_FOXM1_PATHWAY,0.99999
GSE25088_CTRL_VS_IL4_STIM_MA...2,SET,171,0.016978,0.0016309,0.067288,0.4004,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP,0.99999
HP_ABNORMALITY_OF_THE_FIRST_...,SET,11,0.065192,0.0015953,0.25865,0.4005,HP_ABNORMALITY_OF_THE_FIRST_METATARSAL_BONE,0.99999
KEGG_MEDICUS_REFERENCE_ITGA_...5,SET,27,0.041899,0.0016057,0.16642,0.40061,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY,0.99999
GOMF_RETROMER_COMPLEX_BINDING,SET,6,0.10012,0.0018098,0.39767,0.40061,GOMF_RETROMER_COMPLEX_BINDING,0.99999
GSE26669_CD4_VS_CD8_TCELL_IN...3,SET,179,0.015993,0.0015715,0.063537,0.40063,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN,0.99999
HP_UNBALANCED_ATRIOVENTRICUL...,SET,5,0.091544,0.0015106,0.36378,0.40066,HP_UNBALANCED_ATRIOVENTRICULAR_CANAL_DEFECT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...231,SET,32,0.038346,0.0015996,0.1524,0.40067,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,0.99999
BIOCARTA_MEF2D_PATHWAY,SET,18,0.052926,0.0016564,0.21054,0.40076,BIOCARTA_MEF2D_PATHWAY,0.99999
JAATINEN_HEMATOPOIETIC_STEM_...1,SET,208,0.016186,0.0017131,0.064397,0.40078,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,0.99999
MATZUK_EMBRYONIC_GERM_CELL,SET,18,0.053689,0.0016803,0.21362,0.40078,MATZUK_EMBRYONIC_GERM_CELL,0.99999
GSE3982_BASOPHIL_VS_NKCELL_UP,SET,177,0.016213,0.0015843,0.06454,0.40083,GSE3982_BASOPHIL_VS_NKCELL_UP,0.99999
HP_MILDLY_ELEVATED_CREATINE_...,SET,53,0.02827,0.0015168,0.11256,0.40085,HP_MILDLY_ELEVATED_CREATINE_KINASE,0.99999
GOBP_RESPONSE_TO_INTERLEUKIN...5,SET,17,0.059389,0.0018064,0.23653,0.40088,GOBP_RESPONSE_TO_INTERLEUKIN_17,0.99999
GOCC_ATPASE_DEPENDENT_TRANSM...,SET,24,0.047808,0.0017275,0.19041,0.40088,GOCC_ATPASE_DEPENDENT_TRANSMEMBRANE_TRANSPORT_COMPLEX,0.99999
GCM_ACTG1,SET,109,0.019371,0.0014882,0.077162,0.40089,GCM_ACTG1,0.99999
GOBP_INFLAMMATORY_RESPONSE_T...1,SET,70,0.027466,0.0016928,0.10944,0.40092,GOBP_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.99999
ZNF224_TARGET_GENES,SET,1078,0.0067075,0.001577,0.026728,0.40093,ZNF224_TARGET_GENES,0.99999
GSE1432_CTRL_VS_IFNG_6H_MICR...1,SET,183,0.01634,0.0016232,0.065131,0.40096,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,0.99999
HP_ABNORMAL_SYNOVIAL_MEMBRAN...,SET,15,0.054962,0.0015704,0.21919,0.401,HP_ABNORMAL_SYNOVIAL_MEMBRANE_MORPHOLOGY,0.99999
GOBP_CELL_AGGREGATION,SET,22,0.051407,0.0017785,0.20511,0.40105,GOBP_CELL_AGGREGATION,0.99999
GOBP_INORGANIC_ION_HOMEOSTAS...,SET,488,0.010394,0.001672,0.041526,0.40118,GOBP_INORGANIC_ION_HOMEOSTASIS,0.99999
GOMF_HETEROTRIMERIC_G_PROTEI...,SET,5,0.10501,0.0017328,0.41961,0.4012,GOMF_HETEROTRIMERIC_G_PROTEIN_BINDING,0.99999
GOBP_REGULATION_OF_SECRETION,SET,559,0.0095401,0.0016392,0.038132,0.40122,GOBP_REGULATION_OF_SECRETION,0.99999
GGCKCATGS_UNKNOWN,SET,68,0.026807,0.0016285,0.10718,0.40125,GGCKCATGS_UNKNOWN,0.99999
PITX2_Q2,SET,236,0.014519,0.0016356,0.058066,0.40128,PITX2_Q2,0.99999
GSE28783_CTRL_ANTI_MIR_VS_UN...1,SET,182,0.016253,0.0016102,0.065004,0.40128,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,0.99999
GSE22935_WT_VS_MYD88_KO_MACR...6,SET,184,0.01566,0.0015599,0.062652,0.40131,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP,0.99999
DACOSTA_ERCC3_ALLELE_XPCS_VS...2,SET,26,0.045025,0.0016932,0.18032,0.40141,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,0.99999
PAX3_B,SET,83,0.024718,0.0016582,0.098991,0.40141,PAX3_B,0.99999
MIR3189_5P,SET,47,0.028788,0.0014548,0.11533,0.40144,MIR3189_5P,0.99999
GOBP_PROLINE_TRANSPORT,SET,11,0.069383,0.0016979,0.27794,0.40144,GOBP_PROLINE_TRANSPORT,0.99999
GSE43956_WT_VS_SGK1_KO_TH17_...1,SET,180,0.016675,0.0016431,0.066811,0.40145,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN,0.99999
GSE11864_UNTREATED_VS_CSF1_I...4,SET,169,0.015763,0.0015054,0.063173,0.40148,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.99999
HEBERT_MATRISOME_TNBC_BRAIN_...2,SET,9,0.077154,0.0017079,0.30923,0.40149,HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS_TUMOR_CELL_DERIVED,0.99999
GOBP_NEGATIVE_REGULATION_OF_...389,SET,2,0.18086,0.0018876,0.72524,0.40153,GOBP_NEGATIVE_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_TNF_R...,SET,7,0.078567,0.0015339,0.3152,0.40158,KEGG_MEDICUS_REFERENCE_TNF_RIPK1_3_SIGNALING_PATHWAY,0.99999
CCAWYNNGAAR_UNKNOWN,SET,123,0.019147,0.001562,0.07684,0.40161,CCAWYNNGAAR_UNKNOWN,0.99999
GOBP_NK_T_CELL_PROLIFERATION,SET,8,0.086746,0.0018105,0.34811,0.40161,GOBP_NK_T_CELL_PROLIFERATION,0.99999
HP_ABNORMALITY_OF_THE_HAMATE...,SET,9,0.073018,0.0016163,0.29304,0.40161,HP_ABNORMALITY_OF_THE_HAMATE_BONE,0.99999
GSE45365_NK_CELL_VS_CD11B_DC...2,SET,178,0.016073,0.001575,0.064554,0.40169,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN,0.99999
GOCC_ACROSOMAL_VESICLE,SET,132,0.018972,0.0016029,0.076234,0.40174,GOCC_ACROSOMAL_VESICLE,0.99999
GSE9037_CTRL_VS_LPS_1H_STIM_...4,SET,185,0.014897,0.0014879,0.059865,0.40174,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP,0.99999
GOMF_GLYCOGEN_BINDING,SET,7,0.088385,0.0017256,0.35599,0.40196,GOMF_GLYCOGEN_BINDING,0.99999
GSE11961_GERMINAL_CENTER_BCE...5,SET,183,0.015684,0.0015581,0.06319,0.40199,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,0.99999
MIR1281,SET,9,0.07466,0.0016527,0.30096,0.40204,MIR1281,0.99999
GSE411_100MIN_VS_400MIN_IL6_...1,SET,182,0.014745,0.0014609,0.059501,0.40214,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_DN,0.99999
GSE29618_PDC_VS_MDC_DAY7_FLU...1,SET,179,0.016308,0.0016024,0.065826,0.40217,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN,0.99999
MIR4526,SET,94,0.022462,0.0016032,0.090676,0.40218,MIR4526,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...9,SET,7,0.081573,0.0015926,0.32942,0.40221,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN,0.99999
MIR1244,SET,86,0.022753,0.0015537,0.091921,0.40225,MIR1244,0.99999
GOBP_LUNG_EPITHELIUM_DEVELOP...,SET,45,0.033692,0.0016661,0.13612,0.40225,GOBP_LUNG_EPITHELIUM_DEVELOPMENT,0.99999
JINESH_BLEBBISHIELD_VS_LIVE_...2,SET,303,0.01202,0.0015314,0.048572,0.40228,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,0.99999
GOCC_CILIARY_PLASM,SET,135,0.017219,0.0014712,0.069621,0.40233,GOCC_CILIARY_PLASM,0.99999
HP_ALOPECIA,SET,218,0.014745,0.0015973,0.059623,0.40233,HP_ALOPECIA,0.99999
GSE14908_ATOPIC_VS_NONATOPIC...1,SET,174,0.015747,0.0015258,0.063682,0.40235,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_DN,0.99999
GOMF_TRANSMEMBRANE_RECEPTOR_...5,SET,16,0.062683,0.0018497,0.25351,0.40236,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...310,SET,15,0.05938,0.0016967,0.24019,0.40237,GOBP_POSITIVE_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS,0.99999
HP_GENERALIZED_MYOCLONIC_ATO...,SET,9,0.069304,0.0015341,0.28033,0.40237,HP_GENERALIZED_MYOCLONIC_ATONIC_SEIZURE,0.99999
GOBP_FIBROBLAST_PROLIFERATION,SET,105,0.020964,0.001581,0.084818,0.40239,GOBP_FIBROBLAST_PROLIFERATION,0.99999
GOMF_TOLL_LIKE_RECEPTOR_BIND...,SET,14,0.061799,0.0017059,0.25016,0.40244,GOMF_TOLL_LIKE_RECEPTOR_BINDING,0.99999
WILLIAMS_ESR1_TARGETS_UP,SET,25,0.043922,0.0016197,0.178,0.40255,WILLIAMS_ESR1_TARGETS_UP,0.99999
GSE22432_CONVENTIONAL_CDC_VS...1,SET,184,0.01502,0.0014962,0.060964,0.4027,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN,0.99999
KANG_CISPLATIN_RESISTANCE_DN,SET,8,0.071137,0.0014847,0.28878,0.40271,KANG_CISPLATIN_RESISTANCE_DN,0.99999
GSE18804_SPLEEN_MACROPHAGE_V...1,SET,170,0.015889,0.0015219,0.064498,0.40271,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN,0.99999
NFAT_Q4_01,SET,243,0.01413,0.0016149,0.057374,0.40274,NFAT_Q4_01,0.99999
HP_ANOMALOUS_TRICHROMACY,SET,9,0.091657,0.0020289,0.37246,0.40281,HP_ANOMALOUS_TRICHROMACY,0.99999
HP_TRITANOMALY,SET,9,0.091657,0.0020289,0.37246,0.40281,HP_TRITANOMALY,0.99999
GNF2_LCAT,SET,118,0.01973,0.0015767,0.080183,0.40282,GNF2_LCAT,0.99999
GSE10325_LUPUS_CD4_TCELL_VS_...1,SET,166,0.017388,0.0016459,0.070665,0.40282,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN,0.99999
GOCC_PTW_PP1_PHOSPHATASE_COM...,SET,7,0.070721,0.0013807,0.28744,0.40283,GOCC_PTW_PP1_PHOSPHATASE_COMPLEX,0.99999
HP_SECONDARY_MICROCEPHALY,SET,174,0.015414,0.0014935,0.062656,0.40284,HP_SECONDARY_MICROCEPHALY,0.99999
MARCHINI_TRABECTEDIN_RESISTA...1,SET,42,0.033219,0.0015871,0.13508,0.40287,MARCHINI_TRABECTEDIN_RESISTANCE_DN,0.99999
MIR3142,SET,49,0.028598,0.0014755,0.1163,0.40288,MIR3142,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...3,SET,44,0.030981,0.0015149,0.126,0.40289,GAVISH_3CA_METAPROGRAM_EPITHELIAL_CELL_CYCLE,0.99999
GOBP_THROMBIN_ACTIVATED_RECE...,SET,13,0.065982,0.0017552,0.26836,0.40289,GOBP_THROMBIN_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE360_CTRL_VS_B_MALAYI_LOW_...3,SET,179,0.015289,0.0015023,0.062189,0.4029,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.99999
MEBARKI_HCC_PROGENITOR_WNT_U...2,SET,72,0.027489,0.0017181,0.11185,0.40294,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...27,SET,4,0.10264,0.001515,0.41772,0.40295,GOBP_POSITIVE_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.99999
GSE20715_0H_VS_48H_OZONE_LUN...2,SET,180,0.015868,0.0015635,0.064592,0.40297,GSE20715_0H_VS_48H_OZONE_LUNG_UP,0.99999
KEGG_MEDICUS_PATHOGEN_HCV_CO...2,SET,6,0.083031,0.0015008,0.33801,0.40298,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_LXRA_MEDIATED_TRANSCRIPTION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...162,SET,33,0.040313,0.0017076,0.16418,0.40302,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
WP_EBOLA_VIRUS_INFECTION_IN_...,SET,122,0.019838,0.0016118,0.0808,0.40303,WP_EBOLA_VIRUS_INFECTION_IN_HOST,0.99999
GOBP_POSITIVE_REGULATION_OF_...229,SET,10,0.058649,0.0013685,0.23895,0.40306,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.99999
MATSUMIYA_PBMC_MODIFIED_VACC...2,SET,9,0.067465,0.0014934,0.27501,0.40311,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_HIGH_RESPONDERS_VS_LOW_RESPONDERS_0DY_UP,0.99999
GOMF_14_3_3_PROTEIN_BINDING,SET,29,0.039813,0.0015811,0.16235,0.40314,GOMF_14_3_3_PROTEIN_BINDING,0.99999
HP_HEAD_TREMOR,SET,39,0.033779,0.0015553,0.13777,0.40315,HP_HEAD_TREMOR,0.99999
GSE3982_BASOPHIL_VS_TH2_UP,SET,172,0.016193,0.00156,0.066054,0.40317,GSE3982_BASOPHIL_VS_TH2_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...654,SET,5,0.10445,0.0017236,0.4264,0.40324,GOBP_NEGATIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,0.99999
KEGG_MEDICUS_REFERENCE_FLT3L...1,SET,14,0.053435,0.0014751,0.21821,0.40328,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY,0.99999
REACTOME_FLT3_SIGNALING_BY_C...,SET,6,0.082787,0.0014964,0.33816,0.4033,REACTOME_FLT3_SIGNALING_BY_CBL_MUTANTS,0.99999
REACTOME_SUPPRESSION_OF_PHAG...,SET,12,0.057017,0.0014573,0.23294,0.40332,REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION,0.99999
GSE21033_CTRL_VS_POLYIC_STIM...10,SET,183,0.015515,0.0015413,0.063392,0.40333,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP,0.99999
MIR4460,SET,78,0.023405,0.0015224,0.095648,0.40334,MIR4460,0.99999
HP_LEWY_BODIES,SET,25,0.041979,0.0015481,0.17158,0.40336,HP_LEWY_BODIES,0.99999
CHIARETTI_T_ALL_RELAPSE_PROG...,SET,17,0.05164,0.0015707,0.21114,0.40339,CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,0.99999
MIR525_5P,SET,143,0.017111,0.0015043,0.06996,0.40339,MIR525_5P,0.99999
PID_ENDOTHELIN_PATHWAY,SET,62,0.028434,0.0016497,0.11632,0.40344,PID_ENDOTHELIN_PATHWAY,0.99999
MODULE_361,SET,127,0.01907,0.0015806,0.078025,0.40346,MODULE_361,0.99999
GOBP_POSITIVE_REGULATION_OF_...167,SET,28,0.03463,0.0013514,0.14177,0.40351,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEPARATION,0.99999
GILMORE_CORE_NFKB_PATHWAY,SET,10,0.064149,0.0014968,0.26271,0.40355,GILMORE_CORE_NFKB_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...98,SET,41,0.035932,0.0016962,0.14724,0.4036,GOBP_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,0.99999
GOCC_CCR4_NOT_CORE_COMPLEX,SET,5,0.080301,0.0013251,0.32939,0.4037,GOCC_CCR4_NOT_CORE_COMPLEX,0.99999
MORF_FOSL1,SET,371,0.011049,0.0015548,0.045335,0.40372,MORF_FOSL1,0.99999
MORF_MBD4,SET,75,0.021679,0.0013828,0.088947,0.40372,MORF_MBD4,0.99999
HP_SPONDYLOLYSIS,SET,5,0.090296,0.00149,0.37046,0.40372,HP_SPONDYLOLYSIS,0.99999
chr1p34,SET,154,0.035212,0.0032115,0.14448,0.40373,chr1p34,0.99999
HP_MEMBRANOPROLIFERATIVE_GLO...,SET,9,0.071944,0.0015926,0.2952,0.40373,HP_MEMBRANOPROLIFERATIVE_GLOMERULONEPHRITIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...342,SET,136,0.01836,0.0015744,0.075347,0.40374,GOBP_POSITIVE_REGULATION_OF_HORMONE_SECRETION,0.99999
HP_ABNORMALITY_OF_THE_BLADDER,SET,465,0.0097425,0.0015308,0.039989,0.40376,HP_ABNORMALITY_OF_THE_BLADDER,0.99999
chr12q22,SET,18,0.086288,0.0027006,0.35448,0.40384,chr12q22,0.99999
MIR495_3P,SET,639,0.0086147,0.001579,0.03539,0.40384,MIR495_3P,0.99999
MIR3143,SET,412,0.010448,0.0015475,0.042941,0.40389,MIR3143,0.99999
GOMF_PROTEIN_PHOSPHATASE_BIN...,SET,136,0.017546,0.0015046,0.072144,0.40392,GOMF_PROTEIN_PHOSPHATASE_BINDING,0.99999
GOCC_CYTOCHROME_COMPLEX,SET,34,0.033346,0.0014337,0.13712,0.40393,GOCC_CYTOCHROME_COMPLEX,0.99999
GOBP_GPI_ANCHOR_METABOLIC_PR...,SET,30,0.034038,0.0013749,0.13998,0.40394,GOBP_GPI_ANCHOR_METABOLIC_PROCESS,0.99999
WONG_EMBRYONIC_STEM_CELL_CORE,SET,309,0.011185,0.0014389,0.046004,0.40395,WONG_EMBRYONIC_STEM_CELL_CORE,0.99999
KEGG_AUTOIMMUNE_THYROID_DISE...,SET,44,0.03735,0.0018264,0.15368,0.40399,KEGG_AUTOIMMUNE_THYROID_DISEASE,0.99999
HP_NONPROGRESSIVE_CEREBELLAR...,SET,8,0.07954,0.0016601,0.32728,0.40399,HP_NONPROGRESSIVE_CEREBELLAR_ATAXIA,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_TH...4,SET,635,0.0084062,0.0015361,0.03462,0.40407,HP_ABNORMAL_MORPHOLOGY_OF_THE_GREAT_VESSELS,0.99999
GOBP_TOLL_LIKE_RECEPTOR_3_SI...,SET,28,0.037847,0.0014769,0.15588,0.40408,GOBP_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_THIRD_TOE_MORPHO...,SET,7,0.088443,0.0017267,0.36436,0.40411,HP_ABNORMAL_THIRD_TOE_MORPHOLOGY,0.99999
ATGCACG_MIR517B,SET,18,0.051323,0.0016063,0.21156,0.40416,ATGCACG_MIR517B,0.99999
FAN_OVARY_CL11_MURAL_GRANULO...,SET,387,0.011046,0.0015868,0.045545,0.40418,FAN_OVARY_CL11_MURAL_GRANULOSA_CELL,0.99999
KEGG_MEDICUS_REFERENCE_GLYCO...5,SET,5,0.079105,0.0013053,0.32619,0.40419,KEGG_MEDICUS_REFERENCE_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_LINKAGE_TETRASACCHARIDE,0.99999
GSE37605_C57BL6_VS_NOD_FOXP3...4,SET,109,0.020908,0.0016062,0.086237,0.40422,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_UP,0.99999
TRAVAGLINI_LUNG_PLATELET_MEG...,SET,513,0.0092355,0.0015221,0.038103,0.40424,TRAVAGLINI_LUNG_PLATELET_MEGAKARYOCYTE_CELL,0.99999
REACTOME_UCH_PROTEINASES,SET,80,0.021464,0.0014138,0.088569,0.40426,REACTOME_UCH_PROTEINASES,0.99999
GOBP_REGULATION_OF_CALCIUM_I...5,SET,11,0.054727,0.0013392,0.22581,0.40426,GOBP_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
FARDIN_HYPOXIA_9,SET,7,0.074065,0.001446,0.30576,0.4043,FARDIN_HYPOXIA_9,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...30,SET,6,0.094165,0.0017021,0.38874,0.4043,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_IRE1A_JNK_SIGNALING_PATHWAY,0.99999
ZNF677_TARGET_GENES,SET,128,0.018304,0.0015231,0.075582,0.40432,ZNF677_TARGET_GENES,0.99999
REACTOME_DOWNREGULATION_OF_E...2,SET,27,0.040139,0.0015382,0.16583,0.40437,REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,0.99999
WP_UREA_CYCLE_AND_RELATED_DI...,SET,8,0.070652,0.0014746,0.29194,0.40439,WP_UREA_CYCLE_AND_RELATED_DISEASES,0.99999
GSE7548_NAIVE_VS_DAY7_PCC_IM...2,SET,184,0.014775,0.0014718,0.061065,0.40441,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_HI...,SET,6,0.085136,0.0015389,0.35203,0.40445,GOBP_CELLULAR_RESPONSE_TO_HISTAMINE,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...25,SET,25,0.039634,0.0014616,0.16397,0.4045,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_UNSPECIFIED,0.99999
JIANG_CORE_DUPLICON_GENES,SET,4,0.093746,0.0013836,0.38791,0.40452,JIANG_CORE_DUPLICON_GENES,0.99999
GSE34006_UNTREATED_VS_A2AR_A...2,SET,176,0.015301,0.001491,0.063359,0.40459,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_UP,0.99999
GOMF_MANNOSE_BINDING,SET,22,0.046086,0.0015945,0.19095,0.40464,GOMF_MANNOSE_BINDING,0.99999
HP_REDUCED_CIRCULATING_GROWT...,SET,10,0.068671,0.0016023,0.28452,0.40464,HP_REDUCED_CIRCULATING_GROWTH_HORMONE_CONCENTRATION,0.99999
HP_MITRAL_VALVE_CALCIFICATION,SET,7,0.084697,0.0016536,0.35104,0.40467,HP_MITRAL_VALVE_CALCIFICATION,0.99999
BURTON_ADIPOGENESIS_PEAK_AT_...2,SET,39,0.02936,0.0013518,0.1219,0.40484,BURTON_ADIPOGENESIS_PEAK_AT_16HR,0.99999
HP_CALCIFICATION_OF_FALX_CER...,SET,7,0.071366,0.0013933,0.29636,0.40485,HP_CALCIFICATION_OF_FALX_CEREBRI,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...5,SET,177,0.014833,0.0014494,0.061603,0.40487,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_DN,0.99999
GOBP_CITRULLINE_METABOLIC_PR...,SET,7,0.073361,0.0014322,0.30502,0.40497,GOBP_CITRULLINE_METABOLIC_PROCESS,0.99999
HP_TRUE_HERMAPHRODITISM,SET,20,0.042088,0.0013884,0.17511,0.40503,HP_TRUE_HERMAPHRODITISM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...327,SET,5,0.096082,0.0015855,0.39986,0.40505,GOBP_NEGATIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.99999
GOBP_NON_MOTILE_CILIUM_ASSEM...,SET,60,0.025934,0.0014802,0.10793,0.40505,GOBP_NON_MOTILE_CILIUM_ASSEMBLY,0.99999
GOBP_REGULATION_OF_HIPPOCAMP...,SET,5,0.10908,0.0017999,0.45393,0.40505,GOBP_REGULATION_OF_HIPPOCAMPAL_NEURON_APOPTOTIC_PROCESS,0.99999
HP_ABNORMAL_DENTAL_ROOT_MORP...,SET,47,0.029406,0.001486,0.12239,0.40506,HP_ABNORMAL_DENTAL_ROOT_MORPHOLOGY,0.99999
HP_CALVARIAL_SKULL_DEFECT,SET,27,0.040364,0.0015468,0.16809,0.40511,HP_CALVARIAL_SKULL_DEFECT,0.99999
GOBP_RESPONSE_TO_FORSKOLIN,SET,13,0.065792,0.0017502,0.27404,0.40514,GOBP_RESPONSE_TO_FORSKOLIN,0.99999
GOMF_PROTEIN_PHOSPHATASE_1_B...,SET,23,0.04125,0.0014592,0.17196,0.40521,GOMF_PROTEIN_PHOSPHATASE_1_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...563,SET,44,0.033428,0.0016346,0.13943,0.40527,GOBP_POSITIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,0.99999
HP_CHILLS,SET,18,0.047011,0.0014713,0.1962,0.40532,HP_CHILLS,0.99999
GSE6674_ANTI_IGM_VS_CPG_STIM...2,SET,180,0.015421,0.0015195,0.064376,0.40534,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP,0.99999
KEGG_MEDICUS_REFERENCE_AHR_S...,SET,8,0.077946,0.0016268,0.32555,0.40539,KEGG_MEDICUS_REFERENCE_AHR_SIGNALING_PATHWAY,0.99999
GSE17721_POLYIC_VS_CPG_2H_BM...1,SET,182,0.015172,0.0015031,0.06338,0.40541,GSE17721_POLYIC_VS_CPG_2H_BMDC_DN,0.99999
HP_ABSENT_EPIPHYSES,SET,20,0.050229,0.001657,0.20986,0.40542,HP_ABSENT_EPIPHYSES,0.99999
GSE9960_GRAM_NEG_VS_GRAM_POS...2,SET,174,0.015201,0.0014729,0.063512,0.40542,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP,0.99999
GOCC_ENDOPLASMIC_RETICULUM_C...,SET,11,0.054996,0.0013458,0.22983,0.40544,GOCC_ENDOPLASMIC_RETICULUM_CHAPERONE_COMPLEX,0.99999
GOBP_POSITIVE_REGULATION_OF_...392,SET,15,0.063482,0.0018139,0.2653,0.40545,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,0.99999
HP_ABNORMAL_AUTONOMIC_NERVOU...,SET,121,0.019209,0.0015543,0.080283,0.40545,HP_ABNORMAL_AUTONOMIC_NERVOUS_SYSTEM_PHYSIOLOGY,0.99999
HP_EYE_MOVEMENT_INDUCED_PAIN,SET,5,0.098114,0.001619,0.41004,0.40545,HP_EYE_MOVEMENT_INDUCED_PAIN,0.99999
GOBP_REGULATION_OF_VASCULAR_...3,SET,8,0.074301,0.0015507,0.31073,0.40551,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CONTRACTION,0.99999
GOBP_EXPORT_ACROSS_PLASMA_ME...,SET,65,0.027538,0.0016357,0.11523,0.40556,GOBP_EXPORT_ACROSS_PLASMA_MEMBRANE,0.99999
CUI_DEVELOPING_HEART_C2_CARD...,SET,85,0.022928,0.0015565,0.095939,0.40556,CUI_DEVELOPING_HEART_C2_CARDIOMYOCYTE,0.99999
HP_ABNORMAL_MEGAKARYOCYTE_MO...,SET,23,0.042202,0.0014928,0.17673,0.40563,HP_ABNORMAL_MEGAKARYOCYTE_MORPHOLOGY,0.99999
SCHERER_PBMC_YF_VAX_OR_APSV_...,SET,21,0.046902,0.0015854,0.19645,0.40565,SCHERER_PBMC_YF_VAX_OR_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_DN,0.99999
GOBP_CARDIAC_EPITHELIAL_TO_M...,SET,36,0.037587,0.0016628,0.15752,0.4057,GOBP_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.99999
GOBP_DENDRITIC_SPINE_MORPHOG...,SET,54,0.028579,0.0015477,0.11978,0.40571,GOBP_DENDRITIC_SPINE_MORPHOGENESIS,0.99999
LINDGREN_BLADDER_CANCER_CLUS...6,SET,205,0.013967,0.0014677,0.058558,0.40574,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,0.99999
KEGG_MEDICUS_PATHOGEN_KSHV_K...,SET,7,0.070055,0.0013677,0.29372,0.40574,KEGG_MEDICUS_PATHOGEN_KSHV_K15_TO_TNF_NFKB_SIGNALING_PATHWAY,0.99999
HP_PARAGANGLIOMA,SET,19,0.041611,0.001338,0.17448,0.40575,HP_PARAGANGLIOMA,0.99999
GSE3039_NKT_CELL_VS_B2_BCELL...2,SET,190,0.015573,0.0015761,0.065298,0.40575,GSE3039_NKT_CELL_VS_B2_BCELL_UP,0.99999
ENK_UV_RESPONSE_EPIDERMIS_UP,SET,268,0.012427,0.0014904,0.052124,0.40579,ENK_UV_RESPONSE_EPIDERMIS_UP,0.99999
GOBP_INTERNEURON_MIGRATION_F...,SET,6,0.10069,0.00182,0.42266,0.40585,GOBP_INTERNEURON_MIGRATION_FROM_THE_SUBPALLIUM_TO_THE_CORTEX,0.99999
REACTOME_VIRAL_INFECTION_PAT...,SET,707,0.0073995,0.0014239,0.031082,0.40592,REACTOME_VIRAL_INFECTION_PATHWAYS,0.99999
LIAO_HAVE_SOX4_BINDING_SITES,SET,40,0.029637,0.0013819,0.12452,0.40594,LIAO_HAVE_SOX4_BINDING_SITES,0.99999
GOMF_MDM2_MDM4_FAMILY_PROTEI...,SET,10,0.06828,0.0015932,0.28701,0.40598,GOMF_MDM2_MDM4_FAMILY_PROTEIN_BINDING,0.99999
GOBP_HETEROCHROMATIN_FORMATI...,SET,95,0.020382,0.0014624,0.085688,0.40599,GOBP_HETEROCHROMATIN_FORMATION,0.99999
GSE12392_WT_VS_IFNB_KO_CD8A_...1,SET,183,0.015409,0.0015308,0.064792,0.40601,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN,0.99999
GOBP_PUTRESCINE_METABOLIC_PR...,SET,7,0.070096,0.0013685,0.29496,0.40608,GOBP_PUTRESCINE_METABOLIC_PROCESS,0.99999
GOBP_CELLULAR_RESPONSE_TO_CO...2,SET,13,0.05254,0.0013976,0.22118,0.40612,GOBP_CELLULAR_RESPONSE_TO_COLD,0.99999
REACTOME_VITAMIN_B1_THIAMIN_...,SET,5,0.085228,0.0014064,0.35895,0.40616,REACTOME_VITAMIN_B1_THIAMIN_METABOLISM,0.99999
GOBP_THIAMINE_CONTAINING_COM...,SET,5,0.085228,0.0014064,0.35895,0.40616,GOBP_THIAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
GOBP_THIAMINE_DIPHOSPHATE_ME...,SET,5,0.085228,0.0014064,0.35895,0.40616,GOBP_THIAMINE_DIPHOSPHATE_METABOLIC_PROCESS,0.99999
KRAS.BREAST_UP.V1_DN,SET,124,0.018906,0.0015485,0.079635,0.40617,KRAS.BREAST_UP.V1_DN,0.99999
GOBP_MUSCLE_TISSUE_DEVELOPME...,SET,398,0.010721,0.0015614,0.045163,0.40618,GOBP_MUSCLE_TISSUE_DEVELOPMENT,0.99999
chr21q21,SET,25,0.066651,0.0024579,0.28081,0.40619,chr21q21,0.99999
HP_OSTEOPATHIA_STRIATA,SET,3,0.16523,0.002112,0.69675,0.40628,HP_OSTEOPATHIA_STRIATA,0.99999
HP_ABNORMAL_HEMATOCRIT,SET,11,0.062616,0.0015323,0.26417,0.40632,HP_ABNORMAL_HEMATOCRIT,0.99999
GSE15930_NAIVE_VS_24H_IN_VIT...4,SET,188,0.014543,0.0014642,0.061364,0.40633,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,0.99999
GOBP_PODOCYTE_CELL_MIGRATION,SET,7,0.080734,0.0015762,0.34091,0.4064,GOBP_PODOCYTE_CELL_MIGRATION,0.99999
MIR372_3P,SET,304,0.01173,0.0014969,0.049569,0.40647,MIR372_3P,0.99999
GOBP_RESPONSE_TO_PROTOZOAN,SET,27,0.043723,0.0016756,0.18478,0.40648,GOBP_RESPONSE_TO_PROTOZOAN,0.99999
GOMF_FATTY_ACID_OMEGA_HYDROX...,SET,7,0.088366,0.0017252,0.37388,0.40658,GOMF_FATTY_ACID_OMEGA_HYDROXYLASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...483,SET,184,0.01586,0.0015799,0.067131,0.40662,GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,0.99999
HP_MACULAR_PURPURA,SET,78,0.024037,0.0015634,0.10175,0.40663,HP_MACULAR_PURPURA,0.99999
GSE20727_CTRL_VS_DNFB_ALLERG...2,SET,179,0.014724,0.0014468,0.062339,0.40664,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_UP,0.99999
WP_FIBRIN_COMPLEMENT_RECEPTO...,SET,41,0.032448,0.0015317,0.13738,0.40665,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.99999
HP_URETEROPELVIC_JUNCTION_OB...,SET,20,0.042877,0.0014145,0.18154,0.40665,HP_URETEROPELVIC_JUNCTION_OBSTRUCTION,0.99999
REACTOME_VEGFR2_MEDIATED_VAS...,SET,26,0.040141,0.0015096,0.1701,0.40672,REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,0.99999
GSE13547_WT_VS_ZFX_KO_BCELL_...4,SET,158,0.0158,0.0014595,0.066952,0.40672,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_UP,0.99999
REN_BOUND_BY_E2F,SET,53,0.02465,0.0013226,0.10446,0.40673,REN_BOUND_BY_E2F,0.99999
SHIN_B_CELL_LYMPHOMA_CLUSTER...3,SET,27,0.042581,0.0016318,0.18047,0.40674,SHIN_B_CELL_LYMPHOMA_CLUSTER_3,0.99999
HP_ENLARGED_OVARIES,SET,16,0.048031,0.0014174,0.20362,0.40676,HP_ENLARGED_OVARIES,0.99999
GSE41867_NAIVE_VS_DAY8_LCMV_...3,SET,159,0.015481,0.0014345,0.065644,0.40678,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...17,SET,180,0.01405,0.0013844,0.05961,0.40683,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_DN,0.99999
WP_EPITHELIAL_TO_MESENCHYMAL...,SET,153,0.017576,0.0015979,0.074645,0.40692,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,0.99999
HP_TOE_DEFORMITY,SET,112,0.018987,0.0014785,0.080667,0.40696,HP_TOE_DEFORMITY,0.99999
RAMALHO_STEMNESS_DN,SET,65,0.025879,0.0015372,0.10995,0.40697,RAMALHO_STEMNESS_DN,0.99999
MIR4441,SET,271,0.012258,0.0014783,0.0521,0.407,MIR4441,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...36,SET,12,0.054352,0.0013892,0.23102,0.407,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEAR_ENVELOPE,0.99999
GSE10240_CTRL_VS_IL17_AND_IL...2,SET,182,0.014133,0.0014002,0.060102,0.40705,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.99999
GOBP_COLUMNAR_CUBOIDAL_EPITH...2,SET,119,0.020053,0.0016093,0.085328,0.4071,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
GROSS_HIF1A_TARGETS_DN,SET,21,0.043429,0.001468,0.18481,0.40711,GROSS_HIF1A_TARGETS_DN,0.99999
HP_ABNORMAL_LOWER_LIMB_MOTOR...,SET,5,0.089004,0.0014687,0.37876,0.40711,HP_ABNORMAL_LOWER_LIMB_MOTOR_EVOKED_POTENTIALS,0.99999
GOBP_PROTEIN_GERANYLGERANYLA...,SET,6,0.077747,0.0014053,0.33089,0.40712,GOBP_PROTEIN_GERANYLGERANYLATION,0.99999
GSE7509_UNSTIM_VS_TNFA_IL1B_...2,SET,175,0.014652,0.0014237,0.062407,0.40719,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,0.99999
DESCARTES_FETAL_HEART_VISCER...,SET,73,0.02536,0.001596,0.10807,0.40723,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,0.99999
GOBP_ADHESION_OF_SYMBIONT_TO...1,SET,12,0.060866,0.0015556,0.2595,0.40728,GOBP_ADHESION_OF_SYMBIONT_TO_HOST,0.99999
GOBP_NEGATIVE_REGULATION_OF_...496,SET,8,0.071527,0.0014928,0.30504,0.4073,GOBP_NEGATIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.99999
GOBP_REGULATION_OF_VIRAL_GEN...,SET,80,0.023536,0.0015503,0.10059,0.4075,GOBP_REGULATION_OF_VIRAL_GENOME_REPLICATION,0.99999
MIR5189_5P,SET,139,0.016553,0.0014349,0.070754,0.40751,MIR5189_5P,0.99999
GOBP_DOUBLE_STRAND_BREAK_REP...4,SET,12,0.054186,0.0013849,0.23207,0.40769,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_BREAK_INDUCED_REPLICATION,0.99999
GOMF_TRIGLYCERIDE_LIPASE_ACT...,SET,24,0.048916,0.0017675,0.20954,0.40771,GOMF_TRIGLYCERIDE_LIPASE_ACTIVITY,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...53,SET,27,0.039533,0.001515,0.16938,0.40773,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_5TH_FINGER,0.99999
GSE5589_WT_VS_IL6_KO_LPS_AND...6,SET,180,0.015183,0.0014961,0.065064,0.40774,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.99999
YCATTAA_UNKNOWN,SET,499,0.0095103,0.0015465,0.040768,0.40777,YCATTAA_UNKNOWN,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...21,SET,48,0.026691,0.001363,0.11456,0.40789,GAVISH_3CA_MALIGNANT_METAPROGRAM_2_CELL_CYCLE_G1_S,0.99999
WP_METHIONINE_DE_NOVO_AND_SA...,SET,21,0.047413,0.0016027,0.20357,0.40792,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,0.99999
HP_SECOND_DEGREE_ATRIOVENTRI...,SET,12,0.056978,0.0014563,0.24469,0.40794,HP_SECOND_DEGREE_ATRIOVENTRICULAR_BLOCK,0.99999
HOLLERN_SOLID_NODULAR_BREAST...1,SET,29,0.041611,0.0016525,0.17877,0.40797,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN,0.99999
MIR222_5P,SET,174,0.014851,0.001439,0.063829,0.40801,MIR222_5P,0.99999
HP_ABNORMAL_BREATH_SOUND,SET,112,0.01895,0.0014756,0.081456,0.40802,HP_ABNORMAL_BREATH_SOUND,0.99999
GSE21670_TGFB_VS_TGFB_AND_IL...3,SET,184,0.01387,0.0013817,0.059618,0.40802,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.99999
GOMF_ARACHIDONATE_COA_LIGASE...,SET,10,0.062016,0.001447,0.26676,0.40809,GOMF_ARACHIDONATE_COA_LIGASE_ACTIVITY,0.99999
GSE25088_ROSIGLITAZONE_VS_IL...3,SET,178,0.014827,0.0014529,0.063784,0.40809,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,0.99999
YAGI_AML_WITH_T_8_21_TRANSLO...,SET,325,0.011195,0.0014763,0.048187,0.40814,YAGI_AML_WITH_T_8_21_TRANSLOCATION,0.99999
HP_COGWHEEL_RIGIDITY,SET,25,0.042226,0.0015572,0.18176,0.40815,HP_COGWHEEL_RIGIDITY,0.99999
TSUNODA_CISPLATIN_RESISTANCE...2,SET,11,0.071408,0.0017474,0.3074,0.40816,TSUNODA_CISPLATIN_RESISTANCE_UP,0.99999
GSE28237_FOLLICULAR_VS_LATE_...2,SET,180,0.015371,0.0015145,0.066169,0.40816,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP,0.99999
GOCC_POSTSYNAPTIC_CYTOSKELET...,SET,13,0.054475,0.0014491,0.23467,0.40822,GOCC_POSTSYNAPTIC_CYTOSKELETON,0.99999
GSE37605_C57BL6_VS_NOD_FOXP3...3,SET,178,0.015088,0.0014785,0.065004,0.40823,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN,0.99999
GOBP_NEUTRAL_AMINO_ACID_TRAN...,SET,54,0.027952,0.0015137,0.12044,0.40824,GOBP_NEUTRAL_AMINO_ACID_TRANSPORT,0.99999
WP_SELENIUM_METABOLISM_AND_S...,SET,34,0.034762,0.0014946,0.14987,0.40829,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,0.99999
GOCC_INNER_MITOCHONDRIAL_MEM...,SET,113,0.016909,0.0013225,0.072908,0.4083,GOCC_INNER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX,0.99999
KEGG_MEDICUS_PATHOGEN_HPV_E6...3,SET,13,0.053324,0.0014185,0.23002,0.40834,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382,0.99999
HP_AMBIGUOUS_GENITALIA_MALE,SET,11,0.061622,0.001508,0.26583,0.40834,HP_AMBIGUOUS_GENITALIA_MALE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...171,SET,7,0.08112,0.0015837,0.34995,0.40835,GOBP_NEGATIVE_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.99999
HP_TONIC_SEIZURE,SET,121,0.017745,0.0014359,0.076563,0.40836,HP_TONIC_SEIZURE,0.99999
GOBP_REGULATION_OF_CELL_PROJ...3,SET,11,0.055557,0.0013595,0.23973,0.40837,GOBP_REGULATION_OF_CELL_PROJECTION_SIZE,0.99999
GOCC_INNER_DYNEIN_ARM,SET,4,0.072735,0.0010735,0.314,0.40841,GOCC_INNER_DYNEIN_ARM,0.99999
GOMF_LIPOTEICHOIC_ACID_BINDI...,SET,5,0.093421,0.0015416,0.4034,0.40843,GOMF_LIPOTEICHOIC_ACID_BINDING,0.99999
GOCC_CYTOPLASMIC_SIDE_OF_MEM...,SET,186,0.014725,0.0014747,0.063588,0.40844,GOCC_CYTOPLASMIC_SIDE_OF_MEMBRANE,0.99999
GOBP_MAINTENANCE_OF_ORGANELL...,SET,11,0.051987,0.0012722,0.22458,0.40847,GOBP_MAINTENANCE_OF_ORGANELLE_LOCATION,0.99999
WP_MICRORNA_FOR_TARGETING_CA...,SET,7,0.071883,0.0014034,0.3106,0.40849,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,0.99999
GOMF_CARNITINE_O_ACYLTRANSFE...,SET,6,0.06905,0.0012481,0.29859,0.40856,GOMF_CARNITINE_O_ACYLTRANSFERASE_ACTIVITY,0.99999
REACTOME_PLASMA_LIPOPROTEIN_...1,SET,14,0.050255,0.0013873,0.21737,0.40858,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY,0.99999
SMTTTTGT_UNKNOWN,SET,359,0.010959,0.0015175,0.047404,0.40858,SMTTTTGT_UNKNOWN,0.99999
GOBP_REGULATION_OF_P38MAPK_C...,SET,41,0.03373,0.0015923,0.14598,0.40864,GOBP_REGULATION_OF_P38MAPK_CASCADE,0.99999
GOBP_POSITIVE_REGULATION_OF_...192,SET,155,0.017836,0.001632,0.077206,0.40865,GOBP_POSITIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.99999
GOBP_REGULATION_OF_LEUKOCYTE...2,SET,30,0.038003,0.001535,0.1645,0.40865,GOBP_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.99999
GOCC_KINOCILIUM,SET,10,0.065459,0.0015273,0.2834,0.40867,GOCC_KINOCILIUM,0.99999
HP_ABNORMAL_PERITONEUM_MORPH...,SET,59,0.025822,0.0014615,0.11179,0.40867,HP_ABNORMAL_PERITONEUM_MORPHOLOGY,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...6,SET,9,0.065696,0.0014543,0.28453,0.4087,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY,0.99999
GOCC_MHC_CLASS_I_PEPTIDE_LOA...,SET,8,0.066617,0.0013903,0.28867,0.40875,GOCC_MHC_CLASS_I_PEPTIDE_LOADING_COMPLEX,0.99999
GSE17721_PAM3CSK4_VS_CPG_12H...1,SET,187,0.014143,0.0014201,0.061308,0.40878,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_DN,0.99999
REACTOME_REGULATION_OF_NPAS4...3,SET,9,0.068721,0.0015212,0.29792,0.40879,REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION,0.99999
LI_LUNG_CANCER,SET,40,0.031009,0.0014459,0.13445,0.4088,LI_LUNG_CANCER,0.99999
WU_APOPTOSIS_BY_CDKN1A_NOT_V...,SET,9,0.057028,0.0012624,0.24737,0.40884,WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53,0.99999
MODULE_94,SET,342,0.011097,0.0015005,0.048144,0.40885,MODULE_94,0.99999
MIR383_3P,SET,122,0.018144,0.0014742,0.078724,0.40886,MIR383_3P,0.99999
GNF2_CDH11,SET,24,0.047974,0.0017334,0.20816,0.40886,GNF2_CDH11,0.99999
ZAIDI_OSTEOBLAST_TRANSCRIPTI...,SET,13,0.061431,0.0016342,0.26658,0.40888,ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS,0.99999
GOBP_CELL_CELL_RECOGNITION,SET,71,0.023731,0.001473,0.10298,0.40888,GOBP_CELL_CELL_RECOGNITION,0.99999
GOMF_PRE_MRNA_INTRONIC_BINDI...,SET,13,0.04852,0.0012907,0.21057,0.40888,GOMF_PRE_MRNA_INTRONIC_BINDING,0.99999
HP_MOLAR_TOOTH_SIGN_ON_MRI,SET,37,0.029126,0.0013063,0.12646,0.40892,HP_MOLAR_TOOTH_SIGN_ON_MRI,0.99999
GOBP_DNA_BIOSYNTHETIC_PROCESS,SET,177,0.013543,0.0013233,0.058803,0.40893,GOBP_DNA_BIOSYNTHETIC_PROCESS,0.99999
MIR4735_3P,SET,107,0.01931,0.00147,0.083898,0.40898,MIR4735_3P,0.99999
GOBP_EARLY_ENDOSOME_TO_GOLGI...,SET,16,0.049381,0.0014572,0.21454,0.40898,GOBP_EARLY_ENDOSOME_TO_GOLGI_TRANSPORT,0.99999
KEGG_MEDICUS_PATHOGEN_HCMV_U...4,SET,8,0.075241,0.0015703,0.32708,0.40903,KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,0.99999
GOMF_KETOSTEROID_MONOOXYGENA...,SET,5,0.124,0.0020461,0.53914,0.40905,GOMF_KETOSTEROID_MONOOXYGENASE_ACTIVITY,0.99999
HP_ABNORMAL_PROXIMAL_FEMORAL...,SET,8,0.068544,0.0014306,0.2981,0.40907,HP_ABNORMAL_PROXIMAL_FEMORAL_METAPHYSIS_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...444,SET,10,0.06468,0.0015092,0.28144,0.40912,GOBP_POSITIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,0.99999
MANALO_HYPOXIA_DN,SET,263,0.011293,0.0013419,0.049157,0.40915,MANALO_HYPOXIA_DN,0.99999
GSE40274_CTRL_VS_SATB1_TRANS...2,SET,150,0.016635,0.0014975,0.072466,0.40922,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GSE21360_NAIVE_VS_TERTIARY_M...1,SET,178,0.014342,0.0014054,0.062484,0.40923,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_DN,0.99999
GOBP_METANEPHRIC_MESENCHYME_...,SET,13,0.062656,0.0016667,0.27307,0.40926,GOBP_METANEPHRIC_MESENCHYME_DEVELOPMENT,0.99999
HP_APLASIA_OF_THE_PECTORALIS...,SET,4,0.10052,0.0014836,0.43821,0.40929,HP_APLASIA_OF_THE_PECTORALIS_MAJOR_MUSCLE,0.99999
MODULE_332,SET,42,0.028469,0.0013601,0.12412,0.4093,MODULE_332,0.99999
GOBP_PROTEIN_LIPOYLATION,SET,5,0.080633,0.0013305,0.35166,0.40932,GOBP_PROTEIN_LIPOYLATION,0.99999
GSE22886_NAIVE_VS_IGG_IGA_ME...2,SET,169,0.015078,0.00144,0.065767,0.40933,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP,0.99999
GOMF_GROWTH_FACTOR_ACTIVITY,SET,145,0.017091,0.001513,0.0746,0.40939,GOMF_GROWTH_FACTOR_ACTIVITY,0.99999
BYSTRYKH_HEMATOPOIESIS_STEM_...4,SET,8,0.06261,0.0013067,0.27333,0.40941,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1,0.99999
GSE12003_MIR223_KO_VS_WT_BM_...2,SET,178,0.014521,0.0014229,0.063402,0.40942,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP,0.99999
GSE21927_SPLEEN_VS_C26GM_TUM...2,SET,137,0.017864,0.0015374,0.077989,0.40942,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_UP,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...3,SET,47,0.032471,0.0016409,0.14179,0.40943,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2,0.99999
GOBP_POLYPRENOL_METABOLIC_PR...,SET,23,0.036458,0.0012896,0.15926,0.40947,GOBP_POLYPRENOL_METABOLIC_PROCESS,0.99999
HP_CALCIFIC_STIPPLING,SET,3,0.13844,0.0017696,0.60478,0.40947,HP_CALCIFIC_STIPPLING,0.99999
GOBP_FC_EPSILON_RECEPTOR_SIG...,SET,24,0.040665,0.0014694,0.1777,0.4095,GOBP_FC_EPSILON_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_PYRIMIDINE_DIMER_REPAIR,SET,9,0.046677,0.0010333,0.20397,0.4095,GOBP_PYRIMIDINE_DIMER_REPAIR,0.99999
HP_BRACHYDACTYLY,SET,337,0.010632,0.0014272,0.046477,0.40953,HP_BRACHYDACTYLY,0.99999
GOBP_POSITIVE_REGULATION_OF_...241,SET,4,0.11184,0.0016507,0.48948,0.40964,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MATRIX_ADHESION_VIA_FIBRONECTIN,0.99999
REACTOME_NEGATIVE_EPIGENETIC...,SET,44,0.026404,0.0012911,0.11572,0.40975,REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,0.99999
GOBP_TELOMERE_LOCALIZATION,SET,8,0.060387,0.0012603,0.26479,0.4098,GOBP_TELOMERE_LOCALIZATION,0.99999
GOBP_NON_PROTEINOGENIC_AMINO...1,SET,16,0.048807,0.0014403,0.21403,0.40981,GOBP_NON_PROTEINOGENIC_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.99999
BIOCARTA_CARM_ER_PATHWAY,SET,22,0.039494,0.0013664,0.17322,0.40982,BIOCARTA_CARM_ER_PATHWAY,0.99999
DESCARTES_MAIN_FETAL_ENDOCAR...,SET,66,0.024508,0.0014669,0.10754,0.40986,DESCARTES_MAIN_FETAL_ENDOCARDIAL_CELLS,0.99999
GSE6259_DEC205_POS_DC_VS_BCE...1,SET,165,0.015213,0.0014358,0.066765,0.40988,GSE6259_DEC205_POS_DC_VS_BCELL_DN,0.99999
GOMF_HORMONE_RECEPTOR_BINDING,SET,29,0.039144,0.0015546,0.17195,0.40996,GOMF_HORMONE_RECEPTOR_BINDING,0.99999
RIZKI_TUMOR_INVASIVENESS_2D_...2,SET,60,0.02494,0.0014235,0.10959,0.40999,RIZKI_TUMOR_INVASIVENESS_2D_UP,0.99999
PEPPER_CHRONIC_LYMPHOCYTIC_L...2,SET,29,0.038325,0.001522,0.16861,0.4101,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,0.99999
GOCC_RNA_POLYMERASE_II_CORE_...,SET,13,0.048646,0.0012941,0.21427,0.4102,GOCC_RNA_POLYMERASE_II_CORE_COMPLEX,0.99999
GOCC_SUMO_LIGASE_COMPLEX,SET,10,0.064262,0.0014994,0.2831,0.41022,GOCC_SUMO_LIGASE_COMPLEX,0.99999
HP_NAIL_DYSTROPHY,SET,125,0.017967,0.0014775,0.079176,0.41024,HP_NAIL_DYSTROPHY,0.99999
HP_FIBROUS_TISSUE_NEOPLASM,SET,78,0.021869,0.0014224,0.096406,0.41028,HP_FIBROUS_TISSUE_NEOPLASM,0.99999
GSE37534_UNTREATED_VS_PIOGLI...2,SET,176,0.014283,0.0013918,0.062982,0.4103,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.99999
COREBINDINGFACTOR_Q6,SET,247,0.01243,0.0014321,0.054854,0.41037,COREBINDINGFACTOR_Q6,0.99999
GSE24574_NAIVE_VS_TCONV_CD4_...2,SET,181,0.015043,0.0014863,0.066428,0.41043,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP,0.99999
REACTOME_NOTCH4_INTRACELLULA...,SET,19,0.043324,0.0013931,0.19154,0.41053,REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.99999
GOBP_ICOSANOID_CATABOLIC_PRO...,SET,9,0.062147,0.0013757,0.27483,0.41055,GOBP_ICOSANOID_CATABOLIC_PROCESS,0.99999
TRAVAGLINI_LUNG_SEROUS_CELL,SET,86,0.021505,0.0014684,0.095164,0.41061,TRAVAGLINI_LUNG_SEROUS_CELL,0.99999
GOCC_SEROTONIN_RECEPTOR_COMP...,SET,5,0.10669,0.0017604,0.47217,0.41062,GOCC_SEROTONIN_RECEPTOR_COMPLEX,0.99999
GOMF_SEROTONIN_GATED_MONOATO...,SET,5,0.10669,0.0017604,0.47217,0.41062,GOMF_SEROTONIN_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.99999
GOMF_CYCLIC_NUCLEOTIDE_PHOSP...,SET,26,0.038562,0.0014502,0.17075,0.41066,GOMF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY,0.99999
GOBP_AZOLE_TRANSMEMBRANE_TRA...,SET,13,0.057444,0.0015281,0.25438,0.41067,GOBP_AZOLE_TRANSMEMBRANE_TRANSPORT,0.99999
KEGG_MEDICUS_ENV_FACTOR_META...4,SET,11,0.059699,0.0014609,0.26438,0.41068,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
GSE17721_LPS_VS_CPG_2H_BMDC_...1,SET,181,0.014353,0.0014181,0.063609,0.41074,GSE17721_LPS_VS_CPG_2H_BMDC_DN,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...14,SET,49,0.031031,0.0016011,0.13753,0.41075,GAVISH_3CA_MALIGNANT_METAPROGRAM_23_SECRETED_2,0.99999
GOBP_TYPE_2_IMMUNE_RESPONSE,SET,41,0.032476,0.0015331,0.14395,0.41075,GOBP_TYPE_2_IMMUNE_RESPONSE,0.99999
GOBP_VENTRAL_SPINAL_CORD_DEV...,SET,44,0.031262,0.0015287,0.13858,0.41076,GOBP_VENTRAL_SPINAL_CORD_DEVELOPMENT,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...4,SET,22,0.045268,0.0015662,0.20077,0.41081,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,0.99999
RAMPON_ENRICHED_LEARNING_ENV...3,SET,21,0.038216,0.0012918,0.16958,0.41085,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP,0.99999
GSE23502_BM_VS_COLON_TUMOR_H...1,SET,187,0.013799,0.0013856,0.06127,0.41091,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,0.99999
GSE31082_CD4_VS_CD8_SP_THYMO...2,SET,178,0.014547,0.0014254,0.064618,0.41095,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP,0.99999
KEGG_PHENYLALANINE_METABOLISM,SET,15,0.055261,0.001579,0.24554,0.41097,KEGG_PHENYLALANINE_METABOLISM,0.99999
GOBP_POSITIVE_REGULATION_OF_...766,SET,65,0.023546,0.0013986,0.10468,0.41102,GOBP_POSITIVE_REGULATION_OF_TOR_SIGNALING,0.99999
KEGG_NON_HOMOLOGOUS_END_JOIN...,SET,12,0.045579,0.0011649,0.20269,0.41104,KEGG_NON_HOMOLOGOUS_END_JOINING,0.99999
PLASARI_NFIC_TARGETS_BASAL_UP,SET,28,0.041981,0.0016383,0.18675,0.41107,PLASARI_NFIC_TARGETS_BASAL_UP,0.99999
chr5q32,SET,44,0.052259,0.0025554,0.23249,0.41108,chr5q32,0.99999
KEGG_MEDICUS_PATHOGEN_SALMON...7,SET,8,0.058199,0.0012147,0.25907,0.41113,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_E2_TO_NOD_NFKB_SIGNALING_PATHWAY,0.99999
WP_COVID19_ADVERSE_OUTCOME_P...,SET,14,0.05577,0.0015395,0.24837,0.41117,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,0.99999
MIR185_3P,SET,137,0.016697,0.001437,0.074364,0.41117,MIR185_3P,0.99999
MIR506_3P,SET,693,0.0075319,0.0014355,0.033544,0.41117,MIR506_3P,0.99999
MIR491_5P,SET,97,0.019041,0.0013804,0.084862,0.41123,MIR491_5P,0.99999
HP_HIGH_FREQUENCY_HEARING_IM...,SET,5,0.098891,0.0016318,0.44073,0.41123,HP_HIGH_FREQUENCY_HEARING_IMPAIRMENT,0.99999
BUSSLINGER_DUODENAL_I_CELLS,SET,14,0.052571,0.0014512,0.23434,0.41125,BUSSLINGER_DUODENAL_I_CELLS,0.99999
KEGG_MEDICUS_REFERENCE_FAS_J...,SET,7,0.076265,0.0014889,0.34005,0.41127,KEGG_MEDICUS_REFERENCE_FAS_JNK_SIGNALING_PATHWAY,0.99999
GOBP_LYMPHOCYTE_CHEMOTAXIS,SET,42,0.031751,0.001517,0.1416,0.41129,GOBP_LYMPHOCYTE_CHEMOTAXIS,0.99999
GSE6674_UNSTIM_VS_ANTI_IGM_S...2,SET,149,0.014659,0.0013152,0.065421,0.41135,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_UP,0.99999
GOMF_LIPASE_INHIBITOR_ACTIVI...,SET,14,0.05574,0.0015387,0.24879,0.41136,GOMF_LIPASE_INHIBITOR_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...237,SET,16,0.048363,0.0014271,0.21602,0.41143,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.99999
GOBP_REGULATION_OF_GLUTAMATE...2,SET,6,0.084004,0.0015184,0.37528,0.41144,GOBP_REGULATION_OF_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.99999
FLETCHER_PBMC_BCG_10W_INFANT...4,SET,89,0.022993,0.0015971,0.10274,0.41145,FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP,0.99999
MIR6845_5P,SET,56,0.024362,0.0013435,0.10887,0.41147,MIR6845_5P,0.99999
GOBP_CELLULAR_RESPONSE_TO_EX...2,SET,72,0.02456,0.0015351,0.10978,0.41149,GOBP_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS,0.99999
GOBP_MAINTENANCE_OF_SISTER_C...,SET,8,0.061433,0.0012821,0.27464,0.4115,GOBP_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,0.99999
GOBP_INNATE_IMMUNE_RESPONSE_...1,SET,88,0.021145,0.0014604,0.094532,0.41151,GOBP_INNATE_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_RENAL_INSTERSTIT...,SET,52,0.026161,0.0013904,0.11698,0.41152,HP_ABNORMAL_RENAL_INSTERSTITIAL_MORPHOLOGY,0.99999
WP_MITOCHONDRIAL_FATTY_ACID_...1,SET,18,0.044029,0.001378,0.19699,0.41157,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,0.99999
GSE17812_WT_VS_THPOK_KO_MEMO...1,SET,181,0.014848,0.0014671,0.066501,0.41166,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...521,SET,270,0.012374,0.0014896,0.055443,0.4117,GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.99999
SENGUPTA_NASOPHARYNGEAL_CARC...4,SET,362,0.010528,0.0014637,0.047183,0.41172,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,0.99999
HP_ANTINUCLEAR_ANTIBODY_POSI...,SET,62,0.026101,0.0015143,0.11699,0.41173,HP_ANTINUCLEAR_ANTIBODY_POSITIVITY,0.99999
HP_DECREASED_SPECIFIC_ANTIBO...3,SET,13,0.059609,0.0015857,0.26718,0.41173,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_PROTEIN_VACCINE,0.99999
HP1SITEFACTOR_Q6,SET,204,0.013925,0.0014598,0.062459,0.41179,HP1SITEFACTOR_Q6,0.99999
GSE17721_LPS_VS_POLYIC_12H_B...1,SET,187,0.013795,0.0013852,0.061874,0.41179,GSE17721_LPS_VS_POLYIC_12H_BMDC_DN,0.99999
GOCC_AXONAL_GROWTH_CONE,SET,23,0.040285,0.001425,0.18099,0.41193,GOCC_AXONAL_GROWTH_CONE,0.99999
GOBP_LEUKOTRIENE_D4_METABOLI...,SET,7,0.072374,0.001413,0.32529,0.41197,GOBP_LEUKOTRIENE_D4_METABOLIC_PROCESS,0.99999
LI_PBMC_MENACTRA_AGE_18_45YO...2,SET,15,0.052502,0.0015001,0.23607,0.412,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_DN,0.99999
REACTOME_PRE_NOTCH_PROCESSIN...1,SET,18,0.041274,0.0012918,0.18564,0.41203,REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,0.99999
ZNF138_TARGET_GENES,SET,3,0.09352,0.0011954,0.42067,0.41204,ZNF138_TARGET_GENES,0.99999
GOBP_INTERSTRAND_CROSS_LINK_...,SET,34,0.027481,0.0011816,0.12361,0.41204,GOBP_INTERSTRAND_CROSS_LINK_REPAIR,0.99999
PXR_Q2,SET,241,0.012449,0.001417,0.056008,0.41205,PXR_Q2,0.99999
GOBP_EPITHELIAL_STRUCTURE_MA...,SET,32,0.03711,0.001548,0.16695,0.41205,GOBP_EPITHELIAL_STRUCTURE_MAINTENANCE,0.99999
TURJANSKI_MAPK11_TARGETS,SET,4,0.097262,0.0014355,0.43796,0.41213,TURJANSKI_MAPK11_TARGETS,0.99999
HP_ACUTE_PANCREATITIS,SET,6,0.08038,0.0014529,0.36199,0.41214,HP_ACUTE_PANCREATITIS,0.99999
GSE21380_NON_TFH_VS_TFH_CD4_...2,SET,183,0.014317,0.0014223,0.064476,0.41214,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP,0.99999
HP_SUBMUCOUS_CLEFT_SOFT_PALA...,SET,9,0.060037,0.001329,0.2708,0.41227,HP_SUBMUCOUS_CLEFT_SOFT_PALATE,0.99999
HP_FEMALE_PSEUDOHERMAPHRODIT...,SET,7,0.083872,0.0016375,0.37838,0.41229,HP_FEMALE_PSEUDOHERMAPHRODITISM,0.99999
GSE17974_1H_VS_72H_UNTREATED...2,SET,179,0.013958,0.0013716,0.062992,0.41232,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.99999
TCF4_Q5,SET,219,0.013767,0.0014947,0.062142,0.41234,TCF4_Q5,0.99999
HP_INERTIA,SET,4,0.10533,0.0015546,0.47572,0.41239,HP_INERTIA,0.99999
HP_ABNORMAL_THROMBOSIS,SET,185,0.01496,0.0014942,0.067606,0.41244,HP_ABNORMAL_THROMBOSIS,0.99999
FLOTHO_PEDIATRIC_ALL_THERAPY...1,SET,28,0.037383,0.0014588,0.16898,0.41246,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...189,SET,29,0.032289,0.0012823,0.14604,0.41251,GOBP_NEGATIVE_REGULATION_OF_DNA_REPAIR,0.99999
GSE2405_0H_VS_3H_A_PHAGOCYTO...1,SET,163,0.016008,0.0015017,0.07241,0.41252,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.99999
GSE19888_ADENOSINE_A3R_INH_P...1,SET,181,0.013671,0.0013508,0.06192,0.41263,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN,0.99999
HP_PANCREATIC_APLASIA,SET,6,0.077251,0.0013964,0.34992,0.41264,HP_PANCREATIC_APLASIA,0.99999
CUI_DEVELOPING_HEART_C8_MACR...,SET,248,0.012846,0.0014829,0.058186,0.41264,CUI_DEVELOPING_HEART_C8_MACROPHAGE,0.99999
GOBP_EPITHELIAL_CELL_DIFFERE...2,SET,46,0.031816,0.0015906,0.14414,0.41265,GOBP_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.99999
GOBP_NEUROINFLAMMATORY_RESPO...,SET,75,0.023615,0.0015063,0.10698,0.41265,GOBP_NEUROINFLAMMATORY_RESPONSE,0.99999
MIR6831_5P,SET,106,0.018611,0.0014101,0.084348,0.41268,MIR6831_5P,0.99999
GSE42021_TREG_VS_TCONV_PLN_UP,SET,186,0.014411,0.0014432,0.065314,0.41269,GSE42021_TREG_VS_TCONV_PLN_UP,0.99999
GSE15330_HSC_VS_MEGAKARYOCYT...4,SET,149,0.0153,0.0013727,0.069366,0.41272,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,0.99999
GOBP_ADIPONECTIN_ACTIVATED_S...,SET,7,0.072083,0.0014073,0.32698,0.41276,GOBP_ADIPONECTIN_ACTIVATED_SIGNALING_PATHWAY,0.99999
HP_OVERFOLDING_OF_THE_SUPERI...,SET,4,0.099127,0.0014631,0.44982,0.41279,HP_OVERFOLDING_OF_THE_SUPERIOR_HELICES,0.99999
REACTOME_RA_BIOSYNTHESIS_PAT...,SET,22,0.04382,0.0015161,0.19936,0.41301,REACTOME_RA_BIOSYNTHESIS_PATHWAY,0.99999
GOBP_NK_T_CELL_ACTIVATION,SET,13,0.061326,0.0016314,0.27898,0.41301,GOBP_NK_T_CELL_ACTIVATION,0.99999
GSE13547_CTRL_VS_ANTI_IGM_ST...8,SET,139,0.014824,0.001285,0.067465,0.41304,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_UP,0.99999
HP_POSTAXIAL_FOOT_POLYDACTYLY,SET,63,0.022894,0.0013389,0.10428,0.41312,HP_POSTAXIAL_FOOT_POLYDACTYLY,0.99999
GOCC_NEURONAL_RIBONUCLEOPROT...,SET,3,0.10549,0.0013484,0.48069,0.41315,GOCC_NEURONAL_RIBONUCLEOPROTEIN_GRANULE,0.99999
GOBP_EMBRYONIC_SKELETAL_SYST...2,SET,89,0.02238,0.0015545,0.102,0.41317,GOBP_EMBRYONIC_SKELETAL_SYSTEM_MORPHOGENESIS,0.99999
KEGG_ECM_RECEPTOR_INTERACTION,SET,82,0.022072,0.0014719,0.10062,0.41318,KEGG_ECM_RECEPTOR_INTERACTION,0.99999
MODULE_328,SET,13,0.051553,0.0013714,0.235,0.41318,MODULE_328,0.99999
GOMF_T_CELL_RECEPTOR_BINDING,SET,10,0.061891,0.0014441,0.28214,0.41318,GOMF_T_CELL_RECEPTOR_BINDING,0.99999
HP_PROGRESSIVE_PERIPHERAL_NE...,SET,4,0.10525,0.0015534,0.47987,0.4132,HP_PROGRESSIVE_PERIPHERAL_NEUROPATHY,0.99999
GOCC_ROUGH_ENDOPLASMIC_RETIC...1,SET,52,0.025047,0.0013312,0.11425,0.41324,GOCC_ROUGH_ENDOPLASMIC_RETICULUM,0.99999
GSE22935_UNSTIM_VS_48H_MBOVI...1,SET,180,0.014051,0.0013845,0.0641,0.41324,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.99999
GOMF_PEROXISOME_TARGETING_SE...,SET,3,0.10326,0.0013199,0.47133,0.41329,GOMF_PEROXISOME_TARGETING_SEQUENCE_BINDING,0.99999
MIR337_3P,SET,110,0.017978,0.0013874,0.082077,0.41331,MIR337_3P,0.99999
GSE13484_3H_UNSTIM_VS_YF17D_...2,SET,185,0.013297,0.0013281,0.06073,0.41335,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,0.99999
YANG_BREAST_CANCER_ESR1_DN,SET,21,0.045003,0.0015212,0.20579,0.41345,YANG_BREAST_CANCER_ESR1_DN,0.99999
GOBP_TRNA_METABOLIC_PROCESS,SET,167,0.013049,0.0012389,0.059672,0.41345,GOBP_TRNA_METABOLIC_PROCESS,0.99999
REACTOME_SMAD2_SMAD3_SMAD4_H...,SET,35,0.03094,0.0013497,0.14154,0.41348,REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,0.99999
WP_NEURAL_CREST_CELL_MIGRATI...1,SET,37,0.03328,0.0014926,0.15235,0.41354,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,0.99999
HP_ABNORMALITY_OF_THE_UPPER_...2,SET,1520,0.0049827,0.0013731,0.02281,0.41354,HP_ABNORMALITY_OF_THE_UPPER_LIMB,0.99999
HP_OVERGROWTH_OF_EXTERNAL_GE...,SET,9,0.071996,0.0015937,0.32974,0.41358,HP_OVERGROWTH_OF_EXTERNAL_GENITALIA,0.99999
GOCC_SMOOTH_ENDOPLASMIC_RETI...1,SET,28,0.035802,0.0013972,0.16401,0.4136,GOCC_SMOOTH_ENDOPLASMIC_RETICULUM,0.99999
HP_MESOAXIAL_FOOT_POLYDACTYLY,SET,4,0.1123,0.0016575,0.51443,0.4136,HP_MESOAXIAL_FOOT_POLYDACTYLY,0.99999
GOMF_SMALL_RIBOSOMAL_SUBUNIT...,SET,7,0.066578,0.0012998,0.30509,0.41363,GOMF_SMALL_RIBOSOMAL_SUBUNIT_RRNA_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...828,SET,17,0.044859,0.0013645,0.2056,0.41364,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,0.99999
GOCC_CELL_TIP,SET,7,0.069133,0.0013497,0.31686,0.41364,GOCC_CELL_TIP,0.99999
MORF_MSH2,SET,58,0.021353,0.0011983,0.097884,0.41366,MORF_MSH2,0.99999
WATANABE_COLON_CANCER_MSI_VS...1,SET,53,0.027148,0.0014566,0.12447,0.41368,WATANABE_COLON_CANCER_MSI_VS_MSS_DN,0.99999
INGRAM_SHH_TARGETS_UP,SET,113,0.019447,0.001521,0.089181,0.41369,INGRAM_SHH_TARGETS_UP,0.99999
GSE36078_UNTREATED_VS_AD5_IN...1,SET,183,0.013434,0.0013346,0.061612,0.4137,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_DN,0.99999
LCORL_TARGET_GENES,SET,359,0.0097247,0.0013465,0.044604,0.41371,LCORL_TARGET_GENES,0.99999
GSE7831_1H_VS_4H_INFLUENZA_S...2,SET,182,0.013988,0.0013859,0.064162,0.41371,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_UP,0.99999
GOBP_BLASTODERM_SEGMENTATION,SET,22,0.043446,0.0015031,0.19941,0.41377,GOBP_BLASTODERM_SEGMENTATION,0.99999
GOCC_IGM_IMMUNOGLOBULIN_COMP...,SET,3,0.12259,0.0015669,0.56293,0.41381,GOCC_IGM_IMMUNOGLOBULIN_COMPLEX,0.99999
GSE12839_CTRL_VS_IL12_TREATE...2,SET,135,0.015586,0.0013317,0.071597,0.41383,GSE12839_CTRL_VS_IL12_TREATED_PBMC_UP,0.99999
GSE21670_UNTREATED_VS_IL6_TR...2,SET,168,0.013756,0.0013099,0.063197,0.41385,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_UP,0.99999
HOEBEKE_LYMPHOID_STEM_CELL_UP,SET,86,0.020051,0.0013691,0.09213,0.41386,HOEBEKE_LYMPHOID_STEM_CELL_UP,0.99999
GOCC_TRANSLOCON_COMPLEX,SET,5,0.085504,0.0014109,0.3929,0.41386,GOCC_TRANSLOCON_COMPLEX,0.99999
GOBP_STEROL_METABOLIC_PROCESS,SET,138,0.016,0.001382,0.073558,0.4139,GOBP_STEROL_METABOLIC_PROCESS,0.99999
GOBP_BICARBONATE_TRANSPORT,SET,36,0.030136,0.0013332,0.13858,0.41392,GOBP_BICARBONATE_TRANSPORT,0.99999
GOMF_PROTON_CHANNEL_ACTIVITY,SET,9,0.064822,0.0014349,0.29806,0.41392,GOMF_PROTON_CHANNEL_ACTIVITY,0.99999
HP_SPERMATOGENESIS_MATURATIO...,SET,11,0.050392,0.0012331,0.23171,0.41392,HP_SPERMATOGENESIS_MATURATION_ARREST,0.99999
HP_BRANCHIAL_CYST,SET,4,0.073118,0.0010792,0.33649,0.41399,HP_BRANCHIAL_CYST,0.99999
GSE360_T_GONDII_VS_B_MALAYI_...1,SET,186,0.013399,0.0013419,0.061664,0.41399,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...5,SET,179,0.013557,0.0013322,0.062395,0.414,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_DN,0.99999
HP_ELEVATED_URINARY_CATECHOL...,SET,27,0.034687,0.0013293,0.15976,0.41406,HP_ELEVATED_URINARY_CATECHOLAMINE_LEVEL,0.99999
GSE17974_0H_VS_48H_IN_VITRO_...1,SET,173,0.01339,0.0012937,0.061698,0.41409,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN,0.99999
GSE21360_SECONDARY_VS_TERTIA...2,SET,179,0.013211,0.0012982,0.060881,0.41411,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,0.99999
GOMF_TAT_PROTEIN_BINDING,SET,10,0.052736,0.0012305,0.2431,0.41413,GOMF_TAT_PROTEIN_BINDING,0.99999
GOBP_IMPORT_INTO_CELL,SET,844,0.0066892,0.0014009,0.030847,0.41416,GOBP_IMPORT_INTO_CELL,0.99999
HALLMARK_APICAL_JUNCTION,SET,183,0.014134,0.0014041,0.06519,0.41418,HALLMARK_APICAL_JUNCTION,0.99999
MIR3157_5P,SET,97,0.018309,0.0013274,0.084468,0.4142,MIR3157_5P,0.99999
REACTOME_SIRT1_NEGATIVELY_RE...,SET,7,0.058944,0.0011508,0.27196,0.41421,REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION,0.99999
MIR1224_3P,SET,63,0.022951,0.0013422,0.10599,0.41428,MIR1224_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...211,SET,62,0.024758,0.0014363,0.11434,0.41429,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,0.99999
HP_DERMATOCHALASIS,SET,8,0.071459,0.0014914,0.33027,0.41435,HP_DERMATOCHALASIS,0.99999
GOCC_HIPPOCAMPAL_MOSSY_FIBER...,SET,41,0.030494,0.0014395,0.14099,0.41438,GOCC_HIPPOCAMPAL_MOSSY_FIBER_TO_CA3_SYNAPSE,0.99999
GSE2128_C57BL6_VS_NOD_THYMOC...1,SET,176,0.013407,0.0013065,0.061994,0.41439,GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN,0.99999
HAHTOLA_MYCOSIS_FUNGOIDES_SK...2,SET,163,0.014504,0.0013606,0.067118,0.41446,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,0.99999
MIR6792_5P,SET,113,0.018772,0.0014682,0.086887,0.41448,MIR6792_5P,0.99999
REACTOME_LOSS_OF_FUNCTION_OF...1,SET,11,0.060508,0.0014807,0.28013,0.4145,REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME,0.99999
HP_RECURRENT_SPONTANEOUS_ABO...,SET,11,0.058047,0.0014205,0.26891,0.41455,HP_RECURRENT_SPONTANEOUS_ABORTION,0.99999
NIKOLSKY_BREAST_CANCER_19Q13...1,SET,21,0.059774,0.0020205,0.27695,0.41456,NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON,0.99999
GOBP_NEGATIVE_REGULATION_OF_...433,SET,21,0.041188,0.0013923,0.19089,0.41459,GOBP_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.99999
GOBP_NEUROBLAST_PROLIFERATION,SET,78,0.021648,0.0014081,0.1004,0.41464,GOBP_NEUROBLAST_PROLIFERATION,0.99999
GOBP_REGULATION_OF_REACTIVE_...1,SET,35,0.030629,0.0013361,0.14206,0.41465,GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,0.99999
GSE19888_ADENOSINE_A3R_INH_V...3,SET,179,0.013914,0.0013672,0.064561,0.41468,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN,0.99999
GSE40666_WT_VS_STAT1_KO_CD8_...3,SET,185,0.012953,0.0012937,0.060127,0.41472,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.99999
GOMF_INTRAMOLECULAR_TRANSFER...,SET,26,0.032462,0.0012208,0.15079,0.41478,GOMF_INTRAMOLECULAR_TRANSFERASE_ACTIVITY,0.99999
GOBP_AMINOACYL_TRNA_METABOLI...,SET,8,0.054732,0.0011423,0.2543,0.4148,GOBP_AMINOACYL_TRNA_METABOLISM_INVOLVED_IN_TRANSLATIONAL_FIDELITY,0.99999
GOMF_AMINOACYL_TRNA_EDITING_...,SET,8,0.054732,0.0011423,0.2543,0.4148,GOMF_AMINOACYL_TRNA_EDITING_ACTIVITY,0.99999
GGCNNMSMYNTTG_UNKNOWN,SET,69,0.021893,0.0013397,0.10176,0.41483,GGCNNMSMYNTTG_UNKNOWN,0.99999
HP_ABNORMALITY_OF_THE_STAPES,SET,13,0.056295,0.0014975,0.26171,0.41484,HP_ABNORMALITY_OF_THE_STAPES,0.99999
GOBP_CANONICAL_WNT_SIGNALING...,SET,287,0.011596,0.0014385,0.053916,0.41485,GOBP_CANONICAL_WNT_SIGNALING_PATHWAY,0.99999
HP_ABDOMINAL_MASS,SET,9,0.07842,0.0017359,0.36474,0.41488,HP_ABDOMINAL_MASS,0.99999
GSE17721_ALL_VS_24H_PAM3CSK4...1,SET,174,0.013564,0.0013142,0.063099,0.4149,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_DN,0.99999
COATES_MACROPHAGE_M1_VS_M2_DN,SET,75,0.022257,0.0014197,0.10361,0.41496,COATES_MACROPHAGE_M1_VS_M2_DN,0.99999
BARRIER_CANCER_RELAPSE_NORMA...1,SET,27,0.033899,0.0012991,0.15787,0.41499,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,0.99999
ZHENG_CORD_BLOOD_C1_PUTATIVE...,SET,92,0.020613,0.0014555,0.096009,0.415,ZHENG_CORD_BLOOD_C1_PUTATIVE_MEGAKARYOCYTE_PROGENITOR,0.99999
HP_URETHRAL_VALVE,SET,11,0.054483,0.0013333,0.25385,0.41503,HP_URETHRAL_VALVE,0.99999
REACTOME_COHESIN_LOADING_ONT...,SET,7,0.073016,0.0014255,0.34043,0.41509,REACTOME_COHESIN_LOADING_ONTO_CHROMATIN,0.99999
REACTOME_KERATAN_SULFATE_KER...,SET,36,0.031544,0.0013955,0.14719,0.41516,REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,0.99999
OCT1_01,SET,227,0.013051,0.0014422,0.060902,0.41516,OCT1_01,0.99999
DAIRKEE_CANCER_PRONE_RESPONS...2,SET,107,0.017381,0.0013231,0.081128,0.41518,DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,0.99999
GOCC_GLYCOGEN_GRANULE,SET,6,0.070431,0.0012731,0.3288,0.41519,GOCC_GLYCOGEN_GRANULE,0.99999
GOBP_CHONDROITIN_SULFATE_PRO...2,SET,29,0.033846,0.0013442,0.15802,0.4152,GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,0.99999
GOBP_DNA_TEMPLATED_TRANSCRIP...1,SET,123,0.015597,0.0012724,0.072822,0.4152,GOBP_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,0.99999
GOBP_LONG_CHAIN_FATTY_ACYL_C...2,SET,24,0.040562,0.0014656,0.18945,0.41523,GOBP_LONG_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS,0.99999
GSE5542_IFNG_VS_IFNA_AND_IFN...4,SET,166,0.013895,0.0013153,0.0649,0.41523,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.99999
HP_RECURRENT_SYSTEMIC_PYOGEN...,SET,5,0.081737,0.0013487,0.38184,0.41525,HP_RECURRENT_SYSTEMIC_PYOGENIC_INFECTIONS,0.99999
GOBP_POSITIVE_REGULATION_OF_...404,SET,134,0.01692,0.0014403,0.079055,0.41526,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,0.99999
WP_ROLES_OF_CERAMIDES_IN_DEV...,SET,23,0.040521,0.0014334,0.18934,0.41527,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,0.99999
STK33_SKM_UP,SET,229,0.012041,0.0013364,0.056268,0.41528,STK33_SKM_UP,0.99999
BLANCO_MELO_HUMAN_PARAINFLUE...2,SET,188,0.014617,0.0014716,0.068324,0.4153,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,0.99999
GOMF_AMINO_ACID_TRANSMEMBRAN...,SET,91,0.020353,0.0014294,0.095194,0.41535,GOMF_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
PUJANA_XPRSS_INT_NETWORK,SET,155,0.013514,0.0012365,0.06323,0.41538,PUJANA_XPRSS_INT_NETWORK,0.99999
HP_CORNEAL_NEOVASCULARIZATION,SET,23,0.040433,0.0014302,0.18924,0.41541,HP_CORNEAL_NEOVASCULARIZATION,0.99999
ESC_J1_UP_EARLY.V1_UP,SET,154,0.01499,0.0013671,0.070163,0.41542,ESC_J1_UP_EARLY.V1_UP,0.99999
MIR1199_5P,SET,72,0.020813,0.0013009,0.097439,0.41543,MIR1199_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...486,SET,19,0.036748,0.0011816,0.17208,0.41545,GOBP_NEGATIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.99999
GSE11961_UNSTIM_VS_ANTI_IGM_...1,SET,177,0.013937,0.0013619,0.065263,0.41545,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN,0.99999
MIR4498,SET,231,0.012073,0.0013457,0.056567,0.4155,MIR4498,0.99999
GOBP_POSITIVE_REGULATION_OF_...349,SET,233,0.012638,0.0014147,0.059215,0.4155,GOBP_POSITIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,0.99999
HP_ADRENOCORTICOTROPIN_DEFIC...,SET,6,0.073475,0.0013281,0.34425,0.4155,HP_ADRENOCORTICOTROPIN_DEFICIENT_ADRENAL_INSUFFICIENCY,0.99999
GSE11961_MEMORY_BCELL_DAY7_V...2,SET,180,0.013359,0.0013163,0.062635,0.41555,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.99999
ZHAN_MULTIPLE_MYELOMA_MS_UP,SET,41,0.033453,0.0015792,0.15688,0.41557,ZHAN_MULTIPLE_MYELOMA_MS_UP,0.99999
GOBP_NUCLEAR_TRANSCRIBED_MRN...2,SET,57,0.023746,0.0013211,0.11138,0.41558,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.99999
HP_ABNORMALITY_OF_THE_DIENCE...,SET,122,0.016278,0.0013226,0.076343,0.41558,HP_ABNORMALITY_OF_THE_DIENCEPHALON,0.99999
GSE13547_2H_VS_12_H_ANTI_IGM...4,SET,153,0.01463,0.00133,0.068629,0.4156,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP,0.99999
GOBP_MAST_CELL_CHEMOTAXIS,SET,11,0.058503,0.0014316,0.27449,0.41561,GOBP_MAST_CELL_CHEMOTAXIS,0.99999
GOMF_INTERLEUKIN_12_RECEPTOR...,SET,5,0.10025,0.0016542,0.47045,0.41563,GOMF_INTERLEUKIN_12_RECEPTOR_BINDING,0.99999
WP_PHOTODYNAMIC_THERAPYINDUC...4,SET,33,0.033535,0.0014205,0.15742,0.41565,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,0.99999
MIR493_3P,SET,61,0.022376,0.0012877,0.1051,0.4157,MIR493_3P,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...15,SET,10,0.064924,0.0015149,0.30511,0.41575,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP,0.99999
BOCHKIS_FOXA2_TARGETS,SET,392,0.0093085,0.0013456,0.04379,0.41583,BOCHKIS_FOXA2_TARGETS,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...18,SET,153,0.015431,0.0014028,0.072591,0.41583,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP,0.99999
GOBP_REGULATION_OF_PRO_B_CEL...,SET,8,0.067302,0.0014046,0.31665,0.41584,GOBP_REGULATION_OF_PRO_B_CELL_DIFFERENTIATION,0.99999
MIR6778_3P,SET,204,0.012115,0.00127,0.057006,0.41585,MIR6778_3P,0.99999
GOBP_APPENDAGE_DEVELOPMENT,SET,173,0.014697,0.00142,0.069194,0.4159,GOBP_APPENDAGE_DEVELOPMENT,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...24,SET,9,0.072279,0.0016,0.3403,0.4159,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_IRON_SULFUR_PROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.99999
GOBP_GAMMA_AMINOBUTYRIC_ACID...4,SET,13,0.056113,0.0014927,0.26433,0.41594,GOBP_GAMMA_AMINOBUTYRIC_ACID_SECRETION,0.99999
HP_ABNORMALITY_OF_GLYCOLIPID...,SET,9,0.058363,0.0012919,0.27508,0.41599,HP_ABNORMALITY_OF_GLYCOLIPID_METABOLISM,0.99999
PTEN_DN.V1_DN,SET,151,0.015532,0.0014028,0.073209,0.41599,PTEN_DN.V1_DN,0.99999
GGCCAGT_MIR193A_MIR193B,SET,84,0.018874,0.0012738,0.088975,0.41601,GGCCAGT_MIR193A_MIR193B,0.99999
MIR6744_3P,SET,56,0.025387,0.0014,0.11979,0.41608,MIR6744_3P,0.99999
GOBP_VENTRICULAR_CARDIAC_MUS...2,SET,10,0.068098,0.0015889,0.32139,0.4161,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_DEVELOPMENT,0.99999
REACTOME_SIGNALING_BY_FLT3_F...,SET,19,0.041163,0.0013236,0.19429,0.41611,REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,0.99999
GOBP_ESTABLISHMENT_OF_RNA_LO...,SET,143,0.013678,0.0012025,0.064574,0.41613,GOBP_ESTABLISHMENT_OF_RNA_LOCALIZATION,0.99999
GSE12845_PRE_GC_VS_DARKZONE_...2,SET,173,0.013803,0.0013336,0.065198,0.41617,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.99999
GSE34156_NOD2_LIGAND_VS_NOD2...4,SET,161,0.013451,0.0012542,0.063558,0.4162,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,0.99999
REACTOME_CONSTITUTIVE_SIGNAL...2,SET,25,0.034736,0.001281,0.16423,0.41625,REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,0.99999
KAUFFMANN_DNA_REPAIR_GENES,SET,208,0.011055,0.0011701,0.052284,0.41627,KAUFFMANN_DNA_REPAIR_GENES,0.99999
GOBP_GLUTAMATE_SECRETION_NEU...,SET,8,0.070044,0.0014619,0.33134,0.41629,GOBP_GLUTAMATE_SECRETION_NEUROTRANSMISSION,0.99999
ZNF157_TARGET_GENES,SET,58,0.023291,0.0013071,0.11019,0.4163,ZNF157_TARGET_GENES,0.99999
HP_LOCALIZED_OSTEOPOROSIS,SET,19,0.037747,0.0012137,0.1787,0.41636,HP_LOCALIZED_OSTEOPOROSIS,0.99999
HP_ABNORMALITY_OF_THE_PHILTR...,SET,621,0.0072194,0.0013051,0.034202,0.41641,HP_ABNORMALITY_OF_THE_PHILTRUM,0.99999
GOMF_LIPID_TRANSMEMBRANE_TRA...,SET,54,0.025152,0.0013621,0.11917,0.41642,GOMF_LIPID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MIR3173_5P,SET,93,0.018688,0.0013267,0.088586,0.41646,MIR3173_5P,0.99999
HP_BROAD_PHALANX_OF_THE_TOES,SET,38,0.030377,0.0013806,0.14399,0.41646,HP_BROAD_PHALANX_OF_THE_TOES,0.99999
GOBP_HEME_TRANSPORT,SET,8,0.06382,0.001332,0.30263,0.41649,GOBP_HEME_TRANSPORT,0.99999
GOBP_REGULATION_OF_SODIUM_IO...3,SET,76,0.022785,0.001463,0.10804,0.41649,GOBP_REGULATION_OF_SODIUM_ION_TRANSPORT,0.99999
GOMF_HEME_TRANSMEMBRANE_TRAN...,SET,8,0.06382,0.001332,0.30263,0.41649,GOMF_HEME_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MIR4301,SET,34,0.028563,0.0012281,0.13547,0.41651,MIR4301,0.99999
GOCC_MITOTIC_SPINDLE_POLE,SET,36,0.028744,0.0012716,0.13633,0.41651,GOCC_MITOTIC_SPINDLE_POLE,0.99999
HP_ANTERIOR_PITUITARY_AGENES...,SET,10,0.063055,0.0014713,0.29921,0.41655,HP_ANTERIOR_PITUITARY_AGENESIS,0.99999
GSE32255_UNSTIM_VS_4H_LPS_ST...1,SET,140,0.015041,0.0013085,0.071377,0.41655,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_DN,0.99999
CARRILLOREIXACH_MRS3_VS_LOWE...2,SET,38,0.02764,0.0012562,0.13118,0.41656,CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_UP,0.99999
IL2_UP.V1_UP,SET,159,0.014723,0.0013642,0.069881,0.41657,IL2_UP.V1_UP,0.99999
TTTGCAC_MIR19A_MIR19B,SET,466,0.0085278,0.0013413,0.040488,0.41659,TTTGCAC_MIR19A_MIR19B,0.99999
HP_CHONDROCALCINOSIS,SET,21,0.044048,0.0014889,0.20912,0.41659,HP_CHONDROCALCINOSIS,0.99999
GOMF_HYDROLASE_ACTIVITY_ACTI...2,SET,128,0.016369,0.0013621,0.077747,0.41662,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS,0.99999
GOBP_GRANULOCYTE_COLONY_STIM...1,SET,5,0.081658,0.0013475,0.38786,0.41663,GOBP_GRANULOCYTE_COLONY_STIMULATING_FACTOR_PRODUCTION,0.99999
CRX_Q4,SET,247,0.011913,0.0013725,0.056599,0.41665,CRX_Q4,0.99999
WP_GLP1_FROM_INTESTINE_AND_P...,SET,6,0.086381,0.0015614,0.41079,0.41672,WP_GLP1_FROM_INTESTINE_AND_PANCREAS_AND_ROLE_IN_GLUCOSE_HOMEOSTASIS,0.99999
GOBP_NEUROTRANSMITTER_SECRET...,SET,135,0.015352,0.0013116,0.073066,0.41679,GOBP_NEUROTRANSMITTER_SECRETION,0.99999
REACTOME_ENHANCED_BINDING_OF...,SET,7,0.079169,0.0015456,0.37685,0.4168,REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN,0.99999
HP_INVOLUNTARY_MOVEMENTS,SET,908,0.0059601,0.0012923,0.02837,0.4168,HP_INVOLUNTARY_MOVEMENTS,0.99999
HP_APLASIA_HYPOPLASIA_AFFECT...4,SET,140,0.015271,0.0013285,0.072703,0.41682,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_FUNDUS,0.99999
KEGG_MEDICUS_REFERENCE_TNF_P...,SET,24,0.035337,0.0012768,0.16826,0.41683,KEGG_MEDICUS_REFERENCE_TNF_P38_SIGNALING_PATHWAY,0.99999
BROWNE_HCMV_INFECTION_2HR_DN,SET,47,0.027474,0.0013883,0.13088,0.41687,BROWNE_HCMV_INFECTION_2HR_DN,0.99999
GOBP_TESTOSTERONE_BIOSYNTHET...,SET,10,0.055826,0.0013026,0.26611,0.41692,GOBP_TESTOSTERONE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_CELL_MATR...,SET,115,0.017325,0.0013669,0.082601,0.41693,GOBP_REGULATION_OF_CELL_MATRIX_ADHESION,0.99999
GOBP_TELOMERE_MAINTENANCE,SET,142,0.01392,0.0012195,0.066376,0.41695,GOBP_TELOMERE_MAINTENANCE,0.99999
GOBP_PROLACTIN_SECRETION,SET,5,0.088968,0.0014681,0.42451,0.417,GOBP_PROLACTIN_SECRETION,0.99999
GSE19923_WT_VS_HEB_AND_E2A_K...1,SET,185,0.013229,0.0013213,0.06313,0.41701,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...17,SET,38,0.032624,0.0014828,0.15579,0.41706,GAVISH_3CA_MALIGNANT_METAPROGRAM_26_NPC_GLIOMA,0.99999
GOBP_ACTIN_FILAMENT_BASED_PR...,SET,755,0.0067784,0.0013461,0.032366,0.41706,GOBP_ACTIN_FILAMENT_BASED_PROCESS,0.99999
HP_ORTHOKERATOTIC_HYPERKERAT...,SET,7,0.067611,0.00132,0.32292,0.41708,HP_ORTHOKERATOTIC_HYPERKERATOSIS,0.99999
GOMF_PROTEIN_ARGININE_DEIMIN...,SET,5,0.097327,0.001606,0.46516,0.41713,GOMF_PROTEIN_ARGININE_DEIMINASE_ACTIVITY,0.99999
GSE15930_NAIVE_VS_48H_IN_VIT...3,SET,181,0.012554,0.0012403,0.060026,0.41717,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,0.99999
GOCC_GID_COMPLEX,SET,5,0.078132,0.0012893,0.37387,0.41723,GOCC_GID_COMPLEX,0.99999
MIR5693,SET,78,0.02066,0.0013438,0.098872,0.41724,MIR5693,0.99999
LI_PBMC_ZOSTAVAX_AGE_25_40_A...2,SET,7,0.071674,0.0013993,0.343,0.41724,LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_79YO_3DY_UP,0.99999
GSE13493_DP_VS_CD4INTCD8POS_...2,SET,177,0.01321,0.0012909,0.063278,0.41732,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP,0.99999
HP_MYELODYSPLASIA,SET,100,0.01719,0.0012653,0.082395,0.41737,HP_MYELODYSPLASIA,0.99999
HP_ATROPHY_DEGENERATION_AFFE...3,SET,591,0.0072039,0.0012716,0.034535,0.41738,HP_ATROPHY_DEGENERATION_AFFECTING_THE_CEREBRUM,0.99999
GSE7852_TREG_VS_TCONV_UP,SET,181,0.013784,0.001362,0.066086,0.41739,GSE7852_TREG_VS_TCONV_UP,0.99999
GSE14350_TREG_VS_TEFF_UP,SET,181,0.01328,0.0013121,0.063677,0.4174,GSE14350_TREG_VS_TEFF_UP,0.99999
HAY_BONE_MARROW_IMMATURE_NEU...,SET,173,0.013982,0.0013509,0.067047,0.4174,HAY_BONE_MARROW_IMMATURE_NEUTROPHIL,0.99999
GSE42088_UNINF_VS_LEISHMANIA...2,SET,183,0.013397,0.0013309,0.064265,0.41743,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP,0.99999
GOBP_TRANSFORMING_GROWTH_FAC...1,SET,11,0.061018,0.0014932,0.29276,0.41745,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,0.99999
GSE3039_ALPHAALPHA_CD8_TCELL...2,SET,189,0.012576,0.0012695,0.060365,0.41748,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_UP,0.99999
GOBP_ENDOPLASMIC_RETICULUM_L...,SET,9,0.067526,0.0014948,0.32416,0.4175,GOBP_ENDOPLASMIC_RETICULUM_LOCALIZATION,0.99999
SAKAI_TUMOR_INFILTRATING_MON...1,SET,75,0.019135,0.0012206,0.09188,0.41751,SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,0.99999
MORF_BUB1,SET,43,0.025241,0.0012202,0.12128,0.41757,MORF_BUB1,0.99999
KYNG_NORMAL_AGING_UP,SET,13,0.048321,0.0012854,0.23233,0.41762,KYNG_NORMAL_AGING_UP,0.99999
KEGG_GLYCOSAMINOGLYCAN_BIOSY...3,SET,15,0.050394,0.0014399,0.24228,0.41762,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE,0.99999
GSE32986_UNSTIM_VS_CURDLAN_L...1,SET,176,0.0133,0.001296,0.064104,0.41782,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_DN,0.99999
chr6p25,SET,31,0.049127,0.0020171,0.23686,0.41785,chr6p25,0.99999
TGCTTTG_MIR330,SET,297,0.010495,0.001324,0.050625,0.41789,TGCTTTG_MIR330,0.99999
GSE12366_PLASMA_CELL_VS_MEMO...1,SET,175,0.012949,0.0012582,0.062471,0.4179,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN,0.99999
MIR4782_3P,SET,140,0.015027,0.0013073,0.072527,0.41793,MIR4782_3P,0.99999
MIR769_5P,SET,46,0.026315,0.0013156,0.12704,0.41795,MIR769_5P,0.99999
MIR5000_5P,SET,91,0.01803,0.0012663,0.087087,0.41799,MIR5000_5P,0.99999
GOBP_RETINAL_CONE_CELL_DEVEL...,SET,11,0.059679,0.0014604,0.2883,0.41801,GOBP_RETINAL_CONE_CELL_DEVELOPMENT,0.99999
KEGG_ARGININE_AND_PROLINE_ME...,SET,47,0.023705,0.0011979,0.11457,0.41804,KEGG_ARGININE_AND_PROLINE_METABOLISM,0.99999
GOBP_REGULATION_OF_ENDOTHELI...2,SET,18,0.041347,0.001294,0.19982,0.41804,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DEVELOPMENT,0.99999
SCHERER_PBMC_YF_VAX_AGE_18_4...4,SET,10,0.056971,0.0013293,0.27533,0.41804,SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANYD_UP,0.99999
GOBP_HOMOTYPIC_CELL_CELL_ADH...,SET,94,0.019398,0.0013845,0.093768,0.41806,GOBP_HOMOTYPIC_CELL_CELL_ADHESION,0.99999
GOBP_EPIGENETIC_PROGRAMMING_...1,SET,12,0.052882,0.0013516,0.25577,0.4181,GOBP_EPIGENETIC_PROGRAMMING_IN_THE_ZYGOTIC_PRONUCLEI,0.99999
HP_LOWER_EYELID_COLOBOMA,SET,10,0.051326,0.0011976,0.24832,0.41813,HP_LOWER_EYELID_COLOBOMA,0.99999
GSE360_DC_VS_MAC_B_MALAYI_HI...1,SET,181,0.013153,0.0012995,0.063643,0.41814,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN,0.99999
GOBP_PURINE_RIBONUCLEOTIDE_S...,SET,7,0.068515,0.0013376,0.33161,0.41816,GOBP_PURINE_RIBONUCLEOTIDE_SALVAGE,0.99999
HALLMARK_MYC_TARGETS_V2,SET,56,0.021305,0.0011749,0.10314,0.41818,HALLMARK_MYC_TARGETS_V2,0.99999
GSE29164_CD8_TCELL_VS_CD8_TC...4,SET,174,0.013366,0.0012951,0.064717,0.41819,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,0.99999
HP_ABNORMAL_LIBIDO,SET,37,0.029598,0.0013274,0.1434,0.41824,HP_ABNORMAL_LIBIDO,0.99999
HP_ABNORMAL_DESCEMET_MEMBRAN...,SET,14,0.053785,0.0014847,0.26068,0.41827,HP_ABNORMAL_DESCEMET_MEMBRANE_MORPHOLOGY,0.99999
ZSCAN5B_TARGET_GENES,SET,48,0.026072,0.0013314,0.12638,0.41828,ZSCAN5B_TARGET_GENES,0.99999
MARKS_ACETYLATED_NON_HISTONE...,SET,11,0.051471,0.0012596,0.24953,0.41829,MARKS_ACETYLATED_NON_HISTONE_PROTEINS,0.99999
GOBP_CENTRAL_NERVOUS_SYSTEM_...3,SET,8,0.06818,0.001423,0.33052,0.41829,GOBP_CENTRAL_NERVOUS_SYSTEM_MYELIN_FORMATION,0.99999
GSE16385_IFNG_TNF_VS_UNSTIM_...2,SET,153,0.013963,0.0012693,0.067703,0.41831,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,0.99999
PID_P38_MK2_PATHWAY,SET,21,0.042539,0.0014379,0.20631,0.41832,PID_P38_MK2_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...131,SET,11,0.052745,0.0012907,0.256,0.41838,GOBP_NEGATIVE_REGULATION_OF_CENTROSOME_DUPLICATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...188,SET,6,0.071139,0.0012859,0.34527,0.41838,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY,0.99999
GOBP_POSITIVE_REGULATION_OF_...406,SET,151,0.01547,0.0013972,0.07511,0.41841,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,0.99999
MIR6853_3P,SET,186,0.012943,0.0012962,0.062861,0.41844,MIR6853_3P,0.99999
GOBP_GMP_METABOLIC_PROCESS,SET,25,0.03537,0.0013044,0.17179,0.41844,GOBP_GMP_METABOLIC_PROCESS,0.99999
HP_EEG_WITH_SERIES_OF_FOCAL_...,SET,10,0.057185,0.0013343,0.27792,0.41849,HP_EEG_WITH_SERIES_OF_FOCAL_SPIKES,0.99999
GOCC_L_TYPE_VOLTAGE_GATED_CA...,SET,12,0.057069,0.0014586,0.27786,0.41864,GOCC_L_TYPE_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX,0.99999
GSE17974_0H_VS_0.5H_IN_VITRO...2,SET,161,0.013536,0.001262,0.065926,0.41866,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP,0.99999
GOMF_CARBON_CARBON_LYASE_ACT...,SET,50,0.024412,0.0012723,0.11891,0.41867,GOMF_CARBON_CARBON_LYASE_ACTIVITY,0.99999
MIR6880_5P,SET,87,0.01904,0.0013076,0.092826,0.41874,MIR6880_5P,0.99999
REACTOME_ACTIVATED_TAK1_MEDI...,SET,19,0.042718,0.0013736,0.2083,0.41876,REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,0.99999
REACTOME_REGULATION_OF_CDH11...2,SET,10,0.06171,0.0014399,0.30098,0.41877,REACTOME_REGULATION_OF_CDH11_GENE_TRANSCRIPTION,0.99999
BROWNE_HCMV_INFECTION_14HR_UP,SET,137,0.014214,0.0012233,0.06934,0.41879,BROWNE_HCMV_INFECTION_14HR_UP,0.99999
HP_TREMOR_BY_ANATOMICAL_SITE,SET,86,0.019216,0.0013121,0.093751,0.4188,HP_TREMOR_BY_ANATOMICAL_SITE,0.99999
GOMF_TYPE_2_FIBROBLAST_GROWT...,SET,5,0.095956,0.0015834,0.46827,0.41882,GOMF_TYPE_2_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,0.99999
HP_ANISOPOIKILOCYTOSIS,SET,9,0.064125,0.0014195,0.31305,0.41885,HP_ANISOPOIKILOCYTOSIS,0.99999
MIR132_5P,SET,8,0.064889,0.0013543,0.31681,0.41886,MIR132_5P,0.99999
HP_ARTERIOSCLEROSIS,SET,85,0.020486,0.0013908,0.10021,0.419,HP_ARTERIOSCLEROSIS,0.99999
ATF6_01,SET,118,0.015688,0.0012537,0.076734,0.41901,ATF6_01,0.99999
LI_ESTROGENE_MCF7_E2_RESPONS...1,SET,35,0.033249,0.0014504,0.16267,0.41902,LI_ESTROGENE_MCF7_E2_RESPONSE_DN,0.99999
MOHANKUMAR_HOXA1_TARGETS_UP,SET,364,0.0089488,0.0012475,0.043799,0.41905,MOHANKUMAR_HOXA1_TARGETS_UP,0.99999
WP_RETINOL_METABOLISM,SET,15,0.047596,0.00136,0.23297,0.41906,WP_RETINOL_METABOLISM,0.99999
MIR1908_5P,SET,16,0.045417,0.0013402,0.22231,0.41906,MIR1908_5P,0.99999
GOBP_PEPTIDYL_TYROSINE_DEPHO...2,SET,7,0.070065,0.0013679,0.34296,0.41906,GOBP_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION_INVOLVED_IN_INACTIVATION_OF_PROTEIN_KINASE_ACTIVITY,0.99999
GOMF_PHOSPHATIDYLINOSITOL_TR...2,SET,8,0.055844,0.0011655,0.27339,0.41908,GOMF_PHOSPHATIDYLINOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.99999
RACTNNRTTTNC_UNKNOWN,SET,111,0.016279,0.001262,0.079707,0.41909,RACTNNRTTTNC_UNKNOWN,0.99999
GOMF_ACYL_COA_HYDROLASE_ACTI...,SET,22,0.037676,0.0013035,0.18458,0.41913,GOMF_ACYL_COA_HYDROLASE_ACTIVITY,0.99999
SMIRNOV_CIRCULATING_ENDOTHEL...1,SET,5,0.078277,0.0012917,0.3836,0.41915,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN,0.99999
GOBP_RECOMBINATIONAL_REPAIR,SET,165,0.012546,0.001184,0.061575,0.41928,GOBP_RECOMBINATIONAL_REPAIR,0.99999
BERTUCCI_INVASIVE_CARCINOMA_...2,SET,20,0.039582,0.0013058,0.1944,0.41933,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP,0.99999
GOMF_TRANSCRIPTION_COREPRESS...1,SET,173,0.01298,0.0012541,0.063759,0.41934,GOMF_TRANSCRIPTION_COREPRESSOR_ACTIVITY,0.99999
HP_RIGIDITY,SET,185,0.012668,0.0012653,0.062257,0.41938,HP_RIGIDITY,0.99999
GSE22919_RESTING_VS_IL2_IL12...2,SET,181,0.012236,0.001209,0.060143,0.41939,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP,0.99999
GOBP_DNA_DAMAGE_RESPONSE_SIG...2,SET,19,0.036047,0.0011591,0.17723,0.41941,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_CELL_CYCLE_ARREST,0.99999
SASSON_FSH_RESPONSE,SET,7,0.075289,0.0014699,0.37019,0.41942,SASSON_FSH_RESPONSE,0.99999
FAN_EMBRYONIC_CTX_ASTROCYTE_1,SET,73,0.021281,0.0013393,0.10466,0.41944,FAN_EMBRYONIC_CTX_ASTROCYTE_1,0.99999
TURASHVILI_BREAST_NORMAL_DUC...2,SET,57,0.022456,0.0012493,0.11047,0.41946,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,0.99999
HP_DECREASED_CIRCULATING_IRO...,SET,5,0.066767,0.0011017,0.32855,0.41948,HP_DECREASED_CIRCULATING_IRON_CONCENTRATION,0.99999
REACTOME_SENSORY_PERCEPTION_...2,SET,45,0.030304,0.0014985,0.14915,0.4195,REACTOME_SENSORY_PERCEPTION_OF_TASTE,0.99999
GOCC_CELL_CELL_JUNCTION,SET,471,0.0084351,0.0013337,0.041544,0.41955,GOCC_CELL_CELL_JUNCTION,0.99999
WP_WNT_SIGNALING_AND_PLURIPO...,SET,95,0.018969,0.001361,0.093437,0.41956,WP_WNT_SIGNALING_AND_PLURIPOTENCY,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...16,SET,46,0.027952,0.0013974,0.13773,0.41959,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_METAL_RESPONSE,0.99999
GOBP_ATTACHMENT_OF_SPINDLE_M...,SET,49,0.0234,0.0012073,0.1154,0.41966,GOBP_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.99999
HP_ANGIOSARCOMA,SET,5,0.075474,0.0012454,0.3722,0.41966,HP_ANGIOSARCOMA,0.99999
HP_INVERTED_NIPPLES,SET,44,0.024173,0.001182,0.11926,0.41969,HP_INVERTED_NIPPLES,0.99999
MARSON_BOUND_BY_E2F4_UNSTIMU...,SET,613,0.0071672,0.0012876,0.035378,0.41973,MARSON_BOUND_BY_E2F4_UNSTIMULATED,0.99999
GOBP_NEGATIVE_REGULATION_OF_...456,SET,10,0.053929,0.0012583,0.26625,0.41975,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.99999
HP_TICS,SET,22,0.035725,0.001236,0.17654,0.41982,HP_TICS,0.99999
HP_ABDOMINAL_SITUS_AMBIGUUS,SET,4,0.092821,0.00137,0.45933,0.41993,HP_ABDOMINAL_SITUS_AMBIGUUS,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...10,SET,17,0.036858,0.0011211,0.18271,0.42006,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE,0.99999
GOCC_PROTON_TRANSPORTING_TWO...3,SET,10,0.049879,0.0011638,0.24723,0.42006,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_PROTON_TRANSPORTING_DOMAIN,0.99999
GOCC_PROTON_TRANSPORTING_V_T...2,SET,10,0.049879,0.0011638,0.24723,0.42006,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN,0.99999
GSE12366_GC_VS_MEMORY_BCELL_...2,SET,174,0.012677,0.0012283,0.062842,0.42007,GSE12366_GC_VS_MEMORY_BCELL_UP,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...10,SET,175,0.012846,0.0012483,0.063693,0.42008,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_PE...3,SET,5,0.077396,0.0012771,0.38382,0.4201,GOBP_CELLULAR_RESPONSE_TO_PEPTIDOGLYCAN,0.99999
chr15q12,SET,4,0.10967,0.0016187,0.54396,0.42011,chr15q12,0.99999
GOBP_POSITIVE_REGULATION_OF_...128,SET,91,0.019818,0.0013918,0.09835,0.42015,GOBP_POSITIVE_REGULATION_OF_CELL_DIVISION,0.99999
GSE9960_HEALTHY_VS_GRAM_POS_...2,SET,165,0.01262,0.001191,0.062633,0.42016,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_UP,0.99999
HOXC13_TARGET_GENES,SET,95,0.017243,0.0012372,0.085626,0.42021,HOXC13_TARGET_GENES,0.99999
LEE_LIVER_CANCER_ACOX1_UP,SET,62,0.024526,0.0014229,0.12182,0.42022,LEE_LIVER_CANCER_ACOX1_UP,0.99999
GSE3982_MAC_VS_NEUTROPHIL_LP...1,SET,166,0.013468,0.0012749,0.066898,0.42022,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN,0.99999
GOCC_GUANYL_NUCLEOTIDE_EXCHA...,SET,22,0.034323,0.0011875,0.17049,0.42023,GOCC_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_COMPLEX,0.99999
MIR5706,SET,150,0.014277,0.0012853,0.070928,0.42024,MIR5706,0.99999
WP_CONGENITAL_GENERALIZED_LI...,SET,16,0.043902,0.0012955,0.21818,0.42026,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,0.99999
GOCC_NURD_COMPLEX,SET,14,0.04346,0.0011997,0.21598,0.42026,GOCC_NURD_COMPLEX,0.99999
MIR3926,SET,160,0.013387,0.0012443,0.066579,0.42032,MIR3926,0.99999
CROSBY_E2F4_TARGETS,SET,6,0.065567,0.0011852,0.32623,0.42036,CROSBY_E2F4_TARGETS,0.99999
KEGG_N_GLYCAN_BIOSYNTHESIS,SET,44,0.024666,0.0012061,0.12285,0.42044,KEGG_N_GLYCAN_BIOSYNTHESIS,0.99999
REACTOME_DEVELOPMENTAL_BIOLO...,SET,1245,0.005308,0.0013346,0.026438,0.42044,REACTOME_DEVELOPMENTAL_BIOLOGY,0.99999
TGAYRTCA_ATF3_Q6,SET,496,0.0080296,0.0013019,0.040017,0.42049,TGAYRTCA_ATF3_Q6,0.99999
HP_JOINT_SUBLUXATION,SET,26,0.034343,0.0012915,0.17119,0.4205,HP_JOINT_SUBLUXATION,0.99999
GOMF_MISMATCH_REPAIR_COMPLEX...,SET,11,0.050517,0.0012362,0.25187,0.42052,GOMF_MISMATCH_REPAIR_COMPLEX_BINDING,0.99999
GSE7460_FOXP3_MUT_VS_HET_ACT...1,SET,181,0.012683,0.0012531,0.063236,0.42052,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN,0.99999
KEGG_SPHINGOLIPID_METABOLISM,SET,34,0.030996,0.0013327,0.15467,0.42058,KEGG_SPHINGOLIPID_METABOLISM,0.99999
GOBP_POSITIVE_REGULATION_OF_...546,SET,6,0.067165,0.001214,0.33572,0.42072,GOBP_POSITIVE_REGULATION_OF_NON_MOTILE_CILIUM_ASSEMBLY,0.99999
GOBP_VASCULAR_ENDOTHELIAL_GR...3,SET,53,0.024283,0.0013028,0.12176,0.42096,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_ACTIN_FIL...1,SET,39,0.027239,0.0012541,0.1368,0.42109,GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_MOVEMENT,0.99999
GSE2585_THYMIC_DC_VS_MTEC_UP,SET,172,0.012799,0.001233,0.064276,0.42109,GSE2585_THYMIC_DC_VS_MTEC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...207,SET,12,0.055488,0.0014182,0.27874,0.42111,GOBP_NEGATIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT,0.99999
REACTOME_ARACHIDONATE_PRODUC...,SET,5,0.062859,0.0010372,0.31582,0.42112,REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG,0.99999
GOBP_POSITIVE_REGULATION_OF_...306,SET,33,0.030844,0.0013065,0.15498,0.42113,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT,0.99999
HP_ASTHENIA,SET,8,0.057774,0.0012058,0.29032,0.42113,HP_ASTHENIA,0.99999
GOCC_ROD_PHOTORECEPTOR_OUTER...,SET,7,0.063056,0.0012311,0.31707,0.42118,GOCC_ROD_PHOTORECEPTOR_OUTER_SEGMENT,0.99999
GOBP_CELLULAR_RESPONSE_TO_HO...,SET,568,0.0075216,0.0013024,0.037844,0.42123,GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS,0.99999
WP_DEVELOPMENT_OF_PULMONARY_...,SET,13,0.04889,0.0013005,0.24601,0.42124,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...482,SET,16,0.044589,0.0013158,0.22445,0.42126,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,0.99999
GSE40274_CTRL_VS_FOXP3_AND_H...1,SET,171,0.012749,0.0012247,0.064165,0.42126,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
GSE13306_TREG_RA_VS_TCONV_RA...1,SET,177,0.013001,0.0012704,0.065509,0.42134,GSE13306_TREG_RA_VS_TCONV_RA_DN,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_HSC...2,SET,350,0.0091766,0.0012549,0.046282,0.42142,HE_LIM_SUN_FETAL_LUNG_C2_HSC_ELP_CELL,0.99999
REACTOME_CELL_JUNCTION_ORGAN...,SET,105,0.017979,0.0013558,0.090716,0.42145,REACTOME_CELL_JUNCTION_ORGANIZATION,0.99999
GSE3982_CENT_MEMORY_CD4_TCEL...6,SET,175,0.01272,0.001236,0.064178,0.42145,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP,0.99999
PACHER_TARGETS_OF_IGF1_AND_I...,SET,35,0.031357,0.0013678,0.15829,0.42149,PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,0.99999
GOBP_G_QUADRUPLEX_DNA_UNWIND...,SET,7,0.057859,0.0011296,0.29209,0.42149,GOBP_G_QUADRUPLEX_DNA_UNWINDING,0.99999
GSE360_CTRL_VS_T_GONDII_DC_DN,SET,175,0.01348,0.0013098,0.068133,0.42158,GSE360_CTRL_VS_T_GONDII_DC_DN,0.99999
HP_HYPOPLASTIC_FIFTH_FINGERN...,SET,14,0.043589,0.0012033,0.22037,0.4216,HP_HYPOPLASTIC_FIFTH_FINGERNAIL,0.99999
GOBP_REGULATION_OF_HEMATOPOI...1,SET,41,0.025005,0.0011804,0.1265,0.42165,GOBP_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,0.99999
WP_2Q211_COPY_NUMBER_VARIATI...,SET,15,0.050723,0.0014493,0.25681,0.42171,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GSE30971_CTRL_VS_LPS_STIM_MA...4,SET,178,0.012773,0.0012516,0.064667,0.42171,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP,0.99999
GOBP_REGULATION_OF_BILE_ACID...1,SET,11,0.056542,0.0013836,0.28627,0.42172,GOBP_REGULATION_OF_BILE_ACID_BIOSYNTHETIC_PROCESS,0.99999
GSE10240_IL22_VS_IL17_STIM_P...2,SET,171,0.012429,0.001194,0.063004,0.42181,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.99999
HP_MYOSITIS,SET,34,0.029942,0.0012874,0.15196,0.4219,HP_MYOSITIS,0.99999
HP_GOUT,SET,15,0.03967,0.0011335,0.20135,0.42191,HP_GOUT,0.99999
WP_NONALCOHOLIC_FATTY_LIVER_...,SET,146,0.012898,0.0011457,0.065594,0.42206,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,0.99999
GOBP_REGULATION_OF_STORE_OPE...1,SET,5,0.06947,0.0011463,0.35351,0.4221,GOBP_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,0.99999
MODULE_367,SET,28,0.033307,0.0012998,0.16951,0.42211,MODULE_367,0.99999
USF_Q6,SET,227,0.010941,0.0012091,0.055724,0.42217,USF_Q6,0.99999
GSE2405_0H_VS_6H_A_PHAGOCYTO...2,SET,171,0.01188,0.0011412,0.060505,0.42217,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.99999
MODULE_69,SET,479,0.0075823,0.0012087,0.038628,0.42219,MODULE_69,0.99999
GSE20727_CTRL_VS_H2O2_TREATE...2,SET,178,0.012229,0.0011983,0.0623,0.42219,GSE20727_CTRL_VS_H2O2_TREATED_DC_UP,0.99999
HP_ABNORMAL_ARTERIAL_PHYSIOL...,SET,154,0.014146,0.0012902,0.072085,0.42221,HP_ABNORMAL_ARTERIAL_PHYSIOLOGY,0.99999
GSE21380_TFH_VS_GERMINAL_CEN...2,SET,183,0.012907,0.0012823,0.065782,0.42222,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,0.99999
GSE36009_UNSTIM_VS_LPS_STIM_...2,SET,174,0.012955,0.0012552,0.066019,0.42222,GSE36009_UNSTIM_VS_LPS_STIM_DC_UP,0.99999
HP_ANOPHTHALMIA,SET,59,0.021593,0.0012221,0.1101,0.42226,HP_ANOPHTHALMIA,0.99999
MODULE_45,SET,527,0.0077262,0.0012901,0.039414,0.42229,MODULE_45,0.99999
HP_TAPERED_SPERM_HEAD,SET,7,0.068762,0.0013425,0.35075,0.42229,HP_TAPERED_SPERM_HEAD,0.99999
GOBP_VIRAL_LIFE_CYCLE,SET,297,0.010132,0.0012783,0.051791,0.42245,GOBP_VIRAL_LIFE_CYCLE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...203,SET,7,0.067585,0.0013195,0.34574,0.42251,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,0.99999
GOBP_METANEPHRIC_DISTAL_TUBU...,SET,6,0.076181,0.001377,0.38976,0.42252,GOBP_METANEPHRIC_DISTAL_TUBULE_DEVELOPMENT,0.99999
GOBP_FLAVONOID_METABOLIC_PRO...,SET,11,0.058213,0.0014245,0.2983,0.42264,GOBP_FLAVONOID_METABOLIC_PROCESS,0.99999
GOMF_PHOSPHOLIPASE_BINDING,SET,17,0.042698,0.0012987,0.21879,0.42264,GOMF_PHOSPHOLIPASE_BINDING,0.99999
CSHL1_TARGET_GENES,SET,177,0.012612,0.0012324,0.064641,0.42266,CSHL1_TARGET_GENES,0.99999
HP_PERIPHERAL_HYPERMYELINATI...,SET,9,0.056047,0.0012407,0.28729,0.42266,HP_PERIPHERAL_HYPERMYELINATION,0.99999
MIR7844_5P,SET,139,0.014437,0.0012515,0.07402,0.42268,MIR7844_5P,0.99999
GOBP_CARDIAC_SEPTUM_CELL_DIF...,SET,5,0.079051,0.0013044,0.40535,0.42269,GOBP_CARDIAC_SEPTUM_CELL_DIFFERENTIATION,0.99999
KEGG_MEDICUS_REFERENCE_ITGA_...2,SET,29,0.032935,0.001308,0.16895,0.42272,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY,0.99999
GOBP_DENDRITIC_TRANSPORT_OF_...,SET,5,0.070764,0.0011677,0.36303,0.42273,GOBP_DENDRITIC_TRANSPORT_OF_RIBONUCLEOPROTEIN_COMPLEX,0.99999
MARSON_BOUND_BY_FOXP3_STIMUL...,SET,880,0.0058025,0.0012396,0.029803,0.42282,MARSON_BOUND_BY_FOXP3_STIMULATED,0.99999
GSE2770_IL12_ACT_VS_ACT_CD4_...1,SET,181,0.011949,0.0011806,0.0614,0.42285,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_DN,0.99999
GSE21546_UNSTIM_VS_ANTI_CD3_...5,SET,134,0.0154,0.0013109,0.079171,0.42289,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.99999
GOBP_REGULATION_OF_BMP_SIGNA...,SET,93,0.018612,0.0013214,0.095696,0.4229,GOBP_REGULATION_OF_BMP_SIGNALING_PATHWAY,0.99999
GOCC_POLYPRENYL_DIPHOSPHATE_...,SET,10,0.049269,0.0011496,0.2535,0.42295,GOCC_POLYPRENYL_DIPHOSPHATE_SYNTHASE_COMPLEX,0.99999
HP_ABNORMAL_PR_INTERVAL,SET,17,0.042901,0.0013049,0.22076,0.42296,HP_ABNORMAL_PR_INTERVAL,0.99999
HP_CHRONIC_FURUNCULOSIS,SET,4,0.084968,0.0012541,0.43736,0.42298,HP_CHRONIC_FURUNCULOSIS,0.99999
REACTOME_TRANSCRIPTIONAL_REG...7,SET,45,0.023377,0.001156,0.12035,0.423,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS,0.99999
GOBP_DNA_INTEGRITY_CHECKPOIN...,SET,125,0.013374,0.0010998,0.068925,0.42308,GOBP_DNA_INTEGRITY_CHECKPOINT_SIGNALING,0.99999
REACTOME_ANTI_INFLAMMATORY_R...,SET,74,0.019929,0.0012628,0.10283,0.42316,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,0.99999
GOBP_ESTABLISHMENT_OF_PIGMEN...,SET,21,0.037572,0.00127,0.19384,0.42316,GOBP_ESTABLISHMENT_OF_PIGMENT_GRANULE_LOCALIZATION,0.99999
HP_PARAKERATOSIS,SET,30,0.031183,0.0012596,0.16097,0.4232,HP_PARAKERATOSIS,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...11,SET,41,0.026087,0.0012315,0.13471,0.42322,GAVISH_3CA_METAPROGRAM_B_CELLS_RESPIRATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...689,SET,40,0.024124,0.0011249,0.12457,0.42322,GOBP_POSITIVE_REGULATION_OF_RNA_SPLICING,0.99999
REACTOME_DNA_REPLICATION,SET,122,0.013194,0.001072,0.068176,0.42327,REACTOME_DNA_REPLICATION,0.99999
GSE2128_C57BL6_VS_NOD_CD4CD8...1,SET,187,0.011876,0.0011925,0.061388,0.4233,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN,0.99999
GOCC_GOLGI_TRANSPORT_COMPLEX,SET,10,0.052786,0.0012316,0.27296,0.42333,GOCC_GOLGI_TRANSPORT_COMPLEX,0.99999
WP_MIR124_PREDICTED_INTERACT...,SET,6,0.061474,0.0011112,0.31808,0.42338,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,0.99999
GOMF_COENZYME_A_DIPHOSPHATAS...,SET,5,0.071795,0.0011847,0.37177,0.42343,GOMF_COENZYME_A_DIPHOSPHATASE_ACTIVITY,0.99999
CHESLER_BRAIN_D6MIT150_QTL_T...,SET,9,0.058959,0.0013051,0.3054,0.42346,CHESLER_BRAIN_D6MIT150_QTL_TRANS,0.99999
KEGG_PORPHYRIN_AND_CHLOROPHY...,SET,35,0.031911,0.001392,0.16532,0.42347,KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...539,SET,4,0.08857,0.0013072,0.45882,0.42347,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,0.99999
GOBP_REGULATION_OF_STEM_CELL...3,SET,67,0.019473,0.0011743,0.10095,0.42352,GOBP_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.99999
JIANG_MELANOMA_TRM7_CD8,SET,78,0.018147,0.0011804,0.094093,0.42353,JIANG_MELANOMA_TRM7_CD8,0.99999
HP_SPECIFIC_LEARNING_DISABIL...,SET,267,0.010047,0.0012028,0.052118,0.42357,HP_SPECIFIC_LEARNING_DISABILITY,0.99999
CHOI_ATL_STAGE_PREDICTOR,SET,39,0.027746,0.0012775,0.14398,0.42359,CHOI_ATL_STAGE_PREDICTOR,0.99999
NF1_Q6_01,SET,249,0.010869,0.0012572,0.056408,0.4236,NF1_Q6_01,0.99999
GOMF_COPPER_CHAPERONE_ACTIVI...,SET,6,0.052574,0.00095031,0.27301,0.42365,GOMF_COPPER_CHAPERONE_ACTIVITY,0.99999
HP_DECREASED_CIRCULATING_COP...,SET,6,0.073483,0.0013282,0.38179,0.42369,HP_DECREASED_CIRCULATING_COPPER_CONCENTRATION,0.99999
GSE26495_NAIVE_VS_PD1LOW_CD8...1,SET,185,0.01254,0.0012525,0.065216,0.42376,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN,0.99999
MIR6715A_3P,SET,148,0.013769,0.0012313,0.07163,0.42378,MIR6715A_3P,0.99999
GENTLES_LEUKEMIC_STEM_CELL_UP,SET,28,0.034678,0.0013533,0.18051,0.42383,GENTLES_LEUKEMIC_STEM_CELL_UP,0.99999
GSE15330_WT_VS_IKAROS_KO_GRA...2,SET,187,0.011871,0.001192,0.061887,0.42395,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.99999
SYATTGTG_UNKNOWN,SET,204,0.012004,0.0012584,0.062631,0.424,SYATTGTG_UNKNOWN,0.99999
ZHAN_V2_LATE_DIFFERENTIATION...,SET,36,0.028073,0.001242,0.14661,0.42407,ZHAN_V2_LATE_DIFFERENTIATION_GENES,0.99999
DAZARD_UV_RESPONSE_CLUSTER_G1,SET,53,0.021952,0.0011778,0.1147,0.42411,DAZARD_UV_RESPONSE_CLUSTER_G1,0.99999
GOMF_DIPHOSPHOTRANSFERASE_AC...,SET,4,0.073699,0.0010878,0.3852,0.42414,GOMF_DIPHOSPHOTRANSFERASE_ACTIVITY,0.99999
HP_DYSMENORRHEA,SET,12,0.049043,0.0012535,0.25635,0.42414,HP_DYSMENORRHEA,0.99999
GOBP_ADAPTIVE_IMMUNE_RESPONS...,SET,281,0.010518,0.0012912,0.05498,0.42415,GOBP_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS,0.99999
HP_HYPOPLASIA_OF_THE_COCHLEA,SET,8,0.060695,0.0012667,0.31744,0.42418,HP_HYPOPLASIA_OF_THE_COCHLEA,0.99999
MIR10393_3P,SET,96,0.017887,0.0012901,0.093567,0.4242,MIR10393_3P,0.99999
GOBP_RIGHTING_REFLEX,SET,8,0.060689,0.0012666,0.31803,0.42433,GOBP_RIGHTING_REFLEX,0.99999
GOBP_CELLULAR_MODIFIED_AMINO...2,SET,29,0.029539,0.0011731,0.15496,0.42441,GOBP_CELLULAR_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS,0.99999
GOBP_ATRIAL_CARDIAC_MUSCLE_C...1,SET,8,0.06319,0.0013188,0.33167,0.42445,GOBP_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.99999
GOBP_REGULATION_OF_NAD_P_H_O...,SET,5,0.072843,0.001202,0.38241,0.42447,GOBP_REGULATION_OF_NAD_P_H_OXIDASE_ACTIVITY,0.99999
GSE2770_TGFB_AND_IL4_VS_IL4_...4,SET,177,0.012029,0.0011755,0.063152,0.42447,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...466,SET,9,0.054366,0.0012035,0.28579,0.42456,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_CALCIUM_ION_CONCENTRATION,0.99999
PTF1BETA_Q6,SET,213,0.011298,0.0012099,0.059424,0.42461,PTF1BETA_Q6,0.99999
MODULE_291,SET,61,0.022487,0.0012941,0.11828,0.42461,MODULE_291,0.99999
GOMF_CARBOHYDRATE_PROTON_SYM...,SET,7,0.071486,0.0013957,0.3766,0.42473,GOMF_CARBOHYDRATE_PROTON_SYMPORTER_ACTIVITY,0.99999
GOBP_NEPHRON_EPITHELIUM_DEVE...,SET,113,0.016914,0.0013229,0.08912,0.42474,GOBP_NEPHRON_EPITHELIUM_DEVELOPMENT,0.99999
GOBP_RESPONSE_TO_NITROSATIVE...,SET,10,0.045341,0.0010579,0.2389,0.42474,GOBP_RESPONSE_TO_NITROSATIVE_STRESS,0.99999
GOBP_PHOSPHATIDYLGLYCEROL_AC...,SET,9,0.060778,0.0013454,0.32028,0.42475,GOBP_PHOSPHATIDYLGLYCEROL_ACYL_CHAIN_REMODELING,0.99999
HP_UPLIFTED_EARLOBE,SET,20,0.038798,0.0012799,0.20449,0.42476,HP_UPLIFTED_EARLOBE,0.99999
GOCC_PROTEIN_KINASE_COMPLEX,SET,135,0.012913,0.0011033,0.068068,0.42477,GOCC_PROTEIN_KINASE_COMPLEX,0.99999
GSE360_CTRL_VS_M_TUBERCULOSI...3,SET,177,0.0119,0.0011628,0.062742,0.42479,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN,0.99999
GSE45739_UNSTIM_VS_ACD3_ACD2...1,SET,176,0.012823,0.0012496,0.067642,0.42482,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN,0.99999
GOBP_MESENCHYMAL_CELL_PROLIF...1,SET,42,0.029171,0.0013937,0.15395,0.42486,GOBP_MESENCHYMAL_CELL_PROLIFERATION,0.99999
MIR6081,SET,97,0.016811,0.0012188,0.088776,0.4249,MIR6081,0.99999
GSE10239_NAIVE_VS_MEMORY_CD8...1,SET,181,0.011788,0.0011647,0.06225,0.42491,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.99999
GOBP_PROTEIN_KINASE_C_ACTIVA...,SET,24,0.033229,0.0012007,0.17552,0.42492,GOBP_PROTEIN_KINASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...474,SET,12,0.049058,0.0012538,0.25928,0.42497,GOBP_POSITIVE_REGULATION_OF_MITOPHAGY,0.99999
REACTOME_DEATH_RECEPTOR_SIGN...,SET,139,0.013791,0.0011955,0.072944,0.42502,REACTOME_DEATH_RECEPTOR_SIGNALING,0.99999
OSMAN_BLADDER_CANCER_UP,SET,363,0.0083884,0.0011678,0.044397,0.42507,OSMAN_BLADDER_CANCER_UP,0.99999
GSE25088_WT_VS_STAT6_KO_MACR...5,SET,183,0.011452,0.0011376,0.060627,0.42509,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_UP,0.99999
LU_EZH2_TARGETS_DN,SET,343,0.008781,0.001189,0.046501,0.42511,LU_EZH2_TARGETS_DN,0.99999
KEGG_MEDICUS_REFERENCE_DRD1_...,SET,16,0.038414,0.0011336,0.20348,0.42513,KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY,0.99999
GSE27786_CD4_TCELL_VS_NKCELL...1,SET,180,0.011992,0.0011816,0.063551,0.42516,GSE27786_CD4_TCELL_VS_NKCELL_DN,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...12,SET,8,0.046369,0.00096775,0.24598,0.42524,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_PRIMING,0.99999
GSE22527_ANTI_CD3_INVIVO_VS_...2,SET,176,0.012427,0.0012109,0.065958,0.42528,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP,0.99999
GOMF_COPPER_ION_BINDING,SET,57,0.021513,0.0011969,0.11425,0.42532,GOMF_COPPER_ION_BINDING,0.99999
GOBP_INTERLEUKIN_6_MEDIATED_...,SET,18,0.042442,0.0013283,0.22567,0.42541,GOBP_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY,0.99999
HP_ABSENT_PUBIC_HAIR,SET,8,0.060204,0.0012565,0.32011,0.42541,HP_ABSENT_PUBIC_HAIR,0.99999
REACTOME_ERBB2_REGULATES_CEL...,SET,15,0.040284,0.001151,0.21438,0.42547,REACTOME_ERBB2_REGULATES_CELL_MOTILITY,0.99999
GSE10240_CTRL_VS_IL17_STIM_P...1,SET,180,0.011809,0.0011636,0.062838,0.42547,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.99999
NFY_Q6,SET,223,0.010998,0.0012047,0.05853,0.42548,NFY_Q6,0.99999
GSE12507_PDC_CELL_LINE_VS_IM...2,SET,136,0.013813,0.0011844,0.073636,0.4256,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP,0.99999
GOBP_CENTRAL_NERVOUS_SYSTEM_...5,SET,35,0.028946,0.0012627,0.15439,0.42564,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_AXONOGENESIS,0.99999
KANG_AR_TARGETS_UP,SET,16,0.046908,0.0013842,0.25055,0.42574,KANG_AR_TARGETS_UP,0.99999
MCBRYAN_PUBERTAL_BREAST_6_7W...1,SET,71,0.019255,0.0011951,0.10289,0.42578,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,0.99999
BIOCARTA_CIRCADIAN_PATHWAY,SET,5,0.081413,0.0013434,0.43509,0.42579,BIOCARTA_CIRCADIAN_PATHWAY,0.99999
BIOCARTA_HIF_PATHWAY,SET,15,0.039611,0.0011318,0.21175,0.42581,BIOCARTA_HIF_PATHWAY,0.99999
MIR302A_5P,SET,175,0.012078,0.0011736,0.064567,0.42581,MIR302A_5P,0.99999
GSE17721_CTRL_VS_PAM3CSK4_24...1,SET,180,0.011781,0.0011608,0.063003,0.42583,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_DN,0.99999
REACTOME_INTERLEUKIN_15_SIGN...,SET,13,0.048946,0.001302,0.26181,0.42585,REACTOME_INTERLEUKIN_15_SIGNALING,0.99999
MIR6751_3P,SET,73,0.018127,0.0011408,0.096993,0.42587,MIR6751_3P,0.99999
GSE43863_NAIVE_VS_LY6C_LOW_C...2,SET,139,0.013522,0.0011721,0.072343,0.42587,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_UP,0.99999
TGCACTT_MIR519C_MIR519B_MIR5...,SET,409,0.00797,0.0011763,0.042665,0.42591,TGCACTT_MIR519C_MIR519B_MIR519A,0.99999
GOBP_RECEPTOR_MEDIATED_ENDOC...3,SET,10,0.055484,0.0012946,0.29712,0.42593,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS_OF_VIRUS_BY_HOST_CELL,0.99999
GOBP_NEGATIVE_REGULATION_OF_...57,SET,6,0.07558,0.0013662,0.40494,0.42597,GOBP_NEGATIVE_REGULATION_OF_B_CELL_DIFFERENTIATION,0.99999
HP_APLASIA_OF_THE_ULNA,SET,5,0.09052,0.0014937,0.48495,0.42597,HP_APLASIA_OF_THE_ULNA,0.99999
GOBP_L_AMINO_ACID_TRANSPORT,SET,88,0.017856,0.0012333,0.095677,0.42598,GOBP_L_AMINO_ACID_TRANSPORT,0.99999
SOX5_01,SET,236,0.010877,0.0012253,0.058344,0.42605,SOX5_01,0.99999
KEGG_MEDICUS_REFERENCE_BMP_S...1,SET,20,0.035788,0.0011806,0.19207,0.42609,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY,0.99999
GSE29618_PRE_VS_DAY7_POST_LA...7,SET,177,0.011253,0.0010996,0.060392,0.42609,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN,0.99999
MIR6766_3P,SET,139,0.013513,0.0011714,0.072588,0.42616,MIR6766_3P,0.99999
GOBP_SRP_DEPENDENT_COTRANSLA...2,SET,3,0.10545,0.0013479,0.56641,0.42616,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_SIGNAL_SEQUENCE_RECOGNITION,0.99999
HP_ECTOPIA_LENTIS,SET,39,0.027894,0.0012843,0.14985,0.42617,HP_ECTOPIA_LENTIS,0.99999
GOBP_ANTRAL_OVARIAN_FOLLICLE...,SET,12,0.046481,0.001188,0.25016,0.4263,GOBP_ANTRAL_OVARIAN_FOLLICLE_GROWTH,0.99999
HP_MICROPENIS,SET,226,0.010517,0.0011597,0.056609,0.42631,HP_MICROPENIS,0.99999
GOBP_FOLIC_ACID_CONTAINING_C...3,SET,27,0.02796,0.0010715,0.15052,0.42632,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
HP_DEEP_SET_NAILS,SET,6,0.060138,0.001087,0.32403,0.42638,HP_DEEP_SET_NAILS,0.99999
HP_RENAL_HAMARTOMA,SET,7,0.060079,0.001173,0.32388,0.42642,HP_RENAL_HAMARTOMA,0.99999
GOBP_CELL_PROJECTION_MORPHOG...,SET,613,0.0067945,0.0012207,0.036636,0.42644,GOBP_CELL_PROJECTION_MORPHOGENESIS,0.99999
GOMF_CATALYTIC_ACTIVITY_ACTI...4,SET,109,0.013673,0.0010505,0.073735,0.42644,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_TRNA,0.99999
HP_PTOSIS,SET,652,0.0061627,0.0011406,0.033261,0.42651,HP_PTOSIS,0.99999
PID_SYNDECAN_3_PATHWAY,SET,15,0.041441,0.0011841,0.22379,0.42654,PID_SYNDECAN_3_PATHWAY,0.99999
HP_CONGENITAL_DIAPHRAGMATIC_...,SET,79,0.018026,0.00118,0.097357,0.42656,HP_CONGENITAL_DIAPHRAGMATIC_HERNIA,0.99999
GOBP_AXONOGENESIS_INVOLVED_I...,SET,9,0.055805,0.0012353,0.30158,0.4266,GOBP_AXONOGENESIS_INVOLVED_IN_INNERVATION,0.99999
GSE17974_0.5H_VS_72H_IL4_AND...2,SET,178,0.011906,0.0011667,0.064345,0.4266,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,0.99999
GOBP_DUCTUS_ARTERIOSUS_CLOSU...,SET,5,0.082434,0.0013603,0.44589,0.42666,GOBP_DUCTUS_ARTERIOSUS_CLOSURE,0.99999
YANG_BREAST_CANCER_ESR1_UP,SET,35,0.027683,0.0012076,0.14979,0.42669,YANG_BREAST_CANCER_ESR1_UP,0.99999
BLANCO_MELO_BETA_INTERFERON_...1,SET,183,0.012228,0.0012148,0.066174,0.4267,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,0.99999
GSE15330_HSC_VS_GRANULOCYTE_...1,SET,174,0.011899,0.0011529,0.064455,0.42677,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.99999
MIR3135A,SET,30,0.028625,0.0011562,0.15509,0.42678,MIR3135A,0.99999
AAAGGGA_MIR204_MIR211,SET,211,0.011093,0.0011824,0.060157,0.42685,AAAGGGA_MIR204_MIR211,0.99999
GOBP_NUCLEOLAR_LARGE_RRNA_TR...,SET,19,0.033862,0.0010888,0.18368,0.42687,GOBP_NUCLEOLAR_LARGE_RRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.99999
IIZUKA_LIVER_CANCER_PROGRESS...8,SET,19,0.039458,0.0012687,0.21416,0.42691,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,0.99999
GOMF_CYTOSKELETAL_ANCHOR_ACT...,SET,23,0.03268,0.001156,0.17747,0.42695,GOMF_CYTOSKELETAL_ANCHOR_ACTIVITY,0.99999
GSE21927_SPLEEN_VS_4T1_TUMOR...1,SET,173,0.011683,0.0011288,0.063441,0.42695,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,0.99999
GSE43955_10H_VS_60H_ACT_CD4_...2,SET,177,0.011715,0.0011448,0.06363,0.42696,GSE43955_10H_VS_60H_ACT_CD4_TCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...289,SET,5,0.073164,0.0012073,0.39744,0.42697,GOBP_POSITIVE_REGULATION_OF_G0_TO_G1_TRANSITION,0.99999
REACTOME_RSK_ACTIVATION,SET,5,0.077017,0.0012709,0.41866,0.42702,REACTOME_RSK_ACTIVATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...812,SET,6,0.074512,0.0013469,0.4052,0.42705,GOBP_POSITIVE_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION,0.99999
HP_PENDULAR_NYSTAGMUS,SET,37,0.024918,0.0011175,0.13551,0.42705,HP_PENDULAR_NYSTAGMUS,0.99999
GOCC_MIDBODY,SET,185,0.011051,0.0011038,0.060111,0.42707,GOCC_MIDBODY,0.99999
GSE40274_CTRL_VS_FOXP3_AND_L...2,SET,153,0.013584,0.0012349,0.073892,0.42707,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...17,SET,169,0.011767,0.0011238,0.064027,0.4271,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN,0.99999
MIR6715B_3P,SET,116,0.014081,0.0011158,0.076679,0.42715,MIR6715B_3P,0.99999
HP_THYROID_AGENESIS,SET,7,0.067817,0.001324,0.36936,0.42716,HP_THYROID_AGENESIS,0.99999
GOCC_3M_COMPLEX,SET,5,0.063177,0.0010425,0.34418,0.42718,GOCC_3M_COMPLEX,0.99999
GSE19923_E2A_KO_VS_E2A_AND_H...2,SET,194,0.011061,0.0011311,0.06026,0.42718,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_UP,0.99999
MIR5700,SET,269,0.0097845,0.0011757,0.053358,0.42725,MIR5700,0.99999
GSE21927_SPLEEN_VS_TUMOR_MON...1,SET,168,0.012099,0.0011522,0.065982,0.42725,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN,0.99999
MIR4659A_5P,SET,73,0.018673,0.0011752,0.102,0.42738,MIR4659A_5P,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...3,SET,42,0.026936,0.0012869,0.14722,0.42741,GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1,0.99999
HP_ABNORMAL_MESENTERY_MORPHO...,SET,4,0.063961,0.00094402,0.34955,0.42741,HP_ABNORMAL_MESENTERY_MORPHOLOGY,0.99999
HP_ECTOPIC_ANTERIOR_PITUITAR...,SET,8,0.057371,0.0011974,0.31367,0.42744,HP_ECTOPIC_ANTERIOR_PITUITARY_GLAND,0.99999
GSE24574_BCL6_HIGH_TFH_VS_TF...2,SET,176,0.012046,0.0011738,0.065893,0.42748,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...707,SET,38,0.027534,0.0012514,0.15073,0.42753,GOBP_POSITIVE_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
REACTOME_TELOMERE_EXTENSION_...,SET,22,0.031301,0.0010829,0.17139,0.42754,REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE,0.99999
REACTOME_CATION_COUPLED_CHLO...,SET,7,0.055428,0.0010821,0.30351,0.42755,REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS,0.99999
MIR8084,SET,213,0.011205,0.0011999,0.061354,0.42755,MIR8084,0.99999
HP_LIMB_GIRDLE_MUSCLE_WEAKNE...,SET,86,0.016625,0.0011352,0.091082,0.42758,HP_LIMB_GIRDLE_MUSCLE_WEAKNESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...565,SET,363,0.008423,0.0011727,0.046155,0.4276,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,0.99999
HP_DISTAL_ARTHROGRYPOSIS,SET,24,0.033127,0.001197,0.18161,0.42763,HP_DISTAL_ARTHROGRYPOSIS,0.99999
MIR1200,SET,301,0.0091619,0.0011635,0.050271,0.42769,MIR1200,0.99999
GOBP_RESPONSE_TO_CYCLOHEXIMI...,SET,5,0.077314,0.0012758,0.42418,0.42769,GOBP_RESPONSE_TO_CYCLOHEXIMIDE,0.99999
GOBP_POSITIVE_REGULATION_OF_...9,SET,7,0.048811,0.00095295,0.26806,0.42776,GOBP_POSITIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
MORF_BUB1B,SET,56,0.019887,0.0010967,0.10936,0.42785,MORF_BUB1B,0.99999
KAECH_NAIVE_VS_DAY15_EFF_CD8...2,SET,177,0.011268,0.0011011,0.061969,0.42786,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP,0.99999
GSE44649_WT_VS_MIR155_KO_ACT...1,SET,182,0.01129,0.0011185,0.062095,0.42787,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_DN,0.99999
REACTOME_METABOLISM_OF_COFAC...,SET,22,0.030828,0.0010666,0.16964,0.4279,REACTOME_METABOLISM_OF_COFACTORS,0.99999
HP_RENAL_DUPLICATION,SET,31,0.030012,0.0012322,0.16517,0.42791,HP_RENAL_DUPLICATION,0.99999
LI_PBMC_MENACTRA_AGE_18_45YO...1,SET,8,0.057671,0.0012036,0.31745,0.42792,LI_PBMC_MENACTRA_AGE_18_45YO_7DY_UP,0.99999
REACTOME_DEPOLYMERIZATION_OF...,SET,14,0.039915,0.0011018,0.21999,0.42801,REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA,0.99999
GSE22886_TCELL_VS_BCELL_NAIV...2,SET,182,0.01126,0.0011156,0.062055,0.42801,GSE22886_TCELL_VS_BCELL_NAIVE_UP,0.99999
REACTOME_TRANSCRIPTIONAL_REG...9,SET,337,0.0080579,0.0010817,0.044463,0.4281,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,0.99999
BIOCARTA_TUBBY_PATHWAY,SET,4,0.090777,0.0013398,0.50136,0.42816,BIOCARTA_TUBBY_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...521,SET,15,0.039679,0.0011338,0.21919,0.42817,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,0.99999
NIKOLSKY_BREAST_CANCER_7P22_...,SET,37,0.044598,0.0020002,0.2465,0.42821,NIKOLSKY_BREAST_CANCER_7P22_AMPLICON,0.99999
GOBP_POSITIVE_REGULATION_OF_...117,SET,305,0.009478,0.0012115,0.052409,0.42825,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION,0.99999
HP_URTICARIA,SET,49,0.021263,0.0010971,0.11758,0.42825,HP_URTICARIA,0.99999
DESCARTES_FETAL_HEART_ENDOCA...,SET,29,0.032094,0.0012746,0.17763,0.42831,DESCARTES_FETAL_HEART_ENDOCARDIAL_CELLS,0.99999
WANG_RECURRENT_LIVER_CANCER_...2,SET,16,0.039076,0.0011531,0.21641,0.42835,WANG_RECURRENT_LIVER_CANCER_UP,0.99999
ONDER_CDH1_TARGETS_3_DN,SET,55,0.022959,0.0012548,0.12717,0.42836,ONDER_CDH1_TARGETS_3_DN,0.99999
GOMF_LIPID_KINASE_ACTIVITY,SET,39,0.024152,0.001112,0.13381,0.42838,GOMF_LIPID_KINASE_ACTIVITY,0.99999
BIOCARTA_MET_PATHWAY,SET,32,0.028029,0.0011692,0.1556,0.42853,BIOCARTA_MET_PATHWAY,0.99999
chr16q12,SET,35,0.043803,0.0019108,0.24324,0.42855,chr16q12,0.99999
GOBP_RESPONSE_TO_PHENYLPROPA...,SET,4,0.088029,0.0012993,0.48928,0.42861,GOBP_RESPONSE_TO_PHENYLPROPANOID,0.99999
GOBP_INTRACELLULAR_WATER_HOM...,SET,6,0.069271,0.0012521,0.38508,0.42862,GOBP_INTRACELLULAR_WATER_HOMEOSTASIS,0.99999
NKX2_8_TARGET_GENES,SET,31,0.030754,0.0012627,0.17104,0.42865,NKX2_8_TARGET_GENES,0.99999
LEIN_MIDBRAIN_MARKERS,SET,68,0.019634,0.0011927,0.10923,0.42868,LEIN_MIDBRAIN_MARKERS,0.99999
HALLMARK_OXIDATIVE_PHOSPHORY...,SET,169,0.010956,0.0010463,0.061016,0.42875,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.99999
GOBP_PROTEOLYSIS,SET,1452,0.0042302,0.0011417,0.023597,0.42887,GOBP_PROTEOLYSIS,0.99999
GOBP_REGULATION_OF_PROTEIN_P...2,SET,22,0.033643,0.0011639,0.18788,0.42894,GOBP_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...10,SET,183,0.011488,0.0011413,0.064163,0.42895,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_UP,0.99999
ZNF618_TARGET_GENES,SET,1048,0.0049477,0.0011479,0.027662,0.42902,ZNF618_TARGET_GENES,0.99999
GOBP_POSITIVE_REGULATION_OF_...468,SET,19,0.037339,0.0012006,0.2088,0.42904,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FISSION,0.99999
MIR11399,SET,68,0.018135,0.0011017,0.10143,0.42906,MIR11399,0.99999
GOMF_TRANSLATION_FACTOR_ACTI...,SET,71,0.016533,0.0010262,0.092549,0.42911,GOMF_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING,0.99999
MIR580_5P,SET,210,0.010488,0.0011153,0.058723,0.42913,MIR580_5P,0.99999
HP_MELANOCYTIC_NEVUS,SET,64,0.017339,0.001022,0.097179,0.4292,HP_MELANOCYTIC_NEVUS,0.99999
GOMF_ALPHA_KETOGLUTARATE_TRA...,SET,6,0.060332,0.0010905,0.33827,0.42922,GOMF_ALPHA_KETOGLUTARATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
BUSSLINGER_GASTRIC_PREZYMOGE...,SET,57,0.021698,0.0012071,0.12174,0.42928,BUSSLINGER_GASTRIC_PREZYMOGENIC_CELLS,0.99999
GOBP_REGULATION_OF_POSTSYNAP...4,SET,13,0.044758,0.0011906,0.25133,0.42933,GOBP_REGULATION_OF_POSTSYNAPTIC_DENSITY_ASSEMBLY,0.99999
HP_PREMATURE_GRAYING_OF_HAIR,SET,46,0.021335,0.0010666,0.11984,0.42935,HP_PREMATURE_GRAYING_OF_HAIR,0.99999
HAY_BONE_MARROW_CD34_POS_MUL...,SET,17,0.037025,0.0011262,0.20799,0.42936,HAY_BONE_MARROW_CD34_POS_MULTILIN,0.99999
WILLIAMS_ESR2_TARGETS_DN,SET,10,0.052165,0.0012172,0.29315,0.42938,WILLIAMS_ESR2_TARGETS_DN,0.99999
GOBP_BIOLOGICAL_PROCESS_INVO...1,SET,190,0.011359,0.0011496,0.063949,0.42951,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_HOST,0.99999
GSE40666_UNTREATED_VS_IFNA_S...7,SET,176,0.01162,0.0011323,0.065416,0.42951,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN,0.99999
REACTOME_REGULATED_NECROSIS,SET,54,0.021484,0.0011635,0.12097,0.42952,REACTOME_REGULATED_NECROSIS,0.99999
KEGG_MEDICUS_REFERENCE_GPI_A...,SET,23,0.028984,0.0010253,0.16323,0.42953,KEGG_MEDICUS_REFERENCE_GPI_ANCHOR_BIOSYNTHESIS,0.99999
IGF1R_TARGET_GENES,SET,2,0.12626,0.0013177,0.7112,0.42955,IGF1R_TARGET_GENES,0.99999
DESCARTES_FETAL_KIDNEY_MEGAK...,SET,103,0.015987,0.0011942,0.090123,0.4296,DESCARTES_FETAL_KIDNEY_MEGAKARYOCYTES,0.99999
GOMF_N_FORMYL_PEPTIDE_RECEPT...,SET,4,0.097905,0.001445,0.5526,0.42969,GOMF_N_FORMYL_PEPTIDE_RECEPTOR_ACTIVITY,0.99999
WEINMANN_ADAPTATION_TO_HYPOX...1,SET,37,0.02771,0.0012428,0.15668,0.42981,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,0.99999
GSE23505_IL6_IL1_IL23_VS_IL6...2,SET,180,0.011118,0.0010955,0.062876,0.42982,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,0.99999
GSE27786_BCELL_VS_ERYTHROBLA...2,SET,179,0.010777,0.001059,0.060946,0.42982,GSE27786_BCELL_VS_ERYTHROBLAST_UP,0.99999
GOCC_MYOFILAMENT,SET,25,0.030173,0.0011127,0.17064,0.42983,GOCC_MYOFILAMENT,0.99999
GOCC_CIS_GOLGI_NETWORK,SET,56,0.018974,0.0010463,0.10734,0.42985,GOCC_CIS_GOLGI_NETWORK,0.99999
GSE32901_TH1_VS_TH17_ENRICHE...1,SET,142,0.012795,0.0011209,0.072459,0.42992,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN,0.99999
GOCC_CHYLOMICRON,SET,10,0.057918,0.0013514,0.32803,0.42993,GOCC_CHYLOMICRON,0.99999
MIR155_3P,SET,85,0.016414,0.0011143,0.092995,0.42995,MIR155_3P,0.99999
GOBP_CENTROSOME_DUPLICATION,SET,71,0.017008,0.0010557,0.096379,0.42996,GOBP_CENTROSOME_DUPLICATION,0.99999
EBAUER_TARGETS_OF_PAX3_FOXO1...1,SET,46,0.023067,0.0011532,0.13078,0.43,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,0.99999
GSE37534_GW1929_VS_PIOGLITAZ...2,SET,179,0.011241,0.0011046,0.063777,0.43005,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,0.99999
HP_IMPAIRED_DISTAL_PROPRIOCE...,SET,16,0.033315,0.0009831,0.18908,0.43007,HP_IMPAIRED_DISTAL_PROPRIOCEPTION,0.99999
HP_ABNORMALITY_OF_THE_UTERUS,SET,225,0.009905,0.0010898,0.056224,0.43008,HP_ABNORMALITY_OF_THE_UTERUS,0.99999
GOBP_PHENOL_CONTAINING_COMPO...3,SET,103,0.016158,0.0012069,0.091832,0.43017,GOBP_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
REACTOME_POLO_LIKE_KINASE_ME...,SET,16,0.032351,0.00095466,0.18408,0.43025,REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS,0.99999
GSE21360_SECONDARY_VS_QUATER...2,SET,173,0.012538,0.0012114,0.071385,0.43029,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.99999
MIR3123,SET,229,0.010161,0.0011278,0.05787,0.43031,MIR3123,0.99999
GSE7460_CTRL_VS_FOXP3_OVEREX...1,SET,184,0.011317,0.0011273,0.06447,0.43033,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN,0.99999
HP_LONG_PALPEBRAL_FISSURE,SET,62,0.017647,0.0010238,0.10058,0.43036,HP_LONG_PALPEBRAL_FISSURE,0.99999
HP_ABNORMAL_URINE_POTASSIUM_...,SET,16,0.041109,0.0012131,0.23434,0.43038,HP_ABNORMAL_URINE_POTASSIUM_CONCENTRATION,0.99999
KORKOLA_TERATOMA_UP,SET,13,0.046598,0.0012396,0.26588,0.43044,KORKOLA_TERATOMA_UP,0.99999
MIR376A_5P,SET,56,0.020488,0.0011298,0.11691,0.43044,MIR376A_5P,0.99999
MIR5187_5P,SET,97,0.015421,0.0011179,0.087987,0.43044,MIR5187_5P,0.99999
HP_NEOPLASM,SET,880,0.0051561,0.0011015,0.029425,0.43045,HP_NEOPLASM,0.99999
KEGG_MEDICUS_REFERENCE_ACH_C...2,SET,20,0.031565,0.0010413,0.18027,0.4305,KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOMF_PDZ_DOMAIN_BINDING,SET,80,0.017432,0.0011482,0.099682,0.43059,GOMF_PDZ_DOMAIN_BINDING,0.99999
HP_ECLAMPSIA,SET,7,0.062295,0.0012162,0.35626,0.4306,HP_ECLAMPSIA,0.99999
GSE20715_0H_VS_48H_OZONE_TLR...2,SET,186,0.011205,0.0011221,0.064096,0.43061,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP,0.99999
MIKKELSEN_ES_ICP_WITH_H3K4ME3,SET,619,0.0060249,0.0010875,0.034473,0.43063,MIKKELSEN_ES_ICP_WITH_H3K4ME3,0.99999
MIR5701,SET,179,0.011257,0.0011062,0.064424,0.43064,MIR5701,0.99999
GOBP_REGULATION_OF_SKELETAL_...10,SET,24,0.031464,0.0011369,0.18012,0.43066,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_MESENCHYM...1,SET,32,0.030558,0.0012747,0.17499,0.43069,GOBP_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...355,SET,11,0.0427,0.0010449,0.24482,0.43077,GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...1,SET,68,0.018402,0.0011179,0.10554,0.43079,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,0.99999
ABE_VEGFA_TARGETS_30MIN,SET,25,0.031142,0.0011484,0.17864,0.43081,ABE_VEGFA_TARGETS_30MIN,0.99999
GSE3982_NEUTROPHIL_VS_EFF_ME...2,SET,182,0.011143,0.001104,0.063984,0.43087,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
GOBP_RNA_LOCALIZATION,SET,180,0.010077,0.00099293,0.057896,0.43091,GOBP_RNA_LOCALIZATION,0.99999
MIR4715_5P,SET,39,0.025152,0.0011581,0.14479,0.43104,MIR4715_5P,0.99999
NIKOLSKY_BREAST_CANCER_17P11...,SET,9,0.066683,0.0014761,0.38401,0.43107,NIKOLSKY_BREAST_CANCER_17P11_AMPLICON,0.99999
REACTOME_DEFECTIVE_FACTOR_IX...,SET,7,0.063077,0.0012315,0.36327,0.43108,REACTOME_DEFECTIVE_FACTOR_IX_CAUSES_HEMOPHILIA_B,0.99999
GOBP_NEURON_NEURON_SYNAPTIC_...,SET,8,0.054797,0.0011436,0.3156,0.43108,GOBP_NEURON_NEURON_SYNAPTIC_TRANSMISSION,0.99999
HP_MULTIPLE_BLADDER_DIVERTIC...,SET,4,0.07996,0.0011802,0.46061,0.43109,HP_MULTIPLE_BLADDER_DIVERTICULA,0.99999
PID_MET_PATHWAY,SET,77,0.016571,0.0010709,0.095478,0.43111,PID_MET_PATHWAY,0.99999
GOBP_ENDOCYTOSIS,SET,643,0.0060323,0.001109,0.034773,0.43114,GOBP_ENDOCYTOSIS,0.99999
ELF2_TARGET_GENES,SET,1228,0.0043237,0.0010802,0.024946,0.4312,ELF2_TARGET_GENES,0.99999
GSE28726_NAIVE_VS_ACTIVATED_...1,SET,185,0.010757,0.0010744,0.062109,0.43125,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN,0.99999
GOBP_CATECHOL_CONTAINING_COM...3,SET,46,0.02409,0.0012043,0.13915,0.43128,GOBP_CATECHOL_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
HP_FOCAL_SENSORY_SEIZURE_WIT...,SET,6,0.051935,0.00093875,0.30015,0.43131,HP_FOCAL_SENSORY_SEIZURE_WITH_VISUAL_FEATURES,0.99999
GOBP_MACROPHAGE_MIGRATION,SET,57,0.019615,0.0010913,0.11341,0.43134,GOBP_MACROPHAGE_MIGRATION,0.99999
KEGG_MEDICUS_REFERENCE_STRAD...,SET,8,0.050843,0.0010611,0.29397,0.43135,KEGG_MEDICUS_REFERENCE_STRAD_STK11_TSC_SIGNALING_PATHWAY,0.99999
GSE22033_WT_VS_PPARG_KO_MEF_...1,SET,180,0.011054,0.0010892,0.063931,0.43136,GSE22033_WT_VS_PPARG_KO_MEF_DN,0.99999
GOBP_REGULATION_OF_ORGANELLE...3,SET,8,0.053301,0.0011124,0.3083,0.43137,GOBP_REGULATION_OF_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,0.99999
HP_DECREASED_CIRCULATING_COM...1,SET,33,0.026588,0.0011263,0.15398,0.43146,HP_DECREASED_CIRCULATING_COMPLEMENT_C3_CONCENTRATION,0.99999
GOBP_ATRIAL_CARDIAC_MUSCLE_C...2,SET,16,0.041552,0.0012262,0.24068,0.43147,GOBP_ATRIAL_CARDIAC_MUSCLE_CELL_TO_AV_NODE_CELL_COMMUNICATION,0.99999
QI_HYPOXIA_TARGETS_OF_HIF1A_...,SET,32,0.027222,0.0011355,0.1578,0.43152,QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,0.99999
HP_SUBCORTICAL_HETEROTOPIA,SET,11,0.039803,0.00097403,0.23085,0.43155,HP_SUBCORTICAL_HETEROTOPIA,0.99999
MIR196A_3P,SET,115,0.013784,0.0010875,0.079965,0.43157,MIR196A_3P,0.99999
DESCARTES_FETAL_EYE_RETINAL_...2,SET,10,0.051831,0.0012094,0.30076,0.43159,DESCARTES_FETAL_EYE_RETINAL_PROGENITORS_AND_MULLER_GLIA,0.99999
KEGG_VASOPRESSIN_REGULATED_W...,SET,42,0.021297,0.0010175,0.12367,0.43164,KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,0.99999
HP_LACRIMAL_DUCT_APLASIA,SET,9,0.048377,0.0010709,0.28103,0.43166,HP_LACRIMAL_DUCT_APLASIA,0.99999
GOBP_REGULATION_OF_SNRNA_TRA...,SET,5,0.055032,0.00090808,0.32002,0.43173,GOBP_REGULATION_OF_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.99999
REACTOME_MITOCHONDRIAL_CALCI...,SET,19,0.035616,0.0011452,0.20744,0.43184,REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT,0.99999
AIZARANI_LIVER_C24_EPCAM_POS...,SET,174,0.012133,0.0011756,0.070716,0.43189,AIZARANI_LIVER_C24_EPCAM_POS_BILE_DUCT_CELLS_3,0.99999
HP_CHRONIC_HEPATITIS_DUE_TO_...,SET,5,0.073823,0.0012182,0.43041,0.43191,HP_CHRONIC_HEPATITIS_DUE_TO_CRYPTOSPORIDIUM_INFECTION,0.99999
GOBP_NEGATIVE_REGULATION_BY_...2,SET,13,0.0403,0.001072,0.2352,0.43198,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS,0.99999
GSE29164_UNTREATED_VS_CD8_TC...2,SET,173,0.01095,0.001058,0.063998,0.43207,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,0.99999
GSE26030_UNSTIM_VS_RESTIM_TH...1,SET,178,0.010898,0.0010679,0.063736,0.43212,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN,0.99999
FUNG_IL2_TARGETS_WITH_STAT5_...2,SET,9,0.053468,0.0011836,0.31283,0.43215,FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1,0.99999
BLALOCK_ALZHEIMERS_DISEASE_DN,SET,1103,0.0044562,0.001059,0.026087,0.43218,BLALOCK_ALZHEIMERS_DISEASE_DN,0.99999
HP_PERIMEMBRANOUS_VENTRICULA...,SET,23,0.032339,0.0011439,0.18935,0.43219,HP_PERIMEMBRANOUS_VENTRICULAR_SEPTAL_DEFECT,0.99999
HP_MINIMAL_CHANGE_GLOMERULON...,SET,34,0.025538,0.001098,0.14956,0.43221,HP_MINIMAL_CHANGE_GLOMERULONEPHRITIS,0.99999
GOBP_REGULATION_OF_GAMMA_AMI...,SET,8,0.05726,0.0011951,0.33536,0.43222,GOBP_REGULATION_OF_GAMMA_AMINOBUTYRIC_ACID_SECRETION,0.99999
GOCC_DNA_REPLICATION_FACTOR_...2,SET,5,0.062935,0.0010385,0.36897,0.43228,GOCC_DNA_REPLICATION_FACTOR_C_COMPLEX,0.99999
WP_HEDGEHOG_SIGNALING_WP47,SET,14,0.036229,0.0010001,0.21282,0.43242,WP_HEDGEHOG_SIGNALING_WP47,0.99999
GOBP_EXCITATORY_SYNAPSE_ASSE...,SET,34,0.026294,0.0011305,0.15453,0.43244,GOBP_EXCITATORY_SYNAPSE_ASSEMBLY,0.99999
GSE11864_CSF1_IFNG_VS_CSF1_I...1,SET,167,0.011074,0.0010514,0.065083,0.43245,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.99999
REACTOME_INTERLEUKIN_23_SIGN...,SET,9,0.05136,0.0011369,0.30215,0.43251,REACTOME_INTERLEUKIN_23_SIGNALING,0.99999
WP_AMPACTIVATED_PROTEIN_KINA...,SET,67,0.017666,0.0010653,0.10396,0.43253,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,0.99999
HP_HYPERPIGMENTATION_OF_THE_...1,SET,6,0.064854,0.0011723,0.3817,0.43254,HP_HYPERPIGMENTATION_OF_THE_FUNDUS,0.99999
GAZDA_DIAMOND_BLACKFAN_ANEMI...3,SET,30,0.026916,0.0010872,0.15844,0.43256,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN,0.99999
REACTOME_REVERSIBLE_HYDRATIO...,SET,11,0.047121,0.0011531,0.27761,0.43261,REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE,0.99999
GOBP_VASCULAR_ENDOTHELIAL_GR...2,SET,6,0.072246,0.0013059,0.42561,0.43261,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_SIGNALING_PATHWAY,0.99999
HP_RECURRENT_OPPORTUNISTIC_I...,SET,9,0.05068,0.0011219,0.29907,0.43272,HP_RECURRENT_OPPORTUNISTIC_INFECTIONS,0.99999
HP_CLEFT_SOFT_PALATE,SET,49,0.019815,0.0010224,0.1171,0.43281,HP_CLEFT_SOFT_PALATE,0.99999
HP_DECREASED_ACTIVITY_OF_NAD...,SET,3,0.090058,0.0011512,0.5325,0.43285,HP_DECREASED_ACTIVITY_OF_NADPH_OXIDASE,0.99999
HP_ANGIOEDEMA,SET,12,0.047814,0.0012221,0.28276,0.43286,HP_ANGIOEDEMA,0.99999
HP_ABNORMAL_ERYTHROCYTE_SEDI...,SET,57,0.020531,0.0011422,0.12147,0.43289,HP_ABNORMAL_ERYTHROCYTE_SEDIMENTATION_RATE,0.99999
CTCAAGA_MIR526B,SET,61,0.017934,0.0010321,0.10612,0.4329,CTCAAGA_MIR526B,0.99999
GCM_BECN1,SET,62,0.01715,0.00099495,0.10149,0.43291,GCM_BECN1,0.99999
PID_HDAC_CLASSII_PATHWAY,SET,30,0.027359,0.0011051,0.16195,0.43293,PID_HDAC_CLASSII_PATHWAY,0.99999
WP_THIAMINE_METABOLIC_PATHWA...,SET,8,0.048749,0.0010174,0.28875,0.43297,WP_THIAMINE_METABOLIC_PATHWAYS,0.99999
GOBP_ISG15_PROTEIN_CONJUGATI...,SET,6,0.059638,0.001078,0.35329,0.43297,GOBP_ISG15_PROTEIN_CONJUGATION,0.99999
GOBP_RETINAL_CELL_APOPTOTIC_...,SET,6,0.060979,0.0011022,0.36139,0.433,GOBP_RETINAL_CELL_APOPTOTIC_PROCESS,0.99999
GSE14415_ACT_TCONV_VS_ACT_NA...1,SET,164,0.011588,0.0010904,0.068686,0.43301,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN,0.99999
HP_DUPLICATION_OF_THE_DISTAL...2,SET,6,0.05517,0.00099722,0.32705,0.43302,HP_DUPLICATION_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,0.99999
HP_METATARSUS_VALGUS,SET,19,0.034082,0.0010959,0.20202,0.43302,HP_METATARSUS_VALGUS,0.99999
GOBP_POST_TRANSLATIONAL_PROT...3,SET,8,0.054392,0.0011352,0.32256,0.43305,GOBP_POST_TRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_TRANSLOCATION,0.99999
GSE6269_HEALTHY_VS_E_COLI_IN...2,SET,157,0.011025,0.0010152,0.065507,0.43317,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP,0.99999
HP_STIFF_NECK,SET,5,0.068866,0.0011364,0.40929,0.43319,HP_STIFF_NECK,0.99999
MORF_ITGA2,SET,47,0.021924,0.0011079,0.13035,0.43322,MORF_ITGA2,0.99999
HP_MEDULLARY_NEPHROCALCINOSIS,SET,10,0.050693,0.0011828,0.30152,0.43325,HP_MEDULLARY_NEPHROCALCINOSIS,0.99999
GOCC_U2_TYPE_SPLICEOSOMAL_CO...,SET,86,0.01353,0.00092386,0.080515,0.43328,GOCC_U2_TYPE_SPLICEOSOMAL_COMPLEX,0.99999
ICSBP_Q6,SET,230,0.0097,0.0010789,0.057841,0.43341,ICSBP_Q6,0.99999
WP_CATALYTIC_CYCLE_OF_MAMMAL...,SET,5,0.0837,0.0013811,0.49944,0.43345,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,0.99999
GOMF_N_N_DIMETHYLANILINE_MON...,SET,5,0.0837,0.0013811,0.49944,0.43345,GOMF_N_N_DIMETHYLANILINE_MONOOXYGENASE_ACTIVITY,0.99999
LINDVALL_IMMORTALIZED_BY_TER...1,SET,64,0.018879,0.0011127,0.11267,0.43347,LINDVALL_IMMORTALIZED_BY_TERT_DN,0.99999
GOBP_GDP_MANNOSE_METABOLIC_P...,SET,6,0.044376,0.00080213,0.26484,0.43347,GOBP_GDP_MANNOSE_METABOLIC_PROCESS,0.99999
WP_PHOSPHODIESTERASES_IN_NEU...,SET,52,0.020766,0.0011036,0.12401,0.43351,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,0.99999
HP_ABNORMAL_PENIS_MORPHOLOGY,SET,559,0.0060247,0.0010352,0.035999,0.43354,HP_ABNORMAL_PENIS_MORPHOLOGY,0.99999
REACTOME_GLYCOSPHINGOLIPID_C...,SET,31,0.025766,0.0010579,0.1544,0.43373,REACTOME_GLYCOSPHINGOLIPID_CATABOLISM,0.99999
MIR4529_5P,SET,45,0.021822,0.0010791,0.13085,0.43378,MIR4529_5P,0.99999
TUOMISTO_TUMOR_SUPPRESSION_B...1,SET,19,0.034187,0.0010993,0.20516,0.43383,TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN,0.99999
GOBP_REGULATION_OF_CELL_CYCL...3,SET,103,0.013504,0.0010086,0.081039,0.43383,GOBP_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.99999
GOBP_CYTOCHROME_METABOLIC_PR...,SET,5,0.070906,0.00117,0.42556,0.43384,GOBP_CYTOCHROME_METABOLIC_PROCESS,0.99999
HP_CARDIOMYOCYTE_HYPERTROPHY,SET,8,0.049676,0.0010368,0.29856,0.43393,HP_CARDIOMYOCYTE_HYPERTROPHY,0.99999
GOBP_MRNA_SPLICE_SITE_RECOGN...,SET,30,0.024012,0.00096989,0.1445,0.43401,GOBP_MRNA_SPLICE_SITE_RECOGNITION,0.99999
GOMF_LRR_DOMAIN_BINDING,SET,15,0.037426,0.0010694,0.22526,0.43402,GOMF_LRR_DOMAIN_BINDING,0.99999
GOMF_SECONDARY_ACTIVE_SULFAT...,SET,11,0.043175,0.0010565,0.25985,0.43402,GOMF_SECONDARY_ACTIVE_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOMF_ANTIGEN_BINDING,SET,63,0.020889,0.0012216,0.12576,0.43404,GOMF_ANTIGEN_BINDING,0.99999
IKEDA_MIR30_TARGETS_UP,SET,110,0.013876,0.0010709,0.083597,0.43409,IKEDA_MIR30_TARGETS_UP,0.99999
BAKER_HEMATOPOESIS_STAT5_TAR...,SET,7,0.062211,0.0012146,0.37487,0.4341,BAKER_HEMATOPOESIS_STAT5_TARGETS,0.99999
GOBP_POSITIVE_REGULATION_OF_...647,SET,140,0.012321,0.0010719,0.074251,0.4341,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SECRETION,0.99999
UNTERMAN_PROGRESSIVE_VS_STAB...3,SET,5,0.068762,0.0011347,0.41466,0.43415,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_CD8T_UP,0.99999
GOCC_SERINE_PROTEASE_INHIBIT...,SET,6,0.068856,0.0012446,0.41531,0.43416,GOCC_SERINE_PROTEASE_INHIBITOR_COMPLEX,0.99999
REACTOME_APC_C_CDH1_MEDIATED...,SET,70,0.014776,0.00091068,0.089164,0.43419,REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,0.99999
GOBP_ESTABLISHMENT_OF_MITOCH...2,SET,22,0.031535,0.001091,0.1903,0.43419,GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION_MICROTUBULE_MEDIATED,0.99999
LTE2_UP.V1_UP,SET,178,0.011322,0.0011094,0.068333,0.4342,LTE2_UP.V1_UP,0.99999
REACTOME_MEIOTIC_RECOMBINATI...,SET,26,0.024457,0.00091975,0.14762,0.43421,REACTOME_MEIOTIC_RECOMBINATION,0.99999
FUJIWARA_PARK2_IN_LIVER_CANC...2,SET,8,0.05198,0.0010849,0.31382,0.43422,FUJIWARA_PARK2_IN_LIVER_CANCER_UP,0.99999
GOBP_REGULATION_OF_INNATE_IM...,SET,395,0.0071167,0.0010326,0.042971,0.43423,GOBP_REGULATION_OF_INNATE_IMMUNE_RESPONSE,0.99999
WP_COMPLEMENTMEDIATED_INFLAM...,SET,10,0.04653,0.0010857,0.28142,0.43434,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,0.99999
GOBP_CORPUS_CALLOSUM_DEVELOP...,SET,25,0.029413,0.0010847,0.17794,0.43436,GOBP_CORPUS_CALLOSUM_DEVELOPMENT,0.99999
GOBP_RNA_SPLICING_VIA_ENDONU...,SET,13,0.041142,0.0010944,0.24893,0.43436,GOBP_RNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION,0.99999
GOCC_POSTSYNAPTIC_ENDOSOME,SET,13,0.037812,0.0010059,0.22899,0.43442,GOCC_POSTSYNAPTIC_ENDOSOME,0.99999
GOMF_BASAL_TRANSCRIPTION_MAC...,SET,56,0.018354,0.0010122,0.11121,0.43446,GOMF_BASAL_TRANSCRIPTION_MACHINERY_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...380,SET,9,0.047069,0.0010419,0.28551,0.43453,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_TELECANTHUS,SET,148,0.011848,0.0010595,0.071878,0.43454,HP_TELECANTHUS,0.99999
GOBP_GANGLIOSIDE_METABOLIC_P...,SET,28,0.02765,0.001079,0.16784,0.43457,GOBP_GANGLIOSIDE_METABOLIC_PROCESS,0.99999
GSE2706_R848_VS_R848_AND_LPS...4,SET,156,0.011893,0.0010916,0.072189,0.43457,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP,0.99999
GOBP_ANTIBACTERIAL_PEPTIDE_P...,SET,10,0.05091,0.0011879,0.30908,0.43459,GOBP_ANTIBACTERIAL_PEPTIDE_PRODUCTION,0.99999
CAR_MLANA,SET,40,0.021652,0.0010096,0.13151,0.43462,CAR_MLANA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...469,SET,43,0.02392,0.0011563,0.14529,0.43462,GOBP_NEGATIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.99999
HP_TRICHORRHEXIS_NODOSA,SET,9,0.042222,0.00093463,0.25662,0.43466,HP_TRICHORRHEXIS_NODOSA,0.99999
GOMF_PATTERN_RECOGNITION_REC...,SET,28,0.027173,0.0010604,0.16523,0.43469,GOMF_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY,0.99999
REACTOME_TFAP2_AP_2_FAMILY_R...2,SET,14,0.042474,0.0011725,0.25834,0.43471,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS,0.99999
GOBP_ZYMOGEN_INHIBITION,SET,7,0.046677,0.00091129,0.28416,0.43476,GOBP_ZYMOGEN_INHIBITION,0.99999
MIR558,SET,106,0.013991,0.0010601,0.085214,0.43479,MIR558,0.99999
PID_VEGFR1_PATHWAY,SET,26,0.025419,0.00095593,0.15488,0.43482,PID_VEGFR1_PATHWAY,0.99999
GOMF_NADH_DEHYDROGENASE_ACTI...,SET,8,0.045553,0.00095073,0.27756,0.43482,GOMF_NADH_DEHYDROGENASE_ACTIVITY,0.99999
HP_ABNORMAL_EXTERNAL_NOSE_MO...,SET,789,0.0049525,0.0010044,0.030179,0.43483,HP_ABNORMAL_EXTERNAL_NOSE_MORPHOLOGY,0.99999
GOBP_FIBRINOLYSIS,SET,27,0.027495,0.0010537,0.16759,0.43484,GOBP_FIBRINOLYSIS,0.99999
GOBP_PRIMARY_AMINO_COMPOUND_...2,SET,13,0.036481,0.00097045,0.22241,0.43485,GOBP_PRIMARY_AMINO_COMPOUND_METABOLIC_PROCESS,0.99999
GSE16450_IMMATURE_VS_MATURE_...2,SET,180,0.010531,0.0010377,0.064193,0.43485,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...785,SET,772,0.0052451,0.0010527,0.031977,0.43486,GOBP_POSITIVE_REGULATION_OF_TRANSPORT,0.99999
GSE14769_UNSTIM_VS_120MIN_LP...2,SET,184,0.0097271,0.00096893,0.059337,0.43489,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_UP,0.99999
CREB_01,SET,241,0.0091336,0.0010396,0.055723,0.4349,CREB_01,0.99999
HP_ABNORMAL_CHOROID_MORPHOLO...,SET,169,0.011047,0.0010551,0.067418,0.43492,HP_ABNORMAL_CHOROID_MORPHOLOGY,0.99999
HP_OVERLAPPING_TOE,SET,60,0.018117,0.001034,0.11062,0.43495,HP_OVERLAPPING_TOE,0.99999
HP_ABNORMALITY_OF_HEPATOBILI...,SET,181,0.010132,0.0010011,0.061872,0.43496,HP_ABNORMALITY_OF_HEPATOBILIARY_SYSTEM_PHYSIOLOGY,0.99999
GOMF_MAP_KINASE_KINASE_KINAS...1,SET,22,0.030165,0.0010436,0.18427,0.43499,GOMF_MAP_KINASE_KINASE_KINASE_ACTIVITY,0.99999
GOMF_GLYCEROL_3_PHOSPHATE_O_...,SET,3,0.092598,0.0011836,0.56577,0.435,GOMF_GLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY,0.99999
HP_SCLEROSIS_OF_SKULL_BASE,SET,13,0.04341,0.0011548,0.26538,0.43503,HP_SCLEROSIS_OF_SKULL_BASE,0.99999
GOBP_EXCRETION,SET,28,0.027926,0.0010898,0.17078,0.43506,GOBP_EXCRETION,0.99999
CAO_BLOOD_FLUMIST_AGE_05_14Y...5,SET,7,0.050345,0.00098289,0.3079,0.43506,CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_DN,0.99999
BOQUEST_STEM_CELL_CULTURED_V...1,SET,29,0.027787,0.0011035,0.17005,0.4351,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...364,SET,42,0.022765,0.0010876,0.13941,0.43514,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,0.99999
GOBP_REGULATION_OF_ERBB_SIGN...,SET,65,0.017546,0.0010422,0.10745,0.43514,GOBP_REGULATION_OF_ERBB_SIGNALING_PATHWAY,0.99999
GOBP_SYNAPTIC_TRANSMISSION_D...,SET,27,0.026268,0.0010067,0.16092,0.43517,GOBP_SYNAPTIC_TRANSMISSION_DOPAMINERGIC,0.99999
GOBP_PROTEIN_O_LINKED_MANNOS...,SET,14,0.035276,0.00097378,0.21614,0.43518,GOBP_PROTEIN_O_LINKED_MANNOSYLATION,0.99999
WP_STING_PATHWAY_IN_KAWASAKI...,SET,18,0.032224,0.0010085,0.19755,0.43521,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,0.99999
GOBP_REGULATION_OF_MONOATOMI...2,SET,13,0.040137,0.0010677,0.24603,0.43521,GOBP_REGULATION_OF_MONOATOMIC_ANION_TRANSPORT,0.99999
MUNSHI_MULTIPLE_MYELOMA_UP,SET,70,0.016539,0.0010193,0.10156,0.43532,MUNSHI_MULTIPLE_MYELOMA_UP,0.99999
GOBP_FOLLICLE_STIMULATING_HO...,SET,8,0.057779,0.0012059,0.35511,0.43537,GOBP_FOLLICLE_STIMULATING_HORMONE_SECRETION,0.99999
GSE40493_BCL6_KO_VS_WT_TREG_...2,SET,167,0.010385,0.00098594,0.063817,0.43537,GSE40493_BCL6_KO_VS_WT_TREG_UP,0.99999
GOBP_REGULATION_OF_HORMONE_L...,SET,511,0.0065396,0.0010758,0.040206,0.4354,GOBP_REGULATION_OF_HORMONE_LEVELS,0.99999
GSE18281_CORTEX_VS_MEDULLA_T...2,SET,162,0.010593,0.00099072,0.065225,0.43549,GSE18281_CORTEX_VS_MEDULLA_THYMUS_UP,0.99999
HP_ATYPICAL_SCARRING_OF_SKIN,SET,64,0.018144,0.0010694,0.11181,0.43554,HP_ATYPICAL_SCARRING_OF_SKIN,0.99999
REACTOME_VIRAL_MESSENGER_RNA...,SET,42,0.020131,0.00096181,0.12406,0.43555,REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS,0.99999
GOBP_PROTEIN_CONTAINING_COMP...1,SET,1372,0.0037633,0.00098961,0.023194,0.43555,GOBP_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.99999
GSE12366_PLASMA_CELL_VS_NAIV...1,SET,170,0.01045,0.0010009,0.064402,0.43555,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN,0.99999
TGCTGCT_MIR15A_MIR16_MIR15B_...,SET,554,0.0058717,0.0010045,0.036199,0.43557,TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497,0.99999
GSE15930_NAIVE_VS_24H_IN_VIT...2,SET,187,0.010013,0.0010054,0.061752,0.4356,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP,0.99999
GOBP_REGULATION_OF_THE_FORCE...1,SET,24,0.030093,0.0010874,0.1857,0.43564,GOBP_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION,0.99999
HP_SHALLOW_ACETABULAR_FOSSAE,SET,10,0.041774,0.00097471,0.25784,0.43565,HP_SHALLOW_ACETABULAR_FOSSAE,0.99999
GOBP_MYELOID_LEUKOCYTE_CYTOK...,SET,47,0.021084,0.0010654,0.13023,0.43569,GOBP_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION,0.99999
GOBP_RESPONSE_TO_MURAMYL_DIP...,SET,18,0.030088,0.00094169,0.18593,0.43572,GOBP_RESPONSE_TO_MURAMYL_DIPEPTIDE,0.99999
MODULE_493,SET,58,0.01837,0.0010309,0.11356,0.43575,MODULE_493,0.99999
HP_GASTRITIS,SET,18,0.03324,0.0010403,0.20556,0.43577,HP_GASTRITIS,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...31,SET,37,0.021308,0.00095562,0.13183,0.4358,GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE_ORGANIZING_CENTER,0.99999
NAKAYA_PBMC_FLUAD_MALE_AGE_1...3,SET,17,0.038112,0.0011592,0.23581,0.4358,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_UP,0.99999
BIOCARTA_EPO_PATHWAY,SET,17,0.034468,0.0010484,0.21333,0.43582,BIOCARTA_EPO_PATHWAY,0.99999
GOBP_RNA_PROCESSING,SET,831,0.004523,0.00094028,0.027993,0.43582,GOBP_RNA_PROCESSING,0.99999
HP_BLEPHAROPHIMOSIS,SET,111,0.013824,0.0010717,0.085599,0.43585,HP_BLEPHAROPHIMOSIS,0.99999
HP_DISTAL_PERIPHERAL_SENSORY...,SET,6,0.054517,0.00098543,0.33758,0.43585,HP_DISTAL_PERIPHERAL_SENSORY_NEUROPATHY,0.99999
GOMF_FATTY_ACID_ELONGASE_ACT...,SET,7,0.058995,0.0011518,0.3656,0.4359,GOMF_FATTY_ACID_ELONGASE_ACTIVITY,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...7,SET,182,0.010221,0.0010126,0.063357,0.43592,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_DN,0.99999
HP_ABNORMAL_PATTERN_ELECTROR...,SET,7,0.055069,0.0010751,0.34145,0.43594,HP_ABNORMAL_PATTERN_ELECTRORETINOGRAM,0.99999
GNF2_SPINK1,SET,24,0.032543,0.0011759,0.20193,0.43598,GNF2_SPINK1,0.99999
MIR10396B_5P,SET,19,0.033162,0.0010663,0.20602,0.43606,MIR10396B_5P,0.99999
GOMF_UBIQUITIN_MODIFIED_HIST...,SET,7,0.04291,0.00083775,0.26676,0.4361,GOMF_UBIQUITIN_MODIFIED_HISTONE_READER_ACTIVITY,0.99999
KEGG_VASCULAR_SMOOTH_MUSCLE_...,SET,109,0.013781,0.0010588,0.085802,0.4362,KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,0.99999
MIR16_5P,SET,532,0.0059412,0.00099663,0.036989,0.4362,MIR16_5P,0.99999
GSE14769_UNSTIM_VS_240MIN_LP...2,SET,181,0.0094888,0.00093753,0.059119,0.43624,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP,0.99999
GSE39820_TGFBETA1_IL6_VS_TGF...1,SET,181,0.009958,0.0009839,0.062089,0.43629,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN,0.99999
GOBP_EMBRYONIC_HEART_TUBE_MO...,SET,70,0.016582,0.001022,0.10343,0.43631,GOBP_EMBRYONIC_HEART_TUBE_MORPHOGENESIS,0.99999
MODULE_121,SET,94,0.015875,0.0011331,0.099217,0.43644,MODULE_121,0.99999
ZHAN_MULTIPLE_MYELOMA_HP_UP,SET,39,0.022285,0.0010261,0.13949,0.43653,ZHAN_MULTIPLE_MYELOMA_HP_UP,0.99999
GOMF_NAD_P_H_DEHYDROGENASE_Q...,SET,5,0.062907,0.001038,0.3937,0.43653,GOMF_NAD_P_H_DEHYDROGENASE_QUINONE_ACTIVITY,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...17,SET,183,0.0099288,0.00098636,0.062264,0.43665,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN,0.99999
MIR4743_3P,SET,185,0.010144,0.0010131,0.06365,0.43669,MIR4743_3P,0.99999
GOBP_LIPOPROTEIN_CATABOLIC_P...,SET,14,0.03517,0.00097087,0.22076,0.43671,GOBP_LIPOPROTEIN_CATABOLIC_PROCESS,0.99999
HP_SHORT_DIGIT,SET,523,0.0059862,0.00099589,0.037574,0.43671,HP_SHORT_DIGIT,0.99999
HP_FACIAL_GRIMACING,SET,10,0.040132,0.0009364,0.25195,0.43672,HP_FACIAL_GRIMACING,0.99999
GOBP_REGULATION_OF_FATTY_ACI...1,SET,17,0.03198,0.00097273,0.20094,0.43677,GOBP_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,0.99999
GOMF_LYSINE_N_ACETYLTRANSFER...,SET,6,0.057011,0.0010305,0.35831,0.43679,GOMF_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY_ACTING_ON_ACETYL_PHOSPHATE_AS_DONOR,0.99999
GOBP_POSITIVE_REGULATION_OF_...505,SET,97,0.014387,0.001043,0.09056,0.43689,GOBP_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.99999
KEGG_MEDICUS_ENV_FACTOR_DCE_...,SET,15,0.046891,0.0013398,0.29526,0.43691,KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS,0.99999
MIR455_3P,SET,84,0.014885,0.0010046,0.093769,0.43694,MIR455_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...61,SET,30,0.026025,0.0010512,0.16397,0.43694,GOBP_POSITIVE_REGULATION_OF_BLOOD_PRESSURE,0.99999
GSE20366_EX_VIVO_VS_HOMEOSTA...4,SET,187,0.0094254,0.00094642,0.059395,0.43696,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP,0.99999
GOBP_KERATAN_SULFATE_METABOL...,SET,18,0.032637,0.0010215,0.20569,0.43697,GOBP_KERATAN_SULFATE_METABOLIC_PROCESS,0.99999
GOBP_MITOTIC_NUCLEAR_MEMBRAN...1,SET,8,0.044737,0.00093369,0.28205,0.43699,GOBP_MITOTIC_NUCLEAR_MEMBRANE_DISASSEMBLY,0.99999
GOBP_TELENCEPHALON_DEVELOPME...,SET,257,0.0087714,0.0010305,0.055322,0.43701,GOBP_TELENCEPHALON_DEVELOPMENT,0.99999
GOBP_MINERALOCORTICOID_SECRE...,SET,7,0.057854,0.0011295,0.36503,0.43703,GOBP_MINERALOCORTICOID_SECRETION,0.99999
MIR4256,SET,68,0.015925,0.00096741,0.10051,0.43706,MIR4256,0.99999
GOBP_CELL_DIFFERENTIATION_IN...2,SET,53,0.021206,0.0011378,0.13391,0.43709,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.99999
GOBP_SEROTONIN_UPTAKE,SET,12,0.042565,0.0010879,0.26878,0.43709,GOBP_SEROTONIN_UPTAKE,0.99999
GNF2_CD53,SET,52,0.019482,0.0010354,0.12305,0.4371,GNF2_CD53,0.99999
HP_ABNORMAL_RENAL_CORTICOMED...,SET,21,0.031356,0.0010599,0.19804,0.4371,HP_ABNORMAL_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,0.99999
REACTOME_FGFR1B_LIGAND_BINDI...,SET,8,0.052524,0.0010962,0.33185,0.43712,REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION,0.99999
CHUANG_OXIDATIVE_STRESS_RESP...2,SET,26,0.027821,0.0010463,0.17581,0.43713,CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,0.99999
HP_IMPAIRED_OCULAR_ABDUCTION,SET,4,0.079927,0.0011797,0.50512,0.43714,HP_IMPAIRED_OCULAR_ABDUCTION,0.99999
GNF2_UBE2I,SET,36,0.0213,0.00094232,0.13469,0.43717,GNF2_UBE2I,0.99999
WEBER_METHYLATED_ICP_IN_SPER...1,SET,8,0.050439,0.0010527,0.31902,0.43719,WEBER_METHYLATED_ICP_IN_SPERM_DN,0.99999
REACTOME_NUCLEAR_EVENTS_STIM...,SET,32,0.024186,0.0010089,0.15299,0.4372,REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,0.99999
BILANGES_RAPAMYCIN_SENSITIVE...1,SET,35,0.022647,0.0009879,0.14335,0.43724,BILANGES_RAPAMYCIN_SENSITIVE_GENES,0.99999
HP_ABNORMAL_3RD_FINGER_PHALA...,SET,6,0.0625,0.0011297,0.39603,0.4373,HP_ABNORMAL_3RD_FINGER_PHALANX_MORPHOLOGY,0.99999
VERHAAK_GLIOBLASTOMA_MESENCH...,SET,203,0.010055,0.0010515,0.063787,0.43737,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,0.99999
GOBP_PROTEIN_DEPALMITOYLATION,SET,8,0.046479,0.00097006,0.29487,0.43738,GOBP_PROTEIN_DEPALMITOYLATION,0.99999
FAN_EMBRYONIC_CTX_EX_4_EXCIT...,SET,133,0.011769,0.00099806,0.074692,0.4374,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,0.99999
GOBP_MORPHOGENESIS_OF_A_POLA...,SET,58,0.018953,0.0010636,0.1204,0.43746,GOBP_MORPHOGENESIS_OF_A_POLARIZED_EPITHELIUM,0.99999
KEGG_MEDICUS_PATHOGEN_HTLV_1...4,SET,11,0.046083,0.0011277,0.29322,0.43756,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION,0.99999
GOBP_RNA_GUANINE_N7_METHYLAT...,SET,4,0.054607,0.00080597,0.34768,0.4376,GOBP_RNA_GUANINE_N7_METHYLATION,0.99999
GOBP_T_CELL_MEDIATED_IMMUNITY,SET,121,0.01353,0.0010949,0.086151,0.4376,GOBP_T_CELL_MEDIATED_IMMUNITY,0.99999
GOMF_PHOSPHATIDYLCHOLINE_STE...,SET,4,0.075816,0.001119,0.48276,0.4376,GOMF_PHOSPHATIDYLCHOLINE_STEROL_O_ACYLTRANSFERASE_ACTIVATOR_ACTIVITY,0.99999
HP_ABNORMAL_FRONTAL_BONE_MOR...,SET,365,0.0068422,0.00095515,0.043562,0.4376,HP_ABNORMAL_FRONTAL_BONE_MORPHOLOGY,0.99999
HP_PRENATAL_MOVEMENT_ABNORMA...,SET,211,0.0093587,0.00099755,0.059615,0.43763,HP_PRENATAL_MOVEMENT_ABNORMALITY,0.99999
HP_PORENCEPHALIC_CYST,SET,30,0.024044,0.00097116,0.15331,0.43769,HP_PORENCEPHALIC_CYST,0.99999
MODULE_575,SET,12,0.044382,0.0011343,0.28325,0.43775,MODULE_575,0.99999
HP_GIANT_PLATELETS,SET,10,0.045713,0.0010666,0.29174,0.43775,HP_GIANT_PLATELETS,0.99999
MEBARKI_HCC_PROGENITOR_WNT_UP,SET,168,0.01115,0.0010617,0.071191,0.43778,MEBARKI_HCC_PROGENITOR_WNT_UP,0.99999
GOBP_AORTIC_VALVE_MORPHOGENE...,SET,39,0.023161,0.0010664,0.14794,0.4378,GOBP_AORTIC_VALVE_MORPHOGENESIS,0.99999
GOBP_RIBOSOMAL_LARGE_SUBUNIT...1,SET,19,0.029022,0.00093318,0.18538,0.4378,GOBP_RIBOSOMAL_LARGE_SUBUNIT_ASSEMBLY,0.99999
REACTOME_RESPONSE_OF_MTB_TO_...,SET,21,0.027802,0.00093978,0.17762,0.43781,REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS,0.99999
GSE21033_3H_VS_24H_POLYIC_ST...2,SET,148,0.011101,0.00099275,0.070935,0.43782,GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP,0.99999
HP_MALE_PSEUDOHERMAPHRODITISM,SET,36,0.021651,0.00095785,0.13854,0.43791,HP_MALE_PSEUDOHERMAPHRODITISM,0.99999
PID_TRAIL_PATHWAY,SET,27,0.026518,0.0010162,0.16977,0.43794,PID_TRAIL_PATHWAY,0.99999
WP_SOMATROPH_AXIS_GH_AND_ITS...,SET,6,0.054687,0.0009885,0.35045,0.438,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,0.99999
CHESLER_BRAIN_D6MIT150_QTL_C...,SET,3,0.079508,0.0010163,0.50964,0.43801,CHESLER_BRAIN_D6MIT150_QTL_CIS,0.99999
GSE2197_CPG_DNA_VS_UNTREATED...1,SET,175,0.010081,0.0009796,0.064653,0.43804,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN,0.99999
GOBP_STEROID_METABOLIC_PROCE...,SET,299,0.0081414,0.0010305,0.052213,0.43805,GOBP_STEROID_METABOLIC_PROCESS,0.99999
MIR512_5P,SET,49,0.018945,0.00097748,0.12167,0.43813,MIR512_5P,0.99999
HUPER_BREAST_BASAL_VS_LUMINA...1,SET,54,0.020783,0.0011255,0.13353,0.43816,HUPER_BREAST_BASAL_VS_LUMINAL_DN,0.99999
HP_PANCREATIC_HYPOPLASIA,SET,24,0.029138,0.0010529,0.18729,0.43818,HP_PANCREATIC_HYPOPLASIA,0.99999
REACTOME_NOD1_2_SIGNALING_PA...,SET,32,0.022996,0.00095926,0.14784,0.4382,REACTOME_NOD1_2_SIGNALING_PATHWAY,0.99999
MIR4252,SET,86,0.01448,0.00098876,0.093144,0.43823,MIR4252,0.99999
GOBP_SPLICEOSOMAL_TRI_SNRNP_...,SET,15,0.02969,0.00084832,0.19098,0.43823,GOBP_SPLICEOSOMAL_TRI_SNRNP_COMPLEX_ASSEMBLY,0.99999
GOBP_CATECHOLAMINE_TRANSPORT,SET,61,0.018032,0.0010377,0.11608,0.43827,GOBP_CATECHOLAMINE_TRANSPORT,0.99999
DACOSTA_LOW_DOSE_UV_RESPONSE...1,SET,8,0.0466,0.00097257,0.3,0.43828,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...420,SET,22,0.029038,0.0010046,0.18702,0.43831,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,0.99999
GOBP_REGULATION_OF_PROSTATIC...,SET,5,0.072136,0.0011903,0.46479,0.43833,GOBP_REGULATION_OF_PROSTATIC_BUD_FORMATION,0.99999
GSE2405_HEAT_KILLED_VS_LIVE_...2,SET,174,0.010335,0.0010014,0.066595,0.43833,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,0.99999
GSE37301_MULTIPOTENT_PROGENI...9,SET,162,0.010908,0.0010202,0.070303,0.43835,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_DN,0.99999
GOCC_CLATHRIN_VESICLE_COAT,SET,32,0.02335,0.00097404,0.15051,0.43836,GOCC_CLATHRIN_VESICLE_COAT,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...7,SET,27,0.028498,0.0010921,0.18387,0.43841,BOYAULT_LIVER_CANCER_SUBCLASS_G2,0.99999
HP_ADENOMATOUS_COLONIC_POLYP...,SET,17,0.028024,0.00085241,0.18079,0.43841,HP_ADENOMATOUS_COLONIC_POLYPOSIS,0.99999
HP_CENTRAL_ADRENAL_INSUFFICI...,SET,18,0.030438,0.00095263,0.19644,0.43843,HP_CENTRAL_ADRENAL_INSUFFICIENCY,0.99999
GOMF_CAMP_RESPONSE_ELEMENT_B...2,SET,8,0.047203,0.00098516,0.30468,0.43844,GOMF_CAMP_RESPONSE_ELEMENT_BINDING_PROTEIN_BINDING,0.99999
GOBP_MANCHETTE_ASSEMBLY,SET,8,0.043951,0.00091729,0.28373,0.43845,GOBP_MANCHETTE_ASSEMBLY,0.99999
HP_PRURITUS,SET,140,0.011424,0.00099382,0.07375,0.43845,HP_PRURITUS,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...8,SET,7,0.054539,0.0010648,0.35289,0.43859,GOMF_STRUCTURAL_CONSTITUENT_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.99999
GNF2_FEN1,SET,54,0.016414,0.00088889,0.10626,0.43862,GNF2_FEN1,0.99999
GOBP_REGULATION_OF_MODIFICAT...2,SET,9,0.041332,0.00091494,0.26763,0.43863,GOBP_REGULATION_OF_MODIFICATION_OF_POSTSYNAPTIC_STRUCTURE,0.99999
GSE46606_IRF4HIGH_VS_WT_CD40...2,SET,177,0.0095429,0.0009325,0.061813,0.43865,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.99999
FOXQ1_TARGET_GENES,SET,34,0.024764,0.0010647,0.16055,0.43871,FOXQ1_TARGET_GENES,0.99999
GOMF_BETA_GLUCOSIDASE_ACTIVI...,SET,5,0.059962,0.00098944,0.38875,0.43871,GOMF_BETA_GLUCOSIDASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...141,SET,5,0.06074,0.0010023,0.39416,0.43877,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.99999
GOCC_POSTSYNAPTIC_MEMBRANE,SET,257,0.0089411,0.0010505,0.058025,0.43877,GOCC_POSTSYNAPTIC_MEMBRANE,0.99999
GOCC_PLASMA_MEMBRANE_SIGNALI...,SET,180,0.010416,0.0010263,0.067663,0.43883,GOCC_PLASMA_MEMBRANE_SIGNALING_RECEPTOR_COMPLEX,0.99999
KAYO_AGING_MUSCLE_UP,SET,208,0.0090325,0.00095599,0.05871,0.43886,KAYO_AGING_MUSCLE_UP,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...6,SET,47,0.018395,0.00092957,0.11968,0.43892,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_HEAT_SHOCK,0.99999
GSE7509_UNSTIM_VS_FCGRIIB_ST...2,SET,167,0.010085,0.00095752,0.0657,0.439,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP,0.99999
GOBP_CELL_CYCLE_G2_M_PHASE_T...,SET,139,0.011022,0.00095544,0.071812,0.43901,GOBP_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.99999
GSE12963_UNINF_VS_ENV_AND_NE...3,SET,129,0.011709,0.00097807,0.076331,0.43904,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.99999
GOBP_ACETYL_COA_METABOLIC_PR...,SET,30,0.022735,0.00091832,0.14833,0.43909,GOBP_ACETYL_COA_METABOLIC_PROCESS,0.99999
HP_TENTED_UPPER_LIP_VERMILION,SET,101,0.012714,0.00094045,0.082962,0.4391,HP_TENTED_UPPER_LIP_VERMILION,0.99999
HP_MITRAL_ATRESIA,SET,11,0.044613,0.0010917,0.29118,0.43912,HP_MITRAL_ATRESIA,0.99999
GOBP_NUCLEOLAR_CHROMATIN_ORG...,SET,8,0.042439,0.00088573,0.27705,0.43913,GOBP_NUCLEOLAR_CHROMATIN_ORGANIZATION,0.99999
WIERENGA_STAT5A_TARGETS_DN,SET,175,0.010472,0.0010176,0.068467,0.43922,WIERENGA_STAT5A_TARGETS_DN,0.99999
BLANCO_MELO_COVID19_SARS_COV...11,SET,159,0.0097346,0.00090202,0.063682,0.43925,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN,0.99999
HU_ANGIOGENESIS_UP,SET,20,0.030928,0.0010203,0.20229,0.43925,HU_ANGIOGENESIS_UP,0.99999
chr4q33,SET,5,0.084819,0.0013996,0.55517,0.43929,chr4q33,0.99999
GSE9239_CTRL_VS_TNF_INHIBITO...1,SET,177,0.0094204,0.00092053,0.061681,0.43931,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN,0.99999
HARALAMBIEVA_PBMC_TIV_AGE_50...1,SET,19,0.030565,0.0009828,0.20017,0.43932,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_28DY_NEGATIVE,0.99999
BIOCARTA_MYOSIN_PATHWAY,SET,11,0.047881,0.0011717,0.31363,0.43933,BIOCARTA_MYOSIN_PATHWAY,0.99999
GNF2_RAB7L1,SET,31,0.022957,0.00094256,0.15042,0.43935,GNF2_RAB7L1,0.99999
GSE17721_LPS_VS_POLYIC_1H_BM...2,SET,177,0.01001,0.00097812,0.065617,0.43938,GSE17721_LPS_VS_POLYIC_1H_BMDC_UP,0.99999
GOMF_GLUTAMATE_BINDING,SET,8,0.052767,0.0011013,0.34626,0.43944,GOMF_GLUTAMATE_BINDING,0.99999
GSE8685_IL2_STARVED_VS_IL21_...2,SET,182,0.0095926,0.00095037,0.063016,0.43951,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,0.99999
REACTOME_ATORVASTATIN_ADME,SET,9,0.047077,0.0010421,0.30931,0.43952,REACTOME_ATORVASTATIN_ADME,0.99999
GSE19888_ADENOSINE_A3R_INH_V...2,SET,173,0.0095925,0.0009268,0.063038,0.43953,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_UP,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...2,SET,102,0.01343,0.00099831,0.088271,0.43954,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,0.99999
TAVAZOIE_METASTASIS,SET,87,0.014271,0.00098011,0.093862,0.43958,TAVAZOIE_METASTASIS,0.99999
GOBP_ACTIN_FILAMENT_ORGANIZA...,SET,412,0.0066031,0.00097804,0.043447,0.4396,GOBP_ACTIN_FILAMENT_ORGANIZATION,0.99999
HP_OBSTRUCTIVE_AZOOSPERMIA,SET,27,0.023001,0.00088146,0.15157,0.43969,HP_OBSTRUCTIVE_AZOOSPERMIA,0.99999
KEGG_MEDICUS_REFERENCE_EGF_J...,SET,7,0.063177,0.0012334,0.41711,0.43981,KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY,0.99999
WEI_MIR34A_TARGETS,SET,136,0.011465,0.00098315,0.075754,0.43985,WEI_MIR34A_TARGETS,0.99999
MIR4680_5P,SET,58,0.016621,0.00093276,0.10983,0.43986,MIR4680_5P,0.99999
GOMF_SULFATE_TRANSMEMBRANE_T...,SET,15,0.033551,0.00095864,0.2219,0.43991,GOMF_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
BIOCARTA_TNFR2_PATHWAY,SET,15,0.032819,0.00093774,0.21708,0.43992,BIOCARTA_TNFR2_PATHWAY,0.99999
MIR4446_3P,SET,56,0.016666,0.00091908,0.11025,0.43992,MIR4446_3P,0.99999
GOBP_GTP_BIOSYNTHETIC_PROCESS,SET,10,0.042589,0.00099372,0.28187,0.43995,GOBP_GTP_BIOSYNTHETIC_PROCESS,0.99999
PID_CDC42_PATHWAY,SET,68,0.016018,0.0009731,0.10604,0.43997,PID_CDC42_PATHWAY,0.99999
GOBP_REGULATION_OF_REGULATOR...,SET,15,0.033165,0.00094763,0.21959,0.43997,GOBP_REGULATION_OF_REGULATORY_NCRNA_PROCESSING,0.99999
HP_LOWER_LIMB_MUSCLE_WEAKNESS,SET,196,0.0092288,0.00094849,0.061124,0.43999,HP_LOWER_LIMB_MUSCLE_WEAKNESS,0.99999
MIR4768_5P,SET,302,0.0076494,0.00097301,0.050679,0.44001,MIR4768_5P,0.99999
MEDINA_SMARCA4_TARGETS,SET,35,0.021772,0.00094976,0.14425,0.44002,MEDINA_SMARCA4_TARGETS,0.99999
GOBP_NADH_METABOLIC_PROCESS,SET,28,0.022647,0.00088377,0.15006,0.44002,GOBP_NADH_METABOLIC_PROCESS,0.99999
WANG_ESOPHAGUS_CANCER_VS_NOR...2,SET,114,0.012778,0.0010038,0.084808,0.44012,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,0.99999
MODULE_146,SET,96,0.014126,0.0010188,0.09375,0.44012,MODULE_146,0.99999
GSE26290_CTRL_VS_AKT_INHIBIT...1,SET,181,0.0098778,0.00097597,0.065573,0.44013,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,0.99999
GOBP_REGULATION_OF_IMMUNE_RE...,SET,833,0.0046632,0.00097053,0.030961,0.44014,GOBP_REGULATION_OF_IMMUNE_RESPONSE,0.99999
GOMF_CDP_ALCOHOL_PHOSPHATIDY...,SET,7,0.04429,0.00086468,0.29412,0.44015,GOMF_CDP_ALCOHOL_PHOSPHATIDYLTRANSFERASE_ACTIVITY,0.99999
KRAS.LUNG_UP.V1_DN,SET,128,0.011712,0.00097457,0.077813,0.44018,KRAS.LUNG_UP.V1_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...661,SET,17,0.033335,0.001014,0.22154,0.4402,GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,0.99999
GSE14699_DELETIONAL_TOLERANC...2,SET,169,0.0099789,0.00095303,0.066347,0.44022,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.99999
HP_ABNORMALITY_OF_BLOOD_CIRC...,SET,333,0.0072702,0.00097024,0.048379,0.44027,HP_ABNORMALITY_OF_BLOOD_CIRCULATION,0.99999
HP_EEG_WITH_ABNORMALLY_SLOW_...,SET,86,0.013863,0.00094661,0.092289,0.4403,HP_EEG_WITH_ABNORMALLY_SLOW_FREQUENCIES,0.99999
HP_ABNORMALITY_OF_VITAMIN_D_...,SET,45,0.018845,0.00093189,0.12578,0.44045,HP_ABNORMALITY_OF_VITAMIN_D_METABOLISM,0.99999
WANG_CLIM2_TARGETS_DN,SET,162,0.0094957,0.00088807,0.063398,0.44047,WANG_CLIM2_TARGETS_DN,0.99999
HP_CENTRAL_SCOTOMA,SET,36,0.021847,0.0009665,0.14587,0.44047,HP_CENTRAL_SCOTOMA,0.99999
TDRD3_TARGET_GENES,SET,3,0.069622,0.00088994,0.46488,0.44048,TDRD3_TARGET_GENES,0.99999
CREB3L2_TARGET_GENES,SET,115,0.012394,0.00097786,0.082802,0.44051,CREB3L2_TARGET_GENES,0.99999
GOMF_POLYPEPTIDE_N_ACETYLGAL...,SET,17,0.035575,0.0010821,0.23769,0.44051,GOMF_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,0.99999
BIOCARTA_IL5_PATHWAY,SET,9,0.044933,0.00099465,0.30036,0.44054,BIOCARTA_IL5_PATHWAY,0.99999
REACTOME_PI_3K_CASCADE_FGFR3,SET,17,0.031376,0.00095434,0.20973,0.44054,REACTOME_PI_3K_CASCADE_FGFR3,0.99999
REACTOME_RRNA_MODIFICATION_I...1,SET,4,0.050875,0.00075089,0.34045,0.44061,REACTOME_RRNA_MODIFICATION_IN_THE_MITOCHONDRION,0.99999
GOBP_MIGRACYTOSIS,SET,5,0.059063,0.00097461,0.39662,0.44081,GOBP_MIGRACYTOSIS,0.99999
SCHERER_PBMC_APSV_WETVAX_AGE...9,SET,55,0.018919,0.001034,0.12716,0.44086,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,0.99999
SCHERER_PBMC_YF_VAX_AGE_18_4...5,SET,55,0.018919,0.001034,0.12716,0.44086,SCHERER_PBMC_YF_VAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,0.99999
GOBP_REGULATION_OF_CIRCADIAN...1,SET,105,0.01284,0.00096829,0.086308,0.44087,GOBP_REGULATION_OF_CIRCADIAN_RHYTHM,0.99999
GOBP_REGULATION_OF_NUCLEASE_...,SET,21,0.028813,0.00097395,0.19381,0.44091,GOBP_REGULATION_OF_NUCLEASE_ACTIVITY,0.99999
HP_RIGHT_VENTRICULAR_DILATAT...,SET,17,0.034037,0.0010353,0.2292,0.44097,HP_RIGHT_VENTRICULAR_DILATATION,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...8,SET,184,0.0095834,0.00095462,0.064545,0.44098,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP,0.99999
GOBP_REGULATION_OF_RAB_PROTE...,SET,7,0.044933,0.00087725,0.3027,0.441,GOBP_REGULATION_OF_RAB_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_MID...1,SET,14,0.038067,0.0010508,0.25671,0.44106,HE_LIM_SUN_FETAL_LUNG_C1_MID_AIRWAY_PROGENITOR_CELL,0.99999
HP_ABNORMAL_BLOOD_ION_CONCEN...,SET,321,0.0073321,0.00096103,0.049463,0.44108,HP_ABNORMAL_BLOOD_ION_CONCENTRATION,0.99999
HP_ABNORMAL_EOSINOPHIL_MORPH...,SET,65,0.016391,0.0009736,0.11062,0.4411,HP_ABNORMAL_EOSINOPHIL_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...434,SET,15,0.03189,0.0009112,0.21526,0.44111,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,0.99999
GOBP_METAPHASE_CHROMOSOME_AL...,SET,96,0.012406,0.00089477,0.083788,0.44115,GOBP_METAPHASE_CHROMOSOME_ALIGNMENT,0.99999
GOBP_REGULATION_OF_PROTEIN_L...4,SET,38,0.019855,0.00090242,0.13411,0.44115,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,0.99999
GOBP_REGULATION_OF_APOPTOTIC...1,SET,8,0.045145,0.00094222,0.30517,0.4412,GOBP_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...4,SET,184,0.009616,0.00095786,0.065077,0.44127,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_UP,0.99999
GAUCHER_PBMC_YF_VAX_STAMARIL...5,SET,12,0.034834,0.0008903,0.23576,0.44127,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_DN,0.99999
GSE17721_POLYIC_VS_CPG_1H_BM...1,SET,183,0.0093894,0.00093277,0.063558,0.44128,GSE17721_POLYIC_VS_CPG_1H_BMDC_DN,0.99999
GOMF_FATTY_ACID_TRANSMEMBRAN...,SET,18,0.029351,0.00091861,0.19873,0.44129,GOMF_FATTY_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
KORKOLA_EMBRYONIC_CARCINOMA_...1,SET,19,0.029929,0.00096235,0.20267,0.4413,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN,0.99999
HP_ABNORMAL_PULMONARY_THORAC...,SET,131,0.011575,0.00097432,0.078395,0.44131,HP_ABNORMAL_PULMONARY_THORACIC_IMAGING_FINDING,0.99999
HP_2_4_FINGER_SYNDACTYLY,SET,4,0.058786,0.00086764,0.39826,0.44133,HP_2_4_FINGER_SYNDACTYLY,0.99999
GOBP_COMMA_SHAPED_BODY_MORPH...,SET,5,0.070487,0.0011631,0.47764,0.44134,GOBP_COMMA_SHAPED_BODY_MORPHOGENESIS,0.99999
GOLUB_ALL_VS_AML_DN,SET,22,0.028867,0.00099871,0.19564,0.44135,GOLUB_ALL_VS_AML_DN,0.99999
WP_NETRINUNC5B_SIGNALING,SET,48,0.018743,0.00095716,0.12704,0.44135,WP_NETRINUNC5B_SIGNALING,0.99999
GOMF_MITOCHONDRION_TARGETING...,SET,5,0.048743,0.00080431,0.3304,0.44136,GOMF_MITOCHONDRION_TARGETING_SEQUENCE_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...452,SET,8,0.054587,0.0011393,0.37021,0.44139,GOBP_POSITIVE_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION,0.99999
GOCC_RIBBON_SYNAPSE,SET,15,0.034341,0.00098122,0.23305,0.44143,GOCC_RIBBON_SYNAPSE,0.99999
WP_ACUTE_VIRAL_MYOCARDITIS,SET,82,0.014731,0.00098233,0.10001,0.44145,WP_ACUTE_VIRAL_MYOCARDITIS,0.99999
LI_ESTROGENE_BIDIRECTIONAL_E...,SET,85,0.015191,0.0010313,0.10331,0.44155,LI_ESTROGENE_BIDIRECTIONAL_E2_RESPONSE,0.99999
GOBP_CELL_FATE_COMMITMENT_IN...1,SET,31,0.023653,0.00097116,0.16085,0.44155,GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_FORMATION_OF_PRIMARY_GERM_LAYER,0.99999
GOBP_RESPONSE_TO_IRON_ION,SET,27,0.025066,0.00096057,0.17049,0.44156,GOBP_RESPONSE_TO_IRON_ION,0.99999
GOMF_BETA_TUBULIN_BINDING,SET,35,0.020604,0.00089878,0.14015,0.44156,GOMF_BETA_TUBULIN_BINDING,0.99999
GOBP_REGULATION_OF_LYMPHOCYT...2,SET,55,0.017275,0.00094414,0.11759,0.4416,GOBP_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.99999
GOBP_S_ADENOSYLMETHIONINE_CY...,SET,7,0.049879,0.0009738,0.3397,0.44163,GOBP_S_ADENOSYLMETHIONINE_CYCLE,0.99999
chr2q14,SET,65,0.027556,0.0016368,0.18768,0.44164,chr2q14,0.99999
WP_NITRIC_OXIDE_METABOLISM_I...,SET,13,0.03619,0.00096271,0.24649,0.44164,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,0.99999
GSE13229_IMM_VS_INTMATURE_NK...1,SET,176,0.0091132,0.00088802,0.062127,0.44169,GSE13229_IMM_VS_INTMATURE_NKCELL_DN,0.99999
MORF_PRKCA,SET,154,0.010433,0.00095154,0.071227,0.44177,MORF_PRKCA,0.99999
HP_PULMONARY_ARTERY_ATRESIA,SET,29,0.023835,0.00094658,0.16283,0.44181,HP_PULMONARY_ARTERY_ATRESIA,0.99999
MIR6718_5P,SET,63,0.015815,0.00092489,0.10806,0.44182,MIR6718_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...30,SET,5,0.066505,0.0010974,0.45438,0.44182,GOBP_NEGATIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.99999
GSE37301_COMMON_LYMPHOID_PRO...1,SET,181,0.0090071,0.00088994,0.061587,0.44186,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN,0.99999
GSE8921_UNSTIM_0H_VS_TLR1_2_...4,SET,171,0.0097981,0.00094123,0.066993,0.44186,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP,0.99999
GOBP_TACHYKININ_RECEPTOR_SIG...,SET,7,0.045732,0.00089284,0.31272,0.44187,GOBP_TACHYKININ_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...257,SET,29,0.023818,0.00094591,0.1629,0.44188,GOBP_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,0.99999
HP_ABSENT_HAND,SET,17,0.032053,0.00097496,0.21945,0.44194,HP_ABSENT_HAND,0.99999
MIR520A_5P,SET,146,0.010151,0.00090161,0.069525,0.44196,MIR520A_5P,0.99999
GSE11864_UNTREATED_VS_CSF1_I...1,SET,172,0.0092273,0.00088896,0.063226,0.44198,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN,0.99999
HP_OCCIPITAL_MENINGOCELE,SET,7,0.050959,0.00099489,0.34919,0.44199,HP_OCCIPITAL_MENINGOCELE,0.99999
HP_ABNORMAL_URINARY_PURINE_L...,SET,7,0.055594,0.0010854,0.38106,0.442,HP_ABNORMAL_URINARY_PURINE_LEVEL,0.99999
HP_ACUTE_PHASE_RESPONSE,SET,168,0.0099558,0.00094803,0.068455,0.44218,HP_ACUTE_PHASE_RESPONSE,0.99999
HP_CEREBELLAR_ATROPHY,SET,393,0.0059506,0.00086129,0.040918,0.44219,HP_CEREBELLAR_ATROPHY,0.99999
HP_ABNORMALITY_OF_SPINAL_FAC...,SET,5,0.059807,0.00098688,0.41132,0.4422,HP_ABNORMALITY_OF_SPINAL_FACET_JOINT,0.99999
GOBP_INTERLEUKIN_4_PRODUCTION,SET,29,0.025158,0.0009991,0.1731,0.44222,GOBP_INTERLEUKIN_4_PRODUCTION,0.99999
HP_INCREASED_HEPATIC_ECHOGEN...,SET,5,0.057049,0.00094137,0.39249,0.44222,HP_INCREASED_HEPATIC_ECHOGENICITY,0.99999
GOBP_CARDIAC_SEPTUM_DEVELOPM...,SET,104,0.013111,0.00098404,0.090255,0.44225,GOBP_CARDIAC_SEPTUM_DEVELOPMENT,0.99999
GSE32255_WT_UNSTIM_VS_JMJD2D...1,SET,155,0.0098319,0.0008996,0.067727,0.44229,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,0.99999
GOBP_TETRAPYRROLE_BIOSYNTHET...,SET,29,0.021213,0.00084247,0.14617,0.44231,GOBP_TETRAPYRROLE_BIOSYNTHETIC_PROCESS,0.99999
BURTON_ADIPOGENESIS_11,SET,47,0.017564,0.00088755,0.12112,0.44235,BURTON_ADIPOGENESIS_11,0.99999
GOBP_REGULATION_OF_CELL_CYCLE,SET,997,0.0040001,0.00090653,0.027609,0.4424,GOBP_REGULATION_OF_CELL_CYCLE,0.99999
GOBP_FERMENTATION,SET,3,0.070912,0.00090643,0.48948,0.44241,GOBP_FERMENTATION,0.99999
HP_MADELUNG_DEFORMITY,SET,4,0.060127,0.00088744,0.4152,0.44243,HP_MADELUNG_DEFORMITY,0.99999
BARIS_THYROID_CANCER_UP,SET,23,0.023923,0.00084623,0.16526,0.44245,BARIS_THYROID_CANCER_UP,0.99999
CUI_DEVELOPING_HEART_C3_FIBR...,SET,103,0.013582,0.0010145,0.093906,0.4425,CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL,0.99999
KEGG_MEDICUS_REFERENCE_TLR3_...3,SET,9,0.041516,0.000919,0.28708,0.44251,KEGG_MEDICUS_REFERENCE_TLR3_NFKB_SIGNALING_PATHWAY,0.99999
HP_UPPER_LIMB_HYPERTONIA,SET,9,0.04331,0.00095871,0.29951,0.44251,HP_UPPER_LIMB_HYPERTONIA,0.99999
GSE15930_NAIVE_VS_48H_IN_VIT...6,SET,187,0.0091098,0.00091474,0.063001,0.44252,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,0.99999
GSE24142_DN2_VS_DN3_THYMOCYT...4,SET,184,0.0092844,0.00092483,0.064294,0.44259,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN,0.99999
GOBP_SOMATIC_MOTOR_NEURON_DI...,SET,5,0.056349,0.00092983,0.39044,0.44262,GOBP_SOMATIC_MOTOR_NEURON_DIFFERENTIATION,0.99999
CHO_NR4A1_TARGETS,SET,29,0.02506,0.00099522,0.17371,0.44265,CHO_NR4A1_TARGETS,0.99999
GSE21670_TGFB_VS_IL6_TREATED...3,SET,185,0.0093227,0.00093115,0.064639,0.44266,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.99999
chr17q24,SET,32,0.036681,0.0015301,0.2548,0.44277,chr17q24,0.99999
GOBP_CORPUS_CALLOSUM_MORPHOG...,SET,5,0.05131,0.00084668,0.35647,0.44277,GOBP_CORPUS_CALLOSUM_MORPHOGENESIS,0.99999
MIR6788_3P,SET,3,0.067955,0.00086863,0.4725,0.44282,MIR6788_3P,0.99999
GOBP_COGNITION,SET,290,0.0075246,0.00093824,0.052319,0.44282,GOBP_COGNITION,0.99999
GOCC_CYTOSOLIC_PROTEASOME_CO...,SET,5,0.042556,0.00070223,0.29588,0.44282,GOCC_CYTOSOLIC_PROTEASOME_COMPLEX,0.99999
VALK_AML_CLUSTER_3,SET,27,0.024212,0.00092786,0.16846,0.44286,VALK_AML_CLUSTER_3,0.99999
GOBP_NEGATIVE_REGULATION_OF_...175,SET,6,0.058553,0.0010584,0.40766,0.4429,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,0.99999
KEGG_INOSITOL_PHOSPHATE_META...,SET,52,0.016546,0.00087938,0.11525,0.44292,KEGG_INOSITOL_PHOSPHATE_METABOLISM,0.99999
GSE9509_LPS_VS_LPS_AND_IL10_...4,SET,168,0.0098944,0.00094219,0.068932,0.44293,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP,0.99999
HP_ABNORMALITY_OF_THE_EPIPHY...3,SET,5,0.057275,0.00094509,0.39908,0.44294,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,0.99999
GOBP_NUCLEOTIDE_EXCISION_REP...1,SET,80,0.011961,0.00078787,0.083362,0.44295,GOBP_NUCLEOTIDE_EXCISION_REPAIR,0.99999
LI_PBMC_ZOSTAVAX_AGE_25_40_A...1,SET,7,0.038394,0.00074957,0.26771,0.44298,LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_79YO_1DY_UP,0.99999
HP_BRONCHIECTASIS,SET,154,0.0099994,0.000912,0.069776,0.44302,HP_BRONCHIECTASIS,0.99999
HP_ABNORMAL_MEAN_CORPUSCULAR...2,SET,55,0.015332,0.00083794,0.10701,0.44304,HP_ABNORMAL_MEAN_CORPUSCULAR_VOLUME,0.99999
GOBP_REGULATION_OF_DENDRITIC...5,SET,11,0.040073,0.00098063,0.27976,0.44305,GOBP_REGULATION_OF_DENDRITIC_SPINE_MAINTENANCE,0.99999
GOBP_CELL_MORPHOGENESIS,SET,895,0.004343,0.00093528,0.030327,0.44306,GOBP_CELL_MORPHOGENESIS,0.99999
MYOD_Q6_01,SET,237,0.0079836,0.00090123,0.055752,0.44307,MYOD_Q6_01,0.99999
GOBP_CELLULAR_RESPONSE_TO_OX...1,SET,225,0.0082247,0.00090494,0.057474,0.44311,GOBP_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,0.99999
KEGG_DILATED_CARDIOMYOPATHY,SET,85,0.014156,0.00096104,0.099015,0.44316,KEGG_DILATED_CARDIOMYOPATHY,0.99999
GOCC_STEREOCILIUM_BASE,SET,7,0.046226,0.00090249,0.32352,0.44319,GOCC_STEREOCILIUM_BASE,0.99999
MIR6731_3P,SET,68,0.014755,0.00089636,0.10334,0.44323,MIR6731_3P,0.99999
HP_INTRACELLULAR_ACCUMULATIO...,SET,13,0.032876,0.00087454,0.23047,0.44329,HP_INTRACELLULAR_ACCUMULATION_OF_AUTOFLUORESCENT_LIPOPIGMENT_STORAGE_MATERIAL,0.99999
GOBP_NEGATIVE_REGULATION_OF_...103,SET,272,0.0077836,0.00094039,0.054577,0.4433,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION,0.99999
MIR302A_3P_MIR302B_3P_MIR302...,SET,323,0.006865,0.00090256,0.048154,0.44332,MIR302A_3P_MIR302B_3P_MIR302C_3P_MIR302D_3P,0.99999
REACTOME_TRANSCRIPTION_OF_E2...1,SET,19,0.024729,0.00079515,0.17367,0.44338,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX,0.99999
NOTCH_DN.V1_UP,SET,157,0.010005,0.00092126,0.070278,0.4434,NOTCH_DN.V1_UP,0.99999
MIR3612,SET,110,0.01141,0.00088061,0.080175,0.44341,MIR3612,0.99999
ZNF589_TARGET_GENES,SET,509,0.0054097,0.0008882,0.038041,0.44346,ZNF589_TARGET_GENES,0.99999
GSE21379_WT_VS_SAP_KO_TFH_CD...2,SET,175,0.0094882,0.00092195,0.066727,0.44346,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP,0.99999
GOBP_CYTOSKELETON_DEPENDENT_...2,SET,180,0.0089665,0.0008835,0.063123,0.44352,GOBP_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT,0.99999
BUCASAS_PBMC_FLUARIX_FLUVIRI...1,SET,6,0.049943,0.00090274,0.35237,0.44365,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_3DY_POSITIVE_PREDICTIVE_OF_TITER,0.99999
STAMBOLSKY_RESPONSE_TO_VITAM...1,SET,22,0.02654,0.00091821,0.18735,0.44367,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN,0.99999
GOBP_REGULATION_OF_CELLULAR_...18,SET,137,0.010676,0.00091885,0.075357,0.44367,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,0.99999
HP_ABSENT_STERNAL_OSSIFICATI...,SET,5,0.045073,0.00074376,0.31855,0.44374,HP_ABSENT_STERNAL_OSSIFICATION,0.99999
GSE2706_2H_VS_8H_R848_AND_LP...2,SET,174,0.0088773,0.00086016,0.062753,0.44375,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP,0.99999
chr3q27,SET,60,0.032479,0.0018538,0.22971,0.44378,chr3q27,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...1,SET,44,0.018275,0.00089363,0.12927,0.44379,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CELL_CYCLE,0.99999
GOCC_RNA_POLYMERASE_II_TRANS...1,SET,233,0.0076104,0.00085192,0.053903,0.44386,GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATOR_COMPLEX,0.99999
GSE37533_PPARG1_FOXP3_VS_PPA...4,SET,164,0.0091348,0.00085953,0.06473,0.44389,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP,0.99999
GOMF_PHOSPHOPROTEIN_PHOSPHAT...,SET,159,0.0091235,0.00084539,0.064663,0.4439,GOMF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,0.99999
GOMF_TRANSFORMING_GROWTH_FAC...3,SET,5,0.061914,0.0010217,0.43881,0.4439,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_ACTIVITY_TYPE_I,0.99999
YBX1_TARGET_GENES,SET,57,0.015287,0.00085051,0.10839,0.44392,YBX1_TARGET_GENES,0.99999
GSE29618_PRE_VS_DAY7_FLU_VAC...7,SET,177,0.0084608,0.00082677,0.060062,0.44399,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN,0.99999
MIR6506_5P,SET,93,0.012802,0.00090886,0.090892,0.444,MIR6506_5P,0.99999
TRAVAGLINI_LUNG_NEUTROPHIL_C...,SET,293,0.0070728,0.00088637,0.050218,0.444,TRAVAGLINI_LUNG_NEUTROPHIL_CELL,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...13,SET,176,0.0085843,0.00083649,0.061034,0.44407,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_DN,0.99999
GOBP_VENTRICULAR_TRABECULA_M...,SET,14,0.03763,0.0010388,0.26755,0.44408,GOBP_VENTRICULAR_TRABECULA_MYOCARDIUM_MORPHOGENESIS,0.99999
GOMF_ATP_ADP_ANTIPORTER_ACTI...,SET,3,0.065683,0.00083959,0.46772,0.44416,GOMF_ATP_ADP_ANTIPORTER_ACTIVITY,0.99999
MORF_PRKAG1,SET,203,0.0079803,0.00083453,0.056918,0.44425,MORF_PRKAG1,0.99999
HP_ABNORMAL_CIRCULATING_FREE...2,SET,7,0.040456,0.00078983,0.28855,0.44425,HP_ABNORMAL_CIRCULATING_FREE_T3_CONCENTRATION,0.99999
GOBP_THYROID_HORMONE_METABOL...,SET,28,0.024378,0.00095132,0.17391,0.44426,GOBP_THYROID_HORMONE_METABOLIC_PROCESS,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...13,SET,181,0.0090544,0.00089461,0.064598,0.44427,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_DN,0.99999
GSE17721_0.5H_VS_4H_LPS_BMDC...1,SET,184,0.0089352,0.00089005,0.063782,0.4443,GSE17721_0.5H_VS_4H_LPS_BMDC_DN,0.99999
HP_IMPOTENCE,SET,47,0.017536,0.00088617,0.12521,0.44431,HP_IMPOTENCE,0.99999
GOBP_POST_EMBRYONIC_DEVELOPM...,SET,80,0.013472,0.0008874,0.096236,0.44433,GOBP_POST_EMBRYONIC_DEVELOPMENT,0.99999
HP_KELOIDS,SET,9,0.040184,0.00088953,0.28719,0.44436,HP_KELOIDS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...562,SET,114,0.011025,0.00086613,0.078886,0.44442,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,0.99999
HP_NON_PERIODIC_RECURRENT_FE...,SET,11,0.036845,0.00090165,0.26364,0.44443,HP_NON_PERIODIC_RECURRENT_FEVER,0.99999
WP_LDLRAD4_AND_WHAT_WE_KNOW_...,SET,7,0.055089,0.0010755,0.3943,0.44444,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,0.99999
GOMF_P53_BINDING,SET,64,0.014432,0.00085065,0.10336,0.44448,GOMF_P53_BINDING,0.99999
GOMF_G_PROTEIN_COUPLED_CHEMO...,SET,24,0.027895,0.0010079,0.19999,0.44454,GOMF_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...80,SET,18,0.026017,0.00081426,0.1866,0.44456,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.99999
GOBP_EXOCYTIC_PROCESS,SET,75,0.013074,0.00083392,0.093786,0.44457,GOBP_EXOCYTIC_PROCESS,0.99999
GOBP_ACETYL_COA_BIOSYNTHETIC...1,SET,15,0.029201,0.00083437,0.20958,0.4446,GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS,0.99999
GOBP_MATING_BEHAVIOR,SET,36,0.02143,0.00094807,0.15394,0.44464,GOBP_MATING_BEHAVIOR,0.99999
HP_ANKLE_CLONUS,SET,44,0.017694,0.00086518,0.12715,0.44467,HP_ANKLE_CLONUS,0.99999
NOUZOVA_METHYLATED_IN_APL,SET,57,0.017149,0.0009541,0.12338,0.44473,NOUZOVA_METHYLATED_IN_APL,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...24,SET,44,0.019196,0.00093864,0.1381,0.44473,GAVISH_3CA_METAPROGRAM_EPITHELIAL_V_ATPASE,0.99999
BLANCO_MELO_COVID19_SARS_COV...9,SET,14,0.036502,0.0010076,0.26274,0.44475,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,0.99999
MIR18A_5P_MIR18B_5P,SET,117,0.011135,0.00088608,0.08018,0.44478,MIR18A_5P_MIR18B_5P,0.99999
HP_VENTRICULAR_ESCAPE_RHYTHM,SET,8,0.043153,0.00090063,0.31093,0.44481,HP_VENTRICULAR_ESCAPE_RHYTHM,0.99999
GOBP_VESICLE_MEDIATED_TRANSP...1,SET,1409,0.0032857,0.00087464,0.023685,0.44483,GOBP_VESICLE_MEDIATED_TRANSPORT,0.99999
GSE20366_EX_VIVO_VS_DEC205_C...1,SET,182,0.0089099,0.00088274,0.064314,0.44491,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN,0.99999
GOMF_C_PALMITOYLTRANSFERASE_...,SET,5,0.056899,0.0009389,0.41103,0.44495,GOMF_C_PALMITOYLTRANSFERASE_ACTIVITY,0.99999
GOMF_GAMMA_CATENIN_BINDING,SET,12,0.036259,0.00092673,0.26209,0.44498,GOMF_GAMMA_CATENIN_BINDING,0.99999
REACTOME_FATTY_ACID_METABOLI...,SET,167,0.0093742,0.00089001,0.067793,0.44501,REACTOME_FATTY_ACID_METABOLISM,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...11,SET,190,0.0086841,0.00087888,0.062862,0.44506,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN,0.99999
MIR519E_5P,SET,285,0.0070187,0.0008677,0.050842,0.4451,MIR519E_5P,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...28,SET,19,0.030141,0.00096916,0.21865,0.44518,GAVISH_3CA_MALIGNANT_METAPROGRAM_36_IG,0.99999
GOBP_MUSCLE_ORGAN_DEVELOPMENT,SET,328,0.0068482,0.00090717,0.049679,0.44518,GOBP_MUSCLE_ORGAN_DEVELOPMENT,0.99999
GSE2128_C57BL6_VS_NOD_CD4CD8...2,SET,175,0.008931,0.00086781,0.064806,0.4452,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_UP,0.99999
HP_PILOMATRIXOMA,SET,7,0.048373,0.00094439,0.35127,0.44524,HP_PILOMATRIXOMA,0.99999
KEGG_MEDICUS_REFERENCE_TGF_B...,SET,8,0.047744,0.00099646,0.3468,0.44525,KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY,0.99999
HP_DELAYED_GROSS_MOTOR_DEVEL...,SET,410,0.005878,0.00086856,0.042724,0.44529,HP_DELAYED_GROSS_MOTOR_DEVELOPMENT,0.99999
HP_HYPOCALCEMIC_TETANY,SET,7,0.047988,0.00093688,0.34886,0.4453,HP_HYPOCALCEMIC_TETANY,0.99999
GSE25088_IL4_VS_IL4_AND_ROSI...4,SET,177,0.0089944,0.00087891,0.065414,0.44532,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,0.99999
HP_PSEUDOARTHROSIS,SET,8,0.041165,0.00085915,0.29948,0.44534,HP_PSEUDOARTHROSIS,0.99999
HP_TOE_JOINT_CONTRACTURE,SET,27,0.023394,0.00089651,0.17043,0.44541,HP_TOE_JOINT_CONTRACTURE,0.99999
HP_SUDDEN_UNEXPECTED_DEATH_I...,SET,9,0.038815,0.00085921,0.28283,0.44542,HP_SUDDEN_UNEXPECTED_DEATH_IN_EPILEPSY,0.99999
HP_UPPER_LIMB_SPASTICITY,SET,22,0.025129,0.00086938,0.18322,0.44546,HP_UPPER_LIMB_SPASTICITY,0.99999
VANHARANTA_UTERINE_FIBROID_W...1,SET,35,0.021003,0.00091621,0.15331,0.44552,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...807,SET,17,0.029504,0.00089741,0.21539,0.44552,GOBP_POSITIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_STATUS_EPILEPTICUS_WITH_P...,SET,24,0.024092,0.00087052,0.17599,0.44556,HP_STATUS_EPILEPTICUS_WITH_PROMINENT_MOTOR_SYMPTOMS,0.99999
GOMF_AXON_GUIDANCE_RECEPTOR_...,SET,10,0.040918,0.00095475,0.29899,0.44557,GOMF_AXON_GUIDANCE_RECEPTOR_ACTIVITY,0.99999
MIR137_3P,SET,482,0.0056102,0.00089704,0.041005,0.44559,MIR137_3P,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...4,SET,176,0.0079459,0.00077427,0.058197,0.4457,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_UP,0.99999
GOBP_REGULATION_OF_CELLULAR_...11,SET,16,0.028711,0.00084724,0.21034,0.44572,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT,0.99999
GOMF_HISTONE_H3K9ME_H3K9ME2_...,SET,4,0.06163,0.00090962,0.45164,0.44573,GOMF_HISTONE_H3K9ME_H3K9ME2_DEMETHYLASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_LEUKOCYTE...3,SET,83,0.013105,0.00087922,0.096097,0.44576,GOBP_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.99999
GOBP_NEGATIVE_T_CELL_SELECTI...,SET,13,0.036831,0.00097975,0.27073,0.44589,GOBP_NEGATIVE_T_CELL_SELECTION,0.99999
GSE32255_WT_UNSTIM_VS_JMJD2D...2,SET,159,0.0092273,0.00085501,0.067894,0.44595,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,0.99999
GOBP_CATECHOL_CONTAINING_COM...2,SET,5,0.059931,0.00098893,0.44109,0.44596,GOBP_CATECHOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.99999
BREDEMEYER_RAG_SIGNALING_VIA...1,SET,38,0.019011,0.00086403,0.14038,0.44614,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,0.99999
GOBP_KIDNEY_MESENCHYME_DEVEL...,SET,15,0.034796,0.00099422,0.25711,0.44617,GOBP_KIDNEY_MESENCHYME_DEVELOPMENT,0.99999
GOMF_COLLAGEN_BINDING_INVOLV...,SET,4,0.064858,0.00095726,0.48096,0.44637,GOMF_COLLAGEN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION,0.99999
REACTOME_THE_ROLE_OF_NEF_IN_...,SET,27,0.021639,0.00082924,0.16051,0.44638,REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS,0.99999
GOBP_CELLULAR_RESPONSE_TO_CH...1,SET,286,0.0069143,0.00085626,0.051308,0.4464,GOBP_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,0.99999
GSE46242_TH1_VS_ANERGIC_TH1_...4,SET,166,0.00906,0.00085762,0.067254,0.44642,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_UP,0.99999
GOBP_PROTEIN_O_LINKED_GLYCOS...3,SET,10,0.041535,0.00096914,0.30837,0.44643,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION_VIA_THREONINE,0.99999
TCF1P_Q6,SET,238,0.0076155,0.00086148,0.056551,0.44644,TCF1P_Q6,0.99999
JIANG_MELANOMA_TRM1_CD8,SET,152,0.0098411,0.00089176,0.07312,0.44647,JIANG_MELANOMA_TRM1_CD8,0.99999
FIRESTEIN_CTNNB1_PATHWAY_AND...,SET,6,0.044661,0.00080726,0.33201,0.4465,FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION,0.99999
GOBP_T_CELL_LINEAGE_COMMITME...,SET,35,0.020533,0.00089571,0.15269,0.44651,GOBP_T_CELL_LINEAGE_COMMITMENT,0.99999
GSE13306_TREG_VS_TCONV_SPLEE...1,SET,177,0.008874,0.00086714,0.065991,0.44652,GSE13306_TREG_VS_TCONV_SPLEEN_DN,0.99999
FARDIN_HYPOXIA_11,SET,28,0.021551,0.00084101,0.16045,0.44658,FARDIN_HYPOXIA_11,0.99999
MIR188_3P,SET,139,0.0096693,0.00083818,0.072073,0.44664,MIR188_3P,0.99999
GOCC_GOLGI_ASSOCIATED_VESICLE,SET,85,0.011841,0.00080385,0.088256,0.44664,GOCC_GOLGI_ASSOCIATED_VESICLE,0.99999
GOBP_MONOSACCHARIDE_BIOSYNTH...,SET,79,0.012363,0.00080926,0.092165,0.44665,GOBP_MONOSACCHARIDE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_GLYCOGEN_...1,SET,25,0.023294,0.00085902,0.17374,0.44667,GOBP_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS,0.99999
GOBP_PYROPTOSIS,SET,33,0.02031,0.00086031,0.15165,0.44673,GOBP_PYROPTOSIS,0.99999
LOPEZ_MESOTELIOMA_SURVIVAL_T...1,SET,7,0.043335,0.00084604,0.3237,0.44675,LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN,0.99999
CHARAFE_BREAST_CANCER_LUMINA...2,SET,340,0.0063769,0.00085976,0.047658,0.44678,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,0.99999
GOMF_INTRACILIARY_TRANSPORT_...,SET,2,0.074953,0.00078229,0.56086,0.44685,GOMF_INTRACILIARY_TRANSPORT_PARTICLE_B_BINDING,0.99999
HP_PAROXYSMAL_SUPRAVENTRICUL...,SET,5,0.056508,0.00093245,0.42302,0.44687,HP_PAROXYSMAL_SUPRAVENTRICULAR_TACHYCARDIA,0.99999
HP_SHORT_MIDDLE_PHALANX_OF_T...1,SET,7,0.043894,0.00085695,0.32861,0.44687,HP_SHORT_MIDDLE_PHALANX_OF_THE_2ND_FINGER,0.99999
UBE2I_TARGET_GENES,SET,70,0.013914,0.00085754,0.10425,0.44692,UBE2I_TARGET_GENES,0.99999
REACTOME_DOWNREGULATION_OF_E...1,SET,12,0.033495,0.00085608,0.25132,0.44699,REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING,0.99999
KEGG_MEDICUS_REFERENCE_ANTIG...2,SET,12,0.03462,0.00088483,0.26021,0.44708,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.99999
REACTOME_SEALING_OF_THE_NUCL...,SET,29,0.020967,0.00083269,0.1576,0.44708,REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III,0.99999
MILICIC_FAMILIAL_ADENOMATOUS...1,SET,9,0.042324,0.0009369,0.31827,0.4471,MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN,0.99999
GOBP_REGULATION_OF_CANONICAL...,SET,233,0.0079555,0.00089055,0.059833,0.44711,GOBP_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,0.99999
NFE2L1_TARGET_GENES,SET,1471,0.00304,0.00082533,0.022887,0.44717,NFE2L1_TARGET_GENES,0.99999
GOMF_MYOSIN_BINDING,SET,69,0.013381,0.00081879,0.10095,0.44728,GOMF_MYOSIN_BINDING,0.99999
GSE42021_CD24HI_VS_CD24INT_T...2,SET,182,0.008409,0.00083311,0.063471,0.4473,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP,0.99999
GSE21063_WT_VS_NFATC1_KO_3H_...2,SET,184,0.0080691,0.00080378,0.060911,0.44731,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_UP,0.99999
GSE360_CTRL_VS_M_TUBERCULOSI...1,SET,183,0.008488,0.00084322,0.064121,0.44734,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN,0.99999
REACTOME_CREATION_OF_C4_AND_...,SET,12,0.039708,0.0010149,0.30026,0.4474,REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS,0.99999
ZNF490_TARGET_GENES,SET,335,0.0061341,0.00082103,0.046397,0.44741,ZNF490_TARGET_GENES,0.99999
MENON_FETAL_KIDNEY_10_IMMUNE...,SET,71,0.013612,0.00084488,0.10299,0.44743,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.99999
GOCC_SCHAFFER_COLLATERAL_CA1...,SET,88,0.012496,0.00086309,0.09458,0.44745,GOCC_SCHAFFER_COLLATERAL_CA1_SYNAPSE,0.99999
REACTOME_SIGNALING_BY_TGFBR3,SET,44,0.017474,0.00085447,0.13229,0.44746,REACTOME_SIGNALING_BY_TGFBR3,0.99999
HP_ABNORMAL_2ND_FINGER_MORPH...,SET,37,0.019152,0.00085895,0.145,0.44746,HP_ABNORMAL_2ND_FINGER_MORPHOLOGY,0.99999
HP_RECURRENT_FRACTURES,SET,124,0.010145,0.00083092,0.076817,0.44747,HP_RECURRENT_FRACTURES,0.99999
WP_PROXIMAL_TUBULE_TRANSPORT,SET,55,0.015904,0.00086923,0.12046,0.44748,WP_PROXIMAL_TUBULE_TRANSPORT,0.99999
GOCC_PLATELET_ALPHA_GRANULE_...2,SET,16,0.031663,0.00093436,0.2398,0.44748,GOCC_PLATELET_ALPHA_GRANULE_MEMBRANE,0.99999
MORF_RAF1,SET,108,0.0098096,0.00075019,0.074365,0.44753,MORF_RAF1,0.99999
PAX5_02,SET,16,0.026339,0.00077724,0.19983,0.44757,PAX5_02,0.99999
GOBP_CARNITINE_METABOLIC_PRO...,SET,11,0.031019,0.00075907,0.23581,0.44767,GOBP_CARNITINE_METABOLIC_PROCESS,0.99999
BHATI_G2M_ARREST_BY_2METHOXY...1,SET,107,0.011137,0.00084776,0.084757,0.44773,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,0.99999
GOBP_ORGANELLE_LOCALIZATION,SET,556,0.0047383,0.00081203,0.036078,0.44776,GOBP_ORGANELLE_LOCALIZATION,0.99999
KEGG_MEDICUS_REFERENCE_AGE_R...,SET,15,0.029145,0.00083275,0.22197,0.44777,KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HR...2,SET,513,0.005327,0.00087797,0.040603,0.44781,MANNO_MIDBRAIN_NEUROTYPES_HRGL2A,0.99999
GOBP_SIGNAL_TRANSDUCTION_IN_...1,SET,66,0.01434,0.00085827,0.10941,0.44786,GOBP_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,0.99999
HP_PATELLAR_HYPOPLASIA,SET,14,0.031304,0.00086413,0.23885,0.44786,HP_PATELLAR_HYPOPLASIA,0.99999
GOBP_PURINE_NUCLEOTIDE_SALVA...,SET,10,0.036257,0.00084598,0.27671,0.44788,GOBP_PURINE_NUCLEOTIDE_SALVAGE,0.99999
HP_UNCOMBABLE_HAIR,SET,4,0.064727,0.00095533,0.49444,0.44792,HP_UNCOMBABLE_HAIR,0.99999
REACTOME_MYD88_INDEPENDENT_T...,SET,103,0.010831,0.00080901,0.0828,0.44796,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,0.99999
GOBP_REGULATION_OF_NMDA_RECE...,SET,14,0.029958,0.00082698,0.22925,0.44802,GOBP_REGULATION_OF_NMDA_RECEPTOR_ACTIVITY,0.99999
GSE21927_SPLEEN_VS_4T1_TUMOR...2,SET,162,0.0089393,0.00083603,0.068467,0.44806,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,0.99999
GOBP_REGULATION_OF_GLUTAMATE...3,SET,19,0.028854,0.00092777,0.22145,0.44817,GOBP_REGULATION_OF_GLUTAMATE_SECRETION,0.99999
MIR12123,SET,429,0.0054366,0.00082132,0.041825,0.44829,MIR12123,0.99999
chr1p13,SET,106,0.021979,0.0016653,0.16929,0.44835,chr1p13,0.99999
DESCARTES_FETAL_HEART_MEGAKA...,SET,80,0.013325,0.00087768,0.10265,0.44836,DESCARTES_FETAL_HEART_MEGAKARYOCYTES,0.99999
MIR6824_5P,SET,73,0.014589,0.00091813,0.11241,0.44837,MIR6824_5P,0.99999
GOBP_RESPONSE_TO_INTERLEUKIN...2,SET,12,0.033706,0.00086147,0.25971,0.44837,GOBP_RESPONSE_TO_INTERLEUKIN_12,0.99999
AIZARANI_LIVER_C32_MVECS_3,SET,121,0.011121,0.0008999,0.085685,0.44837,AIZARANI_LIVER_C32_MVECS_3,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...15,SET,168,0.008031,0.00076475,0.061908,0.44839,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.99999
HP_PROLONGED_BLEEDING_AFTER_...1,SET,21,0.028302,0.00095668,0.2182,0.4484,HP_PROLONGED_BLEEDING_AFTER_DENTAL_EXTRACTION,0.99999
MIR519A_3P_MIR519B_3P,SET,374,0.0056973,0.00080487,0.043942,0.44842,MIR519A_3P_MIR519B_3P,0.99999
GOBP_ANTIGEN_PROCESSING_AND_...4,SET,23,0.025777,0.00091183,0.19905,0.44848,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN,0.99999
KONDO_PROSTATE_CANCER_HCP_WI...,SET,87,0.013117,0.00090085,0.10139,0.44853,KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3,0.99999
NGFIC_01,SET,223,0.007242,0.00079331,0.055991,0.44854,NGFIC_01,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...12,SET,41,0.018769,0.00088602,0.14539,0.44864,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_COMPLEMENT,0.99999
REACTOME_SIGNALING_BY_RHO_GT...,SET,608,0.004491,0.00080366,0.034804,0.44866,REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,0.99999
GOBP_LENS_FIBER_CELL_DIFFERE...,SET,34,0.020364,0.00087557,0.15784,0.44867,GOBP_LENS_FIBER_CELL_DIFFERENTIATION,0.99999
REACTOME_P75NTR_NEGATIVELY_R...,SET,6,0.044889,0.0008114,0.3482,0.44871,REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...6,SET,45,0.01757,0.00086885,0.13632,0.44872,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1,0.99999
FOROUTAN_PRODRANK_TGFB_EMT_DN,SET,76,0.013599,0.00087318,0.10553,0.44873,FOROUTAN_PRODRANK_TGFB_EMT_DN,0.99999
GOBP_FERROPTOSIS,SET,9,0.040123,0.00088816,0.31135,0.44873,GOBP_FERROPTOSIS,0.99999
GOBP_DNA_CYTOSINE_DEAMINATION,SET,8,0.056309,0.0011752,0.43744,0.44879,GOBP_DNA_CYTOSINE_DEAMINATION,0.99999
FOURATI_BLOOD_TWINRIX_AGE_65...1,SET,4,0.063115,0.00093155,0.49049,0.44881,FOURATI_BLOOD_TWINRIX_AGE_65_81Y0_RESPONDERS_VS_POOR_RESPONDERS_TRAINING_SET_0DY_NETWORK_INFERENCE_UP,0.99999
GSE36891_UNSTIM_VS_PAM_TLR2_...2,SET,173,0.0086941,0.00084,0.067577,0.44882,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...46,SET,11,0.029691,0.00072657,0.23108,0.44888,GOBP_POSITIVE_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.99999
MIR6819_3P,SET,32,0.019339,0.00080672,0.15052,0.44889,MIR6819_3P,0.99999
GOBP_DNA_METHYLATION_DEPENDE...,SET,30,0.021234,0.00085767,0.16533,0.44891,GOBP_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,0.99999
GOBP_SIGNAL_PEPTIDE_PROCESSI...,SET,13,0.02989,0.00079512,0.23293,0.44895,GOBP_SIGNAL_PEPTIDE_PROCESSING,0.99999
ZHAN_MULTIPLE_MYELOMA_CD1_AN...1,SET,51,0.016367,0.00086144,0.12772,0.44902,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,0.99999
MIR640,SET,46,0.014849,0.00074236,0.11596,0.44905,MIR640,0.99999
CEBP_Q2_01,SET,239,0.0074586,0.00084547,0.05833,0.44913,CEBP_Q2_01,0.99999
GOCC_RIBOSE_PHOSPHATE_DIPHOS...,SET,3,0.053241,0.00068055,0.41717,0.44922,GOCC_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_COMPLEX,0.99999
GOMF_RIBOSE_PHOSPHATE_DIPHOS...,SET,3,0.053241,0.00068055,0.41717,0.44922,GOMF_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_ACTIVITY,0.99999
MIR338_3P,SET,132,0.0097529,0.00082402,0.076437,0.44924,MIR338_3P,0.99999
GOBP_PITUITARY_GLAND_DEVELOP...,SET,39,0.019909,0.00091667,0.15628,0.44931,GOBP_PITUITARY_GLAND_DEVELOPMENT,0.99999
ACCAATC_MIR509,SET,45,0.018649,0.00092216,0.14643,0.44933,ACCAATC_MIR509,0.99999
GOBP_HIGH_DENSITY_LIPOPROTEI...3,SET,15,0.030505,0.00087161,0.23957,0.44934,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,0.99999
GOBP_REGULATION_OF_TRANSMEMB...1,SET,247,0.0073189,0.00084322,0.057502,0.44936,GOBP_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.99999
HP_POLYGENIC_INHERITANCE,SET,32,0.020867,0.00087045,0.16395,0.44936,HP_POLYGENIC_INHERITANCE,0.99999
CHEMELLO_SOLEUS_VS_EDL_MYOFI...1,SET,5,0.049908,0.00082353,0.39225,0.44938,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN,0.99999
GOBP_TRIGEMINAL_NERVE_DEVELO...,SET,12,0.037638,0.00096197,0.29592,0.4494,GOBP_TRIGEMINAL_NERVE_DEVELOPMENT,0.99999
MIR6768_5P,SET,186,0.0082125,0.00082245,0.064593,0.44941,MIR6768_5P,0.99999
GOBP_RESPONSE_TO_MITOCHONDRI...,SET,16,0.026959,0.00079555,0.21209,0.44943,GOBP_RESPONSE_TO_MITOCHONDRIAL_DEPOLARISATION,0.99999
GATAAGR_GATA_C,SET,277,0.0067523,0.00082315,0.053182,0.44948,GATAAGR_GATA_C,0.99999
CHEN_HOXA5_TARGETS_6HR_UP,SET,9,0.038465,0.00085148,0.30332,0.44954,CHEN_HOXA5_TARGETS_6HR_UP,0.99999
HP_BENIGN_NEOPLASM_OF_THE_CE...,SET,100,0.010019,0.0007374,0.078999,0.44954,HP_BENIGN_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM,0.99999
HP_DECREASED_MINIATURE_ENDPL...,SET,13,0.028141,0.0007486,0.222,0.44957,HP_DECREASED_MINIATURE_ENDPLATE_POTENTIALS,0.99999
GOBP_REGULATION_OF_ATRIAL_CA...2,SET,5,0.051983,0.00085778,0.41026,0.44959,GOBP_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.99999
HP_UTERINE_LEIOMYOMA,SET,8,0.037232,0.00077706,0.2941,0.44963,HP_UTERINE_LEIOMYOMA,0.99999
GSE21063_WT_VS_NFATC1_KO_BCE...2,SET,186,0.00787,0.00078815,0.062295,0.44973,GSE21063_WT_VS_NFATC1_KO_BCELL_UP,0.99999
MIR3613_5P,SET,64,0.013834,0.00081541,0.10951,0.44974,MIR3613_5P,0.99999
MIR11181_3P,SET,182,0.0081386,0.00080632,0.064501,0.4498,MIR11181_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...84,SET,384,0.0056553,0.00080931,0.044825,0.4498,GOBP_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...473,SET,25,0.01993,0.00073498,0.15811,0.44985,GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
MASRI_RESISTANCE_TO_TAMOXIFE...1,SET,16,0.029974,0.00088452,0.23797,0.44988,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...5,SET,6,0.049164,0.00088866,0.39096,0.44997,GOBP_NEGATIVE_REGULATION_OF_ACTION_POTENTIAL,0.99999
HES4_TARGET_GENES,SET,489,0.0049256,0.00079313,0.039183,0.44998,HES4_TARGET_GENES,0.99999
HP_VERTEBRAL_COMPRESSION_FRA...,SET,32,0.018447,0.00076949,0.14677,0.44999,HP_VERTEBRAL_COMPRESSION_FRACTURE,0.99999
NIKOLSKY_BREAST_CANCER_8Q12_...,SET,124,0.016966,0.0013897,0.13503,0.45001,NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,0.99999
GOBP_REGULATION_OF_ANDROGEN_...,SET,25,0.020991,0.00077408,0.16708,0.45001,GOBP_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_OBSERVATIONAL_LEARNING,SET,7,0.041374,0.00080777,0.32937,0.45002,GOBP_OBSERVATIONAL_LEARNING,0.99999
GSE9037_CTRL_VS_LPS_4H_STIM_...2,SET,177,0.0080628,0.00078788,0.064186,0.45002,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP,0.99999
AMIT_EGF_RESPONSE_240_MCF10A,SET,21,0.02676,0.00090454,0.21322,0.45006,AMIT_EGF_RESPONSE_240_MCF10A,0.99999
REACTOME_MICRORNA_MIRNA_BIOG...,SET,24,0.020259,0.00073203,0.16152,0.45009,REACTOME_MICRORNA_MIRNA_BIOGENESIS,0.99999
GSE411_UNSTIM_VS_400MIN_IL6_...3,SET,175,0.0082443,0.00080108,0.065743,0.4501,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,0.99999
GHANDHI_DIRECT_IRRADIATION_UP,SET,97,0.01178,0.00085399,0.09395,0.45011,GHANDHI_DIRECT_IRRADIATION_UP,0.99999
HP_AXIAL_DYSTONIA,SET,15,0.026472,0.00075638,0.2111,0.45011,HP_AXIAL_DYSTONIA,0.99999
REACTOME_FORMATION_OF_SENESC...,SET,11,0.028281,0.00069206,0.22559,0.45012,REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF,0.99999
GTGCAAT_MIR25_MIR32_MIR92_MI...,SET,281,0.0064596,0.00079305,0.051536,0.45013,GTGCAAT_MIR25_MIR32_MIR92_MIR363_MIR367,0.99999
GOCC_TRANS_GOLGI_NETWORK,SET,228,0.0068972,0.00076387,0.0551,0.45019,GOCC_TRANS_GOLGI_NETWORK,0.99999
GOBP_RESPONSE_TO_LIPID,SET,853,0.0039335,0.00082796,0.03144,0.45022,GOBP_RESPONSE_TO_LIPID,0.99999
GSE36891_UNSTIM_VS_POLYIC_TL...1,SET,178,0.007901,0.00077421,0.063153,0.45022,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN,0.99999
GOMF_GUANYLATE_CYCLASE_ACTIV...,SET,5,0.048516,0.00080056,0.38794,0.45024,GOMF_GUANYLATE_CYCLASE_ACTIVITY,0.99999
GSE7764_NKCELL_VS_SPLENOCYTE...2,SET,184,0.008127,0.00080954,0.064985,0.45024,GSE7764_NKCELL_VS_SPLENOCYTE_UP,0.99999
GOCC_ACTIN_CYTOSKELETON,SET,481,0.0049962,0.00079805,0.039986,0.45028,GOCC_ACTIN_CYTOSKELETON,0.99999
TAVOR_CEBPA_TARGETS_DN,SET,29,0.020898,0.00082994,0.16738,0.45032,TAVOR_CEBPA_TARGETS_DN,0.99999
MIR607,SET,872,0.0038025,0.00080881,0.030452,0.45032,MIR607,0.99999
GOBP_CARNITINE_TRANSMEMBRANE...,SET,6,0.0585,0.0010574,0.46855,0.45032,GOBP_CARNITINE_TRANSMEMBRANE_TRANSPORT,0.99999
GOBP_REGULATION_OF_PROGRAMME...2,SET,27,0.020624,0.00079036,0.16546,0.4504,GOBP_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,0.99999
GOBP_SUCCINYL_COA_METABOLIC_...,SET,9,0.031643,0.00070047,0.25412,0.45045,GOBP_SUCCINYL_COA_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_FIBROBLAS...1,SET,18,0.024479,0.00076612,0.19663,0.45046,GOBP_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,0.99999
GOBP_NONASSOCIATIVE_LEARNING,SET,6,0.044408,0.0008027,0.35681,0.45048,GOBP_NONASSOCIATIVE_LEARNING,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...6,SET,139,0.009649,0.00083643,0.077636,0.45055,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP,0.99999
GOMF_ORGANOPHOSPHATE_ESTER_T...,SET,35,0.019162,0.00083588,0.15423,0.45056,GOMF_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HOEK_MONOCYTE_2011_2012_TIV_...2,SET,7,0.049919,0.00097459,0.40227,0.45062,HOEK_MONOCYTE_2011_2012_TIV_ADULT_1DY_UP,0.99999
GSE3039_NKT_CELL_VS_ALPHAALP...1,SET,188,0.0079333,0.0007987,0.06409,0.45074,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_DN,0.99999
IL15_UP.V1_UP,SET,164,0.0083969,0.0007901,0.067843,0.45075,IL15_UP.V1_UP,0.99999
ZHONG_RESPONSE_TO_AZACITIDIN...2,SET,150,0.0085546,0.00077011,0.069134,0.45076,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,0.99999
REACTOME_ATTENUATION_PHASE,SET,26,0.020718,0.00077914,0.16748,0.45078,REACTOME_ATTENUATION_PHASE,0.99999
GOBP_PROGESTERONE_METABOLIC_...,SET,15,0.028536,0.00081537,0.23084,0.45081,GOBP_PROGESTERONE_METABOLIC_PROCESS,0.99999
HP_ABNORMAL_GLYCOSPHINGOLIPI...,SET,6,0.047105,0.00085145,0.38146,0.45086,HP_ABNORMAL_GLYCOSPHINGOLIPID_METABOLISM,0.99999
GOBP_GLYOXYLATE_METABOLIC_PR...,SET,8,0.037432,0.00078124,0.30316,0.45087,GOBP_GLYOXYLATE_METABOLIC_PROCESS,0.99999
GSE36527_CD62L_HIGH_VS_CD62L...2,SET,180,0.0078419,0.00077269,0.063537,0.45089,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP,0.99999
HP_HEPATIC_ENCEPHALOPATHY,SET,19,0.027373,0.00088016,0.22203,0.45094,HP_HEPATIC_ENCEPHALOPATHY,0.99999
KEGG_HISTIDINE_METABOLISM,SET,26,0.020247,0.00076141,0.16426,0.45095,KEGG_HISTIDINE_METABOLISM,0.99999
TRAVAGLINI_LUNG_TREM2_DENDRI...,SET,516,0.0047417,0.00078372,0.038519,0.45101,TRAVAGLINI_LUNG_TREM2_DENDRITIC_CELL,0.99999
HP_DECREASED_CORNEAL_SENSATI...,SET,5,0.053861,0.00088876,0.43786,0.45105,HP_DECREASED_CORNEAL_SENSATION,0.99999
LAKE_ADULT_KIDNEY_C6_PROXIMA...,SET,171,0.008324,0.00079962,0.067682,0.45106,LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3,0.99999
HP_ABNORMAL_MITOCHONDRIAL_MO...,SET,23,0.019762,0.00069907,0.16071,0.45107,HP_ABNORMAL_MITOCHONDRIAL_MORPHOLOGY,0.99999
RORIE_TARGETS_OF_EWSR1_FLI1_...2,SET,24,0.024961,0.00090193,0.20319,0.45111,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,0.99999
REACTOME_BETA_OXIDATION_OF_V...,SET,10,0.034092,0.00079546,0.27795,0.45119,REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS,0.99999
GCM_HMGA2,SET,107,0.0098527,0.00075,0.080362,0.45121,GCM_HMGA2,0.99999
MIR1_5P,SET,82,0.011689,0.00077944,0.095371,0.45123,MIR1_5P,0.99999
GOBP_ANGIOGENESIS_INVOLVED_I...1,SET,5,0.05253,0.00086681,0.42889,0.45126,GOBP_ANGIOGENESIS_INVOLVED_IN_CORONARY_VASCULAR_MORPHOGENESIS,0.99999
WP_SPHINGOLIPID_METABOLISM_I...2,SET,27,0.020688,0.00079281,0.16924,0.45135,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.99999
GOBP_POSITIVE_REGULATION_OF_...348,SET,5,0.057549,0.00094963,0.4714,0.45142,GOBP_POSITIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION,0.99999
REACTOME_E2F_ENABLED_INHIBIT...,SET,9,0.028314,0.00062676,0.23197,0.45143,REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION,0.99999
GOMF_PEPTIDASE_ACTIVATOR_ACT...2,SET,21,0.022385,0.00075667,0.18355,0.45147,GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.99999
GOBP_HEART_VALVE_MORPHOGENES...,SET,60,0.014677,0.00083773,0.12037,0.45148,GOBP_HEART_VALVE_MORPHOGENESIS,0.99999
GOMF_CYCLOSPORIN_A_BINDING,SET,17,0.023429,0.00071264,0.19253,0.45157,GOMF_CYCLOSPORIN_A_BINDING,0.99999
MIR648,SET,47,0.015278,0.00077205,0.12561,0.4516,MIR648,0.99999
GOBP_RESOLUTION_OF_MEIOTIC_R...,SET,13,0.025475,0.00067768,0.20953,0.45161,GOBP_RESOLUTION_OF_MEIOTIC_RECOMBINATION_INTERMEDIATES,0.99999
GOMF_DIPEPTIDASE_ACTIVITY,SET,17,0.025875,0.00078704,0.21281,0.45161,GOMF_DIPEPTIDASE_ACTIVITY,0.99999
SABATES_COLORECTAL_ADENOMA_S...2,SET,15,0.026929,0.00076943,0.22165,0.45165,SABATES_COLORECTAL_ADENOMA_SIZE_UP,0.99999
HP_LEFT_BUNDLE_BRANCH_BLOCK,SET,18,0.025509,0.00079837,0.21011,0.45168,HP_LEFT_BUNDLE_BRANCH_BLOCK,0.99999
GSE19941_UNSTIM_VS_LPS_AND_I...1,SET,184,0.0074774,0.00074484,0.061585,0.45168,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...37,SET,4,0.045446,0.00067076,0.3748,0.45175,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION,0.99999
GSE24142_EARLY_THYMIC_PROGEN...11,SET,180,0.0079878,0.00078707,0.065891,0.45176,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP,0.99999
GOCC_SPINDLE_MICROTUBULE,SET,76,0.011037,0.00070865,0.091108,0.45179,GOCC_SPINDLE_MICROTUBULE,0.99999
GSE360_L_MAJOR_VS_B_MALAYI_L...3,SET,176,0.0075459,0.0007353,0.062289,0.45179,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.99999
MIR654_3P,SET,71,0.012207,0.00075769,0.10079,0.4518,MIR654_3P,0.99999
HP_AV_NODAL_TACHYCARDIA,SET,2,0.08571,0.00089456,0.70801,0.45182,HP_AV_NODAL_TACHYCARDIA,0.99999
GOBP_DENDRITIC_CELL_CYTOKINE...,SET,17,0.026498,0.00080598,0.21893,0.45183,GOBP_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.99999
GOBP_CONNECTIVE_TISSUE_REPLA...1,SET,11,0.031867,0.00077983,0.26333,0.45184,GOBP_CONNECTIVE_TISSUE_REPLACEMENT,0.99999
GOBP_AMINOGLYCOSIDE_ANTIBIOT...,SET,10,0.041582,0.00097023,0.34419,0.45192,GOBP_AMINOGLYCOSIDE_ANTIBIOTIC_METABOLIC_PROCESS,0.99999
GSE26488_WT_VS_HDAC7_DELTAP_...1,SET,184,0.0076547,0.0007625,0.063406,0.45196,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN,0.99999
WP_ULCERATIVE_COLITIS_SIGNAL...,SET,16,0.02663,0.00078583,0.22073,0.45199,WP_ULCERATIVE_COLITIS_SIGNALING,0.99999
GOBP_REGULATORY_T_CELL_DIFFE...,SET,35,0.017933,0.00078229,0.14864,0.45199,GOBP_REGULATORY_T_CELL_DIFFERENTIATION,0.99999
HP_PERINEAL_HYPOSPADIAS,SET,4,0.051165,0.00075516,0.42433,0.45201,HP_PERINEAL_HYPOSPADIAS,0.99999
REACTOME_RAC1_GTPASE_CYCLE,SET,167,0.0083139,0.00078934,0.068982,0.45204,REACTOME_RAC1_GTPASE_CYCLE,0.99999
HP_ERYTHROID_HYPOPLASIA,SET,26,0.019031,0.0007157,0.15804,0.45208,HP_ERYTHROID_HYPOPLASIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...663,SET,56,0.014727,0.00081216,0.12254,0.45217,GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.99999
CAHOY_ASTROCYTIC,SET,94,0.011119,0.0007936,0.092546,0.45218,CAHOY_ASTROCYTIC,0.99999
BERENJENO_TRANSFORMED_BY_RHO...3,SET,20,0.023958,0.00079035,0.19957,0.45222,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,0.99999
WP_TYPE_II_DIABETES_MELLITUS,SET,20,0.023358,0.00077056,0.19464,0.45224,WP_TYPE_II_DIABETES_MELLITUS,0.99999
TAKEDA_TARGETS_OF_NUP98_HOXA...10,SET,144,0.0094809,0.00083639,0.079018,0.45225,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,0.99999
MIR4473,SET,79,0.011343,0.00074249,0.094532,0.45225,MIR4473,0.99999
GSE43863_TFH_VS_LY6C_INT_CXC...3,SET,178,0.0078017,0.00076449,0.065022,0.45225,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,0.99999
BIOCARTA_VOBESITY_PATHWAY,SET,8,0.041363,0.00086328,0.34481,0.45226,BIOCARTA_VOBESITY_PATHWAY,0.99999
GSE7852_THYMUS_VS_FAT_TCONV_...1,SET,178,0.0082283,0.00080629,0.068624,0.45228,GSE7852_THYMUS_VS_FAT_TCONV_DN,0.99999
HP_CHRONIC_FATIGUE,SET,24,0.021822,0.00078852,0.18203,0.45229,HP_CHRONIC_FATIGUE,0.99999
GSE360_L_MAJOR_VS_B_MALAYI_H...3,SET,183,0.0071904,0.00071432,0.060049,0.45234,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN,0.99999
GSE22589_SIV_VS_HIV_AND_SIV_...2,SET,178,0.0077622,0.00076062,0.064839,0.45235,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...19,SET,7,0.040007,0.00078108,0.33453,0.4524,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9,0.99999
HOXB6_TARGET_GENES,SET,514,0.0044084,0.00072725,0.036904,0.45246,HOXB6_TARGET_GENES,0.99999
HP_MODERATE_MYOPIA,SET,3,0.063379,0.00081013,0.53093,0.45249,HP_MODERATE_MYOPIA,0.99999
chr10p11,SET,23,0.037553,0.0013284,0.31465,0.4525,chr10p11,0.99999
GOBP_MULTICELLULAR_ORGANISMA...2,SET,757,0.0039185,0.00077913,0.032841,0.45251,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_HOMEOSTASIS,0.99999
BRUINS_UVC_RESPONSE_EARLY_LA...,SET,286,0.0059156,0.00073259,0.049608,0.45254,BRUINS_UVC_RESPONSE_EARLY_LATE,0.99999
HP_PHYSICAL_URTICARIA,SET,14,0.027929,0.00077097,0.23451,0.4526,HP_PHYSICAL_URTICARIA,0.99999
GOBP_NADP_METABOLIC_PROCESS,SET,40,0.016821,0.00078431,0.14148,0.45268,GOBP_NADP_METABOLIC_PROCESS,0.99999
CAO_BLOOD_FLUMIST_AGE_05_14Y...3,SET,7,0.04408,0.00086059,0.37108,0.45272,CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_DN,0.99999
MATZUK_CENTRAL_FOR_FEMALE_FE...,SET,29,0.018594,0.00073842,0.15669,0.45277,MATZUK_CENTRAL_FOR_FEMALE_FERTILITY,0.99999
GOBP_VESICLE_DOCKING,SET,57,0.013498,0.00075097,0.11375,0.45277,GOBP_VESICLE_DOCKING,0.99999
HP_PARASOMNIA,SET,37,0.016969,0.00076105,0.14298,0.45277,HP_PARASOMNIA,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...13,SET,11,0.034907,0.00085422,0.2942,0.45278,BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP,0.99999
BRIDEAU_IMPRINTED_GENES,SET,59,0.015432,0.00087345,0.13009,0.45278,BRIDEAU_IMPRINTED_GENES,0.99999
PID_CD8_TCR_DOWNSTREAM_PATHW...,SET,61,0.014345,0.00082554,0.12099,0.45281,PID_CD8_TCR_DOWNSTREAM_PATHWAY,0.99999
HP_ABNORMAL_BRAIN_N_ACETYL_A...,SET,19,0.021116,0.00067896,0.1781,0.45281,HP_ABNORMAL_BRAIN_N_ACETYL_ASPARTATE_LEVEL_BY_MRS,0.99999
REACTOME_DEFECTIVE_GALNT3_CA...,SET,14,0.028949,0.00079915,0.24459,0.45289,REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC,0.99999
GOBP_CYTOPLASMIC_PATTERN_REC...,SET,148,0.0081018,0.0007245,0.068471,0.45291,GOBP_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.99999
SAKAI_CHRONIC_HEPATITIS_VS_L...2,SET,79,0.010377,0.00067928,0.087781,0.45295,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,0.99999
GSE45365_CD8A_DC_VS_CD11B_DC...3,SET,142,0.0088179,0.00077252,0.074629,0.45297,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...6,SET,15,0.023912,0.00068322,0.20246,0.45299,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP,0.99999
GALINDO_IMMUNE_RESPONSE_TO_E...,SET,72,0.012649,0.00079063,0.10714,0.45301,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,0.99999
GSE22611_UNSTIM_VS_6H_MDP_ST...2,SET,178,0.0074907,0.00073401,0.063453,0.45301,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...16,SET,1045,0.0032146,0.00074482,0.027235,0.45302,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETON,0.99999
HP_PARADOXICAL_INCREASED_COR...,SET,14,0.028342,0.00078238,0.24015,0.45303,HP_PARADOXICAL_INCREASED_CORTISOL_SECRETION_ON_DEXAMETHASONE_SUPPRESSION_TEST,0.99999
MIR195_5P,SET,534,0.0043484,0.00073076,0.03686,0.45305,MIR195_5P,0.99999
GNF2_PTPN4,SET,45,0.015463,0.00076462,0.13116,0.45308,GNF2_PTPN4,0.99999
WP_VASOPRESSINREGULATED_WATE...,SET,43,0.014457,0.00069888,0.12283,0.45315,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...41,SET,13,0.025381,0.00067518,0.21602,0.45323,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_CREB_MEDIATED_TRANSCRIPTION,0.99999
GOBP_REGULATION_OF_CENTRIOLE...,SET,22,0.019687,0.00068109,0.1676,0.45325,GOBP_REGULATION_OF_CENTRIOLE_REPLICATION,0.99999
HP_EEG_WITH_GENERALIZED_SLOW...2,SET,9,0.03384,0.0007491,0.28818,0.45326,HP_EEG_WITH_GENERALIZED_SLOW_ACTIVITY_GRADE_4,0.99999
GOCC_SPERM_FIBROUS_SHEATH,SET,5,0.04979,0.00082159,0.42404,0.45327,GOCC_SPERM_FIBROUS_SHEATH,0.99999
HP_MACULAR_HYPOPLASIA,SET,13,0.030341,0.00080713,0.25863,0.45331,HP_MACULAR_HYPOPLASIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...283,SET,9,0.038032,0.00084187,0.32439,0.45334,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,0.99999
REACTOME_ROLE_OF_LAT2_NTAL_L...,SET,16,0.024584,0.00072545,0.2098,0.45336,REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION,0.99999
HAY_BONE_MARROW_CD34_POS_ERP,SET,8,0.038495,0.00080342,0.32876,0.45339,HAY_BONE_MARROW_CD34_POS_ERP,0.99999
MIR3936,SET,30,0.01723,0.00069594,0.14722,0.45342,MIR3936,0.99999
GOBP_ACUTE_PHASE_RESPONSE,SET,44,0.016983,0.00083042,0.14518,0.45344,GOBP_ACUTE_PHASE_RESPONSE,0.99999
MIR4311,SET,325,0.0055358,0.00073002,0.047353,0.45347,MIR4311,0.99999
GOBP_NEURON_DEVELOPMENT,SET,1052,0.0032853,0.00076359,0.028112,0.45348,GOBP_NEURON_DEVELOPMENT,0.99999
HP_SPOTTY_HYPERPIGMENTATION,SET,9,0.032749,0.00072494,0.28021,0.45348,HP_SPOTTY_HYPERPIGMENTATION,0.99999
GOBP_GTP_METABOLIC_PROCESS,SET,22,0.022193,0.00076782,0.1901,0.45353,GOBP_GTP_METABOLIC_PROCESS,0.99999
IVANOVA_HEMATOPOIESIS_STEM_C...4,SET,18,0.021598,0.00067596,0.18505,0.45354,IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM,0.99999
HP_PRIMARY_PERITONEAL_CARCIN...,SET,13,0.025991,0.00069139,0.22292,0.45359,HP_PRIMARY_PERITONEAL_CARCINOMA,0.99999
REACTOME_FGFR1C_LIGAND_BINDI...,SET,13,0.031279,0.00083206,0.26855,0.45364,REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION,0.99999
MIR4689,SET,78,0.011386,0.00074063,0.097908,0.45371,MIR4689,0.99999
JOHANSSON_GLIOMAGENESIS_BY_P...2,SET,55,0.013715,0.00074955,0.11803,0.45375,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,0.99999
GSE41978_ID2_KO_AND_BIM_KO_V...2,SET,174,0.0075773,0.00073419,0.065284,0.4538,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.99999
MIR6874_3P,SET,70,0.011848,0.00073022,0.1021,0.45381,MIR6874_3P,0.99999
HP_ABNORMAL_CIRCULATING_GLOB...,SET,10,0.033406,0.00077947,0.28798,0.45383,HP_ABNORMAL_CIRCULATING_GLOBULIN_CONCENTRATION,0.99999
GOCC_SMN_COMPLEX,SET,6,0.036949,0.00066788,0.31919,0.45392,GOCC_SMN_COMPLEX,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...11,SET,11,0.028943,0.00070826,0.25027,0.45397,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY,0.99999
GOBP_FIBROBLAST_GROWTH_FACTO...1,SET,7,0.040295,0.00078669,0.349,0.45404,GOBP_FIBROBLAST_GROWTH_FACTOR_PRODUCTION,0.99999
GOBP_EMBRYONIC_PATTERN_SPECI...,SET,63,0.013147,0.00076883,0.11398,0.45409,GOBP_EMBRYONIC_PATTERN_SPECIFICATION,0.99999
GOCC_MICROVILLUS,SET,94,0.010206,0.00072847,0.088492,0.45409,GOCC_MICROVILLUS,0.99999
REACTOME_TCR_SIGNALING,SET,108,0.0091256,0.00069788,0.079211,0.45414,REACTOME_TCR_SIGNALING,0.99999
RUAN_RESPONSE_TO_TNF_UP,SET,13,0.028841,0.00076722,0.2504,0.45415,RUAN_RESPONSE_TO_TNF_UP,0.99999
GOBP_CORNIFICATION,SET,9,0.040593,0.00089857,0.35254,0.45417,GOBP_CORNIFICATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...682,SET,70,0.012178,0.00075054,0.10578,0.45418,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,0.99999
GOBP_RESPONSE_TO_VITAMIN_E,SET,9,0.033221,0.00073539,0.28875,0.4542,GOBP_RESPONSE_TO_VITAMIN_E,0.99999
FAN_EMBRYONIC_CTX_BIG_GROUPS...7,SET,333,0.0057107,0.00076212,0.0497,0.45426,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,0.99999
GSE39820_TGFBETA3_IL6_VS_TGF...1,SET,179,0.0070009,0.00068792,0.060961,0.45429,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN,0.99999
REACTOME_SLC15A4_TASL_DEPEND...,SET,4,0.041179,0.00060779,0.35899,0.45434,REACTOME_SLC15A4_TASL_DEPENDENT_IRF5_ACTIVATION,0.99999
HP_DISCOID_LUPUS_RASH,SET,28,0.020164,0.00078689,0.17587,0.45436,HP_DISCOID_LUPUS_RASH,0.99999
MIR519C_3P,SET,375,0.005026,0.00071096,0.043896,0.45442,MIR519C_3P,0.99999
GOMF_DYNEIN_LIGHT_CHAIN_BIND...,SET,5,0.041258,0.0006808,0.36053,0.45445,GOMF_DYNEIN_LIGHT_CHAIN_BINDING,0.99999
GOBP_PROTEIN_CATABOLIC_PROCE...1,SET,909,0.0032297,0.00070066,0.028229,0.45446,GOBP_PROTEIN_CATABOLIC_PROCESS,0.99999
HP_ABNORMALITY_OF_THE_MIDDLE...4,SET,12,0.029233,0.00074715,0.25594,0.45453,HP_ABNORMALITY_OF_THE_MIDDLE_PHALANX_OF_THE_2ND_FINGER,0.99999
GOBP_REGULATION_OF_ENDOPLASM...3,SET,27,0.019148,0.0007338,0.16768,0.45454,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.99999
AIZARANI_LIVER_C39_EPCAM_POS...,SET,177,0.0078837,0.00077038,0.069213,0.45466,AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4,0.99999
CUI_DEVELOPING_HEART_COMPACT...1,SET,15,0.025322,0.00072354,0.22238,0.45467,CUI_DEVELOPING_HEART_COMPACT_ATRIAL_CARDIOMYOCYTE,0.99999
KOHN_EMT_EPITHELIAL,SET,22,0.02221,0.0007684,0.19522,0.45471,KOHN_EMT_EPITHELIAL,0.99999
MIR3974,SET,86,0.011435,0.00078084,0.10062,0.45476,MIR3974,0.99999
GOCC_SM_LIKE_PROTEIN_FAMILY_...,SET,77,0.0095233,0.00061547,0.083855,0.45479,GOCC_SM_LIKE_PROTEIN_FAMILY_COMPLEX,0.99999
ALCALA_APOPTOSIS,SET,80,0.010619,0.00069944,0.093513,0.4548,ALCALA_APOPTOSIS,0.99999
MIR6780B_5P,SET,258,0.0059021,0.00069475,0.052015,0.45483,MIR6780B_5P,0.99999
HOEK_T_CELL_2011_2012_TIV_AD...3,SET,8,0.04087,0.00085299,0.36078,0.4549,HOEK_T_CELL_2011_2012_TIV_ADULT_3DY_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...520,SET,6,0.038358,0.00069334,0.33897,0.45495,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.99999
HP_AMEGAKARYOCYTIC_THROMBOCY...,SET,6,0.035171,0.00063573,0.31096,0.45497,HP_AMEGAKARYOCYTIC_THROMBOCYTOPENIA,0.99999
GAO_LARGE_INTESTINE_24W_C11_...,SET,293,0.0061662,0.00077276,0.054542,0.45499,GAO_LARGE_INTESTINE_24W_C11_PANETH_LIKE_CELL,0.99999
GOBP_PRO_B_CELL_DIFFERENTIAT...,SET,12,0.028638,0.00073195,0.25368,0.45506,GOBP_PRO_B_CELL_DIFFERENTIATION,0.99999
GSE23505_UNTREATED_VS_4DAY_I...2,SET,185,0.0072207,0.00072119,0.063992,0.45508,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,0.99999
GOBP_RIBOSOME_DISASSEMBLY,SET,32,0.015835,0.00066054,0.14047,0.45512,GOBP_RIBOSOME_DISASSEMBLY,0.99999
HP_NARROW_NASAL_RIDGE,SET,19,0.021863,0.000703,0.19394,0.45512,HP_NARROW_NASAL_RIDGE,0.99999
MOHANKUMAR_HOXA1_TARGETS_DN,SET,151,0.0084485,0.00076307,0.075032,0.45518,MOHANKUMAR_HOXA1_TARGETS_DN,0.99999
HP_SUDDEN_EPISODIC_APNEA,SET,16,0.024827,0.00073262,0.22068,0.45521,HP_SUDDEN_EPISODIC_APNEA,0.99999
HP_ORCHITIS,SET,14,0.028667,0.00079134,0.25513,0.45527,HP_ORCHITIS,0.99999
WP_PROSTAGLANDIN_AND_LEUKOTR...2,SET,32,0.017146,0.00071524,0.15277,0.45532,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,0.99999
GSE4590_PRE_BCELL_VS_SMALL_P...2,SET,136,0.0080798,0.00069285,0.072072,0.45537,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP,0.99999
HP_ABNORMAL_METENCEPHALON_MO...,SET,887,0.003199,0.00068597,0.028539,0.45538,HP_ABNORMAL_METENCEPHALON_MORPHOLOGY,0.99999
GOCC_90S_PRERIBOSOME,SET,23,0.01901,0.00067246,0.16972,0.45541,GOCC_90S_PRERIBOSOME,0.99999
OHM_METHYLATED_IN_ADULT_CANC...,SET,26,0.019163,0.00072067,0.17116,0.45543,OHM_METHYLATED_IN_ADULT_CANCERS,0.99999
HP_BICARBONATE_WASTING_RENAL...,SET,5,0.045713,0.00075432,0.40928,0.45553,HP_BICARBONATE_WASTING_RENAL_TUBULAR_ACIDOSIS,0.99999
HP_MESOAXIAL_POLYDACTYLY,SET,18,0.021262,0.00066543,0.19036,0.45553,HP_MESOAXIAL_POLYDACTYLY,0.99999
GOBP_REGULATION_OF_POSTSYNAP...1,SET,6,0.048258,0.00087229,0.43226,0.45555,GOBP_REGULATION_OF_POSTSYNAPSE_ASSEMBLY,0.99999
HP_PETECHIAE,SET,54,0.013609,0.00073698,0.12192,0.45556,HP_PETECHIAE,0.99999
DBP_Q6,SET,224,0.0066066,0.00072531,0.059212,0.45558,DBP_Q6,0.99999
MODULE_85,SET,47,0.014996,0.00075781,0.13464,0.45566,MODULE_85,0.99999
HP_ABNORMAL_FEMUR_MORPHOLOGY,SET,270,0.0057671,0.00069424,0.051787,0.45567,HP_ABNORMAL_FEMUR_MORPHOLOGY,0.99999
HP_DYSPLASTIC_CORPUS_CALLOSUM,SET,40,0.014751,0.00068779,0.13264,0.45573,HP_DYSPLASTIC_CORPUS_CALLOSUM,0.99999
HP_REDUCED_NUMBER_OF_CORNEAL...,SET,8,0.037477,0.00078217,0.33716,0.45575,HP_REDUCED_NUMBER_OF_CORNEAL_ENDOTHELIAL_CELLS,0.99999
GSE24634_NAIVE_CD4_TCELL_VS_...4,SET,172,0.0070194,0.00067625,0.063154,0.45575,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP,0.99999
CACCCBINDINGFACTOR_Q6,SET,242,0.0061363,0.00069987,0.055234,0.45577,CACCCBINDINGFACTOR_Q6,0.99999
HP_MULTIPLE_RIB_FRACTURES,SET,10,0.03343,0.00078003,0.30101,0.45578,HP_MULTIPLE_RIB_FRACTURES,0.99999
REACTOME_LYSINE_CATABOLISM,SET,12,0.026257,0.00067108,0.23667,0.45583,REACTOME_LYSINE_CATABOLISM,0.99999
CAMP_UP.V1_UP,SET,179,0.0066877,0.00065715,0.060287,0.45584,CAMP_UP.V1_UP,0.99999
CHIARADONNA_NEOPLASTIC_TRANS...6,SET,113,0.0091462,0.00071536,0.082481,0.45585,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,0.99999
HP_NEONATAL_ALLOIMMUNE_THROM...,SET,14,0.024876,0.00068671,0.22449,0.45588,HP_NEONATAL_ALLOIMMUNE_THROMBOCYTOPENIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...397,SET,6,0.037314,0.00067447,0.3368,0.45589,GOBP_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_FUSION,0.99999
HP_ABNORMAL_VERTEBRAL_SEGMEN...,SET,8,0.037831,0.00078956,0.34167,0.45592,HP_ABNORMAL_VERTEBRAL_SEGMENTATION_AND_FUSION,0.99999
REACTOME_INTERLEUKIN_1_PROCE...,SET,9,0.030591,0.00067716,0.27653,0.45596,REACTOME_INTERLEUKIN_1_PROCESSING,0.99999
WP_INTEGRINMEDIATED_CELL_ADH...,SET,95,0.010175,0.00073003,0.092095,0.45601,WP_INTEGRINMEDIATED_CELL_ADHESION,0.99999
MIR4708_5P,SET,80,0.010169,0.0006698,0.09212,0.45605,MIR4708_5P,0.99999
GOBP_TUBULIN_COMPLEX_ASSEMBLY,SET,8,0.024958,0.0005209,0.22614,0.45606,GOBP_TUBULIN_COMPLEX_ASSEMBLY,0.99999
REACTOME_MITOCHONDRIAL_IRON_...,SET,12,0.026288,0.00067189,0.23831,0.45608,REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS,0.99999
GOBP_VERY_LONG_CHAIN_FATTY_A...2,SET,6,0.032252,0.00058298,0.29239,0.45608,GOBP_VERY_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.99999
GSE39916_B_CELL_SPLEEN_VS_PL...1,SET,179,0.0074283,0.00072992,0.067357,0.45609,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN,0.99999
HEIDENBLAD_AMPLICON_12P11_12...1,SET,20,0.021252,0.00070109,0.19275,0.4561,HEIDENBLAD_AMPLICON_12P11_12_DN,0.99999
GSE22886_NAIVE_BCELL_VS_DC_UP,SET,153,0.0077344,0.00070314,0.070312,0.45621,GSE22886_NAIVE_BCELL_VS_DC_UP,0.99999
HP_HYPOPLASIA_OF_THE_FOVEA,SET,25,0.020385,0.00075173,0.18538,0.45622,HP_HYPOPLASIA_OF_THE_FOVEA,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_TM4...2,SET,107,0.009578,0.0007291,0.087152,0.45624,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,0.99999
HP_SMALL_INTESTINAL_POLYPOSIS,SET,5,0.038553,0.00063616,0.35106,0.45628,HP_SMALL_INTESTINAL_POLYPOSIS,0.99999
GOBP_KILLING_BY_HOST_OF_SYMB...,SET,23,0.022183,0.0007847,0.20223,0.45633,GOBP_KILLING_BY_HOST_OF_SYMBIONT_CELLS,0.99999
FEKIR_HEPARG_SIDE_POP_VS_HEP...2,SET,77,0.010436,0.00067445,0.095229,0.45637,FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP,0.99999
GSE17721_LPS_VS_PAM3CSK4_1H_...2,SET,174,0.0066449,0.00064385,0.060739,0.45644,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_UP,0.99999
GSE19941_IL10_KO_VS_IL10_KO_...1,SET,150,0.0073227,0.00065921,0.067067,0.45653,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN,0.99999
RAY_ALZHEIMERS_DISEASE,SET,13,0.026627,0.00070832,0.24425,0.4566,RAY_ALZHEIMERS_DISEASE,0.99999
GSE13411_NAIVE_VS_SWITCHED_M...1,SET,178,0.0068795,0.00067412,0.063117,0.4566,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN,0.99999
GOMF_MICROFIBRIL_BINDING,SET,6,0.043023,0.00077767,0.39496,0.45663,GOMF_MICROFIBRIL_BINDING,0.99999
REACTOME_INTERCONVERSION_OF_...,SET,28,0.018267,0.00071286,0.16775,0.45665,REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES,0.99999
HP_AUTOAMPUTATION,SET,15,0.023503,0.00067154,0.21587,0.45665,HP_AUTOAMPUTATION,0.99999
HP_PERSISTENT_BLEEDING_AFTER...,SET,12,0.030032,0.00076756,0.27602,0.45668,HP_PERSISTENT_BLEEDING_AFTER_TRAUMA,0.99999
HP_HAMMERTOE,SET,52,0.012803,0.00068044,0.1177,0.45669,HP_HAMMERTOE,0.99999
MIR5696,SET,621,0.0038692,0.0006995,0.035575,0.4567,MIR5696,0.99999
GSE30971_CTRL_VS_LPS_STIM_MA...6,SET,168,0.0081934,0.00078021,0.075395,0.45673,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_UP,0.99999
LIANG_HEMATOPOIESIS_STEM_CEL...1,SET,37,0.015257,0.00068427,0.14059,0.45679,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,0.99999
MIR433_3P,SET,127,0.008592,0.00071216,0.079201,0.45681,MIR433_3P,0.99999
BONOME_OVARIAN_CANCER_POOR_S...2,SET,28,0.017825,0.00069559,0.16438,0.45683,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP,0.99999
CHEN_PDGF_TARGETS,SET,18,0.024959,0.00078117,0.23047,0.45688,CHEN_PDGF_TARGETS,0.99999
REACTOME_TP53_REGULATES_TRAN...3,SET,48,0.01308,0.00066794,0.12084,0.4569,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,0.99999
GOBP_IMMUNOLOGICAL_SYNAPSE_F...,SET,16,0.024941,0.00073599,0.23055,0.45693,GOBP_IMMUNOLOGICAL_SYNAPSE_FORMATION,0.99999
GSE29617_CTRL_VS_DAY3_TIV_FL...2,SET,165,0.0070731,0.00066754,0.065418,0.45695,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP,0.99999
MIR517_5P,SET,78,0.01035,0.00067323,0.095741,0.45696,MIR517_5P,0.99999
GSE17974_1.5H_VS_72H_IL4_AND...1,SET,165,0.0066891,0.0006313,0.06189,0.45697,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,0.99999
WEINBERGER_BLOOD_TWINRIX_AGE...3,SET,6,0.044286,0.0008005,0.41032,0.45703,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_HIGH_ANTI_HBS_CONC_AT_WEEK_4_POST_BOOSTER_VACC_1DY_POSITIVE,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...2,SET,17,0.021637,0.00065812,0.20057,0.45705,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP,0.99999
GOBP_NEURONAL_DENSE_CORE_VES...,SET,7,0.039049,0.00076237,0.36219,0.45707,GOBP_NEURONAL_DENSE_CORE_VESICLE_EXOCYTOSIS,0.99999
MIR4438,SET,61,0.011995,0.00069029,0.1113,0.45709,MIR4438,0.99999
GOBP_REGULATION_OF_ACYL_COA_...,SET,4,0.051529,0.00076054,0.47857,0.45713,GOBP_REGULATION_OF_ACYL_COA_BIOSYNTHETIC_PROCESS,0.99999
GOMF_MUTLALPHA_COMPLEX_BINDI...,SET,7,0.036361,0.00070989,0.33777,0.45714,GOMF_MUTLALPHA_COMPLEX_BINDING,0.99999
GSE27786_LSK_VS_MONO_MAC_DN,SET,186,0.0067334,0.00067432,0.062667,0.45722,GSE27786_LSK_VS_MONO_MAC_DN,0.99999
REACTOME_RETROGRADE_NEUROTRO...,SET,14,0.024085,0.00066486,0.22434,0.45725,REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING,0.99999
GOMF_HISTONE_H2A_DEUBIQUITIN...,SET,5,0.031273,0.00051604,0.29137,0.45726,GOMF_HISTONE_H2A_DEUBIQUITINASE_ACTIVITY,0.99999
MARIADASON_RESPONSE_TO_BUTYR...1,SET,6,0.043519,0.00078664,0.40554,0.45727,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...21,SET,48,0.012543,0.00064053,0.11696,0.4573,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,0.99999
GOCC_NUCLEAR_LAMINA,SET,10,0.027727,0.00064696,0.25854,0.4573,GOCC_NUCLEAR_LAMINA,0.99999
MIR6801_5P,SET,97,0.010007,0.0007255,0.093339,0.45731,MIR6801_5P,0.99999
GOBP_REGULATION_OF_INOSITOL_...1,SET,4,0.04896,0.00072262,0.45678,0.45732,GOBP_REGULATION_OF_INOSITOL_1_4_5_TRISPHOSPHATE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.99999
EHLERS_ANEUPLOIDY_UP,SET,35,0.014366,0.00062665,0.1342,0.45738,EHLERS_ANEUPLOIDY_UP,0.99999
REACTOME_SIGNALING_BY_RECEPT...,SET,508,0.0042331,0.00069437,0.039591,0.45743,REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,0.99999
GNF2_HPN,SET,127,0.0082759,0.00068596,0.077474,0.45747,GNF2_HPN,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...9,SET,71,0.010927,0.00067824,0.10239,0.45751,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,0.99999
REACTOME_SMOOTH_MUSCLE_CONTR...,SET,40,0.015298,0.00071331,0.14378,0.45763,REACTOME_SMOOTH_MUSCLE_CONTRACTION,0.99999
GSE6259_FLT3L_INDUCED_33D1_P...5,SET,129,0.0079928,0.00066766,0.075289,0.45773,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_DN,0.99999
HP_PSEUDOBULBAR_PARALYSIS,SET,20,0.02044,0.00067429,0.1927,0.45776,HP_PSEUDOBULBAR_PARALYSIS,0.99999
HP_HETEROPHORIA,SET,11,0.024936,0.00061022,0.23521,0.45778,HP_HETEROPHORIA,0.99999
MIR1323,SET,285,0.0055835,0.00069027,0.052685,0.4578,MIR1323,0.99999
HP_HYPOPLASTIC_ANEMIA,SET,6,0.031218,0.00056428,0.29459,0.4578,HP_HYPOPLASTIC_ANEMIA,0.99999
GOCC_PLASMA_MEMBRANE_REGION,SET,1187,0.0027963,0.00068768,0.026399,0.45782,GOCC_PLASMA_MEMBRANE_REGION,0.99999
GCNP_SHH_UP_LATE.V1_DN,SET,159,0.0072221,0.00066921,0.068234,0.45785,GCNP_SHH_UP_LATE.V1_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...823,SET,23,0.018526,0.00065532,0.1752,0.45789,GOBP_POSITIVE_REGULATION_OF_VACUOLE_ORGANIZATION,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...15,SET,184,0.0066974,0.00066714,0.063341,0.4579,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_DN,0.99999
GOBP_ACTIVATION_OF_MEIOSIS,SET,5,0.04285,0.00070707,0.40565,0.45794,GOBP_ACTIVATION_OF_MEIOSIS,0.99999
MIR3943,SET,39,0.014997,0.00069049,0.14202,0.45795,MIR3943,0.99999
GOBP_LONG_CHAIN_FATTY_ACYL_C...1,SET,18,0.02363,0.00073958,0.22387,0.45797,GOBP_LONG_CHAIN_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMAL_T_CELL_ACTIVATION,SET,5,0.04019,0.00066317,0.3812,0.45802,HP_ABNORMAL_T_CELL_ACTIVATION,0.99999
HP_GENERALIZED_OSTEOPOROSIS,SET,17,0.022016,0.00066964,0.20901,0.45806,HP_GENERALIZED_OSTEOPOROSIS,0.99999
ROY_WOUND_BLOOD_VESSEL_DN,SET,19,0.021454,0.00068985,0.20426,0.45818,ROY_WOUND_BLOOD_VESSEL_DN,0.99999
HP_ABNORMAL_BLOOD_GLUCOSE_CO...,SET,285,0.0053212,0.00065785,0.050769,0.45826,HP_ABNORMAL_BLOOD_GLUCOSE_CONCENTRATION,0.99999
GOBP_MIRNA_MEDIATED_GENE_SIL...2,SET,8,0.031091,0.0006489,0.29711,0.45833,GOBP_MIRNA_MEDIATED_GENE_SILENCING_BY_MRNA_DESTABILIZATION,0.99999
GSE33162_HDAC3_KO_VS_HDAC3_K...3,SET,176,0.0067811,0.00066078,0.064822,0.45834,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_DN,0.99999
OCT1_Q6,SET,229,0.006209,0.00068913,0.059358,0.45835,OCT1_Q6,0.99999
GSE2706_UNSTIM_VS_8H_LPS_DC_...1,SET,171,0.0069812,0.00067063,0.066757,0.45836,GSE2706_UNSTIM_VS_8H_LPS_DC_DN,0.99999
GSE7219_WT_VS_NIK_NFKB2_KO_D...2,SET,175,0.0068554,0.00066613,0.065581,0.45837,GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP,0.99999
GSE7460_FOXP3_MUT_VS_WT_ACT_...2,SET,182,0.0068486,0.00067852,0.065534,0.45838,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP,0.99999
CAGCCTC_MIR4855P,SET,135,0.0075249,0.00064291,0.072323,0.45857,CAGCCTC_MIR4855P,0.99999
GSE14000_TRANSLATED_RNA_VS_M...2,SET,146,0.0073832,0.00065581,0.070989,0.45858,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...71,SET,6,0.034801,0.00062905,0.33467,0.45859,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_DJ1_TO_FAS_JNK_SIGNALING_PATWHAY,0.99999
WP_VITAMIN_D_METABOLISM,SET,10,0.028119,0.00065609,0.27052,0.45861,WP_VITAMIN_D_METABOLISM,0.99999
GSE2128_CTRL_VS_MIMETOPE_NEG...3,SET,164,0.0068257,0.00064226,0.065788,0.45868,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN,0.99999
GSE22935_WT_VS_MYD88_KO_MACR...7,SET,180,0.0069443,0.00068425,0.067007,0.45873,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_DN,0.99999
GSE19888_CTRL_VS_TCELL_MEMBR...2,SET,171,0.0066744,0.00064116,0.064446,0.45876,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP,0.99999
HP_DECREASED_CIRCULATING_ANT...,SET,175,0.0066203,0.00064329,0.063956,0.45878,HP_DECREASED_CIRCULATING_ANTIBODY_LEVEL,0.99999
HP_BLUE_SCLERAE,SET,97,0.0087251,0.00063254,0.084318,0.45879,HP_BLUE_SCLERAE,0.99999
HP_PROGRESSIVE_DISTAL_MUSCUL...,SET,37,0.013938,0.00062508,0.13469,0.45879,HP_PROGRESSIVE_DISTAL_MUSCULAR_ATROPHY,0.99999
GOBP_FATTY_ACYL_COA_METABOLI...,SET,37,0.015047,0.00067485,0.14544,0.4588,GOBP_FATTY_ACYL_COA_METABOLIC_PROCESS,0.99999
GOBP_SNO_S_RNA_METABOLIC_PRO...,SET,11,0.024635,0.00060286,0.2381,0.4588,GOBP_SNO_S_RNA_METABOLIC_PROCESS,0.99999
REACTOME_FLT3_SIGNALING_IN_D...,SET,27,0.016358,0.00062686,0.15819,0.45882,REACTOME_FLT3_SIGNALING_IN_DISEASE,0.99999
WP_ACE_INHIBITOR_PATHWAY,SET,14,0.028543,0.00078792,0.27618,0.45884,WP_ACE_INHIBITOR_PATHWAY,0.99999
MILI_PSEUDOPODIA_CHEMOTAXIS_...1,SET,419,0.0041617,0.00062152,0.040275,0.45885,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,0.99999
WP_SARSCOV2_INNATE_IMMUNITY_...,SET,62,0.011617,0.00067397,0.11245,0.45886,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.99999
KEGG_MEDICUS_REFERENCE_SKELE...,SET,21,0.021137,0.00071449,0.2047,0.45888,KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING,0.99999
HP_NEUROMA,SET,6,0.03217,0.0005815,0.31177,0.45891,HP_NEUROMA,0.99999
GOBP_INSULIN_LIKE_GROWTH_FAC...,SET,48,0.013582,0.00069361,0.13187,0.45898,GOBP_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE21927_GMCSF_IL6_VS_GMCSF_...2,SET,144,0.0072149,0.00063648,0.07004,0.45898,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,0.99999
HP_ERLENMEYER_FLASK_DEFORMIT...,SET,8,0.033449,0.0006981,0.32494,0.45901,HP_ERLENMEYER_FLASK_DEFORMITY_OF_THE_FEMURS,0.99999
HP_ABNORMAL_MASTOID_MORPHOLO...,SET,10,0.027937,0.00065185,0.2715,0.45902,HP_ABNORMAL_MASTOID_MORPHOLOGY,0.99999
REACTOME_RUNX1_REGULATES_GEN...,SET,35,0.015296,0.00066725,0.1487,0.45903,REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION,0.99999
HP_EEG_WITH_POLYSPIKE_WAVE_C...,SET,46,0.013721,0.00068599,0.13352,0.45908,HP_EEG_WITH_POLYSPIKE_WAVE_COMPLEXES,0.99999
HP_HORIZONTAL_NYSTAGMUS,SET,102,0.0084433,0.00062761,0.082251,0.45912,HP_HORIZONTAL_NYSTAGMUS,0.99999
GOBP_MITOTIC_SPINDLE_ASSEMBLY,SET,68,0.010164,0.00061743,0.099042,0.45913,GOBP_MITOTIC_SPINDLE_ASSEMBLY,0.99999
HP_TYPE_II_TRANSFERRIN_ISOFO...,SET,13,0.024757,0.00065857,0.24122,0.45913,HP_TYPE_II_TRANSFERRIN_ISOFORM_PROFILE,0.99999
GSE34156_UNTREATED_VS_6H_NOD...1,SET,146,0.0072456,0.00064358,0.070621,0.45914,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.99999
GOBP_DNA_CONFORMATION_CHANGE,SET,83,0.0089356,0.00059947,0.087135,0.45916,GOBP_DNA_CONFORMATION_CHANGE,0.99999
GSE9006_TYPE_1_DIABETES_AT_D...4,SET,184,0.0063544,0.00063297,0.06196,0.45916,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP,0.99999
SETBP1_TARGET_GENES,SET,149,0.0072234,0.00064812,0.070472,0.45918,SETBP1_TARGET_GENES,0.99999
HP_ECZEMATOID_DERMATITIS,SET,145,0.0071605,0.00063386,0.06987,0.45919,HP_ECZEMATOID_DERMATITIS,0.99999
GSE12366_GC_VS_MEMORY_BCELL_...1,SET,180,0.0066056,0.00065087,0.06456,0.45925,GSE12366_GC_VS_MEMORY_BCELL_DN,0.99999
HP_AUTOIMMUNE_ANTIBODY_POSIT...,SET,148,0.00754,0.00067427,0.073709,0.45926,HP_AUTOIMMUNE_ANTIBODY_POSITIVITY,0.99999
HP_THORACOLUMBAR_SCOLIOSIS,SET,37,0.013273,0.00059529,0.12976,0.45926,HP_THORACOLUMBAR_SCOLIOSIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...112,SET,11,0.026724,0.00065397,0.26145,0.45929,GOBP_POSITIVE_REGULATION_OF_CELLULAR_SENESCENCE,0.99999
AZARE_NEOPLASTIC_TRANSFORMAT...1,SET,17,0.022707,0.00069067,0.22226,0.45931,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN,0.99999
REACTOME_THROMBIN_SIGNALLING...,SET,32,0.017071,0.00071209,0.16706,0.45931,REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS,0.99999
GOBP_POSITIVE_REGULATION_OF_...281,SET,5,0.041818,0.00069004,0.40927,0.45931,GOBP_POSITIVE_REGULATION_OF_FERTILIZATION,0.99999
GSE22140_GERMFREE_VS_SPF_MOU...2,SET,184,0.0065683,0.00065427,0.064295,0.45932,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP,0.99999
GOBP_PROTEIN_ACYLATION,SET,83,0.0091573,0.00061434,0.089686,0.45934,GOBP_PROTEIN_ACYLATION,0.99999
GSE41087_WT_VS_FOXP3_MUT_ANT...1,SET,173,0.006313,0.00060994,0.061831,0.45934,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...9,SET,187,0.0064906,0.00065174,0.063598,0.45936,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN,0.99999
ZHENG_FOXP3_TARGETS_IN_THYMU...2,SET,189,0.0067906,0.00068546,0.066648,0.45942,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,0.99999
GOCC_ENDOPEPTIDASE_COMPLEX,SET,84,0.0087039,0.00058742,0.085413,0.45942,GOCC_ENDOPEPTIDASE_COMPLEX,0.99999
MORI_PRE_BI_LYMPHOCYTE_UP,SET,73,0.010197,0.00064171,0.10012,0.45944,MORI_PRE_BI_LYMPHOCYTE_UP,0.99999
SCHAEFFER_SOX9_TARGETS_IN_PR...2,SET,19,0.022529,0.00072439,0.2212,0.45944,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,0.99999
MODULE_537,SET,17,0.021701,0.00066007,0.21342,0.4595,MODULE_537,0.99999
GOCC_NUCLEOLUS,SET,908,0.002806,0.00060843,0.027666,0.45961,GOCC_NUCLEOLUS,0.99999
GOBP_VENTRAL_SPINAL_CORD_INT...,SET,13,0.026531,0.00070576,0.26176,0.45964,GOBP_VENTRAL_SPINAL_CORD_INTERNEURON_DIFFERENTIATION,0.99999
GOBP_PROTECTION_FROM_NATURAL...,SET,6,0.038567,0.00069713,0.3814,0.45973,GOBP_PROTECTION_FROM_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,0.99999
GOMF_TRANSLATION_REGULATOR_A...1,SET,115,0.0074807,0.00059022,0.074157,0.45983,GOMF_TRANSLATION_REGULATOR_ACTIVITY,0.99999
GOBP_AMINO_ACID_SALVAGE,SET,7,0.037753,0.00073707,0.37506,0.45991,GOBP_AMINO_ACID_SALVAGE,0.99999
HP_VITILIGO,SET,22,0.019769,0.00068393,0.19659,0.45995,HP_VITILIGO,0.99999
GOBP_NEGATIVE_REGULATION_OF_...682,SET,5,0.045153,0.00074507,0.44921,0.45997,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,0.99999
HP_NEOPLASM_OF_THE_PITUITARY...,SET,64,0.01008,0.00059412,0.10028,0.45997,HP_NEOPLASM_OF_THE_PITUITARY_GLAND,0.99999
REACTOME_TICAM1_RIP1_MEDIATE...,SET,17,0.022062,0.00067105,0.21986,0.46004,REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,0.99999
GSE21670_STAT3_KO_VS_WT_CD4_...4,SET,175,0.0067299,0.00065394,0.067087,0.46005,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_DN,0.99999
HP_RENAL_TUBULAR_ACIDOSIS,SET,39,0.014085,0.00064849,0.14049,0.46007,HP_RENAL_TUBULAR_ACIDOSIS,0.99999
GSE360_LOW_DOSE_B_MALAYI_VS_...2,SET,183,0.0060278,0.00059882,0.060127,0.46007,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,0.99999
GOMF_UBIQUITIN_LIKE_PROTEIN_...8,SET,5,0.034546,0.00057005,0.34485,0.4601,GOMF_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_ENDOPEPTIDASE_ACTIVITY,0.99999
GSE1925_CTRL_VS_IFNG_PRIMED_...3,SET,115,0.0081672,0.00064439,0.081591,0.46013,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_DN,0.99999
PID_TCR_RAS_PATHWAY,SET,13,0.024694,0.00065689,0.24693,0.46017,PID_TCR_RAS_PATHWAY,0.99999
MODULE_110,SET,4,0.032444,0.00047885,0.32442,0.46017,MODULE_110,0.99999
GOBP_ACTIN_CROSSLINK_FORMATI...,SET,13,0.026518,0.00070541,0.26527,0.46019,GOBP_ACTIN_CROSSLINK_FORMATION,0.99999
GOBP_ESTABLISHMENT_OF_ENDOTH...1,SET,50,0.012868,0.00067062,0.12874,0.46019,GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_BARRIER,0.99999
OHM_EMBRYONIC_CARCINOMA_DN,SET,8,0.033959,0.00070874,0.34001,0.46022,OHM_EMBRYONIC_CARCINOMA_DN,0.99999
ENK_UV_RESPONSE_EPIDERMIS_DN,SET,481,0.0041014,0.00065513,0.041102,0.46026,ENK_UV_RESPONSE_EPIDERMIS_DN,0.99999
GOBP_NON_MEMBRANE_BOUNDED_OR...,SET,385,0.0042029,0.00060223,0.042116,0.46026,GOBP_NON_MEMBRANE_BOUNDED_ORGANELLE_ASSEMBLY,0.99999
GSE1460_CD4_THYMOCYTE_VS_NAI...1,SET,174,0.0065435,0.00063402,0.065682,0.46032,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,0.99999
GOBP_POLY_A_PLUS_MRNA_EXPORT...,SET,18,0.01717,0.00053738,0.17239,0.46033,GOBP_POLY_A_PLUS_MRNA_EXPORT_FROM_NUCLEUS,0.99999
GOCC_SEMAPHORIN_RECEPTOR_COM...,SET,11,0.028362,0.00069405,0.28493,0.46036,GOCC_SEMAPHORIN_RECEPTOR_COMPLEX,0.99999
GOBP_LEUKOCYTE_DIFFERENTIATI...,SET,579,0.0037962,0.00066347,0.038147,0.46037,GOBP_LEUKOCYTE_DIFFERENTIATION,0.99999
GSE24142_DN2_VS_DN3_THYMOCYT...2,SET,173,0.006484,0.00062647,0.065184,0.46038,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP,0.99999
SEMBA_FHIT_TARGETS_UP,SET,11,0.023814,0.00058275,0.23946,0.46039,SEMBA_FHIT_TARGETS_UP,0.99999
MORF_RRM1,SET,89,0.0082184,0.00057084,0.082715,0.46043,MORF_RRM1,0.99999
GOCC_POST_MRNA_RELEASE_SPLIC...,SET,10,0.025634,0.0005981,0.25809,0.46044,GOCC_POST_MRNA_RELEASE_SPLICEOSOMAL_COMPLEX,0.99999
GOCC_CUL4B_RING_E3_UBIQUITIN...,SET,5,0.031622,0.0005218,0.31893,0.46051,GOCC_CUL4B_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.99999
PID_HNF3B_PATHWAY,SET,43,0.013898,0.00067182,0.14053,0.46061,PID_HNF3B_PATHWAY,0.99999
GOMF_1_PHOSPHATIDYLINOSITOL_...5,SET,8,0.030244,0.00063121,0.30663,0.46071,GOMF_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_ACTIVITY,0.99999
LA_MEN1_TARGETS,SET,21,0.019825,0.00067015,0.2013,0.46077,LA_MEN1_TARGETS,0.99999
HP_ABNORMAL_CARDIOVASCULAR_S...,SET,1282,0.0024438,0.00062285,0.024815,0.46078,HP_ABNORMAL_CARDIOVASCULAR_SYSTEM_PHYSIOLOGY,0.99999
SEKI_INFLAMMATORY_RESPONSE_L...2,SET,72,0.011127,0.00069549,0.11311,0.46082,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,0.99999
GSE25087_FETAL_VS_ADULT_TREG...2,SET,176,0.0061358,0.0005979,0.06249,0.46089,GSE25087_FETAL_VS_ADULT_TREG_UP,0.99999
WP_SMITHMAGENIS_AND_POTOCKIL...,SET,144,0.0076333,0.0006734,0.077799,0.46092,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,0.99999
GCM_BNIP1,SET,67,0.0097212,0.00058621,0.099175,0.46096,GCM_BNIP1,0.99999
GOBP_NEGATIVE_REGULATION_OF_...64,SET,14,0.020791,0.00057394,0.21234,0.461,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT,0.99999
STEIN_ESRRA_TARGETS_DN,SET,94,0.008501,0.00060674,0.086867,0.46102,STEIN_ESRRA_TARGETS_DN,0.99999
KAUFFMANN_MELANOMA_RELAPSE_DN,SET,6,0.032642,0.00059003,0.33371,0.46104,KAUFFMANN_MELANOMA_RELAPSE_DN,0.99999
chr6q13,SET,19,0.02965,0.00095339,0.30334,0.46107,chr6q13,0.99999
KEGG_MEDICUS_REFERENCE_IGF_I...3,SET,13,0.022032,0.0005861,0.22543,0.46107,KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY,0.99999
GOMF_TRANSLATION_REPRESSOR_A...,SET,30,0.014022,0.00056638,0.14346,0.46107,GOMF_TRANSLATION_REPRESSOR_ACTIVITY,0.99999
GSE19941_UNSTIM_VS_LPS_STIM_...4,SET,182,0.0059959,0.00059404,0.0614,0.4611,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.99999
DESCARTES_FETAL_PANCREAS_MYE...,SET,185,0.006612,0.0006604,0.067711,0.46111,DESCARTES_FETAL_PANCREAS_MYELOID_CELLS,0.99999
GOMF_ISOMERASE_ACTIVITY,SET,158,0.0062036,0.00057304,0.063578,0.46114,GOMF_ISOMERASE_ACTIVITY,0.99999
GSE13485_CTRL_VS_DAY7_YF17D_...1,SET,187,0.0063688,0.0006395,0.065284,0.46114,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN,0.99999
GSE24492_LYVE_NEG_VS_POS_MAC...1,SET,177,0.0062856,0.00061421,0.064447,0.46115,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_DN,0.99999
ZNF184_TARGET_GENES,SET,1075,0.0025816,0.00060616,0.026475,0.46116,ZNF184_TARGET_GENES,0.99999
GOCC_VCP_NPL4_UFD1_AAA_ATPAS...,SET,7,0.032107,0.00062684,0.32979,0.46122,GOCC_VCP_NPL4_UFD1_AAA_ATPASE_COMPLEX,0.99999
MIR5194,SET,33,0.014953,0.00063339,0.15373,0.46126,MIR5194,0.99999
KUMAR_TARGETS_OF_MLL_AF9_FUS...,SET,367,0.0044943,0.00062907,0.046264,0.46131,KUMAR_TARGETS_OF_MLL_AF9_FUSION,0.99999
WP_TYPE_III_INTERFERON_SIGNA...,SET,10,0.025399,0.00059263,0.26147,0.46131,WP_TYPE_III_INTERFERON_SIGNALING,0.99999
HP_LUPUS_NEPHRITIS,SET,25,0.017884,0.00065953,0.18427,0.46134,HP_LUPUS_NEPHRITIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...194,SET,5,0.036329,0.00059947,0.37475,0.46139,GOBP_NEGATIVE_REGULATION_OF_DOPAMINE_SECRETION,0.99999
HP_FINGER_SYNDACTYLY,SET,177,0.0061525,0.0006012,0.063519,0.46142,HP_FINGER_SYNDACTYLY,0.99999
GOBP_NEUROTRANSMITTER_GATED_...,SET,15,0.023831,0.00068092,0.24641,0.46148,GOBP_NEUROTRANSMITTER_GATED_ION_CHANNEL_CLUSTERING,0.99999
FIGUEROA_AML_METHYLATION_CLU...9,SET,42,0.014562,0.00069572,0.15067,0.4615,FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,0.99999
XPO1_TARGET_GENES,SET,19,0.020409,0.00065624,0.21113,0.4615,XPO1_TARGET_GENES,0.99999
GOBP_POSITIVE_REGULATION_OF_...201,SET,4,0.046809,0.00069088,0.48456,0.46152,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MAINTENANCE,0.99999
GSE43863_DAY6_EFF_VS_DAY150_...3,SET,181,0.0064204,0.00063436,0.066559,0.46158,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_DN,0.99999
WP_MICROGLIA_PATHOGEN_PHAGOC...,SET,37,0.014275,0.00064023,0.14818,0.46163,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.99999
KONDO_COLON_CANCER_HCP_WITH_...2,SET,4,0.046158,0.00068127,0.47929,0.46164,KONDO_COLON_CANCER_HCP_WITH_H3K27ME3,0.99999
AML1_01,SET,251,0.0053473,0.00062096,0.055543,0.46165,AML1_01,0.99999
AML1_Q6,SET,251,0.0053473,0.00062096,0.055543,0.46165,AML1_Q6,0.99999
GSE39820_CTRL_VS_TGFBETA1_IL...3,SET,179,0.0059562,0.00058527,0.061894,0.46167,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_DN,0.99999
WP_LEUKOTRIENE_METABOLIC_PAT...,SET,13,0.023384,0.00062204,0.24319,0.4617,WP_LEUKOTRIENE_METABOLIC_PATHWAY,0.99999
GSE37301_HEMATOPOIETIC_STEM_...5,SET,162,0.006651,0.00062203,0.069206,0.46172,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN,0.99999
GRANDVAUX_IRF3_TARGETS_UP,SET,13,0.023757,0.00063197,0.24737,0.46175,GRANDVAUX_IRF3_TARGETS_UP,0.99999
HP_GOWERS_SIGN,SET,68,0.010445,0.00063454,0.10882,0.46177,HP_GOWERS_SIGN,0.99999
GOCC_CONDENSED_CHROMOSOME_CE...,SET,164,0.0061324,0.00057702,0.063941,0.4618,GOCC_CONDENSED_CHROMOSOME_CENTROMERIC_REGION,0.99999
MAINA_HYPOXIA_VHL_TARGETS_UP,SET,6,0.041141,0.00074365,0.42957,0.46185,MAINA_HYPOXIA_VHL_TARGETS_UP,0.99999
HP_ANTERIOR_BEAKING_OF_LUMBA...,SET,5,0.036813,0.00060746,0.38469,0.46188,HP_ANTERIOR_BEAKING_OF_LUMBAR_VERTEBRAE,0.99999
GSE5589_LPS_AND_IL10_VS_LPS_...3,SET,179,0.0061937,0.00060861,0.064712,0.46188,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,0.99999
MIR873_5P,SET,101,0.00828,0.00061247,0.086683,0.46195,MIR873_5P,0.99999
HP_HYPSARRHYTHMIA,SET,159,0.0064922,0.00060157,0.068107,0.46203,HP_HYPSARRHYTHMIA,0.99999
GSE9650_EFFECTOR_VS_EXHAUSTE...1,SET,177,0.0063806,0.00062349,0.067012,0.46207,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN,0.99999
REACTOME_SIGNALING_BY_NOTCH1...1,SET,14,0.022673,0.00062589,0.23831,0.4621,REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER,0.99999
HP_ORTHOPNEA,SET,68,0.010216,0.00062063,0.10769,0.46221,HP_ORTHOPNEA,0.99999
KEGG_PATHWAYS_IN_CANCER,SET,310,0.0048165,0.00062058,0.050805,0.46224,KEGG_PATHWAYS_IN_CANCER,0.99999
GSE17186_MEMORY_VS_CD21LOW_T...2,SET,176,0.0059042,0.00057532,0.062286,0.46224,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_UP,0.99999
TST1_01,SET,219,0.0058377,0.00063379,0.061688,0.4623,TST1_01,0.99999
MODULE_363,SET,41,0.011572,0.00054628,0.12228,0.4623,MODULE_363,0.99999
GOBP_POSITIVE_REGULATION_OF_...197,SET,7,0.029523,0.00057638,0.31225,0.46234,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,0.99999
GOBP_DNA_DAMAGE_RESPONSE_SIG...3,SET,15,0.020215,0.00057759,0.2142,0.46241,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_RESULTING_IN_TRANSCRIPTION,0.99999
AUJLA_IL22_AND_IL17A_SIGNALI...,SET,10,0.025301,0.00059035,0.26884,0.46251,AUJLA_IL22_AND_IL17A_SIGNALING,0.99999
RBM17_TARGET_GENES,SET,5,0.034362,0.00056702,0.36517,0.46252,RBM17_TARGET_GENES,0.99999
HP_CEREBRAL_CAVERNOUS_MALFOR...,SET,5,0.030396,0.00050157,0.32315,0.46253,HP_CEREBRAL_CAVERNOUS_MALFORMATION,0.99999
GSE25088_CTRL_VS_ROSIGLITAZO...1,SET,138,0.0066693,0.00057606,0.071,0.46258,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.99999
ZHONG_PFC_C2_THY1_POS_OPC,SET,22,0.018849,0.00065213,0.20076,0.4626,ZHONG_PFC_C2_THY1_POS_OPC,0.99999
WTGAAAT_UNKNOWN,SET,529,0.0037049,0.00061979,0.039491,0.46263,WTGAAAT_UNKNOWN,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...50,SET,85,0.0085771,0.00058228,0.091445,0.46264,HP_APLASIA_HYPOPLASIA_OF_THE_OVARY,0.99999
GOBP_POSITIVE_REGULATION_OF_...416,SET,6,0.034973,0.00063216,0.37305,0.46265,GOBP_POSITIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
HP_BRANCHIAL_FISTULA,SET,9,0.029347,0.00064963,0.3132,0.46267,HP_BRANCHIAL_FISTULA,0.99999
HP_MULTIPLE_SUTURE_CRANIOSYN...,SET,11,0.02341,0.00057286,0.25018,0.46272,HP_MULTIPLE_SUTURE_CRANIOSYNOSTOSIS,0.99999
STAT5A_03,SET,233,0.0055275,0.00061875,0.059086,0.46273,STAT5A_03,0.99999
HP_RENOVASCULAR_HYPERTENSION,SET,25,0.016377,0.00060395,0.17511,0.46274,HP_RENOVASCULAR_HYPERTENSION,0.99999
GOBP_PULMONARY_VALVE_DEVELOP...,SET,24,0.019053,0.00068844,0.20374,0.46275,GOBP_PULMONARY_VALVE_DEVELOPMENT,0.99999
GSE43863_DAY6_EFF_VS_DAY150_...5,SET,183,0.0061739,0.00061334,0.066083,0.46278,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...582,SET,5,0.036664,0.000605,0.39266,0.4628,GOBP_NEGATIVE_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_PROGRAMMED_NECROTIC_CEL...,SET,47,0.011695,0.00059099,0.1255,0.46288,GOBP_PROGRAMMED_NECROTIC_CELL_DEATH,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...5,SET,46,0.012413,0.00062057,0.13323,0.46289,GAVISH_3CA_MALIGNANT_METAPROGRAM_14_EMT_3,0.99999
PID_ALK2_PATHWAY,SET,10,0.026449,0.00061714,0.28403,0.4629,PID_ALK2_PATHWAY,0.99999
MIR4725_3P,SET,260,0.0048118,0.00056857,0.051671,0.4629,MIR4725_3P,0.99999
GOBP_RESPONSE_TO_GRAVITY,SET,8,0.027128,0.00056618,0.29129,0.4629,GOBP_RESPONSE_TO_GRAVITY,0.99999
HP_PATCHY_PALMOPLANTAR_HYPER...,SET,6,0.037459,0.00067709,0.40234,0.46291,HP_PATCHY_PALMOPLANTAR_HYPERKERATOSIS,0.99999
WP_EXERCISEINDUCED_CIRCADIAN...,SET,46,0.011946,0.00059725,0.12837,0.46293,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,0.99999
NR5A1_TARGET_GENES,SET,11,0.024194,0.00059207,0.2603,0.46297,NR5A1_TARGET_GENES,0.99999
HALLMARK_UNFOLDED_PROTEIN_RE...,SET,104,0.0077088,0.00057857,0.082953,0.46298,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.99999
GOMF_AZOLE_TRANSMEMBRANE_TRA...,SET,12,0.024424,0.00062423,0.2629,0.46299,GOMF_AZOLE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_REGULATION_OF_G2_MI_TRA...,SET,4,0.036198,0.00053426,0.3897,0.463,GOBP_REGULATION_OF_G2_MI_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.99999
chr7q22,SET,121,0.016488,0.0013341,0.17777,0.46305,chr7q22,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...9,SET,172,0.0060358,0.00058149,0.065194,0.46312,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP,0.99999
GOMF_NUCLEOSIDE_MONOPHOSPHAT...,SET,19,0.017846,0.00057382,0.1928,0.46313,GOMF_NUCLEOSIDE_MONOPHOSPHATE_KINASE_ACTIVITY,0.99999
GOBP_AUTOPHAGY_OF_MITOCHONDR...,SET,91,0.0081034,0.00056911,0.087664,0.46318,GOBP_AUTOPHAGY_OF_MITOCHONDRION,0.99999
GOCC_MHC_CLASS_I_PROTEIN_COM...,SET,9,0.02873,0.00063598,0.31093,0.46319,GOCC_MHC_CLASS_I_PROTEIN_COMPLEX,0.99999
KEGG_MEDICUS_REFERENCE_DISAS...,SET,16,0.018685,0.00055138,0.20232,0.46321,KEGG_MEDICUS_REFERENCE_DISASSEMBLY_OF_MCC,0.99999
GSE15750_WT_VS_TRAF6KO_DAY6_...2,SET,176,0.0056931,0.00055475,0.06173,0.46326,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP,0.99999
GSE43955_TH0_VS_TGFB_IL6_IL2...2,SET,182,0.0059136,0.00058588,0.064144,0.46327,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,0.99999
WP_OSTEOCLAST_SIGNALING,SET,16,0.020341,0.00060025,0.22106,0.46334,WP_OSTEOCLAST_SIGNALING,0.99999
CCCAGAG_MIR326,SET,137,0.0067769,0.00058325,0.073656,0.46335,CCCAGAG_MIR326,0.99999
GOBP_MAINTENANCE_OF_PRESYNAP...,SET,5,0.038581,0.00063664,0.4194,0.46335,GOBP_MAINTENANCE_OF_PRESYNAPTIC_ACTIVE_ZONE_STRUCTURE,0.99999
REACTOME_TP53_REGULATES_TRAN...9,SET,18,0.01736,0.00054334,0.18884,0.46338,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST,0.99999
GSE5503_MLN_DC_VS_PLN_DC_ACT...1,SET,183,0.0059282,0.00058892,0.064495,0.46338,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.99999
GOBP_PENTOSE_METABOLIC_PROCE...,SET,12,0.023059,0.00058936,0.25093,0.46339,GOBP_PENTOSE_METABOLIC_PROCESS,0.99999
TIEN_INTESTINE_PROBIOTICS_24...2,SET,514,0.0033339,0.00054999,0.036407,0.46352,TIEN_INTESTINE_PROBIOTICS_24HR_UP,0.99999
GROSS_HYPOXIA_VIA_ELK3_AND_H...2,SET,125,0.007211,0.000593,0.078765,0.46353,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,0.99999
MIR449C_3P,SET,50,0.010818,0.00056381,0.11825,0.46355,MIR449C_3P,0.99999
GOBP_MICROTUBULE_POLYMERIZAT...2,SET,124,0.0067156,0.00055006,0.073427,0.46356,GOBP_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,0.99999
GOBP_RESPONSE_TO_INTERLEUKIN...10,SET,32,0.015292,0.00063791,0.16755,0.46364,GOBP_RESPONSE_TO_INTERLEUKIN_6,0.99999
MIR515_5P,SET,282,0.0046681,0.00057411,0.05119,0.46367,MIR515_5P,0.99999
GOBP_ENDOCYTIC_RECYCLING,SET,74,0.0091705,0.00058106,0.10059,0.46368,GOBP_ENDOCYTIC_RECYCLING,0.99999
HP_INCREASED_CIRCULATING_INT...1,SET,20,0.017773,0.00058631,0.19492,0.46368,HP_INCREASED_CIRCULATING_INTERFERON_GAMMA_CONCENTRATION,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...56,SET,24,0.016041,0.00057963,0.17601,0.46369,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.99999
GSE12198_CTRL_VS_HIGH_IL2_ST...1,SET,186,0.0055591,0.00055672,0.061044,0.46372,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_DN,0.99999
MIR15B_5P,SET,532,0.0033602,0.00056366,0.036921,0.46374,MIR15B_5P,0.99999
GSE30971_WBP7_HET_VS_KO_MACR...3,SET,173,0.0059518,0.00057505,0.065388,0.46374,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_DN,0.99999
MIR4669,SET,10,0.02281,0.00053222,0.25095,0.46379,MIR4669,0.99999
GSE26030_TH1_VS_TH17_RESTIMU...2,SET,175,0.0059833,0.00058139,0.065956,0.46386,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP,0.99999
GSE44955_MCSF_VS_MCSF_AND_IL...2,SET,175,0.0058602,0.00056943,0.064619,0.46387,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...77,SET,8,0.026982,0.00056314,0.29797,0.46392,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...22,SET,4,0.04327,0.00063864,0.47893,0.46401,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_ASCORBATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.99999
KEGG_MEDICUS_VARIANT_SCRAPIE...4,SET,16,0.01956,0.00057722,0.21659,0.46402,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM,0.99999
ZBED5_TARGET_GENES,SET,1305,0.0022114,0.00056826,0.024513,0.46406,ZBED5_TARGET_GENES,0.99999
GSE7568_CTRL_VS_3H_TGFB_TREA...2,SET,139,0.0068443,0.0005933,0.075967,0.46411,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,0.99999
HP_SUBCUTANEOUS_NODULE,SET,87,0.0084462,0.00058007,0.093786,0.46412,HP_SUBCUTANEOUS_NODULE,0.99999
REACTOME_RESPONSE_TO_METAL_I...,SET,14,0.026404,0.00072888,0.29337,0.46414,REACTOME_RESPONSE_TO_METAL_IONS,0.99999
GSE42021_CD24INT_TREG_VS_CD2...1,SET,178,0.0055908,0.00054785,0.062117,0.46414,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_DN,0.99999
GOMF_SHORT_CHAIN_FATTY_ACYL_...,SET,5,0.032581,0.00053761,0.36237,0.46418,GOMF_SHORT_CHAIN_FATTY_ACYL_COA_DEHYDROGENASE_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_NODAL...,SET,8,0.024098,0.00050293,0.26815,0.4642,KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY,0.99999
GSE360_CTRL_VS_B_MALAYI_LOW_...4,SET,181,0.0056511,0.00055835,0.062894,0.4642,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.99999
GOBP_MODULATION_BY_SYMBIONT_...,SET,53,0.011091,0.00059509,0.12368,0.46427,GOBP_MODULATION_BY_SYMBIONT_OF_ENTRY_INTO_HOST,0.99999
GOMF_SHORT_CHAIN_CARBOXYLEST...,SET,6,0.030196,0.00054581,0.33718,0.46432,GOMF_SHORT_CHAIN_CARBOXYLESTERASE_ACTIVITY,0.99999
GOBP_FC_RECEPTOR_MEDIATED_IN...,SET,5,0.039919,0.00065871,0.44616,0.46435,GOBP_FC_RECEPTOR_MEDIATED_INHIBITORY_SIGNALING_PATHWAY,0.99999
TRAVAGLINI_LUNG_PLASMACYTOID...,SET,101,0.0081499,0.00060284,0.091373,0.46446,TRAVAGLINI_LUNG_PLASMACYTOID_DENDRITIC_CELL,0.99999
BIOCARTA_ARF_PATHWAY,SET,17,0.017647,0.00053677,0.1979,0.46447,BIOCARTA_ARF_PATHWAY,0.99999
MOREAUX_B_LYMPHOCYTE_MATURAT...1,SET,69,0.008157,0.00049914,0.091596,0.46452,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN,0.99999
GOBP_CGMP_BIOSYNTHETIC_PROCE...,SET,7,0.030023,0.00058615,0.33718,0.46452,GOBP_CGMP_BIOSYNTHETIC_PROCESS,0.99999
FARMER_BREAST_CANCER_CLUSTER...1,SET,38,0.014126,0.00064201,0.15886,0.46457,FARMER_BREAST_CANCER_CLUSTER_1,0.99999
HE_LIM_SUN_FETAL_LUNG_C5_CD5...3,SET,586,0.0031637,0.00055615,0.035585,0.46458,HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_POS_MATURE_B_CELL,0.99999
chr5p15,SET,52,0.017369,0.00092308,0.19558,0.46462,chr5p15,0.99999
HP_ADENOCARCINOMA_OF_THE_COL...,SET,30,0.012581,0.00050816,0.14174,0.46464,HP_ADENOCARCINOMA_OF_THE_COLON,0.99999
BUSSLINGER_GASTRIC_PARIETAL_...,SET,220,0.0049373,0.00053724,0.055657,0.46466,BUSSLINGER_GASTRIC_PARIETAL_CELLS,0.99999
YGCANTGCR_UNKNOWN,SET,109,0.007249,0.00055691,0.081763,0.46468,YGCANTGCR_UNKNOWN,0.99999
GOCC_INHIBITORY_SYNAPSE,SET,13,0.022635,0.00060211,0.25561,0.46472,GOCC_INHIBITORY_SYNAPSE,0.99999
HP_ABNORMAL_ORAL_FRENULUM_MO...,SET,58,0.0094161,0.00052843,0.10634,0.46472,HP_ABNORMAL_ORAL_FRENULUM_MORPHOLOGY,0.99999
HP_DYSOSTOSIS_MULTIPLEX,SET,21,0.016072,0.00054329,0.18157,0.46473,HP_DYSOSTOSIS_MULTIPLEX,0.99999
GSE22601_DOUBLE_POSITIVE_VS_...1,SET,183,0.0052791,0.00052444,0.059684,0.46476,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.99999
GSE21774_CD62L_POS_CD56_DIM_...2,SET,183,0.0057455,0.00057078,0.065049,0.46481,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,0.99999
GSE3337_CTRL_VS_4H_IFNG_IN_C...1,SET,187,0.0054194,0.00054418,0.061355,0.46481,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN,0.99999
GOCC_CENTRIOLE,SET,144,0.0059558,0.00052541,0.067464,0.46483,GOCC_CENTRIOLE,0.99999
CUI_DEVELOPING_HEART_C7_MAST...,SET,135,0.0067869,0.00057986,0.076911,0.46484,CUI_DEVELOPING_HEART_C7_MAST_CELL,0.99999
HP_ABNORMAL_CORNEAL_STROMA_M...,SET,95,0.0078068,0.00056014,0.088749,0.46495,HP_ABNORMAL_CORNEAL_STROMA_MORPHOLOGY,0.99999
GOBP_CELLULAR_RESPONSE_TO_ST...1,SET,157,0.0060698,0.00055891,0.069057,0.46498,GOBP_CELLULAR_RESPONSE_TO_STARVATION,0.99999
HP_INTERMITTENT_EPISODES_OF_...,SET,13,0.022316,0.00059363,0.25392,0.46498,HP_INTERMITTENT_EPISODES_OF_RESPIRATORY_INSUFFICIENCY_DUE_TO_MUSCLE_WEAKNESS,0.99999
GOMF_LAMININ_1_BINDING,SET,7,0.033748,0.00065887,0.38448,0.46503,GOMF_LAMININ_1_BINDING,0.99999
GOMF_CYSTEINE_TYPE_EXOPEPTID...,SET,4,0.038584,0.00056948,0.43977,0.46504,GOMF_CYSTEINE_TYPE_EXOPEPTIDASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...488,SET,5,0.035706,0.00058919,0.40757,0.4651,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,0.99999
GOBP_DENDRITIC_CELL_MIGRATION,SET,31,0.014574,0.00059838,0.16644,0.46511,GOBP_DENDRITIC_CELL_MIGRATION,0.99999
WP_MYD88_DISTINCT_INPUTOUTPU...,SET,15,0.021928,0.00062654,0.25061,0.46514,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,0.99999
GOBP_POSTSYNAPTIC_SIGNAL_TRA...,SET,46,0.010962,0.00054801,0.12531,0.46515,GOBP_POSTSYNAPTIC_SIGNAL_TRANSDUCTION,0.99999
KEGG_MEDICUS_REFERENCE_E2_ER...,SET,22,0.015259,0.00052792,0.17458,0.46518,KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY,0.99999
REACTOME_RHOA_GTPASE_CYCLE,SET,138,0.0065188,0.00056306,0.074621,0.46519,REACTOME_RHOA_GTPASE_CYCLE,0.99999
DACOSTA_UV_RESPONSE_VIA_ERCC...6,SET,287,0.0042285,0.00052456,0.048426,0.46521,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,0.99999
REACTOME_AMINO_ACIDS_REGULAT...,SET,49,0.01061,0.00054743,0.12155,0.46522,REACTOME_AMINO_ACIDS_REGULATE_MTORC1,0.99999
HP_SHORT_CLAVICLES,SET,29,0.013686,0.00054351,0.1568,0.46523,HP_SHORT_CLAVICLES,0.99999
GOBP_POSITIVE_REGULATION_OF_...739,SET,8,0.026439,0.0005518,0.30305,0.46524,GOBP_POSITIVE_REGULATION_OF_SYNAPSE_MATURATION,0.99999
KYNG_WERNER_SYNDROM_AND_NORM...1,SET,163,0.0054993,0.00051588,0.063054,0.46525,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,0.99999
MODULE_288,SET,34,0.01516,0.00065183,0.174,0.46528,MODULE_288,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...11,SET,174,0.0058458,0.00056642,0.06709,0.46528,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN,0.99999
GOBP_CORTICOTROPIN_SECRETION,SET,6,0.034362,0.00062111,0.3944,0.46529,GOBP_CORTICOTROPIN_SECRETION,0.99999
GSE13493_CD4INTCD8POS_VS_CD8...1,SET,182,0.0052805,0.00052316,0.060626,0.4653,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN,0.99999
HP_HYPEROPIC_ASTIGMATISM,SET,5,0.028487,0.00047008,0.32747,0.46534,HP_HYPEROPIC_ASTIGMATISM,0.99999
ZHAN_MULTIPLE_MYELOMA_PR_UP,SET,41,0.011676,0.00055118,0.13428,0.46535,ZHAN_MULTIPLE_MYELOMA_PR_UP,0.99999
GSE17721_LPS_VS_PAM3CSK4_8H_...2,SET,182,0.005509,0.0005458,0.063475,0.46542,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_UP,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...3,SET,5,0.037229,0.00061431,0.42907,0.46543,HP_APLASIA_HYPOPLASIA_OF_THE_2ND_METACARPAL,0.99999
GSE36527_CD62L_HIGH_VS_CD62L...1,SET,188,0.0053438,0.000538,0.061621,0.46545,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_DN,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...8,SET,181,0.0056961,0.0005628,0.065714,0.46546,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_UP,0.99999
REACTOME_RHOBTB3_ATPASE_CYCLE,SET,8,0.025644,0.00053521,0.2959,0.46547,REACTOME_RHOBTB3_ATPASE_CYCLE,0.99999
GOBP_SOMATIC_STEM_CELL_DIVIS...,SET,11,0.024615,0.00060235,0.28509,0.4656,GOBP_SOMATIC_STEM_CELL_DIVISION,0.99999
HP_PROGEROID_FACIAL_APPEARAN...,SET,29,0.013526,0.00053717,0.15674,0.46562,HP_PROGEROID_FACIAL_APPEARANCE,0.99999
MIR581,SET,73,0.0085527,0.00053825,0.099251,0.46567,MIR581,0.99999
HP_ACTION_TREMOR,SET,167,0.0054952,0.00052173,0.063789,0.46568,HP_ACTION_TREMOR,0.99999
QIU_PBMC_HEPTATITIS_B_SURFAC...4,SET,14,0.021236,0.00058623,0.24664,0.46569,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_28DY_UP,0.99999
MIR6128,SET,153,0.0059488,0.00054081,0.069183,0.46574,MIR6128,0.99999
GOBP_GLYCOSYL_COMPOUND_METAB...,SET,75,0.0092859,0.00059232,0.10808,0.46577,GOBP_GLYCOSYL_COMPOUND_METABOLIC_PROCESS,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...11,SET,163,0.0058342,0.0005473,0.06792,0.46577,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN,0.99999
MIR221_5P,SET,74,0.0085496,0.00054172,0.099717,0.46584,MIR221_5P,0.99999
HP_EMG_MYOTONIC_DISCHARGES,SET,8,0.025557,0.0005334,0.29903,0.46595,HP_EMG_MYOTONIC_DISCHARGES,0.99999
GOMF_PHOSPHATIDIC_ACID_BINDI...,SET,23,0.016046,0.00056762,0.18813,0.46601,GOMF_PHOSPHATIDIC_ACID_BINDING,0.99999
REACTOME_ECM_PROTEOGLYCANS,SET,73,0.0091534,0.00057606,0.10759,0.4661,REACTOME_ECM_PROTEOGLYCANS,0.99999
GOBP_CHROMOSOME_CONDENSATION,SET,31,0.012265,0.00050357,0.14426,0.46612,GOBP_CHROMOSOME_CONDENSATION,0.99999
E2F2_TARGET_GENES,SET,1185,0.0021644,0.00053187,0.025472,0.46614,E2F2_TARGET_GENES,0.99999
GSE29618_PRE_VS_DAY7_POST_TI...7,SET,175,0.0052978,0.00051478,0.062372,0.46616,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN,0.99999
GSE3982_NEUTROPHIL_VS_CENT_M...1,SET,183,0.0050105,0.00049776,0.059017,0.46617,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.99999
KANNAN_TP53_TARGETS_DN,SET,21,0.01696,0.0005733,0.19984,0.46618,KANNAN_TP53_TARGETS_DN,0.99999
REACTOME_MUCOPOLYSACCHARIDOS...,SET,10,0.023227,0.00054196,0.2738,0.4662,REACTOME_MUCOPOLYSACCHARIDOSES,0.99999
GOBP_ESTABLISHMENT_OF_SISTER...,SET,7,0.033341,0.00065092,0.39313,0.46621,GOBP_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,0.99999
HP_ATELECTASIS,SET,67,0.0089794,0.00054147,0.10589,0.46621,HP_ATELECTASIS,0.99999
REACTOME_INFECTION_WITH_MYCO...,SET,25,0.014095,0.00051978,0.16624,0.46622,REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...442,SET,113,0.0070613,0.0005523,0.083292,0.46622,GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,0.99999
GOMF_PEROXISOME_PROLIFERATOR...,SET,10,0.027798,0.0006486,0.32826,0.46626,GOMF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_BINDING,0.99999
MIR5196_3P,SET,60,0.00933,0.00053252,0.1104,0.46633,MIR5196_3P,0.99999
HP_AORTIC_ANEURYSM,SET,152,0.0059225,0.00053667,0.07011,0.46634,HP_AORTIC_ANEURYSM,0.99999
MODULE_242,SET,187,0.0052993,0.00053211,0.062742,0.46635,MODULE_242,0.99999
GOMF_PHOSPHATIDYLINOSITOL_PH...4,SET,23,0.012842,0.00045428,0.15215,0.46637,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.99999
HP_ELEVATED_CREATINE_KINASE_...,SET,10,0.022075,0.00051506,0.26185,0.46641,HP_ELEVATED_CREATINE_KINASE_AFTER_EXERCISE,0.99999
HP_ABNORMAL_CIRCULATING_SERI...2,SET,30,0.012993,0.00052481,0.15425,0.46644,HP_ABNORMAL_CIRCULATING_SERINE_FAMILY_AMINO_ACID_CONCENTRATION,0.99999
FIRESTEIN_PROLIFERATION,SET,150,0.0057782,0.00052017,0.06871,0.46649,FIRESTEIN_PROLIFERATION,0.99999
KEGG_MEDICUS_REFERENCE_CXCR_...1,SET,27,0.014778,0.00056633,0.17585,0.46651,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY,0.99999
REACTOME_EPHB_MEDIATED_FORWA...,SET,41,0.011337,0.00053515,0.13494,0.46652,REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,0.99999
MIR5585_5P,SET,115,0.0066471,0.00052445,0.079132,0.46653,MIR5585_5P,0.99999
GOBP_REGULATION_OF_TYPE_2_IM...,SET,34,0.013124,0.00056427,0.15644,0.46657,GOBP_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,0.99999
HP_ABNORMAL_PERIPHERAL_ACTIO...,SET,37,0.01194,0.00053549,0.14237,0.46658,HP_ABNORMAL_PERIPHERAL_ACTION_POTENTIAL_AMPLITUDE,0.99999
GSE339_EX_VIVO_VS_IN_CULTURE...5,SET,187,0.0054438,0.00054662,0.064997,0.46663,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN,0.99999
HP_NON_OBSTRUCTIVE_AZOOSPERM...,SET,48,0.0099506,0.00050814,0.11884,0.46664,HP_NON_OBSTRUCTIVE_AZOOSPERMIA,0.99999
HALLMARK_ADIPOGENESIS,SET,186,0.0050852,0.00050926,0.060817,0.46668,HALLMARK_ADIPOGENESIS,0.99999
GOCC_OUTER_KINETOCHORE,SET,19,0.016377,0.00052658,0.19589,0.46669,GOCC_OUTER_KINETOCHORE,0.99999
HP_PROGRESSIVE_GAIT_ATAXIA,SET,26,0.013391,0.00050358,0.16036,0.46673,HP_PROGRESSIVE_GAIT_ATAXIA,0.99999
ZSCAN23_TARGET_GENES,SET,63,0.009134,0.00053416,0.10946,0.46675,ZSCAN23_TARGET_GENES,0.99999
MIR4742_5P,SET,169,0.0056847,0.00054292,0.068184,0.46678,MIR4742_5P,0.99999
PID_TNF_PATHWAY,SET,43,0.010261,0.00049601,0.12338,0.46686,PID_TNF_PATHWAY,0.99999
GOMF_PROTON_TRANSMEMBRANE_TR...,SET,143,0.0056352,0.00049541,0.067815,0.46689,GOMF_PROTON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
INGA_TP53_TARGETS,SET,16,0.017457,0.00051514,0.21017,0.4669,INGA_TP53_TARGETS,0.99999
GOMF_PROTEIN_BINDING_INVOLVE...,SET,12,0.023693,0.00060555,0.28521,0.4669,GOMF_PROTEIN_BINDING_INVOLVED_IN_HETEROTYPIC_CELL_CELL_ADHESION,0.99999
GOMF_SEMAPHORIN_RECEPTOR_BIN...,SET,23,0.015511,0.00054868,0.18688,0.46693,GOMF_SEMAPHORIN_RECEPTOR_BINDING,0.99999
HP_ABNORMALITY_OF_DERMAL_MEL...,SET,5,0.033753,0.00055696,0.4069,0.46695,HP_ABNORMALITY_OF_DERMAL_MELANOSOMES,0.99999
REACTOME_SUMOYLATION_OF_TRAN...2,SET,19,0.016269,0.00052313,0.19671,0.46704,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS,0.99999
GSE40666_STAT1_KO_VS_STAT4_K...4,SET,167,0.0050042,0.00047511,0.060518,0.46705,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.99999
GOBP_RESPONSE_TO_LEPTIN,SET,21,0.016375,0.00055353,0.19818,0.46707,GOBP_RESPONSE_TO_LEPTIN,0.99999
REACTOME_SYNTHESIS_SECRETION...3,SET,12,0.019928,0.00050934,0.24126,0.46709,REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP,0.99999
GOMF_DNA_DEMETHYLASE_ACTIVITY,SET,5,0.027565,0.00045485,0.33416,0.46713,GOMF_DNA_DEMETHYLASE_ACTIVITY,0.99999
MIR4638_3P,SET,56,0.0093256,0.00051428,0.11319,0.46717,MIR4638_3P,0.99999
ACTGAAA_MIR30A3P_MIR30E3P,SET,180,0.0052095,0.00051331,0.063311,0.46721,ACTGAAA_MIR30A3P_MIR30E3P,0.99999
MIR4709_3P,SET,148,0.005864,0.00052439,0.071331,0.46724,MIR4709_3P,0.99999
GSE29618_LAIV_VS_TIV_FLU_VAC...4,SET,179,0.0053619,0.00052687,0.0653,0.46728,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP,0.99999
MURARO_PANCREAS_PANCREATIC_P...,SET,134,0.0066961,0.00057,0.081588,0.4673,MURARO_PANCREAS_PANCREATIC_POLYPEPTIDE_CELL,0.99999
GOCC_KINETOCHORE_MICROTUBULE,SET,19,0.015802,0.0005081,0.19269,0.46732,GOCC_KINETOCHORE_MICROTUBULE,0.99999
AGTCAGC_MIR345,SET,55,0.0085697,0.00046836,0.10454,0.46733,AGTCAGC_MIR345,0.99999
MIR6826_3P,SET,93,0.0068732,0.00048796,0.084038,0.46741,MIR6826_3P,0.99999
ZHONG_PFC_C3_HOPX_POS_OPC,SET,7,0.0263,0.00051346,0.32154,0.46741,ZHONG_PFC_C3_HOPX_POS_OPC,0.99999
MIR148A_5P,SET,102,0.0068786,0.0005113,0.084213,0.46745,MIR148A_5P,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...12,SET,9,0.025082,0.00055521,0.30725,0.46747,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_OMD...,SET,323,0.0041743,0.00054881,0.051167,0.46749,HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL,0.99999
BENPORATH_OCT4_TARGETS,SET,258,0.0045481,0.00053538,0.055776,0.46751,BENPORATH_OCT4_TARGETS,0.99999
HP_MICROGLOSSIA,SET,17,0.017181,0.0005226,0.21082,0.46752,HP_MICROGLOSSIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...136,SET,4,0.034894,0.00051502,0.42852,0.46755,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,0.99999
HP_LARGE_FACE,SET,225,0.0045714,0.00050298,0.056219,0.4676,HP_LARGE_FACE,0.99999
HP_ELEVATED_CIRCULATING_CALC...,SET,22,0.01319,0.00045633,0.16239,0.46763,HP_ELEVATED_CIRCULATING_CALCITONIN_CONCENTRATION,0.99999
PRC1_BMI_UP.V1_DN,SET,155,0.0055763,0.00051022,0.068662,0.46764,PRC1_BMI_UP.V1_DN,0.99999
GSE22432_MULTIPOTENT_VS_COMM...3,SET,175,0.0050492,0.00049062,0.062236,0.46767,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_UP,0.99999
NELSON_RESPONSE_TO_ANDROGEN_...2,SET,75,0.0085415,0.00054483,0.10538,0.4677,NELSON_RESPONSE_TO_ANDROGEN_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...135,SET,5,0.032676,0.0005392,0.40323,0.46771,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,0.99999
KEGG_GRAFT_VERSUS_HOST_DISEA...,SET,33,0.013932,0.00059018,0.17211,0.46774,KEGG_GRAFT_VERSUS_HOST_DISEASE,0.99999
GSE36009_UNSTIM_VS_LPS_STIM_...3,SET,169,0.0049454,0.00047231,0.061443,0.46793,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN,0.99999
HP_DECREASED_TESTICULAR_SIZE,SET,148,0.0055893,0.00049982,0.069518,0.46796,HP_DECREASED_TESTICULAR_SIZE,0.99999
GOCC_VACUOLAR_MEMBRANE,SET,438,0.0032904,0.00050214,0.040942,0.46797,GOCC_VACUOLAR_MEMBRANE,0.99999
WRNIP1_TARGET_GENES,SET,967,0.0022198,0.00049587,0.027628,0.46798,WRNIP1_TARGET_GENES,0.99999
GOCC_R2TP_COMPLEX,SET,5,0.028413,0.00046885,0.35363,0.46798,GOCC_R2TP_COMPLEX,0.99999
GOBP_INTRACELLULAR_IRON_ION_...,SET,60,0.00908,0.00051825,0.11313,0.46802,GOBP_INTRACELLULAR_IRON_ION_HOMEOSTASIS,0.99999
HP_RECURRENT_EAR_INFECTIONS,SET,16,0.019089,0.00056329,0.23796,0.46803,HP_RECURRENT_EAR_INFECTIONS,0.99999
GOBP_POSITIVE_REGULATION_OF_...351,SET,975,0.0023157,0.00051929,0.028872,0.46804,GOBP_POSITIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,0.99999
HP_DEEP_VENOUS_THROMBOSIS,SET,17,0.015136,0.00046037,0.18872,0.46804,HP_DEEP_VENOUS_THROMBOSIS,0.99999
WP_DOPAMINERGIC_NEUROGENESIS,SET,28,0.014485,0.00056525,0.18097,0.4681,WP_DOPAMINERGIC_NEUROGENESIS,0.99999
HP_MALE_REPRODUCTIVE_SYSTEM_...,SET,59,0.0092792,0.0005252,0.11632,0.46821,HP_MALE_REPRODUCTIVE_SYSTEM_NEOPLASM,0.99999
HP_DEVIATION_OF_THE_THUMB,SET,41,0.010316,0.00048698,0.12939,0.46823,HP_DEVIATION_OF_THE_THUMB,0.99999
REACTOME_TOLL_LIKE_RECEPTOR_...2,SET,159,0.0054824,0.00050801,0.068799,0.46824,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,0.99999
GSE27670_CTRL_VS_BLIMP1_TRAN...2,SET,186,0.0050692,0.00050765,0.063662,0.46827,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP,0.99999
GOCC_CHROMOSOME_PASSENGER_CO...,SET,6,0.028148,0.00050879,0.35387,0.4683,GOCC_CHROMOSOME_PASSENGER_COMPLEX,0.99999
MIR4310,SET,262,0.0042586,0.00050511,0.053567,0.46832,MIR4310,0.99999
GOBP_PEPTIDYL_LYSINE_TRIMETH...,SET,5,0.025364,0.00041853,0.31938,0.46835,GOBP_PEPTIDYL_LYSINE_TRIMETHYLATION,0.99999
GOBP_MESANGIAL_CELL_DIFFEREN...,SET,6,0.030524,0.00055173,0.3856,0.46845,GOBP_MESANGIAL_CELL_DIFFERENTIATION,0.99999
GSE40274_CTRL_VS_HELIOS_TRAN...2,SET,146,0.0058135,0.00051638,0.073431,0.46845,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
MORF_DCC,SET,99,0.0070328,0.00051506,0.088919,0.46848,MORF_DCC,0.99999
GSE29617_CTRL_VS_TIV_FLU_VAC...1,SET,171,0.0049522,0.00047572,0.062638,0.46849,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN,0.99999
REACTOME_ALPHA_PROTEIN_KINAS...,SET,9,0.024978,0.00055292,0.31655,0.46855,REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY,0.99999
HP_ERYSIPELAS,SET,11,0.021153,0.00051763,0.26806,0.46855,HP_ERYSIPELAS,0.99999
REACTOME_REGULATION_OF_CHOLE...,SET,53,0.0086484,0.00046402,0.10964,0.46856,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,0.99999
EGFR_TARGET_GENES,SET,20,0.015476,0.00051053,0.19614,0.46856,EGFR_TARGET_GENES,0.99999
GSE15930_STIM_VS_STIM_AND_IF...2,SET,176,0.0048967,0.00047715,0.06213,0.46859,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP,0.99999
MODULE_32,SET,210,0.00438,0.00046577,0.055582,0.4686,MODULE_32,0.99999
KEGG_MEDICUS_REFERENCE_DERMA...,SET,7,0.026664,0.00052056,0.33877,0.46863,KEGG_MEDICUS_REFERENCE_DERMATAN_SULFATE_DEGRADATION,0.99999
GSE22886_IGM_MEMORY_BCELL_VS...1,SET,174,0.0050099,0.00048543,0.063647,0.46863,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,0.99999
GOBP_HORMONE_METABOLIC_PROCE...,SET,228,0.0048921,0.0005418,0.06222,0.46867,GOBP_HORMONE_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_T_CELL_PR...,SET,163,0.0058207,0.00054604,0.074032,0.46867,GOBP_REGULATION_OF_T_CELL_PROLIFERATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...568,SET,1520,0.0018164,0.00050055,0.023167,0.46875,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_STIMULUS,0.99999
GOBP_METANEPHRIC_NEPHRON_TUB...1,SET,6,0.032312,0.00058406,0.41215,0.46876,GOBP_METANEPHRIC_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
GAJATE_RESPONSE_TO_TRABECTED...1,SET,16,0.018256,0.00053871,0.2332,0.4688,GAJATE_RESPONSE_TO_TRABECTEDIN_DN,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...1,SET,167,0.0050758,0.00048191,0.064906,0.46883,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN,0.99999
GSE3982_EOSINOPHIL_VS_NKCELL...1,SET,171,0.0050888,0.00048885,0.065123,0.46886,GSE3982_EOSINOPHIL_VS_NKCELL_DN,0.99999
ROYLANCE_BREAST_CANCER_16Q_C...2,SET,59,0.012869,0.00072841,0.16474,0.46887,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP,0.99999
HP_LYMPHEDEMA,SET,68,0.0078412,0.00047634,0.10042,0.46888,HP_LYMPHEDEMA,0.99999
GOBP_POSITIVE_REGULATION_OF_...153,SET,11,0.020852,0.00051026,0.26752,0.46894,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,0.99999
GCM_PTK2,SET,135,0.0055899,0.00047759,0.071773,0.46896,GCM_PTK2,0.99999
GOBP_AXONEMAL_CENTRAL_APPARA...,SET,5,0.029817,0.00049201,0.38345,0.46901,GOBP_AXONEMAL_CENTRAL_APPARATUS_ASSEMBLY,0.99999
HP_ABNORMALITY_OF_DENTAL_ERU...,SET,209,0.0046583,0.00049419,0.060005,0.46906,HP_ABNORMALITY_OF_DENTAL_ERUPTION,0.99999
MORF_PHB,SET,115,0.0057465,0.00045339,0.074051,0.46907,MORF_PHB,0.99999
GOCC_APOLIPOPROTEIN_B_MRNA_E...,SET,4,0.036521,0.00053903,0.4708,0.46908,GOCC_APOLIPOPROTEIN_B_MRNA_EDITING_ENZYME_COMPLEX,0.99999
REACTOME_RUNX1_INTERACTS_WIT...,SET,36,0.011164,0.00049387,0.14414,0.46913,REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN,0.99999
GOMF_G_RICH_STRAND_TELOMERIC...,SET,10,0.018984,0.00044296,0.2451,0.46913,GOMF_G_RICH_STRAND_TELOMERIC_DNA_BINDING,0.99999
GSE10240_CTRL_VS_IL17_STIM_P...2,SET,177,0.0050487,0.00049334,0.065261,0.46917,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.99999
MIR203B_5P,SET,64,0.0082904,0.00048864,0.10721,0.46918,MIR203B_5P,0.99999
GSE6674_PL2_3_VS_ANTI_IGM_AN...1,SET,179,0.0051331,0.00050439,0.066418,0.4692,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,0.99999
HP_ELEVATED_CIRCULATING_CREA...,SET,265,0.0039564,0.0004719,0.051211,0.46921,HP_ELEVATED_CIRCULATING_CREATINE_KINASE_CONCENTRATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...105,SET,5,0.032714,0.00053982,0.42389,0.46924,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION_MOLECULE_PRODUCTION,0.99999
GSE40666_UNTREATED_VS_IFNA_S...1,SET,174,0.0047177,0.00045711,0.06115,0.46925,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_DN,0.99999
CUI_DEVELOPING_HEART_C6_EPIC...,SET,178,0.0052952,0.00051888,0.068661,0.46926,CUI_DEVELOPING_HEART_C6_EPICARDIAL_CELL,0.99999
HP_ABNORMAL_4TH_FINGER_MORPH...,SET,20,0.016302,0.00053779,0.21185,0.46933,HP_ABNORMAL_4TH_FINGER_MORPHOLOGY,0.99999
WP_GASTRIC_CANCER_NETWORK_1,SET,24,0.014042,0.0005074,0.18256,0.46934,WP_GASTRIC_CANCER_NETWORK_1,0.99999
GOBP_CARDIAC_VASCULAR_SMOOTH...,SET,8,0.026583,0.0005548,0.34562,0.46935,GOBP_CARDIAC_VASCULAR_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.99999
CROMER_TUMORIGENESIS_UP,SET,53,0.010608,0.00056918,0.13804,0.46937,CROMER_TUMORIGENESIS_UP,0.99999
HP_CLUBBING,SET,128,0.0055994,0.00046593,0.072889,0.46938,HP_CLUBBING,0.99999
GOBP_RESPONSE_TO_INTERFERON_...1,SET,17,0.016521,0.00050253,0.21516,0.4694,GOBP_RESPONSE_TO_INTERFERON_ALPHA,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...9,SET,8,0.019229,0.00040133,0.25061,0.46942,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_DIPHENOLS_AND_RELATED_SUBSTANCES_AS_DONORS,0.99999
GSE10325_CD4_TCELL_VS_BCELL_...1,SET,166,0.0054043,0.00051157,0.070445,0.46943,GSE10325_CD4_TCELL_VS_BCELL_DN,0.99999
HP_DEATH_IN_ADOLESCENCE,SET,21,0.014631,0.00049458,0.1911,0.46949,HP_DEATH_IN_ADOLESCENCE,0.99999
HP_LARGE_CENTRAL_VISUAL_FIEL...,SET,13,0.018706,0.0004976,0.24478,0.46954,HP_LARGE_CENTRAL_VISUAL_FIELD_DEFECT,0.99999
GOBP_DEFENSE_RESPONSE_TO_OTH...,SET,1091,0.0021186,0.00050089,0.027728,0.46955,GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM,0.99999
HP_NEOPLASM_OF_THE_GENITOURI...,SET,213,0.0043803,0.00046908,0.057348,0.46956,HP_NEOPLASM_OF_THE_GENITOURINARY_TRACT,0.99999
GOBP_NITROGEN_CYCLE_METABOLI...,SET,12,0.017538,0.00044826,0.22989,0.46959,GOBP_NITROGEN_CYCLE_METABOLIC_PROCESS,0.99999
GOBP_MORPHOGENESIS_OF_A_BRAN...,SET,189,0.0050805,0.00051284,0.066794,0.46969,GOBP_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,0.99999
GOCC_GOLGI_ASSOCIATED_VESICL...,SET,52,0.0082246,0.0004371,0.10817,0.4697,GOCC_GOLGI_ASSOCIATED_VESICLE_MEMBRANE,0.99999
GSE2770_IL4_ACT_VS_ACT_CD4_T...1,SET,176,0.0049284,0.00048024,0.064828,0.4697,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,0.99999
GOBP_REGULATION_OF_DNA_CATAB...,SET,10,0.019174,0.00044739,0.25243,0.46973,GOBP_REGULATION_OF_DNA_CATABOLIC_PROCESS,0.99999
GSE34205_HEALTHY_VS_FLU_INF_...2,SET,173,0.0048491,0.00046851,0.063893,0.46975,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP,0.99999
MIR518D_5P_MIR518F_5P_MIR520...,SET,85,0.0068975,0.00046825,0.090903,0.46976,MIR518D_5P_MIR518F_5P_MIR520C_5P_MIR526A_5P,0.99999
GSE10239_MEMORY_VS_KLRG1HIGH...1,SET,182,0.0047882,0.00047438,0.063105,0.46976,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.99999
MORI_IMMATURE_B_LYMPHOCYTE_DN,SET,86,0.0066972,0.00045731,0.088283,0.46977,MORI_IMMATURE_B_LYMPHOCYTE_DN,0.99999
MIR129_5P,SET,336,0.0036767,0.00049284,0.048512,0.46979,MIR129_5P,0.99999
MIR4646_3P,SET,54,0.0092165,0.00049913,0.12165,0.4698,MIR4646_3P,0.99999
GOBP_CALCIUM_ION_IMPORT_INTO...,SET,5,0.022281,0.00036767,0.29451,0.46985,GOBP_CALCIUM_ION_IMPORT_INTO_SARCOPLASMIC_RETICULUM,0.99999
GOBP_CELLULAR_RESPONSE_TO_ES...2,SET,18,0.015116,0.00047308,0.20004,0.46988,GOBP_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS,0.99999
HP_MISALIGNMENT_OF_INCISORS,SET,14,0.015547,0.00042918,0.20576,0.46988,HP_MISALIGNMENT_OF_INCISORS,0.99999
MIR7974,SET,80,0.0071577,0.00047147,0.094759,0.46989,MIR7974,0.99999
HP_ABNORMAL_FOURTH_TOE_MORPH...,SET,8,0.025846,0.00053943,0.34229,0.4699,HP_ABNORMAL_FOURTH_TOE_MORPHOLOGY,0.99999
GOBP_LABYRINTHINE_LAYER_BLOO...,SET,18,0.015596,0.00048812,0.20663,0.46992,GOBP_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT,0.99999
GOMF_BETA_2_ADRENERGIC_RECEP...,SET,5,0.027987,0.00046182,0.3708,0.46992,GOMF_BETA_2_ADRENERGIC_RECEPTOR_BINDING,0.99999
WP_INFLAMMATORY_BOWEL_DISEAS...,SET,41,0.010995,0.00051902,0.14575,0.46993,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,0.99999
GOBP_REGULATION_OF_RENAL_SOD...,SET,7,0.025414,0.00049616,0.3381,0.47004,GOBP_REGULATION_OF_RENAL_SODIUM_EXCRETION,0.99999
HP_GRAVES_DISEASE,SET,3,0.039139,0.0005003,0.52064,0.47004,HP_GRAVES_DISEASE,0.99999
MIR4776_3P,SET,152,0.0055577,0.00050362,0.074126,0.47012,MIR4776_3P,0.99999
TBK1.DF_DN,SET,264,0.0039251,0.0004673,0.052354,0.47012,TBK1.DF_DN,0.99999
GSE33162_HDAC3_KO_VS_HDAC3_K...1,SET,184,0.0048581,0.00048393,0.064889,0.47016,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_DN,0.99999
GOBP_PHOSPHATE_ION_TRANSPORT,SET,27,0.013541,0.00051891,0.1809,0.47017,GOBP_PHOSPHATE_ION_TRANSPORT,0.99999
MCCABE_HOXC6_TARGETS_CANCER_...2,SET,23,0.013805,0.00048835,0.18483,0.47023,MCCABE_HOXC6_TARGETS_CANCER_UP,0.99999
HP_RECURRENT_RESPIRATORY_INF...,SET,544,0.0028189,0.00047801,0.037741,0.47023,HP_RECURRENT_RESPIRATORY_INFECTIONS,0.99999
GOCC_CILIARY_MEMBRANE,SET,72,0.0073197,0.0004575,0.098018,0.47024,GOCC_CILIARY_MEMBRANE,0.99999
HP_HYPERKERATOSIS,SET,212,0.0044225,0.0004725,0.059224,0.47024,HP_HYPERKERATOSIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...91,SET,6,0.025455,0.00046011,0.34153,0.47029,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,0.99999
GOMF_VINCULIN_BINDING,SET,11,0.020211,0.00049459,0.27146,0.47033,GOMF_VINCULIN_BINDING,0.99999
GOBP_VASCULAR_ASSOCIATED_SMO...3,SET,28,0.013201,0.00051517,0.17757,0.47037,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOMF_ISOCITRATE_DEHYDROGENAS...,SET,4,0.0325,0.00047968,0.4372,0.47037,GOMF_ISOCITRATE_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,0.99999
REACTOME_ANCHORING_FIBRIL_FO...,SET,13,0.019409,0.00051631,0.26139,0.4704,REACTOME_ANCHORING_FIBRIL_FORMATION,0.99999
WP_PLATELETMEDIATED_INTERACT...,SET,15,0.017204,0.00049156,0.23175,0.47041,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,0.99999
GOBP_PIGMENT_BIOSYNTHETIC_PR...,SET,49,0.0088683,0.00045756,0.11975,0.47048,GOBP_PIGMENT_BIOSYNTHETIC_PROCESS,0.99999
GOBP_GAMMA_DELTA_T_CELL_ACTI...,SET,23,0.013383,0.00047341,0.18087,0.47051,GOBP_GAMMA_DELTA_T_CELL_ACTIVATION,0.99999
GSE39820_CTRL_VS_IL1B_IL6_IL...2,SET,180,0.0047399,0.00046704,0.064096,0.47053,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP,0.99999
HP_RESTRICTIVE_BEHAVIOR,SET,12,0.018567,0.00047454,0.25119,0.47054,HP_RESTRICTIVE_BEHAVIOR,0.99999
GOBP_CELLULAR_RESPONSE_TO_AM...1,SET,5,0.03191,0.00052654,0.43208,0.47056,GOBP_CELLULAR_RESPONSE_TO_AMMONIUM_ION,0.99999
GOBP_RESPONSE_TO_AMMONIUM_ION,SET,5,0.03191,0.00052654,0.43208,0.47056,GOBP_RESPONSE_TO_AMMONIUM_ION,0.99999
WP_NEURODEGENERATION_WITH_BR...,SET,41,0.0094973,0.00044832,0.12866,0.47058,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,0.99999
GOBP_SCHWANN_CELL_DIFFERENTI...,SET,47,0.0093408,0.00047202,0.12685,0.47065,GOBP_SCHWANN_CELL_DIFFERENTIATION,0.99999
MIR7702,SET,50,0.008604,0.00044841,0.11695,0.47068,MIR7702,0.99999
WP_AUTOPHAGY,SET,30,0.011124,0.00044931,0.15137,0.47071,WP_AUTOPHAGY,0.99999
GOBP_NEURAL_RETINA_DEVELOPME...,SET,79,0.0075202,0.00049226,0.10266,0.4708,GOBP_NEURAL_RETINA_DEVELOPMENT,0.99999
GOBP_HEPATICOBILIARY_SYSTEM_...,SET,141,0.0053737,0.00046913,0.07337,0.47081,GOBP_HEPATICOBILIARY_SYSTEM_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_ANTIBACTE...,SET,7,0.026545,0.00051825,0.36308,0.47086,GOBP_REGULATION_OF_ANTIBACTERIAL_PEPTIDE_PRODUCTION,0.99999
VANASSE_BCL2_TARGETS_DN,SET,53,0.0083326,0.00044707,0.11414,0.4709,VANASSE_BCL2_TARGETS_DN,0.99999
HP_APLASIA_HYPOPLASIA_AFFECT...1,SET,814,0.0022208,0.00045714,0.030433,0.47091,HP_APLASIA_HYPOPLASIA_AFFECTING_BONES_OF_THE_AXIAL_SKELETON,0.99999
MIR5001_5P,SET,159,0.0046614,0.00043193,0.063953,0.47095,MIR5001_5P,0.99999
MIR520B_3P_MIR520C_3P_MIR520...,SET,302,0.0036124,0.0004595,0.049644,0.471,MIR520B_3P_MIR520C_3P_MIR520E_3P,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...50,SET,81,0.0066628,0.0004416,0.091618,0.47101,GOBP_PROTEIN_LOCALIZATION_TO_VACUOLE,0.99999
GOBP_GLYCOPHAGY,SET,11,0.020136,0.00049276,0.277,0.47102,GOBP_GLYCOPHAGY,0.99999
REACTOME_MATURATION_OF_PROTE...,SET,9,0.021057,0.00046612,0.2902,0.47108,REACTOME_MATURATION_OF_PROTEIN_3A,0.99999
HP_SPHEROPHAKIA,SET,5,0.029897,0.00049334,0.41242,0.47111,HP_SPHEROPHAKIA,0.99999
REACTOME_INTERFERON_ALPHA_BE...,SET,72,0.0078208,0.00048882,0.108,0.47114,REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,0.99999
MIR4727_3P,SET,31,0.011411,0.00046851,0.15764,0.47115,MIR4727_3P,0.99999
GOBP_VACUOLAR_ACIDIFICATION,SET,32,0.011371,0.00047433,0.15707,0.47115,GOBP_VACUOLAR_ACIDIFICATION,0.99999
GOBP_RNA_SPLICING_VIA_TRANSE...,SET,269,0.0034261,0.00041168,0.047361,0.47117,GOBP_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS,0.99999
GSE29949_CD8_NEG_DC_SPLEEN_V...4,SET,167,0.0048589,0.00046131,0.067178,0.47117,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_UP,0.99999
REACTOME_SEMA3A_PLEXIN_REPUL...,SET,13,0.0182,0.00048415,0.25206,0.47122,REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION,0.99999
ZNF781_TARGET_GENES,SET,121,0.0053218,0.00043063,0.074097,0.47137,ZNF781_TARGET_GENES,0.99999
GOBP_REGULATION_OF_PHOSPHOLI...3,SET,5,0.032488,0.00053608,0.4524,0.47138,GOBP_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
KIM_WT1_TARGETS_UP,SET,211,0.0044722,0.00047669,0.062303,0.47139,KIM_WT1_TARGETS_UP,0.99999
GOBP_REGULATION_OF_NUCLEOBAS...,SET,17,0.012741,0.00038752,0.17782,0.47144,GOBP_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,0.99999
HP_OLIVOPONTOCEREBELLAR_HYPO...,SET,12,0.016465,0.00042081,0.22985,0.47145,HP_OLIVOPONTOCEREBELLAR_HYPOPLASIA,0.99999
HP_NATAL_TOOTH,SET,31,0.011051,0.00045375,0.15441,0.47147,HP_NATAL_TOOTH,0.99999
HP_ABLEPHARON,SET,5,0.028699,0.00047356,0.40141,0.4715,HP_ABLEPHARON,0.99999
REACTOME_SYNTHESIS_OF_PYROPH...,SET,8,0.018879,0.00039401,0.26429,0.47153,REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL,0.99999
GOMF_5_3_DNA_HELICASE_ACTIVI...,SET,8,0.020661,0.0004312,0.28974,0.47158,GOMF_5_3_DNA_HELICASE_ACTIVITY,0.99999
HP_SICK_SINUS_SYNDROME,SET,27,0.012665,0.00048536,0.17771,0.47159,HP_SICK_SINUS_SYNDROME,0.99999
WP_HAIR_FOLLICLE_DEVELOPMENT...1,SET,86,0.0072992,0.00049842,0.10251,0.47162,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,0.99999
GOBP_EMBRYONIC_AXIS_SPECIFIC...,SET,35,0.010859,0.00047369,0.15262,0.47164,GOBP_EMBRYONIC_AXIS_SPECIFICATION,0.99999
MIR451B,SET,150,0.0051462,0.00046327,0.072357,0.47165,MIR451B,0.99999
REACTOME_ERYTHROCYTES_TAKE_U...2,SET,7,0.024615,0.00048057,0.34646,0.47168,REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE,0.99999
HP_DIGENIC_INHERITANCE,SET,13,0.018416,0.00048989,0.25969,0.47173,HP_DIGENIC_INHERITANCE,0.99999
DESCARTES_FETAL_CEREBRUM_SKO...,SET,48,0.0095681,0.00048861,0.13506,0.47176,DESCARTES_FETAL_CEREBRUM_SKOR2_NPSR1_POSITIVE_CELLS,0.99999
GSE10500_ARTHRITIC_SYNOVIAL_...2,SET,135,0.0051512,0.00044011,0.072819,0.4718,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_UP,0.99999
GOBP_EPIDERMAL_CELL_DIFFEREN...,SET,225,0.0046328,0.00050974,0.065508,0.47181,GOBP_EPIDERMAL_CELL_DIFFERENTIATION,0.99999
THAKAR_PBMC_INACTIVATED_INFL...11,SET,97,0.0057289,0.00041533,0.08111,0.47185,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_UP,0.99999
KEGG_MEDICUS_PATHOGEN_HTLV_1...1,SET,7,0.025795,0.00050361,0.36561,0.47188,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.99999
PPAR_DR1_Q2,SET,235,0.0038373,0.00043137,0.054437,0.4719,PPAR_DR1_Q2,0.99999
GOBP_ENDONUCLEOLYTIC_CLEAVAG...3,SET,16,0.014804,0.00043686,0.21082,0.47201,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.99999
GSE14769_20MIN_VS_360MIN_LPS...1,SET,178,0.0045012,0.00044107,0.064117,0.47202,GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN,0.99999
GOMF_MAP_KINASE_KINASE_ACTIV...,SET,15,0.015687,0.00044822,0.2236,0.47204,GOMF_MAP_KINASE_KINASE_ACTIVITY,0.99999
NAKAYA_MYELOID_DENDRITIC_CEL...1,SET,238,0.0036697,0.00041512,0.052317,0.47204,NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.99999
GGCAGCT_MIR22,SET,209,0.0041452,0.00043977,0.059126,0.47205,GGCAGCT_MIR22,0.99999
GSE14699_NAIVE_VS_DELETIONAL...2,SET,133,0.0053395,0.00045283,0.076168,0.47206,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.99999
HP_ABNORMAL_LEFT_VENTRICULAR...,SET,26,0.012367,0.00046509,0.17707,0.47216,HP_ABNORMAL_LEFT_VENTRICULAR_OUTFLOW_TRACT_MORPHOLOGY,0.99999
GOMF_PRENYLTRANSFERASE_ACTIV...,SET,16,0.01411,0.00041637,0.20216,0.47218,GOMF_PRENYLTRANSFERASE_ACTIVITY,0.99999
MIR5192,SET,45,0.0086934,0.00042988,0.12504,0.47229,MIR5192,0.99999
GOBP_AMINO_ACID_BETAINE_TRAN...,SET,12,0.020159,0.00051525,0.29044,0.47233,GOBP_AMINO_ACID_BETAINE_TRANSPORT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...268,SET,5,0.023396,0.00038606,0.33756,0.47237,GOBP_NEGATIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,0.99999
NUYTTEN_NIPP1_TARGETS_DN,SET,766,0.0021866,0.00043724,0.031598,0.47241,NUYTTEN_NIPP1_TARGETS_DN,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...10,SET,37,0.0098399,0.00044131,0.1422,0.47242,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...1,SET,186,0.0046098,0.00046165,0.066723,0.47246,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN,0.99999
SASAI_TARGETS_OF_CXCR6_AND_P...2,SET,12,0.018385,0.0004699,0.26626,0.47247,SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP,0.99999
HP_EPISCLERITIS,SET,4,0.033862,0.00049979,0.49063,0.47249,HP_EPISCLERITIS,0.99999
CTCTGGA_MIR520A_MIR525,SET,141,0.0048949,0.00042733,0.070968,0.47251,CTCTGGA_MIR520A_MIR525,0.99999
GSE15330_LYMPHOID_MULTIPOTEN...7,SET,149,0.0048987,0.00043953,0.071098,0.47253,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,0.99999
SHARMA_PILOCYTIC_ASTROCYTOMA...2,SET,26,0.012947,0.00048688,0.18837,0.4726,SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP,0.99999
GOBP_PRIMARY_ALCOHOL_METABOL...,SET,95,0.0065096,0.00046706,0.094771,0.47262,GOBP_PRIMARY_ALCOHOL_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_ENDOPLASM...1,SET,29,0.010196,0.00040491,0.14849,0.47263,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
HP_FIBULAR_APLASIA,SET,6,0.026779,0.00048404,0.39018,0.47264,HP_FIBULAR_APLASIA,0.99999
REACTOME_CELLULAR_RESPONSE_T...4,SET,6,0.020522,0.00037095,0.29969,0.4727,REACTOME_CELLULAR_RESPONSE_TO_MITOCHONDRIAL_STRESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...558,SET,18,0.013743,0.00043014,0.20074,0.47271,GOBP_NEGATIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.99999
GSE40666_STAT1_KO_VS_STAT4_K...2,SET,172,0.0041388,0.00039874,0.060456,0.47271,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP,0.99999
REACTOME_ESTROGEN_DEPENDENT_...2,SET,23,0.013568,0.00047995,0.19832,0.47273,REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING,0.99999
GOCC_DENSE_CORE_GRANULE_MEMB...,SET,7,0.022821,0.00044554,0.33353,0.47273,GOCC_DENSE_CORE_GRANULE_MEMBRANE,0.99999
MIR610,SET,77,0.0068545,0.00044299,0.10024,0.47274,MIR610,0.99999
GSE21063_WT_VS_NFATC1_KO_BCE...1,SET,181,0.0039489,0.00039017,0.057812,0.47277,GSE21063_WT_VS_NFATC1_KO_BCELL_DN,0.99999
REACTOME_RNA_POLYMERASE_II_P...,SET,72,0.0058105,0.00036317,0.085397,0.47288,REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,0.99999
GSE9946_IMMATURE_VS_LISTERIA...2,SET,118,0.0054238,0.00043344,0.079755,0.47289,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_UP,0.99999
HP_BLUE_NEVUS,SET,11,0.017736,0.00043402,0.26117,0.47293,HP_BLUE_NEVUS,0.99999
KEGG_MEDICUS_PATHOGEN_HBV_LH...,SET,11,0.018816,0.00046044,0.27718,0.47294,KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...760,SET,8,0.019785,0.00041292,0.29162,0.47296,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.99999
HP_SPINOCEREBELLAR_TRACT_DEG...,SET,8,0.020333,0.00042436,0.29999,0.47298,HP_SPINOCEREBELLAR_TRACT_DEGENERATION,0.99999
GOBP_PLASMA_MEMBRANE_PHOSPHO...,SET,24,0.012364,0.00044674,0.18244,0.47299,GOBP_PLASMA_MEMBRANE_PHOSPHOLIPID_SCRAMBLING,0.99999
GSE16385_UNTREATED_VS_12H_RO...3,SET,175,0.0044461,0.00043202,0.065802,0.47306,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,0.99999
GCM_MAP4K4,SET,161,0.0044021,0.00041044,0.065154,0.47307,GCM_MAP4K4,0.99999
GRAHAM_CML_DIVIDING_VS_NORMA...1,SET,9,0.022863,0.00050609,0.33868,0.47309,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN,0.99999
HP_CAMPTODACTYLY_OF_TOE,SET,11,0.018265,0.00044698,0.27077,0.47311,HP_CAMPTODACTYLY_OF_TOE,0.99999
REACTOME_CD163_MEDIATING_AN_...,SET,8,0.02068,0.00043161,0.30864,0.47329,REACTOME_CD163_MEDIATING_AN_ANTI_INFLAMMATORY_RESPONSE,0.99999
GSE21360_PRIMARY_VS_QUATERNA...1,SET,180,0.0040735,0.00040138,0.061007,0.47338,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.99999
GOBP_REGULATION_OF_PEPTIDE_T...,SET,187,0.0042963,0.0004314,0.06438,0.4734,GOBP_REGULATION_OF_PEPTIDE_TRANSPORT,0.99999
BIOCARTA_INFLAM_PATHWAY,SET,25,0.01253,0.00046207,0.18785,0.47341,BIOCARTA_INFLAM_PATHWAY,0.99999
MIR374B_5P,SET,343,0.0032375,0.00043838,0.04853,0.47341,MIR374B_5P,0.99999
GOBP_REGULATION_OF_RECEPTOR_...1,SET,13,0.01586,0.0004219,0.23838,0.47348,GOBP_REGULATION_OF_RECEPTOR_BINDING,0.99999
HP_ABNORMAL_CIRCULATING_ATRI...,SET,8,0.016584,0.00034612,0.24929,0.47348,HP_ABNORMAL_CIRCULATING_ATRIAL_NATRIURETIC_PEPTIDE_PRO_HORMONE_CONCENTRATION,0.99999
HP_GRANULOMA,SET,6,0.025762,0.00046567,0.38868,0.47358,HP_GRANULOMA,0.99999
GOBP_CELLULAR_RESPONSE_TO_XE...,SET,187,0.0044189,0.00044371,0.067251,0.47381,GOBP_CELLULAR_RESPONSE_TO_XENOBIOTIC_STIMULUS,0.99999
WP_NANOPARTICLE_TRIGGERED_AU...,SET,22,0.011819,0.00040889,0.17996,0.47382,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,0.99999
GOMF_LIGAND_ACTIVATED_TRANSC...,SET,52,0.0080416,0.00042738,0.1226,0.47385,GOMF_LIGAND_ACTIVATED_TRANSCRIPTION_FACTOR_ACTIVITY,0.99999
GOBP_ETHER_METABOLIC_PROCESS,SET,24,0.012121,0.00043798,0.18484,0.47386,GOBP_ETHER_METABOLIC_PROCESS,0.99999
HP_LENTICONUS,SET,8,0.019499,0.00040695,0.29782,0.4739,HP_LENTICONUS,0.99999
REACTOME_REGULATION_OF_GENE_...5,SET,15,0.014331,0.00040948,0.21894,0.47391,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS,0.99999
GOBP_GLYCOSIDE_CATABOLIC_PRO...,SET,7,0.019587,0.00038241,0.29946,0.47392,GOBP_GLYCOSIDE_CATABOLIC_PROCESS,0.99999
GOBP_MESONEPHRIC_TUBULE_FORM...,SET,8,0.023033,0.00048073,0.35219,0.47393,GOBP_MESONEPHRIC_TUBULE_FORMATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...533,SET,9,0.019402,0.00042949,0.29685,0.47394,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION,0.99999
BILD_CTNNB1_ONCOGENIC_SIGNAT...,SET,72,0.0064423,0.00040266,0.098575,0.47395,BILD_CTNNB1_ONCOGENIC_SIGNATURE,0.99999
HP_C1_C2_SUBLUXATION,SET,5,0.023075,0.00038076,0.35363,0.47399,HP_C1_C2_SUBLUXATION,0.99999
REACTOME_TIGHT_JUNCTION_INTE...,SET,27,0.011645,0.00044627,0.17858,0.474,REACTOME_TIGHT_JUNCTION_INTERACTIONS,0.99999
GSE16522_MEMORY_VS_NAIVE_CD8...1,SET,180,0.0041482,0.00040874,0.06368,0.47403,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.99999
GAO_LARGE_INTESTINE_24W_C8_G...,SET,38,0.010105,0.00045925,0.15534,0.47407,GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL,0.99999
MEF2_Q6_01,SET,221,0.003931,0.00042871,0.060474,0.47409,MEF2_Q6_01,0.99999
GOBP_POSITIVE_REGULATION_OF_...771,SET,48,0.0072293,0.00036918,0.11128,0.4741,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_ELONGATION_BY_RNA_POLYMERASE_II,0.99999
GSE16385_MONOCYTE_VS_12H_ROS...4,SET,173,0.0040411,0.00039044,0.06226,0.47412,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,0.99999
MACLACHLAN_BRCA1_TARGETS_DN,SET,16,0.013333,0.00039344,0.20567,0.47416,MACLACHLAN_BRCA1_TARGETS_DN,0.99999
HP_BONE_MARROW_HYPOCELLULARI...,SET,64,0.0065694,0.00038721,0.10149,0.47419,HP_BONE_MARROW_HYPOCELLULARITY,0.99999
KEGG_MEDICUS_REFERENCE_BMP_H...2,SET,6,0.02047,0.00037001,0.3163,0.4742,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY_AUXILIARY_FACTOR,0.99999
GNF2_MYL3,SET,31,0.010509,0.00043148,0.16291,0.47428,GNF2_MYL3,0.99999
HP_SUBCUTANEOUS_HEMORRHAGE,SET,233,0.0037198,0.0004164,0.057648,0.47428,HP_SUBCUTANEOUS_HEMORRHAGE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...237,SET,8,0.021116,0.00044072,0.32765,0.47431,GOBP_NEGATIVE_REGULATION_OF_FERROPTOSIS,0.99999
HP_PROMINENT_SUPRAORBITAL_RI...,SET,33,0.0097135,0.00041146,0.15088,0.47433,HP_PROMINENT_SUPRAORBITAL_RIDGES,0.99999
GSE1925_CTRL_VS_IFNG_PRIMED_...1,SET,183,0.0041427,0.00041155,0.064468,0.47438,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN,0.99999
WP_BMP2WNT4FOXO1_PATHWAY_IN_...,SET,13,0.01813,0.00048228,0.28231,0.4744,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,0.99999
HP_FACIAL_PARALYSIS,SET,10,0.018811,0.00043892,0.29289,0.4744,HP_FACIAL_PARALYSIS,0.99999
GSE22611_UNSTIM_VS_2H_MDP_ST...1,SET,171,0.0039375,0.00037825,0.061412,0.47444,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...70,SET,15,0.013455,0.00038444,0.21014,0.47447,GOBP_POSITIVE_REGULATION_OF_B_CELL_DIFFERENTIATION,0.99999
GSE3982_MAST_CELL_VS_MAC_DN,SET,171,0.0042228,0.00040565,0.066057,0.47451,GSE3982_MAST_CELL_VS_MAC_DN,0.99999
CHEN_ETV5_TARGETS_TESTIS,SET,21,0.011455,0.00038721,0.17941,0.47455,CHEN_ETV5_TARGETS_TESTIS,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...11,SET,61,0.0067971,0.00039116,0.10667,0.4746,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_VACUOLE,0.99999
HP_ABNORMALITY_OF_THE_SENSE_...,SET,119,0.0049388,0.00039634,0.077549,0.47461,HP_ABNORMALITY_OF_THE_SENSE_OF_SMELL,0.99999
KEGG_MEDICUS_VARIANT_BCR_ABL...1,SET,11,0.015904,0.00038918,0.24985,0.47462,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,0.99999
GOMF_OMEGA_PEPTIDASE_ACTIVITY,SET,12,0.016741,0.00042788,0.26301,0.47462,GOMF_OMEGA_PEPTIDASE_ACTIVITY,0.99999
GSE30971_WBP7_HET_VS_KO_MACR...5,SET,179,0.0045062,0.00044279,0.070967,0.47469,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN,0.99999
MIR6762_5P,SET,54,0.0071775,0.0003887,0.11309,0.4747,MIR6762_5P,0.99999
GOBP_REVERSE_CHOLESTEROL_TRA...,SET,15,0.015359,0.00043886,0.24245,0.47474,GOBP_REVERSE_CHOLESTEROL_TRANSPORT,0.99999
HP_ABNORMAL_MITOCHONDRIA_IN_...,SET,25,0.0094879,0.00034989,0.14976,0.47474,HP_ABNORMAL_MITOCHONDRIA_IN_MUSCLE_TISSUE,0.99999
GOBP_RETINAL_BLOOD_VESSEL_MO...,SET,5,0.024173,0.00039889,0.38244,0.4748,GOBP_RETINAL_BLOOD_VESSEL_MORPHOGENESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...308,SET,40,0.0087206,0.00040662,0.13839,0.47488,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,0.99999
DESCARTES_FETAL_ADRENAL_LYMP...,SET,131,0.0051256,0.00043144,0.081377,0.47489,DESCARTES_FETAL_ADRENAL_LYMPHOID_CELLS,0.99999
chr15q24,SET,57,0.014439,0.0008033,0.22997,0.47497,chr15q24,0.99999
REACTOME_LEUKOTRIENE_RECEPTO...,SET,4,0.023837,0.00035182,0.38051,0.47502,REACTOME_LEUKOTRIENE_RECEPTORS,0.99999
GSE19401_UNSTIM_VS_PAM2CSK4_...1,SET,183,0.0039392,0.00039134,0.06289,0.47503,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.99999
GOBP_CHONDROITIN_SULFATE_BIO...,SET,18,0.012321,0.00038561,0.19679,0.47504,GOBP_CHONDROITIN_SULFATE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_PROTOPORPHYRINOGEN_IX_M...,SET,10,0.016035,0.00037414,0.25727,0.47515,GOBP_PROTOPORPHYRINOGEN_IX_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_MITOCHOND...6,SET,12,0.014504,0.00037069,0.23326,0.47521,GOBP_REGULATION_OF_MITOCHONDRIAL_FUSION,0.99999
GOBP_REGULATION_OF_POST_TRAN...,SET,211,0.0036202,0.00038588,0.05823,0.47521,GOBP_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.99999
EPPERT_LSC_R,SET,36,0.0082429,0.00036466,0.13284,0.47526,EPPERT_LSC_R,0.99999
XU_HGF_SIGNALING_NOT_VIA_AKT...1,SET,18,0.012154,0.00038039,0.19632,0.47532,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN,0.99999
GOCC_BRISC_COMPLEX,SET,3,0.030415,0.00038878,0.49191,0.47535,GOCC_BRISC_COMPLEX,0.99999
GCM_CRKL,SET,59,0.0065329,0.00036976,0.10615,0.47546,GCM_CRKL,0.99999
MIR6735_3P,SET,33,0.0088222,0.00037371,0.14351,0.47549,MIR6735_3P,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...20,SET,27,0.011467,0.00043943,0.18657,0.4755,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_COLUMNAR_CELLS,0.99999
GSE11057_NAIVE_CD4_VS_PBMC_C...2,SET,163,0.0039888,0.00037419,0.06497,0.47552,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP,0.99999
WP_SIGNAL_TRANSDUCTION_THROU...,SET,32,0.0098938,0.00041271,0.16139,0.47556,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,0.99999
HP_ADENOCARCINOMA_OF_THE_INT...,SET,38,0.0079157,0.00035976,0.12912,0.47556,HP_ADENOCARCINOMA_OF_THE_INTESTINES,0.99999
BLANCO_MELO_BRONCHIAL_EPITHE...3,SET,69,0.0065137,0.00039858,0.1063,0.47557,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN,0.99999
GOBP_FLOOR_PLATE_DEVELOPMENT,SET,10,0.015156,0.00035364,0.24756,0.47559,GOBP_FLOOR_PLATE_DEVELOPMENT,0.99999
GOCC_DENDRITIC_SHAFT,SET,39,0.0087558,0.00040314,0.143,0.47559,GOCC_DENDRITIC_SHAFT,0.99999
FAN_EMBRYONIC_CTX_BRAIN_ENDO...1,SET,402,0.0028315,0.0004144,0.046428,0.47568,FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1,0.99999
MIR758_5P,SET,31,0.0089169,0.00036611,0.14623,0.47569,MIR758_5P,0.99999
REACTOME_TRIGLYCERIDE_METABO...,SET,35,0.0092042,0.00040151,0.15122,0.47573,REACTOME_TRIGLYCERIDE_METABOLISM,0.99999
GOBP_HYDROGEN_SULFIDE_METABO...,SET,4,0.023406,0.00034546,0.38527,0.47578,GOBP_HYDROGEN_SULFIDE_METABOLIC_PROCESS,0.99999
GOMF_NEUREXIN_FAMILY_PROTEIN...,SET,8,0.019498,0.00040695,0.32119,0.4758,GOMF_NEUREXIN_FAMILY_PROTEIN_BINDING,0.99999
WIEMANN_TELOMERE_SHORTENING_...2,SET,9,0.018173,0.00040228,0.29948,0.47581,WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP,0.99999
MIR3920,SET,123,0.0047739,0.00038946,0.078676,0.47581,MIR3920,0.99999
GSE37301_MULTIPOTENT_PROGENI...8,SET,146,0.0041052,0.00036464,0.067879,0.47589,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP,0.99999
MIR765,SET,256,0.0034149,0.00040044,0.056561,0.47593,MIR765,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_GMP...,SET,33,0.0097996,0.00041511,0.16234,0.47593,HE_LIM_SUN_FETAL_LUNG_C2_GMP_CELL,0.99999
GSE22611_UNSTIM_VS_2H_MDP_ST...4,SET,168,0.0039424,0.00037541,0.065329,0.47594,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.99999
QI_PLASMACYTOMA_DN,SET,92,0.0052321,0.00036946,0.086742,0.47595,QI_PLASMACYTOMA_DN,0.99999
GOBP_R_LOOP_PROCESSING,SET,8,0.015783,0.0003294,0.2616,0.47595,GOBP_R_LOOP_PROCESSING,0.99999
GOBP_ENDOPLASMIC_RETICULUM_T...4,SET,19,0.01178,0.00037878,0.19549,0.47598,GOBP_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION,0.99999
GOBP_ROOF_OF_MOUTH_DEVELOPME...,SET,89,0.0061779,0.00042911,0.10268,0.47601,GOBP_ROOF_OF_MOUTH_DEVELOPMENT,0.99999
GSE2405_HEAT_KILLED_LYSATE_V...3,SET,182,0.0036432,0.00036095,0.060659,0.47605,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,0.99999
YEMELYANOV_GR_TARGETS_DN,SET,10,0.016588,0.00038704,0.27637,0.47607,YEMELYANOV_GR_TARGETS_DN,0.99999
TNCATNTCCYR_UNKNOWN,SET,119,0.0046733,0.00037504,0.07786,0.47607,TNCATNTCCYR_UNKNOWN,0.99999
WP_EICOSANOID_METABOLISM_VIA...1,SET,30,0.0097369,0.00039329,0.16244,0.4761,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.99999
REACTOME_NEF_MEDIATED_CD8_DO...,SET,7,0.019335,0.00037748,0.32321,0.47615,REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION,0.99999
GSE17721_12H_VS_24H_POLYIC_B...2,SET,178,0.0038611,0.00037835,0.064582,0.47616,GSE17721_12H_VS_24H_POLYIC_BMDC_UP,0.99999
KEGG_MEDICUS_REFERENCE_NLRP3...,SET,5,0.021169,0.00034931,0.35471,0.47621,KEGG_MEDICUS_REFERENCE_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...666,SET,25,0.010981,0.00040496,0.1841,0.47622,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION,0.99999
MIR4670_3P,SET,137,0.0043854,0.00037742,0.073639,0.47626,MIR4670_3P,0.99999
MIR766_5P,SET,195,0.0036944,0.00037873,0.062272,0.47635,MIR766_5P,0.99999
GSE17186_BLOOD_VS_CORD_BLOOD...5,SET,175,0.0036761,0.0003572,0.061966,0.47635,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN,0.99999
HP_RADIAL_HEAD_SUBLUXATION,SET,7,0.020954,0.0004091,0.35475,0.47645,HP_RADIAL_HEAD_SUBLUXATION,0.99999
GOBP_REGULATION_OF_EXCITATOR...,SET,17,0.012361,0.00037598,0.20933,0.47646,GOBP_REGULATION_OF_EXCITATORY_SYNAPSE_ASSEMBLY,0.99999
AIZARANI_LIVER_C29_MVECS_2,SET,287,0.003233,0.00040106,0.054825,0.47649,AIZARANI_LIVER_C29_MVECS_2,0.99999
HP_MICROPHTHALMIA,SET,239,0.0032303,0.00036617,0.054897,0.47654,HP_MICROPHTHALMIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...266,SET,17,0.012113,0.00036844,0.20605,0.47656,GOBP_NEGATIVE_REGULATION_OF_GTPASE_ACTIVITY,0.99999
GOBP_HIS_PURKINJE_SYSTEM_DEV...,SET,7,0.023709,0.00046287,0.40345,0.47657,GOBP_HIS_PURKINJE_SYSTEM_DEVELOPMENT,0.99999
GOMF_POU_DOMAIN_BINDING,SET,2,0.042909,0.00044785,0.73176,0.47662,GOMF_POU_DOMAIN_BINDING,0.99999
REACTOME_MITOCHONDRIAL_BIOGE...,SET,68,0.0060896,0.00036993,0.1039,0.47663,REACTOME_MITOCHONDRIAL_BIOGENESIS,0.99999
MODULE_92,SET,143,0.00476,0.00041847,0.081354,0.47667,MODULE_92,0.99999
NRL_DN.V1_UP,SET,130,0.004472,0.00037499,0.076416,0.47667,NRL_DN.V1_UP,0.99999
GOBP_CLATHRIN_COAT_ASSEMBLY,SET,18,0.011523,0.00036064,0.19713,0.47669,GOBP_CLATHRIN_COAT_ASSEMBLY,0.99999
MIR4999_3P,SET,35,0.0079291,0.00034588,0.13568,0.4767,MIR4999_3P,0.99999
HSF_Q6,SET,183,0.0036804,0.00036562,0.06297,0.4767,HSF_Q6,0.99999
GOBP_POSITIVE_REGULATION_OF_...432,SET,22,0.010734,0.00037138,0.18372,0.4767,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION,0.99999
FAN_EMBRYONIC_CTX_IN_1_INTER...,SET,10,0.018224,0.00042522,0.31266,0.47676,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.99999
GSE3982_DC_VS_EFF_MEMORY_CD4...1,SET,162,0.0037231,0.0003482,0.063896,0.47677,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN,0.99999
GOBP_SKELETAL_MUSCLE_SATELLI...3,SET,4,0.028233,0.00041671,0.48482,0.47678,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_MAINTENANCE_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.99999
GOBP_REGULATION_OF_TYPE_B_PA...2,SET,11,0.016264,0.00039799,0.27953,0.4768,GOBP_REGULATION_OF_TYPE_B_PANCREATIC_CELL_PROLIFERATION,0.99999
HP_ABNORMAL_VAGINA_MORPHOLOGY,SET,111,0.004841,0.00037529,0.083293,0.47683,HP_ABNORMAL_VAGINA_MORPHOLOGY,0.99999
DANG_REGULATED_BY_MYC_UP,SET,65,0.0060621,0.00036008,0.10444,0.47686,DANG_REGULATED_BY_MYC_UP,0.99999
HP_RESPONSE_TO_DRUGS_ACTING_...,SET,6,0.020667,0.00037356,0.35607,0.47686,HP_RESPONSE_TO_DRUGS_ACTING_ON_NEUROMUSCULAR_TRANSMISSION,0.99999
CHIARADONNA_NEOPLASTIC_TRANS...1,SET,135,0.0043559,0.00037216,0.075133,0.47688,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,0.99999
MCBRYAN_PUBERTAL_BREAST_5_6W...1,SET,119,0.0044027,0.00035332,0.076006,0.4769,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,0.99999
GOBP_D_ASPARTATE_TRANSMEMBRA...,SET,5,0.022821,0.00037656,0.39526,0.47698,GOBP_D_ASPARTATE_TRANSMEMBRANE_TRANSPORT,0.99999
HP_MOTOR_STEREOTYPY,SET,224,0.0032449,0.00035624,0.056221,0.47699,HP_MOTOR_STEREOTYPY,0.99999
REACTOME_SYNTHESIS_OF_BILE_A...1,SET,33,0.0092082,0.00039006,0.15977,0.47702,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,0.99999
HP_STEREOTYPICAL_BODY_ROCKING,SET,6,0.017972,0.00032486,0.31179,0.47702,HP_STEREOTYPICAL_BODY_ROCKING,0.99999
GOBP_RESPONSE_TO_TUMOR_CELL,SET,38,0.0084249,0.00038291,0.14657,0.47708,GOBP_RESPONSE_TO_TUMOR_CELL,0.99999
MIR10524_5P,SET,79,0.0056653,0.00037084,0.098855,0.47715,MIR10524_5P,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...15,SET,173,0.0037952,0.00036668,0.066213,0.47715,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN,0.99999
BIOCARTA_WNT_PATHWAY,SET,23,0.010633,0.00037611,0.18558,0.47716,BIOCARTA_WNT_PATHWAY,0.99999
GOBP_REGULATION_OF_CELL_FATE...1,SET,38,0.0083683,0.00038034,0.14608,0.47716,GOBP_REGULATION_OF_CELL_FATE_COMMITMENT,0.99999
GOCC_RNA_POLYMERASE_I_COMPLEX,SET,10,0.013451,0.00031386,0.23481,0.47716,GOCC_RNA_POLYMERASE_I_COMPLEX,0.99999
REACTOME_GAB1_SIGNALOSOME,SET,17,0.012154,0.00036967,0.21242,0.47719,REACTOME_GAB1_SIGNALOSOME,0.99999
CREBP1_Q2,SET,231,0.0032168,0.00035857,0.056223,0.47719,CREBP1_Q2,0.99999
MIR6818_3P,SET,108,0.0050025,0.00038257,0.087966,0.47733,MIR6818_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...506,SET,32,0.0087712,0.00036588,0.15518,0.47746,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
GNF2_HPX,SET,128,0.0043964,0.00036583,0.077837,0.47748,GNF2_HPX,0.99999
MIR494_3P,SET,346,0.0026801,0.00036446,0.047519,0.47751,MIR494_3P,0.99999
HP_ABNORMAL_HARD_PALATE_MORP...,SET,71,0.005578,0.00034622,0.099118,0.47756,HP_ABNORMAL_HARD_PALATE_MORPHOLOGY,0.99999
HP_IRREGULAR_EPIPHYSES,SET,21,0.010544,0.00035641,0.18745,0.47757,HP_IRREGULAR_EPIPHYSES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...514,SET,101,0.0046624,0.00034487,0.082926,0.47758,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_RETINAL_METABOLIC_PROCE...,SET,18,0.012262,0.00038376,0.21846,0.47762,GOBP_RETINAL_METABOLIC_PROCESS,0.99999
GSE16451_CTRL_VS_WEST_EQUINE...2,SET,178,0.0036556,0.00035821,0.065488,0.47774,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...47,SET,44,0.0068878,0.0003368,0.12373,0.4778,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT,0.99999
GOMF_MACROMOLECULE_TRANSMEMB...,SET,29,0.0086019,0.00034162,0.15473,0.47783,GOMF_MACROMOLECULE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOMF_SINGLE_STRANDED_DNA_BIN...,SET,107,0.0041842,0.00031851,0.075342,0.47786,GOMF_SINGLE_STRANDED_DNA_BINDING,0.99999
chr8p11,SET,50,0.012537,0.00065338,0.22584,0.47787,chr8p11,0.99999
YOSHIMURA_MAPK8_TARGETS_DN,SET,350,0.0025882,0.00035395,0.046783,0.47794,YOSHIMURA_MAPK8_TARGETS_DN,0.99999
GSE22229_RENAL_TRANSPLANT_IM...1,SET,183,0.0035749,0.00035514,0.064634,0.47795,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN,0.99999
GOCC_AXON_CYTOPLASM,SET,61,0.0061025,0.00035119,0.11063,0.478,GOCC_AXON_CYTOPLASM,0.99999
ALK_DN.V1_UP,SET,122,0.0044245,0.00035949,0.080242,0.47801,ALK_DN.V1_UP,0.99999
BLANCO_MELO_COVID19_SARS_COV...1,SET,90,0.0052194,0.00036455,0.094809,0.47805,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,0.99999
HP_SPIDER_HEMANGIOMA,SET,5,0.020204,0.00033338,0.36694,0.47805,HP_SPIDER_HEMANGIOMA,0.99999
GOMF_CHEMOKINE_ACTIVITY,SET,45,0.0086344,0.00042697,0.15695,0.47806,GOMF_CHEMOKINE_ACTIVITY,0.99999
HP_CARDIOVASCULAR_CALCIFICAT...,SET,36,0.0083294,0.00036849,0.15134,0.47806,HP_CARDIOVASCULAR_CALCIFICATION,0.99999
GSE22886_CD8_TCELL_VS_BCELL_...1,SET,170,0.0036578,0.00035036,0.066477,0.47806,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN,0.99999
ONGUSAHA_BRCA1_TARGETS_DN,SET,11,0.01431,0.00035019,0.26055,0.4781,ONGUSAHA_BRCA1_TARGETS_DN,0.99999
MEISSNER_NPC_ICP_WITH_H3_UNM...,SET,20,0.011386,0.0003756,0.20778,0.47815,MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED,0.99999
HP_ABNORMAL_MIDDLE_PHALANX_M...,SET,58,0.0061943,0.00034762,0.11314,0.47817,HP_ABNORMAL_MIDDLE_PHALANX_MORPHOLOGY_OF_THE_HAND,0.99999
BIOCARTA_VIP_PATHWAY,SET,26,0.0096808,0.00036407,0.17689,0.47818,BIOCARTA_VIP_PATHWAY,0.99999
MODULE_7,SET,214,0.0031903,0.00034244,0.058358,0.4782,MODULE_7,0.99999
HP_PUNDING,SET,6,0.022188,0.00040106,0.40589,0.4782,HP_PUNDING,0.99999
GSE24574_BCL6_HIGH_VS_LOW_TF...2,SET,183,0.0035487,0.00035254,0.064912,0.4782,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP,0.99999
GOBP_CELL_JUNCTION_ORGANIZAT...,SET,704,0.0018978,0.00036445,0.034748,0.47822,GOBP_CELL_JUNCTION_ORGANIZATION,0.99999
GOBP_NITRIC_OXIDE_MEDIATED_S...,SET,18,0.012368,0.00038708,0.22646,0.47822,GOBP_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION,0.99999
WP_LEPTININSULIN_SIGNALING_O...,SET,16,0.013461,0.00039724,0.24654,0.47823,WP_LEPTININSULIN_SIGNALING_OVERLAP,0.99999
HP_ABNORMAL_OVARIAN_MORPHOLO...,SET,158,0.0036998,0.00034176,0.06782,0.47825,HP_ABNORMAL_OVARIAN_MORPHOLOGY,0.99999
KEGG_MEDICUS_ENV_FACTOR_E2_T...2,SET,15,0.012561,0.0003589,0.23089,0.47831,KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOCC_CELL_TRAILING_EDGE,SET,14,0.012484,0.00034463,0.22954,0.47831,GOCC_CELL_TRAILING_EDGE,0.99999
HP_OVERHANGING_NASAL_TIP,SET,7,0.014498,0.00028304,0.2672,0.47837,HP_OVERHANGING_NASAL_TIP,0.99999
MURARO_PANCREAS_MESENCHYMAL_...,SET,620,0.0019968,0.00036071,0.03686,0.4784,MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL,0.99999
BIOCARTA_TCYTOTOXIC_PATHWAY,SET,12,0.014996,0.00038328,0.27696,0.47841,BIOCARTA_TCYTOTOXIC_PATHWAY,0.99999
GOBP_PULMONARY_ARTERY_MORPHO...,SET,6,0.021815,0.00039432,0.40286,0.47841,GOBP_PULMONARY_ARTERY_MORPHOGENESIS,0.99999
GSE16385_MONOCYTE_VS_12H_ROS...6,SET,171,0.00362,0.00034775,0.066863,0.47841,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,0.99999
HARALAMBIEVA_PBMC_TIV_AGE_50...2,SET,13,0.010518,0.0002798,0.19429,0.47841,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_3DY_NEGATIVE,0.99999
HP_ABNORMALITY_OF_THE_MIDDLE...2,SET,19,0.011418,0.00036713,0.21137,0.47846,HP_ABNORMALITY_OF_THE_MIDDLE_EAR_OSSICLES,0.99999
GOBP_HIGH_DENSITY_LIPOPROTEI...1,SET,11,0.011823,0.00028932,0.21947,0.47852,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY,0.99999
GOBP_POSITIVE_REGULATION_OF_...428,SET,4,0.018586,0.00027432,0.34519,0.47853,GOBP_POSITIVE_REGULATION_OF_LYSOSOMAL_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_NUCLEOCYT...,SET,108,0.004266,0.00032624,0.079234,0.47853,GOBP_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,0.99999
LTE2_UP.V1_DN,SET,172,0.0037839,0.00036454,0.070354,0.47855,LTE2_UP.V1_DN,0.99999
HP_ABNORMAL_RENAL_PHYSIOLOGY,SET,624,0.0018525,0.00033568,0.034488,0.47858,HP_ABNORMAL_RENAL_PHYSIOLOGY,0.99999
GSE3982_MAST_CELL_VS_TH1_UP,SET,180,0.0035273,0.00034756,0.065653,0.47858,GSE3982_MAST_CELL_VS_TH1_UP,0.99999
VALK_AML_CLUSTER_11,SET,37,0.0083055,0.00037249,0.155,0.47863,VALK_AML_CLUSTER_11,0.99999
GOBP_MONOATOMIC_CATION_TRANS...2,SET,917,0.0016241,0.0003538,0.030358,0.47867,GOBP_MONOATOMIC_CATION_TRANSPORT,0.99999
GOBP_PORE_COMPLEX_ASSEMBLY,SET,18,0.0108,0.00033803,0.20202,0.47868,GOBP_PORE_COMPLEX_ASSEMBLY,0.99999
HP_INTELLECTUAL_DISABILITY_M...2,SET,132,0.0037935,0.00032052,0.071097,0.47872,HP_INTELLECTUAL_DISABILITY_MODERATE,0.99999
YAMANAKA_GLIOBLASTOMA_SURVIV...2,SET,9,0.016263,0.00036,0.30489,0.47873,YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP,0.99999
chr20p12,SET,39,0.012441,0.00057281,0.23344,0.47875,chr20p12,0.99999
REACTOME_NOTCH_HLH_TRANSCRIP...,SET,24,0.0092597,0.00033458,0.17417,0.4788,REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY,0.99999
CHYLA_CBFA2T3_TARGETS_DN,SET,212,0.003117,0.00033302,0.05871,0.47883,CHYLA_CBFA2T3_TARGETS_DN,0.99999
GOCC_B_WICH_COMPLEX,SET,7,0.016393,0.00032004,0.30946,0.47888,GOCC_B_WICH_COMPLEX,0.99999
GSE12845_IGD_POS_BLOOD_VS_DA...2,SET,166,0.0034483,0.00032642,0.065157,0.4789,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.99999
GOMF_LIGASE_ACTIVITY_FORMING...5,SET,5,0.018202,0.00030036,0.34433,0.47892,GOMF_LIGASE_ACTIVITY_FORMING_PHOSPHORIC_ESTER_BONDS,0.99999
GOCC_SMC5_SMC6_COMPLEX,SET,6,0.019591,0.00035411,0.37107,0.47895,GOCC_SMC5_SMC6_COMPLEX,0.99999
GSE15324_ELF4_KO_VS_WT_ACTIV...1,SET,180,0.0033046,0.00032561,0.062619,0.47896,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN,0.99999
GOMF_CELL_CELL_ADHESION_MEDI...,SET,50,0.0072897,0.00037992,0.13847,0.47901,GOMF_CELL_CELL_ADHESION_MEDIATOR_ACTIVITY,0.99999
HP_DUODENAL_ULCER,SET,12,0.012928,0.00033041,0.24559,0.47901,HP_DUODENAL_ULCER,0.99999
MIR216B_3P,SET,115,0.0041731,0.00032925,0.079377,0.47904,MIR216B_3P,0.99999
GSE14699_DELETIONAL_TOLERANC...1,SET,167,0.0034168,0.0003244,0.065037,0.47905,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.99999
GSE2706_2H_VS_8H_R848_AND_LP...1,SET,177,0.0033982,0.00033206,0.0647,0.47906,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HD...1,SET,516,0.0021644,0.00035773,0.04129,0.4791,MANNO_MIDBRAIN_NEUROTYPES_HDA1,0.99999
HP_ANAPHYLACTIC_SHOCK,SET,8,0.01679,0.00035042,0.32073,0.47913,HP_ANAPHYLACTIC_SHOCK,0.99999
REACTOME_SARS_COV_1_INFECTION,SET,129,0.003815,0.00031868,0.072979,0.47915,REACTOME_SARS_COV_1_INFECTION,0.99999
GOBP_PROTEIN_INSERTION_INTO_...3,SET,40,0.0069491,0.00032402,0.13323,0.4792,GOBP_PROTEIN_INSERTION_INTO_MEMBRANE,0.99999
GOBP_DOPAMINE_METABOLIC_PROC...,SET,33,0.0083163,0.00035228,0.15982,0.47925,GOBP_DOPAMINE_METABOLIC_PROCESS,0.99999
GATA6_01,SET,236,0.0030818,0.00034717,0.059251,0.47926,GATA6_01,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...8,SET,24,0.0088901,0.00032123,0.17118,0.47929,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.99999
GOMF_L_PROLINE_TRANSMEMBRANE...,SET,7,0.019119,0.00037327,0.36817,0.47929,GOMF_L_PROLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOMF_CHOLESTEROL_BINDING,SET,51,0.0063618,0.00033485,0.12273,0.47933,GOMF_CHOLESTEROL_BINDING,0.99999
GOBP_MACROPHAGE_ACTIVATION,SET,103,0.0046651,0.00034846,0.090313,0.4794,GOBP_MACROPHAGE_ACTIVATION,0.99999
GSE369_SOCS3_KO_VS_IFNG_KO_L...1,SET,181,0.0033508,0.00033107,0.064902,0.47941,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_OR...2,SET,1775,0.0011374,0.00033614,0.022171,0.47954,GOBP_CELLULAR_RESPONSE_TO_ORGANIC_SUBSTANCE,0.99999
GOCC_CHROMAFFIN_GRANULE,SET,14,0.013323,0.00036779,0.26096,0.47964,GOCC_CHROMAFFIN_GRANULE,0.99999
MIR6719_3P,SET,110,0.0044319,0.00034203,0.087047,0.4797,MIR6719_3P,0.99999
HP_INCREASED_GLUTAMINE_FAMIL...,SET,5,0.016595,0.00027383,0.32678,0.47975,HP_INCREASED_GLUTAMINE_FAMILY_AMINO_ACID_LEVEL_IN_URINE,0.99999
RODWELL_AGING_KIDNEY_UP,SET,422,0.0022092,0.00033108,0.043554,0.47977,RODWELL_AGING_KIDNEY_UP,0.99999
HP_RECURRENT_MYCOBACTERIAL_I...,SET,48,0.0061755,0.00031536,0.12184,0.47979,HP_RECURRENT_MYCOBACTERIAL_INFECTIONS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...14,SET,13,0.01281,0.00034078,0.25345,0.47984,GOBP_NEGATIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,0.99999
GSE4984_GALECTIN1_VS_LPS_STI...1,SET,156,0.0034673,0.00031826,0.06888,0.47993,GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN,0.99999
PID_IL27_PATHWAY,SET,26,0.008668,0.00032598,0.17236,0.47995,PID_IL27_PATHWAY,0.99999
HP_ABNORMALITY_OF_CIRCULATIN...2,SET,62,0.0054677,0.00031721,0.10895,0.47999,HP_ABNORMALITY_OF_CIRCULATING_GLUCOCORTICOID_LEVEL,0.99999
REACTOME_PRE_NOTCH_EXPRESSIO...,SET,48,0.005844,0.00029843,0.11651,0.48,REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,0.99999
chr18q21,SET,76,0.0091003,0.00058431,0.18152,0.48001,chr18q21,0.99999
HP_ABNORMAL_SCLERA_MORPHOLOGY,SET,127,0.0037234,0.00030862,0.07428,0.48001,HP_ABNORMAL_SCLERA_MORPHOLOGY,0.99999
GSE39110_UNTREATED_VS_IL2_TR...1,SET,182,0.0031186,0.00030897,0.06222,0.48001,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_DN,0.99999
GOBP_PYRIMIDINE_RIBONUCLEOTI...2,SET,8,0.015583,0.00032523,0.31119,0.48003,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_CATABOLIC_PROCESS,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...3,SET,181,0.0030783,0.00030415,0.061474,0.48003,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN,0.99999
GOBP_TRANSCRIPTION_INITIATIO...2,SET,142,0.0034303,0.00030052,0.068934,0.48016,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_II_PROMOTER,0.99999
HP_DISTAL_SENSORY_IMPAIRMENT,SET,117,0.0036841,0.00029317,0.074096,0.48017,HP_DISTAL_SENSORY_IMPAIRMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...409,SET,7,0.017277,0.00033731,0.34788,0.4802,GOBP_NEGATIVE_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,0.99999
BLANCO_MELO_RESPIRATORY_SYNC...1,SET,103,0.0041972,0.0003135,0.084977,0.4803,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,0.99999
REACTOME_NUCLEOTIDE_SALVAGE,SET,21,0.0093312,0.00031542,0.18919,0.48033,REACTOME_NUCLEOTIDE_SALVAGE,0.99999
HP_ELEVATED_TISSUE_NON_SPECI...,SET,17,0.01051,0.00031967,0.21363,0.48038,HP_ELEVATED_TISSUE_NON_SPECIFIC_ALKALINE_PHOSPHATASE,0.99999
GOMF_TRANSFORMING_GROWTH_FAC...2,SET,13,0.012759,0.00033941,0.25945,0.48039,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_ACTIVITY,0.99999
HARALAMBIEVA_PBMC_FLUARIX_AG...4,SET,15,0.012086,0.00034532,0.24573,0.48039,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_POSITIVE,0.99999
WIEMANN_TELOMERE_SHORTENING_...1,SET,5,0.015432,0.00025465,0.31454,0.48043,WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN,0.99999
GOBP_REGULATION_OF_TYPE_I_IN...,SET,40,0.0065433,0.0003051,0.13349,0.48045,GOBP_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.99999
GOCC_MULTIVESICULAR_BODY_LUM...,SET,5,0.019029,0.00031399,0.38811,0.48045,GOCC_MULTIVESICULAR_BODY_LUMEN,0.99999
GOBP_DENDRITE_SELF_AVOIDANCE,SET,14,0.013613,0.00037577,0.27901,0.48054,GOBP_DENDRITE_SELF_AVOIDANCE,0.99999
GOBP_INTERLEUKIN_5_MEDIATED_...,SET,6,0.018192,0.00032883,0.37315,0.48056,GOBP_INTERLEUKIN_5_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...634,SET,8,0.01584,0.00033058,0.3252,0.48058,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_EARLY_ENDOSOME,0.99999
WP_DYRK1A_INVOLVEMENT_REGARD...,SET,59,0.0053064,0.00030034,0.10967,0.4807,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,0.99999
MODULE_215,SET,14,0.013103,0.00036172,0.2709,0.48071,MODULE_215,0.99999
HP_QUADRICEPS_MUSCLE_ATROPHY,SET,3,0.025427,0.00032502,0.52607,0.48073,HP_QUADRICEPS_MUSCLE_ATROPHY,0.99999
GSE37533_PPARG1_FOXP3_VS_FOX...4,SET,184,0.0030083,0.00029966,0.062279,0.48074,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,0.99999
GOBP_DNA_MODIFICATION,SET,38,0.0069063,0.00031389,0.14322,0.48077,GOBP_DNA_MODIFICATION,0.99999
AIZARANI_LIVER_C11_HEPATOCYT...,SET,274,0.0027083,0.0003284,0.056222,0.48079,AIZARANI_LIVER_C11_HEPATOCYTES_1,0.99999
GOBP_LIPID_METABOLIC_PROCESS,SET,1263,0.0012285,0.00031095,0.02552,0.4808,GOBP_LIPID_METABOLIC_PROCESS,0.99999
MIR1207_3P,SET,124,0.0037972,0.00031102,0.079045,0.48084,MIR1207_3P,0.99999
GOBP_REGULATION_OF_MYELOID_C...1,SET,29,0.0076237,0.00030277,0.15867,0.48084,GOBP_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,0.99999
PARK_TRETINOIN_RESPONSE_AND_...1,SET,27,0.0083275,0.00031913,0.1735,0.48086,PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,0.99999
HP_POLYCLONAL_ELEVATION_OF_I...,SET,6,0.015484,0.00027989,0.32289,0.48088,HP_POLYCLONAL_ELEVATION_OF_IGM,0.99999
GOBP_EPITHELIAL_CELL_PROLIFE...4,SET,5,0.020855,0.00034413,0.43555,0.48091,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,0.99999
BIOCARTA_RACCYCD_PATHWAY,SET,25,0.0075555,0.00027863,0.15789,0.48092,BIOCARTA_RACCYCD_PATHWAY,0.99999
GOBP_ISOTYPE_SWITCHING_TO_IG...1,SET,6,0.015636,0.00028264,0.32718,0.48094,GOBP_ISOTYPE_SWITCHING_TO_IGA_ISOTYPES,0.99999
WANG_IMMORTALIZED_BY_HOXA9_A...2,SET,30,0.0080961,0.00032702,0.16965,0.48097,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP,0.99999
TGAGATT_MIR216,SET,101,0.0040733,0.0003013,0.085565,0.48102,TGAGATT_MIR216,0.99999
HP_IMPAIRED_OXIDATIVE_BURST,SET,5,0.020088,0.00033148,0.42221,0.48103,HP_IMPAIRED_OXIDATIVE_BURST,0.99999
GSE37301_COMMON_LYMPHOID_PRO...8,SET,166,0.0031832,0.00030133,0.067147,0.48109,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,0.99999
GOBP_SENSORY_SYSTEM_DEVELOPM...,SET,383,0.00224,0.00032015,0.047271,0.4811,GOBP_SENSORY_SYSTEM_DEVELOPMENT,0.99999
HP_HISTIOCYTOSIS,SET,6,0.017222,0.00031129,0.36578,0.48122,HP_HISTIOCYTOSIS,0.99999
GOBP_ATRIOVENTRICULAR_NODE_D...,SET,9,0.013876,0.00030717,0.2954,0.48127,GOBP_ATRIOVENTRICULAR_NODE_DEVELOPMENT,0.99999
GOBP_EATING_BEHAVIOR,SET,37,0.0072278,0.00032416,0.15391,0.48127,GOBP_EATING_BEHAVIOR,0.99999
GSE15330_HSC_VS_LYMPHOID_PRI...3,SET,181,0.0029501,0.00029148,0.063043,0.48134,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_UP,0.99999
GSE3982_MAC_VS_NKCELL_UP,SET,180,0.0030503,0.00030056,0.065344,0.48138,GSE3982_MAC_VS_NKCELL_UP,0.99999
MIR15A_5P,SET,535,0.0017159,0.00028863,0.036782,0.4814,MIR15A_5P,0.99999
GSE17721_0.5H_VS_8H_PAM3CSK4...2,SET,181,0.0028747,0.00028403,0.06175,0.48143,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_UP,0.99999
REACTOME_DEADENYLATION_OF_MR...,SET,22,0.0084534,0.00029246,0.18225,0.4815,REACTOME_DEADENYLATION_OF_MRNA,0.99999
HP_THROMBOEMBOLISM,SET,91,0.0043748,0.00030724,0.094771,0.48159,HP_THROMBOEMBOLISM,0.99999
JAZAG_TGFB1_SIGNALING_VIA_SM...1,SET,59,0.0050929,0.00028826,0.11052,0.48162,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,0.99999
GOBP_CARDIAC_MUSCLE_CELL_PRO...,SET,45,0.0065025,0.00032155,0.14115,0.48163,GOBP_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.99999
GOBP_PHOTORECEPTOR_CELL_MAIN...,SET,43,0.0061976,0.0002996,0.13515,0.48171,GOBP_PHOTORECEPTOR_CELL_MAINTENANCE,0.99999
GOBP_REGULATION_OF_TRANSPORT,SET,1447,0.0010948,0.000295,0.023956,0.48178,GOBP_REGULATION_OF_TRANSPORT,0.99999
GSE12392_CD8A_POS_VS_NEG_SPL...3,SET,188,0.0027814,0.00028002,0.061056,0.48183,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN,0.99999
BENPORATH_PRC2_TARGETS,SET,575,0.0018969,0.00033041,0.041663,0.48184,BENPORATH_PRC2_TARGETS,0.99999
chr17q23,SET,51,0.0094218,0.00049591,0.20719,0.48186,chr17q23,0.99999
REACTOME_STRIATED_MUSCLE_CON...,SET,35,0.0063888,0.00027869,0.14061,0.48188,REACTOME_STRIATED_MUSCLE_CONTRACTION,0.99999
KEGG_MEDICUS_PATHOGEN_KSHV_V...3,SET,6,0.013827,0.00024993,0.30471,0.4819,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_TNF_NFKB_SIGNALING_PATHWAY,0.99999
BEIER_GLIOMA_STEM_CELL_UP,SET,35,0.0072691,0.0003171,0.16089,0.48198,BEIER_GLIOMA_STEM_CELL_UP,0.99999
REACTOME_SIGNALING_BY_INTERL...,SET,430,0.0018988,0.00028718,0.04208,0.482,REACTOME_SIGNALING_BY_INTERLEUKINS,0.99999
GOBP_MODIFICATION_DEPENDENT_...,SET,565,0.0015698,0.00027113,0.034814,0.48202,GOBP_MODIFICATION_DEPENDENT_MACROMOLECULE_CATABOLIC_PROCESS,0.99999
GNF2_RBBP6,SET,65,0.0043215,0.00025669,0.096262,0.4821,GNF2_RBBP6,0.99999
REACTOME_LRR_FLII_INTERACTIN...,SET,5,0.016399,0.0002706,0.36695,0.48218,REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION,0.99999
GSE6259_FLT3L_INDUCED_VS_WT_...1,SET,145,0.0033716,0.00029846,0.075578,0.48221,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN,0.99999
GSE2706_UNSTIM_VS_2H_R848_DC...1,SET,172,0.0031627,0.0003047,0.071114,0.48226,GSE2706_UNSTIM_VS_2H_R848_DC_DN,0.99999
GOMF_PROTEIN_DISULFIDE_ISOME...,SET,21,0.0086023,0.00029078,0.19361,0.48228,GOMF_PROTEIN_DISULFIDE_ISOMERASE_ACTIVITY,0.99999
GSE10094_LCMV_VS_LISTERIA_IN...2,SET,175,0.0026791,0.00026033,0.060332,0.48229,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP,0.99999
NABA_MATRISOME_METASTATIC_CO...,SET,26,0.0086363,0.00032478,0.19458,0.4823,NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS,0.99999
NAKAYA_MYELOID_DENDRITIC_CEL...4,SET,337,0.0020276,0.00027219,0.045695,0.4823,NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP,0.99999
AIZARANI_LIVER_C20_LSECS_3,SET,271,0.0024563,0.00029623,0.055378,0.48231,AIZARANI_LIVER_C20_LSECS_3,0.99999
DESCARTES_FETAL_PANCREAS_ERY...,SET,107,0.0037308,0.00028399,0.084296,0.48235,DESCARTES_FETAL_PANCREAS_ERYTHROBLASTS,0.99999
BIOCARTA_NFAT_PATHWAY,SET,50,0.0056255,0.00029319,0.12721,0.48236,BIOCARTA_NFAT_PATHWAY,0.99999
KOHN_EMT_MESENCHYMAL,SET,14,0.0096863,0.00026739,0.21917,0.48237,KOHN_EMT_MESENCHYMAL,0.99999
GOMF_RRNA_CYTOSINE_METHYLTRA...,SET,4,0.017476,0.00025794,0.39572,0.48239,GOMF_RRNA_CYTOSINE_METHYLTRANSFERASE_ACTIVITY,0.99999
BIOCARTA_DEATH_PATHWAY,SET,28,0.0073791,0.00028796,0.16742,0.48242,BIOCARTA_DEATH_PATHWAY,0.99999
KOKKINAKIS_METHIONINE_DEPRIV...3,SET,69,0.0044369,0.0002715,0.10084,0.48245,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,0.99999
HP_ABNORMAL_GLOMERULAR_FILTR...,SET,26,0.0070913,0.00026668,0.16158,0.4825,HP_ABNORMAL_GLOMERULAR_FILTRATION_RATE,0.99999
GOBP_PURINE_CONTAINING_COMPO...1,SET,138,0.0031438,0.00027155,0.072064,0.4826,GOBP_PURINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.99999
GOMF_NADPLUS_BINDING,SET,18,0.0086872,0.00027189,0.20033,0.48271,GOMF_NADPLUS_BINDING,0.99999
HP_HYPERCHOLESTEROLEMIA,SET,69,0.0047572,0.0002911,0.10983,0.48273,HP_HYPERCHOLESTEROLEMIA,0.99999
KEGG_MEDICUS_REFERENCE_ICOSL...,SET,8,0.013909,0.00029029,0.32231,0.48279,KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY,0.99999
GSE24142_DN2_VS_DN3_THYMOCYT...5,SET,179,0.0028216,0.00027726,0.065441,0.4828,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP,0.99999
GOCC_FILAMENTOUS_ACTIN,SET,30,0.0066902,0.00027023,0.15533,0.48282,GOCC_FILAMENTOUS_ACTIN,0.99999
FALVELLA_SMOKERS_WITH_LUNG_C...,SET,72,0.0044551,0.00027846,0.10363,0.48285,FALVELLA_SMOKERS_WITH_LUNG_CANCER,0.99999
GOBP_NEURON_FATE_SPECIFICATI...,SET,32,0.007147,0.00029813,0.16642,0.48287,GOBP_NEURON_FATE_SPECIFICATION,0.99999
GOBP_AMIDE_METABOLIC_PROCESS,SET,398,0.0018867,0.00027477,0.04395,0.48288,GOBP_AMIDE_METABOLIC_PROCESS,0.99999
DACOSTA_UV_RESPONSE_VIA_ERCC...7,SET,79,0.0041787,0.00027353,0.097433,0.4829,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,0.99999
GOCC_WASH_COMPLEX,SET,7,0.012338,0.00024087,0.28787,0.48291,GOCC_WASH_COMPLEX,0.99999
SCHERER_PBMC_APSV_WETVAX_AGE...5,SET,171,0.0027482,0.000264,0.064147,0.48291,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_DN,0.99999
DAZARD_RESPONSE_TO_UV_SCC_DN,SET,110,0.0035136,0.00027116,0.082047,0.48292,DAZARD_RESPONSE_TO_UV_SCC_DN,0.99999
AIZARANI_LIVER_C38_RESIDENT_...,SET,19,0.008281,0.00026627,0.19404,0.48298,AIZARANI_LIVER_C38_RESIDENT_B_CELLS_3,0.99999
GOBP_SKELETAL_MUSCLE_ORGAN_D...,SET,169,0.0028845,0.00027548,0.067746,0.48302,GOBP_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT,0.99999
GOMF_NON_MEMBRANE_SPANNING_P...2,SET,10,0.010963,0.0002558,0.25764,0.48303,GOMF_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY,0.99999
LIU_IL13_MEMORY_MODEL_UP,SET,17,0.0087745,0.00026689,0.20654,0.48306,LIU_IL13_MEMORY_MODEL_UP,0.99999
HP_HYPOMETRIC_SACCADES,SET,13,0.0098696,0.00026254,0.23363,0.48315,HP_HYPOMETRIC_SACCADES,0.99999
DORMOY_ELAVL1_TARGETS,SET,17,0.00926,0.00028166,0.21955,0.48318,DORMOY_ELAVL1_TARGETS,0.99999
REACTOME_SYNTHESIS_OF_PIPS_A...1,SET,15,0.0074941,0.00021413,0.17802,0.48321,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE,0.99999
MIR4771,SET,48,0.0050336,0.00025705,0.11982,0.48325,MIR4771,0.99999
GOBP_NEGATIVE_REGULATION_BY_...3,SET,14,0.009463,0.00026123,0.22525,0.48325,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION,0.99999
DESCARTES_FETAL_LUNG_LYMPHAT...,SET,48,0.0054852,0.00028011,0.13097,0.4833,DESCARTES_FETAL_LUNG_LYMPHATIC_ENDOTHELIAL_CELLS,0.99999
HP_ABNORMAL_CARTILAGE_MORPHO...,SET,41,0.0058292,0.00027517,0.13934,0.48332,HP_ABNORMAL_CARTILAGE_MORPHOLOGY,0.99999
GOMF_LONG_CHAIN_FATTY_ACYL_C...,SET,12,0.0097046,0.00024803,0.23319,0.4834,GOMF_LONG_CHAIN_FATTY_ACYL_COA_HYDROLASE_ACTIVITY,0.99999
DI_MARTINO_MATRISOME_HIGHLY_...2,SET,17,0.0091148,0.00027724,0.21917,0.48341,DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED,0.99999
GSE9601_NFKB_INHIBITOR_VS_PI...2,SET,177,0.0026034,0.00025439,0.062591,0.48341,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,0.99999
HP_STATUS_EPILEPTICUS_WITHOU...,SET,24,0.0071131,0.00025702,0.1717,0.48348,HP_STATUS_EPILEPTICUS_WITHOUT_PROMINENT_MOTOR_SYMPTOMS,0.99999
GOBP_TRANSPOSITION,SET,35,0.0058582,0.00025555,0.14151,0.48349,GOBP_TRANSPOSITION,0.99999
HP_AMBLYOPIA,SET,99,0.0034689,0.00025405,0.08383,0.4835,HP_AMBLYOPIA,0.99999
HP_WOOLLY_HAIR,SET,22,0.0077575,0.00026839,0.18764,0.48351,HP_WOOLLY_HAIR,0.99999
GOBP_CARTILAGE_CONDENSATION,SET,18,0.00935,0.00029263,0.2265,0.48354,GOBP_CARTILAGE_CONDENSATION,0.99999
IWANAGA_E2F1_TARGETS_INDUCED...,SET,22,0.0073448,0.00025411,0.17814,0.48356,IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM,0.99999
AIZARANI_LIVER_C21_STELLATE_...,SET,176,0.0029642,0.00028884,0.072052,0.48359,AIZARANI_LIVER_C21_STELLATE_CELLS_1,0.99999
GOCC_CEREBELLAR_CLIMBING_FIB...,SET,7,0.015398,0.00030063,0.37519,0.48363,GOCC_CEREBELLAR_CLIMBING_FIBER_TO_PURKINJE_CELL_SYNAPSE,0.99999
GOBP_REGULATION_OF_ACTOMYOSI...,SET,94,0.0037581,0.00026823,0.091704,0.48366,GOBP_REGULATION_OF_ACTOMYOSIN_STRUCTURE_ORGANIZATION,0.99999
HP_RECURRENT_UPPER_AND_LOWER...,SET,14,0.010388,0.00028676,0.25395,0.48369,HP_RECURRENT_UPPER_AND_LOWER_RESPIRATORY_TRACT_INFECTIONS,0.99999
KEGG_MEDICUS_REFERENCE_PTH_P...,SET,15,0.0094114,0.00026891,0.23041,0.48371,KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY,0.99999
HP_HEMIPLEGIA_HEMIPARESIS,SET,192,0.0025431,0.00025871,0.062329,0.48373,HP_HEMIPLEGIA_HEMIPARESIS,0.99999
STEGMEIER_PREMITOTIC_CELL_CY...,SET,11,0.01001,0.00024495,0.24577,0.48376,STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS,0.99999
HP_FOLLICULITIS,SET,7,0.016084,0.00031402,0.39618,0.48381,HP_FOLLICULITIS,0.99999
GOBP_REGULATION_OF_CYSTEINE_...2,SET,146,0.0029008,0.00025766,0.071624,0.48385,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...836,SET,30,0.0071345,0.00028817,0.17662,0.48389,GOBP_POSITIVE_REGULATION_OF_VASOCONSTRICTION,0.99999
TCTCTCC_MIR185,SET,115,0.0033293,0.00026268,0.082451,0.4839,TCTCTCC_MIR185,0.99999
GOBP_REGULATION_OF_RESPONSE_...13,SET,14,0.0083986,0.00023184,0.20884,0.48396,GOBP_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,0.99999
MIR4699_5P,SET,95,0.0035886,0.00025748,0.089512,0.48401,MIR4699_5P,0.99999
HP_HYPODONTIA,SET,206,0.0023776,0.00025044,0.059378,0.48403,HP_HYPODONTIA,0.99999
GOBP_MULTICELLULAR_ORGANISMA...7,SET,90,0.0038487,0.00026882,0.096345,0.48407,GOBP_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...302,SET,17,0.0095185,0.00028952,0.23858,0.48409,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,0.99999
HP_CONGENITAL_POSTERIOR_URET...,SET,8,0.011264,0.00023509,0.28252,0.4841,HP_CONGENITAL_POSTERIOR_URETHRAL_VALVE,0.99999
KEGG_MEDICUS_VARIANT_RET_FUS...,SET,10,0.010712,0.00024994,0.2689,0.48411,KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
HP_SENSORY_NEUROPATHY,SET,88,0.0034979,0.0002416,0.087768,0.48411,HP_SENSORY_NEUROPATHY,0.99999
WP_INTERFERON_TYPE_I_SIGNALI...,SET,51,0.0047906,0.00025215,0.12193,0.48433,WP_INTERFERON_TYPE_I_SIGNALING,0.99999
GOBP_AUTONOMIC_NERVOUS_SYSTE...,SET,40,0.0058522,0.00027288,0.14898,0.48433,GOBP_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT,0.99999
HP_ABNORMALITY_OF_THE_INNER_...,SET,79,0.0037559,0.00024585,0.095696,0.48435,HP_ABNORMALITY_OF_THE_INNER_EAR,0.99999
GOBP_CELL_MIGRATION_IN_HINDB...,SET,16,0.008793,0.00025948,0.22427,0.48436,GOBP_CELL_MIGRATION_IN_HINDBRAIN,0.99999
GOBP_ANTIGEN_PROCESSING_AND_...8,SET,27,0.0074524,0.00028559,0.19026,0.48438,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_II,0.99999
GSE3920_UNTREATED_VS_IFNA_TR...4,SET,158,0.0026818,0.00024772,0.068571,0.4844,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP,0.99999
GSE43955_10H_VS_60H_ACT_CD4_...4,SET,180,0.0024181,0.00023826,0.061958,0.48443,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.99999
MIR3119,SET,341,0.001827,0.00024667,0.046927,0.48447,MIR3119,0.99999
HP_RETINOPATHY,SET,127,0.0029832,0.00024726,0.076755,0.4845,HP_RETINOPATHY,0.99999
MODULE_223,SET,132,0.003183,0.00026893,0.08202,0.48452,MODULE_223,0.99999
GOBP_NEGATIVE_REGULATION_OF_...662,SET,26,0.0065232,0.00024532,0.16811,0.48452,GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.99999
HP_CRYPTORCHIDISM,SET,636,0.0013115,0.00023985,0.03384,0.48454,HP_CRYPTORCHIDISM,0.99999
GOCC_INNER_ACROSOMAL_MEMBRANE,SET,5,0.016866,0.00027831,0.43573,0.48456,GOCC_INNER_ACROSOMAL_MEMBRANE,0.99999
REACTOME_HDMS_DEMETHYLATE_HI...,SET,17,0.0069535,0.0002115,0.17978,0.48457,REACTOME_HDMS_DEMETHYLATE_HISTONES,0.99999
GOBP_INTERLEUKIN_10_MEDIATED...,SET,11,0.012874,0.00031504,0.33281,0.48457,GOBP_INTERLEUKIN_10_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_TELOMERIC_D_LOOP_DISASS...,SET,7,0.012757,0.00024907,0.32981,0.48457,GOBP_TELOMERIC_D_LOOP_DISASSEMBLY,0.99999
GOBP_REGULATION_OF_MOLECULAR...,SET,1741,0.00085049,0.00024918,0.022029,0.4846,GOBP_REGULATION_OF_MOLECULAR_FUNCTION,0.99999
GAUTAM_EYE_CORNEA_MELANOCYTES,SET,235,0.002079,0.00023371,0.054004,0.48465,GAUTAM_EYE_CORNEA_MELANOCYTES,0.99999
MIR5580_3P,SET,222,0.0023028,0.0002517,0.059859,0.48466,MIR5580_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...533,SET,360,0.0017662,0.0002449,0.045983,0.48468,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.99999
GSE24671_CTRL_VS_SENDAI_VIRU...2,SET,146,0.0027931,0.0002481,0.072916,0.48472,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,0.99999
GSE43955_1H_VS_60H_ACT_CD4_T...1,SET,182,0.0024888,0.00024658,0.065369,0.48481,GSE43955_1H_VS_60H_ACT_CD4_TCELL_DN,0.99999
REACTOME_REGULATION_OF_PYRUV...1,SET,12,0.0095753,0.00024473,0.25187,0.48484,REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX,0.99999
GSE22025_UNTREATED_VS_TGFB1_...2,SET,177,0.0024828,0.00024262,0.065535,0.48489,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.99999
GSE22443_IL2_VS_IL12_TREATED...2,SET,185,0.0023987,0.00023958,0.063418,0.48491,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_UP,0.99999
HP_THICKENED_SKIN,SET,381,0.0016942,0.00024152,0.044867,0.48494,HP_THICKENED_SKIN,0.99999
KASLER_HDAC7_TARGETS_1_UP,SET,179,0.0024202,0.00023781,0.064617,0.48506,KASLER_HDAC7_TARGETS_1_UP,0.99999
VDR_Q3,SET,211,0.0022254,0.0002372,0.059398,0.48506,VDR_Q3,0.99999
GOMF_MEDIUM_CHAIN_FATTY_ACID...,SET,9,0.011319,0.00025057,0.30248,0.48507,GOMF_MEDIUM_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,0.99999
GOCC_PROTEIN_PHOSPHATASE_4_C...,SET,3,0.015341,0.0001961,0.41115,0.48512,GOCC_PROTEIN_PHOSPHATASE_4_COMPLEX,0.99999
HP_AVASCULAR_NECROSIS_OF_THE...,SET,29,0.005964,0.00023685,0.16002,0.48513,HP_AVASCULAR_NECROSIS_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS,0.99999
HP_GENERALIZED_AMINOACIDURIA,SET,14,0.0089972,0.00024837,0.24136,0.48513,HP_GENERALIZED_AMINOACIDURIA,0.99999
GOBP_ENDOLYSOSOMAL_TOLL_LIKE...,SET,45,0.0046851,0.00023167,0.12583,0.48515,GOBP_ENDOLYSOSOMAL_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE29949_MICROGLIA_VS_DC_BRA...2,SET,185,0.0023371,0.00023343,0.062837,0.48517,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.99999
GSE32986_CURDLAN_LOWDOSE_VS_...1,SET,190,0.002409,0.00024381,0.065069,0.48523,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,0.99999
KUMAR_PATHOGEN_LOAD_BY_MACRO...,SET,228,0.0020945,0.00023196,0.056609,0.48524,KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,0.99999
GSE36888_UNTREATED_VS_IL2_TR...3,SET,173,0.0023908,0.00023099,0.064628,0.48525,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_DN,0.99999
GOBP_GLYCOLYTIC_PROCESS_THRO...2,SET,16,0.0071315,0.00021045,0.19409,0.48535,GOBP_GLYCOLYTIC_PROCESS_THROUGH_GLUCOSE_6_PHOSPHATE,0.99999
GOBP_DETOXIFICATION_OF_NITRO...,SET,2,0.026181,0.00027326,0.71495,0.48539,GOBP_DETOXIFICATION_OF_NITROGEN_COMPOUND,0.99999
THUM_SYSTOLIC_HEART_FAILURE_...1,SET,190,0.0022659,0.00022932,0.062215,0.48547,THUM_SYSTOLIC_HEART_FAILURE_DN,0.99999
HP_SEVERE_LACTIC_ACIDOSIS,SET,11,0.0092761,0.000227,0.25496,0.48549,HP_SEVERE_LACTIC_ACIDOSIS,0.99999
GOBP_MITOTIC_CYTOKINETIC_PRO...,SET,31,0.0054671,0.00022447,0.15043,0.4855,GOBP_MITOTIC_CYTOKINETIC_PROCESS,0.99999
GOCC_ZONULA_ADHERENS,SET,7,0.012031,0.00023488,0.33213,0.48555,GOCC_ZONULA_ADHERENS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...330,SET,8,0.012617,0.00026332,0.34839,0.48556,GOBP_NEGATIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,0.99999
GOMF_C_METHYLTRANSFERASE_ACT...,SET,6,0.010923,0.00019744,0.30242,0.48559,GOMF_C_METHYLTRANSFERASE_ACTIVITY,0.99999
GSE21670_STAT3_KO_VS_WT_CD4_...7,SET,180,0.0021823,0.00021503,0.060697,0.48566,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_UP,0.99999
REACTOME_FASTK_FAMILY_PROTEI...,SET,4,0.01231,0.00018169,0.34352,0.48571,REACTOME_FASTK_FAMILY_PROTEINS_REGULATE_PROCESSING_AND_STABILITY_OF_MITOCHONDRIAL_RNAS,0.99999
HP_ABNORMAL_URINE_SODIUM_CON...,SET,16,0.0080118,0.00023642,0.22463,0.48577,HP_ABNORMAL_URINE_SODIUM_CONCENTRATION,0.99999
WEIGEL_OXIDATIVE_STRESS_BY_H...2,SET,59,0.0041681,0.00023591,0.11726,0.48582,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,0.99999
GOBP_ENERGY_DERIVATION_BY_OX...,SET,277,0.0017313,0.00021106,0.048854,0.48586,GOBP_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS,0.99999
GOBP_MEDIUM_CHAIN_FATTY_ACID...1,SET,6,0.011157,0.00020168,0.31521,0.48588,GOBP_MEDIUM_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.99999
PID_E2F_PATHWAY,SET,70,0.0034068,0.00020997,0.096554,0.48593,PID_E2F_PATHWAY,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...39,SET,296,0.0017285,0.00021771,0.049006,0.48593,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.99999
chr10q24,SET,109,0.0054718,0.00042038,0.15587,0.486,chr10q24,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...11,SET,179,0.002159,0.00021215,0.061697,0.48604,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...238,SET,13,0.0091767,0.00024411,0.26257,0.48606,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,0.99999
HP_PROLONGED_BLEEDING_FOLLOW...2,SET,29,0.0059716,0.00023716,0.17223,0.48617,HP_PROLONGED_BLEEDING_FOLLOWING_PROCEDURE,0.99999
HP_CUTANEOUS_CYST,SET,21,0.006157,0.00020812,0.17805,0.48621,HP_CUTANEOUS_CYST,0.99999
MIR4435,SET,79,0.0033522,0.00021943,0.097359,0.48627,MIR4435,0.99999
GOCC_A_BAND,SET,39,0.0045395,0.00020901,0.13215,0.4863,GOCC_A_BAND,0.99999
LET_7C_3P,SET,537,0.001305,0.0002199,0.038034,0.48631,LET_7C_3P,0.99999
GSE24634_IL4_VS_CTRL_TREATED...2,SET,174,0.0022881,0.00022171,0.066687,0.48631,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP,0.99999
GSE43863_LY6C_INT_CXCR5POS_V...1,SET,180,0.0022331,0.00022003,0.065062,0.48631,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,0.99999
BROWNE_HCMV_INFECTION_4HR_DN,SET,227,0.0019434,0.00021476,0.056729,0.48634,BROWNE_HCMV_INFECTION_4HR_DN,0.99999
GOBP_ACTIVATION_OF_IMMUNE_RE...,SET,485,0.0013486,0.00021628,0.039544,0.4864,GOBP_ACTIVATION_OF_IMMUNE_RESPONSE,0.99999
ZNF331_TARGET_GENES,SET,270,0.0017835,0.0002147,0.052527,0.48646,ZNF331_TARGET_GENES,0.99999
BUSSLINGER_ESOPHAGEAL_DENDRI...,SET,194,0.0021853,0.00022345,0.064696,0.48653,BUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS,0.99999
GOMF_GUANYLATE_CYCLASE_REGUL...,SET,7,0.011674,0.00022792,0.34703,0.48658,GOMF_GUANYLATE_CYCLASE_REGULATOR_ACTIVITY,0.99999
HP_CEREBELLAR_HEMORRHAGE,SET,5,0.015049,0.00024833,0.44735,0.48658,HP_CEREBELLAR_HEMORRHAGE,0.99999
REACTOME_REGULATION_OF_INSUL...2,SET,77,0.0035088,0.00022677,0.10488,0.48666,REACTOME_REGULATION_OF_INSULIN_SECRETION,0.99999
REACTOME_NEGATIVE_REGULATION...9,SET,20,0.0065274,0.00021533,0.19745,0.48681,REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION,0.99999
HP_THYROID_DEFECT_IN_OXIDATI...,SET,6,0.011794,0.00021318,0.35658,0.48681,HP_THYROID_DEFECT_IN_OXIDATION_AND_ORGANIFICATION_OF_IODIDE,0.99999
GSE36888_UNTREATED_VS_IL2_TR...5,SET,178,0.0020548,0.00020135,0.062163,0.48682,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_DN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...25,SET,16,0.0071433,0.00021079,0.21723,0.48688,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY,0.99999
REACTOME_SIGNALING_BY_CSF1_M...,SET,29,0.0052462,0.00020835,0.15954,0.48688,REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS,0.99999
GOBP_SMALL_GTPASE_MEDIATED_S...,SET,461,0.0013369,0.00020918,0.040714,0.4869,GOBP_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,0.99999
HP_EPISODIC_TACHYPNEA,SET,48,0.0036237,0.00018505,0.11108,0.48699,HP_EPISODIC_TACHYPNEA,0.99999
HP_VENOUS_INSUFFICIENCY,SET,35,0.0048042,0.00020957,0.14725,0.48699,HP_VENOUS_INSUFFICIENCY,0.99999
FOURNIER_ACINAR_DEVELOPMENT_...5,SET,10,0.0094094,0.00021955,0.28869,0.487,FOURNIER_ACINAR_DEVELOPMENT_LATE_UP,0.99999
REACTOME_ASSOCIATION_OF_TRIC...,SET,36,0.0041583,0.00018396,0.12828,0.48707,REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS,0.99999
HP_DEEP_PHILTRUM,SET,63,0.0033866,0.00019805,0.10523,0.48716,HP_DEEP_PHILTRUM,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...7,SET,48,0.0043213,0.00022067,0.13447,0.48718,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_6,0.99999
GOBP_POSITIVE_REGULATION_OF_...126,SET,428,0.0013976,0.00021089,0.043491,0.48718,GOBP_POSITIVE_REGULATION_OF_CELL_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_DNA_REPAIR,SET,194,0.0018194,0.00018604,0.056865,0.48724,GOBP_REGULATION_OF_DNA_REPAIR,0.99999
REACTOME_NONHOMOLOGOUS_END_J...,SET,29,0.0042545,0.00016896,0.13353,0.48729,REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ,0.99999
GOMF_ACETYLESTERASE_ACTIVITY,SET,5,0.011418,0.00018842,0.35893,0.48731,GOMF_ACETYLESTERASE_ACTIVITY,0.99999
HP_ABNORMALITY_OF_THE_FOOT_M...,SET,11,0.0085489,0.0002092,0.27007,0.48737,HP_ABNORMALITY_OF_THE_FOOT_MUSCULATURE,0.99999
GOBP_MEMBRANE_LIPID_CATABOLI...,SET,44,0.0041286,0.00020188,0.13116,0.48744,GOBP_MEMBRANE_LIPID_CATABOLIC_PROCESS,0.99999
GSE360_CTRL_VS_B_MALAYI_LOW_...1,SET,177,0.0020555,0.00020086,0.065431,0.48747,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN,0.99999
GOMF_CARGO_ADAPTOR_ACTIVITY,SET,20,0.0059388,0.00019591,0.18933,0.48749,GOMF_CARGO_ADAPTOR_ACTIVITY,0.99999
GSE24210_CTRL_VS_IL35_TREATE...1,SET,180,0.0019083,0.00018803,0.061035,0.48753,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_DN,0.99999
GOCC_KAINATE_SELECTIVE_GLUTA...,SET,5,0.012732,0.0002101,0.40749,0.48754,GOCC_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX,0.99999
GOMF_KAINATE_SELECTIVE_GLUTA...,SET,5,0.012732,0.0002101,0.40749,0.48754,GOMF_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY,0.99999
TRAVAGLINI_LUNG_NEUROENDOCRI...,SET,114,0.0026893,0.00021127,0.086491,0.4876,TRAVAGLINI_LUNG_NEUROENDOCRINE_CELL,0.99999
GOBP_ACROSOMAL_VESICLE_EXOCY...,SET,9,0.0091282,0.00020206,0.29375,0.48761,GOBP_ACROSOMAL_VESICLE_EXOCYTOSIS,0.99999
GSE5589_IL6_KO_VS_IL10_KO_LP...9,SET,180,0.0019541,0.00019255,0.062972,0.48762,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,0.99999
HUI_MAPK14_TARGETS_UP,SET,18,0.0065011,0.00020347,0.20984,0.48764,HUI_MAPK14_TARGETS_UP,0.99999
REACTOME_PI5P_REGULATES_TP53...,SET,8,0.009842,0.00020541,0.31806,0.48766,REACTOME_PI5P_REGULATES_TP53_ACETYLATION,0.99999
GOBP_MUCOCILIARY_CLEARANCE,SET,7,0.010506,0.00020511,0.3412,0.48772,GOBP_MUCOCILIARY_CLEARANCE,0.99999
GOMF_SEROTONIN_RECEPTOR_ACTI...,SET,6,0.013073,0.00023629,0.42741,0.4878,GOMF_SEROTONIN_RECEPTOR_ACTIVITY,0.99999
MIR876_3P,SET,80,0.0030921,0.00020368,0.10115,0.48781,MIR876_3P,0.99999
HP_INGUINAL_HERNIA,SET,265,0.0016212,0.00019337,0.053033,0.48781,HP_INGUINAL_HERNIA,0.99999
WEST_ADRENOCORTICAL_CARCINOM...2,SET,16,0.0068076,0.00020089,0.22391,0.48787,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP,0.99999
MIR1178_3P,SET,83,0.0029065,0.00019499,0.095734,0.48789,MIR1178_3P,0.99999
HP_BELL_SHAPED_THORAX,SET,32,0.004913,0.00020494,0.16302,0.48798,HP_BELL_SHAPED_THORAX,0.99999
GOBP_POSITIVE_REGULATION_OF_...613,SET,5,0.0097913,0.00016157,0.3255,0.488,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,0.99999
E12_Q6,SET,245,0.0016687,0.00019149,0.055575,0.48802,E12_Q6,0.99999
HP_SUBCORTICAL_BAND_HETEROTO...,SET,10,0.0071227,0.00016619,0.23708,0.48802,HP_SUBCORTICAL_BAND_HETEROTOPIA,0.99999
GSE10463_CD40L_AND_VA347_VS_...1,SET,147,0.0021139,0.0001884,0.07041,0.48802,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN,0.99999
MIR3689D,SET,87,0.0026926,0.00018492,0.089974,0.48806,MIR3689D,0.99999
HP_CEREBRAL_HYPOPLASIA,SET,53,0.0033875,0.00018175,0.11406,0.48815,HP_CEREBRAL_HYPOPLASIA,0.99999
HP_ABNORMAL_ERYTHROCYTE_ADEN...,SET,22,0.0050203,0.00017369,0.16932,0.48817,HP_ABNORMAL_ERYTHROCYTE_ADENOSINE_DEAMINASE_ACTIVITY,0.99999
HP_ANTERIOR_CREASES_OF_EARLO...,SET,3,0.013796,0.00017634,0.46692,0.48821,HP_ANTERIOR_CREASES_OF_EARLOBE,0.99999
HP_ARTHRALGIA_OF_THE_HIP,SET,8,0.0091297,0.00019054,0.30953,0.48823,HP_ARTHRALGIA_OF_THE_HIP,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...5,SET,9,0.0092194,0.00020408,0.31381,0.48828,GOMF_STRUCTURAL_CONSTITUENT_OF_MYELIN_SHEATH,0.99999
MIR483_5P,SET,7,0.010436,0.00020374,0.35556,0.48829,MIR483_5P,0.99999
GOBP_ACID_SECRETION,SET,43,0.0038664,0.0001869,0.13382,0.48848,GOBP_ACID_SECRETION,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...6,SET,185,0.0018337,0.00018315,0.064271,0.48862,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_UP,0.99999
HAY_BONE_MARROW_STROMAL,SET,669,0.0010572,0.00019811,0.037055,0.48862,HAY_BONE_MARROW_STROMAL,0.99999
GOBP_RETINAL_CELL_PROGRAMMED...,SET,6,0.010462,0.0001891,0.36688,0.48863,GOBP_RETINAL_CELL_PROGRAMMED_CELL_DEATH,0.99999
GOBP_POSITIVE_REGULATION_OF_...330,SET,6,0.00866,0.00015654,0.30579,0.4887,GOBP_POSITIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_CENTROMER...1,SET,4,0.0098542,0.00014544,0.34919,0.48874,GOBP_REGULATION_OF_CENTROMERE_COMPLEX_ASSEMBLY,0.99999
GOBP_CHROMOSOME_LOCALIZATION,SET,112,0.0021783,0.00016963,0.07728,0.48876,GOBP_CHROMOSOME_LOCALIZATION,0.99999
GOMF_MOLECULAR_TRANSDUCER_AC...,SET,1298,0.00080738,0.00020696,0.028677,0.48877,GOMF_MOLECULAR_TRANSDUCER_ACTIVITY,0.99999
REACTOME_O_LINKED_GLYCOSYLAT...2,SET,56,0.0035454,0.00019552,0.126,0.48878,REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,0.99999
GSE40274_CTRL_VS_GATA1_TRANS...2,SET,128,0.002083,0.00017333,0.074073,0.48878,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
NAKAMURA_TUMOR_ZONE_PERIPHER...1,SET,549,0.0010523,0.00017923,0.037509,0.48881,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN,0.99999
GSE2770_IL12_VS_TGFB_AND_IL1...6,SET,168,0.0018852,0.00017952,0.067313,0.48883,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.99999
HP_HAMARTOMATOUS_POLYPOSIS,SET,14,0.0058868,0.0001625,0.2111,0.48888,HP_HAMARTOMATOUS_POLYPOSIS,0.99999
HP_GANGLIONEUROBLASTOMA,SET,7,0.010869,0.00021221,0.39328,0.48898,HP_GANGLIONEUROBLASTOMA,0.99999
MIR1185_1_3P_MIR1185_2_3P,SET,376,0.0012413,0.00017581,0.044999,0.489,MIR1185_1_3P_MIR1185_2_3P,0.99999
GOBP_REGULATION_OF_ENDOCYTOS...,SET,266,0.0014704,0.00017571,0.053452,0.48903,GOBP_REGULATION_OF_ENDOCYTOSIS,0.99999
MODULE_165,SET,77,0.0028984,0.00018731,0.10556,0.48905,MODULE_165,0.99999
ZHAN_LATE_DIFFERENTIATION_GE...1,SET,14,0.0058385,0.00016117,0.21289,0.48906,ZHAN_LATE_DIFFERENTIATION_GENES_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...53,SET,18,0.0063173,0.00019772,0.23058,0.48907,GOBP_NEGATIVE_REGULATION_OF_BONE_REMODELING,0.99999
HP_PROTRACTED_DIARRHEA,SET,13,0.0064971,0.00017283,0.23813,0.48912,HP_PROTRACTED_DIARRHEA,0.99999
GSE22886_IGA_VS_IGM_MEMORY_B...2,SET,172,0.0018345,0.00017673,0.067327,0.48913,GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP,0.99999
GOMF_MANNOSYLTRANSFERASE_ACT...,SET,24,0.0044774,0.00016178,0.16445,0.48914,GOMF_MANNOSYLTRANSFERASE_ACTIVITY,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...5,SET,183,0.0017494,0.00017379,0.064258,0.48914,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_DN,0.99999
INAMURA_LUNG_CANCER_SCC_SUBT...,SET,12,0.0059267,0.00015148,0.21989,0.48925,INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP,0.99999
GOBP_DIGESTIVE_SYSTEM_DEVELO...,SET,140,0.0020391,0.00017739,0.076078,0.48931,GOBP_DIGESTIVE_SYSTEM_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...576,SET,79,0.0027973,0.00018311,0.10452,0.48932,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...20,SET,48,0.0034046,0.00017386,0.12759,0.48936,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE,0.99999
HP_BRACHYCEPHALY,SET,216,0.0015759,0.00016993,0.059239,0.48939,HP_BRACHYCEPHALY,0.99999
GOBP_MORPHOGENESIS_OF_AN_END...,SET,16,0.0060283,0.00017789,0.22836,0.48947,GOBP_MORPHOGENESIS_OF_AN_ENDOTHELIUM,0.99999
GSE13522_CTRL_VS_T_CRUZI_Y_S...2,SET,120,0.0020339,0.0001639,0.077428,0.48952,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP,0.99999
CDH4_TARGET_GENES,SET,56,0.0030517,0.00016829,0.11655,0.48956,CDH4_TARGET_GENES,0.99999
REACTOME_HS_GAG_BIOSYNTHESIS,SET,28,0.0047413,0.00018503,0.18171,0.48959,REACTOME_HS_GAG_BIOSYNTHESIS,0.99999
GOBP_AUTOPHAGOSOME_ORGANIZAT...,SET,112,0.0019988,0.00015565,0.077195,0.48967,GOBP_AUTOPHAGOSOME_ORGANIZATION,0.99999
ZHONG_PFC_C2_UNKNOWN_NPC,SET,72,0.0024343,0.00015215,0.093954,0.48967,ZHONG_PFC_C2_UNKNOWN_NPC,0.99999
GOBP_MEMBRANE_LIPID_BIOSYNTH...,SET,143,0.0018757,0.0001649,0.072561,0.48969,GOBP_MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS,0.99999
GOBP_VIRAL_GENE_EXPRESSION,SET,98,0.0020892,0.00015224,0.081085,0.48972,GOBP_VIRAL_GENE_EXPRESSION,0.99999
BROWNE_HCMV_INFECTION_1HR_UP,SET,47,0.0033124,0.00016739,0.1312,0.48993,BROWNE_HCMV_INFECTION_1HR_UP,0.99999
GSE4535_BM_DERIVED_DC_VS_FOL...1,SET,177,0.0015867,0.00015505,0.062828,0.48993,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_DN,0.99999
HP_TELANGIECTASIA,SET,136,0.0016941,0.00014527,0.067451,0.48998,HP_TELANGIECTASIA,0.99999
WP_BIOMARKERS_FOR_UREA_CYCLE...,SET,11,0.0065646,0.00016064,0.26486,0.49011,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,0.99999
GOBP_REGULATION_OF_KERATINOC...2,SET,14,0.0065574,0.00018102,0.2646,0.49011,GOBP_REGULATION_OF_KERATINOCYTE_MIGRATION,0.99999
ESC_J1_UP_LATE.V1_DN,SET,150,0.0017583,0.00015828,0.070957,0.49012,ESC_J1_UP_LATE.V1_DN,0.99999
WP_CELL_LINEAGE_MAP_FOR_NEUR...,SET,122,0.0020676,0.00016799,0.083596,0.49013,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.99999
MIR6852_5P,SET,175,0.0015865,0.00015416,0.06411,0.49013,MIR6852_5P,0.99999
GSE14000_TRANSLATED_RNA_VS_M...1,SET,161,0.0016185,0.00015091,0.065421,0.49013,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN,0.99999
MORF_DAP,SET,69,0.0023831,0.00014583,0.096733,0.49017,MORF_DAP,0.99999
WAMUNYOKOLI_OVARIAN_CANCER_L...1,SET,173,0.001669,0.00016125,0.067906,0.4902,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,0.99999
BIOCARTA_PYK2_PATHWAY,SET,27,0.0040257,0.00015427,0.16459,0.49024,BIOCARTA_PYK2_PATHWAY,0.99999
GOCC_TRANSCRIPTION_FACTOR_TF...5,SET,17,0.0043213,0.00013144,0.17705,0.49026,GOCC_TRANSCRIPTION_FACTOR_TFTC_COMPLEX,0.99999
CHEMNITZ_RESPONSE_TO_PROSTAG...1,SET,348,0.001135,0.00015478,0.046581,0.49028,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,0.99999
GSE20715_0H_VS_6H_OZONE_TLR4...1,SET,189,0.0015031,0.00015172,0.062229,0.49037,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...123,SET,31,0.0038344,0.00015743,0.15916,0.49039,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.99999
MIKKELSEN_IPS_HCP_WITH_H3_UN...,SET,77,0.0025137,0.00016246,0.10448,0.4904,MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED,0.99999
FERNANDEZ_BOUND_BY_MYC,SET,169,0.0015526,0.00014828,0.064671,0.49042,FERNANDEZ_BOUND_BY_MYC,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...8,SET,36,0.0034642,0.00015325,0.14507,0.49047,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...612,SET,178,0.0015039,0.00014737,0.063124,0.4905,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...8,SET,6,0.0090647,0.00016385,0.38177,0.49053,GOCC_EXTRINSIC_COMPONENT_OF_PRESYNAPTIC_MEMBRANE,0.99999
MIR181B_2_3P_MIR181B_3P,SET,188,0.0014702,0.00014801,0.062257,0.49058,MIR181B_2_3P_MIR181B_3P,0.99999
GOBP_EPIDERMIS_MORPHOGENESIS,SET,36,0.0038996,0.00017252,0.1657,0.49061,GOBP_EPIDERMIS_MORPHOGENESIS,0.99999
GOMF_VASCULAR_ENDOTHELIAL_GR...2,SET,9,0.0072529,0.00016055,0.30814,0.49061,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_BINDING,0.99999
GOMF_FATTY_ACID_DERIVATIVE_B...,SET,18,0.004699,0.00014707,0.19986,0.49062,GOMF_FATTY_ACID_DERIVATIVE_BINDING,0.99999
HP_KYPHOSIS,SET,380,0.0010188,0.00014505,0.043326,0.49062,HP_KYPHOSIS,0.99999
DORN_ADENOVIRUS_INFECTION_24...1,SET,38,0.0031624,0.00014373,0.13465,0.49063,DORN_ADENOVIRUS_INFECTION_24HR_DN,0.99999
HP_COLORECTAL_POLYPOSIS,SET,23,0.0038773,0.00013716,0.16514,0.49063,HP_COLORECTAL_POLYPOSIS,0.99999
GSE37301_LYMPHOID_PRIMED_MPP...2,SET,167,0.0015531,0.00014746,0.066164,0.49064,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP,0.99999
GOMF_TRANSFORMING_GROWTH_FAC...1,SET,23,0.0043476,0.00015379,0.18872,0.49081,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_BINDING,0.99999
MIR561_5P,SET,131,0.0016905,0.00014229,0.073567,0.49083,MIR561_5P,0.99999
HP_RENAL_POTASSIUM_WASTING,SET,6,0.0090684,0.00016392,0.39606,0.49087,HP_RENAL_POTASSIUM_WASTING,0.99999
GOBP_UBIQUITIN_RECYCLING,SET,12,0.0057144,0.00014605,0.24997,0.49088,GOBP_UBIQUITIN_RECYCLING,0.99999
WOOD_EBV_EBNA1_TARGETS_DN,SET,43,0.0030809,0.00014893,0.13522,0.49091,WOOD_EBV_EBNA1_TARGETS_DN,0.99999
WANG_PROSTATE_CANCER_ANDROGE...,SET,58,0.0026573,0.00014913,0.11713,0.49095,WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,0.99999
WP_8Q1123_RB1CC1_COPY_NUMBER...,SET,16,0.0044747,0.00013205,0.19749,0.49096,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,0.99999
HARALAMBIEVA_PBMC_M_M_R_II_A...4,SET,11,0.0066568,0.0001629,0.29411,0.49097,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_LOW_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_DN,0.99999
MIR3194_3P,SET,90,0.0019663,0.00013734,0.087053,0.49099,MIR3194_3P,0.99999
HP_KNEE_DISLOCATION,SET,13,0.0052413,0.00013943,0.23214,0.49099,HP_KNEE_DISLOCATION,0.99999
DESCARTES_FETAL_HEART_LYMPHA...,SET,28,0.0040948,0.0001598,0.18243,0.49105,DESCARTES_FETAL_HEART_LYMPHATIC_ENDOTHELIAL_CELLS,0.99999
NADERI_BREAST_CANCER_PROGNOS...1,SET,14,0.0057154,0.00015777,0.25597,0.49109,NADERI_BREAST_CANCER_PROGNOSIS_DN,0.99999
YAN_ESCAPE_FROM_ANOIKIS,SET,23,0.0039274,0.00013893,0.17672,0.49113,YAN_ESCAPE_FROM_ANOIKIS,0.99999
GOBP_METANEPHRIC_GLOMERULAR_...,SET,5,0.010239,0.00016895,0.4622,0.49116,GOBP_METANEPHRIC_GLOMERULAR_MESANGIUM_DEVELOPMENT,0.99999
GOBP_NUCLEUS_LOCALIZATION,SET,31,0.0033349,0.00013693,0.15071,0.49117,GOBP_NUCLEUS_LOCALIZATION,0.99999
STEARMAN_LUNG_CANCER_EARLY_V...2,SET,118,0.001613,0.0001289,0.073048,0.49119,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,0.99999
WP_NUCLEOTIDE_GPCRS,SET,9,0.0058373,0.00012922,0.26662,0.49127,WP_NUCLEOTIDE_GPCRS,0.99999
GSE15659_RESTING_VS_ACTIVATE...2,SET,153,0.0014921,0.00013565,0.069065,0.49138,GSE15659_RESTING_VS_ACTIVATED_TREG_UP,0.99999
GSE37416_0H_VS_48H_F_TULAREN...1,SET,168,0.0013408,0.00012768,0.062879,0.49149,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
MORF_ARAF1,SET,70,0.002045,0.00012604,0.096009,0.4915,MORF_ARAF1,0.99999
HP_CORNEAL_SCARRING,SET,19,0.0040725,0.00013095,0.19134,0.49151,HP_CORNEAL_SCARRING,0.99999
MEF2_02,SET,201,0.0013095,0.00013627,0.062042,0.49158,MEF2_02,0.99999
chr7q21,SET,73,0.0038432,0.00024186,0.18259,0.4916,chr7q21,0.99999
GOBP_POSITIVE_REGULATION_OF_...702,SET,6,0.0074687,0.000135,0.35599,0.49163,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,0.99999
MIR511_3P,SET,154,0.0014491,0.00013217,0.069249,0.49165,MIR511_3P,0.99999
BIOCARTA_ACH_PATHWAY,SET,14,0.004961,0.00013695,0.23726,0.49166,BIOCARTA_ACH_PATHWAY,0.99999
GOMF_TRANSPORTER_INHIBITOR_A...,SET,38,0.0030126,0.00013692,0.14425,0.49167,GOMF_TRANSPORTER_INHIBITOR_ACTIVITY,0.99999
HP_SYSTEMIC_LUPUS_ERYTHEMATO...,SET,29,0.0035351,0.00014039,0.17092,0.49175,HP_SYSTEMIC_LUPUS_ERYTHEMATOSUS,0.99999
LAKE_ADULT_KIDNEY_C30_IMMUNE...,SET,9,0.0062337,0.00013799,0.303,0.49179,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.99999
MIR11181_5P,SET,65,0.0021186,0.00012584,0.10338,0.49182,MIR11181_5P,0.99999
HP_ABNORMAL_URINE_HORMONE_LE...,SET,16,0.0045398,0.00013397,0.22158,0.49183,HP_ABNORMAL_URINE_HORMONE_LEVEL,0.99999
MIR3912_5P,SET,77,0.0020399,0.00013183,0.099898,0.49185,MIR3912_5P,0.99999
HP_ABNORMAL_THORACIC_SPINE_M...,SET,94,0.0017021,0.00012148,0.083478,0.49187,HP_ABNORMAL_THORACIC_SPINE_MORPHOLOGY,0.99999
MIR4457,SET,112,0.001653,0.00012872,0.081212,0.49188,MIR4457,0.99999
GOBP_RECEPTOR_GUANYLYL_CYCLA...,SET,8,0.0058124,0.00012131,0.2855,0.49188,GOBP_RECEPTOR_GUANYLYL_CYCLASE_SIGNALING_PATHWAY,0.99999
HP_CAVERNOUS_HEMANGIOMA,SET,33,0.0029221,0.00012378,0.14365,0.49189,HP_CAVERNOUS_HEMANGIOMA,0.99999
MIR4797_3P,SET,94,0.0017245,0.00012308,0.085182,0.49192,MIR4797_3P,0.99999
GOCC_NEURON_PROJECTION_TERMI...,SET,117,0.0017056,0.00013573,0.084421,0.49194,GOCC_NEURON_PROJECTION_TERMINUS,0.99999
SABATES_COLORECTAL_ADENOMA_UP,SET,127,0.0017287,0.00014328,0.085682,0.49195,SABATES_COLORECTAL_ADENOMA_UP,0.99999
HP_ABNORMALITY_OF_TUMOR_NECR...,SET,5,0.0085923,0.00014178,0.42643,0.49196,HP_ABNORMALITY_OF_TUMOR_NECROSIS_FACTOR_SECRETION,0.99999
GOBP_POSITIVE_REGULATION_OF_...493,SET,29,0.0028227,0.0001121,0.14192,0.49207,GOBP_POSITIVE_REGULATION_OF_MRNA_PROCESSING,0.99999
MCBRYAN_PUBERTAL_BREAST_5_6W...2,SET,115,0.001656,0.00013066,0.083604,0.4921,MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,0.99999
GOBP_DISRUPTION_OF_ANATOMICA...,SET,81,0.0020783,0.00013775,0.10527,0.49212,GOBP_DISRUPTION_OF_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM,0.99999
CHICAS_RB1_TARGETS_SENESCENT,SET,506,0.00076618,0.00012544,0.038859,0.49213,CHICAS_RB1_TARGETS_SENESCENT,0.99999
HP_ABNORMAL_AORTIC_VALVE_CUS...,SET,101,0.0017506,0.00012949,0.089157,0.49217,HP_ABNORMAL_AORTIC_VALVE_CUSP_MORPHOLOGY,0.99999
DUTTA_APOPTOSIS_VIA_NFKB,SET,32,0.0031359,0.00013081,0.16014,0.49219,DUTTA_APOPTOSIS_VIA_NFKB,0.99999
REACTOME_FORMATION_OF_PARAXI...,SET,63,0.0018737,0.00010958,0.095834,0.4922,REACTOME_FORMATION_OF_PARAXIAL_MESODERM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...660,SET,5,0.0074728,0.00012331,0.38235,0.4922,GOBP_NEGATIVE_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION,0.99999
ER_Q6,SET,245,0.0010795,0.00012387,0.055361,0.49222,ER_Q6,0.99999
GSE7460_WT_VS_FOXP3_HET_ACT_...1,SET,183,0.0012039,0.0001196,0.061705,0.49222,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...563,SET,79,0.0018504,0.00012113,0.094997,0.49223,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,0.99999
MEISSNER_NPC_HCP_WITH_H3K4ME2,SET,447,0.00083623,0.00012889,0.042991,0.49224,MEISSNER_NPC_HCP_WITH_H3K4ME2,0.99999
HP_ABNORMALITY_OF_CYTOKINE_S...,SET,6,0.0076371,0.00013805,0.39673,0.49232,HP_ABNORMALITY_OF_CYTOKINE_SECRETION,0.99999
AAGGGAT_MIR188,SET,67,0.002024,0.00012205,0.10549,0.49235,AAGGGAT_MIR188,0.99999
KEGG_MEDICUS_REFERENCE_PDL_P...,SET,8,0.0061259,0.00012785,0.3213,0.49239,KEGG_MEDICUS_REFERENCE_PDL_PD1_SHP_PI3K_SIGNALING_PATHWAY,0.99999
GSE15750_DAY6_VS_DAY10_EFF_C...1,SET,180,0.001167,0.00011498,0.061739,0.49246,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN,0.99999
GOBP_LYMPHATIC_ENDOTHELIAL_C...,SET,8,0.0057853,0.00012074,0.3063,0.49247,GOBP_LYMPHATIC_ENDOTHELIAL_CELL_DIFFERENTIATION,0.99999
GOBP_NEURAL_CREST_CELL_MIGRA...,SET,6,0.0072014,0.00013017,0.38242,0.49249,GOBP_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT,0.99999
WP_PROSTAGLANDIN_AND_LEUKOTR...1,SET,29,0.0030288,0.00012028,0.16212,0.49255,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,0.99999
GOMF_ATPASE_BINDING,SET,78,0.0019011,0.00012366,0.10177,0.49255,GOMF_ATPASE_BINDING,0.99999
GOMF_CYCLASE_REGULATOR_ACTIV...,SET,15,0.0042796,0.00012228,0.22939,0.49256,GOMF_CYCLASE_REGULATOR_ACTIVITY,0.99999
MIR12121,SET,27,0.0033534,0.00012851,0.17994,0.49257,MIR12121,0.99999
HP_ABNORMALITY_OF_THE_PROXIM...1,SET,4,0.0077043,0.00011371,0.41401,0.49258,HP_ABNORMALITY_OF_THE_PROXIMAL_PHALANX_OF_THE_5TH_FINGER,0.99999
GSE22886_DAY0_VS_DAY1_MONOCY...2,SET,183,0.0012107,0.00012027,0.065064,0.49258,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP,0.99999
REACTOME_GABA_RECEPTOR_ACTIV...,SET,57,0.0023588,0.00013123,0.12703,0.49259,REACTOME_GABA_RECEPTOR_ACTIVATION,0.99999
GOCC_POSTSYNAPTIC_ACTIN_CYTO...,SET,8,0.0056746,0.00011843,0.30638,0.49261,GOCC_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.99999
GOBP_GROWTH_HORMONE_SECRETION,SET,12,0.0047437,0.00012124,0.25648,0.49262,GOBP_GROWTH_HORMONE_SECRETION,0.99999
HP_ABNORMAL_DENTAL_PULP_MORP...,SET,50,0.0022119,0.00011528,0.11971,0.49263,HP_ABNORMAL_DENTAL_PULP_MORPHOLOGY,0.99999
GOBP_PROTEIN_AUTOPROCESSING,SET,26,0.0030906,0.00011623,0.16754,0.49264,GOBP_PROTEIN_AUTOPROCESSING,0.99999
GOMF_INTRAMOLECULAR_OXIDORED...3,SET,15,0.0039707,0.00011345,0.21522,0.49264,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_C_C_BONDS,0.99999
LEE_EARLY_T_LYMPHOCYTE_DN,SET,54,0.0022749,0.0001232,0.12391,0.49268,LEE_EARLY_T_LYMPHOCYTE_DN,0.99999
LIAN_LIPA_TARGETS_3M,SET,52,0.0023458,0.00012467,0.12803,0.49269,LIAN_LIPA_TARGETS_3M,0.99999
HP_ABNORMALITY_OF_ACID_BASE_...,SET,378,0.00076423,0.00010853,0.042043,0.49275,HP_ABNORMALITY_OF_ACID_BASE_HOMEOSTASIS,0.99999
HP_GLOMERULONEPHRITIS,SET,86,0.0017279,0.00011799,0.095514,0.49278,HP_GLOMERULONEPHRITIS,0.99999
GOBP_CELLULAR_RESPONSE_TO_CO...3,SET,22,0.0039221,0.00013569,0.21808,0.49283,GOBP_CELLULAR_RESPONSE_TO_COPPER_ION,0.99999
GOBP_REGULATION_OF_LIPID_BIO...,SET,159,0.0012375,0.00011467,0.068803,0.49283,GOBP_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...401,SET,258,0.0010274,0.00012094,0.057355,0.49285,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION,0.99999
MIR6750_3P,SET,62,0.0020497,0.00011892,0.11484,0.49288,MIR6750_3P,0.99999
GSE17721_POLYIC_VS_CPG_12H_B...1,SET,183,0.0011054,0.00010981,0.06195,0.49288,GSE17721_POLYIC_VS_CPG_12H_BMDC_DN,0.99999
REACTOME_TRANSLATION_OF_REPL...,SET,14,0.0042477,0.00011726,0.2433,0.49304,REACTOME_TRANSLATION_OF_REPLICASE_AND_ASSEMBLY_OF_THE_REPLICATION_TRANSCRIPTION_COMPLEX,0.99999
HP_ELBOW_ANKYLOSIS,SET,7,0.006191,0.00012087,0.35578,0.49306,HP_ELBOW_ANKYLOSIS,0.99999
PAL_PRMT5_TARGETS_DN,SET,27,0.0031453,0.00012053,0.18165,0.49309,PAL_PRMT5_TARGETS_DN,0.99999
GOBP_INHIBITORY_SYNAPSE_ASSE...,SET,23,0.0036792,0.00013015,0.2124,0.49309,GOBP_INHIBITORY_SYNAPSE_ASSEMBLY,0.99999
REACTOME_CONJUGATION_OF_BENZ...,SET,6,0.0080771,0.000146,0.46678,0.4931,REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE,0.99999
REACTOME_HSF1_DEPENDENT_TRAN...,SET,36,0.0024419,0.00010803,0.14133,0.49311,REACTOME_HSF1_DEPENDENT_TRANSACTIVATION,0.99999
MIR487B_3P,SET,9,0.0052745,0.00011676,0.30629,0.49313,MIR487B_3P,0.99999
HP_OVARIAN_PAPILLARY_ADENOCA...,SET,6,0.0056569,0.00010225,0.32849,0.49313,HP_OVARIAN_PAPILLARY_ADENOCARCINOMA,0.99999
GOBP_CILIUM_OR_FLAGELLUM_DEP...,SET,149,0.0011703,0.000105,0.068198,0.49315,GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY,0.99999
MIR6736_3P,SET,113,0.0013929,0.00010894,0.081501,0.49318,MIR6736_3P,0.99999
CACTGTG_MIR128A_MIR128B,SET,306,0.00084123,0.0001077,0.04936,0.4932,CACTGTG_MIR128A_MIR128B,0.99999
MIR298,SET,170,0.00112,0.00010728,0.065778,0.49321,MIR298,0.99999
HP_HYPERACTIVE_RENIN_ANGIOTE...,SET,8,0.005993,0.00012508,0.35238,0.49322,HP_HYPERACTIVE_RENIN_ANGIOTENSIN_SYSTEM,0.99999
GOBP_POSITIVE_REGULATION_OF_...509,SET,42,0.0022641,0.00010817,0.1341,0.49326,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,0.99999
HP_ABNORMAL_INVOLUNTARY_EYE_...,SET,961,0.00047336,0.00010543,0.028008,0.49326,HP_ABNORMAL_INVOLUNTARY_EYE_MOVEMENTS,0.99999
THAKAR_PBMC_INACTIVATED_INFL...7,SET,546,0.00059497,0.00010107,0.035347,0.49329,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN,0.99999
GOBP_SOMATIC_DIVERSIFICATION...1,SET,66,0.0016015,9.5854e-05,0.096065,0.49335,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS,0.99999
NIKOLSKY_BREAST_CANCER_20Q12...,SET,136,0.002276,0.00019517,0.13776,0.49341,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,0.99999
GOBP_RESPONSE_TO_BMP,SET,147,0.0012191,0.00010865,0.073782,0.49341,GOBP_RESPONSE_TO_BMP,0.99999
GOBP_MYELOID_CELL_ACTIVATION...,SET,91,0.0015154,0.00010643,0.092349,0.49345,GOBP_MYELOID_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
GOBP_REGULATION_OF_REACTIVE_...2,SET,130,0.0012456,0.00010444,0.076127,0.49347,GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,0.99999
HP_CHRONIC_HEMOLYTIC_ANEMIA,SET,5,0.0059186,9.7664e-05,0.36383,0.49351,HP_CHRONIC_HEMOLYTIC_ANEMIA,0.99999
EWSR1_TARGET_GENES,SET,769,0.00050005,0.00010018,0.030944,0.49355,EWSR1_TARGET_GENES,0.99999
GOCC_NUCLEAR_PORE_NUCLEAR_BA...,SET,11,0.0040081,9.8083e-05,0.24963,0.49359,GOCC_NUCLEAR_PORE_NUCLEAR_BASKET,0.99999
GSE360_L_MAJOR_VS_B_MALAYI_H...2,SET,177,0.0010575,0.00010333,0.066165,0.49362,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...577,SET,26,0.0027125,0.00010201,0.17097,0.49367,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,0.99999
REACTOME_SUMO_IS_PROTEOLYTIC...,SET,6,0.004762,8.6076e-05,0.30362,0.49374,REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED,0.99999
GALI_TP53_TARGETS_APOPTOTIC_...1,SET,6,0.0045709,8.2622e-05,0.29173,0.49375,GALI_TP53_TARGETS_APOPTOTIC_DN,0.99999
HP_NREM_PARASOMNIA,SET,16,0.0035126,0.00010365,0.22476,0.49377,HP_NREM_PARASOMNIA,0.99999
GSE10240_IL17_VS_IL17_AND_IL...2,SET,180,0.00096426,9.5012e-05,0.062028,0.4938,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.99999
PETROVA_ENDOTHELIUM_LYMPHATI...2,SET,125,0.0012222,0.00010051,0.079311,0.49385,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,0.99999
DITTMER_PTHLH_TARGETS_DN,SET,69,0.0016273,9.9576e-05,0.10579,0.49386,DITTMER_PTHLH_TARGETS_DN,0.99999
GOBP_REGULATION_OF_RENAL_SYS...,SET,20,0.0032786,0.00010816,0.21362,0.49388,GOBP_REGULATION_OF_RENAL_SYSTEM_PROCESS,0.99999
HP_MICROPHALLUS,SET,14,0.003766,0.00010396,0.24725,0.49392,HP_MICROPHALLUS,0.99999
GOMF_G_PROTEIN_COUPLED_ADENO...,SET,5,0.0058913,9.7212e-05,0.38882,0.49396,GOMF_G_PROTEIN_COUPLED_ADENOSINE_RECEPTOR_ACTIVITY,0.99999
PANAPASA_BLOOD_FLUENZ_AGE_03...1,SET,6,0.0049422,8.9333e-05,0.33162,0.49405,PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_3DY_4DY_DN,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...18,SET,182,0.0009581,9.4923e-05,0.064976,0.49412,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_UP,0.99999
BASSO_HAIRY_CELL_LEUKEMIA_DN,SET,4,0.0068668,0.00010135,0.46969,0.49417,BASSO_HAIRY_CELL_LEUKEMIA_DN,0.99999
GOBP_INTERMEDIATE_FILAMENT_B...2,SET,7,0.0054197,0.00010581,0.37156,0.49418,GOBP_INTERMEDIATE_FILAMENT_BUNDLE_ASSEMBLY,0.99999
GSE11961_MEMORY_BCELL_DAY7_V...8,SET,185,0.00090126,9.0017e-05,0.062173,0.49422,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,0.99999
GSE2405_0H_VS_24H_A_PHAGOCYT...1,SET,183,0.00093461,9.2847e-05,0.064765,0.49424,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.99999
GOBP_RESPONSE_TO_CARBOHYDRATE,SET,212,0.00083936,8.9678e-05,0.058555,0.49428,GOBP_RESPONSE_TO_CARBOHYDRATE,0.99999
GOBP_CELL_SURFACE_RECEPTOR_P...1,SET,333,0.00069687,9.3e-05,0.048912,0.49432,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.99999
GOCC_RECYCLING_ENDOSOME_MEMB...,SET,97,0.0012064,8.7461e-05,0.085074,0.49434,GOCC_RECYCLING_ENDOSOME_MEMBRANE,0.99999
GOBP_T_HELPER_17_CELL_LINEAG...,SET,19,0.0030605,9.8407e-05,0.22056,0.49446,GOBP_T_HELPER_17_CELL_LINEAGE_COMMITMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...27,SET,18,0.0030338,9.4951e-05,0.22135,0.49453,GOBP_NEGATIVE_REGULATION_OF_ANOIKIS,0.99999
GOBP_VALINE_METABOLIC_PROCESS,SET,7,0.0044289,8.6467e-05,0.32306,0.49453,GOBP_VALINE_METABOLIC_PROCESS,0.99999
GOCC_PLATELET_ALPHA_GRANULE,SET,81,0.0013971,9.2599e-05,0.10243,0.49456,GOCC_PLATELET_ALPHA_GRANULE,0.99999
GSE27786_LSK_VS_CD8_TCELL_UP,SET,168,0.0008682,8.2674e-05,0.064337,0.49462,GSE27786_LSK_VS_CD8_TCELL_UP,0.99999
REACTOME_REGULATION_OF_HSF1_...,SET,77,0.0012346,7.9791e-05,0.091783,0.49463,REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,0.99999
HP_CHOKING_EPISODES,SET,16,0.002953,8.7142e-05,0.22111,0.49467,HP_CHOKING_EPISODES,0.99999
GSE43863_NAIVE_VS_LY6C_INT_C...2,SET,160,0.00088752,8.2494e-05,0.066821,0.4947,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_UP,0.99999
HP_ABNORMAL_THUMB_MORPHOLOGY,SET,344,0.0005928,8.0384e-05,0.045212,0.49477,HP_ABNORMAL_THUMB_MORPHOLOGY,0.99999
REACTOME_MTORC1_MEDIATED_SIG...,SET,23,0.0022485,7.9539e-05,0.17242,0.4948,REACTOME_MTORC1_MEDIATED_SIGNALLING,0.99999
GOBP_CUT_METABOLIC_PROCESS,SET,5,0.0043467,7.1726e-05,0.3362,0.49484,GOBP_CUT_METABOLIC_PROCESS,0.99999
MIR652_3P,SET,4,0.0063914,9.4333e-05,0.49738,0.49487,MIR652_3P,0.99999
PATEL_SKIN_OF_BODY_ZOSTAVAX_...5,SET,28,0.002309,9.0108e-05,0.17973,0.49488,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_TOP_30_DEG_UP,0.99999
YTATTTTNR_MEF2_02,SET,627,0.00046127,8.3777e-05,0.035981,0.49489,YTATTTTNR_MEF2_02,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...11,SET,150,0.00089494,8.0565e-05,0.07072,0.49495,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN,0.99999
REACTOME_ADHERENS_JUNCTIONS_...,SET,51,0.0016889,8.8895e-05,0.13363,0.49496,REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,0.99999
MIR6882_3P,SET,106,0.0010296,7.8007e-05,0.082131,0.495,MIR6882_3P,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...17,SET,24,0.0022435,8.1065e-05,0.1814,0.49507,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN,0.99999
GOBP_FOREBRAIN_NEURON_FATE_C...,SET,7,0.0047504,9.2743e-05,0.38524,0.49508,GOBP_FOREBRAIN_NEURON_FATE_COMMITMENT,0.99999
HP_LIMB_MUSCLE_WEAKNESS,SET,306,0.00060258,7.7146e-05,0.048974,0.49509,HP_LIMB_MUSCLE_WEAKNESS,0.99999
HP_HYPOCHROMIC_MICROCYTIC_AN...,SET,15,0.0027635,7.8961e-05,0.23078,0.49522,HP_HYPOCHROMIC_MICROCYTIC_ANEMIA,0.99999
HP_ABNORMAL_PORTAL_VENOUS_SY...,SET,13,0.0029475,7.8408e-05,0.24736,0.49525,HP_ABNORMAL_PORTAL_VENOUS_SYSTEM_MORPHOLOGY,0.99999
GSE4142_PLASMA_CELL_VS_MEMOR...1,SET,183,0.00075141,7.4648e-05,0.063402,0.49527,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_DN,0.99999
GSE45837_WT_VS_GFI1_KO_PDC_DN,SET,173,0.00072279,6.9834e-05,0.061532,0.49531,GSE45837_WT_VS_GFI1_KO_PDC_DN,0.99999
MIR10396A_3P_MIR10396B_3P,SET,4,0.0061959,9.1449e-05,0.52874,0.49533,MIR10396A_3P_MIR10396B_3P,0.99999
HP_DECREASED_ACTIVITY_OF_THE...,SET,10,0.0033338,7.7786e-05,0.28794,0.49538,HP_DECREASED_ACTIVITY_OF_THE_PYRUVATE_DEHYDROGENASE_COMPLEX,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_PLA...,SET,316,0.00056493,7.3478e-05,0.048751,0.49538,HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL,0.99999
REACTOME_SODIUM_CALCIUM_EXCH...,SET,11,0.0035166,8.6056e-05,0.30535,0.49541,REACTOME_SODIUM_CALCIUM_EXCHANGERS,0.99999
GSE22601_DOUBLE_NEGATIVE_VS_...4,SET,163,0.0008235,7.7252e-05,0.071592,0.49541,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...313,SET,4,0.0049216,7.264e-05,0.43112,0.49545,GOBP_POSITIVE_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.99999
SMID_BREAST_CANCER_LUMINAL_A...1,SET,16,0.0025434,7.5053e-05,0.22351,0.49546,SMID_BREAST_CANCER_LUMINAL_A_DN,0.99999
chr10q21,SET,41,0.0027609,0.00013033,0.24399,0.49549,chr10q21,0.99999
AIZARANI_LIVER_C9_LSECS_1,SET,280,0.00061226,7.5035e-05,0.054483,0.49552,AIZARANI_LIVER_C9_LSECS_1,0.99999
GOBP_ANTEROGRADE_AXONAL_TRAN...1,SET,48,0.001385,7.0725e-05,0.12413,0.49555,GOBP_ANTEROGRADE_AXONAL_TRANSPORT,0.99999
MIR4757_5P,SET,55,0.0012913,7.0574e-05,0.11965,0.49569,MIR4757_5P,0.99999
GOCC_SYNAPTIC_VESICLE_MEMBRA...,SET,124,0.00085029,6.9646e-05,0.079832,0.49575,GOCC_SYNAPTIC_VESICLE_MEMBRANE,0.99999
GOBP_LIPID_BIOSYNTHETIC_PROC...,SET,668,0.00035957,6.7331e-05,0.033856,0.49576,GOBP_LIPID_BIOSYNTHETIC_PROCESS,0.99999
REACTOME_APC_C_MEDIATED_DEGR...,SET,84,0.00087674,5.917e-05,0.082623,0.49577,REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,0.99999
DIDO1_TARGET_GENES,SET,1306,0.00025636,6.5899e-05,0.02418,0.49577,DIDO1_TARGET_GENES,0.99999
WP_GENE_REGULATORY_NETWORK_M...,SET,11,0.0027577,6.7483e-05,0.26066,0.49578,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,0.99999
KAECH_DAY15_EFF_VS_MEMORY_CD...1,SET,182,0.00066922,6.6302e-05,0.063311,0.49578,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...609,SET,22,0.0019548,6.7632e-05,0.18544,0.49579,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.99999
GOBP_POSITIVE_REGULATION_OF_...395,SET,273,0.00056557,6.8454e-05,0.053638,0.49579,GOBP_POSITIVE_REGULATION_OF_KINASE_ACTIVITY,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...2,SET,171,0.00066504,6.3886e-05,0.065883,0.49597,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,0.99999
HP_PROLONGED_PARTIAL_THROMBO...,SET,30,0.0016676,6.7359e-05,0.16557,0.49598,HP_PROLONGED_PARTIAL_THROMBOPLASTIN_TIME,0.99999
GSE5589_LPS_VS_LPS_AND_IL10_...9,SET,176,0.00065277,6.3608e-05,0.064817,0.49598,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.99999
HP_ABNORMAL_CORNEAL_ENDOTHEL...,SET,18,0.0022453,7.0272e-05,0.22455,0.49601,HP_ABNORMAL_CORNEAL_ENDOTHELIUM_MORPHOLOGY,0.99999
GOBP_DERMATAN_SULFATE_PROTEO...1,SET,8,0.0028795,6.0097e-05,0.29138,0.49606,GOBP_DERMATAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.99999
GARCIA_PINERES_PBMC_HPV_16_L...1,SET,20,0.001973,6.5086e-05,0.19956,0.49606,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE,0.99999
GSE32901_NAIVE_VS_TH1_CD4_TC...2,SET,113,0.00080572,6.3019e-05,0.082299,0.49609,GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP,0.99999
WP_MODULATORS_OF_TCR_SIGNALI...,SET,57,0.0010776,5.995e-05,0.11147,0.49614,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,0.99999
GOBP_KERATINOCYTE_MIGRATION,SET,20,0.0020369,6.7195e-05,0.21365,0.4962,GOBP_KERATINOCYTE_MIGRATION,0.99999
REACTOME_CONSTITUTIVE_SIGNAL...1,SET,82,0.00096655,6.4453e-05,0.1026,0.49624,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,0.99999
HP_ABNORMAL_STERNUM_MORPHOLO...,SET,402,0.000396,5.7955e-05,0.042222,0.49626,HP_ABNORMAL_STERNUM_MORPHOLOGY,0.99999
DESCARTES_FETAL_EYE_AMACRINE...,SET,7,0.0030999,6.0519e-05,0.33251,0.49628,DESCARTES_FETAL_EYE_AMACRINE_CELLS,0.99999
REACTOME_NR1H2_NR1H3_REGULAT...4,SET,9,0.0023804,5.2693e-05,0.25887,0.49633,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS,0.99999
JONES_OVARY_NK_CELL,SET,79,0.0009594,6.2801e-05,0.10453,0.49634,JONES_OVARY_NK_CELL,0.99999
MIR1224_5P,SET,55,0.0010229,5.5903e-05,0.1124,0.49637,MIR1224_5P,0.99999
GOBP_RESPONSE_TO_INTERLEUKIN...3,SET,5,0.003547,5.8529e-05,0.39006,0.49637,GOBP_RESPONSE_TO_INTERLEUKIN_13,0.99999
GSE13306_RA_VS_UNTREATED_TCO...1,SET,179,0.00060037,5.8994e-05,0.066092,0.49638,GSE13306_RA_VS_UNTREATED_TCONV_DN,0.99999
GOMF_D_LOOP_DNA_BINDING,SET,5,0.004028,6.6467e-05,0.44529,0.49639,GOMF_D_LOOP_DNA_BINDING,0.99999
GOMF_TRANSPORTER_REGULATOR_A...,SET,141,0.0006827,5.9601e-05,0.075938,0.49641,GOMF_TRANSPORTER_REGULATOR_ACTIVITY,0.99999
GOBP_MITOTIC_METAPHASE_CHROM...,SET,62,0.00090026,5.223e-05,0.10093,0.49644,GOBP_MITOTIC_METAPHASE_CHROMOSOME_ALIGNMENT,0.99999
HP_ABNORMAL_HEMOGLOBIN,SET,65,0.00093245,5.5386e-05,0.10441,0.49644,HP_ABNORMAL_HEMOGLOBIN,0.99999
GSE3039_NKT_CELL_VS_B2_BCELL...1,SET,185,0.00056858,5.6789e-05,0.063874,0.49645,GSE3039_NKT_CELL_VS_B2_BCELL_DN,0.99999
GOBP_REGULATION_OF_GAMMA_DEL...2,SET,9,0.0026554,5.8781e-05,0.29948,0.49646,GOBP_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION,0.99999
GSE15659_CD45RA_NEG_CD4_TCEL...2,SET,163,0.00058214,5.461e-05,0.06679,0.49652,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP,0.99999
GSE15330_WT_VS_IKAROS_KO_MEG...1,SET,184,0.0005575,5.5534e-05,0.064045,0.49653,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,0.99999
ZIRN_TRETINOIN_RESPONSE_WT1_...1,SET,5,0.0034823,5.7461e-05,0.40237,0.49655,ZIRN_TRETINOIN_RESPONSE_WT1_DN,0.99999
JIANG_MELANOMA_TRM10_LAMINA_...,SET,79,0.00092124,6.0303e-05,0.1075,0.49658,JIANG_MELANOMA_TRM10_LAMINA_PROPRIA,0.99999
HP_DEHYDRATION,SET,99,0.000776,5.6832e-05,0.090728,0.49659,HP_DEHYDRATION,0.99999
AGCATTA_MIR155,SET,124,0.00066043,5.4095e-05,0.078584,0.49665,AGCATTA_MIR155,0.99999
GSE5542_UNTREATED_VS_IFNA_AN...1,SET,179,0.00051952,5.1049e-05,0.0622,0.49667,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.99999
WP_EXTRAFOLLICULAR_AND_FOLLI...,SET,65,0.00097661,5.8009e-05,0.11938,0.49674,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,0.99999
WP_GNAQ_PATHWAYS_IN_PORTWINE...,SET,20,0.0015928,5.2545e-05,0.19787,0.49679,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,0.99999
HP_ABNORMAL_HAND_MORPHOLOGY,SET,920,0.00022686,4.9498e-05,0.028505,0.49682,HP_ABNORMAL_HAND_MORPHOLOGY,0.99999
WP_ACTIVATION_OF_NLRP3_INFLA...,SET,6,0.002591,4.6834e-05,0.32766,0.49685,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,0.99999
GSE21546_WT_VS_SAP1A_KO_AND_...4,SET,184,0.00050521,5.0325e-05,0.064019,0.49685,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.99999
RYTAAWNNNTGAY_UNKNOWN,SET,55,0.00094289,5.1532e-05,0.12181,0.49691,RYTAAWNNNTGAY_UNKNOWN,0.99999
RNCTGNYNRNCTGNY_UNKNOWN,SET,65,0.00082011,4.8713e-05,0.10677,0.49694,RNCTGNYNRNCTGNY_UNKNOWN,0.99999
GOBP_POSITIVE_REGULATION_OF_...407,SET,13,0.0018551,4.9349e-05,0.24284,0.49695,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING,0.99999
GOBP_BRANCHING_MORPHOGENESIS...1,SET,144,0.00058209,5.1351e-05,0.076759,0.49697,GOBP_BRANCHING_MORPHOGENESIS_OF_AN_EPITHELIAL_TUBE,0.99999
HP_ANEMIA_DUE_TO_REDUCED_LIF...,SET,139,0.00052958,4.5907e-05,0.072886,0.4971,HP_ANEMIA_DUE_TO_REDUCED_LIFE_SPAN_OF_RED_CELLS,0.99999
GOBP_SULFUR_AMINO_ACID_TRANS...,SET,12,0.0017949,4.5874e-05,0.24787,0.49711,GOBP_SULFUR_AMINO_ACID_TRANSPORT,0.99999
MIR3678_3P,SET,115,0.00061393,4.8439e-05,0.085393,0.49713,MIR3678_3P,0.99999
chr7p21,SET,35,0.0016801,7.3288e-05,0.23528,0.49715,chr7p21,0.99999
REACTOME_SOMITOGENESIS,SET,52,0.00074297,3.9486e-05,0.10534,0.49719,REACTOME_SOMITOGENESIS,0.99999
GSE18893_TCONV_VS_TREG_24H_C...2,SET,189,0.00043564,4.3975e-05,0.063706,0.49727,GSE18893_TCONV_VS_TREG_24H_CULTURE_UP,0.99999
DESCARTES_MAIN_FETAL_BIPOLAR...,SET,48,0.00094926,4.8476e-05,0.13958,0.49729,DESCARTES_MAIN_FETAL_BIPOLAR_CELLS,0.99999
HP_CONTRACTURE_OF_THE_PROXIM...3,SET,5,0.0027191,4.4868e-05,0.41921,0.49741,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_5TH_FINGER,0.99999
GOBP_MITOPHAGY,SET,57,0.00071529,3.9795e-05,0.11091,0.49743,GOBP_MITOPHAGY,0.99999
PDGF_UP.V1_DN,SET,107,0.00055695,4.2396e-05,0.087226,0.49745,PDGF_UP.V1_DN,0.99999
UZONYI_RESPONSE_TO_LEUKOTRIE...,SET,34,0.0011162,4.7994e-05,0.17541,0.49746,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,0.99999
GOMF_UBIQUITIN_LIKE_PROTEIN_...7,SET,19,0.0010615,3.4133e-05,0.16719,0.49747,GOMF_UBIQUITIN_LIKE_PROTEIN_READER_ACTIVITY,0.99999
HP_ABNORMAL_HAND_BONE_OSSIFI...,SET,34,0.00089632,3.8538e-05,0.14533,0.49754,HP_ABNORMAL_HAND_BONE_OSSIFICATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...570,SET,7,0.0016925,3.3043e-05,0.27755,0.49757,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,0.99999
MORF_JUND,SET,57,0.000631,3.5106e-05,0.10777,0.49766,MORF_JUND,0.99999
WP_TRIACYLGLYCERIDE_SYNTHESIS,SET,20,0.0012027,3.9677e-05,0.20735,0.49769,WP_TRIACYLGLYCERIDE_SYNTHESIS,0.99999
HP_FETAL_DISTRESS,SET,52,0.00064353,3.4201e-05,0.11168,0.4977,HP_FETAL_DISTRESS,0.99999
KUROKAWA_LIVER_CANCER_EARLY_...1,SET,6,0.0019397,3.5061e-05,0.3388,0.49772,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN,0.99999
WP_BLOOD_CLOTTING_CASCADE,SET,20,0.0012447,4.1061e-05,0.22067,0.49775,WP_BLOOD_CLOTTING_CASCADE,0.99999
GNF2_PTX3,SET,34,0.00094643,4.0692e-05,0.16869,0.49776,GNF2_PTX3,0.99999
GOMF_UBIQUITIN_LIKE_PROTEIN_...5,SET,291,0.00027041,3.3774e-05,0.048515,0.49778,GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING,0.99999
WP_BLADDER_CANCER,SET,39,0.00075014,3.4538e-05,0.13599,0.4978,WP_BLADDER_CANCER,0.99999
GOBP_POST_CHAPERONIN_TUBULIN...,SET,6,0.0014069,2.5431e-05,0.26863,0.49791,GOBP_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,0.99999
MODULE_124,SET,92,0.00043076,3.0417e-05,0.082796,0.49792,MODULE_124,0.99999
MIR134_3P,SET,81,0.00049023,3.2492e-05,0.094986,0.49794,MIR134_3P,0.99999
MIR3074_3P,SET,79,0.00050166,3.2838e-05,0.10021,0.498,MIR3074_3P,0.99999
GOBP_REGULATION_OF_LYMPHOCYT...3,SET,25,0.00089537,3.3019e-05,0.17992,0.49801,GOBP_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS,0.99999
GSE2706_R848_VS_LPS_8H_STIM_...2,SET,141,0.00036718,3.2055e-05,0.074011,0.49802,GSE2706_R848_VS_LPS_8H_STIM_DC_UP,0.99999
GOBP_WNT_SIGNALING_PATHWAY_C...,SET,5,0.0022587,3.727e-05,0.47255,0.49809,GOBP_WNT_SIGNALING_PATHWAY_CALCIUM_MODULATING_PATHWAY,0.99999
HP_TRIANGULAR_FACE,SET,145,0.00033057,2.9262e-05,0.07172,0.49816,HP_TRIANGULAR_FACE,0.99999
GSE19825_NAIVE_VS_IL2RAHIGH_...2,SET,182,0.00030892,3.0606e-05,0.066802,0.49816,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP,0.99999
KEGG_CYSTEINE_AND_METHIONINE...,SET,32,0.00077514,3.2334e-05,0.16889,0.49817,KEGG_CYSTEINE_AND_METHIONINE_METABOLISM,0.99999
REACTOME_INHIBITION_OF_DNA_R...,SET,19,0.00077918,2.5054e-05,0.17429,0.49822,REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE,0.99999
HP_FOCAL_CORTICAL_DYSPLASIA_...,SET,5,0.0017308,2.856e-05,0.40289,0.49829,HP_FOCAL_CORTICAL_DYSPLASIA_TYPE_II,0.99999
GSE2826_WT_VS_BTK_KO_BCELL_DN,SET,193,0.0002666,2.7191e-05,0.063329,0.49832,GSE2826_WT_VS_BTK_KO_BCELL_DN,0.99999
NAKAMURA_ADIPOGENESIS_LATE_DN,SET,33,0.00065239,2.7635e-05,0.15545,0.49833,NAKAMURA_ADIPOGENESIS_LATE_DN,0.99999
NUNODA_RESPONSE_TO_DASATINIB...1,SET,13,0.00090641,2.4112e-05,0.22415,0.49839,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,0.99999
GAO_SMALL_INTESTINE_24W_C7_S...,SET,38,0.00053833,2.4467e-05,0.13711,0.49843,GAO_SMALL_INTESTINE_24W_C7_SECRETORY_PROGENITOR,0.99999
GSE29618_PRE_VS_DAY7_POST_LA...8,SET,178,0.00025332,2.4823e-05,0.064764,0.49844,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP,0.99999
WILLIAMS_ESR2_TARGETS_UP,SET,25,0.00061374,2.2633e-05,0.16374,0.4985,WILLIAMS_ESR2_TARGETS_UP,0.99999
MARSON_FOXP3_CORE_DIRECT_TAR...,SET,17,0.00085586,2.6032e-05,0.23801,0.49857,MARSON_FOXP3_CORE_DIRECT_TARGETS,0.99999
HP_CHRONIC_SINUSITIS,SET,57,0.00039239,2.1831e-05,0.11026,0.49858,HP_CHRONIC_SINUSITIS,0.99999
HP_ABNORMAL_MYELOID_LEUKOCYT...,SET,300,0.0001764,2.2365e-05,0.049811,0.49859,HP_ABNORMAL_MYELOID_LEUKOCYTE_MORPHOLOGY,0.99999
HP_BASAL_GANGLIA_CALCIFICATI...,SET,36,0.00052826,2.337e-05,0.15055,0.4986,HP_BASAL_GANGLIA_CALCIFICATION,0.99999
MIR1272,SET,80,0.00032035,2.1101e-05,0.092456,0.49862,MIR1272,0.99999
GSE17721_POLYIC_VS_CPG_24H_B...1,SET,181,0.00021099,2.0846e-05,0.063438,0.49867,GSE17721_POLYIC_VS_CPG_24H_BMDC_DN,0.99999
MIR4489,SET,49,0.00040012,2.0644e-05,0.12146,0.49869,MIR4489,0.99999
BIOCARTA_SAM68_PATHWAY,SET,6,0.0011345,2.0508e-05,0.35361,0.49872,BIOCARTA_SAM68_PATHWAY,0.99999
GOBP_ORNITHINE_METABOLIC_PRO...,SET,9,0.00073003,1.616e-05,0.24127,0.49879,GOBP_ORNITHINE_METABOLIC_PROCESS,0.99999
REACTOME_NR1H2_NR1H3_REGULAT...1,SET,5,0.0010123,1.6704e-05,0.34586,0.49883,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS,0.99999
HP_INCREASED_NUCHAL_TRANSLUC...,SET,46,0.00037851,1.8923e-05,0.13349,0.49887,HP_INCREASED_NUCHAL_TRANSLUCENCY,0.99999
HP_ABNORMAL_FETAL_PHYSIOLOGY,SET,261,0.00014504,1.7171e-05,0.052806,0.4989,HP_ABNORMAL_FETAL_PHYSIOLOGY,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_MUC...,SET,48,0.00037251,1.9023e-05,0.13513,0.4989,HE_LIM_SUN_FETAL_LUNG_C1_MUC5AC_POS_ASCL1_POS_PROGENITOR_CELL,0.99999
HP_HOFFMANN_SIGN,SET,9,0.00063428,1.4041e-05,0.25646,0.49901,HP_HOFFMANN_SIGN,0.99999
GSE10147_IL3_VS_IL3_AND_HIVP...2,SET,151,0.00015926,1.4385e-05,0.06455,0.49902,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP,0.99999
BERENJENO_ROCK_SIGNALING_NOT...1,SET,48,0.00031369,1.6019e-05,0.13056,0.49904,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...428,SET,2,0.0015133,1.5794e-05,0.69124,0.49913,GOBP_NEGATIVE_REGULATION_OF_MYOBLAST_PROLIFERATION,0.99999
LIM_MAMMARY_STEM_CELL_DN,SET,385,8.868e-05,1.2707e-05,0.043321,0.49918,LIM_MAMMARY_STEM_CELL_DN,0.99999
SHAFFER_IRF4_TARGETS_IN_MYEL...,SET,94,0.0001815,1.2954e-05,0.090291,0.4992,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,0.99999
HP_ABNORMAL_CIRCULATING_GLYC...,SET,27,0.00031133,1.1931e-05,0.16395,0.49924,HP_ABNORMAL_CIRCULATING_GLYCINE_CONCENTRATION,0.99999
HP_SHORT_UPPER_LIP,SET,9,0.00053421,1.1825e-05,0.28247,0.49925,HP_SHORT_UPPER_LIP,0.99999
HP_METABOLIC_ACIDOSIS,SET,149,0.00012594,1.13e-05,0.067807,0.49926,HP_METABOLIC_ACIDOSIS,0.99999
WP_HYPOTHETICAL_CRANIOFACIAL...,SET,7,0.0005783,1.129e-05,0.32668,0.49929,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,0.99999
HP_TACHYPNEA,SET,88,0.00015588,1.0767e-05,0.087583,0.49929,HP_TACHYPNEA,0.99999
GSE6259_33D1_POS_DC_VS_BCELL...2,SET,136,0.00012767,1.0948e-05,0.073856,0.49931,GSE6259_33D1_POS_DC_VS_BCELL_UP,0.99999
GOMF_K63_LINKED_POLYUBIQUITI...,SET,22,0.00025061,8.6703e-06,0.15773,0.49937,GOMF_K63_LINKED_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...601,SET,22,0.0003081,1.0659e-05,0.20691,0.49941,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,0.99999
HP_REDUCED_RENAL_CORTICOMEDU...,SET,14,0.00035105,9.6907e-06,0.23646,0.49941,HP_REDUCED_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,0.99999
OCONNOR_PBMC_MENVEO_ACWYVAX_...2,SET,124,9.1949e-05,7.5314e-06,0.073459,0.4995,OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP,0.99999
GSE17721_0.5H_VS_24H_PAM3CSK...2,SET,186,7.5521e-05,7.5631e-06,0.061416,0.49951,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_UP,0.99999
GOBP_REGULATION_OF_GAMMA_DEL...1,SET,11,0.0002981,7.2949e-06,0.26968,0.49956,GOBP_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION,0.99999
REACTOME_SIGNALING_BY_MRAS_C...,SET,7,0.00030205,5.897e-06,0.28264,0.49957,REACTOME_SIGNALING_BY_MRAS_COMPLEX_MUTANTS,0.99999
MILICIC_FAMILIAL_ADENOMATOUS...2,SET,9,0.00030796,6.8169e-06,0.30979,0.4996,MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP,0.99999
HP_DEMENTIA,SET,186,6.2703e-05,6.2794e-06,0.063078,0.4996,HP_DEMENTIA,0.99999
DESCARTES_FETAL_PLACENTA_STR...,SET,56,7.7059e-05,4.2495e-06,0.131,0.49977,DESCARTES_FETAL_PLACENTA_STROMAL_CELLS,0.99999
PID_INTEGRIN5_PATHWAY,SET,16,0.00012109,3.5734e-06,0.22617,0.49979,PID_INTEGRIN5_PATHWAY,0.99999
WP_COMMON_PATHWAYS_UNDERLYIN...,SET,38,6.8832e-05,3.1284e-06,0.14837,0.49981,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,0.99999
chr9p23,SET,4,0.00023124,3.413e-06,0.54822,0.49983,chr9p23,0.99999
GOCC_MEMBRANE_MICRODOMAIN,SET,269,2.0761e-05,2.4946e-06,0.05459,0.49985,GOCC_MEMBRANE_MICRODOMAIN,0.99999
GOBP_NUCLEAR_TRANSCRIBED_MRN...1,SET,108,1.9227e-05,1.4704e-06,0.077241,0.4999,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS,0.99999
GOBP_THYMOCYTE_MIGRATION,SET,7,6.6351e-05,1.2954e-06,0.35503,0.49993,GOBP_THYMOCYTE_MIGRATION,0.99999
HP_ABNORMAL_RENAL_MORPHOLOGY,SET,983,2.0906e-06,4.7064e-07,0.02797,0.49997,HP_ABNORMAL_RENAL_MORPHOLOGY,0.99999
GOBP_MAINTENANCE_OF_PROTEIN_...4,SET,62,5.9426e-06,3.4477e-07,0.10519,0.49998,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_CELL,0.99999
MIR6512_5P,SET,106,-1.95e-06,-1.4775e-07,0.082371,0.50001,MIR6512_5P,0.99999
MIR4487,SET,73,-5.6601e-06,-3.5621e-07,0.10363,0.50002,MIR4487,0.99999
GSE3720_VD1_VS_VD2_GAMMADELT...1,SET,184,-6.5242e-06,-6.4988e-07,0.062254,0.50004,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN,0.99999
HP_LEFT_ANTERIOR_FASCICULAR_...,SET,7,-7.7244e-05,-1.5081e-06,0.35107,0.50009,HP_LEFT_ANTERIOR_FASCICULAR_BLOCK,0.99999
MIR4764_5P,SET,67,-4.2297e-05,-2.5506e-06,0.10451,0.50016,MIR4764_5P,0.99999
REACTOME_SYNTHESIS_OF_DNA,SET,116,-3.2424e-05,-2.5693e-06,0.070222,0.50018,REACTOME_SYNTHESIS_OF_DNA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...460,SET,23,-8.7394e-05,-3.0914e-06,0.17297,0.5002,GOBP_NEGATIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,0.99999
GSE37532_TREG_VS_TCONV_PPARG...4,SET,186,-3.2892e-05,-3.294e-06,0.062047,0.50021,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,0.99999
WP_INCLUSION_BODY_MYOSITIS,SET,10,-0.00014337,-3.3452e-06,0.26457,0.50022,WP_INCLUSION_BODY_MYOSITIS,0.99999
GOBP_REGULATION_OF_CELL_CYCL...5,SET,665,-2.2397e-05,-4.1848e-06,0.033155,0.50027,GOBP_REGULATION_OF_CELL_CYCLE_PROCESS,0.99999
HP_MACROSCOPIC_HEMATURIA,SET,8,-0.00024289,-5.0692e-06,0.34095,0.50028,HP_MACROSCOPIC_HEMATURIA,0.99999
REACTOME_RESPONSE_OF_EIF2AK1...,SET,14,-0.00018291,-5.0491e-06,0.23342,0.50031,REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,0.99999
GSE43863_NAIVE_VS_TFH_CD4_EF...2,SET,173,-6.8147e-05,-6.5841e-06,0.064303,0.50042,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP,0.99999
GOBP_REACTIVE_GLIOSIS,SET,5,-0.00047153,-7.7808e-06,0.43453,0.50043,GOBP_REACTIVE_GLIOSIS,0.99999
BIOCARTA_TOLL_PATHWAY,SET,22,-0.00021805,-7.5439e-06,0.19154,0.50045,BIOCARTA_TOLL_PATHWAY,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...3,SET,21,-0.00022826,-7.7159e-06,0.20409,0.50045,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_CD4_T_CELLS,0.99999
GSE14350_TREG_VS_TEFF_IN_IL2...1,SET,183,-7.313e-05,-7.2649e-06,0.062908,0.50046,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN,0.99999
MMEF2_Q6,SET,245,-7.1671e-05,-8.2243e-06,0.057149,0.5005,MMEF2_Q6,0.99999
GSE39820_CTRL_VS_TGFBETA3_IL...3,SET,176,-9.0138e-05,-8.7833e-06,0.064616,0.50056,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_DN,0.99999
MTOR_UP.V1_DN,SET,171,-0.00010238,-9.8353e-06,0.065708,0.50062,MTOR_UP.V1_DN,0.99999
GNF2_PECAM1,SET,48,-0.00020592,-1.0516e-05,0.13067,0.50063,GNF2_PECAM1,0.99999
GOCC_PLASMA_MEMBRANE_PROTEIN...,SET,566,-6.1932e-05,-1.0706e-05,0.039171,0.50063,GOCC_PLASMA_MEMBRANE_PROTEIN_COMPLEX,0.99999
CHEOK_RESPONSE_TO_HD_MTX_UP,SET,19,-0.0003441,-1.1064e-05,0.19992,0.50069,CHEOK_RESPONSE_TO_HD_MTX_UP,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...49,SET,71,-0.00020259,-1.2575e-05,0.10428,0.50078,GOBP_PROTEIN_LOCALIZATION_TO_SYNAPSE,0.99999
GSE27786_LIN_NEG_VS_NEUTROPH...2,SET,172,-0.00012432,-1.1977e-05,0.063308,0.50078,GSE27786_LIN_NEG_VS_NEUTROPHIL_UP,0.99999
chr11p11,SET,62,-0.00043246,-2.509e-05,0.21817,0.50079,chr11p11,0.99999
MIR4271,SET,198,-0.00011582,-1.1963e-05,0.058721,0.50079,MIR4271,0.99999
GOBP_CANONICAL_NF_KAPPAB_SIG...,SET,279,-0.00010568,-1.2929e-05,0.051824,0.50081,GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.99999
HP_ANGINA_PECTORIS,SET,36,-0.00032443,-1.4353e-05,0.15241,0.50085,HP_ANGINA_PECTORIS,0.99999
GOBP_MACROMOLECULE_DEPALMITO...,SET,14,-0.00046265,-1.2771e-05,0.20505,0.5009,GOBP_MACROMOLECULE_DEPALMITOYLATION,0.99999
GOMF_PALMITOYL_HYDROLASE_ACT...,SET,14,-0.00046265,-1.2771e-05,0.20505,0.5009,GOMF_PALMITOYL_HYDROLASE_ACTIVITY,0.99999
GSE43955_1H_VS_10H_ACT_CD4_T...2,SET,185,-0.00014075,-1.4058e-05,0.061562,0.50091,GSE43955_1H_VS_10H_ACT_CD4_TCELL_UP,0.99999
MORF_CASP10,SET,109,-0.0001936,-1.4873e-05,0.080378,0.50096,MORF_CASP10,0.99999
HP_SCARRING,SET,88,-0.0002267,-1.5658e-05,0.094214,0.50096,HP_SCARRING,0.99999
REACTOME_DNA_DAMAGE_TELOMERE...,SET,27,-0.00040985,-1.5706e-05,0.14469,0.50113,REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,0.99999
HUANG_FOXA2_TARGETS_UP,SET,45,-0.00040631,-2.0092e-05,0.14076,0.50115,HUANG_FOXA2_TARGETS_UP,0.99999
REACTOME_EXPORT_OF_VIRAL_RIB...,SET,31,-0.00042748,-1.7552e-05,0.14709,0.50116,REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...238,SET,7,-0.00092289,-1.8018e-05,0.31115,0.50118,GOBP_NEGATIVE_REGULATION_OF_FERTILIZATION,0.99999
GOBP_PERICARDIUM_DEVELOPMENT,SET,18,-0.00070769,-2.2149e-05,0.21631,0.50131,GOBP_PERICARDIUM_DEVELOPMENT,0.99999
WENG_POR_TARGETS_LIVER_DN,SET,22,-0.00069236,-2.3954e-05,0.20862,0.50132,WENG_POR_TARGETS_LIVER_DN,0.99999
GSE28237_FOLLICULAR_VS_EARLY...2,SET,167,-0.0002153,-2.0442e-05,0.063095,0.50136,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP,0.99999
REACTOME_SIGNALING_BY_TYPE_1...,SET,52,-0.00041889,-2.2263e-05,0.12157,0.50137,REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,0.99999
GOBP_OSSIFICATION,SET,382,-0.00016433,-2.3457e-05,0.046174,0.50142,GOBP_OSSIFICATION,0.99999
GOBP_VESTIBULOCOCHLEAR_NERVE...3,SET,7,-0.0014892,-2.9075e-05,0.39349,0.50151,GOBP_VESTIBULOCOCHLEAR_NERVE_MORPHOGENESIS,0.99999
GSE41867_DAY6_VS_DAY15_LCMV_...4,SET,147,-0.00028677,-2.5559e-05,0.07418,0.50154,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.99999
GOBP_HAIR_CELL_DIFFERENTIATI...,SET,50,-0.00049704,-2.5905e-05,0.12716,0.50156,GOBP_HAIR_CELL_DIFFERENTIATION,0.99999
HP_RESPIRATORY_FAILURE,SET,228,-0.00023147,-2.5635e-05,0.055886,0.50165,HP_RESPIRATORY_FAILURE,0.99999
HP_PULMONARY_EDEMA,SET,25,-0.00077043,-2.8412e-05,0.18287,0.50168,HP_PULMONARY_EDEMA,0.99999
SRC_UP.V1_DN,SET,147,-0.00030518,-2.7199e-05,0.070385,0.50173,SRC_UP.V1_DN,0.99999
HP_EXODEVIATION,SET,104,-0.00035397,-2.6567e-05,0.080401,0.50176,HP_EXODEVIATION,0.99999
GOBP_CELL_DIFFERENTIATION_IN...6,SET,47,-0.00061392,-3.1023e-05,0.13794,0.50178,GOBP_CELL_DIFFERENTIATION_IN_SPINAL_CORD,0.99999
PID_THROMBIN_PAR1_PATHWAY,SET,42,-0.00061911,-2.9579e-05,0.13648,0.50181,PID_THROMBIN_PAR1_PATHWAY,0.99999
REACTOME_DISEASES_OF_DNA_REP...,SET,49,-0.00052889,-2.7288e-05,0.11475,0.50184,REACTOME_DISEASES_OF_DNA_REPAIR,0.99999
MIR216A_5P,SET,118,-0.00036642,-2.9283e-05,0.079007,0.50185,MIR216A_5P,0.99999
GSE23925_LIGHT_ZONE_VS_DARK_...1,SET,187,-0.00029005,-2.9125e-05,0.062021,0.50187,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,0.99999
WP_AMYOTROPHIC_LATERAL_SCLER...,SET,36,-0.00065164,-2.8828e-05,0.13721,0.50189,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,0.99999
GOMF_ADENYLATE_CYCLASE_REGUL...,SET,8,-0.0014585,-3.0441e-05,0.30569,0.5019,GOMF_ADENYLATE_CYCLASE_REGULATOR_ACTIVITY,0.99999
HP_HETEROTAXY,SET,21,-0.00094466,-3.1932e-05,0.19437,0.50194,HP_HETEROTAXY,0.99999
GSE5589_WT_VS_IL10_KO_LPS_AN...1,SET,102,-0.00042979,-3.1947e-05,0.087079,0.50197,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.99999
MODULE_484,SET,39,-0.00066555,-3.0643e-05,0.13245,0.502,MODULE_484,0.99999
REACTOME_GLYCOGEN_METABOLISM,SET,21,-0.00087032,-2.9419e-05,0.17047,0.50204,REACTOME_GLYCOGEN_METABOLISM,0.99999
GOBP_CARBOHYDRATE_DERIVATIVE...1,SET,569,-0.00019026,-3.2973e-05,0.036146,0.5021,GOBP_CARBOHYDRATE_DERIVATIVE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_LYMPHOCYTE_MIGRATION,SET,96,-0.00048848,-3.5232e-05,0.092622,0.5021,GOBP_LYMPHOCYTE_MIGRATION,0.99999
GOCC_SYNAPTIC_MEMBRANE,SET,369,-0.00025086,-3.5206e-05,0.047756,0.5021,GOCC_SYNAPTIC_MEMBRANE,0.99999
MIR148B_5P,SET,70,-0.00053799,-3.3157e-05,0.10161,0.50211,MIR148B_5P,0.99999
GOBP_REGULATION_OF_COAGULATI...,SET,72,-0.00056292,-3.5184e-05,0.106,0.50212,GOBP_REGULATION_OF_COAGULATION,0.99999
HP_SHORTENING_OF_ALL_DISTAL_...,SET,12,-0.001191,-3.044e-05,0.22241,0.50214,HP_SHORTENING_OF_ALL_DISTAL_PHALANGES_OF_THE_FINGERS,0.99999
ATAACCT_MIR154,SET,59,-0.00056558,-3.2011e-05,0.10433,0.50216,ATAACCT_MIR154,0.99999
HP_CENTRAL_APNEA,SET,37,-0.0007628,-3.421e-05,0.14068,0.50216,HP_CENTRAL_APNEA,0.99999
GSE34156_UNTREATED_VS_6H_TLR...1,SET,163,-0.00035009,-3.2842e-05,0.06472,0.50216,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...257,SET,12,-0.0013464,-3.4411e-05,0.24485,0.50219,GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_IMPORT,0.99999
KEGG_SELENOAMINO_ACID_METABO...,SET,23,-0.00098815,-3.4955e-05,0.17701,0.50223,KEGG_SELENOAMINO_ACID_METABOLISM,0.99999
GOBP_CELL_CELL_SIGNALING_INV...,SET,30,-0.0009784,-3.9519e-05,0.17458,0.50224,GOBP_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION,0.99999
HP_ABNORMAL_SKIN_ADNEXA_MORP...,SET,1292,-0.00013926,-3.5619e-05,0.024341,0.50228,HP_ABNORMAL_SKIN_ADNEXA_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...227,SET,92,-0.00052089,-3.6782e-05,0.090735,0.50229,GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOBP_MUSCLE_HYPERTROPHY_IN_R...,SET,24,-0.0010225,-3.6945e-05,0.17614,0.50232,GOBP_MUSCLE_HYPERTROPHY_IN_RESPONSE_TO_STRESS,0.99999
GOBP_INTERFERON_ALPHA_PRODUC...,SET,26,-0.00088342,-3.3223e-05,0.14687,0.5024,GOBP_INTERFERON_ALPHA_PRODUCTION,0.99999
MIR7160_3P,SET,27,-0.0010136,-3.8845e-05,0.1656,0.50244,MIR7160_3P,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...55,SET,6,-0.002057,-3.7181e-05,0.33352,0.50246,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_HALLUX,0.99999
GOBP_INTERLEUKIN_5_PRODUCTION,SET,19,-0.0012918,-4.1535e-05,0.207,0.50249,GOBP_INTERLEUKIN_5_PRODUCTION,0.99999
HP_NEPHROTIC_SYNDROME,SET,118,-0.00048762,-3.8968e-05,0.07801,0.50249,HP_NEPHROTIC_SYNDROME,0.99999
GOBP_OXALATE_TRANSPORT,SET,11,-0.0016261,-3.9793e-05,0.25531,0.50254,GOBP_OXALATE_TRANSPORT,0.99999
HP_RETINAL_HAMARTOMA,SET,22,-0.001051,-3.6362e-05,0.16477,0.50254,HP_RETINAL_HAMARTOMA,0.99999
HP_INTESTINAL_CARCINOID,SET,6,-0.0019856,-3.5891e-05,0.30585,0.50259,HP_INTESTINAL_CARCINOID,0.99999
REACTOME_RRNA_PROCESSING_IN_...,SET,6,-0.0019425,-3.5112e-05,0.29489,0.50263,REACTOME_RRNA_PROCESSING_IN_THE_MITOCHONDRION,0.99999
GOBP_PROTEIN_SUMOYLATION,SET,59,-0.00072968,-4.13e-05,0.10804,0.50269,GOBP_PROTEIN_SUMOYLATION,0.99999
GSE5542_UNTREATED_VS_IFNA_AN...3,SET,177,-0.00043086,-4.2103e-05,0.063773,0.5027,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.99999
FOURNIER_ACINAR_DEVELOPMENT_...4,SET,22,-0.0012735,-4.4058e-05,0.17885,0.50284,FOURNIER_ACINAR_DEVELOPMENT_LATE_DN,0.99999
REACTOME_REGULATION_OF_TP53_...1,SET,152,-0.00049649,-4.499e-05,0.067737,0.50292,REACTOME_REGULATION_OF_TP53_ACTIVITY,0.99999
REACTOME_KERATAN_SULFATE_BIO...,SET,28,-0.0012215,-4.7668e-05,0.16655,0.50293,REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,0.99999
GOMF_LIPOPROTEIN_LIPASE_ACTI...,SET,9,-0.0026061,-5.7689e-05,0.35159,0.50296,GOMF_LIPOPROTEIN_LIPASE_ACTIVITY,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...16,SET,182,-0.00044347,-4.3936e-05,0.059774,0.50296,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP,0.99999
GOBP_VIRAL_PROCESS,SET,396,-0.0003282,-4.768e-05,0.04402,0.50297,GOBP_VIRAL_PROCESS,0.99999
GSE22313_HEALTHY_VS_SLE_MOUS...2,SET,164,-0.0005015,-4.7188e-05,0.0674,0.50297,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_UP,0.99999
GOBP_MEMBRANE_DEPOLARIZATION...1,SET,27,-0.0013802,-5.2891e-05,0.18452,0.50298,GOBP_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL,0.99999
PID_IL8_CXCR1_PATHWAY,SET,27,-0.0012857,-4.927e-05,0.17048,0.50301,PID_IL8_CXCR1_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_CHRNA...,SET,6,-0.0022894,-4.1382e-05,0.30168,0.50303,KEGG_MEDICUS_REFERENCE_CHRNA7_E2F_SIGNALING_PATHWAY,0.99999
GOCC_OLIGOSACCHARYLTRANSFERA...,SET,13,-0.0018264,-4.8585e-05,0.23993,0.50304,GOCC_OLIGOSACCHARYLTRANSFERASE_COMPLEX,0.99999
REACTOME_CIRCADIAN_CLOCK,SET,64,-0.0008556,-5.043e-05,0.11148,0.50306,REACTOME_CIRCADIAN_CLOCK,0.99999
MIR22_3P,SET,126,-0.00059983,-4.9523e-05,0.078322,0.50306,MIR22_3P,0.99999
GOBP_ACTOMYOSIN_STRUCTURE_OR...,SET,205,-0.00047255,-4.9656e-05,0.061031,0.50309,GOBP_ACTOMYOSIN_STRUCTURE_ORGANIZATION,0.99999
HP_TYPE_A_BRACHYDACTYLY,SET,20,-0.0015442,-5.094e-05,0.19868,0.5031,HP_TYPE_A_BRACHYDACTYLY,0.99999
REACTOME_PROTEIN_REPAIR,SET,6,-0.0027037,-4.8871e-05,0.34682,0.50311,REACTOME_PROTEIN_REPAIR,0.99999
HP_POSTERIOR_HELIX_PIT,SET,4,-0.0036658,-5.4105e-05,0.46848,0.50312,HP_POSTERIOR_HELIX_PIT,0.99999
WP_EUKARYOTIC_TRANSCRIPTION_...,SET,41,-0.00089914,-4.2444e-05,0.11283,0.50318,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,0.99999
GOBP_SULFUR_COMPOUND_CATABOL...,SET,40,-0.001096,-5.1102e-05,0.13661,0.5032,GOBP_SULFUR_COMPOUND_CATABOLIC_PROCESS,0.99999
GOBP_TAURINE_METABOLIC_PROCE...,SET,9,-0.0025978,-5.7506e-05,0.32229,0.50322,GOBP_TAURINE_METABOLIC_PROCESS,0.99999
GOBP_INSULIN_SECRETION,SET,187,-0.00051176,-5.1387e-05,0.063192,0.50323,GOBP_INSULIN_SECRETION,0.99999
HP_ABNORMAL_FUNDUS_MORPHOLOGY,SET,1213,-0.00020553,-5.1057e-05,0.025064,0.50327,HP_ABNORMAL_FUNDUS_MORPHOLOGY,0.99999
MIKKELSEN_MEF_ICP_WITH_H3K27...,SET,187,-0.0005317,-5.3389e-05,0.064692,0.50328,MIKKELSEN_MEF_ICP_WITH_H3K27ME3,0.99999
HP_BROAD_CHIN,SET,8,-0.002968,-6.1943e-05,0.35923,0.5033,HP_BROAD_CHIN,0.99999
GSE3982_MAC_VS_EFF_MEMORY_CD...2,SET,180,-0.00052997,-5.222e-05,0.063869,0.50331,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
REACTOME_NUCLEAR_IMPORT_OF_R...,SET,32,-0.0012099,-5.0471e-05,0.14426,0.50335,REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN,0.99999
KIM_HYPOXIA,SET,15,-0.0019643,-5.6125e-05,0.22298,0.50351,KIM_HYPOXIA,0.99999
GSE360_L_MAJOR_VS_M_TUBERCUL...2,SET,167,-0.00058522,-5.5562e-05,0.066182,0.50353,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP,0.99999
GSE2770_UNTREATED_VS_IL4_TRE...1,SET,179,-0.00053378,-5.245e-05,0.059939,0.50355,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.99999
GOBP_RNA_METHYLATION,SET,66,-0.00081379,-4.8707e-05,0.090769,0.50358,GOBP_RNA_METHYLATION,0.99999
ACCATTT_MIR522,SET,144,-0.00067033,-5.9135e-05,0.072372,0.50369,ACCATTT_MIR522,0.99999
GSE25085_FETAL_BM_VS_ADULT_B...2,SET,186,-0.00059512,-5.9599e-05,0.064091,0.5037,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,0.99999
HP_SHORT_FIRST_METATARSAL,SET,4,-0.0041578,-6.1367e-05,0.44649,0.50371,HP_SHORT_FIRST_METATARSAL,0.99999
REACTOME_SEROTONIN_AND_MELAT...,SET,4,-0.0040093,-5.9174e-05,0.42748,0.50374,REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS,0.99999
GOBP_ADULT_FEEDING_BEHAVIOR,SET,9,-0.0029977,-6.6358e-05,0.31989,0.50374,GOBP_ADULT_FEEDING_BEHAVIOR,0.99999
CHIN_BREAST_CANCER_COPY_NUMB...2,SET,27,-0.0016116,-6.1758e-05,0.17112,0.50376,CHIN_BREAST_CANCER_COPY_NUMBER_UP,0.99999
GSE3039_B2_VS_B1_BCELL_UP,SET,186,-0.0005838,-5.8466e-05,0.06193,0.50376,GSE3039_B2_VS_B1_BCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...59,SET,5,-0.0042766,-7.0569e-05,0.45159,0.50378,GOBP_POSITIVE_REGULATION_OF_BLOOD_BRAIN_BARRIER_PERMEABILITY,0.99999
GOBP_REGULATION_OF_DEOXYRIBO...,SET,10,-0.0025926,-6.0493e-05,0.27334,0.50378,GOBP_REGULATION_OF_DEOXYRIBONUCLEASE_ACTIVITY,0.99999
GSE45382_UNTREATED_VS_TGFB_T...1,SET,166,-0.00063186,-5.9812e-05,0.065407,0.50385,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_DN,0.99999
MIR6812_5P,SET,62,-0.0010333,-5.9947e-05,0.10653,0.50387,MIR6812_5P,0.99999
GOCC_CILIUM,SET,635,-0.0003316,-6.0596e-05,0.034096,0.50388,GOCC_CILIUM,0.99999
DUTERTRE_ESTRADIOL_RESPONSE_...2,SET,297,-0.00046436,-5.8584e-05,0.047568,0.50389,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,0.99999
HP_UNSTEADY_GAIT,SET,169,-0.00063677,-6.0815e-05,0.065243,0.50389,HP_UNSTEADY_GAIT,0.99999
GRANDVAUX_IFN_RESPONSE_NOT_V...,SET,14,-0.0021775,-6.0108e-05,0.21924,0.50396,GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...16,SET,151,-0.00072543,-6.5521e-05,0.071872,0.50403,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP,0.99999
GSE6259_BCELL_VS_CD4_TCELL_UP,SET,154,-0.00067912,-6.1939e-05,0.067092,0.50404,GSE6259_BCELL_VS_CD4_TCELL_UP,0.99999
SIX4_TARGET_GENES,SET,33,-0.0014584,-6.1777e-05,0.14377,0.50405,SIX4_TARGET_GENES,0.99999
HP_RECURRENT_FEVER,SET,85,-0.00096164,-6.5283e-05,0.094339,0.50407,HP_RECURRENT_FEVER,0.99999
GOBP_PLASMA_MEMBRANE_ORGANIZ...,SET,149,-0.00073749,-6.6171e-05,0.071152,0.50413,GOBP_PLASMA_MEMBRANE_ORGANIZATION,0.99999
GOBP_MACROMOLECULE_DEACYLATI...,SET,53,-0.001134,-6.084e-05,0.10856,0.50417,GOBP_MACROMOLECULE_DEACYLATION,0.99999
RHODES_CANCER_META_SIGNATURE,SET,58,-0.0010828,-6.0766e-05,0.1021,0.50423,RHODES_CANCER_META_SIGNATURE,0.99999
GOBP_TRANSLATIONAL_ELONGATION,SET,59,-0.0010986,-6.218e-05,0.10357,0.50423,GOBP_TRANSLATIONAL_ELONGATION,0.99999
GOBP_HINDBRAIN_DEVELOPMENT,SET,142,-0.00081036,-7.0994e-05,0.074764,0.50432,GOBP_HINDBRAIN_DEVELOPMENT,0.99999
REACTOME_SCAVENGING_BY_CLASS...3,SET,6,-0.0036293,-6.5602e-05,0.33403,0.50433,REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS,0.99999
CAO_BLOOD_FLUZONE_AGE_05_14Y...6,SET,5,-0.003741,-6.1731e-05,0.34405,0.50434,CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_UP,0.99999
HP_MACROTHROMBOCYTOPENIA,SET,12,-0.0027843,-7.1162e-05,0.25231,0.5044,HP_MACROTHROMBOCYTOPENIA,0.99999
DESCARTES_FETAL_STOMACH_GOBL...,SET,16,-0.0026514,-7.8242e-05,0.23984,0.50441,DESCARTES_FETAL_STOMACH_GOBLET_CELLS,0.99999
MMS_MOUSE_LYMPH_HIGH_4HRS_UP,SET,28,-0.0017272,-6.7404e-05,0.15581,0.50442,MMS_MOUSE_LYMPH_HIGH_4HRS_UP,0.99999
OCT1_06,SET,221,-0.00068634,-7.485e-05,0.061872,0.50443,OCT1_06,0.99999
GSE11818_WT_VS_DICER_KO_TREG...2,SET,129,-0.0009149,-7.6424e-05,0.081895,0.50446,GSE11818_WT_VS_DICER_KO_TREG_UP,0.99999
HP_DECREASED_CIRCULATING_FOL...,SET,30,-0.0017267,-6.9746e-05,0.15389,0.50448,HP_DECREASED_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_CONCENTRATION,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...7,SET,183,-0.00071978,-7.1505e-05,0.063817,0.5045,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN,0.99999
GSE14769_UNSTIM_VS_80MIN_LPS...2,SET,182,-0.00067839,-6.7211e-05,0.059595,0.50454,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_UP,0.99999
GOBP_REGULATION_OF_OPSIN_MED...,SET,8,-0.0032085,-6.6963e-05,0.28073,0.50456,GOBP_REGULATION_OF_OPSIN_MEDIATED_SIGNALING_PATHWAY,0.99999
CCAWWNAAGG_SRF_Q4,SET,77,-0.001167,-7.542e-05,0.10177,0.50457,CCAWWNAAGG_SRF_Q4,0.99999
HP_INTRACRANIAL_HEMORRHAGE,SET,141,-0.0008391,-7.3255e-05,0.073256,0.50457,HP_INTRACRANIAL_HEMORRHAGE,0.99999
MODULE_458,SET,31,-0.0017713,-7.2727e-05,0.15427,0.50458,MODULE_458,0.99999
REACTOME_ANTIGEN_PROCESSING_...2,SET,287,-0.00055713,-6.9113e-05,0.048084,0.50462,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,0.99999
HP_ENLARGED_VESTIBULAR_AQUED...,SET,7,-0.0039828,-7.7757e-05,0.34115,0.50466,HP_ENLARGED_VESTIBULAR_AQUEDUCT,0.99999
REACTOME_ACTIVATION_OF_PPARG...,SET,10,-0.0033524,-7.822e-05,0.28572,0.50468,REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION,0.99999
GOBP_REGULATION_OF_INSULIN_L...,SET,20,-0.002578,-8.5046e-05,0.21923,0.50469,GOBP_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
VARELA_ZMPSTE24_TARGETS_UP,SET,40,-0.0015941,-7.4329e-05,0.13544,0.5047,VARELA_ZMPSTE24_TARGETS_UP,0.99999
KEGG_REGULATION_OF_ACTIN_CYT...,SET,196,-0.00076458,-7.8579e-05,0.064624,0.50472,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,0.99999
MORF_DDB1,SET,224,-0.00063221,-6.9408e-05,0.053475,0.50472,MORF_DDB1,0.99999
HU_FETAL_RETINA_BLOOD,SET,244,-0.00067608,-7.7424e-05,0.056987,0.50473,HU_FETAL_RETINA_BLOOD,0.99999
HP_POLYCYSTIC_LIVER_DISEASE,SET,11,-0.0028787,-7.0445e-05,0.24019,0.50478,HP_POLYCYSTIC_LIVER_DISEASE,0.99999
GSE42724_NAIVE_VS_MEMORY_BCE...1,SET,172,-0.00078514,-7.564e-05,0.065314,0.5048,GSE42724_NAIVE_VS_MEMORY_BCELL_DN,0.99999
MIR15B_3P,SET,73,-0.0012282,-7.7294e-05,0.10184,0.50481,MIR15B_3P,0.99999
HP_FOCAL_EMOTIONAL_SEIZURE,SET,17,-0.0025069,-7.6253e-05,0.20745,0.50482,HP_FOCAL_EMOTIONAL_SEIZURE,0.99999
GOBP_RESPONSE_TO_SALT_STRESS,SET,24,-0.0021016,-7.5938e-05,0.17348,0.50483,GOBP_RESPONSE_TO_SALT_STRESS,0.99999
GOBP_RECEPTOR_INTERNALIZATION,SET,120,-0.00098064,-7.9025e-05,0.079625,0.50491,GOBP_RECEPTOR_INTERNALIZATION,0.99999
GOMF_HYDROLASE_ACTIVITY_ACTI...5,SET,69,-0.0012768,-7.8132e-05,0.10259,0.50497,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDES,0.99999
MYOD_01,SET,232,-0.00072646,-8.1149e-05,0.058118,0.50499,MYOD_01,0.99999
GOBP_INTRACILIARY_RETROGRADE...,SET,10,-0.0028735,-6.7047e-05,0.22958,0.50499,GOBP_INTRACILIARY_RETROGRADE_TRANSPORT,0.99999
HP_ABNORMAL_HEART_VALVE_PHYS...,SET,336,-0.00060169,-8.0652e-05,0.048132,0.50499,HP_ABNORMAL_HEART_VALVE_PHYSIOLOGY,0.99999
GOMF_CALCIUM_POTASSIUM_SODIU...,SET,5,-0.0059345,-9.7927e-05,0.4724,0.50501,GOMF_CALCIUM_POTASSIUM_SODIUM_ANTIPORTER_ACTIVITY,0.99999
GOBP_CALCIUM_INDEPENDENT_CEL...,SET,22,-0.0024972,-8.6396e-05,0.19794,0.50503,GOBP_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,0.99999
GOBP_POSITIVE_REGULATION_OF_...357,SET,81,-0.0011895,-7.8841e-05,0.094078,0.50504,GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION,0.99999
WP_COMPLEMENT_SYSTEM_IN_NEUR...,SET,95,-0.0011788,-8.4578e-05,0.092919,0.50506,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.99999
GSE24634_TREG_VS_TCONV_POST_...2,SET,180,-0.00078211,-7.7064e-05,0.061701,0.50506,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP,0.99999
WP_FERROPTOSIS,SET,56,-0.0015353,-8.4665e-05,0.11975,0.50511,WP_FERROPTOSIS,0.99999
GOBP_NEUTROPHIL_MEDIATED_KIL...2,SET,13,-0.0035543,-9.4549e-05,0.27688,0.50512,GOBP_NEUTROPHIL_MEDIATED_KILLING_OF_SYMBIONT_CELL,0.99999
HP_ABNORMALITY_OF_THE_URETER,SET,328,-0.00060852,-8.0609e-05,0.047041,0.50516,HP_ABNORMALITY_OF_THE_URETER,0.99999
GOCC_PI_BODY,SET,9,-0.0036771,-8.1398e-05,0.28317,0.50518,GOCC_PI_BODY,0.99999
GSE29618_PRE_VS_DAY7_FLU_VAC...6,SET,170,-0.00087213,-8.3536e-05,0.066282,0.50525,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP,0.99999
GOBP_PROXIMAL_DISTAL_PATTERN...2,SET,5,-0.006385,-0.00010536,0.47372,0.50538,GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION_INVOLVED_IN_NEPHRON_DEVELOPMENT,0.99999
chr13q22,SET,14,-0.0052187,-0.00014406,0.3853,0.5054,chr13q22,0.99999
WP_ETHANOL_EFFECTS_ON_HISTON...,SET,29,-0.0021453,-8.5197e-05,0.15635,0.50547,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,0.99999
GOBP_GMP_BIOSYNTHETIC_PROCESS,SET,13,-0.0031947,-8.4983e-05,0.23228,0.50549,GOBP_GMP_BIOSYNTHETIC_PROCESS,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...13,SET,189,-0.00091136,-9.1994e-05,0.065774,0.50553,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN,0.99999
ZHENG_CORD_BLOOD_C9_GRANULOC...,SET,90,-0.0012261,-8.5638e-05,0.087563,0.50559,ZHENG_CORD_BLOOD_C9_GRANULOCYTE_MACROPHAGE_PROGENITOR,0.99999
NKX3A_01,SET,205,-0.00089755,-9.4316e-05,0.063888,0.5056,NKX3A_01,0.99999
GOBP_POSITIVE_REGULATION_OF_...190,SET,4,-0.0049488,-7.3042e-05,0.35099,0.50562,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATIONAL_INITIATION,0.99999
GSE18893_CTRL_VS_TNF_TREATED...8,SET,178,-0.00092593,-9.0732e-05,0.065602,0.50563,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...15,SET,182,-0.00092029,-9.1177e-05,0.064379,0.5057,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_DN,0.99999
GOBP_SULFUR_AMINO_ACID_CATAB...,SET,9,-0.0042573,-9.4241e-05,0.29423,0.50577,GOBP_SULFUR_AMINO_ACID_CATABOLIC_PROCESS,0.99999
MIR10526_3P,SET,105,-0.0012124,-9.1426e-05,0.083743,0.50578,MIR10526_3P,0.99999
GOBP_TERTIARY_ALCOHOL_METABO...,SET,22,-0.0030694,-0.00010619,0.21201,0.50578,GOBP_TERTIARY_ALCOHOL_METABOLIC_PROCESS,0.99999
GSE14000_UNSTIM_VS_16H_LPS_D...1,SET,174,-0.00093728,-9.0816e-05,0.06467,0.50578,GSE14000_UNSTIM_VS_16H_LPS_DC_DN,0.99999
WP_JAKSTAT_SIGNALING_IN_THE_...,SET,34,-0.0022404,-9.6329e-05,0.15438,0.50579,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,0.99999
PID_SYNDECAN_1_PATHWAY,SET,43,-0.0020066,-9.6999e-05,0.13764,0.50582,PID_SYNDECAN_1_PATHWAY,0.99999
REACTOME_DEFECTIVE_C1GALT1C1...,SET,14,-0.0035636,-9.8372e-05,0.24423,0.50582,REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS,0.99999
REACTOME_Z_DECAY_DEGRADATION...,SET,10,-0.0038343,-8.9466e-05,0.26278,0.50582,REACTOME_Z_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_ZYGOTICALLY_EXPRESSED_FACTORS,0.99999
GOBP_POSITIVE_REGULATION_OF_...826,SET,14,-0.0039872,-0.00011007,0.27215,0.50584,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,0.99999
GSE10147_IL3_AND_HIVP17_VS_I...2,SET,132,-0.00114,-9.6316e-05,0.077771,0.50585,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP,0.99999
GSE11924_TH1_VS_TH17_CD4_TCE...2,SET,182,-0.0009347,-9.2605e-05,0.063469,0.50587,GSE11924_TH1_VS_TH17_CD4_TCELL_UP,0.99999
GOBP_REGULATION_OF_LYMPHOID_...,SET,12,-0.003439,-8.7895e-05,0.23269,0.5059,GOBP_REGULATION_OF_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION,0.99999
GSE8685_IL2_STARVED_VS_IL15_...1,SET,178,-0.00093371,-9.1494e-05,0.063032,0.50591,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,0.99999
ROVERSI_GLIOMA_COPY_NUMBER_DN,SET,51,-0.0022182,-0.00011675,0.14867,0.50595,ROVERSI_GLIOMA_COPY_NUMBER_DN,0.99999
GOBP_MAINTENANCE_OF_PROTEIN_...1,SET,12,-0.0034401,-8.7924e-05,0.23038,0.50596,GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ENDOPLASMIC_RETICULUM,0.99999
GOMF_GLUTATHIONE_PEROXIDASE_...,SET,21,-0.0029611,-0.00010009,0.19807,0.50596,GOMF_GLUTATHIONE_PEROXIDASE_ACTIVITY,0.99999
WP_MICROTUBULE_CYTOSKELETON_...,SET,48,-0.0018233,-9.311e-05,0.11974,0.50607,WP_MICROTUBULE_CYTOSKELETON_REGULATION,0.99999
REACTOME_CELL_CELL_COMMUNICA...,SET,139,-0.0012053,-0.00010448,0.078036,0.50616,REACTOME_CELL_CELL_COMMUNICATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_PRO...4,SET,204,-0.00098889,-0.00010366,0.063956,0.50617,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_3_CELL,0.99999
GOBP_IMPORT_INTO_THE_MITOCHO...,SET,45,-0.0018346,-9.0721e-05,0.11839,0.50618,GOBP_IMPORT_INTO_THE_MITOCHONDRION,0.99999
REACTOME_EGFR_DOWNREGULATION,SET,29,-0.0026067,-0.00010352,0.16736,0.50621,REACTOME_EGFR_DOWNREGULATION,0.99999
GOCC_ACTIVIN_RECEPTOR_COMPLEX,SET,6,-0.0049409,-8.9309e-05,0.31593,0.50624,GOCC_ACTIVIN_RECEPTOR_COMPLEX,0.99999
GSE1925_3H_VS_24H_IFNG_STIM_...2,SET,187,-0.00099549,-9.9959e-05,0.06332,0.50627,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,0.99999
TGACCTY_ERR1_Q2,SET,933,-0.00045383,-9.9677e-05,0.028809,0.50628,TGACCTY_ERR1_Q2,0.99999
GSE20715_0H_VS_6H_OZONE_LUNG...2,SET,182,-0.0010088,-9.995e-05,0.064123,0.50628,GSE20715_0H_VS_6H_OZONE_LUNG_UP,0.99999
HP_COMPENSATED_HYPOTHYROIDISM,SET,9,-0.0046242,-0.00010236,0.29329,0.50629,HP_COMPENSATED_HYPOTHYROIDISM,0.99999
HP_ABDOMINAL_OBESITY,SET,24,-0.002869,-0.00010367,0.18094,0.50633,HP_ABDOMINAL_OBESITY,0.99999
MARIADASON_RESPONSE_TO_CURCU...1,SET,22,-0.0027028,-9.3509e-05,0.17004,0.50634,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5,0.99999
GSE11961_PLASMA_CELL_DAY7_VS...1,SET,187,-0.00097097,-9.7497e-05,0.061021,0.50635,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.99999
GSE7568_CTRL_VS_24H_TGFB_TRE...2,SET,180,-0.00099717,-9.8254e-05,0.062667,0.50635,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,0.99999
GSE18893_TCONV_VS_TREG_24H_T...1,SET,169,-0.0010117,-9.6626e-05,0.062869,0.50642,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN,0.99999
KEGG_MEDICUS_REFERENCE_CD80_...1,SET,10,-0.0043828,-0.00010226,0.27167,0.50644,KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY,0.99999
ACEVEDO_LIVER_CANCER_WITH_H3...2,SET,229,-0.0010488,-0.00011641,0.064372,0.5065,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,0.99999
MURARO_PANCREAS_DELTA_CELL,SET,222,-0.0010407,-0.00011374,0.063594,0.50653,MURARO_PANCREAS_DELTA_CELL,0.99999
HP_ABNORMALITY_OF_THE_LOWER_...,SET,739,-0.00051891,-0.00010199,0.031464,0.50658,HP_ABNORMALITY_OF_THE_LOWER_URINARY_TRACT,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...62,SET,44,-0.0023511,-0.00011497,0.14254,0.50658,HP_APLASIA_HYPOPLASIA_OF_THE_RETINA,0.99999
GSE5589_LPS_VS_LPS_AND_IL6_S...1,SET,180,-0.0010151,-0.00010002,0.061327,0.5066,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,0.99999
GOBP_CALCIUM_ION_TRANSMEMBRA...1,SET,172,-0.0011379,-0.00010963,0.06844,0.50663,GOBP_CALCIUM_ION_TRANSMEMBRANE_IMPORT_INTO_CYTOSOL,0.99999
GOBP_PROTEIN_INSERTION_INTO_...5,SET,10,-0.004033,-9.4101e-05,0.2411,0.50667,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_INNER_MEMBRANE,0.99999
GSE360_HIGH_DOSE_B_MALAYI_VS...4,SET,187,-0.00098762,-9.9168e-05,0.058813,0.5067,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,0.99999
GOCC_CALCINEURIN_COMPLEX,SET,6,-0.0049034,-8.8631e-05,0.28877,0.50677,GOCC_CALCINEURIN_COMPLEX,0.99999
HP_FRAGILE_NAILS,SET,23,-0.0029966,-0.000106,0.17571,0.5068,HP_FRAGILE_NAILS,0.99999
GSE17721_12H_VS_24H_PAM3CSK4...2,SET,180,-0.0010627,-0.00010471,0.062283,0.50681,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_UP,0.99999
GOBP_RETROGRADE_TRANS_SYNAPT...1,SET,9,-0.0055649,-0.00012319,0.32491,0.50683,GOBP_RETROGRADE_TRANS_SYNAPTIC_SIGNALING,0.99999
KEGG_MEDICUS_REFERENCE_FASLG...,SET,5,-0.0074086,-0.00012225,0.43147,0.50685,KEGG_MEDICUS_REFERENCE_FASLG_RIPK1_3_SIGNALING_PATHWAY,0.99999
HP_CONJUNCTIVAL_HAMARTOMA,SET,10,-0.00397,-9.2632e-05,0.23047,0.50687,HP_CONJUNCTIVAL_HAMARTOMA,0.99999
YAUCH_HEDGEHOG_SIGNALING_PAR...2,SET,132,-0.0013644,-0.00011528,0.079158,0.50688,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,0.99999
WP_GLYCOSAMINOGLYCAN_DEGRADA...,SET,16,-0.0038252,-0.00011288,0.22156,0.50689,WP_GLYCOSAMINOGLYCAN_DEGRADATION,0.99999
GOBP_DETECTION_OF_LIGHT_STIM...1,SET,58,-0.0020011,-0.0001123,0.11548,0.50691,GOBP_DETECTION_OF_LIGHT_STIMULUS,0.99999
MURATA_VIRULENCE_OF_H_PILORI,SET,20,-0.0035294,-0.00011643,0.20268,0.50695,MURATA_VIRULENCE_OF_H_PILORI,0.99999
GSE41867_NAIVE_VS_DAY6_LCMV_...3,SET,179,-0.0011041,-0.0001085,0.063303,0.50696,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN,0.99999
GOBP_MESANGIAL_CELL_DEVELOPM...,SET,5,-0.0073317,-0.00012098,0.41797,0.507,GOBP_MESANGIAL_CELL_DEVELOPMENT,0.99999
MIR6796_3P,SET,55,-0.0019992,-0.00010926,0.11371,0.50701,MIR6796_3P,0.99999
GOBP_REGULATION_OF_TERMINATI...,SET,5,-0.0070766,-0.00011677,0.39558,0.50714,GOBP_REGULATION_OF_TERMINATION_OF_DNA_TEMPLATED_TRANSCRIPTION,0.99999
GSE22935_WT_VS_MYD88_KO_MACR...4,SET,180,-0.0010943,-0.00010782,0.060498,0.50722,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_UP,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...5,SET,163,-0.0012002,-0.00011259,0.065908,0.50726,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN,0.99999
KYNG_DNA_DAMAGE_DN,SET,171,-0.0011725,-0.00011263,0.064329,0.50727,KYNG_DNA_DAMAGE_DN,0.99999
BLANCO_MELO_INFLUENZA_A_INFE...2,SET,37,-0.0026237,-0.00011767,0.14351,0.50729,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,0.99999
MIR140_3P,SET,129,-0.0013848,-0.00011568,0.075604,0.50731,MIR140_3P,0.99999
GOBP_EPIGENETIC_PROGRAMING_O...,SET,4,-0.0083424,-0.00012313,0.45502,0.50731,GOBP_EPIGENETIC_PROGRAMING_OF_MALE_PRONUCLEUS,0.99999
HP_PERSEVERATIVE_THOUGHT,SET,19,-0.0034804,-0.00011191,0.18895,0.50735,HP_PERSEVERATIVE_THOUGHT,0.99999
MIR6741_5P,SET,22,-0.0030574,-0.00010578,0.16545,0.50737,MIR6741_5P,0.99999
GSE23114_WT_VS_SLE2C1_MOUSE_...1,SET,167,-0.0012655,-0.00012015,0.067489,0.50748,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_DN,0.99999
GOMF_LBD_DOMAIN_BINDING,SET,6,-0.0079745,-0.00014414,0.41788,0.50761,GOMF_LBD_DOMAIN_BINDING,0.99999
MODULE_299,SET,34,-0.0025306,-0.0001088,0.13242,0.50762,MODULE_299,0.99999
GOBP_POSITIVE_REGULATION_OF_...181,SET,14,-0.0042418,-0.00011709,0.2218,0.50763,GOBP_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.99999
GOBP_HOMOSERINE_METABOLIC_PR...,SET,3,-0.010092,-0.000129,0.52531,0.50766,GOBP_HOMOSERINE_METABOLIC_PROCESS,0.99999
MODULE_360,SET,12,-0.0051525,-0.00013169,0.26793,0.50767,MODULE_360,0.99999
HP_CUTANEOUS_SYNDACTYLY_OF_T...,SET,25,-0.003357,-0.0001238,0.17467,0.50767,HP_CUTANEOUS_SYNDACTYLY_OF_TOES,0.99999
GOBP_SNRNA_TRANSCRIPTION,SET,20,-0.0033966,-0.00011205,0.17651,0.50768,GOBP_SNRNA_TRANSCRIPTION,0.99999
GSE21927_SPLEEN_C57BL6_VS_EL...1,SET,184,-0.0011335,-0.0001129,0.058416,0.50774,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_DN,0.99999
GOBP_REGULATION_OF_MYOBLAST_...3,SET,15,-0.0040981,-0.0001171,0.21078,0.50776,GOBP_REGULATION_OF_MYOBLAST_PROLIFERATION,0.99999
REACTOME_REGULATION_OF_TP53_...5,SET,87,-0.0017069,-0.00011722,0.087265,0.5078,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,0.99999
GOBP_RESPONSE_TO_TEMPERATURE...,SET,160,-0.0013106,-0.00012182,0.066936,0.50781,GOBP_RESPONSE_TO_TEMPERATURE_STIMULUS,0.99999
WP_CARDIAC_HYPERTROPHIC_RESP...,SET,53,-0.0024007,-0.00012881,0.12183,0.50786,WP_CARDIAC_HYPERTROPHIC_RESPONSE,0.99999
GOBP_MICROVILLUS_ASSEMBLY,SET,19,-0.0043055,-0.00013844,0.21838,0.50786,GOBP_MICROVILLUS_ASSEMBLY,0.99999
HES2_TARGET_GENES,SET,1001,-0.00055898,-0.00012692,0.028309,0.50788,HES2_TARGET_GENES,0.99999
AKT_UP_MTOR_DN.V1_UP,SET,165,-0.001359,-0.00012826,0.068266,0.50794,AKT_UP_MTOR_DN.V1_UP,0.99999
GOBP_SPONTANEOUS_NEUROTRANSM...,SET,7,-0.0069464,-0.00013562,0.34866,0.50795,GOBP_SPONTANEOUS_NEUROTRANSMITTER_SECRETION,0.99999
HP_ELEVATED_MEAN_ARTERIAL_PR...,SET,10,-0.0056214,-0.00013116,0.28197,0.50795,HP_ELEVATED_MEAN_ARTERIAL_PRESSURE,0.99999
HP_ACEPHALIC_SPERMATOZOA,SET,7,-0.0072508,-0.00014156,0.3632,0.50796,HP_ACEPHALIC_SPERMATOZOA,0.99999
WANG_METASTASIS_OF_BREAST_CA...3,SET,19,-0.0032969,-0.00010601,0.16338,0.50805,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP,0.99999
GOBP_DOLICHYL_DIPHOSPHATE_ME...,SET,4,-0.0086663,-0.00012791,0.4297,0.50805,GOBP_DOLICHYL_DIPHOSPHATE_METABOLIC_PROCESS,0.99999
GOBP_MEIOTIC_CELL_CYCLE,SET,249,-0.0010328,-0.00011946,0.05081,0.50811,GOBP_MEIOTIC_CELL_CYCLE,0.99999
KEGG_MEDICUS_REFERENCE_HIF_1...,SET,9,-0.0062815,-0.00013905,0.30852,0.50812,KEGG_MEDICUS_REFERENCE_HIF_1_SIGNALING_PATHWAY,0.99999
MORF_PPP2R5B,SET,156,-0.0014064,-0.00012909,0.068966,0.50813,MORF_PPP2R5B,0.99999
GSE3982_BCELL_VS_EFF_MEMORY_...1,SET,177,-0.0013411,-0.00013105,0.065625,0.50815,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN,0.99999
MIR3116,SET,87,-0.0018285,-0.00012558,0.089007,0.50819,MIR3116,0.99999
ZNF555_TARGET_GENES,SET,91,-0.0017553,-0.00012328,0.085279,0.50821,ZNF555_TARGET_GENES,0.99999
MIR1246,SET,47,-0.0025927,-0.00013102,0.12536,0.50825,MIR1246,0.99999
GOBP_RESPONSE_TO_BACTERIAL_L...,SET,8,-0.0065728,-0.00013718,0.31748,0.50826,GOBP_RESPONSE_TO_BACTERIAL_LIPOPROTEIN,0.99999
MIR450A_1_3P,SET,168,-0.0013892,-0.00013229,0.067028,0.50827,MIR450A_1_3P,0.99999
HP_SUPERNUMERARY_CUSP,SET,4,-0.0088025,-0.00012992,0.42387,0.50828,HP_SUPERNUMERARY_CUSP,0.99999
GSE18893_TCONV_VS_TREG_24H_C...1,SET,177,-0.0014163,-0.0001384,0.067825,0.50833,GSE18893_TCONV_VS_TREG_24H_CULTURE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...212,SET,120,-0.0017318,-0.00013955,0.082875,0.50834,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,0.99999
GOMF_NF_KAPPAB_BINDING,SET,28,-0.0031615,-0.00012337,0.15118,0.50834,GOMF_NF_KAPPAB_BINDING,0.99999
GSE25146_UNSTIM_VS_HELIOBACT...2,SET,165,-0.0013153,-0.00012414,0.062881,0.50834,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP,0.99999
GOBP_TRACHEA_CARTILAGE_DEVEL...,SET,7,-0.0068975,-0.00013466,0.32824,0.50838,GOBP_TRACHEA_CARTILAGE_DEVELOPMENT,0.99999
HP_MOTOR_DETERIORATION,SET,27,-0.0034223,-0.00013115,0.16288,0.50838,HP_MOTOR_DETERIORATION,0.99999
SIRNA_EIF4GI_DN,SET,84,-0.0020275,-0.00013683,0.096487,0.50838,SIRNA_EIF4GI_DN,0.99999
HP_DUPLICATION_OF_THE_DISTAL...1,SET,12,-0.0050755,-0.00012972,0.23949,0.50845,HP_DUPLICATION_OF_THE_DISTAL_PHALANX_OF_HAND,0.99999
REACTOME_PKA_MEDIATED_PHOSPH...1,SET,19,-0.0045381,-0.00014592,0.21404,0.50846,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,0.99999
GSE27786_LIN_NEG_VS_NKCELL_DN,SET,180,-0.0012914,-0.00012725,0.060874,0.50846,GSE27786_LIN_NEG_VS_NKCELL_DN,0.99999
HP_STROKE_LIKE_EPISODE,SET,12,-0.005241,-0.00013395,0.24612,0.50849,HP_STROKE_LIKE_EPISODE,0.99999
BIOCARTA_IGF1_PATHWAY,SET,20,-0.0040161,-0.00013249,0.18727,0.50855,BIOCARTA_IGF1_PATHWAY,0.99999
WP_PURINERGIC_SIGNALING,SET,29,-0.0034621,-0.0001375,0.16134,0.50856,WP_PURINERGIC_SIGNALING,0.99999
MIR6738_5P,SET,25,-0.0038531,-0.00014209,0.17953,0.50856,MIR6738_5P,0.99999
GOBP_REGULATION_OF_CALCIUM_I...3,SET,5,-0.009651,-0.00015925,0.44872,0.50858,GOBP_REGULATION_OF_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GOBP_POSITIVE_REGULATION_OF_...694,SET,9,-0.0065475,-0.00014494,0.303,0.50862,GOBP_POSITIVE_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,0.99999
REACTOME_ESTROGEN_DEPENDENT_...1,SET,87,-0.0019449,-0.00013357,0.089791,0.50864,REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,0.99999
MIR6728_5P,SET,66,-0.0022542,-0.00013492,0.10411,0.50864,MIR6728_5P,0.99999
GEORGES_TARGETS_OF_MIR192_AN...,SET,796,-0.00067403,-0.00013728,0.030928,0.50869,GEORGES_TARGETS_OF_MIR192_AND_MIR215,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...17,SET,7,-0.0077357,-0.00015103,0.35488,0.5087,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP,0.99999
GOMF_PHOSPHOFRUCTOKINASE_ACT...,SET,6,-0.0060266,-0.00010893,0.27305,0.5088,GOMF_PHOSPHOFRUCTOKINASE_ACTIVITY,0.99999
GOBP_RESPONSE_TO_ZINC_ION,SET,44,-0.0030349,-0.0001484,0.13739,0.50881,GOBP_RESPONSE_TO_ZINC_ION,0.99999
GOCC_PRESYNAPSE,SET,524,-0.0008587,-0.00014299,0.038821,0.50882,GOCC_PRESYNAPSE,0.99999
GSE12839_CTRL_VS_IL12_TREATE...1,SET,111,-0.0018062,-0.00014002,0.081356,0.50886,GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN,0.99999
GOMF_STRUCTURAL_MOLECULE_ACT...2,SET,12,-0.0059045,-0.00015091,0.2647,0.5089,GOMF_STRUCTURAL_MOLECULE_ACTIVITY_CONFERRING_ELASTICITY,0.99999
chr18q22,SET,23,-0.0067569,-0.00023902,0.30222,0.50892,chr18q22,0.99999
REACTOME_DIGESTION_AND_ABSOR...,SET,22,-0.0046684,-0.00016151,0.20816,0.50895,REACTOME_DIGESTION_AND_ABSORPTION,0.99999
GOBP_MAMMARY_GLAND_FORMATION,SET,7,-0.0084771,-0.0001655,0.3778,0.50895,GOBP_MAMMARY_GLAND_FORMATION,0.99999
GSE13547_CTRL_VS_ANTI_IGM_ST...1,SET,151,-0.0015566,-0.00014059,0.068748,0.50903,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...666,SET,38,-0.0035056,-0.00015933,0.15409,0.50907,GOBP_NEGATIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION,0.99999
GOBP_MITOCHONDRIAL_ATP_TRANS...,SET,6,-0.0087056,-0.00015736,0.38253,0.50908,GOBP_MITOCHONDRIAL_ATP_TRANSMEMBRANE_TRANSPORT,0.99999
WP_PROTEOGLYCAN_BIOSYNTHESIS,SET,17,-0.0048669,-0.00014803,0.21246,0.50914,WP_PROTEOGLYCAN_BIOSYNTHESIS,0.99999
GOBP_ERK5_CASCADE,SET,3,-0.010427,-0.00013328,0.4513,0.50922,GOBP_ERK5_CASCADE,0.99999
WP_DISORDERS_OF_FRUCTOSE_MET...,SET,12,-0.0051056,-0.00013049,0.22029,0.50925,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,0.99999
GSE14026_TH1_VS_TH17_UP,SET,178,-0.0014661,-0.00014366,0.063201,0.50925,GSE14026_TH1_VS_TH17_UP,0.99999
FOXO4_02,SET,239,-0.0013467,-0.00015266,0.058009,0.50926,FOXO4_02,0.99999
GOBP_POSITIVE_REGULATION_OF_...454,SET,6,-0.0085188,-0.00015398,0.36712,0.50926,GOBP_POSITIVE_REGULATION_OF_MESENCHYMAL_STEM_CELL_PROLIFERATION,0.99999
GSE16385_IFNG_TNF_VS_IL4_STI...3,SET,161,-0.0015793,-0.00014725,0.067428,0.50934,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,0.99999
HP_HYPERCALCEMIA,SET,63,-0.0026319,-0.00015391,0.11036,0.50951,HP_HYPERCALCEMIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...730,SET,20,-0.0040698,-0.00013426,0.17028,0.50953,GOBP_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.99999
HP_ABNORMALITY_OF_THE_MITOCH...,SET,190,-0.0013664,-0.00013829,0.057195,0.50953,HP_ABNORMALITY_OF_THE_MITOCHONDRION,0.99999
GSE17721_CTRL_VS_CPG_2H_BMDC...2,SET,176,-0.0015496,-0.000151,0.064827,0.50954,GSE17721_CTRL_VS_CPG_2H_BMDC_UP,0.99999
GOMF_SERINE_TYPE_EXOPEPTIDAS...,SET,12,-0.0057987,-0.00014821,0.24142,0.50958,GOMF_SERINE_TYPE_EXOPEPTIDASE_ACTIVITY,0.99999
WP_THYROID_STIMULATING_HORMO...,SET,66,-0.0027578,-0.00016506,0.11424,0.50963,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,0.99999
MIR3185,SET,188,-0.0015277,-0.0001538,0.063082,0.50966,MIR3185,0.99999
GOBP_PTERIDINE_CONTAINING_CO...2,SET,33,-0.0033633,-0.00014247,0.13807,0.50972,GOBP_PTERIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
HP_HYPOPIGMENTED_MACULE,SET,24,-0.0040247,-0.00014543,0.16494,0.50973,HP_HYPOPIGMENTED_MACULE,0.99999
NAKAYA_PBMC_FLUARIX_FLUVIRIN...2,SET,564,-0.00086869,-0.00014991,0.035508,0.50976,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP,0.99999
GOCC_TERTIARY_GRANULE,SET,147,-0.0017754,-0.00015823,0.072333,0.50979,GOCC_TERTIARY_GRANULE,0.99999
GSE4984_GALECTIN1_VS_VEHICLE...2,SET,164,-0.0015581,-0.00014661,0.063286,0.50982,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_UP,0.99999
GSE14308_TH1_VS_INDUCED_TREG...2,SET,180,-0.0015167,-0.00014944,0.061419,0.50985,GSE14308_TH1_VS_INDUCED_TREG_UP,0.99999
GOBP_VENTRICULAR_CARDIAC_MUS...3,SET,14,-0.0065083,-0.00017966,0.263,0.50987,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.99999
KEGG_MEDICUS_REFERENCE_LESIO...,SET,12,-0.004609,-0.0001178,0.18566,0.5099,KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION,0.99999
WP_ESTROGEN_SIGNALING,SET,21,-0.0047269,-0.00015978,0.18969,0.50994,WP_ESTROGEN_SIGNALING,0.99999
GOBP_L_PHENYLALANINE_METABOL...,SET,8,-0.0082331,-0.00017183,0.33002,0.50995,GOBP_L_PHENYLALANINE_METABOLIC_PROCESS,0.99999
REACTOME_SUMOYLATION_OF_CHRO...,SET,53,-0.0028774,-0.00015438,0.11516,0.50997,REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,0.99999
GOCC_SPLICEOSOMAL_COMPLEX,SET,178,-0.0014639,-0.00014344,0.058593,0.50997,GOCC_SPLICEOSOMAL_COMPLEX,0.99999
CATGTAA_MIR496,SET,161,-0.0016909,-0.00015766,0.067396,0.51001,CATGTAA_MIR496,0.99999
GOBP_CLATHRIN_COATED_VESICLE...,SET,7,-0.0079632,-0.00015547,0.31688,0.51002,GOBP_CLATHRIN_COATED_VESICLE_CARGO_LOADING,0.99999
REACTOME_SIGNALING_BY_NODAL,SET,19,-0.0050546,-0.00016253,0.20028,0.51007,REACTOME_SIGNALING_BY_NODAL,0.99999
GOBP_APOPTOTIC_SIGNALING_PAT...,SET,558,-0.00092014,-0.00015796,0.036461,0.51007,GOBP_APOPTOTIC_SIGNALING_PATHWAY,0.99999
MIR105_3P,SET,4,-0.013269,-0.00019584,0.52508,0.51008,MIR105_3P,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...1,SET,104,-0.0020434,-0.00015337,0.080793,0.51009,GAUTAM_EYE_IRIS_CILIARY_BODY_ACTIVATED_T_CELLS,0.99999
KEGG_ARRHYTHMOGENIC_RIGHT_VE...,SET,70,-0.0028375,-0.00017488,0.11187,0.51012,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,0.99999
WP_ARRHYTHMOGENIC_RIGHT_VENT...,SET,70,-0.0028375,-0.00017488,0.11187,0.51012,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,0.99999
GOBP_ASYMMETRIC_CELL_DIVISION,SET,18,-0.0054868,-0.00017172,0.21602,0.51013,GOBP_ASYMMETRIC_CELL_DIVISION,0.99999
JIANG_AGING_CEREBRAL_CORTEX_...2,SET,31,-0.0040716,-0.00016717,0.16001,0.51015,JIANG_AGING_CEREBRAL_CORTEX_UP,0.99999
LEE_LIVER_CANCER_DENA_UP,SET,56,-0.0030999,-0.00017095,0.1218,0.51015,LEE_LIVER_CANCER_DENA_UP,0.99999
GOMF_PHOSPHATIDYLCHOLINE_TRA...2,SET,18,-0.0052643,-0.00016476,0.20651,0.51017,GOMF_PHOSPHATIDYLCHOLINE_TRANSPORTER_ACTIVITY,0.99999
DESCARTES_MAIN_FETAL_LYMPHAT...,SET,64,-0.0029098,-0.00017151,0.11359,0.51022,DESCARTES_MAIN_FETAL_LYMPHATIC_ENDOTHELIAL_CELLS,0.99999
MORF_RUNX1,SET,139,-0.0018017,-0.00015618,0.070222,0.51023,MORF_RUNX1,0.99999
REACTOME_CREB1_PHOSPHORYLATI...2,SET,11,-0.0072281,-0.00017688,0.28149,0.51024,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE,0.99999
GOBP_IMPORT_ACROSS_PLASMA_ME...,SET,184,-0.0017231,-0.00017164,0.067078,0.51025,GOBP_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GSE26351_UNSTIM_VS_WNT_PATHW...1,SET,175,-0.0016426,-0.00015961,0.063194,0.51037,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,0.99999
GOMF_NFAT_PROTEIN_BINDING,SET,5,-0.0098708,-0.00016288,0.37676,0.51045,GOMF_NFAT_PROTEIN_BINDING,0.99999
GOBP_DNA_RECOMBINATION,SET,284,-0.0012598,-0.00015547,0.047851,0.5105,GOBP_DNA_RECOMBINATION,0.99999
HP_IRREGULAR_ILIAC_CREST,SET,6,-0.0098408,-0.00017788,0.3722,0.51055,HP_IRREGULAR_ILIAC_CREST,0.99999
GSE17721_LPS_VS_CPG_1H_BMDC_...2,SET,180,-0.0016104,-0.00015868,0.060592,0.5106,GSE17721_LPS_VS_CPG_1H_BMDC_UP,0.99999
GSE12003_4D_VS_8D_CULTURE_BM...1,SET,127,-0.0019427,-0.00016102,0.072477,0.51069,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN,0.99999
HP_RADIAL_DEVIATION_OF_FINGER,SET,43,-0.0034444,-0.0001665,0.12804,0.51073,HP_RADIAL_DEVIATION_OF_FINGER,0.99999
MORF_PPP2R4,SET,44,-0.0031862,-0.0001558,0.11822,0.51075,MORF_PPP2R4,0.99999
HP_ABNORMALITY_OF_THE_URETHRA,SET,375,-0.0011778,-0.00016661,0.043361,0.51083,HP_ABNORMALITY_OF_THE_URETHRA,0.99999
RUBENSTEIN_SKELETAL_MUSCLE_M...,SET,306,-0.0013322,-0.00017056,0.049044,0.51084,RUBENSTEIN_SKELETAL_MUSCLE_MYELOID_CELLS,0.99999
GSE16266_CTRL_VS_HEATSHOCK_A...2,SET,173,-0.0017379,-0.00016791,0.063274,0.51096,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,0.99999
HP_ABNORMAL_BLOOD_CHLORIDE_C...,SET,10,-0.0082965,-0.00019358,0.30091,0.511,HP_ABNORMAL_BLOOD_CHLORIDE_CONCENTRATION,0.99999
GOBP_RESPONSE_TO_YEAST,SET,6,-0.010773,-0.00019473,0.38934,0.51104,GOBP_RESPONSE_TO_YEAST,0.99999
GOBP_REGULATION_OF_RECEPTOR_...5,SET,16,-0.0056414,-0.00016647,0.2033,0.51107,GOBP_REGULATION_OF_RECEPTOR_LOCALIZATION_TO_SYNAPSE,0.99999
GSE3982_DC_VS_EFF_MEMORY_CD4...2,SET,187,-0.0017697,-0.00017769,0.063356,0.51114,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
DESERT_PERIVENOUS_HEPATOCELL...,SET,143,-0.0020541,-0.00018059,0.073235,0.51119,DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.99999
KEGG_MEDICUS_PATHOGEN_ESCHER...4,SET,5,-0.012317,-0.00020325,0.4389,0.51119,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPJ_TO_IGG_FCGR_RAC_SIGNALING_PATHWAY,0.99999
REACTOME_GLYCINE_DEGRADATION,SET,7,-0.0072917,-0.00014236,0.2599,0.51119,REACTOME_GLYCINE_DEGRADATION,0.99999
HP_RESTING_TREMOR,SET,45,-0.0034558,-0.00017088,0.12302,0.51121,HP_RESTING_TREMOR,0.99999
ZWANG_CLASS_1_TRANSIENTLY_IN...,SET,454,-0.0011923,-0.00018516,0.042405,0.51122,ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF,0.99999
WP_ROBO4_AND_VEGF_SIGNALING_...,SET,6,-0.010693,-0.00019328,0.37982,0.51123,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,0.99999
GOBP_REGULATION_OF_DEVELOPME...1,SET,271,-0.0015777,-0.00019027,0.055894,0.51126,GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH,0.99999
GOBP_POSITIVE_REGULATION_OF_...492,SET,125,-0.002097,-0.00017245,0.074141,0.51128,GOBP_POSITIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,0.99999
MIR200C_5P,SET,58,-0.0033504,-0.00018802,0.11787,0.51134,MIR200C_5P,0.99999
GOBP_GERM_CELL_MIGRATION,SET,9,-0.0093358,-0.00020666,0.32821,0.51135,GOBP_GERM_CELL_MIGRATION,0.99999
GOBP_CELL_PROLIFERATION_IN_B...,SET,8,-0.0087048,-0.00018168,0.30532,0.51137,GOBP_CELL_PROLIFERATION_IN_BONE_MARROW,0.99999
ZWANG_TRANSIENTLY_UP_BY_2ND_...,SET,1329,-0.00071557,-0.00018543,0.025065,0.51139,ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY,0.99999
GOBP_THYROID_GLAND_DEVELOPME...,SET,30,-0.0046123,-0.0001863,0.16124,0.51141,GOBP_THYROID_GLAND_DEVELOPMENT,0.99999
GSE20754_WT_VS_TCF1_KO_MEMOR...1,SET,179,-0.0018656,-0.00018332,0.065169,0.51142,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN,0.99999
GOBP_RRNA_MODIFICATION,SET,25,-0.0042587,-0.00015705,0.14861,0.51143,GOBP_RRNA_MODIFICATION,0.99999
GOBP_REGULATION_OF_METANEPHR...,SET,5,-0.013126,-0.0002166,0.45686,0.51146,GOBP_REGULATION_OF_METANEPHROS_DEVELOPMENT,0.99999
GOMF_PROTEIN_GLUTAMINE_GAMMA...,SET,9,-0.0088884,-0.00019676,0.3084,0.5115,GOMF_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY,0.99999
HP_IRREGULAR_ACETABULAR_ROOF,SET,6,-0.0091657,-0.00016568,0.31802,0.5115,HP_IRREGULAR_ACETABULAR_ROOF,0.99999
KEGG_MEDICUS_REFERENCE_MICRO...2,SET,19,-0.0058428,-0.00018787,0.1998,0.51166,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...47,SET,20,-0.0055053,-0.00018161,0.1877,0.5117,GOBP_NEGATIVE_REGULATION_OF_BLOOD_CIRCULATION,0.99999
HP_UNILATERAL_CLEFT_LIP,SET,8,-0.0075048,-0.00015663,0.25401,0.51178,HP_UNILATERAL_CLEFT_LIP,0.99999
TERF2_TARGET_GENES,SET,97,-0.002539,-0.00018407,0.085882,0.51179,TERF2_TARGET_GENES,0.99999
HOEK_B_CELL_2011_2012_TIV_AD...2,SET,3,-0.015013,-0.0001919,0.50624,0.51183,HOEK_B_CELL_2011_2012_TIV_ADULT_3DY_DN,0.99999
BLANCO_MELO_SARS_COV_1_INFEC...2,SET,11,-0.0071987,-0.00017616,0.24202,0.51186,BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP,0.99999
MIR29A_5P,SET,183,-0.0019114,-0.00018988,0.064182,0.51188,MIR29A_5P,0.99999
HP_DUPLICATION_OF_PHALANX_OF...,SET,12,-0.0064563,-0.00016501,0.21682,0.51188,HP_DUPLICATION_OF_PHALANX_OF_TOE,0.99999
NAKAYA_PBMC_FLUARIX_FLUVIRIN...7,SET,423,-0.0012338,-0.00018511,0.04128,0.51192,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE,0.99999
YBX3_TARGET_GENES,SET,52,-0.0034397,-0.00018281,0.11499,0.51193,YBX3_TARGET_GENES,0.99999
GOBP_POSITIVE_REGULATION_OF_...648,SET,114,-0.0024949,-0.000196,0.083432,0.51193,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_INSULIN_R...,SET,65,-0.0030994,-0.0001841,0.10331,0.51197,GOBP_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...14,SET,8,-0.009393,-0.00019604,0.31236,0.51199,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN,0.99999
HP_EPIPHYSEAL_DYSPLASIA,SET,28,-0.0049076,-0.00019152,0.1628,0.51202,HP_EPIPHYSEAL_DYSPLASIA,0.99999
GOBP_STEROL_BIOSYNTHETIC_PRO...,SET,53,-0.0034012,-0.00018248,0.11254,0.51205,GOBP_STEROL_BIOSYNTHETIC_PROCESS,0.99999
KAECH_NAIVE_VS_DAY8_EFF_CD8_...2,SET,185,-0.0018502,-0.0001848,0.061193,0.51206,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP,0.99999
KYNG_ENVIRONMENTAL_STRESS_RE...8,SET,48,-0.003659,-0.00018685,0.12084,0.51208,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,0.99999
GOBP_SYNAPTIC_VESICLE_MEMBRA...,SET,27,-0.0048467,-0.00018574,0.16008,0.51208,GOBP_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...489,SET,4,-0.015021,-0.0002217,0.49563,0.51209,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...490,SET,4,-0.015021,-0.0002217,0.49563,0.51209,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.99999
IBRAHIM_NRF2_DOWN,SET,129,-0.0022738,-0.00018993,0.074855,0.51212,IBRAHIM_NRF2_DOWN,0.99999
GOBP_POSITIVE_REGULATION_OF_...847,SET,60,-0.0034815,-0.00019871,0.11454,0.51212,GOBP_POSITIVE_REGULATION_OF_WOUND_HEALING,0.99999
chr14q13,SET,22,-0.0076993,-0.00026637,0.25315,0.51213,chr14q13,0.99999
KANNAN_TP53_TARGETS_UP,SET,55,-0.0033644,-0.00018388,0.11058,0.51214,KANNAN_TP53_TARGETS_UP,0.99999
GOBP_DIOL_BIOSYNTHETIC_PROCE...,SET,20,-0.0057355,-0.00018921,0.18851,0.51214,GOBP_DIOL_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMAL_INTERVERTEBRAL_D...,SET,39,-0.0039779,-0.00018315,0.13067,0.51214,HP_ABNORMAL_INTERVERTEBRAL_DISK_MORPHOLOGY,0.99999
HP_MULTIPLE_EXOSTOSES,SET,7,-0.010281,-0.00020071,0.33775,0.51214,HP_MULTIPLE_EXOSTOSES,0.99999
GOCC_AP_1_ADAPTOR_COMPLEX,SET,10,-0.008021,-0.00018715,0.26337,0.51215,GOCC_AP_1_ADAPTOR_COMPLEX,0.99999
GOMF_TRAIL_BINDING,SET,5,-0.015054,-0.00024841,0.49408,0.51215,GOMF_TRAIL_BINDING,0.99999
GOBP_REGULATION_OF_APOPTOTIC...3,SET,11,-0.0092957,-0.00022748,0.30465,0.51217,GOBP_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.99999
GSE17721_POLYIC_VS_CPG_0.5H_...2,SET,184,-0.0019247,-0.00019172,0.062381,0.51231,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_UP,0.99999
HP_RENAL_CORTICAL_CYSTS,SET,16,-0.0064042,-0.00018898,0.2072,0.51233,HP_RENAL_CORTICAL_CYSTS,0.99999
SHARMA_ASTROCYTOMA_WITH_NF1_...,SET,4,-0.013664,-0.00020167,0.44139,0.51235,SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM,0.99999
HP_FOCAL_MOTOR_STATUS_EPILEP...,SET,13,-0.0075468,-0.00020075,0.24331,0.51237,HP_FOCAL_MOTOR_STATUS_EPILEPTICUS,0.99999
GSE27786_NKTCELL_VS_ERYTHROB...2,SET,185,-0.0018869,-0.00018846,0.060764,0.51239,GSE27786_NKTCELL_VS_ERYTHROBLAST_UP,0.99999
GOBP_LUNG_CELL_DIFFERENTIATI...,SET,29,-0.0052832,-0.00020982,0.16987,0.51241,GOBP_LUNG_CELL_DIFFERENTIATION,0.99999
GSE11961_MEMORY_BCELL_DAY40_...2,SET,182,-0.0019366,-0.00019187,0.062209,0.51242,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.99999
HP_MEGAKARYOCYTOPENIA,SET,6,-0.010257,-0.00018541,0.32905,0.51243,HP_MEGAKARYOCYTOPENIA,0.99999
BLANCO_MELO_COVID19_SARS_COV...2,SET,68,-0.0034493,-0.00020954,0.11044,0.51246,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,0.99999
REACTOME_SUMOYLATION_OF_SUMO...,SET,33,-0.0043837,-0.00018569,0.14031,0.51246,REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS,0.99999
MIKKELSEN_MEF_LCP_WITH_H3K4M...,SET,112,-0.0025709,-0.0002002,0.081984,0.51251,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,0.99999
GOBP_APOPTOTIC_PROCESS,SET,1728,-0.00068291,-0.00019941,0.021657,0.51258,GOBP_APOPTOTIC_PROCESS,0.99999
GOCC_CULLIN_RING_UBIQUITIN_L...,SET,164,-0.0021028,-0.00019786,0.06643,0.51263,GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX,0.99999
HP_AMBIGUOUS_GENITALIA_FEMALE,SET,8,-0.010159,-0.00021204,0.31996,0.51266,HP_AMBIGUOUS_GENITALIA_FEMALE,0.99999
GSE35825_UNTREATED_VS_IFNG_S...2,SET,186,-0.0021479,-0.0002151,0.067609,0.51267,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP,0.99999
GOMF_PEPTIDE_HORMONE_RECEPTO...,SET,19,-0.0066451,-0.00021367,0.20783,0.51275,GOMF_PEPTIDE_HORMONE_RECEPTOR_BINDING,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...8,SET,99,-0.0029256,-0.00021426,0.090946,0.51283,GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS,0.99999
GSE2405_0H_VS_6H_A_PHAGOCYTO...1,SET,170,-0.0022141,-0.00021207,0.068801,0.51284,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.99999
GOBP_REGULATION_OF_CHRONIC_I...,SET,8,-0.0094868,-0.000198,0.29384,0.51288,GOBP_REGULATION_OF_CHRONIC_INFLAMMATORY_RESPONSE,0.99999
GSE43955_TGFB_IL6_VS_TGFB_IL...3,SET,180,-0.0020697,-0.00020393,0.064073,0.51288,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,0.99999
GOBP_PROTON_TRANSPORTING_V_T...,SET,6,-0.011512,-0.00020808,0.3552,0.51293,GOBP_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY,0.99999
BANG_VERTEPORFIN_ENDOMETRIAL...1,SET,13,-0.0070026,-0.00018628,0.21588,0.51294,BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_DN,0.99999
HP_ANARTHRIA,SET,15,-0.0063792,-0.00018227,0.19599,0.51298,HP_ANARTHRIA,0.99999
GSE17721_PAM3CSK4_VS_CPG_6H_...1,SET,186,-0.0020474,-0.00020504,0.062881,0.51299,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_DN,0.99999
MORF_PAX7,SET,242,-0.0018326,-0.00020902,0.056043,0.51304,MORF_PAX7,0.99999
BIOCARTA_PROTEASOME_PATHWAY,SET,17,-0.0056427,-0.00017163,0.17214,0.51307,BIOCARTA_PROTEASOME_PATHWAY,0.99999
STEGER_ADIPOGENESIS_UP,SET,21,-0.0065748,-0.00022224,0.20041,0.51309,STEGER_ADIPOGENESIS_UP,0.99999
HP_CYSTINURIA,SET,6,-0.015395,-0.00027827,0.46866,0.5131,HP_CYSTINURIA,0.99999
GSE21546_SAP1A_KO_VS_SAP1A_K...2,SET,178,-0.0021219,-0.00020792,0.064602,0.5131,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.99999
KEGG_MEDICUS_REFERENCE_CLASS...,SET,4,-0.016199,-0.00023908,0.49263,0.51312,KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,0.99999
HP_PROLONGED_BLEEDING_FOLLOW...1,SET,11,-0.010168,-0.00024883,0.30862,0.51314,HP_PROLONGED_BLEEDING_FOLLOWING_CIRCUMCISION,0.99999
GOBP_POSITIVE_REGULATION_OF_...207,SET,1215,-0.00087357,-0.00021717,0.026501,0.51315,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS,0.99999
GOBP_CARDIAC_MUSCLE_TISSUE_R...,SET,6,-0.011209,-0.00020261,0.33929,0.51318,GOBP_CARDIAC_MUSCLE_TISSUE_REGENERATION,0.99999
GSE14386_UNTREATED_VS_IFNA_T...2,SET,126,-0.0026282,-0.00021698,0.079525,0.51318,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP,0.99999
GOBP_REGULATION_OF_EXTRACELL...2,SET,9,-0.011038,-0.00024434,0.33204,0.51326,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_CONSTITUENT_SECRETION,0.99999
HP_ANOTIA,SET,12,-0.0071001,-0.00018147,0.21357,0.51326,HP_ANOTIA,0.99999
REACTOME_NR1H3_NR1H2_REGULAT...,SET,32,-0.0050218,-0.00020948,0.15068,0.51329,REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX,0.99999
NAKAYA_PBMC_FLUAD_MALE_AGE_1...2,SET,49,-0.0044204,-0.00022807,0.13256,0.5133,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN,0.99999
chr16p12,SET,78,-0.0059523,-0.00038717,0.17838,0.51331,chr16p12,0.99999
GOBP_POSITIVE_REGULATION_OF_...453,SET,25,-0.0066838,-0.00024648,0.19995,0.51333,GOBP_POSITIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,0.99999
HP_PITUITARY_GROWTH_HORMONE_...,SET,16,-0.0065618,-0.00019363,0.19588,0.51336,HP_PITUITARY_GROWTH_HORMONE_CELL_ADENOMA,0.99999
HP_ABNORMAL_VENTRICULAR_SEPT...,SET,429,-0.0013858,-0.00020936,0.041112,0.51344,HP_ABNORMAL_VENTRICULAR_SEPTUM_MORPHOLOGY,0.99999
GOBP_RESPONSE_TO_GONADOTROPIN,SET,27,-0.0062393,-0.0002391,0.18509,0.51345,GOBP_RESPONSE_TO_GONADOTROPIN,0.99999
GOBP_MITOCHONDRIAL_FUSION,SET,30,-0.0051959,-0.00020987,0.1539,0.51347,GOBP_MITOCHONDRIAL_FUSION,0.99999
GSE25088_CTRL_VS_IL4_AND_ROS...2,SET,160,-0.0023684,-0.00022014,0.070022,0.51349,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.99999
REACTOME_WAX_AND_PLASMALOGEN...,SET,5,-0.013558,-0.00022372,0.39943,0.51354,REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS,0.99999
RADAEVA_RESPONSE_TO_IFNA1_UP,SET,46,-0.0043255,-0.00021625,0.12715,0.51357,RADAEVA_RESPONSE_TO_IFNA1_UP,0.99999
GSE25123_WT_VS_PPARG_KO_MACR...1,SET,177,-0.0021927,-0.00021426,0.064217,0.51362,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_DN,0.99999
HP_PROMINENT_INTERPHALANGEAL...,SET,6,-0.011734,-0.00021211,0.34299,0.51365,HP_PROMINENT_INTERPHALANGEAL_JOINTS,0.99999
BIOCARTA_SHH_PATHWAY,SET,16,-0.0076789,-0.0002266,0.2234,0.51371,BIOCARTA_SHH_PATHWAY,0.99999
WP_INTERACTIONS_OF_NATURAL_K...,SET,28,-0.0059497,-0.00023218,0.17309,0.51371,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,0.99999
GOBP_EOSINOPHIL_DIFFERENTIAT...,SET,6,-0.012388,-0.00022392,0.36044,0.51371,GOBP_EOSINOPHIL_DIFFERENTIATION,0.99999
GSE14308_NAIVE_CD4_TCELL_VS_...2,SET,178,-0.0022037,-0.00021594,0.064053,0.51372,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP,0.99999
GOBP_REGULATION_OF_NUCLEAR_T...1,SET,21,-0.0061607,-0.00020825,0.17898,0.51373,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.99999
MIR4671_5P,SET,7,-0.011115,-0.00021701,0.32169,0.51378,MIR4671_5P,0.99999
chr2q37,SET,107,-0.0056689,-0.00043153,0.16361,0.51382,chr2q37,0.99999
GSE3982_DC_VS_CENT_MEMORY_CD...2,SET,186,-0.0021742,-0.00021774,0.062712,0.51383,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_AL...1,SET,96,-0.003245,-0.00023404,0.093423,0.51385,GOBP_CELLULAR_RESPONSE_TO_ALCOHOL,0.99999
IWANAGA_E2F1_TARGETS_NOT_IND...,SET,6,-0.011252,-0.00020339,0.32269,0.51391,IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM,0.99999
WP_SEROTONIN_RECEPTOR_2_AND_...,SET,18,-0.007152,-0.00022384,0.20396,0.51399,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,0.99999
KEGG_MEDICUS_REFERENCE_PROMO...,SET,21,-0.0071974,-0.00024329,0.20448,0.51404,KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH,0.99999
HP_VISUAL_HALLUCINATION,SET,21,-0.0063552,-0.00021482,0.18009,0.51408,HP_VISUAL_HALLUCINATION,0.99999
GSE2706_R848_VS_R848_AND_LPS...3,SET,158,-0.002529,-0.0002336,0.071363,0.51413,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN,0.99999
GOBP_MITOCHONDRIAL_PROTON_TR...,SET,5,-0.01433,-0.00023647,0.40422,0.51414,GOBP_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_ASSEMBLY,0.99999
REACTOME_CELL_CELL_JUNCTION_...,SET,80,-0.0037552,-0.00024735,0.10556,0.51419,REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,0.99999
MATZUK_IMPLANTATION_AND_UTER...,SET,18,-0.0077696,-0.00024317,0.21794,0.51422,MATZUK_IMPLANTATION_AND_UTERINE,0.99999
MIR548AW,SET,539,-0.0013633,-0.00023014,0.038168,0.51425,MIR548AW,0.99999
GOBP_REGULATION_OF_UBIQUITIN...1,SET,149,-0.002473,-0.00022189,0.069056,0.51428,GOBP_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
ZAMORA_NOS2_TARGETS_DN,SET,76,-0.0035795,-0.00022983,0.099545,0.51434,ZAMORA_NOS2_TARGETS_DN,0.99999
HP_STRIAE_DISTENSAE,SET,33,-0.0055054,-0.00023321,0.1531,0.51434,HP_STRIAE_DISTENSAE,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...51,SET,9,-0.0088716,-0.00019638,0.24636,0.51436,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.99999
HP_NEONATAL_ONSET,SET,427,-0.0014785,-0.00022284,0.041047,0.51437,HP_NEONATAL_ONSET,0.99999
REACTOME_TYPE_I_HEMIDESMOSOM...,SET,11,-0.0096711,-0.00023666,0.26817,0.51438,REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY,0.99999
GOMF_CALCIUM_DEPENDENT_PROTE...2,SET,10,-0.0099112,-0.00023126,0.27479,0.51439,GOMF_CALCIUM_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.99999
GOBP_INTERLEUKIN_1_ALPHA_PRO...,SET,8,-0.013572,-0.00028326,0.37328,0.5145,GOBP_INTERLEUKIN_1_ALPHA_PRODUCTION,0.99999
GOCC_HFE_TRANSFERRIN_RECEPTO...,SET,7,-0.011842,-0.0002312,0.32414,0.51457,GOCC_HFE_TRANSFERRIN_RECEPTOR_COMPLEX,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...6,SET,173,-0.0023787,-0.00022983,0.064884,0.51462,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_UP,0.99999
GOBP_REGULATION_OF_GENE_SILE...,SET,25,-0.0064989,-0.00023966,0.17679,0.51466,GOBP_REGULATION_OF_GENE_SILENCING_BY_REGULATORY_NCRNA,0.99999
GOCC_CHROMOSOME_TELOMERIC_RE...2,SET,12,-0.0082018,-0.00020963,0.22205,0.51473,GOCC_CHROMOSOME_TELOMERIC_REPEAT_REGION,0.99999
MORF_SKP1A,SET,179,-0.0021221,-0.00020852,0.057394,0.51475,MORF_SKP1A,0.99999
HP_APRAXIA,SET,190,-0.0021878,-0.00022142,0.059161,0.51475,HP_APRAXIA,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...1,SET,185,-0.0023528,-0.000235,0.063531,0.51477,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,0.99999
REACTOME_INTERLEUKIN_18_SIGN...,SET,8,-0.012105,-0.00025263,0.32651,0.51479,REACTOME_INTERLEUKIN_18_SIGNALING,0.99999
GSE3920_IFNB_VS_IFNG_TREATED...1,SET,158,-0.0024012,-0.0002218,0.064756,0.51479,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,0.99999
HP_HALITOSIS,SET,6,-0.014275,-0.00025803,0.38331,0.51485,HP_HALITOSIS,0.99999
REACTOME_ORGANELLE_BIOGENESI...,SET,250,-0.0019279,-0.00022344,0.051696,0.51487,REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,0.99999
WP_GPR143_IN_MELANOCYTES_AND...,SET,29,-0.0062747,-0.00024919,0.16786,0.51491,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,0.99999
GOBP_GLUTAMATE_RECEPTOR_SIGN...,SET,48,-0.0050621,-0.00025851,0.13488,0.51497,GOBP_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_ABNORMALITY_OF_TEMPERATUR...,SET,490,-0.0015006,-0.00024187,0.039888,0.515,HP_ABNORMALITY_OF_TEMPERATURE_REGULATION,0.99999
MIR151A_5P_MIR151B,SET,10,-0.0098487,-0.0002298,0.26144,0.51502,MIR151A_5P_MIR151B,0.99999
GOBP_ORGANIC_ACID_TRANSPORT,SET,330,-0.001868,-0.00024819,0.049527,0.51504,GOBP_ORGANIC_ACID_TRANSPORT,0.99999
MIR4782_5P,SET,150,-0.0026645,-0.00023987,0.070591,0.51505,MIR4782_5P,0.99999
GOBP_VITAMIN_D_RECEPTOR_SIGN...,SET,12,-0.009389,-0.00023997,0.24797,0.5151,GOBP_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE37605_TREG_VS_TCONV_NOD_F...1,SET,154,-0.0026394,-0.00024072,0.069638,0.51512,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_DN,0.99999
DESCARTES_FETAL_STOMACH_ENS_...1,SET,42,-0.0054473,-0.00026025,0.14367,0.51512,DESCARTES_FETAL_STOMACH_ENS_GLIA,0.99999
GSE24574_BCL6_LOW_TFH_VS_TCO...1,SET,179,-0.0023313,-0.00022908,0.0614,0.51514,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_DN,0.99999
GOCC_ENDONUCLEASE_COMPLEX,SET,35,-0.0051931,-0.00022654,0.13673,0.51515,GOCC_ENDONUCLEASE_COMPLEX,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...9,SET,41,-0.0054062,-0.00025521,0.14181,0.5152,GAVISH_3CA_MALIGNANT_METAPROGRAM_18_INTERFERON_MHC_II_2,0.99999
HP_RESPIRATORY_TRACT_INFECTI...,SET,680,-0.0012861,-0.0002429,0.033759,0.5152,HP_RESPIRATORY_TRACT_INFECTION,0.99999
chr8p22,SET,20,-0.013093,-0.00043194,0.34307,0.51522,chr8p22,0.99999
HP_CORNEAL_GUTTATA,SET,6,-0.014432,-0.00026087,0.37807,0.51522,HP_CORNEAL_GUTTATA,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...14,SET,8,-0.011658,-0.00024331,0.30478,0.51526,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY,0.99999
FAN_OVARY_CL0_XBP1_SELK_HIGH...,SET,123,-0.0028858,-0.00023542,0.075353,0.51527,FAN_OVARY_CL0_XBP1_SELK_HIGH_STROMAL_CELL,0.99999
RIEGE_DELTANP63_DIRECT_TARGE...,SET,130,-0.0028693,-0.0002406,0.074509,0.51536,RIEGE_DELTANP63_DIRECT_TARGETS_UP,0.99999
LEIN_CEREBELLUM_MARKERS,SET,76,-0.0039969,-0.00025663,0.10351,0.5154,LEIN_CEREBELLUM_MARKERS,0.99999
GOCC_AXOLEMMA,SET,15,-0.0099209,-0.00028347,0.25669,0.51541,GOCC_AXOLEMMA,0.99999
GSE21379_TFH_VS_NON_TFH_CD4_...1,SET,176,-0.0026268,-0.00025596,0.067731,0.51547,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN,0.99999
GSE45365_WT_VS_IFNAR_KO_CD11...4,SET,161,-0.0025248,-0.0002354,0.065094,0.51547,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_UP,0.99999
BIOCARTA_GH_PATHWAY,SET,26,-0.0068025,-0.00025582,0.1731,0.51567,BIOCARTA_GH_PATHWAY,0.99999
GOBP_REGULATION_PROTEIN_CATA...,SET,4,-0.014099,-0.00020809,0.35881,0.51567,GOBP_REGULATION_PROTEIN_CATABOLIC_PROCESS_AT_SYNAPSE,0.99999
GSE22601_DOUBLE_NEGATIVE_VS_...1,SET,179,-0.0024589,-0.00024162,0.062391,0.51572,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.99999
GOBP_ACROSOME_REACTION,SET,39,-0.0056092,-0.00025826,0.14207,0.51575,GOBP_ACROSOME_REACTION,0.99999
GOMF_SULFUR_AMINO_ACID_TRANS...,SET,11,-0.0095913,-0.00023471,0.24262,0.51577,GOMF_SULFUR_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
LU_TUMOR_ENDOTHELIAL_MARKERS...2,SET,20,-0.0080075,-0.00026416,0.2023,0.51579,LU_TUMOR_ENDOTHELIAL_MARKERS_UP,0.99999
REACTOME_METABOLISM_OF_NUCLE...,SET,92,-0.0035792,-0.00025274,0.090393,0.51579,REACTOME_METABOLISM_OF_NUCLEOTIDES,0.99999
REACTOME_SYNTHESIS_OF_PA,SET,35,-0.0064223,-0.00028015,0.16194,0.51582,REACTOME_SYNTHESIS_OF_PA,0.99999
HP_ABNORMAL_NATURAL_KILLER_C...,SET,38,-0.0052889,-0.00024038,0.13295,0.51587,HP_ABNORMAL_NATURAL_KILLER_CELL_MORPHOLOGY,0.99999
WP_MICRORNAS_IN_CARDIOMYOCYT...,SET,81,-0.0038487,-0.00025508,0.09666,0.51588,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,0.99999
MIR625_3P,SET,45,-0.0053587,-0.00026498,0.13458,0.51588,MIR625_3P,0.99999
FAN_EMBRYONIC_CTX_MICROGLIA_2,SET,8,-0.013457,-0.00028087,0.33802,0.51588,FAN_EMBRYONIC_CTX_MICROGLIA_2,0.99999
GSE40666_WT_VS_STAT4_KO_CD8_...1,SET,174,-0.0024831,-0.0002406,0.062134,0.51594,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...451,SET,14,-0.008999,-0.00024842,0.22459,0.51598,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.99999
GOBP_THYMOCYTE_APOPTOTIC_PRO...,SET,19,-0.008098,-0.00026039,0.20165,0.51602,GOBP_THYMOCYTE_APOPTOTIC_PROCESS,0.99999
HP_DUPLICATED_COLLECTING_SYS...,SET,19,-0.0074239,-0.00023871,0.18439,0.51606,HP_DUPLICATED_COLLECTING_SYSTEM,0.99999
GSE13485_CTRL_VS_DAY3_YF17D_...2,SET,151,-0.0028797,-0.00026009,0.071389,0.51609,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP,0.99999
DELPUECH_FOXO3_TARGETS_UP,SET,61,-0.0047188,-0.00027156,0.11681,0.51611,DELPUECH_FOXO3_TARGETS_UP,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...6,SET,180,-0.0025864,-0.00025485,0.064025,0.51611,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_UP,0.99999
GOBP_BROWN_FAT_CELL_DIFFEREN...,SET,50,-0.0050379,-0.00026256,0.12455,0.51613,GOBP_BROWN_FAT_CELL_DIFFERENTIATION,0.99999
HP_THIRD_DEGREE_ATRIOVENTRIC...,SET,9,-0.010264,-0.00022721,0.25372,0.51613,HP_THIRD_DEGREE_ATRIOVENTRICULAR_BLOCK,0.99999
GOBP_MESODERMAL_CELL_FATE_CO...,SET,17,-0.00868,-0.00026402,0.21405,0.51617,GOBP_MESODERMAL_CELL_FATE_COMMITMENT,0.99999
HP_ABNORMAL_EYEBROW_MORPHOLO...,SET,580,-0.0014505,-0.00025371,0.035624,0.51624,HP_ABNORMAL_EYEBROW_MORPHOLOGY,0.99999
BIOCARTA_FCER1_PATHWAY,SET,37,-0.0058182,-0.00026094,0.14281,0.51625,BIOCARTA_FCER1_PATHWAY,0.99999
GGCNKCCATNK_UNKNOWN,SET,111,-0.0031867,-0.00024704,0.078114,0.51627,GGCNKCCATNK_UNKNOWN,0.99999
HP_HEPARAN_SULFATE_EXCRETION...,SET,8,-0.011436,-0.00023868,0.27887,0.51636,HP_HEPARAN_SULFATE_EXCRETION_IN_URINE,0.99999
HP_AXONAL_DEGENERATION,SET,20,-0.0075478,-0.00024899,0.18318,0.51643,HP_AXONAL_DEGENERATION,0.99999
HP_HIGH_HYPERMETROPIA,SET,70,-0.0043951,-0.00027088,0.10643,0.51647,HP_HIGH_HYPERMETROPIA,0.99999
GSE41176_WT_VS_TAK1_KO_UNSTI...1,SET,175,-0.002693,-0.00026168,0.065208,0.51647,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN,0.99999
E2F_03,SET,218,-0.0023453,-0.00025405,0.056739,0.51649,E2F_03,0.99999
GOBP_SENSORY_PERCEPTION_OF_T...2,SET,29,-0.0069411,-0.00027566,0.16746,0.51653,GOBP_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS,0.99999
HP_EVERSION_OF_LATERAL_THIRD...,SET,4,-0.013609,-0.00020086,0.32811,0.51654,HP_EVERSION_OF_LATERAL_THIRD_OF_LOWER_EYELIDS,0.99999
MIR4319,SET,404,-0.0017575,-0.00025783,0.04217,0.51662,MIR4319,0.99999
GOBP_BASE_EXCISION_REPAIR,SET,41,-0.0047518,-0.00022431,0.1138,0.51665,GOBP_BASE_EXCISION_REPAIR,0.99999
GOBP_NEGATIVE_REGULATION_OF_...380,SET,6,-0.015409,-0.00027853,0.36905,0.51665,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.99999
CREBP1CJUN_01,SET,237,-0.0023627,-0.00026672,0.056474,0.51669,CREBP1CJUN_01,0.99999
ZNF318_TARGET_GENES,SET,824,-0.0012729,-0.00026355,0.030281,0.51676,ZNF318_TARGET_GENES,0.99999
WATANABE_COLON_CANCER_MSI_VS...2,SET,28,-0.0070375,-0.00027463,0.16739,0.51677,WATANABE_COLON_CANCER_MSI_VS_MSS_UP,0.99999
GOMF_LIPID_BINDING,SET,787,-0.0013425,-0.00027193,0.031926,0.51677,GOMF_LIPID_BINDING,0.99999
GTGCCAA_MIR96,SET,276,-0.0022022,-0.00026799,0.05234,0.51678,GTGCCAA_MIR96,0.99999
BIOCARTA_FREE_PATHWAY,SET,9,-0.01127,-0.00024948,0.26701,0.51683,BIOCARTA_FREE_PATHWAY,0.99999
GOCC_WNT_SIGNALOSOME,SET,13,-0.010391,-0.00027641,0.24574,0.51686,GOCC_WNT_SIGNALOSOME,0.99999
GOBP_REGULATORY_NCRNA_MEDIAT...1,SET,112,-0.0032528,-0.00025329,0.076919,0.51687,GOBP_REGULATORY_NCRNA_MEDIATED_GENE_SILENCING,0.99999
GCM_ING1,SET,61,-0.0039699,-0.00022846,0.093453,0.51694,GCM_ING1,0.99999
GOBP_HOMOLOGOUS_CHROMOSOME_P...,SET,44,-0.004975,-0.00024327,0.1168,0.51699,GOBP_HOMOLOGOUS_CHROMOSOME_PAIRING_AT_MEIOSIS,0.99999
GSE2706_R848_VS_R848_AND_LPS...2,SET,148,-0.0028317,-0.00025323,0.066454,0.51699,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP,0.99999
HASLINGER_B_CLL_WITH_11Q23_D...,SET,20,-0.0074518,-0.00024583,0.17462,0.51702,HASLINGER_B_CLL_WITH_11Q23_DELETION,0.99999
GOBP_NEUTROPHIL_DEGRANULATION,SET,13,-0.010161,-0.00027029,0.23814,0.51702,GOBP_NEUTROPHIL_DEGRANULATION,0.99999
GOMF_G_PROTEIN_COUPLED_GLUTA...2,SET,8,-0.013652,-0.00028492,0.31921,0.51706,GOMF_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_BINDING,0.99999
GSE15330_HSC_VS_PRO_BCELL_UP,SET,176,-0.0026779,-0.00026094,0.06249,0.51709,GSE15330_HSC_VS_PRO_BCELL_UP,0.99999
GSE43955_TH0_VS_TGFB_IL6_IL2...3,SET,187,-0.0027379,-0.00027491,0.062989,0.51733,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,0.99999
HP_SUBSTANTIA_NIGRA_GLIOSIS,SET,10,-0.01186,-0.00027672,0.27244,0.51736,HP_SUBSTANTIA_NIGRA_GLIOSIS,0.99999
HP_DEVELOPMENTAL_REGRESSION,SET,360,-0.0019319,-0.00026787,0.044276,0.5174,HP_DEVELOPMENTAL_REGRESSION,0.99999
GOBP_REGULATION_OF_ASPARTIC_...2,SET,7,-0.015405,-0.00030076,0.35279,0.51741,GOBP_REGULATION_OF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY,0.99999
GOBP_CEREBELLAR_GRANULAR_LAY...2,SET,6,-0.01953,-0.00035302,0.44638,0.51745,GOBP_CEREBELLAR_GRANULAR_LAYER_FORMATION,0.99999
QIU_PBMC_HEPTATITIS_B_SURFAC...1,SET,15,-0.010619,-0.00030343,0.2427,0.51745,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0DY_UP,0.99999
GOBP_REGULATION_OF_PROTEIN_S...4,SET,20,-0.0076704,-0.00025304,0.175,0.51748,GOBP_REGULATION_OF_PROTEIN_SUMOYLATION,0.99999
GSE11924_TH2_VS_TH17_CD4_TCE...2,SET,178,-0.0028531,-0.00027958,0.065019,0.5175,GSE11924_TH2_VS_TH17_CD4_TCELL_UP,0.99999
GROSS_HYPOXIA_VIA_ELK3_DN,SET,137,-0.0034422,-0.00029625,0.078325,0.51753,GROSS_HYPOXIA_VIA_ELK3_DN,0.99999
HP_PERIPHERAL_RETINAL_DEGENE...,SET,6,-0.017557,-0.00031735,0.39882,0.51756,HP_PERIPHERAL_RETINAL_DEGENERATION,0.99999
WANG_CISPLATIN_RESPONSE_AND_...1,SET,207,-0.0025962,-0.00027412,0.058736,0.51763,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,0.99999
chr17q22,SET,42,-0.0098341,-0.00046984,0.22105,0.51774,chr17q22,0.99999
GOBP_NEGATIVE_REGULATION_OF_...557,SET,6,-0.018392,-0.00033245,0.41263,0.51778,GOBP_NEGATIVE_REGULATION_OF_RELAXATION_OF_MUSCLE,0.99999
GSE27786_LSK_VS_ERYTHROBLAST...1,SET,178,-0.0027424,-0.00026873,0.061379,0.51782,GSE27786_LSK_VS_ERYTHROBLAST_DN,0.99999
QUEREC_MODEL_PBMC_YF_17D_VAC...2,SET,35,-0.0062748,-0.00027372,0.14021,0.51785,QUEREC_MODEL_PBMC_YF_17D_VACCINE_AGE_18_45_7DY_PREDICTIVE,0.99999
GOCC_BRUSH_BORDER,SET,100,-0.0037774,-0.00027803,0.084327,0.51786,GOCC_BRUSH_BORDER,0.99999
HP_RECURRENT_ASPIRATION_PNEU...,SET,23,-0.0078531,-0.00027779,0.17497,0.5179,HP_RECURRENT_ASPIRATION_PNEUMONIA,0.99999
GOCC_CELL_POLE,SET,9,-0.01241,-0.00027472,0.27542,0.51797,GOCC_CELL_POLE,0.99999
HP_ABNORMAL_3RD_FINGER_MORPH...,SET,24,-0.0084811,-0.00030645,0.18826,0.51797,HP_ABNORMAL_3RD_FINGER_MORPHOLOGY,0.99999
GOBP_RIBOFLAVIN_TRANSPORT,SET,6,-0.017089,-0.00030889,0.37777,0.51804,GOBP_RIBOFLAVIN_TRANSPORT,0.99999
GOMF_RIBOFLAVIN_TRANSMEMBRAN...,SET,6,-0.017089,-0.00030889,0.37777,0.51804,GOMF_RIBOFLAVIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_RECURRENT_PHARYNGITIS,SET,7,-0.017759,-0.00034671,0.39152,0.51809,HP_RECURRENT_PHARYNGITIS,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...4,SET,45,-0.0055686,-0.00027536,0.12267,0.5181,GAVISH_3CA_METAPROGRAM_B_CELLS_HSP_STRESS,0.99999
HP_PROMINENT_STERNUM,SET,12,-0.012879,-0.00032917,0.28367,0.51811,HP_PROMINENT_STERNUM,0.99999
HP_FETAL_POLYURIA,SET,11,-0.012395,-0.00030331,0.27228,0.51815,HP_FETAL_POLYURIA,0.99999
GOMF_LIGASE_ACTIVITY_FORMING...2,SET,45,-0.0057496,-0.00028432,0.12617,0.51817,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS,0.99999
LET_7F_2_3P,SET,371,-0.0020636,-0.00029038,0.045271,0.51818,LET_7F_2_3P,0.99999
GOBP_REGULATION_OF_TRANSFERA...,SET,563,-0.0016782,-0.00028936,0.03674,0.51822,GOBP_REGULATION_OF_TRANSFERASE_ACTIVITY,0.99999
MIR1253,SET,158,-0.0032404,-0.00029932,0.070483,0.51833,MIR1253,0.99999
GOCC_LEWY_BODY,SET,7,-0.01385,-0.0002704,0.3014,0.51833,GOCC_LEWY_BODY,0.99999
GSE17721_LPS_VS_CPG_4H_BMDC_...2,SET,188,-0.0029051,-0.00029248,0.063217,0.51833,GSE17721_LPS_VS_CPG_4H_BMDC_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...96,SET,4,-0.019292,-0.00028474,0.41931,0.51835,GOBP_POSITIVE_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS,0.99999
GSE6092_B_BURGDOFERI_VS_B_BU...2,SET,160,-0.003165,-0.00029419,0.068771,0.51835,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP,0.99999
HP_ABNORMAL_UTERINE_CERVIX_M...,SET,11,-0.013915,-0.00034052,0.3023,0.51836,HP_ABNORMAL_UTERINE_CERVIX_MORPHOLOGY,0.99999
REACTOME_G2_PHASE,SET,5,-0.019089,-0.00031498,0.41077,0.51853,REACTOME_G2_PHASE,0.99999
GOBP_PEPTIDYL_LYSINE_HYDROXY...,SET,8,-0.014328,-0.00029904,0.30753,0.51858,GOBP_PEPTIDYL_LYSINE_HYDROXYLATION,0.99999
HP_ELEVATED_TRANSFERRIN_SATU...,SET,9,-0.012326,-0.00027284,0.26414,0.51861,HP_ELEVATED_TRANSFERRIN_SATURATION,0.99999
WP_ROS_IN_COVID19_ENDOTHELIA...,SET,6,-0.018104,-0.00032724,0.38598,0.51871,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,0.99999
GSE40274_CTRL_VS_HELIOS_TRAN...1,SET,162,-0.0031182,-0.00029162,0.066425,0.51872,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
HP_MULTIFOCAL_CEREBRAL_WHITE...,SET,15,-0.0099055,-0.00028303,0.21073,0.51875,HP_MULTIFOCAL_CEREBRAL_WHITE_MATTER_ABNORMALITIES,0.99999
REACTOME_WNT5A_DEPENDENT_INT...1,SET,13,-0.011113,-0.00029563,0.23478,0.51888,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2,0.99999
GOBP_NECROPTOTIC_PROCESS,SET,36,-0.0071107,-0.00031458,0.14999,0.51891,GOBP_NECROPTOTIC_PROCESS,0.99999
HP_PROXIMAL_HYPERREFLEXIA,SET,36,-0.0063981,-0.00028305,0.13478,0.51893,HP_PROXIMAL_HYPERREFLEXIA,0.99999
GOBP_REGULATION_OF_PROTEIN_L...6,SET,9,-0.011374,-0.00025178,0.23953,0.51894,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.99999
PRC2_EZH2_UP.V1_DN,SET,169,-0.0030577,-0.00029202,0.064367,0.51894,PRC2_EZH2_UP.V1_DN,0.99999
WP_NEURAL_CREST_CELL_MIGRATI...2,SET,40,-0.0070524,-0.00032884,0.14814,0.51899,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,0.99999
GOBP_PROTON_TRANSPORTING_TWO...,SET,11,-0.012741,-0.00031178,0.26683,0.51904,GOBP_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_ASSEMBLY,0.99999
GSE43863_TH1_VS_LY6C_INT_CXC...1,SET,189,-0.0030029,-0.00030312,0.062637,0.51912,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,0.99999
GSE2770_UNTREATED_VS_IL12_TR...1,SET,172,-0.0029795,-0.00028704,0.062053,0.51915,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...556,SET,5,-0.019807,-0.00032684,0.41205,0.51917,GOBP_NEGATIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION,0.99999
GOMF_S_ADENOSYL_L_METHIONINE...,SET,16,-0.0092135,-0.00027188,0.19169,0.51917,GOMF_S_ADENOSYL_L_METHIONINE_BINDING,0.99999
GSE3039_NKT_CELL_VS_ALPHABET...1,SET,174,-0.0031286,-0.00030314,0.065088,0.51917,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN,0.99999
GOBP_NERVE_GROWTH_FACTOR_SIG...,SET,14,-0.012042,-0.00033243,0.25028,0.51919,GOBP_NERVE_GROWTH_FACTOR_SIGNALING_PATHWAY,0.99999
BURTON_ADIPOGENESIS_4,SET,42,-0.0062997,-0.00030098,0.13086,0.5192,BURTON_ADIPOGENESIS_4,0.99999
HP_RECURRENT_CANDIDA_INFECTI...,SET,17,-0.010993,-0.00033438,0.22825,0.51921,HP_RECURRENT_CANDIDA_INFECTIONS,0.99999
GSE360_DC_VS_MAC_L_DONOVANI_...2,SET,188,-0.0030543,-0.0003075,0.063255,0.51926,GSE360_DC_VS_MAC_L_DONOVANI_UP,0.99999
HP_HEAD_BANGING,SET,9,-0.013464,-0.00029803,0.27766,0.51934,HP_HEAD_BANGING,0.99999
HP_PREMATURE_RUPTURE_OF_MEMB...,SET,15,-0.0097514,-0.00027863,0.20103,0.51934,HP_PREMATURE_RUPTURE_OF_MEMBRANES,0.99999
GSE37301_MULTIPOTENT_PROGENI...3,SET,186,-0.0029487,-0.0002953,0.060709,0.51937,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN,0.99999
KEGG_MEDICUS_REFERENCE_IRE1A...,SET,7,-0.016162,-0.00031553,0.33149,0.51944,KEGG_MEDICUS_REFERENCE_IRE1A_JNK_SIGNALING_PATHWAY,0.99999
GRABARCZYK_BCL11B_TARGETS_DN,SET,56,-0.0058694,-0.00032368,0.1203,0.51946,GRABARCZYK_BCL11B_TARGETS_DN,0.99999
F10_TARGET_GENES,SET,211,-0.0029851,-0.00031819,0.061168,0.51946,F10_TARGET_GENES,0.99999
HP_CHIARI_MALFORMATION,SET,91,-0.0044563,-0.00031297,0.09131,0.51946,HP_CHIARI_MALFORMATION,0.99999
GOMF_HISTONE_H3K9ME2_METHYLT...,SET,7,-0.015467,-0.00030196,0.31651,0.51949,GOMF_HISTONE_H3K9ME2_METHYLTRANSFERASE_ACTIVITY,0.99999
HP_ABSENT_AXILLARY_HAIR,SET,11,-0.013074,-0.00031993,0.26695,0.51953,HP_ABSENT_AXILLARY_HAIR,0.99999
GSE37416_CTRL_VS_12H_F_TULAR...1,SET,175,-0.0030106,-0.00029254,0.061391,0.51956,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
REACTOME_PI3K_AKT_SIGNALING_...,SET,108,-0.0042734,-0.00032681,0.087042,0.51958,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,0.99999
WP_DDX1_AS_A_REGULATORY_COMP...,SET,6,-0.014099,-0.00025485,0.28721,0.51958,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,0.99999
MORF_PRKDC,SET,168,-0.0030413,-0.0002896,0.0619,0.51959,MORF_PRKDC,0.99999
REACTOME_BASE_EXCISION_REPAI...,SET,17,-0.0093097,-0.00028317,0.18932,0.51961,REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,0.99999
LEE_BMP2_TARGETS_DN,SET,824,-0.0014482,-0.00029985,0.029371,0.51966,LEE_BMP2_TARGETS_DN,0.99999
GOMF_TRANSLATION_INITIATION_...1,SET,43,-0.0059551,-0.00028787,0.1206,0.51969,GOMF_TRANSLATION_INITIATION_FACTOR_ACTIVITY,0.99999
GOBP_REPRODUCTIVE_PROCESS,SET,1328,-0.0012102,-0.0003135,0.024387,0.51979,GOBP_REPRODUCTIVE_PROCESS,0.99999
MIR7156_3P,SET,89,-0.0044378,-0.00030825,0.089331,0.51981,MIR7156_3P,0.99999
GOBP_LEARNING,SET,143,-0.0036509,-0.00032096,0.073244,0.51988,GOBP_LEARNING,0.99999
GRESHOCK_CANCER_COPY_NUMBER_...,SET,309,-0.0024282,-0.00031237,0.048694,0.51989,GRESHOCK_CANCER_COPY_NUMBER_UP,0.99999
MAML1_TARGET_GENES,SET,212,-0.0030425,-0.00032506,0.060988,0.51989,MAML1_TARGET_GENES,0.99999
HP_DECREASED_SIZE_OF_NERVE_T...,SET,15,-0.010526,-0.00030076,0.21059,0.51993,HP_DECREASED_SIZE_OF_NERVE_TERMINALS,0.99999
GOBP_G_PROTEIN_COUPLED_RECEP...4,SET,9,-0.014155,-0.00031335,0.28251,0.51998,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_PROCESS,0.99999
HP_ERYTHROID_DYSPLASIA,SET,4,-0.022055,-0.00032552,0.4378,0.52009,HP_ERYTHROID_DYSPLASIA,0.99999
GOBP_NUCLEOBASE_CONTAINING_S...3,SET,8,-0.01564,-0.00032641,0.3102,0.5201,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_INTERCONVERSION,0.99999
HP_JUVENILE_CATARACT,SET,10,-0.012642,-0.00029496,0.25074,0.5201,HP_JUVENILE_CATARACT,0.99999
GSE2770_IL12_VS_TGFB_AND_IL1...3,SET,184,-0.0032292,-0.00032167,0.063829,0.52017,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.99999
NEBEN_AML_WITH_FLT3_OR_NRAS_...2,SET,7,-0.017522,-0.00034209,0.34625,0.52018,NEBEN_AML_WITH_FLT3_OR_NRAS_UP,0.99999
GOBP_REGULATION_OF_T_HELPER_...3,SET,31,-0.0080499,-0.00033052,0.15884,0.52021,GOBP_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.99999
FLECHNER_BIOPSY_KIDNEY_TRANS...2,SET,509,-0.0019199,-0.00031522,0.037732,0.52029,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,0.99999
KEGG_PRIMARY_BILE_ACID_BIOSY...,SET,16,-0.011701,-0.00034529,0.22966,0.52032,KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,0.99999
GOBP_NUCLEOSIDE_MONOPHOSPHAT...3,SET,69,-0.0052123,-0.00031895,0.10228,0.52032,GOBP_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.99999
GOBP_CELLULAR_RESPONSE_TO_IN...2,SET,5,-0.019847,-0.00032749,0.38936,0.52033,GOBP_CELLULAR_RESPONSE_TO_INDOLE_3_METHANOL,0.99999
HP_MITOCHONDRIAL_INHERITANCE,SET,4,-0.019814,-0.00029245,0.38875,0.52033,HP_MITOCHONDRIAL_INHERITANCE,0.99999
GOBP_SIGNALING_RECEPTOR_LIGA...,SET,36,-0.0076226,-0.00033722,0.14906,0.52039,GOBP_SIGNALING_RECEPTOR_LIGAND_PRECURSOR_PROCESSING,0.99999
GOBP_LEUKOTRIENE_D4_BIOSYNTH...,SET,5,-0.020703,-0.00034163,0.40472,0.5204,GOBP_LEUKOTRIENE_D4_BIOSYNTHETIC_PROCESS,0.99999
GOBP_NOREPINEPHRINE_METABOLI...,SET,10,-0.016189,-0.00037775,0.31651,0.5204,GOBP_NOREPINEPHRINE_METABOLIC_PROCESS,0.99999
GOMF_GLUTATHIONE_HYDROLASE_A...,SET,5,-0.020703,-0.00034163,0.40472,0.5204,GOMF_GLUTATHIONE_HYDROLASE_ACTIVITY,0.99999
XU_HGF_SIGNALING_NOT_VIA_AKT...3,SET,23,-0.0098366,-0.00034796,0.19201,0.52043,XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,0.99999
ZHOU_INFLAMMATORY_RESPONSE_L...2,SET,387,-0.002344,-0.00033672,0.045683,0.52046,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...18,SET,45,-0.0069062,-0.00034151,0.13452,0.52047,GAVISH_3CA_MALIGNANT_METAPROGRAM_27_OLIGO_PROGENITOR,0.99999
MIR6886_5P,SET,8,-0.016847,-0.0003516,0.32763,0.5205,MIR6886_5P,0.99999
WP_SEROTONIN_RECEPTOR_467_AN...,SET,18,-0.011373,-0.00035593,0.22107,0.52051,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,0.99999
GSE25088_CTRL_VS_IL4_STIM_ST...1,SET,155,-0.00358,-0.00032756,0.069542,0.52053,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_DN,0.99999
GSE7460_CD8_TCELL_VS_CD4_TCE...2,SET,173,-0.0033993,-0.00032843,0.066002,0.52054,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP,0.99999
MODULE_114,SET,290,-0.0024609,-0.00030684,0.047714,0.52057,MODULE_114,0.99999
PID_MTOR_4PATHWAY,SET,67,-0.0054572,-0.00032908,0.10563,0.5206,PID_MTOR_4PATHWAY,0.99999
CUI_DEVELOPING_HEART_CARDIAC...,SET,100,-0.0046093,-0.00033927,0.0892,0.52061,CUI_DEVELOPING_HEART_CARDIAC_FIBROBLASTS,0.99999
GOBP_UTP_METABOLIC_PROCESS,SET,11,-0.014592,-0.00035709,0.28147,0.52067,GOBP_UTP_METABOLIC_PROCESS,0.99999
MODULE_495,SET,13,-0.01273,-0.00033865,0.2454,0.52069,MODULE_495,0.99999
REACTOME_PROCESSING_AND_ACTI...,SET,10,-0.012167,-0.00028389,0.2341,0.52072,REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO,0.99999
GSE9946_IMMATURE_VS_MATURE_S...1,SET,124,-0.0040942,-0.00033534,0.078644,0.52076,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN,0.99999
HP_CRANIOFACIAL_HYPEROSTOSIS,SET,24,-0.0083463,-0.00030158,0.16027,0.52077,HP_CRANIOFACIAL_HYPEROSTOSIS,0.99999
NABA_ECM_GLYCOPROTEINS,SET,177,-0.0036114,-0.0003529,0.069278,0.52079,NABA_ECM_GLYCOPROTEINS,0.99999
GSE3982_EFF_MEMORY_VS_CENT_M...2,SET,174,-0.003379,-0.0003274,0.064811,0.52079,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP,0.99999
GOMF_GPI_ANCHOR_BINDING,SET,8,-0.015199,-0.00031722,0.29105,0.52082,GOMF_GPI_ANCHOR_BINDING,0.99999
GOMF_PYRIMIDINE_NUCLEOTIDE_S...,SET,10,-0.01354,-0.00031593,0.25934,0.52082,GOMF_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOMF_LAMININ_BINDING,SET,27,-0.0087237,-0.00033431,0.16678,0.52086,GOMF_LAMININ_BINDING,0.99999
GOBP_MESENCHYMAL_CELL_DIFFER...1,SET,237,-0.0031188,-0.00035207,0.059522,0.52089,GOBP_MESENCHYMAL_CELL_DIFFERENTIATION,0.99999
TASOR_TARGET_GENES,SET,209,-0.003135,-0.0003326,0.059805,0.5209,TASOR_TARGET_GENES,0.99999
SARTIPY_NORMAL_AT_INSULIN_RE...2,SET,27,-0.008614,-0.00033011,0.16384,0.52096,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...525,SET,8,-0.017014,-0.0003551,0.32372,0.52096,GOBP_POSITIVE_REGULATION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.99999
HP_APLASIA_OF_THE_2ND_FINGER,SET,4,-0.023059,-0.00034034,0.43876,0.52096,HP_APLASIA_OF_THE_2ND_FINGER,0.99999
GOBP_PEPTIDE_TRANSPORT,SET,244,-0.0029591,-0.00033887,0.056262,0.52097,GOBP_PEPTIDE_TRANSPORT,0.99999
GOBP_PYRIDINE_CONTAINING_COM...1,SET,30,-0.0085355,-0.00034476,0.16227,0.52097,GOBP_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
HP_LOWER_LIMB_METAPHYSEAL_IR...,SET,9,-0.015507,-0.00034327,0.29456,0.52099,HP_LOWER_LIMB_METAPHYSEAL_IRREGULARITY,0.99999
GRAHAM_CML_QUIESCENT_VS_NORM...4,SET,80,-0.0050856,-0.00033498,0.096559,0.521,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,0.99999
GSE5589_LPS_VS_LPS_AND_IL6_S...5,SET,173,-0.003315,-0.00032029,0.062905,0.52101,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.99999
TRAVAGLINI_LUNG_PROLIFERATIN...2,SET,872,-0.0015272,-0.00032485,0.028894,0.52108,TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL,0.99999
GOBP_MESODERMAL_CELL_FATE_SP...,SET,13,-0.012799,-0.00034047,0.2415,0.52113,GOBP_MESODERMAL_CELL_FATE_SPECIFICATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...253,SET,16,-0.010626,-0.00031357,0.20042,0.52114,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION,0.99999
MIR197_5P,SET,57,-0.0059755,-0.00033245,0.11238,0.5212,MIR197_5P,0.99999
GGCACAT_MIR455,SET,54,-0.0060767,-0.00032909,0.11413,0.52123,GGCACAT_MIR455,0.99999
GOCC_BRUSH_BORDER_MEMBRANE,SET,55,-0.0059112,-0.00032306,0.1109,0.52125,GOCC_BRUSH_BORDER_MEMBRANE,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...13,SET,10,-0.015047,-0.00035109,0.28228,0.52126,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP,0.99999
MIR3973,SET,233,-0.0030393,-0.00034022,0.056899,0.5213,MIR3973,0.99999
CHUNG_BLISTER_CYTOTOXICITY_DN,SET,40,-0.0072893,-0.00033988,0.13639,0.52131,CHUNG_BLISTER_CYTOTOXICITY_DN,0.99999
GTCAACC_MIR3805P,SET,20,-0.011406,-0.00037627,0.21334,0.52132,GTCAACC_MIR3805P,0.99999
GCM_ANP32B,SET,31,-0.0079776,-0.00032755,0.14907,0.52134,GCM_ANP32B,0.99999
GOBP_SECRETION,SET,898,-0.0016003,-0.00034517,0.029858,0.52137,GOBP_SECRETION,0.99999
HP_HYPNOPOMPIC_HALLUCINATION,SET,6,-0.020743,-0.00037495,0.38712,0.52137,HP_HYPNOPOMPIC_HALLUCINATION,0.99999
MODULE_152,SET,102,-0.0040756,-0.00030295,0.076022,0.52138,MODULE_152,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...25,SET,7,-0.017868,-0.00034884,0.333,0.5214,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_PTERIDINE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.99999
GOBP_MODIFICATION_OF_POSTSYN...2,SET,21,-0.0097228,-0.00032866,0.18106,0.52141,GOBP_MODIFICATION_OF_POSTSYNAPTIC_STRUCTURE,0.99999
GSE360_T_GONDII_VS_M_TUBERCU...3,SET,176,-0.0034987,-0.00034093,0.064909,0.52149,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...7,SET,10,-0.013517,-0.00031539,0.249,0.52165,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS,0.99999
HP_SEVERE_EPSTEIN_BARR_VIRUS...,SET,4,-0.026662,-0.00039351,0.49095,0.52165,HP_SEVERE_EPSTEIN_BARR_VIRUS_INFECTION,0.99999
GSE19888_CTRL_VS_A3R_ACTIVAT...1,SET,171,-0.003621,-0.00034784,0.066526,0.5217,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_DN,0.99999
REACTOME_ETHANOL_OXIDATION,SET,12,-0.016819,-0.00042987,0.30877,0.52172,REACTOME_ETHANOL_OXIDATION,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...5,SET,426,-0.002215,-0.00033348,0.040486,0.52182,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,0.99999
REACTOME_FORMATION_OF_RNA_PO...,SET,52,-0.0055075,-0.0002927,0.10038,0.52188,REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX,0.99999
MODULE_105,SET,188,-0.0033087,-0.00033311,0.060166,0.52193,MODULE_105,0.99999
SPIELMAN_LYMPHOBLAST_EUROPEA...3,SET,545,-0.0019607,-0.00033278,0.035627,0.52194,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN,0.99999
REACTOME_DEGRADATION_OF_THE_...,SET,132,-0.0045334,-0.00038303,0.08228,0.52197,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,0.99999
GOBP_B_1_B_CELL_DIFFERENTIAT...,SET,5,-0.02347,-0.00038728,0.42511,0.52201,GOBP_B_1_B_CELL_DIFFERENTIATION,0.99999
GOCC_SPERMATOPROTEASOME_COMP...,SET,5,-0.018601,-0.00030693,0.33623,0.52206,GOCC_SPERMATOPROTEASOME_COMPLEX,0.99999
GOBP_AMP_METABOLIC_PROCESS,SET,20,-0.01074,-0.00035429,0.19359,0.52212,GOBP_AMP_METABOLIC_PROCESS,0.99999
GOCC_JUNCTIONAL_MEMBRANE_COM...,SET,6,-0.019627,-0.00035477,0.35356,0.52213,GOCC_JUNCTIONAL_MEMBRANE_COMPLEX,0.99999
GSE11864_UNTREATED_VS_CSF1_P...1,SET,176,-0.0033635,-0.00032775,0.060467,0.52218,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN,0.99999
GSE40274_CTRL_VS_FOXP3_AND_I...1,SET,147,-0.0037594,-0.00033505,0.067412,0.52224,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
MIR4752,SET,74,-0.0054974,-0.00034832,0.098537,0.52225,MIR4752,0.99999
HP_WIDE_ANTERIOR_FONTANEL,SET,80,-0.0053529,-0.00035259,0.095849,0.52227,HP_WIDE_ANTERIOR_FONTANEL,0.99999
GOBP_MEMBRANE_RAFT_ORGANIZAT...,SET,24,-0.010045,-0.00036296,0.17933,0.52233,GOBP_MEMBRANE_RAFT_ORGANIZATION,0.99999
GOCC_MICROTUBULE_ASSOCIATED_...,SET,139,-0.0037512,-0.00032517,0.066945,0.52234,GOCC_MICROTUBULE_ASSOCIATED_COMPLEX,0.99999
GSE43863_NAIVE_VS_MEMORY_TH1...1,SET,139,-0.0040424,-0.00035042,0.071967,0.5224,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_DN,0.99999
WIEDERSCHAIN_TARGETS_OF_BMI1...,SET,55,-0.0069841,-0.0003817,0.12393,0.52247,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,0.99999
GOBP_L_CYSTINE_TRANSPORT,SET,6,-0.019501,-0.00035249,0.3452,0.52252,GOBP_L_CYSTINE_TRANSPORT,0.99999
GCM_MLL,SET,157,-0.0035769,-0.00032937,0.063282,0.52254,GCM_MLL,0.99999
HP_LOWER_LIMB_HYPERREFLEXIA,SET,71,-0.0055263,-0.00034301,0.097724,0.52255,HP_LOWER_LIMB_HYPERREFLEXIA,0.99999
GOBP_SUBSTRATE_DEPENDENT_CEL...2,SET,7,-0.017404,-0.00033978,0.30693,0.52261,GOBP_SUBSTRATE_DEPENDENT_CELL_MIGRATION_CELL_EXTENSION,0.99999
HP_ATROPHY_OF_ALVEOLAR_RIDGES,SET,3,-0.033148,-0.00042371,0.58461,0.52261,HP_ATROPHY_OF_ALVEOLAR_RIDGES,0.99999
HP_POLYMICROGYRIA,SET,179,-0.0036048,-0.00035421,0.063569,0.52261,HP_POLYMICROGYRIA,0.99999
ALTEMEIER_RESPONSE_TO_LPS_WI...,SET,112,-0.0048478,-0.0003775,0.085466,0.52262,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,0.99999
MIR6072,SET,72,-0.0057204,-0.00035754,0.10079,0.52263,MIR6072,0.99999
HP_URINARY_TRACT_NEOPLASM,SET,133,-0.0042013,-0.0003563,0.07382,0.52269,HP_URINARY_TRACT_NEOPLASM,0.99999
GOBP_POSITIVE_REGULATION_OF_...745,SET,6,-0.019377,-0.00035025,0.34028,0.5227,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_ENDOCYTOSIS,0.99999
HP_ABNORMALITY_OF_THE_PHALAN...1,SET,16,-0.012461,-0.00036772,0.21881,0.52271,HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_2ND_FINGER,0.99999
GOBP_RESPONSE_TO_PH,SET,38,-0.0080754,-0.00036702,0.14164,0.52273,GOBP_RESPONSE_TO_PH,0.99999
GOBP_PROTEIN_MATURATION_BY_4...,SET,4,-0.030367,-0.0004482,0.5313,0.52279,GOBP_PROTEIN_MATURATION_BY_4FE_4S_CLUSTER_TRANSFER,0.99999
HP_BROAD_BASED_GAIT,SET,99,-0.0048633,-0.00035617,0.085014,0.52281,HP_BROAD_BASED_GAIT,0.99999
KEGG_PROGESTERONE_MEDIATED_O...,SET,79,-0.0053939,-0.00035308,0.094134,0.52285,KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,0.99999
GSE42021_CD24INT_VS_CD24LOW_...3,SET,179,-0.0036652,-0.00036015,0.06395,0.52285,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...9,SET,119,-0.0045523,-0.00036533,0.079306,0.52289,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_METACARPAL_BONES,0.99999
HP_INTRACEREBRAL_PERIVENTRIC...,SET,6,-0.018835,-0.00034045,0.32763,0.52292,HP_INTRACEREBRAL_PERIVENTRICULAR_CALCIFICATIONS,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...5,SET,36,-0.0080831,-0.0003576,0.14038,0.52296,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN,0.99999
HASINA_NOL7_TARGETS_UP,SET,10,-0.016721,-0.00039014,0.29007,0.52298,HASINA_NOL7_TARGETS_UP,0.99999
HP_DIMPLE_CHIN,SET,14,-0.01483,-0.00040939,0.25709,0.523,HP_DIMPLE_CHIN,0.99999
GALE_APL_WITH_FLT3_MUTATED_UP,SET,55,-0.0065789,-0.00035956,0.1137,0.52307,GALE_APL_WITH_FLT3_MUTATED_UP,0.99999
GOBP_TRYPTOPHAN_CATABOLIC_PR...,SET,5,-0.02689,-0.00044371,0.46339,0.52314,GOBP_TRYPTOPHAN_CATABOLIC_PROCESS_TO_KYNURENINE,0.99999
GOBP_RESPONSE_TO_VASOPRESSIN,SET,8,-0.019049,-0.00039756,0.32777,0.52317,GOBP_RESPONSE_TO_VASOPRESSIN,0.99999
MORF_BAG5,SET,52,-0.0061152,-0.000325,0.10514,0.52319,MORF_BAG5,0.99999
MIR27A_5P,SET,34,-0.0084267,-0.00036231,0.14452,0.52325,MIR27A_5P,0.99999
GOBP_REGULATION_OF_ATTACHMEN...2,SET,22,-0.0099194,-0.00034318,0.17009,0.52325,GOBP_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.99999
GOBP_POSITIVE_REGULATION_OF_...332,SET,6,-0.021417,-0.00038712,0.36632,0.52331,GOBP_POSITIVE_REGULATION_OF_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,0.99999
WP_CANONICAL_AND_NONCANONICA...2,SET,17,-0.01332,-0.00040513,0.22715,0.52338,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,0.99999
GOBP_POSITIVE_REGULATION_OF_...491,SET,98,-0.0050357,-0.00036694,0.085537,0.52347,GOBP_POSITIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_PHOSPHOLI...1,SET,7,-0.020198,-0.00039434,0.34304,0.52348,GOBP_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY,0.99999
GSE13887_HEALTHY_VS_LUPUS_RE...2,SET,104,-0.0050639,-0.00038007,0.085992,0.52348,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP,0.99999
MIR424_5P,SET,476,-0.0022961,-0.00036491,0.038977,0.52349,MIR424_5P,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...7,SET,181,-0.0038064,-0.00037609,0.064517,0.52352,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_DN,0.99999
MORF_CDH4,SET,115,-0.0048724,-0.00038442,0.082503,0.52355,MORF_CDH4,0.99999
KEGG_MEDICUS_ENV_FACTOR_NNK_...3,SET,12,-0.014946,-0.00038201,0.2528,0.52357,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350,0.99999
ZWANG_CLASS_3_TRANSIENTLY_IN...,SET,205,-0.0038504,-0.00040461,0.065067,0.52359,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,0.99999
HP_HYPERGLUTAMINEMIA,SET,8,-0.014976,-0.00031256,0.25316,0.52359,HP_HYPERGLUTAMINEMIA,0.99999
KEGG_SYSTEMIC_LUPUS_ERYTHEMA...,SET,48,-0.0078618,-0.00040148,0.13275,0.52361,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,0.99999
HP_SPASTIC_ATAXIA,SET,18,-0.011612,-0.00036342,0.19587,0.52364,HP_SPASTIC_ATAXIA,0.99999
MODULE_86,SET,42,-0.0077788,-0.00037164,0.13114,0.52365,MODULE_86,0.99999
REACTOME_NFE2L2_REGULATING_T...,SET,11,-0.016523,-0.00040433,0.27769,0.52372,REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...4,SET,40,-0.007946,-0.0003705,0.13343,0.52374,GOMF_STRUCTURAL_CONSTITUENT_OF_MUSCLE,0.99999
MIR520F_5P,SET,182,-0.0038836,-0.00038477,0.06513,0.52377,MIR520F_5P,0.99999
GOUYER_TATI_TARGETS_DN,SET,17,-0.01222,-0.0003717,0.20486,0.52378,GOUYER_TATI_TARGETS_DN,0.99999
HP_NON_MIDLINE_CLEFT_PALATE,SET,26,-0.01071,-0.00040276,0.17944,0.5238,HP_NON_MIDLINE_CLEFT_PALATE,0.99999
GSE32423_IL7_VS_IL7_IL4_MEMO...1,SET,180,-0.0036374,-0.0003584,0.060759,0.52387,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,0.99999
HP_INCREASED_PROTEINOGENIC_A...,SET,42,-0.0080898,-0.0003865,0.13487,0.52391,HP_INCREASED_PROTEINOGENIC_AMINO_ACID_LEVEL_IN_URINE,0.99999
HP_REDUCED_PROTEIN_S_ACTIVITY,SET,8,-0.014658,-0.00030592,0.24444,0.52391,HP_REDUCED_PROTEIN_S_ACTIVITY,0.99999
MIR3201,SET,74,-0.0058087,-0.00036805,0.096799,0.52392,MIR3201,0.99999
GOBP_REGULATION_OF_MONOATOMI...4,SET,410,-0.0027269,-0.00040295,0.045244,0.52403,GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,0.99999
GOBP_REGULATION_OF_NK_T_CELL...3,SET,7,-0.022201,-0.00043343,0.36774,0.52407,GOBP_REGULATION_OF_NK_T_CELL_PROLIFERATION,0.99999
NAKAYA_MONOCYTE_FLUARIX_FLUV...1,SET,86,-0.0056995,-0.00038918,0.094338,0.52409,NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.99999
GOCC_SODIUM_POTASSIUM_EXCHAN...,SET,11,-0.017941,-0.00043904,0.29647,0.52413,GOCC_SODIUM_POTASSIUM_EXCHANGING_ATPASE_COMPLEX,0.99999
GOBP_EMBRYO_IMPLANTATION,SET,50,-0.0075958,-0.00039587,0.12547,0.52414,GOBP_EMBRYO_IMPLANTATION,0.99999
HP_ABNORMAL_MAXILLA_MORPHOLO...,SET,133,-0.0044992,-0.00038156,0.074245,0.52416,HP_ABNORMAL_MAXILLA_MORPHOLOGY,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...7,SET,188,-0.0035788,-0.0003603,0.059069,0.52416,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN,0.99999
REACTOME_SIGNALING_BY_LTK_IN...,SET,7,-0.019895,-0.00038841,0.32815,0.52417,REACTOME_SIGNALING_BY_LTK_IN_CANCER,0.99999
GENTILE_UV_LOW_DOSE_UP,SET,23,-0.01098,-0.00038841,0.18108,0.52418,GENTILE_UV_LOW_DOSE_UP,0.99999
HP_BABINSKI_SIGN,SET,254,-0.0031844,-0.00037197,0.052452,0.5242,HP_BABINSKI_SIGN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...671,SET,10,-0.017861,-0.00041676,0.29406,0.52422,GOBP_NEGATIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION,0.99999
DESCARTES_MAIN_FETAL_PDE11A_...,SET,37,-0.0098125,-0.00044008,0.16133,0.52425,DESCARTES_MAIN_FETAL_PDE11A_FAM19A2_POSITIVE_CELLS,0.99999
HP_ABNORMAL_CIRCULATING_NITR...,SET,154,-0.0040759,-0.00037175,0.066868,0.5243,HP_ABNORMAL_CIRCULATING_NITROGEN_COMPOUND_CONCENTRATION,0.99999
MIR513A_3P_MIR513C_3P,SET,409,-0.0026292,-0.00038805,0.043015,0.52437,MIR513A_3P_MIR513C_3P,0.99999
HP_RENAL_TUBULAR_DYSFUNCTION,SET,90,-0.0053548,-0.00037401,0.087604,0.52437,HP_RENAL_TUBULAR_DYSFUNCTION,0.99999
MEBARKI_HCC_PROGENITOR_WNT_D...3,SET,18,-0.013496,-0.0004224,0.22056,0.5244,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,0.99999
GOCC_CATSPER_COMPLEX,SET,11,-0.014963,-0.00036616,0.24449,0.5244,GOCC_CATSPER_COMPLEX,0.99999
HP_EXAGGERATED_STARTLE_RESPO...,SET,29,-0.010286,-0.0004085,0.16799,0.52441,HP_EXAGGERATED_STARTLE_RESPONSE,0.99999
PIT1_Q6,SET,202,-0.0039272,-0.00040968,0.06404,0.52445,PIT1_Q6,0.99999
REACTOME_COLLAGEN_DEGRADATION,SET,61,-0.0073983,-0.00042576,0.12055,0.52447,REACTOME_COLLAGEN_DEGRADATION,0.99999
REACTOME_RORA_ACTIVATES_GENE...,SET,17,-0.012552,-0.0003818,0.20434,0.52449,REACTOME_RORA_ACTIVATES_GENE_EXPRESSION,0.99999
HP_DELAYED_CRANIAL_SUTURE_CL...,SET,87,-0.0056705,-0.00038943,0.092297,0.52449,HP_DELAYED_CRANIAL_SUTURE_CLOSURE,0.99999
WP_SECRETION_OF_HYDROCHLORIC...,SET,5,-0.026162,-0.0004317,0.4239,0.52461,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,0.99999
ERR1_Q2,SET,228,-0.0035299,-0.00039093,0.05712,0.52464,ERR1_Q2,0.99999
GOBP_VENTRICULAR_COMPACT_MYO...,SET,7,-0.022752,-0.00044419,0.36762,0.52467,GOBP_VENTRICULAR_COMPACT_MYOCARDIUM_MORPHOGENESIS,0.99999
MODULE_274,SET,76,-0.0065101,-0.00041801,0.10509,0.5247,MODULE_274,0.99999
KEGG_GLYCOSPHINGOLIPID_BIOSY...1,SET,15,-0.015466,-0.0004419,0.24949,0.52471,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,0.99999
DESCARTES_FETAL_MUSCLE_LYMPH...1,SET,56,-0.0078624,-0.00043358,0.12683,0.52471,DESCARTES_FETAL_MUSCLE_LYMPHATIC_ENDOTHELIAL_CELLS,0.99999
WDHD1_TARGET_GENES,SET,148,-0.0044258,-0.00039578,0.071295,0.52475,WDHD1_TARGET_GENES,0.99999
GOCC_SYNAPTOBREVIN_2_SNAP_25...,SET,5,-0.01842,-0.00030395,0.29612,0.5248,GOCC_SYNAPTOBREVIN_2_SNAP_25_SYNTAXIN_1A_COMPLEX,0.99999
GOBP_REGULATION_OF_CELL_GROW...1,SET,353,-0.0028861,-0.00039635,0.046385,0.52481,GOBP_REGULATION_OF_CELL_GROWTH,0.99999
HP_ATHETOSIS,SET,139,-0.0043505,-0.00037712,0.069788,0.52485,HP_ATHETOSIS,0.99999
REACTOME_ACTIVATION_OF_THE_P...2,SET,31,-0.0083933,-0.00034462,0.13456,0.52487,REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,0.99999
HP_ANTIMITOCHONDRIAL_ANTIBOD...,SET,11,-0.019073,-0.00046673,0.30564,0.52488,HP_ANTIMITOCHONDRIAL_ANTIBODY_POSITIVITY,0.99999
CAIRO_HEPATOBLASTOMA_CLASSES...2,SET,559,-0.0021553,-0.00037034,0.03451,0.5249,CAIRO_HEPATOBLASTOMA_CLASSES_UP,0.99999
GSE36078_UNTREATED_VS_AD5_T4...4,SET,179,-0.0039798,-0.00039106,0.06373,0.5249,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP,0.99999
GOBP_REGULATION_OF_T_CELL_AC...2,SET,6,-0.021141,-0.00038214,0.33761,0.52497,GOBP_REGULATION_OF_T_CELL_ACTIVATION_VIA_T_CELL_RECEPTOR_CONTACT_WITH_ANTIGEN_BOUND_TO_MHC_MOLECULE_ON_ANTIGEN_PRESENTING_CELL,0.99999
GNF2_CD14,SET,32,-0.010497,-0.00043786,0.16738,0.525,GNF2_CD14,0.99999
GOBP_NEUTROPHIL_EXTRAVASATION,SET,9,-0.020267,-0.00044863,0.32257,0.52505,GOBP_NEUTROPHIL_EXTRAVASATION,0.99999
MIR3122,SET,59,-0.0067325,-0.00038106,0.10677,0.52514,MIR3122,0.99999
GOCC_STEREOCILIA_COUPLING_LI...,SET,7,-0.022102,-0.00043151,0.3501,0.52517,GOCC_STEREOCILIA_COUPLING_LINK,0.99999
MIR651_3P,SET,728,-0.0020847,-0.00040682,0.03295,0.52522,MIR651_3P,0.99999
GCGCTTT_MIR518B_MIR518C_MIR5...,SET,17,-0.01238,-0.00037657,0.19574,0.52522,GCGCTTT_MIR518B_MIR518C_MIR518D,0.99999
HP_METACARPOPHALANGEAL_JOINT...,SET,3,-0.040457,-0.00051713,0.63957,0.52522,HP_METACARPOPHALANGEAL_JOINT_CONTRACTURE,0.99999
HP_PRURITIS_ON_HAND,SET,5,-0.025746,-0.00042484,0.40615,0.52527,HP_PRURITIS_ON_HAND,0.99999
GOMF_PHOSPHOLIPASE_C_ACTIVITY,SET,29,-0.010071,-0.00039997,0.15862,0.52531,GOMF_PHOSPHOLIPASE_C_ACTIVITY,0.99999
MIR891A_3P,SET,119,-0.0052104,-0.00041814,0.082001,0.52533,MIR891A_3P,0.99999
GOMF_MAP_KINASE_KINASE_KINAS...2,SET,6,-0.022313,-0.00040332,0.35118,0.52533,GOMF_MAP_KINASE_KINASE_KINASE_KINASE_ACTIVITY,0.99999
DELASERNA_MYOD_TARGETS_UP,SET,81,-0.0061099,-0.00040495,0.09608,0.52535,DELASERNA_MYOD_TARGETS_UP,0.99999
GOBP_DETECTION_OF_LIPOPOLYSA...,SET,5,-0.026999,-0.00044551,0.42423,0.52537,GOBP_DETECTION_OF_LIPOPOLYSACCHARIDE,0.99999
TAGCTTT_MIR9,SET,210,-0.0038313,-0.00040742,0.060177,0.52538,TAGCTTT_MIR9,0.99999
GOBP_POLYSACCHARIDE_BIOSYNTH...,SET,60,-0.0070074,-0.00039995,0.10982,0.52544,GOBP_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS,0.99999
FERREIRA_EWINGS_SARCOMA_UNST...2,SET,148,-0.0041885,-0.00037456,0.0656,0.52545,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,0.99999
HUTTMANN_B_CLL_POOR_SURVIVAL...1,SET,57,-0.0073705,-0.00041006,0.11534,0.52548,HUTTMANN_B_CLL_POOR_SURVIVAL_DN,0.99999
TAGGTCA_MIR192_MIR215,SET,36,-0.0086833,-0.00038415,0.13519,0.52561,TAGGTCA_MIR192_MIR215,0.99999
STAT6_02,SET,239,-0.0036899,-0.00041827,0.057301,0.52567,STAT6_02,0.99999
MORF_BNIP1,SET,174,-0.0040765,-0.00039498,0.063194,0.52572,MORF_BNIP1,0.99999
LIU_TOPBP1_TARGETS,SET,12,-0.016978,-0.00043394,0.263,0.52574,LIU_TOPBP1_TARGETS,0.99999
HP_ABNORMAL_BLOOD_INORGANIC_...,SET,160,-0.0045317,-0.00042122,0.070117,0.52577,HP_ABNORMAL_BLOOD_INORGANIC_CATION_CONCENTRATION,0.99999
GOBP_REGULATION_OF_EXTRINSIC...2,SET,43,-0.0087459,-0.00042278,0.13519,0.52579,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND,0.99999
GOBP_ANATOMICAL_STRUCTURE_AR...,SET,16,-0.015475,-0.00045667,0.23897,0.52582,GOBP_ANATOMICAL_STRUCTURE_ARRANGEMENT,0.99999
GSE3982_CENT_MEMORY_CD4_TCEL...2,SET,176,-0.0041981,-0.00040908,0.064738,0.52585,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP,0.99999
KEGG_MEDICUS_REFERENCE_ERK_R...,SET,4,-0.029818,-0.0004401,0.45908,0.52589,KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING,0.99999
MIR3161,SET,69,-0.0073244,-0.0004482,0.11277,0.52589,MIR3161,0.99999
GOMF_NUCLEOSIDE_TRIPHOSPHATA...,SET,445,-0.0026441,-0.00040665,0.0406,0.52596,GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY,0.99999
GSE18893_CTRL_VS_TNF_TREATED...6,SET,182,-0.004027,-0.00039897,0.061599,0.52606,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_UP,0.99999
KEGG_MEDICUS_REFERENCE_IL12_...,SET,10,-0.020533,-0.0004791,0.31395,0.52607,KEGG_MEDICUS_REFERENCE_IL12_23_TO_JAK_STAT_SIGNALING_PATHWAY,0.99999
HP_GLOMERULOPATHY,SET,30,-0.011395,-0.00046024,0.17415,0.52608,HP_GLOMERULOPATHY,0.99999
HP_EEG_WITH_PARIETAL_EPILEPT...,SET,4,-0.035204,-0.0005196,0.53669,0.52615,HP_EEG_WITH_PARIETAL_EPILEPTIFORM_DISCHARGES,0.99999
GOBP_SEROTONIN_SECRETION,SET,9,-0.019516,-0.00043202,0.29742,0.52616,GOBP_SEROTONIN_SECRETION,0.99999
WP_IMMUNE_RESPONSE_TO_TUBERC...,SET,22,-0.011893,-0.00041148,0.18117,0.52617,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.99999
HP_CHORIORETINAL_ATROPHY,SET,40,-0.0091352,-0.00042595,0.13912,0.52618,HP_CHORIORETINAL_ATROPHY,0.99999
GSE21670_IL6_VS_TGFB_AND_IL6...4,SET,187,-0.0037565,-0.0003772,0.057211,0.52618,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.99999
HP_TYPE_I_DIABETES_MELLITUS,SET,51,-0.0081517,-0.00042906,0.12366,0.52628,HP_TYPE_I_DIABETES_MELLITUS,0.99999
WP_EDA_SIGNALING_IN_HAIR_FOL...,SET,11,-0.016836,-0.000412,0.2545,0.52637,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,0.99999
MEISSNER_NPC_HCP_WITH_H3_UNM...,SET,487,-0.0027122,-0.00043584,0.040964,0.52639,MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED,0.99999
HP_PALLOR,SET,140,-0.0046519,-0.00040469,0.070212,0.52641,HP_PALLOR,0.99999
FAN_EMBRYONIC_CTX_BRAIN_NAIV...,SET,139,-0.0050001,-0.00043343,0.075392,0.52644,FAN_EMBRYONIC_CTX_BRAIN_NAIVE_LIKE_T_CELL,0.99999
WP_NAD_METABOLISM_IN_ONCOGEN...,SET,22,-0.011251,-0.00038924,0.1693,0.52649,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.99999
KEGG_MEDICUS_PATHOGEN_SALMON...9,SET,5,-0.020305,-0.00033506,0.30367,0.52666,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SPVD_TO_TNF_NFKB_SIGNALING_PATHWAY,0.99999
GOBP_CELL_MOTILITY_INVOLVED_...,SET,5,-0.024909,-0.00041103,0.37187,0.5267,GOBP_CELL_MOTILITY_INVOLVED_IN_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION,0.99999
MIR520E_5P,SET,147,-0.0048613,-0.00043327,0.072541,0.52671,MIR520E_5P,0.99999
GSE34006_A2AR_KO_VS_A2AR_AGO...2,SET,190,-0.0043299,-0.00043821,0.064592,0.52672,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP,0.99999
MIR23A_3P_MIR23B_3P,SET,536,-0.0025645,-0.00043175,0.038231,0.52674,MIR23A_3P_MIR23B_3P,0.99999
TOMLINS_PROSTATE_CANCER_UP,SET,36,-0.0092832,-0.00041069,0.13836,0.52675,TOMLINS_PROSTATE_CANCER_UP,0.99999
GOBP_T_CELL_DIFFERENTIATION_...2,SET,81,-0.0065213,-0.00043222,0.097004,0.5268,GOBP_T_CELL_DIFFERENTIATION_IN_THYMUS,0.99999
HP_FOCAL_T2_HYPERINTENSE_BRA...,SET,26,-0.0096447,-0.00036271,0.14328,0.52683,HP_FOCAL_T2_HYPERINTENSE_BRAINSTEM_LESION,0.99999
HP_ABNORMAL_2ND_METACARPAL_M...,SET,6,-0.026237,-0.00047424,0.38971,0.52684,HP_ABNORMAL_2ND_METACARPAL_MORPHOLOGY,0.99999
DESCARTES_FETAL_HEART_LYMPHO...,SET,86,-0.0068066,-0.00046478,0.10082,0.52691,DESCARTES_FETAL_HEART_LYMPHOID_CELLS,0.99999
GSE369_SOCS3_KO_VS_WT_LIVER_...1,SET,184,-0.0040924,-0.00040765,0.060585,0.52693,GSE369_SOCS3_KO_VS_WT_LIVER_DN,0.99999
MAEKAWA_ATF2_TARGETS,SET,22,-0.012459,-0.00043104,0.18407,0.52698,MAEKAWA_ATF2_TARGETS,0.99999
GSE13485_DAY3_VS_DAY7_YF17D_...2,SET,151,-0.0047023,-0.00042471,0.069411,0.52701,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP,0.99999
HP_MATERNAL_DIABETES,SET,39,-0.0098357,-0.00045286,0.14459,0.52712,HP_MATERNAL_DIABETES,0.99999
LEE_METASTASIS_AND_RNA_PROCE...,SET,16,-0.013137,-0.00038767,0.1925,0.5272,LEE_METASTASIS_AND_RNA_PROCESSING_UP,0.99999
GSE28783_ANTI_MIR33_VS_CTRL_...2,SET,183,-0.0045437,-0.00045138,0.066541,0.52722,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_UP,0.99999
LIU_SOX4_TARGETS_DN,SET,286,-0.0033985,-0.00042087,0.04969,0.52726,LIU_SOX4_TARGETS_DN,0.99999
GOMF_TRANSLATION_REGULATOR_A...2,SET,91,-0.0055898,-0.00039258,0.081609,0.5273,GOMF_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING,0.99999
HP_FUNCTIONAL_ABNORMALITY_OF...2,SET,1079,-0.0018531,-0.00043586,0.027054,0.5273,HP_FUNCTIONAL_ABNORMALITY_OF_THE_GASTROINTESTINAL_TRACT,0.99999
GRAHAM_CML_QUIESCENT_VS_NORM...3,SET,37,-0.010461,-0.00046916,0.15248,0.52735,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...5,SET,70,-0.0070408,-0.00043394,0.10244,0.5274,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...7,SET,58,-0.0078168,-0.00043867,0.11355,0.52744,HP_APLASIA_HYPOPLASIA_OF_THE_5TH_FINGER,0.99999
MIR1266_5P,SET,83,-0.0063381,-0.00042521,0.091882,0.5275,MIR1266_5P,0.99999
HP_LIPEMIA_RETINALIS,SET,3,-0.036971,-0.00047257,0.53569,0.52751,HP_LIPEMIA_RETINALIS,0.99999
WP_GLYCOSYLATION_AND_RELATED...,SET,20,-0.011129,-0.00036714,0.16118,0.52752,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,0.99999
GOBP_TERPENOID_BIOSYNTHETIC_...,SET,16,-0.014823,-0.00043741,0.21467,0.52752,GOBP_TERPENOID_BIOSYNTHETIC_PROCESS,0.99999
GSE15659_TREG_VS_TCONV_DN,SET,149,-0.0049465,-0.00044382,0.071607,0.52754,GSE15659_TREG_VS_TCONV_DN,0.99999
RYAAAKNNNNNNTTGW_UNKNOWN,SET,74,-0.0071753,-0.00045464,0.10351,0.52763,RYAAAKNNNNNNTTGW_UNKNOWN,0.99999
KEGG_MEDICUS_REFERENCE_PKA_H...,SET,7,-0.022792,-0.00044498,0.3287,0.52764,KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME,0.99999
MODULE_123,SET,232,-0.0040878,-0.00045663,0.058951,0.52764,MODULE_123,0.99999
GOCC_CAMP_DEPENDENT_PROTEIN_...,SET,7,-0.022792,-0.00044498,0.3287,0.52764,GOCC_CAMP_DEPENDENT_PROTEIN_KINASE_COMPLEX,0.99999
DESCARTES_FETAL_CEREBELLUM_O...,SET,68,-0.0080476,-0.00048888,0.11603,0.52765,DESCARTES_FETAL_CEREBELLUM_OLIGODENDROCYTES,0.99999
GSE32423_MEMORY_VS_NAIVE_CD8...3,SET,178,-0.0044441,-0.00043548,0.064006,0.52768,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN,0.99999
ELVIDGE_HIF1A_TARGETS_UP,SET,62,-0.0069741,-0.00040461,0.1002,0.52774,ELVIDGE_HIF1A_TARGETS_UP,0.99999
GOCC_POSTSYNAPTIC_SPECIALIZA...1,SET,324,-0.003439,-0.00045281,0.049407,0.52775,GOCC_POSTSYNAPTIC_SPECIALIZATION,0.99999
GOBP_REGULATION_OF_LYMPHOCYT...6,SET,63,-0.0077661,-0.00045416,0.11147,0.52777,GOBP_REGULATION_OF_LYMPHOCYTE_MIGRATION,0.99999
GNF2_IGF1,SET,25,-0.012361,-0.00045584,0.17729,0.52779,GNF2_IGF1,0.99999
MIR3168,SET,122,-0.0054112,-0.00043966,0.077576,0.5278,MIR3168,0.99999
REACTOME_SELECTIVE_AUTOPHAGY,SET,80,-0.0065101,-0.00042882,0.09295,0.52792,REACTOME_SELECTIVE_AUTOPHAGY,0.99999
GOBP_TYPE_B_PANCREATIC_CELL_...2,SET,22,-0.01356,-0.00046914,0.19345,0.52794,GOBP_TYPE_B_PANCREATIC_CELL_DEVELOPMENT,0.99999
MIR4453,SET,24,-0.012967,-0.00046854,0.18471,0.52798,MIR4453,0.99999
CREB_Q4_01,SET,191,-0.004409,-0.00044737,0.062766,0.528,CREB_Q4_01,0.99999
KEGG_LEISHMANIA_INFECTION,SET,63,-0.0085225,-0.0004984,0.12126,0.52802,KEGG_LEISHMANIA_INFECTION,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...5,SET,139,-0.005244,-0.00045458,0.074484,0.52806,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN,0.99999
HP_FAVORABLE_RESPONSE_OF_WEA...,SET,4,-0.031031,-0.00045799,0.43995,0.52811,HP_FAVORABLE_RESPONSE_OF_WEAKNESS_TO_ACETYLCHOLINE_ESTERASE_INHIBITORS,0.99999
IRX3_TARGET_GENES,SET,44,-0.0091071,-0.00044532,0.12907,0.52813,IRX3_TARGET_GENES,0.99999
MIR5591_5P,SET,59,-0.0077471,-0.00043848,0.10974,0.52814,MIR5591_5P,0.99999
GAO_LARGE_INTESTINE_24W_C5_L...,SET,49,-0.0091726,-0.00047326,0.12969,0.52819,GAO_LARGE_INTESTINE_24W_C5_LGR5POS_STEM_CELL,0.99999
KEGG_MEDICUS_PATHOGEN_HCV_CO...1,SET,12,-0.01883,-0.00048126,0.26587,0.52823,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY,0.99999
REACTOME_RUNX2_REGULATES_OST...,SET,21,-0.013348,-0.0004512,0.18833,0.52825,REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION,0.99999
GOBP_SEX_DIFFERENTIATION,SET,260,-0.0039655,-0.00046857,0.055844,0.5283,GOBP_SEX_DIFFERENTIATION,0.99999
GOBP_CHORIONIC_TROPHOBLAST_C...2,SET,5,-0.028325,-0.00046739,0.39871,0.52832,GOBP_CHORIONIC_TROPHOBLAST_CELL_PROLIFERATION,0.99999
MIR3182,SET,238,-0.0039814,-0.00045038,0.05599,0.52834,MIR3182,0.99999
HP_TINNITUS,SET,65,-0.0072177,-0.00042872,0.10143,0.52837,HP_TINNITUS,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...15,SET,173,-0.0047477,-0.00045871,0.066668,0.52839,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN,0.99999
GSE4748_CTRL_VS_CYANOBACTERI...4,SET,187,-0.0043772,-0.00043953,0.061456,0.52839,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.99999
HP_GENERALIZED_NEONATAL_HYPO...,SET,18,-0.012848,-0.00040212,0.18035,0.5284,HP_GENERALIZED_NEONATAL_HYPOTONIA,0.99999
GOBP_GLANDULAR_EPITHELIAL_CE...3,SET,8,-0.024871,-0.00051907,0.34876,0.52842,GOBP_GLANDULAR_EPITHELIAL_CELL_MATURATION,0.99999
GSE25088_CTRL_VS_IL4_STIM_ST...2,SET,156,-0.0051009,-0.00046822,0.071494,0.52844,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP,0.99999
MIR5690,SET,110,-0.0060586,-0.00046757,0.084893,0.52845,MIR5690,0.99999
MODULE_417,SET,20,-0.014727,-0.00048581,0.20617,0.52847,MODULE_417,0.99999
DAUER_STAT3_TARGETS_DN,SET,46,-0.009571,-0.0004785,0.13371,0.52853,DAUER_STAT3_TARGETS_DN,0.99999
HP_ABNORMALITY_OF_THE_DISTAL...2,SET,5,-0.026561,-0.00043829,0.3711,0.52853,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_2ND_FINGER,0.99999
HP_ABNORMAL_CSF_GLUCOSE_CONC...,SET,6,-0.026624,-0.00048125,0.3718,0.52854,HP_ABNORMAL_CSF_GLUCOSE_CONCENTRATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...446,SET,5,-0.031683,-0.0005228,0.44073,0.52865,GOBP_NEGATIVE_REGULATION_OF_NEUTROPHIL_MIGRATION,0.99999
GOCC_AXONEMAL_A_TUBULE_INNER...,SET,9,-0.022876,-0.0005064,0.31819,0.52866,GOCC_AXONEMAL_A_TUBULE_INNER_SHEATH,0.99999
GSE17186_NAIVE_VS_CD21LOW_TR...3,SET,180,-0.0045116,-0.00044455,0.062723,0.52867,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_DN,0.99999
GCM_RING1,SET,98,-0.0059232,-0.00043161,0.082317,0.52868,GCM_RING1,0.99999
KEGG_MEDICUS_REFERENCE_TYROS...,SET,5,-0.027688,-0.00045688,0.38466,0.52869,KEGG_MEDICUS_REFERENCE_TYROSINE_DEGRADATION,0.99999
REACTOME_TYROSINE_CATABOLISM,SET,5,-0.027688,-0.00045688,0.38466,0.52869,REACTOME_TYROSINE_CATABOLISM,0.99999
WP_TYROSINE_METABOLISM_AND_R...,SET,5,-0.027688,-0.00045688,0.38466,0.52869,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,0.99999
HP_FEBRILE_SEIZURE_WITHIN_TH...,SET,123,-0.0057207,-0.00046669,0.079294,0.52876,HP_FEBRILE_SEIZURE_WITHIN_THE_AGE_RANGE_OF_3_MONTHS_TO_6_YEARS,0.99999
WP_PRIMARY_OVARIAN_INSUFFICI...,SET,159,-0.0046111,-0.00042727,0.063841,0.52879,WP_PRIMARY_OVARIAN_INSUFFICIENCY,0.99999
HP_ABNORMAL_CARPAL_MORPHOLOGY,SET,79,-0.0071458,-0.00046775,0.098926,0.52879,HP_ABNORMAL_CARPAL_MORPHOLOGY,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...19,SET,646,-0.0023947,-0.00044124,0.03315,0.52879,HP_APLASIA_HYPOPLASIA_OF_THE_CORPUS_CALLOSUM,0.99999
KEGG_MEDICUS_REFERENCE_NOTCH...4,SET,13,-0.017683,-0.00047039,0.24468,0.52881,KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY,0.99999
GOBP_SEROTONIN_METABOLIC_PRO...,SET,10,-0.02128,-0.00049652,0.29433,0.52882,GOBP_SEROTONIN_METABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...481,SET,1055,-0.0020056,-0.00046677,0.02773,0.52883,GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION,0.99999
chr13q32,SET,29,-0.021833,-0.00086707,0.30177,0.52884,chr13q32,0.99999
REACTOME_INOSITOL_PHOSPHATE_...,SET,45,-0.0084572,-0.0004182,0.11687,0.52884,REACTOME_INOSITOL_PHOSPHATE_METABOLISM,0.99999
HP_LONG_FOOT,SET,22,-0.012241,-0.0004235,0.16884,0.5289,HP_LONG_FOOT,0.99999
GOBP_HEART_MORPHOGENESIS,SET,251,-0.0042407,-0.00049247,0.058381,0.52895,GOBP_HEART_MORPHOGENESIS,0.99999
SP1_Q2_01,SET,236,-0.0041426,-0.00046666,0.056986,0.52897,SP1_Q2_01,0.99999
GOBP_NEGATIVE_REGULATION_OF_...305,SET,13,-0.019026,-0.00050612,0.26127,0.52903,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION,0.99999
GOMF_PHOSPHOTRANSFERASE_ACTI...3,SET,34,-0.010311,-0.00044333,0.14083,0.52918,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR,0.99999
GOBP_G1_TO_G0_TRANSITION_INV...,SET,6,-0.024049,-0.00043469,0.32778,0.52924,GOBP_G1_TO_G0_TRANSITION_INVOLVED_IN_CELL_DIFFERENTIATION,0.99999
GSE3982_EFF_MEMORY_CD4_TCELL...3,SET,181,-0.0045436,-0.00044892,0.061893,0.52926,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN,0.99999
GOBP_HOMOCYSTEINE_METABOLIC_...,SET,11,-0.018166,-0.00044454,0.24718,0.52929,GOBP_HOMOCYSTEINE_METABOLIC_PROCESS,0.99999
RADMACHER_AML_PROGNOSIS,SET,73,-0.0078888,-0.00049647,0.10733,0.5293,RADMACHER_AML_PROGNOSIS,0.99999
GOCC_PROTEASOME_CORE_COMPLEX...2,SET,11,-0.017639,-0.00043164,0.23988,0.52931,GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX,0.99999
DING_LUNG_CANCER_MUTATED_REC...,SET,6,-0.026954,-0.00048722,0.36576,0.52937,DING_LUNG_CANCER_MUTATED_RECURRENTLY,0.99999
HP_CHOREA,SET,202,-0.0043365,-0.00045238,0.058796,0.5294,HP_CHOREA,0.99999
GOCC_CLATHRIN_COMPLEX,SET,8,-0.018874,-0.00039391,0.25577,0.52941,GOCC_CLATHRIN_COMPLEX,0.99999
GOBP_NEGATIVE_REGULATION_OF_...356,SET,293,-0.0039239,-0.00049176,0.053165,0.52942,GOBP_NEGATIVE_REGULATION_OF_LOCOMOTION,0.99999
HP_ABNORMAL_CSF_HOMOVANILLIC...,SET,9,-0.021802,-0.00048261,0.29517,0.52944,HP_ABNORMAL_CSF_HOMOVANILLIC_ACID_CONCENTRATION,0.99999
GOBP_AMINO_ACID_BETAINE_BIOS...,SET,5,-0.032504,-0.00053635,0.43879,0.52952,GOBP_AMINO_ACID_BETAINE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_ORGANELLE_FUSION,SET,152,-0.0050798,-0.00046031,0.068555,0.52953,GOBP_ORGANELLE_FUSION,0.99999
MCAATNNNNNGCG_UNKNOWN,SET,74,-0.0076911,-0.00048732,0.10336,0.52966,MCAATNNNNNGCG_UNKNOWN,0.99999
KEGG_MEDICUS_ENV_FACTOR_NNK_...2,SET,11,-0.019016,-0.00046535,0.25533,0.52968,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339,0.99999
RICKMAN_TUMOR_DIFFERENTIATED...1,SET,15,-0.017368,-0.00049625,0.23285,0.52973,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN,0.99999
HP_DUPLICATION_OF_RENAL_PELV...,SET,3,-0.04549,-0.00058147,0.60986,0.52973,HP_DUPLICATION_OF_RENAL_PELVIS,0.99999
GSE6875_TCONV_VS_FOXP3_KO_TR...2,SET,179,-0.0047068,-0.0004625,0.063103,0.52973,GSE6875_TCONV_VS_FOXP3_KO_TREG_UP,0.99999
GSE27786_CD4_TCELL_VS_MONO_M...1,SET,180,-0.0047421,-0.00046725,0.063467,0.52978,GSE27786_CD4_TCELL_VS_MONO_MAC_DN,0.99999
GSE1925_CTRL_VS_3H_IFNG_STIM...4,SET,185,-0.0045708,-0.00045653,0.061033,0.52985,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...4,SET,6,-0.030241,-0.00054662,0.40337,0.52988,HP_APLASIA_HYPOPLASIA_OF_THE_3RD_FINGER,0.99999
BMI1_DN.V1_DN,SET,122,-0.0064093,-0.00052075,0.085477,0.52989,BMI1_DN.V1_DN,0.99999
GOBP_GRANULOCYTE_MACROPHAGE_...,SET,17,-0.016314,-0.00049621,0.21741,0.52991,GOBP_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,0.99999
GOMF_HISTAMINE_RECEPTOR_ACTI...,SET,6,-0.026872,-0.00048572,0.35751,0.52996,GOMF_HISTAMINE_RECEPTOR_ACTIVITY,0.99999
GSE15930_NAIVE_VS_24H_IN_VIT...6,SET,187,-0.0046756,-0.00046948,0.062206,0.52996,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP,0.99999
MIR23C,SET,538,-0.0028723,-0.00048445,0.038168,0.52999,MIR23C,0.99999
GSE26669_CTRL_VS_COSTIM_BLOC...2,SET,186,-0.0045685,-0.00045752,0.06065,0.53002,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP,0.99999
REACTOME_ROLE_OF_SECOND_MESS...,SET,9,-0.021995,-0.00048688,0.29163,0.53006,REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING,0.99999
DESCARTES_MAIN_FETAL_PAEP_ME...,SET,109,-0.0063044,-0.00048434,0.083566,0.53007,DESCARTES_MAIN_FETAL_PAEP_MECOM_POSITIVE_CELLS,0.99999
REACTOME_SYNTHESIS_OF_LIPOXI...,SET,6,-0.028553,-0.00051612,0.37834,0.53008,REACTOME_SYNTHESIS_OF_LIPOXINS_LX,0.99999
MIR711,SET,36,-0.010441,-0.00046189,0.13835,0.53008,MIR711,0.99999
GSE15930_STIM_VS_STIM_AND_TR...3,SET,190,-0.004544,-0.00045988,0.060198,0.53008,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...22,SET,6,-0.027223,-0.00049206,0.36021,0.53012,GOBP_POSITIVE_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.99999
PID_FGF_PATHWAY,SET,54,-0.0091098,-0.00049335,0.12045,0.53014,PID_FGF_PATHWAY,0.99999
MORF_EIF3S2,SET,220,-0.0039892,-0.00043408,0.05273,0.53015,MORF_EIF3S2,0.99999
MIR1183,SET,112,-0.0061395,-0.00047808,0.081028,0.5302,MIR1183,0.99999
GOBP_REGULATION_OF_CYTOKINES...,SET,87,-0.0068698,-0.0004718,0.090605,0.53022,GOBP_REGULATION_OF_CYTOKINESIS,0.99999
GOBP_RENAL_SYSTEM_PROCESS,SET,117,-0.0064704,-0.0005149,0.085333,0.53022,GOBP_RENAL_SYSTEM_PROCESS,0.99999
HP_DERMAL_TRANSLUCENCY,SET,25,-0.013492,-0.00049756,0.17788,0.53023,HP_DERMAL_TRANSLUCENCY,0.99999
HP_SPINAL_MUSCULAR_ATROPHY,SET,51,-0.0086657,-0.00045611,0.11418,0.53025,HP_SPINAL_MUSCULAR_ATROPHY,0.99999
WP_CONVERSION_OF_ANGIOTENSIN...,SET,5,-0.035805,-0.00059083,0.47153,0.53026,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,0.99999
GOMF_HORMONE_ACTIVITY,SET,111,-0.0066772,-0.00051764,0.087867,0.53029,GOMF_HORMONE_ACTIVITY,0.99999
MUELLER_COMMON_TARGETS_OF_AM...1,SET,28,-0.013387,-0.00052243,0.17586,0.53034,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,0.99999
REACTOME_CILIUM_ASSEMBLY,SET,182,-0.0045208,-0.00044789,0.059301,0.53038,REACTOME_CILIUM_ASSEMBLY,0.99999
WP_MRNA_VACCINE_ACTIVATION_O...,SET,7,-0.022155,-0.00043254,0.29064,0.53038,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,0.99999
chr17q25,SET,176,-0.009668,-0.00094208,0.12668,0.53042,chr17q25,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...76,SET,20,-0.013764,-0.00045406,0.18026,0.53043,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.99999
HP_DEMYELINATING_MOTOR_NEURO...,SET,5,-0.031781,-0.00052443,0.41613,0.53044,HP_DEMYELINATING_MOTOR_NEUROPATHY,0.99999
MIR6853_5P,SET,6,-0.027397,-0.00049522,0.35803,0.5305,MIR6853_5P,0.99999
GSE13762_CTRL_VS_125_VITAMIN...3,SET,119,-0.0061154,-0.00049076,0.079918,0.5305,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...8,SET,22,-0.015947,-0.00055173,0.20732,0.53066,GOBP_POSITIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,0.99999
HP_RECURRENT_LOWER_RESPIRATO...,SET,212,-0.0046472,-0.00049651,0.060305,0.53071,HP_RECURRENT_LOWER_RESPIRATORY_TRACT_INFECTIONS,0.99999
HP_ESOPHAGEAL_VARIX,SET,39,-0.011673,-0.00053747,0.15146,0.53072,HP_ESOPHAGEAL_VARIX,0.99999
MODULE_221,SET,29,-0.011478,-0.00045583,0.14862,0.53078,MODULE_221,0.99999
YIH_RESPONSE_TO_ARSENITE_C5,SET,10,-0.027332,-0.00063773,0.35355,0.53081,YIH_RESPONSE_TO_ARSENITE_C5,0.99999
GOBP_REGULATION_OF_STEROID_B...,SET,68,-0.0086125,-0.00052319,0.11124,0.53086,GOBP_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS,0.99999
GOMF_RNA_METHYLTRANSFERASE_A...,SET,53,-0.0076935,-0.00041278,0.099198,0.53091,GOMF_RNA_METHYLTRANSFERASE_ACTIVITY,0.99999
HP_ANTINEUTROPHIL_ANTIBODY_P...,SET,42,-0.01047,-0.00050023,0.13486,0.53094,HP_ANTINEUTROPHIL_ANTIBODY_POSITIVITY,0.99999
GOBP_DIOL_METABOLIC_PROCESS,SET,26,-0.013183,-0.00049576,0.16945,0.531,GOBP_DIOL_METABOLIC_PROCESS,0.99999
GSE16385_IL4_VS_ROSIGLITAZON...1,SET,157,-0.0051915,-0.00047804,0.066692,0.53102,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.99999
RORA1_01,SET,217,-0.0045598,-0.00049281,0.058571,0.53103,RORA1_01,0.99999
GOBP_REGULATION_OF_INSULIN_S...1,SET,157,-0.005421,-0.00049918,0.069603,0.53104,GOBP_REGULATION_OF_INSULIN_SECRETION,0.99999
MIR4432,SET,62,-0.0083991,-0.00048728,0.1077,0.53108,MIR4432,0.99999
GOMF_BMP_RECEPTOR_BINDING,SET,10,-0.022126,-0.00051625,0.28362,0.53109,GOMF_BMP_RECEPTOR_BINDING,0.99999
LEE_NEURAL_CREST_STEM_CELL_UP,SET,139,-0.0061552,-0.00053357,0.07878,0.53114,LEE_NEURAL_CREST_STEM_CELL_UP,0.99999
REACTOME_HS_GAG_DEGRADATION,SET,21,-0.015584,-0.00052678,0.19945,0.53114,REACTOME_HS_GAG_DEGRADATION,0.99999
GOBP_CELLULAR_RESPONSE_TO_CO...4,SET,62,-0.009204,-0.00053398,0.11778,0.53114,GOBP_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS,0.99999
GOBP_TRNA_5_LEADER_REMOVAL,SET,11,-0.017251,-0.00042215,0.22075,0.53114,GOBP_TRNA_5_LEADER_REMOVAL,0.99999
GOMF_FK506_BINDING,SET,10,-0.017977,-0.00041945,0.22998,0.53115,GOMF_FK506_BINDING,0.99999
HP_WIDE_NOSE,SET,108,-0.0063349,-0.00048446,0.081052,0.53115,HP_WIDE_NOSE,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...4,SET,171,-0.005161,-0.00049578,0.066009,0.53116,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP,0.99999
GOBP_AMYLOID_FIBRIL_FORMATION,SET,34,-0.011436,-0.0004917,0.14594,0.53123,GOBP_AMYLOID_FIBRIL_FORMATION,0.99999
GNF2_RPA1,SET,25,-0.012517,-0.00046158,0.15961,0.53125,GNF2_RPA1,0.99999
GSE40274_GATA1_VS_FOXP3_AND_...2,SET,179,-0.004998,-0.00049111,0.063739,0.53125,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
BERENJENO_TRANSFORMED_BY_RHO...4,SET,25,-0.014615,-0.00053897,0.18627,0.53127,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,0.99999
HP_FETAL_ULTRASOUND_SOFT_MAR...,SET,104,-0.006334,-0.00047539,0.080696,0.53128,HP_FETAL_ULTRASOUND_SOFT_MARKER,0.99999
GOMF_PROTEIN_PHOSPHATASE_2B_...,SET,6,-0.02258,-0.00040814,0.28735,0.53132,GOMF_PROTEIN_PHOSPHATASE_2B_BINDING,0.99999
REACTOME_ANTIVIRAL_MECHANISM...,SET,135,-0.0056313,-0.00048113,0.071455,0.53141,REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...8,SET,183,-0.0046554,-0.00046249,0.059059,0.53141,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_UP,0.99999
GSE22601_DOUBLE_NEGATIVE_VS_...5,SET,184,-0.0047516,-0.00047331,0.060236,0.53144,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...797,SET,63,-0.0079395,-0.00046431,0.1006,0.53145,GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,0.99999
HP_ABNORMAL_FEMALE_EXTERNAL_...,SET,137,-0.005916,-0.00050915,0.07492,0.53147,HP_ABNORMAL_FEMALE_EXTERNAL_GENITALIA_MORPHOLOGY,0.99999
KUNINGER_IGF1_VS_PDGFB_TARGE...2,SET,75,-0.007733,-0.00049326,0.097709,0.53154,KUNINGER_IGF1_VS_PDGFB_TARGETS_UP,0.99999
MIR3688_5P,SET,126,-0.006238,-0.00051502,0.078828,0.53154,MIR3688_5P,0.99999
REACTOME_DIGESTION_OF_DIETAR...2,SET,6,-0.036604,-0.00066164,0.46215,0.53156,REACTOME_DIGESTION_OF_DIETARY_LIPID,0.99999
HP_DIASTEMA,SET,22,-0.013241,-0.0004581,0.16705,0.53159,HP_DIASTEMA,0.99999
HP_ACCELERATED_ATHEROSCLEROS...,SET,7,-0.025474,-0.00049734,0.32127,0.5316,HP_ACCELERATED_ATHEROSCLEROSIS,0.99999
ZFP91_TARGET_GENES,SET,1121,-0.0020759,-0.00049706,0.026115,0.53168,ZFP91_TARGET_GENES,0.99999
GSE23502_BM_VS_COLON_TUMOR_H...2,SET,178,-0.0052724,-0.00051665,0.066227,0.53173,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...645,SET,185,-0.0050686,-0.00050624,0.063492,0.53181,GOBP_NEGATIVE_REGULATION_OF_TRANSFERASE_ACTIVITY,0.99999
HP_NEONATAL_HYPERBILIRUBINEM...,SET,22,-0.014748,-0.00051022,0.18473,0.53182,HP_NEONATAL_HYPERBILIRUBINEMIA,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...36,SET,14,-0.021359,-0.00058963,0.2674,0.53183,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,0.99999
PID_TOLL_ENDOGENOUS_PATHWAY,SET,21,-0.013538,-0.00045761,0.16931,0.53187,PID_TOLL_ENDOGENOUS_PATHWAY,0.99999
FULLER_PBMC_F_TULARENSIS_VAC...11,SET,57,-0.0099097,-0.00055133,0.12373,0.53192,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_UP,0.99999
GSE26030_TH1_VS_TH17_RESTIMU...4,SET,185,-0.004962,-0.0004956,0.061911,0.53194,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_UP,0.99999
TESAR_JAK_TARGETS_MOUSE_ES_D...,SET,7,-0.029939,-0.0005845,0.3734,0.53195,TESAR_JAK_TARGETS_MOUSE_ES_D3_DN,0.99999
HP_ABNORMAL_PROSTATE_MORPHOL...,SET,38,-0.011488,-0.00052214,0.14307,0.532,HP_ABNORMAL_PROSTATE_MORPHOLOGY,0.99999
SREBP1_02,SET,79,-0.0073947,-0.00048404,0.092018,0.53202,SREBP1_02,0.99999
WP_STEROID_BIOSYNTHESIS,SET,10,-0.022219,-0.00051842,0.27642,0.53203,WP_STEROID_BIOSYNTHESIS,0.99999
LIU_CMYB_TARGETS_UP,SET,147,-0.0059302,-0.00052853,0.073663,0.53208,LIU_CMYB_TARGETS_UP,0.99999
GOBP_ENUCLEATE_ERYTHROCYTE_M...,SET,3,-0.049121,-0.00062789,0.60911,0.53214,GOBP_ENUCLEATE_ERYTHROCYTE_MATURATION,0.99999
GOCC_PAR_POLARITY_COMPLEX,SET,6,-0.030196,-0.00054581,0.37437,0.53214,GOCC_PAR_POLARITY_COMPLEX,0.99999
FRANCO_BLOOD_SANOFI_PASTEUR_...2,SET,19,-0.016136,-0.00051883,0.19999,0.53215,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_0DY_POSITIVE,0.99999
HMGA1_TARGET_GENES,SET,703,-0.0026643,-0.0005113,0.03297,0.5322,HMGA1_TARGET_GENES,0.99999
REACTOME_DISEASES_OF_CARBOHY...,SET,30,-0.012077,-0.00048781,0.14923,0.53225,REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,0.99999
HP_SCHIZOPHRENIA,SET,61,-0.0096457,-0.00055509,0.11916,0.53226,HP_SCHIZOPHRENIA,0.99999
HP_ABNORMAL_INTRAOCULAR_PRES...,SET,36,-0.012277,-0.00054313,0.15136,0.53232,HP_ABNORMAL_INTRAOCULAR_PRESSURE,0.99999
GOBP_REGULATION_OF_PROTEASOM...1,SET,163,-0.0052829,-0.00049559,0.065094,0.53234,GOBP_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.99999
REACTOME_TRAF6_MEDIATED_IRF7...1,SET,26,-0.015185,-0.00057106,0.18693,0.53237,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION,0.99999
MIR4732_3P,SET,81,-0.0079235,-0.00052515,0.09749,0.53239,MIR4732_3P,0.99999
MIR593_5P,SET,146,-0.0057903,-0.00051431,0.071249,0.53239,MIR593_5P,0.99999
BIOCARTA_NO1_PATHWAY,SET,28,-0.014177,-0.00055326,0.17406,0.53246,BIOCARTA_NO1_PATHWAY,0.99999
BEIER_GLIOMA_STEM_CELL_DN,SET,60,-0.0090048,-0.00051396,0.11034,0.53252,BEIER_GLIOMA_STEM_CELL_DN,0.99999
GSE19374_UNINF_VS_LISTERIA_I...2,SET,177,-0.0051945,-0.00050759,0.063656,0.53252,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP,0.99999
GOMF_RECEPTOR_SIGNALING_PROT...,SET,3,-0.034441,-0.00044024,0.42174,0.53254,GOMF_RECEPTOR_SIGNALING_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,0.99999
GOMF_CYCLIN_BINDING,SET,33,-0.011289,-0.0004782,0.13812,0.53257,GOMF_CYCLIN_BINDING,0.99999
GOBP_REGULATION_OF_LIPID_KIN...,SET,8,-0.021625,-0.00045132,0.2642,0.53262,GOBP_REGULATION_OF_LIPID_KINASE_ACTIVITY,0.99999
HP_DIFFUSE_DEMYELINATION_OF_...,SET,8,-0.025775,-0.00053794,0.31483,0.53262,HP_DIFFUSE_DEMYELINATION_OF_THE_CEREBRAL_WHITE_MATTER,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...61,SET,74,-0.007892,-0.00050005,0.096394,0.53263,HP_APLASIA_HYPOPLASIA_OF_THE_RADIUS,0.99999
ZHANG_ANTIVIRAL_RESPONSE_TO_...1,SET,43,-0.011476,-0.00055475,0.13986,0.5327,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,0.99999
GOMF_MHC_PROTEIN_COMPLEX_BIN...,SET,30,-0.013256,-0.00053545,0.16141,0.53273,GOMF_MHC_PROTEIN_COMPLEX_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...780,SET,4,-0.030071,-0.00044382,0.36394,0.53292,GOBP_POSITIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.99999
GOBP_D_AMINO_ACID_TRANSPORT,SET,6,-0.030324,-0.00054812,0.36595,0.53302,GOBP_D_AMINO_ACID_TRANSPORT,0.99999
GOBP_REGULATION_OF_INTERLEUK...2,SET,4,-0.038714,-0.0005714,0.46723,0.53302,GOBP_REGULATION_OF_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_PATHOGEN_HCMV_U...7,SET,30,-0.013306,-0.00053745,0.1605,0.53304,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,0.99999
HSIAO_LIVER_SPECIFIC_GENES,SET,225,-0.0050453,-0.00055512,0.06073,0.5331,HSIAO_LIVER_SPECIFIC_GENES,0.99999
GOBP_DTTP_METABOLIC_PROCESS,SET,5,-0.032298,-0.00053295,0.38871,0.53311,GOBP_DTTP_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_PEPTIDYL_...6,SET,199,-0.005275,-0.00054622,0.06348,0.53311,GOBP_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,0.99999
WP_PGK1_PKM2_KHKCKHKA_ACTING...,SET,10,-0.018174,-0.00042405,0.21838,0.53316,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,0.99999
MIR3065_5P,SET,414,-0.0035169,-0.00052215,0.042172,0.53323,MIR3065_5P,0.99999
GOBP_SUPEROXIDE_ANION_GENERA...,SET,36,-0.012695,-0.00056163,0.15218,0.53324,GOBP_SUPEROXIDE_ANION_GENERATION,0.99999
GSE17974_0H_VS_72H_IN_VITRO_...1,SET,170,-0.0052535,-0.0005032,0.062984,0.53324,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN,0.99999
GOBP_PYRIMIDINE_DEOXYRIBONUC...5,SET,23,-0.014276,-0.00050501,0.17095,0.53328,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,0.99999
MIR4660,SET,124,-0.0063937,-0.0005237,0.076441,0.53333,MIR4660,0.99999
MIR5697,SET,139,-0.0059659,-0.00051715,0.071335,0.53333,MIR5697,0.99999
GSE5589_IL6_KO_VS_IL10_KO_LP...8,SET,176,-0.0055977,-0.00054546,0.066698,0.53344,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,0.99999
MEBARKI_HCC_PROGENITOR_WNT_U...3,SET,39,-0.013206,-0.00060803,0.15726,0.53346,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,0.99999
GOMF_COA_TRANSFERASE_ACTIVITY,SET,5,-0.031611,-0.00052161,0.37559,0.53354,GOMF_COA_TRANSFERASE_ACTIVITY,0.99999
GOBP_CHEMOKINE_C_X_C_MOTIF_L...3,SET,18,-0.017736,-0.00055511,0.21058,0.53356,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,0.99999
GSE12003_4D_VS_8D_CULTURE_MI...2,SET,133,-0.0065745,-0.00055757,0.078054,0.53356,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_UP,0.99999
HP_SPHEROCYTOSIS,SET,8,-0.027009,-0.00056369,0.31954,0.53368,HP_SPHEROCYTOSIS,0.99999
MIR4681,SET,5,-0.028904,-0.00047695,0.34155,0.53372,MIR4681,0.99999
HP_ABNORMAL_GRANULOCYTE_COUNT,SET,234,-0.0047407,-0.00053181,0.056004,0.53373,HP_ABNORMAL_GRANULOCYTE_COUNT,0.99999
HP_ABNORMAL_GLOBUS_PALLIDUS_...,SET,21,-0.014893,-0.00050343,0.17591,0.53374,HP_ABNORMAL_GLOBUS_PALLIDUS_MORPHOLOGY,0.99999
GOMF_POLYUBIQUITIN_MODIFICAT...,SET,45,-0.0092678,-0.00045829,0.10941,0.53375,GOMF_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.99999
NIKOLSKY_BREAST_CANCER_7P15_...,SET,11,-0.03483,-0.00085234,0.41111,0.53376,NIKOLSKY_BREAST_CANCER_7P15_AMPLICON,0.99999
MIR4731_5P,SET,238,-0.0046392,-0.00052479,0.054572,0.53387,MIR4731_5P,0.99999
HP_ABNORMAL_CIRCULATING_GLUT...2,SET,30,-0.012237,-0.00049429,0.14367,0.53394,HP_ABNORMAL_CIRCULATING_GLUTAMINE_FAMILY_AMINO_ACID_CONCENTRATION,0.99999
GSE20500_CTRL_VS_RARA_ANTAGO...2,SET,182,-0.0053146,-0.00052654,0.062368,0.53395,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,0.99999
MIR4791,SET,58,-0.0094399,-0.00052976,0.11076,0.53396,MIR4791,0.99999
GOBP_AMYLOID_BETA_CLEARANCE,SET,35,-0.012641,-0.00055142,0.14831,0.53396,GOBP_AMYLOID_BETA_CLEARANCE,0.99999
RUTELLA_RESPONSE_TO_HGF_VS_C...1,SET,223,-0.0050425,-0.00055237,0.059049,0.53403,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,0.99999
HP_ATONIC_SEIZURE,SET,87,-0.0077632,-0.00053316,0.090747,0.53409,HP_ATONIC_SEIZURE,0.99999
GSE18281_PERIMEDULLARY_CORTI...2,SET,186,-0.005198,-0.00052056,0.060737,0.5341,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,0.99999
HP_ABNORMAL_SERUM_BICARBONAT...,SET,5,-0.033636,-0.00055504,0.39277,0.53412,HP_ABNORMAL_SERUM_BICARBONATE_CONCENTRATION,0.99999
MEISSNER_NPC_HCP_WITH_H3K4ME...1,SET,329,-0.0045526,-0.00060397,0.053123,0.53415,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,0.99999
MIR10395_3P,SET,130,-0.006281,-0.00052667,0.073262,0.53416,MIR10395_3P,0.99999
MIR3121_5P,SET,95,-0.0080842,-0.00058004,0.094165,0.53421,MIR3121_5P,0.99999
GOBP_REGULATION_OF_PROTEIN_G...,SET,11,-0.021395,-0.00052355,0.24899,0.53424,GOBP_REGULATION_OF_PROTEIN_GLYCOSYLATION,0.99999
GOBP_FACE_DEVELOPMENT,SET,49,-0.010946,-0.00056476,0.12735,0.53425,GOBP_FACE_DEVELOPMENT,0.99999
GOMF_CHOLINE_TRANSMEMBRANE_T...,SET,7,-0.031078,-0.00060674,0.36115,0.53429,GOMF_CHOLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
REACTOME_PHOSPHOLIPID_METABO...,SET,189,-0.0054068,-0.00054577,0.062806,0.5343,REACTOME_PHOSPHOLIPID_METABOLISM,0.99999
GOBP_DESMOSOME_ORGANIZATION,SET,9,-0.029186,-0.00064606,0.33739,0.53447,GOBP_DESMOSOME_ORGANIZATION,0.99999
BASAKI_YBX1_TARGETS_UP,SET,261,-0.0044337,-0.00052489,0.051232,0.53448,BASAKI_YBX1_TARGETS_UP,0.99999
GSE22886_DAY0_VS_DAY7_MONOCY...2,SET,176,-0.0055381,-0.00053965,0.063979,0.53449,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...599,SET,111,-0.0068197,-0.00052869,0.078749,0.53451,GOBP_POSITIVE_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...817,SET,92,-0.0077455,-0.00054694,0.089196,0.5346,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_GAS_TRANSPORT,SET,18,-0.020721,-0.00064852,0.23839,0.53463,GOBP_GAS_TRANSPORT,0.99999
RAFFEL_VEGFA_TARGETS_DN,SET,5,-0.033751,-0.00055693,0.38822,0.53464,RAFFEL_VEGFA_TARGETS_DN,0.99999
GSE8685_IL2_STARVED_VS_IL2_A...1,SET,177,-0.0054629,-0.00053382,0.062718,0.5347,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN,0.99999
MIR497_5P,SET,476,-0.0033963,-0.00053975,0.038958,0.53473,MIR497_5P,0.99999
WP_PEROXIREDOXIN_2_INDUCED_O...,SET,8,-0.027125,-0.00056611,0.31089,0.53476,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,0.99999
HP_ABNORMAL_LOCALIZATION_OF_...,SET,202,-0.0051694,-0.00053927,0.059158,0.53482,HP_ABNORMAL_LOCALIZATION_OF_KIDNEY,0.99999
GSE26559_TCF1_KO_VS_WT_LIN_N...1,SET,174,-0.005693,-0.00055161,0.065014,0.53489,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_DN,0.99999
GSE360_HIGH_VS_LOW_DOSE_B_MA...4,SET,177,-0.0053494,-0.00052273,0.061051,0.53491,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP,0.99999
LEE_CALORIE_RESTRICTION_MUSC...2,SET,36,-0.012821,-0.00056721,0.14623,0.53493,LEE_CALORIE_RESTRICTION_MUSCLE_UP,0.99999
GOMF_CALCIUM_CHANNEL_REGULAT...,SET,47,-0.011959,-0.00060433,0.13615,0.535,GOMF_CALCIUM_CHANNEL_REGULATOR_ACTIVITY,0.99999
GOMF_POTASSIUM_CHANNEL_REGUL...,SET,46,-0.011609,-0.00058038,0.13209,0.53502,GOMF_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY,0.99999
GOBP_REGULATION_OF_HEPATOCYT...2,SET,16,-0.018248,-0.00053849,0.20726,0.53508,GOBP_REGULATION_OF_HEPATOCYTE_PROLIFERATION,0.99999
HP_INTESTINAL_LYMPHANGIECTAS...,SET,5,-0.036571,-0.00060346,0.4153,0.53508,HP_INTESTINAL_LYMPHANGIECTASIA,0.99999
MODULE_116,SET,13,-0.02079,-0.00055306,0.23601,0.5351,MODULE_116,0.99999
GOMF_LEUKOTRIENE_C4_GAMMA_GL...,SET,4,-0.038593,-0.00056962,0.43805,0.5351,GOMF_LEUKOTRIENE_C4_GAMMA_GLUTAMYL_TRANSFERASE_ACTIVITY,0.99999
HP_PREAURICULAR_SKIN_TAG,SET,59,-0.0096436,-0.00054583,0.10948,0.5351,HP_PREAURICULAR_SKIN_TAG,0.99999
GSE3982_MAST_CELL_VS_CENT_ME...2,SET,185,-0.0054755,-0.00054689,0.062134,0.53511,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP,0.99999
GOMF_THIOESTERASE_BINDING,SET,9,-0.021959,-0.00048609,0.24889,0.53515,GOMF_THIOESTERASE_BINDING,0.99999
REACTOME_B_WICH_COMPLEX_POSI...,SET,28,-0.013103,-0.00051132,0.14819,0.53523,REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,0.99999
GSE27859_MACROPHAGE_VS_DC_UP,SET,154,-0.006093,-0.00055571,0.068742,0.53531,GSE27859_MACROPHAGE_VS_DC_UP,0.99999
MIR218_1_3P,SET,84,-0.0085222,-0.00057515,0.095905,0.5354,MIR218_1_3P,0.99999
ANDERSON_BLOOD_CN54GP140_ADJ...7,SET,6,-0.029714,-0.0005371,0.33342,0.53551,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_7DY_DN,0.99999
HALLMARK_TNFA_SIGNALING_VIA_...,SET,188,-0.0060849,-0.00061261,0.068268,0.53551,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.99999
ZHENG_CORD_BLOOD_C2_PUTATIVE...,SET,86,-0.0084879,-0.00057959,0.095127,0.53555,ZHENG_CORD_BLOOD_C2_PUTATIVE_BASOPHIL_EOSINOPHIL_MAST_CELL_PROGENITOR,0.99999
GOBP_NEGATIVE_REGULATION_OF_...450,SET,5,-0.040454,-0.00066754,0.45329,0.53556,GOBP_NEGATIVE_REGULATION_OF_NODAL_SIGNALING_PATHWAY,0.99999
GOCC_MICROBODY_LUMEN,SET,50,-0.010656,-0.00055534,0.11939,0.53556,GOCC_MICROBODY_LUMEN,0.99999
GOMF_PHOSPHATASE_INHIBITOR_A...,SET,40,-0.011789,-0.00054971,0.13181,0.53563,GOMF_PHOSPHATASE_INHIBITOR_ACTIVITY,0.99999
KEGG_MEDICUS_VARIANT_IGF2_OV...,SET,14,-0.021037,-0.00058071,0.23513,0.53564,KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
HP_FEVER,SET,372,-0.0040733,-0.00057393,0.04554,0.53564,HP_FEVER,0.99999
DALESSIO_TSA_RESPONSE,SET,19,-0.02021,-0.00064985,0.22583,0.53566,DALESSIO_TSA_RESPONSE,0.99999
MIKKELSEN_DEDIFFERENTIATED_S...1,SET,7,-0.0335,-0.00065403,0.37336,0.53575,MIKKELSEN_DEDIFFERENTIATED_STATE_DN,0.99999
GOBP_LYMPH_VESSEL_MORPHOGENE...,SET,21,-0.01716,-0.00058006,0.1909,0.53581,GOBP_LYMPH_VESSEL_MORPHOGENESIS,0.99999
GOBP_T_CELL_MIGRATION,SET,63,-0.01025,-0.00059942,0.11401,0.53582,GOBP_T_CELL_MIGRATION,0.99999
XU_CREBBP_TARGETS_DN,SET,35,-0.012413,-0.00054147,0.13774,0.5359,XU_CREBBP_TARGETS_DN,0.99999
MIR627_5P,SET,36,-0.012525,-0.00055408,0.1389,0.53592,MIR627_5P,0.99999
DACOSTA_UV_RESPONSE_VIA_ERCC...3,SET,808,-0.002789,-0.00057209,0.030916,0.53594,DACOSTA_UV_RESPONSE_VIA_ERCC3_DN,0.99999
KEGG_MEDICUS_REFERENCE_TRH_T...,SET,12,-0.023511,-0.0006009,0.26046,0.53596,KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY,0.99999
CHARAFE_BREAST_CANCER_LUMINA...1,SET,414,-0.0041161,-0.00061112,0.045474,0.53606,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,0.99999
GOMF_ALPHA_2A_ADRENERGIC_REC...,SET,4,-0.043381,-0.00064028,0.47896,0.53608,GOMF_ALPHA_2A_ADRENERGIC_RECEPTOR_BINDING,0.99999
MODULE_76,SET,78,-0.0099426,-0.00064671,0.10975,0.53609,MODULE_76,0.99999
GSE11924_TH2_VS_TH17_CD4_TCE...1,SET,184,-0.0057194,-0.00056972,0.063034,0.53615,GSE11924_TH2_VS_TH17_CD4_TCELL_DN,0.99999
WP_PLEURAL_MESOTHELIOMA,SET,419,-0.0040521,-0.00060514,0.044641,0.53616,WP_PLEURAL_MESOTHELIOMA,0.99999
GSE17721_CTRL_VS_PAM3CSK4_8H...2,SET,177,-0.0056755,-0.00055459,0.062262,0.53631,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_UP,0.99999
MEK_UP.V1_UP,SET,175,-0.0062361,-0.00060595,0.068375,0.53633,MEK_UP.V1_UP,0.99999
MIR4328,SET,518,-0.0035527,-0.00058829,0.038871,0.53641,MIR4328,0.99999
HP_RIGHT_VENTRICULAR_CARDIOM...,SET,7,-0.034706,-0.00067758,0.37959,0.53642,HP_RIGHT_VENTRICULAR_CARDIOMYOPATHY,0.99999
chr20q12,SET,7,-0.05344,-0.0010433,0.58414,0.53645,chr20q12,0.99999
GSE22140_GERMFREE_VS_SPF_MOU...1,SET,187,-0.005769,-0.00057928,0.062983,0.53649,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN,0.99999
MIR377_3P,SET,216,-0.005348,-0.00057668,0.058329,0.53653,MIR377_3P,0.99999
GOBP_CELLULAR_PROCESS_INVOLV...,SET,356,-0.0041753,-0.00057577,0.045433,0.53661,GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM,0.99999
GOBP_REGULATION_OF_OSTEOCLAS...3,SET,6,-0.030411,-0.00054969,0.33067,0.53664,GOBP_REGULATION_OF_OSTEOCLAST_PROLIFERATION,0.99999
HP_ABNORMAL_UTERUS_MORPHOLOGY,SET,138,-0.0064432,-0.00055653,0.070056,0.53664,HP_ABNORMAL_UTERUS_MORPHOLOGY,0.99999
GSE33424_CD161_HIGH_VS_INT_C...2,SET,183,-0.0060416,-0.00060019,0.065665,0.53665,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP,0.99999
HP_ANOSMIA,SET,47,-0.012476,-0.00063043,0.13555,0.53666,HP_ANOSMIA,0.99999
MIR7108_3P,SET,12,-0.022844,-0.00058385,0.24809,0.53668,MIR7108_3P,0.99999
ZNF112_TARGET_GENES,SET,3,-0.048901,-0.00062507,0.53075,0.5367,ZNF112_TARGET_GENES,0.99999
REACTOME_FORMATION_OF_AXIAL_...,SET,13,-0.023652,-0.00062918,0.25653,0.53673,REACTOME_FORMATION_OF_AXIAL_MESODERM,0.99999
REACTOME_NFE2L2_REGULATES_PE...,SET,7,-0.033113,-0.00064648,0.35908,0.53674,REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES,0.99999
GOBP_MULTI_MULTICELLULAR_ORG...,SET,191,-0.0060529,-0.00061418,0.065618,0.53675,GOBP_MULTI_MULTICELLULAR_ORGANISM_PROCESS,0.99999
WP_TCA_CYCLE_IN_SENESCENCE,SET,9,-0.029145,-0.00064516,0.3156,0.53679,WP_TCA_CYCLE_IN_SENESCENCE,0.99999
HP_STEROETYPIC_MOVEMENTS_OF_...,SET,50,-0.010913,-0.00056876,0.11818,0.53679,HP_STEROETYPIC_MOVEMENTS_OF_FACE_AND_HEAD,0.99999
GOBP_FAT_SOLUBLE_VITAMIN_CAT...,SET,12,-0.026164,-0.00066871,0.28313,0.53681,GOBP_FAT_SOLUBLE_VITAMIN_CATABOLIC_PROCESS,0.99999
HP_ABNORMAL_UPPER_LIMB_METAP...,SET,15,-0.02402,-0.00068632,0.25982,0.53683,HP_ABNORMAL_UPPER_LIMB_METAPHYSIS_MORPHOLOGY,0.99999
GOBP_PUTRESCINE_BIOSYNTHETIC...,SET,5,-0.030398,-0.0005016,0.32757,0.53697,GOBP_PUTRESCINE_BIOSYNTHETIC_PROCESS,0.99999
GSE17721_LPS_VS_CPG_12H_BMDC...2,SET,178,-0.0061013,-0.00059787,0.065719,0.53698,GSE17721_LPS_VS_CPG_12H_BMDC_UP,0.99999
GOBP_RESPIRATORY_SYSTEM_DEVE...,SET,209,-0.0058622,-0.00062192,0.062977,0.53708,GOBP_RESPIRATORY_SYSTEM_DEVELOPMENT,0.99999
CTCAGGG_MIR125B_MIR125A,SET,303,-0.0045029,-0.0005737,0.048331,0.53711,CTCAGGG_MIR125B_MIR125A,0.99999
WP_CYTOKINES_AND_INFLAMMATOR...,SET,25,-0.017511,-0.00064575,0.18784,0.53714,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,0.99999
GSE6674_UNSTIM_VS_PL2_3_STIM...2,SET,132,-0.0072388,-0.00061161,0.0774,0.53726,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_UP,0.99999
MARZEC_IL2_SIGNALING_UP,SET,109,-0.0077628,-0.00059638,0.082961,0.53728,MARZEC_IL2_SIGNALING_UP,0.99999
GOMF_ATP_DEPENDENT_ACTIVITY_...1,SET,109,-0.0071653,-0.00055048,0.076571,0.53728,GOMF_ATP_DEPENDENT_ACTIVITY_ACTING_ON_DNA,0.99999
GOBP_LIPID_DROPLET_FORMATION,SET,12,-0.02297,-0.00058709,0.24525,0.53731,GOBP_LIPID_DROPLET_FORMATION,0.99999
GOCC_NEURON_TO_NEURON_SYNAPSE,SET,338,-0.0045132,-0.00060673,0.048154,0.53734,GOCC_NEURON_TO_NEURON_SYNAPSE,0.99999
WP_SULFATASE_AND_AROMATASE_P...,SET,14,-0.02225,-0.00061422,0.23713,0.53738,WP_SULFATASE_AND_AROMATASE_PATHWAY,0.99999
HP_DECREASED_CIRCULATING_COM...2,SET,27,-0.016222,-0.00062165,0.17286,0.53738,HP_DECREASED_CIRCULATING_COMPLEMENT_C4_CONCENTRATION,0.99999
KAZMIN_PBMC_P_FALCIPARUM_RTS...3,SET,9,-0.030344,-0.0006717,0.32336,0.53738,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_UNKN_AGE_IMM_WITH_ARR_VS_IMM_BY_RRR_PRIMARY_IMMUNIZ_WITH_RECOMB_ADENOVIRUS_35_1DY_UP,0.99999
REACTOME_NFE2L2_REGULATING_A...,SET,19,-0.01969,-0.00063313,0.20965,0.53741,REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES,0.99999
GOBP_REGULATION_OF_MONOCYTE_...2,SET,18,-0.020548,-0.00064309,0.2188,0.53741,GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.99999
DESCARTES_MAIN_FETAL_CILIATE...,SET,449,-0.0036518,-0.00056408,0.038875,0.53742,DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS,0.99999
KEGG_MEDICUS_REFERENCE_ANTER...,SET,23,-0.016816,-0.00059484,0.17859,0.53751,KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT,0.99999
BRACHAT_RESPONSE_TO_CAMPTOTH...2,SET,19,-0.017347,-0.00055779,0.18405,0.53754,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,0.99999
MIR136_3P,SET,8,-0.026905,-0.00056153,0.28553,0.53754,MIR136_3P,0.99999
GOBP_INSEMINATION,SET,13,-0.022584,-0.00060078,0.23958,0.53755,GOBP_INSEMINATION,0.99999
ATM_DN.V1_DN,SET,124,-0.0076962,-0.00063038,0.081609,0.53757,ATM_DN.V1_DN,0.99999
GOMF_BIOACTIVE_LIPID_RECEPTO...,SET,13,-0.022576,-0.00060055,0.23932,0.53758,GOMF_BIOACTIVE_LIPID_RECEPTOR_ACTIVITY,0.99999
GAO_LARGE_INTESTINE_24W_C10_...,SET,55,-0.010714,-0.00058555,0.11334,0.53766,GAO_LARGE_INTESTINE_24W_C10_ENTEROCYTE,0.99999
BIOCARTA_IL3_PATHWAY,SET,13,-0.023541,-0.00062623,0.24889,0.53768,BIOCARTA_IL3_PATHWAY,0.99999
LI_ESTROGENE_MID_E2_RESPONSE...1,SET,40,-0.013939,-0.00064996,0.14731,0.53769,LI_ESTROGENE_MID_E2_RESPONSE_DN,0.99999
HP_GLUTARIC_ACIDURIA,SET,7,-0.030171,-0.00058904,0.31874,0.53771,HP_GLUTARIC_ACIDURIA,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...15,SET,5,-0.03643,-0.00060113,0.3847,0.53772,KEGG_MEDICUS_REFERENCE_REGULATION_OF_TNF_NFKB_SIGNALING_PATHWAY_LUBAC_MEDIATED_LINEAR_UBIQUITINATION,0.99999
HP_HYPOPLASTIC_TOENAILS,SET,75,-0.009269,-0.00059124,0.097724,0.53778,HP_HYPOPLASTIC_TOENAILS,0.99999
GOCC_PSEUDOPODIUM,SET,16,-0.020296,-0.00059892,0.21393,0.53779,GOCC_PSEUDOPODIUM,0.99999
GOMF_KINASE_BINDING,SET,730,-0.0030751,-0.00060089,0.032377,0.53783,GOMF_KINASE_BINDING,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...29,SET,47,-0.01182,-0.0005973,0.12432,0.53787,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS,0.99999
ANDERSON_BLOOD_CN54GP140_ADJ...1,SET,77,-0.0083853,-0.00054193,0.088139,0.5379,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN,0.99999
HP_ABNORMAL_NASAL_CAVITY_MOR...,SET,16,-0.02161,-0.00063768,0.22651,0.538,HP_ABNORMAL_NASAL_CAVITY_MORPHOLOGY,0.99999
HP_DECREASED_CIRCULATING_GON...,SET,37,-0.013552,-0.00060778,0.14188,0.53805,HP_DECREASED_CIRCULATING_GONADOTROPIN_CONCENTRATION,0.99999
FULLER_PBMC_F_TULARENSIS_VAC...7,SET,42,-0.013019,-0.000622,0.13623,0.53807,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_UP,0.99999
MORF_DNMT1,SET,104,-0.0074329,-0.00055786,0.077486,0.53821,MORF_DNMT1,0.99999
HP_DELAYED_CNS_MYELINATION,SET,171,-0.0061133,-0.00058725,0.063729,0.53821,HP_DELAYED_CNS_MYELINATION,0.99999
chr17p11,SET,61,-0.018341,-0.0010555,0.19109,0.53823,chr17p11,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...2,SET,15,-0.021378,-0.00061083,0.22268,0.53824,HP_APLASIA_HYPOPLASIA_OF_THE_2ND_FINGER,0.99999
chr1p21,SET,29,-0.025231,-0.001002,0.26268,0.53826,chr1p21,0.99999
GOBP_NEGATIVE_REGULATION_OF_...265,SET,200,-0.0060512,-0.00062815,0.062978,0.53827,GOBP_NEGATIVE_REGULATION_OF_GROWTH,0.99999
GSE2770_IL12_AND_TGFB_ACT_VS...3,SET,181,-0.0058829,-0.00058125,0.061198,0.53829,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN,0.99999
HP_PULMONARY_EMBOLISM,SET,35,-0.014442,-0.00063001,0.15014,0.53831,HP_PULMONARY_EMBOLISM,0.99999
GOBP_SYNAPTIC_VESICLE_UNCOAT...,SET,7,-0.028642,-0.00055918,0.29773,0.53832,GOBP_SYNAPTIC_VESICLE_UNCOATING,0.99999
GOMF_STEROL_TRANSFER_ACTIVITY,SET,23,-0.01855,-0.00065616,0.19284,0.53832,GOMF_STEROL_TRANSFER_ACTIVITY,0.99999
WP_OCTADECANOID_FORMATION_FR...,SET,12,-0.026226,-0.0006703,0.27252,0.53833,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,0.99999
GOBP_PROTEIN_DESTABILIZATION,SET,45,-0.012094,-0.00059802,0.12563,0.53834,GOBP_PROTEIN_DESTABILIZATION,0.99999
REACTOME_GENE_SILENCING_BY_R...,SET,77,-0.0087729,-0.00056697,0.091013,0.53839,REACTOME_GENE_SILENCING_BY_RNA,0.99999
HP_SANDWICH_APPEARANCE_OF_VE...,SET,5,-0.035787,-0.00059053,0.37135,0.53839,HP_SANDWICH_APPEARANCE_OF_VERTEBRAL_BODIES,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...74,SET,37,-0.012822,-0.00057504,0.13295,0.53841,HP_APLASIA_HYPOPLASIA_OF_THE_TONGUE,0.99999
GOBP_RESCUE_OF_STALLED_RIBOS...,SET,25,-0.015264,-0.00056289,0.15824,0.53842,GOBP_RESCUE_OF_STALLED_RIBOSOME,0.99999
RATTENBACHER_BOUND_BY_CELF1,SET,365,-0.0043409,-0.00060598,0.044932,0.53848,RATTENBACHER_BOUND_BY_CELF1,0.99999
HP_HIGH_FREQUENCY_SENSORINEU...,SET,6,-0.031934,-0.00057722,0.3306,0.53848,HP_HIGH_FREQUENCY_SENSORINEURAL_HEARING_IMPAIRMENT,0.99999
GOBP_REGULATION_OF_MITOCHOND...15,SET,23,-0.015699,-0.00055533,0.16227,0.53853,GOBP_REGULATION_OF_MITOCHONDRIAL_TRANSLATION,0.99999
GOMF_FUCOSYLTRANSFERASE_ACTI...,SET,13,-0.025185,-0.00066996,0.2602,0.53855,GOMF_FUCOSYLTRANSFERASE_ACTIVITY,0.99999
HP_RICKETS,SET,37,-0.014964,-0.00067112,0.15455,0.53857,HP_RICKETS,0.99999
ZNF350_TARGET_GENES,SET,1153,-0.0024977,-0.00060598,0.025773,0.5386,ZNF350_TARGET_GENES,0.99999
GSE2826_WT_VS_BTK_KO_BCELL_UP,SET,181,-0.0060211,-0.00059491,0.062116,0.53861,GSE2826_WT_VS_BTK_KO_BCELL_UP,0.99999
HP_MUSCLE_FIBER_CYTOPLASMATI...,SET,29,-0.015182,-0.00060292,0.15653,0.53863,HP_MUSCLE_FIBER_CYTOPLASMATIC_INCLUSION_BODIES,0.99999
GSE18281_CORTICAL_THYMOCYTE_...2,SET,173,-0.0066249,-0.00064008,0.068312,0.53863,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP,0.99999
KEGG_MEDICUS_REFERENCE_ANXA2...,SET,5,-0.04027,-0.0006645,0.41507,0.53864,KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON,0.99999
GSE3982_DC_VS_NEUTROPHIL_UP,SET,181,-0.0060636,-0.00059911,0.062474,0.53866,GSE3982_DC_VS_NEUTROPHIL_UP,0.99999
chr7p13,SET,30,-0.02804,-0.0011326,0.28869,0.53869,chr7p13,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...12,SET,177,-0.0060823,-0.00059434,0.062588,0.53871,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP,0.99999
GOBP_RETINA_HOMEOSTASIS,SET,53,-0.012021,-0.00064497,0.12365,0.53872,GOBP_RETINA_HOMEOSTASIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...681,SET,8,-0.033594,-0.00070114,0.34547,0.53873,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.99999
DESCARTES_FETAL_ADRENAL_MYEL...,SET,151,-0.0073786,-0.00066643,0.075838,0.53875,DESCARTES_FETAL_ADRENAL_MYELOID_CELLS,0.99999
MIR10226,SET,69,-0.010383,-0.00063536,0.10667,0.53877,MIR10226,0.99999
HP_DEFORMED_TARSAL_BONES,SET,13,-0.027702,-0.00073692,0.2845,0.53878,HP_DEFORMED_TARSAL_BONES,0.99999
HP_ABNORMAL_SACRUM_MORPHOLOGY,SET,139,-0.0073861,-0.00064026,0.075759,0.53883,HP_ABNORMAL_SACRUM_MORPHOLOGY,0.99999
MIR6515_5P,SET,79,-0.0091839,-0.00060116,0.094148,0.53885,MIR6515_5P,0.99999
GOBP_REGULATION_OF_TISSUE_RE...,SET,72,-0.010707,-0.0006692,0.10971,0.53887,GOBP_REGULATION_OF_TISSUE_REMODELING,0.99999
GSE17721_CTRL_VS_PAM3CSK4_0....2,SET,179,-0.0061182,-0.00060119,0.062701,0.53887,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_UP,0.99999
chr17p12,SET,22,-0.028393,-0.00098231,0.29039,0.53894,chr17p12,0.99999
AGARWAL_AKT_PATHWAY_TARGETS,SET,10,-0.030748,-0.00071745,0.31441,0.53895,AGARWAL_AKT_PATHWAY_TARGETS,0.99999
GOMF_PHOSPHOLIPASE_INHIBITOR...,SET,11,-0.027437,-0.00067142,0.28049,0.53896,GOMF_PHOSPHOLIPASE_INHIBITOR_ACTIVITY,0.99999
E2F1_Q3,SET,221,-0.0055099,-0.00060089,0.056285,0.53899,E2F1_Q3,0.99999
BARRIER_CANCER_RELAPSE_TUMOR...1,SET,10,-0.02342,-0.00054646,0.23919,0.539,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN,0.99999
KEGG_MEDICUS_REFERENCE_TGFA_...1,SET,9,-0.028529,-0.00063153,0.29074,0.53908,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY,0.99999
KRAS.AMP.LUNG_UP.V1_DN,SET,120,-0.0079211,-0.00063832,0.080677,0.53911,KRAS.AMP.LUNG_UP.V1_DN,0.99999
KEGG_MEDICUS_REFERENCE_TLR7_...2,SET,15,-0.025507,-0.0007288,0.25962,0.53913,KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY,0.99999
KRAS.KIDNEY_UP.V1_UP,SET,127,-0.0083633,-0.0006932,0.085114,0.53914,KRAS.KIDNEY_UP.V1_UP,0.99999
GOBP_REGULATION_OF_FIBROBLAS...4,SET,87,-0.0092424,-0.00063474,0.093988,0.53917,GOBP_REGULATION_OF_FIBROBLAST_PROLIFERATION,0.99999
GCM_SMARCD1,SET,90,-0.0085743,-0.00059888,0.087114,0.5392,GCM_SMARCD1,0.99999
GOBP_MUSCLE_CELL_PROLIFERATI...,SET,188,-0.006488,-0.00065319,0.065782,0.53928,GOBP_MUSCLE_CELL_PROLIFERATION,0.99999
NAKAYA_PBMC_FLUARIX_FLUVIRIN...6,SET,379,-0.0043656,-0.00062076,0.044219,0.53932,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE,0.99999
HP_TOTAL_ANOMALOUS_PULMONARY...,SET,11,-0.023487,-0.00057475,0.23776,0.53934,HP_TOTAL_ANOMALOUS_PULMONARY_VENOUS_RETURN,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...13,SET,72,-0.010828,-0.00067681,0.10954,0.53937,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_NK_CELLS,0.99999
WAKABAYASHI_ADIPOGENESIS_PPA...1,SET,28,-0.016075,-0.00062732,0.16219,0.53947,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR,0.99999
GOBP_FRUCTOSE_6_PHOSPHATE_ME...,SET,12,-0.023966,-0.00061252,0.24174,0.53948,GOBP_FRUCTOSE_6_PHOSPHATE_METABOLIC_PROCESS,0.99999
GOBP_LEFT_RIGHT_AXIS_SPECIFI...,SET,12,-0.026558,-0.00067877,0.26694,0.53962,GOBP_LEFT_RIGHT_AXIS_SPECIFICATION,0.99999
KIM_ALL_DISORDERS_CALB1_CORR...1,SET,35,-0.014892,-0.00064962,0.14965,0.53963,KIM_ALL_DISORDERS_CALB1_CORR_DN,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...16,SET,9,-0.031636,-0.00070029,0.31784,0.53964,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN,0.99999
GSE3982_MAC_VS_NEUTROPHIL_UP,SET,181,-0.0060579,-0.00059854,0.060769,0.5397,GSE3982_MAC_VS_NEUTROPHIL_UP,0.99999
HP_HYPOCHROMIA,SET,13,-0.023286,-0.00061944,0.23338,0.53974,HP_HYPOCHROMIA,0.99999
HP_EXTRAMEDULLARY_HEMATOPOIE...,SET,19,-0.020005,-0.00064324,0.20034,0.53977,HP_EXTRAMEDULLARY_HEMATOPOIESIS,0.99999
GOCC_ENDOPLASMIC_RETICULUM_G...1,SET,121,-0.0076929,-0.00062249,0.076764,0.53991,GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT,0.99999
KEGG_GLYCINE_SERINE_AND_THRE...,SET,27,-0.016114,-0.00061752,0.16066,0.53994,KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM,0.99999
GOMF_NUCLEAR_GLUCOCORTICOID_...,SET,12,-0.027942,-0.00071414,0.2785,0.53996,GOMF_NUCLEAR_GLUCOCORTICOID_RECEPTOR_BINDING,0.99999
MIR615_5P,SET,37,-0.015256,-0.00068419,0.15184,0.54001,MIR615_5P,0.99999
GOBP_WALKING_BEHAVIOR,SET,34,-0.014844,-0.00063822,0.14765,0.54004,GOBP_WALKING_BEHAVIOR,0.99999
DESCARTES_FETAL_LIVER_HEMATO...,SET,23,-0.019447,-0.00068791,0.19323,0.54008,DESCARTES_FETAL_LIVER_HEMATOPOIETIC_STEM_CELLS,0.99999
ZNF512B_TARGET_GENES,SET,176,-0.0068368,-0.0006662,0.067849,0.54013,ZNF512B_TARGET_GENES,0.99999
FRANCO_BLOOD_SANOFI_PASTEUR_...3,SET,24,-0.01795,-0.00064859,0.17807,0.54015,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_NEGATIVE,0.99999
GOBP_RESPIRATORY_GASEOUS_EXC...,SET,72,-0.010738,-0.00067115,0.1065,0.54016,GOBP_RESPIRATORY_GASEOUS_EXCHANGE_BY_RESPIRATORY_SYSTEM,0.99999
GSE46468_LUNG_INNATE_LYMPHOI...1,SET,178,-0.0061233,-0.00060002,0.060718,0.54016,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...133,SET,70,-0.012143,-0.00074841,0.12026,0.54021,GOBP_POSITIVE_REGULATION_OF_CELL_KILLING,0.99999
GAVISH_3CA_METAPROGRAM_CD4_T...1,SET,45,-0.013039,-0.00064475,0.12878,0.54032,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CELL_CYCLE,0.99999
GOBP_REGULATION_OF_THYMOCYTE...,SET,13,-0.023975,-0.00063777,0.23677,0.54033,GOBP_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...8,SET,182,-0.0060202,-0.00059645,0.059444,0.54033,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,0.99999
REACTOME_RHO_GTPASES_ACTIVAT...1,SET,19,-0.019811,-0.00063702,0.19533,0.54039,REACTOME_RHO_GTPASES_ACTIVATE_CIT,0.99999
GNF2_CASP8,SET,24,-0.018668,-0.00067452,0.18406,0.54039,GNF2_CASP8,0.99999
GSE36888_STAT5_AB_KNOCKIN_VS...3,SET,186,-0.0065216,-0.00065311,0.06424,0.54043,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN,0.99999
MIKHAYLOVA_OXIDATIVE_STRESS_...1,SET,6,-0.043109,-0.00077923,0.42459,0.54044,MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN,0.99999
GOBP_HOMOLOGOUS_CHROMOSOME_S...,SET,56,-0.010458,-0.00057673,0.10299,0.54044,GOBP_HOMOLOGOUS_CHROMOSOME_SEGREGATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...683,SET,5,-0.044174,-0.00072891,0.43506,0.54044,GOBP_POSITIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.99999
DR3_Q4,SET,133,-0.0076553,-0.00064923,0.075335,0.54047,DR3_Q4,0.99999
GOBP_POSITIVE_REGULATION_OF_...841,SET,60,-0.010783,-0.00061542,0.10608,0.54048,GOBP_POSITIVE_REGULATION_OF_VIRAL_PROCESS,0.99999
KASLER_HDAC7_TARGETS_2_UP,SET,5,-0.051004,-0.00084162,0.50112,0.54053,KASLER_HDAC7_TARGETS_2_UP,0.99999
MIR2052,SET,220,-0.0059245,-0.00064466,0.05813,0.54059,MIR2052,0.99999
GSE22589_HEALTHY_VS_SIV_INFE...1,SET,186,-0.0066765,-0.00066863,0.065486,0.5406,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN,0.99999
HP_ABNORMAL_MATERNAL_SERUM_S...,SET,6,-0.039942,-0.00072198,0.39156,0.54062,HP_ABNORMAL_MATERNAL_SERUM_SCREENING,0.99999
GOBP_REGULATION_OF_INTEGRIN_...3,SET,18,-0.022312,-0.00069831,0.21813,0.54073,GOBP_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,0.99999
WP_NUCLEAR_RECEPTORS,SET,36,-0.014821,-0.00065567,0.14476,0.54077,WP_NUCLEAR_RECEPTORS,0.99999
GSE14308_TH2_VS_TH1_UP,SET,174,-0.0065123,-0.000631,0.06358,0.54079,GSE14308_TH2_VS_TH1_UP,0.99999
GSE3982_MAC_VS_BASOPHIL_DN,SET,167,-0.0066621,-0.00063252,0.06504,0.54079,GSE3982_MAC_VS_BASOPHIL_DN,0.99999
HP_NEPHROPATHY,SET,82,-0.0097883,-0.00065273,0.095514,0.54081,HP_NEPHROPATHY,0.99999
GOMF_N_ACETYLGALACTOSAMINE_4...,SET,5,-0.036672,-0.00060512,0.35763,0.54084,GOMF_N_ACETYLGALACTOSAMINE_4_O_SULFOTRANSFERASE_ACTIVITY,0.99999
HP_ELEVATED_HEMOGLOBIN_A1C,SET,26,-0.018282,-0.00068754,0.17819,0.54086,HP_ELEVATED_HEMOGLOBIN_A1C,0.99999
GSE7852_LN_VS_FAT_TCONV_DN,SET,176,-0.0068759,-0.00067001,0.066996,0.54087,GSE7852_LN_VS_FAT_TCONV_DN,0.99999
HP_ABNORMAL_HIP_JOINT_MORPHO...,SET,336,-0.0048134,-0.0006452,0.046801,0.54096,HP_ABNORMAL_HIP_JOINT_MORPHOLOGY,0.99999
MULLIGHAN_NPM1_SIGNATURE_3_DN,SET,143,-0.0072258,-0.00063524,0.070039,0.54108,MULLIGHAN_NPM1_SIGNATURE_3_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...319,SET,509,-0.0039685,-0.00065158,0.03847,0.54108,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,0.99999
FAN_OVARY_CL16_LYMPHATIC_END...,SET,206,-0.0065759,-0.00069267,0.063731,0.54109,FAN_OVARY_CL16_LYMPHATIC_ENDOTHELIAL_CELL,0.99999
GOBP_NEGATIVE_REGULATION_OF_...516,SET,129,-0.0076119,-0.00063583,0.073747,0.5411,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.99999
WCAANNNYCAG_UNKNOWN,SET,228,-0.0059358,-0.00065739,0.057474,0.54113,WCAANNNYCAG_UNKNOWN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...591,SET,13,-0.029321,-0.00077998,0.28339,0.5412,GOBP_NEGATIVE_REGULATION_OF_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE,0.99999
HP_ABNORMAL_ATRIOVENTRICULAR...4,SET,183,-0.0066627,-0.0006619,0.064373,0.54122,HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_PHYSIOLOGY,0.99999
GSE36826_NORMAL_VS_STAPH_AUR...1,SET,183,-0.0063223,-0.00062808,0.061052,0.54124,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN,0.99999
WP_TROP2_REGULATORY_SIGNALING,SET,48,-0.012965,-0.00066207,0.12512,0.54126,WP_TROP2_REGULATORY_SIGNALING,0.99999
GOBP_NADH_OXIDATION,SET,6,-0.035021,-0.00063303,0.33796,0.54127,GOBP_NADH_OXIDATION,0.99999
WP_MITOCHONDRIAL_LONG_CHAIN_...,SET,16,-0.022899,-0.00067572,0.22016,0.54142,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,0.99999
YAMASHITA_SILENCED_BY_METHYL...,SET,7,-0.036729,-0.00071707,0.35301,0.54143,YAMASHITA_SILENCED_BY_METHYLATION,0.99999
MIR4506,SET,42,-0.013096,-0.0006257,0.12579,0.54146,MIR4506,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...22,SET,75,-0.010539,-0.00067227,0.10118,0.54148,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,0.99999
JIANG_MELANOMA_TRM11_CD8,SET,43,-0.014321,-0.0006923,0.13729,0.54154,JIANG_MELANOMA_TRM11_CD8,0.99999
REACTOME_PTEN_REGULATION,SET,131,-0.0073289,-0.00061689,0.070213,0.54157,REACTOME_PTEN_REGULATION,0.99999
REACTOME_FACTORS_INVOLVED_IN...,SET,144,-0.0077608,-0.00068464,0.074288,0.5416,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,0.99999
REACTOME_HATS_ACETYLATE_HIST...,SET,71,-0.0099179,-0.0006156,0.094806,0.54166,REACTOME_HATS_ACETYLATE_HISTONES,0.99999
WP_REGULATION_OF_WNT_BCATENI...,SET,16,-0.024461,-0.00072183,0.23378,0.54167,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,0.99999
GOBP_RENAL_SODIUM_EXCRETION,SET,11,-0.029027,-0.00071033,0.27721,0.5417,GOBP_RENAL_SODIUM_EXCRETION,0.99999
MIR4675,SET,38,-0.014325,-0.00065107,0.13623,0.54187,MIR4675,0.99999
HP_ABNORMAL_CIRCULATING_VITA...1,SET,17,-0.021582,-0.00065644,0.20518,0.54188,HP_ABNORMAL_CIRCULATING_VITAMIN_A_CONCENTRATION,0.99999
AMIT_EGF_RESPONSE_60_HELA,SET,42,-0.014065,-0.00067199,0.1336,0.54192,AMIT_EGF_RESPONSE_60_HELA,0.99999
BIOCARTA_ATM_PATHWAY,SET,19,-0.018062,-0.00058078,0.17135,0.54198,BIOCARTA_ATM_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_CA2_E...2,SET,5,-0.040119,-0.000662,0.38012,0.54203,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_STORE_OPERATED_CA2_CHANNEL,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...14,SET,47,-0.01431,-0.00072314,0.13552,0.54205,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_INTERFERON,0.99999
GSE21774_CD56_BRIGHT_VS_DIM_...2,SET,176,-0.0071771,-0.00069936,0.067961,0.54205,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP,0.99999
GOMF_CYSTEINE_TYPE_ENDOPEPTI...3,SET,12,-0.027372,-0.0006996,0.25899,0.54209,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.99999
GSE13547_WT_VS_ZFX_KO_BCELL_...1,SET,142,-0.0074699,-0.00065442,0.070568,0.54215,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HR...5,SET,502,-0.0043273,-0.00070573,0.040883,0.54215,MANNO_MIDBRAIN_NEUROTYPES_HRGL3,0.99999
MODY_HIPPOCAMPUS_NEONATAL,SET,30,-0.017227,-0.00069584,0.16264,0.54218,MODY_HIPPOCAMPUS_NEONATAL,0.99999
GOBP_PROTEIN_TRANSPORT_WITHI...,SET,6,-0.037167,-0.00067182,0.35074,0.5422,GOBP_PROTEIN_TRANSPORT_WITHIN_LIPID_BILAYER,0.99999
GSE15330_WT_VS_IKAROS_KO_HSC...2,SET,178,-0.0067169,-0.00065819,0.063347,0.54222,GSE15330_WT_VS_IKAROS_KO_HSC_UP,0.99999
REACTOME_TRNA_PROCESSING,SET,96,-0.008541,-0.00061602,0.08044,0.54228,REACTOME_TRNA_PROCESSING,0.99999
GOBP_EXTRACELLULAR_MATRIX_DI...,SET,58,-0.012876,-0.00072257,0.1211,0.54233,GOBP_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.99999
GOMF_TYPE_5_METABOTROPIC_GLU...,SET,6,-0.040587,-0.00073362,0.38136,0.54238,GOMF_TYPE_5_METABOTROPIC_GLUTAMATE_RECEPTOR_BINDING,0.99999
BIOCARTA_EOSINOPHILS_PATHWAY,SET,7,-0.031889,-0.00062257,0.29954,0.54239,BIOCARTA_EOSINOPHILS_PATHWAY,0.99999
GOBP_DENDRITE_EXTENSION,SET,32,-0.016815,-0.00070143,0.15784,0.54242,GOBP_DENDRITE_EXTENSION,0.99999
HP_MENINGIOMA,SET,42,-0.012916,-0.0006171,0.12125,0.54242,HP_MENINGIOMA,0.99999
GOBP_PIGMENTATION,SET,104,-0.0092077,-0.00069107,0.08636,0.54245,GOBP_PIGMENTATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...599,SET,12,-0.02742,-0.00070081,0.25676,0.54252,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...8,SET,49,-0.013422,-0.00069249,0.12561,0.54255,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3,0.99999
GOBP_ADHERENS_JUNCTION_ORGAN...,SET,56,-0.013307,-0.00073381,0.12452,0.54255,GOBP_ADHERENS_JUNCTION_ORGANIZATION,0.99999
GSE12845_IGD_POS_BLOOD_VS_NA...1,SET,187,-0.0065547,-0.00065817,0.061235,0.54262,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,0.99999
WP_PHOTODYNAMIC_THERAPYINDUC...3,SET,23,-0.022012,-0.00077864,0.20544,0.54266,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,0.99999
GAO_ESOPHAGUS_25W_C3_FGFR1LO...,SET,43,-0.013459,-0.00065062,0.12543,0.54273,GAO_ESOPHAGUS_25W_C3_FGFR1LOW_EPITHELIAL_CELLS,0.99999
HP_ABNORMALITY_OF_THE_TESTIS...,SET,177,-0.006743,-0.00065891,0.062799,0.54275,HP_ABNORMALITY_OF_THE_TESTIS_SIZE,0.99999
GOBP_LACTONE_METABOLIC_PROCE...,SET,12,-0.029249,-0.00074756,0.2723,0.54277,GOBP_LACTONE_METABOLIC_PROCESS,0.99999
GSE29618_MONOCYTE_VS_PDC_UP,SET,185,-0.0070824,-0.00070738,0.06593,0.54277,GSE29618_MONOCYTE_VS_PDC_UP,0.99999
HP_ELEVATED_URINARY_MONOCARB...,SET,11,-0.028109,-0.00068786,0.26163,0.54278,HP_ELEVATED_URINARY_MONOCARBOXYLIC_ACID_LEVEL,0.99999
GOBP_SPHINGOLIPID_BIOSYNTHET...,SET,107,-0.0094799,-0.00072163,0.088192,0.5428,GOBP_SPHINGOLIPID_BIOSYNTHETIC_PROCESS,0.99999
GOBP_CDC42_PROTEIN_SIGNAL_TR...,SET,14,-0.027807,-0.00076761,0.25848,0.54283,GOBP_CDC42_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...448,SET,10,-0.032169,-0.00075059,0.29909,0.54283,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_DEPOLARIZATION,0.99999
GOBP_CATECHOLAMINE_UPTAKE,SET,17,-0.023202,-0.00070573,0.21525,0.54292,GOBP_CATECHOLAMINE_UPTAKE,0.99999
HP_ABNORMAL_CIRCULATING_PROT...3,SET,606,-0.0038015,-0.00067918,0.035265,0.54292,HP_ABNORMAL_CIRCULATING_PROTEIN_CONCENTRATION,0.99999
LANDIS_ERBB2_BREAST_PRENEOPL...2,SET,17,-0.021971,-0.00066828,0.20377,0.54293,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP,0.99999
GOMF_LONG_CHAIN_FATTY_ACID_C...,SET,14,-0.023319,-0.00064372,0.21626,0.54293,GOMF_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,0.99999
MIR5006_5P,SET,109,-0.0086145,-0.00066182,0.079876,0.54294,MIR5006_5P,0.99999
HP_CHRONIC_DIARRHEA,SET,93,-0.0094728,-0.00067252,0.087814,0.54295,HP_CHRONIC_DIARRHEA,0.99999
GOBP_POSITIVE_REGULATION_OF_...663,SET,5,-0.043586,-0.00071921,0.40383,0.54297,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_BINDING,0.99999
HP_SPINAL_DYSRAPHISM,SET,129,-0.0080987,-0.0006765,0.074922,0.54304,HP_SPINAL_DYSRAPHISM,0.99999
GSE14415_FOXP3_KO_NATURAL_TR...1,SET,158,-0.0074708,-0.00069009,0.069108,0.54304,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_DN,0.99999
GOBP_REGULATION_OF_CELL_CHEM...,SET,5,-0.045148,-0.00074499,0.41733,0.54307,GOBP_REGULATION_OF_CELL_CHEMOTAXIS_TO_FIBROBLAST_GROWTH_FACTOR,0.99999
HP_MESOMELIC_LEG_SHORTENING,SET,5,-0.040655,-0.00067084,0.37584,0.54307,HP_MESOMELIC_LEG_SHORTENING,0.99999
REACTOME_THE_RETINOID_CYCLE_...,SET,3,-0.069709,-0.00089105,0.64412,0.54309,REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION,0.99999
TATAAA_TATA_01,SET,1142,-0.0029858,-0.00072116,0.027579,0.54311,TATAAA_TATA_01,0.99999
GSE22886_NAIVE_BCELL_VS_BLOO...1,SET,175,-0.0068068,-0.00066141,0.062869,0.54311,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN,0.99999
GSE45365_NK_CELL_VS_CD8_TCEL...4,SET,143,-0.0076059,-0.00066867,0.070202,0.54314,GSE45365_NK_CELL_VS_CD8_TCELL_UP,0.99999
MIR544A,SET,202,-0.0065614,-0.00068448,0.06054,0.54315,MIR544A,0.99999
MIR532_5P,SET,68,-0.011327,-0.00068811,0.10409,0.54333,MIR532_5P,0.99999
REACTOME_ACTIVATION_OF_KAINA...,SET,29,-0.018218,-0.0007235,0.16736,0.54334,REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING,0.99999
HOXA9_DN.V1_UP,SET,172,-0.0074924,-0.00072182,0.06881,0.54335,HOXA9_DN.V1_UP,0.99999
REACTOME_WNT_MEDIATED_ACTIVA...,SET,8,-0.031267,-0.00065256,0.28711,0.54336,REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL,0.99999
MORF_MAGEA8,SET,226,-0.0064553,-0.00071182,0.059269,0.54336,MORF_MAGEA8,0.99999
GOMF_BICARBONATE_TRANSMEMBRA...,SET,31,-0.016244,-0.00066695,0.1491,0.54338,GOMF_BICARBONATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_MORPHOGENESIS_OF_AN_EPI...1,SET,13,-0.03039,-0.00080843,0.27874,0.54341,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_BUD,0.99999
HP_CLITORAL_HYPERTROPHY,SET,60,-0.012114,-0.00069142,0.11108,0.54342,HP_CLITORAL_HYPERTROPHY,0.99999
GOBP_ANTIMICROBIAL_PEPTIDE_P...,SET,12,-0.031123,-0.00079545,0.28503,0.54347,GOBP_ANTIMICROBIAL_PEPTIDE_PRODUCTION,0.99999
GOMF_RECEPTOR_ANTAGONIST_ACT...,SET,16,-0.021239,-0.00062676,0.19454,0.54347,GOMF_RECEPTOR_ANTAGONIST_ACTIVITY,0.99999
GOBP_RESPONSE_TO_DEXAMETHASO...,SET,42,-0.015783,-0.00075405,0.14452,0.54348,GOBP_RESPONSE_TO_DEXAMETHASONE,0.99999
PID_HDAC_CLASSIII_PATHWAY,SET,23,-0.01949,-0.00068944,0.17843,0.54349,PID_HDAC_CLASSIII_PATHWAY,0.99999
GSE21670_IL6_VS_TGFB_AND_IL6...3,SET,178,-0.006896,-0.00067574,0.063084,0.54352,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.99999
MURAKAMI_UV_RESPONSE_1HR_DN,SET,10,-0.028272,-0.00065967,0.25845,0.54355,MURAKAMI_UV_RESPONSE_1HR_DN,0.99999
GOBP_ACTIVATION_OF_INNATE_IM...,SET,266,-0.005667,-0.00067719,0.051808,0.54355,GOBP_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE,0.99999
GOBP_VESICLE_BUDDING_FROM_ME...,SET,82,-0.0098949,-0.00065983,0.090449,0.54356,GOBP_VESICLE_BUDDING_FROM_MEMBRANE,0.99999
GOBP_PROTEIN_DEUBIQUITINATION,SET,71,-0.010302,-0.00063943,0.094105,0.54359,GOBP_PROTEIN_DEUBIQUITINATION,0.99999
GOBP_DETERMINATION_OF_DIGEST...,SET,6,-0.03221,-0.00058222,0.29392,0.54363,GOBP_DETERMINATION_OF_DIGESTIVE_TRACT_LEFT_RIGHT_ASYMMETRY,0.99999
GOBP_PROTEIN_COMPLEX_OLIGOME...,SET,250,-0.0060962,-0.00070655,0.055489,0.54374,GOBP_PROTEIN_COMPLEX_OLIGOMERIZATION,0.99999
E2F5_TARGET_GENES,SET,1007,-0.0030679,-0.00069855,0.027896,0.54379,E2F5_TARGET_GENES,0.99999
REACTOME_SIGNALING_BY_ACTIVA...,SET,11,-0.031915,-0.00078099,0.29013,0.5438,REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1,0.99999
GOBP_VACUOLAR_PROTON_TRANSPO...,SET,5,-0.041604,-0.00068651,0.37808,0.54381,GOBP_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY,0.99999
GSE37605_C57BL6_VS_NOD_FOXP3...8,SET,107,-0.009201,-0.0007004,0.083572,0.54383,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_UP,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...6,SET,7,-0.029419,-0.00057435,0.26693,0.54388,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE,0.99999
GOBP_CHROMOSOME_ORGANIZATION,SET,543,-0.00388,-0.00065735,0.035114,0.54399,GOBP_CHROMOSOME_ORGANIZATION,0.99999
HP_HYPOPLASIA_OF_THE_FRONTAL...,SET,33,-0.015246,-0.00064583,0.138,0.54399,HP_HYPOPLASIA_OF_THE_FRONTAL_LOBES,0.99999
GOBP_COMPARTMENT_PATTERN_SPE...,SET,5,-0.046153,-0.00076157,0.41653,0.54411,GOBP_COMPARTMENT_PATTERN_SPECIFICATION,0.99999
MIR4712_3P,SET,57,-0.012999,-0.0007232,0.11698,0.54424,MIR4712_3P,0.99999
GOBP_BOX_C_D_SNORNP_ASSEMBLY,SET,8,-0.031935,-0.0006665,0.28739,0.54424,GOBP_BOX_C_D_SNORNP_ASSEMBLY,0.99999
DAVICIONI_PAX_FOXO1_SIGNATUR...2,SET,52,-0.014492,-0.00077017,0.13014,0.54433,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,0.99999
LEE_CALORIE_RESTRICTION_NEOC...1,SET,59,-0.011706,-0.00066255,0.10512,0.54433,LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,0.99999
GOMF_VASOPRESSIN_RECEPTOR_AC...,SET,6,-0.043347,-0.00078351,0.38932,0.54433,GOMF_VASOPRESSIN_RECEPTOR_ACTIVITY,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...8,SET,46,-0.015221,-0.00076096,0.13662,0.54435,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_6,0.99999
REACTOME_UB_SPECIFIC_PROCESS...,SET,148,-0.0071696,-0.00064114,0.06433,0.54437,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,0.99999
WP_DOPAMINE_METABOLISM,SET,11,-0.028654,-0.0007012,0.25707,0.54438,WP_DOPAMINE_METABOLISM,0.99999
GOMF_TUBULIN_BINDING,SET,346,-0.005005,-0.0006806,0.044897,0.54438,GOMF_TUBULIN_BINDING,0.99999
HP_ABNORMAL_LOWER_LIMB_EPIPH...,SET,84,-0.01063,-0.00071738,0.095303,0.5444,HP_ABNORMAL_LOWER_LIMB_EPIPHYSIS_MORPHOLOGY,0.99999
REACTOME_APOPTOSIS_INDUCED_D...,SET,7,-0.0331,-0.00064622,0.29674,0.54441,REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION,0.99999
GOMF_LARGE_RIBOSOMAL_SUBUNIT...,SET,5,-0.040825,-0.00067366,0.36597,0.54441,GOMF_LARGE_RIBOSOMAL_SUBUNIT_RRNA_BINDING,0.99999
BENITEZ_GBM_PROTEASOME_INHIB...,SET,45,-0.014643,-0.0007241,0.13078,0.54458,BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE,0.99999
MIR6083,SET,236,-0.0064766,-0.00072959,0.057723,0.54467,MIR6083,0.99999
GOBP_EPITHELIAL_CELL_PROLIFE...1,SET,407,-0.0050179,-0.00073882,0.044694,0.5447,GOBP_EPITHELIAL_CELL_PROLIFERATION,0.99999
MORF_TNFRSF25,SET,244,-0.0061869,-0.00070852,0.055081,0.54472,MORF_TNFRSF25,0.99999
GOBP_REGULATION_OF_PROTEIN_S...1,SET,245,-0.0063506,-0.00072873,0.056515,0.54473,GOBP_REGULATION_OF_PROTEIN_SECRETION,0.99999
GSE24634_IL4_VS_CTRL_TREATED...7,SET,176,-0.0075378,-0.00073451,0.066993,0.54479,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN,0.99999
GOBP_REGULATION_OF_STRESS_GR...,SET,11,-0.024263,-0.00059374,0.21561,0.5448,GOBP_REGULATION_OF_STRESS_GRANULE_ASSEMBLY,0.99999
HP_POSTERIOR_SYNECHIAE_OF_TH...,SET,10,-0.032678,-0.00076247,0.29003,0.54485,HP_POSTERIOR_SYNECHIAE_OF_THE_ANTERIOR_CHAMBER,0.99999
HP_HEART_BLOCK,SET,116,-0.0091027,-0.00072129,0.080734,0.54488,HP_HEART_BLOCK,0.99999
GOBP_POSITIVE_REGULATION_OF_...450,SET,11,-0.031059,-0.00076004,0.27526,0.54492,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_POTENTIAL,0.99999
GOMF_NUCLEAR_ESTROGEN_RECEPT...,SET,35,-0.016129,-0.00070358,0.14292,0.54492,GOMF_NUCLEAR_ESTROGEN_RECEPTOR_BINDING,0.99999
ITO_PTTG1_TARGETS_UP,SET,11,-0.033864,-0.00082868,0.29953,0.54501,ITO_PTTG1_TARGETS_UP,0.99999
GATA1_04,SET,222,-0.0068617,-0.00074999,0.060654,0.54504,GATA1_04,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...29,SET,607,-0.0040109,-0.00071716,0.035414,0.54509,HP_APLASIA_HYPOPLASIA_OF_THE_EXTREMITIES,0.99999
BIOCARTA_CDK5_PATHWAY,SET,13,-0.028151,-0.00074886,0.24847,0.5451,BIOCARTA_CDK5_PATHWAY,0.99999
MORI_LARGE_PRE_BII_LYMPHOCYT...1,SET,53,-0.013759,-0.00073824,0.12142,0.54511,MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,0.99999
GSE20727_DNFB_ALLERGEN_VS_RO...1,SET,188,-0.0070671,-0.00071149,0.062368,0.54511,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,0.99999
REACTOME_CHEMOKINE_RECEPTORS...,SET,54,-0.015879,-0.00085992,0.14002,0.54514,REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,0.99999
PID_RXR_VDR_PATHWAY,SET,26,-0.018597,-0.00069938,0.16392,0.54516,PID_RXR_VDR_PATHWAY,0.99999
BIOCARTA_FOSB_PATHWAY,SET,5,-0.044941,-0.00074158,0.39398,0.54541,BIOCARTA_FOSB_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...681,SET,6,-0.039105,-0.00070684,0.34278,0.54541,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,0.99999
GSE14769_UNSTIM_VS_360MIN_LP...2,SET,175,-0.0068756,-0.00066809,0.060254,0.54542,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP,0.99999
GOMF_SPLICING_FACTOR_BINDING,SET,5,-0.039551,-0.00065263,0.3465,0.54544,GOMF_SPLICING_FACTOR_BINDING,0.99999
CAATGCA_MIR33,SET,88,-0.010359,-0.00071551,0.090704,0.54546,CAATGCA_MIR33,0.99999
HP_INTRA_EPIDERMAL_BLISTERING,SET,6,-0.037077,-0.00067019,0.32445,0.54549,HP_INTRA_EPIDERMAL_BLISTERING,0.99999
BIOCARTA_IL7_PATHWAY,SET,16,-0.025648,-0.00075685,0.22434,0.54551,BIOCARTA_IL7_PATHWAY,0.99999
GSE22886_NAIVE_VS_IGM_MEMORY...1,SET,176,-0.0075288,-0.00073363,0.065753,0.54558,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN,0.99999
HP_STAGE_5_CHRONIC_KIDNEY_DI...,SET,124,-0.0085603,-0.00070116,0.074727,0.5456,HP_STAGE_5_CHRONIC_KIDNEY_DISEASE,0.99999
NIKOLSKY_BREAST_CANCER_8Q23_...,SET,144,-0.015579,-0.0013744,0.13574,0.54569,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,0.99999
GOBP_REGULATION_OF_BLOOD_CIR...,SET,240,-0.0069232,-0.00078639,0.060296,0.54571,GOBP_REGULATION_OF_BLOOD_CIRCULATION,0.99999
GOMF_3_5_CYCLIC_AMP_PHOSPHOD...,SET,22,-0.021731,-0.00075183,0.18907,0.54575,GOMF_3_5_CYCLIC_AMP_PHOSPHODIESTERASE_ACTIVITY,0.99999
GOBP_RRNA_BASE_METHYLATION,SET,6,-0.037827,-0.00068375,0.32866,0.54582,GOBP_RRNA_BASE_METHYLATION,0.99999
MORF_ATRX,SET,204,-0.0065567,-0.00068732,0.056893,0.54587,MORF_ATRX,0.99999
GSE13484_12H_UNSTIM_VS_YF17D...1,SET,177,-0.0076629,-0.00074879,0.066354,0.54597,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,0.99999
GOCC_ENDOLYSOSOME,SET,26,-0.019494,-0.00073312,0.16863,0.54602,GOCC_ENDOLYSOSOME,0.99999
KEGG_SULFUR_METABOLISM,SET,11,-0.029212,-0.00071485,0.25249,0.54605,KEGG_SULFUR_METABOLISM,0.99999
GSE39820_TGFBETA1_VS_TGFBETA...3,SET,179,-0.0073068,-0.00071798,0.063077,0.54611,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN,0.99999
GSE15750_DAY6_VS_DAY10_TRAF6...1,SET,183,-0.0069458,-0.00069002,0.059953,0.54612,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN,0.99999
REACTOME_CHONDROITIN_SULFATE...2,SET,45,-0.014683,-0.00072607,0.12671,0.54613,REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,0.99999
NIKOLSKY_BREAST_CANCER_5P15_...,SET,25,-0.035635,-0.0013141,0.30721,0.54617,NIKOLSKY_BREAST_CANCER_5P15_AMPLICON,0.99999
MIR376A_3P_MIR376B_3P,SET,133,-0.0083106,-0.0007048,0.071654,0.54617,MIR376A_3P_MIR376B_3P,0.99999
GOBP_NEURAL_PLATE_DEVELOPMENT,SET,7,-0.03623,-0.00070732,0.31199,0.54622,GOBP_NEURAL_PLATE_DEVELOPMENT,0.99999
GSE2770_IL12_AND_TGFB_ACT_VS...5,SET,180,-0.0072234,-0.00071175,0.062153,0.54626,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN,0.99999
GOBP_DENDRITIC_SPINE_DEVELOP...,SET,87,-0.010812,-0.00074256,0.092864,0.54634,GOBP_DENDRITIC_SPINE_DEVELOPMENT,0.99999
MIR4300,SET,57,-0.012942,-0.00072004,0.11104,0.54639,MIR4300,0.99999
GAVIN_FOXP3_TARGETS_CLUSTER_...4,SET,84,-0.010971,-0.00074042,0.09408,0.54642,GAVIN_FOXP3_TARGETS_CLUSTER_P6,0.99999
GOBP_POSITIVE_REGULATION_OF_...297,SET,49,-0.013802,-0.00071213,0.11832,0.54643,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,0.99999
GOCC_SYNAPSE,SET,1365,-0.0028855,-0.00075701,0.024722,0.54646,GOCC_SYNAPSE,0.99999
GOBP_REGULATION_OF_LIPID_MET...,SET,279,-0.0061589,-0.00075348,0.052729,0.54649,GOBP_REGULATION_OF_LIPID_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...242,SET,16,-0.027652,-0.00081599,0.23667,0.5465,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
WP_OVERVIEW_OF_NANOPARTICLE_...,SET,19,-0.025264,-0.00081236,0.21622,0.54651,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,0.99999
GOMF_SODIUM_CHANNEL_REGULATO...,SET,38,-0.017448,-0.00079302,0.14925,0.54653,GOMF_SODIUM_CHANNEL_REGULATOR_ACTIVITY,0.99999
GOMF_AMINO_ACID_PROTON_SYMPO...,SET,6,-0.046606,-0.00084244,0.3981,0.5466,GOMF_AMINO_ACID_PROTON_SYMPORTER_ACTIVITY,0.99999
GSE6259_CD4_TCELL_VS_CD8_TCE...2,SET,173,-0.0080016,-0.00077309,0.068344,0.5466,GSE6259_CD4_TCELL_VS_CD8_TCELL_UP,0.99999
HALLMARK_UV_RESPONSE_UP,SET,149,-0.0081718,-0.00073321,0.069785,0.54661,HALLMARK_UV_RESPONSE_UP,0.99999
HP_HYPERCONVEX_NAIL,SET,16,-0.025982,-0.00076672,0.22184,0.54662,HP_HYPERCONVEX_NAIL,0.99999
GOBP_NEGATIVE_REGULATION_OF_...198,SET,6,-0.04031,-0.00072863,0.34384,0.54666,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_CALCIUM_ION_CONCENTRATION,0.99999
GSE40666_NAIVE_VS_EFFECTOR_C...3,SET,179,-0.0072982,-0.00071713,0.06217,0.54672,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.99999
MIR155_5P,SET,215,-0.0072273,-0.00077754,0.061493,0.54678,MIR155_5P,0.99999
GOMF_NUCLEAR_RETINOIC_ACID_R...,SET,24,-0.020079,-0.00072551,0.17069,0.54682,GOMF_NUCLEAR_RETINOIC_ACID_RECEPTOR_BINDING,0.99999
GOBP_OSTEOBLAST_DIFFERENTIAT...,SET,209,-0.0072806,-0.0007724,0.061865,0.54684,GOBP_OSTEOBLAST_DIFFERENTIATION,0.99999
GNF2_DDX5,SET,58,-0.012257,-0.00068786,0.10406,0.54688,GNF2_DDX5,0.99999
MIR202_3P,SET,229,-0.0067432,-0.00074842,0.057222,0.5469,MIR202_3P,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...10,SET,169,-0.0072694,-0.00069426,0.061614,0.54696,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,0.99999
REACTOME_CASPASE_MEDIATED_CL...,SET,12,-0.028398,-0.00072582,0.24069,0.54696,REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS,0.99999
REACTOME_REDUCTION_OF_CYTOSO...,SET,11,-0.029008,-0.00070986,0.24584,0.54696,REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS,0.99999
REACTOME_SIGNALING_BY_TGFB_F...,SET,149,-0.0083285,-0.00074727,0.070586,0.54696,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,0.99999
HP_DELAYED_EARLY_CHILDHOOD_S...,SET,20,-0.02161,-0.00071288,0.18314,0.54696,HP_DELAYED_EARLY_CHILDHOOD_SOCIAL_MILESTONE_DEVELOPMENT,0.99999
EVI1_01,SET,14,-0.026552,-0.00073296,0.22499,0.54697,EVI1_01,0.99999
MODULE_273,SET,40,-0.015005,-0.00069966,0.12708,0.547,MODULE_273,0.99999
GSE9601_UNTREATED_VS_PI3K_IN...2,SET,156,-0.0078209,-0.00071789,0.066194,0.54703,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,0.99999
FAN_OVARY_CL10_PUTATIVE_EARL...,SET,225,-0.0063062,-0.00069386,0.053318,0.54707,FAN_OVARY_CL10_PUTATIVE_EARLY_ATRESIA_GRANULOSA_CELL,0.99999
GAUTAM_EYE_CORNEA_ELF3_HIGH_...,SET,134,-0.0087913,-0.00074834,0.074288,0.5471,GAUTAM_EYE_CORNEA_ELF3_HIGH_EPITHELIAL_CELLS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...43,SET,11,-0.034188,-0.00083661,0.28869,0.54713,GOBP_NEGATIVE_REGULATION_OF_BEHAVIOR,0.99999
HP_EEG_WITH_GENERALIZED_EPIL...,SET,247,-0.0064745,-0.00074593,0.054664,0.54714,HP_EEG_WITH_GENERALIZED_EPILEPTIFORM_DISCHARGES,0.99999
GSE12845_IGD_POS_BLOOD_VS_PR...1,SET,186,-0.0072405,-0.0007251,0.06108,0.54718,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...512,SET,13,-0.03094,-0.00082304,0.26087,0.5472,GOBP_POSITIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.99999
BAKER_HEMATOPOESIS_STAT1_TAR...,SET,10,-0.031486,-0.00073466,0.26539,0.54722,BAKER_HEMATOPOESIS_STAT1_TARGETS,0.99999
DESCARTES_MAIN_FETAL_DUCTAL_...,SET,50,-0.015658,-0.00081603,0.13177,0.54729,DESCARTES_MAIN_FETAL_DUCTAL_CELLS,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...2,SET,13,-0.026974,-0.00071756,0.22691,0.54731,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY,0.99999
HP_EXUDATIVE_VITREORETINOPAT...,SET,7,-0.032934,-0.00064298,0.27652,0.5474,HP_EXUDATIVE_VITREORETINOPATHY,0.99999
HP_SYNOSTOSIS_INVOLVING_BONE...2,SET,43,-0.016882,-0.00081611,0.14174,0.54741,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_HAND,0.99999
MIR4714_3P,SET,53,-0.014233,-0.00076367,0.11946,0.54742,MIR4714_3P,0.99999
HP_HYPERTYROSINEMIA,SET,6,-0.045417,-0.00082094,0.38115,0.54742,HP_HYPERTYROSINEMIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...511,SET,11,-0.029571,-0.00072365,0.24801,0.54745,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_PROLIFERATION,0.99999
GSE4142_NAIVE_VS_GC_BCELL_UP,SET,181,-0.0074759,-0.00073865,0.06263,0.54751,GSE4142_NAIVE_VS_GC_BCELL_UP,0.99999
GOMF_MONOAMINE_TRANSMEMBRANE...,SET,12,-0.032603,-0.00083329,0.27259,0.5476,GOMF_MONOAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MIR3670,SET,50,-0.013936,-0.00072629,0.11646,0.54762,MIR3670,0.99999
MODULE_492,SET,16,-0.026138,-0.00077132,0.21832,0.54765,MODULE_492,0.99999
CROONQUIST_STROMAL_STIMULATI...1,SET,11,-0.03348,-0.00081929,0.27934,0.5477,CROONQUIST_STROMAL_STIMULATION_DN,0.99999
VANTVEER_BREAST_CANCER_POOR_...,SET,44,-0.016105,-0.00078753,0.13438,0.5477,VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,0.99999
MODULE_37,SET,427,-0.0048913,-0.00073725,0.040809,0.5477,MODULE_37,0.99999
GOBP_POSITIVE_REGULATION_OF_...773,SET,9,-0.030231,-0.00066919,0.25219,0.54771,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NUCLEOLAR_LARGE_RRNA_BY_RNA_POLYMERASE_I,0.99999
GOBP_PROTEIN_TARGETING_TO_LY...,SET,29,-0.018046,-0.00071668,0.15038,0.54776,GOBP_PROTEIN_TARGETING_TO_LYSOSOME,0.99999
HP_ABNORMAL_HEMIDIAPHRAGM_MO...,SET,7,-0.043804,-0.0008552,0.36489,0.54778,HP_ABNORMAL_HEMIDIAPHRAGM_MORPHOLOGY,0.99999
GOBP_ANTERIOR_HEAD_DEVELOPME...,SET,7,-0.043261,-0.00084459,0.36015,0.54781,GOBP_ANTERIOR_HEAD_DEVELOPMENT,0.99999
MODULE_295,SET,19,-0.022767,-0.00073205,0.18942,0.54783,MODULE_295,0.99999
GOBP_TRNA_5_END_PROCESSING,SET,13,-0.024478,-0.00065115,0.20369,0.54783,GOBP_TRNA_5_END_PROCESSING,0.99999
SCHEIDEREIT_IKK_TARGETS,SET,17,-0.027644,-0.00084084,0.22983,0.54787,SCHEIDEREIT_IKK_TARGETS,0.99999
RORIE_TARGETS_OF_EWSR1_FLI1_...1,SET,25,-0.022997,-0.00084806,0.19107,0.5479,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN,0.99999
GOBP_HEART_VALVE_DEVELOPMENT,SET,72,-0.013216,-0.00082606,0.10943,0.54806,GOBP_HEART_VALVE_DEVELOPMENT,0.99999
ROPERO_HDAC2_TARGETS,SET,98,-0.010534,-0.00076757,0.087191,0.54808,ROPERO_HDAC2_TARGETS,0.99999
MAGRANGEAS_MULTIPLE_MYELOMA_...3,SET,22,-0.021875,-0.0007568,0.18099,0.5481,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,0.99999
BIOCARTA_RNA_PATHWAY,SET,10,-0.0325,-0.00075831,0.26867,0.54814,BIOCARTA_RNA_PATHWAY,0.99999
MIR6794_3P,SET,77,-0.012797,-0.00082702,0.10577,0.54815,MIR6794_3P,0.99999
ZHAN_MULTIPLE_MYELOMA_CD1_VS...1,SET,48,-0.016113,-0.00082284,0.13302,0.5482,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,0.99999
GOBP_EPITHELIAL_CELL_FATE_CO...,SET,14,-0.03103,-0.00085659,0.25596,0.54825,GOBP_EPITHELIAL_CELL_FATE_COMMITMENT,0.99999
GOBP_MODULATION_OF_PROCESS_O...,SET,14,-0.03033,-0.00083725,0.25006,0.54827,GOBP_MODULATION_OF_PROCESS_OF_ANOTHER_ORGANISM,0.99999
PATEL_SKIN_OF_BODY_ZOSTAVAX_...3,SET,96,-0.011199,-0.0008077,0.092325,0.54827,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_UP,0.99999
RICHERT_PBMC_HIV_LIPO_5_AGE_...4,SET,25,-0.023506,-0.00086686,0.19378,0.54827,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_TOP_FUNCTIONAL_NETWORK_UP,0.99999
GSE6674_UNSTIM_VS_PL2_3_STIM...1,SET,152,-0.0080768,-0.00073188,0.066573,0.54828,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_DN,0.99999
GOBP_REGULATION_OF_LYSOSOME_...1,SET,12,-0.030362,-0.00077601,0.24968,0.54839,GOBP_REGULATION_OF_LYSOSOME_ORGANIZATION,0.99999
GOBP_RIBONUCLEOSIDE_MONOPHOS...3,SET,52,-0.014584,-0.00077509,0.11988,0.54841,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.99999
HP_PARTIAL_AGENESIS_OF_THE_C...,SET,46,-0.0144,-0.0007199,0.11831,0.54843,HP_PARTIAL_AGENESIS_OF_THE_CORPUS_CALLOSUM,0.99999
HP_PARESIS_OF_EXTENSOR_MUSCL...,SET,6,-0.049231,-0.00088987,0.40361,0.54854,HP_PARESIS_OF_EXTENSOR_MUSCLES_OF_THE_BIG_TOE,0.99999
GSE2585_CTEC_VS_THYMIC_MACRO...2,SET,183,-0.007915,-0.0007863,0.064835,0.54858,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP,0.99999
MARTIN_VIRAL_GPCR_SIGNALING_...2,SET,82,-0.011619,-0.00077477,0.095158,0.54859,MARTIN_VIRAL_GPCR_SIGNALING_UP,0.99999
HP_PERIPHERAL_DEMYELINATION,SET,40,-0.016352,-0.00076246,0.13385,0.54862,HP_PERIPHERAL_DEMYELINATION,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...9,SET,9,-0.035445,-0.00078462,0.28992,0.54865,KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY,0.99999
MIR3924,SET,306,-0.0062773,-0.00080366,0.051281,0.54871,MIR3924,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_DC2...,SET,49,-0.015688,-0.0008094,0.12815,0.54872,HE_LIM_SUN_FETAL_LUNG_C2_DC2_CELL,0.99999
GOBP_IONOTROPIC_GLUTAMATE_RE...,SET,21,-0.02513,-0.00084947,0.20518,0.54874,GOBP_IONOTROPIC_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.99999
BRCA1_DN.V1_UP,SET,112,-0.010518,-0.00081905,0.085816,0.54877,BRCA1_DN.V1_UP,0.99999
GSE41867_DAY15_EFFECTOR_VS_D...2,SET,189,-0.0075252,-0.00075961,0.061394,0.54878,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,0.99999
MODULE_143,SET,12,-0.033619,-0.00085925,0.27414,0.5488,MODULE_143,0.99999
DEBIASI_APOPTOSIS_BY_REOVIRU...1,SET,246,-0.0064928,-0.00074655,0.052925,0.54882,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,0.99999
JIANG_AGING_HYPOTHALAMUS_UP,SET,39,-0.016253,-0.00074833,0.13218,0.54893,JIANG_AGING_HYPOTHALAMUS_UP,0.99999
GOBP_CONVERGENT_EXTENSION,SET,15,-0.028354,-0.00081015,0.23053,0.54894,GOBP_CONVERGENT_EXTENSION,0.99999
GOBP_RESPONSE_TO_RETINOIC_AC...,SET,101,-0.011238,-0.00083125,0.091374,0.54894,GOBP_RESPONSE_TO_RETINOIC_ACID,0.99999
ACEVEDO_LIVER_CANCER_DN,SET,490,-0.0048139,-0.0007759,0.039126,0.54896,ACEVEDO_LIVER_CANCER_DN,0.99999
GOBP_CELL_CELL_JUNCTION_DISA...,SET,5,-0.058122,-0.00095907,0.47241,0.54896,GOBP_CELL_CELL_JUNCTION_DISASSEMBLY,0.99999
GOBP_REGULATION_OF_CHROMOSOM...1,SET,11,-0.027101,-0.00066319,0.22027,0.54896,GOBP_REGULATION_OF_CHROMOSOME_CONDENSATION,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...7,SET,166,-0.0084324,-0.00079821,0.068473,0.549,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,0.99999
GSE37416_CTRL_VS_48H_F_TULAR...2,SET,167,-0.0083143,-0.00078939,0.06741,0.54908,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
CHOW_RASSF1_TARGETS_DN,SET,28,-0.018315,-0.00071475,0.14823,0.54917,CHOW_RASSF1_TARGETS_DN,0.99999
GOBP_CELL_ACTIVATION,SET,1021,-0.0035628,-0.00081652,0.028825,0.54918,GOBP_CELL_ACTIVATION,0.99999
LANDIS_BREAST_CANCER_PROGRES...2,SET,40,-0.01723,-0.00080341,0.13932,0.54921,LANDIS_BREAST_CANCER_PROGRESSION_UP,0.99999
GOBP_DEVELOPMENTAL_MATURATION,SET,310,-0.0062917,-0.00081066,0.050862,0.54922,GOBP_DEVELOPMENTAL_MATURATION,0.99999
HP_ABNORMAL_ILIUM_MORPHOLOGY,SET,85,-0.011393,-0.00077344,0.092116,0.54922,HP_ABNORMAL_ILIUM_MORPHOLOGY,0.99999
KEGG_MEDICUS_PATHOGEN_SALMON...1,SET,6,-0.043469,-0.00078572,0.35129,0.54924,KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY,0.99999
GOMF_ACYLTRANSFERASE_ACTIVITY,SET,650,-0.0041302,-0.00076328,0.033374,0.54924,GOMF_ACYLTRANSFERASE_ACTIVITY,0.99999
H1_6_TARGET_GENES,SET,405,-0.0053662,-0.00078821,0.043332,0.54928,H1_6_TARGET_GENES,0.99999
GOBP_GLYCEROLIPID_BIOSYNTHET...,SET,226,-0.0068605,-0.0007565,0.055352,0.54932,GOBP_GLYCEROLIPID_BIOSYNTHETIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_CXCR4...1,SET,9,-0.038507,-0.0008524,0.31036,0.54937,KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY,0.99999
GOCC_ENDOSOME_LUMEN,SET,37,-0.01857,-0.00083283,0.14945,0.54944,GOCC_ENDOSOME_LUMEN,0.99999
LEE_AGING_MUSCLE_UP,SET,34,-0.019293,-0.00082951,0.15515,0.54948,LEE_AGING_MUSCLE_UP,0.99999
BIOCARTA_LECTIN_PATHWAY,SET,10,-0.033441,-0.00078028,0.26889,0.54949,BIOCARTA_LECTIN_PATHWAY,0.99999
NIKOLSKY_BREAST_CANCER_22Q13...,SET,16,-0.041195,-0.0012156,0.33111,0.54951,NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON,0.99999
GOBP_NEUROTRANSMITTER_RECEPT...5,SET,7,-0.045516,-0.00088862,0.36532,0.54958,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_POSTSYNAPTIC_ENDOSOME_TO_LYSOSOME,0.99999
NUNODA_RESPONSE_TO_DASATINIB...2,SET,29,-0.018878,-0.00074973,0.15128,0.54965,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,0.99999
GOBP_REGULATION_OF_ANATOMICA...1,SET,750,-0.0041356,-0.00081865,0.033141,0.54965,GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_MORPHOGENESIS,0.99999
GOBP_CELLULAR_RESPONSE_TO_AB...,SET,307,-0.0060458,-0.00077526,0.048443,0.54966,GOBP_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS,0.99999
GOMF_ALPHA_CATENIN_BINDING,SET,10,-0.036119,-0.00084277,0.28871,0.54978,GOMF_ALPHA_CATENIN_BINDING,0.99999
GOMF_L_ASPARTATE_TRANSMEMBRA...,SET,9,-0.033974,-0.00075204,0.27148,0.54979,GOMF_L_ASPARTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_PLATELET_AGGREGATION,SET,73,-0.013517,-0.00085068,0.10796,0.54982,GOBP_PLATELET_AGGREGATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...86,SET,72,-0.013135,-0.00082095,0.10489,0.54983,GOBP_POSITIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,0.99999
HUNSBERGER_EXERCISE_REGULATE...,SET,28,-0.022398,-0.00087407,0.17869,0.54987,HUNSBERGER_EXERCISE_REGULATED_GENES,0.99999
MIR6728_3P,SET,134,-0.009323,-0.00079361,0.074388,0.54987,MIR6728_3P,0.99999
NAKAYA_PBMC_FLUMIST_AGE_18_5...3,SET,502,-0.0047354,-0.00077228,0.037706,0.54997,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...33,SET,4,-0.049635,-0.00073259,0.39517,0.54998,GOBP_PROTEIN_LOCALIZATION_TO_MOTILE_CILIUM,0.99999
GSE5503_MLN_DC_VS_SPLEEN_DC_...1,SET,178,-0.0079144,-0.00077553,0.062991,0.54999,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.99999
GSE3920_UNTREATED_VS_IFNA_TR...2,SET,163,-0.0088163,-0.00082705,0.070143,0.55001,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...10,SET,170,-0.0078261,-0.00074961,0.062258,0.55002,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_UP,0.99999
MIR6729_3P,SET,63,-0.013034,-0.00076222,0.10363,0.55005,MIR6729_3P,0.99999
MODULE_112,SET,237,-0.0077459,-0.0008744,0.061533,0.55009,MODULE_112,0.99999
GOBP_MESONEPHRIC_DUCT_DEVELO...,SET,8,-0.038987,-0.00081369,0.30966,0.55009,GOBP_MESONEPHRIC_DUCT_DEVELOPMENT,0.99999
GSE32986_UNSTIM_VS_GMCSF_AND...3,SET,174,-0.008049,-0.0007799,0.063904,0.55012,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,0.99999
GOBP_ENDOCARDIAL_CUSHION_FOR...,SET,30,-0.023004,-0.00092916,0.18249,0.55015,GOBP_ENDOCARDIAL_CUSHION_FORMATION,0.99999
PID_IL2_STAT5_PATHWAY,SET,28,-0.020571,-0.00080277,0.16301,0.55021,PID_IL2_STAT5_PATHWAY,0.99999
HP_SLOPING_FOREHEAD,SET,165,-0.0078827,-0.00074395,0.062459,0.55021,HP_SLOPING_FOREHEAD,0.99999
WP_DNA_IRDOUBLE_STRAND_BREAK...,SET,52,-0.01332,-0.0007079,0.10551,0.55023,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,0.99999
GOBP_REGULATION_OF_NOTCH_SIG...,SET,86,-0.012085,-0.00082519,0.095705,0.55024,GOBP_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,0.99999
BIOCARTA_ERAD_PATHWAY,SET,19,-0.023065,-0.00074163,0.18244,0.5503,BIOCARTA_ERAD_PATHWAY,0.99999
GOBP_PYRIMIDINE_NUCLEOBASE_B...,SET,7,-0.037155,-0.00072539,0.29349,0.55037,GOBP_PYRIMIDINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_PRE_MIRNA...,SET,5,-0.048253,-0.00079623,0.38115,0.55037,GOBP_REGULATION_OF_PRE_MIRNA_PROCESSING,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_M...1,SET,22,-0.026133,-0.00090414,0.20641,0.55038,GOBP_PYRIMIDINE_NUCLEOSIDE_METABOLIC_PROCESS,0.99999
TRAVAGLINI_LUNG_ALVEOLAR_EPI...2,SET,126,-0.010694,-0.00088291,0.084425,0.5504,TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_2_CELL,0.99999
GOBP_CERAMIDE_METABOLIC_PROC...,SET,99,-0.011251,-0.00082396,0.088775,0.55042,GOBP_CERAMIDE_METABOLIC_PROCESS,0.99999
GOBP_NEPHRIC_DUCT_DEVELOPMENT,SET,14,-0.031395,-0.00086665,0.24769,0.55043,GOBP_NEPHRIC_DUCT_DEVELOPMENT,0.99999
GOMF_CHROMATIN_PROTEIN_ADAPT...,SET,24,-0.020333,-0.00073471,0.16036,0.55045,GOMF_CHROMATIN_PROTEIN_ADAPTOR_ACTIVITY,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...22,SET,32,-0.020744,-0.0008653,0.16344,0.5505,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_HORIZONTAL_BASAL_CELLS,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...9,SET,164,-0.0084543,-0.0007955,0.066584,0.55052,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN,0.99999
LI_WILMS_TUMOR_VS_FETAL_KIDN...3,SET,45,-0.018502,-0.00091492,0.14522,0.55069,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...778,SET,111,-0.0098039,-0.00076003,0.07694,0.5507,GOBP_POSITIVE_REGULATION_OF_TRANSLATION,0.99999
GOBP_REGULATION_OF_HEART_RAT...2,SET,5,-0.052167,-0.00086082,0.40905,0.55074,GOBP_REGULATION_OF_HEART_RATE_BY_CHEMICAL_SIGNAL,0.99999
GSE34515_CD16_POS_MONOCYTE_V...1,SET,182,-0.0079497,-0.00078761,0.062302,0.55077,GSE34515_CD16_POS_MONOCYTE_VS_DC_DN,0.99999
KYNG_ENVIRONMENTAL_STRESS_RE...7,SET,12,-0.03293,-0.00084165,0.25798,0.55079,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,0.99999
QI_PBMC_ZOSTAVAX_AGE_50_75YO...3,SET,158,-0.0082464,-0.00076173,0.064554,0.55082,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DYAT_1DY_NEGATIVE,0.99999
KEGG_GLYCOSPHINGOLIPID_BIOSY...2,SET,13,-0.03189,-0.00084832,0.24955,0.55084,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES,0.99999
HP_SHALLOW_ORBITS,SET,32,-0.018985,-0.00079195,0.14848,0.55087,HP_SHALLOW_ORBITS,0.99999
BIOCARTA_SLRP_PATHWAY,SET,5,-0.070759,-0.0011676,0.55305,0.5509,BIOCARTA_SLRP_PATHWAY,0.99999
HP_FIBULAR_HYPOPLASIA,SET,22,-0.022571,-0.00078088,0.17635,0.55092,HP_FIBULAR_HYPOPLASIA,0.99999
HP_ABNORMAL_DISTAL_FEMORAL_M...,SET,5,-0.052476,-0.00086591,0.40984,0.55094,HP_ABNORMAL_DISTAL_FEMORAL_METAPHYSIS_MORPHOLOGY,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...11,SET,5,-0.050388,-0.00083145,0.39324,0.55098,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3,0.99999
GOMF_SYMPORTER_ACTIVITY,SET,144,-0.0097212,-0.00085758,0.075862,0.55098,GOMF_SYMPORTER_ACTIVITY,0.99999
HP_LYMPHOCYTOSIS,SET,22,-0.024145,-0.00083534,0.18843,0.55098,HP_LYMPHOCYTOSIS,0.99999
MODULE_313,SET,13,-0.029744,-0.00079124,0.23203,0.551,MODULE_313,0.99999
HP_REDUCED_VITAL_CAPACITY,SET,26,-0.020408,-0.00076748,0.1592,0.551,HP_REDUCED_VITAL_CAPACITY,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HP...3,SET,284,-0.0066541,-0.0008212,0.051887,0.55102,MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL,0.99999
GOBP_PROTEIN_PROCESSING,SET,217,-0.0075201,-0.00081275,0.058631,0.55103,GOBP_PROTEIN_PROCESSING,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...32,SET,31,-0.018556,-0.00076188,0.14465,0.55104,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,0.99999
HP_ABNORMAL_METATARSAL_MORPH...,SET,139,-0.0095695,-0.00082954,0.074522,0.55109,HP_ABNORMAL_METATARSAL_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...676,SET,30,-0.021513,-0.00086895,0.16736,0.55114,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,0.99999
GSE37605_FOXP3_FUSION_GFP_VS...3,SET,151,-0.009241,-0.00083464,0.071833,0.55118,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN,0.99999
GOBP_REGULATION_OF_ASPARTIC_...1,SET,6,-0.049167,-0.00088873,0.38212,0.55119,GOBP_REGULATION_OF_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.99999
MIR1909_5P,SET,34,-0.018284,-0.00078612,0.14208,0.5512,MIR1909_5P,0.99999
MIR6858_3P,SET,41,-0.017263,-0.00081491,0.13406,0.55123,MIR6858_3P,0.99999
GSE37605_C57BL6_VS_NOD_FOXP3...6,SET,123,-0.010197,-0.00083185,0.079161,0.55125,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP,0.99999
GOCC_CUL3_RING_UBIQUITIN_LIG...,SET,37,-0.018042,-0.00080916,0.14004,0.55126,GOCC_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX,0.99999
GOMF_PROTEIN_DISULFIDE_REDUC...,SET,7,-0.038007,-0.00074203,0.29485,0.55128,GOMF_PROTEIN_DISULFIDE_REDUCTASE_NAD_P_H_ACTIVITY,0.99999
GSE360_DC_VS_MAC_M_TUBERCULO...2,SET,179,-0.0082247,-0.00080817,0.063811,0.55128,GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP,0.99999
GOBP_PROTEIN_K48_LINKED_DEUB...,SET,22,-0.020449,-0.00070747,0.15845,0.55134,GOBP_PROTEIN_K48_LINKED_DEUBIQUITINATION,0.99999
MIR6090,SET,9,-0.039709,-0.000879,0.30741,0.55139,MIR6090,0.99999
GSE37301_MULTIPOTENT_PROGENI...4,SET,153,-0.0085656,-0.00077871,0.066315,0.55139,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_UP,0.99999
GOBP_REGULATION_OF_PHOSPHORU...,SET,1027,-0.003605,-0.00082848,0.027902,0.5514,GOBP_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_ADHERENS_...,SET,5,-0.05074,-0.00083726,0.3926,0.55142,GOBP_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION,0.99999
REACTOME_AMINO_ACID_CONJUGAT...,SET,8,-0.05517,-0.0011514,0.42656,0.55145,REACTOME_AMINO_ACID_CONJUGATION,0.99999
WP_SARSCOV2_MITOCHONDRIAL_CH...,SET,22,-0.024048,-0.00083198,0.18596,0.55145,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.99999
GOBP_REGULATION_OF_ENDOTHELI...3,SET,34,-0.019589,-0.00084226,0.15143,0.55147,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,0.99999
GOBP_TROPHOBLAST_CELL_MIGRAT...,SET,15,-0.029255,-0.00083591,0.22608,0.55148,GOBP_TROPHOBLAST_CELL_MIGRATION,0.99999
MIR3138,SET,65,-0.014002,-0.00083171,0.10816,0.5515,MIR3138,0.99999
HP_DILATATION_OF_THE_VENTRIC...,SET,9,-0.035358,-0.00078269,0.2731,0.55151,HP_DILATATION_OF_THE_VENTRICULAR_CAVITY,0.99999
AREB6_04,SET,226,-0.0078604,-0.00086675,0.060622,0.55158,AREB6_04,0.99999
GOBP_ACETYL_COA_BIOSYNTHETIC...2,SET,8,-0.038888,-0.00081161,0.29961,0.55163,GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS_FROM_PYRUVATE,0.99999
GOBP_BLEB_ASSEMBLY,SET,11,-0.035596,-0.00087108,0.27391,0.5517,GOBP_BLEB_ASSEMBLY,0.99999
GOBP_CRANIAL_SKELETAL_SYSTEM...,SET,67,-0.014821,-0.00089374,0.11404,0.5517,GOBP_CRANIAL_SKELETAL_SYSTEM_DEVELOPMENT,0.99999
REACTOME_TP53_REGULATES_META...,SET,77,-0.012257,-0.00079214,0.094205,0.55176,REACTOME_TP53_REGULATES_METABOLIC_GENES,0.99999
HP_FOAMY_URINE,SET,29,-0.020823,-0.00082695,0.16002,0.55176,HP_FOAMY_URINE,0.99999
VEGF_A_UP.V1_UP,SET,176,-0.0083347,-0.00081216,0.064015,0.5518,VEGF_A_UP.V1_UP,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...1,SET,177,-0.0085112,-0.00083169,0.065354,0.55181,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN,0.99999
HP_GALACTORRHEA,SET,9,-0.035923,-0.00079519,0.27575,0.55182,HP_GALACTORRHEA,0.99999
LEE_RECENT_THYMIC_EMIGRANT,SET,197,-0.0081285,-0.00083751,0.062391,0.55183,LEE_RECENT_THYMIC_EMIGRANT,0.99999
E2F1_Q6_01,SET,214,-0.0073375,-0.00078758,0.056265,0.55188,E2F1_Q6_01,0.99999
FUJIWARA_PARK2_HEPATOCYTE_PR...1,SET,7,-0.04762,-0.0009297,0.36491,0.55191,FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN,0.99999
KEGG_MEDICUS_REFERENCE_NUCLE...1,SET,27,-0.019187,-0.00073527,0.14679,0.55199,KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA,0.99999
GSE46606_IRF4_KO_VS_WT_CD40L...4,SET,176,-0.0090248,-0.00087941,0.068938,0.55208,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_UP,0.99999
HP_ABNORMAL_ALPHA_GRANULES,SET,4,-0.047286,-0.00069791,0.36102,0.5521,HP_ABNORMAL_ALPHA_GRANULES,0.99999
MEISSNER_BRAIN_HCP_WITH_H3K4...2,SET,54,-0.016066,-0.00087004,0.12255,0.55215,MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3,0.99999
GOBP_REGULATION_OF_PROTEIN_M...3,SET,5,-0.047386,-0.00078192,0.36144,0.55215,GOBP_REGULATION_OF_PROTEIN_MONOUBIQUITINATION,0.99999
MIR4749_3P,SET,49,-0.015736,-0.00081188,0.11988,0.55222,MIR4749_3P,0.99999
GOBP_REGULATION_OF_CARDIAC_C...,SET,23,-0.023748,-0.00084004,0.18074,0.55227,GOBP_REGULATION_OF_CARDIAC_CONDUCTION,0.99999
COLINA_TARGETS_OF_4EBP1_AND_...,SET,320,-0.0064255,-0.00084091,0.048868,0.5523,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,0.99999
HP_BILATERAL_TONIC_CLONIC_SE...1,SET,322,-0.0061689,-0.00080981,0.046925,0.5523,HP_BILATERAL_TONIC_CLONIC_SEIZURE,0.99999
MORF_CTSB,SET,156,-0.0094692,-0.00086918,0.072011,0.55231,MORF_CTSB,0.99999
GSE19825_IL2RALOW_VS_IL2RAHI...2,SET,173,-0.0083022,-0.00080214,0.06313,0.55231,GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP,0.99999
GOMF_LEUCINE_ZIPPER_DOMAIN_B...,SET,10,-0.036947,-0.00086208,0.28089,0.55232,GOMF_LEUCINE_ZIPPER_DOMAIN_BINDING,0.99999
CAFFAREL_RESPONSE_TO_THC_UP,SET,29,-0.020032,-0.00079554,0.15223,0.55235,CAFFAREL_RESPONSE_TO_THC_UP,0.99999
HP_SYNOSTOSIS_OF_CARPALS_TAR...,SET,42,-0.01955,-0.00093405,0.14856,0.55235,HP_SYNOSTOSIS_OF_CARPALS_TARSALS,0.99999
chr1q43,SET,21,-0.041135,-0.0013905,0.31231,0.55239,chr1q43,0.99999
HP_HYPOPLASTIC_IRIS_STROMA,SET,8,-0.048583,-0.001014,0.36874,0.55241,HP_HYPOPLASTIC_IRIS_STROMA,0.99999
GOBP_REGULATION_OF_EXCRETION,SET,9,-0.040329,-0.00089274,0.30602,0.55242,GOBP_REGULATION_OF_EXCRETION,0.99999
GSE21380_NON_TFH_VS_GERMINAL...1,SET,184,-0.0080369,-0.00080056,0.060992,0.55242,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,0.99999
GSE42088_UNINF_VS_LEISHMANIA...1,SET,184,-0.0082392,-0.00082072,0.062515,0.55243,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_DN,0.99999
GOMF_HYDROLASE_ACTIVITY_HYDR...2,SET,83,-0.01274,-0.00085472,0.096404,0.55257,GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS,0.99999
HP_MOTOR_TICS,SET,11,-0.035228,-0.00086207,0.26647,0.55259,HP_MOTOR_TICS,0.99999
chr19p12,SET,29,-0.033958,-0.0013486,0.25676,0.55261,chr19p12,0.99999
WP_CIRCADIAN_RHYTHM_GENES,SET,190,-0.0086946,-0.00087994,0.065729,0.55262,WP_CIRCADIAN_RHYTHM_GENES,0.99999
GAGCTGG_MIR337,SET,144,-0.0091197,-0.00080452,0.068945,0.55262,GAGCTGG_MIR337,0.99999
NIKOLSKY_BREAST_CANCER_20P13...,SET,7,-0.058201,-0.0011363,0.4399,0.55263,NIKOLSKY_BREAST_CANCER_20P13_AMPLICON,0.99999
BIOCARTA_NEUTROPHIL_PATHWAY,SET,8,-0.048303,-0.0010081,0.36487,0.55266,BIOCARTA_NEUTROPHIL_PATHWAY,0.99999
GOBP_REGULATION_OF_PHOSPHOLI...6,SET,5,-0.059503,-0.00098186,0.44939,0.55267,GOBP_REGULATION_OF_PHOSPHOLIPID_CATABOLIC_PROCESS,0.99999
GSE5542_UNTREATED_VS_IFNG_TR...1,SET,167,-0.0085783,-0.00081445,0.064716,0.55273,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.99999
KEGG_MEDICUS_REFERENCE_GPCR_...2,SET,47,-0.018283,-0.00092388,0.13788,0.55274,KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...12,SET,184,-0.007938,-0.00079072,0.059843,0.55276,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP,0.99999
GOBP_MEMBRANE_TUBULATION,SET,4,-0.061716,-0.00091089,0.46405,0.5529,GOBP_MEMBRANE_TUBULATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...295,SET,5,-0.061651,-0.0010173,0.46359,0.5529,GOBP_POSITIVE_REGULATION_OF_GASTRULATION,0.99999
HORTON_SREBF_TARGETS,SET,24,-0.021935,-0.0007926,0.16464,0.55299,HORTON_SREBF_TARGETS,0.99999
WP_PROSTAGLANDIN_SYNTHESIS_A...,SET,45,-0.019398,-0.00095923,0.14549,0.55303,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,0.99999
HP_MUCOSAL_TELANGIECTASIAE,SET,36,-0.016532,-0.00073137,0.12401,0.55303,HP_MUCOSAL_TELANGIECTASIAE,0.99999
REACTOME_CARGO_RECOGNITION_F...,SET,95,-0.011903,-0.00085403,0.089229,0.55306,REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...17,SET,104,-0.01181,-0.00088638,0.088463,0.5531,GAUTAM_EYE_IRIS_CILIARY_BODY_WIF1_HIGH_FIBROBLASTS,0.99999
REACTOME_NUCLEOTIDE_LIKE_PUR...,SET,13,-0.032689,-0.00086958,0.24475,0.55312,REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS,0.99999
GNF2_MCM4,SET,52,-0.014536,-0.00077252,0.1088,0.55314,GNF2_MCM4,0.99999
FONTAINE_PAPILLARY_THYROID_C...1,SET,73,-0.013987,-0.00088025,0.10463,0.55317,FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN,0.99999
GOBP_SOMITE_ROSTRAL_CAUDAL_A...,SET,9,-0.037729,-0.00083517,0.28179,0.55325,GOBP_SOMITE_ROSTRAL_CAUDAL_AXIS_SPECIFICATION,0.99999
PID_IL8_CXCR2_PATHWAY,SET,34,-0.020529,-0.00088267,0.15308,0.55334,PID_IL8_CXCR2_PATHWAY,0.99999
HP_LARGE_INTESTINAL_POLYPOSIS,SET,31,-0.018632,-0.00076499,0.13893,0.55334,HP_LARGE_INTESTINAL_POLYPOSIS,0.99999
AIZARANI_LIVER_C8_RESIDENT_B...,SET,30,-0.020389,-0.00082353,0.15201,0.55335,AIZARANI_LIVER_C8_RESIDENT_B_CELLS_1,0.99999
BOQUEST_STEM_CELL_UP,SET,232,-0.0082521,-0.0009218,0.061483,0.55338,BOQUEST_STEM_CELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...726,SET,11,-0.038204,-0.0009349,0.28454,0.5534,GOBP_POSITIVE_REGULATION_OF_STEROID_HORMONE_SECRETION,0.99999
YANAGIHARA_ESX1_TARGETS,SET,26,-0.024114,-0.00090684,0.17956,0.55341,YANAGIHARA_ESX1_TARGETS,0.99999
HP_LONG_FINGERS,SET,246,-0.0071601,-0.00082327,0.053322,0.55341,HP_LONG_FINGERS,0.99999
TSAI_DNAJB4_TARGETS_DN,SET,6,-0.04982,-0.00090053,0.37065,0.55346,TSAI_DNAJB4_TARGETS_DN,0.99999
GOBP_REGULATION_OF_CELL_MATU...,SET,22,-0.025644,-0.00088721,0.19066,0.5535,GOBP_REGULATION_OF_CELL_MATURATION,0.99999
KEGG_NOD_LIKE_RECEPTOR_SIGNA...,SET,57,-0.014968,-0.00083275,0.11122,0.55353,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.99999
WP_FAMILIAL_HYPERLIPIDEMIA_T...4,SET,21,-0.025324,-0.000856,0.18801,0.55357,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,0.99999
GOCC_MEMBRANE_COAT,SET,93,-0.011283,-0.00080105,0.083777,0.55357,GOCC_MEMBRANE_COAT,0.99999
HP_CORTICAL_MYOCLONUS,SET,14,-0.031625,-0.00087301,0.23421,0.55371,HP_CORTICAL_MYOCLONUS,0.99999
REACTOME_TRANSLATION_OF_SARS...1,SET,28,-0.020715,-0.00080838,0.15328,0.55375,REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS,0.99999
GALIE_TUMOR_STEMNESS_GENES,SET,6,-0.054251,-0.00098061,0.40129,0.55377,GALIE_TUMOR_STEMNESS_GENES,0.99999
GOBP_CELL_PROLIFERATION_INVO...2,SET,21,-0.029031,-0.00098132,0.21456,0.55381,GOBP_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.99999
REACTOME_RUNX1_AND_FOXP3_CON...,SET,9,-0.041753,-0.00092425,0.30846,0.55384,REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...9,SET,4,-0.066938,-0.00098796,0.49411,0.55388,GOBP_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.99999
GSE339_EX_VIVO_VS_IN_CULTURE...2,SET,180,-0.0084115,-0.00082881,0.062076,0.55389,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP,0.99999
MIR4678,SET,100,-0.011692,-0.00086055,0.086192,0.55395,MIR4678,0.99999
SHARMA_PILOCYTIC_ASTROCYTOMA...1,SET,6,-0.054497,-0.00098506,0.40161,0.55397,SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN,0.99999
GSE26912_TUMORICIDAL_VS_CTRL...2,SET,187,-0.0086923,-0.00087281,0.064058,0.55397,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_UP,0.99999
HP_HYPEROXALURIA,SET,6,-0.044515,-0.00080463,0.32795,0.55398,HP_HYPEROXALURIA,0.99999
NGUYEN_NOTCH1_TARGETS_UP,SET,25,-0.024109,-0.00088908,0.17747,0.55403,NGUYEN_NOTCH1_TARGETS_UP,0.99999
ZHAN_V1_LATE_DIFFERENTIATION...1,SET,11,-0.03204,-0.00078404,0.23584,0.55403,ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN,0.99999
GOMF_BETA_2_MICROGLOBULIN_BI...,SET,8,-0.042296,-0.00088275,0.31132,0.55403,GOMF_BETA_2_MICROGLOBULIN_BINDING,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...20,SET,8,-0.040687,-0.00084916,0.29936,0.55405,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...4,SET,38,-0.020859,-0.00094802,0.1533,0.55411,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_3,0.99999
MORF_IL13,SET,216,-0.0078763,-0.00084931,0.057885,0.55412,MORF_IL13,0.99999
GOCC_COPI_VESICLE_COAT,SET,12,-0.028197,-0.00072067,0.20719,0.55412,GOCC_COPI_VESICLE_COAT,0.99999
HP_HYPERESTHESIA,SET,9,-0.038782,-0.00085847,0.28465,0.55419,HP_HYPERESTHESIA,0.99999
GSE7764_IL15_NK_CELL_24H_VS_...1,SET,176,-0.0085987,-0.00083788,0.063071,0.55422,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN,0.99999
HDAC4_TARGET_GENES,SET,516,-0.0053095,-0.00087756,0.038936,0.55423,HDAC4_TARGET_GENES,0.99999
GOBP_RETINAL_ROD_CELL_DIFFER...,SET,16,-0.02979,-0.00087909,0.21782,0.55439,GOBP_RETINAL_ROD_CELL_DIFFERENTIATION,0.99999
GSE3994_WT_VS_PAC1_KO_ACTIVA...2,SET,187,-0.0089861,-0.00090232,0.06571,0.55439,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_UP,0.99999
HP_ASYMMETRY_OF_SPINAL_FACET...,SET,4,-0.063672,-0.00093976,0.46545,0.5544,HP_ASYMMETRY_OF_SPINAL_FACET_JOINTS,0.99999
HP_ABNORMALITY_OF_THE_MALE_G...,SET,1026,-0.0037091,-0.000852,0.027112,0.55441,HP_ABNORMALITY_OF_THE_MALE_GENITALIA,0.99999
WP_SREBF_AND_MIR33_IN_CHOLES...,SET,16,-0.027418,-0.00080909,0.20037,0.55442,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,0.99999
MORF_SUPT3H,SET,288,-0.0071077,-0.00088324,0.051931,0.55443,MORF_SUPT3H,0.99999
GOBP_NEGATIVE_REGULATION_OF_...315,SET,15,-0.029866,-0.00085336,0.21821,0.55443,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,0.99999
MIR449B_3P,SET,110,-0.011593,-0.00089468,0.084643,0.55447,MIR449B_3P,0.99999
MORF_RFC4,SET,132,-0.0096606,-0.00081623,0.070518,0.55448,MORF_RFC4,0.99999
GOBP_PROTEIN_DNA_COMPLEX_ORG...,SET,726,-0.0042215,-0.00082274,0.030808,0.55449,GOBP_PROTEIN_DNA_COMPLEX_ORGANIZATION,0.99999
MIR7159_5P,SET,323,-0.0067875,-0.00089237,0.049522,0.55451,MIR7159_5P,0.99999
GOCC_SEH1_ASSOCIATED_COMPLEX,SET,12,-0.032748,-0.00083698,0.23856,0.55459,GOCC_SEH1_ASSOCIATED_COMPLEX,0.99999
HP_CERVICAL_MYELOPATHY,SET,7,-0.047338,-0.00092419,0.34467,0.55462,HP_CERVICAL_MYELOPATHY,0.99999
GOBP_INTRACELLULAR_MAGNESIUM...,SET,3,-0.06976,-0.0008917,0.50751,0.55466,GOBP_INTRACELLULAR_MAGNESIUM_ION_HOMEOSTASIS,0.99999
HP_ABNORMAL_MUSCLE_TISSUE_ME...,SET,45,-0.017042,-0.0008427,0.12383,0.55473,HP_ABNORMAL_MUSCLE_TISSUE_METABOLITE_CONCENTRATION,0.99999
GOBP_NUCLEAR_PORE_ORGANIZATI...,SET,15,-0.029065,-0.00083049,0.21078,0.55484,GOBP_NUCLEAR_PORE_ORGANIZATION,0.99999
GSE36009_WT_VS_NLRP10_KO_DC_...1,SET,187,-0.0083007,-0.00083349,0.060193,0.55484,GSE36009_WT_VS_NLRP10_KO_DC_DN,0.99999
GOCC_EXOCYTIC_VESICLE,SET,217,-0.0082865,-0.00089559,0.060078,0.55485,GOCC_EXOCYTIC_VESICLE,0.99999
GOBP_TRIPARTITE_REGIONAL_SUB...,SET,17,-0.031534,-0.00095914,0.22844,0.55489,GOBP_TRIPARTITE_REGIONAL_SUBDIVISION,0.99999
GOBP_PROTEIN_INSERTION_INTO_...1,SET,25,-0.023032,-0.00084935,0.1668,0.55491,GOBP_PROTEIN_INSERTION_INTO_ER_MEMBRANE,0.99999
GSE34392_ST2_KO_VS_WT_DAY8_L...2,SET,182,-0.0083995,-0.00083217,0.060807,0.55493,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,0.99999
TOMIDA_LUNG_CANCER_POOR_SURV...,SET,5,-0.060254,-0.00099426,0.43601,0.55496,TOMIDA_LUNG_CANCER_POOR_SURVIVAL,0.99999
BIOCARTA_NOTCH_PATHWAY,SET,6,-0.042213,-0.00076303,0.3053,0.55498,BIOCARTA_NOTCH_PATHWAY,0.99999
REACTOME_SARS_COV_2_INFECTION,SET,268,-0.0071544,-0.0008581,0.051726,0.555,REACTOME_SARS_COV_2_INFECTION,0.99999
HP_INCREASED_PROPORTION_OF_C...,SET,6,-0.049681,-0.00089802,0.35898,0.55504,HP_INCREASED_PROPORTION_OF_CD25_MAST_CELLS,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...17,SET,7,-0.047974,-0.00093661,0.34655,0.55505,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7,0.99999
GSE3720_UNSTIM_VS_PMA_STIM_V...4,SET,148,-0.0093621,-0.00083721,0.067534,0.55513,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,0.99999
JOHNSTONE_PARVB_TARGETS_2_DN,SET,306,-0.0071664,-0.00091749,0.051599,0.55523,JOHNSTONE_PARVB_TARGETS_2_DN,0.99999
VERHAAK_GLIOBLASTOMA_NEURAL,SET,112,-0.011331,-0.00088233,0.081495,0.55529,VERHAAK_GLIOBLASTOMA_NEURAL,0.99999
GOBP_RESPONSE_TO_CORTICOTROP...,SET,5,-0.062979,-0.0010392,0.45242,0.55536,GOBP_RESPONSE_TO_CORTICOTROPIN_RELEASING_HORMONE,0.99999
GOBP_CAMERA_TYPE_EYE_PHOTORE...,SET,31,-0.021862,-0.00089762,0.15694,0.55539,GOBP_CAMERA_TYPE_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.99999
RRAGTTGT_UNKNOWN,SET,228,-0.0081933,-0.0009074,0.058772,0.55544,RRAGTTGT_UNKNOWN,0.99999
WP_ELECTRON_TRANSPORT_CHAIN_...,SET,69,-0.012248,-0.00074948,0.087806,0.55547,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,0.99999
HP_PROXIMAL_MUSCLE_WEAKNESS_...2,SET,54,-0.016242,-0.0008796,0.1164,0.55548,HP_PROXIMAL_MUSCLE_WEAKNESS_IN_UPPER_LIMBS,0.99999
PID_PI3KCI_AKT_PATHWAY,SET,34,-0.019432,-0.00083551,0.1392,0.55551,PID_PI3KCI_AKT_PATHWAY,0.99999
HP_ABNORMAL_VISUAL_FIELD_TEST,SET,20,-0.024906,-0.00082161,0.17839,0.55552,HP_ABNORMAL_VISUAL_FIELD_TEST,0.99999
GOBP_MRNA_METABOLIC_PROCESS,SET,641,-0.0044454,-0.00081603,0.03181,0.55557,GOBP_MRNA_METABOLIC_PROCESS,0.99999
HP_APLASIA_OF_THE_LEFT_HEMID...,SET,5,-0.061291,-0.0010114,0.43841,0.55559,HP_APLASIA_OF_THE_LEFT_HEMIDIAPHRAGM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...152,SET,8,-0.049888,-0.0010412,0.35644,0.55565,GOBP_NEGATIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.99999
MULLIGHAN_NPM1_MUTATED_SIGNA...4,SET,114,-0.011018,-0.00086552,0.078694,0.55567,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...21,SET,38,-0.020504,-0.00093189,0.14647,0.55567,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_NAD_P_H_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.99999
MIR3186_5P,SET,2,-0.076127,-0.00079454,0.54267,0.55578,MIR3186_5P,0.99999
GOBP_RESPONSE_TO_UV_C,SET,12,-0.034824,-0.00089004,0.24804,0.55583,GOBP_RESPONSE_TO_UV_C,0.99999
GSE43863_TFH_VS_LY6C_LOW_CXC...1,SET,174,-0.0095744,-0.0009277,0.068148,0.55586,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,0.99999
JOHNSTONE_PARVB_TARGETS_3_UP,SET,384,-0.0063449,-0.00090801,0.045142,0.55589,JOHNSTONE_PARVB_TARGETS_3_UP,0.99999
DYRK1A_TARGET_GENES,SET,599,-0.0049585,-0.00088095,0.035277,0.55589,DYRK1A_TARGET_GENES,0.99999
GOBP_METANEPHRIC_NEPHRON_TUB...2,SET,8,-0.046031,-0.00096069,0.32736,0.55591,GOBP_METANEPHRIC_NEPHRON_TUBULE_MORPHOGENESIS,0.99999
GSE27786_NKCELL_VS_NKTCELL_UP,SET,187,-0.0086509,-0.00086865,0.061494,0.55594,GSE27786_NKCELL_VS_NKTCELL_UP,0.99999
KEGG_MEDICUS_REFERENCE_ANGIO...,SET,28,-0.022757,-0.00088808,0.16164,0.55598,KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.99999
REACTOME_LDL_CLEARANCE,SET,19,-0.028326,-0.00091081,0.20121,0.55598,REACTOME_LDL_CLEARANCE,0.99999
HP_DEPRESSED_NASAL_BRIDGE,SET,527,-0.0052706,-0.0008801,0.037435,0.55598,HP_DEPRESSED_NASAL_BRIDGE,0.99999
HP_WHITE_LESION_OF_THE_ORAL_...,SET,26,-0.025159,-0.00094615,0.17866,0.55599,HP_WHITE_LESION_OF_THE_ORAL_MUCOSA,0.99999
CARRILLOREIXACH_14Q32OVEREXP...,SET,2,-0.10668,-0.0011134,0.75626,0.55609,CARRILLOREIXACH_14Q32OVEREXPRESSION_IN_HEPATOBLASTOMA,0.99999
LOPEZ_MESOTHELIOMA_SURVIVAL_...5,SET,7,-0.0461,-0.00090003,0.32629,0.55618,LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN,0.99999
HP_CHILDHOOD_ONSET_SENSORINE...,SET,18,-0.029974,-0.00093812,0.21205,0.5562,HP_CHILDHOOD_ONSET_SENSORINEURAL_HEARING_IMPAIRMENT,0.99999
GSE16385_MONOCYTE_VS_12H_IL4...2,SET,175,-0.0094551,-0.00091874,0.066853,0.55623,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP,0.99999
CUI_DEVELOPING_HEART_5TH_WEE...1,SET,36,-0.020968,-0.00092761,0.14825,0.55624,CUI_DEVELOPING_HEART_5TH_WEEK_ATRIAL_CARDIOMYOCYTE,0.99999
P53_02,SET,228,-0.0081122,-0.00089842,0.057318,0.55627,P53_02,0.99999
BIOCARTA_SRCRPTP_PATHWAY,SET,11,-0.033793,-0.00082696,0.23868,0.5563,BIOCARTA_SRCRPTP_PATHWAY,0.99999
HP_REDUCED_SUBCUTANEOUS_ADIP...,SET,30,-0.023893,-0.0009651,0.16876,0.5563,HP_REDUCED_SUBCUTANEOUS_ADIPOSE_TISSUE,0.99999
MOOTHA_FFA_OXYDATION,SET,22,-0.025263,-0.00087402,0.17818,0.55637,MOOTHA_FFA_OXYDATION,0.99999
WP_PATHOPHYSIOLOGICAL_ROLES_...,SET,15,-0.032595,-0.00093132,0.22974,0.55641,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,0.99999
HP_ABNORMAL_MIDFACE_MORPHOLO...,SET,533,-0.0052589,-0.00088297,0.03704,0.55645,HP_ABNORMAL_MIDFACE_MORPHOLOGY,0.99999
HP_POSTERIORLY_ROTATED_EARS,SET,397,-0.0060947,-0.00088651,0.042866,0.55653,HP_POSTERIORLY_ROTATED_EARS,0.99999
SHIN_B_CELL_LYMPHOMA_CLUSTER...7,SET,36,-0.020113,-0.00088978,0.14144,0.55654,SHIN_B_CELL_LYMPHOMA_CLUSTER_8,0.99999
REACTOME_FRS_MEDIATED_FGFR2_...,SET,24,-0.025455,-0.00091976,0.17879,0.55661,REACTOME_FRS_MEDIATED_FGFR2_SIGNALING,0.99999
FULLER_PBMC_F_TULARENSIS_VAC...5,SET,54,-0.017766,-0.00096213,0.12473,0.55663,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP,0.99999
PID_RHOA_PATHWAY,SET,42,-0.019018,-0.00090861,0.1334,0.55668,PID_RHOA_PATHWAY,0.99999
GOMF_CALCIUM_MONOATOMIC_CATI...,SET,13,-0.038394,-0.0010213,0.26923,0.5567,GOMF_CALCIUM_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,0.99999
MULLIGHAN_MLL_SIGNATURE_1_DN,SET,216,-0.0086391,-0.00093156,0.060571,0.55671,MULLIGHAN_MLL_SIGNATURE_1_DN,0.99999
MIR124_5P,SET,102,-0.012098,-0.0008993,0.08473,0.55677,MIR124_5P,0.99999
GOBP_REGULATION_OF_SPINDLE_C...,SET,22,-0.023083,-0.00079861,0.16161,0.55679,GOBP_REGULATION_OF_SPINDLE_CHECKPOINT,0.99999
GSE360_CTRL_VS_M_TUBERCULOSI...4,SET,179,-0.0088489,-0.00086951,0.061951,0.55679,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP,0.99999
HP_MACROCYTIC_ANEMIA,SET,63,-0.015454,-0.00090378,0.10815,0.55681,HP_MACROCYTIC_ANEMIA,0.99999
GREENBAUM_E2A_TARGETS_UP,SET,27,-0.022562,-0.00086461,0.15785,0.55683,GREENBAUM_E2A_TARGETS_UP,0.99999
GSE5589_WT_VS_IL10_KO_LPS_ST...2,SET,140,-0.0099093,-0.00086205,0.069323,0.55683,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,0.99999
GOBP_NEURAL_PLATE_PATTERN_SP...,SET,7,-0.048153,-0.0009401,0.33683,0.55684,GOBP_NEURAL_PLATE_PATTERN_SPECIFICATION,0.99999
GSE25088_CTRL_VS_IL4_AND_ROS...3,SET,152,-0.0096349,-0.00087307,0.067378,0.55685,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,0.99999
MODULE_240,SET,14,-0.032402,-0.00089446,0.22653,0.55687,MODULE_240,0.99999
HP_PERSISTENCE_OF_HEMOGLOBIN...,SET,32,-0.020499,-0.00085511,0.14332,0.55687,HP_PERSISTENCE_OF_HEMOGLOBIN_F,0.99999
GSE13485_CTRL_VS_DAY3_YF17D_...1,SET,179,-0.0091091,-0.00089508,0.063676,0.55688,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN,0.99999
GSE17580_TREG_VS_TEFF_UP,SET,182,-0.0089821,-0.00088989,0.062783,0.55688,GSE17580_TREG_VS_TEFF_UP,0.99999
GOBP_MACROMOLECULE_CATABOLIC...,SET,1245,-0.0034889,-0.00087722,0.024354,0.55696,GOBP_MACROMOLECULE_CATABOLIC_PROCESS,0.99999
GSE20715_WT_VS_TLR4_KO_24H_O...1,SET,180,-0.0088357,-0.00087061,0.061645,0.55698,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_AC...2,SET,79,-0.014046,-0.00091941,0.097989,0.55699,GOBP_CELLULAR_RESPONSE_TO_ACID_CHEMICAL,0.99999
KEGG_MEDICUS_REFERENCE_ACTIV...3,SET,8,-0.040863,-0.00085284,0.28469,0.55707,KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY,0.99999
WP_HEMATOPOIETIC_STEM_CELL_D...,SET,52,-0.018056,-0.00095959,0.12573,0.5571,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_LUNG_BLOO...,SET,3,-0.075302,-0.00096254,0.5243,0.5571,GOBP_REGULATION_OF_LUNG_BLOOD_PRESSURE,0.99999
GOBP_RESPIRATORY_CHAIN_COMPL...1,SET,8,-0.043412,-0.00090605,0.30228,0.5571,GOBP_RESPIRATORY_CHAIN_COMPLEX_III_ASSEMBLY,0.99999
MIR6877_3P,SET,31,-0.021982,-0.00090253,0.1529,0.55715,MIR6877_3P,0.99999
GOBP_GLYCOPROTEIN_METABOLIC_...,SET,344,-0.0068484,-0.00092865,0.047633,0.55716,GOBP_GLYCOPROTEIN_METABOLIC_PROCESS,0.99999
HP_ABNORMAL_CIRCULATING_DEHY...,SET,15,-0.032989,-0.0009426,0.22946,0.55716,HP_ABNORMAL_CIRCULATING_DEHYDROEPIANDROSTERONE_CONCENTRATION,0.99999
REACTOME_FORMATION_OF_THE_EA...,SET,32,-0.018376,-0.00076654,0.12775,0.55719,REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX,0.99999
ETS1_B,SET,241,-0.007908,-0.00090011,0.054887,0.55728,ETS1_B,0.99999
MIR1299,SET,300,-0.0072273,-0.00091632,0.050155,0.55729,MIR1299,0.99999
MIR4535,SET,26,-0.024509,-0.0009217,0.17005,0.5573,MIR4535,0.99999
RUIZ_TNC_TARGETS_UP,SET,137,-0.011511,-0.00099071,0.079786,0.55736,RUIZ_TNC_TARGETS_UP,0.99999
GSE19401_UNSTIM_VS_RETINOIC_...2,SET,177,-0.0088069,-0.00086059,0.061026,0.55737,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...35,SET,17,-0.033866,-0.0010301,0.23422,0.55748,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS,0.99999
REACTOME_MET_RECEPTOR_RECYCL...,SET,10,-0.034119,-0.00079609,0.23591,0.5575,REACTOME_MET_RECEPTOR_RECYCLING,0.99999
GCM_MAX,SET,29,-0.021922,-0.00087063,0.15158,0.5575,GCM_MAX,0.99999
GOBP_CARDIAC_NEURAL_CREST_CE...3,SET,10,-0.045848,-0.0010698,0.31699,0.5575,GOBP_CARDIAC_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS,0.99999
GOBP_PARKIN_MEDIATED_STIMULA...,SET,4,-0.067659,-0.00099861,0.46724,0.55757,GOBP_PARKIN_MEDIATED_STIMULATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,0.99999
HP_ABNORMAL_RENAL_COLLECTING...,SET,24,-0.024509,-0.00088561,0.16923,0.55758,HP_ABNORMAL_RENAL_COLLECTING_SYSTEM_MORPHOLOGY,0.99999
GOCC_GLIAL_CELL_PROJECTION,SET,38,-0.021682,-0.00098542,0.14967,0.55759,GOCC_GLIAL_CELL_PROJECTION,0.99999
chr11q14,SET,48,-0.034049,-0.0017388,0.23499,0.5576,chr11q14,0.99999
MIR562,SET,59,-0.015698,-0.00088849,0.10831,0.55762,MIR562,0.99999
HP_EMG_SLOW_MOTOR_CONDUCTION,SET,5,-0.051276,-0.00084612,0.35378,0.55762,HP_EMG_SLOW_MOTOR_CONDUCTION,0.99999
ATGTACA_MIR493,SET,294,-0.0075872,-0.00095244,0.05228,0.55769,ATGTACA_MIR493,0.99999
GOBP_REGULATION_OF_AMINO_ACI...2,SET,40,-0.021693,-0.0010115,0.14944,0.55771,GOBP_REGULATION_OF_AMINO_ACID_TRANSPORT,0.99999
HP_DELAYED_MYELINATION,SET,245,-0.0077435,-0.00088857,0.053324,0.55773,HP_DELAYED_MYELINATION,0.99999
HP_SMALL_BOWEL_DIVERTICULA,SET,5,-0.050198,-0.00082832,0.34559,0.55774,HP_SMALL_BOWEL_DIVERTICULA,0.99999
CROONQUIST_IL6_DEPRIVATION_UP,SET,17,-0.030901,-0.00093991,0.21268,0.55776,CROONQUIST_IL6_DEPRIVATION_UP,0.99999
XU_AKT1_TARGETS_48HR,SET,9,-0.040184,-0.00088952,0.27657,0.55776,XU_AKT1_TARGETS_48HR,0.99999
GOBP_RESPONSE_TO_GRAM_POSITI...,SET,6,-0.052366,-0.00094655,0.36024,0.55779,GOBP_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM,0.99999
REACTOME_REGULATION_OF_HOMOT...,SET,30,-0.023887,-0.00096485,0.16429,0.5578,REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,0.99999
MIR8057,SET,79,-0.01346,-0.00088104,0.092539,0.55782,MIR8057,0.99999
MIR3685,SET,166,-0.009583,-0.00090713,0.065819,0.55788,MIR3685,0.99999
GOBP_NEGATIVE_REGULATION_OF_...332,SET,5,-0.067919,-0.0011207,0.46637,0.55789,GOBP_NEGATIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,0.99999
MUELLER_METHYLATED_IN_GLIOBL...,SET,35,-0.022163,-0.00096681,0.15214,0.55791,MUELLER_METHYLATED_IN_GLIOBLASTOMA,0.99999
PRC2_EED_DN.V1_UP,SET,172,-0.009903,-0.00095406,0.067977,0.55791,PRC2_EED_DN.V1_UP,0.99999
HP_NEOPLASM_OF_THE_MALE_EXTE...,SET,32,-0.024709,-0.0010307,0.16929,0.55802,HP_NEOPLASM_OF_THE_MALE_EXTERNAL_GENITALIA,0.99999
GOMF_ICOSANOID_TRANSMEMBRANE...,SET,13,-0.037484,-0.00099712,0.25661,0.55807,GOMF_ICOSANOID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MIR16_2_3P,SET,205,-0.0087443,-0.00091886,0.059794,0.55813,MIR16_2_3P,0.99999
GOBP_REGULATION_OF_SMAD_PROT...,SET,59,-0.017983,-0.0010179,0.12287,0.55818,GOBP_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GOBP_REGULATION_OF_CARBOHYDR...3,SET,163,-0.0098832,-0.00092713,0.06752,0.55819,GOBP_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,0.99999
PID_TXA2PATHWAY,SET,52,-0.018369,-0.00097627,0.12543,0.55821,PID_TXA2PATHWAY,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...9,SET,188,-0.0091882,-0.00092505,0.062672,0.55828,GSE22886_NAIVE_CD4_TCELL_VS_DC_DN,0.99999
GOBP_MACROPHAGE_PROLIFERATION,SET,10,-0.044892,-0.0010475,0.30599,0.55832,GOBP_MACROPHAGE_PROLIFERATION,0.99999
GNF2_PAK2,SET,25,-0.02363,-0.00087143,0.16102,0.55834,GNF2_PAK2,0.99999
HP_TONGUE_ATROPHY,SET,49,-0.017542,-0.00090508,0.11952,0.55835,HP_TONGUE_ATROPHY,0.99999
MIR3127_5P,SET,49,-0.017467,-0.00090123,0.11898,0.55836,MIR3127_5P,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...13,SET,42,-0.018819,-0.00089911,0.12811,0.55839,GAVISH_3CA_METAPROGRAM_MACROPHAGES_UNFOLDED_PROTEIN_RESPONSE,0.99999
REACTOME_LOSS_OF_FUNCTION_OF...2,SET,7,-0.050296,-0.00098194,0.34226,0.55841,REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER,0.99999
HP_FAILURE_TO_THRIVE_SECONDA...,SET,6,-0.05553,-0.0010037,0.37771,0.55844,HP_FAILURE_TO_THRIVE_SECONDARY_TO_RECURRENT_INFECTIONS,0.99999
GSE27786_CD4_TCELL_VS_NEUTRO...1,SET,180,-0.0095113,-0.00093719,0.064664,0.55847,GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN,0.99999
GSE13484_UNSTIM_VS_YF17D_VAC...2,SET,179,-0.0089722,-0.00088162,0.060952,0.55851,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,0.99999
GOBP_PROSTATIC_BUD_FORMATION,SET,7,-0.058152,-0.0011353,0.39483,0.55855,GOBP_PROSTATIC_BUD_FORMATION,0.99999
MIR1470,SET,14,-0.033861,-0.00093474,0.22968,0.5586,MIR1470,0.99999
GOBP_CELLULAR_RESPONSE_TO_DS...,SET,19,-0.029104,-0.0009358,0.19718,0.55867,GOBP_CELLULAR_RESPONSE_TO_DSRNA,0.99999
GOBP_POSITIVE_REGULATION_OF_...513,SET,21,-0.02992,-0.0010114,0.20265,0.55869,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,0.99999
GOBP_REGULATION_OF_RIBONUCLE...,SET,9,-0.049094,-0.0010867,0.33244,0.5587,GOBP_REGULATION_OF_RIBONUCLEASE_ACTIVITY,0.99999
HP_RENAL_ARTERY_STENOSIS,SET,21,-0.026553,-0.00089756,0.17981,0.5587,HP_RENAL_ARTERY_STENOSIS,0.99999
LI_WILMS_TUMOR_ANAPLASTIC_UP,SET,17,-0.030494,-0.00092753,0.20626,0.55877,LI_WILMS_TUMOR_ANAPLASTIC_UP,0.99999
GSE41867_DAY15_EFFECTOR_VS_D...3,SET,154,-0.0098343,-0.00089694,0.066499,0.55878,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,0.99999
GSE14908_ATOPIC_VS_NONATOPIC...2,SET,177,-0.0091135,-0.00089054,0.061595,0.55881,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_UP,0.99999
GUO_HEX_TARGETS_DN,SET,60,-0.015845,-0.00090436,0.10704,0.55884,GUO_HEX_TARGETS_DN,0.99999
HP_ABNORMALITY_OF_PATTERN_VI...,SET,5,-0.071039,-0.0011722,0.47966,0.55887,HP_ABNORMALITY_OF_PATTERN_VISUAL_EVOKED_POTENTIALS,0.99999
SHIPP_DLBCL_VS_FOLLICULAR_LY...1,SET,36,-0.021471,-0.00094986,0.14487,0.55891,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...185,SET,454,-0.0062061,-0.00096383,0.04187,0.55892,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION,0.99999
SCHWAB_TARGETS_OF_BMYB_POLYM...2,SET,12,-0.035883,-0.00091711,0.24171,0.55901,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP,0.99999
VECCHI_GASTRIC_CANCER_EARLY_...2,SET,386,-0.0064558,-0.00092623,0.043487,0.55901,VECCHI_GASTRIC_CANCER_EARLY_UP,0.99999
GOMF_GROWTH_FACTOR_RECEPTOR_...,SET,132,-0.011593,-0.00097948,0.078005,0.55907,GOMF_GROWTH_FACTOR_RECEPTOR_BINDING,0.99999
HP_STAPES_ANKYLOSIS,SET,6,-0.056795,-0.0010266,0.3821,0.55908,HP_STAPES_ANKYLOSIS,0.99999
ZNF746_TARGET_GENES,SET,55,-0.016851,-0.00092094,0.11334,0.55909,ZNF746_TARGET_GENES,0.99999
HP_DECREASED_MEAN_CORPUSCULA...2,SET,11,-0.033741,-0.00082568,0.22694,0.55909,HP_DECREASED_MEAN_CORPUSCULAR_VOLUME,0.99999
GOBP_CELL_CELL_ADHESION_VIA_...,SET,259,-0.0096706,-0.0011405,0.065026,0.55911,GOBP_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,0.99999
GOBP_REGULATION_OF_RETINOIC_...,SET,15,-0.032005,-0.00091449,0.21512,0.55913,GOBP_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...35,SET,6,-0.049592,-0.0008964,0.33327,0.55915,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE,0.99999
ZNF322_TARGET_GENES,SET,714,-0.004703,-0.00090928,0.031595,0.55916,ZNF322_TARGET_GENES,0.99999
GOBP_7_METHYLGUANOSINE_CAP_H...,SET,8,-0.037253,-0.0007775,0.25023,0.55917,GOBP_7_METHYLGUANOSINE_CAP_HYPERMETHYLATION,0.99999
E2F1_Q6,SET,207,-0.0087314,-0.00092193,0.058619,0.5592,E2F1_Q6,0.99999
GSE2770_IL12_VS_TGFB_AND_IL1...5,SET,184,-0.0091184,-0.00090829,0.061182,0.55924,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.99999
HP_METHEMOGLOBINEMIA,SET,5,-0.058189,-0.00096019,0.39038,0.55925,HP_METHEMOGLOBINEMIA,0.99999
HP_ACUTE_HEPATIC_FAILURE,SET,31,-0.021512,-0.00088324,0.14418,0.5593,HP_ACUTE_HEPATIC_FAILURE,0.99999
GSE37416_12H_VS_48H_F_TULARE...1,SET,148,-0.010622,-0.00094988,0.071181,0.55931,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
HOFT_PBMC_TICE_BCG_RBCG_AG85...,SET,35,-0.023085,-0.001007,0.15468,0.55932,HOFT_PBMC_TICE_BCG_RBCG_AG85A_AG85B_AGE_18_40YO_CORRELATED_WITH_WHOLE_BLOOD_BACTERICIDAL_ACTIVITY_NEGATIVE,0.99999
HP_AGITATION,SET,95,-0.013256,-0.00095109,0.088796,0.55933,HP_AGITATION,0.99999
GSE15330_MEGAKARYOCYTE_ERYTH...5,SET,178,-0.0089081,-0.0008729,0.059618,0.55939,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,0.99999
HP_ABNORMAL_LOWER_MOTOR_NEUR...,SET,26,-0.024382,-0.00091694,0.16315,0.5594,HP_ABNORMAL_LOWER_MOTOR_NEURON_MORPHOLOGY,0.99999
GOBP_GLYCOSYLCERAMIDE_CATABO...,SET,6,-0.052387,-0.00094692,0.35,0.55949,GOBP_GLYCOSYLCERAMIDE_CATABOLIC_PROCESS,0.99999
GOBP_TRANSPORT_OF_VIRUS,SET,20,-0.02932,-0.00096724,0.19577,0.55952,GOBP_TRANSPORT_OF_VIRUS,0.99999
GOBP_POSITIVE_REGULATION_OF_...177,SET,3,-0.073325,-0.00093726,0.48894,0.5596,GOBP_POSITIVE_REGULATION_OF_CONNECTIVE_TISSUE_REPLACEMENT,0.99999
HP_OROTICACIDURIA,SET,7,-0.048022,-0.00093755,0.32,0.55964,HP_OROTICACIDURIA,0.99999
BIOCARTA_RELA_PATHWAY,SET,14,-0.034231,-0.00094495,0.22793,0.55969,BIOCARTA_RELA_PATHWAY,0.99999
GOMF_SODIUM_CHANNEL_INHIBITO...,SET,8,-0.052649,-0.0010988,0.35043,0.55971,GOMF_SODIUM_CHANNEL_INHIBITOR_ACTIVITY,0.99999
NAKAMURA_METASTASIS,SET,42,-0.018867,-0.00090138,0.1255,0.55975,NAKAMURA_METASTASIS,0.99999
WP_GLYCOSAMINOGLYCAN_SYNTHES...,SET,39,-0.021052,-0.00096927,0.13998,0.55977,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,0.99999
GOBP_DEOXYRIBONUCLEOSIDE_DIP...,SET,5,-0.055666,-0.00091855,0.36937,0.55989,GOBP_DEOXYRIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.99999
CUI_DEVELOPING_HEART_TRABECU...2,SET,99,-0.013021,-0.00095362,0.086373,0.55991,CUI_DEVELOPING_HEART_TRABECULAR_VENTRICULAR_CARDIOMYOCYTE,0.99999
GOBP_TETRAHYDROFOLATE_BIOSYN...,SET,6,-0.047209,-0.00085334,0.31313,0.55992,GOBP_TETRAHYDROFOLATE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_RESPONSE_TO_INORGANIC_S...,SET,469,-0.0061836,-0.00097566,0.041003,0.55994,GOBP_RESPONSE_TO_INORGANIC_SUBSTANCE,0.99999
MELLMAN_TUT1_TARGETS_UP,SET,19,-0.029499,-0.00094851,0.19552,0.55996,MELLMAN_TUT1_TARGETS_UP,0.99999
GSE1925_3H_VS_24H_IFNG_STIM_...4,SET,170,-0.0098655,-0.00094495,0.065386,0.55996,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_UP,0.99999
DROSHA_TARGET_GENES,SET,36,-0.022041,-0.00097507,0.14603,0.55998,DROSHA_TARGET_GENES,0.99999
MIR195_3P,SET,206,-0.0090153,-0.00094962,0.059706,0.56001,MIR195_3P,0.99999
GOBP_REGULATION_OF_APOPTOTIC...5,SET,347,-0.0070198,-0.00095595,0.046426,0.56009,GOBP_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,0.99999
HP_BREATHING_DYSREGULATION,SET,19,-0.0303,-0.00097429,0.20025,0.56014,HP_BREATHING_DYSREGULATION,0.99999
MIR6856_3P,SET,65,-0.015671,-0.0009308,0.10347,0.56019,MIR6856_3P,0.99999
GNF2_RAN,SET,78,-0.012731,-0.00082808,0.084066,0.56019,GNF2_RAN,0.99999
GOBP_EPITHELIAL_CILIUM_MOVEM...,SET,9,-0.039746,-0.00087983,0.26227,0.56023,GOBP_EPITHELIAL_CILIUM_MOVEMENT_INVOLVED_IN_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY,0.99999
GOBP_POSITIVE_REGULATION_OF_...88,SET,2,-0.10307,-0.0010757,0.68005,0.56023,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,0.99999
KEGG_OXIDATIVE_PHOSPHORYLATI...,SET,96,-0.012019,-0.00086688,0.079287,0.56024,KEGG_OXIDATIVE_PHOSPHORYLATION,0.99999
MIR3074_5P,SET,136,-0.011571,-0.0009922,0.0763,0.56027,MIR3074_5P,0.99999
HP_IMPAIRED_EPINEPHRINE_INDU...,SET,9,-0.043343,-0.00095945,0.28578,0.56027,HP_IMPAIRED_EPINEPHRINE_INDUCED_PLATELET_AGGREGATION,0.99999
HP_HYPOPLASIA_OF_THE_OLFACTO...,SET,6,-0.058383,-0.0010553,0.38488,0.56028,HP_HYPOPLASIA_OF_THE_OLFACTORY_BULB,0.99999
REACTOME_SYNTHESIS_OF_IP3_AN...,SET,25,-0.024635,-0.00090849,0.16236,0.5603,REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL,0.99999
REACTOME_GLYCOGEN_SYNTHESIS,SET,12,-0.036619,-0.00093592,0.24117,0.56034,REACTOME_GLYCOGEN_SYNTHESIS,0.99999
GOMF_RAGE_RECEPTOR_BINDING,SET,10,-0.044293,-0.0010335,0.29166,0.56035,GOMF_RAGE_RECEPTOR_BINDING,0.99999
GSE360_L_DONOVANI_VS_B_MALAY...7,SET,179,-0.009681,-0.00095128,0.063701,0.5604,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.99999
MODULE_87,SET,41,-0.02044,-0.00096489,0.13437,0.56045,MODULE_87,0.99999
SANSOM_APC_TARGETS_REQUIRE_M...,SET,210,-0.0084793,-0.0009017,0.055696,0.5605,SANSOM_APC_TARGETS_REQUIRE_MYC,0.99999
MIR2909,SET,47,-0.01791,-0.00090506,0.11764,0.5605,MIR2909,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...8,SET,143,-0.011228,-0.00098706,0.073704,0.56054,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP,0.99999
GOMF_INOSITOL_PHOSPHATE_PHOS...,SET,18,-0.02776,-0.00086882,0.1821,0.56058,GOMF_INOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.99999
REACTOME_RHOC_GTPASE_CYCLE,SET,68,-0.016203,-0.0009843,0.10625,0.5606,REACTOME_RHOC_GTPASE_CYCLE,0.99999
SHEDDEN_LUNG_CANCER_POOR_SUR...,SET,416,-0.0063921,-0.00095126,0.041818,0.56074,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,0.99999
PID_RANBP2_PATHWAY,SET,11,-0.041277,-0.0010101,0.27,0.56075,PID_RANBP2_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...84,SET,193,-0.0096341,-0.00098261,0.062984,0.56079,GOBP_POSITIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.99999
DEURIG_T_CELL_PROLYMPHOCYTIC...1,SET,282,-0.0078812,-0.00096926,0.05145,0.56087,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,0.99999
GSE37533_PPARG1_FOXP3_VS_PPA...1,SET,183,-0.0095864,-0.00095234,0.062553,0.5609,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN,0.99999
MIR19A_3P,SET,592,-0.0056708,-0.0010018,0.036999,0.56091,MIR19A_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...531,SET,8,-0.046563,-0.00097181,0.3036,0.56095,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_ARBORIZATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...75,SET,47,-0.01808,-0.00091365,0.11781,0.56099,GOBP_NEGATIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_EPITHELIA...5,SET,334,-0.0075821,-0.0010134,0.049402,0.56099,GOBP_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...262,SET,14,-0.037801,-0.0010435,0.24597,0.56107,GOBP_POSITIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,0.99999
GOBP_REGULATION_OF_SYNAPSE_P...,SET,6,-0.059537,-0.0010762,0.38739,0.56107,GOBP_REGULATION_OF_SYNAPSE_PRUNING,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...9,SET,174,-0.010605,-0.0010275,0.068869,0.56119,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN,0.99999
GGGACCA_MIR133A_MIR133B,SET,184,-0.010197,-0.0010157,0.06614,0.56126,GGGACCA_MIR133A_MIR133B,0.99999
GOBP_INOSITOL_METABOLIC_PROC...,SET,8,-0.040371,-0.00084257,0.26165,0.56131,GOBP_INOSITOL_METABOLIC_PROCESS,0.99999
GOBP_CELLULAR_RESPIRATION,SET,189,-0.00889,-0.00089737,0.057601,0.56133,GOBP_CELLULAR_RESPIRATION,0.99999
GSE2706_R848_VS_LPS_2H_STIM_...2,SET,142,-0.011459,-0.0010039,0.074242,0.56133,GSE2706_R848_VS_LPS_2H_STIM_DC_UP,0.99999
KEGG_MEDICUS_REFERENCE_COHES...2,SET,15,-0.032266,-0.00092192,0.20901,0.56134,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_ANAPHASE,0.99999
GSE28737_FOLLICULAR_VS_MARGI...2,SET,175,-0.0098577,-0.00095786,0.063856,0.56134,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP,0.99999
QI_PBMC_ZOSTAVAX_AGE_50_75YO...8,SET,13,-0.036064,-0.00095934,0.23353,0.56136,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_T_CELL_RESPONSES_EXPANSION_AND_CONTRACTION_1D_NOT_INFORMATIVE_OF_LONG_TERM_RESPONSES_POSITIVE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...439,SET,146,-0.011555,-0.0010263,0.074817,0.56137,GOBP_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,0.99999
GSE4142_NAIVE_BCELL_VS_PLASM...1,SET,187,-0.0096339,-0.00096736,0.062367,0.56138,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_DN,0.99999
GSE3720_VD1_VS_VD2_GAMMADELT...3,SET,183,-0.0094559,-0.00093938,0.061162,0.56143,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN,0.99999
HP_TYPIFIED_BY_INCOMPLETE_PE...,SET,132,-0.011626,-0.00098228,0.07519,0.56144,HP_TYPIFIED_BY_INCOMPLETE_PENETRANCE,0.99999
HP_CEREBELLAR_CALCIFICATIONS,SET,8,-0.052745,-0.0011008,0.34088,0.56148,HP_CEREBELLAR_CALCIFICATIONS,0.99999
GOBP_REGULATION_OF_CILIUM_BE...1,SET,15,-0.034061,-0.00097324,0.21996,0.56153,GOBP_REGULATION_OF_CILIUM_BEAT_FREQUENCY,0.99999
GAUTAM_EYE_CHOROID_SCLERA_CH...,SET,128,-0.011407,-0.00094916,0.073604,0.56158,GAUTAM_EYE_CHOROID_SCLERA_CHOROID_ENDOTHELIAL_CELLS,0.99999
HEIDENBLAD_AMPLIFIED_IN_SOFT...,SET,13,-0.036497,-0.00097086,0.23545,0.56159,HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER,0.99999
GOMF_EXTRACELLULAR_MATRIX_CO...,SET,10,-0.045826,-0.0010692,0.29561,0.5616,GOMF_EXTRACELLULAR_MATRIX_CONSTITUENT_CONFERRING_ELASTICITY,0.99999
MODULE_557,SET,9,-0.052841,-0.0011697,0.34075,0.56162,MODULE_557,0.99999
CASTELLANO_HRAS_TARGETS_UP,SET,5,-0.055109,-0.00090936,0.35487,0.5617,CASTELLANO_HRAS_TARGETS_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...273,SET,17,-0.031559,-0.00095991,0.20324,0.5617,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.99999
HALLMARK_MTORC1_SIGNALING,SET,184,-0.0094983,-0.00094614,0.061168,0.5617,HALLMARK_MTORC1_SIGNALING,0.99999
MIR20A_3P,SET,173,-0.0099859,-0.00096481,0.064238,0.56177,MIR20A_3P,0.99999
HP_OPTIC_ATROPHY,SET,512,-0.0057414,-0.00094536,0.036931,0.56177,HP_OPTIC_ATROPHY,0.99999
MIR4420,SET,176,-0.010011,-0.00097553,0.064327,0.56184,MIR4420,0.99999
GOCC_NLRP1_INFLAMMASOME_COMP...,SET,5,-0.071787,-0.0011846,0.46109,0.56186,GOCC_NLRP1_INFLAMMASOME_COMPLEX,0.99999
GOMF_VASCULAR_ENDOTHELIAL_GR...1,SET,4,-0.084033,-0.0012403,0.53958,0.56188,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_BINDING,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...6,SET,30,-0.022484,-0.00090818,0.14425,0.56193,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRIAL_MEMBRANE,0.99999
GOMF_ACTIVIN_RECEPTOR_ACTIVI...1,SET,9,-0.043154,-0.00095527,0.27688,0.56193,GOMF_ACTIVIN_RECEPTOR_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...10,SET,60,-0.018684,-0.0010664,0.11985,0.56194,GOBP_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,0.99999
GOBP_REGULATION_OF_RAC_PROTE...,SET,23,-0.029321,-0.0010372,0.18809,0.56194,GOBP_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GOBP_THERMOCEPTION,SET,8,-0.052347,-0.0010925,0.33577,0.56194,GOBP_THERMOCEPTION,0.99999
HP_PORPHYRINURIA,SET,7,-0.047696,-0.00093118,0.30589,0.56195,HP_PORPHYRINURIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...114,SET,453,-0.006638,-0.0010298,0.042563,0.56197,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION,0.99999
HP_ABNORMALITY_OF_THE_LYMPHA...,SET,692,-0.005155,-0.0009818,0.033051,0.56197,HP_ABNORMALITY_OF_THE_LYMPHATIC_SYSTEM,0.99999
HP_ABNORMAL_ANTERIOR_CHAMBER...,SET,54,-0.019594,-0.0010611,0.12558,0.56199,HP_ABNORMAL_ANTERIOR_CHAMBER_MORPHOLOGY,0.99999
WWTAAGGC_UNKNOWN,SET,130,-0.012367,-0.001037,0.079233,0.56201,WWTAAGGC_UNKNOWN,0.99999
GSE3720_UNSTIM_VS_LPS_STIM_V...4,SET,143,-0.01132,-0.0009952,0.072523,0.56202,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_UP,0.99999
WP_IL2_SIGNALING,SET,41,-0.021838,-0.0010309,0.13981,0.56206,WP_IL2_SIGNALING,0.99999
GOCC_PLATELET_ALPHA_GRANULE_...1,SET,59,-0.018363,-0.0010394,0.11751,0.56209,GOCC_PLATELET_ALPHA_GRANULE_LUMEN,0.99999
GOBP_RESPONSE_TO_METHIONINE,SET,5,-0.066089,-0.0010905,0.42241,0.56216,GOBP_RESPONSE_TO_METHIONINE,0.99999
GOBP_ORGANIC_ANION_TRANSPORT,SET,424,-0.0067997,-0.0010214,0.04345,0.56218,GOBP_ORGANIC_ANION_TRANSPORT,0.99999
MCBRYAN_PUBERTAL_BREAST_3_4W...1,SET,32,-0.023195,-0.00096754,0.14803,0.56225,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,0.99999
MORF_TTN,SET,45,-0.020391,-0.0010083,0.13008,0.56228,MORF_TTN,0.99999
GSE19198_CTRL_VS_IL21_TREATE...6,SET,172,-0.01053,-0.0010144,0.067138,0.56231,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_UP,0.99999
MIR549A_5P,SET,43,-0.020986,-0.0010145,0.13371,0.56236,MIR549A_5P,0.99999
REACTOME_ACYL_CHAIN_REMODELI...2,SET,5,-0.064629,-0.0010664,0.41049,0.56255,REACTOME_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG,0.99999
GOBP_NEGATIVE_REGULATION_OF_...114,SET,14,-0.037835,-0.0010444,0.24024,0.56257,GOBP_NEGATIVE_REGULATION_OF_CELL_DIVISION,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...12,SET,184,-0.010107,-0.0010068,0.064162,0.56258,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_UP,0.99999
GNF2_CYP2B6,SET,47,-0.019613,-0.00099114,0.12446,0.56261,GNF2_CYP2B6,0.99999
GOBP_BLOOD_COAGULATION_INTRI...,SET,6,-0.066197,-0.0011965,0.42006,0.56261,GOBP_BLOOD_COAGULATION_INTRINSIC_PATHWAY,0.99999
GOBP_REGULATION_OF_ANTIGEN_R...,SET,61,-0.017327,-0.00099712,0.10968,0.56276,GOBP_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.99999
GSE3982_DC_VS_NEUTROPHIL_LPS...1,SET,176,-0.010478,-0.001021,0.066315,0.56277,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...32,SET,8,-0.046928,-0.00097942,0.29696,0.56278,GOBP_POSITIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,0.99999
GOBP_REGULATION_OF_NATURAL_K...3,SET,13,-0.039091,-0.0010399,0.24727,0.56281,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION,0.99999
MODULE_489,SET,26,-0.026616,-0.0010009,0.16826,0.56284,MODULE_489,0.99999
KEGG_MEDICUS_PATHOGEN_HPV_E5...1,SET,6,-0.065261,-0.0011796,0.41233,0.56288,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.99999
KEGG_MEDICUS_PATHOGEN_KSHV_M...1,SET,6,-0.065261,-0.0011796,0.41233,0.56288,KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.99999
GSE1925_CTRL_VS_3H_IFNG_STIM...1,SET,181,-0.01042,-0.0010296,0.065791,0.56292,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,0.99999
GOMF_CALCIUM_SODIUM_ANTIPORT...,SET,10,-0.047899,-0.0011176,0.30207,0.563,GOMF_CALCIUM_SODIUM_ANTIPORTER_ACTIVITY,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...4,SET,46,-0.021665,-0.0010831,0.13656,0.56302,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_1,0.99999
GOBP_POSITIVE_REGULATION_OF_...326,SET,31,-0.027722,-0.0011382,0.17471,0.56304,GOBP_POSITIVE_REGULATION_OF_HEART_GROWTH,0.99999
GOBP_CELLULAR_SENESCENCE,SET,93,-0.014159,-0.0010052,0.08899,0.56321,GOBP_CELLULAR_SENESCENCE,0.99999
KAAB_FAILED_HEART_ATRIUM_DN,SET,133,-0.011686,-0.00099106,0.073419,0.56323,KAAB_FAILED_HEART_ATRIUM_DN,0.99999
GOMF_ACYLGLYCEROL_LIPASE_ACT...,SET,15,-0.031766,-0.00090766,0.19923,0.56334,GOMF_ACYLGLYCEROL_LIPASE_ACTIVITY,0.99999
BRACHAT_RESPONSE_TO_METHOTRE...2,SET,18,-0.029537,-0.00092444,0.1852,0.56336,BRACHAT_RESPONSE_TO_METHOTREXATE_UP,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...4,SET,183,-0.010108,-0.0010042,0.063279,0.56345,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_GRI...,SET,113,-0.0143,-0.0011185,0.089521,0.56346,HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL,0.99999
GOBP_EPITHELIAL_TO_MESENCHYM...2,SET,18,-0.037506,-0.0011738,0.23471,0.56348,GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...4,SET,37,-0.022723,-0.0010191,0.14216,0.56349,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY_UP,0.99999
NADLER_OBESITY_DN,SET,46,-0.019193,-0.00095956,0.12007,0.5635,NADLER_OBESITY_DN,0.99999
HP_ANHIDROSIS,SET,29,-0.02799,-0.0011116,0.17508,0.56351,HP_ANHIDROSIS,0.99999
GSE14769_UNSTIM_VS_60MIN_LPS...1,SET,188,-0.010566,-0.0010638,0.066072,0.56353,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN,0.99999
HP_TARSAL_SYNOSTOSIS,SET,21,-0.034272,-0.0011585,0.21425,0.56354,HP_TARSAL_SYNOSTOSIS,0.99999
REACTOME_NICOTINAMIDE_SALVAG...,SET,17,-0.033119,-0.0010074,0.20698,0.56356,REACTOME_NICOTINAMIDE_SALVAGING,0.99999
KEGG_MEDICUS_REFERENCE_LIGHT...,SET,9,-0.042665,-0.00094445,0.26659,0.56357,KEGG_MEDICUS_REFERENCE_LIGHT_HVEM_NFKB_SIGNALING_PATHWAY,0.99999
GOBP_MISMATCH_REPAIR,SET,31,-0.022238,-0.00091306,0.13883,0.56363,GOBP_MISMATCH_REPAIR,0.99999
GOBP_PIRNA_PROCESSING,SET,21,-0.027089,-0.00091568,0.16908,0.56364,GOBP_PIRNA_PROCESSING,0.99999
CAGTCAC_MIR134,SET,48,-0.019666,-0.0010043,0.12264,0.5637,CAGTCAC_MIR134,0.99999
GSE20727_CTRL_VS_ROS_INH_AND...1,SET,170,-0.010301,-0.00098667,0.064199,0.56374,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,0.99999
DESCARTES_FETAL_HEART_ELF3_A...,SET,34,-0.023801,-0.0010233,0.14821,0.56379,DESCARTES_FETAL_HEART_ELF3_AGBL2_POSITIVE_CELLS,0.99999
WP_BRAINDERIVED_NEUROTROPHIC...,SET,135,-0.01262,-0.0010782,0.078538,0.56383,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,0.99999
GOMF_PHOSPHATIDYLINOSITOL_PH...3,SET,162,-0.010758,-0.0010061,0.066902,0.56387,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING,0.99999
GOMF_CUPRIC_ION_BINDING,SET,5,-0.060334,-0.00099558,0.3752,0.56388,GOMF_CUPRIC_ION_BINDING,0.99999
GOBP_VITAMIN_METABOLIC_PROCE...,SET,109,-0.012945,-0.00099454,0.080478,0.5639,GOBP_VITAMIN_METABOLIC_PROCESS,0.99999
FOURNIER_ACINAR_DEVELOPMENT_...3,SET,264,-0.0081178,-0.00096646,0.050428,0.56394,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,0.99999
GOBP_PROTEIN_IMPORT_INTO_PER...3,SET,4,-0.066363,-0.00097949,0.41229,0.56394,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX_SUBSTRATE_RELEASE,0.99999
GOBP_PLASMA_MEMBRANE_FUSION,SET,25,-0.029711,-0.0010957,0.18453,0.56396,GOBP_PLASMA_MEMBRANE_FUSION,0.99999
JINESH_BLEBBISHIELD_VS_LIVE_...1,SET,241,-0.0094199,-0.0010722,0.058435,0.56403,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,0.99999
GAO_ESOPHAGUS_25W_C4_FGFR1HI...,SET,178,-0.010219,-0.0010013,0.063389,0.56403,GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS,0.99999
GSE39864_WT_VS_GATA3_KO_TREG...2,SET,188,-0.010467,-0.0010538,0.064905,0.56406,GSE39864_WT_VS_GATA3_KO_TREG_UP,0.99999
HP_GRANULOCYTIC_HYPERPLASIA,SET,6,-0.066873,-0.0012088,0.41457,0.56407,HP_GRANULOCYTIC_HYPERPLASIA,0.99999
AP1_Q4_01,SET,241,-0.0088759,-0.0010103,0.054999,0.5641,AP1_Q4_01,0.99999
GOERING_BLOOD_HDL_CHOLESTERO...2,SET,12,-0.041699,-0.0010658,0.25824,0.56414,GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS,0.99999
YAGI_AML_WITH_INV_16_TRANSLO...,SET,371,-0.0072058,-0.001014,0.044617,0.56415,YAGI_AML_WITH_INV_16_TRANSLOCATION,0.99999
REACTOME_REGULATION_OF_PTEN_...3,SET,9,-0.048559,-0.0010749,0.30058,0.56417,REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION,0.99999
KEGG_MEDICUS_PATHOGEN_HIV_TA...2,SET,14,-0.049619,-0.0013697,0.30699,0.5642,KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY,0.99999
HP_ANHYDRAMNIOS,SET,6,-0.054035,-0.0009767,0.33427,0.56421,HP_ANHYDRAMNIOS,0.99999
GOBP_AGGREPHAGY,SET,16,-0.031482,-0.00092901,0.19458,0.56426,GOBP_AGGREPHAGY,0.99999
BROWNE_HCMV_INFECTION_48HR_DN,SET,425,-0.0067514,-0.0010153,0.041724,0.56427,BROWNE_HCMV_INFECTION_48HR_DN,0.99999
MIR888_5P,SET,220,-0.0093764,-0.0010203,0.057953,0.56427,MIR888_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...192,SET,22,-0.028822,-0.00099714,0.17813,0.56427,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,0.99999
MIR513B_3P,SET,144,-0.012039,-0.0010621,0.074315,0.56435,MIR513B_3P,0.99999
TSENG_ADIPOGENIC_POTENTIAL_UP,SET,25,-0.028685,-0.0010578,0.17704,0.56436,TSENG_ADIPOGENIC_POTENTIAL_UP,0.99999
KEGG_MEDICUS_REFERENCE_SPIND...,SET,20,-0.030923,-0.0010201,0.19076,0.56439,KEGG_MEDICUS_REFERENCE_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...633,SET,9,-0.045697,-0.0010116,0.28175,0.56442,GOBP_NEGATIVE_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS,0.99999
GOCC_SECRETORY_GRANULE_MEMBR...,SET,291,-0.008506,-0.0010624,0.052442,0.56442,GOCC_SECRETORY_GRANULE_MEMBRANE,0.99999
KEGG_CARDIAC_MUSCLE_CONTRACT...,SET,68,-0.017013,-0.0010335,0.10489,0.56443,KEGG_CARDIAC_MUSCLE_CONTRACTION,0.99999
HP_MENTAL_DETERIORATION,SET,333,-0.0075647,-0.0010095,0.046625,0.56444,HP_MENTAL_DETERIORATION,0.99999
GOCC_POSTSYNAPTIC_RECYCLING_...,SET,7,-0.047535,-0.00092803,0.29274,0.5645,GOCC_POSTSYNAPTIC_RECYCLING_ENDOSOME,0.99999
GOBP_NON_PROTEINOGENIC_AMINO...2,SET,14,-0.040214,-0.0011101,0.24751,0.56453,GOBP_NON_PROTEINOGENIC_AMINO_ACID_CATABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...371,SET,13,-0.038937,-0.0010358,0.23963,0.56454,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,0.99999
GOMF_CALCIUM_DEPENDENT_PROTE...3,SET,7,-0.040216,-0.00078514,0.24748,0.56454,GOMF_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.99999
GOBP_STEROID_BIOSYNTHETIC_PR...,SET,166,-0.011037,-0.0010448,0.067879,0.56458,GOBP_STEROID_BIOSYNTHETIC_PROCESS,0.99999
HAY_BONE_MARROW_PLASMA_CELL,SET,85,-0.01541,-0.0010461,0.094774,0.56458,HAY_BONE_MARROW_PLASMA_CELL,0.99999
FOROUTAN_INTEGRATED_TGFB_EMT...1,SET,70,-0.018867,-0.0011628,0.11603,0.56459,FOROUTAN_INTEGRATED_TGFB_EMT_DN,0.99999
REACTOME_C_TYPE_LECTIN_RECEP...,SET,125,-0.011823,-0.0009723,0.072682,0.56461,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,0.99999
HP_DYSMETRIC_SACCADES,SET,15,-0.033277,-0.00095081,0.20451,0.56463,HP_DYSMETRIC_SACCADES,0.99999
GSE35543_IN_VIVO_NTREG_VS_IN...2,SET,169,-0.011973,-0.0011434,0.073227,0.56494,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP,0.99999
PID_TCR_CALCIUM_PATHWAY,SET,27,-0.025983,-0.00099573,0.15884,0.56497,PID_TCR_CALCIUM_PATHWAY,0.99999
GSE2706_UNSTIM_VS_8H_LPS_DC_...2,SET,178,-0.010331,-0.0010124,0.063156,0.56497,GSE2706_UNSTIM_VS_8H_LPS_DC_UP,0.99999
GSE24142_EARLY_THYMIC_PROGEN...1,SET,183,-0.010205,-0.0010138,0.062349,0.56501,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN,0.99999
GSE46242_TH1_VS_ANERGIC_TH1_...1,SET,158,-0.010987,-0.0010149,0.067067,0.56506,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_DN,0.99999
ELVIDGE_HYPOXIA_UP,SET,155,-0.011886,-0.0010875,0.072551,0.56507,ELVIDGE_HYPOXIA_UP,0.99999
GOBP_N_ACYLPHOSPHATIDYLETHAN...,SET,4,-0.072461,-0.0010695,0.44188,0.56513,GOBP_N_ACYLPHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS,0.99999
HP_GONADAL_NEOPLASM,SET,100,-0.01375,-0.0010121,0.083777,0.56518,HP_GONADAL_NEOPLASM,0.99999
FOXE1_TARGET_GENES,SET,566,-0.0060961,-0.0010538,0.037127,0.56521,FOXE1_TARGET_GENES,0.99999
WP_IL18_SIGNALING,SET,259,-0.0090764,-0.0010704,0.055266,0.56522,WP_IL18_SIGNALING,0.99999
GSE37301_PRO_BCELL_VS_RAG2_K...1,SET,169,-0.010955,-0.0010463,0.06671,0.56522,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN,0.99999
GOBP_PERIPHERAL_NERVOUS_SYST...1,SET,28,-0.027378,-0.0010684,0.16666,0.56524,GOBP_PERIPHERAL_NERVOUS_SYSTEM_AXON_ENSHEATHMENT,0.99999
WP_GLYCEROLIPIDS_AND_GLYCERO...,SET,21,-0.030459,-0.0010296,0.18536,0.56526,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,0.99999
TOMLINS_METASTASIS_UP,SET,14,-0.036,-0.00099378,0.21902,0.56528,TOMLINS_METASTASIS_UP,0.99999
GOBP_ETHER_BIOSYNTHETIC_PROC...,SET,11,-0.044094,-0.001079,0.26828,0.56528,GOBP_ETHER_BIOSYNTHETIC_PROCESS,0.99999
GOMF_ACTIN_FILAMENT_BINDING,SET,197,-0.0102,-0.001051,0.062025,0.56531,GOMF_ACTIN_FILAMENT_BINDING,0.99999
HP_CONGENITAL_HYPOTHYROIDISM,SET,30,-0.027599,-0.0011148,0.1678,0.56532,HP_CONGENITAL_HYPOTHYROIDISM,0.99999
GSE17721_CTRL_VS_LPS_8H_BMDC...1,SET,184,-0.010442,-0.0010401,0.06343,0.56538,GSE17721_CTRL_VS_LPS_8H_BMDC_DN,0.99999
KEGG_MEDICUS_REFERENCE_TLR3_...1,SET,9,-0.046687,-0.0010335,0.28332,0.56544,KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY,0.99999
CACBINDINGPROTEIN_Q6,SET,231,-0.0093095,-0.0010377,0.056478,0.56546,CACBINDINGPROTEIN_Q6,0.99999
GOMF_PHOSPHATIDYLSERINE_1_AC...,SET,6,-0.052061,-0.00094104,0.31565,0.5655,GOMF_PHOSPHATIDYLSERINE_1_ACYLHYDROLASE_ACTIVITY,0.99999
HP_IRIS_HYPOPIGMENTATION,SET,58,-0.019896,-0.0011165,0.12063,0.5655,HP_IRIS_HYPOPIGMENTATION,0.99999
GOBP_POSTSYNAPTIC_DENSITY_AS...,SET,24,-0.031279,-0.0011302,0.18952,0.56555,GOBP_POSTSYNAPTIC_DENSITY_ASSEMBLY,0.99999
GACTGTT_MIR212_MIR132,SET,144,-0.011674,-0.0010299,0.070695,0.56558,GACTGTT_MIR212_MIR132,0.99999
GOBP_MACROPHAGE_COLONY_STIMU...1,SET,6,-0.059054,-0.0010674,0.3576,0.56558,GOBP_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,0.99999
MORF_CCNI,SET,82,-0.015054,-0.0010039,0.091136,0.5656,MORF_CCNI,0.99999
GOBP_SEMAPHORIN_PLEXIN_SIGNA...,SET,42,-0.023145,-0.0011058,0.14007,0.56562,GOBP_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY,0.99999
GOBP_LUNG_LOBE_DEVELOPMENT,SET,7,-0.064734,-0.0012638,0.39169,0.56563,GOBP_LUNG_LOBE_DEVELOPMENT,0.99999
GOBP_PALLIUM_DEVELOPMENT,SET,174,-0.011025,-0.0010683,0.066711,0.56563,GOBP_PALLIUM_DEVELOPMENT,0.99999
MIR5702,SET,68,-0.017613,-0.0010699,0.10654,0.56565,MIR5702,0.99999
HP_FOCAL_ONSET_SEIZURE,SET,296,-0.0080949,-0.0010196,0.048953,0.56567,HP_FOCAL_ONSET_SEIZURE,0.99999
GOBP_REGULATION_OF_INNER_EAR...,SET,8,-0.052941,-0.0011049,0.32011,0.56568,GOBP_REGULATION_OF_INNER_EAR_AUDITORY_RECEPTOR_CELL_DIFFERENTIATION,0.99999
COULOUARN_TEMPORAL_TGFB1_SIG...1,SET,124,-0.012757,-0.0010449,0.077127,0.56569,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...30,SET,45,-0.020848,-0.0010309,0.12601,0.56571,GAVISH_3CA_MALIGNANT_METAPROGRAM_38_GLUTATHIONE,0.99999
COLE_BLOOD_FLUZONE_FLUARIX_A...,SET,7,-0.062544,-0.0012211,0.37802,0.56571,COLE_BLOOD_FLUZONE_FLUARIX_AGE_03_17YO_7DY_DN,0.99999
MIR96_5P,SET,414,-0.0072586,-0.0010777,0.04384,0.56575,MIR96_5P,0.99999
GOBP_MALE_MEIOSIS_I,SET,25,-0.025379,-0.00093592,0.15326,0.56576,GOBP_MALE_MEIOSIS_I,0.99999
STK33_NOMO_UP,SET,262,-0.009291,-0.001102,0.056101,0.56577,STK33_NOMO_UP,0.99999
GSE13522_WT_VS_IFNAR_KO_SKIN...2,SET,187,-0.010883,-0.0010928,0.065692,0.56579,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,0.99999
WP_SRF_AND_MIRS_IN_SMOOTH_MU...,SET,10,-0.050896,-0.0011876,0.30711,0.56581,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,0.99999
GSE7764_IL15_NK_CELL_24H_VS_...2,SET,171,-0.010469,-0.0010057,0.063077,0.56591,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP,0.99999
WP_FOCAL_ADHESION,SET,190,-0.010941,-0.0011073,0.065893,0.56594,WP_FOCAL_ADHESION,0.99999
HP_RETROGNATHIA,SET,308,-0.0079043,-0.0010152,0.047585,0.56596,HP_RETROGNATHIA,0.99999
KEGG_MEDICUS_REFERENCE_BMP15...,SET,6,-0.065297,-0.0011803,0.39263,0.56604,KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY,0.99999
GOBP_DOPAMINERGIC_NEURON_DIF...,SET,37,-0.026097,-0.0011704,0.15688,0.56606,GOBP_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.99999
chr11q13,SET,240,-0.018922,-0.0021494,0.1137,0.56609,chr11q13,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...8,SET,11,-0.04497,-0.0011005,0.27019,0.56609,HP_APLASIA_HYPOPLASIA_OF_THE_5TH_METACARPAL,0.99999
HP_LOP_EAR,SET,3,-0.091668,-0.0011717,0.55073,0.5661,HP_LOP_EAR,0.99999
GOMF_GENERAL_TRANSCRIPTION_I...1,SET,46,-0.018172,-0.00090849,0.10915,0.56611,GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.99999
KEGG_BETA_ALANINE_METABOLISM,SET,21,-0.032392,-0.0010949,0.1945,0.56613,KEGG_BETA_ALANINE_METABOLISM,0.99999
GOBP_GLAND_MORPHOGENESIS,SET,121,-0.013989,-0.001132,0.08399,0.56614,GOBP_GLAND_MORPHOGENESIS,0.99999
GOCC_MESSENGER_RIBONUCLEOPRO...,SET,6,-0.051292,-0.00092713,0.30796,0.56614,GOCC_MESSENGER_RIBONUCLEOPROTEIN_COMPLEX,0.99999
GSE11961_MEMORY_BCELL_DAY40_...1,SET,178,-0.010797,-0.001058,0.064799,0.56616,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.99999
GOBP_SPERM_MITOCHONDRIAL_SHE...,SET,6,-0.062664,-0.0011327,0.3758,0.56622,GOBP_SPERM_MITOCHONDRIAL_SHEATH_ASSEMBLY,0.99999
ROSTY_CERVICAL_CANCER_PROLIF...,SET,130,-0.011622,-0.00097455,0.069669,0.56624,ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER,0.99999
PAX2_01,SET,49,-0.019736,-0.0010183,0.11827,0.56626,PAX2_01,0.99999
HP_BIFID_SCROTUM,SET,30,-0.028992,-0.001171,0.17371,0.56628,HP_BIFID_SCROTUM,0.99999
LEI_HOXC8_TARGETS_UP,SET,11,-0.043875,-0.0010737,0.2627,0.56632,LEI_HOXC8_TARGETS_UP,0.99999
GSE42724_MEMORY_BCELL_VS_PLA...2,SET,189,-0.010394,-0.0010492,0.062203,0.56635,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_UP,0.99999
MIR584_3P,SET,96,-0.014191,-0.0010235,0.084888,0.56638,MIR584_3P,0.99999
AIZARANI_LIVER_C6_KUPFFER_CE...,SET,203,-0.010675,-0.0011163,0.06385,0.56639,AIZARANI_LIVER_C6_KUPFFER_CELLS_2,0.99999
GOMF_RNA_ENDONUCLEASE_ACTIVI...3,SET,27,-0.028563,-0.0010946,0.17074,0.56643,GOMF_RNA_ENDONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,0.99999
TRAVAGLINI_LUNG_CAPILLARY_AE...,SET,41,-0.023886,-0.0011275,0.14272,0.56646,TRAVAGLINI_LUNG_CAPILLARY_AEROCYTE_CELL,0.99999
REACTOME_SEMA4D_MEDIATED_INH...,SET,8,-0.055169,-0.0011514,0.32944,0.5665,REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION,0.99999
MIR6737_5P,SET,72,-0.016439,-0.0010275,0.098079,0.56655,MIR6737_5P,0.99999
HP_RECURRENT_BACTERIAL_SKIN_...,SET,23,-0.030927,-0.001094,0.18415,0.56668,HP_RECURRENT_BACTERIAL_SKIN_INFECTIONS,0.99999
S8_01,SET,230,-0.010035,-0.0011162,0.059674,0.56677,S8_01,0.99999
GSE15930_STIM_VS_STIM_AND_IF...6,SET,171,-0.011072,-0.0010636,0.065792,0.56682,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP,0.99999
LEE_LIVER_CANCER_E2F1_UP,SET,60,-0.021286,-0.0012149,0.12647,0.56683,LEE_LIVER_CANCER_E2F1_UP,0.99999
LEE_AGING_NEOCORTEX_UP,SET,72,-0.017473,-0.0010921,0.10378,0.56685,LEE_AGING_NEOCORTEX_UP,0.99999
GOBP_REGULATION_OF_DEFENSE_R...1,SET,727,-0.0055072,-0.001074,0.032705,0.56686,GOBP_REGULATION_OF_DEFENSE_RESPONSE,0.99999
MIR4643,SET,197,-0.01045,-0.0010767,0.062023,0.5669,MIR4643,0.99999
HP_DECREASED_CIRCULATING_FRE...2,SET,4,-0.063026,-0.00093023,0.37409,0.5669,HP_DECREASED_CIRCULATING_FREE_T4_CONCENTRATION,0.99999
WP_7Q1123_COPY_NUMBER_VARIAT...,SET,86,-0.016116,-0.0011004,0.095592,0.56694,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,0.99999
MODULE_287,SET,47,-0.022146,-0.0011191,0.13135,0.56694,MODULE_287,0.99999
HP_INCREASED_JITTER_AT_SINGL...,SET,7,-0.05342,-0.0010429,0.3168,0.56695,HP_INCREASED_JITTER_AT_SINGLE_FIBER_EMG,0.99999
HARALAMBIEVA_PBMC_FLUARIX_AG...3,SET,8,-0.049376,-0.0010305,0.29275,0.56697,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_NEGATIVE,0.99999
GSE17721_ALL_VS_24H_PAM3CSK4...2,SET,178,-0.010924,-0.0010704,0.064701,0.56704,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP,0.99999
CROONQUIST_NRAS_VS_STROMAL_S...1,SET,86,-0.016124,-0.001101,0.095461,0.56706,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,0.99999
GSE14415_NATURAL_TREG_VS_FOX...1,SET,144,-0.012,-0.0010586,0.071033,0.56707,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN,0.99999
MIR3918,SET,83,-0.015063,-0.0010106,0.089151,0.56709,MIR3918,0.99999
GOBP_GLIAL_CELL_DERIVED_NEUR...,SET,15,-0.038024,-0.0010865,0.22504,0.56709,GOBP_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
CDPCR3_01,SET,50,-0.022856,-0.0011912,0.13524,0.5671,CDPCR3_01,0.99999
PPARA_01,SET,31,-0.026405,-0.0010841,0.15619,0.56712,PPARA_01,0.99999
GOCC_PROTEASOME_CORE_COMPLEX...1,SET,8,-0.036655,-0.00076501,0.21672,0.56715,GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX,0.99999
GOBP_DNA_STRAND_RESECTION_IN...,SET,9,-0.042632,-0.0009437,0.25175,0.56723,GOBP_DNA_STRAND_RESECTION_INVOLVED_IN_REPLICATION_FORK_PROCESSING,0.99999
NADELLA_PRKAR1A_TARGETS_UP,SET,9,-0.055682,-0.0012326,0.32881,0.56724,NADELLA_PRKAR1A_TARGETS_UP,0.99999
OCT1_02,SET,187,-0.011546,-0.0011594,0.068182,0.56724,OCT1_02,0.99999
GOCC_AXON_INITIAL_SEGMENT,SET,21,-0.033995,-0.0011491,0.20074,0.56724,GOCC_AXON_INITIAL_SEGMENT,0.99999
HP_CHERRY_RED_SPOT_OF_THE_MA...,SET,13,-0.040284,-0.0010716,0.23765,0.5673,HP_CHERRY_RED_SPOT_OF_THE_MACULA,0.99999
REACTOME_METABOLISM_OF_POLYA...,SET,55,-0.016701,-0.00091277,0.098516,0.56731,REACTOME_METABOLISM_OF_POLYAMINES,0.99999
ZNF708_TARGET_GENES,SET,72,-0.016478,-0.0010299,0.097187,0.56732,ZNF708_TARGET_GENES,0.99999
GOBP_PROTEIN_SULFATION,SET,6,-0.061796,-0.001117,0.36439,0.56733,GOBP_PROTEIN_SULFATION,0.99999
GSE22886_TH1_VS_TH2_48H_ACT_...2,SET,177,-0.011488,-0.0011225,0.06774,0.56733,GSE22886_TH1_VS_TH2_48H_ACT_UP,0.99999
GOCC_PRESYNAPTIC_MEMBRANE,SET,159,-0.012428,-0.0011516,0.073267,0.56735,GOCC_PRESYNAPTIC_MEMBRANE,0.99999
GSE7568_IL4_VS_IL4_AND_TGFB_...2,SET,151,-0.011626,-0.0010501,0.068471,0.56742,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP,0.99999
HP_ELEVATED_HEPATIC_IRON_CON...,SET,11,-0.047681,-0.0011668,0.28052,0.56748,HP_ELEVATED_HEPATIC_IRON_CONCENTRATION,0.99999
GSE34205_RSV_VS_FLU_INF_INFA...2,SET,154,-0.011991,-0.0010936,0.070531,0.5675,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP,0.99999
REACTOME_IRAK4_DEFICIENCY_TL...,SET,17,-0.03693,-0.0011233,0.2172,0.56751,REACTOME_IRAK4_DEFICIENCY_TLR2_4,0.99999
GOBP_EPINEPHRINE_SECRETION,SET,7,-0.061127,-0.0011934,0.35919,0.56757,GOBP_EPINEPHRINE_SECRETION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...240,SET,7,-0.047159,-0.0009207,0.27708,0.56757,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,0.99999
JIANG_MELANOMA_TRM6_CD8,SET,122,-0.012673,-0.0010296,0.074407,0.56762,JIANG_MELANOMA_TRM6_CD8,0.99999
GOBP_REGULATION_OF_POSITIVE_...,SET,25,-0.032202,-0.0011875,0.18898,0.56765,GOBP_REGULATION_OF_POSITIVE_CHEMOTAXIS,0.99999
GOBP_CRANIAL_NERVE_DEVELOPME...,SET,61,-0.020034,-0.0011529,0.11751,0.56768,GOBP_CRANIAL_NERVE_DEVELOPMENT,0.99999
SASSON_RESPONSE_TO_FORSKOLIN...2,SET,78,-0.016248,-0.0010568,0.095276,0.5677,SASSON_RESPONSE_TO_FORSKOLIN_UP,0.99999
MORF_TPT1,SET,90,-0.015077,-0.0010531,0.088401,0.56771,MORF_TPT1,0.99999
SUMI_HNF4A_TARGETS,SET,28,-0.029883,-0.0011662,0.17519,0.56772,SUMI_HNF4A_TARGETS,0.99999
MODULE_308,SET,63,-0.018037,-0.0010548,0.10572,0.56773,MODULE_308,0.99999
GOBP_INTERFERON_BETA_PRODUCT...,SET,49,-0.019532,-0.0010078,0.11446,0.56775,GOBP_INTERFERON_BETA_PRODUCTION,0.99999
REACTOME_FGFR2B_LIGAND_BINDI...,SET,10,-0.053634,-0.0012514,0.31407,0.5678,REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION,0.99999
SMCHD1_TARGET_GENES,SET,30,-0.027791,-0.0011225,0.16274,0.5678,SMCHD1_TARGET_GENES,0.99999
GSE13493_DP_VS_CD8POS_THYMOC...2,SET,171,-0.010866,-0.0010438,0.063594,0.56784,GSE13493_DP_VS_CD8POS_THYMOCYTE_UP,0.99999
MIR6846_3P,SET,23,-0.030029,-0.0010622,0.17562,0.56788,MIR6846_3P,0.99999
GOBP_REGULATION_OF_NEURON_PR...3,SET,30,-0.028297,-0.001143,0.16541,0.56792,GOBP_REGULATION_OF_NEURON_PROJECTION_REGENERATION,0.99999
REACTOME_TRIGLYCERIDE_CATABO...,SET,23,-0.03143,-0.0011118,0.18364,0.56795,REACTOME_TRIGLYCERIDE_CATABOLISM,0.99999
WNT_UP.V1_UP,SET,167,-0.011721,-0.0011129,0.068486,0.56795,WNT_UP.V1_UP,0.99999
HP_DELAYED_ERUPTION_OF_TEETH,SET,153,-0.012069,-0.0010972,0.070477,0.56799,HP_DELAYED_ERUPTION_OF_TEETH,0.99999
MIR214_5P,SET,49,-0.021435,-0.0011059,0.12514,0.568,MIR214_5P,0.99999
HP_ABNORMAL_FEMORAL_TORSION,SET,9,-0.044348,-0.00098169,0.25891,0.568,HP_ABNORMAL_FEMORAL_TORSION,0.99999
GSE37301_HEMATOPOIETIC_STEM_...14,SET,155,-0.011854,-0.0010846,0.069208,0.568,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP,0.99999
HP_ABNORMAL_CIRCULATING_LYSI...,SET,5,-0.080262,-0.0013244,0.46755,0.56815,HP_ABNORMAL_CIRCULATING_LYSINE_CONCENTRATION,0.99999
HP_PROXIMAL_RADIO_ULNAR_SYNO...,SET,6,-0.071982,-0.0013011,0.41929,0.56815,HP_PROXIMAL_RADIO_ULNAR_SYNOSTOSIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...474,SET,9,-0.050136,-0.0011098,0.29175,0.56822,GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GSE15930_NAIVE_VS_72H_IN_VIT...5,SET,182,-0.010737,-0.0010637,0.062474,0.56823,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.99999
GOMF_CHEMOKINE_BINDING,SET,29,-0.030824,-0.0012242,0.17932,0.56824,GOMF_CHEMOKINE_BINDING,0.99999
MIR657,SET,68,-0.017529,-0.0010649,0.10197,0.56825,MIR657,0.99999
HP_ABNORMAL_PULMONARY_INTERS...,SET,135,-0.012618,-0.0010781,0.073383,0.56826,HP_ABNORMAL_PULMONARY_INTERSTITIAL_MORPHOLOGY,0.99999
GOCC_SNARE_COMPLEX,SET,48,-0.02005,-0.0010239,0.11652,0.56831,GOCC_SNARE_COMPLEX,0.99999
HP_HYPERLYSINURIA,SET,5,-0.063067,-0.0010407,0.3664,0.56833,HP_HYPERLYSINURIA,0.99999
DESCARTES_FETAL_STOMACH_PARI...,SET,36,-0.026179,-0.0011582,0.15197,0.56838,DESCARTES_FETAL_STOMACH_PARIETAL_AND_CHIEF_CELLS,0.99999
GOBP_REGULATION_OF_NEUROTRAN...3,SET,72,-0.017556,-0.0010973,0.1019,0.56839,GOBP_REGULATION_OF_NEUROTRANSMITTER_SECRETION,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...16,SET,47,-0.024136,-0.0012197,0.14002,0.56842,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_MICROVILLAR_CELLS,0.99999
KEGG_O_GLYCAN_BIOSYNTHESIS,SET,27,-0.032639,-0.0012508,0.18933,0.56843,KEGG_O_GLYCAN_BIOSYNTHESIS,0.99999
NAKAMURA_ADIPOGENESIS_LATE_UP,SET,93,-0.015034,-0.0010674,0.087128,0.5685,NAKAMURA_ADIPOGENESIS_LATE_UP,0.99999
PID_CXCR3_PATHWAY,SET,42,-0.024463,-0.0011688,0.14169,0.56854,PID_CXCR3_PATHWAY,0.99999
ZHU_CMV_8_HR_DN,SET,44,-0.024064,-0.0011767,0.13932,0.56857,ZHU_CMV_8_HR_DN,0.99999
MIR8053,SET,5,-0.049915,-0.00082365,0.28889,0.56859,MIR8053,0.99999
REACTOME_HIGHLY_SODIUM_PERME...,SET,7,-0.052241,-0.0010199,0.30203,0.56866,REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...7,SET,88,-0.017612,-0.0012164,0.10183,0.56866,GAUTAM_EYE_IRIS_CILIARY_BODY_FIBROBLASTS,0.99999
GSE7852_THYMUS_VS_FAT_TCONV_...2,SET,178,-0.010997,-0.0010776,0.063557,0.56868,GSE7852_THYMUS_VS_FAT_TCONV_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_AL...4,SET,36,-0.024612,-0.0010888,0.14215,0.56873,GOBP_CELLULAR_RESPONSE_TO_ALKALOID,0.99999
YRTCANNRCGC_UNKNOWN,SET,61,-0.018542,-0.0010671,0.10701,0.56878,YRTCANNRCGC_UNKNOWN,0.99999
GOBP_SIGNAL_RELEASE,SET,456,-0.0071875,-0.0011186,0.041475,0.56879,GOBP_SIGNAL_RELEASE,0.99999
GOBP_OTOLITH_MORPHOGENESIS,SET,5,-0.069996,-0.001155,0.40346,0.56887,GOBP_OTOLITH_MORPHOGENESIS,0.99999
GSE21360_SECONDARY_VS_QUATER...1,SET,147,-0.01281,-0.0011417,0.073792,0.56891,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.99999
GSE9316_IL6_KO_VS_IFNG_KO_IN...2,SET,184,-0.011143,-0.00111,0.064157,0.56894,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...532,SET,723,-0.0056695,-0.0011027,0.032638,0.56895,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS,0.99999
GOCC_MICROTUBULE_CYTOSKELETON,SET,1223,-0.0042397,-0.0010572,0.0244,0.56897,GOCC_MICROTUBULE_CYTOSKELETON,0.99999
WP_AUTOPHAGY_IN_PANCREATIC_D...,SET,18,-0.035613,-0.0011146,0.20491,0.56899,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,0.99999
HP_IRIS_TRANSILLUMINATION_DE...,SET,12,-0.04778,-0.0012212,0.27483,0.56901,HP_IRIS_TRANSILLUMINATION_DEFECT,0.99999
DORSEY_GAB2_TARGETS,SET,27,-0.030969,-0.0011868,0.17805,0.56904,DORSEY_GAB2_TARGETS,0.99999
SMID_BREAST_CANCER_RELAPSE_I...5,SET,10,-0.044778,-0.0010448,0.2574,0.56905,SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN,0.99999
GSE2770_UNTREATED_VS_ACT_CD4...6,SET,180,-0.011178,-0.0011015,0.064255,0.56906,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP,0.99999
MCBRYAN_PUBERTAL_TGFB1_TARGE...2,SET,156,-0.012129,-0.0011133,0.069694,0.56908,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,0.99999
HP_ACCESSORY_ORAL_FRENULUM,SET,16,-0.035377,-0.001044,0.20328,0.56908,HP_ACCESSORY_ORAL_FRENULUM,0.99999
HP_HYPOCHLOREMIA,SET,6,-0.070551,-0.0012753,0.40515,0.56912,HP_HYPOCHLOREMIA,0.99999
MIR184,SET,7,-0.059837,-0.0011682,0.34337,0.56917,MIR184,0.99999
HP_ALOBAR_HOLOPROSENCEPHALY,SET,6,-0.0713,-0.0012888,0.40891,0.56921,HP_ALOBAR_HOLOPROSENCEPHALY,0.99999
REACTOME_PHOSPHOLIPASE_C_MED...2,SET,17,-0.04056,-0.0012337,0.23254,0.56923,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2,0.99999
GOCC_PRERIBOSOME_LARGE_SUBUN...,SET,18,-0.03234,-0.0010122,0.18534,0.56926,GOCC_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR,0.99999
GSE22103_LPS_VS_GMCSF_AND_IF...1,SET,187,-0.010551,-0.0010594,0.060429,0.5693,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,0.99999
GOBP_APICAL_PROTEIN_LOCALIZA...,SET,14,-0.038377,-0.0010594,0.21964,0.56935,GOBP_APICAL_PROTEIN_LOCALIZATION,0.99999
MORI_PLASMA_CELL_DN,SET,34,-0.027802,-0.0011954,0.15904,0.56939,MORI_PLASMA_CELL_DN,0.99999
REACTOME_TRAF6_MEDIATED_INDU...,SET,14,-0.040981,-0.0011313,0.23433,0.56942,REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX,0.99999
MIR6892_3P,SET,92,-0.016132,-0.0011392,0.092238,0.56942,MIR6892_3P,0.99999
CAIRO_PML_TARGETS_BOUND_BY_M...2,SET,22,-0.033423,-0.0011563,0.19104,0.56944,CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,0.99999
GOMF_DNA_DIRECTED_DNA_POLYME...,SET,22,-0.024276,-0.00083988,0.13867,0.56949,GOMF_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,0.99999
WP_MITOCHONDRIAL_FATTY_ACID_...3,SET,5,-0.061229,-0.0010104,0.34968,0.5695,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,0.99999
MIR4722_5P,SET,127,-0.01357,-0.0011247,0.077404,0.56958,MIR4722_5P,0.99999
NAGASHIMA_EGF_SIGNALING_UP,SET,53,-0.02247,-0.0012056,0.12804,0.56966,NAGASHIMA_EGF_SIGNALING_UP,0.99999
BUSSLINGER_GASTRIC_ANTRAL_ECS,SET,10,-0.054652,-0.0012752,0.31108,0.56973,BUSSLINGER_GASTRIC_ANTRAL_ECS,0.99999
REACTOME_ACTIVATION_OF_RAC1_...,SET,7,-0.053135,-0.0010374,0.30222,0.56978,REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS,0.99999
WP_KISSPEPTINKISSPEPTIN_RECE...,SET,38,-0.025145,-0.0011428,0.14292,0.56983,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...12,SET,158,-0.012809,-0.0011832,0.072805,0.56983,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP,0.99999
GSE5503_LIVER_DC_VS_PLN_DC_A...2,SET,182,-0.010992,-0.001089,0.062464,0.56984,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.99999
GOBP_MITRAL_VALVE_DEVELOPMENT,SET,14,-0.044219,-0.0012207,0.25124,0.56985,GOBP_MITRAL_VALVE_DEVELOPMENT,0.99999
GSE34392_ST2_KO_VS_WT_DAY8_L...1,SET,187,-0.011799,-0.0011847,0.067016,0.56987,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,0.99999
GOBP_COLLAGEN_BIOSYNTHETIC_P...,SET,39,-0.026576,-0.0012236,0.15083,0.56993,GOBP_COLLAGEN_BIOSYNTHETIC_PROCESS,0.99999
MORF_PTEN,SET,77,-0.016063,-0.0010381,0.091143,0.56995,MORF_PTEN,0.99999
GOBP_DETECTION_OF_BACTERIUM,SET,15,-0.040292,-0.0011513,0.22861,0.56995,GOBP_DETECTION_OF_BACTERIUM,0.99999
EIF4E_DN,SET,90,-0.016171,-0.0011295,0.091728,0.56997,EIF4E_DN,0.99999
GSE18281_CORTICAL_VS_MEDULLA...1,SET,169,-0.011779,-0.001125,0.066731,0.57006,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_DN,0.99999
GOBP_AV_NODE_CELL_TO_BUNDLE_...2,SET,10,-0.055501,-0.001295,0.31435,0.57007,GOBP_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_SIGNALING,0.99999
GOMF_PRIMARY_ACTIVE_TRANSMEM...,SET,143,-0.012072,-0.0010613,0.068376,0.57007,GOMF_PRIMARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE22935_UNSTIM_VS_48H_MBOVI...3,SET,176,-0.011487,-0.0011193,0.065063,0.57007,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.99999
HP_SOFT_TISSUE_SARCOMA,SET,124,-0.013725,-0.0011242,0.07771,0.5701,HP_SOFT_TISSUE_SARCOMA,0.99999
WP_INDUCTION_OF_AUTOPHAGY_AN...,SET,11,-0.043834,-0.0010727,0.24814,0.57011,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,0.99999
GOBP_REGULATION_OF_SOMITOGEN...,SET,6,-0.068788,-0.0012434,0.3894,0.57011,GOBP_REGULATION_OF_SOMITOGENESIS,0.99999
GOBP_REGULATION_OF_WNT_SIGNA...2,SET,15,-0.042697,-0.00122,0.2417,0.57011,GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,0.99999
LUI_THYROID_CANCER_CLUSTER_1,SET,47,-0.023184,-0.0011716,0.13119,0.57013,LUI_THYROID_CANCER_CLUSTER_1,0.99999
GSE24102_GRANULOCYSTIC_MDSC_...2,SET,183,-0.011106,-0.0011033,0.062802,0.57018,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP,0.99999
REACTOME_PREDNISONE_ADME,SET,9,-0.050142,-0.00111,0.28329,0.57024,REACTOME_PREDNISONE_ADME,0.99999
WP_NF1_COPY_NUMBER_VARIATION...,SET,74,-0.018482,-0.0011711,0.10443,0.57024,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,0.99999
PHESSE_TARGETS_OF_APC_AND_MB...1,SET,9,-0.05532,-0.0012246,0.31251,0.57025,PHESSE_TARGETS_OF_APC_AND_MBD2_DN,0.99999
GSE9650_EXHAUSTED_VS_MEMORY_...1,SET,187,-0.01092,-0.0010965,0.061669,0.57028,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN,0.99999
HP_MULTIPLE_GASTRIC_POLYPS,SET,7,-0.054356,-0.0010612,0.30667,0.57034,HP_MULTIPLE_GASTRIC_POLYPS,0.99999
KEGG_MEDICUS_REFERENCE_EP_NE...,SET,15,-0.039431,-0.0011267,0.22221,0.57042,KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY,0.99999
HP_PERITONITIS,SET,41,-0.023411,-0.0011051,0.13184,0.57047,HP_PERITONITIS,0.99999
chr5p13,SET,54,-0.040412,-0.0021886,0.2274,0.57053,chr5p13,0.99999
GSE19401_PAM2CSK4_VS_RETINOI...1,SET,178,-0.011123,-0.00109,0.062567,0.57055,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.99999
REACTOME_CD22_MEDIATED_BCR_R...,SET,4,-0.086108,-0.0012709,0.48431,0.57056,REACTOME_CD22_MEDIATED_BCR_REGULATION,0.99999
MORF_RFC1,SET,100,-0.014681,-0.0010806,0.082534,0.57059,MORF_RFC1,0.99999
GSE1925_CTRL_VS_IFNG_PRIMED_...5,SET,184,-0.011064,-0.0011021,0.062198,0.57059,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_DN,0.99999
HP_ABNORMAL_NEUTROPHIL_COUNT,SET,196,-0.01083,-0.001113,0.060876,0.5706,HP_ABNORMAL_NEUTROPHIL_COUNT,0.99999
HP_ABNORMAL_SPERM_AXONEME_MO...,SET,6,-0.065878,-0.0011908,0.37023,0.57061,HP_ABNORMAL_SPERM_AXONEME_MORPHOLOGY,0.99999
GSE21670_STAT3_KO_VS_WT_CD4_...5,SET,173,-0.010891,-0.0010522,0.061205,0.57061,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_UP,0.99999
GATA1_05,SET,260,-0.0099103,-0.001171,0.055691,0.57062,GATA1_05,0.99999
REACTOME_SUMOYLATION_OF_IMMU...,SET,10,-0.04862,-0.0011344,0.27307,0.57066,REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS,0.99999
HP_MIDLINE_DEFECT_OF_THE_NOSE,SET,15,-0.040268,-0.0011506,0.22611,0.57067,HP_MIDLINE_DEFECT_OF_THE_NOSE,0.99999
GOBP_VITAMIN_CATABOLIC_PROCE...,SET,15,-0.040682,-0.0011624,0.22833,0.5707,GOBP_VITAMIN_CATABOLIC_PROCESS,0.99999
MODULE_89,SET,2,-0.1223,-0.0012764,0.686,0.57074,MODULE_89,0.99999
MARTENS_BOUND_BY_PML_RARA_FU...,SET,410,-0.0075858,-0.0011209,0.042532,0.57078,MARTENS_BOUND_BY_PML_RARA_FUSION,0.99999
HP_FLARED_METAPHYSIS,SET,49,-0.020958,-0.0010813,0.11751,0.57078,HP_FLARED_METAPHYSIS,0.99999
HOWARD_NEUTROPHIL_INACT_MONO...3,SET,8,-0.053611,-0.0011189,0.30054,0.57079,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_DN,0.99999
HP_POLYMORPHIC_VENTRICULAR_T...,SET,6,-0.072627,-0.0013128,0.40699,0.57081,HP_POLYMORPHIC_VENTRICULAR_TACHYCARDIA,0.99999
KAECH_DAY15_EFF_VS_MEMORY_CD...2,SET,186,-0.011093,-0.0011109,0.062148,0.57083,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP,0.99999
GSE2770_UNTREATED_VS_TGFB_AN...11,SET,114,-0.013745,-0.0010798,0.076994,0.57084,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN,0.99999
MCCLUNG_CREB1_TARGETS_DN,SET,51,-0.022375,-0.0011777,0.12529,0.57087,MCCLUNG_CREB1_TARGETS_DN,0.99999
MONNIER_POSTRADIATION_TUMOR_...2,SET,374,-0.0075022,-0.0010599,0.042004,0.57088,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,0.99999
GSE33292_DN3_THYMOCYTE_VS_TC...4,SET,184,-0.011332,-0.0011288,0.063442,0.57088,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_UP,0.99999
GOBP_L_ASPARTATE_TRANSMEMBRA...,SET,11,-0.045398,-0.001111,0.25413,0.57089,GOBP_L_ASPARTATE_TRANSMEMBRANE_TRANSPORT,0.99999
FERRARI_RESPONSE_TO_FENRETIN...1,SET,5,-0.078957,-0.0013029,0.44177,0.57092,FERRARI_RESPONSE_TO_FENRETINIDE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...398,SET,11,-0.049045,-0.0012002,0.27443,0.57092,GOBP_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.99999
HP_AREFLEXIA_OF_LOWER_LIMBS,SET,76,-0.01671,-0.0010729,0.093492,0.57092,HP_AREFLEXIA_OF_LOWER_LIMBS,0.99999
HP_POOR_SUCK,SET,126,-0.014325,-0.0011827,0.080154,0.57092,HP_POOR_SUCK,0.99999
MIR490_3P,SET,40,-0.023801,-0.0011098,0.13308,0.57097,MIR490_3P,0.99999
FARMER_BREAST_CANCER_CLUSTER...6,SET,14,-0.048192,-0.0013303,0.26925,0.57102,FARMER_BREAST_CANCER_CLUSTER_6,0.99999
FERRANDO_T_ALL_WITH_MLL_ENL_...1,SET,78,-0.0167,-0.0010862,0.093262,0.57106,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,0.99999
HP_ABNORMAL_FEMALE_REPRODUCT...,SET,354,-0.0082323,-0.0011321,0.045915,0.57114,HP_ABNORMAL_FEMALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,0.99999
GOMF_IRON_ION_BINDING,SET,139,-0.013845,-0.0012002,0.077181,0.57118,GOMF_IRON_ION_BINDING,0.99999
GOBP_SMOOTH_MUSCLE_CELL_DIFF...,SET,59,-0.02108,-0.0011931,0.11739,0.57125,GOBP_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.99999
MODULE_470,SET,15,-0.045998,-0.0013143,0.25578,0.57136,MODULE_470,0.99999
HALLMARK_UV_RESPONSE_DN,SET,136,-0.014464,-0.0012403,0.080434,0.57136,HALLMARK_UV_RESPONSE_DN,0.99999
GSE35685_CD34POS_CD38NEG_VS_...2,SET,171,-0.011717,-0.0011256,0.065123,0.57139,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP,0.99999
IIZUKA_LIVER_CANCER_PROGRESS...2,SET,12,-0.047722,-0.0012197,0.2651,0.57143,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,0.99999
GSE16386_IL4_VS_IL4_AND_ROSI...2,SET,181,-0.010861,-0.0010731,0.060329,0.57144,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP,0.99999
PURWIN_A375_SOX10_TARGETS,SET,43,-0.02429,-0.0011742,0.13488,0.57146,PURWIN_A375_SOX10_TARGETS,0.99999
HP_SELF_BITING,SET,8,-0.056646,-0.0011822,0.31444,0.57148,HP_SELF_BITING,0.99999
HP_CHEILITIS,SET,48,-0.023973,-0.0012242,0.13306,0.57149,HP_CHEILITIS,0.99999
HP_LIMB_GIRDLE_MUSCULAR_DYST...,SET,13,-0.041159,-0.0010949,0.22843,0.57149,HP_LIMB_GIRDLE_MUSCULAR_DYSTROPHY,0.99999
HP_CONGENITAL_PTOSIS,SET,4,-0.079559,-0.0011742,0.44095,0.57159,HP_CONGENITAL_PTOSIS,0.99999
HP_ENDOCARDIAL_FIBROELASTOSIS,SET,7,-0.05933,-0.0011583,0.32859,0.57164,HP_ENDOCARDIAL_FIBROELASTOSIS,0.99999
GSE14908_ATOPIC_VS_NONATOPIC...4,SET,176,-0.011446,-0.0011154,0.063335,0.57171,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP,0.99999
GSE3982_DC_VS_BCELL_DN,SET,163,-0.011903,-0.0011166,0.065841,0.57173,GSE3982_DC_VS_BCELL_DN,0.99999
GOBP_NEUROTRANSMITTER_LOADIN...,SET,7,-0.065229,-0.0012735,0.3607,0.57175,GOBP_NEUROTRANSMITTER_LOADING_INTO_SYNAPTIC_VESICLE,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...11,SET,12,-0.046347,-0.0011846,0.25627,0.57176,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION,0.99999
MIR6529_5P,SET,42,-0.024087,-0.0011508,0.13316,0.57177,MIR6529_5P,0.99999
HP_ABNORMAL_SPERM_TAIL_MORPH...,SET,36,-0.024364,-0.0010779,0.1347,0.57177,HP_ABNORMAL_SPERM_TAIL_MORPHOLOGY,0.99999
GSE41867_DAY6_VS_DAY8_LCMV_A...2,SET,175,-0.011431,-0.0011107,0.063138,0.57183,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.99999
REACTOME_FGFR2_ALTERNATIVE_S...,SET,27,-0.027806,-0.0010656,0.15347,0.57188,REACTOME_FGFR2_ALTERNATIVE_SPLICING,0.99999
GSE32423_MEMORY_VS_NAIVE_CD8...4,SET,178,-0.012399,-0.001215,0.068422,0.5719,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP,0.99999
HP_CEREBRAL_ARTERIOVENOUS_MA...,SET,7,-0.058527,-0.0011426,0.32251,0.572,HP_CEREBRAL_ARTERIOVENOUS_MALFORMATION,0.99999
HTF_01,SET,65,-0.0183,-0.001087,0.10081,0.57202,HTF_01,0.99999
PLASARI_TGFB1_SIGNALING_VIA_...4,SET,27,-0.030822,-0.0011812,0.16968,0.57207,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP,0.99999
HP_WEIGHT_LOSS,SET,351,-0.0083596,-0.0011448,0.045949,0.57218,HP_WEIGHT_LOSS,0.99999
HP_HYDROCELE_TESTIS,SET,35,-0.026257,-0.0011454,0.14431,0.57219,HP_HYDROCELE_TESTIS,0.99999
GOBP_PRE_MIRNA_PROCESSING,SET,14,-0.041708,-0.0011514,0.22901,0.57225,GOBP_PRE_MIRNA_PROCESSING,0.99999
DOANE_BREAST_CANCER_ESR1_DN,SET,42,-0.026379,-0.0012603,0.14484,0.57226,DOANE_BREAST_CANCER_ESR1_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...130,SET,7,-0.055045,-0.0010747,0.30208,0.57229,GOBP_NEGATIVE_REGULATION_OF_CENTRIOLE_REPLICATION,0.99999
GSE21063_3H_VS_16H_ANTI_IGM_...3,SET,182,-0.011308,-0.0011203,0.062051,0.5723,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN,0.99999
HP_OPSOCLONUS,SET,14,-0.046884,-0.0012942,0.25711,0.57234,HP_OPSOCLONUS,0.99999
chr13q14,SET,81,-0.035019,-0.002321,0.19198,0.57237,chr13q14,0.99999
GOBP_MITOCHONDRIAL_ELECTRON_...2,SET,42,-0.020569,-0.00098274,0.11276,0.57237,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...244,SET,33,-0.026763,-0.0011337,0.14668,0.57239,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,0.99999
HP_PROXIMAL_AMYOTROPHY,SET,48,-0.022833,-0.001166,0.1251,0.57241,HP_PROXIMAL_AMYOTROPHY,0.99999
WP_EFFECT_OF_OMEGA3_PUFA_ON_...,SET,114,-0.015292,-0.0012013,0.083762,0.57243,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,0.99999
ZHENG_RESPONSE_TO_ARSENITE_UP,SET,14,-0.049692,-0.0013717,0.2718,0.57253,ZHENG_RESPONSE_TO_ARSENITE_UP,0.99999
GOBP_L_SERINE_BIOSYNTHETIC_P...,SET,6,-0.056938,-0.0010292,0.31141,0.57254,GOBP_L_SERINE_BIOSYNTHETIC_PROCESS,0.99999
HP_INCREASED_LAXITY_OF_ANKLES,SET,5,-0.080162,-0.0013228,0.43823,0.57257,HP_INCREASED_LAXITY_OF_ANKLES,0.99999
GOMF_2_IRON_2_SULFUR_CLUSTER...,SET,23,-0.028865,-0.0010211,0.15771,0.57261,GOMF_2_IRON_2_SULFUR_CLUSTER_BINDING,0.99999
GSE17721_CTRL_VS_LPS_12H_BMD...2,SET,173,-0.011489,-0.00111,0.062665,0.57273,GSE17721_CTRL_VS_LPS_12H_BMDC_UP,0.99999
GOBP_REGULATION_OF_CATECHOLA...2,SET,8,-0.056673,-0.0011828,0.30908,0.57274,GOBP_REGULATION_OF_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION,0.99999
GSE43863_TH1_VS_TFH_MEMORY_C...1,SET,181,-0.011755,-0.0011615,0.064094,0.57276,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN,0.99999
GSE21670_UNTREATED_VS_TGFB_T...1,SET,177,-0.011977,-0.0011704,0.06527,0.5728,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN,0.99999
HP_RENAL_FANCONI_SYNDROME,SET,10,-0.051264,-0.0011961,0.2793,0.57281,HP_RENAL_FANCONI_SYNDROME,0.99999
GOBP_NEGATIVE_REGULATION_OF_...48,SET,45,-0.024581,-0.0012155,0.13391,0.57282,GOBP_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE,0.99999
KEGG_MEDICUS_REFERENCE_IGF2_...,SET,11,-0.04825,-0.0011807,0.26273,0.57285,KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY,0.99999
GSE29614_CTRL_VS_DAY7_TIV_FL...2,SET,145,-0.013808,-0.0012224,0.075188,0.57286,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...7,SET,14,-0.042008,-0.0011596,0.2287,0.57287,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
REACTOME_RNA_POLYMERASE_II_T...1,SET,71,-0.016491,-0.0010236,0.089769,0.57288,REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,0.99999
GOBP_VACUOLE_ORGANIZATION,SET,212,-0.010499,-0.0011217,0.057147,0.57288,GOBP_VACUOLE_ORGANIZATION,0.99999
GSE27786_LIN_NEG_VS_BCELL_DN,SET,182,-0.011084,-0.0010982,0.06033,0.57289,GSE27786_LIN_NEG_VS_BCELL_DN,0.99999
GOBP_DELAMINATION,SET,7,-0.054055,-0.0010553,0.29374,0.573,GOBP_DELAMINATION,0.99999
MATSUMIYA_BLOOD_MODIFIED_VAC...2,SET,13,-0.042694,-0.0011357,0.23196,0.57302,MATSUMIYA_BLOOD_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_UP,0.99999
HP_CARPAL_SYNOSTOSIS,SET,33,-0.030706,-0.0013007,0.16678,0.57304,HP_CARPAL_SYNOSTOSIS,0.99999
GOBP_MODULATION_BY_HOST_OF_V...1,SET,21,-0.034583,-0.001169,0.18775,0.57307,GOBP_MODULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,0.99999
WP_CHOLESTEROL_BIOSYNTHESIS_...2,SET,106,-0.015244,-0.001155,0.082736,0.57309,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,0.99999
GOMF_SIGNALING_ADAPTOR_ACTIV...,SET,109,-0.015256,-0.0011721,0.082794,0.5731,GOMF_SIGNALING_ADAPTOR_ACTIVITY,0.99999
MORF_ESPL1,SET,54,-0.019449,-0.0010533,0.10553,0.57311,MORF_ESPL1,0.99999
GOBP_PURINE_NUCLEOSIDE_MONOP...1,SET,18,-0.037128,-0.001162,0.20141,0.57313,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
MIR4538,SET,25,-0.03328,-0.0012273,0.1805,0.57314,MIR4538,0.99999
HP_CARCINOMA,SET,6,-0.057781,-0.0010444,0.31334,0.57315,HP_CARCINOMA,0.99999
GOMF_INOSITOL_TETRAKISPHOSPH...2,SET,7,-0.058923,-0.0011504,0.31948,0.57316,GOMF_INOSITOL_TETRAKISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.99999
GOMF_MAP_KINASE_ACTIVITY,SET,16,-0.044096,-0.0013012,0.2391,0.57316,GOMF_MAP_KINASE_ACTIVITY,0.99999
GOBP_TRANSCRIPTION_ELONGATIO...2,SET,8,-0.052008,-0.0010854,0.28188,0.57319,GOBP_TRANSCRIPTION_ELONGATION_COUPLED_CHROMATIN_REMODELING,0.99999
GOMF_STEROL_BINDING,SET,65,-0.020701,-0.0012296,0.11217,0.57321,GOMF_STEROL_BINDING,0.99999
GOBP_REGULATION_OF_FOREBRAIN...,SET,5,-0.081531,-0.0013453,0.44172,0.57322,GOBP_REGULATION_OF_FOREBRAIN_NEURON_DIFFERENTIATION,0.99999
WP_CILIOPATHIES,SET,162,-0.011929,-0.0011157,0.064601,0.57325,WP_CILIOPATHIES,0.99999
GSE19923_WT_VS_HEB_AND_E2A_K...2,SET,182,-0.011357,-0.0011252,0.06147,0.57329,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,0.99999
SCHUETZ_BREAST_CANCER_DUCTAL...1,SET,78,-0.019316,-0.0012564,0.1045,0.57332,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,0.99999
GOBP_REGULATION_OF_MITOTIC_C...4,SET,16,-0.0371,-0.0010948,0.2007,0.57333,GOBP_REGULATION_OF_MITOTIC_CYTOKINESIS,0.99999
BIOCARTA_TID_PATHWAY,SET,19,-0.034692,-0.0011155,0.18761,0.57335,BIOCARTA_TID_PATHWAY,0.99999
HP_RECURRENT_SINOPULMONARY_I...,SET,58,-0.020724,-0.001163,0.11205,0.57336,HP_RECURRENT_SINOPULMONARY_INFECTIONS,0.99999
GSE29618_LAIV_VS_TIV_FLU_VAC...5,SET,173,-0.011749,-0.0011352,0.063525,0.57337,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN,0.99999
HOEK_NEUTROPHIL_2011_2012_TI...3,SET,7,-0.071998,-0.0014056,0.38907,0.5734,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_3DY_DN,0.99999
NRF1_Q6,SET,231,-0.0099801,-0.0011124,0.053928,0.57341,NRF1_Q6,0.99999
GOMF_FIBROBLAST_GROWTH_FACTO...3,SET,24,-0.03601,-0.0013011,0.19441,0.57347,GOMF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,0.99999
GOBP_PROTEIN_LIPID_COMPLEX_O...,SET,49,-0.023562,-0.0012157,0.1271,0.57353,GOBP_PROTEIN_LIPID_COMPLEX_ORGANIZATION,0.99999
KEGG_MEDICUS_REFERENCE_IGF_I...2,SET,15,-0.042394,-0.0012113,0.22863,0.57355,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY,0.99999
MODULE_324,SET,126,-0.015743,-0.0012997,0.084903,0.57355,MODULE_324,0.99999
GOBP_POSITIVE_REGULATION_OF_...765,SET,47,-0.022124,-0.001118,0.1193,0.57356,GOBP_POSITIVE_REGULATION_OF_TORC1_SIGNALING,0.99999
GOBP_REGULATION_OF_PEPTIDYL_...5,SET,39,-0.025964,-0.0011955,0.13998,0.57357,GOBP_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,0.99999
GOBP_MACROPHAGE_CYTOKINE_PRO...,SET,35,-0.027757,-0.0012108,0.14959,0.5736,GOBP_MACROPHAGE_CYTOKINE_PRODUCTION,0.99999
GOBP_SYNAPTIC_VESICLE_RECYCL...1,SET,74,-0.017893,-0.0011337,0.096427,0.5736,GOBP_SYNAPTIC_VESICLE_RECYCLING,0.99999
GOBP_AMINE_METABOLIC_PROCESS,SET,102,-0.016652,-0.0012378,0.089699,0.57364,GOBP_AMINE_METABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...472,SET,7,-0.052786,-0.0010306,0.28432,0.57364,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GSE30971_CTRL_VS_LPS_STIM_MA...2,SET,167,-0.013603,-0.0012915,0.073265,0.57365,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_UP,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...9,SET,185,-0.011616,-0.0011602,0.062496,0.57373,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN,0.99999
GOBP_REGULATION_OF_PHOSPHOLI...8,SET,6,-0.066955,-0.0012103,0.35976,0.57382,GOBP_REGULATION_OF_PHOSPHOLIPID_TRANSLOCATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...373,SET,12,-0.04386,-0.001121,0.23554,0.57386,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_MIGRATION,0.99999
GOBP_CEREBRAL_CORTEX_DEVELOP...,SET,112,-0.015779,-0.0012287,0.084676,0.57391,GOBP_CEREBRAL_CORTEX_DEVELOPMENT,0.99999
GOBP_CELL_JUNCTION_DISASSEMB...,SET,27,-0.035817,-0.0013726,0.19215,0.57394,GOBP_CELL_JUNCTION_DISASSEMBLY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...448,SET,11,-0.048999,-0.001199,0.26285,0.57394,GOBP_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,0.99999
HP_ABNORMAL_ARM_SPAN,SET,11,-0.04585,-0.001122,0.24597,0.57394,HP_ABNORMAL_ARM_SPAN,0.99999
GOMF_BH3_DOMAIN_BINDING,SET,5,-0.07645,-0.0012615,0.40997,0.57396,GOMF_BH3_DOMAIN_BINDING,0.99999
DESCARTES_FETAL_HEART_STROMA...,SET,25,-0.034821,-0.0012841,0.18671,0.57397,DESCARTES_FETAL_HEART_STROMAL_CELLS,0.99999
GOBP_SPONTANEOUS_SYNAPTIC_TR...,SET,13,-0.047771,-0.0012708,0.25561,0.57413,GOBP_SPONTANEOUS_SYNAPTIC_TRANSMISSION,0.99999
GOBP_SNRNA_METABOLIC_PROCESS,SET,50,-0.020855,-0.0010869,0.11146,0.57421,GOBP_SNRNA_METABOLIC_PROCESS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...9,SET,32,-0.028605,-0.0011933,0.15277,0.57426,HP_APLASIA_HYPOPLASIA_OF_THE_ABDOMINAL_WALL_MUSCULATURE,0.99999
GSE13229_IMM_VS_MATURE_NKCEL...1,SET,183,-0.011816,-0.0011738,0.06311,0.57426,GSE13229_IMM_VS_MATURE_NKCELL_DN,0.99999
CAFFAREL_RESPONSE_TO_THC_DN,SET,29,-0.027324,-0.0010852,0.14593,0.57427,CAFFAREL_RESPONSE_TO_THC_DN,0.99999
GSE27786_BCELL_VS_NKTCELL_UP,SET,180,-0.01143,-0.0011262,0.060898,0.57444,GSE27786_BCELL_VS_NKTCELL_UP,0.99999
MIR3651,SET,18,-0.036354,-0.0011378,0.19364,0.57446,MIR3651,0.99999
GOBP_NEPHRIC_DUCT_MORPHOGENE...,SET,10,-0.060432,-0.00141,0.32187,0.57446,GOBP_NEPHRIC_DUCT_MORPHOGENESIS,0.99999
DESCARTES_MAIN_FETAL_CLC_IL5...,SET,151,-0.012563,-0.0011347,0.066915,0.57446,DESCARTES_MAIN_FETAL_CLC_IL5RA_POSITIVE_CELLS,0.99999
GSE360_DC_VS_MAC_L_MAJOR_DN,SET,177,-0.011966,-0.0011693,0.063733,0.57447,GSE360_DC_VS_MAC_L_MAJOR_DN,0.99999
REACTOME_BILE_ACID_AND_BILE_...,SET,44,-0.025672,-0.0012553,0.1367,0.57448,REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,0.99999
HP_RETINAL_COLOBOMA,SET,37,-0.02668,-0.0011966,0.14205,0.57449,HP_RETINAL_COLOBOMA,0.99999
WP_GLUCOCORTICOID_RECEPTOR_P...,SET,68,-0.020754,-0.0012608,0.11048,0.5745,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,0.99999
WP_UROTENSINIIMEDIATED_SIGNA...,SET,66,-0.019948,-0.0011939,0.10616,0.57452,WP_UROTENSINIIMEDIATED_SIGNALING,0.99999
MIZUKAMI_HYPOXIA_DN,SET,6,-0.072985,-0.0013192,0.38838,0.57453,MIZUKAMI_HYPOXIA_DN,0.99999
DOANE_RESPONSE_TO_ANDROGEN_DN,SET,220,-0.011016,-0.0011987,0.058545,0.57462,DOANE_RESPONSE_TO_ANDROGEN_DN,0.99999
WP_ARYL_HYDROCARBON_RECEPTOR...1,SET,46,-0.02339,-0.0011694,0.12424,0.57466,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,0.99999
GOBP_POSITIVE_REGULATION_OF_...164,SET,8,-0.047024,-0.00098143,0.24979,0.57466,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_CONDENSATION,0.99999
GOCC_CONDENSIN_COMPLEX,SET,8,-0.047024,-0.00098143,0.24979,0.57466,GOCC_CONDENSIN_COMPLEX,0.99999
GSE13411_IGM_MEMORY_BCELL_VS...2,SET,178,-0.012347,-0.0012099,0.065588,0.57466,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP,0.99999
GOCC_CLATHRIN_COATED_ENDOCYT...2,SET,66,-0.021584,-0.0012918,0.11459,0.5747,GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE_MEMBRANE,0.99999
GSE28783_ANTI_MIR33_VS_CTRL_...1,SET,166,-0.01296,-0.0012268,0.068777,0.57473,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN,0.99999
HP_CONVEX_NASAL_RIDGE,SET,82,-0.016569,-0.0011049,0.087815,0.57483,HP_CONVEX_NASAL_RIDGE,0.99999
GNF2_IL2RB,SET,41,-0.02727,-0.0012873,0.14433,0.57493,GNF2_IL2RB,0.99999
HP_ABNORMAL_PROTEIN_GLYCOSYL...,SET,39,-0.024044,-0.001107,0.12726,0.57493,HP_ABNORMAL_PROTEIN_GLYCOSYLATION,0.99999
MIR647,SET,75,-0.018313,-0.0011681,0.096911,0.57494,MIR647,0.99999
GSE10325_CD4_TCELL_VS_LUPUS_...1,SET,178,-0.012854,-0.0012596,0.067955,0.57501,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN,0.99999
BAHD1_TARGET_GENES,SET,18,-0.037273,-0.0011666,0.19696,0.57505,BAHD1_TARGET_GENES,0.99999
HEDENFALK_BREAST_CANCER_BRAC...1,SET,18,-0.035384,-0.0011074,0.18678,0.57513,HEDENFALK_BREAST_CANCER_BRACX_DN,0.99999
GOBP_PARATHYROID_GLAND_DEVEL...,SET,7,-0.058398,-0.0011401,0.30817,0.57515,GOBP_PARATHYROID_GLAND_DEVELOPMENT,0.99999
HP_VAGINAL_ATRESIA,SET,18,-0.043324,-0.0013559,0.22859,0.57516,HP_VAGINAL_ATRESIA,0.99999
GSE557_WT_VS_I_AB_KO_DC_UP,SET,178,-0.011644,-0.001141,0.061418,0.57518,GSE557_WT_VS_I_AB_KO_DC_UP,0.99999
GOBP_FATTY_ACYL_COA_BIOSYNTH...,SET,25,-0.034101,-0.0012576,0.17985,0.57519,GOBP_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMAL_PULMONARY_VALVE_...3,SET,137,-0.014515,-0.0012493,0.076551,0.57519,HP_ABNORMAL_PULMONARY_VALVE_PHYSIOLOGY,0.99999
HP_ABNORMAL_RIGHT_VENTRICULA...,SET,19,-0.038871,-0.0012499,0.20486,0.57524,HP_ABNORMAL_RIGHT_VENTRICULAR_FUNCTION,0.99999
BIOCARTA_TCR_PATHWAY,SET,43,-0.024428,-0.0011809,0.12873,0.57525,BIOCARTA_TCR_PATHWAY,0.99999
MODULE_35,SET,4,-0.072517,-0.0010703,0.38207,0.57527,MODULE_35,0.99999
KANG_DOXORUBICIN_RESISTANCE_...1,SET,16,-0.042461,-0.001253,0.22358,0.57531,KANG_DOXORUBICIN_RESISTANCE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...155,SET,15,-0.042889,-0.0012255,0.22581,0.57532,GOBP_NEGATIVE_REGULATION_OF_CYCLASE_ACTIVITY,0.99999
HP_OLIGOARTHRITIS,SET,12,-0.049918,-0.0012758,0.26275,0.57534,HP_OLIGOARTHRITIS,0.99999
PID_ILK_PATHWAY,SET,44,-0.024414,-0.0011938,0.12849,0.57535,PID_ILK_PATHWAY,0.99999
GOMF_HISTONE_H3_METHYLTRANSF...,SET,40,-0.025306,-0.00118,0.13311,0.57539,GOMF_HISTONE_H3_METHYLTRANSFERASE_ACTIVITY,0.99999
ZNF33A_TARGET_GENES,SET,175,-0.011987,-0.0011648,0.063041,0.5754,ZNF33A_TARGET_GENES,0.99999
MIR4521,SET,67,-0.020745,-0.001251,0.10909,0.57541,MIR4521,0.99999
GOBP_LATERAL_SPROUTING_FROM_...,SET,9,-0.06345,-0.0014045,0.33331,0.57549,GOBP_LATERAL_SPROUTING_FROM_AN_EPITHELIUM,0.99999
GOBP_4FE_4S_CLUSTER_ASSEMBLY,SET,4,-0.10255,-0.0015135,0.53819,0.57556,GOBP_4FE_4S_CLUSTER_ASSEMBLY,0.99999
HP_METAPHYSEAL_CHONDRODYSPLA...,SET,10,-0.055189,-0.0012877,0.28961,0.57556,HP_METAPHYSEAL_CHONDRODYSPLASIA,0.99999
MODULE_49,SET,249,-0.010369,-0.0011994,0.054412,0.57557,MODULE_49,0.99999
GOBP_PHOSPHORYLATION,SET,1255,-0.0048437,-0.0012224,0.025412,0.57558,GOBP_PHOSPHORYLATION,0.99999
HP_NASAL_REGURGITATION,SET,13,-0.046427,-0.001235,0.24353,0.5756,HP_NASAL_REGURGITATION,0.99999
GOMF_HMG_BOX_DOMAIN_BINDING,SET,12,-0.045016,-0.0011505,0.23604,0.57562,GOMF_HMG_BOX_DOMAIN_BINDING,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...16,SET,228,-0.010492,-0.001162,0.054979,0.57567,GAUTAM_EYE_IRIS_CILIARY_BODY_SMOOTH_MUSCLE_CELLS,0.99999
HP_MUTISM,SET,46,-0.023252,-0.0011625,0.12183,0.57568,HP_MUTISM,0.99999
SNACANNNYSYAGA_UNKNOWN,SET,79,-0.017703,-0.0011588,0.092741,0.57569,SNACANNNYSYAGA_UNKNOWN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...583,SET,152,-0.013977,-0.0012666,0.073082,0.57584,GOBP_NEGATIVE_REGULATION_OF_SECRETION,0.99999
HP_VASCULAR_CALCIFICATION,SET,31,-0.031029,-0.001274,0.16223,0.57584,HP_VASCULAR_CALCIFICATION,0.99999
HP_FLARING_OF_RIB_CAGE,SET,7,-0.068946,-0.0013461,0.36023,0.57589,HP_FLARING_OF_RIB_CAGE,0.99999
HUMMERICH_SKIN_CANCER_PROGRE...1,SET,89,-0.017472,-0.0012136,0.091202,0.57596,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,0.99999
GSE4984_LPS_VS_VEHICLE_CTRL_...2,SET,168,-0.012415,-0.0011822,0.064807,0.57596,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_UP,0.99999
HP_SPINA_BIFIDA_OCCULTA,SET,68,-0.020476,-0.0012439,0.10681,0.57601,HP_SPINA_BIFIDA_OCCULTA,0.99999
GSE37416_CTRL_VS_0H_F_TULARE...2,SET,147,-0.013156,-0.0011725,0.06863,0.57601,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
HP_ERYTHROID_HYPERPLASIA,SET,14,-0.039861,-0.0011004,0.20791,0.57602,HP_ERYTHROID_HYPERPLASIA,0.99999
YAMAZAKI_TCEB3_TARGETS_DN,SET,179,-0.012475,-0.0012258,0.065046,0.57604,YAMAZAKI_TCEB3_TARGETS_DN,0.99999
GOBP_REGULATION_OF_NK_T_CELL...1,SET,11,-0.057525,-0.0014077,0.29995,0.57604,GOBP_REGULATION_OF_NK_T_CELL_ACTIVATION,0.99999
HP_GENERALIZED_MUSCLE_WEAKNE...,SET,120,-0.014816,-0.001194,0.077244,0.57605,HP_GENERALIZED_MUSCLE_WEAKNESS,0.99999
CCTNTMAGA_UNKNOWN,SET,120,-0.015466,-0.0012463,0.080563,0.57612,CCTNTMAGA_UNKNOWN,0.99999
GOCC_NLRP3_INFLAMMASOME_COMP...,SET,6,-0.067806,-0.0012256,0.35314,0.57613,GOCC_NLRP3_INFLAMMASOME_COMPLEX,0.99999
MIR6847_3P,SET,55,-0.021265,-0.0011622,0.11073,0.57615,MIR6847_3P,0.99999
HP_MITRAL_STENOSIS,SET,21,-0.038316,-0.0012952,0.19951,0.57615,HP_MITRAL_STENOSIS,0.99999
REACTOME_BLOOD_GROUP_SYSTEMS...,SET,21,-0.038644,-0.0013063,0.20117,0.57617,REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS,0.99999
GOCC_NMDA_SELECTIVE_GLUTAMAT...,SET,9,-0.05816,-0.0012874,0.30274,0.57617,GOCC_NMDA_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX,0.99999
GOBP_NEGATIVE_REGULATION_OF_...331,SET,21,-0.038476,-0.0013006,0.20023,0.57619,GOBP_NEGATIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION,0.99999
LI_ESTROGENE_NON_MCF7_T47D_E...1,SET,6,-0.074076,-0.001339,0.38543,0.5762,LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_DN,0.99999
GSE35543_IN_VIVO_NTREG_VS_IN...1,SET,144,-0.014127,-0.0012462,0.073507,0.5762,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_DN,0.99999
GOMF_THYROID_HORMONE_BINDING,SET,6,-0.074973,-0.0013552,0.38995,0.57623,GOMF_THYROID_HORMONE_BINDING,0.99999
HP_ABNORMAL_B_CELL_SUBSET_DI...,SET,26,-0.033993,-0.0012784,0.17674,0.57626,HP_ABNORMAL_B_CELL_SUBSET_DISTRIBUTION,0.99999
CALVET_IRINOTECAN_SENSITIVE_...3,SET,5,-0.078013,-0.0012873,0.40554,0.57627,CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP,0.99999
GOBP_REGULATION_OF_SREBP_SIG...,SET,6,-0.065426,-0.0011826,0.34013,0.57627,GOBP_REGULATION_OF_SREBP_SIGNALING_PATHWAY,0.99999
GTTATAT_MIR410,SET,80,-0.018632,-0.0012273,0.096846,0.57628,GTTATAT_MIR410,0.99999
KEGG_VEGF_SIGNALING_PATHWAY,SET,76,-0.019279,-0.0012379,0.10016,0.57632,KEGG_VEGF_SIGNALING_PATHWAY,0.99999
ZHENG_CORD_BLOOD_C7_PUTATIVE...,SET,81,-0.01874,-0.001242,0.097267,0.57639,ZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1,0.99999
MIR4426,SET,133,-0.014344,-0.0012164,0.074436,0.5764,MIR4426,0.99999
GSE21546_WT_VS_SAP1A_KO_DP_T...2,SET,176,-0.012859,-0.0012531,0.066737,0.5764,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP,0.99999
MIR424_3P,SET,34,-0.027268,-0.0011724,0.14141,0.57645,MIR424_3P,0.99999
TCTGGAC_MIR198,SET,78,-0.018923,-0.0012308,0.09805,0.57652,TCTGGAC_MIR198,0.99999
GOBP_REGULATION_OF_EPITHELIA...6,SET,7,-0.071588,-0.0013976,0.37093,0.57652,GOBP_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,0.99999
IVANOVSKA_MIR106B_TARGETS,SET,82,-0.017159,-0.0011442,0.088895,0.57653,IVANOVSKA_MIR106B_TARGETS,0.99999
HP_ABNORMAL_BRONCHUS_MORPHOL...,SET,186,-0.012082,-0.00121,0.062588,0.57654,HP_ABNORMAL_BRONCHUS_MORPHOLOGY,0.99999
GOMF_LIPID_PHOSPHATASE_ACTIV...,SET,7,-0.064611,-0.0012614,0.33463,0.57655,GOMF_LIPID_PHOSPHATASE_ACTIVITY,0.99999
HP_ABNORMALITY_OF_FLUID_REGU...,SET,705,-0.0065052,-0.0012501,0.033684,0.57657,HP_ABNORMALITY_OF_FLUID_REGULATION,0.99999
HANN_RESISTANCE_TO_BCL2_INHI...2,SET,30,-0.03346,-0.0013515,0.17323,0.57658,HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP,0.99999
GOMF_MRNA_3_UTR_BINDING,SET,98,-0.015815,-0.0011524,0.081854,0.5766,GOMF_MRNA_3_UTR_BINDING,0.99999
MODULE_355,SET,29,-0.027601,-0.0010962,0.1428,0.57663,MODULE_355,0.99999
CDPCR3HD_01,SET,213,-0.012003,-0.0012854,0.062061,0.57668,CDPCR3HD_01,0.99999
REACTOME_MITOCHONDRIAL_TRANS...,SET,90,-0.016164,-0.001129,0.083551,0.5767,REACTOME_MITOCHONDRIAL_TRANSLATION,0.99999
MIR4715_3P,SET,67,-0.020851,-0.0012574,0.10775,0.57672,MIR4715_3P,0.99999
GSE22103_UNSTIM_VS_LPS_STIM_...2,SET,188,-0.011773,-0.0011853,0.060819,0.57674,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP,0.99999
GOBP_REGULATION_OF_HAIR_CYCLE,SET,28,-0.032798,-0.0012799,0.16935,0.57678,GOBP_REGULATION_OF_HAIR_CYCLE,0.99999
REACTOME_TP53_REGULATES_TRAN...8,SET,14,-0.045152,-0.0012464,0.23311,0.57679,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST,0.99999
HP_SEVERE_DEMYELINATION_OF_T...,SET,6,-0.068923,-0.0012458,0.35574,0.57681,HP_SEVERE_DEMYELINATION_OF_THE_WHITE_MATTER,0.99999
GSE22886_NAIVE_BCELL_VS_MONO...1,SET,188,-0.012296,-0.001238,0.063422,0.57686,GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN,0.99999
HP_DELAYED_PUBERTY,SET,177,-0.012376,-0.0012094,0.063827,0.57687,HP_DELAYED_PUBERTY,0.99999
KEGG_ONE_CARBON_POOL_BY_FOLA...,SET,17,-0.034441,-0.0010476,0.17761,0.57688,KEGG_ONE_CARBON_POOL_BY_FOLATE,0.99999
WP_DRAVET_SYNDROME,SET,26,-0.036178,-0.0013605,0.18643,0.57693,WP_DRAVET_SYNDROME,0.99999
KEGG_MEDICUS_REFERENCE_CRHR_...,SET,27,-0.031882,-0.0012218,0.16428,0.57694,KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.99999
GSE46606_IRF4HIGH_VS_IRF4MID...2,SET,185,-0.011914,-0.00119,0.061385,0.57694,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.99999
ZBTB18_TARGET_GENES,SET,670,-0.0064988,-0.0012187,0.033475,0.57697,ZBTB18_TARGET_GENES,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_T_A...,SET,66,-0.021393,-0.0012804,0.11016,0.57699,HE_LIM_SUN_FETAL_LUNG_C4_T_ALPHA_BETA_ENTRY_CELL,0.99999
GOBP_UTP_BIOSYNTHETIC_PROCESS,SET,9,-0.05836,-0.0012919,0.30043,0.57701,GOBP_UTP_BIOSYNTHETIC_PROCESS,0.99999
GOCC_SODIUM_CHANNEL_COMPLEX,SET,24,-0.038232,-0.0013815,0.19675,0.57704,GOCC_SODIUM_CHANNEL_COMPLEX,0.99999
GOMF_NERVE_GROWTH_FACTOR_REC...,SET,4,-0.10096,-0.0014901,0.51939,0.57706,GOMF_NERVE_GROWTH_FACTOR_RECEPTOR_BINDING,0.99999
HP_CONVULSIVE_STATUS_EPILEPT...,SET,6,-0.062256,-0.0011253,0.32023,0.57707,HP_CONVULSIVE_STATUS_EPILEPTICUS,0.99999
GSE40068_CXCR5POS_BCL6POS_TF...1,SET,183,-0.01303,-0.0012944,0.066933,0.57717,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN,0.99999
AIZARANI_LIVER_C22_RESIDENT_...,SET,26,-0.03198,-0.0012027,0.16424,0.57719,AIZARANI_LIVER_C22_RESIDENT_B_CELLS_2,0.99999
HP_MESANGIAL_HYPERCELLULARITY,SET,5,-0.070204,-0.0011584,0.36019,0.57727,HP_MESANGIAL_HYPERCELLULARITY,0.99999
GSE15324_NAIVE_VS_ACTIVATED_...4,SET,183,-0.011825,-0.0011748,0.060551,0.57742,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP,0.99999
REACTOME_DIGESTION_OF_DIETAR...1,SET,7,-0.064994,-0.0012689,0.3326,0.57746,REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE,0.99999
GOBP_VESICLE_CARGO_LOADING,SET,31,-0.028424,-0.001167,0.14538,0.5775,GOBP_VESICLE_CARGO_LOADING,0.99999
SCHLOSSER_SERUM_RESPONSE_DN,SET,635,-0.0066506,-0.0012153,0.034009,0.57752,SCHLOSSER_SERUM_RESPONSE_DN,0.99999
GOMF_PRE_MRNA_BINDING,SET,36,-0.025363,-0.001122,0.12964,0.57755,GOMF_PRE_MRNA_BINDING,0.99999
GOBP_ENDOTHELIAL_CELL_PROLIF...,SET,146,-0.014761,-0.0013111,0.07537,0.57763,GOBP_ENDOTHELIAL_CELL_PROLIFERATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...385,SET,12,-0.049049,-0.0012536,0.25042,0.57764,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_POTENTIAL,0.99999
GOBP_SOMATIC_DIVERSIFICATION...2,SET,13,-0.039041,-0.0010385,0.19933,0.57764,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS_VIA_SOMATIC_MUTATION,0.99999
GOBP_REGULATION_OF_CHROMATIN...1,SET,10,-0.048973,-0.0011427,0.24987,0.57769,GOBP_REGULATION_OF_CHROMATIN_BINDING,0.99999
GSE20152_HTNFA_OVERXPRESS_AN...1,SET,173,-0.012383,-0.0011964,0.063147,0.57773,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_DN,0.99999
GSE11057_NAIVE_CD4_VS_PBMC_C...1,SET,186,-0.012274,-0.0012292,0.062541,0.57779,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN,0.99999
GRAHAM_NORMAL_QUIESCENT_VS_N...2,SET,54,-0.024642,-0.0013345,0.12546,0.57786,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,0.99999
HP_ABNORMALITY_OF_THE_ENDOCR...,SET,1248,-0.004869,-0.0012256,0.024787,0.57786,HP_ABNORMALITY_OF_THE_ENDOCRINE_SYSTEM,0.99999
HP_SYMPHALANGISM_AFFECTING_T...,SET,16,-0.041177,-0.0012151,0.20961,0.57787,HP_SYMPHALANGISM_AFFECTING_THE_PHALANGES_OF_THE_HAND,0.99999
GOBP_CELLULAR_RESPONSE_TO_LE...2,SET,17,-0.04273,-0.0012997,0.21745,0.57789,GOBP_CELLULAR_RESPONSE_TO_LEPTIN_STIMULUS,0.99999
GOBP_MESENCHYMAL_STEM_CELL_P...,SET,7,-0.068408,-0.0013355,0.34803,0.57791,GOBP_MESENCHYMAL_STEM_CELL_PROLIFERATION,0.99999
GOBP_REGULATION_OF_ELECTRON_...,SET,3,-0.093059,-0.0011895,0.47332,0.57793,GOBP_REGULATION_OF_ELECTRON_TRANSFER_ACTIVITY,0.99999
WP_FATTY_ACID_TRANSPORTERS,SET,17,-0.042349,-0.0012881,0.21539,0.57794,WP_FATTY_ACID_TRANSPORTERS,0.99999
GSE46606_IRF4HIGH_VS_WT_CD40...3,SET,183,-0.012471,-0.0012389,0.063394,0.57797,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.99999
GOBP_MIDBODY_ABSCISSION,SET,17,-0.041231,-0.0012541,0.20934,0.57807,GOBP_MIDBODY_ABSCISSION,0.99999
BIOCARTA_NFKB_PATHWAY,SET,20,-0.039266,-0.0012953,0.19912,0.57816,BIOCARTA_NFKB_PATHWAY,0.99999
HP_DELAYED_FINE_MOTOR_DEVELO...,SET,45,-0.025128,-0.0012425,0.12741,0.57817,HP_DELAYED_FINE_MOTOR_DEVELOPMENT,0.99999
MODULE_184,SET,28,-0.029913,-0.0011673,0.15164,0.57819,MODULE_184,0.99999
WP_ENDOTHELIN_PATHWAYS,SET,31,-0.032785,-0.0013461,0.16617,0.5782,WP_ENDOTHELIN_PATHWAYS,0.99999
KEGG_THYROID_CANCER,SET,29,-0.030883,-0.0012265,0.15641,0.57826,KEGG_THYROID_CANCER,0.99999
HP_LUMBAR_KYPHOSIS,SET,6,-0.06846,-0.0012375,0.34668,0.57827,HP_LUMBAR_KYPHOSIS,0.99999
GSE25123_CTRL_VS_ROSIGLITAZO...1,SET,178,-0.012761,-0.0012505,0.064621,0.57827,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.99999
ALCALAY_AML_BY_NPM1_LOCALIZA...1,SET,168,-0.013276,-0.0012642,0.067187,0.57832,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,0.99999
FOURATI_BLOOD_TWINRIX_AGE_65...2,SET,5,-0.078289,-0.0012919,0.39564,0.57843,FOURATI_BLOOD_TWINRIX_AGE_65_81YO_RESPONDERS_VS_POOR_RESPONDERS_TRAINING_SET_0DY_NETWORK_INFERENCE_DN,0.99999
BIOCARTA_ATRBRCA_PATHWAY,SET,21,-0.030604,-0.0010345,0.15462,0.57845,BIOCARTA_ATRBRCA_PATHWAY,0.99999
HP_INCREASED_CIRCULATING_THY...,SET,8,-0.067746,-0.0014139,0.34217,0.57847,HP_INCREASED_CIRCULATING_THYROGLOBULIN_CONCENTRATION,0.99999
MIR3912_3P,SET,5,-0.070939,-0.0011706,0.3582,0.57849,MIR3912_3P,0.99999
HP_ASYMMETRY_OF_THE_EARS,SET,4,-0.075247,-0.0011106,0.37976,0.57853,HP_ASYMMETRY_OF_THE_EARS,0.99999
GOBP_PHOSPHATIDYLINOSITOL_ME...2,SET,147,-0.013319,-0.0011871,0.067214,0.57854,GOBP_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS,0.99999
GOMF_ENDONUCLEASE_ACTIVITY,SET,111,-0.015571,-0.0012071,0.078528,0.57859,GOMF_ENDONUCLEASE_ACTIVITY,0.99999
GSE25123_WT_VS_PPARG_KO_MACR...4,SET,182,-0.013122,-0.0013,0.066169,0.5786,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN,0.99999
MIR874_5P,SET,55,-0.02175,-0.0011887,0.10958,0.57867,MIR874_5P,0.99999
GOBP_MAST_CELL_MIGRATION,SET,14,-0.048876,-0.0013492,0.2462,0.57868,GOBP_MAST_CELL_MIGRATION,0.99999
HP_CLONIC_SEIZURE,SET,72,-0.020203,-0.0012628,0.1017,0.57873,HP_CLONIC_SEIZURE,0.99999
GOBP_CELL_PROLIFERATION_IN_F...,SET,25,-0.035057,-0.0012928,0.17645,0.57874,GOBP_CELL_PROLIFERATION_IN_FOREBRAIN,0.99999
HP_CEREBRAL_INCLUSION_BODIES,SET,43,-0.026248,-0.0012688,0.13201,0.5788,HP_CEREBRAL_INCLUSION_BODIES,0.99999
HP_SPLENIC_RUPTURE,SET,4,-0.11345,-0.0016745,0.57024,0.57885,HP_SPLENIC_RUPTURE,0.99999
HP_VASCULAR_GRANULAR_OSMIOPH...,SET,12,-0.048995,-0.0012522,0.24627,0.57885,HP_VASCULAR_GRANULAR_OSMIOPHILIC_MATERIAL_DEPOSITION,0.99999
HP_PATELLAR_APLASIA,SET,20,-0.037471,-0.0012361,0.18827,0.57888,HP_PATELLAR_APLASIA,0.99999
GNF2_CARD15,SET,62,-0.022569,-0.0013094,0.11337,0.5789,GNF2_CARD15,0.99999
GSE360_HIGH_VS_LOW_DOSE_B_MA...1,SET,178,-0.012746,-0.001249,0.064013,0.57891,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN,0.99999
BERENJENO_TRANSFORMED_BY_RHO...2,SET,27,-0.033282,-0.0012754,0.16711,0.57893,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,0.99999
GOMF_UDP_GLUCOSYLTRANSFERASE...,SET,8,-0.050353,-0.0010509,0.25276,0.57895,GOMF_UDP_GLUCOSYLTRANSFERASE_ACTIVITY,0.99999
ZNF85_TARGET_GENES,SET,252,-0.010565,-0.0012293,0.053007,0.57899,ZNF85_TARGET_GENES,0.99999
WP_FATTY_ACID_BIOSYNTHESIS,SET,21,-0.036487,-0.0012333,0.18303,0.579,WP_FATTY_ACID_BIOSYNTHESIS,0.99999
GSE15330_HSC_VS_PRO_BCELL_DN,SET,177,-0.012088,-0.0011812,0.060633,0.57901,GSE15330_HSC_VS_PRO_BCELL_DN,0.99999
HP_SLOW_SACCADIC_EYE_MOVEMEN...,SET,34,-0.027109,-0.0011656,0.13592,0.57904,HP_SLOW_SACCADIC_EYE_MOVEMENTS,0.99999
HP_LOW_MOLECULAR_WEIGHT_PROT...,SET,5,-0.080882,-0.0013346,0.40536,0.57908,HP_LOW_MOLECULAR_WEIGHT_PROTEINURIA,0.99999
CAFFAREL_RESPONSE_TO_THC_8HR...4,SET,13,-0.044567,-0.0011856,0.22328,0.5791,CAFFAREL_RESPONSE_TO_THC_8HR_5_UP,0.99999
HP_HYPERMETROPIA,SET,240,-0.011174,-0.0012692,0.055976,0.57911,HP_HYPERMETROPIA,0.99999
RICHERT_PBMC_HIV_LIPO_5_AGE_...1,SET,8,-0.094881,-0.0019802,0.47505,0.57915,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_0W_14W_METALLOTHIONEIN_SUBSET_UP,0.99999
MIR194_5P,SET,179,-0.012908,-0.0012684,0.064571,0.57922,MIR194_5P,0.99999
MYB_Q6,SET,228,-0.011297,-0.0012511,0.056486,0.57925,MYB_Q6,0.99999
GOBP_RECEPTOR_CLUSTERING,SET,54,-0.023586,-0.0012773,0.11794,0.57925,GOBP_RECEPTOR_CLUSTERING,0.99999
GSE30971_2H_VS_4H_LPS_STIM_M...4,SET,184,-0.012536,-0.0012487,0.062675,0.57926,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_UP,0.99999
GOBP_HEART_GROWTH,SET,76,-0.021508,-0.001381,0.10751,0.57928,GOBP_HEART_GROWTH,0.99999
MIR654_5P,SET,95,-0.017453,-0.0012522,0.087205,0.57931,MIR654_5P,0.99999
GOCC_MKS_COMPLEX,SET,13,-0.041596,-0.0011065,0.20751,0.57943,GOCC_MKS_COMPLEX,0.99999
HP_INTELLECTUAL_DISABILITY_B...,SET,24,-0.036576,-0.0013216,0.18249,0.57943,HP_INTELLECTUAL_DISABILITY_BORDERLINE,0.99999
IWANAGA_CARCINOGENESIS_BY_KR...2,SET,333,-0.0095981,-0.0012809,0.047858,0.57948,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,0.99999
HP_SOMNAMBULISM,SET,7,-0.066236,-0.0012932,0.33006,0.57952,HP_SOMNAMBULISM,0.99999
HP_PUNCTATE_OPACIFICATION_OF...,SET,5,-0.078025,-0.0012875,0.38871,0.57954,HP_PUNCTATE_OPACIFICATION_OF_THE_CORNEA,0.99999
GOMF_MRNA_REGULATORY_ELEMENT...,SET,15,-0.037719,-0.0010777,0.18785,0.57957,GOMF_MRNA_REGULATORY_ELEMENT_BINDING_TRANSLATION_REPRESSOR_ACTIVITY,0.99999
MIR5092,SET,6,-0.065272,-0.0011798,0.32496,0.5796,MIR5092,0.99999
GOBP_NEGATIVE_REGULATION_OF_...180,SET,796,-0.0064622,-0.0013161,0.032168,0.5796,GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS,0.99999
GOBP_SPERM_MOTILITY,SET,122,-0.015002,-0.0012189,0.074675,0.57961,GOBP_SPERM_MOTILITY,0.99999
SENESE_HDAC1_TARGETS_UP,SET,398,-0.0086506,-0.0012598,0.043052,0.57962,SENESE_HDAC1_TARGETS_UP,0.99999
KEGG_GLYOXYLATE_AND_DICARBOX...,SET,16,-0.037524,-0.0011073,0.18664,0.57967,KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM,0.99999
GOBP_VASCULAR_ENDOTHELIAL_CE...,SET,25,-0.03608,-0.0013305,0.17942,0.57968,GOBP_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,0.99999
GSE22229_RENAL_TRANSPLANT_VS...2,SET,183,-0.012565,-0.0012482,0.062462,0.57971,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP,0.99999
HP_URETEROCELE,SET,25,-0.036681,-0.0013527,0.18228,0.57974,HP_URETEROCELE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...56,SET,14,-0.045935,-0.001268,0.22819,0.57977,GOBP_NEGATIVE_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS,0.99999
GOBP_SUBSTRATE_ADHESION_DEPE...,SET,97,-0.017921,-0.0012992,0.088974,0.57981,GOBP_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...1,SET,174,-0.013448,-0.001303,0.066754,0.57982,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN,0.99999
MIR541_3P,SET,94,-0.017657,-0.0012603,0.087612,0.57986,MIR541_3P,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MID...1,SET,57,-0.024966,-0.001389,0.12383,0.57989,HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_1_CELL,0.99999
GOBP_CARBON_CATABOLITE_REGUL...,SET,7,-0.058732,-0.0011466,0.29123,0.57991,GOBP_CARBON_CATABOLITE_REGULATION_OF_TRANSCRIPTION,0.99999
BIOCARTA_FAS_PATHWAY,SET,30,-0.030508,-0.0012323,0.15126,0.57992,BIOCARTA_FAS_PATHWAY,0.99999
HP_ARTERIAL_STENOSIS,SET,94,-0.018745,-0.0013379,0.092905,0.57995,HP_ARTERIAL_STENOSIS,0.99999
PID_P53_DOWNSTREAM_PATHWAY,SET,134,-0.014507,-0.0012348,0.071878,0.57997,PID_P53_DOWNSTREAM_PATHWAY,0.99999
HEIDENBLAD_AMPLICON_12P11_12...2,SET,33,-0.030921,-0.0013098,0.15308,0.58004,HEIDENBLAD_AMPLICON_12P11_12_UP,0.99999
GIAROLA_SILVA_BLOOD_INFLUENZ...,SET,4,-0.092482,-0.001365,0.45771,0.58006,GIAROLA_SILVA_BLOOD_INFLUENZA_A_AGE_21_51YO_3DY_UP,0.99999
MULLIGHAN_MLL_SIGNATURE_2_UP,SET,388,-0.00858,-0.0012341,0.042453,0.58008,MULLIGHAN_MLL_SIGNATURE_2_UP,0.99999
HP_MILD_MYOPIA,SET,4,-0.10669,-0.0015747,0.5278,0.5801,HP_MILD_MYOPIA,0.99999
GSE39820_CTRL_VS_TGFBETA1_IL...2,SET,181,-0.01328,-0.0013121,0.065694,0.5801,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP,0.99999
HP_HEPATITIS,SET,82,-0.020109,-0.001341,0.099442,0.58013,HP_HEPATITIS,0.99999
REACTOME_ACTIVATION_OF_THE_A...,SET,10,-0.058489,-0.0013647,0.28889,0.58022,REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS,0.99999
REACTOME_P2Y_RECEPTORS,SET,9,-0.060023,-0.0013287,0.29648,0.58022,REACTOME_P2Y_RECEPTORS,0.99999
GOMF_DYNEIN_COMPLEX_BINDING,SET,19,-0.038107,-0.0012253,0.18803,0.5803,GOMF_DYNEIN_COMPLEX_BINDING,0.99999
REACTOME_NA_CL_DEPENDENT_NEU...,SET,18,-0.048955,-0.0015322,0.24137,0.58036,REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS,0.99999
HP_PULMONARY_FIBROSIS,SET,68,-0.02095,-0.0012727,0.10324,0.5804,HP_PULMONARY_FIBROSIS,0.99999
REACTOME_CELLULAR_RESPONSE_T...3,SET,70,-0.018794,-0.0011583,0.092606,0.58041,REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,0.99999
GOMF_MICROTUBULE_BINDING,SET,255,-0.010881,-0.0012735,0.053581,0.58046,GOMF_MICROTUBULE_BINDING,0.99999
GOBP_PURKINJE_MYOCYTE_TO_VEN...,SET,6,-0.079628,-0.0014393,0.39197,0.58049,GOBP_PURKINJE_MYOCYTE_TO_VENTRICULAR_CARDIAC_MUSCLE_CELL_COMMUNICATION,0.99999
JAZAG_TGFB1_SIGNALING_DN,SET,32,-0.028174,-0.0011753,0.13862,0.58053,JAZAG_TGFB1_SIGNALING_DN,0.99999
MIR1277_3P,SET,14,-0.046008,-0.00127,0.22632,0.58054,MIR1277_3P,0.99999
GATA2_01,SET,99,-0.017872,-0.0013089,0.087922,0.58054,GATA2_01,0.99999
MEISSNER_NPC_ICP_WITH_H3K4ME3,SET,17,-0.038112,-0.0011592,0.18743,0.58057,MEISSNER_NPC_ICP_WITH_H3K4ME3,0.99999
GOBP_NEGATIVE_REGULATION_OF_...647,SET,9,-0.063911,-0.0014148,0.31413,0.58061,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...413,SET,23,-0.039126,-0.001384,0.19222,0.58064,GOBP_POSITIVE_REGULATION_OF_LIPID_STORAGE,0.99999
GOBP_SCHWANN_CELL_PROLIFERAT...,SET,9,-0.050098,-0.001109,0.24611,0.58065,GOBP_SCHWANN_CELL_PROLIFERATION,0.99999
GSE36476_CTRL_VS_TSST_ACT_72...4,SET,175,-0.013296,-0.0012919,0.065315,0.58065,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP,0.99999
WP_OMEGA6FATTY_ACIDS_IN_SENE...,SET,55,-0.023637,-0.0012919,0.1161,0.58066,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,0.99999
GOBP_TRANSFORMING_GROWTH_FAC...4,SET,196,-0.012891,-0.0013248,0.063321,0.58066,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_OROMANDIBULAR_DYSTONIA,SET,18,-0.036905,-0.001155,0.18117,0.5807,HP_OROMANDIBULAR_DYSTONIA,0.99999
GOBP_NEURAL_FOLD_FORMATION,SET,7,-0.067007,-0.0013082,0.32886,0.58073,GOBP_NEURAL_FOLD_FORMATION,0.99999
GSE37301_LYMPHOID_PRIMED_MPP...6,SET,180,-0.012778,-0.0012591,0.062701,0.58074,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_RE...3,SET,63,-0.023327,-0.0013642,0.11445,0.58075,GOBP_CELLULAR_RESPONSE_TO_RETINOIC_ACID,0.99999
GOBP_POSITIVE_REGULATION_OF_...385,SET,7,-0.077662,-0.0015162,0.38101,0.58076,GOBP_POSITIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.99999
MIR3907,SET,49,-0.02432,-0.0012548,0.11922,0.58082,MIR3907,0.99999
GOBP_ENDOCRINE_HORMONE_SECRE...,SET,54,-0.025549,-0.0013836,0.12509,0.58092,GOBP_ENDOCRINE_HORMONE_SECRETION,0.99999
BROWNE_HCMV_INFECTION_14HR_DN,SET,257,-0.011112,-0.0013055,0.054398,0.58093,BROWNE_HCMV_INFECTION_14HR_DN,0.99999
GOBP_RESPONSE_TO_GLUCAGON,SET,21,-0.038757,-0.0013101,0.18973,0.58093,GOBP_RESPONSE_TO_GLUCAGON,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...1,SET,4,-0.11866,-0.0017513,0.58072,0.58095,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR,0.99999
GOBP_MITOCHONDRIAL_ELECTRON_...1,SET,16,-0.040697,-0.0012009,0.19914,0.58097,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_CYTOCHROME_C_TO_OXYGEN,0.99999
GOMF_DNA_BINDING_TRANSCRIPTI...3,SET,440,-0.0084226,-0.0012882,0.041191,0.58101,GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...477,SET,13,-0.045724,-0.0012163,0.22354,0.58104,GOBP_POSITIVE_REGULATION_OF_MITOTIC_CYTOKINESIS,0.99999
MODULE_303,SET,27,-0.033891,-0.0012988,0.16565,0.58105,MODULE_303,0.99999
ABE_INNER_EAR,SET,39,-0.029334,-0.0013506,0.14326,0.58112,ABE_INNER_EAR,0.99999
MIR499B_3P,SET,153,-0.01521,-0.0013827,0.074229,0.58117,MIR499B_3P,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...3,SET,43,-0.028233,-0.0013648,0.13778,0.58118,GAVISH_3CA_METAPROGRAM_MACROPHAGES_LIPID_ASSOCIATED,0.99999
HP_SALIVARY_GLAND_NEOPLASM,SET,12,-0.046915,-0.0011991,0.22895,0.58118,HP_SALIVARY_GLAND_NEOPLASM,0.99999
ZHOU_INFLAMMATORY_RESPONSE_L...1,SET,323,-0.0095767,-0.0012591,0.046679,0.58128,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,0.99999
GSE25088_CTRL_VS_ROSIGLITAZO...3,SET,182,-0.01283,-0.0012711,0.062534,0.58128,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,0.99999
GSE25123_IL4_VS_IL4_AND_ROSI...3,SET,170,-0.014007,-0.0013416,0.068241,0.58131,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,0.99999
GUO_TARGETS_OF_IRS1_AND_IRS2,SET,90,-0.017937,-0.0012528,0.087356,0.58134,GUO_TARGETS_OF_IRS1_AND_IRS2,0.99999
TCGA_GLIOBLASTOMA_COPY_NUMBE...1,SET,28,-0.043061,-0.0016804,0.20969,0.58135,TCGA_GLIOBLASTOMA_COPY_NUMBER_DN,0.99999
GOBP_LACTATION,SET,37,-0.029788,-0.001336,0.14505,0.58135,GOBP_LACTATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...152,SET,5,-0.079772,-0.0013163,0.38842,0.58136,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_1_PRODUCTION,0.99999
KEGG_MEDICUS_REFERENCE_HEDGE...2,SET,6,-0.078912,-0.0014264,0.38388,0.58143,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_HH_LIGAND_SECRETION,0.99999
BRAUNE_GEIST_20_GENE_NOTCH_S...,SET,20,-0.043029,-0.0014195,0.20929,0.58144,BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER,0.99999
HP_THICK_CORPUS_CALLOSUM,SET,15,-0.041352,-0.0011816,0.20101,0.5815,HP_THICK_CORPUS_CALLOSUM,0.99999
GOBP_N_TERMINAL_PROTEIN_LIPI...,SET,6,-0.074002,-0.0013376,0.35963,0.58151,GOBP_N_TERMINAL_PROTEIN_LIPIDATION,0.99999
MIR5699_5P,SET,98,-0.01711,-0.0012468,0.08312,0.58155,MIR5699_5P,0.99999
HP_HEPATOSPLENOMEGALY,SET,152,-0.014465,-0.0013107,0.070236,0.58158,HP_HEPATOSPLENOMEGALY,0.99999
MIR432_3P,SET,57,-0.023324,-0.0012976,0.11323,0.58159,MIR432_3P,0.99999
GSE23308_CTRL_VS_CORTICOSTER...2,SET,173,-0.013129,-0.0012685,0.063683,0.58167,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN,0.99999
HP_ABNORMAL_CRY,SET,54,-0.023592,-0.0012776,0.11441,0.58168,HP_ABNORMAL_CRY,0.99999
WIERENGA_STAT5A_TARGETS_UP,SET,186,-0.013663,-0.0013683,0.066192,0.58176,WIERENGA_STAT5A_TARGETS_UP,0.99999
GOBP_REGULATION_OF_PHOSPHOLI...7,SET,27,-0.033242,-0.0012739,0.16099,0.58179,GOBP_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.99999
BIOCARTA_AGR_PATHWAY,SET,29,-0.034344,-0.0013639,0.16623,0.58184,BIOCARTA_AGR_PATHWAY,0.99999
GRYDER_PAX3FOXO1_ENHANCERS_K...,SET,412,-0.0093737,-0.0013884,0.045349,0.58188,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,0.99999
NIKOLSKY_BREAST_CANCER_19Q13...2,SET,7,-0.10019,-0.0019559,0.48444,0.58192,NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON,0.99999
GSE4748_LPS_VS_LPS_AND_CYANO...1,SET,142,-0.014337,-0.001256,0.069323,0.58192,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,0.99999
chr13q31,SET,9,-0.082213,-0.0018199,0.39737,0.58195,chr13q31,0.99999
HP_MIDFACE_RETRUSION,SET,253,-0.010901,-0.0012709,0.052644,0.58202,HP_MIDFACE_RETRUSION,0.99999
GOBP_RENAL_ALBUMIN_ABSORPTION,SET,7,-0.076187,-0.0014874,0.36779,0.58205,GOBP_RENAL_ALBUMIN_ABSORPTION,0.99999
GOBP_REGULATION_OF_FATTY_ACI...4,SET,31,-0.032141,-0.0013197,0.15513,0.58207,GOBP_REGULATION_OF_FATTY_ACID_OXIDATION,0.99999
TAAWWATAG_RSRFC4_Q2,SET,148,-0.01469,-0.0013137,0.070873,0.5821,TAAWWATAG_RSRFC4_Q2,0.99999
GSE26030_UNSTIM_VS_RESTIM_TH...4,SET,166,-0.014166,-0.001341,0.068321,0.58213,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_UP,0.99999
GSE22886_UNSTIM_VS_STIM_MEMO...1,SET,182,-0.012196,-0.0012084,0.058811,0.58214,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN,0.99999
GOBP_HYDROGEN_PEROXIDE_METAB...,SET,46,-0.027959,-0.0013978,0.13476,0.58218,GOBP_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,0.99999
TERAO_AOX4_TARGETS_HG_UP,SET,27,-0.033831,-0.0012965,0.16294,0.58224,TERAO_AOX4_TARGETS_HG_UP,0.99999
GOBP_PERISTALSIS,SET,12,-0.059355,-0.001517,0.28581,0.58226,GOBP_PERISTALSIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...162,SET,9,-0.055078,-0.0012192,0.26515,0.58228,GOBP_POSITIVE_REGULATION_OF_CHROMATIN_BINDING,0.99999
BOUDOUKHA_BOUND_BY_IGF2BP2,SET,92,-0.017739,-0.0012526,0.085368,0.5823,BOUDOUKHA_BOUND_BY_IGF2BP2,0.99999
WP_MRNA_PROCESSING,SET,116,-0.014816,-0.001174,0.071264,0.58234,WP_MRNA_PROCESSING,0.99999
HP_SHORT_STEPPED_SHUFFLING_G...,SET,14,-0.045602,-0.0012589,0.21937,0.58234,HP_SHORT_STEPPED_SHUFFLING_GAIT,0.99999
GSE2770_UNTREATED_VS_TGFB_AN...12,SET,183,-0.012963,-0.0012878,0.062294,0.58242,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP,0.99999
MIR1226_3P,SET,99,-0.017856,-0.0013077,0.085746,0.58248,MIR1226_3P,0.99999
HP_HYPOMIMIC_FACE,SET,35,-0.029657,-0.0012937,0.14239,0.5825,HP_HYPOMIMIC_FACE,0.99999
GOBP_ENTRAINMENT_OF_CIRCADIA...,SET,27,-0.035141,-0.0013467,0.16865,0.58253,GOBP_ENTRAINMENT_OF_CIRCADIAN_CLOCK,0.99999
HP_DECREASED_HIP_ABDUCTION,SET,7,-0.068105,-0.0013296,0.32681,0.58254,HP_DECREASED_HIP_ABDUCTION,0.99999
KEGG_PHOSPHATIDYLINOSITOL_SI...,SET,75,-0.020491,-0.0013071,0.098296,0.58257,KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM,0.99999
AGTCTAG_MIR151,SET,20,-0.041416,-0.0013663,0.19863,0.58258,AGTCTAG_MIR151,0.99999
HP_EYELID_APRAXIA,SET,5,-0.0753,-0.0012425,0.36114,0.58258,HP_EYELID_APRAXIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...436,SET,24,-0.036932,-0.0013345,0.17702,0.58263,GOBP_NEGATIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,0.99999
HOEK_MONOCYTE_2011_2012_TIV_...3,SET,4,-0.097274,-0.0014357,0.46616,0.58265,HOEK_MONOCYTE_2011_2012_TIV_ADULT_3DY_DN,0.99999
HP_ABNORMAL_MOTOR_EVOKED_POT...,SET,10,-0.056217,-0.0013117,0.26933,0.58267,HP_ABNORMAL_MOTOR_EVOKED_POTENTIALS,0.99999
MIR744_3P,SET,55,-0.023346,-0.0012759,0.11184,0.58268,MIR744_3P,0.99999
GSE21927_HEALTHY_VS_TUMOROUS...1,SET,139,-0.015581,-0.0013506,0.074638,0.58268,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_DN,0.99999
PRKDC_TARGET_GENES,SET,696,-0.006845,-0.0013073,0.032767,0.58273,PRKDC_TARGET_GENES,0.99999
HAY_BONE_MARROW_PRE_DENDRITIC,SET,5,-0.083454,-0.0013771,0.39952,0.58273,HAY_BONE_MARROW_PRE_DENDRITIC,0.99999
KEGG_MEDICUS_REFERENCE_AMH_S...,SET,9,-0.061514,-0.0013617,0.29428,0.58279,KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY,0.99999
HP_HEMIPLEGIA,SET,33,-0.034635,-0.0014671,0.1656,0.58283,HP_HEMIPLEGIA,0.99999
GOBP_ANTIGEN_PROCESSING_AND_...3,SET,30,-0.038442,-0.0015527,0.18369,0.58288,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN,0.99999
GOBP_NEURON_FATE_DETERMINATI...,SET,8,-0.075965,-0.0015854,0.36291,0.5829,GOBP_NEURON_FATE_DETERMINATION,0.99999
GOBP_VESTIBULOCOCHLEAR_NERVE...2,SET,5,-0.099188,-0.0016367,0.47381,0.58291,GOBP_VESTIBULOCOCHLEAR_NERVE_FORMATION,0.99999
MIR193B_5P,SET,55,-0.023947,-0.0013088,0.11437,0.58292,MIR193B_5P,0.99999
LEE_AGING_CEREBELLUM_UP,SET,77,-0.020066,-0.0012968,0.095787,0.58297,LEE_AGING_CEREBELLUM_UP,0.99999
GRYDER_PAX3FOXO1_ENHANCERS_I...,SET,942,-0.0063011,-0.0013903,0.030065,0.583,GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...36,SET,32,-0.033609,-0.001402,0.16036,0.583,HP_APLASIA_HYPOPLASIA_OF_THE_HALLUX,0.99999
HP_HYPERPIGMENTED_PAPULE,SET,5,-0.066539,-0.001098,0.31745,0.58301,HP_HYPERPIGMENTED_PAPULE,0.99999
GOBP_EMBRYONIC_CLEAVAGE,SET,8,-0.061699,-0.0012877,0.29431,0.58303,GOBP_EMBRYONIC_CLEAVAGE,0.99999
HP_APLASIA_OF_THE_BLADDER,SET,5,-0.08453,-0.0013948,0.40318,0.58303,HP_APLASIA_OF_THE_BLADDER,0.99999
TATA_01,SET,222,-0.012607,-0.0013779,0.060127,0.58304,TATA_01,0.99999
GOBP_FOLIC_ACID_CONTAINING_C...1,SET,8,-0.057916,-0.0012087,0.27612,0.58307,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
POS_RESPONSE_TO_HISTAMINE_UP,SET,11,-0.051195,-0.0012528,0.24358,0.58323,POS_RESPONSE_TO_HISTAMINE_UP,0.99999
HP_ABNORMAL_URINE_PROTEIN_LE...,SET,212,-0.01232,-0.0013163,0.058612,0.58324,HP_ABNORMAL_URINE_PROTEIN_LEVEL,0.99999
HP_INCREASED_CIRCULATING_REN...,SET,18,-0.048344,-0.0015131,0.22999,0.58324,HP_INCREASED_CIRCULATING_RENIN_LEVEL,0.99999
MIR548AS_3P,SET,241,-0.011487,-0.0013075,0.054596,0.58332,MIR548AS_3P,0.99999
GOMF_PHOSPHATIDYLINOSITOL_3_...14,SET,41,-0.028588,-0.0013495,0.13575,0.58339,GOMF_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BINDING,0.99999
THEILGAARD_NEUTROPHIL_AT_SKI...1,SET,213,-0.01177,-0.0012604,0.055885,0.5834,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,0.99999
HP_HYPOPHOSPHATEMIC_RICKETS,SET,18,-0.047139,-0.0014753,0.22381,0.58341,HP_HYPOPHOSPHATEMIC_RICKETS,0.99999
GOCC_GRANULAR_COMPONENT,SET,7,-0.066995,-0.001308,0.31794,0.58344,GOCC_GRANULAR_COMPONENT,0.99999
MIR576_3P,SET,58,-0.024162,-0.001356,0.11446,0.58359,MIR576_3P,0.99999
GOBP_INTRACILIARY_TRANSPORT,SET,40,-0.027616,-0.0012877,0.13083,0.58359,GOBP_INTRACILIARY_TRANSPORT,0.99999
GOMF_RNA_ENDONUCLEASE_ACTIVI...1,SET,63,-0.022981,-0.0013439,0.10884,0.58361,GOMF_RNA_ENDONUCLEASE_ACTIVITY,0.99999
CHEN_NEUROBLASTOMA_COPY_NUMB...,SET,48,-0.030534,-0.0015593,0.14457,0.58363,CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,0.99999
MORF_UBE2I,SET,216,-0.011397,-0.0012289,0.053965,0.58363,MORF_UBE2I,0.99999
HU_FETAL_RETINA_BIPOLAR,SET,79,-0.021906,-0.0014339,0.1037,0.58365,HU_FETAL_RETINA_BIPOLAR,0.99999
GOMF_CILIARY_NEUROTROPHIC_FA...,SET,6,-0.072151,-0.0013042,0.34128,0.58372,GOMF_CILIARY_NEUROTROPHIC_FACTOR_RECEPTOR_BINDING,0.99999
GSE3039_CD4_TCELL_VS_B1_BCEL...1,SET,175,-0.014059,-0.0013661,0.066502,0.58372,GSE3039_CD4_TCELL_VS_B1_BCELL_DN,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_MY...,SET,19,-0.0429,-0.0013794,0.20276,0.58378,HP_ABNORMAL_MORPHOLOGY_OF_MYOCARDIAL_TRABECULAE,0.99999
MIR6800_5P,SET,42,-0.025688,-0.0012273,0.12139,0.58379,MIR6800_5P,0.99999
GSE5589_LPS_VS_LPS_AND_IL10_...12,SET,183,-0.013568,-0.0013479,0.064117,0.58379,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...3,SET,47,-0.03015,-0.0015236,0.14245,0.58381,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1,0.99999
GSE20198_UNTREATED_VS_IL12_T...1,SET,182,-0.013163,-0.0013041,0.062192,0.58381,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN,0.99999
GSE19923_HEB_KO_VS_HEB_AND_E...2,SET,177,-0.013394,-0.0013088,0.063259,0.58384,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,0.99999
GOBP_EYE_PIGMENTATION,SET,4,-0.089295,-0.0013179,0.42131,0.58392,GOBP_EYE_PIGMENTATION,0.99999
WANG_TUMOR_INVASIVENESS_UP,SET,362,-0.0092169,-0.0012814,0.043478,0.58394,WANG_TUMOR_INVASIVENESS_UP,0.99999
GOBP_AUTOPHAGOSOME_LYSOSOME_...,SET,11,-0.053491,-0.001309,0.2522,0.58398,GOBP_AUTOPHAGOSOME_LYSOSOME_FUSION,0.99999
GOBP_HRI_MEDIATED_SIGNALING,SET,5,-0.074504,-0.0012294,0.35131,0.58398,GOBP_HRI_MEDIATED_SIGNALING,0.99999
GOBP_REGULATION_OF_INTRINSIC...5,SET,3,-0.088718,-0.001134,0.4183,0.58398,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYDROGEN_PEROXIDE,0.99999
MIR1225_5P,SET,25,-0.035798,-0.0013201,0.16865,0.58405,MIR1225_5P,0.99999
HP_RECURRENT_HAND_FLAPPING,SET,24,-0.034741,-0.0012553,0.16366,0.58405,HP_RECURRENT_HAND_FLAPPING,0.99999
GSE25677_MPL_VS_MPL_AND_R848...1,SET,118,-0.016642,-0.0013299,0.07839,0.58406,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN,0.99999
chr12q24,SET,200,-0.028696,-0.0029789,0.13511,0.5841,chr12q24,0.99999
LEE_LIVER_CANCER_SURVIVAL_DN,SET,165,-0.013917,-0.0013135,0.06551,0.58412,LEE_LIVER_CANCER_SURVIVAL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...564,SET,39,-0.028341,-0.0013049,0.1334,0.58412,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.99999
MIR4299,SET,67,-0.021761,-0.0013122,0.10242,0.58413,MIR4299,0.99999
TRAVAGLINI_LUNG_CAPILLARY_CE...,SET,14,-0.053939,-0.001489,0.25382,0.58414,TRAVAGLINI_LUNG_CAPILLARY_CELL,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...4,SET,8,-0.06452,-0.0013466,0.30351,0.58417,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY,0.99999
MIR10398_5P,SET,70,-0.021577,-0.0013298,0.10149,0.58418,MIR10398_5P,0.99999
HP_LONG_PALM,SET,3,-0.13495,-0.001725,0.63435,0.58423,HP_LONG_PALM,0.99999
MODULE_547,SET,11,-0.054644,-0.0013372,0.25677,0.58426,MODULE_547,0.99999
PID_NFKAPPAB_CANONICAL_PATHW...,SET,21,-0.039519,-0.0013358,0.18568,0.58427,PID_NFKAPPAB_CANONICAL_PATHWAY,0.99999
GSE7768_OVA_ALONE_VS_OVA_WIT...1,SET,157,-0.015039,-0.0013848,0.070592,0.58435,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,0.99999
HP_BLISTERING_BY_ANATOMICAL_...,SET,25,-0.038392,-0.0014158,0.18012,0.58439,HP_BLISTERING_BY_ANATOMICAL_LOCATION,0.99999
GSE32533_MIR17_KO_VS_MIR17_O...2,SET,180,-0.013668,-0.0013468,0.064001,0.58455,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,0.99999
GSE21033_CTRL_VS_POLYIC_STIM...5,SET,137,-0.015726,-0.0013534,0.073623,0.58457,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_DN,0.99999
HP_SEVERE_TEMPER_TANTRUMS,SET,6,-0.077914,-0.0014083,0.36467,0.58459,HP_SEVERE_TEMPER_TANTRUMS,0.99999
HP_SOLITARY_MEDIAN_MAXILLARY...,SET,22,-0.037811,-0.0013082,0.17697,0.58459,HP_SOLITARY_MEDIAN_MAXILLARY_CENTRAL_INCISOR,0.99999
GSE20198_UNTREATED_VS_IL12_I...2,SET,183,-0.013633,-0.0013543,0.063717,0.58471,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,0.99999
GOBP_REGULATION_OF_MITOCHOND...2,SET,17,-0.046305,-0.0014084,0.21636,0.58473,GOBP_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION,0.99999
HP_COCHLEAR_MALFORMATION,SET,8,-0.059167,-0.0012349,0.27621,0.58481,HP_COCHLEAR_MALFORMATION,0.99999
HOEK_NK_CELL_2011_2012_TIV_A...2,SET,12,-0.051647,-0.00132,0.24091,0.58487,HOEK_NK_CELL_2011_2012_TIV_ADULT_3DY_UP,0.99999
GSE6269_STAPH_AUREUS_VS_STRE...1,SET,158,-0.014456,-0.0013353,0.067425,0.58488,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN,0.99999
MIR875_5P,SET,49,-0.026644,-0.0013747,0.12416,0.58495,MIR875_5P,0.99999
HP_REDUCED_FACTOR_XIII_ACTIV...,SET,6,-0.069893,-0.0012633,0.32574,0.58495,HP_REDUCED_FACTOR_XIII_ACTIVITY,0.99999
MORF_BCL2L11,SET,161,-0.014892,-0.0013885,0.069393,0.58496,MORF_BCL2L11,0.99999
LEIN_MEDULLA_MARKERS,SET,76,-0.021578,-0.0013855,0.1005,0.585,LEIN_MEDULLA_MARKERS,0.99999
HP_GLYCOSURIA,SET,40,-0.028668,-0.0013367,0.13351,0.58501,HP_GLYCOSURIA,0.99999
GSE22935_UNSTIM_VS_12H_MBOVI...1,SET,183,-0.013084,-0.0012998,0.060918,0.58503,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.99999
GSE21546_UNSTIM_VS_ANTI_CD3_...6,SET,147,-0.015783,-0.0014067,0.073478,0.58504,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.99999
MIR367_5P,SET,67,-0.021678,-0.0013072,0.1009,0.58506,MIR367_5P,0.99999
GOBP_CELLULAR_RESPONSE_TO_HE...,SET,59,-0.023835,-0.001349,0.11087,0.5851,GOBP_CELLULAR_RESPONSE_TO_HEAT,0.99999
GOBP_ORGANISM_EMERGENCE_FROM...,SET,22,-0.034623,-0.0011978,0.16101,0.58513,GOBP_ORGANISM_EMERGENCE_FROM_PROTECTIVE_STRUCTURE,0.99999
GOBP_REGULATION_OF_CD40_SIGN...,SET,6,-0.061409,-0.00111,0.28556,0.58513,GOBP_REGULATION_OF_CD40_SIGNALING_PATHWAY,0.99999
GOMF_SIALIC_ACID_BINDING,SET,20,-0.050025,-0.0016502,0.23261,0.58514,GOMF_SIALIC_ACID_BINDING,0.99999
HP_ABNORMAL_CORTICAL_GYRATION,SET,347,-0.0098285,-0.0013384,0.045677,0.58518,HP_ABNORMAL_CORTICAL_GYRATION,0.99999
CHANDRAN_METASTASIS_TOP50_UP,SET,29,-0.03029,-0.0012029,0.14072,0.58521,CHANDRAN_METASTASIS_TOP50_UP,0.99999
HP_ABNORMAL_URINARY_COLOR,SET,18,-0.041514,-0.0012993,0.19288,0.58521,HP_ABNORMAL_URINARY_COLOR,0.99999
GOBP_REGULATION_OF_MAST_CELL...3,SET,7,-0.069488,-0.0013566,0.32274,0.58523,GOBP_REGULATION_OF_MAST_CELL_CHEMOTAXIS,0.99999
GOCC_GARP_COMPLEX,SET,4,-0.081105,-0.0011971,0.3766,0.58525,GOCC_GARP_COMPLEX,0.99999
GOBP_INDOLE_CONTAINING_COMPO...1,SET,5,-0.079049,-0.0013044,0.36684,0.5853,GOBP_INDOLE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
GOMF_U4_SNRNA_BINDING,SET,5,-0.06672,-0.001101,0.30965,0.5853,GOMF_U4_SNRNA_BINDING,0.99999
HP_ABNORMAL_ERYTHROCYTE_ENZY...,SET,37,-0.027597,-0.0012377,0.12803,0.58533,HP_ABNORMAL_ERYTHROCYTE_ENZYME_CONCENTRATION_OR_ACTIVITY,0.99999
NKX6_1_TARGET_GENES,SET,23,-0.037783,-0.0013365,0.17527,0.58534,NKX6_1_TARGET_GENES,0.99999
HP_ABNORMAL_EPIDIDYMIS_MORPH...,SET,10,-0.059283,-0.0013832,0.2748,0.5854,HP_ABNORMAL_EPIDIDYMIS_MORPHOLOGY,0.99999
AIZARANI_LIVER_C33_STELLATE_...,SET,117,-0.018534,-0.0014749,0.08587,0.58544,AIZARANI_LIVER_C33_STELLATE_CELLS_2,0.99999
FOROUTAN_TGFB_EMT_UP,SET,185,-0.014464,-0.0014446,0.066909,0.58557,FOROUTAN_TGFB_EMT_UP,0.99999
ERWIN_COHEN_PBMC_TC_83_AGE_1...3,SET,16,-0.05039,-0.001487,0.23293,0.58563,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,0.99999
PATEL_SKIN_OF_BODY_ZOSTAVAX_...4,SET,91,-0.019686,-0.0013826,0.090968,0.58566,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_DN,0.99999
MIR4324,SET,238,-0.012124,-0.0013715,0.056015,0.58568,MIR4324,0.99999
GOMF_BETA_CATENIN_BINDING,SET,98,-0.01958,-0.0014268,0.090441,0.5857,GOMF_BETA_CATENIN_BINDING,0.99999
GOBP_RESPONSE_TO_TOXIC_SUBST...,SET,225,-0.012923,-0.0014219,0.059643,0.58577,GOBP_RESPONSE_TO_TOXIC_SUBSTANCE,0.99999
GOMF_SINGLE_STRANDED_RNA_BIN...,SET,75,-0.021005,-0.0013398,0.096938,0.58577,GOMF_SINGLE_STRANDED_RNA_BINDING,0.99999
GOBP_CENTRIOLE_ASSEMBLY,SET,45,-0.025515,-0.0012617,0.11774,0.58578,GOBP_CENTRIOLE_ASSEMBLY,0.99999
KEGG_MEDICUS_REFERENCE_TRAPP...,SET,8,-0.058384,-0.0012185,0.26932,0.58581,KEGG_MEDICUS_REFERENCE_TRAPPI_RAB1_SIGNALING_PATHWAY,0.99999
YANG_BCL3_TARGETS_UP,SET,308,-0.010715,-0.0013761,0.049419,0.58582,YANG_BCL3_TARGETS_UP,0.99999
NABA_MATRISOME_HIGHLY_METAST...2,SET,26,-0.034852,-0.0013107,0.16072,0.58583,NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED,0.99999
HP_DYSGRAPHIA,SET,51,-0.025525,-0.0013435,0.1177,0.58584,HP_DYSGRAPHIA,0.99999
HP_EMBRYONAL_NEOPLASM,SET,73,-0.022594,-0.0014219,0.10416,0.58587,HP_EMBRYONAL_NEOPLASM,0.99999
GSE40685_TREG_VS_FOXP3_KO_TR...1,SET,182,-0.013824,-0.0013696,0.063719,0.58587,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...2,SET,32,-0.034625,-0.0014444,0.15959,0.58588,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,0.99999
GOBP_RESPONSE_TO_GROWTH_FACT...,SET,662,-0.0076891,-0.0014336,0.035432,0.5859,GOBP_RESPONSE_TO_GROWTH_FACTOR,0.99999
GOBP_POSITIVE_REGULATION_OF_...568,SET,28,-0.039553,-0.0015435,0.18223,0.58592,GOBP_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.99999
GOBP_PLASMA_MEMBRANE_TO_ENDO...,SET,8,-0.064275,-0.0013415,0.29609,0.58593,GOBP_PLASMA_MEMBRANE_TO_ENDOSOME_TRANSPORT,0.99999
HP_MECONIUM_STAINED_AMNIOTIC...,SET,8,-0.06904,-0.0014409,0.31799,0.58594,HP_MECONIUM_STAINED_AMNIOTIC_FLUID,0.99999
GNF2_AF1Q,SET,25,-0.039112,-0.0014424,0.18008,0.58597,GNF2_AF1Q,0.99999
GSE23925_LIGHT_ZONE_VS_DARK_...2,SET,179,-0.013818,-0.0013577,0.063602,0.58599,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,0.99999
CHICAS_RB1_TARGETS_GROWING,SET,221,-0.012951,-0.0014124,0.059594,0.58602,CHICAS_RB1_TARGETS_GROWING,0.99999
GSE6092_CTRL_VS_BORRELIA_BIR...2,SET,143,-0.014993,-0.0013181,0.068905,0.58613,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP,0.99999
HOLLERN_SOLID_NODULAR_BREAST...2,SET,9,-0.073074,-0.0016176,0.33573,0.58615,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP,0.99999
REACTOME_VITAMIN_C_ASCORBATE...,SET,7,-0.067382,-0.0013155,0.30939,0.5862,REACTOME_VITAMIN_C_ASCORBATE_METABOLISM,0.99999
HP_PALMOPLANTAR_CUTIS_LAXA,SET,8,-0.064762,-0.0013516,0.29731,0.58622,HP_PALMOPLANTAR_CUTIS_LAXA,0.99999
MIR575,SET,49,-0.025274,-0.001304,0.11602,0.58623,MIR575,0.99999
MIR7157_5P,SET,194,-0.013745,-0.0014054,0.063072,0.58625,MIR7157_5P,0.99999
GOMF_EXOGENOUS_PROTEIN_BINDI...,SET,78,-0.022731,-0.0014786,0.10429,0.58627,GOMF_EXOGENOUS_PROTEIN_BINDING,0.99999
PID_AP1_PATHWAY,SET,68,-0.024131,-0.0014659,0.11059,0.58637,PID_AP1_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...510,SET,33,-0.030202,-0.0012794,0.1384,0.58637,GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_RNA_SPLICING,SET,396,-0.0087718,-0.0012744,0.040184,0.5864,GOBP_RNA_SPLICING,0.99999
HP_MYOTONIA,SET,28,-0.036049,-0.0014068,0.16512,0.58641,HP_MYOTONIA,0.99999
GOBP_CYTOKINE_PRODUCTION_INV...1,SET,115,-0.018389,-0.0014509,0.08422,0.58642,GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
GSE5679_PPARG_LIGAND_ROSIGLI...1,SET,184,-0.013511,-0.0013459,0.061829,0.58649,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN,0.99999
HP_ELEVATED_TOTAL_SERUM_TRYP...,SET,6,-0.079971,-0.0014455,0.36593,0.5865,HP_ELEVATED_TOTAL_SERUM_TRYPTASE,0.99999
GOMF_HISTONE_H3_KINASE_ACTIV...,SET,10,-0.059566,-0.0013898,0.27227,0.58659,GOMF_HISTONE_H3_KINASE_ACTIVITY,0.99999
GOBP_REGULATORY_NCRNA_PROCES...,SET,65,-0.021918,-0.0013019,0.10015,0.58661,GOBP_REGULATORY_NCRNA_PROCESSING,0.99999
HP_ENCHONDROMA,SET,21,-0.038839,-0.0013129,0.17747,0.58661,HP_ENCHONDROMA,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_MEG...,SET,615,-0.0078637,-0.001415,0.035914,0.58666,HE_LIM_SUN_FETAL_LUNG_C2_MEGAKARYOCYTE,0.99999
MIR3650,SET,49,-0.026232,-0.0013534,0.11973,0.58671,MIR3650,0.99999
GCM_PRKCG,SET,55,-0.023597,-0.0012896,0.1077,0.58671,GCM_PRKCG,0.99999
COMP1_01,SET,103,-0.020996,-0.0015682,0.095799,0.58674,COMP1_01,0.99999
GSE6674_ANTI_IGM_VS_ANTI_IGM...2,SET,183,-0.013652,-0.0013562,0.062277,0.58676,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,0.99999
MIR1296_3P,SET,34,-0.030861,-0.0013269,0.14074,0.58678,MIR1296_3P,0.99999
GSE369_SOCS3_KO_VS_IFNG_KO_L...2,SET,170,-0.014936,-0.0014306,0.068113,0.58678,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP,0.99999
GSE2770_UNTREATED_VS_ACT_CD4...2,SET,180,-0.014504,-0.0014291,0.066139,0.58679,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP,0.99999
GSE43955_1H_VS_10H_ACT_CD4_T...3,SET,179,-0.014315,-0.0014066,0.065265,0.5868,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.99999
GOBP_RETROGRADE_VESICLE_MEDI...,SET,48,-0.024551,-0.0012537,0.11188,0.58685,GOBP_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ENDOPLASMIC_RETICULUM,0.99999
TEF1_Q6,SET,209,-0.013399,-0.0014214,0.061024,0.58689,TEF1_Q6,0.99999
GOBP_INDUCTION_OF_POSITIVE_C...,SET,13,-0.05852,-0.0015567,0.26651,0.5869,GOBP_INDUCTION_OF_POSITIVE_CHEMOTAXIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...226,SET,13,-0.056658,-0.0015072,0.25804,0.5869,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,0.99999
GOBP_REGULATION_OF_T_CELL_MI...,SET,44,-0.029135,-0.0014247,0.13258,0.58697,GOBP_REGULATION_OF_T_CELL_MIGRATION,0.99999
ZNF512_TARGET_GENES,SET,327,-0.010559,-0.0013966,0.048029,0.587,ZNF512_TARGET_GENES,0.99999
MIR3649,SET,18,-0.045738,-0.0014315,0.20801,0.58702,MIR3649,0.99999
MIR211_5P,SET,346,-0.010373,-0.0014106,0.047135,0.58709,MIR211_5P,0.99999
HP_BICONVEX_VERTEBRAL_BODIES,SET,3,-0.10888,-0.0013918,0.49419,0.58719,HP_BICONVEX_VERTEBRAL_BODIES,0.99999
HOEK_PBMC_INACTIVATED_INFLUE...5,SET,16,-0.047722,-0.0014082,0.21656,0.5872,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_DN,0.99999
GOBP_COTRANSLATIONAL_PROTEIN...,SET,21,-0.042335,-0.001431,0.1921,0.58721,GOBP_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.99999
MIR6838_5P,SET,489,-0.0084724,-0.0013642,0.038399,0.58731,MIR6838_5P,0.99999
GOBP_TERPENOID_CATABOLIC_PRO...,SET,7,-0.075933,-0.0014825,0.34402,0.58734,GOBP_TERPENOID_CATABOLIC_PROCESS,0.99999
GSE40274_HELIOS_VS_FOXP3_AND...1,SET,179,-0.013776,-0.0013536,0.062371,0.5874,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
LI_WILMS_TUMOR,SET,22,-0.047064,-0.0016283,0.21297,0.58745,LI_WILMS_TUMOR,0.99999
GOBP_RESPONSE_TO_GLYCOPROTEIN,SET,11,-0.062826,-0.0015374,0.28424,0.58746,GOBP_RESPONSE_TO_GLYCOPROTEIN,0.99999
HP_HYPOCALCEMIC_SEIZURES,SET,12,-0.057525,-0.0014702,0.26022,0.58748,HP_HYPOCALCEMIC_SEIZURES,0.99999
MODULE_284,SET,40,-0.030006,-0.0013991,0.13561,0.58756,MODULE_284,0.99999
HP_VISUAL_FIXATION_INSTABILI...,SET,12,-0.054682,-0.0013976,0.24699,0.5876,HP_VISUAL_FIXATION_INSTABILITY,0.99999
NAKAYA_PBMC_FLUARIX_FLUVIRIN...5,SET,315,-0.010523,-0.0013666,0.0475,0.58766,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE,0.99999
GOBP_REGULATION_OF_MEIOTIC_C...2,SET,10,-0.0579,-0.001351,0.26133,0.58767,GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.99999
MOREIRA_RESPONSE_TO_TSA_DN,SET,18,-0.045618,-0.0014277,0.20586,0.58768,MOREIRA_RESPONSE_TO_TSA_DN,0.99999
HP_SUPRANUCLEAR_OPHTHALMOPLE...,SET,4,-0.082073,-0.0012114,0.37034,0.58769,HP_SUPRANUCLEAR_OPHTHALMOPLEGIA,0.99999
GOMF_PATCHED_BINDING,SET,8,-0.068744,-0.0014347,0.31008,0.58772,GOMF_PATCHED_BINDING,0.99999
FOXJ2_02,SET,214,-0.013346,-0.0014325,0.060147,0.5878,FOXJ2_02,0.99999
REACTOME_GPVI_MEDIATED_ACTIV...,SET,33,-0.034314,-0.0014535,0.15457,0.58784,REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,0.99999
GOBP_PROTEOGLYCAN_METABOLIC_...,SET,83,-0.021595,-0.0014487,0.097269,0.58785,GOBP_PROTEOGLYCAN_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...185,SET,3,-0.11083,-0.0014167,0.4988,0.58792,GOBP_NEGATIVE_REGULATION_OF_DNA_CATABOLIC_PROCESS,0.99999
HP_SPASTIC_PARAPARETIC_GAIT,SET,9,-0.072661,-0.0016084,0.32695,0.58793,HP_SPASTIC_PARAPARETIC_GAIT,0.99999
HP_RENAL_SODIUM_WASTING,SET,7,-0.070217,-0.0013709,0.31584,0.58796,HP_RENAL_SODIUM_WASTING,0.99999
GOBP_GLYCOSYLATION,SET,223,-0.013032,-0.0014276,0.05862,0.58797,GOBP_GLYCOSYLATION,0.99999
HP_BRONCHOMALACIA,SET,23,-0.036098,-0.0012769,0.16229,0.58801,HP_BRONCHOMALACIA,0.99999
GOBP_REGULATION_OF_PROTEIN_D...1,SET,25,-0.034676,-0.0012787,0.15573,0.5881,GOBP_REGULATION_OF_PROTEIN_DEACETYLATION,0.99999
STAT5A_04,SET,188,-0.014187,-0.0014284,0.06369,0.58814,STAT5A_04,0.99999
GOBP_NEGATIVE_REGULATION_OF_...225,SET,4,-0.094879,-0.0014004,0.42584,0.58816,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.99999
BIOCARTA_GCR_PATHWAY,SET,17,-0.048548,-0.0014767,0.21783,0.58818,BIOCARTA_GCR_PATHWAY,0.99999
BIOCARTA_INTEGRIN_PATHWAY,SET,34,-0.03351,-0.0014408,0.15034,0.58819,BIOCARTA_INTEGRIN_PATHWAY,0.99999
LIU_TARGETS_OF_VMYB_VS_CMYB_...2,SET,15,-0.051937,-0.001484,0.23278,0.58828,LIU_TARGETS_OF_VMYB_VS_CMYB_UP,0.99999
STARK_PREFRONTAL_CORTEX_22Q1...2,SET,180,-0.014435,-0.0014223,0.064693,0.58828,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,0.99999
HP_NEONATAL_DEATH,SET,82,-0.02033,-0.0013557,0.091066,0.58833,HP_NEONATAL_DEATH,0.99999
GOCC_SPECIFIC_GRANULE,SET,148,-0.015976,-0.0014287,0.071555,0.58834,GOCC_SPECIFIC_GRANULE,0.99999
GSE23502_WT_VS_HDC_KO_MYELOI...2,SET,179,-0.014045,-0.0013801,0.062858,0.5884,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP,0.99999
HMCES_TARGET_GENES,SET,6,-0.072262,-0.0013062,0.32333,0.58842,HMCES_TARGET_GENES,0.99999
BIOCARTA_CERAMIDE_PATHWAY,SET,20,-0.043706,-0.0014418,0.19535,0.58852,BIOCARTA_CERAMIDE_PATHWAY,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...3,SET,6,-0.088785,-0.0016048,0.3968,0.58852,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_ENDOTHELIN,0.99999
GSE15930_NAIVE_VS_48H_IN_VIT...1,SET,183,-0.013176,-0.001309,0.058891,0.58852,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...6,SET,138,-0.016889,-0.0014588,0.07546,0.58855,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
MODULE_47,SET,208,-0.014246,-0.0015077,0.063624,0.58858,MODULE_47,0.99999
MODULE_346,SET,17,-0.050335,-0.001531,0.22479,0.58859,MODULE_346,0.99999
GOMF_SOLUTE_SODIUM_SYMPORTER...,SET,77,-0.023021,-0.0014878,0.10261,0.58876,GOMF_SOLUTE_SODIUM_SYMPORTER_ACTIVITY,0.99999
HP_CENTROCECAL_SCOTOMA,SET,3,-0.088517,-0.0011315,0.39445,0.58878,HP_CENTROCECAL_SCOTOMA,0.99999
REACTOME_APOPTOTIC_CLEAVAGE_...1,SET,35,-0.032774,-0.0014297,0.146,0.5888,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,0.99999
GOBP_POSITIVE_REGULATION_OF_...384,SET,6,-0.07589,-0.0013717,0.33805,0.58881,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.99999
MIR6783_5P,SET,144,-0.016716,-0.0014746,0.074446,0.58883,MIR6783_5P,0.99999
MORF_MYC,SET,75,-0.022029,-0.0014051,0.098059,0.58887,MORF_MYC,0.99999
HP_PULMONARY_INTERSTITIAL_TH...,SET,7,-0.082319,-0.0016071,0.36628,0.58891,HP_PULMONARY_INTERSTITIAL_THICKENING,0.99999
PID_UPA_UPAR_PATHWAY,SET,42,-0.033506,-0.0016008,0.14906,0.58893,PID_UPA_UPAR_PATHWAY,0.99999
PID_WNT_SIGNALING_PATHWAY,SET,25,-0.04264,-0.0015724,0.18954,0.589,PID_WNT_SIGNALING_PATHWAY,0.99999
HP_HEMIANOPIA,SET,37,-0.030578,-0.0013714,0.13591,0.58901,HP_HEMIANOPIA,0.99999
SU_PLACENTA,SET,23,-0.041861,-0.0014808,0.18602,0.58903,SU_PLACENTA,0.99999
REACTOME_PEROXISOMAL_LIPID_M...,SET,28,-0.03453,-0.0013475,0.15335,0.58908,REACTOME_PEROXISOMAL_LIPID_METABOLISM,0.99999
GOBP_REGULATION_OF_PHENOTYPI...,SET,3,-0.13317,-0.0017023,0.59138,0.58908,GOBP_REGULATION_OF_PHENOTYPIC_SWITCHING,0.99999
ANDERSON_BLOOD_CN54GP140_ADJ...10,SET,5,-0.085869,-0.0014169,0.3813,0.58909,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_LOW_IGM_RESPONDERS_6HY_1DY_UP,0.99999
GSE25846_IL10_POS_VS_NEG_CD8...2,SET,175,-0.014733,-0.0014316,0.065345,0.58919,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP,0.99999
NABA_MATRISOME_HIGHLY_METAST...4,SET,12,-0.058654,-0.0014991,0.26005,0.58922,NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED,0.99999
HP_ABNORMAL_FEMORAL_NECK_HEA...,SET,180,-0.014444,-0.0014232,0.064041,0.58922,HP_ABNORMAL_FEMORAL_NECK_HEAD_MORPHOLOGY,0.99999
HP_TEMPORAL_PATTERN,SET,18,-0.045306,-0.001418,0.20087,0.58922,HP_TEMPORAL_PATTERN,0.99999
REACTOME_VLDLR_INTERNALISATI...,SET,15,-0.048176,-0.0013765,0.21359,0.58923,REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION,0.99999
GOBP_DNA_REPLICATION_INITIAT...,SET,35,-0.029979,-0.0013077,0.13284,0.58927,GOBP_DNA_REPLICATION_INITIATION,0.99999
REACTOME_VITAMINS,SET,6,-0.089133,-0.0016111,0.39459,0.58935,REACTOME_VITAMINS,0.99999
GSE39556_CD8A_DC_VS_NK_CELL_...1,SET,177,-0.015108,-0.0014763,0.066887,0.58935,GSE39556_CD8A_DC_VS_NK_CELL_DN,0.99999
HP_CONGENITAL_SENSORINEURAL_...,SET,54,-0.027488,-0.0014886,0.12168,0.58936,HP_CONGENITAL_SENSORINEURAL_HEARING_IMPAIRMENT,0.99999
HP_ABNORMAL_PINEAL_MORPHOLOGY,SET,10,-0.060457,-0.0014106,0.26759,0.58937,HP_ABNORMAL_PINEAL_MORPHOLOGY,0.99999
HNF1_01,SET,220,-0.014079,-0.0015319,0.062288,0.58941,HNF1_01,0.99999
KEGG_PARKINSONS_DISEASE,SET,92,-0.017977,-0.0012695,0.079524,0.58942,KEGG_PARKINSONS_DISEASE,0.99999
PAX8_B,SET,91,-0.020894,-0.0014674,0.092386,0.58946,PAX8_B,0.99999
GSE22025_UNTREATED_VS_PROGES...1,SET,184,-0.014603,-0.0014546,0.064569,0.58946,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN,0.99999
KEGG_MEDICUS_REFERENCE_P15_C...,SET,13,-0.048302,-0.0012849,0.2134,0.58953,KEGG_MEDICUS_REFERENCE_P15_CELL_CYCLE_G1_S,0.99999
GOBP_RIBOSOME_ASSOCIATED_UBI...,SET,7,-0.0529,-0.0010328,0.23348,0.58962,GOBP_RIBOSOME_ASSOCIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_RESPONSE_...1,SET,474,-0.0089969,-0.0014269,0.039652,0.58975,GOBP_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,0.99999
GOBP_GOLGI_TO_VACUOLE_TRANSP...,SET,20,-0.040852,-0.0013477,0.18002,0.58976,GOBP_GOLGI_TO_VACUOLE_TRANSPORT,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...3,SET,182,-0.013737,-0.0013609,0.06048,0.58984,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
GSE26351_UNSTIM_VS_BMP_PATHW...1,SET,176,-0.014313,-0.0013947,0.063,0.58986,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,0.99999
MIR769_3P,SET,27,-0.03776,-0.001447,0.16614,0.5899,MIR769_3P,0.99999
REACTOME_TGFBR3_PTM_REGULATI...,SET,9,-0.064397,-0.0014255,0.28321,0.58994,REACTOME_TGFBR3_PTM_REGULATION,0.99999
GSE14415_INDUCED_TREG_VS_TCO...2,SET,158,-0.014653,-0.0013535,0.064439,0.58994,GSE14415_INDUCED_TREG_VS_TCONV_UP,0.99999
GOBP_EPITHELIUM_DEVELOPMENT,SET,1134,-0.0063816,-0.0015363,0.028051,0.58998,GOBP_EPITHELIUM_DEVELOPMENT,0.99999
UNTERMAN_IPF_VS_CTRL_TREG_CE...2,SET,13,-0.0609,-0.00162,0.26764,0.59,UNTERMAN_IPF_VS_CTRL_TREG_CELL_UP,0.99999
WP_NONHOMOLOGOUS_END_JOINING,SET,10,-0.050251,-0.0011725,0.22083,0.59,WP_NONHOMOLOGOUS_END_JOINING,0.99999
MODULE_178,SET,15,-0.057604,-0.0016459,0.25314,0.59,MODULE_178,0.99999
AACATTC_MIR4093P,SET,137,-0.017026,-0.0014653,0.074706,0.59014,AACATTC_MIR4093P,0.99999
GOMF_DIACYLGLYCEROL_DEPENDEN...,SET,16,-0.050375,-0.0014865,0.22104,0.59014,GOMF_DIACYLGLYCEROL_DEPENDENT_SERINE_THREONINE_KINASE_ACTIVITY,0.99999
GSE37533_PPARG1_FOXP3_VS_PPA...2,SET,189,-0.014904,-0.0015044,0.065395,0.59014,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,0.99999
GOBP_NEURON_GLIAL_CELL_SIGNA...,SET,5,-0.10531,-0.0017377,0.46191,0.59017,GOBP_NEURON_GLIAL_CELL_SIGNALING,0.99999
GSE43863_TFH_VS_LY6C_INT_CXC...2,SET,182,-0.014214,-0.0014082,0.062334,0.59019,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,0.99999
MIR582_5P,SET,326,-0.011025,-0.0014561,0.04834,0.59021,MIR582_5P,0.99999
GSE2770_UNTREATED_VS_TGFB_AN...2,SET,183,-0.014618,-0.0014521,0.064044,0.59027,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
RUBENSTEIN_SKELETAL_MUSCLE_P...1,SET,202,-0.014748,-0.0015385,0.064611,0.59028,RUBENSTEIN_SKELETAL_MUSCLE_PCV_ENDOTHELIAL_CELLS,0.99999
LIU_OVARIAN_CANCER_TUMORS_AN...3,SET,74,-0.022425,-0.0014209,0.098168,0.59034,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP,0.99999
GOBP_MEMBRANE_DOCKING,SET,83,-0.021287,-0.0014281,0.093184,0.59035,GOBP_MEMBRANE_DOCKING,0.99999
GOBP_DETECTION_OF_STIMULUS_I...2,SET,27,-0.039316,-0.0015067,0.17204,0.59038,GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.99999
HOLLEMAN_VINCRISTINE_RESISTA...1,SET,19,-0.044971,-0.001446,0.19676,0.59039,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN,0.99999
WP_INTERFERONMEDIATED_SIGNAL...,SET,33,-0.041028,-0.0017379,0.17939,0.59045,WP_INTERFERONMEDIATED_SIGNALING,0.99999
HP_EXOPHORIA,SET,6,-0.073465,-0.0013279,0.32116,0.59047,HP_EXOPHORIA,0.99999
KEGG_VIRAL_MYOCARDITIS,SET,64,-0.02742,-0.0016161,0.11983,0.59049,KEGG_VIRAL_MYOCARDITIS,0.99999
GSE3982_MAST_CELL_VS_BASOPHI...2,SET,174,-0.014972,-0.0014506,0.065428,0.5905,GSE3982_MAST_CELL_VS_BASOPHIL_UP,0.99999
GOBP_ENDOCRINE_PROCESS,SET,84,-0.022971,-0.0015503,0.10033,0.59054,GOBP_ENDOCRINE_PROCESS,0.99999
P53_DN.V1_UP,SET,178,-0.015921,-0.0015601,0.069548,0.59054,P53_DN.V1_UP,0.99999
GOMF_PROTEIN_TRANSMEMBRANE_T...,SET,24,-0.039567,-0.0014297,0.17281,0.59055,GOMF_PROTEIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOMF_RS_DOMAIN_BINDING,SET,4,-0.082024,-0.0012106,0.35813,0.59058,GOMF_RS_DOMAIN_BINDING,0.99999
HP_BOWED_HUMERUS,SET,7,-0.074927,-0.0014628,0.32709,0.59059,HP_BOWED_HUMERUS,0.99999
DESCARTES_MAIN_FETAL_STELLAT...,SET,44,-0.032904,-0.001609,0.14355,0.59065,DESCARTES_MAIN_FETAL_STELLATE_CELLS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...316,SET,13,-0.054611,-0.0014527,0.23822,0.59066,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_ANTIGEN_PROCESSING_AND_...13,SET,30,-0.041022,-0.0016569,0.1789,0.59068,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II,0.99999
HP_SINGLE_NARIS,SET,19,-0.047505,-0.0015275,0.20712,0.5907,HP_SINGLE_NARIS,0.99999
GOBP_AMYLOID_BETA_CLEARANCE_...2,SET,7,-0.070066,-0.0013679,0.3053,0.59076,GOBP_AMYLOID_BETA_CLEARANCE_BY_TRANSCYTOSIS,0.99999
GOMF_PHOSPHATIDYLINOSITOL_3_...1,SET,4,-0.098842,-0.0014589,0.43061,0.59077,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_3_PHOSPHATASE_ACTIVITY,0.99999
HP_JOINT_DISLOCATION,SET,330,-0.010849,-0.0014415,0.04725,0.5908,HP_JOINT_DISLOCATION,0.99999
GSE6269_FLU_VS_STREP_PNEUMO_...1,SET,146,-0.016369,-0.001454,0.071285,0.59081,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN,0.99999
GOMF_ALCOHOL_DEHYDROGENASE_N...1,SET,7,-0.12359,-0.0024129,0.53794,0.59085,GOMF_ALCOHOL_DEHYDROGENASE_NADPLUS_ACTIVITY_ZINC_DEPENDENT,0.99999
GSE26030_UNSTIM_VS_RESTIM_TH...5,SET,192,-0.013965,-0.0014206,0.06078,0.59086,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN,0.99999
MODULE_236,SET,16,-0.051694,-0.0015255,0.22489,0.5909,MODULE_236,0.99999
GSE23925_LIGHT_ZONE_VS_NAIVE...1,SET,174,-0.014439,-0.0013991,0.062789,0.59094,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_DN,0.99999
GOBP_PHOTOPERIODISM,SET,26,-0.037966,-0.0014278,0.16504,0.59097,GOBP_PHOTOPERIODISM,0.99999
HP_PAST_MEDICAL_HISTORY,SET,156,-0.016478,-0.0015126,0.071575,0.59104,HP_PAST_MEDICAL_HISTORY,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...16,SET,185,-0.014497,-0.001448,0.062966,0.59105,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP,0.99999
HP_ABNORMAL_SHOULDER_MORPHOL...,SET,79,-0.023023,-0.001507,0.099938,0.5911,HP_ABNORMAL_SHOULDER_MORPHOLOGY,0.99999
GOMF_DIPEPTIDE_TRANSMEMBRANE...,SET,5,-0.095412,-0.0015744,0.41405,0.59112,GOMF_DIPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
LUI_THYROID_CANCER_CLUSTER_5,SET,14,-0.050888,-0.0014048,0.22077,0.59115,LUI_THYROID_CANCER_CLUSTER_5,0.99999
REACTOME_TRANSPORT_OF_MATURE...1,SET,40,-0.028401,-0.0013243,0.12309,0.59124,REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS,0.99999
BIOCARTA_RHO_PATHWAY,SET,18,-0.045694,-0.0014301,0.198,0.59125,BIOCARTA_RHO_PATHWAY,0.99999
HP_POSTERIOR_EMBRYOTOXON,SET,46,-0.030513,-0.0015255,0.13219,0.59127,HP_POSTERIOR_EMBRYOTOXON,0.99999
MIR4800_5P,SET,23,-0.041547,-0.0014697,0.17992,0.59131,MIR4800_5P,0.99999
REACTOME_FRS_MEDIATED_FGFR4_...,SET,21,-0.04288,-0.0014494,0.1856,0.59135,REACTOME_FRS_MEDIATED_FGFR4_SIGNALING,0.99999
HP_LATE_FIRST_TRIMESTER_ONSET,SET,7,-0.069193,-0.0013509,0.29949,0.59136,HP_LATE_FIRST_TRIMESTER_ONSET,0.99999
GSE40666_UNTREATED_VS_IFNA_S...8,SET,188,-0.014679,-0.0014778,0.063519,0.59138,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_UP,0.99999
HP_BILIARY_ATRESIA,SET,11,-0.058129,-0.0014225,0.25146,0.5914,HP_BILIARY_ATRESIA,0.99999
BUYTAERT_PHOTODYNAMIC_THERAP...1,SET,578,-0.0080572,-0.001407,0.034835,0.59146,BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN,0.99999
GOMF_MONOCARBOXYLIC_ACID_TRA...,SET,67,-0.024995,-0.0015073,0.10801,0.5915,GOMF_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_CORNEAL_DYSTROPHY,SET,29,-0.039752,-0.0015787,0.17176,0.59151,HP_CORNEAL_DYSTROPHY,0.99999
GOCC_PROTEIN_FOLDING_CHAPERO...,SET,40,-0.028044,-0.0013076,0.12116,0.59152,GOCC_PROTEIN_FOLDING_CHAPERONE_COMPLEX,0.99999
RICKMAN_TUMOR_DIFFERENTIATED...3,SET,101,-0.019968,-0.001477,0.086253,0.59154,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,0.99999
FIGUEROA_AML_METHYLATION_CLU...13,SET,4,-0.11867,-0.0017515,0.51248,0.59156,FIGUEROA_AML_METHYLATION_CLUSTER_7_DN,0.99999
GOBP_REGULATION_OF_PROTEIN_K...1,SET,6,-0.078765,-0.0014237,0.34005,0.59158,GOBP_REGULATION_OF_PROTEIN_K48_LINKED_UBIQUITINATION,0.99999
GOBP_SPERM_FLAGELLUM_ASSEMBLY,SET,42,-0.029056,-0.0013882,0.12542,0.5916,GOBP_SPERM_FLAGELLUM_ASSEMBLY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...354,SET,5,-0.094299,-0.001556,0.40633,0.59176,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS,0.99999
GOBP_RESPONSE_TO_MANGANESE_I...,SET,16,-0.050839,-0.0015002,0.21901,0.59178,GOBP_RESPONSE_TO_MANGANESE_ION,0.99999
GOBP_VESICLE_COATING,SET,37,-0.030207,-0.0013548,0.13013,0.59178,GOBP_VESICLE_COATING,0.99999
MARKEY_RB1_CHRONIC_LOF_DN,SET,107,-0.020064,-0.0015273,0.086426,0.59179,MARKEY_RB1_CHRONIC_LOF_DN,0.99999
HP_INFERIOR_CEREBELLAR_VERMI...,SET,13,-0.054421,-0.0014477,0.23442,0.59179,HP_INFERIOR_CEREBELLAR_VERMIS_HYPOPLASIA,0.99999
HP_ENLARGED_TONSILS,SET,5,-0.084666,-0.0013971,0.36465,0.5918,HP_ENLARGED_TONSILS,0.99999
GOBP_GLYCOLIPID_CATABOLIC_PR...,SET,20,-0.045952,-0.0015159,0.19784,0.59183,GOBP_GLYCOLIPID_CATABOLIC_PROCESS,0.99999
HP_NEPHRONOPHTHISIS,SET,35,-0.031782,-0.0013864,0.13684,0.59183,HP_NEPHRONOPHTHISIS,0.99999
GOBP_ANTEROGRADE_NEURONAL_DE...,SET,6,-0.079514,-0.0014373,0.34214,0.59188,GOBP_ANTEROGRADE_NEURONAL_DENSE_CORE_VESICLE_TRANSPORT,0.99999
GSE42724_MEMORY_VS_B1_BCELL_...2,SET,185,-0.013965,-0.0013948,0.060069,0.59192,GSE42724_MEMORY_VS_B1_BCELL_UP,0.99999
HP_OVERWEIGHT,SET,42,-0.030567,-0.0014604,0.13146,0.59193,HP_OVERWEIGHT,0.99999
GOBP_REGULATION_OF_ANTIMICRO...2,SET,9,-0.07581,-0.0016781,0.3257,0.59203,GOBP_REGULATION_OF_ANTIMICROBIAL_PEPTIDE_PRODUCTION,0.99999
chr4q22,SET,31,-0.065844,-0.0027035,0.28281,0.59205,chr4q22,0.99999
REACTOME_PTK6_PROMOTES_HIF1A...,SET,6,-0.086999,-0.0015726,0.37369,0.59205,REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...776,SET,4,-0.11535,-0.0017026,0.49542,0.59206,GOBP_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,0.99999
MODULE_50,SET,13,-0.042068,-0.0011191,0.18065,0.59207,MODULE_50,0.99999
GOBP_REGULATION_OF_HEPATOCYT...1,SET,8,-0.06224,-0.001299,0.26723,0.59208,GOBP_REGULATION_OF_HEPATOCYTE_APOPTOTIC_PROCESS,0.99999
GSE16522_MEMORY_VS_NAIVE_ANT...1,SET,183,-0.014773,-0.0014676,0.063423,0.59209,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN,0.99999
HP_INTRAVENTRICULAR_HEMORRHA...,SET,7,-0.085088,-0.0016612,0.36519,0.59212,HP_INTRAVENTRICULAR_HEMORRHAGE,0.99999
MODULE_373,SET,20,-0.045226,-0.001492,0.19406,0.59214,MODULE_373,0.99999
GOBP_REGULATION_OF_IRE1_MEDI...,SET,14,-0.056218,-0.0015519,0.24111,0.59218,GOBP_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.99999
TORCHIA_TARGETS_OF_EWSR1_FLI...3,SET,17,-0.052318,-0.0015913,0.22436,0.59219,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP,0.99999
GOMF_OXYSTEROL_BINDING,SET,16,-0.05719,-0.0016876,0.24524,0.5922,GOMF_OXYSTEROL_BINDING,0.99999
BLALOCK_ALZHEIMERS_DISEASE_I...2,SET,348,-0.010491,-0.0014306,0.044961,0.59225,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,0.99999
METHYLCYTOSINE_DIOXYGENASE_T...,SET,117,-0.017491,-0.0013919,0.074954,0.59226,METHYLCYTOSINE_DIOXYGENASE_TET_UNIPROT_A0A023HHK9_UNREVIEWED_TARGET_GENES,0.99999
HP_ANKLE_WEAKNESS,SET,17,-0.044573,-0.0013558,0.19096,0.59228,HP_ANKLE_WEAKNESS,0.99999
SESTO_RESPONSE_TO_UV_C4,SET,20,-0.04167,-0.0013746,0.17846,0.59231,SESTO_RESPONSE_TO_UV_C4,0.99999
SOX11_TARGET_GENES,SET,35,-0.032077,-0.0013993,0.13738,0.59231,SOX11_TARGET_GENES,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...39,SET,25,-0.040103,-0.0014789,0.17156,0.59241,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.99999
HP_DISTAL_UPPER_LIMB_MUSCLE_...,SET,37,-0.034762,-0.001559,0.14871,0.59241,HP_DISTAL_UPPER_LIMB_MUSCLE_WEAKNESS,0.99999
GOMF_POLY_A_BINDING,SET,21,-0.043756,-0.0014791,0.18718,0.59242,GOMF_POLY_A_BINDING,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...58,SET,6,-0.086769,-0.0015684,0.37071,0.59253,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_PERK_ATF4_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_GLYCOGEN_...4,SET,4,-0.090633,-0.0013377,0.38697,0.59259,GOBP_REGULATION_OF_GLYCOGEN_STARCH_SYNTHASE_ACTIVITY,0.99999
MIR4652_5P,SET,32,-0.034891,-0.0014554,0.14893,0.59261,MIR4652_5P,0.99999
REACTOME_METHYLATION,SET,14,-0.053636,-0.0014806,0.22892,0.59262,REACTOME_METHYLATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...467,SET,8,-0.077182,-0.0016108,0.32935,0.59264,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION,0.99999
WP_GANGLIO_SPHINGOLIPID_META...,SET,13,-0.061728,-0.0016421,0.26316,0.59272,WP_GANGLIO_SPHINGOLIPID_METABOLISM,0.99999
GOBP_REGULATION_OF_ISOTYPE_S...2,SET,6,-0.080433,-0.0014539,0.3426,0.59281,GOBP_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGE_ISOTYPES,0.99999
chr2q32,SET,41,-0.058739,-0.0027728,0.25015,0.59282,chr2q32,0.99999
GOBP_CELL_CELL_ADHESION,SET,897,-0.0075704,-0.001632,0.032239,0.59282,GOBP_CELL_CELL_ADHESION,0.99999
HP_CARDIOMEGALY,SET,114,-0.018819,-0.0014784,0.080134,0.59283,HP_CARDIOMEGALY,0.99999
MIR382_5P,SET,52,-0.026914,-0.0014304,0.11459,0.59285,MIR382_5P,0.99999
GSE45739_NRAS_KO_VS_WT_ACD3_...1,SET,166,-0.015073,-0.0014268,0.06414,0.59289,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN,0.99999
GOMF_INSULIN_LIKE_GROWTH_FAC...3,SET,13,-0.065237,-0.0017354,0.27753,0.59292,GOMF_INSULIN_LIKE_GROWTH_FACTOR_I_BINDING,0.99999
MIR6813_3P,SET,30,-0.035816,-0.0014467,0.15216,0.59304,MIR6813_3P,0.99999
KORKOLA_YOLK_SAC_TUMOR_UP,SET,13,-0.067143,-0.0017861,0.28521,0.59305,KORKOLA_YOLK_SAC_TUMOR_UP,0.99999
GOBP_CATECHOLAMINE_UPTAKE_IN...,SET,11,-0.060851,-0.0014891,0.25841,0.59308,GOBP_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION,0.99999
MODULE_464,SET,14,-0.052382,-0.001446,0.22239,0.5931,MODULE_464,0.99999
GOCC_TROPONIN_COMPLEX,SET,8,-0.076137,-0.001589,0.32327,0.5931,GOCC_TROPONIN_COMPLEX,0.99999
GSE12001_MIR223_KO_VS_WT_NEU...1,SET,178,-0.01483,-0.0014532,0.062956,0.59311,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN,0.99999
DLX4_TARGET_GENES,SET,686,-0.0077167,-0.0014636,0.032756,0.59312,DLX4_TARGET_GENES,0.99999
GOBP_CARDIAC_MYOFIBRIL_ASSEM...,SET,19,-0.046624,-0.0014992,0.1979,0.59313,GOBP_CARDIAC_MYOFIBRIL_ASSEMBLY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...256,SET,15,-0.048257,-0.0013789,0.20477,0.59315,GOBP_NEGATIVE_REGULATION_OF_GLUCONEOGENESIS,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_UL...,SET,140,-0.017361,-0.0015103,0.073652,0.59317,HP_ABNORMAL_MORPHOLOGY_OF_ULNA,0.99999
GOMF_DNA_N_GLYCOSYLASE_ACTIV...,SET,14,-0.050126,-0.0013837,0.21262,0.59319,GOMF_DNA_N_GLYCOSYLASE_ACTIVITY,0.99999
GSE27786_CD4_TCELL_VS_ERYTHT...1,SET,180,-0.014399,-0.0014188,0.061025,0.59327,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN,0.99999
HP_DISTAL_LOWER_LIMB_MUSCLE_...,SET,84,-0.022229,-0.0015002,0.094136,0.59333,HP_DISTAL_LOWER_LIMB_MUSCLE_WEAKNESS,0.99999
HP_ABNORMAL_BLOOD_TRANSITION...,SET,37,-0.032146,-0.0014417,0.1361,0.59335,HP_ABNORMAL_BLOOD_TRANSITION_ELEMENT_CATION_CONCENTRATION,0.99999
GOMF_VOLTAGE_GATED_SODIUM_CH...1,SET,23,-0.045676,-0.0016157,0.19339,0.59336,GOMF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...322,SET,96,-0.020284,-0.001463,0.085863,0.59338,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GSE27241_WT_VS_RORGT_KO_TH17...1,SET,152,-0.0154,-0.0013955,0.065164,0.59341,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...619,SET,136,-0.016928,-0.0014516,0.071587,0.59346,GOBP_NEGATIVE_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...15,SET,30,-0.040596,-0.0016398,0.17156,0.59353,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN,0.99999
REACTOME_REGULATION_OF_TP53_...3,SET,14,-0.05297,-0.0014622,0.22381,0.59355,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS,0.99999
GOBP_DENDRITIC_CELL_CHEMOTAX...,SET,24,-0.044278,-0.0015999,0.18707,0.59355,GOBP_DENDRITIC_CELL_CHEMOTAXIS,0.99999
KEGG_MEDICUS_REFERENCE_BREAK...,SET,8,-0.070871,-0.0014791,0.29925,0.5936,KEGG_MEDICUS_REFERENCE_BREAK_INDUCED_REPLICATION,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...13,SET,8,-0.078537,-0.0016391,0.33156,0.59362,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29,0.99999
MIR4305,SET,50,-0.02796,-0.0014572,0.11798,0.59366,MIR4305,0.99999
KEGG_JAK_STAT_SIGNALING_PATH...,SET,139,-0.01906,-0.0016523,0.080418,0.59368,KEGG_JAK_STAT_SIGNALING_PATHWAY,0.99999
GSE32164_ALTERNATIVELY_ACT_M...1,SET,179,-0.014692,-0.0014437,0.061978,0.59369,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN,0.99999
GAUCHER_PBMC_YF_VAX_STAMARIL...2,SET,183,-0.015395,-0.0015293,0.064942,0.59369,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP,0.99999
HP_ABNORMAL_CIRCULATING_LACT...,SET,90,-0.021825,-0.0015244,0.092043,0.59371,HP_ABNORMAL_CIRCULATING_LACTATE_DEHYDROGENASE_CONCENTRATION,0.99999
HP_ABNORMAL_MACROSCOPIC_URIN...,SET,47,-0.029186,-0.0014749,0.123,0.59378,HP_ABNORMAL_MACROSCOPIC_URINE_APPEARANCE,0.99999
GOBP_REPRODUCTIVE_BEHAVIOR,SET,44,-0.033557,-0.0016409,0.14129,0.59387,GOBP_REPRODUCTIVE_BEHAVIOR,0.99999
GOBP_SMOOTH_MUSCLE_ADAPTATION,SET,4,-0.12408,-0.0018314,0.5224,0.59387,GOBP_SMOOTH_MUSCLE_ADAPTATION,0.99999
GOBP_PLASMA_MEMBRANE_TUBULAT...,SET,18,-0.045158,-0.0014133,0.18989,0.59399,GOBP_PLASMA_MEMBRANE_TUBULATION,0.99999
GOBP_PROTEIN_DNA_COVALENT_CR...,SET,8,-0.057974,-0.00121,0.24376,0.59399,GOBP_PROTEIN_DNA_COVALENT_CROSS_LINKING_REPAIR,0.99999
GSE30083_SP1_VS_SP4_THYMOCYT...2,SET,180,-0.015082,-0.0014861,0.063366,0.59406,GSE30083_SP1_VS_SP4_THYMOCYTE_UP,0.99999
TSAI_RESPONSE_TO_IONIZING_RA...,SET,142,-0.016638,-0.0014576,0.069853,0.59413,TSAI_RESPONSE_TO_IONIZING_RADIATION,0.99999
MIR6891_3P,SET,62,-0.026403,-0.0015318,0.11084,0.59414,MIR6891_3P,0.99999
GOBP_REGULATION_OF_STRIATED_...3,SET,18,-0.055951,-0.0017511,0.23489,0.59414,GOBP_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT,0.99999
GOBP_FEAR_RESPONSE,SET,44,-0.034105,-0.0016677,0.14311,0.59418,GOBP_FEAR_RESPONSE,0.99999
HP_ABNORMAL_PERIPHERAL_MYELI...,SET,92,-0.020683,-0.0014605,0.086762,0.59421,HP_ABNORMAL_PERIPHERAL_MYELINATION,0.99999
HP_MYOFIBER_DISARRAY,SET,10,-0.061252,-0.0014292,0.25693,0.59421,HP_MYOFIBER_DISARRAY,0.99999
GOBP_RESPONSE_TO_INTERLEUKIN...8,SET,6,-0.081589,-0.0014748,0.34186,0.59431,GOBP_RESPONSE_TO_INTERLEUKIN_3,0.99999
GOTZMANN_EPITHELIAL_TO_MESEN...1,SET,192,-0.014877,-0.0015135,0.062324,0.59433,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,0.99999
MIR4518,SET,81,-0.022244,-0.0014743,0.093185,0.59433,MIR4518,0.99999
MODULE_108,SET,52,-0.034925,-0.0018561,0.14626,0.59436,MODULE_108,0.99999
GOBP_NEGATIVE_REGULATION_OF_...640,SET,61,-0.024663,-0.0014193,0.10328,0.59437,GOBP_NEGATIVE_REGULATION_OF_TOR_SIGNALING,0.99999
GRANDVAUX_IRF3_TARGETS_DN,SET,17,-0.053535,-0.0016284,0.22415,0.59438,GRANDVAUX_IRF3_TARGETS_DN,0.99999
HP_EEG_WITH_FOCAL_SPIKES,SET,30,-0.039452,-0.0015935,0.16503,0.59447,HP_EEG_WITH_FOCAL_SPIKES,0.99999
GSE15930_STIM_VS_STIM_AND_TR...2,SET,177,-0.015527,-0.0015173,0.064929,0.5945,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP,0.99999
WELCH_GATA1_TARGETS,SET,21,-0.045679,-0.0015441,0.19099,0.59451,WELCH_GATA1_TARGETS,0.99999
GOMF_SYNTAXIN_BINDING,SET,59,-0.025839,-0.0014625,0.10804,0.59451,GOMF_SYNTAXIN_BINDING,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...3,SET,164,-0.015523,-0.0014606,0.064877,0.59455,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_THORAX,0.99999
HP_SEVERE_COMBINED_IMMUNODEF...,SET,19,-0.048882,-0.0015718,0.20427,0.59456,HP_SEVERE_COMBINED_IMMUNODEFICIENCY,0.99999
GSE360_DC_VS_MAC_B_MALAYI_LO...1,SET,175,-0.015237,-0.0014806,0.063675,0.59456,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN,0.99999
GNF2_MYL2,SET,32,-0.037637,-0.00157,0.15725,0.59458,GNF2_MYL2,0.99999
MIR19B_3P,SET,594,-0.0088638,-0.0015684,0.036954,0.59478,MIR19B_3P,0.99999
FULLER_PBMC_F_TULARENSIS_VAC...8,SET,30,-0.041283,-0.0016675,0.17211,0.59478,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_DN,0.99999
MIR3144_5P,SET,46,-0.031107,-0.0015552,0.12966,0.5948,MIR3144_5P,0.99999
HP_ABNORMALITY_OF_THE_MIDDLE...3,SET,10,-0.062911,-0.0014679,0.26215,0.59483,HP_ABNORMALITY_OF_THE_MIDDLE_PHALANGES_OF_THE_TOES,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_INT...,SET,243,-0.014165,-0.0016189,0.059014,0.59485,HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL,0.99999
HP_DELAYED_ABILITY_TO_SIT,SET,76,-0.023537,-0.0015113,0.098027,0.59488,HP_DELAYED_ABILITY_TO_SIT,0.99999
HOUNKPE_HOUSEKEEPING_GENES,SET,1052,-0.0059986,-0.0013942,0.024976,0.5949,HOUNKPE_HOUSEKEEPING_GENES,0.99999
MATSUMIYA_PBMC_MODIFIED_VACC...5,SET,26,-0.041275,-0.0015522,0.17176,0.59495,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_WILD_TYPE_MVA_6HR_UP,0.99999
GSE46242_CTRL_VS_EGR2_DELETE...3,SET,161,-0.016437,-0.0015325,0.068354,0.59502,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN,0.99999
GSE22935_UNSTIM_VS_48H_MBOVI...2,SET,178,-0.015687,-0.0015371,0.06519,0.59508,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.99999
ROYLANCE_BREAST_CANCER_16Q_C...1,SET,24,-0.063515,-0.002295,0.26393,0.59509,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN,0.99999
KEGG_MEDICUS_REFERENCE_MODIF...1,SET,6,-0.074066,-0.0013388,0.30764,0.59513,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_II_SUBUNITS,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...28,SET,53,-0.027084,-0.0014532,0.1125,0.59513,GOBP_PROTEIN_LOCALIZATION_TO_LYSOSOME,0.99999
GSE7831_1H_VS_4H_CPG_STIM_PD...2,SET,179,-0.014769,-0.0014513,0.061339,0.59514,GSE7831_1H_VS_4H_CPG_STIM_PDC_UP,0.99999
HP_ABNORMAL_ESOPHAGUS_PHYSIO...,SET,773,-0.0075411,-0.0015145,0.031315,0.59515,HP_ABNORMAL_ESOPHAGUS_PHYSIOLOGY,0.99999
REACTOME_NGF_STIMULATED_TRAN...,SET,38,-0.03479,-0.0015812,0.14443,0.59517,REACTOME_NGF_STIMULATED_TRANSCRIPTION,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...4,SET,160,-0.016346,-0.0015193,0.067811,0.59524,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN,0.99999
E2F_Q6_01,SET,206,-0.014009,-0.0014756,0.058084,0.59529,E2F_Q6_01,0.99999
MIR6501_5P,SET,65,-0.025964,-0.0015422,0.10759,0.59535,MIR6501_5P,0.99999
ZNF20_TARGET_GENES,SET,5,-0.082513,-0.0013616,0.34191,0.59535,ZNF20_TARGET_GENES,0.99999
GOBP_MICROTUBULE_BASED_PROTE...,SET,14,-0.057216,-0.0015794,0.23703,0.59537,GOBP_MICROTUBULE_BASED_PROTEIN_TRANSPORT,0.99999
GSE2405_0H_VS_3H_A_PHAGOCYTO...2,SET,188,-0.0161,-0.0016209,0.066675,0.59541,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.99999
MIR6884_3P,SET,60,-0.027595,-0.001575,0.11422,0.59545,MIR6884_3P,0.99999
MODULE_126,SET,166,-0.016306,-0.0015435,0.067491,0.59545,MODULE_126,0.99999
MIR5094,SET,85,-0.02323,-0.001577,0.096099,0.5955,MIR5094,0.99999
HP_ABNORMALITY_OF_SUBCUTANEO...,SET,60,-0.027539,-0.0015718,0.1139,0.59552,HP_ABNORMALITY_OF_SUBCUTANEOUS_FAT_TISSUE,0.99999
GOBP_POSITIVE_REGULATION_OF_...775,SET,339,-0.011437,-0.0015397,0.047299,0.59553,GOBP_POSITIVE_REGULATION_OF_TRANSFERASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_HAIR_FOLL...,SET,20,-0.046859,-0.0015458,0.19378,0.59553,GOBP_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,0.99999
BIOCARTA_CLASSIC_PATHWAY,SET,10,-0.069347,-0.0016181,0.28672,0.59556,BIOCARTA_CLASSIC_PATHWAY,0.99999
REACTOME_RIPK1_MEDIATED_REGU...,SET,28,-0.03877,-0.001513,0.16028,0.59556,REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS,0.99999
WP_TRANSCRIPTIONAL_CASCADE_R...,SET,12,-0.068286,-0.0017453,0.28214,0.59562,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,0.99999
MODULE_286,SET,35,-0.03544,-0.0015459,0.14639,0.59564,MODULE_286,0.99999
GSE14350_TREG_VS_TEFF_DN,SET,185,-0.015865,-0.0015846,0.065538,0.59564,GSE14350_TREG_VS_TEFF_DN,0.99999
BLANCO_MELO_COVID19_BRONCHIA...1,SET,49,-0.032326,-0.0016679,0.13345,0.5957,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,0.99999
HP_ABNORMAL_FOREARM_MORPHOLO...,SET,211,-0.01451,-0.0015466,0.059897,0.5957,HP_ABNORMAL_FOREARM_MORPHOLOGY,0.99999
DEURIG_T_CELL_PROLYMPHOCYTIC...2,SET,310,-0.011719,-0.0015099,0.048368,0.59572,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,0.99999
HP_ABNORMAL_LENS_MORPHOLOGY,SET,720,-0.0078647,-0.0015267,0.032426,0.59582,HP_ABNORMAL_LENS_MORPHOLOGY,0.99999
HNF1_C,SET,225,-0.01465,-0.0016119,0.060381,0.59585,HNF1_C,0.99999
DAIRKEE_CANCER_PRONE_RESPONS...3,SET,27,-0.042607,-0.0016328,0.17559,0.59586,DAIRKEE_CANCER_PRONE_RESPONSE_E2,0.99999
JOHNSTONE_PARVB_TARGETS_3_DN,SET,758,-0.0075155,-0.0014953,0.030973,0.59586,JOHNSTONE_PARVB_TARGETS_3_DN,0.99999
HP_SYNOSTOSIS_INVOLVING_BONE...3,SET,106,-0.02134,-0.0016169,0.087946,0.59586,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.99999
GOMF_PHOSPHATIDYL_PHOSPHOLIP...,SET,11,-0.06459,-0.0015806,0.26616,0.59587,GOMF_PHOSPHATIDYL_PHOSPHOLIPASE_B_ACTIVITY,0.99999
GOBP_POSTSYNAPSE_ASSEMBLY,SET,41,-0.035398,-0.001671,0.14578,0.59592,GOBP_POSTSYNAPSE_ASSEMBLY,0.99999
GOBP_MICROAUTOPHAGY,SET,22,-0.042177,-0.0014592,0.17367,0.59594,GOBP_MICROAUTOPHAGY,0.99999
WP_NGLYCAN_BIOSYNTHESIS,SET,53,-0.026604,-0.0014274,0.10953,0.59595,WP_NGLYCAN_BIOSYNTHESIS,0.99999
HP_PSYCHOTIC_MENTATION,SET,15,-0.04838,-0.0013823,0.19912,0.59598,HP_PSYCHOTIC_MENTATION,0.99999
HP_HORIZONTAL_RIBS,SET,15,-0.05037,-0.0014392,0.20723,0.59602,HP_HORIZONTAL_RIBS,0.99999
HP_SENILE_PLAQUES,SET,10,-0.066841,-0.0015596,0.27482,0.59608,HP_SENILE_PLAQUES,0.99999
GSE3982_CENT_MEMORY_CD4_TCEL...1,SET,175,-0.016062,-0.0015607,0.066037,0.59608,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN,0.99999
GOBP_NATURAL_KILLER_CELL_CYT...,SET,8,-0.082396,-0.0017197,0.33865,0.59612,GOBP_NATURAL_KILLER_CELL_CYTOKINE_PRODUCTION,0.99999
MIR196A_1_3P,SET,358,-0.011405,-0.001577,0.046863,0.59614,MIR196A_1_3P,0.99999
LOCKWOOD_AMPLIFIED_IN_LUNG_C...,SET,203,-0.016189,-0.0016929,0.06649,0.59618,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,0.99999
HP_DYSPNEA,SET,432,-0.010405,-0.0015772,0.042716,0.59622,HP_DYSPNEA,0.99999
FARMER_BREAST_CANCER_CLUSTER...5,SET,19,-0.050222,-0.0016149,0.20612,0.59625,FARMER_BREAST_CANCER_CLUSTER_5,0.99999
YEGNASUBRAMANIAN_PROSTATE_CA...,SET,100,-0.02142,-0.0015766,0.087903,0.59626,YEGNASUBRAMANIAN_PROSTATE_CANCER,0.99999
KEGG_MEDICUS_REFERENCE_ITGA_...6,SET,29,-0.041131,-0.0016335,0.16878,0.59626,KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...263,SET,4,-0.12321,-0.0018185,0.50529,0.59632,GOBP_NEGATIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,0.99999
ABE_VEGFA_TARGETS_2HR,SET,27,-0.041589,-0.0015938,0.17055,0.59633,ABE_VEGFA_TARGETS_2HR,0.99999
MIR370_5P,SET,67,-0.025618,-0.0015448,0.10502,0.59636,MIR370_5P,0.99999
KEGG_MEDICUS_PATHOGEN_HCMV_U...3,SET,33,-0.037465,-0.001587,0.15356,0.59637,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY,0.99999
GSE20715_0H_VS_24H_OZONE_LUN...2,SET,183,-0.015429,-0.0015327,0.063245,0.59637,GSE20715_0H_VS_24H_OZONE_LUNG_UP,0.99999
GOBP_DENTATE_GYRUS_DEVELOPME...,SET,23,-0.045173,-0.0015979,0.18513,0.59639,GOBP_DENTATE_GYRUS_DEVELOPMENT,0.99999
HP_BILATERAL_RENAL_AGENESIS,SET,10,-0.077158,-0.0018003,0.31608,0.59643,HP_BILATERAL_RENAL_AGENESIS,0.99999
DESCARTES_FETAL_LUNG_BRONCHI...,SET,48,-0.034494,-0.0017615,0.14127,0.59645,DESCARTES_FETAL_LUNG_BRONCHIOLAR_AND_ALVEOLAR_EPITHELIAL_CELLS,0.99999
REACTOME_SUMOYLATION_OF_UBIQ...,SET,37,-0.032931,-0.0014769,0.13479,0.59651,REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS,0.99999
GOMF_CHROMATIN_BINDING,SET,522,-0.0090533,-0.0015047,0.037019,0.5966,GOMF_CHROMATIN_BINDING,0.99999
GSE9006_HEALTHY_VS_TYPE_1_DI...4,SET,183,-0.01535,-0.0015249,0.06277,0.5966,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP,0.99999
HP_MULTIPLE_GLOMERULAR_CYSTS,SET,3,-0.13022,-0.0016645,0.53226,0.59663,HP_MULTIPLE_GLOMERULAR_CYSTS,0.99999
GSE360_HIGH_VS_LOW_DOSE_B_MA...3,SET,179,-0.015397,-0.0015129,0.062939,0.59663,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN,0.99999
HP_BLOODY_DIARRHEA,SET,45,-0.032072,-0.0015859,0.13101,0.5967,HP_BLOODY_DIARRHEA,0.99999
GOBP_OSMOSENSORY_SIGNALING_P...,SET,6,-0.083496,-0.0015092,0.34085,0.59676,GOBP_OSMOSENSORY_SIGNALING_PATHWAY,0.99999
REACTOME_FOXO_MEDIATED_TRANS...3,SET,15,-0.056178,-0.0016052,0.22915,0.59683,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES,0.99999
MORF_DEAF1,SET,46,-0.029757,-0.0014877,0.12138,0.59683,MORF_DEAF1,0.99999
ATF2_S_UP.V1_UP,SET,174,-0.017165,-0.0016632,0.070006,0.59684,ATF2_S_UP.V1_UP,0.99999
MIR3662,SET,850,-0.0075202,-0.0015803,0.03067,0.59685,MIR3662,0.99999
GOBP_2FE_2S_CLUSTER_ASSEMBLY,SET,8,-0.087679,-0.0018299,0.3575,0.59687,GOBP_2FE_2S_CLUSTER_ASSEMBLY,0.99999
GOBP_POSITIVE_REGULATION_OF_...336,SET,14,-0.060886,-0.0016807,0.24823,0.59688,GOBP_POSITIVE_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION,0.99999
HP_PERSISTENT_CMV_VIREMIA,SET,5,-0.09727,-0.0016051,0.39645,0.59691,HP_PERSISTENT_CMV_VIREMIA,0.99999
HP_PERIPHERAL_OPACIFICATION_...,SET,15,-0.054175,-0.0015479,0.22076,0.59693,HP_PERIPHERAL_OPACIFICATION_OF_THE_CORNEA,0.99999
CREB_Q2_01,SET,205,-0.014565,-0.0015305,0.059341,0.59694,CREB_Q2_01,0.99999
CREBP1_01,SET,156,-0.017588,-0.0016144,0.071651,0.59695,CREBP1_01,0.99999
GOMF_HAPTOGLOBIN_BINDING,SET,6,-0.11262,-0.0020357,0.45879,0.59695,GOMF_HAPTOGLOBIN_BINDING,0.99999
TRAVAGLINI_LUNG_PROLIFERATIN...3,SET,121,-0.01848,-0.0014954,0.075246,0.597,TRAVAGLINI_LUNG_PROLIFERATING_NK_T_CELL,0.99999
GOBP_REGULATION_OF_MESODERMA...1,SET,8,-0.080549,-0.0016811,0.32794,0.59701,GOBP_REGULATION_OF_MESODERMAL_CELL_DIFFERENTIATION,0.99999
BIOCARTA_IL2RB_PATHWAY,SET,35,-0.037865,-0.0016517,0.15405,0.59708,BIOCARTA_IL2RB_PATHWAY,0.99999
REACTOME_DNA_DAMAGE_RECOGNIT...,SET,35,-0.03447,-0.0015037,0.14021,0.5971,REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER,0.99999
HP_MACULE,SET,209,-0.013715,-0.001455,0.055784,0.5971,HP_MACULE,0.99999
MIR1233_3P,SET,71,-0.028635,-0.0017774,0.11644,0.59713,MIR1233_3P,0.99999
HP_PANCREATIC_FIBROSIS,SET,21,-0.040346,-0.0013638,0.16401,0.59715,HP_PANCREATIC_FIBROSIS,0.99999
GOCC_NONHOMOLOGOUS_END_JOINI...,SET,7,-0.068092,-0.0013294,0.27666,0.5972,GOCC_NONHOMOLOGOUS_END_JOINING_COMPLEX,0.99999
GSE12392_WT_VS_IFNAR_KO_CD8A...2,SET,174,-0.015906,-0.0015412,0.064631,0.5972,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP,0.99999
GOBP_CHOLESTEROL_IMPORT,SET,9,-0.079083,-0.0017506,0.32115,0.59725,GOBP_CHOLESTEROL_IMPORT,0.99999
GOBP_REGULATION_OF_CYSTEINE_...1,SET,176,-0.016237,-0.0015821,0.065919,0.59728,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.99999
GOBP_CELLULAR_RESPONSE_TO_IN...6,SET,7,-0.08467,-0.001653,0.34361,0.59732,GOBP_CELLULAR_RESPONSE_TO_INTERFERON_ALPHA,0.99999
GOCC_ER_UBIQUITIN_LIGASE_COM...,SET,4,-0.11183,-0.0016505,0.45345,0.5974,GOCC_ER_UBIQUITIN_LIGASE_COMPLEX,0.99999
GNF2_CASP4,SET,21,-0.047105,-0.0015923,0.19092,0.59744,GNF2_CASP4,0.99999
GOBP_SULFUR_AMINO_ACID_BIOSY...,SET,15,-0.054474,-0.0015565,0.22069,0.59748,GOBP_SULFUR_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...369,SET,56,-0.029353,-0.0016187,0.11891,0.59749,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,0.99999
ZNF418_TARGET_GENES,SET,26,-0.043877,-0.0016501,0.17773,0.5975,ZNF418_TARGET_GENES,0.99999
HP_THORACIC_DYSPLASIA,SET,4,-0.089378,-0.0013192,0.36204,0.5975,HP_THORACIC_DYSPLASIA,0.99999
HP_INCREASED_TOTAL_BILIRUBIN,SET,14,-0.052771,-0.0014567,0.21371,0.59751,HP_INCREASED_TOTAL_BILIRUBIN,0.99999
GOMF_CARBON_NITROGEN_LYASE_A...,SET,13,-0.065134,-0.0017327,0.26361,0.59758,GOMF_CARBON_NITROGEN_LYASE_ACTIVITY,0.99999
HP_ABNORMAL_IMMUNE_SERUM_PRO...,SET,42,-0.033834,-0.0016164,0.1369,0.5976,HP_ABNORMAL_IMMUNE_SERUM_PROTEIN_PHYSIOLOGY,0.99999
GOBP_REGULATION_OF_MEMBRANE_...14,SET,5,-0.089403,-0.0014753,0.36168,0.59762,GOBP_REGULATION_OF_MEMBRANE_TUBULATION,0.99999
HP_DELAYED_ABILITY_TO_STAND,SET,14,-0.055265,-0.0015256,0.22356,0.59762,HP_DELAYED_ABILITY_TO_STAND,0.99999
GOBP_POSITIVE_REGULATION_OF_...276,SET,23,-0.047416,-0.0016773,0.19167,0.59769,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_TRANSPORT,0.99999
GOBP_GLUTAMATE_CATABOLIC_PRO...,SET,7,-0.082377,-0.0016083,0.3329,0.59772,GOBP_GLUTAMATE_CATABOLIC_PROCESS,0.99999
MORF_RAB1A,SET,173,-0.01481,-0.0014309,0.059843,0.59773,MORF_RAB1A,0.99999
MIR369_3P,SET,276,-0.013017,-0.001584,0.052584,0.59775,MIR369_3P,0.99999
HP_BLADDER_DIVERTICULUM,SET,29,-0.04201,-0.0016684,0.1697,0.59776,HP_BLADDER_DIVERTICULUM,0.99999
MIR4667_5P,SET,157,-0.0175,-0.0016114,0.070685,0.59777,MIR4667_5P,0.99999
CUI_DEVELOPING_HEART_C9_B_T_...,SET,133,-0.019092,-0.0016192,0.077102,0.59779,CUI_DEVELOPING_HEART_C9_B_T_CELL,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_CYC...2,SET,809,-0.0072158,-0.001481,0.029109,0.59789,HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL,0.99999
GNF2_GSTM1,SET,102,-0.02116,-0.0015729,0.085348,0.5979,GNF2_GSTM1,0.99999
GOBP_REGULATION_OF_NEUROTRAN...2,SET,8,-0.075282,-0.0015712,0.30336,0.59799,GOBP_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_LOCALIZATION_TO_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,0.99999
HP_EPICANTHUS,SET,527,-0.0091465,-0.0015273,0.036855,0.598,HP_EPICANTHUS,0.99999
GSE6092_CTRL_VS_BORRELIA_BIR...1,SET,140,-0.017966,-0.0015629,0.072378,0.59802,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN,0.99999
HP_CHRONIC_LUNG_DISEASE,SET,39,-0.033609,-0.0015475,0.13539,0.59803,HP_CHRONIC_LUNG_DISEASE,0.99999
WELCSH_BRCA1_TARGETS_UP,SET,180,-0.015574,-0.0015345,0.062698,0.59808,WELCSH_BRCA1_TARGETS_UP,0.99999
HP_PERIPHERAL_AXONAL_NEUROPA...,SET,152,-0.016829,-0.001525,0.067755,0.59808,HP_PERIPHERAL_AXONAL_NEUROPATHY,0.99999
GOMF_5S_RRNA_BINDING,SET,8,-0.07302,-0.001524,0.29378,0.59814,GOMF_5S_RRNA_BINDING,0.99999
GSE21546_WT_VS_SAP1A_KO_DP_T...1,SET,156,-0.017617,-0.0016171,0.07087,0.59816,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN,0.99999
HP_ABNORMAL_CIRCULATING_INTE...1,SET,23,-0.044556,-0.0015761,0.17922,0.59817,HP_ABNORMAL_CIRCULATING_INTERFERON_CONCENTRATION,0.99999
GOMF_DISULFIDE_OXIDOREDUCTAS...,SET,37,-0.034301,-0.0015384,0.13788,0.59823,GOMF_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,0.99999
HP_NEOPLASM_OF_THE_ENDOCRINE...,SET,150,-0.017191,-0.0015476,0.069077,0.59827,HP_NEOPLASM_OF_THE_ENDOCRINE_SYSTEM,0.99999
GSE26343_UNSTIM_VS_LPS_STIM_...4,SET,184,-0.015533,-0.0015472,0.062412,0.59827,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP,0.99999
chr19q12,SET,9,-0.099108,-0.0021939,0.39813,0.59829,chr19q12,0.99999
HP_SLEEP_ABNORMALITY,SET,504,-0.0096883,-0.0015831,0.038902,0.59834,HP_SLEEP_ABNORMALITY,0.99999
MIR8089,SET,155,-0.017802,-0.0016289,0.071469,0.59835,MIR8089,0.99999
HP_PARALYSIS,SET,146,-0.017745,-0.0015762,0.071227,0.59837,HP_PARALYSIS,0.99999
MENON_FETAL_KIDNEY_6_COLLECT...,SET,84,-0.024715,-0.001668,0.099163,0.59841,MENON_FETAL_KIDNEY_6_COLLECTING_DUCT_CELLS,0.99999
REACTOME_PHENYLALANINE_AND_T...,SET,10,-0.072216,-0.001685,0.28971,0.59842,REACTOME_PHENYLALANINE_AND_TYROSINE_METABOLISM,0.99999
GOBP_CERAMIDE_TRANSPORT,SET,15,-0.056427,-0.0016123,0.22627,0.59847,GOBP_CERAMIDE_TRANSPORT,0.99999
HP_TYPE_1_MUSCLE_FIBER_ATROP...,SET,14,-0.055854,-0.0015418,0.22378,0.59855,HP_TYPE_1_MUSCLE_FIBER_ATROPHY,0.99999
GOBP_SUBSTRATE_DEPENDENT_CEL...1,SET,23,-0.046035,-0.0016284,0.1844,0.59857,GOBP_SUBSTRATE_DEPENDENT_CELL_MIGRATION,0.99999
KRAS.BREAST_UP.V1_UP,SET,118,-0.021736,-0.0017371,0.087065,0.59857,KRAS.BREAST_UP.V1_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...502,SET,21,-0.051433,-0.0017386,0.20598,0.59859,GOBP_POSITIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,0.99999
REACTOME_PRE_NOTCH_PROCESSIN...2,SET,6,-0.070217,-0.0012692,0.28117,0.5986,REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM,0.99999
MIR208A_3P,SET,38,-0.035513,-0.001614,0.14201,0.59873,MIR208A_3P,0.99999
GOBP_REGULATION_OF_CALCIUM_I...8,SET,223,-0.015013,-0.0016446,0.06003,0.59874,GOBP_REGULATION_OF_CALCIUM_ION_TRANSPORT,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...10,SET,15,-0.05785,-0.001653,0.23133,0.59874,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS,0.99999
KYNG_WERNER_SYNDROM_DN,SET,18,-0.051327,-0.0016064,0.2052,0.59876,KYNG_WERNER_SYNDROM_DN,0.99999
GOCC_VACUOLAR_PROTON_TRANSPO...,SET,8,-0.067037,-0.0013991,0.26794,0.59878,GOCC_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN,0.99999
GOBP_XENOBIOTIC_EXPORT_FROM_...,SET,13,-0.055461,-0.0014753,0.22162,0.5988,GOBP_XENOBIOTIC_EXPORT_FROM_CELL,0.99999
HP_UNILATERAL_RENAL_AGENESIS,SET,83,-0.023394,-0.0015694,0.093467,0.59882,HP_UNILATERAL_RENAL_AGENESIS,0.99999
GSE23568_CTRL_TRANSDUCED_VS_...1,SET,187,-0.015218,-0.001528,0.0608,0.59882,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN,0.99999
HP_GENERALIZED_OSTEOSCLEROSIS,SET,8,-0.071627,-0.0014949,0.28607,0.59885,HP_GENERALIZED_OSTEOSCLEROSIS,0.99999
MIR5087,SET,85,-0.023436,-0.001591,0.093572,0.59888,MIR5087,0.99999
GOBP_MIDBRAIN_DEVELOPMENT,SET,81,-0.023864,-0.0015817,0.095262,0.5989,GOBP_MIDBRAIN_DEVELOPMENT,0.99999
GOBP_MONOSACCHARIDE_METABOLI...,SET,226,-0.013891,-0.0015317,0.055413,0.59897,GOBP_MONOSACCHARIDE_METABOLIC_PROCESS,0.99999
COUP_01,SET,235,-0.013626,-0.0015318,0.054325,0.59902,COUP_01,0.99999
KEGG_MEDICUS_REFERENCE_BCR_P...2,SET,7,-0.083891,-0.0016378,0.33436,0.59905,KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...376,SET,9,-0.079015,-0.0017491,0.31448,0.59919,GOBP_NEGATIVE_REGULATION_OF_MAST_CELL_ACTIVATION,0.99999
GSE2585_CTEC_VS_THYMIC_MACRO...1,SET,187,-0.015271,-0.0015334,0.060781,0.59919,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN,0.99999
GOBP_REGULATION_OF_ODONTOGEN...1,SET,19,-0.056627,-0.0018208,0.22535,0.5992,GOBP_REGULATION_OF_ODONTOGENESIS,0.99999
MIR217_3P,SET,83,-0.023247,-0.0015596,0.092506,0.59921,MIR217_3P,0.99999
MIR4326,SET,78,-0.025846,-0.0016812,0.10283,0.59923,MIR4326,0.99999
GOBP_CYTOSKELETON_DEPENDENT_...1,SET,103,-0.019686,-0.0014704,0.078294,0.59926,GOBP_CYTOSKELETON_DEPENDENT_CYTOKINESIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...531,SET,25,-0.04221,-0.0015566,0.16787,0.59926,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MATURATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...743,SET,15,-0.057472,-0.0016421,0.22848,0.5993,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,0.99999
GOBP_VESICLE_LOCALIZATION,SET,202,-0.014771,-0.0015409,0.058698,0.59934,GOBP_VESICLE_LOCALIZATION,0.99999
GOBP_INTRINSIC_APOPTOTIC_SIG...8,SET,10,-0.067624,-0.0015779,0.26862,0.59938,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,0.99999
GOBP_SYNAPTIC_VESICLE_CLUSTE...,SET,15,-0.058968,-0.0016849,0.23421,0.59939,GOBP_SYNAPTIC_VESICLE_CLUSTERING,0.99999
MIR4259,SET,23,-0.043488,-0.0015383,0.17268,0.59941,MIR4259,0.99999
DR1_Q3,SET,229,-0.013896,-0.0015424,0.055132,0.5995,DR1_Q3,0.99999
LOPEZ_MESOTHELIOMA_SURVIVAL_...2,SET,11,-0.072953,-0.0017853,0.28912,0.5996,LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN,0.99999
GOBP_REGULATION_OF_MAST_CELL...2,SET,4,-0.11253,-0.0016609,0.44565,0.59967,GOBP_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
GSE29949_DC_BRAIN_VS_MONOCYT...1,SET,178,-0.016567,-0.0016234,0.065587,0.59971,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.99999
MIR649,SET,62,-0.026052,-0.0015114,0.10307,0.59977,MIR649,0.99999
GSE7831_CPG_VS_INFLUENZA_STI...2,SET,181,-0.015363,-0.0015179,0.060725,0.59986,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP,0.99999
HP_TONGUE_NODULES,SET,12,-0.051633,-0.0013197,0.20396,0.59992,HP_TONGUE_NODULES,0.99999
ZNF528_TARGET_GENES,SET,595,-0.0088954,-0.0015753,0.03512,0.59997,ZNF528_TARGET_GENES,0.99999
WP_PATHWAYS_OF_NUCLEIC_ACID_...,SET,13,-0.057219,-0.0015221,0.22582,0.60001,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,0.99999
GAO_LARGE_INTESTINE_ADULT_CA...,SET,260,-0.014277,-0.001687,0.056349,0.60001,GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS,0.99999
GOBP_HEAT_ACCLIMATION,SET,5,-0.10198,-0.0016828,0.40243,0.60003,GOBP_HEAT_ACCLIMATION,0.99999
HP_UNCONJUGATED_HYPERBILIRUB...,SET,11,-0.059028,-0.0014445,0.23289,0.60004,HP_UNCONJUGATED_HYPERBILIRUBINEMIA,0.99999
GOCC_GBAF_COMPLEX,SET,12,-0.060802,-0.001554,0.23988,0.60005,GOCC_GBAF_COMPLEX,0.99999
GOBP_NON_PROTEINOGENIC_AMINO...3,SET,68,-0.025949,-0.0015764,0.10233,0.60009,GOBP_NON_PROTEINOGENIC_AMINO_ACID_METABOLIC_PROCESS,0.99999
ICHIBA_GRAFT_VERSUS_HOST_DIS...2,SET,130,-0.019675,-0.0016498,0.077532,0.60016,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,0.99999
HP_HYPOPLASTIC_ILIAC_WING,SET,27,-0.043317,-0.00166,0.17068,0.60017,HP_HYPOPLASTIC_ILIAC_WING,0.99999
DESCARTES_FETAL_STOMACH_SQUA...,SET,60,-0.030386,-0.0017343,0.11972,0.60018,DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS,0.99999
REACTOME_WNT5A_DEPENDENT_INT...2,SET,15,-0.05433,-0.0015524,0.21385,0.60027,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4,0.99999
GOBP_DNA_DAMAGE_RESPONSE,SET,793,-0.0073918,-0.0015027,0.02909,0.60029,GOBP_DNA_DAMAGE_RESPONSE,0.99999
GSE19888_ADENOSINE_A3R_ACT_V...3,SET,182,-0.015633,-0.0015488,0.061467,0.60038,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN,0.99999
DEBOSSCHER_NFKB_TARGETS_REPR...,SET,21,-0.049813,-0.0016838,0.19564,0.60049,DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS,0.99999
MORF_RAC1,SET,186,-0.015167,-0.0015189,0.059525,0.60056,MORF_RAC1,0.99999
REACTOME_REGULATION_OF_LOCAL...,SET,11,-0.066726,-0.0016328,0.26179,0.60059,REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS,0.99999
GOBP_PEROXISOMAL_TRANSPORT,SET,19,-0.045689,-0.0014691,0.17922,0.60061,GOBP_PEROXISOMAL_TRANSPORT,0.99999
GOBP_MICROTUBULE_POLYMERIZAT...1,SET,87,-0.022529,-0.0015473,0.088348,0.60064,GOBP_MICROTUBULE_POLYMERIZATION,0.99999
WP_TCELL_ACTIVATION_SARSCOV2,SET,86,-0.024625,-0.0016815,0.09647,0.60074,WP_TCELL_ACTIVATION_SARSCOV2,0.99999
REACTOME_ION_HOMEOSTASIS,SET,52,-0.030911,-0.0016428,0.121,0.60081,REACTOME_ION_HOMEOSTASIS,0.99999
GSE3982_EOSINOPHIL_VS_TH2_UP,SET,174,-0.016222,-0.0015718,0.063468,0.60086,GSE3982_EOSINOPHIL_VS_TH2_UP,0.99999
GOBP_PROTEIN_OXIDATION,SET,12,-0.069262,-0.0017702,0.27089,0.6009,GOBP_PROTEIN_OXIDATION,0.99999
REACTOME_PRESYNAPTIC_NICOTIN...,SET,12,-0.069136,-0.001767,0.27031,0.60093,REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,0.99999
GSE3920_IFNA_VS_IFNG_TREATED...1,SET,153,-0.017635,-0.0016032,0.068937,0.60095,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,0.99999
GOMF_NEUROTROPHIN_TRK_RECEPT...,SET,6,-0.076252,-0.0013783,0.29803,0.60097,GOMF_NEUROTROPHIN_TRK_RECEPTOR_BINDING,0.99999
GOBP_DETECTION_OF_MECHANICAL...3,SET,14,-0.061517,-0.0016982,0.24034,0.60101,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.99999
GOBP_STEROID_HORMONE_BIOSYNT...,SET,43,-0.034564,-0.0016708,0.13491,0.6011,GOBP_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.99999
MIR602,SET,7,-0.072601,-0.0014174,0.28336,0.60111,MIR602,0.99999
GOBP_FATTY_ACID_ELONGATION_S...,SET,8,-0.088661,-0.0018504,0.34596,0.60113,GOBP_FATTY_ACID_ELONGATION_SATURATED_FATTY_ACID,0.99999
GOBP_NEGATIVE_REGULATION_OF_...347,SET,25,-0.044639,-0.0016462,0.17414,0.60116,GOBP_NEGATIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,0.99999
GOCC_ENDOCYTIC_VESICLE_MEMBR...,SET,177,-0.017581,-0.001718,0.068585,0.60116,GOCC_ENDOCYTIC_VESICLE_MEMBRANE,0.99999
GOBP_POSITIVE_REGULATION_OF_...802,SET,37,-0.045065,-0.0020211,0.17576,0.60118,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,0.99999
MORF_JAG1,SET,91,-0.023227,-0.0016312,0.09056,0.60121,MORF_JAG1,0.99999
HP_OPISTHOTONUS,SET,47,-0.031555,-0.0015946,0.12302,0.60122,HP_OPISTHOTONUS,0.99999
CHANG_IMMORTALIZED_BY_HPV31_...2,SET,65,-0.027198,-0.0016155,0.10595,0.60129,CHANG_IMMORTALIZED_BY_HPV31_UP,0.99999
MIR5681A,SET,135,-0.018499,-0.0015805,0.072009,0.60137,MIR5681A,0.99999
GSE22282_HYPOXIA_VS_NORMOXIA...2,SET,174,-0.016737,-0.0016217,0.065103,0.60144,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP,0.99999
HP_RENAL_AGENESIS,SET,178,-0.01629,-0.0015963,0.06335,0.60147,HP_RENAL_AGENESIS,0.99999
GSE17186_BLOOD_VS_CORD_BLOOD...1,SET,182,-0.016189,-0.0016039,0.062926,0.60151,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN,0.99999
GOBP_PRESYNAPTIC_ACTIVE_ZONE...,SET,7,-0.092784,-0.0018114,0.36051,0.60155,GOBP_PRESYNAPTIC_ACTIVE_ZONE_ORGANIZATION,0.99999
GSE24972_WT_VS_IRF8_KO_MARGI...1,SET,181,-0.016675,-0.0016476,0.06479,0.60155,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_DN,0.99999
GOBP_PROTEIN_DNA_COMPLEX_DIS...,SET,21,-0.047877,-0.0016184,0.18595,0.60159,GOBP_PROTEIN_DNA_COMPLEX_DISASSEMBLY,0.99999
GSE20152_HTNFA_OVERXPRESS_AN...2,SET,174,-0.017136,-0.0016604,0.066542,0.60161,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_UP,0.99999
GSE1112_OT1_CD8AB_VS_HY_CD8A...2,SET,132,-0.019578,-0.0016542,0.07601,0.60163,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,0.99999
GOBP_REGULATION_OF_DEFENSE_R...5,SET,34,-0.039561,-0.001701,0.15357,0.60164,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST,0.99999
GSE37534_UNTREATED_VS_ROSIGL...1,SET,182,-0.016689,-0.0016535,0.064729,0.60173,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.99999
GOBP_MEMBRANE_LIPID_METABOLI...,SET,203,-0.015826,-0.0016549,0.061369,0.60175,GOBP_MEMBRANE_LIPID_METABOLIC_PROCESS,0.99999
HP_CONGENITAL_NYSTAGMUS,SET,19,-0.052833,-0.0016988,0.20483,0.60177,HP_CONGENITAL_NYSTAGMUS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...407,SET,30,-0.040645,-0.0016417,0.15748,0.60183,GOBP_NEGATIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,0.99999
REACTOME_DNA_STRAND_ELONGATI...,SET,31,-0.036166,-0.0014849,0.14011,0.60184,REACTOME_DNA_STRAND_ELONGATION,0.99999
GOMF_QUATERNARY_AMMONIUM_GRO...2,SET,13,-0.071928,-0.0019134,0.27858,0.60187,GOMF_QUATERNARY_AMMONIUM_GROUP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_CELLULAR_RESPONSE_TO_GL...2,SET,53,-0.032617,-0.00175,0.1263,0.6019,GOBP_CELLULAR_RESPONSE_TO_GLUCOCORTICOID_STIMULUS,0.99999
GCANCTGNY_MYOD_Q6,SET,845,-0.0079356,-0.0016629,0.030717,0.60193,GCANCTGNY_MYOD_Q6,0.99999
GOBP_REGULATION_OF_ESTABLISH...3,SET,11,-0.054317,-0.0013292,0.21024,0.60193,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME,0.99999
WP_RESOLVIN_E1_AND_RESOLVIN_...,SET,11,-0.068677,-0.0016806,0.26563,0.602,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.99999
GOMF_POTASSIUM_CHANNEL_INHIB...,SET,5,-0.10092,-0.0016654,0.39009,0.60207,GOMF_POTASSIUM_CHANNEL_INHIBITOR_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...325,SET,5,-0.10002,-0.0016505,0.38625,0.60216,GOBP_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_MATURATION,0.99999
REACTOME_IRAK1_RECRUITS_IKK_...,SET,11,-0.068463,-0.0016754,0.2642,0.60223,REACTOME_IRAK1_RECRUITS_IKK_COMPLEX,0.99999
MIR380_3P,SET,210,-0.015277,-0.0016246,0.058958,0.60223,MIR380_3P,0.99999
GOCC_PALMITOYLTRANSFERASE_CO...,SET,10,-0.070781,-0.0016515,0.27312,0.60224,GOCC_PALMITOYLTRANSFERASE_COMPLEX,0.99999
GSE2405_HEAT_KILLED_LYSATE_V...4,SET,186,-0.016855,-0.0016879,0.065015,0.60228,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,0.99999
QI_PBMC_ZOSTAVAX_AGE_50_75YO...1,SET,6,-0.085492,-0.0015453,0.32976,0.60228,QI_PBMC_ZOSTAVAX_AGE_50_75YO_1DY_UP,0.99999
GOBP_CARDIAC_CONDUCTION_SYST...,SET,36,-0.041764,-0.0018476,0.16108,0.60229,GOBP_CARDIAC_CONDUCTION_SYSTEM_DEVELOPMENT,0.99999
MZF1_01,SET,222,-0.014813,-0.0016191,0.05711,0.60233,MZF1_01,0.99999
KIM_MYC_AMPLIFICATION_TARGET...2,SET,170,-0.016825,-0.0016115,0.064847,0.60236,KIM_MYC_AMPLIFICATION_TARGETS_UP,0.99999
GOBP_MESENCHYMAL_CELL_DEVELO...,SET,6,-0.10564,-0.0019094,0.40704,0.60238,GOBP_MESENCHYMAL_CELL_DEVELOPMENT,0.99999
HP_SUPRANUCLEAR_GAZE_PALSY,SET,49,-0.031314,-0.0016156,0.12066,0.60238,HP_SUPRANUCLEAR_GAZE_PALSY,0.99999
NCOA4_TARGET_GENES,SET,844,-0.0076889,-0.0016103,0.029603,0.60246,NCOA4_TARGET_GENES,0.99999
HP_PARIETAL_FORAMINA,SET,12,-0.066805,-0.0017074,0.25721,0.60246,HP_PARIETAL_FORAMINA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...372,SET,7,-0.101,-0.0019718,0.38883,0.60247,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,0.99999
NUYTTEN_EZH2_TARGETS_UP,SET,942,-0.0076223,-0.0016818,0.029328,0.60253,NUYTTEN_EZH2_TARGETS_UP,0.99999
MIR5088_3P,SET,121,-0.019967,-0.0016157,0.076762,0.60261,MIR5088_3P,0.99999
REACTOME_HOMOLOGOUS_DNA_PAIR...,SET,41,-0.03207,-0.0015139,0.12324,0.60265,REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,0.99999
GOBP_DETOXIFICATION,SET,129,-0.020821,-0.0017392,0.07999,0.60268,GOBP_DETOXIFICATION,0.99999
GNF2_RTN1,SET,47,-0.035807,-0.0018095,0.13749,0.60274,GNF2_RTN1,0.99999
MIR4789_5P,SET,350,-0.012049,-0.0016478,0.046231,0.60281,MIR4789_5P,0.99999
GOMF_RNA_DNA_HYBRID_RIBONUCL...,SET,6,-0.095833,-0.0017322,0.36758,0.60284,GOMF_RNA_DNA_HYBRID_RIBONUCLEASE_ACTIVITY,0.99999
CHARAFE_BREAST_CANCER_BASAL_...2,SET,107,-0.021803,-0.0016597,0.0836,0.60287,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,0.99999
STEIN_ESR1_TARGETS,SET,77,-0.02649,-0.001712,0.10154,0.6029,STEIN_ESR1_TARGETS,0.99999
GSE11924_TFH_VS_TH17_CD4_TCE...1,SET,180,-0.016197,-0.001596,0.062078,0.60292,GSE11924_TFH_VS_TH17_CD4_TCELL_DN,0.99999
GOBP_MONOCYTE_AGGREGATION,SET,5,-0.12161,-0.0020066,0.46581,0.60298,GOBP_MONOCYTE_AGGREGATION,0.99999
HP_THICKENED_HELICES,SET,43,-0.031508,-0.0015231,0.12067,0.60299,HP_THICKENED_HELICES,0.99999
COLIN_PILOCYTIC_ASTROCYTOMA_...2,SET,33,-0.041446,-0.0017556,0.15873,0.603,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,0.99999
MARTINELLI_IMMATURE_NEUTROPH...1,SET,13,-0.073362,-0.0019515,0.28087,0.60303,MARTINELLI_IMMATURE_NEUTROPHIL_DN,0.99999
GSE17721_12H_VS_24H_PAM3CSK4...1,SET,185,-0.016213,-0.0016193,0.062055,0.60305,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_DN,0.99999
HP_AUTISM,SET,216,-0.015681,-0.0016909,0.060002,0.60309,HP_AUTISM,0.99999
HP_ABNORMAL_LACRIMAL_DUCT_MO...,SET,41,-0.034751,-0.0016404,0.13293,0.60311,HP_ABNORMAL_LACRIMAL_DUCT_MORPHOLOGY,0.99999
HP_ABNORMAL_URINE_ALPHA_KETO...,SET,14,-0.057146,-0.0015775,0.21851,0.60316,HP_ABNORMAL_URINE_ALPHA_KETOGLUTARATE_CONCENTRATION,0.99999
GSE37532_VISCERAL_ADIPOSE_TI...6,SET,112,-0.022441,-0.0017475,0.085782,0.60319,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_UP,0.99999
HP_ABNORMALITY_OF_THE_FRONTA...,SET,184,-0.016006,-0.0015944,0.061137,0.60326,HP_ABNORMALITY_OF_THE_FRONTAL_HAIRLINE,0.99999
HP_ABNORMAL_INFERIOR_VENA_CA...,SET,42,-0.033513,-0.0016012,0.12797,0.60329,HP_ABNORMAL_INFERIOR_VENA_CAVA_MORPHOLOGY,0.99999
GOBP_NOTCH_RECEPTOR_PROCESSI...,SET,8,-0.071079,-0.0014835,0.27111,0.60341,GOBP_NOTCH_RECEPTOR_PROCESSING,0.99999
GOCC_NUCLEAR_BODY,SET,747,-0.0078728,-0.0015554,0.030016,0.60345,GOCC_NUCLEAR_BODY,0.99999
GOBP_CARDIAC_VENTRICLE_MORPH...,SET,68,-0.03061,-0.0018595,0.11669,0.60346,GOBP_CARDIAC_VENTRICLE_MORPHOGENESIS,0.99999
MELLMAN_TUT1_TARGETS_DN,SET,45,-0.032622,-0.0016131,0.12432,0.6035,MELLMAN_TUT1_TARGETS_DN,0.99999
GOBP_ISOPRENOID_CATABOLIC_PR...,SET,9,-0.080837,-0.0017894,0.30776,0.60359,GOBP_ISOPRENOID_CATABOLIC_PROCESS,0.99999
LBP1_Q6,SET,211,-0.015903,-0.0016951,0.06051,0.60365,LBP1_Q6,0.99999
chr2q11,SET,69,-0.060205,-0.003684,0.22898,0.60369,chr2q11,0.99999
GOBP_SYNAPTIC_VESICLE_EXOCYT...,SET,90,-0.022999,-0.0016064,0.087475,0.60369,GOBP_SYNAPTIC_VESICLE_EXOCYTOSIS,0.99999
HP_RIGHT_BUNDLE_BRANCH_BLOCK,SET,50,-0.032178,-0.001677,0.12239,0.60369,HP_RIGHT_BUNDLE_BRANCH_BLOCK,0.99999
STANHILL_HRAS_TRANSFROMATION...,SET,5,-0.11057,-0.0018246,0.42047,0.60371,STANHILL_HRAS_TRANSFROMATION_UP,0.99999
GOCC_RAGULATOR_COMPLEX,SET,6,-0.07485,-0.0013529,0.28464,0.60371,GOCC_RAGULATOR_COMPLEX,0.99999
PID_PS1_PATHWAY,SET,42,-0.036461,-0.001742,0.13859,0.60376,PID_PS1_PATHWAY,0.99999
MIR4764_3P,SET,62,-0.028934,-0.0016786,0.10995,0.60378,MIR4764_3P,0.99999
BONOME_OVARIAN_CANCER_SURVIV...1,SET,215,-0.015727,-0.001692,0.059759,0.60379,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,0.99999
GOCC_VARICOSITY,SET,8,-0.096281,-0.0020094,0.36576,0.60381,GOCC_VARICOSITY,0.99999
KEGG_FC_EPSILON_RI_SIGNALING...,SET,78,-0.027022,-0.0017576,0.10264,0.60383,KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,0.99999
HP_GENERALIZED_HYPOPIGMENTAT...1,SET,28,-0.04752,-0.0018544,0.18046,0.60385,HP_GENERALIZED_HYPOPIGMENTATION,0.99999
ASH1L_TARGET_GENES,SET,1136,-0.0069307,-0.0016699,0.026313,0.60388,ASH1L_TARGET_GENES,0.99999
GSE6259_FLT3L_INDUCED_33D1_P...3,SET,149,-0.018315,-0.0016433,0.06951,0.60391,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_DN,0.99999
MIR4786_5P,SET,85,-0.024721,-0.0016782,0.093795,0.60394,MIR4786_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...106,SET,181,-0.017832,-0.0017619,0.067648,0.60396,GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION,0.99999
GOBP_KETONE_CATABOLIC_PROCESS,SET,12,-0.062977,-0.0016096,0.23888,0.60397,GOBP_KETONE_CATABOLIC_PROCESS,0.99999
DAVICIONI_MOLECULAR_ARMS_VS_...1,SET,166,-0.018845,-0.0017839,0.071456,0.604,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,0.99999
GAUCHER_PBMC_YF_VAX_STAMARIL...10,SET,44,-0.034596,-0.0016917,0.13118,0.60401,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_UP,0.99999
GSE37301_COMMON_LYMPHOID_PRO...2,SET,168,-0.016983,-0.0016171,0.064341,0.60409,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP,0.99999
WP_CORTICOTROPINRELEASING_HO...,SET,89,-0.024982,-0.0017352,0.09458,0.60416,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,0.99999
MIR592,SET,70,-0.02712,-0.0016714,0.10263,0.6042,MIR592,0.99999
GOBP_REGULATION_OF_GLOMERULA...,SET,9,-0.087605,-0.0019392,0.33142,0.60424,GOBP_REGULATION_OF_GLOMERULAR_FILTRATION,0.99999
GSE5503_LIVER_DC_VS_MLN_DC_A...1,SET,176,-0.016191,-0.0015777,0.061253,0.60424,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...6,SET,42,-0.039656,-0.0018946,0.14993,0.6043,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_4,0.99999
GOBP_CANNABINOID_SIGNALING_P...,SET,7,-0.096935,-0.0018925,0.36645,0.60431,GOBP_CANNABINOID_SIGNALING_PATHWAY,0.99999
MIR12127,SET,74,-0.026334,-0.0016686,0.09947,0.60439,MIR12127,0.99999
GSE7831_CPG_VS_INFLUENZA_STI...4,SET,175,-0.017149,-0.0016664,0.064774,0.6044,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_UP,0.99999
GOMF_SERINE_TYPE_CARBOXYPEPT...,SET,5,-0.092005,-0.0015182,0.34741,0.60443,GOMF_SERINE_TYPE_CARBOXYPEPTIDASE_ACTIVITY,0.99999
GSE36888_UNTREATED_VS_IL2_TR...11,SET,174,-0.016331,-0.0015823,0.061665,0.60443,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_DN,0.99999
GOMF_MYOSIN_PHOSPHATASE_ACTI...,SET,69,-0.02613,-0.0015989,0.098645,0.60445,GOMF_MYOSIN_PHOSPHATASE_ACTIVITY,0.99999
GSE5542_UNTREATED_VS_IFNA_TR...1,SET,168,-0.016921,-0.0016113,0.063883,0.60445,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,0.99999
GOBP_HYDROGEN_PEROXIDE_CATAB...,SET,26,-0.049128,-0.0018475,0.18545,0.60446,GOBP_HYDROGEN_PEROXIDE_CATABOLIC_PROCESS,0.99999
ZHONG_PFC_C1_OPC,SET,218,-0.014789,-0.001602,0.055814,0.60448,ZHONG_PFC_C1_OPC,0.99999
REACTOME_NEUROTRANSMITTER_RE...1,SET,191,-0.01766,-0.001792,0.066638,0.6045,REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,0.99999
GTGGTGA_MIR197,SET,64,-0.027774,-0.001637,0.10472,0.60458,GTGGTGA_MIR197,0.99999
GSE24026_PD1_LIGATION_VS_CTR...2,SET,180,-0.017078,-0.0016827,0.064381,0.60459,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP,0.99999
GNF2_KPNB1,SET,65,-0.026083,-0.0015493,0.098289,0.60464,GNF2_KPNB1,0.99999
GOBP_MEMBRANE_INVAGINATION,SET,65,-0.028941,-0.001719,0.10898,0.60471,GOBP_MEMBRANE_INVAGINATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...413,SET,998,-0.0076353,-0.0017312,0.028744,0.60474,GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS,0.99999
GOCC_CLATHRIN_COATED_ENDOCYT...1,SET,84,-0.026832,-0.0018109,0.10101,0.60474,GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE,0.99999
ZNF768_TARGET_GENES,SET,1013,-0.0073048,-0.0016679,0.027479,0.60481,ZNF768_TARGET_GENES,0.99999
GOBP_3_UTR_MEDIATED_MRNA_STA...,SET,19,-0.053878,-0.0017324,0.20269,0.60481,GOBP_3_UTR_MEDIATED_MRNA_STABILIZATION,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...5,SET,180,-0.01705,-0.00168,0.064117,0.60485,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN,0.99999
GOBP_DENDRITIC_CELL_APOPTOTI...,SET,12,-0.07318,-0.0018704,0.27509,0.60489,GOBP_DENDRITIC_CELL_APOPTOTIC_PROCESS,0.99999
HP_EMG_ABNORMALITY,SET,250,-0.014437,-0.0016733,0.054265,0.6049,HP_EMG_ABNORMALITY,0.99999
NAKAMURA_METASTASIS_MODEL_DN,SET,43,-0.037024,-0.0017898,0.13913,0.60492,NAKAMURA_METASTASIS_MODEL_DN,0.99999
GSE15659_NAIVE_CD4_TCELL_VS_...5,SET,171,-0.016895,-0.0016229,0.063469,0.60495,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...160,SET,7,-0.081962,-0.0016002,0.30779,0.60499,GOBP_NEGATIVE_REGULATION_OF_CYTOKINESIS,0.99999
GSE17721_POLYIC_VS_CPG_8H_BM...1,SET,181,-0.016371,-0.0016176,0.061454,0.60503,GSE17721_POLYIC_VS_CPG_8H_BMDC_DN,0.99999
GOBP_REGULATION_OF_ACTIN_FIL...3,SET,94,-0.02445,-0.0017451,0.091758,0.60506,GOBP_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.99999
GOBP_REGULATION_OF_KINASE_AC...,SET,466,-0.010848,-0.0017063,0.040708,0.60506,GOBP_REGULATION_OF_KINASE_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...3,SET,4,-0.123,-0.0018154,0.46136,0.60511,KEGG_MEDICUS_REFERENCE_REGULATION_OF_EXTRINSIC_APOPTOTIC_PATHWAY_XIAP,0.99999
KEGG_MEDICUS_PATHOGEN_KSHV_V...6,SET,29,-0.046233,-0.0018361,0.17339,0.60512,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...10,SET,186,-0.01647,-0.0016494,0.061766,0.60513,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP,0.99999
GOBERT_CORE_OLIGODENDROCYTE_...,SET,40,-0.036629,-0.0017079,0.13722,0.60524,GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,0.99999
GSE19401_UNSTIM_VS_RETINOIC_...4,SET,183,-0.016928,-0.0016816,0.063394,0.60527,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,0.99999
GOBP_REGULATION_OF_POSTSYNAP...3,SET,9,-0.078937,-0.0017474,0.29561,0.60528,GOBP_REGULATION_OF_POSTSYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.99999
HP_CHORIORETINAL_DEGENERATION,SET,48,-0.034376,-0.0017555,0.12863,0.60536,HP_CHORIORETINAL_DEGENERATION,0.99999
KEGG_BLADDER_CANCER,SET,40,-0.035488,-0.0016547,0.13278,0.60537,KEGG_BLADDER_CANCER,0.99999
MIR6780B_3P,SET,56,-0.030746,-0.0016955,0.115,0.6054,MIR6780B_3P,0.99999
GOMF_RNA_POLYMERASE_III_TYPE...,SET,6,-0.075851,-0.0013711,0.28372,0.6054,GOMF_RNA_POLYMERASE_III_TYPE_3_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,0.99999
GSE18281_PERIMEDULLARY_CORTI...4,SET,187,-0.016756,-0.0016825,0.062628,0.60547,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,0.99999
TTGGAGA_MIR5155P_MIR519E,SET,123,-0.02033,-0.0016585,0.075953,0.60552,TTGGAGA_MIR5155P_MIR519E,0.99999
REACTOME_ACTIVATION_OF_ANTER...,SET,60,-0.029727,-0.0016967,0.11105,0.60553,REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,0.99999
GSE22313_HEALTHY_VS_SLE_MOUS...1,SET,179,-0.017369,-0.0017068,0.064853,0.60558,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_DN,0.99999
DESCARTES_FETAL_INTESTINE_LY...2,SET,129,-0.021866,-0.0018265,0.081607,0.60563,DESCARTES_FETAL_INTESTINE_LYMPHOID_CELLS,0.99999
GSE9650_GP33_VS_GP276_LCMV_S...2,SET,179,-0.017308,-0.0017007,0.064582,0.60565,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP,0.99999
HP_DERMATAN_SULFATE_EXCRETIO...,SET,4,-0.10269,-0.0015157,0.3829,0.60572,HP_DERMATAN_SULFATE_EXCRETION_IN_URINE,0.99999
CHEMNITZ_RESPONSE_TO_PROSTAG...2,SET,126,-0.019444,-0.0016053,0.072493,0.60573,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,0.99999
REACTOME_DCC_MEDIATED_ATTRAC...,SET,14,-0.059561,-0.0016442,0.22198,0.60577,REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING,0.99999
ZNF707_TARGET_GENES,SET,35,-0.036821,-0.0016062,0.13723,0.60577,ZNF707_TARGET_GENES,0.99999
HP_ABNORMAL_EYELID_PHYSIOLOGY,SET,36,-0.03707,-0.00164,0.13812,0.6058,HP_ABNORMAL_EYELID_PHYSIOLOGY,0.99999
HP_UNUSUAL_VIRUS_REACTIVATION,SET,21,-0.053547,-0.00181,0.19945,0.60583,HP_UNUSUAL_VIRUS_REACTIVATION,0.99999
GOMF_NEUTRAL_L_AMINO_ACID_SO...,SET,8,-0.095384,-0.0019907,0.35504,0.6059,GOMF_NEUTRAL_L_AMINO_ACID_SODIUM_SYMPORTER_ACTIVITY,0.99999
KIM_LRRC3B_TARGETS,SET,29,-0.041707,-0.0016563,0.15519,0.60593,KIM_LRRC3B_TARGETS,0.99999
ERBB2_UP.V1_UP,SET,168,-0.018563,-0.0017677,0.06906,0.60596,ERBB2_UP.V1_UP,0.99999
REACTOME_CYTOPROTECTION_BY_H...,SET,51,-0.03159,-0.0016627,0.11751,0.60597,REACTOME_CYTOPROTECTION_BY_HMOX1,0.99999
GOBP_THORAX_AND_ANTERIOR_ABD...,SET,5,-0.14091,-0.0023251,0.52389,0.60602,GOBP_THORAX_AND_ANTERIOR_ABDOMEN_DETERMINATION,0.99999
REACTOME_REPRODUCTION,SET,93,-0.022372,-0.0015883,0.083168,0.60603,REACTOME_REPRODUCTION,0.99999
KUNINGER_IGF1_VS_PDGFB_TARGE...1,SET,41,-0.038691,-0.0018264,0.14381,0.60605,KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,0.99999
GOMF_ALKALINE_PHOSPHATASE_AC...,SET,5,-0.12734,-0.0021013,0.47329,0.60605,GOMF_ALKALINE_PHOSPHATASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_TAU_PROTE...,SET,4,-0.084447,-0.0012464,0.31376,0.60609,GOBP_REGULATION_OF_TAU_PROTEIN_KINASE_ACTIVITY,0.99999
GSE24142_EARLY_THYMIC_PROGEN...6,SET,188,-0.018064,-0.0018186,0.067096,0.60612,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP,0.99999
MORF_PML,SET,133,-0.020059,-0.0017011,0.074496,0.60613,MORF_PML,0.99999
SHAFFER_IRF4_MULTIPLE_MYELOM...,SET,33,-0.042818,-0.0018137,0.15886,0.60624,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...3,SET,46,-0.034418,-0.0017207,0.12767,0.60626,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,0.99999
HP_ABNORMAL_AORTIC_ARCH_MORP...,SET,58,-0.030629,-0.0017189,0.11362,0.60626,HP_ABNORMAL_AORTIC_ARCH_MORPHOLOGY,0.99999
GSE17721_LPS_VS_PAM3CSK4_16H...1,SET,182,-0.017226,-0.0017067,0.063855,0.60633,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN,0.99999
GOBP_NEUROTRANSMITTER_RECEPT...1,SET,33,-0.040836,-0.0017298,0.15137,0.60634,GOBP_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,0.99999
GOBP_UREA_CYCLE,SET,10,-0.067592,-0.0015771,0.25053,0.60634,GOBP_UREA_CYCLE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...66,SET,40,-0.035776,-0.0016681,0.13252,0.6064,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.99999
USF_Q6_01,SET,221,-0.015437,-0.0016835,0.057176,0.60642,USF_Q6_01,0.99999
MIR550B_3P,SET,49,-0.034071,-0.0017579,0.12618,0.60643,MIR550B_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...768,SET,31,-0.038504,-0.0015809,0.14257,0.60644,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.99999
REACTOME_NEF_MEDIATED_DOWNRE...,SET,9,-0.068608,-0.0015187,0.25401,0.60645,REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION,0.99999
MIR920,SET,47,-0.032071,-0.0016207,0.1187,0.60649,MIR920,0.99999
HP_ABNORMAL_PULMONARY_VALVE_...2,SET,52,-0.0317,-0.0016847,0.11732,0.6065,HP_ABNORMAL_PULMONARY_VALVE_MORPHOLOGY,0.99999
MORF_CSNK2B,SET,251,-0.013575,-0.0015764,0.050217,0.60654,MORF_CSNK2B,0.99999
MODULE_5,SET,398,-0.012483,-0.001818,0.046179,0.60654,MODULE_5,0.99999
HP_CHOLANGITIS,SET,18,-0.057323,-0.0017941,0.21202,0.60656,HP_CHOLANGITIS,0.99999
GSE16385_MONOCYTE_VS_12H_ROS...2,SET,186,-0.01676,-0.0016785,0.061972,0.60659,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,0.99999
GOCC_RNA_N6_METHYLADENOSINE_...,SET,8,-0.078745,-0.0016435,0.29114,0.6066,GOCC_RNA_N6_METHYLADENOSINE_METHYLTRANSFERASE_COMPLEX,0.99999
NFKAPPAB_01,SET,232,-0.01566,-0.0017493,0.057892,0.60661,NFKAPPAB_01,0.99999
MODULE_511,SET,34,-0.03964,-0.0017044,0.14652,0.60663,MODULE_511,0.99999
MODULE_14,SET,13,-0.073071,-0.0019438,0.27004,0.60664,MODULE_14,0.99999
REACTOME_HOST_INTERACTIONS_O...,SET,121,-0.019279,-0.00156,0.071231,0.60667,REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,0.99999
GOMF_RNA_POLYMERASE_I_TRANSC...,SET,9,-0.065602,-0.0014522,0.24225,0.60673,GOMF_RNA_POLYMERASE_I_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.99999
HP_ABNORMAL_SCALP_MORPHOLOGY,SET,385,-0.011633,-0.0016669,0.042949,0.60674,HP_ABNORMAL_SCALP_MORPHOLOGY,0.99999
GOMF_HEPARAN_SULFATE_SULFOTR...,SET,14,-0.069468,-0.0019176,0.25643,0.60676,GOMF_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY,0.99999
SNF5_DN.V1_UP,SET,147,-0.01975,-0.0017603,0.072902,0.60677,SNF5_DN.V1_UP,0.99999
GOBP_CONVERGENT_EXTENSION_IN...3,SET,5,-0.10079,-0.0016631,0.37195,0.60679,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_ORGANOGENESIS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...88,SET,11,-0.069006,-0.0016886,0.25442,0.60689,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY,0.99999
YNGTTNNNATT_UNKNOWN,SET,339,-0.013743,-0.0018502,0.050617,0.607,YNGTTNNNATT_UNKNOWN,0.99999
GSE33292_WT_VS_TCF1_KO_DN3_T...2,SET,175,-0.018206,-0.001769,0.067019,0.60705,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP,0.99999
REACTOME_IFNG_SIGNALING_ACTI...,SET,8,-0.084669,-0.0017671,0.31162,0.60707,REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS,0.99999
HP_ABNORMAL_GREATER_SCIATIC_...,SET,19,-0.053766,-0.0017288,0.19788,0.60708,HP_ABNORMAL_GREATER_SCIATIC_NOTCH_MORPHOLOGY,0.99999
HP_EPIGASTRIC_PAIN,SET,11,-0.075673,-0.0018518,0.27838,0.60712,HP_EPIGASTRIC_PAIN,0.99999
HP_FLUCTUATIONS_IN_CONSCIOUS...,SET,6,-0.10835,-0.0019585,0.3986,0.60712,HP_FLUCTUATIONS_IN_CONSCIOUSNESS,0.99999
NAKAYAMA_FRA2_TARGETS,SET,43,-0.039009,-0.0018857,0.14348,0.60714,NAKAYAMA_FRA2_TARGETS,0.99999
GSE39820_IL1B_IL6_VS_IL1B_IL...1,SET,179,-0.017762,-0.0017453,0.065313,0.60717,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN,0.99999
HP_HIGH_SERUM_CALCITRIOL,SET,5,-0.12485,-0.0020601,0.459,0.60719,HP_HIGH_SERUM_CALCITRIOL,0.99999
GOMF_PROTEIN_MEMBRANE_ADAPTO...,SET,32,-0.04011,-0.0016732,0.14745,0.6072,GOMF_PROTEIN_MEMBRANE_ADAPTOR_ACTIVITY,0.99999
REACTOME_ADP_SIGNALLING_THRO...1,SET,25,-0.05224,-0.0019265,0.19193,0.60726,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1,0.99999
HP_LIMB_MYOCLONUS,SET,25,-0.046422,-0.0017119,0.17054,0.60726,HP_LIMB_MYOCLONUS,0.99999
GOBP_NEURON_PROJECTION_GUIDA...,SET,217,-0.017335,-0.0018735,0.063661,0.6073,GOBP_NEURON_PROJECTION_GUIDANCE,0.99999
HOWARD_B_CELL_INACT_MONOV_IN...,SET,14,-0.062079,-0.0017137,0.22791,0.60734,HOWARD_B_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...3,SET,9,-0.084747,-0.001876,0.31106,0.60736,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR,0.99999
REACTOME_ACETYLCHOLINE_BINDI...,SET,14,-0.067908,-0.0018746,0.24914,0.60741,REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS,0.99999
HP_CENTRALLY_NUCLEATED_SKELE...,SET,47,-0.032528,-0.0016437,0.11928,0.60745,HP_CENTRALLY_NUCLEATED_SKELETAL_MUSCLE_FIBERS,0.99999
GOBP_MITOTIC_SPINDLE_ELONGAT...,SET,11,-0.074844,-0.0018315,0.27445,0.60746,GOBP_MITOTIC_SPINDLE_ELONGATION,0.99999
GOBP_ENDOPLASMIC_RETICULUM_U...,SET,70,-0.027452,-0.0016919,0.10064,0.60748,GOBP_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.99999
GOCC_CENTRIOLAR_SUBDISTAL_AP...,SET,9,-0.080756,-0.0017876,0.29604,0.60749,GOCC_CENTRIOLAR_SUBDISTAL_APPENDAGE,0.99999
GOCC_F_ACTIN_CAPPING_PROTEIN...,SET,8,-0.076922,-0.0016054,0.28186,0.60754,GOCC_F_ACTIN_CAPPING_PROTEIN_COMPLEX,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...18,SET,177,-0.016816,-0.0016432,0.061611,0.60755,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP,0.99999
GOCC_CORNIFIED_ENVELOPE,SET,58,-0.037349,-0.002096,0.13681,0.60757,GOCC_CORNIFIED_ENVELOPE,0.99999
REACTOME_PHASE_1_INACTIVATIO...,SET,6,-0.097034,-0.001754,0.35534,0.6076,REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS,0.99999
NOJIMA_SFRP2_TARGETS_UP,SET,29,-0.046761,-0.0018571,0.1712,0.60762,NOJIMA_SFRP2_TARGETS_UP,0.99999
DI_MARTINO_MATRISOME_HIGHLY_...1,SET,26,-0.046366,-0.0017437,0.16968,0.60767,DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC,0.99999
REACTOME_ENDOGENOUS_STEROLS,SET,24,-0.051507,-0.0018611,0.1885,0.60767,REACTOME_ENDOGENOUS_STEROLS,0.99999
GSE17721_CTRL_VS_POLYIC_1H_B...2,SET,176,-0.016659,-0.0016233,0.060891,0.6078,GSE17721_CTRL_VS_POLYIC_1H_BMDC_UP,0.99999
MIR3913_5P,SET,79,-0.025486,-0.0016683,0.093109,0.60785,MIR3913_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...747,SET,8,-0.081631,-0.0017037,0.29823,0.60785,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING,0.99999
GOBP_POSITIVE_REGULATION_OF_...102,SET,8,-0.085669,-0.001788,0.31295,0.60786,GOBP_POSITIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
GOBP_MEMBRANE_DEPOLARIZATION...4,SET,5,-0.11237,-0.0018542,0.41038,0.60788,GOBP_MEMBRANE_DEPOLARIZATION_DURING_SA_NODE_CELL_ACTION_POTENTIAL,0.99999
GSE27786_LIN_NEG_VS_MONO_MAC...1,SET,182,-0.016808,-0.0016653,0.061383,0.60789,GSE27786_LIN_NEG_VS_MONO_MAC_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...549,SET,9,-0.074883,-0.0016576,0.27343,0.6079,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_BINDING,0.99999
DELACROIX_RAR_BOUND_ES,SET,410,-0.011956,-0.0017667,0.043654,0.60791,DELACROIX_RAR_BOUND_ES,0.99999
GSE38681_WT_VS_LYL1_KO_LYMPH...1,SET,191,-0.017464,-0.0017721,0.063758,0.60792,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,0.99999
GOMF_FERROUS_IRON_BINDING,SET,23,-0.047867,-0.0016932,0.17461,0.60801,GOMF_FERROUS_IRON_BINDING,0.99999
HP_ABNORMAL_MACULAR_MORPHOLO...,SET,188,-0.017465,-0.0017584,0.063705,0.60802,HP_ABNORMAL_MACULAR_MORPHOLOGY,0.99999
REACTOME_REGULATION_BY_C_FLIP,SET,11,-0.073369,-0.0017954,0.26748,0.60807,REACTOME_REGULATION_BY_C_FLIP,0.99999
MIR518E_5P_MIR519A_5P_MIR519...,SET,82,-0.025429,-0.0016957,0.092645,0.60814,MIR518E_5P_MIR519A_5P_MIR519B_5P_MIR519C_5P_MIR522_5P_MIR523_5P,0.99999
GOMF_PROTEIN_DIMERIZATION_AC...,SET,893,-0.0081125,-0.0017452,0.029553,0.60815,GOMF_PROTEIN_DIMERIZATION_ACTIVITY,0.99999
MIR548AZ_5P,SET,393,-0.012425,-0.0017983,0.04526,0.60816,MIR548AZ_5P,0.99999
AP1_Q4,SET,251,-0.015242,-0.00177,0.05552,0.60816,AP1_Q4,0.99999
MIR3620_3P,SET,58,-0.031648,-0.0017761,0.11527,0.60817,MIR3620_3P,0.99999
DESCARTES_MAIN_FETAL_URETERI...,SET,27,-0.047637,-0.0018255,0.17347,0.60819,DESCARTES_MAIN_FETAL_URETERIC_BUD_CELLS,0.99999
GOBP_SA_NODE_CELL_TO_ATRIAL_...2,SET,9,-0.08813,-0.0019509,0.32086,0.60821,GOBP_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_SIGNALING,0.99999
GSE40274_HELIOS_VS_FOXP3_AND...2,SET,182,-0.017704,-0.001754,0.064419,0.60827,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
FINETTI_BREAST_CANCER_KINOME...2,SET,16,-0.055115,-0.0016264,0.20046,0.60832,FINETTI_BREAST_CANCER_KINOME_RED,0.99999
REACTOME_CROSS_PRESENTATION_...2,SET,47,-0.029805,-0.0015061,0.1084,0.60832,REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES,0.99999
MIR942_5P,SET,194,-0.017003,-0.0017386,0.061839,0.60832,MIR942_5P,0.99999
MIR661,SET,146,-0.019634,-0.0017439,0.071399,0.60833,MIR661,0.99999
KEGG_MEDICUS_PATHOGEN_KSHV_M...2,SET,6,-0.10981,-0.0019848,0.39926,0.60835,KEGG_MEDICUS_PATHOGEN_KSHV_MIR2_TO_CELL_SURFACE_MOLECULE_ENDOCYTOSIS,0.99999
GSE34515_CD16_NEG_MONOCYTE_V...1,SET,176,-0.0171,-0.0016663,0.062151,0.60839,GSE34515_CD16_NEG_MONOCYTE_VS_DC_DN,0.99999
HP_HEPATIC_BRIDGING_FIBROSIS,SET,9,-0.078423,-0.001736,0.28485,0.60846,HP_HEPATIC_BRIDGING_FIBROSIS,0.99999
WENG_POR_TARGETS_GLOBAL_DN,SET,23,-0.050978,-0.0018033,0.18514,0.60848,WENG_POR_TARGETS_GLOBAL_DN,0.99999
GOMF_3_HYDROXYACYL_COA_DEHYD...1,SET,7,-0.11707,-0.0022856,0.42501,0.60851,GOMF_3_HYDROXYACYL_COA_DEHYDRATASE_ACTIVITY,0.99999
MARIADASON_RESPONSE_TO_BUTYR...2,SET,7,-0.092208,-0.0018002,0.33464,0.60855,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2,0.99999
GSE34179_THPOK_KO_VS_WT_VA14...2,SET,187,-0.016374,-0.0016442,0.059411,0.60857,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP,0.99999
KEGG_MEDICUS_REFERENCE_KEAP1...,SET,20,-0.065708,-0.0021676,0.23838,0.60859,KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY,0.99999
GOBP_CELLULAR_RESPONSE_TO_WA...,SET,6,-0.10092,-0.0018242,0.36603,0.60861,GOBP_CELLULAR_RESPONSE_TO_WATER_STIMULUS,0.99999
BROWNE_HCMV_INFECTION_8HR_DN,SET,40,-0.03997,-0.0018637,0.14489,0.60867,BROWNE_HCMV_INFECTION_8HR_DN,0.99999
MIR4774_3P,SET,75,-0.027673,-0.0017652,0.1003,0.60869,MIR4774_3P,0.99999
HAY_BONE_MARROW_NEUTROPHIL,SET,397,-0.012336,-0.0017943,0.044707,0.60869,HAY_BONE_MARROW_NEUTROPHIL,0.99999
GOBP_ALANINE_TRANSPORT,SET,16,-0.065547,-0.0019343,0.23749,0.60873,GOBP_ALANINE_TRANSPORT,0.99999
HP_MEDIAN_CLEFT_PALATE,SET,24,-0.051302,-0.0018537,0.18575,0.6088,HP_MEDIAN_CLEFT_PALATE,0.99999
GOMF_HYDROLASE_ACTIVITY_ACTI...9,SET,121,-0.02234,-0.0018077,0.080872,0.60882,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS,0.99999
MIR8064,SET,73,-0.029313,-0.0018448,0.10609,0.60884,MIR8064,0.99999
GSE360_T_GONDII_VS_B_MALAYI_...6,SET,174,-0.018671,-0.0018091,0.067545,0.60889,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP,0.99999
GSE19923_E2A_KO_VS_E2A_AND_H...1,SET,182,-0.018143,-0.0017975,0.065609,0.60893,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...23,SET,6,-0.095709,-0.00173,0.34604,0.60895,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_5TH_FINGER,0.99999
GOBP_RESPONSE_TO_BLUE_LIGHT,SET,6,-0.093131,-0.0016834,0.3363,0.60908,GOBP_RESPONSE_TO_BLUE_LIGHT,0.99999
GSE22935_WT_VS_MYD88_KO_MACR...3,SET,182,-0.017531,-0.0017369,0.063308,0.60908,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_DN,0.99999
MIR208B_5P,SET,232,-0.015926,-0.001779,0.057499,0.6091,MIR208B_5P,0.99999
GOBP_CELLULAR_RESPONSE_TO_ET...1,SET,12,-0.069581,-0.0017784,0.25123,0.6091,GOBP_CELLULAR_RESPONSE_TO_ETHANOL,0.99999
PID_ECADHERIN_KERATINOCYTE_P...,SET,21,-0.050472,-0.0017061,0.18221,0.60911,PID_ECADHERIN_KERATINOCYTE_PATHWAY,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...30,SET,7,-0.096231,-0.0018787,0.34735,0.60912,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR,0.99999
GOBP_SECONDARY_PALATE_DEVELO...,SET,26,-0.053549,-0.0020138,0.19311,0.60922,GOBP_SECONDARY_PALATE_DEVELOPMENT,0.99999
GSE7460_TCONV_VS_TREG_THYMUS...1,SET,184,-0.018379,-0.0018308,0.066276,0.60923,GSE7460_TCONV_VS_TREG_THYMUS_DN,0.99999
SRSF9_TARGET_GENES,SET,613,-0.009811,-0.0017626,0.035362,0.60928,SRSF9_TARGET_GENES,0.99999
GOBP_CHONDROITIN_SULFATE_MET...,SET,24,-0.048131,-0.0017391,0.17341,0.60932,GOBP_CHONDROITIN_SULFATE_METABOLIC_PROCESS,0.99999
WP_HEPATITIS_B_INFECTION,SET,141,-0.020566,-0.0017954,0.074086,0.60933,WP_HEPATITIS_B_INFECTION,0.99999
GNF2_TM4SF2,SET,23,-0.053505,-0.0018927,0.19272,0.60935,GNF2_TM4SF2,0.99999
GOBP_MYD88_INDEPENDENT_TOLL_...,SET,16,-0.053666,-0.0015837,0.19329,0.60936,GOBP_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.99999
MCCABE_BOUND_BY_HOXC6,SET,356,-0.012788,-0.0017634,0.046051,0.60937,MCCABE_BOUND_BY_HOXC6,0.99999
KEGG_MEDICUS_REFERENCE_FLT3L...2,SET,15,-0.058165,-0.001662,0.20937,0.60942,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY,0.99999
RAG1_TARGET_GENES,SET,852,-0.0083126,-0.0017487,0.029921,0.60942,RAG1_TARGET_GENES,0.99999
HP_DIAPHYSEAL_DYSPLASIA,SET,5,-0.11601,-0.0019143,0.41748,0.60945,HP_DIAPHYSEAL_DYSPLASIA,0.99999
DESCARTES_FETAL_THYMUS_THYMI...,SET,197,-0.018372,-0.0018929,0.066072,0.60951,DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS,0.99999
GOBP_MODULATION_BY_VIRUS_OF_...,SET,3,-0.13626,-0.0017417,0.48987,0.60955,GOBP_MODULATION_BY_VIRUS_OF_HOST_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...181,SET,14,-0.069316,-0.0019135,0.24919,0.60956,GOBP_NEGATIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...358,SET,28,-0.041369,-0.0016144,0.14872,0.60956,GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.99999
HP_HYPOPLASIA_OF_THE_RADIUS,SET,38,-0.037637,-0.0017106,0.13527,0.60958,HP_HYPOPLASIA_OF_THE_RADIUS,0.99999
GOBP_CAMERA_TYPE_EYE_MORPHOG...,SET,127,-0.022537,-0.001868,0.080993,0.60959,GOBP_CAMERA_TYPE_EYE_MORPHOGENESIS,0.99999
KEGG_FRUCTOSE_AND_MANNOSE_ME...,SET,28,-0.039113,-0.0015263,0.14045,0.60967,KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM,0.99999
LIU_NASOPHARYNGEAL_CARCINOMA,SET,62,-0.029042,-0.0016849,0.10423,0.60974,LIU_NASOPHARYNGEAL_CARCINOMA,0.99999
GOMF_SNARE_BINDING,SET,102,-0.023446,-0.0017428,0.084136,0.60975,GOMF_SNARE_BINDING,0.99999
REACTOME_REGULATION_OF_IFNA_...,SET,22,-0.058672,-0.0020299,0.21047,0.60979,REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING,0.99999
CARD_MIR302A_TARGETS,SET,74,-0.029031,-0.0018394,0.10412,0.60981,CARD_MIR302A_TARGETS,0.99999
GOBP_BLOOD_COAGULATION_FIBRI...,SET,14,-0.079564,-0.0021963,0.28535,0.60981,GOBP_BLOOD_COAGULATION_FIBRIN_CLOT_FORMATION,0.99999
FUNG_IL2_TARGETS_WITH_STAT5_...1,SET,6,-0.10338,-0.0018687,0.37061,0.60986,FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES,0.99999
GNF2_SNRK,SET,26,-0.046594,-0.0017522,0.16701,0.60987,GNF2_SNRK,0.99999
AIZARANI_LIVER_C3_NK_NKT_CEL...,SET,139,-0.020909,-0.0018125,0.074929,0.6099,AIZARANI_LIVER_C3_NK_NKT_CELLS_2,0.99999
MIR6752_5P,SET,112,-0.022969,-0.0017886,0.082274,0.60994,MIR6752_5P,0.99999
DESCARTES_FETAL_STOMACH_LYMP...1,SET,19,-0.063299,-0.0020353,0.22663,0.60999,DESCARTES_FETAL_STOMACH_LYMPHATIC_ENDOTHELIAL_CELLS,0.99999
GOBP_RESPONSE_TO_STEROID_HOR...,SET,310,-0.014086,-0.0018149,0.050427,0.61,GOBP_RESPONSE_TO_STEROID_HORMONE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...626,SET,4,-0.11754,-0.0017348,0.42065,0.61004,GOBP_NEGATIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,0.99999
GOBP_REGULATION_OF_CELL_COMM...2,SET,12,-0.080822,-0.0020657,0.2891,0.61009,GOBP_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION,0.99999
GOBP_RESPONSE_TO_HYPEROXIA,SET,17,-0.056648,-0.001723,0.20254,0.61014,GOBP_RESPONSE_TO_HYPEROXIA,0.99999
GSE32986_CURDLAN_LOWDOSE_VS_...3,SET,180,-0.017213,-0.0016961,0.06152,0.61018,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_AM...2,SET,40,-0.04082,-0.0019033,0.14585,0.61021,GOBP_CELLULAR_RESPONSE_TO_AMYLOID_BETA,0.99999
TURASHVILI_BREAST_DUCTAL_CAR...3,SET,60,-0.033255,-0.0018981,0.11881,0.61023,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,0.99999
ZID_01,SET,232,-0.015155,-0.0016928,0.054128,0.61025,ZID_01,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...8,SET,40,-0.038547,-0.0017974,0.13768,0.61025,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_FEMORAL_HEAD_AND_NECK,0.99999
GOBP_MICROGLIAL_CELL_ACTIVAT...,SET,5,-0.1176,-0.0019405,0.41975,0.61032,GOBP_MICROGLIAL_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
WP_NRXN1_DELETION_SYNDROME,SET,14,-0.068903,-0.0019021,0.24593,0.61033,WP_NRXN1_DELETION_SYNDROME,0.99999
MENON_FETAL_KIDNEY_2_NEPHRON...,SET,35,-0.0411,-0.0017929,0.14664,0.61037,MENON_FETAL_KIDNEY_2_NEPHRON_PROGENITOR_CELLS,0.99999
GOBP_BONE_MORPHOGENESIS,SET,96,-0.02601,-0.001876,0.092794,0.61038,GOBP_BONE_MORPHOGENESIS,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...12,SET,11,-0.065463,-0.0016019,0.23337,0.61046,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_CELL_CYCLE_G1_S,0.99999
GOBP_SEROTONERGIC_NEURON_AXO...,SET,5,-0.10108,-0.001668,0.36036,0.61046,GOBP_SEROTONERGIC_NEURON_AXON_GUIDANCE,0.99999
HE_LIM_SUN_FETAL_LUNG_C5_LAR...,SET,1181,-0.0067767,-0.0016626,0.024156,0.61047,HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL,0.99999
GOBP_SMALL_NUCLEOLAR_RIBONUC...,SET,10,-0.075226,-0.0017552,0.26803,0.61051,GOBP_SMALL_NUCLEOLAR_RIBONUCLEOPROTEIN_COMPLEX_ASSEMBLY,0.99999
HP_XANTHOMATOSIS,SET,36,-0.044851,-0.0019842,0.1598,0.61051,HP_XANTHOMATOSIS,0.99999
HOWARD_NEUTROPHIL_INACT_MONO...1,SET,102,-0.023999,-0.0017839,0.085509,0.61052,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.99999
GOMF_NADPLUS_NUCLEOTIDASE_CY...,SET,14,-0.077542,-0.0021405,0.27624,0.61053,GOMF_NADPLUS_NUCLEOTIDASE_CYCLIC_ADP_RIBOSE_GENERATING,0.99999
THAKAR_PBMC_INACTIVATED_INFL...10,SET,125,-0.02138,-0.0017582,0.07615,0.61055,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_DN,0.99999
GOMF_TAURINE_TRANSMEMBRANE_T...,SET,5,-0.12037,-0.0019862,0.42859,0.61058,GOMF_TAURINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_ABNORMALITY_OF_THE_MENSTR...,SET,290,-0.014265,-0.0017787,0.050795,0.61058,HP_ABNORMALITY_OF_THE_MENSTRUAL_CYCLE,0.99999
GOBP_PLATELET_DERIVED_GROWTH...3,SET,53,-0.034614,-0.0018572,0.12321,0.61062,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE8685_IL2_STARVED_VS_IL15_...2,SET,181,-0.017827,-0.0017614,0.063451,0.61063,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,0.99999
JONES_OVARY_ENDOTHELIAL,SET,144,-0.022175,-0.0019563,0.078919,0.61064,JONES_OVARY_ENDOTHELIAL,0.99999
WP_SEROTONIN_AND_ANXIETY,SET,15,-0.070699,-0.0020201,0.25151,0.61068,WP_SEROTONIN_AND_ANXIETY,0.99999
ELVIDGE_HYPOXIA_DN,SET,137,-0.019138,-0.0016471,0.068081,0.61069,ELVIDGE_HYPOXIA_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...246,SET,57,-0.035739,-0.0019884,0.12713,0.61069,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
WP_FRAGILE_X_SYNDROME,SET,117,-0.021774,-0.0017328,0.077416,0.61074,WP_FRAGILE_X_SYNDROME,0.99999
GOCC_PROTEASOME_CORE_COMPLEX,SET,20,-0.044591,-0.001471,0.15855,0.61074,GOCC_PROTEASOME_CORE_COMPLEX,0.99999
STREICHER_LSM1_TARGETS_UP,SET,40,-0.039303,-0.0018326,0.13966,0.6108,STREICHER_LSM1_TARGETS_UP,0.99999
GOBP_REGULATION_OF_TRANSMISS...,SET,13,-0.071702,-0.0019074,0.2548,0.6108,GOBP_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,0.99999
GSE24634_TREG_VS_TCONV_POST_...1,SET,188,-0.018385,-0.001851,0.065293,0.61087,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN,0.99999
REACTOME_DNA_DOUBLE_STRAND_B...2,SET,38,-0.036782,-0.0016717,0.1306,0.61089,REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE,0.99999
PARK_APL_PATHOGENESIS_UP,SET,14,-0.068295,-0.0018853,0.24241,0.61092,PARK_APL_PATHOGENESIS_UP,0.99999
GOBP_CEMENTUM_MINERALIZATION,SET,5,-0.11649,-0.0019222,0.41341,0.61094,GOBP_CEMENTUM_MINERALIZATION,0.99999
GOMF_ADRENERGIC_RECEPTOR_BIN...,SET,16,-0.061905,-0.0018268,0.21962,0.61098,GOMF_ADRENERGIC_RECEPTOR_BINDING,0.99999
DESCARTES_MAIN_FETAL_ENS_NEU...,SET,27,-0.049316,-0.0018899,0.17492,0.611,DESCARTES_MAIN_FETAL_ENS_NEURONS,0.99999
HP_SQUAMOUS_CELL_CARCINOMA_O...,SET,22,-0.045202,-0.0015639,0.16032,0.61101,HP_SQUAMOUS_CELL_CARCINOMA_OF_THE_SKIN,0.99999
HP_DYSGENESIS_OF_THE_BASAL_G...,SET,5,-0.10543,-0.0017397,0.37387,0.61102,HP_DYSGENESIS_OF_THE_BASAL_GANGLIA,0.99999
GOBP_NITRIC_OXIDE_SYNTHASE_B...,SET,18,-0.066441,-0.0020794,0.23537,0.61113,GOBP_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS,0.99999
PARENT_MTOR_SIGNALING_UP,SET,504,-0.010412,-0.0017014,0.036882,0.61115,PARENT_MTOR_SIGNALING_UP,0.99999
GSE22140_GERMFREE_VS_SPF_ART...2,SET,186,-0.017645,-0.0017671,0.062487,0.61117,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP,0.99999
HP_DEVELOPMENTAL_CATARACT,SET,109,-0.022444,-0.0017243,0.079445,0.61122,HP_DEVELOPMENTAL_CATARACT,0.99999
HP_PREMATURE_LOSS_OF_PRIMARY...,SET,19,-0.058712,-0.0018878,0.20783,0.61122,HP_PREMATURE_LOSS_OF_PRIMARY_TEETH,0.99999
HP_RECURRENT_MENINGITIS,SET,3,-0.15886,-0.0020306,0.56223,0.61124,HP_RECURRENT_MENINGITIS,0.99999
REACTOME_SWITCHING_OF_ORIGIN...,SET,88,-0.022855,-0.0015786,0.080821,0.61133,REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,0.99999
HP_ABNORMAL_CIRCULATING_INHI...,SET,6,-0.12307,-0.0022245,0.43518,0.61133,HP_ABNORMAL_CIRCULATING_INHIBIN_B_CONCENTRATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...52,SET,31,-0.041711,-0.0017126,0.14744,0.61138,GOBP_POSITIVE_REGULATION_OF_AXON_EXTENSION,0.99999
PID_PTP1B_PATHWAY,SET,52,-0.036669,-0.0019488,0.12952,0.61145,PID_PTP1B_PATHWAY,0.99999
HP_DUPLICATION_OF_THUMB_PHAL...,SET,53,-0.032048,-0.0017195,0.11319,0.61146,HP_DUPLICATION_OF_THUMB_PHALANX,0.99999
HP_HEMOTHORAX,SET,6,-0.098944,-0.0017885,0.34946,0.61146,HP_HEMOTHORAX,0.99999
GSE17721_PAM3CSK4_VS_CPG_2H_...1,SET,181,-0.017445,-0.0017237,0.061596,0.6115,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN,0.99999
MIR208B_3P,SET,39,-0.039972,-0.0018404,0.14108,0.61154,MIR208B_3P,0.99999
MORF_MDM2,SET,248,-0.015579,-0.0017985,0.05497,0.61157,MORF_MDM2,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...71,SET,36,-0.041215,-0.0018234,0.14541,0.61158,HP_APLASIA_HYPOPLASIA_OF_THE_THYMUS,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...16,SET,8,-0.073994,-0.0015443,0.26092,0.61164,GOBP_PROTEIN_LOCALIZATION_TO_CILIARY_TRANSITION_ZONE,0.99999
GSE2770_TGFB_AND_IL4_ACT_VS_...5,SET,174,-0.018074,-0.0017513,0.063733,0.61164,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,0.99999
GSE36476_CTRL_VS_TSST_ACT_40...4,SET,177,-0.01843,-0.001801,0.064956,0.61169,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP,0.99999
GSE17721_CTRL_VS_POLYIC_12H_...1,SET,188,-0.017439,-0.0017557,0.061451,0.61171,GSE17721_CTRL_VS_POLYIC_12H_BMDC_DN,0.99999
HP_MODERATE_GLOBAL_DEVELOPME...,SET,22,-0.049601,-0.001716,0.17469,0.61177,HP_MODERATE_GLOBAL_DEVELOPMENTAL_DELAY,0.99999
GOBP_NOTCH_SIGNALING_PATHWAY,SET,164,-0.01975,-0.0018584,0.069538,0.6118,GOBP_NOTCH_SIGNALING_PATHWAY,0.99999
MIR4313,SET,26,-0.047565,-0.0017888,0.16742,0.61184,MIR4313,0.99999
KEGG_MEDICUS_VARIANT_EML4_AL...4,SET,11,-0.073788,-0.0018057,0.25969,0.61185,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOBP_NEURON_PROJECTION_MAINT...,SET,10,-0.069646,-0.0016251,0.24499,0.6119,GOBP_NEURON_PROJECTION_MAINTENANCE,0.99999
FAN_OVARY_CL1_GPRC5A_TNFRS12...,SET,342,-0.012846,-0.0017369,0.045138,0.61202,FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...8,SET,191,-0.017924,-0.0018188,0.062934,0.6121,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...4,SET,48,-0.039078,-0.0019956,0.13714,0.61216,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_2,0.99999
HP_ELEVATED_SERUM_ACID_PHOSP...,SET,5,-0.11093,-0.0018305,0.38928,0.61217,HP_ELEVATED_SERUM_ACID_PHOSPHATASE,0.99999
GSE3982_EOSINOPHIL_VS_MAST_C...1,SET,174,-0.018483,-0.0017909,0.064819,0.61223,GSE3982_EOSINOPHIL_VS_MAST_CELL_DN,0.99999
GOBP_MEMBRANE_PROTEIN_PROTEO...,SET,56,-0.031293,-0.0017257,0.10973,0.61224,GOBP_MEMBRANE_PROTEIN_PROTEOLYSIS,0.99999
REACTOME_TRAFFICKING_OF_AMPA...,SET,29,-0.046901,-0.0018626,0.16445,0.61225,REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...8,SET,128,-0.022862,-0.0019023,0.080152,0.61227,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.99999
HP_GERMINOMA,SET,12,-0.07359,-0.0018809,0.25788,0.61232,HP_GERMINOMA,0.99999
HE_LIM_SUN_FETAL_LUNG_C5_CD5...1,SET,46,-0.038308,-0.0019152,0.13419,0.61235,HE_LIM_SUN_FETAL_LUNG_C5_CD5_NEG_MATURE_B_CELL,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...10,SET,36,-0.05147,-0.002277,0.18025,0.61238,GOMF_STRUCTURAL_CONSTITUENT_OF_SKIN_EPIDERMIS,0.99999
KEGG_MEDICUS_REFERENCE_KISS1...,SET,11,-0.07889,-0.0019305,0.27615,0.61244,KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY,0.99999
HP_ELEVATED_ALKALINE_PHOSPHA...,SET,13,-0.07097,-0.0018879,0.24837,0.61246,HP_ELEVATED_ALKALINE_PHOSPHATASE_OF_BONE_ORIGIN,0.99999
GSE21774_CD62L_POS_CD56_BRIG...2,SET,173,-0.019703,-0.0019037,0.068947,0.61247,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,0.99999
MORF_BRCA1,SET,242,-0.015241,-0.0017384,0.05333,0.61248,MORF_BRCA1,0.99999
GSE36009_WT_VS_NLRP10_KO_DC_...4,SET,184,-0.018248,-0.0018177,0.063844,0.61249,GSE36009_WT_VS_NLRP10_KO_DC_UP,0.99999
HP_RADIAL_DEVIATION_OF_THE_H...2,SET,51,-0.034407,-0.001811,0.12034,0.61253,HP_RADIAL_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,0.99999
WP_CELLTYPE_DEPENDENT_SELECT...,SET,13,-0.077147,-0.0020522,0.26975,0.61256,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,0.99999
DMRT1_TARGET_GENES,SET,328,-0.013611,-0.0018031,0.047592,0.61256,DMRT1_TARGET_GENES,0.99999
GOMF_PHOSPHOTRANSFERASE_ACTI...2,SET,7,-0.086229,-0.0016835,0.30149,0.61256,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_NITROGENOUS_GROUP_AS_ACCEPTOR,0.99999
GOCC_AUTOLYSOSOME,SET,12,-0.072291,-0.0018477,0.25274,0.61257,GOCC_AUTOLYSOSOME,0.99999
GOBP_NEGATIVE_REGULATION_OF_...85,SET,13,-0.072358,-0.0019248,0.25294,0.61259,GOBP_NEGATIVE_REGULATION_OF_CATECHOLAMINE_SECRETION,0.99999
VERHAAK_AML_WITH_NPM1_MUTATE...2,SET,168,-0.020562,-0.001958,0.071858,0.61262,VERHAAK_AML_WITH_NPM1_MUTATED_UP,0.99999
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,SET,55,-0.032961,-0.0018015,0.11517,0.61264,KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,0.99999
WP_15Q25_COPY_NUMBER_VARIATI...,SET,42,-0.041563,-0.0019857,0.14522,0.61264,WP_15Q25_COPY_NUMBER_VARIATION,0.99999
HP_CHRONIC_KIDNEY_DISEASE,SET,178,-0.017849,-0.0017491,0.062355,0.61266,HP_CHRONIC_KIDNEY_DISEASE,0.99999
MIR924,SET,44,-0.035565,-0.0017391,0.12419,0.61271,MIR924,0.99999
REACTOME_INTRAFLAGELLAR_TRAN...,SET,44,-0.036269,-0.0017735,0.12661,0.61274,REACTOME_INTRAFLAGELLAR_TRANSPORT,0.99999
GOBP_RESPONSE_TO_NERVE_GROWT...,SET,51,-0.035734,-0.0018808,0.12473,0.61275,GOBP_RESPONSE_TO_NERVE_GROWTH_FACTOR,0.99999
GOBP_REGULATION_OF_MESODERMA...2,SET,6,-0.10414,-0.0018825,0.36347,0.61276,GOBP_REGULATION_OF_MESODERMAL_CELL_FATE_SPECIFICATION,0.99999
HP_STRIDOR,SET,45,-0.036651,-0.0018124,0.12792,0.61276,HP_STRIDOR,0.99999
GOBP_ARF_PROTEIN_SIGNAL_TRAN...,SET,21,-0.05073,-0.0017148,0.17702,0.61278,GOBP_ARF_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
STAT1_02,SET,233,-0.015734,-0.0017613,0.054848,0.61289,STAT1_02,0.99999
HP_LIVEDO_RETICULARIS,SET,4,-0.1189,-0.0017549,0.41442,0.61291,HP_LIVEDO_RETICULARIS,0.99999
GOBP_MAINTENANCE_OF_ANIMAL_O...,SET,5,-0.1166,-0.001924,0.40627,0.61294,GOBP_MAINTENANCE_OF_ANIMAL_ORGAN_IDENTITY,0.99999
REACTOME_APOPTOTIC_EXECUTION...,SET,43,-0.037563,-0.0018158,0.13082,0.613,REACTOME_APOPTOTIC_EXECUTION_PHASE,0.99999
MOOTHA_PGC,SET,377,-0.012168,-0.0017258,0.042366,0.61303,MOOTHA_PGC,0.99999
WP_GAMMAGLUTAMYL_CYCLE_FOR_T...,SET,6,-0.093804,-0.0016956,0.32648,0.61306,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,0.99999
GOBP_TRANSMISSION_OF_NERVE_I...,SET,71,-0.031751,-0.0019708,0.11051,0.61306,GOBP_TRANSMISSION_OF_NERVE_IMPULSE,0.99999
HP_SKIN_NODULE,SET,120,-0.02346,-0.0018905,0.081651,0.61306,HP_SKIN_NODULE,0.99999
GOBP_REGULATION_OF_STORE_OPE...2,SET,14,-0.070214,-0.0019383,0.24437,0.61307,GOBP_REGULATION_OF_STORE_OPERATED_CALCIUM_ENTRY,0.99999
CORDENONSI_YAP_CONSERVED_SIG...,SET,52,-0.03755,-0.0019957,0.13068,0.61307,CORDENONSI_YAP_CONSERVED_SIGNATURE,0.99999
GOBP_ENDOCARDIAL_CUSHION_MOR...,SET,42,-0.044491,-0.0021256,0.15475,0.61313,GOBP_ENDOCARDIAL_CUSHION_MORPHOGENESIS,0.99999
GSE43955_1H_VS_20H_ACT_CD4_T...2,SET,184,-0.018273,-0.0018202,0.063559,0.61313,GSE43955_1H_VS_20H_ACT_CD4_TCELL_UP,0.99999
GOBP_CEREBELLAR_CORTEX_FORMA...,SET,22,-0.05561,-0.0019239,0.19338,0.61316,GOBP_CEREBELLAR_CORTEX_FORMATION,0.99999
CAGCACT_MIR5123P,SET,141,-0.022286,-0.0019456,0.077449,0.61323,CAGCACT_MIR5123P,0.99999
GOBP_POSITIVE_REGULATION_OF_...320,SET,8,-0.10339,-0.0021579,0.35925,0.61325,GOBP_POSITIVE_REGULATION_OF_GROWTH_HORMONE_SECRETION,0.99999
IGLESIAS_E2F_TARGETS_DN,SET,11,-0.080376,-0.0019669,0.27918,0.61329,IGLESIAS_E2F_TARGETS_DN,0.99999
GOBP_DENSE_CORE_GRANULE_TRAN...,SET,10,-0.07916,-0.001847,0.27494,0.6133,GOBP_DENSE_CORE_GRANULE_TRANSPORT,0.99999
MIR4656,SET,98,-0.024966,-0.0018192,0.086634,0.61339,MIR4656,0.99999
HP_AORTIC_DISSECTION,SET,37,-0.04462,-0.0020012,0.15484,0.61339,HP_AORTIC_DISSECTION,0.99999
GOMF_GLUCOSYLTRANSFERASE_ACT...,SET,16,-0.055773,-0.0016458,0.19353,0.6134,GOMF_GLUCOSYLTRANSFERASE_ACTIVITY,0.99999
MIR3152_5P,SET,55,-0.031633,-0.0017289,0.10975,0.61341,MIR3152_5P,0.99999
GAUCHER_PBMC_YF_VAX_STAMARIL...4,SET,53,-0.033751,-0.0018108,0.11709,0.61342,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_UP,0.99999
GCM_BAG5,SET,34,-0.037113,-0.0015957,0.1287,0.61346,GCM_BAG5,0.99999
GOMF_AMINOACYL_TRNA_HYDROLAS...,SET,4,-0.095938,-0.001416,0.33265,0.61348,GOMF_AMINOACYL_TRNA_HYDROLASE_ACTIVITY,0.99999
DACOSTA_UV_RESPONSE_VIA_ERCC...5,SET,49,-0.036048,-0.0018599,0.12497,0.6135,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,0.99999
HP_HYPOPLASIA_OF_PENIS,SET,340,-0.01358,-0.0018309,0.047057,0.61355,HP_HYPOPLASIA_OF_PENIS,0.99999
GOBP_MESODERMAL_CELL_DIFFERE...,SET,31,-0.046513,-0.0019098,0.16112,0.61359,GOBP_MESODERMAL_CELL_DIFFERENTIATION,0.99999
SONG_TARGETS_OF_IE86_CMV_PRO...,SET,51,-0.035784,-0.0018835,0.12386,0.61367,SONG_TARGETS_OF_IE86_CMV_PROTEIN,0.99999
MIR6798_5P,SET,41,-0.038602,-0.0018222,0.1336,0.61368,MIR6798_5P,0.99999
GOMF_TYPE_I_TRANSFORMING_GRO...,SET,11,-0.083531,-0.0020441,0.28911,0.61368,GOMF_TYPE_I_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.99999
ANDERSON_BLOOD_CN54GP140_ADJ...3,SET,30,-0.040979,-0.0016552,0.14182,0.61369,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_DN,0.99999
GOBP_INTRACILIARY_TRANSPORT_...,SET,6,-0.10466,-0.0018917,0.36172,0.61383,GOBP_INTRACILIARY_TRANSPORT_INVOLVED_IN_CILIUM_ASSEMBLY,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...9,SET,176,-0.017948,-0.0017489,0.062035,0.61383,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN,0.99999
HAHTOLA_CTCL_CUTANEOUS,SET,21,-0.050633,-0.0017115,0.17495,0.61387,HAHTOLA_CTCL_CUTANEOUS,0.99999
SASAKI_ADULT_T_CELL_LEUKEMIA,SET,154,-0.020117,-0.0018348,0.069499,0.61388,SASAKI_ADULT_T_CELL_LEUKEMIA,0.99999
NIKOLSKY_OVERCONNECTED_IN_BR...,SET,21,-0.054052,-0.0018271,0.18671,0.6139,NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,0.99999
HP_NEOPLASM_OF_THE_SMALL_INT...,SET,18,-0.055844,-0.0017478,0.19286,0.61392,HP_NEOPLASM_OF_THE_SMALL_INTESTINE,0.99999
MIR3910,SET,365,-0.013589,-0.001897,0.04692,0.61394,MIR3910,0.99999
FAN_OVARY_CL6_PUTATIVE_EARLY...,SET,259,-0.016049,-0.0018928,0.055408,0.61396,FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2,0.99999
chr7p12,SET,18,-0.098581,-0.0030853,0.3403,0.61397,chr7p12,0.99999
MAGRANGEAS_MULTIPLE_MYELOMA_...4,SET,38,-0.042006,-0.0019092,0.14498,0.61399,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP,0.99999
CUI_DEVELOPING_HEART_LEFT_VE...,SET,37,-0.045486,-0.00204,0.1569,0.61405,CUI_DEVELOPING_HEART_LEFT_VENTRICULAR_CARDIOMYOCYTE,0.99999
GOBP_2_OXOGLUTARATE_METABOLI...,SET,16,-0.060839,-0.0017953,0.20981,0.61408,GOBP_2_OXOGLUTARATE_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_POLYSACCH...1,SET,33,-0.043779,-0.0018545,0.15095,0.6141,GOBP_REGULATION_OF_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS,0.99999
CCAWNWWNNNGGC_UNKNOWN,SET,75,-0.029025,-0.0018514,0.10001,0.61417,CCAWNWWNNNGGC_UNKNOWN,0.99999
BIOCARTA_IL1R_PATHWAY,SET,30,-0.04933,-0.0019925,0.16996,0.61419,BIOCARTA_IL1R_PATHWAY,0.99999
GSE10239_MEMORY_VS_DAY4.5_EF...1,SET,181,-0.018001,-0.0017785,0.062018,0.61419,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN,0.99999
GOCC_CCR4_NOT_COMPLEX,SET,15,-0.062974,-0.0017994,0.21685,0.61424,GOCC_CCR4_NOT_COMPLEX,0.99999
MANALO_HYPOXIA_UP,SET,184,-0.019934,-0.0019856,0.068622,0.61428,MANALO_HYPOXIA_UP,0.99999
HP_PAPILLARY_THYROID_CARCINO...,SET,24,-0.05128,-0.0018529,0.17643,0.61434,HP_PAPILLARY_THYROID_CARCINOMA,0.99999
HP_FRONTAL_UPSWEEP_OF_HAIR,SET,20,-0.059174,-0.0019521,0.20355,0.61436,HP_FRONTAL_UPSWEEP_OF_HAIR,0.99999
HSD17B8_TARGET_GENES,SET,517,-0.01147,-0.0018976,0.03945,0.61438,HSD17B8_TARGET_GENES,0.99999
GOMF_CATALYTIC_ACTIVITY_ACTI...3,SET,16,-0.05201,-0.0015348,0.17886,0.61439,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_RRNA,0.99999
HP_SUBUNGUAL_HYPERKERATOSIS,SET,6,-0.1026,-0.0018546,0.35264,0.61445,HP_SUBUNGUAL_HYPERKERATOSIS,0.99999
GOBP_AMINO_ACID_TRANSPORT,SET,147,-0.021759,-0.0019393,0.074776,0.61447,GOBP_AMINO_ACID_TRANSPORT,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...41,SET,51,-0.035193,-0.0018524,0.12094,0.61447,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANGES_OF_THE_HAND,0.99999
KIM_GERMINAL_CENTER_T_HELPER...2,SET,57,-0.035238,-0.0019605,0.12108,0.61449,KIM_GERMINAL_CENTER_T_HELPER_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...280,SET,64,-0.033242,-0.0019593,0.11414,0.61456,GOBP_NEGATIVE_REGULATION_OF_HORMONE_SECRETION,0.99999
GOBP_PROTEIN_MODIFICATION_BY...1,SET,745,-0.0090182,-0.0017795,0.030958,0.61459,GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION,0.99999
GOMF_PLATELET_DERIVED_GROWTH...1,SET,11,-0.088625,-0.0021687,0.30424,0.61459,GOMF_PLATELET_DERIVED_GROWTH_FACTOR_BINDING,0.99999
HP_MULTIPLE_CAFE_AU_LAIT_SPO...,SET,61,-0.029054,-0.001672,0.099717,0.61461,HP_MULTIPLE_CAFE_AU_LAIT_SPOTS,0.99999
HP_OPEN_MOUTH,SET,98,-0.025489,-0.0018574,0.087483,0.61461,HP_OPEN_MOUTH,0.99999
ZFP82_TARGET_GENES,SET,25,-0.047506,-0.0017519,0.16304,0.61462,ZFP82_TARGET_GENES,0.99999
FOROUTAN_TGFB_EMT_DN,SET,102,-0.027022,-0.0020086,0.092722,0.61464,FOROUTAN_TGFB_EMT_DN,0.99999
BOYLAN_MULTIPLE_MYELOMA_C_D_...2,SET,125,-0.02206,-0.0018141,0.07568,0.61466,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,0.99999
CEBPZ_TARGET_GENES,SET,1238,-0.0072183,-0.0018102,0.024742,0.61476,CEBPZ_TARGET_GENES,0.99999
NUP214_TARGET_GENES,SET,7,-0.10941,-0.002136,0.37493,0.61478,NUP214_TARGET_GENES,0.99999
GOBP_MORPHOGENESIS_OF_AN_EPI...4,SET,472,-0.012097,-0.0019146,0.041448,0.6148,GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM,0.99999
AIZARANI_LIVER_C28_NK_NKT_CE...,SET,85,-0.028273,-0.0019194,0.096831,0.61485,AIZARANI_LIVER_C28_NK_NKT_CELLS_6,0.99999
PID_ALK1_PATHWAY,SET,24,-0.048946,-0.0017686,0.1676,0.61487,PID_ALK1_PATHWAY,0.99999
ZHONG_PFC_C1_NEUROD1_POS_EXC...,SET,25,-0.056035,-0.0020664,0.19187,0.61487,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.99999
GOMF_LYSOPHOSPHATIDIC_ACID_B...,SET,7,-0.087568,-0.0017096,0.29983,0.61488,GOMF_LYSOPHOSPHATIDIC_ACID_BINDING,0.99999
GOBP_WYBUTOSINE_METABOLIC_PR...,SET,6,-0.08604,-0.0015552,0.29452,0.61491,GOBP_WYBUTOSINE_METABOLIC_PROCESS,0.99999
HALLMARK_INTERFERON_ALPHA_RE...,SET,93,-0.025718,-0.0018259,0.087987,0.61497,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.99999
GOBP_MALE_GENITALIA_DEVELOPM...,SET,23,-0.057216,-0.0020239,0.1957,0.61499,GOBP_MALE_GENITALIA_DEVELOPMENT,0.99999
GOBP_PHENOL_CONTAINING_COMPO...2,SET,7,-0.11105,-0.0021681,0.3798,0.61501,GOBP_PHENOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.99999
HP_ABNORMAL_EATING_BEHAVIOR,SET,114,-0.024474,-0.0019226,0.083688,0.61503,HP_ABNORMAL_EATING_BEHAVIOR,0.99999
GOBP_RESPONSE_TO_AXON_INJURY,SET,79,-0.028883,-0.0018906,0.098735,0.61506,GOBP_RESPONSE_TO_AXON_INJURY,0.99999
KEGG_MEDICUS_REFERENCE_V_D_J...,SET,12,-0.060086,-0.0015357,0.20535,0.61508,KEGG_MEDICUS_REFERENCE_V_D_J_RECOMBINATION,0.99999
REACTOME_SUMO_IS_CONJUGATED_...,SET,5,-0.090454,-0.0014926,0.30914,0.61508,REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1,0.99999
CROMER_METASTASIS_UP,SET,59,-0.033253,-0.0018821,0.11361,0.61512,CROMER_METASTASIS_UP,0.99999
HOLLMANN_APOPTOSIS_VIA_CD40_...1,SET,234,-0.016781,-0.0018825,0.057316,0.61515,HOLLMANN_APOPTOSIS_VIA_CD40_DN,0.99999
MIR7852_3P,SET,66,-0.030517,-0.0018265,0.10422,0.61517,MIR7852_3P,0.99999
MYOGNF1_01,SET,41,-0.040489,-0.0019113,0.13822,0.61521,MYOGNF1_01,0.99999
GSE1112_OT1_VS_HY_CD8AB_THYM...2,SET,180,-0.0181,-0.0017835,0.061776,0.61524,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_UP,0.99999
GOMF_SUMO_TRANSFERASE_ACTIVI...,SET,24,-0.05474,-0.0019779,0.1868,0.61525,GOMF_SUMO_TRANSFERASE_ACTIVITY,0.99999
WP_SILDENAFIL_TREATMENT,SET,19,-0.061327,-0.0019719,0.20916,0.61532,WP_SILDENAFIL_TREATMENT,0.99999
HP_CORTICAL_DYSPLASIA,SET,51,-0.036505,-0.0019214,0.12442,0.61539,HP_CORTICAL_DYSPLASIA,0.99999
GSE360_LOW_DOSE_B_MALAYI_VS_...4,SET,184,-0.017916,-0.0017846,0.061065,0.61539,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,0.99999
GSE31082_DN_VS_DP_THYMOCYTE_...1,SET,184,-0.017459,-0.0017391,0.059401,0.61559,GSE31082_DN_VS_DP_THYMOCYTE_DN,0.99999
GOMF_SUPERCOILED_DNA_BINDING,SET,6,-0.097071,-0.0017546,0.33022,0.6156,GOMF_SUPERCOILED_DNA_BINDING,0.99999
GOBP_PIECEMEAL_MICROAUTOPHAG...,SET,17,-0.05891,-0.0017918,0.20037,0.61562,GOBP_PIECEMEAL_MICROAUTOPHAGY_OF_THE_NUCLEUS,0.99999
MULLIGAN_NTF3_SIGNALING_VIA_...1,SET,7,-0.11377,-0.0022211,0.38692,0.61563,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN,0.99999
MIR655_3P,SET,382,-0.013515,-0.0019292,0.045961,0.61564,MIR655_3P,0.99999
GERY_CEBP_TARGETS,SET,118,-0.02532,-0.0020234,0.086062,0.6157,GERY_CEBP_TARGETS,0.99999
MODULE_545,SET,18,-0.060925,-0.0019068,0.20706,0.61571,MODULE_545,0.99999
GOMF_AMINOACYLASE_ACTIVITY,SET,4,-0.13113,-0.0019354,0.44561,0.61573,GOMF_AMINOACYLASE_ACTIVITY,0.99999
GSE17974_0H_VS_1H_IN_VITRO_A...1,SET,183,-0.018171,-0.0018052,0.061746,0.61573,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN,0.99999
GOBP_CARDIAC_CHAMBER_DEVELOP...,SET,162,-0.021461,-0.0020071,0.072897,0.61577,GOBP_CARDIAC_CHAMBER_DEVELOPMENT,0.99999
GOMF_RETINOIC_ACID_RESPONSIV...,SET,6,-0.099369,-0.0017961,0.33753,0.61577,GOMF_RETINOIC_ACID_RESPONSIVE_ELEMENT_BINDING,0.99999
HP_ABNORMAL_PULMONARY_ALVEOL...,SET,5,-0.13422,-0.0022148,0.45547,0.61588,HP_ABNORMAL_PULMONARY_ALVEOLAR_SYSTEM_MORPHOLOGY,0.99999
HP_LOWER_LIMB_UNDERGROWTH,SET,14,-0.06747,-0.0018625,0.22888,0.61592,HP_LOWER_LIMB_UNDERGROWTH,0.99999
GOBP_LYSINE_METABOLIC_PROCESS,SET,8,-0.081987,-0.0017111,0.27808,0.61594,GOBP_LYSINE_METABOLIC_PROCESS,0.99999
KERLEY_RESPONSE_TO_CISPLATIN...2,SET,44,-0.03788,-0.0018523,0.12843,0.61598,KERLEY_RESPONSE_TO_CISPLATIN_UP,0.99999
TOMIDA_METASTASIS_DN,SET,11,-0.075305,-0.0018428,0.25529,0.61599,TOMIDA_METASTASIS_DN,0.99999
HP_BICARBONATURIA,SET,5,-0.11108,-0.0018329,0.3764,0.61604,HP_BICARBONATURIA,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...37,SET,17,-0.065871,-0.0020036,0.22298,0.61616,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT,0.99999
GSE12845_NAIVE_VS_PRE_GC_TON...1,SET,175,-0.017938,-0.001743,0.060716,0.61617,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN,0.99999
GAO_STOMACH_24W_C4_PARIETAL_...,SET,8,-0.097127,-0.0020271,0.32873,0.61618,GAO_STOMACH_24W_C4_PARIETAL_PROGENITOR,0.99999
NR0B1_TARGET_GENES,SET,276,-0.015582,-0.0018962,0.052719,0.61622,NR0B1_TARGET_GENES,0.99999
GSE21670_UNTREATED_VS_TGFB_I...3,SET,177,-0.018357,-0.0017938,0.062092,0.61625,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...81,SET,11,-0.078731,-0.0019266,0.26626,0.61627,GOBP_NEGATIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.99999
KEGG_MEDICUS_PATHOGEN_HPV_E7...1,SET,6,-0.086062,-0.0015556,0.29101,0.61628,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_CELL_CYCLE_G1_S,0.99999
HP_PHONOPHOBIA,SET,22,-0.060231,-0.0020838,0.20353,0.61636,HP_PHONOPHOBIA,0.99999
MIR3120_3P,SET,320,-0.014564,-0.001906,0.049206,0.61637,MIR3120_3P,0.99999
GOCC_TRANSCRIPTION_FACTOR_AP...,SET,5,-0.13169,-0.002173,0.44493,0.61637,GOCC_TRANSCRIPTION_FACTOR_AP_1_COMPLEX,0.99999
HP_MYOPATHY,SET,280,-0.015123,-0.0018534,0.051097,0.61637,HP_MYOPATHY,0.99999
GOBP_RESPONSE_TO_ORGANIC_CYC...,SET,826,-0.0092403,-0.0019154,0.031219,0.61638,GOBP_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND,0.99999
MIDORIKAWA_AMPLIFIED_IN_LIVE...,SET,51,-0.049744,-0.0026182,0.16805,0.61639,MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,0.99999
chr2p23,SET,84,-0.053914,-0.0036386,0.1821,0.61641,chr2p23,0.99999
PID_EPHA2_FWD_PATHWAY,SET,19,-0.056155,-0.0018056,0.18957,0.61647,PID_EPHA2_FWD_PATHWAY,0.99999
REACTOME_PHENYLALANINE_METAB...,SET,5,-0.13055,-0.0021543,0.44035,0.61657,REACTOME_PHENYLALANINE_METABOLISM,0.99999
chr6p21,SET,271,-0.034826,-0.0042,0.11742,0.61661,chr6p21,0.99999
GOBP_POSITIVE_REGULATION_OF_...67,SET,19,-0.062674,-0.0020152,0.21121,0.61666,GOBP_POSITIVE_REGULATION_OF_BONE_RESORPTION,0.99999
HP_ABNORMALLY_LOW_T_CELL_REC...,SET,6,-0.11508,-0.0020801,0.3878,0.61667,HP_ABNORMALLY_LOW_T_CELL_RECEPTOR_EXCISION_CIRCLE_LEVEL,0.99999
HP_ORAL_AVERSION,SET,16,-0.060837,-0.0017953,0.2049,0.61673,HP_ORAL_AVERSION,0.99999
BUSSLINGER_DUODENAL_GOBLET_C...,SET,15,-0.0762,-0.0021773,0.25662,0.61674,BUSSLINGER_DUODENAL_GOBLET_CELLS,0.99999
GOMF_ADENOSINE_RECEPTOR_BIND...,SET,7,-0.10023,-0.0019569,0.33748,0.61677,GOMF_ADENOSINE_RECEPTOR_BINDING,0.99999
HALLMARK_HEME_METABOLISM,SET,178,-0.019159,-0.0018773,0.064499,0.61678,HALLMARK_HEME_METABOLISM,0.99999
MIR204_5P,SET,347,-0.013979,-0.0019036,0.047049,0.61681,MIR204_5P,0.99999
HP_INCREASED_SERUM_SEROTONIN,SET,9,-0.077707,-0.0017201,0.2615,0.61683,HP_INCREASED_SERUM_SEROTONIN,0.99999
REACTOME_PHOSPHOLIPASE_C_MED...3,SET,14,-0.07381,-0.0020375,0.24816,0.61693,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4,0.99999
GSE42021_CD24HI_VS_CD24INT_T...4,SET,180,-0.019206,-0.0018924,0.064568,0.61694,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP,0.99999
REACTOME_MRNA_DECAY_BY_3_TO_...,SET,12,-0.061369,-0.0015685,0.20623,0.61698,REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE,0.99999
GNF2_SMC4L1,SET,80,-0.026246,-0.0017288,0.088195,0.61699,GNF2_SMC4L1,0.99999
QIU_PBMC_HEPTATITIS_B_SURFAC...6,SET,13,-0.081196,-0.0021599,0.27278,0.61702,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_3DY_UP,0.99999
GOBP_GLUCOSE_METABOLIC_PROCE...,SET,168,-0.019344,-0.001842,0.064963,0.61706,GOBP_GLUCOSE_METABOLIC_PROCESS,0.99999
MORF_TERF1,SET,61,-0.030296,-0.0017435,0.10173,0.61707,MORF_TERF1,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...6,SET,11,-0.074132,-0.0018141,0.24891,0.61708,GOBP_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,0.99999
RNGTGGGC_UNKNOWN,SET,709,-0.009894,-0.0019065,0.033219,0.61709,RNGTGGGC_UNKNOWN,0.99999
YORDY_RECIPROCAL_REGULATION_...1,SET,63,-0.034484,-0.0020167,0.11576,0.6171,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,0.99999
GOCC_SPERM_MITOCHONDRIAL_SHE...,SET,6,-0.1003,-0.001813,0.33668,0.61711,GOCC_SPERM_MITOCHONDRIAL_SHEATH,0.99999
INAMURA_LUNG_CANCER_SCC_DN,SET,13,-0.07194,-0.0019137,0.24127,0.61721,INAMURA_LUNG_CANCER_SCC_DN,0.99999
GSE3920_IFNA_VS_IFNG_TREATED...2,SET,153,-0.020398,-0.0018544,0.068358,0.6173,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.99999
DESCARTES_FETAL_CEREBRUM_OLI...,SET,48,-0.041882,-0.0021388,0.14022,0.61741,DESCARTES_FETAL_CEREBRUM_OLIGODENDROCYTES,0.99999
HP_SENSORY_BEHAVIORAL_ABNORM...,SET,295,-0.015112,-0.0019003,0.050586,0.61743,HP_SENSORY_BEHAVIORAL_ABNORMALITY,0.99999
GOBP_REGULATION_OF_NEURON_MI...,SET,43,-0.041004,-0.0019822,0.13722,0.61746,GOBP_REGULATION_OF_NEURON_MIGRATION,0.99999
MIR587,SET,338,-0.014549,-0.0019559,0.048684,0.61747,MIR587,0.99999
TERAO_AOX4_TARGETS_SKIN_UP,SET,24,-0.050342,-0.001819,0.16842,0.61749,TERAO_AOX4_TARGETS_SKIN_UP,0.99999
HP_ABNORMAL_PERICARDIUM_MORP...,SET,71,-0.031525,-0.0019567,0.10547,0.61749,HP_ABNORMAL_PERICARDIUM_MORPHOLOGY,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...8,SET,18,-0.05722,-0.0017908,0.19121,0.61762,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PEROXISOME,0.99999
SALVADOR_MARTIN_PEDIATRIC_TB...2,SET,19,-0.063741,-0.0020495,0.21279,0.61774,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP,0.99999
PBX1_02,SET,113,-0.026281,-0.0020555,0.087657,0.61784,PBX1_02,0.99999
REACTOME_BUTYROPHILIN_BTN_FA...,SET,12,-0.10093,-0.0025797,0.33662,0.61785,REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS,0.99999
GOBP_REGULATION_OF_THE_FORCE...2,SET,5,-0.13816,-0.0022798,0.46074,0.61786,GOBP_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION_BY_CHEMICAL_SIGNAL,0.99999
HP_IMPAIRED_VIBRATION_SENSAT...1,SET,10,-0.077569,-0.0018099,0.25867,0.61786,HP_IMPAIRED_VIBRATION_SENSATION_AT_ANKLES,0.99999
MIR4480,SET,49,-0.037044,-0.0019113,0.1235,0.61789,MIR4480,0.99999
HP_REDUCED_CONSCIOUSNESS,SET,206,-0.01777,-0.0018718,0.059224,0.61793,HP_REDUCED_CONSCIOUSNESS,0.99999
AMIT_EGF_RESPONSE_120_HELA,SET,63,-0.032054,-0.0018746,0.10682,0.61794,AMIT_EGF_RESPONSE_120_HELA,0.99999
MATZUK_SPERMATOCYTE,SET,67,-0.028961,-0.0017464,0.096482,0.61797,MATZUK_SPERMATOCYTE,0.99999
MIR4524A_5P,SET,221,-0.017742,-0.0019349,0.059077,0.61803,MIR4524A_5P,0.99999
MIR4524B_5P,SET,221,-0.017742,-0.0019349,0.059077,0.61803,MIR4524B_5P,0.99999
GSE37532_WT_VS_PPARG_KO_VISC...4,SET,167,-0.019114,-0.0018147,0.063622,0.61807,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP,0.99999
HP_ABNORMAL_CLITORIS_MORPHOL...,SET,81,-0.029181,-0.0019341,0.097129,0.61808,HP_ABNORMAL_CLITORIS_MORPHOLOGY,0.99999
ER_Q6_02,SET,234,-0.017023,-0.0019096,0.056649,0.6181,ER_Q6_02,0.99999
KARLSSON_TGFB1_TARGETS_UP,SET,113,-0.023868,-0.0018668,0.079409,0.61813,KARLSSON_TGFB1_TARGETS_UP,0.99999
MIR374C_5P,SET,381,-0.013841,-0.0019731,0.046028,0.61818,MIR374C_5P,0.99999
GSE11818_WT_VS_DICER_KO_TREG...1,SET,143,-0.020825,-0.0018308,0.069251,0.61818,GSE11818_WT_VS_DICER_KO_TREG_DN,0.99999
GOBP_REGULATION_OF_TYPE_B_PA...1,SET,8,-0.095688,-0.0019971,0.31819,0.61819,GOBP_REGULATION_OF_TYPE_B_PANCREATIC_CELL_DEVELOPMENT,0.99999
MIR6740_5P,SET,58,-0.033122,-0.0018588,0.11013,0.6182,MIR6740_5P,0.99999
GOBP_MULTI_PASS_TRANSMEMBRAN...,SET,8,-0.10965,-0.0022885,0.36458,0.6182,GOBP_MULTI_PASS_TRANSMEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE,0.99999
GOCC_MULTI_PASS_TRANSLOCON_C...,SET,8,-0.10965,-0.0022885,0.36458,0.6182,GOCC_MULTI_PASS_TRANSLOCON_COMPLEX,0.99999
GOBP_HEMOGLOBIN_BIOSYNTHETIC...,SET,13,-0.073053,-0.0019433,0.24286,0.61822,GOBP_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...5,SET,48,-0.034615,-0.0017677,0.11498,0.6183,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_GLYCOLYSIS_MYC,0.99999
HP_PERIODONTITIS,SET,33,-0.045552,-0.0019296,0.15122,0.61838,HP_PERIODONTITIS,0.99999
MIR1256,SET,64,-0.032075,-0.0018905,0.10647,0.61839,MIR1256,0.99999
GOBP_GLUCOSE_6_PHOSPHATE_MET...,SET,26,-0.05242,-0.0019713,0.17398,0.61841,GOBP_GLUCOSE_6_PHOSPHATE_METABOLIC_PROCESS,0.99999
GOMF_RNA_POLYMERASE_BINDING,SET,56,-0.034332,-0.0018933,0.11393,0.61842,GOMF_RNA_POLYMERASE_BINDING,0.99999
GOBP_LIPOXIN_METABOLIC_PROCE...,SET,5,-0.12435,-0.0020519,0.41254,0.61845,GOBP_LIPOXIN_METABOLIC_PROCESS,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...8,SET,4,-0.12464,-0.0018396,0.41346,0.61846,GOBP_PROTEIN_LOCALIZATION_TO_CELL_LEADING_EDGE,0.99999
HP_KERATOACANTHOMA,SET,4,-0.10099,-0.0014906,0.33487,0.61852,HP_KERATOACANTHOMA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...441,SET,9,-0.095432,-0.0021125,0.31627,0.61857,GOBP_NEGATIVE_REGULATION_OF_NEURON_MIGRATION,0.99999
GOCC_SPECIFIC_GRANULE_MEMBRA...,SET,84,-0.028197,-0.001903,0.093454,0.61857,GOCC_SPECIFIC_GRANULE_MEMBRANE,0.99999
REACTOME_DEFECTIVE_FACTOR_VI...,SET,5,-0.12556,-0.0020719,0.41606,0.61859,REACTOME_DEFECTIVE_FACTOR_VIII_CAUSES_HEMOPHILIA_A,0.99999
REACTOME_SARS_COV_2_TARGETS_...2,SET,3,-0.17792,-0.0022743,0.58925,0.61865,REACTOME_SARS_COV_2_TARGETS_PDZ_PROTEINS_IN_CELL_CELL_JUNCTION,0.99999
GOBP_FRUCTOSE_METABOLIC_PROC...,SET,13,-0.059535,-0.0015837,0.19717,0.61865,GOBP_FRUCTOSE_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...631,SET,18,-0.059851,-0.0018732,0.19822,0.61865,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERASE,0.99999
GOBP_VESICLE_MEDIATED_CHOLES...,SET,9,-0.087848,-0.0019446,0.29091,0.61867,GOBP_VESICLE_MEDIATED_CHOLESTEROL_TRANSPORT,0.99999
HP_FLAT_ACETABULAR_ROOF,SET,26,-0.04945,-0.0018596,0.16372,0.61868,HP_FLAT_ACETABULAR_ROOF,0.99999
HP_ABNORMAL_FEMORAL_NECK_MOR...,SET,139,-0.021922,-0.0019003,0.07257,0.6187,HP_ABNORMAL_FEMORAL_NECK_MORPHOLOGY,0.99999
RODRIGUES_THYROID_CARCINOMA_...6,SET,14,-0.078772,-0.0021745,0.26075,0.61871,RODRIGUES_THYROID_CARCINOMA_UP,0.99999
GOBP_GAMMA_DELTA_T_CELL_DIFF...,SET,13,-0.071254,-0.0018955,0.23579,0.61875,GOBP_GAMMA_DELTA_T_CELL_DIFFERENTIATION,0.99999
HARALAMBIEVA_PBMC_DRYVAX_AGE...,SET,14,-0.073826,-0.002038,0.24418,0.6188,HARALAMBIEVA_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_9_TO_34MO_UP,0.99999
LAKE_ADULT_KIDNEY_C10_THIN_A...,SET,317,-0.014729,-0.0019187,0.048701,0.61884,LAKE_ADULT_KIDNEY_C10_THIN_ASCENDING_LIMB,0.99999
MIR6832_3P,SET,233,-0.017503,-0.0019593,0.057861,0.61886,MIR6832_3P,0.99999
DESCARTES_MAIN_FETAL_MUC13_D...,SET,48,-0.037963,-0.0019386,0.12549,0.61887,DESCARTES_MAIN_FETAL_MUC13_DMBT1_POSITIVE_CELLS,0.99999
GOBP_DERMATAN_SULFATE_PROTEO...2,SET,11,-0.075627,-0.0018507,0.24988,0.61892,GOBP_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,0.99999
WP_SUDDEN_INFANT_DEATH_SYNDR...,SET,148,-0.0232,-0.0020747,0.076649,0.61893,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,0.99999
GSE34156_NOD2_LIGAND_VS_TLR1...2,SET,152,-0.020629,-0.0018693,0.068135,0.61897,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,0.99999
GOMF_CTPASE_ACTIVITY,SET,5,-0.10359,-0.0017093,0.34199,0.61901,GOMF_CTPASE_ACTIVITY,0.99999
HP_CUBITUS_VALGUS,SET,45,-0.036885,-0.001824,0.12177,0.61902,HP_CUBITUS_VALGUS,0.99999
GOMF_QUINONE_BINDING,SET,14,-0.058439,-0.0016132,0.19289,0.61904,GOMF_QUINONE_BINDING,0.99999
SASAI_RESISTANCE_TO_NEOPLAST...,SET,45,-0.041761,-0.002065,0.13772,0.61914,SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,0.99999
GSE10147_IL3_AND_HIVP17_VS_I...1,SET,134,-0.021695,-0.0018467,0.071544,0.61914,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN,0.99999
MIR6795_3P,SET,12,-0.078535,-0.0020072,0.25894,0.61916,MIR6795_3P,0.99999
RUBENSTEIN_SKELETAL_MUSCLE_E...,SET,123,-0.02555,-0.0020844,0.084239,0.61917,RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...5,SET,160,-0.020713,-0.0019252,0.068241,0.61925,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP,0.99999
UEDA_PERIFERAL_CLOCK,SET,157,-0.021122,-0.0019449,0.06958,0.61927,UEDA_PERIFERAL_CLOCK,0.99999
MIR568,SET,239,-0.017285,-0.0019593,0.05694,0.61927,MIR568,0.99999
GSE30962_PRIMARY_VS_SECONDAR...1,SET,180,-0.019618,-0.0019331,0.064611,0.6193,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN,0.99999
REACTOME_NUCLEAR_EVENTS_MEDI...,SET,92,-0.026047,-0.0018393,0.085764,0.61932,REACTOME_NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,0.99999
REACTOME_CYTOKINE_SIGNALING_...,SET,714,-0.01007,-0.001947,0.03314,0.61938,REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,0.99999
MODULE_55,SET,758,-0.010024,-0.0019943,0.032973,0.61943,MODULE_55,0.99999
HP_SPONTANEOUS_PNEUMOTHORAX,SET,14,-0.078359,-0.0021631,0.25777,0.61943,HP_SPONTANEOUS_PNEUMOTHORAX,0.99999
HP_HYPOPLASTIC_FIFTH_TOENAIL,SET,16,-0.06576,-0.0019405,0.21629,0.61945,HP_HYPOPLASTIC_FIFTH_TOENAIL,0.99999
GSE36392_EOSINOPHIL_VS_NEUTR...1,SET,179,-0.018919,-0.001859,0.062207,0.61948,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...11,SET,23,-0.056995,-0.0020161,0.1874,0.61949,GOMF_STRUCTURAL_CONSTITUENT_OF_SYNAPSE,0.99999
HP_ADENOMA_SEBACEUM,SET,26,-0.047691,-0.0017935,0.15674,0.61954,HP_ADENOMA_SEBACEUM,0.99999
DER_IFN_BETA_RESPONSE_DN,SET,6,-0.10844,-0.0019602,0.35608,0.61964,DER_IFN_BETA_RESPONSE_DN,0.99999
BIOCARTA_LDL_PATHWAY,SET,6,-0.12625,-0.0022821,0.4144,0.61969,BIOCARTA_LDL_PATHWAY,0.99999
GSE7219_UNSTIM_VS_LPS_AND_AN...4,SET,168,-0.020289,-0.001932,0.06656,0.61975,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP,0.99999
SMAD4_Q6,SET,222,-0.01834,-0.0020046,0.060145,0.61979,SMAD4_Q6,0.99999
HP_DECREASED_CIRCULATING_TOT...3,SET,66,-0.032299,-0.0019331,0.10591,0.6198,HP_DECREASED_CIRCULATING_TOTAL_IGM,0.99999
HP_RENAL_HYPOPLASIA_APLASIA,SET,298,-0.014814,-0.001872,0.048575,0.6198,HP_RENAL_HYPOPLASIA_APLASIA,0.99999
DESCARTES_MAIN_FETAL_INHIBIT...1,SET,25,-0.059828,-0.0022063,0.19619,0.6198,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.99999
GOBP_AXIS_SPECIFICATION,SET,87,-0.030214,-0.002075,0.099031,0.61985,GOBP_AXIS_SPECIFICATION,0.99999
HP_HERPES_SIMPLEX_ENCEPHALIT...,SET,9,-0.087367,-0.001934,0.28635,0.61986,HP_HERPES_SIMPLEX_ENCEPHALITIS,0.99999
GOBP_CARDIAC_CHAMBER_MORPHOG...,SET,121,-0.026816,-0.0021699,0.087878,0.61987,GOBP_CARDIAC_CHAMBER_MORPHOGENESIS,0.99999
GOBP_GLANDULAR_EPITHELIAL_CE...2,SET,68,-0.034582,-0.0021008,0.11331,0.61988,GOBP_GLANDULAR_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
LEE_SP4_THYMOCYTE,SET,15,-0.074643,-0.0021328,0.24442,0.61996,LEE_SP4_THYMOCYTE,0.99999
HP_HYPOVOLEMIC_SHOCK,SET,5,-0.13738,-0.0022669,0.44984,0.61996,HP_HYPOVOLEMIC_SHOCK,0.99999
MIR4651,SET,188,-0.020175,-0.0020312,0.066053,0.61998,MIR4651,0.99999
GSE19888_NO_PRETREAT_VS_ADEN...1,SET,179,-0.018783,-0.0018457,0.061483,0.62,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN,0.99999
HP_ABNORMAL_RIB_MORPHOLOGY,SET,290,-0.015617,-0.0019473,0.05111,0.62003,HP_ABNORMAL_RIB_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...340,SET,20,-0.060611,-0.0019995,0.19832,0.62005,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,0.99999
HP_ANTI_THYROID_ANTIBODY_POS...,SET,10,-0.085685,-0.0019993,0.28018,0.62013,HP_ANTI_THYROID_ANTIBODY_POSITIVITY,0.99999
GOCC_SOMATODENDRITIC_COMPART...,SET,770,-0.0099472,-0.001994,0.032524,0.62014,GOCC_SOMATODENDRITIC_COMPARTMENT,0.99999
GOBP_CELLULAR_LIPID_BIOSYNTH...,SET,11,-0.082702,-0.0020238,0.27022,0.62022,GOBP_CELLULAR_LIPID_BIOSYNTHETIC_PROCESS,0.99999
CHIN_BREAST_CANCER_COPY_NUMB...1,SET,12,-0.069188,-0.0017683,0.22597,0.62026,CHIN_BREAST_CANCER_COPY_NUMBER_DN,0.99999
KEGG_MEDICUS_REFERENCE_SIALY...,SET,6,-0.12013,-0.0021715,0.39234,0.62027,KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS,0.99999
GSE43863_NAIVE_VS_MEMORY_TFH...1,SET,183,-0.019361,-0.0019233,0.063225,0.62028,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_DN,0.99999
GOBP_PEPTIDYL_PROLINE_HYDROX...2,SET,8,-0.073013,-0.0015238,0.23839,0.6203,GOBP_PEPTIDYL_PROLINE_HYDROXYLATION_TO_4_HYDROXY_L_PROLINE,0.99999
GOMF_PEPTIDYL_PROLINE_4_DIOX...,SET,8,-0.073013,-0.0015238,0.23839,0.6203,GOMF_PEPTIDYL_PROLINE_4_DIOXYGENASE_ACTIVITY,0.99999
GROSS_HYPOXIA_VIA_ELK3_AND_H...1,SET,98,-0.026647,-0.0019417,0.086997,0.62031,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,0.99999
MODULE_539,SET,15,-0.072668,-0.0020763,0.2372,0.62033,MODULE_539,0.99999
DESCARTES_MAIN_FETAL_IGFBP1_...,SET,128,-0.024299,-0.0020219,0.079318,0.62033,DESCARTES_MAIN_FETAL_IGFBP1_DKK1_POSITIVE_CELLS,0.99999
GOMF_PROTEIN_TYROSINE_KINASE...4,SET,5,-0.13032,-0.0021504,0.42517,0.62039,GOMF_PROTEIN_TYROSINE_KINASE_INHIBITOR_ACTIVITY,0.99999
GSE1432_6H_VS_24H_IFNG_MICRO...2,SET,178,-0.019747,-0.001935,0.064419,0.6204,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.99999
MIR143_5P,SET,120,-0.024594,-0.0019819,0.080158,0.62051,MIR143_5P,0.99999
MIR500B_5P,SET,51,-0.035709,-0.0018795,0.11638,0.62051,MIR500B_5P,0.99999
HP_ABNORMAL_CORTICAL_BONE_MO...,SET,77,-0.030366,-0.0019625,0.098942,0.62054,HP_ABNORMAL_CORTICAL_BONE_MORPHOLOGY,0.99999
GSE20198_IL12_IL18_VS_IFNA_T...1,SET,178,-0.018996,-0.0018614,0.061887,0.62055,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,0.99999
HP_HORNER_SYNDROME,SET,9,-0.10799,-0.0023905,0.35148,0.62067,HP_HORNER_SYNDROME,0.99999
HALLMARK_ALLOGRAFT_REJECTION,SET,183,-0.020392,-0.0020258,0.06633,0.62074,HALLMARK_ALLOGRAFT_REJECTION,0.99999
TOOKER_GEMCITABINE_RESISTANC...1,SET,115,-0.025368,-0.0020015,0.082451,0.62083,TOOKER_GEMCITABINE_RESISTANCE_DN,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...9,SET,175,-0.019339,-0.0018791,0.062811,0.62092,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN,0.99999
HP_ECTOPIC_CALCIFICATION,SET,209,-0.018865,-0.0020014,0.061242,0.62097,HP_ECTOPIC_CALCIFICATION,0.99999
GOBP_PROSTATE_GLANDULAR_ACIN...2,SET,6,-0.11416,-0.0020635,0.37055,0.62099,GOBP_PROSTATE_GLANDULAR_ACINUS_MORPHOGENESIS,0.99999
BIOCARTA_LAIR_PATHWAY,SET,17,-0.069343,-0.0021092,0.22506,0.621,BIOCARTA_LAIR_PATHWAY,0.99999
WP_CELLS_AND_MOLECULES_INVOL...,SET,17,-0.069343,-0.0021092,0.22506,0.621,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,0.99999
VANTVEER_BREAST_CANCER_METAS...1,SET,96,-0.028453,-0.0020522,0.092337,0.62101,VANTVEER_BREAST_CANCER_METASTASIS_DN,0.99999
GOBP_DNA_REPLICATION,SET,260,-0.015479,-0.0018291,0.050232,0.62102,GOBP_DNA_REPLICATION,0.99999
WP_OXIDATIVE_STRESS_RESPONSE,SET,29,-0.051611,-0.0020497,0.16745,0.62104,WP_OXIDATIVE_STRESS_RESPONSE,0.99999
HP_PSYCHIC_EPILEPTIC_AURA,SET,10,-0.079677,-0.0018591,0.25843,0.62107,HP_PSYCHIC_EPILEPTIC_AURA,0.99999
GOMF_MOLYBDOPTERIN_COFACTOR_...,SET,4,-0.13725,-0.0020257,0.44514,0.62108,GOMF_MOLYBDOPTERIN_COFACTOR_BINDING,0.99999
BARX2_TARGET_GENES,SET,1488,-0.0069722,-0.0019029,0.022609,0.6211,BARX2_TARGET_GENES,0.99999
GOBP_PROTEIN_IMPORT_INTO_PER...4,SET,5,-0.10839,-0.0017885,0.35147,0.6211,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MEMBRANE,0.99999
ZHANG_RESPONSE_TO_IKK_INHIBI...2,SET,213,-0.019173,-0.0020532,0.062166,0.62112,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,0.99999
KEGG_MEDICUS_PATHOGEN_HSV_GD...,SET,11,-0.076394,-0.0018694,0.2476,0.62116,KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY,0.99999
REACTOME_LYSOSPHINGOLIPID_AN...,SET,9,-0.097199,-0.0021516,0.31498,0.62118,REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS,0.99999
GOBP_REGULATION_OF_T_HELPER_...4,SET,11,-0.091043,-0.0022279,0.29497,0.62121,GOBP_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION,0.99999
GRAHAM_CML_DIVIDING_VS_NORMA...4,SET,170,-0.01969,-0.001886,0.063772,0.62124,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,0.99999
REACTOME_OLFACTORY_SIGNALING...,SET,316,-0.021615,-0.0028113,0.070006,0.62124,REACTOME_OLFACTORY_SIGNALING_PATHWAY,0.99999
GOBP_MAINTENANCE_OF_SYNAPSE_...,SET,24,-0.056901,-0.002056,0.18422,0.62129,GOBP_MAINTENANCE_OF_SYNAPSE_STRUCTURE,0.99999
GOBP_POST_ANAL_TAIL_MORPHOGE...,SET,18,-0.06202,-0.0019411,0.20079,0.62129,GOBP_POST_ANAL_TAIL_MORPHOGENESIS,0.99999
GSE26030_TH1_VS_TH17_DAY15_P...1,SET,176,-0.020571,-0.0020045,0.066575,0.62133,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_DN,0.99999
GSE45739_NRAS_KO_VS_WT_ACD3_...2,SET,180,-0.018784,-0.0018509,0.060778,0.62136,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_UP,0.99999
DESCARTES_FETAL_KIDNEY_VASCU...,SET,79,-0.031538,-0.0020644,0.10198,0.62144,DESCARTES_FETAL_KIDNEY_VASCULAR_ENDOTHELIAL_CELLS,0.99999
VALK_AML_CLUSTER_9,SET,32,-0.04887,-0.0020386,0.15791,0.62152,VALK_AML_CLUSTER_9,0.99999
GSE7219_UNSTIM_VS_LPS_AND_AN...3,SET,185,-0.020094,-0.0020069,0.064911,0.62155,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN,0.99999
HAMAI_APOPTOSIS_VIA_TRAIL_UP,SET,596,-0.010856,-0.001924,0.035062,0.62157,HAMAI_APOPTOSIS_VIA_TRAIL_UP,0.99999
CLASPER_LYMPHATIC_VESSELS_DU...2,SET,18,-0.067475,-0.0021118,0.2179,0.62159,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...486,SET,9,-0.10021,-0.0022184,0.32358,0.6216,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.99999
GSE13173_UNTREATED_VS_IL12_T...1,SET,117,-0.024098,-0.0019177,0.07778,0.62165,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN,0.99999
HP_ABNORMALITY_OF_THE_CHIN,SET,336,-0.014449,-0.0019368,0.046633,0.62166,HP_ABNORMALITY_OF_THE_CHIN,0.99999
GSE17721_0.5H_VS_8H_PAM3CSK4...1,SET,185,-0.019099,-0.0019076,0.061608,0.62172,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_DN,0.99999
GSE41867_DAY8_EFFECTOR_VS_DA...3,SET,185,-0.019007,-0.0018984,0.061301,0.62174,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,0.99999
MIR762,SET,163,-0.019461,-0.0018256,0.062705,0.62185,MIR762,0.99999
REACTOME_REGULATION_OF_NF_KA...,SET,16,-0.062266,-0.0018374,0.20056,0.62189,REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING,0.99999
TGAATGT_MIR181A_MIR181B_MIR1...,SET,449,-0.013301,-0.0020546,0.042846,0.62189,TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D,0.99999
GOMF_NEUROTROPHIN_RECEPTOR_B...,SET,11,-0.076197,-0.0018646,0.24543,0.6219,GOMF_NEUROTROPHIN_RECEPTOR_BINDING,0.99999
REACTOME_P75NTR_SIGNALS_VIA_...,SET,14,-0.075566,-0.002086,0.24335,0.62192,REACTOME_P75NTR_SIGNALS_VIA_NF_KB,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...11,SET,182,-0.019686,-0.0019504,0.06338,0.62195,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
GSE29617_CTRL_VS_TIV_FLU_VAC...2,SET,162,-0.021037,-0.0019675,0.067691,0.62202,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP,0.99999
TOMLINS_PROSTATE_CANCER_DN,SET,36,-0.045775,-0.0020251,0.14726,0.62204,TOMLINS_PROSTATE_CANCER_DN,0.99999
GOBP_RENAL_SYSTEM_PROCESS_IN...1,SET,14,-0.075633,-0.0020878,0.24328,0.62205,GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_BLOOD_VOLUME,0.99999
GOBP_RESPONSE_TO_LIGHT_STIMU...,SET,288,-0.015635,-0.0019429,0.050236,0.62219,GOBP_RESPONSE_TO_LIGHT_STIMULUS,0.99999
GSE360_L_DONOVANI_VS_T_GONDI...3,SET,184,-0.019029,-0.0018955,0.061138,0.62219,GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN,0.99999
BRACHAT_RESPONSE_TO_CAMPTOTH...1,SET,39,-0.040568,-0.0018679,0.13032,0.62221,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,0.99999
REACTOME_JOSEPHIN_DOMAIN_DUBS,SET,9,-0.08605,-0.0019048,0.27625,0.62228,REACTOME_JOSEPHIN_DOMAIN_DUBS,0.99999
HP_FOCAL_MYOCLONIC_SEIZURE,SET,18,-0.061011,-0.0019095,0.19586,0.62229,HP_FOCAL_MYOCLONIC_SEIZURE,0.99999
GOMF_HISTONE_METHYLTRANSFERA...2,SET,13,-0.064155,-0.0017066,0.20581,0.62237,GOMF_HISTONE_METHYLTRANSFERASE_BINDING,0.99999
TIAN_TNF_SIGNALING_VIA_NFKB,SET,24,-0.061588,-0.0022254,0.19753,0.6224,TIAN_TNF_SIGNALING_VIA_NFKB,0.99999
GOBP_NEGATIVE_REGULATION_OF_...461,SET,18,-0.060717,-0.0019003,0.19455,0.62251,GOBP_NEGATIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,0.99999
TRAVAGLINI_LUNG_NATURAL_KILL...1,SET,121,-0.026171,-0.0021177,0.083831,0.62255,TRAVAGLINI_LUNG_NATURAL_KILLER_CELL,0.99999
HP_ABNORMALITY_OF_ENDOCRINE_...,SET,28,-0.054926,-0.0021435,0.17585,0.62261,HP_ABNORMALITY_OF_ENDOCRINE_PANCREAS_PHYSIOLOGY,0.99999
AR_Q6,SET,234,-0.017743,-0.0019904,0.056797,0.62262,AR_Q6,0.99999
HP_ABNORMAL_HAIR_QUANTITY,SET,757,-0.009799,-0.0019484,0.031368,0.62262,HP_ABNORMAL_HAIR_QUANTITY,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...14,SET,10,-0.07476,-0.0017444,0.23925,0.62266,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_HEME_PROTEIN_AS_ACCEPTOR,0.99999
chr1q44,SET,56,-0.064084,-0.003534,0.20499,0.62271,chr1q44,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...59,SET,15,-0.065558,-0.0018732,0.20971,0.62271,HP_APLASIA_HYPOPLASIA_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,0.99999
MODULE_305,SET,19,-0.055456,-0.0017832,0.17733,0.62276,MODULE_305,0.99999
GSE13522_WT_VS_IFNG_KO_SKIN_...2,SET,119,-0.025953,-0.0020828,0.082957,0.6228,GSE13522_WT_VS_IFNG_KO_SKIN_UP,0.99999
GSE17721_LPS_VS_CPG_16H_BMDC...2,SET,183,-0.019758,-0.0019628,0.063145,0.62282,GSE17721_LPS_VS_CPG_16H_BMDC_UP,0.99999
GAVIN_FOXP3_TARGETS_CLUSTER_...7,SET,91,-0.027544,-0.0019345,0.088006,0.62285,GAVIN_FOXP3_TARGETS_CLUSTER_T7,0.99999
EGFR_UP.V1_DN,SET,162,-0.021423,-0.0020036,0.06843,0.62288,EGFR_UP.V1_DN,0.99999
MIR6819_5P,SET,75,-0.030131,-0.001922,0.096227,0.62291,MIR6819_5P,0.99999
HP_PROGRESSIVE_HEARING_IMPAI...,SET,35,-0.042531,-0.0018553,0.1358,0.62293,HP_PROGRESSIVE_HEARING_IMPAIRMENT,0.99999
GOMF_ARYLESTERASE_ACTIVITY,SET,6,-0.1413,-0.002554,0.45111,0.62294,GOMF_ARYLESTERASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...638,SET,18,-0.057746,-0.0018073,0.18426,0.623,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.99999
REACTOME_MULTIFUNCTIONAL_ANI...,SET,9,-0.089024,-0.0019707,0.28399,0.62304,REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...504,SET,26,-0.058701,-0.0022075,0.18723,0.62306,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,0.99999
GOBP_NUCLEOPHAGY,SET,21,-0.058864,-0.0019897,0.18745,0.62325,GOBP_NUCLEOPHAGY,0.99999
GOMF_ALPHA_N_ACETYLNEURAMINA...,SET,6,-0.13445,-0.0024302,0.42814,0.62325,GOMF_ALPHA_N_ACETYLNEURAMINATE_ALPHA_2_8_SIALYLTRANSFERASE_ACTIVITY,0.99999
DESCARTES_MAIN_FETAL_RETINAL...1,SET,106,-0.028239,-0.0021396,0.089927,0.62325,DESCARTES_MAIN_FETAL_RETINAL_PIGMENT_CELLS,0.99999
GOBP_CARBOHYDRATE_METABOLIC_...,SET,516,-0.011836,-0.0019563,0.037681,0.62328,GOBP_CARBOHYDRATE_METABOLIC_PROCESS,0.99999
PID_THROMBIN_PAR4_PATHWAY,SET,15,-0.076362,-0.0021819,0.24299,0.62333,PID_THROMBIN_PAR4_PATHWAY,0.99999
GOMF_1_PHOSPHATIDYLINOSITOL_...3,SET,7,-0.10533,-0.0020564,0.3352,0.62333,GOMF_1_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_3_KINASE_ACTIVITY,0.99999
REACTOME_TRANSPORT_OF_BILE_S...,SET,82,-0.031555,-0.0021042,0.1004,0.62334,REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,0.99999
CROONQUIST_NRAS_SIGNALING_DN,SET,68,-0.030296,-0.0018404,0.09637,0.62338,CROONQUIST_NRAS_SIGNALING_DN,0.99999
chr3p13,SET,10,-0.13055,-0.003046,0.4151,0.62343,chr3p13,0.99999
REACTOME_HCMV_INFECTION,SET,91,-0.027449,-0.0019278,0.087265,0.62345,REACTOME_HCMV_INFECTION,0.99999
BIOCARTA_STRESS_PATHWAY,SET,23,-0.056521,-0.0019993,0.17965,0.62347,BIOCARTA_STRESS_PATHWAY,0.99999
GOBP_PROTEIN_TETRAMERIZATION,SET,91,-0.02771,-0.0019461,0.088079,0.62347,GOBP_PROTEIN_TETRAMERIZATION,0.99999
HP_SIRENOMELIA,SET,11,-0.08583,-0.0021004,0.27269,0.62352,HP_SIRENOMELIA,0.99999
chr3p26,SET,14,-0.12545,-0.003463,0.39851,0.62354,chr3p26,0.99999
IRITANI_MAD1_TARGETS_UP,SET,12,-0.085842,-0.002194,0.27256,0.6236,IRITANI_MAD1_TARGETS_UP,0.99999
GOMF_3_BETA_HYDROXY_DELTA5_S...,SET,5,-0.13333,-0.0022002,0.42334,0.6236,GOMF_3_BETA_HYDROXY_DELTA5_STEROID_DEHYDROGENASE_ACTIVITY,0.99999
REACTOME_GAP_JUNCTION_DEGRAD...,SET,12,-0.074867,-0.0019135,0.23751,0.6237,REACTOME_GAP_JUNCTION_DEGRADATION,0.99999
MODULE_416,SET,22,-0.05934,-0.002053,0.18825,0.6237,MODULE_416,0.99999
GSE37533_PPARG1_FOXP3_VS_FOX...1,SET,189,-0.020221,-0.0020411,0.064147,0.6237,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,0.99999
GOBP_CHRONIC_INFLAMMATORY_RE...,SET,18,-0.065046,-0.0020358,0.20634,0.62371,GOBP_CHRONIC_INFLAMMATORY_RESPONSE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...613,SET,9,-0.092107,-0.0020389,0.29203,0.62377,GOBP_NEGATIVE_REGULATION_OF_STEROL_TRANSPORT,0.99999
GOMF_G_PROTEIN_ALPHA_SUBUNIT...,SET,29,-0.051926,-0.0020622,0.16463,0.62377,GOMF_G_PROTEIN_ALPHA_SUBUNIT_BINDING,0.99999
GSE6566_STRONG_VS_WEAK_DC_ST...1,SET,156,-0.021441,-0.0019681,0.067977,0.62377,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN,0.99999
MODULE_457,SET,10,-0.084231,-0.0019653,0.26704,0.62378,MODULE_457,0.99999
DESCARTES_MAIN_FETAL_SLC26A4...,SET,195,-0.018305,-0.0018765,0.058012,0.62382,DESCARTES_MAIN_FETAL_SLC26A4_PAEP_POSITIVE_CELLS,0.99999
GOBP_SOFT_PALATE_DEVELOPMENT,SET,5,-0.14518,-0.0023957,0.46005,0.62384,GOBP_SOFT_PALATE_DEVELOPMENT,0.99999
HP_ABNORMAL_RETINAL_MORPHOLO...,SET,845,-0.0094613,-0.0019826,0.029979,0.62384,HP_ABNORMAL_RETINAL_MORPHOLOGY,0.99999
MODULE_352,SET,17,-0.059974,-0.0018242,0.19003,0.62385,MODULE_352,0.99999
GSE2770_IL12_VS_IL4_TREATED_...5,SET,183,-0.018983,-0.0018858,0.06014,0.62386,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.99999
GSE29618_LAIV_VS_TIV_FLU_VAC...8,SET,171,-0.019821,-0.0019041,0.0628,0.62386,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP,0.99999
GOCC_H4_H2A_HISTONE_ACETYLTR...,SET,26,-0.052573,-0.0019771,0.16651,0.6239,GOCC_H4_H2A_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.99999
GOMF_NADPLUS_PROTEIN_ADP_RIB...,SET,28,-0.050356,-0.0019651,0.1594,0.62396,GOMF_NADPLUS_PROTEIN_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.99999
GOBP_SIRNA_MEDIATED_RETROTRA...,SET,10,-0.076361,-0.0017817,0.24171,0.62397,GOBP_SIRNA_MEDIATED_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.99999
GOBP_CHORIO_ALLANTOIC_FUSION,SET,6,-0.12312,-0.0022255,0.38953,0.62403,GOBP_CHORIO_ALLANTOIC_FUSION,0.99999
GOMF_HISTONE_H4K16_ACETYLTRA...,SET,8,-0.088335,-0.0018436,0.27947,0.62403,GOMF_HISTONE_H4K16_ACETYLTRANSFERASE_ACTIVITY,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_PRO...5,SET,120,-0.027245,-0.0021956,0.086194,0.62403,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_PROGENITORS_CELL,0.99999
HP_APATHY,SET,82,-0.030177,-0.0020123,0.095443,0.62406,HP_APATHY,0.99999
REACTOME_SIGNALING_BY_MEMBRA...,SET,5,-0.12445,-0.0020535,0.39345,0.62411,REACTOME_SIGNALING_BY_MEMBRANE_TETHERED_FUSIONS_OF_PDGFRA_OR_PDGFRB,0.99999
GOBP_AXON_ENSHEATHMENT_IN_CE...,SET,23,-0.057762,-0.0020433,0.18262,0.62411,GOBP_AXON_ENSHEATHMENT_IN_CENTRAL_NERVOUS_SYSTEM,0.99999
MIR3156_3P,SET,86,-0.027533,-0.00188,0.087024,0.62414,MIR3156_3P,0.99999
HP_INCOMPREHENSIBLE_SPEECH,SET,8,-0.089424,-0.0018663,0.28258,0.62417,HP_INCOMPREHENSIBLE_SPEECH,0.99999
HERNANDEZ_ABERRANT_MITOSIS_B...4,SET,18,-0.067148,-0.0021016,0.21215,0.62419,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,0.99999
FREAC4_01,SET,134,-0.025326,-0.0021559,0.080014,0.6242,FREAC4_01,0.99999
HP_HEMERALOPIA,SET,8,-0.10025,-0.0020923,0.31672,0.6242,HP_HEMERALOPIA,0.99999
GOBP_PHOTORECEPTOR_CELL_DIFF...,SET,63,-0.036092,-0.0021107,0.11398,0.62425,GOBP_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.99999
GOBP_NADPH_OXIDATION,SET,6,-0.11414,-0.0020631,0.36039,0.62426,GOBP_NADPH_OXIDATION,0.99999
KAAB_FAILED_HEART_VENTRICLE_...,SET,37,-0.04555,-0.0020429,0.14361,0.62444,KAAB_FAILED_HEART_VENTRICLE_DN,0.99999
GOBP_REGULATION_OF_POSTSYNAP...9,SET,18,-0.062479,-0.0019554,0.19691,0.62449,GOBP_REGULATION_OF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,0.99999
GTACTGT_MIR101,SET,233,-0.018287,-0.0020471,0.057595,0.62457,GTACTGT_MIR101,0.99999
CREB_Q2,SET,237,-0.017788,-0.0020081,0.056018,0.62458,CREB_Q2,0.99999
GOBP_PROTEIN_TARGETING_TO_VA...1,SET,44,-0.03849,-0.0018821,0.12122,0.62458,GOBP_PROTEIN_TARGETING_TO_VACUOLE,0.99999
ZNF501_TARGET_GENES,SET,13,-0.080317,-0.0021365,0.2528,0.62465,ZNF501_TARGET_GENES,0.99999
HP_HYPOPLASIA_OF_THE_EAR_CAR...,SET,10,-0.076377,-0.0017821,0.24037,0.62466,HP_HYPOPLASIA_OF_THE_EAR_CARTILAGE,0.99999
chr15q22,SET,65,-0.063324,-0.0037613,0.19918,0.62472,chr15q22,0.99999
GSE3720_UNSTIM_VS_LPS_STIM_V...3,SET,129,-0.024906,-0.0020805,0.078348,0.62472,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN,0.99999
GOBP_REGULATION_OF_PROTEIN_L...14,SET,102,-0.026414,-0.0019634,0.08307,0.62475,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,0.99999
SEF1_C,SET,5,-0.12795,-0.0021113,0.40232,0.62477,SEF1_C,0.99999
MIR3915,SET,197,-0.019014,-0.0019591,0.05978,0.62478,MIR3915,0.99999
GOBP_REGULATION_OF_CELLULAR_...12,SET,17,-0.06228,-0.0018944,0.19581,0.62478,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA,0.99999
GOBP_CELL_ADHESION_MOLECULE_...,SET,11,-0.093394,-0.0022855,0.29353,0.62482,GOBP_CELL_ADHESION_MOLECULE_PRODUCTION,0.99999
GSE11864_CSF1_VS_CSF1_IFNG_I...1,SET,168,-0.02081,-0.0019816,0.06539,0.62485,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN,0.99999
BLANCO_MELO_RESPIRATORY_SYNC...2,SET,272,-0.01812,-0.0021892,0.056931,0.62486,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,0.99999
MIR143_3P_MIR4770,SET,187,-0.020314,-0.0020398,0.063815,0.62488,MIR143_3P_MIR4770,0.99999
GOBP_VENTRICULAR_CARDIAC_MUS...6,SET,45,-0.046029,-0.0022761,0.1446,0.62488,GOBP_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,0.99999
GOBP_CELL_SURFACE_PATTERN_RE...,SET,71,-0.032994,-0.0020479,0.10353,0.62502,GOBP_CELL_SURFACE_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE32423_MEMORY_VS_NAIVE_CD8...5,SET,182,-0.019295,-0.0019116,0.060539,0.62503,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP,0.99999
GOMF_HYDROLASE_ACTIVITY_HYDR...1,SET,37,-0.047545,-0.0021323,0.14912,0.62507,GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS,0.99999
GSE7509_UNSTIM_VS_IFNA_STIM_...2,SET,169,-0.020711,-0.001978,0.064951,0.62509,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP,0.99999
MARTINEZ_RESPONSE_TO_TRABECT...1,SET,45,-0.041103,-0.0020325,0.12889,0.6251,MARTINEZ_RESPONSE_TO_TRABECTEDIN,0.99999
GSE34205_HEALTHY_VS_RSV_INF_...1,SET,170,-0.021437,-0.0020534,0.067223,0.6251,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN,0.99999
GAZDA_DIAMOND_BLACKFAN_ANEMI...2,SET,23,-0.055117,-0.0019497,0.17279,0.62513,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,0.99999
SHI_SPARC_TARGETS_UP,SET,24,-0.058873,-0.0021273,0.18456,0.62513,SHI_SPARC_TARGETS_UP,0.99999
GOBP_RESPONSE_TO_MAGNESIUM_I...,SET,20,-0.066691,-0.0022001,0.20904,0.62515,GOBP_RESPONSE_TO_MAGNESIUM_ION,0.99999
GSE15330_WT_VS_IKAROS_KO_MEG...2,SET,179,-0.019815,-0.0019471,0.062102,0.62516,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,0.99999
HP_CONFUSIONAL_AROUSAL,SET,9,-0.096486,-0.0021358,0.30237,0.62517,HP_CONFUSIONAL_AROUSAL,0.99999
ZNF354A_TARGET_GENES,SET,15,-0.066625,-0.0019037,0.20876,0.62519,ZNF354A_TARGET_GENES,0.99999
CTGRYYYNATT_UNKNOWN,SET,63,-0.035376,-0.0020688,0.11079,0.62525,CTGRYYYNATT_UNKNOWN,0.99999
GSE12845_NAIVE_VS_DARKZONE_G...1,SET,176,-0.019021,-0.0018535,0.059573,0.62525,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.99999
MODULE_362,SET,19,-0.071827,-0.0023095,0.22493,0.62526,MODULE_362,0.99999
GOBP_NEGATIVE_REGULATION_OF_...592,SET,2,-0.19814,-0.002068,0.62048,0.62526,GOBP_NEGATIVE_REGULATION_OF_SISTER_CHROMATID_COHESION,0.99999
GOMF_RNA_POLYMERASE_II_CTD_H...1,SET,10,-0.083524,-0.0019489,0.26138,0.62534,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_KINASE_ACTIVITY,0.99999
GOBP_NUCLEOSIDE_SALVAGE,SET,10,-0.091511,-0.0021352,0.2862,0.62542,GOBP_NUCLEOSIDE_SALVAGE,0.99999
REACTOME_RHO_GTPASES_ACTIVAT...8,SET,9,-0.085363,-0.0018896,0.26694,0.62543,REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS,0.99999
GOBP_IMMUNE_RESPONSE_INHIBIT...1,SET,8,-0.1058,-0.0022081,0.33083,0.62544,GOBP_IMMUNE_RESPONSE_INHIBITING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_HEPARAN_SULFATE_PROTEOG...2,SET,11,-0.093666,-0.0022921,0.29283,0.62546,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_ENZYMATIC_MODIFICATION,0.99999
WP_TGFBETA_RECEPTOR_SIGNALIN...,SET,55,-0.041129,-0.0022478,0.12852,0.62552,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,0.99999
GOBP_POSITIVE_REGULATION_OF_...658,SET,5,-0.14001,-0.0023104,0.43746,0.62554,GOBP_POSITIVE_REGULATION_OF_PYROPTOSIS,0.99999
GOBP_SEXUAL_REPRODUCTION,SET,922,-0.0090032,-0.0019663,0.028129,0.62554,GOBP_SEXUAL_REPRODUCTION,0.99999
HP_PREMATURE_THELARCHE,SET,10,-0.08893,-0.002075,0.27778,0.62557,HP_PREMATURE_THELARCHE,0.99999
GOMF_LIM_DOMAIN_BINDING,SET,5,-0.13106,-0.0021626,0.40916,0.62563,GOMF_LIM_DOMAIN_BINDING,0.99999
CHANGOLKAR_H2AFY_TARGETS_UP,SET,42,-0.04346,-0.0020764,0.13558,0.62572,CHANGOLKAR_H2AFY_TARGETS_UP,0.99999
GOBP_RESPONSE_TO_CORTICOSTER...1,SET,146,-0.024241,-0.0021532,0.0756,0.62576,GOBP_RESPONSE_TO_CORTICOSTEROID,0.99999
GOCC_INTEGRIN_COMPLEX,SET,29,-0.055224,-0.0021932,0.1722,0.62577,GOCC_INTEGRIN_COMPLEX,0.99999
HP_ABNORMAL_METAPHYSIS_MORPH...,SET,204,-0.018942,-0.0019857,0.059067,0.62578,HP_ABNORMAL_METAPHYSIS_MORPHOLOGY,0.99999
KRAS.600_UP.V1_DN,SET,254,-0.018288,-0.0021362,0.057025,0.62578,KRAS.600_UP.V1_DN,0.99999
GSE32164_RESTING_DIFFERENTIA...4,SET,181,-0.020713,-0.0020466,0.064571,0.62581,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP,0.99999
GSE8835_CD4_VS_CD8_TCELL_DN,SET,178,-0.021222,-0.0020796,0.066155,0.62582,GSE8835_CD4_VS_CD8_TCELL_DN,0.99999
MIR6886_3P,SET,84,-0.029135,-0.0019663,0.090756,0.6259,MIR6886_3P,0.99999
MODULE_573,SET,24,-0.058369,-0.0021091,0.18181,0.62591,MODULE_573,0.99999
WP_CANCER_IMMUNOTHERAPY_BY_P...,SET,22,-0.062824,-0.0021735,0.19567,0.62592,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,0.99999
GESERICK_TERT_TARGETS_DN,SET,21,-0.065752,-0.0022226,0.20475,0.62594,GESERICK_TERT_TARGETS_DN,0.99999
GSE6259_33D1_POS_VS_DEC205_P...2,SET,159,-0.021994,-0.002038,0.068492,0.62594,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP,0.99999
HP_GASTROINTESTINAL_INFLAMMA...,SET,150,-0.023628,-0.0021271,0.073534,0.62602,HP_GASTROINTESTINAL_INFLAMMATION,0.99999
GSE25088_WT_VS_STAT6_KO_MACR...7,SET,167,-0.019696,-0.00187,0.061284,0.62604,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,0.99999
MORF_IL4,SET,162,-0.022277,-0.0020834,0.069295,0.62607,MORF_IL4,0.99999
GOBP_NEURON_RECOGNITION,SET,46,-0.04801,-0.0024002,0.14928,0.62613,GOBP_NEURON_RECOGNITION,0.99999
HP_ABNORMALITY_OF_IMMUNE_SYS...,SET,1559,-0.0072995,-0.0020349,0.022688,0.62617,HP_ABNORMALITY_OF_IMMUNE_SYSTEM_PHYSIOLOGY,0.99999
GSE21546_WT_VS_SAP1A_KO_AND_...3,SET,183,-0.021172,-0.0021033,0.065799,0.62618,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.99999
REACTOME_CARBOXYTERMINAL_POS...,SET,41,-0.045005,-0.0021245,0.13985,0.6262,REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN,0.99999
GOBP_DIAPHRAGM_DEVELOPMENT,SET,9,-0.10018,-0.0022177,0.31127,0.62621,GOBP_DIAPHRAGM_DEVELOPMENT,0.99999
HP_ABNORMAL_HUMERUS_MORPHOLO...,SET,14,-0.071622,-0.0019771,0.2225,0.62623,HP_ABNORMAL_HUMERUS_MORPHOLOGY,0.99999
HP_ABSENT_TOE,SET,61,-0.036832,-0.0021196,0.11441,0.62624,HP_ABSENT_TOE,0.99999
REACTOME_LTC4_CYSLTR_MEDIATE...,SET,6,-0.11728,-0.0021199,0.36426,0.62626,REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION,0.99999
LY_AGING_OLD_DN,SET,53,-0.034034,-0.001826,0.10568,0.62629,LY_AGING_OLD_DN,0.99999
WP_EGFEGFR_SIGNALING,SET,154,-0.022677,-0.0020683,0.070394,0.62633,WP_EGFEGFR_SIGNALING,0.99999
SVIL_TARGET_GENES,SET,10,-0.093458,-0.0021807,0.29012,0.62633,SVIL_TARGET_GENES,0.99999
GOCC_AUTOPHAGOSOME,SET,105,-0.026252,-0.0019797,0.081479,0.62634,GOCC_AUTOPHAGOSOME,0.99999
HOOI_ST7_TARGETS_DN,SET,95,-0.030607,-0.0021961,0.094989,0.62635,HOOI_ST7_TARGETS_DN,0.99999
GOBP_NEUROTRANSMITTER_TRANSP...,SET,194,-0.020053,-0.0020505,0.062216,0.62639,GOBP_NEUROTRANSMITTER_TRANSPORT,0.99999
REACTOME_TRANSCRIPTIONAL_REG...8,SET,35,-0.047907,-0.0020898,0.14851,0.62649,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,0.99999
HP_THICKENED_RIBS,SET,7,-0.10936,-0.0021352,0.33899,0.6265,HP_THICKENED_RIBS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...343,SET,49,-0.041441,-0.0021381,0.12845,0.62651,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,0.99999
GOMF_LYSOPHOSPHOLIPASE_ACTIV...,SET,26,-0.052674,-0.0019809,0.16321,0.62655,GOMF_LYSOPHOSPHOLIPASE_ACTIVITY,0.99999
LIU_CDX2_TARGETS_DN,SET,8,-0.11296,-0.0023575,0.34997,0.62656,LIU_CDX2_TARGETS_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...508,SET,2,-0.13005,-0.0013573,0.40288,0.62657,GOBP_NEGATIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS,0.99999
GOCC_HISTONE_PRE_MRNA_3_END_...,SET,6,-0.10563,-0.0019093,0.32724,0.62657,GOCC_HISTONE_PRE_MRNA_3_END_PROCESSING_COMPLEX,0.99999
HP_RECURRENT_ENTEROVIRAL_INF...,SET,3,-0.16079,-0.0020553,0.49786,0.62664,HP_RECURRENT_ENTEROVIRAL_INFECTIONS,0.99999
GOMF_MRNA_5_UTR_BINDING,SET,22,-0.05273,-0.0018243,0.16323,0.62667,GOMF_MRNA_5_UTR_BINDING,0.99999
GSE29618_PDC_VS_MDC_DN,SET,183,-0.020937,-0.0020799,0.064791,0.62671,GSE29618_PDC_VS_MDC_DN,0.99999
HP_T_CELL_LYMPHOMA,SET,14,-0.070535,-0.0019471,0.21816,0.62677,HP_T_CELL_LYMPHOMA,0.99999
GOBP_INTERLEUKIN_13_PRODUCTI...,SET,21,-0.061713,-0.002086,0.19085,0.62678,GOBP_INTERLEUKIN_13_PRODUCTION,0.99999
GOBP_REGULATION_OF_CELL_PROJ...2,SET,613,-0.011626,-0.0020887,0.035955,0.62678,GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.99999
KEGG_MEDICUS_PATHOGEN_HIV_VP...2,SET,8,-0.079894,-0.0016674,0.24706,0.62679,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M,0.99999
GOBP_POSITIVE_REGULATION_OF_...286,SET,53,-0.03996,-0.002144,0.12354,0.62683,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,0.99999
REACTOME_P75NTR_RECRUITS_SIG...,SET,11,-0.089108,-0.0021806,0.27542,0.62685,REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,0.99999
NAGASHIMA_NRG1_SIGNALING_UP,SET,166,-0.022914,-0.0021691,0.070814,0.62687,NAGASHIMA_NRG1_SIGNALING_UP,0.99999
GOMF_PEPTIDASE_REGULATOR_ACT...,SET,208,-0.020946,-0.0022169,0.064716,0.6269,GOMF_PEPTIDASE_REGULATOR_ACTIVITY,0.99999
GSE9946_MATURE_STIMULATORY_V...3,SET,117,-0.026747,-0.0021284,0.082599,0.62696,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,0.99999
REACTOME_REGULATION_OF_GLUCO...,SET,30,-0.047613,-0.0019232,0.14692,0.62706,REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN,0.99999
GOBP_REGULATION_OF_CELL_CELL...1,SET,461,-0.013818,-0.0021621,0.042627,0.62709,GOBP_REGULATION_OF_CELL_CELL_ADHESION,0.99999
GSE26669_CD4_VS_CD8_TCELL_IN...1,SET,189,-0.020755,-0.002095,0.064016,0.62711,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN,0.99999
GOBP_MEIOSIS_I_CELL_CYCLE_PR...,SET,120,-0.022925,-0.0018474,0.070698,0.62713,GOBP_MEIOSIS_I_CELL_CYCLE_PROCESS,0.99999
GSE21670_STAT3_KO_VS_WT_CD4_...8,SET,174,-0.021208,-0.0020549,0.065403,0.62713,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_UP,0.99999
GSE17721_0.5H_VS_8H_GARDIQUI...1,SET,184,-0.020486,-0.0020407,0.063156,0.62717,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN,0.99999
HOWLIN_CITED1_TARGETS_1_UP,SET,31,-0.052701,-0.0021638,0.16246,0.62718,HOWLIN_CITED1_TARGETS_1_UP,0.99999
MIR518C_5P,SET,175,-0.021162,-0.0020562,0.065208,0.62723,MIR518C_5P,0.99999
MONTERO_THYROID_CANCER_POOR_...1,SET,9,-0.09594,-0.0021237,0.29555,0.62726,MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN,0.99999
GSE23321_CD8_STEM_CELL_MEMOR...6,SET,167,-0.021267,-0.0020191,0.065511,0.62727,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.99999
HP_DIMINISHED_MOTIVATION,SET,563,-0.011772,-0.0020297,0.036258,0.62728,HP_DIMINISHED_MOTIVATION,0.99999
GOBP_SPERM_EJACULATION,SET,6,-0.10299,-0.0018617,0.31712,0.62732,GOBP_SPERM_EJACULATION,0.99999
HP_NEPHROLITHIASIS,SET,131,-0.02552,-0.0021481,0.078529,0.6274,HP_NEPHROLITHIASIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...18,SET,67,-0.037137,-0.0022394,0.11425,0.62742,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
HP_UNUSUAL_INFECTION_BY_ANAT...,SET,95,-0.029557,-0.0021207,0.090911,0.62745,HP_UNUSUAL_INFECTION_BY_ANATOMICAL_SITE,0.99999
chr8q22,SET,62,-0.064158,-0.0037222,0.19721,0.62753,chr8q22,0.99999
ZHANG_PROLIFERATING_VS_QUIES...,SET,45,-0.04072,-0.0020136,0.12508,0.62761,ZHANG_PROLIFERATING_VS_QUIESCENT,0.99999
GOMF_DNA_ENDONUCLEASE_ACTIVI...2,SET,9,-0.08684,-0.0019223,0.26676,0.62761,GOMF_DNA_ENDONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS,0.99999
REACTOME_SUMOYLATION_OF_INTR...,SET,28,-0.052657,-0.0020549,0.1617,0.62765,REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS,0.99999
GNF2_SELL,SET,44,-0.041013,-0.0020055,0.12594,0.62765,GNF2_SELL,0.99999
GTGCAAA_MIR507,SET,117,-0.027425,-0.0021824,0.084207,0.62767,GTGCAAA_MIR507,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...1,SET,45,-0.04081,-0.002018,0.12527,0.6277,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_CELL_CYCLE,0.99999
GOCC_HIPPOCAMPAL_MOSSY_FIBER,SET,6,-0.10538,-0.0019048,0.32344,0.62771,GOCC_HIPPOCAMPAL_MOSSY_FIBER,0.99999
ELLWOOD_MYC_TARGETS_DN,SET,40,-0.044143,-0.0020583,0.13536,0.62783,ELLWOOD_MYC_TARGETS_DN,0.99999
HP_ABNORMAL_DENTATE_NUCLEUS_...,SET,12,-0.073244,-0.001872,0.22446,0.6279,HP_ABNORMAL_DENTATE_NUCLEUS_MORPHOLOGY,0.99999
MIR4804_5P,SET,8,-0.10634,-0.0022195,0.32581,0.62794,MIR4804_5P,0.99999
HP_FOCAL_CORTICAL_DYSPLASIA,SET,15,-0.070787,-0.0020226,0.21688,0.62794,HP_FOCAL_CORTICAL_DYSPLASIA,0.99999
GSE3039_CD4_TCELL_VS_B2_BCEL...1,SET,181,-0.02112,-0.0020868,0.064688,0.62797,GSE3039_CD4_TCELL_VS_B2_BCELL_DN,0.99999
KEGG_MEDICUS_PATHOGEN_HBV_HB...3,SET,13,-0.077624,-0.0020649,0.23766,0.62802,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
MIR548G_3P,SET,216,-0.019075,-0.0020568,0.058377,0.62807,MIR548G_3P,0.99999
HP_ENCEPHALOMALACIA,SET,12,-0.093146,-0.0023807,0.28486,0.62816,HP_ENCEPHALOMALACIA,0.99999
MORF_RPA1,SET,59,-0.03328,-0.0018836,0.10177,0.62817,MORF_RPA1,0.99999
GOBP_NEGATIVE_REGULATION_OF_...360,SET,17,-0.067722,-0.0020599,0.20691,0.62828,GOBP_NEGATIVE_REGULATION_OF_LYASE_ACTIVITY,0.99999
ZNF493_TARGET_GENES,SET,6,-0.11486,-0.0020762,0.35092,0.62829,ZNF493_TARGET_GENES,0.99999
WINZEN_DEGRADED_VIA_KHSRP,SET,96,-0.033135,-0.0023899,0.10122,0.6283,WINZEN_DEGRADED_VIA_KHSRP,0.99999
GSE22140_HEALTHY_VS_ARTHRITI...4,SET,178,-0.020539,-0.0020126,0.062715,0.62835,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP,0.99999
GOMF_RNA_POLYMERASE_II_SPECI...,SET,318,-0.015603,-0.0020357,0.047632,0.62838,GOMF_RNA_POLYMERASE_II_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING,0.99999
GOBP_PHYSIOLOGICAL_CARDIAC_M...,SET,21,-0.063882,-0.0021594,0.19497,0.62841,GOBP_PHYSIOLOGICAL_CARDIAC_MUSCLE_HYPERTROPHY,0.99999
GOBP_RESPONSE_TO_ENDOPLASMIC...,SET,244,-0.017214,-0.0019713,0.052533,0.62842,GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.99999
HP_WIDENED_SUBARACHNOID_SPACE,SET,28,-0.050968,-0.001989,0.15554,0.62842,HP_WIDENED_SUBARACHNOID_SPACE,0.99999
HP_POLLAKISURIA,SET,7,-0.099508,-0.0019427,0.30365,0.62843,HP_POLLAKISURIA,0.99999
GSE3982_MAST_CELL_VS_CENT_ME...1,SET,163,-0.021132,-0.0019824,0.064453,0.62849,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN,0.99999
MIR6851_5P,SET,94,-0.028427,-0.002029,0.086694,0.62851,MIR6851_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...805,SET,32,-0.050354,-0.0021005,0.15355,0.62851,GOBP_POSITIVE_REGULATION_OF_T_CELL_MIGRATION,0.99999
SABATES_COLORECTAL_ADENOMA_DN,SET,260,-0.018945,-0.0022386,0.057767,0.62853,SABATES_COLORECTAL_ADENOMA_DN,0.99999
WP_KALLMANN_SYNDROME,SET,23,-0.058087,-0.0020548,0.17704,0.62858,WP_KALLMANN_SYNDROME,0.99999
chr7q35,SET,17,-0.10913,-0.0033192,0.33256,0.62859,chr7q35,0.99999
HP_DECREASED_CIRCULATING_IGG...2,SET,9,-0.084036,-0.0018602,0.25609,0.6286,HP_DECREASED_CIRCULATING_IGG_SUBCLASS_LEVEL,0.99999
GOBP_MIDBRAIN_HINDBRAIN_BOUN...,SET,5,-0.12657,-0.0020886,0.38559,0.62864,GOBP_MIDBRAIN_HINDBRAIN_BOUNDARY_DEVELOPMENT,0.99999
GOCC_PROTEASOME_ACCESSORY_CO...,SET,23,-0.051888,-0.0018355,0.15807,0.62864,GOCC_PROTEASOME_ACCESSORY_COMPLEX,0.99999
GOBP_NEGATIVE_REGULATION_OF_...70,SET,21,-0.060989,-0.0020616,0.18578,0.62865,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,0.99999
HP_LARYNGEAL_HYPOPLASIA,SET,8,-0.091273,-0.0019049,0.27802,0.62865,HP_LARYNGEAL_HYPOPLASIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...312,SET,6,-0.13514,-0.0024426,0.41161,0.62866,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,0.99999
HP_ARTERIAL_DISSECTION,SET,12,-0.094693,-0.0024202,0.28827,0.62873,HP_ARTERIAL_DISSECTION,0.99999
GOCC_MITOCHONDRIAL_ENVELOPE,SET,685,-0.010509,-0.0019917,0.031985,0.62875,GOCC_MITOCHONDRIAL_ENVELOPE,0.99999
GOBP_POSITIVE_REGULATION_OF_...244,SET,26,-0.059368,-0.0022327,0.18067,0.62877,GOBP_POSITIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT,0.99999
HP_ABNORMAL_AUDITORY_EVOKED_...,SET,22,-0.060382,-0.002089,0.18376,0.62877,HP_ABNORMAL_AUDITORY_EVOKED_POTENTIALS,0.99999
WP_CORI_CYCLE,SET,13,-0.072542,-0.0019297,0.22071,0.6288,WP_CORI_CYCLE,0.99999
GCTGAGT_MIR5125P,SET,42,-0.041098,-0.0019635,0.12504,0.6288,GCTGAGT_MIR5125P,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...80,SET,33,-0.050487,-0.0021386,0.15358,0.62882,HP_APLASIA_HYPOPLASIA_OF_THE_VERTEBRAE,0.99999
DAWSON_METHYLATED_IN_LYMPHOM...,SET,55,-0.045094,-0.0024645,0.13715,0.62884,DAWSON_METHYLATED_IN_LYMPHOMA_TCL1,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...3,SET,8,-0.090667,-0.0018923,0.27574,0.62885,KEGG_MEDICUS_VARIANT_AMPLIFIED_CDK4_TO_CELL_CYCLE_G1_S,0.99999
GOBP_CELL_DIFFERENTIATION_IN...1,SET,24,-0.060711,-0.0021937,0.18462,0.62886,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT,0.99999
GOBP_NUCLEAR_PORE_COMPLEX_AS...,SET,11,-0.080342,-0.001966,0.2443,0.62887,GOBP_NUCLEAR_PORE_COMPLEX_ASSEMBLY,0.99999
MODULE_218,SET,18,-0.074367,-0.0023275,0.22611,0.62888,MODULE_218,0.99999
GSE20366_EX_VIVO_VS_HOMEOSTA...3,SET,179,-0.021402,-0.002103,0.06507,0.62888,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN,0.99999
HP_ABNORMAL_P_WAVE,SET,5,-0.14728,-0.0024302,0.44771,0.6289,HP_ABNORMAL_P_WAVE,0.99999
GSE3982_BCELL_VS_CENT_MEMORY...1,SET,175,-0.021982,-0.002136,0.066793,0.62896,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN,0.99999
CUI_DEVELOPING_HEART_COMPACT...2,SET,58,-0.040569,-0.0022767,0.12323,0.62901,CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE,0.99999
MIR578,SET,168,-0.022432,-0.002136,0.068129,0.62902,MIR578,0.99999
HP_ABNORMAL_ZYGOMATIC_BONE_M...,SET,206,-0.019883,-0.0020944,0.060372,0.62905,HP_ABNORMAL_ZYGOMATIC_BONE_MORPHOLOGY,0.99999
HP_PERIPHERAL_HYPOMYELINATION,SET,9,-0.082648,-0.0018295,0.25075,0.62915,HP_PERIPHERAL_HYPOMYELINATION,0.99999
HAY_BONE_MARROW_EARLY_ERYTHR...,SET,81,-0.030805,-0.0020417,0.093431,0.62919,HAY_BONE_MARROW_EARLY_ERYTHROBLAST,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...4,SET,58,-0.039331,-0.0022072,0.11927,0.6292,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_CD8_T_CELLS,0.99999
GSE46606_DAY1_VS_DAY3_CD40L_...2,SET,155,-0.02404,-0.0021996,0.072898,0.62922,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP,0.99999
GOBP_MEIOTIC_CELL_CYCLE_PROC...2,SET,6,-0.11814,-0.0021354,0.35804,0.62928,GOBP_MEIOTIC_CELL_CYCLE_PROCESS_INVOLVED_IN_OOCYTE_MATURATION,0.99999
GSE18893_CTRL_VS_TNF_TREATED...7,SET,179,-0.021292,-0.0020922,0.064533,0.62928,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN,0.99999
KEGG_B_CELL_RECEPTOR_SIGNALI...,SET,72,-0.033644,-0.0021029,0.10194,0.62931,KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.99999
BALDWIN_PRKCI_TARGETS_UP,SET,32,-0.056376,-0.0023517,0.17075,0.62936,BALDWIN_PRKCI_TARGETS_UP,0.99999
BLALOCK_ALZHEIMERS_DISEASE_UP,SET,1508,-0.0074235,-0.0020384,0.022484,0.62936,BLALOCK_ALZHEIMERS_DISEASE_UP,0.99999
NAKAYA_MONOCYTE_FLUMIST_AGE_...2,SET,436,-0.013361,-0.0020344,0.040444,0.62943,NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP,0.99999
GSE3982_CTRL_VS_LPS_4H_MAC_UP,SET,177,-0.019844,-0.0019391,0.060053,0.62946,GSE3982_CTRL_VS_LPS_4H_MAC_UP,0.99999
CROMER_TUMORIGENESIS_DN,SET,46,-0.043936,-0.0021966,0.13287,0.62955,CROMER_TUMORIGENESIS_DN,0.99999
PEPPER_CHRONIC_LYMPHOCYTIC_L...1,SET,21,-0.068301,-0.0023088,0.20656,0.62955,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,0.99999
GOBP_T_CELL_PROLIFERATION_IN...,SET,5,-0.13834,-0.0022828,0.41832,0.62956,GOBP_T_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
BACOLOD_RESISTANCE_TO_ALKYLA...1,SET,44,-0.043958,-0.0021495,0.13292,0.62957,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN,0.99999
HOWARD_NK_CELL_INACT_MONOV_I...2,SET,56,-0.039883,-0.0021994,0.1206,0.62957,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_28DY_DN,0.99999
ZHONG_PFC_C1_DLX5_POS_INTERN...,SET,6,-0.13644,-0.0024663,0.41243,0.62961,ZHONG_PFC_C1_DLX5_POS_INTERNEURON,0.99999
HALLMARK_INTERFERON_GAMMA_RE...,SET,190,-0.021239,-0.0021495,0.064183,0.62964,HALLMARK_INTERFERON_GAMMA_RESPONSE,0.99999
HOFMANN_MYELODYSPLASTIC_SYND...2,SET,8,-0.1028,-0.0021456,0.3106,0.62967,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...827,SET,35,-0.05368,-0.0023417,0.16216,0.62969,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.99999
HP_PSORIASIFORM_LESION,SET,3,-0.1874,-0.0023955,0.56602,0.62971,HP_PSORIASIFORM_LESION,0.99999
HP_DISPLACEMENT_OF_THE_URETH...,SET,315,-0.015519,-0.0020154,0.046864,0.62974,HP_DISPLACEMENT_OF_THE_URETHRAL_MEATUS,0.99999
MIR4697_3P,SET,99,-0.028222,-0.0020669,0.085205,0.62976,MIR4697_3P,0.99999
GOBP_NAD_METABOLIC_PROCESS,SET,57,-0.036112,-0.0020091,0.10902,0.62977,GOBP_NAD_METABOLIC_PROCESS,0.99999
GOBP_PROTEIN_N_LINKED_GLYCOS...1,SET,69,-0.033187,-0.0020308,0.10018,0.62978,GOBP_PROTEIN_N_LINKED_GLYCOSYLATION,0.99999
GOBP_ENDOPLASMIC_RETICULUM_M...,SET,11,-0.07656,-0.0018735,0.23109,0.62979,GOBP_ENDOPLASMIC_RETICULUM_MEMBRANE_ORGANIZATION,0.99999
GOBP_REGULATION_OF_INFLAMMAT...3,SET,10,-0.094018,-0.0021937,0.28366,0.62984,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_WOUNDING,0.99999
GOBP_LIPID_STORAGE,SET,85,-0.032785,-0.0022257,0.098893,0.62987,GOBP_LIPID_STORAGE,0.99999
MIR1263,SET,50,-0.041188,-0.0021466,0.12423,0.62989,MIR1263,0.99999
GOCC_GABA_ERGIC_SYNAPSE,SET,69,-0.038084,-0.0023304,0.11486,0.62989,GOCC_GABA_ERGIC_SYNAPSE,0.99999
PRC1_BMI_UP.V1_UP,SET,162,-0.023198,-0.0021696,0.069967,0.62989,PRC1_BMI_UP.V1_UP,0.99999
GALI_TP53_TARGETS_APOPTOTIC_...2,SET,8,-0.097105,-0.0020267,0.29282,0.62991,GALI_TP53_TARGETS_APOPTOTIC_UP,0.99999
HP_SMOOTH_PHILTRUM,SET,159,-0.022044,-0.0020426,0.06646,0.62994,HP_SMOOTH_PHILTRUM,0.99999
GOBP_PEPTIDE_CROSS_LINKING,SET,26,-0.05737,-0.0021575,0.17291,0.62997,GOBP_PEPTIDE_CROSS_LINKING,0.99999
REACTOME_SIGNALING_BY_TGF_BE...1,SET,91,-0.029234,-0.0020531,0.088104,0.62998,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,0.99999
HP_ABNORMAL_ENZYME_ACTIVITY_...2,SET,7,-0.091357,-0.0017836,0.27516,0.63006,HP_ABNORMAL_ENZYME_ACTIVITY_IN_MUSCLE_TISSUE,0.99999
GOBP_SYNAPTIC_VESICLE_ENDOSO...,SET,8,-0.096284,-0.0020095,0.28995,0.63008,GOBP_SYNAPTIC_VESICLE_ENDOSOMAL_PROCESSING,0.99999
GSE13484_UNSTIM_VS_3H_YF17D_...1,SET,179,-0.021116,-0.002075,0.063575,0.63011,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,0.99999
REACTOME_TRANSCRIPTIONAL_REG...2,SET,57,-0.040316,-0.002243,0.12136,0.63013,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,0.99999
MIR4492,SET,387,-0.014492,-0.0020818,0.043605,0.63019,MIR4492,0.99999
GOBP_VESICLE_TRANSPORT_ALONG...1,SET,8,-0.10076,-0.0021029,0.30317,0.63019,GOBP_VESICLE_TRANSPORT_ALONG_ACTIN_FILAMENT,0.99999
MORF_FBL,SET,125,-0.023128,-0.0019019,0.069582,0.6302,MORF_FBL,0.99999
GOBP_NEGATIVE_REGULATION_OF_...134,SET,5,-0.14651,-0.0024176,0.4408,0.6302,GOBP_NEGATIVE_REGULATION_OF_CGMP_MEDIATED_SIGNALING,0.99999
GSE29164_UNTREATED_VS_CD8_TC...1,SET,183,-0.020338,-0.0020204,0.061178,0.63022,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,0.99999
LI_ESTROGENE_EARLY_E2_RESPON...2,SET,82,-0.033883,-0.0022594,0.10189,0.63026,LI_ESTROGENE_EARLY_E2_RESPONSE_UP,0.99999
GOBP_REGULATION_OF_HOMOPHILI...,SET,5,-0.13582,-0.0022412,0.40831,0.63029,GOBP_REGULATION_OF_HOMOPHILIC_CELL_ADHESION,0.99999
GOBP_RESPONSE_TO_ISCHEMIA,SET,62,-0.038374,-0.0022263,0.11534,0.63032,GOBP_RESPONSE_TO_ISCHEMIA,0.99999
QI_PBMC_ZOSTAVAX_AGE_50_75YO...7,SET,12,-0.08682,-0.002219,0.26092,0.63033,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_T_CELL_RESPONSES_1D_INFORMATIVE_OF_LONG_TERM_RESPONSES_NEGATIVE,0.99999
HP_EXSTROPHY,SET,6,-0.13093,-0.0023666,0.39322,0.63041,HP_EXSTROPHY,0.99999
GSE40274_CTRL_VS_FOXP3_TRANS...2,SET,181,-0.020454,-0.0020209,0.061418,0.63044,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...551,SET,6,-0.11724,-0.0021191,0.35196,0.63047,GOBP_POSITIVE_REGULATION_OF_NUCLEASE_ACTIVITY,0.99999
GSE3982_BASOPHIL_VS_EFF_MEMO...2,SET,184,-0.02085,-0.0020769,0.062579,0.6305,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
GOBP_REGULATION_OF_LIPID_STO...,SET,49,-0.042491,-0.0021923,0.1275,0.63053,GOBP_REGULATION_OF_LIPID_STORAGE,0.99999
MIR371B_3P,SET,36,-0.050854,-0.0022498,0.15259,0.63054,MIR371B_3P,0.99999
GSE18893_TCONV_VS_TREG_2H_CU...1,SET,187,-0.020988,-0.0021074,0.06296,0.63056,GSE18893_TCONV_VS_TREG_2H_CULTURE_DN,0.99999
GOBP_REGULATION_OF_EXTRINSIC...1,SET,145,-0.024199,-0.0021421,0.072569,0.6306,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...494,SET,5,-0.10077,-0.0016628,0.30216,0.63062,GOBP_NEGATIVE_REGULATION_OF_PINOCYTOSIS,0.99999
GOMF_C_X_C_CHEMOKINE_RECEPTO...,SET,7,-0.11011,-0.0021498,0.33017,0.63062,GOMF_C_X_C_CHEMOKINE_RECEPTOR_ACTIVITY,0.99999
MODULE_96,SET,36,-0.052581,-0.0023262,0.15755,0.63071,MODULE_96,0.99999
HOEK_NK_CELL_2011_2012_TIV_1...,SET,42,-0.046657,-0.0022291,0.13974,0.63076,HOEK_NK_CELL_2011_2012_TIV_1D_VS_0DY_ADULT_1D_DN,0.99999
HP_LACK_OF_INSIGHT,SET,10,-0.080649,-0.0018818,0.24152,0.63078,HP_LACK_OF_INSIGHT,0.99999
BEGUM_TARGETS_OF_PAX3_FOXO1_...2,SET,46,-0.046972,-0.0023483,0.14065,0.6308,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,0.99999
REACTOME_RUNX2_REGULATES_BON...,SET,28,-0.055433,-0.0021632,0.16597,0.63081,REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT,0.99999
GSE3982_EOSINOPHIL_VS_NKCELL...2,SET,179,-0.021477,-0.0021104,0.06429,0.63083,GSE3982_EOSINOPHIL_VS_NKCELL_UP,0.99999
GOBP_CELL_DIFFERENTIATION_IN...4,SET,3,-0.19079,-0.0024387,0.57107,0.63084,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_PHENOTYPIC_SWITCHING,0.99999
TERAMOTO_OPN_TARGETS_CLUSTER...2,SET,7,-0.080931,-0.0015801,0.24217,0.63088,TERAMOTO_OPN_TARGETS_CLUSTER_3,0.99999
REACTOME_DOPAMINE_CLEARANCE_...,SET,3,-0.21319,-0.0027251,0.63782,0.6309,REACTOME_DOPAMINE_CLEARANCE_FROM_THE_SYNAPTIC_CLEFT,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...24,SET,46,-0.047713,-0.0023854,0.14275,0.6309,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_SUSTENTACULAR_CELLS,0.99999
RAF_UP.V1_DN,SET,171,-0.024105,-0.0023156,0.07211,0.63091,RAF_UP.V1_DN,0.99999
MIR548AB,SET,444,-0.013865,-0.00213,0.041467,0.63095,MIR548AB,0.99999
GSE39820_CTRL_VS_TGFBETA3_IL...4,SET,173,-0.020368,-0.0019679,0.060907,0.63097,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP,0.99999
GSE3039_CD4_TCELL_VS_B1_BCEL...2,SET,184,-0.021197,-0.0021115,0.063377,0.63098,GSE3039_CD4_TCELL_VS_B1_BCELL_UP,0.99999
GOBP_REGULATION_OF_TRANSPORT...,SET,194,-0.021915,-0.0022409,0.065516,0.631,GOBP_REGULATION_OF_TRANSPORTER_ACTIVITY,0.99999
HP_LACTOSE_INTOLERANCE,SET,5,-0.13082,-0.0021588,0.39108,0.631,HP_LACTOSE_INTOLERANCE,0.99999
GSE35825_UNTREATED_VS_IFNA_S...2,SET,161,-0.021865,-0.0020386,0.065357,0.63101,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_UP,0.99999
GSE37301_LYMPHOID_PRIMED_MPP...1,SET,176,-0.020512,-0.0019987,0.061287,0.63106,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_DN,0.99999
MIR4477A,SET,329,-0.01589,-0.002108,0.047448,0.63114,MIR4477A,0.99999
GOBP_POSITIVE_REGULATION_OF_...814,SET,9,-0.10354,-0.0022919,0.30911,0.63117,GOBP_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_CYTOKINE_PRODUCTION,0.99999
REACTOME_ESTABLISHMENT_OF_SI...,SET,8,-0.10047,-0.0020969,0.29993,0.63118,REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,0.99999
GOCC_GEMINI_OF_COILED_BODIES,SET,8,-0.084806,-0.00177,0.25317,0.63118,GOCC_GEMINI_OF_COILED_BODIES,0.99999
HP_ABSENT_HYPOPLASTIC_PARANA...,SET,5,-0.14153,-0.0023355,0.4224,0.63121,HP_ABSENT_HYPOPLASTIC_PARANASAL_SINUSES,0.99999
GSE22935_UNSTIM_VS_12H_MBOVI...3,SET,181,-0.020672,-0.0020425,0.061695,0.63121,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.99999
MIR4708_3P,SET,91,-0.030077,-0.0021123,0.089739,0.63124,MIR4708_3P,0.99999
WP_HORMONAL_CONTROL_OF_PUBER...,SET,5,-0.14566,-0.0024036,0.43451,0.63127,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,0.99999
GSE43955_1H_VS_20H_ACT_CD4_T...1,SET,182,-0.021693,-0.0021493,0.064703,0.63129,GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN,0.99999
HP_HYPOVOLEMIA,SET,30,-0.058346,-0.0023567,0.17399,0.63131,HP_HYPOVOLEMIA,0.99999
WP_TRANSLATION_INHIBITORS_IN...,SET,45,-0.042732,-0.002113,0.12741,0.63133,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,0.99999
GOLDRATH_NAIVE_VS_MEMORY_CD8...2,SET,190,-0.020699,-0.0020948,0.061716,0.63133,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...13,SET,21,-0.068313,-0.0023091,0.20367,0.63134,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...2,SET,180,-0.021203,-0.0020892,0.0632,0.63137,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_UP,0.99999
MIR6815_3P,SET,187,-0.02087,-0.0020956,0.062193,0.6314,MIR6815_3P,0.99999
GSE5589_LPS_VS_LPS_AND_IL10_...3,SET,185,-0.021971,-0.0021945,0.065446,0.63145,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_DN,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...6,SET,43,-0.048179,-0.002329,0.1435,0.63146,GAVISH_3CA_MALIGNANT_METAPROGRAM_15_EMT_4,0.99999
GOCC_MAIN_AXON,SET,67,-0.038966,-0.0023497,0.11602,0.63151,GOCC_MAIN_AXON,0.99999
KAN_RESPONSE_TO_ARSENIC_TRIO...,SET,108,-0.030351,-0.0023211,0.090335,0.63156,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,0.99999
MIR7154_3P,SET,56,-0.039473,-0.0021768,0.11748,0.63156,MIR7154_3P,0.99999
KEGG_MEDICUS_VARIANT_ERBB2_O...1,SET,7,-0.11732,-0.0022905,0.34897,0.63164,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY,0.99999
HP_NOCTURNAL_SEIZURES,SET,18,-0.073544,-0.0023017,0.21867,0.63168,HP_NOCTURNAL_SEIZURES,0.99999
GSE29617_CTRL_VS_DAY3_TIV_FL...1,SET,178,-0.020649,-0.0020234,0.061395,0.63169,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN,0.99999
GOBP_REGULATION_OF_BONE_RESO...,SET,42,-0.048869,-0.0023348,0.14528,0.6317,GOBP_REGULATION_OF_BONE_RESORPTION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...165,SET,9,-0.095215,-0.0021077,0.28284,0.6318,GOBP_NEGATIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION,0.99999
REACTOME_VLDL_CLEARANCE,SET,4,-0.15809,-0.0023333,0.46937,0.63187,REACTOME_VLDL_CLEARANCE,0.99999
COUP_DR1_Q6,SET,217,-0.018828,-0.0020349,0.0559,0.63187,COUP_DR1_Q6,0.99999
GOBP_NEGATIVE_REGULATION_OF_...362,SET,34,-0.049501,-0.0021283,0.14697,0.63187,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...75,SET,11,-0.082142,-0.0020101,0.24385,0.63188,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_P62_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,0.99999
GOBP_PEPTIDYL_SERINE_DEPHOSP...,SET,14,-0.06912,-0.0019081,0.20508,0.63196,GOBP_PEPTIDYL_SERINE_DEPHOSPHORYLATION,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...13,SET,48,-0.04675,-0.0023874,0.13869,0.63197,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_HYPOXIA,0.99999
GOBP_UTERUS_MORPHOGENESIS,SET,6,-0.11634,-0.0021029,0.34506,0.632,GOBP_UTERUS_MORPHOGENESIS,0.99999
HP_RESPIRATORY_DISTRESS,SET,192,-0.020844,-0.0021205,0.061816,0.63201,HP_RESPIRATORY_DISTRESS,0.99999
GOCC_MCM_COMPLEX,SET,11,-0.097869,-0.002395,0.29013,0.63206,GOCC_MCM_COMPLEX,0.99999
HP_VIRAL_ENCEPHALITIS,SET,11,-0.087341,-0.0021373,0.25885,0.6321,HP_VIRAL_ENCEPHALITIS,0.99999
HP_MENOMETRORRHAGIA,SET,5,-0.15903,-0.0026242,0.47113,0.63215,HP_MENOMETRORRHAGIA,0.99999
GOBP_COBALT_ION_TRANSPORT,SET,6,-0.12144,-0.002195,0.35954,0.63222,GOBP_COBALT_ION_TRANSPORT,0.99999
KEGG_MEDICUS_REFERENCE_NON_C...,SET,6,-0.13354,-0.0024138,0.39535,0.63223,KEGG_MEDICUS_REFERENCE_NON_CANONICAL_INFLAMMASOME_SIGNALING_PATHWAY,0.99999
HP_INSULINOMA,SET,6,-0.11757,-0.0021251,0.34796,0.63227,HP_INSULINOMA,0.99999
GOBP_GLOMERULAR_EPITHELIUM_D...,SET,25,-0.065786,-0.002426,0.19468,0.63229,GOBP_GLOMERULAR_EPITHELIUM_DEVELOPMENT,0.99999
GOBP_CHONDROBLAST_DIFFERENTI...,SET,4,-0.13763,-0.0020314,0.40724,0.6323,GOBP_CHONDROBLAST_DIFFERENTIATION,0.99999
BIERIE_INFLAMMATORY_RESPONSE...,SET,5,-0.16251,-0.0026816,0.48063,0.63236,BIERIE_INFLAMMATORY_RESPONSE_TGFB1,0.99999
GSE43955_1H_VS_42H_ACT_CD4_T...3,SET,181,-0.02119,-0.0020936,0.06266,0.63238,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.99999
MIR4746_5P,SET,8,-0.092628,-0.0019332,0.27387,0.6324,MIR4746_5P,0.99999
GSE17186_MEMORY_VS_NAIVE_BCE...2,SET,169,-0.022269,-0.0021268,0.065835,0.63241,GSE17186_MEMORY_VS_NAIVE_BCELL_UP,0.99999
GSE25147_UNSTIM_VS_HELIOBACT...1,SET,148,-0.025501,-0.0022804,0.075377,0.63243,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...809,SET,11,-0.089069,-0.0021796,0.26326,0.63244,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION,0.99999
GSE5589_LPS_VS_LPS_AND_IL6_S...4,SET,172,-0.022563,-0.0021738,0.066693,0.63244,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,0.99999
GSE10239_MEMORY_VS_KLRG1HIGH...2,SET,180,-0.02149,-0.0021175,0.063514,0.63245,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.99999
UNTERMAN_PROGRESSIVE_VS_STAB...4,SET,26,-0.067946,-0.0025552,0.20075,0.63249,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_MONOCYTE_DN,0.99999
KEGG_MEDICUS_VARIANT_DUPLICA...2,SET,13,-0.080585,-0.0021437,0.23802,0.63253,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_OPTIC_CHIASM_MOR...,SET,6,-0.13911,-0.0025144,0.41087,0.63253,HP_ABNORMAL_OPTIC_CHIASM_MORPHOLOGY,0.99999
REACTOME_DDX58_IFIH1_MEDIATE...,SET,74,-0.034996,-0.0022174,0.10335,0.63255,REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,0.99999
WP_HYPERTROPHY_MODEL,SET,19,-0.070633,-0.0022712,0.2086,0.63255,WP_HYPERTROPHY_MODEL,0.99999
KEGG_GLYCEROPHOSPHOLIPID_MET...,SET,69,-0.035875,-0.0021952,0.10593,0.63257,KEGG_GLYCEROPHOSPHOLIPID_METABOLISM,0.99999
PDGF_ERK_DN.V1_DN,SET,135,-0.024547,-0.0020973,0.072474,0.63258,PDGF_ERK_DN.V1_DN,0.99999
GOBP_CHEMOKINE_C_X_C_MOTIF_L...2,SET,6,-0.12209,-0.0022069,0.36043,0.63259,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_1_PRODUCTION,0.99999
HE_LIM_SUN_FETAL_LUNG_C6_MUC...,SET,49,-0.04429,-0.0022851,0.13056,0.63278,HE_LIM_SUN_FETAL_LUNG_C6_MUC16_POS_CILIATED_CELL,0.99999
HP_ABNORMAL_PROXIMAL_PHALANX...,SET,27,-0.05639,-0.002161,0.16621,0.63279,HP_ABNORMAL_PROXIMAL_PHALANX_MORPHOLOGY_OF_THE_HAND,0.99999
GOBP_IMMATURE_B_CELL_DIFFERE...,SET,12,-0.080262,-0.0020514,0.23649,0.63284,GOBP_IMMATURE_B_CELL_DIFFERENTIATION,0.99999
GOBP_RESPONSE_TO_ERYTHROPOIE...,SET,6,-0.14141,-0.0025561,0.41662,0.63285,GOBP_RESPONSE_TO_ERYTHROPOIETIN,0.99999
RICKMAN_HEAD_AND_NECK_CANCER...3,SET,101,-0.03129,-0.0023145,0.092116,0.63295,RICKMAN_HEAD_AND_NECK_CANCER_C,0.99999
MORF_LMO1,SET,48,-0.042281,-0.0021592,0.12441,0.63301,MORF_LMO1,0.99999
HP_ABNORMALITY_OF_THE_COAGUL...,SET,136,-0.025206,-0.0021614,0.074139,0.63306,HP_ABNORMALITY_OF_THE_COAGULATION_CASCADE,0.99999
WP_1P36_COPY_NUMBER_VARIATIO...,SET,89,-0.037799,-0.0026255,0.11116,0.63308,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GOMF_ACETYLCHOLINE_RECEPTOR_...2,SET,11,-0.095853,-0.0023456,0.28183,0.63311,GOMF_ACETYLCHOLINE_RECEPTOR_BINDING,0.99999
GOBP_SHORT_TERM_MEMORY,SET,10,-0.088722,-0.0020701,0.26059,0.63324,GOBP_SHORT_TERM_MEMORY,0.99999
HP_GENETIC_ANTICIPATION,SET,8,-0.097535,-0.0020356,0.28648,0.63324,HP_GENETIC_ANTICIPATION,0.99999
HESS_TARGETS_OF_HOXA9_AND_ME...2,SET,67,-0.036026,-0.0021724,0.10579,0.63328,HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,0.99999
VANTVEER_BREAST_CANCER_ESR1_...2,SET,136,-0.025567,-0.0021924,0.075071,0.63329,VANTVEER_BREAST_CANCER_ESR1_UP,0.99999
GOBP_RETINA_LAYER_FORMATION,SET,22,-0.06751,-0.0023356,0.19821,0.63329,GOBP_RETINA_LAYER_FORMATION,0.99999
HP_NARROW_JAW,SET,13,-0.078013,-0.0020753,0.22905,0.63329,HP_NARROW_JAW,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...29,SET,42,-0.047107,-0.0022506,0.13826,0.63334,GAVISH_3CA_MALIGNANT_METAPROGRAM_37_HEMATO_RELATED_2,0.99999
KEGG_MEDICUS_VARIANT_EML4_AL...3,SET,13,-0.081084,-0.0021569,0.23794,0.63336,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY,0.99999
HP_UPPER_LIMB_UNDERGROWTH,SET,78,-0.031331,-0.0020379,0.091945,0.63336,HP_UPPER_LIMB_UNDERGROWTH,0.99999
DACOSTA_UV_RESPONSE_VIA_ERCC...2,SET,65,-0.035486,-0.0021078,0.10399,0.63353,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,0.99999
MORF_XPC,SET,53,-0.035605,-0.0019103,0.10432,0.63357,MORF_XPC,0.99999
HP_ABNORMAL_ODONTOID_PROCESS...,SET,28,-0.053225,-0.0020771,0.15593,0.63358,HP_ABNORMAL_ODONTOID_PROCESS_MORPHOLOGY,0.99999
HP_SENSORIMOTOR_NEUROPATHY,SET,73,-0.034254,-0.0021558,0.10034,0.63359,HP_SENSORIMOTOR_NEUROPATHY,0.99999
GSE9988_LPS_VS_LOW_LPS_MONOC...2,SET,137,-0.024957,-0.0021479,0.073098,0.6336,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP,0.99999
GOBP_CD40_SIGNALING_PATHWAY,SET,13,-0.073484,-0.0019548,0.21519,0.63363,GOBP_CD40_SIGNALING_PATHWAY,0.99999
HP_GRANULOCYTOPENIA,SET,6,-0.11406,-0.0020617,0.33376,0.63372,HP_GRANULOCYTOPENIA,0.99999
GOCC_CAJAL_BODY,SET,56,-0.03601,-0.0019858,0.10533,0.63377,GOCC_CAJAL_BODY,0.99999
TCTAGAG_MIR517,SET,41,-0.044719,-0.002111,0.13073,0.63385,TCTAGAG_MIR517,0.99999
GOCC_UNIPLEX_COMPLEX,SET,5,-0.16222,-0.0026768,0.47421,0.63385,GOCC_UNIPLEX_COMPLEX,0.99999
MIR224_5P,SET,164,-0.022755,-0.0021411,0.066504,0.63388,MIR224_5P,0.99999
GOBP_IMPORT_INTO_NUCLEUS,SET,159,-0.0227,-0.0021034,0.066323,0.63392,GOBP_IMPORT_INTO_NUCLEUS,0.99999
GOBP_RIBOSOMAL_SMALL_SUBUNIT...3,SET,8,-0.11799,-0.0024625,0.34473,0.63392,GOBP_RIBOSOMAL_SMALL_SUBUNIT_EXPORT_FROM_NUCLEUS,0.99999
BRUINS_UVC_RESPONSE_VIA_TP53...2,SET,492,-0.013343,-0.0021548,0.03898,0.63393,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B,0.99999
GSE3337_CTRL_VS_4H_IFNG_IN_C...2,SET,185,-0.021155,-0.0021129,0.061802,0.63393,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP,0.99999
KEGG_MEDICUS_REFERENCE_LPA_G...2,SET,8,-0.10733,-0.00224,0.31355,0.63394,KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...677,SET,61,-0.03691,-0.0021241,0.10782,0.63395,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...370,SET,12,-0.090973,-0.0023251,0.26549,0.63407,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION,0.99999
WANG_RESPONSE_TO_FORSKOLIN_DN,SET,9,-0.088809,-0.0019659,0.25911,0.6341,WANG_RESPONSE_TO_FORSKOLIN_DN,0.99999
GOMF_GDP_BINDING,SET,70,-0.035754,-0.0022036,0.10431,0.63411,GOMF_GDP_BINDING,0.99999
WP_GLYCINE_METABOLISM_INCLUD...,SET,15,-0.069179,-0.0019767,0.20181,0.63412,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,0.99999
GOBP_VESICLE_FUSION_WITH_GOL...,SET,8,-0.096468,-0.0020133,0.28139,0.63413,GOBP_VESICLE_FUSION_WITH_GOLGI_APPARATUS,0.99999
REACTOME_DEGRADATION_OF_CYST...,SET,14,-0.079964,-0.0022074,0.23317,0.63418,REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...689,SET,8,-0.10615,-0.0022153,0.30916,0.63432,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.99999
MIR6873_3P,SET,340,-0.016789,-0.0022635,0.048889,0.63435,MIR6873_3P,0.99999
GOCC_BETA_CATENIN_TCF_COMPLEX,SET,13,-0.087455,-0.0023264,0.25455,0.63441,GOCC_BETA_CATENIN_TCF_COMPLEX,0.99999
BOYLAN_MULTIPLE_MYELOMA_PCA3...2,SET,75,-0.038164,-0.0024344,0.11104,0.63446,BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,0.99999
HP_RENAL_HYPOPLASIA,SET,116,-0.027099,-0.0021473,0.078848,0.63446,HP_RENAL_HYPOPLASIA,0.99999
HP_ABNORMAL_CONUS_TERMINALIS...,SET,29,-0.052392,-0.0020807,0.15243,0.63447,HP_ABNORMAL_CONUS_TERMINALIS_MORPHOLOGY,0.99999
HP_RENAL_CELL_CARCINOMA,SET,70,-0.034837,-0.0021471,0.10133,0.6345,HP_RENAL_CELL_CARCINOMA,0.99999
HP_GENITAL_NEOPLASM,SET,146,-0.024033,-0.0021347,0.069885,0.63454,HP_GENITAL_NEOPLASM,0.99999
GOBP_MECHANORECEPTOR_DIFFERE...,SET,65,-0.038975,-0.002315,0.11331,0.63456,GOBP_MECHANORECEPTOR_DIFFERENTIATION,0.99999
HP_MOVEMENT_ABNORMALITY_OF_T...,SET,15,-0.077053,-0.0022016,0.22394,0.63461,HP_MOVEMENT_ABNORMALITY_OF_THE_TONGUE,0.99999
REACTOME_G_PROTEIN_ACTIVATION,SET,24,-0.065956,-0.0023832,0.19145,0.63476,REACTOME_G_PROTEIN_ACTIVATION,0.99999
HP_POSITIVE_ROMBERG_SIGN,SET,26,-0.054297,-0.0020419,0.15758,0.63479,HP_POSITIVE_ROMBERG_SIGN,0.99999
HP_MALIGNANT_GENITOURINARY_T...,SET,33,-0.04735,-0.0020057,0.13739,0.63481,HP_MALIGNANT_GENITOURINARY_TRACT_TUMOR,0.99999
GOBP_POSITIVE_REGULATION_OF_...65,SET,32,-0.057008,-0.002378,0.16536,0.63486,GOBP_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,0.99999
GOMF_HEXOKINASE_ACTIVITY,SET,5,-0.153,-0.0025247,0.44377,0.63487,GOMF_HEXOKINASE_ACTIVITY,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...10,SET,62,-0.036271,-0.0021043,0.10518,0.63489,GOBP_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,0.99999
HP_ABNORMALITY_OF_THE_SHOULD...,SET,128,-0.025555,-0.0021264,0.0741,0.6349,HP_ABNORMALITY_OF_THE_SHOULDER_GIRDLE_MUSCULATURE,0.99999
VERNELL_RETINOBLASTOMA_PATHW...1,SET,19,-0.068508,-0.0022028,0.19858,0.63495,VERNELL_RETINOBLASTOMA_PATHWAY_DN,0.99999
YAGI_AML_SURVIVAL,SET,108,-0.028444,-0.0021753,0.082446,0.63495,YAGI_AML_SURVIVAL,0.99999
GOBP_DNA_TEMPLATED_TRANSCRIP...2,SET,175,-0.021339,-0.0020735,0.06183,0.635,GOBP_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.99999
GOCC_PROTEASOME_COMPLEX,SET,60,-0.033436,-0.0019084,0.096811,0.63509,GOCC_PROTEASOME_COMPLEX,0.99999
GOBP_MALE_MEIOTIC_NUCLEAR_DI...,SET,49,-0.037128,-0.0019156,0.10748,0.63511,GOBP_MALE_MEIOTIC_NUCLEAR_DIVISION,0.99999
HP_ABNORMAL_CIRCULATING_NON_...,SET,21,-0.063297,-0.0021396,0.18312,0.6352,HP_ABNORMAL_CIRCULATING_NON_PROTEINOGENIC_AMINO_ACID_CONCENTRATION,0.99999
GOBP_HIPPOCAMPUS_DEVELOPMENT,SET,90,-0.032011,-0.0022358,0.092535,0.6353,GOBP_HIPPOCAMPUS_DEVELOPMENT,0.99999
WP_APOPTOSISRELATED_NETWORK_...,SET,50,-0.044074,-0.002297,0.1273,0.63541,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,0.99999
GNF2_HDAC1,SET,99,-0.027054,-0.0019814,0.078106,0.63547,GNF2_HDAC1,0.99999
HP_FACIAL_ERYTHEMA,SET,11,-0.093902,-0.0022979,0.27106,0.63549,HP_FACIAL_ERYTHEMA,0.99999
GSE17721_POLYIC_VS_CPG_4H_BM...2,SET,180,-0.02153,-0.0021215,0.062149,0.63549,GSE17721_POLYIC_VS_CPG_4H_BMDC_UP,0.99999
GOBP_OXALOACETATE_METABOLIC_...,SET,9,-0.090227,-0.0019973,0.26043,0.6355,GOBP_OXALOACETATE_METABOLIC_PROCESS,0.99999
EFC_Q6,SET,242,-0.019279,-0.0021989,0.055636,0.63552,EFC_Q6,0.99999
ZHAN_MULTIPLE_MYELOMA_MS_DN,SET,38,-0.047118,-0.0021415,0.13594,0.63555,ZHAN_MULTIPLE_MYELOMA_MS_DN,0.99999
GCM_ERCC4,SET,25,-0.057993,-0.0021386,0.16727,0.63559,GCM_ERCC4,0.99999
HP_INTERICTAL_EEG_ABNORMALITY,SET,289,-0.017569,-0.0021869,0.050666,0.63561,HP_INTERICTAL_EEG_ABNORMALITY,0.99999
MIR208A_5P,SET,228,-0.020086,-0.0022245,0.057906,0.63565,MIR208A_5P,0.99999
HP_CONJUNCTIVAL_HYPEREMIA,SET,5,-0.13946,-0.0023013,0.40203,0.63567,HP_CONJUNCTIVAL_HYPEREMIA,0.99999
HP_ABNORMAL_RETINAL_VASCULAR...,SET,226,-0.019778,-0.0021809,0.057006,0.63568,HP_ABNORMAL_RETINAL_VASCULAR_MORPHOLOGY,0.99999
GOCC_ORGANELLE_INNER_MEMBRANE,SET,465,-0.013207,-0.0020752,0.038067,0.63569,GOCC_ORGANELLE_INNER_MEMBRANE,0.99999
GOBP_MYELOID_PROGENITOR_CELL...,SET,9,-0.094013,-0.0020811,0.27094,0.6357,GOBP_MYELOID_PROGENITOR_CELL_DIFFERENTIATION,0.99999
JOHNSTONE_PARVB_TARGETS_1_DN,SET,56,-0.040327,-0.0022239,0.11618,0.63574,JOHNSTONE_PARVB_TARGETS_1_DN,0.99999
GOBP_NEUROMUSCULAR_SYNAPTIC_...,SET,26,-0.059709,-0.0022455,0.17202,0.63574,GOBP_NEUROMUSCULAR_SYNAPTIC_TRANSMISSION,0.99999
MIR618,SET,59,-0.038518,-0.0021801,0.11096,0.63575,MIR618,0.99999
HP_ASCENDING_TUBULAR_AORTA_A...,SET,26,-0.06054,-0.0022767,0.17438,0.63577,HP_ASCENDING_TUBULAR_AORTA_ANEURYSM,0.99999
REACTOME_TGF_BETA_RECEPTOR_S...1,SET,46,-0.043728,-0.0021862,0.12588,0.63585,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,0.99999
REACTOME_SUMOYLATION_OF_DNA_...3,SET,43,-0.042726,-0.0020654,0.12298,0.63586,REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS,0.99999
GOBP_NITROGEN_COMPOUND_TRANS...,SET,1728,-0.0073722,-0.0021527,0.021218,0.63587,GOBP_NITROGEN_COMPOUND_TRANSPORT,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...14,SET,116,-0.028618,-0.0022676,0.082353,0.63589,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
MIR6500_3P,SET,73,-0.034074,-0.0021444,0.098046,0.6359,MIR6500_3P,0.99999
GOMF_FOUR_WAY_JUNCTION_DNA_B...,SET,16,-0.076556,-0.0022591,0.22029,0.6359,GOMF_FOUR_WAY_JUNCTION_DNA_BINDING,0.99999
DESCARTES_FETAL_PANCREAS_CCL...,SET,43,-0.051123,-0.0024713,0.14711,0.6359,DESCARTES_FETAL_PANCREAS_CCL19_CCL21_POSITIVE_CELLS,0.99999
YKACATTT_UNKNOWN,SET,257,-0.019175,-0.0022529,0.055174,0.63591,YKACATTT_UNKNOWN,0.99999
HP_DEATH_IN_ADULTHOOD,SET,42,-0.046227,-0.0022085,0.133,0.63591,HP_DEATH_IN_ADULTHOOD,0.99999
GOCC_RECYCLING_ENDOSOME,SET,187,-0.020915,-0.0021001,0.060168,0.63593,GOCC_RECYCLING_ENDOSOME,0.99999
GOBP_BONE_DEVELOPMENT,SET,196,-0.022503,-0.0023127,0.064722,0.63596,GOBP_BONE_DEVELOPMENT,0.99999
GSE27786_ERYTHROBLAST_VS_MON...1,SET,184,-0.021229,-0.0021147,0.061051,0.63598,GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN,0.99999
WP_THYROXINE_THYROID_HORMONE...,SET,23,-0.064178,-0.0022702,0.18455,0.63599,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,0.99999
REACTOME_PRC2_METHYLATES_HIS...,SET,12,-0.087146,-0.0022273,0.25046,0.63606,REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA,0.99999
HP_URETERAL_DUPLICATION,SET,41,-0.043492,-0.002053,0.12498,0.63607,HP_URETERAL_DUPLICATION,0.99999
DESCARTES_MAIN_FETAL_SQUAMOU...,SET,94,-0.03325,-0.0023731,0.095514,0.63612,DESCARTES_MAIN_FETAL_SQUAMOUS_EPITHELIAL_CELLS,0.99999
HP_DIARRHEA,SET,362,-0.016151,-0.0022455,0.046373,0.63618,HP_DIARRHEA,0.99999
HP_PULMONARY_CARCINOID_TUMOR,SET,8,-0.093425,-0.0019498,0.26809,0.63626,HP_PULMONARY_CARCINOID_TUMOR,0.99999
DODD_NASOPHARYNGEAL_CARCINOM...2,SET,1245,-0.0087256,-0.0021939,0.025035,0.63628,DODD_NASOPHARYNGEAL_CARCINOMA_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...462,SET,33,-0.054113,-0.0022922,0.15522,0.63631,GOBP_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,0.99999
GOBP_VESICLE_DOCKING_INVOLVE...,SET,35,-0.049385,-0.0021543,0.14163,0.63633,GOBP_VESICLE_DOCKING_INVOLVED_IN_EXOCYTOSIS,0.99999
GOMF_NEUROPEPTIDE_ACTIVITY,SET,25,-0.063474,-0.0023408,0.18201,0.63636,GOMF_NEUROPEPTIDE_ACTIVITY,0.99999
DESCARTES_FETAL_PLACENTA_LYM...,SET,114,-0.029965,-0.002354,0.085919,0.63636,DESCARTES_FETAL_PLACENTA_LYMPHOID_CELLS,0.99999
HOLLERN_EMT_BREAST_TUMOR_DN,SET,115,-0.028528,-0.0022509,0.081798,0.63637,HOLLERN_EMT_BREAST_TUMOR_DN,0.99999
GOBP_CELL_COMMUNICATION_BY_E...1,SET,33,-0.056948,-0.0024123,0.16324,0.6364,GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,0.99999
HP_LIPOMA,SET,22,-0.06132,-0.0021215,0.17578,0.6364,HP_LIPOMA,0.99999
HP_ABNORMAL_FETAL_GENITOURIN...,SET,11,-0.094369,-0.0023093,0.27043,0.63644,HP_ABNORMAL_FETAL_GENITOURINARY_SYSTEM_MORPHOLOGY,0.99999
KEGG_AMYOTROPHIC_LATERAL_SCL...,SET,52,-0.040446,-0.0021495,0.11585,0.6365,KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_M...4,SET,20,-0.062642,-0.0020665,0.17943,0.6365,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.99999
WP_VITAMIN_A1_AND_A5X_PATHWA...,SET,6,-0.11859,-0.0021436,0.33964,0.63652,WP_VITAMIN_A1_AND_A5X_PATHWAYS,0.99999
MORF_MT4,SET,234,-0.019386,-0.0021747,0.055519,0.63652,MORF_MT4,0.99999
GOBP_REGULATION_OF_HORMONE_S...,SET,243,-0.020129,-0.0023005,0.057639,0.63654,GOBP_REGULATION_OF_HORMONE_SECRETION,0.99999
GOBP_REGULATION_OF_PROTEOLYS...2,SET,196,-0.020992,-0.0021574,0.060109,0.63654,GOBP_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.99999
GCM_BMPR2,SET,78,-0.032119,-0.0020892,0.091942,0.63658,GCM_BMPR2,0.99999
KEGG_MEDICUS_REFERENCE_PDGF_...3,SET,16,-0.077794,-0.0022956,0.2226,0.63663,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY,0.99999
PRAMOONJAGO_SOX4_TARGETS_UP,SET,48,-0.045586,-0.0023279,0.13038,0.63669,PRAMOONJAGO_SOX4_TARGETS_UP,0.99999
HP_ABNORMAL_CIRCULATING_ALBU...,SET,108,-0.028175,-0.0021547,0.08058,0.6367,HP_ABNORMAL_CIRCULATING_ALBUMIN_CONCENTRATION,0.99999
GOBP_INTRACELLULAR_OXYGEN_HO...,SET,6,-0.11961,-0.0021621,0.34195,0.63675,GOBP_INTRACELLULAR_OXYGEN_HOMEOSTASIS,0.99999
KEGG_MEDICUS_VARIANT_PAX8_PP...,SET,5,-0.13484,-0.002225,0.38503,0.6369,KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION,0.99999
GOBP_ARTERY_DEVELOPMENT,SET,99,-0.032601,-0.0023876,0.093093,0.6369,GOBP_ARTERY_DEVELOPMENT,0.99999
TAKAYAMA_BOUND_BY_AR,SET,10,-0.09695,-0.0022621,0.2768,0.63692,TAKAYAMA_BOUND_BY_AR,0.99999
HP_INCREASED_ASPARTATE_FAMIL...,SET,7,-0.1138,-0.0022217,0.32481,0.63696,HP_INCREASED_ASPARTATE_FAMILY_AMINO_ACID_LEVEL_IN_URINE,0.99999
HEBERT_MATRISOME_TNBC_LIVER_...,SET,13,-0.087561,-0.0023293,0.24991,0.63697,HEBERT_MATRISOME_TNBC_LIVER_METASTASIS,0.99999
GOBP_REGULATION_OF_BONE_REMO...,SET,50,-0.047056,-0.0024524,0.1343,0.63697,GOBP_REGULATION_OF_BONE_REMODELING,0.99999
GSE43955_1H_VS_60H_ACT_CD4_T...4,SET,185,-0.021198,-0.0021172,0.060491,0.63699,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...124,SET,157,-0.024719,-0.0022761,0.070524,0.63702,GOBP_NEGATIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.99999
SCHAVOLT_TARGETS_OF_TP53_AND...,SET,15,-0.067054,-0.0019159,0.19127,0.63704,SCHAVOLT_TARGETS_OF_TP53_AND_TP63,0.99999
GOBP_PRESYNAPSE_ORGANIZATION,SET,46,-0.049211,-0.0024603,0.14031,0.6371,GOBP_PRESYNAPSE_ORGANIZATION,0.99999
LEE_TARGETS_OF_PTCH1_AND_SUF...1,SET,80,-0.034125,-0.0022478,0.097278,0.63713,LEE_TARGETS_OF_PTCH1_AND_SUFU_DN,0.99999
GOBP_REGULATION_OF_CYTOKINET...,SET,7,-0.11245,-0.0021955,0.32056,0.63713,GOBP_REGULATION_OF_CYTOKINETIC_PROCESS,0.99999
IVANOVA_HEMATOPOIESIS_EARLY_...,SET,404,-0.014862,-0.0021803,0.042359,0.63715,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,0.99999
HP_CLOVERLEAF_SKULL,SET,8,-0.096245,-0.0020087,0.27425,0.63718,HP_CLOVERLEAF_SKULL,0.99999
HP_ANURIA,SET,11,-0.10276,-0.0025146,0.2928,0.63719,HP_ANURIA,0.99999
REACTOME_KSRP_KHSRP_BINDS_AN...,SET,16,-0.068637,-0.0020254,0.19555,0.6372,REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA,0.99999
GSE7348_UNSTIM_VS_TOLERIZED_...1,SET,144,-0.025003,-0.0022057,0.071225,0.63722,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,0.99999
REACTOME_SYNTHESIS_OF_PIPS_A...3,SET,16,-0.069021,-0.0020368,0.19655,0.63726,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...247,SET,951,-0.0098509,-0.0021833,0.028049,0.63728,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION,0.99999
MCCOLLUM_GELDANAMYCIN_RESIST...1,SET,7,-0.12378,-0.0024166,0.35241,0.63729,MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN,0.99999
ZWANG_CLASS_2_TRANSIENTLY_IN...,SET,47,-0.045043,-0.0022762,0.12824,0.63729,ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,0.99999
WAKASUGI_HAVE_ZNF143_BINDING...,SET,51,-0.035251,-0.0018554,0.10036,0.6373,WAKASUGI_HAVE_ZNF143_BINDING_SITES,0.99999
GOBP_REGULATION_OF_CARDIAC_M...1,SET,10,-0.106,-0.0024733,0.30178,0.6373,GOBP_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,0.99999
GOCC_PHAGOCYTIC_VESICLE_LUMEN,SET,5,-0.13401,-0.0022113,0.38134,0.63736,GOCC_PHAGOCYTIC_VESICLE_LUMEN,0.99999
GSE35543_IN_VITRO_ITREG_VS_C...2,SET,183,-0.021303,-0.0021163,0.060616,0.63737,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP,0.99999
HP_ALTERNATING_ESOTROPIA,SET,10,-0.096588,-0.0022537,0.27474,0.63741,HP_ALTERNATING_ESOTROPIA,0.99999
HP_ECTRODACTYLY,SET,66,-0.039136,-0.0023423,0.11127,0.63747,HP_ECTRODACTYLY,0.99999
GNF2_CD1D,SET,38,-0.051097,-0.0023223,0.14524,0.6375,GNF2_CD1D,0.99999
HP_11_PAIRS_OF_RIBS,SET,44,-0.044681,-0.0021848,0.12697,0.63754,HP_11_PAIRS_OF_RIBS,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...7,SET,168,-0.023798,-0.0022661,0.067602,0.63759,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN,0.99999
GOBP_MEIOTIC_METAPHASE_CHROM...,SET,3,-0.1644,-0.0021015,0.46683,0.63764,GOBP_MEIOTIC_METAPHASE_CHROMOSOME_ALIGNMENT,0.99999
GOCC_VESICLE_MEMBRANE,SET,1141,-0.0093051,-0.0022466,0.02642,0.63765,GOCC_VESICLE_MEMBRANE,0.99999
REACTOME_RESPIRATORY_SYNCYTI...3,SET,16,-0.067941,-0.0020049,0.19261,0.63786,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION,0.99999
GSE40666_NAIVE_VS_EFFECTOR_C...1,SET,185,-0.022982,-0.0022954,0.065151,0.63786,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,0.99999
GOCC_PROTEASOME_REGULATORY_P...2,SET,7,-0.10073,-0.0019665,0.28551,0.63788,GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX,0.99999
HP_LOW_FRUSTRATION_TOLERANCE,SET,22,-0.065435,-0.0022638,0.18547,0.63788,HP_LOW_FRUSTRATION_TOLERANCE,0.99999
HP_VERTEBRAL_WEDGING,SET,16,-0.07187,-0.0021208,0.20369,0.63789,HP_VERTEBRAL_WEDGING,0.99999
GOMF_INTRACELLULARLY_CALCIUM...,SET,20,-0.075503,-0.0024907,0.21398,0.6379,GOMF_INTRACELLULARLY_CALCIUM_GATED_CHLORIDE_CHANNEL_ACTIVITY,0.99999
GSE17721_0.5H_VS_12H_GARDIQU...2,SET,184,-0.020815,-0.0020735,0.058963,0.63796,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_UP,0.99999
GLI3_TARGET_GENES,SET,587,-0.012445,-0.0021894,0.03525,0.63797,GLI3_TARGET_GENES,0.99999
NABA_MATRISOME_HIGHLY_METAST...3,SET,18,-0.076046,-0.0023801,0.21537,0.63799,NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA,0.99999
KEGG_CHRONIC_MYELOID_LEUKEMIA,SET,70,-0.036285,-0.0022363,0.10275,0.638,KEGG_CHRONIC_MYELOID_LEUKEMIA,0.99999
HP_BRAIN_NEOPLASM,SET,16,-0.065712,-0.0019391,0.18605,0.63803,HP_BRAIN_NEOPLASM,0.99999
WP_FAS_LIGAND_PATHWAY_AND_ST...,SET,42,-0.04624,-0.0022092,0.13082,0.63812,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,0.99999
GCGSCMNTTT_UNKNOWN,SET,62,-0.03723,-0.0021599,0.10534,0.63812,GCGSCMNTTT_UNKNOWN,0.99999
MIR3922_5P,SET,92,-0.032169,-0.0022716,0.090997,0.63815,MIR3922_5P,0.99999
TGACCTTG_SF1_Q6,SET,214,-0.020794,-0.0022319,0.058787,0.63822,TGACCTTG_SF1_Q6,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_LAT...,SET,90,-0.034305,-0.0023961,0.096976,0.63823,HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL,0.99999
WATANABE_RECTAL_CANCER_RADIO...2,SET,96,-0.02854,-0.0020585,0.080656,0.63827,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,0.99999
MIR132_3P,SET,173,-0.022764,-0.0021994,0.064314,0.63831,MIR132_3P,0.99999
GOBP_REGULATION_OF_CELL_ACTI...,SET,578,-0.01342,-0.0023435,0.037916,0.63831,GOBP_REGULATION_OF_CELL_ACTIVATION,0.99999
AP1_C,SET,249,-0.019357,-0.002239,0.054677,0.63834,AP1_C,0.99999
REACTOME_SYNAPTIC_ADHESION_L...,SET,19,-0.069476,-0.0022339,0.19621,0.63836,REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES,0.99999
HP_LOWER_LIMB_SPASTICITY,SET,189,-0.021028,-0.0021226,0.059388,0.63836,HP_LOWER_LIMB_SPASTICITY,0.99999
HP_ABNORMALITY_OF_CORNEAL_TH...,SET,115,-0.028395,-0.0022404,0.080129,0.63847,HP_ABNORMALITY_OF_CORNEAL_THICKNESS,0.99999
GSE27786_CD8_TCELL_VS_NEUTRO...2,SET,175,-0.021674,-0.002106,0.061149,0.63849,GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP,0.99999
HP_PANCREATIC_ISLET_CELL_ADE...,SET,9,-0.10693,-0.0023671,0.3016,0.63854,HP_PANCREATIC_ISLET_CELL_ADENOMA,0.99999
HP_ABNORMALITY_OF_THE_DISTAL...6,SET,29,-0.053957,-0.0021428,0.15215,0.63856,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,0.99999
KEGG_ANTIGEN_PROCESSING_AND_...,SET,72,-0.042004,-0.0026254,0.11844,0.63857,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,0.99999
GSE41867_DAY8_EFFECTOR_VS_DA...4,SET,186,-0.021211,-0.0021242,0.059782,0.63863,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,0.99999
GOBP_MITOCHONDRION_LOCALIZAT...,SET,45,-0.045411,-0.0022455,0.12793,0.63869,GOBP_MITOCHONDRION_LOCALIZATION,0.99999
GOMF_MODIFIED_AMINO_ACID_BIN...,SET,91,-0.033808,-0.0023744,0.095195,0.63876,GOMF_MODIFIED_AMINO_ACID_BINDING,0.99999
ZNF37A_TARGET_GENES,SET,116,-0.028473,-0.0022562,0.080122,0.63884,ZNF37A_TARGET_GENES,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...12,SET,182,-0.022907,-0.0022695,0.064449,0.63886,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_UP,0.99999
TCCAGAT_MIR5165P,SET,96,-0.030614,-0.002208,0.086131,0.63887,TCCAGAT_MIR5165P,0.99999
GSE23505_IL6_IL1_VS_IL6_IL1_...2,SET,178,-0.022133,-0.0021689,0.062249,0.63891,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,0.99999
YU_BAP1_TARGETS,SET,29,-0.053954,-0.0021427,0.15174,0.63892,YU_BAP1_TARGETS,0.99999
GOMF_L_ASCORBIC_ACID_BINDING,SET,20,-0.067391,-0.0022232,0.18949,0.63895,GOMF_L_ASCORBIC_ACID_BINDING,0.99999
GSE37532_VISCERAL_ADIPOSE_TI...1,SET,89,-0.033351,-0.0023166,0.093763,0.63897,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_DN,0.99999
GOBP_MIRNA_PROCESSING,SET,40,-0.045881,-0.0021393,0.12891,0.63905,GOBP_MIRNA_PROCESSING,0.99999
FAN_OVARY_CL12_T_LYMPHOCYTE_...,SET,138,-0.026254,-0.0022677,0.073762,0.63905,FAN_OVARY_CL12_T_LYMPHOCYTE_NK_CELL_2,0.99999
GSE3039_CD4_TCELL_VS_B2_BCEL...2,SET,182,-0.023435,-0.0023218,0.065837,0.63906,GSE3039_CD4_TCELL_VS_B2_BCELL_UP,0.99999
HP_ABNORMAL_SENSORY_NERVE_CO...,SET,24,-0.059346,-0.0021444,0.16671,0.63907,HP_ABNORMAL_SENSORY_NERVE_CONDUCTION_VELOCITY,0.99999
HP_ABNORMAL_CIRCULATING_PORP...,SET,8,-0.10852,-0.0022648,0.30474,0.63912,HP_ABNORMAL_CIRCULATING_PORPHYRIN_CONCENTRATION,0.99999
GSE18281_CORTEX_VS_MEDULLA_T...1,SET,158,-0.024909,-0.0023009,0.069945,0.63912,GSE18281_CORTEX_VS_MEDULLA_THYMUS_DN,0.99999
HP_ABNORMAL_RAPID_EYE_MOVEME...,SET,13,-0.093488,-0.0024869,0.26251,0.63913,HP_ABNORMAL_RAPID_EYE_MOVEMENT_SLEEP,0.99999
MIR320E,SET,60,-0.041469,-0.0023669,0.11641,0.63916,MIR320E,0.99999
GOMF_CLATHRIN_BINDING,SET,53,-0.040933,-0.0021962,0.1149,0.63917,GOMF_CLATHRIN_BINDING,0.99999
GSE37416_12H_VS_48H_F_TULARE...2,SET,182,-0.02276,-0.0022549,0.063888,0.63917,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
HP_ANTI_SMOOTH_MUSCLE_ANTIBO...,SET,5,-0.13073,-0.0021572,0.3669,0.6392,HP_ANTI_SMOOTH_MUSCLE_ANTIBODY_POSITIVITY,0.99999
HP_ABNORMALITY_OF_OCULAR_SMO...,SET,64,-0.035093,-0.0020684,0.098476,0.63921,HP_ABNORMALITY_OF_OCULAR_SMOOTH_PURSUIT,0.99999
BROWNE_HCMV_INFECTION_30MIN_...2,SET,47,-0.046901,-0.0023701,0.1316,0.63923,BROWNE_HCMV_INFECTION_30MIN_UP,0.99999
GOBP_PYRIMIDINE_DEOXYRIBONUC...3,SET,6,-0.12976,-0.0023454,0.36408,0.63923,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.99999
MIR586,SET,256,-0.019512,-0.002288,0.054728,0.63927,MIR586,0.99999
GAVISH_3CA_METAPROGRAM_CD4_T...6,SET,44,-0.050128,-0.0024512,0.14055,0.63932,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_NAIVE_1,0.99999
MIR345_5P,SET,40,-0.049744,-0.0023194,0.13943,0.63936,MIR345_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...135,SET,9,-0.10687,-0.0023657,0.29943,0.63942,GOBP_POSITIVE_REGULATION_OF_CELL_MATURATION,0.99999
PID_LPA4_PATHWAY,SET,14,-0.087287,-0.0024095,0.24453,0.63944,PID_LPA4_PATHWAY,0.99999
GOBP_DNA_PROTECTION,SET,5,-0.13385,-0.0022087,0.37491,0.63946,GOBP_DNA_PROTECTION,0.99999
MIR3132,SET,62,-0.038231,-0.002218,0.10704,0.63951,MIR3132,0.99999
HP_ATROPHY_DEGENERATION_AFFE...2,SET,750,-0.010996,-0.0021767,0.030786,0.63952,HP_ATROPHY_DEGENERATION_AFFECTING_THE_CENTRAL_NERVOUS_SYSTEM,0.99999
REACTOME_REGULATION_OF_KIT_S...,SET,15,-0.082472,-0.0023565,0.23088,0.63953,REACTOME_REGULATION_OF_KIT_SIGNALING,0.99999
HP_DECREASED_LIBIDO,SET,11,-0.086822,-0.0021246,0.24306,0.63953,HP_DECREASED_LIBIDO,0.99999
WP_KENNEDY_PATHWAY_FROM_SPHI...,SET,13,-0.081791,-0.0021758,0.22884,0.63961,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,0.99999
GOBP_REGULATION_OF_CILIUM_AS...,SET,89,-0.032069,-0.0022275,0.089719,0.63961,GOBP_REGULATION_OF_CILIUM_ASSEMBLY,0.99999
GOCC_U4_SNRNP,SET,10,-0.08224,-0.0019189,0.23009,0.63961,GOCC_U4_SNRNP,0.99999
GOBP_RESPONSE_TO_ENDOGENOUS_...,SET,1522,-0.00844,-0.0023273,0.023612,0.63962,GOBP_RESPONSE_TO_ENDOGENOUS_STIMULUS,0.99999
HP_BASAL_GANGLIA_CYSTS,SET,6,-0.11107,-0.0020077,0.31045,0.63974,HP_BASAL_GANGLIA_CYSTS,0.99999
GOBP_REGULATION_OF_NEUROTRAN...1,SET,40,-0.050913,-0.002374,0.14227,0.63977,GOBP_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.99999
GOBP_GLUTAMINE_FAMILY_AMINO_...1,SET,14,-0.077282,-0.0021334,0.21592,0.6398,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_DOPAMINER...,SET,9,-0.11555,-0.0025579,0.32281,0.63981,GOBP_REGULATION_OF_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.99999
DESCARTES_FETAL_SPLEEN_ERYTH...,SET,53,-0.042897,-0.0023016,0.11979,0.63986,DESCARTES_FETAL_SPLEEN_ERYTHROBLASTS,0.99999
DELYS_THYROID_CANCER_UP,SET,412,-0.016011,-0.0023715,0.044653,0.64004,DELYS_THYROID_CANCER_UP,0.99999
GSE17721_0.5H_VS_4H_LPS_BMDC...2,SET,183,-0.021897,-0.0021753,0.060988,0.64021,GSE17721_0.5H_VS_4H_LPS_BMDC_UP,0.99999
GOMF_BMP_BINDING,SET,18,-0.076113,-0.0023822,0.21192,0.64026,GOMF_BMP_BINDING,0.99999
DESCARTES_FETAL_STOMACH_ERYT...,SET,86,-0.032833,-0.0022419,0.091413,0.64026,DESCARTES_FETAL_STOMACH_ERYTHROBLASTS,0.99999
MCDOWELL_ACUTE_LUNG_INJURY_UP,SET,43,-0.05137,-0.0024833,0.14301,0.64028,MCDOWELL_ACUTE_LUNG_INJURY_UP,0.99999
HP_LIPOATROPHY,SET,71,-0.037728,-0.0023418,0.105,0.64031,HP_LIPOATROPHY,0.99999
HP_VENTRICULOMEGALY,SET,641,-0.012111,-0.0022232,0.033698,0.64035,HP_VENTRICULOMEGALY,0.99999
GOBP_REGULATION_OF_MITOCHOND...10,SET,62,-0.039856,-0.0023123,0.11087,0.64039,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL,0.99999
REACTOME_ACTIVATED_NTRK2_SIG...4,SET,7,-0.12526,-0.0024454,0.34823,0.64046,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K,0.99999
GOBP_POSITIVE_REGULATION_OF_...132,SET,99,-0.033489,-0.0024527,0.09308,0.6405,GOBP_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,0.99999
GOMF_TELOMERASE_INHIBITOR_AC...,SET,5,-0.13559,-0.0022375,0.37686,0.6405,GOMF_TELOMERASE_INHIBITOR_ACTIVITY,0.99999
KEGG_NEUROACTIVE_LIGAND_RECE...,SET,252,-0.021677,-0.0025222,0.060238,0.64052,KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,0.99999
HOLLERN_MICROACINAR_BREAST_T...1,SET,14,-0.087851,-0.0024251,0.24412,0.64053,HOLLERN_MICROACINAR_BREAST_TUMOR_DN,0.99999
GOBP_CALCIUM_ION_HOMEOSTASIS,SET,302,-0.018922,-0.0024069,0.052567,0.64056,GOBP_CALCIUM_ION_HOMEOSTASIS,0.99999
FAN_OVARY_CL4_T_LYMPHOCYTE_N...,SET,212,-0.020957,-0.002239,0.058204,0.6406,FAN_OVARY_CL4_T_LYMPHOCYTE_NK_CELL_1,0.99999
HP_ABNORMAL_ACTIVITY_OF_MITO...,SET,125,-0.024749,-0.0020353,0.068731,0.64061,HP_ABNORMAL_ACTIVITY_OF_MITOCHONDRIAL_RESPIRATORY_CHAIN,0.99999
MIR7153_5P,SET,103,-0.02998,-0.0022393,0.08323,0.64065,MIR7153_5P,0.99999
GOBP_HISTAMINE_TRANSPORT,SET,15,-0.078691,-0.0022484,0.21843,0.64067,GOBP_HISTAMINE_TRANSPORT,0.99999
HP_CORNEAL_EROSION,SET,40,-0.049636,-0.0023144,0.13778,0.64067,HP_CORNEAL_EROSION,0.99999
MIR4733_5P,SET,83,-0.034851,-0.0023381,0.096716,0.6407,MIR4733_5P,0.99999
GSE3920_UNTREATED_VS_IFNA_TR...3,SET,179,-0.022463,-0.0022073,0.06232,0.64074,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN,0.99999
MIR656_5P,SET,32,-0.056732,-0.0023665,0.15735,0.64078,MIR656_5P,0.99999
MIR153_3P,SET,308,-0.018578,-0.002386,0.051471,0.64092,MIR153_3P,0.99999
HALLMARK_IL2_STAT5_SIGNALING,SET,187,-0.023866,-0.0023964,0.066112,0.64094,HALLMARK_IL2_STAT5_SIGNALING,0.99999
KEGG_MEDICUS_REFERENCE_CA2_C...1,SET,19,-0.06904,-0.0022199,0.19122,0.64096,KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY,0.99999
HP_SKIN_PICKING,SET,12,-0.097041,-0.0024802,0.26872,0.64099,HP_SKIN_PICKING,0.99999
GSE17721_4_VS_24H_CPG_BMDC_UP,SET,177,-0.023971,-0.0023423,0.066378,0.64099,GSE17721_4_VS_24H_CPG_BMDC_UP,0.99999
GSE23505_UNTREATED_VS_4DAY_I...5,SET,184,-0.022997,-0.0022907,0.063678,0.641,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_DN,0.99999
GSE29618_PRE_VS_DAY7_FLU_VAC...8,SET,175,-0.022962,-0.0022312,0.063577,0.64101,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP,0.99999
REACTOME_FORMATION_OF_WDR5_C...,SET,37,-0.046658,-0.0020925,0.1291,0.64111,REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,0.99999
KEGG_MEDICUS_PATHOGEN_SARS_C...3,SET,3,-0.26284,-0.0033597,0.72707,0.64114,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE,0.99999
HP_CHORIORETINAL_COLOBOMA,SET,40,-0.051159,-0.0023854,0.14152,0.64114,HP_CHORIORETINAL_COLOBOMA,0.99999
HP_SKIN_TAGS,SET,72,-0.036302,-0.002269,0.10041,0.64114,HP_SKIN_TAGS,0.99999
GOMF_ORGANIC_ACID_SODIUM_SYM...,SET,32,-0.056102,-0.0023403,0.15515,0.64117,GOMF_ORGANIC_ACID_SODIUM_SYMPORTER_ACTIVITY,0.99999
GOCC_LAMELLIPODIUM_MEMBRANE,SET,22,-0.066401,-0.0022973,0.18361,0.64119,GOCC_LAMELLIPODIUM_MEMBRANE,0.99999
HP_POOR_HEAD_CONTROL,SET,208,-0.020582,-0.0021784,0.056888,0.64124,HP_POOR_HEAD_CONTROL,0.99999
GOMF_TRANSMEMBRANE_EPHRIN_RE...,SET,15,-0.092579,-0.0026452,0.25586,0.64126,GOMF_TRANSMEMBRANE_EPHRIN_RECEPTOR_ACTIVITY,0.99999
GOBP_NUCLEOBASE_CONTAINING_S...1,SET,15,-0.083333,-0.0023811,0.23026,0.64129,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMAL_INTONATION,SET,59,-0.040878,-0.0023137,0.11294,0.64131,HP_ABNORMAL_INTONATION,0.99999
KYNG_DNA_DAMAGE_BY_UV,SET,51,-0.042875,-0.0022567,0.11842,0.64135,KYNG_DNA_DAMAGE_BY_UV,0.99999
HP_PICA,SET,8,-0.097463,-0.0020341,0.26916,0.64136,HP_PICA,0.99999
HP_LOWER_LIMB_AMYOTROPHY,SET,69,-0.03836,-0.0023473,0.10589,0.64141,HP_LOWER_LIMB_AMYOTROPHY,0.99999
ID2_TARGET_GENES,SET,872,-0.010658,-0.002267,0.029422,0.64142,ID2_TARGET_GENES,0.99999
UNTERMAN_IPF_VS_CTRL_MONOCYT...2,SET,11,-0.093426,-0.0022862,0.25786,0.64144,UNTERMAN_IPF_VS_CTRL_MONOCYTE_UP,0.99999
BIOCARTA_CYTOKINE_PATHWAY,SET,19,-0.076558,-0.0024617,0.21121,0.6415,BIOCARTA_CYTOKINE_PATHWAY,0.99999
LINDGREN_BLADDER_CANCER_CLUS...3,SET,118,-0.030807,-0.0024619,0.08498,0.64152,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,0.99999
HP_ACUTE_ENCEPHALOPATHY,SET,10,-0.10275,-0.0023974,0.28339,0.64153,HP_ACUTE_ENCEPHALOPATHY,0.99999
HP_NOCTURNAL_HYPOVENTILATION,SET,15,-0.073375,-0.0020965,0.20217,0.64167,HP_NOCTURNAL_HYPOVENTILATION,0.99999
GSE10211_UV_INACT_SENDAI_VS_...2,SET,141,-0.025939,-0.0022646,0.071472,0.64167,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP,0.99999
HP_HEPATOMEGALY,SET,572,-0.013136,-0.0022823,0.036188,0.64169,HP_HEPATOMEGALY,0.99999
GSE46606_IRF4_KO_VS_WT_CD40L...1,SET,168,-0.023452,-0.0022331,0.064602,0.6417,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_DN,0.99999
GOBP_CHEMOKINE_C_C_MOTIF_LIG...,SET,10,-0.10291,-0.0024011,0.28344,0.64172,GOBP_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,0.99999
MIR603,SET,150,-0.025667,-0.0023106,0.070688,0.64173,MIR603,0.99999
GSE9988_ANTI_TREM1_AND_LPS_V...2,SET,165,-0.025774,-0.0024325,0.070952,0.64179,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP,0.99999
GOBP_REGULATION_OF_ATTACHMEN...1,SET,9,-0.098305,-0.0021761,0.27048,0.64186,GOBP_REGULATION_OF_ATTACHMENT_OF_MITOTIC_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.99999
MIR182_3P,SET,61,-0.041622,-0.0023952,0.11448,0.64191,MIR182_3P,0.99999
GOBP_POSTSYNAPTIC_NEUROTRANS...,SET,26,-0.059692,-0.0022448,0.16411,0.64197,GOBP_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,0.99999
BIOCARTA_MAPK_PATHWAY,SET,79,-0.03522,-0.0023054,0.096818,0.64198,BIOCARTA_MAPK_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...61,SET,15,-0.079053,-0.0022588,0.21731,0.64198,GOBP_NEGATIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,0.99999
HP_EMG_MYOPATHIC_ABNORMALITI...,SET,116,-0.028306,-0.0022429,0.077798,0.64201,HP_EMG_MYOPATHIC_ABNORMALITIES,0.99999
GOBP_PHAGOSOME_ACIDIFICATION,SET,7,-0.13318,-0.0026002,0.36589,0.64207,GOBP_PHAGOSOME_ACIDIFICATION,0.99999
GOBP_MRNA_PROCESSING,SET,423,-0.013963,-0.0020949,0.038352,0.64209,GOBP_MRNA_PROCESSING,0.99999
GSE3565_DUSP1_VS_WT_SPLENOCY...1,SET,164,-0.024464,-0.0023019,0.067172,0.64214,GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN,0.99999
HP_ABNORMAL_THALAMUS_MORPHOL...,SET,53,-0.03956,-0.0021225,0.10858,0.64219,HP_ABNORMAL_THALAMUS_MORPHOLOGY,0.99999
HP_APNEIC_EPISODES_PRECIPITA...,SET,11,-0.0917,-0.002244,0.25169,0.6422,HP_APNEIC_EPISODES_PRECIPITATED_BY_ILLNESS_FATIGUE_STRESS,0.99999
GOMF_L_ALANINE_TRANSMEMBRANE...,SET,9,-0.10714,-0.0023717,0.29401,0.64222,GOMF_L_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOCC_ANNULATE_LAMELLAE,SET,5,-0.12604,-0.0020798,0.34565,0.64231,GOCC_ANNULATE_LAMELLAE,0.99999
PATIL_LIVER_CANCER,SET,585,-0.012751,-0.0022396,0.034957,0.64235,PATIL_LIVER_CANCER,0.99999
GSE25088_WT_VS_STAT6_KO_MACR...2,SET,178,-0.022684,-0.0022228,0.062176,0.64238,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN,0.99999
GOMF_ENZYME_ACTIVATOR_ACTIVI...,SET,540,-0.013631,-0.0023032,0.037358,0.6424,GOMF_ENZYME_ACTIVATOR_ACTIVITY,0.99999
GOZGIT_ESR1_TARGETS_UP,SET,130,-0.028451,-0.0023857,0.077961,0.64242,GOZGIT_ESR1_TARGETS_UP,0.99999
MIR659_3P,SET,204,-0.022613,-0.0023705,0.061948,0.64245,MIR659_3P,0.99999
MORF_ATOX1,SET,68,-0.033958,-0.0020629,0.092996,0.6425,MORF_ATOX1,0.99999
MIR27A_3P_MIR27B_3P,SET,570,-0.013613,-0.0023611,0.037263,0.64256,MIR27A_3P_MIR27B_3P,0.99999
GSE18281_MEDULLARY_THYMOCYTE...1,SET,167,-0.023602,-0.0022408,0.064594,0.64259,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN,0.99999
HP_NEUROPATHIC_ARTHROPATHY,SET,5,-0.12457,-0.0020556,0.34089,0.6426,HP_NEUROPATHIC_ARTHROPATHY,0.99999
HP_TROPHIC_CHANGES_RELATED_T...,SET,5,-0.12457,-0.0020556,0.34089,0.6426,HP_TROPHIC_CHANGES_RELATED_TO_PAIN,0.99999
GOCC_FILTRATION_DIAPHRAGM,SET,9,-0.11127,-0.002463,0.30446,0.64261,GOCC_FILTRATION_DIAPHRAGM,0.99999
REACTOME_FOXO_MEDIATED_TRANS...1,SET,63,-0.040726,-0.0023817,0.11142,0.64264,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,0.99999
REACTOME_SUMO_IS_TRANSFERRED...,SET,7,-0.10207,-0.0019928,0.27926,0.64264,REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9,0.99999
GOBP_REGULATION_OF_GLUTAMATE...4,SET,5,-0.14804,-0.0024428,0.40498,0.64265,GOBP_REGULATION_OF_GLUTAMATE_SECRETION_NEUROTRANSMISSION,0.99999
GOCC_CORTICAL_ENDOPLASMIC_RE...,SET,5,-0.12973,-0.0021407,0.35487,0.64266,GOCC_CORTICAL_ENDOPLASMIC_RETICULUM,0.99999
GOBP_RESPONSE_TO_HYDROSTATIC...,SET,7,-0.12555,-0.0024512,0.34339,0.64268,GOBP_RESPONSE_TO_HYDROSTATIC_PRESSURE,0.99999
GOMF_P_TYPE_CALCIUM_TRANSPOR...,SET,8,-0.096327,-0.0020104,0.26343,0.64269,GOMF_P_TYPE_CALCIUM_TRANSPORTER_ACTIVITY,0.99999
GSE18148_CBFB_KO_VS_WT_TREG_...1,SET,174,-0.025108,-0.0024328,0.068661,0.64269,GSE18148_CBFB_KO_VS_WT_TREG_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...283,SET,6,-0.12466,-0.0022533,0.3408,0.64273,GOBP_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH,0.99999
HP_AORTIC_ROOT_ANEURYSM,SET,64,-0.039138,-0.0023069,0.10691,0.64284,HP_AORTIC_ROOT_ANEURYSM,0.99999
MIR652_5P,SET,34,-0.052382,-0.0022522,0.14303,0.6429,MIR652_5P,0.99999
GSE11057_NAIVE_VS_EFF_MEMORY...2,SET,165,-0.024435,-0.0023062,0.066701,0.64294,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
VANDESLUIS_COMMD1_TARGETS_GR...4,SET,17,-0.081793,-0.0024879,0.22321,0.64298,VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN,0.99999
REACTOME_SARS_COV_2_HOST_INT...,SET,178,-0.023174,-0.0022708,0.063235,0.64299,REACTOME_SARS_COV_2_HOST_INTERACTIONS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...208,SET,5,-0.14934,-0.0024642,0.4074,0.64302,GOBP_NEGATIVE_REGULATION_OF_EPINEPHRINE_SECRETION,0.99999
GSE41867_DAY6_VS_DAY15_LCMV_...3,SET,142,-0.026304,-0.0023044,0.07176,0.64302,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,0.99999
PID_AR_PATHWAY,SET,57,-0.041472,-0.0023073,0.11313,0.64303,PID_AR_PATHWAY,0.99999
CAVARD_LIVER_CANCER_MALIGNAN...,SET,28,-0.064681,-0.0025241,0.17639,0.64307,CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN,0.99999
MIR133A_3P_MIR133B,SET,222,-0.020499,-0.0022406,0.055875,0.64314,MIR133A_3P_MIR133B,0.99999
PID_IL12_2PATHWAY,SET,60,-0.043886,-0.0025049,0.1196,0.64317,PID_IL12_2PATHWAY,0.99999
HP_OVERGROWTH,SET,37,-0.050618,-0.0022702,0.13792,0.64319,HP_OVERGROWTH,0.99999
HP_INFANTILE_SENSORINEURAL_H...,SET,5,-0.13442,-0.0022181,0.36597,0.6433,HP_INFANTILE_SENSORINEURAL_HEARING_IMPAIRMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...228,SET,38,-0.050892,-0.002313,0.13852,0.64333,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,0.99999
SU_KIDNEY,SET,12,-0.097856,-0.0025011,0.26632,0.64335,SU_KIDNEY,0.99999
GOBP_FAT_CELL_DIFFERENTIATION,SET,218,-0.022666,-0.0024552,0.061655,0.64342,GOBP_FAT_CELL_DIFFERENTIATION,0.99999
REACTOME_INTEGRATION_OF_ENER...,SET,106,-0.032207,-0.0024402,0.087587,0.64345,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,0.99999
GSE2770_IL12_ACT_VS_ACT_CD4_...5,SET,158,-0.024676,-0.0022794,0.06711,0.64345,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN,0.99999
CUI_DEVELOPING_HEART_VASCULA...,SET,178,-0.02506,-0.0024556,0.068154,0.64345,CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL,0.99999
GOBP_MYOBLAST_FUSION_INVOLVE...,SET,3,-0.21024,-0.0026874,0.57173,0.64346,GOBP_MYOBLAST_FUSION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...109,SET,13,-0.08721,-0.0023199,0.2371,0.6435,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPIRATION,0.99999
MIR3190_3P,SET,109,-0.029859,-0.002294,0.081138,0.64356,MIR3190_3P,0.99999
MIR548I,SET,442,-0.015263,-0.0023396,0.041454,0.64363,MIR548I,0.99999
HP_ABNORMAL_LIVER_MORPHOLOGY,SET,790,-0.01141,-0.0023155,0.030991,0.64363,HP_ABNORMAL_LIVER_MORPHOLOGY,0.99999
HP_ABNORMAL_ANKLE_MORPHOLOGY,SET,87,-0.034541,-0.0023722,0.093801,0.64365,HP_ABNORMAL_ANKLE_MORPHOLOGY,0.99999
WP_DEVELOPMENT_OF_URETERIC_C...,SET,57,-0.046736,-0.0026002,0.12689,0.64368,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,0.99999
GOCC_SMN_SM_PROTEIN_COMPLEX,SET,13,-0.077483,-0.0020612,0.21031,0.64372,GOCC_SMN_SM_PROTEIN_COMPLEX,0.99999
GOBP_PERIPHERAL_NERVOUS_SYST...3,SET,83,-0.035728,-0.0023969,0.096957,0.64375,GOBP_PERIPHERAL_NERVOUS_SYSTEM_DEVELOPMENT,0.99999
GOCC_PHAGOLYSOSOME,SET,7,-0.11136,-0.0021741,0.30213,0.64378,GOCC_PHAGOLYSOSOME,0.99999
GOBP_ANTERIOR_POSTERIOR_PATT...,SET,200,-0.024991,-0.0025942,0.067777,0.64383,GOBP_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION,0.99999
GOBP_GLUCOCORTICOID_METABOLI...,SET,24,-0.067845,-0.0024515,0.18397,0.64385,GOBP_GLUCOCORTICOID_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_PROTON_TR...,SET,12,-0.093854,-0.0023988,0.2545,0.64385,GOBP_REGULATION_OF_PROTON_TRANSPORT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...453,SET,6,-0.14164,-0.0025602,0.38402,0.64387,GOBP_NEGATIVE_REGULATION_OF_NOREPINEPHRINE_SECRETION,0.99999
HP_COMPLETE_OR_NEAR_COMPLETE...1,SET,7,-0.13921,-0.0027179,0.37741,0.64388,HP_COMPLETE_OR_NEAR_COMPLETE_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_TETANUS_VACCINE,0.99999
GOBP_REGULATION_OF_EXECUTION...,SET,22,-0.071632,-0.0024783,0.19412,0.64394,GOBP_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,0.99999
FARMER_BREAST_CANCER_CLUSTER...3,SET,13,-0.10163,-0.0027036,0.27536,0.64397,FARMER_BREAST_CANCER_CLUSTER_3,0.99999
MONTERO_THYROID_CANCER_POOR_...2,SET,12,-0.10213,-0.0026104,0.27671,0.64397,MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP,0.99999
GOBP_I_KAPPAB_PHOSPHORYLATION,SET,13,-0.09779,-0.0026014,0.26495,0.64397,GOBP_I_KAPPAB_PHOSPHORYLATION,0.99999
GSE10239_NAIVE_VS_KLRG1INT_E...2,SET,181,-0.023021,-0.0022746,0.062367,0.64398,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP,0.99999
BYSTRYKH_HEMATOPOIESIS_STEM_...5,SET,8,-0.11477,-0.0023952,0.3106,0.64412,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA,0.99999
GOBP_URETERIC_BUD_ELONGATION,SET,7,-0.11572,-0.0022592,0.31302,0.64419,GOBP_URETERIC_BUD_ELONGATION,0.99999
GSE39152_SPLEEN_CD103_NEG_VS...1,SET,188,-0.02338,-0.0023539,0.063245,0.64419,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN,0.99999
GOMF_PHOSPHATIDYLINOSITOL_3_...3,SET,35,-0.052412,-0.0022863,0.14169,0.64427,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_BINDING,0.99999
HASLINGER_B_CLL_WITH_CHROMOS...,SET,20,-0.066,-0.0021773,0.1784,0.64429,HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY,0.99999
HOLLEMAN_ASPARAGINASE_RESIST...4,SET,24,-0.05909,-0.0021351,0.1597,0.64431,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP,0.99999
MCBRYAN_TERMINAL_END_BUD_DN,SET,6,-0.14345,-0.002593,0.38771,0.64431,MCBRYAN_TERMINAL_END_BUD_DN,0.99999
GOBP_ACIDIC_AMINO_ACID_TRANS...,SET,65,-0.04223,-0.0025084,0.11412,0.64432,GOBP_ACIDIC_AMINO_ACID_TRANSPORT,0.99999
HOLLEMAN_VINCRISTINE_RESISTA...3,SET,16,-0.076834,-0.0022673,0.20759,0.64435,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN,0.99999
HP_HYPERCAPNIA,SET,12,-0.096425,-0.0024645,0.26041,0.64441,HP_HYPERCAPNIA,0.99999
CTACTGT_MIR199A,SET,172,-0.023829,-0.0022956,0.06434,0.64444,CTACTGT_MIR199A,0.99999
GSE33424_CD161_INT_VS_NEG_CD...2,SET,181,-0.02354,-0.0023259,0.063548,0.64447,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP,0.99999
GOBP_ESTABLISHMENT_OF_CELL_P...,SET,145,-0.026641,-0.0023583,0.071915,0.64448,GOBP_ESTABLISHMENT_OF_CELL_POLARITY,0.99999
HP_ABNORMAL_TESTIS_MORPHOLOGY,SET,832,-0.011045,-0.0022975,0.02981,0.64451,HP_ABNORMAL_TESTIS_MORPHOLOGY,0.99999
GSE20727_CTRL_VS_H2O2_TREATE...1,SET,174,-0.023518,-0.0022787,0.063452,0.64455,GSE20727_CTRL_VS_H2O2_TREATED_DC_DN,0.99999
REACTOME_PIWI_INTERACTING_RN...,SET,29,-0.05103,-0.0020266,0.13766,0.64456,REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS,0.99999
HP_CURVILINEAR_INTRACELLULAR...,SET,11,-0.09849,-0.0024102,0.26569,0.64457,HP_CURVILINEAR_INTRACELLULAR_ACCUMULATION_OF_AUTOFLUORESCENT_LIPOPIGMENT_STORAGE_MATERIAL,0.99999
GOBP_FATTY_ACID_BETA_OXIDATI...2,SET,11,-0.085304,-0.0020875,0.23009,0.64458,GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_DEHYDROGENASE,0.99999
GSE14308_TH17_VS_NATURAL_TRE...1,SET,179,-0.022709,-0.0022315,0.061253,0.64458,GSE14308_TH17_VS_NATURAL_TREG_DN,0.99999
REACTOME_NUCLEOTIDE_BIOSYNTH...,SET,12,-0.090127,-0.0023035,0.24305,0.64461,REACTOME_NUCLEOTIDE_BIOSYNTHESIS,0.99999
GOBP_REGULATION_OF_POSTSYNAP...5,SET,17,-0.083622,-0.0025435,0.22547,0.64464,GOBP_REGULATION_OF_POSTSYNAPTIC_DENSITY_ORGANIZATION,0.99999
HP_HYDROXYPROLINURIA,SET,9,-0.12829,-0.0028399,0.34576,0.64469,HP_HYDROXYPROLINURIA,0.99999
SRF_Q5_01,SET,203,-0.023051,-0.0024106,0.062125,0.6447,SRF_Q5_01,0.99999
GOBP_VASCULAR_PROCESS_IN_CIR...,SET,253,-0.021853,-0.0025477,0.058867,0.64476,GOBP_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM,0.99999
HP_ABNORMALLY_SHAPED_CARPAL_...,SET,7,-0.1281,-0.0025008,0.34472,0.6449,HP_ABNORMALLY_SHAPED_CARPAL_BONES,0.99999
NOURUZI_NEPC_ASCL1_TARGETS,SET,124,-0.031675,-0.0025944,0.085186,0.64499,NOURUZI_NEPC_ASCL1_TARGETS,0.99999
ZHAN_EARLY_DIFFERENTIATION_G...1,SET,41,-0.054033,-0.0025507,0.14527,0.64503,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,0.99999
HP_EEG_WITH_SPIKE_WAVE_COMPL...1,SET,88,-0.035738,-0.0024684,0.096034,0.6451,HP_EEG_WITH_SPIKE_WAVE_COMPLEXES,0.99999
HONMA_DOCETAXEL_RESISTANCE,SET,32,-0.057075,-0.0023808,0.15336,0.64511,HONMA_DOCETAXEL_RESISTANCE,0.99999
MIR499A_3P,SET,152,-0.027695,-0.0025096,0.074414,0.64512,MIR499A_3P,0.99999
REACTOME_RAS_PROCESSING,SET,21,-0.06882,-0.0023263,0.18485,0.64517,REACTOME_RAS_PROCESSING,0.99999
GOBP_RETROGRADE_AXONAL_TRANS...,SET,21,-0.069441,-0.0023473,0.18647,0.6452,GOBP_RETROGRADE_AXONAL_TRANSPORT,0.99999
GOCC_RIPOPTOSOME,SET,6,-0.15771,-0.0028507,0.42349,0.6452,GOCC_RIPOPTOSOME,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...10,SET,6,-0.11999,-0.0021689,0.32204,0.64527,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX,0.99999
GSE2706_UNSTIM_VS_2H_R848_DC...2,SET,172,-0.022771,-0.0021937,0.061098,0.64531,GSE2706_UNSTIM_VS_2H_R848_DC_UP,0.99999
REACTOME_INTERACTION_BETWEEN...,SET,30,-0.063422,-0.0025617,0.17013,0.64534,REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS,0.99999
GOBP_FACULTATIVE_HETEROCHROM...,SET,37,-0.053738,-0.0024101,0.14416,0.64534,GOBP_FACULTATIVE_HETEROCHROMATIN_FORMATION,0.99999
MIR4275,SET,139,-0.027323,-0.0023685,0.073292,0.64535,MIR4275,0.99999
GOCC_RNA_POLYMERASE_I_TRANSC...,SET,5,-0.12973,-0.0021407,0.34794,0.64537,GOCC_RNA_POLYMERASE_I_TRANSCRIPTION_REGULATOR_COMPLEX,0.99999
GOCC_RNA_POLYMERASE_TRANSCRI...,SET,5,-0.12973,-0.0021407,0.34794,0.64537,GOCC_RNA_POLYMERASE_TRANSCRIPTION_FACTOR_SL1_COMPLEX,0.99999
GOBP_PLACENTA_BLOOD_VESSEL_D...,SET,29,-0.062073,-0.0024652,0.16642,0.64542,GOBP_PLACENTA_BLOOD_VESSEL_DEVELOPMENT,0.99999
GOCC_ENZYME_ACTIVATOR_COMPLEX,SET,13,-0.076204,-0.0020271,0.2043,0.64542,GOCC_ENZYME_ACTIVATOR_COMPLEX,0.99999
REACTOME_DEFECTIVE_INTRINSIC...,SET,25,-0.066813,-0.0024639,0.17909,0.64545,REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,0.99999
KUUSELO_PANCREATIC_CANCER_19...,SET,31,-0.094611,-0.0038846,0.25353,0.64549,KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION,0.99999
GSE27786_LSK_VS_LIN_NEG_CELL...2,SET,179,-0.023765,-0.0023352,0.063678,0.6455,GSE27786_LSK_VS_LIN_NEG_CELL_UP,0.99999
HP_CONSPICUOUSLY_HAPPY_DISPO...,SET,5,-0.19355,-0.0031938,0.51858,0.64551,HP_CONSPICUOUSLY_HAPPY_DISPOSITION,0.99999
GSE360_LOW_DOSE_B_MALAYI_VS_...1,SET,184,-0.023724,-0.0023632,0.063564,0.64551,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,0.99999
HP_ABNORMAL_UVEA_MORPHOLOGY,SET,522,-0.014506,-0.002411,0.038856,0.64554,HP_ABNORMAL_UVEA_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...20,SET,27,-0.067028,-0.0025686,0.17948,0.6456,GOBP_NEGATIVE_REGULATION_OF_AMINE_TRANSPORT,0.99999
KEGG_MEDICUS_PATHOGEN_HCV_CO...3,SET,5,-0.14914,-0.0024609,0.3993,0.64561,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_PPARA_MEDIATED_TRANSCRIPTION,0.99999
GOBP_GLUTATHIONE_CATABOLIC_P...,SET,7,-0.12828,-0.0025044,0.34344,0.64561,GOBP_GLUTATHIONE_CATABOLIC_PROCESS,0.99999
GOLDRATH_NAIVE_VS_EFF_CD8_TC...2,SET,181,-0.022743,-0.0022471,0.060892,0.64561,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP,0.99999
GOBP_MAST_CELL_ACTIVATION_IN...,SET,52,-0.046102,-0.0024501,0.12342,0.64563,GOBP_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
WP_MFAP5_EFFECT_ON_PERMEABIL...,SET,17,-0.081025,-0.0024645,0.21689,0.64564,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,0.99999
HP_ERRATIC_MYOCLONUS,SET,4,-0.13101,-0.0019336,0.35064,0.64566,HP_ERRATIC_MYOCLONUS,0.99999
HP_LOWER_LIMB_JOINT_CONTRACT...,SET,197,-0.023134,-0.0023836,0.061913,0.64567,HP_LOWER_LIMB_JOINT_CONTRACTURE,0.99999
KIM_LIVER_CANCER_POOR_SURVIV...2,SET,21,-0.071433,-0.0024146,0.19116,0.64568,KIM_LIVER_CANCER_POOR_SURVIVAL_UP,0.99999
OUELLET_CULTURED_OVARIAN_CAN...2,SET,60,-0.039308,-0.0022435,0.10516,0.64572,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,0.99999
GSE3982_EOSINOPHIL_VS_CENT_M...1,SET,178,-0.02344,-0.0022969,0.062706,0.64572,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.99999
HALLMARK_P53_PATHWAY,SET,187,-0.022791,-0.0022885,0.060966,0.64573,HALLMARK_P53_PATHWAY,0.99999
FARMER_BREAST_CANCER_BASAL_V...,SET,292,-0.019159,-0.0023971,0.051248,0.64574,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,0.99999
MIR6734_5P,SET,63,-0.039161,-0.0022902,0.10468,0.64583,MIR6734_5P,0.99999
SREBP1_01,SET,140,-0.027022,-0.0023508,0.072236,0.64583,SREBP1_01,0.99999
GSE22886_DC_VS_MONOCYTE_UP,SET,186,-0.023549,-0.0023583,0.062931,0.64587,GSE22886_DC_VS_MONOCYTE_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_EX...1,SET,13,-0.083393,-0.0022184,0.22271,0.64596,GOBP_CELLULAR_RESPONSE_TO_EXOGENOUS_DSRNA,0.99999
MODULE_227,SET,14,-0.086283,-0.0023818,0.2304,0.64598,MODULE_227,0.99999
MODULE_194,SET,15,-0.080223,-0.0022922,0.2142,0.64599,MODULE_194,0.99999
MODULE_237,SET,54,-0.04203,-0.0022762,0.11221,0.646,MODULE_237,0.99999
MENON_FETAL_KIDNEY_8_CONNECT...,SET,223,-0.021492,-0.0023543,0.057374,0.64601,MENON_FETAL_KIDNEY_8_CONNECTING_TUBULE_CELLS,0.99999
HP_PULMONARY_INFILTRATES,SET,51,-0.049197,-0.0025894,0.13132,0.64603,HP_PULMONARY_INFILTRATES,0.99999
THAKAR_PBMC_INACTIVATED_INFL...9,SET,15,-0.07904,-0.0022584,0.21093,0.64607,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP,0.99999
GOBP_DIPHOSPHOINOSITOL_POLYP...,SET,2,-0.32129,-0.0033533,0.85726,0.64609,GOBP_DIPHOSPHOINOSITOL_POLYPHOSPHATE_METABOLIC_PROCESS,0.99999
GOMF_ENDOPOLYPHOSPHATASE_ACT...,SET,2,-0.32129,-0.0033533,0.85726,0.64609,GOMF_ENDOPOLYPHOSPHATASE_ACTIVITY,0.99999
GOBP_RIG_I_SIGNALING_PATHWAY,SET,22,-0.065964,-0.0022821,0.17598,0.64611,GOBP_RIG_I_SIGNALING_PATHWAY,0.99999
HP_CARDIAC_SHUNT,SET,14,-0.095847,-0.0026458,0.25569,0.64611,HP_CARDIAC_SHUNT,0.99999
GOMF_ALKALI_METAL_ION_BINDING,SET,19,-0.070779,-0.0022759,0.18879,0.64613,GOMF_ALKALI_METAL_ION_BINDING,0.99999
HP_CONCENTRIC_HYPERTROPHIC_C...,SET,7,-0.12867,-0.002512,0.34318,0.64614,HP_CONCENTRIC_HYPERTROPHIC_CARDIOMYOPATHY,0.99999
GSE45382_UNTREATED_VS_TGFB_T...2,SET,179,-0.02474,-0.002431,0.065976,0.64616,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP,0.99999
MIR1208,SET,119,-0.02922,-0.002345,0.077917,0.64617,MIR1208,0.99999
GSE7831_UNSTIM_VS_CPG_STIM_P...1,SET,175,-0.024595,-0.0023899,0.065568,0.64621,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...543,SET,9,-0.12757,-0.0028239,0.34001,0.64624,GOBP_POSITIVE_REGULATION_OF_NK_T_CELL_ACTIVATION,0.99999
GOBP_TOLL_LIKE_RECEPTOR_SIGN...,SET,68,-0.037348,-0.0022688,0.099539,0.64625,GOBP_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_INTERLEUKIN_12_MEDIATED...,SET,9,-0.1079,-0.0023884,0.28746,0.6463,GOBP_INTERLEUKIN_12_MEDIATED_SIGNALING_PATHWAY,0.99999
GSE22611_UNSTIM_VS_6H_MDP_ST...3,SET,180,-0.023574,-0.0023228,0.062786,0.64634,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.99999
GOBP_NEURAL_TUBE_FORMATION,SET,99,-0.031627,-0.0023163,0.084212,0.64638,GOBP_NEURAL_TUBE_FORMATION,0.99999
DESCARTES_FETAL_PANCREAS_VAS...,SET,54,-0.04767,-0.0025816,0.12691,0.6464,DESCARTES_FETAL_PANCREAS_VASCULAR_ENDOTHELIAL_CELLS,0.99999
LEIN_CHOROID_PLEXUS_MARKERS,SET,98,-0.033831,-0.0024652,0.090053,0.64642,LEIN_CHOROID_PLEXUS_MARKERS,0.99999
MIR1911_3P,SET,42,-0.052345,-0.0025009,0.13934,0.64642,MIR1911_3P,0.99999
GOCC_PLATELET_DENSE_TUBULAR_...2,SET,8,-0.10236,-0.0021364,0.27245,0.64643,GOCC_PLATELET_DENSE_TUBULAR_NETWORK_MEMBRANE,0.99999
HP_AGGRESSIVE_BEHAVIOR,SET,242,-0.020704,-0.0023614,0.055101,0.64644,HP_AGGRESSIVE_BEHAVIOR,0.99999
GOBP_LATERAL_MESODERM_MORPHO...,SET,5,-0.1566,-0.0025841,0.41674,0.64646,GOBP_LATERAL_MESODERM_MORPHOGENESIS,0.99999
GOCC_MICROVESICLE,SET,8,-0.12032,-0.0025111,0.32012,0.64649,GOCC_MICROVESICLE,0.99999
MODULE_222,SET,10,-0.10413,-0.0024297,0.27673,0.64664,MODULE_222,0.99999
GOBP_CELLULAR_RESPONSE_TO_PO...,SET,12,-0.10404,-0.0026592,0.27651,0.64664,GOBP_CELLULAR_RESPONSE_TO_POTASSIUM_ION,0.99999
CHIBA_RESPONSE_TO_TSA,SET,37,-0.053191,-0.0023855,0.14136,0.64665,CHIBA_RESPONSE_TO_TSA,0.99999
GOMF_CADMIUM_ION_BINDING,SET,5,-0.14928,-0.0024632,0.39669,0.64665,GOMF_CADMIUM_ION_BINDING,0.99999
GSE36078_WT_VS_IL1R_KO_LUNG_...3,SET,180,-0.024159,-0.0023805,0.064177,0.64671,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN,0.99999
GOBP_REGULATION_OF_INFLAMMAS...,SET,35,-0.05477,-0.0023892,0.14537,0.64682,GOBP_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_CELLULAR_RESPONSE_TO_IN...4,SET,8,-0.11778,-0.0024582,0.31256,0.64685,GOBP_CELLULAR_RESPONSE_TO_INSULIN_LIKE_GROWTH_FACTOR_STIMULUS,0.99999
MIR1184,SET,151,-0.025402,-0.0022943,0.067385,0.6469,MIR1184,0.99999
REACTOME_RETINOID_CYCLE_DISE...,SET,11,-0.097631,-0.0023891,0.25889,0.64695,REACTOME_RETINOID_CYCLE_DISEASE_EVENTS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...34,SET,26,-0.062228,-0.0023402,0.165,0.64696,HP_APLASIA_HYPOPLASIA_OF_THE_FIBULA,0.99999
HP_FEMUR_FRACTURE,SET,5,-0.11896,-0.0019629,0.31533,0.647,HP_FEMUR_FRACTURE,0.99999
GATA_C,SET,237,-0.021636,-0.0024424,0.057312,0.6471,GATA_C,0.99999
GOBP_CEREBELLAR_PURKINJE_CEL...2,SET,12,-0.096138,-0.0024572,0.25466,0.6471,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_FORMATION,0.99999
GOMF_SCAVENGER_RECEPTOR_ACTI...,SET,25,-0.063967,-0.0023589,0.16944,0.6471,GOMF_SCAVENGER_RECEPTOR_ACTIVITY,0.99999
REACTOME_SYNTHESIS_OF_GLYCOS...,SET,17,-0.075484,-0.002296,0.19989,0.64715,REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI,0.99999
GOBP_PEPTIDYL_THREONINE_MODI...,SET,100,-0.033059,-0.0024332,0.087535,0.64716,GOBP_PEPTIDYL_THREONINE_MODIFICATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...665,SET,6,-0.15381,-0.0027802,0.40718,0.64719,GOBP_NEGATIVE_REGULATION_OF_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS,0.99999
GOBP_ANTIGEN_PROCESSING_AND_...12,SET,17,-0.094889,-0.0028862,0.25117,0.6472,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_IB,0.99999
GOBP_REGULATION_OF_LIPOPHAGY,SET,5,-0.14891,-0.0024572,0.39416,0.6472,GOBP_REGULATION_OF_LIPOPHAGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...255,SET,29,-0.060098,-0.0023867,0.15905,0.64722,GOBP_POSITIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,0.99999
SRY_01,SET,210,-0.022833,-0.0024281,0.060409,0.64727,SRY_01,0.99999
GOCC_ACTOMYOSIN,SET,86,-0.036123,-0.0024666,0.095537,0.64732,GOCC_ACTOMYOSIN,0.99999
WAGSCHAL_EHMT2_TARGETS_UP,SET,10,-0.10701,-0.002497,0.28295,0.64736,WAGSCHAL_EHMT2_TARGETS_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...506,SET,813,-0.011704,-0.002408,0.030942,0.64738,GOBP_NEGATIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH,0.99999
WP_MECHANOREGULATION_AND_PAT...,SET,44,-0.051457,-0.0025162,0.13603,0.64739,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...1,SET,185,-0.023618,-0.002359,0.062404,0.64746,GSE22886_NAIVE_CD8_TCELL_VS_DC_DN,0.99999
MCBRYAN_PUBERTAL_BREAST_4_5W...2,SET,242,-0.022835,-0.0026045,0.060325,0.64748,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,0.99999
GALIE_TUMOR_ANGIOGENESIS,SET,7,-0.13335,-0.0026033,0.35213,0.64753,GALIE_TUMOR_ANGIOGENESIS,0.99999
GSE32986_UNSTIM_VS_GMCSF_AND...4,SET,180,-0.022534,-0.0022203,0.059508,0.64753,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.99999
GOMF_CROSSOVER_JUNCTION_DNA_...,SET,7,-0.10918,-0.0021316,0.28828,0.64755,GOMF_CROSSOVER_JUNCTION_DNA_ENDONUCLEASE_ACTIVITY,0.99999
REACTOME_PRESYNAPTIC_FUNCTIO...,SET,21,-0.074285,-0.002511,0.19614,0.64756,REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS,0.99999
GOMF_SEMAPHORIN_RECEPTOR_ACT...,SET,10,-0.1197,-0.0027929,0.31599,0.64758,GOMF_SEMAPHORIN_RECEPTOR_ACTIVITY,0.99999
GCM_NF2,SET,266,-0.018633,-0.0022266,0.049159,0.64767,GCM_NF2,0.99999
WP_PDGF_PATHWAY,SET,38,-0.051243,-0.002329,0.13516,0.6477,WP_PDGF_PATHWAY,0.99999
LET_7A_5P_LET_7C_5P_LET_7E_5P,SET,360,-0.017484,-0.0024242,0.046112,0.64771,LET_7A_5P_LET_7C_5P_LET_7E_5P,0.99999
REACTOME_HDR_THROUGH_SINGLE_...,SET,36,-0.049405,-0.0021857,0.1303,0.64772,REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,0.99999
DESCARTES_FETAL_LUNG_MYELOID...,SET,143,-0.029556,-0.0025984,0.077949,0.64772,DESCARTES_FETAL_LUNG_MYELOID_CELLS,0.99999
REACTOME_ZYGOTIC_GENOME_ACTI...,SET,13,-0.093828,-0.002496,0.24738,0.64776,REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA,0.99999
HP_LETHARGY,SET,191,-0.022954,-0.0023291,0.060477,0.64786,HP_LETHARGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...274,SET,7,-0.10526,-0.002055,0.27729,0.64788,GOBP_NEGATIVE_REGULATION_OF_HEPATOCYTE_APOPTOTIC_PROCESS,0.99999
BLANCO_MELO_INFLUENZA_A_INFE...1,SET,101,-0.030035,-0.0022217,0.079115,0.64789,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN,0.99999
GOBP_DETOXIFICATION_OF_INORG...,SET,20,-0.091515,-0.003019,0.24107,0.64789,GOBP_DETOXIFICATION_OF_INORGANIC_COMPOUND,0.99999
GOBP_STRESS_INDUCED_PREMATUR...,SET,7,-0.10139,-0.0019795,0.26704,0.64791,GOBP_STRESS_INDUCED_PREMATURE_SENESCENCE,0.99999
HP_CHRONIC_LYMPHATIC_LEUKEMIA,SET,14,-0.086547,-0.0023891,0.22794,0.64791,HP_CHRONIC_LYMPHATIC_LEUKEMIA,0.99999
HP_ABNORMALITY_OF_MULTIPLE_C...,SET,165,-0.024893,-0.0023493,0.06555,0.64793,HP_ABNORMALITY_OF_MULTIPLE_CELL_LINEAGES_IN_THE_BONE_MARROW,0.99999
GOBP_PEPTIDYL_PROLINE_MODIFI...,SET,29,-0.053961,-0.002143,0.14207,0.64795,GOBP_PEPTIDYL_PROLINE_MODIFICATION,0.99999
WU_ALZHEIMER_DISEASE_UP,SET,9,-0.10863,-0.0024047,0.28581,0.64805,WU_ALZHEIMER_DISEASE_UP,0.99999
REACTOME_PHYSIOLOGICAL_FACTO...,SET,14,-0.093094,-0.0025698,0.2449,0.64807,REACTOME_PHYSIOLOGICAL_FACTORS,0.99999
DESCARTES_FETAL_HEART_SMOOTH...,SET,36,-0.059467,-0.0026308,0.15637,0.64813,DESCARTES_FETAL_HEART_SMOOTH_MUSCLE_CELLS,0.99999
GSE21360_PRIMARY_VS_QUATERNA...2,SET,157,-0.027596,-0.0025411,0.072553,0.64816,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.99999
REACTOME_CLASS_I_PEROXISOMAL...,SET,18,-0.068164,-0.0021334,0.17916,0.6482,REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT,0.99999
SERVITJA_ISLET_HNF1A_TARGETS...2,SET,154,-0.028427,-0.0025927,0.074684,0.64826,SERVITJA_ISLET_HNF1A_TARGETS_UP,0.99999
HP_ABNORMAL_RENAL_TUBULE_MOR...,SET,74,-0.037555,-0.0023795,0.098657,0.64827,HP_ABNORMAL_RENAL_TUBULE_MORPHOLOGY,0.99999
RASHI_RESPONSE_TO_IONIZING_R...1,SET,36,-0.053795,-0.0023799,0.14128,0.64831,RASHI_RESPONSE_TO_IONIZING_RADIATION_1,0.99999
GSE33292_DN3_THYMOCYTE_VS_TC...2,SET,154,-0.024293,-0.0022157,0.063782,0.64835,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_UP,0.99999
KEGG_MEDICUS_VARIANT_TMPRSS2...,SET,7,-0.14058,-0.0027446,0.36908,0.64836,KEGG_MEDICUS_VARIANT_TMPRSS2_ERG_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.99999
REACTOME_CELLULAR_RESPONSE_T...1,SET,191,-0.022801,-0.0023136,0.059855,0.64837,REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,0.99999
MIR4279,SET,198,-0.024211,-0.0025008,0.063547,0.6484,MIR4279,0.99999
MORF_RFC5,SET,72,-0.036179,-0.0022613,0.094951,0.64841,MORF_RFC5,0.99999
MIR329_3P,SET,106,-0.033716,-0.0025546,0.088444,0.64847,MIR329_3P,0.99999
GSE11864_CSF1_IFNG_VS_CSF1_P...1,SET,161,-0.025729,-0.0023989,0.067494,0.64847,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN,0.99999
GOBP_RESPONSE_TO_HORMONE,SET,816,-0.012056,-0.0024847,0.031622,0.64849,GOBP_RESPONSE_TO_HORMONE,0.99999
GOBP_WOUND_HEALING_SPREADING...,SET,26,-0.064204,-0.0024145,0.1684,0.64849,GOBP_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,0.99999
GOBP_POSITIVE_REGULATION_OF_...794,SET,18,-0.082626,-0.002586,0.21669,0.64851,GOBP_POSITIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,0.99999
GNF2_RAD23A,SET,60,-0.041504,-0.0023689,0.10884,0.64852,GNF2_RAD23A,0.99999
GOBP_NEGATIVE_REGULATION_OF_...636,SET,11,-0.10497,-0.0025688,0.27508,0.64862,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.99999
WP_UREA_CYCLE_AND_ASSOCIATED...,SET,23,-0.06633,-0.0023463,0.17381,0.64863,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,0.99999
GOBP_ACTIN_MYOSIN_FILAMENT_S...,SET,15,-0.085644,-0.0024471,0.22436,0.64866,GOBP_ACTIN_MYOSIN_FILAMENT_SLIDING,0.99999
GOBP_GAMMA_AMINOBUTYRIC_ACID...6,SET,19,-0.085975,-0.0027645,0.22522,0.64867,GOBP_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT,0.99999
MIR6817_3P,SET,203,-0.023976,-0.0025072,0.062797,0.64869,MIR6817_3P,0.99999
BUSSLINGER_DUODENAL_MX_CELLS,SET,10,-0.10735,-0.0025048,0.28112,0.64872,BUSSLINGER_DUODENAL_MX_CELLS,0.99999
GSE11057_PBMC_VS_MEM_CD4_TCE...2,SET,178,-0.026139,-0.0025614,0.068441,0.64874,GSE11057_PBMC_VS_MEM_CD4_TCELL_UP,0.99999
HP_PANHYPOPITUITARISM,SET,25,-0.063777,-0.0023519,0.16687,0.64884,HP_PANHYPOPITUITARISM,0.99999
REACTOME_DOPAMINE_RECEPTORS,SET,5,-0.16736,-0.0027617,0.43782,0.64887,REACTOME_DOPAMINE_RECEPTORS,0.99999
GOMF_DOPAMINE_NEUROTRANSMITT...,SET,5,-0.16736,-0.0027617,0.43782,0.64887,GOMF_DOPAMINE_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.99999
GOBP_CYTOLYSIS_BY_HOST_OF_SY...,SET,6,-0.13368,-0.0024164,0.34954,0.64893,GOBP_CYTOLYSIS_BY_HOST_OF_SYMBIONT_CELLS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...222,SET,8,-0.11461,-0.0023921,0.29968,0.64894,GOBP_NEGATIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,0.99999
GOBP_NEURONAL_ION_CHANNEL_CL...,SET,12,-0.096308,-0.0024615,0.25172,0.64899,GOBP_NEURONAL_ION_CHANNEL_CLUSTERING,0.99999
HP_ABNORMAL_LUNG_LOBATION,SET,37,-0.054465,-0.0024427,0.14233,0.64901,HP_ABNORMAL_LUNG_LOBATION,0.99999
REACTOME_UPTAKE_AND_FUNCTION...2,SET,6,-0.12463,-0.0022528,0.32568,0.64902,REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN,0.99999
MORF_IFNA1,SET,175,-0.025868,-0.0025136,0.067591,0.64903,MORF_IFNA1,0.99999
GOCC_EXTERNAL_ENCAPSULATING_...,SET,518,-0.015652,-0.0025919,0.040898,0.64903,GOCC_EXTERNAL_ENCAPSULATING_STRUCTURE,0.99999
GOBP_FATTY_ACID_ALPHA_OXIDAT...,SET,8,-0.12349,-0.0025773,0.3225,0.6491,GOBP_FATTY_ACID_ALPHA_OXIDATION,0.99999
GOCC_STEREOCILIA_ANKLE_LINK_...,SET,5,-0.15208,-0.0025096,0.39713,0.64912,GOCC_STEREOCILIA_ANKLE_LINK_COMPLEX,0.99999
GOBP_POSITIVE_REGULATION_OF_...203,SET,5,-0.14618,-0.0024122,0.3816,0.64916,GOBP_POSITIVE_REGULATION_OF_DEOXYRIBONUCLEASE_ACTIVITY,0.99999
GSE360_L_DONOVANI_VS_L_MAJOR...1,SET,177,-0.024142,-0.0023591,0.063021,0.64917,GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN,0.99999
HP_ABNORMALITY_OF_VISION,SET,1184,-0.0097907,-0.0024049,0.025553,0.64919,HP_ABNORMALITY_OF_VISION,0.99999
SWEET_KRAS_TARGETS_DN,SET,56,-0.047303,-0.0026086,0.12342,0.64923,SWEET_KRAS_TARGETS_DN,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...39,SET,14,-0.090526,-0.002499,0.23616,0.64926,HP_APLASIA_HYPOPLASIA_OF_THE_LENS,0.99999
GSE27241_WT_VS_RORGT_KO_TH17...4,SET,138,-0.027144,-0.0023446,0.070801,0.64928,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP,0.99999
GOMF_PHOSPHATASE_REGULATOR_A...,SET,92,-0.034042,-0.0024039,0.08878,0.6493,GOMF_PHOSPHATASE_REGULATOR_ACTIVITY,0.99999
BIOCARTA_HSWI_SNF_PATHWAY,SET,12,-0.086993,-0.0022234,0.22686,0.64931,BIOCARTA_HSWI_SNF_PATHWAY,0.99999
HP_MACULAR_EDEMA,SET,32,-0.059114,-0.0024659,0.15416,0.64931,HP_MACULAR_EDEMA,0.99999
MEISSNER_BRAIN_HCP_WITH_H3K4...1,SET,16,-0.083188,-0.0024548,0.21692,0.64932,MEISSNER_BRAIN_HCP_WITH_H3K4ME2,0.99999
HP_BROAD_EYEBROW,SET,23,-0.066846,-0.0023646,0.17431,0.64932,HP_BROAD_EYEBROW,0.99999
HP_THYROTOXICOSIS_WITH_DIFFU...,SET,4,-0.17678,-0.0026092,0.4608,0.64938,HP_THYROTOXICOSIS_WITH_DIFFUSE_GOITER,0.99999
YTCCCRNNAGGY_UNKNOWN,SET,59,-0.0419,-0.0023715,0.10915,0.64947,YTCCCRNNAGGY_UNKNOWN,0.99999
GSE1460_DP_THYMOCYTE_VS_NAIV...4,SET,162,-0.024674,-0.0023076,0.064249,0.64952,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,0.99999
HP_ANTERIOR_CHAMBER_SYNECHIAE,SET,27,-0.071027,-0.0027219,0.18493,0.64953,HP_ANTERIOR_CHAMBER_SYNECHIAE,0.99999
MIR4254,SET,92,-0.034852,-0.002461,0.090701,0.6496,MIR4254,0.99999
WATANABE_ULCERATIVE_COLITIS_...1,SET,14,-0.09222,-0.0025457,0.23999,0.64961,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN,0.99999
GOBP_T_CELL_MEDIATED_CYTOTOX...,SET,56,-0.050671,-0.0027944,0.13184,0.64963,GOBP_T_CELL_MEDIATED_CYTOTOXICITY,0.99999
chr6q25,SET,67,-0.086813,-0.005235,0.22579,0.64969,chr6q25,0.99999
GOBP_CELLULAR_RESPONSE_TO_NI...3,SET,11,-0.099829,-0.0024429,0.25964,0.64969,GOBP_CELLULAR_RESPONSE_TO_NITROGEN_LEVELS,0.99999
GOBP_TYPE_III_INTERFERON_PRO...,SET,3,-0.16947,-0.0021662,0.44064,0.64973,GOBP_TYPE_III_INTERFERON_PRODUCTION,0.99999
GSE7348_LPS_VS_TOLERIZED_AND...2,SET,170,-0.024603,-0.0023565,0.063969,0.64973,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,0.99999
WP_4P163_COPY_NUMBER_VARIATI...,SET,27,-0.061063,-0.0023401,0.15875,0.64975,WP_4P163_COPY_NUMBER_VARIATION,0.99999
GOBP_PYRIMIDINE_NUCLEOTIDE_C...,SET,21,-0.071363,-0.0024123,0.1855,0.64977,GOBP_PYRIMIDINE_NUCLEOTIDE_CATABOLIC_PROCESS,0.99999
WP_NAD_METABOLISM,SET,15,-0.083345,-0.0023814,0.21657,0.64982,WP_NAD_METABOLISM,0.99999
GSE17974_0H_VS_1H_IN_VITRO_A...2,SET,159,-0.025305,-0.0023448,0.065748,0.64984,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP,0.99999
HP_HYPERSOMNIA,SET,15,-0.089117,-0.0025463,0.23151,0.64986,HP_HYPERSOMNIA,0.99999
GOCC_POSTSYNAPTIC_CYTOSOL,SET,13,-0.090242,-0.0024006,0.23437,0.6499,GOCC_POSTSYNAPTIC_CYTOSOL,0.99999
GOBP_CONSTITUTIVE_SECRETORY_...,SET,7,-0.12705,-0.0024804,0.3299,0.64992,GOBP_CONSTITUTIVE_SECRETORY_PATHWAY,0.99999
GOCC_BRCA1_A_COMPLEX,SET,5,-0.12335,-0.0020354,0.32019,0.64996,GOCC_BRCA1_A_COMPLEX,0.99999
GOBP_MYOBLAST_MIGRATION,SET,12,-0.092492,-0.002364,0.24008,0.64997,GOBP_MYOBLAST_MIGRATION,0.99999
GSE411_100MIN_VS_400MIN_IL6_...4,SET,187,-0.023175,-0.002327,0.060156,0.64997,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,0.99999
MIR554,SET,16,-0.081541,-0.0024062,0.21164,0.64998,MIR554,0.99999
GOBP_TRABECULA_MORPHOGENESIS,SET,46,-0.053554,-0.0026774,0.13896,0.65003,GOBP_TRABECULA_MORPHOGENESIS,0.99999
DORN_ADENOVIRUS_INFECTION_48...2,SET,12,-0.094704,-0.0024205,0.2456,0.6501,DORN_ADENOVIRUS_INFECTION_48HR_UP,0.99999
GSE11961_GERMINAL_CENTER_BCE...2,SET,179,-0.025115,-0.0024679,0.065135,0.6501,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.99999
GOBP_REGULATION_OF_CAVEOLIN_...,SET,6,-0.14446,-0.0026112,0.37459,0.65012,GOBP_REGULATION_OF_CAVEOLIN_MEDIATED_ENDOCYTOSIS,0.99999
GOBP_FOREBRAIN_RADIAL_GLIAL_...,SET,7,-0.13066,-0.002551,0.3387,0.65017,GOBP_FOREBRAIN_RADIAL_GLIAL_CELL_DIFFERENTIATION,0.99999
MODULE_118,SET,366,-0.017733,-0.0024788,0.045964,0.65018,MODULE_118,0.99999
HP_ACROMICRIA,SET,8,-0.1417,-0.0029573,0.36727,0.65018,HP_ACROMICRIA,0.99999
GOCC_NUCLEAR_INNER_MEMBRANE,SET,48,-0.045633,-0.0023304,0.11825,0.65021,GOCC_NUCLEAR_INNER_MEMBRANE,0.99999
SESTO_RESPONSE_TO_UV_C0,SET,98,-0.032066,-0.0023366,0.083091,0.65022,SESTO_RESPONSE_TO_UV_C0,0.99999
GOBP_REGULATION_OF_PROGRAMME...1,SET,1346,-0.0094108,-0.002453,0.024374,0.65028,GOBP_REGULATION_OF_PROGRAMMED_CELL_DEATH,0.99999
REACTOME_G0_AND_EARLY_G1,SET,27,-0.058643,-0.0022473,0.15186,0.65031,REACTOME_G0_AND_EARLY_G1,0.99999
GOBP_PROTEIN_HETEROTETRAMERI...,SET,15,-0.075591,-0.0021599,0.19572,0.65033,GOBP_PROTEIN_HETEROTETRAMERIZATION,0.99999
REACTOME_FIBRONECTIN_MATRIX_...,SET,6,-0.15284,-0.0027627,0.39571,0.65034,REACTOME_FIBRONECTIN_MATRIX_FORMATION,0.99999
HP_SHORT_LOWER_LIMBS,SET,12,-0.094362,-0.0024117,0.24426,0.65036,HP_SHORT_LOWER_LIMBS,0.99999
GOBP_REGULATION_OF_HEAT_GENE...,SET,13,-0.10269,-0.0027316,0.26581,0.65037,GOBP_REGULATION_OF_HEAT_GENERATION,0.99999
GSE360_T_GONDII_VS_B_MALAYI_...5,SET,181,-0.024333,-0.0024042,0.062972,0.6504,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...2,SET,154,-0.027975,-0.0025514,0.072391,0.65041,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,0.99999
HP_DISTAL_MUSCLE_WEAKNESS,SET,205,-0.022422,-0.0023562,0.057979,0.65052,HP_DISTAL_MUSCLE_WEAKNESS,0.99999
GOCC_MRNA_CLEAVAGE_FACTOR_CO...,SET,22,-0.06718,-0.0023242,0.17369,0.65054,GOCC_MRNA_CLEAVAGE_FACTOR_COMPLEX,0.99999
GSE3203_UNTREATED_VS_IFNB_TR...2,SET,169,-0.024702,-0.0023591,0.063866,0.65054,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP,0.99999
GOMF_PROTEIN_TYROSINE_KINASE...1,SET,29,-0.068695,-0.0027281,0.17755,0.65058,GOMF_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,0.99999
ZNF816_TARGET_GENES,SET,419,-0.016503,-0.0024645,0.042625,0.65068,ZNF816_TARGET_GENES,0.99999
HP_LIMITED_PRONATION_SUPINAT...,SET,11,-0.11509,-0.0028165,0.29728,0.65068,HP_LIMITED_PRONATION_SUPINATION_OF_FOREARM,0.99999
GOBP_SYNAPTIC_VESICLE_COATING,SET,5,-0.14307,-0.0023608,0.36947,0.65071,GOBP_SYNAPTIC_VESICLE_COATING,0.99999
GOBP_ZYMOGEN_ACTIVATION,SET,51,-0.049366,-0.0025983,0.12747,0.65072,GOBP_ZYMOGEN_ACTIVATION,0.99999
GOMF_ENDOPEPTIDASE_REGULATOR...,SET,168,-0.028641,-0.0027273,0.073929,0.65077,GOMF_ENDOPEPTIDASE_REGULATOR_ACTIVITY,0.99999
GOBP_REGULATION_OF_HORMONE_M...,SET,38,-0.057075,-0.002594,0.14731,0.65078,GOBP_REGULATION_OF_HORMONE_METABOLIC_PROCESS,0.99999
HP_ABDOMINAL_PAIN,SET,308,-0.019563,-0.0025126,0.050481,0.65081,HP_ABDOMINAL_PAIN,0.99999
NKX25_02,SET,232,-0.023195,-0.002591,0.059847,0.65083,NKX25_02,0.99999
REACTOME_FGFR2C_LIGAND_BINDI...,SET,12,-0.11027,-0.0028183,0.28445,0.65086,REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION,0.99999
HP_ABNORMAL_URINE_PHOSPHATE_...,SET,26,-0.066777,-0.0025113,0.17223,0.65088,HP_ABNORMAL_URINE_PHOSPHATE_CONCENTRATION,0.99999
GSE15659_NAIVE_CD4_TCELL_VS_...6,SET,156,-0.026164,-0.0024016,0.067458,0.65094,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP,0.99999
GOBP_MUSCULAR_SEPTUM_MORPHOG...,SET,5,-0.18309,-0.0030212,0.47198,0.65096,GOBP_MUSCULAR_SEPTUM_MORPHOGENESIS,0.99999
MIR4263,SET,240,-0.021962,-0.0024946,0.056586,0.65103,MIR4263,0.99999
MARIADASON_REGULATED_BY_HIST...1,SET,37,-0.056471,-0.0025326,0.14548,0.65105,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,0.99999
GOMF_GTPASE_INHIBITOR_ACTIVI...,SET,12,-0.092873,-0.0023737,0.23922,0.65107,GOMF_GTPASE_INHIBITOR_ACTIVITY,0.99999
GOBP_GONADOTROPIN_SECRETION,SET,17,-0.089141,-0.0027114,0.22958,0.65109,GOBP_GONADOTROPIN_SECRETION,0.99999
PDGF_ERK_DN.V1_UP,SET,125,-0.028004,-0.0023029,0.072119,0.6511,PDGF_ERK_DN.V1_UP,0.99999
MIR383_5P,SET,70,-0.038843,-0.002394,0.10001,0.65113,MIR383_5P,0.99999
chr17p13,SET,218,-0.051514,-0.0055802,0.13259,0.65119,chr17p13,0.99999
MIR3690,SET,52,-0.046836,-0.0024891,0.12051,0.65122,MIR3690,0.99999
CHOP_01,SET,207,-0.023743,-0.0025069,0.061086,0.65124,CHOP_01,0.99999
BUSSLINGER_GASTRIC_NECK_CELLS,SET,34,-0.063089,-0.0027126,0.16232,0.65124,BUSSLINGER_GASTRIC_NECK_CELLS,0.99999
GSE3982_EOSINOPHIL_VS_NEUTRO...1,SET,170,-0.025578,-0.0024499,0.065784,0.65129,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN,0.99999
GGCGGCA_MIR371,SET,5,-0.13695,-0.0022598,0.35221,0.6513,GGCGGCA_MIR371,0.99999
DESCARTES_FETAL_LIVER_LYMPHO...,SET,90,-0.038492,-0.0026885,0.098952,0.65136,DESCARTES_FETAL_LIVER_LYMPHOID_CELLS,0.99999
GOCC_ENDOPLASMIC_RETICULUM_T...2,SET,4,-0.15548,-0.0022949,0.39964,0.65138,GOCC_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_MEMBRANE,0.99999
GSE24634_TEFF_VS_TCONV_DAY3_...1,SET,169,-0.026353,-0.0025169,0.067736,0.65138,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN,0.99999
TAATTA_CHX10_01,SET,730,-0.013197,-0.0025788,0.033916,0.6514,TAATTA_CHX10_01,0.99999
GOBP_HISTAMINE_SECRETION,SET,12,-0.090983,-0.0023254,0.23376,0.65144,GOBP_HISTAMINE_SECRETION,0.99999
REACTOME_PROTEIN_PROTEIN_INT...,SET,77,-0.04004,-0.0025877,0.10286,0.65146,REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,0.99999
GOMF_VASCULAR_ENDOTHELIAL_GR...4,SET,12,-0.10153,-0.002595,0.2608,0.65147,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_BINDING,0.99999
MIR4684_3P,SET,114,-0.033584,-0.0026383,0.086247,0.6515,MIR4684_3P,0.99999
AATGGAG_MIR136,SET,68,-0.040237,-0.0024443,0.10332,0.65153,AATGGAG_MIR136,0.99999
HP_ABNORMAL_INTERNAL_CAROTID...,SET,10,-0.12167,-0.0028389,0.31234,0.65156,HP_ABNORMAL_INTERNAL_CAROTID_ARTERY_MORPHOLOGY,0.99999
GOBP_CELLULAR_RESPONSE_TO_AN...1,SET,32,-0.06483,-0.0027043,0.1664,0.65158,GOBP_CELLULAR_RESPONSE_TO_ANGIOTENSIN,0.99999
HP_ARTERIOVENOUS_MALFORMATION,SET,53,-0.044675,-0.002397,0.11464,0.65162,HP_ARTERIOVENOUS_MALFORMATION,0.99999
GSE21670_UNTREATED_VS_TGFB_T...2,SET,180,-0.02594,-0.0025559,0.066537,0.65168,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP,0.99999
HP_PAPILLARY_RENAL_CELL_CARC...,SET,8,-0.13468,-0.0028109,0.34544,0.65169,HP_PAPILLARY_RENAL_CELL_CARCINOMA,0.99999
GOBP_REGULATION_OF_MAMMARY_G...,SET,14,-0.09407,-0.0025968,0.24118,0.65174,GOBP_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,0.99999
GOBP_VESICLE_UNCOATING,SET,9,-0.095785,-0.0021203,0.24555,0.65176,GOBP_VESICLE_UNCOATING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...587,SET,1298,-0.0096724,-0.0024794,0.024791,0.65179,GOBP_NEGATIVE_REGULATION_OF_SIGNALING,0.99999
DORN_ADENOVIRUS_INFECTION_24...2,SET,11,-0.092352,-0.0022599,0.23668,0.6518,DORN_ADENOVIRUS_INFECTION_24HR_UP,0.99999
GSE7852_LN_VS_FAT_TREG_DN,SET,181,-0.025904,-0.0025595,0.066375,0.65183,GSE7852_LN_VS_FAT_TREG_DN,0.99999
SHIPP_DLBCL_VS_FOLLICULAR_LY...2,SET,44,-0.050167,-0.0024531,0.12849,0.65189,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,0.99999
GSE42088_2H_VS_24H_LEISHMANI...2,SET,176,-0.025356,-0.0024707,0.064923,0.65193,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP,0.99999
chr9p13,SET,78,-0.080505,-0.0052364,0.20612,0.65194,chr9p13,0.99999
HP_CENTRAL_HYPOVENTILATION,SET,11,-0.11557,-0.0028281,0.29585,0.65197,HP_CENTRAL_HYPOVENTILATION,0.99999
GSE10325_BCELL_VS_LUPUS_BCEL...2,SET,163,-0.026018,-0.0024407,0.066593,0.65199,GSE10325_BCELL_VS_LUPUS_BCELL_UP,0.99999
GOBP_ANTEROGRADE_DENDRITIC_T...1,SET,9,-0.11223,-0.0024844,0.28724,0.652,GOBP_ANTEROGRADE_DENDRITIC_TRANSPORT,0.99999
GOBP_3_UTR_MEDIATED_MRNA_DES...,SET,19,-0.078947,-0.0025385,0.20203,0.65202,GOBP_3_UTR_MEDIATED_MRNA_DESTABILIZATION,0.99999
KUMAR_AUTOPHAGY_NETWORK,SET,59,-0.043657,-0.002471,0.1117,0.65203,KUMAR_AUTOPHAGY_NETWORK,0.99999
WP_EICOSANOID_METABOLISM_VIA...3,SET,28,-0.062948,-0.0024565,0.16106,0.65204,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.99999
GSE7831_UNSTIM_VS_INFLUENZA_...4,SET,184,-0.025079,-0.0024982,0.06416,0.65206,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_UP,0.99999
WP_ARSENIC_METABOLISM_AND_RE...,SET,9,-0.11513,-0.0025484,0.29447,0.65208,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,0.99999
MIR30C_1_3P,SET,119,-0.032146,-0.0025797,0.082185,0.65215,MIR30C_1_3P,0.99999
GOBP_TUBULIN_DEACETYLATION,SET,18,-0.071664,-0.0022429,0.18322,0.65215,GOBP_TUBULIN_DEACETYLATION,0.99999
WANG_RESPONSE_TO_ANDROGEN_UP,SET,28,-0.062317,-0.0024319,0.15928,0.65219,WANG_RESPONSE_TO_ANDROGEN_UP,0.99999
KOBAYASHI_EGFR_SIGNALING_24H...2,SET,83,-0.03696,-0.0024796,0.094428,0.65225,KOBAYASHI_EGFR_SIGNALING_24HR_UP,0.99999
WP_ALSTROM_SYNDROME,SET,30,-0.061363,-0.0024786,0.15676,0.65226,WP_ALSTROM_SYNDROME,0.99999
GOMF_SMALL_PROTEIN_ACTIVATIN...,SET,5,-0.12128,-0.0020013,0.30953,0.65241,GOMF_SMALL_PROTEIN_ACTIVATING_ENZYME_BINDING,0.99999
GSE6269_STAPH_AUREUS_VS_STRE...2,SET,145,-0.028038,-0.002482,0.071558,0.65241,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP,0.99999
YANG_BREAST_CANCER_ESR1_LASE...1,SET,42,-0.052538,-0.0025101,0.13407,0.65242,YANG_BREAST_CANCER_ESR1_LASER_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...240,SET,10,-0.11887,-0.0027737,0.30335,0.65242,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...491,SET,330,-0.018535,-0.0024627,0.047281,0.65248,GOBP_NEGATIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,0.99999
GOBP_DNA_DEAMINATION,SET,11,-0.11485,-0.0028105,0.29284,0.65254,GOBP_DNA_DEAMINATION,0.99999
HP_INCREASED_CORNEAL_THICKNE...,SET,5,-0.17627,-0.0029087,0.44939,0.65256,HP_INCREASED_CORNEAL_THICKNESS,0.99999
ZHU_SKIL_TARGETS_UP,SET,19,-0.080865,-0.0026002,0.20609,0.65261,ZHU_SKIL_TARGETS_UP,0.99999
GOBP_INTRACILIARY_ANTEROGRAD...,SET,15,-0.082728,-0.0023638,0.21082,0.65262,GOBP_INTRACILIARY_ANTEROGRADE_TRANSPORT,0.99999
GOBP_SNRNA_CATABOLIC_PROCESS,SET,4,-0.13667,-0.0020172,0.34812,0.65269,GOBP_SNRNA_CATABOLIC_PROCESS,0.99999
KRISHNAN_FURIN_TARGETS_UP,SET,8,-0.12634,-0.0026368,0.32178,0.6527,KRISHNAN_FURIN_TARGETS_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...595,SET,20,-0.084955,-0.0028026,0.21633,0.65273,GOBP_NEGATIVE_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...3,SET,149,-0.026216,-0.0023522,0.066752,0.65274,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_DN,0.99999
HP_FRONTAL_POLYMICROGYRIA,SET,5,-0.16826,-0.0027764,0.42824,0.6528,HP_FRONTAL_POLYMICROGYRIA,0.99999
GOBP_MICROVILLUS_ORGANIZATION,SET,27,-0.064399,-0.0024679,0.1639,0.65281,GOBP_MICROVILLUS_ORGANIZATION,0.99999
GOCC_APICAL_JUNCTION_COMPLEX,SET,130,-0.030328,-0.0025431,0.077175,0.65283,GOCC_APICAL_JUNCTION_COMPLEX,0.99999
HP_GUSTATORY_LACRIMATION,SET,4,-0.19802,-0.0029227,0.50389,0.65283,HP_GUSTATORY_LACRIMATION,0.99999
GSE45365_WT_VS_IFNAR_KO_BCEL...2,SET,153,-0.027249,-0.0024772,0.069321,0.65287,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN,0.99999
KRIGE_RESPONSE_TO_TOSEDOSTAT...1,SET,910,-0.010944,-0.0023755,0.027839,0.65288,KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN,0.99999
GOMF_ARRESTIN_FAMILY_PROTEIN...,SET,9,-0.098114,-0.0021719,0.24957,0.65289,GOMF_ARRESTIN_FAMILY_PROTEIN_BINDING,0.99999
TMTCGCGANR_UNKNOWN,SET,148,-0.026786,-0.0023953,0.068121,0.65291,TMTCGCGANR_UNKNOWN,0.99999
KEGG_MEDICUS_PATHOGEN_HCMV_G...2,SET,7,-0.12715,-0.0024825,0.32333,0.65293,KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY,0.99999
GOMF_PRE_MRNA_3_SPLICE_SITE_...,SET,3,-0.18344,-0.0023448,0.46639,0.65296,GOMF_PRE_MRNA_3_SPLICE_SITE_BINDING,0.99999
GSE43863_TH1_VS_TFH_EFFECTOR...1,SET,173,-0.025757,-0.0024886,0.065475,0.65298,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN,0.99999
KAMMINGA_SENESCENCE,SET,38,-0.050257,-0.0022842,0.12774,0.653,KAMMINGA_SENESCENCE,0.99999
chr14q32,SET,129,-0.058471,-0.0048842,0.1486,0.65301,chr14q32,0.99999
GSE2706_UNSTIM_VS_8H_LPS_AND...2,SET,176,-0.025048,-0.0024408,0.063655,0.65302,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP,0.99999
WP_MODULATION_OF_PI3KAKTMTOR...,SET,14,-0.098522,-0.0027197,0.2503,0.65306,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,0.99999
GOBP_ARGININE_BIOSYNTHETIC_P...,SET,4,-0.14885,-0.0021969,0.37806,0.6531,GOBP_ARGININE_BIOSYNTHETIC_PROCESS,0.99999
HP_POLYCYSTIC_KIDNEY_DYSPLAS...,SET,48,-0.047703,-0.002436,0.12116,0.6531,HP_POLYCYSTIC_KIDNEY_DYSPLASIA,0.99999
GOMF_1_PHOSPHATIDYLINOSITOL_...4,SET,7,-0.12713,-0.002482,0.3228,0.65314,GOMF_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_3_KINASE_ACTIVITY,0.99999
MIR7845_5P,SET,54,-0.044241,-0.0023959,0.11228,0.65321,MIR7845_5P,0.99999
GOMF_CALCIUM_DEPENDENT_PHOSP...2,SET,52,-0.052182,-0.0027733,0.13238,0.65328,GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING,0.99999
GSE15659_CD45RA_NEG_CD4_TCEL...6,SET,158,-0.027546,-0.0025445,0.069877,0.65328,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP,0.99999
MODULE_155,SET,24,-0.064718,-0.0023385,0.16416,0.6533,MODULE_155,0.99999
HP_TYPE_I_TRANSFERRIN_ISOFOR...,SET,17,-0.066679,-0.0020282,0.16913,0.6533,HP_TYPE_I_TRANSFERRIN_ISOFORM_PROFILE,0.99999
HP_ST_SEGMENT_DEPRESSION,SET,13,-0.10544,-0.0028048,0.2674,0.65332,HP_ST_SEGMENT_DEPRESSION,0.99999
MIR7151_3P,SET,249,-0.021193,-0.0024515,0.053727,0.65338,MIR7151_3P,0.99999
HP_INCREASED_MEAN_PLATELET_V...,SET,21,-0.078229,-0.0026443,0.19826,0.65342,HP_INCREASED_MEAN_PLATELET_VOLUME,0.99999
ROAZ_01,SET,8,-0.10775,-0.0022488,0.27306,0.65343,ROAZ_01,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...16,SET,5,-0.17129,-0.0028264,0.43402,0.65345,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN,0.99999
GOBP_CELL_DIFFERENTIATION_IN...5,SET,20,-0.083901,-0.0027678,0.21253,0.65349,GOBP_CELL_DIFFERENTIATION_IN_HINDBRAIN,0.99999
KEGG_AXON_GUIDANCE,SET,122,-0.032045,-0.0026036,0.081165,0.65351,KEGG_AXON_GUIDANCE,0.99999
SHIRAISHI_PLZF_TARGETS_DN,SET,9,-0.12151,-0.0026897,0.30773,0.65352,SHIRAISHI_PLZF_TARGETS_DN,0.99999
HP_OSTEOSARCOMA,SET,32,-0.056121,-0.002341,0.14213,0.65352,HP_OSTEOSARCOMA,0.99999
GOMF_SIGNAL_SEQUENCE_BINDING,SET,43,-0.048744,-0.0023563,0.12344,0.65353,GOMF_SIGNAL_SEQUENCE_BINDING,0.99999
BIOCARTA_PDGF_PATHWAY,SET,27,-0.06619,-0.0025366,0.16761,0.65354,BIOCARTA_PDGF_PATHWAY,0.99999
HP_ABNORMAL_TRANSFERRIN_SATU...,SET,12,-0.094634,-0.0024187,0.23958,0.65358,HP_ABNORMAL_TRANSFERRIN_SATURATION,0.99999
HP_NONPROGRESSIVE,SET,18,-0.077003,-0.00241,0.19493,0.65359,HP_NONPROGRESSIVE,0.99999
LI_CISPLATIN_RESISTANCE_UP,SET,24,-0.076989,-0.0027819,0.19485,0.65362,LI_CISPLATIN_RESISTANCE_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...509,SET,44,-0.048782,-0.0023853,0.12345,0.65364,GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.99999
DESCARTES_MAIN_FETAL_HEPATOB...,SET,86,-0.037428,-0.0025557,0.094697,0.65366,DESCARTES_MAIN_FETAL_HEPATOBLASTS,0.99999
GOCC_RESPIRATORY_CHAIN_COMPL...,SET,21,-0.073113,-0.0024714,0.18497,0.65367,GOCC_RESPIRATORY_CHAIN_COMPLEX_IV,0.99999
LAKE_ADULT_KIDNEY_C24_ENDOTH...,SET,144,-0.030333,-0.0026759,0.076591,0.65396,LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR,0.99999
REACTOME_PHASE_0_RAPID_DEPOL...,SET,31,-0.068469,-0.0028112,0.17285,0.65398,REACTOME_PHASE_0_RAPID_DEPOLARISATION,0.99999
GOBP_PYRIMIDINE_RIBONUCLEOSI...3,SET,15,-0.084507,-0.0024146,0.21313,0.65413,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.99999
PEDRIOLI_MIR31_TARGETS_DN,SET,367,-0.018486,-0.0025874,0.046615,0.65415,PEDRIOLI_MIR31_TARGETS_DN,0.99999
GSE23568_CTRL_VS_ID3_TRANSDU...2,SET,183,-0.024422,-0.0024262,0.061588,0.65415,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP,0.99999
PANGAS_TUMOR_SUPPRESSION_BY_...1,SET,128,-0.030165,-0.00251,0.076064,0.65416,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,0.99999
REACTOME_TRANSCRIPTIONAL_REG...11,SET,30,-0.062607,-0.0025288,0.15783,0.65419,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION,0.99999
KEGG_MEDICUS_PATHOGEN_SALMON...5,SET,9,-0.13004,-0.0028786,0.32778,0.65421,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOA_SIGNALING_PATHWAY,0.99999
GSE16755_CTRL_VS_IFNA_TREATE...2,SET,180,-0.0242,-0.0023845,0.060985,0.65424,GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP,0.99999
BUSSLINGER_GASTRIC_PPP1R1B_P...,SET,114,-0.031816,-0.0024994,0.080183,0.65424,BUSSLINGER_GASTRIC_PPP1R1B_POSITIVE_CELLS,0.99999
HP_ASPIRATION_PNEUMONIA,SET,88,-0.035573,-0.002457,0.089635,0.65426,HP_ASPIRATION_PNEUMONIA,0.99999
GSE37301_LYMPHOID_PRIMED_MPP...5,SET,178,-0.024213,-0.0023726,0.061012,0.65426,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN,0.99999
NFE2_01,SET,237,-0.022496,-0.0025394,0.05667,0.6543,NFE2_01,0.99999
BOSCO_ALLERGEN_INDUCED_TH2_A...,SET,133,-0.031878,-0.0027035,0.080267,0.65437,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,0.99999
GSE9509_LPS_VS_LPS_AND_IL10_...3,SET,173,-0.025531,-0.0024667,0.064258,0.65443,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_DN,0.99999
HP_DECREASED_BODY_WEIGHT,SET,1374,-0.0093732,-0.0024665,0.023587,0.65446,HP_DECREASED_BODY_WEIGHT,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...7,SET,176,-0.024096,-0.002348,0.060622,0.65449,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN,0.99999
GOMF_NAD_DEPENDENT_PROTEIN_L...,SET,7,-0.12049,-0.0023523,0.30309,0.65451,GOMF_NAD_DEPENDENT_PROTEIN_LYSINE_DEACETYLASE_ACTIVITY,0.99999
WP_TCELL_ANTIGEN_RECEPTOR_TC...,SET,59,-0.044394,-0.0025127,0.11167,0.65452,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,0.99999
NKX22_01,SET,169,-0.027938,-0.0026682,0.070272,0.65452,NKX22_01,0.99999
WP_NANOPARTICLEMEDIATED_ACTI...,SET,28,-0.069281,-0.0027036,0.17423,0.65455,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...622,SET,52,-0.050954,-0.002708,0.12811,0.65458,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,0.99999
GOCC_SECONDARY_LYSOSOME,SET,19,-0.077052,-0.0024775,0.19374,0.65458,GOCC_SECONDARY_LYSOSOME,0.99999
MIR9985,SET,570,-0.014831,-0.0025724,0.037283,0.6546,MIR9985,0.99999
MIR5582_3P,SET,601,-0.014405,-0.0025634,0.036211,0.65461,MIR5582_3P,0.99999
IIZUKA_LIVER_CANCER_PROGRESS...3,SET,8,-0.13259,-0.0027673,0.33313,0.65469,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN,0.99999
BRF1_TARGET_GENES,SET,37,-0.059875,-0.0026853,0.15042,0.6547,BRF1_TARGET_GENES,0.99999
GENTILE_UV_RESPONSE_CLUSTER_...2,SET,37,-0.059366,-0.0026625,0.1491,0.65474,GENTILE_UV_RESPONSE_CLUSTER_D2,0.99999
GOBP_LIPID_OXIDATION,SET,107,-0.033014,-0.0025131,0.082905,0.65476,GOBP_LIPID_OXIDATION,0.99999
GOBP_PLANAR_CELL_POLARITY_PA...1,SET,6,-0.16657,-0.0030109,0.41829,0.65477,GOBP_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_AXIS_ELONGATION,0.99999
GSE37532_WT_VS_PPARG_KO_VISC...2,SET,172,-0.025876,-0.0024929,0.064955,0.65482,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_UP,0.99999
GOMF_GROWTH_FACTOR_BINDING,SET,126,-0.032891,-0.0027155,0.082529,0.65488,GOMF_GROWTH_FACTOR_BINDING,0.99999
HP_HIGH_PITCHED_VOICE,SET,41,-0.052797,-0.0024923,0.13247,0.65489,HP_HIGH_PITCHED_VOICE,0.99999
HP_HYPERVENTILATION,SET,26,-0.074919,-0.0028175,0.18798,0.65489,HP_HYPERVENTILATION,0.99999
GARCIA_PINERES_PBMC_HPV_16_L...4,SET,305,-0.019949,-0.0025498,0.05004,0.65492,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_CLU...,SET,64,-0.047673,-0.0028099,0.11958,0.65493,HE_LIM_SUN_FETAL_LUNG_C1_CLUB_CELL,0.99999
MIR362_5P,SET,50,-0.046748,-0.0024364,0.11721,0.65499,MIR362_5P,0.99999
LET_7B_5P,SET,362,-0.018331,-0.0025486,0.045935,0.65507,LET_7B_5P,0.99999
MODULE_294,SET,18,-0.07345,-0.0022988,0.18407,0.65507,MODULE_294,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HN...2,SET,262,-0.022221,-0.0026356,0.055686,0.65507,MANNO_MIDBRAIN_NEUROTYPES_HNBM,0.99999
GOBP_EMBRYONIC_VISCEROCRANIU...,SET,9,-0.12243,-0.0027101,0.30675,0.65509,GOBP_EMBRYONIC_VISCEROCRANIUM_MORPHOGENESIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...513,SET,62,-0.042003,-0.0024369,0.10524,0.6551,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_BINDING,0.99999
GSE30971_WBP7_HET_VS_KO_MACR...6,SET,184,-0.025551,-0.0025452,0.064018,0.6551,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_UP,0.99999
DESCARTES_FETAL_CEREBELLUM_A...,SET,112,-0.035028,-0.0027276,0.087742,0.65513,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.99999
REACTOME_PROGRAMMED_CELL_DEA...,SET,193,-0.023963,-0.0024441,0.060015,0.65515,REACTOME_PROGRAMMED_CELL_DEATH,0.99999
KEGG_MEDICUS_PATHOGEN_SALMON...6,SET,5,-0.1322,-0.0021815,0.33108,0.65516,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOG_SIGNALING_PATHWAY,0.99999
RICKMAN_METASTASIS_UP,SET,273,-0.020983,-0.0025397,0.052537,0.6552,RICKMAN_METASTASIS_UP,0.99999
GOBP_NUCLEAR_MIGRATION_ALONG...,SET,5,-0.14551,-0.0024011,0.36427,0.65522,GOBP_NUCLEAR_MIGRATION_ALONG_MICROTUBULE,0.99999
BIOCARTA_GABA_PATHWAY,SET,9,-0.11559,-0.0025587,0.28934,0.65523,BIOCARTA_GABA_PATHWAY,0.99999
GOMF_CADHERIN_BINDING,SET,302,-0.019622,-0.0024959,0.049113,0.65524,GOMF_CADHERIN_BINDING,0.99999
ZBTB44_TARGET_GENES,SET,621,-0.014,-0.0025311,0.035034,0.65528,ZBTB44_TARGET_GENES,0.99999
HU_FETAL_RETINA_MULLER,SET,36,-0.061018,-0.0026994,0.15267,0.65529,HU_FETAL_RETINA_MULLER,0.99999
GOBP_L_ARGININE_IMPORT_ACROS...,SET,4,-0.21055,-0.0031076,0.52681,0.6553,GOBP_L_ARGININE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
WP_LIPID_METABOLISM_IN_SENES...,SET,20,-0.079371,-0.0026183,0.19854,0.65533,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,0.99999
GSE5542_UNTREATED_VS_IFNG_TR...3,SET,180,-0.026711,-0.0026319,0.066806,0.65535,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.99999
HP_RETINAL_ARTERIAL_TORTUOSI...,SET,3,-0.15483,-0.0019791,0.38713,0.6554,HP_RETINAL_ARTERIAL_TORTUOSITY,0.99999
GOCC_ACETYLTRANSFERASE_COMPL...,SET,89,-0.033185,-0.002305,0.082962,0.65542,GOCC_ACETYLTRANSFERASE_COMPLEX,0.99999
GOBP_PROTOPORPHYRINOGEN_IX_B...,SET,8,-0.11701,-0.0024422,0.29242,0.65548,GOBP_PROTOPORPHYRINOGEN_IX_BIOSYNTHETIC_PROCESS,0.99999
HP_SYSTOLIC_HEART_MURMUR,SET,13,-0.11182,-0.0029745,0.27939,0.6555,HP_SYSTOLIC_HEART_MURMUR,0.99999
chr2q35,SET,64,-0.085349,-0.0050306,0.21324,0.65551,chr2q35,0.99999
GSE2706_UNSTIM_VS_2H_LPS_AND...2,SET,162,-0.025525,-0.0023872,0.063767,0.65553,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP,0.99999
GSE45365_NK_CELL_VS_CD11B_DC...3,SET,186,-0.025681,-0.0025719,0.064137,0.65557,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_UP,0.99999
HP_BILATERAL_CHOANAL_ATRESIA,SET,9,-0.097688,-0.0021624,0.24395,0.65559,HP_BILATERAL_CHOANAL_ATRESIA,0.99999
GSE21033_CTRL_VS_POLYIC_STIM...1,SET,177,-0.026082,-0.0025486,0.065113,0.65563,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_DN,0.99999
GOMF_TRANSMEMBRANE_RECEPTOR_...3,SET,18,-0.08213,-0.0025705,0.20502,0.65564,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.99999
REACTOME_SNRNP_ASSEMBLY,SET,48,-0.044568,-0.002276,0.11124,0.65566,REACTOME_SNRNP_ASSEMBLY,0.99999
GOBP_DOUBLE_STRAND_BREAK_REP...7,SET,6,-0.13329,-0.0024093,0.3327,0.65566,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_SINGLE_STRAND_ANNEALING,0.99999
HP_ABNORMAL_PARANASAL_SINUS_...,SET,158,-0.028103,-0.002596,0.070146,0.65566,HP_ABNORMAL_PARANASAL_SINUS_MORPHOLOGY,0.99999
GSE7460_CD8_TCELL_VS_TREG_AC...2,SET,179,-0.02488,-0.0024447,0.062056,0.65576,GSE7460_CD8_TCELL_VS_TREG_ACT_UP,0.99999
WP_ANGIOPOIETINLIKE_PROTEIN_...,SET,125,-0.031869,-0.0026208,0.079452,0.65583,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,0.99999
GSE10147_IL3_VS_IL3_AND_HIVP...1,SET,131,-0.031426,-0.0026452,0.078323,0.65587,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_GHR...1,SET,140,-0.031048,-0.002701,0.077383,0.65587,HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NEUROENDOCRINE_CELL,0.99999
CAO_BLOOD_FLUMIST_AGE_05_14Y...7,SET,9,-0.12062,-0.0026701,0.30055,0.65591,CAO_BLOOD_FLUMIST_AGE_05_14YO_CORRELATED_WITH_H3N2_VN_TITER_7DY_POSITIVE,0.99999
GOBP_REGULATION_OF_NEUTROPHI...4,SET,4,-0.18133,-0.0026764,0.45165,0.65597,GOBP_REGULATION_OF_NEUTROPHIL_EXTRAVASATION,0.99999
ZNF292_TARGET_GENES,SET,21,-0.070816,-0.0023938,0.17637,0.65598,ZNF292_TARGET_GENES,0.99999
GSE22527_ANTI_CD3_INVIVO_VS_...1,SET,178,-0.023991,-0.0023509,0.05975,0.65598,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_DN,0.99999
GSE32533_MIR17_KO_VS_MIR17_O...1,SET,175,-0.025899,-0.0025166,0.064493,0.656,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,0.99999
HP_SPARSE_HAIR,SET,332,-0.018672,-0.0024882,0.046494,0.65601,HP_SPARSE_HAIR,0.99999
GLI1_UP.V1_DN,SET,16,-0.08015,-0.0023652,0.19958,0.65601,GLI1_UP.V1_DN,0.99999
GSE39152_CD103_NEG_VS_POS_ME...1,SET,186,-0.025232,-0.0025269,0.062827,0.65601,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN,0.99999
BORCZUK_MALIGNANT_MESOTHELIO...2,SET,266,-0.019681,-0.0023519,0.048975,0.65611,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,0.99999
HP_ALBINISM,SET,18,-0.087301,-0.0027323,0.21723,0.65611,HP_ALBINISM,0.99999
HP_HYPERHIDROSIS,SET,149,-0.028147,-0.0025255,0.069972,0.65625,HP_HYPERHIDROSIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...670,SET,22,-0.074372,-0.002573,0.18487,0.65626,GOBP_NEGATIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.99999
HP_ABNORMALITY_OF_THE_UPPER_...1,SET,65,-0.045181,-0.0026837,0.1123,0.65628,HP_ABNORMALITY_OF_THE_UPPER_ARM,0.99999
REACTOME_INLA_MEDIATED_ENTRY...,SET,8,-0.12677,-0.0026458,0.31505,0.6563,REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS,0.99999
REACTOME_SIGNALING_BY_HEDGEH...,SET,144,-0.027239,-0.002403,0.067694,0.6563,REACTOME_SIGNALING_BY_HEDGEHOG,0.99999
STEIN_ESRRA_TARGETS,SET,473,-0.015887,-0.002517,0.039479,0.65631,STEIN_ESRRA_TARGETS,0.99999
HP_HEINZ_BODIES,SET,2,-0.22496,-0.0023479,0.55886,0.65635,HP_HEINZ_BODIES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...455,SET,61,-0.041851,-0.0024084,0.10396,0.65637,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_DIVISION,0.99999
GOMF_CYTOSKELETON_NUCLEAR_ME...,SET,5,-0.14603,-0.0024096,0.36268,0.65639,GOMF_CYTOSKELETON_NUCLEAR_MEMBRANE_ANCHOR_ACTIVITY,0.99999
AHRARNT_01,SET,129,-0.03188,-0.002663,0.079172,0.6564,AHRARNT_01,0.99999
BIOCARTA_INTRINSIC_PATHWAY,SET,19,-0.088323,-0.00284,0.21933,0.65641,BIOCARTA_INTRINSIC_PATHWAY,0.99999
HOLLEMAN_PREDNISOLONE_RESIST...4,SET,16,-0.072756,-0.002147,0.18056,0.6565,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP,0.99999
KOBAYASHI_EGFR_SIGNALING_6HR...2,SET,6,-0.1307,-0.0023624,0.32428,0.65654,KOBAYASHI_EGFR_SIGNALING_6HR_UP,0.99999
KEGG_MEDICUS_PATHOGEN_KSHV_V...4,SET,31,-0.066405,-0.0027265,0.16472,0.65657,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY,0.99999
GOBP_TYPE_B_PANCREATIC_CELL_...4,SET,23,-0.077314,-0.0027349,0.19177,0.65658,GOBP_TYPE_B_PANCREATIC_CELL_PROLIFERATION,0.99999
GOBP_RESPONSE_TO_POTASSIUM_I...,SET,18,-0.088122,-0.002758,0.21852,0.65662,GOBP_RESPONSE_TO_POTASSIUM_ION,0.99999
GSE24634_NAIVE_CD4_TCELL_VS_...6,SET,184,-0.024939,-0.0024842,0.061843,0.65662,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP,0.99999
MEISSNER_ES_ICP_WITH_H3K4ME3,SET,29,-0.061526,-0.0024434,0.15256,0.65663,MEISSNER_ES_ICP_WITH_H3K4ME3,0.99999
ZAMORA_NOS2_TARGETS_UP,SET,51,-0.047856,-0.0025189,0.11865,0.65664,ZAMORA_NOS2_TARGETS_UP,0.99999
GOBP_BIOLOGICAL_PROCESS_INVO...3,SET,1525,-0.009518,-0.0026268,0.023598,0.65664,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS,0.99999
GOBP_POSITIVE_REGULATION_OF_...569,SET,8,-0.12348,-0.0025771,0.30609,0.65667,GOBP_POSITIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
HP_PULMONARY_LYMPHANGIECTASIA,SET,5,-0.18564,-0.0030633,0.46019,0.65667,HP_PULMONARY_LYMPHANGIECTASIA,0.99999
GOBP_REGULATION_OF_PHOSPHORY...,SET,888,-0.012113,-0.0025989,0.030026,0.65668,GOBP_REGULATION_OF_PHOSPHORYLATION,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...3,SET,182,-0.025385,-0.002515,0.06291,0.65671,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN,0.99999
MIR5739,SET,6,-0.16394,-0.0029633,0.40607,0.65679,MIR5739,0.99999
GOBP_NEGATIVE_REGULATION_OF_...95,SET,92,-0.038125,-0.0026922,0.094435,0.65679,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...13,SET,10,-0.10764,-0.0025116,0.2666,0.6568,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...21,SET,15,-0.098128,-0.0028038,0.24304,0.6568,GOBP_NEGATIVE_REGULATION_OF_AMINO_ACID_TRANSPORT,0.99999
GOBP_OSTEOCLAST_PROLIFERATION,SET,11,-0.10697,-0.0026176,0.26493,0.6568,GOBP_OSTEOCLAST_PROLIFERATION,0.99999
DESCARTES_FETAL_KIDNEY_URETE...,SET,235,-0.024706,-0.0027773,0.061181,0.65683,DESCARTES_FETAL_KIDNEY_URETERIC_BUD_CELLS,0.99999
WP_15Q133_COPY_NUMBER_VARIAT...,SET,16,-0.081299,-0.0023991,0.2013,0.65685,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,0.99999
REACTOME_SIGNALING_BY_ERBB2_...2,SET,25,-0.065662,-0.0024215,0.16255,0.65687,REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,0.99999
MIR4650_5P,SET,64,-0.042076,-0.00248,0.10416,0.65688,MIR4650_5P,0.99999
REACTOME_PKA_ACTIVATION_IN_G...,SET,17,-0.088606,-0.0026951,0.21926,0.65693,REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING,0.99999
GOBP_RESPONSE_TO_MERCURY_ION,SET,10,-0.10862,-0.0025343,0.26875,0.65695,GOBP_RESPONSE_TO_MERCURY_ION,0.99999
MIR4274,SET,51,-0.049433,-0.0026018,0.12229,0.65698,MIR4274,0.99999
HP_VERTEBRAL_CLEFTING,SET,35,-0.058851,-0.0025672,0.14557,0.657,HP_VERTEBRAL_CLEFTING,0.99999
GOBP_REGULATION_OF_CELL_COMM...1,SET,16,-0.10188,-0.0030065,0.25192,0.65705,GOBP_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,0.99999
FAELT_B_CLL_WITH_VH_REARRANG...1,SET,43,-0.052435,-0.0025347,0.1296,0.65711,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,0.99999
KEGG_PEROXISOME,SET,74,-0.039229,-0.0024856,0.096946,0.65713,KEGG_PEROXISOME,0.99999
GOBP_PROTEOLYSIS_INVOLVED_IN...,SET,696,-0.012826,-0.0024496,0.031693,0.65715,GOBP_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.99999
GSE17721_0.5H_VS_12H_POLYIC_...2,SET,180,-0.024773,-0.002441,0.061183,0.65722,GSE17721_0.5H_VS_12H_POLYIC_BMDC_UP,0.99999
HP_PRIMARY_ADRENAL_INSUFFICI...,SET,55,-0.045825,-0.0025045,0.11312,0.65729,HP_PRIMARY_ADRENAL_INSUFFICIENCY,0.99999
NIKOLSKY_BREAST_CANCER_8P12_...,SET,50,-0.091603,-0.0047741,0.22609,0.65732,NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,0.99999
MIR103A_3P_MIR107,SET,234,-0.022615,-0.0025369,0.055815,0.65732,MIR103A_3P_MIR107,0.99999
MIR486_5P,SET,85,-0.036258,-0.0024615,0.089482,0.65733,MIR486_5P,0.99999
WP_CONTROL_OF_IMMUNE_TOLERAN...,SET,13,-0.1023,-0.0027213,0.25245,0.65734,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,0.99999
HP_WEBBED_NECK,SET,104,-0.032929,-0.0024714,0.081255,0.65735,HP_WEBBED_NECK,0.99999
GOMF_CALCIUM_INDUCED_CALCIUM...,SET,6,-0.13594,-0.0024571,0.33534,0.65739,GOMF_CALCIUM_INDUCED_CALCIUM_RELEASE_ACTIVITY,0.99999
MIR4284,SET,99,-0.033489,-0.0024527,0.082586,0.65745,MIR4284,0.99999
KRIGE_RESPONSE_TO_TOSEDOSTAT...3,SET,822,-0.011762,-0.0024325,0.028991,0.65751,KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN,0.99999
HP_PROFOUND_GLOBAL_DEVELOPME...,SET,59,-0.043921,-0.0024859,0.10826,0.65751,HP_PROFOUND_GLOBAL_DEVELOPMENTAL_DELAY,0.99999
VALK_AML_CLUSTER_5,SET,28,-0.063722,-0.0024867,0.15705,0.65753,VALK_AML_CLUSTER_5,0.99999
GOMF_CONNEXIN_BINDING,SET,5,-0.18224,-0.0030071,0.44913,0.65754,GOMF_CONNEXIN_BINDING,0.99999
ENK_UV_RESPONSE_KERATINOCYTE...1,SET,438,-0.0164,-0.0025027,0.040405,0.65758,ENK_UV_RESPONSE_KERATINOCYTE_DN,0.99999
PLASARI_NFIC_TARGETS_BASAL_DN,SET,20,-0.089052,-0.0029377,0.21937,0.65761,PLASARI_NFIC_TARGETS_BASAL_DN,0.99999
ZHANG_GATA6_TARGETS_UP,SET,12,-0.10601,-0.0027096,0.26113,0.65762,ZHANG_GATA6_TARGETS_UP,0.99999
HP_SPASTICITY,SET,776,-0.012278,-0.0024703,0.03023,0.65768,HP_SPASTICITY,0.99999
KIM_RESPONSE_TO_TSA_AND_DECI...2,SET,108,-0.032896,-0.0025157,0.080984,0.6577,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,0.99999
HP_SELF_MUTILATION,SET,39,-0.052765,-0.0024294,0.12989,0.65771,HP_SELF_MUTILATION,0.99999
LI_ESTROGENE_META_E2_RESPONS...2,SET,61,-0.048998,-0.0028197,0.1206,0.65773,LI_ESTROGENE_META_E2_RESPONSE_UP,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...5,SET,20,-0.086372,-0.0028493,0.21253,0.65777,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...374,SET,139,-0.030295,-0.0026261,0.074548,0.65777,GOBP_NEGATIVE_REGULATION_OF_MAPK_CASCADE,0.99999
TCCGTCC_MIR184,SET,12,-0.10347,-0.0026447,0.25457,0.6578,TCCGTCC_MIR184,0.99999
GOBP_NEGATIVE_REGULATION_OF_...596,SET,50,-0.051273,-0.0026722,0.12611,0.65783,GOBP_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,0.99999
HP_MULTIPLE_JOINT_CONTRACTUR...,SET,57,-0.042501,-0.0023646,0.1045,0.65789,HP_MULTIPLE_JOINT_CONTRACTURES,0.99999
REACTOME_SIGNALING_BY_MST1,SET,5,-0.13632,-0.0022494,0.33502,0.65795,REACTOME_SIGNALING_BY_MST1,0.99999
GSE24634_NAIVE_CD4_TCELL_VS_...1,SET,187,-0.025153,-0.0025257,0.061813,0.65797,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN,0.99999
GSE26488_CTRL_VS_PEPTIDE_INJ...1,SET,177,-0.026346,-0.0025744,0.064736,0.65798,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_DN,0.99999
GSE44732_UNSTIM_VS_IL27_STIM...1,SET,182,-0.025873,-0.0025634,0.063572,0.65799,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN,0.99999
GSE9988_LOW_LPS_VS_VEHICLE_T...2,SET,164,-0.029782,-0.0028023,0.073174,0.65799,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...9,SET,163,-0.026232,-0.0024608,0.064442,0.65802,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...550,SET,12,-0.098407,-0.0025151,0.2417,0.65805,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.99999
MIR3194_5P,SET,71,-0.040492,-0.0025133,0.099444,0.65806,MIR3194_5P,0.99999
KEGG_ADHERENS_JUNCTION,SET,66,-0.044594,-0.002669,0.10948,0.65812,KEGG_ADHERENS_JUNCTION,0.99999
MODULE_272,SET,12,-0.088126,-0.0022524,0.21631,0.65815,MODULE_272,0.99999
MURAKAMI_UV_RESPONSE_6HR_UP,SET,31,-0.061816,-0.0025381,0.15165,0.65822,MURAKAMI_UV_RESPONSE_6HR_UP,0.99999
GOBP_IMMUNOLOGICAL_MEMORY_PR...,SET,18,-0.096713,-0.0030269,0.23724,0.65823,GOBP_IMMUNOLOGICAL_MEMORY_PROCESS,0.99999
GOBP_RESPONSE_TO_OXYGEN_RADI...,SET,25,-0.070758,-0.0026094,0.17356,0.65825,GOBP_RESPONSE_TO_OXYGEN_RADICAL,0.99999
GOBP_UNSATURATED_FATTY_ACID_...1,SET,45,-0.053383,-0.0026398,0.13094,0.65825,GOBP_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_SPINDLE_O...,SET,46,-0.0472,-0.0023598,0.11575,0.65828,GOBP_REGULATION_OF_SPINDLE_ORGANIZATION,0.99999
HP_ABNORMAL_NASAL_BASE_NORPH...,SET,24,-0.068037,-0.0024584,0.16677,0.65834,HP_ABNORMAL_NASAL_BASE_NORPHOLOGY,0.99999
REACTOME_RAB_GERANYLGERANYLA...,SET,57,-0.046264,-0.0025739,0.1134,0.65835,REACTOME_RAB_GERANYLGERANYLATION,0.99999
WP_LEPTIN_AND_ADIPONECTIN,SET,10,-0.10773,-0.0025137,0.26406,0.65836,WP_LEPTIN_AND_ADIPONECTIN,0.99999
WP_NEUROGENESIS_REGULATION_I...,SET,55,-0.050555,-0.002763,0.12391,0.65836,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,0.99999
MIR146A_5P,SET,103,-0.033812,-0.0025256,0.082855,0.65839,MIR146A_5P,0.99999
GOMF_CALCIUM_CHANNEL_INHIBIT...,SET,12,-0.10687,-0.0027314,0.2618,0.65844,GOMF_CALCIUM_CHANNEL_INHIBITOR_ACTIVITY,0.99999
REACTOME_INTERACTIONS_OF_REV...,SET,35,-0.055503,-0.0024212,0.13595,0.65846,REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS,0.99999
GOBP_PROTON_MOTIVE_FORCE_DRI...,SET,43,-0.044173,-0.0021353,0.10819,0.65847,GOBP_PROTON_MOTIVE_FORCE_DRIVEN_ATP_SYNTHESIS,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...7,SET,18,-0.084912,-0.0026575,0.20794,0.65849,GOMF_STRUCTURAL_CONSTITUENT_OF_POSTSYNAPSE,0.99999
GSE28237_FOLLICULAR_VS_LATE_...1,SET,177,-0.025921,-0.0025329,0.063433,0.65859,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN,0.99999
HP_MICRORETROGNATHIA,SET,71,-0.041105,-0.0025514,0.10056,0.65864,HP_MICRORETROGNATHIA,0.99999
GSE17721_LPS_VS_PAM3CSK4_24H...1,SET,177,-0.025536,-0.0024953,0.062469,0.65864,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_DN,0.99999
REACTOME_ORGANIC_CATION_ANIO...,SET,15,-0.097424,-0.0027837,0.23832,0.65865,REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT,0.99999
REACTOME_INTRA_GOLGI_TRAFFIC,SET,43,-0.053538,-0.002588,0.1309,0.65873,REACTOME_INTRA_GOLGI_TRAFFIC,0.99999
HP_NARROW_FACE,SET,83,-0.038927,-0.0026115,0.095151,0.65877,HP_NARROW_FACE,0.99999
REACTOME_SIGNALING_BY_KIT_IN...,SET,20,-0.08716,-0.0028753,0.21291,0.65887,REACTOME_SIGNALING_BY_KIT_IN_DISEASE,0.99999
GOBP_POSITIVE_REGULATION_OF_...791,SET,7,-0.13148,-0.0025669,0.32113,0.65888,GOBP_POSITIVE_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION,0.99999
GOBP_MICROTUBULE_BUNDLE_FORM...,SET,99,-0.034354,-0.002516,0.083903,0.6589,GOBP_MICROTUBULE_BUNDLE_FORMATION,0.99999
MIR198,SET,76,-0.0431,-0.0027674,0.10518,0.65902,MIR198,0.99999
FIGUEROA_AML_METHYLATION_CLU...1,SET,41,-0.055836,-0.0026358,0.1362,0.65908,FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,0.99999
GOBP_INTRACELLULAR_SIGNALING...,SET,1727,-0.0091405,-0.0026684,0.022294,0.65909,GOBP_INTRACELLULAR_SIGNALING_CASSETTE,0.99999
GOBP_COPPER_ION_TRANSPORT,SET,15,-0.088416,-0.0025263,0.21564,0.6591,GOBP_COPPER_ION_TRANSPORT,0.99999
GOBP_DIGESTIVE_TRACT_MORPHOG...,SET,48,-0.05494,-0.0028056,0.13394,0.65917,GOBP_DIGESTIVE_TRACT_MORPHOGENESIS,0.99999
GOBP_SYNAPSE_ORGANIZATION,SET,448,-0.017716,-0.0027335,0.043183,0.65918,GOBP_SYNAPSE_ORGANIZATION,0.99999
GSE1112_HY_CD8AB_VS_HY_CD8AA...2,SET,160,-0.028263,-0.0026271,0.068884,0.65921,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,0.99999
GSE13485_PRE_VS_POST_YF17D_V...1,SET,179,-0.026163,-0.0025708,0.063752,0.65923,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN,0.99999
GSE23695_CD57_POS_VS_NEG_NK_...1,SET,184,-0.024698,-0.0024602,0.060176,0.65925,GSE23695_CD57_POS_VS_NEG_NK_CELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...634,SET,21,-0.087064,-0.002943,0.21212,0.65926,GOBP_NEGATIVE_REGULATION_OF_TISSUE_REMODELING,0.99999
HP_ABNORMAL_NONVERBAL_COMMUN...,SET,89,-0.034409,-0.00239,0.083819,0.65929,HP_ABNORMAL_NONVERBAL_COMMUNICATIVE_BEHAVIOR,0.99999
MIR3927_5P,SET,35,-0.058002,-0.0025302,0.14127,0.65931,MIR3927_5P,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...7,SET,6,-0.14093,-0.0025474,0.34321,0.65932,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21,0.99999
PID_P75_NTR_PATHWAY,SET,59,-0.045749,-0.0025894,0.11141,0.65933,PID_P75_NTR_PATHWAY,0.99999
HP_EOSINOPHILIA,SET,52,-0.050971,-0.0027089,0.12407,0.6594,HP_EOSINOPHILIA,0.99999
KEGG_MEDICUS_REFERENCE_WEE1_...,SET,6,-0.12084,-0.0021842,0.29408,0.65942,KEGG_MEDICUS_REFERENCE_WEE1_CELL_CYCLE_G2_M,0.99999
GOBP_POSITIVE_REGULATION_OF_...260,SET,9,-0.095343,-0.0021105,0.23202,0.65943,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE,0.99999
GOBP_REGULATION_OF_MIRNA_TRA...,SET,72,-0.043,-0.0026876,0.10461,0.65948,GOBP_REGULATION_OF_MIRNA_TRANSCRIPTION,0.99999
GOBP_REGULATION_OF_3_UTR_MED...,SET,5,-0.18125,-0.0029909,0.4408,0.65953,GOBP_REGULATION_OF_3_UTR_MEDIATED_MRNA_STABILIZATION,0.99999
HP_MUSCLE_FIBER_SPLITTING,SET,19,-0.076038,-0.0024449,0.18492,0.65953,HP_MUSCLE_FIBER_SPLITTING,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...32,SET,20,-0.078477,-0.0025888,0.19085,0.65954,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.99999
WP_GPCRS_OTHER,SET,86,-0.041299,-0.0028201,0.10042,0.65956,WP_GPCRS_OTHER,0.99999
GCTTGAA_MIR498,SET,98,-0.037001,-0.0026962,0.089968,0.65956,GCTTGAA_MIR498,0.99999
CCAATNNSNNNGCG_UNKNOWN,SET,53,-0.050655,-0.0027178,0.12315,0.65958,CCAATNNSNNNGCG_UNKNOWN,0.99999
WP_FGF23_SIGNALING_IN_HYPOPH...,SET,22,-0.081726,-0.0028275,0.19868,0.65959,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,0.99999
GOMF_CAMP_DEPENDENT_PROTEIN_...1,SET,5,-0.12897,-0.0021281,0.31347,0.65961,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.99999
GSE1460_CD4_THYMOCYTE_VS_NAI...4,SET,191,-0.02547,-0.0025844,0.061881,0.65968,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,0.99999
HOEK_MYELOID_DENDRITIC_CELL_...5,SET,6,-0.15333,-0.0027715,0.37251,0.65969,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_DN,0.99999
GRASEMANN_RETINOBLASTOMA_WIT...,SET,14,-0.095499,-0.0026362,0.23193,0.65974,GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION,0.99999
CURSONS_NATURAL_KILLER_CELLS,SET,17,-0.092108,-0.0028016,0.22367,0.65975,CURSONS_NATURAL_KILLER_CELLS,0.99999
LEE_CALORIE_RESTRICTION_NEOC...2,SET,65,-0.04429,-0.0026307,0.10756,0.65975,LEE_CALORIE_RESTRICTION_NEOCORTEX_UP,0.99999
KEGG_MEDICUS_ENV_FACTOR_META...1,SET,8,-0.13749,-0.0028695,0.33372,0.65983,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY,0.99999
GSE22886_NAIVE_BCELL_VS_DC_DN,SET,188,-0.025406,-0.0025578,0.061659,0.65984,GSE22886_NAIVE_BCELL_VS_DC_DN,0.99999
GOMF_UBIQUITIN_PROTEIN_TRANS...3,SET,30,-0.068147,-0.0027526,0.16531,0.65991,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_REGULATOR_ACTIVITY,0.99999
REACTOME_DOWNSTREAM_SIGNAL_T...,SET,29,-0.064926,-0.0025785,0.15748,0.65993,REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,0.99999
MODULE_322,SET,51,-0.047582,-0.0025044,0.11541,0.65993,MODULE_322,0.99999
GOBP_POSITIVE_REGULATION_OF_...786,SET,75,-0.042637,-0.0027197,0.1034,0.65995,GOBP_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,0.99999
HP_CHRONIC_CSF_LYMPHOCYTOSIS,SET,8,-0.11295,-0.0023573,0.27384,0.65999,HP_CHRONIC_CSF_LYMPHOCYTOSIS,0.99999
GSE13547_CTRL_VS_ANTI_IGM_ST...6,SET,126,-0.031864,-0.0026308,0.077242,0.66002,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_UP,0.99999
GSE21670_STAT3_KO_VS_WT_CD4_...6,SET,174,-0.02817,-0.0027295,0.068288,0.66002,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_DN,0.99999
WP_PROSTAGLANDIN_SIGNALING,SET,32,-0.068229,-0.0028461,0.16538,0.66003,WP_PROSTAGLANDIN_SIGNALING,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...68,SET,22,-0.07499,-0.0025944,0.18168,0.6601,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.99999
GOCC_TIM23_MITOCHONDRIAL_IMP...,SET,14,-0.087516,-0.0024159,0.21202,0.66011,GOCC_TIM23_MITOCHONDRIAL_IMPORT_INNER_MEMBRANE_TRANSLOCASE_COMPLEX,0.99999
WILENSKY_RESPONSE_TO_DARAPLA...,SET,25,-0.068393,-0.0025222,0.16567,0.66013,WILENSKY_RESPONSE_TO_DARAPLADIB,0.99999
KEGG_MEDICUS_REFERENCE_BASE_...2,SET,8,-0.10298,-0.0021492,0.24914,0.66031,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_MONOFUNCTIONAL_GLYCOSYLASE,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...5,SET,5,-0.16567,-0.0027337,0.4008,0.66032,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18,0.99999
HP_ODONTOGENIC_NEOPLASM,SET,6,-0.12814,-0.0023162,0.30995,0.66035,HP_ODONTOGENIC_NEOPLASM,0.99999
GOCC_COP9_SIGNALOSOME,SET,31,-0.058535,-0.0024033,0.14158,0.66036,GOCC_COP9_SIGNALOSOME,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...1,SET,3,-0.20783,-0.0026566,0.50252,0.6604,GOMF_STRUCTURAL_CONSTITUENT_OF_CHROMATIN,0.99999
HUANG_AML_LSC47,SET,41,-0.062651,-0.0029575,0.15148,0.66041,HUANG_AML_LSC47,0.99999
GOBP_LYMPHOID_PROGENITOR_CEL...,SET,24,-0.071516,-0.0025841,0.17292,0.66041,GOBP_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION,0.99999
GOCC_STEREOCILIUM_MEMBRANE,SET,5,-0.16051,-0.0026485,0.38799,0.66045,GOCC_STEREOCILIUM_MEMBRANE,0.99999
GENTILE_UV_RESPONSE_CLUSTER_...1,SET,17,-0.084251,-0.0025626,0.20363,0.66047,GENTILE_UV_RESPONSE_CLUSTER_D1,0.99999
GOBP_ENDOSOME_TO_PLASMA_MEMB...,SET,14,-0.095696,-0.0026417,0.2312,0.66053,GOBP_ENDOSOME_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.99999
GOCC_PHOSPHATIDYLINOSITOL_3_...2,SET,9,-0.13636,-0.0030186,0.32945,0.66053,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_I,0.99999
GOCC_SPINDLE_POLE,SET,162,-0.027111,-0.0025355,0.065483,0.66057,GOCC_SPINDLE_POLE,0.99999
GSE45365_WT_VS_IFNAR_KO_BCEL...4,SET,161,-0.026267,-0.0024491,0.063441,0.66058,GSE45365_WT_VS_IFNAR_KO_BCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...676,SET,350,-0.01891,-0.0025861,0.045663,0.66061,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,0.99999
ABRAMSON_INTERACT_WITH_AIRE,SET,39,-0.050944,-0.0023456,0.12286,0.6608,ABRAMSON_INTERACT_WITH_AIRE,0.99999
MODULE_481,SET,81,-0.03942,-0.0026127,0.095013,0.66089,MODULE_481,0.99999
MODULE_544,SET,81,-0.03942,-0.0026127,0.095013,0.66089,MODULE_544,0.99999
HP_ABNORMALITY_OF_LENS_SHAPE,SET,15,-0.09561,-0.0027319,0.23039,0.66092,HP_ABNORMALITY_OF_LENS_SHAPE,0.99999
REACTOME_DOWNREGULATION_OF_E...3,SET,8,-0.12109,-0.0025272,0.29177,0.66093,REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING,0.99999
GAZDA_DIAMOND_BLACKFAN_ANEMI...5,SET,55,-0.04246,-0.0023206,0.10229,0.66096,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,0.99999
BIOCARTA_NPP1_PATHWAY,SET,8,-0.14534,-0.0030333,0.3501,0.66097,BIOCARTA_NPP1_PATHWAY,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...48,SET,11,-0.10179,-0.0024909,0.24513,0.66102,GOBP_PROTEIN_LOCALIZATION_TO_SITE_OF_DOUBLE_STRAND_BREAK,0.99999
THAKAR_PBMC_INACTIVATED_INFL...4,SET,115,-0.032797,-0.0025876,0.078974,0.66103,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP,0.99999
REACTOME_SENSING_OF_DNA_DOUB...,SET,5,-0.12438,-0.0020524,0.29949,0.66104,REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS,0.99999
REACTOME_CLEC7A_INFLAMMASOME...,SET,5,-0.15972,-0.0026355,0.38439,0.66112,REACTOME_CLEC7A_INFLAMMASOME_PATHWAY,0.99999
REACTOME_NEGATIVE_REGULATION...11,SET,5,-0.14889,-0.0024568,0.35829,0.66113,REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...16,SET,13,-0.099256,-0.0026403,0.23883,0.66114,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
GCM_CALM1,SET,98,-0.03479,-0.0025351,0.083715,0.66114,GCM_CALM1,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...6,SET,180,-0.026563,-0.0026173,0.06391,0.66116,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_UP,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...17,SET,182,-0.025856,-0.0025617,0.062184,0.66122,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_DN,0.99999
HP_EXAGGERATED_CUPID_S_BOW,SET,31,-0.06282,-0.0025793,0.15105,0.66126,HP_EXAGGERATED_CUPID_S_BOW,0.99999
GSE14308_NAIVE_CD4_TCELL_VS_...1,SET,182,-0.025467,-0.0025232,0.06122,0.66129,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_DN,0.99999
HP_INCREASED_URINARY_POTASSI...,SET,9,-0.13038,-0.0028861,0.31339,0.6613,HP_INCREASED_URINARY_POTASSIUM,0.99999
WP_STEROL_REGULATORY_ELEMENT...,SET,67,-0.040634,-0.0024503,0.097636,0.66136,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,0.99999
GSE17974_0H_VS_2H_IN_VITRO_A...1,SET,177,-0.025739,-0.0025151,0.061832,0.66139,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN,0.99999
BUCASAS_PBMC_FLUARIX_FLUVIRI...2,SET,18,-0.075372,-0.002359,0.18104,0.66141,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_TOP_FUNCTIONAL_NETWORK_POSITIVE,0.99999
KEGG_MEDICUS_REFERENCE_ORIGI...,SET,29,-0.059661,-0.0023694,0.14318,0.66155,KEGG_MEDICUS_REFERENCE_ORIGIN_UNWINDING_AND_ELONGATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...543,SET,193,-0.026553,-0.0027083,0.063686,0.66164,GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS,0.99999
KEGG_MEDICUS_REFERENCE_MANNO...2,SET,5,-0.14237,-0.0023493,0.34137,0.66168,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_POMT_TO_POMK,0.99999
HP_COMBINED_IMMUNODEFICIENCY,SET,35,-0.063986,-0.0027912,0.1534,0.6617,HP_COMBINED_IMMUNODEFICIENCY,0.99999
OCT1_07,SET,143,-0.031989,-0.0028123,0.076672,0.66174,OCT1_07,0.99999
MIR6774_5P,SET,43,-0.053294,-0.0025763,0.12772,0.66176,MIR6774_5P,0.99999
FUNG_IL2_SIGNALING_1,SET,9,-0.1184,-0.0026209,0.28367,0.6618,FUNG_IL2_SIGNALING_1,0.99999
KEGG_MEDICUS_REFERENCE_NOTCH...2,SET,6,-0.14731,-0.0026628,0.35293,0.6618,KEGG_MEDICUS_REFERENCE_NOTCH_MESP2_SIGNALING,0.99999
GOBP_POSITIVE_REGULATION_OF_...291,SET,9,-0.13167,-0.0029146,0.31547,0.6618,GOBP_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION,0.99999
BIOCARTA_VITCB_PATHWAY,SET,8,-0.11404,-0.0023801,0.27319,0.66182,BIOCARTA_VITCB_PATHWAY,0.99999
HP_ABNORMAL_CONJUGATE_EYE_MO...,SET,1020,-0.01123,-0.0025724,0.026901,0.66182,HP_ABNORMAL_CONJUGATE_EYE_MOVEMENT,0.99999
GOCC_NADPH_OXIDASE_COMPLEX,SET,13,-0.10041,-0.0026709,0.2405,0.66184,GOCC_NADPH_OXIDASE_COMPLEX,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...12,SET,9,-0.11842,-0.0026213,0.28361,0.66186,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY,0.99999
NIKOLSKY_BREAST_CANCER_6P24_...,SET,21,-0.12478,-0.0042179,0.29878,0.66189,NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON,0.99999
GSE5679_PPARG_LIGAND_ROSIGLI...2,SET,181,-0.025581,-0.0025275,0.061233,0.66194,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_UP,0.99999
GAO_SMALL_INTESTINE_24W_C6_G...,SET,40,-0.057376,-0.0026753,0.13734,0.66194,GAO_SMALL_INTESTINE_24W_C6_GOBLET_CELLS,0.99999
GOCC_PRE_SNORNP_COMPLEX,SET,7,-0.12399,-0.0024208,0.29675,0.66196,GOCC_PRE_SNORNP_COMPLEX,0.99999
REACTOME_NON_INTEGRIN_MEMBRA...,SET,55,-0.050827,-0.0027778,0.12163,0.66198,REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,0.99999
GOBP_POSITIVE_REGULATION_OF_...837,SET,10,-0.12619,-0.0029444,0.30198,0.66198,GOBP_POSITIVE_REGULATION_OF_VESICLE_FUSION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...320,SET,32,-0.06501,-0.0027119,0.15543,0.66212,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_MAST_CELL_ACTIVATION,SET,64,-0.046781,-0.0027573,0.11182,0.66215,GOBP_MAST_CELL_ACTIVATION,0.99999
MIR6849_5P,SET,28,-0.074517,-0.002908,0.178,0.66225,MIR6849_5P,0.99999
GOBP_L_GLUTAMATE_TRANSMEMBRA...,SET,29,-0.067623,-0.0026856,0.16146,0.66232,GOBP_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORT,0.99999
HP_VILLOUS_ATROPHY,SET,24,-0.06568,-0.0023732,0.15682,0.66232,HP_VILLOUS_ATROPHY,0.99999
UNTERMAN_IPF_VS_CTRL_CD4T_DN,SET,9,-0.1426,-0.0031565,0.34033,0.66239,UNTERMAN_IPF_VS_CTRL_CD4T_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...365,SET,14,-0.097486,-0.0026911,0.23265,0.6624,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION,0.99999
HP_MICRODONTIA,SET,157,-0.028932,-0.0026641,0.069043,0.6624,HP_MICRODONTIA,0.99999
GSE6875_WT_VS_FOXP3_KO_TREG_...2,SET,177,-0.027414,-0.0026789,0.065406,0.66244,GSE6875_WT_VS_FOXP3_KO_TREG_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...439,SET,428,-0.018338,-0.0027672,0.043744,0.66246,GOBP_POSITIVE_REGULATION_OF_MAPK_CASCADE,0.99999
GSE27859_DC_VS_CD11C_INT_F48...3,SET,183,-0.024457,-0.0024296,0.058305,0.66256,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN,0.99999
HP_ABNORMAL_RESPIRATORY_SYST...,SET,1271,-0.010484,-0.0026613,0.024992,0.66257,HP_ABNORMAL_RESPIRATORY_SYSTEM_MORPHOLOGY,0.99999
HP_HYPOSEGMENTATION_OF_NEUTR...,SET,6,-0.15376,-0.0027793,0.36653,0.66257,HP_HYPOSEGMENTATION_OF_NEUTROPHIL_NUCLEI,0.99999
GSE17721_LPS_VS_PAM3CSK4_6H_...1,SET,182,-0.025451,-0.0025215,0.06067,0.66257,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_DN,0.99999
HP_ABNORMALITY_OF_IRON_HOMEO...,SET,23,-0.071305,-0.0025223,0.1699,0.66264,HP_ABNORMALITY_OF_IRON_HOMEOSTASIS,0.99999
MIR146B_5P,SET,102,-0.03492,-0.0025957,0.083198,0.66265,MIR146B_5P,0.99999
MIR5680,SET,425,-0.018225,-0.0027407,0.043421,0.66265,MIR5680,0.99999
HP_ABNORMAL_URINARY_NUCLEOBA...,SET,11,-0.12739,-0.0031175,0.30342,0.66271,HP_ABNORMAL_URINARY_NUCLEOBASE_CONCENTRATION,0.99999
GOMF_AMINOACYLTRANSFERASE_AC...,SET,443,-0.0169,-0.0025934,0.040242,0.66274,GOMF_AMINOACYLTRANSFERASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...142,SET,10,-0.10852,-0.002532,0.25837,0.66276,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_STORAGE,0.99999
GOCC_PRESYNAPTIC_ENDOCYTIC_Z...,SET,9,-0.12795,-0.0028324,0.30452,0.66282,GOCC_PRESYNAPTIC_ENDOCYTIC_ZONE,0.99999
HP_HYPERTONIC_DEHYDRATION,SET,4,-0.20765,-0.0030648,0.49396,0.66289,HP_HYPERTONIC_DEHYDRATION,0.99999
TCATCTC_MIR143,SET,131,-0.03121,-0.002627,0.07424,0.6629,TCATCTC_MIR143,0.99999
chr6q23,SET,45,-0.10202,-0.0050449,0.24262,0.66294,chr6q23,0.99999
MODULE_424,SET,17,-0.091227,-0.0027748,0.21692,0.66296,MODULE_424,0.99999
HOSHIDA_LIVER_CANCER_SURVIVA...2,SET,71,-0.045981,-0.002854,0.10932,0.66298,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,0.99999
GSE22601_DOUBLE_POSITIVE_VS_...2,SET,167,-0.028022,-0.0026605,0.066612,0.663,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.99999
GSE15330_LYMPHOID_MULTIPOTEN...4,SET,180,-0.0269,-0.0026506,0.06389,0.66314,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.99999
GSE2770_IL4_ACT_VS_ACT_CD4_T...3,SET,179,-0.02706,-0.002659,0.064255,0.66317,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,0.99999
GOBP_NEURAL_PLATE_REGIONALIZ...,SET,5,-0.17058,-0.0028147,0.40501,0.66318,GOBP_NEURAL_PLATE_REGIONALIZATION,0.99999
GOBP_NON_CANONICAL_NF_KAPPAB...,SET,112,-0.034204,-0.0026634,0.081203,0.6632,GOBP_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.99999
GOBP_CELL_JUNCTION_ASSEMBLY,SET,421,-0.018967,-0.0028391,0.045018,0.66324,GOBP_CELL_JUNCTION_ASSEMBLY,0.99999
ZNF837_TARGET_GENES,SET,5,-0.16657,-0.0027486,0.39533,0.66325,ZNF837_TARGET_GENES,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...6,SET,174,-0.027384,-0.0026533,0.064979,0.66327,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_UP,0.99999
REACTOME_SIGNALING_BY_ALK,SET,26,-0.074196,-0.0027903,0.17606,0.66328,REACTOME_SIGNALING_BY_ALK,0.99999
GSE27786_CD8_TCELL_VS_NKCELL...2,SET,187,-0.025995,-0.0026102,0.061677,0.66329,GSE27786_CD8_TCELL_VS_NKCELL_UP,0.99999
GOBP_VENTRICULAR_CARDIAC_MUS...5,SET,60,-0.053073,-0.0030292,0.12588,0.66334,GOBP_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,0.99999
HP_AUTOIMMUNITY,SET,264,-0.023329,-0.0027774,0.055324,0.66337,HP_AUTOIMMUNITY,0.99999
GSE29615_CTRL_VS_LAIV_FLU_VA...1,SET,135,-0.030124,-0.0025738,0.071413,0.66342,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN,0.99999
GOBP_XENOBIOTIC_TRANSPORT,SET,47,-0.05603,-0.0028314,0.13282,0.66343,GOBP_XENOBIOTIC_TRANSPORT,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...8,SET,44,-0.058883,-0.0028793,0.13954,0.66348,GAVISH_3CA_METAPROGRAM_B_CELLS_MHC_II,0.99999
GOBP_REGULATION_OF_CELL_DIVI...,SET,171,-0.028302,-0.0027187,0.067061,0.66349,GOBP_REGULATION_OF_CELL_DIVISION,0.99999
RAY_TUMORIGENESIS_BY_ERBB2_C...2,SET,176,-0.027141,-0.0026447,0.064299,0.66353,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,0.99999
GSE2770_TGFB_AND_IL4_VS_IL4_...1,SET,178,-0.027388,-0.0026838,0.064875,0.66355,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.99999
GSE2405_0H_VS_12H_A_PHAGOCYT...2,SET,184,-0.027644,-0.0027537,0.065458,0.6636,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.99999
HP_ABNORMAL_GLYCOSYLATION,SET,44,-0.051168,-0.002502,0.12111,0.66366,HP_ABNORMAL_GLYCOSYLATION,0.99999
ELLWOOD_MYC_TARGETS_UP,SET,13,-0.10404,-0.0027677,0.24618,0.66371,ELLWOOD_MYC_TARGETS_UP,0.99999
MIR203A_3P,SET,334,-0.02069,-0.0027653,0.048955,0.66372,MIR203A_3P,0.99999
NAKAYA_PBMC_FLUARIX_FLUVIRIN...3,SET,259,-0.023861,-0.0028142,0.056456,0.66372,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.99999
GOBP_REGULATION_OF_CALCIUM_I...4,SET,40,-0.056932,-0.0026546,0.13469,0.66373,GOBP_REGULATION_OF_CALCIUM_ION_IMPORT,0.99999
GOBP_REGULATION_OF_KILLING_O...,SET,9,-0.13823,-0.0030599,0.32704,0.66373,GOBP_REGULATION_OF_KILLING_OF_CELLS_OF_ANOTHER_ORGANISM,0.99999
HP_3_METHYLGLUTARIC_ACIDURIA,SET,5,-0.15474,-0.0025533,0.36606,0.66374,HP_3_METHYLGLUTARIC_ACIDURIA,0.99999
BIOCARTA_MITOCHONDRIA_PATHWAY,SET,17,-0.0867,-0.0026371,0.20509,0.66376,BIOCARTA_MITOCHONDRIA_PATHWAY,0.99999
RGAGGAARY_PU1_Q6,SET,462,-0.017416,-0.0027278,0.041177,0.66383,RGAGGAARY_PU1_Q6,0.99999
BIOCARTA_EIF2_PATHWAY,SET,9,-0.11735,-0.0025977,0.27742,0.66385,BIOCARTA_EIF2_PATHWAY,0.99999
GSE26030_TH1_VS_TH17_RESTIMU...1,SET,181,-0.026341,-0.0026026,0.062269,0.66386,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_DN,0.99999
WP_OSTEOBLAST_DIFFERENTIATIO...,SET,116,-0.037358,-0.0029602,0.088288,0.6639,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,0.99999
GOCC_NEURONAL_DENSE_CORE_VES...1,SET,25,-0.081478,-0.0030047,0.1925,0.66395,GOCC_NEURONAL_DENSE_CORE_VESICLE,0.99999
MIR4422,SET,416,-0.01855,-0.0027605,0.04382,0.66397,MIR4422,0.99999
MIR7976,SET,91,-0.036992,-0.002598,0.087371,0.66399,MIR7976,0.99999
REACTOME_TICAM1_DEPENDENT_AC...,SET,12,-0.10629,-0.0027165,0.25103,0.664,REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7,0.99999
REACTOME_GLYCOSPHINGOLIPID_M...,SET,50,-0.052943,-0.0027592,0.12502,0.66402,REACTOME_GLYCOSPHINGOLIPID_METABOLISM,0.99999
HP_YELLOW_WHITE_LESIONS_OF_T...2,SET,55,-0.049381,-0.0026988,0.1166,0.66403,HP_YELLOW_WHITE_LESIONS_OF_THE_RETINA,0.99999
GSE13547_CTRL_VS_ANTI_IGM_ST...7,SET,149,-0.028793,-0.0025834,0.06799,0.66403,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_DN,0.99999
LET_7F_5P,SET,362,-0.019467,-0.0027065,0.04596,0.66405,LET_7F_5P,0.99999
GSE15330_LYMPHOID_MULTIPOTEN...8,SET,181,-0.026557,-0.0026239,0.062697,0.66406,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,0.99999
EGFR_UP.V1_UP,SET,169,-0.030346,-0.0028981,0.071627,0.66409,EGFR_UP.V1_UP,0.99999
GSE22886_DAY1_VS_DAY7_MONOCY...2,SET,181,-0.027551,-0.0027221,0.065021,0.66411,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP,0.99999
HP_ABNORMAL_HEMOGLOBIN_CONCE...,SET,17,-0.085916,-0.0026133,0.20276,0.66412,HP_ABNORMAL_HEMOGLOBIN_CONCENTRATION,0.99999
GOBP_REGULATION_OF_TRANSLATI...13,SET,20,-0.077556,-0.0025585,0.18295,0.66419,GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS,0.99999
HP_ABNORMAL_ATRIAL_ARRANGEME...,SET,41,-0.054393,-0.0025677,0.12827,0.66423,HP_ABNORMAL_ATRIAL_ARRANGEMENT,0.99999
HP_SPONDYLOMETAPHYSEAL_DYSPL...,SET,8,-0.12745,-0.00266,0.30056,0.66423,HP_SPONDYLOMETAPHYSEAL_DYSPLASIA,0.99999
GSE33513_TCF7_KO_VS_HET_EARL...1,SET,181,-0.026607,-0.0026288,0.062736,0.66425,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN,0.99999
CARRILLOREIXACH_HEPATOBLASTO...4,SET,735,-0.014078,-0.0027599,0.033193,0.66426,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP,0.99999
JOHNSTONE_PARVB_TARGETS_1_UP,SET,6,-0.15229,-0.0027527,0.35904,0.66427,JOHNSTONE_PARVB_TARGETS_1_UP,0.99999
GOCC_MCRD_MEDIATED_MRNA_STAB...,SET,5,-0.16381,-0.002703,0.38616,0.66429,GOCC_MCRD_MEDIATED_MRNA_STABILITY_COMPLEX,0.99999
HP_OPTIC_NERVE_DYSPLASIA,SET,6,-0.16019,-0.0028954,0.37757,0.66431,HP_OPTIC_NERVE_DYSPLASIA,0.99999
HP_ABNORMALITY_OF_THE_URINAR...,SET,988,-0.011778,-0.0026578,0.027759,0.66432,HP_ABNORMALITY_OF_THE_URINARY_SYSTEM_PHYSIOLOGY,0.99999
HP_AMYOTROPHIC_LATERAL_SCLER...,SET,48,-0.049931,-0.0025498,0.11768,0.66432,HP_AMYOTROPHIC_LATERAL_SCLEROSIS,0.99999
MIR4691_3P,SET,90,-0.037735,-0.0026357,0.088929,0.66433,MIR4691_3P,0.99999
chr4p15,SET,46,-0.10684,-0.0053416,0.25178,0.66434,chr4p15,0.99999
GOBP_KIDNEY_EPITHELIUM_DEVEL...,SET,143,-0.033885,-0.002979,0.079822,0.6644,GOBP_KIDNEY_EPITHELIUM_DEVELOPMENT,0.99999
AAGWWRNYGGC_UNKNOWN,SET,111,-0.0336,-0.0026048,0.079139,0.66442,AAGWWRNYGGC_UNKNOWN,0.99999
GOBP_GAMMA_AMINOBUTYRIC_ACID...5,SET,26,-0.081298,-0.0030574,0.19144,0.66446,GOBP_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY,0.99999
ZHONG_SECRETOME_OF_LUNG_CANC...2,SET,122,-0.031924,-0.0025938,0.075163,0.66448,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,0.99999
WP_CEREBRAL_ORGANIC_ACIDURIA...,SET,8,-0.12517,-0.0026124,0.2947,0.66449,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,0.99999
GNF2_PCNA,SET,64,-0.043452,-0.0025611,0.1023,0.66449,GNF2_PCNA,0.99999
GSE21927_SPLEEN_MONOCYTE_VS_...2,SET,151,-0.027535,-0.0024869,0.064821,0.6645,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_UP,0.99999
WP_LTF_DANGER_SIGNAL_RESPONS...,SET,18,-0.092152,-0.0028841,0.21691,0.66452,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,0.99999
HP_INFECTIOUS_ENCEPHALITIS,SET,39,-0.061017,-0.0028094,0.1436,0.66455,HP_INFECTIOUS_ENCEPHALITIS,0.99999
GOBP_ERYTHROSE_4_PHOSPHATE_P...,SET,17,-0.094953,-0.0028882,0.22341,0.66459,GOBP_ERYTHROSE_4_PHOSPHATE_PHOSPHOENOLPYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_EREG_...2,SET,14,-0.098861,-0.002729,0.23258,0.6646,KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...367,SET,14,-0.10241,-0.0028272,0.24084,0.66467,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_ACTIVATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_CD4...,SET,30,-0.072232,-0.0029176,0.16982,0.6647,HE_LIM_SUN_FETAL_LUNG_C4_CD4_T_CELL,0.99999
HP_TETRAPLEGIA_TETRAPARESIS,SET,124,-0.032404,-0.0026541,0.076179,0.66471,HP_TETRAPLEGIA_TETRAPARESIS,0.99999
HP_ADVANCED_OSSIFICATION_OF_...,SET,10,-0.11269,-0.0026294,0.26492,0.66472,HP_ADVANCED_OSSIFICATION_OF_CARPAL_BONES,0.99999
KEGG_MEDICUS_REFERENCE_CCR2_...,SET,30,-0.068016,-0.0027473,0.15984,0.66477,KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,0.99999
GOBP_FIBROBLAST_MIGRATION,SET,49,-0.054157,-0.0027942,0.12725,0.6648,GOBP_FIBROBLAST_MIGRATION,0.99999
ZNF547_TARGET_GENES,SET,263,-0.023185,-0.0027551,0.054458,0.66485,ZNF547_TARGET_GENES,0.99999
GCATTTG_MIR105,SET,153,-0.030297,-0.0027543,0.071153,0.66487,GCATTTG_MIR105,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...18,SET,47,-0.060796,-0.0030723,0.14277,0.66488,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_1,0.99999
GOBP_METHIONINE_BIOSYNTHETIC...,SET,12,-0.10398,-0.0026575,0.24416,0.66489,GOBP_METHIONINE_BIOSYNTHETIC_PROCESS,0.99999
KYNG_ENVIRONMENTAL_STRESS_RE...6,SET,23,-0.074228,-0.0026257,0.17428,0.66491,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,0.99999
GSE27786_CD8_TCELL_VS_MONO_M...1,SET,179,-0.02649,-0.002603,0.062194,0.66492,GSE27786_CD8_TCELL_VS_MONO_MAC_DN,0.99999
KEGG_TRYPTOPHAN_METABOLISM,SET,36,-0.061776,-0.002733,0.14502,0.66494,KEGG_TRYPTOPHAN_METABOLISM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...344,SET,88,-0.04249,-0.0029347,0.099708,0.66499,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,0.99999
HOEGERKORP_CD44_TARGETS_TEMP...2,SET,10,-0.12132,-0.0028308,0.28465,0.66502,HOEGERKORP_CD44_TARGETS_TEMPORAL_UP,0.99999
GNF2_SPRR1B,SET,23,-0.082898,-0.0029324,0.19439,0.6651,GNF2_SPRR1B,0.99999
LAKE_ADULT_KIDNEY_C5_PROXIMA...,SET,359,-0.019898,-0.0027552,0.046648,0.66515,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,0.99999
REACTOME_ACTIVATED_NTRK2_SIG...2,SET,11,-0.099353,-0.0024313,0.2329,0.66516,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3,0.99999
HP_CONGENITAL_HEPATIC_FIBROS...,SET,42,-0.053369,-0.0025498,0.12511,0.66516,HP_CONGENITAL_HEPATIC_FIBROSIS,0.99999
BIOCARTA_CARDIACEGF_PATHWAY,SET,17,-0.096823,-0.002945,0.22673,0.66532,BIOCARTA_CARDIACEGF_PATHWAY,0.99999
HP_EXTRAPYRAMIDAL_DYSKINESIA,SET,6,-0.16785,-0.003034,0.3929,0.66538,HP_EXTRAPYRAMIDAL_DYSKINESIA,0.99999
HP_ABNORMAL_MIDDLE_EAR_MORPH...,SET,322,-0.021329,-0.0027999,0.049907,0.66544,HP_ABNORMAL_MIDDLE_EAR_MORPHOLOGY,0.99999
HP_VESTIBULAR_SCHWANNOMA,SET,6,-0.13974,-0.0025259,0.32697,0.66545,HP_VESTIBULAR_SCHWANNOMA,0.99999
REACTOME_INTERLEUKIN_4_AND_I...,SET,101,-0.040901,-0.0030254,0.095667,0.6655,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,0.99999
GSE360_L_DONOVANI_VS_M_TUBER...1,SET,183,-0.02677,-0.0026594,0.062597,0.66555,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN,0.99999
IZADPANAH_STEM_CELL_ADIPOSE_...1,SET,97,-0.038251,-0.0027731,0.089427,0.66558,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,0.99999
GOBP_REGULATION_OF_CARDIAC_M...7,SET,35,-0.070248,-0.0030644,0.16418,0.66562,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.99999
MIR6811_3P,SET,55,-0.049821,-0.0027229,0.11644,0.66563,MIR6811_3P,0.99999
MODULE_156,SET,16,-0.092359,-0.0027255,0.2158,0.66566,MODULE_156,0.99999
GOBP_MAMMARY_GLAND_EPITHELIA...2,SET,25,-0.081229,-0.0029955,0.1898,0.66566,GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,0.99999
GSE25123_ROSIGLITAZONE_VS_IL...2,SET,177,-0.027651,-0.002702,0.064607,0.66567,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,0.99999
HP_ADRENAL_OVERACTIVITY,SET,49,-0.057084,-0.0029452,0.13335,0.6657,HP_ADRENAL_OVERACTIVITY,0.99999
GSE27859_DC_VS_CD11C_INT_F48...2,SET,182,-0.025486,-0.002525,0.059525,0.66573,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,0.99999
HP_REDUCED_BRAIN_N_ACETYL_AS...,SET,16,-0.081861,-0.0024157,0.19118,0.66574,HP_REDUCED_BRAIN_N_ACETYL_ASPARTATE_LEVEL_BY_MRS,0.99999
AIZARANI_LIVER_C5_NK_NKT_CEL...,SET,110,-0.0368,-0.0028401,0.085938,0.66575,AIZARANI_LIVER_C5_NK_NKT_CELLS_3,0.99999
GOBP_SOMITE_DEVELOPMENT,SET,74,-0.044132,-0.0027963,0.10305,0.66576,GOBP_SOMITE_DEVELOPMENT,0.99999
BLANCO_MELO_BRONCHIAL_EPITHE...2,SET,577,-0.016385,-0.0028589,0.03826,0.66577,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP,0.99999
KEGG_MEDICUS_PATHOGEN_ESCHER...3,SET,16,-0.099677,-0.0029414,0.23269,0.66581,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY,0.99999
GOMF_INOSITOL_BISPHOSPHATE_P...,SET,7,-0.12683,-0.0024761,0.29606,0.66581,GOMF_INOSITOL_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.99999
HP_ABNORMAL_CIRCULATING_FERR...,SET,47,-0.054805,-0.0027695,0.12794,0.66581,HP_ABNORMAL_CIRCULATING_FERRITIN_CONCENTRATION,0.99999
GOBP_DERMATAN_SULFATE_BIOSYN...,SET,5,-0.17084,-0.0028191,0.39873,0.66584,GOBP_DERMATAN_SULFATE_BIOSYNTHETIC_PROCESS,0.99999
IGARASHI_ATF4_TARGETS_DN,SET,88,-0.040522,-0.0027988,0.09457,0.66585,IGARASHI_ATF4_TARGETS_DN,0.99999
GOBP_QUATERNARY_AMMONIUM_GRO...,SET,16,-0.105,-0.0030985,0.24504,0.66585,GOBP_QUATERNARY_AMMONIUM_GROUP_TRANSPORT,0.99999
BROWNE_HCMV_INFECTION_18HR_UP,SET,156,-0.029554,-0.0027128,0.068964,0.66587,BROWNE_HCMV_INFECTION_18HR_UP,0.99999
GOCC_SORTING_ENDOSOME,SET,6,-0.14114,-0.0025513,0.32927,0.66591,GOCC_SORTING_ENDOSOME,0.99999
LET_7D_3P,SET,8,-0.14581,-0.0030431,0.34008,0.66594,LET_7D_3P,0.99999
MIR5197_5P,SET,164,-0.02893,-0.0027222,0.06748,0.66594,MIR5197_5P,0.99999
GOBP_PENILE_ERECTION,SET,7,-0.14115,-0.0027558,0.32921,0.66595,GOBP_PENILE_ERECTION,0.99999
GOMF_NUCLEOSIDE_TRIPHOSPHATE...,SET,9,-0.12406,-0.0027461,0.28927,0.66598,GOMF_NUCLEOSIDE_TRIPHOSPHATE_DIPHOSPHATASE_ACTIVITY,0.99999
HP_LONG_PHILTRUM,SET,371,-0.019004,-0.0026742,0.044308,0.66601,HP_LONG_PHILTRUM,0.99999
HP_ABNORMALITY_OF_THE_ANTERI...2,SET,110,-0.034627,-0.0026723,0.080724,0.66602,HP_ABNORMALITY_OF_THE_ANTERIOR_FONTANELLE,0.99999
REACTOME_SIGNALING_BY_FGFR_I...,SET,61,-0.04795,-0.0027594,0.11176,0.66605,REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,0.99999
GSE29618_MONOCYTE_VS_MDC_DN,SET,170,-0.02931,-0.0028074,0.068307,0.66607,GSE29618_MONOCYTE_VS_MDC_DN,0.99999
SU_SALIVARY_GLAND,SET,10,-0.12377,-0.0028878,0.28826,0.66616,SU_SALIVARY_GLAND,0.99999
HP_HEMOPHAGOCYTOSIS,SET,19,-0.092929,-0.0029881,0.2164,0.66619,HP_HEMOPHAGOCYTOSIS,0.99999
MODULE_497,SET,29,-0.074787,-0.0029701,0.17414,0.66621,MODULE_497,0.99999
GOMF_APOLIPOPROTEIN_BINDING,SET,17,-0.089586,-0.0027249,0.20856,0.66623,GOMF_APOLIPOPROTEIN_BINDING,0.99999
GOBP_REGULATION_OF_MUSCLE_TI...,SET,42,-0.061633,-0.0029446,0.14348,0.66624,GOBP_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,0.99999
PETRETTO_CARDIAC_HYPERTROPHY,SET,32,-0.066626,-0.0027792,0.1551,0.66625,PETRETTO_CARDIAC_HYPERTROPHY,0.99999
GOBP_REGULATION_OF_ENDOCRINE...,SET,39,-0.065599,-0.0030203,0.15269,0.66626,GOBP_REGULATION_OF_ENDOCRINE_PROCESS,0.99999
GOMF_RNA_POLYMERASE_III_TRAN...,SET,8,-0.10733,-0.0022401,0.24978,0.66629,GOMF_RNA_POLYMERASE_III_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.99999
SEITZ_NEOPLASTIC_TRANSFORMAT...1,SET,30,-0.066228,-0.002675,0.15411,0.6663,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,0.99999
GOBP_POLY_A_DEPENDENT_SNORNA...,SET,6,-0.12909,-0.0023334,0.30039,0.66631,GOBP_POLY_A_DEPENDENT_SNORNA_3_END_PROCESSING,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...14,SET,27,-0.062428,-0.0023924,0.14523,0.66634,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION,0.99999
HP_IRREGULAR_VERTEBRAL_ENDPL...,SET,27,-0.073728,-0.0028254,0.17152,0.66635,HP_IRREGULAR_VERTEBRAL_ENDPLATES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...350,SET,21,-0.082165,-0.0027774,0.19109,0.6664,GOBP_NEGATIVE_REGULATION_OF_LIPID_STORAGE,0.99999
GOMF_MYOSIN_V_BINDING,SET,16,-0.097835,-0.002887,0.22749,0.66642,GOMF_MYOSIN_V_BINDING,0.99999
GSE42021_TCONV_PLN_VS_CD24HI...2,SET,186,-0.027375,-0.0027415,0.063643,0.66645,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP,0.99999
CHEOK_RESPONSE_TO_MERCAPTOPU...3,SET,17,-0.097774,-0.0029739,0.22729,0.66646,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN,0.99999
REACTOME_ERKS_ARE_INACTIVATED,SET,13,-0.098771,-0.0026274,0.2296,0.66646,REACTOME_ERKS_ARE_INACTIVATED,0.99999
GOMF_3_PHOSPHOADENOSINE_5_PH...,SET,9,-0.12497,-0.0027663,0.2905,0.66646,GOMF_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_BINDING,0.99999
HP_SOMATIC_SENSORY_DYSFUNCTI...,SET,379,-0.018645,-0.0026512,0.043342,0.66647,HP_SOMATIC_SENSORY_DYSFUNCTION,0.99999
REACTOME_ONCOGENIC_MAPK_SIGN...,SET,77,-0.042975,-0.0027774,0.099893,0.66648,REACTOME_ONCOGENIC_MAPK_SIGNALING,0.99999
ACCAAAG_MIR9,SET,467,-0.017223,-0.0027118,0.040031,0.66649,ACCAAAG_MIR9,0.99999
COBLL1_TARGET_GENES,SET,115,-0.032577,-0.0025703,0.075703,0.66652,COBLL1_TARGET_GENES,0.99999
GOBP_FIBROBLAST_APOPTOTIC_PR...,SET,24,-0.074969,-0.0027089,0.1742,0.66653,GOBP_FIBROBLAST_APOPTOTIC_PROCESS,0.99999
KEGG_SNARE_INTERACTIONS_IN_V...,SET,36,-0.058935,-0.0026073,0.1369,0.66658,KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT,0.99999
GARCIA_PINERES_PBMC_HPV_16_L...5,SET,12,-0.10853,-0.0027738,0.25205,0.66661,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_7MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE,0.99999
REACTOME_SIGNALLING_TO_P38_V...,SET,5,-0.14539,-0.002399,0.33764,0.66662,REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN,0.99999
GOBP_C_TERMINAL_PROTEIN_LIPI...,SET,8,-0.12516,-0.0026122,0.29065,0.66663,GOBP_C_TERMINAL_PROTEIN_LIPIDATION,0.99999
GSE9509_LPS_VS_LPS_AND_IL10_...2,SET,187,-0.028488,-0.0028605,0.066147,0.66665,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP,0.99999
GOBP_REGULATION_OF_REMOVAL_O...,SET,6,-0.14748,-0.0026658,0.34239,0.66667,GOBP_REGULATION_OF_REMOVAL_OF_SUPEROXIDE_RADICALS,0.99999
MODULE_59,SET,22,-0.087467,-0.0030261,0.20304,0.66669,MODULE_59,0.99999
GOBP_IMMUNE_RESPONSE_REGULAT...1,SET,307,-0.022043,-0.0028266,0.05117,0.66669,GOBP_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.99999
ZHAN_MULTIPLE_MYELOMA_LB_UP,SET,45,-0.059886,-0.0029613,0.139,0.6667,ZHAN_MULTIPLE_MYELOMA_LB_UP,0.99999
GOBP_AUDITORY_RECEPTOR_CELL_...1,SET,24,-0.077678,-0.0028068,0.18023,0.66676,GOBP_AUDITORY_RECEPTOR_CELL_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_CELL_PROJ...1,SET,202,-0.026728,-0.0027882,0.062009,0.66678,GOBP_REGULATION_OF_CELL_PROJECTION_ASSEMBLY,0.99999
LAIHO_COLORECTAL_CANCER_SERR...2,SET,103,-0.035379,-0.0026426,0.082068,0.6668,LAIHO_COLORECTAL_CANCER_SERRATED_UP,0.99999
ELF5_TARGET_GENES,SET,379,-0.01894,-0.0026932,0.043924,0.66684,ELF5_TARGET_GENES,0.99999
HP_CEREBELLAR_DENTATE_NUCLEU...,SET,5,-0.18783,-0.0030994,0.43558,0.66684,HP_CEREBELLAR_DENTATE_NUCLEUS_CALCIFICATION,0.99999
GSE15659_RESTING_TREG_VS_NON...2,SET,160,-0.029032,-0.0026985,0.067323,0.66685,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP,0.99999
GSE14308_TH2_VS_NATURAL_TREG...1,SET,180,-0.027623,-0.0027218,0.064048,0.66687,GSE14308_TH2_VS_NATURAL_TREG_DN,0.99999
HP_ABNORMAL_ORAL_PHYSIOLOGY,SET,286,-0.022544,-0.0027918,0.052263,0.66689,HP_ABNORMAL_ORAL_PHYSIOLOGY,0.99999
HP_IMMUNOLOGIC_HYPERSENSITIV...,SET,209,-0.02618,-0.0027774,0.060657,0.66698,HP_IMMUNOLOGIC_HYPERSENSITIVITY,0.99999
GOMF_C2H2_ZINC_FINGER_DOMAIN...,SET,12,-0.11255,-0.0028767,0.26061,0.66708,GOMF_C2H2_ZINC_FINGER_DOMAIN_BINDING,0.99999
HP_IRREGULAR_FEMORAL_EPIPHYS...,SET,8,-0.12749,-0.0026609,0.29519,0.66709,HP_IRREGULAR_FEMORAL_EPIPHYSIS,0.99999
RIGGINS_TAMOXIFEN_RESISTANCE...1,SET,202,-0.027603,-0.0028795,0.063899,0.66712,RIGGINS_TAMOXIFEN_RESISTANCE_DN,0.99999
LEE_LIVER_CANCER_CIPROFIBRAT...1,SET,63,-0.050604,-0.0029594,0.11714,0.66713,LEE_LIVER_CANCER_CIPROFIBRATE_DN,0.99999
MODULE_103,SET,10,-0.10179,-0.0023751,0.23563,0.66713,MODULE_103,0.99999
HP_ABNORMAL_FRONTALIS_MUSCLE...,SET,10,-0.1229,-0.0028677,0.28444,0.66716,HP_ABNORMAL_FRONTALIS_MUSCLE_PHYSIOLOGY,0.99999
HP_EPISODIC_RESPIRATORY_DIST...,SET,10,-0.1229,-0.0028677,0.28444,0.66716,HP_EPISODIC_RESPIRATORY_DISTRESS,0.99999
GOBP_DENDRITIC_CELL_ANTIGEN_...,SET,13,-0.099942,-0.0026586,0.23126,0.66718,GOBP_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,0.99999
GOBP_GOLGI_TO_LYSOSOME_TRANS...,SET,12,-0.098744,-0.0025238,0.22845,0.66721,GOBP_GOLGI_TO_LYSOSOME_TRANSPORT,0.99999
HP_SLOWED_SLURRED_SPEECH,SET,6,-0.14551,-0.0026302,0.33664,0.66721,HP_SLOWED_SLURRED_SPEECH,0.99999
HP_INCREASED_ERYTHROCYTE_PRO...,SET,4,-0.18335,-0.0027061,0.42414,0.66723,HP_INCREASED_ERYTHROCYTE_PROTOPORPHYRIN_CONCENTRATION,0.99999
HP_GASTROINTESTINAL_STROMA_T...,SET,19,-0.088137,-0.002834,0.20387,0.66725,HP_GASTROINTESTINAL_STROMA_TUMOR,0.99999
HP_PERIORBITAL_ECCHYMOSIS_WI...,SET,7,-0.17356,-0.0033885,0.40142,0.66726,HP_PERIORBITAL_ECCHYMOSIS_WITH_TARSAL_PLATE_SPARING,0.99999
HP_APPENDICULAR_HYPOTONIA,SET,16,-0.085389,-0.0025198,0.19748,0.66727,HP_APPENDICULAR_HYPOTONIA,0.99999
BIOCARTA_TGFB_PATHWAY,SET,19,-0.089601,-0.0028811,0.20718,0.6673,BIOCARTA_TGFB_PATHWAY,0.99999
GOBP_DOPAMINE_SECRETION,SET,29,-0.073063,-0.0029016,0.16894,0.6673,GOBP_DOPAMINE_SECRETION,0.99999
GOBP_REGULATION_OF_NEURON_AP...,SET,219,-0.026038,-0.0028269,0.060188,0.66735,GOBP_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,0.99999
GCM_Q2,SET,212,-0.025979,-0.0027755,0.060042,0.66737,GCM_Q2,0.99999
GSE24142_ADULT_VS_FETAL_EARL...1,SET,177,-0.028752,-0.0028095,0.066451,0.66737,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN,0.99999
PELLICCIOTTA_HDAC_IN_ANTIGEN...1,SET,49,-0.046584,-0.0024035,0.10764,0.6674,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,0.99999
LEE_LIVER_CANCER_MYC_TGFA_UP,SET,58,-0.053037,-0.0029764,0.12254,0.66742,LEE_LIVER_CANCER_MYC_TGFA_UP,0.99999
GOMF_PHOSPHATE_TRANSMEMBRANE...,SET,16,-0.094611,-0.0027919,0.21854,0.66746,GOMF_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE3982_BCELL_VS_TH1_DN,SET,176,-0.028172,-0.0027451,0.065074,0.66746,GSE3982_BCELL_VS_TH1_DN,0.99999
HP_AGYRIA,SET,15,-0.083739,-0.0023927,0.19339,0.66749,HP_AGYRIA,0.99999
MIR635,SET,40,-0.061041,-0.0028462,0.14096,0.6675,MIR635,0.99999
ZFP37_TARGET_GENES,SET,4,-0.22244,-0.0032831,0.5137,0.6675,ZFP37_TARGET_GENES,0.99999
GOBP_GUANINE_METABOLIC_PROCE...,SET,4,-0.17889,-0.0026403,0.41291,0.66758,GOBP_GUANINE_METABOLIC_PROCESS,0.99999
GOCC_SCF_UBIQUITIN_LIGASE_CO...,SET,59,-0.050255,-0.0028444,0.11599,0.66759,GOCC_SCF_UBIQUITIN_LIGASE_COMPLEX,0.99999
GSE22611_NOD2_TRANSD_VS_CTRL...1,SET,114,-0.035281,-0.0027716,0.081412,0.66762,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN,0.99999
GOCC_CD95_DEATH_INDUCING_SIG...,SET,6,-0.16742,-0.0030262,0.38604,0.66774,GOCC_CD95_DEATH_INDUCING_SIGNALING_COMPLEX,0.99999
HP_HAMARTOMA_OF_THE_ORBITAL_...,SET,29,-0.062843,-0.0024958,0.14487,0.66777,HP_HAMARTOMA_OF_THE_ORBITAL_REGION,0.99999
REACTOME_SCAVENGING_BY_CLASS...1,SET,18,-0.09693,-0.0030337,0.22341,0.66781,REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS,0.99999
GOMF_PROTEIN_FOLDING_CHAPERO...2,SET,125,-0.032372,-0.0026622,0.074609,0.66781,GOMF_PROTEIN_FOLDING_CHAPERONE_BINDING,0.99999
GOBP_POLYSACCHARIDE_METABOLI...,SET,97,-0.037492,-0.0027181,0.086395,0.66784,GOBP_POLYSACCHARIDE_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...8,SET,12,-0.10296,-0.0026315,0.23721,0.66787,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CYCLE,0.99999
BURTON_ADIPOGENESIS_12,SET,28,-0.068769,-0.0026837,0.15839,0.66791,BURTON_ADIPOGENESIS_12,0.99999
GOBP_CONVERGENT_EXTENSION_IN...2,SET,9,-0.12513,-0.00277,0.2881,0.66797,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_GASTRULATION,0.99999
GOBP_REGULATION_OF_POTASSIUM...4,SET,87,-0.042906,-0.0029467,0.098776,0.66799,GOBP_REGULATION_OF_POTASSIUM_ION_TRANSPORT,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...9,SET,200,-0.025626,-0.0026602,0.058975,0.66804,GAUTAM_EYE_IRIS_CILIARY_BODY_MELANOCYTES,0.99999
HP_OPTIC_NERVE_MISROUTING,SET,5,-0.18495,-0.0030518,0.42557,0.66806,HP_OPTIC_NERVE_MISROUTING,0.99999
GOBP_PSYCHOMOTOR_BEHAVIOR,SET,3,-0.2607,-0.0033324,0.59985,0.66807,GOBP_PSYCHOMOTOR_BEHAVIOR,0.99999
HUMMERICH_MALIGNANT_SKIN_TUM...2,SET,16,-0.090623,-0.0026742,0.2085,0.66808,HUMMERICH_MALIGNANT_SKIN_TUMOR_UP,0.99999
ERWIN_COHEN_BLOOD_LIVE_VACCI...,SET,618,-0.015213,-0.0027438,0.034991,0.66813,ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP,0.99999
HP_POLYNEUROPATHY,SET,45,-0.056582,-0.0027979,0.13012,0.66816,HP_POLYNEUROPATHY,0.99999
WP_OLIGODENDROCYTE_SPECIFICA...,SET,29,-0.074902,-0.0029747,0.17222,0.66819,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,0.99999
GOCC_RNA_POLYMERASE_COMPLEX,SET,90,-0.035315,-0.0024666,0.081186,0.66821,GOCC_RNA_POLYMERASE_COMPLEX,0.99999
CHUNG_BLISTER_CYTOTOXICITY_UP,SET,120,-0.033406,-0.002692,0.076792,0.66822,CHUNG_BLISTER_CYTOTOXICITY_UP,0.99999
GSE5542_IFNA_VS_IFNA_AND_IFN...2,SET,183,-0.027531,-0.002735,0.063288,0.66822,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.99999
HP_ABDOMINAL_WALL_MUSCLE_WEA...,SET,14,-0.095504,-0.0026364,0.2195,0.66825,HP_ABDOMINAL_WALL_MUSCLE_WEAKNESS,0.99999
REACTOME_CONDENSATION_OF_PRO...2,SET,11,-0.084499,-0.0020678,0.19419,0.66826,REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES,0.99999
WP_TGFBETA_RECEPTOR_SIGNALING,SET,51,-0.058568,-0.0030827,0.13459,0.66827,WP_TGFBETA_RECEPTOR_SIGNALING,0.99999
HP_LOSS_OF_SUBCUTANEOUS_ADIP...,SET,9,-0.13078,-0.0028949,0.30042,0.66833,HP_LOSS_OF_SUBCUTANEOUS_ADIPOSE_TISSUE_IN_LIMBS,0.99999
GOBP_POSITIVE_REGULATION_OF_...804,SET,63,-0.051852,-0.0030323,0.11909,0.66836,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,0.99999
CCACACA_MIR147,SET,56,-0.049207,-0.0027136,0.11301,0.66837,CCACACA_MIR147,0.99999
GOBP_PYRIMIDINE_CONTAINING_C...3,SET,80,-0.043307,-0.0028526,0.099416,0.66844,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
GOBP_GENITALIA_MORPHOGENESIS,SET,11,-0.12765,-0.0031237,0.29282,0.66855,GOBP_GENITALIA_MORPHOGENESIS,0.99999
HP_ABNORMAL_GLUCOSE_HOMEOSTA...,SET,622,-0.01531,-0.00277,0.035119,0.66856,HP_ABNORMAL_GLUCOSE_HOMEOSTASIS,0.99999
GOBP_PERICARDIUM_MORPHOGENES...,SET,8,-0.15032,-0.0031373,0.34467,0.66862,GOBP_PERICARDIUM_MORPHOGENESIS,0.99999
MIR5583_5P,SET,93,-0.039647,-0.0028147,0.090895,0.66865,MIR5583_5P,0.99999
GOBP_RETINA_DEVELOPMENT_IN_C...,SET,155,-0.031656,-0.0028964,0.072556,0.66868,GOBP_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.99999
GOBP_PROTEIN_REPAIR,SET,7,-0.12788,-0.0024967,0.29295,0.66878,GOBP_PROTEIN_REPAIR,0.99999
GOCC_SCHMIDT_LANTERMAN_INCIS...,SET,10,-0.13019,-0.0030376,0.29821,0.66878,GOCC_SCHMIDT_LANTERMAN_INCISURE,0.99999
MODULE_72,SET,284,-0.022232,-0.0027437,0.050921,0.66879,MODULE_72,0.99999
GOBP_POSITIVE_REGULATION_OF_...749,SET,11,-0.10956,-0.002681,0.25086,0.66884,GOBP_POSITIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.99999
HP_CONGENITAL_THROMBOCYTOPEN...,SET,4,-0.16014,-0.0023636,0.3667,0.66884,HP_CONGENITAL_THROMBOCYTOPENIA,0.99999
PEA3_Q6,SET,242,-0.025184,-0.0028723,0.05766,0.66886,PEA3_Q6,0.99999
GOBP_REGULATION_OF_METALLOEN...,SET,4,-0.21562,-0.0031825,0.49363,0.66887,GOBP_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.99999
GSE21774_CD62L_POS_CD56_BRIG...1,SET,173,-0.029233,-0.0028244,0.066917,0.66889,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,0.99999
GOBP_T_CELL_APOPTOTIC_PROCESS,SET,56,-0.051609,-0.0028461,0.11807,0.66898,GOBP_T_CELL_APOPTOTIC_PROCESS,0.99999
MIR1295B_5P,SET,69,-0.044293,-0.0027104,0.10133,0.66899,MIR1295B_5P,0.99999
GSE17721_LPS_VS_POLYIC_4H_BM...2,SET,184,-0.026789,-0.0026685,0.061272,0.66902,GSE17721_LPS_VS_POLYIC_4H_BMDC_UP,0.99999
MIR885_5P,SET,102,-0.036015,-0.0026771,0.08237,0.66903,MIR885_5P,0.99999
REACTOME_SULFIDE_OXIDATION_T...,SET,5,-0.13964,-0.0023042,0.31933,0.66905,REACTOME_SULFIDE_OXIDATION_TO_SULFATE,0.99999
KRAS.600.LUNG.BREAST_UP.V1_DN,SET,253,-0.024403,-0.002845,0.055791,0.66909,KRAS.600.LUNG.BREAST_UP.V1_DN,0.99999
chr13q33,SET,18,-0.13211,-0.0041347,0.30199,0.66911,chr13q33,0.99999
WP_PATHWAYS_AFFECTED_IN_ADEN...,SET,56,-0.045896,-0.002531,0.10489,0.66914,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,0.99999
HP_DYSDIADOCHOKINESIS,SET,49,-0.04942,-0.0025498,0.11294,0.66915,HP_DYSDIADOCHOKINESIS,0.99999
HP_DELUSION,SET,28,-0.073512,-0.0028688,0.16795,0.6692,HP_DELUSION,0.99999
KRIGE_RESPONSE_TO_TOSEDOSTAT...2,SET,644,-0.014987,-0.0027574,0.03423,0.66925,KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP,0.99999
GSE2706_UNSTIM_VS_2H_LPS_DC_...1,SET,168,-0.030801,-0.002933,0.070339,0.66927,GSE2706_UNSTIM_VS_2H_LPS_DC_DN,0.99999
REACTOME_CHREBP_ACTIVATES_ME...,SET,8,-0.11132,-0.0023232,0.25394,0.66943,REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION,0.99999
FOROUTAN_PRODRANK_TGFB_EMT_UP,SET,178,-0.029771,-0.0029172,0.067901,0.66946,FOROUTAN_PRODRANK_TGFB_EMT_UP,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...14,SET,105,-0.039845,-0.0030048,0.090852,0.66951,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_ENSHEATHING_GLIA,0.99999
GSE1925_CTRL_VS_24H_IFNG_STI...1,SET,185,-0.027517,-0.0027484,0.062741,0.66952,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,0.99999
CAMPS_COLON_CANCER_COPY_NUMB...1,SET,35,-0.07198,-0.0031399,0.16409,0.66955,CAMPS_COLON_CANCER_COPY_NUMBER_DN,0.99999
LAKE_ADULT_KIDNEY_C2_PODOCYT...,SET,192,-0.029679,-0.0030193,0.067655,0.66955,LAKE_ADULT_KIDNEY_C2_PODOCYTES,0.99999
GOMF_BUBBLE_DNA_BINDING,SET,8,-0.13779,-0.0028758,0.31407,0.66957,GOMF_BUBBLE_DNA_BINDING,0.99999
GSE26030_UNSTIM_VS_RESTIM_TH...7,SET,180,-0.028263,-0.0027849,0.064416,0.66958,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_DN,0.99999
REACTOME_TP53_REGULATES_TRAN...5,SET,12,-0.1156,-0.0029546,0.2633,0.66968,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS,0.99999
HP_APLASIA_HYPOPLASIA_OF_FIN...,SET,314,-0.021244,-0.0027544,0.048388,0.66968,HP_APLASIA_HYPOPLASIA_OF_FINGERS,0.99999
GOBP_REGULATION_OF_NON_MOTIL...,SET,9,-0.1143,-0.0025302,0.26031,0.6697,GOBP_REGULATION_OF_NON_MOTILE_CILIUM_ASSEMBLY,0.99999
GOBP_FORMATION_OF_ANATOMICAL...,SET,6,-0.15975,-0.0028876,0.36373,0.66974,GOBP_FORMATION_OF_ANATOMICAL_BOUNDARY,0.99999
HP_GASTROESOPHAGEAL_REFLUX,SET,434,-0.018302,-0.0027805,0.041668,0.66975,HP_GASTROESOPHAGEAL_REFLUX,0.99999
KEGG_MEDICUS_REFERENCE_TRAIP...,SET,14,-0.095328,-0.0026315,0.21696,0.66981,KEGG_MEDICUS_REFERENCE_TRAIP_DEPENDENT_REPLISOME_DISASSEMBLY,0.99999
GOMF_UBIQUITIN_LIKE_PROTEIN_...4,SET,332,-0.020461,-0.0027267,0.046568,0.66981,GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY,0.99999
HP_FETAL_ASCITES,SET,8,-0.14891,-0.0031079,0.33886,0.66983,HP_FETAL_ASCITES,0.99999
GOCC_CILIARY_BASAL_BODY,SET,144,-0.030746,-0.0027124,0.069957,0.66985,GOCC_CILIARY_BASAL_BODY,0.99999
MIR4302,SET,115,-0.035157,-0.0027738,0.079966,0.6699,MIR4302,0.99999
GOBP_PERICENTRIC_HETEROCHROM...,SET,3,-0.25305,-0.0032346,0.57558,0.6699,GOBP_PERICENTRIC_HETEROCHROMATIN_FORMATION,0.99999
REACTOME_REGULATION_OF_MITF_...1,SET,18,-0.098652,-0.0030876,0.22438,0.66991,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS,0.99999
STARK_HYPPOCAMPUS_22Q11_DELE...1,SET,19,-0.10386,-0.0033394,0.2362,0.66992,STARK_HYPPOCAMPUS_22Q11_DELETION_DN,0.99999
HP_MOTOR_POLYNEUROPATHY,SET,33,-0.06445,-0.0027301,0.14657,0.66993,HP_MOTOR_POLYNEUROPATHY,0.99999
FXR_Q3,SET,102,-0.039467,-0.0029336,0.089745,0.66994,FXR_Q3,0.99999
REACTOME_CROSS_PRESENTATION_...1,SET,6,-0.16703,-0.0030191,0.3796,0.67003,REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...8,SET,10,-0.12803,-0.0029872,0.29094,0.67004,GOBP_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,0.99999
GOBP_NUCLEOBASE_METABOLIC_PR...,SET,36,-0.059994,-0.0026541,0.13633,0.67005,GOBP_NUCLEOBASE_METABOLIC_PROCESS,0.99999
GOBP_SMALL_MOLECULE_METABOLI...,SET,1628,-0.0097932,-0.002784,0.022253,0.67006,GOBP_SMALL_MOLECULE_METABOLIC_PROCESS,0.99999
HALLMARK_ANDROGEN_RESPONSE,SET,94,-0.040114,-0.0028631,0.091147,0.67007,HALLMARK_ANDROGEN_RESPONSE,0.99999
HP_ABNORMAL_ATRIOVENTRICULAR...3,SET,150,-0.031945,-0.0028758,0.07258,0.67008,HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_MORPHOLOGY,0.99999
HP_HYPOPLASIA_OF_THE_CORPUS_...,SET,391,-0.018541,-0.0026769,0.042116,0.67011,HP_HYPOPLASIA_OF_THE_CORPUS_CALLOSUM,0.99999
REACTOME_MECP2_REGULATES_NEU...,SET,16,-0.10353,-0.0030551,0.2351,0.67016,REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,0.99999
GSE5589_WT_VS_IL6_KO_LPS_STI...4,SET,172,-0.027691,-0.0026678,0.062868,0.6702,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP,0.99999
MIR3615,SET,8,-0.14548,-0.0030363,0.33026,0.67021,MIR3615,0.99999
GSE22886_DAY0_VS_DAY7_MONOCY...1,SET,182,-0.027725,-0.0027468,0.062934,0.67022,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN,0.99999
EINAV_INTERFERON_SIGNATURE_I...,SET,27,-0.074701,-0.0028627,0.16948,0.6703,EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.99999
GOMF_SNRNP_BINDING,SET,9,-0.11248,-0.00249,0.25506,0.6704,GOMF_SNRNP_BINDING,0.99999
STEIN_ESTROGEN_RESPONSE_NOT_...,SET,17,-0.10791,-0.0032821,0.24465,0.67041,STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA,0.99999
HP_BILATERAL_CONDUCTIVE_HEAR...,SET,6,-0.13718,-0.0024796,0.31103,0.67041,HP_BILATERAL_CONDUCTIVE_HEARING_IMPAIRMENT,0.99999
PCGF6_TARGET_GENES,SET,64,-0.043837,-0.0025838,0.099376,0.67043,PCGF6_TARGET_GENES,0.99999
GSE22025_UNTREATED_VS_TGFB1_...3,SET,184,-0.028863,-0.002875,0.065429,0.67044,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...571,SET,26,-0.079225,-0.0029794,0.17951,0.67051,GOBP_POSITIVE_REGULATION_OF_P38MAPK_CASCADE,0.99999
AUNG_GASTRIC_CANCER,SET,47,-0.0526,-0.0026581,0.11916,0.67055,AUNG_GASTRIC_CANCER,0.99999
GSE9509_10MIN_VS_30MIN_LPS_A...2,SET,162,-0.027939,-0.002613,0.063292,0.67055,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,0.99999
HP_PARAPARESIS,SET,67,-0.042805,-0.0025812,0.096961,0.67056,HP_PARAPARESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...592,SET,97,-0.039347,-0.0028526,0.089115,0.67058,GOBP_POSITIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY,0.99999
HP_ABNORMALITY_OF_PANCREAS_P...,SET,147,-0.03247,-0.0028939,0.073531,0.6706,HP_ABNORMALITY_OF_PANCREAS_PHYSIOLOGY,0.99999
NAKAYAMA_SOFT_TISSUE_TUMORS_...2,SET,69,-0.048774,-0.0029846,0.11044,0.67062,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,0.99999
GSE5960_TH1_VS_ANERGIC_TH1_UP,SET,183,-0.026977,-0.00268,0.061079,0.67064,GSE5960_TH1_VS_ANERGIC_TH1_UP,0.99999
GSE26156_DOUBLE_POSITIVE_VS_...2,SET,178,-0.028894,-0.0028314,0.065414,0.67065,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.99999
GOCC_SMALL_NUCLEAR_RIBONUCLE...,SET,70,-0.03866,-0.0023827,0.087518,0.67066,GOCC_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX,0.99999
GOBP_PROTEIN_K29_LINKED_DEUB...,SET,4,-0.18437,-0.0027212,0.41719,0.67073,GOBP_PROTEIN_K29_LINKED_DEUBIQUITINATION,0.99999
HP_ANGIOFIBROMAS,SET,31,-0.062479,-0.0025653,0.14122,0.67091,HP_ANGIOFIBROMAS,0.99999
MIR4267,SET,203,-0.025942,-0.0027128,0.058618,0.67095,MIR4267,0.99999
REACTOME_REGULATION_OF_FOXO_...,SET,8,-0.13435,-0.0028039,0.30348,0.671,REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION,0.99999
HP_ABNORMAL_PATELLA_MORPHOLO...,SET,91,-0.04113,-0.0028886,0.09289,0.67103,HP_ABNORMAL_PATELLA_MORPHOLOGY,0.99999
GSE17721_CTRL_VS_POLYIC_2H_B...1,SET,188,-0.027731,-0.0027919,0.062626,0.67104,GSE17721_CTRL_VS_POLYIC_2H_BMDC_DN,0.99999
GOBP_INTRACELLULAR_PROTEIN_T...2,SET,628,-0.014785,-0.0026874,0.033387,0.67106,GOBP_INTRACELLULAR_PROTEIN_TRANSPORT,0.99999
AIZARANI_LIVER_C1_NK_NKT_CEL...,SET,136,-0.03436,-0.0029464,0.077572,0.67109,AIZARANI_LIVER_C1_NK_NKT_CELLS_1,0.99999
GOBP_RESPONSE_TO_DIACYL_BACT...,SET,4,-0.19743,-0.002914,0.44566,0.67112,GOBP_RESPONSE_TO_DIACYL_BACTERIAL_LIPOPEPTIDE,0.99999
HP_PERIPHERAL_AXONAL_DEGENER...,SET,179,-0.02736,-0.0026885,0.06175,0.67114,HP_PERIPHERAL_AXONAL_DEGENERATION,0.99999
HP_CRYPTOZOOSPERMIA,SET,6,-0.12929,-0.002337,0.29178,0.67115,HP_CRYPTOZOOSPERMIA,0.99999
GOMF_SNAP_RECEPTOR_ACTIVITY,SET,35,-0.061205,-0.0026699,0.13807,0.67122,GOMF_SNAP_RECEPTOR_ACTIVITY,0.99999
SCIAN_CELL_CYCLE_TARGETS_OF_...2,SET,8,-0.129,-0.0026924,0.29088,0.67129,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP,0.99999
GOMF_HISTONE_READER_ACTIVITY,SET,16,-0.084072,-0.0024809,0.18952,0.67133,GOMF_HISTONE_READER_ACTIVITY,0.99999
GOMF_VITAMIN_B6_BINDING,SET,48,-0.05523,-0.0028204,0.12447,0.67137,GOMF_VITAMIN_B6_BINDING,0.99999
PID_CD8_TCR_PATHWAY,SET,51,-0.052639,-0.0027706,0.11857,0.67146,PID_CD8_TCR_PATHWAY,0.99999
HP_NEOPLASM_OF_THE_TRACHEOBR...,SET,19,-0.089699,-0.0028842,0.20202,0.67148,HP_NEOPLASM_OF_THE_TRACHEOBRONCHIAL_SYSTEM,0.99999
REACTOME_INTERLEUKIN_17_SIGN...,SET,65,-0.04879,-0.0028981,0.10988,0.67149,REACTOME_INTERLEUKIN_17_SIGNALING,0.99999
GOBP_INTESTINAL_HEXOSE_ABSOR...,SET,5,-0.15866,-0.0026181,0.35732,0.67149,GOBP_INTESTINAL_HEXOSE_ABSORPTION,0.99999
GSE9988_LPS_VS_CTRL_TREATED_...2,SET,163,-0.032063,-0.0030078,0.072206,0.6715,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP,0.99999
HP_SMALL_BASAL_GANGLIA,SET,13,-0.099932,-0.0026583,0.22501,0.67152,HP_SMALL_BASAL_GANGLIA,0.99999
MOOTHA_VOXPHOS,SET,68,-0.039535,-0.0024017,0.089007,0.67154,MOOTHA_VOXPHOS,0.99999
GOBP_POSITIVE_REGULATION_OF_...649,SET,11,-0.097289,-0.0023808,0.21899,0.67157,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SUMOYLATION,0.99999
MIR212_3P,SET,170,-0.028691,-0.0027481,0.064576,0.67158,MIR212_3P,0.99999
GSE10856_CTRL_VS_TNFRSF6B_IN...2,SET,157,-0.031247,-0.0028772,0.07033,0.67158,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP,0.99999
RICKMAN_HEAD_AND_NECK_CANCER...6,SET,50,-0.058456,-0.0030465,0.13153,0.67163,RICKMAN_HEAD_AND_NECK_CANCER_F,0.99999
GOBP_DETECTION_OF_STIMULUS,SET,532,-0.020919,-0.0035092,0.047065,0.67165,GOBP_DETECTION_OF_STIMULUS,0.99999
GOBP_POSITIVE_REGULATION_OF_...25,SET,7,-0.14506,-0.002832,0.32628,0.67168,GOBP_POSITIVE_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.99999
GSE12963_UNINF_VS_ENV_AND_NE...1,SET,121,-0.033848,-0.0027389,0.076136,0.67168,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.99999
GSE23308_CTRL_VS_CORTICOSTER...4,SET,188,-0.026848,-0.002703,0.060359,0.67177,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP,0.99999
GOBP_ORGANIC_ACID_CATABOLIC_...,SET,234,-0.024803,-0.0027823,0.055757,0.67178,GOBP_ORGANIC_ACID_CATABOLIC_PROCESS,0.99999
HP_MYOCARDITIS,SET,6,-0.18183,-0.0032866,0.40875,0.67178,HP_MYOCARDITIS,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...1,SET,185,-0.028178,-0.0028144,0.06334,0.67179,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...541,SET,18,-0.090793,-0.0028416,0.20407,0.6718,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.99999
HP_AUTOIMMUNE_THROMBOCYTOPEN...,SET,43,-0.061264,-0.0029616,0.13767,0.67184,HP_AUTOIMMUNE_THROMBOCYTOPENIA,0.99999
ISHIDA_E2F_TARGETS,SET,50,-0.050274,-0.0026201,0.11295,0.67187,ISHIDA_E2F_TARGETS,0.99999
GOBP_BASE_EXCISION_REPAIR_AP...,SET,12,-0.10243,-0.0026179,0.23011,0.67188,GOBP_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,0.99999
GOMF_KINETOCHORE_BINDING,SET,6,-0.20415,-0.0036901,0.45864,0.67188,GOMF_KINETOCHORE_BINDING,0.99999
GGAMTNNNNNTCCY_UNKNOWN,SET,107,-0.035288,-0.0026862,0.079263,0.67191,GGAMTNNNNNTCCY_UNKNOWN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...678,SET,65,-0.052192,-0.0031001,0.11722,0.67193,GOBP_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION,0.99999
FERRANDO_HOX11_NEIGHBORS,SET,22,-0.086772,-0.003002,0.19483,0.67197,FERRANDO_HOX11_NEIGHBORS,0.99999
WP_TRANSSULFURATION_PATHWAY,SET,9,-0.15047,-0.0033309,0.33785,0.67198,WP_TRANSSULFURATION_PATHWAY,0.99999
GOBP_CHOLESTEROL_CATABOLIC_P...,SET,8,-0.14171,-0.0029575,0.31814,0.67199,GOBP_CHOLESTEROL_CATABOLIC_PROCESS,0.99999
HP_TYPICAL_ABSENCE_SEIZURE,SET,37,-0.065174,-0.002923,0.14632,0.67199,HP_TYPICAL_ABSENCE_SEIZURE,0.99999
GOBP_HEPARAN_SULFATE_PROTEOG...1,SET,32,-0.07019,-0.0029279,0.15755,0.67202,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.99999
REACTOME_HDL_ASSEMBLY,SET,7,-0.13074,-0.0025524,0.29282,0.67237,REACTOME_HDL_ASSEMBLY,0.99999
GSE24972_WT_VS_IRF8_KO_SPLEE...1,SET,176,-0.028581,-0.002785,0.064014,0.67237,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_DN,0.99999
GOBP_RENAL_CONTROL_OF_PERIPH...,SET,4,-0.17894,-0.002641,0.40075,0.67238,GOBP_RENAL_CONTROL_OF_PERIPHERAL_VASCULAR_RESISTANCE_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.99999
RAY_TUMORIGENESIS_BY_ERBB2_C...1,SET,243,-0.025692,-0.0029363,0.057537,0.67239,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,0.99999
GOMF_HISTONE_H3K4_MONOMETHYL...,SET,8,-0.13191,-0.0027531,0.29541,0.67239,GOMF_HISTONE_H3K4_MONOMETHYLTRANSFERASE_ACTIVITY,0.99999
HP_OMPHALOCELE,SET,67,-0.047438,-0.0028606,0.10623,0.6724,HP_OMPHALOCELE,0.99999
CAGTATT_MIR200B_MIR200C_MIR4...,SET,423,-0.019151,-0.0028734,0.04287,0.67246,CAGTATT_MIR200B_MIR200C_MIR429,0.99999
GOMF_TYPE_II_TRANSFORMING_GR...,SET,11,-0.13147,-0.0032173,0.29426,0.67249,GOMF_TYPE_II_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.99999
MIR374A_5P,SET,396,-0.020246,-0.0029413,0.045307,0.67251,MIR374A_5P,0.99999
MIR1304_3P,SET,100,-0.039147,-0.0028814,0.087589,0.67254,MIR1304_3P,0.99999
WP_COVID19_STRUCTURAL_COVERA...,SET,19,-0.087101,-0.0028007,0.19485,0.67256,WP_COVID19_STRUCTURAL_COVERAGE_MAP,0.99999
GOCC_UBIQUITIN_CONJUGATING_E...,SET,7,-0.13308,-0.0025981,0.29759,0.67262,GOCC_UBIQUITIN_CONJUGATING_ENZYME_COMPLEX,0.99999
REACTOME_NOSTRIN_MEDIATED_EN...,SET,5,-0.16676,-0.0027517,0.3729,0.67263,REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING,0.99999
GSE360_CTRL_VS_T_GONDII_MAC_...1,SET,179,-0.028478,-0.0027983,0.063684,0.67263,GSE360_CTRL_VS_T_GONDII_MAC_DN,0.99999
HP_APHASIA,SET,70,-0.047104,-0.0029031,0.1053,0.67267,HP_APHASIA,0.99999
LI_INDUCED_T_TO_NATURAL_KILL...1,SET,127,-0.034136,-0.0028294,0.076309,0.67268,LI_INDUCED_T_TO_NATURAL_KILLER_DN,0.99999
HP_WEAK_CRY,SET,44,-0.056699,-0.0027725,0.12672,0.67271,HP_WEAK_CRY,0.99999
MIR486_3P,SET,152,-0.030979,-0.0028071,0.069224,0.67274,MIR486_3P,0.99999
HP_PARONYCHIA,SET,16,-0.10166,-0.0029999,0.22714,0.67277,HP_PARONYCHIA,0.99999
GOBP_CELLULAR_RESPONSE_TO_IO...,SET,66,-0.043482,-0.0026025,0.097138,0.67279,GOBP_CELLULAR_RESPONSE_TO_IONIZING_RADIATION,0.99999
GOBP_DETECTION_OF_TEMPERATUR...3,SET,5,-0.18864,-0.0031128,0.42136,0.67281,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_THERMOCEPTION,0.99999
GSE9006_HEALTHY_VS_TYPE_1_DI...2,SET,179,-0.027005,-0.0026535,0.060312,0.67283,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP,0.99999
REACTOME_MYOCLONIC_EPILEPSY_...,SET,8,-0.12939,-0.0027005,0.28893,0.67286,REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA,0.99999
chr10p13,SET,28,-0.1157,-0.0045151,0.25834,0.67287,chr10p13,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...5,SET,37,-0.064603,-0.0028974,0.14425,0.67287,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,0.99999
HP_RETINAL_HEMORRHAGE,SET,25,-0.083336,-0.0030732,0.18605,0.67289,HP_RETINAL_HEMORRHAGE,0.99999
GOBP_DEFENSE_RESPONSE,SET,1629,-0.010345,-0.0029418,0.023094,0.6729,GOBP_DEFENSE_RESPONSE,0.99999
HOLLERN_ADENOMYOEPITHELIAL_B...,SET,17,-0.089894,-0.0027343,0.20061,0.67296,HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR,0.99999
GOBP_POSITIVE_REGULATION_OF_...656,SET,115,-0.034761,-0.0027426,0.077548,0.67301,GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.99999
GSE30083_SP2_VS_SP4_THYMOCYT...2,SET,182,-0.029542,-0.0029268,0.0659,0.67302,GSE30083_SP2_VS_SP4_THYMOCYTE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...90,SET,23,-0.090844,-0.0032135,0.2026,0.67306,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.99999
GSE10240_IL17_VS_IL17_AND_IL...1,SET,187,-0.028459,-0.0028576,0.063464,0.67307,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.99999
REACTOME_ADAPTIVE_IMMUNE_SYS...,SET,707,-0.014668,-0.0028226,0.032703,0.67311,REACTOME_ADAPTIVE_IMMUNE_SYSTEM,0.99999
MIR4321,SET,4,-0.18329,-0.0027052,0.40862,0.67312,MIR4321,0.99999
HP_PROLINURIA,SET,7,-0.15859,-0.0030961,0.35345,0.67317,HP_PROLINURIA,0.99999
GOBP_ENDOPLASMIC_RETICULUM_P...,SET,5,-0.17977,-0.0029664,0.40059,0.6732,GOBP_ENDOPLASMIC_RETICULUM_PLASMA_MEMBRANE_TETHERING,0.99999
GOBP_POSITIVE_REGULATION_OF_...537,SET,4,-0.16913,-0.0024962,0.37665,0.67329,GOBP_POSITIVE_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_SECONDARY_AMENORRHEA,SET,62,-0.046543,-0.0027003,0.10362,0.67334,HP_SECONDARY_AMENORRHEA,0.99999
GCM_CDH5,SET,31,-0.067069,-0.0027537,0.14929,0.67337,GCM_CDH5,0.99999
HP_DYSMETRIA,SET,158,-0.02976,-0.002749,0.066246,0.67337,HP_DYSMETRIA,0.99999
HP_ABNORMAL_URINE_CHLORIDE_C...,SET,5,-0.19696,-0.00325,0.43833,0.6734,HP_ABNORMAL_URINE_CHLORIDE_CONCENTRATION,0.99999
CUI_DEVELOPING_HEART_LEFT_AT...,SET,16,-0.10436,-0.0030795,0.23221,0.67343,CUI_DEVELOPING_HEART_LEFT_ATRIAL_CARDIOMYOCYTE,0.99999
ATGTTAA_MIR302C,SET,217,-0.026979,-0.0029158,0.060026,0.67345,ATGTTAA_MIR302C,0.99999
GSE40685_NAIVE_CD4_TCELL_VS_...4,SET,164,-0.029207,-0.0027482,0.064979,0.67346,GSE40685_NAIVE_CD4_TCELL_VS_TREG_UP,0.99999
GOBP_REGULATION_OF_VESICLE_F...,SET,22,-0.088314,-0.0030554,0.19645,0.67348,GOBP_REGULATION_OF_VESICLE_FUSION,0.99999
SARTIPY_NORMAL_AT_INSULIN_RE...1,SET,17,-0.094445,-0.0028727,0.21004,0.67351,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN,0.99999
WHITFIELD_CELL_CYCLE_G2_M,SET,183,-0.027866,-0.0027683,0.061962,0.67354,WHITFIELD_CELL_CYCLE_G2_M,0.99999
GSE27786_NKCELL_VS_NKTCELL_DN,SET,182,-0.028334,-0.0028072,0.063002,0.67355,GSE27786_NKCELL_VS_NKTCELL_DN,0.99999
GOBP_DNA_DOUBLE_STRAND_BREAK...,SET,19,-0.08166,-0.0026257,0.18156,0.67356,GOBP_DNA_DOUBLE_STRAND_BREAK_PROCESSING,0.99999
GOBP_AIM2_INFLAMMASOME_COMPL...,SET,5,-0.1465,-0.0024174,0.3257,0.67357,GOBP_AIM2_INFLAMMASOME_COMPLEX_ASSEMBLY,0.99999
GOBP_PARENTAL_BEHAVIOR,SET,13,-0.12658,-0.0033671,0.28139,0.67358,GOBP_PARENTAL_BEHAVIOR,0.99999
GOBP_AMINOGLYCAN_BIOSYNTHETI...,SET,74,-0.045342,-0.0028729,0.10076,0.67364,GOBP_AMINOGLYCAN_BIOSYNTHETIC_PROCESS,0.99999
HP_SHOULDER_GIRDLE_MUSCLE_WE...,SET,50,-0.052118,-0.0027162,0.11576,0.67372,HP_SHOULDER_GIRDLE_MUSCLE_WEAKNESS,0.99999
HP_BONE_SPICULE_PIGMENTATION...,SET,101,-0.038343,-0.0028362,0.085077,0.67389,HP_BONE_SPICULE_PIGMENTATION_OF_THE_RETINA,0.99999
REACTOME_SIGNALING_BY_EGFR,SET,51,-0.053183,-0.0027992,0.11799,0.67391,REACTOME_SIGNALING_BY_EGFR,0.99999
GOBP_CHORION_DEVELOPMENT,SET,10,-0.13823,-0.0032253,0.30659,0.67395,GOBP_CHORION_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_TRANSLATI...1,SET,333,-0.020821,-0.0027786,0.046182,0.67395,GOBP_REGULATION_OF_TRANSLATION,0.99999
HP_ABNORMAL_MOTOR_NERVE_COND...,SET,60,-0.047678,-0.0027213,0.10575,0.67395,HP_ABNORMAL_MOTOR_NERVE_CONDUCTION_VELOCITY,0.99999
GOMF_MONOATOMIC_ANION_MONOAT...,SET,24,-0.080722,-0.0029168,0.17902,0.67397,GOMF_MONOATOMIC_ANION_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.99999
REACTOME_CD28_DEPENDENT_VAV1...,SET,11,-0.11556,-0.002828,0.25623,0.67401,REACTOME_CD28_DEPENDENT_VAV1_PATHWAY,0.99999
HALLMARK_KRAS_SIGNALING_UP,SET,186,-0.031165,-0.003121,0.069096,0.67401,HALLMARK_KRAS_SIGNALING_UP,0.99999
HP_ABNORMALITY_OF_THE_THORAC...,SET,46,-0.058003,-0.0028998,0.12855,0.67408,HP_ABNORMALITY_OF_THE_THORACIC_CAVITY,0.99999
BIOCARTA_CDC42RAC_PATHWAY,SET,8,-0.12756,-0.0026623,0.28267,0.6741,BIOCARTA_CDC42RAC_PATHWAY,0.99999
GSE42021_TREG_PLN_VS_TREG_PR...1,SET,188,-0.029792,-0.0029994,0.066015,0.67411,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN,0.99999
REACTOME_BETA_OXIDATION_OF_P...,SET,9,-0.11324,-0.0025066,0.2509,0.67412,REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA,0.99999
CAR_HPX,SET,69,-0.050558,-0.0030937,0.11202,0.67413,CAR_HPX,0.99999
TAL1BETAE47_01,SET,225,-0.02698,-0.0029685,0.059771,0.67414,TAL1BETAE47_01,0.99999
HP_EYE_OF_THE_TIGER_ANOMALY_...,SET,9,-0.1163,-0.0025744,0.25763,0.67415,HP_EYE_OF_THE_TIGER_ANOMALY_OF_GLOBUS_PALLIDUS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...502,SET,21,-0.094977,-0.0032104,0.21035,0.67419,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,0.99999
REACTOME_REGULATION_OF_TBK1_...2,SET,10,-0.14134,-0.0032979,0.31294,0.67424,REACTOME_REGULATION_OF_TBK1_IKK_MEDIATED_ACTIVATION_OF_IRF3_IRF7_UPON_TLR3_LIGATION,0.99999
MIR6810_5P,SET,57,-0.050435,-0.002806,0.11166,0.67425,MIR6810_5P,0.99999
GSE2770_TGFB_AND_IL4_VS_IL12...3,SET,183,-0.027891,-0.0027708,0.061749,0.67425,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.99999
MIR135B_5P,SET,282,-0.023756,-0.0029216,0.052572,0.67432,MIR135B_5P,0.99999
GOBP_REGULATION_OF_BONE_MINE...2,SET,5,-0.1819,-0.0030016,0.40231,0.67441,GOBP_REGULATION_OF_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION,0.99999
HP_SECUNDUM_ATRIAL_SEPTAL_DE...,SET,38,-0.0629,-0.0028588,0.13911,0.67442,HP_SECUNDUM_ATRIAL_SEPTAL_DEFECT,0.99999
GOBP_POSITIVE_REGULATION_OF_...43,SET,8,-0.13828,-0.0028859,0.30573,0.67446,GOBP_POSITIVE_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS,0.99999
GOBP_SPINAL_CORD_OLIGODENDRO...,SET,5,-0.21154,-0.0034907,0.46756,0.67452,GOBP_SPINAL_CORD_OLIGODENDROCYTE_CELL_DIFFERENTIATION,0.99999
MIR4676_5P,SET,51,-0.051765,-0.0027246,0.11441,0.67453,MIR4676_5P,0.99999
GSE3565_DUSP1_VS_WT_SPLENOCY...3,SET,141,-0.03185,-0.0027806,0.070389,0.67454,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_UP,0.99999
NOUSHMEHR_GBM_SILENCED_BY_ME...,SET,45,-0.059649,-0.0029496,0.13179,0.67458,NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,0.99999
GNF2_MAPT,SET,39,-0.070496,-0.0032458,0.15575,0.67459,GNF2_MAPT,0.99999
GOMF_MONOSACCHARIDE_BINDING,SET,69,-0.045793,-0.0028021,0.10116,0.6746,GOMF_MONOSACCHARIDE_BINDING,0.99999
KEGG_MEDICUS_REFERENCE_TGFA_...3,SET,14,-0.10497,-0.0028977,0.23189,0.67461,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.99999
MORF_FEN1,SET,56,-0.0475,-0.0026195,0.10492,0.67462,MORF_FEN1,0.99999
HP_ABNORMAL_ERYTHROID_LINEAG...,SET,6,-0.16347,-0.0029548,0.36088,0.67471,HP_ABNORMAL_ERYTHROID_LINEAGE_CELL_MORPHOLOGY,0.99999
KORKOLA_TERATOMA,SET,38,-0.066598,-0.0030268,0.14698,0.67476,KORKOLA_TERATOMA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...553,SET,19,-0.081476,-0.0026198,0.17979,0.67479,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT,0.99999
GOBP_PROTEIN_HETEROOLIGOMERI...,SET,29,-0.069005,-0.0027405,0.15223,0.67482,GOBP_PROTEIN_HETEROOLIGOMERIZATION,0.99999
GOCC_GINS_COMPLEX,SET,5,-0.17557,-0.0028971,0.38732,0.67483,GOCC_GINS_COMPLEX,0.99999
GSE36392_EOSINOPHIL_VS_MAC_I...2,SET,176,-0.030182,-0.0029411,0.066582,0.67483,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP,0.99999
WP_INTERACTIONS_BETWEEN_IMMU...,SET,24,-0.08424,-0.0030439,0.18582,0.67484,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.99999
GOBP_RESPONSE_TO_FLUID_SHEAR...,SET,33,-0.073386,-0.0031086,0.16187,0.67486,GOBP_RESPONSE_TO_FLUID_SHEAR_STRESS,0.99999
KEGG_RNA_DEGRADATION,SET,49,-0.052069,-0.0026865,0.11484,0.67487,KEGG_RNA_DEGRADATION,0.99999
GOBP_NUCLEIC_ACID_CATABOLIC_...,SET,606,-0.015001,-0.0026801,0.033081,0.67489,GOBP_NUCLEIC_ACID_CATABOLIC_PROCESS,0.99999
GOBP_ALANINE_METABOLIC_PROCE...,SET,5,-0.18058,-0.0029798,0.3982,0.6749,GOBP_ALANINE_METABOLIC_PROCESS,0.99999
REACTOME_SIGNALING_BY_MET,SET,76,-0.044569,-0.0028617,0.098268,0.67492,REACTOME_SIGNALING_BY_MET,0.99999
HP_LIMBAL_STEM_CELL_DEFICIEN...,SET,8,-0.16506,-0.0034449,0.36385,0.67496,HP_LIMBAL_STEM_CELL_DEFICIENCY,0.99999
BIOCARTA_HSP27_PATHWAY,SET,14,-0.10324,-0.00285,0.22753,0.675,BIOCARTA_HSP27_PATHWAY,0.99999
GOBP_METANEPHRIC_GLOMERULUS_...2,SET,9,-0.15913,-0.0035225,0.35068,0.675,GOBP_METANEPHRIC_GLOMERULUS_VASCULATURE_DEVELOPMENT,0.99999
GOCC_PROTON_TRANSPORTING_TWO...1,SET,26,-0.079535,-0.0029911,0.17527,0.675,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...4,SET,83,-0.043152,-0.002895,0.095089,0.67501,GAUTAM_EYE_IRIS_CILIARY_BODY_COL9A1_HIGH_CILIARY_BODY_CELLS,0.99999
GOBP_INNER_EAR_RECEPTOR_CELL...1,SET,44,-0.062103,-0.0030367,0.13683,0.67504,GOBP_INNER_EAR_RECEPTOR_CELL_DEVELOPMENT,0.99999
GOBP_SERINE_FAMILY_AMINO_ACI...1,SET,15,-0.094775,-0.002708,0.20878,0.67506,GOBP_SERINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.99999
GSE42724_NAIVE_VS_B1_BCELL_UP,SET,182,-0.028277,-0.0028015,0.062272,0.67511,GSE42724_NAIVE_VS_B1_BCELL_UP,0.99999
KEGG_T_CELL_RECEPTOR_SIGNALI...,SET,102,-0.039108,-0.002907,0.086106,0.67515,KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.99999
TATA_C,SET,259,-0.025645,-0.0030245,0.056462,0.67515,TATA_C,0.99999
HP_LARYNGOMALACIA,SET,77,-0.043534,-0.0028135,0.095807,0.67522,HP_LARYNGOMALACIA,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...40,SET,45,-0.057332,-0.002835,0.12617,0.67523,GAVISH_3CA_MALIGNANT_METAPROGRAM_METAPROGRAM_6_HYPOXIA,0.99999
GOBP_REGULATION_OF_UNSATURAT...,SET,10,-0.11446,-0.0026707,0.25187,0.67524,GOBP_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.99999
GSE5589_IL6_KO_VS_IL10_KO_LP...2,SET,179,-0.028529,-0.0028034,0.062763,0.67528,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.99999
GSE360_DC_VS_MAC_T_GONDII_DN,SET,180,-0.029096,-0.0028669,0.064007,0.67529,GSE360_DC_VS_MAC_T_GONDII_DN,0.99999
GSE25085_FETAL_BM_VS_ADULT_B...1,SET,179,-0.029631,-0.0029116,0.065154,0.67536,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,0.99999
KEGG_MEDICUS_REFERENCE_TCR_P...,SET,19,-0.088955,-0.0028603,0.19555,0.6754,KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...607,SET,96,-0.038023,-0.0027424,0.083582,0.67541,GOBP_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.99999
HP_FINGER_APLASIA,SET,77,-0.042742,-0.0027623,0.093959,0.67541,HP_FINGER_APLASIA,0.99999
chr1q41,SET,31,-0.12298,-0.0050495,0.27029,0.67545,chr1q41,0.99999
GSE25088_CTRL_VS_IL4_AND_ROS...4,SET,172,-0.027788,-0.0026771,0.06107,0.67545,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,0.99999
RSRFC4_01,SET,219,-0.027467,-0.002982,0.060346,0.6755,RSRFC4_01,0.99999
GSE19825_IL2RALOW_VS_IL2RAHI...1,SET,182,-0.028091,-0.002783,0.061715,0.6755,GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN,0.99999
GOBP_PHARYNGEAL_SYSTEM_DEVEL...,SET,29,-0.08352,-0.0033169,0.18349,0.67551,GOBP_PHARYNGEAL_SYSTEM_DEVELOPMENT,0.99999
GOBP_EYE_MORPHOGENESIS,SET,155,-0.0336,-0.0030743,0.073782,0.67558,GOBP_EYE_MORPHOGENESIS,0.99999
PANAPASA_BLOOD_FLUENZ_AGE_03...2,SET,9,-0.14449,-0.0031985,0.31727,0.6756,PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_6DY_7DY_UP,0.99999
GSE10240_IL22_VS_IL22_AND_IL...2,SET,185,-0.028127,-0.0028093,0.06173,0.67567,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...2,SET,6,-0.14593,-0.0026378,0.32015,0.67574,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCNE_TO_CELL_CYCLE_G1_S,0.99999
HP_DECREASED_ADIPOSE_TISSUE,SET,43,-0.060588,-0.0029289,0.1329,0.67576,HP_DECREASED_ADIPOSE_TISSUE,0.99999
GSE3982_DC_VS_MAC_LPS_STIM_DN,SET,173,-0.030623,-0.0029587,0.067174,0.67576,GSE3982_DC_VS_MAC_LPS_STIM_DN,0.99999
GOBP_DIET_INDUCED_THERMOGENE...,SET,13,-0.11193,-0.0029775,0.24539,0.67585,GOBP_DIET_INDUCED_THERMOGENESIS,0.99999
HP_ABNORMAL_OPTICAL_COHERENC...,SET,18,-0.097134,-0.00304,0.21291,0.67588,HP_ABNORMAL_OPTICAL_COHERENCE_TOMOGRAPHY,0.99999
MIR6796_5P,SET,67,-0.046349,-0.0027949,0.10155,0.67594,MIR6796_5P,0.99999
GOBP_LIPOXYGENASE_PATHWAY,SET,11,-0.13324,-0.0032606,0.29195,0.67594,GOBP_LIPOXYGENASE_PATHWAY,0.99999
GSE3982_EFF_MEMORY_CD4_TCELL...6,SET,174,-0.029338,-0.0028426,0.064283,0.67594,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP,0.99999
MIR2053,SET,159,-0.031283,-0.0028987,0.068527,0.67598,MIR2053,0.99999
GOBP_ARTERIAL_ENDOTHELIAL_CE...,SET,6,-0.17944,-0.0032435,0.39304,0.676,GOBP_ARTERIAL_ENDOTHELIAL_CELL_DIFFERENTIATION,0.99999
MIZUKAMI_HYPOXIA_UP,SET,11,-0.13288,-0.0032518,0.29101,0.67603,MIZUKAMI_HYPOXIA_UP,0.99999
GSE22045_TREG_VS_TCONV_UP,SET,153,-0.032083,-0.0029167,0.070232,0.6761,GSE22045_TREG_VS_TCONV_UP,0.99999
MIR328_5P,SET,53,-0.052566,-0.0028204,0.11502,0.67617,MIR328_5P,0.99999
GOBP_REGULATION_OF_PEPTIDASE...,SET,268,-0.025388,-0.003045,0.055551,0.67617,GOBP_REGULATION_OF_PEPTIDASE_ACTIVITY,0.99999
HP_TOXEMIA_OF_PREGNANCY,SET,24,-0.088379,-0.0031934,0.19337,0.67618,HP_TOXEMIA_OF_PREGNANCY,0.99999
GOMF_U6_SNRNA_BINDING,SET,14,-0.092119,-0.0025429,0.20154,0.67619,GOMF_U6_SNRNA_BINDING,0.99999
HP_EEG_WITH_BURST_SUPPRESSION,SET,56,-0.05141,-0.0028351,0.11246,0.67621,HP_EEG_WITH_BURST_SUPPRESSION,0.99999
HP_BULBAR_SIGNS,SET,32,-0.065306,-0.0027242,0.14279,0.67628,HP_BULBAR_SIGNS,0.99999
GSE13484_12H_VS_3H_YF17D_VAC...1,SET,178,-0.028478,-0.0027905,0.062258,0.67631,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,0.99999
GOBP_TRYPTOPHAN_TRANSPORT,SET,5,-0.16943,-0.0027958,0.37036,0.67633,GOBP_TRYPTOPHAN_TRANSPORT,0.99999
MIR3681_5P,SET,31,-0.07683,-0.0031545,0.1679,0.67637,MIR3681_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...324,SET,12,-0.12128,-0.0030997,0.26504,0.67637,GOBP_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,0.99999
GSE40225_WT_VS_RIP_B7X_DIABE...1,SET,168,-0.028624,-0.0027257,0.062502,0.67651,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN,0.99999
GOBP_LEUKOCYTE_ADHESION_TO_V...,SET,47,-0.061829,-0.0031245,0.13499,0.67653,GOBP_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.99999
GSE17721_0.5H_VS_12H_CPG_BMD...1,SET,186,-0.028203,-0.0028244,0.061569,0.67655,GSE17721_0.5H_VS_12H_CPG_BMDC_DN,0.99999
GOBP_ACTIN_FILAMENT_BASED_TR...,SET,10,-0.12081,-0.0028189,0.26366,0.6766,GOBP_ACTIN_FILAMENT_BASED_TRANSPORT,0.99999
GOCC_U2_SNRNP,SET,22,-0.073179,-0.0025318,0.15961,0.67669,GOCC_U2_SNRNP,0.99999
GOMF_PHOSPHATIDYLSERINE_BIND...,SET,65,-0.052357,-0.0031099,0.1142,0.6767,GOMF_PHOSPHATIDYLSERINE_BINDING,0.99999
MIR4470,SET,227,-0.027049,-0.0029892,0.058989,0.67672,MIR4470,0.99999
MIR4687_5P,SET,40,-0.061565,-0.0028706,0.13426,0.67672,MIR4687_5P,0.99999
REACTOME_EVASION_BY_RSV_OF_H...,SET,28,-0.083353,-0.0032528,0.18175,0.67675,REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES,0.99999
HP_BRUISING_SUSCEPTIBILITY,SET,162,-0.031561,-0.0029517,0.068816,0.67675,HP_BRUISING_SUSCEPTIBILITY,0.99999
GOMF_HSP70_PROTEIN_BINDING,SET,48,-0.056627,-0.0028917,0.12341,0.67682,GOMF_HSP70_PROTEIN_BINDING,0.99999
GOBP_REGULATION_OF_PROTEIN_S...2,SET,237,-0.025718,-0.0029033,0.05605,0.67683,GOBP_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.99999
GOBP_EPOXIDE_METABOLIC_PROCE...,SET,5,-0.20056,-0.0033095,0.43707,0.67684,GOBP_EPOXIDE_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...121,SET,8,-0.1409,-0.0029407,0.30704,0.67685,GOBP_NEGATIVE_REGULATION_OF_CELL_MATURATION,0.99999
MIR8056,SET,40,-0.061416,-0.0028637,0.1338,0.67689,MIR8056,0.99999
MIR6862_5P,SET,44,-0.063158,-0.0030883,0.13758,0.67691,MIR6862_5P,0.99999
GOCC_PHOTORECEPTOR_OUTER_SEG...2,SET,16,-0.087909,-0.0025941,0.19147,0.67693,GOCC_PHOTORECEPTOR_OUTER_SEGMENT_MEMBRANE,0.99999
GOBP_NUCLEOTIDE_SALVAGE,SET,16,-0.10119,-0.0029861,0.22024,0.67704,GOBP_NUCLEOTIDE_SALVAGE,0.99999
REACTOME_TRISTETRAPROLIN_TTP...,SET,16,-0.090603,-0.0026736,0.19714,0.67709,REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA,0.99999
IGARASHI_ATF4_TARGETS_UP,SET,4,-0.26259,-0.0038757,0.57124,0.67713,IGARASHI_ATF4_TARGETS_UP,0.99999
ONDER_CDH1_SIGNALING_VIA_CTN...,SET,79,-0.049856,-0.0032635,0.10838,0.67724,ONDER_CDH1_SIGNALING_VIA_CTNNB1,0.99999
MIR4257,SET,120,-0.034105,-0.0027483,0.074136,0.67725,MIR4257,0.99999
GOBP_REGULATION_OF_RECEPTOR_...2,SET,10,-0.12457,-0.0029066,0.27078,0.67725,GOBP_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS,0.99999
MODULE_183,SET,62,-0.04557,-0.0026438,0.099002,0.67734,MODULE_183,0.99999
HP_SPLENOMEGALY,SET,429,-0.019532,-0.0029508,0.042428,0.67737,HP_SPLENOMEGALY,0.99999
AEBP2_TARGET_GENES,SET,990,-0.012709,-0.0028707,0.0276,0.67741,AEBP2_TARGET_GENES,0.99999
SRC_UP.V1_UP,SET,148,-0.032899,-0.002942,0.071438,0.67743,SRC_UP.V1_UP,0.99999
ZHOU_INFLAMMATORY_RESPONSE_F...1,SET,250,-0.0252,-0.0029206,0.054712,0.67745,ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...111,SET,272,-0.023124,-0.0027938,0.050189,0.67751,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS,0.99999
REACTOME_GLYCOGEN_STORAGE_DI...,SET,13,-0.10574,-0.0028129,0.22948,0.67753,REACTOME_GLYCOGEN_STORAGE_DISEASES,0.99999
HP_AXIAL_HYPOTONIA,SET,288,-0.022816,-0.0028353,0.049512,0.67754,HP_AXIAL_HYPOTONIA,0.99999
HP_NEOPLASM_OF_THE_ADRENAL_G...,SET,45,-0.058902,-0.0029127,0.12781,0.67755,HP_NEOPLASM_OF_THE_ADRENAL_GLAND,0.99999
WP_MET_IN_TYPE_1_PAPILLARY_R...,SET,53,-0.05458,-0.0029284,0.11842,0.67756,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,0.99999
GOMF_ACETYLTRANSFERASE_ACTIV...,SET,88,-0.039318,-0.0027157,0.085298,0.67758,GOMF_ACETYLTRANSFERASE_ACTIVITY,0.99999
GCM_ZNF198,SET,111,-0.035757,-0.002772,0.077559,0.67761,GCM_ZNF198,0.99999
GOBP_REGULATION_OF_APOPTOTIC...4,SET,4,-0.21688,-0.003201,0.47018,0.67769,GOBP_REGULATION_OF_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL,0.99999
GOBP_MRNA_EXPORT_FROM_NUCLEUS,SET,60,-0.044887,-0.002562,0.097233,0.67783,GOBP_MRNA_EXPORT_FROM_NUCLEUS,0.99999
GSE21063_WT_VS_NFATC1_KO_3H_...1,SET,190,-0.029182,-0.0029534,0.063202,0.67786,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_DN,0.99999
XU_GH1_AUTOCRINE_TARGETS_UP,SET,158,-0.031566,-0.0029158,0.068357,0.67788,XU_GH1_AUTOCRINE_TARGETS_UP,0.99999
WP_GLYCEROPHOSPHOLIPID_BIOSY...,SET,27,-0.077373,-0.0029651,0.16755,0.67788,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,0.99999
HOXC11_TARGET_GENES,SET,48,-0.052207,-0.002666,0.11302,0.67793,HOXC11_TARGET_GENES,0.99999
MIR135A_5P,SET,283,-0.02424,-0.0029863,0.052471,0.67795,MIR135A_5P,0.99999
GOBP_RIBOSOMAL_SMALL_SUBUNIT...2,SET,93,-0.039327,-0.002792,0.08512,0.67796,GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS,0.99999
GOBP_MACROPHAGE_COLONY_STIMU...2,SET,7,-0.17231,-0.0033641,0.37283,0.67802,GOBP_MACROPHAGE_COLONY_STIMULATING_FACTOR_SIGNALING_PATHWAY,0.99999
GSE25088_CTRL_VS_ROSIGLITAZO...2,SET,183,-0.029654,-0.0029459,0.064145,0.67806,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.99999
GOBP_CELL_CYCLE_CHECKPOINT_S...,SET,180,-0.02754,-0.0027136,0.05957,0.67807,GOBP_CELL_CYCLE_CHECKPOINT_SIGNALING,0.99999
KARLSSON_TGFB1_TARGETS_DN,SET,175,-0.029707,-0.0028866,0.064249,0.67809,KARLSSON_TGFB1_TARGETS_DN,0.99999
HP_ABNORMAL_RETICULOCYTE_MOR...,SET,73,-0.044373,-0.0027925,0.09593,0.67815,HP_ABNORMAL_RETICULOCYTE_MORPHOLOGY,0.99999
GOBP_RESPONSE_TO_UV_A,SET,13,-0.12661,-0.003368,0.27366,0.67819,GOBP_RESPONSE_TO_UV_A,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...2,SET,185,-0.028241,-0.0028207,0.061042,0.67819,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.99999
MODULE_540,SET,10,-0.14102,-0.0032904,0.30478,0.6782,MODULE_540,0.99999
HP_FINE_HAIR,SET,69,-0.046508,-0.0028459,0.10051,0.67821,HP_FINE_HAIR,0.99999
HP_OCULOGYRIC_CRISIS,SET,12,-0.11749,-0.0030029,0.25385,0.67826,HP_OCULOGYRIC_CRISIS,0.99999
HP_SLOW_PUPILLARY_LIGHT_RESP...,SET,17,-0.092924,-0.0028264,0.20072,0.6783,HP_SLOW_PUPILLARY_LIGHT_RESPONSE,0.99999
HP_MOTOR_SEIZURE,SET,367,-0.020632,-0.0028879,0.044562,0.67832,HP_MOTOR_SEIZURE,0.99999
GSE27786_LIN_NEG_VS_NKCELL_UP,SET,174,-0.028741,-0.0027848,0.062074,0.67832,GSE27786_LIN_NEG_VS_NKCELL_UP,0.99999
GOCC_PROTEASOME_REGULATORY_P...1,SET,11,-0.095558,-0.0023384,0.20637,0.67833,GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX,0.99999
HUANG_GATA2_TARGETS_UP,SET,141,-0.034021,-0.0029701,0.073464,0.67835,HUANG_GATA2_TARGETS_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...544,SET,57,-0.05227,-0.0029081,0.11287,0.67835,GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.99999
GOCC_MITOCHONDRIAL_MATRIX,SET,448,-0.017942,-0.0027684,0.038742,0.67836,GOCC_MITOCHONDRIAL_MATRIX,0.99999
PODAR_RESPONSE_TO_ADAPHOSTIN...1,SET,17,-0.10904,-0.0033165,0.23542,0.67837,PODAR_RESPONSE_TO_ADAPHOSTIN_DN,0.99999
GSE27241_CTRL_VS_DIGOXIN_TRE...1,SET,176,-0.030008,-0.0029241,0.064792,0.67837,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,0.99999
REACTOME_PROTEIN_HYDROXYLATI...,SET,17,-0.092534,-0.0028146,0.19977,0.67839,REACTOME_PROTEIN_HYDROXYLATION,0.99999
GOBP_PROTEIN_POLY_ADP_RIBOSY...,SET,10,-0.11825,-0.002759,0.25512,0.67849,GOBP_PROTEIN_POLY_ADP_RIBOSYLATION,0.99999
MODULE_327,SET,21,-0.089148,-0.0030134,0.19227,0.67855,MODULE_327,0.99999
MIR6760_3P,SET,96,-0.042437,-0.0030608,0.091511,0.67858,MIR6760_3P,0.99999
REACTOME_CARDIOGENESIS,SET,24,-0.08909,-0.0032191,0.19209,0.6786,REACTOME_CARDIOGENESIS,0.99999
GOBP_REGULATION_OF_LEUKOCYTE...9,SET,246,-0.027448,-0.003156,0.059182,0.6786,GOBP_REGULATION_OF_LEUKOCYTE_PROLIFERATION,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...21,SET,45,-0.062953,-0.003113,0.13573,0.67861,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PI16_POS,0.99999
GOBP_POSITIVE_REGULATION_OF_...567,SET,11,-0.1232,-0.0030148,0.26558,0.67863,GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION,0.99999
GOBP_CARDIAC_FIBROBLAST_CELL...,SET,4,-0.18565,-0.0027401,0.40013,0.67866,GOBP_CARDIAC_FIBROBLAST_CELL_DIFFERENTIATION,0.99999
MATZUK_MEIOTIC_AND_DNA_REPAIR,SET,35,-0.056112,-0.0024477,0.1209,0.67872,MATZUK_MEIOTIC_AND_DNA_REPAIR,0.99999
HP_DORSOCERVICAL_FAT_PAD,SET,14,-0.10137,-0.0027982,0.2184,0.67872,HP_DORSOCERVICAL_FAT_PAD,0.99999
GSE1791_CTRL_VS_NEUROMEDINU_...4,SET,173,-0.030037,-0.0029021,0.064718,0.67872,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_UP,0.99999
PAX4_03,SET,234,-0.026303,-0.0029507,0.05667,0.67873,PAX4_03,0.99999
GOBP_REGULATION_OF_NITRIC_OX...2,SET,54,-0.055853,-0.0030247,0.1203,0.67877,GOBP_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,0.99999
GOMF_HISTONE_H3K4_TRIMETHYLT...,SET,10,-0.12773,-0.0029804,0.27509,0.67879,GOMF_HISTONE_H3K4_TRIMETHYLTRANSFERASE_ACTIVITY,0.99999
HP_DIFFUSE_OPTIC_DISC_PALLOR,SET,14,-0.1101,-0.0030392,0.23711,0.67879,HP_DIFFUSE_OPTIC_DISC_PALLOR,0.99999
MIR6077,SET,220,-0.026944,-0.0029319,0.058021,0.67881,MIR6077,0.99999
GOBP_POSITIVE_REGULATION_OF_...183,SET,6,-0.1588,-0.0028704,0.34192,0.67883,GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOBP_PLASMA_MEMBRANE_RAFT_OR...,SET,11,-0.12753,-0.0031209,0.27458,0.67884,GOBP_PLASMA_MEMBRANE_RAFT_ORGANIZATION,0.99999
HP_RENAL_INSUFFICIENCY,SET,364,-0.020762,-0.0028944,0.0447,0.67885,HP_RENAL_INSUFFICIENCY,0.99999
GOBP_EXTRINSIC_APOPTOTIC_SIG...1,SET,216,-0.027848,-0.0030029,0.05995,0.67886,GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOBP_RESPONSE_TO_PROGESTERONE,SET,42,-0.061694,-0.0029475,0.13277,0.67891,GOBP_RESPONSE_TO_PROGESTERONE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...462,SET,26,-0.077531,-0.0029157,0.16683,0.67894,GOBP_NEGATIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,0.99999
GSE360_T_GONDII_VS_M_TUBERCU...4,SET,181,-0.029564,-0.002921,0.063609,0.67895,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP,0.99999
GSE9650_NAIVE_VS_EFF_CD8_TCE...1,SET,188,-0.029708,-0.0029909,0.063922,0.67895,GSE9650_NAIVE_VS_EFF_CD8_TCELL_DN,0.99999
MODULE_60,SET,378,-0.020862,-0.0029625,0.044876,0.67899,MODULE_60,0.99999
KEGG_MEDICUS_REFERENCE_PDGF_...1,SET,13,-0.11454,-0.003047,0.24627,0.67907,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY,0.99999
WP_MITOCHONDRIAL_COMPLEX_II_...,SET,8,-0.12298,-0.0025668,0.26438,0.6791,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,0.99999
MIR8080,SET,127,-0.03547,-0.0029399,0.076248,0.6791,MIR8080,0.99999
REACTOME_NUCLEAR_EVENTS_KINA...,SET,59,-0.053695,-0.0030391,0.11541,0.67913,REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,0.99999
HFH3_01,SET,176,-0.030642,-0.0029858,0.065854,0.67914,HFH3_01,0.99999
KEGG_OLFACTORY_TRANSDUCTION,SET,320,-0.030913,-0.0040456,0.066422,0.67918,KEGG_OLFACTORY_TRANSDUCTION,0.99999
OVSYANNIKOVA_PBMC_FLUARIX_AG...4,SET,23,-0.081663,-0.0028887,0.17537,0.67927,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP,0.99999
MIR6803_5P,SET,52,-0.056744,-0.0030157,0.12183,0.67931,MIR6803_5P,0.99999
HP_ABNORMAL_BRAINSTEM_MRI_SI...,SET,31,-0.061387,-0.0025204,0.13178,0.67933,HP_ABNORMAL_BRAINSTEM_MRI_SIGNAL_INTENSITY,0.99999
GSE14413_UNSTIM_VS_IFNB_STIM...5,SET,105,-0.03894,-0.0029365,0.083571,0.67937,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN,0.99999
KEGG_GLYCOSAMINOGLYCAN_BIOSY...2,SET,25,-0.083303,-0.003072,0.17876,0.67939,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,0.99999
MATHEW_FANCONI_ANEMIA_GENES,SET,10,-0.10876,-0.0025376,0.23337,0.6794,MATHEW_FANCONI_ANEMIA_GENES,0.99999
GSE8384_CTRL_VS_B_ABORTUS_4H...2,SET,174,-0.03011,-0.0029175,0.064598,0.67943,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP,0.99999
GOBP_GLYCOSYL_COMPOUND_BIOSY...,SET,21,-0.084786,-0.002866,0.18186,0.67947,GOBP_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMAL_CARDIAC_VENTRICL...,SET,599,-0.016194,-0.002877,0.034728,0.6795,HP_ABNORMAL_CARDIAC_VENTRICLE_MORPHOLOGY,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...52,SET,11,-0.11806,-0.002889,0.25287,0.6797,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.99999
KEGG_MEDICUS_PATHOGEN_HTLV_1...7,SET,15,-0.098397,-0.0028115,0.2107,0.67975,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,0.99999
HP_ELEVATED_URINARY_HOMOVANI...,SET,9,-0.15951,-0.0035308,0.34139,0.67983,HP_ELEVATED_URINARY_HOMOVANILLIC_ACID,0.99999
BIOCARTA_PS1_PATHWAY,SET,13,-0.10044,-0.0026718,0.21495,0.67984,BIOCARTA_PS1_PATHWAY,0.99999
GOBP_REGULATION_OF_TRANSLATI...8,SET,5,-0.1973,-0.0032557,0.4222,0.67986,GOBP_REGULATION_OF_TRANSLATION_AT_POSTSYNAPSE,0.99999
HP_OLIVOPONTOCEREBELLAR_ATRO...,SET,6,-0.14641,-0.0026465,0.31323,0.6799,HP_OLIVOPONTOCEREBELLAR_ATROPHY,0.99999
HP_HYPEREOSINOPHILIA,SET,5,-0.17675,-0.0029165,0.37805,0.67993,HP_HYPEREOSINOPHILIA,0.99999
MIR8075,SET,90,-0.044696,-0.0031219,0.095598,0.67994,MIR8075,0.99999
GOBP_CHOLESTEROL_STORAGE,SET,23,-0.088078,-0.0031156,0.18839,0.67994,GOBP_CHOLESTEROL_STORAGE,0.99999
DCA_UP.V1_DN,SET,165,-0.030767,-0.0029037,0.065795,0.67997,DCA_UP.V1_DN,0.99999
GOBP_CILIUM_MOVEMENT,SET,172,-0.029711,-0.0028624,0.063521,0.68001,GOBP_CILIUM_MOVEMENT,0.99999
GSE24634_TREG_VS_TCONV_POST_...5,SET,177,-0.030605,-0.0029906,0.065424,0.68003,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_ADC...2,SET,95,-0.044363,-0.0031831,0.094826,0.68005,HE_LIM_SUN_FETAL_LUNG_C2_ADC_2_CELL,0.99999
BLANCO_MELO_COVID19_SARS_COV...8,SET,302,-0.025611,-0.0032577,0.054736,0.68007,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...63,SET,116,-0.03568,-0.0028272,0.076244,0.68009,HP_APLASIA_HYPOPLASIA_OF_THE_RIBS,0.99999
GOMF_RNA_POLYMERASE_III_ACTI...,SET,10,-0.11061,-0.0025808,0.23631,0.68013,GOMF_RNA_POLYMERASE_III_ACTIVITY,0.99999
GSE17721_LPS_VS_POLYIC_2H_BM...2,SET,187,-0.030331,-0.0030456,0.064794,0.68015,GSE17721_LPS_VS_POLYIC_2H_BMDC_UP,0.99999
HP_PAROXYSMAL_INVOLUNTARY_EY...,SET,30,-0.066996,-0.0027061,0.1431,0.68017,HP_PAROXYSMAL_INVOLUNTARY_EYE_MOVEMENTS,0.99999
GSE360_L_MAJOR_VS_B_MALAYI_L...4,SET,178,-0.029121,-0.0028536,0.062194,0.68019,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.99999
CHANDRAN_METASTASIS_UP,SET,176,-0.030013,-0.0029246,0.064078,0.68024,CHANDRAN_METASTASIS_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...421,SET,5,-0.1723,-0.0028431,0.36777,0.68028,GOBP_POSITIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY,0.99999
REACTOME_SIGNAL_ATTENUATION,SET,10,-0.12908,-0.0030117,0.27534,0.68039,REACTOME_SIGNAL_ATTENUATION,0.99999
MODULE_81,SET,18,-0.090992,-0.0028478,0.19407,0.68041,MODULE_81,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...2,SET,149,-0.031213,-0.0028006,0.066575,0.68041,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP,0.99999
GOMF_INSULIN_LIKE_GROWTH_FAC...1,SET,18,-0.11067,-0.0034636,0.2359,0.68051,GOMF_INSULIN_LIKE_GROWTH_FACTOR_BINDING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...125,SET,5,-0.19321,-0.0031881,0.41176,0.68054,GOBP_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.99999
HP_CACHEXIA,SET,89,-0.039859,-0.0027686,0.084934,0.68057,HP_CACHEXIA,0.99999
GOMF_RRNA_BINDING,SET,56,-0.049632,-0.002737,0.10574,0.6806,GOMF_RRNA_BINDING,0.99999
GOMF_SOLUTE_MONOATOMIC_CATIO...,SET,114,-0.039012,-0.0030647,0.083111,0.6806,GOMF_SOLUTE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.99999
GOMF_NEUROTRANSMITTER_TRANSM...,SET,20,-0.09611,-0.0031706,0.20473,0.68062,GOMF_NEUROTRANSMITTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
POMEROY_MEDULLOBLASTOMA_PROG...1,SET,40,-0.061829,-0.0028829,0.13164,0.6807,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN,0.99999
GSE40666_UNTREATED_VS_IFNA_S...2,SET,147,-0.034289,-0.003056,0.072999,0.68072,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_UP,0.99999
REACTOME_KEAP1_NFE2L2_PATHWAY,SET,119,-0.03548,-0.0028473,0.075531,0.68073,REACTOME_KEAP1_NFE2L2_PATHWAY,0.99999
GOBP_SYNOVIOCYTE_PROLIFERATI...,SET,2,-0.27066,-0.0028249,0.57579,0.68084,GOBP_SYNOVIOCYTE_PROLIFERATION,0.99999
GSE15733_BM_VS_SPLEEN_MEMORY...1,SET,176,-0.02923,-0.0028483,0.062182,0.68085,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN,0.99999
GOBP_CYTOKINESIS,SET,164,-0.030169,-0.0028387,0.064165,0.68088,GOBP_CYTOKINESIS,0.99999
MODULE_505,SET,16,-0.10452,-0.0030843,0.22215,0.681,MODULE_505,0.99999
FOXO3_01,SET,228,-0.028076,-0.0031094,0.059644,0.68108,FOXO3_01,0.99999
MIR223_3P,SET,112,-0.038096,-0.0029665,0.080922,0.6811,MIR223_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...92,SET,622,-0.016339,-0.0029561,0.034688,0.68118,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION,0.99999
SMID_BREAST_CANCER_RELAPSE_I...9,SET,22,-0.085972,-0.0029744,0.18246,0.68124,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN,0.99999
VANDESLUIS_COMMD1_TARGETS_GR...3,SET,70,-0.047606,-0.0029341,0.10103,0.68125,VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,0.99999
GROSS_HYPOXIA_VIA_ELK3_UP,SET,192,-0.028638,-0.0029134,0.060774,0.68126,GROSS_HYPOXIA_VIA_ELK3_UP,0.99999
REACTOME_MATURATION_OF_SPIKE...,SET,35,-0.066525,-0.002902,0.14117,0.68126,REACTOME_MATURATION_OF_SPIKE_PROTEIN,0.99999
LINDGREN_BLADDER_CANCER_HIGH...,SET,47,-0.061656,-0.0031157,0.13083,0.68127,LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,0.99999
GOBP_SKELETAL_SYSTEM_DEVELOP...,SET,484,-0.01996,-0.003198,0.04235,0.68129,GOBP_SKELETAL_SYSTEM_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_PROTEIN_L...10,SET,4,-0.1921,-0.0028353,0.40739,0.68137,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_LYSOSOME,0.99999
WP_TRANSCRIPTION_FACTORS_REG...,SET,8,-0.13015,-0.0027163,0.27594,0.68141,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,0.99999
HP_ABNORMAL_CAUDATE_NUCLEUS_...,SET,19,-0.09378,-0.0030154,0.19883,0.68141,HP_ABNORMAL_CAUDATE_NUCLEUS_MORPHOLOGY,0.99999
MORF_ORC1L,SET,62,-0.047649,-0.0027644,0.10101,0.68143,MORF_ORC1L,0.99999
BOYLAN_MULTIPLE_MYELOMA_C_CL...2,SET,35,-0.067814,-0.0029582,0.14374,0.68146,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP,0.99999
GOBP_REGULATION_OF_FIBROBLAS...2,SET,29,-0.080553,-0.0031991,0.17072,0.68148,GOBP_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...15,SET,6,-0.17032,-0.0030785,0.36093,0.68149,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...9,SET,179,-0.028971,-0.0028467,0.061391,0.6815,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_DN,0.99999
LI_AMPLIFIED_IN_LUNG_CANCER,SET,165,-0.031933,-0.0030137,0.067651,0.68154,LI_AMPLIFIED_IN_LUNG_CANCER,0.99999
TESAR_ALK_TARGETS_HUMAN_ES_5...1,SET,5,-0.16618,-0.0027421,0.35197,0.68158,TESAR_ALK_TARGETS_HUMAN_ES_5D_DN,0.99999
HP_LARYNGEAL_CARCINOMA,SET,12,-0.10711,-0.0027375,0.22683,0.6816,HP_LARYNGEAL_CARCINOMA,0.99999
GSE21033_1H_VS_12H_POLYIC_ST...1,SET,124,-0.03731,-0.003056,0.079007,0.68162,GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN,0.99999
NAKAYA_B_CELL_FLUARIX_FLUVIR...1,SET,261,-0.023535,-0.0027862,0.049838,0.68162,NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.99999
KHETCHOUMIAN_TRIM24_TARGETS_...1,SET,7,-0.16601,-0.003241,0.35146,0.68165,KHETCHOUMIAN_TRIM24_TARGETS_DN,0.99999
WP_PRADERWILLI_AND_ANGELMAN_...,SET,93,-0.044489,-0.0031585,0.094173,0.68168,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,0.99999
GSE7852_TREG_VS_TCONV_FAT_UP,SET,183,-0.030487,-0.0030287,0.064536,0.68168,GSE7852_TREG_VS_TCONV_FAT_UP,0.99999
GSE25087_FETAL_VS_ADULT_TCON...1,SET,156,-0.031306,-0.0028736,0.066253,0.68172,GSE25087_FETAL_VS_ADULT_TCONV_DN,0.99999
SCHERER_PBMC_APSV_WETVAX_AGE...8,SET,23,-0.086734,-0.0030681,0.18356,0.68172,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_5_TO_7DY_UP,0.99999
GOBP_MIDDLE_EAR_MORPHOGENESIS,SET,19,-0.10296,-0.0033105,0.21786,0.68174,GOBP_MIDDLE_EAR_MORPHOGENESIS,0.99999
REACTOME_STING_MEDIATED_INDU...,SET,13,-0.097279,-0.0025878,0.20583,0.68175,REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES,0.99999
GOMF_CYCLASE_INHIBITOR_ACTIV...,SET,4,-0.18231,-0.0026908,0.38575,0.68175,GOMF_CYCLASE_INHIBITOR_ACTIVITY,0.99999
TRAVAGLINI_LUNG_CAPILLARY_IN...1,SET,150,-0.036007,-0.0032414,0.076164,0.6818,TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_1_CELL,0.99999
TOX4_TARGET_GENES,SET,163,-0.030598,-0.0028704,0.064721,0.68181,TOX4_TARGET_GENES,0.99999
GOBP_POSITIVE_REGULATION_OF_...418,SET,8,-0.14095,-0.0029417,0.29812,0.68181,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY,0.99999
HP_ABNORMAL_CIRCULATING_CREA...1,SET,10,-0.10945,-0.0025538,0.23138,0.6819,HP_ABNORMAL_CIRCULATING_CREATINE_CONCENTRATION,0.99999
GOBP_SPHINGOSINE_1_PHOSPHATE...,SET,15,-0.1085,-0.0031,0.22932,0.68193,GOBP_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...649,SET,118,-0.036696,-0.0029326,0.077561,0.68194,GOBP_NEGATIVE_REGULATION_OF_TRANSLATION,0.99999
GOBP_REGULATION_OF_CYTOPLASM...2,SET,101,-0.039307,-0.0029075,0.083079,0.68194,GOBP_REGULATION_OF_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE11864_CSF1_IFNG_VS_CSF1_P...2,SET,174,-0.029807,-0.0028881,0.06299,0.68196,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP,0.99999
GOBP_PEPTIDYL_LYSINE_MODIFIC...,SET,127,-0.034361,-0.002848,0.072608,0.68197,GOBP_PEPTIDYL_LYSINE_MODIFICATION,0.99999
GOBP_PROTEOGLYCAN_CATABOLIC_...,SET,9,-0.13732,-0.0030397,0.29016,0.68198,GOBP_PROTEOGLYCAN_CATABOLIC_PROCESS,0.99999
MODULE_51,SET,36,-0.077391,-0.0034238,0.16352,0.68199,MODULE_51,0.99999
GOBP_NUCLEOSIDE_PHOSPHATE_CA...,SET,165,-0.030871,-0.0029135,0.065205,0.68205,GOBP_NUCLEOSIDE_PHOSPHATE_CATABOLIC_PROCESS,0.99999
GOMF_GLYCINE_TRANSMEMBRANE_T...,SET,9,-0.14012,-0.0031018,0.29585,0.68212,GOMF_GLYCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_PROTRUSIO_ACETABULI,SET,12,-0.12906,-0.0032986,0.27247,0.68213,HP_PROTRUSIO_ACETABULI,0.99999
REACTOME_MAPK_TARGETS_NUCLEA...,SET,29,-0.078527,-0.0031186,0.16574,0.68217,REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,0.99999
GOBP_LAMELLIPODIUM_MORPHOGEN...,SET,18,-0.09028,-0.0028255,0.1905,0.68221,GOBP_LAMELLIPODIUM_MORPHOGENESIS,0.99999
GOBP_REGULATION_OF_CHLORIDE_...,SET,6,-0.15288,-0.0027633,0.3226,0.68221,GOBP_REGULATION_OF_CHLORIDE_TRANSPORT,0.99999
HP_ABNORMALITY_OF_EXTRAPYRAM...,SET,268,-0.024463,-0.0029341,0.051622,0.68221,HP_ABNORMALITY_OF_EXTRAPYRAMIDAL_MOTOR_FUNCTION,0.99999
BIOCARTA_CFTR_PATHWAY,SET,10,-0.14156,-0.0033029,0.29845,0.68236,BIOCARTA_CFTR_PATHWAY,0.99999
HP_ABNORMAL_NASOPHARYNX_MORP...,SET,159,-0.032736,-0.0030334,0.069013,0.68237,HP_ABNORMAL_NASOPHARYNX_MORPHOLOGY,0.99999
GSE29618_PRE_VS_DAY7_POST_LA...3,SET,172,-0.030498,-0.0029382,0.064287,0.68239,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN,0.99999
MIR3136_3P,SET,60,-0.049576,-0.0028296,0.10449,0.68242,MIR3136_3P,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...2,SET,143,-0.036885,-0.0032427,0.077693,0.68252,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,0.99999
GRAESSMANN_RESPONSE_TO_MC_AN...4,SET,200,-0.029593,-0.0030719,0.062298,0.68261,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,0.99999
GSE22886_UNSTIM_VS_IL15_STIM...1,SET,183,-0.028296,-0.002811,0.059562,0.68263,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...10,SET,11,-0.14966,-0.0036623,0.31496,0.68266,GOCC_EXTRINSIC_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE,0.99999
GSE1448_ANTI_VALPHA2_VS_VBET...2,SET,184,-0.030252,-0.0030134,0.063657,0.68268,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP,0.99999
HOEK_NEUTROPHIL_2011_2012_TI...5,SET,37,-0.072244,-0.0032401,0.152,0.68271,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_DN,0.99999
MIR3616_3P,SET,54,-0.052991,-0.0028698,0.11148,0.68272,MIR3616_3P,0.99999
MIR95_5P,SET,606,-0.016765,-0.0029952,0.035267,0.68273,MIR95_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...292,SET,7,-0.17422,-0.0034014,0.36643,0.68276,GOBP_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION,0.99999
MIR549A_3P,SET,69,-0.049244,-0.0030133,0.10354,0.68282,MIR549A_3P,0.99999
HP_NEOPLASM_OF_THE_LIVER,SET,132,-0.036093,-0.0030495,0.075871,0.68286,HP_NEOPLASM_OF_THE_LIVER,0.99999
UNTERMAN_IPF_VS_CTRL_NK_CELL...2,SET,2,-0.22147,-0.0023115,0.46553,0.68287,UNTERMAN_IPF_VS_CTRL_NK_CELL_UP,0.99999
GSE36476_YOUNG_VS_OLD_DONOR_...6,SET,173,-0.031262,-0.0030205,0.065661,0.683,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP,0.99999
REACTOME_G_PROTEIN_BETA_GAMM...,SET,30,-0.076824,-0.003103,0.16133,0.68302,REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING,0.99999
GOBP_RESPONSE_TO_AUDITORY_ST...,SET,32,-0.070152,-0.0029263,0.14732,0.68302,GOBP_RESPONSE_TO_AUDITORY_STIMULUS,0.99999
HHEX_TARGET_GENES,SET,824,-0.014121,-0.0029238,0.02965,0.68305,HHEX_TARGET_GENES,0.99999
GOBP_NAD_CATABOLIC_PROCESS,SET,16,-0.089702,-0.0026471,0.18827,0.68313,GOBP_NAD_CATABOLIC_PROCESS,0.99999
GOBP_PANCREATIC_A_CELL_DIFFE...,SET,10,-0.15829,-0.0036933,0.3322,0.68313,GOBP_PANCREATIC_A_CELL_DIFFERENTIATION,0.99999
REACTOME_INTERLEUKIN_RECEPTO...,SET,23,-0.090202,-0.0031908,0.18926,0.68317,REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING,0.99999
GOBP_NON_CANONICAL_WNT_SIGNA...,SET,68,-0.052138,-0.0031673,0.10939,0.68318,GOBP_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...8,SET,9,-0.12532,-0.0027742,0.26289,0.68321,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22,0.99999
GOMF_MELANOCORTIN_RECEPTOR_A...,SET,6,-0.18215,-0.0032924,0.38205,0.68323,GOMF_MELANOCORTIN_RECEPTOR_ACTIVITY,0.99999
MODULE_342,SET,194,-0.03059,-0.0031279,0.064149,0.68326,MODULE_342,0.99999
HP_BULBAR_PALSY,SET,39,-0.062401,-0.0028731,0.13085,0.68327,HP_BULBAR_PALSY,0.99999
GSE26343_WT_VS_NFAT5_KO_MACR...3,SET,189,-0.030013,-0.0030296,0.062934,0.68328,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_UP,0.99999
JOSEPH_RESPONSE_TO_SODIUM_BU...2,SET,26,-0.081414,-0.0030617,0.17069,0.68331,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,0.99999
REACTOME_MITOTIC_METAPHASE_A...,SET,217,-0.02625,-0.002837,0.055028,0.68332,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,0.99999
KEGG_MEDICUS_REFERENCE_MODIF...2,SET,5,-0.17022,-0.0028089,0.35683,0.68333,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_I_SUBUNITS,0.99999
GOBP_POSITIVE_REGULATION_OF_...285,SET,14,-0.11265,-0.0031096,0.23613,0.68333,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_MIGRATION,0.99999
HP_SKIN_APPENDAGE_NEOPLASM,SET,16,-0.11159,-0.003293,0.23373,0.68347,HP_SKIN_APPENDAGE_NEOPLASM,0.99999
HP_WIDE_FEMORAL_METAPHYSIS,SET,6,-0.15368,-0.0027778,0.32186,0.68348,HP_WIDE_FEMORAL_METAPHYSIS,0.99999
BHATTACHARYA_EMBRYONIC_STEM_...,SET,76,-0.044111,-0.0028323,0.092361,0.68353,BHATTACHARYA_EMBRYONIC_STEM_CELL,0.99999
GSE30971_CTRL_VS_LPS_STIM_MA...3,SET,170,-0.029196,-0.0027965,0.061131,0.68353,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN,0.99999
chr13q12,SET,65,-0.094543,-0.0056157,0.19793,0.68355,chr13q12,0.99999
MODULE_176,SET,209,-0.031324,-0.0033231,0.065568,0.68358,MODULE_176,0.99999
GOCC_ENDOPLASMIC_RETICULUM_P...1,SET,8,-0.14029,-0.002928,0.29365,0.68358,GOCC_ENDOPLASMIC_RETICULUM_PALMITOYLTRANSFERASE_COMPLEX,0.99999
HP_ABNORMAL_MIDBRAIN_MORPHOL...,SET,72,-0.045203,-0.0028253,0.09459,0.68363,HP_ABNORMAL_MIDBRAIN_MORPHOLOGY,0.99999
GOMF_DISORDERED_DOMAIN_SPECI...,SET,27,-0.077591,-0.0029734,0.16233,0.68367,GOMF_DISORDERED_DOMAIN_SPECIFIC_BINDING,0.99999
GOMF_EUKARYOTIC_TRANSLATION_...,SET,6,-0.16588,-0.0029984,0.34693,0.68372,GOMF_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2ALPHA_KINASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_DOPAMINE_...1,SET,11,-0.14891,-0.0036441,0.31143,0.68373,GOBP_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_MICROTUBULE_ANCHORING,SET,21,-0.092419,-0.003124,0.19322,0.68378,GOBP_MICROTUBULE_ANCHORING,0.99999
FULLER_PBMC_F_TULARENSIS_VAC...9,SET,43,-0.062514,-0.003022,0.1307,0.68378,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_UP,0.99999
WANG_BARRETTS_ESOPHAGUS_AND_...2,SET,24,-0.091697,-0.0033133,0.1917,0.68379,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,0.99999
MIR4760_3P,SET,249,-0.026713,-0.0030899,0.055846,0.68379,MIR4760_3P,0.99999
KEGG_RNA_POLYMERASE,SET,24,-0.074672,-0.0026981,0.15604,0.68386,KEGG_RNA_POLYMERASE,0.99999
KOYAMA_SEMA3B_TARGETS_UP,SET,221,-0.028084,-0.0030628,0.058684,0.68387,KOYAMA_SEMA3B_TARGETS_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...204,SET,35,-0.074394,-0.0032452,0.15545,0.68388,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,0.99999
GSE37563_WT_VS_CTLA4_KO_CD4_...1,SET,168,-0.030037,-0.0028602,0.062759,0.68389,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_DN,0.99999
GSE1566_WT_VS_EZH2_KO_LN_TCE...2,SET,164,-0.033098,-0.0031143,0.069112,0.68399,GSE1566_WT_VS_EZH2_KO_LN_TCELL_UP,0.99999
GOBP_REGULATION_OF_CYCLIC_NU...,SET,6,-0.1549,-0.0027999,0.32339,0.68402,GOBP_REGULATION_OF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_CELL_SHAPE,SET,125,-0.037763,-0.0031054,0.078836,0.68403,GOBP_REGULATION_OF_CELL_SHAPE,0.99999
GOBP_MORPHOGENESIS_OF_AN_EPI...2,SET,22,-0.098005,-0.0033907,0.20459,0.68404,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_FOLD,0.99999
GOBP_NEGATIVE_REGULATION_OF_...60,SET,7,-0.16307,-0.0031836,0.34034,0.68408,GOBP_NEGATIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_PYRIDINE_NUCLEOTIDE_BIO...,SET,27,-0.081469,-0.0031221,0.16999,0.68412,GOBP_PYRIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
GSE14413_UNSTIM_VS_IFNB_STIM...2,SET,110,-0.039318,-0.0030343,0.082001,0.6842,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_UP,0.99999
GSE20366_EX_VIVO_VS_HOMEOSTA...1,SET,182,-0.030596,-0.0030313,0.063736,0.6844,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN,0.99999
DESCARTES_MAIN_FETAL_LYMPHOI...,SET,116,-0.040952,-0.003245,0.08529,0.68444,DESCARTES_MAIN_FETAL_LYMPHOID_CELLS,0.99999
HP_ABNORMAL_CIRCULATING_T4_C...,SET,24,-0.08634,-0.0031197,0.17981,0.68445,HP_ABNORMAL_CIRCULATING_T4_CONCENTRATION,0.99999
BIOCARTA_SUMO_PATHWAY,SET,6,-0.141,-0.0025486,0.29357,0.68448,BIOCARTA_SUMO_PATHWAY,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...40,SET,866,-0.01382,-0.0029299,0.028775,0.68448,GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE,0.99999
GOBP_SPHINGOLIPID_MEDIATED_S...,SET,17,-0.10377,-0.0031563,0.21601,0.68452,GOBP_SPHINGOLIPID_MEDIATED_SIGNALING_PATHWAY,0.99999
HP_MICROCEPHALIC_SPERM_HEAD,SET,2,-0.30869,-0.0032218,0.64252,0.68454,HP_MICROCEPHALIC_SPERM_HEAD,0.99999
HP_HYPERACTIVE_PATELLAR_REFL...,SET,16,-0.094107,-0.002777,0.19587,0.68455,HP_HYPERACTIVE_PATELLAR_REFLEX,0.99999
ZHU_SKIL_TARGETS_DN,SET,9,-0.13898,-0.0030766,0.28922,0.68458,ZHU_SKIL_TARGETS_DN,0.99999
STAMBOLSKY_TARGETS_OF_MUTATE...2,SET,45,-0.063856,-0.0031576,0.1328,0.68468,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP,0.99999
HP_PROGRESSIVE_LEUKOENCEPHAL...,SET,4,-0.20313,-0.0029981,0.42244,0.68469,HP_PROGRESSIVE_LEUKOENCEPHALOPATHY,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...5,SET,171,-0.032497,-0.0031218,0.067577,0.6847,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,0.99999
BCAT_BILD_ET_AL_DN,SET,42,-0.06223,-0.0029731,0.12937,0.68475,BCAT_BILD_ET_AL_DN,0.99999
REACTOME_TRANSCRIPTIONAL_ACT...1,SET,50,-0.058923,-0.0030709,0.12249,0.68476,REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,0.99999
REACTOME_DEGRADATION_OF_GLI1...,SET,57,-0.047548,-0.0026453,0.098805,0.68482,REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,0.99999
HP_ABNORMALITY_OF_THE_PINEAL...,SET,14,-0.1119,-0.0030889,0.23252,0.68482,HP_ABNORMALITY_OF_THE_PINEAL_GLAND,0.99999
CCTGTGA_MIR513,SET,116,-0.037814,-0.0029964,0.07855,0.68488,CCTGTGA_MIR513,0.99999
GSE7460_WT_VS_FOXP3_HET_ACT_...2,SET,186,-0.030633,-0.0030678,0.06363,0.68489,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP,0.99999
GOBP_MUSCLE_ADAPTATION,SET,98,-0.044264,-0.0032254,0.091895,0.68498,GOBP_MUSCLE_ADAPTATION,0.99999
GOBP_SUGAR_MEDIATED_SIGNALIN...,SET,9,-0.12776,-0.0028281,0.26524,0.68498,GOBP_SUGAR_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_HEPOXILIN_METABOLIC_PRO...,SET,7,-0.18665,-0.0036439,0.38747,0.68499,GOBP_HEPOXILIN_METABOLIC_PROCESS,0.99999
JIANG_TIP30_TARGETS_UP,SET,42,-0.066728,-0.003188,0.13849,0.68503,JIANG_TIP30_TARGETS_UP,0.99999
MIR409_3P,SET,88,-0.044881,-0.0030999,0.09309,0.68514,MIR409_3P,0.99999
PID_ECADHERIN_STABILIZATION_...,SET,39,-0.063999,-0.0029467,0.13271,0.68518,PID_ECADHERIN_STABILIZATION_PATHWAY,0.99999
KEGG_SPLICEOSOME,SET,117,-0.033798,-0.0026895,0.070071,0.68521,KEGG_SPLICEOSOME,0.99999
MIR4288,SET,144,-0.035772,-0.0031557,0.074164,0.68521,MIR4288,0.99999
REACTOME_PI3K_AKT_ACTIVATION,SET,9,-0.14811,-0.0032785,0.30704,0.68522,REACTOME_PI3K_AKT_ACTIVATION,0.99999
MIR4724_5P,SET,116,-0.04037,-0.0031989,0.083687,0.68523,MIR4724_5P,0.99999
HP_ABNORMALITY_OF_THE_HEPATI...,SET,84,-0.045448,-0.0030672,0.094209,0.68524,HP_ABNORMALITY_OF_THE_HEPATIC_VASCULATURE,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...2,SET,186,-0.029793,-0.0029837,0.06176,0.68524,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP,0.99999
MIR4682,SET,117,-0.037381,-0.0029747,0.077478,0.68526,MIR4682,0.99999
KEGG_MEDICUS_REFERENCE_CXCR4...4,SET,31,-0.079346,-0.0032578,0.16444,0.68528,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,0.99999
GSE22886_NAIVE_TCELL_VS_NKCE...2,SET,173,-0.031475,-0.0030411,0.065231,0.68528,GSE22886_NAIVE_TCELL_VS_NKCELL_UP,0.99999
GOBP_EYELID_DEVELOPMENT_IN_C...,SET,13,-0.13081,-0.0034796,0.27104,0.68531,GOBP_EYELID_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.99999
HP_KYPHOSCOLIOSIS,SET,164,-0.031703,-0.0029831,0.065673,0.68536,HP_KYPHOSCOLIOSIS,0.99999
GSE2706_R848_VS_R848_AND_LPS...1,SET,164,-0.034031,-0.0032021,0.070493,0.68536,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN,0.99999
HOWLIN_CITED1_TARGETS_1_DN,SET,36,-0.075042,-0.0033199,0.1554,0.68541,HOWLIN_CITED1_TARGETS_1_DN,0.99999
GOBP_REGULATION_OF_PERK_MEDI...,SET,12,-0.12679,-0.0032407,0.26255,0.68542,GOBP_REGULATION_OF_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.99999
GSE2826_XID_VS_BTK_KO_BCELL_...2,SET,186,-0.030616,-0.0030661,0.063349,0.68555,GSE2826_XID_VS_BTK_KO_BCELL_UP,0.99999
HP_INSIDIOUS_ONSET,SET,15,-0.10447,-0.0029851,0.21614,0.68557,HP_INSIDIOUS_ONSET,0.99999
GOBP_HEME_B_METABOLIC_PROCESS,SET,9,-0.13263,-0.002936,0.27437,0.68559,GOBP_HEME_B_METABOLIC_PROCESS,0.99999
WGTTNNNNNAAA_UNKNOWN,SET,484,-0.01992,-0.0031916,0.041205,0.68561,WGTTNNNNNAAA_UNKNOWN,0.99999
HP_SCLEROSIS_OF_HAND_BONE,SET,11,-0.13659,-0.0033425,0.28249,0.68563,HP_SCLEROSIS_OF_HAND_BONE,0.99999
HP_ABNORMAL_EKG,SET,120,-0.039439,-0.0031782,0.081547,0.68567,HP_ABNORMAL_EKG,0.99999
GOBP_NERVOUS_SYSTEM_PROCESS,SET,1292,-0.013262,-0.0033921,0.027417,0.68569,GOBP_NERVOUS_SYSTEM_PROCESS,0.99999
GOCC_RADIAL_SPOKE,SET,12,-0.096618,-0.0024694,0.19973,0.68571,GOCC_RADIAL_SPOKE,0.99999
GOBP_LIPOPHAGY,SET,7,-0.15982,-0.0031202,0.33031,0.68575,GOBP_LIPOPHAGY,0.99999
HP_INCREASED_B_CELL_COUNT,SET,11,-0.13888,-0.0033985,0.28703,0.68575,HP_INCREASED_B_CELL_COUNT,0.99999
HP_HEPATOBLASTOMA,SET,21,-0.09239,-0.003123,0.19091,0.68578,HP_HEPATOBLASTOMA,0.99999
BANDRES_RESPONSE_TO_CARMUSTI...8,SET,18,-0.089782,-0.0028099,0.18547,0.68583,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP,0.99999
QI_HYPOXIA,SET,128,-0.036401,-0.0030289,0.075188,0.68585,QI_HYPOXIA,0.99999
REACTOME_ANTIGEN_ACTIVATES_B...,SET,27,-0.078215,-0.0029974,0.16149,0.68593,REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS,0.99999
YAMAZAKI_TCEB3_TARGETS_UP,SET,155,-0.034973,-0.0032,0.072195,0.68596,YAMAZAKI_TCEB3_TARGETS_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_NU...2,SET,223,-0.028505,-0.0031225,0.058828,0.686,GOBP_CELLULAR_RESPONSE_TO_NUTRIENT_LEVELS,0.99999
GOMF_GLUTAMATE_RECEPTOR_BIND...,SET,42,-0.064111,-0.003063,0.13227,0.68605,GOMF_GLUTAMATE_RECEPTOR_BINDING,0.99999
GOBP_MUSCLE_HYPERTROPHY,SET,84,-0.048329,-0.0032616,0.099702,0.68606,GOBP_MUSCLE_HYPERTROPHY,0.99999
GOMF_CARDIOLIPIN_BINDING,SET,10,-0.13842,-0.0032298,0.28546,0.68613,GOMF_CARDIOLIPIN_BINDING,0.99999
HP_ABNORMAL_NASAL_BRIDGE_MOR...,SET,882,-0.014188,-0.0030343,0.029258,0.68614,HP_ABNORMAL_NASAL_BRIDGE_MORPHOLOGY,0.99999
HARALAMBIEVA_PBMC_M_M_R_II_A...1,SET,639,-0.017713,-0.0032467,0.036524,0.68615,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN,0.99999
GNF2_NS,SET,37,-0.061316,-0.0027499,0.12636,0.68625,GNF2_NS,0.99999
KRAS.DF.V1_DN,SET,168,-0.032782,-0.0031217,0.067549,0.68627,KRAS.DF.V1_DN,0.99999
GOBP_POSITIVE_REGULATION_BY_...3,SET,17,-0.087061,-0.0026481,0.17936,0.6863,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION,0.99999
GUCY1B1_TARGET_GENES,SET,517,-0.018412,-0.0030461,0.037927,0.68632,GUCY1B1_TARGET_GENES,0.99999
HADDAD_B_LYMPHOCYTE_PROGENIT...,SET,248,-0.027886,-0.0032192,0.057442,0.68633,HADDAD_B_LYMPHOCYTE_PROGENITOR,0.99999
HP_DERMOID_CYST,SET,6,-0.18082,-0.0032684,0.37242,0.68635,HP_DERMOID_CYST,0.99999
HP_PUNCTATE_KERATITIS,SET,5,-0.22226,-0.0036675,0.4577,0.68637,HP_PUNCTATE_KERATITIS,0.99999
GSE1432_1H_VS_6H_IFNG_MICROG...1,SET,179,-0.030992,-0.0030453,0.06381,0.6864,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.99999
HP_MOYAMOYA_PHENOMENON,SET,12,-0.1045,-0.0026709,0.21515,0.68641,HP_MOYAMOYA_PHENOMENON,0.99999
WP_OSTEOARTHRITIC_CHONDROCYT...,SET,47,-0.063381,-0.0032028,0.13048,0.68642,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,0.99999
HP_TESTICULAR_ADRENAL_REST_T...,SET,8,-0.16256,-0.0033927,0.33458,0.68647,HP_TESTICULAR_ADRENAL_REST_TUMOR,0.99999
GSE40068_BCL6_POS_VS_NEG_CXC...1,SET,178,-0.031801,-0.0031162,0.065433,0.68652,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN,0.99999
HP_DECREASED_ACTIVITY_OF_MIT...5,SET,60,-0.047894,-0.0027336,0.098531,0.68654,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_IV,0.99999
GOBP_LOCOMOTORY_BEHAVIOR,SET,193,-0.03085,-0.0031465,0.063466,0.68655,GOBP_LOCOMOTORY_BEHAVIOR,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...2,SET,9,-0.13562,-0.0030021,0.2789,0.68661,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION,0.99999
GNF2_IGFBP1,SET,30,-0.084578,-0.0034162,0.17391,0.68663,GNF2_IGFBP1,0.99999
GOBP_SYMPATHETIC_NEURON_PROJ...,SET,5,-0.19575,-0.00323,0.40217,0.68677,GOBP_SYMPATHETIC_NEURON_PROJECTION_EXTENSION,0.99999
MARSON_FOXP3_TARGETS_STIMULA...1,SET,10,-0.12729,-0.0029701,0.26132,0.68691,MARSON_FOXP3_TARGETS_STIMULATED_DN,0.99999
GOBP_REGULATION_OF_CD8_POSIT...1,SET,19,-0.1027,-0.0033024,0.21081,0.68693,GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
REACTOME_MEMBRANE_TRAFFICKING,SET,596,-0.016894,-0.0029942,0.034651,0.68707,REACTOME_MEMBRANE_TRAFFICKING,0.99999
MIR1182,SET,28,-0.083576,-0.0032615,0.17138,0.68711,MIR1182,0.99999
GOBP_POSITIVE_REGULATION_OF_...845,SET,129,-0.039526,-0.0033017,0.081046,0.68711,GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,0.99999
HP_TRACHEOBRONCHOMALACIA,SET,7,-0.13729,-0.0026803,0.28137,0.68719,HP_TRACHEOBRONCHOMALACIA,0.99999
GSE12707_AT16L1_HYPOMORPH_VS...1,SET,113,-0.038894,-0.003042,0.079703,0.68722,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_DN,0.99999
HP_HYPERKERATOTIC_PAPULE,SET,12,-0.10675,-0.0027284,0.21874,0.68723,HP_HYPERKERATOTIC_PAPULE,0.99999
GOBP_REGULATION_OF_T_CELL_RE...,SET,43,-0.064111,-0.0030992,0.1313,0.68732,GOBP_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.99999
CERVERA_SDHB_TARGETS_1_UP,SET,111,-0.043786,-0.0033944,0.089655,0.68736,CERVERA_SDHB_TARGETS_1_UP,0.99999
HP_RIB_SEGMENTATION_ABNORMAL...,SET,11,-0.13597,-0.0033273,0.27835,0.68739,HP_RIB_SEGMENTATION_ABNORMALITIES,0.99999
MIR545_3P,SET,349,-0.023488,-0.0032076,0.048058,0.68748,MIR545_3P,0.99999
MIR496,SET,95,-0.044175,-0.0031696,0.090384,0.68749,MIR496,0.99999
VERNOCHET_ADIPOGENESIS,SET,18,-0.11312,-0.0035404,0.23143,0.6875,VERNOCHET_ADIPOGENESIS,0.99999
GOBP_VASCULAR_ASSOCIATED_SMO...2,SET,11,-0.14343,-0.0035099,0.29342,0.68752,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DEVELOPMENT,0.99999
REACTOME_KERATAN_SULFATE_DEG...,SET,15,-0.11176,-0.0031933,0.22852,0.6876,REACTOME_KERATAN_SULFATE_DEGRADATION,0.99999
GSE36078_UNTREATED_VS_AD5_IN...2,SET,182,-0.030478,-0.0030195,0.062315,0.68761,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP,0.99999
GSE36826_NORMAL_VS_STAPH_AUR...3,SET,185,-0.031059,-0.0031022,0.063465,0.68772,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_DN,0.99999
KEGG_MEDICUS_REFERENCE_BRANC...,SET,30,-0.076559,-0.0030924,0.15642,0.68774,KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION,0.99999
MIR6125,SET,8,-0.16046,-0.0033488,0.32781,0.68775,MIR6125,0.99999
GOBP_REGULATION_OF_RESPONSE_...4,SET,74,-0.046176,-0.0029258,0.094329,0.68776,GOBP_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.99999
GOCC_ATP_BINDING_CASSETTE_AB...,SET,6,-0.17978,-0.0032496,0.36725,0.68776,GOCC_ATP_BINDING_CASSETTE_ABC_TRANSPORTER_COMPLEX,0.99999
REACTOME_SIGNALING_BY_NTRK3_...,SET,17,-0.093188,-0.0028345,0.19036,0.68777,REACTOME_SIGNALING_BY_NTRK3_TRKC,0.99999
GOBP_REGULATION_OF_SYNAPSE_S...1,SET,7,-0.15531,-0.0030322,0.31726,0.68777,GOBP_REGULATION_OF_SYNAPSE_STRUCTURAL_PLASTICITY,0.99999
KIM_PTEN_TARGETS_UP,SET,17,-0.096395,-0.002932,0.19689,0.68778,KIM_PTEN_TARGETS_UP,0.99999
GSE4748_CYANOBACTERIUM_LPSLI...2,SET,166,-0.034036,-0.0032219,0.069511,0.68781,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.99999
GOBP_INHIBITORY_POSTSYNAPTIC...,SET,13,-0.12779,-0.0033995,0.26092,0.68785,GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL,0.99999
MIR7106_5P,SET,325,-0.023522,-0.0031019,0.048023,0.68786,MIR7106_5P,0.99999
HP_ABNORMAL_PHAGOCYTOSIS,SET,3,-0.24946,-0.0031886,0.50926,0.68787,HP_ABNORMAL_PHAGOCYTOSIS,0.99999
MODULE_571,SET,14,-0.11843,-0.0032691,0.24176,0.68788,MODULE_571,0.99999
GOBP_REGULATION_OF_NEUROBLAS...,SET,51,-0.06193,-0.0032596,0.12639,0.68793,GOBP_REGULATION_OF_NEUROBLAST_PROLIFERATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...779,SET,22,-0.082333,-0.0028485,0.16802,0.68794,GOBP_POSITIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,0.99999
GOCC_MITOCHONDRIAL_PROTEIN_C...,SET,228,-0.026071,-0.0028874,0.053199,0.68795,GOCC_MITOCHONDRIAL_PROTEIN_CONTAINING_COMPLEX,0.99999
GOMF_CULLIN_FAMILY_PROTEIN_B...,SET,21,-0.084303,-0.0028497,0.17202,0.68796,GOMF_CULLIN_FAMILY_PROTEIN_BINDING,0.99999
MIR548T_5P,SET,389,-0.022306,-0.0032124,0.04551,0.68798,MIR548T_5P,0.99999
GOBP_ENDOTHELIAL_CELL_ACTIVA...,SET,9,-0.16271,-0.0036018,0.33191,0.68801,GOBP_ENDOTHELIAL_CELL_ACTIVATION,0.99999
HP_ABNORMAL_ERYTHROCYTE_MORP...,SET,599,-0.017386,-0.0030889,0.035454,0.68807,HP_ABNORMAL_ERYTHROCYTE_MORPHOLOGY,0.99999
HP_PENILE_FRECKLING,SET,5,-0.15367,-0.0025357,0.31332,0.68809,HP_PENILE_FRECKLING,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HO...1,SET,339,-0.024387,-0.0032833,0.049721,0.6881,MANNO_MIDBRAIN_NEUROTYPES_HOMTN,0.99999
GOBP_REGULATION_OF_FATTY_ACI...5,SET,31,-0.079771,-0.0032753,0.16262,0.68811,GOBP_REGULATION_OF_FATTY_ACID_TRANSPORT,0.99999
GOBP_DNA_LIGATION_INVOLVED_I...,SET,5,-0.15437,-0.0025473,0.31466,0.68814,GOBP_DNA_LIGATION_INVOLVED_IN_DNA_REPAIR,0.99999
GOBP_REGULATION_OF_GONADOTRO...,SET,12,-0.14279,-0.0036495,0.29106,0.68814,GOBP_REGULATION_OF_GONADOTROPIN_SECRETION,0.99999
KEGG_MEDICUS_VARIANT_LOSS_OF...2,SET,5,-0.18666,-0.00308,0.3804,0.68817,KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY,0.99999
MATZUK_PREOVULATORY_FOLLICLE,SET,9,-0.16256,-0.0035984,0.33119,0.68822,MATZUK_PREOVULATORY_FOLLICLE,0.99999
GOBP_INTRACELLULAR_TRANSPORT,SET,1225,-0.011843,-0.0029555,0.024127,0.68824,GOBP_INTRACELLULAR_TRANSPORT,0.99999
GSE37301_HEMATOPOIETIC_STEM_...7,SET,154,-0.032359,-0.0029513,0.06592,0.68824,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_DN,0.99999
MIR4781_3P,SET,35,-0.067269,-0.0029344,0.13703,0.68825,MIR4781_3P,0.99999
GOBP_STRIATED_MUSCLE_ATROPHY,SET,7,-0.16235,-0.0031696,0.33062,0.6883,GOBP_STRIATED_MUSCLE_ATROPHY,0.99999
GOBP_ANTIGEN_RECEPTOR_MEDIAT...,SET,171,-0.032975,-0.0031677,0.067142,0.68833,GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.99999
GOMF_LAMIN_BINDING,SET,16,-0.1091,-0.0032195,0.2221,0.68837,GOMF_LAMIN_BINDING,0.99999
HP_MYOGLOBINURIA,SET,23,-0.081232,-0.0028735,0.16533,0.6884,HP_MYOGLOBINURIA,0.99999
GOBP_CELLULAR_RESPONSE_TO_OX...3,SET,1069,-0.013698,-0.0032078,0.027871,0.68845,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND,0.99999
MODULE_415,SET,11,-0.12691,-0.0031056,0.25813,0.68851,MODULE_415,0.99999
GOCC_PERIKARYON,SET,131,-0.038731,-0.0032601,0.078779,0.68851,GOCC_PERIKARYON,0.99999
GOBP_NEGATIVE_REGULATION_OF_...59,SET,15,-0.11337,-0.0032394,0.23057,0.68853,GOBP_NEGATIVE_REGULATION_OF_B_CELL_PROLIFERATION,0.99999
GOCC_G_PROTEIN_COUPLED_RECEP...2,SET,7,-0.16835,-0.0032868,0.34239,0.68853,GOCC_G_PROTEIN_COUPLED_RECEPTOR_DIMERIC_COMPLEX,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...6,SET,5,-0.21074,-0.0034774,0.42857,0.68854,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2,0.99999
GOBP_ADAPTIVE_THERMOGENESIS,SET,160,-0.034128,-0.0031722,0.06937,0.68862,GOBP_ADAPTIVE_THERMOGENESIS,0.99999
LET_7I_5P,SET,362,-0.022622,-0.0031452,0.045978,0.68864,LET_7I_5P,0.99999
GOMF_SODIUM_ION_BINDING,SET,8,-0.14465,-0.0030189,0.29399,0.68864,GOMF_SODIUM_ION_BINDING,0.99999
MIR6833_3P,SET,375,-0.022379,-0.0031657,0.045477,0.68867,MIR6833_3P,0.99999
MODULE_41,SET,510,-0.019123,-0.0031427,0.038857,0.68868,MODULE_41,0.99999
GOBP_PHOTORECEPTOR_CELL_OUTE...,SET,12,-0.11404,-0.0029147,0.23174,0.68868,GOBP_PHOTORECEPTOR_CELL_OUTER_SEGMENT_ORGANIZATION,0.99999
GOBP_CONVERGENT_EXTENSION_IN...1,SET,5,-0.21738,-0.003587,0.44167,0.6887,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_AXIS_ELONGATION,0.99999
WP_ALLOGRAFT_REJECTION,SET,82,-0.052278,-0.0034861,0.10618,0.68877,WP_ALLOGRAFT_REJECTION,0.99999
GOBP_BIOGENIC_AMINE_METABOLI...,SET,83,-0.048475,-0.003252,0.098444,0.68878,GOBP_BIOGENIC_AMINE_METABOLIC_PROCESS,0.99999
GSE10325_LUPUS_CD4_TCELL_VS_...4,SET,172,-0.032794,-0.0031594,0.066597,0.68879,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP,0.99999
GSE11961_MARGINAL_ZONE_BCELL...9,SET,176,-0.031292,-0.0030492,0.063537,0.68881,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_DN,0.99999
HP_VIRAL_HEPATITIS,SET,13,-0.12208,-0.0032474,0.24776,0.68889,HP_VIRAL_HEPATITIS,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...7,SET,12,-0.12132,-0.0031009,0.24617,0.68894,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_7DY_TOP_100_DEG_EX_VIVO_DN,0.99999
chr11p13,SET,36,-0.1482,-0.0065563,0.30062,0.68899,chr11p13,0.99999
GOBP_VASCULAR_ENDOTHELIAL_GR...1,SET,34,-0.074896,-0.0032202,0.15191,0.689,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,0.99999
GSE21360_PRIMARY_VS_TERTIARY...1,SET,180,-0.032675,-0.0032196,0.066271,0.68901,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,0.99999
MIR3179,SET,117,-0.037188,-0.0029594,0.075357,0.68917,MIR3179,0.99999
ZHONG_PFC_C7_ORG_UNDERGOING_...,SET,61,-0.058656,-0.0033755,0.11885,0.68917,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION,0.99999
HOWLIN_CITED1_TARGETS_2_DN,SET,15,-0.12225,-0.003493,0.2477,0.68918,HOWLIN_CITED1_TARGETS_2_DN,0.99999
REACTOME_HEMOSTASIS,SET,570,-0.01889,-0.0032765,0.038271,0.6892,REACTOME_HEMOSTASIS,0.99999
HP_ABNORMAL_SPINAL_CORD_PHYS...,SET,7,-0.16171,-0.0031572,0.32757,0.68923,HP_ABNORMAL_SPINAL_CORD_PHYSIOLOGY,0.99999
GOCC_MICROTUBULE_BUNDLE,SET,6,-0.14554,-0.0026307,0.29471,0.68929,GOCC_MICROTUBULE_BUNDLE,0.99999
KEGG_MEDICUS_PATHOGEN_YERSIN...1,SET,5,-0.18705,-0.0030866,0.37865,0.68935,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPH_TO_TCR_NFAT_SIGNALING_PATHWAY,0.99999
GSE25085_FETAL_LIVER_VS_ADUL...1,SET,167,-0.030189,-0.0028662,0.061101,0.68937,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,0.99999
GOMF_TRANSFERASE_ACTIVITY_TR...1,SET,54,-0.059932,-0.0032457,0.1213,0.68938,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ALKYL_OR_ARYL_OTHER_THAN_METHYL_GROUPS,0.99999
GOBP_POSITIVE_REGULATION_OF_...601,SET,18,-0.099588,-0.0031169,0.20155,0.68939,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
BANDRES_RESPONSE_TO_CARMUSTI...7,SET,28,-0.084892,-0.0033128,0.1718,0.6894,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,0.99999
REACTOME_RESOLUTION_OF_D_LOO...1,SET,32,-0.067073,-0.0027979,0.13573,0.6894,REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES,0.99999
chr5q33,SET,63,-0.094867,-0.0055479,0.19193,0.68944,chr5q33,0.99999
WP_GASTRIN_SIGNALING,SET,113,-0.041239,-0.0032255,0.083411,0.68949,WP_GASTRIN_SIGNALING,0.99999
HP_ABNORMAL_SUBSTANTIA_NIGRA...,SET,18,-0.096716,-0.003027,0.19559,0.68951,HP_ABNORMAL_SUBSTANTIA_NIGRA_MORPHOLOGY,0.99999
OHASHI_AURKA_TARGETS,SET,5,-0.18337,-0.0030258,0.37082,0.68952,OHASHI_AURKA_TARGETS,0.99999
chr2q36,SET,34,-0.12315,-0.0052949,0.24898,0.68956,chr2q36,0.99999
GOBP_PROTEIN_NEDDYLATION,SET,27,-0.076543,-0.0029333,0.15462,0.68971,GOBP_PROTEIN_NEDDYLATION,0.99999
REACTOME_MET_ACTIVATES_PTPN11,SET,5,-0.17458,-0.0028807,0.35262,0.68972,REACTOME_MET_ACTIVATES_PTPN11,0.99999
GOBP_SNO_S_RNA_PROCESSING,SET,9,-0.12453,-0.0027567,0.25152,0.68974,GOBP_SNO_S_RNA_PROCESSING,0.99999
GOBP_METANEPHRIC_COLLECTING_...,SET,10,-0.15447,-0.0036041,0.31193,0.68977,GOBP_METANEPHRIC_COLLECTING_DUCT_DEVELOPMENT,0.99999
HP_INCREASED_CIRCULATING_COR...,SET,29,-0.084062,-0.0033384,0.16974,0.68978,HP_INCREASED_CIRCULATING_CORTISOL_LEVEL,0.99999
REACTOME_ENDOSOMAL_VACUOLAR_...,SET,11,-0.13994,-0.0034245,0.28247,0.68984,REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY,0.99999
MIR4774_5P,SET,87,-0.044053,-0.0030255,0.088896,0.68989,MIR4774_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...370,SET,66,-0.055639,-0.0033301,0.11227,0.6899,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,0.99999
GOCC_CHAPERONIN_CONTAINING_T...,SET,10,-0.11324,-0.0026423,0.22849,0.68991,GOCC_CHAPERONIN_CONTAINING_T_COMPLEX,0.99999
SMID_BREAST_CANCER_BASAL_UP,SET,588,-0.018666,-0.0032867,0.037648,0.68998,SMID_BREAST_CANCER_BASAL_UP,0.99999
GSE13485_CTRL_VS_DAY7_YF17D_...2,SET,163,-0.033839,-0.0031744,0.068237,0.69002,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP,0.99999
GOBP_ACTIVATION_OF_CYSTEINE_...1,SET,13,-0.11959,-0.0031812,0.24105,0.69009,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.99999
HP_CEREBRAL_AMYLOID_ANGIOPAT...,SET,4,-0.24537,-0.0036215,0.49448,0.69013,HP_CEREBRAL_AMYLOID_ANGIOPATHY,0.99999
GOBP_PHOSPHATIDYLETHANOLAMIN...1,SET,7,-0.18097,-0.003533,0.36466,0.69014,GOBP_PHOSPHATIDYLETHANOLAMINE_ACYL_CHAIN_REMODELING,0.99999
chr6p11,SET,2,-0.31466,-0.0032841,0.63405,0.69015,chr6p11,0.99999
HP_ABNORMAL_5TH_METACARPAL_M...,SET,17,-0.10859,-0.0033031,0.21879,0.69017,HP_ABNORMAL_5TH_METACARPAL_MORPHOLOGY,0.99999
HP_ABNORMAL_HYPNAGOGIA,SET,8,-0.16666,-0.0034783,0.33575,0.69019,HP_ABNORMAL_HYPNAGOGIA,0.99999
TIAN_BHLHA15_TARGETS,SET,15,-0.10514,-0.0030042,0.21175,0.69024,TIAN_BHLHA15_TARGETS,0.99999
GOCC_SIGNAL_RECOGNITION_PART...,SET,6,-0.15947,-0.0028824,0.32115,0.69024,GOCC_SIGNAL_RECOGNITION_PARTICLE,0.99999
HP_BOWING_OF_THE_ARM,SET,38,-0.071601,-0.0032542,0.1442,0.69024,HP_BOWING_OF_THE_ARM,0.99999
GSE22886_NEUTROPHIL_VS_MONOC...2,SET,169,-0.033893,-0.003237,0.068261,0.69024,GSE22886_NEUTROPHIL_VS_MONOCYTE_UP,0.99999
HP_PROGRESSIVE_MICROCEPHALY,SET,82,-0.044682,-0.0029796,0.089974,0.69026,HP_PROGRESSIVE_MICROCEPHALY,0.99999
BIOCARTA_UCALPAIN_PATHWAY,SET,14,-0.11544,-0.0031867,0.23244,0.69028,BIOCARTA_UCALPAIN_PATHWAY,0.99999
MODULE_343,SET,24,-0.079494,-0.0028724,0.16006,0.69028,MODULE_343,0.99999
GOBP_PRESYNAPTIC_MEMBRANE_OR...,SET,6,-0.19793,-0.0035777,0.39852,0.69029,GOBP_PRESYNAPTIC_MEMBRANE_ORGANIZATION,0.99999
MODULE_208,SET,108,-0.043365,-0.0033164,0.087307,0.6903,MODULE_208,0.99999
GSE37533_UNTREATED_VS_PIOGLI...4,SET,181,-0.032786,-0.0032394,0.066001,0.69031,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.99999
GOMF_BETA_N_ACETYLHEXOSAMINI...,SET,3,-0.25404,-0.0032472,0.51117,0.69039,GOMF_BETA_N_ACETYLHEXOSAMINIDASE_ACTIVITY,0.99999
HP_APLASIA_OF_THE_PROXIMAL_P...,SET,9,-0.13147,-0.0029102,0.26454,0.69039,HP_APLASIA_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,0.99999
SHAFFER_IRF4_TARGETS_IN_ACTI...1,SET,74,-0.049561,-0.0031403,0.099694,0.69045,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,0.99999
HP_PULMONARY_ARTERIAL_HYPERT...,SET,130,-0.037171,-0.0031169,0.074752,0.69049,HP_PULMONARY_ARTERIAL_HYPERTENSION,0.99999
GOCC_DNA_REPAIR_COMPLEX,SET,20,-0.07777,-0.0025655,0.15639,0.6905,GOCC_DNA_REPAIR_COMPLEX,0.99999
HP_JAUNDICE,SET,200,-0.029502,-0.0030624,0.059322,0.69051,HP_JAUNDICE,0.99999
GOMF_CATALYTIC_ACTIVITY_ACTI...6,SET,341,-0.021387,-0.0028876,0.043004,0.69052,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_RNA,0.99999
MORF_DAP3,SET,175,-0.029007,-0.0028185,0.058321,0.69053,MORF_DAP3,0.99999
GSE21927_C26GM_VS_4T1_TUMOR_...2,SET,175,-0.032143,-0.0031233,0.064619,0.69055,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,0.99999
WANG_CLASSIC_ADIPOGENIC_TARG...,SET,27,-0.084544,-0.0032399,0.16996,0.69056,WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,0.99999
GOBP_IMMUNE_RESPONSE_REGULAT...3,SET,478,-0.019984,-0.0031824,0.040169,0.69058,GOBP_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY,0.99999
GOBP_RESPONSE_TO_LIGHT_INTEN...,SET,15,-0.10775,-0.0030787,0.21657,0.69059,GOBP_RESPONSE_TO_LIGHT_INTENSITY,0.99999
WANG_HCP_PROSTATE_CANCER,SET,100,-0.044037,-0.0032413,0.088508,0.6906,WANG_HCP_PROSTATE_CANCER,0.99999
GSE3982_EOSINOPHIL_VS_NEUTRO...2,SET,179,-0.029427,-0.0028916,0.05914,0.69061,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP,0.99999
GCM_PPM1D,SET,23,-0.086129,-0.0030467,0.17308,0.69062,GCM_PPM1D,0.99999
HP_ABDOMINAL_COLIC,SET,5,-0.21817,-0.0036001,0.43841,0.69063,HP_ABDOMINAL_COLIC,0.99999
GOBP_PROLINE_TRANSMEMBRANE_T...,SET,9,-0.16247,-0.0035965,0.32631,0.69072,GOBP_PROLINE_TRANSMEMBRANE_TRANSPORT,0.99999
GOBP_THYROID_STIMULATING_HOR...,SET,6,-0.18697,-0.0033796,0.37552,0.69072,GOBP_THYROID_STIMULATING_HORMONE_SECRETING_CELL_DIFFERENTIATION,0.99999
HP_ABNORMAL_PATTERN_OF_RESPI...,SET,677,-0.016865,-0.0031783,0.033863,0.69076,HP_ABNORMAL_PATTERN_OF_RESPIRATION,0.99999
LAKE_ADULT_KIDNEY_C27_VASCUL...,SET,145,-0.039102,-0.0034614,0.078515,0.69076,LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES,0.99999
GOBP_POSITIVE_REGULATION_OF_...825,SET,6,-0.18579,-0.0033583,0.37292,0.69083,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOCC_CKM_COMPLEX,SET,4,-0.16363,-0.002415,0.32842,0.69083,GOCC_CKM_COMPLEX,0.99999
GSE17721_POLYIC_VS_CPG_16H_B...1,SET,180,-0.030962,-0.0030508,0.062131,0.69087,GSE17721_POLYIC_VS_CPG_16H_BMDC_DN,0.99999
REACTOME_ACTIVATED_NOTCH1_TR...,SET,29,-0.076644,-0.0030438,0.15373,0.69096,REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS,0.99999
GOBP_PROLINE_METABOLIC_PROCE...,SET,9,-0.15034,-0.0033279,0.30153,0.69096,GOBP_PROLINE_METABOLIC_PROCESS,0.99999
TAKAO_RESPONSE_TO_UVB_RADIAT...1,SET,87,-0.045427,-0.0031198,0.09111,0.69097,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,0.99999
KEGG_MEDICUS_PATHOGEN_HCMV_G...1,SET,14,-0.1162,-0.0032078,0.23295,0.69105,KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY,0.99999
MIR4649_3P,SET,186,-0.031935,-0.0031982,0.063998,0.69111,MIR4649_3P,0.99999
GSE29618_BCELL_VS_MONOCYTE_DN,SET,179,-0.03323,-0.0032652,0.066593,0.69111,GSE29618_BCELL_VS_MONOCYTE_DN,0.99999
LET_7G_5P,SET,361,-0.022976,-0.0031901,0.046037,0.69114,LET_7G_5P,0.99999
GOBP_MESENCHYME_DEVELOPMENT,SET,293,-0.026865,-0.0033667,0.053822,0.69115,GOBP_MESENCHYME_DEVELOPMENT,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HN...3,SET,287,-0.026874,-0.0033338,0.05383,0.69119,MANNO_MIDBRAIN_NEUROTYPES_HNBML1,0.99999
MODULE_244,SET,172,-0.030318,-0.0029209,0.060727,0.6912,MODULE_244,0.99999
GSE23321_CD8_STEM_CELL_MEMOR...1,SET,159,-0.031298,-0.0029001,0.062687,0.69121,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN,0.99999
BOHN_PRIMARY_IMMUNODEFICIENC...1,SET,36,-0.075034,-0.0033195,0.15025,0.69125,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...9,SET,48,-0.067764,-0.0034605,0.13569,0.69125,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_8,0.99999
GSE14000_UNSTIM_VS_16H_LPS_D...2,SET,176,-0.033495,-0.0032638,0.067059,0.69128,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN,0.99999
GOCC_POSTSYNAPTIC_ENDOCYTIC_...,SET,5,-0.213,-0.0035148,0.42641,0.69129,GOCC_POSTSYNAPTIC_ENDOCYTIC_ZONE,0.99999
MODULE_149,SET,34,-0.070722,-0.0030407,0.14155,0.69132,MODULE_149,0.99999
GSE38697_LIGHT_ZONE_VS_DARK_...2,SET,154,-0.033172,-0.0030255,0.066381,0.69136,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,0.99999
REACTOME_FOXO_MEDIATED_TRANS...2,SET,16,-0.11284,-0.0033298,0.22568,0.69145,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,0.99999
HP_DUPLICATION_INVOLVING_BON...,SET,122,-0.037509,-0.0030476,0.075022,0.69145,HP_DUPLICATION_INVOLVING_BONES_OF_THE_FEET,0.99999
GOBP_REGULATION_OF_CARDIAC_M...5,SET,7,-0.1486,-0.0029012,0.29719,0.69147,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_POTENTIAL,0.99999
chr15q14,SET,23,-0.15772,-0.005579,0.31535,0.6915,chr15q14,0.99999
WP_7OXOC_AND_7BETAHC_PATHWAYS,SET,25,-0.088454,-0.0032619,0.17686,0.69151,WP_7OXOC_AND_7BETAHC_PATHWAYS,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...5,SET,12,-0.12243,-0.0031291,0.24469,0.69157,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_LC3_II_FORMATION,0.99999
GOBP_LEUKOCYTE_CELL_CELL_ADH...,SET,384,-0.023681,-0.0033889,0.047321,0.69161,GOBP_LEUKOCYTE_CELL_CELL_ADHESION,0.99999
GSE40685_NAIVE_CD4_TCELL_VS_...1,SET,171,-0.033999,-0.0032661,0.067912,0.69168,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...18,SET,181,-0.031579,-0.0031201,0.063076,0.69169,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP,0.99999
YAMASHITA_LIVER_CANCER_STEM_...1,SET,69,-0.055287,-0.0033831,0.11037,0.69178,YAMASHITA_LIVER_CANCER_STEM_CELL_DN,0.99999
GSE26495_PD1HIGH_VS_PD1LOW_C...1,SET,148,-0.034613,-0.0030953,0.069076,0.69184,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN,0.99999
RUBENSTEIN_SKELETAL_MUSCLE_S...1,SET,264,-0.026039,-0.0031,0.051966,0.69184,RUBENSTEIN_SKELETAL_MUSCLE_SATELLITE_CELLS,0.99999
GOMF_CATALYTIC_ACTIVITY_ACTI...5,SET,225,-0.025775,-0.0028359,0.051431,0.69187,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_DNA,0.99999
GOBP_PURINE_NUCLEOSIDE_TRIPH...,SET,5,-0.18647,-0.003077,0.37199,0.69191,GOBP_PURINE_NUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS,0.99999
GSE12845_IGD_NEG_BLOOD_VS_NA...2,SET,173,-0.031281,-0.0030223,0.062384,0.69196,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...7,SET,45,-0.070346,-0.0034785,0.14025,0.69201,GAVISH_3CA_MALIGNANT_METAPROGRAM_16_MES_GLIOMA,0.99999
HP_CROSSED_FUSED_RENAL_ECTOP...,SET,9,-0.14663,-0.0032459,0.29232,0.69203,HP_CROSSED_FUSED_RENAL_ECTOPIA,0.99999
GOMF_SODIUM_CHANNEL_ACTIVITY,SET,47,-0.067461,-0.0034091,0.13443,0.69211,GOMF_SODIUM_CHANNEL_ACTIVITY,0.99999
HP_BIFID_URETER,SET,4,-0.20202,-0.0029817,0.4024,0.69218,HP_BIFID_URETER,0.99999
GSE22432_CONVENTIONAL_CDC_VS...2,SET,180,-0.030905,-0.0030451,0.061538,0.69224,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_UP,0.99999
ZEILSTRA_CD44_TARGETS_UP,SET,8,-0.16952,-0.0035379,0.33746,0.69228,ZEILSTRA_CD44_TARGETS_UP,0.99999
GOBP_REGULATION_OF_CELLULAR_...13,SET,70,-0.05034,-0.0031026,0.10021,0.69228,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.99999
GOBP_POSITIVE_REGULATION_OF_...704,SET,18,-0.10893,-0.0034093,0.21685,0.69229,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,0.99999
GOMF_MONOATOMIC_ANION_SODIUM...,SET,17,-0.11742,-0.0035714,0.23374,0.69229,GOMF_MONOATOMIC_ANION_SODIUM_SYMPORTER_ACTIVITY,0.99999
MIR4636,SET,3,-0.40233,-0.0051427,0.80071,0.69232,MIR4636,0.99999
GOMF_BIS_5_ADENOSYL_PENTAPHO...,SET,3,-0.32382,-0.0041392,0.64447,0.69233,GOMF_BIS_5_ADENOSYL_PENTAPHOSPHATASE_ACTIVITY,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...10,SET,155,-0.035184,-0.0032192,0.070009,0.69236,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP,0.99999
KEGG_MEDICUS_VARIANT_LMO2_RE...2,SET,5,-0.19636,-0.0032401,0.39068,0.69237,KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_REPRESSION,0.99999
KUROKAWA_LIVER_CANCER_EARLY_...2,SET,12,-0.10955,-0.0027998,0.21795,0.69238,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP,0.99999
HP_APLASIA_HYPOPLASIA_AFFECT...3,SET,418,-0.021201,-0.0031625,0.042176,0.6924,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_EYE,0.99999
BIOCARTA_GRANULOCYTES_PATHWAY,SET,15,-0.11567,-0.003305,0.23004,0.69245,BIOCARTA_GRANULOCYTES_PATHWAY,0.99999
HP_ROD_CONE_DYSTROPHY,SET,197,-0.02979,-0.0030693,0.059245,0.69245,HP_ROD_CONE_DYSTROPHY,0.99999
HP_APLASIA_OF_THE_OVARY,SET,4,-0.17097,-0.0025234,0.34,0.69246,HP_APLASIA_OF_THE_OVARY,0.99999
GOCC_TRANSCRIPTION_PREINITIA...,SET,13,-0.11013,-0.0029296,0.21901,0.69247,GOCC_TRANSCRIPTION_PREINITIATION_COMPLEX,0.99999
GOBP_RESPONSE_TO_PROSTAGLAND...2,SET,5,-0.23967,-0.0039548,0.4765,0.69251,GOBP_RESPONSE_TO_PROSTAGLANDIN_D,0.99999
GSE9988_LOW_LPS_VS_CTRL_TREA...2,SET,165,-0.03637,-0.0034325,0.072283,0.69257,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP,0.99999
BROWNE_HCMV_INFECTION_10HR_UP,SET,90,-0.043889,-0.0030655,0.087222,0.69258,BROWNE_HCMV_INFECTION_10HR_UP,0.99999
SCHERER_PBMC_APSV_WETVAX_AGE...3,SET,130,-0.037083,-0.0031095,0.073686,0.69261,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_DN,0.99999
GSE42088_UNINF_VS_LEISHMANIA...3,SET,178,-0.033371,-0.00327,0.066292,0.69265,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN,0.99999
WP_ATM_SIGNALING_IN_DEVELOPM...,SET,43,-0.060587,-0.0029288,0.12033,0.69269,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...1,SET,41,-0.065497,-0.0030918,0.13008,0.6927,GAVISH_3CA_METAPROGRAM_MACROPHAGES_CELL_CYCLE,0.99999
HP_ABSENT_THUMBNAIL,SET,16,-0.10971,-0.0032376,0.2178,0.69277,HP_ABSENT_THUMBNAIL,0.99999
GOMF_EPINEPHRINE_BINDING,SET,6,-0.19221,-0.0034743,0.38151,0.6928,GOMF_EPINEPHRINE_BINDING,0.99999
GATA1_01,SET,216,-0.029812,-0.0032147,0.059148,0.69288,GATA1_01,0.99999
WP_DEGRADATION_PATHWAY_OF_SP...,SET,15,-0.12462,-0.0035608,0.24693,0.69311,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,0.99999
BIOCARTA_PLK3_PATHWAY,SET,8,-0.12484,-0.0026055,0.24733,0.69313,BIOCARTA_PLK3_PATHWAY,0.99999
REACTOME_MOLYBDENUM_COFACTOR...,SET,6,-0.20335,-0.0036757,0.40287,0.69313,REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS,0.99999
GOBP_PROSTHETIC_GROUP_METABO...,SET,6,-0.20335,-0.0036757,0.40287,0.69313,GOBP_PROSTHETIC_GROUP_METABOLIC_PROCESS,0.99999
GOMF_SUPEROXIDE_DISMUTASE_AC...,SET,5,-0.20547,-0.0033905,0.40707,0.69313,GOMF_SUPEROXIDE_DISMUTASE_ACTIVITY,0.99999
GSE7509_FCGRIIB_VS_TNFA_IL1B...1,SET,131,-0.036144,-0.0030423,0.071601,0.69315,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,0.99999
REACTOME_ACTIVATION_OF_NIMA_...,SET,7,-0.14277,-0.0027873,0.28274,0.6932,REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7,0.99999
GOBP_VESICLE_CYTOSKELETAL_TR...,SET,55,-0.05743,-0.0031387,0.11369,0.69326,GOBP_VESICLE_CYTOSKELETAL_TRAFFICKING,0.99999
GOBP_CD8_POSITIVE_ALPHA_BETA...2,SET,15,-0.11689,-0.0033399,0.2314,0.69327,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
HP_CHOREOATHETOSIS,SET,101,-0.0419,-0.0030993,0.082947,0.69327,HP_CHOREOATHETOSIS,0.99999
HP_ABNORMAL_RENAL_VASCULAR_M...,SET,24,-0.083443,-0.0030151,0.16513,0.69333,HP_ABNORMAL_RENAL_VASCULAR_MORPHOLOGY,0.99999
DESCARTES_MAIN_FETAL_CARDIOM...,SET,24,-0.092156,-0.0033299,0.18233,0.69337,DESCARTES_MAIN_FETAL_CARDIOMYOCYTES,0.99999
GOBP_TELOMERASE_RNA_LOCALIZA...,SET,18,-0.092252,-0.0028873,0.18241,0.69348,GOBP_TELOMERASE_RNA_LOCALIZATION,0.99999
chr4p14,SET,29,-0.15191,-0.006033,0.30022,0.69357,chr4p14,0.99999
MIR181C_5P,SET,556,-0.019174,-0.003286,0.037885,0.69361,MIR181C_5P,0.99999
HP_ABNORMAL_AMPLITUDE_OF_DAR...,SET,14,-0.11871,-0.003277,0.23453,0.69363,HP_ABNORMAL_AMPLITUDE_OF_DARK_ADAPTED_BRIGHT_FLASH_ELECTRORETINOGRAM,0.99999
MIR95_3P,SET,5,-0.21103,-0.0034823,0.41677,0.69369,MIR95_3P,0.99999
GOBP_REGULATION_OF_NUCLEAR_D...,SET,142,-0.036362,-0.0031856,0.071808,0.6937,GOBP_REGULATION_OF_NUCLEAR_DIVISION,0.99999
MORF_PTPRB,SET,222,-0.029798,-0.003257,0.058843,0.69371,MORF_PTPRB,0.99999
GSE26890_CXCR1_NEG_VS_POS_EF...2,SET,180,-0.032909,-0.0032426,0.064974,0.69374,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP,0.99999
GSE40068_CXCR5NEG_BCL6NEG_CD...1,SET,183,-0.03217,-0.0031958,0.063509,0.69376,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN,0.99999
GAZDA_DIAMOND_BLACKFAN_ANEMI...1,SET,403,-0.020744,-0.0030396,0.040921,0.6939,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,0.99999
GOMF_PROMOTER_SPECIFIC_CHROM...,SET,62,-0.052398,-0.0030399,0.10335,0.69391,GOMF_PROMOTER_SPECIFIC_CHROMATIN_BINDING,0.99999
LU_TUMOR_ENDOTHELIAL_MARKERS...1,SET,4,-0.17097,-0.0025234,0.33723,0.69392,LU_TUMOR_ENDOTHELIAL_MARKERS_DN,0.99999
GOBP_PHARYNGEAL_ARCH_ARTERY_...,SET,9,-0.16376,-0.0036251,0.32299,0.69393,GOBP_PHARYNGEAL_ARCH_ARTERY_MORPHOGENESIS,0.99999
WP_EICOSANOID_METABOLISM_VIA...2,SET,9,-0.14522,-0.0032147,0.28641,0.69394,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_LOADI...,SET,7,-0.17601,-0.0034363,0.3471,0.69395,KEGG_MEDICUS_REFERENCE_LOADING_OF_THE_SMC5_SMC6_COMPLEX,0.99999
PID_P38_ALPHA_BETA_DOWNSTREA...,SET,37,-0.073373,-0.0032907,0.14468,0.69396,PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,0.99999
GOBP_REGULATION_OF_MYELOID_D...,SET,4,-0.24996,-0.0036892,0.49279,0.694,GOBP_REGULATION_OF_MYELOID_DENDRITIC_CELL_ACTIVATION,0.99999
REACTOME_KERATINIZATION,SET,183,-0.046147,-0.0045844,0.090956,0.69405,REACTOME_KERATINIZATION,0.99999
TOP2B_TARGET_GENES,SET,483,-0.020247,-0.0032406,0.039903,0.69406,TOP2B_TARGET_GENES,0.99999
GSE25123_CTRL_VS_IL4_STIM_PP...1,SET,175,-0.033278,-0.0032336,0.06558,0.69408,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN,0.99999
WP_SELECTIVE_EXPRESSION_OF_C...,SET,27,-0.090996,-0.0034872,0.17927,0.69412,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...2,SET,42,-0.06009,-0.0028709,0.11837,0.69414,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN,0.99999
GOBP_STORE_OPERATED_CALCIUM_...,SET,20,-0.10222,-0.0033721,0.20131,0.69419,GOBP_STORE_OPERATED_CALCIUM_ENTRY,0.99999
REACTOME_PROLACTIN_RECEPTOR_...,SET,14,-0.11755,-0.0032449,0.23146,0.69422,REACTOME_PROLACTIN_RECEPTOR_SIGNALING,0.99999
REACTOME_MATURATION_OF_SARS_...1,SET,11,-0.11378,-0.0027844,0.22399,0.69426,REACTOME_MATURATION_OF_SARS_COV_1_NUCLEOPROTEIN,0.99999
GOMF_CCR6_CHEMOKINE_RECEPTOR...,SET,5,-0.23712,-0.0039127,0.4668,0.69426,GOMF_CCR6_CHEMOKINE_RECEPTOR_BINDING,0.99999
GOMF_POTASSIUM_CHANNEL_ACTIV...1,SET,5,-0.2183,-0.0036022,0.42956,0.69434,GOMF_POTASSIUM_CHANNEL_ACTIVATOR_ACTIVITY,0.99999
GOBP_RECEPTOR_DIFFUSION_TRAP...,SET,10,-0.14942,-0.0034864,0.29397,0.69437,GOBP_RECEPTOR_DIFFUSION_TRAPPING,0.99999
GSE21927_SPLEEN_VS_C26GM_TUM...1,SET,162,-0.033862,-0.0031669,0.066612,0.69439,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_DN,0.99999
GOBP_MACROPHAGE_DIFFERENTIAT...,SET,57,-0.061266,-0.0034086,0.12052,0.6944,GOBP_MACROPHAGE_DIFFERENTIATION,0.99999
ZNF436_TARGET_GENES,SET,409,-0.022054,-0.003255,0.043371,0.69445,ZNF436_TARGET_GENES,0.99999
GOCC_CATENIN_COMPLEX,SET,31,-0.089987,-0.0036947,0.17689,0.69452,GOCC_CATENIN_COMPLEX,0.99999
GOBP_POSITIVE_REGULATION_OF_...277,SET,61,-0.059014,-0.0033961,0.116,0.69454,GOBP_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.99999
HP_LOSS_OF_PURKINJE_CELLS_IN...,SET,5,-0.20289,-0.003348,0.3986,0.69463,HP_LOSS_OF_PURKINJE_CELLS_IN_THE_CEREBELLAR_VERMIS,0.99999
GSE3565_CTRL_VS_LPS_INJECTED...1,SET,155,-0.035984,-0.0032925,0.070684,0.69465,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN,0.99999
REACTOME_PTK6_EXPRESSION,SET,5,-0.18837,-0.0031083,0.36993,0.69469,REACTOME_PTK6_EXPRESSION,0.99999
MIKKELSEN_ES_ICP_WITH_H3K27M...,SET,41,-0.071277,-0.0033647,0.13997,0.6947,MIKKELSEN_ES_ICP_WITH_H3K27ME3,0.99999
DACOSTA_UV_RESPONSE_VIA_ERCC...1,SET,436,-0.021538,-0.0032796,0.042292,0.69472,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,0.99999
HP_SCLEROCORNEA,SET,43,-0.064957,-0.0031401,0.12752,0.69475,HP_SCLEROCORNEA,0.99999
WP_RAC1PAK1P38MMP2_PATHWAY,SET,66,-0.053635,-0.0032102,0.10529,0.69477,WP_RAC1PAK1P38MMP2_PATHWAY,0.99999
BLANCO_MELO_BRONCHIAL_EPITHE...1,SET,159,-0.032888,-0.0030475,0.064548,0.6948,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN,0.99999
MORF_PDCD1,SET,64,-0.057137,-0.0033677,0.11212,0.69483,MORF_PDCD1,0.99999
GOBP_TRANSLATION,SET,578,-0.0175,-0.0030559,0.03434,0.69483,GOBP_TRANSLATION,0.99999
MULLIGHAN_NPM1_MUTATED_SIGNA...3,SET,65,-0.048974,-0.0029089,0.096052,0.69492,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,0.99999
GOBP_IMMUNE_RESPONSE_INHIBIT...2,SET,10,-0.1527,-0.003563,0.29947,0.69494,GOBP_IMMUNE_RESPONSE_INHIBITING_SIGNAL_TRANSDUCTION,0.99999
GSE13522_WT_VS_IFNG_KO_SKIN_...1,SET,108,-0.043129,-0.0032983,0.084582,0.69494,GSE13522_WT_VS_IFNG_KO_SKIN_DN,0.99999
BIOCARTA_SODD_PATHWAY,SET,10,-0.13525,-0.0031559,0.26515,0.69501,BIOCARTA_SODD_PATHWAY,0.99999
LUDWICZEK_TREATING_IRON_OVER...,SET,7,-0.19205,-0.0037495,0.37642,0.69504,LUDWICZEK_TREATING_IRON_OVERLOAD,0.99999
GAVIN_FOXP3_TARGETS_CLUSTER_...5,SET,82,-0.048717,-0.0032486,0.095476,0.69506,GAVIN_FOXP3_TARGETS_CLUSTER_P7,0.99999
GOBP_REGULATION_OF_MITOTIC_C...1,SET,472,-0.020092,-0.00318,0.039363,0.69512,GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...12,SET,143,-0.036335,-0.0031944,0.071183,0.69513,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_UP,0.99999
GSE10463_CD40L_AND_VA347_VS_...2,SET,167,-0.034126,-0.00324,0.066844,0.69516,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP,0.99999
GOBP_CELL_SUBSTRATE_ADHESION,SET,332,-0.024898,-0.0033179,0.048735,0.69528,GOBP_CELL_SUBSTRATE_ADHESION,0.99999
QI_PBMC_ZOSTAVAX_AGE_50_75YO...5,SET,107,-0.039178,-0.0029823,0.076672,0.69531,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_NEGATIVE,0.99999
HP_PIERRE_ROBIN_SEQUENCE,SET,25,-0.088915,-0.003279,0.17401,0.69532,HP_PIERRE_ROBIN_SEQUENCE,0.99999
GSE21063_WT_VS_NFATC1_KO_16H...1,SET,164,-0.037877,-0.003564,0.074105,0.69537,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_DN,0.99999
GOBP_SCF_DEPENDENT_PROTEASOM...,SET,43,-0.069864,-0.0033772,0.13666,0.6954,GOBP_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
HP_ABNORMALITY_OF_THE_FIFTH_...,SET,8,-0.17606,-0.0036744,0.34435,0.69542,HP_ABNORMALITY_OF_THE_FIFTH_METATARSAL_BONE,0.99999
GSE27786_CD8_TCELL_VS_ERYTHR...2,SET,182,-0.030485,-0.0030203,0.059614,0.69545,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP,0.99999
GOMF_FIBRONECTIN_BINDING,SET,30,-0.09208,-0.0037193,0.1799,0.69562,GOMF_FIBRONECTIN_BINDING,0.99999
MIR10397_5P,SET,67,-0.052204,-0.003148,0.10198,0.69564,MIR10397_5P,0.99999
GOMF_PHOSPHOLIPASE_A1_ACTIVI...,SET,13,-0.12409,-0.003301,0.2424,0.69565,GOMF_PHOSPHOLIPASE_A1_ACTIVITY,0.99999
HP_IMPAIRED_TEMPERATURE_SENS...,SET,34,-0.079384,-0.0034132,0.15506,0.69566,HP_IMPAIRED_TEMPERATURE_SENSATION,0.99999
GOMF_HISTONE_CHAPERONE_ACTIV...,SET,12,-0.12112,-0.0030956,0.23645,0.69575,GOMF_HISTONE_CHAPERONE_ACTIVITY,0.99999
GOBP_VERY_LOW_DENSITY_LIPOPR...1,SET,10,-0.14465,-0.003375,0.2823,0.6958,GOBP_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY,0.99999
SRY_02,SET,229,-0.030532,-0.0033887,0.059588,0.69581,SRY_02,0.99999
HP_RETINAL_NONATTACHMENT,SET,7,-0.17561,-0.0034285,0.34271,0.69582,HP_RETINAL_NONATTACHMENT,0.99999
KANG_AR_TARGETS_DN,SET,18,-0.11067,-0.0034636,0.21588,0.69589,KANG_AR_TARGETS_DN,0.99999
HP_ABNORMAL_PERIPHERAL_NERVO...1,SET,360,-0.022923,-0.0031784,0.044716,0.69589,HP_ABNORMAL_PERIPHERAL_NERVOUS_SYSTEM_MORPHOLOGY,0.99999
WP_GLUTATHIONE_METABOLISM,SET,16,-0.10979,-0.0032399,0.21414,0.69592,WP_GLUTATHIONE_METABOLISM,0.99999
MIR24_1_5P_MIR24_2_5P,SET,42,-0.065699,-0.0031389,0.12814,0.69592,MIR24_1_5P_MIR24_2_5P,0.99999
MODULE_43,SET,92,-0.043877,-0.0030983,0.085575,0.69593,MODULE_43,0.99999
HP_THIN_CORPUS_CALLOSUM,SET,735,-0.016059,-0.0031482,0.031315,0.69595,HP_THIN_CORPUS_CALLOSUM,0.99999
GSE3920_IFNA_VS_IFNB_TREATED...2,SET,159,-0.035427,-0.0032827,0.069075,0.69598,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,0.99999
DESCARTES_FETAL_INTESTINE_CH...,SET,86,-0.051439,-0.0035125,0.10029,0.69599,DESCARTES_FETAL_INTESTINE_CHROMAFFIN_CELLS,0.99999
KIM_PTEN_TARGETS_DN,SET,4,-0.19373,-0.0028593,0.37769,0.696,KIM_PTEN_TARGETS_DN,0.99999
GOBP_RECEPTOR_MEDIATED_ENDOC...2,SET,5,-0.21237,-0.0035044,0.41393,0.69604,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS_INVOLVED_IN_CHOLESTEROL_TRANSPORT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...696,SET,88,-0.049254,-0.0034019,0.095979,0.69608,GOBP_NEGATIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,0.99999
GOBP_ENTEROENDOCRINE_CELL_DI...,SET,33,-0.082655,-0.0035012,0.16101,0.69615,GOBP_ENTEROENDOCRINE_CELL_DIFFERENTIATION,0.99999
HP_OCULAR_FLUTTER,SET,5,-0.22217,-0.003666,0.43271,0.69617,HP_OCULAR_FLUTTER,0.99999
KEGG_MEDICUS_REFERENCE_MICRO...1,SET,22,-0.096037,-0.0033226,0.18702,0.6962,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION,0.99999
GOBP_CHAPERONE_MEDIATED_PROT...1,SET,22,-0.083166,-0.0028773,0.16195,0.69621,GOBP_CHAPERONE_MEDIATED_PROTEIN_COMPLEX_ASSEMBLY,0.99999
COLE_BLOOD_FLUMIST_QUADRIVAL...,SET,5,-0.2364,-0.0039009,0.46025,0.69624,COLE_BLOOD_FLUMIST_QUADRIVALENT_AGE_03_17YO_7DY_UP,0.99999
GOCC_APICAL_CORTEX,SET,8,-0.14778,-0.0030842,0.28762,0.6963,GOCC_APICAL_CORTEX,0.99999
GOBP_REGULATION_OF_CELL_CYCL...4,SET,398,-0.02167,-0.0031559,0.042172,0.69631,GOBP_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,0.99999
HP_FOCAL_IMPAIRED_AWARENESS_...,SET,113,-0.042217,-0.003302,0.082134,0.69637,HP_FOCAL_IMPAIRED_AWARENESS_SEIZURE,0.99999
HP_MALIGNANT_GASTROINTESTINA...,SET,70,-0.051151,-0.0031525,0.099512,0.69638,HP_MALIGNANT_GASTROINTESTINAL_TRACT_TUMORS,0.99999
HP_MESOAXIAL_HAND_POLYDACTYLY,SET,10,-0.14325,-0.0033425,0.27865,0.6964,HP_MESOAXIAL_HAND_POLYDACTYLY,0.99999
HP_SUTURAL_CATARACT,SET,7,-0.1527,-0.0029812,0.29697,0.69644,HP_SUTURAL_CATARACT,0.99999
HP_SUBARACHNOID_HEMORRHAGE,SET,36,-0.07925,-0.003506,0.15411,0.69645,HP_SUBARACHNOID_HEMORRHAGE,0.99999
GOBP_POSITIVE_REGULATION_OF_...784,SET,5,-0.22236,-0.0036693,0.43241,0.69646,GOBP_POSITIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,0.99999
GSE40274_CTRL_VS_FOXP3_AND_S...2,SET,150,-0.035045,-0.0031548,0.068093,0.6966,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
MIR1180_3P,SET,6,-0.18951,-0.0034255,0.36807,0.69668,MIR1180_3P,0.99999
GSE32986_UNSTIM_VS_CURDLAN_H...1,SET,174,-0.033326,-0.0032291,0.064713,0.69671,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,0.99999
GOMF_EPOXIDE_HYDROLASE_ACTIV...,SET,8,-0.17756,-0.0037058,0.34469,0.69677,GOMF_EPOXIDE_HYDROLASE_ACTIVITY,0.99999
MIR183_3P,SET,186,-0.032461,-0.0032509,0.063008,0.69679,MIR183_3P,0.99999
GSE3982_CTRL_VS_PMA_STIM_EOS...2,SET,173,-0.033134,-0.0032013,0.064297,0.69683,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...314,SET,7,-0.19304,-0.0037688,0.37442,0.69692,GOBP_POSITIVE_REGULATION_OF_GONADOTROPIN_SECRETION,0.99999
GOMF_IGE_BINDING,SET,5,-0.19009,-0.0031367,0.36867,0.69693,GOMF_IGE_BINDING,0.99999
CREIGHTON_AKT1_SIGNALING_VIA...2,SET,32,-0.076261,-0.0031812,0.14789,0.69695,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP,0.99999
GSE9960_GRAM_NEG_VS_GRAM_NEG...1,SET,167,-0.031715,-0.0030111,0.061499,0.69696,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,0.99999
GOCC_CONNEXIN_COMPLEX,SET,18,-0.127,-0.0039749,0.24627,0.69697,GOCC_CONNEXIN_COMPLEX,0.99999
HP_ABNORMAL_HEART_VALVE_MORP...,SET,307,-0.02593,-0.003325,0.050273,0.69699,HP_ABNORMAL_HEART_VALVE_MORPHOLOGY,0.99999
GOBP_HEAT_GENERATION,SET,18,-0.12002,-0.0037563,0.23268,0.697,GOBP_HEAT_GENERATION,0.99999
NAKAYA_PLASMACYTOID_DENDRITI...4,SET,1082,-0.013201,-0.0031091,0.025594,0.697,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP,0.99999
MIR12116,SET,48,-0.060019,-0.003065,0.11635,0.69701,MIR12116,0.99999
GOBP_CHONDROCYTE_DEVELOPMENT...,SET,8,-0.1791,-0.003738,0.34719,0.69702,GOBP_CHONDROCYTE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,0.99999
REACTOME_TRAF6_MEDIATED_NF_K...,SET,23,-0.091473,-0.0032357,0.17732,0.69703,REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...403,SET,103,-0.046213,-0.0034518,0.089573,0.69705,GOBP_NEGATIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,0.99999
KEGG_MEDICUS_REFERENCE_MGLUR...2,SET,20,-0.098015,-0.0032334,0.18995,0.69707,KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.99999
ATF6_TARGET_GENES,SET,864,-0.01514,-0.0032063,0.02934,0.69707,ATF6_TARGET_GENES,0.99999
GOBP_PROTEIN_HYDROXYLATION,SET,23,-0.085435,-0.0030221,0.16556,0.69708,GOBP_PROTEIN_HYDROXYLATION,0.99999
HP_NONCOMPACTION_CARDIOMYOPA...,SET,15,-0.12211,-0.003489,0.23663,0.69708,HP_NONCOMPACTION_CARDIOMYOPATHY,0.99999
GSE22140_HEALTHY_VS_ARTHRITI...2,SET,175,-0.032587,-0.0031664,0.063148,0.69708,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_UP,0.99999
CGGAARNGGCNG_UNKNOWN,SET,52,-0.057315,-0.0030461,0.11106,0.69709,CGGAARNGGCNG_UNKNOWN,0.99999
HP_BRAIN_IMAGING_ABNORMALITY,SET,137,-0.037144,-0.0031967,0.071974,0.69709,HP_BRAIN_IMAGING_ABNORMALITY,0.99999
REACTOME_ACYL_CHAIN_REMODELL...4,SET,16,-0.1189,-0.0035088,0.2304,0.6971,REACTOME_ACYL_CHAIN_REMODELLING_OF_PI,0.99999
GOMF_PYRUVATE_TRANSMEMBRANE_...,SET,5,-0.20488,-0.0033808,0.39697,0.69711,GOMF_PYRUVATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE7568_CTRL_VS_3H_TGFB_TREA...1,SET,150,-0.03565,-0.0032093,0.06907,0.69712,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,0.99999
GOBP_SKELETAL_SYSTEM_MORPHOG...,SET,218,-0.032422,-0.0035121,0.062807,0.69715,GOBP_SKELETAL_SYSTEM_MORPHOGENESIS,0.99999
HP_NEOPLASM_OF_THE_PERIPHERA...,SET,68,-0.05083,-0.0030878,0.098429,0.69721,HP_NEOPLASM_OF_THE_PERIPHERAL_NERVOUS_SYSTEM,0.99999
HP_AUTOPHAGIC_VACUOLES,SET,8,-0.14887,-0.0031071,0.28823,0.69725,HP_AUTOPHAGIC_VACUOLES,0.99999
GOBP_REGULATION_OF_T_CELL_ME...3,SET,94,-0.050044,-0.0035718,0.096869,0.69728,GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,0.99999
HP_ABNORMAL_TENDON_MORPHOLOGY,SET,751,-0.0164,-0.0032485,0.031744,0.69729,HP_ABNORMAL_TENDON_MORPHOLOGY,0.99999
GSE43863_NAIVE_VS_MEMORY_TFH...2,SET,178,-0.033482,-0.0032809,0.064783,0.69736,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP,0.99999
HSF2_TARGET_GENES,SET,196,-0.029865,-0.0030694,0.05778,0.69737,HSF2_TARGET_GENES,0.99999
GOMF_N_ACETYLLACTOSAMINE_SYN...,SET,5,-0.21383,-0.0035284,0.4137,0.69737,GOMF_N_ACETYLLACTOSAMINE_SYNTHASE_ACTIVITY,0.99999
NOTCH_DN.V1_DN,SET,161,-0.036099,-0.0033658,0.069785,0.69752,NOTCH_DN.V1_DN,0.99999
HP_SCALING_SKIN,SET,42,-0.068117,-0.0032544,0.13167,0.69754,HP_SCALING_SKIN,0.99999
HP_VOCAL_CORD_PARALYSIS,SET,53,-0.059063,-0.0031689,0.11417,0.69754,HP_VOCAL_CORD_PARALYSIS,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...3,SET,375,-0.025218,-0.0035673,0.048735,0.69758,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,0.99999
ZFHX3_TARGET_GENES,SET,1384,-0.012185,-0.003217,0.023548,0.69758,ZFHX3_TARGET_GENES,0.99999
GOBP_GLUCOSYLCERAMIDE_CATABO...,SET,4,-0.24607,-0.0036319,0.47555,0.69758,GOBP_GLUCOSYLCERAMIDE_CATABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...554,SET,22,-0.088798,-0.0030722,0.17153,0.69766,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.99999
BILANGES_SERUM_SENSITIVE_GEN...,SET,72,-0.05183,-0.0032395,0.10011,0.69768,BILANGES_SERUM_SENSITIVE_GENES,0.99999
MORF_MSH3,SET,225,-0.028744,-0.0031627,0.055482,0.6978,MORF_MSH3,0.99999
KEGG_MEDICUS_REFERENCE_TELOM...2,SET,16,-0.10294,-0.0030377,0.19868,0.69781,KEGG_MEDICUS_REFERENCE_TELOMERE_ELONGATION,0.99999
MIR627_3P,SET,423,-0.022314,-0.0033478,0.043061,0.69783,MIR627_3P,0.99999
GOBP_ACTIN_FILAMENT_SEVERING,SET,16,-0.10178,-0.0030034,0.19641,0.69783,GOBP_ACTIN_FILAMENT_SEVERING,0.99999
GSE34156_UNTREATED_VS_6H_NOD...3,SET,166,-0.034339,-0.0032506,0.066266,0.69784,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN,0.99999
HP_ABNORMALITY_OF_THE_DISTAL...5,SET,9,-0.15066,-0.0033351,0.2907,0.69786,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_HALLUX,0.99999
HP_ABNORMAL_PROPORTION_OF_CD...3,SET,17,-0.10388,-0.0031598,0.20042,0.69789,HP_ABNORMAL_PROPORTION_OF_CD8_POSITIVE_T_CELLS,0.99999
GOBP_PROGESTERONE_RECEPTOR_S...,SET,10,-0.14547,-0.0033942,0.28055,0.69795,GOBP_PROGESTERONE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE5589_LPS_AND_IL10_VS_LPS_...2,SET,178,-0.033513,-0.0032839,0.064627,0.69796,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...781,SET,5,-0.17665,-0.0029149,0.34061,0.69799,GOBP_POSITIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS,0.99999
GOMF_MUTSALPHA_COMPLEX_BINDI...,SET,7,-0.15725,-0.0030701,0.30319,0.698,GOMF_MUTSALPHA_COMPLEX_BINDING,0.99999
MIR7159_3P,SET,199,-0.032033,-0.003317,0.061746,0.69804,MIR7159_3P,0.99999
HP_HYPOCALCEMIA,SET,74,-0.053347,-0.0033801,0.10283,0.69805,HP_HYPOCALCEMIA,0.99999
GSE21360_NAIVE_VS_PRIMARY_ME...2,SET,157,-0.036655,-0.0033752,0.070652,0.69805,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_UP,0.99999
chr4q21,SET,60,-0.10393,-0.0059321,0.2003,0.69808,chr4q21,0.99999
GOBP_REGULATION_OF_AMPA_RECE...,SET,19,-0.10704,-0.0034419,0.2062,0.69816,GOBP_REGULATION_OF_AMPA_RECEPTOR_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...194,SET,13,-0.13286,-0.0035341,0.25587,0.69819,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,0.99999
KEGG_MEDICUS_PATHOGEN_EBV_EB...4,SET,5,-0.17287,-0.0028525,0.33287,0.69823,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00484,0.99999
KEGG_MEDICUS_VARIANT_MLL_ENL...,SET,11,-0.15339,-0.0037537,0.29533,0.69826,KEGG_MEDICUS_VARIANT_MLL_ENL_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.99999
GOCC_SECRETORY_VESICLE,SET,986,-0.014831,-0.0033435,0.028552,0.69826,GOCC_SECRETORY_VESICLE,0.99999
GSE14415_INDUCED_TREG_VS_FOX...2,SET,124,-0.041617,-0.0034087,0.080109,0.69829,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN,0.99999
STAT1_01,SET,62,-0.054986,-0.0031901,0.10584,0.6983,STAT1_01,0.99999
GOCC_AMINOACYL_TRNA_SYNTHETA...,SET,3,-0.18656,-0.0023847,0.35899,0.69835,GOCC_AMINOACYL_TRNA_SYNTHETASE_MULTIENZYME_COMPLEX,0.99999
LEE_AGING_NEOCORTEX_DN,SET,62,-0.053736,-0.0031176,0.1034,0.69837,LEE_AGING_NEOCORTEX_DN,0.99999
GHANDHI_BYSTANDER_IRRADIATIO...1,SET,11,-0.16335,-0.0039973,0.31405,0.69851,GHANDHI_BYSTANDER_IRRADIATION_DN,0.99999
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...2,SET,727,-0.016984,-0.0033123,0.032642,0.69858,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN,0.99999
MIR3129_3P,SET,94,-0.047122,-0.0033633,0.090528,0.69865,MIR3129_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...243,SET,87,-0.050155,-0.0034445,0.096339,0.69868,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...10,SET,185,-0.032182,-0.0032143,0.06181,0.6987,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GOBP_REGULATION_OF_PEPTIDYL_...3,SET,7,-0.15403,-0.0030073,0.29576,0.69875,GOBP_REGULATION_OF_PEPTIDYL_SERINE_DEPHOSPHORYLATION,0.99999
GOBP_EPITHELIAL_TUBE_FORMATI...,SET,131,-0.038888,-0.0032733,0.074646,0.6988,GOBP_EPITHELIAL_TUBE_FORMATION,0.99999
HOSHIDA_LIVER_CANCER_SUBCLAS...1,SET,216,-0.030152,-0.0032513,0.057865,0.69884,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,0.99999
HP_CHORIORETINAL_DYSPLASIA,SET,14,-0.11957,-0.0033008,0.22945,0.69886,HP_CHORIORETINAL_DYSPLASIA,0.99999
HP_ABNORMALITY_OF_LYSOSOMAL_...,SET,8,-0.16589,-0.0034623,0.31824,0.69891,HP_ABNORMALITY_OF_LYSOSOMAL_METABOLISM,0.99999
GOMF_NEUROTROPHIN_BINDING,SET,9,-0.1658,-0.0036703,0.31804,0.69893,GOMF_NEUROTROPHIN_BINDING,0.99999
REACTOME_SIGNALLING_TO_RAS,SET,20,-0.10233,-0.0033759,0.19629,0.69894,REACTOME_SIGNALLING_TO_RAS,0.99999
HP_SMALL_FOREHEAD,SET,11,-0.13352,-0.0032675,0.25596,0.69904,HP_SMALL_FOREHEAD,0.99999
INAMURA_LUNG_CANCER_SCC_UP,SET,11,-0.13903,-0.0034022,0.26648,0.69906,INAMURA_LUNG_CANCER_SCC_UP,0.99999
HP_ADRENOCORTICOTROPIC_HORMO...1,SET,14,-0.12263,-0.0033851,0.23501,0.69909,HP_ADRENOCORTICOTROPIC_HORMONE_DEFICIENCY,0.99999
HP_ABNORMAL_SPACED_INCISORS,SET,12,-0.11875,-0.0030351,0.22754,0.69912,HP_ABNORMAL_SPACED_INCISORS,0.99999
RICKMAN_TUMOR_DIFFERENTIATED...4,SET,97,-0.046089,-0.0033413,0.088304,0.69914,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,0.99999
DESCARTES_FETAL_EYE_RETINAL_...1,SET,63,-0.06168,-0.0036071,0.11817,0.69915,DESCARTES_FETAL_EYE_RETINAL_PIGMENT_CELLS,0.99999
REACTOME_NOTCH4_ACTIVATION_A...,SET,10,-0.14031,-0.0032739,0.26879,0.69916,REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,0.99999
DORN_ADENOVIRUS_INFECTION_32...2,SET,9,-0.14309,-0.0031674,0.27407,0.69919,DORN_ADENOVIRUS_INFECTION_32HR_UP,0.99999
MIR5698,SET,187,-0.031946,-0.0032078,0.061174,0.69924,MIR5698,0.99999
HAHTOLA_MYCOSIS_FUNGOIDES_CD...1,SET,101,-0.042581,-0.0031497,0.081517,0.69929,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,0.99999
TGGNNNNNNKCCAR_UNKNOWN,SET,382,-0.023754,-0.0033907,0.04547,0.69931,TGGNNNNNNKCCAR_UNKNOWN,0.99999
GOBP_METHIONINE_METABOLIC_PR...,SET,15,-0.11772,-0.0033636,0.22532,0.69932,GOBP_METHIONINE_METABOLIC_PROCESS,0.99999
GOMF_SOLUTE_PROTON_SYMPORTER...,SET,24,-0.098706,-0.0035666,0.18892,0.69933,GOMF_SOLUTE_PROTON_SYMPORTER_ACTIVITY,0.99999
chr8q24,SET,152,-0.075745,-0.0068637,0.14497,0.69934,chr8q24,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_LYM...,SET,345,-0.025978,-0.0035276,0.049713,0.69936,HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL,0.99999
GSE339_CD8POS_VS_CD4CD8DN_DC...4,SET,184,-0.03237,-0.0032244,0.061913,0.69945,GSE339_CD8POS_VS_CD4CD8DN_DC_UP,0.99999
GOBP_PARTURITION,SET,14,-0.12457,-0.0034387,0.23825,0.69946,GOBP_PARTURITION,0.99999
GSE25085_FETAL_LIVER_VS_FETA...2,SET,181,-0.031528,-0.0031151,0.060263,0.69957,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP,0.99999
GOCC_CHROMATOID_BODY,SET,12,-0.15071,-0.0038518,0.28796,0.69963,GOCC_CHROMATOID_BODY,0.99999
HP_ORTHOKERATOSIS,SET,18,-0.10694,-0.003347,0.2043,0.69966,HP_ORTHOKERATOSIS,0.99999
HP_CONSTITUTIONAL_SYMPTOM,SET,1128,-0.014071,-0.0033791,0.026879,0.69968,HP_CONSTITUTIONAL_SYMPTOM,0.99999
GOBP_RAS_PROTEIN_SIGNAL_TRAN...,SET,116,-0.041351,-0.0032767,0.078984,0.6997,GOBP_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GOBP_TRNA_DECAY,SET,16,-0.11412,-0.0033677,0.21797,0.69971,GOBP_TRNA_DECAY,0.99999
GSE40274_LEF1_VS_FOXP3_AND_L...2,SET,180,-0.034376,-0.0033871,0.065651,0.69972,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
MODULE_199,SET,52,-0.067481,-0.0035863,0.12887,0.69973,MODULE_199,0.99999
GOBP_OTOLITH_DEVELOPMENT,SET,10,-0.14832,-0.0034608,0.28324,0.69974,GOBP_OTOLITH_DEVELOPMENT,0.99999
GSE5679_CTRL_VS_PPARG_LIGAND...2,SET,179,-0.035546,-0.0034928,0.067858,0.6998,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,0.99999
MCGOWAN_RSP6_TARGETS_UP,SET,20,-0.10614,-0.0035013,0.20254,0.69987,MCGOWAN_RSP6_TARGETS_UP,0.99999
GOBP_MRNA_TRANSCRIPTION,SET,46,-0.06004,-0.0030017,0.11457,0.69987,GOBP_MRNA_TRANSCRIPTION,0.99999
GOBP_REGULATION_OF_PRESYNAPT...1,SET,12,-0.14562,-0.0037219,0.27777,0.69995,GOBP_REGULATION_OF_PRESYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HM...,SET,521,-0.020517,-0.003407,0.039134,0.69996,MANNO_MIDBRAIN_NEUROTYPES_HMGL,0.99999
HP_CARDIAC_CONDUCTION_ABNORM...,SET,127,-0.040394,-0.0033481,0.077022,0.70001,HP_CARDIAC_CONDUCTION_ABNORMALITY,0.99999
HOFFMANN_LARGE_TO_SMALL_PRE_...1,SET,60,-0.057598,-0.0032874,0.10982,0.70002,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,0.99999
HP_DEXTROTRANSPOSITION_OF_TH...,SET,5,-0.18072,-0.002982,0.34454,0.70004,HP_DEXTROTRANSPOSITION_OF_THE_GREAT_ARTERIES,0.99999
REACTOME_METAL_SEQUESTRATION...,SET,6,-0.20508,-0.0037068,0.39094,0.70006,REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS,0.99999
KEGG_MEDICUS_REFERENCE_TBK1_...,SET,10,-0.14096,-0.003289,0.26858,0.70014,KEGG_MEDICUS_REFERENCE_TBK1_MEDIATED_AUTOPHAGOSOME_FORMATION,0.99999
GSE1460_DP_THYMOCYTE_VS_NAIV...2,SET,170,-0.033346,-0.003194,0.063522,0.70019,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,0.99999
HP_RESTLESSNESS,SET,127,-0.040967,-0.0033956,0.078034,0.7002,HP_RESTLESSNESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...440,SET,76,-0.054117,-0.0034748,0.10303,0.70029,GOBP_POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,0.99999
MIR3680_5P,SET,31,-0.073865,-0.0030328,0.14059,0.70034,MIR3680_5P,0.99999
RODRIGUES_DCC_TARGETS_DN,SET,110,-0.041971,-0.0032391,0.079853,0.70041,RODRIGUES_DCC_TARGETS_DN,0.99999
GOBP_REGULATORY_NCRNA_MEDIAT...2,SET,16,-0.10957,-0.0032334,0.20844,0.70044,GOBP_REGULATORY_NCRNA_MEDIATED_HETEROCHROMATIN_FORMATION,0.99999
HP_ABNORMALITY_OF_COAGULATION,SET,201,-0.031551,-0.0032833,0.060016,0.70045,HP_ABNORMALITY_OF_COAGULATION,0.99999
HP_STROKE,SET,148,-0.037892,-0.0033885,0.07207,0.70047,HP_STROKE,0.99999
MODULE_297,SET,72,-0.055971,-0.0034983,0.10645,0.70048,MODULE_297,0.99999
GSE39556_UNTREATED_VS_3H_POL...1,SET,184,-0.034493,-0.0034359,0.065601,0.70048,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN,0.99999
ONKEN_UVEAL_MELANOMA_DN,SET,474,-0.021378,-0.0033905,0.040653,0.70051,ONKEN_UVEAL_MELANOMA_DN,0.99999
KEGG_MEDICUS_PATHOGEN_SHIGEL...8,SET,6,-0.21092,-0.0038125,0.40108,0.70051,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,0.99999
GSE1925_CTRL_VS_IFNG_PRIMED_...2,SET,179,-0.033323,-0.0032743,0.063366,0.70051,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP,0.99999
GSE22611_UNSTIM_VS_2H_MDP_ST...3,SET,176,-0.033693,-0.0032831,0.064052,0.70056,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.99999
GOCC_VESICLE_COAT,SET,59,-0.055033,-0.0031149,0.10461,0.70057,GOCC_VESICLE_COAT,0.99999
PID_KIT_PATHWAY,SET,51,-0.067651,-0.0035608,0.12858,0.70061,PID_KIT_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...205,SET,12,-0.12724,-0.0032522,0.24182,0.70062,GOBP_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY,0.99999
GSE36392_EOSINOPHIL_VS_NEUTR...2,SET,183,-0.033786,-0.0033564,0.064199,0.70065,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,0.99999
HP_ABNORMAL_TRACHEOBRONCHIAL...,SET,330,-0.024715,-0.0032838,0.046926,0.70079,HP_ABNORMAL_TRACHEOBRONCHIAL_MORPHOLOGY,0.99999
GSE11924_TFH_VS_TH17_CD4_TCE...2,SET,176,-0.03155,-0.0030744,0.059895,0.70082,GSE11924_TFH_VS_TH17_CD4_TCELL_UP,0.99999
MIR6754_3P,SET,87,-0.04973,-0.0034153,0.094394,0.70084,MIR6754_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...72,SET,43,-0.071319,-0.0034476,0.13537,0.70085,GOBP_POSITIVE_REGULATION_OF_B_CELL_PROLIFERATION,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...8,SET,10,-0.14472,-0.0033768,0.27466,0.70087,BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN,0.99999
GOBP_AXO_DENDRITIC_TRANSPORT,SET,74,-0.053556,-0.0033934,0.10164,0.70087,GOBP_AXO_DENDRITIC_TRANSPORT,0.99999
RIZ_ERYTHROID_DIFFERENTIATIO...1,SET,32,-0.087315,-0.0036423,0.1657,0.70088,RIZ_ERYTHROID_DIFFERENTIATION_12HR,0.99999
MIR375_3P,SET,36,-0.075674,-0.0033478,0.14356,0.70094,MIR375_3P,0.99999
HP_NON_CONVULSIVE_STATUS_EPI...,SET,18,-0.10578,-0.0033105,0.20067,0.70094,HP_NON_CONVULSIVE_STATUS_EPILEPTICUS_WITHOUT_COMA,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...42,SET,15,-0.1144,-0.0032689,0.21696,0.701,GOBP_PROTEIN_LOCALIZATION_TO_PHAGOPHORE_ASSEMBLY_SITE,0.99999
WP_NEPHROGENESIS,SET,18,-0.11331,-0.0035462,0.2147,0.70116,WP_NEPHROGENESIS,0.99999
LIU_COMMON_CANCER_GENES,SET,59,-0.055865,-0.0031619,0.10585,0.70117,LIU_COMMON_CANCER_GENES,0.99999
GOCC_CELL_SURFACE,SET,815,-0.017793,-0.0036648,0.033713,0.70117,GOCC_CELL_SURFACE,0.99999
MALONEY_RESPONSE_TO_17AAG_UP,SET,37,-0.078589,-0.0035246,0.14889,0.70118,MALONEY_RESPONSE_TO_17AAG_UP,0.99999
HP_DELAYED_PUBIC_BONE_OSSIFI...,SET,7,-0.18075,-0.0035289,0.34235,0.70124,HP_DELAYED_PUBIC_BONE_OSSIFICATION,0.99999
BIOCARTA_EIF4_PATHWAY,SET,24,-0.096034,-0.0034701,0.18187,0.70126,BIOCARTA_EIF4_PATHWAY,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...11,SET,13,-0.12601,-0.0033519,0.23859,0.70129,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
LIU_CDX2_TARGETS_UP,SET,32,-0.085072,-0.0035487,0.16107,0.7013,LIU_CDX2_TARGETS_UP,0.99999
HP_DECREASED_METHYLMALONYL_C...,SET,5,-0.19682,-0.0032478,0.37268,0.7013,HP_DECREASED_METHYLMALONYL_COA_MUTASE_ACTIVITY,0.99999
HP_LYMPHADENITIS,SET,13,-0.11819,-0.0031441,0.22375,0.70133,HP_LYMPHADENITIS,0.99999
HP_WIDENED_CEREBRAL_SUBARACH...,SET,3,-0.32806,-0.0041934,0.62095,0.70136,HP_WIDENED_CEREBRAL_SUBARACHNOID_SPACE,0.99999
UBN1_TARGET_GENES,SET,1414,-0.012424,-0.0033127,0.023515,0.70138,UBN1_TARGET_GENES,0.99999
GOBP_REGULATION_OF_OXIDATIVE...2,SET,37,-0.069569,-0.0031201,0.13167,0.70138,GOBP_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOBP_BODY_FLUID_SECRETION,SET,87,-0.050907,-0.0034962,0.096334,0.7014,GOBP_BODY_FLUID_SECRETION,0.99999
GSE2197_IMMUNOSUPPRESSIVE_DN...2,SET,179,-0.034594,-0.0033993,0.065451,0.70144,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP,0.99999
AMUNDSON_RESPONSE_TO_ARSENITE,SET,193,-0.033069,-0.0033728,0.062562,0.70145,AMUNDSON_RESPONSE_TO_ARSENITE,0.99999
GOBP_OOCYTE_CONSTRUCTION,SET,8,-0.15989,-0.0033371,0.3025,0.70145,GOBP_OOCYTE_CONSTRUCTION,0.99999
HP_HAIR_PULLING,SET,7,-0.20051,-0.0039146,0.37928,0.70147,HP_HAIR_PULLING,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_CXC...,SET,118,-0.044802,-0.0035804,0.084741,0.70149,HE_LIM_SUN_FETAL_LUNG_C2_CXCL9_POS_MACROPHAGE_CELL,0.99999
MIR138_2_3P,SET,154,-0.039151,-0.0035708,0.074016,0.70158,MIR138_2_3P,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...8,SET,180,-0.033986,-0.0033488,0.064239,0.70161,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP,0.99999
HP_PANNICULITIS,SET,25,-0.09416,-0.0034724,0.17795,0.70164,HP_PANNICULITIS,0.99999
REACTOME_METABOLISM_OF_INGES...,SET,7,-0.19153,-0.0037392,0.36195,0.70165,REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE,0.99999
MODULE_245,SET,25,-0.088166,-0.0032513,0.16658,0.70169,MODULE_245,0.99999
MODULE_326,SET,13,-0.1414,-0.0037613,0.26713,0.7017,MODULE_326,0.99999
REACTOME_FORMATION_OF_INTERM...,SET,7,-0.19608,-0.0038281,0.37032,0.70176,REACTOME_FORMATION_OF_INTERMEDIATE_MESODERM,0.99999
MIR4477B,SET,242,-0.029917,-0.0034122,0.056496,0.70178,MIR4477B,0.99999
GRADE_COLON_VS_RECTAL_CANCER...2,SET,34,-0.077479,-0.0033312,0.14625,0.70185,GRADE_COLON_VS_RECTAL_CANCER_UP,0.99999
HP_ABNORMAL_CIRCULATING_IGG_...,SET,107,-0.043536,-0.003314,0.082168,0.70188,HP_ABNORMAL_CIRCULATING_IGG_LEVEL,0.99999
MIR362_3P,SET,107,-0.046992,-0.0035771,0.088673,0.70192,MIR362_3P,0.99999
HP_PAIN,SET,754,-0.016994,-0.0033725,0.032065,0.70193,HP_PAIN,0.99999
REACTOME_INCRETIN_SYNTHESIS_...,SET,23,-0.10032,-0.0035489,0.18919,0.70204,REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION,0.99999
GOMF_POLY_PYRIMIDINE_TRACT_B...,SET,25,-0.090732,-0.003346,0.1711,0.70204,GOMF_POLY_PYRIMIDINE_TRACT_BINDING,0.99999
GSE17580_TREG_VS_TEFF_S_MANS...2,SET,180,-0.03377,-0.0033275,0.06367,0.70208,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP,0.99999
MIR3140_5P,SET,121,-0.04093,-0.003312,0.077127,0.70218,MIR3140_5P,0.99999
REACTOME_TRANSPORT_OF_NUCLEO...2,SET,8,-0.14877,-0.0031048,0.28024,0.70223,REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS,0.99999
HP_POSTURAL_INSTABILITY,SET,74,-0.05353,-0.0033917,0.10079,0.70233,HP_POSTURAL_INSTABILITY,0.99999
GSE22229_RENAL_TRANSPLANT_VS...1,SET,178,-0.034354,-0.0033663,0.064676,0.70234,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_GR...,SET,24,-0.10125,-0.0036586,0.19062,0.70235,GOBP_CELLULAR_RESPONSE_TO_GROWTH_HORMONE_STIMULUS,0.99999
E2F1_Q3_01,SET,220,-0.030554,-0.0033247,0.057505,0.7024,E2F1_Q3_01,0.99999
GOBP_ATRIOVENTRICULAR_VALVE_...1,SET,29,-0.094575,-0.003756,0.178,0.7024,GOBP_ATRIOVENTRICULAR_VALVE_DEVELOPMENT,0.99999
HP_ANTALGIC_GAIT,SET,9,-0.18094,-0.0040053,0.34055,0.7024,HP_ANTALGIC_GAIT,0.99999
YUAN_ZNF143_PARTNERS,SET,20,-0.099662,-0.0032877,0.18756,0.70242,YUAN_ZNF143_PARTNERS,0.99999
HP_LIMITED_WRIST_MOVEMENT,SET,12,-0.13406,-0.0034263,0.25216,0.70251,HP_LIMITED_WRIST_MOVEMENT,0.99999
GOCC_M_BAND,SET,27,-0.084526,-0.0032392,0.15898,0.70252,GOCC_M_BAND,0.99999
GSE40274_EOS_VS_FOXP3_AND_EO...2,SET,135,-0.036732,-0.0031383,0.06908,0.70254,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GOBP_MALE_GAMETE_GENERATION,SET,529,-0.019179,-0.0032084,0.036067,0.70255,GOBP_MALE_GAMETE_GENERATION,0.99999
STAMBOLSKY_RESPONSE_TO_VITAM...2,SET,75,-0.05306,-0.0033845,0.099756,0.7026,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,0.99999
GOBP_DITERPENOID_BIOSYNTHETI...,SET,10,-0.15666,-0.0036554,0.29451,0.70261,GOBP_DITERPENOID_BIOSYNTHETIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_ACH_C...1,SET,7,-0.16303,-0.0031829,0.30646,0.70263,KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY,0.99999
CATTTCA_MIR203,SET,259,-0.027908,-0.0032914,0.052452,0.70266,CATTTCA_MIR203,0.99999
HP_ANTERIOR_SUBCAPSULAR_CATA...,SET,6,-0.19287,-0.0034863,0.36247,0.70267,HP_ANTERIOR_SUBCAPSULAR_CATARACT,0.99999
GOBP_REGULATION_OF_VASCULATU...,SET,265,-0.029644,-0.0035358,0.055705,0.70269,GOBP_REGULATION_OF_VASCULATURE_DEVELOPMENT,0.99999
KIM_TIAL1_TARGETS,SET,29,-0.086326,-0.0034284,0.1622,0.70271,KIM_TIAL1_TARGETS,0.99999
HP_HEMATURIA,SET,164,-0.036569,-0.0034409,0.068706,0.70272,HP_HEMATURIA,0.99999
QI_PBMC_ZOSTAVAX_AGE_50_75YO...2,SET,35,-0.073935,-0.0032252,0.13891,0.70272,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_28D_PEAK_T_CELL_RESPONSE_14DY_NEGATIVE,0.99999
GOBP_PEPTIDYL_CYSTEINE_MODIF...,SET,39,-0.073559,-0.0033868,0.13818,0.70276,GOBP_PEPTIDYL_CYSTEINE_MODIFICATION,0.99999
CCGNMNNTNACG_UNKNOWN,SET,74,-0.049363,-0.0031278,0.092708,0.70279,CCGNMNNTNACG_UNKNOWN,0.99999
WP_ERK_PATHWAY_IN_HUNTINGTON...,SET,16,-0.12502,-0.0036893,0.23479,0.7028,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,0.99999
HP_CERVICAL_SPINE_INSTABILITY,SET,8,-0.18684,-0.0038995,0.35089,0.7028,HP_CERVICAL_SPINE_INSTABILITY,0.99999
GSE17974_0H_VS_2H_IN_VITRO_A...2,SET,166,-0.035163,-0.0033286,0.066038,0.7028,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP,0.99999
GSE29949_CD8_POS_DC_SPLEEN_V...2,SET,184,-0.033038,-0.003291,0.062043,0.70281,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP,0.99999
KEGG_MEDICUS_REFERENCE_MICRO...4,SET,20,-0.10419,-0.0034371,0.19564,0.70283,KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY,0.99999
GSE36826_WT_VS_IL1R_KO_SKIN_...4,SET,178,-0.035497,-0.0034783,0.066648,0.70284,GSE36826_WT_VS_IL1R_KO_SKIN_UP,0.99999
REACTOME_NICOTINATE_METABOLI...,SET,29,-0.085287,-0.0033871,0.16012,0.70286,REACTOME_NICOTINATE_METABOLISM,0.99999
PID_CASPASE_PATHWAY,SET,50,-0.064315,-0.0033519,0.12073,0.70288,PID_CASPASE_PATHWAY,0.99999
GOBP_ENDONUCLEOLYTIC_CLEAVAG...2,SET,9,-0.14992,-0.0033186,0.28141,0.70289,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_IN_ITS1_TO_SEPARATE_SSU_RRNA_FROM_5_8S_RRNA_AND_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.99999
GOMF_HISTONE_H3K9_TRIMETHYLT...,SET,4,-0.25227,-0.0037234,0.47342,0.70293,GOMF_HISTONE_H3K9_TRIMETHYLTRANSFERASE_ACTIVITY,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...2,SET,100,-0.047402,-0.0034889,0.088941,0.70296,GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON,0.99999
GOBP_PIRNA_MEDIATED_RETROTRA...,SET,5,-0.17968,-0.0029649,0.3371,0.70299,GOBP_PIRNA_MEDIATED_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.99999
KEGG_RENIN_ANGIOTENSIN_SYSTEM,SET,15,-0.12936,-0.0036963,0.24265,0.70303,KEGG_RENIN_ANGIOTENSIN_SYSTEM,0.99999
MODULE_357,SET,72,-0.05763,-0.003602,0.10808,0.70305,MODULE_357,0.99999
HP_LIMB_PAIN,SET,52,-0.065751,-0.0034944,0.12328,0.70311,HP_LIMB_PAIN,0.99999
MIR3130_3P,SET,45,-0.064175,-0.0031734,0.1203,0.70313,MIR3130_3P,0.99999
ZNF579_TARGET_GENES,SET,611,-0.018691,-0.0033527,0.035039,0.70313,ZNF579_TARGET_GENES,0.99999
MIR1243,SET,56,-0.059681,-0.0032912,0.11185,0.70318,MIR1243,0.99999
TRAVAGLINI_LUNG_B_CELL,SET,142,-0.039151,-0.0034299,0.073368,0.70319,TRAVAGLINI_LUNG_B_CELL,0.99999
GOBP_CELLULAR_RESPONSE_TO_ST...5,SET,1635,-0.011442,-0.003259,0.021438,0.70323,GOBP_CELLULAR_RESPONSE_TO_STRESS,0.99999
GSE16522_MEMORY_VS_NAIVE_ANT...2,SET,172,-0.035428,-0.0034132,0.066358,0.70329,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP,0.99999
GOBP_REGULATION_OF_COLLAGEN_...1,SET,8,-0.14126,-0.0029481,0.26454,0.70331,GOBP_REGULATION_OF_COLLAGEN_FIBRIL_ORGANIZATION,0.99999
MIR497_3P,SET,217,-0.031757,-0.0034322,0.059465,0.70334,MIR497_3P,0.99999
PID_SMAD2_3PATHWAY,SET,16,-0.12116,-0.0035754,0.22686,0.70335,PID_SMAD2_3PATHWAY,0.99999
POU1F1_Q6,SET,218,-0.033435,-0.0036218,0.062604,0.70335,POU1F1_Q6,0.99999
CCCNNGGGAR_OLF1_01,SET,293,-0.027245,-0.0034144,0.051011,0.70336,CCCNNGGGAR_OLF1_01,0.99999
HP_POLYPHAGIA,SET,67,-0.060486,-0.0036474,0.11324,0.70337,HP_POLYPHAGIA,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...4,SET,47,-0.069886,-0.0035316,0.13083,0.70339,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,0.99999
SNIJDERS_AMPLIFIED_IN_HEAD_A...,SET,37,-0.085387,-0.0038295,0.15984,0.7034,SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,0.99999
GSE44649_NAIVE_VS_ACTIVATED_...2,SET,175,-0.031479,-0.0030588,0.058877,0.70355,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...458,SET,7,-0.16665,-0.0032535,0.31157,0.70363,GOBP_NEGATIVE_REGULATION_OF_NUCLEASE_ACTIVITY,0.99999
GOBP_NEURAL_PRECURSOR_CELL_P...,SET,157,-0.037745,-0.0034757,0.070557,0.70366,GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION,0.99999
GOBP_REGULATION_OF_VENTRICUL...2,SET,7,-0.21235,-0.0041457,0.39694,0.70366,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION,0.99999
HILLION_HMGA1_TARGETS,SET,75,-0.052574,-0.0033535,0.098238,0.70373,HILLION_HMGA1_TARGETS,0.99999
SCIAN_INVERSED_TARGETS_OF_TP...1,SET,25,-0.095035,-0.0035047,0.17755,0.70376,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,0.99999
GOBP_RIBOSE_PHOSPHATE_BIOSYN...,SET,176,-0.032655,-0.003182,0.061009,0.70376,GOBP_RIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
MIKKELSEN_NPC_ICP_WITH_H3K4M...,SET,381,-0.023276,-0.0033182,0.043477,0.70379,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,0.99999
GOMF_HYDROXYMETHYL_FORMYL_AN...,SET,8,-0.13418,-0.0028004,0.25063,0.7038,GOMF_HYDROXYMETHYL_FORMYL_AND_RELATED_TRANSFERASE_ACTIVITY,0.99999
GSE25123_WT_VS_PPARG_KO_MACR...2,SET,163,-0.035395,-0.0033204,0.066088,0.70387,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN,0.99999
KEGG_CALCIUM_SIGNALING_PATHW...,SET,167,-0.036847,-0.0034983,0.068795,0.70388,KEGG_CALCIUM_SIGNALING_PATHWAY,0.99999
PID_ARF6_TRAFFICKING_PATHWAY,SET,47,-0.06924,-0.0034989,0.12926,0.7039,PID_ARF6_TRAFFICKING_PATHWAY,0.99999
BIOCARTA_EGF_PATHWAY,SET,26,-0.090721,-0.0034117,0.16935,0.70391,BIOCARTA_EGF_PATHWAY,0.99999
GEISS_RESPONSE_TO_DSRNA_UP,SET,37,-0.074352,-0.0033346,0.13878,0.70393,GEISS_RESPONSE_TO_DSRNA_UP,0.99999
GOBP_SPERM_AXONEME_ASSEMBLY,SET,26,-0.090376,-0.0033987,0.16869,0.70393,GOBP_SPERM_AXONEME_ASSEMBLY,0.99999
GOCC_COPI_COATED_VESICLE_MEM...,SET,17,-0.096416,-0.0029327,0.17992,0.70398,GOCC_COPI_COATED_VESICLE_MEMBRANE,0.99999
GOBP_BLASTOCYST_GROWTH,SET,21,-0.095916,-0.0032422,0.17892,0.70405,GOBP_BLASTOCYST_GROWTH,0.99999
GSE14350_IL2RB_KO_VS_WT_TEFF...1,SET,184,-0.033573,-0.0033442,0.062618,0.70407,GSE14350_IL2RB_KO_VS_WT_TEFF_DN,0.99999
MIR4520_3P,SET,81,-0.051302,-0.0034002,0.095665,0.70411,MIR4520_3P,0.99999
GSE5589_WT_VS_IL10_KO_LPS_AN...2,SET,140,-0.037241,-0.0032398,0.069442,0.70412,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.99999
MIR1229_5P,SET,30,-0.091474,-0.0036948,0.17054,0.70415,MIR1229_5P,0.99999
MOREAUX_MULTIPLE_MYELOMA_BY_...1,SET,153,-0.033805,-0.0030732,0.063008,0.7042,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,0.99999
GOBP_PYRAMIDAL_NEURON_DIFFER...,SET,12,-0.13322,-0.0034048,0.24827,0.70422,GOBP_PYRAMIDAL_NEURON_DIFFERENTIATION,0.99999
HP_CONGENITAL_MUSCULAR_TORTI...,SET,6,-0.19571,-0.0035375,0.36471,0.70423,HP_CONGENITAL_MUSCULAR_TORTICOLLIS,0.99999
ACACTAC_MIR1423P,SET,118,-0.04323,-0.0034547,0.080554,0.70424,ACACTAC_MIR1423P,0.99999
GOMF_TAU_PROTEIN_BINDING,SET,41,-0.066827,-0.0031546,0.12452,0.70425,GOMF_TAU_PROTEIN_BINDING,0.99999
HOEK_NEUTROPHIL_2011_2012_TI...6,SET,17,-0.11213,-0.0034106,0.20893,0.70425,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_UP,0.99999
WANG_ESOPHAGUS_CANCER_VS_NOR...1,SET,95,-0.045676,-0.0032772,0.085103,0.70426,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,0.99999
HP_LIMITED_HIP_EXTENSION,SET,5,-0.22387,-0.0036941,0.41711,0.70427,HP_LIMITED_HIP_EXTENSION,0.99999
HP_SPASTIC_HYPERACTIVE_BLADD...,SET,9,-0.15818,-0.0035015,0.29472,0.70427,HP_SPASTIC_HYPERACTIVE_BLADDER,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...11,SET,183,-0.033039,-0.0032822,0.061554,0.70428,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN,0.99999
MIR299_3P,SET,50,-0.065066,-0.0033911,0.12121,0.70429,MIR299_3P,0.99999
HP_MOTOR_DELAY,SET,852,-0.015878,-0.0033402,0.029571,0.70434,HP_MOTOR_DELAY,0.99999
GOBP_GLUTAMINE_METABOLIC_PRO...,SET,25,-0.092095,-0.0033962,0.1715,0.70436,GOBP_GLUTAMINE_METABOLIC_PROCESS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...4,SET,13,-0.12808,-0.0034072,0.23851,0.70437,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY,0.99999
GOBP_INTRACELLULAR_PH_REDUCT...,SET,51,-0.067563,-0.0035561,0.12581,0.70437,GOBP_INTRACELLULAR_PH_REDUCTION,0.99999
GOCC_ORGANELLAR_RIBOSOME,SET,85,-0.046045,-0.0031259,0.085717,0.70442,GOCC_ORGANELLAR_RIBOSOME,0.99999
HALLMARK_REACTIVE_OXYGEN_SPE...,SET,45,-0.071247,-0.0035231,0.13254,0.70455,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.99999
GOBP_RESPONSE_TO_VITAMIN_K,SET,4,-0.27288,-0.0040276,0.50762,0.70456,GOBP_RESPONSE_TO_VITAMIN_K,0.99999
GOBP_NEGATIVE_REGULATION_OF_...679,SET,22,-0.096224,-0.0033291,0.17895,0.7046,GOBP_NEGATIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.99999
NAKAYA_B_CELL_FLUARIX_FLUVIR...2,SET,321,-0.02452,-0.0032138,0.045597,0.70462,NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.99999
HP_HAND_MUSCLE_ATROPHY,SET,48,-0.064814,-0.0033098,0.1205,0.70466,HP_HAND_MUSCLE_ATROPHY,0.99999
XU_GH1_AUTOCRINE_TARGETS_DN,SET,117,-0.044278,-0.0035236,0.082315,0.70468,XU_GH1_AUTOCRINE_TARGETS_DN,0.99999
MIR147B_3P,SET,5,-0.22562,-0.003723,0.41942,0.70469,MIR147B_3P,0.99999
WP_CCL18_SIGNALING,SET,33,-0.090238,-0.0038224,0.16769,0.70475,WP_CCL18_SIGNALING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...573,SET,20,-0.099954,-0.0032974,0.18571,0.70478,GOBP_NEGATIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
HP_BIPARIETAL_NARROWING,SET,60,-0.053417,-0.0030488,0.09923,0.70482,HP_BIPARIETAL_NARROWING,0.99999
GOBP_NUCLEOSIDE_PHOSPHATE_BI...,SET,232,-0.029196,-0.0032613,0.054218,0.70487,GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOCC_NUCLEAR_PORE_CENTRAL_TR...,SET,5,-0.19404,-0.0032019,0.36021,0.70495,GOCC_NUCLEAR_PORE_CENTRAL_TRANSPORT_CHANNEL,0.99999
GOBP_LIPID_CATABOLIC_PROCESS,SET,322,-0.026227,-0.0034429,0.048679,0.70498,GOBP_LIPID_CATABOLIC_PROCESS,0.99999
GOBP_VERY_LONG_CHAIN_FATTY_A...1,SET,13,-0.15076,-0.0040105,0.27974,0.70503,GOBP_VERY_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.99999
GOBP_KERATINIZATION,SET,72,-0.071506,-0.0044694,0.13262,0.70512,GOBP_KERATINIZATION,0.99999
HP_THICK_NASAL_ALAE,SET,34,-0.076366,-0.0032834,0.14162,0.70514,HP_THICK_NASAL_ALAE,0.99999
MIR488_5P,SET,71,-0.053541,-0.0033232,0.099283,0.70515,MIR488_5P,0.99999
HP_ABNORMAL_CHORIORETINAL_MO...,SET,135,-0.040461,-0.0034569,0.075022,0.70516,HP_ABNORMAL_CHORIORETINAL_MORPHOLOGY,0.99999
MIR5694,SET,49,-0.065844,-0.0033972,0.12206,0.7052,MIR5694,0.99999
HP_DECREASED_ACHILLES_REFLEX,SET,8,-0.15749,-0.003287,0.2918,0.7053,HP_DECREASED_ACHILLES_REFLEX,0.99999
MIR4491,SET,67,-0.054279,-0.0032731,0.10056,0.70532,MIR4491,0.99999
HOLLERN_EMT_BREAST_TUMOR_UP,SET,128,-0.042483,-0.003535,0.078689,0.70536,HOLLERN_EMT_BREAST_TUMOR_UP,0.99999
HASLINGER_B_CLL_WITH_6Q21_DE...,SET,11,-0.13108,-0.0032077,0.24275,0.70539,HASLINGER_B_CLL_WITH_6Q21_DELETION,0.99999
GOBP_GENITALIA_DEVELOPMENT,SET,46,-0.073711,-0.0036851,0.13649,0.70541,GOBP_GENITALIA_DEVELOPMENT,0.99999
PETRETTO_LEFT_VENTRICLE_MASS...1,SET,9,-0.1421,-0.0031455,0.26307,0.70545,PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN,0.99999
BACH2_01,SET,242,-0.029942,-0.0034151,0.055433,0.70545,BACH2_01,0.99999
HP_ABNORMAL_CEREBRAL_SUBCORT...,SET,1030,-0.014588,-0.0033571,0.026998,0.70552,HP_ABNORMAL_CEREBRAL_SUBCORTEX_MORPHOLOGY,0.99999
HP_ABNORMAL_PANCREAS_MORPHOL...,SET,99,-0.046305,-0.0033913,0.085679,0.70555,HP_ABNORMAL_PANCREAS_MORPHOLOGY,0.99999
POMEROY_MEDULLOBLASTOMA_PROG...2,SET,42,-0.070166,-0.0033523,0.12974,0.70568,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP,0.99999
GOBP_FATTY_ACID_DERIVATIVE_C...,SET,17,-0.10869,-0.0033061,0.20097,0.70569,GOBP_FATTY_ACID_DERIVATIVE_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_HEXOKINAS...,SET,5,-0.22567,-0.0037237,0.41722,0.7057,GOBP_REGULATION_OF_HEXOKINASE_ACTIVITY,0.99999
GSE14769_UNSTIM_VS_80MIN_LPS...1,SET,188,-0.035865,-0.0036108,0.066305,0.70571,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN,0.99999
KRAS.LUNG.BREAST_UP.V1_DN,SET,129,-0.042346,-0.0035373,0.078274,0.70574,KRAS.LUNG.BREAST_UP.V1_DN,0.99999
MIR6502_5P,SET,51,-0.064827,-0.0034121,0.11976,0.70586,MIR6502_5P,0.99999
BIOCARTA_NO2IL12_PATHWAY,SET,14,-0.13563,-0.0037442,0.25054,0.70587,BIOCARTA_NO2IL12_PATHWAY,0.99999
HP_INFRA_ORBITAL_CREASE,SET,7,-0.17508,-0.0034181,0.32333,0.70591,HP_INFRA_ORBITAL_CREASE,0.99999
GSE557_CIITA_KO_VS_I_AB_KO_D...1,SET,183,-0.033242,-0.0033023,0.061375,0.70595,GSE557_CIITA_KO_VS_I_AB_KO_DC_DN,0.99999
GOBP_SENSORY_PERCEPTION_OF_S...1,SET,331,-0.036576,-0.0048668,0.067529,0.70596,GOBP_SENSORY_PERCEPTION_OF_SMELL,0.99999
MIR548BB_5P,SET,447,-0.022405,-0.0034532,0.041362,0.70597,MIR548BB_5P,0.99999
GOMF_CARBON_NITROGEN_LIGASE_...,SET,10,-0.13515,-0.0031534,0.24947,0.706,GOMF_CARBON_NITROGEN_LIGASE_ACTIVITY_WITH_GLUTAMINE_AS_AMIDO_N_DONOR,0.99999
LI_ADIPOGENESIS_BY_ACTIVATED...,SET,18,-0.1139,-0.0035648,0.21023,0.70601,LI_ADIPOGENESIS_BY_ACTIVATED_PPARG,0.99999
MODULE_80,SET,32,-0.093655,-0.0039067,0.17287,0.70601,MODULE_80,0.99999
GSE27291_0H_VS_6H_STIM_GAMMA...1,SET,157,-0.036436,-0.0033551,0.06725,0.70602,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...328,SET,10,-0.15988,-0.0037306,0.29508,0.70603,GOBP_POSITIVE_REGULATION_OF_HEAT_GENERATION,0.99999
MIR92B_5P,SET,8,-0.15521,-0.0032394,0.28637,0.70608,MIR92B_5P,0.99999
MODULE_177,SET,95,-0.04714,-0.0033823,0.086957,0.70612,MODULE_177,0.99999
GOMF_ATPASE_COUPLED_ION_TRAN...,SET,22,-0.10498,-0.0036319,0.1936,0.70616,GOMF_ATPASE_COUPLED_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_BMP_H...1,SET,11,-0.14278,-0.0034941,0.26323,0.70623,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY,0.99999
REACTOME_SIGNALING_BY_FLT3_I...,SET,16,-0.11078,-0.003269,0.20424,0.70623,REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,0.99999
WP_MTHFR_DEFICIENCY,SET,22,-0.098643,-0.0034127,0.18185,0.70624,WP_MTHFR_DEFICIENCY,0.99999
GOBP_GMP_SALVAGE,SET,4,-0.22348,-0.0032984,0.41194,0.70626,GOBP_GMP_SALVAGE,0.99999
HP_ABNORMAL_U_WAVE,SET,5,-0.23508,-0.0038791,0.43327,0.70628,HP_ABNORMAL_U_WAVE,0.99999
GSE411_UNSTIM_VS_400MIN_IL6_...4,SET,188,-0.033175,-0.00334,0.061143,0.70629,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,0.99999
HP_SHORT_THORAX,SET,45,-0.065815,-0.0032545,0.12127,0.70633,HP_SHORT_THORAX,0.99999
GOMF_IRON_ION_TRANSMEMBRANE_...,SET,9,-0.14186,-0.0031402,0.26137,0.70634,GOMF_IRON_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_G_PROTEIN_COUPLED_GLUTA...,SET,15,-0.12629,-0.0036085,0.23267,0.70636,GOBP_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_TH...10,SET,28,-0.083475,-0.0032576,0.15371,0.70646,HP_ABNORMAL_MORPHOLOGY_OF_THE_VESTIBULE_OF_THE_INNER_EAR,0.99999
MARTINEZ_RB1_TARGETS_UP,SET,643,-0.018683,-0.0034348,0.034377,0.7066,MARTINEZ_RB1_TARGETS_UP,0.99999
GOBP_BENZENE_CONTAINING_COMP...,SET,23,-0.10644,-0.0037652,0.19582,0.70663,GOBP_BENZENE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
GSE7348_UNSTIM_VS_LPS_STIM_M...1,SET,157,-0.040318,-0.0037125,0.07417,0.70663,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.99999
MIR5004_3P,SET,124,-0.04163,-0.0034099,0.076583,0.70664,MIR5004_3P,0.99999
GOMF_CALCIUM_SENSITIVE_GUANY...,SET,5,-0.20693,-0.0034147,0.38063,0.70666,GOMF_CALCIUM_SENSITIVE_GUANYLATE_CYCLASE_ACTIVATOR_ACTIVITY,0.99999
HP_RACHITIC_ROSARY,SET,6,-0.205,-0.0037055,0.37708,0.70666,HP_RACHITIC_ROSARY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...479,SET,44,-0.073799,-0.0036086,0.13572,0.7067,GOBP_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION,0.99999
GSE17721_LPS_VS_PAM3CSK4_16H...2,SET,190,-0.033005,-0.0033403,0.060694,0.70671,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_UP,0.99999
GSE46606_IRF4HIGH_VS_WT_CD40...4,SET,180,-0.035796,-0.0035271,0.065824,0.70671,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.99999
HP_MINIMAL_SUBCUTANEOUS_FAT,SET,4,-0.2468,-0.0036426,0.45377,0.70673,HP_MINIMAL_SUBCUTANEOUS_FAT,0.99999
GSE40685_TREG_VS_FOXP3_KO_TR...2,SET,171,-0.037423,-0.003595,0.068763,0.70686,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP,0.99999
SAGIV_CD24_TARGETS_UP,SET,21,-0.096859,-0.0032741,0.17793,0.7069,SAGIV_CD24_TARGETS_UP,0.99999
GOBP_ENDOPLASMIC_RETICULUM_T...1,SET,25,-0.085001,-0.0031346,0.15612,0.70694,GOBP_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT,0.99999
REACTOME_INTERACTION_WITH_CU...,SET,11,-0.13353,-0.0032675,0.24521,0.70696,REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA,0.99999
GSE17301_IFNA2_VS_IFNA5_STIM...1,SET,174,-0.035886,-0.0034771,0.065882,0.70702,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN,0.99999
GSE3982_EFF_MEMORY_CD4_TCELL...2,SET,179,-0.034968,-0.0034361,0.064171,0.70709,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP,0.99999
chr6q24,SET,32,-0.14984,-0.0062504,0.27497,0.7071,chr6q24,0.99999
DELACROIX_RAR_TARGETS_UP,SET,44,-0.080896,-0.0039557,0.14844,0.70711,DELACROIX_RAR_TARGETS_UP,0.99999
GOBP_SEGMENT_SPECIFICATION,SET,15,-0.13435,-0.0038389,0.2465,0.70713,GOBP_SEGMENT_SPECIFICATION,0.99999
ZZZ3_TARGET_GENES,SET,233,-0.029807,-0.0033367,0.054678,0.70717,ZZZ3_TARGET_GENES,0.99999
GOBP_SEMI_LUNAR_VALVE_DEVELO...,SET,48,-0.072876,-0.0037216,0.13366,0.7072,GOBP_SEMI_LUNAR_VALVE_DEVELOPMENT,0.99999
REACTOME_NEGATIVE_REGULATION...2,SET,31,-0.087905,-0.0036092,0.16121,0.70722,REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING,0.99999
GOCC_CYTOPLASMIC_UBIQUITIN_L...,SET,6,-0.19664,-0.0035544,0.36057,0.70724,GOCC_CYTOPLASMIC_UBIQUITIN_LIGASE_COMPLEX,0.99999
HP_PROSTATE_CANCER,SET,32,-0.082424,-0.0034382,0.15113,0.70725,HP_PROSTATE_CANCER,0.99999
HP_ABNORMALITY_IRIS_MORPHOLO...,SET,404,-0.023826,-0.0034953,0.043685,0.70726,HP_ABNORMALITY_IRIS_MORPHOLOGY,0.99999
MODULE_22,SET,31,-0.069551,-0.0028556,0.12751,0.70728,MODULE_22,0.99999
GOBP_POSITIVE_REGULATION_OF_...638,SET,58,-0.060525,-0.0033966,0.11095,0.70729,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,0.99999
HP_ABNORMAL_METABOLIC_BRAIN_...,SET,46,-0.065378,-0.0032685,0.11981,0.70735,HP_ABNORMAL_METABOLIC_BRAIN_IMAGING_BY_MRS,0.99999
HP_OCULOMOTOR_APRAXIA,SET,102,-0.043038,-0.0031991,0.078873,0.70735,HP_OCULOMOTOR_APRAXIA,0.99999
GAO_LARGE_INTESTINE_24W_C2_M...,SET,104,-0.049932,-0.0037475,0.091501,0.70736,GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR,0.99999
GOBP_NEGATIVE_REGULATION_OF_...102,SET,196,-0.035836,-0.0036831,0.06565,0.70742,GOBP_NEGATIVE_REGULATION_OF_CELL_ACTIVATION,0.99999
REACTOME_ADRENOCEPTORS,SET,9,-0.17973,-0.0039785,0.32915,0.70747,REACTOME_ADRENOCEPTORS,0.99999
MIR1915_5P,SET,42,-0.076188,-0.00364,0.13951,0.70751,MIR1915_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...264,SET,8,-0.16812,-0.0035088,0.30778,0.70755,GOBP_NEGATIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,0.99999
PID_SMAD2_3NUCLEAR_PATHWAY,SET,75,-0.056424,-0.0035991,0.10329,0.70756,PID_SMAD2_3NUCLEAR_PATHWAY,0.99999
GCM_MYST2,SET,159,-0.034831,-0.0032275,0.063761,0.70756,GCM_MYST2,0.99999
PLASARI_TGFB1_SIGNALING_VIA_...1,SET,29,-0.09981,-0.0039639,0.18269,0.70758,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN,0.99999
KEGG_LIMONENE_AND_PINENE_DEG...,SET,9,-0.14184,-0.0031398,0.25962,0.70758,KEGG_LIMONENE_AND_PINENE_DEGRADATION,0.99999
GOBP_PYRIDINE_CONTAINING_COM...2,SET,91,-0.04657,-0.0032707,0.085221,0.70762,GOBP_PYRIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.99999
GSE11961_MARGINAL_ZONE_BCELL...2,SET,179,-0.033128,-0.0032552,0.06062,0.70763,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.99999
AMIT_DELAYED_EARLY_GENES,SET,18,-0.1177,-0.0036839,0.21538,0.70764,AMIT_DELAYED_EARLY_GENES,0.99999
GOBP_PROTEIN_DEACETYLATION,SET,37,-0.071495,-0.0032065,0.13082,0.70764,GOBP_PROTEIN_DEACETYLATION,0.99999
REACTOME_FOLDING_OF_ACTIN_BY...,SET,10,-0.12453,-0.0029056,0.22784,0.70765,REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC,0.99999
GOBP_GLOSSOPHARYNGEAL_NERVE_...,SET,5,-0.17435,-0.002877,0.31896,0.70768,GOBP_GLOSSOPHARYNGEAL_NERVE_DEVELOPMENT,0.99999
GSE37336_LY6C_POS_VS_NEG_NAI...2,SET,132,-0.042212,-0.0035665,0.077207,0.70772,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP,0.99999
HP_ABNORMALITY_OF_THE_SPLEEN,SET,555,-0.020212,-0.0034608,0.036967,0.70773,HP_ABNORMALITY_OF_THE_SPLEEN,0.99999
GOBP_POSITIVE_REGULATION_OF_...388,SET,6,-0.19765,-0.0035726,0.36141,0.70777,GOBP_POSITIVE_REGULATION_OF_I_KAPPAB_PHOSPHORYLATION,0.99999
GOMF_MRNA_3_UTR_AU_RICH_REGI...,SET,28,-0.084363,-0.0032922,0.15424,0.70779,GOMF_MRNA_3_UTR_AU_RICH_REGION_BINDING,0.99999
WP_DNA_DAMAGE_RESPONSE_ONLY_...,SET,108,-0.04655,-0.0035599,0.085106,0.7078,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,0.99999
GOBP_MAINTENANCE_OF_CELL_NUM...,SET,170,-0.035966,-0.003445,0.065744,0.70783,GOBP_MAINTENANCE_OF_CELL_NUMBER,0.99999
GSE8921_UNSTIM_VS_TLR1_2_STI...5,SET,183,-0.033828,-0.0033605,0.061815,0.70789,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN,0.99999
GOCC_MULTIMERIC_RIBONUCLEASE...,SET,9,-0.14634,-0.0032395,0.2674,0.70791,GOCC_MULTIMERIC_RIBONUCLEASE_P_COMPLEX,0.99999
GOMF_RIBONUCLEASE_P_ACTIVITY,SET,9,-0.14634,-0.0032395,0.2674,0.70791,GOMF_RIBONUCLEASE_P_ACTIVITY,0.99999
GOMF_RIBONUCLEASE_P_RNA_BIND...,SET,9,-0.14634,-0.0032395,0.2674,0.70791,GOMF_RIBONUCLEASE_P_RNA_BINDING,0.99999
MIR2276_3P,SET,109,-0.046086,-0.0035406,0.084201,0.70792,MIR2276_3P,0.99999
GOBP_REGULATION_OF_ANIMAL_OR...2,SET,82,-0.056409,-0.0037616,0.10303,0.70797,GOBP_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_TM4...1,SET,51,-0.068232,-0.0035913,0.12463,0.70797,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_NEURON_CELL,0.99999
HP_ALEXIA,SET,7,-0.17086,-0.0033357,0.31198,0.70803,HP_ALEXIA,0.99999
VALK_AML_CLUSTER_13,SET,29,-0.092459,-0.0036719,0.1688,0.70806,VALK_AML_CLUSTER_13,0.99999
MGGAAGTG_GABP_B,SET,698,-0.017624,-0.0033706,0.032171,0.70809,MGGAAGTG_GABP_B,0.99999
GSE24634_IL4_VS_CTRL_TREATED...3,SET,176,-0.036197,-0.0035272,0.066072,0.7081,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN,0.99999
GOBP_ORGANOPHOSPHATE_BIOSYNT...,SET,508,-0.020422,-0.0033499,0.037274,0.70812,GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GSE28237_FOLLICULAR_VS_EARLY...1,SET,181,-0.033943,-0.0033537,0.061946,0.70813,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN,0.99999
PRC2_EZH2_UP.V1_UP,SET,171,-0.038346,-0.0036837,0.069952,0.70821,PRC2_EZH2_UP.V1_UP,0.99999
GOBP_MICROTUBULE_ANCHORING_A...,SET,13,-0.13058,-0.0034736,0.23818,0.70823,GOBP_MICROTUBULE_ANCHORING_AT_MICROTUBULE_ORGANIZING_CENTER,0.99999
GOBP_REGULATION_OF_TELOMERE_...2,SET,94,-0.045179,-0.0032246,0.082394,0.70826,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE,0.99999
GOBP_REGULATION_OF_MITOCHOND...11,SET,7,-0.1544,-0.0030144,0.28155,0.70829,GOBP_REGULATION_OF_MITOCHONDRIAL_MRNA_STABILITY,0.99999
GOBP_SYMBIONT_ENTRY_INTO_HOST,SET,154,-0.039794,-0.0036294,0.072554,0.70831,GOBP_SYMBIONT_ENTRY_INTO_HOST,0.99999
GOCC_NUCLEAR_OUTER_MEMBRANE,SET,26,-0.087164,-0.003278,0.15893,0.70831,GOCC_NUCLEAR_OUTER_MEMBRANE,0.99999
ZHONG_PFC_HES1_POS_C1_NPC,SET,6,-0.20922,-0.0037818,0.38145,0.70832,ZHONG_PFC_HES1_POS_C1_NPC,0.99999
HP_HYPERTRIGLYCERIDEMIA,SET,110,-0.046215,-0.0035667,0.084256,0.70833,HP_HYPERTRIGLYCERIDEMIA,0.99999
DESCARTES_MAIN_FETAL_ADRENOC...,SET,62,-0.060499,-0.0035099,0.11029,0.70834,DESCARTES_MAIN_FETAL_ADRENOCORTICAL_CELLS,0.99999
HP_INTESTINAL_FISTULA,SET,29,-0.084887,-0.0033712,0.1547,0.7084,HP_INTESTINAL_FISTULA,0.99999
HP_ACUTE_INFECTIOUS_PNEUMONIA,SET,5,-0.23444,-0.0038685,0.42722,0.70841,HP_ACUTE_INFECTIOUS_PNEUMONIA,0.99999
GOBP_ENZYME_LINKED_RECEPTOR_...,SET,890,-0.016782,-0.0036045,0.030571,0.70848,GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY,0.99999
BENPORATH_NANOG_TARGETS,SET,877,-0.016326,-0.0034821,0.029735,0.70851,BENPORATH_NANOG_TARGETS,0.99999
LU_AGING_BRAIN_DN,SET,139,-0.040281,-0.0034918,0.073358,0.70853,LU_AGING_BRAIN_DN,0.99999
HP_ABNORMAL_SMALL_INTESTINE_...,SET,244,-0.030322,-0.0034725,0.055194,0.70862,HP_ABNORMAL_SMALL_INTESTINE_MORPHOLOGY,0.99999
GOBP_ARTERY_MORPHOGENESIS,SET,68,-0.064137,-0.0038963,0.11674,0.70863,GOBP_ARTERY_MORPHOGENESIS,0.99999
HP_PROXIMAL_FEMORAL_EPIPHYSI...,SET,7,-0.1473,-0.0028758,0.26805,0.70867,HP_PROXIMAL_FEMORAL_EPIPHYSIOLYSIS,0.99999
CARRILLOREIXACH_HEPATOBLASTO...1,SET,971,-0.016365,-0.0036629,0.029775,0.70871,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN,0.99999
GSE37416_0H_VS_3H_F_TULARENS...2,SET,178,-0.034228,-0.003354,0.062261,0.70875,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
KEGG_MEDICUS_VARIANT_CDH1_RE...,SET,8,-0.16312,-0.0034044,0.2967,0.70876,KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY,0.99999
GSE25123_ROSIGLITAZONE_VS_IL...3,SET,175,-0.035472,-0.0034468,0.064512,0.70879,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,0.99999
MIR125A_5P,SET,298,-0.027034,-0.0034163,0.049143,0.70888,MIR125A_5P,0.99999
HP_EURYBLEPHARON,SET,9,-0.14991,-0.0033185,0.2725,0.70889,HP_EURYBLEPHARON,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_EAR...2,SET,497,-0.020929,-0.0033968,0.03801,0.70905,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL,0.99999
RASHI_NFKB1_TARGETS,SET,16,-0.12853,-0.0037928,0.23341,0.70906,RASHI_NFKB1_TARGETS,0.99999
IM_SREBF1A_TARGETS,SET,5,-0.20392,-0.0033649,0.37002,0.70921,IM_SREBF1A_TARGETS,0.99999
NAKAYAMA_SOFT_TISSUE_TUMORS_...1,SET,66,-0.064039,-0.0038328,0.11618,0.70925,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN,0.99999
KEGG_MEDICUS_PATHOGEN_HPV_E5...2,SET,13,-0.13137,-0.0034946,0.23822,0.70934,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.99999
HP_UTERINE_PROLAPSE,SET,6,-0.22486,-0.0040645,0.40774,0.70934,HP_UTERINE_PROLAPSE,0.99999
WP_ALZHEIMERS_DISEASE,SET,247,-0.02947,-0.0033952,0.053416,0.70942,WP_ALZHEIMERS_DISEASE,0.99999
WP_ALZHEIMERS_DISEASE_AND_MI...,SET,247,-0.02947,-0.0033952,0.053416,0.70942,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,0.99999
HP_ABNORMAL_BONE_MARROW_CELL...,SET,199,-0.033133,-0.0034309,0.06005,0.70944,HP_ABNORMAL_BONE_MARROW_CELL_MORPHOLOGY,0.99999
MIR4448,SET,61,-0.062201,-0.0035795,0.11273,0.70945,MIR4448,0.99999
REACTOME_CHAPERONE_MEDIATED_...,SET,19,-0.1063,-0.0034181,0.19255,0.70955,REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY,0.99999
GOBP_REGULATION_OF_SKELETAL_...8,SET,10,-0.17382,-0.0040558,0.31484,0.70956,GOBP_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT,0.99999
GSE17721_LPS_VS_POLYIC_12H_B...2,SET,185,-0.033787,-0.0033746,0.061197,0.70956,GSE17721_LPS_VS_POLYIC_12H_BMDC_UP,0.99999
GNF2_DAP3,SET,105,-0.042836,-0.0032303,0.077581,0.70957,GNF2_DAP3,0.99999
chr6p24,SET,31,-0.15204,-0.0062426,0.27531,0.70961,chr6p24,0.99999
REACTOME_CLEC7A_DECTIN_1_SIG...,SET,93,-0.045273,-0.0032142,0.081978,0.70961,REACTOME_CLEC7A_DECTIN_1_SIGNALING,0.99999
GSE7831_1H_VS_4H_CPG_STIM_PD...1,SET,181,-0.034336,-0.0033926,0.062174,0.70961,GSE7831_1H_VS_4H_CPG_STIM_PDC_DN,0.99999
GOBP_REGULATION_OF_TRANSLATI...11,SET,8,-0.1515,-0.0031619,0.2743,0.70963,GOBP_REGULATION_OF_TRANSLATION_INITIATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.99999
GNF2_BNIP3L,SET,61,-0.059543,-0.0034266,0.10779,0.70966,GNF2_BNIP3L,0.99999
GOBP_PYRIDINE_CONTAINING_COM...3,SET,158,-0.037023,-0.0034199,0.067015,0.70968,GOBP_PYRIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
HP_MUSCLE_FIBER_INCLUSION_BO...,SET,36,-0.076509,-0.0033847,0.13847,0.7097,HP_MUSCLE_FIBER_INCLUSION_BODIES,0.99999
GOBP_REGULATION_OF_I_KAPPAB_...,SET,7,-0.18886,-0.0036873,0.34175,0.70974,GOBP_REGULATION_OF_I_KAPPAB_PHOSPHORYLATION,0.99999
HP_ABNORMAL_ENERGY_EXPENDITU...,SET,12,-0.14554,-0.0037199,0.26334,0.70975,HP_ABNORMAL_ENERGY_EXPENDITURE,0.99999
BURTON_ADIPOGENESIS_9,SET,73,-0.058404,-0.0036756,0.10567,0.70976,BURTON_ADIPOGENESIS_9,0.99999
ISSAEVA_MLL2_TARGETS,SET,52,-0.072083,-0.0038309,0.13042,0.70976,ISSAEVA_MLL2_TARGETS,0.99999
MIR7111_5P,SET,189,-0.033516,-0.0033831,0.060638,0.70977,MIR7111_5P,0.99999
HP_MACULAR_THICKENING,SET,38,-0.078828,-0.0035827,0.14259,0.70981,HP_MACULAR_THICKENING,0.99999
GSE42021_TREG_PLN_VS_TREG_PR...2,SET,175,-0.036293,-0.0035266,0.065634,0.70985,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP,0.99999
GOBP_T_CELL_CYTOKINE_PRODUCT...,SET,36,-0.082932,-0.0036689,0.14995,0.70988,GOBP_T_CELL_CYTOKINE_PRODUCTION,0.99999
HP_VAGINAL_NEOPLASM,SET,8,-0.20949,-0.0043721,0.37877,0.70989,HP_VAGINAL_NEOPLASM,0.99999
HP_PARTIAL_DUPLICATION_OF_TH...1,SET,6,-0.18241,-0.0032971,0.32971,0.70995,HP_PARTIAL_DUPLICATION_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,0.99999
COLDREN_GEFITINIB_RESISTANCE...2,SET,72,-0.053299,-0.0033313,0.096318,0.70999,COLDREN_GEFITINIB_RESISTANCE_UP,0.99999
GOMF_PROTEIN_KINASE_C_BINDING,SET,48,-0.073295,-0.0037429,0.13243,0.71002,GOMF_PROTEIN_KINASE_C_BINDING,0.99999
HP_ABNORMAL_CIRCULATING_IGM_...,SET,94,-0.04954,-0.0035358,0.089509,0.71002,HP_ABNORMAL_CIRCULATING_IGM_LEVEL,0.99999
WANG_ESOPHAGUS_CANCER_PROGRE...,SET,9,-0.17421,-0.0038563,0.31476,0.71003,WANG_ESOPHAGUS_CANCER_PROGRESSION_UP,0.99999
MIR3191_5P,SET,147,-0.039748,-0.0035425,0.071811,0.71004,MIR3191_5P,0.99999
HP_ABNORMAL_GALLBLADDER_MORP...,SET,84,-0.051759,-0.0034931,0.093499,0.71006,HP_ABNORMAL_GALLBLADDER_MORPHOLOGY,0.99999
GOBP_PROTEIN_TO_MEMBRANE_DOC...,SET,5,-0.21989,-0.0036284,0.39717,0.71008,GOBP_PROTEIN_TO_MEMBRANE_DOCKING,0.99999
HP_CORNEAL_OPACITY,SET,246,-0.030615,-0.0035201,0.055281,0.71014,HP_CORNEAL_OPACITY,0.99999
HP_ABNORMAL_PROPORTION_OF_CD...1,SET,26,-0.090931,-0.0034196,0.16416,0.71018,HP_ABNORMAL_PROPORTION_OF_CD4_POSITIVE_HELPER_T_CELLS,0.99999
MIR4524A_3P,SET,200,-0.033837,-0.0035125,0.061075,0.71021,MIR4524A_3P,0.99999
SCHERER_PBMC_YF_VAX_AGE_18_4...2,SET,317,-0.027046,-0.0035232,0.048816,0.71022,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP,0.99999
MIR802,SET,121,-0.044485,-0.0035996,0.080287,0.71023,MIR802,0.99999
GSE39556_CD8A_DC_VS_NK_CELL_...2,SET,180,-0.036539,-0.0036003,0.065946,0.71023,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN,0.99999
VILIMAS_NOTCH1_TARGETS_UP,SET,49,-0.070967,-0.0036615,0.12806,0.71027,VILIMAS_NOTCH1_TARGETS_UP,0.99999
GOBP_MEIOTIC_CHROMOSOME_SEGR...,SET,79,-0.049487,-0.0032393,0.089293,0.71028,GOBP_MEIOTIC_CHROMOSOME_SEGREGATION,0.99999
GSE3982_BCELL_VS_BASOPHIL_DN,SET,176,-0.037046,-0.0036099,0.066846,0.71028,GSE3982_BCELL_VS_BASOPHIL_DN,0.99999
REACTOME_REGULATION_OF_RUNX1...,SET,17,-0.11505,-0.0034995,0.20753,0.71034,REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY,0.99999
HP_CEREBELLAR_MALFORMATION,SET,219,-0.031789,-0.0034513,0.05734,0.71034,HP_CEREBELLAR_MALFORMATION,0.99999
REACTOME_NEF_AND_SIGNAL_TRAN...,SET,8,-0.17554,-0.0036637,0.31655,0.71039,REACTOME_NEF_AND_SIGNAL_TRANSDUCTION,0.99999
VERHAAK_GLIOBLASTOMA_CLASSIC...,SET,152,-0.040247,-0.003647,0.072545,0.71048,VERHAAK_GLIOBLASTOMA_CLASSICAL,0.99999
MTHFD1_TARGET_GENES,SET,16,-0.11284,-0.0033299,0.20334,0.71053,MTHFD1_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...673,SET,9,-0.16018,-0.0035458,0.28854,0.7106,GOBP_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,0.99999
GSE16385_IFNG_TNF_VS_UNSTIM_...1,SET,179,-0.035567,-0.0034949,0.064058,0.71063,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,0.99999
MIR6726_5P,SET,45,-0.067001,-0.0033131,0.12064,0.71068,MIR6726_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...416,SET,41,-0.077471,-0.003657,0.13945,0.71073,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...2,SET,172,-0.035232,-0.0033942,0.063419,0.71073,GSE22886_NAIVE_CD8_TCELL_VS_DC_UP,0.99999
GSE21927_SPLEEN_MONOCYTE_VS_...1,SET,166,-0.036924,-0.0034952,0.066464,0.71074,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_DN,0.99999
REACTOME_ADORA2B_MEDIATED_AN...,SET,42,-0.076688,-0.0036639,0.13803,0.71076,REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,0.99999
MIR4456,SET,119,-0.042587,-0.0034176,0.076639,0.71078,MIR4456,0.99999
chr11q11,SET,10,-0.23159,-0.0054037,0.41673,0.7108,chr11q11,0.99999
KOYAMA_SEMA3B_TARGETS_DN,SET,319,-0.027423,-0.0035834,0.049329,0.71086,KOYAMA_SEMA3B_TARGETS_DN,0.99999
VANGURP_PANCREATIC_GAMMA_CELL,SET,41,-0.084298,-0.0039794,0.15163,0.71087,VANGURP_PANCREATIC_GAMMA_CELL,0.99999
GSE22611_NOD2_TRANSD_VS_CTRL...4,SET,173,-0.034633,-0.0033461,0.062286,0.7109,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP,0.99999
GOCC_GOLGI_MEDIAL_CISTERNA,SET,11,-0.1552,-0.0037978,0.27907,0.71093,GOCC_GOLGI_MEDIAL_CISTERNA,0.99999
WANG_BARRETTS_ESOPHAGUS_DN,SET,24,-0.1082,-0.0039095,0.19446,0.71102,WANG_BARRETTS_ESOPHAGUS_DN,0.99999
DURCHDEWALD_SKIN_CARCINOGENE...2,SET,74,-0.055364,-0.003508,0.099505,0.71103,DURCHDEWALD_SKIN_CARCINOGENESIS_UP,0.99999
GOCC_MITOCHONDRION,SET,1451,-0.012591,-0.0033972,0.02263,0.71103,GOCC_MITOCHONDRION,0.99999
GSE43863_NAIVE_VS_MEMORY_LY6...1,SET,184,-0.033369,-0.0033239,0.059968,0.71104,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_DN,0.99999
GOBP_NUCLEAR_MRNA_SURVEILLAN...,SET,10,-0.12622,-0.002945,0.22679,0.71107,GOBP_NUCLEAR_MRNA_SURVEILLANCE,0.99999
GOBP_POSITIVE_REGULATION_OF_...796,SET,18,-0.11132,-0.0034841,0.19992,0.71118,GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.99999
HP_ABNORMALITY_OF_THE_MIDDLE...1,SET,543,-0.020958,-0.0035507,0.037636,0.71118,HP_ABNORMALITY_OF_THE_MIDDLE_EAR,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...6,SET,145,-0.036488,-0.0032299,0.065523,0.71119,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,0.99999
GOBP_ASPARTATE_FAMILY_AMINO_...2,SET,12,-0.13602,-0.0034764,0.24419,0.71123,GOBP_ASPARTATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,0.99999
MORF_AP2M1,SET,194,-0.031444,-0.0032153,0.056448,0.71125,MORF_AP2M1,0.99999
HP_CONGENITAL_STATIONARY_NIG...,SET,18,-0.11516,-0.0036042,0.20673,0.71125,HP_CONGENITAL_STATIONARY_NIGHT_BLINDNESS,0.99999
GOMF_CYCLASE_ACTIVITY,SET,17,-0.12132,-0.00369,0.21776,0.71127,GOMF_CYCLASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...300,SET,6,-0.19259,-0.0034811,0.34566,0.71129,GOBP_NEGATIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,0.99999
HP_ABNORMALITY_OF_THE_LIVER,SET,984,-0.015477,-0.0034859,0.027773,0.71133,HP_ABNORMALITY_OF_THE_LIVER,0.99999
GOMF_ADRENERGIC_RECEPTOR_ACT...,SET,10,-0.17498,-0.0040829,0.31397,0.71134,GOMF_ADRENERGIC_RECEPTOR_ACTIVITY,0.99999
GOBP_REGULATION_OF_CELLULAR_...8,SET,7,-0.18099,-0.0035336,0.32461,0.71143,GOBP_REGULATION_OF_CELLULAR_PH_REDUCTION,0.99999
HP_SLEEP_RELATED_BREATHING_D...,SET,148,-0.040036,-0.0035803,0.071795,0.71145,HP_SLEEP_RELATED_BREATHING_DISORDERS,0.99999
HP_ENLARGEMENT_OF_THE_WRISTS,SET,6,-0.21539,-0.0038933,0.38619,0.71148,HP_ENLARGEMENT_OF_THE_WRISTS,0.99999
GOBP_CELLULAR_RESPONSE_TO_OX...4,SET,145,-0.039389,-0.0034868,0.070617,0.7115,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,0.99999
HP_LARYNGEAL_STENOSIS,SET,14,-0.14721,-0.0040638,0.26392,0.71151,HP_LARYNGEAL_STENOSIS,0.99999
KEGG_MEDICUS_REFERENCE_EREG_...1,SET,11,-0.14506,-0.0035498,0.25999,0.71156,KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY,0.99999
MIR7111_3P,SET,112,-0.045087,-0.0035109,0.080799,0.71158,MIR7111_3P,0.99999
REACTOME_IRF3_MEDIATED_INDUC...,SET,11,-0.12073,-0.0029544,0.21632,0.71161,REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN,0.99999
GSE43955_1H_VS_10H_ACT_CD4_T...1,SET,185,-0.034481,-0.0034439,0.061781,0.71161,GSE43955_1H_VS_10H_ACT_CD4_TCELL_DN,0.99999
GOBP_HOMOLOGOUS_RECOMBINATION,SET,58,-0.056356,-0.0031627,0.10093,0.71169,GOBP_HOMOLOGOUS_RECOMBINATION,0.99999
REACTOME_AURKA_ACTIVATION_BY...,SET,67,-0.052669,-0.0031761,0.094311,0.71173,REACTOME_AURKA_ACTIVATION_BY_TPX2,0.99999
GSE18281_PERIMEDULLARY_CORTI...1,SET,170,-0.036667,-0.0035121,0.065637,0.71179,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,0.99999
GSE11924_TH1_VS_TH17_CD4_TCE...1,SET,186,-0.033325,-0.0033374,0.059654,0.7118,GSE11924_TH1_VS_TH17_CD4_TCELL_DN,0.99999
GSE4984_GALECTIN1_VS_VEHICLE...1,SET,176,-0.034073,-0.0033202,0.060988,0.71181,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN,0.99999
HP_AMAUROSIS_FUGAX,SET,40,-0.070613,-0.0032925,0.12638,0.71182,HP_AMAUROSIS_FUGAX,0.99999
GOBP_RESPONSE_TO_HISTAMINE,SET,10,-0.15777,-0.0036811,0.28227,0.71189,GOBP_RESPONSE_TO_HISTAMINE,0.99999
MODULE_400,SET,18,-0.12077,-0.0037798,0.21596,0.71199,MODULE_400,0.99999
GOBP_DE_NOVO_PROTEIN_FOLDING,SET,39,-0.070756,-0.0032578,0.12653,0.71199,GOBP_DE_NOVO_PROTEIN_FOLDING,0.99999
GSE17974_0H_VS_12H_IN_VITRO_...2,SET,167,-0.037199,-0.0035317,0.066506,0.71203,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP,0.99999
WP_ANDROGEN_RECEPTOR_NETWORK...,SET,106,-0.046423,-0.0035174,0.082984,0.71206,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...34,SET,36,-0.074662,-0.003303,0.13343,0.7121,GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED,0.99999
GSE17721_CTRL_VS_LPS_0.5H_BM...1,SET,182,-0.035664,-0.0035334,0.063737,0.7121,GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN,0.99999
GOMF_INTERFERON_RECEPTOR_ACT...,SET,5,-0.22954,-0.0037876,0.41017,0.71212,GOMF_INTERFERON_RECEPTOR_ACTIVITY,0.99999
MIR186_3P,SET,131,-0.041278,-0.0034744,0.07375,0.71215,MIR186_3P,0.99999
MIR4444,SET,5,-0.19695,-0.0032499,0.35188,0.71215,MIR4444,0.99999
MIR181D_5P,SET,554,-0.021228,-0.0036316,0.037925,0.71217,MIR181D_5P,0.99999
GOBP_THALAMUS_DEVELOPMENT,SET,10,-0.16196,-0.0037789,0.28912,0.71231,GOBP_THALAMUS_DEVELOPMENT,0.99999
WP_NEPHROTIC_SYNDROME,SET,42,-0.076825,-0.0036704,0.13714,0.71233,WP_NEPHROTIC_SYNDROME,0.99999
MIR548AD_5P_MIR548AE_5P_MIR5...,SET,445,-0.023213,-0.0035701,0.041425,0.71238,MIR548AD_5P_MIR548AE_5P_MIR548AY_5P_MIR548B_5P_MIR548D_5P,0.99999
GSE15324_NAIVE_VS_ACTIVATED_...3,SET,185,-0.033912,-0.0033871,0.06051,0.71241,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN,0.99999
HP_PHEOCHROMOCYTOMA,SET,28,-0.083557,-0.0032608,0.14906,0.71244,HP_PHEOCHROMOCYTOMA,0.99999
GSE9946_MATURE_STIMULATORY_V...1,SET,114,-0.046436,-0.0036479,0.082836,0.71245,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN,0.99999
BUSSLINGER_DUODENAL_STEM_CEL...,SET,281,-0.029428,-0.0036129,0.052493,0.71246,BUSSLINGER_DUODENAL_STEM_CELLS,0.99999
KEGG_MEDICUS_REFERENCE_GH_JA...,SET,7,-0.21439,-0.0041857,0.38229,0.71253,KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY,0.99999
GOCC_DNA_DEPENDENT_PROTEIN_K...2,SET,6,-0.1633,-0.0029517,0.29119,0.71253,GOCC_DNA_DEPENDENT_PROTEIN_KINASE_DNA_LIGASE_4_COMPLEX,0.99999
GOMF_TESTOSTERONE_DEHYDROGEN...1,SET,7,-0.16609,-0.0032426,0.29608,0.71258,GOMF_TESTOSTERONE_DEHYDROGENASE_NADPLUS_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...801,SET,10,-0.16134,-0.0037645,0.28761,0.71259,GOBP_POSITIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,0.99999
GOCC_INTRACILIARY_TRANSPORT_...1,SET,22,-0.096648,-0.0033437,0.17227,0.7126,GOCC_INTRACILIARY_TRANSPORT_PARTICLE,0.99999
HP_CONGENITAL_HYPOPLASTIC_AN...,SET,4,-0.21888,-0.0032306,0.39015,0.71261,HP_CONGENITAL_HYPOPLASTIC_ANEMIA,0.99999
GOMF_INOSITOL_1_3_4_5_6_PENT...,SET,5,-0.17008,-0.0028065,0.30296,0.71273,GOMF_INOSITOL_1_3_4_5_6_PENTAKISPHOSPHATE_KINASE_ACTIVITY,0.99999
MIR642A_3P_MIR642B_3P,SET,126,-0.043002,-0.0035503,0.076569,0.71281,MIR642A_3P_MIR642B_3P,0.99999
KERLEY_RESPONSE_TO_CISPLATIN...1,SET,5,-0.22662,-0.0037394,0.40348,0.71282,KERLEY_RESPONSE_TO_CISPLATIN_DN,0.99999
WP_PHOSPHATIDYL_INOSITOL_PHO...,SET,40,-0.073027,-0.0034051,0.13,0.71285,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,0.99999
WP_METABOLIC_PATHWAY_OF_LDL_...,SET,15,-0.13098,-0.0037424,0.23314,0.71287,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,0.99999
HP_ABNORMAL_DIGESTIVE_SYSTEM...,SET,923,-0.016251,-0.0035512,0.028927,0.71287,HP_ABNORMAL_DIGESTIVE_SYSTEM_MORPHOLOGY,0.99999
WANG_CISPLATIN_RESPONSE_AND_...2,SET,158,-0.038493,-0.0035557,0.068514,0.71288,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,0.99999
GOMF_PHOSPHATIDYLGLYCEROL_BI...,SET,14,-0.13651,-0.0037682,0.24297,0.71288,GOMF_PHOSPHATIDYLGLYCEROL_BINDING,0.99999
GOBP_ASPARTATE_FAMILY_AMINO_...1,SET,21,-0.11021,-0.0037254,0.1961,0.71294,GOBP_ASPARTATE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.99999
WGGAATGY_TEF1_Q6,SET,329,-0.027612,-0.0036632,0.04913,0.71295,WGGAATGY_TEF1_Q6,0.99999
KEGG_MEDICUS_VARIANT_TGFA_OV...,SET,8,-0.16932,-0.0035338,0.30118,0.713,KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,0.99999
MIR4762_5P,SET,128,-0.043012,-0.003579,0.076512,0.713,MIR4762_5P,0.99999
HP_EEG_WITH_FOCAL_SPIKE_WAVES,SET,13,-0.13976,-0.0037179,0.24862,0.713,HP_EEG_WITH_FOCAL_SPIKE_WAVES,0.99999
HP_APNEA,SET,213,-0.032692,-0.0035009,0.058135,0.71306,HP_APNEA,0.99999
GNF2_TTN,SET,26,-0.088669,-0.0033346,0.15764,0.7131,GNF2_TTN,0.99999
ZHOU_CELL_CYCLE_GENES_IN_IR_...3,SET,79,-0.052932,-0.0034648,0.094101,0.71311,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR,0.99999
DESCARTES_FETAL_ADRENAL_SYMP...,SET,90,-0.057257,-0.0039992,0.10179,0.71311,DESCARTES_FETAL_ADRENAL_SYMPATHOBLASTS,0.99999
GOBP_MONOACYLGLYCEROL_CATABO...,SET,7,-0.15294,-0.0029859,0.27188,0.71312,GOBP_MONOACYLGLYCEROL_CATABOLIC_PROCESS,0.99999
GOBP_TRICUSPID_VALVE_DEVELOP...,SET,7,-0.20286,-0.0039605,0.36061,0.71312,GOBP_TRICUSPID_VALVE_DEVELOPMENT,0.99999
GOMF_1_PHOSPHATIDYLINOSITOL_...6,SET,15,-0.12522,-0.003578,0.22261,0.71312,GOMF_1_PHOSPHATIDYLINOSITOL_BINDING,0.99999
MODULE_91,SET,35,-0.068689,-0.0029964,0.1221,0.71313,MODULE_91,0.99999
REACTOME_G_BETA_GAMMA_SIGNAL...1,SET,19,-0.11729,-0.0037715,0.20849,0.71314,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42,0.99999
REACTOME_SARS_COV_1_HOST_INT...,SET,85,-0.051718,-0.003511,0.091908,0.71318,REACTOME_SARS_COV_1_HOST_INTERACTIONS,0.99999
GOBP_RESPONSE_TO_ALKALOID,SET,97,-0.048712,-0.0035315,0.086568,0.71318,GOBP_RESPONSE_TO_ALKALOID,0.99999
HP_INCOMPLETE_PARTITION_OF_T...,SET,7,-0.17452,-0.0034073,0.31007,0.71323,HP_INCOMPLETE_PARTITION_OF_THE_COCHLEA_TYPE_II,0.99999
GSE22601_IMMATURE_CD4_SINGLE...5,SET,180,-0.036332,-0.0035799,0.064526,0.7133,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,0.99999
GAO_SMALL_INTESTINE_24W_C4_E...,SET,87,-0.053396,-0.0036671,0.094824,0.71331,GAO_SMALL_INTESTINE_24W_C4_ENTEROCYTE_PROGENITOR_SUBTYPE_2,0.99999
KEGG_MEDICUS_REFERENCE_MLK_J...,SET,10,-0.16075,-0.0037509,0.28547,0.71332,KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY,0.99999
HP_BOWED_FOREARM_BONES,SET,31,-0.091876,-0.0037723,0.16316,0.71332,HP_BOWED_FOREARM_BONES,0.99999
HP_SUBCUTANEOUS_LIPOMA,SET,7,-0.18405,-0.0035933,0.32684,0.71332,HP_SUBCUTANEOUS_LIPOMA,0.99999
GSE14413_UNSTIM_VS_IFNB_STIM...1,SET,104,-0.048616,-0.0036488,0.086334,0.71332,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_DN,0.99999
HP_NEOPLASM_OF_THE_AUTONOMIC...,SET,10,-0.17698,-0.0041295,0.31426,0.71333,HP_NEOPLASM_OF_THE_AUTONOMIC_NERVOUS_SYSTEM,0.99999
GOMF_RNA_POLYMERASE_II_CTD_H...3,SET,7,-0.16241,-0.0031708,0.28837,0.71335,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_PHOSPHATASE_ACTIVITY,0.99999
GSE411_100MIN_VS_400MIN_IL6_...3,SET,183,-0.034571,-0.0034344,0.061375,0.71338,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,0.99999
GOMF_ENDODEOXYRIBONUCLEASE_A...,SET,11,-0.13781,-0.0033724,0.24461,0.71341,GOMF_ENDODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,0.99999
HP_ABNORMALITY_OF_ABDOMINAL_...,SET,15,-0.13016,-0.0037191,0.23095,0.71348,HP_ABNORMALITY_OF_ABDOMINAL_SITUS,0.99999
AGTGCGT_MIR521,SET,6,-0.17138,-0.0030978,0.30406,0.7135,AGTGCGT_MIR521,0.99999
BCAT_BILD_ET_AL_UP,SET,42,-0.077065,-0.0036819,0.13672,0.7135,BCAT_BILD_ET_AL_UP,0.99999
GOBP_VIRAL_RNA_GENOME_REPLIC...,SET,24,-0.10877,-0.0039302,0.19293,0.71355,GOBP_VIRAL_RNA_GENOME_REPLICATION,0.99999
GOMF_COLLAGEN_RECEPTOR_ACTIV...,SET,6,-0.18293,-0.0033066,0.32435,0.71362,GOMF_COLLAGEN_RECEPTOR_ACTIVITY,0.99999
DESCARTES_MAIN_FETAL_TROPHOB...,SET,125,-0.044676,-0.0036739,0.079206,0.71363,DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS,0.99999
GSE42021_CD24HI_VS_CD24LOW_T...1,SET,183,-0.036535,-0.0036295,0.064744,0.71372,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN,0.99999
MIR98_5P,SET,361,-0.026018,-0.0036125,0.046101,0.71374,MIR98_5P,0.99999
GSE369_PRE_VS_POST_IL6_INJEC...2,SET,176,-0.0364,-0.0035469,0.064492,0.71376,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP,0.99999
GSE3400_UNTREATED_VS_IFNB_TR...1,SET,154,-0.040036,-0.0036515,0.070914,0.71381,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_DN,0.99999
GSE9037_WT_VS_IRAK4_KO_LPS_1...1,SET,172,-0.037755,-0.0036373,0.066872,0.71382,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN,0.99999
REACTOME_DEFECTIVE_LFNG_CAUS...,SET,5,-0.22263,-0.0036737,0.39431,0.71383,REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3,0.99999
GLI4_TARGET_GENES,SET,663,-0.018894,-0.0035252,0.033464,0.71383,GLI4_TARGET_GENES,0.99999
HP_INCREASED_CIRCULATING_LAC...1,SET,180,-0.032852,-0.003237,0.058186,0.71383,HP_INCREASED_CIRCULATING_LACTATE_CONCENTRATION,0.99999
HP_HEPATOCELLULAR_ADENOMA,SET,17,-0.12693,-0.0038607,0.22478,0.71385,HP_HEPATOCELLULAR_ADENOMA,0.99999
GSE22611_NOD2_VS_MUTANT_NOD2...2,SET,170,-0.0352,-0.0033716,0.062311,0.71393,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...195,SET,23,-0.10373,-0.0036694,0.1836,0.71395,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST,0.99999
WP_MIR517_RELATIONSHIP_WITH_...,SET,5,-0.18753,-0.0030945,0.33192,0.71396,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,0.99999
HP_ABNORMAL_CARDIAC_BIOMARKE...,SET,6,-0.22358,-0.0040414,0.39569,0.71397,HP_ABNORMAL_CARDIAC_BIOMARKER_TEST,0.99999
GSE9960_GRAM_POS_VS_GRAM_NEG...2,SET,178,-0.035856,-0.0035135,0.063456,0.71398,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,0.99999
HP_DEPRESSED_NASAL_TIP,SET,22,-0.10843,-0.0037515,0.19189,0.71399,HP_DEPRESSED_NASAL_TIP,0.99999
MODULE_444,SET,17,-0.13438,-0.0040873,0.23774,0.71404,MODULE_444,0.99999
REACTOME_METALLOTHIONEINS_BI...,SET,11,-0.22857,-0.0055933,0.40431,0.71407,REACTOME_METALLOTHIONEINS_BIND_METALS,0.99999
DESCARTES_FETAL_LUNG_CILIATE...,SET,360,-0.025179,-0.0034912,0.044535,0.71409,DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS,0.99999
HP_LOWER_LIMB_ASYMMETRY,SET,41,-0.08124,-0.003835,0.14368,0.7141,HP_LOWER_LIMB_ASYMMETRY,0.99999
HP_SKELETAL_MUSCLE_ATROPHY,SET,497,-0.021666,-0.0035164,0.038309,0.71416,HP_SKELETAL_MUSCLE_ATROPHY,0.99999
MEF2C_TARGET_GENES,SET,1332,-0.013637,-0.0035376,0.024109,0.71418,MEF2C_TARGET_GENES,0.99999
GOBP_NEUROTROPHIN_SIGNALING_...,SET,38,-0.078377,-0.0035622,0.13856,0.71418,GOBP_NEUROTROPHIN_SIGNALING_PATHWAY,0.99999
GSE6269_E_COLI_VS_STAPH_AURE...2,SET,126,-0.042567,-0.0035144,0.075249,0.71419,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_UP,0.99999
MORF_NOS2A,SET,263,-0.030311,-0.0036019,0.053575,0.71422,MORF_NOS2A,0.99999
GSE21774_CD62L_POS_CD56_DIM_...1,SET,180,-0.036143,-0.0035613,0.063882,0.71422,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,0.99999
DESCARTES_FETAL_EYE_PHOTOREC...,SET,29,-0.10199,-0.0040506,0.18028,0.71422,DESCARTES_FETAL_EYE_PHOTORECEPTOR_CELLS,0.99999
CREIGHTON_ENDOCRINE_THERAPY_...3,SET,650,-0.02043,-0.0037757,0.03611,0.71423,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3,0.99999
GOMF_CARGO_RECEPTOR_ACTIVITY,SET,71,-0.058088,-0.0036055,0.10263,0.7143,GOMF_CARGO_RECEPTOR_ACTIVITY,0.99999
GSE3982_NEUTROPHIL_VS_CENT_M...2,SET,188,-0.035519,-0.0035759,0.062754,0.7143,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,0.99999
GOBP_SCARNA_LOCALIZATION_TO_...,SET,4,-0.1857,-0.0027409,0.32804,0.71433,GOBP_SCARNA_LOCALIZATION_TO_CAJAL_BODY,0.99999
HP_IMPAIRED_VISUOSPATIAL_CON...,SET,19,-0.1104,-0.0035499,0.19485,0.7145,HP_IMPAIRED_VISUOSPATIAL_CONSTRUCTIVE_COGNITION,0.99999
REACTOME_SENSORY_PROCESSING_...2,SET,49,-0.07353,-0.0037938,0.12977,0.71451,REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,0.99999
GSE21360_NAIVE_VS_PRIMARY_ME...1,SET,169,-0.039179,-0.0037418,0.069137,0.71453,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN,0.99999
HP_ATRIAL_STANDSTILL,SET,6,-0.22419,-0.0040523,0.39558,0.71454,HP_ATRIAL_STANDSTILL,0.99999
REACTOME_TERMINAL_PATHWAY_OF...,SET,8,-0.18269,-0.003813,0.32233,0.71457,REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT,0.99999
GOBP_RESPONSE_TO_ESTRADIOL,SET,113,-0.047667,-0.0037282,0.084095,0.71458,GOBP_RESPONSE_TO_ESTRADIOL,0.99999
GOCC_RUFFLE,SET,172,-0.036795,-0.0035448,0.064906,0.7146,GOCC_RUFFLE,0.99999
GOBP_NEGATIVE_CHEMOTAXIS,SET,46,-0.078658,-0.0039324,0.13874,0.71462,GOBP_NEGATIVE_CHEMOTAXIS,0.99999
ZIC2_01,SET,228,-0.032432,-0.0035919,0.057204,0.71463,ZIC2_01,0.99999
GSE14415_INDUCED_TREG_VS_FOX...3,SET,161,-0.039297,-0.0036639,0.069305,0.71464,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_UP,0.99999
HP_ALZHEIMER_DISEASE,SET,8,-0.19198,-0.0040067,0.33844,0.71472,HP_ALZHEIMER_DISEASE,0.99999
GOBP_RIBONUCLEOPROTEIN_COMPL...1,SET,397,-0.022353,-0.0032514,0.0394,0.71476,GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS,0.99999
GOCC_OTHER_ORGANISM_PART,SET,4,-0.28355,-0.004185,0.49977,0.71476,GOCC_OTHER_ORGANISM_PART,0.99999
MIR4741,SET,41,-0.074702,-0.0035264,0.13164,0.71479,MIR4741,0.99999
WP_6Q16_COPY_NUMBER_VARIATION,SET,14,-0.13786,-0.0038057,0.24295,0.7148,WP_6Q16_COPY_NUMBER_VARIATION,0.99999
HP_CAFE_AU_LAIT_SPOT,SET,120,-0.041081,-0.0033105,0.072381,0.71483,HP_CAFE_AU_LAIT_SPOT,0.99999
KEGG_MEDICUS_PATHOGEN_SARS_C...2,SET,12,-0.15782,-0.0040335,0.27805,0.71484,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_TELOMERE_...1,SET,26,-0.085852,-0.0032286,0.15125,0.71484,GOBP_REGULATION_OF_TELOMERE_CAPPING,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...48,SET,6,-0.20867,-0.0037718,0.36762,0.71485,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY,0.99999
WP_CELL_DIFFERENTIATION_EXPA...,SET,18,-0.12755,-0.0039919,0.22471,0.71485,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,0.99999
GSE20715_0H_VS_24H_OZONE_TLR...2,SET,175,-0.037955,-0.003688,0.066864,0.71485,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...800,SET,25,-0.10091,-0.0037214,0.17777,0.71486,GOBP_POSITIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION,0.99999
HP_SPRENGEL_ANOMALY,SET,43,-0.070525,-0.0034092,0.12423,0.71487,HP_SPRENGEL_ANOMALY,0.99999
HP_CORONAL_CLEFT_VERTEBRAE,SET,17,-0.11849,-0.0036042,0.20872,0.71488,HP_CORONAL_CLEFT_VERTEBRAE,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...2,SET,62,-0.068264,-0.0039604,0.12023,0.71491,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,0.99999
HP_WEAKNESS_OF_MUSCLES_OF_RE...,SET,99,-0.048739,-0.0035695,0.085811,0.71497,HP_WEAKNESS_OF_MUSCLES_OF_RESPIRATION,0.99999
HP_WIDELY_SPACED_MAXILLARY_C...,SET,9,-0.1498,-0.0033161,0.26372,0.715,HP_WIDELY_SPACED_MAXILLARY_CENTRAL_INCISORS,0.99999
GTTGNYNNRGNAAC_UNKNOWN,SET,94,-0.051599,-0.0036828,0.090822,0.71502,GTTGNYNNRGNAAC_UNKNOWN,0.99999
GOBP_CELLULAR_RESPONSE_TO_L_...2,SET,11,-0.14296,-0.0034984,0.25161,0.71504,GOBP_CELLULAR_RESPONSE_TO_L_LEUCINE,0.99999
MIR181A_5P_MIR181B_5P,SET,555,-0.021546,-0.0036891,0.037916,0.71506,MIR181A_5P_MIR181B_5P,0.99999
MIR890,SET,88,-0.053801,-0.003716,0.094649,0.71512,MIR890,0.99999
HP_AUDITORY_HYPERSENSITIVITY,SET,30,-0.092394,-0.003732,0.16255,0.71512,HP_AUDITORY_HYPERSENSITIVITY,0.99999
REACTOME_CHROMATIN_MODIFYING...,SET,183,-0.033622,-0.0033401,0.059126,0.7152,REACTOME_CHROMATIN_MODIFYING_ENZYMES,0.99999
KEGG_WNT_SIGNALING_PATHWAY,SET,144,-0.042366,-0.0037374,0.07449,0.71523,KEGG_WNT_SIGNALING_PATHWAY,0.99999
REACTOME_PYRIMIDINE_SALVAGE,SET,10,-0.15124,-0.0035289,0.26593,0.71523,REACTOME_PYRIMIDINE_SALVAGE,0.99999
MOOTHA_MITOCHONDRIA,SET,396,-0.023844,-0.0034641,0.041922,0.71524,MOOTHA_MITOCHONDRIA,0.99999
GSE28449_WT_VS_LRF_KO_GERMIN...1,SET,171,-0.038201,-0.0036697,0.067165,0.71524,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_DN,0.99999
GGGTGGRR_PAX4_03,SET,1156,-0.014935,-0.0036279,0.026236,0.71541,GGGTGGRR_PAX4_03,0.99999
HP_DISTURBANCE_DURING_TRANSI...,SET,17,-0.12791,-0.0038906,0.22468,0.71542,HP_DISTURBANCE_DURING_TRANSITIONS_BETWEEN_SLEEP_AND_WAKE_STATES,0.99999
WP_MIRNA_REGULATION_OF_PROST...,SET,29,-0.09347,-0.0037121,0.16412,0.7155,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,0.99999
GOBP_REGULATION_OF_PIGMENTAT...,SET,17,-0.12284,-0.0037364,0.21567,0.71552,GOBP_REGULATION_OF_PIGMENTATION,0.99999
MODULE_289,SET,117,-0.049221,-0.0039169,0.086404,0.71554,MODULE_289,0.99999
HP_ST_SEGMENT_ELEVATION,SET,24,-0.10148,-0.0036667,0.17808,0.7156,HP_ST_SEGMENT_ELEVATION,0.99999
MODULE_57,SET,55,-0.062176,-0.0033981,0.10906,0.71569,MODULE_57,0.99999
GSE5455_HEALTHY_VS_TUMOR_BEA...3,SET,183,-0.037265,-0.003702,0.065335,0.71578,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_DN,0.99999
DESCARTES_FETAL_PANCREAS_SMO...,SET,30,-0.097365,-0.0039327,0.17068,0.71581,DESCARTES_FETAL_PANCREAS_SMOOTH_MUSCLE_CELLS,0.99999
GOBP_REGULATION_OF_NEUTROPHI...1,SET,5,-0.23921,-0.0039472,0.41931,0.71582,GOBP_REGULATION_OF_NEUTROPHIL_ACTIVATION,0.99999
GSE12198_LOW_IL2_STIM_NK_CEL...2,SET,183,-0.033915,-0.0033692,0.059449,0.71582,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP,0.99999
FEKIR_HEPARG_SPHERE_VS_HEPAR...1,SET,34,-0.087986,-0.003783,0.15422,0.71583,FEKIR_HEPARG_SPHERE_VS_HEPARG_DN,0.99999
HP_MONOCHROMACY,SET,8,-0.17973,-0.0037511,0.31502,0.71584,HP_MONOCHROMACY,0.99999
HP_LOW_SET_POSTERIORLY_ROTAT...,SET,216,-0.033147,-0.0035743,0.058093,0.71586,HP_LOW_SET_POSTERIORLY_ROTATED_EARS,0.99999
GOBP_REGULATION_OF_ANTIFUNGA...,SET,4,-0.21152,-0.0031219,0.37065,0.71588,GOBP_REGULATION_OF_ANTIFUNGAL_INNATE_IMMUNE_RESPONSE,0.99999
SNAPC2_TARGET_GENES,SET,4,-0.20876,-0.0030813,0.36572,0.71594,SNAPC2_TARGET_GENES,0.99999
REACTOME_SURFACTANT_METABOLI...,SET,26,-0.10664,-0.0040103,0.18676,0.71599,REACTOME_SURFACTANT_METABOLISM,0.99999
GSE21360_TERTIARY_VS_QUATERN...2,SET,172,-0.038675,-0.003726,0.067736,0.71599,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.99999
LIANG_SILENCED_BY_METHYLATIO...3,SET,26,-0.11041,-0.0041523,0.19336,0.716,LIANG_SILENCED_BY_METHYLATION_UP,0.99999
ABBUD_LIF_SIGNALING_2_DN,SET,7,-0.21908,-0.0042771,0.3836,0.71603,ABBUD_LIF_SIGNALING_2_DN,0.99999
GOMF_SYNTAXIN_1_BINDING,SET,19,-0.11172,-0.0035924,0.19558,0.71608,GOMF_SYNTAXIN_1_BINDING,0.99999
OUELLET_OVARIAN_CANCER_INVAS...2,SET,104,-0.044712,-0.0033558,0.07825,0.71613,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,0.99999
MODULE_431,SET,15,-0.13946,-0.0039847,0.24407,0.71613,MODULE_431,0.99999
GSE15659_CD45RA_NEG_CD4_TCEL...1,SET,164,-0.037221,-0.0035022,0.065137,0.71614,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN,0.99999
DELACROIX_RAR_TARGETS_DN,SET,25,-0.10265,-0.0037854,0.17953,0.71626,DELACROIX_RAR_TARGETS_DN,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...10,SET,16,-0.12533,-0.0036984,0.21916,0.71629,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,0.99999
KORKOLA_SEMINOMA_UP,SET,29,-0.10783,-0.0042825,0.18856,0.71629,KORKOLA_SEMINOMA_UP,0.99999
PUJANA_BRCA_CENTERED_NETWORK,SET,110,-0.041971,-0.0032391,0.073385,0.71631,PUJANA_BRCA_CENTERED_NETWORK,0.99999
KEGG_MEDICUS_REFERENCE_TSH_T...,SET,29,-0.089182,-0.0035418,0.15591,0.71634,KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY,0.99999
GSE17974_0H_VS_24H_IN_VITRO_...2,SET,162,-0.039168,-0.0036631,0.068469,0.71635,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP,0.99999
GOBP_GROWTH_PLATE_CARTILAGE_...1,SET,5,-0.25687,-0.0042386,0.44895,0.71639,GOBP_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DEVELOPMENT,0.99999
REACTOME_DISPLACEMENT_OF_DNA...,SET,9,-0.14987,-0.0033174,0.26188,0.71643,REACTOME_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1,0.99999
GSE25088_IL4_VS_IL4_AND_ROSI...1,SET,185,-0.035503,-0.003546,0.062026,0.71647,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.99999
HP_ABSENT_DISTAL_INTERPHALAN...,SET,7,-0.19679,-0.0038419,0.34372,0.71651,HP_ABSENT_DISTAL_INTERPHALANGEAL_CREASES,0.99999
MARTIN_INTERACT_WITH_HDAC,SET,37,-0.079522,-0.0035664,0.13886,0.71656,MARTIN_INTERACT_WITH_HDAC,0.99999
GOBP_HEAD_DEVELOPMENT,SET,702,-0.019446,-0.0037292,0.033955,0.71657,GOBP_HEAD_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_LEUKOCYTE...6,SET,308,-0.029285,-0.0037613,0.051134,0.71658,GOBP_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION,0.99999
HP_ASPIRATION,SET,26,-0.095556,-0.0035936,0.16684,0.71658,HP_ASPIRATION,0.99999
HP_NARROW_INTERNAL_AUDITORY_...,SET,15,-0.13254,-0.003787,0.23142,0.71658,HP_NARROW_INTERNAL_AUDITORY_CANAL,0.99999
GOBP_LIPOSACCHARIDE_METABOLI...,SET,103,-0.047693,-0.0035623,0.083268,0.71659,GOBP_LIPOSACCHARIDE_METABOLIC_PROCESS,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...37,SET,15,-0.11864,-0.00339,0.20715,0.71659,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,0.99999
GSE411_UNSTIM_VS_400MIN_IL6_...1,SET,180,-0.035086,-0.0034571,0.061241,0.71665,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN,0.99999
GAO_STOMACH_24W_C6_PIT_CELL,SET,12,-0.13953,-0.0035661,0.24354,0.71665,GAO_STOMACH_24W_C6_PIT_CELL,0.99999
MIR6808_3P,SET,37,-0.082006,-0.0036779,0.14313,0.71666,MIR6808_3P,0.99999
HP_GERM_CELL_NEOPLASIA,SET,40,-0.080075,-0.0037337,0.13971,0.71672,HP_GERM_CELL_NEOPLASIA,0.99999
GOBP_PROTEIN_RNA_COMPLEX_ORG...,SET,181,-0.032695,-0.0032304,0.057044,0.71673,GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION,0.99999
GSE14000_4H_VS_16H_LPS_DC_TR...1,SET,172,-0.035677,-0.0034371,0.062238,0.71675,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN,0.99999
HP_HEMATEMESIS,SET,17,-0.12813,-0.0038974,0.22345,0.71682,HP_HEMATEMESIS,0.99999
HP_COLOR_VISION_TEST_ABNORMA...,SET,9,-0.18989,-0.0042034,0.33108,0.71686,HP_COLOR_VISION_TEST_ABNORMALITY,0.99999
REACTOME_REGULATION_OF_SIGNA...2,SET,9,-0.14983,-0.0033167,0.26119,0.71689,REACTOME_REGULATION_OF_SIGNALING_BY_NODAL,0.99999
GSE3982_EOSINOPHIL_VS_MAC_UP,SET,173,-0.037837,-0.0036557,0.065958,0.71689,GSE3982_EOSINOPHIL_VS_MAC_UP,0.99999
MIR125B_5P,SET,296,-0.028287,-0.0035627,0.049309,0.7169,MIR125B_5P,0.99999
HP_SHORT_TERM_MEMORY_IMPAIRM...,SET,6,-0.23223,-0.0041977,0.40477,0.71693,HP_SHORT_TERM_MEMORY_IMPAIRMENT,0.99999
PRMT5_TARGET_GENES,SET,64,-0.061364,-0.0036169,0.10694,0.71695,PRMT5_TARGET_GENES,0.99999
GOBP_CELLULAR_RESPONSE_TO_EL...,SET,10,-0.15236,-0.0035551,0.26544,0.71702,GOBP_CELLULAR_RESPONSE_TO_ELECTRICAL_STIMULUS,0.99999
REACTOME_NUCLEAR_PORE_COMPLE...,SET,34,-0.079424,-0.0034149,0.13835,0.71704,REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY,0.99999
GOBP_RESPONSE_TO_INCREASED_O...,SET,23,-0.10004,-0.0035389,0.17421,0.71711,GOBP_RESPONSE_TO_INCREASED_OXYGEN_LEVELS,0.99999
GOBP_L_ALANINE_TRANSPORT,SET,10,-0.16183,-0.0037761,0.28178,0.71713,GOBP_L_ALANINE_TRANSPORT,0.99999
HP_DISINHIBITION,SET,539,-0.021591,-0.0036449,0.037583,0.71718,HP_DISINHIBITION,0.99999
CATRRAGC_UNKNOWN,SET,122,-0.043928,-0.0035691,0.076447,0.71722,CATRRAGC_UNKNOWN,0.99999
HP_DECREASED_SERUM_ZINC,SET,4,-0.2256,-0.0033297,0.39261,0.71722,HP_DECREASED_SERUM_ZINC,0.99999
REACTOME_SYNDECAN_INTERACTIO...,SET,26,-0.099383,-0.0037375,0.17294,0.71724,REACTOME_SYNDECAN_INTERACTIONS,0.99999
VAN_DEN_BIGGELAAR_PBMC_PREVN...1,SET,62,-0.060962,-0.0035368,0.10608,0.71725,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_8MO_UP,0.99999
GOBP_GLYCOSIDE_METABOLIC_PRO...,SET,19,-0.12349,-0.0039707,0.21484,0.71728,GOBP_GLYCOSIDE_METABOLIC_PROCESS,0.99999
TTAYRTAA_E4BP4_01,SET,236,-0.034192,-0.0038517,0.059481,0.7173,TTAYRTAA_E4BP4_01,0.99999
GSE20198_IL12_VS_IFNA_TREATE...2,SET,181,-0.035941,-0.0035511,0.062517,0.71732,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.99999
HP_SHORT_PALM,SET,93,-0.051043,-0.0036238,0.088705,0.71749,HP_SHORT_PALM,0.99999
HP_SHORTENING_OF_ALL_PHALANG...,SET,6,-0.1876,-0.003391,0.326,0.71751,HP_SHORTENING_OF_ALL_PHALANGES_OF_THE_TOES,0.99999
MIR7706,SET,10,-0.17871,-0.0041699,0.3105,0.71754,MIR7706,0.99999
GSE46606_DAY1_VS_DAY3_CD40L_...7,SET,179,-0.036184,-0.0035556,0.062867,0.71754,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN,0.99999
GOBP_BIOLOGICAL_PROCESS_INVO...5,SET,286,-0.029721,-0.0036806,0.051635,0.71755,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION,0.99999
WANG_RESPONSE_TO_BEXAROTENE_...1,SET,28,-0.097636,-0.0038102,0.1696,0.71758,WANG_RESPONSE_TO_BEXAROTENE_DN,0.99999
SP1_01,SET,214,-0.033573,-0.0036036,0.058301,0.71764,SP1_01,0.99999
REACTOME_SIGNALING_BY_INSULI...,SET,79,-0.056955,-0.0037282,0.098896,0.71766,REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,0.99999
HP_NASAL_CONGESTION,SET,47,-0.070511,-0.0035632,0.12241,0.7177,HP_NASAL_CONGESTION,0.99999
HP_PARTIAL_ABSENCE_OF_CEREBE...,SET,4,-0.20343,-0.0030025,0.35304,0.71776,HP_PARTIAL_ABSENCE_OF_CEREBELLAR_VERMIS,0.99999
PID_EPHA_FWDPATHWAY,SET,34,-0.08956,-0.0038507,0.1554,0.71779,PID_EPHA_FWDPATHWAY,0.99999
GOBP_RESPONSE_TO_FIBROBLAST_...,SET,107,-0.051395,-0.0039123,0.08917,0.71781,GOBP_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR,0.99999
HP_LOWER_EXTREMITY_JOINT_DIS...,SET,271,-0.03001,-0.0036191,0.052062,0.71783,HP_LOWER_EXTREMITY_JOINT_DISLOCATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...662,SET,66,-0.065164,-0.0039002,0.11303,0.71786,GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,0.99999
GSE19888_CTRL_VS_A3R_ACT_TRE...2,SET,185,-0.036598,-0.0036554,0.063457,0.71794,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_UP,0.99999
YOSHIMURA_MAPK8_TARGETS_UP,SET,1186,-0.015391,-0.0037836,0.02668,0.71799,YOSHIMURA_MAPK8_TARGETS_UP,0.99999
HP_NEOPLASIA_OF_THE_NASOPHAR...,SET,5,-0.22059,-0.00364,0.38232,0.71802,HP_NEOPLASIA_OF_THE_NASOPHARYNX,0.99999
HP_ABNORMAL_CIRCULATING_BETA...,SET,8,-0.18034,-0.0037638,0.31252,0.71805,HP_ABNORMAL_CIRCULATING_BETA_GLOBULIN_LEVEL,0.99999
REACTOME_FRS_MEDIATED_FGFR3_...,SET,19,-0.11115,-0.0035739,0.19256,0.7181,REACTOME_FRS_MEDIATED_FGFR3_SIGNALING,0.99999
ZHONG_PFC_C2_ASCL1_POS_ASTRO...,SET,4,-0.29439,-0.004345,0.5099,0.71814,ZHONG_PFC_C2_ASCL1_POS_ASTROCYTE,0.99999
CYCLIN_D1_UP.V1_UP,SET,169,-0.039033,-0.0037278,0.067598,0.71817,CYCLIN_D1_UP.V1_UP,0.99999
MIR579_3P,SET,449,-0.024357,-0.0037623,0.042175,0.7182,MIR579_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...615,SET,32,-0.087516,-0.0036507,0.1515,0.71826,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.99999
GSE41978_WT_VS_ID2_KO_AND_BI...1,SET,179,-0.035961,-0.0035336,0.062245,0.71827,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.99999
HP_ABNORMALITY_OF_FOLATE_MET...,SET,13,-0.13995,-0.003723,0.24222,0.71829,HP_ABNORMALITY_OF_FOLATE_METABOLISM,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...19,SET,45,-0.079588,-0.0039356,0.13764,0.71844,GAVISH_3CA_MALIGNANT_METAPROGRAM_28_OLIGO_NORMAL,0.99999
ZIRN_TRETINOIN_RESPONSE_DN,SET,5,-0.21142,-0.0034887,0.36559,0.71847,ZIRN_TRETINOIN_RESPONSE_DN,0.99999
GOCC_KINESIN_COMPLEX,SET,47,-0.067209,-0.0033963,0.11621,0.71848,GOCC_KINESIN_COMPLEX,0.99999
GOBP_MITOTIC_G2_DNA_DAMAGE_C...,SET,29,-0.076758,-0.0030484,0.13271,0.7185,GOBP_MITOTIC_G2_DNA_DAMAGE_CHECKPOINT_SIGNALING,0.99999
HP_ABNORMAL_MUSCLE_FIBER_TYP...,SET,76,-0.053022,-0.0034045,0.091666,0.71851,HP_ABNORMAL_MUSCLE_FIBER_TYPE_DISTRIBUTION,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...10,SET,184,-0.03709,-0.0036946,0.064108,0.71856,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP,0.99999
CAGNWMCNNNGAC_UNKNOWN,SET,79,-0.056783,-0.0037169,0.098119,0.71861,CAGNWMCNNNGAC_UNKNOWN,0.99999
GOBP_REGULATION_OF_NEURONAL_...2,SET,52,-0.069766,-0.0037078,0.12054,0.71863,GOBP_REGULATION_OF_NEURONAL_SYNAPTIC_PLASTICITY,0.99999
HP_ABNORMALITY_OF_TASTE_SENS...,SET,5,-0.23364,-0.0038553,0.40359,0.71867,HP_ABNORMALITY_OF_TASTE_SENSATION,0.99999
GOBP_GLOMERULUS_DEVELOPMENT,SET,68,-0.067305,-0.0040887,0.11625,0.7187,GOBP_GLOMERULUS_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...718,SET,28,-0.10307,-0.0040222,0.178,0.71871,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSPORT,0.99999
HP_SEPTATE_VAGINA,SET,10,-0.16327,-0.0038095,0.28196,0.71872,HP_SEPTATE_VAGINA,0.99999
GSE11961_MEMORY_BCELL_DAY7_V...1,SET,174,-0.036998,-0.0035848,0.063893,0.71872,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.99999
BIOCARTA_ECM_PATHWAY,SET,19,-0.11068,-0.0035587,0.1911,0.71875,BIOCARTA_ECM_PATHWAY,0.99999
MIR6769A_3P,SET,17,-0.13028,-0.0039628,0.22494,0.71877,MIR6769A_3P,0.99999
GOCC_AXON,SET,601,-0.021328,-0.0037953,0.03681,0.71884,GOCC_AXON,0.99999
HP_SCANNING_SPEECH,SET,14,-0.14573,-0.0040227,0.25151,0.71884,HP_SCANNING_SPEECH,0.99999
GOBP_NEGATIVE_REGULATION_OF_...624,SET,8,-0.19586,-0.0040877,0.338,0.71886,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,0.99999
MIR548A_5P,SET,444,-0.024031,-0.0036918,0.041469,0.71887,MIR548A_5P,0.99999
GOMF_TRNA_BINDING,SET,62,-0.055884,-0.0032422,0.096421,0.7189,GOMF_TRNA_BINDING,0.99999
GOBP_POSITIVE_REGULATION_BY_...1,SET,10,-0.16052,-0.0037454,0.27686,0.71897,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,0.99999
GOBP_RENAL_PROTEIN_ABSORPTION,SET,9,-0.18538,-0.0041036,0.31974,0.71897,GOBP_RENAL_PROTEIN_ABSORPTION,0.99999
GSE29949_CD8_NEG_DC_SPLEEN_V...2,SET,176,-0.039001,-0.0038004,0.067268,0.71897,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP,0.99999
GOMF_DEUBIQUITINASE_ACTIVATO...,SET,7,-0.15116,-0.0029511,0.26069,0.71899,GOMF_DEUBIQUITINASE_ACTIVATOR_ACTIVITY,0.99999
GSE7460_CD8_TCELL_VS_CD4_TCE...1,SET,191,-0.036413,-0.0036948,0.062782,0.71904,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN,0.99999
MIR548AS_5P,SET,442,-0.024102,-0.0036945,0.04154,0.71911,MIR548AS_5P,0.99999
WIERENGA_STAT5A_TARGETS_GROU...2,SET,50,-0.076806,-0.0040029,0.1323,0.71922,WIERENGA_STAT5A_TARGETS_GROUP2,0.99999
HP_ULNAR_DEVIATION_OF_THE_HA...1,SET,27,-0.10125,-0.0038802,0.17438,0.71925,HP_ULNAR_DEVIATION_OF_THE_HAND,0.99999
APRELIKOVA_BRCA1_TARGETS,SET,42,-0.07403,-0.0035369,0.12741,0.71939,APRELIKOVA_BRCA1_TARGETS,0.99999
GOBP_RESPONSE_TO_LAMINAR_FLU...,SET,14,-0.1378,-0.0038039,0.23716,0.71939,GOBP_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS,0.99999
HP_PROGRESSIVE_VISUAL_LOSS,SET,92,-0.051338,-0.0036252,0.088333,0.71944,HP_PROGRESSIVE_VISUAL_LOSS,0.99999
GSE29618_BCELL_VS_MDC_DAY7_F...1,SET,183,-0.037946,-0.0037696,0.06529,0.71944,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN,0.99999
GOBP_INTRACELLULAR_AMINO_ACI...,SET,8,-0.18337,-0.003827,0.31548,0.71946,GOBP_INTRACELLULAR_AMINO_ACID_HOMEOSTASIS,0.99999
HP_ABNORMAL_RENAL_TUBULAR_RE...,SET,19,-0.11968,-0.0038483,0.20584,0.71953,HP_ABNORMAL_RENAL_TUBULAR_RESORPTION,0.99999
MODULE_259,SET,41,-0.083144,-0.0039249,0.14298,0.71955,MODULE_259,0.99999
GOCC_SYMMETRIC_SYNAPSE,SET,7,-0.19747,-0.0038552,0.33954,0.71957,GOCC_SYMMETRIC_SYNAPSE,0.99999
BROWNE_HCMV_INFECTION_1HR_DN,SET,186,-0.035362,-0.0035413,0.060772,0.71967,BROWNE_HCMV_INFECTION_1HR_DN,0.99999
HP_IMPAIRED_T_CELL_FUNCTION,SET,28,-0.093641,-0.0036543,0.16091,0.71969,HP_IMPAIRED_T_CELL_FUNCTION,0.99999
FARMER_BREAST_CANCER_CLUSTER...7,SET,19,-0.11316,-0.0036386,0.19437,0.71978,FARMER_BREAST_CANCER_CLUSTER_7,0.99999
LEE_AGING_MUSCLE_DN,SET,38,-0.081978,-0.0037258,0.14081,0.71978,LEE_AGING_MUSCLE_DN,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...10,SET,48,-0.070472,-0.0035988,0.12102,0.71982,GAVISH_3CA_METAPROGRAM_MACROPHAGES_PROTEASOMAL_DEGRADATION,0.99999
GOBP_REGULATION_OF_VASCULAR_...2,SET,14,-0.1386,-0.0038259,0.23801,0.71982,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.99999
MODULE_503,SET,103,-0.049344,-0.0036857,0.084734,0.71983,MODULE_503,0.99999
HP_DEFICIT_IN_GRAMMAR,SET,9,-0.1519,-0.0033624,0.26081,0.71984,HP_DEFICIT_IN_GRAMMAR,0.99999
MIR548AK_MIR548AM_5P_MIR548C...,SET,444,-0.02416,-0.0037115,0.041481,0.71985,MIR548AK_MIR548AM_5P_MIR548C_5P_MIR548H_5P_MIR548O_5P_MIR548AU_5P,0.99999
MIR548O_5P_MIR548W,SET,444,-0.02416,-0.0037115,0.041481,0.71985,MIR548O_5P_MIR548W,0.99999
KEGG_MEDICUS_PATHOGEN_HIV_GP...1,SET,12,-0.14298,-0.0036544,0.24547,0.71987,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,0.99999
KRIGE_RESPONSE_TO_TOSEDOSTAT...4,SET,793,-0.017904,-0.00364,0.030738,0.71988,KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP,0.99999
GCM_FANCC,SET,111,-0.045795,-0.0035501,0.078618,0.71988,GCM_FANCC,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_TH...7,SET,496,-0.021832,-0.0035397,0.037475,0.7199,HP_ABNORMAL_MORPHOLOGY_OF_THE_NASAL_ALAE,0.99999
MIR4726_5P,SET,89,-0.049688,-0.0034513,0.08529,0.71991,MIR4726_5P,0.99999
HP_AXILLARY_FRECKLING,SET,5,-0.20672,-0.0034112,0.35482,0.71992,HP_AXILLARY_FRECKLING,0.99999
PEDERSEN_TARGETS_OF_611CTF_I...,SET,68,-0.06663,-0.0040477,0.11435,0.71995,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,0.99999
KEGG_MEDICUS_REFERENCE_CXCR_...2,SET,26,-0.10609,-0.0039898,0.18202,0.72001,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,0.99999
GOBP_CELLULAR_EXTRAVASATION,SET,69,-0.065289,-0.0039952,0.11201,0.72002,GOBP_CELLULAR_EXTRAVASATION,0.99999
GOBP_TRABECULA_FORMATION,SET,27,-0.10353,-0.0039674,0.1776,0.72002,GOBP_TRABECULA_FORMATION,0.99999
MIR522_3P,SET,159,-0.039511,-0.0036611,0.067715,0.72021,MIR522_3P,0.99999
MATZUK_MALE_REPRODUCTION_SER...,SET,25,-0.097801,-0.0036067,0.16761,0.72022,MATZUK_MALE_REPRODUCTION_SERTOLI,0.99999
HP_ABNORMAL_VENA_CAVA_MORPHO...,SET,68,-0.060644,-0.003684,0.10393,0.72023,HP_ABNORMAL_VENA_CAVA_MORPHOLOGY,0.99999
GAO_LARGE_INTESTINE_ADULT_CG...,SET,42,-0.083406,-0.0039848,0.14292,0.72024,GAO_LARGE_INTESTINE_ADULT_CG_GOBLET_CELL_SUBTYPE_2,0.99999
GOBP_PYRIMIDINE_DEOXYRIBONUC...4,SET,6,-0.18677,-0.003376,0.32002,0.72026,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
GOMF_HISTONE_H3K36_METHYLTRA...,SET,11,-0.1373,-0.0033598,0.23522,0.72028,GOMF_HISTONE_H3K36_METHYLTRANSFERASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...235,SET,5,-0.25619,-0.0042274,0.43888,0.7203,GOBP_NEGATIVE_REGULATION_OF_FAT_CELL_PROLIFERATION,0.99999
GOMF_COMPLEMENT_COMPONENT_C1...,SET,7,-0.18522,-0.0036161,0.31715,0.72039,GOMF_COMPLEMENT_COMPONENT_C1Q_COMPLEX_BINDING,0.99999
HP_HYPERCOAGULABILITY,SET,15,-0.1369,-0.0039116,0.23437,0.72042,HP_HYPERCOAGULABILITY,0.99999
GSE27786_CD8_TCELL_VS_ERYTHR...1,SET,182,-0.038082,-0.0037729,0.065183,0.72046,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN,0.99999
HP_INCREASED_ARM_SPAN,SET,7,-0.16742,-0.0032686,0.28654,0.72048,HP_INCREASED_ARM_SPAN,0.99999
CEBP_C,SET,184,-0.037071,-0.0036927,0.063429,0.72053,CEBP_C,0.99999
HP_MONOCYTOPENIA,SET,5,-0.26963,-0.0044492,0.46125,0.72057,HP_MONOCYTOPENIA,0.99999
STEIN_ESRRA_TARGETS_RESPONSI...1,SET,39,-0.078536,-0.003616,0.13433,0.72061,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN,0.99999
GOBP_VASCULAR_ASSOCIATED_SMO...5,SET,57,-0.071128,-0.0039572,0.12166,0.72061,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.99999
HELLER_SILENCED_BY_METHYLATI...2,SET,237,-0.034409,-0.0038843,0.058848,0.72062,HELLER_SILENCED_BY_METHYLATION_UP,0.99999
MIR4262,SET,704,-0.019782,-0.0037989,0.03383,0.72064,MIR4262,0.99999
GSE6269_E_COLI_VS_STREP_PNEU...2,SET,145,-0.042996,-0.003806,0.073497,0.72072,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP,0.99999
GOMF_CXCR_CHEMOKINE_RECEPTOR...,SET,17,-0.15131,-0.0046022,0.25863,0.72073,GOMF_CXCR_CHEMOKINE_RECEPTOR_BINDING,0.99999
GSE16522_ANTI_CD3CD28_STIM_V...2,SET,186,-0.035638,-0.003569,0.060918,0.72073,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP,0.99999
HP_ALVEOLAR_CELL_CARCINOMA,SET,17,-0.12318,-0.0037467,0.21053,0.72075,HP_ALVEOLAR_CELL_CARCINOMA,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...5,SET,24,-0.10977,-0.0039664,0.18761,0.72076,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN,0.99999
ZFP28_TARGET_GENES,SET,69,-0.060854,-0.0037238,0.104,0.72077,ZFP28_TARGET_GENES,0.99999
HP_ULNAR_DEVIATION_OF_THE_HA...2,SET,58,-0.069718,-0.0039125,0.11913,0.7208,HP_ULNAR_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,0.99999
MIR4452,SET,148,-0.041371,-0.0036996,0.070678,0.72084,MIR4452,0.99999
HP_VOMITING,SET,301,-0.028769,-0.0036535,0.049129,0.72092,HP_VOMITING,0.99999
HOFMANN_MYELODYSPLASTIC_SYND...3,SET,24,-0.09773,-0.0035313,0.16687,0.72094,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN,0.99999
WP_AMPLIFICATION_AND_EXPANSI...,SET,17,-0.13624,-0.0041441,0.23264,0.72094,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,0.99999
MIR12136,SET,903,-0.017421,-0.0037674,0.02974,0.72098,MIR12136,0.99999
GOMF_ALPHA_ADRENERGIC_RECEPT...,SET,6,-0.22564,-0.0040786,0.38511,0.72103,GOMF_ALPHA_ADRENERGIC_RECEPTOR_ACTIVITY,0.99999
REACTOME_DEACTIVATION_OF_THE...,SET,38,-0.083632,-0.003801,0.14268,0.7211,REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX,0.99999
GOBP_BINDING_OF_SPERM_TO_ZON...,SET,38,-0.077923,-0.0035415,0.13294,0.7211,GOBP_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA,0.99999
GOBP_PLATELET_DERIVED_GROWTH...2,SET,14,-0.14076,-0.0038857,0.24014,0.72112,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...659,SET,10,-0.1658,-0.0038686,0.28279,0.72116,GOBP_POSITIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
REACTOME_NTRK2_ACTIVATES_RAC1,SET,5,-0.23106,-0.0038127,0.39407,0.72117,REACTOME_NTRK2_ACTIVATES_RAC1,0.99999
GOBP_FATTY_ACID_BETA_OXIDATI...3,SET,12,-0.1329,-0.0033967,0.22664,0.72119,GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_OXIDASE,0.99999
GOBP_NEURONAL_STEM_CELL_POPU...,SET,25,-0.098558,-0.0036346,0.16805,0.72121,GOBP_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE,0.99999
REACTOME_ACYL_CHAIN_REMODELL...3,SET,18,-0.12859,-0.0040245,0.21922,0.72126,REACTOME_ACYL_CHAIN_REMODELLING_OF_PG,0.99999
GOBP_GLAND_DEVELOPMENT,SET,427,-0.025843,-0.0038953,0.044053,0.72127,GOBP_GLAND_DEVELOPMENT,0.99999
HP_ABNORMALITY_OF_THE_UPPER_...3,SET,442,-0.024224,-0.0037132,0.041294,0.72127,HP_ABNORMALITY_OF_THE_UPPER_RESPIRATORY_TRACT,0.99999
GSE2585_THYMIC_DC_VS_THYMIC_...2,SET,158,-0.04051,-0.003742,0.069055,0.72127,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_UP,0.99999
HP_DEPRESSION,SET,380,-0.026025,-0.0037053,0.044353,0.72131,HP_DEPRESSION,0.99999
GSE14769_UNSTIM_VS_120MIN_LP...1,SET,194,-0.037224,-0.0038063,0.063438,0.72132,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN,0.99999
HP_ABNORMALITY_OF_HAIR_GROWTH,SET,29,-0.090066,-0.0035769,0.15346,0.72136,HP_ABNORMALITY_OF_HAIR_GROWTH,0.99999
GSE17721_CTRL_VS_CPG_24H_BMD...1,SET,182,-0.036229,-0.0035893,0.061723,0.72138,GSE17721_CTRL_VS_CPG_24H_BMDC_DN,0.99999
MIR4446_5P,SET,271,-0.031029,-0.0037421,0.052845,0.72145,MIR4446_5P,0.99999
chr3p21,SET,185,-0.078435,-0.007834,0.13357,0.72146,chr3p21,0.99999
HP_ABNORMAL_SHOULDER_PHYSIOL...,SET,12,-0.16022,-0.0040949,0.27284,0.72147,HP_ABNORMAL_SHOULDER_PHYSIOLOGY,0.99999
REACTOME_CHL1_INTERACTIONS,SET,8,-0.21083,-0.0044002,0.35892,0.72153,REACTOME_CHL1_INTERACTIONS,0.99999
GSE15659_CD45RA_NEG_CD4_TCEL...3,SET,172,-0.037641,-0.0036264,0.064082,0.72153,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,0.99999
MCLACHLAN_DENTAL_CARIES_DN,SET,70,-0.063789,-0.0039315,0.10856,0.72159,MCLACHLAN_DENTAL_CARIES_DN,0.99999
ALX4_TARGET_GENES,SET,23,-0.11729,-0.004149,0.19961,0.7216,ALX4_TARGET_GENES,0.99999
GOBP_NEPHRON_TUBULE_EPITHELI...,SET,13,-0.16529,-0.0043969,0.28124,0.72163,GOBP_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
BIOCARTA_RAS_PATHWAY,SET,20,-0.1139,-0.0037573,0.19379,0.72164,BIOCARTA_RAS_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...374,SET,10,-0.15949,-0.0037213,0.27128,0.7217,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...77,SET,70,-0.060791,-0.0037467,0.1034,0.72171,HP_APLASIA_HYPOPLASIA_OF_THE_UTERUS,0.99999
GOBP_RESPONSE_TO_ANGIOTENSIN,SET,38,-0.0908,-0.0041268,0.15441,0.72174,GOBP_RESPONSE_TO_ANGIOTENSIN,0.99999
HP_DYSKINESIA,SET,172,-0.037276,-0.0035912,0.063392,0.72174,HP_DYSKINESIA,0.99999
HP_OLIGOSACCHARIDURIA,SET,9,-0.16261,-0.0035996,0.27651,0.72176,HP_OLIGOSACCHARIDURIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...588,SET,24,-0.10487,-0.0037891,0.17826,0.72182,GOBP_NEGATIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...79,SET,6,-0.22096,-0.003994,0.37559,0.72183,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,0.99999
HP_SOFT_TISSUE_NEOPLASM,SET,5,-0.26005,-0.0042911,0.44198,0.72185,HP_SOFT_TISSUE_NEOPLASM,0.99999
REACTOME_NF_KB_IS_ACTIVATED_...,SET,11,-0.15722,-0.0038473,0.26717,0.72188,REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL,0.99999
GOBP_REGULATION_OF_EPIDERMAL...,SET,15,-0.12468,-0.0035624,0.21183,0.72192,GOBP_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY,0.99999
GOBP_REGULATION_OF_CELLULAR_...10,SET,285,-0.031438,-0.0038866,0.053411,0.72193,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,0.99999
ZHONG_PFC_MAJOR_TYPES_ASTROC...,SET,298,-0.031378,-0.0039652,0.053284,0.72202,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,0.99999
RAO_BOUND_BY_SALL4,SET,205,-0.035948,-0.0037775,0.061031,0.72207,RAO_BOUND_BY_SALL4,0.99999
REACTOME_ACTIVATION_OF_RAC1,SET,11,-0.14885,-0.0036424,0.2527,0.72208,REACTOME_ACTIVATION_OF_RAC1,0.99999
GOMF_TRANSCRIPTION_COACTIVAT...1,SET,250,-0.030499,-0.0035348,0.051767,0.72212,GOMF_TRANSCRIPTION_COACTIVATOR_ACTIVITY,0.99999
GOMF_LACTATE_DEHYDROGENASE_A...,SET,6,-0.26701,-0.0048264,0.45303,0.7222,GOMF_LACTATE_DEHYDROGENASE_ACTIVITY,0.99999
HERNANDEZ_ABERRANT_MITOSIS_B...3,SET,5,-0.26976,-0.0044514,0.45764,0.72222,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN,0.99999
GOBP_AXON_DEVELOPMENT,SET,469,-0.024959,-0.0039381,0.042333,0.72226,GOBP_AXON_DEVELOPMENT,0.99999
WANG_TUMOR_INVASIVENESS_DN,SET,192,-0.036042,-0.0036667,0.06113,0.72227,WANG_TUMOR_INVASIVENESS_DN,0.99999
GSE360_L_MAJOR_VS_M_TUBERCUL...1,SET,168,-0.039357,-0.0037477,0.066752,0.72227,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN,0.99999
GOBP_SPERM_EGG_RECOGNITION,SET,49,-0.070277,-0.0036259,0.11914,0.72236,GOBP_SPERM_EGG_RECOGNITION,0.99999
GOBP_ADENYLATE_CYCLASE_ACTIV...1,SET,23,-0.11442,-0.0040476,0.19396,0.72238,GOBP_ADENYLATE_CYCLASE_ACTIVATING_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,0.99999
CROONQUIST_IL6_DEPRIVATION_DN,SET,91,-0.048755,-0.0034241,0.082636,0.7224,CROONQUIST_IL6_DEPRIVATION_DN,0.99999
HP_DUODENAL_ATRESIA,SET,39,-0.086075,-0.0039631,0.14583,0.72249,HP_DUODENAL_ATRESIA,0.99999
REACTOME_ABC_TRANSPORTERS_IN...,SET,17,-0.12829,-0.0039022,0.21732,0.72252,REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...151,SET,5,-0.23529,-0.0038826,0.39847,0.72257,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...103,SET,5,-0.22917,-0.0037816,0.38803,0.7226,GOBP_POSITIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
GSE22611_NOD2_TRANSD_VS_CTRL...2,SET,163,-0.038797,-0.0036395,0.06569,0.7226,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP,0.99999
KEGG_MEDICUS_REFERENCE_NLRP1...,SET,4,-0.2192,-0.0032353,0.37113,0.72261,KEGG_MEDICUS_REFERENCE_NLRP1_INFLAMMASOME_SIGNALING_PATHWAY,0.99999
HP_MALAR_RASH,SET,29,-0.10031,-0.0039836,0.16983,0.72261,HP_MALAR_RASH,0.99999
GSE339_CD4POS_VS_CD4CD8DN_DC...4,SET,187,-0.035383,-0.0035529,0.059909,0.72261,GSE339_CD4POS_VS_CD4CD8DN_DC_UP,0.99999
GSE2770_UNTREATED_VS_TGFB_AN...1,SET,177,-0.038166,-0.0037295,0.064562,0.72279,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.99999
HP_APLASTIC_CLAVICLE,SET,16,-0.11029,-0.0032546,0.1865,0.72286,HP_APLASTIC_CLAVICLE,0.99999
GOBP_POSITIVE_REGULATION_OF_...234,SET,142,-0.044612,-0.0039084,0.075433,0.72287,GOBP_POSITIVE_REGULATION_OF_ENDOCYTOSIS,0.99999
GOBP_REGULATION_OF_GLYCOGEN_...3,SET,31,-0.091518,-0.0037576,0.15474,0.72288,GOBP_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,0.99999
GOCC_COLLAGEN_TRIMER,SET,83,-0.063406,-0.0042538,0.10719,0.72291,GOCC_COLLAGEN_TRIMER,0.99999
MIR197_3P,SET,90,-0.051265,-0.0035807,0.086652,0.72294,MIR197_3P,0.99999
GOMF_PROLINE_RICH_REGION_BIN...,SET,16,-0.13731,-0.0040521,0.23205,0.72299,GOMF_PROLINE_RICH_REGION_BINDING,0.99999
GSE43955_10H_VS_30H_ACT_CD4_...3,SET,182,-0.038507,-0.0038151,0.06506,0.72303,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.99999
REACTOME_BICARBONATE_TRANSPO...,SET,10,-0.15343,-0.0035799,0.25921,0.72304,REACTOME_BICARBONATE_TRANSPORTERS,0.99999
MIR542_3P,SET,125,-0.046452,-0.00382,0.078472,0.72306,MIR542_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...108,SET,351,-0.026629,-0.0036468,0.044972,0.72311,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE,0.99999
MIR6765_5P,SET,7,-0.18264,-0.0035657,0.30836,0.72316,MIR6765_5P,0.99999
REACTOME_REGULATION_OF_INNAT...,SET,13,-0.14477,-0.0038511,0.24431,0.72326,REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA,0.99999
GSE15930_STIM_VS_STIM_AND_IL...4,SET,186,-0.036013,-0.0036065,0.060774,0.72326,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_UP,0.99999
PAX8_01,SET,33,-0.088031,-0.003729,0.14855,0.72327,PAX8_01,0.99999
GOBP_POSITIVE_REGULATION_OF_...186,SET,76,-0.060101,-0.003859,0.10141,0.72328,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
GOBP_TUBE_FORMATION,SET,144,-0.042577,-0.0037561,0.071828,0.72333,GOBP_TUBE_FORMATION,0.99999
BUSSLINGER_DUODENAL_DIFFEREN...,SET,266,-0.030562,-0.0036521,0.051548,0.72337,BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS,0.99999
KEGG_MEDICUS_REFERENCE_ELECT...3,SET,14,-0.12422,-0.0034291,0.20948,0.7234,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_IV,0.99999
REACTOME_GABA_B_RECEPTOR_ACT...,SET,43,-0.085184,-0.0041179,0.14363,0.72343,REACTOME_GABA_B_RECEPTOR_ACTIVATION,0.99999
MIR216A_3P,SET,409,-0.026196,-0.0038663,0.04417,0.72343,MIR216A_3P,0.99999
GOBP_RESPONSE_TO_GRANULOCYTE...,SET,9,-0.18139,-0.0040154,0.30586,0.72343,GOBP_RESPONSE_TO_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR,0.99999
MULLIGHAN_NPM1_SIGNATURE_3_UP,SET,290,-0.029249,-0.0036471,0.049312,0.72345,MULLIGHAN_NPM1_SIGNATURE_3_UP,0.99999
REACTOME_P130CAS_LINKAGE_TO_...,SET,15,-0.14903,-0.0042581,0.25122,0.72348,REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,0.99999
GOBP_IMMUNE_SYSTEM_DEVELOPME...,SET,181,-0.037482,-0.0037033,0.063183,0.72348,GOBP_IMMUNE_SYSTEM_DEVELOPMENT,0.99999
GSE1432_6H_VS_24H_IFNG_MICRO...1,SET,179,-0.035641,-0.0035022,0.060082,0.72348,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.99999
GOCC_NEUROMUSCULAR_JUNCTION,SET,70,-0.060203,-0.0037105,0.10148,0.7235,GOCC_NEUROMUSCULAR_JUNCTION,0.99999
GOBP_REGULATION_OF_DOUBLE_ST...1,SET,119,-0.04381,-0.0035157,0.073835,0.72352,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_PRO...1,SET,258,-0.030568,-0.0035982,0.051514,0.72354,HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL,0.99999
BIOCARTA_ACETAMINOPHEN_PATHW...,SET,5,-0.24794,-0.0040912,0.41779,0.72356,BIOCARTA_ACETAMINOPHEN_PATHWAY,0.99999
GOCC_LAMELLAR_BODY,SET,18,-0.13255,-0.0041485,0.22335,0.72356,GOCC_LAMELLAR_BODY,0.99999
KEGG_MEDICUS_REFERENCE_BLOOD...2,SET,7,-0.21315,-0.0041614,0.35913,0.72358,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_2_BIOSYNTHESIS,0.99999
HP_VERY_LOW_VISUAL_ACUITY,SET,5,-0.25074,-0.0041375,0.42239,0.72361,HP_VERY_LOW_VISUAL_ACUITY,0.99999
HP_PHARYNGITIS,SET,15,-0.14282,-0.0040809,0.24058,0.72363,HP_PHARYNGITIS,0.99999
TTGGGAG_MIR150,SET,82,-0.053821,-0.003589,0.090647,0.72365,TTGGGAG_MIR150,0.99999
NOUZOVA_TRETINOIN_AND_H4_ACE...,SET,122,-0.042599,-0.0034611,0.071739,0.72367,NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...40,SET,6,-0.21218,-0.0038354,0.35727,0.72371,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_AUTOPHAGY_VESICLE_NUCLEATION,0.99999
GOBP_DENSE_CORE_GRANULE_EXOC...,SET,10,-0.17818,-0.0041575,0.29999,0.72373,GOBP_DENSE_CORE_GRANULE_EXOCYTOSIS,0.99999
GSE17721_12H_VS_24H_CPG_BMDC...1,SET,178,-0.036536,-0.0035802,0.061508,0.72374,GSE17721_12H_VS_24H_CPG_BMDC_DN,0.99999
GSE20366_TREG_VS_NAIVE_CD4_T...1,SET,182,-0.038287,-0.0037933,0.064452,0.72375,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN,0.99999
REACTOME_BH3_ONLY_PROTEINS_A...,SET,9,-0.19728,-0.004367,0.33202,0.7238,REACTOME_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS,0.99999
GOBP_RRNA_TRANSCRIPTION,SET,33,-0.082298,-0.0034861,0.13849,0.72383,GOBP_RRNA_TRANSCRIPTION,0.99999
JONES_OVARY_GRANULOSA,SET,69,-0.063564,-0.0038896,0.10694,0.72386,JONES_OVARY_GRANULOSA,0.99999
GOBP_IMMUNOGLOBULIN_V_D_J_RE...,SET,7,-0.15672,-0.0030597,0.26363,0.7239,GOBP_IMMUNOGLOBULIN_V_D_J_RECOMBINATION,0.99999
HP_LONG_HALLUX,SET,20,-0.11311,-0.0037312,0.19026,0.7239,HP_LONG_HALLUX,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...2,SET,317,-0.029396,-0.0038293,0.049426,0.72399,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_LOWER_LIMBS,0.99999
GOBP_NEUROBLAST_DIFFERENTIAT...,SET,6,-0.26347,-0.0047624,0.44297,0.724,GOBP_NEUROBLAST_DIFFERENTIATION,0.99999
HP_ABNORMAL_ANTERIOR_HORN_CE...,SET,18,-0.1166,-0.0036491,0.19596,0.72407,HP_ABNORMAL_ANTERIOR_HORN_CELL_MORPHOLOGY,0.99999
GOBP_CORTICOSTERONE_SECRETION,SET,5,-0.25878,-0.0042702,0.43491,0.72409,GOBP_CORTICOSTERONE_SECRETION,0.99999
SASSON_RESPONSE_TO_GONADOTRO...2,SET,76,-0.057351,-0.0036825,0.096376,0.7241,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,0.99999
WIERENGA_PML_INTERACTOME,SET,38,-0.079713,-0.0036229,0.13394,0.72412,WIERENGA_PML_INTERACTOME,0.99999
HP_REDUCED_FEV1_FVC_RATIO,SET,7,-0.19726,-0.0038512,0.33142,0.72414,HP_REDUCED_FEV1_FVC_RATIO,0.99999
WP_PAFAH1B1_COPY_NUMBER_VARI...,SET,10,-0.14026,-0.0032726,0.23564,0.72415,WP_PAFAH1B1_COPY_NUMBER_VARIATION,0.99999
REACTOME_SARS_COV_1_TARGETS_...,SET,16,-0.13443,-0.003967,0.22578,0.72421,REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS,0.99999
HP_ACUTE_MYELOID_LEUKEMIA,SET,68,-0.063042,-0.0038297,0.10587,0.72422,HP_ACUTE_MYELOID_LEUKEMIA,0.99999
DESCARTES_FETAL_SPLEEN_STROM...,SET,31,-0.10546,-0.0043302,0.17712,0.72422,DESCARTES_FETAL_SPLEEN_STROMAL_CELLS,0.99999
HP_CUTIS_MARMORATA,SET,60,-0.067817,-0.0038707,0.11388,0.72424,HP_CUTIS_MARMORATA,0.99999
GSE7459_UNTREATED_VS_IL6_TRE...2,SET,117,-0.04785,-0.0038078,0.080343,0.72426,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_UP,0.99999
REACTOME_TRYPTOPHAN_CATABOLI...,SET,12,-0.1541,-0.0039385,0.25874,0.72427,REACTOME_TRYPTOPHAN_CATABOLISM,0.99999
GOBP_RENAL_RESPONSE_TO_BLOOD...,SET,7,-0.23783,-0.0046432,0.39918,0.72434,GOBP_RENAL_RESPONSE_TO_BLOOD_FLOW_INVOLVED_IN_CIRCULATORY_RENIN_ANGIOTENSIN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.99999
GSE40277_EOS_AND_LEF1_TRANSD...1,SET,188,-0.036923,-0.0037173,0.061961,0.72438,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,0.99999
RFX1_02,SET,252,-0.031444,-0.0036587,0.052764,0.72439,RFX1_02,0.99999
GOBP_ORGANONITROGEN_COMPOUND...1,SET,1501,-0.013513,-0.0037025,0.022672,0.72441,GOBP_ORGANONITROGEN_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
HORIUCHI_WTAP_TARGETS_DN,SET,284,-0.029684,-0.0036634,0.049803,0.72442,HORIUCHI_WTAP_TARGETS_DN,0.99999
HP_DILATATED_INTERNAL_AUDITO...,SET,3,-0.36812,-0.0047054,0.61751,0.72445,HP_DILATATED_INTERNAL_AUDITORY_CANAL,0.99999
GOBP_MRNA_3_END_PROCESSING_B...,SET,6,-0.17534,-0.0031693,0.29412,0.72446,GOBP_MRNA_3_END_PROCESSING_BY_STEM_LOOP_BINDING_AND_CLEAVAGE,0.99999
MIR3929,SET,73,-0.056916,-0.0035819,0.095446,0.72451,MIR3929,0.99999
GSE17721_0.5H_VS_12H_GARDIQU...1,SET,189,-0.036695,-0.0037041,0.061526,0.72455,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN,0.99999
GSE339_EX_VIVO_VS_IN_CULTURE...6,SET,182,-0.03625,-0.0035914,0.060775,0.72456,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP,0.99999
PUJANA_ATM_PCC_NETWORK,SET,1242,-0.014506,-0.0036431,0.024313,0.72462,PUJANA_ATM_PCC_NETWORK,0.99999
KEGG_MEDICUS_REFERENCE_EXTRI...,SET,10,-0.16045,-0.0037438,0.26892,0.72463,KEGG_MEDICUS_REFERENCE_EXTRINSIC_APOPTOTIC_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...421,SET,12,-0.15601,-0.0039873,0.26143,0.72466,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,0.99999
HP_SMALL_PITUITARY_GLAND,SET,12,-0.15625,-0.0039934,0.26179,0.72469,HP_SMALL_PITUITARY_GLAND,0.99999
HP_NON_MOTOR_SEIZURE,SET,174,-0.038459,-0.0037264,0.064427,0.72472,HP_NON_MOTOR_SEIZURE,0.99999
GOBP_L_SERINE_CATABOLIC_PROC...,SET,3,-0.26513,-0.003389,0.4441,0.72474,GOBP_L_SERINE_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_LAMELLIPO...2,SET,11,-0.14925,-0.0036523,0.25001,0.72474,GOBP_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...8,SET,187,-0.036602,-0.0036752,0.06129,0.7248,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_UP,0.99999
GSE9946_IMMATURE_VS_PROSTAGL...1,SET,124,-0.045891,-0.0037588,0.076829,0.72485,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,0.99999
TURASHVILI_BREAST_LOBULAR_CA...1,SET,81,-0.060462,-0.0040073,0.10119,0.72491,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,0.99999
GSE29949_MICROGLIA_BRAIN_VS_...4,SET,180,-0.039161,-0.0038587,0.065528,0.72495,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.99999
LAKE_ADULT_KIDNEY_C19_COLLEC...,SET,288,-0.029686,-0.0036889,0.04967,0.72496,LAKE_ADULT_KIDNEY_C19_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_MEDULLA,0.99999
HP_DEVELOPMENTAL_STAGNATION,SET,16,-0.13517,-0.0039887,0.22615,0.72498,HP_DEVELOPMENTAL_STAGNATION,0.99999
HNF3ALPHA_Q6,SET,184,-0.038558,-0.0038408,0.064504,0.725,HNF3ALPHA_Q6,0.99999
GSE15330_LYMPHOID_MULTIPOTEN...2,SET,187,-0.036512,-0.0036663,0.061081,0.725,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.99999
MODULE_38,SET,422,-0.02614,-0.0039174,0.043726,0.72501,MODULE_38,0.99999
GOCC_DOPAMINERGIC_SYNAPSE,SET,13,-0.13893,-0.0036956,0.23229,0.7251,GOCC_DOPAMINERGIC_SYNAPSE,0.99999
GSE3982_MAST_CELL_VS_NEUTROP...2,SET,180,-0.035163,-0.0034648,0.058789,0.72512,GSE3982_MAST_CELL_VS_NEUTROPHIL_UP,0.99999
GNF2_SPTA1,SET,69,-0.061957,-0.0037913,0.10357,0.72515,GNF2_SPTA1,0.99999
GSE42021_CD24HI_VS_CD24LOW_T...2,SET,178,-0.039276,-0.0038487,0.06565,0.72516,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP,0.99999
GOBP_REGULATION_OF_RNA_EXPOR...,SET,14,-0.11328,-0.003127,0.18932,0.72518,GOBP_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS,0.99999
HP_ACUTE_LEUKEMIA,SET,110,-0.050108,-0.0038671,0.083731,0.72523,HP_ACUTE_LEUKEMIA,0.99999
MIR224_3P,SET,160,-0.040473,-0.0037619,0.067614,0.72527,MIR224_3P,0.99999
GSE22886_DAY0_VS_DAY1_MONOCY...1,SET,185,-0.038369,-0.0038322,0.064089,0.7253,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN,0.99999
GOBP_TRNA_TRANSPORT,SET,6,-0.16979,-0.003069,0.28354,0.72535,GOBP_TRNA_TRANSPORT,0.99999
HAN_JNK_SINGALING_UP,SET,34,-0.093212,-0.0040077,0.15565,0.72536,HAN_JNK_SINGALING_UP,0.99999
HAY_BONE_MARROW_CD34_POS_GRAN,SET,24,-0.10836,-0.0039153,0.18092,0.72538,HAY_BONE_MARROW_CD34_POS_GRAN,0.99999
MIR3120_5P,SET,77,-0.057244,-0.0036996,0.095572,0.7254,MIR3120_5P,0.99999
HP_INTERMITTENT_JAUNDICE,SET,9,-0.17693,-0.0039166,0.29539,0.7254,HP_INTERMITTENT_JAUNDICE,0.99999
SCHERER_PBMC_APSV_WETVAX_AGE...4,SET,156,-0.04308,-0.0039543,0.071923,0.7254,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP,0.99999
GRABARCZYK_BCL11B_TARGETS_UP,SET,68,-0.061,-0.0037056,0.10183,0.72543,GRABARCZYK_BCL11B_TARGETS_UP,0.99999
HP_SARCOMA,SET,167,-0.039714,-0.0037705,0.066271,0.7255,HP_SARCOMA,0.99999
KEGG_PROTEASOME,SET,43,-0.06803,-0.0032886,0.1135,0.72553,KEGG_PROTEASOME,0.99999
GSE27786_NKTCELL_VS_ERYTHROB...1,SET,186,-0.03777,-0.0037825,0.06301,0.72555,GSE27786_NKTCELL_VS_ERYTHROBLAST_DN,0.99999
HP_ASTERIXIS,SET,5,-0.25697,-0.0042403,0.42863,0.72558,HP_ASTERIXIS,0.99999
GOCC_PROTEIN_COMPLEX_INVOLVE...3,SET,17,-0.12585,-0.0038279,0.2099,0.72559,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_MATRIX_ADHESION,0.99999
MIR10392_3P,SET,5,-0.20756,-0.0034249,0.34608,0.72565,MIR10392_3P,0.99999
GSE35543_IN_VIVO_NTREG_VS_CO...2,SET,157,-0.0395,-0.0036372,0.06586,0.72566,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_UP,0.99999
GOMF_CALCIUM_DEPENDENT_CYSTE...,SET,15,-0.14935,-0.0042675,0.249,0.72569,GOMF_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.99999
GSE45365_NK_CELL_VS_BCELL_MC...1,SET,171,-0.040229,-0.0038645,0.067061,0.7257,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...495,SET,1503,-0.014346,-0.0039332,0.02391,0.72574,GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS,0.99999
GSE29614_CTRL_VS_TIV_FLU_VAC...1,SET,152,-0.042079,-0.003813,0.070127,0.72576,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...706,SET,10,-0.17948,-0.0041877,0.29898,0.72584,GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.99999
GOBP_REGULATION_OF_CYSTEINE_...4,SET,5,-0.21203,-0.0034988,0.35322,0.72584,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,0.99999
GOBP_CELLULAR_RESPONSE_TO_VI...3,SET,19,-0.12554,-0.0040367,0.2091,0.72587,GOBP_CELLULAR_RESPONSE_TO_VITAMIN_D,0.99999
GSE18893_TCONV_VS_TREG_2H_TN...2,SET,185,-0.037371,-0.0037326,0.062242,0.72588,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP,0.99999
REACTOME_ASPARTATE_AND_ASPAR...,SET,11,-0.1509,-0.0036928,0.25131,0.7259,REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM,0.99999
GSE14415_NATURAL_TREG_VS_TCO...2,SET,146,-0.043186,-0.003836,0.071917,0.72591,GSE14415_NATURAL_TREG_VS_TCONV_UP,0.99999
GOBP_MATERNAL_PLACENTA_DEVEL...,SET,33,-0.090964,-0.0038532,0.15147,0.72593,GOBP_MATERNAL_PLACENTA_DEVELOPMENT,0.99999
GOBP_T_CELL_EXTRAVASATION,SET,11,-0.1634,-0.0039985,0.27207,0.72593,GOBP_T_CELL_EXTRAVASATION,0.99999
GSE13306_RA_VS_UNTREATED_TRE...2,SET,173,-0.038272,-0.0036978,0.063723,0.72594,GSE13306_RA_VS_UNTREATED_TREG_UP,0.99999
REACTOME_CREB_PHOSPHORYLATION,SET,6,-0.24271,-0.0043872,0.40402,0.72599,REACTOME_CREB_PHOSPHORYLATION,0.99999
GSE40274_CTRL_VS_SATB1_TRANS...1,SET,151,-0.040817,-0.0036866,0.067894,0.72614,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
GOCC_SMALL_RIBOSOMAL_SUBUNIT,SET,66,-0.059914,-0.0035859,0.099655,0.72615,GOCC_SMALL_RIBOSOMAL_SUBUNIT,0.99999
GOBP_MAMMARY_GLAND_BRANCHING...,SET,6,-0.24359,-0.004403,0.4051,0.72618,GOBP_MAMMARY_GLAND_BRANCHING_INVOLVED_IN_PREGNANCY,0.99999
HP_ABNORMAL_SEMICIRCULAR_CAN...,SET,21,-0.10335,-0.0034936,0.17187,0.7262,HP_ABNORMAL_SEMICIRCULAR_CANAL_MORPHOLOGY,0.99999
BIOCARTA_RANBP2_PATHWAY,SET,10,-0.16858,-0.0039335,0.28031,0.72621,BIOCARTA_RANBP2_PATHWAY,0.99999
GOBP_ESTABLISHMENT_OF_GOLGI_...,SET,6,-0.22153,-0.0040043,0.36832,0.72623,GOBP_ESTABLISHMENT_OF_GOLGI_LOCALIZATION,0.99999
HP_ABNORMALITY_OF_THE_VESTIB...,SET,9,-0.17377,-0.0038466,0.28889,0.72625,HP_ABNORMALITY_OF_THE_VESTIBULOCOCHLEAR_NERVE,0.99999
MIR10393_5P,SET,135,-0.0445,-0.003802,0.073972,0.72627,MIR10393_5P,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...19,SET,119,-0.045824,-0.0036774,0.076168,0.72628,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_CILIATED_CELLS,0.99999
HP_2_HYDROXYGLUTARATE_ACIDUR...,SET,5,-0.21759,-0.0035905,0.36166,0.72629,HP_2_HYDROXYGLUTARATE_ACIDURIA,0.99999
HP_POOR_SPEECH,SET,167,-0.038335,-0.0036397,0.063704,0.72634,HP_POOR_SPEECH,0.99999
BIOCARTA_RARRXR_PATHWAY,SET,7,-0.17817,-0.0034785,0.29606,0.72635,BIOCARTA_RARRXR_PATHWAY,0.99999
HP_RESPIRATORY_ARREST,SET,27,-0.10311,-0.0039516,0.17134,0.72635,HP_RESPIRATORY_ARREST,0.99999
DESCARTES_FETAL_CEREBELLUM_M...,SET,487,-0.02535,-0.0040737,0.042118,0.72637,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,0.99999
ZMYM2_TARGET_GENES,SET,109,-0.050353,-0.0038684,0.083655,0.72638,ZMYM2_TARGET_GENES,0.99999
HP_PUBERTY_AND_GONADAL_DISOR...,SET,561,-0.021783,-0.0037493,0.036172,0.72648,HP_PUBERTY_AND_GONADAL_DISORDERS,0.99999
REACTOME_SYNTHESIS_OF_BILE_A...3,SET,14,-0.16642,-0.0045939,0.27629,0.72652,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL,0.99999
CAFFAREL_RESPONSE_TO_THC_8HR...1,SET,9,-0.14497,-0.0032092,0.24065,0.72655,CAFFAREL_RESPONSE_TO_THC_8HR_3_DN,0.99999
MIR7515,SET,142,-0.042857,-0.0037546,0.07114,0.72655,MIR7515,0.99999
KEGG_LONG_TERM_DEPRESSION,SET,66,-0.067465,-0.0040379,0.11198,0.72657,KEGG_LONG_TERM_DEPRESSION,0.99999
HP_REDUCED_VISUAL_ACUITY,SET,518,-0.022745,-0.0037663,0.037749,0.72658,HP_REDUCED_VISUAL_ACUITY,0.99999
GSE37605_C57BL6_VS_NOD_FOXP3...1,SET,169,-0.03834,-0.0036616,0.063618,0.72663,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN,0.99999
GSE3920_UNTREATED_VS_IFNG_TR...3,SET,166,-0.041078,-0.0038884,0.068159,0.72663,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN,0.99999
GSE27859_CD11C_INT_F480_HI_M...2,SET,159,-0.039536,-0.0036635,0.065578,0.7267,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_UP,0.99999
HP_PENETRATING_FOOT_ULCERS,SET,6,-0.2012,-0.0036369,0.33372,0.72671,HP_PENETRATING_FOOT_ULCERS,0.99999
HP_EXCESSIVE_DAYTIME_SOMNOLE...,SET,64,-0.063697,-0.0037544,0.10563,0.72674,HP_EXCESSIVE_DAYTIME_SOMNOLENCE,0.99999
BUSSLINGER_GASTRIC_IMMATURE_...,SET,156,-0.04339,-0.0039828,0.071947,0.72677,BUSSLINGER_GASTRIC_IMMATURE_PIT_CELLS,0.99999
HP_PERSONALITY_CHANGES,SET,32,-0.088749,-0.0037021,0.14712,0.72682,HP_PERSONALITY_CHANGES,0.99999
HP_ABNORMAL_RESPONSE_TO_ACTH...,SET,6,-0.21688,-0.0039202,0.35943,0.72687,HP_ABNORMAL_RESPONSE_TO_ACTH_STIMULATION_TEST,0.99999
chr9q34,SET,182,-0.067452,-0.0066827,0.11177,0.7269,chr9q34,0.99999
GSE5679_CTRL_VS_PPARG_LIGAND...4,SET,179,-0.035538,-0.0034921,0.05889,0.7269,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP,0.99999
HP_INCREASED_CIRCULATING_FRE...,SET,5,-0.19415,-0.0032036,0.32164,0.72695,HP_INCREASED_CIRCULATING_FREE_FATTY_ACID_LEVEL,0.99999
HP_ABNORMAL_MYELINATION,SET,539,-0.021496,-0.0036289,0.035608,0.72698,HP_ABNORMAL_MYELINATION,0.99999
GNF2_RFC4,SET,57,-0.059946,-0.0033351,0.099289,0.72699,GNF2_RFC4,0.99999
GOMF_ACTIN_MONOMER_BINDING,SET,21,-0.11187,-0.0037814,0.18528,0.727,GOMF_ACTIN_MONOMER_BINDING,0.99999
HP_ABSENT_OUTER_DYNEIN_ARMS,SET,9,-0.16054,-0.0035536,0.26589,0.727,HP_ABSENT_OUTER_DYNEIN_ARMS,0.99999
REACTOME_SLC_TRANSPORTER_DIS...,SET,92,-0.054669,-0.0038604,0.090534,0.72702,REACTOME_SLC_TRANSPORTER_DISORDERS,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_VEN...,SET,76,-0.062267,-0.0039981,0.1031,0.72705,HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL,0.99999
GOBP_REGULATION_OF_VITAMIN_D...2,SET,10,-0.15781,-0.0036822,0.26127,0.72708,GOBP_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE28737_WT_VS_BCL6_KO_MARGI...2,SET,178,-0.038375,-0.0037603,0.063511,0.72715,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,0.99999
MIR4537,SET,6,-0.21875,-0.003954,0.362,0.72717,MIR4537,0.99999
BIOCARTA_AKT_PATHWAY,SET,20,-0.11479,-0.0037869,0.18996,0.72718,BIOCARTA_AKT_PATHWAY,0.99999
KEGG_PRIMARY_IMMUNODEFICIENCY,SET,30,-0.10546,-0.0042598,0.17452,0.72718,KEGG_PRIMARY_IMMUNODEFICIENCY,0.99999
REACTOME_P75_NTR_RECEPTOR_ME...,SET,87,-0.055721,-0.0038268,0.092199,0.72719,REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,0.99999
GOBP_MECHANOSENSORY_BEHAVIOR,SET,14,-0.15166,-0.0041866,0.25093,0.72721,GOBP_MECHANOSENSORY_BEHAVIOR,0.99999
GOCC_MYELIN_SHEATH_ABAXONAL_...,SET,6,-0.19873,-0.0035921,0.3288,0.72721,GOCC_MYELIN_SHEATH_ABAXONAL_REGION,0.99999
GSE2826_WT_VS_XID_BCELL_UP,SET,183,-0.037631,-0.0037384,0.06226,0.72722,GSE2826_WT_VS_XID_BCELL_UP,0.99999
MORF_UNG,SET,65,-0.05818,-0.0034558,0.09625,0.72723,MORF_UNG,0.99999
HP_HYPERTONIA,SET,975,-0.016447,-0.0036883,0.027204,0.72727,HP_HYPERTONIA,0.99999
GSE17721_CTRL_VS_POLYIC_24H_...1,SET,186,-0.03806,-0.0038115,0.062953,0.72727,GSE17721_CTRL_VS_POLYIC_24H_BMDC_DN,0.99999
REACTOME_CLEC7A_DECTIN_1_IND...,SET,11,-0.14339,-0.0035088,0.23714,0.72729,REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION,0.99999
MIR3913_3P,SET,73,-0.062662,-0.0039435,0.10362,0.72732,MIR3913_3P,0.99999
GOBP_TOLL_LIKE_RECEPTOR_9_SI...,SET,18,-0.12234,-0.0038289,0.20229,0.72733,GOBP_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.99999
GSE21546_WT_VS_ELK1_KO_ANTI_...2,SET,183,-0.037868,-0.0037619,0.062598,0.72739,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.99999
HP_CEREBELLAR_HEMISPHERE_HYP...,SET,8,-0.16171,-0.003375,0.26729,0.7274,HP_CEREBELLAR_HEMISPHERE_HYPOPLASIA,0.99999
GSE29618_BCELL_VS_MDC_DAY7_F...2,SET,169,-0.041721,-0.0039846,0.068934,0.72749,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...6,SET,15,-0.13733,-0.003924,0.22688,0.72751,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_NK_T_CELL...2,SET,6,-0.24232,-0.0043801,0.40033,0.72751,GOBP_REGULATION_OF_NK_T_CELL_DIFFERENTIATION,0.99999
DESCARTES_MAIN_FETAL_AFP_ALB...,SET,77,-0.058472,-0.0037789,0.096578,0.72755,DESCARTES_MAIN_FETAL_AFP_ALB_POSITIVE_CELLS,0.99999
GOMF_RDNA_BINDING,SET,8,-0.16083,-0.0033567,0.26562,0.72757,GOMF_RDNA_BINDING,0.99999
HP_METAPHYSEAL_SCLEROSIS,SET,12,-0.16382,-0.0041871,0.27056,0.72757,HP_METAPHYSEAL_SCLEROSIS,0.99999
HP_HYPOPLASIA_OF_THE_PONS,SET,82,-0.054812,-0.0036551,0.090484,0.72766,HP_HYPOPLASIA_OF_THE_PONS,0.99999
KEGG_MEDICUS_PATHOGEN_EBV_EB...2,SET,7,-0.19415,-0.0037905,0.32049,0.72767,KEGG_MEDICUS_PATHOGEN_EBV_EBNA2_TO_RBP_JK_MEDIATED_TRANSCRIPTION,0.99999
WP_MITOCHONDRIAL_COMPLEX_I_A...,SET,45,-0.065313,-0.0032297,0.10782,0.72767,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,0.99999
GOBP_CELLULAR_RESPONSE_TO_NI...1,SET,9,-0.17611,-0.0038984,0.29069,0.72769,GOBP_CELLULAR_RESPONSE_TO_NICOTINE,0.99999
GSE6092_UNSTIM_VS_IFNG_STIM_...2,SET,179,-0.038685,-0.0038012,0.063844,0.72771,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,0.99999
SESTO_RESPONSE_TO_UV_C2,SET,50,-0.069941,-0.0036451,0.11543,0.72772,SESTO_RESPONSE_TO_UV_C2,0.99999
ZNF10_TARGET_GENES,SET,643,-0.02043,-0.003756,0.033717,0.72772,ZNF10_TARGET_GENES,0.99999
GOBP_REGULATION_OF_LYMPHANGI...,SET,6,-0.24344,-0.0044002,0.40168,0.72775,GOBP_REGULATION_OF_LYMPHANGIOGENESIS,0.99999
HP_CONGESTIVE_HEART_FAILURE,SET,220,-0.035166,-0.0038265,0.058013,0.72779,HP_CONGESTIVE_HEART_FAILURE,0.99999
GOBP_ESTABLISHMENT_OF_CENTRO...,SET,10,-0.1801,-0.0042023,0.29709,0.72781,GOBP_ESTABLISHMENT_OF_CENTROSOME_LOCALIZATION,0.99999
GSE41978_WT_VS_ID2_KO_AND_BI...2,SET,179,-0.037025,-0.0036381,0.061065,0.72784,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...630,SET,70,-0.061301,-0.0037781,0.10109,0.72787,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...7,SET,98,-0.054154,-0.0039461,0.089299,0.72788,GOBP_PROTEIN_LOCALIZATION_TO_CELL_JUNCTION,0.99999
GSE9006_HEALTHY_VS_TYPE_1_DI...1,SET,170,-0.038435,-0.0036815,0.063371,0.72791,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...118,SET,10,-0.14645,-0.0034171,0.24142,0.72794,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.99999
AMIT_SERUM_RESPONSE_20_MCF10A,SET,15,-0.14848,-0.0042426,0.24474,0.72797,AMIT_SERUM_RESPONSE_20_MCF10A,0.99999
GSE3039_ALPHAALPHA_VS_ALPHAB...2,SET,179,-0.038639,-0.0037967,0.063672,0.72802,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_UP,0.99999
GOBP_PROTEIN_DEGLYCOSYLATION,SET,14,-0.13995,-0.0038632,0.23059,0.72804,GOBP_PROTEIN_DEGLYCOSYLATION,0.99999
REACTOME_TP53_REGULATES_TRAN...7,SET,19,-0.11974,-0.0038502,0.19723,0.7281,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE,0.99999
GOBP_CELLULAR_COMPONENT_DISA...2,SET,31,-0.093946,-0.0038573,0.15474,0.72811,GOBP_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,0.99999
WP_FEMALE_STEROID_HORMONES_I...,SET,14,-0.13077,-0.0036099,0.21535,0.72815,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.99999
HP_APLASIA_OF_THE_OLFACTORY_...,SET,13,-0.14862,-0.0039534,0.24466,0.72822,HP_APLASIA_OF_THE_OLFACTORY_BULB,0.99999
MIR548AI_MIR570_5P,SET,161,-0.04082,-0.003806,0.067196,0.72823,MIR548AI_MIR570_5P,0.99999
GOBP_MEIOTIC_SPINDLE_ASSEMBLY,SET,10,-0.18265,-0.0042617,0.3006,0.72827,GOBP_MEIOTIC_SPINDLE_ASSEMBLY,0.99999
HP_OVARIAN_CARCINOMA,SET,14,-0.13625,-0.0037612,0.22424,0.72827,HP_OVARIAN_CARCINOMA,0.99999
KEGG_MEDICUS_PATHOGEN_KSHV_V...1,SET,6,-0.18627,-0.003367,0.30648,0.72833,KEGG_MEDICUS_PATHOGEN_KSHV_VCYCLIN_TO_CELL_CYCLE_G1_S,0.99999
GOBP_COPPER_ION_HOMEOSTASIS,SET,18,-0.12029,-0.0037649,0.19792,0.72833,GOBP_COPPER_ION_HOMEOSTASIS,0.99999
REACTOME_FORMATION_OF_THE_BE...,SET,31,-0.096291,-0.0039536,0.1584,0.72837,REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,0.99999
HP_ABNORMAL_MALE_GERM_CELL_M...,SET,57,-0.067378,-0.0037486,0.11081,0.72841,HP_ABNORMAL_MALE_GERM_CELL_MORPHOLOGY,0.99999
JIANG_AGING_CEREBRAL_CORTEX_...1,SET,43,-0.078277,-0.003784,0.12872,0.72844,JIANG_AGING_CEREBRAL_CORTEX_DN,0.99999
VERRECCHIA_RESPONSE_TO_TGFB1...4,SET,11,-0.16972,-0.0041532,0.27909,0.72844,VERRECCHIA_RESPONSE_TO_TGFB1_C4,0.99999
GSE17721_CTRL_VS_CPG_6H_BMDC...1,SET,178,-0.038218,-0.003745,0.062847,0.72844,GSE17721_CTRL_VS_CPG_6H_BMDC_DN,0.99999
FLOTHO_PEDIATRIC_ALL_THERAPY...2,SET,50,-0.069892,-0.0036426,0.11492,0.72846,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,0.99999
HP_ABNORMAL_HAIR_WHORL,SET,27,-0.10607,-0.004065,0.1744,0.72847,HP_ABNORMAL_HAIR_WHORL,0.99999
KEGG_LONG_TERM_POTENTIATION,SET,66,-0.063143,-0.0037792,0.10377,0.72857,KEGG_LONG_TERM_POTENTIATION,0.99999
REACTOME_SCF_BETA_TRCP_MEDIA...,SET,52,-0.063399,-0.0033694,0.10415,0.72865,REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,0.99999
DARWICHE_PAPILLOMA_RISK_LOW_...2,SET,148,-0.042876,-0.0038342,0.070426,0.72867,DARWICHE_PAPILLOMA_RISK_LOW_UP,0.99999
GOBP_DETECTION_OF_ABIOTIC_ST...,SET,130,-0.047538,-0.0039862,0.07805,0.72876,GOBP_DETECTION_OF_ABIOTIC_STIMULUS,0.99999
HP_CALCIFICATION_OF_CARTILAGE,SET,11,-0.17423,-0.0042636,0.28599,0.7288,HP_CALCIFICATION_OF_CARTILAGE,0.99999
MAFG_TARGET_GENES,SET,1313,-0.014747,-0.0038002,0.024193,0.72891,MAFG_TARGET_GENES,0.99999
GOBP_TYPE_B_PANCREATIC_CELL_...3,SET,27,-0.10869,-0.0041654,0.17832,0.72891,GOBP_TYPE_B_PANCREATIC_CELL_DIFFERENTIATION,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_MU...,SET,4,-0.22272,-0.0032872,0.36539,0.72891,HP_ABNORMAL_MORPHOLOGY_OF_MUSCULATURE_OF_PHARYNX,0.99999
HP_ABNORMAL_VOCAL_CORD_MORPH...,SET,4,-0.22272,-0.0032872,0.36539,0.72891,HP_ABNORMAL_VOCAL_CORD_MORPHOLOGY,0.99999
WANG_TNF_TARGETS,SET,24,-0.11414,-0.0041244,0.18725,0.72892,WANG_TNF_TARGETS,0.99999
MIR187_5P,SET,163,-0.042642,-0.0040002,0.069926,0.72901,MIR187_5P,0.99999
HP_UTERUS_DIDELPHYS,SET,10,-0.15294,-0.0035685,0.25066,0.72912,HP_UTERUS_DIDELPHYS,0.99999
GOBP_POSITIVE_REGULATION_OF_...830,SET,14,-0.14366,-0.0039658,0.23539,0.72917,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
MIR4772_5P,SET,48,-0.078379,-0.0040026,0.12841,0.7292,MIR4772_5P,0.99999
HP_AIRWAY_HYPERRESPONSIVENESS,SET,8,-0.1972,-0.0041158,0.32293,0.72929,HP_AIRWAY_HYPERRESPONSIVENESS,0.99999
MIR6866_5P,SET,67,-0.064494,-0.0038891,0.10559,0.72932,MIR6866_5P,0.99999
DICER1_TARGET_GENES,SET,52,-0.0704,-0.0037415,0.11526,0.72933,DICER1_TARGET_GENES,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HE...,SET,803,-0.02008,-0.0041068,0.032864,0.7294,MANNO_MIDBRAIN_NEUROTYPES_HENDO,0.99999
REACTOME_SIGNALING_BY_ERBB2,SET,48,-0.074366,-0.0037976,0.12169,0.72943,REACTOME_SIGNALING_BY_ERBB2,0.99999
GOBP_DIRECT_OSSIFICATION,SET,7,-0.19393,-0.0037862,0.31732,0.72945,GOBP_DIRECT_OSSIFICATION,0.99999
ROSS_ACUTE_MYELOID_LEUKEMIA_...,SET,77,-0.064487,-0.0041677,0.10549,0.7295,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,0.99999
GOBP_NEGATIVE_REGULATION_OF_...26,SET,14,-0.14666,-0.0040486,0.23985,0.72956,GOBP_NEGATIVE_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_VARIANT_LMO2_RE...1,SET,5,-0.24105,-0.0039776,0.39417,0.72958,KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_ACTIVATION,0.99999
MIR4657,SET,66,-0.062432,-0.0037367,0.10207,0.72962,MIR4657,0.99999
MOOTHA_GLYCOGEN_METABOLISM,SET,18,-0.11357,-0.0035544,0.18564,0.72965,MOOTHA_GLYCOGEN_METABOLISM,0.99999
GSE37301_CD4_TCELL_VS_RAG2_K...1,SET,165,-0.039733,-0.0037499,0.064943,0.72967,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN,0.99999
HP_SPASTIC_DYSARTHRIA,SET,22,-0.10378,-0.0035906,0.16962,0.72968,HP_SPASTIC_DYSARTHRIA,0.99999
HP_FRONTAL_LOBE_DEMENTIA,SET,18,-0.11618,-0.003636,0.18986,0.72969,HP_FRONTAL_LOBE_DEMENTIA,0.99999
DAVICIONI_RHABDOMYOSARCOMA_P...2,SET,56,-0.076095,-0.0041964,0.12435,0.72971,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,0.99999
KUROZUMI_RESPONSE_TO_ONCOCYT...2,SET,20,-0.12801,-0.0042229,0.20918,0.72971,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD,0.99999
GOMF_LIGAND_GATED_CALCIUM_CH...,SET,30,-0.099578,-0.0040221,0.16269,0.72976,GOMF_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY,0.99999
HP_SPOKEN_WORD_RECOGNITION_D...,SET,8,-0.18236,-0.003806,0.29793,0.72976,HP_SPOKEN_WORD_RECOGNITION_DEFICIT,0.99999
GCM_AIP,SET,34,-0.084182,-0.0036194,0.13752,0.72978,GCM_AIP,0.99999
GOBP_MORPHOGENESIS_OF_AN_EPI...3,SET,60,-0.066596,-0.003801,0.10877,0.72982,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_SHEET,0.99999
HP_3_4_FINGER_CUTANEOUS_SYND...,SET,6,-0.25354,-0.0045829,0.41401,0.72986,HP_3_4_FINGER_CUTANEOUS_SYNDACTYLY,0.99999
HP_ALBUMINURIA,SET,22,-0.1051,-0.0036363,0.17159,0.7299,HP_ALBUMINURIA,0.99999
REACTOME_DOWNSTREAM_SIGNALIN...3,SET,29,-0.097078,-0.0038553,0.15847,0.72993,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2,0.99999
GSE1432_CTRL_VS_IFNG_24H_MIC...2,SET,186,-0.039459,-0.0039516,0.064396,0.72998,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_KCN...,SET,95,-0.06091,-0.0043703,0.09939,0.73,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.99999
TCTGATA_MIR361,SET,79,-0.05904,-0.0038647,0.096334,0.73001,TCTGATA_MIR361,0.99999
HP_ESOPHAGEAL_STENOSIS,SET,29,-0.09564,-0.0037983,0.15605,0.73002,HP_ESOPHAGEAL_STENOSIS,0.99999
GSE31622_WT_VS_KLF3_KO_BCELL...1,SET,178,-0.040309,-0.0039499,0.065765,0.73003,GSE31622_WT_VS_KLF3_KO_BCELL_DN,0.99999
WP_IL19_SIGNALING,SET,28,-0.10356,-0.0040413,0.16894,0.73006,WP_IL19_SIGNALING,0.99999
GOMF_PROCOLLAGEN_PROLINE_4_D...,SET,5,-0.17675,-0.0029166,0.28831,0.73008,GOMF_PROCOLLAGEN_PROLINE_4_DIOXYGENASE_ACTIVITY,0.99999
MOOTHA_PYR,SET,5,-0.30836,-0.0050883,0.50296,0.73009,MOOTHA_PYR,0.99999
REACTOME_PLATELET_CALCIUM_HO...,SET,27,-0.10127,-0.0038807,0.16515,0.73011,REACTOME_PLATELET_CALCIUM_HOMEOSTASIS,0.99999
HNF3_Q6,SET,165,-0.042443,-0.0040056,0.069214,0.73013,HNF3_Q6,0.99999
ZNF329_TARGET_GENES,SET,438,-0.02503,-0.0038199,0.040817,0.73014,ZNF329_TARGET_GENES,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_INT...2,SET,9,-0.19678,-0.0043559,0.32086,0.73015,HE_LIM_SUN_FETAL_LUNG_C0_INTERM_FIBROBLAST,0.99999
HP_INCREASED_CIRCULATING_VER...,SET,8,-0.20307,-0.0042382,0.33111,0.73016,HP_INCREASED_CIRCULATING_VERY_LONG_CHAIN_FATTY_ACID_CONCENTRATION,0.99999
GOBP_TRANSLATIONAL_READTHROU...,SET,8,-0.19352,-0.0040389,0.31548,0.73019,GOBP_TRANSLATIONAL_READTHROUGH,0.99999
REACTOME_FBXW7_MUTANTS_AND_N...,SET,5,-0.219,-0.0036137,0.35691,0.73025,REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER,0.99999
HP_ABNORMAL_CIRCULATING_ALPH...,SET,30,-0.10044,-0.0040569,0.16361,0.73035,HP_ABNORMAL_CIRCULATING_ALPHA_FETOPROTEIN_CONCENTRATION,0.99999
GOBP_INNER_EAR_RECEPTOR_CELL...3,SET,32,-0.097221,-0.0040555,0.15835,0.73037,GOBP_INNER_EAR_RECEPTOR_CELL_STEREOCILIUM_ORGANIZATION,0.99999
WP_STRIATED_MUSCLE_CONTRACTI...,SET,37,-0.086839,-0.0038946,0.14144,0.73038,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,0.99999
MIR4289,SET,63,-0.068351,-0.0039972,0.11132,0.73038,MIR4289,0.99999
GSE339_CD4POS_VS_CD8POS_DC_UP,SET,183,-0.039111,-0.0038854,0.0637,0.73039,GSE339_CD4POS_VS_CD8POS_DC_UP,0.99999
HP_IMMUNODEFICIENCY,SET,194,-0.03858,-0.003945,0.062819,0.73044,HP_IMMUNODEFICIENCY,0.99999
GOBP_DOPAMINE_TRANSPORT,SET,43,-0.084224,-0.0040714,0.13711,0.73049,GOBP_DOPAMINE_TRANSPORT,0.99999
HP_BLIND_VAGINA,SET,2,-0.35148,-0.0036684,0.57209,0.73051,HP_BLIND_VAGINA,0.99999
HP_PHOTORECEPTOR_LAYER_LOSS_...,SET,5,-0.22241,-0.00367,0.36202,0.73051,HP_PHOTORECEPTOR_LAYER_LOSS_ON_MACULAR_OCT,0.99999
RRCCGTTA_UNKNOWN,SET,79,-0.058933,-0.0038577,0.095864,0.73064,RRCCGTTA_UNKNOWN,0.99999
KEGG_MEDICUS_REFERENCE_KINET...2,SET,19,-0.13258,-0.0042631,0.21563,0.73067,KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT,0.99999
DESCARTES_FETAL_INTESTINE_VA...,SET,38,-0.092073,-0.0041847,0.14975,0.73067,DESCARTES_FETAL_INTESTINE_VASCULAR_ENDOTHELIAL_CELLS,0.99999
GOBP_POSITIVE_REGULATION_OF_...390,SET,27,-0.10354,-0.0039678,0.16837,0.7307,GOBP_POSITIVE_REGULATION_OF_JUN_KINASE_ACTIVITY,0.99999
GOMF_RNA_POLYMERASE_II_CTD_H...2,SET,17,-0.1191,-0.0036227,0.19367,0.73072,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_MODIFYING_ACTIVITY,0.99999
HP_LARYNGEAL_EDEMA,SET,4,-0.29616,-0.0043712,0.48156,0.73072,HP_LARYNGEAL_EDEMA,0.99999
GOCC_PRERIBOSOME,SET,94,-0.050778,-0.0036242,0.08256,0.73073,GOCC_PRERIBOSOME,0.99999
FEVR_CTNNB1_TARGETS_UP,SET,635,-0.021763,-0.0039769,0.035379,0.73077,FEVR_CTNNB1_TARGETS_UP,0.99999
WP_NSP1_FROM_SARSCOV2_INHIBI...,SET,12,-0.14428,-0.0036875,0.23453,0.73077,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,0.99999
GOBP_NEGATIVE_REGULATION_OF_...307,SET,2,-0.44881,-0.0046843,0.7296,0.73077,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION,0.99999
GOBP_UDP_N_ACETYLGLUCOSAMINE...3,SET,5,-0.21163,-0.0034921,0.344,0.73078,GOBP_UDP_N_ACETYLGLUCOSAMINE_TRANSMEMBRANE_TRANSPORT,0.99999
GOMF_UDP_N_ACETYLGLUCOSAMINE...,SET,5,-0.21163,-0.0034921,0.344,0.73078,GOMF_UDP_N_ACETYLGLUCOSAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE3982_CTRL_VS_LPS_48H_DC_UP,SET,183,-0.039697,-0.0039436,0.064522,0.7308,GSE3982_CTRL_VS_LPS_48H_DC_UP,0.99999
HP_LOCALIZED_HIRSUTISM,SET,17,-0.11613,-0.0035322,0.1887,0.73086,HP_LOCALIZED_HIRSUTISM,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...27,SET,5,-0.22171,-0.0036585,0.36016,0.73091,GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_MEMBRANE,0.99999
MIKKELSEN_ES_ICP_WITH_H3K4ME...,SET,126,-0.050819,-0.0041957,0.082547,0.73093,MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,0.99999
GOMF_CASPASE_BINDING,SET,12,-0.13953,-0.0035662,0.22658,0.73099,GOMF_CASPASE_BINDING,0.99999
HP_SEESAW_NYSTAGMUS,SET,6,-0.18884,-0.0034135,0.30664,0.731,HP_SEESAW_NYSTAGMUS,0.99999
WP_MAPK_PATHWAY_IN_CONGENITA...,SET,14,-0.1464,-0.0040415,0.23772,0.73101,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,0.99999
KEGG_MEDICUS_REFERENCE_AREG_...2,SET,14,-0.14341,-0.0039589,0.23278,0.73108,KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.99999
MIR3064_3P,SET,154,-0.043801,-0.0039948,0.071094,0.73108,MIR3064_3P,0.99999
GOBP_RNA_EXPORT_FROM_NUCLEUS,SET,80,-0.052331,-0.003447,0.084912,0.73115,GOBP_RNA_EXPORT_FROM_NUCLEUS,0.99999
HOFMANN_MYELODYSPLASTIC_SYND...4,SET,20,-0.11731,-0.0038701,0.19032,0.73119,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,0.99999
GSE24972_WT_VS_IRF8_KO_SPLEE...2,SET,180,-0.040803,-0.0040204,0.066163,0.73128,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_UP,0.99999
DESCARTES_FETAL_LIVER_ERYTHR...,SET,55,-0.072966,-0.0039878,0.11832,0.73128,DESCARTES_FETAL_LIVER_ERYTHROBLASTS,0.99999
GHO_ATF5_TARGETS_DN,SET,16,-0.14684,-0.004333,0.23809,0.73129,GHO_ATF5_TARGETS_DN,0.99999
HP_ELEVATED_BRAIN_CHOLINE_LE...,SET,8,-0.17116,-0.0035722,0.27749,0.73132,HP_ELEVATED_BRAIN_CHOLINE_LEVEL_BY_MRS,0.99999
REACTOME_ESR_MEDIATED_SIGNAL...,SET,157,-0.043129,-0.0039714,0.069912,0.73135,REACTOME_ESR_MEDIATED_SIGNALING,0.99999
HSF2_01,SET,229,-0.035564,-0.0039472,0.057631,0.73141,HSF2_01,0.99999
GSE29615_CTRL_VS_DAY3_LAIV_I...1,SET,153,-0.040962,-0.0037239,0.06638,0.73141,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN,0.99999
HOXA13_TARGET_GENES,SET,39,-0.08443,-0.0038874,0.13677,0.73148,HOXA13_TARGET_GENES,0.99999
HP_IMMUNE_DYSREGULATION,SET,10,-0.16159,-0.0037704,0.26175,0.73149,HP_IMMUNE_DYSREGULATION,0.99999
WANG_RESPONSE_TO_GSK3_INHIBI...2,SET,310,-0.030208,-0.0038921,0.048925,0.73152,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...615,SET,25,-0.10907,-0.0040221,0.17665,0.73152,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
PID_FAK_PATHWAY,SET,57,-0.068541,-0.0038133,0.11099,0.73156,PID_FAK_PATHWAY,0.99999
REACTOME_ERK_MAPK_TARGETS,SET,20,-0.1209,-0.0039884,0.19574,0.73159,REACTOME_ERK_MAPK_TARGETS,0.99999
GOBP_BRAINSTEM_DEVELOPMENT,SET,7,-0.19425,-0.0037924,0.31446,0.73162,GOBP_BRAINSTEM_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_EPITHELIA...2,SET,144,-0.048287,-0.0042598,0.078167,0.73162,GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
MIR619_3P,SET,53,-0.073005,-0.003917,0.11818,0.73163,MIR619_3P,0.99999
GOBP_RENAL_SYSTEM_VASCULATUR...2,SET,8,-0.21183,-0.004421,0.34289,0.73163,GOBP_RENAL_SYSTEM_VASCULATURE_MORPHOGENESIS,0.99999
GSE21678_WT_VS_FOXO1_FOXO3_K...1,SET,163,-0.039145,-0.0036721,0.063367,0.73163,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_DN,0.99999
REACTOME_PROCESSING_OF_SMDT1,SET,12,-0.15862,-0.0040541,0.25675,0.73164,REACTOME_PROCESSING_OF_SMDT1,0.99999
ZNF597_TARGET_GENES,SET,606,-0.021715,-0.0038796,0.035145,0.73166,ZNF597_TARGET_GENES,0.99999
MIR218_5P,SET,384,-0.02854,-0.0040843,0.046184,0.73169,MIR218_5P,0.99999
POU3F2_01,SET,96,-0.057028,-0.0041131,0.092277,0.73171,POU3F2_01,0.99999
REACTOME_INFLUENZA_INFECTION,SET,145,-0.041784,-0.0036988,0.067603,0.73174,REACTOME_INFLUENZA_INFECTION,0.99999
HP_SHORT_4TH_TOE,SET,5,-0.20249,-0.0033413,0.32756,0.73177,HP_SHORT_4TH_TOE,0.99999
HP_PROGRESSIVE_LANGUAGE_DETE...,SET,11,-0.16326,-0.0039952,0.26407,0.73179,HP_PROGRESSIVE_LANGUAGE_DETERIORATION,0.99999
REACTOME_BIOSYNTHESIS_OF_EPA...,SET,6,-0.25453,-0.0046008,0.41165,0.73182,REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS,0.99999
REACTOME_TNFR1_MEDIATED_CERA...,SET,5,-0.21821,-0.0036008,0.3529,0.73182,REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION,0.99999
WP_HUNGER_AND_SATIETY,SET,8,-0.18738,-0.0039107,0.30303,0.73182,WP_HUNGER_AND_SATIETY,0.99999
GOCC_NUCLEOLAR_RIBONUCLEASE_...,SET,7,-0.18168,-0.003547,0.29379,0.73184,GOCC_NUCLEOLAR_RIBONUCLEASE_P_COMPLEX,0.99999
WP_PROTEASOME_DEGRADATION,SET,56,-0.063963,-0.0035274,0.10342,0.73187,WP_PROTEASOME_DEGRADATION,0.99999
GOBP_B_CELL_LINEAGE_COMMITME...,SET,6,-0.19867,-0.0035911,0.32089,0.73208,GOBP_B_CELL_LINEAGE_COMMITMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...1,SET,3,-0.35483,-0.0045356,0.57312,0.73208,GOBP_POSITIVE_REGULATION_OF_3_UTR_MEDIATED_MRNA_STABILIZATION,0.99999
GOMF_ATPASE_REGULATOR_ACTIVI...,SET,45,-0.072049,-0.0035628,0.11636,0.73209,GOMF_ATPASE_REGULATOR_ACTIVITY,0.99999
GSE15930_NAIVE_VS_72H_IN_VIT...1,SET,182,-0.038265,-0.003791,0.0618,0.73209,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN,0.99999
GSE2770_IL12_ACT_VS_ACT_CD4_...4,SET,181,-0.038723,-0.003826,0.062529,0.73213,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_UP,0.99999
HARRIS_BRAIN_CANCER_PROGENIT...,SET,37,-0.090605,-0.0040635,0.1463,0.73214,HARRIS_BRAIN_CANCER_PROGENITORS,0.99999
MIR559,SET,497,-0.024351,-0.0039521,0.039317,0.73216,MIR559,0.99999
SIG_BCR_SIGNALING_PATHWAY,SET,45,-0.078118,-0.0038629,0.1261,0.7322,SIG_BCR_SIGNALING_PATHWAY,0.99999
GSE4590_PRE_BCELL_VS_VPREB_P...2,SET,140,-0.045217,-0.0039336,0.072983,0.73222,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,0.99999
GOMF_DOUBLE_STRANDED_TELOMER...,SET,9,-0.16659,-0.0036878,0.26888,0.73223,GOMF_DOUBLE_STRANDED_TELOMERIC_DNA_BINDING,0.99999
DER_IFN_ALPHA_RESPONSE_DN,SET,4,-0.26317,-0.0038843,0.42474,0.73224,DER_IFN_ALPHA_RESPONSE_DN,0.99999
HP_TREMOR,SET,540,-0.022702,-0.0038359,0.036637,0.73225,HP_TREMOR,0.99999
GSE18281_SUBCAPSULAR_VS_CENT...1,SET,187,-0.038891,-0.0039051,0.062764,0.73225,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN,0.99999
MIR503_5P,SET,95,-0.055485,-0.003981,0.089529,0.73228,MIR503_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...452,SET,7,-0.17684,-0.0034526,0.28528,0.73233,GOBP_NEGATIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.99999
MIR379_5P,SET,41,-0.086381,-0.0040777,0.13934,0.73235,MIR379_5P,0.99999
HP_AMNIOTIC_CONSTRICTION_RING,SET,10,-0.17523,-0.0040887,0.28265,0.73235,HP_AMNIOTIC_CONSTRICTION_RING,0.99999
GOBP_CYTOPLASM_ORGANIZATION,SET,15,-0.13873,-0.003964,0.22369,0.73243,GOBP_CYTOPLASM_ORGANIZATION,0.99999
HP_CORNEAL_ULCERATION,SET,18,-0.12324,-0.0038571,0.1987,0.73244,HP_CORNEAL_ULCERATION,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...6,SET,14,-0.14431,-0.0039837,0.23262,0.73249,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...30,SET,182,-0.038934,-0.0038573,0.062755,0.7325,HP_APLASIA_HYPOPLASIA_OF_THE_EYEBROW,0.99999
BIOCARTA_RAB_PATHWAY,SET,12,-0.1487,-0.0038005,0.23967,0.73251,BIOCARTA_RAB_PATHWAY,0.99999
HP_DENTAL_CROWDING,SET,119,-0.049263,-0.0039534,0.079398,0.73252,HP_DENTAL_CROWDING,0.99999
MIR6789_5P,SET,20,-0.10348,-0.0034137,0.16676,0.73255,MIR6789_5P,0.99999
HP_AUTOIMMUNE_HEMOLYTIC_ANEM...,SET,39,-0.091292,-0.0042033,0.14711,0.73255,HP_AUTOIMMUNE_HEMOLYTIC_ANEMIA,0.99999
HP_TRUNCUS_ARTERIOSUS,SET,24,-0.11414,-0.0041243,0.18393,0.73256,HP_TRUNCUS_ARTERIOSUS,0.99999
WP_NAD_METABOLISM_SIRTUINS_A...,SET,11,-0.17151,-0.0041971,0.27628,0.73262,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...12,SET,46,-0.08261,-0.0041301,0.13308,0.73262,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_2,0.99999
BIOCARTA_TNFR1_PATHWAY,SET,29,-0.093946,-0.003731,0.15133,0.73264,BIOCARTA_TNFR1_PATHWAY,0.99999
ZNF101_TARGET_GENES,SET,359,-0.027795,-0.0038487,0.044763,0.73268,ZNF101_TARGET_GENES,0.99999
MODULE_168,SET,10,-0.1801,-0.0042023,0.29001,0.7327,MODULE_168,0.99999
REACTOME_GOLGI_CISTERNAE_PER...,SET,14,-0.12169,-0.0033592,0.19582,0.73283,REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION,0.99999
GSE40666_WT_VS_STAT4_KO_CD8_...4,SET,174,-0.040234,-0.0038984,0.064735,0.73287,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.99999
REACTOME_SIGNALING_BY_PDGF,SET,57,-0.073281,-0.004077,0.11789,0.7329,REACTOME_SIGNALING_BY_PDGF,0.99999
REACTOME_INTERLEUKIN_1_FAMIL...,SET,143,-0.042508,-0.003737,0.068379,0.73291,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,0.99999
GSE15930_STIM_VS_STIM_AND_TR...6,SET,180,-0.037341,-0.0036793,0.060067,0.73291,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP,0.99999
MIR323A_3P,SET,206,-0.037549,-0.0039552,0.060379,0.73299,MIR323A_3P,0.99999
MIR4748,SET,61,-0.066496,-0.0038267,0.1069,0.73303,MIR4748,0.99999
REACTOME_TAK1_DEPENDENT_IKK_...,SET,40,-0.082074,-0.0038269,0.13194,0.73305,REACTOME_TAK1_DEPENDENT_IKK_AND_NF_KAPPA_B_ACTIVATION,0.99999
MIR548M,SET,172,-0.040506,-0.0039023,0.065114,0.73305,MIR548M,0.99999
WP_MAMMARY_GLAND_DEVELOPMENT...4,SET,12,-0.1651,-0.0042196,0.26537,0.73307,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,0.99999
HP_DISTAL_LOWER_LIMB_AMYOTRO...,SET,46,-0.081072,-0.0040532,0.13025,0.73317,HP_DISTAL_LOWER_LIMB_AMYOTROPHY,0.99999
GOCC_TRAMP_COMPLEX,SET,2,-0.33537,-0.0035003,0.53871,0.7332,GOCC_TRAMP_COMPLEX,0.99999
HP_CONGENITAL_GIANT_MELANOCY...,SET,5,-0.22095,-0.0036459,0.35491,0.7332,HP_CONGENITAL_GIANT_MELANOCYTIC_NEVUS,0.99999
CAFFAREL_RESPONSE_TO_THC_24H...1,SET,12,-0.15178,-0.0038792,0.24373,0.73327,CAFFAREL_RESPONSE_TO_THC_24HR_3_DN,0.99999
HP_ABNORMAL_GASTROINTESTINAL...2,SET,6,-0.24766,-0.0044765,0.39759,0.73332,HP_ABNORMAL_GASTROINTESTINAL_VASCULAR_MORPHOLOGY,0.99999
GOMF_HISTONE_H4_ACETYLTRANSF...,SET,21,-0.10604,-0.0035844,0.1702,0.73336,GOMF_HISTONE_H4_ACETYLTRANSFERASE_ACTIVITY,0.99999
MIR3149,SET,130,-0.046489,-0.0038983,0.074592,0.73344,MIR3149,0.99999
JIANG_MELANOMA_TRM8_CD4,SET,364,-0.028397,-0.0039588,0.045556,0.73347,JIANG_MELANOMA_TRM8_CD4,0.99999
BIOCARTA_KERATINOCYTE_PATHWAY,SET,46,-0.082301,-0.0041146,0.13201,0.7335,BIOCARTA_KERATINOCYTE_PATHWAY,0.99999
WU_CELL_MIGRATION,SET,167,-0.044669,-0.004241,0.071646,0.73351,WU_CELL_MIGRATION,0.99999
GSE5589_UNSTIM_VS_45MIN_LPS_...4,SET,182,-0.03901,-0.0038649,0.062552,0.73356,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP,0.99999
ONDER_CDH1_TARGETS_2_DN,SET,443,-0.02754,-0.0042263,0.044157,0.73358,ONDER_CDH1_TARGETS_2_DN,0.99999
KRAS.PROSTATE_UP.V1_UP,SET,122,-0.050734,-0.0041221,0.08133,0.73362,KRAS.PROSTATE_UP.V1_UP,0.99999
GSE15330_WT_VS_IKAROS_KO_HSC...1,SET,184,-0.03968,-0.0039526,0.06359,0.73368,GSE15330_WT_VS_IKAROS_KO_HSC_DN,0.99999
KEGG_MEDICUS_ENV_FACTOR_NICO...1,SET,11,-0.1591,-0.0038933,0.25495,0.73369,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY,0.99999
BIOCARTA_AT1R_PATHWAY,SET,26,-0.10575,-0.0039768,0.16945,0.7337,BIOCARTA_AT1R_PATHWAY,0.99999
GOBP_RESPONSE_TO_COBALT_ION,SET,9,-0.17545,-0.0038837,0.28112,0.73371,GOBP_RESPONSE_TO_COBALT_ION,0.99999
GOMF_HYALURONONGLUCOSAMINIDA...,SET,6,-0.22859,-0.004132,0.36618,0.73377,GOMF_HYALURONONGLUCOSAMINIDASE_ACTIVITY,0.99999
HP_ABNORMAL_PYRAMIDAL_SIGN,SET,382,-0.026551,-0.0037899,0.042532,0.73377,HP_ABNORMAL_PYRAMIDAL_SIGN,0.99999
GNATENKO_PLATELET_SIGNATURE,SET,34,-0.088656,-0.0038118,0.14198,0.73382,GNATENKO_PLATELET_SIGNATURE,0.99999
GOBP_SEQUESTERING_OF_ACTIN_M...,SET,6,-0.22542,-0.0040745,0.36096,0.73384,GOBP_SEQUESTERING_OF_ACTIN_MONOMERS,0.99999
FLECHNER_BIOPSY_KIDNEY_TRANS...4,SET,80,-0.0601,-0.0039588,0.096222,0.73388,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,0.99999
GOBP_REGULATION_OF_CELL_PROL...2,SET,6,-0.20789,-0.0037577,0.33282,0.73389,GOBP_REGULATION_OF_CELL_PROLIFERATION_IN_BONE_MARROW,0.99999
YANG_BREAST_CANCER_ESR1_LASE...2,SET,27,-0.10138,-0.0038852,0.16227,0.73394,YANG_BREAST_CANCER_ESR1_LASER_UP,0.99999
chr12q23,SET,68,-0.12363,-0.0075106,0.19786,0.73397,chr12q23,0.99999
GOBP_DETECTION_OF_MECHANICAL...2,SET,33,-0.099065,-0.0041964,0.15853,0.73397,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,0.99999
GOBP_METANEPHRIC_GLOMERULUS_...1,SET,16,-0.15711,-0.0046362,0.25138,0.73401,GOBP_METANEPHRIC_GLOMERULUS_DEVELOPMENT,0.99999
HP_RETINAL_PERFORATION,SET,10,-0.17411,-0.0040626,0.27856,0.73402,HP_RETINAL_PERFORATION,0.99999
HP_4_5_TOE_SYNDACTYLY,SET,8,-0.20733,-0.0043272,0.3317,0.73403,HP_4_5_TOE_SYNDACTYLY,0.99999
CHANG_POU5F1_TARGETS_DN,SET,7,-0.23069,-0.0045039,0.36903,0.73406,CHANG_POU5F1_TARGETS_DN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...17,SET,7,-0.1913,-0.0037347,0.30597,0.73408,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY,0.99999
ZIRN_TRETINOIN_RESPONSE_WT1_...2,SET,23,-0.12348,-0.0043679,0.19746,0.73412,ZIRN_TRETINOIN_RESPONSE_WT1_UP,0.99999
GOBP_RESPONSE_TO_INSULIN,SET,251,-0.033813,-0.0039266,0.054057,0.73418,GOBP_RESPONSE_TO_INSULIN,0.99999
CEBPGAMMA_Q6,SET,233,-0.036082,-0.004039,0.05767,0.73423,CEBPGAMMA_Q6,0.99999
REACTOME_METABOLISM_OF_RNA,SET,646,-0.019531,-0.0035987,0.031204,0.7343,REACTOME_METABOLISM_OF_RNA,0.99999
RAAGNYNNCTTY_UNKNOWN,SET,134,-0.049316,-0.0041979,0.078787,0.73432,RAAGNYNNCTTY_UNKNOWN,0.99999
GOBP_DORSAL_SPINAL_CORD_DEVE...,SET,19,-0.14468,-0.0046521,0.23105,0.7344,GOBP_DORSAL_SPINAL_CORD_DEVELOPMENT,0.99999
HP_HIRSUTISM,SET,195,-0.037742,-0.0038691,0.06027,0.73441,HP_HIRSUTISM,0.99999
HALLMARK_APICAL_SURFACE,SET,39,-0.089067,-0.0041008,0.14221,0.73444,HALLMARK_APICAL_SURFACE,0.99999
GOBP_POSITIVE_REGULATION_OF_...142,SET,5,-0.22153,-0.0036554,0.35361,0.73449,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_IN_BONE_MARROW,0.99999
REN_ALVEOLAR_RHABDOMYOSARCOM...1,SET,369,-0.028758,-0.004036,0.045892,0.73455,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,0.99999
REACTOME_CDC42_GTPASE_CYCLE,SET,142,-0.046487,-0.0040726,0.074171,0.73458,REACTOME_CDC42_GTPASE_CYCLE,0.99999
MIR200B_3P,SET,448,-0.026565,-0.004099,0.042386,0.73458,MIR200B_3P,0.99999
MIR200C_3P,SET,448,-0.026565,-0.004099,0.042386,0.73458,MIR200C_3P,0.99999
LAKE_ADULT_KIDNEY_C8_DECENDI...,SET,253,-0.034114,-0.0039771,0.054422,0.73461,LAKE_ADULT_KIDNEY_C8_DECENDING_THIN_LIMB,0.99999
GSE17721_CTRL_VS_LPS_24H_BMD...2,SET,187,-0.038005,-0.0038161,0.060626,0.73462,GSE17721_CTRL_VS_LPS_24H_BMDC_UP,0.99999
HP_ABNORMAL_EXTEROCEPTIVE_SE...,SET,219,-0.036131,-0.0039227,0.057637,0.73463,HP_ABNORMAL_EXTEROCEPTIVE_SENSATION,0.99999
MORF_RAB5A,SET,85,-0.051601,-0.0035031,0.082275,0.73473,MORF_RAB5A,0.99999
GOBP_SMOOTH_MUSCLE_TISSUE_DE...,SET,24,-0.12021,-0.0043436,0.19165,0.73475,GOBP_SMOOTH_MUSCLE_TISSUE_DEVELOPMENT,0.99999
GOMF_FERRIC_IRON_BINDING,SET,8,-0.20889,-0.0043596,0.33302,0.73475,GOMF_FERRIC_IRON_BINDING,0.99999
GSE24210_IL35_TREATED_VS_UNT...2,SET,173,-0.039756,-0.0038412,0.063382,0.73475,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP,0.99999
GSE36826_WT_VS_IL1R_KO_SKIN_...1,SET,170,-0.040389,-0.0038686,0.064372,0.73481,GSE36826_WT_VS_IL1R_KO_SKIN_DN,0.99999
ROY_WOUND_BLOOD_VESSEL_UP,SET,45,-0.086914,-0.0042979,0.13851,0.73483,ROY_WOUND_BLOOD_VESSEL_UP,0.99999
KEGG_MEDICUS_REFERENCE_COMMO...,SET,7,-0.21195,-0.0041379,0.33776,0.73483,KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION,0.99999
GFI1_01,SET,241,-0.035198,-0.0040063,0.056092,0.73483,GFI1_01,0.99999
GOCC_MEMBRANE_ATTACK_COMPLEX,SET,7,-0.21195,-0.0041379,0.33776,0.73483,GOCC_MEMBRANE_ATTACK_COMPLEX,0.99999
MIR2276_5P,SET,63,-0.070368,-0.0041152,0.11213,0.73485,MIR2276_5P,0.99999
GOBP_REGULATION_OF_PEPTIDYL_...4,SET,106,-0.054677,-0.0041428,0.087117,0.73487,GOBP_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,0.99999
GOBP_ISOCITRATE_METABOLIC_PR...,SET,5,-0.20975,-0.0034611,0.33415,0.7349,GOBP_ISOCITRATE_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_LONG_TERM...1,SET,23,-0.11168,-0.0039506,0.17789,0.73493,GOBP_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY,0.99999
GNF2_MCM5,SET,54,-0.068306,-0.0036992,0.10879,0.73494,GNF2_MCM5,0.99999
GSE37416_0H_VS_6H_F_TULARENS...2,SET,166,-0.041217,-0.0039016,0.06565,0.73494,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
REN_MIF_TARGETS_DN,SET,4,-0.2638,-0.0038936,0.42009,0.73498,REN_MIF_TARGETS_DN,0.99999
WCTCNATGGY_UNKNOWN,SET,69,-0.064361,-0.0039384,0.10248,0.73502,WCTCNATGGY_UNKNOWN,0.99999
PROVENZANI_METASTASIS_UP,SET,169,-0.043459,-0.0041505,0.069185,0.73504,PROVENZANI_METASTASIS_UP,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...33,SET,50,-0.084767,-0.0044178,0.13495,0.73504,GAVISH_3CA_MALIGNANT_METAPROGRAM_40_PDAC_RELATED,0.99999
GOMF_METAL_CLUSTER_BINDING,SET,69,-0.061293,-0.0037506,0.097562,0.73507,GOMF_METAL_CLUSTER_BINDING,0.99999
chr4p13,SET,12,-0.24216,-0.0061892,0.38542,0.73509,chr4p13,0.99999
DESCARTES_FETAL_LUNG_CSH1_CS...,SET,180,-0.03974,-0.0039158,0.063229,0.73516,DESCARTES_FETAL_LUNG_CSH1_CSH2_POSITIVE_CELLS,0.99999
GOMF_NUCLEAR_ANDROGEN_RECEPT...,SET,25,-0.098583,-0.0036355,0.15679,0.73525,GOMF_NUCLEAR_ANDROGEN_RECEPTOR_BINDING,0.99999
GROSS_ELK3_TARGETS_UP,SET,25,-0.11536,-0.0042541,0.18342,0.7353,GROSS_ELK3_TARGETS_UP,0.99999
HP_ABNORMAL_FEAR_INDUCED_BEH...,SET,7,-0.18228,-0.0035587,0.28976,0.73535,HP_ABNORMAL_FEAR_INDUCED_BEHAVIOR,0.99999
REACTOME_PROCESSING_OF_DNA_D...,SET,57,-0.064522,-0.0035897,0.10255,0.73537,REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,0.99999
GOMF_UBIQUITIN_LIGASE_ACTIVA...,SET,9,-0.17825,-0.0039457,0.28329,0.73538,GOMF_UBIQUITIN_LIGASE_ACTIVATOR_ACTIVITY,0.99999
HP_IRIDODONESIS,SET,4,-0.31058,-0.004584,0.49363,0.73538,HP_IRIDODONESIS,0.99999
GSE15659_NONSUPPRESSIVE_TCEL...1,SET,170,-0.04009,-0.00384,0.063704,0.73542,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN,0.99999
BIOCARTA_EPHA4_PATHWAY,SET,8,-0.21046,-0.0043924,0.33439,0.73545,BIOCARTA_EPHA4_PATHWAY,0.99999
HP_ABNORMAL_PHALANGEAL_JOINT...,SET,194,-0.039315,-0.0040201,0.062455,0.73548,HP_ABNORMAL_PHALANGEAL_JOINT_MORPHOLOGY_OF_THE_HAND,0.99999
MIR7843_3P,SET,80,-0.060982,-0.0040168,0.096857,0.73552,MIR7843_3P,0.99999
REACTOME_FORMYL_PEPTIDE_RECE...,SET,8,-0.23048,-0.0048102,0.36601,0.73555,REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS,0.99999
GSE22935_24H_VS_48H_MBOVIS_B...4,SET,183,-0.039621,-0.0039361,0.062891,0.73565,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.99999
GSE8621_LPS_PRIMED_UNSTIM_VS...1,SET,177,-0.038173,-0.0037301,0.060587,0.73567,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,0.99999
HP_URIC_ACID_NEPHROLITHIASIS,SET,11,-0.14918,-0.0036505,0.23673,0.7357,HP_URIC_ACID_NEPHROLITHIASIS,0.99999
GOBP_LEPTIN_MEDIATED_SIGNALI...,SET,10,-0.17195,-0.0040121,0.27282,0.73574,GOBP_LEPTIN_MEDIATED_SIGNALING_PATHWAY,0.99999
MIR6841_5P,SET,32,-0.098701,-0.0041172,0.15659,0.73575,MIR6841_5P,0.99999
MIR548AU_3P,SET,157,-0.042357,-0.0039003,0.067188,0.73579,MIR548AU_3P,0.99999
ABRAHAM_ALPC_VS_MULTIPLE_MYE...1,SET,20,-0.12054,-0.0039765,0.19116,0.73583,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,0.99999
GSE9946_LISTERIA_INF_MATURE_...1,SET,100,-0.054993,-0.0040477,0.087201,0.73586,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,0.99999
HP_EASY_FATIGABILITY,SET,85,-0.054596,-0.0037064,0.086567,0.73587,HP_EASY_FATIGABILITY,0.99999
GOBP_REGULATION_OF_MITOCHOND...12,SET,18,-0.12389,-0.0038776,0.19644,0.73588,GOBP_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.99999
MIR3945,SET,34,-0.090156,-0.0038763,0.14292,0.73591,MIR3945,0.99999
TRAVAGLINI_LUNG_MYOFIBROBLAS...,SET,60,-0.075779,-0.0043251,0.12012,0.73594,TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL,0.99999
E2F_01,SET,59,-0.065699,-0.0037185,0.10412,0.73597,E2F_01,0.99999
HP_SACCADIC_OSCILLATION,SET,20,-0.13627,-0.0044954,0.21597,0.73597,HP_SACCADIC_OSCILLATION,0.99999
HP_RENAL_CYST,SET,245,-0.034481,-0.0039567,0.054634,0.73602,HP_RENAL_CYST,0.99999
GOCC_RUFFLE_MEMBRANE,SET,95,-0.054303,-0.0038962,0.086035,0.73603,GOCC_RUFFLE_MEMBRANE,0.99999
GSE41867_NAIVE_VS_DAY6_LCMV_...1,SET,187,-0.040146,-0.0040312,0.063571,0.73615,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.99999
GSE13229_IMM_VS_INTMATURE_NK...2,SET,180,-0.041381,-0.0040775,0.0655,0.73623,GSE13229_IMM_VS_INTMATURE_NKCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...547,SET,12,-0.14476,-0.0036997,0.22904,0.73631,GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,0.99999
HP_FRAGMENTED_ELASTIC_FIBERS...,SET,9,-0.17313,-0.0038324,0.27393,0.73631,HP_FRAGMENTED_ELASTIC_FIBERS_IN_THE_DERMIS,0.99999
GSE29949_CD8_NEG_DC_SPLEEN_V...1,SET,175,-0.04086,-0.0039703,0.064626,0.73638,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_DN,0.99999
CRX_NRL_DN.V1_UP,SET,131,-0.047186,-0.0039717,0.074593,0.73649,CRX_NRL_DN.V1_UP,0.99999
GOCC_PROTEIN_PHOSPHATASE_TYP...1,SET,18,-0.12122,-0.0037938,0.1916,0.73651,GOCC_PROTEIN_PHOSPHATASE_TYPE_1_COMPLEX,0.99999
MIR6885_5P,SET,46,-0.078545,-0.0039268,0.12414,0.73653,MIR6885_5P,0.99999
GSE13484_UNSTIM_VS_12H_YF17D...1,SET,177,-0.039605,-0.0038701,0.062591,0.73655,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN,0.99999
GOCC_PERINUCLEAR_REGION_OF_C...,SET,668,-0.021253,-0.0039797,0.033586,0.73656,GOCC_PERINUCLEAR_REGION_OF_CYTOPLASM,0.99999
REACTOME_GLYCEROPHOSPHOLIPID...1,SET,113,-0.053577,-0.0041905,0.084663,0.73657,REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,0.99999
MIR1236_5P,SET,73,-0.06278,-0.003951,0.099209,0.73657,MIR1236_5P,0.99999
GOBP_REGULATION_OF_ADIPONECT...,SET,7,-0.21464,-0.0041904,0.33916,0.73658,GOBP_REGULATION_OF_ADIPONECTIN_SECRETION,0.99999
KEGG_NOTCH_SIGNALING_PATHWAY,SET,46,-0.075675,-0.0037833,0.11957,0.7366,KEGG_NOTCH_SIGNALING_PATHWAY,0.99999
MIR8061,SET,150,-0.045178,-0.004067,0.071358,0.73667,MIR8061,0.99999
GOBP_CYCLIC_NUCLEOTIDE_METAB...,SET,37,-0.093965,-0.0042142,0.14842,0.73667,GOBP_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS,0.99999
GSE13411_IGM_VS_SWITCHED_MEM...1,SET,176,-0.040147,-0.0039121,0.063411,0.73667,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN,0.99999
HP_HYPERALDOSTERONISM,SET,30,-0.11198,-0.0045231,0.17678,0.73677,HP_HYPERALDOSTERONISM,0.99999
GOCC_ALVEOLAR_LAMELLAR_BODY,SET,8,-0.19933,-0.0041602,0.31466,0.73678,GOCC_ALVEOLAR_LAMELLAR_BODY,0.99999
MIR4799_3P,SET,78,-0.061108,-0.0039747,0.096463,0.73679,MIR4799_3P,0.99999
GSE24142_EARLY_THYMIC_PROGEN...10,SET,187,-0.039849,-0.0040013,0.062902,0.7368,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN,0.99999
GOBP_ENDOCYTOSIS_INVOLVED_IN...,SET,11,-0.16786,-0.0041077,0.26494,0.73682,GOBP_ENDOCYTOSIS_INVOLVED_IN_VIRAL_ENTRY_INTO_HOST_CELL,0.99999
VANLOO_SP3_TARGETS_UP,SET,9,-0.18854,-0.0041736,0.29741,0.73694,VANLOO_SP3_TARGETS_UP,0.99999
MIR6739_3P,SET,174,-0.04199,-0.0040686,0.066236,0.73694,MIR6739_3P,0.99999
BIOCARTA_RNAPOL3_PATHWAY,SET,7,-0.14929,-0.0029146,0.23546,0.73696,BIOCARTA_RNAPOL3_PATHWAY,0.99999
PID_HIV_NEF_PATHWAY,SET,35,-0.092139,-0.0040193,0.14528,0.73702,PID_HIV_NEF_PATHWAY,0.99999
GSE15930_NAIVE_VS_72H_IN_VIT...2,SET,188,-0.038303,-0.0038563,0.060385,0.73706,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP,0.99999
KEGG_MEDICUS_VARIANT_EGF_OVE...2,SET,14,-0.1474,-0.004069,0.23235,0.73708,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOCC_ROUGH_ENDOPLASMIC_RETIC...2,SET,20,-0.12363,-0.0040784,0.19487,0.73709,GOCC_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE,0.99999
BIOCARTA_PTC1_PATHWAY,SET,11,-0.14808,-0.0036237,0.2334,0.7371,BIOCARTA_PTC1_PATHWAY,0.99999
HP_LOSS_OF_AMBULATION,SET,114,-0.049149,-0.003861,0.077462,0.73711,HP_LOSS_OF_AMBULATION,0.99999
PID_HEDGEHOG_GLI_PATHWAY,SET,46,-0.080452,-0.0040222,0.12677,0.73716,PID_HEDGEHOG_GLI_PATHWAY,0.99999
GSE12003_MIR223_KO_VS_WT_BM_...3,SET,125,-0.047514,-0.0039073,0.07487,0.73716,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_DN,0.99999
GOBP_RETINAL_ROD_CELL_DEVELO...,SET,10,-0.17972,-0.0041934,0.28318,0.73717,GOBP_RETINAL_ROD_CELL_DEVELOPMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...123,SET,640,-0.02292,-0.0042042,0.036104,0.73722,GOBP_NEGATIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION,0.99999
GOCC_AZUROPHIL_GRANULE_MEMBR...,SET,51,-0.073817,-0.0038853,0.11627,0.73723,GOCC_AZUROPHIL_GRANULE_MEMBRANE,0.99999
MIR451A,SET,6,-0.24329,-0.0043977,0.38322,0.73724,MIR451A,0.99999
GOBP_POSITIVE_REGULATION_OF_...99,SET,41,-0.092358,-0.0043598,0.14548,0.73724,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
BIOCARTA_P38MAPK_PATHWAY,SET,35,-0.091609,-0.0039962,0.14418,0.73741,BIOCARTA_P38MAPK_PATHWAY,0.99999
GSE45739_UNSTIM_VS_ACD3_ACD2...3,SET,178,-0.042502,-0.0041647,0.066886,0.73742,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_DN,0.99999
GSE11961_MARGINAL_ZONE_BCELL...4,SET,180,-0.04067,-0.0040073,0.064002,0.73743,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,0.99999
GOMF_DOUBLE_STRANDED_DNA_3_5...,SET,4,-0.27201,-0.0040148,0.42804,0.73744,GOMF_DOUBLE_STRANDED_DNA_3_5_DNA_EXONUCLEASE_ACTIVITY,0.99999
SHEDDEN_LUNG_CANCER_GOOD_SUR...2,SET,182,-0.042607,-0.0042212,0.067043,0.73745,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,0.99999
GSE27786_ERYTHROBLAST_VS_MON...2,SET,173,-0.039987,-0.0038634,0.062921,0.73745,GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP,0.99999
BANG_VERTEPORFIN_ENDOMETRIAL...2,SET,16,-0.13696,-0.0040417,0.21548,0.73748,BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP,0.99999
HP_ABNORMAL_LEFT_VENTRICLE_M...,SET,111,-0.049182,-0.0038127,0.07737,0.7375,HP_ABNORMAL_LEFT_VENTRICLE_MORPHOLOGY,0.99999
HOEK_MONOCYTE_2011_2012_TIV_...1,SET,13,-0.1466,-0.0038997,0.23059,0.73752,HOEK_MONOCYTE_2011_2012_TIV_ADULT_1DY_DN,0.99999
BIOCARTA_IL12_PATHWAY,SET,18,-0.13259,-0.0041497,0.20855,0.73753,BIOCARTA_IL12_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_CXCR4...2,SET,12,-0.15798,-0.0040378,0.2485,0.73753,KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,0.99999
REACTOME_CITRIC_ACID_CYCLE_T...,SET,32,-0.087406,-0.0036461,0.13747,0.73754,REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE,0.99999
MIR3184_3P,SET,66,-0.066063,-0.003954,0.1039,0.73754,MIR3184_3P,0.99999
GOBP_REGULATION_OF_SPONTANEO...,SET,5,-0.24664,-0.0040698,0.38792,0.73754,GOBP_REGULATION_OF_SPONTANEOUS_SYNAPTIC_TRANSMISSION,0.99999
YGTCCTTGR_UNKNOWN,SET,85,-0.056829,-0.003858,0.089355,0.7376,YGTCCTTGR_UNKNOWN,0.99999
GSE13411_PLASMA_CELL_VS_MEMO...1,SET,175,-0.041797,-0.0040613,0.065717,0.73761,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN,0.99999
KEGG_TYROSINE_METABOLISM,SET,38,-0.097244,-0.0044197,0.15285,0.73767,KEGG_TYROSINE_METABOLISM,0.99999
HP_LEUKOCYTOSIS,SET,140,-0.047307,-0.0041154,0.074339,0.73773,HP_LEUKOCYTOSIS,0.99999
MIR3675_5P,SET,30,-0.096105,-0.0038819,0.15095,0.73782,MIR3675_5P,0.99999
GOMF_ACYL_COA_OXIDASE_ACTIVI...,SET,7,-0.18163,-0.003546,0.28527,0.73783,GOMF_ACYL_COA_OXIDASE_ACTIVITY,0.99999
REACTOME_IRON_UPTAKE_AND_TRA...,SET,53,-0.079139,-0.0042461,0.12429,0.73784,REACTOME_IRON_UPTAKE_AND_TRANSPORT,0.99999
GOBP_CIRCADIAN_SLEEP_WAKE_CY...2,SET,6,-0.24789,-0.0044807,0.38919,0.73791,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP,0.99999
TAL1BETAITF2_01,SET,237,-0.036865,-0.0041615,0.057863,0.73797,TAL1BETAITF2_01,0.99999
GOBP_RELAXATION_OF_VASCULAR_...,SET,4,-0.28118,-0.0041501,0.44131,0.73798,GOBP_RELAXATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE,0.99999
HP_ENDOCARDITIS,SET,14,-0.15815,-0.0043658,0.24819,0.73801,HP_ENDOCARDITIS,0.99999
GOBP_UDP_GLUCOSE_METABOLIC_P...,SET,6,-0.17708,-0.0032007,0.27772,0.73813,GOBP_UDP_GLUCOSE_METABOLIC_PROCESS,0.99999
HP_RETINOSCHISIS,SET,7,-0.24778,-0.0048375,0.38859,0.73814,HP_RETINOSCHISIS,0.99999
CUI_DEVELOPING_HEART_SMOOTH_...,SET,41,-0.088188,-0.0041629,0.13827,0.7382,CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL,0.99999
GOBP_FATTY_ACID_ELONGATION,SET,13,-0.17832,-0.0047436,0.27948,0.73827,GOBP_FATTY_ACID_ELONGATION,0.99999
GOBP_REGULATION_OF_INTRINSIC...1,SET,160,-0.04221,-0.0039234,0.066155,0.73828,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
UDAYAKUMAR_MED1_TARGETS_UP,SET,118,-0.049531,-0.0039583,0.077605,0.73834,UDAYAKUMAR_MED1_TARGETS_UP,0.99999
HP_RECURRENT_CUTANEOUS_ABSCE...,SET,6,-0.24575,-0.004442,0.38504,0.73834,HP_RECURRENT_CUTANEOUS_ABSCESS_FORMATION,0.99999
ZNF622_TARGET_GENES,SET,55,-0.073491,-0.0040166,0.11514,0.73836,ZNF622_TARGET_GENES,0.99999
GOMF_DIOXYGENASE_ACTIVITY,SET,82,-0.05662,-0.0037757,0.088699,0.73837,GOMF_DIOXYGENASE_ACTIVITY,0.99999
GOCC_TRANSCRIPTION_REGULATOR...,SET,477,-0.025047,-0.0039846,0.039235,0.73838,GOCC_TRANSCRIPTION_REGULATOR_COMPLEX,0.99999
MOLENAAR_TARGETS_OF_CCND1_AN...2,SET,58,-0.068285,-0.0038321,0.10695,0.7384,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,0.99999
GOBP_HEPATOCYTE_GROWTH_FACTO...,SET,11,-0.17448,-0.0042697,0.2733,0.7384,GOBP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
MODULE_265,SET,25,-0.11952,-0.0044076,0.18719,0.73842,MODULE_265,0.99999
GOBP_ANTIGEN_PROCESSING_AND_...14,SET,24,-0.14086,-0.0050899,0.2206,0.73844,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_VIA_MHC_CLASS_IB,0.99999
SMID_BREAST_CANCER_NORMAL_LI...1,SET,6,-0.24581,-0.0044432,0.38482,0.73851,SMID_BREAST_CANCER_NORMAL_LIKE_DN,0.99999
GSE15659_NONSUPPRESSIVE_TCEL...2,SET,161,-0.043339,-0.0040408,0.067849,0.73851,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP,0.99999
GOMF_HISTONE_H3K9_METHYLTRAN...,SET,12,-0.16243,-0.0041514,0.25427,0.73852,GOMF_HISTONE_H3K9_METHYLTRANSFERASE_ACTIVITY,0.99999
REACTOME_INTEGRIN_CELL_SURFA...,SET,81,-0.066885,-0.004433,0.1047,0.73854,REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,0.99999
HP_VACUOLATED_LYMPHOCYTES,SET,11,-0.17604,-0.004308,0.27555,0.73854,HP_VACUOLATED_LYMPHOCYTES,0.99999
HP_PATENT_FORAMEN_OVALE,SET,112,-0.04985,-0.0038818,0.078022,0.73856,HP_PATENT_FORAMEN_OVALE,0.99999
MIR4281,SET,18,-0.14021,-0.0043882,0.21935,0.73864,MIR4281,0.99999
HP_ABDOMINAL_AORTIC_ANEURYSM,SET,22,-0.12885,-0.0044579,0.20159,0.73864,HP_ABDOMINAL_AORTIC_ANEURYSM,0.99999
GNF2_ANK1,SET,61,-0.07123,-0.0040991,0.11142,0.73867,GNF2_ANK1,0.99999
GNF2_SPTB,SET,61,-0.07123,-0.0040991,0.11142,0.73867,GNF2_SPTB,0.99999
HP_PARTIAL_ANOMALOUS_PULMONA...,SET,6,-0.23507,-0.004249,0.36771,0.73867,HP_PARTIAL_ANOMALOUS_PULMONARY_VENOUS_RETURN,0.99999
GOBP_TRANSCRIPTION_BY_RNA_PO...2,SET,56,-0.064213,-0.0035411,0.10043,0.73871,GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.99999
HP_HAND_POLYDACTYLY,SET,149,-0.043519,-0.0039047,0.068032,0.73881,HP_HAND_POLYDACTYLY,0.99999
GOMF_EXTRACELLULAR_MATRIX_ST...3,SET,42,-0.094846,-0.0045314,0.14826,0.73882,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_TENSILE_STRENGTH,0.99999
WATANABE_RECTAL_CANCER_RADIO...1,SET,89,-0.059174,-0.0041101,0.092486,0.73885,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,0.99999
HP_CHILBLAINS,SET,10,-0.15975,-0.0037274,0.2496,0.73891,HP_CHILBLAINS,0.99999
GSE11961_MARGINAL_ZONE_BCELL...5,SET,184,-0.039284,-0.0039132,0.061377,0.73893,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN,0.99999
MODULE_235,SET,76,-0.064249,-0.0041254,0.10037,0.73894,MODULE_235,0.99999
KEGG_ACUTE_MYELOID_LEUKEMIA,SET,54,-0.076761,-0.004157,0.11989,0.73899,KEGG_ACUTE_MYELOID_LEUKEMIA,0.99999
HP_DUPLICATION_OF_BONES_INVO...,SET,193,-0.038444,-0.003921,0.060043,0.739,HP_DUPLICATION_OF_BONES_INVOLVING_THE_UPPER_EXTREMITIES,0.99999
MIR6731_5P,SET,206,-0.039034,-0.0041116,0.060962,0.73901,MIR6731_5P,0.99999
GOBP_RESPONSE_TO_ABIOTIC_STI...,SET,1024,-0.017752,-0.004074,0.027724,0.73901,GOBP_RESPONSE_TO_ABIOTIC_STIMULUS,0.99999
MIR6772_5P,SET,31,-0.09231,-0.0037901,0.14409,0.73912,MIR6772_5P,0.99999
HP_ABNORMAL_NUMBER_OF_PERMAN...,SET,30,-0.099078,-0.0040019,0.15461,0.73918,HP_ABNORMAL_NUMBER_OF_PERMANENT_TEETH,0.99999
HP_STEPPAGE_GAIT,SET,49,-0.074863,-0.0038625,0.11682,0.73919,HP_STEPPAGE_GAIT,0.99999
HP_AXONAL_LOSS,SET,17,-0.12348,-0.0037559,0.19261,0.73927,HP_AXONAL_LOSS,0.99999
GSE17721_LPS_VS_CPG_1H_BMDC_...1,SET,192,-0.040234,-0.0040931,0.062754,0.73928,GSE17721_LPS_VS_CPG_1H_BMDC_DN,0.99999
GOMF_TRANSCRIPTION_COREPRESS...2,SET,42,-0.084806,-0.0040517,0.13223,0.73935,GOMF_TRANSCRIPTION_COREPRESSOR_BINDING,0.99999
TCANNTGAY_SREBP1_01,SET,421,-0.026604,-0.0039824,0.041473,0.73939,TCANNTGAY_SREBP1_01,0.99999
GOBP_ANTIGEN_PROCESSING_AND_...9,SET,7,-0.29595,-0.005778,0.46135,0.7394,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_LIPID_ANTIGEN_VIA_MHC_CLASS_IB,0.99999
HP_ABNORMAL_NEURON_MORPHOLOGY,SET,79,-0.060451,-0.003957,0.094218,0.73943,HP_ABNORMAL_NEURON_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_NUCLEAR_T...2,SET,11,-0.15357,-0.003758,0.23929,0.73948,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,0.99999
GSE17721_POLYIC_VS_CPG_2H_BM...2,SET,182,-0.040046,-0.0039676,0.062396,0.7395,GSE17721_POLYIC_VS_CPG_2H_BMDC_UP,0.99999
MODULE_17,SET,316,-0.030139,-0.00392,0.046957,0.73951,MODULE_17,0.99999
GOBP_TEMPERATURE_HOMEOSTASIS,SET,177,-0.042625,-0.0041652,0.066411,0.73951,GOBP_TEMPERATURE_HOMEOSTASIS,0.99999
HP_ABNORMAL_MUSCLE_FIBER_MOR...,SET,233,-0.034831,-0.0038991,0.054267,0.73951,HP_ABNORMAL_MUSCLE_FIBER_MORPHOLOGY,0.99999
MIR516A_3P_MIR516B_3P,SET,160,-0.044017,-0.0040914,0.068577,0.73952,MIR516A_3P_MIR516B_3P,0.99999
CHEOK_RESPONSE_TO_MERCAPTOPU...5,SET,19,-0.13117,-0.0042176,0.2043,0.73957,CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN,0.99999
WP_ERBB_SIGNALING,SET,86,-0.061255,-0.0041827,0.095406,0.73957,WP_ERBB_SIGNALING,0.99999
WP_MACROPHAGE_MARKERS,SET,8,-0.20561,-0.0042912,0.32023,0.73958,WP_MACROPHAGE_MARKERS,0.99999
GSE5099_MONOCYTE_VS_ALTERNAT...1,SET,166,-0.039738,-0.0037616,0.061892,0.73958,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN,0.99999
REACTOME_DOWNSTREAM_SIGNALIN...2,SET,31,-0.098882,-0.0040599,0.15399,0.73961,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1,0.99999
MIR1301_5P,SET,50,-0.077237,-0.0040254,0.12027,0.73963,MIR1301_5P,0.99999
GOMF_HISTONE_H4_DEMETHYLASE_...,SET,4,-0.27399,-0.004044,0.42649,0.7397,GOMF_HISTONE_H4_DEMETHYLASE_ACTIVITY,0.99999
HP_ABNORMAL_DURA_MATER_MORPH...,SET,23,-0.11266,-0.0039851,0.17535,0.73971,HP_ABNORMAL_DURA_MATER_MORPHOLOGY,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...13,SET,75,-0.057547,-0.0036708,0.089558,0.73975,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H,0.99999
GSE37301_HEMATOPOIETIC_STEM_...2,SET,167,-0.043321,-0.004113,0.06741,0.73977,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP,0.99999
REACTOME_REGULATION_OF_MECP2...,SET,29,-0.11042,-0.0043853,0.17175,0.73986,REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY,0.99999
MIR6824_3P,SET,99,-0.053417,-0.0039121,0.083055,0.73993,MIR6824_3P,0.99999
GSE21360_PRIMARY_VS_SECONDAR...2,SET,176,-0.04132,-0.0040263,0.064247,0.73993,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP,0.99999
REACTOME_GRB2_EVENTS_IN_ERBB...,SET,16,-0.13697,-0.0040419,0.21296,0.73994,REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,0.99999
GSE21670_UNTREATED_VS_TGFB_T...3,SET,180,-0.04224,-0.0041621,0.065656,0.74,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_DN,0.99999
LEE_NAIVE_T_LYMPHOCYTE,SET,16,-0.14804,-0.0043685,0.23008,0.74001,LEE_NAIVE_T_LYMPHOCYTE,0.99999
REACTOME_PLASMA_LIPOPROTEIN_...4,SET,30,-0.10508,-0.0042446,0.16332,0.74002,REACTOME_PLASMA_LIPOPROTEIN_REMODELING,0.99999
HP_REDUCED_FACTOR_XI_ACTIVITY,SET,13,-0.13651,-0.0036314,0.21206,0.74012,HP_REDUCED_FACTOR_XI_ACTIVITY,0.99999
GOMF_ANKYRIN_BINDING,SET,19,-0.13668,-0.0043949,0.21225,0.74019,GOMF_ANKYRIN_BINDING,0.99999
HP_ECCHYMOSIS,SET,54,-0.079682,-0.0043152,0.12373,0.74021,HP_ECCHYMOSIS,0.99999
GOBP_REGULATION_OF_TRANSLATI...12,SET,11,-0.15478,-0.0037877,0.24029,0.74025,GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.99999
HP_ABNORMALITY_OF_THE_PULMON...1,SET,119,-0.052361,-0.004202,0.081291,0.74025,HP_ABNORMALITY_OF_THE_PULMONARY_ARTERY,0.99999
MIR17_5P,SET,580,-0.023725,-0.0041499,0.036825,0.74029,MIR17_5P,0.99999
HP_ABNORMALITY_OF_THE_UPPER_...4,SET,1280,-0.015877,-0.0040437,0.024639,0.74034,HP_ABNORMALITY_OF_THE_UPPER_URINARY_TRACT,0.99999
GOBP_PEPTIDYL_LYSINE_OXIDATI...,SET,5,-0.27806,-0.0045882,0.43147,0.74035,GOBP_PEPTIDYL_LYSINE_OXIDATION,0.99999
GOMF_PROTEIN_LYSINE_6_OXIDAS...,SET,5,-0.27806,-0.0045882,0.43147,0.74035,GOMF_PROTEIN_LYSINE_6_OXIDASE_ACTIVITY,0.99999
GSE13547_WT_VS_ZFX_KO_BCELL_...6,SET,156,-0.046974,-0.0043118,0.072892,0.74035,GSE13547_WT_VS_ZFX_KO_BCELL_UP,0.99999
GOMF_PSEUDOURIDINE_SYNTHASE_...,SET,12,-0.13837,-0.0035365,0.2147,0.74037,GOMF_PSEUDOURIDINE_SYNTHASE_ACTIVITY,0.99999
HP_HYPERGLYCEMIA,SET,77,-0.062901,-0.0040652,0.097589,0.74039,HP_HYPERGLYCEMIA,0.99999
HP_TIP_TOE_GAIT,SET,75,-0.062457,-0.0039839,0.096876,0.74044,HP_TIP_TOE_GAIT,0.99999
MORF_FSHR,SET,244,-0.036439,-0.004173,0.056514,0.74046,MORF_FSHR,0.99999
GOBP_REGULATION_OF_TOLL_LIKE...6,SET,29,-0.094545,-0.0037548,0.14663,0.74046,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.99999
ACTGCCT_MIR34B,SET,200,-0.039361,-0.0040859,0.061038,0.74049,ACTGCCT_MIR34B,0.99999
GOBP_NADH_DEHYDROGENASE_COMP...,SET,48,-0.070828,-0.003617,0.10981,0.74052,GOBP_NADH_DEHYDROGENASE_COMPLEX_ASSEMBLY,0.99999
KEGG_MEDICUS_REFERENCE_CCR_C...,SET,31,-0.1105,-0.004537,0.17127,0.74059,KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY,0.99999
GOMF_ORGANIC_ACID_BINDING,SET,188,-0.043164,-0.0043456,0.066901,0.74059,GOMF_ORGANIC_ACID_BINDING,0.99999
GOBP_RESPONSE_TO_HEAT,SET,94,-0.055459,-0.0039583,0.085947,0.74062,GOBP_RESPONSE_TO_HEAT,0.99999
REACTOME_GLUTAMATE_AND_GLUTA...,SET,10,-0.16635,-0.0038815,0.25779,0.74063,REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM,0.99999
GSE41867_DAY8_VS_DAY15_LCMV_...2,SET,147,-0.046343,-0.0041303,0.071801,0.74067,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...199,SET,17,-0.12847,-0.0039078,0.199,0.74072,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
SHIN_B_CELL_LYMPHOMA_CLUSTER...2,SET,31,-0.10273,-0.0042179,0.15911,0.74074,SHIN_B_CELL_LYMPHOMA_CLUSTER_2,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...10,SET,186,-0.04025,-0.0040309,0.062341,0.74074,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_UP,0.99999
GOBP_MITOTIC_DNA_INTEGRITY_C...,SET,79,-0.055639,-0.0036421,0.086151,0.7408,GOBP_MITOTIC_DNA_INTEGRITY_CHECKPOINT_SIGNALING,0.99999
GOBP_REGULATION_OF_PATTERN_R...,SET,149,-0.043956,-0.0039439,0.067992,0.74102,GOBP_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_PECTORAL_MUSCLE_HYPOPLASI...,SET,7,-0.21389,-0.0041759,0.33083,0.74103,HP_PECTORAL_MUSCLE_HYPOPLASIA_APLASIA,0.99999
MIR339_5P,SET,65,-0.069398,-0.0041221,0.10732,0.74106,MIR339_5P,0.99999
GSE6674_UNSTIM_VS_ANTI_IGM_A...1,SET,178,-0.039002,-0.0038218,0.060314,0.74107,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...492,SET,272,-0.033856,-0.0040903,0.052339,0.74113,GOBP_NEGATIVE_REGULATION_OF_PHOSPHORYLATION,0.99999
HP_T_LYMPHOCYTOPENIA,SET,60,-0.07148,-0.0040798,0.1105,0.74114,HP_T_LYMPHOCYTOPENIA,0.99999
KEGG_MEDICUS_PATHOGEN_EBV_EB...3,SET,9,-0.17217,-0.0038112,0.26612,0.74117,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00483,0.99999
PID_EPO_PATHWAY,SET,31,-0.10036,-0.0041206,0.1551,0.7412,PID_EPO_PATHWAY,0.99999
CTCTATG_MIR368,SET,38,-0.092395,-0.0041993,0.14277,0.74123,CTCTATG_MIR368,0.99999
GOBP_CELLULAR_RESPONSE_TO_FL...,SET,19,-0.13601,-0.0043732,0.21016,0.74124,GOBP_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS,0.99999
MEISSNER_BRAIN_ICP_WITH_H3K4...,SET,27,-0.099752,-0.0038227,0.15412,0.74126,MEISSNER_BRAIN_ICP_WITH_H3K4ME3,0.99999
GOBP_NEGATIVE_REGULATION_OF_...500,SET,11,-0.17595,-0.0043056,0.27184,0.74126,GOBP_NEGATIVE_REGULATION_OF_POST_TRANSCRIPTIONAL_GENE_SILENCING,0.99999
HP_LINGUAL_DYSTONIA,SET,5,-0.24705,-0.0040765,0.38166,0.74127,HP_LINGUAL_DYSTONIA,0.99999
GOBP_CELLULAR_RESPONSE_TO_VI...1,SET,70,-0.070628,-0.004353,0.1091,0.74129,GOBP_CELLULAR_RESPONSE_TO_VIRUS,0.99999
SCHOEN_NFKB_SIGNALING,SET,32,-0.11535,-0.0048118,0.17815,0.74134,SCHOEN_NFKB_SIGNALING,0.99999
AMIT_SERUM_RESPONSE_240_MCF1...,SET,53,-0.083284,-0.0044685,0.12857,0.74142,AMIT_SERUM_RESPONSE_240_MCF10A,0.99999
GSE12845_IGD_POS_BLOOD_VS_PR...2,SET,169,-0.0426,-0.0040685,0.065764,0.74143,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,0.99999
REACTOME_SIGNALING_BY_FGFR4_...,SET,11,-0.15285,-0.0037405,0.23592,0.74147,REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE,0.99999
HP_HOARSE_VOICE,SET,91,-0.058377,-0.0040998,0.090075,0.74153,HP_HOARSE_VOICE,0.99999
REACTOME_DNA_METHYLATION,SET,5,-0.27671,-0.004566,0.42694,0.74154,REACTOME_DNA_METHYLATION,0.99999
GOBP_TETRAHYDROBIOPTERIN_MET...,SET,8,-0.17953,-0.0037468,0.27698,0.74155,GOBP_TETRAHYDROBIOPTERIN_METABOLIC_PROCESS,0.99999
GGATTA_PITX2_Q2,SET,522,-0.025915,-0.0043074,0.039982,0.74156,GGATTA_PITX2_Q2,0.99999
GSE12963_ENV_NEF_VS_ENV_NEF_...1,SET,132,-0.048213,-0.0040736,0.074381,0.74157,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.99999
HP_BROAD_DISTAL_PHALANX_OF_F...,SET,20,-0.12336,-0.0040694,0.19028,0.7416,HP_BROAD_DISTAL_PHALANX_OF_FINGER,0.99999
GOBP_REGULATION_OF_TRANSLATI...5,SET,12,-0.1512,-0.0038645,0.23315,0.74167,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_BY_EIF2_ALPHA_PHOSPHORYLATION,0.99999
HP_THYMOMA,SET,5,-0.23872,-0.0039392,0.36803,0.74171,HP_THYMOMA,0.99999
GOBP_NERVE_DEVELOPMENT,SET,92,-0.062844,-0.0044377,0.096862,0.74176,GOBP_NERVE_DEVELOPMENT,0.99999
RUTELLA_RESPONSE_TO_CSF2RB_A...2,SET,299,-0.033087,-0.0041881,0.050985,0.74181,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...67,SET,21,-0.12202,-0.0041246,0.188,0.74184,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
DODD_NASOPHARYNGEAL_CARCINOM...1,SET,1481,-0.015282,-0.0041618,0.023545,0.74185,DODD_NASOPHARYNGEAL_CARCINOMA_DN,0.99999
HP_ULNAR_DEVIATION_OF_THE_WR...,SET,19,-0.14894,-0.004789,0.22945,0.74186,HP_ULNAR_DEVIATION_OF_THE_WRIST,0.99999
HP_ABNORMALITY_OF_FRONTAL_SI...,SET,13,-0.14878,-0.0039577,0.22908,0.74197,HP_ABNORMALITY_OF_FRONTAL_SINUS,0.99999
GOMF_MACROLIDE_BINDING,SET,12,-0.13852,-0.0035404,0.21328,0.74199,GOMF_MACROLIDE_BINDING,0.99999
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...6,SET,113,-0.052267,-0.004088,0.080467,0.742,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GTE_200_VS_LTE_200_1DY_UP,0.99999
GSE360_T_GONDII_VS_B_MALAYI_...8,SET,174,-0.040997,-0.0039724,0.063116,0.74201,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.99999
KEGG_MEDICUS_PATHOGEN_SHIGEL...6,SET,5,-0.20485,-0.0033802,0.31529,0.74206,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGB1_TO_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY,0.99999
HP_ANORECTAL_ANOMALY,SET,149,-0.045746,-0.0041045,0.070406,0.74207,HP_ANORECTAL_ANOMALY,0.99999
GSE3920_IFNB_VS_IFNG_TREATED...2,SET,144,-0.047481,-0.0041887,0.073048,0.74215,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.99999
KAECH_DAY8_EFF_VS_DAY15_EFF_...2,SET,176,-0.039439,-0.003843,0.060668,0.74217,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP,0.99999
GSE10094_LCMV_VS_LISTERIA_IN...1,SET,178,-0.041613,-0.0040776,0.06401,0.74218,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN,0.99999
ACATTCC_MIR1_MIR206,SET,279,-0.033174,-0.0040585,0.051027,0.74219,ACATTCC_MIR1_MIR206,0.99999
chr11q23,SET,107,-0.10621,-0.0080848,0.16335,0.74221,chr11q23,0.99999
GSE34156_UNTREATED_VS_24H_TL...1,SET,160,-0.042928,-0.0039901,0.066017,0.74223,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.99999
GOBP_ORGANELLE_FISSION,SET,450,-0.025429,-0.0039322,0.039106,0.74224,GOBP_ORGANELLE_FISSION,0.99999
DASU_IL6_SIGNALING_SCAR_DN,SET,13,-0.1716,-0.0045649,0.26386,0.74226,DASU_IL6_SIGNALING_SCAR_DN,0.99999
REACTOME_METABOLISM_OF_ANGIO...,SET,15,-0.17257,-0.0049309,0.26536,0.74226,REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS,0.99999
GOCC_RIBONUCLEASE_P_COMPLEX,SET,10,-0.16284,-0.0037995,0.25035,0.7423,GOCC_RIBONUCLEASE_P_COMPLEX,0.99999
MIR3978,SET,228,-0.037411,-0.0041432,0.05751,0.74231,MIR3978,0.99999
MEBARKI_HCC_PROGENITOR_WNT_U...1,SET,107,-0.058598,-0.0044606,0.090041,0.7424,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,0.99999
GOBP_FIBROBLAST_GROWTH_FACTO...2,SET,74,-0.069725,-0.0044179,0.10714,0.7424,GOBP_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GCNP_SHH_UP_LATE.V1_UP,SET,163,-0.041617,-0.003904,0.063944,0.74242,GCNP_SHH_UP_LATE.V1_UP,0.99999
HP_EXERTIONAL_DYSPNEA,SET,134,-0.049685,-0.0042294,0.076329,0.74245,HP_EXERTIONAL_DYSPNEA,0.99999
GCM_TEC,SET,29,-0.10045,-0.0039892,0.15431,0.74246,GCM_TEC,0.99999
MIR1207_5P,SET,305,-0.032673,-0.0041762,0.05018,0.74251,MIR1207_5P,0.99999
GOCC_TIGHT_JUNCTION,SET,116,-0.053612,-0.0042482,0.082336,0.74252,GOCC_TIGHT_JUNCTION,0.99999
GOBP_PERIPHERAL_NERVOUS_SYST...5,SET,14,-0.16297,-0.0044988,0.25018,0.7426,GOBP_PERIPHERAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION,0.99999
chr16q23,SET,51,-0.12771,-0.0067221,0.19605,0.74261,chr16q23,0.99999
GOBP_POSITIVE_REGULATION_OF_...36,SET,5,-0.29313,-0.004837,0.45,0.74261,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...37,SET,5,-0.29313,-0.004837,0.45,0.74261,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS,0.99999
REACTOME_RESOLUTION_OF_D_LOO...2,SET,25,-0.10161,-0.0037471,0.15595,0.74265,REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA,0.99999
AR_02,SET,34,-0.095045,-0.0040865,0.14579,0.74277,AR_02,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...20,SET,6,-0.23366,-0.0042236,0.35843,0.74277,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_ANOTHER_COMPOUND_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.99999
TRAVAGLINI_LUNG_PERICYTE_CELL,SET,109,-0.060119,-0.0046187,0.092204,0.7428,TRAVAGLINI_LUNG_PERICYTE_CELL,0.99999
GOMF_ALPHA_1_3_FUCOSYLTRANSF...,SET,8,-0.23654,-0.0049368,0.3627,0.74285,GOMF_ALPHA_1_3_FUCOSYLTRANSFERASE_ACTIVITY,0.99999
GOBP_VESICLE_MEDIATED_TRANSP...3,SET,209,-0.038668,-0.0041023,0.059289,0.74286,GOBP_VESICLE_MEDIATED_TRANSPORT_IN_SYNAPSE,0.99999
BIOCARTA_HES_PATHWAY,SET,11,-0.16618,-0.0040666,0.25479,0.74287,BIOCARTA_HES_PATHWAY,0.99999
GOBP_ANDROGEN_BIOSYNTHETIC_P...,SET,10,-0.17575,-0.0041008,0.26942,0.7429,GOBP_ANDROGEN_BIOSYNTHETIC_PROCESS,0.99999
HP_ULNAR_DEVIATION_OF_FINGER,SET,33,-0.10314,-0.0043689,0.15807,0.74295,HP_ULNAR_DEVIATION_OF_FINGER,0.99999
WP_EICOSANOID_SYNTHESIS,SET,22,-0.13412,-0.00464,0.20551,0.74299,WP_EICOSANOID_SYNTHESIS,0.99999
GOMF_TRANSFORMING_GROWTH_FAC...4,SET,26,-0.12003,-0.004514,0.18387,0.74306,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.99999
MODULE_16,SET,461,-0.02623,-0.0041041,0.040172,0.7431,MODULE_16,0.99999
HP_ABSENT_THUMB,SET,51,-0.072423,-0.003812,0.11091,0.74311,HP_ABSENT_THUMB,0.99999
HP_CENTRAL_DIABETES_INSIPIDUS,SET,20,-0.13248,-0.0043704,0.20289,0.74311,HP_CENTRAL_DIABETES_INSIPIDUS,0.99999
GSE37301_CD4_TCELL_VS_GRANUL...2,SET,148,-0.047508,-0.0042485,0.072743,0.74315,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.99999
HP_PROGRESSIVE_NEUROLOGIC_DE...,SET,62,-0.067079,-0.0038917,0.10269,0.74318,HP_PROGRESSIVE_NEUROLOGIC_DETERIORATION,0.99999
HP_INAPPROPRIATE_BEHAVIOR,SET,14,-0.14728,-0.0040658,0.22541,0.74324,HP_INAPPROPRIATE_BEHAVIOR,0.99999
HP_ABNORMAL_RIB_OSSIFICATION,SET,8,-0.20743,-0.0043292,0.31745,0.74325,HP_ABNORMAL_RIB_OSSIFICATION,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...54,SET,14,-0.14688,-0.0040547,0.22468,0.74336,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.99999
MODULE_191,SET,19,-0.15397,-0.0049507,0.23551,0.74336,MODULE_191,0.99999
DORN_ADENOVIRUS_INFECTION_12...1,SET,30,-0.096409,-0.0038941,0.14745,0.74338,DORN_ADENOVIRUS_INFECTION_12HR_DN,0.99999
SLEBOS_HEAD_AND_NECK_CANCER_...,SET,66,-0.06491,-0.003885,0.099271,0.7434,SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP,0.99999
HP_KERATAN_SULFATE_EXCRETION...,SET,5,-0.24546,-0.0040503,0.37536,0.74341,HP_KERATAN_SULFATE_EXCRETION_IN_URINE,0.99999
BIOCARTA_PELP1_PATHWAY,SET,6,-0.21725,-0.0039269,0.3322,0.74343,BIOCARTA_PELP1_PATHWAY,0.99999
HP_FLEXION_CONTRACTURE_OF_TH...,SET,4,-0.33564,-0.0049539,0.51324,0.74343,HP_FLEXION_CONTRACTURE_OF_THE_2ND_FINGER,0.99999
ZNF8_TARGET_GENES,SET,785,-0.020264,-0.0040998,0.030983,0.74345,ZNF8_TARGET_GENES,0.99999
GSE3039_ALPHABETA_CD8_TCELL_...3,SET,184,-0.040058,-0.0039903,0.061247,0.74345,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_DN,0.99999
HP_IRREGULAR_DENTITION,SET,7,-0.2154,-0.0042053,0.32932,0.74346,HP_IRREGULAR_DENTITION,0.99999
WP_PDGFRBETA_PATHWAY,SET,28,-0.10853,-0.0042351,0.16591,0.74348,WP_PDGFRBETA_PATHWAY,0.99999
HE_LIM_SUN_FETAL_LUNG_C5_PRO...,SET,407,-0.026905,-0.0039615,0.041133,0.74348,HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL,0.99999
ZNF320_TARGET_GENES,SET,1227,-0.01658,-0.0041406,0.025344,0.7435,ZNF320_TARGET_GENES,0.99999
GSE40274_CTRL_VS_LEF1_TRANSD...2,SET,155,-0.04533,-0.0041476,0.069291,0.7435,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
PID_AR_TF_PATHWAY,SET,49,-0.079128,-0.0040826,0.12092,0.74356,PID_AR_TF_PATHWAY,0.99999
WP_NANOPARTICLE_TRIGGERED_RE...,SET,12,-0.17593,-0.0044964,0.26884,0.74357,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,0.99999
HP_CHIN_WITH_H_SHAPED_CREASE,SET,4,-0.34611,-0.0051085,0.52885,0.74359,HP_CHIN_WITH_H_SHAPED_CREASE,0.99999
REACTOME_SIGNALING_BY_BRAF_A...,SET,62,-0.07344,-0.0042607,0.11221,0.7436,REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,0.99999
GOMF_NITRIC_OXIDE_SYNTHASE_R...,SET,7,-0.18078,-0.0035295,0.27616,0.74364,GOMF_NITRIC_OXIDE_SYNTHASE_REGULATOR_ACTIVITY,0.99999
GSE3565_CTRL_VS_LPS_INJECTED...4,SET,160,-0.04635,-0.0043082,0.070806,0.74364,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP,0.99999
GSE2770_UNTREATED_VS_IL12_TR...5,SET,178,-0.040986,-0.0040162,0.062603,0.74366,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.99999
REACTOME_A_TETRASACCHARIDE_L...,SET,23,-0.11513,-0.0040725,0.17584,0.74367,REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS,0.99999
HP_UROGENITAL_FISTULA,SET,46,-0.079528,-0.0039759,0.12146,0.74369,HP_UROGENITAL_FISTULA,0.99999
KEGG_GLYCOLYSIS_GLUCONEOGENE...,SET,54,-0.075575,-0.0040928,0.11539,0.74374,KEGG_GLYCOLYSIS_GLUCONEOGENESIS,0.99999
XU_HGF_TARGETS_REPRESSED_BY_...1,SET,81,-0.061048,-0.0040461,0.093209,0.74375,XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,0.99999
HP_IVORY_EPIPHYSES_OF_THE_PH...,SET,6,-0.25032,-0.0045247,0.38203,0.74383,HP_IVORY_EPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,0.99999
HP_ABNORMALITY_OF_T_CELL_PHY...,SET,50,-0.080275,-0.0041837,0.12249,0.74389,HP_ABNORMALITY_OF_T_CELL_PHYSIOLOGY,0.99999
GSE3039_ALPHAALPHA_CD8_TCELL...1,SET,184,-0.041882,-0.0041719,0.06388,0.74397,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_DN,0.99999
GOBP_INTESTINAL_ABSORPTION,SET,40,-0.091372,-0.0042604,0.13935,0.74399,GOBP_INTESTINAL_ABSORPTION,0.99999
ZHANG_RESPONSE_TO_CANTHARIDI...1,SET,60,-0.066325,-0.0037856,0.10111,0.74407,ZHANG_RESPONSE_TO_CANTHARIDIN_DN,0.99999
GARCIA_PINERES_PBMC_HPV_16_L...6,SET,20,-0.13172,-0.0043454,0.20078,0.7441,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_7MO_CORRELATED_WITH_ANTIBODY_RESPONSE_POSITIVE,0.99999
GSE25087_TREG_VS_TCONV_ADULT...2,SET,174,-0.044104,-0.0042734,0.067222,0.74412,GSE25087_TREG_VS_TCONV_ADULT_UP,0.99999
REACTOME_EPH_EPHRIN_MEDIATED...,SET,49,-0.083055,-0.0042852,0.12655,0.74418,REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,0.99999
GSE557_WT_VS_CIITA_KO_DC_UP,SET,182,-0.039501,-0.0039136,0.060187,0.74418,GSE557_WT_VS_CIITA_KO_DC_UP,0.99999
MODULE_90,SET,3,-0.25112,-0.00321,0.38261,0.74419,MODULE_90,0.99999
BOSCO_EPITHELIAL_DIFFERENTIA...,SET,60,-0.080546,-0.0045972,0.12271,0.74421,BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE,0.99999
GSE9239_CTRL_VS_TNF_INHIBITO...2,SET,175,-0.042433,-0.0041232,0.06463,0.74427,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP,0.99999
MODULE_115,SET,25,-0.10869,-0.0040081,0.16549,0.74432,MODULE_115,0.99999
GSE20366_EX_VIVO_VS_HOMEOSTA...2,SET,180,-0.039893,-0.0039308,0.060707,0.74445,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP,0.99999
GOMF_OLFACTORY_RECEPTOR_ACTI...,SET,305,-0.047724,-0.0061001,0.072582,0.74457,GOMF_OLFACTORY_RECEPTOR_ACTIVITY,0.99999
GOBP_FORMATION_OF_TRANSLATIO...,SET,5,-0.20095,-0.0033158,0.3056,0.74458,GOBP_FORMATION_OF_TRANSLATION_PREINITIATION_COMPLEX,0.99999
GOBP_REGULATION_OF_HORMONE_B...,SET,23,-0.1276,-0.0045135,0.19405,0.74458,GOBP_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,0.99999
GOCC_PHAGOPHORE_ASSEMBLY_SIT...,SET,20,-0.12377,-0.004083,0.18819,0.74462,GOCC_PHAGOPHORE_ASSEMBLY_SITE_MEMBRANE,0.99999
GSE15330_MEGAKARYOCYTE_ERYTH...3,SET,180,-0.042068,-0.0041451,0.063965,0.74462,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...8,SET,191,-0.043316,-0.0043953,0.06586,0.74463,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_UP,0.99999
MODULE_1,SET,334,-0.033358,-0.0044584,0.050718,0.74464,MODULE_1,0.99999
GOBP_POSITIVE_REGULATION_OF_...736,SET,41,-0.086867,-0.0041006,0.13207,0.74464,GOBP_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.99999
HP_CONJUGATED_HYPERBILIRUBIN...,SET,34,-0.10591,-0.0045537,0.16101,0.74466,HP_CONJUGATED_HYPERBILIRUBINEMIA,0.99999
HP_HEADACHE,SET,298,-0.033057,-0.0041774,0.050254,0.74466,HP_HEADACHE,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...2,SET,184,-0.040926,-0.0040767,0.06221,0.74468,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...50,SET,7,-0.22433,-0.0043797,0.34099,0.74469,GOBP_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.99999
REACTOME_HEDGEHOG_LIGAND_BIO...,SET,62,-0.063564,-0.0036878,0.09659,0.74475,REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,0.99999
GOBP_BRANCHIOMOTOR_NEURON_AX...,SET,6,-0.24933,-0.0045069,0.37881,0.74479,GOBP_BRANCHIOMOTOR_NEURON_AXON_GUIDANCE,0.99999
GSE6875_WT_VS_FOXP3_KO_TREG_...1,SET,179,-0.042875,-0.004213,0.065122,0.74485,GSE6875_WT_VS_FOXP3_KO_TREG_DN,0.99999
GSE24574_BCL6_LOW_TFH_VS_TCO...2,SET,168,-0.044789,-0.004265,0.068005,0.74492,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...596,SET,5,-0.24693,-0.0040746,0.37491,0.74493,GOBP_POSITIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
MIR873_3P,SET,55,-0.074866,-0.0040917,0.11366,0.74495,MIR873_3P,0.99999
GOBP_LIPID_TRANSPORT_ACROSS_...,SET,5,-0.24066,-0.0039711,0.36536,0.74495,GOBP_LIPID_TRANSPORT_ACROSS_BLOOD_BRAIN_BARRIER,0.99999
GOBP_RNA_POLYMERASE_I_PREINI...,SET,9,-0.16415,-0.0036337,0.2492,0.74495,GOBP_RNA_POLYMERASE_I_PREINITIATION_COMPLEX_ASSEMBLY,0.99999
GOBP_TRANSCRIPTION_INITIATIO...3,SET,9,-0.16415,-0.0036337,0.2492,0.74495,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_I_PROMOTER,0.99999
HP_AIRWAY_OBSTRUCTION,SET,115,-0.053463,-0.0042182,0.081164,0.74495,HP_AIRWAY_OBSTRUCTION,0.99999
GSE18203_CTRL_VS_INTRATUMORA...1,SET,176,-0.042737,-0.0041644,0.064881,0.74495,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_DN,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_PRO...,SET,909,-0.018753,-0.0040684,0.02847,0.74495,HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL,0.99999
HP_CEREBRAL_BERRY_ANEURYSM,SET,6,-0.23073,-0.0041706,0.35027,0.74496,HP_CEREBRAL_BERRY_ANEURYSM,0.99999
GSE24972_WT_VS_IRF8_KO_MARGI...2,SET,174,-0.043509,-0.0042158,0.066026,0.74504,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP,0.99999
HP_HYPOPLASTIC_HEART,SET,43,-0.093012,-0.0044962,0.14113,0.74506,HP_HYPOPLASTIC_HEART,0.99999
MIR4520_2_3P,SET,111,-0.055654,-0.0043145,0.084441,0.74508,MIR4520_2_3P,0.99999
GOBP_REGULATION_OF_SIGNALING...,SET,88,-0.063894,-0.0044131,0.096934,0.7451,GOBP_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,0.99999
MODULE_381,SET,11,-0.16715,-0.0040905,0.25358,0.74511,MODULE_381,0.99999
WP_EFFECTS_OF_MFN2_MUTATION,SET,22,-0.12773,-0.0044191,0.19373,0.74516,WP_EFFECTS_OF_MFN2_MUTATION,0.99999
MIR548AR_5P,SET,450,-0.027237,-0.0042117,0.041307,0.74517,MIR548AR_5P,0.99999
GSE37533_PPARG2_FOXP3_VS_FOX...2,SET,172,-0.04039,-0.0038912,0.06125,0.74519,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,0.99999
REACTOME_RESPIRATORY_ELECTRO...,SET,135,-0.042226,-0.0036077,0.064028,0.7452,REACTOME_RESPIRATORY_ELECTRON_TRANSPORT,0.99999
GSE30153_LUPUS_VS_HEALTHY_DO...2,SET,184,-0.040871,-0.0040712,0.061942,0.74531,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP,0.99999
MODULE_77,SET,27,-0.091499,-0.0035064,0.13867,0.74532,MODULE_77,0.99999
GOBP_REGULATION_OF_ARACHIDON...,SET,7,-0.20355,-0.0039741,0.30847,0.74533,GOBP_REGULATION_OF_ARACHIDONIC_ACID_SECRETION,0.99999
GOMF_ALANINE_TRANSMEMBRANE_T...,SET,14,-0.16645,-0.0045947,0.2522,0.74536,GOMF_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
TESAR_ALK_AND_JAK_TARGETS_MO...1,SET,4,-0.24563,-0.0036254,0.37215,0.74538,TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN,0.99999
GSE29618_MONOCYTE_VS_MDC_UP,SET,186,-0.043386,-0.0043449,0.065706,0.74546,GSE29618_MONOCYTE_VS_MDC_UP,0.99999
HP_ABNORMAL_AMPLITUDE_OF_PAT...,SET,6,-0.24518,-0.0044318,0.37128,0.74549,HP_ABNORMAL_AMPLITUDE_OF_PATTERN_ELECTRORETINOGRAM,0.99999
GSE27786_CD8_TCELL_VS_NKTCEL...1,SET,178,-0.042636,-0.0041779,0.064554,0.74552,GSE27786_CD8_TCELL_VS_NKTCELL_DN,0.99999
HP_SECRETORY_DIARRHEA,SET,12,-0.15171,-0.0038775,0.22969,0.74553,HP_SECRETORY_DIARRHEA,0.99999
GSE17974_0H_VS_48H_IN_VITRO_...2,SET,164,-0.045444,-0.004276,0.068792,0.74556,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP,0.99999
WP_NOCGMPPKG_MEDIATED_NEUROP...,SET,41,-0.092079,-0.0043466,0.13936,0.7456,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,0.99999
CUI_DEVELOPING_HEART_CORONAR...,SET,37,-0.10709,-0.004803,0.16209,0.7456,CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL,0.99999
GOBP_VITAMIN_TRANSPORT,SET,48,-0.083723,-0.0042755,0.1267,0.74563,GOBP_VITAMIN_TRANSPORT,0.99999
RODWELL_AGING_KIDNEY_NO_BLOO...2,SET,196,-0.043305,-0.0044507,0.065528,0.74565,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,0.99999
GSE5589_LPS_AND_IL10_VS_LPS_...6,SET,180,-0.040062,-0.0039474,0.060584,0.74577,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.99999
DAVICIONI_RHABDOMYOSARCOMA_P...1,SET,13,-0.19319,-0.0051392,0.2921,0.74581,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,0.99999
HP_DEXAMETHASONE_SUPPRESSIBL...,SET,5,-0.30573,-0.0050449,0.46203,0.74592,HP_DEXAMETHASONE_SUPPRESSIBLE_PRIMARY_HYPERALDOSTERONISM,0.99999
GOBP_GROOMING_BEHAVIOR,SET,18,-0.15207,-0.0047595,0.2298,0.74593,GOBP_GROOMING_BEHAVIOR,0.99999
WESTON_VEGFA_TARGETS_6HR,SET,43,-0.092897,-0.0044907,0.14033,0.74601,WESTON_VEGFA_TARGETS_6HR,0.99999
HP_METABOLIC_ALKALOSIS,SET,18,-0.1432,-0.0044817,0.21627,0.74605,HP_METABOLIC_ALKALOSIS,0.99999
REACTOME_DISEASES_OF_IMMUNE_...,SET,29,-0.11003,-0.0043696,0.16609,0.74615,REACTOME_DISEASES_OF_IMMUNE_SYSTEM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...76,SET,6,-0.25539,-0.0046163,0.38551,0.74616,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,0.99999
ZHENG_CORD_BLOOD_C5_SIMILAR_...,SET,53,-0.087238,-0.0046806,0.13168,0.74616,ZHENG_CORD_BLOOD_C5_SIMILAR_TO_HSC_C6_PUTATIVE_ALTERED_METABOLIC_STATE,0.99999
GSE34205_HEALTHY_VS_FLU_INF_...1,SET,174,-0.044513,-0.0043131,0.067188,0.74618,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN,0.99999
GOCC_CYTOSOLIC_LARGE_RIBOSOM...,SET,50,-0.076828,-0.0040041,0.11596,0.74619,GOCC_CYTOSOLIC_LARGE_RIBOSOMAL_SUBUNIT,0.99999
KEGG_MEDICUS_REFERENCE_TAC3_...,SET,10,-0.17906,-0.004178,0.27024,0.7462,KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY,0.99999
GSE39382_IL3_VS_IL3_IL33_TRE...1,SET,177,-0.043461,-0.0042469,0.065593,0.7462,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN,0.99999
GSE19941_UNSTIM_VS_LPS_STIM_...2,SET,178,-0.042713,-0.0041854,0.064454,0.74623,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP,0.99999
GSE34006_UNTREATED_VS_A2AR_A...1,SET,182,-0.042817,-0.0042421,0.06461,0.74624,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_DN,0.99999
HP_HYPERCONVEX_FINGERNAILS,SET,6,-0.25515,-0.0046119,0.38494,0.74627,HP_HYPERCONVEX_FINGERNAILS,0.99999
GOMF_GLUTAMATE_GATED_RECEPTO...,SET,15,-0.15865,-0.0045332,0.23933,0.7463,GOMF_GLUTAMATE_GATED_RECEPTOR_ACTIVITY,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...45,SET,21,-0.12266,-0.0041462,0.18501,0.74632,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.99999
MODULE_280,SET,44,-0.089906,-0.0043962,0.13561,0.74632,MODULE_280,0.99999
HP_GENERALIZED_AMYLOID_DEPOS...,SET,6,-0.24205,-0.0043752,0.3651,0.74632,HP_GENERALIZED_AMYLOID_DEPOSITION,0.99999
MIR6837_5P,SET,116,-0.051837,-0.0041076,0.078158,0.74641,MIR6837_5P,0.99999
GOBP_T_FOLLICULAR_HELPER_CEL...,SET,7,-0.21309,-0.0041603,0.32117,0.74649,GOBP_T_FOLLICULAR_HELPER_CELL_DIFFERENTIATION,0.99999
GOBP_TRANSLATIONAL_INITIATION,SET,106,-0.050061,-0.003793,0.075448,0.7465,GOBP_TRANSLATIONAL_INITIATION,0.99999
GSE26488_WT_VS_VP16_TRANSGEN...1,SET,150,-0.048419,-0.0043588,0.072972,0.7465,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...757,SET,11,-0.17787,-0.0043528,0.26806,0.74651,GOBP_POSITIVE_REGULATION_OF_TISSUE_REMODELING,0.99999
REACTOME_SUMOYLATION_OF_DNA_...1,SET,70,-0.066301,-0.0040863,0.09987,0.74661,REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,0.99999
GOBP_REGULATION_OF_T_CELL_CH...,SET,15,-0.1436,-0.0041031,0.21629,0.74662,GOBP_REGULATION_OF_T_CELL_CHEMOTAXIS,0.99999
NKX62_Q2,SET,220,-0.041012,-0.0044627,0.061757,0.74668,NKX62_Q2,0.99999
MIR7162_5P,SET,162,-0.045338,-0.0042402,0.068259,0.74672,MIR7162_5P,0.99999
GOBP_REGULATION_OF_PROTEIN_A...3,SET,34,-0.098782,-0.0042472,0.14871,0.74674,GOBP_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,0.99999
HP_PULMONARY_ARTERIOVENOUS_M...,SET,4,-0.31168,-0.0046002,0.46912,0.74677,HP_PULMONARY_ARTERIOVENOUS_MALFORMATION,0.99999
HP_REMNANTS_OF_THE_HYALOID_V...,SET,9,-0.20735,-0.00459,0.31201,0.74683,HP_REMNANTS_OF_THE_HYALOID_VASCULAR_SYSTEM,0.99999
MXD1_TARGET_GENES,SET,504,-0.025479,-0.0041633,0.038336,0.74685,MXD1_TARGET_GENES,0.99999
RAMPON_ENRICHED_LEARNING_ENV...2,SET,14,-0.1452,-0.0040082,0.21837,0.74695,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP,0.99999
HOLLEMAN_VINCRISTINE_RESISTA...4,SET,36,-0.095553,-0.0042272,0.14369,0.74697,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,0.99999
GOBP_DEOXYRIBONUCLEOSIDE_MET...,SET,10,-0.19313,-0.0045064,0.29041,0.74698,GOBP_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,0.99999
GOCC_LOW_DENSITY_LIPOPROTEIN...,SET,11,-0.17321,-0.0042386,0.26045,0.74698,GOCC_LOW_DENSITY_LIPOPROTEIN_PARTICLE,0.99999
PID_ERBB1_DOWNSTREAM_PATHWAY,SET,102,-0.058098,-0.0043185,0.087344,0.74702,PID_ERBB1_DOWNSTREAM_PATHWAY,0.99999
MIR30C_2_3P,SET,117,-0.054877,-0.004367,0.082502,0.74702,MIR30C_2_3P,0.99999
XU_RESPONSE_TO_TRETINOIN_AND...1,SET,13,-0.16017,-0.0042608,0.24079,0.74703,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,0.99999
MIR4517,SET,189,-0.04312,-0.0043526,0.064821,0.74704,MIR4517,0.99999
HP_ABNORMALLY_LOW_PITCHED_VO...,SET,10,-0.18327,-0.0042761,0.27536,0.74714,HP_ABNORMALLY_LOW_PITCHED_VOICE,0.99999
GOBP_SERINE_PHOSPHORYLATION_...,SET,19,-0.15467,-0.0049734,0.23239,0.74716,GOBP_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...9,SET,176,-0.041965,-0.0040892,0.063046,0.74717,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_DN,0.99999
MIR6881_3P,SET,160,-0.046243,-0.0042982,0.069469,0.74718,MIR6881_3P,0.99999
MARCINIAK_ER_STRESS_RESPONSE...,SET,20,-0.12988,-0.0042845,0.19507,0.74722,MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP,0.99999
MIR6870_5P,SET,199,-0.039883,-0.0041298,0.059897,0.74724,MIR6870_5P,0.99999
GSE32901_TH1_VS_TH17_NEG_CD4...2,SET,114,-0.053656,-0.0042151,0.080575,0.74726,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP,0.99999
GOBP_ERAD_PATHWAY,SET,104,-0.052917,-0.0039716,0.079458,0.74728,GOBP_ERAD_PATHWAY,0.99999
GOCC_APICAL_PART_OF_CELL,SET,434,-0.028828,-0.0043797,0.043283,0.7473,GOCC_APICAL_PART_OF_CELL,0.99999
GOBP_GLYCOLIPID_BIOSYNTHETIC...,SET,74,-0.064597,-0.004093,0.096984,0.74731,GOBP_GLYCOLIPID_BIOSYNTHETIC_PROCESS,0.99999
GSE5099_DAY3_VS_DAY7_MCSF_TR...1,SET,144,-0.047687,-0.0042068,0.071593,0.74731,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN,0.99999
MIR4697_5P,SET,14,-0.16526,-0.004562,0.248,0.74741,MIR4697_5P,0.99999
HP_GINGIVITIS,SET,29,-0.11346,-0.0045058,0.17026,0.74742,HP_GINGIVITIS,0.99999
REACTOME_TRP_CHANNELS,SET,27,-0.12366,-0.004739,0.18555,0.74744,REACTOME_TRP_CHANNELS,0.99999
GSE360_CTRL_VS_L_MAJOR_MAC_UP,SET,182,-0.041265,-0.0040882,0.061909,0.74746,GSE360_CTRL_VS_L_MAJOR_MAC_UP,0.99999
REACTOME_CELLULAR_RESPONSES_...,SET,700,-0.021248,-0.0040692,0.031876,0.74747,REACTOME_CELLULAR_RESPONSES_TO_STIMULI,0.99999
WP_MAMMARY_GLAND_DEVELOPMENT...1,SET,15,-0.16023,-0.0045782,0.24036,0.74749,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,0.99999
HP_ANTERIOR_SYNECHIAE_OF_THE...,SET,13,-0.18313,-0.0048716,0.27472,0.74749,HP_ANTERIOR_SYNECHIAE_OF_THE_ANTERIOR_CHAMBER,0.99999
MORF_MAP2K7,SET,157,-0.047789,-0.0044005,0.071667,0.74755,MORF_MAP2K7,0.99999
GOBP_POSITIVE_REGULATION_OF_...834,SET,156,-0.048742,-0.004474,0.073094,0.74756,GOBP_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,0.99999
GOBP_CELL_CYCLE_PHASE_TRANSI...,SET,495,-0.025554,-0.0041392,0.038317,0.74759,GOBP_CELL_CYCLE_PHASE_TRANSITION,0.99999
GOBP_NUCLEOBASE_TRANSPORT,SET,12,-0.15794,-0.0040366,0.23681,0.74759,GOBP_NUCLEOBASE_TRANSPORT,0.99999
GSE2405_S_AUREUS_VS_UNTREATE...2,SET,173,-0.040578,-0.0039205,0.060836,0.74761,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...684,SET,46,-0.077934,-0.0038962,0.11675,0.74777,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_TRANSCRIPTION_DEPENDENT...,SET,7,-0.21597,-0.0042164,0.32348,0.74782,GOBP_TRANSCRIPTION_DEPENDENT_TETHERING_OF_RNA_POLYMERASE_II_GENE_DNA_AT_NUCLEAR_PERIPHERY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...200,SET,13,-0.15968,-0.0042477,0.23908,0.7479,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.99999
GOBP_METANEPHRIC_PROXIMAL_TU...,SET,5,-0.28438,-0.0046926,0.42571,0.74793,GOBP_METANEPHRIC_PROXIMAL_TUBULE_DEVELOPMENT,0.99999
MIR5580_5P,SET,109,-0.055603,-0.0042717,0.083225,0.74796,MIR5580_5P,0.99999
GOBP_PROTEIN_DENEDDYLATION,SET,11,-0.15683,-0.0038377,0.23465,0.74804,GOBP_PROTEIN_DENEDDYLATION,0.99999
MIR3529_3P,SET,493,-0.026532,-0.0042891,0.039691,0.74807,MIR3529_3P,0.99999
GSE4984_UNTREATED_VS_VEHICLE...1,SET,153,-0.045842,-0.0041676,0.068567,0.74811,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_DN,0.99999
GROSS_HYPOXIA_VIA_ELK3_ONLY_...1,SET,44,-0.085095,-0.004161,0.12724,0.74817,GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,0.99999
GSE12198_NK_VS_NK_ACT_EXPANS...1,SET,184,-0.040884,-0.0040725,0.061134,0.74817,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN,0.99999
GSE28237_EARLY_VS_LATE_GC_BC...1,SET,175,-0.04218,-0.0040986,0.063063,0.7482,GSE28237_EARLY_VS_LATE_GC_BCELL_DN,0.99999
HP_GENERALIZED_NON_CONVULSIV...,SET,16,-0.13956,-0.0041182,0.20859,0.74826,HP_GENERALIZED_NON_CONVULSIVE_STATUS_EPILEPTICUS_WITHOUT_COMA,0.99999
HALLMARK_G2M_CHECKPOINT,SET,181,-0.040328,-0.0039845,0.060266,0.7483,HALLMARK_G2M_CHECKPOINT,0.99999
GOMF_DOPAMINE_BINDING,SET,6,-0.26757,-0.0048365,0.3998,0.74833,GOMF_DOPAMINE_BINDING,0.99999
GSE17186_BLOOD_VS_CORD_BLOOD...4,SET,189,-0.040254,-0.0040633,0.060142,0.74835,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP,0.99999
HP_ABNORMAL_NASAL_DORSUM_MOR...,SET,228,-0.037347,-0.0041362,0.055792,0.74838,HP_ABNORMAL_NASAL_DORSUM_MORPHOLOGY,0.99999
GOBP_BLOOD_VESSEL_ENDOTHELIA...2,SET,108,-0.057417,-0.0043909,0.085768,0.74839,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...623,SET,6,-0.26859,-0.0048549,0.40118,0.7484,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,0.99999
GSE23114_WT_VS_SLE2C1_MOUSE_...4,SET,191,-0.040555,-0.0041151,0.06057,0.74843,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP,0.99999
GSE25088_IL4_VS_IL4_AND_ROSI...3,SET,178,-0.042648,-0.0041791,0.063694,0.74843,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,0.99999
MZF1_TARGET_GENES,SET,1376,-0.016078,-0.0042337,0.024009,0.74846,MZF1_TARGET_GENES,0.99999
MODULE_307,SET,21,-0.11703,-0.003956,0.17477,0.74846,MODULE_307,0.99999
REACTOME_SIGNALING_BY_NTRK2_...,SET,25,-0.10867,-0.0040076,0.16224,0.74852,REACTOME_SIGNALING_BY_NTRK2_TRKB,0.99999
HP_BONE_CYST,SET,27,-0.10991,-0.0042121,0.16404,0.74857,HP_BONE_CYST,0.99999
GSE28737_WT_VS_BCL6_KO_FOLLI...2,SET,180,-0.043059,-0.0042427,0.064241,0.74865,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP,0.99999
MIR22_5P,SET,127,-0.050251,-0.0041651,0.074956,0.7487,MIR22_5P,0.99999
GSE16385_MONOCYTE_VS_MACROPH...2,SET,178,-0.042829,-0.0041968,0.063882,0.7487,GSE16385_MONOCYTE_VS_MACROPHAGE_UP,0.99999
WP_OXYSTEROLS_DERIVED_FROM_C...,SET,49,-0.086745,-0.0044756,0.12937,0.74873,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,0.99999
MIR3150A_3P,SET,85,-0.059839,-0.0040623,0.089244,0.74873,MIR3150A_3P,0.99999
GOBP_PSEUDOPODIUM_ORGANIZATI...,SET,15,-0.15371,-0.004392,0.22924,0.74873,GOBP_PSEUDOPODIUM_ORGANIZATION,0.99999
MIR1273C,SET,6,-0.22147,-0.0040032,0.33008,0.74888,MIR1273C,0.99999
REACTOME_TOLL_LIKE_RECEPTOR_...1,SET,101,-0.056427,-0.0041738,0.08405,0.749,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,0.99999
GOMF_CAMP_RESPONSE_ELEMENT_B...1,SET,12,-0.17551,-0.0044857,0.2614,0.74902,GOMF_CAMP_RESPONSE_ELEMENT_BINDING,0.99999
MEISSNER_ES_ICP_WITH_H3K4ME3...,SET,11,-0.18082,-0.0044249,0.26931,0.74903,MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,0.99999
REACTOME_ATF6_ATF6_ALPHA_ACT...2,SET,10,-0.15729,-0.0036701,0.23425,0.74904,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES,0.99999
MIR9_5P,SET,436,-0.028235,-0.0042993,0.042049,0.74904,MIR9_5P,0.99999
NADELLA_PRKAR1A_TARGETS_DN,SET,7,-0.22814,-0.004454,0.33971,0.74906,NADELLA_PRKAR1A_TARGETS_DN,0.99999
GSE22432_MULTIPOTENT_PROGENI...2,SET,183,-0.042719,-0.0042438,0.063612,0.74906,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP,0.99999
GOCC_CILIARY_ROOTLET,SET,12,-0.16942,-0.00433,0.25221,0.74912,GOCC_CILIARY_ROOTLET,0.99999
GOBP_LYMPH_VESSEL_DEVELOPMENT,SET,29,-0.11196,-0.0044463,0.16665,0.74914,GOBP_LYMPH_VESSEL_DEVELOPMENT,0.99999
GOMF_ENZYME_REGULATOR_ACTIVI...,SET,1187,-0.017453,-0.0042921,0.02598,0.74914,GOMF_ENZYME_REGULATOR_ACTIVITY,0.99999
HP_INTRAUTERINE_GROWTH_RETAR...,SET,547,-0.02389,-0.0040619,0.03555,0.7492,HP_INTRAUTERINE_GROWTH_RETARDATION,0.99999
HP_PALMOPLANTAR_HYPERKERATOS...,SET,120,-0.056214,-0.00453,0.083649,0.74921,HP_PALMOPLANTAR_HYPERKERATOSIS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...29,SET,15,-0.13811,-0.0039463,0.20548,0.74924,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,0.99999
MIR6764_3P,SET,98,-0.055977,-0.0040789,0.083286,0.74924,MIR6764_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...219,SET,117,-0.05203,-0.0041404,0.077403,0.74926,GOBP_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.99999
GOBP_BLOOD_VESSEL_REMODELING,SET,40,-0.091922,-0.0042861,0.13671,0.74932,GOBP_BLOOD_VESSEL_REMODELING,0.99999
KEGG_PROTEIN_EXPORT,SET,22,-0.12305,-0.0042571,0.18299,0.74934,KEGG_PROTEIN_EXPORT,0.99999
KEGG_MEDICUS_REFERENCE_CCR5_...,SET,26,-0.11573,-0.0043521,0.17208,0.74937,KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY,0.99999
chr8q12,SET,27,-0.19997,-0.0076633,0.29727,0.74942,chr8q12,0.99999
HP_INCREASED_CIRCULATING_IGM...,SET,32,-0.10673,-0.004452,0.15866,0.74942,HP_INCREASED_CIRCULATING_IGM_LEVEL,0.99999
GOCC_MICROTUBULE_ORGANIZING_...1,SET,779,-0.02035,-0.0041021,0.03025,0.74944,GOCC_MICROTUBULE_ORGANIZING_CENTER,0.99999
GSE37534_GW1929_VS_PIOGLITAZ...1,SET,179,-0.042749,-0.0042006,0.06354,0.74946,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...725,SET,44,-0.088326,-0.004319,0.13126,0.74948,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,0.99999
KEGG_MEDICUS_REFERENCE_MYOST...,SET,8,-0.20916,-0.0043653,0.31073,0.74956,KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY,0.99999
HP_PROLONGED_PR_INTERVAL,SET,10,-0.20534,-0.0047912,0.30503,0.74958,HP_PROLONGED_PR_INTERVAL,0.99999
WP_OXIDATIVE_PHOSPHORYLATION,SET,35,-0.082605,-0.0036034,0.12269,0.74962,WP_OXIDATIVE_PHOSPHORYLATION,0.99999
MIR7113_3P,SET,83,-0.06025,-0.0040421,0.089481,0.74963,MIR7113_3P,0.99999
GOCC_SECRETORY_GRANULE,SET,826,-0.020926,-0.0043379,0.031073,0.74967,GOCC_SECRETORY_GRANULE,0.99999
KEGG_LEUKOCYTE_TRANSENDOTHEL...,SET,108,-0.059177,-0.0045256,0.087862,0.74969,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,0.99999
GOBP_LYMPHOCYTE_COSTIMULATION,SET,44,-0.092182,-0.0045075,0.13686,0.7497,GOBP_LYMPHOCYTE_COSTIMULATION,0.99999
HP_CELIAC_DISEASE,SET,52,-0.08315,-0.0044191,0.12342,0.74975,HP_CELIAC_DISEASE,0.99999
GOBP_REGULATION_OF_MICROVILL...2,SET,7,-0.18778,-0.0036661,0.27851,0.74992,GOBP_REGULATION_OF_MICROVILLUS_LENGTH,0.99999
LOPES_METHYLATED_IN_COLON_CA...1,SET,28,-0.11414,-0.0044543,0.16927,0.74994,LOPES_METHYLATED_IN_COLON_CANCER_DN,0.99999
GSE29164_DAY3_VS_DAY7_UNTREA...2,SET,163,-0.044623,-0.004186,0.066163,0.74998,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP,0.99999
HP_SMALL_HAND,SET,94,-0.061716,-0.0044049,0.091495,0.75001,HP_SMALL_HAND,0.99999
GSE15330_HSC_VS_MEGAKARYOCYT...2,SET,176,-0.044706,-0.0043563,0.066276,0.75001,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,0.99999
FOXO1_01,SET,220,-0.040231,-0.0043776,0.059635,0.75004,FOXO1_01,0.99999
REACTOME_SIGNALING_BY_BMP,SET,28,-0.10795,-0.0042125,0.16,0.75005,REACTOME_SIGNALING_BY_BMP,0.99999
HP_INCREASED_PULMONARY_VASCU...,SET,13,-0.18477,-0.0049151,0.27387,0.75005,HP_INCREASED_PULMONARY_VASCULAR_RESISTANCE,0.99999
GNF2_H2AFX,SET,29,-0.10629,-0.0042212,0.15751,0.7501,GNF2_H2AFX,0.99999
GOCC_CONTRACTILE_RING,SET,11,-0.14319,-0.003504,0.21218,0.7501,GOCC_CONTRACTILE_RING,0.99999
VANHARANTA_UTERINE_FIBROID_UP,SET,39,-0.096124,-0.0044258,0.14244,0.75011,VANHARANTA_UTERINE_FIBROID_UP,0.99999
GOBP_L_GLUTAMATE_IMPORT,SET,39,-0.094997,-0.0043739,0.14074,0.75015,GOBP_L_GLUTAMATE_IMPORT,0.99999
GOBP_RESPONSE_TO_VITAMIN_D,SET,35,-0.10789,-0.0047066,0.15985,0.75015,GOBP_RESPONSE_TO_VITAMIN_D,0.99999
JONES_OVARY_PERICYTE,SET,151,-0.050191,-0.0045333,0.074356,0.75016,JONES_OVARY_PERICYTE,0.99999
PID_ARF_3PATHWAY,SET,19,-0.11863,-0.0038146,0.17574,0.75017,PID_ARF_3PATHWAY,0.99999
GSE36527_CD69_NEG_VS_POS_TRE...1,SET,185,-0.040153,-0.0040104,0.059474,0.7502,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_DN,0.99999
GOBP_RESPONSE_TO_MECHANICAL_...,SET,209,-0.041457,-0.0043981,0.06139,0.75025,GOBP_RESPONSE_TO_MECHANICAL_STIMULUS,0.99999
WP_IRON_METABOLISM_IN_PLACEN...,SET,12,-0.17828,-0.0045565,0.26397,0.75027,WP_IRON_METABOLISM_IN_PLACENTA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...361,SET,151,-0.05028,-0.0045413,0.074449,0.75027,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_ACTIVATION,0.99999
ZHENG_FOXP3_TARGETS_UP,SET,24,-0.12748,-0.0046064,0.18875,0.75028,ZHENG_FOXP3_TARGETS_UP,0.99999
MODULE_98,SET,368,-0.028155,-0.0039462,0.04168,0.75032,MODULE_98,0.99999
REACTOME_MET_ACTIVATES_RAP1_...,SET,11,-0.18705,-0.0045773,0.27687,0.75034,REACTOME_MET_ACTIVATES_RAP1_AND_RAC1,0.99999
SOGA_COLORECTAL_CANCER_MYC_DN,SET,69,-0.071839,-0.004396,0.10632,0.75038,SOGA_COLORECTAL_CANCER_MYC_DN,0.99999
GSE15930_NAIVE_VS_72H_IN_VIT...4,SET,187,-0.040657,-0.0040825,0.060159,0.75042,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,0.99999
KRIEG_HYPOXIA_VIA_KDM3A,SET,46,-0.091736,-0.0045863,0.13572,0.75045,KRIEG_HYPOXIA_VIA_KDM3A,0.99999
GSE29617_CTRL_VS_DAY7_TIV_FL...2,SET,170,-0.048685,-0.0046632,0.072026,0.75046,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,0.99999
GSE21927_SPLENIC_C26GM_TUMOR...4,SET,135,-0.049868,-0.0042606,0.073771,0.75047,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...580,SET,64,-0.080117,-0.0047222,0.11852,0.75048,GOBP_POSITIVE_REGULATION_OF_PHAGOCYTOSIS,0.99999
MIR6721_5P,SET,316,-0.032886,-0.0042773,0.048644,0.75049,MIR6721_5P,0.99999
HP_GIANT_SOMATOSENSORY_EVOKE...,SET,5,-0.23821,-0.0039307,0.35229,0.75053,HP_GIANT_SOMATOSENSORY_EVOKED_POTENTIALS,0.99999
GOBP_SKELETAL_MUSCLE_ACETYLC...,SET,11,-0.16379,-0.0040081,0.24221,0.75054,GOBP_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING,0.99999
KEGG_MEDICUS_REFERENCE_LEWIS...,SET,5,-0.3104,-0.0051219,0.45894,0.75058,KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS,0.99999
MORF_THPO,SET,109,-0.057802,-0.0044407,0.085421,0.75069,MORF_THPO,0.99999
HP_ABNORMALITY_OF_THE_INTERN...,SET,19,-0.14382,-0.0046243,0.21249,0.75073,HP_ABNORMALITY_OF_THE_INTERNAL_AUDITORY_CANAL,0.99999
ZSCAN5C_TARGET_GENES,SET,111,-0.055796,-0.0043255,0.082417,0.75079,ZSCAN5C_TARGET_GENES,0.99999
GOBP_OLIGOSACCHARIDE_METABOL...,SET,63,-0.076107,-0.0044508,0.11241,0.7508,GOBP_OLIGOSACCHARIDE_METABOLIC_PROCESS,0.99999
GOMF_AMINO_ACID_MONOATOMIC_C...2,SET,27,-0.13117,-0.0050266,0.1937,0.75084,GOMF_AMINO_ACID_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.99999
HP_BREAST_CARCINOMA,SET,68,-0.065247,-0.0039637,0.096343,0.75087,HP_BREAST_CARCINOMA,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...6,SET,20,-0.14057,-0.0046372,0.20753,0.7509,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_RENIN_ANGIOTENSIN,0.99999
GSE360_CTRL_VS_L_MAJOR_MAC_DN,SET,171,-0.043342,-0.0041635,0.063981,0.75093,GSE360_CTRL_VS_L_MAJOR_MAC_DN,0.99999
GSE41867_NAIVE_VS_DAY30_LCMV...1,SET,175,-0.041877,-0.0040691,0.061798,0.75099,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_DN,0.99999
HP_ACIDEMIA,SET,22,-0.11883,-0.0041112,0.17536,0.751,HP_ACIDEMIA,0.99999
MCCABE_HOXC6_TARGETS_CANCER_...1,SET,19,-0.12971,-0.0041709,0.19138,0.75104,MCCABE_HOXC6_TARGETS_CANCER_DN,0.99999
GOBP_POSITIVE_REGULATION_BY_...4,SET,13,-0.1582,-0.0042082,0.23337,0.75107,GOBP_POSITIVE_REGULATION_BY_SYMBIONT_OF_ENTRY_INTO_HOST,0.99999
GSE38696_LIGHT_ZONE_VS_DARK_...1,SET,122,-0.052982,-0.0043048,0.07816,0.75107,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,0.99999
KEGG_MEDICUS_REFERENCE_FE3_F...,SET,5,-0.28477,-0.004699,0.42001,0.75111,KEGG_MEDICUS_REFERENCE_FE3_FERRITIN_TRANSPORT,0.99999
GSE17721_0.5H_VS_8H_CPG_BMDC...1,SET,183,-0.041624,-0.004135,0.06139,0.75112,GSE17721_0.5H_VS_8H_CPG_BMDC_DN,0.99999
ROVERSI_GLIOMA_LOH_REGIONS,SET,45,-0.11158,-0.0055175,0.16456,0.75113,ROVERSI_GLIOMA_LOH_REGIONS,0.99999
HP_GENERALIZED_TONIC_SEIZURE,SET,50,-0.082346,-0.0042916,0.12145,0.75113,HP_GENERALIZED_TONIC_SEIZURE,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...11,SET,98,-0.057635,-0.0041997,0.084995,0.75114,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_NOSE,0.99999
GOBP_AXIAL_MESODERM_DEVELOPM...,SET,7,-0.19163,-0.0037413,0.28251,0.75122,GOBP_AXIAL_MESODERM_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...198,SET,11,-0.17936,-0.0043892,0.26442,0.75122,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.99999
HP_LEFT_VENTRICULAR_NONCOMPA...,SET,9,-0.2234,-0.0049451,0.32926,0.75126,HP_LEFT_VENTRICULAR_NONCOMPACTION_CARDIOMYOPATHY,0.99999
GSE17301_CTRL_VS_48H_ACD3_AC...2,SET,178,-0.04221,-0.0041362,0.062214,0.75126,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP,0.99999
GOBP_TRNA_3_END_PROCESSING,SET,6,-0.19109,-0.003454,0.28163,0.75127,GOBP_TRNA_3_END_PROCESSING,0.99999
ATM_DN.V1_UP,SET,138,-0.051005,-0.0044056,0.075167,0.75129,ATM_DN.V1_UP,0.99999
AMIT_SERUM_RESPONSE_120_MCF1...,SET,63,-0.075276,-0.0044022,0.11093,0.7513,AMIT_SERUM_RESPONSE_120_MCF10A,0.99999
GSE22886_NAIVE_TCELL_VS_NKCE...1,SET,181,-0.04268,-0.004217,0.062892,0.75131,GSE22886_NAIVE_TCELL_VS_NKCELL_DN,0.99999
GOMF_DOUBLE_STRANDED_DNA_EXO...,SET,6,-0.24804,-0.0044834,0.36536,0.75139,GOMF_DOUBLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY,0.99999
PEDRIOLI_MIR31_TARGETS_UP,SET,189,-0.043008,-0.0043413,0.063347,0.75141,PEDRIOLI_MIR31_TARGETS_UP,0.99999
NIKOLSKY_BREAST_CANCER_12Q13...,SET,42,-0.14775,-0.0070591,0.21749,0.75153,NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON,0.99999
GOBP_VERY_LONG_CHAIN_FATTY_A...3,SET,33,-0.10634,-0.0045044,0.15652,0.75155,GOBP_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.99999
HP_LACTIC_ACIDOSIS,SET,149,-0.045193,-0.0040549,0.06651,0.75159,HP_LACTIC_ACIDOSIS,0.99999
GSE1448_CTRL_VS_ANTI_VALPHA2...1,SET,181,-0.042911,-0.0042398,0.06315,0.75159,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN,0.99999
GSE1791_CTRL_VS_NEUROMEDINU_...6,SET,160,-0.047493,-0.0044144,0.069888,0.7516,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_UP,0.99999
REACTOME_PTK6_REGULATES_CELL...,SET,6,-0.245,-0.0044286,0.36051,0.75162,REACTOME_PTK6_REGULATES_CELL_CYCLE,0.99999
KEGG_NITROGEN_METABOLISM,SET,21,-0.12814,-0.0043314,0.1885,0.75168,KEGG_NITROGEN_METABOLISM,0.99999
HP_INCREASED_CIRCULATING_CRE...,SET,3,-0.25922,-0.0033134,0.38132,0.75168,HP_INCREASED_CIRCULATING_CREATINE_KINASE_MB_ISOFORM,0.99999
GSE32901_TH1_VS_TH17_NEG_CD4...1,SET,104,-0.056339,-0.0042284,0.082875,0.75168,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN,0.99999
ROETH_TERT_TARGETS_UP,SET,14,-0.17593,-0.0048566,0.25873,0.75174,ROETH_TERT_TARGETS_UP,0.99999
GOMF_HISTONE_H3K4ME_H3K4ME2_...,SET,2,-0.45294,-0.0047274,0.66605,0.75176,GOMF_HISTONE_H3K4ME_H3K4ME2_H3K4ME3_DEMETHYLASE_ACTIVITY,0.99999
KEGG_MEDICUS_PATHOGEN_HTLV_1...3,SET,5,-0.23114,-0.003814,0.33976,0.75184,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_E47_MEDIATED_TRANSCRIPTION,0.99999
MIR3654,SET,43,-0.085175,-0.0041174,0.12515,0.75194,MIR3654,0.99999
GOBP_OXYGEN_TRANSPORT,SET,11,-0.21153,-0.0051764,0.31076,0.75196,GOBP_OXYGEN_TRANSPORT,0.99999
GOMF_HEPARAN_SULFATE_PROTEOG...,SET,17,-0.16276,-0.0049506,0.23909,0.75198,GOMF_HEPARAN_SULFATE_PROTEOGLYCAN_BINDING,0.99999
GOCC_IKAPPAB_KINASE_COMPLEX,SET,6,-0.19756,-0.003571,0.2902,0.75199,GOCC_IKAPPAB_KINASE_COMPLEX,0.99999
HP_ABNORMAL_METABOLISM,SET,146,-0.047138,-0.004187,0.069225,0.75204,HP_ABNORMAL_METABOLISM,0.99999
GSE19888_CTRL_VS_TCELL_MEMBR...1,SET,184,-0.043857,-0.0043686,0.064406,0.75204,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN,0.99999
TIAN_TNF_SIGNALING_NOT_VIA_N...,SET,21,-0.14174,-0.0047911,0.20814,0.75205,TIAN_TNF_SIGNALING_NOT_VIA_NFKB,0.99999
GOBP_ESTABLISHMENT_OF_TISSUE...,SET,35,-0.10455,-0.0045605,0.15351,0.75207,GOBP_ESTABLISHMENT_OF_TISSUE_POLARITY,0.99999
GOMF_NADPH_BINDING,SET,16,-0.12619,-0.0037237,0.18522,0.75214,GOMF_NADPH_BINDING,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...4,SET,33,-0.10976,-0.0046496,0.16111,0.75215,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_HORMONE,0.99999
HP_ABNORMAL_BASOPHIL_COUNT,SET,5,-0.31017,-0.0051182,0.45505,0.75225,HP_ABNORMAL_BASOPHIL_COUNT,0.99999
LEE_DOUBLE_POLAR_THYMOCYTE,SET,24,-0.1367,-0.0049395,0.20053,0.75228,LEE_DOUBLE_POLAR_THYMOCYTE,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_ILC...3,SET,166,-0.048391,-0.0045807,0.070977,0.75231,HE_LIM_SUN_FETAL_LUNG_C4_ILCP_CELL,0.99999
GSE17974_0.5H_VS_72H_IL4_AND...1,SET,175,-0.041477,-0.0040302,0.060828,0.75233,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,0.99999
HP_DIASTASIS_RECTI,SET,21,-0.12377,-0.0041836,0.18145,0.75241,HP_DIASTASIS_RECTI,0.99999
GSE28737_WT_VS_BCL6_HET_FOLL...1,SET,178,-0.042663,-0.0041806,0.062543,0.75242,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_DN,0.99999
GOMF_RNA_CAP_BINDING,SET,17,-0.12875,-0.0039161,0.1887,0.75246,GOMF_RNA_CAP_BINDING,0.99999
GOMF_ENDONUCLEASE_ACTIVITY_A...2,SET,33,-0.10053,-0.0042584,0.14733,0.75248,GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,0.99999
GOBP_MICROTUBULE_ORGANIZING_...1,SET,30,-0.1017,-0.0041077,0.14902,0.75251,GOBP_MICROTUBULE_ORGANIZING_CENTER_LOCALIZATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...829,SET,28,-0.11364,-0.0044346,0.16652,0.75251,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,0.99999
GTGACGY_E4F1_Q6,SET,589,-0.024427,-0.0043046,0.035792,0.75252,GTGACGY_E4F1_Q6,0.99999
HP_LEG_DYSTONIA,SET,7,-0.20657,-0.004033,0.30263,0.75256,HP_LEG_DYSTONIA,0.99999
SMID_BREAST_CANCER_LUMINAL_A...2,SET,78,-0.070471,-0.0045838,0.10323,0.75258,SMID_BREAST_CANCER_LUMINAL_A_UP,0.99999
HP_ELEVATED_SERUM_ANION_GAP,SET,4,-0.29588,-0.004367,0.43342,0.75258,HP_ELEVATED_SERUM_ANION_GAP,0.99999
SEKI_INFLAMMATORY_RESPONSE_L...1,SET,20,-0.14717,-0.004855,0.21558,0.75259,SEKI_INFLAMMATORY_RESPONSE_LPS_DN,0.99999
GOBP_INDOLE_CONTAINING_COMPO...2,SET,9,-0.22934,-0.0050767,0.33594,0.75259,GOBP_INDOLE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.99999
CTAWWWATA_RSRFC4_Q2,SET,324,-0.033701,-0.0044375,0.049342,0.7527,CTAWWWATA_RSRFC4_Q2,0.99999
WILCOX_RESPONSE_TO_PROGESTER...2,SET,136,-0.050384,-0.0043205,0.073753,0.75274,WILCOX_RESPONSE_TO_PROGESTERONE_UP,0.99999
GOBP_REGULATION_OF_BONE_DEVE...,SET,8,-0.21411,-0.0044686,0.31341,0.75274,GOBP_REGULATION_OF_BONE_DEVELOPMENT,0.99999
REACTOME_PTK6_REGULATES_RTKS...,SET,8,-0.22541,-0.0047044,0.32993,0.75276,REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1,0.99999
GOBP_U2_TYPE_PRESPLICEOSOME_...,SET,22,-0.10996,-0.0038042,0.16092,0.75279,GOBP_U2_TYPE_PRESPLICEOSOME_ASSEMBLY,0.99999
GOCC_EARLY_ENDOSOME_LUMEN,SET,5,-0.26034,-0.0042959,0.38098,0.7528,GOCC_EARLY_ENDOSOME_LUMEN,0.99999
PID_BARD1_PATHWAY,SET,28,-0.093829,-0.0036616,0.13729,0.75283,PID_BARD1_PATHWAY,0.99999
REACTOME_DISEASES_OF_MITOTIC...,SET,36,-0.09033,-0.0039962,0.13216,0.75284,REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,0.99999
MIR567,SET,95,-0.060335,-0.004329,0.088275,0.75284,MIR567,0.99999
MIR3085_5P,SET,33,-0.10166,-0.0043065,0.14871,0.7529,MIR3085_5P,0.99999
WP_SYNAPTIC_SIGNALING_ASSOCI...,SET,50,-0.086114,-0.004488,0.12594,0.75294,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,0.99999
LUCAS_HNF4A_TARGETS_UP,SET,53,-0.077919,-0.0041806,0.11395,0.75295,LUCAS_HNF4A_TARGETS_UP,0.99999
WP_FGFR3_SIGNALING_IN_CHONDR...,SET,27,-0.11844,-0.0045387,0.1732,0.75295,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,0.99999
REACTOME_COMPLEX_I_BIOGENESIS,SET,56,-0.068388,-0.0037714,0.099994,0.75298,REACTOME_COMPLEX_I_BIOGENESIS,0.99999
KEGG_MEDICUS_REFERENCE_P16_C...,SET,10,-0.17632,-0.0041141,0.25778,0.75301,KEGG_MEDICUS_REFERENCE_P16_CELL_CYCLE_G1_S,0.99999
GSE17974_0H_VS_24H_IN_VITRO_...1,SET,178,-0.041001,-0.0040177,0.059934,0.75304,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN,0.99999
HP_MUSCULAR_DYSTROPHY,SET,69,-0.071065,-0.0043486,0.10387,0.75307,HP_MUSCULAR_DYSTROPHY,0.99999
WOTTON_RUNX_TARGETS_DN,SET,26,-0.12685,-0.0047705,0.18537,0.75311,WOTTON_RUNX_TARGETS_DN,0.99999
HP_ASTHMA,SET,149,-0.048325,-0.0043359,0.070603,0.75315,HP_ASTHMA,0.99999
GOBP_GLYCEROPHOSPHOLIPID_CAT...,SET,33,-0.10141,-0.0042959,0.14816,0.75317,GOBP_GLYCEROPHOSPHOLIPID_CATABOLIC_PROCESS,0.99999
GOMF_HYDROLASE_ACTIVITY_ACTI...7,SET,677,-0.022239,-0.0041913,0.032478,0.75324,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS,0.99999
HP_ABSENT_FOREARM_BONE,SET,24,-0.12081,-0.0043653,0.1764,0.75328,HP_ABSENT_FOREARM_BONE,0.99999
HP_FACIAL_MYOKYMIA,SET,7,-0.18977,-0.0037048,0.27708,0.75329,HP_FACIAL_MYOKYMIA,0.99999
GOBP_UBIQUITIN_DEPENDENT_PRO...1,SET,12,-0.16621,-0.0042482,0.24264,0.75333,GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY,0.99999
GOBP_SUPEROXIDE_METABOLIC_PR...,SET,62,-0.078288,-0.004542,0.11425,0.75339,GOBP_SUPEROXIDE_METABOLIC_PROCESS,0.99999
GOCC_RESPIRASOME,SET,82,-0.055823,-0.0037225,0.081454,0.75343,GOCC_RESPIRASOME,0.99999
GSE37533_PPARG2_FOXP3_VS_FOX...1,SET,182,-0.044951,-0.0044535,0.065584,0.75345,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,0.99999
HP_ABDOMINAL_SITUS_INVERSUS,SET,12,-0.1691,-0.0043219,0.2467,0.75346,HP_ABDOMINAL_SITUS_INVERSUS,0.99999
CUI_DEVELOPING_HEART_RIGHT_V...,SET,20,-0.12097,-0.0039908,0.17648,0.75348,CUI_DEVELOPING_HEART_RIGHT_VENTRICULAR_CARDIOMYOCYTE,0.99999
LEE_LIVER_CANCER_CIPROFIBRAT...2,SET,57,-0.080275,-0.0044661,0.1171,0.75349,LEE_LIVER_CANCER_CIPROFIBRATE_UP,0.99999
chr16p13,SET,209,-0.082455,-0.0087477,0.12027,0.75351,chr16p13,0.99999
GSE2128_CTRL_VS_MIMETOPE_NEG...1,SET,182,-0.041799,-0.0041412,0.060959,0.75355,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN,0.99999
HP_EVERTED_UPPER_LIP_VERMILI...,SET,19,-0.13557,-0.0043592,0.19769,0.75357,HP_EVERTED_UPPER_LIP_VERMILION,0.99999
REACTOME_INNATE_IMMUNE_SYSTEM,SET,961,-0.019652,-0.004377,0.028654,0.75358,REACTOME_INNATE_IMMUNE_SYSTEM,0.99999
GOBP_POSITIVE_REGULATION_OF_...471,SET,6,-0.23343,-0.0042194,0.34034,0.7536,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL,0.99999
GOCC_PLATELET_DENSE_TUBULAR_...1,SET,10,-0.17478,-0.0040781,0.25477,0.75365,GOCC_PLATELET_DENSE_TUBULAR_NETWORK,0.99999
GOMF_PEPTIDE_HORMONE_BINDING,SET,48,-0.094254,-0.0048133,0.13734,0.75372,GOMF_PEPTIDE_HORMONE_BINDING,0.99999
GSE24634_IL4_VS_CTRL_TREATED...4,SET,184,-0.044613,-0.0044439,0.064987,0.75379,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP,0.99999
GSE36078_UNTREATED_VS_AD5_T4...2,SET,177,-0.043802,-0.0042802,0.063808,0.75379,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_UP,0.99999
MIR548Y,SET,451,-0.028329,-0.0043853,0.041262,0.75381,MIR548Y,0.99999
LEF1_UP.V1_DN,SET,166,-0.047184,-0.0044664,0.068726,0.75381,LEF1_UP.V1_DN,0.99999
DESCARTES_FETAL_SPLEEN_LYMPH...,SET,93,-0.065588,-0.0046564,0.095532,0.75381,DESCARTES_FETAL_SPLEEN_LYMPHOID_CELLS,0.99999
GOBP_RESPONSE_TO_CALCIUM_ION,SET,124,-0.055347,-0.0045334,0.080609,0.75383,GOBP_RESPONSE_TO_CALCIUM_ION,0.99999
GSE44649_NAIVE_VS_ACTIVATED_...4,SET,186,-0.043259,-0.0043322,0.063005,0.75383,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,0.99999
HP_METHYLMALONIC_ACIDEMIA,SET,13,-0.15065,-0.0040075,0.21938,0.75386,HP_METHYLMALONIC_ACIDEMIA,0.99999
MODULE_451,SET,30,-0.099615,-0.0040236,0.14504,0.7539,MODULE_451,0.99999
GOBP_REGULATION_OF_CHONDROCY...1,SET,4,-0.36463,-0.0053818,0.5309,0.7539,GOBP_REGULATION_OF_CHONDROCYTE_DEVELOPMENT,0.99999
FAN_OVARY_CL7_ANGEIOGENIC_EN...,SET,223,-0.042129,-0.0046149,0.061335,0.75391,FAN_OVARY_CL7_ANGEIOGENIC_ENDOTHELIAL_CELL,0.99999
GOBP_POSITIVE_REGULATION_OF_...233,SET,7,-0.21357,-0.0041696,0.31092,0.75392,GOBP_POSITIVE_REGULATION_OF_ENDOCYTIC_RECYCLING,0.99999
MIR144_3P,SET,451,-0.029019,-0.0044921,0.042242,0.75394,MIR144_3P,0.99999
SABATES_COLORECTAL_ADENOMA_S...1,SET,11,-0.16603,-0.004063,0.24167,0.75396,SABATES_COLORECTAL_ADENOMA_SIZE_DN,0.99999
GOBP_SPINDLE_ASSEMBLY,SET,119,-0.050852,-0.0040809,0.074018,0.75396,GOBP_SPINDLE_ASSEMBLY,0.99999
GSE21360_PRIMARY_VS_TERTIARY...2,SET,185,-0.04171,-0.0041659,0.0607,0.754,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,0.99999
WP_AMINO_ACID_METABOLISM,SET,80,-0.066685,-0.0043925,0.097038,0.75402,WP_AMINO_ACID_METABOLISM,0.99999
RB_P130_DN.V1_UP,SET,117,-0.054203,-0.0043134,0.078863,0.75405,RB_P130_DN.V1_UP,0.99999
REACTOME_FORMATION_OF_THE_CO...,SET,120,-0.070125,-0.005651,0.10202,0.75407,REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,0.99999
GOMF_INSULIN_RECEPTOR_BINDING,SET,21,-0.13938,-0.0047115,0.20278,0.75407,GOMF_INSULIN_RECEPTOR_BINDING,0.99999
GSE25123_IL4_VS_IL4_AND_ROSI...2,SET,190,-0.04504,-0.0045583,0.065518,0.75409,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...381,SET,4,-0.31367,-0.0046295,0.45623,0.75412,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CHROMOSOME_SEPARATION,0.99999
KEGG_MEDICUS_REFERENCE_CARDI...,SET,21,-0.14187,-0.0047956,0.20633,0.75414,KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...352,SET,13,-0.15823,-0.004209,0.23006,0.75419,GOBP_NEGATIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,0.99999
WP_IMMUNE_INFILTRATION_IN_PA...,SET,38,-0.10043,-0.0045646,0.14595,0.75431,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.99999
GOCC_RSC_TYPE_COMPLEX,SET,15,-0.1411,-0.0040315,0.20503,0.75432,GOCC_RSC_TYPE_COMPLEX,0.99999
GOMF_CYTOKINE_RECEPTOR_BINDI...,SET,247,-0.040618,-0.0046797,0.059024,0.75432,GOMF_CYTOKINE_RECEPTOR_BINDING,0.99999
GOBP_SECRETION_BY_TISSUE,SET,46,-0.092609,-0.0046299,0.13456,0.75434,GOBP_SECRETION_BY_TISSUE,0.99999
GSE13411_NAIVE_VS_MEMORY_BCE...2,SET,163,-0.046645,-0.0043757,0.067759,0.75439,GSE13411_NAIVE_VS_MEMORY_BCELL_UP,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...2,SET,184,-0.043673,-0.0043503,0.063429,0.75444,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
KEGG_FOCAL_ADHESION,SET,190,-0.045291,-0.0045837,0.065769,0.75447,KEGG_FOCAL_ADHESION,0.99999
GOBP_APICAL_JUNCTION_ASSEMBLY,SET,71,-0.072753,-0.0045157,0.10564,0.75449,GOBP_APICAL_JUNCTION_ASSEMBLY,0.99999
HP_EXTRA_AXIAL_CEREBROSPINAL...,SET,14,-0.14605,-0.0040317,0.21206,0.7545,HP_EXTRA_AXIAL_CEREBROSPINAL_FLUID_ACCUMULATION,0.99999
GSE3982_BCELL_VS_TH2_DN,SET,173,-0.043574,-0.00421,0.063259,0.75452,GSE3982_BCELL_VS_TH2_DN,0.99999
GOBP_CELL_MATRIX_ADHESION,SET,224,-0.040689,-0.004467,0.059066,0.75454,GOBP_CELL_MATRIX_ADHESION,0.99999
GOBP_NECROPTOTIC_SIGNALING_P...,SET,8,-0.22652,-0.0047276,0.32875,0.75459,GOBP_NECROPTOTIC_SIGNALING_PATHWAY,0.99999
HP_RADIOULNAR_SYNOSTOSIS,SET,68,-0.075076,-0.0045608,0.10892,0.75466,HP_RADIOULNAR_SYNOSTOSIS,0.99999
MIER1_TARGET_GENES,SET,297,-0.034847,-0.0043964,0.050546,0.75472,MIER1_TARGET_GENES,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...31,SET,42,-0.092064,-0.0043985,0.13353,0.75473,GAVISH_3CA_MALIGNANT_METAPROGRAM_39_METAL_RESPONSE,0.99999
GSE9037_WT_VS_IRAK4_KO_LPS_1...2,SET,180,-0.044167,-0.0043519,0.064046,0.75478,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...788,SET,7,-0.22993,-0.004489,0.33327,0.75488,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,0.99999
HP_INTESTINAL_MALROTATION,SET,126,-0.053388,-0.0044078,0.077381,0.75488,HP_INTESTINAL_MALROTATION,0.99999
GSE20198_UNTREATED_VS_IL12_T...2,SET,178,-0.041519,-0.0040685,0.060172,0.7549,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP,0.99999
MIR664B_5P,SET,53,-0.079432,-0.0042618,0.11511,0.75491,MIR664B_5P,0.99999
GOBP_HEPARAN_SULFATE_PROTEOG...5,SET,15,-0.17199,-0.0049143,0.24924,0.75491,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,0.99999
HEDVAT_ELF4_TARGETS_UP,SET,12,-0.20113,-0.0051405,0.29146,0.75492,HEDVAT_ELF4_TARGETS_UP,0.99999
TRAVAGLINI_LUNG_LYMPHATIC_CE...,SET,191,-0.046118,-0.0046796,0.066788,0.75506,TRAVAGLINI_LUNG_LYMPHATIC_CELL,0.99999
REACTOME_TRANSPORT_OF_SMALL_...,SET,684,-0.023578,-0.0044655,0.034139,0.7551,REACTOME_TRANSPORT_OF_SMALL_MOLECULES,0.99999
GOCC_CALCITONIN_FAMILY_RECEP...,SET,5,-0.29549,-0.0048759,0.42783,0.75511,GOCC_CALCITONIN_FAMILY_RECEPTOR_COMPLEX,0.99999
GOBP_POSITIVE_REGULATION_OF_...206,SET,9,-0.2216,-0.0049055,0.32078,0.75516,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PIGMENTATION,0.99999
GOMF_DOUBLE_STRANDED_METHYLA...,SET,4,-0.28402,-0.004192,0.41106,0.7552,GOMF_DOUBLE_STRANDED_METHYLATED_DNA_BINDING,0.99999
HP_FASCICULATIONS,SET,123,-0.052393,-0.0042742,0.075821,0.75522,HP_FASCICULATIONS,0.99999
GCM_RAN,SET,178,-0.042455,-0.0041602,0.061421,0.75528,GCM_RAN,0.99999
GSE3982_NKCELL_VS_TH1_UP,SET,172,-0.047213,-0.0045485,0.068302,0.75529,GSE3982_NKCELL_VS_TH1_UP,0.99999
REACTOME_TRANSCRIPTIONAL_REG...3,SET,32,-0.11308,-0.004717,0.16357,0.75532,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4,0.99999
NADERI_BREAST_CANCER_PROGNOS...2,SET,47,-0.088741,-0.0044844,0.12826,0.75549,NADERI_BREAST_CANCER_PROGNOSIS_UP,0.99999
LEIN_LOCALIZED_TO_DISTAL_AND...,SET,16,-0.1591,-0.0046948,0.22984,0.75559,LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...2,SET,5,-0.24266,-0.0040042,0.35057,0.75559,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR_GRASP55,0.99999
WP_PANCREATIC_CANCER_SUBTYPES,SET,46,-0.097113,-0.0048551,0.14029,0.7556,WP_PANCREATIC_CANCER_SUBTYPES,0.99999
GOBP_POSITIVE_REGULATION_OF_...382,SET,52,-0.080421,-0.0042741,0.11616,0.75562,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GSE7460_CTRL_VS_FOXP3_OVEREX...4,SET,181,-0.043314,-0.0042796,0.062535,0.75573,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP,0.99999
GSE41978_ID2_KO_VS_ID2_KO_AN...1,SET,188,-0.042623,-0.0042911,0.061528,0.75576,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.99999
SESTO_RESPONSE_TO_UV_C6,SET,36,-0.10063,-0.0044517,0.14524,0.75578,SESTO_RESPONSE_TO_UV_C6,0.99999
HP_LIPOMATOUS_TUMOR,SET,42,-0.091204,-0.0043574,0.1316,0.75585,HP_LIPOMATOUS_TUMOR,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...3,SET,59,-0.075787,-0.0042895,0.10931,0.75594,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN,0.99999
GOBP_REGULATION_OF_PROTEIN_F...,SET,9,-0.20078,-0.0044444,0.2896,0.75594,GOBP_REGULATION_OF_PROTEIN_FOLDING,0.99999
HP_HYPOPLASIA_OF_TEETH,SET,109,-0.056096,-0.0043096,0.080908,0.75594,HP_HYPOPLASIA_OF_TEETH,0.99999
HP_SUPERNUMERARY_SPLEENS,SET,81,-0.061561,-0.0040802,0.088761,0.75602,HP_SUPERNUMERARY_SPLEENS,0.99999
REACTOME_TFAP2_AP_2_FAMILY_R...1,SET,5,-0.27293,-0.0045036,0.3934,0.75608,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS,0.99999
CTGTTAC_MIR194,SET,92,-0.061266,-0.0043262,0.088301,0.7561,CTGTTAC_MIR194,0.99999
PID_MYC_REPRESS_PATHWAY,SET,60,-0.074405,-0.0042467,0.10723,0.75612,PID_MYC_REPRESS_PATHWAY,0.99999
MORF_SS18,SET,56,-0.07504,-0.0041382,0.10813,0.75615,MORF_SS18,0.99999
GSE3039_CD4_TCELL_VS_ALPHABE...1,SET,183,-0.043204,-0.004292,0.062231,0.75623,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_DN,0.99999
HP_ABNORMAL_FACIAL_EXPRESSION,SET,165,-0.047038,-0.0044394,0.067748,0.75625,HP_ABNORMAL_FACIAL_EXPRESSION,0.99999
HP_PERIPHERAL_ARTERIAL_STENO...,SET,30,-0.11985,-0.0048411,0.17263,0.75625,HP_PERIPHERAL_ARTERIAL_STENOSIS,0.99999
CHNG_MULTIPLE_MYELOMA_HYPERP...1,SET,28,-0.10538,-0.0041125,0.15177,0.75627,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,0.99999
REACTOME_MITOCHONDRIAL_RNA_D...,SET,10,-0.1552,-0.0036212,0.2235,0.75628,REACTOME_MITOCHONDRIAL_RNA_DEGRADATION,0.99999
MIR26A_1_3P,SET,66,-0.070875,-0.004242,0.10206,0.7563,MIR26A_1_3P,0.99999
HO_LIVER_CANCER_VASCULAR_INV...,SET,12,-0.18563,-0.0047444,0.26721,0.75637,HO_LIVER_CANCER_VASCULAR_INVASION,0.99999
SHIRAISHI_PLZF_TARGETS_UP,SET,9,-0.18908,-0.0041855,0.27215,0.75639,SHIRAISHI_PLZF_TARGETS_UP,0.99999
MIR5682,SET,205,-0.042766,-0.0044939,0.06155,0.75641,MIR5682,0.99999
HP_UPPER_LIMB_PAIN,SET,8,-0.22275,-0.004649,0.32056,0.75643,HP_UPPER_LIMB_PAIN,0.99999
HP_NEGATIVISM,SET,10,-0.18524,-0.0043222,0.26657,0.75644,HP_NEGATIVISM,0.99999
KEGG_MEDICUS_REFERENCE_TRANS...3,SET,72,-0.067975,-0.0042486,0.097774,0.75654,KEGG_MEDICUS_REFERENCE_TRANSLATION_INITIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...1,SET,27,-0.12443,-0.0047684,0.17897,0.75654,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.99999
HP_ABNORMALITY_OF_THE_GALLBL...,SET,99,-0.06036,-0.0044206,0.086813,0.75656,HP_ABNORMALITY_OF_THE_GALLBLADDER,0.99999
HP_UNDERFOLDED_HELIX,SET,4,-0.32824,-0.0048446,0.47205,0.75657,HP_UNDERFOLDED_HELIX,0.99999
REACTOME_SMALL_INTERFERING_R...,SET,9,-0.20088,-0.0044466,0.28884,0.75661,REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS,0.99999
WP_ACUTE_MYELOID_LEUKEMIA,SET,65,-0.07604,-0.0045167,0.10934,0.75661,WP_ACUTE_MYELOID_LEUKEMIA,0.99999
GSE45365_WT_VS_IFNAR_KO_CD8A...1,SET,183,-0.043994,-0.0043705,0.063257,0.75662,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_DN,0.99999
MODULE_111,SET,140,-0.049747,-0.0043277,0.071516,0.75666,MODULE_111,0.99999
GOBP_RESPONSE_TO_CADMIUM_ION,SET,55,-0.087306,-0.0047715,0.12551,0.75666,GOBP_RESPONSE_TO_CADMIUM_ION,0.99999
GOBP_PTERIDINE_CONTAINING_CO...1,SET,13,-0.15367,-0.0040879,0.22091,0.75667,GOBP_PTERIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
HP_ABSENT_SPERM_FLAGELLA,SET,23,-0.11533,-0.0040795,0.16578,0.75667,HP_ABSENT_SPERM_FLAGELLA,0.99999
MORF_PPP6C,SET,95,-0.054757,-0.0039288,0.078699,0.75671,MORF_PPP6C,0.99999
GOBP_MRNA_MODIFICATION,SET,17,-0.12202,-0.0037114,0.17536,0.75672,GOBP_MRNA_MODIFICATION,0.99999
REACTOME_DOWNREGULATION_OF_T...,SET,25,-0.11356,-0.0041877,0.16318,0.75675,REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,0.99999
REACTOME_NEDDYLATION,SET,227,-0.03802,-0.0042016,0.054629,0.75677,REACTOME_NEDDYLATION,0.99999
GOBP_NEUROTRANSMITTER_REUPTA...,SET,33,-0.11195,-0.004742,0.16085,0.75677,GOBP_NEUROTRANSMITTER_REUPTAKE,0.99999
GOBP_NUCLEOSIDE_TRIPHOSPHATE...2,SET,12,-0.18473,-0.0047214,0.26542,0.75678,GOBP_NUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS,0.99999
KYNG_DNA_DAMAGE_BY_GAMMA_AND...,SET,74,-0.068382,-0.0043328,0.098237,0.75681,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,0.99999
GSE11884_WT_VS_FURIN_KO_NAIV...1,SET,116,-0.05512,-0.0043677,0.079184,0.75681,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN,0.99999
HP_ABNORMAL_QRS_COMPLEX,SET,9,-0.22205,-0.0049154,0.31896,0.75684,HP_ABNORMAL_QRS_COMPLEX,0.99999
HP_LUMBAR_SCOLIOSIS,SET,15,-0.13572,-0.0038778,0.19491,0.75688,HP_LUMBAR_SCOLIOSIS,0.99999
GOCC_AUTOPHAGOSOME_MEMBRANE,SET,49,-0.084294,-0.0043491,0.12103,0.75693,GOCC_AUTOPHAGOSOME_MEMBRANE,0.99999
HP_EXERCISE_INTOLERANCE,SET,119,-0.055584,-0.0044606,0.079803,0.75694,HP_EXERCISE_INTOLERANCE,0.99999
FRASOR_RESPONSE_TO_ESTRADIOL...2,SET,33,-0.10836,-0.00459,0.15555,0.75697,FRASOR_RESPONSE_TO_ESTRADIOL_UP,0.99999
FRASOR_RESPONSE_TO_SERM_OR_F...2,SET,21,-0.13938,-0.0047113,0.20007,0.75698,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,0.99999
GOBP_CIRCADIAN_REGULATION_OF...,SET,61,-0.078729,-0.0045307,0.113,0.75701,GOBP_CIRCADIAN_REGULATION_OF_GENE_EXPRESSION,0.99999
GOBP_PROTEIN_K11_LINKED_DEUB...,SET,9,-0.17391,-0.0038498,0.24949,0.75712,GOBP_PROTEIN_K11_LINKED_DEUBIQUITINATION,0.99999
GOMF_TRNA_SPECIFIC_RIBONUCLE...,SET,13,-0.16027,-0.0042634,0.22991,0.75712,GOMF_TRNA_SPECIFIC_RIBONUCLEASE_ACTIVITY,0.99999
GOCC_PIP_BODY,SET,5,-0.21414,-0.0035335,0.30718,0.75713,GOCC_PIP_BODY,0.99999
WANG_CLIM2_TARGETS_UP,SET,214,-0.039679,-0.004259,0.056913,0.75715,WANG_CLIM2_TARGETS_UP,0.99999
MIR20B_5P,SET,571,-0.025874,-0.0044916,0.037113,0.75715,MIR20B_5P,0.99999
HP_ELEVATED_URINARY_VANILLYL...,SET,9,-0.24882,-0.0055079,0.35684,0.75718,HP_ELEVATED_URINARY_VANILLYLMANDELIC_ACID,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...10,SET,46,-0.097225,-0.0048607,0.13943,0.75719,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_1,0.99999
GOMF_VOLTAGE_GATED_MONOATOMI...3,SET,11,-0.20918,-0.0051188,0.29997,0.75719,GOMF_VOLTAGE_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY_INVOLVED_IN_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.99999
GSE43863_TFH_VS_LY6C_LOW_CXC...2,SET,184,-0.045347,-0.0045171,0.065017,0.75724,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.99999
OCONNOR_PBMC_MENVEO_ACWYVAX_...1,SET,221,-0.039482,-0.0043058,0.056594,0.75729,OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN,0.99999
MIR9_3P,SET,308,-0.034542,-0.0044364,0.049511,0.7573,MIR9_3P,0.99999
DESCARTES_FETAL_CEREBRUM_MIC...,SET,362,-0.033782,-0.0046968,0.048422,0.7573,DESCARTES_FETAL_CEREBRUM_MICROGLIA,0.99999
MIR4505,SET,237,-0.03873,-0.0043721,0.055505,0.75734,MIR4505,0.99999
GSE29618_PRE_VS_DAY7_POST_TI...5,SET,171,-0.0413,-0.0039673,0.059174,0.75739,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN,0.99999
ZHAN_MULTIPLE_MYELOMA_MF_DN,SET,40,-0.1002,-0.0046722,0.14356,0.75741,ZHAN_MULTIPLE_MYELOMA_MF_DN,0.99999
HP_COILED_SPERM_FLAGELLA,SET,26,-0.11174,-0.0042023,0.16005,0.75746,HP_COILED_SPERM_FLAGELLA,0.99999
REACTOME_TFAP2A_ACTS_AS_A_TR...,SET,5,-0.23427,-0.0038657,0.33542,0.75754,REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION,0.99999
MODULE_306,SET,22,-0.11391,-0.0039409,0.16307,0.75757,MODULE_306,0.99999
GOBP_NEGATIVE_REGULATION_OF_...29,SET,29,-0.11066,-0.0043946,0.15836,0.75765,GOBP_NEGATIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.99999
GAUTAM_EYE_CORNEA_MONOCYTES,SET,218,-0.03858,-0.0041791,0.055206,0.75767,GAUTAM_EYE_CORNEA_MONOCYTES,0.99999
KYNG_WERNER_SYNDROM_AND_NORM...2,SET,74,-0.066743,-0.0042289,0.09549,0.7577,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,0.99999
REACTOME_SYNTHESIS_OF_BILE_A...4,SET,23,-0.13537,-0.0047887,0.19368,0.7577,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL,0.99999
MIR3146,SET,44,-0.09025,-0.004413,0.12911,0.75772,MIR3146,0.99999
GOBP_REGULATION_OF_HYDROGEN_...2,SET,9,-0.20471,-0.0045314,0.29285,0.75772,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH,0.99999
HP_NEOPLASM_OF_THE_EAR,SET,22,-0.12598,-0.0043586,0.18018,0.75778,HP_NEOPLASM_OF_THE_EAR,0.99999
GOBP_POSITIVE_REGULATION_OF_...646,SET,13,-0.16701,-0.0044428,0.23884,0.7578,GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,0.99999
HP_ABNORMAL_OSSIFICATION_OF_...,SET,10,-0.19024,-0.0044388,0.27202,0.75783,HP_ABNORMAL_OSSIFICATION_OF_THE_PUBIC_BONE,0.99999
MIR4703_5P,SET,225,-0.042149,-0.0046376,0.060261,0.75786,MIR4703_5P,0.99999
KEGG_MEDICUS_REFERENCE_DOUBL...2,SET,11,-0.16482,-0.0040332,0.23563,0.75787,KEGG_MEDICUS_REFERENCE_DOUBLE_STRAND_BREAK_SIGNALING,0.99999
GOBP_NEURON_PROJECTION_REGEN...,SET,55,-0.084944,-0.0046425,0.12141,0.75791,GOBP_NEURON_PROJECTION_REGENERATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...839,SET,30,-0.10239,-0.0041356,0.14634,0.75792,GOBP_POSITIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,0.99999
DE_YY1_TARGETS_DN,SET,88,-0.064659,-0.004466,0.092407,0.75795,DE_YY1_TARGETS_DN,0.99999
HP_ENURESIS,SET,29,-0.11599,-0.0046065,0.16576,0.75796,HP_ENURESIS,0.99999
MIR4464,SET,62,-0.072979,-0.004234,0.10427,0.758,MIR4464,0.99999
HP_NAUSEA_AND_VOMITING,SET,487,-0.027006,-0.0043398,0.038582,0.75801,HP_NAUSEA_AND_VOMITING,0.99999
GSE12845_IGD_POS_VS_NEG_BLOO...1,SET,171,-0.04446,-0.0042709,0.063518,0.75802,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN,0.99999
GOBP_EYE_PHOTORECEPTOR_CELL_...2,SET,49,-0.089196,-0.004602,0.12741,0.75806,GOBP_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.99999
HP_ECTODERMAL_DYSPLASIA,SET,23,-0.12653,-0.0044758,0.18073,0.75806,HP_ECTODERMAL_DYSPLASIA,0.99999
GOBP_SPHINGOLIPID_METABOLIC_...,SET,158,-0.050705,-0.0046837,0.072403,0.75813,GOBP_SPHINGOLIPID_METABOLIC_PROCESS,0.99999
GSE17974_0H_VS_0.5H_IN_VITRO...1,SET,160,-0.045821,-0.0042591,0.06543,0.75813,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN,0.99999
WP_ID_SIGNALING,SET,15,-0.14458,-0.0041311,0.2064,0.75819,WP_ID_SIGNALING,0.99999
GOBP_REGULATION_OF_SKELETAL_...1,SET,5,-0.27112,-0.0044739,0.38683,0.75831,GOBP_REGULATION_OF_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING,0.99999
GOLDRATH_ANTIGEN_RESPONSE,SET,322,-0.033748,-0.0044302,0.048147,0.75833,GOLDRATH_ANTIGEN_RESPONSE,0.99999
HP_RIDGED_FINGERNAIL,SET,7,-0.22418,-0.0043768,0.31979,0.75836,HP_RIDGED_FINGERNAIL,0.99999
GOBP_REGULATION_OF_T_CELL_AP...,SET,38,-0.099757,-0.0045339,0.14229,0.75837,GOBP_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.99999
GSE37533_UNTREATED_VS_PIOGLI...6,SET,129,-0.052528,-0.0043878,0.074924,0.75837,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_UP,0.99999
HALLMARK_HEDGEHOG_SIGNALING,SET,33,-0.11411,-0.0048336,0.16276,0.75837,HALLMARK_HEDGEHOG_SIGNALING,0.99999
REACTOME_COOPERATION_OF_PDCL...,SET,38,-0.098065,-0.004457,0.13985,0.75841,REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING,0.99999
chr18q11,SET,27,-0.23934,-0.009172,0.3413,0.75843,chr18q11,0.99999
HP_WHEEZING,SET,52,-0.082421,-0.0043804,0.11751,0.75847,HP_WHEEZING,0.99999
REACTOME_GAMMA_CARBOXYLATION...1,SET,51,-0.081845,-0.0043079,0.11668,0.75848,REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...136,SET,19,-0.14425,-0.0046382,0.20559,0.75854,GOBP_POSITIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.99999
HP_ABNORMALITY_OF_THE_PROTEI...,SET,13,-0.14627,-0.003891,0.20841,0.7586,HP_ABNORMALITY_OF_THE_PROTEIN_C_ANTICOAGULANT_PATHWAY,0.99999
GOBP_PROTEIN_IMPORT_INTO_PER...1,SET,13,-0.15774,-0.0041961,0.22465,0.75871,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX,0.99999
HP_ABNORMAL_MAST_CELL_MORPHO...,SET,8,-0.2224,-0.0046417,0.31672,0.75872,HP_ABNORMAL_MAST_CELL_MORPHOLOGY,0.99999
GOBP_G_PROTEIN_COUPLED_PURIN...2,SET,10,-0.19619,-0.0045776,0.27932,0.75877,GOBP_G_PROTEIN_COUPLED_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE9509_LPS_VS_LPS_AND_IL10_...5,SET,169,-0.046619,-0.0044523,0.066376,0.75877,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN,0.99999
GOBP_NUCLEOBASE_BIOSYNTHETIC...,SET,15,-0.1424,-0.0040689,0.20272,0.7588,GOBP_NUCLEOBASE_BIOSYNTHETIC_PROCESS,0.99999
HP_LONG_UPPER_LIP,SET,6,-0.29467,-0.0053263,0.41947,0.75881,HP_LONG_UPPER_LIP,0.99999
GSE3982_NEUTROPHIL_VS_TH2_DN,SET,182,-0.041318,-0.0040936,0.058802,0.75887,GSE3982_NEUTROPHIL_VS_TH2_DN,0.99999
GNF2_RRM2,SET,38,-0.095728,-0.0043508,0.13622,0.75889,GNF2_RRM2,0.99999
MIR25_5P,SET,6,-0.25735,-0.0046517,0.36618,0.7589,MIR25_5P,0.99999
GOBP_VESICLE_TRANSPORT_ALONG...2,SET,43,-0.089868,-0.0043443,0.12785,0.75894,GOBP_VESICLE_TRANSPORT_ALONG_MICROTUBULE,0.99999
GOBP_CADMIUM_ION_TRANSMEMBRA...,SET,6,-0.2561,-0.0046292,0.36434,0.75895,GOBP_CADMIUM_ION_TRANSMEMBRANE_TRANSPORT,0.99999
MIR6794_5P,SET,78,-0.068425,-0.0044507,0.097318,0.759,MIR6794_5P,0.99999
MIR760,SET,116,-0.053449,-0.0042353,0.07599,0.75908,MIR760,0.99999
GSE34156_NOD2_LIGAND_VS_TLR1...3,SET,169,-0.048063,-0.0045902,0.068286,0.75923,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,0.99999
GOBP_MATERNAL_PROCESS_INVOLV...1,SET,52,-0.08653,-0.0045987,0.12294,0.75924,GOBP_MATERNAL_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY,0.99999
REACTOME_DOWNSTREAM_SIGNALIN...5,SET,26,-0.11484,-0.0043189,0.16315,0.75925,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_TH...1,SET,52,-0.082788,-0.0043999,0.11761,0.75926,HP_ABNORMAL_MORPHOLOGY_OF_THE_ABDOMINAL_MUSCULATURE,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...3,SET,174,-0.046545,-0.0045099,0.066111,0.75929,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN,0.99999
HP_BASAL_GANGLIA_GLIOSIS,SET,8,-0.22391,-0.0046731,0.31798,0.75933,HP_BASAL_GANGLIA_GLIOSIS,0.99999
MODULE_28,SET,31,-0.089311,-0.003667,0.1268,0.75938,MODULE_28,0.99999
HP_LISSENCEPHALY,SET,166,-0.046296,-0.0043824,0.065732,0.75938,HP_LISSENCEPHALY,0.99999
CP2_02,SET,220,-0.040855,-0.0044456,0.057991,0.75943,CP2_02,0.99999
GOMF_PRIMARY_AMINE_OXIDASE_A...,SET,7,-0.288,-0.0056226,0.40869,0.75949,GOMF_PRIMARY_AMINE_OXIDASE_ACTIVITY,0.99999
HP_ABNORMALITY_OF_HAIR_TEXTU...,SET,157,-0.047568,-0.0043801,0.067504,0.75949,HP_ABNORMALITY_OF_HAIR_TEXTURE,0.99999
GOCC_IRON_SULFUR_CLUSTER_ASS...,SET,8,-0.25253,-0.0052706,0.35831,0.75953,GOCC_IRON_SULFUR_CLUSTER_ASSEMBLY_COMPLEX,0.99999
HP_UNILATERAL_PTOSIS,SET,8,-0.20555,-0.00429,0.29163,0.75954,HP_UNILATERAL_PTOSIS,0.99999
OHGUCHI_LIVER_HNF4A_TARGETS_...2,SET,45,-0.094209,-0.0046586,0.13365,0.75956,OHGUCHI_LIVER_HNF4A_TARGETS_UP,0.99999
YY1_01,SET,224,-0.039679,-0.0043561,0.056286,0.75957,YY1_01,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...4,SET,4,-0.34807,-0.0051373,0.49374,0.75958,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_C1INH,0.99999
GOBP_DETECTION_OF_CHEMICAL_S...,SET,45,-0.10561,-0.0052223,0.14977,0.75963,GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE,0.99999
GOCC_PWP2P_CONTAINING_SUBCOM...,SET,4,-0.25739,-0.0037989,0.36502,0.75963,GOCC_PWP2P_CONTAINING_SUBCOMPLEX_OF_90S_PRERIBOSOME,0.99999
BLANCO_MELO_COVID19_SARS_COV...5,SET,69,-0.077991,-0.0047724,0.11059,0.75965,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN,0.99999
HP_EXANTHEM,SET,20,-0.13842,-0.0045664,0.19626,0.75969,HP_EXANTHEM,0.99999
MIR875_3P,SET,283,-0.036729,-0.0045249,0.052071,0.7597,MIR875_3P,0.99999
HP_INGUINAL_FRECKLING,SET,6,-0.20812,-0.0037619,0.29504,0.75971,HP_INGUINAL_FRECKLING,0.99999
GOBP_POSITIVE_REGULATION_OF_...218,SET,9,-0.21722,-0.0048085,0.30793,0.75972,GOBP_POSITIVE_REGULATION_OF_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,0.99999
GSE7548_NAIVE_VS_DAY7_PCC_IM...1,SET,184,-0.045018,-0.0044843,0.063802,0.75977,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN,0.99999
KEGG_MEDICUS_VARIANT_EGFR_OV...,SET,10,-0.18905,-0.0044111,0.26793,0.75978,KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_ERAD_PATH...,SET,22,-0.1203,-0.0041619,0.17048,0.75978,GOBP_REGULATION_OF_ERAD_PATHWAY,0.99999
GSE2128_C57BL6_VS_NOD_THYMOC...3,SET,183,-0.045232,-0.0044935,0.064088,0.75983,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_UP,0.99999
MIR4316,SET,131,-0.05185,-0.0043643,0.073461,0.75984,MIR4316,0.99999
GSE27241_CTRL_VS_DIGOXIN_TRE...3,SET,164,-0.047574,-0.0044764,0.067395,0.75987,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,0.99999
GOBP_CELLULAR_OXIDANT_DETOXI...,SET,83,-0.068409,-0.0045894,0.096888,0.75992,GOBP_CELLULAR_OXIDANT_DETOXIFICATION,0.99999
HOQUE_METHYLATED_IN_CANCER,SET,55,-0.083611,-0.0045696,0.11841,0.75994,HOQUE_METHYLATED_IN_CANCER,0.99999
GOBP_TOLL_SIGNALING_PATHWAY,SET,11,-0.18079,-0.0044241,0.25599,0.75997,GOBP_TOLL_SIGNALING_PATHWAY,0.99999
E4F1_Q6,SET,255,-0.038104,-0.0044595,0.05395,0.75999,E4F1_Q6,0.99999
HP_ABNORMAL_SUBARACHNOID_SPA...,SET,70,-0.073686,-0.0045414,0.10432,0.76001,HP_ABNORMAL_SUBARACHNOID_SPACE_MORPHOLOGY,0.99999
REACTOME_CREB1_PHOSPHORYLATI...1,SET,25,-0.13221,-0.0048757,0.18716,0.76003,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING,0.99999
GOMF_AMINO_ACID_SODIUM_SYMPO...,SET,21,-0.15587,-0.0052688,0.22064,0.76004,GOMF_AMINO_ACID_SODIUM_SYMPORTER_ACTIVITY,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...10,SET,185,-0.045566,-0.0045511,0.064489,0.76008,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_UP,0.99999
GOBP_ORGANIC_CYCLIC_COMPOUND...,SET,558,-0.025701,-0.0044121,0.036372,0.76009,GOBP_ORGANIC_CYCLIC_COMPOUND_CATABOLIC_PROCESS,0.99999
GOBP_RELAXATION_OF_SMOOTH_MU...,SET,6,-0.2636,-0.0047647,0.373,0.76012,GOBP_RELAXATION_OF_SMOOTH_MUSCLE,0.99999
GOBP_REGULATION_OF_PROTEIN_L...7,SET,11,-0.14432,-0.0035317,0.20404,0.76032,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION,0.99999
GSE42021_CD24INT_TREG_VS_CD2...2,SET,177,-0.043243,-0.0042256,0.061133,0.76033,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_UP,0.99999
GSE29618_BCELL_VS_PDC_DAY7_F...2,SET,165,-0.048775,-0.0046033,0.068948,0.76034,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP,0.99999
KEGG_SMALL_CELL_LUNG_CANCER,SET,80,-0.067403,-0.0044398,0.095266,0.76038,KEGG_SMALL_CELL_LUNG_CANCER,0.99999
MIR6756_5P,SET,241,-0.039553,-0.004502,0.055887,0.76044,MIR6756_5P,0.99999
GOBP_VITAMIN_D_METABOLIC_PRO...,SET,21,-0.13313,-0.0045,0.18808,0.76046,GOBP_VITAMIN_D_METABOLIC_PROCESS,0.99999
HP_SLENDER_LONG_BONES_WITH_N...,SET,5,-0.24276,-0.0040057,0.34294,0.76048,HP_SLENDER_LONG_BONES_WITH_NARROW_DIAPHYSES,0.99999
MIR4716_3P,SET,77,-0.069208,-0.0044728,0.097766,0.76049,MIR4716_3P,0.99999
HP_ABNORMAL_PROSODY,SET,61,-0.079284,-0.0045626,0.112,0.7605,HP_ABNORMAL_PROSODY,0.99999
HP_HEMIHYPERTROPHY,SET,14,-0.15899,-0.0043888,0.22457,0.76051,HP_HEMIHYPERTROPHY,0.99999
GSE46143_CTRL_VS_LMP2A_TRANS...2,SET,181,-0.04512,-0.0044581,0.06373,0.76052,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP,0.99999
WP_NUCLEOTIDEBINDING_OLIGOME...,SET,37,-0.093594,-0.0041976,0.13218,0.76054,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,0.99999
GSE21033_1H_VS_24H_POLYIC_ST...2,SET,154,-0.05014,-0.004573,0.070812,0.76054,GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP,0.99999
SOBOLEV_T_CELL_PANDEMRIX_AGE...2,SET,21,-0.13253,-0.00448,0.18718,0.76054,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_7DY_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...581,SET,8,-0.18934,-0.0039517,0.2674,0.76055,GOBP_NEGATIVE_REGULATION_OF_SCHWANN_CELL_PROLIFERATION,0.99999
AGGAGTG_MIR483,SET,54,-0.080019,-0.0043335,0.11298,0.7606,AGGAGTG_MIR483,0.99999
PID_P38_GAMMA_DELTA_PATHWAY,SET,10,-0.19455,-0.0045394,0.27466,0.76063,PID_P38_GAMMA_DELTA_PATHWAY,0.99999
GOBP_FATTY_ACID_TRANSMEMBRAN...,SET,19,-0.13318,-0.0042822,0.18801,0.76063,GOBP_FATTY_ACID_TRANSMEMBRANE_TRANSPORT,0.99999
HP_DECREASED_NUMBER_OF_PERIP...,SET,45,-0.090502,-0.0044753,0.12775,0.76066,HP_DECREASED_NUMBER_OF_PERIPHERAL_MYELINATED_NERVE_FIBERS,0.99999
WP_SERINE_METABOLISM,SET,8,-0.17832,-0.0037217,0.25166,0.7607,WP_SERINE_METABOLISM,0.99999
GOBP_TELOMERIC_LOOP_DISASSEM...,SET,9,-0.18843,-0.0041711,0.26593,0.7607,GOBP_TELOMERIC_LOOP_DISASSEMBLY,0.99999
WATANABE_ULCERATIVE_COLITIS_...2,SET,17,-0.15215,-0.004628,0.21472,0.76071,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...720,SET,8,-0.19056,-0.0039772,0.26891,0.76072,GOBP_POSITIVE_REGULATION_OF_SPINDLE_ASSEMBLY,0.99999
HP_EEG_WITH_GENERALIZED_POLY...,SET,6,-0.25961,-0.0046926,0.36627,0.76077,HP_EEG_WITH_GENERALIZED_POLYSPIKES,0.99999
GOMF_TELOMERASE_RNA_BINDING,SET,20,-0.12781,-0.0042161,0.18031,0.76078,GOMF_TELOMERASE_RNA_BINDING,0.99999
GOBP_REGULATION_OF_APPETITE,SET,20,-0.14807,-0.0048847,0.20889,0.76079,GOBP_REGULATION_OF_APPETITE,0.99999
MIR4745_5P,SET,79,-0.067489,-0.0044177,0.095199,0.76081,MIR4745_5P,0.99999
BIOCARTA_AHSP_PATHWAY,SET,9,-0.19806,-0.0043843,0.27936,0.76083,BIOCARTA_AHSP_PATHWAY,0.99999
HP_SEVERE_SHORT_STATURE,SET,96,-0.061429,-0.0044305,0.086625,0.76088,HP_SEVERE_SHORT_STATURE,0.99999
FOROUTAN_INTEGRATED_TGFB_EMT...2,SET,116,-0.059541,-0.004718,0.083945,0.76092,FOROUTAN_INTEGRATED_TGFB_EMT_UP,0.99999
GOCC_EUKARYOTIC_TRANSLATION_...2,SET,3,-0.3457,-0.0044189,0.4874,0.76092,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2_COMPLEX,0.99999
GOMF_MODIFICATION_DEPENDENT_...,SET,156,-0.044515,-0.0040861,0.062757,0.76094,GOMF_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.99999
GOMF_CALMODULIN_DEPENDENT_PR...1,SET,24,-0.11749,-0.0042452,0.16558,0.761,GOMF_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.99999
GSE34006_WT_VS_A2AR_KO_TREG_...1,SET,182,-0.046296,-0.0045867,0.065242,0.76102,GSE34006_WT_VS_A2AR_KO_TREG_DN,0.99999
GOCC_NF_KAPPAB_COMPLEX,SET,4,-0.30581,-0.0045136,0.43086,0.76107,GOCC_NF_KAPPAB_COMPLEX,0.99999
MIR4512,SET,17,-0.15123,-0.0045999,0.21306,0.76108,MIR4512,0.99999
GOBP_REGULATION_OF_NUCLEAR_T...3,SET,13,-0.16517,-0.0043937,0.23268,0.7611,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING,0.99999
BIOCARTA_CDC25_PATHWAY,SET,9,-0.17561,-0.0038874,0.24734,0.76115,BIOCARTA_CDC25_PATHWAY,0.99999
MIR2682_5P,SET,106,-0.060917,-0.0046155,0.085787,0.76117,MIR2682_5P,0.99999
GOBP_GLANDULAR_EPITHELIAL_CE...1,SET,33,-0.11426,-0.0048399,0.1609,0.76118,GOBP_GLANDULAR_EPITHELIAL_CELL_DEVELOPMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...495,SET,34,-0.10684,-0.0045938,0.15044,0.7612,GOBP_NEGATIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY,0.99999
GSE13229_IMM_VS_MATURE_NKCEL...2,SET,181,-0.045101,-0.0044562,0.063507,0.7612,GSE13229_IMM_VS_MATURE_NKCELL_UP,0.99999
HP_VERRUCAE,SET,25,-0.12557,-0.0046308,0.17676,0.76127,HP_VERRUCAE,0.99999
HP_THORACIC_KYPHOSIS,SET,43,-0.084935,-0.0041058,0.11954,0.7613,HP_THORACIC_KYPHOSIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...457,SET,7,-0.22181,-0.0043305,0.31218,0.76131,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,0.99999
GOBP_REGULATION_OF_ANTIGEN_P...1,SET,18,-0.14662,-0.004589,0.20633,0.76134,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,0.99999
GOBP_RETINOIC_ACID_RECEPTOR_...,SET,31,-0.11151,-0.0045784,0.15691,0.76135,GOBP_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.99999
REACTOME_PEPTIDE_HORMONE_BIO...,SET,13,-0.18002,-0.0047888,0.2533,0.76136,REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS,0.99999
REACTOME_SUMOYLATION_OF_DNA_...2,SET,15,-0.16053,-0.0045868,0.22579,0.76144,REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...69,SET,6,-0.25106,-0.0045381,0.35307,0.76148,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATXN3_TO_AUTOPHAGY_VESICLE_NUCLEATION,0.99999
GSE7219_UNSTIM_VS_LPS_AND_AN...1,SET,162,-0.0478,-0.0044704,0.067219,0.76148,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_DN,0.99999
SMID_BREAST_CANCER_LUMINAL_B...1,SET,494,-0.030645,-0.0049589,0.04308,0.76156,SMID_BREAST_CANCER_LUMINAL_B_DN,0.99999
GSE40274_CTRL_VS_FOXP3_AND_I...2,SET,146,-0.05146,-0.0045709,0.072338,0.76157,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GSE40666_NAIVE_VS_EFFECTOR_C...2,SET,177,-0.046892,-0.0045822,0.065904,0.76162,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,0.99999
HP_RAGGED_RED_MUSCLE_FIBERS,SET,40,-0.092479,-0.0043121,0.12997,0.76163,HP_RAGGED_RED_MUSCLE_FIBERS,0.99999
MAHAJAN_RESPONSE_TO_IL1A_DN,SET,63,-0.074624,-0.0043641,0.10486,0.76165,MAHAJAN_RESPONSE_TO_IL1A_DN,0.99999
FAN_OVARY_CL5_HEALTHY_SELECT...,SET,281,-0.037768,-0.0046368,0.053071,0.76166,FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL,0.99999
GSE8515_CTRL_VS_IL6_4H_STIM_...1,SET,170,-0.048567,-0.004652,0.068215,0.76176,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN,0.99999
HP_SKELETAL_DYSPLASIA,SET,169,-0.046643,-0.0044546,0.0655,0.7618,HP_SKELETAL_DYSPLASIA,0.99999
GOBP_REGULATION_OF_GLUTAMINE...,SET,6,-0.26286,-0.0047513,0.36899,0.76187,GOBP_REGULATION_OF_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.99999
WP_MAJOR_RECEPTORS_TARGETED_...,SET,16,-0.16666,-0.004918,0.23382,0.762,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,0.99999
GOBP_COLUMNAR_CUBOIDAL_EPITH...3,SET,14,-0.16931,-0.0046737,0.23754,0.762,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_MATURATION,0.99999
GOBP_REGULATION_OF_CELLULAR_...15,SET,13,-0.17522,-0.0046612,0.2458,0.76203,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS,0.99999
STEIN_ESRRA_TARGETS_UP,SET,345,-0.032532,-0.0044176,0.045624,0.76208,STEIN_ESRRA_TARGETS_UP,0.99999
HINATA_NFKB_TARGETS_KERATINO...1,SET,22,-0.14623,-0.0050591,0.20506,0.76211,HINATA_NFKB_TARGETS_KERATINOCYTE_DN,0.99999
MIR6821_3P,SET,47,-0.084472,-0.0042687,0.11845,0.76211,MIR6821_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...678,SET,35,-0.096569,-0.0042126,0.13541,0.76213,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.99999
JIANG_MELANOMA_TRM4,SET,185,-0.047567,-0.0047509,0.066694,0.76214,JIANG_MELANOMA_TRM4,0.99999
REACTOME_GLUCAGON_SIGNALING_...,SET,33,-0.11422,-0.0048384,0.16014,0.76216,REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,0.99999
LE_SKI_TARGETS_DN,SET,6,-0.31091,-0.0056198,0.43584,0.76218,LE_SKI_TARGETS_DN,0.99999
TAAYNRNNTCC_UNKNOWN,SET,159,-0.049622,-0.004598,0.069563,0.76218,TAAYNRNNTCC_UNKNOWN,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MYO...1,SET,46,-0.1041,-0.0052047,0.14594,0.76218,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...14,SET,183,-0.045515,-0.0045216,0.063802,0.76219,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP,0.99999
HP_INCREASED_ADIPOSE_TISSUE,SET,9,-0.20437,-0.004524,0.28648,0.7622,HP_INCREASED_ADIPOSE_TISSUE,0.99999
MODULE_189,SET,10,-0.16478,-0.0038448,0.23094,0.76223,MODULE_189,0.99999
HP_MULTICYSTIC_KIDNEY_DYSPLA...,SET,82,-0.065965,-0.0043988,0.092451,0.76223,HP_MULTICYSTIC_KIDNEY_DYSPLASIA,0.99999
DANG_BOUND_BY_MYC,SET,941,-0.019399,-0.004278,0.027183,0.76227,DANG_BOUND_BY_MYC,0.99999
GOBP_NEGATIVE_REGULATION_OF_...210,SET,46,-0.10139,-0.0050689,0.14207,0.76227,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
GOCC_NETWORK_FORMING_COLLAGE...,SET,6,-0.27808,-0.0050265,0.38961,0.7623,GOCC_NETWORK_FORMING_COLLAGEN_TRIMER,0.99999
WP_PI3KAKTMTOR_SIGNALING_AND...,SET,31,-0.1196,-0.0049106,0.16755,0.76232,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,0.99999
MISSIAGLIA_REGULATED_BY_METH...1,SET,107,-0.055184,-0.0042007,0.077307,0.76233,MISSIAGLIA_REGULATED_BY_METHYLATION_DN,0.99999
BIOCARTA_MITR_PATHWAY,SET,5,-0.291,-0.0048018,0.40759,0.76237,BIOCARTA_MITR_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...121,SET,17,-0.13575,-0.0041291,0.19012,0.76239,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_CHECKPOINT,0.99999
HP_NON_MEDULLARY_THYROID_CAR...,SET,6,-0.28083,-0.0050762,0.39323,0.76243,HP_NON_MEDULLARY_THYROID_CARCINOMA,0.99999
GSE26727_WT_VS_KLF2_KO_LPS_S...2,SET,179,-0.046875,-0.0046061,0.06563,0.76245,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP,0.99999
MIR3977,SET,139,-0.050725,-0.0043971,0.071002,0.76251,MIR3977,0.99999
MIR27B_5P,SET,43,-0.090783,-0.0043885,0.12706,0.76253,MIR27B_5P,0.99999
IZADPANAH_STEM_CELL_ADIPOSE_...2,SET,118,-0.059105,-0.0047234,0.082722,0.76254,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,0.99999
MIR548AP_5P_MIR548J_5P,SET,442,-0.029688,-0.0045508,0.041551,0.76254,MIR548AP_5P_MIR548J_5P,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_AER...,SET,84,-0.072151,-0.0048694,0.10096,0.76258,HE_LIM_SUN_FETAL_LUNG_C3_AEROCYTE,0.99999
GOCC_SWI_SNF_COMPLEX,SET,28,-0.10727,-0.004186,0.15009,0.76259,GOCC_SWI_SNF_COMPLEX,0.99999
WHITFIELD_CELL_CYCLE_M_G1,SET,115,-0.054988,-0.0043385,0.076938,0.7626,WHITFIELD_CELL_CYCLE_M_G1,0.99999
HP_DYSCALCULIA,SET,22,-0.12004,-0.0041531,0.16793,0.76264,HP_DYSCALCULIA,0.99999
HP_MEMORY_IMPAIRMENT,SET,128,-0.053176,-0.0044248,0.074391,0.76264,HP_MEMORY_IMPAIRMENT,0.99999
HP_INCREASED_NEURONAL_AUTOFL...,SET,9,-0.20582,-0.0045561,0.28791,0.76265,HP_INCREASED_NEURONAL_AUTOFLUORESCENT_LIPOPIGMENT,0.99999
FUKUSHIMA_TNFSF11_TARGETS,SET,16,-0.16727,-0.0049359,0.23397,0.76266,FUKUSHIMA_TNFSF11_TARGETS,0.99999
GOBP_DERMATAN_SULFATE_METABO...,SET,8,-0.22036,-0.0045991,0.30822,0.76268,GOBP_DERMATAN_SULFATE_METABOLIC_PROCESS,0.99999
GOBP_LIPID_IMPORT_INTO_CELL,SET,19,-0.13927,-0.0044781,0.19477,0.7627,GOBP_LIPID_IMPORT_INTO_CELL,0.99999
GSE29618_PRE_VS_DAY7_POST_LA...6,SET,182,-0.043999,-0.0043591,0.061531,0.76271,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP,0.99999
GOBP_REGULATION_OF_POSTSYNAP...2,SET,99,-0.064469,-0.0047215,0.090155,0.76272,GOBP_REGULATION_OF_POSTSYNAPSE_ORGANIZATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...537,SET,80,-0.067868,-0.0044704,0.094905,0.76273,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.99999
SEAVEY_EPITHELIOID_HEMANGIOE...,SET,87,-0.070592,-0.0048481,0.098707,0.76274,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,0.99999
HP_RAPIDLY_PROGRESSIVE,SET,34,-0.10231,-0.004399,0.14304,0.76277,HP_RAPIDLY_PROGRESSIVE,0.99999
PLASARI_TGFB1_SIGNALING_VIA_...2,SET,51,-0.092496,-0.0048685,0.1293,0.76281,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,0.99999
ZWANG_EGF_INTERVAL_DN,SET,185,-0.045343,-0.0045288,0.06337,0.76285,ZWANG_EGF_INTERVAL_DN,0.99999
REACTOME_ASYMMETRIC_LOCALIZA...,SET,61,-0.071367,-0.004107,0.099739,0.76285,REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,0.99999
MIR4502,SET,68,-0.072159,-0.0043835,0.10085,0.76286,MIR4502,0.99999
OCT_C,SET,220,-0.043571,-0.0047411,0.060893,0.76286,OCT_C,0.99999
HP_MYOPATHIC_FACIES,SET,46,-0.094162,-0.0047076,0.1316,0.76286,HP_MYOPATHIC_FACIES,0.99999
REACTOME_REGULATED_PROTEOLYS...,SET,10,-0.17796,-0.0041524,0.24861,0.76295,REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR,0.99999
REACTOME_AUF1_HNRNP_D0_BINDS...,SET,52,-0.076771,-0.0040801,0.10719,0.76306,REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,0.99999
PHB2_TARGET_GENES,SET,149,-0.049138,-0.0044089,0.068609,0.76306,PHB2_TARGET_GENES,0.99999
PID_LYSOPHOSPHOLIPID_PATHWAY,SET,63,-0.081015,-0.0047378,0.11311,0.76307,PID_LYSOPHOSPHOLIPID_PATHWAY,0.99999
HP_CAESARIAN_SECTION,SET,13,-0.18556,-0.0049361,0.25898,0.76315,HP_CAESARIAN_SECTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...564,SET,41,-0.10653,-0.005029,0.14865,0.76321,GOBP_POSITIVE_REGULATION_OF_ORGAN_GROWTH,0.99999
GSE1460_DP_VS_CD4_THYMOCYTE_...2,SET,176,-0.045424,-0.0044263,0.063358,0.76329,GSE1460_DP_VS_CD4_THYMOCYTE_UP,0.99999
GOBP_TRANS_SYNAPTIC_SIGNALIN...1,SET,4,-0.34549,-0.0050992,0.4818,0.76333,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_BDNF,0.99999
GSE22033_UNTREATED_VS_ROSIGL...2,SET,182,-0.042848,-0.0042451,0.059753,0.76333,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_UP,0.99999
REACTOME_MRNA_CAPPING,SET,28,-0.09901,-0.0038638,0.13805,0.76337,REACTOME_MRNA_CAPPING,0.99999
MODULE_82,SET,22,-0.11621,-0.0040206,0.16199,0.76343,MODULE_82,0.99999
HALLMARK_BILE_ACID_METABOLISM,SET,110,-0.061072,-0.0047133,0.085131,0.76343,HALLMARK_BILE_ACID_METABOLISM,0.99999
REACTOME_MATURATION_OF_SARS_...2,SET,15,-0.13973,-0.0039924,0.19476,0.76344,REACTOME_MATURATION_OF_SARS_COV_2_NUCLEOPROTEIN,0.99999
HP_LONG_NASAL_BRIDGE,SET,4,-0.29597,-0.0043683,0.41253,0.76344,HP_LONG_NASAL_BRIDGE,0.99999
REACTOME_HEDGEHOG_OFF_STATE,SET,108,-0.055732,-0.0042621,0.077662,0.7635,REACTOME_HEDGEHOG_OFF_STATE,0.99999
REACTOME_METABOLISM_OF_STERO...1,SET,146,-0.05071,-0.0045043,0.070654,0.76353,REACTOME_METABOLISM_OF_STEROIDS,0.99999
DESCARTES_FETAL_INTESTINE_ME...,SET,67,-0.078857,-0.0047552,0.10987,0.76353,DESCARTES_FETAL_INTESTINE_MESOTHELIAL_CELLS,0.99999
GOCC_EUKARYOTIC_TRANSLATION_...1,SET,5,-0.23855,-0.0039363,0.33235,0.76354,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2B_COMPLEX,0.99999
GOBP_REGULATION_OF_ANTIMICRO...1,SET,11,-0.20222,-0.0049486,0.28171,0.76357,GOBP_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE,0.99999
MODULE_440,SET,18,-0.14669,-0.004591,0.20429,0.76363,MODULE_440,0.99999
HP_NASOGASTRIC_TUBE_FEEDING,SET,34,-0.10214,-0.0043916,0.14222,0.76367,HP_NASOGASTRIC_TUBE_FEEDING,0.99999
GOMF_PRE_MIRNA_BINDING,SET,9,-0.20486,-0.0045347,0.28523,0.76368,GOMF_PRE_MIRNA_BINDING,0.99999
KARAKAS_TGFB1_SIGNALING,SET,18,-0.14323,-0.0044827,0.19933,0.76379,KARAKAS_TGFB1_SIGNALING,0.99999
WTTGKCTG_UNKNOWN,SET,455,-0.029892,-0.0046473,0.0416,0.76379,WTTGKCTG_UNKNOWN,0.99999
HP_RHEGMATOGENOUS_RETINAL_DE...,SET,11,-0.19396,-0.0047464,0.26989,0.76382,HP_RHEGMATOGENOUS_RETINAL_DETACHMENT,0.99999
REACTOME_DEFECTIVE_RIPK1_MED...,SET,7,-0.2276,-0.0044435,0.31662,0.76388,REACTOME_DEFECTIVE_RIPK1_MEDIATED_REGULATED_NECROSIS,0.99999
GSE45365_WT_VS_IFNAR_KO_BCEL...1,SET,149,-0.051267,-0.0045999,0.071305,0.76392,GSE45365_WT_VS_IFNAR_KO_BCELL_DN,0.99999
REACTOME_TRANSPORT_OF_THE_SL...,SET,33,-0.097225,-0.0041184,0.13521,0.76395,REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA,0.99999
GOMF_TAU_PROTEIN_KINASE_ACTI...,SET,22,-0.11466,-0.0039668,0.1594,0.76402,GOMF_TAU_PROTEIN_KINASE_ACTIVITY,0.99999
MIR101_2_5P,SET,6,-0.26408,-0.0047734,0.36708,0.76405,MIR101_2_5P,0.99999
REACTOME_FCERI_MEDIATED_NF_K...,SET,76,-0.065178,-0.004185,0.090595,0.76406,REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,0.99999
SMIRNOV_CIRCULATING_ENDOTHEL...2,SET,145,-0.054269,-0.004804,0.075424,0.76409,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,0.99999
LEE_DIFFERENTIATING_T_LYMPHO...,SET,170,-0.046742,-0.0044771,0.06495,0.76413,LEE_DIFFERENTIATING_T_LYMPHOCYTE,0.99999
GSE1740_UNSTIM_VS_IFNA_STIMU...2,SET,154,-0.048498,-0.0044233,0.067367,0.76421,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_UP,0.99999
GSE22601_IMMATURE_CD4_SINGLE...2,SET,179,-0.043676,-0.0042917,0.060661,0.76423,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.99999
REACTOME_ELEVATION_OF_CYTOSO...,SET,16,-0.1604,-0.0047332,0.22275,0.76426,REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS,0.99999
GOBP_REGULATION_OF_KERATINOC...1,SET,35,-0.11557,-0.0050413,0.16047,0.76428,GOBP_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,0.99999
BMI1_DN.V1_UP,SET,137,-0.056687,-0.0048787,0.078697,0.76433,BMI1_DN.V1_UP,0.99999
GOBP_G_PROTEIN_COUPLED_SEROT...,SET,22,-0.13765,-0.0047623,0.19108,0.76435,GOBP_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_DNA_REPAIR_DEPENDENT_CH...,SET,18,-0.12694,-0.0039728,0.17619,0.76437,GOBP_DNA_REPAIR_DEPENDENT_CHROMATIN_REMODELING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...146,SET,83,-0.064445,-0.0043235,0.089442,0.76439,GOBP_NEGATIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,0.99999
GSE22601_IMMATURE_CD4_SINGLE...6,SET,162,-0.05192,-0.0048557,0.072061,0.76439,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...68,SET,16,-0.149,-0.004397,0.20675,0.76445,HP_APLASIA_HYPOPLASIA_OF_THE_STERNUM,0.99999
ATGGYGGA_UNKNOWN,SET,85,-0.06572,-0.0044616,0.091174,0.76449,ATGGYGGA_UNKNOWN,0.99999
HP_IMPAIRED_LYMPHOCYTE_TRANS...,SET,10,-0.2043,-0.0047669,0.2834,0.7645,HP_IMPAIRED_LYMPHOCYTE_TRANSFORMATION_WITH_PHYTOHEMAGGLUTININ,0.99999
GOBP_PROTEIN_AUTOUBIQUITINAT...,SET,67,-0.074648,-0.0045014,0.10354,0.76452,GOBP_PROTEIN_AUTOUBIQUITINATION,0.99999
HP_RETICULATED_SKIN_PIGMENTA...,SET,5,-0.26933,-0.0044443,0.37357,0.76453,HP_RETICULATED_SKIN_PIGMENTATION,0.99999
BIOCARTA_PLCD_PATHWAY,SET,5,-0.33208,-0.0054797,0.46051,0.76458,BIOCARTA_PLCD_PATHWAY,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_D...1,SET,6,-0.22291,-0.0040293,0.30911,0.76458,GOBP_PYRIMIDINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
BIOCARTA_GLEEVEC_PATHWAY,SET,23,-0.13998,-0.0049515,0.19407,0.76463,BIOCARTA_GLEEVEC_PATHWAY,0.99999
GOBP_RESPONSE_TO_ESTROGEN,SET,64,-0.078036,-0.0045996,0.10819,0.76463,GOBP_RESPONSE_TO_ESTROGEN,0.99999
TRAVAGLINI_LUNG_NATURAL_KILL...2,SET,30,-0.1274,-0.005146,0.17657,0.76471,TRAVAGLINI_LUNG_NATURAL_KILLER_T_CELL,0.99999
BOYLAN_MULTIPLE_MYELOMA_D_CL...2,SET,25,-0.128,-0.0047202,0.17739,0.76472,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP,0.99999
GOBP_ORGANELLE_TRANSPORT_ALO...,SET,79,-0.069098,-0.004523,0.095746,0.76475,GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,0.99999
GSE13547_WT_VS_ZFX_KO_BCELL_...5,SET,164,-0.048475,-0.0045612,0.067169,0.76475,GSE13547_WT_VS_ZFX_KO_BCELL_DN,0.99999
KEGG_PANCREATIC_CANCER,SET,66,-0.076548,-0.0045815,0.10606,0.76476,KEGG_PANCREATIC_CANCER,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...18,SET,42,-0.10318,-0.0049294,0.14295,0.76477,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II_CYTOKINE,0.99999
HP_LIMITED_ELBOW_FLEXION,SET,10,-0.2204,-0.0051426,0.3053,0.76482,HP_LIMITED_ELBOW_FLEXION,0.99999
REACTOME_GPCR_LIGAND_BINDING,SET,426,-0.034087,-0.0051319,0.047214,0.76484,REACTOME_GPCR_LIGAND_BINDING,0.99999
GOBP_CEREBELLAR_PURKINJE_CEL...3,SET,15,-0.1552,-0.0044344,0.21495,0.76485,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_MORPHOGENESIS,0.99999
HP_CLEFT_UPPER_LIP,SET,126,-0.054718,-0.0045176,0.075787,0.76485,HP_CLEFT_UPPER_LIP,0.99999
SA_G2_AND_M_PHASES,SET,8,-0.18347,-0.0038291,0.25408,0.76487,SA_G2_AND_M_PHASES,0.99999
WP_GPR40_PATHWAY,SET,15,-0.14925,-0.0042644,0.20665,0.76492,WP_GPR40_PATHWAY,0.99999
AGCGCTT_MIR518F_MIR518E_MIR5...,SET,16,-0.15319,-0.0045205,0.2121,0.76492,AGCGCTT_MIR518F_MIR518E_MIR518A,0.99999
GOBP_ACTIN_FILAMENT_BUNDLE_O...,SET,152,-0.051908,-0.0047037,0.071873,0.76492,GOBP_ACTIN_FILAMENT_BUNDLE_ORGANIZATION,0.99999
HP_DECREASED_SERUM_INSULIN_L...,SET,21,-0.13563,-0.0045845,0.18778,0.76492,HP_DECREASED_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1,0.99999
LIN_APC_TARGETS,SET,63,-0.078498,-0.0045906,0.10868,0.76493,LIN_APC_TARGETS,0.99999
NIKOLSKY_BREAST_CANCER_16P13...,SET,101,-0.10725,-0.0079334,0.14848,0.76495,NIKOLSKY_BREAST_CANCER_16P13_AMPLICON,0.99999
KEGG_MEDICUS_VARIANT_MET_OVE...,SET,13,-0.17215,-0.0045794,0.23828,0.76499,KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOBP_CELLULAR_RESPONSE_TO_OX...5,SET,21,-0.13416,-0.0045349,0.1857,0.76499,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_RADICAL,0.99999
HP_ABNORMAL_FACTOR_IX_ACTIVI...,SET,5,-0.22735,-0.0037515,0.31467,0.765,HP_ABNORMAL_FACTOR_IX_ACTIVITY,0.99999
GOBP_GDP_METABOLIC_PROCESS,SET,9,-0.21158,-0.0046837,0.29283,0.76502,GOBP_GDP_METABOLIC_PROCESS,0.99999
GOCC_RIBONUCLEASE_MRP_COMPLEX,SET,8,-0.19636,-0.0040982,0.27172,0.76505,GOCC_RIBONUCLEASE_MRP_COMPLEX,0.99999
HP_THORACOLUMBAR_KYPHOSCOLIO...,SET,6,-0.26172,-0.0047307,0.3621,0.76508,HP_THORACOLUMBAR_KYPHOSCOLIOSIS,0.99999
HP_RECURRENT_PATELLAR_DISLOC...,SET,3,-0.40274,-0.0051479,0.55715,0.76511,HP_RECURRENT_PATELLAR_DISLOCATION,0.99999
GSE8835_CD4_VS_CD8_TCELL_UP,SET,179,-0.044437,-0.0043664,0.061475,0.76511,GSE8835_CD4_VS_CD8_TCELL_UP,0.99999
BAKKER_FOXO3_TARGETS_DN,SET,157,-0.047459,-0.0043701,0.065651,0.76512,BAKKER_FOXO3_TARGETS_DN,0.99999
GOBP_TYPE_I_INTERFERON_PRODU...,SET,106,-0.056634,-0.004291,0.078331,0.76516,GOBP_TYPE_I_INTERFERON_PRODUCTION,0.99999
GALE_APL_WITH_FLT3_MUTATED_DN,SET,13,-0.16967,-0.0045135,0.23462,0.7652,GALE_APL_WITH_FLT3_MUTATED_DN,0.99999
HP_SHORT_LONG_BONE,SET,238,-0.039957,-0.0045199,0.055253,0.7652,HP_SHORT_LONG_BONE,0.99999
GSE41867_LCMV_ARMSTRONG_VS_C...3,SET,186,-0.042369,-0.0042431,0.058591,0.7652,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_DN,0.99999
HP_DECREASED_CIRCULATING_TER...,SET,6,-0.26606,-0.0048092,0.36788,0.76522,HP_DECREASED_CIRCULATING_TERMINAL_COMPLEMENT_COMPONENT_CONCENTRATION,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...10,SET,80,-0.073098,-0.0048149,0.10102,0.76533,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,0.99999
GOBP_HISTONE_MRNA_CATABOLIC_...,SET,11,-0.15406,-0.0037701,0.21287,0.76538,GOBP_HISTONE_MRNA_CATABOLIC_PROCESS,0.99999
HP_ABNORMAL_DENTAL_MORPHOLOGY,SET,255,-0.039815,-0.0046598,0.055006,0.76541,HP_ABNORMAL_DENTAL_MORPHOLOGY,0.99999
MIR651_5P,SET,107,-0.06242,-0.0047515,0.086216,0.76546,MIR651_5P,0.99999
REACTOME_TYSND1_CLEAVES_PERO...,SET,7,-0.22272,-0.0043483,0.30757,0.7655,REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS,0.99999
HP_ABNORMALITY_OF_PULMONARY_...,SET,168,-0.04829,-0.0045983,0.066674,0.76554,HP_ABNORMALITY_OF_PULMONARY_CIRCULATION,0.99999
GOCC_GOLGI_TRANS_CISTERNA,SET,9,-0.2302,-0.0050958,0.3178,0.76557,GOCC_GOLGI_TRANS_CISTERNA,0.99999
GOCC_PHOTORECEPTOR_RIBBON_SY...,SET,9,-0.22196,-0.0049134,0.30639,0.7656,GOCC_PHOTORECEPTOR_RIBBON_SYNAPSE,0.99999
HP_BIVENTRICULAR_HYPERTROPHY,SET,13,-0.16258,-0.0043248,0.22441,0.76561,HP_BIVENTRICULAR_HYPERTROPHY,0.99999
GOBP_CELL_PROLIFERATION_INVO...3,SET,9,-0.25389,-0.0056201,0.35038,0.76565,GOBP_CELL_PROLIFERATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,0.99999
HP_ABNORMAL_CIRCULATING_DICA...,SET,139,-0.052597,-0.0045594,0.072583,0.76566,HP_ABNORMAL_CIRCULATING_DICARBOXYLIC_ACID_CONCENTRATION,0.99999
MIR664B_3P,SET,442,-0.030848,-0.0047286,0.042568,0.76567,MIR664B_3P,0.99999
GOMF_CALMODULIN_BINDING,SET,197,-0.0446,-0.0045953,0.06153,0.76572,GOMF_CALMODULIN_BINDING,0.99999
WU_APOPTOSIS_BY_CDKN1A_VIA_T...,SET,50,-0.084875,-0.0044234,0.11709,0.76573,WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,0.99999
TGACAGNY_MEIS1_01,SET,766,-0.023365,-0.004672,0.032233,0.76573,TGACAGNY_MEIS1_01,0.99999
PLASARI_TGFB1_TARGETS_10HR_DN,SET,235,-0.043883,-0.0049331,0.060534,0.76575,PLASARI_TGFB1_TARGETS_10HR_DN,0.99999
GOBP_GRANZYME_MEDIATED_PROGR...,SET,8,-0.24005,-0.0050101,0.3311,0.76577,GOBP_GRANZYME_MEDIATED_PROGRAMMED_CELL_DEATH_SIGNALING_PATHWAY,0.99999
HP_LEUKOCORIA,SET,6,-0.21499,-0.0038861,0.29654,0.76577,HP_LEUKOCORIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...339,SET,17,-0.16431,-0.0049978,0.22661,0.76579,GOBP_POSITIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,0.99999
HP_SPINAL_CORD_TUMOR,SET,9,-0.20062,-0.004441,0.2767,0.76579,HP_SPINAL_CORD_TUMOR,0.99999
HP_ABNORMAL_MENINGEAL_MORPHO...,SET,177,-0.045915,-0.0044867,0.063319,0.76581,HP_ABNORMAL_MENINGEAL_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...680,SET,10,-0.19934,-0.0046511,0.27483,0.76586,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.99999
GOBP_GAMMA_AMINOBUTYRIC_ACID...2,SET,5,-0.33757,-0.0055702,0.46536,0.76589,GOBP_GAMMA_AMINOBUTYRIC_ACID_IMPORT,0.99999
REACTOME_SIGNALING_BY_ERBB4,SET,54,-0.083094,-0.0045,0.11451,0.76596,REACTOME_SIGNALING_BY_ERBB4,0.99999
MIR4307,SET,389,-0.03283,-0.004728,0.045222,0.76606,MIR4307,0.99999
GSE34006_A2AR_KO_VS_A2AR_AGO...1,SET,188,-0.043619,-0.0043915,0.060068,0.76613,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...16,SET,161,-0.048225,-0.0044963,0.066411,0.76613,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_UP,0.99999
E2F3_UP.V1_DN,SET,131,-0.052871,-0.0044503,0.072802,0.76615,E2F3_UP.V1_DN,0.99999
DESCARTES_FETAL_INTESTINE_MY...,SET,187,-0.050283,-0.005049,0.069233,0.76616,DESCARTES_FETAL_INTESTINE_MYELOID_CELLS,0.99999
MIR4664_5P,SET,76,-0.069766,-0.0044796,0.096045,0.76619,MIR4664_5P,0.99999
GOMF_CYCLIN_DEPENDENT_PROTEI...1,SET,26,-0.11704,-0.0044014,0.16104,0.76631,GOMF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.99999
MODULE_368,SET,17,-0.15585,-0.0047405,0.21444,0.76632,MODULE_368,0.99999
GOBP_OSTEOBLAST_PROLIFERATION,SET,32,-0.11178,-0.0046629,0.1538,0.76632,GOBP_OSTEOBLAST_PROLIFERATION,0.99999
GSE35825_IFNA_VS_IFNG_STIM_M...2,SET,154,-0.050687,-0.0046229,0.069726,0.76636,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP,0.99999
WP_IL1_AND_MEGAKARYOCYTES_IN...,SET,22,-0.14163,-0.0049001,0.19481,0.76639,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,0.99999
MARTINEZ_RB1_AND_TP53_TARGET...2,SET,568,-0.026817,-0.0046435,0.036884,0.7664,MARTINEZ_RB1_AND_TP53_TARGETS_UP,0.99999
chr11q22,SET,51,-0.16423,-0.008644,0.22587,0.76641,chr11q22,0.99999
HP_ERYTHRODERMA,SET,56,-0.082367,-0.0045423,0.11327,0.76644,HP_ERYTHRODERMA,0.99999
GOMF_THIAMINE_PYROPHOSPHATE_...,SET,6,-0.26152,-0.0047272,0.35955,0.76649,GOMF_THIAMINE_PYROPHOSPHATE_BINDING,0.99999
PID_AURORA_B_PATHWAY,SET,36,-0.099982,-0.0044232,0.13745,0.76651,PID_AURORA_B_PATHWAY,0.99999
GOBP_SYNAPTIC_TRANSMISSION_G...1,SET,56,-0.089343,-0.004927,0.12278,0.76659,GOBP_SYNAPTIC_TRANSMISSION_GABAERGIC,0.99999
ACACTGG_MIR199A_MIR199B,SET,139,-0.052404,-0.0045427,0.072013,0.7666,ACACTGG_MIR199A_MIR199B,0.99999
MODULE_552,SET,7,-0.21842,-0.0042642,0.30011,0.76662,MODULE_552,0.99999
GOMF_UBIQUITIN_UBIQUITIN_LIG...,SET,13,-0.14701,-0.0039106,0.20199,0.76662,GOMF_UBIQUITIN_UBIQUITIN_LIGASE_ACTIVITY,0.99999
GOBP_PROTEIN_HOMOTETRAMERIZA...,SET,60,-0.07979,-0.0045541,0.10963,0.76663,GOBP_PROTEIN_HOMOTETRAMERIZATION,0.99999
MIR1537_3P,SET,9,-0.24545,-0.0054333,0.33723,0.76664,MIR1537_3P,0.99999
MIR26A_2_3P,SET,66,-0.074625,-0.0044664,0.10253,0.76664,MIR26A_2_3P,0.99999
GSE9006_HEALTHY_VS_TYPE_2_DI...2,SET,176,-0.043502,-0.004239,0.059761,0.76667,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,0.99999
MIR7155_3P,SET,61,-0.074398,-0.0042815,0.10216,0.76676,MIR7155_3P,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...6,SET,173,-0.046547,-0.0044972,0.063918,0.76676,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP,0.99999
GOBP_EPITHELIAL_CELL_MATURAT...,SET,26,-0.13594,-0.0051121,0.18665,0.76678,GOBP_EPITHELIAL_CELL_MATURATION,0.99999
GOBP_VITAMIN_K_METABOLIC_PRO...,SET,11,-0.17724,-0.0043373,0.2433,0.76684,GOBP_VITAMIN_K_METABOLIC_PROCESS,0.99999
SHEN_SMARCA2_TARGETS_DN,SET,265,-0.040304,-0.0048073,0.055315,0.76688,SHEN_SMARCA2_TARGETS_DN,0.99999
HP_MULTIPLE_PRENATAL_FRACTUR...,SET,16,-0.14773,-0.0043593,0.20274,0.76689,HP_MULTIPLE_PRENATAL_FRACTURES,0.99999
HP_PULMONARY_VENOUS_HYPERTEN...,SET,9,-0.21392,-0.0047354,0.29355,0.76691,HP_PULMONARY_VENOUS_HYPERTENSION,0.99999
GOMF_GPI_LINKED_EPHRIN_RECEP...,SET,6,-0.29227,-0.0052829,0.40087,0.76702,GOMF_GPI_LINKED_EPHRIN_RECEPTOR_ACTIVITY,0.99999
REACTOME_NEUROTOXICITY_OF_CL...,SET,10,-0.19155,-0.0044693,0.26271,0.76703,REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS,0.99999
KEGG_MEDICUS_PATHOGEN_EBV_EB...5,SET,11,-0.17636,-0.0043156,0.24182,0.76709,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00264,0.99999
GCM_GSTA4,SET,57,-0.079917,-0.0044462,0.10958,0.7671,GCM_GSTA4,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...5,SET,6,-0.31664,-0.0057234,0.43406,0.76714,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_NOREPINEPHRINE_EPINEPHRINE,0.99999
ZHU_CMV_ALL_UP,SET,102,-0.060527,-0.0044991,0.082966,0.76716,ZHU_CMV_ALL_UP,0.99999
GOCC_CALCIUM_CHANNEL_COMPLEX,SET,63,-0.081538,-0.0047684,0.11175,0.76718,GOCC_CALCIUM_CHANNEL_COMPLEX,0.99999
GOBP_CELL_CYCLE,SET,1476,-0.016526,-0.0044937,0.022649,0.7672,GOBP_CELL_CYCLE,0.99999
HP_ANTECUBITAL_PTERYGIUM,SET,7,-0.26964,-0.0052642,0.36943,0.76726,HP_ANTECUBITAL_PTERYGIUM,0.99999
GOBP_REGULATION_OF_ATP_BIOSY...,SET,11,-0.17617,-0.0043111,0.24136,0.76727,GOBP_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS,0.99999
GOBP_SPERM_CAPACITATION,SET,29,-0.118,-0.0046864,0.16166,0.76728,GOBP_SPERM_CAPACITATION,0.99999
GSE45365_NK_CELL_VS_CD8A_DC_...4,SET,181,-0.044791,-0.0044255,0.06136,0.76729,GSE45365_NK_CELL_VS_CD8A_DC_UP,0.99999
REACTOME_RHOF_GTPASE_CYCLE,SET,39,-0.10245,-0.0047171,0.14032,0.76733,REACTOME_RHOF_GTPASE_CYCLE,0.99999
HP_SQUARE_FACE,SET,11,-0.20821,-0.0050951,0.28518,0.76733,HP_SQUARE_FACE,0.99999
HP_ATTENUATION_OF_RETINAL_BL...,SET,118,-0.057475,-0.0045931,0.07871,0.76736,HP_ATTENUATION_OF_RETINAL_BLOOD_VESSELS,0.99999
LE_NEURONAL_DIFFERENTIATION_...1,SET,18,-0.13407,-0.0041962,0.1836,0.76737,LE_NEURONAL_DIFFERENTIATION_DN,0.99999
HP_HYPERMAGNESEMIA,SET,7,-0.25295,-0.0049384,0.34627,0.76745,HP_HYPERMAGNESEMIA,0.99999
GOBP_REGULATION_BY_VIRUS_OF_...,SET,7,-0.22035,-0.0043019,0.30163,0.76746,GOBP_REGULATION_BY_VIRUS_OF_VIRAL_PROTEIN_LEVELS_IN_HOST_CELL,0.99999
TBP_01,SET,223,-0.044046,-0.0048249,0.060287,0.76748,TBP_01,0.99999
WP_WHITE_FAT_CELL_DIFFERENTI...,SET,31,-0.12486,-0.0051267,0.17089,0.7675,WP_WHITE_FAT_CELL_DIFFERENTIATION,0.99999
HP_ELEVATED_URINARY_DELTA_AM...,SET,5,-0.32388,-0.0053444,0.44319,0.76755,HP_ELEVATED_URINARY_DELTA_AMINOLEVULINIC_ACID,0.99999
REACTOME_UNBLOCKING_OF_NMDA_...,SET,19,-0.15757,-0.0050665,0.21553,0.76763,REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION,0.99999
ALK_DN.V1_DN,SET,129,-0.056305,-0.0047033,0.076995,0.76769,ALK_DN.V1_DN,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...14,SET,172,-0.049276,-0.0047473,0.067379,0.76771,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP,0.99999
KEGG_ARACHIDONIC_ACID_METABO...,SET,58,-0.091773,-0.0051503,0.12548,0.76772,KEGG_ARACHIDONIC_ACID_METABOLISM,0.99999
GRUETZMANN_PANCREATIC_CANCER...2,SET,330,-0.034872,-0.0046332,0.047667,0.76778,GRUETZMANN_PANCREATIC_CANCER_UP,0.99999
CAMP_UP.V1_DN,SET,178,-0.047414,-0.0046461,0.064809,0.76779,CAMP_UP.V1_DN,0.99999
GOBP_REGULATION_OF_SHORT_TER...,SET,14,-0.17438,-0.0048139,0.23835,0.7678,GOBP_REGULATION_OF_SHORT_TERM_NEURONAL_SYNAPTIC_PLASTICITY,0.99999
GSE22886_NAIVE_TCELL_VS_DC_DN,SET,189,-0.045821,-0.0046253,0.0626,0.7679,GSE22886_NAIVE_TCELL_VS_DC_DN,0.99999
GOBP_ESTABLISHMENT_OF_PLANAR...2,SET,15,-0.16683,-0.0047668,0.22785,0.76797,GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_OF_EMBRYONIC_EPITHELIUM,0.99999
GOBP_DEOXYRIBONUCLEOSIDE_TRI...,SET,9,-0.19893,-0.0044036,0.27165,0.76801,GOBP_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.99999
HP_DIGESTIVE_SYSTEM_NEOPLASM,SET,343,-0.033993,-0.0046029,0.04641,0.76805,HP_DIGESTIVE_SYSTEM_NEOPLASM,0.99999
HP_ABNORMAL_CIRCULATING_ANDR...2,SET,11,-0.2025,-0.0049554,0.27642,0.76808,HP_ABNORMAL_CIRCULATING_ANDROSTENEDIONE_CONCENTRATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...76,SET,23,-0.12302,-0.0043515,0.1679,0.76812,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT,0.99999
GOCC_POLAR_MICROTUBULE,SET,5,-0.26086,-0.0043046,0.35604,0.76812,GOCC_POLAR_MICROTUBULE,0.99999
GSE17721_PAM3CSK4_VS_CPG_12H...2,SET,174,-0.045244,-0.0043839,0.061716,0.76825,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_UP,0.99999
HP_GLOMERULAR_DEPOSITS,SET,18,-0.14438,-0.0045187,0.19689,0.76831,HP_GLOMERULAR_DEPOSITS,0.99999
HARALAMBIEVA_PBMC_FLUARIX_AG...1,SET,376,-0.033316,-0.004719,0.045424,0.76835,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE,0.99999
GOBP_REGULATION_OF_CELL_ADHE...1,SET,738,-0.024588,-0.0048298,0.033521,0.76837,GOBP_REGULATION_OF_CELL_ADHESION,0.99999
GSE29949_MICROGLIA_BRAIN_VS_...5,SET,182,-0.044715,-0.0044301,0.060956,0.76838,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.99999
GOBP_MITOTIC_NUCLEAR_DIVISION,SET,265,-0.037351,-0.0044551,0.050915,0.7684,GOBP_MITOTIC_NUCLEAR_DIVISION,0.99999
HP_SQUARED_ILIAC_BONES,SET,11,-0.18194,-0.0044522,0.24799,0.76842,HP_SQUARED_ILIAC_BONES,0.99999
HP_TONGUE_FASCICULATIONS,SET,36,-0.10392,-0.0045976,0.14163,0.76845,HP_TONGUE_FASCICULATIONS,0.99999
MIR1271_5P,SET,355,-0.03497,-0.0048157,0.047649,0.7685,MIR1271_5P,0.99999
GSE17721_CTRL_VS_POLYIC_8H_B...1,SET,183,-0.046534,-0.0046228,0.063397,0.76852,GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN,0.99999
GOBP_PHOSPHATIDYLCHOLINE_MET...,SET,67,-0.078486,-0.0047328,0.10687,0.76864,GOBP_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS,0.99999
LIU_OVARIAN_CANCER_TUMORS_AN...2,SET,1379,-0.019508,-0.0051419,0.02656,0.76866,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_DN,0.99999
QIU_PBMC_HEPTATITIS_B_SURFAC...7,SET,28,-0.13026,-0.0050833,0.17735,0.76867,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_7DY_UP,0.99999
WP_16P112_PROXIMAL_DELETION_...,SET,68,-0.084942,-0.0051601,0.1156,0.76876,WP_16P112_PROXIMAL_DELETION_SYNDROME,0.99999
GOBP_NUCLEAR_BODY_ORGANIZATI...,SET,15,-0.15498,-0.0044283,0.21085,0.76883,GOBP_NUCLEAR_BODY_ORGANIZATION,0.99999
HP_ABNORMALITY_OF_PRENATAL_D...,SET,881,-0.0213,-0.0045528,0.028977,0.76885,HP_ABNORMALITY_OF_PRENATAL_DEVELOPMENT_OR_BIRTH,0.99999
GOBP_FAT_PAD_DEVELOPMENT,SET,8,-0.22349,-0.0046645,0.30399,0.76889,GOBP_FAT_PAD_DEVELOPMENT,0.99999
BERTUCCI_MEDULLARY_VS_DUCTAL...1,SET,153,-0.053079,-0.0048254,0.072182,0.76893,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,0.99999
LANDIS_ERBB2_BREAST_TUMORS_3...2,SET,140,-0.054111,-0.0047073,0.073583,0.76894,LANDIS_ERBB2_BREAST_TUMORS_324_UP,0.99999
DNMT1_TARGET_GENES,SET,173,-0.047658,-0.0046046,0.064785,0.76902,DNMT1_TARGET_GENES,0.99999
HP_CURLY_EYELASHES,SET,12,-0.19658,-0.0050244,0.26722,0.76903,HP_CURLY_EYELASHES,0.99999
HP_ABNORMALITY_OF_THE_COMMON...,SET,61,-0.083561,-0.0048088,0.11356,0.76908,HP_ABNORMALITY_OF_THE_COMMON_COAGULATION_PATHWAY,0.99999
HP_APNEIC_EPISODES_IN_INFANCY,SET,9,-0.21543,-0.0047688,0.29271,0.76912,HP_APNEIC_EPISODES_IN_INFANCY,0.99999
HP_LONG_TOE,SET,38,-0.10213,-0.0046416,0.13874,0.76915,HP_LONG_TOE,0.99999
GSE3203_WT_VS_IFNAR1_KO_INFL...1,SET,186,-0.046977,-0.0047045,0.063809,0.76919,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_DN,0.99999
GOCC_VOLTAGE_GATED_CALCIUM_C...,SET,41,-0.10396,-0.0049076,0.1412,0.76921,GOCC_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX,0.99999
KEGG_MEDICUS_REFERENCE_P4_PR...1,SET,8,-0.22137,-0.0046203,0.30065,0.76922,KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY,0.99999
MCM3_TARGET_GENES,SET,184,-0.046899,-0.0046717,0.063683,0.76927,MCM3_TARGET_GENES,0.99999
GOMF_NUCLEAR_RECEPTOR_COACTI...,SET,51,-0.083773,-0.0044093,0.11372,0.76933,GOMF_NUCLEAR_RECEPTOR_COACTIVATOR_ACTIVITY,0.99999
GOBP_MALE_SEX_DIFFERENTIATION,SET,158,-0.052543,-0.0048535,0.071315,0.76936,GOBP_MALE_SEX_DIFFERENTIATION,0.99999
MIR126_5P,SET,405,-0.032276,-0.0047408,0.043804,0.76938,MIR126_5P,0.99999
VISALA_AGING_LYMPHOCYTE_UP,SET,6,-0.30541,-0.0055204,0.41448,0.76939,VISALA_AGING_LYMPHOCYTE_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...67,SET,25,-0.12659,-0.0046682,0.17178,0.7694,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.99999
VIETOR_IFRD1_TARGETS,SET,20,-0.14552,-0.0048004,0.19745,0.76942,VIETOR_IFRD1_TARGETS,0.99999
GSE17721_CTRL_VS_LPS_8H_BMDC...2,SET,179,-0.047092,-0.0046274,0.063895,0.76944,GSE17721_CTRL_VS_LPS_8H_BMDC_UP,0.99999
GOBP_L_AMINO_ACID_BIOSYNTHET...,SET,55,-0.083066,-0.0045398,0.11269,0.76947,GOBP_L_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.99999
GOMF_N_ACETYLTRANSFERASE_ACT...,SET,61,-0.076755,-0.0044171,0.10412,0.76948,GOMF_N_ACETYLTRANSFERASE_ACTIVITY,0.99999
LEE_LIVER_CANCER_SURVIVAL_UP,SET,166,-0.049927,-0.0047261,0.067727,0.76949,LEE_LIVER_CANCER_SURVIVAL_UP,0.99999
GOCC_G_PROTEIN_COUPLED_RECEP...1,SET,11,-0.20655,-0.0050546,0.28012,0.76955,GOCC_G_PROTEIN_COUPLED_RECEPTOR_COMPLEX,0.99999
GOCC_PERINUCLEOLAR_COMPARTME...,SET,5,-0.32521,-0.0053663,0.44103,0.76955,GOCC_PERINUCLEOLAR_COMPARTMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...842,SET,6,-0.22104,-0.0039954,0.29976,0.76956,GOBP_POSITIVE_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_NEOPLASM_OF_THE_INNER_EAR,SET,8,-0.21676,-0.0045239,0.29393,0.76957,HP_NEOPLASM_OF_THE_INNER_EAR,0.99999
GSE25123_CTRL_VS_IL4_AND_ROS...3,SET,185,-0.046934,-0.0046877,0.063639,0.76959,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,0.99999
HP_ASYMMETRIC_GROWTH,SET,58,-0.087266,-0.0048973,0.1183,0.76963,HP_ASYMMETRIC_GROWTH,0.99999
GOCC_SIDE_OF_MEMBRANE,SET,659,-0.027354,-0.0050888,0.037059,0.76978,GOCC_SIDE_OF_MEMBRANE,0.99999
GOCC_CONE_PHOTORECEPTOR_OUTE...,SET,7,-0.27074,-0.0052856,0.36677,0.76979,GOCC_CONE_PHOTORECEPTOR_OUTER_SEGMENT,0.99999
HP_ABNORMAL_NOSTRIL_MORPHOLO...,SET,434,-0.029931,-0.0045473,0.04054,0.76983,HP_ABNORMAL_NOSTRIL_MORPHOLOGY,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...5,SET,166,-0.0505,-0.0047803,0.068388,0.76987,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN,0.99999
GSE13411_SWITCHED_MEMORY_BCE...2,SET,178,-0.046908,-0.0045966,0.063518,0.76989,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...8,SET,9,-0.20548,-0.0045484,0.27818,0.76993,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PI3P_SYNTHESIS_BY_PI3KC3_C1,0.99999
GOBP_POSITIVE_REGULATION_OF_...810,SET,8,-0.22904,-0.0047803,0.31008,0.76993,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT,0.99999
GOBP_TROPHOBLAST_GIANT_CELL_...,SET,12,-0.1887,-0.004823,0.25535,0.77005,GOBP_TROPHOBLAST_GIANT_CELL_DIFFERENTIATION,0.99999
MULLIGHAN_NPM1_MUTATED_SIGNA...2,SET,234,-0.040549,-0.0045488,0.05486,0.77008,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,0.99999
KEGG_MEDICUS_REFERENCE_CD40_...,SET,6,-0.2628,-0.0047502,0.35554,0.77008,KEGG_MEDICUS_REFERENCE_CD40_NFKB_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_LEUKOCYTE_COUNT,SET,435,-0.03055,-0.0046466,0.041325,0.77012,HP_ABNORMAL_LEUKOCYTE_COUNT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...655,SET,374,-0.033607,-0.0047476,0.045448,0.77018,GOBP_NEGATIVE_REGULATION_OF_TRANSPORT,0.99999
GOBP_INTESTINAL_STEM_CELL_HO...,SET,5,-0.27834,-0.004593,0.37638,0.7702,GOBP_INTESTINAL_STEM_CELL_HOMEOSTASIS,0.99999
GOBP_PEPTIDYL_TYROSINE_AUTOP...,SET,16,-0.15877,-0.0046853,0.21467,0.77023,GOBP_PEPTIDYL_TYROSINE_AUTOPHOSPHORYLATION,0.99999
GSE5542_IFNG_VS_IFNA_TREATED...3,SET,172,-0.049969,-0.0048141,0.067561,0.77023,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...217,SET,59,-0.085,-0.004811,0.1149,0.77028,GOBP_NEGATIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,0.99999
GOBP_REGULATION_OF_FEVER_GEN...,SET,9,-0.23954,-0.0053025,0.32378,0.77029,GOBP_REGULATION_OF_FEVER_GENERATION,0.99999
CSR_EARLY_UP.V1_DN,SET,113,-0.058239,-0.0045551,0.078716,0.7703,CSR_EARLY_UP.V1_DN,0.99999
BIOCARTA_ALK_PATHWAY,SET,34,-0.11579,-0.0049786,0.1565,0.77032,BIOCARTA_ALK_PATHWAY,0.99999
GOBP_FOAM_CELL_DIFFERENTIATI...,SET,37,-0.11187,-0.0050172,0.15119,0.77032,GOBP_FOAM_CELL_DIFFERENTIATION,0.99999
PID_IL1_PATHWAY,SET,32,-0.11171,-0.0046601,0.15095,0.77037,PID_IL1_PATHWAY,0.99999
FAN_EMBRYONIC_CTX_ASTROCYTE_2,SET,138,-0.060982,-0.0052673,0.082397,0.77038,FAN_EMBRYONIC_CTX_ASTROCYTE_2,0.99999
GOBP_INTERLEUKIN_23_PRODUCTI...,SET,10,-0.21223,-0.0049519,0.28671,0.77041,GOBP_INTERLEUKIN_23_PRODUCTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...712,SET,16,-0.1556,-0.0045916,0.21019,0.77043,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOBP_PROTEIN_DE_ADP_RIBOSYLA...,SET,4,-0.3698,-0.0054581,0.49954,0.77043,GOBP_PROTEIN_DE_ADP_RIBOSYLATION,0.99999
NFKB_C,SET,243,-0.041487,-0.0047414,0.056027,0.77049,NFKB_C,0.99999
HP_HEREDITARY_NONPOLYPOSIS_C...,SET,32,-0.11403,-0.0047566,0.15395,0.77055,HP_HEREDITARY_NONPOLYPOSIS_COLORECTAL_CARCINOMA,0.99999
REACTOME_ONCOGENE_INDUCED_SE...,SET,32,-0.11219,-0.0046797,0.15146,0.77056,REACTOME_ONCOGENE_INDUCED_SENESCENCE,0.99999
GSE22919_RESTING_VS_IL2_IL12...1,SET,181,-0.045511,-0.0044966,0.061432,0.7706,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN,0.99999
NABA_MATRISOME_POORLY_METAST...2,SET,12,-0.17968,-0.0045924,0.24253,0.77061,NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED,0.99999
GOBP_CD8_POSITIVE_ALPHA_BETA...1,SET,26,-0.13092,-0.0049236,0.17669,0.77063,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
WP_BILE_ACID_SYNTHESIS_AND_E...,SET,12,-0.20961,-0.0053574,0.28281,0.7707,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,0.99999
KEGG_MEDICUS_VARIANT_LOSS_OF...1,SET,8,-0.20475,-0.0042734,0.27621,0.77074,KEGG_MEDICUS_VARIANT_LOSS_OF_CDKN1B_TO_P27_CELL_CYCLE_G1_S,0.99999
MORF_PPP1CA,SET,145,-0.046814,-0.004144,0.063149,0.77075,MORF_PPP1CA,0.99999
GOBP_MEMBRANE_TO_MEMBRANE_DO...,SET,4,-0.33324,-0.0049185,0.44951,0.77075,GOBP_MEMBRANE_TO_MEMBRANE_DOCKING,0.99999
GOCC_DNA_RECOMBINASE_MEDIATO...,SET,7,-0.23888,-0.0046637,0.32223,0.77075,GOCC_DNA_RECOMBINASE_MEDIATOR_COMPLEX,0.99999
DESCARTES_FETAL_STOMACH_CILI...,SET,225,-0.040802,-0.0044893,0.055032,0.77077,DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS,0.99999
GOBP_SENSORY_PERCEPTION_OF_S...3,SET,7,-0.23219,-0.0045331,0.31316,0.77078,GOBP_SENSORY_PERCEPTION_OF_SWEET_TASTE,0.99999
HP_INTERHEMISPHERIC_CYST,SET,5,-0.2975,-0.004909,0.40121,0.7708,HP_INTERHEMISPHERIC_CYST,0.99999
HP_MACULAR_HYPOPIGMENTATION,SET,5,-0.31311,-0.0051666,0.42223,0.77082,HP_MACULAR_HYPOPIGMENTATION,0.99999
WANG_NEOPLASTIC_TRANSFORMATI...,SET,17,-0.18389,-0.0055933,0.24793,0.77086,WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC,0.99999
GOBP_TONIC_SMOOTH_MUSCLE_CON...,SET,11,-0.22309,-0.0054591,0.30075,0.77088,GOBP_TONIC_SMOOTH_MUSCLE_CONTRACTION,0.99999
HEIDENBLAD_AMPLIFIED_IN_PANC...,SET,53,-0.089823,-0.0048193,0.12105,0.77096,HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,0.99999
GSE27786_ERYTHROBLAST_VS_NEU...1,SET,176,-0.044905,-0.0043757,0.060515,0.77097,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN,0.99999
DASU_IL6_SIGNALING_UP,SET,56,-0.088325,-0.0048708,0.11898,0.77106,DASU_IL6_SIGNALING_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...156,SET,20,-0.1399,-0.004615,0.18839,0.77113,GOBP_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.99999
GSE43700_UNTREATED_VS_IL10_T...2,SET,184,-0.047325,-0.0047141,0.06373,0.77113,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...86,SET,28,-0.12734,-0.0049695,0.17146,0.77116,GOBP_NEGATIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,0.99999
GSE3982_NEUTROPHIL_VS_TH2_UP,SET,181,-0.04744,-0.0046873,0.063874,0.77117,GSE3982_NEUTROPHIL_VS_TH2_UP,0.99999
REACTOME_HYDROLYSIS_OF_LPC,SET,9,-0.22645,-0.0050128,0.30488,0.77118,REACTOME_HYDROLYSIS_OF_LPC,0.99999
MIR4665_5P,SET,137,-0.056073,-0.0048259,0.075483,0.77121,MIR4665_5P,0.99999
GOBP_DECIDUALIZATION,SET,24,-0.13463,-0.0048647,0.1812,0.77125,GOBP_DECIDUALIZATION,0.99999
MIR4298,SET,50,-0.085055,-0.0044328,0.11446,0.77127,MIR4298,0.99999
MIR624_3P,SET,90,-0.065372,-0.0045659,0.087972,0.77128,MIR624_3P,0.99999
MODULE_162,SET,17,-0.17338,-0.0052735,0.23332,0.77128,MODULE_162,0.99999
GOMF_CATALYTIC_ACTIVITY_ACTI...2,SET,541,-0.025287,-0.0042765,0.034015,0.77138,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_NUCLEIC_ACID,0.99999
MCCLUNG_COCAINE_REWARD_5D,SET,68,-0.077613,-0.0047149,0.1044,0.77139,MCCLUNG_COCAINE_REWARD_5D,0.99999
GOBP_LYMPHOCYTE_ACTIVATION,SET,725,-0.025182,-0.0049045,0.033871,0.7714,GOBP_LYMPHOCYTE_ACTIVATION,0.99999
HP_INCREASED_CIRCULATING_LAC...2,SET,73,-0.075752,-0.0047674,0.10187,0.77144,HP_INCREASED_CIRCULATING_LACTATE_DEHYDROGENASE_CONCENTRATION,0.99999
GOBP_EPITHELIAL_TUBE_MORPHOG...,SET,315,-0.036981,-0.0048025,0.049729,0.77145,GOBP_EPITHELIAL_TUBE_MORPHOGENESIS,0.99999
REACTOME_EGFR_INTERACTS_WITH...,SET,9,-0.22874,-0.0050635,0.30759,0.77146,REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA,0.99999
HOXA3_01,SET,14,-0.17107,-0.0047224,0.22985,0.77164,HOXA3_01,0.99999
HP_DYSGERMINOMA,SET,9,-0.20907,-0.004628,0.2809,0.77165,HP_DYSGERMINOMA,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...7,SET,45,-0.098691,-0.0048802,0.13259,0.77166,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MES_GLYCOLYSIS,0.99999
GOBP_ANTEROGRADE_AXONAL_TRAN...2,SET,6,-0.25545,-0.0046174,0.34318,0.77167,GOBP_ANTEROGRADE_AXONAL_TRANSPORT_OF_MITOCHONDRION,0.99999
ZHAN_MULTIPLE_MYELOMA_CD1_AN...2,SET,78,-0.071187,-0.0046303,0.09563,0.77168,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,0.99999
HP_SPONTANEOUS_HEMOLYTIC_CRI...,SET,7,-0.21911,-0.0042778,0.29435,0.77168,HP_SPONTANEOUS_HEMOLYTIC_CRISES,0.99999
REACTOME_OREXIN_AND_NEUROPEP...,SET,6,-0.32598,-0.0058922,0.43785,0.77171,REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS,0.99999
HP_HYPERMETHIONINEMIA,SET,7,-0.27685,-0.0054049,0.37182,0.77173,HP_HYPERMETHIONINEMIA,0.99999
BIOCARTA_BARD1_PATHWAY,SET,8,-0.18509,-0.003863,0.24855,0.77176,BIOCARTA_BARD1_PATHWAY,0.99999
GAVIN_FOXP3_TARGETS_CLUSTER_...6,SET,82,-0.070536,-0.0047036,0.094701,0.77181,GAVIN_FOXP3_TARGETS_CLUSTER_T4,0.99999
CHARAFE_BREAST_CANCER_LUMINA...4,SET,400,-0.032978,-0.0048145,0.044268,0.77185,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,0.99999
HP_POPLITEAL_PTERYGIUM,SET,8,-0.25054,-0.005229,0.33631,0.77185,HP_POPLITEAL_PTERYGIUM,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...12,SET,11,-0.18211,-0.0044564,0.24443,0.77187,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP,0.99999
GNF2_CENPF,SET,57,-0.081484,-0.0045334,0.10936,0.77189,GNF2_CENPF,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...13,SET,4,-0.34253,-0.0050555,0.45959,0.77195,KEGG_MEDICUS_REFERENCE_REGULATION_OF_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY_NLRP3_INHIBITION,0.99999
USF2_Q6,SET,246,-0.042613,-0.0048997,0.057161,0.77201,USF2_Q6,0.99999
GCM_BCL2L1,SET,33,-0.10496,-0.0044462,0.1408,0.77201,GCM_BCL2L1,0.99999
GSE28737_FOLLICULAR_VS_MARGI...3,SET,179,-0.048918,-0.0048068,0.065619,0.77201,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_DN,0.99999
GOMF_TRANSMEMBRANE_RECEPTOR_...2,SET,16,-0.16788,-0.004954,0.22515,0.77205,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY,0.99999
MODULE_262,SET,19,-0.17882,-0.0057499,0.23982,0.77206,MODULE_262,0.99999
GOBP_RIBOSOME_BIOGENESIS,SET,272,-0.035921,-0.0043399,0.048171,0.77207,GOBP_RIBOSOME_BIOGENESIS,0.99999
REACTOME_LIPID_PARTICLE_ORGA...,SET,6,-0.28255,-0.0051072,0.37884,0.77211,REACTOME_LIPID_PARTICLE_ORGANIZATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...115,SET,10,-0.25573,-0.005967,0.34288,0.77211,GOBP_NEGATIVE_REGULATION_OF_CELL_FATE_COMMITMENT,0.99999
GOBP_RIBONUCLEOPROTEIN_COMPL...2,SET,10,-0.17796,-0.0041524,0.23861,0.77211,GOBP_RIBONUCLEOPROTEIN_COMPLEX_LOCALIZATION,0.99999
HOEK_NEUTROPHIL_2011_2012_TI...1,SET,50,-0.090686,-0.0047263,0.12159,0.77211,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_DN,0.99999
MA_MYELOID_DIFFERENTIATION_DN,SET,40,-0.10235,-0.0047725,0.13722,0.77213,MA_MYELOID_DIFFERENTIATION_DN,0.99999
GSE29949_MICROGLIA_BRAIN_VS_...6,SET,182,-0.048501,-0.0048052,0.065019,0.77214,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.99999
GOCC_CHROMOSOME_CENTROMERIC_...1,SET,2,-0.48227,-0.0050335,0.64645,0.77217,GOCC_CHROMOSOME_CENTROMERIC_CORE_DOMAIN,0.99999
GOMF_G_PROTEIN_BETA_GAMMA_SU...,SET,21,-0.14741,-0.0049828,0.1976,0.77217,GOMF_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX_BINDING,0.99999
KYNG_ENVIRONMENTAL_STRESS_RE...2,SET,12,-0.17951,-0.004588,0.24059,0.7722,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD,0.99999
HP_MUSCULAR_VENTRICULAR_SEPT...,SET,22,-0.13963,-0.0048307,0.1871,0.77224,HP_MUSCULAR_VENTRICULAR_SEPTAL_DEFECT,0.99999
ZHANG_ANTIVIRAL_RESPONSE_TO_...2,SET,24,-0.13408,-0.0048446,0.17963,0.77229,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,0.99999
REACTOME_ACTIVATION_OF_THE_P...1,SET,11,-0.18795,-0.0045994,0.25174,0.77235,REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...77,SET,37,-0.088186,-0.003955,0.11808,0.77241,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,0.99999
MODULE_576,SET,102,-0.06368,-0.0047335,0.085256,0.77244,MODULE_576,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...3,SET,182,-0.044255,-0.0043845,0.059246,0.77245,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN,0.99999
WP_GLUCOSE_METABOLISM_IN_TRI...,SET,8,-0.22746,-0.0047473,0.30451,0.77246,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.99999
GOCC_GTPASE_ACTIVATOR_COMPLEX,SET,11,-0.1665,-0.0040745,0.22286,0.7725,GOCC_GTPASE_ACTIVATOR_COMPLEX,0.99999
MODULE_418,SET,56,-0.083925,-0.0046282,0.11232,0.77252,MODULE_418,0.99999
AGCGCAG_MIR191,SET,12,-0.16559,-0.0042324,0.22158,0.77257,AGCGCAG_MIR191,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_ACT...,SET,46,-0.097761,-0.0048875,0.13078,0.77261,HE_LIM_SUN_FETAL_LUNG_C4_ACTIVATED_NK_CELL,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...7,SET,182,-0.04552,-0.0045099,0.060894,0.77262,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN,0.99999
GOBP_TELOMERE_CAPPING,SET,37,-0.094374,-0.0042326,0.12624,0.77264,GOBP_TELOMERE_CAPPING,0.99999
HP_HYPERGASTRINEMIA,SET,6,-0.25721,-0.0046492,0.34406,0.77264,HP_HYPERGASTRINEMIA,0.99999
GOMF_SPHINGOMYELIN_PHOSPHODI...,SET,7,-0.2347,-0.0045821,0.31393,0.77265,GOMF_SPHINGOMYELIN_PHOSPHODIESTERASE_ACTIVITY,0.99999
GOBP_MIRNA_METABOLIC_PROCESS,SET,92,-0.066948,-0.0047274,0.089535,0.77268,GOBP_MIRNA_METABOLIC_PROCESS,0.99999
HP_RECURRENT_STREPTOCOCCAL_I...,SET,3,-0.32818,-0.0041949,0.43883,0.77272,HP_RECURRENT_STREPTOCOCCAL_INFECTIONS,0.99999
HP_DELIRIUM,SET,8,-0.22876,-0.0047744,0.30585,0.77275,HP_DELIRIUM,0.99999
GOMF_OXYGEN_CARRIER_ACTIVITY,SET,10,-0.24253,-0.005659,0.32424,0.77276,GOMF_OXYGEN_CARRIER_ACTIVITY,0.99999
BIOCARTA_AKAPCENTROSOME_PATH...,SET,14,-0.15338,-0.004234,0.20504,0.77278,BIOCARTA_AKAPCENTROSOME_PATHWAY,0.99999
chr12p11,SET,31,-0.19595,-0.0080453,0.26192,0.7728,chr12p11,0.99999
KEGG_MEDICUS_PATHOGEN_KSHV_L...,SET,7,-0.24033,-0.004692,0.32121,0.77282,KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY,0.99999
NUFIP1_TARGET_GENES,SET,39,-0.10855,-0.0049979,0.14506,0.77286,NUFIP1_TARGET_GENES,0.99999
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SET,157,-0.050321,-0.0046336,0.067213,0.77297,SMIRNOV_RESPONSE_TO_IR_6HR_UP,0.99999
HU_FETAL_RETINA_RPC,SET,97,-0.069517,-0.0050398,0.092855,0.77297,HU_FETAL_RETINA_RPC,0.99999
GOMF_ADP_RIBOSE_DIPHOSPHATAS...,SET,6,-0.26677,-0.0048221,0.35629,0.773,GOMF_ADP_RIBOSE_DIPHOSPHATASE_ACTIVITY,0.99999
MIR3674,SET,123,-0.057677,-0.0047052,0.077022,0.77302,MIR3674,0.99999
GSE17301_IFNA2_VS_IFNA5_STIM...2,SET,176,-0.047239,-0.0046031,0.063081,0.77302,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP,0.99999
GSE24142_EARLY_THYMIC_PROGEN...3,SET,183,-0.047279,-0.0046969,0.063136,0.77302,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN,0.99999
GSE27786_LSK_VS_NKTCELL_DN,SET,173,-0.046778,-0.0045195,0.062464,0.77303,GSE27786_LSK_VS_NKTCELL_DN,0.99999
GSE5589_UNSTIM_VS_45MIN_LPS_...5,SET,182,-0.044601,-0.0044188,0.059551,0.77305,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_DN,0.99999
RBL1_TARGET_GENES,SET,36,-0.10426,-0.0046122,0.13919,0.77306,RBL1_TARGET_GENES,0.99999
HP_FRONTAL_HIRSUTISM,SET,8,-0.18819,-0.0039278,0.25125,0.77308,HP_FRONTAL_HIRSUTISM,0.99999
SGCGSSAAA_E2F1DP2_01,SET,147,-0.05242,-0.0046719,0.069969,0.77312,SGCGSSAAA_E2F1DP2_01,0.99999
HP_ABNORMAL_NERVE_CONDUCTION...,SET,104,-0.059721,-0.0044823,0.079703,0.77315,HP_ABNORMAL_NERVE_CONDUCTION_VELOCITY,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...2,SET,9,-0.2071,-0.0045843,0.27626,0.77326,GOBP_PROTEIN_LOCALIZATION_TO_AXON,0.99999
HP_CHRONIC_PULMONARY_OBSTRUC...,SET,30,-0.12355,-0.0049903,0.16481,0.77326,HP_CHRONIC_PULMONARY_OBSTRUCTION,0.99999
HP_ABNORMAL_CARDIAC_SEPTUM_M...,SET,657,-0.024947,-0.0046341,0.033275,0.77328,HP_ABNORMAL_CARDIAC_SEPTUM_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...735,SET,11,-0.17926,-0.0043868,0.2391,0.7733,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,0.99999
POS_RESPONSE_TO_HISTAMINE_DN,SET,11,-0.16003,-0.0039161,0.21343,0.77331,POS_RESPONSE_TO_HISTAMINE_DN,0.99999
GSE28737_WT_VS_BCL6_HET_MARG...1,SET,179,-0.046193,-0.0045391,0.061607,0.77331,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_DN,0.99999
HP_FOCAL_T2_HYPERINTENSE_BAS...,SET,23,-0.12747,-0.0045089,0.16996,0.77336,HP_FOCAL_T2_HYPERINTENSE_BASAL_GANGLIA_LESION,0.99999
RTAAACA_FREAC2_01,SET,846,-0.023755,-0.0049806,0.031669,0.7734,RTAAACA_FREAC2_01,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...24,SET,4,-0.29995,-0.0044271,0.39987,0.7734,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_HALLUX,0.99999
GOCC_PRESPLICEOSOME,SET,17,-0.14837,-0.0045129,0.19777,0.77343,GOCC_PRESPLICEOSOME,0.99999
HP_TRANSIENT_HYPERPHENYLALAN...,SET,5,-0.30591,-0.0050478,0.40777,0.77343,HP_TRANSIENT_HYPERPHENYLALANINEMIA,0.99999
ACEVEDO_LIVER_TUMOR_VS_NORMA...1,SET,241,-0.042279,-0.0048122,0.056353,0.77344,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,0.99999
SETLUR_PROSTATE_CANCER_TMPRS...1,SET,16,-0.16794,-0.0049559,0.22386,0.77344,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...12,SET,182,-0.045874,-0.004545,0.061142,0.77345,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP,0.99999
KEGG_MEDICUS_REFERENCE_FGF_F...2,SET,33,-0.12244,-0.0051867,0.16318,0.77348,KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...12,SET,25,-0.14295,-0.0052716,0.19046,0.77353,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL,0.99999
REACTOME_S_PHASE,SET,155,-0.045639,-0.0041759,0.060805,0.77354,REACTOME_S_PHASE,0.99999
GOBP_INFLAMMASOME_MEDIATED_S...,SET,39,-0.10474,-0.0048227,0.13955,0.77354,GOBP_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,0.99999
DELASERNA_TARGETS_OF_MYOD_AN...,SET,10,-0.21755,-0.005076,0.28976,0.7736,DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4,0.99999
GOBP_GLYCEROLIPID_METABOLIC_...,SET,354,-0.034172,-0.0046993,0.045508,0.77364,GOBP_GLYCEROLIPID_METABOLIC_PROCESS,0.99999
EGR3_01,SET,72,-0.075159,-0.0046976,0.10008,0.77367,EGR3_01,0.99999
BIOCARTA_CSK_PATHWAY,SET,18,-0.16236,-0.0050815,0.21615,0.77371,BIOCARTA_CSK_PATHWAY,0.99999
GOMF_PHOSPHATIDYLINOSITOL_KI...,SET,25,-0.12843,-0.004736,0.17097,0.77371,GOMF_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY,0.99999
HOFFMANN_LARGE_TO_SMALL_PRE_...2,SET,142,-0.05167,-0.0045267,0.068788,0.77372,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,0.99999
CREBL2_TARGET_GENES,SET,7,-0.27498,-0.0053686,0.36603,0.77375,CREBL2_TARGET_GENES,0.99999
HP_REDUCED_AMPLITUDE_OF_DARK...,SET,12,-0.18807,-0.0048068,0.25028,0.7738,HP_REDUCED_AMPLITUDE_OF_DARK_ADAPTED_BRIGHT_FLASH_ELECTRORETINOGRAM_A_WAVE,0.99999
LAKE_ADULT_KIDNEY_C28_INTERS...,SET,79,-0.080097,-0.005243,0.10659,0.77381,LAKE_ADULT_KIDNEY_C28_INTERSTITIUM,0.99999
GSE21927_SPLEEN_VS_BONE_MARR...1,SET,164,-0.050816,-0.0047815,0.067592,0.77391,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_DN,0.99999
REACTOME_NCAM1_INTERACTIONS,SET,41,-0.10939,-0.005164,0.14549,0.77394,REACTOME_NCAM1_INTERACTIONS,0.99999
GOBP_DNA_REPAIR,SET,530,-0.026054,-0.0043625,0.034646,0.77397,GOBP_DNA_REPAIR,0.99999
GOBP_NEGATIVE_REGULATION_OF_...296,SET,8,-0.23622,-0.0049301,0.31411,0.77397,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_WOUNDING,0.99999
PID_IL2_PI3K_PATHWAY,SET,33,-0.11204,-0.0047462,0.14898,0.77399,PID_IL2_PI3K_PATHWAY,0.99999
HP_SEVERE_HEARING_IMPAIRMENT,SET,14,-0.16344,-0.0045118,0.21729,0.77403,HP_SEVERE_HEARING_IMPAIRMENT,0.99999
HNF3B_01,SET,196,-0.048477,-0.0049822,0.064441,0.77405,HNF3B_01,0.99999
HP_NEUTROPENIA_IN_PRESENCE_O...,SET,21,-0.1445,-0.0048846,0.19204,0.7741,HP_NEUTROPENIA_IN_PRESENCE_OF_ANTI_NEUTROPIL_ANTIBODIES,0.99999
PID_NEPHRIN_NEPH1_PATHWAY,SET,30,-0.11599,-0.0046852,0.15408,0.77422,PID_NEPHRIN_NEPH1_PATHWAY,0.99999
TRAVAGLINI_LUNG_BRONCHIAL_VE...2,SET,243,-0.043378,-0.0049575,0.057619,0.77422,TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_2_CELL,0.99999
GOBP_AUTOSOME_GENOMIC_IMPRIN...,SET,5,-0.26585,-0.0043869,0.3531,0.77424,GOBP_AUTOSOME_GENOMIC_IMPRINTING,0.99999
GOBP_POSITIVE_REGULATION_OF_...714,SET,79,-0.077284,-0.0050589,0.10263,0.77428,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.99999
HP_CHYLOTHORAX,SET,16,-0.15259,-0.0045028,0.20261,0.77431,HP_CHYLOTHORAX,0.99999
GSE15139_GMCSF_TREATED_VS_UN...1,SET,186,-0.045222,-0.0045288,0.060039,0.77433,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN,0.99999
SCHERER_PBMC_YF_VAX_AGE_18_4...3,SET,17,-0.16393,-0.0049862,0.21762,0.77435,SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANYD_DN,0.99999
GOMF_I_SMAD_BINDING,SET,16,-0.18149,-0.0053556,0.2409,0.77438,GOMF_I_SMAD_BINDING,0.99999
KEGG_ERBB_SIGNALING_PATHWAY,SET,82,-0.073319,-0.0048892,0.097314,0.7744,KEGG_ERBB_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...62,SET,6,-0.26505,-0.004791,0.3518,0.7744,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_PERK_ATF4_SIGNALING_PATHWAY,0.99999
GOMF_SOLUTE_INORGANIC_ANION_...,SET,31,-0.11476,-0.004712,0.15227,0.77448,GOMF_SOLUTE_INORGANIC_ANION_ANTIPORTER_ACTIVITY,0.99999
HP_PNEUMOCYSTIS_JIROVECII_PN...,SET,3,-0.3426,-0.0043793,0.45452,0.7745,HP_PNEUMOCYSTIS_JIROVECII_PNEUMONIA,0.99999
GOMF_G_PROTEIN_COUPLED_OPIOI...,SET,7,-0.24507,-0.0047845,0.3251,0.77452,GOMF_G_PROTEIN_COUPLED_OPIOID_RECEPTOR_ACTIVITY,0.99999
MIR1343_3P,SET,144,-0.054366,-0.0047961,0.07211,0.77455,MIR1343_3P,0.99999
LI_ESTROGENE_EARLY_E2_RESPON...1,SET,73,-0.083271,-0.0052405,0.11044,0.77457,LI_ESTROGENE_EARLY_E2_RESPONSE_DN,0.99999
WP_CELL_DIFFERENTIATION_INDEX,SET,12,-0.20568,-0.0052569,0.27267,0.77467,WP_CELL_DIFFERENTIATION_INDEX,0.99999
REACTOME_FANCONI_ANEMIA_PATH...,SET,30,-0.099788,-0.0040306,0.13225,0.77473,REACTOME_FANCONI_ANEMIA_PATHWAY,0.99999
GOMF_PIRNA_BINDING,SET,5,-0.32149,-0.0053049,0.42599,0.77477,GOMF_PIRNA_BINDING,0.99999
REACTOME_RUNX1_REGULATES_TRA...5,SET,5,-0.29794,-0.0049163,0.39476,0.77479,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING,0.99999
MIR3664_3P,SET,141,-0.052183,-0.0045556,0.069141,0.77479,MIR3664_3P,0.99999
GOCC_PIGMENT_GRANULE,SET,106,-0.063986,-0.0048481,0.084772,0.77481,GOCC_PIGMENT_GRANULE,0.99999
GRAESSMANN_APOPTOSIS_BY_SERU...1,SET,215,-0.04469,-0.0048079,0.059202,0.77483,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,0.99999
HOXC6_TARGET_GENES,SET,948,-0.02119,-0.0046892,0.028067,0.77486,HOXC6_TARGET_GENES,0.99999
GOCC_NEUROTRANSMITTER_RECEPT...,SET,43,-0.10517,-0.0050839,0.13929,0.77488,GOCC_NEUROTRANSMITTER_RECEPTOR_COMPLEX,0.99999
WP_GPCRS_CLASS_C_METABOTROPI...,SET,15,-0.18487,-0.0052823,0.24479,0.77493,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.99999
HP_ABNORMAL_CIRCULATING_PROL...,SET,19,-0.13417,-0.004314,0.17763,0.77496,HP_ABNORMAL_CIRCULATING_PROLINE_CONCENTRATION,0.99999
HP_ABNORMAL_URETER_MORPHOLOGY,SET,136,-0.054588,-0.004681,0.072271,0.77497,HP_ABNORMAL_URETER_MORPHOLOGY,0.99999
DAZARD_UV_RESPONSE_CLUSTER_G3,SET,13,-0.18242,-0.0048526,0.24147,0.77501,DAZARD_UV_RESPONSE_CLUSTER_G3,0.99999
GOMF_RNA_POLYMERASE_I_GENERA...,SET,3,-0.35527,-0.0045412,0.47026,0.77501,GOMF_RNA_POLYMERASE_I_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.99999
GSE13522_WT_VS_IFNG_KO_SKING...2,SET,107,-0.063918,-0.0048656,0.084609,0.77501,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,0.99999
HP_LIMB_JOINT_CONTRACTURE,SET,399,-0.033112,-0.0048282,0.043817,0.77507,HP_LIMB_JOINT_CONTRACTURE,0.99999
GSE15930_STIM_VS_STIM_AND_IL...5,SET,174,-0.049171,-0.0047644,0.065068,0.77508,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN,0.99999
TRAVAGLINI_LUNG_PROXIMAL_BAS...,SET,556,-0.027617,-0.0047328,0.036542,0.77509,TRAVAGLINI_LUNG_PROXIMAL_BASAL_CELL,0.99999
REACTOME_TOLL_LIKE_RECEPTOR_...3,SET,108,-0.063155,-0.0048297,0.083555,0.77512,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,0.99999
GOMF_DNA_METHYLTRANSFERASE_A...,SET,7,-0.27482,-0.0053654,0.36357,0.77514,GOMF_DNA_METHYLTRANSFERASE_ACTIVITY,0.99999
HP_PROXIMAL_MUSCLE_WEAKNESS_...1,SET,62,-0.081276,-0.0047153,0.10752,0.77514,HP_PROXIMAL_MUSCLE_WEAKNESS_IN_LOWER_LIMBS,0.99999
HP_INCREASED_LEFT_VENTRICULA...,SET,21,-0.14552,-0.0049191,0.19251,0.77515,HP_INCREASED_LEFT_VENTRICULAR_END_DIASTOLIC_VOLUME,0.99999
HP_HYPOPLASIA_OF_THE_ODONTOI...,SET,22,-0.13431,-0.0046469,0.17765,0.77519,HP_HYPOPLASIA_OF_THE_ODONTOID_PROCESS,0.99999
VANGURP_PANCREATIC_ALPHA_CELL,SET,38,-0.11444,-0.0052014,0.15135,0.77521,VANGURP_PANCREATIC_ALPHA_CELL,0.99999
GOBP_INTRINSIC_APOPTOTIC_SIG...4,SET,40,-0.095944,-0.0044736,0.12688,0.77523,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR,0.99999
GOMF_GAMMA_AMINOBUTYRIC_ACID...1,SET,5,-0.35335,-0.0058307,0.46726,0.77524,GOMF_GAMMA_AMINOBUTYRIC_ACID_SODIUM_CHLORIDE_SYMPORTER_ACTIVITY,0.99999
HP_THYMUS_HYPERPLASIA,SET,6,-0.2486,-0.0044936,0.32872,0.77525,HP_THYMUS_HYPERPLASIA,0.99999
FULCHER_INFLAMMATORY_RESPONS...2,SET,525,-0.029779,-0.0049633,0.03936,0.77534,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP,0.99999
GOBP_PHAGOCYTOSIS_ENGULFMENT,SET,49,-0.098103,-0.0050616,0.12965,0.77538,GOBP_PHAGOCYTOSIS_ENGULFMENT,0.99999
GOCC_CMG_COMPLEX,SET,11,-0.185,-0.0045273,0.24448,0.77539,GOCC_CMG_COMPLEX,0.99999
GOBP_RRNA_PROCESSING,SET,194,-0.042713,-0.0043676,0.056441,0.7754,GOBP_RRNA_PROCESSING,0.99999
MIR8086,SET,21,-0.14962,-0.0050574,0.19764,0.77547,MIR8086,0.99999
GOCC_MITOTIC_COHESIN_COMPLEX,SET,4,-0.39502,-0.0058303,0.52167,0.77554,GOCC_MITOTIC_COHESIN_COMPLEX,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...4,SET,183,-0.050047,-0.0049718,0.066086,0.77556,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP,0.99999
TRAVAGLINI_LUNG_LIPOFIBROBLA...,SET,138,-0.059649,-0.0051522,0.078763,0.77557,TRAVAGLINI_LUNG_LIPOFIBROBLAST_CELL,0.99999
MENON_FETAL_KIDNEY_3_STROMAL...,SET,68,-0.084508,-0.0051338,0.11156,0.77563,MENON_FETAL_KIDNEY_3_STROMAL_CELLS,0.99999
DESCARTES_FETAL_PANCREAS_ACI...,SET,68,-0.087404,-0.0053097,0.11537,0.77565,DESCARTES_FETAL_PANCREAS_ACINAR_CELLS,0.99999
JIANG_MELANOMA_TRM2_CD8,SET,127,-0.062655,-0.0051932,0.082698,0.77566,JIANG_MELANOMA_TRM2_CD8,0.99999
BERTUCCI_INVASIVE_CARCINOMA_...1,SET,41,-0.10972,-0.0051794,0.14479,0.7757,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,0.99999
GSE37532_WT_VS_PPARG_KO_LN_T...1,SET,166,-0.048709,-0.0046108,0.064279,0.7757,GSE37532_WT_VS_PPARG_KO_LN_TCONV_DN,0.99999
BILBAN_B_CLL_LPL_UP,SET,55,-0.088797,-0.004853,0.11717,0.77572,BILBAN_B_CLL_LPL_UP,0.99999
GSE2770_IL12_VS_IL4_TREATED_...2,SET,128,-0.054813,-0.0045609,0.072326,0.77573,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
PHONG_TNF_TARGETS_DN,SET,8,-0.24409,-0.0050944,0.32204,0.77576,PHONG_TNF_TARGETS_DN,0.99999
GSE2124_CTRL_VS_LYMPHOTOXIN_...2,SET,182,-0.050035,-0.0049571,0.066,0.7758,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_UP,0.99999
chr6q16,SET,24,-0.2499,-0.0090299,0.32963,0.77581,chr6q16,0.99999
HP_CHOLESTASIS,SET,257,-0.040161,-0.0047184,0.05297,0.77583,HP_CHOLESTASIS,0.99999
KIM_GASTRIC_CANCER_CHEMOSENS...,SET,86,-0.070049,-0.0047832,0.092373,0.77587,KIM_GASTRIC_CANCER_CHEMOSENSITIVITY,0.99999
HP_DIAPHYSEAL_UNDERTUBULATION,SET,13,-0.18225,-0.004848,0.24033,0.77587,HP_DIAPHYSEAL_UNDERTUBULATION,0.99999
WP_ALTERNATIVE_PATHWAY_OF_FE...,SET,11,-0.19985,-0.0048904,0.26351,0.77589,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,0.99999
SIG_IL4RECEPTOR_IN_B_LYPHOCY...,SET,27,-0.12503,-0.0047916,0.16484,0.77592,SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,0.99999
GSE15930_NAIVE_VS_72H_IN_VIT...3,SET,183,-0.046205,-0.0045901,0.060901,0.77597,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,0.99999
GOBP_ASPARTATE_METABOLIC_PRO...,SET,6,-0.29565,-0.005344,0.38967,0.77598,GOBP_ASPARTATE_METABOLIC_PROCESS,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...13,SET,182,-0.046817,-0.0046383,0.061693,0.77603,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN,0.99999
GSE17974_0H_VS_72H_IN_VITRO_...2,SET,162,-0.052313,-0.0048925,0.068935,0.77603,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...9,SET,36,-0.10179,-0.0045031,0.13412,0.77604,GAVISH_3CA_METAPROGRAM_B_CELLS_PLASMA,0.99999
BUSSLINGER_GASTRIC_REG3A_POS...,SET,40,-0.11699,-0.0054551,0.15413,0.77608,BUSSLINGER_GASTRIC_REG3A_POSITIVE_CELLS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...69,SET,56,-0.087535,-0.0048272,0.11532,0.77609,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,0.99999
GSE17721_CTRL_VS_PAM3CSK4_12...2,SET,181,-0.047081,-0.0046518,0.062006,0.77616,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_UP,0.99999
MODULE_256,SET,54,-0.082304,-0.0044572,0.10835,0.77626,MODULE_256,0.99999
GOBP_SMOOTH_MUSCLE_CELL_PROL...,SET,130,-0.060405,-0.0050651,0.079508,0.77629,GOBP_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.99999
HP_PROXIMAL_PLACEMENT_OF_THU...,SET,34,-0.11172,-0.0048034,0.14704,0.7763,HP_PROXIMAL_PLACEMENT_OF_THUMB,0.99999
REACTOME_ACTIVATED_NTRK2_SIG...3,SET,7,-0.26249,-0.0051247,0.34543,0.77633,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN,0.99999
GSE27786_CD8_TCELL_VS_NKCELL...1,SET,182,-0.04751,-0.004707,0.062519,0.77634,GSE27786_CD8_TCELL_VS_NKCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...168,SET,27,-0.12685,-0.004861,0.16691,0.77636,GOBP_POSITIVE_REGULATION_OF_CILIUM_ASSEMBLY,0.99999
TURASHVILI_BREAST_CARCINOMA_...1,SET,3,-0.33672,-0.0043041,0.44306,0.77637,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN,0.99999
BIOCARTA_ERK5_PATHWAY,SET,14,-0.17139,-0.0047313,0.22546,0.77643,BIOCARTA_ERK5_PATHWAY,0.99999
GOBP_CELLULAR_RESPONSE_TO_GL...1,SET,12,-0.19718,-0.0050397,0.25935,0.77645,GOBP_CELLULAR_RESPONSE_TO_GLUCAGON_STIMULUS,0.99999
HP_ABNORMAL_LYMPHOCYTE_PROLI...,SET,39,-0.10415,-0.0047954,0.13697,0.77649,HP_ABNORMAL_LYMPHOCYTE_PROLIFERATION,0.99999
GSE17721_CTRL_VS_CPG_12H_BMD...1,SET,184,-0.047017,-0.0046835,0.061831,0.77649,GSE17721_CTRL_VS_CPG_12H_BMDC_DN,0.99999
REACTOME_INTESTINAL_ABSORPTI...,SET,5,-0.31029,-0.0051202,0.408,0.77652,REACTOME_INTESTINAL_ABSORPTION,0.99999
HP_ABNORMALITY_OF_THE_DISTAL...3,SET,4,-0.36821,-0.0054346,0.48413,0.77654,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_3RD_FINGER,0.99999
HP_ABNORMAL_PUPILLARY_FUNCTI...,SET,70,-0.082116,-0.005061,0.10796,0.77656,HP_ABNORMAL_PUPILLARY_FUNCTION,0.99999
GSE3982_NEUTROPHIL_VS_BASOPH...1,SET,172,-0.046789,-0.0045077,0.061513,0.77656,GSE3982_NEUTROPHIL_VS_BASOPHIL_DN,0.99999
GOCC_PHOTORECEPTOR_INNER_SEG...,SET,65,-0.083135,-0.0049381,0.10929,0.77657,GOCC_PHOTORECEPTOR_INNER_SEGMENT,0.99999
LAKE_ADULT_KIDNEY_C12_THICK_...,SET,328,-0.036413,-0.0048235,0.047864,0.77659,LAKE_ADULT_KIDNEY_C12_THICK_ASCENDING_LIMB,0.99999
GSE3982_BCELL_VS_BASOPHIL_UP,SET,164,-0.049294,-0.0046382,0.064786,0.77663,GSE3982_BCELL_VS_BASOPHIL_UP,0.99999
HP_RADIAL_DEVIATION_OF_THE_H...1,SET,8,-0.26731,-0.0055789,0.35131,0.77664,HP_RADIAL_DEVIATION_OF_THE_HAND,0.99999
HP_ABSENCE_OF_RENAL_CORTICOM...,SET,6,-0.30662,-0.0055423,0.40292,0.77666,HP_ABSENCE_OF_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,0.99999
MIR4804_3P,SET,79,-0.072408,-0.0047397,0.095143,0.77668,MIR4804_3P,0.99999
CERIBELLI_GENES_INACTIVE_AND...,SET,29,-0.13297,-0.0052809,0.17471,0.77669,CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,0.99999
GOBP_RESPONSE_TO_AMYLOID_BETA,SET,50,-0.1014,-0.0052848,0.13321,0.77674,GOBP_RESPONSE_TO_AMYLOID_BETA,0.99999
GOCC_DNA_REPLICATION_PREINIT...,SET,13,-0.17566,-0.0046729,0.23072,0.77678,GOCC_DNA_REPLICATION_PREINITIATION_COMPLEX,0.99999
XBP1_01,SET,113,-0.061138,-0.0047818,0.080295,0.77679,XBP1_01,0.99999
GSE4590_LARGE_PRE_BCELL_VS_V...1,SET,172,-0.050885,-0.0049023,0.066826,0.7768,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.99999
HP_EPILEPTIC_SPASM,SET,167,-0.050574,-0.0048016,0.066416,0.77681,HP_EPILEPTIC_SPASM,0.99999
HP_ABNORMAL_CIRCULATING_BILI...,SET,114,-0.061564,-0.0048363,0.080841,0.77683,HP_ABNORMAL_CIRCULATING_BILIRUBIN_CONCENTRATION,0.99999
HP_GLUCAGONOMA,SET,6,-0.26451,-0.0047812,0.3472,0.77692,HP_GLUCAGONOMA,0.99999
WP_22Q112_COPY_NUMBER_VARIAT...,SET,105,-0.071514,-0.0053929,0.093849,0.77697,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,0.99999
MORF_MLLT10,SET,268,-0.040467,-0.0048536,0.053106,0.77697,MORF_MLLT10,0.99999
APPEL_IMATINIB_RESPONSE,SET,28,-0.13,-0.0050732,0.17058,0.777,APPEL_IMATINIB_RESPONSE,0.99999
GOCC_BOX_H_ACA_RNP_COMPLEX,SET,3,-0.30931,-0.0039538,0.40581,0.77703,GOCC_BOX_H_ACA_RNP_COMPLEX,0.99999
GOCC_BOX_H_ACA_TELOMERASE_RN...,SET,3,-0.30931,-0.0039538,0.40581,0.77703,GOCC_BOX_H_ACA_TELOMERASE_RNP_COMPLEX,0.99999
GGCAGAC_MIR346,SET,40,-0.10158,-0.0047365,0.13326,0.77705,GGCAGAC_MIR346,0.99999
chr5q31,SET,179,-0.11294,-0.011097,0.14815,0.77707,chr5q31,0.99999
GOBP_REGULATION_OF_FIBROBLAS...3,SET,35,-0.11347,-0.00495,0.1488,0.77714,GOBP_REGULATION_OF_FIBROBLAST_MIGRATION,0.99999
AHRR_TARGET_GENES,SET,1029,-0.021034,-0.0048382,0.027578,0.77717,AHRR_TARGET_GENES,0.99999
MIR660_5P,SET,68,-0.083506,-0.0050729,0.10948,0.77719,MIR660_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...699,SET,21,-0.14484,-0.0048961,0.18988,0.7772,GOBP_POSITIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,0.99999
HP_NEOPLASM_OF_THE_ADRENAL_C...,SET,26,-0.14052,-0.0052846,0.18421,0.77721,HP_NEOPLASM_OF_THE_ADRENAL_CORTEX,0.99999
REACTOME_TRANSCRIPTION_OF_E2...2,SET,16,-0.14933,-0.0044066,0.19575,0.77722,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1,0.99999
GOBP_TELOMERE_MAINTENANCE_VI...3,SET,74,-0.068284,-0.0043266,0.089508,0.77723,GOBP_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.99999
LI_PBMC_MENOMUNE_A_C_Y_W_135...4,SET,41,-0.1106,-0.005221,0.14496,0.77725,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_POSITIVE,0.99999
REACTOME_G_BETA_GAMMA_SIGNAL...2,SET,25,-0.13956,-0.0051466,0.18288,0.7773,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA,0.99999
WP_ENVELOPE_PROTEINS_AND_THE...,SET,43,-0.10479,-0.0050656,0.13732,0.7773,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,0.99999
PID_HDAC_CLASSI_PATHWAY,SET,60,-0.082366,-0.0047011,0.10793,0.77732,PID_HDAC_CLASSI_PATHWAY,0.99999
HP_DIALEPTIC_SEIZURE,SET,221,-0.044202,-0.0048205,0.057915,0.77733,HP_DIALEPTIC_SEIZURE,0.99999
MARTINEZ_TP53_TARGETS_UP,SET,569,-0.028115,-0.0048724,0.036828,0.77739,MARTINEZ_TP53_TARGETS_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...507,SET,16,-0.15935,-0.0047024,0.20871,0.77742,GOBP_NEGATIVE_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,0.99999
GSE43863_TH1_VS_LY6C_LOW_CXC...2,SET,179,-0.045755,-0.004496,0.059923,0.77743,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.99999
HP_NEOPLASM_OF_THE_PANCREAS,SET,86,-0.068296,-0.0046635,0.089418,0.77749,HP_NEOPLASM_OF_THE_PANCREAS,0.99999
HASLINGER_B_CLL_WITH_13Q14_D...,SET,23,-0.13849,-0.0048988,0.18132,0.7775,HASLINGER_B_CLL_WITH_13Q14_DELETION,0.99999
MIR221_3P,SET,161,-0.053228,-0.0049628,0.069663,0.77759,MIR221_3P,0.99999
HP_HYPERLIPIDEMIA,SET,136,-0.058615,-0.0050263,0.076711,0.77759,HP_HYPERLIPIDEMIA,0.99999
GSE7831_CPG_VS_INFLUENZA_STI...1,SET,186,-0.049666,-0.0049738,0.064991,0.77762,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN,0.99999
GNF2_ESPL1,SET,35,-0.10276,-0.0044825,0.13445,0.77764,GNF2_ESPL1,0.99999
GOBP_EPITHELIAL_CELL_APOPTOT...,SET,128,-0.060082,-0.0049994,0.078612,0.77765,GOBP_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.99999
GOBP_MONONUCLEAR_CELL_DIFFER...,SET,487,-0.031662,-0.0050881,0.041424,0.77766,GOBP_MONONUCLEAR_CELL_DIFFERENTIATION,0.99999
HP_CAROTID_ARTERY_DILATATION,SET,23,-0.14386,-0.0050888,0.18817,0.77771,HP_CAROTID_ARTERY_DILATATION,0.99999
GSE5455_EX_VIVO_VS_POST_24H_...1,SET,180,-0.047683,-0.0046983,0.062367,0.77772,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN,0.99999
HP_ABNORMAL_ENZYME_ACTIVITY_...1,SET,21,-0.14894,-0.0050347,0.19481,0.77773,HP_ABNORMAL_ENZYME_ACTIVITY_IN_CULTURED_FIBROBLASTS,0.99999
REACTOME_MODULATION_BY_MTB_O...,SET,6,-0.31831,-0.0057536,0.41628,0.77775,REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM,0.99999
AGGGCAG_MIR18A,SET,130,-0.060592,-0.0050808,0.079238,0.77776,AGGGCAG_MIR18A,0.99999
GSE39152_BRAIN_VS_SPLEEN_CD1...2,SET,179,-0.049035,-0.0048183,0.064125,0.77776,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP,0.99999
WP_DISRUPTION_OF_POSTSYNAPTI...,SET,29,-0.12769,-0.0050711,0.16697,0.77778,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,0.99999
GOMF_FERROUS_IRON_TRANSMEMBR...,SET,5,-0.24112,-0.0039788,0.3153,0.77778,GOMF_FERROUS_IRON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_HEPAR...2,SET,6,-0.25756,-0.0046556,0.33661,0.77791,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_DEGRADATION,0.99999
GOBP_G2_MI_TRANSITION_OF_MEI...,SET,6,-0.25207,-0.0045564,0.32944,0.77791,GOBP_G2_MI_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.99999
GOBP_RETINA_MORPHOGENESIS_IN...,SET,62,-0.087533,-0.0050783,0.11439,0.77791,GOBP_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.99999
HP_NODULAR_GOITER,SET,11,-0.21888,-0.0053563,0.28604,0.77792,HP_NODULAR_GOITER,0.99999
chr7q36,SET,76,-0.14855,-0.009538,0.19412,0.77793,chr7q36,0.99999
MIR3130_5P,SET,49,-0.093669,-0.0048328,0.12237,0.77799,MIR3130_5P,0.99999
PYEON_CANCER_HEAD_AND_NECK_V...1,SET,19,-0.15896,-0.0051113,0.20766,0.778,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN,0.99999
GOBP_WNT_SIGNALING_PATHWAY,SET,415,-0.034061,-0.0050629,0.044486,0.77805,GOBP_WNT_SIGNALING_PATHWAY,0.99999
DESCARTES_FETAL_MUSCLE_LYMPH...2,SET,96,-0.067383,-0.00486,0.088009,0.77805,DESCARTES_FETAL_MUSCLE_LYMPHOID_CELLS,0.99999
BIOCARTA_TH1TH2_PATHWAY,SET,18,-0.15757,-0.0049314,0.20579,0.77806,BIOCARTA_TH1TH2_PATHWAY,0.99999
JIANG_MELANOMA_TRM5_CD8,SET,180,-0.049807,-0.0049077,0.065033,0.77812,JIANG_MELANOMA_TRM5_CD8,0.99999
CHENG_RESPONSE_TO_NICKEL_ACE...,SET,40,-0.095373,-0.004447,0.12452,0.77814,CHENG_RESPONSE_TO_NICKEL_ACETATE,0.99999
KRAS.LUNG_UP.V1_UP,SET,122,-0.063299,-0.005143,0.082642,0.77814,KRAS.LUNG_UP.V1_UP,0.99999
GSE19512_NAUTRAL_VS_INDUCED_...2,SET,179,-0.050713,-0.0049831,0.06621,0.77814,GSE19512_NAUTRAL_VS_INDUCED_TREG_UP,0.99999
GSE1112_OT1_CD8AB_VS_HY_CD8A...1,SET,153,-0.051671,-0.0046974,0.067452,0.77817,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,0.99999
GOBP_FOREBRAIN_MORPHOGENESIS,SET,13,-0.1925,-0.0051207,0.25127,0.77818,GOBP_FOREBRAIN_MORPHOGENESIS,0.99999
GOMF_PHOSPHATIDATE_PHOSPHATA...,SET,3,-0.37121,-0.0047449,0.48456,0.77818,GOMF_PHOSPHATIDATE_PHOSPHATASE_ACTIVITY,0.99999
GOBP_T_CELL_RECEPTOR_SIGNALI...,SET,127,-0.059658,-0.0049448,0.077859,0.77822,GOBP_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.99999
AIZARANI_LIVER_C13_LSECS_2,SET,255,-0.045309,-0.0053028,0.059132,0.77823,AIZARANI_LIVER_C13_LSECS_2,0.99999
AMIT_EGF_RESPONSE_60_MCF10A,SET,36,-0.11456,-0.0050683,0.14949,0.77826,AMIT_EGF_RESPONSE_60_MCF10A,0.99999
RUAN_RESPONSE_TO_TNF_TROGLIT...2,SET,17,-0.16934,-0.0051508,0.22094,0.77829,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,0.99999
GSE3720_LPS_VS_PMA_STIM_VD1_...1,SET,157,-0.051357,-0.0047291,0.067006,0.77829,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,0.99999
GSE22432_MULTIPOTENT_VS_COMM...2,SET,174,-0.047925,-0.0046436,0.062525,0.7783,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_DN,0.99999
UNTERMAN_IPF_VS_CTRL_MONOCYT...1,SET,19,-0.17296,-0.0055614,0.2256,0.77835,UNTERMAN_IPF_VS_CTRL_MONOCYTE_DN,0.99999
PID_IL3_PATHWAY,SET,25,-0.13316,-0.0049108,0.17367,0.77838,PID_IL3_PATHWAY,0.99999
GOBP_PROTEIN_FOLDING,SET,200,-0.043482,-0.0045137,0.056706,0.77839,GOBP_PROTEIN_FOLDING,0.99999
GOBP_ADENYLATE_CYCLASE_INHIB...4,SET,77,-0.081617,-0.0052747,0.10641,0.77846,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE21927_SPLENIC_C26GM_TUMOR...3,SET,162,-0.050762,-0.0047474,0.066174,0.77848,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_DN,0.99999
GOMF_ARGININE_BINDING,SET,6,-0.29503,-0.0053328,0.38451,0.77854,GOMF_ARGININE_BINDING,0.99999
GOCC_PINOSOME,SET,7,-0.24865,-0.0048546,0.32395,0.77862,GOCC_PINOSOME,0.99999
GOBP_NEGATIVE_REGULATION_OF_...357,SET,12,-0.2057,-0.0052575,0.26799,0.77863,GOBP_NEGATIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,0.99999
BURTON_ADIPOGENESIS_PEAK_AT_...3,SET,42,-0.097285,-0.004648,0.12673,0.77864,BURTON_ADIPOGENESIS_PEAK_AT_24HR,0.99999
GOMF_NADP_BINDING,SET,50,-0.088745,-0.0046251,0.1156,0.77866,GOMF_NADP_BINDING,0.99999
GOBP_REGULATION_OF_MEMBRANE_...9,SET,24,-0.13401,-0.0048422,0.17451,0.77873,GOBP_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.99999
HP_ABNORMALITY_OF_THE_PERIUN...,SET,20,-0.15544,-0.0051279,0.20238,0.77878,HP_ABNORMALITY_OF_THE_PERIUNGUAL_REGION,0.99999
GOCC_POSTSYNAPTIC_ENDOSOME_M...,SET,4,-0.29255,-0.0043178,0.38073,0.77887,GOCC_POSTSYNAPTIC_ENDOSOME_MEMBRANE,0.99999
GOBP_REGULATION_OF_PROTEIN_L...2,SET,9,-0.20739,-0.0045909,0.26982,0.77894,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,0.99999
WNT_SIGNALING,SET,82,-0.075387,-0.0050271,0.098065,0.77897,WNT_SIGNALING,0.99999
MENON_FETAL_KIDNEY_4_PODOCYT...,SET,181,-0.050121,-0.0049522,0.065197,0.77898,MENON_FETAL_KIDNEY_4_PODOCYTES,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...11,SET,163,-0.051896,-0.0048683,0.067504,0.77899,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.99999
REACTOME_BUTYRATE_RESPONSE_F...,SET,16,-0.1498,-0.0044204,0.19484,0.779,REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA,0.99999
GSE29618_PRE_VS_DAY7_POST_TI...1,SET,171,-0.046588,-0.0044754,0.060573,0.77908,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN,0.99999
GSE15330_HSC_VS_MEGAKARYOCYT...3,SET,188,-0.047754,-0.0048078,0.062085,0.7791,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,0.99999
MODULE_249,SET,21,-0.13327,-0.0045047,0.17319,0.77919,MODULE_249,0.99999
KEGG_MEDICUS_VARIANT_EML4_AL...2,SET,8,-0.23174,-0.0048366,0.30116,0.7792,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,0.99999
WP_VEGFAVEGFR2_SIGNALING,SET,404,-0.033118,-0.0048586,0.04303,0.77924,WP_VEGFAVEGFR2_SIGNALING,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...13,SET,3,-0.46406,-0.0059318,0.60296,0.77924,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SHOULDER_MUSCULATURE,0.99999
GOBP_INTRACELLULAR_GLUTAMATE...,SET,6,-0.28396,-0.0051327,0.36889,0.77928,GOBP_INTRACELLULAR_GLUTAMATE_HOMEOSTASIS,0.99999
REACTOME_ORC1_REMOVAL_FROM_C...,SET,68,-0.070578,-0.0042875,0.091664,0.77934,REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,0.99999
GSE17721_PAM3CSK4_VS_CPG_1H_...1,SET,176,-0.049092,-0.0047836,0.063757,0.77934,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_DN,0.99999
HP_INCREASED_SKULL_OSSIFICAT...,SET,8,-0.22779,-0.0047541,0.29582,0.77935,HP_INCREASED_SKULL_OSSIFICATION,0.99999
VERRECCHIA_RESPONSE_TO_TGFB1...6,SET,5,-0.29985,-0.0049479,0.38938,0.77937,VERRECCHIA_RESPONSE_TO_TGFB1_C6,0.99999
LINDGREN_BLADDER_CANCER_CLUS...2,SET,104,-0.066335,-0.0049787,0.086121,0.77942,LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,0.99999
HP_RECURRENT_MALADAPTIVE_BEH...,SET,960,-0.022001,-0.0048978,0.028562,0.77943,HP_RECURRENT_MALADAPTIVE_BEHAVIOR,0.99999
BROWNE_HCMV_INFECTION_18HR_DN,SET,166,-0.052087,-0.0049306,0.067618,0.77944,BROWNE_HCMV_INFECTION_18HR_DN,0.99999
XU_CREBBP_TARGETS_UP,SET,20,-0.13702,-0.0045201,0.17786,0.77946,XU_CREBBP_TARGETS_UP,0.99999
HP_UNILATERAL_CRYPTORCHIDISM,SET,11,-0.21429,-0.0052439,0.27815,0.77946,HP_UNILATERAL_CRYPTORCHIDISM,0.99999
MIR3136_5P,SET,69,-0.083966,-0.0051381,0.10896,0.77952,MIR3136_5P,0.99999
HP_VISUAL_ACUITY_TEST_ABNORM...,SET,21,-0.13744,-0.0046459,0.17835,0.77953,HP_VISUAL_ACUITY_TEST_ABNORMALITY,0.99999
GSE4748_CTRL_VS_LPS_AND_CYAN...1,SET,189,-0.049094,-0.0049556,0.063693,0.77958,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,0.99999
GOBP_POLYKETIDE_METABOLIC_PR...,SET,10,-0.26369,-0.0061527,0.34202,0.77964,GOBP_POLYKETIDE_METABOLIC_PROCESS,0.99999
GOBP_SEQUESTERING_OF_TRIGLYC...,SET,17,-0.17383,-0.0052872,0.22546,0.77964,GOBP_SEQUESTERING_OF_TRIGLYCERIDE,0.99999
HP_ABNORMAL_T_CELL_MORPHOLOGY,SET,105,-0.064981,-0.0049003,0.084281,0.77964,HP_ABNORMAL_T_CELL_MORPHOLOGY,0.99999
GSE20198_IL12_VS_IL12_IL18_T...1,SET,191,-0.047388,-0.0048084,0.061433,0.77975,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,0.99999
HP_ABNORMAL_ABDOMEN_MORPHOLO...,SET,721,-0.025092,-0.004874,0.032522,0.7798,HP_ABNORMAL_ABDOMEN_MORPHOLOGY,0.99999
HP_NEVUS_FLAMMEUS_OF_THE_FOR...,SET,6,-0.28643,-0.0051774,0.37125,0.7798,HP_NEVUS_FLAMMEUS_OF_THE_FOREHEAD,0.99999
GOMF_PRERIBOSOME_BINDING,SET,6,-0.29376,-0.0053098,0.38067,0.77984,GOMF_PRERIBOSOME_BINDING,0.99999
KEGG_MEDICUS_REFERENCE_AREG_...1,SET,11,-0.20086,-0.0049152,0.26027,0.77986,KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY,0.99999
MIR543,SET,295,-0.039619,-0.0049818,0.051325,0.77991,MIR543,0.99999
HP_DUODENAL_ADENOCARCINOMA,SET,7,-0.2498,-0.0048769,0.32362,0.77991,HP_DUODENAL_ADENOCARCINOMA,0.99999
WP_HIPPOCAMPAL_SYNAPTOGENESI...,SET,27,-0.1462,-0.0056026,0.18939,0.77992,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,0.99999
E4BP4_01,SET,194,-0.050139,-0.0051269,0.064951,0.77992,E4BP4_01,0.99999
MIKKELSEN_IPS_ICP_WITH_H3K4M...,SET,116,-0.065691,-0.0052053,0.085083,0.77996,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,0.99999
NABA_MATRISOME_POORLY_METAST...4,SET,23,-0.1404,-0.0049663,0.18184,0.77997,NABA_MATRISOME_POORLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED,0.99999
GOBP_POSITIVE_REGULATION_OF_...716,SET,15,-0.18595,-0.005313,0.24079,0.78001,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,0.99999
DESCARTES_FETAL_LIVER_HEPATO...,SET,378,-0.037294,-0.0052961,0.048293,0.78001,DESCARTES_FETAL_LIVER_HEPATOBLASTS,0.99999
GOBP_AROMATIC_AMINO_ACID_FAM...,SET,16,-0.18481,-0.0054537,0.23926,0.78007,GOBP_AROMATIC_AMINO_ACID_FAMILY_CATABOLIC_PROCESS,0.99999
WP_MESODERMAL_COMMITMENT_PAT...,SET,132,-0.060655,-0.0051247,0.078519,0.78008,WP_MESODERMAL_COMMITMENT_PATHWAY,0.99999
KEGG_NATURAL_KILLER_CELL_MED...,SET,121,-0.064752,-0.0052396,0.083818,0.78009,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...6,SET,188,-0.046698,-0.0047014,0.060436,0.78014,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_UP,0.99999
GOBP_RESPONSE_TO_RADIATION,SET,390,-0.032627,-0.0047047,0.042208,0.78023,GOBP_RESPONSE_TO_RADIATION,0.99999
GSE22886_NAIVE_BCELL_VS_NEUT...2,SET,171,-0.052146,-0.0050092,0.067452,0.78026,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP,0.99999
GOBP_PROTEIN_INSERTION_INTO_...6,SET,6,-0.24495,-0.0044276,0.31681,0.78028,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE,0.99999
GOBP_POSITIVE_REGULATION_OF_...515,SET,8,-0.23951,-0.0049987,0.30976,0.78029,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION,0.99999
GOMF_ENZYME_INHIBITOR_ACTIVI...,SET,352,-0.037013,-0.0050758,0.04787,0.78029,GOMF_ENZYME_INHIBITOR_ACTIVITY,0.99999
MIR4760_5P,SET,181,-0.050689,-0.0050083,0.06555,0.78032,MIR4760_5P,0.99999
GOBP_REGULATION_OF_CD8_POSIT...2,SET,8,-0.24047,-0.0050188,0.31097,0.78032,GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
GSE8685_IL2_ACT_IL2_STARVED_...1,SET,181,-0.048781,-0.0048198,0.063051,0.78043,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,0.99999
GOMF_CARBOHYDRATE_BINDING,SET,248,-0.045058,-0.0052015,0.058235,0.78045,GOMF_CARBOHYDRATE_BINDING,0.99999
HP_MESOMELIC_ARM_SHORTENING,SET,3,-0.45729,-0.0058453,0.59097,0.78047,HP_MESOMELIC_ARM_SHORTENING,0.99999
KEGG_MEDICUS_PATHOGEN_KSHV_V...5,SET,24,-0.14536,-0.0052523,0.18784,0.78048,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,0.99999
KUMAMOTO_RESPONSE_TO_NUTLIN_...2,SET,9,-0.21609,-0.0047835,0.27922,0.78051,KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP,0.99999
GOBP_MESONEPHROS_DEVELOPMENT,SET,97,-0.073932,-0.0053599,0.095519,0.78053,GOBP_MESONEPHROS_DEVELOPMENT,0.99999
HLF_01,SET,228,-0.044692,-0.0049496,0.057732,0.78057,HLF_01,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...10,SET,47,-0.1073,-0.0054224,0.13861,0.78057,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_3,0.99999
SYNCRIP_TARGET_GENES,SET,16,-0.16265,-0.0047997,0.21009,0.78059,SYNCRIP_TARGET_GENES,0.99999
GOBP_TRNA_THREONYLCARBAMOYLA...2,SET,4,-0.25273,-0.0037302,0.32641,0.78061,GOBP_TRNA_THREONYLCARBAMOYLADENOSINE_MODIFICATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...205,SET,145,-0.057966,-0.0051312,0.074857,0.78063,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,0.99999
GOMF_LIPOPROTEIN_PARTICLE_RE...2,SET,27,-0.12758,-0.0048892,0.16476,0.78063,GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,0.99999
LASTOWSKA_NEUROBLASTOMA_COPY...1,SET,731,-0.028232,-0.0055204,0.036459,0.78064,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN,0.99999
HP_LACK_OF_SKIN_ELASTICITY,SET,56,-0.091799,-0.0050624,0.1185,0.78074,HP_LACK_OF_SKIN_ELASTICITY,0.99999
GSE27786_CD4_TCELL_VS_ERYTHT...2,SET,182,-0.04595,-0.0045524,0.05931,0.78075,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP,0.99999
HP_REACTIVE_HYPOGLYCEMIA,SET,7,-0.24196,-0.0047239,0.31225,0.7808,HP_REACTIVE_HYPOGLYCEMIA,0.99999
SEMENZA_HIF1_TARGETS,SET,32,-0.12449,-0.0051929,0.16063,0.78083,SEMENZA_HIF1_TARGETS,0.99999
RB_DN.V1_UP,SET,111,-0.060795,-0.004713,0.078444,0.78083,RB_DN.V1_UP,0.99999
BIOCARTA_IL4_PATHWAY,SET,10,-0.2183,-0.0050936,0.28159,0.7809,BIOCARTA_IL4_PATHWAY,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...1,SET,6,-0.23493,-0.0042464,0.30294,0.78097,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCND1_TO_CELL_CYCLE_G1_S,0.99999
REACTOME_ABC_FAMILY_PROTEINS...,SET,97,-0.063335,-0.0045916,0.081659,0.781,REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,0.99999
HP_EEG_WITH_IRREGULAR_GENERA...,SET,11,-0.20828,-0.0050969,0.26852,0.78102,HP_EEG_WITH_IRREGULAR_GENERALIZED_SPIKE_AND_WAVE_COMPLEXES,0.99999
GSE9988_LPS_VS_VEHICLE_TREAT...2,SET,162,-0.056294,-0.0052648,0.072565,0.78106,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,0.99999
CAR_IGFBP1,SET,55,-0.097463,-0.0053267,0.12563,0.78107,CAR_IGFBP1,0.99999
GOMF_CALCIUM_DEPENDENT_PROTE...4,SET,5,-0.28654,-0.0047282,0.36934,0.78107,GOMF_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_REGULATOR_ACTIVITY,0.99999
GSE29618_MONOCYTE_VS_PDC_DAY...2,SET,186,-0.049813,-0.0049885,0.064194,0.78111,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP,0.99999
chr15q26,SET,67,-0.1582,-0.0095399,0.20385,0.78114,chr15q26,0.99999
HP_ENURESIS_NOCTURNA,SET,10,-0.21484,-0.0050127,0.27681,0.78116,HP_ENURESIS_NOCTURNA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...4,SET,8,-0.20579,-0.0042951,0.26514,0.78117,GOBP_NEGATIVE_REGULATION_OF_ACTIN_NUCLEATION,0.99999
GOBP_WOUND_HEALING_INVOLVED_...,SET,7,-0.28674,-0.0055981,0.3693,0.78125,GOBP_WOUND_HEALING_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.99999
GOBP_POSITIVE_REGULATION_OF_...629,SET,6,-0.28254,-0.0051071,0.36387,0.78127,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,0.99999
GOBP_POSITIVE_REGULATION_OF_...701,SET,6,-0.33014,-0.0059675,0.42515,0.78128,GOBP_POSITIVE_REGULATION_OF_SISTER_CHROMATID_COHESION,0.99999
WORSCHECH_TUMOR_REJECTION_UP,SET,58,-0.091146,-0.0051151,0.11737,0.78129,WORSCHECH_TUMOR_REJECTION_UP,0.99999
HP_CONGENITAL_LARYNGEAL_STRI...,SET,7,-0.24426,-0.0047687,0.31442,0.78137,HP_CONGENITAL_LARYNGEAL_STRIDOR,0.99999
HESSON_TUMOR_SUPPRESSOR_CLUS...,SET,8,-0.27178,-0.0056722,0.34983,0.78138,HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3,0.99999
VART_KSHV_INFECTION_ANGIOGEN...1,SET,124,-0.063819,-0.0052273,0.082142,0.7814,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,0.99999
MIR662,SET,4,-0.27168,-0.0040098,0.34964,0.78142,MIR662,0.99999
HP_CEREBRAL_WHITE_MATTER_ATR...,SET,56,-0.086945,-0.0047947,0.11186,0.78149,HP_CEREBRAL_WHITE_MATTER_ATROPHY,0.99999
BOGNI_TREATMENT_RELATED_MYEL...2,SET,25,-0.13287,-0.0048998,0.1709,0.78155,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,0.99999
BUYTAERT_PHOTODYNAMIC_THERAP...2,SET,758,-0.024512,-0.004877,0.031525,0.78158,BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...12,SET,181,-0.04661,-0.0046052,0.059939,0.7816,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_UP,0.99999
REACTOME_INTERFERON_GAMMA_SI...,SET,90,-0.076058,-0.0053124,0.097796,0.78163,REACTOME_INTERFERON_GAMMA_SIGNALING,0.99999
GOCC_ASTROCYTE_PROJECTION,SET,21,-0.16107,-0.0054445,0.20709,0.78164,GOCC_ASTROCYTE_PROJECTION,0.99999
HP_ABNORMALITY_OF_THE_PHARYNX,SET,197,-0.047855,-0.0049307,0.06153,0.78164,HP_ABNORMALITY_OF_THE_PHARYNX,0.99999
GSE360_CTRL_VS_B_MALAYI_HIGH...2,SET,173,-0.048664,-0.0047018,0.062566,0.78165,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP,0.99999
GOBP_RESPONSE_TO_COPPER_ION,SET,31,-0.13369,-0.005489,0.17185,0.78168,GOBP_RESPONSE_TO_COPPER_ION,0.99999
REACTOME_EPITHELIAL_MESENCHY...,SET,6,-0.2635,-0.0047629,0.33872,0.78169,REACTOME_EPITHELIAL_MESENCHYMAL_TRANSITION_EMT_DURING_GASTRULATION,0.99999
HP_ANOREXIA,SET,107,-0.066732,-0.0050798,0.085756,0.78176,HP_ANOREXIA,0.99999
HP_TYPE_2_MUSCLE_FIBER_ATROP...,SET,16,-0.15583,-0.0045984,0.20025,0.78176,HP_TYPE_2_MUSCLE_FIBER_ATROPHY,0.99999
GOBP_CELLULAR_RESPONSE_TO_VA...,SET,61,-0.092962,-0.0053498,0.11945,0.78179,GOBP_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.99999
BIOCARTA_PTDINS_PATHWAY,SET,22,-0.12714,-0.0043987,0.1633,0.78188,BIOCARTA_PTDINS_PATHWAY,0.99999
HP_HYPOPLASTIC_SACRUM,SET,6,-0.25184,-0.0045522,0.32341,0.78192,HP_HYPOPLASTIC_SACRUM,0.99999
GSE17721_CTRL_VS_PAM3CSK4_8H...1,SET,180,-0.047423,-0.0046727,0.060895,0.78194,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN,0.99999
GOBP_REGULATION_OF_POSTSYNAP...10,SET,15,-0.17231,-0.0049233,0.2212,0.782,GOBP_REGULATION_OF_POSTSYNAPTIC_SPECIALIZATION_ASSEMBLY,0.99999
GOBP_B_CELL_PROLIFERATION,SET,96,-0.07345,-0.0052976,0.094268,0.78205,GOBP_B_CELL_PROLIFERATION,0.99999
HP_HIP_DISLOCATION,SET,226,-0.043958,-0.0048472,0.056409,0.78209,HP_HIP_DISLOCATION,0.99999
WEINBERGER_BLOOD_TWINRIX_AGE...1,SET,32,-0.124,-0.0051727,0.15912,0.78209,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_ANTI_HBS_CONC_PRIMARY_VACC_1DY_SIGNIFICANT,0.99999
GOBP_POSITIVE_REGULATION_OF_...130,SET,137,-0.058183,-0.0050074,0.074657,0.7821,GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH,0.99999
GSE12003_4D_VS_8D_CULTURE_BM...2,SET,153,-0.053659,-0.0048782,0.068848,0.78212,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP,0.99999
REACTOME_PKMTS_METHYLATE_HIS...,SET,36,-0.10459,-0.0046272,0.13419,0.78214,REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES,0.99999
HP_HYPOPLASIA_OF_THE_VENTRAL...,SET,6,-0.29934,-0.0054107,0.384,0.78216,HP_HYPOPLASIA_OF_THE_VENTRAL_PONS,0.99999
GOBP_REGULATION_OF_MULTICELL...2,SET,61,-0.094522,-0.0054396,0.12123,0.7822,GOBP_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,0.99999
GSE21670_STAT3_KO_VS_WT_CD4_...3,SET,178,-0.051123,-0.0050095,0.065565,0.78222,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_UP,0.99999
GSE13547_CTRL_VS_ANTI_IGM_ST...4,SET,169,-0.051592,-0.0049273,0.066157,0.78225,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP,0.99999
HP_VOCAL_CORD_PARESIS,SET,14,-0.18132,-0.0050054,0.2325,0.78226,HP_VOCAL_CORD_PARESIS,0.99999
MIR1287_3P,SET,31,-0.1153,-0.004734,0.14779,0.78234,MIR1287_3P,0.99999
GOBP_REGULATION_OF_PROTEIN_D...4,SET,9,-0.19944,-0.0044148,0.25564,0.78234,GOBP_REGULATION_OF_PROTEIN_DEUBIQUITINATION,0.99999
HP_FLATTENED_FEMORAL_EPIPHYS...,SET,12,-0.18833,-0.0048135,0.24135,0.78239,HP_FLATTENED_FEMORAL_EPIPHYSIS,0.99999
HP_PROMINENT_VEINS_ON_TRUNK,SET,5,-0.31745,-0.0052382,0.40679,0.7824,HP_PROMINENT_VEINS_ON_TRUNK,0.99999
ZNF596_TARGET_GENES,SET,485,-0.031395,-0.0050351,0.040228,0.78243,ZNF596_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...627,SET,20,-0.15103,-0.0049823,0.19351,0.78244,GOBP_NEGATIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.99999
IGLESIAS_E2F_TARGETS_UP,SET,135,-0.061762,-0.0052768,0.079131,0.78245,IGLESIAS_E2F_TARGETS_UP,0.99999
MIR100_5P_MIR99A_5P_MIR99B_5P,SET,17,-0.17662,-0.0053722,0.22625,0.78249,MIR100_5P_MIR99A_5P_MIR99B_5P,0.99999
GOMF_APOLIPOPROTEIN_A_I_BIND...,SET,5,-0.25092,-0.0041404,0.32138,0.78252,GOMF_APOLIPOPROTEIN_A_I_BINDING,0.99999
GOMF_TRANSMEMBRANE_RECEPTOR_...4,SET,18,-0.16356,-0.0051191,0.20949,0.78252,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_BINDING,0.99999
HP_CONGENITAL_ICHTHYOSIFORM_...,SET,27,-0.13485,-0.0051678,0.17272,0.78253,HP_CONGENITAL_ICHTHYOSIFORM_ERYTHRODERMA,0.99999
GOMF_NUCLEOSIDE_DIPHOSPHATE_...2,SET,17,-0.14563,-0.0044297,0.18648,0.78259,GOMF_NUCLEOSIDE_DIPHOSPHATE_PHOSPHATASE_ACTIVITY,0.99999
GSE5960_TH1_VS_ANERGIC_TH1_DN,SET,184,-0.048343,-0.0048155,0.061889,0.78263,GSE5960_TH1_VS_ANERGIC_TH1_DN,0.99999
GOBP_REGULATION_OF_DOPAMINE_...2,SET,24,-0.15082,-0.0054498,0.19301,0.78272,GOBP_REGULATION_OF_DOPAMINE_SECRETION,0.99999
GOBP_CELLULAR_RESPONSE_TO_TO...1,SET,95,-0.06702,-0.0048087,0.085755,0.78275,GOBP_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,0.99999
WP_TP53_NETWORK,SET,19,-0.15828,-0.0050894,0.20246,0.78283,WP_TP53_NETWORK,0.99999
GSE20152_SPHK1_KO_VS_HTNFA_O...2,SET,171,-0.049494,-0.0047545,0.063295,0.78287,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP,0.99999
HP_TYPICALLY_DE_NOVO,SET,11,-0.19532,-0.0047797,0.24975,0.7829,HP_TYPICALLY_DE_NOVO,0.99999
NOUSHMEHR_GBM_GERMLINE_MUTAT...,SET,7,-0.27295,-0.0053289,0.34896,0.78294,NOUSHMEHR_GBM_GERMLINE_MUTATED,0.99999
HP_FREQUENT_FALLS,SET,117,-0.061931,-0.0049284,0.079179,0.78294,HP_FREQUENT_FALLS,0.99999
WP_INSULIN_SIGNALING,SET,155,-0.053912,-0.0049329,0.068918,0.78297,WP_INSULIN_SIGNALING,0.99999
SENGUPTA_NASOPHARYNGEAL_CARC...2,SET,285,-0.041483,-0.0051285,0.053027,0.78298,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,0.99999
MIR3164,SET,93,-0.069431,-0.0049292,0.088745,0.78299,MIR3164,0.99999
IBRAHIM_NRF1_UP,SET,390,-0.033227,-0.0047912,0.042468,0.78301,IBRAHIM_NRF1_UP,0.99999
GOBP_RESPIRATORY_SYSTEM_PROC...,SET,40,-0.11437,-0.005333,0.14617,0.78302,GOBP_RESPIRATORY_SYSTEM_PROCESS,0.99999
GSE6259_33D1_POS_VS_DEC205_P...4,SET,173,-0.053124,-0.0051327,0.067894,0.78302,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP,0.99999
GSE42021_TREG_PLN_VS_CD24HI_...1,SET,183,-0.046472,-0.0046167,0.059377,0.78308,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_DN,0.99999
WP_PHYSICOCHEMICAL_FEATURES_...,SET,62,-0.085472,-0.0049588,0.10921,0.78309,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,0.99999
GOBP_CALCIUM_ION_TRANSMEMBRA...2,SET,311,-0.039761,-0.0051312,0.050799,0.7831,GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.99999
GOBP_SKELETAL_MUSCLE_SATELLI...1,SET,9,-0.20589,-0.0045576,0.26295,0.78318,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_ACTIVATION,0.99999
SCHMAHL_PDGF_SIGNALING,SET,9,-0.25422,-0.0056274,0.32466,0.78319,SCHMAHL_PDGF_SIGNALING,0.99999
GOBP_TRANS_SYNAPTIC_SIGNALIN...4,SET,9,-0.25873,-0.0057272,0.33039,0.78321,GOBP_TRANS_SYNAPTIC_SIGNALING_MODULATING_SYNAPTIC_TRANSMISSION,0.99999
HP_SCAPULAR_WINGING,SET,88,-0.069998,-0.0048347,0.089374,0.78324,HP_SCAPULAR_WINGING,0.99999
GSE1460_CORD_VS_ADULT_BLOOD_...1,SET,175,-0.049041,-0.0047653,0.062612,0.78326,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN,0.99999
FUNG_IL2_SIGNALING_2,SET,12,-0.19204,-0.0049083,0.24516,0.78328,FUNG_IL2_SIGNALING_2,0.99999
HP_EEG_WITH_CONTINUOUS_SLOW_...,SET,8,-0.22814,-0.0047613,0.29122,0.78329,HP_EEG_WITH_CONTINUOUS_SLOW_ACTIVITY,0.99999
UNTERMAN_PROGRESSIVE_VS_STAB...2,SET,12,-0.23862,-0.0060989,0.30461,0.7833,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_CD8T_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...625,SET,4,-0.36019,-0.0053162,0.45973,0.78332,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS,0.99999
FARMER_BREAST_CANCER_APOCRIN...1,SET,297,-0.040939,-0.0051648,0.052245,0.78335,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,0.99999
SUZUKI_AMPLIFIED_IN_ORAL_CAN...,SET,17,-0.18618,-0.0056629,0.2376,0.78335,SUZUKI_AMPLIFIED_IN_ORAL_CANCER,0.99999
PTTG1_TARGET_GENES,SET,55,-0.089745,-0.0049048,0.11452,0.78337,PTTG1_TARGET_GENES,0.99999
GSE14308_TH1_VS_TH17_UP,SET,177,-0.049623,-0.004849,0.06332,0.78338,GSE14308_TH1_VS_TH17_UP,0.99999
GSE37534_UNTREATED_VS_GW1929...2,SET,183,-0.050673,-0.005034,0.064658,0.78339,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.99999
GOCC_NUCLEOTIDE_ACTIVATED_PR...,SET,10,-0.20317,-0.0047405,0.25921,0.78341,GOCC_NUCLEOTIDE_ACTIVATED_PROTEIN_KINASE_COMPLEX,0.99999
REACTOME_SYNTHESIS_OF_5_EICO...,SET,9,-0.24264,-0.0053712,0.30955,0.78344,REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS,0.99999
GSE360_L_MAJOR_VS_T_GONDII_D...1,SET,176,-0.049917,-0.0048641,0.063678,0.78345,GSE360_L_MAJOR_VS_T_GONDII_DC_DN,0.99999
MIR494_5P,SET,38,-0.10437,-0.0047433,0.13313,0.78346,MIR494_5P,0.99999
MIR4445_5P,SET,85,-0.07492,-0.0050861,0.095558,0.78348,MIR4445_5P,0.99999
MIR6849_3P,SET,68,-0.079424,-0.0048249,0.10128,0.78352,MIR6849_3P,0.99999
GOMF_MHC_CLASS_I_PROTEIN_COM...,SET,5,-0.27132,-0.004477,0.34588,0.7836,GOMF_MHC_CLASS_I_PROTEIN_COMPLEX_BINDING,0.99999
HP_ABNORMALITY_OF_THE_ABDOMI...1,SET,1200,-0.01982,-0.0048989,0.025261,0.78365,HP_ABNORMALITY_OF_THE_ABDOMINAL_ORGANS,0.99999
WP_CALCIUM_MEDIATED_TCELL_AP...,SET,20,-0.14672,-0.0048403,0.187,0.78366,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...163,SET,12,-0.19984,-0.0051077,0.25463,0.78372,GOBP_POSITIVE_REGULATION_OF_CHROMATIN_ORGANIZATION,0.99999
HP_IRREGULARLY_SHAPED_SPERM_...,SET,11,-0.17804,-0.0043567,0.22685,0.78372,HP_IRREGULARLY_SHAPED_SPERM_TAIL,0.99999
MIR6775_5P,SET,4,-0.37391,-0.0055186,0.47631,0.78377,MIR6775_5P,0.99999
TACTTGA_MIR26A_MIR26B,SET,273,-0.041212,-0.0049882,0.052492,0.7838,TACTTGA_MIR26A_MIR26B,0.99999
GOMF_HYDROLASE_ACTIVITY_ACTI...8,SET,10,-0.24384,-0.0056895,0.31059,0.7838,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ETHER_BONDS,0.99999
GOBP_POSITIVE_REGULATION_OF_...144,SET,119,-0.06365,-0.005108,0.081025,0.78393,GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,0.99999
KRIEG_KDM3A_TARGETS_NOT_HYPO...,SET,176,-0.048514,-0.0047274,0.061755,0.78394,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,0.99999
MIR6508_5P,SET,300,-0.03889,-0.0049306,0.0495,0.78396,MIR6508_5P,0.99999
REACTOME_NEURONAL_SYSTEM,SET,384,-0.03735,-0.0053451,0.047528,0.78402,REACTOME_NEURONAL_SYSTEM,0.99999
WP_PILOCYTIC_ASTROCYTOMA,SET,6,-0.22885,-0.0041366,0.29112,0.78409,WP_PILOCYTIC_ASTROCYTOMA,0.99999
WP_MINERALOCORTICOID_BIOSYNT...,SET,14,-0.21476,-0.0059283,0.27309,0.78418,WP_MINERALOCORTICOID_BIOSYNTHESIS,0.99999
HP_DELAYED_EPIPHYSEAL_OSSIFI...,SET,37,-0.114,-0.0051127,0.14495,0.78419,HP_DELAYED_EPIPHYSEAL_OSSIFICATION,0.99999
GSE17721_0.5H_VS_4H_PAM3CSK4...2,SET,181,-0.049143,-0.0048556,0.062478,0.78423,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_UP,0.99999
HP_SEVERELY_REDUCED_VISUAL_A...,SET,39,-0.10831,-0.004987,0.13769,0.78425,HP_SEVERELY_REDUCED_VISUAL_ACUITY,0.99999
HP_ABNORMAL_THIRD_VENTRICLE_...,SET,14,-0.19798,-0.0054653,0.25164,0.78429,HP_ABNORMAL_THIRD_VENTRICLE_MORPHOLOGY,0.99999
MIR6733_3P,SET,128,-0.062321,-0.0051857,0.079185,0.78436,MIR6733_3P,0.99999
GOBP_OUTER_EAR_MORPHOGENESIS,SET,8,-0.24378,-0.0050878,0.3097,0.78439,GOBP_OUTER_EAR_MORPHOGENESIS,0.99999
KEGG_PYRIMIDINE_METABOLISM,SET,90,-0.066727,-0.0046606,0.084763,0.78442,KEGG_PYRIMIDINE_METABOLISM,0.99999
GOBP_POSITIVE_REGULATION_OF_...94,SET,483,-0.030658,-0.004907,0.038942,0.78443,GOBP_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS,0.99999
HP_PERIVENTRICULAR_LEUKOMALA...,SET,38,-0.10267,-0.0046663,0.1304,0.78445,HP_PERIVENTRICULAR_LEUKOMALACIA,0.99999
GOMF_DIACYLGLYCEROL_BINDING,SET,13,-0.18767,-0.0049923,0.23835,0.78447,GOMF_DIACYLGLYCEROL_BINDING,0.99999
MIR12133,SET,352,-0.037729,-0.0051741,0.047905,0.78453,MIR12133,0.99999
KEGG_MEDICUS_REFERENCE_HEME_...,SET,8,-0.23011,-0.0048026,0.29211,0.78457,KEGG_MEDICUS_REFERENCE_HEME_BIOSYNTHESIS,0.99999
WP_HEMESYNTHESIS_DEFECTS_AND...,SET,8,-0.23011,-0.0048026,0.29211,0.78457,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,0.99999
WP_HEME_BIOSYNTHESIS,SET,8,-0.23011,-0.0048026,0.29211,0.78457,WP_HEME_BIOSYNTHESIS,0.99999
GSE24726_WT_VS_E2_22_KO_PDC_...,SET,177,-0.049982,-0.0048841,0.063446,0.78458,GSE24726_WT_VS_E2_22_KO_PDC_DAY4_POST_DELETION_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...447,SET,65,-0.081518,-0.004842,0.10348,0.78459,GOBP_NEGATIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,0.99999
KEGG_MEDICUS_ENV_FACTOR_ZN_T...,SET,18,-0.1758,-0.005502,0.22312,0.78462,KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.99999
HP_FATIGABLE_WEAKNESS_OF_BUL...,SET,52,-0.090901,-0.0048311,0.11529,0.78479,HP_FATIGABLE_WEAKNESS_OF_BULBAR_MUSCLES,0.99999
GSE5589_LPS_VS_LPS_AND_IL6_S...3,SET,188,-0.048962,-0.0049294,0.062076,0.78486,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,0.99999
DAVICIONI_TARGETS_OF_PAX_FOX...2,SET,233,-0.049183,-0.0055057,0.062356,0.78487,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,0.99999
GOBP_DETECTION_OF_MECHANICAL...1,SET,51,-0.09756,-0.005135,0.12369,0.78487,GOBP_DETECTION_OF_MECHANICAL_STIMULUS,0.99999
HP_METHYLMALONIC_ACIDURIA,SET,18,-0.15435,-0.0048307,0.19568,0.78487,HP_METHYLMALONIC_ACIDURIA,0.99999
HP_ABNORMAL_CIRCULATING_AROM...,SET,18,-0.17159,-0.0053703,0.21751,0.7849,HP_ABNORMAL_CIRCULATING_AROMATIC_AMINO_ACID_CONCENTRATION,0.99999
WP_SYNAPTIC_VESICLE_PATHWAY,SET,49,-0.09578,-0.0049417,0.12139,0.78494,WP_SYNAPTIC_VESICLE_PATHWAY,0.99999
MIR6885_3P,SET,364,-0.036418,-0.0050769,0.046152,0.78496,MIR6885_3P,0.99999
GSE32034_LY6C_HIGH_VS_LOW_MO...1,SET,188,-0.047318,-0.0047638,0.059939,0.78506,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN,0.99999
GSE2770_UNTREATED_VS_IL4_TRE...5,SET,185,-0.048491,-0.0048432,0.061415,0.7851,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.99999
WP_IL4_SIGNALING,SET,50,-0.09949,-0.0051851,0.126,0.78511,WP_IL4_SIGNALING,0.99999
HP_SEPTIC_ARTHRITIS,SET,7,-0.2282,-0.0044551,0.28898,0.78513,HP_SEPTIC_ARTHRITIS,0.99999
GSE360_L_MAJOR_VS_M_TUBERCUL...3,SET,166,-0.052414,-0.0049616,0.066362,0.78518,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN,0.99999
GOBP_PHOSPHOLIPASE_C_ACTIVAT...3,SET,107,-0.071535,-0.0054454,0.090555,0.78522,GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
DESCARTES_MAIN_FETAL_ANTIGEN...,SET,91,-0.073089,-0.0051331,0.092524,0.78522,DESCARTES_MAIN_FETAL_ANTIGEN_PRESENTING_CELLS,0.99999
CHAF1A_TARGET_GENES,SET,79,-0.077429,-0.0050684,0.098007,0.78524,CHAF1A_TARGET_GENES,0.99999
GSE5679_CTRL_VS_PPARG_LIGAND...3,SET,181,-0.049509,-0.0048917,0.06265,0.7853,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN,0.99999
GOBP_CYSTEINE_CATABOLIC_PROC...,SET,3,-0.40607,-0.0051905,0.51373,0.78536,GOBP_CYSTEINE_CATABOLIC_PROCESS,0.99999
SU_TESTIS,SET,68,-0.079289,-0.0048167,0.10029,0.7854,SU_TESTIS,0.99999
MIR548S,SET,119,-0.061103,-0.0049035,0.077289,0.7854,MIR548S,0.99999
GSE22886_TH1_VS_TH2_12H_ACT_...1,SET,178,-0.051192,-0.0050163,0.064746,0.78542,GSE22886_TH1_VS_TH2_12H_ACT_DN,0.99999
DESCARTES_FETAL_PANCREAS_ENS...2,SET,125,-0.065374,-0.0053761,0.082674,0.78545,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,0.99999
MEF2_03,SET,204,-0.049656,-0.0052053,0.062792,0.78546,MEF2_03,0.99999
GSE3039_CD4_TCELL_VS_ALPHAAL...2,SET,180,-0.051472,-0.0050717,0.065086,0.78547,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP,0.99999
TAKADA_GASTRIC_CANCER_COPY_N...2,SET,7,-0.28012,-0.0054689,0.35414,0.78552,TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP,0.99999
HP_TRANSIENT_ISCHEMIC_ATTACK,SET,53,-0.098185,-0.005268,0.12413,0.78552,HP_TRANSIENT_ISCHEMIC_ATTACK,0.99999
GSE2770_IL12_ACT_VS_ACT_CD4_...6,SET,169,-0.050934,-0.0048644,0.064391,0.78553,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP,0.99999
MIR150_5P,SET,160,-0.052021,-0.0048353,0.065742,0.78561,MIR150_5P,0.99999
GOBP_LYMPHOCYTE_MIGRATION_IN...,SET,9,-0.25428,-0.0056289,0.32122,0.7857,GOBP_LYMPHOCYTE_MIGRATION_INTO_LYMPHOID_ORGANS,0.99999
GSE14415_INDUCED_VS_NATURAL_...1,SET,162,-0.051349,-0.0048024,0.06486,0.78573,GSE14415_INDUCED_VS_NATURAL_TREG_DN,0.99999
DESCARTES_FETAL_PLACENTA_TRO...,SET,66,-0.093187,-0.0055774,0.11771,0.78573,DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS,0.99999
GOBP_CELLULAR_RESPONSE_TO_NI...4,SET,6,-0.21783,-0.0039374,0.27513,0.78574,GOBP_CELLULAR_RESPONSE_TO_NITROSATIVE_STRESS,0.99999
DESCARTES_MAIN_FETAL_VISCERA...,SET,43,-0.1062,-0.0051338,0.13412,0.78576,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,0.99999
REACTOME_PROTEIN_LOCALIZATION,SET,143,-0.053257,-0.004682,0.067247,0.7858,REACTOME_PROTEIN_LOCALIZATION,0.99999
GSE3203_HEALTHY_VS_INFLUENZA...1,SET,179,-0.050955,-0.005007,0.064321,0.78587,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_DN,0.99999
GOBP_GLYCINE_BIOSYNTHETIC_PR...,SET,5,-0.28376,-0.0046823,0.35816,0.78589,GOBP_GLYCINE_BIOSYNTHETIC_PROCESS,0.99999
HP_PROPORTIONATE_SHORT_STATU...,SET,130,-0.05912,-0.0049574,0.074624,0.78589,HP_PROPORTIONATE_SHORT_STATURE,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...12,SET,15,-0.1741,-0.0049746,0.21974,0.7859,KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOBP_PYRUVATE_TRANSPORT,SET,7,-0.27638,-0.0053958,0.34881,0.78591,GOBP_PYRUVATE_TRANSPORT,0.99999
GSE19888_ADENOSINE_A3R_INH_V...8,SET,183,-0.050713,-0.005038,0.063994,0.78595,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,0.99999
HP_LACRIMAL_DUCT_ATRESIA,SET,5,-0.35374,-0.0058372,0.44633,0.78598,HP_LACRIMAL_DUCT_ATRESIA,0.99999
RORA_TARGET_GENES,SET,214,-0.045275,-0.0048597,0.057118,0.78601,RORA_TARGET_GENES,0.99999
NABA_MATRISOME_POORLY_METAST...3,SET,35,-0.11516,-0.0050234,0.14526,0.78604,NABA_MATRISOME_POORLY_METASTATIC_MELANOMA,0.99999
MIR6805_5P,SET,40,-0.1002,-0.0046723,0.12639,0.78605,MIR6805_5P,0.99999
GOBP_DETECTION_OF_VIRUS,SET,5,-0.2782,-0.0045907,0.35091,0.78605,GOBP_DETECTION_OF_VIRUS,0.99999
HP_REDUCED_NATURAL_KILLER_CE...1,SET,11,-0.21973,-0.0053771,0.27714,0.78607,HP_REDUCED_NATURAL_KILLER_CELL_ACTIVITY,0.99999
GOBP_NEURON_CELL_CELL_ADHESI...,SET,13,-0.20576,-0.0054735,0.25947,0.78611,GOBP_NEURON_CELL_CELL_ADHESION,0.99999
GSE34006_WT_VS_A2AR_KO_TREG_...2,SET,183,-0.05131,-0.0050973,0.064701,0.78611,GSE34006_WT_VS_A2AR_KO_TREG_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...57,SET,37,-0.094021,-0.0042167,0.11855,0.78614,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,0.99999
TRAVAGLINI_LUNG_VASCULAR_SMO...,SET,57,-0.096695,-0.0053796,0.12191,0.78615,TRAVAGLINI_LUNG_VASCULAR_SMOOTH_MUSCLE_CELL,0.99999
GSE16450_IMMATURE_VS_MATURE_...6,SET,164,-0.053361,-0.0050209,0.06727,0.78617,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,0.99999
HP_ABNORMAL_PROPORTION_OF_CD...2,SET,39,-0.10358,-0.0047692,0.13057,0.7862,HP_ABNORMAL_PROPORTION_OF_CD4_POSITIVE_T_CELLS,0.99999
GOCC_SIN3_TYPE_COMPLEX,SET,19,-0.15165,-0.0048761,0.19115,0.78621,GOCC_SIN3_TYPE_COMPLEX,0.99999
MIR588,SET,108,-0.068032,-0.0052027,0.085742,0.78623,MIR588,0.99999
GSE37532_WT_VS_PPARG_KO_LN_T...2,SET,181,-0.05083,-0.0050223,0.064038,0.78633,GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP,0.99999
REACTOME_TOXICITY_OF_BOTULIN...,SET,5,-0.28838,-0.0047586,0.36326,0.78636,REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BOTD,0.99999
GSE19374_UNINF_VS_LISTERIA_I...1,SET,182,-0.048829,-0.0048377,0.061503,0.78638,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN,0.99999
GSE8835_CD4_VS_CD8_TCELL_CLL...1,SET,185,-0.052195,-0.0052132,0.065743,0.78638,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN,0.99999
GSE2706_UNSTIM_VS_8H_LPS_AND...1,SET,173,-0.053957,-0.0052132,0.067959,0.78639,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN,0.99999
GOMF_MICROTUBULE_MOTOR_ACTIV...,SET,68,-0.079742,-0.0048442,0.10043,0.7864,GOMF_MICROTUBULE_MOTOR_ACTIVITY,0.99999
HU_FETAL_RETINA_FIBROBLAST,SET,337,-0.04046,-0.0054314,0.050952,0.78642,HU_FETAL_RETINA_FIBROBLAST,0.99999
GSE2585_CTEC_VS_THYMIC_DC_UP,SET,178,-0.051206,-0.0050177,0.064482,0.78643,GSE2585_CTEC_VS_THYMIC_DC_UP,0.99999
MIR4469,SET,104,-0.066008,-0.0049541,0.08311,0.78646,MIR4469,0.99999
GSE22886_NAIVE_TCELL_VS_MONO...1,SET,189,-0.052186,-0.0052677,0.0657,0.78649,GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN,0.99999
ZNF581_TARGET_GENES,SET,266,-0.040511,-0.004841,0.050996,0.78651,ZNF581_TARGET_GENES,0.99999
GOCC_COLLAGEN_TYPE_IV_TRIMER,SET,4,-0.3888,-0.0057384,0.48934,0.78655,GOCC_COLLAGEN_TYPE_IV_TRIMER,0.99999
REACTOME_SYNTHESIS_OF_12_EIC...,SET,7,-0.26342,-0.0051429,0.33153,0.78656,REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES,0.99999
HP_SCLERODACTYLY,SET,5,-0.31541,-0.0052047,0.39694,0.78658,HP_SCLERODACTYLY,0.99999
GOBP_REGULATION_OF_LEUKOCYTE...10,SET,18,-0.16927,-0.0052977,0.21292,0.78668,GOBP_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING,0.99999
GOBP_REGULATION_OF_RECEPTOR_...3,SET,14,-0.19315,-0.0053318,0.24289,0.78675,GOBP_REGULATION_OF_RECEPTOR_CLUSTERING,0.99999
CTACTAG_MIR325,SET,13,-0.18505,-0.0049226,0.23269,0.78677,CTACTAG_MIR325,0.99999
GOBP_LYSOSOMAL_LUMEN_ACIDIFI...,SET,20,-0.15769,-0.0052019,0.19828,0.78677,GOBP_LYSOSOMAL_LUMEN_ACIDIFICATION,0.99999
HP_ABNORMAL_RESPIRATORY_MOTI...,SET,29,-0.11988,-0.0047609,0.15074,0.78677,HP_ABNORMAL_RESPIRATORY_MOTILE_CILIUM_PHYSIOLOGY,0.99999
ESC_V6.5_UP_LATE.V1_UP,SET,161,-0.056126,-0.005233,0.070566,0.78679,ESC_V6.5_UP_LATE.V1_UP,0.99999
AP1_Q6_01,SET,239,-0.045169,-0.0051201,0.056787,0.78681,AP1_Q6_01,0.99999
RICKMAN_HEAD_AND_NECK_CANCER...4,SET,30,-0.14375,-0.0058062,0.1807,0.78683,RICKMAN_HEAD_AND_NECK_CANCER_D,0.99999
GOBP_HEPARAN_SULFATE_PROTEOG...4,SET,8,-0.24039,-0.0050171,0.30217,0.78684,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_DENDRITIC...1,SET,11,-0.20698,-0.0050649,0.26008,0.78692,GOBP_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,0.99999
HP_CARCINOID_TUMOR,SET,12,-0.18112,-0.0046292,0.22759,0.78692,HP_CARCINOID_TUMOR,0.99999
HP_ONYCHOGRYPOSIS_OF_FINGERN...,SET,9,-0.21928,-0.004854,0.27553,0.78693,HP_ONYCHOGRYPOSIS_OF_FINGERNAIL,0.99999
SHAFFER_IRF4_TARGETS_IN_ACTI...2,SET,58,-0.093351,-0.0052388,0.11729,0.78696,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,0.99999
GSE411_WT_VS_SOCS3_KO_MACROP...6,SET,177,-0.050225,-0.0049078,0.0631,0.78697,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_UP,0.99999
GCM_CBFB,SET,63,-0.07788,-0.0045545,0.097819,0.78703,GCM_CBFB,0.99999
MODULE_171,SET,122,-0.064018,-0.0052014,0.080406,0.78703,MODULE_171,0.99999
HP_ABNORMAL_BLADDER_MORPHOLO...,SET,66,-0.088488,-0.0052962,0.11113,0.78705,HP_ABNORMAL_BLADDER_MORPHOLOGY,0.99999
GOBP_VESICLE_TARGETING_TO_FR...,SET,31,-0.11218,-0.004606,0.14086,0.78709,GOBP_VESICLE_TARGETING_TO_FROM_OR_WITHIN_GOLGI,0.99999
REACTOME_AQUAPORIN_MEDIATED_...,SET,50,-0.10676,-0.0055641,0.13402,0.78716,REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,0.99999
HP_ABNORMAL_CONSUMPTION_BEHA...,SET,253,-0.044823,-0.0052256,0.056259,0.78719,HP_ABNORMAL_CONSUMPTION_BEHAVIOR,0.99999
GOBP_REGULATION_OF_T_CELL_ME...1,SET,47,-0.11504,-0.0058135,0.14438,0.78721,GOBP_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,0.99999
HP_CONSTRICTION_OF_PERIPHERA...,SET,126,-0.061184,-0.0050514,0.076776,0.78724,HP_CONSTRICTION_OF_PERIPHERAL_VISUAL_FIELD,0.99999
GOBP_DORSAL_AORTA_DEVELOPMENT,SET,10,-0.24564,-0.0057316,0.30821,0.78727,GOBP_DORSAL_AORTA_DEVELOPMENT,0.99999
HP_RECTAL_POLYPOSIS,SET,5,-0.32073,-0.0052925,0.40239,0.78729,HP_RECTAL_POLYPOSIS,0.99999
HALLMARK_NOTCH_SIGNALING,SET,31,-0.12286,-0.0050445,0.15414,0.78729,HALLMARK_NOTCH_SIGNALING,0.99999
HP_DECREASED_CIRCULATING_IGG...1,SET,7,-0.22657,-0.0044234,0.28423,0.78731,HP_DECREASED_CIRCULATING_IGG2_LEVEL,0.99999
DPPA3_TARGET_GENES,SET,16,-0.15566,-0.0045935,0.19525,0.78734,DPPA3_TARGET_GENES,0.99999
GSE40274_CTRL_VS_FOXP3_AND_X...2,SET,148,-0.05226,-0.0046733,0.065542,0.78737,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
SCHUHMACHER_MYC_TARGETS_DN,SET,7,-0.25721,-0.0050217,0.32257,0.78738,SCHUHMACHER_MYC_TARGETS_DN,0.99999
GOBP_TRNA_TRANSCRIPTION,SET,13,-0.15189,-0.0040406,0.19049,0.78738,GOBP_TRNA_TRANSCRIPTION,0.99999
GOMF_PHOSPHATIDYLINOSITOL_BI...1,SET,253,-0.042082,-0.004906,0.052775,0.78738,GOMF_PHOSPHATIDYLINOSITOL_BINDING,0.99999
VANGURP_PANCREATIC_DELTA_CELL,SET,73,-0.089147,-0.0056104,0.1118,0.78738,VANGURP_PANCREATIC_DELTA_CELL,0.99999
HP_OSTEOMYELITIS,SET,58,-0.094099,-0.0052808,0.118,0.78739,HP_OSTEOMYELITIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...620,SET,12,-0.18438,-0.0047126,0.2312,0.78741,GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,0.99999
HP_ABNORMAL_HEART_MORPHOLOGY,SET,1338,-0.019179,-0.0049855,0.02405,0.78741,HP_ABNORMAL_HEART_MORPHOLOGY,0.99999
HP_PARATHYROID_CARCINOMA,SET,7,-0.27323,-0.0053343,0.34258,0.78743,HP_PARATHYROID_CARCINOMA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...49,SET,31,-0.12554,-0.0051544,0.15737,0.78748,GOBP_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,0.99999
HP_MYOCLONUS,SET,321,-0.038059,-0.0049885,0.047705,0.7875,HP_MYOCLONUS,0.99999
HP_ENLARGED_EPIPHYSES,SET,12,-0.19117,-0.0048861,0.2396,0.78753,HP_ENLARGED_EPIPHYSES,0.99999
GOBP_MITOCHONDRIAL_TRANSLATI...1,SET,122,-0.056514,-0.0045917,0.070825,0.78754,GOBP_MITOCHONDRIAL_TRANSLATION,0.99999
GSE42021_CD24INT_VS_CD24LOW_...4,SET,172,-0.052426,-0.0050507,0.065697,0.78756,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_UP,0.99999
GOBP_MITOTIC_CYTOKINESIS,SET,88,-0.067784,-0.0046818,0.084902,0.78767,GOBP_MITOTIC_CYTOKINESIS,0.99999
GOBP_SENSORY_PERCEPTION_OF_B...,SET,43,-0.12566,-0.0060745,0.15736,0.78773,GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE,0.99999
WP_2Q13_COPY_NUMBER_VARIATIO...,SET,57,-0.10915,-0.0060726,0.13667,0.78774,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GOBP_LYMPHOCYTE_HOMEOSTASIS,SET,71,-0.083645,-0.0051918,0.10474,0.78774,GOBP_LYMPHOCYTE_HOMEOSTASIS,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...16,SET,50,-0.084893,-0.0044244,0.1063,0.78774,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR,0.99999
HP_ABNORMAL_ASCENDING_AORTA_...,SET,26,-0.14834,-0.0055786,0.18575,0.78774,HP_ABNORMAL_ASCENDING_AORTA_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...245,SET,4,-0.37363,-0.0055146,0.46778,0.78777,GOBP_NEGATIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY,0.99999
REACTOME_CHONDROITIN_SULFATE...1,SET,18,-0.15399,-0.0048195,0.19275,0.78782,REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS,0.99999
GOBP_RNA_CATABOLIC_PROCESS,SET,264,-0.040563,-0.0048292,0.050767,0.78785,GOBP_RNA_CATABOLIC_PROCESS,0.99999
GOMF_CATALYTIC_ACTIVITY_ACTI...1,SET,22,-0.16979,-0.0058742,0.21248,0.78788,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_GLYCOPROTEIN,0.99999
GSE33162_UNTREATED_VS_4H_LPS...4,SET,185,-0.048476,-0.0048417,0.060658,0.7879,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_UP,0.99999
KEGG_MEDICUS_VARIANT_EGF_OVE...1,SET,8,-0.24152,-0.0050407,0.30219,0.78792,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_HAIR_PATTERN,SET,308,-0.038591,-0.0049564,0.048269,0.78799,HP_ABNORMAL_HAIR_PATTERN,0.99999
GOCC_U12_TYPE_SPLICEOSOMAL_C...,SET,24,-0.12534,-0.004529,0.15676,0.78801,GOCC_U12_TYPE_SPLICEOSOMAL_COMPLEX,0.99999
GOBP_MICROTUBULE_BASED_TRANS...,SET,187,-0.048577,-0.0048777,0.060752,0.78803,GOBP_MICROTUBULE_BASED_TRANSPORT,0.99999
REACTOME_REGULATION_OF_MITF_...3,SET,15,-0.19114,-0.0054614,0.23902,0.78805,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_LYSOSOME_BIOGENESIS_AND_AUTOPHAGY,0.99999
HP_ABSENT_NIPPLE,SET,9,-0.21047,-0.0046591,0.2632,0.78805,HP_ABSENT_NIPPLE,0.99999
MCLACHLAN_DENTAL_CARIES_UP,SET,211,-0.05214,-0.0055576,0.065196,0.78806,MCLACHLAN_DENTAL_CARIES_UP,0.99999
MARIADASON_RESPONSE_TO_BUTYR...4,SET,16,-0.16585,-0.0048941,0.20736,0.78809,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...79,SET,6,-0.26491,-0.0047883,0.33116,0.78812,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01050,0.99999
WP_OMEGA3_OMEGA6_FATTY_ACID_...,SET,14,-0.20084,-0.005544,0.25106,0.78813,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...11,SET,14,-0.19886,-0.0054895,0.24857,0.78814,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP,0.99999
GOBP_NEUROTROPHIN_TRK_RECEPT...,SET,24,-0.13285,-0.0048002,0.16605,0.78815,GOBP_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOMF_WNT_PROTEIN_BINDING,SET,30,-0.14259,-0.0057594,0.17823,0.78815,GOMF_WNT_PROTEIN_BINDING,0.99999
REACTOME_RUNX3_REGULATES_CDK...,SET,7,-0.25335,-0.0049462,0.31666,0.78816,REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION,0.99999
GSE41867_LCMV_ARMSTRONG_VS_C...2,SET,175,-0.050235,-0.0048813,0.062744,0.78832,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP,0.99999
REACTOME_NEUTROPHIL_DEGRANUL...,SET,439,-0.033434,-0.005108,0.041757,0.78833,REACTOME_NEUTROPHIL_DEGRANULATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...619,SET,4,-0.35324,-0.0052137,0.44119,0.78833,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEUBIQUITINATION,0.99999
GOMF_1_ACYLGLYCEROPHOSPHOCHO...,SET,6,-0.32737,-0.0059175,0.40888,0.78833,GOMF_1_ACYLGLYCEROPHOSPHOCHOLINE_O_ACYLTRANSFERASE_ACTIVITY,0.99999
KINNEY_DNMT1_METHYLATION_TAR...,SET,14,-0.19491,-0.0053804,0.24341,0.78835,KINNEY_DNMT1_METHYLATION_TARGETS,0.99999
HP_ABNORMAL_HEART_RATE_VARIA...,SET,22,-0.14755,-0.0051048,0.18425,0.78837,HP_ABNORMAL_HEART_RATE_VARIABILITY,0.99999
HP_PROGRESSIVE_CEREBELLAR_AT...,SET,57,-0.084362,-0.0046935,0.10534,0.78839,HP_PROGRESSIVE_CEREBELLAR_ATAXIA,0.99999
REACTOME_SIGNALING_BY_NOTCH1...2,SET,52,-0.094588,-0.005027,0.1181,0.78841,REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER,0.99999
TOMLINS_METASTASIS_DN,SET,18,-0.15871,-0.0049673,0.19812,0.78846,TOMLINS_METASTASIS_DN,0.99999
FOXO4_TARGET_GENES,SET,293,-0.037736,-0.0047292,0.047106,0.78846,FOXO4_TARGET_GENES,0.99999
GSE24292_WT_VS_PPARG_KO_MACR...2,SET,185,-0.050602,-0.005054,0.063162,0.78847,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_UP,0.99999
HP_CAPILLARY_MALFORMATION,SET,58,-0.097853,-0.0054914,0.12213,0.78849,HP_CAPILLARY_MALFORMATION,0.99999
GOBP_REGULATION_OF_ESTABLISH...4,SET,43,-0.096801,-0.0046794,0.12081,0.7885,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.99999
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...5,SET,125,-0.064045,-0.0052668,0.079919,0.78854,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_UP,0.99999
HU_FETAL_RETINA_RPE,SET,252,-0.047209,-0.005493,0.058905,0.78856,HU_FETAL_RETINA_RPE,0.99999
CAVIN1_TARGET_GENES,SET,62,-0.084268,-0.0048889,0.10514,0.78857,CAVIN1_TARGET_GENES,0.99999
HP_CONGENITAL_CONTRACTURE,SET,156,-0.054828,-0.0050327,0.068389,0.78864,HP_CONGENITAL_CONTRACTURE,0.99999
NABA_MATRISOME_POORLY_METAST...1,SET,25,-0.14527,-0.0053572,0.18118,0.78865,NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER,0.99999
GOMF_7S_RNA_BINDING,SET,7,-0.24332,-0.0047503,0.30345,0.78867,GOMF_7S_RNA_BINDING,0.99999
GSE10422_WT_VS_BAFF_TRANSGEN...1,SET,120,-0.065162,-0.005251,0.081257,0.7887,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN,0.99999
MIR5588_5P,SET,80,-0.076544,-0.0050419,0.095438,0.78873,MIR5588_5P,0.99999
JOHANSSON_BRAIN_CANCER_EARLY...2,SET,6,-0.26819,-0.0048477,0.33433,0.78877,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP,0.99999
GOMF_HEPARAN_SULFATE_BINDING,SET,7,-0.27794,-0.0054263,0.34641,0.78882,GOMF_HEPARAN_SULFATE_BINDING,0.99999
MODULE_407,SET,13,-0.20781,-0.0055279,0.25899,0.78883,MODULE_407,0.99999
MIR3121_3P,SET,590,-0.028699,-0.0050616,0.035762,0.78886,MIR3121_3P,0.99999
GSE24726_WT_VS_E2_2_KO_PDC_D...1,SET,186,-0.050792,-0.0050866,0.063284,0.78889,GSE24726_WT_VS_E2_2_KO_PDC_DAY4_POST_DELETION_UP,0.99999
GOBP_POSTSYNAPTIC_SPECIALIZA...1,SET,29,-0.13387,-0.0053163,0.16674,0.78896,GOBP_POSTSYNAPTIC_SPECIALIZATION_ASSEMBLY,0.99999
KEGG_MEDICUS_REFERENCE_RECRU...,SET,9,-0.25811,-0.0057136,0.32145,0.78899,KEGG_MEDICUS_REFERENCE_RECRUITMENT_AND_FORMATION_OF_THE_MCC,0.99999
MORF_DDX11,SET,145,-0.054203,-0.0047982,0.067493,0.78904,MORF_DDX11,0.99999
MODULE_402,SET,12,-0.21616,-0.0055246,0.2691,0.78908,MODULE_402,0.99999
MIR2114_3P,SET,40,-0.10689,-0.0049839,0.13306,0.7891,MIR2114_3P,0.99999
REACTOME_NUCLEOTIDE_BINDING_...,SET,50,-0.095809,-0.0049933,0.11924,0.78915,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,0.99999
HP_ABNORMAL_T_CELL_SUBSET_DI...,SET,69,-0.082748,-0.0050635,0.10294,0.78925,HP_ABNORMAL_T_CELL_SUBSET_DISTRIBUTION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...55,SET,29,-0.1358,-0.0053931,0.16891,0.78929,GOBP_NEGATIVE_REGULATION_OF_B_CELL_ACTIVATION,0.99999
REACTOME_OTHER_SEMAPHORIN_IN...,SET,18,-0.18227,-0.0057047,0.2267,0.7893,REACTOME_OTHER_SEMAPHORIN_INTERACTIONS,0.99999
HP_ABNORMAL_PONS_MORPHOLOGY,SET,105,-0.064089,-0.0048331,0.079712,0.7893,HP_ABNORMAL_PONS_MORPHOLOGY,0.99999
HP_PROMINENT_NASAL_BRIDGE,SET,202,-0.046277,-0.0048275,0.05755,0.78933,HP_PROMINENT_NASAL_BRIDGE,0.99999
GSE20500_RETINOIC_ACID_VS_RA...1,SET,175,-0.05289,-0.0051393,0.065771,0.78934,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,0.99999
MIR3672,SET,41,-0.10796,-0.0050962,0.13422,0.7894,MIR3672,0.99999
GNF2_CDC20,SET,52,-0.091598,-0.0048681,0.11387,0.7894,GNF2_CDC20,0.99999
GOBP_POSITIVE_REGULATION_OF_...831,SET,7,-0.28651,-0.0055937,0.35613,0.78944,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY,0.99999
GSE37534_PIOGLITAZONE_VS_ROS...1,SET,144,-0.06004,-0.0052967,0.074623,0.78946,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,0.99999
HP_AGENESIS_OF_PERMANENT_TEE...,SET,19,-0.14557,-0.0046806,0.1809,0.78949,HP_AGENESIS_OF_PERMANENT_TEETH,0.99999
BURTON_ADIPOGENESIS_5,SET,100,-0.06303,-0.0046392,0.078327,0.7895,BURTON_ADIPOGENESIS_5,0.99999
WHITESIDE_CISPLATIN_RESISTAN...2,SET,11,-0.20591,-0.0050389,0.25589,0.7895,WHITESIDE_CISPLATIN_RESISTANCE_UP,0.99999
MIR3177_3P,SET,8,-0.27938,-0.0058309,0.34719,0.7895,MIR3177_3P,0.99999
HP_HYPOTHERMIA,SET,40,-0.1068,-0.0049796,0.13271,0.7895,HP_HYPOTHERMIA,0.99999
GSE13484_UNSTIM_VS_YF17D_VAC...1,SET,188,-0.052135,-0.0052488,0.064786,0.78951,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,0.99999
GOCC_PLATELET_DENSE_GRANULE_...1,SET,13,-0.18003,-0.0047891,0.2237,0.78952,GOCC_PLATELET_DENSE_GRANULE_LUMEN,0.99999
GOMF_STORE_OPERATED_CALCIUM_...,SET,9,-0.24516,-0.005427,0.30463,0.78952,GOMF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,0.99999
LINDSTEDT_DENDRITIC_CELL_MAT...3,SET,60,-0.093716,-0.0053489,0.1164,0.78962,LINDSTEDT_DENDRITIC_CELL_MATURATION_C,0.99999
GSE17721_0.5H_VS_4H_CPG_BMDC...1,SET,188,-0.05176,-0.0052111,0.064276,0.78966,GSE17721_0.5H_VS_4H_CPG_BMDC_DN,0.99999
GSE3982_NKCELL_VS_TH2_DN,SET,179,-0.04896,-0.0048109,0.0608,0.78966,GSE3982_NKCELL_VS_TH2_DN,0.99999
GSE3982_EOSINOPHIL_VS_BCELL_...1,SET,177,-0.051133,-0.0049966,0.063495,0.78967,GSE3982_EOSINOPHIL_VS_BCELL_DN,0.99999
HONRADO_BREAST_CANCER_BRCA1_...,SET,17,-0.17406,-0.0052943,0.21614,0.78968,HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2,0.99999
HP_SQUAMOUS_CELL_CARCINOMA,SET,62,-0.081451,-0.0047255,0.10114,0.78968,HP_SQUAMOUS_CELL_CARCINOMA,0.99999
HP_GASTROPARESIS,SET,30,-0.11643,-0.0047027,0.14456,0.7897,HP_GASTROPARESIS,0.99999
KEGG_EPITHELIAL_CELL_SIGNALI...,SET,65,-0.083446,-0.0049566,0.1036,0.78971,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,0.99999
KYNG_RESPONSE_TO_H2O2_VIA_ER...3,SET,35,-0.11375,-0.0049618,0.14121,0.78973,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,0.99999
AP1_Q6,SET,233,-0.045991,-0.0051483,0.057091,0.78975,AP1_Q6,0.99999
GOBP_SEQUESTERING_OF_IRON_ION,SET,5,-0.33212,-0.0054804,0.41227,0.78976,GOBP_SEQUESTERING_OF_IRON_ION,0.99999
HP_HYPERPROSTAGLANDINURIA,SET,6,-0.32365,-0.0058502,0.40173,0.78977,HP_HYPERPROSTAGLANDINURIA,0.99999
MORI_PLASMA_CELL_UP,SET,45,-0.10212,-0.00505,0.12675,0.78979,MORI_PLASMA_CELL_UP,0.99999
XU_HGF_TARGETS_REPRESSED_BY_...2,SET,9,-0.23401,-0.00518,0.29041,0.78981,XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP,0.99999
MIR4642,SET,90,-0.075058,-0.0052425,0.093149,0.78981,MIR4642,0.99999
HP_INCREASED_LEVEL_OF_L_FUCO...,SET,16,-0.17618,-0.0051989,0.21857,0.78989,HP_INCREASED_LEVEL_OF_L_FUCOSE_IN_URINE,0.99999
GSE11057_CD4_EFF_MEM_VS_PBMC...1,SET,183,-0.053614,-0.0053262,0.066511,0.7899,GSE11057_CD4_EFF_MEM_VS_PBMC_DN,0.99999
HP_IMPAIRED_VIBRATION_SENSAT...2,SET,46,-0.095741,-0.0047865,0.11875,0.78993,HP_IMPAIRED_VIBRATION_SENSATION_IN_THE_LOWER_LIMBS,0.99999
MODULE_203,SET,3,-0.41493,-0.0053037,0.51462,0.78995,MODULE_203,0.99999
GOBP_CHORIONIC_TROPHOBLAST_C...1,SET,7,-0.31605,-0.0061704,0.39199,0.78995,GOBP_CHORIONIC_TROPHOBLAST_CELL_DIFFERENTIATION,0.99999
CIZ_01,SET,216,-0.048983,-0.0052819,0.060737,0.79001,CIZ_01,0.99999
KEGG_MEDICUS_REFERENCE_TSH_D...,SET,12,-0.1948,-0.0049788,0.24149,0.79006,KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY,0.99999
MIR222_3P,SET,158,-0.056767,-0.0052437,0.070367,0.79009,MIR222_3P,0.99999
GSE5589_WT_VS_IL6_KO_LPS_STI...1,SET,129,-0.062209,-0.0051964,0.07711,0.79009,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_DN,0.99999
MIR6504_3P,SET,342,-0.038753,-0.0052399,0.048013,0.7902,MIR6504_3P,0.99999
GOBP_CHIASMA_ASSEMBLY,SET,6,-0.25481,-0.0046058,0.31566,0.79023,GOBP_CHIASMA_ASSEMBLY,0.99999
ZNF419_TARGET_GENES,SET,5,-0.31354,-0.0051737,0.38838,0.79025,ZNF419_TARGET_GENES,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...3,SET,48,-0.10374,-0.0052975,0.12849,0.79026,GAVISH_3CA_METAPROGRAM_B_CELLS_GERMINAL_CENTER,0.99999
CEBPDELTA_Q6,SET,217,-0.048649,-0.0052579,0.06025,0.79029,CEBPDELTA_Q6,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...29,SET,9,-0.25094,-0.0055549,0.31074,0.79032,GOBP_PROTEIN_LOCALIZATION_TO_MEMBRANE_RAFT,0.99999
GOCC_CARDIAC_MYOFIBRIL,SET,6,-0.27837,-0.0050317,0.34465,0.79036,GOCC_CARDIAC_MYOFIBRIL,0.99999
GOBP_REGULATION_OF_CONNECTIV...,SET,5,-0.31206,-0.0051494,0.38631,0.79039,GOBP_REGULATION_OF_CONNECTIVE_TISSUE_REPLACEMENT,0.99999
ZHONG_PFC_C3_UNKNOWN_INP,SET,36,-0.11533,-0.005102,0.14276,0.7904,ZHONG_PFC_C3_UNKNOWN_INP,0.99999
DESCARTES_MAIN_FETAL_STROMAL...,SET,11,-0.24437,-0.0059801,0.30241,0.79047,DESCARTES_MAIN_FETAL_STROMAL_CELLS,0.99999
GOCC_CATALYTIC_STEP_2_SPLICE...,SET,83,-0.067963,-0.0045595,0.084085,0.79052,GOCC_CATALYTIC_STEP_2_SPLICEOSOME,0.99999
HP_PLATYBASIA,SET,16,-0.18335,-0.0054106,0.22676,0.79061,HP_PLATYBASIA,0.99999
MORF_MAGEA9,SET,376,-0.036724,-0.0052017,0.045405,0.79069,MORF_MAGEA9,0.99999
KEGG_MEDICUS_REFERENCE_PINK_...,SET,15,-0.17643,-0.005041,0.2181,0.79072,KEGG_MEDICUS_REFERENCE_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,0.99999
GOBP_SATELLITE_CELL_ACTIVATI...,SET,6,-0.25157,-0.0045473,0.31092,0.79077,GOBP_SATELLITE_CELL_ACTIVATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.99999
HP_SLENDER_TOE,SET,4,-0.34417,-0.0050798,0.42536,0.79078,HP_SLENDER_TOE,0.99999
GSE42021_TREG_PLN_VS_CD24INT...2,SET,182,-0.05308,-0.0052588,0.065593,0.7908,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_UP,0.99999
GSE3982_EOSINOPHIL_VS_TH2_DN,SET,179,-0.051448,-0.0050554,0.063576,0.79081,GSE3982_EOSINOPHIL_VS_TH2_DN,0.99999
REACTOME_EFFECTS_OF_PIP2_HYD...,SET,26,-0.12846,-0.0048309,0.15872,0.79083,REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS,0.99999
HP_PANCREATIC_ENDOCRINE_TUMOR,SET,13,-0.20453,-0.0054409,0.25272,0.79083,HP_PANCREATIC_ENDOCRINE_TUMOR,0.99999
GOBP_REGULATION_OF_OOCYTE_MA...,SET,7,-0.25022,-0.0048851,0.30916,0.79084,GOBP_REGULATION_OF_OOCYTE_MATURATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...402,SET,79,-0.081812,-0.0053553,0.10105,0.79091,GOBP_NEGATIVE_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.99999
REACTOME_REGULATION_OF_PYRUV...2,SET,29,-0.12716,-0.0050499,0.15705,0.79092,REACTOME_REGULATION_OF_PYRUVATE_METABOLISM,0.99999
GSE21670_TGFB_VS_IL6_TREATED...4,SET,188,-0.050515,-0.0050857,0.06237,0.791,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.99999
GSE22611_UNSTIM_VS_6H_MDP_ST...4,SET,176,-0.051819,-0.0050494,0.063975,0.79102,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.99999
HP_VISUAL_IMPAIRMENT,SET,993,-0.022485,-0.005086,0.027758,0.79103,HP_VISUAL_IMPAIRMENT,0.99999
HILLION_HMGA1B_TARGETS,SET,78,-0.080111,-0.0052108,0.098896,0.79104,HILLION_HMGA1B_TARGETS,0.99999
MIR548AQ_5P,SET,445,-0.033632,-0.0051724,0.041518,0.79104,MIR548AQ_5P,0.99999
HP_BIFID_TONGUE,SET,22,-0.13564,-0.0046927,0.16742,0.79107,HP_BIFID_TONGUE,0.99999
REACTOME_SENSORY_PERCEPTION_...1,SET,6,-0.33812,-0.0061117,0.41734,0.79108,REACTOME_SENSORY_PERCEPTION_OF_SALTY_TASTE,0.99999
ACEVEDO_LIVER_TUMOR_VS_NORMA...2,SET,753,-0.025047,-0.0049676,0.030906,0.79115,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP,0.99999
HP_BROAD_METACARPALS,SET,17,-0.18555,-0.0056437,0.22895,0.79115,HP_BROAD_METACARPALS,0.99999
GOBP_FOREBRAIN_NEUROBLAST_DI...,SET,6,-0.31333,-0.0056637,0.38652,0.79121,GOBP_FOREBRAIN_NEUROBLAST_DIVISION,0.99999
GOBP_IRON_ION_IMPORT_ACROSS_...,SET,4,-0.38027,-0.0056126,0.46911,0.79121,GOBP_IRON_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GSE16450_IMMATURE_VS_MATURE_...5,SET,183,-0.049096,-0.0048773,0.060553,0.79125,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.99999
GSE27786_LIN_NEG_VS_NKTCELL_...1,SET,184,-0.048954,-0.0048764,0.060366,0.7913,GSE27786_LIN_NEG_VS_NKTCELL_DN,0.99999
CREB_Q4,SET,236,-0.045664,-0.005144,0.056293,0.79136,CREB_Q4,0.99999
GOCC_CLUSTER_OF_ACTIN_BASED_...,SET,154,-0.056125,-0.0051189,0.069191,0.79136,GOCC_CLUSTER_OF_ACTIN_BASED_CELL_PROJECTIONS,0.99999
REACTOME_TIE2_SIGNALING,SET,18,-0.15636,-0.0048938,0.19273,0.7914,REACTOME_TIE2_SIGNALING,0.99999
GOBP_LIPID_EXPORT_FROM_CELL,SET,49,-0.10681,-0.0055108,0.13164,0.79143,GOBP_LIPID_EXPORT_FROM_CELL,0.99999
GOBP_VOLUNTARY_SKELETAL_MUSC...,SET,5,-0.26433,-0.0043617,0.32572,0.79146,GOBP_VOLUNTARY_SKELETAL_MUSCLE_CONTRACTION,0.99999
MIR1278,SET,56,-0.094391,-0.0052054,0.11629,0.79151,MIR1278,0.99999
GOBP_URATE_METABOLIC_PROCESS,SET,10,-0.23458,-0.0054735,0.28898,0.79153,GOBP_URATE_METABOLIC_PROCESS,0.99999
ESC_V6.5_UP_LATE.V1_DN,SET,161,-0.054377,-0.00507,0.066987,0.79153,ESC_V6.5_UP_LATE.V1_DN,0.99999
GSE45365_CD8A_DC_VS_CD11B_DC...6,SET,166,-0.054356,-0.0051453,0.066948,0.79157,GSE45365_CD8A_DC_VS_CD11B_DC_UP,0.99999
MIR548AN,SET,438,-0.034208,-0.0052205,0.042131,0.79158,MIR548AN,0.99999
GSE40274_CTRL_VS_GATA1_TRANS...1,SET,147,-0.0568,-0.0050623,0.069956,0.79158,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
HP_ABNORMAL_RETINAL_NERVE_FI...,SET,5,-0.29271,-0.00483,0.3604,0.79165,HP_ABNORMAL_RETINAL_NERVE_FIBER_LAYER_MORPHOLOGY,0.99999
TRAVAGLINI_LUNG_ARTERY_CELL,SET,124,-0.068045,-0.0055734,0.083747,0.79174,TRAVAGLINI_LUNG_ARTERY_CELL,0.99999
HP_DRY_HAIR,SET,16,-0.17507,-0.0051662,0.21546,0.79175,HP_DRY_HAIR,0.99999
GOMF_CATECHOLAMINE_BINDING,SET,12,-0.22642,-0.005787,0.27865,0.79176,GOMF_CATECHOLAMINE_BINDING,0.99999
BRUINS_UVC_RESPONSE_VIA_TP53...4,SET,246,-0.045714,-0.0052562,0.056253,0.79178,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,0.99999
HP_ABNORMAL_ADIPOSE_TISSUE_M...,SET,214,-0.048417,-0.0051969,0.059573,0.79181,HP_ABNORMAL_ADIPOSE_TISSUE_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...318,SET,32,-0.11997,-0.0050043,0.1476,0.79182,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HP...1,SET,701,-0.028088,-0.0053828,0.034555,0.79184,MANNO_MIDBRAIN_NEUROTYPES_HPERIC,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...13,SET,26,-0.13335,-0.0050147,0.16403,0.79186,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN,0.99999
GOMF_HISTONE_H3K9ME2_H3K9ME3...,SET,5,-0.26997,-0.0044548,0.332,0.79193,GOMF_HISTONE_H3K9ME2_H3K9ME3_DEMETHYLASE_ACTIVITY,0.99999
GOCC_SMAD_PROTEIN_COMPLEX,SET,9,-0.2595,-0.0057444,0.31901,0.79202,GOCC_SMAD_PROTEIN_COMPLEX,0.99999
REACTOME_GLUCOCORTICOID_BIOS...,SET,10,-0.23844,-0.0055635,0.29308,0.79205,REACTOME_GLUCOCORTICOID_BIOSYNTHESIS,0.99999
HP_ORAL_PHARYNGEAL_DYSPHAGIA,SET,39,-0.11421,-0.0052587,0.14038,0.79207,HP_ORAL_PHARYNGEAL_DYSPHAGIA,0.99999
GAZDA_DIAMOND_BLACKFAN_ANEMI...4,SET,27,-0.1272,-0.0048746,0.15633,0.79208,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,0.99999
GSE17721_CTRL_VS_LPS_6H_BMDC...2,SET,178,-0.050947,-0.0049923,0.062612,0.79208,GSE17721_CTRL_VS_LPS_6H_BMDC_UP,0.99999
HP_PERIPORTAL_FIBROSIS,SET,10,-0.2139,-0.004991,0.26285,0.79211,HP_PERIPORTAL_FIBROSIS,0.99999
HP_APLASIA_HYPOPLASIA_OF_MET...,SET,59,-0.093171,-0.0052734,0.11447,0.79216,HP_APLASIA_HYPOPLASIA_OF_METATARSAL_BONES,0.99999
GOBP_REGULATION_OF_ADENYLATE...2,SET,42,-0.11689,-0.0055845,0.14359,0.79218,GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,0.99999
XU_HGF_SIGNALING_NOT_VIA_AKT...2,SET,32,-0.12879,-0.0053723,0.15819,0.79221,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,0.99999
MIR548AG,SET,158,-0.055219,-0.0051007,0.067817,0.79224,MIR548AG,0.99999
HP_LEFT_VENTRICULAR_HYPERTRO...,SET,87,-0.069769,-0.0047916,0.085685,0.79224,HP_LEFT_VENTRICULAR_HYPERTROPHY,0.99999
HP_SUNKEN_CHEEKS,SET,5,-0.31023,-0.0051192,0.38099,0.79225,HP_SUNKEN_CHEEKS,0.99999
GSE2585_THYMIC_DC_VS_MTEC_DN,SET,177,-0.052895,-0.0051688,0.06492,0.79239,GSE2585_THYMIC_DC_VS_MTEC_DN,0.99999
VRTN_TARGET_GENES,SET,9,-0.21553,-0.0047711,0.26451,0.79241,VRTN_TARGET_GENES,0.99999
GOMF_SNRNA_BINDING,SET,44,-0.089273,-0.0043653,0.10955,0.79243,GOMF_SNRNA_BINDING,0.99999
GTF3C1_TARGET_GENES,SET,4,-0.3519,-0.0051938,0.43171,0.79249,GTF3C1_TARGET_GENES,0.99999
MIR4439,SET,66,-0.091746,-0.0054912,0.11255,0.79251,MIR4439,0.99999
MORF_PPP1CC,SET,146,-0.054662,-0.0048553,0.067054,0.79251,MORF_PPP1CC,0.99999
HP_IMPAIRED_EXECUTIVE_FUNCTI...,SET,9,-0.24231,-0.0053639,0.29721,0.79255,HP_IMPAIRED_EXECUTIVE_FUNCTIONING,0.99999
BOYLAN_MULTIPLE_MYELOMA_D_CL...1,SET,35,-0.11796,-0.0051456,0.14467,0.79256,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,0.99999
GSE21927_GMCSF_IL6_VS_GMCSF_...1,SET,181,-0.048313,-0.0047735,0.05924,0.79262,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...363,SET,54,-0.1013,-0.0054859,0.12419,0.79265,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,0.99999
HP_ABNORMAL_NUMBER_OF_VERTEB...,SET,3,-0.36822,-0.0047068,0.45124,0.79275,HP_ABNORMAL_NUMBER_OF_VERTEBRAE,0.99999
GSE42724_NAIVE_BCELL_VS_PLAS...1,SET,179,-0.053136,-0.0052213,0.065117,0.79275,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN,0.99999
MIR4720_3P,SET,106,-0.068654,-0.0052017,0.084122,0.79278,MIR4720_3P,0.99999
GSE20715_WT_VS_TLR4_KO_6H_OZ...2,SET,183,-0.049945,-0.0049617,0.061186,0.79282,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...494,SET,6,-0.33437,-0.006044,0.40951,0.79289,GOBP_POSITIVE_REGULATION_OF_MUCUS_SECRETION,0.99999
HP_ABNORMAL_CIRCULATING_FATT...1,SET,39,-0.10704,-0.0049284,0.13109,0.7929,HP_ABNORMAL_CIRCULATING_FATTY_ACID_ANION_CONCENTRATION,0.99999
GSE3691_IFN_PRODUCING_KILLER...4,SET,177,-0.051887,-0.0050702,0.063542,0.79291,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_UP,0.99999
MIR3681_3P,SET,357,-0.038472,-0.0053126,0.047106,0.79295,MIR3681_3P,0.99999
TANG_SENESCENCE_TP53_TARGETS...1,SET,51,-0.098492,-0.005184,0.12059,0.79296,TANG_SENESCENCE_TP53_TARGETS_DN,0.99999
GOBP_PROTEIN_HOMOOLIGOMERIZA...,SET,190,-0.05182,-0.0052445,0.063445,0.79296,GOBP_PROTEIN_HOMOOLIGOMERIZATION,0.99999
SENESE_HDAC1_AND_HDAC2_TARGE...2,SET,212,-0.050237,-0.0053673,0.061486,0.79305,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,0.99999
HP_SHORT_RIBS,SET,58,-0.087753,-0.0049246,0.10739,0.79308,HP_SHORT_RIBS,0.99999
GOBP_MEIOTIC_CELL_CYCLE_PHAS...,SET,13,-0.1889,-0.0050251,0.23112,0.79312,GOBP_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...4,SET,176,-0.050391,-0.0049102,0.061655,0.79312,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP,0.99999
TCF11MAFG_01,SET,182,-0.053039,-0.0052548,0.064888,0.79314,TCF11MAFG_01,0.99999
DELPUECH_FOXO3_TARGETS_DN,SET,34,-0.12368,-0.0053178,0.15131,0.79315,DELPUECH_FOXO3_TARGETS_DN,0.99999
GOCC_INTERSTITIAL_MATRIX,SET,11,-0.21574,-0.0052795,0.26392,0.79316,GOCC_INTERSTITIAL_MATRIX,0.99999
GSE26030_TH1_VS_TH17_RESTIMU...3,SET,180,-0.051244,-0.0050493,0.062686,0.79317,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN,0.99999
NAM_FXYD5_TARGETS_DN,SET,17,-0.16157,-0.0049145,0.1976,0.79323,NAM_FXYD5_TARGETS_DN,0.99999
GOBP_DETERMINATION_OF_LIVER_...,SET,5,-0.31935,-0.0052696,0.39054,0.79323,GOBP_DETERMINATION_OF_LIVER_LEFT_RIGHT_ASYMMETRY,0.99999
BIOCARTA_G1_PATHWAY,SET,28,-0.12608,-0.00492,0.15418,0.79324,BIOCARTA_G1_PATHWAY,0.99999
GOBP_ATP_BIOSYNTHETIC_PROCESS,SET,62,-0.07725,-0.0044817,0.094466,0.79324,GOBP_ATP_BIOSYNTHETIC_PROCESS,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HG...,SET,972,-0.024144,-0.0054066,0.029526,0.79324,MANNO_MIDBRAIN_NEUROTYPES_HGABA,0.99999
MIR653_5P,SET,116,-0.06529,-0.0051736,0.079838,0.79325,MIR653_5P,0.99999
NFAT_Q6,SET,217,-0.050051,-0.0054094,0.061188,0.79331,NFAT_Q6,0.99999
GSE27434_WT_VS_DNMT1_KO_TREG...2,SET,182,-0.049229,-0.0048773,0.060185,0.79331,GSE27434_WT_VS_DNMT1_KO_TREG_UP,0.99999
REACTOME_TRANSLOCATION_OF_SL...,SET,69,-0.083861,-0.0051316,0.10252,0.79332,REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE,0.99999
MIR324_5P,SET,39,-0.1076,-0.0049543,0.13153,0.79334,MIR324_5P,0.99999
HP_ABNORMAL_PROPORTION_OF_ME...,SET,5,-0.32947,-0.0054367,0.40272,0.79335,HP_ABNORMAL_PROPORTION_OF_MEMORY_T_CELLS,0.99999
CHIARETTI_ACUTE_LYMPHOBLASTI...,SET,63,-0.080076,-0.0046829,0.097872,0.79336,CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,0.99999
HP_ANENCEPHALY,SET,37,-0.10762,-0.0048266,0.13151,0.79341,HP_ANENCEPHALY,0.99999
HP_EEG_WITH_FOCAL_EPILEPTIFO...,SET,108,-0.069081,-0.005283,0.084418,0.79341,HP_EEG_WITH_FOCAL_EPILEPTIFORM_DISCHARGES,0.99999
GGAANCGGAANY_UNKNOWN,SET,102,-0.064143,-0.0047679,0.078381,0.79342,GGAANCGGAANY_UNKNOWN,0.99999
HP_ABNORMALITY_OF_THE_AMNIOT...,SET,418,-0.033866,-0.0050516,0.041378,0.79344,HP_ABNORMALITY_OF_THE_AMNIOTIC_FLUID,0.99999
LUI_THYROID_CANCER_PAX8_PPAR...2,SET,44,-0.10434,-0.005102,0.12748,0.79345,LUI_THYROID_CANCER_PAX8_PPARG_UP,0.99999
HAN_JNK_SINGALING_DN,SET,36,-0.12068,-0.0053387,0.14739,0.79353,HAN_JNK_SINGALING_DN,0.99999
GOBP_REGULATION_OF_B_CELL_PR...,SET,62,-0.092852,-0.0053869,0.1134,0.79355,GOBP_REGULATION_OF_B_CELL_PROLIFERATION,0.99999
HP_INFANTILE_SPASMS,SET,119,-0.064897,-0.005208,0.079241,0.79359,HP_INFANTILE_SPASMS,0.99999
CHANG_IMMORTALIZED_BY_HPV31_...1,SET,58,-0.094291,-0.0052916,0.11513,0.7936,CHANG_IMMORTALIZED_BY_HPV31_DN,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...15,SET,49,-0.10486,-0.0054103,0.12804,0.7936,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_STRESS,0.99999
GOMF_CYSTEINE_TYPE_ENDOPEPTI...6,SET,34,-0.14343,-0.0061669,0.17512,0.79362,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.99999
GSE360_HIGH_DOSE_B_MALAYI_VS...1,SET,186,-0.051574,-0.0051649,0.062966,0.79362,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,0.99999
DER_IFN_GAMMA_RESPONSE_DN,SET,10,-0.23108,-0.0053918,0.28204,0.7937,DER_IFN_GAMMA_RESPONSE_DN,0.99999
CCAGGTT_MIR490,SET,58,-0.088942,-0.0049914,0.10853,0.79374,CCAGGTT_MIR490,0.99999
GOBP_REGULATION_OF_HYALURONA...,SET,8,-0.24961,-0.0052095,0.30444,0.79385,GOBP_REGULATION_OF_HYALURONAN_BIOSYNTHETIC_PROCESS,0.99999
GSE21546_UNSTIM_VS_ANTI_CD3_...4,SET,160,-0.056444,-0.0052465,0.068842,0.79386,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP,0.99999
MIR10399_5P,SET,332,-0.040228,-0.0053607,0.049063,0.79387,MIR10399_5P,0.99999
MORF_RAN,SET,232,-0.042876,-0.0047894,0.05229,0.79387,MORF_RAN,0.99999
VANDESLUIS_COMMD1_TARGETS_GR...5,SET,13,-0.2017,-0.0053654,0.24597,0.79389,VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...651,SET,21,-0.13256,-0.004481,0.16163,0.79393,GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,0.99999
BROWNE_HCMV_INFECTION_48HR_UP,SET,168,-0.054407,-0.0051809,0.066331,0.79395,BROWNE_HCMV_INFECTION_48HR_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...148,SET,6,-0.27169,-0.004911,0.33122,0.79396,GOBP_POSITIVE_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS,0.99999
LET_7D_5P,SET,316,-0.040581,-0.0052782,0.049459,0.79403,LET_7D_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...299,SET,9,-0.26242,-0.005809,0.31982,0.79403,GOBP_NEGATIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.99999
GOMF_FLAP_ENDONUCLEASE_ACTIV...,SET,6,-0.23601,-0.0042659,0.28764,0.79403,GOMF_FLAP_ENDONUCLEASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_GLUCOSYLC...,SET,2,-0.56649,-0.0059125,0.69017,0.79411,GOBP_REGULATION_OF_GLUCOSYLCERAMIDE_CATABOLIC_PROCESS,0.99999
HU_FETAL_RETINA_AMACRINE,SET,57,-0.10367,-0.0057675,0.1263,0.79411,HU_FETAL_RETINA_AMACRINE,0.99999
GOBP_MITOCHONDRIAL_RNA_MODIF...,SET,8,-0.22695,-0.0047366,0.27648,0.79413,GOBP_MITOCHONDRIAL_RNA_MODIFICATION,0.99999
GSE17721_CTRL_VS_POLYIC_1H_B...1,SET,180,-0.054036,-0.0053243,0.065777,0.79432,GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN,0.99999
HP_SERTOLI_CELL_NEOPLASM,SET,5,-0.3374,-0.0055675,0.41068,0.79433,HP_SERTOLI_CELL_NEOPLASM,0.99999
GABRIELY_MIR21_TARGETS,SET,261,-0.044671,-0.0052884,0.054364,0.79437,GABRIELY_MIR21_TARGETS,0.99999
GOBP_RESPONSE_TO_COCAINE,SET,54,-0.10044,-0.0054394,0.12223,0.79439,GOBP_RESPONSE_TO_COCAINE,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...13,SET,256,-0.044005,-0.0051601,0.053543,0.79441,GAUTAM_EYE_IRIS_CILIARY_BODY_PUTATIVE_STEM_CELLS,0.99999
GOBP_REGULATION_OF_AMINO_ACI...1,SET,14,-0.20061,-0.0055379,0.24407,0.79444,GOBP_REGULATION_OF_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,0.99999
HP_TYPE_E_BRACHYDACTYLY,SET,5,-0.35773,-0.0059029,0.43517,0.79446,HP_TYPE_E_BRACHYDACTYLY,0.99999
MIR93_5P,SET,570,-0.030579,-0.005304,0.037196,0.79449,MIR93_5P,0.99999
GAUCHER_PBMC_YF_VAX_STAMARIL...11,SET,171,-0.054553,-0.0052405,0.066346,0.79453,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_DN,0.99999
GOBP_DOUBLE_STRAND_BREAK_REP...1,SET,272,-0.040386,-0.0048794,0.049114,0.79454,GOBP_DOUBLE_STRAND_BREAK_REPAIR,0.99999
HP_PITUITARY_ADENOMA,SET,51,-0.092885,-0.0048889,0.11296,0.79455,HP_PITUITARY_ADENOMA,0.99999
GOMF_7SK_SNRNA_BINDING,SET,9,-0.19327,-0.0042783,0.23496,0.79462,GOMF_7SK_SNRNA_BINDING,0.99999
GOBP_ESTABLISHMENT_OF_SERTOL...,SET,4,-0.28915,-0.0042676,0.35147,0.79465,GOBP_ESTABLISHMENT_OF_SERTOLI_CELL_BARRIER,0.99999
YATTNATC_UNKNOWN,SET,340,-0.040833,-0.0055052,0.049627,0.79468,YATTNATC_UNKNOWN,0.99999
WP_HYPOTHESIZED_PATHWAYS_IN_...,SET,23,-0.15538,-0.0054965,0.18881,0.79473,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,0.99999
MODULE_23,SET,517,-0.032245,-0.0053345,0.039168,0.79481,MODULE_23,0.99999
GOBP_POST_TRANSLATIONAL_PROT...2,SET,14,-0.17696,-0.0048849,0.21494,0.79482,GOBP_POST_TRANSLATIONAL_PROTEIN_TARGETING_TO_ENDOPLASMIC_RETICULUM_MEMBRANE,0.99999
WP_NOTCH_SIGNALING_WP268,SET,45,-0.10172,-0.0050298,0.12351,0.79489,WP_NOTCH_SIGNALING_WP268,0.99999
DESCARTES_MAIN_FETAL_SLC24A4...,SET,16,-0.20443,-0.0060325,0.24823,0.7949,DESCARTES_MAIN_FETAL_SLC24A4_PEX5L_POSITIVE_CELLS,0.99999
TESAR_ALK_TARGETS_HUMAN_ES_4...,SET,4,-0.35841,-0.0052899,0.43508,0.79496,TESAR_ALK_TARGETS_HUMAN_ES_4D_DN,0.99999
HP_DIFFICULTY_STANDING,SET,28,-0.13313,-0.0051952,0.16158,0.795,HP_DIFFICULTY_STANDING,0.99999
GOMF_GUANYLATE_KINASE_ACTIVI...,SET,7,-0.26957,-0.0052628,0.32714,0.79503,GOMF_GUANYLATE_KINASE_ACTIVITY,0.99999
GOCC_PHOTORECEPTOR_DISC_MEMB...,SET,18,-0.1626,-0.005089,0.19724,0.79513,GOCC_PHOTORECEPTOR_DISC_MEMBRANE,0.99999
GSE32034_LY6C_HIGH_VS_LOW_MO...2,SET,181,-0.054899,-0.0054242,0.066591,0.79514,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_UP,0.99999
ZHOU_TNF_SIGNALING_30MIN,SET,42,-0.10416,-0.0049764,0.12632,0.79518,ZHOU_TNF_SIGNALING_30MIN,0.99999
GSE21546_UNSTIM_VS_ANTI_CD3_...2,SET,163,-0.056643,-0.0053136,0.068696,0.79518,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.99999
MIR6795_5P,SET,120,-0.064232,-0.0051761,0.077894,0.7952,MIR6795_5P,0.99999
WP_BENZENE_METABOLISM,SET,5,-0.31817,-0.0052502,0.38575,0.79526,WP_BENZENE_METABOLISM,0.99999
BCAT_GDS748_DN,SET,40,-0.10925,-0.0050939,0.13237,0.79539,BCAT_GDS748_DN,0.99999
MIR4723_5P,SET,194,-0.049642,-0.0050761,0.060146,0.79541,MIR4723_5P,0.99999
GOCC_BLOOD_MICROPARTICLE,SET,97,-0.077557,-0.0056227,0.093967,0.79541,GOCC_BLOOD_MICROPARTICLE,0.99999
GOBP_RAC_PROTEIN_SIGNAL_TRAN...,SET,44,-0.10734,-0.0052488,0.13005,0.79542,GOBP_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
BIOCARTA_PLC_PATHWAY,SET,9,-0.23982,-0.0053087,0.29051,0.79546,BIOCARTA_PLC_PATHWAY,0.99999
GSE36476_YOUNG_VS_OLD_DONOR_...7,SET,166,-0.059663,-0.0056477,0.072263,0.79549,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN,0.99999
MIR4724_3P,SET,78,-0.076256,-0.00496,0.092358,0.7955,MIR4724_3P,0.99999
HP_CONNECTIVE_TISSUE_NEVI,SET,6,-0.31506,-0.0056949,0.38148,0.79556,HP_CONNECTIVE_TISSUE_NEVI,0.99999
GSE360_DC_VS_MAC_T_GONDII_UP,SET,182,-0.055877,-0.0055359,0.067651,0.79558,GSE360_DC_VS_MAC_T_GONDII_UP,0.99999
KEGG_CHEMOKINE_SIGNALING_PAT...,SET,176,-0.056632,-0.0055185,0.068559,0.7956,KEGG_CHEMOKINE_SIGNALING_PATHWAY,0.99999
GSE42021_CD24HI_VS_CD24INT_T...1,SET,187,-0.054022,-0.0054245,0.065393,0.79563,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN,0.99999
GSE17721_PAM3CSK4_VS_CPG_4H_...2,SET,177,-0.05091,-0.0049748,0.06161,0.79568,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP,0.99999
MIR4458,SET,318,-0.040715,-0.0053121,0.049264,0.79573,MIR4458,0.99999
HP_CSF_PLEOCYTOSIS,SET,23,-0.14241,-0.0050377,0.17231,0.79573,HP_CSF_PLEOCYTOSIS,0.99999
HARALAMBIEVA_PBMC_FLUARIX_AG...7,SET,1111,-0.022598,-0.0053885,0.027334,0.79581,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE,0.99999
VERRECCHIA_RESPONSE_TO_TGFB1...5,SET,20,-0.16423,-0.0054179,0.19861,0.79585,VERRECCHIA_RESPONSE_TO_TGFB1_C5,0.99999
GOBP_RESPONSE_TO_INSECTICIDE,SET,6,-0.32922,-0.0059509,0.39809,0.79588,GOBP_RESPONSE_TO_INSECTICIDE,0.99999
KEGG_MEDICUS_REFERENCE_NLRC4...,SET,4,-0.27647,-0.0040805,0.3342,0.79595,KEGG_MEDICUS_REFERENCE_NLRC4_INFLAMMASOME_SIGNALING_PATHWAY,0.99999
GOMF_PHOSPHOLIPID_BINDING,SET,444,-0.034296,-0.0052688,0.041456,0.79596,GOMF_PHOSPHOLIPID_BINDING,0.99999
HP_ABNORMALITY_OF_BLOOD_AND_...,SET,1317,-0.020266,-0.0052298,0.024497,0.79596,HP_ABNORMALITY_OF_BLOOD_AND_BLOOD_FORMING_TISSUES,0.99999
WP_HIPPOYAP_SIGNALING,SET,22,-0.15018,-0.0051956,0.18152,0.79597,WP_HIPPOYAP_SIGNALING,0.99999
KEGG_TAURINE_AND_HYPOTAURINE...,SET,10,-0.23784,-0.0055496,0.28746,0.79599,KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM,0.99999
REICHERT_MITOSIS_LIN9_TARGETS,SET,25,-0.12822,-0.0047285,0.15496,0.796,REICHERT_MITOSIS_LIN9_TARGETS,0.99999
GOBP_AMINO_ACID_BIOSYNTHETIC...,SET,71,-0.083757,-0.0051987,0.1012,0.79605,GOBP_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMAL_TONGUE_PHYSIOLOGY,SET,57,-0.093035,-0.005176,0.11241,0.79606,HP_ABNORMAL_TONGUE_PHYSIOLOGY,0.99999
GOBP_RESPONSE_TO_MINERALOCOR...,SET,36,-0.12545,-0.0055497,0.15152,0.79613,GOBP_RESPONSE_TO_MINERALOCORTICOID,0.99999
GOBP_DEFENSE_RESPONSE_TO_TUM...,SET,12,-0.21119,-0.0053976,0.25508,0.79614,GOBP_DEFENSE_RESPONSE_TO_TUMOR_CELL,0.99999
GOBP_POSITIVE_REGULATION_OF_...455,SET,2,-0.55784,-0.0058222,0.67377,0.79614,GOBP_POSITIVE_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.99999
MORI_MATURE_B_LYMPHOCYTE_UP,SET,79,-0.085261,-0.005581,0.10298,0.79615,MORI_MATURE_B_LYMPHOCYTE_UP,0.99999
MIR215_3P,SET,119,-0.06665,-0.0053487,0.080483,0.79619,MIR215_3P,0.99999
KEGG_MEDICUS_ENV_FACTOR_IRON...,SET,18,-0.18357,-0.0057454,0.22166,0.79621,KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.99999
BAE_BRCA1_TARGETS_DN,SET,29,-0.1359,-0.005397,0.16404,0.79628,BAE_BRCA1_TARGETS_DN,0.99999
REACTOME_ACTIVATION_OF_NMDA_...,SET,85,-0.081198,-0.0055123,0.098008,0.7963,REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,0.99999
GOBP_NUCLEAR_MIGRATION,SET,24,-0.14004,-0.0050602,0.16903,0.7963,GOBP_NUCLEAR_MIGRATION,0.99999
REACTOME_NOTCH2_INTRACELLULA...,SET,11,-0.23382,-0.0057218,0.28221,0.79631,REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.99999
WP_FTO_OBESITY_VARIANT_MECHA...,SET,8,-0.26922,-0.0056188,0.32493,0.79632,WP_FTO_OBESITY_VARIANT_MECHANISM,0.99999
GCM_RBM8A,SET,70,-0.081262,-0.0050084,0.098064,0.79635,GCM_RBM8A,0.99999
KOBAYASHI_EGFR_SIGNALING_24H...1,SET,240,-0.043761,-0.0049708,0.052803,0.79637,KOBAYASHI_EGFR_SIGNALING_24HR_DN,0.99999
DESCARTES_FETAL_EYE_CORNEAL_...,SET,222,-0.051609,-0.0056409,0.062274,0.79637,DESCARTES_FETAL_EYE_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS,0.99999
COLDREN_GEFITINIB_RESISTANCE...1,SET,205,-0.052214,-0.0054867,0.062994,0.7964,COLDREN_GEFITINIB_RESISTANCE_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...182,SET,120,-0.065731,-0.0052969,0.079302,0.79641,GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.99999
chr5q22,SET,26,-0.27235,-0.010242,0.32854,0.79643,chr5q22,0.99999
HP_RHIZOMELIC_ARM_SHORTENING,SET,9,-0.27127,-0.0060048,0.32724,0.79643,HP_RHIZOMELIC_ARM_SHORTENING,0.99999
GOBP_TOLL_LIKE_RECEPTOR_7_SI...,SET,8,-0.27468,-0.0057328,0.33134,0.79644,GOBP_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.99999
GSE19941_IL10_KO_VS_IL10_KO_...2,SET,177,-0.055458,-0.0054192,0.066896,0.79645,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP,0.99999
GOBP_RESPONSE_TO_X_RAY,SET,26,-0.12457,-0.0046848,0.15023,0.79651,GOBP_RESPONSE_TO_X_RAY,0.99999
GSE7509_DC_VS_MONOCYTE_WITH_...2,SET,181,-0.052965,-0.0052331,0.063861,0.79655,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP,0.99999
HP_DECREASED_CIRCULATING_IGA...,SET,70,-0.084484,-0.0052069,0.10186,0.79656,HP_DECREASED_CIRCULATING_IGA_LEVEL,0.99999
REACTOME_HSP90_CHAPERONE_CYC...,SET,53,-0.092745,-0.0049761,0.11178,0.79665,REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,0.99999
KEGG_MEDICUS_REFERENCE_TLR7_...1,SET,16,-0.21349,-0.0063001,0.25724,0.79671,KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY,0.99999
HP_REGIONAL_ABNORMALITY_OF_S...,SET,469,-0.033264,-0.0052484,0.040077,0.79673,HP_REGIONAL_ABNORMALITY_OF_SKIN,0.99999
GOCC_CDC73_PAF1_COMPLEX,SET,6,-0.30156,-0.0054508,0.36329,0.79674,GOCC_CDC73_PAF1_COMPLEX,0.99999
GSE15930_NAIVE_VS_48H_IN_VIT...4,SET,183,-0.052414,-0.0052069,0.063143,0.79675,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,0.99999
WP_SARSCOV2_AND_COVID19_PATH...,SET,8,-0.29242,-0.0061031,0.35224,0.79678,WP_SARSCOV2_AND_COVID19_PATHWAY,0.99999
GOBP_TRANS_SYNAPTIC_SIGNALIN...3,SET,7,-0.2966,-0.0057906,0.35719,0.79683,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_TRANS_SYNAPTIC_COMPLEX,0.99999
MODULE_447,SET,35,-0.1211,-0.0052827,0.14581,0.79688,MODULE_447,0.99999
GOBP_NEGATIVE_REGULATION_OF_...632,SET,23,-0.14904,-0.005272,0.17941,0.79693,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.99999
REACTOME_GLUCAGON_LIKE_PEPTI...,SET,42,-0.11479,-0.0054842,0.13816,0.79696,REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,0.99999
GRAHAM_NORMAL_QUIESCENT_VS_N...1,SET,84,-0.075083,-0.0050673,0.090355,0.797,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN,0.99999
IBRAHIM_NRF3_DOWN,SET,13,-0.17855,-0.0047498,0.21486,0.79701,IBRAHIM_NRF3_DOWN,0.99999
MIR4525,SET,32,-0.1237,-0.0051599,0.14884,0.79703,MIR4525,0.99999
GOBP_INDOLE_CONTAINING_COMPO...3,SET,22,-0.16804,-0.0058136,0.20218,0.79705,GOBP_INDOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
GOBP_PEPTIDYL_AMINO_ACID_MOD...,SET,762,-0.026289,-0.0052436,0.031622,0.7971,GOBP_PEPTIDYL_AMINO_ACID_MODIFICATION,0.99999
GOBP_PONS_DEVELOPMENT,SET,11,-0.21357,-0.0052262,0.25687,0.79713,GOBP_PONS_DEVELOPMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...566,SET,11,-0.23111,-0.0056556,0.2779,0.79718,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...1,SET,185,-0.051558,-0.0051496,0.061992,0.7972,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN,0.99999
SAGIV_CD24_TARGETS_DN,SET,43,-0.1102,-0.0053271,0.13249,0.79722,SAGIV_CD24_TARGETS_DN,0.99999
MIR6759_3P,SET,93,-0.076957,-0.0054635,0.092525,0.79722,MIR6759_3P,0.99999
MODULE_220,SET,309,-0.044613,-0.0057391,0.053637,0.79722,MODULE_220,0.99999
GSE2706_R848_VS_LPS_8H_STIM_...1,SET,158,-0.059766,-0.0055207,0.071847,0.79725,GSE2706_R848_VS_LPS_8H_STIM_DC_DN,0.99999
GSE25088_CTRL_VS_ROSIGLITAZO...4,SET,159,-0.056394,-0.0052255,0.067786,0.79728,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...11,SET,5,-0.35376,-0.0058374,0.42516,0.7973,GOBP_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_MDA_5_SIGNALING_PATHWAY,SET,10,-0.18443,-0.0043032,0.22159,0.79737,GOBP_MDA_5_SIGNALING_PATHWAY,0.99999
GSE36888_STAT5_AB_KNOCKIN_VS...5,SET,181,-0.051715,-0.0051096,0.062137,0.79737,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_DN,0.99999
GSE23308_WT_VS_MINERALCORTIC...4,SET,187,-0.049574,-0.0049778,0.059556,0.7974,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP,0.99999
GSE21379_WT_VS_SAP_KO_CD4_TC...2,SET,185,-0.052339,-0.0052276,0.062876,0.79741,GSE21379_WT_VS_SAP_KO_CD4_TCELL_UP,0.99999
GSE37416_12H_VS_24H_F_TULARE...2,SET,181,-0.053347,-0.0052709,0.064085,0.79742,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
CTATGCA_MIR153,SET,203,-0.05188,-0.0054253,0.062312,0.79745,CTATGCA_MIR153,0.99999
GOBP_NEGATIVE_REGULATION_OF_...89,SET,9,-0.2541,-0.0056248,0.30513,0.7975,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.99999
chr15q13,SET,18,-0.22853,-0.0071523,0.27441,0.79751,chr15q13,0.99999
GSE42021_TREG_PLN_VS_CD24HI_...2,SET,184,-0.054893,-0.005468,0.065915,0.79751,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_UP,0.99999
GSE7509_DC_VS_MONOCYTE_UP,SET,181,-0.052386,-0.005176,0.062905,0.79751,GSE7509_DC_VS_MONOCYTE_UP,0.99999
PID_CONE_PATHWAY,SET,20,-0.16281,-0.005371,0.1955,0.79752,PID_CONE_PATHWAY,0.99999
CRGAARNNNNCGA_UNKNOWN,SET,39,-0.11353,-0.0052274,0.13632,0.79753,CRGAARNNNNCGA_UNKNOWN,0.99999
BENPORATH_SUZ12_TARGETS,SET,874,-0.027731,-0.005905,0.033294,0.79755,BENPORATH_SUZ12_TARGETS,0.99999
GOBP_REGULATION_OF_RESPIRATO...4,SET,11,-0.23419,-0.0057309,0.28115,0.79756,GOBP_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE_BY_NERVOUS_SYSTEM_PROCESS,0.99999
WP_RENINANGIOTENSINALDOSTERO...,SET,43,-0.11132,-0.0053813,0.13364,0.79758,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,0.99999
HP_NON_MIDLINE_CLEFT_OF_THE_...,SET,34,-0.11896,-0.0051147,0.14277,0.79763,HP_NON_MIDLINE_CLEFT_OF_THE_UPPER_LIP,0.99999
GSE17721_0.5H_VS_24H_GARDIQU...1,SET,184,-0.049673,-0.004948,0.059617,0.79763,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_DN,0.99999
TGCCTTA_MIR124A,SET,511,-0.032122,-0.0052842,0.038549,0.79766,TGCCTTA_MIR124A,0.99999
YAP1_DN,SET,37,-0.12064,-0.0054106,0.14476,0.79768,YAP1_DN,0.99999
GTGCCAT_MIR183,SET,159,-0.058643,-0.0054339,0.070364,0.79769,GTGCCAT_MIR183,0.99999
MAHADEVAN_IMATINIB_RESISTANC...2,SET,17,-0.20159,-0.0061317,0.2418,0.79777,MAHADEVAN_IMATINIB_RESISTANCE_UP,0.99999
GOBP_LUTEINIZATION,SET,11,-0.23618,-0.0057796,0.28329,0.79777,GOBP_LUTEINIZATION,0.99999
GOBP_FOREBRAIN_VENTRICULAR_Z...,SET,5,-0.26662,-0.0043996,0.31977,0.79779,GOBP_FOREBRAIN_VENTRICULAR_ZONE_PROGENITOR_CELL_DIVISION,0.99999
HP_ABNORMAL_ANTIHELIX_MORPHO...,SET,36,-0.11624,-0.0051423,0.1394,0.79781,HP_ABNORMAL_ANTIHELIX_MORPHOLOGY,0.99999
MIR6752_3P,SET,131,-0.060567,-0.005098,0.072625,0.79784,MIR6752_3P,0.99999
MURARO_PANCREAS_ACINAR_CELL,SET,659,-0.029506,-0.0054891,0.035381,0.79784,MURARO_PANCREAS_ACINAR_CELL,0.99999
HP_CONGENITAL_NONBULLOUS_ICH...,SET,20,-0.1611,-0.0053146,0.19317,0.79785,HP_CONGENITAL_NONBULLOUS_ICHTHYOSIFORM_ERYTHRODERMA,0.99999
HP_FRAGMENTED_EPIPHYSES,SET,5,-0.36963,-0.0060993,0.44321,0.79785,HP_FRAGMENTED_EPIPHYSES,0.99999
REACTOME_REGULATION_OF_ENDOG...3,SET,37,-0.11638,-0.0052195,0.13954,0.79786,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS,0.99999
MIR342_5P,SET,57,-0.09229,-0.0051346,0.11064,0.79791,MIR342_5P,0.99999
HP_FOCAL_NON_MOTOR_SEIZURE,SET,37,-0.11705,-0.0052497,0.14031,0.79793,HP_FOCAL_NON_MOTOR_SEIZURE,0.99999
HP_LACRIMATION_ABNORMALITY,SET,76,-0.084979,-0.0054564,0.10186,0.79793,HP_LACRIMATION_ABNORMALITY,0.99999
GOBP_REGULATION_OF_MELANOCYT...,SET,6,-0.34853,-0.0062999,0.41764,0.798,GOBP_REGULATION_OF_MELANOCYTE_DIFFERENTIATION,0.99999
GOBP_CELLULAR_RESPONSE_TO_CG...,SET,7,-0.26126,-0.0051006,0.31299,0.79806,GOBP_CELLULAR_RESPONSE_TO_CGMP,0.99999
MAZR_01,SET,204,-0.047274,-0.0049556,0.056627,0.79809,MAZR_01,0.99999
GOBP_POSITIVE_REGULATION_OF_...227,SET,80,-0.079302,-0.0052236,0.094992,0.79809,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR,0.99999
HP_ABNORMALITY_OF_THE_PARATH...,SET,68,-0.089786,-0.0054543,0.10751,0.79817,HP_ABNORMALITY_OF_THE_PARATHYROID_GLAND,0.99999
GOBP_N_ACETYLGLUCOSAMINE_MET...,SET,14,-0.20297,-0.005603,0.24298,0.79823,GOBP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS,0.99999
BIOCARTA_PPARA_PATHWAY,SET,52,-0.10403,-0.0055286,0.12453,0.79824,BIOCARTA_PPARA_PATHWAY,0.99999
GSE11386_NAIVE_VS_MEMORY_BCE...2,SET,159,-0.053915,-0.0049959,0.064531,0.79827,GSE11386_NAIVE_VS_MEMORY_BCELL_UP,0.99999
GTF2E2_TARGET_GENES,SET,263,-0.044405,-0.0052767,0.053146,0.79828,GTF2E2_TARGET_GENES,0.99999
GOBP_RESPONSE_TO_STEROL_DEPL...,SET,15,-0.18314,-0.0052328,0.21915,0.79833,GOBP_RESPONSE_TO_STEROL_DEPLETION,0.99999
HP_GLUCOCORTOCOID_INSENSITIV...,SET,5,-0.35509,-0.0058594,0.42491,0.79833,HP_GLUCOCORTOCOID_INSENSITIVE_PRIMARY_HYPERALDOSTERONISM,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...1,SET,41,-0.10777,-0.0050876,0.12895,0.79835,GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1,0.99999
GOCC_CYTOPLASMIC_DYNEIN_COMP...,SET,16,-0.16639,-0.0049101,0.19909,0.79835,GOCC_CYTOPLASMIC_DYNEIN_COMPLEX,0.99999
HP_ANEMIC_PALLOR,SET,14,-0.18732,-0.005171,0.22413,0.79836,HP_ANEMIC_PALLOR,0.99999
REACTOME_INTERFERON_SIGNALING,SET,246,-0.046788,-0.0053797,0.055975,0.79838,REACTOME_INTERFERON_SIGNALING,0.99999
SMID_BREAST_CANCER_ERBB2_DN,SET,5,-0.32719,-0.0053989,0.39141,0.7984,SMID_BREAST_CANCER_ERBB2_DN,0.99999
IIZUKA_LIVER_CANCER_PROGRESS...6,SET,13,-0.20416,-0.005431,0.24418,0.79845,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP,0.99999
HP_DEPRESSED_NASAL_RIDGE,SET,112,-0.06908,-0.0053792,0.082617,0.79846,HP_DEPRESSED_NASAL_RIDGE,0.99999
MIR4649_5P,SET,8,-0.24215,-0.0050538,0.28959,0.79847,MIR4649_5P,0.99999
HP_UNDETECTABLE_LIGHT_ADAPTE...,SET,6,-0.33706,-0.0060925,0.40305,0.79849,HP_UNDETECTABLE_LIGHT_ADAPTED_ELECTRORETINOGRAM,0.99999
BENPORATH_ES_CORE_NINE,SET,8,-0.24554,-0.0051246,0.29359,0.79851,BENPORATH_ES_CORE_NINE,0.99999
GOBP_ANATOMICAL_STRUCTURE_FO...,SET,1096,-0.022988,-0.0054467,0.027487,0.79851,GOBP_ANATOMICAL_STRUCTURE_FORMATION_INVOLVED_IN_MORPHOGENESIS,0.99999
DESCARTES_FETAL_STOMACH_VASC...,SET,28,-0.15236,-0.0059458,0.18216,0.79853,DESCARTES_FETAL_STOMACH_VASCULAR_ENDOTHELIAL_CELLS,0.99999
REACTOME_HYALURONAN_BIOSYNTH...,SET,5,-0.34462,-0.0056865,0.41194,0.79858,REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT,0.99999
HP_PALMAR_HYPERLINEARITY,SET,6,-0.29594,-0.0053493,0.35365,0.79865,HP_PALMAR_HYPERLINEARITY,0.99999
HP_MICROGRAPHIA,SET,13,-0.20366,-0.0054176,0.24336,0.79866,HP_MICROGRAPHIA,0.99999
PID_INTEGRIN2_PATHWAY,SET,26,-0.16273,-0.0061199,0.19444,0.79868,PID_INTEGRIN2_PATHWAY,0.99999
MIR569,SET,69,-0.088641,-0.0054241,0.10589,0.79872,MIR569,0.99999
GOBP_ERBB2_EGFR_SIGNALING_PA...,SET,8,-0.2811,-0.0058669,0.33575,0.79877,GOBP_ERBB2_EGFR_SIGNALING_PATHWAY,0.99999
DELASERNA_MYOD_TARGETS_DN,SET,49,-0.11064,-0.0057086,0.13213,0.7988,DELASERNA_MYOD_TARGETS_DN,0.99999
GSE2770_UNTREATED_VS_TGFB_AN...6,SET,174,-0.050138,-0.0048581,0.059874,0.79881,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.99999
WP_GLIAL_CELL_DIFFERENTIATION,SET,5,-0.31121,-0.0051353,0.37163,0.79882,WP_GLIAL_CELL_DIFFERENTIATION,0.99999
MORF_FDXR,SET,210,-0.047735,-0.0050762,0.056997,0.79884,MORF_FDXR,0.99999
GOBP_POSITIVE_REGULATION_OF_...437,SET,6,-0.32647,-0.0059012,0.38981,0.79884,GOBP_POSITIVE_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,0.99999
GSE29618_BCELL_VS_MDC_UP,SET,160,-0.060289,-0.0056038,0.071975,0.79888,GSE29618_BCELL_VS_MDC_UP,0.99999
GSE37319_WT_VS_RC3H1_KO_CD44...2,SET,130,-0.0645,-0.0054085,0.076998,0.79889,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP,0.99999
GOBP_LACRIMAL_GLAND_DEVELOPM...,SET,7,-0.28921,-0.0056463,0.34524,0.7989,GOBP_LACRIMAL_GLAND_DEVELOPMENT,0.99999
HP_UPPER_AIRWAY_OBSTRUCTION,SET,15,-0.20249,-0.0057858,0.24171,0.79891,HP_UPPER_AIRWAY_OBSTRUCTION,0.99999
KEGG_MEDICUS_REFERENCE_PDGF_...2,SET,17,-0.18725,-0.0056954,0.2235,0.79892,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY,0.99999
WP_T_CELL_RECEPTOR_AND_COSTI...,SET,27,-0.14443,-0.0055349,0.17235,0.79898,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,0.99999
GOBP_CELLULAR_RESPONSE_TO_PR...1,SET,6,-0.27092,-0.004897,0.32326,0.799,GOBP_CELLULAR_RESPONSE_TO_PROGESTERONE_STIMULUS,0.99999
GOBP_POST_TRANSLATIONAL_PROT...1,SET,870,-0.024102,-0.005121,0.028757,0.79901,GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.99999
GSE2770_IL12_AND_TGFB_VS_IL4...5,SET,175,-0.058477,-0.0056822,0.069768,0.79902,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...600,SET,15,-0.17865,-0.0051046,0.21313,0.79904,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.99999
MIR2116_3P,SET,68,-0.088326,-0.0053657,0.10535,0.79908,MIR2116_3P,0.99999
GSE27786_LSK_VS_NKCELL_DN,SET,182,-0.053324,-0.005283,0.063595,0.79912,GSE27786_LSK_VS_NKCELL_DN,0.99999
HP_ABNORMAL_OVARIAN_PHYSIOLO...,SET,87,-0.073689,-0.0050608,0.087875,0.79914,HP_ABNORMAL_OVARIAN_PHYSIOLOGY,0.99999
UNTERMAN_IPF_VS_CTRL_CD8T_UP,SET,2,-0.4996,-0.0052143,0.59575,0.79915,UNTERMAN_IPF_VS_CTRL_CD8T_UP,0.99999
MIR9983_3P,SET,423,-0.036158,-0.005425,0.043115,0.79916,MIR9983_3P,0.99999
VANHARANTA_UTERINE_FIBROID_W...2,SET,57,-0.0927,-0.0051574,0.1105,0.79923,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,0.99999
HP_SEVERE_GLOBAL_DEVELOPMENT...,SET,197,-0.049582,-0.0051086,0.059105,0.79923,HP_SEVERE_GLOBAL_DEVELOPMENTAL_DELAY,0.99999
HP_FOOT_DORSIFLEXOR_WEAKNESS,SET,128,-0.062213,-0.0051767,0.074156,0.79925,HP_FOOT_DORSIFLEXOR_WEAKNESS,0.99999
DESCARTES_FETAL_THYMUS_THYMO...,SET,19,-0.17351,-0.005579,0.2068,0.79927,DESCARTES_FETAL_THYMUS_THYMOCYTES,0.99999
REACTOME_CARGO_TRAFFICKING_T...,SET,49,-0.097749,-0.0050434,0.1165,0.79928,REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE,0.99999
MIR4736,SET,100,-0.070448,-0.0051852,0.083947,0.79931,MIR4736,0.99999
HUMMERICH_BENIGN_SKIN_TUMOR_...1,SET,19,-0.1746,-0.0056142,0.20804,0.79933,HUMMERICH_BENIGN_SKIN_TUMOR_DN,0.99999
NICK_RESPONSE_TO_PROC_TREATM...1,SET,23,-0.13969,-0.0049414,0.16642,0.79936,NICK_RESPONSE_TO_PROC_TREATMENT_DN,0.99999
MIR3909,SET,68,-0.089128,-0.0054144,0.10618,0.79937,MIR3909,0.99999
REACTOME_DEFECTIVE_ST3GAL3_C...,SET,8,-0.24584,-0.0051309,0.29279,0.79945,REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15,0.99999
HP_ABNORMALITY_OF_URINE_CALC...,SET,63,-0.097729,-0.0057153,0.11636,0.79951,HP_ABNORMALITY_OF_URINE_CALCIUM_CONCENTRATION,0.99999
HP_MELENA,SET,21,-0.16087,-0.0054377,0.19152,0.79953,HP_MELENA,0.99999
KEGG_MEDICUS_REFERENCE_IGG_F...,SET,9,-0.25485,-0.0056414,0.30338,0.79955,KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...693,SET,10,-0.21044,-0.0049101,0.25047,0.79958,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE22443_NAIVE_VS_ACT_AND_IL...2,SET,186,-0.052693,-0.0052769,0.062719,0.79958,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_UP,0.99999
HP_MYALGIA,SET,157,-0.057275,-0.005274,0.068152,0.79965,HP_MYALGIA,0.99999
GOBP_FEMALE_GENITALIA_DEVELO...,SET,19,-0.17983,-0.0057825,0.21398,0.79966,GOBP_FEMALE_GENITALIA_DEVELOPMENT,0.99999
HP_UVEAL_ECTROPION,SET,7,-0.29039,-0.0056694,0.34551,0.79967,HP_UVEAL_ECTROPION,0.99999
REACTOME_TP53_REGULATES_TRAN...2,SET,12,-0.17751,-0.0045369,0.21119,0.79968,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES,0.99999
GSE5463_CTRL_VS_DEXAMETHASON...2,SET,187,-0.052593,-0.0052809,0.062568,0.7997,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP,0.99999
GOBP_GENERATION_OF_PRECURSOR...,SET,393,-0.034934,-0.0050563,0.041556,0.79972,GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,0.99999
HP_ABNORMAL_DRINKING_BEHAVIOR,SET,50,-0.10777,-0.0056168,0.12819,0.79974,HP_ABNORMAL_DRINKING_BEHAVIOR,0.99999
REACTOME_ADVANCED_GLYCOSYLAT...,SET,13,-0.1912,-0.0050862,0.2274,0.79976,REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING,0.99999
HP_ABNORMAL_ST_SEGMENT,SET,38,-0.12259,-0.0055717,0.14579,0.79978,HP_ABNORMAL_ST_SEGMENT,0.99999
MAZ_Q6,SET,179,-0.05381,-0.0052875,0.06399,0.7998,MAZ_Q6,0.99999
HP_NECK_MUSCLE_WEAKNESS,SET,84,-0.077224,-0.0052118,0.0918,0.79988,HP_NECK_MUSCLE_WEAKNESS,0.99999
HP_DEFICIT_IN_PHONOLOGIC_SHO...,SET,5,-0.37741,-0.0062276,0.44861,0.7999,HP_DEFICIT_IN_PHONOLOGIC_SHORT_TERM_MEMORY,0.99999
REACTOME_PLASMA_LIPOPROTEIN_...2,SET,67,-0.089925,-0.0054226,0.10686,0.79997,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,0.99999
GOMF_STEROL_ESTERASE_ACTIVITY,SET,7,-0.28685,-0.0056002,0.34086,0.79997,GOMF_STEROL_ESTERASE_ACTIVITY,0.99999
GOBP_MICROTUBULE_BASED_MOVEM...,SET,367,-0.036815,-0.0051531,0.043746,0.79998,GOBP_MICROTUBULE_BASED_MOVEMENT,0.99999
GOBP_RETINA_VASCULATURE_DEVE...,SET,18,-0.16985,-0.0053159,0.20182,0.79998,GOBP_RETINA_VASCULATURE_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.99999
BURTON_ADIPOGENESIS_8,SET,70,-0.090018,-0.005548,0.10693,0.80006,BURTON_ADIPOGENESIS_8,0.99999
BUSSLINGER_ESOPHAGEAL_PROLIF...,SET,67,-0.090214,-0.0054401,0.10716,0.80006,BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS,0.99999
RECHTIEN_PBMC_RVSV_ZEBOV_AGE...,SET,10,-0.25076,-0.005851,0.29782,0.80009,RECHTIEN_PBMC_RVSV_ZEBOV_AGE_18_55YO_1DY_UP,0.99999
GOMF_4_IRON_4_SULFUR_CLUSTER...,SET,44,-0.10459,-0.0051142,0.12418,0.80017,GOMF_4_IRON_4_SULFUR_CLUSTER_BINDING,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...2,SET,24,-0.14682,-0.005305,0.17428,0.80021,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.99999
HP_SPASTIC_TETRAPARESIS,SET,59,-0.092607,-0.0052415,0.10993,0.80021,HP_SPASTIC_TETRAPARESIS,0.99999
GOBP_DEOXYRIBONUCLEOTIDE_BIO...,SET,14,-0.18568,-0.0051257,0.22037,0.80027,GOBP_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
BUSSLINGER_DUODENAL_TRANSIT_...,SET,162,-0.055712,-0.0052104,0.066118,0.80027,BUSSLINGER_DUODENAL_TRANSIT_AMPLIFYING_CELLS,0.99999
HP_RETINAL_PIGMENT_EPITHELIA...1,SET,36,-0.11599,-0.0051314,0.13765,0.80029,HP_RETINAL_PIGMENT_EPITHELIAL_ATROPHY,0.99999
HP_ABNORMAL_ARACHNOID_MATER_...,SET,48,-0.098119,-0.0050106,0.11643,0.8003,HP_ABNORMAL_ARACHNOID_MATER_MORPHOLOGY,0.99999
GOCC_KERATIN_FILAMENT,SET,81,-0.11274,-0.0074723,0.13378,0.80031,GOCC_KERATIN_FILAMENT,0.99999
ALONSO_METASTASIS_NEURAL_UP,SET,15,-0.20221,-0.0057777,0.23993,0.80032,ALONSO_METASTASIS_NEURAL_UP,0.99999
ICHIBA_GRAFT_VERSUS_HOST_DIS...4,SET,108,-0.072128,-0.005516,0.085562,0.80038,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,0.99999
GOBP_REGULATION_OF_BILE_ACID...2,SET,14,-0.21494,-0.0059334,0.25497,0.80038,GOBP_REGULATION_OF_BILE_ACID_METABOLIC_PROCESS,0.99999
CONCANNON_APOPTOSIS_BY_EPOXO...1,SET,146,-0.062038,-0.0055105,0.073588,0.80039,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,0.99999
HP_CONE_SHAPED_EPIPHYSIS,SET,72,-0.081616,-0.0051013,0.0968,0.80042,HP_CONE_SHAPED_EPIPHYSIS,0.99999
BALLIF_DEVELOPMENTAL_DISABIL...,SET,13,-0.20403,-0.0054274,0.24191,0.80049,BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION,0.99999
GOBP_FATTY_ACID_OMEGA_OXIDAT...,SET,5,-0.3905,-0.0064437,0.463,0.8005,GOBP_FATTY_ACID_OMEGA_OXIDATION,0.99999
MIR4719,SET,456,-0.034905,-0.0054324,0.041383,0.80051,MIR4719,0.99999
REACTOME_SIGNALING_BY_PTK6,SET,53,-0.10406,-0.0055834,0.12336,0.80054,REACTOME_SIGNALING_BY_PTK6,0.99999
RAO_BOUND_BY_SALL4_ISOFORM_B,SET,463,-0.034679,-0.0054375,0.041104,0.80058,RAO_BOUND_BY_SALL4_ISOFORM_B,0.99999
GSE32901_NAIVE_VS_TH17_ENRIC...1,SET,154,-0.058058,-0.0052952,0.068814,0.80058,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...60,SET,20,-0.16356,-0.0053958,0.19385,0.80059,HP_APLASIA_HYPOPLASIA_OF_THE_PUBIC_BONE,0.99999
HP_HYPOKALEMIC_METABOLIC_ALK...,SET,9,-0.25272,-0.0055941,0.29942,0.80067,HP_HYPOKALEMIC_METABOLIC_ALKALOSIS,0.99999
HP_CLEFT_LIP,SET,175,-0.053866,-0.0052341,0.063812,0.8007,HP_CLEFT_LIP,0.99999
GOMF_CD4_RECEPTOR_BINDING,SET,7,-0.2929,-0.0057184,0.34688,0.80077,GOMF_CD4_RECEPTOR_BINDING,0.99999
HOLLERN_PAPILLARY_BREAST_TUM...,SET,15,-0.19878,-0.0056798,0.2354,0.80079,HOLLERN_PAPILLARY_BREAST_TUMOR,0.99999
GOBP_REGULATION_OF_MRNA_EXPO...,SET,8,-0.21576,-0.0045031,0.2555,0.80079,GOBP_REGULATION_OF_MRNA_EXPORT_FROM_NUCLEUS,0.99999
GOBP_POSITIVE_REGULATION_OF_...333,SET,184,-0.055547,-0.0055331,0.065774,0.8008,GOBP_POSITIVE_REGULATION_OF_HEMOPOIESIS,0.99999
GSE17721_CTRL_VS_POLYIC_24H_...2,SET,177,-0.051782,-0.00506,0.061306,0.80084,GSE17721_CTRL_VS_POLYIC_24H_BMDC_UP,0.99999
GOBP_ALPHA_BETA_T_CELL_ACTIV...,SET,166,-0.061064,-0.0057804,0.072293,0.80085,GOBP_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
BURTON_ADIPOGENESIS_2,SET,70,-0.086578,-0.005336,0.10249,0.80088,BURTON_ADIPOGENESIS_2,0.99999
GSE369_SOCS3_KO_VS_WT_LIVER_...4,SET,178,-0.051733,-0.0050693,0.061236,0.80088,GSE369_SOCS3_KO_VS_WT_LIVER_UP,0.99999
GCM_IL6ST,SET,52,-0.098826,-0.0052522,0.11697,0.8009,GCM_IL6ST,0.99999
REACTOME_MET_ACTIVATES_PI3K_...,SET,6,-0.31672,-0.005725,0.37473,0.80099,REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING,0.99999
MIR5704,SET,47,-0.10672,-0.0053931,0.12626,0.80102,MIR5704,0.99999
REACTOME_TRANSCRIPTIONAL_REG...13,SET,28,-0.15316,-0.0059769,0.18117,0.80105,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,0.99999
KLF14_TARGET_GENES,SET,203,-0.051385,-0.0053735,0.060767,0.80111,KLF14_TARGET_GENES,0.99999
GROSS_HYPOXIA_VIA_HIF1A_UP,SET,75,-0.081138,-0.0051755,0.095947,0.80112,GROSS_HYPOXIA_VIA_HIF1A_UP,0.99999
KEGG_MEDICUS_REFERENCE_FGF_F...1,SET,30,-0.14549,-0.0058764,0.17201,0.80116,KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY,0.99999
GOMF_NATURAL_KILLER_CELL_LEC...,SET,8,-0.31136,-0.0064983,0.36813,0.80116,GOMF_NATURAL_KILLER_CELL_LECTIN_LIKE_RECEPTOR_BINDING,0.99999
GOBP_CHOLINE_TRANSPORT,SET,9,-0.25435,-0.0056303,0.3007,0.80117,GOBP_CHOLINE_TRANSPORT,0.99999
HP_MULTINODULAR_GOITER,SET,5,-0.34162,-0.0056372,0.40386,0.80119,HP_MULTINODULAR_GOITER,0.99999
HP_HAIR_FOLLICLE_NEOPLASM,SET,5,-0.39773,-0.006563,0.47016,0.8012,HP_HAIR_FOLLICLE_NEOPLASM,0.99999
LET_7F_1_3P,SET,663,-0.02909,-0.0054276,0.034386,0.80122,LET_7F_1_3P,0.99999
GOBP_REGULATION_OF_ENDOSOME_...3,SET,3,-0.34746,-0.0044414,0.41071,0.80122,GOBP_REGULATION_OF_ENDOSOME_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.99999
GSE17301_ACD3_ACD28_VS_ACD3_...2,SET,170,-0.053961,-0.0051686,0.063775,0.80125,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP,0.99999
GSE14308_TH2_VS_TH1_DN,SET,181,-0.052802,-0.005217,0.062381,0.80134,GSE14308_TH2_VS_TH1_DN,0.99999
chr14q12,SET,52,-0.19804,-0.010525,0.23395,0.80136,chr14q12,0.99999
HP_INCREASED_URINARY_PORPHOB...,SET,5,-0.33214,-0.0054807,0.3923,0.8014,HP_INCREASED_URINARY_PORPHOBILINOGEN,0.99999
GSE3691_CONVENTIONAL_VS_PLAS...1,SET,182,-0.053821,-0.0053323,0.06355,0.80147,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_DN,0.99999
MIR3665,SET,73,-0.084024,-0.005288,0.099199,0.8015,MIR3665,0.99999
GSE36826_NORMAL_VS_STAPH_AUR...2,SET,187,-0.05382,-0.0054042,0.063541,0.8015,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_UP,0.99999
GSE3982_BASOPHIL_VS_CENT_MEM...1,SET,172,-0.054577,-0.0052579,0.064426,0.80153,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.99999
GOBP_REGULATION_OF_PINOCYTOS...,SET,12,-0.18459,-0.0047179,0.21785,0.80158,GOBP_REGULATION_OF_PINOCYTOSIS,0.99999
PARK_APL_PATHOGENESIS_DN,SET,47,-0.11046,-0.0055818,0.13035,0.8016,PARK_APL_PATHOGENESIS_DN,0.99999
GOBP_CYCLIC_NUCLEOTIDE_BIOSY...,SET,17,-0.1869,-0.0056847,0.22056,0.8016,GOBP_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
HP_DELAYED_MENARCHE,SET,23,-0.14213,-0.0050277,0.16769,0.80166,HP_DELAYED_MENARCHE,0.99999
HP_NEUROFIBRILLARY_TANGLES,SET,21,-0.17284,-0.0058425,0.20389,0.8017,HP_NEUROFIBRILLARY_TANGLES,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...5,SET,185,-0.056488,-0.005642,0.066633,0.80171,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN,0.99999
PAX8_TARGET_GENES,SET,65,-0.08498,-0.0050477,0.10024,0.80172,PAX8_TARGET_GENES,0.99999
MOROSETTI_FACIOSCAPULOHUMERA...2,SET,19,-0.16739,-0.0053824,0.19744,0.80173,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP,0.99999
GOBP_NEURAL_CREST_CELL_DIFFE...,SET,87,-0.085061,-0.0058418,0.10032,0.80175,GOBP_NEURAL_CREST_CELL_DIFFERENTIATION,0.99999
PAX4_02,SET,217,-0.051558,-0.0055722,0.060803,0.80176,PAX4_02,0.99999
GSE360_DC_VS_MAC_L_MAJOR_UP,SET,172,-0.055974,-0.0053926,0.066004,0.80179,GSE360_DC_VS_MAC_L_MAJOR_UP,0.99999
HP_COMMUNICATING_HYDROCEPHAL...,SET,21,-0.15264,-0.0051595,0.17989,0.80191,HP_COMMUNICATING_HYDROCEPHALUS,0.99999
CASP8AP2_TARGET_GENES,SET,262,-0.043918,-0.0052091,0.051745,0.80198,CASP8AP2_TARGET_GENES,0.99999
MOTAMED_RESPONSE_TO_ANDROGEN...1,SET,6,-0.29469,-0.0053266,0.34713,0.80203,MOTAMED_RESPONSE_TO_ANDROGEN_DN,0.99999
GOMF_PROTEIN_SERINE_THREONIN...5,SET,90,-0.070724,-0.0049398,0.083311,0.80203,GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.99999
FRANCO_BLOOD_SANOFI_PASTEUR_...6,SET,119,-0.068825,-0.0055233,0.081059,0.80207,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE,0.99999
MATZUK_SPERMATOZOA,SET,105,-0.071504,-0.0053922,0.084212,0.80208,MATZUK_SPERMATOZOA,0.99999
MODULE_560,SET,10,-0.19969,-0.0046594,0.23519,0.80208,MODULE_560,0.99999
GOMF_EPHRIN_RECEPTOR_ACTIVITY,SET,18,-0.1937,-0.0060623,0.22809,0.80212,GOMF_EPHRIN_RECEPTOR_ACTIVITY,0.99999
REACTOME_BINDING_OF_TCF_LEF_...,SET,8,-0.26909,-0.0056161,0.31677,0.80218,REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...512,SET,9,-0.24714,-0.0054707,0.29094,0.80218,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,0.99999
REACTOME_MITOCHONDRIAL_PROTE...1,SET,78,-0.07446,-0.0048432,0.087654,0.80219,REACTOME_MITOCHONDRIAL_PROTEIN_DEGRADATION,0.99999
GSE37605_TREG_VS_TCONV_C57BL...4,SET,114,-0.069034,-0.0054232,0.081265,0.80219,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP,0.99999
GOMF_INTRAMEMBRANE_LIPID_TRA...,SET,41,-0.12137,-0.0057293,0.14287,0.8022,GOMF_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY,0.99999
GSE26488_WT_VS_HDAC7_KO_DOUB...1,SET,157,-0.057967,-0.0053377,0.06821,0.80228,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,0.99999
HP_DECREASED_CIRCULATING_VIT...1,SET,8,-0.30253,-0.006314,0.35597,0.80229,HP_DECREASED_CIRCULATING_VITAMIN_B12_CONCENTRATION,0.99999
REACTOME_DISEASES_OF_HEMOSTA...,SET,17,-0.19282,-0.0058649,0.22683,0.80235,REACTOME_DISEASES_OF_HEMOSTASIS,0.99999
HP_THICK_UPPER_LIP_VERMILION,SET,20,-0.17057,-0.005627,0.20063,0.80239,HP_THICK_UPPER_LIP_VERMILION,0.99999
GOMF_RIBOSOMAL_SMALL_SUBUNIT...,SET,15,-0.17438,-0.0049824,0.20509,0.8024,GOMF_RIBOSOMAL_SMALL_SUBUNIT_BINDING,0.99999
GSE6259_DEC205_POS_DC_VS_CD8...1,SET,140,-0.061662,-0.0053642,0.072522,0.8024,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN,0.99999
GOBP_EPHRIN_RECEPTOR_SIGNALI...,SET,48,-0.1094,-0.0055868,0.12866,0.80243,GOBP_EPHRIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_SEGMENTATION,SET,93,-0.079556,-0.0056481,0.093553,0.80244,GOBP_SEGMENTATION,0.99999
GOBP_PURINE_NUCLEOBASE_BIOSY...,SET,8,-0.23842,-0.0049759,0.28033,0.80247,GOBP_PURINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,0.99999
OSMAN_BLOOD_CHAD63_KH_AGE_18...1,SET,1467,-0.019926,-0.0054031,0.023426,0.8025,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN,0.99999
GNF2_CDC27,SET,56,-0.097997,-0.0054042,0.1152,0.80251,GNF2_CDC27,0.99999
GSE35825_UNTREATED_VS_IFNA_S...1,SET,159,-0.060214,-0.0055795,0.070777,0.80254,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_DN,0.99999
MIR591,SET,44,-0.11522,-0.0056341,0.13542,0.80256,MIR591,0.99999
GOBP_MONOCARBOXYLIC_ACID_TRA...,SET,172,-0.058573,-0.0056429,0.068842,0.80256,GOBP_MONOCARBOXYLIC_ACID_TRANSPORT,0.99999
HP_BRADYPHRENIA,SET,5,-0.29695,-0.0049,0.34893,0.80261,HP_BRADYPHRENIA,0.99999
WP_MOLYBDENUM_COFACTOR_MOCO_...,SET,6,-0.31764,-0.0057415,0.37324,0.80262,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,0.99999
HP_ABNORMAL_PALM_MORPHOLOGY,SET,445,-0.035043,-0.0053894,0.041177,0.80262,HP_ABNORMAL_PALM_MORPHOLOGY,0.99999
ID1_TARGET_GENES,SET,1008,-0.023453,-0.0053425,0.027557,0.80263,ID1_TARGET_GENES,0.99999
MIR3529_5P,SET,32,-0.1326,-0.0055315,0.15578,0.80267,MIR3529_5P,0.99999
GSE32034_LY6C_HIGH_VS_LOW_RO...2,SET,183,-0.052527,-0.0052182,0.061707,0.80267,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_UP,0.99999
GRADE_COLON_AND_RECTAL_CANCE...1,SET,94,-0.077275,-0.0055154,0.090779,0.80268,GRADE_COLON_AND_RECTAL_CANCER_DN,0.99999
GAVISH_3CA_METAPROGRAM_CD4_T...10,SET,46,-0.10641,-0.0053201,0.125,0.8027,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_UNASSIGNED,0.99999
NKX2_2_TARGET_GENES,SET,1062,-0.022563,-0.0052675,0.026501,0.80271,NKX2_2_TARGET_GENES,0.99999
GSE27291_6H_VS_7D_STIM_GAMMA...1,SET,156,-0.060141,-0.0055203,0.070626,0.80276,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN,0.99999
WP_GENES_CONTROLLING_NEPHROG...,SET,41,-0.12747,-0.0060173,0.14969,0.80277,WP_GENES_CONTROLLING_NEPHROGENESIS,0.99999
REACTOME_INDUCTION_OF_CELL_C...,SET,12,-0.23194,-0.0059281,0.27235,0.80278,REACTOME_INDUCTION_OF_CELL_CELL_FUSION,0.99999
MIR4641,SET,60,-0.089947,-0.0051338,0.10559,0.80284,MIR4641,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...7,SET,4,-0.2474,-0.0036515,0.29042,0.80285,GOCC_EXTRINSIC_COMPONENT_OF_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,0.99999
HP_EXCESSIVE_WRINKLING_OF_PA...,SET,11,-0.21176,-0.0051821,0.24859,0.80285,HP_EXCESSIVE_WRINKLING_OF_PALMAR_SKIN,0.99999
BIOCARTA_PDZS_PATHWAY,SET,15,-0.18854,-0.005387,0.22131,0.80286,BIOCARTA_PDZS_PATHWAY,0.99999
KRAS.AMP.LUNG_UP.V1_UP,SET,117,-0.070947,-0.0056458,0.08328,0.80286,KRAS.AMP.LUNG_UP.V1_UP,0.99999
MYC_UP.V1_UP,SET,159,-0.055725,-0.0051635,0.06541,0.80287,MYC_UP.V1_UP,0.99999
GSE27859_DC_VS_CD11C_INT_F48...4,SET,184,-0.053452,-0.0053244,0.062738,0.80288,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP,0.99999
ARNT_02,SET,217,-0.049015,-0.0052974,0.057519,0.80293,ARNT_02,0.99999
REACTOME_SIGNALING_BY_MODERA...,SET,42,-0.11757,-0.0056173,0.13793,0.803,REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...2,SET,183,-0.053533,-0.0053181,0.0628,0.803,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_UP,0.99999
HP_ARTHRITIS,SET,206,-0.052231,-0.0055017,0.06127,0.80302,HP_ARTHRITIS,0.99999
MORF_ARL3,SET,280,-0.044307,-0.00543,0.051973,0.80303,MORF_ARL3,0.99999
BIOCARTA_CPSF_PATHWAY,SET,9,-0.24688,-0.0054649,0.28951,0.80309,BIOCARTA_CPSF_PATHWAY,0.99999
RBM34_TARGET_GENES,SET,811,-0.025973,-0.0053371,0.030453,0.80313,RBM34_TARGET_GENES,0.99999
ZNF563_TARGET_GENES,SET,472,-0.033982,-0.0053784,0.039842,0.80314,ZNF563_TARGET_GENES,0.99999
MORF_NPM1,SET,147,-0.057137,-0.0050924,0.066974,0.8032,MORF_NPM1,0.99999
MIR205_3P,SET,359,-0.039349,-0.0054485,0.046106,0.80329,MIR205_3P,0.99999
GSE40273_EOS_KO_VS_WT_TREG_UP,SET,181,-0.053924,-0.0053279,0.063172,0.80333,GSE40273_EOS_KO_VS_WT_TREG_UP,0.99999
HP_ABNORMALITY_OF_THE_BILIAR...,SET,355,-0.038978,-0.0053676,0.045662,0.80334,HP_ABNORMALITY_OF_THE_BILIARY_SYSTEM,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...4,SET,479,-0.033946,-0.0054113,0.03976,0.80338,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.99999
WP_CANCER_PATHWAYS,SET,483,-0.035139,-0.0056242,0.041153,0.8034,WP_CANCER_PATHWAYS,0.99999
GSE35685_CD34POS_CD38NEG_VS_...3,SET,187,-0.054442,-0.0054667,0.063761,0.8034,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN,0.99999
RUBENSTEIN_SKELETAL_MUSCLE_N...,SET,198,-0.051497,-0.0053192,0.06028,0.80352,RUBENSTEIN_SKELETAL_MUSCLE_NK_CELLS,0.99999
MIR4773,SET,171,-0.055661,-0.0053469,0.065144,0.80356,MIR4773,0.99999
GSE3203_HEALTHY_VS_INFLUENZA...2,SET,177,-0.055675,-0.0054404,0.065158,0.80357,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_UP,0.99999
KEGG_MTOR_SIGNALING_PATHWAY,SET,49,-0.11164,-0.0057601,0.13064,0.8036,KEGG_MTOR_SIGNALING_PATHWAY,0.99999
MIR548BA,SET,159,-0.057827,-0.0053583,0.067648,0.80367,MIR548BA,0.99999
GOBP_REGULATION_OF_MUSCLE_AD...,SET,73,-0.09174,-0.0057736,0.10731,0.80369,GOBP_REGULATION_OF_MUSCLE_ADAPTATION,0.99999
GOMF_CELL_MATRIX_ADHESION_ME...,SET,8,-0.28473,-0.0059424,0.33303,0.80371,GOMF_CELL_MATRIX_ADHESION_MEDIATOR_ACTIVITY,0.99999
GSE20366_TREG_VS_TCONV_DN,SET,179,-0.055668,-0.00547,0.065106,0.80373,GSE20366_TREG_VS_TCONV_DN,0.99999
REACTOME_APOPTOSIS,SET,163,-0.055528,-0.005209,0.064926,0.80379,REACTOME_APOPTOSIS,0.99999
RBM15_TARGET_GENES,SET,141,-0.062408,-0.0054483,0.072959,0.80382,RBM15_TARGET_GENES,0.99999
GOMF_PEPTIDYL_PROLINE_DIOXYG...,SET,12,-0.18529,-0.0047357,0.21662,0.80382,GOMF_PEPTIDYL_PROLINE_DIOXYGENASE_ACTIVITY,0.99999
GSE7219_WT_VS_NIK_NFKB2_KO_L...2,SET,180,-0.058663,-0.0057802,0.068583,0.80382,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP,0.99999
GAVIN_IL2_RESPONSIVE_FOXP3_T...2,SET,15,-0.22738,-0.0064969,0.26574,0.8039,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...477,SET,4,-0.32674,-0.0048225,0.38179,0.80394,GOBP_NEGATIVE_REGULATION_OF_PANCREATIC_JUICE_SECRETION,0.99999
MIR6513_3P,SET,133,-0.064095,-0.0054357,0.074887,0.80396,MIR6513_3P,0.99999
HP_EPISTAXIS,SET,96,-0.081237,-0.0058592,0.094907,0.80398,HP_EPISTAXIS,0.99999
GOBP_REGULATION_OF_T_HELPER_...2,SET,10,-0.25161,-0.0058708,0.29394,0.804,GOBP_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT,0.99999
HP_MULTIPLE_JOINT_DISLOCATION,SET,7,-0.23728,-0.0046324,0.27719,0.804,HP_MULTIPLE_JOINT_DISLOCATION,0.99999
HP_ACANTHOCYTOSIS,SET,10,-0.22849,-0.0053313,0.2669,0.80401,HP_ACANTHOCYTOSIS,0.99999
HP_HYPERSEGMENTATION_OF_NEUT...,SET,6,-0.33367,-0.0060313,0.38978,0.80401,HP_HYPERSEGMENTATION_OF_NEUTROPHIL_NUCLEI,0.99999
MIR671_5P,SET,117,-0.06667,-0.0053055,0.077878,0.80402,MIR671_5P,0.99999
GOCC_UBIQUITIN_LIGASE_COMPLEX,SET,282,-0.042823,-0.0052666,0.050022,0.80402,GOCC_UBIQUITIN_LIGASE_COMPLEX,0.99999
HP_VISUAL_LOSS,SET,206,-0.051838,-0.0054603,0.060552,0.80402,HP_VISUAL_LOSS,0.99999
GCM_DPF2,SET,27,-0.12574,-0.0048187,0.14687,0.80404,GCM_DPF2,0.99999
GOBP_REGULATION_OF_SMALL_GTP...,SET,279,-0.045305,-0.0055425,0.052914,0.80405,GOBP_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,0.99999
HP_TALL_CHIN,SET,5,-0.25567,-0.0042189,0.2986,0.80406,HP_TALL_CHIN,0.99999
GSE1432_CTRL_VS_IFNG_24H_MIC...1,SET,182,-0.056684,-0.0056159,0.066185,0.80412,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.99999
GSE19401_UNSTIM_VS_RETINOIC_...1,SET,184,-0.055278,-0.0055063,0.064542,0.80412,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.99999
MIR10A_5P_MIR10B_5P,SET,99,-0.07691,-0.0056327,0.08975,0.80426,MIR10A_5P_MIR10B_5P,0.99999
GOBP_TISSUE_MORPHOGENESIS,SET,576,-0.032566,-0.0056773,0.038003,0.80426,GOBP_TISSUE_MORPHOGENESIS,0.99999
GOBP_PROTEIN_MATURATION,SET,489,-0.032714,-0.0052677,0.038174,0.80427,GOBP_PROTEIN_MATURATION,0.99999
GOMF_RIBOSOME_BINDING,SET,87,-0.07569,-0.0051982,0.088321,0.80427,GOMF_RIBOSOME_BINDING,0.99999
HP_LOW_SERUM_CALCITRIOL,SET,7,-0.29667,-0.0057919,0.34614,0.80429,HP_LOW_SERUM_CALCITRIOL,0.99999
HERNANDEZ_ABERRANT_MITOSIS_B...1,SET,18,-0.18545,-0.005804,0.21634,0.80433,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,0.99999
WP_VITAMIN_DSENSITIVE_CALCIU...,SET,34,-0.1311,-0.0056368,0.15289,0.8044,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,0.99999
GOBP_CELLULAR_RESPONSE_TO_KE...,SET,97,-0.08083,-0.00586,0.094253,0.80443,GOBP_CELLULAR_RESPONSE_TO_KETONE,0.99999
GSE30971_CTRL_VS_LPS_STIM_MA...7,SET,169,-0.058147,-0.0055533,0.067793,0.80447,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...311,SET,17,-0.1946,-0.0059192,0.22688,0.80448,GOBP_POSITIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_MITOCHOND...13,SET,5,-0.26557,-0.0043822,0.30961,0.80448,GOBP_REGULATION_OF_MITOCHONDRIAL_RNA_CATABOLIC_PROCESS,0.99999
REACTOME_FERTILIZATION,SET,26,-0.14089,-0.0052984,0.16422,0.80453,REACTOME_FERTILIZATION,0.99999
GSE11961_UNSTIM_VS_ANTI_IGM_...2,SET,182,-0.05469,-0.0054183,0.063729,0.80459,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_UP,0.99999
HP_EPIDERMAL_HYPERKERATOSIS,SET,11,-0.23446,-0.0057376,0.27315,0.80465,HP_EPIDERMAL_HYPERKERATOSIS,0.99999
ZHAN_MULTIPLE_MYELOMA_CD2_UP,SET,42,-0.1231,-0.0058814,0.14341,0.80466,ZHAN_MULTIPLE_MYELOMA_CD2_UP,0.99999
GOBP_REGULATION_OF_MITOTIC_N...,SET,116,-0.067053,-0.0053133,0.078106,0.80468,GOBP_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,0.99999
ATF2_S_UP.V1_DN,SET,168,-0.058985,-0.0056168,0.068706,0.80469,ATF2_S_UP.V1_DN,0.99999
GOCC_EKC_KEOPS_COMPLEX,SET,3,-0.39726,-0.005078,0.46264,0.80474,GOCC_EKC_KEOPS_COMPLEX,0.99999
GOBP_MACROMOLECULE_METHYLATI...,SET,104,-0.063563,-0.0047706,0.074019,0.80475,GOBP_MACROMOLECULE_METHYLATION,0.99999
GOBP_SYNAPTIC_SIGNALING,SET,716,-0.029014,-0.0056172,0.033787,0.80475,GOBP_SYNAPTIC_SIGNALING,0.99999
DESCARTES_FETAL_PLACENTA_AFP...,SET,156,-0.061976,-0.0056888,0.072168,0.80476,DESCARTES_FETAL_PLACENTA_AFP_ALB_POSITIVE_CELLS,0.99999
HP_SKELETAL_MYOPATHY,SET,9,-0.21552,-0.0047707,0.25095,0.80477,HP_SKELETAL_MYOPATHY,0.99999
PRDM4_TARGET_GENES,SET,467,-0.034955,-0.0055037,0.040701,0.80478,PRDM4_TARGET_GENES,0.99999
HP_NEOPLASM_OF_STRIATED_MUSC...,SET,29,-0.14522,-0.0057672,0.16908,0.80478,HP_NEOPLASM_OF_STRIATED_MUSCLE,0.99999
GOUYER_TUMOR_INVASIVENESS,SET,8,-0.30619,-0.0063903,0.35649,0.80479,GOUYER_TUMOR_INVASIVENESS,0.99999
REACTOME_METALLOPROTEASE_DUBS,SET,15,-0.19648,-0.0056141,0.22867,0.80489,REACTOME_METALLOPROTEASE_DUBS,0.99999
GOBP_ESTROGEN_BIOSYNTHETIC_P...,SET,11,-0.21171,-0.0051808,0.24637,0.80491,GOBP_ESTROGEN_BIOSYNTHETIC_PROCESS,0.99999
GSE22601_DOUBLE_NEGATIVE_VS_...7,SET,163,-0.058685,-0.0055052,0.068293,0.80491,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN,0.99999
GSE360_HIGH_DOSE_B_MALAYI_VS...2,SET,175,-0.054584,-0.0053039,0.063521,0.80491,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,0.99999
GOMF_GDP_PHOSPHATASE_ACTIVITY,SET,10,-0.21476,-0.0050111,0.24992,0.80492,GOMF_GDP_PHOSPHATASE_ACTIVITY,0.99999
GOBP_SEMICIRCULAR_CANAL_MORP...,SET,7,-0.32251,-0.0062965,0.37527,0.80493,GOBP_SEMICIRCULAR_CANAL_MORPHOGENESIS,0.99999
MIR210_3P,SET,10,-0.24236,-0.0056549,0.28197,0.80496,MIR210_3P,0.99999
GOMF_CUPROUS_ION_BINDING,SET,8,-0.24693,-0.0051536,0.2873,0.80496,GOMF_CUPROUS_ION_BINDING,0.99999
GSE13547_2H_VS_12_H_ANTI_IGM...1,SET,165,-0.053358,-0.0050358,0.062082,0.80496,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_DN,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...3,SET,194,-0.052886,-0.0054078,0.061527,0.80498,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN,0.99999
REACTOME_RNA_POLYMERASE_II_T...2,SET,1233,-0.021895,-0.0054804,0.025466,0.80503,REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION,0.99999
GOMF_AMMONIA_LYASE_ACTIVITY,SET,5,-0.37411,-0.0061732,0.43489,0.80516,GOMF_AMMONIA_LYASE_ACTIVITY,0.99999
GNF2_MAP2K3,SET,66,-0.090718,-0.0054296,0.10545,0.80519,GNF2_MAP2K3,0.99999
HP_CRANIOFACIAL_ASYMMETRY,SET,5,-0.35587,-0.0058722,0.41364,0.80519,HP_CRANIOFACIAL_ASYMMETRY,0.99999
HP_SHORT_THUMB,SET,104,-0.073176,-0.0054921,0.085052,0.8052,HP_SHORT_THUMB,0.99999
MIR412_3P,SET,66,-0.094863,-0.0056777,0.11023,0.80525,MIR412_3P,0.99999
BIOCARTA_PLCE_PATHWAY,SET,11,-0.2475,-0.0060566,0.28754,0.8053,BIOCARTA_PLCE_PATHWAY,0.99999
GSE17721_LPS_VS_POLYIC_4H_BM...1,SET,173,-0.052277,-0.0050508,0.06073,0.80532,GSE17721_LPS_VS_POLYIC_4H_BMDC_DN,0.99999
GOBP_ADRENERGIC_RECEPTOR_SIG...,SET,30,-0.14356,-0.0057986,0.16677,0.80533,GOBP_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,0.99999
KUROZUMI_RESPONSE_TO_ONCOCYT...1,SET,41,-0.12518,-0.0059091,0.1454,0.80536,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_AIR...,SET,20,-0.17844,-0.0058866,0.20722,0.80541,HE_LIM_SUN_FETAL_LUNG_C0_AIRWAY_FIBROBLAST,0.99999
BIOCARTA_RB_PATHWAY,SET,13,-0.17182,-0.0045706,0.19951,0.80543,BIOCARTA_RB_PATHWAY,0.99999
GOBP_CHAPERONE_COFACTOR_DEPE...,SET,30,-0.12324,-0.0049777,0.14309,0.80545,GOBP_CHAPERONE_COFACTOR_DEPENDENT_PROTEIN_REFOLDING,0.99999
PID_BCR_5PATHWAY,SET,59,-0.096082,-0.0054382,0.11155,0.80547,PID_BCR_5PATHWAY,0.99999
GOCC_INTRACILIARY_TRANSPORT_...3,SET,15,-0.18801,-0.005372,0.21818,0.80558,GOCC_INTRACILIARY_TRANSPORT_PARTICLE_B,0.99999
GSE3982_CTRL_VS_PMA_STIM_EOS...1,SET,174,-0.056755,-0.0054992,0.065862,0.80558,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN,0.99999
LET_7A_3P,SET,665,-0.029606,-0.0055317,0.034355,0.80559,LET_7A_3P,0.99999
HP_SUBEPENDYMAL_CYSTS,SET,8,-0.24428,-0.0050983,0.28346,0.80559,HP_SUBEPENDYMAL_CYSTS,0.99999
MIR1289,SET,52,-0.10745,-0.0057104,0.12467,0.80562,MIR1289,0.99999
PID_A6B1_A6B4_INTEGRIN_PATHW...,SET,46,-0.11251,-0.0056247,0.13053,0.80564,PID_A6B1_A6B4_INTEGRIN_PATHWAY,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...36,SET,48,-0.11581,-0.0059138,0.13431,0.80571,GAVISH_3CA_MALIGNANT_METAPROGRAM_5_STRESS,0.99999
LHX3_TARGET_GENES,SET,18,-0.18952,-0.0059316,0.21978,0.80574,LHX3_TARGET_GENES,0.99999
chr21q11,SET,4,-0.47941,-0.0070758,0.55586,0.80578,chr21q11,0.99999
HP_CURLY_HAIR,SET,30,-0.12948,-0.0052301,0.1501,0.80583,HP_CURLY_HAIR,0.99999
JONES_OVARY_MACROPHAGE,SET,213,-0.055088,-0.0058993,0.063836,0.80591,JONES_OVARY_MACROPHAGE,0.99999
GOMF_4_GALACTOSYL_N_ACETYLGL...,SET,6,-0.37494,-0.0067773,0.43445,0.80593,GOMF_4_GALACTOSYL_N_ACETYLGLUCOSAMINIDE_3_ALPHA_L_FUCOSYLTRANSFERASE_ACTIVITY,0.99999
GSE19198_1H_VS_24H_IL21_TREA...2,SET,179,-0.056663,-0.0055679,0.06565,0.80596,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP,0.99999
HP_SEPSIS,SET,106,-0.074802,-0.0056675,0.086662,0.80597,HP_SEPSIS,0.99999
REACTOME_SIGNALING_BY_ERYTHR...,SET,25,-0.15254,-0.0056254,0.17671,0.806,REACTOME_SIGNALING_BY_ERYTHROPOIETIN,0.99999
GOBP_LYMPHOCYTE_DIFFERENTIAT...,SET,402,-0.039256,-0.0057451,0.045465,0.80604,GOBP_LYMPHOCYTE_DIFFERENTIATION,0.99999
GOBP_FEVER_GENERATION,SET,11,-0.25621,-0.0062696,0.29667,0.80609,GOBP_FEVER_GENERATION,0.99999
GOBP_EGG_ACTIVATION,SET,11,-0.21645,-0.0052968,0.25062,0.8061,GOBP_EGG_ACTIVATION,0.99999
MARKS_HDAC_TARGETS_UP,SET,20,-0.17799,-0.0058718,0.20608,0.80611,MARKS_HDAC_TARGETS_UP,0.99999
GOMF_ELECTRON_TRANSFER_ACTIV...,SET,96,-0.068375,-0.0049315,0.079166,0.80612,GOMF_ELECTRON_TRANSFER_ACTIVITY,0.99999
GOBP_RENAL_SYSTEM_PROCESS_IN...2,SET,24,-0.16086,-0.0058123,0.1862,0.80617,GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...1,SET,167,-0.056115,-0.0053277,0.064917,0.80631,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_DN,0.99999
GOBP_REGULATION_OF_BLOOD_VES...,SET,7,-0.26489,-0.0051715,0.30641,0.80633,GOBP_REGULATION_OF_BLOOD_VESSEL_REMODELING,0.99999
WP_NEUROINFLAMMATION_AND_GLU...,SET,135,-0.067675,-0.005782,0.078282,0.80634,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,0.99999
GSE17301_ACD3_ACD28_VS_ACD3_...4,SET,175,-0.054218,-0.0052683,0.062701,0.80639,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP,0.99999
GOMF_HISTONE_H3K4_METHYLTRAN...,SET,18,-0.17156,-0.0053693,0.19839,0.80641,GOMF_HISTONE_H3K4_METHYLTRANSFERASE_ACTIVITY,0.99999
GSE29618_MONOCYTE_VS_MDC_DAY...1,SET,171,-0.059019,-0.0056695,0.068207,0.80655,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...35,SET,11,-0.17687,-0.0043282,0.20435,0.80661,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEAR_BODY,0.99999
GSE33292_DN3_THYMOCYTE_VS_TC...1,SET,183,-0.055468,-0.0055104,0.064072,0.80667,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN,0.99999
KEGG_ALZHEIMERS_DISEASE,SET,138,-0.057815,-0.0049937,0.066768,0.80672,KEGG_ALZHEIMERS_DISEASE,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...7,SET,48,-0.1173,-0.0059903,0.13541,0.80683,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_5,0.99999
GOBP_REGULATION_OF_OSTEOBLAS...2,SET,26,-0.15692,-0.0059014,0.18113,0.80685,GOBP_REGULATION_OF_OSTEOBLAST_PROLIFERATION,0.99999
GOBP_O_GLYCAN_PROCESSING,SET,41,-0.12549,-0.0059238,0.14484,0.80686,GOBP_O_GLYCAN_PROCESSING,0.99999
GSE23502_WT_VS_HDC_KO_MYELOI...1,SET,185,-0.055704,-0.0055637,0.064292,0.80687,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_DN,0.99999
chr7p14,SET,54,-0.14378,-0.0077867,0.16594,0.80688,chr7p14,0.99999
GOBP_AUDITORY_RECEPTOR_CELL_...2,SET,19,-0.17398,-0.0055941,0.20077,0.8069,GOBP_AUDITORY_RECEPTOR_CELL_MORPHOGENESIS,0.99999
GSE10147_IL3_VS_IL3_AND_CPG_...1,SET,147,-0.058806,-0.0052411,0.067862,0.8069,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN,0.99999
WP_NEURAL_CREST_DIFFERENTIAT...,SET,94,-0.082356,-0.0058781,0.095036,0.80691,WP_NEURAL_CREST_DIFFERENTIATION,0.99999
GSE30153_LUPUS_VS_HEALTHY_DO...1,SET,180,-0.057602,-0.0056758,0.066465,0.80693,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_DN,0.99999
GSE2770_TGFB_AND_IL4_VS_TGFB...3,SET,170,-0.056207,-0.0053837,0.064847,0.80696,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.99999
GSE32128_INOS_DEPENDENT_VS_I...2,SET,186,-0.054838,-0.0054918,0.063262,0.80698,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_UP,0.99999
BIOCARTA_FBW7_PATHWAY,SET,9,-0.22365,-0.0049507,0.25798,0.807,BIOCARTA_FBW7_PATHWAY,0.99999
GSE18281_SUBCAPSULAR_CORTICA...1,SET,167,-0.056984,-0.0054102,0.065732,0.807,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,0.99999
REACTOME_ION_TRANSPORT_BY_P_...,SET,51,-0.10712,-0.005638,0.12355,0.80702,REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,0.99999
GCM_SUFU,SET,70,-0.080492,-0.0049609,0.092841,0.80702,GCM_SUFU,0.99999
PARK_HSC_AND_MULTIPOTENT_PRO...,SET,42,-0.10985,-0.0052482,0.12668,0.80706,PARK_HSC_AND_MULTIPOTENT_PROGENITORS,0.99999
HP_PARTIAL_DUPLICATION_OF_TH...2,SET,38,-0.11132,-0.0050596,0.12838,0.80706,HP_PARTIAL_DUPLICATION_OF_THE_PHALANX_OF_HAND,0.99999
GNF2_HLA_C,SET,40,-0.1169,-0.0054507,0.1348,0.80707,GNF2_HLA_C,0.99999
GOBP_SA_NODE_CELL_TO_ATRIAL_...1,SET,11,-0.24953,-0.0061063,0.28774,0.80708,GOBP_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_COMMUNICATION,0.99999
GNF2_EIF3S6,SET,106,-0.068534,-0.0051926,0.079017,0.80711,GNF2_EIF3S6,0.99999
KEGG_MEDICUS_REFERENCE_PRNP_...,SET,27,-0.14542,-0.0055728,0.16763,0.80716,KEGG_MEDICUS_REFERENCE_PRNP_PI3K_NOX2_SIGNALING_PATHWAY,0.99999
GOCC_CHROMAFFIN_GRANULE_MEMB...,SET,9,-0.27425,-0.0060708,0.31614,0.80716,GOCC_CHROMAFFIN_GRANULE_MEMBRANE,0.99999
GOCC_LYSOSOMAL_LUMEN,SET,89,-0.07983,-0.0055449,0.092021,0.80717,GOCC_LYSOSOMAL_LUMEN,0.99999
DESCARTES_MAIN_FETAL_LIMBIC_...,SET,6,-0.30503,-0.0055135,0.35157,0.80719,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,0.99999
HP_MITOCHONDRIAL_RESPIRATORY...,SET,10,-0.22733,-0.0053042,0.26189,0.80731,HP_MITOCHONDRIAL_RESPIRATORY_CHAIN_DEFECTS,0.99999
GOCC_ACROSOMAL_MEMBRANE,SET,30,-0.15178,-0.0061307,0.17484,0.80732,GOCC_ACROSOMAL_MEMBRANE,0.99999
NFKB_Q6_01,SET,221,-0.050536,-0.0055113,0.058208,0.80735,NFKB_Q6_01,0.99999
GOBP_POSITIVE_REGULATION_OF_...282,SET,7,-0.31312,-0.0061131,0.36066,0.80735,GOBP_POSITIVE_REGULATION_OF_FEVER_GENERATION,0.99999
TRAVAGLINI_LUNG_EREG_DENDRIT...,SET,525,-0.034758,-0.0057932,0.040017,0.80745,TRAVAGLINI_LUNG_EREG_DENDRITIC_CELL,0.99999
GSE13547_CTRL_VS_ANTI_IGM_ST...3,SET,149,-0.060991,-0.0054724,0.070216,0.80747,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN,0.99999
GOBP_GLYCOSAMINOGLYCAN_CATAB...,SET,26,-0.14553,-0.0054731,0.16753,0.80749,GOBP_GLYCOSAMINOGLYCAN_CATABOLIC_PROCESS,0.99999
HP_MYOFIBRILLAR_MYOPATHY,SET,10,-0.25062,-0.0058478,0.28844,0.80754,HP_MYOFIBRILLAR_MYOPATHY,0.99999
GOCC_CYTOPLASMIC_MICROTUBULE,SET,81,-0.081758,-0.0054188,0.094093,0.80755,GOCC_CYTOPLASMIC_MICROTUBULE,0.99999
MIR140_5P,SET,82,-0.082262,-0.0054856,0.094624,0.80767,MIR140_5P,0.99999
GAO_LARGE_INTESTINE_ADULT_CH...,SET,92,-0.072842,-0.0051437,0.083788,0.80767,GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS,0.99999
MIR2355_3P,SET,97,-0.077773,-0.0056383,0.089455,0.80768,MIR2355_3P,0.99999
GOBP_MYOTUBE_DIFFERENTIATION...,SET,7,-0.32361,-0.0063179,0.37217,0.80772,GOBP_MYOTUBE_DIFFERENTIATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.99999
GOBP_PROTEIN_TARGETING_TO_ME...,SET,107,-0.070122,-0.0053378,0.080611,0.80781,GOBP_PROTEIN_TARGETING_TO_MEMBRANE,0.99999
REACTOME_REGULATION_OF_GLYCO...,SET,11,-0.20807,-0.0050916,0.23915,0.80785,REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM,0.99999
GOCC_EXOCYST,SET,16,-0.18404,-0.0054308,0.21153,0.80785,GOCC_EXOCYST,0.99999
HP_PANCREATIC_ADENOCARCINOMA,SET,35,-0.11642,-0.0050784,0.1338,0.80786,HP_PANCREATIC_ADENOCARCINOMA,0.99999
GSE17721_PAM3CSK4_VS_CPG_8H_...2,SET,182,-0.053851,-0.0053352,0.061879,0.80791,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP,0.99999
GOBP_REGULATION_OF_EXTRINSIC...3,SET,45,-0.10567,-0.0052255,0.12143,0.80792,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,0.99999
GOCC_PAM_COMPLEX_TIM23_ASSOC...,SET,5,-0.31593,-0.0052132,0.36301,0.80793,GOCC_PAM_COMPLEX_TIM23_ASSOCIATED_IMPORT_MOTOR,0.99999
PKCA_DN.V1_DN,SET,140,-0.065607,-0.0057074,0.075379,0.80794,PKCA_DN.V1_DN,0.99999
GOBP_ASYMMETRIC_NEUROBLAST_D...,SET,5,-0.31489,-0.005196,0.36176,0.80796,GOBP_ASYMMETRIC_NEUROBLAST_DIVISION,0.99999
MODULE_73,SET,20,-0.1878,-0.0061954,0.21575,0.80797,MODULE_73,0.99999
GOBP_EMBRYONIC_ORGAN_MORPHOG...,SET,281,-0.048021,-0.0058955,0.055163,0.80799,GOBP_EMBRYONIC_ORGAN_MORPHOGENESIS,0.99999
MIR450A_2_3P,SET,114,-0.069967,-0.0054964,0.080358,0.80803,MIR450A_2_3P,0.99999
SA_PROGRAMMED_CELL_DEATH,SET,12,-0.2199,-0.0056204,0.25254,0.80805,SA_PROGRAMMED_CELL_DEATH,0.99999
MIR3617_5P,SET,232,-0.049152,-0.0054905,0.056435,0.8081,MIR3617_5P,0.99999
GSE29618_PRE_VS_DAY7_POST_LA...1,SET,174,-0.058417,-0.0056602,0.067067,0.80812,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN,0.99999
GOMF_PROTEIN_PRENYLTRANSFERA...,SET,6,-0.28514,-0.005154,0.32734,0.80814,GOMF_PROTEIN_PRENYLTRANSFERASE_ACTIVITY,0.99999
GOBP_T_HELPER_1_CELL_CYTOKIN...,SET,8,-0.25916,-0.0054089,0.2975,0.80816,GOBP_T_HELPER_1_CELL_CYTOKINE_PRODUCTION,0.99999
GSE12963_ENV_NEF_VS_ENV_NEF_...2,SET,117,-0.066457,-0.0052885,0.07628,0.80818,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,0.99999
REACTOME_CYTOSOLIC_SENSORS_O...,SET,57,-0.092636,-0.0051538,0.10631,0.80821,REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,0.99999
HP_SEMANTIC_DEMENTIA,SET,6,-0.31757,-0.0057402,0.36446,0.80821,HP_SEMANTIC_DEMENTIA,0.99999
GOBP_REGULATION_OF_NEUROTRAN...4,SET,88,-0.079647,-0.0055012,0.091401,0.80823,GOBP_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,0.99999
MODULE_234,SET,53,-0.11752,-0.0063053,0.13485,0.80824,MODULE_234,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...15,SET,17,-0.20482,-0.0062299,0.23503,0.80824,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_HORIZONTAL_BASAL_CELLS,0.99999
MODULE_61,SET,47,-0.10718,-0.0054161,0.12297,0.80827,MODULE_61,0.99999
TOYOTA_TARGETS_OF_MIR34B_AND...,SET,399,-0.035153,-0.0051258,0.040329,0.8083,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,0.99999
WP_STEROID_HORMONE_PRECURSOR...,SET,9,-0.26411,-0.0058463,0.30299,0.8083,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,0.99999
MIR519D_3P,SET,567,-0.032495,-0.0056219,0.037276,0.80832,MIR519D_3P,0.99999
GOBP_MICROGLIAL_CELL_PROLIFE...,SET,7,-0.32855,-0.0064143,0.37684,0.80835,GOBP_MICROGLIAL_CELL_PROLIFERATION,0.99999
GOCC_RIBONUCLEOPROTEIN_GRANU...,SET,246,-0.04547,-0.0052282,0.05215,0.80837,GOCC_RIBONUCLEOPROTEIN_GRANULE,0.99999
GSE11961_FOLLICULAR_BCELL_VS...7,SET,178,-0.055549,-0.0054433,0.063701,0.8084,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN,0.99999
GSE17721_CTRL_VS_CPG_1H_BMDC...1,SET,187,-0.055066,-0.0055293,0.063148,0.8084,GSE17721_CTRL_VS_CPG_1H_BMDC_DN,0.99999
FLORIO_NEOCORTEX_BASAL_RADIA...1,SET,170,-0.057082,-0.0054676,0.065456,0.80841,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,0.99999
HP_RECURRENT_MYOGLOBINURIA,SET,5,-0.284,-0.0046862,0.32563,0.80843,HP_RECURRENT_MYOGLOBINURIA,0.99999
GOMF_INTRAMOLECULAR_OXIDORED...2,SET,5,-0.2586,-0.0042671,0.29648,0.80845,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_INTERCONVERTING_ALDOSES_AND_KETOSES,0.99999
KAZMIN_PBMC_P_FALCIPARUM_RTS...1,SET,39,-0.13127,-0.0060441,0.15048,0.80849,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE,0.99999
HP_PROGRESSIVE_SPASTICITY,SET,26,-0.13569,-0.0051029,0.15551,0.80854,HP_PROGRESSIVE_SPASTICITY,0.99999
MIR4428,SET,114,-0.067534,-0.0053053,0.077388,0.80857,MIR4428,0.99999
HP_PROPORTIONATE_TALL_STATURE,SET,14,-0.19386,-0.0053514,0.22213,0.80858,HP_PROPORTIONATE_TALL_STATURE,0.99999
GNF2_PTPRC,SET,59,-0.097714,-0.0055306,0.11196,0.80859,GNF2_PTPRC,0.99999
KIM_ALL_DISORDERS_CALB1_CORR...2,SET,497,-0.033532,-0.0054422,0.038419,0.80861,KIM_ALL_DISORDERS_CALB1_CORR_UP,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...38,SET,12,-0.17442,-0.0044579,0.19978,0.80868,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOPLASM,0.99999
GSE10239_NAIVE_VS_KLRG1INT_E...1,SET,184,-0.052902,-0.0052697,0.060589,0.8087,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN,0.99999
BIOCARTA_RAN_PATHWAY,SET,5,-0.29967,-0.0049449,0.34307,0.80879,BIOCARTA_RAN_PATHWAY,0.99999
GSE21360_SECONDARY_VS_TERTIA...1,SET,149,-0.059071,-0.0053001,0.067602,0.80888,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,0.99999
chr10p12,SET,46,-0.19863,-0.0099302,0.2273,0.80889,chr10p12,0.99999
REACTOME_PHOSPHATE_BOND_HYDR...1,SET,8,-0.23493,-0.0049031,0.26884,0.80889,REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS,0.99999
DESCARTES_FETAL_ADRENAL_ERYT...,SET,84,-0.083111,-0.0056091,0.095106,0.8089,DESCARTES_FETAL_ADRENAL_ERYTHROBLASTS,0.99999
GOBP_POSITIVE_REGULATION_OF_...469,SET,4,-0.33732,-0.0049787,0.38597,0.80892,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FUSION,0.99999
HP_SEVERELY_REDUCED_LEFT_VEN...,SET,13,-0.17569,-0.0046736,0.20103,0.80893,HP_SEVERELY_REDUCED_LEFT_VENTRICULAR_EJECTION_FRACTION,0.99999
HP_B_CELL_LYMPHOMA,SET,21,-0.16896,-0.0057114,0.19331,0.80894,HP_B_CELL_LYMPHOMA,0.99999
BORCZUK_MALIGNANT_MESOTHELIO...1,SET,86,-0.079145,-0.0054043,0.090551,0.80895,BORCZUK_MALIGNANT_MESOTHELIOMA_DN,0.99999
MIR625_5P,SET,190,-0.054134,-0.0054787,0.061935,0.80895,MIR625_5P,0.99999
HOWARD_NEUTROPHIL_INACT_MONO...2,SET,358,-0.042191,-0.0058341,0.048268,0.80896,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_SA...2,SET,14,-0.20046,-0.0055337,0.2293,0.80899,GOBP_CELLULAR_RESPONSE_TO_SALT_STRESS,0.99999
GOMF_PHOSPHOLIPASE_D_ACTIVITY,SET,6,-0.28433,-0.0051395,0.3252,0.80902,GOMF_PHOSPHOLIPASE_D_ACTIVITY,0.99999
HP_TIBIALIS_MUSCLE_WEAKNESS,SET,6,-0.32063,-0.0057955,0.36661,0.80909,HP_TIBIALIS_MUSCLE_WEAKNESS,0.99999
MIR4700_5P,SET,200,-0.053553,-0.0055592,0.061215,0.80917,MIR4700_5P,0.99999
GOMF_BHLH_TRANSCRIPTION_FACT...,SET,31,-0.13938,-0.0057226,0.1593,0.80919,GOMF_BHLH_TRANSCRIPTION_FACTOR_BINDING,0.99999
GOCC_MICROVILLUS_MEMBRANE,SET,29,-0.14282,-0.0056718,0.16322,0.8092,GOCC_MICROVILLUS_MEMBRANE,0.99999
HP_ABNORMALITY_OF_THE_MUSCUL...2,SET,564,-0.031701,-0.0054705,0.036231,0.8092,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LIMBS,0.99999
GOCC_COLLAGEN_CONTAINING_EXT...,SET,391,-0.040754,-0.005884,0.046573,0.80923,GOCC_COLLAGEN_CONTAINING_EXTRACELLULAR_MATRIX,0.99999
GSE17721_CTRL_VS_CPG_6H_BMDC...2,SET,181,-0.052959,-0.0052326,0.060516,0.80924,GSE17721_CTRL_VS_CPG_6H_BMDC_UP,0.99999
KORKOLA_EMBRYONAL_CARCINOMA_...2,SET,28,-0.16866,-0.0065817,0.19272,0.80925,KORKOLA_EMBRYONAL_CARCINOMA_UP,0.99999
KEGG_NON_SMALL_CELL_LUNG_CAN...,SET,53,-0.1016,-0.0054512,0.11609,0.80927,KEGG_NON_SMALL_CELL_LUNG_CANCER,0.99999
GOBP_VASCULAR_ASSOCIATED_SMO...6,SET,24,-0.16636,-0.0060111,0.19006,0.80928,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CONTRACTION,0.99999
BIOCARTA_PML_PATHWAY,SET,17,-0.16748,-0.0050943,0.19135,0.80929,BIOCARTA_PML_PATHWAY,0.99999
GOCC_JUXTAPARANODE_REGION_OF...,SET,12,-0.2327,-0.0059475,0.26586,0.80929,GOCC_JUXTAPARANODE_REGION_OF_AXON,0.99999
LET_7B_3P,SET,662,-0.030117,-0.005615,0.034404,0.80931,LET_7B_3P,0.99999
GSE16385_ROSIGLITAZONE_IL4_V...2,SET,184,-0.054224,-0.0054013,0.061939,0.80933,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP,0.99999
GSE36476_YOUNG_VS_OLD_DONOR_...2,SET,174,-0.056563,-0.0054806,0.064607,0.80934,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP,0.99999
OUELLET_CULTURED_OVARIAN_CAN...1,SET,30,-0.13767,-0.0055607,0.15724,0.80935,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,0.99999
GSE6259_33D1_POS_DC_VS_CD8_T...2,SET,122,-0.068778,-0.0055882,0.078549,0.80937,GSE6259_33D1_POS_DC_VS_CD8_TCELL_UP,0.99999
GSE20366_CD103_KLRG1_DP_VS_D...2,SET,180,-0.055586,-0.0054771,0.063481,0.80938,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP,0.99999
MIR429,SET,457,-0.03671,-0.0057195,0.041917,0.80942,MIR429,0.99999
ZNF664_TARGET_GENES,SET,764,-0.027249,-0.0054419,0.031112,0.80943,ZNF664_TARGET_GENES,0.99999
HP_ABNORMALITY_OF_ALKALINE_P...,SET,120,-0.069476,-0.0055987,0.07932,0.80945,HP_ABNORMALITY_OF_ALKALINE_PHOSPHATASE_LEVEL,0.99999
GSE17721_CTRL_VS_CPG_0.5H_BM...1,SET,181,-0.055345,-0.0054683,0.063174,0.8095,GSE17721_CTRL_VS_CPG_0.5H_BMDC_DN,0.99999
WP_MFAP5MEDIATED_OVARIAN_CAN...,SET,12,-0.22149,-0.0056609,0.2528,0.80952,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,0.99999
TGACATY_UNKNOWN,SET,613,-0.031994,-0.005748,0.036515,0.80953,TGACATY_UNKNOWN,0.99999
BRUECKNER_TARGETS_OF_MIRLET7...1,SET,72,-0.095257,-0.0059538,0.10871,0.80954,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,0.99999
HP_HYPERPHOSPHATEMIA,SET,17,-0.19412,-0.0059046,0.22153,0.80956,HP_HYPERPHOSPHATEMIA,0.99999
GSE37605_TREG_VS_TCONV_C57BL...2,SET,122,-0.0721,-0.0058581,0.082245,0.80965,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_UP,0.99999
REACTOME_ACTIVATION_OF_BH3_O...,SET,30,-0.14011,-0.0056592,0.15982,0.80966,REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS,0.99999
GOMF_MRNA_CDS_BINDING,SET,3,-0.43489,-0.0055589,0.49607,0.80966,GOMF_MRNA_CDS_BINDING,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...2,SET,185,-0.054903,-0.0054837,0.062623,0.80968,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.99999
GOBP_PURINE_DEOXYRIBONUCLEOS...4,SET,7,-0.26611,-0.0051954,0.30351,0.80969,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.99999
WP_CYTOKINECYTOKINE_RECEPTOR...,SET,241,-0.055283,-0.0062924,0.063045,0.80972,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,0.99999
GOBP_ALDITOL_PHOSPHATE_METAB...,SET,9,-0.28133,-0.0062276,0.32079,0.80975,GOBP_ALDITOL_PHOSPHATE_METABOLIC_PROCESS,0.99999
GOBP_IRIS_MORPHOGENESIS,SET,9,-0.29059,-0.0064327,0.33135,0.80975,GOBP_IRIS_MORPHOGENESIS,0.99999
GNF2_DNM1,SET,68,-0.097677,-0.0059337,0.11137,0.80977,GNF2_DNM1,0.99999
GOBP_VESICLE_TETHERING,SET,30,-0.13429,-0.0054242,0.15311,0.80978,GOBP_VESICLE_TETHERING,0.99999
GSE25890_CTRL_VS_IL33_IL7_TR...1,SET,185,-0.053739,-0.0053674,0.061267,0.80978,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN,0.99999
GOMF_GALACTOSYLTRANSFERASE_A...,SET,32,-0.1451,-0.0060527,0.16543,0.80979,GOMF_GALACTOSYLTRANSFERASE_ACTIVITY,0.99999
GSE18893_CTRL_VS_TNF_TREATED...1,SET,177,-0.057178,-0.0055873,0.065178,0.80982,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN,0.99999
GOBP_RESPONSE_TO_OXYGEN_CONT...,SET,1509,-0.020712,-0.0056888,0.023608,0.80984,GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND,0.99999
HP_TYPE_2_MUSCLE_FIBER_PREDO...,SET,9,-0.23981,-0.0053085,0.27333,0.80985,HP_TYPE_2_MUSCLE_FIBER_PREDOMINANCE,0.99999
GOMF_FIBROBLAST_GROWTH_FACTO...2,SET,5,-0.38152,-0.0062955,0.43479,0.80988,GOMF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_ACTIVITY,0.99999
GOCC_RECEPTOR_COMPLEX,SET,382,-0.040765,-0.0058189,0.046453,0.8099,GOCC_RECEPTOR_COMPLEX,0.99999
MORF_GSPT1,SET,43,-0.10491,-0.0050716,0.11954,0.80992,MORF_GSPT1,0.99999
GOBP_NEURAL_PLATE_MORPHOGENE...,SET,4,-0.33996,-0.0050177,0.38729,0.80997,GOBP_NEURAL_PLATE_MORPHOGENESIS,0.99999
HP_EXERCISE_INDUCED_RHABDOMY...,SET,6,-0.24993,-0.0045175,0.28472,0.80997,HP_EXERCISE_INDUCED_RHABDOMYOLYSIS,0.99999
CREIGHTON_ENDOCRINE_THERAPY_...5,SET,429,-0.037478,-0.0056618,0.042693,0.80998,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,0.99999
GOBP_ENGULFMENT_OF_APOPTOTIC...,SET,15,-0.18779,-0.0053657,0.21391,0.80998,GOBP_ENGULFMENT_OF_APOPTOTIC_CELL,0.99999
WP_AXON_GUIDANCE,SET,69,-0.096702,-0.0059174,0.11015,0.81,WP_AXON_GUIDANCE,0.99999
GSE21927_SPLEEN_VS_TUMOR_MON...3,SET,149,-0.06291,-0.0056446,0.071653,0.81002,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_DN,0.99999
GOBP_REGULATION_OF_SEQUESTER...,SET,14,-0.2191,-0.0060483,0.24954,0.81003,GOBP_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.99999
MIKKELSEN_PLURIPOTENT_STATE_...1,SET,8,-0.31454,-0.0065647,0.3582,0.81005,MIKKELSEN_PLURIPOTENT_STATE_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...591,SET,7,-0.27683,-0.0054046,0.31524,0.81006,GOBP_POSITIVE_REGULATION_OF_PINOCYTOSIS,0.99999
GOBP_MRNA_5_SPLICE_SITE_RECO...,SET,6,-0.2491,-0.0045026,0.28366,0.81007,GOBP_MRNA_5_SPLICE_SITE_RECOGNITION,0.99999
TARTE_PLASMA_CELL_VS_PLASMAB...1,SET,276,-0.042316,-0.0051494,0.048181,0.8101,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,0.99999
GOBP_REGULATION_OF_HEART_GRO...,SET,55,-0.11182,-0.0061116,0.12728,0.81018,GOBP_REGULATION_OF_HEART_GROWTH,0.99999
MODULE_403,SET,43,-0.1104,-0.0053369,0.12561,0.81027,MODULE_403,0.99999
GSE36891_UNSTIM_VS_PAM_TLR2_...1,SET,143,-0.059375,-0.0052199,0.06754,0.81033,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,0.99999
CENPT_TARGET_GENES,SET,49,-0.10077,-0.005199,0.11461,0.81034,CENPT_TARGET_GENES,0.99999
AR_Q2,SET,115,-0.073092,-0.0057669,0.083134,0.81035,AR_Q2,0.99999
GSE22033_WT_VS_PPARG_KO_MEF_...2,SET,173,-0.056401,-0.0054493,0.064143,0.81038,GSE22033_WT_VS_PPARG_KO_MEF_UP,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...1,SET,183,-0.056305,-0.0055935,0.064018,0.81043,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN,0.99999
GCACCTT_MIR18A_MIR18B,SET,112,-0.071939,-0.0056019,0.081785,0.81046,GCACCTT_MIR18A_MIR18B,0.99999
HP_PROLONGED_QRS_COMPLEX,SET,6,-0.3579,-0.0064692,0.40685,0.81047,HP_PROLONGED_QRS_COMPLEX,0.99999
HP_ABNORMALITY_OF_THE_THENAR...,SET,30,-0.13285,-0.0053661,0.151,0.81051,HP_ABNORMALITY_OF_THE_THENAR_EMINENCE,0.99999
GSE17721_0.5H_VS_4H_POLYIC_B...1,SET,178,-0.057156,-0.0056007,0.064964,0.81051,GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN,0.99999
REACTOME_AKT_PHOSPHORYLATES_...1,SET,14,-0.18006,-0.0049707,0.20466,0.81052,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL,0.99999
GOMF_U1_SNRNA_BINDING,SET,8,-0.23175,-0.0048369,0.26341,0.81052,GOMF_U1_SNRNA_BINDING,0.99999
GOBP_VACUOLAR_TRANSMEMBRANE_...,SET,8,-0.26189,-0.0054658,0.2976,0.81056,GOBP_VACUOLAR_TRANSMEMBRANE_TRANSPORT,0.99999
GSE43863_TH1_VS_LY6C_INT_CXC...4,SET,187,-0.054641,-0.0054866,0.062094,0.81056,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,0.99999
GOMF_BITTER_TASTE_RECEPTOR_A...,SET,22,-0.22156,-0.0076652,0.25171,0.81062,GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY,0.99999
HP_SHORT_5TH_TOE,SET,5,-0.37298,-0.0061546,0.42374,0.81062,HP_SHORT_5TH_TOE,0.99999
GOBP_REGULATION_OF_ENDOSOME_...1,SET,4,-0.30563,-0.0045109,0.34717,0.81066,GOBP_REGULATION_OF_ENDOSOME_ORGANIZATION,0.99999
RB_P107_DN.V1_UP,SET,121,-0.066849,-0.0054093,0.075917,0.81072,RB_P107_DN.V1_UP,0.99999
GOBP_RECEPTOR_RECYCLING,SET,43,-0.11236,-0.0054314,0.12759,0.81074,GOBP_RECEPTOR_RECYCLING,0.99999
MIR5010_5P,SET,33,-0.12973,-0.0054953,0.1473,0.81075,MIR5010_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...325,SET,5,-0.32298,-0.0053296,0.36674,0.81075,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,0.99999
GSE9650_GP33_VS_GP276_LCMV_S...1,SET,185,-0.052326,-0.0052263,0.059416,0.81075,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN,0.99999
NOTCH3_TARGET_GENES,SET,1079,-0.02414,-0.0056778,0.027406,0.81079,NOTCH3_TARGET_GENES,0.99999
HP_CRUMPLED_EAR,SET,5,-0.32172,-0.0053087,0.36524,0.81079,HP_CRUMPLED_EAR,0.99999
HP_RETINAL_TELANGIECTASIA,SET,14,-0.1859,-0.0051317,0.21105,0.81079,HP_RETINAL_TELANGIECTASIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...507,SET,58,-0.10559,-0.0059254,0.11986,0.8108,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.99999
HP_ABNORMAL_URINE_OSMOLALITY,SET,6,-0.35417,-0.0064018,0.40203,0.81082,HP_ABNORMAL_URINE_OSMOLALITY,0.99999
GSE40274_LEF1_VS_FOXP3_AND_L...1,SET,173,-0.057702,-0.005575,0.065497,0.81083,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
REACTOME_NEGATIVE_REGULATION...12,SET,15,-0.19856,-0.0056734,0.22538,0.81084,REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS,0.99999
MASSARWEH_RESPONSE_TO_ESTRAD...,SET,59,-0.10742,-0.0060802,0.12193,0.81085,MASSARWEH_RESPONSE_TO_ESTRADIOL,0.99999
GOBP_ENUCLEATE_ERYTHROCYTE_D...2,SET,12,-0.21317,-0.0054482,0.24194,0.81085,GOBP_ENUCLEATE_ERYTHROCYTE_DIFFERENTIATION,0.99999
MIR454_5P,SET,21,-0.1673,-0.0056551,0.18987,0.81087,MIR454_5P,0.99999
MODULE_19,SET,281,-0.047363,-0.0058147,0.053746,0.8109,MODULE_19,0.99999
BUSSLINGER_DUODENAL_MATURE_E...,SET,237,-0.049305,-0.0055659,0.05591,0.81107,BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES,0.99999
HP_PATELLAR_DISLOCATION,SET,56,-0.10651,-0.0058739,0.12076,0.81112,HP_PATELLAR_DISLOCATION,0.99999
REACTOME_LOSS_OF_MECP2_BINDI...,SET,5,-0.36263,-0.0059839,0.41103,0.81118,REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX,0.99999
BOSCO_INTERFERON_INDUCED_ANT...,SET,72,-0.086509,-0.0054071,0.098049,0.81119,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,0.99999
HP_ABNORMAL_VITREOUS_HUMOR_M...,SET,42,-0.11376,-0.005435,0.12893,0.81119,HP_ABNORMAL_VITREOUS_HUMOR_MORPHOLOGY,0.99999
HP_APLASIA_OF_THE_MUSCULATURE,SET,9,-0.27322,-0.006048,0.30966,0.81119,HP_APLASIA_OF_THE_MUSCULATURE,0.99999
GSE42724_MEMORY_VS_B1_BCELL_...1,SET,168,-0.05922,-0.0056391,0.06712,0.81119,GSE42724_MEMORY_VS_B1_BCELL_DN,0.99999
GOBP_CYTOPLASMIC_TRANSLATION...2,SET,37,-0.10659,-0.0047803,0.1208,0.81121,GOBP_CYTOPLASMIC_TRANSLATIONAL_INITIATION,0.99999
GSE25677_MPL_VS_R848_STIM_BC...1,SET,166,-0.059564,-0.0056383,0.067491,0.81125,GSE25677_MPL_VS_R848_STIM_BCELL_DN,0.99999
BANDRES_RESPONSE_TO_CARMUSTI...4,SET,18,-0.16723,-0.0052339,0.18943,0.81132,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP,0.99999
GOBP_REGULATION_OF_CHOLESTER...4,SET,17,-0.1858,-0.0056514,0.21045,0.81135,GOBP_REGULATION_OF_CHOLESTEROL_STORAGE,0.99999
GOBP_POSITIVE_REGULATION_OF_...717,SET,11,-0.24615,-0.0060236,0.27877,0.81137,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_INTRACELLULAR_SPHINGOLI...,SET,5,-0.29966,-0.0049447,0.33927,0.81144,GOBP_INTRACELLULAR_SPHINGOLIPID_HOMEOSTASIS,0.99999
HP_X_LINKED_RECESSIVE_INHERI...,SET,10,-0.23028,-0.0053732,0.26072,0.81145,HP_X_LINKED_RECESSIVE_INHERITANCE,0.99999
DESCARTES_FETAL_LUNG_SQUAMOU...,SET,176,-0.061862,-0.0060281,0.070038,0.81145,DESCARTES_FETAL_LUNG_SQUAMOUS_EPITHELIAL_CELLS,0.99999
HP_FOLLICULAR_HYPERKERATOSIS,SET,26,-0.15096,-0.005677,0.17089,0.81147,HP_FOLLICULAR_HYPERKERATOSIS,0.99999
HP_DEFICIENT_EXCISION_OF_UV_...,SET,5,-0.27132,-0.004477,0.30714,0.81148,HP_DEFICIENT_EXCISION_OF_UV_INDUCED_PYRIMIDINE_DIMERS_IN_DNA,0.99999
HFH4_01,SET,180,-0.058775,-0.0057914,0.066526,0.81151,HFH4_01,0.99999
GSE23505_IL6_IL1_VS_IL6_IL1_...4,SET,186,-0.054133,-0.0054212,0.061272,0.81151,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,0.99999
GSE5589_WT_VS_IL10_KO_LPS_ST...3,SET,185,-0.055472,-0.0055405,0.062788,0.81151,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,0.99999
TRAVAGLINI_LUNG_BASOPHIL_MAS...1,SET,248,-0.049447,-0.0057082,0.055968,0.81151,TRAVAGLINI_LUNG_BASOPHIL_MAST_1_CELL,0.99999
BIOCARTA_MPR_PATHWAY,SET,21,-0.16852,-0.0056963,0.19073,0.81152,BIOCARTA_MPR_PATHWAY,0.99999
REACTOME_NOTCH3_INTRACELLULA...,SET,24,-0.15476,-0.0055921,0.17516,0.81152,REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.99999
NAKAYAMA_SOFT_TISSUE_TUMORS_...4,SET,78,-0.088723,-0.0057709,0.1004,0.81156,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP,0.99999
HP_EEG_WITH_GENERALIZED_SLOW...1,SET,32,-0.13214,-0.0055121,0.14951,0.81159,HP_EEG_WITH_GENERALIZED_SLOW_ACTIVITY,0.99999
REACTOME_SHC1_EVENTS_IN_ERBB...2,SET,14,-0.19647,-0.0054237,0.2223,0.8116,REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...25,SET,42,-0.12137,-0.0057985,0.13732,0.8116,GAVISH_3CA_MALIGNANT_METAPROGRAM_33_RBCS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...396,SET,8,-0.28465,-0.0059408,0.32205,0.81161,GOBP_NEGATIVE_REGULATION_OF_MIRNA_PROCESSING,0.99999
GSE37301_LYMPHOID_PRIMED_MPP...8,SET,175,-0.053712,-0.0052191,0.060752,0.81168,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_UP,0.99999
GOCC_PROTON_TRANSPORTING_V_T...1,SET,24,-0.16024,-0.0057902,0.18123,0.8117,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX,0.99999
GSE24102_GRANULOCYSTIC_MDSC_...1,SET,181,-0.055261,-0.00546,0.062485,0.81175,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN,0.99999
GOBP_HEART_DEVELOPMENT,SET,557,-0.033665,-0.0057744,0.038064,0.81176,GOBP_HEART_DEVELOPMENT,0.99999
CAFFAREL_RESPONSE_TO_THC_8HR...3,SET,11,-0.21796,-0.0053337,0.24641,0.81179,CAFFAREL_RESPONSE_TO_THC_8HR_5_DN,0.99999
HP_ABNORMAL_EPIPHYSIS_MORPHO...1,SET,246,-0.048007,-0.0055198,0.054269,0.81181,HP_ABNORMAL_EPIPHYSIS_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_PROTEIN_L...3,SET,128,-0.06524,-0.0054286,0.07374,0.81184,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,0.99999
MIR12128,SET,129,-0.067128,-0.0056073,0.075871,0.81185,MIR12128,0.99999
REACTOME_DRUG_MEDIATED_INHIB...,SET,5,-0.35286,-0.0058226,0.39857,0.812,REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY,0.99999
GOBP_RECEPTOR_MEDIATED_ENDOC...1,SET,239,-0.04958,-0.0056201,0.055998,0.81202,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.99999
GSE13762_CTRL_VS_125_VITAMIN...2,SET,131,-0.066151,-0.0055681,0.074714,0.81202,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP,0.99999
GSE14308_TH1_VS_NAIVE_CD4_TC...2,SET,178,-0.054529,-0.0053433,0.061586,0.81203,GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP,0.99999
HOEK_NK_CELL_2011_2012_TIV_7...,SET,14,-0.18707,-0.0051641,0.21128,0.81203,HOEK_NK_CELL_2011_2012_TIV_7D_VS_0DY_ADULT_7D_DN,0.99999
REACTOME_SENSORY_PROCESSING_...1,SET,69,-0.095391,-0.0058372,0.10773,0.81204,REACTOME_SENSORY_PROCESSING_OF_SOUND,0.99999
GSE17721_PAM3CSK4_VS_CPG_0.5...1,SET,181,-0.054164,-0.0053516,0.061167,0.81205,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN,0.99999
HP_NEOPLASM_OF_THE_BREAST,SET,95,-0.073191,-0.0052514,0.082625,0.81214,HP_NEOPLASM_OF_THE_BREAST,0.99999
GSE15271_CXCR4_POS_VS_NEG_GC...1,SET,164,-0.058728,-0.005526,0.066291,0.81216,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN,0.99999
GOCC_MITOTIC_SPINDLE_MIDZONE,SET,13,-0.20579,-0.0054744,0.23226,0.8122,GOCC_MITOTIC_SPINDLE_MIDZONE,0.99999
GSE24574_BCL6_HIGH_TFH_VS_NA...2,SET,179,-0.056586,-0.0055603,0.063857,0.81222,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_UP,0.99999
HAY_BONE_MARROW_NAIVE_T_CELL,SET,324,-0.043778,-0.0057643,0.049395,0.81226,HAY_BONE_MARROW_NAIVE_T_CELL,0.99999
MIR4482_5P,SET,32,-0.13558,-0.0056557,0.15297,0.81227,MIR4482_5P,0.99999
GOBP_ORGANOPHOSPHATE_CATABOL...,SET,220,-0.05043,-0.0054875,0.056888,0.81231,GOBP_ORGANOPHOSPHATE_CATABOLIC_PROCESS,0.99999
GOBP_MRNA_PSEUDOURIDINE_SYNT...,SET,8,-0.21769,-0.0045433,0.24554,0.81234,GOBP_MRNA_PSEUDOURIDINE_SYNTHESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...595,SET,12,-0.2527,-0.0064586,0.28494,0.81241,GOBP_POSITIVE_REGULATION_OF_PLATELET_AGGREGATION,0.99999
WOOD_EBV_EBNA1_TARGETS_UP,SET,103,-0.078475,-0.0058616,0.088476,0.81245,WOOD_EBV_EBNA1_TARGETS_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...14,SET,5,-0.31859,-0.0052571,0.35906,0.81253,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_LRRK2_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.99999
GOBP_ENDOTHELIAL_CELL_DEVELO...,SET,64,-0.10047,-0.0059216,0.11323,0.81253,GOBP_ENDOTHELIAL_CELL_DEVELOPMENT,0.99999
MIR151A_3P,SET,30,-0.14821,-0.0059866,0.16704,0.81254,MIR151A_3P,0.99999
UNTERMAN_IPF_VS_CTRL_DC_UP,SET,4,-0.35375,-0.0052211,0.39853,0.81263,UNTERMAN_IPF_VS_CTRL_DC_UP,0.99999
GOBP_EMBRYO_DEVELOPMENT_ENDI...,SET,642,-0.031084,-0.0057104,0.035013,0.81267,GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING,0.99999
HP_PULMONIC_STENOSIS,SET,115,-0.07437,-0.0058677,0.083766,0.81268,HP_PULMONIC_STENOSIS,0.99999
GSE28737_BCL6_HET_VS_BCL6_KO...3,SET,186,-0.054436,-0.0054515,0.061311,0.81269,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,0.99999
HUMMERICH_MALIGNANT_SKIN_TUM...1,SET,19,-0.16525,-0.0053133,0.18593,0.81292,HUMMERICH_MALIGNANT_SKIN_TUMOR_DN,0.99999
AMUNDSON_DNA_DAMAGE_RESPONSE...,SET,16,-0.18039,-0.0053232,0.20297,0.81293,AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,0.99999
GNF2_CD33,SET,43,-0.12132,-0.0058646,0.13649,0.81295,GNF2_CD33,0.99999
DESCARTES_MAIN_FETAL_AMACRIN...,SET,16,-0.20426,-0.0060277,0.22978,0.81298,DESCARTES_MAIN_FETAL_AMACRINE_CELLS,0.99999
GOBP_REGULATION_OF_LYMPHOCYT...1,SET,467,-0.037179,-0.0058539,0.041822,0.81299,GOBP_REGULATION_OF_LYMPHOCYTE_ACTIVATION,0.99999
DESCARTES_MAIN_FETAL_MYELOID...,SET,78,-0.090771,-0.0059041,0.1021,0.813,DESCARTES_MAIN_FETAL_MYELOID_CELLS,0.99999
DESCARTES_FETAL_LUNG_VISCERA...,SET,168,-0.064343,-0.006127,0.072353,0.81307,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,0.99999
GOCC_NADH_DEHYDROGENASE_COMP...,SET,40,-0.10139,-0.0047276,0.11398,0.81314,GOCC_NADH_DEHYDROGENASE_COMPLEX,0.99999
GOMF_C_X3_C_CHEMOKINE_BINDING,SET,5,-0.3618,-0.0059702,0.40672,0.81314,GOMF_C_X3_C_CHEMOKINE_BINDING,0.99999
GOBP_T_CELL_DIFFERENTIATION,SET,295,-0.046454,-0.0058412,0.052207,0.81321,GOBP_T_CELL_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_ALPHA_BET...1,SET,107,-0.080282,-0.0061113,0.090206,0.81326,GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...1,SET,236,-0.050916,-0.0057357,0.057208,0.81326,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_FEET,0.99999
REACTOME_RECYCLING_OF_EIF2_G...,SET,7,-0.24954,-0.0048718,0.28036,0.81328,REACTOME_RECYCLING_OF_EIF2_GDP,0.99999
GOCC_BRAHMA_COMPLEX,SET,14,-0.20557,-0.0056747,0.2308,0.81344,GOCC_BRAHMA_COMPLEX,0.99999
GSE14413_UNSTIM_VS_IFNB_STIM...4,SET,129,-0.065253,-0.0054507,0.073264,0.81344,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP,0.99999
HALLMARK_KRAS_SIGNALING_DN,SET,175,-0.059709,-0.0058018,0.067037,0.81344,HALLMARK_KRAS_SIGNALING_DN,0.99999
MASSARWEH_TAMOXIFEN_RESISTAN...2,SET,509,-0.034741,-0.0057041,0.038995,0.8135,MASSARWEH_TAMOXIFEN_RESISTANCE_UP,0.99999
HP_ABNORMAL_CIRCULATING_ALDO...2,SET,10,-0.25507,-0.0059515,0.28629,0.81352,HP_ABNORMAL_CIRCULATING_ALDOSTERONE,0.99999
PID_RAS_PATHWAY,SET,29,-0.13917,-0.0055269,0.15619,0.81353,PID_RAS_PATHWAY,0.99999
MORF_TFDP2,SET,211,-0.052144,-0.0055581,0.058515,0.81356,MORF_TFDP2,0.99999
MIR2681_3P,SET,33,-0.12878,-0.0054549,0.1445,0.81357,MIR2681_3P,0.99999
GOBP_MYELOID_DENDRITIC_CELL_...3,SET,19,-0.19077,-0.0061342,0.21408,0.81357,GOBP_MYELOID_DENDRITIC_CELL_DIFFERENTIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...32,SET,6,-0.282,-0.0050974,0.3164,0.8136,GOBP_NEGATIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,0.99999
WP_G1_TO_S_CELL_CYCLE_CONTROL,SET,64,-0.086875,-0.0051205,0.097466,0.81362,WP_G1_TO_S_CELL_CYCLE_CONTROL,0.99999
GSE21927_SPLEEN_C57BL6_VS_EL...2,SET,178,-0.055781,-0.005466,0.06258,0.81363,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP,0.99999
HP_ECTOPIA_PUPILLAE,SET,21,-0.18599,-0.0062869,0.20863,0.81366,HP_ECTOPIA_PUPILLAE,0.99999
HP_SUBACUTE_PROGRESSIVE_VIRA...,SET,9,-0.25815,-0.0057145,0.28954,0.81369,HP_SUBACUTE_PROGRESSIVE_VIRAL_HEPATITIS,0.99999
GSE2770_UNTREATED_VS_TGFB_AN...10,SET,131,-0.068566,-0.0057713,0.076899,0.8137,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.99999
GOCC_BETA_CATENIN_DESTRUCTIO...,SET,12,-0.21173,-0.0054116,0.23744,0.81372,GOCC_BETA_CATENIN_DESTRUCTION_COMPLEX,0.99999
MIR5579_5P,SET,71,-0.092112,-0.0057173,0.10329,0.81374,MIR5579_5P,0.99999
GOBP_REGULATION_OF_GLUCOKINA...,SET,4,-0.40617,-0.0059948,0.45545,0.81374,GOBP_REGULATION_OF_GLUCOKINASE_ACTIVITY,0.99999
HP_ABNORMAL_PUPILLARY_LIGHT_...,SET,28,-0.14662,-0.0057219,0.16434,0.81385,HP_ABNORMAL_PUPILLARY_LIGHT_REFLEX,0.99999
DESCARTES_FETAL_KIDNEY_ERYTH...,SET,129,-0.069188,-0.0057794,0.077543,0.81387,DESCARTES_FETAL_KIDNEY_ERYTHROBLASTS,0.99999
HP_NEOPLASM_OF_THE_RECTUM,SET,46,-0.10663,-0.005331,0.11948,0.81392,HP_NEOPLASM_OF_THE_RECTUM,0.99999
CEBP_01,SET,238,-0.052875,-0.0059813,0.059239,0.81395,CEBP_01,0.99999
chr10p15,SET,30,-0.22591,-0.0091251,0.25308,0.81398,chr10p15,0.99999
KEGG_LYSINE_DEGRADATION,SET,37,-0.11907,-0.00534,0.13338,0.81398,KEGG_LYSINE_DEGRADATION,0.99999
MIR6797_5P,SET,181,-0.057122,-0.0056439,0.063978,0.81402,MIR6797_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...397,SET,7,-0.28049,-0.005476,0.31415,0.81402,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS,0.99999
GOMF_BMP_RECEPTOR_ACTIVITY,SET,7,-0.28188,-0.0055032,0.3157,0.81403,GOMF_BMP_RECEPTOR_ACTIVITY,0.99999
REACTOME_MAPK6_MAPK4_SIGNALI...,SET,86,-0.078154,-0.0053367,0.08753,0.81404,REACTOME_MAPK6_MAPK4_SIGNALING,0.99999
GOBP_POSITIVE_REGULATION_OF_...753,SET,66,-0.085654,-0.0051265,0.095925,0.81405,GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE,0.99999
HP_NEVUS_SEBACEOUS,SET,5,-0.33063,-0.0054557,0.37024,0.81407,HP_NEVUS_SEBACEOUS,0.99999
LOPEZ_MESOTELIOMA_SURVIVAL_T...2,SET,10,-0.25049,-0.0058446,0.28045,0.81411,LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP,0.99999
MIR409_5P,SET,35,-0.11998,-0.0052336,0.13433,0.81411,MIR409_5P,0.99999
GOBP_RADIAL_GLIAL_CELL_DIFFE...,SET,14,-0.22639,-0.0062494,0.25345,0.81412,GOBP_RADIAL_GLIAL_CELL_DIFFERENTIATION,0.99999
WHITEFORD_PEDIATRIC_CANCER_M...,SET,111,-0.070157,-0.0054388,0.078529,0.81417,WHITEFORD_PEDIATRIC_CANCER_MARKERS,0.99999
GOBP_REGULATION_OF_TRANSLATI...9,SET,7,-0.28281,-0.0055214,0.31655,0.81418,GOBP_REGULATION_OF_TRANSLATION_AT_SYNAPSE,0.99999
REACTOME_HEME_BIOSYNTHESIS,SET,13,-0.20155,-0.0053616,0.22557,0.8142,REACTOME_HEME_BIOSYNTHESIS,0.99999
HP_FLEXION_CONTRACTURE_OF_DI...,SET,276,-0.047087,-0.00573,0.052686,0.81426,HP_FLEXION_CONTRACTURE_OF_DIGIT,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...3,SET,162,-0.062168,-0.0058142,0.069529,0.81437,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN,0.99999
HP_ABNORMAL_CALF_MUSCULATURE...,SET,60,-0.10106,-0.0057681,0.11301,0.8144,HP_ABNORMAL_CALF_MUSCULATURE_MORPHOLOGY,0.99999
HP_DISTAL_SENSORY_IMPAIRMENT...,SET,10,-0.23271,-0.0054298,0.26022,0.8144,HP_DISTAL_SENSORY_IMPAIRMENT_OF_ALL_MODALITIES,0.99999
GOBP_EPIBOLY,SET,39,-0.1179,-0.0054283,0.13183,0.81441,GOBP_EPIBOLY,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...15,SET,9,-0.25834,-0.0057185,0.28887,0.81442,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY,0.99999
HP_POSTEXERTIONAL_SYMPTOM_EX...,SET,14,-0.20547,-0.0056719,0.22974,0.81442,HP_POSTEXERTIONAL_SYMPTOM_EXACERBATION,0.99999
HP_RETINAL_DETACHMENT,SET,97,-0.078793,-0.0057123,0.088105,0.81442,HP_RETINAL_DETACHMENT,0.99999
WP_ANGIOGENESIS,SET,24,-0.16529,-0.0059725,0.1848,0.81445,WP_ANGIOGENESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...178,SET,7,-0.30608,-0.0059757,0.34219,0.81446,GOBP_POSITIVE_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION,0.99999
GOMF_PROTEIN_HOMODIMERIZATIO...,SET,640,-0.030913,-0.0056704,0.034557,0.81448,GOMF_PROTEIN_HOMODIMERIZATION_ACTIVITY,0.99999
REACTOME_GROWTH_HORMONE_RECE...,SET,22,-0.18588,-0.006431,0.20778,0.8145,REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,0.99999
GSE45739_UNSTIM_VS_ACD3_ACD2...2,SET,171,-0.056636,-0.0054406,0.063305,0.81451,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP,0.99999
HP_NEONATAL_SHORT_LIMB_SHORT...,SET,13,-0.22027,-0.0058595,0.24619,0.81452,HP_NEONATAL_SHORT_LIMB_SHORT_STATURE,0.99999
HP_ABNORMAL_RECTUM_MORPHOLOGY,SET,124,-0.068817,-0.0056367,0.076898,0.81458,HP_ABNORMAL_RECTUM_MORPHOLOGY,0.99999
GOCC_CYCLIN_DEPENDENT_PROTEI...,SET,51,-0.095206,-0.0050111,0.10637,0.81461,GOCC_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,0.99999
GSE21546_SAP1A_KO_VS_SAP1A_K...3,SET,185,-0.054579,-0.0054513,0.060972,0.81464,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.99999
GERHOLD_RESPONSE_TO_TZD_DN,SET,11,-0.26062,-0.0063777,0.29109,0.81469,GERHOLD_RESPONSE_TO_TZD_DN,0.99999
GOMF_CLATHRIN_HEAVY_CHAIN_BI...,SET,11,-0.23997,-0.0058724,0.26803,0.81469,GOMF_CLATHRIN_HEAVY_CHAIN_BINDING,0.99999
HP_ABNORMAL_LIGHT_ADAPTED_EL...,SET,9,-0.30113,-0.0066659,0.3363,0.81472,HP_ABNORMAL_LIGHT_ADAPTED_ELECTRORETINOGRAM,0.99999
GSE9509_LPS_VS_LPS_AND_IL10_...1,SET,178,-0.053779,-0.0052698,0.060044,0.81477,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_DN,0.99999
GSE14000_UNSTIM_VS_4H_LPS_DC...4,SET,173,-0.054654,-0.0052805,0.06102,0.81478,GSE14000_UNSTIM_VS_4H_LPS_DC_UP,0.99999
GOBP_LATERAL_MESODERM_DEVELO...,SET,18,-0.2037,-0.0063752,0.22737,0.81483,GOBP_LATERAL_MESODERM_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_TRANSLATI...7,SET,8,-0.26683,-0.005569,0.29785,0.81483,GOBP_REGULATION_OF_TRANSLATIONAL_TERMINATION,0.99999
MOLENAAR_TARGETS_OF_CCND1_AN...1,SET,50,-0.10693,-0.0055727,0.11935,0.81484,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN,0.99999
JAZAG_TGFB1_SIGNALING_UP,SET,93,-0.076004,-0.0053959,0.084821,0.81488,JAZAG_TGFB1_SIGNALING_UP,0.99999
GOBP_T_HELPER_2_CELL_DIFFERE...,SET,17,-0.20129,-0.0061225,0.22451,0.81501,GOBP_T_HELPER_2_CELL_DIFFERENTIATION,0.99999
HP_PERCUSSION_MYOTONIA,SET,9,-0.25031,-0.0055408,0.27919,0.81501,HP_PERCUSSION_MYOTONIA,0.99999
RTTTNNNYTGGM_UNKNOWN,SET,141,-0.068815,-0.0060077,0.076753,0.81502,RTTTNNNYTGGM_UNKNOWN,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...7,SET,414,-0.036753,-0.0054567,0.040989,0.81504,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE,0.99999
GSE24634_NAIVE_CD4_TCELL_VS_...7,SET,178,-0.053738,-0.0052658,0.059932,0.81504,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN,0.99999
TAL1ALPHAE47_01,SET,228,-0.053623,-0.0059388,0.059803,0.81505,TAL1ALPHAE47_01,0.99999
WP_11P112_COPY_NUMBER_VARIAT...,SET,52,-0.12227,-0.006498,0.13635,0.81506,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,0.99999
HP_MULTIPLE_MYELOMA,SET,7,-0.32989,-0.0064406,0.36783,0.8151,HP_MULTIPLE_MYELOMA,0.99999
GOBP_PARAXIAL_MESODERM_MORPH...,SET,9,-0.28394,-0.0062854,0.31652,0.81516,GOBP_PARAXIAL_MESODERM_MORPHOGENESIS,0.99999
GOBP_STEROID_HORMONE_SECRETI...,SET,26,-0.16103,-0.0060558,0.17949,0.81518,GOBP_STEROID_HORMONE_SECRETION,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...1,SET,185,-0.055205,-0.0055138,0.06153,0.81519,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_DN,0.99999
WP_WNTBETACATENIN_SIGNALING_...1,SET,4,-0.4372,-0.0064529,0.48716,0.81526,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,0.99999
DESCARTES_FETAL_HEART_CARDIO...,SET,6,-0.34674,-0.0062675,0.38636,0.81526,DESCARTES_FETAL_HEART_CARDIOMYOCYTES,0.99999
KEGG_REGULATION_OF_AUTOPHAGY,SET,31,-0.15672,-0.0064347,0.17453,0.81539,KEGG_REGULATION_OF_AUTOPHAGY,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...10,SET,11,-0.2452,-0.0060004,0.27304,0.81541,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY,0.99999
MIR4701_5P,SET,107,-0.077262,-0.0058813,0.086017,0.81546,MIR4701_5P,0.99999
GOBP_RENAL_TUBULAR_SECRETION,SET,18,-0.19494,-0.0061013,0.21701,0.81548,GOBP_RENAL_TUBULAR_SECRETION,0.99999
GSE7831_UNSTIM_VS_INFLUENZA_...1,SET,182,-0.058524,-0.0057982,0.065143,0.81551,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN,0.99999
MORI_LARGE_PRE_BII_LYMPHOCYT...2,SET,81,-0.083678,-0.005546,0.093135,0.81552,MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,0.99999
REACTOME_REGULATION_OF_PTEN_...4,SET,65,-0.086497,-0.0051377,0.096267,0.81554,REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...1,SET,47,-0.11886,-0.0060066,0.13226,0.81559,GOCC_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE,0.99999
GOCC_POLE_PLASM,SET,23,-0.15014,-0.0053111,0.16704,0.81563,GOCC_POLE_PLASM,0.99999
ZHOU_TNF_SIGNALING_4HR,SET,42,-0.11644,-0.0055633,0.12953,0.81567,ZHOU_TNF_SIGNALING_4HR,0.99999
GOBP_REGULATION_OF_POLYSACCH...2,SET,39,-0.12405,-0.0057116,0.13799,0.81567,GOBP_REGULATION_OF_POLYSACCHARIDE_METABOLIC_PROCESS,0.99999
GOBP_SMAD_PROTEIN_SIGNAL_TRA...,SET,76,-0.096774,-0.0062137,0.10764,0.81567,GOBP_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
FUJII_YBX1_TARGETS_DN,SET,183,-0.055329,-0.0054966,0.061536,0.81571,FUJII_YBX1_TARGETS_DN,0.99999
HP_CEREBRAL_PALSY,SET,157,-0.061046,-0.0056212,0.067893,0.81571,HP_CEREBRAL_PALSY,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_ILC...2,SET,68,-0.10008,-0.0060796,0.11129,0.81573,HE_LIM_SUN_FETAL_LUNG_C4_ILC3_CELL,0.99999
SHETH_LIVER_CANCER_VS_TXNIP_...5,SET,96,-0.083154,-0.0059975,0.092469,0.81574,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5,0.99999
GOBP_PURINE_NUCLEOSIDE_DIPHO...,SET,6,-0.33733,-0.0060975,0.37509,0.81575,GOBP_PURINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
HP_NAIL_PITS,SET,9,-0.25056,-0.0055464,0.27861,0.81575,HP_NAIL_PITS,0.99999
HP_HYPOPROTEINEMIA,SET,18,-0.17739,-0.0055519,0.19723,0.81578,HP_HYPOPROTEINEMIA,0.99999
GOBP_CELLULAR_RESPONSE_TO_TE...1,SET,5,-0.34022,-0.0056141,0.3782,0.81583,GOBP_CELLULAR_RESPONSE_TO_TEMPERATURE_STIMULUS,0.99999
GRAHAM_CML_QUIESCENT_VS_NORM...1,SET,9,-0.29162,-0.0064553,0.32415,0.81584,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN,0.99999
GOBP_REGULATION_OF_MEIOSIS_I,SET,5,-0.32459,-0.005356,0.36075,0.81587,GOBP_REGULATION_OF_MEIOSIS_I,0.99999
MIR12129,SET,131,-0.070234,-0.0059117,0.078051,0.81589,MIR12129,0.99999
GOBP_EMBRYONIC_PLACENTA_MORP...,SET,24,-0.16624,-0.0060067,0.18473,0.8159,GOBP_EMBRYONIC_PLACENTA_MORPHOGENESIS,0.99999
HP_MUSCLE_SPASM,SET,148,-0.06285,-0.0056203,0.06984,0.81591,HP_MUSCLE_SPASM,0.99999
HP_PERSISTENT_OPEN_ANTERIOR_...,SET,7,-0.26595,-0.0051923,0.29552,0.81592,HP_PERSISTENT_OPEN_ANTERIOR_FONTANELLE,0.99999
GOBP_SEMICIRCULAR_CANAL_DEVE...,SET,9,-0.29788,-0.0065939,0.33096,0.81595,GOBP_SEMICIRCULAR_CANAL_DEVELOPMENT,0.99999
MIR641,SET,232,-0.050733,-0.0056671,0.056336,0.81608,MIR641,0.99999
GSE27786_BCELL_VS_CD8_TCELL_...2,SET,184,-0.054898,-0.0054685,0.060955,0.8161,GSE27786_BCELL_VS_CD8_TCELL_UP,0.99999
BRCA1_DN.V1_DN,SET,115,-0.074511,-0.0058789,0.082716,0.81615,BRCA1_DN.V1_DN,0.99999
GOBP_CERAMIDE_CATABOLIC_PROC...,SET,20,-0.18497,-0.0061021,0.20532,0.81618,GOBP_CERAMIDE_CATABOLIC_PROCESS,0.99999
GSE8921_UNSTIM_0H_VS_TLR1_2_...7,SET,172,-0.058426,-0.0056288,0.064812,0.81632,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN,0.99999
REACTOME_ZINC_INFLUX_INTO_CE...,SET,10,-0.22515,-0.0052533,0.2497,0.81638,REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY,0.99999
GOBP_CELLULAR_RESPONSE_TO_UV...2,SET,10,-0.23757,-0.0055431,0.26347,0.81638,GOBP_CELLULAR_RESPONSE_TO_UV_B,0.99999
GOMF_NEUROPEPTIDE_RECEPTOR_A...,SET,42,-0.13267,-0.0063387,0.14713,0.81639,GOMF_NEUROPEPTIDE_RECEPTOR_ACTIVITY,0.99999
GSE26669_CTRL_VS_COSTIM_BLOC...1,SET,174,-0.058306,-0.0056495,0.064655,0.81641,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN,0.99999
GSE22935_UNSTIM_VS_24H_MBOVI...1,SET,180,-0.060034,-0.0059154,0.066545,0.81651,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.99999
HP_EPILEPSIA_PARTIALIS_CONTI...,SET,8,-0.27599,-0.0057602,0.30588,0.81655,HP_EPILEPSIA_PARTIALIS_CONTINUA,0.99999
HP_OVARIAN_CYST,SET,106,-0.076259,-0.0057779,0.084504,0.81658,HP_OVARIAN_CYST,0.99999
MIR142_3P,SET,162,-0.062156,-0.0058131,0.068872,0.8166,MIR142_3P,0.99999
MIR4684_5P,SET,156,-0.059866,-0.0054951,0.066327,0.81662,MIR4684_5P,0.99999
HP_SEVERE_POSTNATAL_GROWTH_R...,SET,32,-0.1426,-0.0059484,0.15798,0.81664,HP_SEVERE_POSTNATAL_GROWTH_RETARDATION,0.99999
ZHOU_INFLAMMATORY_RESPONSE_L...3,SET,335,-0.044523,-0.0059593,0.049317,0.81668,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,0.99999
GSE27786_BCELL_VS_NEUTROPHIL...1,SET,184,-0.056949,-0.0056727,0.063076,0.81669,GSE27786_BCELL_VS_NEUTROPHIL_DN,0.99999
HP_THIN_BONY_CORTEX,SET,18,-0.18548,-0.0058051,0.20544,0.8167,HP_THIN_BONY_CORTEX,0.99999
GOBP_STEROL_HOMEOSTASIS,SET,82,-0.086065,-0.0057392,0.095316,0.81672,GOBP_STEROL_HOMEOSTASIS,0.99999
HOEK_T_CELL_2011_2012_TIV_AD...1,SET,4,-0.40568,-0.0059877,0.44926,0.81673,HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_DN,0.99999
WESTON_VEGFA_TARGETS_3HR,SET,59,-0.10665,-0.0060365,0.1181,0.81675,WESTON_VEGFA_TARGETS_3HR,0.99999
MORF_IL16,SET,214,-0.052839,-0.0056716,0.058484,0.81686,MORF_IL16,0.99999
GOBP_POSITIVE_REGULATION_OF_...189,SET,15,-0.18971,-0.0054206,0.20996,0.81688,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...683,SET,16,-0.20946,-0.006181,0.23177,0.81692,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,0.99999
WP_CHEMOKINE_SIGNALING,SET,157,-0.064698,-0.0059575,0.071585,0.81694,WP_CHEMOKINE_SIGNALING,0.99999
WP_PYRIMIDINE_METABOLISM,SET,75,-0.08342,-0.005321,0.09228,0.81699,WP_PYRIMIDINE_METABOLISM,0.99999
HP_MALABSORPTION,SET,212,-0.054817,-0.0058567,0.060639,0.81699,HP_MALABSORPTION,0.99999
YAATNRNNNYNATT_UNKNOWN,SET,97,-0.082368,-0.0059715,0.09111,0.81701,YAATNRNNNYNATT_UNKNOWN,0.99999
MIR5685,SET,58,-0.10135,-0.0056875,0.11209,0.81703,MIR5685,0.99999
HOFMANN_MYELODYSPLASTIC_SYND...1,SET,20,-0.16683,-0.0055036,0.18449,0.81707,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,0.99999
GSE7219_WT_VS_NIK_NFKB2_KO_L...1,SET,184,-0.058361,-0.0058134,0.064537,0.81708,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_DN,0.99999
ZHONG_PFC_C8_ORG_PROLIFERATI...,SET,57,-0.098176,-0.005462,0.10856,0.81709,ZHONG_PFC_C8_ORG_PROLIFERATING,0.99999
DESCARTES_FETAL_CEREBELLUM_S...,SET,33,-0.15307,-0.0064842,0.16926,0.8171,DESCARTES_FETAL_CEREBELLUM_SLC24A4_PEX5L_POSITIVE_CELLS,0.99999
GSE12366_PLASMA_CELL_VS_MEMO...2,SET,168,-0.059556,-0.0056712,0.065839,0.81715,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP,0.99999
GSE41867_MEMORY_VS_EXHAUSTED...1,SET,180,-0.05701,-0.0056174,0.063009,0.8172,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_DN,0.99999
HP_PIGMENTARY_RETINOPATHY,SET,163,-0.059983,-0.0056269,0.066293,0.81721,HP_PIGMENTARY_RETINOPATHY,0.99999
GOMF_RNA_STEM_LOOP_BINDING,SET,13,-0.19043,-0.0050658,0.21044,0.81725,GOMF_RNA_STEM_LOOP_BINDING,0.99999
MIR6820_3P,SET,88,-0.082913,-0.0057267,0.091598,0.81731,MIR6820_3P,0.99999
KEGG_MEDICUS_VARIANT_CDX2_OV...,SET,5,-0.41442,-0.0068383,0.45779,0.81733,KEGG_MEDICUS_VARIANT_CDX2_OVEREXPRESSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.99999
PID_EPHB_FWD_PATHWAY,SET,39,-0.12156,-0.0055967,0.13427,0.81735,PID_EPHB_FWD_PATHWAY,0.99999
HP_NONKETOTIC_HYPOGLYCEMIA,SET,13,-0.20322,-0.0054059,0.22446,0.81735,HP_NONKETOTIC_HYPOGLYCEMIA,0.99999
HP_MYOKYMIA,SET,18,-0.15981,-0.0050018,0.17652,0.81736,HP_MYOKYMIA,0.99999
GOBP_POLYSACCHARIDE_CATABOLI...,SET,26,-0.14664,-0.0055147,0.16193,0.81741,GOBP_POLYSACCHARIDE_CATABOLIC_PROCESS,0.99999
MIR6076,SET,49,-0.11712,-0.0060428,0.12933,0.81742,MIR6076,0.99999
GOBP_DEPYRIMIDINATION,SET,8,-0.25571,-0.0053369,0.28235,0.81743,GOBP_DEPYRIMIDINATION,0.99999
GOMF_POLY_G_BINDING,SET,7,-0.27115,-0.0052937,0.2994,0.81743,GOMF_POLY_G_BINDING,0.99999
GSE2770_UNTREATED_VS_ACT_CD4...1,SET,181,-0.054528,-0.0053876,0.060209,0.81743,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN,0.99999
GOBP_VESTIBULOCOCHLEAR_NERVE...1,SET,11,-0.26815,-0.0065619,0.29606,0.81745,GOBP_VESTIBULOCOCHLEAR_NERVE_DEVELOPMENT,0.99999
GOBP_PHENOTYPIC_SWITCHING,SET,7,-0.31749,-0.0061985,0.3505,0.81748,GOBP_PHENOTYPIC_SWITCHING,0.99999
GOBP_SENSORY_ORGAN_DEVELOPME...,SET,554,-0.035777,-0.0061206,0.039488,0.81753,GOBP_SENSORY_ORGAN_DEVELOPMENT,0.99999
HP_RESPIRATORY_INSUFFICIENCY...,SET,5,-0.32054,-0.0052892,0.35377,0.81754,HP_RESPIRATORY_INSUFFICIENCY_DUE_TO_DEFECTIVE_CILIARY_CLEARANCE,0.99999
GOBP_ZINC_ION_IMPORT_INTO_OR...,SET,11,-0.2228,-0.0054521,0.24587,0.81757,GOBP_ZINC_ION_IMPORT_INTO_ORGANELLE,0.99999
GSE37301_HEMATOPOIETIC_STEM_...12,SET,176,-0.059256,-0.0057741,0.065392,0.81757,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_UP,0.99999
GSE1740_UNSTIM_VS_IFNA_STIMU...4,SET,164,-0.063611,-0.0059854,0.070194,0.81758,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP,0.99999
GOBP_PIGMENT_GRANULE_MATURAT...,SET,10,-0.25235,-0.0058881,0.27837,0.81766,GOBP_PIGMENT_GRANULE_MATURATION,0.99999
HP_SUPERNUMERARY_BONES_OF_TH...,SET,23,-0.16166,-0.0057185,0.17829,0.81772,HP_SUPERNUMERARY_BONES_OF_THE_AXIAL_SKELETON,0.99999
HP_BIFID_RIBS,SET,16,-0.19181,-0.0056603,0.21154,0.81773,HP_BIFID_RIBS,0.99999
KEGG_ETHER_LIPID_METABOLISM,SET,30,-0.14895,-0.0060165,0.16425,0.81776,KEGG_ETHER_LIPID_METABOLISM,0.99999
CHIARADONNA_NEOPLASTIC_TRANS...3,SET,49,-0.11975,-0.0061787,0.13205,0.81777,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,0.99999
HP_RETINAL_PIGMENT_EPITHELIA...2,SET,39,-0.12628,-0.0058141,0.13923,0.81777,HP_RETINAL_PIGMENT_EPITHELIAL_MOTTLING,0.99999
BIOCARTA_SPRY_PATHWAY,SET,16,-0.19231,-0.0056748,0.21198,0.81784,BIOCARTA_SPRY_PATHWAY,0.99999
REACTOME_O_LINKED_GLYCOSYLAT...1,SET,100,-0.08552,-0.0062946,0.094251,0.81789,REACTOME_O_LINKED_GLYCOSYLATION,0.99999
HP_NAEVUS_FLAMMEUS_OF_THE_EY...,SET,7,-0.29357,-0.0057315,0.32354,0.81789,HP_NAEVUS_FLAMMEUS_OF_THE_EYELID,0.99999
DAVICIONI_PAX_FOXO1_SIGNATUR...1,SET,19,-0.19639,-0.0063147,0.21641,0.81792,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,0.99999
MODULE_24,SET,407,-0.040363,-0.0059429,0.044477,0.81792,MODULE_24,0.99999
GOCC_ELASTIC_FIBER,SET,4,-0.42115,-0.006216,0.46389,0.81802,GOCC_ELASTIC_FIBER,0.99999
GOBP_POSITIVE_REGULATION_OF_...536,SET,5,-0.36503,-0.0060235,0.40205,0.81803,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_UPTAKE,0.99999
HP_PRIMARY_HYPERCORTISOLISM,SET,9,-0.24402,-0.0054017,0.2687,0.8181,HP_PRIMARY_HYPERCORTISOLISM,0.99999
GOMF_ORGANOPHOSPHATE_PHOSPHA...,SET,7,-0.28454,-0.0055551,0.31328,0.81812,GOMF_ORGANOPHOSPHATE_PHOSPHATE_ANTIPORTER_ACTIVITY,0.99999
GSE9946_MATURE_STIMULATORY_V...2,SET,117,-0.071182,-0.0056645,0.078365,0.81815,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_UP,0.99999
GOBP_STRESS_FIBER_ASSEMBLY,SET,103,-0.080248,-0.005994,0.088341,0.81816,GOBP_STRESS_FIBER_ASSEMBLY,0.99999
HP_FOOT_OLIGODACTYLY,SET,10,-0.24828,-0.005793,0.2733,0.81818,HP_FOOT_OLIGODACTYLY,0.99999
GOBP_RESPONSE_TO_SALT,SET,22,-0.17645,-0.0061047,0.19422,0.81819,GOBP_RESPONSE_TO_SALT,0.99999
MIR1302,SET,63,-0.091976,-0.0053788,0.10123,0.81821,MIR1302,0.99999
SHIN_B_CELL_LYMPHOMA_CLUSTER...4,SET,17,-0.19568,-0.005952,0.21536,0.81822,SHIN_B_CELL_LYMPHOMA_CLUSTER_5,0.99999
HP_ABNORMAL_LOWER_LIMB_METAP...,SET,20,-0.16303,-0.005378,0.17942,0.81822,HP_ABNORMAL_LOWER_LIMB_METAPHYSIS_MORPHOLOGY,0.99999
HP_OPTIC_DISC_PALLOR,SET,216,-0.051108,-0.005511,0.056247,0.81822,HP_OPTIC_DISC_PALLOR,0.99999
GOBP_HEPARIN_BIOSYNTHETIC_PR...,SET,11,-0.23538,-0.0057599,0.25904,0.81823,GOBP_HEPARIN_BIOSYNTHETIC_PROCESS,0.99999
GTGGGTGK_UNKNOWN,SET,264,-0.049518,-0.0058953,0.054492,0.81824,GTGGGTGK_UNKNOWN,0.99999
GSE7219_UNSTIM_VS_LPS_AND_AN...2,SET,159,-0.064927,-0.0060162,0.071435,0.81829,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP,0.99999
SHANK_TAL1_TARGETS_DN,SET,10,-0.25639,-0.0059824,0.28208,0.8183,SHANK_TAL1_TARGETS_DN,0.99999
chr2p24,SET,26,-0.26251,-0.0098722,0.28881,0.81831,chr2p24,0.99999
GOBP_VASCULAR_ENDOTHELIAL_GR...4,SET,40,-0.13321,-0.0062114,0.14654,0.81833,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...19,SET,50,-0.11789,-0.0061443,0.12968,0.81836,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
RUAN_RESPONSE_TO_TROGLITAZON...1,SET,16,-0.2155,-0.0063593,0.23702,0.81837,RUAN_RESPONSE_TO_TROGLITAZONE_DN,0.99999
MIR98_3P,SET,667,-0.03118,-0.0058343,0.034283,0.81844,MIR98_3P,0.99999
HP_SPARSE_SCALP_HAIR,SET,127,-0.06669,-0.0055277,0.073322,0.81846,HP_SPARSE_SCALP_HAIR,0.99999
TRAVAGLINI_LUNG_MYELOID_DEND...,SET,17,-0.19461,-0.0059194,0.21391,0.81852,TRAVAGLINI_LUNG_MYELOID_DENDRITIC_TYPE_1_CELL,0.99999
GOBP_COLUMNAR_CUBOIDAL_EPITH...1,SET,49,-0.11913,-0.0061467,0.1309,0.8186,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_CELL_GROW...2,SET,14,-0.21217,-0.0058569,0.23313,0.8186,GOBP_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,0.99999
GSE29618_MONOCYTE_VS_MDC_DAY...2,SET,189,-0.060813,-0.0061386,0.066823,0.8186,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP,0.99999
GOBP_REGULATION_OF_SUPEROXID...1,SET,20,-0.18504,-0.0061042,0.2033,0.81862,GOBP_REGULATION_OF_SUPEROXIDE_ANION_GENERATION,0.99999
GOMF_CLATHRIN_LIGHT_CHAIN_BI...,SET,6,-0.25026,-0.0045236,0.27497,0.81862,GOMF_CLATHRIN_LIGHT_CHAIN_BINDING,0.99999
GSE2770_IL4_ACT_VS_ACT_CD4_T...2,SET,177,-0.057452,-0.005614,0.063123,0.81862,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,0.99999
GSE42021_TCONV_PLN_VS_TREG_P...1,SET,181,-0.06035,-0.0059628,0.066298,0.81866,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_DN,0.99999
GSE34156_TLR1_TLR2_LIGAND_VS...2,SET,174,-0.060547,-0.0058666,0.066477,0.81879,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,0.99999
LI_ESTROGENE_T47D_E2_RESPONS...2,SET,56,-0.11314,-0.0062392,0.12418,0.81887,LI_ESTROGENE_T47D_E2_RESPONSE_UP,0.99999
KEGG_GLYCOSPHINGOLIPID_BIOSY...3,SET,26,-0.16524,-0.0062141,0.18134,0.81889,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES,0.99999
KIM_ALL_DISORDERS_DURATION_C...2,SET,8,-0.25755,-0.0053752,0.28264,0.81891,KIM_ALL_DISORDERS_DURATION_CORR_UP,0.99999
MODULE_6,SET,381,-0.042671,-0.0060832,0.046826,0.81891,MODULE_6,0.99999
HP_IRIS_ATROPHY,SET,8,-0.33322,-0.0069545,0.36566,0.81892,HP_IRIS_ATROPHY,0.99999
REACTOME_RECRUITMENT_OF_MITO...,SET,74,-0.082721,-0.0052414,0.090742,0.81901,REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,0.99999
HP_ANISOCYTOSIS,SET,17,-0.19511,-0.0059346,0.21401,0.81902,HP_ANISOCYTOSIS,0.99999
CAIRO_HEPATOBLASTOMA_UP,SET,189,-0.059176,-0.0059733,0.064903,0.81905,CAIRO_HEPATOBLASTOMA_UP,0.99999
REACTOME_VESICLE_MEDIATED_TR...,SET,631,-0.030891,-0.0056278,0.033878,0.81906,REACTOME_VESICLE_MEDIATED_TRANSPORT,0.99999
GOBP_CYTOPLASMIC_TRANSLATION,SET,142,-0.061268,-0.0053675,0.067186,0.81908,GOBP_CYTOPLASMIC_TRANSLATION,0.99999
GOBP_REGULATION_OF_PROTEIN_K...4,SET,3,-0.52583,-0.0067214,0.57663,0.81908,GOBP_REGULATION_OF_PROTEIN_KINASE_C_ACTIVITY,0.99999
HP_DECREASED_CIRCULATING_DEH...,SET,7,-0.31398,-0.00613,0.3443,0.81909,HP_DECREASED_CIRCULATING_DEHYDROEPIANDROSTERONE_CONCENTRATION,0.99999
HP_HIP_DYSPLASIA,SET,207,-0.054284,-0.0057316,0.05952,0.81911,HP_HIP_DYSPLASIA,0.99999
HP_LIMITED_ELBOW_MOVEMENT,SET,145,-0.065704,-0.0058163,0.072029,0.81916,HP_LIMITED_ELBOW_MOVEMENT,0.99999
GSE1460_NAIVE_CD4_TCELL_ADUL...2,SET,170,-0.055642,-0.0053296,0.060998,0.81916,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP,0.99999
MIR4729,SET,642,-0.031819,-0.0058453,0.034874,0.81921,MIR4729,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...11,SET,41,-0.11344,-0.0053552,0.12431,0.81927,GAVISH_3CA_METAPROGRAM_MACROPHAGES_RESPIRATION,0.99999
MIR646,SET,225,-0.051384,-0.0056537,0.056303,0.81928,MIR646,0.99999
MIR6865_3P,SET,41,-0.11713,-0.0055292,0.12832,0.81931,MIR6865_3P,0.99999
MODULE_263,SET,44,-0.14998,-0.0073337,0.16431,0.81932,MODULE_263,0.99999
GOMF_NUCLEAR_RETINOID_X_RECE...,SET,17,-0.18981,-0.0057733,0.20793,0.81933,GOMF_NUCLEAR_RETINOID_X_RECEPTOR_BINDING,0.99999
MIR6780A_3P,SET,138,-0.067813,-0.0058573,0.074276,0.81937,MIR6780A_3P,0.99999
MIR128_3P,SET,409,-0.040252,-0.0059407,0.044085,0.81939,MIR128_3P,0.99999
KIM_WT1_TARGETS_12HR_DN,SET,202,-0.054212,-0.0056553,0.059346,0.8195,KIM_WT1_TARGETS_12HR_DN,0.99999
REACTOME_TRNA_PROCESSING_IN_...1,SET,3,-0.42692,-0.0054571,0.46733,0.81951,REACTOME_TRNA_PROCESSING_IN_THE_MITOCHONDRION,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...11,SET,46,-0.10408,-0.0052033,0.11392,0.81953,GAVISH_3CA_MALIGNANT_METAPROGRAM_20_MYC,0.99999
KAECH_NAIVE_VS_DAY8_EFF_CD8_...1,SET,184,-0.057784,-0.0057559,0.063242,0.81956,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN,0.99999
GOBP_BEHAVIORAL_RESPONSE_TO_...1,SET,16,-0.20145,-0.0059447,0.22042,0.81962,GOBP_BEHAVIORAL_RESPONSE_TO_COCAINE,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...18,SET,16,-0.20946,-0.0061809,0.22915,0.81965,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP,0.99999
KEGG_VIBRIO_CHOLERAE_INFECTI...,SET,50,-0.11453,-0.0059688,0.12529,0.81966,KEGG_VIBRIO_CHOLERAE_INFECTION,0.99999
HP_ABNORMAL_PARIETAL_BONE_MO...,SET,28,-0.14021,-0.0054716,0.15338,0.81966,HP_ABNORMAL_PARIETAL_BONE_MORPHOLOGY,0.99999
THAKAR_PBMC_INACTIVATED_INFL...8,SET,582,-0.031385,-0.0054988,0.034334,0.81966,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP,0.99999
KEGG_MEDICUS_REFERENCE_HGF_M...2,SET,14,-0.21293,-0.0058779,0.23289,0.81971,KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_TRANSLATI...6,SET,15,-0.19574,-0.0055929,0.21408,0.81972,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_IN_RESPONSE_TO_STRESS,0.99999
BILANGES_SERUM_SENSITIVE_VIA...1,SET,20,-0.18073,-0.0059622,0.19764,0.81976,BILANGES_SERUM_SENSITIVE_VIA_TSC1,0.99999
REACTOME_RUNX2_REGULATES_CHO...,SET,5,-0.34835,-0.0057482,0.38092,0.81977,REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION,0.99999
LI_PBMC_MENACTRA_AGE_18_45YO...7,SET,34,-0.15373,-0.0066098,0.16803,0.81987,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE,0.99999
GOBP_RESPONSE_TO_METAL_ION,SET,322,-0.045507,-0.0059738,0.049737,0.81989,GOBP_RESPONSE_TO_METAL_ION,0.99999
LIANG_HEMATOPOIESIS_STEM_CEL...5,SET,36,-0.13519,-0.0059807,0.14774,0.81991,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...23,SET,6,-0.24545,-0.0044367,0.26813,0.82001,GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM_EXIT_SITE,0.99999
GOBP_APOPTOTIC_PROCESS_INVOL...3,SET,23,-0.1797,-0.0063565,0.19627,0.82004,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS,0.99999
HP_BASAL_CELL_CARCINOMA,SET,61,-0.091421,-0.0052611,0.099847,0.82006,HP_BASAL_CELL_CARCINOMA,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...9,SET,49,-0.12021,-0.006202,0.13124,0.82014,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI4,0.99999
MIR9986,SET,148,-0.066384,-0.0059364,0.072473,0.82015,MIR9986,0.99999
HP_CIRRHOSIS,SET,146,-0.066313,-0.0058901,0.072391,0.82017,HP_CIRRHOSIS,0.99999
HP_INHERITANCE_QUALIFIER,SET,302,-0.04624,-0.0058818,0.050468,0.82022,HP_INHERITANCE_QUALIFIER,0.99999
GOMF_ANTIOXIDANT_ACTIVITY,SET,72,-0.096847,-0.0060532,0.10567,0.82028,GOMF_ANTIOXIDANT_ACTIVITY,0.99999
REACTOME_MITOTIC_TELOPHASE_C...,SET,10,-0.23572,-0.0055001,0.25718,0.82031,REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS,0.99999
MODULE_278,SET,32,-0.13512,-0.0056366,0.14741,0.82033,MODULE_278,0.99999
REACTOME_TRANSFERRIN_ENDOCYT...,SET,29,-0.15439,-0.0061313,0.16838,0.82039,REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING,0.99999
MODULE_567,SET,90,-0.079561,-0.005557,0.086772,0.82039,MODULE_567,0.99999
MORI_SMALL_PRE_BII_LYMPHOCYT...1,SET,73,-0.086298,-0.0054311,0.094111,0.82042,MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,0.99999
GOBP_T_HELPER_2_CELL_CYTOKIN...,SET,13,-0.23878,-0.0063519,0.2604,0.82042,GOBP_T_HELPER_2_CELL_CYTOKINE_PRODUCTION,0.99999
NAKAMURA_ADIPOGENESIS_EARLY_...2,SET,57,-0.11149,-0.0062025,0.12156,0.82045,NAKAMURA_ADIPOGENESIS_EARLY_UP,0.99999
HP_PSEUDOEPIPHYSES_OF_HAND_B...,SET,14,-0.20537,-0.0056691,0.22393,0.82045,HP_PSEUDOEPIPHYSES_OF_HAND_BONES,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...35,SET,41,-0.11555,-0.0054544,0.12599,0.82046,GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...1,SET,181,-0.057845,-0.0057154,0.063054,0.82053,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_DN,0.99999
ATM_TARGET_GENES,SET,11,-0.25698,-0.0062887,0.2801,0.82055,ATM_TARGET_GENES,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...1,SET,15,-0.19129,-0.0054657,0.20846,0.82058,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR,0.99999
LIU_CMYB_TARGETS_DN,SET,6,-0.31858,-0.0057585,0.34715,0.8206,LIU_CMYB_TARGETS_DN,0.99999
GSE16385_ROSIGLITAZONE_VS_UN...1,SET,188,-0.052545,-0.0052901,0.057255,0.82062,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN,0.99999
GSE2405_HEAT_KILLED_LYSATE_V...2,SET,188,-0.061169,-0.0061583,0.066649,0.82063,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,0.99999
HP_ABNORMAL_RENAL_ECHOGENICI...,SET,31,-0.14614,-0.0060005,0.1592,0.82068,HP_ABNORMAL_RENAL_ECHOGENICITY,0.99999
GOBP_LEUKOCYTE_TETHERING_OR_...,SET,34,-0.14598,-0.0062767,0.15902,0.82069,GOBP_LEUKOCYTE_TETHERING_OR_ROLLING,0.99999
GOMF_CARBONATE_DEHYDRATASE_A...,SET,14,-0.2284,-0.0063049,0.24871,0.82077,GOMF_CARBONATE_DEHYDRATASE_ACTIVITY,0.99999
HP_FUNCTIONAL_ABNORMALITY_OF...4,SET,330,-0.042735,-0.005678,0.046521,0.82085,HP_FUNCTIONAL_ABNORMALITY_OF_THE_MIDDLE_EAR,0.99999
GSE40274_CTRL_VS_XBP1_TRANSD...2,SET,156,-0.066166,-0.0060734,0.072027,0.82085,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...323,SET,29,-0.14552,-0.0057794,0.15838,0.8209,GOBP_POSITIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_MITOTIC_SISTER_CHROMATI...2,SET,3,-0.61843,-0.0079051,0.67303,0.82091,GOBP_MITOTIC_SISTER_CHROMATID_COHESION_CENTROMERIC,0.99999
REACTOME_STIMULI_SENSING_CHA...,SET,99,-0.083912,-0.0061455,0.09132,0.82092,REACTOME_STIMULI_SENSING_CHANNELS,0.99999
MIR191_5P,SET,19,-0.17764,-0.0057119,0.19332,0.82092,MIR191_5P,0.99999
OVSYANNIKOVA_PBMC_FLUARIX_AG...1,SET,7,-0.32475,-0.0063402,0.35333,0.82098,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN,0.99999
MIR412_5P,SET,5,-0.33452,-0.0055199,0.36393,0.82099,MIR412_5P,0.99999
GOBP_CELLULAR_RESPONSE_TO_DE...,SET,27,-0.17041,-0.0065306,0.18539,0.821,GOBP_CELLULAR_RESPONSE_TO_DEXAMETHASONE_STIMULUS,0.99999
GOBP_HEPATOCYTE_APOPTOTIC_PR...,SET,19,-0.17398,-0.0055942,0.18928,0.821,GOBP_HEPATOCYTE_APOPTOTIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...668,SET,38,-0.1208,-0.0054905,0.13141,0.82102,GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,0.99999
PR_01,SET,134,-0.068738,-0.0058513,0.074764,0.82105,PR_01,0.99999
GSE19888_ADENOSINE_A3R_ACT_V...1,SET,183,-0.057241,-0.0056865,0.062259,0.82105,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN,0.99999
REACTOME_DEFECTIVE_CFTR_CAUS...,SET,58,-0.091812,-0.0051524,0.099858,0.82106,REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,0.99999
REACTOME_RHO_GTPASES_ACTIVAT...3,SET,29,-0.15499,-0.0061553,0.16857,0.82107,REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS,0.99999
ABE_VEGFA_TARGETS,SET,15,-0.21644,-0.0061843,0.23538,0.82108,ABE_VEGFA_TARGETS,0.99999
HP_ENAMEL_HYPOPLASIA,SET,90,-0.082747,-0.0057795,0.089966,0.82114,HP_ENAMEL_HYPOPLASIA,0.99999
WP_TRANSLATION_FACTORS,SET,44,-0.10792,-0.0052772,0.11733,0.82115,WP_TRANSLATION_FACTORS,0.99999
GOBP_INTRACELLULAR_STEROL_TR...,SET,32,-0.14122,-0.005891,0.1535,0.82121,GOBP_INTRACELLULAR_STEROL_TRANSPORT,0.99999
HP_ABNORMAL_FIBULA_MORPHOLOGY,SET,51,-0.11353,-0.0059757,0.1234,0.82122,HP_ABNORMAL_FIBULA_MORPHOLOGY,0.99999
WP_AGERAGE_PATHWAY,SET,63,-0.10068,-0.005888,0.10942,0.82125,WP_AGERAGE_PATHWAY,0.99999
GOMF_NADPLUS_PROTEIN_CYSTEIN...,SET,6,-0.32258,-0.0058308,0.35055,0.82126,GOMF_NADPLUS_PROTEIN_CYSTEINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.99999
HP_PERISYLVIAN_POLYMICROGYRIA,SET,32,-0.14947,-0.0062352,0.16243,0.82127,HP_PERISYLVIAN_POLYMICROGYRIA,0.99999
REACTOME_RNA_POLYMERASE_III_...5,SET,21,-0.14995,-0.0050686,0.16294,0.82128,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION,0.99999
GOBP_MEIOTIC_CHROMOSOME_SEPA...,SET,9,-0.25966,-0.0057478,0.28214,0.82129,GOBP_MEIOTIC_CHROMOSOME_SEPARATION,0.99999
GSE5679_RARA_AGONIST_AM580_V...2,SET,182,-0.060421,-0.0059861,0.065646,0.82131,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...321,SET,46,-0.11258,-0.0056282,0.12225,0.82143,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,0.99999
TRAVAGLINI_LUNG_AIRWAY_SMOOT...,SET,156,-0.065064,-0.0059723,0.070653,0.82144,TRAVAGLINI_LUNG_AIRWAY_SMOOTH_MUSCLE_CELL,0.99999
REACTOME_L1CAM_INTERACTIONS,SET,108,-0.079892,-0.0061097,0.086748,0.82146,REACTOME_L1CAM_INTERACTIONS,0.99999
FLORIO_NEOCORTEX_BASAL_RADIA...2,SET,339,-0.04608,-0.0062037,0.050021,0.82152,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,0.99999
GSE13522_CTRL_VS_T_CRUZI_Y_S...8,SET,146,-0.064035,-0.0056878,0.069509,0.82153,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_UP,0.99999
SHEN_SMARCA2_TARGETS_UP,SET,389,-0.039324,-0.0056633,0.042684,0.82154,SHEN_SMARCA2_TARGETS_UP,0.99999
MIR887_5P,SET,92,-0.084255,-0.0059496,0.091437,0.82159,MIR887_5P,0.99999
MIR3605_5P,SET,75,-0.096045,-0.0061264,0.10419,0.82167,MIR3605_5P,0.99999
GOBP_EARLY_ENDOSOME_TO_RECYC...,SET,7,-0.32065,-0.0062601,0.34782,0.82169,GOBP_EARLY_ENDOSOME_TO_RECYCLING_ENDOSOME_TRANSPORT,0.99999
GSE43955_10H_VS_30H_ACT_CD4_...4,SET,183,-0.057502,-0.0057124,0.062377,0.82169,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.99999
GSE9650_EFFECTOR_VS_EXHAUSTE...2,SET,183,-0.055051,-0.0054689,0.059701,0.82176,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP,0.99999
MIR892B,SET,71,-0.095431,-0.0059233,0.10348,0.82178,MIR892B,0.99999
MIR4686,SET,74,-0.087917,-0.0055706,0.09533,0.82179,MIR4686,0.99999
GOBP_FATTY_ACID_DERIVATIVE_B...,SET,43,-0.12711,-0.0061447,0.13781,0.82182,GOBP_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS,0.99999
MORF_MAP3K14,SET,106,-0.078861,-0.0059751,0.085483,0.82187,MORF_MAP3K14,0.99999
GOBP_NEGATIVE_REGULATION_OF_...122,SET,15,-0.20655,-0.0059019,0.22384,0.82193,GOBP_NEGATIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.99999
KRAS.300_UP.V1_DN,SET,125,-0.07317,-0.0060172,0.079287,0.82195,KRAS.300_UP.V1_DN,0.99999
WP_GLUCOCORTICOID_BIOSYNTHES...,SET,14,-0.24686,-0.0068144,0.26749,0.82196,WP_GLUCOCORTICOID_BIOSYNTHESIS,0.99999
KEGG_MEDICUS_REFERENCE_IL1_I...2,SET,15,-0.22316,-0.0063763,0.2418,0.82197,KEGG_MEDICUS_REFERENCE_IL1_IL1R_P38_SIGNALING_PATHWAY,0.99999
CHAF1B_TARGET_GENES,SET,719,-0.03056,-0.0059283,0.033112,0.82197,CHAF1B_TARGET_GENES,0.99999
HP_DEFORMED_RIB_CAGE,SET,7,-0.31013,-0.0060548,0.33603,0.82197,HP_DEFORMED_RIB_CAGE,0.99999
GOBP_POSITIVE_REGULATION_OF_...209,SET,33,-0.14326,-0.0060686,0.15521,0.82199,GOBP_POSITIVE_REGULATION_OF_DNA_BINDING,0.99999
KEGG_MEDICUS_REFERENCE_ELECT...1,SET,36,-0.11014,-0.0048726,0.11932,0.822,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_I,0.99999
GSE5589_WT_VS_IL10_KO_LPS_AN...4,SET,176,-0.057706,-0.005623,0.062512,0.82202,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.99999
HP_CORPUS_CALLOSUM_ATROPHY,SET,37,-0.12781,-0.0057323,0.13845,0.82204,HP_CORPUS_CALLOSUM_ATROPHY,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...18,SET,2,-0.5177,-0.0054033,0.56066,0.82209,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_OTHER_NITROGENOUS_COMPOUNDS_AS_DONORS_CYTOCHROME_AS_ACCEPTOR,0.99999
ILK_TARGET_GENES,SET,15,-0.18938,-0.0054111,0.20507,0.82212,ILK_TARGET_GENES,0.99999
GOBP_CORTICOSTEROID_HORMONE_...,SET,18,-0.19294,-0.0060386,0.20892,0.82213,GOBP_CORTICOSTEROID_HORMONE_SECRETION,0.99999
KEGG_MEDICUS_REFERENCE_ASSEM...,SET,17,-0.1714,-0.0052135,0.18555,0.82219,KEGG_MEDICUS_REFERENCE_ASSEMBLY_AND_TRAFFICKING_OF_TELOMERASE,0.99999
GAO_LARGE_INTESTINE_ADULT_CJ...,SET,438,-0.041912,-0.0063962,0.045371,0.82219,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,0.99999
MORF_FRK,SET,98,-0.080865,-0.0058925,0.087507,0.82228,MORF_FRK,0.99999
IVANOVA_HEMATOPOIESIS_STEM_C...3,SET,201,-0.05686,-0.005917,0.061526,0.82229,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,0.99999
MIR4527,SET,64,-0.095807,-0.005647,0.10359,0.82247,MIR4527,0.99999
MIR20B_3P,SET,65,-0.096656,-0.0057412,0.10449,0.82251,MIR20B_3P,0.99999
MORF_CDC10,SET,140,-0.063358,-0.0055117,0.068481,0.82256,MORF_CDC10,0.99999
GOBP_NEUROMUSCULAR_JUNCTION_...,SET,47,-0.11436,-0.0057788,0.1236,0.82257,GOBP_NEUROMUSCULAR_JUNCTION_DEVELOPMENT,0.99999
GOMF_EUKARYOTIC_INITIATION_F...,SET,9,-0.22681,-0.0050208,0.24513,0.82258,GOMF_EUKARYOTIC_INITIATION_FACTOR_4E_BINDING,0.99999
HP_ABNORMAL_PULMONARY_VEIN_M...,SET,66,-0.095143,-0.0056945,0.10282,0.82259,HP_ABNORMAL_PULMONARY_VEIN_MORPHOLOGY,0.99999
GOMF_ATP_DEPENDENT_DNA_DNA_A...,SET,4,-0.38349,-0.0056601,0.41442,0.82261,GOMF_ATP_DEPENDENT_DNA_DNA_ANNEALING_ACTIVITY,0.99999
HP_HYPOPHOSPHATEMIA,SET,41,-0.13537,-0.0063903,0.14626,0.82266,HP_HYPOPHOSPHATEMIA,0.99999
GOMF_PHOSPHATIDYLCHOLINE_FLI...,SET,5,-0.38042,-0.0062773,0.41096,0.82269,GOMF_PHOSPHATIDYLCHOLINE_FLIPPASE_ACTIVITY,0.99999
ZHONG_PFC_MAJOR_TYPES_NPCS,SET,126,-0.069254,-0.0057177,0.074801,0.82273,ZHONG_PFC_MAJOR_TYPES_NPCS,0.99999
GOBP_NK_T_CELL_DIFFERENTIATI...,SET,11,-0.25665,-0.0062804,0.27717,0.82276,GOBP_NK_T_CELL_DIFFERENTIATION,0.99999
GSE12963_UNINF_VS_ENV_AND_NE...2,SET,119,-0.072246,-0.0057978,0.077985,0.82288,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,0.99999
BERENJENO_TRANSFORMED_BY_RHO...6,SET,496,-0.034257,-0.0055544,0.036976,0.82289,BERENJENO_TRANSFORMED_BY_RHOA_UP,0.99999
MARIADASON_RESPONSE_TO_BUTYR...5,SET,40,-0.12881,-0.0060063,0.13904,0.82289,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6,0.99999
MIR5695,SET,87,-0.086324,-0.0059285,0.09316,0.82293,MIR5695,0.99999
GOBP_HEME_A_METABOLIC_PROCESS,SET,10,-0.23819,-0.0055578,0.25706,0.82293,GOBP_HEME_A_METABOLIC_PROCESS,0.99999
HP_SMALL_EARLOBE,SET,23,-0.16419,-0.005808,0.17718,0.82295,HP_SMALL_EARLOBE,0.99999
GOCC_CD40_RECEPTOR_COMPLEX,SET,11,-0.21956,-0.0053728,0.23689,0.82298,GOCC_CD40_RECEPTOR_COMPLEX,0.99999
MIR128_2_5P,SET,11,-0.26871,-0.0065756,0.28982,0.82307,MIR128_2_5P,0.99999
GSE8384_CTRL_VS_B_ABORTUS_4H...1,SET,177,-0.061024,-0.0059631,0.065819,0.82307,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN,0.99999
GOBP_REGULATION_OF_RECEPTOR_...7,SET,25,-0.15222,-0.0056134,0.16413,0.82314,GOBP_REGULATION_OF_RECEPTOR_RECYCLING,0.99999
GOBP_T_HELPER_17_CELL_DIFFER...,SET,33,-0.14927,-0.0063229,0.16094,0.82315,GOBP_T_HELPER_17_CELL_DIFFERENTIATION,0.99999
HP_ABNORMAL_CIRCULATING_PROG...,SET,6,-0.3114,-0.0056288,0.33572,0.82318,HP_ABNORMAL_CIRCULATING_PROGESTERONE_LEVEL,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_CD5...,SET,5,-0.35539,-0.0058643,0.38307,0.82322,HE_LIM_SUN_FETAL_LUNG_C4_CD56BRIGHT_NK_CELL,0.99999
GOBP_DEVELOPMENTAL_PIGMENTAT...,SET,45,-0.12677,-0.0062687,0.13663,0.82326,GOBP_DEVELOPMENTAL_PIGMENTATION,0.99999
GOBP_AORTA_DEVELOPMENT,SET,60,-0.10987,-0.0062707,0.1184,0.82327,GOBP_AORTA_DEVELOPMENT,0.99999
HFH1_01,SET,217,-0.056619,-0.0061192,0.061015,0.82328,HFH1_01,0.99999
LAKE_ADULT_KIDNEY_C18_COLLEC...,SET,295,-0.046846,-0.0058906,0.050483,0.82328,LAKE_ADULT_KIDNEY_C18_COLLECTING_DUCT_PRINCIPAL_CELLS_MEDULLA,0.99999
HARRIS_HYPOXIA,SET,74,-0.09948,-0.0063032,0.10719,0.82331,HARRIS_HYPOXIA,0.99999
KEGG_MEDICUS_PATHOGEN_EBV_EB...6,SET,9,-0.24107,-0.0053365,0.25975,0.82331,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00482,0.99999
WP_FOLATE_METABOLISM,SET,66,-0.10106,-0.0060483,0.10888,0.82333,WP_FOLATE_METABOLISM,0.99999
IL2_UP.V1_DN,SET,159,-0.065596,-0.0060782,0.070664,0.82336,IL2_UP.V1_DN,0.99999
GSE4142_NAIVE_VS_GC_BCELL_DN,SET,179,-0.056389,-0.0055409,0.060746,0.82336,GSE4142_NAIVE_VS_GC_BCELL_DN,0.99999
KIM_WT1_TARGETS_8HR_DN,SET,113,-0.072492,-0.0056699,0.078091,0.82337,KIM_WT1_TARGETS_8HR_DN,0.99999
MIR6868_5P,SET,111,-0.074764,-0.005796,0.080537,0.82337,MIR6868_5P,0.99999
GSE5589_WT_VS_IL10_KO_LPS_AN...5,SET,182,-0.059193,-0.0058645,0.063755,0.82341,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.99999
GCM_PTPRU,SET,50,-0.10855,-0.0056575,0.11691,0.82342,GCM_PTPRU,0.99999
GOBP_COPPER_ION_IMPORT,SET,6,-0.30466,-0.0055069,0.32812,0.82342,GOBP_COPPER_ION_IMPORT,0.99999
GOMF_CELL_ADHESION_MEDIATOR_...,SET,63,-0.11172,-0.0065335,0.12032,0.82344,GOMF_CELL_ADHESION_MEDIATOR_ACTIVITY,0.99999
GOMF_MOLECULAR_FUNCTION_INHI...,SET,454,-0.039233,-0.0060929,0.042244,0.82347,GOMF_MOLECULAR_FUNCTION_INHIBITOR_ACTIVITY,0.99999
HP_ABNORMALITY_OF_CENTRAL_NE...,SET,525,-0.03478,-0.0057969,0.037449,0.82348,HP_ABNORMALITY_OF_CENTRAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY,0.99999
MCBRYAN_PUBERTAL_BREAST_3_4W...2,SET,192,-0.061864,-0.0062935,0.066604,0.82351,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,0.99999
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SET,104,-0.079952,-0.0060007,0.086066,0.82354,SMIRNOV_RESPONSE_TO_IR_6HR_DN,0.99999
WP_MAP3K1_ROLE_IN_PROMOTING_...,SET,16,-0.21462,-0.0063332,0.23101,0.82356,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,0.99999
GOBP_RETINA_VASCULATURE_MORP...,SET,9,-0.28131,-0.0062272,0.3028,0.82356,GOBP_RETINA_VASCULATURE_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.99999
NAKAJIMA_MAST_CELL,SET,40,-0.13337,-0.006219,0.14356,0.82357,NAKAJIMA_MAST_CELL,0.99999
REACTOME_PLASMA_LIPOPROTEIN_...3,SET,33,-0.14264,-0.0060422,0.15353,0.82357,REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,0.99999
MIR106A_5P,SET,596,-0.033776,-0.0059862,0.036328,0.82374,MIR106A_5P,0.99999
GNF2_EGFR,SET,29,-0.16555,-0.0065748,0.17804,0.82378,GNF2_EGFR,0.99999
GOBP_ESTABLISHMENT_OF_ORGANE...,SET,436,-0.037992,-0.005785,0.04085,0.82382,GOBP_ESTABLISHMENT_OF_ORGANELLE_LOCALIZATION,0.99999
GOBP_REGULATION_OF_GLUTAMATE...1,SET,6,-0.35235,-0.0063689,0.37874,0.82389,GOBP_REGULATION_OF_GLUTAMATE_RECEPTOR_CLUSTERING,0.99999
HP_ABNORMAL_SYSTEMIC_BLOOD_P...,SET,487,-0.037477,-0.0060226,0.040278,0.82393,HP_ABNORMAL_SYSTEMIC_BLOOD_PRESSURE,0.99999
MODULE_8,SET,394,-0.039579,-0.0057358,0.042534,0.82395,MODULE_8,0.99999
GSE15330_LYMPHOID_MULTIPOTEN...3,SET,176,-0.058259,-0.005677,0.062608,0.82395,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,0.99999
WP_INFLUENCE_OF_LAMINOPATHIE...,SET,33,-0.1418,-0.0060065,0.15235,0.824,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,0.99999
MIR3620_5P,SET,49,-0.10908,-0.0056279,0.11718,0.82403,MIR3620_5P,0.99999
BLANCO_MELO_MERS_COV_INFECTI...2,SET,230,-0.052669,-0.0058583,0.05657,0.82408,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,0.99999
REACTOME_COLLAGEN_FORMATION,SET,88,-0.093756,-0.0064757,0.1007,0.82408,REACTOME_COLLAGEN_FORMATION,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...16,SET,161,-0.063925,-0.0059602,0.068654,0.8241,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP,0.99999
REACTOME_DEFECTS_OF_CONTACT_...,SET,14,-0.23676,-0.0065356,0.25425,0.82412,REACTOME_DEFECTS_OF_CONTACT_ACTIVATION_SYSTEM_CAS_AND_KALLIKREIN_KININ_SYSTEM_KKS,0.99999
OVSYANNIKOVA_PBMC_FLUARIX_AG...5,SET,13,-0.23532,-0.0062599,0.25271,0.82412,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_DN,0.99999
GNF2_CCNA2,SET,64,-0.096337,-0.0056782,0.10342,0.82419,GNF2_CCNA2,0.99999
GOCC_SPECTRIN,SET,9,-0.25556,-0.0056571,0.27436,0.82419,GOCC_SPECTRIN,0.99999
MOOTHA_HUMAN_MITODB_6_2002,SET,381,-0.039808,-0.005675,0.042733,0.82421,MOOTHA_HUMAN_MITODB_6_2002,0.99999
GOBP_MYELOID_DENDRITIC_CELL_...1,SET,26,-0.17208,-0.0064715,0.18471,0.82423,GOBP_MYELOID_DENDRITIC_CELL_ACTIVATION,0.99999
MODULE_530,SET,15,-0.2044,-0.0058403,0.21939,0.82424,MODULE_530,0.99999
CAHOY_NEURONAL,SET,97,-0.088919,-0.0064464,0.095433,0.82426,CAHOY_NEURONAL,0.99999
HP_IVORY_EPIPHYSES,SET,9,-0.25177,-0.0055732,0.27019,0.82428,HP_IVORY_EPIPHYSES,0.99999
GSE7852_LN_VS_THYMUS_TCONV_DN,SET,187,-0.05721,-0.0057446,0.061396,0.82428,GSE7852_LN_VS_THYMUS_TCONV_DN,0.99999
GSE35543_IN_VIVO_NTREG_VS_CO...1,SET,179,-0.061038,-0.0059977,0.065493,0.82432,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...79,SET,43,-0.12417,-0.0060027,0.13321,0.82436,HP_APLASIA_HYPOPLASIA_OF_THE_VAGINA,0.99999
HARALAMBIEVA_PBMC_M_M_R_II_A...5,SET,13,-0.25595,-0.0068087,0.27455,0.82439,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_LOW_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_UP,0.99999
MODULE_78,SET,20,-0.17917,-0.0059107,0.19217,0.82442,MODULE_78,0.99999
GSE16385_ROSIGLITAZONE_IFNG_...1,SET,174,-0.059341,-0.0057498,0.063644,0.82442,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,0.99999
GOMF_PHOSPHATASE_ACTIVATOR_A...,SET,16,-0.20511,-0.0060526,0.21996,0.82445,GOMF_PHOSPHATASE_ACTIVATOR_ACTIVITY,0.99999
GOBP_AMINO_ACID_METABOLIC_PR...,SET,255,-0.049644,-0.0058101,0.053231,0.82448,GOBP_AMINO_ACID_METABOLIC_PROCESS,0.99999
HP_BLUE_IRIDES,SET,50,-0.11896,-0.0061997,0.12753,0.82453,HP_BLUE_IRIDES,0.99999
ZHANG_RESPONSE_TO_IKK_INHIBI...1,SET,96,-0.084687,-0.006108,0.090784,0.82454,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,0.99999
GOBP_PHOSPHATE_ION_TRANSMEMB...,SET,14,-0.21747,-0.0060032,0.2331,0.82457,GOBP_PHOSPHATE_ION_TRANSMEMBRANE_TRANSPORT,0.99999
REACTOME_RAC2_GTPASE_CYCLE,SET,78,-0.095326,-0.0062004,0.10216,0.82461,REACTOME_RAC2_GTPASE_CYCLE,0.99999
GSE2770_TGFB_AND_IL4_ACT_VS_...2,SET,163,-0.062051,-0.0058209,0.066485,0.82466,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,0.99999
GSE17721_CTRL_VS_POLYIC_6H_B...2,SET,173,-0.057,-0.0055072,0.061072,0.82467,GSE17721_CTRL_VS_POLYIC_6H_BMDC_UP,0.99999
HOFFMANN_IMMATURE_TO_MATURE_...2,SET,35,-0.14183,-0.0061869,0.15193,0.82473,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP,0.99999
GSE16385_ROSIGLITAZONE_IL4_V...6,SET,177,-0.06342,-0.0061972,0.067934,0.82473,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_UP,0.99999
GSE12366_GC_VS_NAIVE_BCELL_UP,SET,178,-0.057646,-0.0056487,0.061745,0.82474,GSE12366_GC_VS_NAIVE_BCELL_UP,0.99999
HP_NEUROGENIC_BLADDER,SET,65,-0.094155,-0.0055926,0.10084,0.82476,HP_NEUROGENIC_BLADDER,0.99999
MIR1294,SET,150,-0.067279,-0.0060567,0.072045,0.8248,MIR1294,0.99999
PUIFFE_INVASION_INHIBITED_BY...2,SET,64,-0.098863,-0.0058271,0.10586,0.82481,PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...7,SET,140,-0.066673,-0.0058002,0.071387,0.82483,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN,0.99999
HP_TRICUSPID_ATRESIA,SET,11,-0.25529,-0.0062473,0.27327,0.8249,HP_TRICUSPID_ATRESIA,0.99999
GOBP_ESTABLISHMENT_OF_MITOTI...1,SET,5,-0.43301,-0.0071452,0.46349,0.82491,GOBP_ESTABLISHMENT_OF_MITOTIC_SISTER_CHROMATID_COHESION,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...1,SET,135,-0.069905,-0.0059726,0.07481,0.82495,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN,0.99999
HP_DROWSINESS,SET,52,-0.10823,-0.0057519,0.11578,0.82504,HP_DROWSINESS,0.99999
GOBP_EMBRYONIC_NEUROCRANIUM_...,SET,8,-0.31876,-0.0066527,0.34092,0.82509,GOBP_EMBRYONIC_NEUROCRANIUM_MORPHOGENESIS,0.99999
GSE7348_UNSTIM_VS_LPS_STIM_M...2,SET,141,-0.062405,-0.005448,0.066736,0.82512,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,0.99999
GOBP_INTRINSIC_APOPTOTIC_SIG...3,SET,97,-0.078057,-0.0056589,0.08347,0.82514,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.99999
GSE17721_LPS_VS_PAM3CSK4_0.5...2,SET,180,-0.058739,-0.0057878,0.062798,0.8252,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_UP,0.99999
GOCC_ACTIN_FILAMENT_BUNDLE,SET,85,-0.089245,-0.0060586,0.095387,0.82526,GOCC_ACTIN_FILAMENT_BUNDLE,0.99999
HP_ABNORMALITY_OF_NAIL_COLOR,SET,17,-0.20157,-0.0061312,0.21542,0.82528,HP_ABNORMALITY_OF_NAIL_COLOR,0.99999
ANASTASSIOU_MULTICANCER_INVA...,SET,61,-0.11158,-0.0064211,0.11922,0.82532,ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,0.99999
HP_INTERMITTENT_HYPERVENTILA...,SET,3,-0.5244,-0.0067032,0.56019,0.82539,HP_INTERMITTENT_HYPERVENTILATION,0.99999
WP_G_PROTEIN_SIGNALING,SET,90,-0.087899,-0.0061394,0.093894,0.8254,WP_G_PROTEIN_SIGNALING,0.99999
GOCC_OUTER_DENSE_FIBER,SET,4,-0.43919,-0.0064822,0.46909,0.82542,GOCC_OUTER_DENSE_FIBER,0.99999
HP_CHRONIC_OTITIS_MEDIA,SET,136,-0.069952,-0.0059985,0.074696,0.82548,HP_CHRONIC_OTITIS_MEDIA,0.99999
GSE2128_CTRL_VS_MIMETOPE_NEG...4,SET,178,-0.062364,-0.0061111,0.066595,0.82548,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP,0.99999
GSE3982_BASOPHIL_VS_TH1_DN,SET,174,-0.058585,-0.0056765,0.06256,0.82548,GSE3982_BASOPHIL_VS_TH1_DN,0.99999
GOMF_MECHANOSENSITIVE_MONOAT...2,SET,16,-0.21142,-0.006239,0.22573,0.82552,GOMF_MECHANOSENSITIVE_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.99999
HP_ABNORMAL_GROWTH_HORMONE_L...,SET,25,-0.16176,-0.0059655,0.17271,0.82552,HP_ABNORMAL_GROWTH_HORMONE_LEVEL,0.99999
REACTOME_FATTY_ACYL_COA_BIOS...,SET,35,-0.14511,-0.0063299,0.15492,0.82553,REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,0.99999
GSE7460_FOXP3_MUT_VS_HET_ACT...2,SET,183,-0.060414,-0.0060017,0.064499,0.82553,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP,0.99999
REACTOME_PEROXISOMAL_PROTEIN...,SET,60,-0.10258,-0.0058546,0.10951,0.82554,REACTOME_PEROXISOMAL_PROTEIN_IMPORT,0.99999
GOBP_POSITIVE_REGULATION_OF_...41,SET,5,-0.38291,-0.0063185,0.40873,0.82557,GOBP_POSITIVE_REGULATION_OF_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.99999
HP_PHOTOPHOBIA,SET,246,-0.051836,-0.0059601,0.055329,0.82558,HP_PHOTOPHOBIA,0.99999
NABA_COLLAGENS,SET,42,-0.13839,-0.0066116,0.1477,0.8256,NABA_COLLAGENS,0.99999
REACTOME_COLLAGEN_CHAIN_TRIM...,SET,42,-0.13839,-0.0066116,0.1477,0.8256,REACTOME_COLLAGEN_CHAIN_TRIMERIZATION,0.99999
GOBP_TIGHT_JUNCTION_ORGANIZA...,SET,75,-0.097112,-0.0061944,0.10361,0.82568,GOBP_TIGHT_JUNCTION_ORGANIZATION,0.99999
GOBP_RESPONSE_TO_SODIUM_PHOS...,SET,9,-0.30529,-0.006758,0.3257,0.8257,GOBP_RESPONSE_TO_SODIUM_PHOSPHATE,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_APO...2,SET,433,-0.038636,-0.0058633,0.041215,0.82572,HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M2_MACROPHAGE_CELL,0.99999
GSE17721_POLYIC_VS_CPG_6H_BM...2,SET,185,-0.057906,-0.0057836,0.061771,0.82573,GSE17721_POLYIC_VS_CPG_6H_BMDC_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...159,SET,7,-0.34207,-0.0066783,0.36485,0.82576,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_STORAGE,0.99999
GOBP_MAINTENANCE_OF_BLOOD_BR...,SET,37,-0.14797,-0.0066362,0.1578,0.82579,GOBP_MAINTENANCE_OF_BLOOD_BRAIN_BARRIER,0.99999
HP_GENERALIZED_LIPODYSTROPHY,SET,8,-0.33316,-0.0069534,0.35531,0.82579,HP_GENERALIZED_LIPODYSTROPHY,0.99999
MIR4720_5P,SET,79,-0.089889,-0.005884,0.095846,0.82583,MIR4720_5P,0.99999
HP_INCREASED_CIRCULATING_INS...,SET,5,-0.33539,-0.0055342,0.35761,0.82584,HP_INCREASED_CIRCULATING_INSULIN_LIKE_GROWTH_FACTOR_1_CONCENTRATION,0.99999
REACTOME_SPECIFICATION_OF_PR...,SET,11,-0.24189,-0.0059194,0.25789,0.82587,REACTOME_SPECIFICATION_OF_PRIMORDIAL_GERM_CELLS,0.99999
KEGG_MEDICUS_PATHOGEN_SHIGEL...3,SET,9,-0.28169,-0.0062356,0.30028,0.8259,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...473,SET,14,-0.18716,-0.0051666,0.1995,0.82591,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_TRANSLATION,0.99999
MIR218_2_3P,SET,46,-0.11813,-0.0059058,0.1259,0.82594,MIR218_2_3P,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...32,SET,116,-0.070258,-0.0055672,0.074882,0.82594,GOBP_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.99999
GOBP_POSITIVE_REGULATION_OF_...365,SET,14,-0.21161,-0.0058414,0.22551,0.82596,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION,0.99999
GOBP_RESPONSE_TO_OXYGEN_LEVE...,SET,302,-0.046937,-0.0059704,0.050007,0.82602,GOBP_RESPONSE_TO_OXYGEN_LEVELS,0.99999
GOMF_MRNA_METHYLTRANSFERASE_...,SET,12,-0.20283,-0.005184,0.21608,0.82604,GOMF_MRNA_METHYLTRANSFERASE_ACTIVITY,0.99999
HP_NON_HODGKIN_LYMPHOMA,SET,38,-0.13072,-0.0059413,0.13926,0.82605,HP_NON_HODGKIN_LYMPHOMA,0.99999
HP_ABNORMAL_ELECTRORETINOGRAM,SET,188,-0.059841,-0.0060246,0.063743,0.82607,HP_ABNORMAL_ELECTRORETINOGRAM,0.99999
GSE40274_SATB1_VS_FOXP3_AND_...1,SET,105,-0.080867,-0.0060983,0.086134,0.82609,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
ONGUSAHA_TP53_TARGETS,SET,33,-0.13911,-0.0058929,0.14817,0.8261,ONGUSAHA_TP53_TARGETS,0.99999
HP_ABNORMALITY_OF_NEUTROPHILS,SET,230,-0.052857,-0.0058791,0.056296,0.82611,HP_ABNORMALITY_OF_NEUTROPHILS,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...15,SET,14,-0.22505,-0.0062124,0.23965,0.82615,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,0.99999
GOBP_ADENINE_TRANSPORT,SET,5,-0.36204,-0.0059741,0.38551,0.82616,GOBP_ADENINE_TRANSPORT,0.99999
GSE1740_UNSTIM_VS_IFNA_STIMU...1,SET,159,-0.063626,-0.0058957,0.067738,0.8262,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN,0.99999
GSE28726_NAIVE_CD4_TCELL_VS_...2,SET,188,-0.057453,-0.0057842,0.061147,0.82628,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP,0.99999
BERENJENO_TRANSFORMED_BY_RHO...5,SET,8,-0.33312,-0.0069524,0.35452,0.82629,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP,0.99999
GOBP_SPLEEN_DEVELOPMENT,SET,37,-0.13282,-0.0059569,0.14133,0.82633,GOBP_SPLEEN_DEVELOPMENT,0.99999
GSE16451_CTRL_VS_WEST_EQUINE...3,SET,182,-0.058799,-0.0058255,0.062564,0.82634,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...426,SET,129,-0.073132,-0.0061088,0.077807,0.82636,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,0.99999
KEGG_MEDICUS_ENV_FACTOR_NICO...2,SET,5,-0.43047,-0.0071032,0.45796,0.82638,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_TO_JAK_STAT_SIGNALING_PATHWAY,0.99999
GSE14415_INDUCED_TREG_VS_FOX...4,SET,149,-0.06464,-0.0057997,0.068754,0.82643,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP,0.99999
GOBP_MYOSIN_FILAMENT_ORGANIZ...,SET,6,-0.32886,-0.0059444,0.34976,0.82645,GOBP_MYOSIN_FILAMENT_ORGANIZATION,0.99999
GOBP_CEREBELLAR_CORTEX_MORPH...,SET,32,-0.14693,-0.0061291,0.15623,0.8265,GOBP_CEREBELLAR_CORTEX_MORPHOGENESIS,0.99999
REACTOME_VLDL_ASSEMBLY,SET,3,-0.3653,-0.0046694,0.3884,0.82652,REACTOME_VLDL_ASSEMBLY,0.99999
GOBP_RESPONSE_TO_LEAD_ION,SET,19,-0.19728,-0.0063434,0.20974,0.82653,GOBP_RESPONSE_TO_LEAD_ION,0.99999
HP_PREAXIAL_POLYDACTYLY,SET,73,-0.087594,-0.0055126,0.09312,0.82655,HP_PREAXIAL_POLYDACTYLY,0.99999
GSE8685_IL2_STARVED_VS_IL21_...1,SET,186,-0.057124,-0.0057207,0.060729,0.82655,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,0.99999
GOBP_PROTEIN_TARGETING_TO_MI...,SET,96,-0.076853,-0.005543,0.081696,0.82657,GOBP_PROTEIN_TARGETING_TO_MITOCHONDRION,0.99999
GSE17721_0.5H_VS_12H_POLYIC_...1,SET,186,-0.057313,-0.0057397,0.060911,0.82662,GSE17721_0.5H_VS_12H_POLYIC_BMDC_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...128,SET,14,-0.22897,-0.0063208,0.24334,0.82663,GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.99999
HP_THYROID_ADENOMA,SET,13,-0.23335,-0.0062074,0.24795,0.82667,HP_THYROID_ADENOMA,0.99999
GNF2_TAL1,SET,61,-0.10456,-0.0060175,0.11105,0.82678,GNF2_TAL1,0.99999
GOMF_PHOSPHATIDYLSERINE_FLOP...,SET,8,-0.31033,-0.0064769,0.3296,0.82678,GOMF_PHOSPHATIDYLSERINE_FLOPPASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...25,SET,18,-0.18612,-0.0058251,0.19765,0.82681,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...816,SET,25,-0.16902,-0.0062332,0.17948,0.82683,GOBP_POSITIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,0.99999
AIZARANI_LIVER_C7_EPCAM_POS_...,SET,206,-0.060962,-0.0064214,0.064726,0.82686,AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2,0.99999
BANDRES_RESPONSE_TO_CARMUSTI...2,SET,8,-0.23062,-0.0048132,0.24478,0.82694,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...97,SET,41,-0.12167,-0.0057437,0.12914,0.82694,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.99999
GSE3920_UNTREATED_VS_IFNB_TR...2,SET,183,-0.060127,-0.0059732,0.063816,0.82695,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,0.99999
GOBP_REGULATION_OF_WNT_PROTE...,SET,5,-0.37013,-0.0061075,0.39271,0.82702,GOBP_REGULATION_OF_WNT_PROTEIN_SECRETION,0.99999
GOBP_WNT_PROTEIN_SECRETION,SET,5,-0.37013,-0.0061075,0.39271,0.82702,GOBP_WNT_PROTEIN_SECRETION,0.99999
MIR539_3P,SET,207,-0.060647,-0.0064035,0.064345,0.82703,MIR539_3P,0.99999
MIR127_3P,SET,5,-0.35524,-0.0058618,0.37687,0.82705,MIR127_3P,0.99999
BROWNE_HCMV_INFECTION_8HR_UP,SET,91,-0.084035,-0.0059018,0.089112,0.82716,BROWNE_HCMV_INFECTION_8HR_UP,0.99999
GOMF_S100_PROTEIN_BINDING,SET,14,-0.21599,-0.0059624,0.22904,0.82716,GOMF_S100_PROTEIN_BINDING,0.99999
HP_ABULIA,SET,10,-0.25438,-0.0059355,0.26973,0.82718,HP_ABULIA,0.99999
HENDRICKS_SMARCA4_TARGETS_DN,SET,41,-0.1385,-0.0065382,0.14685,0.82719,HENDRICKS_SMARCA4_TARGETS_DN,0.99999
HP_MEDIAN_CLEFT_UPPER_LIP,SET,32,-0.14,-0.0058401,0.14844,0.8272,HP_MEDIAN_CLEFT_UPPER_LIP,0.99999
HP_RHOMBENCEPHALOSYNAPSIS,SET,15,-0.21378,-0.0061084,0.22664,0.82722,HP_RHOMBENCEPHALOSYNAPSIS,0.99999
GOBP_GLUTAMATE_REUPTAKE,SET,6,-0.38389,-0.006939,0.40697,0.82723,GOBP_GLUTAMATE_REUPTAKE,0.99999
GOBP_GLUTAMINE_FAMILY_AMINO_...3,SET,66,-0.1039,-0.0062185,0.11014,0.82723,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.99999
HP_INSULIN_RESISTANCE,SET,104,-0.082938,-0.0062248,0.087914,0.82725,HP_INSULIN_RESISTANCE,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...8,SET,190,-0.058902,-0.0059612,0.062436,0.82726,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_UP,0.99999
CYCLIN_D1_UP.V1_DN,SET,175,-0.061756,-0.0060007,0.065446,0.82731,CYCLIN_D1_UP.V1_DN,0.99999
REACTOME_INTERLEUKIN_10_SIGN...,SET,43,-0.13654,-0.0066002,0.14468,0.82734,REACTOME_INTERLEUKIN_10_SIGNALING,0.99999
GSE5589_LPS_AND_IL10_VS_LPS_...1,SET,177,-0.059835,-0.0058469,0.06339,0.82739,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,0.99999
KEGG_PYRUVATE_METABOLISM,SET,38,-0.12428,-0.0056483,0.13163,0.82744,KEGG_PYRUVATE_METABOLISM,0.99999
ZNF250_TARGET_GENES,SET,444,-0.03815,-0.0058609,0.040409,0.82744,ZNF250_TARGET_GENES,0.99999
GOBP_MITOCHONDRIAL_RNA_CATAB...,SET,6,-0.2905,-0.0052509,0.30767,0.82745,GOBP_MITOCHONDRIAL_RNA_CATABOLIC_PROCESS,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...12,SET,44,-0.13833,-0.006764,0.1465,0.82746,GAVISH_3CA_METAPROGRAM_B_CELLS_STRESS,0.99999
WP_PANCREATIC_ADENOCARCINOMA...,SET,83,-0.088662,-0.0059481,0.09389,0.82749,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,0.99999
HP_DYSPHONIA,SET,111,-0.07649,-0.0059297,0.080999,0.82749,HP_DYSPHONIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...229,SET,5,-0.39657,-0.0065439,0.41989,0.82753,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,0.99999
HP_SYNOSTOSIS_INVOLVING_BONE...1,SET,26,-0.18148,-0.0068249,0.19213,0.82756,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_FEET,0.99999
TBX3_TARGET_GENES,SET,627,-0.03247,-0.0058974,0.034371,0.82758,TBX3_TARGET_GENES,0.99999
NIKOLSKY_BREAST_CANCER_14Q22...,SET,12,-0.35363,-0.0090384,0.37421,0.82767,NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON,0.99999
GOBP_ETHANOLAMINE_CONTAINING...,SET,7,-0.29827,-0.0058232,0.31561,0.82768,GOBP_ETHANOLAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
GSE14000_TRANSLATED_RNA_VS_M...6,SET,178,-0.059298,-0.0058106,0.062744,0.82769,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP,0.99999
GSE2405_0H_VS_24H_A_PHAGOCYT...2,SET,187,-0.058192,-0.0058431,0.061549,0.82778,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.99999
HP_HIP_SUBLUXATION,SET,19,-0.18557,-0.0059668,0.19627,0.82779,HP_HIP_SUBLUXATION,0.99999
GSE29615_CTRL_VS_DAY7_LAIV_F...1,SET,130,-0.06897,-0.0057833,0.072936,0.82782,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...11,SET,177,-0.058798,-0.0057456,0.062174,0.82784,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,0.99999
REACTOME_ADP_SIGNALLING_THRO...2,SET,22,-0.18355,-0.0063504,0.19407,0.82787,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12,0.99999
WAESCH_ANAPHASE_PROMOTING_CO...,SET,12,-0.2253,-0.0057583,0.2382,0.82788,WAESCH_ANAPHASE_PROMOTING_COMPLEX,0.99999
GUTIERREZ_CHRONIC_LYMPHOCYTI...1,SET,50,-0.11595,-0.006043,0.12258,0.82789,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,0.99999
FULLER_PBMC_F_TULARENSIS_VAC...10,SET,16,-0.20318,-0.0059956,0.21474,0.82796,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...129,SET,13,-0.23101,-0.0061451,0.24413,0.82798,GOBP_POSITIVE_REGULATION_OF_CELL_FATE_COMMITMENT,0.99999
HP_ABNORMAL_BASAL_GANGLIA_MR...,SET,35,-0.13216,-0.005765,0.13967,0.82798,HP_ABNORMAL_BASAL_GANGLIA_MRI_SIGNAL_INTENSITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...371,SET,7,-0.34395,-0.006715,0.36344,0.82801,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_23_PRODUCTION,0.99999
HP_RECURRENT_PNEUMONIA,SET,113,-0.077263,-0.006043,0.081641,0.82801,HP_RECURRENT_PNEUMONIA,0.99999
GOBP_CALCIUM_ACTIVATED_PHOSP...,SET,5,-0.39213,-0.0064706,0.41419,0.82811,GOBP_CALCIUM_ACTIVATED_PHOSPHOLIPID_SCRAMBLING,0.99999
HP_BROAD_METATARSAL,SET,12,-0.24199,-0.0061848,0.2556,0.82811,HP_BROAD_METATARSAL,0.99999
CONRAD_STEM_CELL,SET,35,-0.1435,-0.0062596,0.15156,0.82812,CONRAD_STEM_CELL,0.99999
WAKABAYASHI_ADIPOGENESIS_PPA...3,SET,143,-0.070421,-0.006191,0.074372,0.82814,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,0.99999
GOBP_ESTABLISHMENT_OF_ENDOTH...2,SET,13,-0.23807,-0.006333,0.25137,0.8282,GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_INTESTINAL_BARRIER,0.99999
HP_ENLARGED_CISTERNA_MAGNA,SET,52,-0.10247,-0.005446,0.1082,0.8282,HP_ENLARGED_CISTERNA_MAGNA,0.99999
GOCC_CHROMOCENTER,SET,13,-0.19786,-0.0052634,0.20885,0.82827,GOCC_CHROMOCENTER,0.99999
HP_PERIPHERAL_RETINAL_AVASCU...,SET,7,-0.33591,-0.006558,0.35451,0.82831,HP_PERIPHERAL_RETINAL_AVASCULARIZATION,0.99999
GOCC_CLATHRIN_COATED_VESICLE,SET,200,-0.060113,-0.0062401,0.063434,0.82834,GOCC_CLATHRIN_COATED_VESICLE,0.99999
WP_METABOLISM_OF_SPHINGOLIPI...,SET,21,-0.18994,-0.0064206,0.20043,0.82835,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,0.99999
NOUSHMEHR_GBM_SOMATIC_MUTATED,SET,9,-0.31045,-0.0068723,0.32748,0.82843,NOUSHMEHR_GBM_SOMATIC_MUTATED,0.99999
MIR323B_5P,SET,38,-0.12694,-0.0057695,0.1339,0.82845,MIR323B_5P,0.99999
HP_OVAL_FACE,SET,15,-0.2102,-0.006006,0.2217,0.82846,HP_OVAL_FACE,0.99999
GOBP_RESPONSE_TO_SODIUM_ARSE...,SET,6,-0.33499,-0.0060551,0.3533,0.82847,GOBP_RESPONSE_TO_SODIUM_ARSENITE,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...10,SET,66,-0.11146,-0.0066709,0.11754,0.8285,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MAST_CELLS,0.99999
GOBP_MAINTENANCE_OF_POSTSYNA...,SET,8,-0.28684,-0.0059865,0.30247,0.82851,GOBP_MAINTENANCE_OF_POSTSYNAPTIC_SPECIALIZATION_STRUCTURE,0.99999
GOMF_DNA_DNA_ANNEALING_ACTIV...,SET,7,-0.31578,-0.0061651,0.33294,0.82855,GOMF_DNA_DNA_ANNEALING_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...524,SET,192,-0.0573,-0.0058292,0.060401,0.8286,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION,0.99999
MIR12130,SET,29,-0.15019,-0.0059646,0.15829,0.82863,MIR12130,0.99999
GSE9037_CTRL_VS_LPS_4H_STIM_...1,SET,183,-0.058072,-0.005769,0.061206,0.82863,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN,0.99999
GSE40274_IRF4_VS_FOXP3_AND_I...2,SET,157,-0.061059,-0.0056224,0.064345,0.82867,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GOBP_CELL_DIVISION,SET,578,-0.0335,-0.0058499,0.035299,0.82869,GOBP_CELL_DIVISION,0.99999
HP_ABNORMALITY_OF_LIPOPROTEI...,SET,80,-0.093561,-0.0061628,0.098574,0.82872,HP_ABNORMALITY_OF_LIPOPROTEIN_CHOLESTEROL_CONCENTRATION,0.99999
HP_LINEAR_ARRAYS_OF_MACULAR_...,SET,5,-0.40875,-0.0067448,0.43063,0.82873,HP_LINEAR_ARRAYS_OF_MACULAR_HYPERKERATOSES_IN_FLEXURAL_AREAS,0.99999
HMGB2_TARGET_GENES,SET,412,-0.041105,-0.0060884,0.043291,0.82881,HMGB2_TARGET_GENES,0.99999
GOBP_CELLULAR_RESPONSE_TO_PH,SET,25,-0.16314,-0.0060161,0.17181,0.82882,GOBP_CELLULAR_RESPONSE_TO_PH,0.99999
GOBP_REGULATION_OF_NEURONAL_...1,SET,3,-0.54859,-0.0070123,0.57772,0.82883,GOBP_REGULATION_OF_NEURONAL_ACTION_POTENTIAL,0.99999
HP_EXERCISE_INDUCED_MYOGLOBI...,SET,7,-0.24586,-0.0047999,0.25889,0.82885,HP_EXERCISE_INDUCED_MYOGLOBINURIA,0.99999
MIR485_3P,SET,207,-0.061182,-0.00646,0.064418,0.82888,MIR485_3P,0.99999
GOBP_SOMITOGENESIS,SET,59,-0.10906,-0.0061728,0.11483,0.82889,GOBP_SOMITOGENESIS,0.99999
HP_CONFUSION,SET,68,-0.097557,-0.0059264,0.10268,0.82897,HP_CONFUSION,0.99999
HP_ACANTHOSIS_NIGRICANS,SET,57,-0.11266,-0.0062681,0.11856,0.829,HP_ACANTHOSIS_NIGRICANS,0.99999
KEGG_MEDICUS_REFERENCE_MAGI_...,SET,6,-0.32422,-0.0058604,0.34118,0.82901,KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY,0.99999
ZNF524_TARGET_GENES,SET,277,-0.047769,-0.0058233,0.050265,0.82902,ZNF524_TARGET_GENES,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...65,SET,37,-0.11216,-0.0050303,0.11801,0.82904,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_TDP43_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,0.99999
HP_ELEVATED_CIRCULATING_LONG...,SET,3,-0.37829,-0.0048354,0.398,0.82906,HP_ELEVATED_CIRCULATING_LONG_CHAIN_FATTY_ACID_CONCENTRATION,0.99999
MIZUSHIMA_AUTOPHAGOSOME_FORM...,SET,12,-0.22636,-0.0057854,0.23815,0.82907,MIZUSHIMA_AUTOPHAGOSOME_FORMATION,0.99999
HP_OVERLAPPING_FINGERS,SET,29,-0.15094,-0.0059945,0.1588,0.82907,HP_OVERLAPPING_FINGERS,0.99999
GSE16385_UNTREATED_VS_12H_RO...4,SET,186,-0.057123,-0.0057206,0.060096,0.82907,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,0.99999
MIR4481,SET,121,-0.073413,-0.0059404,0.077208,0.82915,MIR4481,0.99999
REACTOME_SYNTHESIS_OF_VERY_L...,SET,23,-0.19259,-0.0068126,0.20252,0.82918,REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS,0.99999
MODULE_127,SET,12,-0.20963,-0.0053577,0.22043,0.82918,MODULE_127,0.99999
KEGG_MEDICUS_VARIANT_ERBB2_O...2,SET,12,-0.23053,-0.005892,0.24237,0.82922,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,0.99999
GSE10147_IL3_VS_IL3_AND_CPG_...2,SET,132,-0.070399,-0.005948,0.074019,0.82922,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP,0.99999
GSE5589_WT_VS_IL6_KO_LPS_AND...3,SET,178,-0.059809,-0.0058607,0.062884,0.82922,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.99999
GSE40273_XBP1_KO_VS_WT_TREG_...2,SET,185,-0.060337,-0.0060264,0.063424,0.82927,GSE40273_XBP1_KO_VS_WT_TREG_UP,0.99999
ZNF394_TARGET_GENES,SET,828,-0.028923,-0.0060023,0.030398,0.82931,ZNF394_TARGET_GENES,0.99999
ZHU_CMV_ALL_DN,SET,108,-0.081932,-0.0062657,0.086102,0.82933,ZHU_CMV_ALL_DN,0.99999
GSE37605_C57BL6_VS_NOD_FOXP3...5,SET,148,-0.065831,-0.0058869,0.069184,0.82933,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_DN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...5,SET,14,-0.21923,-0.0060519,0.23038,0.82934,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOBP_SYNAPTIC_VESICLE_MATURA...,SET,21,-0.18635,-0.0062991,0.19583,0.82934,GOBP_SYNAPTIC_VESICLE_MATURATION,0.99999
GSE38304_MYC_NEG_VS_POS_GC_B...1,SET,182,-0.062207,-0.0061631,0.065371,0.82934,GSE38304_MYC_NEG_VS_POS_GC_BCELL_DN,0.99999
WP_OSTEOBLAST_SIGNALING,SET,13,-0.25201,-0.006704,0.26479,0.82938,WP_OSTEOBLAST_SIGNALING,0.99999
SARRIO_EPITHELIAL_MESENCHYMA...2,SET,159,-0.061775,-0.0057242,0.064903,0.8294,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,0.99999
KIM_ALL_DISORDERS_OLIGODENDR...1,SET,30,-0.14139,-0.0057109,0.14849,0.82949,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,0.99999
GOBP_ACROSOME_ASSEMBLY,SET,25,-0.15488,-0.0057116,0.16262,0.82955,GOBP_ACROSOME_ASSEMBLY,0.99999
MCBRYAN_PUBERTAL_TGFB1_TARGE...1,SET,57,-0.12076,-0.0067187,0.12678,0.82959,MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,0.99999
GSE37416_CTRL_VS_3H_F_TULARE...1,SET,176,-0.061296,-0.0059728,0.064337,0.82963,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
BIOCARTA_D4GDI_PATHWAY,SET,12,-0.23549,-0.0060189,0.24717,0.82964,BIOCARTA_D4GDI_PATHWAY,0.99999
HP_CARDIAC_DIVERTICULUM,SET,20,-0.16192,-0.0053415,0.16992,0.82968,HP_CARDIAC_DIVERTICULUM,0.99999
GOBP_PEROXISOME_ORGANIZATION,SET,30,-0.144,-0.0058164,0.1511,0.8297,GOBP_PEROXISOME_ORGANIZATION,0.99999
REACTOME_TRANSPORT_AND_SYNTH...,SET,6,-0.34464,-0.0062296,0.36162,0.82971,REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS,0.99999
FOXG1_TARGET_GENES,SET,476,-0.037319,-0.0059309,0.039157,0.82972,FOXG1_TARGET_GENES,0.99999
MIR6757_3P,SET,96,-0.08445,-0.006091,0.088592,0.82976,MIR6757_3P,0.99999
HP_FETAL_PYELECTASIS,SET,9,-0.28559,-0.006322,0.2996,0.82976,HP_FETAL_PYELECTASIS,0.99999
MIR6763_5P,SET,92,-0.082122,-0.005799,0.086142,0.82978,MIR6763_5P,0.99999
HP_MALAR_FLATTENING,SET,175,-0.061915,-0.0060162,0.064946,0.82978,HP_MALAR_FLATTENING,0.99999
REACTOME_RUNX1_REGULATES_TRA...1,SET,6,-0.3092,-0.005589,0.32427,0.82983,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING,0.99999
REACTOME_GLYCOSAMINOGLYCAN_M...,SET,120,-0.07665,-0.0061768,0.080372,0.82987,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,0.99999
GNF2_GLTSCR2,SET,30,-0.14551,-0.0058774,0.15258,0.82987,GNF2_GLTSCR2,0.99999
GOBP_DETECTION_OF_TEMPERATUR...1,SET,26,-0.16977,-0.0063844,0.178,0.82989,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...11,SET,186,-0.061243,-0.0061332,0.064211,0.82989,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_DN,0.99999
MEBARKI_HCC_PROGENITOR_FZD8C...2,SET,477,-0.036666,-0.005833,0.038438,0.82993,MEBARKI_HCC_PROGENITOR_FZD8CRD_UP,0.99999
MORF_IL9,SET,86,-0.09071,-0.006194,0.095078,0.82997,MORF_IL9,0.99999
WP_CHROMOSOMAL_AND_MICROSATE...,SET,72,-0.096554,-0.0060349,0.1012,0.82998,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,0.99999
AGUIRRE_PANCREATIC_CANCER_CO...1,SET,221,-0.058192,-0.0063462,0.060986,0.83,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,0.99999
GOMF_HIGH_DENSITY_LIPOPROTEI...,SET,11,-0.24975,-0.0061117,0.26173,0.83001,GOMF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING,0.99999
GOCC_CYTOPLASMIC_SIDE_OF_PLA...,SET,152,-0.068551,-0.0062118,0.071836,0.83002,GOCC_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE,0.99999
REACTOME_GLYCOSPHINGOLIPID_B...,SET,19,-0.20386,-0.0065549,0.2136,0.83005,REACTOME_GLYCOSPHINGOLIPID_BIOSYNTHESIS,0.99999
GSE3203_WT_VS_IFNAR1_KO_INFL...2,SET,178,-0.062296,-0.0061043,0.065274,0.83005,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_UP,0.99999
PATEL_SKIN_OF_BODY_ZOSTAVAX_...1,SET,25,-0.16931,-0.0062437,0.17738,0.83007,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGED_POST_VACCINATION_VS_UNCHALLENGED_72HR_TOP_30_DEG_UP,0.99999
GSE14415_INDUCED_TREG_VS_FAI...2,SET,169,-0.057568,-0.005498,0.060301,0.83012,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_UP,0.99999
GOBP_GLYCERALDEHYDE_3_PHOSPH...,SET,11,-0.22956,-0.0056175,0.24045,0.83013,GOBP_GLYCERALDEHYDE_3_PHOSPHATE_METABOLIC_PROCESS,0.99999
CHANG_POU5F1_TARGETS_UP,SET,13,-0.25371,-0.0067491,0.26573,0.83015,CHANG_POU5F1_TARGETS_UP,0.99999
GOBP_ASCENDING_AORTA_DEVELOP...,SET,5,-0.42134,-0.0069526,0.44129,0.83015,GOBP_ASCENDING_AORTA_DEVELOPMENT,0.99999
GOBP_FILOPODIUM_ASSEMBLY,SET,60,-0.11545,-0.0065893,0.1209,0.83018,GOBP_FILOPODIUM_ASSEMBLY,0.99999
GOBP_POSITIVE_REGULATION_OF_...748,SET,22,-0.17624,-0.0060975,0.18456,0.83018,GOBP_POSITIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,0.99999
GOBP_RESPONSE_TO_ALDOSTERONE,SET,17,-0.20453,-0.006221,0.21416,0.83021,GOBP_RESPONSE_TO_ALDOSTERONE,0.99999
GOBP_RESPONSE_TO_NUTRIENT,SET,156,-0.069226,-0.0063543,0.072487,0.83021,GOBP_RESPONSE_TO_NUTRIENT,0.99999
HP_INCREASED_INFLAMMATORY_RE...,SET,1101,-0.025469,-0.0060472,0.026667,0.83022,HP_INCREASED_INFLAMMATORY_RESPONSE,0.99999
HP_ABNORMAL_CIRCULATING_ALDO...1,SET,21,-0.16493,-0.005575,0.17265,0.83028,HP_ABNORMAL_CIRCULATING_ALDOLASE_CONCENTRATION,0.99999
HP_ABNORMAL_CIRCULATING_IRON...,SET,17,-0.18914,-0.005753,0.19799,0.83028,HP_ABNORMAL_CIRCULATING_IRON_CONCENTRATION,0.99999
GSE33425_CD161_HIGH_VS_NEG_C...2,SET,184,-0.061355,-0.0061116,0.064223,0.83029,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP,0.99999
MODULE_148,SET,13,-0.25764,-0.0068536,0.26964,0.83033,MODULE_148,0.99999
BIOCARTA_DC_PATHWAY,SET,16,-0.22969,-0.0067778,0.24037,0.83034,BIOCARTA_DC_PATHWAY,0.99999
HALLMARK_SPERMATOGENESIS,SET,126,-0.074525,-0.0061529,0.077994,0.83034,HALLMARK_SPERMATOGENESIS,0.99999
DESCARTES_FETAL_MUSCLE_ERYTH...,SET,101,-0.078877,-0.0058345,0.082546,0.83035,DESCARTES_FETAL_MUSCLE_ERYTHROBLASTS,0.99999
ERCC8_TARGET_GENES,SET,7,-0.31493,-0.0061484,0.32955,0.83036,ERCC8_TARGET_GENES,0.99999
GSE17721_CTRL_VS_PAM3CSK4_2H...2,SET,183,-0.058979,-0.0058592,0.061709,0.8304,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_UP,0.99999
MIR617,SET,57,-0.10379,-0.0057746,0.10859,0.83041,MIR617,0.99999
MIKKELSEN_MEF_HCP_WITH_H3_UN...,SET,184,-0.063471,-0.0063224,0.066395,0.83045,MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED,0.99999
GOBP_CELL_CELL_JUNCTION_ASSE...,SET,146,-0.073243,-0.0065057,0.076601,0.8305,GOBP_CELL_CELL_JUNCTION_ASSEMBLY,0.99999
GSE13484_12H_UNSTIM_VS_YF17D...2,SET,177,-0.060202,-0.0058827,0.062958,0.83051,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,0.99999
SANSOM_APC_TARGETS_DN,SET,333,-0.045993,-0.006138,0.048095,0.83053,SANSOM_APC_TARGETS_DN,0.99999
HP_APLASIA_OF_THE_SEMICIRCUL...,SET,16,-0.18566,-0.0054786,0.19412,0.83056,HP_APLASIA_OF_THE_SEMICIRCULAR_CANAL,0.99999
MIR9851_3P,SET,161,-0.06472,-0.0060342,0.067653,0.83062,MIR9851_3P,0.99999
CATTGTYY_SOX9_B1,SET,330,-0.046169,-0.0061341,0.048236,0.83075,CATTGTYY_SOX9_B1,0.99999
GSE29949_CD8_POS_DC_SPLEEN_V...3,SET,175,-0.062138,-0.0060379,0.064916,0.83076,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...132,SET,5,-0.30713,-0.005068,0.32075,0.83084,GOBP_NEGATIVE_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS,0.99999
GSE41867_NAIVE_VS_DAY8_LCMV_...5,SET,179,-0.059139,-0.0058111,0.06176,0.83085,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,0.99999
HP_RIB_FUSION,SET,45,-0.12608,-0.0062347,0.13165,0.83088,HP_RIB_FUSION,0.99999
HP_INCREASED_SERUM_TESTOSTER...,SET,10,-0.27796,-0.0064856,0.29024,0.83089,HP_INCREASED_SERUM_TESTOSTERONE_LEVEL,0.99999
GOBP_CHROMATIN_REMODELING,SET,516,-0.03479,-0.0057502,0.036322,0.83092,GOBP_CHROMATIN_REMODELING,0.99999
GSE41978_ID2_KO_VS_BIM_KO_KL...1,SET,180,-0.061138,-0.0060242,0.063817,0.83097,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.99999
KEGG_MEDICUS_REFERENCE_UREA_...,SET,5,-0.33055,-0.0054544,0.34501,0.83098,KEGG_MEDICUS_REFERENCE_UREA_CYCLE,0.99999
KEGG_PURINE_METABOLISM,SET,144,-0.066486,-0.0058653,0.069391,0.831,KEGG_PURINE_METABOLISM,0.99999
HP_ABNORMAL_CIRCULATING_META...,SET,1249,-0.023915,-0.0060219,0.024957,0.83102,HP_ABNORMAL_CIRCULATING_METABOLITE_CONCENTRATION,0.99999
REACTOME_MET_PROMOTES_CELL_M...,SET,41,-0.14117,-0.0066641,0.1473,0.83106,REACTOME_MET_PROMOTES_CELL_MOTILITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...524,SET,37,-0.14067,-0.0063091,0.14676,0.8311,GOBP_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION,0.99999
MIR6788_5P,SET,115,-0.079951,-0.0063081,0.083398,0.83113,MIR6788_5P,0.99999
HP_SHORT_STERNUM,SET,10,-0.26978,-0.0062948,0.28131,0.83122,HP_SHORT_STERNUM,0.99999
REACTOME_CREB1_PHOSPHORYLATI...3,SET,8,-0.33244,-0.0069383,0.3466,0.83125,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE,0.99999
GSE339_CD8POS_VS_CD4CD8DN_DC...1,SET,182,-0.058614,-0.0058071,0.061088,0.83134,GSE339_CD8POS_VS_CD4CD8DN_DC_DN,0.99999
HP_PRIMITIVE_REFLEX,SET,24,-0.15873,-0.0057353,0.16542,0.83135,HP_PRIMITIVE_REFLEX,0.99999
HP_OSTEOLYSIS,SET,72,-0.096384,-0.0060243,0.10043,0.8314,HP_OSTEOLYSIS,0.99999
HP_FIBROSARCOMA,SET,9,-0.3042,-0.0067338,0.31694,0.83142,HP_FIBROSARCOMA,0.99999
HP_ABNORMAL_TRICUSPID_VALVE_...2,SET,72,-0.096911,-0.0060572,0.10095,0.83146,HP_ABNORMAL_TRICUSPID_VALVE_PHYSIOLOGY,0.99999
HP_CAPILLARY_HEMANGIOMA,SET,37,-0.14073,-0.0063114,0.14659,0.83147,HP_CAPILLARY_HEMANGIOMA,0.99999
GSE11367_CTRL_VS_IL17_TREATE...2,SET,119,-0.077828,-0.0062457,0.081058,0.8315,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP,0.99999
YANG_BREAST_CANCER_ESR1_BULK...2,SET,25,-0.1582,-0.0058339,0.16475,0.83152,YANG_BREAST_CANCER_ESR1_BULK_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...674,SET,10,-0.24399,-0.0056929,0.25407,0.83154,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,0.99999
MIR514A_5P,SET,61,-0.11225,-0.0064596,0.11687,0.83158,MIR514A_5P,0.99999
STEGER_ADIPOGENESIS_DN,SET,22,-0.18655,-0.0064539,0.19421,0.83159,STEGER_ADIPOGENESIS_DN,0.99999
GSE27092_WT_VS_HDAC7_PHOSPHO...2,SET,185,-0.061734,-0.0061659,0.064251,0.83167,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP,0.99999
GSE28737_WT_VS_BCL6_HET_FOLL...2,SET,183,-0.059836,-0.0059443,0.062273,0.83168,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP,0.99999
DESCARTES_FETAL_KIDNEY_LYMPH...,SET,150,-0.073196,-0.0065892,0.076163,0.83173,DESCARTES_FETAL_KIDNEY_LYMPHOID_CELLS,0.99999
MYB_Q5_01,SET,246,-0.052527,-0.0060396,0.054655,0.83174,MYB_Q5_01,0.99999
GOCC_MUSCLE_MYOSIN_COMPLEX,SET,14,-0.29085,-0.0080289,0.30262,0.83174,GOCC_MUSCLE_MYOSIN_COMPLEX,0.99999
AIZARANI_LIVER_C12_NK_NKT_CE...,SET,43,-0.12893,-0.0062323,0.13414,0.83175,AIZARANI_LIVER_C12_NK_NKT_CELLS_4,0.99999
YAGI_AML_WITH_11Q23_REARRANG...,SET,305,-0.047215,-0.006035,0.049121,0.83177,YAGI_AML_WITH_11Q23_REARRANGED,0.99999
GOBP_CAMP_CATABOLIC_PROCESS,SET,9,-0.28757,-0.0063657,0.29908,0.83185,GOBP_CAMP_CATABOLIC_PROCESS,0.99999
REACTOME_MRNA_SPLICING_MINOR...,SET,48,-0.10575,-0.0054005,0.10997,0.83189,REACTOME_MRNA_SPLICING_MINOR_PATHWAY,0.99999
GOBP_REGULATION_OF_SYNAPSE_M...,SET,21,-0.18435,-0.0062316,0.19169,0.8319,GOBP_REGULATION_OF_SYNAPSE_MATURATION,0.99999
GAUTSCHI_SRC_SIGNALING,SET,8,-0.31264,-0.006525,0.32504,0.83193,GAUTSCHI_SRC_SIGNALING,0.99999
MIR3059_3P,SET,47,-0.11341,-0.0057308,0.11791,0.83193,MIR3059_3P,0.99999
GOBP_RESPONSE_TO_PAIN,SET,35,-0.1465,-0.0063905,0.15228,0.83197,GOBP_RESPONSE_TO_PAIN,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...17,SET,70,-0.10918,-0.0067292,0.11349,0.83199,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PERICYTES,0.99999
GOBP_CELLULAR_HYPEROSMOTIC_R...,SET,19,-0.18939,-0.0060898,0.19684,0.83201,GOBP_CELLULAR_HYPEROSMOTIC_RESPONSE,0.99999
GOMF_MOLECULAR_TAG_ACTIVITY,SET,11,-0.25991,-0.0063603,0.27013,0.83201,GOMF_MOLECULAR_TAG_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...542,SET,16,-0.24076,-0.0071047,0.25008,0.83216,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS,0.99999
ACEVEDO_LIVER_CANCER_WITH_H3...3,SET,82,-0.089507,-0.0059687,0.092961,0.83218,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,0.99999
GOBP_CGMP_MEDIATED_SIGNALING,SET,25,-0.17215,-0.0063486,0.17875,0.83225,GOBP_CGMP_MEDIATED_SIGNALING,0.99999
CYCLIN_D1_KE_.V1_DN,SET,179,-0.062557,-0.006147,0.064952,0.83225,CYCLIN_D1_KE_.V1_DN,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...1,SET,6,-0.35569,-0.0064293,0.36927,0.83228,GOBP_PROTEIN_LOCALIZATION_TO_ADHERENS_JUNCTION,0.99999
HP_LIMB_HYPERTONIA,SET,143,-0.066697,-0.0058636,0.069241,0.83228,HP_LIMB_HYPERTONIA,0.99999
GOMF_NAD_BINDING,SET,55,-0.10974,-0.0059976,0.11392,0.83229,GOMF_NAD_BINDING,0.99999
HP_PULMONARY_ARTERY_ANEURYSM,SET,7,-0.3144,-0.0061382,0.32636,0.83231,HP_PULMONARY_ARTERY_ANEURYSM,0.99999
HP_FOLLICULAR_HYPERPLASIA,SET,14,-0.24118,-0.0066578,0.25034,0.83232,HP_FOLLICULAR_HYPERPLASIA,0.99999
MIR499A_5P,SET,160,-0.066335,-0.0061658,0.068853,0.83233,MIR499A_5P,0.99999
GOBP_HYPOXIA_INDUCIBLE_FACTO...,SET,3,-0.52575,-0.0067203,0.54567,0.83234,GOBP_HYPOXIA_INDUCIBLE_FACTOR_1ALPHA_SIGNALING_PATHWAY,0.99999
GOBP_RESPONSE_TO_UV_B,SET,19,-0.18691,-0.00601,0.19398,0.83235,GOBP_RESPONSE_TO_UV_B,0.99999
GSE33292_DN3_THYMOCYTE_VS_TC...3,SET,137,-0.074405,-0.0064036,0.077218,0.83236,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_DN,0.99999
FERREIRA_EWINGS_SARCOMA_UNST...1,SET,86,-0.088935,-0.0060728,0.092291,0.83238,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,0.99999
HP_ABNORMAL_LIVER_ENZYME_ACT...,SET,11,-0.23752,-0.0058124,0.24647,0.83239,HP_ABNORMAL_LIVER_ENZYME_ACTIVITY_OR_CONCENTRATION,0.99999
GOMF_PROTEASOME_ACTIVATING_A...,SET,6,-0.26994,-0.0048793,0.2801,0.8324,GOMF_PROTEASOME_ACTIVATING_ACTIVITY,0.99999
GUTIERREZ_WALDENSTROEMS_MACR...2,SET,10,-0.28599,-0.0066729,0.29674,0.83242,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP,0.99999
GOBP_PROTEIN_MODIFICATION_BY...2,SET,91,-0.080053,-0.0056222,0.083061,0.83242,GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL,0.99999
GOBP_AXONAL_TRANSPORT_OF_MIT...,SET,16,-0.21831,-0.006442,0.22649,0.83243,GOBP_AXONAL_TRANSPORT_OF_MITOCHONDRION,0.99999
GOBP_ANGIOTENSIN_ACTIVATED_S...,SET,17,-0.22116,-0.0067268,0.22942,0.83247,GOBP_ANGIOTENSIN_ACTIVATED_SIGNALING_PATHWAY,0.99999
TRAVAGLINI_LUNG_BASAL_CELL,SET,174,-0.065598,-0.006356,0.068033,0.83252,TRAVAGLINI_LUNG_BASAL_CELL,0.99999
GOCC_GATOR1_COMPLEX,SET,5,-0.34003,-0.0056109,0.35265,0.83253,GOCC_GATOR1_COMPLEX,0.99999
BIOCARTA_CELLCYCLE_PATHWAY,SET,23,-0.161,-0.0056952,0.16691,0.83261,BIOCARTA_CELLCYCLE_PATHWAY,0.99999
FOXN3_TARGET_GENES,SET,1155,-0.025746,-0.0062514,0.026691,0.83262,FOXN3_TARGET_GENES,0.99999
HP_HORIZONTAL_EYEBROW,SET,32,-0.14715,-0.0061383,0.15255,0.83262,HP_HORIZONTAL_EYEBROW,0.99999
HP_ABNORMAL_CEREBRAL_ARTERY_...,SET,74,-0.097408,-0.0061719,0.10098,0.83263,HP_ABNORMAL_CEREBRAL_ARTERY_MORPHOLOGY,0.99999
GSE360_T_GONDII_VS_B_MALAYI_...4,SET,179,-0.062114,-0.0061035,0.064383,0.83266,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.99999
GSE19923_HEB_KO_VS_HEB_AND_E...1,SET,190,-0.059494,-0.0060211,0.061653,0.83271,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.99999
HP_CARDIOGENIC_SHOCK,SET,6,-0.34074,-0.0061591,0.35309,0.83273,HP_CARDIOGENIC_SHOCK,0.99999
GSE3982_EOSINOPHIL_VS_BCELL_...2,SET,182,-0.06441,-0.0063813,0.066743,0.83273,GSE3982_EOSINOPHIL_VS_BCELL_UP,0.99999
HP_ABNORMAL_LENGTH_OF_CORPUS...,SET,6,-0.37282,-0.006739,0.38631,0.83275,HP_ABNORMAL_LENGTH_OF_CORPUS_CALLOSUM,0.99999
HP_ANTI_THYROGLOBULIN_ANTIBO...,SET,6,-0.37395,-0.0067594,0.38747,0.83275,HP_ANTI_THYROGLOBULIN_ANTIBODY_POSITIVITY,0.99999
MODULE_488,SET,29,-0.17326,-0.0068806,0.1795,0.83278,MODULE_488,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...33,SET,10,-0.24576,-0.0057342,0.25457,0.83281,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,0.99999
GOBP_PHOSPHATIDYLSERINE_EXPO...,SET,8,-0.29047,-0.0060624,0.30088,0.83282,GOBP_PHOSPHATIDYLSERINE_EXPOSURE_ON_APOPTOTIC_CELL_SURFACE,0.99999
GOMF_NUCLEASE_INHIBITOR_ACTI...,SET,6,-0.26534,-0.0047961,0.27477,0.83288,GOMF_NUCLEASE_INHIBITOR_ACTIVITY,0.99999
WP_PEPTIDE_GPCRS,SET,66,-0.11471,-0.0068657,0.11879,0.83289,WP_PEPTIDE_GPCRS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...617,SET,7,-0.34114,-0.0066601,0.35324,0.8329,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,0.99999
HAHTOLA_MYCOSIS_FUNGOIDES_CD...2,SET,57,-0.11919,-0.0066312,0.1234,0.83294,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,0.99999
PID_BMP_PATHWAY,SET,38,-0.14668,-0.0066665,0.15184,0.83297,PID_BMP_PATHWAY,0.99999
GOBP_MUSCLE_CELL_CELLULAR_HO...,SET,21,-0.17013,-0.0057507,0.1761,0.83299,GOBP_MUSCLE_CELL_CELLULAR_HOMEOSTASIS,0.99999
GSE21546_ELK1_KO_VS_SAP1A_KO...3,SET,180,-0.057872,-0.0057023,0.059899,0.83301,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.99999
GSE30971_CTRL_VS_LPS_STIM_MA...1,SET,173,-0.063386,-0.0061242,0.065602,0.83302,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN,0.99999
GSE37534_UNTREATED_VS_PIOGLI...1,SET,185,-0.060771,-0.0060697,0.062888,0.83305,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.99999
GOBP_T_HELPER_1_CELL_DIFFERE...,SET,22,-0.1923,-0.0066529,0.19899,0.83306,GOBP_T_HELPER_1_CELL_DIFFERENTIATION,0.99999
MIKKELSEN_ES_HCP_WITH_H3K27M...,SET,38,-0.14779,-0.0067169,0.15292,0.83308,MIKKELSEN_ES_HCP_WITH_H3K27ME3,0.99999
MIR1587,SET,55,-0.10556,-0.0057694,0.10923,0.83308,MIR1587,0.99999
GOBP_POSITIVE_REGULATION_OF_...149,SET,6,-0.38325,-0.0069275,0.39656,0.83309,GOBP_POSITIVE_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION,0.99999
HOXA9_DN.V1_DN,SET,165,-0.063783,-0.0060197,0.065991,0.83311,HOXA9_DN.V1_DN,0.99999
REACTOME_COLLAGEN_BIOSYNTHES...,SET,65,-0.11195,-0.0066495,0.1158,0.83315,REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,0.99999
GOBP_POSITIVE_REGULATION_OF_...555,SET,12,-0.25277,-0.0064605,0.26148,0.83315,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_T_CELL_ACTIVATION,SET,525,-0.038665,-0.0064444,0.039995,0.83316,GOBP_T_CELL_ACTIVATION,0.99999
GOBP_RESPONSE_TO_TYPE_III_IN...,SET,11,-0.28166,-0.0068925,0.29132,0.83318,GOBP_RESPONSE_TO_TYPE_III_INTERFERON,0.99999
GSE20500_CTRL_VS_RETINOIC_AC...2,SET,174,-0.059509,-0.005766,0.061536,0.83324,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_UP,0.99999
ELVIDGE_HIF2A_TARGETS_UP,SET,6,-0.3494,-0.0063155,0.36127,0.83326,ELVIDGE_HIF2A_TARGETS_UP,0.99999
GSE8868_SPLEEN_VS_INTESTINE_...1,SET,178,-0.060796,-0.0059574,0.062847,0.83331,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN,0.99999
chr9q32,SET,31,-0.25038,-0.01028,0.25882,0.83332,chr9q32,0.99999
ZNF445_TARGET_GENES,SET,7,-0.32582,-0.0063612,0.3368,0.83333,ZNF445_TARGET_GENES,0.99999
GOBERT_OLIGODENDROCYTE_DIFFE...1,SET,979,-0.027575,-0.0061957,0.028502,0.83334,GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN,0.99999
GOBP_SKELETAL_MUSCLE_ATROPHY,SET,5,-0.36855,-0.0060815,0.38092,0.83335,GOBP_SKELETAL_MUSCLE_ATROPHY,0.99999
YWATTWNNRGCT_UNKNOWN,SET,63,-0.10958,-0.0064083,0.11325,0.83336,YWATTWNNRGCT_UNKNOWN,0.99999
GSE6259_FLT3L_INDUCED_VS_WT_...2,SET,165,-0.06832,-0.0064479,0.070609,0.83337,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_UP,0.99999
HP_THENAR_MUSCLE_ATROPHY,SET,13,-0.1888,-0.0050224,0.19511,0.83338,HP_THENAR_MUSCLE_ATROPHY,0.99999
GAL_LEUKEMIC_STEM_CELL_DN,SET,212,-0.056836,-0.0060723,0.058714,0.83347,GAL_LEUKEMIC_STEM_CELL_DN,0.99999
GOBP_ENDOCARDIAL_CUSHION_TO_...,SET,6,-0.36785,-0.0066491,0.37989,0.83355,GOBP_ENDOCARDIAL_CUSHION_TO_MESENCHYMAL_TRANSITION,0.99999
GOBP_MYELOID_DENDRITIC_CELL_...2,SET,6,-0.34091,-0.0061622,0.35206,0.83356,GOBP_MYELOID_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.99999
GOBP_SUBPALLIUM_DEVELOPMENT,SET,26,-0.17683,-0.00665,0.18256,0.83362,GOBP_SUBPALLIUM_DEVELOPMENT,0.99999
HP_UPPER_LIMB_JOINT_CONTRACT...,SET,300,-0.049344,-0.0062561,0.050942,0.83363,HP_UPPER_LIMB_JOINT_CONTRACTURE,0.99999
GOBP_REGULATION_OF_DENDRITIC...2,SET,10,-0.27756,-0.0064764,0.28654,0.83364,GOBP_REGULATION_OF_DENDRITIC_CELL_CHEMOTAXIS,0.99999
GOMF_TOXIN_TRANSMEMBRANE_TRA...,SET,9,-0.31149,-0.0068953,0.32157,0.83364,GOMF_TOXIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MIR4497,SET,8,-0.30345,-0.0063333,0.31324,0.83366,MIR4497,0.99999
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...4,SET,7,-0.34073,-0.0066521,0.35165,0.83371,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_DN,0.99999
HOXA7_TARGET_GENES,SET,95,-0.08505,-0.0061024,0.087773,0.83372,HOXA7_TARGET_GENES,0.99999
MIR328_3P,SET,39,-0.13427,-0.006182,0.13856,0.83373,MIR328_3P,0.99999
HP_COXA_VALGA,SET,82,-0.094732,-0.0063171,0.097749,0.83376,HP_COXA_VALGA,0.99999
GOBP_4_HYDROXYPROLINE_METABO...,SET,12,-0.20856,-0.0053306,0.21517,0.8338,GOBP_4_HYDROXYPROLINE_METABOLIC_PROCESS,0.99999
BIOCARTA_G2_PATHWAY,SET,24,-0.14836,-0.0053609,0.15305,0.83381,BIOCARTA_G2_PATHWAY,0.99999
GOBP_VIRAL_TRANSCRIPTION,SET,50,-0.10737,-0.0055957,0.11075,0.83383,GOBP_VIRAL_TRANSCRIPTION,0.99999
GSE29618_PRE_VS_DAY7_FLU_VAC...4,SET,174,-0.064565,-0.0062559,0.066596,0.83385,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP,0.99999
GOMF_OLIGOSACCHARYL_TRANSFER...,SET,5,-0.38411,-0.0063382,0.39616,0.83387,GOMF_OLIGOSACCHARYL_TRANSFERASE_ACTIVITY,0.99999
GNF2_CCNB2,SET,53,-0.11113,-0.0059624,0.11459,0.83391,GNF2_CCNB2,0.99999
GSE15930_NAIVE_VS_48H_IN_VIT...2,SET,181,-0.063052,-0.0062298,0.065019,0.83391,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP,0.99999
HP_ABNORMAL_SPEECH_DISCRIMIN...,SET,4,-0.40428,-0.005967,0.41683,0.83394,HP_ABNORMAL_SPEECH_DISCRIMINATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...503,SET,17,-0.20309,-0.0061773,0.20938,0.83396,GOBP_POSITIVE_REGULATION_OF_MYELINATION,0.99999
GOMF_TRANSLATION_INITIATION_...2,SET,28,-0.14064,-0.0054883,0.14499,0.83397,GOMF_TRANSLATION_INITIATION_FACTOR_BINDING,0.99999
HP_ABNORMAL_EXPERIENCE_OF_RE...,SET,532,-0.036581,-0.0061364,0.0377,0.83405,HP_ABNORMAL_EXPERIENCE_OF_REALITY,0.99999
GSE17721_4H_VS_24H_POLYIC_BM...1,SET,179,-0.059539,-0.0058504,0.061354,0.83407,GSE17721_4H_VS_24H_POLYIC_BMDC_DN,0.99999
GOCC_PHOSPHATIDYLINOSITOL_3_...3,SET,8,-0.29376,-0.0061309,0.30268,0.8341,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_III,0.99999
GOBP_POSITIVE_REGULATION_OF_...63,SET,8,-0.34564,-0.0072138,0.35611,0.83412,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...9,SET,13,-0.20638,-0.0054901,0.21263,0.83413,GOCC_EXTRINSIC_COMPONENT_OF_SYNAPTIC_MEMBRANE,0.99999
GOMF_5_N_7_METHYLGUANOSINE_5...,SET,9,-0.3142,-0.0069552,0.32368,0.83415,GOMF_5_N_7_METHYLGUANOSINE_5_TRIPHOSPHO_MRNA_HYDROLASE_ACTIVITY,0.99999
HP_REPETITIVE_COMPULSIVE_BEH...,SET,12,-0.27483,-0.0070244,0.28312,0.83415,HP_REPETITIVE_COMPULSIVE_BEHAVIOR,0.99999
GOBP_FEEDING_BEHAVIOR,SET,97,-0.09402,-0.0068162,0.096828,0.83422,GOBP_FEEDING_BEHAVIOR,0.99999
BYSTRYKH_SCP2_QTL,SET,6,-0.28791,-0.0052042,0.2965,0.83423,BYSTRYKH_SCP2_QTL,0.99999
GOBP_BRANCHING_INVOLVED_IN_L...,SET,12,-0.2581,-0.0065966,0.26572,0.8343,GOBP_BRANCHING_INVOLVED_IN_LABYRINTHINE_LAYER_MORPHOGENESIS,0.99999
KRAS.300_UP.V1_UP,SET,127,-0.082826,-0.0068651,0.085267,0.83431,KRAS.300_UP.V1_UP,0.99999
GOCC_DISTAL_AXON,SET,249,-0.054333,-0.0062847,0.055928,0.83434,GOCC_DISTAL_AXON,0.99999
GOMF_OXO_ACID_LYASE_ACTIVITY,SET,7,-0.30759,-0.0060052,0.31659,0.83436,GOMF_OXO_ACID_LYASE_ACTIVITY,0.99999
ESC_V6.5_UP_EARLY.V1_UP,SET,154,-0.067854,-0.0061886,0.06984,0.83436,ESC_V6.5_UP_EARLY.V1_UP,0.99999
GOBP_AXONAL_TRANSPORT,SET,62,-0.10801,-0.0062664,0.11116,0.83438,GOBP_AXONAL_TRANSPORT,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_ART...,SET,259,-0.055492,-0.0065446,0.05711,0.83439,HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL,0.99999
HP_URINARY_URGENCY,SET,43,-0.12186,-0.0058908,0.12538,0.83445,HP_URINARY_URGENCY,0.99999
KEGG_MEDICUS_REFERENCE_NOTCH...3,SET,10,-0.23602,-0.0055071,0.24282,0.83447,KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION,0.99999
GSE28737_WT_VS_BCL6_HET_MARG...2,SET,173,-0.062996,-0.0060865,0.064804,0.83449,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_UP,0.99999
REACTOME_RNA_POLYMERASE_III_...1,SET,16,-0.18224,-0.0053778,0.18744,0.83453,REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION,0.99999
GOCC_RNA_POLYMERASE_III_COMP...,SET,16,-0.18224,-0.0053778,0.18744,0.83453,GOCC_RNA_POLYMERASE_III_COMPLEX,0.99999
DANG_MYC_TARGETS_UP,SET,118,-0.074499,-0.0059536,0.076622,0.83454,DANG_MYC_TARGETS_UP,0.99999
BHAT_ESR1_TARGETS_NOT_VIA_AK...2,SET,201,-0.062139,-0.0064663,0.063904,0.83456,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,0.99999
GOMF_POLY_PURINE_TRACT_BINDI...,SET,26,-0.16182,-0.0060857,0.16639,0.8346,GOMF_POLY_PURINE_TRACT_BINDING,0.99999
PID_BETA_CATENIN_NUC_PATHWAY,SET,70,-0.10555,-0.0065055,0.10852,0.83464,PID_BETA_CATENIN_NUC_PATHWAY,0.99999
GOBP_COLLAGEN_ACTIVATED_SIGN...,SET,13,-0.24566,-0.006535,0.25252,0.83468,GOBP_COLLAGEN_ACTIVATED_SIGNALING_PATHWAY,0.99999
GOBP_RETINAL_PIGMENT_EPITHEL...,SET,6,-0.38508,-0.0069605,0.39582,0.83468,GOBP_RETINAL_PIGMENT_EPITHELIUM_DEVELOPMENT,0.99999
GOBP_TOLL_LIKE_RECEPTOR_4_SI...,SET,56,-0.11027,-0.0060812,0.11335,0.83468,GOBP_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.99999
GSE17721_CTRL_VS_LPS_2H_BMDC...1,SET,183,-0.062276,-0.0061867,0.063987,0.83478,GSE17721_CTRL_VS_LPS_2H_BMDC_DN,0.99999
GOBP_RESPONSE_TO_CORTICOSTER...2,SET,15,-0.22267,-0.0063623,0.22878,0.83479,GOBP_RESPONSE_TO_CORTICOSTERONE,0.99999
chr3q11,SET,20,-0.32018,-0.010562,0.3289,0.83483,chr3q11,0.99999
GOMF_METHYLATION_DEPENDENT_P...,SET,66,-0.094953,-0.0056831,0.097543,0.83483,GOMF_METHYLATION_DEPENDENT_PROTEIN_BINDING,0.99999
HP_NON_SMALL_CELL_LUNG_CARCI...,SET,22,-0.1725,-0.0059678,0.17718,0.83486,HP_NON_SMALL_CELL_LUNG_CARCINOMA,0.99999
MEBARKI_HCC_PROGENITOR_FZD8C...1,SET,371,-0.044524,-0.0062652,0.04572,0.83492,MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,0.99999
GSE14308_TH2_VS_TH17_DN,SET,184,-0.057984,-0.0057759,0.05954,0.83493,GSE14308_TH2_VS_TH17_DN,0.99999
HENDRICKS_SMARCA4_TARGETS_UP,SET,51,-0.1285,-0.0067634,0.13194,0.83494,HENDRICKS_SMARCA4_TARGETS_UP,0.99999
GSE37532_VISCERAL_ADIPOSE_TI...7,SET,139,-0.066966,-0.005805,0.068725,0.83506,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN,0.99999
GOBP_PARACRINE_SIGNALING,SET,6,-0.37208,-0.0067256,0.38185,0.83507,GOBP_PARACRINE_SIGNALING,0.99999
HP_HORSESHOE_KIDNEY,SET,122,-0.072577,-0.0058969,0.074482,0.83507,HP_HORSESHOE_KIDNEY,0.99999
BHAT_ESR1_TARGETS_VIA_AKT1_DN,SET,79,-0.10195,-0.0066738,0.10462,0.83509,BHAT_ESR1_TARGETS_VIA_AKT1_DN,0.99999
KEGG_MEDICUS_REFERENCE_TGFA_...2,SET,7,-0.32128,-0.0062725,0.32969,0.83509,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY,0.99999
GSE2770_TGFB_AND_IL4_VS_IL12...5,SET,181,-0.058355,-0.0057658,0.05988,0.8351,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.99999
HP_HYPOESTHESIA,SET,16,-0.19419,-0.0057303,0.19924,0.83512,HP_HYPOESTHESIA,0.99999
HP_GLOBOZOOSPERMIA,SET,6,-0.36343,-0.0065692,0.37278,0.83519,HP_GLOBOZOOSPERMIA,0.99999
GOBP_PROTEIN_RETENTION_IN_ER...,SET,8,-0.27157,-0.0056679,0.27855,0.8352,GOBP_PROTEIN_RETENTION_IN_ER_LUMEN,0.99999
GOBP_ESTABLISHMENT_OF_PLANAR...1,SET,12,-0.24437,-0.0062457,0.25061,0.83524,GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_INVOLVED_IN_NEURAL_TUBE_CLOSURE,0.99999
GOBP_RETROTRANSPOSON_SILENCI...,SET,15,-0.2001,-0.0057173,0.20517,0.83527,GOBP_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.99999
GOCC_MICROBODY,SET,132,-0.069849,-0.0059016,0.07162,0.83528,GOCC_MICROBODY,0.99999
WP_TUMOR_SUPPRESSOR_ACTIVITY...,SET,29,-0.14789,-0.0058733,0.15161,0.83533,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,0.99999
MIR513C_5P,SET,164,-0.064443,-0.0060636,0.066064,0.83533,MIR513C_5P,0.99999
GSE42021_TREG_PLN_VS_CD24LO_...1,SET,180,-0.063694,-0.006276,0.065281,0.83538,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN,0.99999
GAVISH_3CA_METAPROGRAM_CD4_T...4,SET,46,-0.11362,-0.0056803,0.11642,0.83544,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_GLYCOLYSIS_MYC,0.99999
MIR6069,SET,26,-0.15784,-0.0059358,0.16172,0.83547,MIR6069,0.99999
GOMF_K48_LINKED_POLYUBIQUITI...,SET,7,-0.31741,-0.0061969,0.3252,0.83547,GOMF_K48_LINKED_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.99999
GSE17721_LPS_VS_PAM3CSK4_2H_...1,SET,178,-0.061216,-0.0059985,0.06272,0.83547,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_DN,0.99999
HP_IMPAIRED_NEUTROPHIL_CHEMO...,SET,7,-0.31793,-0.0062071,0.32571,0.83549,HP_IMPAIRED_NEUTROPHIL_CHEMOTAXIS,0.99999
KEGG_MEDICUS_REFERENCE_P4_PR...2,SET,15,-0.2191,-0.0062604,0.22443,0.83553,KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY,0.99999
YAP1_UP,SET,40,-0.12649,-0.0058979,0.12956,0.83554,YAP1_UP,0.99999
REACTOME_NOTCH1_INTRACELLULA...,SET,43,-0.13161,-0.0063622,0.1348,0.83555,REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...20,SET,47,-0.12916,-0.006527,0.13228,0.83556,GAVISH_3CA_MALIGNANT_METAPROGRAM_29_NPC_OPC,0.99999
GSE13547_CTRL_VS_ANTI_IGM_ST...2,SET,174,-0.061477,-0.0059568,0.062954,0.8356,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP,0.99999
TING_SILENCED_BY_DICER,SET,26,-0.1736,-0.0065286,0.17776,0.83561,TING_SILENCED_BY_DICER,0.99999
REACTOME_MITOTIC_SPINDLE_CHE...,SET,104,-0.077268,-0.0057992,0.079086,0.83571,REACTOME_MITOTIC_SPINDLE_CHECKPOINT,0.99999
MIR7158_5P,SET,63,-0.10756,-0.0062902,0.11009,0.83571,MIR7158_5P,0.99999
ADNP_TARGET_GENES,SET,507,-0.037017,-0.0060661,0.037882,0.83575,ADNP_TARGET_GENES,0.99999
GOBP_MATURATION_OF_LSU_RRNA,SET,23,-0.15452,-0.0054659,0.1581,0.8358,GOBP_MATURATION_OF_LSU_RRNA,0.99999
AFFAR_YY1_TARGETS_UP,SET,178,-0.064219,-0.0062928,0.065703,0.83581,AFFAR_YY1_TARGETS_UP,0.99999
GCM_RAP2A,SET,33,-0.1467,-0.0062141,0.15009,0.83581,GCM_RAP2A,0.99999
HP_CHRONIC_INFECTION,SET,21,-0.18844,-0.0063697,0.1928,0.83581,HP_CHRONIC_INFECTION,0.99999
DESCARTES_MAIN_FETAL_HORIZON...,SET,26,-0.16998,-0.0063925,0.17391,0.83581,DESCARTES_MAIN_FETAL_HORIZONTAL_CELLS,0.99999
NEUROD2_TARGET_GENES,SET,5,-0.37538,-0.0061941,0.38404,0.83582,NEUROD2_TARGET_GENES,0.99999
GSE21546_UNSTIM_VS_ANTI_CD3_...1,SET,169,-0.059879,-0.0057187,0.06126,0.83582,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.99999
GOCC_CUL5_RING_UBIQUITIN_LIG...,SET,8,-0.32223,-0.0067253,0.32961,0.83586,GOCC_CUL5_RING_UBIQUITIN_LIGASE_COMPLEX,0.99999
BASSO_B_LYMPHOCYTE_NETWORK,SET,129,-0.069294,-0.0057883,0.070876,0.83588,BASSO_B_LYMPHOCYTE_NETWORK,0.99999
chr3q23,SET,27,-0.28078,-0.01076,0.28715,0.83591,chr3q23,0.99999
GOBP_EXTRAEMBRYONIC_MEMBRANE...,SET,13,-0.26614,-0.0070798,0.27217,0.83592,GOBP_EXTRAEMBRYONIC_MEMBRANE_DEVELOPMENT,0.99999
GSE40274_CTRL_VS_FOXP3_AND_S...1,SET,138,-0.071728,-0.0061955,0.073345,0.83595,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
REACTOME_MET_ACTIVATES_PTK2_...,SET,30,-0.17077,-0.0068977,0.17458,0.836,REACTOME_MET_ACTIVATES_PTK2_SIGNALING,0.99999
MIR4253,SET,45,-0.13149,-0.0065022,0.1344,0.83606,MIR4253,0.99999
SA_CASPASE_CASCADE,SET,18,-0.20213,-0.0063262,0.20655,0.83611,SA_CASPASE_CASCADE,0.99999
HP_WEAKNESS_OF_LONG_FINGER_E...,SET,20,-0.17492,-0.0057705,0.17874,0.83611,HP_WEAKNESS_OF_LONG_FINGER_EXTENSOR_MUSCLES,0.99999
SMID_BREAST_CANCER_LUMINAL_B...2,SET,155,-0.07088,-0.0064854,0.072427,0.83612,SMID_BREAST_CANCER_LUMINAL_B_UP,0.99999
HP_PSEUDOEPIPHYSES,SET,17,-0.20364,-0.0061941,0.20804,0.83617,HP_PSEUDOEPIPHYSES,0.99999
URS_ADIPOCYTE_DIFFERENTIATIO...1,SET,31,-0.16098,-0.0066094,0.16444,0.83619,URS_ADIPOCYTE_DIFFERENTIATION_DN,0.99999
MCCLUNG_COCAIN_REWARD_4WK,SET,68,-0.10519,-0.0063904,0.10745,0.8362,MCCLUNG_COCAIN_REWARD_4WK,0.99999
GOBP_CELLULAR_RESPONSE_TO_RE...1,SET,14,-0.23719,-0.0065477,0.24229,0.8362,GOBP_CELLULAR_RESPONSE_TO_REACTIVE_NITROGEN_SPECIES,0.99999
GOBP_REGULATION_OF_MITOCHOND...7,SET,29,-0.14148,-0.0056187,0.14451,0.8362,GOBP_REGULATION_OF_MITOCHONDRIAL_GENE_EXPRESSION,0.99999
HP_ABNORMALITY_OF_THE_AUTONO...,SET,269,-0.050744,-0.0060973,0.051827,0.83623,HP_ABNORMALITY_OF_THE_AUTONOMIC_NERVOUS_SYSTEM,0.99999
GOBP_HEXOSE_PHOSPHATE_TRANSP...,SET,6,-0.33557,-0.0060656,0.34267,0.83627,GOBP_HEXOSE_PHOSPHATE_TRANSPORT,0.99999
GOBP_PHOSPHATIDYLETHANOLAMIN...2,SET,9,-0.29356,-0.0064983,0.29975,0.83629,GOBP_PHOSPHATIDYLETHANOLAMINE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_ESTABLISHMENT_OF_SPINDL...,SET,42,-0.13043,-0.0062314,0.13317,0.8363,GOBP_ESTABLISHMENT_OF_SPINDLE_ORIENTATION,0.99999
GOMF_TASTE_RECEPTOR_ACTIVITY,SET,28,-0.19421,-0.0075788,0.19826,0.83634,GOMF_TASTE_RECEPTOR_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...172,SET,7,-0.35015,-0.0068361,0.35745,0.83635,GOBP_POSITIVE_REGULATION_OF_COA_TRANSFERASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_COA_TRANS...,SET,7,-0.35015,-0.0068361,0.35745,0.83635,GOBP_REGULATION_OF_COA_TRANSFERASE_ACTIVITY,0.99999
HP_TRACHEAL_STENOSIS,SET,25,-0.16267,-0.0059989,0.16602,0.83641,HP_TRACHEAL_STENOSIS,0.99999
GOBP_METANEPHRIC_PART_OF_URE...,SET,6,-0.40512,-0.0073227,0.41343,0.83642,GOBP_METANEPHRIC_PART_OF_URETERIC_BUD_DEVELOPMENT,0.99999
FAN_OVARY_CL8_MATURE_CUMULUS...,SET,540,-0.035819,-0.0060522,0.03655,0.83645,FAN_OVARY_CL8_MATURE_CUMULUS_GRANULOSA_CELL_2,0.99999
SHIN_B_CELL_LYMPHOMA_CLUSTER...1,SET,13,-0.23284,-0.0061938,0.23751,0.83653,SHIN_B_CELL_LYMPHOMA_CLUSTER_1,0.99999
GOBP_POSITIVE_REGULATION_OF_...820,SET,7,-0.33166,-0.0064751,0.33832,0.83653,GOBP_POSITIVE_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...171,SET,30,-0.14992,-0.0060556,0.15293,0.83654,GOBP_POSITIVE_REGULATION_OF_COAGULATION,0.99999
HIPC_SIGNATURES_PROJECT_PBMC...2,SET,9,-0.27935,-0.0061838,0.28494,0.83654,HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_UP,0.99999
GSE7509_UNSTIM_VS_IFNA_STIM_...1,SET,163,-0.068809,-0.0064549,0.070185,0.83655,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN,0.99999
MODULE_27,SET,333,-0.049861,-0.0066542,0.050855,0.83656,MODULE_27,0.99999
GSE17812_WT_VS_THPOK_KO_MEMO...2,SET,182,-0.060751,-0.0060189,0.061949,0.83661,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_UP,0.99999
GOBP_REGULATION_OF_LIPID_TRA...2,SET,4,-0.49749,-0.0073427,0.5073,0.83662,GOBP_REGULATION_OF_LIPID_TRANSPORTER_ACTIVITY,0.99999
GSE16450_CTRL_VS_IFNA_12H_ST...1,SET,155,-0.068987,-0.0063122,0.070344,0.83663,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.99999
LEE_LIVER_CANCER_MYC_UP,SET,49,-0.12525,-0.0064621,0.1277,0.83664,LEE_LIVER_CANCER_MYC_UP,0.99999
GOMF_INTRACELLULARLY_LIGAND_...,SET,30,-0.15606,-0.0063034,0.15907,0.83671,GOMF_INTRACELLULARLY_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.99999
HP_INCREASED_CIRCULATING_IRO...,SET,11,-0.25168,-0.0061588,0.25654,0.83671,HP_INCREASED_CIRCULATING_IRON_CONCENTRATION,0.99999
ZHU_CMV_24_HR_DN,SET,78,-0.0997,-0.0064849,0.10162,0.83673,ZHU_CMV_24_HR_DN,0.99999
GOBP_ESTABLISHMENT_OF_MEIOTI...,SET,6,-0.40405,-0.0073035,0.41182,0.83673,GOBP_ESTABLISHMENT_OF_MEIOTIC_SPINDLE_LOCALIZATION,0.99999
HP_SPONDYLOEPIPHYSEAL_DYSPLA...,SET,9,-0.28208,-0.0062443,0.28742,0.8368,HP_SPONDYLOEPIPHYSEAL_DYSPLASIA,0.99999
KEGG_COLORECTAL_CANCER,SET,61,-0.11139,-0.0064105,0.11348,0.83685,KEGG_COLORECTAL_CANCER,0.99999
GCM_MAPK10,SET,73,-0.10273,-0.0064653,0.10464,0.83689,GCM_MAPK10,0.99999
REACTOME_ATF6_ATF6_ALPHA_ACT...1,SET,11,-0.22287,-0.0054538,0.22699,0.8369,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES,0.99999
EIF4E_UP,SET,88,-0.086088,-0.005946,0.087676,0.83691,EIF4E_UP,0.99999
chr9p22,SET,20,-0.37286,-0.0123,0.37971,0.83693,chr9p22,0.99999
MIR6722_3P,SET,161,-0.066139,-0.0061666,0.067337,0.83699,MIR6722_3P,0.99999
TCTATGA_MIR376A_MIR376B,SET,79,-0.094566,-0.0061901,0.096281,0.83699,TCTATGA_MIR376A_MIR376B,0.99999
KONDO_COLON_CANCER_HCP_WITH_...1,SET,22,-0.19041,-0.0065877,0.19385,0.83701,KONDO_COLON_CANCER_HCP_WITH_H3K27ME1,0.99999
NAKAMURA_ADIPOGENESIS_EARLY_...1,SET,33,-0.157,-0.0066503,0.15983,0.83702,NAKAMURA_ADIPOGENESIS_EARLY_DN,0.99999
GOBP_ADP_BIOSYNTHETIC_PROCESS,SET,5,-0.43129,-0.0071168,0.43906,0.83702,GOBP_ADP_BIOSYNTHETIC_PROCESS,0.99999
GOBP_INSULIN_SECRETION_INVOL...,SET,59,-0.10461,-0.0059209,0.10649,0.83703,GOBP_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.99999
GSE40274_CTRL_VS_EOS_TRANSDU...1,SET,133,-0.076293,-0.0064702,0.077655,0.83706,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
GOMF_NADH_DEHYDROGENASE_UBIQ...,SET,33,-0.12209,-0.0051719,0.12427,0.83707,GOMF_NADH_DEHYDROGENASE_UBIQUINONE_ACTIVITY,0.99999
HP_ESOPHAGEAL_STRICTURE,SET,19,-0.19513,-0.0062744,0.19856,0.83713,HP_ESOPHAGEAL_STRICTURE,0.99999
GOBP_PEPTIDYL_ARGININE_METHY...2,SET,8,-0.26842,-0.005602,0.27309,0.83716,GOBP_PEPTIDYL_ARGININE_METHYLATION_TO_ASYMMETRICAL_DIMETHYL_ARGININE,0.99999
MIR532_3P,SET,74,-0.094139,-0.0059648,0.095766,0.83719,MIR532_3P,0.99999
JOHANSSON_GLIOMAGENESIS_BY_P...1,SET,21,-0.17764,-0.0060046,0.18069,0.83722,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN,0.99999
HP_DIABETES_INSIPIDUS,SET,53,-0.12064,-0.0064726,0.12269,0.83726,HP_DIABETES_INSIPIDUS,0.99999
HP_HYDRANENCEPHALY,SET,8,-0.29351,-0.0061258,0.29845,0.8373,HP_HYDRANENCEPHALY,0.99999
GOBP_CELLULAR_RESPONSE_TO_LE...1,SET,4,-0.50903,-0.0075131,0.51759,0.83731,GOBP_CELLULAR_RESPONSE_TO_LEAD_ION,0.99999
GOBP_SURFACTANT_HOMEOSTASIS,SET,20,-0.19448,-0.0064157,0.19772,0.83734,GOBP_SURFACTANT_HOMEOSTASIS,0.99999
HP_CONGENITAL_ABNORMAL_HAIR_...,SET,272,-0.049755,-0.0060113,0.050582,0.83735,HP_CONGENITAL_ABNORMAL_HAIR_PATTERN,0.99999
GSE37532_VISCERAL_ADIPOSE_TI...8,SET,155,-0.066049,-0.0060434,0.067139,0.83738,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_UP,0.99999
GSE23398_WT_VS_IL2_KO_CD4_TC...1,SET,180,-0.06168,-0.0060775,0.062692,0.8374,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_DN,0.99999
GOBP_EMBRYONIC_RETINA_MORPHO...,SET,6,-0.38847,-0.0070218,0.39483,0.83741,GOBP_EMBRYONIC_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.99999
REACTOME_TP53_REGULATES_TRAN...4,SET,42,-0.12722,-0.0060781,0.12929,0.83742,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES,0.99999
WP_APOPTOSIS,SET,82,-0.095484,-0.0063672,0.097038,0.83743,WP_APOPTOSIS,0.99999
BIOCARTA_CK1_PATHWAY,SET,16,-0.22632,-0.0066785,0.23,0.83744,BIOCARTA_CK1_PATHWAY,0.99999
HP_REDUCED_FACTOR_VII_ACTIVI...,SET,5,-0.35653,-0.0058831,0.36229,0.83746,HP_REDUCED_FACTOR_VII_ACTIVITY,0.99999
GOBP_PHOTORECEPTOR_CELL_MORP...,SET,4,-0.40841,-0.006028,0.41494,0.8375,GOBP_PHOTORECEPTOR_CELL_MORPHOGENESIS,0.99999
HP_LARGE_CAFE_AU_LAIT_MACULE...,SET,6,-0.33921,-0.0061314,0.34463,0.8375,HP_LARGE_CAFE_AU_LAIT_MACULES_WITH_IRREGULAR_MARGINS,0.99999
GSE37416_CTRL_VS_6H_F_TULARE...1,SET,169,-0.064172,-0.0061287,0.065192,0.83752,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
HP_ABNORMAL_BRAIN_LACTATE_LE...,SET,23,-0.17338,-0.0061331,0.17612,0.83755,HP_ABNORMAL_BRAIN_LACTATE_LEVEL_BY_MRS,0.99999
HP_PARKINSONISM,SET,123,-0.075223,-0.0061366,0.076389,0.83762,HP_PARKINSONISM,0.99999
GOBP_NEURAL_NUCLEUS_DEVELOPM...,SET,57,-0.10835,-0.0060281,0.11001,0.83767,GOBP_NEURAL_NUCLEUS_DEVELOPMENT,0.99999
MEIS1AHOXA9_01,SET,107,-0.089745,-0.0068315,0.091106,0.83769,MEIS1AHOXA9_01,0.99999
REACTOME_NEGATIVE_REGULATION...3,SET,32,-0.15782,-0.0065832,0.1602,0.83772,REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING,0.99999
GOMF_UBIQUITIN_PROTEIN_TRANS...1,SET,15,-0.22175,-0.0063359,0.22506,0.83775,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVATOR_ACTIVITY,0.99999
HP_ABNORMALITY_OF_URINE_HOME...,SET,657,-0.033629,-0.0062469,0.034132,0.83775,HP_ABNORMALITY_OF_URINE_HOMEOSTASIS,0.99999
GSE32128_INOS_DEPENDENT_VS_I...1,SET,181,-0.061316,-0.0060583,0.062223,0.83779,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN,0.99999
HP_RETINAL_NEOVASCULARIZATION,SET,9,-0.3048,-0.006747,0.30927,0.83781,HP_RETINAL_NEOVASCULARIZATION,0.99999
MIR621,SET,30,-0.16611,-0.0067096,0.16854,0.83783,MIR621,0.99999
GOBP_CMP_METABOLIC_PROCESS,SET,8,-0.31577,-0.0065903,0.32038,0.83783,GOBP_CMP_METABOLIC_PROCESS,0.99999
GOBP_REACTIVE_NITROGEN_SPECI...,SET,73,-0.10229,-0.0064378,0.10379,0.83783,GOBP_REACTIVE_NITROGEN_SPECIES_METABOLIC_PROCESS,0.99999
MIR196A_5P_MIR196B_5P,SET,85,-0.088301,-0.0059945,0.089581,0.83786,MIR196A_5P_MIR196B_5P,0.99999
SPIELMAN_LYMPHOBLAST_EUROPEA...2,SET,12,-0.24065,-0.0061507,0.24405,0.83794,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP,0.99999
HP_NORMOCHROMIC_ANEMIA,SET,33,-0.13638,-0.0057769,0.13828,0.83799,HP_NORMOCHROMIC_ANEMIA,0.99999
HP_NEONATAL_RESPIRATORY_DIST...,SET,136,-0.070751,-0.006067,0.071733,0.838,HP_NEONATAL_RESPIRATORY_DISTRESS,0.99999
QIU_PBMC_HEPTATITIS_B_SURFAC...5,SET,12,-0.26651,-0.0068117,0.27021,0.838,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_35DY_UP,0.99999
KAUFFMANN_MELANOMA_RELAPSE_UP,SET,59,-0.099772,-0.0056471,0.10115,0.83802,KAUFFMANN_MELANOMA_RELAPSE_UP,0.99999
WEBER_METHYLATED_ICP_IN_FIBR...,SET,16,-0.22608,-0.0066715,0.22918,0.83804,WEBER_METHYLATED_ICP_IN_FIBROBLAST,0.99999
HP_ABNORMAL_DERMATOGLYPHICS,SET,270,-0.05091,-0.0061285,0.051609,0.83804,HP_ABNORMAL_DERMATOGLYPHICS,0.99999
HP_X_LINKED_INHERITANCE,SET,11,-0.23773,-0.0058176,0.24098,0.83806,HP_X_LINKED_INHERITANCE,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...15,SET,459,-0.038492,-0.0060099,0.039006,0.83813,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLUM,0.99999
HP_MIGRAINE,SET,120,-0.078369,-0.0063153,0.079414,0.83813,HP_MIGRAINE,0.99999
BIOCARTA_NKT_PATHWAY,SET,24,-0.18301,-0.0066129,0.18543,0.83817,BIOCARTA_NKT_PATHWAY,0.99999
REACTOME_THE_ROLE_OF_GTSE1_I...,SET,73,-0.088824,-0.00559,0.089979,0.83821,REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,0.99999
GOBP_REGULATION_OF_HIPPO_SIG...,SET,36,-0.15196,-0.0067225,0.15393,0.83821,GOBP_REGULATION_OF_HIPPO_SIGNALING,0.99999
GOCC_ATG12_ATG5_ATG16_COMPLEX,SET,6,-0.38728,-0.0070003,0.39232,0.83821,GOCC_ATG12_ATG5_ATG16_COMPLEX,0.99999
HFH8_01,SET,191,-0.064075,-0.0065017,0.064897,0.83825,HFH8_01,0.99999
MIR8085,SET,207,-0.060533,-0.0063915,0.061283,0.83836,MIR8085,0.99999
SIMBULAN_PARP1_TARGETS_DN,SET,16,-0.19942,-0.0058849,0.20189,0.83837,SIMBULAN_PARP1_TARGETS_DN,0.99999
GOMF_ALDEHYDE_LYASE_ACTIVITY,SET,9,-0.25747,-0.0056995,0.26065,0.83837,GOMF_ALDEHYDE_LYASE_ACTIVITY,0.99999
REACTOME_RHOH_GTPASE_CYCLE,SET,35,-0.14344,-0.0062573,0.1452,0.8384,REACTOME_RHOH_GTPASE_CYCLE,0.99999
HP_ABNORMAL_GAMMA_GLUTAMYLTR...,SET,41,-0.13325,-0.0062902,0.13488,0.8384,HP_ABNORMAL_GAMMA_GLUTAMYLTRANSFERASE_LEVEL,0.99999
HOXB4_TARGET_GENES,SET,929,-0.027415,-0.006009,0.027748,0.83841,HOXB4_TARGET_GENES,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...8,SET,40,-0.14708,-0.0068581,0.14887,0.83842,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_MEDIATED_BY_A_CHEMICAL_SIGNAL,0.99999
GOMF_ALCOHOL_BINDING,SET,85,-0.094087,-0.0063873,0.09522,0.83844,GOMF_ALCOHOL_BINDING,0.99999
GSE46606_DAY1_VS_DAY3_CD40L_...8,SET,183,-0.062146,-0.0061737,0.062892,0.83845,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_UP,0.99999
REACTOME_POU5F1_OCT4_SOX2_NA...1,SET,10,-0.27508,-0.0064185,0.27836,0.83847,REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION,0.99999
GSE22342_CD11C_HIGH_VS_LOW_D...1,SET,154,-0.069436,-0.0063329,0.070264,0.83847,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_DN,0.99999
GOCC_TRANSCRIPTION_EXPORT_CO...2,SET,4,-0.3864,-0.005703,0.39091,0.83853,GOCC_TRANSCRIPTION_EXPORT_COMPLEX_2,0.99999
HP_ABNORMAL_CIRCULATING_APOL...,SET,8,-0.3061,-0.0063885,0.30963,0.83856,HP_ABNORMAL_CIRCULATING_APOLIPOPROTEIN_CONCENTRATION,0.99999
HP_ABNORMALITY_OF_THE_LARYNX,SET,192,-0.061,-0.0062056,0.0617,0.83857,HP_ABNORMALITY_OF_THE_LARYNX,0.99999
REACTOME_PROSTACYCLIN_SIGNAL...,SET,19,-0.215,-0.0069131,0.21746,0.83859,REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...15,SET,71,-0.11065,-0.0068679,0.11188,0.83866,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,0.99999
GOBP_LOW_DENSITY_LIPOPROTEIN...3,SET,5,-0.41681,-0.0068779,0.4214,0.83869,GOBP_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_PARTICLE_METABOLIC_PROCESS,0.99999
GSE19941_IL10_KO_VS_IL10_KO_...5,SET,179,-0.065661,-0.006452,0.066376,0.83872,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN,0.99999
MIR526B_3P,SET,565,-0.036923,-0.0063771,0.03732,0.83875,MIR526B_3P,0.99999
GSE26912_TUMORICIDAL_VS_CTRL...1,SET,184,-0.060628,-0.0060392,0.061281,0.83875,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_DN,0.99999
SIG_CHEMOTAXIS,SET,39,-0.13018,-0.0059939,0.13157,0.83878,SIG_CHEMOTAXIS,0.99999
WP_NICOTINE_EFFECT_ON_DOPAMI...,SET,21,-0.19105,-0.0064578,0.19307,0.83878,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...4,SET,179,-0.062311,-0.0061228,0.062953,0.83885,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_UP,0.99999
GOCC_SEPTIN_CYTOSKELETON,SET,2,-0.54501,-0.0056883,0.55059,0.83887,GOCC_SEPTIN_CYTOSKELETON,0.99999
SAKAI_CHRONIC_HEPATITIS_VS_L...1,SET,33,-0.15269,-0.0064678,0.15424,0.83889,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN,0.99999
HU_GENOTOXIN_ACTION_DIRECT_V...2,SET,37,-0.13637,-0.006116,0.13775,0.8389,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR,0.99999
HP_SHORT_FOOT,SET,111,-0.084816,-0.0065752,0.085677,0.8389,HP_SHORT_FOOT,0.99999
HP_STOMATITIS,SET,66,-0.11273,-0.0067471,0.11384,0.83896,HP_STOMATITIS,0.99999
GOCC_HEMOGLOBIN_COMPLEX,SET,8,-0.3494,-0.0072922,0.35279,0.839,GOCC_HEMOGLOBIN_COMPLEX,0.99999
HP_ABNORMAL_THALAMIC_MRI_SIG...,SET,32,-0.1371,-0.005719,0.13843,0.83901,HP_ABNORMAL_THALAMIC_MRI_SIGNAL_INTENSITY,0.99999
AGTTCTC_MIR146A_MIR146B,SET,50,-0.11827,-0.0061638,0.11939,0.83906,AGTTCTC_MIR146A_MIR146B,0.99999
REACTOME_TRANSPORT_OF_RCBL_W...,SET,8,-0.30001,-0.0062615,0.30284,0.83907,REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY,0.99999
HP_NEUROPATHIC_SPINAL_ARTHRO...,SET,20,-0.18492,-0.0061001,0.18664,0.83909,HP_NEUROPATHIC_SPINAL_ARTHROPATHY,0.99999
GSE2405_S_AUREUS_VS_A_PHAGOC...2,SET,182,-0.065717,-0.0065109,0.066301,0.8392,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP,0.99999
WP_NONGENOMIC_ACTIONS_OF_125...,SET,69,-0.10631,-0.0065054,0.10724,0.83923,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,0.99999
HP_MIGRAINE_WITHOUT_AURA,SET,7,-0.35236,-0.0068792,0.35541,0.83925,HP_MIGRAINE_WITHOUT_AURA,0.99999
PID_ANGIOPOIETIN_RECEPTOR_PA...,SET,47,-0.12155,-0.0061425,0.1226,0.83927,PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,0.99999
BIOCARTA_TERC_PATHWAY,SET,6,-0.27436,-0.0049592,0.27669,0.83929,BIOCARTA_TERC_PATHWAY,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...5,SET,13,-0.22139,-0.0058892,0.22326,0.8393,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_EAR...1,SET,71,-0.099897,-0.0062005,0.10072,0.83935,HE_LIM_SUN_FETAL_LUNG_C0_EARLY_FIBROBLAST,0.99999
WP_FATTY_ACID_BETAOXIDATION,SET,31,-0.15687,-0.0064408,0.15815,0.83937,WP_FATTY_ACID_BETAOXIDATION,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...10,SET,8,-0.30064,-0.0062747,0.30307,0.83939,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY,0.99999
MIR3167,SET,96,-0.089799,-0.0064768,0.090514,0.83942,MIR3167,0.99999
GOBP_NEGATIVE_REGULATION_OF_...481,SET,23,-0.1698,-0.0060066,0.17114,0.83944,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,0.99999
GSE3982_DC_VS_TH2_UP,SET,181,-0.065545,-0.0064761,0.066045,0.8395,GSE3982_DC_VS_TH2_UP,0.99999
ATXN7L3_TARGET_GENES,SET,514,-0.038545,-0.0063588,0.038836,0.83952,ATXN7L3_TARGET_GENES,0.99999
GOBP_RESPONSE_TO_ALCOHOL,SET,244,-0.057312,-0.0065633,0.057741,0.83954,GOBP_RESPONSE_TO_ALCOHOL,0.99999
GSE15930_STIM_VS_STIM_AND_IF...3,SET,190,-0.061569,-0.0062312,0.062017,0.83958,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN,0.99999
ACEVEDO_LIVER_CANCER_UP,SET,861,-0.029071,-0.0061463,0.029282,0.83959,ACEVEDO_LIVER_CANCER_UP,0.99999
GOBP_PEPTIDYL_ARGININE_MODIF...,SET,13,-0.21064,-0.0056033,0.21216,0.8396,GOBP_PEPTIDYL_ARGININE_MODIFICATION,0.99999
GSE22935_UNSTIM_VS_24H_MBOVI...2,SET,189,-0.063007,-0.0063601,0.063455,0.83962,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.99999
GSE20484_MCSG_VS_CXCL4_MONOC...2,SET,159,-0.067505,-0.0062551,0.067982,0.83963,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_UP,0.99999
GOBP_REGULATION_OF_TRANSLATI...2,SET,10,-0.24114,-0.0056266,0.24284,0.83964,GOBP_REGULATION_OF_TRANSLATIONAL_ELONGATION,0.99999
CHIBA_RESPONSE_TO_TSA_UP,SET,48,-0.13114,-0.0066969,0.13205,0.83966,CHIBA_RESPONSE_TO_TSA_UP,0.99999
MIR4690_3P,SET,57,-0.11194,-0.0062279,0.11271,0.83968,MIR4690_3P,0.99999
MODULE_166,SET,48,-0.11652,-0.0059505,0.11732,0.83968,MODULE_166,0.99999
GOBP_ERK1_AND_ERK2_CASCADE,SET,280,-0.053351,-0.0065385,0.053713,0.8397,GOBP_ERK1_AND_ERK2_CASCADE,0.99999
GOBP_PHOSPHOLIPID_CATABOLIC_...,SET,52,-0.11798,-0.00627,0.11877,0.83972,GOBP_PHOSPHOLIPID_CATABOLIC_PROCESS,0.99999
KRISHNAN_FURIN_TARGETS_DN,SET,9,-0.23464,-0.005194,0.23613,0.83981,KRISHNAN_FURIN_TARGETS_DN,0.99999
HOXD11_TARGET_GENES,SET,117,-0.079781,-0.0063488,0.080286,0.83981,HOXD11_TARGET_GENES,0.99999
GSE22935_UNSTIM_VS_12H_MBOVI...2,SET,181,-0.059382,-0.0058672,0.059758,0.83981,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.99999
GSE20715_0H_VS_6H_OZONE_LUNG...1,SET,185,-0.062386,-0.0062311,0.06278,0.83982,GSE20715_0H_VS_6H_OZONE_LUNG_DN,0.99999
GSE1740_MCSF_VS_MCSF_AND_IFN...2,SET,161,-0.067451,-0.006289,0.06787,0.83984,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP,0.99999
GSE14308_TH17_VS_NAIVE_CD4_T...2,SET,179,-0.060706,-0.0059651,0.061079,0.83986,GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP,0.99999
GSE2770_UNTREATED_VS_IL12_TR...6,SET,177,-0.064631,-0.0063156,0.065023,0.83987,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.99999
HALLMARK_MYOGENESIS,SET,191,-0.063797,-0.0064735,0.064177,0.8399,HALLMARK_MYOGENESIS,0.99999
REACTOME_ABORTIVE_ELONGATION...,SET,23,-0.15501,-0.0054833,0.15591,0.83993,REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT,0.99999
GSE15930_STIM_VS_STIM_AND_IL...6,SET,181,-0.06027,-0.005955,0.060611,0.83997,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP,0.99999
HP_ABNORMALITY_OF_THE_ELBOW,SET,246,-0.054323,-0.0062462,0.054617,0.84003,HP_ABNORMALITY_OF_THE_ELBOW,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_LAT...3,SET,6,-0.39232,-0.0070913,0.39439,0.84006,HE_LIM_SUN_FETAL_LUNG_C1_LATE_STALK_CELL,0.99999
WP_FARNESOID_X_RECEPTOR_PATH...,SET,19,-0.2042,-0.0065658,0.20526,0.84008,WP_FARNESOID_X_RECEPTOR_PATHWAY,0.99999
REACTOME_TP53_REGULATES_TRAN...10,SET,13,-0.24369,-0.0064826,0.24496,0.84009,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN,0.99999
MIR548B_3P,SET,91,-0.087543,-0.0061482,0.087996,0.84009,MIR548B_3P,0.99999
WP_DIFFERENTIATION_OF_WHITE_...,SET,25,-0.19274,-0.0071078,0.19372,0.84011,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,0.99999
GOBP_REGULATION_OF_ANION_CHA...,SET,5,-0.44051,-0.0072689,0.44276,0.84011,GOBP_REGULATION_OF_ANION_CHANNEL_ACTIVITY,0.99999
GOBP_L_SERINE_METABOLIC_PROC...,SET,11,-0.23222,-0.0056826,0.23338,0.84013,GOBP_L_SERINE_METABOLIC_PROCESS,0.99999
GSE24634_NAIVE_CD4_TCELL_VS_...5,SET,187,-0.058672,-0.0058914,0.058963,0.84014,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN,0.99999
GNF2_MMP11,SET,36,-0.15865,-0.0070184,0.15942,0.84016,GNF2_MMP11,0.99999
HP_INTERMEDIATE_YOUNG_ADULT_...,SET,19,-0.1867,-0.0060032,0.18761,0.84016,HP_INTERMEDIATE_YOUNG_ADULT_ONSET,0.99999
HP_ABNORMAL_ATRIOVENTRICULAR...2,SET,14,-0.23774,-0.0065628,0.23887,0.8402,HP_ABNORMAL_ATRIOVENTRICULAR_CONNECTION,0.99999
GOMF_OXIDOREDUCTION_DRIVEN_A...,SET,52,-0.098536,-0.0052368,0.098993,0.84022,GOMF_OXIDOREDUCTION_DRIVEN_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_FETAL_NECK_ANOMALY,SET,92,-0.089769,-0.0063389,0.090173,0.84025,HP_FETAL_NECK_ANOMALY,0.99999
GOCC_BLEB,SET,9,-0.28223,-0.0062475,0.28346,0.84028,GOCC_BLEB,0.99999
MIR1539,SET,5,-0.37966,-0.0062648,0.38131,0.84029,MIR1539,0.99999
GOCC_ACTIN_BASED_CELL_PROJEC...,SET,207,-0.061041,-0.0064452,0.061305,0.8403,GOCC_ACTIN_BASED_CELL_PROJECTION,0.99999
LIN_MELANOMA_COPY_NUMBER_UP,SET,65,-0.11265,-0.006691,0.11313,0.84031,LIN_MELANOMA_COPY_NUMBER_UP,0.99999
GOBP_ETHANOL_METABOLIC_PROCE...,SET,11,-0.28726,-0.0070296,0.28849,0.84031,GOBP_ETHANOL_METABOLIC_PROCESS,0.99999
HP_MILD_POSTNATAL_GROWTH_RET...,SET,16,-0.2263,-0.006678,0.22725,0.84033,HP_MILD_POSTNATAL_GROWTH_RETARDATION,0.99999
KIM_ALL_DISORDERS_OLIGODENDR...2,SET,679,-0.03138,-0.0059224,0.03151,0.84034,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP,0.99999
GOBP_SEROTONIN_RECEPTOR_SIGN...,SET,8,-0.33363,-0.0069632,0.335,0.84035,GOBP_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_NUCHAL_RIGIDITY,SET,10,-0.26059,-0.0060804,0.26164,0.84037,HP_NUCHAL_RIGIDITY,0.99999
REACTOME_DIFFERENTIATION_OF_...,SET,37,-0.15141,-0.0067904,0.15197,0.84043,REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN,0.99999
KEGG_GAP_JUNCTION,SET,84,-0.099522,-0.0067166,0.099883,0.84046,KEGG_GAP_JUNCTION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...71,SET,8,-0.29133,-0.0060803,0.29239,0.84046,GOBP_NEGATIVE_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.99999
GOCC_SPECTRIN_ASSOCIATED_CYT...,SET,9,-0.27812,-0.0061564,0.27911,0.84047,GOCC_SPECTRIN_ASSOCIATED_CYTOSKELETON,0.99999
LIU_VAV3_PROSTATE_CARCINOGEN...2,SET,82,-0.10018,-0.0066804,0.10051,0.84053,LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,0.99999
GOBP_RESPONSE_TO_L_LEUCINE,SET,14,-0.23119,-0.0063819,0.23196,0.84053,GOBP_RESPONSE_TO_L_LEUCINE,0.99999
PGF_UP.V1_DN,SET,169,-0.065679,-0.0062727,0.065897,0.84054,PGF_UP.V1_DN,0.99999
KEGG_MEDICUS_REFERENCE_WNT5A...,SET,15,-0.23841,-0.0068121,0.23916,0.84058,KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY,0.99999
GOBP_COPPER_ION_TRANSMEMBRAN...,SET,7,-0.29035,-0.0056686,0.29125,0.84059,GOBP_COPPER_ION_TRANSMEMBRANE_TRANSPORT,0.99999
KAT2A_TARGET_GENES,SET,901,-0.029012,-0.0062677,0.0291,0.8406,KAT2A_TARGET_GENES,0.99999
MORF_RAB6A,SET,60,-0.11243,-0.0064171,0.11277,0.8406,MORF_RAB6A,0.99999
GSE16266_LPS_VS_HEATSHOCK_AN...2,SET,181,-0.065876,-0.0065088,0.066076,0.8406,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,0.99999
GOCC_CUTICULAR_PLATE,SET,8,-0.30883,-0.0064456,0.30975,0.84062,GOCC_CUTICULAR_PLATE,0.99999
HP_AQUEDUCTAL_STENOSIS,SET,21,-0.16914,-0.0057175,0.16965,0.84062,HP_AQUEDUCTAL_STENOSIS,0.99999
WP_RELATIONSHIP_BETWEEN_INFL...,SET,25,-0.17867,-0.0065891,0.17917,0.84067,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,0.99999
GSE1448_CTRL_VS_ANTI_VALPHA2...2,SET,178,-0.062372,-0.0061118,0.062541,0.84068,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP,0.99999
JIANG_MELANOMA_TRM_HIGH_SURV...,SET,19,-0.20101,-0.0064635,0.20155,0.84069,JIANG_MELANOMA_TRM_HIGH_SURVIVAL_22_GENE_SIGNATURE,0.99999
HP_ABNORMAL_VISUAL_FIXATION,SET,24,-0.17807,-0.0064343,0.17854,0.8407,HP_ABNORMAL_VISUAL_FIXATION,0.99999
CERVERA_SDHB_TARGETS_2,SET,102,-0.092901,-0.0069055,0.093126,0.84075,CERVERA_SDHB_TARGETS_2,0.99999
GOBP_TYPE_B_PANCREATIC_CELL_...1,SET,10,-0.31244,-0.0072902,0.3132,0.84076,GOBP_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS,0.99999
GOBP_CELLULAR_RESPONSE_TO_X_...,SET,11,-0.21174,-0.0051815,0.21224,0.84077,GOBP_CELLULAR_RESPONSE_TO_X_RAY,0.99999
KEGG_MEDICUS_REFERENCE_LPA_G...1,SET,12,-0.24329,-0.0062181,0.24383,0.8408,KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY,0.99999
GOBP_ANTIGEN_PROCESSING_AND_...2,SET,5,-0.64088,-0.010575,0.64231,0.8408,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_ENDOGENOUS_LIPID_ANTIGEN_VIA_MHC_CLASS_IB,0.99999
GOMF_LIPID_ANTIGEN_BINDING,SET,5,-0.64088,-0.010575,0.64231,0.8408,GOMF_LIPID_ANTIGEN_BINDING,0.99999
REACTOME_HEPARAN_SULFATE_HEP...,SET,52,-0.12188,-0.0064775,0.12215,0.84081,REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,0.99999
HP_FALCIFORM_RETINAL_FOLD,SET,5,-0.40046,-0.006608,0.40134,0.84081,HP_FALCIFORM_RETINAL_FOLD,0.99999
FEV_TARGET_GENES,SET,1337,-0.023889,-0.0062078,0.02394,0.84083,FEV_TARGET_GENES,0.99999
GOBP_POSITIVE_REGULATION_OF_...751,SET,14,-0.20211,-0.0055793,0.20254,0.84083,GOBP_POSITIVE_REGULATION_OF_TELOMERASE_RNA_LOCALIZATION_TO_CAJAL_BODY,0.99999
HP_PARATHYROID_HYPERPLASIA,SET,10,-0.27453,-0.0064055,0.27503,0.84089,HP_PARATHYROID_HYPERPLASIA,0.99999
WANG_RECURRENT_LIVER_CANCER_...1,SET,16,-0.23055,-0.0068035,0.23097,0.8409,WANG_RECURRENT_LIVER_CANCER_DN,0.99999
GOBP_INSULIN_METABOLIC_PROCE...,SET,15,-0.23372,-0.0066781,0.23413,0.84092,GOBP_INSULIN_METABOLIC_PROCESS,0.99999
LAKE_ADULT_KIDNEY_C13_THICK_...,SET,113,-0.08687,-0.0067945,0.08702,0.84092,LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB,0.99999
HP_PERIPHERAL_NEUROPATHY,SET,407,-0.041229,-0.0060704,0.041294,0.84095,HP_PERIPHERAL_NEUROPATHY,0.99999
GOBP_REGULATION_OF_MUCUS_SEC...,SET,9,-0.32473,-0.0071882,0.32523,0.84096,GOBP_REGULATION_OF_MUCUS_SECRETION,0.99999
GSE17721_POLYIC_VS_CPG_24H_B...2,SET,188,-0.062103,-0.0062523,0.062199,0.84096,GSE17721_POLYIC_VS_CPG_24H_BMDC_UP,0.99999
GOBP_REGULATION_OF_RESPONSE_...3,SET,4,-0.39241,-0.0057917,0.39301,0.84097,GOBP_REGULATION_OF_RESPONSE_TO_DRUG,0.99999
REACTOME_RAS_ACTIVATION_UPON...,SET,19,-0.20997,-0.0067513,0.21024,0.84102,REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR,0.99999
PBRM1_TARGET_GENES,SET,5,-0.45487,-0.0075059,0.45528,0.84112,PBRM1_TARGET_GENES,0.99999
GSE14769_40MIN_VS_360MIN_LPS...1,SET,189,-0.059599,-0.0060161,0.059646,0.84115,GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN,0.99999
HP_UPPER_EXTREMITY_JOINT_DIS...,SET,81,-0.094329,-0.0062519,0.094397,0.84116,HP_UPPER_EXTREMITY_JOINT_DISLOCATION,0.99999
GSE21379_WT_VS_SAP_KO_CD4_TC...1,SET,183,-0.065167,-0.0064739,0.065211,0.84117,GSE21379_WT_VS_SAP_KO_CD4_TCELL_DN,0.99999
GSE26351_UNSTIM_VS_WNT_PATHW...2,SET,178,-0.061529,-0.0060292,0.061556,0.84123,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,0.99999
MIR381_5P,SET,7,-0.32023,-0.0062519,0.32035,0.84125,MIR381_5P,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...10,SET,4,-0.50858,-0.0075063,0.50876,0.84125,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_MUSCULATURE_OF_THE_EXTREMITIES,0.99999
ZIRN_TRETINOIN_RESPONSE_UP,SET,16,-0.2349,-0.0069316,0.23497,0.84126,ZIRN_TRETINOIN_RESPONSE_UP,0.99999
ZNF784_TARGET_GENES,SET,431,-0.040913,-0.0061948,0.040914,0.84133,ZNF784_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...290,SET,472,-0.040912,-0.0064752,0.040911,0.84134,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,0.99999
HP_NEUROENDOCRINE_NEOPLASM,SET,37,-0.13409,-0.0060137,0.13407,0.84136,HP_NEUROENDOCRINE_NEOPLASM,0.99999
MIR622,SET,74,-0.099911,-0.0063305,0.099897,0.84137,MIR622,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...11,SET,6,-0.39335,-0.00711,0.39319,0.84143,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS_NAD_OR_NADP_AS_ACCEPTOR,0.99999
GSE9006_HEALTHY_VS_TYPE_1_DI...3,SET,176,-0.059506,-0.0057984,0.059461,0.84152,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN,0.99999
GOBP_SPINDLE_ASSEMBLY_INVOLV...,SET,8,-0.32212,-0.0067228,0.32186,0.84153,GOBP_SPINDLE_ASSEMBLY_INVOLVED_IN_FEMALE_MEIOSIS,0.99999
HP_INCREASED_SUSCEPTIBILITY_...,SET,212,-0.05843,-0.0062427,0.058375,0.84157,HP_INCREASED_SUSCEPTIBILITY_TO_FRACTURES,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_PRO...3,SET,273,-0.056986,-0.0068974,0.056931,0.84157,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL,0.99999
HP_FRONTAL_BALDING,SET,13,-0.23445,-0.0062367,0.23419,0.8416,HP_FRONTAL_BALDING,0.99999
WINTER_HYPOXIA_METAGENE,SET,216,-0.061608,-0.0066433,0.061533,0.84163,WINTER_HYPOXIA_METAGENE,0.99999
HP_CSF_LYMPHOCYTIC_PLEIOCYTO...,SET,18,-0.18868,-0.0059051,0.18845,0.84163,HP_CSF_LYMPHOCYTIC_PLEIOCYTOSIS,0.99999
HNF4_Q6,SET,244,-0.054618,-0.0062548,0.054551,0.84164,HNF4_Q6,0.99999
GSE29615_DAY3_VS_DAY7_LAIV_F...2,SET,145,-0.0721,-0.0063824,0.072008,0.84165,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,0.99999
REACTOME_CLASS_A_1_RHODOPSIN...,SET,299,-0.056216,-0.0071157,0.056131,0.8417,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,0.99999
GSE43700_UNTREATED_VS_IL10_T...1,SET,187,-0.062913,-0.0063172,0.062815,0.84171,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...484,SET,7,-0.32199,-0.0062863,0.32148,0.84172,GOBP_NEGATIVE_REGULATION_OF_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.99999
GOMF_OPIOID_RECEPTOR_BINDING,SET,7,-0.38017,-0.0074221,0.37952,0.84175,GOMF_OPIOID_RECEPTOR_BINDING,0.99999
REACTOME_MITOTIC_PROPHASE,SET,77,-0.090343,-0.0058387,0.090181,0.84177,REACTOME_MITOTIC_PROPHASE,0.99999
GOBP_T_CELL_ACTIVATION_VIA_T...,SET,10,-0.27887,-0.0065068,0.27835,0.84179,GOBP_T_CELL_ACTIVATION_VIA_T_CELL_RECEPTOR_CONTACT_WITH_ANTIGEN_BOUND_TO_MHC_MOLECULE_ON_ANTIGEN_PRESENTING_CELL,0.99999
WU_SILENCED_BY_METHYLATION_I...,SET,46,-0.14046,-0.0070224,0.14019,0.84182,WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,0.99999
chr3p23,SET,3,-0.60678,-0.0077562,0.60551,0.84185,chr3p23,0.99999
MORF_LTK,SET,137,-0.074977,-0.0064528,0.074818,0.84185,MORF_LTK,0.99999
REACTOME_DEGRADATION_OF_AXIN,SET,52,-0.10625,-0.0056469,0.10601,0.84188,REACTOME_DEGRADATION_OF_AXIN,0.99999
BYSTRYKH_HEMATOPOIESIS_STEM_...8,SET,7,-0.37265,-0.0072754,0.37179,0.8419,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1,0.99999
GOBP_AORTA_MORPHOGENESIS,SET,33,-0.16499,-0.0069889,0.16457,0.84195,GOBP_AORTA_MORPHOGENESIS,0.99999
DESCARTES_MAIN_FETAL_SMOOTH_...,SET,37,-0.14611,-0.0065528,0.14574,0.84195,DESCARTES_MAIN_FETAL_SMOOTH_MUSCLE_CELLS,0.99999
KEGG_MEDICUS_REFERENCE_COPII...,SET,12,-0.22254,-0.0056879,0.22197,0.84196,KEGG_MEDICUS_REFERENCE_COPII_VESICLE_FORMATION,0.99999
WP_CANONICAL_AND_NONCANONICA...1,SET,27,-0.16697,-0.0063987,0.16653,0.84198,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,0.99999
GSE40666_NAIVE_VS_EFFECTOR_C...4,SET,187,-0.063804,-0.0064067,0.06363,0.842,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.99999
WACKER_HYPOXIA_TARGETS_OF_VHL,SET,11,-0.27259,-0.0066705,0.27182,0.84202,WACKER_HYPOXIA_TARGETS_OF_VHL,0.99999
GOBP_NEGATIVE_REGULATION_OF_...196,SET,5,-0.3907,-0.0064469,0.3896,0.84202,GOBP_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.99999
GOBP_TRANSFORMING_GROWTH_FAC...3,SET,31,-0.16651,-0.0068366,0.16603,0.84203,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.99999
WP_METABOLIC_PATHWAYS_OF_FIB...,SET,32,-0.14629,-0.0061024,0.1458,0.84216,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,0.99999
GNF2_PRDX2,SET,27,-0.17162,-0.0065768,0.17102,0.84218,GNF2_PRDX2,0.99999
DING_LUNG_CANCER_EXPRESSION_...,SET,96,-0.090335,-0.0065154,0.090019,0.84219,DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,0.99999
GSE11961_PLASMA_CELL_DAY7_VS...3,SET,177,-0.063739,-0.0062284,0.063504,0.84223,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,0.99999
MIR6863,SET,8,-0.30063,-0.0062744,0.29951,0.84224,MIR6863,0.99999
GOBP_DETECTION_OF_TEMPERATUR...2,SET,19,-0.2031,-0.0065304,0.20232,0.84226,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.99999
REACTOME_FCERI_MEDIATED_CA_2...,SET,30,-0.1515,-0.0061194,0.1509,0.84229,REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION,0.99999
GSE7568_IL4_VS_IL4_AND_DEXAM...1,SET,138,-0.071103,-0.0061416,0.070822,0.8423,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN,0.99999
GOBP_REGULATION_OF_CAMP_DEPE...,SET,13,-0.23501,-0.0062516,0.23406,0.84232,GOBP_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.99999
GSE18281_CORTICAL_THYMOCYTE_...1,SET,177,-0.060891,-0.0059501,0.060644,0.84232,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN,0.99999
REACTOME_COSTIMULATION_BY_TH...,SET,62,-0.1168,-0.0067761,0.11632,0.84233,REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,0.99999
GOBP_REGULATION_OF_EPIDERMIS...,SET,58,-0.12086,-0.0067828,0.12034,0.84238,GOBP_REGULATION_OF_EPIDERMIS_DEVELOPMENT,0.99999
GOBP_CIRCULATORY_SYSTEM_DEVE...,SET,1046,-0.028496,-0.0066053,0.028373,0.84239,GOBP_CIRCULATORY_SYSTEM_DEVELOPMENT,0.99999
GOBP_PERIPHERAL_NERVOUS_SYST...4,SET,8,-0.30578,-0.0063818,0.30443,0.8424,GOBP_PERIPHERAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE,0.99999
GOBP_POSITIVE_REGULATION_OF_...724,SET,43,-0.12683,-0.0061312,0.12627,0.84242,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.99999
GOBP_MODULATION_OF_INHIBITOR...,SET,7,-0.36606,-0.0071468,0.3644,0.84244,GOBP_MODULATION_OF_INHIBITORY_POSTSYNAPTIC_POTENTIAL,0.99999
GOMF_L_LEUCINE_BINDING,SET,6,-0.30504,-0.0055138,0.30356,0.84251,GOMF_L_LEUCINE_BINDING,0.99999
MIR33A_5P_MIR33B_5P,SET,106,-0.086806,-0.0065771,0.086379,0.84253,MIR33A_5P_MIR33B_5P,0.99999
HP_ARTERIAL_RUPTURE,SET,8,-0.32563,-0.0067961,0.32401,0.84254,HP_ARTERIAL_RUPTURE,0.99999
HOLLEMAN_VINCRISTINE_RESISTA...2,SET,25,-0.17702,-0.0065279,0.17613,0.84255,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP,0.99999
HP_RIEGER_ANOMALY,SET,11,-0.29702,-0.0072685,0.29553,0.84256,HP_RIEGER_ANOMALY,0.99999
WP_P38_MAPK_SIGNALING,SET,33,-0.14801,-0.0062697,0.14724,0.8426,WP_P38_MAPK_SIGNALING,0.99999
HP_ABNORMALITY_OF_PRIMARY_TE...,SET,70,-0.10052,-0.0061954,0.099978,0.84265,HP_ABNORMALITY_OF_PRIMARY_TEETH,0.99999
GSE6674_UNSTIM_VS_CPG_STIM_B...2,SET,131,-0.074171,-0.0062431,0.073764,0.84267,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_UP,0.99999
GOMF_GAMMA_TUBULIN_BINDING,SET,28,-0.15103,-0.005894,0.1502,0.84268,GOMF_GAMMA_TUBULIN_BINDING,0.99999
HP_DEFECTIVE_T_CELL_PROLIFER...,SET,7,-0.29449,-0.0057494,0.2928,0.84273,HP_DEFECTIVE_T_CELL_PROLIFERATION,0.99999
GOBP_INTRINSIC_APOPTOTIC_SIG...7,SET,9,-0.25,-0.005534,0.24852,0.84278,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYPOXIA,0.99999
MODULE_421,SET,15,-0.20986,-0.0059963,0.20859,0.84281,MODULE_421,0.99999
HP_ABNORMALITY_OF_RENAL_EXCR...,SET,62,-0.11489,-0.0066657,0.11419,0.84284,HP_ABNORMALITY_OF_RENAL_EXCRETION,0.99999
HP_CONFETTI_LIKE_HYPOPIGMENT...,SET,8,-0.30154,-0.0062933,0.29968,0.84284,HP_CONFETTI_LIKE_HYPOPIGMENTED_MACULES,0.99999
HP_MODERATE_ALBUMINURIA,SET,10,-0.28085,-0.006553,0.27911,0.84284,HP_MODERATE_ALBUMINURIA,0.99999
GSE16266_CTRL_VS_LPS_STIM_ME...1,SET,178,-0.065863,-0.0064539,0.065447,0.84287,GSE16266_CTRL_VS_LPS_STIM_MEF_DN,0.99999
HP_APLASTIC_ANEMIA,SET,24,-0.18021,-0.0065117,0.17907,0.84288,HP_APLASTIC_ANEMIA,0.99999
REACTOME_SIGNALING_BY_NOTCH1,SET,68,-0.10371,-0.0063004,0.10305,0.8429,REACTOME_SIGNALING_BY_NOTCH1,0.99999
WP_THERMOGENESIS,SET,105,-0.084911,-0.0064033,0.084357,0.84292,WP_THERMOGENESIS,0.99999
GSE25123_CTRL_VS_IL4_AND_ROS...1,SET,172,-0.06397,-0.0061629,0.063546,0.84295,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.99999
GOBP_OOCYTE_ANTERIOR_POSTERI...,SET,6,-0.35953,-0.0064987,0.35709,0.84299,GOBP_OOCYTE_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION,0.99999
ATF1_Q6,SET,219,-0.061383,-0.0066642,0.060962,0.843,ATF1_Q6,0.99999
HP_SHORT_NASAL_BRIDGE,SET,5,-0.45621,-0.007528,0.45302,0.84304,HP_SHORT_NASAL_BRIDGE,0.99999
GOMF_U1_SNRNP_BINDING,SET,6,-0.29184,-0.0052752,0.28974,0.84308,GOMF_U1_SNRNP_BINDING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...386,SET,7,-0.31842,-0.0062166,0.31612,0.84309,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.99999
HP_ABNORMAL_PERIFOLLICULAR_M...,SET,5,-0.52799,-0.0087125,0.52417,0.84309,HP_ABNORMAL_PERIFOLLICULAR_MORPHOLOGY,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...9,SET,184,-0.06489,-0.0064638,0.064416,0.84311,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_DN,0.99999
HP_ABNORMAL_CHOROID_PLEXUS_M...,SET,18,-0.21214,-0.0066394,0.21056,0.84314,HP_ABNORMAL_CHOROID_PLEXUS_MORPHOLOGY,0.99999
MODULE_64,SET,490,-0.042676,-0.0068785,0.042351,0.84319,MODULE_64,0.99999
HP_DECREASED_SPECIFIC_ANTIBO...4,SET,29,-0.17095,-0.0067889,0.16964,0.84319,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_VACCINATION,0.99999
GOBP_MITOCHONDRION_ORGANIZAT...,SET,441,-0.039519,-0.0060511,0.039212,0.84323,GOBP_MITOCHONDRION_ORGANIZATION,0.99999
GOCC_AMPA_GLUTAMATE_RECEPTOR...,SET,23,-0.18549,-0.0065615,0.18399,0.8433,GOCC_AMPA_GLUTAMATE_RECEPTOR_COMPLEX,0.99999
GOCC_PHOTORECEPTOR_CONNECTIN...,SET,37,-0.13761,-0.0061716,0.13649,0.84332,GOCC_PHOTORECEPTOR_CONNECTING_CILIUM,0.99999
HP_GENERALIZED_LYMPHADENOPAT...,SET,9,-0.3117,-0.0068998,0.30915,0.84333,HP_GENERALIZED_LYMPHADENOPATHY,0.99999
REACTOME_RMTS_METHYLATE_HIST...,SET,29,-0.15754,-0.0062564,0.15623,0.84336,REACTOME_RMTS_METHYLATE_HISTONE_ARGININES,0.99999
HAY_BONE_MARROW_FOLLICULAR_B...,SET,125,-0.082524,-0.0067864,0.081834,0.84337,HAY_BONE_MARROW_FOLLICULAR_B_CELL,0.99999
GSE34156_UNTREATED_VS_24H_NO...3,SET,176,-0.067792,-0.0066059,0.067221,0.84338,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN,0.99999
SASAKI_TARGETS_OF_TP73_AND_T...,SET,11,-0.25576,-0.0062587,0.2536,0.84339,SASAKI_TARGETS_OF_TP73_AND_TP63,0.99999
GOCC_MYOSIN_II_COMPLEX,SET,25,-0.19439,-0.0071686,0.19273,0.84342,GOCC_MYOSIN_II_COMPLEX,0.99999
HP_ABNORMAL_NASOLABIAL_REGIO...,SET,17,-0.20916,-0.0063619,0.20737,0.84342,HP_ABNORMAL_NASOLABIAL_REGION_MORPHOLOGY,0.99999
BIOCARTA_MONOCYTE_PATHWAY,SET,11,-0.30488,-0.0074608,0.3022,0.84348,BIOCARTA_MONOCYTE_PATHWAY,0.99999
GOCC_SIGNAL_PEPTIDASE_COMPLEX,SET,5,-0.35605,-0.0058751,0.35291,0.84348,GOCC_SIGNAL_PEPTIDASE_COMPLEX,0.99999
CBX5_TARGET_GENES,SET,592,-0.035973,-0.0063548,0.035655,0.84349,CBX5_TARGET_GENES,0.99999
MIR644A,SET,56,-0.11485,-0.0063334,0.11382,0.84351,MIR644A,0.99999
HP_ABNORMALITY_OF_FUNDUS_PIG...,SET,39,-0.13667,-0.0062925,0.13543,0.84353,HP_ABNORMALITY_OF_FUNDUS_PIGMENTATION,0.99999
GOMF_FLAVIN_ADENINE_DINUCLEO...,SET,81,-0.09463,-0.0062719,0.093762,0.84357,GOMF_FLAVIN_ADENINE_DINUCLEOTIDE_BINDING,0.99999
GOBP_FORMATION_OF_PRIMARY_GE...,SET,118,-0.084038,-0.0067159,0.083262,0.84358,GOBP_FORMATION_OF_PRIMARY_GERM_LAYER,0.99999
GOBP_NEGATIVE_REGULATION_OF_...170,SET,15,-0.21888,-0.006254,0.21684,0.8436,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS,0.99999
REACTOME_TRAIL_SIGNALING,SET,8,-0.37246,-0.0077736,0.36898,0.84361,REACTOME_TRAIL_SIGNALING,0.99999
HP_RHABDOMYOLYSIS,SET,37,-0.13721,-0.0061537,0.13593,0.84361,HP_RHABDOMYOLYSIS,0.99999
BIOCARTA_IFNG_PATHWAY,SET,6,-0.38344,-0.0069309,0.37984,0.84362,BIOCARTA_IFNG_PATHWAY,0.99999
GSE6566_STRONG_VS_WEAK_DC_ST...2,SET,156,-0.071794,-0.00659,0.071116,0.84363,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP,0.99999
MTOR_UP.N4.V1_DN,SET,155,-0.068176,-0.006238,0.067524,0.84367,MTOR_UP.N4.V1_DN,0.99999
REACTOME_VEGFR2_MEDIATED_CEL...,SET,19,-0.19896,-0.0063976,0.19704,0.8437,REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...359,SET,6,-0.34459,-0.0062286,0.34116,0.84376,GOBP_NEGATIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY,0.99999
GOBP_NOTOCHORD_MORPHOGENESIS,SET,6,-0.37815,-0.0068354,0.37436,0.84378,GOBP_NOTOCHORD_MORPHOGENESIS,0.99999
GNF2_ZAP70,SET,23,-0.17951,-0.00635,0.1777,0.84379,GNF2_ZAP70,0.99999
HP_RECURRENT_JOINT_DISLOCATI...,SET,10,-0.28915,-0.0067468,0.28611,0.8439,HP_RECURRENT_JOINT_DISLOCATION,0.99999
MIR4711_3P,SET,73,-0.10612,-0.0066787,0.10499,0.84394,MIR4711_3P,0.99999
GSE29617_DAY3_VS_DAY7_TIV_FL...1,SET,151,-0.065495,-0.0059155,0.064786,0.84397,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,0.99999
HP_ESOPHAGEAL_NEOPLASM,SET,27,-0.16996,-0.0065133,0.16805,0.84407,HP_ESOPHAGEAL_NEOPLASM,0.99999
WP_PENTOSE_PHOSPHATE_METABOL...,SET,6,-0.3828,-0.0069194,0.37848,0.84408,WP_PENTOSE_PHOSPHATE_METABOLISM,0.99999
GOBP_SNORNA_LOCALIZATION,SET,6,-0.31527,-0.0056988,0.31172,0.84408,GOBP_SNORNA_LOCALIZATION,0.99999
GOCC_BBAF_COMPLEX,SET,10,-0.27727,-0.0064696,0.27413,0.84409,GOCC_BBAF_COMPLEX,0.99999
HP_DECREASED_SPECIFIC_ANTI_P...,SET,7,-0.36166,-0.0070608,0.35756,0.8441,HP_DECREASED_SPECIFIC_ANTI_POLYSACCHARIDE_ANTIBODY_LEVEL,0.99999
SA_PTEN_PATHWAY,SET,17,-0.19304,-0.0058716,0.19083,0.84413,SA_PTEN_PATHWAY,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...70,SET,127,-0.076883,-0.0063725,0.075995,0.84415,HP_APLASIA_HYPOPLASIA_OF_THE_THUMB,0.99999
HP_OPHTHALMOPARESIS,SET,244,-0.053973,-0.0061809,0.053345,0.84417,HP_OPHTHALMOPARESIS,0.99999
HP_ANGIOID_STREAKS_OF_THE_FU...,SET,10,-0.27053,-0.0063123,0.26737,0.84419,HP_ANGIOID_STREAKS_OF_THE_FUNDUS,0.99999
HP_HYPOVENTILATION,SET,46,-0.12344,-0.0061715,0.12198,0.84422,HP_HYPOVENTILATION,0.99999
GSE21927_SPLEEN_C57BL6_VS_4T...1,SET,185,-0.063545,-0.0063468,0.062792,0.84422,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN,0.99999
MIR4711_5P,SET,94,-0.085144,-0.006077,0.08413,0.84424,MIR4711_5P,0.99999
GOBP_REGULATION_OF_CYCLIN_DE...,SET,73,-0.098396,-0.0061924,0.097207,0.84428,GOBP_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.99999
MIR449C_5P,SET,121,-0.082015,-0.0066364,0.080999,0.84435,MIR449C_5P,0.99999
GSE27786_LIN_NEG_VS_NEUTROPH...1,SET,185,-0.061434,-0.006136,0.060671,0.84436,GSE27786_LIN_NEG_VS_NEUTROPHIL_DN,0.99999
HP_MOTOR_NEURON_ATROPHY,SET,61,-0.10664,-0.006137,0.10531,0.84437,HP_MOTOR_NEURON_ATROPHY,0.99999
GOMF_ANNEALING_ACTIVITY,SET,8,-0.31845,-0.0066463,0.31445,0.8444,GOMF_ANNEALING_ACTIVITY,0.99999
GCM_SIRT2,SET,40,-0.1408,-0.0065653,0.13903,0.84441,GCM_SIRT2,0.99999
HP_ABNORMALITY_OF_PERIPHERAL...,SET,129,-0.073259,-0.0061194,0.072326,0.84444,HP_ABNORMALITY_OF_PERIPHERAL_NERVE_CONDUCTION,0.99999
GOBP_PYRIMIDINE_RIBONUCLEOSI...2,SET,11,-0.24993,-0.0061162,0.24674,0.84445,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_CARBOHYDRATE_DERIVATIVE...2,SET,249,-0.056196,-0.0065002,0.055475,0.84446,GOBP_CARBOHYDRATE_DERIVATIVE_CATABOLIC_PROCESS,0.99999
FERRANDO_TAL1_NEIGHBORS,SET,17,-0.2121,-0.0064513,0.20934,0.8445,FERRANDO_TAL1_NEIGHBORS,0.99999
VANDESLUIS_COMMD1_TARGETS_GR...1,SET,15,-0.23065,-0.0065903,0.22766,0.8445,VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP,0.99999
GSE22886_UNSTIM_VS_IL2_STIM_...1,SET,185,-0.059043,-0.0058972,0.058276,0.8445,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...7,SET,21,-0.18781,-0.0063486,0.18536,0.84452,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN,0.99999
HP_VISUAL_AGNOSIA,SET,7,-0.29463,-0.0057521,0.29078,0.84452,HP_VISUAL_AGNOSIA,0.99999
MIR4740_5P,SET,61,-0.1258,-0.0072393,0.12414,0.84454,MIR4740_5P,0.99999
MIR4793_5P,SET,58,-0.11417,-0.0064073,0.11266,0.84456,MIR4793_5P,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HD...2,SET,450,-0.04455,-0.0068889,0.043952,0.84461,MANNO_MIDBRAIN_NEUROTYPES_HDA2,0.99999
chr16p11,SET,87,-0.1938,-0.01331,0.19119,0.84462,chr16p11,0.99999
GOCC_SUPER_ELONGATION_COMPLEX,SET,5,-0.33961,-0.005604,0.33504,0.84462,GOCC_SUPER_ELONGATION_COMPLEX,0.99999
REACTOME_HDL_REMODELING,SET,8,-0.31454,-0.0065647,0.31027,0.84465,REACTOME_HDL_REMODELING,0.99999
GOMF_DNA_RNA_HYBRID_BINDING,SET,5,-0.34753,-0.0057346,0.34272,0.84471,GOMF_DNA_RNA_HYBRID_BINDING,0.99999
HP_ABNORMALLY_OSSIFIED_VERTE...,SET,19,-0.19255,-0.0061914,0.18986,0.84474,HP_ABNORMALLY_OSSIFIED_VERTEBRAE,0.99999
GATGKMRGCG_UNKNOWN,SET,60,-0.11278,-0.0064371,0.1112,0.84476,GATGKMRGCG_UNKNOWN,0.99999
GSE40274_CTRL_VS_FOXP3_AND_P...2,SET,152,-0.071611,-0.0064891,0.070603,0.84477,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GOBP_FAT_SOLUBLE_VITAMIN_MET...,SET,47,-0.12849,-0.0064931,0.12664,0.84484,GOBP_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS,0.99999
HP_ABNORMAL_CARDIAC_VENTRICU...,SET,142,-0.07554,-0.006618,0.074453,0.84485,HP_ABNORMAL_CARDIAC_VENTRICULAR_FUNCTION,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...12,SET,38,-0.12434,-0.0056511,0.12254,0.84487,GAVISH_3CA_MALIGNANT_METAPROGRAM_21_RESPIRATION,0.99999
GSE30971_WBP7_HET_VS_KO_MACR...4,SET,178,-0.065181,-0.0063871,0.064229,0.8449,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_UP,0.99999
REACTOME_DOPAMINE_NEUROTRANS...,SET,20,-0.20658,-0.0068147,0.20354,0.84492,REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE,0.99999
GOBP_POSTSYNAPSE_TO_NUCLEUS_...,SET,6,-0.25696,-0.0046447,0.25318,0.84493,GOBP_POSTSYNAPSE_TO_NUCLEUS_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_PATHOGEN_SHIGEL...2,SET,10,-0.30418,-0.0070973,0.29964,0.84497,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,0.99999
GSE9509_10MIN_VS_30MIN_LPS_S...1,SET,171,-0.068892,-0.006618,0.067861,0.84499,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN,0.99999
WP_JOUBERT_SYNDROME,SET,69,-0.096922,-0.0059308,0.095467,0.845,WP_JOUBERT_SYNDROME,0.99999
HP_DISSEMINATED_INTRAVASCULA...,SET,25,-0.18527,-0.0068322,0.18247,0.84502,HP_DISSEMINATED_INTRAVASCULAR_COAGULATION,0.99999
WORSCHECH_TUMOR_EVASION_AND_...2,SET,29,-0.17712,-0.0070342,0.17444,0.84503,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,0.99999
GOBP_FATTY_ACID_DERIVATIVE_M...,SET,68,-0.10715,-0.0065092,0.10552,0.84505,GOBP_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS,0.99999
SA_B_CELL_RECEPTOR_COMPLEXES,SET,22,-0.18429,-0.0063759,0.18148,0.84506,SA_B_CELL_RECEPTOR_COMPLEXES,0.99999
DESCARTES_FETAL_SPLEEN_MESOT...,SET,177,-0.069707,-0.0068116,0.068634,0.84509,DESCARTES_FETAL_SPLEEN_MESOTHELIAL_CELLS,0.99999
GOBP_ANTIVIRAL_INNATE_IMMUNE...,SET,49,-0.11937,-0.0061587,0.11753,0.8451,GOBP_ANTIVIRAL_INNATE_IMMUNE_RESPONSE,0.99999
GSE5679_PPARG_LIGAND_ROSIGLI...4,SET,178,-0.064883,-0.0063579,0.063877,0.84512,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,0.99999
REACTOME_FGFR3_LIGAND_BINDIN...,SET,12,-0.28991,-0.0074096,0.28539,0.84514,REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION,0.99999
REACTOME_HYALURONAN_UPTAKE_A...,SET,12,-0.22901,-0.0058531,0.22543,0.84515,REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION,0.99999
ACGCACA_MIR210,SET,8,-0.29561,-0.0061697,0.291,0.84515,ACGCACA_MIR210,0.99999
BENPORATH_MYC_MAX_TARGETS,SET,687,-0.031386,-0.0059569,0.030887,0.84521,BENPORATH_MYC_MAX_TARGETS,0.99999
KEGG_MEDICUS_REFERENCE_N_GLY...4,SET,7,-0.23326,-0.0045541,0.22956,0.84521,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_GLC_6P_TO_MAN_P_DOL,0.99999
REACTOME_VITAMIN_D_CALCIFERO...,SET,12,-0.26688,-0.0068211,0.26262,0.84524,REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM,0.99999
GSE17721_LPS_VS_CPG_16H_BMDC...1,SET,183,-0.059516,-0.0059125,0.058565,0.84524,GSE17721_LPS_VS_CPG_16H_BMDC_DN,0.99999
GOBP_ACYLGLYCEROL_TRANSPORT,SET,6,-0.33016,-0.0059679,0.32484,0.84527,GOBP_ACYLGLYCEROL_TRANSPORT,0.99999
MODULE_54,SET,236,-0.054961,-0.0061914,0.054068,0.8453,MODULE_54,0.99999
GOBP_KYNURENINE_METABOLIC_PR...,SET,9,-0.3326,-0.0073624,0.32712,0.84536,GOBP_KYNURENINE_METABOLIC_PROCESS,0.99999
HP_COMA,SET,91,-0.089453,-0.0062824,0.087979,0.84536,HP_COMA,0.99999
MIR1915_3P,SET,156,-0.07042,-0.0064639,0.069256,0.84537,MIR1915_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...685,SET,9,-0.27721,-0.0061363,0.27262,0.84538,GOBP_POSITIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,0.99999
GSE27786_NEUTROPHIL_VS_MONO_...1,SET,178,-0.062214,-0.0060963,0.061182,0.84539,GSE27786_NEUTROPHIL_VS_MONO_MAC_DN,0.99999
GSE27786_NKCELL_VS_NEUTROPHI...1,SET,180,-0.065406,-0.0064447,0.064308,0.84543,GSE27786_NKCELL_VS_NEUTROPHIL_DN,0.99999
REACTOME_GRB2_SOS_PROVIDES_L...,SET,15,-0.24606,-0.0070306,0.2419,0.84546,REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,0.99999
HP_ABNORMAL_CSF_PYRUVATE_FAM...,SET,5,-0.36853,-0.0060812,0.36218,0.84554,HP_ABNORMAL_CSF_PYRUVATE_FAMILY_AMINO_ACID_CONCENTRATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_VAS...1,SET,117,-0.088952,-0.0070786,0.087403,0.84559,HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL,0.99999
GOBP_REGULATION_OF_CGMP_MEDI...,SET,10,-0.29158,-0.0068033,0.28645,0.84563,GOBP_REGULATION_OF_CGMP_MEDIATED_SIGNALING,0.99999
REACTOME_SIGNALING_BY_NOTCH4,SET,77,-0.089685,-0.0057962,0.088106,0.84564,REACTOME_SIGNALING_BY_NOTCH4,0.99999
BURTON_ADIPOGENESIS_7,SET,41,-0.14598,-0.0068909,0.14339,0.84567,BURTON_ADIPOGENESIS_7,0.99999
GOBP_POSITIVE_REGULATION_OF_...523,SET,61,-0.11858,-0.0068239,0.11647,0.84567,GOBP_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,0.99999
GSE33425_CD161_HIGH_VS_NEG_C...1,SET,178,-0.068171,-0.0066801,0.066956,0.84569,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN,0.99999
REACTOME_DOWNSTREAM_SIGNALIN...4,SET,24,-0.17087,-0.006174,0.16781,0.8457,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3,0.99999
REACTOME_REGULATION_OF_MITF_...4,SET,41,-0.13577,-0.0064091,0.13334,0.8457,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,0.99999
REACTOME_SHC_MEDIATED_CASCAD...1,SET,21,-0.20125,-0.0068026,0.19763,0.84573,REACTOME_SHC_MEDIATED_CASCADE_FGFR1,0.99999
HP_THORACIC_HYPOPLASIA,SET,130,-0.076403,-0.0064066,0.075012,0.84578,HP_THORACIC_HYPOPLASIA,0.99999
GSE17721_CTRL_VS_PAM3CSK4_1H...2,SET,177,-0.061265,-0.0059867,0.060133,0.84585,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_UP,0.99999
MODULE_11,SET,494,-0.041808,-0.0067653,0.04103,0.84588,MODULE_11,0.99999
SOBOLEV_PBMC_PANDEMRIX_AGE_1...4,SET,18,-0.23714,-0.0074218,0.23271,0.8459,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_CORRELATED_WITH_TRANSITIONAL_B_CELLS_UP,0.99999
GOBP_L_ASPARTATE_IMPORT_ACRO...,SET,6,-0.40084,-0.0072453,0.39327,0.84595,GOBP_L_ASPARTATE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
KEGG_MEDICUS_ENV_FACTOR_ARSE...,SET,16,-0.1967,-0.0058045,0.19297,0.84598,KEGG_MEDICUS_ENV_FACTOR_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,0.99999
GOBP_ALPHA_BETA_T_CELL_DIFFE...,SET,118,-0.087034,-0.0069553,0.085372,0.846,GOBP_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
KEGG_MEDICUS_REFERENCE_RTK_P...,SET,53,-0.1305,-0.0070015,0.12799,0.84602,KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_CIRCULATING_THYR...2,SET,31,-0.15866,-0.0065145,0.1556,0.84606,HP_ABNORMAL_CIRCULATING_THYROID_HORMONE_CONCENTRATION,0.99999
GOBP_EMBRYONIC_PROCESS_INVOL...,SET,6,-0.37179,-0.0067203,0.36459,0.84607,GOBP_EMBRYONIC_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...8,SET,25,-0.19732,-0.0072767,0.19349,0.84608,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,0.99999
RUBENSTEIN_SKELETAL_MUSCLE_F...1,SET,154,-0.074972,-0.0068378,0.073511,0.8461,RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS,0.99999
GSE27786_NKTCELL_VS_NEUTROPH...2,SET,175,-0.062911,-0.006113,0.06168,0.84612,GSE27786_NKTCELL_VS_NEUTROPHIL_UP,0.99999
DESCARTES_FETAL_LIVER_MYELOI...,SET,170,-0.074165,-0.0071038,0.072707,0.84614,DESCARTES_FETAL_LIVER_MYELOID_CELLS,0.99999
SARRIO_EPITHELIAL_MESENCHYMA...1,SET,133,-0.080099,-0.006793,0.078522,0.84615,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...3,SET,8,-0.30839,-0.0064364,0.3023,0.84617,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY,0.99999
MODULE_514,SET,10,-0.24654,-0.0057524,0.24166,0.84617,MODULE_514,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...7,SET,48,-0.12122,-0.0061905,0.11882,0.84618,GAVISH_3CA_METAPROGRAM_B_CELLS_METABOLISM_MYC,0.99999
GSE39820_TGFBETA1_VS_TGFBETA...2,SET,185,-0.06238,-0.0062304,0.06114,0.8462,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP,0.99999
GOBP_LOCOMOTOR_RHYTHM,SET,16,-0.24951,-0.0073629,0.24454,0.84621,GOBP_LOCOMOTOR_RHYTHM,0.99999
GOMF_GAP_JUNCTION_CHANNEL_AC...1,SET,21,-0.23035,-0.0077863,0.2257,0.84627,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY,0.99999
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...1,SET,84,-0.096982,-0.0065452,0.095017,0.84629,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_ADDNL_EXON_LVL_UP,0.99999
GOMF_TRANSKETOLASE_OR_TRANSA...,SET,3,-0.52184,-0.0066703,0.51115,0.84634,GOMF_TRANSKETOLASE_OR_TRANSALDOLASE_ACTIVITY,0.99999
ONDER_CDH1_TARGETS_2_UP,SET,225,-0.06347,-0.0069835,0.062165,0.84636,ONDER_CDH1_TARGETS_2_UP,0.99999
CASORELLI_ACUTE_PROMYELOCYTI...1,SET,590,-0.035195,-0.0062073,0.034471,0.84637,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN,0.99999
GOBP_REGULATION_OF_CELL_MORP...,SET,222,-0.059641,-0.0065188,0.058414,0.84637,GOBP_REGULATION_OF_CELL_MORPHOGENESIS,0.99999
MIR145_3P,SET,64,-0.11074,-0.0065272,0.10845,0.84639,MIR145_3P,0.99999
GSE37301_HEMATOPOIETIC_STEM_...13,SET,159,-0.071993,-0.006671,0.07049,0.84644,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN,0.99999
GSE18281_SUBCAPSULAR_VS_PERI...1,SET,184,-0.064021,-0.0063772,0.062673,0.84649,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_DN,0.99999
REACTOME_NCAM_SIGNALING_FOR_...,SET,62,-0.1167,-0.0067707,0.11422,0.84653,REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,0.99999
GOCC_DENDRITIC_GROWTH_CONE,SET,7,-0.29013,-0.0056644,0.28396,0.84654,GOCC_DENDRITIC_GROWTH_CONE,0.99999
WP_KIT_RECEPTOR_SIGNALING,SET,56,-0.12677,-0.0069909,0.12407,0.84655,WP_KIT_RECEPTOR_SIGNALING,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...35,SET,7,-0.30082,-0.0058729,0.2944,0.84655,HP_APLASIA_HYPOPLASIA_OF_THE_GALLBLADDER,0.99999
GOBP_DORSAL_AORTA_MORPHOGENE...,SET,8,-0.3451,-0.0072024,0.33773,0.84656,GOBP_DORSAL_AORTA_MORPHOGENESIS,0.99999
GOBP_BONE_CELL_DEVELOPMENT,SET,18,-0.22494,-0.0070402,0.22013,0.84657,GOBP_BONE_CELL_DEVELOPMENT,0.99999
GTGTCAA_MIR514,SET,55,-0.11064,-0.0060468,0.10826,0.84659,GTGTCAA_MIR514,0.99999
GSE7768_OVA_ALONE_VS_OVA_WIT...2,SET,155,-0.067898,-0.0062125,0.066429,0.84663,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,0.99999
HOEK_T_CELL_2011_2012_TIV_AD...5,SET,2,-0.53055,-0.0055374,0.51906,0.84664,HOEK_T_CELL_2011_2012_TIV_ADULT_7DY_UP,0.99999
JIANG_MELANOMA_TRM3_CD8,SET,363,-0.045146,-0.0062853,0.044154,0.84671,JIANG_MELANOMA_TRM3_CD8,0.99999
REACTOME_THE_PHOTOTRANSDUCTI...,SET,31,-0.15048,-0.0061783,0.14716,0.84673,REACTOME_THE_PHOTOTRANSDUCTION_CASCADE,0.99999
GSE3982_MAST_CELL_VS_NEUTROP...1,SET,176,-0.065321,-0.0063651,0.063865,0.84679,GSE3982_MAST_CELL_VS_NEUTROPHIL_DN,0.99999
GOBP_REGULATION_OF_SODIUM_IO...1,SET,52,-0.13556,-0.0072043,0.13253,0.8468,GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...7,SET,15,-0.23027,-0.0065794,0.22507,0.84686,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...9,SET,25,-0.17501,-0.006454,0.17106,0.84686,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_PLATELET_...4,SET,8,-0.30824,-0.0064332,0.30123,0.84691,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY,0.99999
GOCC_SYNAPTIC_CLEFT,SET,21,-0.21072,-0.0071228,0.20591,0.84692,GOCC_SYNAPTIC_CLEFT,0.99999
MILI_PSEUDOPODIA_CHEMOTAXIS_...2,SET,73,-0.095566,-0.0060143,0.093382,0.84693,MILI_PSEUDOPODIA_CHEMOTAXIS_UP,0.99999
BIOCARTA_RACC_PATHWAY,SET,11,-0.30872,-0.0075547,0.3016,0.84698,BIOCARTA_RACC_PATHWAY,0.99999
GOBP_DNA_METABOLIC_PROCESS,SET,870,-0.028502,-0.006056,0.027843,0.847,GOBP_DNA_METABOLIC_PROCESS,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...10,SET,183,-0.060467,-0.006007,0.059043,0.84711,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP,0.99999
LIU_TARGETS_OF_VMYB_VS_CMYB_...1,SET,38,-0.15037,-0.0068341,0.14681,0.84713,LIU_TARGETS_OF_VMYB_VS_CMYB_DN,0.99999
ODONNELL_TARGETS_OF_MYC_AND_...1,SET,42,-0.12529,-0.0059859,0.1223,0.84718,ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN,0.99999
MIR34B_5P,SET,120,-0.083239,-0.0067078,0.081243,0.84721,MIR34B_5P,0.99999
GOMF_ENONE_REDUCTASE_ACTIVITY,SET,5,-0.41634,-0.0068701,0.40635,0.84722,GOMF_ENONE_REDUCTASE_ACTIVITY,0.99999
GOMF_AP_2_ADAPTOR_COMPLEX_BI...,SET,10,-0.31139,-0.0072657,0.30388,0.84725,GOMF_AP_2_ADAPTOR_COMPLEX_BINDING,0.99999
HP_RETICULOCYTOPENIA,SET,32,-0.14367,-0.0059931,0.14019,0.84727,HP_RETICULOCYTOPENIA,0.99999
GSE41867_NAIVE_VS_DAY15_LCMV...3,SET,164,-0.066722,-0.0062781,0.06509,0.84733,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN,0.99999
MIR556_5P,SET,39,-0.14144,-0.0065124,0.13795,0.84738,MIR556_5P,0.99999
GOMF_CALCIUM_ION_BINDING,SET,660,-0.037755,-0.0070289,0.036822,0.84739,GOMF_CALCIUM_ION_BINDING,0.99999
GSE12003_MIR223_KO_VS_WT_BM_...4,SET,105,-0.08538,-0.0064386,0.083264,0.84741,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_UP,0.99999
WONG_ENDMETRIUM_CANCER_UP,SET,24,-0.17715,-0.0064012,0.17276,0.84742,WONG_ENDMETRIUM_CANCER_UP,0.99999
KEGG_MEDICUS_REFERENCE_METHI...,SET,10,-0.31703,-0.0073971,0.30907,0.84749,KEGG_MEDICUS_REFERENCE_METHIONINE_DEGRADATION,0.99999
HP_NEURODEGENERATION,SET,76,-0.095898,-0.0061575,0.093461,0.84756,HP_NEURODEGENERATION,0.99999
GOBP_INTERLEUKIN_1_PRODUCTION,SET,104,-0.092506,-0.0069429,0.090152,0.84757,GOBP_INTERLEUKIN_1_PRODUCTION,0.99999
GSE14699_NAIVE_VS_DELETIONAL...1,SET,185,-0.065042,-0.0064963,0.063386,0.84758,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...165,SET,99,-0.082145,-0.006016,0.080033,0.84764,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...390,SET,4,-0.47686,-0.0070382,0.46457,0.84766,GOBP_NEGATIVE_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.99999
PID_IL5_PATHWAY,SET,14,-0.2406,-0.0066417,0.23438,0.84767,PID_IL5_PATHWAY,0.99999
GOMF_PHOSPHATIDYLCHOLINE_FLO...,SET,8,-0.33322,-0.0069545,0.3246,0.84767,GOMF_PHOSPHATIDYLCHOLINE_FLOPPASE_ACTIVITY,0.99999
MIR34A_5P,SET,283,-0.050725,-0.0062492,0.049412,0.84768,MIR34A_5P,0.99999
HP_RECURRENT_SINUSITIS,SET,58,-0.11586,-0.0065019,0.11284,0.84771,HP_RECURRENT_SINUSITIS,0.99999
GSE11961_MARGINAL_ZONE_BCELL...3,SET,182,-0.063785,-0.0063194,0.062122,0.84773,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,0.99999
WP_INTERACTIONS_BETWEEN_LOXL...,SET,17,-0.19938,-0.0060646,0.19411,0.84782,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,0.99999
chr4q31,SET,62,-0.19712,-0.011436,0.19187,0.84787,chr4q31,0.99999
HP_ENLARGEMENT_OF_THE_ANKLES,SET,5,-0.4269,-0.0070444,0.41549,0.8479,HP_ENLARGEMENT_OF_THE_ANKLES,0.99999
WP_NEOLACTO_SERIES_SPHINGOLI...,SET,11,-0.26947,-0.0065943,0.26226,0.84791,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,0.99999
GOBP_CILIARY_BASAL_BODY_ORGA...,SET,5,-0.40472,-0.0066783,0.39387,0.84791,GOBP_CILIARY_BASAL_BODY_ORGANIZATION,0.99999
GSE20715_WT_VS_TLR4_KO_LUNG_...2,SET,179,-0.067037,-0.0065872,0.065238,0.84792,GSE20715_WT_VS_TLR4_KO_LUNG_UP,0.99999
GOBP_ASSOCIATIVE_LEARNING,SET,82,-0.10256,-0.0068394,0.099791,0.84797,GOBP_ASSOCIATIVE_LEARNING,0.99999
WP_RALA_DOWNSTREAM_REGULATED...,SET,12,-0.24842,-0.0063492,0.24169,0.84798,WP_RALA_DOWNSTREAM_REGULATED_GENES,0.99999
KYNG_DNA_DAMAGE_UP,SET,188,-0.063647,-0.0064078,0.061921,0.84799,KYNG_DNA_DAMAGE_UP,0.99999
KEGG_MEDICUS_VARIANT_TEL_AML...,SET,10,-0.34937,-0.0081519,0.33989,0.848,KEGG_MEDICUS_VARIANT_TEL_AML1_FUSION_TO_TRANSCRIPTIONAL_REPRESSION,0.99999
GOBP_REGULATION_OF_GROWTH,SET,526,-0.04017,-0.0067015,0.039073,0.84803,GOBP_REGULATION_OF_GROWTH,0.99999
GSE3982_MAC_VS_NEUTROPHIL_DN,SET,174,-0.06791,-0.00658,0.066056,0.84803,GSE3982_MAC_VS_NEUTROPHIL_DN,0.99999
WP_TRYPTOPHAN_METABOLISM,SET,29,-0.17798,-0.0070685,0.17312,0.84804,WP_TRYPTOPHAN_METABOLISM,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...15,SET,11,-0.22229,-0.0054398,0.21618,0.84808,GOBP_PROTEIN_LOCALIZATION_TO_CILIARY_MEMBRANE,0.99999
WEST_ADRENOCORTICAL_TUMOR_MA...2,SET,22,-0.20996,-0.0072641,0.20419,0.84809,WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP,0.99999
chr1q42,SET,83,-0.1937,-0.012995,0.1883,0.84818,chr1q42,0.99999
YIH_RESPONSE_TO_ARSENITE_C2,SET,14,-0.22437,-0.0061937,0.21809,0.84821,YIH_RESPONSE_TO_ARSENITE_C2,0.99999
GOBP_MITOCHONDRIAL_RESPIRASO...,SET,7,-0.28381,-0.0055408,0.27583,0.84823,GOBP_MITOCHONDRIAL_RESPIRASOME_ASSEMBLY,0.99999
HOEK_MYELOID_DENDRITIC_CELL_...3,SET,16,-0.20781,-0.0061322,0.20193,0.84828,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_DN,0.99999
MIR3197,SET,5,-0.4237,-0.0069915,0.41164,0.84832,MIR3197,0.99999
GOBP_POSITIVE_REGULATION_OF_...379,SET,952,-0.0302,-0.0066966,0.029338,0.84834,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,0.99999
FULLER_PBMC_F_TULARENSIS_VAC...6,SET,31,-0.17592,-0.007223,0.17089,0.84835,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_DN,0.99999
GOCC_PRP19_COMPLEX,SET,14,-0.22383,-0.0061789,0.21737,0.84842,GOCC_PRP19_COMPLEX,0.99999
SCHLOSSER_SERUM_RESPONSE_AUG...,SET,99,-0.081246,-0.0059502,0.07887,0.84852,SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,0.99999
BIOCARTA_RAC1_PATHWAY,SET,21,-0.20252,-0.0068455,0.19648,0.84866,BIOCARTA_RAC1_PATHWAY,0.99999
DESCARTES_FETAL_INTESTINE_SM...,SET,41,-0.14498,-0.0068437,0.14063,0.8487,DESCARTES_FETAL_INTESTINE_SMOOTH_MUSCLE_CELLS,0.99999
HP_DYNEIN_ARM_DEFECT_OF_RESP...,SET,14,-0.20803,-0.0057426,0.20173,0.84878,HP_DYNEIN_ARM_DEFECT_OF_RESPIRATORY_MOTILE_CILIA,0.99999
GSE360_CTRL_VS_M_TUBERCULOSI...2,SET,184,-0.065199,-0.0064946,0.063222,0.84879,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP,0.99999
HP_INCREASED_URINE_PROTEINOG...,SET,10,-0.27123,-0.0063287,0.26296,0.84884,HP_INCREASED_URINE_PROTEINOGENIC_AMINO_ACID_DERIVATIVE_LEVEL,0.99999
GOBP_SUBSTANTIA_NIGRA_DEVELO...,SET,37,-0.13335,-0.0059804,0.12927,0.84885,GOBP_SUBSTANTIA_NIGRA_DEVELOPMENT,0.99999
GOMF_CYSTEINE_TYPE_ENDOPEPTI...2,SET,80,-0.0996,-0.0065606,0.096534,0.8489,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.99999
WP_GALANIN_RECEPTOR_PATHWAY,SET,21,-0.20605,-0.0069651,0.1997,0.84891,WP_GALANIN_RECEPTOR_PATHWAY,0.99999
MEBARKI_HCC_PROGENITOR_WNT_D...4,SET,13,-0.25661,-0.0068261,0.24863,0.84897,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_INDEPENDENT,0.99999
KEGG_PROSTATE_CANCER,SET,86,-0.095315,-0.0065085,0.092318,0.84906,KEGG_PROSTATE_CANCER,0.99999
WP_HOSTPATHOGEN_INTERACTION_...4,SET,35,-0.16618,-0.0072491,0.16091,0.84913,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,0.99999
GSE10239_MEMORY_VS_DAY4.5_EF...2,SET,187,-0.063637,-0.0063899,0.061612,0.84916,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_UP,0.99999
MARTIN_NFKB_TARGETS_UP,SET,41,-0.15271,-0.0072089,0.14783,0.84919,MARTIN_NFKB_TARGETS_UP,0.99999
SMN1_SMN2_TARGET_GENES,SET,628,-0.035031,-0.0063674,0.033908,0.84921,SMN1_SMN2_TARGET_GENES,0.99999
DANG_MYC_TARGETS_DN,SET,27,-0.1778,-0.0068137,0.17205,0.84929,DANG_MYC_TARGETS_DN,0.99999
ATTACAT_MIR3803P,SET,87,-0.098626,-0.0067734,0.095433,0.8493,ATTACAT_MIR3803P,0.99999
GSE1740_MCSF_VS_MCSF_AND_IFN...3,SET,146,-0.073135,-0.0064961,0.070759,0.84933,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_DN,0.99999
GSE8685_IL15_ACT_IL2_STARVED...1,SET,141,-0.073526,-0.006419,0.071133,0.84934,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,0.99999
WP_TYPE_I_COLLAGEN_SYNTHESIS...,SET,31,-0.16066,-0.0065963,0.15542,0.84936,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,0.99999
GOMF_NUCLEOTIDYLTRANSFERASE_...,SET,120,-0.073334,-0.0059096,0.070942,0.84936,GOMF_NUCLEOTIDYLTRANSFERASE_ACTIVITY,0.99999
MORF_RAD51L3,SET,343,-0.048949,-0.006628,0.047347,0.84939,MORF_RAD51L3,0.99999
GSE27786_NKTCELL_VS_NEUTROPH...1,SET,181,-0.067023,-0.0066222,0.064826,0.8494,GSE27786_NKTCELL_VS_NEUTROPHIL_DN,0.99999
KEGG_MEDICUS_REFERENCE_BETA_...3,SET,5,-0.36021,-0.0059439,0.34835,0.84944,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_PEROXISOME_VLCFA,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...15,SET,151,-0.072556,-0.0065533,0.070165,0.84944,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
MIR5787,SET,230,-0.058197,-0.0064731,0.056278,0.84945,MIR5787,0.99999
HP_WIDE_NASAL_BRIDGE,SET,433,-0.042743,-0.0064866,0.041333,0.84945,HP_WIDE_NASAL_BRIDGE,0.99999
KEGG_CYTOKINE_CYTOKINE_RECEP...,SET,245,-0.065661,-0.0075346,0.063492,0.84946,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,0.99999
GOBP_SRP_DEPENDENT_COTRANSLA...1,SET,16,-0.22004,-0.0064932,0.21275,0.84949,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.99999
HP_TYPIFIED_BY_SOMATIC_MOSAI...,SET,162,-0.070859,-0.006627,0.068508,0.8495,HP_TYPIFIED_BY_SOMATIC_MOSAICISM,0.99999
GOBP_RNA_TEMPLATED_DNA_BIOSY...,SET,66,-0.099943,-0.0059818,0.096613,0.84953,GOBP_RNA_TEMPLATED_DNA_BIOSYNTHETIC_PROCESS,0.99999
GSE29615_CTRL_VS_DAY7_LAIV_F...2,SET,153,-0.073597,-0.0066907,0.071147,0.84953,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...17,SET,13,-0.26209,-0.0069719,0.25335,0.84954,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...356,SET,10,-0.33475,-0.0078106,0.32355,0.84957,GOBP_POSITIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
CROMER_METASTASIS_DN,SET,74,-0.10239,-0.0064875,0.098948,0.8496,CROMER_METASTASIS_DN,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...5,SET,177,-0.071293,-0.0069665,0.068896,0.84961,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,0.99999
GOBP_PENTOSE_PHOSPHATE_SHUNT...,SET,6,-0.36856,-0.006662,0.35616,0.84962,GOBP_PENTOSE_PHOSPHATE_SHUNT_NON_OXIDATIVE_BRANCH,0.99999
GOBP_ACTIN_FILAMENT_NETWORK_...,SET,6,-0.41071,-0.0074238,0.39678,0.84968,GOBP_ACTIN_FILAMENT_NETWORK_FORMATION,0.99999
GSE41087_WT_VS_FOXP3_MUT_ANT...2,SET,166,-0.06929,-0.006559,0.066936,0.8497,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,0.99999
GSE9601_NFKB_INHIBITOR_VS_PI...1,SET,185,-0.069523,-0.0069438,0.06716,0.8497,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,0.99999
ELK1_02,SET,235,-0.055298,-0.0062163,0.053415,0.84971,ELK1_02,0.99999
GOBP_REGULATION_OF_HISTAMINE...,SET,6,-0.36357,-0.0065717,0.35116,0.84973,GOBP_REGULATION_OF_HISTAMINE_SECRETION_BY_MAST_CELL,0.99999
GSE19941_LPS_VS_LPS_AND_IL10...3,SET,178,-0.065869,-0.0064545,0.063612,0.84977,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_CO...1,SET,10,-0.29941,-0.0069862,0.28914,0.84978,GOBP_CELLULAR_RESPONSE_TO_COCAINE,0.99999
LI_ESTROGENE_META_E2_RESPONS...1,SET,22,-0.20219,-0.0069952,0.19524,0.84981,LI_ESTROGENE_META_E2_RESPONSE_DN,0.99999
chr5q35,SET,116,-0.16704,-0.013236,0.16127,0.84984,chr5q35,0.99999
HP_FINGERNAIL_DYSPLASIA,SET,16,-0.23199,-0.0068458,0.22392,0.8499,HP_FINGERNAIL_DYSPLASIA,0.99999
HP_REDUCED_PROTEIN_C_ACTIVITY,SET,10,-0.24249,-0.0056581,0.23406,0.8499,HP_REDUCED_PROTEIN_C_ACTIVITY,0.99999
GOBP_REGULATION_OF_TRANSLATI...4,SET,76,-0.094294,-0.0060545,0.09101,0.84991,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION,0.99999
CHIARETTI_T_ALL_REFRACTORY_T...,SET,25,-0.17851,-0.0065829,0.17225,0.84997,CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...653,SET,108,-0.08845,-0.0067642,0.085334,0.85001,GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,0.99999
GSE8921_UNSTIM_VS_TLR1_2_STI...3,SET,187,-0.064211,-0.0064475,0.061942,0.85004,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN,0.99999
GERHOLD_RESPONSE_TO_TZD_UP,SET,6,-0.40209,-0.0072679,0.38784,0.85006,GERHOLD_RESPONSE_TO_TZD_UP,0.99999
GOBP_SPINAL_CORD_ASSOCIATION...,SET,11,-0.31498,-0.0077078,0.30382,0.85006,GOBP_SPINAL_CORD_ASSOCIATION_NEURON_DIFFERENTIATION,0.99999
REACTOME_SULFUR_AMINO_ACID_M...,SET,26,-0.18481,-0.0069499,0.17824,0.85009,REACTOME_SULFUR_AMINO_ACID_METABOLISM,0.99999
HARALAMBIEVA_PBMC_FLUARIX_AG...9,SET,317,-0.049356,-0.0064295,0.047602,0.85009,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...691,SET,20,-0.20599,-0.0067954,0.19866,0.8501,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.99999
GSE2770_TGFB_AND_IL4_VS_TGFB...5,SET,174,-0.067268,-0.0065178,0.064848,0.8502,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.99999
GSE15330_HSC_VS_MEGAKARYOCYT...1,SET,150,-0.071347,-0.0064228,0.068768,0.85024,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...9,SET,46,-0.12353,-0.0061759,0.11903,0.85031,BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,0.99999
GOBP_MACROPHAGE_INFLAMMATORY...,SET,6,-0.38867,-0.0070254,0.37448,0.85033,GOBP_MACROPHAGE_INFLAMMATORY_PROTEIN_1_ALPHA_PRODUCTION,0.99999
GOBP_REGULATION_OF_L_GLUTAMA...,SET,8,-0.31973,-0.006673,0.30804,0.85035,GOBP_REGULATION_OF_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MID...2,SET,168,-0.074026,-0.0070491,0.071312,0.85037,HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL,0.99999
MINGUEZ_LIVER_CANCER_VASCULA...2,SET,13,-0.23031,-0.0061265,0.22181,0.85043,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP,0.99999
GSE35685_CD34POS_CD38NEG_VS_...4,SET,181,-0.066325,-0.0065532,0.063872,0.85045,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP,0.99999
MODULE_29,SET,24,-0.16631,-0.0060094,0.16015,0.85047,MODULE_29,0.99999
RIGGI_EWING_SARCOMA_PROGENIT...2,SET,389,-0.051205,-0.0073744,0.049293,0.85054,RIGGI_EWING_SARCOMA_PROGENITOR_UP,0.99999
MODULE_21,SET,9,-0.27777,-0.0061487,0.26729,0.85063,MODULE_21,0.99999
MODULE_56,SET,9,-0.27777,-0.0061487,0.26729,0.85063,MODULE_56,0.99999
GOBP_REGULATION_OF_NEURAL_PR...,SET,96,-0.095978,-0.0069224,0.092357,0.85064,GOBP_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,0.99999
GOCC_ASTER,SET,10,-0.28145,-0.0065671,0.27082,0.85065,GOCC_ASTER,0.99999
REACTOME_KILLING_MECHANISMS,SET,11,-0.26168,-0.0064036,0.25174,0.8507,REACTOME_KILLING_MECHANISMS,0.99999
GOMF_RNA_2_O_METHYLTRANSFERA...,SET,6,-0.31156,-0.0056316,0.29969,0.85073,GOMF_RNA_2_O_METHYLTRANSFERASE_ACTIVITY,0.99999
GSE46025_WT_VS_FOXO1_KO_KLRG...1,SET,161,-0.067866,-0.0063276,0.065276,0.85075,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...447,SET,5,-0.47416,-0.0078241,0.45603,0.85076,GOBP_POSITIVE_REGULATION_OF_MELANOCYTE_DIFFERENTIATION,0.99999
HP_ABNORMAL_SHAPE_OF_THE_RAD...,SET,24,-0.18749,-0.0067747,0.18033,0.85076,HP_ABNORMAL_SHAPE_OF_THE_RADIUS,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...6,SET,142,-0.073891,-0.0064735,0.071053,0.85081,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,0.99999
GOBP_SOMITE_SPECIFICATION,SET,4,-0.47706,-0.0070411,0.45873,0.85081,GOBP_SOMITE_SPECIFICATION,0.99999
HP_MOTOR_REGRESSION,SET,19,-0.19786,-0.006362,0.19026,0.85081,HP_MOTOR_REGRESSION,0.99999
GOCC_PROXIMAL_DENDRITE,SET,6,-0.37764,-0.0068261,0.36305,0.85087,GOCC_PROXIMAL_DENDRITE,0.99999
GSE5589_LPS_VS_LPS_AND_IL10_...5,SET,181,-0.065795,-0.0065008,0.063249,0.85088,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_DN,0.99999
HP_ABNORMALITY_OF_NEUTROPHIL...,SET,14,-0.23383,-0.0064548,0.22475,0.85091,HP_ABNORMALITY_OF_NEUTROPHIL_PHYSIOLOGY,0.99999
GSE24574_BCL6_HIGH_TFH_VS_TF...1,SET,185,-0.066749,-0.0066668,0.064157,0.85091,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN,0.99999
GSE34156_NOD2_LIGAND_VS_TLR1...4,SET,186,-0.066186,-0.0066283,0.063618,0.85091,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,0.99999
MIR637,SET,78,-0.096305,-0.0062641,0.092562,0.85093,MIR637,0.99999
ZNF22_TARGET_GENES,SET,820,-0.030569,-0.0063148,0.029381,0.85093,ZNF22_TARGET_GENES,0.99999
WEST_ADRENOCORTICAL_CARCINOM...1,SET,22,-0.21246,-0.0073506,0.20419,0.85094,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,0.99999
ANDERSON_BLOOD_CN54GP140_ADJ...9,SET,5,-0.47881,-0.0079009,0.46017,0.85094,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_HIGH_IGM_RESPONDERS_3DY_7D_DN,0.99999
GOBP_CELL_COMMUNICATION_BY_E...2,SET,26,-0.19526,-0.0073432,0.18765,0.85096,GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION,0.99999
GSE17721_4_VS_24H_GARDIQUIMO...2,SET,179,-0.067024,-0.006586,0.064392,0.85103,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_UP,0.99999
HP_ABNORMALITY_OF_SKELETAL_M...1,SET,358,-0.046011,-0.0063622,0.044195,0.85107,HP_ABNORMALITY_OF_SKELETAL_MATURATION,0.99999
GSE8621_UNSTIM_VS_LPS_PRIMED...1,SET,188,-0.064946,-0.0065386,0.062357,0.85117,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,0.99999
GOBP_REGULATION_OF_ENDODEOXY...,SET,8,-0.32823,-0.0068503,0.31512,0.85119,GOBP_REGULATION_OF_ENDODEOXYRIBONUCLEASE_ACTIVITY,0.99999
HP_REDUCED_FACTOR_XII_ACTIVI...,SET,6,-0.32721,-0.0059145,0.3141,0.85122,HP_REDUCED_FACTOR_XII_ACTIVITY,0.99999
REACTOME_SYNTHESIS_SECRETION...1,SET,18,-0.21677,-0.0067845,0.20807,0.85125,REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN,0.99999
HP_FACIAL_HYPEROSTOSIS,SET,4,-0.49682,-0.0073328,0.47682,0.85127,HP_FACIAL_HYPEROSTOSIS,0.99999
BIOCARTA_NPC_PATHWAY,SET,11,-0.26474,-0.0064785,0.25407,0.85129,BIOCARTA_NPC_PATHWAY,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...13,SET,43,-0.15459,-0.007473,0.14834,0.85133,GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC,0.99999
HP_INSPIRATORY_STRIDOR,SET,14,-0.23923,-0.006604,0.22955,0.85133,HP_INSPIRATORY_STRIDOR,0.99999
LI_ESTROGENE_T47D_E2_RESPONS...1,SET,33,-0.17613,-0.0074608,0.16898,0.85135,LI_ESTROGENE_T47D_E2_RESPONSE_DN,0.99999
GOMF_PROCOLLAGEN_PROLINE_DIO...,SET,8,-0.26656,-0.0055634,0.25572,0.85138,GOMF_PROCOLLAGEN_PROLINE_DIOXYGENASE_ACTIVITY,0.99999
MIR135A_2_3P,SET,48,-0.11559,-0.0059026,0.11086,0.85143,MIR135A_2_3P,0.99999
MIR135B_3P,SET,48,-0.11559,-0.0059026,0.11086,0.85143,MIR135B_3P,0.99999
GOBP_CHONDROCYTE_PROLIFERATI...,SET,23,-0.19179,-0.0067843,0.18394,0.85145,GOBP_CHONDROCYTE_PROLIFERATION,0.99999
GOBP_LONG_CHAIN_FATTY_ACID_I...,SET,10,-0.28209,-0.006582,0.27052,0.85147,GOBP_LONG_CHAIN_FATTY_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GOMF_TRANSCRIPTION_REGULATOR...3,SET,26,-0.19191,-0.007217,0.18398,0.85154,GOMF_TRANSCRIPTION_REGULATOR_INHIBITOR_ACTIVITY,0.99999
WP_IL5_SIGNALING,SET,38,-0.15254,-0.0069329,0.14623,0.85156,WP_IL5_SIGNALING,0.99999
WP_SPINAL_CORD_INJURY,SET,116,-0.089284,-0.0070748,0.08557,0.85161,WP_SPINAL_CORD_INJURY,0.99999
GOCC_RNA_CAP_BINDING_COMPLEX,SET,15,-0.20598,-0.0058856,0.19741,0.85162,GOCC_RNA_CAP_BINDING_COMPLEX,0.99999
HP_INCREASED_CIRCULATING_IGG...,SET,23,-0.19699,-0.0069682,0.18878,0.85163,HP_INCREASED_CIRCULATING_IGG_LEVEL,0.99999
HP_MASTOIDITIS,SET,7,-0.34924,-0.0068184,0.3347,0.85163,HP_MASTOIDITIS,0.99999
HP_ACCELERATED_SKELETAL_MATU...,SET,63,-0.11748,-0.0068701,0.11255,0.8517,HP_ACCELERATED_SKELETAL_MATURATION,0.99999
REACTOME_ADENYLATE_CYCLASE_A...,SET,10,-0.30281,-0.0070653,0.2901,0.85171,REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...1,SET,1551,-0.023052,-0.0064112,0.02208,0.85175,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...90,SET,7,-0.35666,-0.0069631,0.34157,0.85179,GOBP_NEGATIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
GSE1566_WT_VS_EZH2_KO_LN_TCE...1,SET,178,-0.067286,-0.0065933,0.064438,0.85179,GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN,0.99999
KEGG_INSULIN_SIGNALING_PATHW...,SET,129,-0.078549,-0.0065613,0.075223,0.8518,KEGG_INSULIN_SIGNALING_PATHWAY,0.99999
HP_DECREASED_VIGILANCE,SET,9,-0.28972,-0.0064133,0.27742,0.85183,HP_DECREASED_VIGILANCE,0.99999
GOMF_SELENIUM_BINDING,SET,6,-0.4254,-0.0076893,0.40731,0.85184,GOMF_SELENIUM_BINDING,0.99999
GSE12845_IGD_POS_BLOOD_VS_DA...1,SET,174,-0.065019,-0.0062999,0.062256,0.85184,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.99999
GOBP_FATTY_ACID_TRANSPORT,SET,114,-0.088624,-0.0069621,0.084832,0.85191,GOBP_FATTY_ACID_TRANSPORT,0.99999
WP_INTERLEUKIN1_IL1_STRUCTUR...,SET,46,-0.13339,-0.0066687,0.12767,0.85193,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,0.99999
SIG_CD40PATHWAYMAP,SET,33,-0.1596,-0.0067605,0.15274,0.85195,SIG_CD40PATHWAYMAP,0.99999
GOBP_PROTEIN_IMPORT_INTO_PER...2,SET,5,-0.38461,-0.0063465,0.36808,0.85196,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX_RECEPTOR_RECYCLING,0.99999
DEBIASI_APOPTOSIS_BY_REOVIRU...2,SET,272,-0.055139,-0.0066617,0.052766,0.85197,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,0.99999
HP_REDUCED_CIRCULATING_CH50_...,SET,4,-0.45848,-0.006767,0.43872,0.852,HP_REDUCED_CIRCULATING_CH50_ACTIVITY,0.99999
MIR15A_3P,SET,32,-0.16061,-0.0066995,0.15365,0.85204,MIR15A_3P,0.99999
MIR4504,SET,142,-0.07728,-0.0067704,0.073928,0.85206,MIR4504,0.99999
HP_FASTING_HYPOGLYCEMIA,SET,20,-0.20944,-0.0069091,0.20036,0.85206,HP_FASTING_HYPOGLYCEMIA,0.99999
GOBP_REGULATION_OF_SUPEROXID...2,SET,27,-0.1799,-0.0068942,0.17208,0.85209,GOBP_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS,0.99999
MORF_ATF2,SET,288,-0.053984,-0.0067084,0.051634,0.8521,MORF_ATF2,0.99999
HP_SLENDER_FINGER,SET,130,-0.077268,-0.0064791,0.073906,0.8521,HP_SLENDER_FINGER,0.99999
MIR2682_3P,SET,59,-0.11767,-0.00666,0.11253,0.85213,MIR2682_3P,0.99999
YIH_RESPONSE_TO_ARSENITE_C4,SET,16,-0.21819,-0.0064388,0.20863,0.85217,YIH_RESPONSE_TO_ARSENITE_C4,0.99999
GSE13522_CTRL_VS_T_CRUZI_G_S...1,SET,121,-0.080613,-0.0065231,0.077069,0.85221,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN,0.99999
GOBP_REGULATION_OF_MACROPHAG...4,SET,31,-0.1737,-0.007132,0.16605,0.85223,GOBP_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,0.99999
GSE5099_DAY3_VS_DAY7_MCSF_TR...2,SET,169,-0.068288,-0.0065218,0.065279,0.85223,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP,0.99999
GSE25123_WT_VS_PPARG_KO_MACR...7,SET,181,-0.067451,-0.0066644,0.064468,0.85227,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,0.99999
GOMF_PHOSPHOSERINE_RESIDUE_B...,SET,10,-0.28645,-0.0066836,0.27375,0.8523,GOMF_PHOSPHOSERINE_RESIDUE_BINDING,0.99999
MIR106B_5P,SET,632,-0.036847,-0.006718,0.035212,0.85231,MIR106B_5P,0.99999
HP_CENTRAL_PRIMITIVE_NEUROEC...,SET,6,-0.41604,-0.0075202,0.39759,0.85231,HP_CENTRAL_PRIMITIVE_NEUROECTODERMAL_TUMOR,0.99999
GOBP_POSITIVE_REGULATION_OF_...573,SET,152,-0.074928,-0.0067897,0.071567,0.85243,GOBP_POSITIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,0.99999
MIR4509,SET,60,-0.11868,-0.0067736,0.11335,0.85244,MIR4509,0.99999
GSE9006_1MONTH_VS_4MONTH_POS...2,SET,177,-0.06837,-0.0066809,0.065302,0.85244,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP,0.99999
MORF_RAP1A,SET,133,-0.074598,-0.0063265,0.071233,0.8525,MORF_RAP1A,0.99999
THILLAINADESAN_ZNF217_TARGET...2,SET,38,-0.13893,-0.0063144,0.13265,0.85252,THILLAINADESAN_ZNF217_TARGETS_UP,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...22,SET,48,-0.13507,-0.0068978,0.12897,0.85253,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_STRESS,0.99999
GOMF_CHITIN_BINDING,SET,8,-0.33348,-0.0069601,0.31837,0.85255,GOMF_CHITIN_BINDING,0.99999
GOBP_CELLULAR_RESPONSE_TO_HY...2,SET,9,-0.34485,-0.0076336,0.32919,0.85257,GOBP_CELLULAR_RESPONSE_TO_HYDROPEROXIDE,0.99999
GOBP_COPII_COATED_VESICLE_CA...,SET,18,-0.18955,-0.0059325,0.18091,0.85262,GOBP_COPII_COATED_VESICLE_CARGO_LOADING,0.99999
GSE32901_NAIVE_VS_TH17_NEG_C...2,SET,157,-0.069843,-0.0064312,0.066647,0.85266,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP,0.99999
HP_ABNORMAL_THYMUS_MORPHOLOGY,SET,51,-0.12721,-0.0066958,0.12135,0.85274,HP_ABNORMAL_THYMUS_MORPHOLOGY,0.99999
GSE32986_UNSTIM_VS_CURDLAN_H...2,SET,179,-0.064983,-0.0063854,0.061979,0.85278,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...8,SET,180,-0.066018,-0.006505,0.062961,0.8528,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP,0.99999
GOBP_REGULATION_OF_PROTEIN_L...11,SET,166,-0.069337,-0.0065635,0.066119,0.85283,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.99999
GOBP_POSITIVE_REGULATION_OF_...528,SET,62,-0.11834,-0.0068654,0.11282,0.85287,GOBP_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,0.99999
ONO_FOXP3_TARGETS_DN,SET,40,-0.14503,-0.0067624,0.13827,0.85289,ONO_FOXP3_TARGETS_DN,0.99999
MIR2114_5P,SET,31,-0.16185,-0.0066451,0.15429,0.85289,MIR2114_5P,0.99999
GOMF_RNA_ENDONUCLEASE_ACTIVI...2,SET,5,-0.48502,-0.0080033,0.46234,0.85291,GOMF_RNA_ENDONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS,0.99999
GSE32533_WT_VS_MIR17_KO_ACT_...1,SET,178,-0.063537,-0.006226,0.060567,0.85291,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN,0.99999
GSE19941_IL10_KO_VS_IL10_KO_...3,SET,179,-0.066212,-0.0065062,0.063116,0.85292,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_DN,0.99999
BECKER_TAMOXIFEN_RESISTANCE_...2,SET,51,-0.13224,-0.0069604,0.12604,0.85295,BECKER_TAMOXIFEN_RESISTANCE_UP,0.99999
REACTOME_ACTIVATION_OF_THE_M...,SET,52,-0.11776,-0.0062583,0.11223,0.85296,REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,0.99999
HP_CYSTIC_HYGROMA,SET,50,-0.12219,-0.0063681,0.11645,0.85296,HP_CYSTIC_HYGROMA,0.99999
WP_SEROTONIN_TRANSPORTER_ACT...,SET,10,-0.28567,-0.0066656,0.27226,0.85297,WP_SEROTONIN_TRANSPORTER_ACTIVITY,0.99999
GOBP_PARAXIAL_MESODERM_FORMA...,SET,6,-0.4106,-0.0074218,0.3912,0.85304,GOBP_PARAXIAL_MESODERM_FORMATION,0.99999
GSE17322_CD103_POS_VS_CD11B_...1,SET,173,-0.066207,-0.0063967,0.06308,0.85304,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_DN,0.99999
MIR135A_3P,SET,33,-0.16198,-0.0068615,0.15429,0.85309,MIR135A_3P,0.99999
HP_ABNORMAL_LUNG_MORPHOLOGY,SET,1068,-0.028472,-0.0066647,0.02712,0.8531,HP_ABNORMAL_LUNG_MORPHOLOGY,0.99999
GOBP_ASPARTATE_FAMILY_AMINO_...3,SET,41,-0.13904,-0.0065636,0.13243,0.85312,GOBP_ASPARTATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.99999
MODULE_67,SET,199,-0.0624,-0.0064615,0.059422,0.85316,MODULE_67,0.99999
GOMF_3_5_EXONUCLEASE_ACTIVITY,SET,56,-0.10414,-0.0057428,0.099163,0.85317,GOMF_3_5_EXONUCLEASE_ACTIVITY,0.99999
ACEVEDO_LIVER_CANCER_WITH_H3...4,SET,111,-0.093681,-0.0072625,0.089177,0.85325,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP,0.99999
HP_ABNORMALITY_OF_THE_VOICE,SET,386,-0.046131,-0.0066185,0.043912,0.85326,HP_ABNORMALITY_OF_THE_VOICE,0.99999
VAN_DEN_BIGGELAAR_PBMC_PREVN...3,SET,102,-0.084649,-0.0062921,0.080576,0.85326,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...319,SET,220,-0.062934,-0.0068481,0.059895,0.85331,GOBP_POSITIVE_REGULATION_OF_GROWTH,0.99999
REACTOME_DEFECTIVE_CHST6_CAU...,SET,8,-0.32117,-0.006703,0.30563,0.85333,REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1,0.99999
GOBP_RIBONUCLEOSIDE_MONOPHOS...1,SET,29,-0.16471,-0.0065411,0.1567,0.85338,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOCC_MITOCHONDRIAL_CRISTA,SET,6,-0.41966,-0.0075856,0.39927,0.85338,GOCC_MITOCHONDRIAL_CRISTA,0.99999
GSE36527_CD69_NEG_VS_POS_TRE...2,SET,187,-0.069686,-0.0069973,0.066286,0.85343,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP,0.99999
MIR410_3P,SET,297,-0.053955,-0.0068069,0.051313,0.85347,MIR410_3P,0.99999
HP_LEFT_VENTRICULAR_SYSTOLIC...,SET,81,-0.10098,-0.006693,0.096017,0.85353,HP_LEFT_VENTRICULAR_SYSTOLIC_DYSFUNCTION,0.99999
HP_LEUKOENCEPHALOPATHY,SET,190,-0.061881,-0.0062627,0.058824,0.85359,HP_LEUKOENCEPHALOPATHY,0.99999
WU_ALZHEIMER_DISEASE_DN,SET,17,-0.22651,-0.0068896,0.21527,0.85364,WU_ALZHEIMER_DISEASE_DN,0.99999
GSE360_L_MAJOR_VS_T_GONDII_M...1,SET,177,-0.064935,-0.0063452,0.06171,0.85365,GSE360_L_MAJOR_VS_T_GONDII_MAC_DN,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...5,SET,76,-0.10617,-0.0068167,0.10089,0.85366,GAUTAM_EYE_IRIS_CILIARY_BODY_CRYAA_HIGH_CILIARY_BODY_CELLS,0.99999
GOBP_CILIUM_DISASSEMBLY,SET,5,-0.40282,-0.006647,0.38279,0.85367,GOBP_CILIUM_DISASSEMBLY,0.99999
GOBP_CAMP_PKA_SIGNAL_TRANSDU...,SET,5,-0.44608,-0.0073608,0.42387,0.85368,GOBP_CAMP_PKA_SIGNAL_TRANSDUCTION,0.99999
PID_TCR_PATHWAY,SET,59,-0.11239,-0.0063615,0.10678,0.85373,PID_TCR_PATHWAY,0.99999
GOBP_INTESTINAL_EPITHELIAL_C...1,SET,16,-0.23978,-0.0070757,0.2277,0.85383,GOBP_INTESTINAL_EPITHELIAL_CELL_DEVELOPMENT,0.99999
GOCC_COMPLEX_OF_COLLAGEN_TRI...,SET,19,-0.2225,-0.0071543,0.21128,0.85385,GOCC_COMPLEX_OF_COLLAGEN_TRIMERS,0.99999
HP_DECREASED_CIRCULATING_ADE...,SET,7,-0.33969,-0.0066318,0.32251,0.85388,HP_DECREASED_CIRCULATING_ADENOSYLCOBALAMIN_CONCENTRATION,0.99999
GSE36476_CTRL_VS_TSST_ACT_72...1,SET,181,-0.063719,-0.0062957,0.060497,0.85388,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN,0.99999
GSE41867_NAIVE_VS_DAY30_LCMV...3,SET,180,-0.063196,-0.0062269,0.060002,0.85388,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_DN,0.99999
GSE32423_CTRL_VS_IL7_IL4_MEM...1,SET,190,-0.061522,-0.0062264,0.058399,0.85393,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,0.99999
MODULE_25,SET,13,-0.20121,-0.0053525,0.19096,0.85398,MODULE_25,0.99999
HP_ABNORMAL_BLOOD_PHOSPHATE_...,SET,58,-0.12797,-0.0071817,0.12141,0.85405,HP_ABNORMAL_BLOOD_PHOSPHATE_CONCENTRATION,0.99999
REACTOME_IRAK2_MEDIATED_ACTI...,SET,8,-0.37675,-0.0078631,0.35741,0.85408,REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX,0.99999
GOMF_COPPER_ION_TRANSMEMBRAN...,SET,6,-0.33414,-0.0060398,0.31693,0.85412,GOMF_COPPER_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
REACTOME_REPRESSION_OF_WNT_T...,SET,13,-0.26977,-0.0071763,0.25586,0.85414,REACTOME_REPRESSION_OF_WNT_TARGET_GENES,0.99999
GOBP_PYRIMIDINE_CONTAINING_C...1,SET,37,-0.14622,-0.0065578,0.13866,0.85417,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
REACTOME_FASL_CD95L_SIGNALING,SET,5,-0.44091,-0.0072755,0.41809,0.85419,REACTOME_FASL_CD95L_SIGNALING,0.99999
MIR4494,SET,52,-0.12386,-0.0065828,0.11745,0.85419,MIR4494,0.99999
HP_SEVERE_INFECTION,SET,61,-0.11696,-0.0067307,0.11089,0.85421,HP_SEVERE_INFECTION,0.99999
MIR6864_3P,SET,39,-0.14452,-0.0066541,0.13702,0.85422,MIR6864_3P,0.99999
GSE2770_TGFB_AND_IL4_VS_IL4_...5,SET,171,-0.067442,-0.0064787,0.063931,0.85426,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...150,SET,5,-0.39759,-0.0065607,0.37686,0.85428,GOBP_POSITIVE_REGULATION_OF_CGMP_MEDIATED_SIGNALING,0.99999
GSE6681_DELETED_FOXP3_VS_WT_...2,SET,174,-0.070343,-0.0068158,0.066673,0.85429,GSE6681_DELETED_FOXP3_VS_WT_TREG_UP,0.99999
HP_DIPLOPIA,SET,85,-0.094598,-0.006422,0.089658,0.8543,HP_DIPLOPIA,0.99999
MAINA_VHL_TARGETS_UP,SET,10,-0.32146,-0.0075006,0.30461,0.85435,MAINA_VHL_TARGETS_UP,0.99999
NGO_MALIGNANT_GLIOMA_1P_LOH,SET,13,-0.21428,-0.0057001,0.20301,0.85439,NGO_MALIGNANT_GLIOMA_1P_LOH,0.99999
GSE5679_CTRL_VS_PPARG_LIGAND...1,SET,177,-0.069732,-0.006814,0.066042,0.85448,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,0.99999
HP_HIGH_ANTERIOR_HAIRLINE,SET,59,-0.11232,-0.0063571,0.10635,0.85454,HP_HIGH_ANTERIOR_HAIRLINE,0.99999
GSE13306_TREG_VS_TCONV_SPLEE...2,SET,183,-0.070034,-0.0069574,0.066311,0.85454,GSE13306_TREG_VS_TCONV_SPLEEN_UP,0.99999
GOBP_MATURATION_OF_LSU_RRNA_...,SET,16,-0.20036,-0.0059123,0.18969,0.85456,GOBP_MATURATION_OF_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.99999
GOMF_HISTONE_MODIFYING_ACTIV...,SET,182,-0.063271,-0.0062685,0.059903,0.85456,GOMF_HISTONE_MODIFYING_ACTIVITY,0.99999
GOBP_REGULATION_OF_LENS_FIBE...,SET,8,-0.34699,-0.007242,0.32851,0.85457,GOBP_REGULATION_OF_LENS_FIBER_CELL_DIFFERENTIATION,0.99999
REACTOME_NRCAM_INTERACTIONS,SET,6,-0.38682,-0.006992,0.3662,0.85458,REACTOME_NRCAM_INTERACTIONS,0.99999
GSE2770_IL12_AND_TGFB_ACT_VS...1,SET,167,-0.070166,-0.0066617,0.066408,0.85464,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN,0.99999
HP_ASTROCYTOMA,SET,22,-0.18007,-0.00623,0.17037,0.85473,HP_ASTROCYTOMA,0.99999
MIR550A_3_5P_MIR550A_5P,SET,67,-0.11446,-0.0069021,0.10828,0.85475,MIR550A_3_5P_MIR550A_5P,0.99999
GOBP_TRYPTOPHAN_METABOLIC_PR...,SET,10,-0.33532,-0.0078241,0.31723,0.85475,GOBP_TRYPTOPHAN_METABOLIC_PROCESS,0.99999
REACTOME_SIGNAL_AMPLIFICATION,SET,33,-0.17224,-0.0072961,0.1629,0.85482,REACTOME_SIGNAL_AMPLIFICATION,0.99999
HP_BLINDNESS,SET,266,-0.054796,-0.006548,0.051821,0.85483,HP_BLINDNESS,0.99999
GOBP_PEPTIDYL_SERINE_MODIFIC...,SET,256,-0.05747,-0.0067391,0.054345,0.85485,GOBP_PEPTIDYL_SERINE_MODIFICATION,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...1,SET,180,-0.069183,-0.0068168,0.065419,0.85486,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_DN,0.99999
GOBP_PYRIMIDINE_DEOXYRIBONUC...1,SET,4,-0.43273,-0.0063869,0.40916,0.85488,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,0.99999
GOBP_RESPONSE_TO_INTERFERON_...2,SET,30,-0.18039,-0.0072863,0.17046,0.85502,GOBP_RESPONSE_TO_INTERFERON_BETA,0.99999
REACTOME_SIGNALING_BY_ROBO_R...,SET,198,-0.061356,-0.0063376,0.057975,0.85504,REACTOME_SIGNALING_BY_ROBO_RECEPTORS,0.99999
GSE45365_WT_VS_IFNAR_KO_CD11...1,SET,154,-0.071674,-0.0065371,0.067715,0.85507,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN,0.99999
YANAGISAWA_LUNG_CANCER_RECUR...,SET,6,-0.45448,-0.0082149,0.42936,0.85508,YANAGISAWA_LUNG_CANCER_RECURRENCE,0.99999
WP_CELL_INTERACTIONS_OF_THE_...,SET,23,-0.21212,-0.0075034,0.2003,0.85519,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,0.99999
GOBP_G_PROTEIN_COUPLED_OPIOI...,SET,11,-0.28922,-0.0070775,0.27304,0.85525,GOBP_G_PROTEIN_COUPLED_OPIOID_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE39110_UNTREATED_VS_IL2_TR...3,SET,186,-0.071614,-0.0071719,0.067595,0.8553,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN,0.99999
GSE13547_2H_VS_12_H_ANTI_IGM...3,SET,154,-0.074038,-0.0067527,0.069876,0.85532,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN,0.99999
GOMF_DNA_SECONDARY_STRUCTURE...,SET,34,-0.15956,-0.0068605,0.15059,0.85533,GOMF_DNA_SECONDARY_STRUCTURE_BINDING,0.99999
HP_DISTURBED_PERCEPTION_WITH...,SET,33,-0.14507,-0.006145,0.1369,0.85535,HP_DISTURBED_PERCEPTION_WITH_A_STIMULUS,0.99999
GOMF_PROTEIN_GERANYLGERANYLT...,SET,4,-0.42254,-0.0062365,0.3987,0.85538,GOMF_PROTEIN_GERANYLGERANYLTRANSFERASE_ACTIVITY,0.99999
HP_GANGRENE,SET,52,-0.13656,-0.0072576,0.12884,0.8554,HP_GANGRENE,0.99999
MIR939_3P,SET,138,-0.074698,-0.0064521,0.070459,0.85546,MIR939_3P,0.99999
MIR3679_3P,SET,145,-0.075741,-0.0067048,0.071402,0.8556,MIR3679_3P,0.99999
GOCC_PLASMA_MEMBRANE_RAFT,SET,106,-0.092483,-0.0070072,0.087163,0.85566,GOCC_PLASMA_MEMBRANE_RAFT,0.99999
MARKS_HDAC_TARGETS_DN,SET,14,-0.25289,-0.006981,0.23831,0.85569,MARKS_HDAC_TARGETS_DN,0.99999
LI_WILMS_TUMOR_VS_FETAL_KIDN...1,SET,153,-0.072535,-0.0065943,0.068347,0.85571,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,0.99999
GOMF_TRANSMEMBRANE_RECEPTOR_...6,SET,62,-0.12728,-0.0073842,0.11993,0.85571,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.99999
BIOCARTA_VEGF_PATHWAY,SET,24,-0.17899,-0.0064677,0.16866,0.85572,BIOCARTA_VEGF_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...262,SET,8,-0.38852,-0.0081086,0.36608,0.85572,GOBP_NEGATIVE_REGULATION_OF_GONADOTROPIN_SECRETION,0.99999
GSE29618_BCELL_VS_MONOCYTE_D...1,SET,185,-0.071177,-0.0071091,0.067046,0.85579,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN,0.99999
GSE11961_FOLLICULAR_BCELL_VS...5,SET,184,-0.068014,-0.006775,0.064053,0.85584,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN,0.99999
THAKAR_PBMC_INACTIVATED_INFL...5,SET,785,-0.031852,-0.0064443,0.029989,0.85591,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN,0.99999
MED16_TARGET_GENES,SET,19,-0.22117,-0.0071117,0.2082,0.85594,MED16_TARGET_GENES,0.99999
MIKKELSEN_ES_HCP_WITH_H3_UNM...,SET,55,-0.13216,-0.0072232,0.1244,0.85597,MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED,0.99999
chr12p13,SET,133,-0.17735,-0.015041,0.16691,0.856,chr12p13,0.99999
GSE19825_NAIVE_VS_IL2RALOW_D...1,SET,177,-0.063557,-0.0062106,0.059816,0.856,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN,0.99999
GOBP_CIRCULATORY_SYSTEM_PROC...,SET,565,-0.041843,-0.0072268,0.039379,0.85601,GOBP_CIRCULATORY_SYSTEM_PROCESS,0.99999
GOBP_INTRA_GOLGI_VESICLE_MED...,SET,32,-0.15042,-0.0062748,0.14154,0.85604,GOBP_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.99999
GOMF_U2_SNRNA_BINDING,SET,5,-0.38213,-0.0063056,0.35958,0.85604,GOMF_U2_SNRNA_BINDING,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HN...1,SET,619,-0.040005,-0.0072211,0.037642,0.85605,MANNO_MIDBRAIN_NEUROTYPES_HNBGABA,0.99999
HP_DECREASED_COMPOUND_MUSCLE...,SET,13,-0.24585,-0.0065399,0.23124,0.85614,HP_DECREASED_COMPOUND_MUSCLE_ACTION_POTENTIAL_AMPLITUDE,0.99999
GSE2124_CTRL_VS_LYMPHOTOXIN_...1,SET,178,-0.066465,-0.0065129,0.062514,0.85615,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_DN,0.99999
GSE2770_IL12_VS_IL4_TREATED_...4,SET,182,-0.065458,-0.0064851,0.061554,0.8562,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...12,SET,183,-0.071639,-0.0071168,0.067355,0.85624,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_UP,0.99999
GSE20198_UNTREATED_VS_IFNA_T...1,SET,174,-0.063964,-0.0061977,0.060139,0.85624,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,0.99999
DIAZ_CHRONIC_MYELOGENOUS_LEU...1,SET,106,-0.095266,-0.0072181,0.089564,0.85625,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,0.99999
GSE43955_TH0_VS_TGFB_IL6_IL2...1,SET,187,-0.067476,-0.0067754,0.063438,0.85625,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,0.99999
GOBP_N_TERMINAL_PEPTIDYL_MET...,SET,5,-0.34323,-0.0056637,0.32268,0.85626,GOBP_N_TERMINAL_PEPTIDYL_METHIONINE_ACETYLATION,0.99999
WP_GPCRS_CLASS_A_RHODOPSINLI...,SET,230,-0.068888,-0.0076622,0.064756,0.85628,WP_GPCRS_CLASS_A_RHODOPSINLIKE,0.99999
GOMF_G_PROTEIN_COUPLED_SEROT...,SET,21,-0.21846,-0.0073845,0.20536,0.85628,GOMF_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_ACTIVITY,0.99999
REACTOME_ESTROGEN_STIMULATED...,SET,6,-0.36972,-0.0066829,0.34746,0.85634,REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ,0.99999
GOMF_SULFURTRANSFERASE_ACTIV...,SET,11,-0.2729,-0.0066782,0.25648,0.85634,GOMF_SULFURTRANSFERASE_ACTIVITY,0.99999
IBRAHIM_NRF2_UP,SET,476,-0.041555,-0.006604,0.039047,0.85638,IBRAHIM_NRF2_UP,0.99999
GOBP_CELL_SUBSTRATE_JUNCTION...1,SET,8,-0.35075,-0.0073203,0.32956,0.85639,GOBP_CELL_SUBSTRATE_JUNCTION_DISASSEMBLY,0.99999
REACTOME_THROMBOXANE_SIGNALL...,SET,24,-0.20554,-0.0074269,0.19306,0.85647,REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR,0.99999
GSE43863_TH1_VS_LY6C_INT_CXC...3,SET,177,-0.069381,-0.0067797,0.06517,0.85647,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,0.99999
AIYAR_COBRA1_TARGETS_DN,SET,27,-0.17705,-0.0067849,0.16629,0.85648,AIYAR_COBRA1_TARGETS_DN,0.99999
PID_INTEGRIN_A4B1_PATHWAY,SET,32,-0.16268,-0.0067861,0.15279,0.85649,PID_INTEGRIN_A4B1_PATHWAY,0.99999
REACTOME_TRAFFICKING_OF_MYRI...,SET,4,-0.43918,-0.0064821,0.41246,0.8565,REACTOME_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM,0.99999
HP_BARRETT_ESOPHAGUS,SET,6,-0.38452,-0.0069505,0.3611,0.85652,HP_BARRETT_ESOPHAGUS,0.99999
GSE3982_MEMORY_CD4_TCELL_VS_...1,SET,174,-0.068837,-0.0066698,0.064628,0.85658,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN,0.99999
HP_ABNORMAL_CD4_CD8_RATIO,SET,17,-0.22424,-0.0068208,0.21053,0.85659,HP_ABNORMAL_CD4_CD8_RATIO,0.99999
HP_PARTIAL_ABSENCE_OF_THUMB,SET,9,-0.2806,-0.0062115,0.26344,0.85659,HP_PARTIAL_ABSENCE_OF_THUMB,0.99999
GSE6269_HEALTHY_VS_STAPH_PNE...1,SET,151,-0.075022,-0.006776,0.070431,0.8566,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...5,SET,119,-0.081795,-0.0065641,0.07678,0.85663,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
MODULE_119,SET,130,-0.078113,-0.0065499,0.073317,0.85665,MODULE_119,0.99999
MIR6806_5P,SET,63,-0.11431,-0.0066846,0.10727,0.85668,MIR6806_5P,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...1,SET,11,-0.25449,-0.0062276,0.23878,0.85673,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12,0.99999
MODULE_419,SET,30,-0.1651,-0.0066688,0.15492,0.85673,MODULE_419,0.99999
GSE17721_0.5H_VS_4H_CPG_BMDC...2,SET,185,-0.064701,-0.0064623,0.060693,0.85679,GSE17721_0.5H_VS_4H_CPG_BMDC_UP,0.99999
MIR6509_3P,SET,123,-0.082413,-0.0067232,0.077305,0.8568,MIR6509_3P,0.99999
RNTCANNRNNYNATTW_UNKNOWN,SET,58,-0.12457,-0.006991,0.11684,0.85682,RNTCANNRNNYNATTW_UNKNOWN,0.99999
LOPEZ_MESOTHELIOMA_SURVIVAL_...6,SET,12,-0.27656,-0.0070684,0.25934,0.85687,LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP,0.99999
GSE37532_TREG_VS_TCONV_CD4_T...4,SET,118,-0.090887,-0.0072632,0.085224,0.85688,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,0.99999
FAELT_B_CLL_WITH_VH3_21_DN,SET,44,-0.14219,-0.0069527,0.13331,0.85692,FAELT_B_CLL_WITH_VH3_21_DN,0.99999
GOBP_REGULATION_OF_PROTEIN_L...15,SET,16,-0.22506,-0.0066412,0.211,0.85692,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE,0.99999
GSE12392_WT_VS_IFNB_KO_CD8A_...2,SET,185,-0.065884,-0.0065804,0.061763,0.85694,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_UP,0.99999
GOBP_DIAPEDESIS,SET,6,-0.41522,-0.0075053,0.38921,0.85697,GOBP_DIAPEDESIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...464,SET,42,-0.13255,-0.0063326,0.12423,0.85698,GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,0.99999
REACTOME_ORGANIC_ANION_TRANS...1,SET,5,-0.38627,-0.0063738,0.36203,0.857,REACTOME_ORGANIC_ANION_TRANSPORT,0.99999
MIR943,SET,47,-0.13706,-0.0069259,0.12845,0.857,MIR943,0.99999
GSE14308_TH1_VS_NATURAL_TREG...1,SET,181,-0.065614,-0.0064829,0.06149,0.85702,GSE14308_TH1_VS_NATURAL_TREG_DN,0.99999
OVSYANNIKOVA_PBMC_FLUARIX_AG...2,SET,6,-0.36037,-0.006514,0.33766,0.85707,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP,0.99999
SCIBETTA_KDM5B_TARGETS_UP,SET,18,-0.20159,-0.0063093,0.18886,0.85709,SCIBETTA_KDM5B_TARGETS_UP,0.99999
chr14q21,SET,33,-0.26354,-0.011163,0.24682,0.85717,chr14q21,0.99999
TEL2_Q6,SET,221,-0.059542,-0.0064935,0.055762,0.85718,TEL2_Q6,0.99999
HP_INTERNALLY_NUCLEATED_SKEL...,SET,6,-0.4128,-0.0074616,0.38661,0.85718,HP_INTERNALLY_NUCLEATED_SKELETAL_MUSCLE_FIBERS,0.99999
LEE_LIVER_CANCER_MYC_TGFA_DN,SET,57,-0.12571,-0.0069937,0.11772,0.85719,LEE_LIVER_CANCER_MYC_TGFA_DN,0.99999
HEIDENBLAD_AMPLICON_8Q24_DN,SET,38,-0.15136,-0.0068794,0.14174,0.85721,HEIDENBLAD_AMPLICON_8Q24_DN,0.99999
GOBP_HETEROTYPIC_CELL_CELL_A...,SET,62,-0.12779,-0.0074139,0.11967,0.85721,GOBP_HETEROTYPIC_CELL_CELL_ADHESION,0.99999
WILSON_PROTEASES_AT_TUMOR_BO...2,SET,20,-0.19365,-0.0063883,0.18129,0.85727,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP,0.99999
GOBP_ACTIVATED_T_CELL_PROLIF...,SET,42,-0.15378,-0.0073471,0.14396,0.85728,GOBP_ACTIVATED_T_CELL_PROLIFERATION,0.99999
HP_MICROMELIA,SET,86,-0.09661,-0.0065969,0.090405,0.85738,HP_MICROMELIA,0.99999
GOCC_SMALL_SUBUNIT_PROCESSOME,SET,63,-0.10876,-0.0063602,0.10176,0.8574,GOCC_SMALL_SUBUNIT_PROCESSOME,0.99999
GOBP_APOPTOTIC_PROCESS_IN_BO...,SET,5,-0.44428,-0.0073311,0.41565,0.85743,GOBP_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL,0.99999
HP_ACETABULAR_DYSPLASIA,SET,23,-0.18148,-0.0064195,0.16976,0.85746,HP_ACETABULAR_DYSPLASIA,0.99999
WORSCHECH_TUMOR_EVASION_AND_...1,SET,14,-0.2598,-0.0071718,0.24301,0.85748,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...15,SET,42,-0.14813,-0.007077,0.1385,0.85757,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETAL_MUSCULATURE,0.99999
GOBP_POSITIVE_REGULATION_OF_...249,SET,189,-0.070274,-0.0070936,0.0657,0.8576,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,0.99999
REACTOME_TRNA_PROCESSING_IN_...2,SET,53,-0.12165,-0.0065268,0.11372,0.85761,REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS,0.99999
GOMF_LOW_DENSITY_LIPOPROTEIN...3,SET,22,-0.18831,-0.006515,0.17602,0.85765,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,0.99999
GOMF_TOXIC_SUBSTANCE_BINDING,SET,10,-0.3088,-0.0072051,0.28864,0.85765,GOMF_TOXIC_SUBSTANCE_BINDING,0.99999
KMT2D_TARGET_GENES,SET,584,-0.038919,-0.0068303,0.036374,0.85767,KMT2D_TARGET_GENES,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...1,SET,41,-0.15296,-0.0072204,0.14295,0.85768,GAVISH_3CA_MALIGNANT_METAPROGRAM_10_PROTEIN_MATURATION,0.99999
HP_MILD_HEARING_IMPAIRMENT,SET,7,-0.30483,-0.0059514,0.2849,0.85768,HP_MILD_HEARING_IMPAIRMENT,0.99999
REACTOME_SOS_MEDIATED_SIGNAL...,SET,7,-0.34068,-0.0066513,0.31832,0.85774,REACTOME_SOS_MEDIATED_SIGNALLING,0.99999
MIR410_5P,SET,38,-0.13927,-0.0063298,0.13013,0.85774,MIR410_5P,0.99999
GSE15659_NAIVE_CD4_TCELL_VS_...1,SET,168,-0.070382,-0.006702,0.065753,0.85777,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...13,SET,177,-0.06835,-0.006679,0.063826,0.85788,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_DN,0.99999
GOBP_MAPK_CASCADE,SET,684,-0.037086,-0.0070239,0.03463,0.85789,GOBP_MAPK_CASCADE,0.99999
WP_B_CELL_RECEPTOR_SIGNALING,SET,93,-0.094966,-0.0067421,0.088656,0.85795,WP_B_CELL_RECEPTOR_SIGNALING,0.99999
MIR4306,SET,428,-0.045124,-0.0068092,0.042125,0.85795,MIR4306,0.99999
GSE8921_UNSTIM_0H_VS_TLR1_2_...8,SET,182,-0.067285,-0.0066662,0.062808,0.85797,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP,0.99999
LIU_VMYB_TARGETS_UP,SET,110,-0.089264,-0.006889,0.083317,0.85799,LIU_VMYB_TARGETS_UP,0.99999
GOBP_L_ALANINE_TRANSMEMBRANE...,SET,4,-0.46856,-0.0069157,0.43722,0.85806,GOBP_L_ALANINE_TRANSMEMBRANE_TRANSPORT,0.99999
HP_ABNORMAL_NASAL_SEPTUM_MOR...,SET,15,-0.27017,-0.0077197,0.25206,0.85811,HP_ABNORMAL_NASAL_SEPTUM_MORPHOLOGY,0.99999
GOMF_ATPASE_COUPLED_LIPID_TR...,SET,8,-0.34196,-0.007137,0.31898,0.85814,GOMF_ATPASE_COUPLED_LIPID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
REACTOME_PKR_MEDIATED_SIGNAL...,SET,65,-0.11189,-0.006646,0.10436,0.85816,REACTOME_PKR_MEDIATED_SIGNALING,0.99999
HP_DELAYED_UMBILICAL_CORD_SE...,SET,5,-0.5115,-0.0084403,0.47705,0.85818,HP_DELAYED_UMBILICAL_CORD_SEPARATION,0.99999
KEGG_MEDICUS_PATHOGEN_SHIGEL...9,SET,7,-0.33533,-0.0065468,0.31273,0.85819,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPG_TO_TNF_NFKB_SIGNALING_PATHWAY,0.99999
GOBP_CELLULAR_COMPONENT_MAIN...,SET,64,-0.12245,-0.0072174,0.11417,0.85824,GOBP_CELLULAR_COMPONENT_MAINTENANCE,0.99999
GOBP_REGULATION_OF_MUSCLE_OR...,SET,23,-0.21828,-0.0077212,0.2035,0.85827,GOBP_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT,0.99999
WP_ATM_SIGNALING,SET,36,-0.13023,-0.0057614,0.12137,0.85835,WP_ATM_SIGNALING,0.99999
VERRECCHIA_RESPONSE_TO_TGFB1...2,SET,19,-0.23285,-0.0074872,0.21699,0.85838,VERRECCHIA_RESPONSE_TO_TGFB1_C2,0.99999
GOBP_NEGATIVE_REGULATION_OF_...80,SET,18,-0.22467,-0.0070316,0.20933,0.85842,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH,0.99999
HP_CORONARY_ARTERY_STENOSIS,SET,6,-0.35509,-0.0064184,0.33083,0.85843,HP_CORONARY_ARTERY_STENOSIS,0.99999
GOBP_GLYCINE_TRANSPORT,SET,14,-0.26723,-0.0073768,0.24894,0.85846,GOBP_GLYCINE_TRANSPORT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...650,SET,4,-0.45423,-0.0067042,0.4231,0.85849,GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_ELONGATION,0.99999
GSE34156_UNTREATED_VS_24H_NO...1,SET,144,-0.075502,-0.0066607,0.070324,0.8585,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.99999
GOBP_ORGANOPHOSPHATE_METABOL...,SET,900,-0.030684,-0.0066252,0.028576,0.85853,GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS,0.99999
GSE24142_EARLY_THYMIC_PROGEN...12,SET,185,-0.070548,-0.0070462,0.065701,0.85853,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP,0.99999
GOBP_REPLICATIVE_SENESCENCE,SET,16,-0.20411,-0.0060233,0.19007,0.85856,GOBP_REPLICATIVE_SENESCENCE,0.99999
GSE17721_POLYIC_VS_CPG_16H_B...2,SET,184,-0.06687,-0.006661,0.062266,0.85857,GSE17721_POLYIC_VS_CPG_16H_BMDC_UP,0.99999
GSE1448_ANTI_VALPHA2_VS_VBET...1,SET,178,-0.070339,-0.0068925,0.065478,0.85863,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...5,SET,14,-0.25685,-0.0070902,0.23908,0.85865,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,0.99999
PID_FANCONI_PATHWAY,SET,40,-0.12675,-0.0059099,0.11797,0.85868,PID_FANCONI_PATHWAY,0.99999
HP_ABNORMAL_NERVOUS_SYSTEM_E...,SET,610,-0.037169,-0.0066618,0.034591,0.85869,HP_ABNORMAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY,0.99999
MIR6887_5P,SET,120,-0.083733,-0.0067476,0.077921,0.85871,MIR6887_5P,0.99999
GOBP_REGULATION_OF_DEFENSE_R...3,SET,5,-0.35844,-0.0059147,0.33356,0.85871,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_FUNGUS,0.99999
GOBP_RESPONSE_TO_ETHANOL,SET,118,-0.088501,-0.0070726,0.082356,0.85872,GOBP_RESPONSE_TO_ETHANOL,0.99999
GSE3982_EFF_MEMORY_CD4_TCELL...5,SET,184,-0.064056,-0.0063807,0.059602,0.85874,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_CYC...1,SET,594,-0.035945,-0.0063603,0.033443,0.85876,HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL,0.99999
HP_ABSENCE_OF_THE_SACRUM,SET,8,-0.32969,-0.0068809,0.30663,0.85885,HP_ABSENCE_OF_THE_SACRUM,0.99999
GOBP_AMINO_ACID_NEUROTRANSMI...,SET,10,-0.34279,-0.0079982,0.31875,0.85889,GOBP_AMINO_ACID_NEUROTRANSMITTER_REUPTAKE,0.99999
JONES_OVARY_MAST_CELL,SET,39,-0.15559,-0.0071639,0.14469,0.85889,JONES_OVARY_MAST_CELL,0.99999
GOCC_CORTICAL_ACTIN_CYTOSKEL...,SET,72,-0.10548,-0.0065929,0.098075,0.85892,GOCC_CORTICAL_ACTIN_CYTOSKELETON,0.99999
MIR130A_5P,SET,307,-0.056285,-0.0072175,0.052331,0.85893,MIR130A_5P,0.99999
REACTOME_EXTRA_NUCLEAR_ESTRO...,SET,74,-0.11557,-0.0073227,0.10745,0.85894,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,0.99999
MNX1_TARGET_GENES,SET,8,-0.33038,-0.0068953,0.30715,0.85895,MNX1_TARGET_GENES,0.99999
GOMF_NMDA_GLUTAMATE_RECEPTOR...,SET,7,-0.36858,-0.0071959,0.34261,0.85899,GOMF_NMDA_GLUTAMATE_RECEPTOR_ACTIVITY,0.99999
HP_DYSLEXIA,SET,29,-0.17312,-0.0068753,0.16091,0.859,HP_DYSLEXIA,0.99999
MIR1909_3P,SET,120,-0.084112,-0.0067781,0.078165,0.85905,MIR1909_3P,0.99999
GOMF_ACTIVIN_RECEPTOR_BINDING,SET,8,-0.33549,-0.007002,0.31176,0.85906,GOMF_ACTIVIN_RECEPTOR_BINDING,0.99999
CTTTGTA_MIR524,SET,397,-0.047213,-0.0068675,0.043869,0.85908,CTTTGTA_MIR524,0.99999
HP_DIFFUSE_PALMOPLANTAR_HYPE...,SET,10,-0.33421,-0.0077981,0.31048,0.85912,HP_DIFFUSE_PALMOPLANTAR_HYPERKERATOSIS,0.99999
GOBP_CIRCADIAN_RHYTHM,SET,192,-0.069803,-0.0071011,0.064831,0.85918,GOBP_CIRCADIAN_RHYTHM,0.99999
GOBP_PEXOPHAGY,SET,5,-0.36022,-0.0059441,0.33451,0.85923,GOBP_PEXOPHAGY,0.99999
GOCC_SPERM_HEAD_PLASMA_MEMBR...,SET,6,-0.36977,-0.0066838,0.34321,0.85934,GOCC_SPERM_HEAD_PLASMA_MEMBRANE,0.99999
GOMF_ATP_DEPENDENT_PEPTIDASE...,SET,7,-0.29542,-0.0057676,0.27418,0.85936,GOMF_ATP_DEPENDENT_PEPTIDASE_ACTIVITY,0.99999
HP_ABNORMAL_CEREBRAL_VENTRIC...,SET,816,-0.032448,-0.0066873,0.030114,0.85936,HP_ABNORMAL_CEREBRAL_VENTRICLE_MORPHOLOGY,0.99999
DESERT_STEM_CELL_HEPATOCELLU...,SET,229,-0.06206,-0.0068879,0.057594,0.85937,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.99999
GOBP_REGULATION_OF_MUSCLE_HY...,SET,53,-0.13881,-0.0074476,0.12881,0.8594,GOBP_REGULATION_OF_MUSCLE_HYPERTROPHY,0.99999
MODULE_154,SET,67,-0.11961,-0.0072129,0.11098,0.85942,MODULE_154,0.99999
MATSUMIYA_PBMC_MODIFIED_VACC...7,SET,9,-0.29199,-0.0064634,0.27089,0.85944,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_28DY_UP,0.99999
GSE13306_RA_VS_UNTREATED_TRE...1,SET,190,-0.069161,-0.0069995,0.064163,0.85945,GSE13306_RA_VS_UNTREATED_TREG_DN,0.99999
GOMF_PROTEIN_HORMONE_RECEPTO...,SET,18,-0.23645,-0.0074002,0.2193,0.85951,GOMF_PROTEIN_HORMONE_RECEPTOR_ACTIVITY,0.99999
GOBP_REGULATION_OF_PROTEIN_C...3,SET,13,-0.23843,-0.0063426,0.22113,0.85953,GOBP_REGULATION_OF_PROTEIN_COMPLEX_STABILITY,0.99999
HP_SPINAL_CORD_LESION,SET,41,-0.13691,-0.0064627,0.12697,0.85953,HP_SPINAL_CORD_LESION,0.99999
BIOCARTA_HIVNEF_PATHWAY,SET,54,-0.12437,-0.0067355,0.11534,0.85955,BIOCARTA_HIVNEF_PATHWAY,0.99999
OCT1_04,SET,201,-0.070524,-0.0073389,0.065377,0.85964,OCT1_04,0.99999
GOBP_PEPTIDYL_PROLINE_HYDROX...1,SET,11,-0.24127,-0.0059041,0.22358,0.85972,GOBP_PEPTIDYL_PROLINE_HYDROXYLATION,0.99999
HP_MIGRAINE_WITH_AURA,SET,12,-0.28778,-0.0073552,0.26666,0.85974,HP_MIGRAINE_WITH_AURA,0.99999
GCM_SUPT4H1,SET,52,-0.12192,-0.0064798,0.11296,0.85978,GCM_SUPT4H1,0.99999
GOBP_CALCIUM_ION_EXPORT_ACRO...,SET,9,-0.3485,-0.0077144,0.32287,0.85978,GOBP_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.99999
REACTOME_RHO_GTPASES_ACTIVAT...6,SET,19,-0.21217,-0.0068221,0.19653,0.85983,REACTOME_RHO_GTPASES_ACTIVATE_PAKS,0.99999
GOBP_STRIATUM_DEVELOPMENT,SET,20,-0.21822,-0.0071988,0.20213,0.85983,GOBP_STRIATUM_DEVELOPMENT,0.99999
MIR1249_5P,SET,177,-0.069413,-0.0067828,0.064288,0.85986,MIR1249_5P,0.99999
HP_MEGALOBLASTIC_ANEMIA,SET,17,-0.23017,-0.007001,0.21315,0.85988,HP_MEGALOBLASTIC_ANEMIA,0.99999
GSE13306_LAMINA_PROPRIA_VS_S...2,SET,182,-0.068797,-0.006816,0.063709,0.85989,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP,0.99999
GSE22886_CD8_VS_CD4_NAIVE_TC...2,SET,176,-0.065676,-0.0063997,0.060802,0.85996,GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP,0.99999
PID_ERBB1_RECEPTOR_PROXIMAL_...,SET,34,-0.15069,-0.006479,0.13949,0.85998,PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,0.99999
GOMF_CLASS_I_DNA_APURINIC_OR...,SET,8,-0.28721,-0.0059943,0.26582,0.86003,GOMF_CLASS_I_DNA_APURINIC_OR_APYRIMIDINIC_SITE_ENDONUCLEASE_ACTIVITY,0.99999
WP_GLYCOLYSIS_AND_GLUCONEOGE...,SET,38,-0.13942,-0.0063368,0.12901,0.86008,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,0.99999
GOBP_AMINOPHOSPHOLIPID_TRANS...2,SET,8,-0.32997,-0.0068867,0.30522,0.86016,GOBP_AMINOPHOSPHOLIPID_TRANSPORT,0.99999
GSE11961_MARGINAL_ZONE_BCELL...6,SET,181,-0.068062,-0.0067248,0.062951,0.86019,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP,0.99999
ESC_J1_UP_LATE.V1_UP,SET,162,-0.077017,-0.0072029,0.071225,0.86022,ESC_J1_UP_LATE.V1_UP,0.99999
ROSS_AML_WITH_AML1_ETO_FUSION,SET,67,-0.1188,-0.007164,0.10986,0.86024,ROSS_AML_WITH_AML1_ETO_FUSION,0.99999
GOBP_REGULATION_OF_CYTOPLASM...3,SET,32,-0.15332,-0.0063954,0.14176,0.86026,GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATION,0.99999
GSE24634_TEFF_VS_TCONV_DAY5_...2,SET,188,-0.064456,-0.0064892,0.059596,0.86026,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP,0.99999
REACTOME_SARS_COV_1_MODULATE...,SET,32,-0.15527,-0.0064771,0.14356,0.86027,REACTOME_SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,0.99999
MODULE_173,SET,16,-0.2531,-0.0074688,0.23401,0.86027,MODULE_173,0.99999
SMID_BREAST_CANCER_NORMAL_LI...2,SET,422,-0.048934,-0.0073334,0.045239,0.8603,SMID_BREAST_CANCER_NORMAL_LIKE_UP,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...4,SET,184,-0.067906,-0.0067642,0.062776,0.8603,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP,0.99999
HP_ABNORMALITY_OF_THE_HUMERUS,SET,54,-0.13359,-0.0072346,0.12349,0.86031,HP_ABNORMALITY_OF_THE_HUMERUS,0.99999
GOBP_INSULIN_RECEPTOR_SIGNAL...,SET,119,-0.083595,-0.0067085,0.07727,0.86034,GOBP_INSULIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_TOLERANCE_INDUCTION_DEP...,SET,4,-0.5142,-0.0075894,0.4752,0.86038,GOBP_TOLERANCE_INDUCTION_DEPENDENT_UPON_IMMUNE_RESPONSE,0.99999
GOBP_REGULATION_OF_PROTEIN_M...1,SET,62,-0.11464,-0.0066512,0.10594,0.86039,GOBP_REGULATION_OF_PROTEIN_MATURATION,0.99999
WP_HOSTPATHOGEN_INTERACTION_...2,SET,18,-0.22424,-0.0070183,0.20716,0.86046,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,0.99999
GOBP_PROTEASOME_MEDIATED_UBI...,SET,369,-0.046463,-0.0065207,0.042923,0.86047,GOBP_PROTEASOME_MEDIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
GOMF_MITOGEN_ACTIVATED_PROTE...2,SET,10,-0.28654,-0.0066858,0.26467,0.86051,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_BINDING,0.99999
GSE10273_LOW_IL7_VS_HIGH_IL7...2,SET,176,-0.067685,-0.0065954,0.062519,0.86051,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,0.99999
KORKOLA_EMBRYONAL_CARCINOMA,SET,8,-0.32121,-0.006704,0.29668,0.86052,KORKOLA_EMBRYONAL_CARCINOMA,0.99999
HP_ABNORMAL_SERUM_INSULIN_LI...,SET,26,-0.18121,-0.0068148,0.16737,0.86052,HP_ABNORMAL_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1_LEVEL,0.99999
GOBP_CELLULAR_RESPONSE_TO_BR...,SET,10,-0.31965,-0.0074583,0.2952,0.86055,GOBP_CELLULAR_RESPONSE_TO_BRAIN_DERIVED_NEUROTROPHIC_FACTOR_STIMULUS,0.99999
ENK_UV_RESPONSE_KERATINOCYTE...2,SET,469,-0.042277,-0.0066704,0.039036,0.86059,ENK_UV_RESPONSE_KERATINOCYTE_UP,0.99999
RUBENSTEIN_SKELETAL_MUSCLE_T...,SET,157,-0.073166,-0.0067372,0.067555,0.8606,RUBENSTEIN_SKELETAL_MUSCLE_T_CELLS,0.99999
HP_SIMPLE_FEBRILE_SEIZURE,SET,25,-0.19955,-0.0073589,0.1842,0.86066,HP_SIMPLE_FEBRILE_SEIZURE,0.99999
HP_CORONARY_ARTERY_ATHEROSCL...,SET,50,-0.14556,-0.0075864,0.13435,0.86069,HP_CORONARY_ARTERY_ATHEROSCLEROSIS,0.99999
HP_PROMINENT_NASAL_TIP,SET,25,-0.19525,-0.0072002,0.18021,0.86069,HP_PROMINENT_NASAL_TIP,0.99999
GOBP_PROTEIN_STABILIZATION,SET,186,-0.065486,-0.0065581,0.06039,0.8609,GOBP_PROTEIN_STABILIZATION,0.99999
REACTOME_PLATELET_AGGREGATIO...,SET,39,-0.15437,-0.0071074,0.14234,0.86091,REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,0.99999
FARMER_BREAST_CANCER_APOCRIN...2,SET,290,-0.05731,-0.0071459,0.052844,0.86092,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,0.99999
SENESE_HDAC3_TARGETS_DN,SET,466,-0.044183,-0.0069495,0.04074,0.86093,SENESE_HDAC3_TARGETS_DN,0.99999
GOBP_REGULATION_OF_MRNA_CIS_...,SET,3,-0.48294,-0.0061731,0.4453,0.86093,GOBP_REGULATION_OF_MRNA_CIS_SPLICING_VIA_SPLICEOSOME,0.99999
GOBP_POSITIVE_REGULATION_OF_...698,SET,1621,-0.024787,-0.0070327,0.022849,0.86098,GOBP_POSITIVE_REGULATION_OF_SIGNALING,0.99999
YANG_BCL3_TARGETS_DN,SET,8,-0.34278,-0.0071542,0.31596,0.86101,YANG_BCL3_TARGETS_DN,0.99999
HOFFMANN_PRE_BI_TO_LARGE_PRE...1,SET,73,-0.1129,-0.0071053,0.10405,0.86105,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,0.99999
GOBP_DETECTION_OF_CALCIUM_ION,SET,13,-0.27332,-0.0072707,0.25187,0.86107,GOBP_DETECTION_OF_CALCIUM_ION,0.99999
OHGUCHI_LIVER_HNF4A_TARGETS_...1,SET,153,-0.078603,-0.0071459,0.072429,0.86109,OHGUCHI_LIVER_HNF4A_TARGETS_DN,0.99999
GOBP_REGULATION_OF_T_CELL_AC...1,SET,357,-0.052633,-0.007268,0.048494,0.86111,GOBP_REGULATION_OF_T_CELL_ACTIVATION,0.99999
HP_ABNORMAL_PEER_RELATIONSHI...,SET,6,-0.37174,-0.0067194,0.34251,0.86111,HP_ABNORMAL_PEER_RELATIONSHIPS,0.99999
GOBP_DOUBLE_STRAND_BREAK_REP...2,SET,7,-0.27664,-0.005401,0.25488,0.86112,GOBP_DOUBLE_STRAND_BREAK_REPAIR_INVOLVED_IN_MEIOTIC_RECOMBINATION,0.99999
KEGG_MEDICUS_ENV_FACTOR_E2_T...1,SET,7,-0.37862,-0.0073919,0.34881,0.86113,KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,0.99999
GSE25502_WT_VS_KLF13_KO_THYM...1,SET,154,-0.078854,-0.0071919,0.072633,0.86118,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_DN,0.99999
GSE4811_CLASSSICALY_ACTIVATE...1,SET,176,-0.072175,-0.0070329,0.066466,0.86123,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_DN,0.99999
GSE2770_UNTREATED_VS_IL12_TR...4,SET,179,-0.068598,-0.0067406,0.063168,0.86124,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.99999
CHX10_01,SET,203,-0.069921,-0.0073119,0.06438,0.86127,CHX10_01,0.99999
GAUCHER_PBMC_YF_VAX_STAMARIL...7,SET,91,-0.097578,-0.006853,0.089835,0.8613,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...597,SET,95,-0.094874,-0.0068072,0.087338,0.86132,GOBP_NEGATIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,0.99999
TRAVAGLINI_LUNG_DIFFERENTIAT...,SET,148,-0.08079,-0.0072246,0.074365,0.86134,TRAVAGLINI_LUNG_DIFFERENTIATING_BASAL_CELL,0.99999
HP_GLIOBLASTOMA_MULTIFORME,SET,26,-0.16674,-0.0062705,0.15344,0.8614,HP_GLIOBLASTOMA_MULTIFORME,0.99999
WP_EPO_RECEPTOR_SIGNALING,SET,26,-0.19672,-0.0073979,0.18097,0.86148,WP_EPO_RECEPTOR_SIGNALING,0.99999
GOBP_DETECTION_OF_LIGHT_STIM...2,SET,19,-0.21086,-0.0067801,0.19398,0.86148,GOBP_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,0.99999
GSE15330_LYMPHOID_MULTIPOTEN...9,SET,176,-0.070854,-0.0069042,0.065182,0.86148,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_DN,0.99999
MIR4658,SET,44,-0.15231,-0.0074476,0.14009,0.86153,MIR4658,0.99999
WP_METASTATIC_BRAIN_TUMOR,SET,6,-0.43383,-0.0078417,0.39887,0.86161,WP_METASTATIC_BRAIN_TUMOR,0.99999
HP_ABNORMAL_LIVER_PHYSIOLOGY,SET,24,-0.19908,-0.0071933,0.18302,0.86164,HP_ABNORMAL_LIVER_PHYSIOLOGY,0.99999
MIR3187_3P,SET,63,-0.11609,-0.0067891,0.10672,0.86165,MIR3187_3P,0.99999
HP_ATROPHY_DEGENERATION_INVO...1,SET,14,-0.26759,-0.0073869,0.24593,0.86171,HP_ATROPHY_DEGENERATION_INVOLVING_THE_CAUDATE_NUCLEUS,0.99999
HP_CENTRAL_NERVOUS_SYSTEM_CY...,SET,180,-0.067661,-0.0066668,0.062179,0.86173,HP_CENTRAL_NERVOUS_SYSTEM_CYST,0.99999
GOBP_REGULATION_OF_INTRINSIC...6,SET,8,-0.32846,-0.0068551,0.30182,0.86175,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,0.99999
GOBP_REGULATION_OF_PHOSPHATI...3,SET,4,-0.47191,-0.0069651,0.43359,0.86178,GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS,0.99999
GSE17721_LPS_VS_PAM3CSK4_8H_...1,SET,180,-0.066408,-0.0065434,0.061011,0.86179,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_DN,0.99999
REACTOME_SENSORY_PERCEPTION,SET,513,-0.0524,-0.0086361,0.048134,0.86183,REACTOME_SENSORY_PERCEPTION,0.99999
HP_ABNORMAL_BLOOD_UREA_NITRO...,SET,17,-0.22088,-0.0067184,0.20289,0.86184,HP_ABNORMAL_BLOOD_UREA_NITROGEN_CONCENTRATION,0.99999
NAKAYA_PBMC_FLUAD_IMUVAC_MAL...,SET,17,-0.22031,-0.0067011,0.20237,0.86184,NAKAYA_PBMC_FLUAD_IMUVAC_MALE_AGE_14_27YO_CORRELATED_WITH_HAI_RESPONSE_MF59_ADJUVANTED_AND_NON_1DY_GENES_IN_BTM_M75_POSITIVE,0.99999
REACTOME_NEGATIVE_REGULATION...5,SET,29,-0.17966,-0.007135,0.16501,0.86187,REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING,0.99999
HP_DECREASED_LACRIMATION,SET,26,-0.18874,-0.0070981,0.17334,0.86188,HP_DECREASED_LACRIMATION,0.99999
GOBP_PROTEIN_KINASE_A_SIGNAL...,SET,37,-0.15897,-0.0071297,0.14599,0.86189,GOBP_PROTEIN_KINASE_A_SIGNALING,0.99999
HP_UPPER_LIMB_ASYMMETRY,SET,10,-0.32338,-0.0075455,0.29695,0.86192,HP_UPPER_LIMB_ASYMMETRY,0.99999
ZHONG_SECRETOME_OF_LUNG_CANC...3,SET,69,-0.11215,-0.0068625,0.10298,0.86193,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...471,SET,5,-0.48072,-0.0079324,0.44138,0.86195,GOBP_NEGATIVE_REGULATION_OF_OSTEOCLAST_DEVELOPMENT,0.99999
MIR597_3P,SET,100,-0.093837,-0.0069068,0.086147,0.86197,MIR597_3P,0.99999
GOBP_BONE_MINERALIZATION_INV...,SET,11,-0.27621,-0.0067591,0.25355,0.862,GOBP_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION,0.99999
GOCC_ZONA_PELLUCIDA_RECEPTOR...,SET,8,-0.27509,-0.0057412,0.2525,0.86201,GOCC_ZONA_PELLUCIDA_RECEPTOR_COMPLEX,0.99999
HP_EEG_WITH_FOCAL_SHARP_SLOW...,SET,12,-0.28955,-0.0074006,0.26574,0.86205,HP_EEG_WITH_FOCAL_SHARP_SLOW_WAVES,0.99999
REACTOME_CAMK_IV_MEDIATED_PH...,SET,10,-0.34055,-0.007946,0.3125,0.86208,REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB,0.99999
GSE25677_R848_VS_MPL_AND_R84...1,SET,145,-0.077097,-0.0068247,0.070731,0.86214,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_DN,0.99999
GOCC_DYNACTIN_COMPLEX,SET,8,-0.27861,-0.0058148,0.25559,0.86215,GOCC_DYNACTIN_COMPLEX,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...1,SET,155,-0.08049,-0.0073647,0.073828,0.86219,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...9,SET,7,-0.33293,-0.0064999,0.30536,0.8622,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP,0.99999
GSE16450_IMMATURE_VS_MATURE_...4,SET,182,-0.068875,-0.0068237,0.063161,0.86224,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.99999
GOBP_GAP_JUNCTION_MEDIATED_I...,SET,6,-0.46312,-0.0083712,0.42467,0.86226,GOBP_GAP_JUNCTION_MEDIATED_INTERCELLULAR_TRANSPORT,0.99999
GSE27786_CD4_TCELL_VS_MONO_M...2,SET,176,-0.065809,-0.0064127,0.060315,0.86238,GSE27786_CD4_TCELL_VS_MONO_MAC_UP,0.99999
GSE33162_UNTREATED_VS_4H_LPS...3,SET,186,-0.068691,-0.0068791,0.062953,0.86239,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...145,SET,4,-0.48058,-0.0070931,0.44036,0.86243,GOBP_NEGATIVE_REGULATION_OF_CHROMATIN_ORGANIZATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...275,SET,4,-0.48058,-0.0070931,0.44036,0.86243,GOBP_NEGATIVE_REGULATION_OF_HETEROCHROMATIN_FORMATION,0.99999
GOBP_CELLULAR_RESPONSE_TO_LA...,SET,7,-0.34686,-0.0067718,0.31782,0.86244,GOBP_CELLULAR_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS,0.99999
HP_PACE_OF_PROGRESSION,SET,400,-0.045715,-0.0066741,0.041886,0.86245,HP_PACE_OF_PROGRESSION,0.99999
OHM_EMBRYONIC_CARCINOMA_UP,SET,6,-0.37744,-0.0068225,0.34578,0.86248,OHM_EMBRYONIC_CARCINOMA_UP,0.99999
BACOLOD_RESISTANCE_TO_ALKYLA...2,SET,22,-0.21429,-0.0074139,0.19628,0.86252,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,0.99999
GOCC_FICOLIN_1_RICH_GRANULE,SET,172,-0.070272,-0.0067701,0.064354,0.86257,GOCC_FICOLIN_1_RICH_GRANULE,0.99999
REACTOME_VISUAL_PHOTOTRANSDU...,SET,88,-0.10323,-0.0071299,0.094522,0.8626,REACTOME_VISUAL_PHOTOTRANSDUCTION,0.99999
KEGG_MEDICUS_REFERENCE_TYPE_...1,SET,18,-0.28238,-0.0088379,0.2585,0.86266,KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,0.99999
FISCHER_DIRECT_P53_TARGETS_M...,SET,290,-0.05358,-0.0066808,0.049039,0.86271,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,0.99999
GOBP_REGULATION_OF_ORGANIC_A...,SET,73,-0.11773,-0.0074092,0.10773,0.86276,GOBP_REGULATION_OF_ORGANIC_ACID_TRANSPORT,0.99999
HP_TRIGONOCEPHALY,SET,40,-0.14473,-0.0067486,0.13244,0.86276,HP_TRIGONOCEPHALY,0.99999
GOBP_REGULATION_OF_GTP_BINDI...,SET,8,-0.35243,-0.0073555,0.32248,0.86277,GOBP_REGULATION_OF_GTP_BINDING,0.99999
HP_DEVIATION_OF_THE_4TH_TOE,SET,4,-0.54268,-0.0080096,0.49651,0.86279,HP_DEVIATION_OF_THE_4TH_TOE,0.99999
HP_PROBOSCIS,SET,16,-0.24266,-0.0071606,0.22197,0.86283,HP_PROBOSCIS,0.99999
GOBP_LIPID_DROPLET_ORGANIZAT...,SET,33,-0.16718,-0.0070817,0.15287,0.86293,GOBP_LIPID_DROPLET_ORGANIZATION,0.99999
GOBP_PROTEASOMAL_PROTEIN_CAT...,SET,481,-0.041145,-0.0065722,0.037613,0.86299,GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_SYNCYTIUM...,SET,27,-0.1868,-0.0071585,0.17076,0.863,GOBP_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,0.99999
GOMF_ENDONUCLEASE_ACTIVITY_A...1,SET,15,-0.24381,-0.0069663,0.22288,0.863,GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_3_PHOSPHOMONOESTERS,0.99999
ZNF529_TARGET_GENES,SET,33,-0.15172,-0.0064268,0.13868,0.86302,ZNF529_TARGET_GENES,0.99999
HALLMARK_APOPTOSIS,SET,149,-0.077629,-0.0069652,0.070958,0.86302,HALLMARK_APOPTOSIS,0.99999
GOBP_SRP_DEPENDENT_COTRANSLA...3,SET,8,-0.32797,-0.0068451,0.29974,0.86306,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_TRANSLOCATION,0.99999
HP_ABSENT_EARLOBE,SET,20,-0.18707,-0.0061713,0.17094,0.86309,HP_ABSENT_EARLOBE,0.99999
GOMF_PROTEIN_CONTAINING_COMP...1,SET,1561,-0.024685,-0.0068854,0.022551,0.86316,GOMF_PROTEIN_CONTAINING_COMPLEX_BINDING,0.99999
TERAMOTO_OPN_TARGETS_CLUSTER...4,SET,6,-0.33267,-0.0060131,0.30386,0.86319,TERAMOTO_OPN_TARGETS_CLUSTER_5,0.99999
GSE17186_NAIVE_VS_CD21LOW_TR...4,SET,183,-0.071301,-0.0070833,0.065127,0.86319,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP,0.99999
BIOCARTA_CTBP1_PATHWAY,SET,8,-0.29822,-0.006224,0.27234,0.86324,BIOCARTA_CTBP1_PATHWAY,0.99999
GOBP_PROTEIN_IMPORT_INTO_MIT...,SET,17,-0.20895,-0.0063555,0.19081,0.86325,GOBP_PROTEIN_IMPORT_INTO_MITOCHONDRIAL_MATRIX,0.99999
GOBP_NEGATIVE_REGULATION_OF_...333,SET,155,-0.076531,-0.0070025,0.069884,0.86326,GOBP_NEGATIVE_REGULATION_OF_KINASE_ACTIVITY,0.99999
ZNF213_TARGET_GENES,SET,474,-0.04351,-0.0069006,0.039726,0.86329,ZNF213_TARGET_GENES,0.99999
HP_GENERALIZED_HYPOTONIA,SET,580,-0.038778,-0.0067829,0.035405,0.86329,HP_GENERALIZED_HYPOTONIA,0.99999
REACTOME_NFE2L2_REGULATING_E...,SET,5,-0.41074,-0.0067777,0.37498,0.86332,REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES,0.99999
SA_REG_CASCADE_OF_CYCLIN_EXPR,SET,13,-0.26349,-0.0070091,0.24053,0.86333,SA_REG_CASCADE_OF_CYCLIN_EXPR,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...27,SET,51,-0.13824,-0.0072764,0.12619,0.86336,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR,0.99999
GOMF_NADPLUS_NUCLEOSIDASE_AC...,SET,9,-0.3655,-0.0080909,0.33359,0.86338,GOMF_NADPLUS_NUCLEOSIDASE_ACTIVITY,0.99999
T3R_Q6,SET,229,-0.061649,-0.0068423,0.056256,0.86342,T3R_Q6,0.99999
MIR4761_5P,SET,62,-0.11741,-0.0068118,0.10714,0.86343,MIR4761_5P,0.99999
KEGG_MEDICUS_REFERENCE_N_GLY...2,SET,11,-0.27648,-0.0067657,0.25222,0.86349,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST,0.99999
ZNF165_TARGET_GENES,SET,67,-0.11329,-0.0068314,0.10335,0.86349,ZNF165_TARGET_GENES,0.99999
HP_ABNORMAL_URINE_CARBOHYDRA...,SET,37,-0.15183,-0.0068095,0.13851,0.86349,HP_ABNORMAL_URINE_CARBOHYDRATE_LEVEL,0.99999
HP_HYPOLIPOPROTEINEMIA,SET,57,-0.12652,-0.0070391,0.11538,0.86357,HP_HYPOLIPOPROTEINEMIA,0.99999
REACTOME_REGULATION_OF_CDH19...,SET,7,-0.35082,-0.0068492,0.31991,0.86359,REACTOME_REGULATION_OF_CDH19_EXPRESSION_AND_FUNCTION,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...22,SET,47,-0.15577,-0.0078717,0.14204,0.86361,GAVISH_3CA_MALIGNANT_METAPROGRAM_30_PDAC_CLASSICAL,0.99999
SMID_BREAST_CANCER_RELAPSE_I...1,SET,275,-0.060808,-0.0073864,0.055437,0.86365,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,0.99999
MODULE_195,SET,138,-0.078224,-0.0067566,0.071309,0.86367,MODULE_195,0.99999
GSE5142_HTERT_TRANSDUCED_VS_...2,SET,176,-0.064962,-0.0063301,0.059211,0.8637,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP,0.99999
GOBP_SINGLE_STRANDED_VIRAL_R...,SET,17,-0.25805,-0.007849,0.23518,0.86373,GOBP_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE,0.99999
SCHLOSSER_MYC_TARGETS_AND_SE...1,SET,42,-0.13337,-0.0063718,0.12148,0.86385,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,0.99999
GOBP_RESPONSE_TO_NUTRIENT_LE...,SET,454,-0.045938,-0.0071342,0.041842,0.86387,GOBP_RESPONSE_TO_NUTRIENT_LEVELS,0.99999
JOHNSTONE_PARVB_TARGETS_2_UP,SET,125,-0.086913,-0.0071473,0.07914,0.86394,JOHNSTONE_PARVB_TARGETS_2_UP,0.99999
REACTOME_RECYCLING_OF_BILE_A...,SET,18,-0.22777,-0.0071287,0.20739,0.86395,REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS,0.99999
MIR500B_3P,SET,76,-0.11027,-0.0070802,0.1004,0.86395,MIR500B_3P,0.99999
WP_VITAMIN_A_AND_CAROTENOID_...,SET,42,-0.15098,-0.0072132,0.13745,0.86398,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,0.99999
GOBP_CELLULAR_RESPONSE_TO_SO...,SET,5,-0.41186,-0.0067961,0.37495,0.86398,GOBP_CELLULAR_RESPONSE_TO_SODIUM_ARSENITE,0.99999
GOBP_REGULATION_OF_PROTEIN_T...2,SET,31,-0.16438,-0.0067492,0.14965,0.86399,GOBP_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,0.99999
REACTOME_RIBAVIRIN_ADME,SET,11,-0.32476,-0.0079472,0.29563,0.86401,REACTOME_RIBAVIRIN_ADME,0.99999
GSE2770_TGFB_AND_IL4_ACT_VS_...1,SET,176,-0.070142,-0.0068349,0.063845,0.86403,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,0.99999
KEGG_RENAL_CELL_CARCINOMA,SET,64,-0.12059,-0.007108,0.10976,0.86404,KEGG_RENAL_CELL_CARCINOMA,0.99999
HP_HYPOPLASTIC_CERVICAL_VERT...,SET,6,-0.44266,-0.0080012,0.40289,0.86404,HP_HYPOPLASTIC_CERVICAL_VERTEBRAE,0.99999
MORF_PSMC1,SET,170,-0.064772,-0.0062041,0.05894,0.8641,MORF_PSMC1,0.99999
WP_17P133_YWHAE_COPY_NUMBER_...,SET,21,-0.20079,-0.0067871,0.1827,0.86411,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,0.99999
MODULE_330,SET,27,-0.18428,-0.0070618,0.16767,0.86412,MODULE_330,0.99999
REACTOME_MECP2_REGULATES_TRA...2,SET,7,-0.43749,-0.0085412,0.39802,0.86414,REACTOME_MECP2_REGULATES_TRANSCRIPTION_OF_NEURONAL_LIGANDS,0.99999
REACTOME_RUNX1_REGULATES_TRA...2,SET,66,-0.10522,-0.0062975,0.095721,0.86416,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,0.99999
BIOCARTA_VDR_PATHWAY,SET,24,-0.18638,-0.0067346,0.16954,0.86418,BIOCARTA_VDR_PATHWAY,0.99999
GSE22886_IGM_MEMORY_BCELL_VS...4,SET,180,-0.069732,-0.006871,0.063431,0.86418,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,0.99999
REACTOME_RUNX3_REGULATES_WNT...,SET,8,-0.34205,-0.0071389,0.31113,0.8642,REACTOME_RUNX3_REGULATES_WNT_SIGNALING,0.99999
HP_ENCEPHALOPATHY,SET,276,-0.055061,-0.0067003,0.050079,0.86421,HP_ENCEPHALOPATHY,0.99999
DAZARD_RESPONSE_TO_UV_NHEK_UP,SET,189,-0.06834,-0.0068983,0.062145,0.86425,DAZARD_RESPONSE_TO_UV_NHEK_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...844,SET,9,-0.32358,-0.0071628,0.29413,0.86436,GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.99999
GSE22886_CD8_VS_CD4_NAIVE_TC...1,SET,175,-0.071794,-0.0069761,0.065253,0.86438,GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN,0.99999
GSE41867_LCMV_ARMSTRONG_VS_C...4,SET,181,-0.066702,-0.0065904,0.060604,0.86446,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_UP,0.99999
DESCARTES_FETAL_ADRENAL_STRO...,SET,122,-0.095791,-0.0077829,0.087032,0.86446,DESCARTES_FETAL_ADRENAL_STROMAL_CELLS,0.99999
GOMF_TESTOSTERONE_17_BETA_DE...,SET,9,-0.30772,-0.0068118,0.27953,0.86451,GOMF_TESTOSTERONE_17_BETA_DEHYDROGENASE_NADPPLUS_ACTIVITY,0.99999
HP_RECTAL_ABSCESS,SET,7,-0.42482,-0.0082939,0.38581,0.86457,HP_RECTAL_ABSCESS,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...4,SET,188,-0.069848,-0.0070321,0.063435,0.86457,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_UP,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...3,SET,9,-0.32001,-0.0070837,0.29058,0.86461,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_CELL_MIGR...,SET,36,-0.16333,-0.0072258,0.14828,0.86466,GOBP_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.99999
WP_HIF1A_AND_PPARG_REGULATIO...,SET,6,-0.42848,-0.007745,0.38895,0.86468,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,0.99999
HP_ABNORMAL_PULMONARY_VALVE_...1,SET,3,-0.58476,-0.0074747,0.5308,0.86469,HP_ABNORMAL_PULMONARY_VALVE_CUSP_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_PROTEIN_T...1,SET,72,-0.10523,-0.0065774,0.095516,0.8647,GOBP_REGULATION_OF_PROTEIN_TARGETING,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...14,SET,13,-0.25573,-0.0068028,0.23208,0.86474,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SINUSES,0.99999
GOBP_POSITIVE_REGULATION_OF_...705,SET,4,-0.5064,-0.0074741,0.45943,0.86481,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_GROWTH,0.99999
VISALA_AGING_LYMPHOCYTE_DN,SET,16,-0.22142,-0.0065341,0.20086,0.86484,VISALA_AGING_LYMPHOCYTE_DN,0.99999
GOMF_TESTOSTERONE_DEHYDROGEN...2,SET,10,-0.28365,-0.0066183,0.25727,0.86488,GOMF_TESTOSTERONE_DEHYDROGENASE_NAD_P_ACTIVITY,0.99999
GOBP_THYMUS_DEVELOPMENT,SET,47,-0.13924,-0.0070364,0.12627,0.86492,GOBP_THYMUS_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_INTRACELL...6,SET,242,-0.058311,-0.0066506,0.052875,0.86494,GOBP_REGULATION_OF_INTRACELLULAR_TRANSPORT,0.99999
KEGG_MEDICUS_REFERENCE_GF_RT...1,SET,81,-0.11834,-0.0078433,0.1073,0.86495,KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY,0.99999
SHIPP_DLBCL_CURED_VS_FATAL_DN,SET,38,-0.14988,-0.0068118,0.13589,0.86496,SHIPP_DLBCL_CURED_VS_FATAL_DN,0.99999
GOCC_N_TERMINAL_PROTEIN_ACET...,SET,9,-0.28543,-0.0063183,0.25876,0.86499,GOCC_N_TERMINAL_PROTEIN_ACETYLTRANSFERASE_COMPLEX,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_EAR...3,SET,123,-0.08145,-0.0066447,0.073837,0.865,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_TIP_CELL,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...7,SET,176,-0.06925,-0.0067479,0.062772,0.86502,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_DN,0.99999
GOMF_O_METHYLTRANSFERASE_ACT...,SET,17,-0.19867,-0.0060429,0.18008,0.86503,GOMF_O_METHYLTRANSFERASE_ACTIVITY,0.99999
GOMF_FRUCTOSE_BINDING,SET,6,-0.31057,-0.0056137,0.28149,0.86504,GOMF_FRUCTOSE_BINDING,0.99999
WP_COHESIN_COMPLEX_CORNELIA_...,SET,27,-0.16872,-0.0064658,0.1529,0.86508,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,0.99999
GSE8921_UNSTIM_0H_VS_TLR1_2_...2,SET,188,-0.067247,-0.0067703,0.060943,0.86508,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...738,SET,56,-0.14207,-0.0078349,0.12875,0.86509,GOBP_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY,0.99999
KEGG_MEDICUS_REFERENCE_KITLG...2,SET,14,-0.25689,-0.0070914,0.23272,0.86516,KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_PROTEIN_L...12,SET,9,-0.28731,-0.0063598,0.26021,0.86522,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,0.99999
MODULE_462,SET,15,-0.27885,-0.0079676,0.25253,0.86524,MODULE_462,0.99999
GOCC_VESICLE_LUMEN,SET,301,-0.055307,-0.0070236,0.050088,0.86524,GOCC_VESICLE_LUMEN,0.99999
BROWNE_HCMV_INFECTION_30MIN_...1,SET,126,-0.084454,-0.0069726,0.076481,0.86525,BROWNE_HCMV_INFECTION_30MIN_DN,0.99999
GSE16266_LPS_VS_HEATSHOCK_AN...1,SET,175,-0.069738,-0.0067764,0.063152,0.86526,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,0.99999
REACTOME_ZINC_EFFLUX_AND_COM...,SET,5,-0.43494,-0.007177,0.39383,0.86528,REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY,0.99999
MIR1237_5P_MIR4488,SET,12,-0.29129,-0.0074448,0.26373,0.8653,MIR1237_5P_MIR4488,0.99999
REACTOME_ROS_AND_RNS_PRODUCT...,SET,33,-0.17835,-0.0075547,0.16147,0.86531,REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES,0.99999
GOBP_VASCULATURE_DEVELOPMENT,SET,690,-0.038456,-0.0073141,0.034812,0.86534,GOBP_VASCULATURE_DEVELOPMENT,0.99999
MODULE_356,SET,140,-0.078202,-0.0068031,0.070788,0.86536,MODULE_356,0.99999
GSE32901_NAIVE_VS_TH1_CD4_TC...1,SET,152,-0.076459,-0.0069284,0.069204,0.86538,GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN,0.99999
GSE3691_IFN_PRODUCING_KILLER...2,SET,173,-0.069269,-0.0066926,0.062695,0.86538,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_UP,0.99999
MIR1972,SET,88,-0.097717,-0.0067492,0.088441,0.86539,MIR1972,0.99999
HP_EPIRETINAL_MEMBRANE,SET,12,-0.28942,-0.0073972,0.26193,0.86541,HP_EPIRETINAL_MEMBRANE,0.99999
HP_PANCYTOPENIA,SET,116,-0.087357,-0.0069221,0.079047,0.86544,HP_PANCYTOPENIA,0.99999
CAIRO_HEPATOBLASTOMA_POOR_SU...,SET,12,-0.25692,-0.0065666,0.23247,0.86545,CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL,0.99999
GAO_SMALL_INTESTINE_24W_C2_P...,SET,17,-0.23837,-0.0072505,0.21566,0.86548,GAO_SMALL_INTESTINE_24W_C2_PROCRPOS_PROGENITOR,0.99999
GNF2_CD48,SET,30,-0.168,-0.0067856,0.15198,0.8655,GNF2_CD48,0.99999
GOCC_CENTROSOME,SET,666,-0.035852,-0.0067038,0.032433,0.8655,GOCC_CENTROSOME,0.99999
GOMF_UBIQUITIN_SPECIFIC_PROT...,SET,14,-0.2293,-0.0063299,0.20738,0.86557,GOMF_UBIQUITIN_SPECIFIC_PROTEASE_BINDING,0.99999
PELLICCIOTTA_HDAC_IN_ANTIGEN...2,SET,60,-0.11237,-0.0064139,0.10162,0.86558,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,0.99999
MODULE_292,SET,120,-0.089346,-0.0072,0.080794,0.8656,MODULE_292,0.99999
GNF2_KISS1,SET,43,-0.16097,-0.0077813,0.14552,0.86566,GNF2_KISS1,0.99999
HP_PARIETAL_CORTICAL_ATROPHY,SET,8,-0.3744,-0.0078139,0.33846,0.86567,HP_PARIETAL_CORTICAL_ATROPHY,0.99999
WP_5Q35_COPY_NUMBER_VARIATION,SET,97,-0.1051,-0.0076195,0.094985,0.86574,WP_5Q35_COPY_NUMBER_VARIATION,0.99999
HP_ABNORMAL_CNS_MYELINATION,SET,360,-0.047404,-0.0065728,0.042837,0.86576,HP_ABNORMAL_CNS_MYELINATION,0.99999
GOMF_OLEATE_TRANSMEMBRANE_TR...,SET,6,-0.37164,-0.0067176,0.33572,0.86584,GOMF_OLEATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_SPERMATID_DIFFERENTIATI...,SET,190,-0.067109,-0.0067918,0.060616,0.86587,GOBP_SPERMATID_DIFFERENTIATION,0.99999
MIR345_3P,SET,199,-0.067492,-0.0069887,0.06096,0.86588,MIR345_3P,0.99999
GSE1791_CTRL_VS_NEUROMEDINU_...2,SET,170,-0.069706,-0.0066767,0.062953,0.86591,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_UP,0.99999
HP_ARACHNODACTYLY,SET,109,-0.090759,-0.0069727,0.081949,0.86595,HP_ARACHNODACTYLY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...232,SET,13,-0.28616,-0.0076124,0.25838,0.86596,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_OXIDATION,0.99999
GOBP_MITOCHONDRION_DISTRIBUT...,SET,18,-0.22601,-0.0070734,0.20406,0.86597,GOBP_MITOCHONDRION_DISTRIBUTION,0.99999
GOCC_TRANSFERASE_COMPLEX,SET,758,-0.033137,-0.0065929,0.029918,0.86597,GOCC_TRANSFERASE_COMPLEX,0.99999
HP_CONE_SHAPED_METACARPAL_EP...,SET,4,-0.47655,-0.0070336,0.43027,0.86597,HP_CONE_SHAPED_METACARPAL_EPIPHYSES,0.99999
GOBP_MESENCHYME_MORPHOGENESIS,SET,58,-0.14392,-0.0080766,0.1299,0.86604,GOBP_MESENCHYME_MORPHOGENESIS,0.99999
GOBP_CELL_ADHESION,SET,1400,-0.028422,-0.0075436,0.025645,0.86612,GOBP_CELL_ADHESION,0.99999
HP_RETINAL_HOLE,SET,5,-0.43163,-0.0071224,0.38936,0.86618,HP_RETINAL_HOLE,0.99999
GSE40493_BCL6_KO_VS_WT_TREG_...1,SET,94,-0.099937,-0.0071329,0.090106,0.8663,GSE40493_BCL6_KO_VS_WT_TREG_DN,0.99999
GOBP_GLYCEROPHOSPHOLIPID_MET...,SET,276,-0.056477,-0.0068726,0.050915,0.86633,GOBP_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...338,SET,51,-0.13515,-0.0071137,0.12184,0.86633,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...503,SET,17,-0.25798,-0.0078469,0.23258,0.86633,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
WP_REGULATION_OF_SISTER_CHRO...,SET,13,-0.29256,-0.0077826,0.26374,0.86634,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,0.99999
WP_SULFATION_BIOTRANSFORMATI...,SET,14,-0.29565,-0.0081613,0.26652,0.86634,WP_SULFATION_BIOTRANSFORMATION_REACTION,0.99999
MORF_ZNF10,SET,46,-0.14751,-0.0073748,0.13297,0.86636,MORF_ZNF10,0.99999
GOBP_NEGATIVE_REGULATION_OF_...544,SET,57,-0.1197,-0.0066595,0.10787,0.86642,GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.99999
SENGUPTA_EBNA1_ANTICORRELATED,SET,126,-0.082878,-0.0068426,0.074686,0.86643,SENGUPTA_EBNA1_ANTICORRELATED,0.99999
REACTOME_FCERI_MEDIATED_MAPK...,SET,32,-0.16574,-0.0069139,0.14934,0.86646,REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION,0.99999
GSE33162_UNTREATED_VS_4H_LPS...1,SET,182,-0.070052,-0.0069403,0.063114,0.86648,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN,0.99999
GSE360_T_GONDII_VS_M_TUBERCU...2,SET,178,-0.07072,-0.0069299,0.063667,0.86666,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP,0.99999
YAMANAKA_GLIOBLASTOMA_SURVIV...1,SET,8,-0.29934,-0.0062475,0.26948,0.86667,YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN,0.99999
GSE9878_CTRL_VS_EBF_TRANSDUC...1,SET,180,-0.066624,-0.0065647,0.059973,0.86669,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN,0.99999
REACTOME_ARMS_MEDIATED_ACTIV...,SET,7,-0.38064,-0.0074314,0.34262,0.8667,REACTOME_ARMS_MEDIATED_ACTIVATION,0.99999
TRAVAGLINI_LUNG_PROLIFERATIN...1,SET,798,-0.033004,-0.0067298,0.029707,0.8667,TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL,0.99999
GOMF_PROTEIN_TRANSPORTER_ACT...,SET,36,-0.15305,-0.0067708,0.13774,0.86674,GOMF_PROTEIN_TRANSPORTER_ACTIVITY,0.99999
GSE6259_DEC205_POS_DC_VS_CD4...2,SET,180,-0.068433,-0.0067429,0.061585,0.86675,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_UP,0.99999
HP_CALCINOSIS,SET,11,-0.31545,-0.0077193,0.28385,0.86677,HP_CALCINOSIS,0.99999
REACTOME_PYRUVATE_METABOLISM,SET,44,-0.14328,-0.007006,0.12892,0.86679,REACTOME_PYRUVATE_METABOLISM,0.99999
GOBP_RECEPTOR_METABOLIC_PROC...,SET,66,-0.11492,-0.0068783,0.1034,0.86681,GOBP_RECEPTOR_METABOLIC_PROCESS,0.99999
GSE11973_MIR223_KOVS_WT_BONE...2,SET,179,-0.072504,-0.0071244,0.065228,0.86682,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_UP,0.99999
GNF2_PCAF,SET,31,-0.17317,-0.0071102,0.15574,0.86691,GNF2_PCAF,0.99999
GSE18804_BRAIN_VS_COLON_TUMO...1,SET,174,-0.074504,-0.0072189,0.067002,0.86691,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN,0.99999
GOBP_REGULATION_OF_INTRACELL...4,SET,1634,-0.024923,-0.0070969,0.022411,0.86694,GOBP_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,0.99999
REACTOME_METABOLISM_OF_NITRI...,SET,14,-0.25285,-0.0069798,0.2273,0.867,REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION,0.99999
GSE13484_UNSTIM_VS_3H_YF17D_...2,SET,179,-0.065624,-0.0064484,0.058993,0.86701,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,0.99999
MIR20A_5P,SET,623,-0.039455,-0.007144,0.035466,0.86703,MIR20A_5P,0.99999
BUSSLINGER_GASTRIC_LYZ_POSIT...,SET,101,-0.098471,-0.0072838,0.088506,0.86705,BUSSLINGER_GASTRIC_LYZ_POSITIVE_CELLS,0.99999
MIR10401_3P,SET,6,-0.37149,-0.0067149,0.33388,0.86706,MIR10401_3P,0.99999
GOBP_REGULATION_OF_PROTEIN_L...5,SET,12,-0.29508,-0.0075419,0.26519,0.86708,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CENTROSOME,0.99999
FAN_EMBRYONIC_CTX_BRAIN_ENDO...2,SET,277,-0.062293,-0.0075939,0.055983,0.86708,FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2,0.99999
GOTZMANN_EPITHELIAL_TO_MESEN...2,SET,65,-0.12066,-0.0071671,0.10843,0.86709,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,0.99999
MORF_CDK2,SET,67,-0.10514,-0.0063399,0.09448,0.86709,MORF_CDK2,0.99999
GOCC_NATA_COMPLEX,SET,4,-0.49329,-0.0072806,0.44323,0.86713,GOCC_NATA_COMPLEX,0.99999
GOMF_RNA_POLYMERASE_CORE_ENZ...,SET,40,-0.14951,-0.0069714,0.13429,0.86721,GOMF_RNA_POLYMERASE_CORE_ENZYME_BINDING,0.99999
HP_ROUND_FACE,SET,95,-0.096567,-0.0069287,0.086737,0.86721,HP_ROUND_FACE,0.99999
GOBP_STRIATED_MUSCLE_ADAPTAT...,SET,45,-0.14766,-0.0073018,0.13263,0.86722,GOBP_STRIATED_MUSCLE_ADAPTATION,0.99999
MIR1225_3P,SET,56,-0.13143,-0.0072479,0.11804,0.86723,MIR1225_3P,0.99999
DESCARTES_FETAL_MUSCLE_VASCU...,SET,63,-0.13166,-0.0076993,0.11824,0.86724,DESCARTES_FETAL_MUSCLE_VASCULAR_ENDOTHELIAL_CELLS,0.99999
SWEET_LUNG_CANCER_KRAS_DN,SET,387,-0.052972,-0.0076096,0.047569,0.86726,SWEET_LUNG_CANCER_KRAS_DN,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...10,SET,182,-0.06847,-0.0067836,0.061487,0.86726,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_UP,0.99999
REACTOME_G_ALPHA_S_SIGNALLIN...,SET,152,-0.083672,-0.007582,0.075119,0.86732,REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,0.99999
MIR604,SET,13,-0.24522,-0.0065233,0.22014,0.86734,MIR604,0.99999
HP_HANDGRIP_MYOTONIA,SET,6,-0.4399,-0.0079515,0.3949,0.86734,HP_HANDGRIP_MYOTONIA,0.99999
WP_ACETYLCHOLINE_SYNTHESIS,SET,5,-0.40669,-0.0067108,0.36506,0.86736,WP_ACETYLCHOLINE_SYNTHESIS,0.99999
GOMF_GLUTAMATE_SODIUM_SYMPOR...,SET,5,-0.49999,-0.0082504,0.44872,0.86741,GOMF_GLUTAMATE_SODIUM_SYMPORTER_ACTIVITY,0.99999
chr4q32,SET,38,-0.25673,-0.011668,0.23036,0.86746,chr4q32,0.99999
KEGG_MEDICUS_REFERENCE_HGF_M...1,SET,10,-0.31149,-0.0072679,0.27941,0.86752,KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY,0.99999
HP_ADDUCTED_THUMB,SET,97,-0.098624,-0.00715,0.08846,0.86755,HP_ADDUCTED_THUMB,0.99999
HP_GLAUCOMA,SET,316,-0.054851,-0.0071342,0.049188,0.8676,HP_GLAUCOMA,0.99999
MODULE_426,SET,80,-0.10766,-0.0070914,0.096539,0.86761,MODULE_426,0.99999
HP_ABNORMAL_LACRIMAL_GLAND_M...,SET,9,-0.34036,-0.0075343,0.30521,0.86761,HP_ABNORMAL_LACRIMAL_GLAND_MORPHOLOGY,0.99999
HOWARD_NK_CELL_INACT_MONOV_I...3,SET,66,-0.11444,-0.0068495,0.10259,0.86768,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.99999
HP_JOINT_CONTRACTURE_OF_THE_...3,SET,237,-0.063741,-0.0071955,0.057133,0.86771,HP_JOINT_CONTRACTURE_OF_THE_HAND,0.99999
MIR6745,SET,85,-0.10421,-0.0070748,0.093402,0.86773,MIR6745,0.99999
GOBP_POSITIVE_REGULATION_OF_...294,SET,5,-0.42187,-0.0069612,0.37807,0.86775,GOBP_POSITIVE_REGULATION_OF_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION,0.99999
WP_DISORDERS_OF_BILE_ACID_SY...,SET,29,-0.185,-0.007347,0.16579,0.86776,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,0.99999
GOBP_MITOTIC_SPINDLE_ORGANIZ...,SET,124,-0.081064,-0.0066398,0.072645,0.86776,GOBP_MITOTIC_SPINDLE_ORGANIZATION,0.99999
REACTOME_G1_S_DNA_DAMAGE_CHE...,SET,64,-0.10465,-0.0061681,0.093776,0.86777,REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,0.99999
GOBP_MONOCYTE_DIFFERENTIATION,SET,32,-0.18339,-0.0076501,0.16426,0.86789,GOBP_MONOCYTE_DIFFERENTIATION,0.99999
GOMF_MITOCHONDRIAL_RIBOSOME_...,SET,8,-0.32679,-0.0068202,0.29268,0.8679,GOMF_MITOCHONDRIAL_RIBOSOME_BINDING,0.99999
HP_SPONTANEOUS_PAIN_SENSATION,SET,5,-0.43776,-0.0072236,0.39207,0.8679,HP_SPONTANEOUS_PAIN_SENSATION,0.99999
HP_INTESTINAL_POLYP,SET,63,-0.11817,-0.0069107,0.10583,0.86791,HP_INTESTINAL_POLYP,0.99999
GOBP_RESPONSE_TO_ACIDIC_PH,SET,25,-0.19275,-0.0071081,0.17261,0.86792,GOBP_RESPONSE_TO_ACIDIC_PH,0.99999
GOBP_CARDIAC_MUSCLE_MYOBLAST...,SET,3,-0.53369,-0.0068218,0.47782,0.86798,GOBP_CARDIAC_MUSCLE_MYOBLAST_PROLIFERATION,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...16,SET,14,-0.25742,-0.007106,0.23044,0.86801,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
MIR1271_3P,SET,65,-0.12366,-0.0073453,0.11068,0.86807,MIR1271_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...644,SET,8,-0.36308,-0.0075778,0.32494,0.86808,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,0.99999
GSE24574_BCL6_HIGH_TFH_VS_NA...1,SET,187,-0.069001,-0.0069286,0.061747,0.8681,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_DN,0.99999
ZHONG_SECRETOME_OF_LUNG_CANC...1,SET,63,-0.12386,-0.0072435,0.11082,0.86813,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,0.99999
MORF_BCL2,SET,208,-0.0664,-0.0070277,0.059412,0.86813,MORF_BCL2,0.99999
MISHRA_CARCINOMA_ASSOCIATED_...1,SET,20,-0.23077,-0.0076128,0.20644,0.86818,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,0.99999
HP_LIPODYSTROPHY,SET,114,-0.09186,-0.0072163,0.082171,0.86819,HP_LIPODYSTROPHY,0.99999
GSE5589_IL6_KO_VS_IL10_KO_LP...5,SET,179,-0.072684,-0.0071421,0.065013,0.86821,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...7,SET,4,-0.39625,-0.0058484,0.35439,0.86824,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_CORTICOSPINAL_TRACTS,0.99999
GSE5679_CTRL_VS_RARA_AGONIST...2,SET,179,-0.068048,-0.0066866,0.060853,0.86826,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP,0.99999
GOCC_GAMMA_SECRETASE_COMPLEX,SET,6,-0.39054,-0.0070591,0.34919,0.86829,GOCC_GAMMA_SECRETASE_COMPLEX,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...2,SET,29,-0.18562,-0.0073719,0.16596,0.86831,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_B_CELLS,0.99999
HAY_BONE_MARROW_CD8_T_CELL,SET,61,-0.12688,-0.0073018,0.11344,0.86832,HAY_BONE_MARROW_CD8_T_CELL,0.99999
GOBP_VESICLE_TARGETING,SET,62,-0.11422,-0.0066266,0.10211,0.86835,GOBP_VESICLE_TARGETING,0.99999
GOBP_PROTEIN_LINEAR_POLYUBIQ...,SET,3,-0.51072,-0.0065282,0.45652,0.86836,GOBP_PROTEIN_LINEAR_POLYUBIQUITINATION,0.99999
HP_DEJA_VU_AURA,SET,7,-0.34654,-0.0067657,0.30974,0.86838,HP_DEJA_VU_AURA,0.99999
HP_ALACRIMA,SET,17,-0.22572,-0.0068656,0.20173,0.8684,HP_ALACRIMA,0.99999
GOBP_PROTEIN_O_LINKED_GLYCOS...1,SET,87,-0.10541,-0.0072393,0.094201,0.86842,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION,0.99999
HP_ORGANIC_ACIDURIA,SET,112,-0.09108,-0.0070924,0.081386,0.86845,HP_ORGANIC_ACIDURIA,0.99999
GOBP_RESPONSE_TO_THYROGLOBUL...,SET,5,-0.48942,-0.0080759,0.43727,0.86848,GOBP_RESPONSE_TO_THYROGLOBULIN_TRIIODOTHYRONINE,0.99999
GOBP_INTRINSIC_APOPTOTIC_SIG...1,SET,282,-0.055413,-0.0068149,0.049479,0.86862,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
REACTOME_RRNA_MODIFICATION_I...2,SET,51,-0.12605,-0.0066347,0.11254,0.86865,REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,0.99999
MIR1297,SET,579,-0.041059,-0.0071759,0.036657,0.86866,MIR1297,0.99999
BERNARD_PPAPDC1B_TARGETS_DN,SET,53,-0.14019,-0.0075218,0.12514,0.8687,BERNARD_PPAPDC1B_TARGETS_DN,0.99999
GOBP_REGULATION_OF_T_CIRCLE_...,SET,5,-0.34968,-0.0057702,0.31206,0.86875,GOBP_REGULATION_OF_T_CIRCLE_FORMATION,0.99999
HAY_BONE_MARROW_ERYTHROBLAST,SET,1134,-0.027878,-0.0067113,0.024877,0.86877,HAY_BONE_MARROW_ERYTHROBLAST,0.99999
GOMF_TRANSMEMBRANE_RECEPTOR_...1,SET,80,-0.11625,-0.0076576,0.10374,0.86878,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_CHOLESTER...3,SET,32,-0.17343,-0.0072346,0.15473,0.86882,GOBP_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.99999
GOBP_PHOSPHATIDYLINOSITOL_BI...,SET,117,-0.08406,-0.0066893,0.074978,0.86888,GOBP_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS,0.99999
GOMF_NERVE_GROWTH_FACTOR_BIN...,SET,5,-0.48459,-0.0079963,0.43222,0.86888,GOMF_NERVE_GROWTH_FACTOR_BINDING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...292,SET,12,-0.30812,-0.0078752,0.27481,0.8689,GOBP_NEGATIVE_REGULATION_OF_INCLUSION_BODY_ASSEMBLY,0.99999
WP_PI3KAKT_SIGNALING,SET,322,-0.057471,-0.0075443,0.051254,0.86891,WP_PI3KAKT_SIGNALING,0.99999
GSE360_L_DONOVANI_VS_B_MALAY...4,SET,175,-0.074114,-0.0072016,0.066068,0.86902,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.99999
GOCC_U7_SNRNP,SET,7,-0.33235,-0.0064886,0.29622,0.86905,GOCC_U7_SNRNP,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HS...,SET,389,-0.052585,-0.0075731,0.046869,0.86905,MANNO_MIDBRAIN_NEUROTYPES_HSERT,0.99999
GENTILE_UV_RESPONSE_CLUSTER_...5,SET,33,-0.16487,-0.006984,0.14694,0.86908,GENTILE_UV_RESPONSE_CLUSTER_D6,0.99999
GOBP_WHITE_FAT_CELL_DIFFEREN...,SET,16,-0.24473,-0.0072217,0.2181,0.86908,GOBP_WHITE_FAT_CELL_DIFFERENTIATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...657,SET,12,-0.29027,-0.007419,0.25867,0.86909,GOBP_POSITIVE_REGULATION_OF_PSEUDOPODIUM_ASSEMBLY,0.99999
HP_CHRONIC_RHINITIS,SET,49,-0.13382,-0.0069045,0.11919,0.86922,HP_CHRONIC_RHINITIS,0.99999
MIR4522,SET,52,-0.13905,-0.0073897,0.12383,0.86925,MIR4522,0.99999
SNAI1_TARGET_GENES,SET,370,-0.049915,-0.0070145,0.044448,0.86928,SNAI1_TARGET_GENES,0.99999
MODULE_4,SET,19,-0.20155,-0.0064808,0.17946,0.86929,MODULE_4,0.99999
GOBP_BEHAVIORAL_RESPONSE_TO_...4,SET,19,-0.22461,-0.0072221,0.19998,0.8693,GOBP_BEHAVIORAL_RESPONSE_TO_PAIN,0.99999
GOBP_HYPEROSMOTIC_RESPONSE,SET,25,-0.19967,-0.0073634,0.17777,0.86931,GOBP_HYPEROSMOTIC_RESPONSE,0.99999
GSE22601_DOUBLE_NEGATIVE_VS_...3,SET,165,-0.075365,-0.0071128,0.067097,0.86932,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.99999
GUENTHER_GROWTH_SPHERICAL_VS...1,SET,24,-0.21068,-0.0076124,0.18752,0.86938,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...423,SET,17,-0.22938,-0.006977,0.20417,0.86938,GOBP_NEGATIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,0.99999
GOBP_CELLULAR_RESPONSE_TO_AC...1,SET,14,-0.25887,-0.0071459,0.23032,0.86947,GOBP_CELLULAR_RESPONSE_TO_ACIDIC_PH,0.99999
CAFFAREL_RESPONSE_TO_THC_8HR...2,SET,5,-0.43658,-0.0072041,0.38839,0.8695,CAFFAREL_RESPONSE_TO_THC_8HR_3_UP,0.99999
BUSSLINGER_GASTRIC_METALLOTH...,SET,91,-0.10701,-0.0075154,0.095186,0.86953,BUSSLINGER_GASTRIC_METALLOTHIONEIN_CELLS,0.99999
REACTOME_FGFR3B_LIGAND_BINDI...,SET,7,-0.43676,-0.0085269,0.38837,0.86961,REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION,0.99999
HP_CENTRAL_SLEEP_APNEA,SET,37,-0.16926,-0.0075913,0.15051,0.86961,HP_CENTRAL_SLEEP_APNEA,0.99999
PUJANA_BREAST_CANCER_WITH_BR...1,SET,8,-0.29286,-0.0061122,0.2604,0.86962,PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...351,SET,24,-0.18544,-0.0067007,0.1649,0.86962,GOBP_NEGATIVE_REGULATION_OF_LIPID_TRANSPORT,0.99999
VART_KSHV_INFECTION_ANGIOGEN...2,SET,152,-0.085694,-0.0077652,0.076194,0.86963,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,0.99999
GOCC_XY_BODY,SET,14,-0.22857,-0.0063096,0.20321,0.86965,GOCC_XY_BODY,0.99999
GOBP_AROMATIC_AMINO_ACID_MET...,SET,29,-0.19197,-0.0076241,0.17059,0.86978,GOBP_AROMATIC_AMINO_ACID_METABOLIC_PROCESS,0.99999
HP_ABNORMAL_CIRCULATING_RENIN,SET,29,-0.19469,-0.0077319,0.173,0.86978,HP_ABNORMAL_CIRCULATING_RENIN,0.99999
GOMF_TELOMERIC_DNA_BINDING,SET,37,-0.14938,-0.0066994,0.1327,0.86984,GOMF_TELOMERIC_DNA_BINDING,0.99999
JI_CARCINOGENESIS_BY_KRAS_AN...1,SET,16,-0.28166,-0.0083117,0.2502,0.86986,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_INT...1,SET,62,-0.1371,-0.0079538,0.12178,0.86986,HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE,0.99999
GOMF_G_QUADRUPLEX_DNA_BINDING,SET,11,-0.29028,-0.0071034,0.2578,0.8699,GOMF_G_QUADRUPLEX_DNA_BINDING,0.99999
REACTOME_SIGNALING_BY_FGFR2,SET,71,-0.11289,-0.0070068,0.10025,0.86991,REACTOME_SIGNALING_BY_FGFR2,0.99999
HNF4_DR1_Q3,SET,243,-0.060166,-0.0068762,0.053433,0.86991,HNF4_DR1_Q3,0.99999
HP_SEVERE_INTRAUTERINE_GROWT...,SET,13,-0.2861,-0.0076106,0.25403,0.86996,HP_SEVERE_INTRAUTERINE_GROWTH_RETARDATION,0.99999
HP_ABNORMAL_JUDGMENT,SET,438,-0.046497,-0.0070958,0.041282,0.86998,HP_ABNORMAL_JUDGMENT,0.99999
MAF_Q6,SET,233,-0.065194,-0.0072979,0.057878,0.87,MAF_Q6,0.99999
ODONNELL_METASTASIS_UP,SET,70,-0.12486,-0.0076953,0.11083,0.87002,ODONNELL_METASTASIS_UP,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...4,SET,7,-0.33923,-0.0066228,0.3011,0.87004,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_E3_UBIQUITIN_LIGASE_MALIN,0.99999
GOBP_POSITIVE_REGULATION_OF_...173,SET,98,-0.10403,-0.0075804,0.092337,0.87004,GOBP_POSITIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS,0.99999
GNF2_ATM,SET,25,-0.183,-0.0067486,0.16241,0.87007,GNF2_ATM,0.99999
GOBP_T_CELL_ACTIVATION_INVOL...,SET,115,-0.099323,-0.0078365,0.08815,0.87007,GOBP_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
REACTOME_DEFECTIVE_B4GALT1_C...,SET,8,-0.35374,-0.0073828,0.31393,0.87008,REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D,0.99999
GOBP_RESPONSE_TO_CGMP,SET,8,-0.33623,-0.0070174,0.29839,0.87008,GOBP_RESPONSE_TO_CGMP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...140,SET,5,-0.42253,-0.0069722,0.37497,0.87009,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_EFFLUX,0.99999
GOBP_REGULATION_OF_VASCULAR_...4,SET,29,-0.17909,-0.0071126,0.15889,0.87015,GOBP_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_ABSENCE_OF_LYMPH_NODE_GER...,SET,5,-0.48814,-0.0080549,0.43304,0.87017,HP_ABSENCE_OF_LYMPH_NODE_GERMINAL_CENTER,0.99999
IKEDA_MIR1_TARGETS_DN,SET,6,-0.35766,-0.0064649,0.31728,0.87018,IKEDA_MIR1_TARGETS_DN,0.99999
ZBTB1_TARGET_GENES,SET,90,-0.10207,-0.0071289,0.09054,0.87019,ZBTB1_TARGET_GENES,0.99999
GOBP_TRNA_THREONYLCARBAMOYLA...1,SET,13,-0.23358,-0.0062136,0.20719,0.8702,GOBP_TRNA_THREONYLCARBAMOYLADENOSINE_METABOLIC_PROCESS,0.99999
REACTOME_DISEASES_OF_BASE_EX...,SET,5,-0.44356,-0.0073192,0.3934,0.87022,REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR,0.99999
GOBP_POSITIVE_REGULATION_OF_...322,SET,4,-0.57323,-0.0084606,0.5084,0.87023,GOBP_POSITIVE_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...604,SET,497,-0.044624,-0.0072423,0.039575,0.87024,GOBP_POSITIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH,0.99999
GSE1460_CD4_THYMOCYTE_VS_THY...2,SET,177,-0.071378,-0.0069749,0.063304,0.87024,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,0.99999
HP_ADIPOSE_TISSUE_LOSS,SET,27,-0.18532,-0.0071018,0.16427,0.87036,HP_ADIPOSE_TISSUE_LOSS,0.99999
GSE16450_CTRL_VS_IFNA_6H_STI...4,SET,187,-0.071978,-0.0072275,0.063772,0.87047,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,0.99999
HP_FEEDING_DIFFICULTIES_IN_I...,SET,509,-0.042775,-0.0070232,0.037893,0.87051,HP_FEEDING_DIFFICULTIES_IN_INFANCY,0.99999
MIR5584_3P,SET,124,-0.090545,-0.0074164,0.080209,0.87052,MIR5584_3P,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...27,SET,47,-0.13549,-0.0068468,0.12002,0.87052,HP_APLASIA_HYPOPLASIA_OF_THE_EARLOBES,0.99999
GARY_CD5_TARGETS_DN,SET,396,-0.045649,-0.0066318,0.040433,0.87055,GARY_CD5_TARGETS_DN,0.99999
GOBP_LABYRINTHINE_LAYER_DEVE...,SET,42,-0.15504,-0.0074075,0.13732,0.87056,GOBP_LABYRINTHINE_LAYER_DEVELOPMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...536,SET,63,-0.12363,-0.0072297,0.10948,0.87059,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION,0.99999
WP_LEUKOCYTEINTRINSIC_HIPPO_...,SET,30,-0.1818,-0.0073433,0.16099,0.8706,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,0.99999
MODULE_42,SET,24,-0.16153,-0.0058368,0.14304,0.8706,MODULE_42,0.99999
HP_DIAPHYSEAL_SCLEROSIS,SET,9,-0.35691,-0.0079007,0.31606,0.8706,HP_DIAPHYSEAL_SCLEROSIS,0.99999
LI_PROSTATE_CANCER_EPIGENETIC,SET,30,-0.18782,-0.0075864,0.16631,0.87061,LI_PROSTATE_CANCER_EPIGENETIC,0.99999
WP_MALE_STEROID_HORMONES_IN_...,SET,13,-0.27627,-0.0073492,0.24463,0.87062,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.99999
GSE7764_IL15_TREATED_VS_CTRL...2,SET,175,-0.067966,-0.0066041,0.060162,0.87069,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP,0.99999
REACTOME_LDL_REMODELING,SET,6,-0.35904,-0.0064899,0.31778,0.87073,REACTOME_LDL_REMODELING,0.99999
MIR6861_3P,SET,45,-0.14374,-0.0071081,0.12722,0.87073,MIR6861_3P,0.99999
MIR4742_3P,SET,201,-0.069386,-0.0072205,0.061406,0.87075,MIR4742_3P,0.99999
CIC_TARGET_GENES,SET,376,-0.049778,-0.0070506,0.044049,0.87077,CIC_TARGET_GENES,0.99999
GOBP_DETERMINATION_OF_PANCRE...,SET,4,-0.48094,-0.0070984,0.42553,0.8708,GOBP_DETERMINATION_OF_PANCREATIC_LEFT_RIGHT_ASYMMETRY,0.99999
NEMETH_INFLAMMATORY_RESPONSE...1,SET,28,-0.18436,-0.0071946,0.16312,0.87081,NEMETH_INFLAMMATORY_RESPONSE_LPS_DN,0.99999
GOMF_RNA_EXONUCLEASE_ACTIVIT...,SET,39,-0.14254,-0.0065627,0.12605,0.87091,GOMF_RNA_EXONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,0.99999
REACTOME_TRANSLATION_OF_SARS...2,SET,54,-0.12678,-0.0068661,0.11212,0.87092,REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...14,SET,27,-0.18808,-0.0072077,0.16629,0.87097,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,0.99999
GOMF_CELL_ADHESION_MOLECULE_...,SET,501,-0.044425,-0.0072381,0.039275,0.87099,GOMF_CELL_ADHESION_MOLECULE_BINDING,0.99999
TFDP2_TARGET_GENES,SET,4,-0.42394,-0.0062571,0.37473,0.87103,TFDP2_TARGET_GENES,0.99999
MIR6781_3P,SET,72,-0.1173,-0.0073313,0.10366,0.87109,MIR6781_3P,0.99999
GOBP_ZYGOTIC_DETERMINATION_O...,SET,6,-0.52623,-0.0095119,0.46483,0.87119,GOBP_ZYGOTIC_DETERMINATION_OF_ANTERIOR_POSTERIOR_AXIS_EMBRYO,0.99999
KORKOLA_EMBRYONIC_CARCINOMA_...2,SET,16,-0.24282,-0.0071653,0.21448,0.8712,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...286,SET,6,-0.3479,-0.0062884,0.30729,0.8712,GOBP_NEGATIVE_REGULATION_OF_HYPOXIA_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
NAKAYA_PLASMACYTOID_DENDRITI...1,SET,168,-0.072555,-0.0069089,0.064045,0.87136,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.99999
GOBP_BRANCH_ELONGATION_OF_AN...,SET,19,-0.25915,-0.0083328,0.22873,0.87138,GOBP_BRANCH_ELONGATION_OF_AN_EPITHELIUM,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...1,SET,43,-0.14721,-0.0071163,0.12993,0.87139,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN,0.99999
GAO_LARGE_INTESTINE_24W_C4_P...,SET,5,-0.46926,-0.0077434,0.41413,0.87141,GAO_LARGE_INTESTINE_24W_C4_PROM1LOW_PROGENITOR,0.99999
GOBP_PYRUVATE_METABOLIC_PROC...,SET,109,-0.089514,-0.006877,0.078981,0.87146,GOBP_PYRUVATE_METABOLIC_PROCESS,0.99999
GOBP_ISOPRENOID_TRANSPORT,SET,5,-0.47858,-0.0078972,0.42225,0.87147,GOBP_ISOPRENOID_TRANSPORT,0.99999
GOBP_REGULATION_OF_PROTEIN_T...3,SET,400,-0.048766,-0.0071195,0.043023,0.87149,GOBP_REGULATION_OF_PROTEIN_TRANSPORT,0.99999
JONES_OVARY_THECA,SET,42,-0.16767,-0.0080107,0.14792,0.87149,JONES_OVARY_THECA,0.99999
GOBP_MUCOSA_ASSOCIATED_LYMPH...,SET,8,-0.38109,-0.0079535,0.33618,0.87151,GOBP_MUCOSA_ASSOCIATED_LYMPHOID_TISSUE_DEVELOPMENT,0.99999
BIOCARTA_PITX2_PATHWAY,SET,15,-0.24074,-0.0068787,0.21236,0.87152,BIOCARTA_PITX2_PATHWAY,0.99999
ATCATGA_MIR433,SET,107,-0.091503,-0.0069654,0.080712,0.87153,ATCATGA_MIR433,0.99999
MODULE_157,SET,100,-0.095045,-0.0069957,0.083837,0.87153,MODULE_157,0.99999
MIR3192_5P,SET,142,-0.082419,-0.0072206,0.072685,0.87158,MIR3192_5P,0.99999
GOBP_ECTODERM_DEVELOPMENT,SET,19,-0.23645,-0.007603,0.20849,0.87163,GOBP_ECTODERM_DEVELOPMENT,0.99999
GOCC_ENDOPLASMIC_RETICULUM_G...2,SET,72,-0.11423,-0.0071395,0.10071,0.87164,GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE,0.99999
GSE21927_C26GM_VS_4T1_TUMOR_...1,SET,176,-0.071436,-0.0069609,0.062976,0.87167,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,0.99999
GAO_ESOPHAGUS_25W_C1_CILIATE...,SET,374,-0.049124,-0.0069398,0.043305,0.87168,GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS,0.99999
GSE21670_IL6_VS_TGFB_AND_IL6...1,SET,188,-0.070462,-0.0070939,0.06211,0.87169,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,0.99999
GOBP_KERATINOCYTE_PROLIFERAT...,SET,56,-0.13892,-0.0076607,0.12244,0.87171,GOBP_KERATINOCYTE_PROLIFERATION,0.99999
HP_CONJUNCTIVAL_ICTERUS,SET,6,-0.38591,-0.0069755,0.34013,0.87172,HP_CONJUNCTIVAL_ICTERUS,0.99999
MIR3684,SET,30,-0.1839,-0.007428,0.16206,0.87175,MIR3684,0.99999
REACTOME_DISEASES_ASSOCIATED...2,SET,13,-0.23392,-0.0062226,0.20611,0.87179,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS,0.99999
JOHANSSON_BRAIN_CANCER_EARLY...1,SET,41,-0.14502,-0.0068458,0.12777,0.87181,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN,0.99999
GOBP_NEUROBLAST_DIVISION,SET,14,-0.26692,-0.0073683,0.23515,0.87182,GOBP_NEUROBLAST_DIVISION,0.99999
HP_HYDROCEPHALUS,SET,351,-0.05059,-0.0069281,0.04457,0.87182,HP_HYDROCEPHALUS,0.99999
ASTON_MAJOR_DEPRESSIVE_DISOR...1,SET,146,-0.079902,-0.0070972,0.070385,0.87185,ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,0.99999
GSE5503_MLN_DC_VS_PLN_DC_ACT...2,SET,179,-0.071756,-0.0070509,0.063208,0.87186,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.99999
ELVIDGE_HYPOXIA_BY_DMOG_DN,SET,52,-0.13147,-0.0069872,0.1158,0.87187,ELVIDGE_HYPOXIA_BY_DMOG_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...174,SET,9,-0.35686,-0.0078995,0.31422,0.87195,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_APOPTOTIC_PROCESS,0.99999
DESCARTES_MAIN_FETAL_EXCITAT...,SET,5,-0.49582,-0.0081815,0.43634,0.87208,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,0.99999
GOBP_CELL_CELL_JUNCTION_ORGA...,SET,199,-0.074709,-0.0077361,0.06573,0.87214,GOBP_CELL_CELL_JUNCTION_ORGANIZATION,0.99999
MIR4433A_5P,SET,43,-0.15041,-0.0072711,0.13231,0.87219,MIR4433A_5P,0.99999
AACTGAC_MIR223,SET,90,-0.10192,-0.0071187,0.089639,0.87222,AACTGAC_MIR223,0.99999
GSE28783_ANTI_MIR33_VS_UNTRE...2,SET,177,-0.072752,-0.0071091,0.063977,0.87225,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C5_CD5...2,SET,142,-0.085141,-0.0074591,0.074869,0.87226,HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_NEG_MATURE_B_CELL,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...11,SET,50,-0.14353,-0.0074805,0.12621,0.87228,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_2,0.99999
HP_CYCLOPIA,SET,19,-0.2263,-0.0072764,0.19898,0.87228,HP_CYCLOPIA,0.99999
REACTOME_NEGATIVE_REGULATION...10,SET,51,-0.11914,-0.0062706,0.10475,0.87229,REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,0.99999
GOBP_RESPONSE_TO_IMMOBILIZAT...,SET,25,-0.18585,-0.0068537,0.16339,0.87232,GOBP_RESPONSE_TO_IMMOBILIZATION_STRESS,0.99999
chr11p12,SET,6,-0.51177,-0.0092505,0.44991,0.87233,chr11p12,0.99999
GOBP_PHOSPHOLIPID_METABOLIC_...,SET,340,-0.052234,-0.0070424,0.045919,0.87233,GOBP_PHOSPHOLIPID_METABOLIC_PROCESS,0.99999
SATO_SILENCED_BY_METHYLATION...2,SET,41,-0.16283,-0.0076866,0.14314,0.87234,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,0.99999
TAKEDA_TARGETS_OF_NUP98_HOXA...4,SET,160,-0.084646,-0.0078678,0.074412,0.87234,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,0.99999
GOBP_PROTEIN_TRANSPORT,SET,1298,-0.02734,-0.0070081,0.024033,0.87235,GOBP_PROTEIN_TRANSPORT,0.99999
GOMF_GAMMA_AMINOBUTYRIC_ACID...2,SET,7,-0.45057,-0.0087967,0.39602,0.87238,GOMF_GAMMA_AMINOBUTYRIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MIR506_5P,SET,118,-0.091067,-0.0072776,0.080033,0.8724,MIR506_5P,0.99999
LANDIS_ERBB2_BREAST_TUMORS_6...2,SET,22,-0.22853,-0.0079064,0.20079,0.87247,LANDIS_ERBB2_BREAST_TUMORS_65_UP,0.99999
GSE32986_UNSTIM_VS_GMCSF_STI...1,SET,180,-0.070737,-0.00697,0.062133,0.87253,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN,0.99999
HP_PREMATURE_OSTEOARTHRITIS,SET,9,-0.34438,-0.0076232,0.30247,0.87255,HP_PREMATURE_OSTEOARTHRITIS,0.99999
DESCARTES_FETAL_CEREBELLUM_P...,SET,43,-0.16468,-0.0079607,0.1446,0.87262,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,0.99999
HP_ABNORMAL_GALLBLADDER_PHYS...,SET,18,-0.22268,-0.0069694,0.19551,0.87264,HP_ABNORMAL_GALLBLADDER_PHYSIOLOGY,0.99999
HP_EXOSTOSES,SET,18,-0.2406,-0.0075302,0.21123,0.87265,HP_EXOSTOSES,0.99999
HP_PECTUS_EXCAVATUM_OF_INFER...,SET,5,-0.37701,-0.0062211,0.33098,0.87266,HP_PECTUS_EXCAVATUM_OF_INFERIOR_STERNUM,0.99999
HP_HAMSTRING_CONTRACTURES,SET,5,-0.44503,-0.0073436,0.39065,0.87268,HP_HAMSTRING_CONTRACTURES,0.99999
HP_SHUFFLING_GAIT,SET,30,-0.17776,-0.0071802,0.15601,0.87274,HP_SHUFFLING_GAIT,0.99999
ONDER_CDH1_TARGETS_1_DN,SET,157,-0.076716,-0.0070641,0.067324,0.87275,ONDER_CDH1_TARGETS_1_DN,0.99999
WP_KYNURENINE_PATHWAY_AND_LI...,SET,24,-0.21097,-0.0076229,0.18513,0.87276,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,0.99999
HP_HYPERPLASTIC_CALLUS_FORMA...,SET,5,-0.48195,-0.0079528,0.42289,0.87278,HP_HYPERPLASTIC_CALLUS_FORMATION,0.99999
GSE41867_DAY6_EFFECTOR_VS_DA...3,SET,185,-0.070048,-0.0069963,0.061462,0.87278,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,0.99999
GOMF_LEUKOTRIENE_C4_SYNTHASE...,SET,5,-0.49678,-0.0081973,0.43577,0.87285,GOMF_LEUKOTRIENE_C4_SYNTHASE_ACTIVITY,0.99999
GSE360_DC_VS_MAC_L_DONOVANI_...1,SET,174,-0.071306,-0.0069091,0.062541,0.87288,GSE360_DC_VS_MAC_L_DONOVANI_DN,0.99999
REACTOME_EPIGENETIC_REGULATI...,SET,182,-0.067927,-0.0067298,0.059565,0.87293,REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,0.99999
FINAK_BREAST_CANCER_SDPP_SIG...,SET,20,-0.24571,-0.0081055,0.21535,0.87304,FINAK_BREAST_CANCER_SDPP_SIGNATURE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...317,SET,2,-0.68755,-0.007176,0.60262,0.87304,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,0.99999
GOCC_GTPASE_COMPLEX,SET,38,-0.16693,-0.007587,0.14629,0.87308,GOCC_GTPASE_COMPLEX,0.99999
HP_DISTAL_AMYOTROPHY,SET,199,-0.066767,-0.0069137,0.058509,0.87309,HP_DISTAL_AMYOTROPHY,0.99999
WP_RAS_SIGNALING,SET,174,-0.07588,-0.0073522,0.066491,0.8731,WP_RAS_SIGNALING,0.99999
GSE411_UNSTIM_VS_100MIN_IL6_...4,SET,176,-0.070808,-0.0068997,0.062026,0.87318,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,0.99999
GSE1925_3H_VS_24H_IFNG_STIM_...1,SET,187,-0.069944,-0.0070232,0.061258,0.87322,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,0.99999
MUELLER_PLURINET,SET,276,-0.056765,-0.0069077,0.049682,0.87338,MUELLER_PLURINET,0.99999
ZHAN_MULTIPLE_MYELOMA_PR_DN,SET,45,-0.15208,-0.0075202,0.1331,0.87339,ZHAN_MULTIPLE_MYELOMA_PR_DN,0.99999
HP_EEG_WITH_GENERALIZED_SHAR...,SET,8,-0.34832,-0.0072697,0.30484,0.8734,HP_EEG_WITH_GENERALIZED_SHARP_SLOW_WAVES,0.99999
GOBP_REGULATION_OF_BRANCHING...2,SET,5,-0.52723,-0.0086999,0.46125,0.87349,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS,0.99999
GOMF_HISTONE_H3K9_MONOMETHYL...,SET,6,-0.40165,-0.0072601,0.35138,0.87349,GOMF_HISTONE_H3K9_MONOMETHYLTRANSFERASE_ACTIVITY,0.99999
HP_ARTHROGRYPOSIS_MULTIPLEX_...,SET,122,-0.086888,-0.0070596,0.076011,0.87349,HP_ARTHROGRYPOSIS_MULTIPLEX_CONGENITA,0.99999
GOMF_PROTEIN_ARGININE_N_METH...,SET,12,-0.26143,-0.0066818,0.2287,0.8735,GOMF_PROTEIN_ARGININE_N_METHYLTRANSFERASE_ACTIVITY,0.99999
GSE19401_RETINOIC_ACID_VS_RE...1,SET,187,-0.066965,-0.0067241,0.058581,0.8735,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.99999
MANN_RESPONSE_TO_AMIFOSTINE_...2,SET,19,-0.20298,-0.0065268,0.17756,0.87351,MANN_RESPONSE_TO_AMIFOSTINE_UP,0.99999
HP_FOLLICULAR_THYROID_CARCIN...,SET,16,-0.23585,-0.0069596,0.2063,0.87352,HP_FOLLICULAR_THYROID_CARCINOMA,0.99999
GOBP_REGULATION_OF_PIGMENT_C...,SET,8,-0.40824,-0.0085203,0.35709,0.87353,GOBP_REGULATION_OF_PIGMENT_CELL_DIFFERENTIATION,0.99999
HP_HYPERTENSIVE_CRISIS,SET,14,-0.25871,-0.0071417,0.22629,0.87353,HP_HYPERTENSIVE_CRISIS,0.99999
REACTOME_ACTIVATED_NTRK2_SIG...1,SET,6,-0.41772,-0.0075506,0.36535,0.87354,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_CDK5,0.99999
chr13q13,SET,31,-0.31241,-0.012827,0.27315,0.87362,chr13q13,0.99999
HOSHIDA_LIVER_CANCER_SUBCLAS...3,SET,241,-0.063937,-0.0072774,0.055898,0.87364,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,0.99999
GOBP_CELL_SURFACE_RECEPTOR_P...2,SET,581,-0.042756,-0.007485,0.037366,0.87373,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY,0.99999
HP_LEIOMYOSARCOMA,SET,28,-0.19283,-0.0075251,0.16847,0.8738,HP_LEIOMYOSARCOMA,0.99999
MODULE_341,SET,74,-0.11657,-0.0073863,0.10184,0.87381,MODULE_341,0.99999
GOBP_BONE_TRABECULA_MORPHOGE...,SET,14,-0.27354,-0.0075509,0.23893,0.87385,GOBP_BONE_TRABECULA_MORPHOGENESIS,0.99999
GSE11057_CD4_CENT_MEM_VS_PBM...1,SET,175,-0.077231,-0.0075044,0.067447,0.8739,GSE11057_CD4_CENT_MEM_VS_PBMC_DN,0.99999
GOBP_REGULATION_OF_INSULIN_S...2,SET,51,-0.13277,-0.006988,0.11594,0.87392,GOBP_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.99999
GSE5589_IL6_KO_VS_IL10_KO_LP...3,SET,179,-0.072826,-0.007156,0.063593,0.87392,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.99999
DESCARTES_FETAL_HEART_VASCUL...,SET,16,-0.26375,-0.0077829,0.2303,0.87393,DESCARTES_FETAL_HEART_VASCULAR_ENDOTHELIAL_CELLS,0.99999
HP_TETRAPARESIS,SET,100,-0.098381,-0.0072412,0.085882,0.874,HP_TETRAPARESIS,0.99999
GOBP_PROTEIN_TRANSMEMBRANE_I...,SET,33,-0.15712,-0.0066554,0.13715,0.87401,GOBP_PROTEIN_TRANSMEMBRANE_IMPORT_INTO_INTRACELLULAR_ORGANELLE,0.99999
GSE23505_UNTREATED_VS_4DAY_I...1,SET,178,-0.074399,-0.0072903,0.064932,0.87405,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,0.99999
GOCC_MITOCHONDRIAL_LARGE_RIB...,SET,53,-0.12398,-0.0066519,0.1082,0.87406,GOCC_MITOCHONDRIAL_LARGE_RIBOSOMAL_SUBUNIT,0.99999
SUBTIL_PROGESTIN_TARGETS,SET,31,-0.17883,-0.0073423,0.15606,0.87407,SUBTIL_PROGESTIN_TARGETS,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_SQU...,SET,230,-0.068895,-0.0076631,0.060119,0.87409,HE_LIM_SUN_FETAL_LUNG_C1_SQUAMOUS_CELL,0.99999
MORF_HEAB,SET,79,-0.10417,-0.0068186,0.090893,0.8741,MORF_HEAB,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...15,SET,167,-0.07817,-0.0074217,0.068209,0.8741,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN,0.99999
REACTOME_BIOSYNTHESIS_OF_THE...,SET,72,-0.10931,-0.0068322,0.095378,0.87411,REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,0.99999
GSE5542_IFNG_VS_IFNA_TREATED...1,SET,175,-0.074896,-0.0072775,0.065344,0.87413,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,0.99999
GSE7460_FOXP3_MUT_VS_WT_ACT_...4,SET,180,-0.073208,-0.0072135,0.063868,0.87414,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP,0.99999
GOMF_METAL_ION_SEQUESTERING_...,SET,5,-0.45682,-0.007538,0.39846,0.87419,GOMF_METAL_ION_SEQUESTERING_ACTIVITY,0.99999
MODULE_88,SET,760,-0.037608,-0.007492,0.032801,0.87421,MODULE_88,0.99999
GOBP_NEGATIVE_REGULATION_OF_...415,SET,9,-0.32587,-0.0072135,0.28421,0.87422,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_ADAPTATION,0.99999
HP_ENLARGED_POSTERIOR_FOSSA,SET,163,-0.072971,-0.0068453,0.063642,0.87422,HP_ENLARGED_POSTERIOR_FOSSA,0.99999
GOBP_REVERSIBLE_DIFFERENTIAT...,SET,5,-0.48899,-0.0080689,0.42645,0.87423,GOBP_REVERSIBLE_DIFFERENTIATION,0.99999
REACTOME_COPI_DEPENDENT_GOLG...,SET,95,-0.092919,-0.006667,0.081032,0.87424,REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,0.99999
MIR889_3P,SET,214,-0.06899,-0.0074051,0.060154,0.87428,MIR889_3P,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...64,SET,10,-0.28026,-0.0065393,0.24433,0.87431,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,0.99999
HP_KETONURIA,SET,32,-0.16532,-0.0068962,0.14412,0.87432,HP_KETONURIA,0.99999
BIOCARTA_CHREBP_PATHWAY,SET,19,-0.22426,-0.007211,0.19548,0.87435,BIOCARTA_CHREBP_PATHWAY,0.99999
GOBP_MITOCHONDRIAL_RNA_PROCE...,SET,20,-0.19171,-0.0063243,0.16707,0.8744,GOBP_MITOCHONDRIAL_RNA_PROCESSING,0.99999
DESCARTES_FETAL_CEREBELLUM_U...,SET,19,-0.26167,-0.0084137,0.228,0.87443,DESCARTES_FETAL_CEREBELLUM_UNIPOLAR_BRUSH_CELLS,0.99999
GOBP_NUCLEAR_RNA_SURVEILLANCE,SET,14,-0.23143,-0.0063885,0.20163,0.87446,GOBP_NUCLEAR_RNA_SURVEILLANCE,0.99999
FIGUEROA_AML_METHYLATION_CLU...7,SET,14,-0.28411,-0.0078428,0.24752,0.87447,FIGUEROA_AML_METHYLATION_CLUSTER_4_DN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...55,SET,35,-0.13827,-0.0060315,0.12046,0.87448,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
THAKAR_PBMC_INACTIVATED_INFL...2,SET,158,-0.078298,-0.0072325,0.068191,0.87455,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP,0.99999
GOBP_SPINDLE_ELONGATION,SET,13,-0.2847,-0.0075734,0.24787,0.87463,GOBP_SPINDLE_ELONGATION,0.99999
CREIGHTON_ENDOCRINE_THERAPY_...4,SET,266,-0.062402,-0.0074569,0.054312,0.8747,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...5,SET,15,-0.26897,-0.0076853,0.23408,0.87473,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY,0.99999
GCM_DDX11,SET,44,-0.13487,-0.006595,0.11737,0.87474,GCM_DDX11,0.99999
CAO_BLOOD_FLUZONE_AGE_05_14Y...1,SET,6,-0.39413,-0.0071242,0.34298,0.87474,CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_DN,0.99999
GSE28726_ACT_CD4_TCELL_VS_AC...3,SET,185,-0.073396,-0.0073307,0.063858,0.87479,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN,0.99999
GSE41867_DAY6_VS_DAY8_LCMV_C...1,SET,183,-0.070485,-0.0070022,0.061324,0.87479,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,0.99999
GSE2706_LPS_VS_R848_AND_LPS_...3,SET,159,-0.082227,-0.0076192,0.071537,0.8748,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN,0.99999
REACTOME_ACYL_CHAIN_REMODELL...5,SET,20,-0.24219,-0.0079894,0.21068,0.87483,REACTOME_ACYL_CHAIN_REMODELLING_OF_PS,0.99999
REACTOME_MELANIN_BIOSYNTHESIS,SET,5,-0.52706,-0.0086971,0.45835,0.8749,REACTOME_MELANIN_BIOSYNTHESIS,0.99999
MIR449B_5P,SET,237,-0.062512,-0.0070567,0.054361,0.87491,MIR449B_5P,0.99999
MIR4772_3P,SET,82,-0.11256,-0.0075056,0.097875,0.87492,MIR4772_3P,0.99999
TTCCGTT_MIR191,SET,28,-0.17089,-0.0066688,0.1486,0.87492,TTCCGTT_MIR191,0.99999
GOMF_DNA_NUCLEASE_ACTIVITY,SET,59,-0.11469,-0.0064913,0.099728,0.87492,GOMF_DNA_NUCLEASE_ACTIVITY,0.99999
REACTOME_REGULATION_OF_PLK1_...,SET,81,-0.10032,-0.0066492,0.087229,0.87494,REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,0.99999
BAELDE_DIABETIC_NEPHROPATHY_...1,SET,401,-0.051266,-0.0074936,0.044572,0.87496,BAELDE_DIABETIC_NEPHROPATHY_DN,0.99999
KEGG_MEDICUS_REFERENCE_FE_TF...,SET,7,-0.38209,-0.0074597,0.33219,0.87496,KEGG_MEDICUS_REFERENCE_FE_TF_TRANSPORT,0.99999
REACTOME_SHC1_EVENTS_IN_ERBB...1,SET,22,-0.21081,-0.0072936,0.18326,0.875,REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,0.99999
HP_LARGE_EARLOBE,SET,28,-0.17826,-0.0069563,0.15491,0.87506,HP_LARGE_EARLOBE,0.99999
HP_SHORT_LINGUAL_FRENULUM,SET,11,-0.27714,-0.006782,0.24084,0.87507,HP_SHORT_LINGUAL_FRENULUM,0.99999
GSE21546_UNSTIM_VS_ANTI_CD3_...3,SET,145,-0.085276,-0.0075488,0.074106,0.87507,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_DN,0.99999
GOBP_RESPONSE_TO_PEPTIDE_HOR...,SET,405,-0.050323,-0.0073916,0.04373,0.87508,GOBP_RESPONSE_TO_PEPTIDE_HORMONE,0.99999
HP_INCREASED_CIRCULATING_IGA...,SET,26,-0.20363,-0.007658,0.17693,0.87511,HP_INCREASED_CIRCULATING_IGA_LEVEL,0.99999
MIR10397_3P,SET,42,-0.15794,-0.0075459,0.13723,0.87512,MIR10397_3P,0.99999
MIR876_5P,SET,123,-0.092891,-0.007578,0.080668,0.87523,MIR876_5P,0.99999
HALLMARK_HYPOXIA,SET,178,-0.077244,-0.0075691,0.067081,0.87523,HALLMARK_HYPOXIA,0.99999
GOBP_IRON_IMPORT_INTO_CELL,SET,9,-0.33154,-0.0073391,0.28787,0.87527,GOBP_IRON_IMPORT_INTO_CELL,0.99999
GOMF_PHOSPHATIDYLETHANOLAMIN...1,SET,16,-0.24573,-0.0072513,0.21335,0.87529,GOMF_PHOSPHATIDYLETHANOLAMINE_BINDING,0.99999
REACTOME_MET_RECEPTOR_ACTIVA...,SET,6,-0.42448,-0.0076728,0.36848,0.87533,REACTOME_MET_RECEPTOR_ACTIVATION,0.99999
MORF_PTPRR,SET,83,-0.11304,-0.0075838,0.098116,0.87536,MORF_PTPRR,0.99999
GOMF_PEPTIDASE_ACTIVATOR_ACT...1,SET,52,-0.13315,-0.0070763,0.11555,0.87539,GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY,0.99999
GOBP_SELF_PROTEOLYSIS,SET,12,-0.30103,-0.007694,0.26122,0.87541,GOBP_SELF_PROTEOLYSIS,0.99999
HP_SUBCAPSULAR_CATARACT,SET,104,-0.095126,-0.0071395,0.082547,0.87541,HP_SUBCAPSULAR_CATARACT,0.99999
KEGG_TYPE_II_DIABETES_MELLIT...,SET,46,-0.1547,-0.0077342,0.13423,0.87543,KEGG_TYPE_II_DIABETES_MELLITUS,0.99999
HP_NORMAL_PRESSURE_HYDROCEPH...,SET,5,-0.49996,-0.00825,0.43373,0.87548,HP_NORMAL_PRESSURE_HYDROCEPHALUS,0.99999
GOBP_POSITIVE_REGULATION_OF_...13,SET,6,-0.38094,-0.0068856,0.33045,0.87549,GOBP_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE14769_UNSTIM_VS_240MIN_LP...1,SET,181,-0.07202,-0.0071158,0.062472,0.8755,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN,0.99999
HP_LIVER_ABSCESS,SET,7,-0.38722,-0.0075597,0.33575,0.8756,HP_LIVER_ABSCESS,0.99999
GSE8921_UNSTIM_0H_VS_TLR1_2_...5,SET,186,-0.073613,-0.0073721,0.063826,0.87561,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_DN,0.99999
CONCANNON_APOPTOSIS_BY_EPOXO...2,SET,216,-0.069343,-0.0074773,0.060119,0.87563,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,0.99999
REACTOME_DOWNSTREAM_SIGNALIN...1,SET,77,-0.10195,-0.0065889,0.088377,0.87566,REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,0.99999
GSE2770_UNTREATED_VS_TGFB_AN...8,SET,177,-0.072885,-0.0071222,0.063174,0.87568,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
GOCC_FILOPODIUM_TIP,SET,16,-0.25908,-0.0076452,0.22456,0.87569,GOCC_FILOPODIUM_TIP,0.99999
GSE13738_RESTING_VS_BYSTANDE...1,SET,173,-0.075853,-0.0073287,0.065741,0.8757,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,0.99999
GSE3982_MAC_VS_TH2_DN,SET,187,-0.06854,-0.0068822,0.059401,0.87571,GSE3982_MAC_VS_TH2_DN,0.99999
HP_BROAD_JAW,SET,5,-0.41975,-0.0069264,0.36375,0.87573,HP_BROAD_JAW,0.99999
REACTOME_DISEASES_ASSOCIATED...1,SET,38,-0.16179,-0.0073531,0.14019,0.87575,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,0.99999
GSE30962_PRIMARY_VS_SECONDAR...2,SET,183,-0.070129,-0.0069668,0.060752,0.87582,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP,0.99999
GOBP_PYRIMIDINE_CONTAINING_C...5,SET,16,-0.26714,-0.0078832,0.23139,0.87584,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT,0.99999
GOBP_EMBRYONIC_ORGAN_DEVELOP...,SET,430,-0.050894,-0.0076974,0.044079,0.87587,GOBP_EMBRYONIC_ORGAN_DEVELOPMENT,0.99999
HP_TYPE_II_DIABETES_MELLITUS,SET,191,-0.073253,-0.0074329,0.063432,0.87591,HP_TYPE_II_DIABETES_MELLITUS,0.99999
GOBP_ENDOPLASMIC_RETICULUM_C...,SET,23,-0.20986,-0.0074234,0.18171,0.87592,GOBP_ENDOPLASMIC_RETICULUM_CALCIUM_ION_HOMEOSTASIS,0.99999
HP_CHRONIC_HEPATITIS,SET,9,-0.34971,-0.0077413,0.30274,0.87598,HP_CHRONIC_HEPATITIS,0.99999
GOBP_CELLULAR_RESPONSE_TO_NU...1,SET,45,-0.15506,-0.0076678,0.13422,0.876,GOBP_CELLULAR_RESPONSE_TO_NUTRIENT,0.99999
HP_WIDE_CRANIAL_SUTURES,SET,27,-0.18806,-0.0072067,0.16276,0.87603,HP_WIDE_CRANIAL_SUTURES,0.99999
MIR1178_5P,SET,32,-0.18469,-0.0077041,0.15983,0.87605,MIR1178_5P,0.99999
MORF_ERCC2,SET,98,-0.094742,-0.0069037,0.081979,0.87609,MORF_ERCC2,0.99999
HP_GAZE_EVOKED_HORIZONTAL_NY...,SET,17,-0.24086,-0.007326,0.2084,0.8761,HP_GAZE_EVOKED_HORIZONTAL_NYSTAGMUS,0.99999
ALKBH3_TARGET_GENES,SET,353,-0.052472,-0.0072058,0.045391,0.87615,ALKBH3_TARGET_GENES,0.99999
BIOCARTA_RANMS_PATHWAY,SET,10,-0.3044,-0.0071024,0.26331,0.87616,BIOCARTA_RANMS_PATHWAY,0.99999
GSE4984_UNTREATED_VS_LPS_TRE...2,SET,144,-0.080754,-0.007124,0.069848,0.87618,GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP,0.99999
HP_APLASTIC_HYPOPLASTIC_LACR...,SET,8,-0.37697,-0.0078677,0.326,0.87622,HP_APLASTIC_HYPOPLASTIC_LACRIMAL_GLANDS,0.99999
GOBP_AV_NODE_CELL_TO_BUNDLE_...1,SET,13,-0.31246,-0.0083119,0.27012,0.8763,GOBP_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_COMMUNICATION,0.99999
HP_PULMONARY_ARTERY_DILATATI...,SET,12,-0.29654,-0.0075792,0.25636,0.8763,HP_PULMONARY_ARTERY_DILATATION,0.99999
GOBP_PIGMENT_ACCUMULATION,SET,11,-0.31004,-0.0075871,0.26802,0.87631,GOBP_PIGMENT_ACCUMULATION,0.99999
GOMF_G_PROTEIN_COUPLED_RECEP...1,SET,696,-0.047486,-0.0090691,0.041046,0.87634,GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY,0.99999
GOBP_PARANODAL_JUNCTION_ASSE...,SET,6,-0.4288,-0.0077509,0.37058,0.87638,GOBP_PARANODAL_JUNCTION_ASSEMBLY,0.99999
HP_NASOLACRIMAL_DUCT_OBSTRUC...,SET,29,-0.18554,-0.0073687,0.16035,0.87638,HP_NASOLACRIMAL_DUCT_OBSTRUCTION,0.99999
REACTOME_PEPTIDE_LIGAND_BIND...,SET,180,-0.08518,-0.0083931,0.073606,0.87641,REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,0.99999
MIR7155_5P,SET,86,-0.10161,-0.0069386,0.087805,0.87641,MIR7155_5P,0.99999
REACTOME_DECTIN_1_MEDIATED_N...,SET,58,-0.11561,-0.0064882,0.099889,0.87644,REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,0.99999
GOBP_CAVEOLIN_MEDIATED_ENDOC...,SET,11,-0.30459,-0.0074537,0.26317,0.87644,GOBP_CAVEOLIN_MEDIATED_ENDOCYTOSIS,0.99999
GOCC_U1_SNRNP,SET,18,-0.20731,-0.0064882,0.17907,0.8765,GOCC_U1_SNRNP,0.99999
MODULE_129,SET,203,-0.073981,-0.0077364,0.063899,0.87651,MODULE_129,0.99999
PAPASPYRIDONOS_UNSTABLE_ATER...1,SET,39,-0.15955,-0.0073463,0.1378,0.87653,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,0.99999
LI_WILMS_TUMOR_ANAPLASTIC_DN,SET,5,-0.48714,-0.0080383,0.42061,0.8766,LI_WILMS_TUMOR_ANAPLASTIC_DN,0.99999
GOCC_PHAGOPHORE_ASSEMBLY_SITE,SET,35,-0.17111,-0.0074643,0.14773,0.87661,GOCC_PHAGOPHORE_ASSEMBLY_SITE,0.99999
CHNG_MULTIPLE_MYELOMA_HYPERP...2,SET,50,-0.13225,-0.0068923,0.11417,0.87662,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,0.99999
GSE21546_WT_VS_ELK1_KO_ANTI_...1,SET,177,-0.070374,-0.0068767,0.060757,0.87662,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.99999
HP_NECK_FLEXOR_WEAKNESS,SET,43,-0.1441,-0.0069661,0.1244,0.87665,HP_NECK_FLEXOR_WEAKNESS,0.99999
GSE41867_NAIVE_VS_EFFECTOR_C...2,SET,187,-0.067847,-0.0068126,0.058565,0.87666,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,0.99999
GOBP_MITOTIC_CELL_CYCLE_PHAS...,SET,403,-0.04915,-0.0072018,0.042424,0.87667,GOBP_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,0.99999
GOBP_ACTIVATION_OF_ADENYLATE...,SET,23,-0.23881,-0.0084476,0.20608,0.87672,GOBP_ACTIVATION_OF_ADENYLATE_CYCLASE_ACTIVITY,0.99999
HP_DISTAL_UPPER_LIMB_AMYOTRO...,SET,58,-0.12676,-0.0071137,0.10938,0.87674,HP_DISTAL_UPPER_LIMB_AMYOTROPHY,0.99999
HP_NEOPLASM_OF_THE_GASTROINT...,SET,285,-0.059071,-0.0073028,0.050962,0.87679,HP_NEOPLASM_OF_THE_GASTROINTESTINAL_TRACT,0.99999
REACTOME_GASTRIN_CREB_SIGNAL...,SET,17,-0.25611,-0.0077899,0.22094,0.8768,REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK,0.99999
MIR29A_3P,SET,396,-0.052571,-0.0076374,0.045349,0.87682,MIR29A_3P,0.99999
GOBP_L_GLUTAMATE_IMPORT_ACRO...,SET,17,-0.25645,-0.0078002,0.22121,0.87682,GOBP_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
HP_APLASIA_HYPOPLASIA_OF_TOE,SET,112,-0.095815,-0.007461,0.082643,0.87684,HP_APLASIA_HYPOPLASIA_OF_TOE,0.99999
GOBP_REGULATION_OF_STEROID_H...2,SET,22,-0.2252,-0.0077913,0.19424,0.87685,GOBP_REGULATION_OF_STEROID_HORMONE_SECRETION,0.99999
GOMF_LIPASE_ACTIVITY,SET,127,-0.090587,-0.0075084,0.078121,0.87688,GOMF_LIPASE_ACTIVITY,0.99999
LAKE_ADULT_KIDNEY_C26_MESANG...,SET,164,-0.082761,-0.0077873,0.071364,0.87691,LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS,0.99999
ODONNELL_TFRC_TARGETS_DN,SET,116,-0.086443,-0.0068497,0.074528,0.87694,ODONNELL_TFRC_TARGETS_DN,0.99999
PID_IFNG_PATHWAY,SET,40,-0.16135,-0.0075232,0.13909,0.87696,PID_IFNG_PATHWAY,0.99999
GSE11961_GERMINAL_CENTER_BCE...4,SET,176,-0.075267,-0.0073342,0.064874,0.87701,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.99999
GOBP_RESPONSE_TO_CATECHOLAMI...,SET,55,-0.14434,-0.0078887,0.12436,0.8771,GOBP_RESPONSE_TO_CATECHOLAMINE,0.99999
GSE27786_LSK_VS_LIN_NEG_CELL...1,SET,179,-0.072067,-0.0070815,0.062092,0.8771,GSE27786_LSK_VS_LIN_NEG_CELL_DN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...70,SET,10,-0.31294,-0.0073019,0.26957,0.87715,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...36,SET,6,-0.39034,-0.0070557,0.33622,0.87717,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ATXN1_TO_RORA_MEDIATED_TRANSCRIPTION,0.99999
MIR6764_5P,SET,213,-0.069183,-0.0074087,0.059586,0.87719,MIR6764_5P,0.99999
GSE14769_UNSTIM_VS_40MIN_LPS...2,SET,178,-0.076789,-0.0075245,0.066132,0.8772,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP,0.99999
BIOCARTA_SKP2E2F_PATHWAY,SET,10,-0.28827,-0.0067262,0.24816,0.8773,BIOCARTA_SKP2E2F_PATHWAY,0.99999
GOMF_CARBOXYLIC_ESTER_HYDROL...,SET,138,-0.086566,-0.0074771,0.074522,0.8773,GOMF_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_CELLULAR_...9,SET,42,-0.14898,-0.0071179,0.12824,0.87733,GOBP_REGULATION_OF_CELLULAR_RESPIRATION,0.99999
GOCC_FIBRINOGEN_COMPLEX,SET,8,-0.37476,-0.0078216,0.32258,0.87733,GOCC_FIBRINOGEN_COMPLEX,0.99999
REACTOME_RUNX2_REGULATES_GEN...,SET,8,-0.34834,-0.0072702,0.29978,0.87737,REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION,0.99999
WP_SARSCOV2_AND_ACE2_RECEPTO...,SET,6,-0.48611,-0.0087867,0.41835,0.87737,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,0.99999
KEGG_MEDICUS_REFERENCE_BMP9_...,SET,8,-0.3511,-0.0073278,0.3021,0.87742,KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY,0.99999
WP_TRANSSULFURATION_ONECARBO...,SET,63,-0.12618,-0.0073789,0.10856,0.87743,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,0.99999
HP_INCREASED_INTERVERTEBRAL_...,SET,6,-0.3917,-0.0070803,0.33699,0.87745,HP_INCREASED_INTERVERTEBRAL_SPACE,0.99999
WP_1Q211_COPY_NUMBER_VARIATI...,SET,23,-0.23895,-0.0084524,0.20556,0.87746,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GOBP_ADIPOSE_TISSUE_DEVELOPM...,SET,55,-0.13437,-0.0073439,0.11558,0.87749,GOBP_ADIPOSE_TISSUE_DEVELOPMENT,0.99999
GNF2_VAV1,SET,33,-0.17789,-0.0075354,0.153,0.87751,GNF2_VAV1,0.99999
PHONG_TNF_RESPONSE_NOT_VIA_P...,SET,323,-0.059899,-0.0078751,0.051514,0.87753,PHONG_TNF_RESPONSE_NOT_VIA_P38,0.99999
GSE3982_MEMORY_CD4_TCELL_VS_...3,SET,185,-0.071163,-0.0071077,0.061201,0.87753,GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN,0.99999
REACTOME_RECRUITMENT_OF_NUMA...,SET,87,-0.10009,-0.0068738,0.086071,0.87755,REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...15,SET,184,-0.07007,-0.0069798,0.060254,0.87756,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_DN,0.99999
MIR6511A_5P,SET,175,-0.075976,-0.0073824,0.065324,0.87759,MIR6511A_5P,0.99999
MIR363_5P,SET,65,-0.12579,-0.0074719,0.10815,0.8776,MIR363_5P,0.99999
HP_MALIGNANT_HYPERTHERMIA,SET,25,-0.1985,-0.0073201,0.17066,0.8776,HP_MALIGNANT_HYPERTHERMIA,0.99999
HP_BILATERAL_CAMPTODACTYLY,SET,5,-0.41853,-0.0069062,0.35971,0.87768,HP_BILATERAL_CAMPTODACTYLY,0.99999
GNF2_TIMP2,SET,39,-0.17903,-0.0082428,0.15384,0.87772,GNF2_TIMP2,0.99999
HP_ACHROMATOPSIA,SET,5,-0.51456,-0.0084909,0.4421,0.87776,HP_ACHROMATOPSIA,0.99999
GOMF_HYDROLASE_ACTIVITY_ACTI...3,SET,15,-0.25916,-0.007405,0.22266,0.87777,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDES,0.99999
GSE2585_THYMIC_DC_VS_THYMIC_...1,SET,177,-0.074662,-0.0072957,0.064139,0.87779,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_DN,0.99999
CAO_BLOOD_FLUZONE_AGE_05_14Y...2,SET,5,-0.46335,-0.0076458,0.39794,0.87785,CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_UP,0.99999
MIR4799_5P,SET,364,-0.053661,-0.0074808,0.046077,0.8779,MIR4799_5P,0.99999
GOBP_REGULATION_OF_DEFENSE_R...4,SET,52,-0.13775,-0.0073209,0.11828,0.87791,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS,0.99999
HP_PROMINENT_FOREHEAD,SET,221,-0.065733,-0.0071686,0.056437,0.87792,HP_PROMINENT_FOREHEAD,0.99999
PEDERSEN_METASTASIS_BY_ERBB2...6,SET,346,-0.055156,-0.0075004,0.047332,0.87804,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,0.99999
HP_COLLECTIONISM,SET,10,-0.30149,-0.0070346,0.25872,0.87804,HP_COLLECTIONISM,0.99999
MIR193A_3P_MIR193B_3P,SET,79,-0.11594,-0.0075891,0.099489,0.87805,MIR193A_3P_MIR193B_3P,0.99999
GSE10239_NAIVE_VS_DAY4.5_EFF...2,SET,187,-0.075052,-0.0075361,0.0644,0.87806,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_UP,0.99999
GSE3982_EOSINOPHIL_VS_TH1_DN,SET,178,-0.072237,-0.0070785,0.061982,0.87808,GSE3982_EOSINOPHIL_VS_TH1_DN,0.99999
GOBP_STEROID_CATABOLIC_PROCE...,SET,23,-0.21782,-0.0077051,0.18688,0.8781,GOBP_STEROID_CATABOLIC_PROCESS,0.99999
HP_ABNORMAL_FETAL_SKIN_MORPH...,SET,14,-0.2542,-0.0070173,0.21803,0.87817,HP_ABNORMAL_FETAL_SKIN_MORPHOLOGY,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...15,SET,178,-0.071169,-0.0069739,0.061036,0.87819,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...636,SET,5,-0.49138,-0.0081083,0.4214,0.8782,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,0.99999
MODULE_20,SET,77,-0.10846,-0.0070095,0.092986,0.87826,MODULE_20,0.99999
GOMF_RETINYL_PALMITATE_ESTER...,SET,6,-0.46831,-0.0084649,0.4015,0.87826,GOMF_RETINYL_PALMITATE_ESTERASE_ACTIVITY,0.99999
REACTOME_METABOLISM_OF_LIPIDS,SET,701,-0.038603,-0.007398,0.03309,0.87831,REACTOME_METABOLISM_OF_LIPIDS,0.99999
MIR1238_5P_MIR4758_5P,SET,43,-0.15406,-0.0074472,0.13204,0.87834,MIR1238_5P_MIR4758_5P,0.99999
HP_AKINESIA,SET,37,-0.16065,-0.0072051,0.13769,0.87835,HP_AKINESIA,0.99999
GSE21546_ELK1_KO_VS_SAP1A_KO...1,SET,187,-0.073216,-0.0073518,0.062747,0.87836,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.99999
GSE23568_CTRL_VS_ID3_TRANSDU...1,SET,178,-0.071949,-0.0070502,0.061651,0.87839,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_DN,0.99999
KEGG_MEDICUS_REFERENCE_LPAR_...,SET,22,-0.22812,-0.0078924,0.19545,0.87842,KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY,0.99999
REACTOME_SIGNALING_BY_NOTCH,SET,168,-0.073045,-0.0069557,0.062584,0.87842,REACTOME_SIGNALING_BY_NOTCH,0.99999
HP_ANKLE_CONTRACTURE,SET,52,-0.13675,-0.0072679,0.11714,0.87848,HP_ANKLE_CONTRACTURE,0.99999
HP_FEMALE_REPRODUCTIVE_SYSTE...,SET,70,-0.11568,-0.0071298,0.099085,0.87849,HP_FEMALE_REPRODUCTIVE_SYSTEM_NEOPLASM,0.99999
GOBP_INNERVATION,SET,26,-0.21971,-0.0082626,0.18817,0.87851,GOBP_INNERVATION,0.99999
HP_POSTNATAL_MACROCEPHALY,SET,5,-0.41179,-0.006795,0.3526,0.87857,HP_POSTNATAL_MACROCEPHALY,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...38,SET,46,-0.13038,-0.0065184,0.11163,0.87859,GAVISH_3CA_MALIGNANT_METAPROGRAM_8_PROTEASOMAL_DEGRADATION,0.99999
MIR4780,SET,38,-0.16833,-0.0076504,0.14411,0.8786,MIR4780,0.99999
GSE13887_RESTING_VS_ACT_CD4_...2,SET,94,-0.10394,-0.0074182,0.088983,0.8786,GSE13887_RESTING_VS_ACT_CD4_TCELL_UP,0.99999
GOBP_BIOLOGICAL_PROCESS_INVO...2,SET,106,-0.095406,-0.0072286,0.081657,0.87866,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_SYMBIONT,0.99999
GOBP_MOTILE_CILIUM_ASSEMBLY,SET,64,-0.11692,-0.0068912,0.10005,0.8787,GOBP_MOTILE_CILIUM_ASSEMBLY,0.99999
GSE4590_SMALL_VS_LARGE_PRE_B...1,SET,139,-0.087329,-0.0075701,0.074716,0.87875,GSE4590_SMALL_VS_LARGE_PRE_BCELL_DN,0.99999
chr1p32,SET,63,-0.23455,-0.013717,0.20063,0.8788,chr1p32,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...7,SET,178,-0.075358,-0.0073843,0.064459,0.87881,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,0.99999
HP_GENERALIZED_DYSTONIA,SET,27,-0.17819,-0.0068288,0.1524,0.87884,HP_GENERALIZED_DYSTONIA,0.99999
GSE34156_NOD2_LIGAND_VS_NOD2...3,SET,181,-0.074421,-0.0073531,0.06365,0.87884,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,0.99999
GOBP_MOTOR_NEURON_AXON_GUIDA...,SET,23,-0.22593,-0.0079918,0.19315,0.87893,GOBP_MOTOR_NEURON_AXON_GUIDANCE,0.99999
HP_VISUAL_FIELD_DEFECT,SET,256,-0.061896,-0.007258,0.052915,0.87893,HP_VISUAL_FIELD_DEFECT,0.99999
GOBP_URATE_TRANSPORT,SET,11,-0.30906,-0.0075631,0.26422,0.87894,GOBP_URATE_TRANSPORT,0.99999
HP_PREMATURE_VENTRICULAR_CON...,SET,27,-0.21279,-0.0081547,0.1819,0.87896,HP_PREMATURE_VENTRICULAR_CONTRACTION,0.99999
GSE9006_TYPE_1_VS_TYPE_2_DIA...1,SET,180,-0.07267,-0.0071605,0.062119,0.87896,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,0.99999
MIR3169,SET,54,-0.13385,-0.0072486,0.11441,0.87897,MIR3169,0.99999
GOBP_REGULATION_OF_PROTEOLYS...1,SET,527,-0.044833,-0.0074864,0.038323,0.87897,GOBP_REGULATION_OF_PROTEOLYSIS,0.99999
GOMF_ANDROSTAN_3_ALPHA_17_BE...,SET,8,-0.4059,-0.0084715,0.34695,0.87897,GOMF_ANDROSTAN_3_ALPHA_17_BETA_DIOL_DEHYDROGENASE_ACTIVITY,0.99999
GOBP_SKELETAL_MUSCLE_ADAPTAT...,SET,22,-0.22082,-0.0076396,0.18868,0.87905,GOBP_SKELETAL_MUSCLE_ADAPTATION,0.99999
GOMF_FRUCTOSE_6_PHOSPHATE_BI...,SET,4,-0.39899,-0.0058889,0.34088,0.87909,GOMF_FRUCTOSE_6_PHOSPHATE_BINDING,0.99999
WP_APOPTOSIS_MODULATION_BY_H...,SET,18,-0.24003,-0.0075123,0.20506,0.8791,WP_APOPTOSIS_MODULATION_BY_HSP70,0.99999
GSE40068_BCL6_POS_VS_NEG_CXC...2,SET,186,-0.072435,-0.007254,0.061879,0.87911,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_UP,0.99999
GSE43863_TFH_VS_LY6C_INT_CXC...1,SET,181,-0.078171,-0.0077236,0.066774,0.87913,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,0.99999
MODULE_337,SET,58,-0.124,-0.0069586,0.1059,0.87917,MODULE_337,0.99999
NRSF_01,SET,93,-0.10786,-0.0076574,0.092105,0.8792,NRSF_01,0.99999
HP_THICK_CEREBRAL_CORTEX,SET,9,-0.34297,-0.0075921,0.29288,0.8792,HP_THICK_CEREBRAL_CORTEX,0.99999
FXR1_TARGET_GENES,SET,979,-0.031915,-0.0071708,0.027249,0.87924,FXR1_TARGET_GENES,0.99999
BIOCARTA_HBX_PATHWAY,SET,7,-0.36217,-0.0070707,0.3092,0.87926,BIOCARTA_HBX_PATHWAY,0.99999
GACAATC_MIR219,SET,134,-0.088283,-0.0075149,0.07537,0.87926,GACAATC_MIR219,0.99999
GOBP_PHOSPHATIDYLSERINE_ACYL...,SET,8,-0.4025,-0.0084004,0.34362,0.87926,GOBP_PHOSPHATIDYLSERINE_ACYL_CHAIN_REMODELING,0.99999
GOBP_POSITIVE_REGULATION_OF_...650,SET,27,-0.18279,-0.0070049,0.15605,0.87927,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,0.99999
GSE17974_2.5H_VS_72H_IL4_AND...1,SET,176,-0.072667,-0.0070809,0.062021,0.87932,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,0.99999
HP_DELAYED_ABILITY_TO_ROLL_O...,SET,14,-0.23218,-0.0064093,0.19816,0.87934,HP_DELAYED_ABILITY_TO_ROLL_OVER,0.99999
MARTINEZ_TP53_TARGETS_DN,SET,552,-0.043234,-0.0073833,0.036891,0.87938,MARTINEZ_TP53_TARGETS_DN,0.99999
REACTOME_REGULATION_OF_GENE_...1,SET,11,-0.31412,-0.0076868,0.26801,0.8794,REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR,0.99999
HP_PERICARDIAL_EFFUSION,SET,39,-0.16118,-0.0074211,0.13747,0.87948,HP_PERICARDIAL_EFFUSION,0.99999
GOBP_POSITIVE_REGULATION_OF_...85,SET,95,-0.11214,-0.0080458,0.095618,0.87954,GOBP_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,0.99999
LIU_SMARCA4_TARGETS,SET,43,-0.16561,-0.0080055,0.1412,0.87956,LIU_SMARCA4_TARGETS,0.99999
HP_HYPOCHOLESTEROLEMIA,SET,17,-0.2449,-0.007449,0.20879,0.87958,HP_HYPOCHOLESTEROLEMIA,0.99999
BIOCARTA_GATA3_PATHWAY,SET,14,-0.29124,-0.0080397,0.24828,0.8796,BIOCARTA_GATA3_PATHWAY,0.99999
HP_SHOCK,SET,12,-0.31438,-0.008035,0.26793,0.87966,HP_SHOCK,0.99999
WP_SPLICING_FACTOR_NOVA_REGU...,SET,41,-0.16085,-0.0075931,0.13706,0.87971,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,0.99999
GOBP_PRIMARY_MIRNA_PROCESSING,SET,18,-0.21078,-0.0065968,0.17961,0.87971,GOBP_PRIMARY_MIRNA_PROCESSING,0.99999
REACTOME_PLATELET_HOMEOSTASIS,SET,81,-0.11669,-0.007734,0.099424,0.87973,REACTOME_PLATELET_HOMEOSTASIS,0.99999
GSE45365_NK_CELL_VS_CD8A_DC_...3,SET,154,-0.080718,-0.0073618,0.06877,0.87974,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP,0.99999
SYED_ESTRADIOL_RESPONSE,SET,15,-0.25657,-0.0073309,0.21854,0.8798,SYED_ESTRADIOL_RESPONSE,0.99999
MIR34C_5P,SET,240,-0.063444,-0.0072065,0.054035,0.87982,MIR34C_5P,0.99999
GOBP_SMALL_MOLECULE_CATABOLI...,SET,349,-0.054515,-0.0074448,0.046431,0.87982,GOBP_SMALL_MOLECULE_CATABOLIC_PROCESS,0.99999
GSE24210_RESTING_TREG_VS_TCO...2,SET,179,-0.073463,-0.0072187,0.062568,0.87982,GSE24210_RESTING_TREG_VS_TCONV_UP,0.99999
WP_DRUG_INDUCTION_OF_BILE_AC...,SET,17,-0.25039,-0.007616,0.21323,0.87985,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,0.99999
MIR449A,SET,280,-0.058385,-0.0071554,0.049719,0.87985,MIR449A,0.99999
GOBP_NEGATIVE_REGULATION_OF_...401,SET,616,-0.041911,-0.0075473,0.035689,0.87986,GOBP_NEGATIVE_REGULATION_OF_MOLECULAR_FUNCTION,0.99999
GOMF_PEPTIDE_BINDING,SET,233,-0.070782,-0.0079235,0.060276,0.87986,GOMF_PEPTIDE_BINDING,0.99999
RODRIGUES_NTN1_TARGETS_UP,SET,14,-0.29563,-0.0081607,0.25167,0.87992,RODRIGUES_NTN1_TARGETS_UP,0.99999
GOCC_INTRACELLULAR_PROTEIN_C...,SET,806,-0.034169,-0.0070006,0.029088,0.87993,GOCC_INTRACELLULAR_PROTEIN_CONTAINING_COMPLEX,0.99999
WAMUNYOKOLI_OVARIAN_CANCER_G...1,SET,63,-0.13256,-0.0077524,0.11284,0.87995,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,0.99999
GOBP_METAPHASE_ANAPHASE_TRAN...,SET,6,-0.4075,-0.0073658,0.34686,0.87996,GOBP_METAPHASE_ANAPHASE_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...8,SET,12,-0.26953,-0.0068887,0.2294,0.87998,KEGG_MEDICUS_VARIANT_AMPLIFIED_MDM2_TO_P21_CELL_CYCLE_G1_S,0.99999
GOBP_CELLULAR_RESPONSE_TO_ST...4,SET,14,-0.26499,-0.0073151,0.22554,0.87998,GOBP_CELLULAR_RESPONSE_TO_STEROL_DEPLETION,0.99999
GOCC_RIBONUCLEOPROTEIN_COMPL...,SET,619,-0.038356,-0.0069234,0.032639,0.88002,GOCC_RIBONUCLEOPROTEIN_COMPLEX,0.99999
GOMF_UBIQUITIN_LIGASE_COMPLE...,SET,6,-0.38614,-0.0069798,0.3286,0.88002,GOMF_UBIQUITIN_LIGASE_COMPLEX_SCAFFOLD_ACTIVITY,0.99999
MIR583,SET,156,-0.080417,-0.0073815,0.068425,0.88005,MIR583,0.99999
NAKAYA_PBMC_FLUARIX_FLUVIRIN...1,SET,377,-0.050028,-0.0070953,0.042562,0.88008,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN,0.99999
HP_DECREASED_PALMAR_CREASES,SET,5,-0.46988,-0.0077536,0.39954,0.88021,HP_DECREASED_PALMAR_CREASES,0.99999
MATZUK_POSTIMPLANTATION_AND_...,SET,13,-0.29537,-0.0078572,0.25109,0.88026,MATZUK_POSTIMPLANTATION_AND_POSTPARTUM,0.99999
HP_ABNORMAL_EMOTION,SET,598,-0.041507,-0.0073682,0.035284,0.88027,HP_ABNORMAL_EMOTION,0.99999
GSE9988_ANTI_TREM1_VS_ANTI_T...1,SET,161,-0.085827,-0.0080022,0.072958,0.88027,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,0.99999
MIR1275,SET,258,-0.063952,-0.007528,0.054362,0.88028,MIR1275,0.99999
GOBP_REGULATION_OF_BICELLULA...,SET,21,-0.21739,-0.0073483,0.18477,0.8803,GOBP_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,0.99999
MIR6787_3P,SET,90,-0.10486,-0.0073244,0.089121,0.88032,MIR6787_3P,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...18,SET,14,-0.30009,-0.0082839,0.25502,0.88034,GOBP_PROTEIN_LOCALIZATION_TO_CONDENSED_CHROMOSOME,0.99999
DESCARTES_FETAL_STOMACH_STRO...,SET,42,-0.17041,-0.0081416,0.14482,0.88034,DESCARTES_FETAL_STOMACH_STROMAL_CELLS,0.99999
FAELT_B_CLL_WITH_VH3_21_UP,SET,38,-0.14955,-0.0067972,0.12709,0.88035,FAELT_B_CLL_WITH_VH3_21_UP,0.99999
GSE41867_LCMV_ARMSTRONG_VS_C...6,SET,174,-0.075291,-0.0072952,0.06398,0.88035,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_UP,0.99999
REACTOME_ENOS_ACTIVATION,SET,10,-0.32881,-0.007672,0.2794,0.88036,REACTOME_ENOS_ACTIVATION,0.99999
GOBP_APOPTOTIC_PROCESS_INVOL...1,SET,37,-0.16752,-0.0075132,0.14235,0.88036,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.99999
GSE19401_NAIVE_VS_IMMUNIZED_...2,SET,185,-0.076836,-0.0076743,0.065278,0.8804,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP,0.99999
LHX9_TARGET_GENES,SET,1162,-0.030667,-0.0074673,0.02605,0.88044,LHX9_TARGET_GENES,0.99999
ZHANG_RESPONSE_TO_CANTHARIDI...2,SET,14,-0.27378,-0.0075577,0.23255,0.88046,ZHANG_RESPONSE_TO_CANTHARIDIN_UP,0.99999
GOBP_SECRETORY_GRANULE_LOCAL...,SET,22,-0.22566,-0.007807,0.19165,0.88048,GOBP_SECRETORY_GRANULE_LOCALIZATION,0.99999
BORLAK_LIVER_CANCER_EGF_UP,SET,49,-0.15101,-0.0077911,0.12824,0.88049,BORLAK_LIVER_CANCER_EGF_UP,0.99999
MODULE_340,SET,24,-0.20322,-0.0073431,0.17256,0.88053,MODULE_340,0.99999
VERRECCHIA_RESPONSE_TO_TGFB1...1,SET,19,-0.22453,-0.0072196,0.19064,0.88055,VERRECCHIA_RESPONSE_TO_TGFB1_C1,0.99999
MIR1301_3P_MIR5047,SET,105,-0.099767,-0.0075236,0.084706,0.88056,MIR1301_3P_MIR5047,0.99999
HP_INCREASED_CIRCULATING_AND...,SET,17,-0.2441,-0.0074246,0.20723,0.88057,HP_INCREASED_CIRCULATING_ANDROGEN_CONCENTRATION,0.99999
PIEPOLI_LGI1_TARGETS_DN,SET,12,-0.30556,-0.0078098,0.25935,0.88063,PIEPOLI_LGI1_TARGETS_DN,0.99999
HP_PITUITARY_PROLACTIN_CELL_...,SET,7,-0.35419,-0.006915,0.30055,0.88069,HP_PITUITARY_PROLACTIN_CELL_ADENOMA,0.99999
HP_SPONDYLOLISTHESIS,SET,19,-0.23575,-0.0075805,0.20003,0.88071,HP_SPONDYLOLISTHESIS,0.99999
GSE43863_TH1_VS_TFH_MEMORY_C...2,SET,179,-0.073174,-0.0071902,0.062081,0.88073,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_UP,0.99999
GOBP_DETOXIFICATION_OF_COPPE...,SET,13,-0.37818,-0.01006,0.32083,0.88074,GOBP_DETOXIFICATION_OF_COPPER_ION,0.99999
GOMF_DYNEIN_HEAVY_CHAIN_BIND...,SET,12,-0.2545,-0.0065046,0.21591,0.88074,GOMF_DYNEIN_HEAVY_CHAIN_BINDING,0.99999
GOBP_ASPARAGINE_METABOLIC_PR...,SET,5,-0.42676,-0.0070419,0.36203,0.88075,GOBP_ASPARAGINE_METABOLIC_PROCESS,0.99999
HP_HEPATOCELLULAR_CARCINOMA,SET,75,-0.11784,-0.0075164,0.099965,0.88075,HP_HEPATOCELLULAR_CARCINOMA,0.99999
GSE13946_CTRL_VS_DSS_COLITIS...2,SET,163,-0.083092,-0.0077948,0.07049,0.88075,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_UP,0.99999
MORF_GPX4,SET,47,-0.13926,-0.0070372,0.11812,0.88078,MORF_GPX4,0.99999
PID_AVB3_INTEGRIN_PATHWAY,SET,72,-0.12237,-0.0076482,0.10378,0.8808,PID_AVB3_INTEGRIN_PATHWAY,0.99999
MATZUK_OVULATION,SET,15,-0.2785,-0.0079576,0.23619,0.88082,MATZUK_OVULATION,0.99999
GOMF_CYCLIN_DEPENDENT_PROTEI...4,SET,45,-0.14,-0.0069228,0.11873,0.88083,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_REGULATOR_ACTIVITY,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...22,SET,50,-0.15623,-0.0081425,0.13249,0.88084,GAVISH_3CA_METAPROGRAM_EPITHELIAL_SECRETED,0.99999
GOBP_CARBOHYDRATE_DERIVATIVE...3,SET,965,-0.033465,-0.0074682,0.028378,0.88084,GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS,0.99999
SMITH_TERT_TARGETS_UP,SET,130,-0.087775,-0.0073602,0.074418,0.88089,SMITH_TERT_TARGETS_UP,0.99999
SUPT16H_TARGET_GENES,SET,1357,-0.027962,-0.0073161,0.023705,0.88091,SUPT16H_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...470,SET,12,-0.32716,-0.0083617,0.27734,0.88092,GOBP_NEGATIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION,0.99999
GOCC_GROWTH_CONE_MEMBRANE,SET,7,-0.3938,-0.0076882,0.3338,0.88094,GOCC_GROWTH_CONE_MEMBRANE,0.99999
LMX1B_TARGET_GENES,SET,20,-0.23578,-0.0077779,0.19985,0.88095,LMX1B_TARGET_GENES,0.99999
GOBP_GLOMERULAR_EPITHELIAL_C...,SET,12,-0.31426,-0.0080321,0.26638,0.88095,GOBP_GLOMERULAR_EPITHELIAL_CELL_DEVELOPMENT,0.99999
HP_NYCTALOPIA,SET,200,-0.072536,-0.0075297,0.06148,0.88096,HP_NYCTALOPIA,0.99999
WP_BMP_SIGNALING_IN_EYELID_D...,SET,19,-0.27228,-0.008755,0.23076,0.88098,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,0.99999
GAUTAM_EYE_CHOROID_SCLERA_FI...,SET,185,-0.075517,-0.0075425,0.06396,0.88113,GAUTAM_EYE_CHOROID_SCLERA_FIBROBLASTS,0.99999
REACTOME_DEGRADATION_OF_DVL,SET,54,-0.12103,-0.0065543,0.10249,0.88118,REACTOME_DEGRADATION_OF_DVL,0.99999
JAEGER_METASTASIS_UP,SET,38,-0.16037,-0.0072886,0.13579,0.8812,JAEGER_METASTASIS_UP,0.99999
GNF2_INPP5D,SET,39,-0.17362,-0.007994,0.14701,0.8812,GNF2_INPP5D,0.99999
GOBP_C_X_C_CHEMOKINE_RECEPTO...,SET,5,-0.50884,-0.0083965,0.43082,0.88121,GOBP_C_X_C_CHEMOKINE_RECEPTOR_CXCR4_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_T_HELPER_...1,SET,22,-0.22349,-0.007732,0.18922,0.88121,GOBP_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION,0.99999
REACTOME_SIGNALING_BY_ALK_IN...,SET,86,-0.1087,-0.0074224,0.092029,0.88122,REACTOME_SIGNALING_BY_ALK_IN_CANCER,0.99999
GSE7400_CTRL_VS_CSF3_IN_VIVO...1,SET,175,-0.075516,-0.0073378,0.063935,0.88122,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN,0.99999
GOBP_TRAIL_ACTIVATED_APOPTOT...,SET,9,-0.32655,-0.0072285,0.27639,0.88129,GOBP_TRAIL_ACTIVATED_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOBP_SUCKLING_BEHAVIOR,SET,11,-0.30517,-0.0074679,0.25826,0.88132,GOBP_SUCKLING_BEHAVIOR,0.99999
HP_DYSURIA,SET,14,-0.25795,-0.0071208,0.21826,0.88136,HP_DYSURIA,0.99999
REACTOME_SUMOYLATION,SET,163,-0.078654,-0.0073785,0.066549,0.88137,REACTOME_SUMOYLATION,0.99999
HINATA_NFKB_TARGETS_KERATINO...2,SET,84,-0.11495,-0.007758,0.097255,0.88138,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,0.99999
HP_ABNORMALITY_OF_THE_PULMON...2,SET,185,-0.076074,-0.0075981,0.064356,0.8814,HP_ABNORMALITY_OF_THE_PULMONARY_VASCULATURE,0.99999
HP_HORIZONTAL_PENDULAR_NYSTA...,SET,7,-0.39759,-0.0077622,0.33635,0.8814,HP_HORIZONTAL_PENDULAR_NYSTAGMUS,0.99999
BIOCARTA_ACE2_PATHWAY,SET,9,-0.39792,-0.0088085,0.33657,0.88145,BIOCARTA_ACE2_PATHWAY,0.99999
GSE7509_UNSTIM_VS_TNFA_IL1B_...1,SET,80,-0.10846,-0.0071442,0.091714,0.8815,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...2,SET,38,-0.16309,-0.0074123,0.13789,0.88153,GAVISH_3CA_MALIGNANT_METAPROGRAM_11_TRANSLATION_INITIATION,0.99999
GOBP_AXON_CHOICE_POINT_RECOG...,SET,7,-0.47491,-0.0092718,0.40153,0.88154,GOBP_AXON_CHOICE_POINT_RECOGNITION,0.99999
GOBP_LABYRINTHINE_LAYER_MORP...,SET,20,-0.24578,-0.0081078,0.20778,0.88156,GOBP_LABYRINTHINE_LAYER_MORPHOGENESIS,0.99999
RAMALHO_STEMNESS_UP,SET,180,-0.071892,-0.0070838,0.060772,0.88158,RAMALHO_STEMNESS_UP,0.99999
GOBP_ESTABLISHMENT_OF_LOCALI...,SET,1767,-0.024633,-0.0072652,0.020823,0.88158,GOBP_ESTABLISHMENT_OF_LOCALIZATION_IN_CELL,0.99999
GOMF_ANGIOTENSIN_RECEPTOR_AC...,SET,4,-0.5836,-0.0086137,0.49335,0.88158,GOMF_ANGIOTENSIN_RECEPTOR_ACTIVITY,0.99999
REACTOME_JNK_C_JUN_KINASES_P...,SET,18,-0.25196,-0.0078856,0.21298,0.88159,REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...6,SET,157,-0.077607,-0.0071461,0.065567,0.88171,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,0.99999
HP_ENTRAPMENT_NEUROPATHY,SET,10,-0.32446,-0.0075706,0.27412,0.88171,HP_ENTRAPMENT_NEUROPATHY,0.99999
GSE18281_SUBCAPSULAR_CORTICA...2,SET,189,-0.072983,-0.007367,0.061655,0.88173,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,0.99999
AAAYRNCTG_UNKNOWN,SET,323,-0.058334,-0.0076693,0.049272,0.88177,AAAYRNCTG_UNKNOWN,0.99999
GSE17721_CTRL_VS_LPS_4H_BMDC...1,SET,181,-0.074912,-0.0074017,0.063275,0.88177,GSE17721_CTRL_VS_LPS_4H_BMDC_DN,0.99999
MIR6861_5P,SET,62,-0.12456,-0.0072265,0.10521,0.88178,MIR6861_5P,0.99999
GSE37532_TREG_VS_TCONV_PPARG...2,SET,180,-0.072186,-0.0071127,0.060968,0.88178,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP,0.99999
GOCC_CHITOSOME,SET,20,-0.24698,-0.0081476,0.20856,0.88182,GOCC_CHITOSOME,0.99999
GSE39820_IL1B_IL6_VS_IL1B_IL...2,SET,181,-0.075601,-0.0074697,0.063838,0.88184,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP,0.99999
STAT3_01,SET,21,-0.21403,-0.0072346,0.18072,0.88185,STAT3_01,0.99999
HP_WHITE_HAIR,SET,21,-0.22066,-0.007459,0.1863,0.88187,HP_WHITE_HAIR,0.99999
HP_RIGHT_ATRIAL_ENLARGEMENT,SET,23,-0.2288,-0.0080934,0.19315,0.88189,HP_RIGHT_ATRIAL_ENLARGEMENT,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...6,SET,7,-0.30328,-0.005921,0.25601,0.88191,GOCC_EXTRINSIC_COMPONENT_OF_POSTSYNAPTIC_MEMBRANE,0.99999
RAO_BOUND_BY_SALL4_ISOFORM_A,SET,166,-0.082067,-0.0077685,0.06927,0.88193,RAO_BOUND_BY_SALL4_ISOFORM_A,0.99999
GCM_GSPT1,SET,153,-0.074261,-0.0067511,0.062682,0.88193,GCM_GSPT1,0.99999
GOBP_CONNECTIVE_TISSUE_DEVEL...,SET,260,-0.065475,-0.0077367,0.055261,0.88195,GOBP_CONNECTIVE_TISSUE_DEVELOPMENT,0.99999
GOMF_PROTEIN_FOLDING_CHAPERO...1,SET,62,-0.12192,-0.0070735,0.1029,0.88195,GOMF_PROTEIN_FOLDING_CHAPERONE,0.99999
REACTOME_METAL_ION_SLC_TRANS...,SET,23,-0.20624,-0.0072955,0.17406,0.88196,REACTOME_METAL_ION_SLC_TRANSPORTERS,0.99999
GOBP_EXPLORATION_BEHAVIOR,SET,28,-0.20249,-0.0079022,0.17088,0.88198,GOBP_EXPLORATION_BEHAVIOR,0.99999
GSE25502_WT_VS_KLF13_KO_THYM...2,SET,158,-0.08032,-0.0074193,0.067772,0.88201,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_UP,0.99999
GOCC_TRANSPORT_VESICLE,SET,397,-0.052371,-0.0076177,0.044188,0.88202,GOCC_TRANSPORT_VESICLE,0.99999
FISCHER_G2_M_CELL_CYCLE,SET,221,-0.067348,-0.0073448,0.056811,0.88208,FISCHER_G2_M_CELL_CYCLE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...637,SET,4,-0.55355,-0.0081702,0.4669,0.8821,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.99999
HP_HALLUCINATIONS,SET,145,-0.082599,-0.0073118,0.069638,0.8822,HP_HALLUCINATIONS,0.99999
GOBP_SPHINGOMYELIN_CATABOLIC...,SET,8,-0.35579,-0.0074256,0.29994,0.88222,GOBP_SPHINGOMYELIN_CATABOLIC_PROCESS,0.99999
HP_HYPOPLASIA_OF_THE_PHALANG...,SET,6,-0.38926,-0.0070361,0.3281,0.88226,HP_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_TOES,0.99999
REACTOME_DISEASES_ASSOCIATED...4,SET,61,-0.14285,-0.0082209,0.12041,0.88227,REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS,0.99999
REACTOME_INTERLEUKIN_7_SIGNA...,SET,21,-0.23756,-0.0080302,0.20023,0.88227,REACTOME_INTERLEUKIN_7_SIGNALING,0.99999
FULLER_PBMC_F_TULARENSIS_VAC...1,SET,19,-0.24594,-0.0079081,0.20726,0.8823,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_DN,0.99999
GSE27241_CTRL_VS_DIGOXIN_TRE...2,SET,145,-0.085898,-0.0076039,0.072379,0.88233,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,0.99999
GOBP_LOCOMOTORY_EXPLORATION_...,SET,14,-0.28581,-0.0078899,0.2408,0.88236,GOBP_LOCOMOTORY_EXPLORATION_BEHAVIOR,0.99999
MODULE_524,SET,27,-0.20028,-0.0076752,0.16873,0.88237,MODULE_524,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...18,SET,10,-0.31778,-0.0074146,0.26769,0.88239,HP_APLASIA_HYPOPLASIA_OF_THE_COLON,0.99999
HP_SCLEROSIS_OF_FINGER_PHALA...,SET,8,-0.39331,-0.0082087,0.3313,0.88241,HP_SCLEROSIS_OF_FINGER_PHALANX,0.99999
HP_BCGOSIS,SET,7,-0.45214,-0.0088273,0.38082,0.88243,HP_BCGOSIS,0.99999
ZNF260_TARGET_GENES,SET,667,-0.040445,-0.007568,0.03406,0.88247,ZNF260_TARGET_GENES,0.99999
GOBP_CD4_POSITIVE_CD25_POSIT...,SET,7,-0.45292,-0.0088425,0.38139,0.88249,GOBP_CD4_POSITIVE_CD25_POSITIVE_ALPHA_BETA_REGULATORY_T_CELL_DIFFERENTIATION,0.99999
GOBP_EPITHELIAL_CELL_DEVELOP...,SET,205,-0.075751,-0.00796,0.063786,0.88249,GOBP_EPITHELIAL_CELL_DEVELOPMENT,0.99999
MIR6811_5P,SET,66,-0.12983,-0.0077706,0.10931,0.88252,MIR6811_5P,0.99999
GOBP_DIADENOSINE_POLYPHOSPHA...1,SET,3,-0.69027,-0.0088233,0.58116,0.88253,GOBP_DIADENOSINE_POLYPHOSPHATE_CATABOLIC_PROCESS,0.99999
GOBP_DIADENOSINE_POLYPHOSPHA...2,SET,3,-0.69027,-0.0088233,0.58116,0.88253,GOBP_DIADENOSINE_POLYPHOSPHATE_METABOLIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_KINET...1,SET,22,-0.22417,-0.0077557,0.18872,0.88254,KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION,0.99999
MODULE_436,SET,118,-0.098308,-0.0078563,0.08276,0.88255,MODULE_436,0.99999
REACTOME_TRANSLATION,SET,256,-0.060206,-0.0070599,0.050679,0.88257,REACTOME_TRANSLATION,0.99999
GOCC_IGG_IMMUNOGLOBULIN_COMP...,SET,2,-0.84358,-0.0088045,0.71008,0.88258,GOCC_IGG_IMMUNOGLOBULIN_COMPLEX,0.99999
MIR519E_3P,SET,60,-0.13385,-0.0076395,0.11266,0.88259,MIR519E_3P,0.99999
GOBP_SKELETAL_MUSCLE_THIN_FI...,SET,7,-0.40857,-0.0079767,0.3439,0.88259,GOBP_SKELETAL_MUSCLE_THIN_FILAMENT_ASSEMBLY,0.99999
MIR6511B_5P,SET,66,-0.12938,-0.0077439,0.1089,0.8826,MIR6511B_5P,0.99999
PID_NFAT_3PATHWAY,SET,53,-0.14182,-0.0076089,0.11936,0.88261,PID_NFAT_3PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...733,SET,12,-0.29565,-0.0075565,0.24881,0.88262,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
TBK1.DN.48HRS_UP,SET,47,-0.14093,-0.0071219,0.11861,0.88262,TBK1.DN.48HRS_UP,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...2,SET,40,-0.15493,-0.0072239,0.13038,0.88263,GAVISH_3CA_METAPROGRAM_B_CELLS_CELL_CYCLE,0.99999
GOBP_ENTERIC_NERVOUS_SYSTEM_...,SET,11,-0.31346,-0.0076708,0.26376,0.88267,GOBP_ENTERIC_NERVOUS_SYSTEM_DEVELOPMENT,0.99999
WP_SEBALEIC_ACID_FORMATION_A...,SET,5,-0.49479,-0.0081646,0.41624,0.88272,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,0.99999
HP_ABNORMALITY_OF_RADIAL_EPI...,SET,5,-0.4684,-0.0077291,0.39399,0.88274,HP_ABNORMALITY_OF_RADIAL_EPIPHYSES,0.99999
MIR942_3P,SET,104,-0.09803,-0.0073575,0.082446,0.88278,MIR942_3P,0.99999
MIR3174,SET,38,-0.17495,-0.0079514,0.14713,0.8828,MIR3174,0.99999
GSE21927_BALBC_VS_C57BL6_MON...4,SET,181,-0.070315,-0.0069474,0.059127,0.88281,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP,0.99999
GOMF_HYDROLASE_ACTIVITY_ACTI...6,SET,11,-0.31415,-0.0076877,0.26414,0.88284,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDINES,0.99999
DESCARTES_FETAL_LUNG_LYMPHOI...,SET,118,-0.1013,-0.0080954,0.085171,0.88285,DESCARTES_FETAL_LUNG_LYMPHOID_CELLS,0.99999
TCGA_GLIOBLASTOMA_COPY_NUMBE...2,SET,67,-0.1602,-0.0096605,0.13469,0.88286,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,0.99999
GOMF_INSULIN_LIKE_GROWTH_FAC...2,SET,8,-0.43793,-0.00914,0.36811,0.8829,GOMF_INSULIN_LIKE_GROWTH_FACTOR_II_BINDING,0.99999
HP_GLOMERULAR_SUBEPITHELIAL_...,SET,11,-0.29952,-0.0073297,0.25174,0.88293,HP_GLOMERULAR_SUBEPITHELIAL_DEPOSITS,0.99999
GERHOLD_ADIPOGENESIS_UP,SET,46,-0.15863,-0.0079307,0.13332,0.88294,GERHOLD_ADIPOGENESIS_UP,0.99999
GSE29618_PRE_VS_DAY7_POST_LA...5,SET,185,-0.073154,-0.0073065,0.06148,0.88295,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN,0.99999
REACTOME_POLB_DEPENDENT_LONG...,SET,7,-0.32332,-0.0063123,0.27169,0.88298,REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,0.99999
GOBP_AXIS_ELONGATION,SET,28,-0.21951,-0.0085661,0.18444,0.88299,GOBP_AXIS_ELONGATION,0.99999
GSE2405_0H_VS_1.5H_A_PHAGOCY...1,SET,181,-0.071072,-0.0070222,0.0597,0.88306,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...13,SET,178,-0.071837,-0.0070393,0.060333,0.8831,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN,0.99999
GSE3982_EOSINOPHIL_VS_EFF_ME...2,SET,173,-0.075772,-0.0073209,0.063639,0.8831,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
HP_ABNORMAL_BASAL_GANGLIA_MO...,SET,158,-0.079158,-0.007312,0.066473,0.88313,HP_ABNORMAL_BASAL_GANGLIA_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_T_HELPER_...6,SET,12,-0.31365,-0.0080165,0.26337,0.88315,GOBP_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,0.99999
WP_SELENIUM_MICRONUTRIENT_NE...,SET,70,-0.12917,-0.0079609,0.10845,0.88317,WP_SELENIUM_MICRONUTRIENT_NETWORK,0.99999
GAUCHER_PBMC_YF_VAX_STAMARIL...1,SET,96,-0.10406,-0.0075054,0.087363,0.88319,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_DN,0.99999
HP_LIMITED_ELBOW_EXTENSION,SET,45,-0.14766,-0.0073018,0.12396,0.8832,HP_LIMITED_ELBOW_EXTENSION,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...10,SET,50,-0.16164,-0.0084245,0.13569,0.88321,GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE,0.99999
GOBP_CELLULAR_RESPONSE_TO_HY...3,SET,4,-0.54015,-0.0079723,0.45336,0.88325,GOBP_CELLULAR_RESPONSE_TO_HYPEROXIA,0.99999
GOMF_PHOSPHOLIPASE_A2_ACTIVI...,SET,28,-0.19657,-0.0076709,0.16498,0.88325,GOMF_PHOSPHOLIPASE_A2_ACTIVITY,0.99999
MIR4677_3P,SET,120,-0.093189,-0.0075096,0.078212,0.88326,MIR4677_3P,0.99999
PID_RHOA_REG_PATHWAY,SET,42,-0.16074,-0.0076797,0.1349,0.88328,PID_RHOA_REG_PATHWAY,0.99999
GSE19401_PLN_VS_PEYERS_PATCH...1,SET,186,-0.072384,-0.007249,0.060747,0.88328,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN,0.99999
CADWELL_ATG16L1_TARGETS_DN,SET,61,-0.11746,-0.0067595,0.098528,0.88339,CADWELL_ATG16L1_TARGETS_DN,0.99999
WANG_NFKB_TARGETS,SET,24,-0.203,-0.0073352,0.17027,0.88341,WANG_NFKB_TARGETS,0.99999
GOBP_REGULATION_OF_SMALL_MOL...,SET,286,-0.061087,-0.0075651,0.051237,0.88341,GOBP_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,0.99999
GSE37416_0H_VS_24H_F_TULAREN...2,SET,166,-0.076674,-0.007258,0.06431,0.88341,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
HOFMANN_MYELODYSPLASTIC_SYND...5,SET,20,-0.21678,-0.0071513,0.18181,0.88343,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,0.99999
GOMF_PEPTIDE_TRANSMEMBRANE_T...,SET,9,-0.36641,-0.008111,0.3073,0.88343,GOMF_PEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
SA_TRKA_RECEPTOR,SET,16,-0.24047,-0.0070962,0.20167,0.88344,SA_TRKA_RECEPTOR,0.99999
GSE22501_PERIPHERAL_BLOOD_VS...1,SET,175,-0.078735,-0.0076506,0.066028,0.88345,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN,0.99999
HP_LONG_PENIS,SET,11,-0.32674,-0.0079958,0.27399,0.88346,HP_LONG_PENIS,0.99999
HP_ABNORMALITY_OF_THE_LEYDIG...,SET,12,-0.30169,-0.0077106,0.25294,0.8835,HP_ABNORMALITY_OF_THE_LEYDIG_CELLS,0.99999
GSE39022_LN_VS_SPLEEN_DC_DN,SET,175,-0.076912,-0.0074735,0.064482,0.88351,GSE39022_LN_VS_SPLEEN_DC_DN,0.99999
BROWNE_HCMV_INFECTION_16HR_DN,SET,77,-0.12131,-0.0078402,0.10167,0.88359,BROWNE_HCMV_INFECTION_16HR_DN,0.99999
GSE24634_TEFF_VS_TCONV_DAY7_...2,SET,181,-0.072461,-0.0071595,0.060731,0.88359,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP,0.99999
HP_HYPOPIGMENTATION_OF_THE_F...,SET,22,-0.21467,-0.0074271,0.17991,0.88361,HP_HYPOPIGMENTATION_OF_THE_FUNDUS,0.99999
GSE22601_CD4_SINGLE_POSITIVE...1,SET,180,-0.071686,-0.0070635,0.060069,0.88363,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.99999
SU_THYMUS,SET,19,-0.27612,-0.0088783,0.23135,0.88365,SU_THYMUS,0.99999
GSE15330_LYMPHOID_MULTIPOTEN...5,SET,190,-0.073838,-0.0074728,0.061862,0.88367,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,0.99999
TRAVAGLINI_LUNG_CLUB_CELL,SET,102,-0.10928,-0.0081234,0.091561,0.88367,TRAVAGLINI_LUNG_CLUB_CELL,0.99999
HP_CORTICAL_THICKENING_OF_LO...,SET,5,-0.44481,-0.0073399,0.37265,0.88368,HP_CORTICAL_THICKENING_OF_LONG_BONE_DIAPHYSES,0.99999
POOLA_INVASIVE_BREAST_CANCER...2,SET,256,-0.068704,-0.0080563,0.057552,0.88371,POOLA_INVASIVE_BREAST_CANCER_UP,0.99999
GSE24634_IL4_VS_CTRL_TREATED...6,SET,180,-0.080143,-0.0078967,0.067131,0.88372,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP,0.99999
GSE23502_WT_VS_HDC_KO_MYELOI...4,SET,184,-0.075983,-0.0075688,0.063645,0.88373,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP,0.99999
MIR599,SET,81,-0.11509,-0.0076279,0.096396,0.88374,MIR599,0.99999
GSE33162_HDAC3_KO_VS_HDAC3_K...2,SET,181,-0.073037,-0.0072163,0.061172,0.88374,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP,0.99999
HP_FETAL_ANOMALY,SET,490,-0.046151,-0.0074386,0.038653,0.88375,HP_FETAL_ANOMALY,0.99999
GOBP_REGULATION_OF_RHO_PROTE...,SET,79,-0.11764,-0.0077002,0.09852,0.88376,GOBP_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
MIR188_5P,SET,65,-0.12745,-0.0075705,0.10673,0.88378,MIR188_5P,0.99999
GOCC_SPERM_PRINCIPAL_PIECE,SET,29,-0.18429,-0.0073188,0.15433,0.88378,GOCC_SPERM_PRINCIPAL_PIECE,0.99999
GOMF_AP_1_ADAPTOR_COMPLEX_BI...,SET,5,-0.4284,-0.007069,0.35875,0.88378,GOMF_AP_1_ADAPTOR_COMPLEX_BINDING,0.99999
GSE22611_NOD2_VS_CTRL_TRANSD...1,SET,185,-0.072455,-0.0072367,0.060675,0.88378,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,0.99999
BYSTRYKH_HEMATOPOIESIS_STEM_...6,SET,121,-0.089895,-0.0072741,0.075277,0.88379,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS,0.99999
HP_NEMALINE_BODIES,SET,19,-0.22908,-0.007366,0.19182,0.8838,HP_NEMALINE_BODIES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...672,SET,45,-0.16124,-0.0079734,0.135,0.88384,GOBP_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION,0.99999
MEBARKI_HCC_PROGENITOR_WNT_U...4,SET,21,-0.23104,-0.0078096,0.19342,0.88385,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT,0.99999
GOCC_AXON_HILLOCK,SET,7,-0.40393,-0.0078861,0.33817,0.88385,GOCC_AXON_HILLOCK,0.99999
MSX2_TARGET_GENES,SET,15,-0.2607,-0.0074489,0.21824,0.88386,MSX2_TARGET_GENES,0.99999
GNF2_MMP1,SET,32,-0.21376,-0.0089167,0.17894,0.88386,GNF2_MMP1,0.99999
GOBP_REGULATION_OF_CYTOPLASM...4,SET,7,-0.32326,-0.0063112,0.2706,0.88388,GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATIONAL_INITIATION,0.99999
GOBP_MITOTIC_SISTER_CHROMATI...3,SET,178,-0.073231,-0.0071759,0.061286,0.88393,GOBP_MITOTIC_SISTER_CHROMATID_SEGREGATION,0.99999
GOCC_DENSE_CORE_GRANULE,SET,38,-0.18111,-0.0082312,0.1515,0.88403,GOCC_DENSE_CORE_GRANULE,0.99999
REACTOME_RHO_GTPASE_EFFECTORS,SET,244,-0.064868,-0.0074286,0.054257,0.88406,REACTOME_RHO_GTPASE_EFFECTORS,0.99999
SILIGAN_TARGETS_OF_EWS_FLI1_...1,SET,17,-0.25011,-0.0076076,0.2092,0.88407,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN,0.99999
GOBP_RESPONSE_TO_AMINO_ACID_...,SET,50,-0.14211,-0.0074064,0.11885,0.88408,GOBP_RESPONSE_TO_AMINO_ACID_STARVATION,0.99999
GSE21927_HEALTHY_VS_TUMOROUS...2,SET,167,-0.080172,-0.0076118,0.067053,0.88408,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP,0.99999
GOBP_RRNA_PSEUDOURIDINE_SYNT...,SET,7,-0.35809,-0.006991,0.29947,0.88409,GOBP_RRNA_PSEUDOURIDINE_SYNTHESIS,0.99999
GSE35543_IN_VITRO_ITREG_VS_C...1,SET,178,-0.076008,-0.007448,0.063547,0.88416,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_DN,0.99999
RAPA_EARLY_UP.V1_UP,SET,142,-0.090018,-0.0078864,0.075258,0.88417,RAPA_EARLY_UP.V1_UP,0.99999
FLECHNER_BIOPSY_KIDNEY_TRANS...1,SET,23,-0.19916,-0.0070449,0.16648,0.88419,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,0.99999
REACTOME_CA2_PATHWAY,SET,62,-0.13425,-0.0077885,0.11222,0.8842,REACTOME_CA2_PATHWAY,0.99999
GOBP_PEPTIDYL_ARGININE_METHY...1,SET,10,-0.29885,-0.006973,0.24981,0.88421,GOBP_PEPTIDYL_ARGININE_METHYLATION,0.99999
GGGGCCC_MIR296,SET,66,-0.11929,-0.0071394,0.099698,0.88423,GGGGCCC_MIR296,0.99999
MIR1290,SET,241,-0.066042,-0.007517,0.055191,0.88426,MIR1290,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HP...5,SET,269,-0.065524,-0.0078734,0.054756,0.88427,MANNO_MIDBRAIN_NEUROTYPES_HPROGM,0.99999
HP_HYPOPLASTIC_ILIA,SET,47,-0.15002,-0.0075811,0.12534,0.88433,HP_HYPOPLASTIC_ILIA,0.99999
KEGG_MEDICUS_REFERENCE_MDM2_...1,SET,13,-0.26813,-0.0071326,0.22399,0.88435,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00066,0.99999
GSE360_CTRL_VS_L_MAJOR_DC_UP,SET,180,-0.076194,-0.0075077,0.06365,0.88435,GSE360_CTRL_VS_L_MAJOR_DC_UP,0.99999
HP_HYPOKALEMIC_ALKALOSIS,SET,12,-0.30641,-0.0078315,0.25596,0.88436,HP_HYPOKALEMIC_ALKALOSIS,0.99999
GSE36392_TYPE_2_MYELOID_VS_E...1,SET,176,-0.079065,-0.0077043,0.066045,0.88437,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN,0.99999
HOSHIDA_LIVER_CANCER_LATE_RE...2,SET,56,-0.14592,-0.0080468,0.12188,0.88439,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,0.99999
HP_ABNORMALITY_OF_HAIR_PIGME...,SET,109,-0.099713,-0.0076605,0.083269,0.88443,HP_ABNORMALITY_OF_HAIR_PIGMENTATION,0.99999
GOBP_CAMP_BIOSYNTHETIC_PROCE...,SET,10,-0.34927,-0.0081494,0.29165,0.88444,GOBP_CAMP_BIOSYNTHETIC_PROCESS,0.99999
GSE21670_UNTREATED_VS_TGFB_I...2,SET,170,-0.077158,-0.0073904,0.064432,0.88444,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP,0.99999
MIKKELSEN_IPS_LCP_WITH_H3K4M...1,SET,157,-0.081514,-0.007506,0.068067,0.88445,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,0.99999
GOCC_CLATHRIN_COATED_VESICLE...,SET,123,-0.096431,-0.0078667,0.080523,0.88445,GOCC_CLATHRIN_COATED_VESICLE_MEMBRANE,0.99999
HP_SEVERE_VIRAL_INFECTION,SET,29,-0.18775,-0.0074563,0.15677,0.88446,HP_SEVERE_VIRAL_INFECTION,0.99999
HP_SHORT_SPERM_FLAGELLA,SET,27,-0.18672,-0.0071555,0.1559,0.88447,HP_SHORT_SPERM_FLAGELLA,0.99999
HP_TRICUSPID_VALVE_PROLAPSE,SET,10,-0.35457,-0.0082731,0.29603,0.88448,HP_TRICUSPID_VALVE_PROLAPSE,0.99999
GOBP_POSITIVE_REGULATION_OF_...632,SET,7,-0.40828,-0.0079709,0.34085,0.8845,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CENTROSOME,0.99999
GSE10325_LUPUS_CD4_TCELL_VS_...3,SET,183,-0.079791,-0.0079267,0.066613,0.8845,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN,0.99999
BUSSLINGER_ESOPHAGEAL_EARLY_...,SET,74,-0.1157,-0.007331,0.096595,0.8845,BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS,0.99999
HP_HYPERGRANULOSIS,SET,20,-0.22412,-0.0073933,0.1871,0.88451,HP_HYPERGRANULOSIS,0.99999
GSE21670_UNTREATED_VS_IL6_TR...4,SET,167,-0.080566,-0.0076492,0.067251,0.88453,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.99999
GOMF_NITRIC_OXIDE_SYNTHASE_B...,SET,10,-0.32592,-0.0076046,0.27197,0.8846,GOMF_NITRIC_OXIDE_SYNTHASE_BINDING,0.99999
TGGTGCT_MIR29A_MIR29B_MIR29C,SET,470,-0.048357,-0.0076378,0.040352,0.88461,TGGTGCT_MIR29A_MIR29B_MIR29C,0.99999
BIOCARTA_LYM_PATHWAY,SET,13,-0.31079,-0.0082673,0.25926,0.88468,BIOCARTA_LYM_PATHWAY,0.99999
REACTOME_ACYL_CHAIN_REMODELL...2,SET,23,-0.23768,-0.0084076,0.19822,0.88474,REACTOME_ACYL_CHAIN_REMODELLING_OF_PE,0.99999
GSE19512_NAUTRAL_VS_INDUCED_...1,SET,173,-0.079354,-0.0076669,0.066177,0.88475,GSE19512_NAUTRAL_VS_INDUCED_TREG_DN,0.99999
GOMF_SULFATIDE_BINDING,SET,6,-0.38313,-0.0069254,0.31945,0.8848,GOMF_SULFATIDE_BINDING,0.99999
REACTOME_PENTOSE_PHOSPHATE_P...,SET,12,-0.32412,-0.0082841,0.27024,0.88481,REACTOME_PENTOSE_PHOSPHATE_PATHWAY,0.99999
HP_ABNORMAL_PELVIS_BONE_OSSI...,SET,15,-0.24718,-0.0070626,0.20601,0.8849,HP_ABNORMAL_PELVIS_BONE_OSSIFICATION,0.99999
HP_PROTEIN_LOSING_ENTEROPATHY,SET,20,-0.23019,-0.0075937,0.19184,0.8849,HP_PROTEIN_LOSING_ENTEROPATHY,0.99999
REACTOME_TLR3_MEDIATED_TICAM...,SET,6,-0.46793,-0.008458,0.38996,0.88491,REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH,0.99999
HP_PROMINENT_ANTIHELIX,SET,13,-0.2766,-0.0073579,0.23051,0.88491,HP_PROMINENT_ANTIHELIX,0.99999
REACTOME_CHK1_CHK2_CDS1_MEDI...,SET,13,-0.27436,-0.0072984,0.22862,0.88494,REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX,0.99999
HP_PANCREATIC_CALCIFICATION,SET,8,-0.41359,-0.0086319,0.34459,0.88496,HP_PANCREATIC_CALCIFICATION,0.99999
REACTOME_ANDROGEN_BIOSYNTHES...,SET,11,-0.32115,-0.0078588,0.26756,0.88497,REACTOME_ANDROGEN_BIOSYNTHESIS,0.99999
GOMF_CARBON_SULFUR_LYASE_ACT...,SET,10,-0.34867,-0.0081355,0.29049,0.88498,GOMF_CARBON_SULFUR_LYASE_ACTIVITY,0.99999
LEIN_NEURON_MARKERS,SET,57,-0.13936,-0.0077533,0.1161,0.88499,LEIN_NEURON_MARKERS,0.99999
DESCARTES_FETAL_EYE_STROMAL_...,SET,81,-0.12623,-0.0083664,0.10516,0.885,DESCARTES_FETAL_EYE_STROMAL_CELLS,0.99999
GOBP_POSITIVE_REGULATION_OF_...539,SET,127,-0.091098,-0.0075508,0.075876,0.88504,GOBP_POSITIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,0.99999
REACTOME_GPER1_SIGNALING,SET,45,-0.1585,-0.0078378,0.132,0.88506,REACTOME_GPER1_SIGNALING,0.99999
REACTOME_TNF_RECEPTOR_SUPERF...,SET,16,-0.27846,-0.0082172,0.23189,0.88509,REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,0.99999
MODULE_253,SET,20,-0.21575,-0.0071173,0.17964,0.88512,MODULE_253,0.99999
GOMF_ACETYLGLUCOSAMINYLTRANS...,SET,40,-0.18286,-0.0085265,0.15224,0.88515,GOMF_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY,0.99999
GSE15930_STIM_VS_STIM_AND_IF...5,SET,181,-0.073355,-0.0072478,0.061058,0.88519,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN,0.99999
chr2p22,SET,40,-0.32827,-0.015306,0.27319,0.88523,chr2p22,0.99999
HP_INTESTINAL_PSEUDO_OBSTRUC...,SET,18,-0.2146,-0.0067166,0.17857,0.88527,HP_INTESTINAL_PSEUDO_OBSTRUCTION,0.99999
GOBP_INCLUSION_BODY_ASSEMBLY,SET,22,-0.22666,-0.0078418,0.18857,0.88531,GOBP_INCLUSION_BODY_ASSEMBLY,0.99999
GOBP_AMINOPHOSPHOLIPID_TRANS...1,SET,6,-0.40804,-0.0073755,0.33942,0.88534,GOBP_AMINOPHOSPHOLIPID_TRANSLOCATION,0.99999
GOMF_AMINOPHOSPHOLIPID_FLIPP...,SET,6,-0.40804,-0.0073755,0.33942,0.88534,GOMF_AMINOPHOSPHOLIPID_FLIPPASE_ACTIVITY,0.99999
GSE39820_CTRL_VS_IL1B_IL6_CD...2,SET,171,-0.079135,-0.0076019,0.065828,0.88534,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP,0.99999
HP_ABNORMAL_CIRCULATING_FREE...3,SET,7,-0.33675,-0.0065746,0.2801,0.88536,HP_ABNORMAL_CIRCULATING_FREE_T4_CONCENTRATION,0.99999
GOBP_AXO_DENDRITIC_PROTEIN_T...,SET,9,-0.35023,-0.0077527,0.29128,0.88538,GOBP_AXO_DENDRITIC_PROTEIN_TRANSPORT,0.99999
GOMF_SEQUENCE_SPECIFIC_MRNA_...,SET,11,-0.25742,-0.0062994,0.21408,0.88539,GOMF_SEQUENCE_SPECIFIC_MRNA_BINDING,0.99999
HOFMANN_MYELODYSPLASTIC_SYND...6,SET,19,-0.23011,-0.0073991,0.19136,0.88541,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,0.99999
HP_BLURRED_VISION,SET,33,-0.18754,-0.0079441,0.15595,0.88542,HP_BLURRED_VISION,0.99999
HASLINGER_B_CLL_WITH_17P13_D...,SET,20,-0.21732,-0.007169,0.1807,0.88544,HASLINGER_B_CLL_WITH_17P13_DELETION,0.99999
GOBP_PURINE_DEOXYRIBONUCLEOT...1,SET,5,-0.44469,-0.0073379,0.36973,0.88545,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
GOMF_SULFUR_COMPOUND_BINDING,SET,245,-0.07028,-0.0080647,0.058432,0.88546,GOMF_SULFUR_COMPOUND_BINDING,0.99999
NABA_CORE_MATRISOME,SET,252,-0.07146,-0.0083148,0.059409,0.88547,NABA_CORE_MATRISOME,0.99999
GOBP_REGULATION_OF_EXTRACELL...3,SET,13,-0.29762,-0.0079172,0.24741,0.88549,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.99999
GSE34156_UNTREATED_VS_6H_TLR...2,SET,172,-0.081938,-0.0078939,0.068113,0.8855,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.99999
HP_NONSPHEROCYTIC_HEMOLYTIC_...,SET,7,-0.33621,-0.006564,0.27947,0.88551,HP_NONSPHEROCYTIC_HEMOLYTIC_ANEMIA,0.99999
REACTOME_ABC_TRANSPORTER_DIS...,SET,74,-0.11051,-0.007002,0.091847,0.88554,REACTOME_ABC_TRANSPORTER_DISORDERS,0.99999
GOCC_COPII_VESICLE_COAT,SET,16,-0.23951,-0.0070678,0.19906,0.88554,GOCC_COPII_VESICLE_COAT,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY,SET,653,-0.040647,-0.0075285,0.033767,0.88565,GOMF_OXIDOREDUCTASE_ACTIVITY,0.99999
GOBP_RESPONSE_TO_VITAMIN,SET,85,-0.12174,-0.0082645,0.10112,0.88567,GOBP_RESPONSE_TO_VITAMIN,0.99999
GOBP_AMINO_ACID_CATABOLIC_PR...,SET,94,-0.10638,-0.0075925,0.088361,0.88568,GOBP_AMINO_ACID_CATABOLIC_PROCESS,0.99999
KEGG_OTHER_GLYCAN_DEGRADATION,SET,15,-0.27965,-0.0079905,0.23224,0.88573,KEGG_OTHER_GLYCAN_DEGRADATION,0.99999
SENESE_HDAC2_TARGETS_UP,SET,106,-0.095869,-0.0072637,0.079609,0.88574,SENESE_HDAC2_TARGETS_UP,0.99999
GOBP_PHOSPHATIDYLSERINE_META...,SET,22,-0.21347,-0.0073855,0.17724,0.88577,GOBP_PHOSPHATIDYLSERINE_METABOLIC_PROCESS,0.99999
GNF2_TPT1,SET,34,-0.17821,-0.007662,0.14795,0.88579,GNF2_TPT1,0.99999
SHIPP_DLBCL_CURED_VS_FATAL_UP,SET,36,-0.1772,-0.0078391,0.14708,0.88585,SHIPP_DLBCL_CURED_VS_FATAL_UP,0.99999
GSE34156_NOD2_LIGAND_VS_NOD2...1,SET,158,-0.079365,-0.007331,0.065875,0.88585,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,0.99999
GSE14415_NATURAL_TREG_VS_TCO...1,SET,168,-0.07688,-0.0073208,0.063804,0.88588,GSE14415_NATURAL_TREG_VS_TCONV_DN,0.99999
HP_PUSTULE,SET,25,-0.21441,-0.0079067,0.17793,0.88589,HP_PUSTULE,0.99999
GSE34156_TLR1_TLR2_LIGAND_VS...3,SET,147,-0.083464,-0.0074387,0.069261,0.8859,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,0.99999
RAFFEL_VEGFA_TARGETS_UP,SET,9,-0.36936,-0.0081762,0.30648,0.88592,RAFFEL_VEGFA_TARGETS_UP,0.99999
GOBP_NEURON_APOPTOTIC_PROCESS,SET,262,-0.064757,-0.0076808,0.05373,0.88594,GOBP_NEURON_APOPTOTIC_PROCESS,0.99999
SEIDEN_ONCOGENESIS_BY_MET,SET,79,-0.11305,-0.0074004,0.093786,0.88598,SEIDEN_ONCOGENESIS_BY_MET,0.99999
WP_PENTOSE_PHOSPHATE_PATHWAY...,SET,7,-0.4167,-0.0081354,0.34567,0.88598,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,0.99999
GOBP_GASTRULATION,SET,177,-0.078981,-0.0077178,0.065519,0.88598,GOBP_GASTRULATION,0.99999
GIAROLA_SILVA_BLOOD_PANDEMRI...1,SET,5,-0.38268,-0.0063147,0.31743,0.886,GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_21_51YO_30DY_UP,0.99999
HP_OROPHARYNGEAL_SQUAMOUS_CE...,SET,6,-0.40684,-0.0073539,0.33743,0.88602,HP_OROPHARYNGEAL_SQUAMOUS_CELL_CARCINOMA,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...4,SET,404,-0.05499,-0.0080673,0.045607,0.88603,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,0.99999
RB_DN.V1_DN,SET,109,-0.10113,-0.0077691,0.083865,0.88605,RB_DN.V1_DN,0.99999
ZHENG_CORD_BLOOD_C4_PUTATIVE...,SET,86,-0.11691,-0.007983,0.096939,0.88609,ZHENG_CORD_BLOOD_C4_PUTATIVE_EARLY_ERYTHROID_COMMITMENT,0.99999
REACTOME_EXTRACELLULAR_MATRI...,SET,285,-0.066298,-0.0081962,0.054969,0.8861,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,0.99999
WP_PARKINUBIQUITIN_PROTEASOM...,SET,64,-0.12309,-0.0072551,0.10206,0.8861,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,0.99999
GSE37532_TREG_VS_TCONV_CD4_T...1,SET,173,-0.077534,-0.0074912,0.064285,0.8861,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN,0.99999
GOMF_PALMITOYLTRANSFERASE_AC...,SET,35,-0.16842,-0.0073469,0.13964,0.88611,GOMF_PALMITOYLTRANSFERASE_ACTIVITY,0.99999
E2F4DP1_01,SET,209,-0.071095,-0.0075425,0.058941,0.88612,E2F4DP1_01,0.99999
MAX_01,SET,240,-0.066338,-0.0075352,0.054998,0.88612,MAX_01,0.99999
BIOCARTA_IGF1MTOR_PATHWAY,SET,18,-0.26381,-0.0082565,0.21863,0.88621,BIOCARTA_IGF1MTOR_PATHWAY,0.99999
MIR6773_3P,SET,96,-0.1084,-0.0078185,0.089788,0.88634,MIR6773_3P,0.99999
MIR514B_5P,SET,167,-0.079692,-0.0075662,0.066002,0.88636,MIR514B_5P,0.99999
AHR_01,SET,54,-0.1345,-0.0072841,0.11136,0.88643,AHR_01,0.99999
GOBP_ANIMAL_ORGAN_MATURATION,SET,28,-0.20216,-0.007889,0.16736,0.88646,GOBP_ANIMAL_ORGAN_MATURATION,0.99999
HP_PUNCTATE_PALMOPLANTAR_HYP...,SET,6,-0.38365,-0.0069347,0.3176,0.88646,HP_PUNCTATE_PALMOPLANTAR_HYPERKERATOSIS,0.99999
WP_GANGLIO_SERIES_SPHINGOLIP...,SET,13,-0.29936,-0.0079633,0.2478,0.88648,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,0.99999
RASHI_RESPONSE_TO_IONIZING_R...6,SET,71,-0.11834,-0.0073455,0.097952,0.8865,RASHI_RESPONSE_TO_IONIZING_RADIATION_6,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...5,SET,170,-0.077584,-0.0074312,0.0642,0.88656,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN,0.99999
GTATTAT_MIR3693P,SET,192,-0.080203,-0.0081592,0.066361,0.88658,GTATTAT_MIR3693P,0.99999
WP_DISORDERS_IN_KETOLYSIS,SET,5,-0.42487,-0.0070108,0.35151,0.8866,WP_DISORDERS_IN_KETOLYSIS,0.99999
HP_ABNORMAL_CHEEK_MORPHOLOGY,SET,231,-0.067199,-0.0074904,0.055596,0.8866,HP_ABNORMAL_CHEEK_MORPHOLOGY,0.99999
HP_APLASIA_OF_METACARPAL_BON...,SET,12,-0.29177,-0.0074571,0.24138,0.88661,HP_APLASIA_OF_METACARPAL_BONES,0.99999
HP_HYPOHIDROSIS_OR_HYPERHIDR...,SET,210,-0.07208,-0.007665,0.059626,0.88664,HP_HYPOHIDROSIS_OR_HYPERHIDROSIS,0.99999
DAZARD_UV_RESPONSE_CLUSTER_G...1,SET,21,-0.24294,-0.008212,0.20095,0.88665,DAZARD_UV_RESPONSE_CLUSTER_G24,0.99999
GSE22589_SIV_VS_HIV_AND_SIV_...1,SET,181,-0.074726,-0.0073832,0.061793,0.88672,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN,0.99999
HP_ABSENCE_OF_SUBCUTANEOUS_F...,SET,13,-0.2606,-0.0069323,0.21549,0.88673,HP_ABSENCE_OF_SUBCUTANEOUS_FAT,0.99999
GOMF_RIBONUCLEOPROTEIN_COMPL...,SET,142,-0.082746,-0.0072492,0.068416,0.88675,GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING,0.99999
HP_AGANGLIONIC_MEGACOLON,SET,132,-0.08649,-0.0073076,0.07151,0.88675,HP_AGANGLIONIC_MEGACOLON,0.99999
NFE2L2.V2,SET,396,-0.05536,-0.0080426,0.045772,0.88675,NFE2L2.V2,0.99999
MIKKELSEN_MCV6_ICP_WITH_H3K2...,SET,74,-0.1307,-0.0082813,0.10806,0.88677,MIKKELSEN_MCV6_ICP_WITH_H3K27ME3,0.99999
WORSCHECH_TUMOR_REJECTION_DN,SET,8,-0.35302,-0.0073679,0.29186,0.88677,WORSCHECH_TUMOR_REJECTION_DN,0.99999
GSE19198_1H_VS_6H_IL21_TREAT...2,SET,145,-0.088945,-0.0078736,0.073529,0.88679,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_UP,0.99999
GSE26343_WT_VS_NFAT5_KO_MACR...4,SET,181,-0.073905,-0.0073021,0.061091,0.8868,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP,0.99999
GOBP_CALCIUM_DEPENDENT_CELL_...,SET,47,-0.17202,-0.0086928,0.14219,0.88681,GOBP_CALCIUM_DEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,0.99999
HP_INCREASED_FEMORAL_ANTEVER...,SET,4,-0.41656,-0.0061482,0.34428,0.88684,HP_INCREASED_FEMORAL_ANTEVERSION,0.99999
HP_ABNORMALITY_OF_THE_MUSCUL...5,SET,243,-0.066013,-0.0075444,0.054543,0.88691,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_LIMBS,0.99999
GOBP_PEPTIDYL_L_CYSTEINE_S_P...,SET,21,-0.22441,-0.0075856,0.1854,0.88693,GOBP_PEPTIDYL_L_CYSTEINE_S_PALMITOYLATION,0.99999
HP_WRITER_S_CRAMP,SET,18,-0.22819,-0.0071418,0.18853,0.88693,HP_WRITER_S_CRAMP,0.99999
REACTOME_VASOPRESSIN_REGULAT...,SET,42,-0.17466,-0.0083448,0.14429,0.88694,REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS,0.99999
PID_ERB_GENOMIC_PATHWAY,SET,14,-0.26084,-0.0072006,0.21547,0.88696,PID_ERB_GENOMIC_PATHWAY,0.99999
GSE17301_CTRL_VS_48H_IFNA2_S...2,SET,182,-0.076005,-0.0075301,0.062786,0.88696,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP,0.99999
WP_CILIARY_LANDSCAPE,SET,197,-0.070627,-0.0072769,0.058332,0.887,WP_CILIARY_LANDSCAPE,0.99999
WP_EFFECT_OF_INTESTINAL_MICR...,SET,8,-0.36807,-0.007682,0.304,0.887,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,0.99999
WP_MONOAMINE_GPCRS,SET,32,-0.20472,-0.0085398,0.16907,0.88702,WP_MONOAMINE_GPCRS,0.99999
HP_PINEAL_CYST,SET,8,-0.36039,-0.0075216,0.29756,0.88707,HP_PINEAL_CYST,0.99999
GOBP_LIPID_DROPLET_FUSION,SET,5,-0.54797,-0.0090422,0.45233,0.88713,GOBP_LIPID_DROPLET_FUSION,0.99999
GOCC_SPERM_HEAD,SET,17,-0.24101,-0.0073306,0.19893,0.88714,GOCC_SPERM_HEAD,0.99999
MATTHEWS_AP1_TARGETS,SET,16,-0.28329,-0.0083595,0.23379,0.88718,MATTHEWS_AP1_TARGETS,0.99999
chr16q11,SET,7,-0.81175,-0.015848,0.66981,0.88722,chr16q11,0.99999
GSE30971_WBP7_HET_VS_KO_MACR...2,SET,178,-0.078673,-0.0077092,0.06491,0.88724,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_UP,0.99999
HP_SYNOSTOSIS_INVOLVING_THE_...,SET,10,-0.35287,-0.0082335,0.2911,0.88728,HP_SYNOSTOSIS_INVOLVING_THE_ELBOW,0.99999
PID_HES_HEY_PATHWAY,SET,45,-0.1623,-0.0080256,0.13387,0.8873,PID_HES_HEY_PATHWAY,0.99999
GSE3337_4H_VS_16H_IFNG_IN_CD...1,SET,183,-0.077456,-0.0076947,0.06388,0.88734,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN,0.99999
MIR6842_5P,SET,143,-0.088423,-0.0077736,0.072911,0.88738,MIR6842_5P,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...34,SET,13,-0.26513,-0.0070528,0.21862,0.88738,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_WITH_A_FLAVIN_AS_ACCEPTOR,0.99999
GRYDER_PAX3FOXO1_TOP_ENHANCE...,SET,415,-0.054089,-0.00804,0.044589,0.88744,GRYDER_PAX3FOXO1_TOP_ENHANCERS,0.99999
WP_MAPK_CASCADE,SET,31,-0.18056,-0.0074134,0.14884,0.88744,WP_MAPK_CASCADE,0.99999
MIR103B,SET,36,-0.1689,-0.0074719,0.13919,0.8875,MIR103B,0.99999
HP_IMPAIRED_MASTICATION,SET,41,-0.17011,-0.0080299,0.14019,0.8875,HP_IMPAIRED_MASTICATION,0.99999
MIR3606_3P,SET,331,-0.057533,-0.0076554,0.047413,0.88751,MIR3606_3P,0.99999
GSE360_L_MAJOR_VS_M_TUBERCUL...4,SET,172,-0.080874,-0.0077914,0.066633,0.88756,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP,0.99999
GOBP_REGULATION_OF_LOCOMOTIO...,SET,5,-0.61585,-0.010162,0.50737,0.88758,GOBP_REGULATION_OF_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR,0.99999
GSE3982_CTRL_VS_LPS_1H_NEUTR...1,SET,174,-0.076717,-0.0074334,0.063203,0.88758,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...18,SET,185,-0.07654,-0.0076447,0.06305,0.88761,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...100,SET,14,-0.29515,-0.0081475,0.24306,0.88768,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.99999
MIR6889_5P,SET,11,-0.3316,-0.0081146,0.27305,0.8877,MIR6889_5P,0.99999
HP_LIMB_DYSMETRIA,SET,14,-0.27812,-0.0076775,0.22901,0.8877,HP_LIMB_DYSMETRIA,0.99999
HP_MACROCEPHALY,SET,375,-0.053207,-0.0075264,0.043809,0.88772,HP_MACROCEPHALY,0.99999
GSE16385_MONOCYTE_VS_MACROPH...1,SET,171,-0.080296,-0.0077135,0.066112,0.88772,GSE16385_MONOCYTE_VS_MACROPHAGE_DN,0.99999
MORF_CDC16,SET,63,-0.12623,-0.0073822,0.10393,0.88774,MORF_CDC16,0.99999
GSE15659_RESTING_VS_ACTIVATE...1,SET,167,-0.079792,-0.0075757,0.065692,0.88774,GSE15659_RESTING_VS_ACTIVATED_TREG_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...149,SET,11,-0.33763,-0.0082621,0.27794,0.88776,GOBP_NEGATIVE_REGULATION_OF_CIRCADIAN_RHYTHM,0.99999
YAMASHITA_LIVER_CANCER_WITH_...2,SET,49,-0.14096,-0.0072729,0.11604,0.88777,YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,0.99999
HP_PANCREATITIS,SET,71,-0.13396,-0.0083149,0.11027,0.88778,HP_PANCREATITIS,0.99999
GOBP_PEPTIDYL_METHIONINE_MOD...,SET,11,-0.29564,-0.0072345,0.24332,0.88781,GOBP_PEPTIDYL_METHIONINE_MODIFICATION,0.99999
GOBP_RESPONSE_TO_FOOD,SET,35,-0.18652,-0.0081366,0.1535,0.88784,GOBP_RESPONSE_TO_FOOD,0.99999
MIR8087,SET,125,-0.093965,-0.0077272,0.077325,0.88785,MIR8087,0.99999
REACTOME_EPH_EPHRIN_SIGNALING,SET,89,-0.11203,-0.0077813,0.092152,0.88794,REACTOME_EPH_EPHRIN_SIGNALING,0.99999
ZNF510_TARGET_GENES,SET,36,-0.16954,-0.0075005,0.13942,0.888,ZNF510_TARGET_GENES,0.99999
GOBP_L_KYNURENINE_METABOLIC_...,SET,5,-0.51623,-0.0085184,0.42447,0.88804,GOBP_L_KYNURENINE_METABOLIC_PROCESS,0.99999
BIOCARTA_IGF1R_PATHWAY,SET,23,-0.22506,-0.0079611,0.18503,0.88806,BIOCARTA_IGF1R_PATHWAY,0.99999
REACTOME_NRAGE_SIGNALS_DEATH...,SET,53,-0.14848,-0.0079665,0.12207,0.88806,REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,0.99999
GSE34156_UNTREATED_VS_24H_NO...2,SET,154,-0.08539,-0.007788,0.070191,0.8881,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.99999
HP_MACULAR_COLOBOMA,SET,10,-0.3392,-0.0079144,0.2788,0.88812,HP_MACULAR_COLOBOMA,0.99999
MIR6769B_5P,SET,71,-0.12427,-0.0077133,0.10213,0.88816,MIR6769B_5P,0.99999
HP_CERVICAL_SPINAL_CANAL_STE...,SET,9,-0.39454,-0.0087336,0.32422,0.88817,HP_CERVICAL_SPINAL_CANAL_STENOSIS,0.99999
GSE32164_RESTING_DIFFERENTIA...2,SET,186,-0.076054,-0.0076165,0.062498,0.88817,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...9,SET,71,-0.1378,-0.0085532,0.11324,0.88818,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MACROPHAGES,0.99999
RUAN_RESPONSE_TO_TNF_TROGLIT...1,SET,35,-0.18776,-0.0081905,0.15428,0.88819,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,0.99999
MIR4721,SET,63,-0.12334,-0.007213,0.10135,0.88819,MIR4721,0.99999
FIGUEROA_AML_METHYLATION_CLU...3,SET,8,-0.4007,-0.0083629,0.32924,0.8882,FIGUEROA_AML_METHYLATION_CLUSTER_2_DN,0.99999
GSE3982_MAST_CELL_VS_DC_DN,SET,179,-0.081267,-0.0079855,0.066774,0.8882,GSE3982_MAST_CELL_VS_DC_DN,0.99999
CHEOK_RESPONSE_TO_MERCAPTOPU...6,SET,11,-0.28699,-0.0070228,0.23579,0.88822,CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP,0.99999
WILCOX_RESPONSE_TO_PROGESTER...1,SET,57,-0.1448,-0.0080559,0.11896,0.88822,WILCOX_RESPONSE_TO_PROGESTERONE_DN,0.99999
SIG_PIP3_SIGNALING_IN_CARDIA...,SET,62,-0.14327,-0.0083118,0.11771,0.88822,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,0.99999
MIR7110_3P,SET,366,-0.056879,-0.0079508,0.046731,0.88822,MIR7110_3P,0.99999
GOBP_TENDON_DEVELOPMENT,SET,5,-0.54485,-0.0089906,0.44762,0.88823,GOBP_TENDON_DEVELOPMENT,0.99999
GOBP_CELLULAR_HYPOTONIC_RESP...,SET,11,-0.3341,-0.0081757,0.27446,0.88825,GOBP_CELLULAR_HYPOTONIC_RESPONSE,0.99999
HP_SHORT_MIDDLE_PHALANX_OF_T...2,SET,5,-0.52798,-0.0087122,0.43372,0.88825,HP_SHORT_MIDDLE_PHALANX_OF_TOE,0.99999
BIOCARTA_MSP_PATHWAY,SET,6,-0.41419,-0.0074867,0.34018,0.88829,BIOCARTA_MSP_PATHWAY,0.99999
GOBP_REGULATION_OF_PROTEIN_L...13,SET,137,-0.086719,-0.0074633,0.071214,0.88833,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.99999
GOBP_REGULATION_OF_SMOOTH_MU...2,SET,34,-0.1746,-0.007507,0.14338,0.88833,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.99999
GSE13485_DAY3_VS_DAY21_YF17D...1,SET,139,-0.09246,-0.0080149,0.075914,0.88837,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.99999
chr12q21,SET,59,-0.25054,-0.014181,0.20567,0.88842,chr12q21,0.99999
KANG_FLUOROURACIL_RESISTANCE...2,SET,19,-0.2183,-0.0070193,0.17918,0.88845,KANG_FLUOROURACIL_RESISTANCE_UP,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...17,SET,180,-0.074784,-0.0073687,0.061377,0.88846,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN,0.99999
BUSSLINGER_GASTRIC_ISTHMUS_C...,SET,428,-0.050829,-0.00767,0.041717,0.88846,BUSSLINGER_GASTRIC_ISTHMUS_CELLS,0.99999
MODULE_325,SET,53,-0.14698,-0.007886,0.12062,0.88848,MODULE_325,0.99999
GOBP_REGULATION_OF_CEREBELLA...,SET,9,-0.36477,-0.0080747,0.29936,0.88848,GOBP_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION,0.99999
KEGG_MEDICUS_VARIANT_SCRAPIE...3,SET,6,-0.45299,-0.008188,0.3717,0.88851,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_PERK_ATF4_SIGNALING_PATHWAY,0.99999
GSE30962_PRIMARY_VS_SECONDAR...3,SET,176,-0.082109,-0.008001,0.067357,0.88857,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN,0.99999
GSE3982_DC_VS_MAC_UP,SET,174,-0.076903,-0.0074514,0.063084,0.88858,GSE3982_DC_VS_MAC_UP,0.99999
GOBP_POLYOL_CATABOLIC_PROCESS,SET,8,-0.42663,-0.0089041,0.34995,0.88859,GOBP_POLYOL_CATABOLIC_PROCESS,0.99999
GOBP_AMP_BIOSYNTHETIC_PROCESS,SET,10,-0.31783,-0.0074158,0.26069,0.8886,GOBP_AMP_BIOSYNTHETIC_PROCESS,0.99999
HP_FACIAL_HYPOTONIA,SET,41,-0.15642,-0.0073841,0.12828,0.88864,HP_FACIAL_HYPOTONIA,0.99999
GOMF_SECONDARY_ACTIVE_MONOCA...,SET,17,-0.24762,-0.0075318,0.20305,0.88866,GOMF_SECONDARY_ACTIVE_MONOCARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE25087_TREG_VS_TCONV_FETUS...2,SET,175,-0.080248,-0.0077976,0.0658,0.88868,GSE25087_TREG_VS_TCONV_FETUS_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...546,SET,21,-0.24793,-0.0083806,0.20326,0.88871,GOBP_NEGATIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GSE10239_MEMORY_VS_KLRG1INT_...2,SET,179,-0.078437,-0.0077073,0.064306,0.88871,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...24,SET,43,-0.16489,-0.0079709,0.13517,0.88873,GAVISH_3CA_MALIGNANT_METAPROGRAM_32_SKIN_PIGMENTATION,0.99999
IWANAGA_CARCINOGENESIS_BY_KR...3,SET,169,-0.079938,-0.0076344,0.065517,0.88878,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,0.99999
GOCC_GOLGI_APPARATUS,SET,1465,-0.028511,-0.0077261,0.023368,0.88878,GOCC_GOLGI_APPARATUS,0.99999
HP_DECREASED_LYMPHOCYTE_APOP...,SET,6,-0.43272,-0.0078218,0.35466,0.88878,HP_DECREASED_LYMPHOCYTE_APOPTOSIS,0.99999
GOBP_HOST_MEDIATED_REGULATIO...,SET,9,-0.35043,-0.0077572,0.28711,0.88887,GOBP_HOST_MEDIATED_REGULATION_OF_INTESTINAL_MICROBIOTA_COMPOSITION,0.99999
GSE24814_STAT5_KO_VS_WT_PRE_...1,SET,183,-0.075079,-0.0074586,0.061502,0.8889,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN,0.99999
KANG_IMMORTALIZED_BY_TERT_DN,SET,95,-0.11383,-0.0081675,0.093244,0.88891,KANG_IMMORTALIZED_BY_TERT_DN,0.99999
REACTOME_UNFOLDED_PROTEIN_RE...,SET,87,-0.10421,-0.0071571,0.085358,0.88893,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,0.99999
GSE26030_UNSTIM_VS_RESTIM_TH...6,SET,183,-0.078942,-0.0078423,0.064655,0.88894,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_UP,0.99999
WP_METABOLIC_EPILEPTIC_DISOR...,SET,80,-0.11104,-0.0073138,0.090935,0.88896,WP_METABOLIC_EPILEPTIC_DISORDERS,0.99999
REACTOME_ADENYLATE_CYCLASE_I...,SET,14,-0.29213,-0.0080643,0.2392,0.889,REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY,0.99999
GOMF_HISTONE_H3K36_TRIMETHYL...,SET,4,-0.45596,-0.0067297,0.37324,0.88907,GOMF_HISTONE_H3K36_TRIMETHYLTRANSFERASE_ACTIVITY,0.99999
HP_CEREBELLAR_CYST,SET,138,-0.086141,-0.0074405,0.070504,0.8891,HP_CEREBELLAR_CYST,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...2,SET,49,-0.17197,-0.0088729,0.14072,0.88916,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_10,0.99999
HP_ABNORMAL_URINARY_ORGANIC_...,SET,57,-0.14101,-0.0078448,0.11536,0.88919,HP_ABNORMAL_URINARY_ORGANIC_COMPOUND_LEVEL,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_LAT...4,SET,28,-0.22222,-0.0086721,0.18181,0.88919,HE_LIM_SUN_FETAL_LUNG_C1_LATE_TIP_CELL,0.99999
REACTOME_INSULIN_RECEPTOR_RE...,SET,28,-0.20763,-0.0081026,0.16985,0.88922,REACTOME_INSULIN_RECEPTOR_RECYCLING,0.99999
GOBP_IRON_ION_TRANSMEMBRANE_...,SET,18,-0.23847,-0.0074636,0.19508,0.88922,GOBP_IRON_ION_TRANSMEMBRANE_TRANSPORT,0.99999
GOBP_ADENYLATE_CYCLASE_INHIB...3,SET,9,-0.37035,-0.0081981,0.30274,0.88939,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOMF_G_PROTEIN_COUPLED_GLUTA...1,SET,9,-0.37035,-0.0081981,0.30274,0.88939,GOMF_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_ACTIVITY,0.99999
MIR29B_3P_MIR29C_3P,SET,396,-0.055503,-0.0080634,0.045369,0.8894,MIR29B_3P_MIR29C_3P,0.99999
HP_MEDIASTINAL_LYMPHADENOPAT...,SET,23,-0.23439,-0.008291,0.19156,0.88943,HP_MEDIASTINAL_LYMPHADENOPATHY,0.99999
GOCC_U2_TYPE_CATALYTIC_STEP_...,SET,30,-0.16643,-0.0067223,0.13599,0.88948,GOCC_U2_TYPE_CATALYTIC_STEP_2_SPLICEOSOME,0.99999
REACTOME_RESPONSE_TO_ELEVATE...,SET,120,-0.098266,-0.0079187,0.080289,0.8895,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,0.99999
GSE10500_ARTHRITIC_SYNOVIAL_...1,SET,125,-0.094083,-0.0077369,0.076869,0.8895,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN,0.99999
GSE17721_LPS_VS_POLYIC_16H_B...2,SET,176,-0.074392,-0.007249,0.06078,0.88951,GSE17721_LPS_VS_POLYIC_16H_BMDC_UP,0.99999
HP_PROGRESSIVE_MACROCEPHALY,SET,7,-0.39499,-0.0077115,0.32264,0.88956,HP_PROGRESSIVE_MACROCEPHALY,0.99999
HP_ABNORMAL_MUSCLE_GLYCOGEN_...,SET,10,-0.29526,-0.0068892,0.24115,0.88959,HP_ABNORMAL_MUSCLE_GLYCOGEN_CONTENT,0.99999
MORF_SP3,SET,75,-0.11401,-0.0072724,0.093104,0.88962,MORF_SP3,0.99999
MIR6797_3P,SET,58,-0.14271,-0.0080089,0.11652,0.88966,MIR6797_3P,0.99999
ZNF491_TARGET_GENES,SET,6,-0.41434,-0.0074894,0.33823,0.8897,ZNF491_TARGET_GENES,0.99999
GNF2_ST13,SET,57,-0.12914,-0.0071849,0.10542,0.88971,GNF2_ST13,0.99999
HP_MORTALITY_AGING,SET,399,-0.051693,-0.0075376,0.042185,0.88978,HP_MORTALITY_AGING,0.99999
REACTOME_GLYOXYLATE_METABOLI...,SET,19,-0.22602,-0.0072674,0.18441,0.88982,REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION,0.99999
GOBP_REGULATION_OF_SKELETAL_...11,SET,6,-0.46302,-0.0083694,0.37778,0.88982,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_GROWTH,0.99999
IWANAGA_CARCINOGENESIS_BY_KR...4,SET,158,-0.085081,-0.007859,0.069414,0.88984,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,0.99999
GOBP_REGULATION_OF_MITOTIC_C...2,SET,311,-0.058687,-0.0075735,0.047864,0.88991,GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,0.99999
GOMF_SULFOTRANSFERASE_ACTIVI...,SET,49,-0.16234,-0.0083757,0.13239,0.88993,GOMF_SULFOTRANSFERASE_ACTIVITY,0.99999
HP_EXTRAPYRAMIDAL_MUSCULAR_R...,SET,13,-0.29537,-0.0078571,0.24082,0.88999,HP_EXTRAPYRAMIDAL_MUSCULAR_RIGIDITY,0.99999
chr13q34,SET,34,-0.30336,-0.013043,0.2473,0.89002,chr13q34,0.99999
REACTOME_UNWINDING_OF_DNA,SET,12,-0.28842,-0.0073715,0.23511,0.89003,REACTOME_UNWINDING_OF_DNA,0.99999
HP_DECREASED_CD4_CD8_RATIO,SET,8,-0.36327,-0.0075817,0.29607,0.89008,HP_DECREASED_CD4_CD8_RATIO,0.99999
HP_EYE_POKING,SET,5,-0.45149,-0.0074501,0.36782,0.89017,HP_EYE_POKING,0.99999
HP_SEVERE_CYTOMEGALOVIRUS_IN...,SET,10,-0.33364,-0.0077849,0.27178,0.8902,HP_SEVERE_CYTOMEGALOVIRUS_INFECTION,0.99999
WILLERT_WNT_SIGNALING,SET,21,-0.23762,-0.0080323,0.19355,0.89022,WILLERT_WNT_SIGNALING,0.99999
WP_INTEGRATED_CANCER_PATHWAY,SET,43,-0.15186,-0.0073409,0.12369,0.89022,WP_INTEGRATED_CANCER_PATHWAY,0.99999
GOBP_NUCLEOBASE_CONTAINING_S...4,SET,582,-0.043392,-0.0076026,0.035333,0.89029,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...5,SET,186,-0.080335,-0.0080452,0.065405,0.89032,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN,0.99999
GOMF_TUMOR_NECROSIS_FACTOR_R...2,SET,28,-0.21194,-0.0082708,0.17255,0.89033,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_BINDING,0.99999
HP_RESTRICTIVE_CARDIOMYOPATHY,SET,22,-0.23743,-0.0082142,0.19322,0.89042,HP_RESTRICTIVE_CARDIOMYOPATHY,0.99999
REACTOME_SEMA4D_INDUCED_CELL...,SET,20,-0.23394,-0.0077175,0.19038,0.89043,REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,0.99999
GOBP_POST_EMBRYONIC_ANIMAL_M...,SET,4,-0.48429,-0.0071479,0.39404,0.89046,GOBP_POST_EMBRYONIC_ANIMAL_MORPHOGENESIS,0.99999
MIR12117,SET,84,-0.11135,-0.0075147,0.090594,0.89047,MIR12117,0.99999
GOBP_MITOTIC_G1_S_TRANSITION...,SET,30,-0.18195,-0.0073494,0.14804,0.89047,GOBP_MITOTIC_G1_S_TRANSITION_CHECKPOINT_SIGNALING,0.99999
GOBP_VITAMIN_BIOSYNTHETIC_PR...,SET,24,-0.22103,-0.0079866,0.17983,0.89048,GOBP_VITAMIN_BIOSYNTHETIC_PROCESS,0.99999
GOBP_CENTRIOLE_CENTRIOLE_COH...,SET,14,-0.27921,-0.0077076,0.22714,0.8905,GOBP_CENTRIOLE_CENTRIOLE_COHESION,0.99999
HP_IMPAIRED_OROPHARYNGEAL_SW...,SET,12,-0.30978,-0.0079176,0.25199,0.89052,HP_IMPAIRED_OROPHARYNGEAL_SWALLOW_RESPONSE,0.99999
GSE22886_IGA_VS_IGM_MEMORY_B...1,SET,186,-0.077266,-0.0077378,0.062851,0.89052,GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN,0.99999
HP_ULNAR_BOWING,SET,16,-0.2865,-0.0084543,0.23303,0.89054,HP_ULNAR_BOWING,0.99999
GSE9037_WT_VS_IRAK4_KO_LPS_4...2,SET,183,-0.077136,-0.0076629,0.062737,0.89055,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...246,SET,4,-0.42457,-0.0062664,0.34527,0.89058,GOBP_NEGATIVE_REGULATION_OF_G0_TO_G1_TRANSITION,0.99999
HP_COARSE_HAIR,SET,48,-0.14206,-0.0072547,0.11552,0.89059,HP_COARSE_HAIR,0.99999
GNF2_HMMR,SET,47,-0.14633,-0.0073948,0.11899,0.8906,GNF2_HMMR,0.99999
GOBP_LIPOPROTEIN_BIOSYNTHETI...,SET,90,-0.10667,-0.0074503,0.086739,0.8906,GOBP_LIPOPROTEIN_BIOSYNTHETIC_PROCESS,0.99999
GSE21927_EL4_VS_MCA203_TUMOR...1,SET,153,-0.083927,-0.0076298,0.068247,0.8906,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_DN,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...8,SET,181,-0.082153,-0.008117,0.066793,0.89064,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...12,SET,14,-0.26407,-0.0072895,0.21467,0.89066,GOBP_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOCC_ARYL_HYDROCARBON_RECEPT...,SET,6,-0.37681,-0.0068111,0.30628,0.8907,GOCC_ARYL_HYDROCARBON_RECEPTOR_COMPLEX,0.99999
GOCC_ENDOPLASMIC_RETICULUM_P...2,SET,9,-0.33316,-0.0073749,0.27079,0.89071,GOCC_ENDOPLASMIC_RETICULUM_PLASMA_MEMBRANE_CONTACT_SITE,0.99999
HP_BROAD_DISTAL_PHALANX_OF_T...,SET,5,-0.5269,-0.0086944,0.42818,0.89075,HP_BROAD_DISTAL_PHALANX_OF_THE_TOES,0.99999
GSE8515_IL1_VS_IL6_4H_STIM_M...2,SET,176,-0.080122,-0.0078074,0.065104,0.89077,GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP,0.99999
GSE24634_TREG_VS_TCONV_POST_...7,SET,186,-0.07947,-0.0079586,0.064569,0.89079,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN,0.99999
GSE3982_MAST_CELL_VS_BCELL_DN,SET,161,-0.08222,-0.0076659,0.066804,0.89079,GSE3982_MAST_CELL_VS_BCELL_DN,0.99999
ATF5_TARGET_GENES,SET,349,-0.055859,-0.0076283,0.045384,0.8908,ATF5_TARGET_GENES,0.99999
MIR6825_5P,SET,379,-0.056049,-0.0079698,0.045533,0.89082,MIR6825_5P,0.99999
DESCARTES_MAIN_FETAL_THYMOCY...,SET,70,-0.13311,-0.0082038,0.10813,0.89083,DESCARTES_MAIN_FETAL_THYMOCYTES,0.99999
MIR3692_3P,SET,261,-0.067238,-0.00796,0.054609,0.89088,MIR3692_3P,0.99999
WP_HISTONE_MODIFICATIONS,SET,35,-0.1659,-0.007237,0.13468,0.89098,WP_HISTONE_MODIFICATIONS,0.99999
HOLLEMAN_DAUNORUBICIN_ALL_DN,SET,8,-0.35725,-0.0074561,0.28999,0.89101,HOLLEMAN_DAUNORUBICIN_ALL_DN,0.99999
MIR3960_MIR8072,SET,17,-0.48958,-0.014891,0.39739,0.89101,MIR3960_MIR8072,0.99999
GOBP_RETROGRADE_NEURONAL_DEN...,SET,4,-0.54006,-0.007971,0.43836,0.89102,GOBP_RETROGRADE_NEURONAL_DENSE_CORE_VESICLE_TRANSPORT,0.99999
GOBP_PROTEIN_O_LINKED_GLYCOS...2,SET,8,-0.36711,-0.0076619,0.29795,0.89104,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION_VIA_SERINE,0.99999
GOBP_AMINOGLYCAN_METABOLIC_P...,SET,116,-0.099851,-0.0079121,0.081024,0.89108,GOBP_AMINOGLYCAN_METABOLIC_PROCESS,0.99999
HP_HAND_CLENCHING,SET,27,-0.19142,-0.0073357,0.15533,0.89108,HP_HAND_CLENCHING,0.99999
HP_SYRINGOMYELIA,SET,30,-0.18332,-0.0074047,0.14876,0.89108,HP_SYRINGOMYELIA,0.99999
MULLIGHAN_MLL_SIGNATURE_2_DN,SET,255,-0.069094,-0.0080866,0.056046,0.89117,MULLIGHAN_MLL_SIGNATURE_2_DN,0.99999
GOBP_CELL_PROLIFERATION_IN_H...,SET,13,-0.29417,-0.0078254,0.23858,0.8912,GOBP_CELL_PROLIFERATION_IN_HINDBRAIN,0.99999
GOBP_POSITIVE_REGULATION_OF_...14,SET,28,-0.22477,-0.0087716,0.18229,0.89121,GOBP_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,0.99999
GOBP_AMINO_ACID_IMPORT_ACROS...,SET,45,-0.16577,-0.0081972,0.13439,0.89129,GOBP_AMINO_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...11,SET,182,-0.0749,-0.0074207,0.060724,0.89129,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_DN,0.99999
KEGG_MEDICUS_REFERENCE_P27_C...,SET,14,-0.25676,-0.0070878,0.20813,0.89132,KEGG_MEDICUS_REFERENCE_P27_CELL_CYCLE_G1_S,0.99999
MIR4528,SET,203,-0.078331,-0.0081914,0.063493,0.89133,MIR4528,0.99999
WP_OMEGA9_FATTY_ACID_SYNTHES...,SET,13,-0.33493,-0.0089096,0.27142,0.89139,WP_OMEGA9_FATTY_ACID_SYNTHESIS,0.99999
GOBP_REGULATION_OF_PLASMINOG...,SET,17,-0.26424,-0.0080373,0.21412,0.89141,GOBP_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.99999
GSE19198_1H_VS_6H_IL21_TREAT...1,SET,186,-0.078673,-0.0078787,0.063749,0.89141,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN,0.99999
GSE7852_LN_VS_THYMUS_TCONV_UP,SET,177,-0.081667,-0.0079803,0.06617,0.89143,GSE7852_LN_VS_THYMUS_TCONV_UP,0.99999
GOMF_MICROFILAMENT_MOTOR_ACT...,SET,37,-0.18735,-0.0084024,0.15176,0.89148,GOMF_MICROFILAMENT_MOTOR_ACTIVITY,0.99999
MIR6827_5P,SET,75,-0.11485,-0.0073257,0.092995,0.89157,MIR6827_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...326,SET,50,-0.16033,-0.0083561,0.12982,0.89158,GOBP_NEGATIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_PATHOLOGIC_FRACTURE,SET,57,-0.13916,-0.007742,0.11267,0.89159,HP_PATHOLOGIC_FRACTURE,0.99999
GSE14769_UNSTIM_VS_360MIN_LP...1,SET,192,-0.074321,-0.0075607,0.060174,0.89159,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN,0.99999
MIR5008_5P,SET,78,-0.11315,-0.0073598,0.091598,0.89163,MIR5008_5P,0.99999
GSE21546_WT_VS_ELK1_KO_DP_TH...1,SET,179,-0.076864,-0.0075528,0.06222,0.89164,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_DN,0.99999
WP_IL6_SIGNALING,SET,42,-0.17336,-0.0082826,0.14033,0.89165,WP_IL6_SIGNALING,0.99999
HP_ABNORMAL_CORONARY_ARTERY_...2,SET,6,-0.4351,-0.0078647,0.35217,0.89167,HP_ABNORMAL_CORONARY_ARTERY_ORIGIN,0.99999
GOBP_CHEMOSENSORY_BEHAVIOR,SET,19,-0.25488,-0.0081954,0.20628,0.89169,GOBP_CHEMOSENSORY_BEHAVIOR,0.99999
GOBP_POSITIVE_REGULATION_OF_...553,SET,61,-0.12982,-0.0074708,0.10506,0.89169,GOBP_POSITIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,0.99999
REACTOME_G2_M_CHECKPOINTS,SET,125,-0.085038,-0.0069931,0.068805,0.89175,REACTOME_G2_M_CHECKPOINTS,0.99999
PID_IL23_PATHWAY,SET,37,-0.19536,-0.0087618,0.15805,0.89178,PID_IL23_PATHWAY,0.99999
GSE40068_CXCR5POS_BCL6POS_TF...2,SET,177,-0.076522,-0.0074775,0.061903,0.89179,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP,0.99999
DESCARTES_FETAL_PANCREAS_LYM...1,SET,41,-0.17966,-0.0084809,0.14534,0.89179,DESCARTES_FETAL_PANCREAS_LYMPHATIC_ENDOTHELIAL_CELLS,0.99999
HP_FAIR_HAIR,SET,17,-0.25889,-0.0078745,0.20942,0.8918,HP_FAIR_HAIR,0.99999
GSE7768_OVA_WITH_LPS_VS_OVA_...2,SET,156,-0.081925,-0.00752,0.066267,0.89182,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...26,SET,23,-0.24077,-0.0085167,0.19469,0.89188,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.99999
HP_CONGENITAL_ADRENAL_HYPERP...,SET,5,-0.49455,-0.0081606,0.39992,0.89188,HP_CONGENITAL_ADRENAL_HYPERPLASIA,0.99999
GOBP_RESPONSE_TO_IONIZING_RA...,SET,129,-0.087119,-0.0072772,0.070446,0.89189,GOBP_RESPONSE_TO_IONIZING_RADIATION,0.99999
KEGG_MEDICUS_REFERENCE_NUCLE...3,SET,5,-0.54121,-0.0089306,0.43759,0.89191,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_PROGESTERONE_SIGNALING_PATHWAY,0.99999
HP_SPINAL_RIGIDITY,SET,54,-0.14317,-0.0077535,0.11576,0.89191,HP_SPINAL_RIGIDITY,0.99999
MORF_ERCC4,SET,286,-0.064026,-0.007929,0.051767,0.89192,MORF_ERCC4,0.99999
GSE34217_MIR17_92_OVEREXPRES...2,SET,122,-0.096843,-0.0078685,0.078293,0.89194,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_UP,0.99999
GOBP_GLUCOCORTICOID_SECRETION,SET,11,-0.31519,-0.0077131,0.2548,0.89195,GOBP_GLUCOCORTICOID_SECRETION,0.99999
GSE9316_IL6_KO_VS_IFNG_KO_IN...1,SET,188,-0.07883,-0.0079363,0.063726,0.89195,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN,0.99999
GOBP_PYRIMIDINE_RIBONUCLEOTI...3,SET,29,-0.19641,-0.0078004,0.15877,0.89196,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_METABOLIC_PROCESS,0.99999
DESCARTES_FETAL_STOMACH_MESO...,SET,29,-0.2172,-0.008626,0.17557,0.89197,DESCARTES_FETAL_STOMACH_MESOTHELIAL_CELLS,0.99999
REACTOME_DISEASES_OF_METABOL...,SET,227,-0.071424,-0.007893,0.057731,0.89198,REACTOME_DISEASES_OF_METABOLISM,0.99999
REACTOME_NEPHRIN_FAMILY_INTE...,SET,21,-0.22978,-0.007767,0.18572,0.89199,REACTOME_NEPHRIN_FAMILY_INTERACTIONS,0.99999
GOMF_SODIUM_BICARBONATE_SYMP...,SET,6,-0.38868,-0.0070256,0.31412,0.89201,GOMF_SODIUM_BICARBONATE_SYMPORTER_ACTIVITY,0.99999
HP_ABNORMAL_LIMB_EPIPHYSIS_M...,SET,120,-0.098756,-0.0079583,0.079804,0.89204,HP_ABNORMAL_LIMB_EPIPHYSIS_MORPHOLOGY,0.99999
GSE3691_CONVENTIONAL_VS_PLAS...2,SET,188,-0.077458,-0.0077983,0.06259,0.89205,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP,0.99999
FOSTER_KDM1A_TARGETS_UP,SET,225,-0.075927,-0.0083541,0.06134,0.8921,FOSTER_KDM1A_TARGETS_UP,0.99999
DESCARTES_MAIN_FETAL_CCL19_C...,SET,157,-0.085187,-0.0078441,0.068815,0.89212,DESCARTES_MAIN_FETAL_CCL19_CCL21_POSITIVE_CELLS,0.99999
SOBOLEV_PBMC_PANDEMRIX_AGE_1...7,SET,4,-0.47642,-0.0070317,0.3848,0.89215,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN,0.99999
DESCARTES_FETAL_INTESTINE_LY...1,SET,26,-0.22565,-0.0084861,0.18221,0.89221,DESCARTES_FETAL_INTESTINE_LYMPHATIC_ENDOTHELIAL_CELLS,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...3,SET,6,-0.47609,-0.0086056,0.38434,0.89227,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN,0.99999
GOCC_CANONICAL_INFLAMMASOME_...,SET,16,-0.29929,-0.0088319,0.24162,0.89227,GOCC_CANONICAL_INFLAMMASOME_COMPLEX,0.99999
DANG_REGULATED_BY_MYC_DN,SET,225,-0.071281,-0.0078428,0.057525,0.89234,DANG_REGULATED_BY_MYC_DN,0.99999
GOBP_DE_NOVO_NAD_BIOSYNTHETI...,SET,8,-0.4104,-0.0085654,0.33117,0.89236,GOBP_DE_NOVO_NAD_BIOSYNTHETIC_PROCESS,0.99999
GOBP_CELLULAR_RESPONSE_TO_IN...1,SET,10,-0.33804,-0.0078875,0.27276,0.89238,GOBP_CELLULAR_RESPONSE_TO_INCREASED_OXYGEN_LEVELS,0.99999
HP_ABNORMAL_PSYCHOTIC_PATTERN,SET,171,-0.084276,-0.0080958,0.067981,0.89245,HP_ABNORMAL_PSYCHOTIC_PATTERN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...697,SET,11,-0.36172,-0.0088516,0.29171,0.8925,GOBP_NEGATIVE_REGULATION_OF_VASOCONSTRICTION,0.99999
GOMF_DEOXYNUCLEOSIDE_KINASE_...,SET,5,-0.45716,-0.0075436,0.36868,0.8925,GOMF_DEOXYNUCLEOSIDE_KINASE_ACTIVITY,0.99999
GOBP_COLLAGEN_ACTIVATED_TYRO...,SET,9,-0.36476,-0.0080745,0.29414,0.89252,GOBP_COLLAGEN_ACTIVATED_TYROSINE_KINASE_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_DEGENERATION_OF_THE_STRIA...,SET,11,-0.29568,-0.0072355,0.23842,0.89253,HP_DEGENERATION_OF_THE_STRIATUM,0.99999
MIR2467_5P,SET,102,-0.10238,-0.0076103,0.082553,0.89254,MIR2467_5P,0.99999
CSR_LATE_UP.V1_UP,SET,154,-0.084752,-0.0077298,0.068327,0.89258,CSR_LATE_UP.V1_UP,0.99999
KESHELAVA_MULTIPLE_DRUG_RESI...,SET,66,-0.12513,-0.0074892,0.10086,0.89261,KESHELAVA_MULTIPLE_DRUG_RESISTANCE,0.99999
REACTOME_COBALAMIN_CBL_METAB...,SET,6,-0.39965,-0.0072239,0.32214,0.89262,REACTOME_COBALAMIN_CBL_METABOLISM,0.99999
GSE9650_EXHAUSTED_VS_MEMORY_...2,SET,182,-0.080366,-0.0079621,0.064774,0.89263,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP,0.99999
GSE9960_HEALTHY_VS_GRAM_NEG_...1,SET,163,-0.080696,-0.00757,0.06504,0.89263,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,0.99999
GOBP_SULFATION,SET,20,-0.2687,-0.0088642,0.21657,0.89264,GOBP_SULFATION,0.99999
HOOI_ST7_TARGETS_UP,SET,84,-0.11762,-0.0079378,0.094786,0.89266,HOOI_ST7_TARGETS_UP,0.99999
KOBAYASHI_RESPONSE_TO_ROMIDE...,SET,19,-0.26835,-0.0086285,0.21625,0.89267,KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,0.99999
LI_ESTROGENE_LATE_E2_RESPONS...2,SET,52,-0.15837,-0.0084169,0.1276,0.89272,LI_ESTROGENE_LATE_E2_RESPONSE_UP,0.99999
REACTOME_INFLAMMASOMES,SET,19,-0.23523,-0.0075638,0.18951,0.89274,REACTOME_INFLAMMASOMES,0.99999
SMAD_Q6,SET,232,-0.072845,-0.0081371,0.058683,0.89275,SMAD_Q6,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...53,SET,5,-0.45209,-0.0074599,0.36417,0.89277,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_PERK_ATF4_SIGNALING_PATHWAY,0.99999
GOBP_ESTABLISHMENT_OF_MITOTI...2,SET,40,-0.17345,-0.0080875,0.1397,0.8928,GOBP_ESTABLISHMENT_OF_MITOTIC_SPINDLE_LOCALIZATION,0.99999
GOBP_PYRIMIDINE_NUCLEOTIDE_M...,SET,49,-0.14924,-0.0077001,0.12018,0.89285,GOBP_PYRIMIDINE_NUCLEOTIDE_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_CYCLASE_A...,SET,51,-0.16122,-0.0084857,0.12982,0.89286,GOBP_REGULATION_OF_CYCLASE_ACTIVITY,0.99999
VERRECCHIA_DELAYED_RESPONSE_...,SET,36,-0.18544,-0.0082039,0.14929,0.8929,VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,0.99999
GOBP_INSULIN_PROCESSING,SET,7,-0.42019,-0.0082035,0.33825,0.89292,GOBP_INSULIN_PROCESSING,0.99999
ANDERSEN_LIVER_CANCER_KRT19_...1,SET,70,-0.13185,-0.0081264,0.10613,0.89295,ANDERSEN_LIVER_CANCER_KRT19_DN,0.99999
GOBP_DEVELOPMENTAL_GROWTH,SET,586,-0.04648,-0.0081706,0.037406,0.89298,GOBP_DEVELOPMENTAL_GROWTH,0.99999
GOCC_COMPACT_MYELIN,SET,13,-0.32785,-0.0087212,0.26376,0.89305,GOCC_COMPACT_MYELIN,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_GHR...2,SET,376,-0.057232,-0.0081064,0.046045,0.89305,HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL,0.99999
HEBERT_MATRISOME_TNBC_BONE_M...2,SET,4,-0.58974,-0.0087043,0.47441,0.89308,HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED,0.99999
GOBP_NUCLEOTIDE_SUGAR_BIOSYN...,SET,16,-0.2557,-0.0075456,0.20567,0.8931,GOBP_NUCLEOTIDE_SUGAR_BIOSYNTHETIC_PROCESS,0.99999
GSE27291_6H_VS_7D_STIM_GAMMA...2,SET,176,-0.075149,-0.0073228,0.060406,0.89325,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_UP,0.99999
MODULE_372,SET,20,-0.24792,-0.0081786,0.19928,0.89326,MODULE_372,0.99999
GOBP_T_CELL_HOMEOSTASIS,SET,44,-0.1628,-0.0079607,0.13085,0.89328,GOBP_T_CELL_HOMEOSTASIS,0.99999
GOCC_SITE_OF_POLARIZED_GROWTH,SET,153,-0.085741,-0.0077948,0.068909,0.89329,GOCC_SITE_OF_POLARIZED_GROWTH,0.99999
GOBP_INTRACELLULAR_LIPID_TRA...,SET,44,-0.15613,-0.0076345,0.12546,0.89332,GOBP_INTRACELLULAR_LIPID_TRANSPORT,0.99999
MIR6890_5P,SET,18,-0.256,-0.0080122,0.20571,0.89333,MIR6890_5P,0.99999
HP_CERVICAL_RIBS,SET,10,-0.32614,-0.0076098,0.26207,0.89333,HP_CERVICAL_RIBS,0.99999
MODULE_70,SET,39,-0.17024,-0.0078383,0.13679,0.89334,MODULE_70,0.99999
REACTOME_IRE1ALPHA_ACTIVATES...,SET,47,-0.14465,-0.0073098,0.11619,0.89341,REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,0.99999
GOBP_GLYCOPROTEIN_CATABOLIC_...,SET,31,-0.21182,-0.0086969,0.17015,0.89341,GOBP_GLYCOPROTEIN_CATABOLIC_PROCESS,0.99999
GSE557_WT_VS_I_AB_KO_DC_DN,SET,181,-0.077318,-0.0076393,0.062103,0.89343,GSE557_WT_VS_I_AB_KO_DC_DN,0.99999
HP_ABNORMAL_LUMBAR_SPINE_MOR...,SET,26,-0.21798,-0.0081976,0.17507,0.89345,HP_ABNORMAL_LUMBAR_SPINE_MORPHOLOGY,0.99999
HP_ABNORMALITY_OF_THE_NAIL,SET,449,-0.051243,-0.0079153,0.041151,0.89347,HP_ABNORMALITY_OF_THE_NAIL,0.99999
GOBP_PROTEIN_TRIMERIZATION,SET,17,-0.25884,-0.0078729,0.20784,0.89349,GOBP_PROTEIN_TRIMERIZATION,0.99999
GSE32986_CURDLAN_LOWDOSE_VS_...2,SET,174,-0.079592,-0.0077119,0.063908,0.8935,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,0.99999
MIR3682_5P,SET,88,-0.11204,-0.0077382,0.089931,0.89357,MIR3682_5P,0.99999
NIKOLSKY_BREAST_CANCER_7Q21_...,SET,72,-0.232,-0.014501,0.18617,0.89364,NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON,0.99999
DAZARD_UV_RESPONSE_CLUSTER_G4,SET,17,-0.26591,-0.0080881,0.21336,0.89366,DAZARD_UV_RESPONSE_CLUSTER_G4,0.99999
HP_NEOPLASM_OF_THE_NERVOUS_S...,SET,184,-0.075939,-0.0075643,0.06093,0.89367,HP_NEOPLASM_OF_THE_NERVOUS_SYSTEM,0.99999
HP_THIN_EYEBROW,SET,22,-0.22504,-0.0077856,0.18056,0.89367,HP_THIN_EYEBROW,0.99999
TAKEDA_TARGETS_OF_NUP98_HOXA...1,SET,130,-0.10172,-0.0085297,0.081606,0.8937,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,0.99999
GOBP_MITOCHONDRIAL_GENE_EXPR...,SET,154,-0.07851,-0.0071605,0.062958,0.8938,GOBP_MITOCHONDRIAL_GENE_EXPRESSION,0.99999
GSE3565_CTRL_VS_LPS_INJECTED...3,SET,155,-0.086668,-0.00793,0.069494,0.89382,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_DN,0.99999
KEGG_MEDICUS_REFERENCE_WNT_S...2,SET,13,-0.36235,-0.0096389,0.29052,0.89383,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4,0.99999
VERRECCHIA_RESPONSE_TO_TGFB1...3,SET,14,-0.30121,-0.0083148,0.2415,0.89384,VERRECCHIA_RESPONSE_TO_TGFB1_C3,0.99999
GOBP_CHROMOSOME_SEGREGATION,SET,383,-0.051843,-0.0074097,0.04156,0.89387,GOBP_CHROMOSOME_SEGREGATION,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...26,SET,80,-0.13083,-0.0086177,0.10488,0.89387,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_VASCULAR_SMOOTH_MUSCLE_CELLS,0.99999
GOCC_PHOTORECEPTOR_OUTER_SEG...1,SET,82,-0.11657,-0.0077735,0.093433,0.89391,GOCC_PHOTORECEPTOR_OUTER_SEGMENT,0.99999
GOCC_PERINUCLEAR_THECA,SET,4,-0.63754,-0.0094097,0.51098,0.89392,GOCC_PERINUCLEAR_THECA,0.99999
KEGG_MEDICUS_REFERENCE_INTRI...,SET,13,-0.31398,-0.0083524,0.25161,0.89396,KEGG_MEDICUS_REFERENCE_INTRINSIC_APOPTOTIC_PATHWAY,0.99999
HP_OCULAR_ALBINISM,SET,27,-0.21139,-0.0081011,0.16938,0.89399,HP_OCULAR_ALBINISM,0.99999
FAN_EMBRYONIC_CTX_NSC_2,SET,215,-0.070318,-0.0075651,0.056341,0.89399,FAN_EMBRYONIC_CTX_NSC_2,0.99999
GOBP_REGULATION_OF_CHOLESTER...1,SET,16,-0.25909,-0.0076456,0.20757,0.89402,GOBP_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...412,SET,109,-0.10512,-0.008076,0.084211,0.89403,GOBP_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,0.99999
HP_NO_SOCIAL_INTERACTION,SET,5,-0.59945,-0.0098917,0.48023,0.89403,HP_NO_SOCIAL_INTERACTION,0.99999
MATTIOLI_MGUS_VS_PCL,SET,91,-0.11137,-0.0078218,0.089195,0.89409,MATTIOLI_MGUS_VS_PCL,0.99999
HBZ_TARGET_GENES,SET,836,-0.037739,-0.007868,0.030221,0.89412,HBZ_TARGET_GENES,0.99999
MORF_RAD23B,SET,158,-0.076259,-0.0070442,0.061068,0.89412,MORF_RAD23B,0.99999
GSE369_PRE_VS_POST_IL6_INJEC...6,SET,175,-0.081938,-0.0079618,0.065607,0.89414,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_UP,0.99999
HP_MICROVESICULAR_HEPATIC_ST...,SET,19,-0.23692,-0.0076179,0.18967,0.89418,HP_MICROVESICULAR_HEPATIC_STEATOSIS,0.99999
REACTOME_COPI_MEDIATED_ANTER...,SET,99,-0.099653,-0.0072983,0.079771,0.8942,REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,0.99999
GOMF_RACEMASE_AND_EPIMERASE_...1,SET,15,-0.25645,-0.0073275,0.20529,0.8942,GOMF_RACEMASE_AND_EPIMERASE_ACTIVITY,0.99999
HALLMARK_MYC_TARGETS_V1,SET,182,-0.071002,-0.0070344,0.056837,0.8942,HALLMARK_MYC_TARGETS_V1,0.99999
KAT5_TARGET_GENES,SET,707,-0.039642,-0.0076283,0.031724,0.89427,KAT5_TARGET_GENES,0.99999
UNTERMAN_PROGRESSIVE_VS_STAB...6,SET,8,-0.42746,-0.0089213,0.34201,0.89431,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_NK_CELL_UP,0.99999
DESCARTES_FETAL_ADRENAL_CHRO...,SET,75,-0.13898,-0.0088651,0.11118,0.89436,DESCARTES_FETAL_ADRENAL_CHROMAFFIN_CELLS,0.99999
GOMF_PEPTIDE_LYSINE_N_ACETYL...,SET,43,-0.15129,-0.0073133,0.12101,0.89438,GOMF_PEPTIDE_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY,0.99999
GOMF_TRANSLATION_ACTIVATOR_A...,SET,9,-0.34657,-0.0076718,0.27718,0.89441,GOMF_TRANSLATION_ACTIVATOR_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...45,SET,29,-0.20472,-0.0081302,0.16372,0.89442,GOBP_POSITIVE_REGULATION_OF_ATP_METABOLIC_PROCESS,0.99999
GOMF_HISTONE_H2AX_KINASE_ACT...,SET,5,-0.39855,-0.0065764,0.31868,0.89446,GOMF_HISTONE_H2AX_KINASE_ACTIVITY,0.99999
GOCC_SPERM_CONNECTING_PIECE,SET,11,-0.3409,-0.0083422,0.27257,0.89447,GOCC_SPERM_CONNECTING_PIECE,0.99999
GSE360_L_MAJOR_VS_T_GONDII_D...2,SET,177,-0.084602,-0.008267,0.067614,0.89457,GSE360_L_MAJOR_VS_T_GONDII_DC_UP,0.99999
GSE19888_CTRL_VS_A3R_INHIBIT...1,SET,168,-0.085567,-0.008148,0.068381,0.89458,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN,0.99999
MIR4758_3P,SET,50,-0.14107,-0.0073524,0.11272,0.89463,MIR4758_3P,0.99999
HP_THIN_CLAVICLES,SET,6,-0.39286,-0.0071011,0.31381,0.89469,HP_THIN_CLAVICLES,0.99999
WP_IL1_SIGNALING,SET,52,-0.15018,-0.0079817,0.11996,0.89471,WP_IL1_SIGNALING,0.99999
DESCARTES_MAIN_FETAL_ERYTHRO...,SET,194,-0.075999,-0.0077713,0.060692,0.89474,DESCARTES_MAIN_FETAL_ERYTHROBLASTS,0.99999
HP_ABNORMAL_TRICUSPID_VALVE_...1,SET,35,-0.19656,-0.0085745,0.15696,0.89476,HP_ABNORMAL_TRICUSPID_VALVE_MORPHOLOGY,0.99999
GNF2_CDC2,SET,58,-0.13651,-0.0076609,0.109,0.89478,GNF2_CDC2,0.99999
MIR1305,SET,460,-0.051494,-0.0080485,0.041108,0.89482,MIR1305,0.99999
MODULE_411,SET,72,-0.12944,-0.0080906,0.10334,0.89482,MODULE_411,0.99999
GSE12392_CD8A_POS_VS_NEG_SPL...1,SET,185,-0.077139,-0.0077045,0.061579,0.89483,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN,0.99999
GOBP_FEMALE_MEIOSIS_I,SET,9,-0.34932,-0.0077326,0.27884,0.89485,GOBP_FEMALE_MEIOSIS_I,0.99999
GOBP_NEUROFILAMENT_CYTOSKELE...,SET,10,-0.32666,-0.007622,0.2607,0.8949,GOBP_NEUROFILAMENT_CYTOSKELETON_ORGANIZATION,0.99999
MORF_RAB3A,SET,77,-0.12408,-0.008019,0.099018,0.89491,MORF_RAB3A,0.99999
MIR6790_5P,SET,46,-0.17251,-0.0086247,0.13764,0.89496,MIR6790_5P,0.99999
GOBP_OPTIC_NERVE_DEVELOPMENT,SET,20,-0.25181,-0.0083068,0.20088,0.89498,GOBP_OPTIC_NERVE_DEVELOPMENT,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...17,SET,67,-0.12378,-0.0074643,0.098741,0.895,GOBP_PROTEIN_LOCALIZATION_TO_CILIUM,0.99999
HP_BRUSHFIELD_SPOTS,SET,12,-0.29053,-0.0074254,0.23174,0.89501,HP_BRUSHFIELD_SPOTS,0.99999
GSE25088_WT_VS_STAT6_KO_MACR...8,SET,165,-0.082254,-0.0077629,0.065596,0.89506,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_UP,0.99999
LEE_LIVER_CANCER_MYC_E2F1_UP,SET,55,-0.15228,-0.0083226,0.12144,0.89507,LEE_LIVER_CANCER_MYC_E2F1_UP,0.99999
HP_GOITER,SET,54,-0.14753,-0.0079894,0.11764,0.89508,HP_GOITER,0.99999
MIR182_5P,SET,506,-0.04921,-0.0080565,0.039237,0.8951,MIR182_5P,0.99999
GSE2770_IL12_VS_IL4_TREATED_...3,SET,176,-0.07801,-0.0076015,0.062191,0.89514,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.99999
HP_ABNORMAL_CIRCULATING_IGA_...,SET,95,-0.11114,-0.0079742,0.088598,0.89515,HP_ABNORMAL_CIRCULATING_IGA_LEVEL,0.99999
GOBP_POSITIVE_REGULATION_OF_...665,SET,9,-0.37793,-0.008366,0.3011,0.89528,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_CLUSTERING,0.99999
GOBP_TROPHECTODERMAL_CELL_DI...,SET,19,-0.24905,-0.0080079,0.19836,0.89534,GOBP_TROPHECTODERMAL_CELL_DIFFERENTIATION,0.99999
GOBP_LIPID_LOCALIZATION,SET,449,-0.053221,-0.0082208,0.04238,0.8954,GOBP_LIPID_LOCALIZATION,0.99999
REACTOME_MITF_M_DEPENDENT_GE...,SET,91,-0.11214,-0.0078758,0.089292,0.89542,REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION,0.99999
GSE32164_RESTING_DIFFERENTIA...1,SET,182,-0.080917,-0.0080168,0.06441,0.89548,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN,0.99999
HP_TRACHEOMALACIA,SET,43,-0.15467,-0.0074767,0.1231,0.8955,HP_TRACHEOMALACIA,0.99999
ZHOU_CELL_CYCLE_GENES_IN_IR_...2,SET,8,-0.36548,-0.0076279,0.29088,0.89552,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR,0.99999
GOBP_REGULATION_OF_ANGIOTENS...,SET,8,-0.40679,-0.00849,0.32375,0.89552,GOBP_REGULATION_OF_ANGIOTENSIN_LEVELS_IN_BLOOD,0.99999
HP_DESMOID_TUMORS,SET,6,-0.46774,-0.0084547,0.37222,0.89554,HP_DESMOID_TUMORS,0.99999
WP_CYTOPLASMIC_RIBOSOMAL_PRO...,SET,78,-0.11799,-0.0076745,0.09389,0.89555,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,0.99999
MODULE_382,SET,25,-0.24028,-0.0088608,0.19114,0.89563,MODULE_382,0.99999
GOCC_SPECIFIC_GRANULE_LUMEN,SET,57,-0.15195,-0.0084536,0.12085,0.89567,GOCC_SPECIFIC_GRANULE_LUMEN,0.99999
GOBP_REGULATION_OF_ANTIGEN_P...2,SET,5,-0.48604,-0.0080202,0.38655,0.89568,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN,0.99999
GOMF_PHOSPHOLIPASE_ACTIVITY,SET,101,-0.10705,-0.0079186,0.085142,0.89568,GOMF_PHOSPHOLIPASE_ACTIVITY,0.99999
DESCARTES_FETAL_KIDNEY_MESAN...,SET,42,-0.18534,-0.0088547,0.1474,0.89568,DESCARTES_FETAL_KIDNEY_MESANGIAL_CELLS,0.99999
REACTOME_POST_TRANSLATIONAL_...2,SET,1289,-0.030593,-0.0078168,0.02433,0.8957,REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.99999
GOBP_GLYCOSPHINGOLIPID_BIOSY...,SET,38,-0.18727,-0.0085115,0.14893,0.8957,GOBP_GLYCOSPHINGOLIPID_BIOSYNTHETIC_PROCESS,0.99999
GOMF_NUCLEOBASE_CONTAINING_C...1,SET,40,-0.16852,-0.0078578,0.13401,0.89571,GOMF_NUCLEOBASE_CONTAINING_COMPOUND_KINASE_ACTIVITY,0.99999
GOMF_CHEMOREPELLENT_ACTIVITY,SET,28,-0.21765,-0.0084937,0.17305,0.89574,GOMF_CHEMOREPELLENT_ACTIVITY,0.99999
GOBP_INTESTINAL_EPITHELIAL_C...3,SET,6,-0.41911,-0.0075756,0.33322,0.89575,GOBP_INTESTINAL_EPITHELIAL_CELL_MATURATION,0.99999
GOBP_BEHAVIORAL_RESPONSE_TO_...2,SET,9,-0.39556,-0.0087562,0.31445,0.89579,GOBP_BEHAVIORAL_RESPONSE_TO_ETHANOL,0.99999
REACTOME_UPTAKE_OF_DIETARY_C...,SET,9,-0.40712,-0.009012,0.32362,0.8958,REACTOME_UPTAKE_OF_DIETARY_COBALAMINS_INTO_ENTEROCYTES,0.99999
GSE19888_ADENOSINE_A3R_ACT_V...6,SET,178,-0.08317,-0.0081499,0.066113,0.8958,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...1,SET,11,-0.28457,-0.0069637,0.22619,0.89582,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS,0.99999
KEGG_MEDICUS_PATHOGEN_HIV_VP...3,SET,4,-0.48728,-0.0071919,0.38727,0.89584,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_WEE1_CELL_CYCLE_G2M,0.99999
GOBP_PROGRAMMED_CELL_DEATH_I...1,SET,24,-0.22374,-0.0080845,0.17781,0.89585,GOBP_PROGRAMMED_CELL_DEATH_INVOLVED_IN_CELL_DEVELOPMENT,0.99999
GOBP_RECEPTOR_LOCALIZATION_T...1,SET,4,-0.45259,-0.00668,0.35967,0.89586,GOBP_RECEPTOR_LOCALIZATION_TO_NON_MOTILE_CILIUM,0.99999
MIR1206,SET,105,-0.10318,-0.0077812,0.081983,0.8959,MIR1206,0.99999
GSE15930_NAIVE_VS_72H_IN_VIT...6,SET,185,-0.074742,-0.0074651,0.059377,0.89593,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...1,SET,10,-0.31959,-0.0074571,0.25386,0.89597,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN,0.99999
HP_HYPERTENSION,SET,355,-0.059036,-0.0081298,0.046893,0.89597,HP_HYPERTENSION,0.99999
GOBP_RIBONUCLEOSIDE_DIPHOSPH...,SET,10,-0.3298,-0.0076953,0.26193,0.896,GOBP_RIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...301,SET,12,-0.31465,-0.0080419,0.24985,0.89604,GOBP_NEGATIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION,0.99999
GSE14415_NATURAL_TREG_VS_FOX...2,SET,140,-0.089652,-0.0077992,0.071187,0.89605,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP,0.99999
GSE4811_CLASSSICALY_ACTIVATE...2,SET,174,-0.079267,-0.0076804,0.062937,0.89606,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...652,SET,19,-0.25313,-0.0081392,0.20096,0.89608,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.99999
HP_HYPOPIGMENTATION_OF_HAIR,SET,88,-0.1188,-0.0082052,0.094316,0.89608,HP_HYPOPIGMENTATION_OF_HAIR,0.99999
GOMF_INSULIN_LIKE_GROWTH_FAC...4,SET,16,-0.30897,-0.0091175,0.24528,0.8961,GOMF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_BINDING,0.99999
KOHOUTEK_CCNT2_TARGETS,SET,54,-0.14625,-0.0079202,0.11605,0.89619,KOHOUTEK_CCNT2_TARGETS,0.99999
GOMF_AMINE_BINDING,SET,12,-0.31274,-0.0079932,0.24816,0.8962,GOMF_AMINE_BINDING,0.99999
HP_FOCAL_SENSORY_SEIZURE,SET,15,-0.26866,-0.0076765,0.21318,0.8962,HP_FOCAL_SENSORY_SEIZURE,0.99999
PID_ERA_GENOMIC_PATHWAY,SET,61,-0.13886,-0.0079909,0.11015,0.89626,PID_ERA_GENOMIC_PATHWAY,0.99999
HP_FAILURE_TO_THRIVE_IN_INFA...,SET,108,-0.10265,-0.0078504,0.081432,0.89627,HP_FAILURE_TO_THRIVE_IN_INFANCY,0.99999
KAECH_DAY8_EFF_VS_DAY15_EFF_...1,SET,183,-0.079892,-0.0079367,0.063371,0.89628,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN,0.99999
MIR4659B_5P,SET,91,-0.11554,-0.0081148,0.091632,0.89633,MIR4659B_5P,0.99999
DOUGLAS_BMI1_TARGETS_UP,SET,513,-0.048623,-0.0080137,0.03854,0.89645,DOUGLAS_BMI1_TARGETS_UP,0.99999
GOMF_INTERLEUKIN_1_RECEPTOR_...2,SET,17,-0.30002,-0.0091256,0.23774,0.89651,GOMF_INTERLEUKIN_1_RECEPTOR_BINDING,0.99999
HP_HEMIMEGALENCEPHALY,SET,14,-0.3078,-0.0084967,0.24389,0.89652,HP_HEMIMEGALENCEPHALY,0.99999
GSE21927_SPLEEN_VS_TUMOR_MON...2,SET,142,-0.088517,-0.0077548,0.070125,0.89657,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_UP,0.99999
HP_ABNORMAL_SKIN_MORPHOLOGY_...,SET,361,-0.057534,-0.0079883,0.045575,0.89659,HP_ABNORMAL_SKIN_MORPHOLOGY_OF_THE_PALM,0.99999
HP_SPASTIC_PARAPARESIS,SET,49,-0.13795,-0.0071173,0.10925,0.89663,HP_SPASTIC_PARAPARESIS,0.99999
PID_RHODOPSIN_PATHWAY,SET,21,-0.22434,-0.0075831,0.17765,0.89665,PID_RHODOPSIN_PATHWAY,0.99999
GOMF_GLUTAMATE_RECEPTOR_ACTI...,SET,25,-0.23396,-0.008628,0.18528,0.89665,GOMF_GLUTAMATE_RECEPTOR_ACTIVITY,0.99999
GSE15930_STIM_VS_STIM_AND_TR...4,SET,185,-0.084084,-0.0083982,0.066588,0.89665,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP,0.99999
DESCARTES_FETAL_ADRENAL_CSH1...,SET,146,-0.095943,-0.008522,0.075976,0.89666,DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS,0.99999
GOBP_PSEUDOURIDINE_SYNTHESIS,SET,17,-0.23233,-0.0070668,0.18392,0.89674,GOBP_PSEUDOURIDINE_SYNTHESIS,0.99999
FERRANDO_LYL1_NEIGHBORS,SET,15,-0.30828,-0.0088084,0.244,0.89677,FERRANDO_LYL1_NEIGHBORS,0.99999
SOX10_TARGET_GENES,SET,205,-0.07635,-0.0080229,0.060404,0.89687,SOX10_TARGET_GENES,0.99999
GOBP_MANNOSYLATION,SET,20,-0.24082,-0.0079445,0.19051,0.8969,GOBP_MANNOSYLATION,0.99999
MORI_MATURE_B_LYMPHOCYTE_DN,SET,69,-0.12475,-0.0076334,0.098677,0.89691,MORI_MATURE_B_LYMPHOCYTE_DN,0.99999
ONO_AML1_TARGETS_UP,SET,23,-0.24879,-0.0088006,0.19679,0.89693,ONO_AML1_TARGETS_UP,0.99999
GSE20715_WT_VS_TLR4_KO_48H_O...1,SET,176,-0.077797,-0.0075808,0.061535,0.89693,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN,0.99999
GOBP_QUINOLINATE_METABOLIC_P...,SET,5,-0.51763,-0.0085414,0.40938,0.89695,GOBP_QUINOLINATE_METABOLIC_PROCESS,0.99999
GSE11864_UNTREATED_VS_CSF1_I...6,SET,166,-0.082501,-0.0078096,0.065248,0.89695,GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP,0.99999
MIR6080,SET,42,-0.17175,-0.0082056,0.13583,0.89696,MIR6080,0.99999
WP_MONOAMINE_TRANSPORT,SET,30,-0.20471,-0.0082687,0.16183,0.89705,WP_MONOAMINE_TRANSPORT,0.99999
GOBP_POSITIVE_REGULATION_OF_...556,SET,20,-0.24885,-0.0082094,0.19669,0.89709,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,0.99999
LHX3_01,SET,211,-0.07968,-0.0084931,0.062962,0.89715,LHX3_01,0.99999
WP_EGFR_TYROSINE_KINASE_INHI...,SET,83,-0.12877,-0.0086392,0.10175,0.89717,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,0.99999
WP_RAS_AND_BRADYKININ_PATHWA...,SET,27,-0.23747,-0.0091005,0.18759,0.89722,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,0.99999
HP_PHALANGEAL_DISLOCATION,SET,7,-0.46198,-0.0090193,0.36494,0.89722,HP_PHALANGEAL_DISLOCATION,0.99999
HP_EMOTIONAL_LABILITY,SET,154,-0.086737,-0.0079109,0.068494,0.8973,HP_EMOTIONAL_LABILITY,0.99999
GSE29618_PRE_VS_DAY7_POST_LA...4,SET,169,-0.086509,-0.008262,0.068312,0.8973,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP,0.99999
GSE22589_HEALTHY_VS_HIV_INFE...2,SET,188,-0.073231,-0.0073727,0.057824,0.89732,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP,0.99999
GOMF_ATP_DEPENDENT_PROTEIN_F...,SET,31,-0.16965,-0.0069655,0.13393,0.89735,GOMF_ATP_DEPENDENT_PROTEIN_FOLDING_CHAPERONE,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...9,SET,186,-0.079023,-0.0079138,0.062379,0.89738,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_DN,0.99999
HP_NEOPLASM_OF_THE_LARYNX,SET,18,-0.24752,-0.0077467,0.19538,0.89739,HP_NEOPLASM_OF_THE_LARYNX,0.99999
HP_OSTEOCHONDROMA,SET,7,-0.45987,-0.0089782,0.36294,0.89743,HP_OSTEOCHONDROMA,0.99999
MCRS1_TARGET_GENES,SET,33,-0.18398,-0.0077935,0.14518,0.89747,MCRS1_TARGET_GENES,0.99999
MCMURRAY_TP53_HRAS_COOPERATI...2,SET,26,-0.23631,-0.0088868,0.18645,0.89749,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,0.99999
GOMF_RECEPTOR_SERINE_THREONI...,SET,24,-0.23662,-0.0085498,0.18669,0.89749,GOMF_RECEPTOR_SERINE_THREONINE_KINASE_BINDING,0.99999
GSE40274_CTRL_VS_LEF1_TRANSD...1,SET,156,-0.082439,-0.0075671,0.065042,0.8975,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
GOBP_REGULATION_OF_OSTEOCLAS...1,SET,11,-0.34469,-0.0084351,0.27193,0.89751,GOBP_REGULATION_OF_OSTEOCLAST_DEVELOPMENT,0.99999
KANNAN_BLOOD_2012_2013_TIV_A...2,SET,190,-0.076728,-0.0077653,0.06053,0.89752,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MO_UP,0.99999
MIR8074,SET,17,-0.2405,-0.0073151,0.18971,0.89754,MIR8074,0.99999
MORF_LCAT,SET,118,-0.10447,-0.008349,0.082394,0.89759,MORF_LCAT,0.99999
REACTOME_TETRAHYDROBIOPTERIN...,SET,10,-0.31608,-0.0073751,0.24923,0.89763,REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION,0.99999
MIR6793_3P,SET,70,-0.12112,-0.0074646,0.095497,0.89764,MIR6793_3P,0.99999
GOBP_LIPID_HOMEOSTASIS,SET,147,-0.089335,-0.007962,0.070438,0.89764,GOBP_LIPID_HOMEOSTASIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...270,SET,9,-0.37514,-0.0083042,0.29573,0.89769,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND,0.99999
GOBP_REGULATION_OF_NUCLEOTID...5,SET,28,-0.20131,-0.0078561,0.15869,0.89769,GOBP_REGULATION_OF_NUCLEOTIDE_EXCISION_REPAIR,0.99999
GNF2_PPP6C,SET,35,-0.16853,-0.0073514,0.13283,0.89772,GNF2_PPP6C,0.99999
MIR4732_5P,SET,18,-0.24549,-0.0076832,0.19348,0.89773,MIR4732_5P,0.99999
FOXC1_TARGET_GENES,SET,59,-0.14624,-0.0082771,0.11525,0.89774,FOXC1_TARGET_GENES,0.99999
GOMF_MONOCARBOXYLATE_SODIUM_...,SET,13,-0.28246,-0.0075139,0.2226,0.89775,GOMF_MONOCARBOXYLATE_SODIUM_SYMPORTER_ACTIVITY,0.99999
GSE19941_UNSTIM_VS_LPS_AND_I...2,SET,185,-0.083283,-0.0083182,0.065634,0.89775,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,0.99999
GOBP_COCHLEA_DEVELOPMENT,SET,48,-0.16984,-0.0086734,0.13385,0.89776,GOBP_COCHLEA_DEVELOPMENT,0.99999
REACTOME_CALCITONIN_LIKE_LIG...,SET,9,-0.42532,-0.0094149,0.33517,0.89777,REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS,0.99999
GOBP_AMINO_SUGAR_CATABOLIC_P...,SET,14,-0.31065,-0.0085755,0.2448,0.89777,GOBP_AMINO_SUGAR_CATABOLIC_PROCESS,0.99999
GSE36476_CTRL_VS_TSST_ACT_72...3,SET,179,-0.077672,-0.0076322,0.061198,0.8978,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN,0.99999
MIR6717_5P,SET,4,-0.53922,-0.0079586,0.42475,0.89786,MIR6717_5P,0.99999
GSE41867_DAY6_VS_DAY8_LCMV_A...1,SET,187,-0.075041,-0.007535,0.059108,0.89787,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.99999
GOBP_REGULATION_OF_GRANULOCY...2,SET,15,-0.27752,-0.0079295,0.21853,0.89793,GOBP_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,0.99999
GOMF_AMIDE_BINDING,SET,230,-0.075575,-0.0084061,0.059506,0.89796,GOMF_AMIDE_BINDING,0.99999
HP_CORTICAL_CATARACT,SET,10,-0.35333,-0.0082443,0.27815,0.898,HP_CORTICAL_CATARACT,0.99999
HP_PNEUMONIA,SET,274,-0.066771,-0.0080963,0.052562,0.89801,HP_PNEUMONIA,0.99999
PID_NFAT_TFPATHWAY,SET,42,-0.17861,-0.0085334,0.14059,0.89802,PID_NFAT_TFPATHWAY,0.99999
ZNF549_TARGET_GENES,SET,1014,-0.034475,-0.0078755,0.027137,0.89802,ZNF549_TARGET_GENES,0.99999
TCGA_GLIOBLASTOMA_MUTATED,SET,8,-0.34589,-0.007219,0.27221,0.89807,TCGA_GLIOBLASTOMA_MUTATED,0.99999
HARALAMBIEVA_PBMC_M_M_R_II_A...2,SET,842,-0.040975,-0.0085718,0.032246,0.89808,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_VI...2,SET,27,-0.23033,-0.0088269,0.18125,0.89809,GOBP_CELLULAR_RESPONSE_TO_VITAMIN,0.99999
GOBP_FUCOSE_CATABOLIC_PROCESS,SET,9,-0.42221,-0.0093461,0.33223,0.8981,GOBP_FUCOSE_CATABOLIC_PROCESS,0.99999
GOBP_HYPOTONIC_RESPONSE,SET,13,-0.32092,-0.0085368,0.2525,0.89812,GOBP_HYPOTONIC_RESPONSE,0.99999
MIR4735_5P,SET,170,-0.082043,-0.0078584,0.064546,0.89814,MIR4735_5P,0.99999
WP_CLASSICAL_PATHWAY_OF_STER...,SET,16,-0.29604,-0.0087361,0.23286,0.89819,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,0.99999
HP_ABNORMAL_CIRCULATING_PHEN...,SET,9,-0.38898,-0.0086104,0.30592,0.89821,HP_ABNORMAL_CIRCULATING_PHENYLALANINE_CONCENTRATION,0.99999
HP_ABNORMALITY_OF_VITAMIN_ME...,SET,94,-0.11171,-0.0079731,0.087818,0.89831,HP_ABNORMALITY_OF_VITAMIN_METABOLISM,0.99999
STAT3_02,SET,136,-0.09267,-0.0079466,0.07285,0.89832,STAT3_02,0.99999
HP_NEOPLASM_OF_THE_COLON,SET,77,-0.11711,-0.0075683,0.092046,0.89835,HP_NEOPLASM_OF_THE_COLON,0.99999
PARENT_MTOR_SIGNALING_DN,SET,41,-0.17571,-0.0082947,0.13808,0.8984,PARENT_MTOR_SIGNALING_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...344,SET,7,-0.45334,-0.0088506,0.35624,0.89841,GOBP_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.99999
chr1q24,SET,54,-0.27371,-0.014823,0.21501,0.89848,chr1q24,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_SCG...,SET,522,-0.049541,-0.0082343,0.038912,0.89851,HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL,0.99999
HP_LARGE_FONTANELLES,SET,151,-0.089576,-0.0080905,0.070351,0.89853,HP_LARGE_FONTANELLES,0.99999
REACTOME_ACTIVATED_NTRK3_SIG...2,SET,8,-0.35726,-0.0074563,0.28055,0.89856,REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS,0.99999
GSE9006_HEALTHY_VS_TYPE_2_DI...1,SET,179,-0.082594,-0.0081159,0.06485,0.89859,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,0.99999
WP_EPAC1_AND_PKA_REDUCTION_O...,SET,8,-0.41217,-0.0086023,0.32358,0.89862,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,0.99999
GOMF_HEPARIN_BINDING,SET,159,-0.094964,-0.0087995,0.074539,0.89866,GOMF_HEPARIN_BINDING,0.99999
GSE22196_HEALTHY_VS_OBESE_MO...2,SET,180,-0.083616,-0.008239,0.065614,0.89872,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP,0.99999
TRAVAGLINI_LUNG_IGSF21_DENDR...,SET,43,-0.19195,-0.009279,0.15061,0.89874,TRAVAGLINI_LUNG_IGSF21_DENDRITIC_CELL,0.99999
MIR1914_5P,SET,55,-0.1563,-0.0085422,0.12262,0.89877,MIR1914_5P,0.99999
GOBP_REGULATION_OF_DEFENSE_R...2,SET,18,-0.25808,-0.0080774,0.20246,0.89879,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,0.99999
BIOCARTA_LYMPHOCYTE_PATHWAY,SET,9,-0.42859,-0.0094873,0.3362,0.8988,BIOCARTA_LYMPHOCYTE_PATHWAY,0.99999
MANNO_MIDBRAIN_NEUROTYPES_BA...,SET,64,-0.11995,-0.0070702,0.094091,0.89881,MANNO_MIDBRAIN_NEUROTYPES_BASAL,0.99999
GOMF_ANGIOTENSIN_RECEPTOR_BI...,SET,9,-0.38989,-0.0086307,0.30575,0.89887,GOMF_ANGIOTENSIN_RECEPTOR_BINDING,0.99999
GSE30971_2H_VS_4H_LPS_STIM_M...2,SET,160,-0.083977,-0.0078056,0.065843,0.89891,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_UP,0.99999
HP_RECTAL_FISTULA,SET,23,-0.22573,-0.007985,0.17693,0.89899,HP_RECTAL_FISTULA,0.99999
BLANCO_MELO_COVID19_BRONCHIA...2,SET,135,-0.10249,-0.0087567,0.080329,0.899,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,0.99999
MIR183_5P,SET,210,-0.077675,-0.00826,0.060868,0.89904,MIR183_5P,0.99999
LENAOUR_DENDRITIC_CELL_MATUR...1,SET,115,-0.10491,-0.0082771,0.082194,0.89907,LENAOUR_DENDRITIC_CELL_MATURATION_DN,0.99999
NABA_MATRISOME_MULTIPLE_MYEL...,SET,9,-0.41816,-0.0092564,0.32763,0.89907,NABA_MATRISOME_MULTIPLE_MYELOMA,0.99999
GOBP_LIPOPROTEIN_METABOLIC_P...,SET,125,-0.096111,-0.0079038,0.075293,0.8991,GOBP_LIPOPROTEIN_METABOLIC_PROCESS,0.99999
GOCC_GROWTH_FACTOR_COMPLEX,SET,8,-0.45982,-0.0095968,0.36017,0.89914,GOCC_GROWTH_FACTOR_COMPLEX,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...6,SET,106,-0.10646,-0.0080663,0.083378,0.89917,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,0.99999
HP_VOLVULUS,SET,13,-0.29422,-0.0078268,0.23042,0.89917,HP_VOLVULUS,0.99999
KEGG_MEDICUS_REFERENCE_HEPAR...1,SET,11,-0.344,-0.0084181,0.26938,0.8992,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS,0.99999
GSE19941_IL10_KO_VS_IL10_KO_...6,SET,183,-0.082322,-0.0081782,0.064464,0.8992,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP,0.99999
GSE37534_UNTREATED_VS_ROSIGL...2,SET,177,-0.081118,-0.0079266,0.063518,0.8992,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.99999
HP_ABNORMAL_SKULL_BASE_MORPH...,SET,205,-0.074948,-0.0078757,0.058684,0.89922,HP_ABNORMAL_SKULL_BASE_MORPHOLOGY,0.99999
HP_THICKENED_NUCHAL_SKIN_FOLD,SET,49,-0.14847,-0.0076603,0.11622,0.89928,HP_THICKENED_NUCHAL_SKIN_FOLD,0.99999
HP_MICROSCOPIC_HEMATURIA,SET,18,-0.26026,-0.0081455,0.20371,0.8993,HP_MICROSCOPIC_HEMATURIA,0.99999
GNF2_G22P1,SET,31,-0.17956,-0.0073726,0.14054,0.89931,GNF2_G22P1,0.99999
SANDERSON_PPARA_TARGETS,SET,15,-0.26374,-0.0075359,0.20639,0.89934,SANDERSON_PPARA_TARGETS,0.99999
HDGF_TARGET_GENES,SET,717,-0.040838,-0.0079116,0.03195,0.8994,HDGF_TARGET_GENES,0.99999
GSE15330_WT_VS_IKAROS_KO_GRA...1,SET,185,-0.080746,-0.0080649,0.063169,0.89941,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.99999
MIR6838_3P,SET,58,-0.14767,-0.0082874,0.11552,0.89942,MIR6838_3P,0.99999
GOBP_POSTSYNAPTIC_SPECIALIZA...2,SET,45,-0.17054,-0.0084332,0.13339,0.89946,GOBP_POSTSYNAPTIC_SPECIALIZATION_ORGANIZATION,0.99999
GOMF_HISTONE_H4K20_MONOMETHY...,SET,3,-0.74323,-0.0095003,0.58118,0.89951,GOMF_HISTONE_H4K20_MONOMETHYLTRANSFERASE_ACTIVITY,0.99999
GSE2770_UNTREATED_VS_IL12_TR...3,SET,180,-0.076376,-0.0075256,0.059715,0.89955,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.99999
WP_COPPER_HOMEOSTASIS,SET,49,-0.16008,-0.0082594,0.12514,0.89958,WP_COPPER_HOMEOSTASIS,0.99999
ANDERSEN_CHOLANGIOCARCINOMA_...2,SET,171,-0.088963,-0.008546,0.069531,0.89963,ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,0.99999
SESTO_RESPONSE_TO_UV_C1,SET,68,-0.12899,-0.0078359,0.1008,0.89965,SESTO_RESPONSE_TO_UV_C1,0.99999
REACTOME_DISORDERS_OF_TRANSM...,SET,166,-0.082839,-0.0078415,0.064731,0.89967,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,0.99999
WP_DEVELOPMENT_AND_HETEROGEN...,SET,32,-0.20991,-0.008756,0.16396,0.89976,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,0.99999
CAGCAGG_MIR370,SET,138,-0.089303,-0.0077135,0.069752,0.89977,CAGCAGG_MIR370,0.99999
MIR4784,SET,138,-0.093861,-0.0081073,0.073308,0.89979,MIR4784,0.99999
GOBP_POSITIVE_REGULATION_OF_...635,SET,98,-0.10902,-0.0079444,0.085148,0.89979,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.99999
KEGG_MEDICUS_REFERENCE_CA2_C...3,SET,11,-0.364,-0.0089076,0.28424,0.89983,KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...5,SET,47,-0.17964,-0.009078,0.14023,0.89991,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3,0.99999
PID_INSULIN_PATHWAY,SET,44,-0.16446,-0.0080416,0.12835,0.89995,PID_INSULIN_PATHWAY,0.99999
GOBP_STRIATED_MUSCLE_CELL_AP...,SET,42,-0.16981,-0.008113,0.13252,0.89996,GOBP_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
GOCC_DYNEIN_AXONEMAL_PARTICLE,SET,14,-0.27379,-0.0075579,0.21362,0.90001,GOCC_DYNEIN_AXONEMAL_PARTICLE,0.99999
HOFFMANN_SMALL_PRE_BII_TO_IM...2,SET,62,-0.14701,-0.0085288,0.11469,0.90003,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,0.99999
GOMF_CYSTEINE_TYPE_ENDOPEPTI...4,SET,6,-0.49356,-0.0089213,0.38503,0.90005,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.99999
MIR138_1_3P,SET,79,-0.12055,-0.0078912,0.09404,0.90006,MIR138_1_3P,0.99999
KEGG_GNRH_SIGNALING_PATHWAY,SET,98,-0.11738,-0.0085531,0.091555,0.90008,KEGG_GNRH_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_GF_RT...2,SET,89,-0.12803,-0.0088931,0.099868,0.90008,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_LARYNX_MORPHOLOGY,SET,130,-0.096259,-0.0080716,0.07508,0.90008,HP_ABNORMAL_LARYNX_MORPHOLOGY,0.99999
HP_CONTRACTURE_OF_THE_PROXIM...2,SET,5,-0.51638,-0.0085209,0.40278,0.90008,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_4TH_FINGER,0.99999
HP_LOWER_LIMB_HYPERTONIA,SET,32,-0.1839,-0.0076713,0.1434,0.90015,HP_LOWER_LIMB_HYPERTONIA,0.99999
GOCC_GLYCOSYLPHOSPHATIDYLINO...,SET,6,-0.43567,-0.007875,0.33968,0.90017,GOCC_GLYCOSYLPHOSPHATIDYLINOSITOL_N_ACETYLGLUCOSAMINYLTRANSFERASE_GPI_GNT_COMPLEX,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...37,SET,25,-0.23075,-0.0085095,0.17991,0.90017,HP_APLASIA_HYPOPLASIA_OF_THE_HUMERUS,0.99999
MORF_EPHA7,SET,125,-0.099936,-0.0082183,0.077908,0.9002,MORF_EPHA7,0.99999
DEN_INTERACT_WITH_LCA5,SET,24,-0.2305,-0.0083286,0.17967,0.90022,DEN_INTERACT_WITH_LCA5,0.99999
GOBP_POSITIVE_REGULATION_OF_...606,SET,6,-0.53541,-0.0096778,0.41736,0.90022,GOBP_POSITIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS,0.99999
HP_INABILITY_TO_WALK,SET,327,-0.059338,-0.0078486,0.04625,0.90024,HP_INABILITY_TO_WALK,0.99999
GSE1112_HY_CD8AB_VS_HY_CD8AA...1,SET,163,-0.088866,-0.0083365,0.069264,0.90025,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,0.99999
GOBP_REGULATION_OF_STEROID_M...,SET,90,-0.12299,-0.0085904,0.09585,0.90027,GOBP_REGULATION_OF_STEROID_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_ALPHA_BET...2,SET,70,-0.14122,-0.0087037,0.11,0.90038,GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
HP_ELEVATED_CIRCULATING_PARA...,SET,18,-0.29389,-0.0091979,0.2289,0.9004,HP_ELEVATED_CIRCULATING_PARATHYROID_HORMONE_LEVEL,0.99999
GOCC_NPBAF_COMPLEX,SET,14,-0.27339,-0.0075469,0.21294,0.90041,GOCC_NPBAF_COMPLEX,0.99999
ZHONG_PFC_C5_BCL11B_CALB2_PO...,SET,22,-0.24622,-0.0085185,0.19176,0.90042,ZHONG_PFC_C5_BCL11B_CALB2_POS_INP,0.99999
KRAS.50_UP.V1_DN,SET,44,-0.171,-0.0083615,0.13316,0.90044,KRAS.50_UP.V1_DN,0.99999
MARTINEZ_RB1_AND_TP53_TARGET...1,SET,549,-0.04746,-0.0080836,0.036956,0.90046,MARTINEZ_RB1_AND_TP53_TARGETS_DN,0.99999
PID_WNT_NONCANONICAL_PATHWAY,SET,31,-0.19999,-0.0082114,0.1557,0.9005,PID_WNT_NONCANONICAL_PATHWAY,0.99999
PID_LYMPH_ANGIOGENESIS_PATHW...,SET,24,-0.23996,-0.0086705,0.18679,0.90054,PID_LYMPH_ANGIOGENESIS_PATHWAY,0.99999
GSE13485_DAY7_VS_DAY21_YF17D...1,SET,141,-0.097254,-0.0084905,0.075689,0.90058,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.99999
BARRIER_COLON_CANCER_RECURRE...2,SET,37,-0.18489,-0.0082922,0.14389,0.90059,BARRIER_COLON_CANCER_RECURRENCE_UP,0.99999
REACTOME_G_ALPHA_12_13_SIGNA...,SET,74,-0.13542,-0.0085803,0.10537,0.90062,REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,0.99999
HP_ABNORMAL_FACTOR_VIII_ACTI...,SET,4,-0.557,-0.008221,0.43339,0.90063,HP_ABNORMAL_FACTOR_VIII_ACTIVITY,0.99999
GOBP_EAR_DEVELOPMENT,SET,209,-0.081121,-0.0086061,0.063114,0.90065,GOBP_EAR_DEVELOPMENT,0.99999
E2F1DP1_01,SET,209,-0.076036,-0.0080667,0.059141,0.90071,E2F1DP1_01,0.99999
E2F1DP2_01,SET,209,-0.076036,-0.0080667,0.059141,0.90071,E2F1DP2_01,0.99999
E2F4DP2_01,SET,209,-0.076036,-0.0080667,0.059141,0.90071,E2F4DP2_01,0.99999
E2F_02,SET,209,-0.076036,-0.0080667,0.059141,0.90071,E2F_02,0.99999
HP_BILIARY_TRACT_ABNORMALITY,SET,93,-0.11784,-0.0083661,0.09166,0.90071,HP_BILIARY_TRACT_ABNORMALITY,0.99999
MIR6852_3P,SET,134,-0.096461,-0.0082111,0.075013,0.90075,MIR6852_3P,0.99999
HP_ACCESSORY_SPLEEN,SET,33,-0.17787,-0.0075347,0.13832,0.90076,HP_ACCESSORY_SPLEEN,0.99999
NELSON_RESPONSE_TO_ANDROGEN_...1,SET,17,-0.31521,-0.0095877,0.24511,0.90078,NELSON_RESPONSE_TO_ANDROGEN_DN,0.99999
MIR7114_5P,SET,136,-0.097754,-0.0083826,0.076012,0.90078,MIR7114_5P,0.99999
GSE2770_IL12_AND_TGFB_VS_IL4...3,SET,162,-0.087953,-0.0082257,0.06839,0.90078,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...7,SET,132,-0.094098,-0.0079504,0.073159,0.90081,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,0.99999
HP_ABNORMALITY_OF_FONTANELLES,SET,180,-0.082085,-0.0080881,0.063814,0.90082,HP_ABNORMALITY_OF_FONTANELLES,0.99999
GOCC_POSTSYNAPTIC_SPECIALIZA...3,SET,121,-0.10619,-0.0085925,0.08254,0.90086,GOCC_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,0.99999
HAND1_TARGET_GENES,SET,361,-0.058851,-0.0081711,0.045742,0.90087,HAND1_TARGET_GENES,0.99999
GOMF_OLIGOPEPTIDE_BINDING,SET,10,-0.38251,-0.0089252,0.29731,0.90087,GOMF_OLIGOPEPTIDE_BINDING,0.99999
BIOCARTA_EPONFKB_PATHWAY,SET,11,-0.3363,-0.0082297,0.26138,0.90089,BIOCARTA_EPONFKB_PATHWAY,0.99999
REACTOME_ELASTIC_FIBRE_FORMA...,SET,42,-0.17806,-0.0085072,0.13839,0.90089,REACTOME_ELASTIC_FIBRE_FORMATION,0.99999
REACTOME_REGULATION_OF_RUNX3...,SET,52,-0.13639,-0.0072486,0.106,0.90089,REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,0.99999
HP_SEVERE_PLATYSPONDYLY,SET,8,-0.38312,-0.007996,0.29774,0.9009,HP_SEVERE_PLATYSPONDYLY,0.99999
GOCC_TRANSFERASE_COMPLEX_TRA...,SET,263,-0.062808,-0.0074636,0.048809,0.90091,GOCC_TRANSFERASE_COMPLEX_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS,0.99999
GOBP_CLATHRIN_DEPENDENT_ENDO...,SET,47,-0.16241,-0.0082072,0.1262,0.90094,GOBP_CLATHRIN_DEPENDENT_ENDOCYTOSIS,0.99999
REACTOME_SIGNALING_BY_THE_B_...,SET,103,-0.10025,-0.0074882,0.077883,0.90098,REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,0.99999
DESCARTES_MAIN_FETAL_CSH1_CS...,SET,70,-0.11994,-0.0073923,0.09318,0.90098,DESCARTES_MAIN_FETAL_CSH1_CSH2_POSITIVE_CELLS,0.99999
GOCC_PHOSPHORYLASE_KINASE_CO...,SET,3,-0.56208,-0.0071848,0.43665,0.90099,GOCC_PHOSPHORYLASE_KINASE_COMPLEX,0.99999
GSE27786_CD4_TCELL_VS_NKTCEL...2,SET,180,-0.079595,-0.0078428,0.061821,0.90103,GSE27786_CD4_TCELL_VS_NKTCELL_UP,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...9,SET,46,-0.14811,-0.0074046,0.11503,0.90104,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MYC_MITOCHONDRIA,0.99999
GOBP_LIPID_DIGESTION,SET,20,-0.28127,-0.0092789,0.2184,0.9011,GOBP_LIPID_DIGESTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...755,SET,5,-0.55802,-0.0092079,0.43325,0.90111,GOBP_POSITIVE_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION,0.99999
GOBP_CELLULAR_RESPONSE_TO_MA...2,SET,7,-0.45005,-0.0087865,0.34931,0.90119,GOBP_CELLULAR_RESPONSE_TO_MAGNESIUM_ION,0.99999
HP_EUTHYROID_GOITER,SET,4,-0.59539,-0.0087876,0.46203,0.90123,HP_EUTHYROID_GOITER,0.99999
GSE36078_WT_VS_IL1R_KO_LUNG_...1,SET,184,-0.08641,-0.0086074,0.067047,0.90126,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_DN,0.99999
BROWNE_HCMV_INFECTION_16HR_UP,SET,199,-0.074979,-0.007764,0.05817,0.90129,BROWNE_HCMV_INFECTION_16HR_UP,0.99999
KEGG_MEDICUS_REFERENCE_STERO...,SET,5,-0.50616,-0.0083522,0.39264,0.90131,KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE,0.99999
HP_ANISOCORIA,SET,15,-0.29621,-0.0084635,0.22977,0.90132,HP_ANISOCORIA,0.99999
GHANDHI_BYSTANDER_IRRADIATIO...2,SET,71,-0.14722,-0.0091379,0.11419,0.90134,GHANDHI_BYSTANDER_IRRADIATION_UP,0.99999
HP_ELEVATED_SERUM_11_DEOXYCO...,SET,9,-0.4188,-0.0092706,0.3248,0.90136,HP_ELEVATED_SERUM_11_DEOXYCORTISOL,0.99999
ZNF211_TARGET_GENES,SET,2,-0.79289,-0.0082755,0.61478,0.90142,ZNF211_TARGET_GENES,0.99999
GOBP_TRANSCRIPTION_ELONGATIO...1,SET,6,-0.48134,-0.0087006,0.37322,0.90142,GOBP_TRANSCRIPTION_ELONGATION_BY_RNA_POLYMERASE_I,0.99999
MIR7973,SET,43,-0.16109,-0.007787,0.12489,0.90143,MIR7973,0.99999
RODRIGUES_NTN1_TARGETS_DN,SET,148,-0.093504,-0.0083616,0.072486,0.90146,RODRIGUES_NTN1_TARGETS_DN,0.99999
HP_DECREASED_ACTIVITY_OF_MIT...2,SET,86,-0.10717,-0.0073177,0.083072,0.90147,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_I,0.99999
MIR331_5P,SET,66,-0.13093,-0.0078363,0.10148,0.90151,MIR331_5P,0.99999
HP_CHRONIC_NONINFECTIOUS_LYM...,SET,11,-0.33075,-0.0080939,0.25635,0.90151,HP_CHRONIC_NONINFECTIOUS_LYMPHADENOPATHY,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...12,SET,64,-0.14309,-0.0084338,0.11089,0.90152,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_PELVIS,0.99999
GOBP_U4_SNRNA_3_END_PROCESSI...,SET,7,-0.35329,-0.0068974,0.27373,0.90157,GOBP_U4_SNRNA_3_END_PROCESSING,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...39,SET,41,-0.16745,-0.0079047,0.12968,0.90168,GAVISH_3CA_MALIGNANT_METAPROGRAM_9_UNFOLDED_PROTEIN_RESPONSE,0.99999
GOBP_INTERLEUKIN_33_MEDIATED...,SET,7,-0.41434,-0.0080893,0.32088,0.90168,GOBP_INTERLEUKIN_33_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...96,SET,10,-0.33396,-0.0077923,0.25861,0.90171,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...705,SET,8,-0.42855,-0.0089441,0.33184,0.90172,GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.99999
GOBP_PHOSPHOLIPID_BIOSYNTHET...,SET,230,-0.071026,-0.0079001,0.054994,0.90173,GOBP_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.99999
HP_RECTOVAGINAL_FISTULA,SET,20,-0.24465,-0.0080706,0.18942,0.90173,HP_RECTOVAGINAL_FISTULA,0.99999
MIR4433B_5P,SET,51,-0.16631,-0.0087538,0.12877,0.90174,MIR4433B_5P,0.99999
GOBP_HORMONE_CATABOLIC_PROCE...,SET,12,-0.34274,-0.00876,0.26537,0.90174,GOBP_HORMONE_CATABOLIC_PROCESS,0.99999
GOCC_LARGE_RIBOSOMAL_SUBUNIT,SET,103,-0.10234,-0.0076442,0.079226,0.90177,GOCC_LARGE_RIBOSOMAL_SUBUNIT,0.99999
HP_ABNORMAL_Z_DISK_MORPHOLOGY,SET,8,-0.39953,-0.0083385,0.30929,0.90177,HP_ABNORMAL_Z_DISK_MORPHOLOGY,0.99999
GSE29615_DAY3_VS_DAY7_LAIV_F...1,SET,162,-0.087812,-0.0082124,0.067977,0.90178,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,0.99999
HP_EXPRESSIVE_APHASIA,SET,11,-0.34179,-0.0083639,0.26454,0.90182,HP_EXPRESSIVE_APHASIA,0.99999
MIR3191_3P,SET,21,-0.23616,-0.0079828,0.18277,0.90183,MIR3191_3P,0.99999
GOBP_REGULATION_OF_RETROGRAD...1,SET,12,-0.30208,-0.0077208,0.23378,0.90184,GOBP_REGULATION_OF_RETROGRADE_PROTEIN_TRANSPORT_ER_TO_CYTOSOL,0.99999
GOMF_U3_SNORNA_BINDING,SET,8,-0.38396,-0.0080135,0.29712,0.90186,GOMF_U3_SNORNA_BINDING,0.99999
GOBP_REGULATION_OF_GENERATIO...,SET,121,-0.098173,-0.0079439,0.075946,0.90193,GOBP_REGULATION_OF_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...8,SET,25,-0.21166,-0.0078054,0.16373,0.90193,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_7DY_TOP_100_DEG_EX_VIVO_UP,0.99999
MIR6508_3P,SET,46,-0.16812,-0.0084053,0.13004,0.90196,MIR6508_3P,0.99999
HP_CAVUM_SEPTUM_PELLUCIDUM,SET,30,-0.19456,-0.0078584,0.15048,0.90196,HP_CAVUM_SEPTUM_PELLUCIDUM,0.99999
REACTOME_SCAVENGING_OF_HEME_...,SET,10,-0.37883,-0.0088392,0.293,0.90197,REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA,0.99999
HP_PEDAL_EDEMA,SET,48,-0.16339,-0.0083439,0.12637,0.90198,HP_PEDAL_EDEMA,0.99999
GSE39864_WT_VS_GATA3_KO_TREG...1,SET,178,-0.07943,-0.0077834,0.061429,0.90199,GSE39864_WT_VS_GATA3_KO_TREG_DN,0.99999
GOBP_REGULATION_OF_TRANSLATI...10,SET,4,-0.51138,-0.0075477,0.39546,0.90201,GOBP_REGULATION_OF_TRANSLATION_AT_SYNAPSE_MODULATING_SYNAPTIC_TRANSMISSION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...400,SET,166,-0.082765,-0.0078346,0.063989,0.90206,GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,0.99999
GSE12366_NAIVE_VS_MEMORY_BCE...1,SET,174,-0.088779,-0.0086021,0.068631,0.90208,GSE12366_NAIVE_VS_MEMORY_BCELL_DN,0.99999
AMIT_EGF_RESPONSE_20_MCF10A,SET,11,-0.33458,-0.0081876,0.25864,0.9021,AMIT_EGF_RESPONSE_20_MCF10A,0.99999
REACTOME_HYALURONAN_METABOLI...,SET,17,-0.25612,-0.0077904,0.19793,0.90216,REACTOME_HYALURONAN_METABOLISM,0.99999
GSE22033_UNTREATED_VS_MRL24_...2,SET,178,-0.077651,-0.007609,0.06,0.90219,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...433,SET,18,-0.29804,-0.0093278,0.23025,0.90223,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,0.99999
HP_SPARSE_BONE_TRABECULAE,SET,4,-0.59062,-0.0087173,0.45615,0.9023,HP_SPARSE_BONE_TRABECULAE,0.99999
GOBP_INTRINSIC_APOPTOTIC_SIG...6,SET,6,-0.41438,-0.0074901,0.32002,0.90231,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYDROGEN_PEROXIDE,0.99999
HP_ABNORMAL_CSF_GLYCINE_CONC...,SET,8,-0.34618,-0.0072251,0.26736,0.90231,HP_ABNORMAL_CSF_GLYCINE_CONCENTRATION,0.99999
GSE40274_EOS_VS_FOXP3_AND_EO...1,SET,108,-0.11192,-0.0085593,0.086434,0.90231,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
REACTOME_CONSTITUTIVE_SIGNAL...3,SET,15,-0.25773,-0.007364,0.19902,0.90233,REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII,0.99999
GTAGGCA_MIR189,SET,25,-0.22292,-0.0082207,0.17214,0.90233,GTAGGCA_MIR189,0.99999
GOBP_SHORT_CHAIN_FATTY_ACID_...2,SET,15,-0.28161,-0.0080463,0.21742,0.90236,GOBP_SHORT_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.99999
HP_WIDENED_CEREBELLAR_SUBARA...,SET,6,-0.46851,-0.0084686,0.36173,0.90237,HP_WIDENED_CEREBELLAR_SUBARACHNOID_SPACE,0.99999
KEGG_CELL_ADHESION_MOLECULES...,SET,119,-0.11256,-0.0090327,0.086898,0.90238,KEGG_CELL_ADHESION_MOLECULES_CAMS,0.99999
GSE18804_SPLEEN_MACROPHAGE_V...2,SET,170,-0.087798,-0.0084096,0.067782,0.90238,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...5,SET,172,-0.081991,-0.007899,0.063297,0.90239,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_DN,0.99999
DASU_IL6_SIGNALING_DN,SET,6,-0.51373,-0.009286,0.3965,0.90245,DASU_IL6_SIGNALING_DN,0.99999
BRUNO_HEMATOPOIESIS,SET,61,-0.14875,-0.00856,0.11478,0.90248,BRUNO_HEMATOPOIESIS,0.99999
GSE557_WT_VS_CIITA_KO_DC_DN,SET,186,-0.082966,-0.0083087,0.064019,0.9025,GSE557_WT_VS_CIITA_KO_DC_DN,0.99999
ERBB2_UP.V1_DN,SET,180,-0.081924,-0.0080722,0.063203,0.90254,ERBB2_UP.V1_DN,0.99999
GOMF_GLYCEROPHOSPHODIESTER_P...,SET,4,-0.52548,-0.0077558,0.40538,0.90255,GOMF_GLYCEROPHOSPHODIESTER_PHOSPHODIESTERASE_ACTIVITY,0.99999
HP_NODULAR_CHANGES_AFFECTING...,SET,26,-0.24502,-0.0092145,0.18901,0.90256,HP_NODULAR_CHANGES_AFFECTING_THE_EYELIDS,0.99999
GOBP_MELANOCYTE_DIFFERENTIAT...,SET,23,-0.25589,-0.0090518,0.19738,0.90258,GOBP_MELANOCYTE_DIFFERENTIATION,0.99999
REACTOME_NONCANONICAL_ACTIVA...,SET,7,-0.4139,-0.0080807,0.31919,0.90263,REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3,0.99999
VANDESLUIS_NORMAL_EMBRYOS_UP,SET,5,-0.52427,-0.008651,0.40426,0.90265,VANDESLUIS_NORMAL_EMBRYOS_UP,0.99999
HP_ABNORMAL_FOURTH_VENTRICLE...,SET,132,-0.091677,-0.0077458,0.070693,0.90265,HP_ABNORMAL_FOURTH_VENTRICLE_MORPHOLOGY,0.99999
HP_ELEVATED_CIRCULATING_THYR...,SET,27,-0.21948,-0.008411,0.16923,0.90266,HP_ELEVATED_CIRCULATING_THYROID_STIMULATING_HORMONE_CONCENTRATION,0.99999
MIR6759_5P,SET,56,-0.16126,-0.008893,0.12434,0.90267,MIR6759_5P,0.99999
MIR515_3P,SET,61,-0.14525,-0.0083587,0.11198,0.90269,MIR515_3P,0.99999
LOPEZ_MESOTHELIOMA_SURVIVAL_...1,SET,10,-0.3638,-0.0084886,0.28045,0.90272,LOPEZ_MESOTHELIOMA_SURVIVAL_DN,0.99999
GSE8678_IL7R_LOW_VS_HIGH_EFF...2,SET,183,-0.082507,-0.0081965,0.063601,0.90272,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP,0.99999
MIR6884_5P,SET,132,-0.095473,-0.0080666,0.073592,0.90273,MIR6884_5P,0.99999
REACTOME_ASSEMBLY_OF_COLLAGE...,SET,59,-0.16265,-0.0092061,0.12536,0.90276,REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,0.99999
MIR146B_3P,SET,62,-0.14397,-0.0083523,0.11094,0.9028,MIR146B_3P,0.99999
MAGRANGEAS_MULTIPLE_MYELOMA_...1,SET,24,-0.23539,-0.0085055,0.18135,0.90285,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,0.99999
GOCC_EXTERNAL_SIDE_OF_PLASMA...,SET,360,-0.067068,-0.0092993,0.05166,0.90289,GOCC_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE,0.99999
GOBP_OUTER_DYNEIN_ARM_ASSEMB...,SET,15,-0.25525,-0.0072931,0.19658,0.90292,GOBP_OUTER_DYNEIN_ARM_ASSEMBLY,0.99999
GSE12505_WT_VS_E2_2_HET_PDC_...1,SET,142,-0.093069,-0.0081537,0.071679,0.90292,GSE12505_WT_VS_E2_2_HET_PDC_DN,0.99999
GSE39556_UNTREATED_VS_3H_POL...2,SET,180,-0.087143,-0.0085865,0.067098,0.90297,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP,0.99999
WP_HFE_EFFECT_ON_HEPCIDIN_PR...,SET,6,-0.44486,-0.0080412,0.34246,0.90302,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,0.99999
MEINHOLD_OVARIAN_CANCER_LOW_...1,SET,19,-0.2507,-0.0080612,0.19295,0.90307,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN,0.99999
GSE33292_WT_VS_TCF1_KO_DN3_T...1,SET,189,-0.076714,-0.0077437,0.059044,0.90307,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...10,SET,77,-0.1357,-0.0087702,0.10442,0.90312,GAUTAM_EYE_IRIS_CILIARY_BODY_MGP_HIGH_FIBROBLASTS,0.99999
JIANG_TIP30_TARGETS_DN,SET,22,-0.26849,-0.0092889,0.20657,0.90314,JIANG_TIP30_TARGETS_DN,0.99999
MIR485_5P,SET,127,-0.097079,-0.0080465,0.074689,0.90315,MIR485_5P,0.99999
MIR509_3P,SET,53,-0.15216,-0.0081638,0.11705,0.90318,MIR509_3P,0.99999
HP_LARYNGOTRACHEAL_STENOSIS,SET,5,-0.54553,-0.0090019,0.41966,0.90318,HP_LARYNGOTRACHEAL_STENOSIS,0.99999
GOMF_PHOSPHORIC_DIESTER_HYDR...,SET,86,-0.11821,-0.0080718,0.090917,0.90323,GOMF_PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY,0.99999
MIR6820_5P,SET,11,-0.33502,-0.0081983,0.25765,0.90324,MIR6820_5P,0.99999
REACTOME_ATF4_ACTIVATES_GENE...,SET,26,-0.20931,-0.0078714,0.16096,0.90325,REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.99999
GOBP_REGULATION_OF_CELL_POPU...,SET,1515,-0.030864,-0.0084925,0.023735,0.90325,GOBP_REGULATION_OF_CELL_POPULATION_PROLIFERATION,0.99999
GSE2585_CTEC_VS_MTEC_THYMUS_...1,SET,187,-0.08266,-0.0083001,0.063559,0.90328,GSE2585_CTEC_VS_MTEC_THYMUS_DN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...91,SET,38,-0.15285,-0.0069472,0.11752,0.90331,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
SPIELMAN_LYMPHOBLAST_EUROPEA...4,SET,429,-0.051915,-0.0078429,0.039912,0.90332,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,0.99999
REACTOME_PERK_REGULATES_GENE...,SET,30,-0.1946,-0.0078602,0.14958,0.90336,REACTOME_PERK_REGULATES_GENE_EXPRESSION,0.99999
GSE21774_CD56_BRIGHT_VS_DIM_...1,SET,178,-0.083967,-0.0082279,0.064532,0.90339,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN,0.99999
GSE43863_DAY6_EFF_VS_DAY150_...1,SET,174,-0.0832,-0.0080616,0.063942,0.90339,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_DN,0.99999
GOBP_AMYLOID_PRECURSOR_PROTE...2,SET,53,-0.15139,-0.0081227,0.11634,0.90341,GOBP_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.99999
HP_DEATH_IN_CHILDHOOD,SET,111,-0.10277,-0.007967,0.078974,0.90341,HP_DEATH_IN_CHILDHOOD,0.99999
GSE1791_CTRL_VS_NEUROMEDINU_...1,SET,162,-0.088584,-0.0082847,0.068071,0.90342,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_DN,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...28,SET,12,-0.328,-0.0083832,0.25204,0.90343,HP_APLASIA_HYPOPLASIA_OF_THE_EPIGLOTTIS,0.99999
THAKAR_PBMC_INACTIVATED_INFL...12,SET,5,-0.50679,-0.0083626,0.38941,0.90343,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_VS_21_30YO_0DY_UP,0.99999
UNTERMAN_IPF_VS_CTRL_B_CELL_...,SET,27,-0.25545,-0.0097893,0.19627,0.90345,UNTERMAN_IPF_VS_CTRL_B_CELL_DN,0.99999
GOBP_MAMMARY_GLAND_EPITHELIU...,SET,67,-0.14792,-0.0089197,0.11365,0.90346,GOBP_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT,0.99999
GOMF_ADENYLATE_CYCLASE_ACTIV...,SET,14,-0.31128,-0.0085928,0.2391,0.90351,GOMF_ADENYLATE_CYCLASE_ACTIVITY,0.99999
GOBP_EXTRACELLULAR_TRANSPORT,SET,38,-0.16469,-0.007485,0.12646,0.90358,GOBP_EXTRACELLULAR_TRANSPORT,0.99999
HP_PARTIAL_ABSENCE_OF_SPECIF...2,SET,6,-0.49305,-0.0089122,0.37861,0.90358,HP_PARTIAL_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_UNCONJUGATED_PNEUMOCOCCUS_VACCINE,0.99999
HP_RESPIRATORY_INSUFFICIENCY,SET,561,-0.046807,-0.0080563,0.035942,0.90358,HP_RESPIRATORY_INSUFFICIENCY,0.99999
JISON_SICKLE_CELL_DISEASE_UP,SET,165,-0.088869,-0.0083873,0.068237,0.9036,JISON_SICKLE_CELL_DISEASE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...180,SET,35,-0.21265,-0.0092761,0.16322,0.90367,GOBP_POSITIVE_REGULATION_OF_CYCLASE_ACTIVITY,0.99999
GCM_FCGR2B,SET,35,-0.18435,-0.0080419,0.1415,0.90368,GCM_FCGR2B,0.99999
GOLDRATH_EFF_VS_MEMORY_CD8_T...2,SET,183,-0.08194,-0.0081402,0.062881,0.90372,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP,0.99999
GOBP_GLYCINE_IMPORT_ACROSS_P...,SET,5,-0.59662,-0.0098449,0.45783,0.90373,GOBP_GLYCINE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
FRIDMAN_IMMORTALIZATION_DN,SET,31,-0.20499,-0.0084163,0.15727,0.90378,FRIDMAN_IMMORTALIZATION_DN,0.99999
HMEF2_Q6,SET,129,-0.10042,-0.0083886,0.077033,0.90381,HMEF2_Q6,0.99999
TORCHIA_TARGETS_OF_EWSR1_FLI...4,SET,240,-0.074218,-0.0084304,0.056929,0.90382,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,0.99999
GOBP_BEHAVIOR,SET,611,-0.047689,-0.0085542,0.03658,0.90382,GOBP_BEHAVIOR,0.99999
GSE32255_WT_VS_JMJD2D_KNOCKD...2,SET,129,-0.10226,-0.0085418,0.078432,0.90384,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,0.99999
GOBP_INTERLEUKIN_1_MEDIATED_...,SET,29,-0.20046,-0.0079612,0.15372,0.90389,GOBP_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,0.99999
HP_GENERALIZED_HYPOPIGMENTAT...2,SET,45,-0.16769,-0.0082923,0.12859,0.90389,HP_GENERALIZED_HYPOPIGMENTATION_OF_HAIR,0.99999
REACTOME_SARS_COV_2_MODULATE...2,SET,42,-0.15961,-0.0076257,0.12239,0.9039,REACTOME_SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,0.99999
GOBP_REGULATION_OF_TRANSLATI...3,SET,13,-0.25658,-0.0068255,0.19672,0.90392,GOBP_REGULATION_OF_TRANSLATIONAL_FIDELITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...668,SET,14,-0.29099,-0.0080328,0.22302,0.90401,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_RECYCLING,0.99999
MIR6762_3P,SET,115,-0.099414,-0.0078437,0.076173,0.90406,MIR6762_3P,0.99999
MIR3154,SET,107,-0.1054,-0.0080236,0.080749,0.9041,MIR3154,0.99999
HP_ABNORMALITY_OF_CARDIOVASC...,SET,494,-0.051725,-0.0083701,0.039619,0.90414,HP_ABNORMALITY_OF_CARDIOVASCULAR_SYSTEM_ELECTROPHYSIOLOGY,0.99999
GSE32423_MEMORY_VS_NAIVE_CD8...2,SET,177,-0.08222,-0.0080343,0.062974,0.90415,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN,0.99999
HP_DISTAL_JOINT_HYPERMOBILITY,SET,7,-0.47182,-0.0092114,0.36133,0.90418,HP_DISTAL_JOINT_HYPERMOBILITY,0.99999
CTTGTAT_MIR381,SET,185,-0.083442,-0.0083341,0.063899,0.90419,CTTGTAT_MIR381,0.99999
KIM_WT1_TARGETS_12HR_UP,SET,154,-0.094105,-0.0085828,0.072051,0.90423,KIM_WT1_TARGETS_12HR_UP,0.99999
GSE45881_CXCR6HI_VS_CXCR1LO_...1,SET,184,-0.08198,-0.0081662,0.062768,0.90423,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_DN,0.99999
MIR632,SET,56,-0.15456,-0.0085236,0.11831,0.90429,MIR632,0.99999
MIR4795_3P,SET,629,-0.046504,-0.0084593,0.03559,0.90433,MIR4795_3P,0.99999
MIR8069,SET,57,-0.14728,-0.0081938,0.11271,0.90433,MIR8069,0.99999
REACTOME_G2_M_DNA_DAMAGE_CHE...,SET,55,-0.13935,-0.0076157,0.10662,0.90438,REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...6,SET,71,-0.14696,-0.0091216,0.11244,0.90438,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS,0.99999
REICHERT_G1S_REGULATORS_AS_P...,SET,8,-0.34683,-0.0072385,0.2653,0.90443,REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS,0.99999
MIR7847_3P,SET,65,-0.14302,-0.0084949,0.10937,0.90449,MIR7847_3P,0.99999
GSE36078_WT_VS_IL1R_KO_LUNG_...6,SET,183,-0.084357,-0.0083803,0.064508,0.9045,GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP,0.99999
GOBP_NUCLEOSIDE_TRIPHOSPHATE...1,SET,85,-0.10979,-0.0074531,0.083949,0.90452,GOBP_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GSE7460_TREG_VS_TCONV_ACT_WI...2,SET,175,-0.086276,-0.0083833,0.06596,0.90456,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP,0.99999
WP_PARKINSONS_DISEASE_PATHWAY,SET,33,-0.19353,-0.0081978,0.14794,0.90458,WP_PARKINSONS_DISEASE_PATHWAY,0.99999
MIR8067,SET,250,-0.069921,-0.0081038,0.053448,0.90459,MIR8067,0.99999
SF1_Q6,SET,233,-0.073379,-0.0082141,0.05609,0.90459,SF1_Q6,0.99999
GOBP_NEGATIVE_REGULATION_OF_...22,SET,9,-0.35234,-0.0077994,0.2693,0.90462,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.99999
WP_MBDNF_AND_PROBDNF_REGULAT...,SET,35,-0.21244,-0.0092669,0.16235,0.90464,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,0.99999
PATEL_SKIN_OF_BODY_ZOSTAVAX_...6,SET,259,-0.074292,-0.0087618,0.056775,0.90464,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP,0.99999
MIR4640_5P,SET,118,-0.096898,-0.0077436,0.07405,0.90465,MIR4640_5P,0.99999
GSE22886_CD8_TCELL_VS_BCELL_...2,SET,183,-0.079465,-0.0078943,0.060727,0.90465,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP,0.99999
GOBP_EMBRYONIC_MORPHOGENESIS,SET,573,-0.049971,-0.0086895,0.038186,0.90466,GOBP_EMBRYONIC_MORPHOGENESIS,0.99999
HP_ABNORMAL_PERIPHERAL_NERVO...2,SET,151,-0.087932,-0.007942,0.067185,0.90469,HP_ABNORMAL_PERIPHERAL_NERVOUS_SYSTEM_PHYSIOLOGY,0.99999
GSE3982_DC_VS_NEUTROPHIL_LPS...2,SET,176,-0.081317,-0.0079238,0.062124,0.90472,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP,0.99999
MCBRYAN_TERMINAL_END_BUD_UP,SET,12,-0.34709,-0.0088712,0.26508,0.90479,MCBRYAN_TERMINAL_END_BUD_UP,0.99999
JONES_OVARY_STROMAL,SET,134,-0.10479,-0.0089202,0.08003,0.90479,JONES_OVARY_STROMAL,0.99999
MODULE_345,SET,110,-0.10945,-0.0084466,0.083576,0.90482,MODULE_345,0.99999
HP_FACIAL_CAPILLARY_HEMANGIO...,SET,10,-0.38206,-0.0089146,0.29175,0.90482,HP_FACIAL_CAPILLARY_HEMANGIOMA,0.99999
HP_MACROVESICULAR_HEPATIC_ST...,SET,15,-0.25306,-0.0072306,0.19324,0.90482,HP_MACROVESICULAR_HEPATIC_STEATOSIS,0.99999
GOMF_S_ACYLTRANSFERASE_ACTIV...,SET,28,-0.19259,-0.0075156,0.14706,0.90483,GOMF_S_ACYLTRANSFERASE_ACTIVITY,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...1,SET,171,-0.088018,-0.0084552,0.06721,0.90483,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN,0.99999
HP_ATROPHY_DEGENERATION_INVO...3,SET,19,-0.24349,-0.0078291,0.18591,0.90484,HP_ATROPHY_DEGENERATION_INVOLVING_THE_SPINAL_CORD,0.99999
GOBP_RESPONSE_TO_FOLIC_ACID,SET,9,-0.36491,-0.0080777,0.27859,0.90487,GOBP_RESPONSE_TO_FOLIC_ACID,0.99999
GOBP_RNA_IMPORT_INTO_MITOCHO...,SET,5,-0.36744,-0.0060632,0.28049,0.90489,GOBP_RNA_IMPORT_INTO_MITOCHONDRION,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...1,SET,180,-0.078851,-0.0077694,0.060193,0.90489,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...337,SET,5,-0.57917,-0.009557,0.44207,0.90492,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.99999
UEDA_CENTRAL_CLOCK,SET,79,-0.12689,-0.0083059,0.096836,0.90495,UEDA_CENTRAL_CLOCK,0.99999
GOMF_PHOSPHORUS_OXYGEN_LYASE...,SET,20,-0.27118,-0.0089458,0.20695,0.90495,GOMF_PHOSPHORUS_OXYGEN_LYASE_ACTIVITY,0.99999
VANGURP_PANCREATIC_BETA_CELL,SET,107,-0.11475,-0.0087348,0.087566,0.90497,VANGURP_PANCREATIC_BETA_CELL,0.99999
GOBP_AXONEMAL_DYNEIN_COMPLEX...,SET,26,-0.19871,-0.0074728,0.15162,0.90499,GOBP_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY,0.99999
HP_DARK_URINE,SET,9,-0.37522,-0.0083059,0.28629,0.905,HP_DARK_URINE,0.99999
GOBP_LOW_DENSITY_LIPOPROTEIN...2,SET,15,-0.31342,-0.0089554,0.23912,0.90502,GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,0.99999
GOMF_DNA_APURINIC_OR_APYRIMI...,SET,12,-0.29067,-0.0074292,0.22175,0.90503,GOMF_DNA_APURINIC_OR_APYRIMIDINIC_SITE_ENDONUCLEASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...692,SET,5,-0.58535,-0.009659,0.44654,0.90504,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,0.99999
WANG_LSD1_TARGETS_DN,SET,34,-0.20597,-0.008856,0.15712,0.90505,WANG_LSD1_TARGETS_DN,0.99999
GSE17721_CTRL_VS_PAM3CSK4_2H...1,SET,183,-0.087165,-0.0086592,0.066487,0.90506,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_DN,0.99999
GOMF_GAP_JUNCTION_CHANNEL_AC...3,SET,8,-0.45457,-0.0094873,0.34665,0.90512,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY_INVOLVED_IN_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,0.99999
GOMF_PHOSPHATIDYLINOSITOL_PH...1,SET,6,-0.39845,-0.0072022,0.30383,0.90514,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_4_PHOSPHATASE_ACTIVITY,0.99999
WP_TGFBETA_SIGNALING_IN_THYR...,SET,19,-0.26316,-0.0084619,0.20065,0.90516,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,0.99999
GSE2770_IL4_ACT_VS_ACT_CD4_T...6,SET,171,-0.084864,-0.0081523,0.064702,0.90517,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,0.99999
MIR4766_3P,SET,151,-0.099179,-0.0089578,0.075591,0.90524,MIR4766_3P,0.99999
GOBP_NUCLEOSIDE_DIPHOSPHATE_...1,SET,13,-0.30205,-0.0080349,0.2302,0.90525,GOBP_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
HP_HYPERNASAL_SPEECH,SET,88,-0.12165,-0.0084024,0.0927,0.90529,HP_HYPERNASAL_SPEECH,0.99999
REACTOME_TRAF6_MEDIATED_IRF7...2,SET,10,-0.34933,-0.0081508,0.26609,0.90537,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_TH...6,SET,82,-0.11883,-0.007924,0.090492,0.90542,HP_ABNORMAL_MORPHOLOGY_OF_THE_MUSCULATURE_OF_THE_NECK,0.99999
HP_PROGRESSIVE_PROXIMAL_MUSC...,SET,21,-0.24143,-0.008161,0.18384,0.90545,HP_PROGRESSIVE_PROXIMAL_MUSCLE_WEAKNESS,0.99999
GOBP_GENERAL_ADAPTATION_SYND...1,SET,6,-0.50147,-0.0090644,0.38181,0.90547,GOBP_GENERAL_ADAPTATION_SYNDROME,0.99999
GSE19401_UNSTIM_VS_PAM2CSK4_...2,SET,175,-0.084925,-0.008252,0.064654,0.90549,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP,0.99999
GSE36888_UNTREATED_VS_IL2_TR...9,SET,162,-0.090283,-0.0084436,0.068723,0.90552,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_DN,0.99999
BROWNE_HCMV_INFECTION_20HR_DN,SET,90,-0.12252,-0.0085572,0.093253,0.90553,BROWNE_HCMV_INFECTION_20HR_DN,0.99999
ADA2_TARGET_GENES,SET,753,-0.041932,-0.0083163,0.03191,0.90558,ADA2_TARGET_GENES,0.99999
GOBP_MITOTIC_CELL_CYCLE,SET,838,-0.038827,-0.008104,0.029547,0.90558,GOBP_MITOTIC_CELL_CYCLE,0.99999
GOBP_REGULATION_OF_FOCAL_ADH...,SET,6,-0.48618,-0.008788,0.36997,0.90559,GOBP_REGULATION_OF_FOCAL_ADHESION_DISASSEMBLY,0.99999
HP_ANOMIC_APHASIA,SET,6,-0.45957,-0.0083069,0.3497,0.9056,HP_ANOMIC_APHASIA,0.99999
GOBP_REGULATION_OF_LYASE_ACT...,SET,53,-0.16452,-0.0088273,0.12519,0.90561,GOBP_REGULATION_OF_LYASE_ACTIVITY,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...11,SET,162,-0.08846,-0.0082731,0.067299,0.90564,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN,0.99999
GOBP_AORTA_SMOOTH_MUSCLE_TIS...,SET,4,-0.56782,-0.0083808,0.43181,0.90573,GOBP_AORTA_SMOOTH_MUSCLE_TISSUE_MORPHOGENESIS,0.99999
HP_CYSTATHIONINEMIA,SET,5,-0.49171,-0.0081137,0.37385,0.90578,HP_CYSTATHIONINEMIA,0.99999
GOBP_REGULATION_OF_RESPIRATO...5,SET,14,-0.32949,-0.0090955,0.25049,0.9058,GOBP_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS,0.99999
HP_UNDETECTABLE_VISUAL_EVOKE...,SET,8,-0.36793,-0.0076789,0.2797,0.90581,HP_UNDETECTABLE_VISUAL_EVOKED_POTENTIALS,0.99999
BROCKE_APOPTOSIS_REVERSED_BY...,SET,136,-0.098343,-0.008433,0.074745,0.90585,BROCKE_APOPTOSIS_REVERSED_BY_IL6,0.99999
SCHLINGEMANN_SKIN_CARCINOGEN...1,SET,23,-0.22368,-0.0079123,0.16997,0.9059,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,0.99999
GOMF_WD40_REPEAT_DOMAIN_BIND...,SET,4,-0.49659,-0.0073294,0.37734,0.90591,GOMF_WD40_REPEAT_DOMAIN_BINDING,0.99999
MIR128_1_5P,SET,12,-0.36725,-0.0093864,0.27905,0.90592,MIR128_1_5P,0.99999
HP_SMALL_THENAR_EMINENCE,SET,10,-0.37552,-0.0087621,0.28532,0.90593,HP_SMALL_THENAR_EMINENCE,0.99999
GNF2_FOS,SET,34,-0.20487,-0.0088084,0.15562,0.90598,GNF2_FOS,0.99999
LAKE_ADULT_KIDNEY_C23_ENDOTH...,SET,115,-0.10866,-0.0085729,0.082513,0.90605,LAKE_ADULT_KIDNEY_C23_ENDOTHELIAL_CELLS_AVR,0.99999
KEGG_MEDICUS_REFERENCE_KITLG...1,SET,11,-0.34266,-0.0083853,0.26018,0.90607,KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY,0.99999
DESCARTES_FETAL_PANCREAS_LYM...2,SET,112,-0.11488,-0.008946,0.087231,0.90607,DESCARTES_FETAL_PANCREAS_LYMPHOID_CELLS,0.99999
MODULE_522,SET,30,-0.21447,-0.0086627,0.16283,0.90609,MODULE_522,0.99999
CHEOK_RESPONSE_TO_MERCAPTOPU...1,SET,23,-0.24585,-0.0086965,0.18663,0.90612,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HRN,SET,300,-0.070485,-0.0089365,0.053485,0.90621,MANNO_MIDBRAIN_NEUROTYPES_HRN,0.99999
GOBP_GALACTOLIPID_METABOLIC_...,SET,9,-0.41115,-0.0091013,0.31198,0.90622,GOBP_GALACTOLIPID_METABOLIC_PROCESS,0.99999
chr5p12,SET,12,-0.52175,-0.013335,0.39578,0.90628,chr5p12,0.99999
REACTOME_EPHA_MEDIATED_GROWT...,SET,29,-0.22696,-0.0090134,0.17217,0.90628,REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE,0.99999
GOBP_PLANAR_CELL_POLARITY_PA...2,SET,10,-0.36448,-0.0085044,0.27647,0.90629,GOBP_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_NEURAL_TUBE_CLOSURE,0.99999
GOBP_BRANCHED_CHAIN_AMINO_AC...1,SET,5,-0.56233,-0.009279,0.42651,0.90631,GOBP_BRANCHED_CHAIN_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.99999
GOMF_VITAMIN_D_BINDING,SET,6,-0.52303,-0.009454,0.39667,0.90633,GOMF_VITAMIN_D_BINDING,0.99999
HP_ABNORMAL_NASOLACRIMAL_SYS...,SET,63,-0.13947,-0.0081562,0.10578,0.90633,HP_ABNORMAL_NASOLACRIMAL_SYSTEM_MORPHOLOGY,0.99999
KIM_GERMINAL_CENTER_T_HELPER...1,SET,12,-0.39036,-0.0099771,0.29603,0.90635,KIM_GERMINAL_CENTER_T_HELPER_DN,0.99999
HP_RHABDOMYOMA,SET,5,-0.55851,-0.009216,0.42346,0.90639,HP_RHABDOMYOMA,0.99999
HP_CNS_DEMYELINATION,SET,45,-0.17062,-0.0084369,0.12933,0.90644,HP_CNS_DEMYELINATION,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...13,SET,9,-0.3641,-0.0080598,0.27597,0.90646,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY,0.99999
GOMF_EXTRACELLULAR_MATRIX_ST...1,SET,152,-0.099758,-0.0090397,0.075586,0.90654,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT,0.99999
HP_INCREASED_CEREBRAL_LIPOFU...,SET,11,-0.33066,-0.0080915,0.25051,0.90656,HP_INCREASED_CEREBRAL_LIPOFUSCIN,0.99999
GOMF_CARBON_OXYGEN_LYASE_ACT...,SET,69,-0.13447,-0.0082287,0.10187,0.90658,GOMF_CARBON_OXYGEN_LYASE_ACTIVITY,0.99999
REACTOME_STABILIZATION_OF_P53,SET,53,-0.13562,-0.0072764,0.10272,0.90661,REACTOME_STABILIZATION_OF_P53,0.99999
GSE30971_CTRL_VS_LPS_STIM_MA...5,SET,173,-0.085925,-0.0083019,0.065083,0.90661,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_DN,0.99999
USF_01,SET,229,-0.075216,-0.0083481,0.056959,0.90666,USF_01,0.99999
HP_CERVICAL_LYMPHADENOPATHY,SET,9,-0.33879,-0.0074995,0.25656,0.90666,HP_CERVICAL_LYMPHADENOPATHY,0.99999
WP_GLYCOGEN_SYNTHESIS_AND_DE...,SET,35,-0.17932,-0.0078223,0.13578,0.90669,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,0.99999
HP_ACUTE_LYMPHOBLASTIC_LEUKE...,SET,40,-0.19105,-0.0089084,0.14466,0.9067,HP_ACUTE_LYMPHOBLASTIC_LEUKEMIA,0.99999
REACTOME_EUKARYOTIC_TRANSLAT...1,SET,85,-0.11849,-0.0080443,0.089711,0.90671,REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_D...2,SET,9,-0.35052,-0.0077591,0.26537,0.90671,GOBP_PYRIMIDINE_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.99999
HUMMERICH_SKIN_CANCER_PROGRE...2,SET,83,-0.13311,-0.0089303,0.10078,0.90672,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,0.99999
KENNY_CTNNB1_TARGETS_DN,SET,49,-0.16297,-0.0084086,0.12338,0.90672,KENNY_CTNNB1_TARGETS_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...422,SET,35,-0.21352,-0.0093141,0.16164,0.90673,GOBP_POSITIVE_REGULATION_OF_LYASE_ACTIVITY,0.99999
GOCC_NBAF_COMPLEX,SET,16,-0.27665,-0.0081637,0.20943,0.90673,GOCC_NBAF_COMPLEX,0.99999
GOBP_NEUROPEPTIDE_SIGNALING_...,SET,92,-0.12777,-0.0090224,0.096718,0.90675,GOBP_NEUROPEPTIDE_SIGNALING_PATHWAY,0.99999
MIR5705,SET,5,-0.469,-0.0077391,0.355,0.90676,MIR5705,0.99999
chr8q13,SET,31,-0.4511,-0.018521,0.34143,0.90677,chr8q13,0.99999
MIR3663_3P,SET,134,-0.095232,-0.0081064,0.072078,0.90678,MIR3663_3P,0.99999
MODULE_410,SET,35,-0.21011,-0.0091656,0.15901,0.90681,MODULE_410,0.99999
GSE36392_EOSINOPHIL_VS_MAC_I...1,SET,177,-0.082263,-0.0080385,0.062251,0.90682,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_DN,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_M...2,SET,14,-0.27985,-0.0077253,0.21176,0.90683,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
WP_BREAST_CANCER_PATHWAY,SET,149,-0.095694,-0.0085861,0.072393,0.90689,WP_BREAST_CANCER_PATHWAY,0.99999
REACTOME_SIGNALING_BY_NOTCH2,SET,30,-0.22019,-0.0088937,0.16655,0.90691,REACTOME_SIGNALING_BY_NOTCH2,0.99999
GSE7348_UNSTIM_VS_TOLERIZED_...2,SET,147,-0.086016,-0.0076662,0.065049,0.90696,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,0.99999
HALLMARK_PI3K_AKT_MTOR_SIGNA...,SET,102,-0.10606,-0.0078838,0.080198,0.90699,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.99999
REACTOME_SARS_COV_2_TARGETS_...1,SET,12,-0.34886,-0.0089164,0.26376,0.90702,REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS,0.99999
GOBP_HYALURONAN_BIOSYNTHETIC...,SET,14,-0.31082,-0.0085801,0.235,0.90702,GOBP_HYALURONAN_BIOSYNTHETIC_PROCESS,0.99999
HP_MULTIPLE_LENTIGINES,SET,15,-0.27171,-0.0077637,0.20534,0.90711,HP_MULTIPLE_LENTIGINES,0.99999
KEGG_BUTANOATE_METABOLISM,SET,31,-0.20092,-0.0082496,0.15179,0.90719,KEGG_BUTANOATE_METABOLISM,0.99999
KEGG_MEDICUS_PATHOGEN_HPV_E7...2,SET,7,-0.38168,-0.0074517,0.28833,0.9072,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_P27_CELL_CYCLE_G1_S,0.99999
GSE17721_0.5H_VS_8H_LPS_BMDC...1,SET,180,-0.084286,-0.008305,0.063671,0.9072,GSE17721_0.5H_VS_8H_LPS_BMDC_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...782,SET,95,-0.12375,-0.0088794,0.093476,0.90722,GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.99999
GOBP_RIBOSE_PHOSPHATE_METABO...,SET,405,-0.055395,-0.0081366,0.041841,0.90723,GOBP_RIBOSE_PHOSPHATE_METABOLIC_PROCESS,0.99999
GOBP_N_ACETYLNEURAMINATE_MET...,SET,11,-0.35299,-0.0086381,0.26648,0.90735,GOBP_N_ACETYLNEURAMINATE_METABOLIC_PROCESS,0.99999
GOBP_CAVEOLA_ASSEMBLY,SET,6,-0.52253,-0.009445,0.3944,0.90738,GOBP_CAVEOLA_ASSEMBLY,0.99999
MODULE_454,SET,10,-0.40047,-0.009344,0.30219,0.90744,MODULE_454,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_T...1,SET,17,-0.27676,-0.008418,0.20884,0.90744,GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
MOREAUX_MULTIPLE_MYELOMA_BY_...2,SET,326,-0.065901,-0.0087036,0.049716,0.9075,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,0.99999
GSE21546_SAP1A_KO_VS_SAP1A_K...1,SET,190,-0.085077,-0.0086102,0.064178,0.90751,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.99999
HP_PERIPHERAL_ARTERIOVENOUS_...,SET,7,-0.43413,-0.0084756,0.32748,0.90752,HP_PERIPHERAL_ARTERIOVENOUS_FISTULA,0.99999
GOBP_PROTEIN_EXIT_FROM_ENDOP...,SET,45,-0.15472,-0.007651,0.11671,0.90753,GOBP_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...349,SET,91,-0.12167,-0.0085449,0.091771,0.90754,GOBP_NEGATIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...656,SET,57,-0.16072,-0.0089417,0.12119,0.9076,GOBP_NEGATIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,0.99999
GOMF_FLOPPASE_ACTIVITY,SET,15,-0.31429,-0.0089803,0.23699,0.9076,GOMF_FLOPPASE_ACTIVITY,0.99999
HP_GASTROINTESTINAL_ATRESIA,SET,75,-0.12911,-0.0082356,0.097354,0.90761,HP_GASTROINTESTINAL_ATRESIA,0.99999
KEGG_MEDICUS_REFERENCE_ADRB3...,SET,35,-0.19627,-0.0085617,0.14798,0.90763,KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY,0.99999
MIR4703_3P,SET,37,-0.18351,-0.0082302,0.13832,0.90768,MIR4703_3P,0.99999
HP_DYSGYRIA,SET,7,-0.43139,-0.0084222,0.32512,0.90771,HP_DYSGYRIA,0.99999
GOBP_AMYLOID_PRECURSOR_PROTE...3,SET,70,-0.13387,-0.0082509,0.10089,0.90772,GOBP_AMYLOID_PRECURSOR_PROTEIN_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_PHOSPHOLI...5,SET,14,-0.30936,-0.0085398,0.23312,0.90774,GOBP_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...24,SET,35,-0.15989,-0.0069747,0.12048,0.90775,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
SCHERER_PBMC_APSV_WETVAX_AGE...1,SET,31,-0.19648,-0.0080673,0.14806,0.90775,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_2_TO_4DY_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...256,SET,176,-0.089289,-0.0087006,0.067279,0.90776,GOBP_POSITIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,0.99999
FAN_OVARY_CL9_PUTATIVE_APOPT...,SET,328,-0.062793,-0.008318,0.04731,0.90778,FAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL,0.99999
BIOCARTA_P53_PATHWAY,SET,16,-0.2524,-0.0074482,0.19016,0.90779,BIOCARTA_P53_PATHWAY,0.99999
PID_RB_1PATHWAY,SET,60,-0.14317,-0.0081718,0.10787,0.90779,PID_RB_1PATHWAY,0.99999
MIR6503_5P,SET,52,-0.15117,-0.0080341,0.11386,0.90784,MIR6503_5P,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...66,SET,12,-0.33565,-0.0085787,0.25279,0.90786,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY,0.99999
GOBP_NUCLEOSIDE_DIPHOSPHATE_...2,SET,96,-0.10957,-0.007903,0.082514,0.90789,GOBP_NUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...3,SET,3,-0.55137,-0.0070479,0.4152,0.9079,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY_DN,0.99999
GOBP_SYNAPSE_ASSEMBLY,SET,190,-0.090724,-0.0091818,0.068303,0.90794,GOBP_SYNAPSE_ASSEMBLY,0.99999
HP_EBSTEIN_ANOMALY_OF_THE_TR...,SET,5,-0.5972,-0.0098545,0.44962,0.90794,HP_EBSTEIN_ANOMALY_OF_THE_TRICUSPID_VALVE,0.99999
GOBP_SINGLE_FERTILIZATION,SET,150,-0.095304,-0.0085795,0.071738,0.90799,GOBP_SINGLE_FERTILIZATION,0.99999
GSE17721_0.5H_VS_4H_PAM3CSK4...1,SET,191,-0.083135,-0.0084356,0.062569,0.90802,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN,0.99999
PUJANA_BRCA2_PCC_NETWORK,SET,394,-0.054664,-0.0079218,0.041135,0.90805,PUJANA_BRCA2_PCC_NETWORK,0.99999
REACTOME_DNA_REPLICATION_INI...,SET,7,-0.34095,-0.0066565,0.25656,0.90806,REACTOME_DNA_REPLICATION_INITIATION,0.99999
HP_BROAD_ISCHIA,SET,5,-0.52627,-0.0086841,0.39593,0.9081,HP_BROAD_ISCHIA,0.99999
GSE39556_UNTREATED_VS_3H_POL...4,SET,178,-0.083508,-0.008183,0.062826,0.9081,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP,0.99999
WESTON_VEGFA_TARGETS,SET,85,-0.12941,-0.0087851,0.097344,0.90813,WESTON_VEGFA_TARGETS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...278,SET,10,-0.39003,-0.0091006,0.29339,0.90813,GOBP_NEGATIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...1,SET,32,-0.20634,-0.0086072,0.15521,0.90813,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_BOWMANS_GLAND,0.99999
GOCC_ENDOPLASMIC_RETICULUM_E...,SET,28,-0.20514,-0.0080055,0.1543,0.90816,GOCC_ENDOPLASMIC_RETICULUM_EXIT_SITE,0.99999
MODULE_201,SET,48,-0.16805,-0.0085816,0.12637,0.90819,MODULE_201,0.99999
PECE_MAMMARY_STEM_CELL_DN,SET,122,-0.10214,-0.0082984,0.076804,0.9082,PECE_MAMMARY_STEM_CELL_DN,0.99999
HP_IMPAIRED_TACTILE_SENSATION,SET,32,-0.18617,-0.0077658,0.13997,0.90824,HP_IMPAIRED_TACTILE_SENSATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...602,SET,44,-0.18631,-0.0091103,0.14007,0.90826,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.99999
KAYO_AGING_MUSCLE_DN,SET,106,-0.10332,-0.0078282,0.077663,0.90829,KAYO_AGING_MUSCLE_DN,0.99999
NATSUME_RESPONSE_TO_INTERFER...2,SET,68,-0.14719,-0.0089413,0.11063,0.90829,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,0.99999
MIR3118,SET,70,-0.13986,-0.0086202,0.10513,0.9083,MIR3118,0.99999
JIANG_AGING_HYPOTHALAMUS_DN,SET,30,-0.19895,-0.0080361,0.14951,0.90835,JIANG_AGING_HYPOTHALAMUS_DN,0.99999
WP_PROLACTIN_SIGNALING,SET,72,-0.14207,-0.0088798,0.10675,0.90838,WP_PROLACTIN_SIGNALING,0.99999
CGCTGCT_MIR503,SET,21,-0.24021,-0.0081196,0.18049,0.90838,CGCTGCT_MIR503,0.99999
HP_HYPOHIDROSIS,SET,64,-0.14906,-0.0087858,0.11196,0.90846,HP_HYPOHIDROSIS,0.99999
REACTOME_REGULATION_OF_MRNA_...,SET,83,-0.11648,-0.0078145,0.087436,0.9086,REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,0.99999
GOBP_REGULATION_OF_HETEROTYP...,SET,24,-0.24631,-0.0089,0.18487,0.90861,GOBP_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION,0.99999
MORF_JAK3,SET,90,-0.11873,-0.0082929,0.089114,0.90862,MORF_JAK3,0.99999
GSE30971_2H_VS_4H_LPS_STIM_M...3,SET,176,-0.086936,-0.0084713,0.06524,0.90865,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_DN,0.99999
GOBP_ADENYLATE_CYCLASE_ACTIV...3,SET,162,-0.096438,-0.0090192,0.072357,0.90869,GOBP_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
CYCLIN_D1_KE_.V1_UP,SET,176,-0.084723,-0.0082557,0.063569,0.90869,CYCLIN_D1_KE_.V1_UP,0.99999
HP_GINGIVAL_BLEEDING,SET,52,-0.17219,-0.0091512,0.12917,0.90873,HP_GINGIVAL_BLEEDING,0.99999
HP_CRANIAL_ASYMMETRY,SET,15,-0.29885,-0.008539,0.22416,0.90876,HP_CRANIAL_ASYMMETRY,0.99999
EPC1_TARGET_GENES,SET,308,-0.064293,-0.0082575,0.048218,0.90879,EPC1_TARGET_GENES,0.99999
HP_ABNORMALITY_OF_THE_GLABEL...,SET,22,-0.25024,-0.0086576,0.18767,0.90879,HP_ABNORMALITY_OF_THE_GLABELLA,0.99999
REACTOME_SYNTHESIS_SECRETION...2,SET,20,-0.2826,-0.0093228,0.21184,0.9089,REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1,0.99999
GOBP_REGULATION_OF_MIRNA_MET...,SET,81,-0.12834,-0.0085063,0.09617,0.90898,GOBP_REGULATION_OF_MIRNA_METABOLIC_PROCESS,0.99999
AMEF2_Q6,SET,229,-0.078619,-0.0087258,0.058906,0.909,AMEF2_Q6,0.99999
HP_PAPILLARY_CYSTADENOMA_OF_...,SET,5,-0.5445,-0.0089849,0.40796,0.909,HP_PAPILLARY_CYSTADENOMA_OF_THE_EPIDIDYMIS,0.99999
MODULE_534,SET,9,-0.40795,-0.0090305,0.30553,0.90909,MODULE_534,0.99999
HP_ABNORMAL_HELIX_MORPHOLOGY,SET,151,-0.093509,-0.0084457,0.07002,0.90913,HP_ABNORMAL_HELIX_MORPHOLOGY,0.99999
TAYLOR_METHYLATED_IN_ACUTE_L...,SET,66,-0.14145,-0.0084659,0.10587,0.90922,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,0.99999
REACTOME_FC_EPSILON_RECEPTOR...,SET,125,-0.096323,-0.0079211,0.072096,0.90922,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,0.99999
DAVIES_MULTIPLE_MYELOMA_VS_M...2,SET,12,-0.288,-0.007361,0.21553,0.90926,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP,0.99999
WP_NOTCH_SIGNALING_WP61,SET,58,-0.15,-0.008418,0.11223,0.90931,WP_NOTCH_SIGNALING_WP61,0.99999
GOCC_STEREOCILIUM_TIP,SET,17,-0.29726,-0.0090418,0.22237,0.90935,GOCC_STEREOCILIUM_TIP,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...2,SET,178,-0.082511,-0.0080853,0.061716,0.90937,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP,0.99999
GOBP_MITOCHONDRIAL_TRNA_PROC...,SET,12,-0.28558,-0.0072989,0.21355,0.90942,GOBP_MITOCHONDRIAL_TRNA_PROCESSING,0.99999
SHI_SPARC_TARGETS_DN,SET,12,-0.3649,-0.0093262,0.27283,0.90946,SHI_SPARC_TARGETS_DN,0.99999
GSE7460_CD8_TCELL_VS_TREG_AC...1,SET,179,-0.080931,-0.0079525,0.060489,0.90953,GSE7460_CD8_TCELL_VS_TREG_ACT_DN,0.99999
GOMF_NAADP_SENSITIVE_CALCIUM...,SET,5,-0.53147,-0.0087699,0.39723,0.90954,GOMF_NAADP_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.99999
PAX3_01,SET,18,-0.244,-0.0076368,0.18233,0.90958,PAX3_01,0.99999
GOBP_ICOSANOID_TRANSPORT,SET,64,-0.15522,-0.0091489,0.11598,0.9096,GOBP_ICOSANOID_TRANSPORT,0.99999
TSHZ1_TARGET_GENES,SET,180,-0.082633,-0.0081421,0.061708,0.90972,TSHZ1_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...339,SET,129,-0.10866,-0.0090763,0.081137,0.90973,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION,0.99999
WP_CYTOSINE_METHYLATION,SET,7,-0.46966,-0.0091693,0.35061,0.90979,WP_CYTOSINE_METHYLATION,0.99999
GOBP_REGULATION_OF_PLASMA_ME...2,SET,6,-0.493,-0.0089113,0.368,0.90982,GOBP_REGULATION_OF_PLASMA_MEMBRANE_REPAIR,0.99999
GOMF_HISTONE_H3K4_DEMETHYLAS...,SET,4,-0.53942,-0.0079615,0.40263,0.90982,GOMF_HISTONE_H3K4_DEMETHYLASE_ACTIVITY,0.99999
HP_PURSED_LIPS,SET,4,-0.66978,-0.0098856,0.49982,0.90987,HP_PURSED_LIPS,0.99999
CRX_NRL_DN.V1_DN,SET,112,-0.11319,-0.0088144,0.084466,0.90989,CRX_NRL_DN.V1_DN,0.99999
GSE2770_UNTREATED_VS_IL4_TRE...3,SET,173,-0.082428,-0.0079639,0.061505,0.9099,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.99999
PID_CERAMIDE_PATHWAY,SET,43,-0.17676,-0.0085447,0.13189,0.90991,PID_CERAMIDE_PATHWAY,0.99999
MIR3935,SET,70,-0.13771,-0.0084872,0.10275,0.90991,MIR3935,0.99999
MIR1303,SET,189,-0.083987,-0.0084778,0.062642,0.90999,MIR1303,0.99999
GOBP_REGULATION_OF_CHROMOSOM...3,SET,125,-0.097563,-0.0080232,0.072762,0.91001,GOBP_REGULATION_OF_CHROMOSOME_SEGREGATION,0.99999
GOCC_PROTON_TRANSPORTING_TWO...2,SET,13,-0.37178,-0.0098898,0.27726,0.91002,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_CATALYTIC_DOMAIN,0.99999
MIR3150B_3P,SET,137,-0.098775,-0.0085009,0.073652,0.91005,MIR3150B_3P,0.99999
GSE34179_THPOK_KO_VS_WT_VA14...1,SET,183,-0.087124,-0.0086552,0.064957,0.91007,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN,0.99999
HP_KINETIC_TREMOR,SET,90,-0.11379,-0.0079475,0.084823,0.9101,HP_KINETIC_TREMOR,0.99999
REACTOME_REGULATION_OF_ENDOG...2,SET,47,-0.16151,-0.0081617,0.1204,0.91011,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS,0.99999
HP_ORAL_CAVITY_BLEEDING,SET,19,-0.29313,-0.0094254,0.21848,0.91014,HP_ORAL_CAVITY_BLEEDING,0.99999
LUCAS_HNF4A_TARGETS_DN,SET,7,-0.43975,-0.0085855,0.32775,0.91015,LUCAS_HNF4A_TARGETS_DN,0.99999
GSE13887_RESTING_VS_NO_TREAT...2,SET,113,-0.11314,-0.0088494,0.084327,0.91015,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP,0.99999
MULLIGHAN_MLL_SIGNATURE_1_UP,SET,353,-0.059656,-0.0081924,0.044453,0.91019,MULLIGHAN_MLL_SIGNATURE_1_UP,0.99999
DAZARD_UV_RESPONSE_CLUSTER_G...2,SET,17,-0.32086,-0.0097596,0.23905,0.91023,DAZARD_UV_RESPONSE_CLUSTER_G28,0.99999
GOBP_RESPONSE_TO_PEPTIDE,SET,20,-0.27499,-0.0090717,0.20483,0.91028,GOBP_RESPONSE_TO_PEPTIDE,0.99999
MIR129_1_3P_MIR129_2_3P,SET,120,-0.10615,-0.0085541,0.07906,0.9103,MIR129_1_3P_MIR129_2_3P,0.99999
GOCC_ER_MEMBRANE_INSERTION_C...,SET,12,-0.32574,-0.0083254,0.24258,0.91032,GOCC_ER_MEMBRANE_INSERTION_COMPLEX,0.99999
YAUCH_HEDGEHOG_SIGNALING_PAR...1,SET,237,-0.076349,-0.0086187,0.056838,0.9104,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,0.99999
HALLMARK_ESTROGEN_RESPONSE_E...,SET,187,-0.091385,-0.0091762,0.068011,0.91046,HALLMARK_ESTROGEN_RESPONSE_EARLY,0.99999
MIR10525_3P,SET,55,-0.16363,-0.0089428,0.12177,0.91047,MIR10525_3P,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...9,SET,45,-0.18998,-0.0093946,0.14138,0.91048,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_7,0.99999
chr10q23,SET,81,-0.2459,-0.016298,0.18298,0.91049,chr10q23,0.99999
GOBP_RESPONSE_TO_KETONE,SET,201,-0.086602,-0.0090121,0.064438,0.91051,GOBP_RESPONSE_TO_KETONE,0.99999
HP_ABNORMAL_LATERAL_VENTRICL...,SET,104,-0.11106,-0.0083352,0.082633,0.91051,HP_ABNORMAL_LATERAL_VENTRICLE_MORPHOLOGY,0.99999
HP_PROMINENCE_OF_THE_PREMAXI...,SET,7,-0.40476,-0.0079022,0.30115,0.91053,HP_PROMINENCE_OF_THE_PREMAXILLA,0.99999
HP_RENAL_NECROSIS,SET,5,-0.51157,-0.0084414,0.38059,0.91054,HP_RENAL_NECROSIS,0.99999
GOBP_REGULATION_OF_ADIPOSE_T...,SET,14,-0.31091,-0.0085827,0.2313,0.91055,GOBP_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.99999
HP_NEOPLASM_OF_THE_LARGE_INT...,SET,108,-0.10644,-0.0081401,0.079179,0.91057,HP_NEOPLASM_OF_THE_LARGE_INTESTINE,0.99999
BONCI_TARGETS_OF_MIR15A_AND_...,SET,90,-0.11858,-0.0082825,0.088208,0.91058,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,0.99999
MODULE_315,SET,16,-0.28986,-0.0085535,0.2156,0.91059,MODULE_315,0.99999
HP_ABNORMAL_B_CELL_MORPHOLOGY,SET,90,-0.12323,-0.0086074,0.091639,0.91064,HP_ABNORMAL_B_CELL_MORPHOLOGY,0.99999
GOBP_CD4_POSITIVE_ALPHA_BETA...2,SET,19,-0.27299,-0.0087779,0.203,0.91065,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_CYTOKINE_PRODUCTION,0.99999
ZNF595_TARGET_GENES,SET,99,-0.11586,-0.0084852,0.086147,0.91066,ZNF595_TARGET_GENES,0.99999
GSE21546_SAP1A_KO_VS_SAP1A_K...4,SET,175,-0.083814,-0.0081441,0.062321,0.91066,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.99999
DAZARD_UV_RESPONSE_CLUSTER_G5,SET,8,-0.28946,-0.0060413,0.2152,0.91069,DAZARD_UV_RESPONSE_CLUSTER_G5,0.99999
REACTOME_ACTIVATION_OF_AMPK_...,SET,26,-0.23878,-0.0089797,0.17752,0.91069,REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS,0.99999
MIR10401_5P,SET,73,-0.13881,-0.0087359,0.10316,0.91078,MIR10401_5P,0.99999
GSE3982_CENT_MEMORY_CD4_TCEL...3,SET,182,-0.080345,-0.0079601,0.059707,0.91078,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN,0.99999
MURARO_PANCREAS_ALPHA_CELL,SET,470,-0.055555,-0.0087746,0.04128,0.91081,MURARO_PANCREAS_ALPHA_CELL,0.99999
WP_LUNG_PATHOLOGY_OF_COVID19,SET,15,-0.30299,-0.0086573,0.22511,0.91083,WP_LUNG_PATHOLOGY_OF_COVID19,0.99999
GOBP_POSITIVE_REGULATION_OF_...660,SET,18,-0.27751,-0.0086855,0.20619,0.91083,GOBP_POSITIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
REACTOME_MOLECULES_ASSOCIATE...,SET,35,-0.2014,-0.0087854,0.14956,0.91094,REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,0.99999
HP_DRY_SKIN,SET,163,-0.087763,-0.008233,0.065153,0.91101,HP_DRY_SKIN,0.99999
MIR4268,SET,54,-0.1652,-0.0089466,0.12263,0.91102,MIR4268,0.99999
GSE360_CTRL_VS_B_MALAYI_HIGH...4,SET,178,-0.082698,-0.0081035,0.061374,0.91107,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.99999
ESC_V6.5_UP_EARLY.V1_DN,SET,148,-0.099306,-0.0088805,0.07368,0.91113,ESC_V6.5_UP_EARLY.V1_DN,0.99999
AGCTCCT_MIR28,SET,79,-0.1283,-0.0083981,0.095186,0.91114,AGCTCCT_MIR28,0.99999
GOBP_CALCIUM_ION_TRANSPORT,SET,396,-0.061159,-0.0088851,0.045361,0.91121,GOBP_CALCIUM_ION_TRANSPORT,0.99999
HNF6_Q6,SET,217,-0.084084,-0.0090876,0.062355,0.91124,HNF6_Q6,0.99999
GSE43955_10H_VS_30H_ACT_CD4_...1,SET,185,-0.084834,-0.0084732,0.062912,0.91124,GSE43955_10H_VS_30H_ACT_CD4_TCELL_DN,0.99999
GSE6092_IFNG_VS_IFNG_AND_B_B...1,SET,160,-0.094323,-0.0087673,0.06994,0.91126,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,0.99999
REACTOME_PTK6_REGULATES_RHO_...,SET,14,-0.29579,-0.0081653,0.21932,0.91127,REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES,0.99999
GOBP_REGULATION_OF_CELL_SUBS...1,SET,202,-0.084037,-0.0087666,0.062312,0.91127,GOBP_REGULATION_OF_CELL_SUBSTRATE_ADHESION,0.99999
REACTOME_FORMATION_OF_APOPTO...,SET,10,-0.36549,-0.008528,0.27097,0.9113,REACTOME_FORMATION_OF_APOPTOSOME,0.99999
KAUFFMANN_DNA_REPLICATION_GE...,SET,135,-0.094185,-0.008047,0.06982,0.91132,KAUFFMANN_DNA_REPLICATION_GENES,0.99999
WP_HEAD_AND_NECK_SQUAMOUS_CE...,SET,73,-0.13723,-0.0086365,0.10169,0.9114,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,0.99999
MIR668_3P,SET,54,-0.15441,-0.0083623,0.11441,0.91143,MIR668_3P,0.99999
HP_CELLULAR_IMMUNODEFICIENCY,SET,33,-0.1859,-0.0078746,0.13773,0.91144,HP_CELLULAR_IMMUNODEFICIENCY,0.99999
DE_YY1_TARGETS_UP,SET,17,-0.31079,-0.0094533,0.23025,0.91145,DE_YY1_TARGETS_UP,0.99999
HP_HYPOPLASTIC_PUBIC_RAMUS,SET,6,-0.49951,-0.009029,0.37007,0.91145,HP_HYPOPLASTIC_PUBIC_RAMUS,0.99999
HP_APPENDICULAR_SPASTICITY,SET,334,-0.062025,-0.0082898,0.045943,0.91149,HP_APPENDICULAR_SPASTICITY,0.99999
GOBP_CYTOKINE_PRODUCTION,SET,720,-0.045218,-0.0087777,0.033492,0.9115,GOBP_CYTOKINE_PRODUCTION,0.99999
LEE_LIVER_CANCER_DENA_DN,SET,71,-0.13725,-0.0085193,0.10165,0.91153,LEE_LIVER_CANCER_DENA_DN,0.99999
MIR1825,SET,149,-0.096139,-0.008626,0.071198,0.91153,MIR1825,0.99999
STAT_Q6,SET,234,-0.077564,-0.0087011,0.05744,0.91154,STAT_Q6,0.99999
HP_BILATERAL_PTOSIS,SET,63,-0.14755,-0.0086288,0.10925,0.91157,HP_BILATERAL_PTOSIS,0.99999
DESCARTES_FETAL_PLACENTA_PAE...,SET,132,-0.10758,-0.0090899,0.079647,0.91161,DESCARTES_FETAL_PLACENTA_PAEP_MECOM_POSITIVE_CELLS,0.99999
MIR210_5P,SET,49,-0.16439,-0.0084816,0.12169,0.91162,MIR210_5P,0.99999
LINDGREN_BLADDER_CANCER_CLUS...5,SET,343,-0.067718,-0.0091694,0.050128,0.91163,LINDGREN_BLADDER_CANCER_CLUSTER_2B,0.99999
GSE7764_IL15_TREATED_VS_CTRL...1,SET,180,-0.08997,-0.008865,0.066598,0.91163,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN,0.99999
HP_FOOT_JOINT_CONTRACTURE,SET,123,-0.10349,-0.0084427,0.0766,0.91165,HP_FOOT_JOINT_CONTRACTURE,0.99999
GSE9006_TYPE_1_DIABETES_AT_D...3,SET,172,-0.082393,-0.0079378,0.060984,0.91165,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN,0.99999
GOBP_CELL_CYCLE_PROCESS,SET,1143,-0.034375,-0.0083061,0.02544,0.91168,GOBP_CELL_CYCLE_PROCESS,0.99999
GOCC_APICOLATERAL_PLASMA_MEM...,SET,23,-0.26812,-0.0094844,0.19837,0.91175,GOCC_APICOLATERAL_PLASMA_MEMBRANE,0.99999
GSE4142_GC_BCELL_VS_MEMORY_B...2,SET,182,-0.086104,-0.0085307,0.0637,0.91176,GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP,0.99999
GOBP_GOLGI_RIBBON_FORMATION,SET,11,-0.34457,-0.008432,0.2549,0.91177,GOBP_GOLGI_RIBBON_FORMATION,0.99999
HP_ABNORMAL_METAPHYSEAL_TRAB...,SET,21,-0.24167,-0.0081689,0.17878,0.91177,HP_ABNORMAL_METAPHYSEAL_TRABECULATION,0.99999
MARIADASON_RESPONSE_TO_CURCU...2,SET,12,-0.31993,-0.008177,0.23664,0.9118,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7,0.99999
HP_BICONCAVE_VERTEBRAL_BODIES,SET,21,-0.25189,-0.0085144,0.18631,0.9118,HP_BICONCAVE_VERTEBRAL_BODIES,0.99999
GOBP_LOCALIZATION_WITHIN_MEM...,SET,617,-0.046844,-0.0084422,0.034646,0.91181,GOBP_LOCALIZATION_WITHIN_MEMBRANE,0.99999
SP3_Q3,SET,211,-0.080277,-0.0085568,0.059363,0.91185,SP3_Q3,0.99999
GOMF_CYTOSKELETAL_MOTOR_ACTI...,SET,112,-0.10969,-0.0085415,0.081107,0.91187,GOMF_CYTOSKELETAL_MOTOR_ACTIVITY,0.99999
MIR5589_3P,SET,149,-0.09862,-0.0088487,0.072918,0.91188,MIR5589_3P,0.99999
HP_TUBULOINTERSTITIAL_NEPHRI...,SET,19,-0.22905,-0.007365,0.16934,0.9119,HP_TUBULOINTERSTITIAL_NEPHRITIS,0.99999
REACTOME_ZINC_TRANSPORTERS,SET,15,-0.28532,-0.0081524,0.21089,0.91195,REACTOME_ZINC_TRANSPORTERS,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...10,SET,48,-0.18319,-0.0093548,0.1354,0.91195,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_9,0.99999
GOBP_MITOTIC_CELL_CYCLE_CHEC...,SET,134,-0.093389,-0.0079496,0.069025,0.91196,GOBP_MITOTIC_CELL_CYCLE_CHECKPOINT_SIGNALING,0.99999
HP_LIMBAL_DERMOID,SET,8,-0.41932,-0.0087515,0.30991,0.91197,HP_LIMBAL_DERMOID,0.99999
WP_ENTEROHEPATIC_CIRCULATION...,SET,12,-0.34526,-0.0088244,0.25516,0.91198,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,0.99999
GSE360_L_DONOVANI_VS_L_MAJOR...2,SET,181,-0.086112,-0.0085082,0.06364,0.91198,GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...2,SET,15,-0.34079,-0.0097373,0.25183,0.912,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_CIRCULATORY_RENIN_ANGIOTENSIN,0.99999
MORF_ACTG1,SET,126,-0.10118,-0.0083534,0.074765,0.91201,MORF_ACTG1,0.99999
GOBP_NEGATIVE_REGULATION_OF_...15,SET,42,-0.19213,-0.0091792,0.14195,0.91205,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
KEGG_MEDICUS_REFERENCE_PKR_E...,SET,7,-0.39763,-0.0077631,0.29365,0.91214,KEGG_MEDICUS_REFERENCE_PKR_EIF2ALPHA_SIGNALING_PATHWAY,0.99999
HP_3_METHYLGLUTACONIC_ACIDUR...,SET,17,-0.28328,-0.0086163,0.2092,0.91214,HP_3_METHYLGLUTACONIC_ACIDURIA,0.99999
GOBP_AMINOGLYCAN_CATABOLIC_P...,SET,32,-0.20719,-0.0086426,0.15297,0.91219,GOBP_AMINOGLYCAN_CATABOLIC_PROCESS,0.99999
HEBERT_MATRISOME_TNBC_BONE_M...1,SET,10,-0.42057,-0.0098132,0.31049,0.91221,HEBERT_MATRISOME_TNBC_BONE_METASTASIS,0.99999
GOBP_N_ACYLETHANOLAMINE_META...,SET,5,-0.47779,-0.0078841,0.35271,0.91223,GOBP_N_ACYLETHANOLAMINE_METABOLIC_PROCESS,0.99999
SASSON_RESPONSE_TO_GONADOTRO...1,SET,85,-0.1265,-0.008588,0.093377,0.91224,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,0.99999
VALK_AML_WITH_T_8_21_TRANSLO...,SET,4,-0.67423,-0.0099513,0.49768,0.91224,VALK_AML_WITH_T_8_21_TRANSLOCATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...612,SET,26,-0.24155,-0.0090838,0.1783,0.91224,GOBP_NEGATIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...346,SET,52,-0.16097,-0.0085547,0.11877,0.91232,GOBP_NEGATIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...6,SET,151,-0.09575,-0.0086481,0.070641,0.91235,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP,0.99999
PR_02,SET,123,-0.10745,-0.008766,0.07927,0.91237,PR_02,0.99999
GOMF_FMN_BINDING,SET,15,-0.29586,-0.0084537,0.21823,0.9124,GOMF_FMN_BINDING,0.99999
GOMF_SALT_TRANSMEMBRANE_TRAN...,SET,9,-0.34558,-0.0076499,0.25489,0.91241,GOMF_SALT_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MIR1910_3P,SET,165,-0.09179,-0.0086629,0.067675,0.91249,MIR1910_3P,0.99999
GOMF_TYPE_1_ANGIOTENSIN_RECE...,SET,6,-0.56313,-0.010179,0.41514,0.91252,GOMF_TYPE_1_ANGIOTENSIN_RECEPTOR_BINDING,0.99999
HP_ADULT_ONSET_SENSORINEURAL...,SET,5,-0.65783,-0.010855,0.4849,0.91254,HP_ADULT_ONSET_SENSORINEURAL_HEARING_IMPAIRMENT,0.99999
KEGG_MEDICUS_REFERENCE_CENPE...,SET,12,-0.31693,-0.0081002,0.23357,0.91258,KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX,0.99999
GSE37301_COMMON_LYMPHOID_PRO...4,SET,177,-0.086234,-0.0084265,0.063554,0.91258,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,0.99999
KEGG_ALPHA_LINOLENIC_ACID_ME...,SET,19,-0.28209,-0.0090704,0.20789,0.91259,KEGG_ALPHA_LINOLENIC_ACID_METABOLISM,0.99999
HP_ROUND_EAR,SET,7,-0.48754,-0.0095184,0.3593,0.91259,HP_ROUND_EAR,0.99999
NAKAYAMA_SOFT_TISSUE_TUMORS_...3,SET,71,-0.15195,-0.0094314,0.11197,0.91261,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN,0.99999
REACTOME_SIGNALING_BY_FGFR2_...2,SET,42,-0.17525,-0.0083731,0.12913,0.91263,REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE,0.99999
GSE22886_NAIVE_BCELL_VS_MONO...2,SET,161,-0.094045,-0.0087684,0.06929,0.91264,GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...522,SET,28,-0.23135,-0.0090282,0.17043,0.91267,GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,0.99999
GOBP_PROTEIN_ACTIVATION_CASC...,SET,18,-0.32707,-0.010237,0.24093,0.91268,GOBP_PROTEIN_ACTIVATION_CASCADE,0.99999
BILANGES_SERUM_AND_RAPAMYCIN...,SET,60,-0.14569,-0.0083154,0.10731,0.9127,BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,0.99999
GOMF_MYRISTOYLTRANSFERASE_AC...,SET,10,-0.32983,-0.0076959,0.24294,0.91271,GOMF_MYRISTOYLTRANSFERASE_ACTIVITY,0.99999
MIR5009_3P,SET,155,-0.097764,-0.0089452,0.071993,0.91275,MIR5009_3P,0.99999
GOMF_EXTRACELLULAR_MATRIX_ST...2,SET,19,-0.28716,-0.0092333,0.21144,0.91278,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_COMPRESSION_RESISTANCE,0.99999
GSE37605_C57BL6_VS_NOD_FOXP3...7,SET,177,-0.086531,-0.0084556,0.063709,0.91279,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_DN,0.99999
GOBP_CHONDROCYTE_DIFFERENTIA...1,SET,107,-0.11751,-0.008945,0.086508,0.91282,GOBP_CHONDROCYTE_DIFFERENTIATION,0.99999
WAKABAYASHI_ADIPOGENESIS_PPA...4,SET,780,-0.043107,-0.0086947,0.031727,0.91287,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D,0.99999
HP_FLAT_FOREHEAD,SET,15,-0.29969,-0.0085631,0.22052,0.91292,HP_FLAT_FOREHEAD,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...11,SET,157,-0.094662,-0.0087166,0.069651,0.91293,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN,0.99999
NUTT_GBM_VS_AO_GLIOMA_DN,SET,44,-0.1598,-0.0078139,0.11754,0.913,NUTT_GBM_VS_AO_GLIOMA_DN,0.99999
GOMF_MRF_BINDING,SET,5,-0.53821,-0.008881,0.39581,0.91304,GOMF_MRF_BINDING,0.99999
PID_INTEGRIN_A9B1_PATHWAY,SET,22,-0.27234,-0.0094223,0.20026,0.91307,PID_INTEGRIN_A9B1_PATHWAY,0.99999
GNF2_CDKN1C,SET,25,-0.25606,-0.0094429,0.18828,0.91307,GNF2_CDKN1C,0.99999
GOMF_INTEGRIN_BINDING,SET,145,-0.10166,-0.0089992,0.074752,0.91307,GOMF_INTEGRIN_BINDING,0.99999
LAKE_ADULT_KIDNEY_C9_THIN_AS...,SET,246,-0.075591,-0.0086916,0.055578,0.91309,LAKE_ADULT_KIDNEY_C9_THIN_ASCENDING_LIMB,0.99999
HP_DIMINISHED_ABILITY_TO_CON...,SET,9,-0.3448,-0.0076325,0.25347,0.91312,HP_DIMINISHED_ABILITY_TO_CONCENTRATE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...399,SET,214,-0.077576,-0.0083268,0.057027,0.91313,GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,0.99999
GOMF_CXCR3_CHEMOKINE_RECEPTO...,SET,5,-0.6508,-0.010739,0.47834,0.91316,GOMF_CXCR3_CHEMOKINE_RECEPTOR_BINDING,0.99999
GSE24634_IL4_VS_CTRL_TREATED...1,SET,180,-0.086876,-0.0085602,0.063845,0.91319,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN,0.99999
GOBP_BILE_ACID_SECRETION,SET,10,-0.34756,-0.0081097,0.2553,0.9133,GOBP_BILE_ACID_SECRETION,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...31,SET,59,-0.14038,-0.0079457,0.1031,0.91334,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...9,SET,172,-0.091856,-0.0088494,0.067452,0.91336,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN,0.99999
MATSUMIYA_PBMC_MODIFIED_VACC...6,SET,9,-0.39502,-0.0087441,0.29006,0.91336,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_BCG_PRIMED_28DY_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...183,SET,121,-0.10531,-0.0085212,0.077322,0.91338,GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.99999
GOBP_INNER_CELL_MASS_CELL_PR...,SET,14,-0.28614,-0.0078989,0.21009,0.9134,GOBP_INNER_CELL_MASS_CELL_PROLIFERATION,0.99999
REACTOME_STAT3_NUCLEAR_EVENT...,SET,10,-0.41612,-0.0097092,0.30542,0.91346,REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING,0.99999
HP_ELEVATED_CIRCULATING_GROW...,SET,15,-0.29607,-0.0084597,0.21727,0.9135,HP_ELEVATED_CIRCULATING_GROWTH_HORMONE_CONCENTRATION,0.99999
GAUCHER_PBMC_YF_VAX_STAMARIL...8,SET,206,-0.084317,-0.0088814,0.061867,0.91353,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP,0.99999
HP_VARIABLE_EXPRESSIVITY,SET,63,-0.14347,-0.00839,0.10522,0.91362,HP_VARIABLE_EXPRESSIVITY,0.99999
HOWARD_PBMC_INACT_MONOV_INFL...1,SET,27,-0.24962,-0.009566,0.18308,0.91362,HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN,0.99999
HP_EMPHYSEMA,SET,63,-0.15035,-0.0087928,0.11025,0.91368,HP_EMPHYSEMA,0.99999
GOBP_REGULATION_OF_VASCULAR_...1,SET,2,-0.88456,-0.0092323,0.64842,0.91374,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DEDIFFERENTIATION,0.99999
GOBP_MITOCHONDRIAL_DNA_REPAIR,SET,6,-0.43655,-0.0078908,0.31998,0.91375,GOBP_MITOCHONDRIAL_DNA_REPAIR,0.99999
GOBP_MAMMARY_GLAND_DEVELOPME...,SET,128,-0.11156,-0.0092832,0.081762,0.91378,GOBP_MAMMARY_GLAND_DEVELOPMENT,0.99999
MIR6765_3P,SET,88,-0.12181,-0.0084136,0.089259,0.91382,MIR6765_3P,0.99999
GOCC_GAMMA_TUBULIN_RING_COMP...,SET,8,-0.44217,-0.0092284,0.32384,0.91393,GOCC_GAMMA_TUBULIN_RING_COMPLEX,0.99999
GOBP_PROTEIN_TRANSMEMBRANE_T...,SET,68,-0.13959,-0.0084799,0.10223,0.91394,GOBP_PROTEIN_TRANSMEMBRANE_TRANSPORT,0.99999
HP_B_LYMPHOCYTOPENIA,SET,53,-0.16677,-0.008948,0.12213,0.91395,HP_B_LYMPHOCYTOPENIA,0.99999
HP_NODULAR_REGENERATIVE_HYPE...,SET,5,-0.55052,-0.0090841,0.40315,0.91395,HP_NODULAR_REGENERATIVE_HYPERPLASIA_OF_LIVER,0.99999
MIR181A_3P,SET,7,-0.48281,-0.009426,0.35352,0.91398,MIR181A_3P,0.99999
HP_LAMELLAR_CATARACT,SET,6,-0.46807,-0.0084607,0.34248,0.91413,HP_LAMELLAR_CATARACT,0.99999
IL15_UP.V1_DN,SET,157,-0.094424,-0.0086947,0.06909,0.91413,IL15_UP.V1_DN,0.99999
GSE12845_IGD_NEG_BLOOD_VS_PR...2,SET,169,-0.0879,-0.0083948,0.064314,0.91414,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,0.99999
GSE20198_UNTREATED_VS_IFNA_T...2,SET,186,-0.084065,-0.0084188,0.061501,0.91416,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.99999
GOBP_POLY_N_ACETYLLACTOSAMIN...,SET,9,-0.41214,-0.0091231,0.30149,0.91418,GOBP_POLY_N_ACETYLLACTOSAMINE_METABOLIC_PROCESS,0.99999
GSE28783_CTRL_ANTI_MIR_VS_UN...2,SET,171,-0.087702,-0.0084249,0.064155,0.91418,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,0.99999
GOBP_INDOLALKYLAMINE_METABOL...,SET,11,-0.39509,-0.0096683,0.28901,0.91419,GOBP_INDOLALKYLAMINE_METABOLIC_PROCESS,0.99999
HP_VENTILATOR_DEPENDENCE_WIT...,SET,4,-0.56882,-0.0083955,0.41609,0.91419,HP_VENTILATOR_DEPENDENCE_WITH_INABILITY_TO_WEAN,0.99999
GOBP_POSITIVE_REGULATION_OF_...456,SET,5,-0.63668,-0.010506,0.46567,0.91422,GOBP_POSITIVE_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_CHROMOSOM...2,SET,225,-0.074871,-0.0082379,0.054758,0.91423,GOBP_REGULATION_OF_CHROMOSOME_ORGANIZATION,0.99999
ROSS_LEUKEMIA_WITH_MLL_FUSIO...,SET,76,-0.13335,-0.0085621,0.097518,0.91424,ROSS_LEUKEMIA_WITH_MLL_FUSIONS,0.99999
REACTOME_INSERTION_OF_TAIL_A...,SET,18,-0.26093,-0.0081665,0.1908,0.91427,REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE,0.99999
MEF2_01,SET,137,-0.10439,-0.0089844,0.076333,0.91427,MEF2_01,0.99999
PAX2_02,SET,241,-0.079143,-0.0090082,0.057868,0.91428,PAX2_02,0.99999
GSE21033_3H_VS_12H_POLYIC_ST...2,SET,149,-0.093936,-0.0084283,0.068685,0.91428,GSE21033_3H_VS_12H_POLYIC_STIM_DC_UP,0.99999
GSE24634_NAIVE_CD4_TCELL_VS_...2,SET,168,-0.091163,-0.0086809,0.066657,0.91428,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP,0.99999
GOBP_PURINE_NUCLEOBASE_METAB...,SET,17,-0.27045,-0.0082263,0.19774,0.91429,GOBP_PURINE_NUCLEOBASE_METABOLIC_PROCESS,0.99999
GOBP_NEUROTRANSMITTER_UPTAKE,SET,43,-0.18693,-0.0090363,0.13665,0.91433,GOBP_NEUROTRANSMITTER_UPTAKE,0.99999
DAUER_STAT3_TARGETS_UP,SET,41,-0.20008,-0.009445,0.14626,0.91434,DAUER_STAT3_TARGETS_UP,0.99999
GOBP_EMBRYONIC_CRANIAL_SKELE...,SET,42,-0.1941,-0.0092733,0.14188,0.91434,GOBP_EMBRYONIC_CRANIAL_SKELETON_MORPHOGENESIS,0.99999
HP_DECREASED_FACIAL_EXPRESSI...,SET,126,-0.10611,-0.0087605,0.077555,0.91436,HP_DECREASED_FACIAL_EXPRESSION,0.99999
WP_BIOGENIC_AMINE_SYNTHESIS,SET,13,-0.33521,-0.0089171,0.24497,0.91439,WP_BIOGENIC_AMINE_SYNTHESIS,0.99999
MODULE_438,SET,64,-0.15426,-0.0090921,0.11273,0.91439,MODULE_438,0.99999
HOEK_MYELOID_DENDRITIC_CELL_...2,SET,16,-0.30243,-0.0089244,0.221,0.9144,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_1DY_UP,0.99999
GOBP_PLASMINOGEN_ACTIVATION,SET,24,-0.26084,-0.009425,0.19061,0.91441,GOBP_PLASMINOGEN_ACTIVATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...138,SET,852,-0.043007,-0.0090475,0.031427,0.91441,GOBP_POSITIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION,0.99999
HP_URETHRAL_DIVERTICULUM,SET,4,-0.64349,-0.0094976,0.47023,0.91441,HP_URETHRAL_DIVERTICULUM,0.99999
REACTOME_LATE_SARS_COV_2_INF...,SET,66,-0.14174,-0.0084836,0.10358,0.91442,REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS,0.99999
ZNF391_TARGET_GENES,SET,752,-0.043372,-0.0085965,0.031688,0.91445,ZNF391_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...193,SET,8,-0.47959,-0.010009,0.35034,0.91448,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.99999
GOBP_REGULATION_OF_MITOTIC_C...3,SET,9,-0.35029,-0.007754,0.25588,0.91448,GOBP_REGULATION_OF_MITOTIC_CENTROSOME_SEPARATION,0.99999
GOBP_TRANSFORMING_GROWTH_FAC...2,SET,8,-0.43277,-0.0090322,0.31614,0.91448,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA2_PRODUCTION,0.99999
GSE29618_BCELL_VS_MONOCYTE_D...2,SET,169,-0.094592,-0.0090339,0.069078,0.91455,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP,0.99999
HP_ABNORMALITY_OF_THE_EXTRIN...,SET,20,-0.22522,-0.0074296,0.16446,0.91456,HP_ABNORMALITY_OF_THE_EXTRINSIC_PATHWAY,0.99999
HP_DYSESTHESIA,SET,16,-0.31949,-0.009428,0.2333,0.91456,HP_DYSESTHESIA,0.99999
JAK2_DN.V1_DN,SET,116,-0.1003,-0.0079477,0.073234,0.91458,JAK2_DN.V1_DN,0.99999
REACTOME_METABOLISM_OF_AMINE...,SET,17,-0.3063,-0.0093167,0.22364,0.91459,REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES,0.99999
GOBP_PROTEIN_POLYUBIQUITINAT...,SET,251,-0.07168,-0.008324,0.052335,0.91459,GOBP_PROTEIN_POLYUBIQUITINATION,0.99999
REACTOME_ERYTHROPOIETIN_ACTI...3,SET,14,-0.31764,-0.0087683,0.23177,0.91472,REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS,0.99999
GOMF_TRNA_PSEUDOURIDINE_SYNT...,SET,8,-0.36101,-0.0075345,0.26342,0.91472,GOMF_TRNA_PSEUDOURIDINE_SYNTHASE_ACTIVITY,0.99999
GSE2706_R848_VS_LPS_2H_STIM_...1,SET,145,-0.098734,-0.0087401,0.07204,0.91473,GSE2706_R848_VS_LPS_2H_STIM_DC_DN,0.99999
REACTOME_RELEASE_OF_APOPTOTI...,SET,5,-0.5057,-0.0083445,0.36892,0.91477,REACTOME_RELEASE_OF_APOPTOTIC_FACTORS_FROM_THE_MITOCHONDRIA,0.99999
WP_MELANOMA,SET,66,-0.14043,-0.0084052,0.10243,0.91481,WP_MELANOMA,0.99999
HP_ABNORMAL_CSF_LACTATE_CONC...,SET,82,-0.11895,-0.0079318,0.086735,0.91486,HP_ABNORMAL_CSF_LACTATE_CONCENTRATION,0.99999
GSE23568_ID3_KO_VS_WT_CD8_TC...2,SET,173,-0.087446,-0.0084488,0.063762,0.91487,GSE23568_ID3_KO_VS_WT_CD8_TCELL_UP,0.99999
REACTOME_SIGNALING_BY_PDGFRA...,SET,12,-0.34373,-0.0087851,0.25062,0.91488,REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...605,SET,14,-0.3649,-0.010073,0.26607,0.91488,GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSPORT,0.99999
ZHONG_PFC_MAJOR_TYPES_OPC,SET,86,-0.13878,-0.0094763,0.10115,0.91496,ZHONG_PFC_MAJOR_TYPES_OPC,0.99999
HP_SUBCORTICAL_WHITE_MATTER_...,SET,3,-0.675,-0.0086281,0.49183,0.91502,HP_SUBCORTICAL_WHITE_MATTER_CALCIFICATIONS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...38,SET,35,-0.16464,-0.007182,0.11996,0.91504,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
WP_CYSTEINE_AND_METHIONINE_C...,SET,13,-0.33103,-0.0088058,0.24118,0.91504,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,0.99999
WP_FLUOROACETIC_ACID_TOXICITY,SET,6,-0.36676,-0.0066293,0.26715,0.91509,WP_FLUOROACETIC_ACID_TOXICITY,0.99999
HP_ATROPHIC_GASTRITIS,SET,7,-0.41192,-0.008042,0.30005,0.91509,HP_ATROPHIC_GASTRITIS,0.99999
GOCC_RIBOSOMAL_SUBUNIT,SET,166,-0.08639,-0.0081777,0.062917,0.91513,GOCC_RIBOSOMAL_SUBUNIT,0.99999
GOMF_NEUROPEPTIDE_BINDING,SET,28,-0.24749,-0.0096583,0.18022,0.91516,GOMF_NEUROPEPTIDE_BINDING,0.99999
MIR33B_3P,SET,60,-0.15468,-0.0088284,0.1126,0.91523,MIR33B_3P,0.99999
GOBP_CHONDROCYTE_DEVELOPMENT,SET,29,-0.24711,-0.0098138,0.17988,0.91523,GOBP_CHONDROCYTE_DEVELOPMENT,0.99999
GOBP_SPINDLE_LOCALIZATION,SET,61,-0.15362,-0.0088404,0.11182,0.91524,GOBP_SPINDLE_LOCALIZATION,0.99999
chr4q13,SET,70,-0.2817,-0.017362,0.20503,0.91526,chr4q13,0.99999
WP_NETWORK_MAP_OF_SARSCOV2_S...,SET,203,-0.086234,-0.0090178,0.062764,0.91526,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,0.99999
GOBP_REGULATION_OF_ENDOCYTIC...,SET,18,-0.28017,-0.0087686,0.20388,0.9153,GOBP_REGULATION_OF_ENDOCYTIC_RECYCLING,0.99999
GSE32034_UNTREATED_VS_ROSIGL...3,SET,166,-0.09537,-0.0090278,0.06938,0.91537,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN,0.99999
GOBP_MITOCHONDRIAL_RNA_3_END...,SET,6,-0.44627,-0.0080666,0.32458,0.91541,GOBP_MITOCHONDRIAL_RNA_3_END_PROCESSING,0.99999
HP_DOWN_SLOPING_SHOULDERS,SET,34,-0.21023,-0.0090389,0.1529,0.91541,HP_DOWN_SLOPING_SHOULDERS,0.99999
HP_MEGAKARYOCYTE_DYSPLASIA,SET,4,-0.62128,-0.0091698,0.45173,0.91548,HP_MEGAKARYOCYTE_DYSPLASIA,0.99999
GOBP_MAST_CELL_PROLIFERATION,SET,7,-0.50919,-0.0099411,0.37005,0.91558,GOBP_MAST_CELL_PROLIFERATION,0.99999
HP_WIDELY_SPACED_PRIMARY_TEE...,SET,5,-0.5642,-0.0093099,0.41002,0.91558,HP_WIDELY_SPACED_PRIMARY_TEETH,0.99999
GOBP_CHITIN_METABOLIC_PROCESS,SET,6,-0.51618,-0.0093302,0.3751,0.9156,GOBP_CHITIN_METABOLIC_PROCESS,0.99999
GOMF_CHITINASE_ACTIVITY,SET,6,-0.51618,-0.0093302,0.3751,0.9156,GOMF_CHITINASE_ACTIVITY,0.99999
REACTOME_CONSTITUTIVE_SIGNAL...5,SET,10,-0.31922,-0.0074483,0.23193,0.91563,REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2,0.99999
GOBP_GLYCEROL_3_PHOSPHATE_ME...,SET,7,-0.51149,-0.009986,0.37147,0.91573,GOBP_GLYCEROL_3_PHOSPHATE_METABOLIC_PROCESS,0.99999
GSE7548_NAIVE_VS_DAY28_PCC_I...1,SET,172,-0.092753,-0.0089359,0.067362,0.91573,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,0.99999
ZNF404_TARGET_GENES,SET,17,-0.25528,-0.0077648,0.18537,0.91576,ZNF404_TARGET_GENES,0.99999
GSE14699_NAIVE_VS_ACT_CD8_TC...1,SET,158,-0.094044,-0.008687,0.068282,0.91578,GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...12,SET,10,-0.39307,-0.0091715,0.28537,0.9158,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27,0.99999
KEGG_NEUROTROPHIN_SIGNALING_...,SET,120,-0.10984,-0.0088515,0.079734,0.91583,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,0.99999
HP_ABNORMALITY_OF_THE_PANCRE...,SET,282,-0.07094,-0.0087245,0.051486,0.91587,HP_ABNORMALITY_OF_THE_PANCREAS,0.99999
GSE30971_CTRL_VS_LPS_STIM_MA...8,SET,173,-0.10073,-0.0097325,0.073098,0.9159,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_UP,0.99999
GSE37605_FOXP3_FUSION_GFP_VS...2,SET,174,-0.094807,-0.0091862,0.068795,0.91591,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP,0.99999
GSE37563_WT_VS_CTLA4_KO_CD4_...2,SET,149,-0.096263,-0.0086372,0.069842,0.91594,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP,0.99999
ZHONG_PFC_C3_ASTROCYTE,SET,338,-0.065735,-0.008837,0.047692,0.91594,ZHONG_PFC_C3_ASTROCYTE,0.99999
BIOCARTA_ETS_PATHWAY,SET,17,-0.31089,-0.0094563,0.22554,0.91596,BIOCARTA_ETS_PATHWAY,0.99999
GOBP_CELLULAR_RESPONSE_TO_SA...1,SET,6,-0.48856,-0.008831,0.35441,0.91597,GOBP_CELLULAR_RESPONSE_TO_SALT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...161,SET,263,-0.075627,-0.0089869,0.05486,0.91597,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION,0.99999
HP_DECREASED_CIRCULATING_IGE,SET,5,-0.51137,-0.0084382,0.37093,0.91599,HP_DECREASED_CIRCULATING_IGE,0.99999
GOBP_REGULATION_OF_PLASMA_ME...1,SET,16,-0.29571,-0.0087261,0.21448,0.916,GOBP_REGULATION_OF_PLASMA_MEMBRANE_ORGANIZATION,0.99999
KEGG_MEDICUS_VARIANT_SCRAPIE...2,SET,17,-0.28821,-0.0087665,0.20904,0.91601,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.99999
GSE34156_NOD2_LIGAND_VS_TLR1...1,SET,155,-0.088721,-0.0081178,0.064344,0.91602,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,0.99999
GOBP_REGULATION_OF_CD4_POSIT...3,SET,4,-0.65278,-0.0096347,0.47339,0.91604,GOBP_REGULATION_OF_CD4_POSITIVE_CD25_POSITIVE_ALPHA_BETA_REGULATORY_T_CELL_DIFFERENTIATION,0.99999
HP_ABNORMAL_CEREBELLAR_VERMI...,SET,317,-0.064461,-0.0083971,0.046741,0.91606,HP_ABNORMAL_CEREBELLAR_VERMIS_MORPHOLOGY,0.99999
REACTOME_CYCLIN_A_B1_B2_ASSO...,SET,24,-0.22253,-0.0080408,0.16135,0.91607,REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,0.99999
HU_FETAL_RETINA_PHOTORECEPTOR,SET,65,-0.15397,-0.0091456,0.11161,0.91612,HU_FETAL_RETINA_PHOTORECEPTOR,0.99999
GSE41867_NAIVE_VS_DAY15_LCMV...4,SET,145,-0.10137,-0.0089735,0.073472,0.91616,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_UP,0.99999
BAELDE_DIABETIC_NEPHROPATHY_...2,SET,82,-0.13825,-0.0092189,0.10019,0.91618,BAELDE_DIABETIC_NEPHROPATHY_UP,0.99999
FIGUEROA_AML_METHYLATION_CLU...11,SET,29,-0.22386,-0.0088904,0.16223,0.91618,FIGUEROA_AML_METHYLATION_CLUSTER_6_DN,0.99999
MORF_CDC2L5,SET,134,-0.098475,-0.0083825,0.071356,0.9162,MORF_CDC2L5,0.99999
GOCC_PLATELET_DENSE_GRANULE,SET,19,-0.26494,-0.0085189,0.19197,0.91621,GOCC_PLATELET_DENSE_GRANULE,0.99999
GOBP_PROTEIN_MONOUBIQUITINAT...,SET,42,-0.17023,-0.0081332,0.12333,0.91625,GOBP_PROTEIN_MONOUBIQUITINATION,0.99999
ZHONG_PFC_C4_PTGDS_POS_OPC,SET,132,-0.10563,-0.0089247,0.076525,0.91625,ZHONG_PFC_C4_PTGDS_POS_OPC,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...81,SET,5,-0.49834,-0.0082231,0.36088,0.91633,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.99999
MIR105_5P,SET,198,-0.085993,-0.0088823,0.062258,0.91639,MIR105_5P,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...33,SET,62,-0.15403,-0.0089363,0.11151,0.9164,HP_APLASIA_HYPOPLASIA_OF_THE_FEMUR,0.99999
GOBP_REGULATION_OF_SEROTONIN...,SET,6,-0.50693,-0.009163,0.36691,0.91644,GOBP_REGULATION_OF_SEROTONIN_SECRETION,0.99999
NEWMAN_ERCC6_TARGETS_DN,SET,33,-0.22592,-0.0095699,0.16351,0.91646,NEWMAN_ERCC6_TARGETS_DN,0.99999
HP_NARROW_PALPEBRAL_FISSURE,SET,59,-0.14693,-0.0083161,0.10631,0.91651,HP_NARROW_PALPEBRAL_FISSURE,0.99999
MIR6730_3P,SET,74,-0.1383,-0.0087626,0.10006,0.91653,MIR6730_3P,0.99999
GSE11864_CSF1_PAM3CYS_VS_CSF...1,SET,173,-0.091046,-0.0087966,0.065867,0.91655,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.99999
HP_NEOPLASM_OF_HEAD_AND_NECK,SET,35,-0.20911,-0.0091216,0.15127,0.91656,HP_NEOPLASM_OF_HEAD_AND_NECK,0.99999
MIR6755_3P,SET,72,-0.14599,-0.0091247,0.10557,0.91664,MIR6755_3P,0.99999
REACTOME_MHC_CLASS_II_ANTIGE...,SET,117,-0.10837,-0.008624,0.078362,0.91665,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,0.99999
GSE17721_CTRL_VS_POLYIC_4H_B...1,SET,183,-0.087723,-0.0087146,0.063433,0.91665,GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN,0.99999
GSE27859_MACROPHAGE_VS_CD11C...2,SET,158,-0.090377,-0.0083483,0.065346,0.91667,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,0.99999
GOBP_REGULATION_OF_NEUROTRAN...5,SET,17,-0.2814,-0.0085591,0.20345,0.91668,GOBP_REGULATION_OF_NEUROTRANSMITTER_UPTAKE,0.99999
HP_DYSTONIA,SET,461,-0.053738,-0.008408,0.038849,0.9167,HP_DYSTONIA,0.99999
HP_MULTIPLE_RENAL_CYSTS,SET,67,-0.14774,-0.0089092,0.1068,0.91671,HP_MULTIPLE_RENAL_CYSTS,0.99999
MARTINEZ_RESPONSE_TO_TRABECT...3,SET,65,-0.14867,-0.0088305,0.10747,0.91672,MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,0.99999
GSE22025_TGFB1_VS_TGFB1_AND_...2,SET,179,-0.090428,-0.0088856,0.06536,0.91674,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.99999
KEGG_MEDICUS_REFERENCE_NAD_B...,SET,12,-0.36582,-0.0093499,0.26438,0.91676,KEGG_MEDICUS_REFERENCE_NAD_BIOSYNTHESIS,0.99999
GSE22432_CDC_VS_COMMON_DC_PR...1,SET,184,-0.085306,-0.0084974,0.061651,0.91676,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_DN,0.99999
HP_HYPOPLASIA_OF_THE_IRIS,SET,30,-0.23759,-0.0095965,0.1717,0.91677,HP_HYPOPLASIA_OF_THE_IRIS,0.99999
REACTOME_NFE2L2_REGULATING_I...,SET,5,-0.56448,-0.0093146,0.40793,0.91678,REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES,0.99999
HP_IMPAIRED_NEUTROPHIL_BACTE...,SET,8,-0.41758,-0.0087152,0.30172,0.91681,HP_IMPAIRED_NEUTROPHIL_BACTERICIDAL_ACTIVITY,0.99999
HP_NEOPLASM_OF_THE_SKIN,SET,198,-0.081962,-0.008466,0.059212,0.91684,HP_NEOPLASM_OF_THE_SKIN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...279,SET,12,-0.37282,-0.0095287,0.26929,0.91688,GOBP_NEGATIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_TESTO...,SET,11,-0.34475,-0.0084365,0.24901,0.91689,KEGG_MEDICUS_REFERENCE_TESTOSTERONE_BIOSYNTHESIS,0.99999
HP_ABNORMAL_BLISTERING_OF_TH...,SET,103,-0.12336,-0.0092141,0.08909,0.91691,HP_ABNORMAL_BLISTERING_OF_THE_SKIN,0.99999
REACTOME_CS_DS_DEGRADATION,SET,12,-0.31801,-0.0081278,0.22965,0.91692,REACTOME_CS_DS_DEGRADATION,0.99999
BIOCARTA_BARRESTIN_PATHWAY,SET,11,-0.39604,-0.0096915,0.28595,0.91696,BIOCARTA_BARRESTIN_PATHWAY,0.99999
GOBP_MIRNA_CATABOLIC_PROCESS,SET,8,-0.37775,-0.0078839,0.27271,0.91699,GOBP_MIRNA_CATABOLIC_PROCESS,0.99999
GSE3982_BCELL_VS_NKCELL_UP,SET,177,-0.08825,-0.0086235,0.063708,0.917,GSE3982_BCELL_VS_NKCELL_UP,0.99999
HP_PREMATURE_BIRTH,SET,151,-0.093499,-0.0084448,0.067489,0.91703,HP_PREMATURE_BIRTH,0.99999
GSE12845_IGD_POS_BLOOD_VS_NA...2,SET,160,-0.089328,-0.008303,0.064474,0.91704,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,0.99999
GSE1460_DP_THYMOCYTE_VS_THYM...2,SET,169,-0.088509,-0.008453,0.063877,0.91706,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...28,SET,43,-0.15685,-0.0075824,0.11317,0.91712,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,0.99999
GSE45365_WT_VS_IFNAR_KO_CD8A...2,SET,171,-0.092777,-0.0089124,0.066935,0.91713,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_IN...7,SET,24,-0.2566,-0.0092717,0.1851,0.91716,GOBP_CELLULAR_RESPONSE_TO_INTERFERON_BETA,0.99999
BIOCARTA_P27_PATHWAY,SET,13,-0.30257,-0.0080487,0.21823,0.91719,BIOCARTA_P27_PATHWAY,0.99999
GSE7548_DAY7_VS_DAY28_PCC_IM...2,SET,187,-0.088363,-0.0088727,0.063725,0.91721,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,0.99999
SMID_BREAST_CANCER_RELAPSE_I...4,SET,34,-0.22455,-0.0096545,0.16193,0.91722,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,0.99999
GOCC_ASTROCYTE_END_FOOT,SET,11,-0.38352,-0.0093851,0.27654,0.91724,GOCC_ASTROCYTE_END_FOOT,0.99999
GOBP_MESODERM_DEVELOPMENT,SET,117,-0.11507,-0.0091572,0.082974,0.91725,GOBP_MESODERM_DEVELOPMENT,0.99999
GOBP_PURINE_CONTAINING_COMPO...2,SET,484,-0.053709,-0.0086051,0.038725,0.91726,GOBP_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
GSE37416_0H_VS_12H_F_TULAREN...1,SET,178,-0.087989,-0.008622,0.063441,0.91726,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
HP_CONE_SHAPED_EPIPHYSES_OF_...,SET,27,-0.22523,-0.0086312,0.16238,0.91727,HP_CONE_SHAPED_EPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,0.99999
GGTAACC_MIR4095P,SET,28,-0.21589,-0.0084249,0.15562,0.91731,GGTAACC_MIR4095P,0.99999
GSE17721_PAM3CSK4_VS_CPG_1H_...2,SET,179,-0.084792,-0.0083318,0.061106,0.91736,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP,0.99999
LI_PBMC_MENACTRA_AGE_18_45YO...4,SET,14,-0.33613,-0.0092788,0.24209,0.91749,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN,0.99999
PID_PRL_SIGNALING_EVENTS_PAT...,SET,23,-0.24885,-0.0088027,0.17922,0.9175,PID_PRL_SIGNALING_EVENTS_PATHWAY,0.99999
MIKKELSEN_MEF_ICP_WITH_H3K4M...,SET,37,-0.20915,-0.0093801,0.15058,0.91757,MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3,0.99999
GSE15659_CD45RA_NEG_CD4_TCEL...4,SET,154,-0.097697,-0.0089104,0.070332,0.91759,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,0.99999
chr2q31,SET,73,-0.25404,-0.015988,0.18285,0.91762,chr2q31,0.99999
MIR7152_3P,SET,87,-0.12686,-0.0087122,0.091295,0.91765,MIR7152_3P,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...12,SET,15,-0.33566,-0.0095909,0.24157,0.91766,BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN,0.99999
GOBP_AMP_SALVAGE,SET,4,-0.61758,-0.0091152,0.44445,0.91766,GOBP_AMP_SALVAGE,0.99999
GOBP_REGULATION_OF_KERATINOC...3,SET,44,-0.19398,-0.0094853,0.1396,0.91766,GOBP_REGULATION_OF_KERATINOCYTE_PROLIFERATION,0.99999
GSE43260_BTLA_POS_VS_NEG_INT...2,SET,182,-0.088092,-0.0087276,0.063386,0.91769,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP,0.99999
MIR1227_5P,SET,96,-0.11645,-0.0083987,0.083776,0.91772,MIR1227_5P,0.99999
GSE17721_LPS_VS_POLYIC_24H_B...2,SET,173,-0.086891,-0.0083952,0.062513,0.91772,GSE17721_LPS_VS_POLYIC_24H_BMDC_UP,0.99999
BUCASAS_PBMC_FLUARIX_FLUVIRI...3,SET,5,-0.50618,-0.0083525,0.36407,0.91778,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_LOW_RESPONDERS_1DY_POSITIVE_PREDICTIVE_OF_TITER,0.99999
GOBP_CELLULAR_RESPONSE_TO_PR...2,SET,15,-0.37046,-0.010585,0.26643,0.91779,GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_E_STIMULUS,0.99999
WEIGEL_OXIDATIVE_STRESS_BY_H...1,SET,31,-0.21064,-0.0086485,0.15146,0.91784,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,0.99999
GSE36078_UNTREATED_VS_AD5_T4...3,SET,181,-0.089294,-0.0088226,0.064205,0.91784,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN,0.99999
GOBP_ANIMAL_ORGAN_MORPHOGENE...,SET,953,-0.042197,-0.0093614,0.030327,0.91794,GOBP_ANIMAL_ORGAN_MORPHOGENESIS,0.99999
BURTON_ADIPOGENESIS_PEAK_AT_...5,SET,38,-0.2057,-0.009349,0.1478,0.91799,BURTON_ADIPOGENESIS_PEAK_AT_8HR,0.99999
PID_AURORA_A_PATHWAY,SET,31,-0.20343,-0.0083526,0.14617,0.91799,PID_AURORA_A_PATHWAY,0.99999
GOBP_PLACENTA_DEVELOPMENT,SET,142,-0.10441,-0.0091472,0.075021,0.91799,GOBP_PLACENTA_DEVELOPMENT,0.99999
MIR4280,SET,43,-0.18466,-0.0089265,0.13267,0.91801,MIR4280,0.99999
REACTOME_INTERLEUKIN_1_SIGNA...,SET,108,-0.10614,-0.0081173,0.076251,0.91803,REACTOME_INTERLEUKIN_1_SIGNALING,0.99999
MIR3145_5P,SET,93,-0.11744,-0.0083374,0.08436,0.91804,MIR3145_5P,0.99999
GOBP_CHEMOREPULSION_OF_AXON,SET,6,-0.52415,-0.0094744,0.37645,0.91808,GOBP_CHEMOREPULSION_OF_AXON,0.99999
MODULE_516,SET,15,-0.34532,-0.0098668,0.24797,0.91812,MODULE_516,0.99999
COLLER_MYC_TARGETS_DN,SET,4,-0.60038,-0.0088612,0.43106,0.91815,COLLER_MYC_TARGETS_DN,0.99999
TRAVAGLINI_LUNG_CD4_NAIVE_T_...,SET,118,-0.11194,-0.0089454,0.08036,0.91817,TRAVAGLINI_LUNG_CD4_NAIVE_T_CELL,0.99999
REACTOME_PHOSPHATE_BOND_HYDR...2,SET,7,-0.46398,-0.0090585,0.33309,0.91818,REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS,0.99999
HP_ABSENT_PHALANGEAL_CREASE,SET,15,-0.33662,-0.0096181,0.24163,0.9182,HP_ABSENT_PHALANGEAL_CREASE,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...17,SET,185,-0.083024,-0.0082923,0.059563,0.91831,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN,0.99999
FRANCO_BLOOD_SANOFI_PASTEUR_...5,SET,19,-0.25341,-0.0081482,0.18179,0.91833,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_NEGATIVE,0.99999
HP_COLITIS,SET,62,-0.15659,-0.0090849,0.11232,0.91837,HP_COLITIS,0.99999
HP_HYPOPLASTIC_FRONTAL_SINUS...,SET,6,-0.50395,-0.0091093,0.36145,0.91837,HP_HYPOPLASTIC_FRONTAL_SINUSES,0.99999
HOWARD_DENDRITIC_CELL_INACT_...3,SET,9,-0.44567,-0.0098655,0.31961,0.91839,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.99999
GOBP_ONCOGENE_INDUCED_CELL_S...,SET,6,-0.42755,-0.0077282,0.30662,0.9184,GOBP_ONCOGENE_INDUCED_CELL_SENESCENCE,0.99999
HP_ABNORMAL_SCAPULA_MORPHOLO...,SET,159,-0.092894,-0.0086077,0.066605,0.91844,HP_ABNORMAL_SCAPULA_MORPHOLOGY,0.99999
GOBP_ACETATE_ESTER_METABOLIC...,SET,6,-0.50209,-0.0090756,0.35995,0.91846,GOBP_ACETATE_ESTER_METABOLIC_PROCESS,0.99999
HP_UNDETECTABLE_ELECTRORETIN...,SET,33,-0.22132,-0.0093751,0.15867,0.91846,HP_UNDETECTABLE_ELECTRORETINOGRAM,0.99999
GOBP_POSITIVE_REGULATION_OF_...777,SET,16,-0.31654,-0.0093409,0.22689,0.9185,GOBP_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.99999
GSE3982_BASOPHIL_VS_NKCELL_DN,SET,182,-0.089289,-0.0088463,0.063983,0.91856,GSE3982_BASOPHIL_VS_NKCELL_DN,0.99999
ZNF41_TARGET_GENES,SET,171,-0.090721,-0.0087149,0.065005,0.91857,ZNF41_TARGET_GENES,0.99999
VANASSE_BCL2_TARGETS_UP,SET,29,-0.23205,-0.0092158,0.16627,0.91858,VANASSE_BCL2_TARGETS_UP,0.99999
GOBP_GLYCOSPHINGOLIPID_METAB...,SET,62,-0.16165,-0.0093785,0.11582,0.91859,GOBP_GLYCOSPHINGOLIPID_METABOLIC_PROCESS,0.99999
MIR296_5P,SET,50,-0.15834,-0.0082521,0.11343,0.91861,MIR296_5P,0.99999
MIR142_5P,SET,315,-0.067759,-0.0087994,0.04853,0.91867,MIR142_5P,0.99999
HOWLIN_PUBERTAL_MAMMARY_GLAND,SET,62,-0.17057,-0.0098958,0.12213,0.91873,HOWLIN_PUBERTAL_MAMMARY_GLAND,0.99999
HP_BROAD_RIBS,SET,24,-0.26341,-0.0095178,0.1886,0.91873,HP_BROAD_RIBS,0.99999
MCCABE_HOXC6_TARGETS_UP,SET,7,-0.41798,-0.0081603,0.29924,0.91875,MCCABE_HOXC6_TARGETS_UP,0.99999
HP_FLARED_LOWER_LIMB_METAPHY...,SET,5,-0.51311,-0.0084669,0.36736,0.91875,HP_FLARED_LOWER_LIMB_METAPHYSIS,0.99999
HP_ICHTHYOSIS,SET,123,-0.10902,-0.0088937,0.078039,0.91878,HP_ICHTHYOSIS,0.99999
WP_DNA_DAMAGE_RESPONSE,SET,65,-0.13257,-0.0078744,0.094884,0.91881,WP_DNA_DAMAGE_RESPONSE,0.99999
HP_INCREASED_BONE_MINERAL_DE...,SET,95,-0.1285,-0.0092202,0.091974,0.91881,HP_INCREASED_BONE_MINERAL_DENSITY,0.99999
GOMF_SPECTRIN_BINDING,SET,26,-0.23898,-0.0089871,0.17104,0.91882,GOMF_SPECTRIN_BINDING,0.99999
GOBP_RRNA_CATABOLIC_PROCESS,SET,12,-0.29725,-0.0075973,0.21273,0.91884,GOBP_RRNA_CATABOLIC_PROCESS,0.99999
GOBP_CELLULAR_RESPONSE_TO_PE...2,SET,293,-0.071543,-0.0089659,0.051182,0.91891,GOBP_CELLULAR_RESPONSE_TO_PEPTIDE_HORMONE_STIMULUS,0.99999
GOMF_PHEROMONE_RECEPTOR_ACTI...,SET,3,-0.76563,-0.0097865,0.54762,0.91895,GOMF_PHEROMONE_RECEPTOR_ACTIVITY,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...64,SET,16,-0.29401,-0.0086761,0.21023,0.91901,HP_APLASIA_HYPOPLASIA_OF_THE_SACRUM,0.99999
HP_ABNORMAL_CIRCULATING_ASPA...,SET,22,-0.27153,-0.0093941,0.19412,0.91905,HP_ABNORMAL_CIRCULATING_ASPARTATE_FAMILY_AMINO_ACID_CONCENTRATION,0.99999
MODULE_377,SET,10,-0.40245,-0.0093902,0.28769,0.91907,MODULE_377,0.99999
REACTOME_TRANSCRIPTIONAL_AND...,SET,42,-0.18938,-0.0090481,0.13537,0.91908,REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY,0.99999
GOBP_DETECTION_OF_STIMULUS_I...1,SET,418,-0.079148,-0.011806,0.056573,0.91909,GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,0.99999
GOBP_RRNA_METABOLIC_PROCESS,SET,228,-0.073401,-0.0081291,0.052465,0.91909,GOBP_RRNA_METABOLIC_PROCESS,0.99999
GOCC_BOX_C_D_RNP_COMPLEX,SET,4,-0.53549,-0.0079035,0.38271,0.91912,GOCC_BOX_C_D_RNP_COMPLEX,0.99999
KMCATNNWGGA_UNKNOWN,SET,87,-0.12588,-0.0086453,0.089961,0.91913,KMCATNNWGGA_UNKNOWN,0.99999
GOBP_PROTEIN_K6_LINKED_UBIQU...,SET,15,-0.30375,-0.0086791,0.21708,0.91913,GOBP_PROTEIN_K6_LINKED_UBIQUITINATION,0.99999
GOMF_FIBRINOGEN_BINDING,SET,6,-0.52418,-0.0094749,0.37459,0.91914,GOMF_FIBRINOGEN_BINDING,0.99999
HP_HYPOPLASIA_OF_THE_MUSCULA...,SET,20,-0.28379,-0.0093619,0.20276,0.91918,HP_HYPOPLASIA_OF_THE_MUSCULATURE,0.99999
HP_ABNORMAL_PUPIL_MORPHOLOGY,SET,66,-0.1588,-0.0095044,0.11345,0.9192,HP_ABNORMAL_PUPIL_MORPHOLOGY,0.99999
HP_SEVERE_VARICELLA_ZOSTER_I...,SET,13,-0.34979,-0.009305,0.2499,0.9192,HP_SEVERE_VARICELLA_ZOSTER_INFECTION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...348,SET,41,-0.18693,-0.0088243,0.13353,0.91922,GOBP_NEGATIVE_REGULATION_OF_LIPID_LOCALIZATION,0.99999
GOMF_CALCIUM_DEPENDENT_PHOSP...1,SET,17,-0.33015,-0.010042,0.23579,0.91926,GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY,0.99999
HP_ABSENT_INNER_AND_OUTER_DY...,SET,3,-0.60932,-0.0077886,0.43507,0.91931,HP_ABSENT_INNER_AND_OUTER_DYNEIN_ARMS,0.99999
GOMF_FAD_BINDING,SET,36,-0.19875,-0.0087926,0.14189,0.91935,GOMF_FAD_BINDING,0.99999
REACTOME_M_PHASE,SET,329,-0.062496,-0.0082911,0.044611,0.91937,REACTOME_M_PHASE,0.99999
WP_ALANINE_AND_ASPARTATE_MET...,SET,11,-0.35242,-0.0086241,0.25155,0.91939,WP_ALANINE_AND_ASPARTATE_METABOLISM,0.99999
BIOCARTA_TALL1_PATHWAY,SET,15,-0.34126,-0.0097508,0.24355,0.91942,BIOCARTA_TALL1_PATHWAY,0.99999
GOBP_PLASMA_MEMBRANE_RAFT_AS...,SET,7,-0.47057,-0.0091872,0.33583,0.91942,GOBP_PLASMA_MEMBRANE_RAFT_ASSEMBLY,0.99999
MIR6842_3P,SET,112,-0.11724,-0.0091296,0.083666,0.91943,MIR6842_3P,0.99999
GSE22282_HYPOXIA_VS_NORMOXIA...1,SET,177,-0.093034,-0.009091,0.066369,0.9195,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN,0.99999
MIR4260,SET,64,-0.14999,-0.0088405,0.10699,0.91953,MIR4260,0.99999
GOMF_TRACE_AMINE_RECEPTOR_AC...,SET,6,-0.72793,-0.013158,0.51907,0.91959,GOMF_TRACE_AMINE_RECEPTOR_ACTIVITY,0.99999
STARK_HYPPOCAMPUS_22Q11_DELE...2,SET,46,-0.18387,-0.0091925,0.13111,0.9196,STARK_HYPPOCAMPUS_22Q11_DELETION_UP,0.99999
EHRLICH_ICF_SYNDROM_DN,SET,12,-0.36885,-0.0094272,0.26296,0.91963,EHRLICH_ICF_SYNDROM_DN,0.99999
HP_INCREASED_SERUM_ESTRADIOL,SET,8,-0.437,-0.0091204,0.31143,0.91971,HP_INCREASED_SERUM_ESTRADIOL,0.99999
GOBP_GLYCEROPHOSPHOLIPID_BIO...,SET,190,-0.085249,-0.0086277,0.060736,0.91977,GOBP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMAL_PALMAR_DERMATOGL...,SET,226,-0.078724,-0.0086808,0.056085,0.91978,HP_ABNORMAL_PALMAR_DERMATOGLYPHICS,0.99999
HP_ABNORMAL_SUBCUTANEOUS_FAT...,SET,8,-0.42135,-0.0087939,0.30013,0.91981,HP_ABNORMAL_SUBCUTANEOUS_FAT_TISSUE_DISTRIBUTION,0.99999
HP_PREAXIAL_HAND_POLYDACTYLY,SET,53,-0.14991,-0.0080431,0.10678,0.91982,HP_PREAXIAL_HAND_POLYDACTYLY,0.99999
HP_ABNORMAL_EPIPHYSEAL_OSSIF...,SET,70,-0.14725,-0.0090756,0.10488,0.91984,HP_ABNORMAL_EPIPHYSEAL_OSSIFICATION,0.99999
GSE8621_LPS_STIM_VS_LPS_PRIM...1,SET,183,-0.089178,-0.0088593,0.063515,0.91984,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,0.99999
MIR7853_5P,SET,198,-0.08742,-0.0090298,0.062256,0.91986,MIR7853_5P,0.99999
KOKKINAKIS_METHIONINE_DEPRIV...1,SET,57,-0.15824,-0.0088039,0.11267,0.9199,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,0.99999
MODULE_190,SET,8,-0.53494,-0.011165,0.38088,0.9199,MODULE_190,0.99999
RODRIGUES_THYROID_CARCINOMA_...2,SET,636,-0.048246,-0.0088232,0.034351,0.91991,RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP,0.99999
GOBP_SYNAPSE_MATURATION,SET,33,-0.21664,-0.0091767,0.1542,0.91996,GOBP_SYNAPSE_MATURATION,0.99999
GOBP_REGULATION_OF_ODONTOGEN...2,SET,12,-0.39933,-0.010206,0.28424,0.91997,GOBP_REGULATION_OF_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH,0.99999
MORF_RBBP8,SET,200,-0.084979,-0.0088214,0.060481,0.91999,MORF_RBBP8,0.99999
GSE9601_UNTREATED_VS_PI3K_IN...1,SET,131,-0.10202,-0.0085876,0.072605,0.92001,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,0.99999
BUSSLINGER_GASTRIC_X_CELLS,SET,172,-0.09657,-0.0093036,0.068682,0.92014,BUSSLINGER_GASTRIC_X_CELLS,0.99999
REACTOME_NEUROTRANSMITTER_CL...,SET,9,-0.41253,-0.0091319,0.29334,0.92018,REACTOME_NEUROTRANSMITTER_CLEARANCE,0.99999
HP_MESOMELIA,SET,32,-0.20019,-0.0083509,0.14234,0.9202,HP_MESOMELIA,0.99999
FAN_EMBRYONIC_CTX_BIG_GROUPS...1,SET,341,-0.071811,-0.0096958,0.051053,0.92022,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL,0.99999
MIR6779_3P,SET,64,-0.15349,-0.009047,0.10911,0.92025,MIR6779_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...16,SET,25,-0.25854,-0.0095344,0.18378,0.92025,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
HP_UPGAZE_PALSY,SET,11,-0.35663,-0.0087272,0.25349,0.92026,HP_UPGAZE_PALSY,0.99999
GSE5142_HTERT_TRANSDUCED_VS_...1,SET,178,-0.091633,-0.0089791,0.065121,0.92029,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...5,SET,180,-0.086955,-0.0085679,0.061791,0.92031,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_DN,0.99999
GSE21670_STAT3_KO_VS_WT_CD4_...1,SET,187,-0.091892,-0.009227,0.065295,0.92033,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_DN,0.99999
MYC_UP.V1_DN,SET,145,-0.099165,-0.0087783,0.070455,0.92035,MYC_UP.V1_DN,0.99999
MIR134_5P,SET,68,-0.14967,-0.0090922,0.1063,0.92043,MIR134_5P,0.99999
GOBP_CELL_CELL_SIGNALING,SET,1197,-0.037847,-0.0093438,0.02688,0.92043,GOBP_CELL_CELL_SIGNALING,0.99999
GSE19941_UNSTIM_VS_LPS_AND_I...3,SET,174,-0.090987,-0.008816,0.064606,0.92047,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.99999
MIR6866_3P,SET,66,-0.14839,-0.0088815,0.10536,0.92048,MIR6866_3P,0.99999
GOMF_S_METHYLTRANSFERASE_ACT...,SET,8,-0.49957,-0.010426,0.35471,0.92048,GOMF_S_METHYLTRANSFERASE_ACTIVITY,0.99999
GOBP_GEPHYRIN_CLUSTERING_INV...,SET,5,-0.55487,-0.009156,0.39385,0.92055,GOBP_GEPHYRIN_CLUSTERING_INVOLVED_IN_POSTSYNAPTIC_DENSITY_ASSEMBLY,0.99999
GOBP_DETECTION_OF_MECHANICAL...4,SET,13,-0.36566,-0.009727,0.25952,0.92057,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_SOUND,0.99999
GSE13522_WT_VS_IFNAR_KO_SKIN...3,SET,152,-0.10183,-0.0092274,0.072262,0.9206,GSE13522_WT_VS_IFNAR_KO_SKIN_DN,0.99999
MIR7110_5P,SET,154,-0.09963,-0.0090867,0.07068,0.92066,MIR7110_5P,0.99999
GOBP_SPROUTING_ANGIOGENESIS,SET,126,-0.11401,-0.0094128,0.080863,0.92071,GOBP_SPROUTING_ANGIOGENESIS,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...13,SET,48,-0.18242,-0.0093155,0.12938,0.92072,GAVISH_3CA_MALIGNANT_METAPROGRAM_22_SECRETED_1,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...19,SET,49,-0.18415,-0.0095012,0.1306,0.92072,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MYOFIBROBLASTS,0.99999
GSE43863_NAIVE_VS_MEMORY_TH1...2,SET,153,-0.10086,-0.0091692,0.071514,0.92077,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP,0.99999
GSE39556_CD8A_DC_VS_NK_CELL_...3,SET,179,-0.083119,-0.0081674,0.058925,0.92081,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP,0.99999
REACTOME_PREGNENOLONE_BIOSYN...,SET,10,-0.41429,-0.0096667,0.29365,0.92084,REACTOME_PREGNENOLONE_BIOSYNTHESIS,0.99999
GSE22886_NAIVE_VS_IGM_MEMORY...2,SET,173,-0.092365,-0.0089241,0.065471,0.92084,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP,0.99999
GSE18281_SUBCAPSULAR_VS_CENT...2,SET,168,-0.090483,-0.0086162,0.064118,0.9209,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_UP,0.99999
GOMF_GAP_JUNCTION_HEMI_CHANN...,SET,6,-0.59016,-0.010667,0.41817,0.92091,GOMF_GAP_JUNCTION_HEMI_CHANNEL_ACTIVITY,0.99999
GSE360_L_DONOVANI_VS_L_MAJOR...4,SET,180,-0.09006,-0.0088739,0.063806,0.92094,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP,0.99999
GSE9650_NAIVE_VS_MEMORY_CD8_...2,SET,184,-0.08786,-0.0087519,0.062247,0.92094,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP,0.99999
GOCC_FILOPODIUM,SET,92,-0.13147,-0.0092838,0.093104,0.92103,GOCC_FILOPODIUM,0.99999
SERVITJA_LIVER_HNF1A_TARGETS...1,SET,152,-0.10398,-0.009422,0.073625,0.92105,SERVITJA_LIVER_HNF1A_TARGETS_DN,0.99999
AGGTGCA_MIR500,SET,82,-0.13474,-0.0089851,0.095395,0.92108,AGGTGCA_MIR500,0.99999
REACTOME_FGFR2_MUTANT_RECEPT...,SET,32,-0.21574,-0.0089995,0.15272,0.92111,REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION,0.99999
GOBP_GLOMERULUS_VASCULATURE_...,SET,6,-0.55239,-0.0099848,0.391,0.92113,GOBP_GLOMERULUS_VASCULATURE_MORPHOGENESIS,0.99999
HP_CHRONIC_PANCREATITIS,SET,4,-0.5912,-0.0087258,0.41846,0.92113,HP_CHRONIC_PANCREATITIS,0.99999
GSE27670_CTRL_VS_BLIMP1_TRAN...1,SET,180,-0.093032,-0.0091668,0.06583,0.92119,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN,0.99999
GOBP_REGULATION_OF_ANTIGEN_P...3,SET,4,-0.68096,-0.010051,0.48149,0.92135,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II,0.99999
GSE37301_LYMPHOID_PRIMED_MPP...4,SET,187,-0.088186,-0.0088549,0.06235,0.92136,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP,0.99999
HP_ABNORMAL_FINGER_FLEXION_C...,SET,19,-0.30244,-0.0097248,0.21371,0.92148,HP_ABNORMAL_FINGER_FLEXION_CREASE,0.99999
MIR7108_5P,SET,43,-0.17988,-0.0086957,0.12711,0.92149,MIR7108_5P,0.99999
REACTOME_SYNTHESIS_OF_15_EIC...,SET,6,-0.49893,-0.0090184,0.35244,0.92155,REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES,0.99999
HP_DELAYED_OSSIFICATION_OF_C...,SET,15,-0.28565,-0.0081619,0.20178,0.92155,HP_DELAYED_OSSIFICATION_OF_CARPAL_BONES,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...13,SET,15,-0.2802,-0.0080061,0.19791,0.92157,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_P27_CELL_CYCLE_G1_S,0.99999
HP_ABNORMALITY_OF_TIBIAL_EPI...,SET,4,-0.70072,-0.010342,0.49492,0.92158,HP_ABNORMALITY_OF_TIBIAL_EPIPHYSES,0.99999
REACTOME_CROSSLINKING_OF_COL...,SET,16,-0.35231,-0.010396,0.24878,0.92162,REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS,0.99999
GOMF_N_ACETYLLACTOSAMINIDE_B...,SET,6,-0.59785,-0.010806,0.42207,0.92167,GOMF_N_ACETYLLACTOSAMINIDE_BETA_1_3_N_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...3,SET,182,-0.090184,-0.0089348,0.063648,0.92174,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...557,SET,34,-0.21842,-0.009391,0.15413,0.92177,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,0.99999
GOBP_MESODERMAL_CELL_MIGRATI...,SET,5,-0.59751,-0.0098596,0.42161,0.92178,GOBP_MESODERMAL_CELL_MIGRATION,0.99999
HP_DECREASED_ABSENT_ANKLE_RE...,SET,37,-0.18899,-0.008476,0.13335,0.92178,HP_DECREASED_ABSENT_ANKLE_REFLEXES,0.99999
HP_ABNORMAL_URINE_METABOLITE...,SET,521,-0.053188,-0.0088322,0.037529,0.92179,HP_ABNORMAL_URINE_METABOLITE_LEVEL,0.99999
AR_03,SET,54,-0.16223,-0.0087857,0.11444,0.92184,AR_03,0.99999
GOBP_POSITIVE_REGULATION_OF_...116,SET,2,-1.0113,-0.010555,0.71325,0.92188,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION_MOLECULE_PRODUCTION,0.99999
NIKOLSKY_BREAST_CANCER_11Q12...,SET,144,-0.16992,-0.01499,0.11983,0.9219,NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,0.99999
GSE14308_NAIVE_CD4_TCELL_VS_...3,SET,182,-0.08929,-0.0088463,0.062968,0.9219,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN,0.99999
BOYLAN_MULTIPLE_MYELOMA_D_DN,SET,72,-0.1527,-0.0095442,0.10768,0.92191,BOYLAN_MULTIPLE_MYELOMA_D_DN,0.99999
GOBP_REGULATION_OF_POTASSIUM...3,SET,45,-0.19038,-0.009414,0.13425,0.92191,GOBP_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
REACTOME_NEGATIVE_REGULATION...4,SET,27,-0.24089,-0.0092312,0.16983,0.92195,REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING,0.99999
TAF9B_TARGET_GENES,SET,397,-0.060275,-0.0087674,0.042496,0.92195,TAF9B_TARGET_GENES,0.99999
GOBP_TRANSCYTOSIS,SET,21,-0.27419,-0.0092681,0.19328,0.92198,GOBP_TRANSCYTOSIS,0.99999
GSE22601_DOUBLE_POSITIVE_VS_...3,SET,184,-0.086545,-0.0086208,0.061007,0.92198,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...13,SET,49,-0.18752,-0.0096751,0.13216,0.92202,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NF_KB,0.99999
HP_FALLS,SET,38,-0.20594,-0.0093599,0.14514,0.92202,HP_FALLS,0.99999
GSE17186_MEMORY_VS_NAIVE_BCE...1,SET,183,-0.089818,-0.0089228,0.063303,0.92202,GSE17186_MEMORY_VS_NAIVE_BCELL_DN,0.99999
GOBP_REGULATION_OF_CELLULAR_...7,SET,904,-0.04077,-0.0088217,0.028733,0.92203,GOBP_REGULATION_OF_CELLULAR_LOCALIZATION,0.99999
HP_ABNORMAL_RESPIRATORY_EPIT...,SET,23,-0.22892,-0.0080977,0.16132,0.92204,HP_ABNORMAL_RESPIRATORY_EPITHELIUM_MORPHOLOGY,0.99999
BIOCARTA_CREB_PATHWAY,SET,22,-0.27475,-0.0095055,0.19361,0.92205,BIOCARTA_CREB_PATHWAY,0.99999
REACTOME_ROLE_OF_PHOSPHOLIPI...,SET,23,-0.25405,-0.0089866,0.17902,0.92206,REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS,0.99999
REACTOME_CELLULAR_RESPONSE_T...5,SET,140,-0.10039,-0.0087333,0.070713,0.92214,REACTOME_CELLULAR_RESPONSE_TO_STARVATION,0.99999
MIR5011_3P,SET,46,-0.18751,-0.0093747,0.13208,0.92214,MIR5011_3P,0.99999
BIOCARTA_CARM1_PATHWAY,SET,12,-0.36932,-0.0094393,0.26013,0.92215,BIOCARTA_CARM1_PATHWAY,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_VAS...2,SET,156,-0.10478,-0.0096177,0.073794,0.92217,HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_2_CELL,0.99999
BIOCARTA_SM_PATHWAY,SET,13,-0.2978,-0.0079218,0.20973,0.92218,BIOCARTA_SM_PATHWAY,0.99999
MODULE_478,SET,18,-0.28765,-0.0090027,0.20256,0.9222,MODULE_478,0.99999
WP_INTRAFLAGELLAR_TRANSPORT_...,SET,22,-0.23586,-0.0081602,0.16603,0.92228,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,0.99999
KEGG_MEDICUS_PATHOGEN_EBV_BA...,SET,7,-0.45185,-0.0088217,0.31803,0.9223,KEGG_MEDICUS_PATHOGEN_EBV_BARF1_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.99999
GSE26343_WT_VS_NFAT5_KO_MACR...2,SET,176,-0.090891,-0.0088567,0.06397,0.92231,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...157,SET,25,-0.24079,-0.0088797,0.16946,0.92232,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_EFFLUX,0.99999
HP_OPTIC_NERVE_GLIOMA,SET,5,-0.59373,-0.0097971,0.41776,0.92236,HP_OPTIC_NERVE_GLIOMA,0.99999
GOCC_CATALYTIC_COMPLEX,SET,1516,-0.030819,-0.0084829,0.021682,0.92239,GOCC_CATALYTIC_COMPLEX,0.99999
GOMF_ENDOPEPTIDASE_ACTIVATOR...,SET,17,-0.29888,-0.009091,0.21025,0.92241,GOMF_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY,0.99999
GSE37605_FOXP3_FUSION_GFP_VS...4,SET,171,-0.091447,-0.0087847,0.064323,0.92243,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_UP,0.99999
REACTOME_ACTIVATION_OF_BAD_A...,SET,15,-0.3148,-0.0089948,0.2214,0.92246,REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA,0.99999
MIR3189_3P,SET,69,-0.14322,-0.008764,0.1007,0.92251,MIR3189_3P,0.99999
GOBP_BUD_ELONGATION_INVOLVED...,SET,7,-0.53874,-0.010518,0.37875,0.92254,GOBP_BUD_ELONGATION_INVOLVED_IN_LUNG_BRANCHING,0.99999
GOBP_PYRIMIDINE_RIBONUCLEOTI...1,SET,21,-0.26227,-0.0088653,0.18437,0.92255,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
GOCC_CAVEOLA,SET,75,-0.14856,-0.0094763,0.10444,0.92255,GOCC_CAVEOLA,0.99999
GSE21927_BALBC_VS_C57BL6_MON...2,SET,153,-0.099843,-0.0090769,0.070166,0.92262,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_UP,0.99999
WHITFIELD_CELL_CYCLE_LITERAT...,SET,44,-0.16594,-0.008114,0.1166,0.92265,WHITFIELD_CELL_CYCLE_LITERATURE,0.99999
GOBP_AXONEME_ASSEMBLY,SET,70,-0.14063,-0.0086671,0.098802,0.92267,GOBP_AXONEME_ASSEMBLY,0.99999
REACTOME_G2_M_DNA_REPLICATIO...,SET,5,-0.50296,-0.0082993,0.35334,0.92268,REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT,0.99999
TURASHVILI_BREAST_DUCTAL_CAR...2,SET,42,-0.19322,-0.0092312,0.13573,0.92271,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,0.99999
HP_MACRODACTYLY,SET,4,-0.54856,-0.0080965,0.38534,0.92271,HP_MACRODACTYLY,0.99999
MASSARWEH_TAMOXIFEN_RESISTAN...1,SET,212,-0.08924,-0.0095344,0.062673,0.92276,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,0.99999
MIR6839_5P,SET,88,-0.1369,-0.0094558,0.096102,0.92285,MIR6839_5P,0.99999
HP_ATTENTION_DEFICIT_HYPERAC...,SET,349,-0.065707,-0.0089731,0.046122,0.92286,HP_ATTENTION_DEFICIT_HYPERACTIVITY_DISORDER,0.99999
ETS_Q4,SET,227,-0.0815,-0.0090065,0.057203,0.92287,ETS_Q4,0.99999
HP_HIP_CONTRACTURE,SET,51,-0.17673,-0.0093019,0.12404,0.92287,HP_HIP_CONTRACTURE,0.99999
WP_MIRNA_REGULATION_OF_DNA_D...,SET,67,-0.13325,-0.0080351,0.093518,0.92289,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,0.99999
FAN_EMBRYONIC_CTX_BIG_GROUPS...3,SET,430,-0.060361,-0.0091292,0.042362,0.9229,FAN_EMBRYONIC_CTX_BIG_GROUPS_CAJAL_RETZIUS,0.99999
REACTOME_ION_CHANNEL_TRANSPO...,SET,170,-0.098299,-0.0094154,0.068982,0.92291,REACTOME_ION_CHANNEL_TRANSPORT,0.99999
HP_PORTAL_FIBROSIS,SET,15,-0.2968,-0.0084804,0.20827,0.92292,HP_PORTAL_FIBROSIS,0.99999
GSE46242_TH1_VS_ANERGIC_TH1_...3,SET,169,-0.091807,-0.0087679,0.064377,0.92307,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_DN,0.99999
FAN_EMBRYONIC_CTX_OPC,SET,48,-0.1992,-0.010173,0.13967,0.92309,FAN_EMBRYONIC_CTX_OPC,0.99999
CASTELLANO_NRAS_TARGETS_DN,SET,13,-0.36011,-0.0095794,0.25248,0.9231,CASTELLANO_NRAS_TARGETS_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...409,SET,77,-0.13937,-0.0090075,0.097696,0.92314,GOBP_POSITIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,0.99999
MCCLUNG_CREB1_TARGETS_UP,SET,91,-0.14152,-0.0099389,0.099193,0.92316,MCCLUNG_CREB1_TARGETS_UP,0.99999
ACTTTAT_MIR1425P,SET,268,-0.073746,-0.008845,0.051683,0.92319,ACTTTAT_MIR1425P,0.99999
GSE6269_HEALTHY_VS_FLU_INF_P...1,SET,143,-0.10066,-0.0088497,0.070537,0.92322,GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN,0.99999
NRL_DN.V1_DN,SET,120,-0.11421,-0.0092034,0.080008,0.92326,NRL_DN.V1_DN,0.99999
HP_INFLAMMATION_OF_THE_LARGE...,SET,104,-0.12423,-0.0093238,0.087015,0.9233,HP_INFLAMMATION_OF_THE_LARGE_INTESTINE,0.99999
HP_ABNORMAL_CARDIAC_ATRIUM_M...,SET,518,-0.053435,-0.0088484,0.037416,0.92337,HP_ABNORMAL_CARDIAC_ATRIUM_MORPHOLOGY,0.99999
GOBP_RHO_PROTEIN_SIGNAL_TRAN...,SET,131,-0.10931,-0.0092009,0.076534,0.92338,GOBP_RHO_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GOBP_REGULATION_OF_PROTEIN_I...,SET,56,-0.16271,-0.0089727,0.11391,0.9234,GOBP_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,0.99999
HP_HYPOTELORISM,SET,114,-0.10844,-0.008519,0.075919,0.9234,HP_HYPOTELORISM,0.99999
GSE7218_UNSTIM_VS_ANTIGEN_ST...2,SET,176,-0.086543,-0.008433,0.060589,0.9234,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP,0.99999
HP_CAROTID_ARTERY_STENOSIS,SET,6,-0.50451,-0.0091194,0.35313,0.92345,HP_CAROTID_ARTERY_STENOSIS,0.99999
HP_ABNORMAL_URINE_PH,SET,129,-0.10827,-0.0090437,0.075763,0.92349,HP_ABNORMAL_URINE_PH,0.99999
FAN_EMBRYONIC_CTX_MICROGLIA_3,SET,19,-0.32052,-0.010306,0.22427,0.92351,FAN_EMBRYONIC_CTX_MICROGLIA_3,0.99999
MODULE_15,SET,319,-0.070318,-0.0091885,0.0492,0.92352,MODULE_15,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...10,SET,44,-0.21016,-0.010277,0.14701,0.92357,GAVISH_3CA_METAPROGRAM_B_CELLS_PROGENITOR,0.99999
ZNF560_TARGET_GENES,SET,42,-0.1863,-0.0089008,0.13028,0.92364,ZNF560_TARGET_GENES,0.99999
GOBP_PHOTORECEPTOR_CELL_DEVE...,SET,49,-0.18292,-0.0094377,0.1279,0.92367,GOBP_PHOTORECEPTOR_CELL_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...38,SET,123,-0.1158,-0.0094467,0.080956,0.92369,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,0.99999
MIR5587_5P,SET,101,-0.12172,-0.0090032,0.08507,0.92374,MIR5587_5P,0.99999
GTF2A2_TARGET_GENES,SET,384,-0.064219,-0.0091903,0.044886,0.92374,GTF2A2_TARGET_GENES,0.99999
FRASOR_RESPONSE_TO_SERM_OR_F...1,SET,48,-0.16998,-0.0086804,0.1188,0.92375,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,0.99999
RAX2_TARGET_GENES,SET,62,-0.16118,-0.0093511,0.11262,0.92381,RAX2_TARGET_GENES,0.99999
MCMURRAY_TP53_HRAS_COOPERATI...1,SET,64,-0.16042,-0.0094551,0.11204,0.92389,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,0.99999
RUVBL1_TARGET_GENES,SET,126,-0.11121,-0.0091816,0.077648,0.92395,RUVBL1_TARGET_GENES,0.99999
GOCC_CYTOLYTIC_GRANULE,SET,14,-0.38163,-0.010535,0.26645,0.92396,GOCC_CYTOLYTIC_GRANULE,0.99999
GOBP_LENS_FIBER_CELL_MORPHOG...,SET,6,-0.52898,-0.0095615,0.3693,0.92397,GOBP_LENS_FIBER_CELL_MORPHOGENESIS,0.99999
HP_GENERALIZED_JOINT_HYPERMO...,SET,46,-0.18977,-0.0094873,0.13248,0.92398,HP_GENERALIZED_JOINT_HYPERMOBILITY,0.99999
HP_HYPOINTENSITY_OF_CEREBRAL...,SET,12,-0.34499,-0.0088174,0.24085,0.92398,HP_HYPOINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI,0.99999
MIR6823_3P,SET,56,-0.15925,-0.0087819,0.11115,0.92403,MIR6823_3P,0.99999
GOCC_MYOSIN_COMPLEX,SET,55,-0.18068,-0.0098749,0.12608,0.92407,GOCC_MYOSIN_COMPLEX,0.99999
GOBP_POSITIVE_REGULATION_OF_...287,SET,25,-0.27379,-0.010097,0.19105,0.92408,GOBP_POSITIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY,0.99999
GSE17721_LPS_VS_POLYIC_8H_BM...2,SET,180,-0.089738,-0.0088422,0.062611,0.9241,GSE17721_LPS_VS_POLYIC_8H_BMDC_UP,0.99999
MIR3940_5P,SET,33,-0.19804,-0.008389,0.13812,0.92418,MIR3940_5P,0.99999
OUYANG_PROSTATE_CANCER_MARKE...,SET,20,-0.28474,-0.0093931,0.19854,0.92423,OUYANG_PROSTATE_CANCER_MARKERS,0.99999
FOXO1_02,SET,233,-0.083312,-0.009326,0.058087,0.92424,FOXO1_02,0.99999
GOBP_CARTILAGE_DEVELOPMENT,SET,187,-0.093415,-0.00938,0.065131,0.92424,GOBP_CARTILAGE_DEVELOPMENT,0.99999
HOELZEL_NF1_TARGETS_UP,SET,115,-0.12441,-0.0098159,0.086724,0.92429,HOELZEL_NF1_TARGETS_UP,0.99999
ZHOU_INFLAMMATORY_RESPONSE_F...2,SET,425,-0.061802,-0.0092939,0.043072,0.92432,ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...164,SET,48,-0.16475,-0.0084133,0.11481,0.92435,GOBP_NEGATIVE_REGULATION_OF_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_ELEVATED_CIRCULATING_PHYT...,SET,14,-0.32061,-0.0088504,0.22342,0.92435,HP_ELEVATED_CIRCULATING_PHYTANIC_ACID_CONCENTRATION,0.99999
CUI_GLUCOSE_DEPRIVATION,SET,52,-0.17956,-0.0095431,0.12512,0.92437,CUI_GLUCOSE_DEPRIVATION,0.99999
GSE23321_EFFECTOR_MEMORY_VS_...2,SET,172,-0.095106,-0.0091626,0.06627,0.92437,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.99999
HP_INCREASED_LEVEL_OF_HIPPUR...,SET,5,-0.58107,-0.0095883,0.4048,0.92441,HP_INCREASED_LEVEL_OF_HIPPURIC_ACID_IN_URINE,0.99999
SENESE_HDAC3_TARGETS_UP,SET,437,-0.060969,-0.0092941,0.04247,0.92443,SENESE_HDAC3_TARGETS_UP,0.99999
HP_LENS_LUXATION,SET,6,-0.57004,-0.010304,0.39705,0.92444,HP_LENS_LUXATION,0.99999
GSE27859_MACROPHAGE_VS_CD11C...3,SET,178,-0.092885,-0.0091018,0.064677,0.92451,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_DN,0.99999
GOMF_CALCITONIN_FAMILY_RECEP...,SET,6,-0.53766,-0.0097185,0.37433,0.92453,GOMF_CALCITONIN_FAMILY_RECEPTOR_ACTIVITY,0.99999
GOBP_SPLICEOSOMAL_COMPLEX_AS...,SET,68,-0.12984,-0.0078873,0.09038,0.92457,GOBP_SPLICEOSOMAL_COMPLEX_ASSEMBLY,0.99999
GSE22611_MUTANT_NOD2_TRANSDU...1,SET,184,-0.088912,-0.0088567,0.061893,0.92457,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN,0.99999
HP_LARGE_JOINT_HYPERMOBILTY,SET,6,-0.51475,-0.0093045,0.35829,0.92459,HP_LARGE_JOINT_HYPERMOBILTY,0.99999
GSE6269_FLU_VS_E_COLI_INF_PB...1,SET,120,-0.11639,-0.0093797,0.081012,0.9246,GSE6269_FLU_VS_E_COLI_INF_PBMC_DN,0.99999
GSE27291_0H_VS_7D_STIM_GAMMA...2,SET,154,-0.095925,-0.0087488,0.066742,0.92467,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP,0.99999
GSE10325_MYELOID_VS_LUPUS_MY...2,SET,170,-0.095382,-0.0091361,0.066353,0.9247,GSE10325_MYELOID_VS_LUPUS_MYELOID_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...56,SET,8,-0.498,-0.010394,0.34641,0.92472,GOBP_POSITIVE_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,0.99999
HP_CLUMSINESS,SET,84,-0.13137,-0.008866,0.091373,0.92474,HP_CLUMSINESS,0.99999
GOBP_MESENDODERM_DEVELOPMENT,SET,9,-0.42447,-0.0093961,0.29517,0.92478,GOBP_MESENDODERM_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_IRON_ION_...2,SET,6,-0.52029,-0.0094046,0.36175,0.92481,GOBP_REGULATION_OF_IRON_ION_TRANSPORT,0.99999
GOBP_ACTIVATION_OF_CYSTEINE_...2,SET,68,-0.15251,-0.0092648,0.10602,0.92485,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.99999
BIOCARTA_ACTINY_PATHWAY,SET,11,-0.31717,-0.0077616,0.22047,0.92487,BIOCARTA_ACTINY_PATHWAY,0.99999
MODULE_233,SET,21,-0.25316,-0.0085574,0.17597,0.92487,MODULE_233,0.99999
HP_DEMYELINATING_PERIPHERAL_...,SET,49,-0.16379,-0.0084508,0.11383,0.92491,HP_DEMYELINATING_PERIPHERAL_NEUROPATHY,0.99999
HP_ABNORMAL_TEMPORAL_BONE_MO...,SET,4,-0.77241,-0.0114,0.53667,0.92495,HP_ABNORMAL_TEMPORAL_BONE_MORPHOLOGY,0.99999
LAKE_ADULT_KIDNEY_C1_EPITHEL...,SET,27,-0.24789,-0.0094995,0.17223,0.92495,LAKE_ADULT_KIDNEY_C1_EPITHELIAL_CELLS_UNASSIGNED,0.99999
GSE23984_CTRL_VS_HYPOCALEMIC...1,SET,168,-0.096976,-0.0092344,0.067359,0.92501,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN,0.99999
chr2q22,SET,11,-0.45628,-0.011166,0.31688,0.92505,chr2q22,0.99999
SPIELMAN_LYMPHOBLAST_EUROPEA...1,SET,17,-0.32383,-0.00985,0.22489,0.92505,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,0.99999
WP_GLYOXYLATE_METABOLISM,SET,11,-0.37103,-0.0090795,0.25761,0.9251,WP_GLYOXYLATE_METABOLISM,0.99999
GOMF_MONOATOMIC_CATION_BICAR...,SET,13,-0.31546,-0.0083917,0.219,0.92512,GOMF_MONOATOMIC_CATION_BICARBONATE_SYMPORTER_ACTIVITY,0.99999
GOBP_REGULATION_OF_ENDOTHELI...5,SET,5,-0.65997,-0.01089,0.45814,0.92513,GOBP_REGULATION_OF_ENDOTHELIAL_TUBE_MORPHOGENESIS,0.99999
GOMF_IONOTROPIC_GLUTAMATE_RE...,SET,23,-0.26003,-0.0091983,0.18052,0.92513,GOMF_IONOTROPIC_GLUTAMATE_RECEPTOR_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...250,SET,5,-0.63278,-0.010442,0.43923,0.92515,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,0.99999
GOCC_ER_TO_GOLGI_TRANSPORT_V...,SET,56,-0.17033,-0.0093933,0.11823,0.92515,GOCC_ER_TO_GOLGI_TRANSPORT_VESICLE_MEMBRANE,0.99999
RUAN_RESPONSE_TO_TNF_DN,SET,75,-0.15209,-0.0097013,0.1055,0.92528,RUAN_RESPONSE_TO_TNF_DN,0.99999
MIR4312,SET,42,-0.19442,-0.0092885,0.13486,0.92528,MIR4312,0.99999
GSE23502_BM_VS_COLON_TUMOR_M...1,SET,181,-0.091842,-0.0090744,0.06371,0.92528,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,0.99999
GOBP_REGULATION_OF_PROTEIN_N...,SET,18,-0.28771,-0.0090045,0.19955,0.92531,GOBP_REGULATION_OF_PROTEIN_NEDDYLATION,0.99999
GSE17721_CTRL_VS_CPG_4H_BMDC...2,SET,188,-0.08727,-0.0087861,0.060521,0.92534,GSE17721_CTRL_VS_CPG_4H_BMDC_UP,0.99999
MIR7157_3P,SET,173,-0.095155,-0.0091936,0.065965,0.92541,MIR7157_3P,0.99999
HP_ABNORMAL_MITOCHONDRIAL_NU...,SET,6,-0.42308,-0.0076474,0.29319,0.92548,HP_ABNORMAL_MITOCHONDRIAL_NUMBER,0.99999
HP_OROFACIAL_DYSKINESIA,SET,24,-0.24213,-0.0087489,0.1678,0.92548,HP_OROFACIAL_DYSKINESIA,0.99999
GSE40685_NAIVE_CD4_TCELL_VS_...3,SET,180,-0.091463,-0.0090121,0.063352,0.92558,GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN,0.99999
GOBP_MUCOPOLYSACCHARIDE_META...,SET,86,-0.13607,-0.0092911,0.094228,0.92562,GOBP_MUCOPOLYSACCHARIDE_METABOLIC_PROCESS,0.99999
REACTOME_TRANSPORT_TO_THE_GO...,SET,181,-0.088619,-0.008756,0.061367,0.92563,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,0.99999
GSE27434_WT_VS_DNMT1_KO_TREG...1,SET,182,-0.094787,-0.0093909,0.065637,0.92564,GSE27434_WT_VS_DNMT1_KO_TREG_DN,0.99999
HP_BILATERAL_CLEFT_LIP,SET,12,-0.39902,-0.010198,0.27617,0.92574,HP_BILATERAL_CLEFT_LIP,0.99999
HP_THICKENED_GLOMERULAR_BASE...,SET,9,-0.40986,-0.0090726,0.28367,0.92574,HP_THICKENED_GLOMERULAR_BASEMENT_MEMBRANE,0.99999
HP_DECREASED_NUMBER_OF_LARGE...,SET,18,-0.26848,-0.0084027,0.1858,0.92576,HP_DECREASED_NUMBER_OF_LARGE_PERIPHERAL_MYELINATED_NERVE_FIBERS,0.99999
NAKAYA_PLASMACYTOID_DENDRITI...3,SET,804,-0.044723,-0.009152,0.030946,0.92579,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN,0.99999
REACTOME_SIGNALING_BY_LRP5_M...,SET,6,-0.45167,-0.0081643,0.31252,0.9258,REACTOME_SIGNALING_BY_LRP5_MUTANTS,0.99999
WP_MIRNA_REGULATION_OF_P53_P...,SET,24,-0.24411,-0.0088204,0.1689,0.9258,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,0.99999
HP_HYPOURICEMIA,SET,16,-0.32079,-0.0094661,0.22193,0.92583,HP_HYPOURICEMIA,0.99999
GSE19198_CTRL_VS_IL21_TREATE...4,SET,183,-0.095806,-0.0095176,0.066272,0.92585,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_UP,0.99999
MODULE_134,SET,29,-0.26313,-0.01045,0.18201,0.92586,MODULE_134,0.99999
E2F3_UP.V1_UP,SET,175,-0.09426,-0.0091592,0.065192,0.92589,E2F3_UP.V1_UP,0.99999
HP_ABNORMAL_CIRCULATING_CARB...1,SET,55,-0.1533,-0.0083784,0.10602,0.9259,HP_ABNORMAL_CIRCULATING_CARBOHYDRATE_CONCENTRATION,0.99999
HP_ANTERIOR_POLAR_CATARACT,SET,7,-0.53044,-0.010356,0.36683,0.92591,HP_ANTERIOR_POLAR_CATARACT,0.99999
GSE40273_GATA1_KO_VS_WT_TREG...2,SET,174,-0.091582,-0.0088736,0.063328,0.92592,GSE40273_GATA1_KO_VS_WT_TREG_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_CYC...,SET,1242,-0.034282,-0.0086099,0.023703,0.92595,HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL,0.99999
MIR7848_3P,SET,26,-0.25073,-0.009429,0.17334,0.92596,MIR7848_3P,0.99999
GSE4590_SMALL_VS_VPREB_POS_L...1,SET,139,-0.10861,-0.0094149,0.075091,0.92596,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.99999
GSE5589_WT_VS_IL10_KO_LPS_ST...1,SET,134,-0.1144,-0.0097382,0.079094,0.92596,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,0.99999
GOBP_AMYGDALA_DEVELOPMENT,SET,5,-0.54711,-0.009028,0.37814,0.92602,GOBP_AMYGDALA_DEVELOPMENT,0.99999
GSE24634_TREG_VS_TCONV_POST_...3,SET,180,-0.093933,-0.0092556,0.064916,0.92604,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...61,SET,8,-0.42462,-0.0088621,0.2934,0.92608,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.99999
BLANCO_MELO_COVID19_SARS_COV...3,SET,370,-0.065938,-0.0092662,0.045559,0.92609,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,0.99999
ZNF623_TARGET_GENES,SET,335,-0.067451,-0.0090281,0.046602,0.92609,ZNF623_TARGET_GENES,0.99999
ZWANG_EGF_PERSISTENTLY_UP,SET,27,-0.23959,-0.0091816,0.16551,0.92612,ZWANG_EGF_PERSISTENTLY_UP,0.99999
GSE23505_UNTREATED_VS_4DAY_I...6,SET,171,-0.085187,-0.0081833,0.05883,0.92619,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_UP,0.99999
HP_ANODONTIA,SET,13,-0.33038,-0.0087887,0.22814,0.9262,HP_ANODONTIA,0.99999
HP_OSTEOARTHRITIS,SET,57,-0.17135,-0.0095332,0.11832,0.92621,HP_OSTEOARTHRITIS,0.99999
KOBAYASHI_EGFR_SIGNALING_6HR...1,SET,17,-0.32475,-0.0098779,0.22422,0.92624,KOBAYASHI_EGFR_SIGNALING_6HR_DN,0.99999
GOMF_MHC_CLASS_II_PROTEIN_BI...,SET,7,-0.48759,-0.0095193,0.33663,0.92624,GOMF_MHC_CLASS_II_PROTEIN_BINDING,0.99999
MIR8055,SET,64,-0.15651,-0.0092247,0.10804,0.92626,MIR8055,0.99999
BCAT.100_UP.V1_DN,SET,24,-0.25623,-0.0092586,0.17686,0.92629,BCAT.100_UP.V1_DN,0.99999
GSE20366_TREG_VS_NAIVE_CD4_T...6,SET,181,-0.093957,-0.0092833,0.064852,0.92629,GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP,0.99999
PPARG_01,SET,45,-0.17666,-0.0087356,0.12192,0.92631,PPARG_01,0.99999
GOBP_CONDITIONED_PLACE_PREFE...,SET,5,-0.56619,-0.0093427,0.3907,0.92634,GOBP_CONDITIONED_PLACE_PREFERENCE,0.99999
GOBP_REGULATION_OF_DNA_BINDI...2,SET,319,-0.069842,-0.0091263,0.048196,0.92634,GOBP_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.99999
HP_THICKENED_CALVARIA,SET,32,-0.2248,-0.0093772,0.15512,0.92635,HP_THICKENED_CALVARIA,0.99999
HP_ADRENOCORTICAL_ABNORMALITY,SET,9,-0.42113,-0.0093222,0.29048,0.92643,HP_ADRENOCORTICAL_ABNORMALITY,0.99999
GSE7460_TREG_VS_TCONV_ACT_UP,SET,175,-0.096464,-0.0093733,0.066532,0.92645,GSE7460_TREG_VS_TCONV_ACT_UP,0.99999
GSE20715_0H_VS_24H_OZONE_TLR...1,SET,192,-0.092,-0.0093593,0.06344,0.92649,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN,0.99999
GOBP_REGULATION_OF_NUCLEOTID...3,SET,22,-0.26533,-0.0091798,0.18295,0.92651,GOBP_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
GSE7831_1H_VS_4H_INFLUENZA_S...1,SET,186,-0.093454,-0.009359,0.064437,0.92651,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN,0.99999
HP_ABNORMAL_RENAL_PELVIS_MOR...,SET,244,-0.078927,-0.0090386,0.054401,0.92658,HP_ABNORMAL_RENAL_PELVIS_MORPHOLOGY,0.99999
GSE18148_CBFB_KO_VS_WT_TREG_...2,SET,173,-0.096751,-0.0093478,0.066678,0.9266,GSE18148_CBFB_KO_VS_WT_TREG_UP,0.99999
HP_SEVERE_B_LYMPHOCYTOPENIA,SET,6,-0.48371,-0.0087433,0.3333,0.92664,HP_SEVERE_B_LYMPHOCYTOPENIA,0.99999
GOBP_REGULATION_OF_AMYLOID_F...,SET,14,-0.30184,-0.0083323,0.20796,0.92666,GOBP_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.99999
MIR3677_5P,SET,24,-0.23983,-0.0086657,0.16523,0.92667,MIR3677_5P,0.99999
MODULE_122,SET,129,-0.11945,-0.0099781,0.082289,0.92669,MODULE_122,0.99999
WP_ONECARBON_METABOLISM,SET,29,-0.21373,-0.0084879,0.14721,0.92672,WP_ONECARBON_METABOLISM,0.99999
MIR4685_5P,SET,113,-0.11436,-0.0089445,0.078751,0.92676,MIR4685_5P,0.99999
MIR6802_5P,SET,22,-0.26992,-0.0093385,0.18587,0.92677,MIR6802_5P,0.99999
GOMF_MANGANESE_ION_TRANSMEMB...,SET,9,-0.39864,-0.0088244,0.2745,0.92677,GOMF_MANGANESE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
PID_BETA_CATENIN_DEG_PATHWAY,SET,17,-0.2828,-0.0086018,0.19469,0.92682,PID_BETA_CATENIN_DEG_PATHWAY,0.99999
HP_WRIST_DROP,SET,7,-0.49578,-0.0096793,0.34132,0.92682,HP_WRIST_DROP,0.99999
GOCC_PERICENTRIOLAR_MATERIAL,SET,21,-0.24652,-0.008333,0.1697,0.92683,GOCC_PERICENTRIOLAR_MATERIAL,0.99999
GSE13484_UNSTIM_VS_12H_YF17D...2,SET,185,-0.089146,-0.0089038,0.061355,0.92687,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP,0.99999
GOBP_MESENCHYME_MIGRATION,SET,5,-0.60778,-0.010029,0.41829,0.92688,GOBP_MESENCHYME_MIGRATION,0.99999
BUCKANOVICH_T_LYMPHOCYTE_HOM...1,SET,19,-0.27147,-0.0087289,0.18681,0.92691,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN,0.99999
GOBP_MONOSACCHARIDE_CATABOLI...,SET,44,-0.17657,-0.0086342,0.12148,0.92696,GOBP_MONOSACCHARIDE_CATABOLIC_PROCESS,0.99999
MIR4425,SET,84,-0.13223,-0.0089242,0.090962,0.92698,MIR4425,0.99999
GOCC_DENSE_BODY,SET,5,-0.5901,-0.0097374,0.4059,0.92699,GOCC_DENSE_BODY,0.99999
REACTOME_TRANSCRIPTIONAL_REG...4,SET,171,-0.093167,-0.0089499,0.064079,0.92701,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,0.99999
BIOCARTA_NGF_PATHWAY,SET,19,-0.28302,-0.0091004,0.19464,0.92703,BIOCARTA_NGF_PATHWAY,0.99999
GOMF_TRNA_GUANINE_METHYLTRAN...,SET,11,-0.33396,-0.0081723,0.22965,0.92704,GOMF_TRNA_GUANINE_METHYLTRANSFERASE_ACTIVITY,0.99999
GOBP_TRNA_PSEUDOURIDINE_SYNT...,SET,6,-0.44339,-0.0080144,0.30489,0.92705,GOBP_TRNA_PSEUDOURIDINE_SYNTHESIS,0.99999
BENPORATH_PROLIFERATION,SET,135,-0.10604,-0.0090597,0.072901,0.9271,BENPORATH_PROLIFERATION,0.99999
GOBP_REGULATION_OF_FEMALE_RE...,SET,8,-0.50991,-0.010642,0.35054,0.92711,GOBP_REGULATION_OF_FEMALE_RECEPTIVITY,0.99999
GOBP_REGULATION_OF_DENDRITE_...2,SET,24,-0.28092,-0.010151,0.19309,0.92714,GOBP_REGULATION_OF_DENDRITE_EXTENSION,0.99999
DURAND_STROMA_NS_UP,SET,161,-0.10127,-0.009442,0.069602,0.92715,DURAND_STROMA_NS_UP,0.99999
GOBP_REGULATION_OF_AMYLOID_B...,SET,16,-0.30693,-0.0090573,0.21095,0.92715,GOBP_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.99999
HP_PREMATURE_OVARIAN_INSUFFI...,SET,61,-0.1495,-0.0086033,0.10275,0.92715,HP_PREMATURE_OVARIAN_INSUFFICIENCY,0.99999
HP_GLIOSIS,SET,89,-0.13006,-0.0090339,0.089375,0.92719,HP_GLIOSIS,0.99999
MIR3678_5P,SET,13,-0.33354,-0.0088728,0.22919,0.9272,MIR3678_5P,0.99999
GSE32901_NAIVE_VS_TH17_NEG_C...1,SET,112,-0.1217,-0.0094764,0.083622,0.9272,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN,0.99999
REACTOME_CA_DEPENDENT_EVENTS,SET,35,-0.23239,-0.010137,0.15967,0.92722,REACTOME_CA_DEPENDENT_EVENTS,0.99999
GOBP_POSITIVE_REGULATION_OF_...727,SET,23,-0.27033,-0.0095625,0.18573,0.92722,GOBP_POSITIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,0.99999
GOBP_TRNA_SURVEILLANCE,SET,8,-0.4053,-0.0084588,0.27843,0.92724,GOBP_TRNA_SURVEILLANCE,0.99999
WP_HIPPOMERLIN_SIGNALING_DYS...,SET,113,-0.12807,-0.010017,0.087982,0.92725,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,0.99999
DESCARTES_MAIN_FETAL_SATB2_L...,SET,77,-0.14686,-0.0094914,0.10089,0.92725,DESCARTES_MAIN_FETAL_SATB2_LRRC7_POSITIVE_CELLS,0.99999
GOBP_SYNAPTIC_SIGNALING_VIA_...,SET,6,-0.6157,-0.011129,0.42295,0.92726,GOBP_SYNAPTIC_SIGNALING_VIA_NEUROPEPTIDE,0.99999
GOBP_PYRIMIDINE_RIBONUCLEOSI...4,SET,13,-0.34838,-0.0092675,0.23918,0.92737,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
PID_ATF2_PATHWAY,SET,58,-0.17382,-0.0097547,0.11931,0.92741,PID_ATF2_PATHWAY,0.99999
GOMF_ESTROGEN_RESPONSE_ELEME...,SET,10,-0.45001,-0.0105,0.30884,0.92745,GOMF_ESTROGEN_RESPONSE_ELEMENT_BINDING,0.99999
GOBP_CELLULAR_RESPONSE_TO_PR...3,SET,20,-0.33857,-0.011169,0.23229,0.9275,GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS,0.99999
GCM_LTK,SET,40,-0.18249,-0.008509,0.12519,0.92752,GCM_LTK,0.99999
GOBP_SPHINGOMYELIN_BIOSYNTHE...,SET,11,-0.37295,-0.0091265,0.25583,0.92755,GOBP_SPHINGOMYELIN_BIOSYNTHETIC_PROCESS,0.99999
GOBP_NUCLEAR_CHROMOSOME_SEGR...,SET,293,-0.069966,-0.0087683,0.04799,0.92756,GOBP_NUCLEAR_CHROMOSOME_SEGREGATION,0.99999
GSE40441_NRP1_POS_INDUCED_TR...1,SET,181,-0.090148,-0.008907,0.061817,0.92761,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN,0.99999
REACTOME_NOTCH2_ACTIVATION_A...,SET,20,-0.28872,-0.0095247,0.19785,0.92775,REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,0.99999
GSE34156_TLR1_TLR2_LIGAND_VS...1,SET,176,-0.09406,-0.0091655,0.064442,0.92779,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,0.99999
MIR7161_5P,SET,177,-0.097838,-0.0095604,0.067019,0.92783,MIR7161_5P,0.99999
HP_ABNORMALITY_OF_RENIN_ANGI...,SET,35,-0.22518,-0.009823,0.15425,0.92783,HP_ABNORMALITY_OF_RENIN_ANGIOTENSIN_SYSTEM,0.99999
GOMF_ASPARTIC_TYPE_ENDOPEPTI...,SET,7,-0.52526,-0.010255,0.35977,0.92785,GOMF_ASPARTIC_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.99999
REACTOME_DISEASES_OF_GLYCOSY...,SET,130,-0.11058,-0.0092722,0.075733,0.92786,REACTOME_DISEASES_OF_GLYCOSYLATION,0.99999
GSE33162_HDAC3_KO_VS_HDAC3_K...4,SET,182,-0.089051,-0.0088226,0.060963,0.92795,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP,0.99999
THAKAR_PBMC_INACTIVATED_INFL...3,SET,66,-0.14548,-0.0087072,0.099571,0.92799,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN,0.99999
GSE13306_TREG_RA_VS_TCONV_RA...2,SET,192,-0.089869,-0.0091425,0.061452,0.92818,GSE13306_TREG_RA_VS_TCONV_RA_UP,0.99999
GOCC_TERTIARY_GRANULE_LUMEN,SET,50,-0.18748,-0.0097707,0.12818,0.9282,GOCC_TERTIARY_GRANULE_LUMEN,0.99999
KEGG_MEDICUS_REFERENCE_CITRA...1,SET,8,-0.39639,-0.008273,0.27102,0.92821,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_FIRST_CARBON_OXIDATION,0.99999
REACTOME_SIGNALING_BY_PDGFR_...,SET,20,-0.27615,-0.0091099,0.1888,0.92821,REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE,0.99999
MIR1265,SET,40,-0.19454,-0.0090709,0.13297,0.92826,MIR1265,0.99999
GSE20500_CTRL_VS_RETINOIC_AC...1,SET,174,-0.098031,-0.0094985,0.067005,0.92826,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...13,SET,183,-0.09378,-0.0093164,0.064073,0.92835,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_DN,0.99999
GOCC_CLATHRIN_SCULPTED_MONOA...,SET,5,-0.57402,-0.009472,0.39211,0.92839,GOCC_CLATHRIN_SCULPTED_MONOAMINE_TRANSPORT_VESICLE,0.99999
GNF2_CD7,SET,34,-0.22881,-0.0098377,0.15625,0.92844,GNF2_CD7,0.99999
GOMF_KINASE_REGULATOR_ACTIVI...,SET,253,-0.079063,-0.0092174,0.053993,0.92844,GOMF_KINASE_REGULATOR_ACTIVITY,0.99999
TCCCCAC_MIR491,SET,58,-0.15292,-0.008582,0.10442,0.92845,TCCCCAC_MIR491,0.99999
GOBP_NEGATIVE_REGULATION_OF_...310,SET,35,-0.21807,-0.0095128,0.1489,0.92848,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,0.99999
HP_EPIDERMAL_ACANTHOSIS,SET,49,-0.18155,-0.0093672,0.12396,0.92848,HP_EPIDERMAL_ACANTHOSIS,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...2,SET,43,-0.17667,-0.0085404,0.12062,0.92849,BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP,0.99999
SIMBULAN_UV_RESPONSE_NORMAL_...2,SET,9,-0.44484,-0.009847,0.30368,0.9285,SIMBULAN_UV_RESPONSE_NORMAL_UP,0.99999
GINESTIER_BREAST_CANCER_20Q1...2,SET,95,-0.12634,-0.009065,0.086248,0.92851,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,0.99999
REACTOME_POST_CHAPERONIN_TUB...,SET,21,-0.26131,-0.008833,0.17837,0.92853,REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...147,SET,49,-0.16913,-0.0087262,0.11542,0.92858,GOBP_NEGATIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,0.99999
GSE27786_BCELL_VS_MONO_MAC_DN,SET,180,-0.092719,-0.0091359,0.063274,0.92858,GSE27786_BCELL_VS_MONO_MAC_DN,0.99999
HP_HAND_TREMOR,SET,37,-0.20739,-0.0093012,0.14152,0.92859,HP_HAND_TREMOR,0.99999
GSE2826_WT_VS_XID_BCELL_DN,SET,183,-0.097736,-0.0097094,0.066687,0.92861,GSE2826_WT_VS_XID_BCELL_DN,0.99999
HALLMARK_GLYCOLYSIS,SET,182,-0.091462,-0.0090615,0.062399,0.92863,HALLMARK_GLYCOLYSIS,0.99999
REACTOME_NADE_MODULATES_DEAT...,SET,5,-0.67367,-0.011116,0.45956,0.92865,REACTOME_NADE_MODULATES_DEATH_SIGNALLING,0.99999
GSE21033_CTRL_VS_POLYIC_STIM...2,SET,144,-0.10481,-0.009246,0.071496,0.92866,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_UP,0.99999
REACTOME_ADRENALINE_NORADREN...,SET,28,-0.26078,-0.010177,0.17788,0.92867,REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION,0.99999
HP_ABNORMALITY_OF_UPPER_LIMB...,SET,489,-0.058342,-0.0093942,0.039793,0.92869,HP_ABNORMALITY_OF_UPPER_LIMB_JOINT,0.99999
HP_BIPOLAR_AFFECTIVE_DISORDER,SET,24,-0.24011,-0.0086759,0.16372,0.92874,HP_BIPOLAR_AFFECTIVE_DISORDER,0.99999
HP_UPPER_LIMB_AMYOTROPHY,SET,70,-0.1495,-0.009214,0.10194,0.92875,HP_UPPER_LIMB_AMYOTROPHY,0.99999
GOBP_ARGININE_METABOLIC_PROC...,SET,17,-0.30502,-0.0092775,0.20796,0.92876,GOBP_ARGININE_METABOLIC_PROCESS,0.99999
HP_LIMB_FASCICULATIONS,SET,6,-0.48613,-0.008787,0.33145,0.92876,HP_LIMB_FASCICULATIONS,0.99999
GOBP_REGULATION_OF_MEMBRANE_...5,SET,58,-0.17169,-0.009635,0.11703,0.92881,GOBP_REGULATION_OF_MEMBRANE_LIPID_DISTRIBUTION,0.99999
KEGG_MEDICUS_VARIANT_SCRAPIE...1,SET,35,-0.17678,-0.0077114,0.12049,0.92883,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
HP_CALVARIAL_OSTEOSCLEROSIS,SET,7,-0.44894,-0.0087649,0.30595,0.92886,HP_CALVARIAL_OSTEOSCLEROSIS,0.99999
KEGG_MEDICUS_REFERENCE_ATR_P...,SET,8,-0.34432,-0.0071862,0.23462,0.92888,KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M,0.99999
KEGG_MEDICUS_REFERENCE_IL1_I...1,SET,17,-0.32816,-0.0099815,0.22361,0.92888,KEGG_MEDICUS_REFERENCE_IL1_IL1R_JNK_SIGNALING_PATHWAY,0.99999
HP_KERATOSIS_PILARIS,SET,34,-0.22485,-0.0096676,0.15319,0.92891,HP_KERATOSIS_PILARIS,0.99999
ZHONG_PFC_C8_UNKNOWN_NEUROD2...,SET,80,-0.14935,-0.0098376,0.10175,0.92891,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,0.99999
GOBP_POSITIVE_REGULATION_OF_...393,SET,15,-0.34809,-0.0099459,0.23713,0.92892,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION,0.99999
HP_SPASTIC_TETRAPLEGIA,SET,109,-0.11996,-0.0092157,0.081715,0.92893,HP_SPASTIC_TETRAPLEGIA,0.99999
BIOCARTA_S1P_PATHWAY,SET,7,-0.43026,-0.0084002,0.29307,0.92896,BIOCARTA_S1P_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_GF_RT...3,SET,87,-0.15033,-0.010324,0.10238,0.92899,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...719,SET,5,-0.57516,-0.0094908,0.39162,0.92903,GOBP_POSITIVE_REGULATION_OF_SODIUM_PROTON_ANTIPORTER_ACTIVITY,0.99999
ANDERSEN_LIVER_CANCER_KRT19_...2,SET,33,-0.21373,-0.0090535,0.1455,0.92907,ANDERSEN_LIVER_CANCER_KRT19_UP,0.99999
GSE22886_IL2_VS_IL15_STIM_NK...2,SET,177,-0.1012,-0.0098892,0.068893,0.92907,GSE22886_IL2_VS_IL15_STIM_NKCELL_UP,0.99999
MIR6738_3P,SET,137,-0.10462,-0.0090041,0.071219,0.92908,MIR6738_3P,0.99999
REACTOME_GAP_JUNCTION_ASSEMB...,SET,33,-0.25275,-0.010707,0.17204,0.92909,REACTOME_GAP_JUNCTION_ASSEMBLY,0.99999
GOBP_WNT_SIGNALING_PATHWAY_P...,SET,48,-0.19029,-0.0097177,0.12949,0.92915,GOBP_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,0.99999
GSE15930_STIM_VS_STIM_AND_IF...1,SET,178,-0.095684,-0.009376,0.065092,0.92921,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN,0.99999
GSE11961_FOLLICULAR_BCELL_VS...10,SET,181,-0.090647,-0.0089563,0.061659,0.92923,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_UP,0.99999
GSE40666_UNTREATED_VS_IFNA_S...4,SET,185,-0.097244,-0.0097126,0.066125,0.92929,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP,0.99999
HP_DYSPHAGIA,SET,465,-0.058905,-0.0092553,0.040043,0.92935,HP_DYSPHAGIA,0.99999
GCNP_SHH_UP_EARLY.V1_UP,SET,156,-0.096492,-0.008857,0.065576,0.9294,GCNP_SHH_UP_EARLY.V1_UP,0.99999
GOBP_REGULATION_OF_LONG_CHAI...1,SET,6,-0.51063,-0.0092299,0.34691,0.92947,GOBP_REGULATION_OF_LONG_CHAIN_FATTY_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GOBP_PROTEIN_METHYLATION,SET,40,-0.18284,-0.0085254,0.12421,0.92948,GOBP_PROTEIN_METHYLATION,0.99999
HP_MIOSIS,SET,25,-0.27706,-0.010217,0.18822,0.92948,HP_MIOSIS,0.99999
GOBP_STEM_CELL_DIVISION,SET,30,-0.23878,-0.0096448,0.1622,0.92949,GOBP_STEM_CELL_DIVISION,0.99999
chr3q13,SET,80,-0.26796,-0.017651,0.18202,0.92951,chr3q13,0.99999
HP_ABNORMAL_STERNAL_OSSIFICA...,SET,11,-0.35563,-0.0087026,0.24157,0.92951,HP_ABNORMAL_STERNAL_OSSIFICATION,0.99999
GSE27786_NKTCELL_VS_MONO_MAC...2,SET,175,-0.090256,-0.0087701,0.061302,0.92952,GSE27786_NKTCELL_VS_MONO_MAC_UP,0.99999
GSE4748_CTRL_VS_CYANOBACTERI...1,SET,176,-0.095771,-0.0093322,0.065043,0.92954,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN,0.99999
HP_IRON_ACCUMULATION_IN_BRAIN,SET,14,-0.30062,-0.0082985,0.20411,0.92959,HP_IRON_ACCUMULATION_IN_BRAIN,0.99999
GOBP_REGULATION_OF_PRESYNAPS...,SET,28,-0.27706,-0.010812,0.1881,0.92961,GOBP_REGULATION_OF_PRESYNAPSE_ORGANIZATION,0.99999
CART1_01,SET,201,-0.096074,-0.0099977,0.065215,0.92964,CART1_01,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MYO...2,SET,78,-0.16105,-0.010475,0.10927,0.92972,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL,0.99999
GOBP_LINOLEIC_ACID_METABOLIC...,SET,19,-0.30411,-0.0097784,0.20633,0.92974,GOBP_LINOLEIC_ACID_METABOLIC_PROCESS,0.99999
GSE25123_WT_VS_PPARG_KO_MACR...8,SET,173,-0.10432,-0.010079,0.070779,0.92974,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP,0.99999
GSE41867_LCMV_ARMSTRONG_VS_C...1,SET,141,-0.10745,-0.0093803,0.072887,0.92977,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...167,SET,13,-0.37623,-0.010008,0.25521,0.92978,GOBP_NEGATIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.99999
WP_NRP1TRIGGERED_SIGNALING_I...,SET,51,-0.19314,-0.010166,0.13096,0.92986,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,0.99999
GSE46242_CTRL_VS_EGR2_DELETE...2,SET,169,-0.096896,-0.009254,0.065701,0.92986,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP,0.99999
GOMF_PHOSPHATIDYLSERINE_FLIP...,SET,4,-0.66183,-0.0097683,0.44873,0.92987,GOMF_PHOSPHATIDYLSERINE_FLIPPASE_ACTIVITY,0.99999
REACTOME_THE_CANONICAL_RETIN...,SET,22,-0.27135,-0.0093878,0.18396,0.92989,REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION,0.99999
HP_COGNITIVE_IMPAIRMENT,SET,876,-0.042927,-0.0091506,0.029094,0.92994,HP_COGNITIVE_IMPAIRMENT,0.99999
GSE23502_WT_VS_HDC_KO_MYELOI...3,SET,173,-0.10127,-0.0097846,0.068628,0.92997,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_DN,0.99999
HP_KNEE_JOINT_HYPERMOBILITY,SET,5,-0.64765,-0.010687,0.43878,0.93002,HP_KNEE_JOINT_HYPERMOBILITY,0.99999
GOBP_CONNECTIVE_TISSUE_REPLA...2,SET,5,-0.62871,-0.010374,0.42568,0.93015,GOBP_CONNECTIVE_TISSUE_REPLACEMENT_INVOLVED_IN_INFLAMMATORY_RESPONSE_WOUND_HEALING,0.99999
GOBP_GLOMERULAR_BASEMENT_MEM...,SET,11,-0.39857,-0.0097535,0.26982,0.93018,GOBP_GLOMERULAR_BASEMENT_MEMBRANE_DEVELOPMENT,0.99999
GOMF_WW_DOMAIN_BINDING,SET,21,-0.26807,-0.0090613,0.18146,0.93018,GOMF_WW_DOMAIN_BINDING,0.99999
GOBP_CHOLESTEROL_EFFLUX,SET,53,-0.17974,-0.0096438,0.12166,0.93021,GOBP_CHOLESTEROL_EFFLUX,0.99999
REACTOME_INTRACELLULAR_SIGNA...,SET,300,-0.072833,-0.0092342,0.049278,0.93029,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,0.99999
GOBP_SMOOTH_MUSCLE_CELL_MATR...,SET,6,-0.45544,-0.0082323,0.30809,0.93032,GOBP_SMOOTH_MUSCLE_CELL_MATRIX_ADHESION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...88,SET,20,-0.30428,-0.010038,0.20579,0.93037,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
BHAT_ESR1_TARGETS_NOT_VIA_AK...1,SET,84,-0.14936,-0.01008,0.10101,0.93038,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,0.99999
GOBP_PARAXIAL_MESODERM_DEVEL...,SET,17,-0.31293,-0.0095184,0.21163,0.93038,GOBP_PARAXIAL_MESODERM_DEVELOPMENT,0.99999
GSE23505_UNTREATED_VS_4DAY_I...4,SET,182,-0.092163,-0.009131,0.062326,0.93039,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,0.99999
HP_ABNORMAL_COAGULATION_FACT...,SET,5,-0.63744,-0.010519,0.43099,0.93043,HP_ABNORMAL_COAGULATION_FACTOR_V_ACTIVITY,0.99999
GSE31082_DN_VS_DP_THYMOCYTE_...2,SET,174,-0.08979,-0.0087001,0.060701,0.93045,GSE31082_DN_VS_DP_THYMOCYTE_UP,0.99999
GOBP_REGULATION_OF_MEMBRANE_...6,SET,16,-0.28721,-0.0084754,0.19415,0.93046,GOBP_REGULATION_OF_MEMBRANE_LIPID_METABOLIC_PROCESS,0.99999
TURASHVILI_BREAST_DUCTAL_CAR...1,SET,173,-0.1038,-0.010029,0.070146,0.93053,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,0.99999
GSE3982_MAST_CELL_VS_NKCELL_...2,SET,176,-0.095626,-0.0093181,0.064621,0.93053,GSE3982_MAST_CELL_VS_NKCELL_UP,0.99999
BIOCARTA_PPARG_PATHWAY,SET,8,-0.50061,-0.010448,0.33827,0.93054,BIOCARTA_PPARG_PATHWAY,0.99999
KEGG_MEDICUS_VARIANT_DUPLICA...3,SET,14,-0.33455,-0.0092352,0.22606,0.93054,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY,0.99999
DESCARTES_FETAL_PANCREAS_ISL...,SET,117,-0.1306,-0.010393,0.088246,0.93055,DESCARTES_FETAL_PANCREAS_ISLET_ENDOCRINE_CELLS,0.99999
HP_PATCHY_HYPOPIGMENTATION_O...,SET,21,-0.30748,-0.010393,0.20772,0.93058,HP_PATCHY_HYPOPIGMENTATION_OF_HAIR,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_T...2,SET,22,-0.28243,-0.0097711,0.19073,0.93065,GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.99999
THUM_SYSTOLIC_HEART_FAILURE_...2,SET,366,-0.067523,-0.0094387,0.045601,0.93066,THUM_SYSTOLIC_HEART_FAILURE_UP,0.99999
GSE411_UNSTIM_VS_100MIN_IL6_...2,SET,185,-0.093608,-0.0093495,0.063213,0.93067,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP,0.99999
WP_NONSMALL_CELL_LUNG_CANCER,SET,71,-0.14765,-0.0091643,0.099672,0.93073,WP_NONSMALL_CELL_LUNG_CANCER,0.99999
HP_ABNORMAL_STOOL_COMPOSITION,SET,18,-0.30039,-0.0094014,0.20279,0.93073,HP_ABNORMAL_STOOL_COMPOSITION,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...11,SET,48,-0.19777,-0.010099,0.1335,0.93074,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_1,0.99999
GSE11961_FOLLICULAR_BCELL_VS...12,SET,184,-0.093292,-0.0092929,0.062966,0.93077,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_UP,0.99999
HP_PERIPHERAL_EDEMA,SET,12,-0.38723,-0.0098971,0.26134,0.93078,HP_PERIPHERAL_EDEMA,0.99999
GOMF_MOLECULAR_CONDENSATE_SC...,SET,33,-0.20139,-0.0085307,0.13591,0.93079,GOMF_MOLECULAR_CONDENSATE_SCAFFOLD_ACTIVITY,0.99999
GOBP_IRON_ION_TRANSPORT,SET,48,-0.18597,-0.0094968,0.12543,0.9309,GOBP_IRON_ION_TRANSPORT,0.99999
FOXD3_01,SET,179,-0.098606,-0.0096892,0.066496,0.93094,FOXD3_01,0.99999
WUNDER_INFLAMMATORY_RESPONSE...1,SET,11,-0.37612,-0.009204,0.25358,0.93098,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN,0.99999
KEGG_DORSO_VENTRAL_AXIS_FORM...,SET,24,-0.27225,-0.0098371,0.18352,0.93101,KEGG_DORSO_VENTRAL_AXIS_FORMATION,0.99999
AUTS2_TARGET_GENES,SET,487,-0.058311,-0.0093705,0.0393,0.93105,AUTS2_TARGET_GENES,0.99999
BIOCARTA_TSP1_PATHWAY,SET,7,-0.54759,-0.010691,0.36896,0.93111,BIOCARTA_TSP1_PATHWAY,0.99999
GOCC_STEREOCILIUM_BUNDLE,SET,59,-0.17085,-0.0096698,0.11511,0.93111,GOCC_STEREOCILIUM_BUNDLE,0.99999
GSE37301_PRO_BCELL_VS_RAG2_K...2,SET,164,-0.10106,-0.009509,0.068041,0.93125,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_UP,0.99999
REACTOME_ACYL_CHAIN_REMODELL...1,SET,25,-0.28258,-0.010421,0.19023,0.93128,REACTOME_ACYL_CHAIN_REMODELLING_OF_PC,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...16,SET,6,-0.49442,-0.008937,0.33282,0.9313,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6,0.99999
MIKHAYLOVA_OXIDATIVE_STRESS_...2,SET,6,-0.52616,-0.0095106,0.35416,0.93131,MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP,0.99999
HP_BILIARY_CIRRHOSIS,SET,19,-0.31243,-0.010046,0.21024,0.93136,HP_BILIARY_CIRRHOSIS,0.99999
LIAN_NEUTROPHIL_GRANULE_CONS...,SET,23,-0.29702,-0.010507,0.1998,0.93143,LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS,0.99999
DESCARTES_MAIN_FETAL_GOBLET_...,SET,37,-0.23902,-0.01072,0.16077,0.93144,DESCARTES_MAIN_FETAL_GOBLET_CELLS,0.99999
MCM5_TARGET_GENES,SET,7,-0.47673,-0.0093074,0.32064,0.93146,MCM5_TARGET_GENES,0.99999
GOBP_REGULATION_OF_CLATHRIN_...,SET,16,-0.32295,-0.00953,0.2172,0.93147,GOBP_REGULATION_OF_CLATHRIN_DEPENDENT_ENDOCYTOSIS,0.99999
BIOCARTA_TEL_PATHWAY,SET,17,-0.29239,-0.0088936,0.19659,0.93153,BIOCARTA_TEL_PATHWAY,0.99999
REACTOME_PROTEIN_FOLDING,SET,92,-0.12716,-0.0089791,0.085467,0.93159,REACTOME_PROTEIN_FOLDING,0.99999
GOBP_RESPONSE_TO_AMINE,SET,50,-0.19289,-0.010053,0.12965,0.93159,GOBP_RESPONSE_TO_AMINE,0.99999
GOBP_CENTRAL_NERVOUS_SYSTEM_...4,SET,4,-0.72292,-0.01067,0.48586,0.9316,GOBP_CENTRAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE,0.99999
BREUHAHN_GROWTH_FACTOR_SIGNA...,SET,15,-0.375,-0.010715,0.25202,0.93161,BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,0.99999
WP_PKCGAMMA_CALCIUM_SIGNALIN...,SET,21,-0.29368,-0.009927,0.19737,0.93161,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,0.99999
MODULE_196,SET,22,-0.2595,-0.0089779,0.1744,0.93161,MODULE_196,0.99999
GOBP_REGULATION_OF_MOTOR_NEU...,SET,15,-0.31867,-0.0091054,0.21413,0.93164,GOBP_REGULATION_OF_MOTOR_NEURON_APOPTOTIC_PROCESS,0.99999
GCM_AQP4,SET,41,-0.21315,-0.010062,0.14322,0.93165,GCM_AQP4,0.99999
MIR6755_5P,SET,32,-0.22101,-0.0092194,0.14849,0.93167,MIR6755_5P,0.99999
GOBP_REGULATION_OF_T_CELL_DI...,SET,24,-0.27146,-0.0098088,0.18239,0.93167,GOBP_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...5,SET,180,-0.094427,-0.0093043,0.063441,0.93167,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_DN,0.99999
GSE17721_12H_VS_24H_GARDIQUI...1,SET,175,-0.090448,-0.0087888,0.060766,0.93168,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_DN,0.99999
HP_MULTIPLE_LIPOMAS,SET,31,-0.23649,-0.00971,0.15887,0.93169,HP_MULTIPLE_LIPOMAS,0.99999
GOMF_MINOR_GROOVE_OF_ADENINE...,SET,8,-0.44848,-0.00936,0.30124,0.93172,GOMF_MINOR_GROOVE_OF_ADENINE_THYMINE_RICH_DNA_BINDING,0.99999
REACTOME_AMINE_LIGAND_BINDIN...,SET,40,-0.23349,-0.010887,0.1568,0.93175,REACTOME_AMINE_LIGAND_BINDING_RECEPTORS,0.99999
PID_WNT_CANONICAL_PATHWAY,SET,20,-0.25957,-0.0085627,0.1743,0.93177,PID_WNT_CANONICAL_PATHWAY,0.99999
GSE29614_CTRL_VS_DAY3_TIV_FL...2,SET,151,-0.10514,-0.0094959,0.070586,0.93181,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP,0.99999
HP_PRODUCTIVE_COUGH,SET,56,-0.16744,-0.0092339,0.1124,0.93183,HP_PRODUCTIVE_COUGH,0.99999
HP_ABNORMAL_SARCOMERE_MORPHO...,SET,12,-0.38897,-0.0099416,0.26111,0.93184,HP_ABNORMAL_SARCOMERE_MORPHOLOGY,0.99999
GOBP_FERTILIZATION,SET,183,-0.09569,-0.0095061,0.064231,0.93185,GOBP_FERTILIZATION,0.99999
GSE37301_COMMON_LYMPHOID_PRO...7,SET,177,-0.095723,-0.0093538,0.064255,0.93185,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,0.99999
HP_DILATED_CARDIOMYOPATHY,SET,139,-0.1079,-0.009353,0.072407,0.9319,HP_DILATED_CARDIOMYOPATHY,0.99999
HP_TUBE_FEEDING,SET,186,-0.091768,-0.0091902,0.061583,0.9319,HP_TUBE_FEEDING,0.99999
LMNB2_TARGET_GENES,SET,31,-0.21723,-0.008919,0.14575,0.93194,LMNB2_TARGET_GENES,0.99999
GOMF_RNA_POLYMERASE_ACTIVITY,SET,28,-0.2108,-0.0082261,0.14142,0.93195,GOMF_RNA_POLYMERASE_ACTIVITY,0.99999
HP_KETOSIS,SET,60,-0.16589,-0.0094683,0.1113,0.93195,HP_KETOSIS,0.99999
BLUM_RESPONSE_TO_SALIRASIB_DN,SET,308,-0.069563,-0.0089344,0.046668,0.93196,BLUM_RESPONSE_TO_SALIRASIB_DN,0.99999
HP_PHTHISIS_BULBI,SET,13,-0.37704,-0.01003,0.25295,0.93196,HP_PHTHISIS_BULBI,0.99999
TRAVAGLINI_LUNG_BRONCHIAL_VE...1,SET,207,-0.090003,-0.0095031,0.06036,0.93202,TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_1_CELL,0.99999
REACTOME_MITOTIC_G1_PHASE_AN...,SET,143,-0.096144,-0.0084524,0.064475,0.93203,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,0.99999
GSE8515_IL1_VS_IL6_4H_STIM_M...1,SET,172,-0.09677,-0.0093229,0.064882,0.93207,GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN,0.99999
GSE17721_LPS_VS_PAM3CSK4_4H_...1,SET,188,-0.086052,-0.0086635,0.057685,0.93211,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...419,SET,27,-0.26168,-0.010028,0.17537,0.93216,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_HYPERTROPHY,0.99999
HP_POSTERIOR_POLAR_CATARACT,SET,8,-0.4493,-0.0093771,0.30109,0.93217,HP_POSTERIOR_POLAR_CATARACT,0.99999
GSE7218_IGM_VS_IGG_SIGNAL_TH...1,SET,161,-0.10283,-0.0095871,0.068906,0.93217,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_DN,0.99999
BIOCARTA_41BB_PATHWAY,SET,18,-0.28932,-0.009055,0.19383,0.93222,BIOCARTA_41BB_PATHWAY,0.99999
REACTOME_TRANSCRIPTIONAL_REG...5,SET,112,-0.11419,-0.0088918,0.076499,0.93223,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,0.99999
GOBP_NERVOUS_SYSTEM_PROCESS_...,SET,10,-0.41461,-0.009674,0.27775,0.93224,GOBP_NERVOUS_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.99999
LEE_LIVER_CANCER_E2F1_DN,SET,59,-0.18026,-0.010202,0.12074,0.93226,LEE_LIVER_CANCER_E2F1_DN,0.99999
GSE27786_LIN_NEG_VS_ERYTHROB...2,SET,182,-0.090816,-0.0089975,0.060827,0.93228,GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP,0.99999
ZNF26_TARGET_GENES,SET,20,-0.27574,-0.0090964,0.18462,0.93235,ZNF26_TARGET_GENES,0.99999
HP_ABNORMAL_CIRCULATING_FATT...2,SET,68,-0.15042,-0.0091381,0.10071,0.93235,HP_ABNORMAL_CIRCULATING_FATTY_ACID_CONCENTRATION,0.99999
GOBP_INTRACELLULAR_PROTEIN_T...1,SET,29,-0.23725,-0.0094221,0.15883,0.93237,GOBP_INTRACELLULAR_PROTEIN_TRANSMEMBRANE_TRANSPORT,0.99999
HP_ABNORMAL_CSF_CARBOXYLIC_A...,SET,24,-0.23944,-0.0086517,0.16028,0.93238,HP_ABNORMAL_CSF_CARBOXYLIC_ACID_CONCENTRATION,0.99999
GOBP_GOLGI_TO_ENDOSOME_TRANS...,SET,15,-0.28684,-0.0081959,0.19199,0.93241,GOBP_GOLGI_TO_ENDOSOME_TRANSPORT,0.99999
GOBP_REGULATION_OF_T_HELPER_...7,SET,42,-0.20778,-0.0099268,0.13907,0.93241,GOBP_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,0.99999
GSE11961_MEMORY_BCELL_DAY7_V...7,SET,185,-0.096282,-0.0096165,0.064437,0.93243,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,0.99999
GOCC_DENDRITE_TERMINUS,SET,11,-0.3597,-0.0088022,0.24069,0.93246,GOCC_DENDRITE_TERMINUS,0.99999
GSE17721_PAM3CSK4_VS_CPG_2H_...2,SET,180,-0.097672,-0.0096239,0.06534,0.93251,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_UP,0.99999
GOBP_CD4_POSITIVE_ALPHA_BETA...1,SET,110,-0.1332,-0.01028,0.089086,0.93255,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
GOBP_DNA_REPLICATION_SYNTHES...,SET,6,-0.48167,-0.0087065,0.32214,0.93256,GOBP_DNA_REPLICATION_SYNTHESIS_OF_PRIMER,0.99999
GOBP_PROGRAMMED_CELL_DEATH_I...2,SET,12,-0.37724,-0.0096418,0.2523,0.93256,GOBP_PROGRAMMED_CELL_DEATH_IN_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,0.99999
NOJIMA_SFRP2_TARGETS_DN,SET,23,-0.29767,-0.01053,0.19906,0.93258,NOJIMA_SFRP2_TARGETS_DN,0.99999
GSE32986_GMCSF_AND_CURDLAN_L...2,SET,178,-0.09453,-0.009263,0.06321,0.9326,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.99999
ZHANG_BREAST_CANCER_PROGENIT...1,SET,131,-0.11054,-0.0093046,0.073896,0.93265,ZHANG_BREAST_CANCER_PROGENITORS_DN,0.99999
HP_ENLARGED_CEREBELLUM,SET,6,-0.53648,-0.0096972,0.35864,0.93265,HP_ENLARGED_CEREBELLUM,0.99999
JAZAERI_BREAST_CANCER_BRCA1_...1,SET,40,-0.21946,-0.010233,0.14669,0.93267,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN,0.99999
ZHENG_FOXP3_TARGETS_IN_T_LYM...1,SET,34,-0.22744,-0.009779,0.15202,0.93268,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,0.99999
GOBP_PYRIMIDINE_CONTAINING_C...4,SET,7,-0.49177,-0.009601,0.3286,0.93274,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_SALVAGE,0.99999
GOMF_RNA_POLYMERASE_III_GENE...,SET,12,-0.28646,-0.0073215,0.1914,0.93275,GOMF_RNA_POLYMERASE_III_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.99999
GSE17721_PAM3CSK4_VS_CPG_6H_...2,SET,177,-0.090237,-0.0088177,0.060282,0.93278,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_UP,0.99999
PARK_OSTEOBLAST_DIFFERENTIAT...1,SET,6,-0.64864,-0.011725,0.43324,0.93282,PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN,0.99999
WEST_ADRENOCORTICAL_TUMOR_DN,SET,478,-0.059948,-0.0095466,0.040038,0.93283,WEST_ADRENOCORTICAL_TUMOR_DN,0.99999
MIR548AT_3P,SET,56,-0.17056,-0.009406,0.11389,0.93288,MIR548AT_3P,0.99999
RYBP_TARGET_GENES,SET,1411,-0.036455,-0.0097106,0.024342,0.93288,RYBP_TARGET_GENES,0.99999
MYCMAX_02,SET,240,-0.084796,-0.0096319,0.05662,0.93288,MYCMAX_02,0.99999
HP_CHORIOCARCINOMA,SET,8,-0.49721,-0.010377,0.33199,0.93288,HP_CHORIOCARCINOMA,0.99999
WP_GABA_METABOLISM_AKA_GHB,SET,10,-0.44705,-0.010431,0.29845,0.93291,WP_GABA_METABOLISM_AKA_GHB,0.99999
GROSS_HYPOXIA_VIA_HIF1A_DN,SET,98,-0.13036,-0.009499,0.087008,0.93296,GROSS_HYPOXIA_VIA_HIF1A_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...177,SET,6,-0.56422,-0.010199,0.37651,0.933,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,0.99999
NUMATA_CSF3_SIGNALING_VIA_ST...,SET,21,-0.29004,-0.009804,0.19349,0.93305,NUMATA_CSF3_SIGNALING_VIA_STAT3,0.99999
GOBP_REGULATION_OF_ORGAN_GRO...,SET,80,-0.1569,-0.010335,0.10466,0.93307,GOBP_REGULATION_OF_ORGAN_GROWTH,0.99999
KEGG_ALANINE_ASPARTATE_AND_G...,SET,29,-0.24809,-0.0098526,0.16547,0.93309,KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,0.99999
GOBP_HYPEROSMOTIC_SALINITY_R...,SET,10,-0.42412,-0.0098959,0.28279,0.93315,GOBP_HYPEROSMOTIC_SALINITY_RESPONSE,0.99999
REACTOME_PLATELET_ACTIVATION...,SET,246,-0.084528,-0.0097191,0.056359,0.93316,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,0.99999
GOCC_GAMMA_TUBULIN_COMPLEX,SET,17,-0.29575,-0.0089956,0.19718,0.93317,GOCC_GAMMA_TUBULIN_COMPLEX,0.99999
HP_LIMITED_HIP_MOVEMENT,SET,22,-0.28936,-0.010011,0.1929,0.93319,HP_LIMITED_HIP_MOVEMENT,0.99999
HOFMANN_CELL_LYMPHOMA_UP,SET,44,-0.18253,-0.0089255,0.12167,0.93322,HOFMANN_CELL_LYMPHOMA_UP,0.99999
GOCC_GLYCINERGIC_SYNAPSE,SET,7,-0.53143,-0.010375,0.35415,0.93326,GOCC_GLYCINERGIC_SYNAPSE,0.99999
MIR7154_5P,SET,239,-0.085621,-0.0097056,0.057051,0.93328,MIR7154_5P,0.99999
GOBP_LENS_MORPHOGENESIS_IN_C...,SET,19,-0.32408,-0.010421,0.21594,0.93328,GOBP_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.99999
GOBP_SYNCYTIUM_FORMATION,SET,60,-0.17095,-0.0097572,0.11387,0.93336,GOBP_SYNCYTIUM_FORMATION,0.99999
GOCC_IMMUNOLOGICAL_SYNAPSE,SET,43,-0.1995,-0.0096439,0.13284,0.93342,GOCC_IMMUNOLOGICAL_SYNAPSE,0.99999
KEGG_MEDICUS_VARIANT_ESR1_PO...,SET,5,-0.65601,-0.010825,0.43675,0.93345,KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,0.99999
GSE17186_NAIVE_VS_CD21LOW_TR...1,SET,186,-0.094199,-0.0094336,0.062699,0.93349,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN,0.99999
PID_CDC42_REG_PATHWAY,SET,25,-0.26051,-0.0096069,0.17339,0.9335,PID_CDC42_REG_PATHWAY,0.99999
HP_WEAKNESS_OF_THE_INTRINSIC...,SET,24,-0.24504,-0.0088541,0.16307,0.93353,HP_WEAKNESS_OF_THE_INTRINSIC_HAND_MUSCLES,0.99999
GSE24574_BCL6_LOW_TFH_VS_NAI...2,SET,178,-0.094941,-0.0093033,0.063183,0.93353,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_UP,0.99999
MIR10399_3P,SET,8,-0.4279,-0.0089306,0.28474,0.93354,MIR10399_3P,0.99999
GSE13493_DP_VS_CD4INTCD8POS_...1,SET,183,-0.094067,-0.0093449,0.062571,0.93362,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN,0.99999
HP_ABNORMAL_STOMACH_MORPHOLO...,SET,244,-0.084093,-0.0096302,0.055929,0.93364,HP_ABNORMAL_STOMACH_MORPHOLOGY,0.99999
STK33_UP,SET,253,-0.081986,-0.0095582,0.05452,0.93367,STK33_UP,0.99999
HP_CHONDROSARCOMA,SET,7,-0.55533,-0.010842,0.36919,0.93372,HP_CHONDROSARCOMA,0.99999
KANNAN_BLOOD_2012_2013_TIV_A...1,SET,297,-0.070915,-0.0089467,0.047141,0.93374,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...47,SET,4,-0.76862,-0.011344,0.51092,0.93375,HP_APLASIA_HYPOPLASIA_OF_THE_NASAL_SEPTUM,0.99999
MIR6737_3P,SET,172,-0.099522,-0.009588,0.066123,0.93384,MIR6737_3P,0.99999
HP_IMMOTILE_CILIA,SET,9,-0.43726,-0.0096792,0.2905,0.93385,HP_IMMOTILE_CILIA,0.99999
GOCC_COPI_COATED_VESICLE,SET,24,-0.23821,-0.0086073,0.15824,0.93388,GOCC_COPI_COATED_VESICLE,0.99999
WP_AIRWAY_SMOOTH_MUSCLE_CELL...,SET,15,-0.34133,-0.0097529,0.22672,0.93389,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,0.99999
HP_EPENDYMOMA,SET,19,-0.29034,-0.0093356,0.19283,0.93392,HP_EPENDYMOMA,0.99999
GOBP_CELLULAR_RESPONSE_TO_NI...2,SET,587,-0.054795,-0.0096402,0.036387,0.93394,GOBP_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND,0.99999
GOCC_FIBRILLAR_COLLAGEN_TRIM...,SET,12,-0.41492,-0.010605,0.27553,0.93394,GOCC_FIBRILLAR_COLLAGEN_TRIMER,0.99999
GOMF_ALCOHOL_DEHYDROGENASE_N...3,SET,24,-0.31151,-0.011256,0.20684,0.93396,GOMF_ALCOHOL_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,0.99999
HP_EDEMA_OF_THE_DORSUM_OF_FE...,SET,4,-0.60172,-0.0088811,0.39956,0.93396,HP_EDEMA_OF_THE_DORSUM_OF_FEET,0.99999
KIM_WT1_TARGETS_8HR_UP,SET,159,-0.10342,-0.0095834,0.068671,0.93397,KIM_WT1_TARGETS_8HR_UP,0.99999
RICKMAN_HEAD_AND_NECK_CANCER...1,SET,88,-0.14815,-0.010232,0.098361,0.93398,RICKMAN_HEAD_AND_NECK_CANCER_A,0.99999
DESCARTES_FETAL_EYE_LENS_FIB...,SET,58,-0.18793,-0.010546,0.12477,0.93398,DESCARTES_FETAL_EYE_LENS_FIBRE_CELLS,0.99999
PID_TCPTP_PATHWAY,SET,42,-0.21463,-0.010254,0.14248,0.934,PID_TCPTP_PATHWAY,0.99999
ZWANG_EGF_PERSISTENTLY_DN,SET,56,-0.15959,-0.008801,0.10594,0.93401,ZWANG_EGF_PERSISTENTLY_DN,0.99999
GSE24574_BCL6_HIGH_TFH_VS_TC...2,SET,175,-0.099575,-0.0096756,0.066089,0.93404,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_UP,0.99999
GOBP_REGULATION_OF_ESTABLISH...2,SET,488,-0.058263,-0.0093722,0.038658,0.93411,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.99999
GOCC_CELL_BODY,SET,507,-0.059576,-0.0097629,0.039521,0.93414,GOCC_CELL_BODY,0.99999
GOMF_TRANSFERASE_ACTIVITY_TR...5,SET,67,-0.1649,-0.0099436,0.10939,0.93414,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_SULPHUR_CONTAINING_GROUPS,0.99999
GSE16385_IFNG_TNF_VS_ROSIGLI...1,SET,143,-0.10881,-0.0095661,0.072178,0.93416,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.99999
HDAC8_TARGET_GENES,SET,126,-0.11551,-0.0095364,0.076605,0.93419,HDAC8_TARGET_GENES,0.99999
GOBP_GASTRIC_MOTILITY,SET,5,-0.55563,-0.0091685,0.36849,0.93419,GOBP_GASTRIC_MOTILITY,0.99999
GOBP_PYRIMIDINE_RIBONUCLEOSI...1,SET,7,-0.4503,-0.0087914,0.2985,0.93428,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.99999
REACTOME_ESTROGEN_BIOSYNTHES...,SET,6,-0.50356,-0.0091021,0.33379,0.93429,REACTOME_ESTROGEN_BIOSYNTHESIS,0.99999
MIR6499_3P,SET,111,-0.12296,-0.0095323,0.081507,0.93429,MIR6499_3P,0.99999
HP_ELEVATED_CIRCULATING_ALAN...,SET,69,-0.14813,-0.0090643,0.098178,0.93431,HP_ELEVATED_CIRCULATING_ALANINE_AMINOTRANSFERASE_CONCENTRATION,0.99999
MORI_SMALL_PRE_BII_LYMPHOCYT...2,SET,73,-0.1501,-0.0094466,0.09948,0.93433,MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,0.99999
GSE17721_0.5H_VS_24H_CPG_BMD...2,SET,182,-0.094592,-0.0093716,0.062685,0.93434,GSE17721_0.5H_VS_24H_CPG_BMDC_UP,0.99999
GSE40274_CTRL_VS_EOS_TRANSDU...2,SET,158,-0.10052,-0.0092855,0.066615,0.93434,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
HP_BILATERAL_SUPERIOR_VENA_C...,SET,8,-0.46944,-0.0097976,0.31101,0.93439,HP_BILATERAL_SUPERIOR_VENA_CAVA,0.99999
GSE26030_UNSTIM_VS_RESTIM_TH...8,SET,180,-0.096882,-0.0095461,0.064178,0.93442,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...254,SET,15,-0.29797,-0.008514,0.19733,0.93447,GOBP_POSITIVE_REGULATION_OF_ERAD_PATHWAY,0.99999
GOBP_PROTEIN_INSERTION_INTO_...4,SET,4,-0.53479,-0.0078933,0.35415,0.93448,GOBP_PROTEIN_INSERTION_INTO_MEMBRANE_FROM_INNER_SIDE,0.99999
HP_ABNORMAL_EPIPHYSIS_MORPHO...2,SET,36,-0.22048,-0.0097542,0.14599,0.9345,HP_ABNORMAL_EPIPHYSIS_MORPHOLOGY_OF_THE_PHALANGES_OF_THE_HAND,0.99999
WP_FOCAL_ADHESION_PI3KAKTMTO...,SET,288,-0.080659,-0.010023,0.053406,0.93451,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,0.99999
GSE36095_WT_VS_HDAC9_KO_TREG...2,SET,165,-0.098071,-0.0092558,0.064919,0.93456,GSE36095_WT_VS_HDAC9_KO_TREG_UP,0.99999
MIR636,SET,204,-0.096477,-0.010113,0.06385,0.9346,MIR636,0.99999
HP_MALROTATION_OF_SMALL_BOWEL,SET,8,-0.46299,-0.009663,0.30641,0.9346,HP_MALROTATION_OF_SMALL_BOWEL,0.99999
MASRI_RESISTANCE_TO_TAMOXIFE...2,SET,15,-0.35981,-0.010281,0.2381,0.93461,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...16,SET,47,-0.17898,-0.0090444,0.1184,0.93468,GAVISH_3CA_METAPROGRAM_EPITHELIAL_MYC,0.99999
GOBP_DEOXYRIBONUCLEOSIDE_MON...1,SET,8,-0.41557,-0.0086733,0.27491,0.93468,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GSE11961_MARGINAL_ZONE_BCELL...8,SET,186,-0.09517,-0.0095308,0.062958,0.93468,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP,0.99999
ABDELMOHSEN_ELAVL4_TARGETS,SET,15,-0.35561,-0.010161,0.23519,0.93473,ABDELMOHSEN_ELAVL4_TARGETS,0.99999
PID_TCR_JNK_PATHWAY,SET,14,-0.35495,-0.0097984,0.23474,0.93474,PID_TCR_JNK_PATHWAY,0.99999
GSE13411_IGM_MEMORY_BCELL_VS...1,SET,173,-0.095976,-0.0092729,0.063464,0.93476,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN,0.99999
GOBP_FORMATION_OF_EXTRACHROM...,SET,13,-0.32482,-0.0086407,0.21476,0.93479,GOBP_FORMATION_OF_EXTRACHROMOSOMAL_CIRCULAR_DNA,0.99999
HP_ABNORMAL_PUTAMEN_MORPHOLO...,SET,5,-0.62254,-0.010273,0.4116,0.93479,HP_ABNORMAL_PUTAMEN_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...496,SET,30,-0.25646,-0.010359,0.16953,0.93482,GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,0.99999
GSE3982_DC_VS_TH2_DN,SET,178,-0.093054,-0.0091184,0.061512,0.93482,GSE3982_DC_VS_TH2_DN,0.99999
WP_ASPIRIN_AND_MIRNAS,SET,9,-0.49461,-0.010949,0.32695,0.93483,WP_ASPIRIN_AND_MIRNAS,0.99999
GSE14308_TH2_VS_INDUCED_TREG...2,SET,181,-0.096899,-0.009574,0.06404,0.93486,GSE14308_TH2_VS_INDUCED_TREG_UP,0.99999
CLAUS_PGR_POSITIVE_MENINGIOM...2,SET,8,-0.42639,-0.0088991,0.28178,0.93488,CLAUS_PGR_POSITIVE_MENINGIOMA_UP,0.99999
REACTOME_PCP_CE_PATHWAY,SET,88,-0.12842,-0.0088699,0.084852,0.93491,REACTOME_PCP_CE_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...528,SET,32,-0.2201,-0.0091813,0.14541,0.93494,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.99999
GOBP_REGULATION_OF_SPHINGOLI...,SET,12,-0.32777,-0.0083772,0.21647,0.935,GOBP_REGULATION_OF_SPHINGOLIPID_BIOSYNTHETIC_PROCESS,0.99999
VANDESLUIS_NORMAL_EMBRYOS_DN,SET,19,-0.33479,-0.010765,0.22106,0.93504,VANDESLUIS_NORMAL_EMBRYOS_DN,0.99999
BAFNA_MUC4_TARGETS_UP,SET,3,-0.78274,-0.010005,0.5168,0.93505,BAFNA_MUC4_TARGETS_UP,0.99999
GOBP_PEPTIDYL_LYSINE_DEACETY...,SET,5,-0.57929,-0.009559,0.38249,0.93505,GOBP_PEPTIDYL_LYSINE_DEACETYLATION,0.99999
REACTOME_SYNTHESIS_OF_PE,SET,12,-0.39352,-0.010058,0.25976,0.9351,REACTOME_SYNTHESIS_OF_PE,0.99999
GOBP_POSITIVE_REGULATION_OF_...100,SET,33,-0.24057,-0.01019,0.15879,0.93511,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
chr14q22,SET,43,-0.40733,-0.019691,0.26882,0.93514,chr14q22,0.99999
REACTOME_DEFECTIVE_CHST3_CAU...,SET,7,-0.44339,-0.0086564,0.29256,0.93518,REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD,0.99999
GOBP_G0_TO_G1_TRANSITION,SET,36,-0.20459,-0.009051,0.13497,0.93521,GOBP_G0_TO_G1_TRANSITION,0.99999
HP_LARGE_ILIAC_WING,SET,3,-0.70762,-0.0090451,0.46674,0.93524,HP_LARGE_ILIAC_WING,0.99999
GOMF_ZINC_ION_TRANSMEMBRANE_...,SET,24,-0.23869,-0.0086246,0.15742,0.93526,GOMF_ZINC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
SOTIRIOU_BREAST_CANCER_GRADE...1,SET,48,-0.17711,-0.0090443,0.11679,0.93529,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN,0.99999
HP_REFRACTORY_ANEMIA,SET,6,-0.58597,-0.010592,0.38642,0.93529,HP_REFRACTORY_ANEMIA,0.99999
GOBP_REGULATION_OF_RIG_I_SIG...,SET,17,-0.29423,-0.0089494,0.19399,0.93532,GOBP_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,0.99999
GOBP_T_CELL_DIFFERENTIATION_...1,SET,79,-0.15855,-0.010379,0.10454,0.93532,GOBP_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
HP_JUVENILE_MYELOMONOCYTIC_L...,SET,18,-0.28473,-0.0089114,0.18772,0.93533,HP_JUVENILE_MYELOMONOCYTIC_LEUKEMIA,0.99999
WINNEPENNINCKX_MELANOMA_META...2,SET,151,-0.099248,-0.0089641,0.06543,0.93534,WINNEPENNINCKX_MELANOMA_METASTASIS_UP,0.99999
GOBP_REGULATION_OF_NUCLEOTID...4,SET,49,-0.18236,-0.0094086,0.12021,0.93536,GOBP_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,0.99999
GSE20366_TREG_VS_NAIVE_CD4_T...2,SET,186,-0.095584,-0.0095724,0.063007,0.93536,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP,0.99999
MIR524_5P,SET,853,-0.046449,-0.009777,0.030616,0.93538,MIR524_5P,0.99999
PIEPOLI_LGI1_TARGETS_UP,SET,12,-0.44528,-0.011381,0.29347,0.9354,PIEPOLI_LGI1_TARGETS_UP,0.99999
HP_EPIPHYSEAL_STIPPLING,SET,30,-0.23793,-0.0096102,0.1568,0.9354,HP_EPIPHYSEAL_STIPPLING,0.99999
GOBP_POSITIVE_REGULATION_OF_...28,SET,24,-0.26976,-0.0097472,0.17777,0.93541,GOBP_POSITIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.99999
REACTOME_CLASS_C_3_METABOTRO...,SET,37,-0.2567,-0.011512,0.16916,0.93542,REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS,0.99999
GOBP_TRANSCRIPTION_INITIATIO...1,SET,8,-0.36252,-0.0075661,0.2389,0.93542,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_III_PROMOTER,0.99999
GOBP_BONE_TRABECULA_FORMATION,SET,11,-0.40543,-0.0099213,0.2671,0.93547,GOBP_BONE_TRABECULA_FORMATION,0.99999
HP_COR_PULMONALE,SET,10,-0.41299,-0.0096364,0.27209,0.93547,HP_COR_PULMONALE,0.99999
GSE5589_LPS_AND_IL10_VS_LPS_...4,SET,181,-0.095613,-0.009447,0.06298,0.9355,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,0.99999
MIR6777_5P,SET,5,-0.63225,-0.010433,0.41644,0.93551,MIR6777_5P,0.99999
HP_ABNORMAL_IMMUNE_SYSTEM_MO...,SET,587,-0.054564,-0.0095996,0.035933,0.93554,HP_ABNORMAL_IMMUNE_SYSTEM_MORPHOLOGY,0.99999
THILLAINADESAN_ZNF217_TARGET...1,SET,6,-0.59548,-0.010764,0.39211,0.93557,THILLAINADESAN_ZNF217_TARGETS_DN,0.99999
GOBP_PYRIMIDINE_RIBONUCLEOSI...5,SET,16,-0.34011,-0.010037,0.2239,0.93561,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.99999
ADDYA_ERYTHROID_DIFFERENTIAT...,SET,68,-0.17716,-0.010762,0.1166,0.93567,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,0.99999
GSE6259_FLT3L_INDUCED_DEC205...1,SET,149,-0.10208,-0.0091594,0.067184,0.93567,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN,0.99999
YTTCCNNNGGAMR_UNKNOWN,SET,46,-0.20243,-0.010121,0.13322,0.93569,YTTCCNNNGGAMR_UNKNOWN,0.99999
WP_ADHD_AND_AUTISM_ASD_PATHW...,SET,342,-0.074533,-0.010078,0.049042,0.93571,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,0.99999
REACTOME_GAP_JUNCTION_TRAFFI...,SET,46,-0.20952,-0.010475,0.13784,0.93573,REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION,0.99999
KEGG_MEDICUS_PATHOGEN_HIV_TA...1,SET,8,-0.44501,-0.0092877,0.29273,0.93576,KEGG_MEDICUS_PATHOGEN_HIV_TAT_NEF_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,0.99999
DESCARTES_FETAL_CEREBELLUM_G...,SET,26,-0.27876,-0.010483,0.18337,0.93576,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,0.99999
SHETH_LIVER_CANCER_VS_TXNIP_...2,SET,152,-0.10642,-0.0096429,0.069969,0.93585,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...78,SET,7,-0.46981,-0.0091722,0.30891,0.93585,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01048,0.99999
ATF2_UP.V1_DN,SET,166,-0.10603,-0.010036,0.069687,0.93592,ATF2_UP.V1_DN,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...5,SET,97,-0.13903,-0.010079,0.091345,0.93599,GOCC_EXTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE,0.99999
HP_NEOPLASM_OF_THE_THYROID_G...,SET,87,-0.13646,-0.0093719,0.089654,0.936,HP_NEOPLASM_OF_THE_THYROID_GLAND,0.99999
GOBP_REGULATION_OF_CIRCADIAN...2,SET,5,-0.66455,-0.010966,0.43655,0.93602,GOBP_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP,0.99999
REACTOME_TICAM1_TRAF6_DEPEND...,SET,9,-0.51998,-0.01151,0.34154,0.93604,REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX,0.99999
GOCC_CYTOSOLIC_SMALL_RIBOSOM...,SET,35,-0.21325,-0.0093024,0.14007,0.93605,GOCC_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT,0.99999
KAECH_NAIVE_VS_MEMORY_CD8_TC...2,SET,184,-0.095609,-0.0095238,0.062796,0.93605,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP,0.99999
GOBP_SENSORY_PERCEPTION_OF_C...,SET,403,-0.089529,-0.013118,0.0588,0.93606,GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS,0.99999
GIAROLA_SILVA_BLOOD_PANDEMRI...2,SET,4,-0.54319,-0.0080172,0.35667,0.93611,GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_21_51YO_3DY_UP,0.99999
DESCARTES_FETAL_STOMACH_LYMP...2,SET,68,-0.1637,-0.0099446,0.10746,0.93617,DESCARTES_FETAL_STOMACH_LYMPHOID_CELLS,0.99999
HALMOS_CEBPA_TARGETS_UP,SET,46,-0.22283,-0.01114,0.14625,0.93619,HALMOS_CEBPA_TARGETS_UP,0.99999
REACTOME_O_GLYCOSYLATION_OF_...,SET,36,-0.24298,-0.010749,0.15946,0.93621,REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS,0.99999
GOBP_MYELIN_MAINTENANCE,SET,15,-0.33975,-0.0097078,0.22292,0.93625,GOBP_MYELIN_MAINTENANCE,0.99999
GOBP_POSITIVE_REGULATION_OF_...259,SET,32,-0.21781,-0.0090856,0.14291,0.93625,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.99999
SOBOLEV_PBMC_PANDEMRIX_AGE_1...9,SET,18,-0.32034,-0.010026,0.21018,0.93625,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_RESPONDERS_VS_NONRESPONDERS_7DY_UP,0.99999
GSE32034_UNTREATED_VS_ROSIGL...1,SET,176,-0.096498,-0.009403,0.063286,0.93633,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_DN,0.99999
HP_EPILEPTIC_AURA,SET,20,-0.29004,-0.009568,0.19015,0.9364,HP_EPILEPTIC_AURA,0.99999
HATADA_METHYLATED_IN_LUNG_CA...2,SET,350,-0.071984,-0.0098441,0.047188,0.93642,HATADA_METHYLATED_IN_LUNG_CANCER_UP,0.99999
GOBP_ADAPTIVE_IMMUNE_MEMORY_...,SET,5,-0.68973,-0.011381,0.45214,0.93642,GOBP_ADAPTIVE_IMMUNE_MEMORY_RESPONSE,0.99999
GOCC_BASEMENT_MEMBRANE_COLLA...,SET,6,-0.59015,-0.010667,0.38685,0.93643,GOCC_BASEMENT_MEMBRANE_COLLAGEN_TRIMER,0.99999
GOBP_CORTISOL_SECRETION,SET,5,-0.51477,-0.0084943,0.33737,0.93646,GOBP_CORTISOL_SECRETION,0.99999
ACAGGGT_MIR10A_MIR10B,SET,111,-0.11997,-0.0093002,0.078614,0.93649,ACAGGGT_MIR10A_MIR10B,0.99999
MIR325,SET,28,-0.24523,-0.00957,0.16066,0.93653,MIR325,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...6,SET,46,-0.20606,-0.010302,0.135,0.93654,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_5,0.99999
GSE34205_RSV_VS_FLU_INF_INFA...1,SET,175,-0.10054,-0.0097697,0.065865,0.93655,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN,0.99999
HP_GLOSSOPTOSIS,SET,25,-0.25749,-0.0094955,0.16865,0.93658,HP_GLOSSOPTOSIS,0.99999
GOBP_SKELETAL_MYOFIBRIL_ASSE...,SET,10,-0.43276,-0.010098,0.2834,0.93661,GOBP_SKELETAL_MYOFIBRIL_ASSEMBLY,0.99999
GSE11924_TFH_VS_TH2_CD4_TCEL...2,SET,183,-0.091611,-0.0091009,0.059993,0.93661,GSE11924_TFH_VS_TH2_CD4_TCELL_UP,0.99999
GOBP_ACTIVATION_INDUCED_CELL...,SET,8,-0.49688,-0.01037,0.32538,0.93662,GOBP_ACTIVATION_INDUCED_CELL_DEATH_OF_T_CELLS,0.99999
GOBP_REGULATION_OF_GAP_JUNCT...,SET,9,-0.52055,-0.011523,0.34087,0.93663,GOBP_REGULATION_OF_GAP_JUNCTION_ASSEMBLY,0.99999
WP_TNFALPHA_SIGNALING,SET,89,-0.13284,-0.009227,0.086976,0.93665,WP_TNFALPHA_SIGNALING,0.99999
GOBP_PROTEIN_K29_LINKED_UBIQ...,SET,10,-0.42048,-0.0098111,0.2753,0.93666,GOBP_PROTEIN_K29_LINKED_UBIQUITINATION,0.99999
CHOI_ATL_ACUTE_STAGE,SET,4,-0.72152,-0.010649,0.47236,0.93667,CHOI_ATL_ACUTE_STAGE,0.99999
HP_SELF_INJURIOUS_BEHAVIOR,SET,166,-0.10264,-0.0097164,0.067192,0.93669,HP_SELF_INJURIOUS_BEHAVIOR,0.99999
GSE27670_CTRL_VS_LMP1_TRANSD...2,SET,181,-0.097974,-0.0096802,0.064134,0.93669,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...210,SET,199,-0.093762,-0.0097089,0.061371,0.93671,GOBP_POSITIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.99999
HP_ERYTHROCYTE_INCLUSION_BOD...,SET,6,-0.47211,-0.0085337,0.30901,0.93671,HP_ERYTHROCYTE_INCLUSION_BODIES,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...17,SET,10,-0.42583,-0.0099359,0.27865,0.93676,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_OTHER_NITROGENOUS_COMPOUNDS_AS_DONORS,0.99999
GOBP_PIGMENT_CELL_DIFFERENTI...,SET,34,-0.24302,-0.010449,0.15901,0.93677,GOBP_PIGMENT_CELL_DIFFERENTIATION,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...14,SET,11,-0.41576,-0.010174,0.27205,0.93677,GAUTAM_EYE_IRIS_CILIARY_BODY_RIBOSOMAL_GENES_HIGH_FIBROBLASTS,0.99999
HP_KNUCKLE_PAD,SET,7,-0.47752,-0.0093228,0.31243,0.93679,HP_KNUCKLE_PAD,0.99999
GOBP_ANATOMICAL_STRUCTURE_RE...,SET,15,-0.34759,-0.0099318,0.2274,0.9368,GOBP_ANATOMICAL_STRUCTURE_REGRESSION,0.99999
GSE20152_SPHK1_KO_VS_WT_HTNF...1,SET,180,-0.091523,-0.0090181,0.059866,0.93683,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN,0.99999
MODULE_414,SET,8,-0.52514,-0.01096,0.34341,0.93688,MODULE_414,0.99999
GOBP_CELL_MIGRATION_INVOLVED...5,SET,51,-0.19168,-0.010089,0.12534,0.9369,GOBP_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.99999
KEGG_MEDICUS_REFERENCE_DEPHO...,SET,12,-0.36688,-0.0093768,0.23983,0.93695,KEGG_MEDICUS_REFERENCE_DEPHOSPHORYLATION_OF_KINETOCHORE,0.99999
PID_HIF1_TFPATHWAY,SET,64,-0.17422,-0.010269,0.11385,0.93701,PID_HIF1_TFPATHWAY,0.99999
REACTOME_RNA_POLYMERASE_II_T...3,SET,60,-0.14883,-0.0084949,0.097236,0.93706,REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,0.99999
HP_REDUCED_LEFT_VENTRICULAR_...,SET,55,-0.17483,-0.0095548,0.1142,0.93709,HP_REDUCED_LEFT_VENTRICULAR_EJECTION_FRACTION,0.99999
HP_VASCULAR_DILATATION,SET,196,-0.09391,-0.0096516,0.061343,0.93709,HP_VASCULAR_DILATATION,0.99999
REACTOME_SIALIC_ACID_METABOL...,SET,33,-0.23485,-0.009948,0.15338,0.93712,REACTOME_SIALIC_ACID_METABOLISM,0.99999
HP_PRIMARY_HYPERPARATHYROIDI...,SET,13,-0.39862,-0.010604,0.26035,0.93712,HP_PRIMARY_HYPERPARATHYROIDISM,0.99999
REACTOME_DEFECTIVE_B4GALT7_C...,SET,17,-0.32419,-0.0098608,0.21163,0.93721,REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE,0.99999
GAVISH_3CA_METAPROGRAM_CD4_T...2,SET,44,-0.22217,-0.010864,0.14504,0.93721,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CYTOTOXIC,0.99999
GOBP_INTRACELLULAR_ZINC_ION_...,SET,34,-0.2418,-0.010396,0.15784,0.93721,GOBP_INTRACELLULAR_ZINC_ION_HOMEOSTASIS,0.99999
HP_ABNORMAL_EARLOBE_MORPHOLO...,SET,107,-0.1247,-0.0094926,0.081393,0.93724,HP_ABNORMAL_EARLOBE_MORPHOLOGY,0.99999
EVI1_04,SET,198,-0.10064,-0.010395,0.065678,0.93726,EVI1_04,0.99999
HP_MILD_GLOBAL_DEVELOPMENTAL...,SET,70,-0.15405,-0.0094942,0.10048,0.93737,HP_MILD_GLOBAL_DEVELOPMENTAL_DELAY,0.99999
GSE26343_UNSTIM_VS_LPS_STIM_...2,SET,191,-0.096781,-0.0098203,0.063125,0.93737,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,0.99999
WP_INFLAMMATORY_RESPONSE_PAT...,SET,28,-0.26028,-0.010157,0.16972,0.93743,WP_INFLAMMATORY_RESPONSE_PATHWAY,0.99999
HP_ADRENOCORTICAL_CARCINOMA,SET,17,-0.33356,-0.010146,0.2175,0.93743,HP_ADRENOCORTICAL_CARCINOMA,0.99999
MIR4640_3P,SET,14,-0.30804,-0.0085034,0.20076,0.93752,MIR4640_3P,0.99999
GOCC_POSTSYNAPTIC_DENSITY_ME...,SET,94,-0.14076,-0.010046,0.09173,0.93754,GOCC_POSTSYNAPTIC_DENSITY_MEMBRANE,0.99999
GOBP_POSITIVE_REGULATION_OF_...721,SET,12,-0.35207,-0.0089985,0.22941,0.93757,GOBP_POSITIVE_REGULATION_OF_SPINDLE_CHECKPOINT,0.99999
HP_PRIMARY_HYPERALDOSTERONISM,SET,10,-0.49002,-0.011433,0.31928,0.93757,HP_PRIMARY_HYPERALDOSTERONISM,0.99999
DONATO_CELL_CYCLE_TRETINOIN,SET,6,-0.62122,-0.011229,0.40471,0.9376,DONATO_CELL_CYCLE_TRETINOIN,0.99999
NIKOLSKY_BREAST_CANCER_20Q11...,SET,31,-0.44355,-0.018211,0.28896,0.9376,NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON,0.99999
FOXJ2_01,SET,168,-0.10642,-0.010134,0.069329,0.9376,FOXJ2_01,0.99999
ATGCTGG_MIR338,SET,108,-0.12323,-0.0094237,0.080246,0.93767,ATGCTGG_MIR338,0.99999
GLI1_UP.V1_UP,SET,21,-0.29084,-0.0098312,0.18941,0.93767,GLI1_UP.V1_UP,0.99999
REACTOME_AEROBIC_RESPIRATION...,SET,209,-0.081992,-0.0086985,0.053388,0.93769,REACTOME_AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,0.99999
HP_PARATHYROID_ADENOMA,SET,15,-0.37866,-0.010819,0.24657,0.93769,HP_PARATHYROID_ADENOMA,0.99999
KONDO_PROSTATE_CANCER_WITH_H...,SET,178,-0.10886,-0.010667,0.07088,0.9377,KONDO_PROSTATE_CANCER_WITH_H3K27ME3,0.99999
GOCC_SYNAPSE_ASSOCIATED_EXTR...,SET,12,-0.39603,-0.010122,0.25786,0.9377,GOCC_SYNAPSE_ASSOCIATED_EXTRACELLULAR_MATRIX,0.99999
GNF2_CKS1B,SET,36,-0.20122,-0.008902,0.13101,0.93771,GNF2_CKS1B,0.99999
GOBP_FEMALE_MEIOTIC_NUCLEAR_...,SET,32,-0.22524,-0.0093957,0.14662,0.93775,GOBP_FEMALE_MEIOTIC_NUCLEAR_DIVISION,0.99999
GOBP_CHONDROCYTE_DIFFERENTIA...2,SET,14,-0.34526,-0.009531,0.22469,0.9378,GOBP_CHONDROCYTE_DIFFERENTIATION_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,0.99999
GOBP_DNA_TOPOLOGICAL_CHANGE,SET,9,-0.36755,-0.0081361,0.23919,0.9378,GOBP_DNA_TOPOLOGICAL_CHANGE,0.99999
SAFFORD_T_LYMPHOCYTE_ANERGY,SET,85,-0.14543,-0.0098731,0.094628,0.93783,SAFFORD_T_LYMPHOCYTE_ANERGY,0.99999
LY_AGING_OLD_UP,SET,7,-0.54426,-0.010626,0.35397,0.93792,LY_AGING_OLD_UP,0.99999
LAU_APOPTOSIS_CDKN2A_DN,SET,5,-0.55568,-0.0091694,0.36133,0.93795,LAU_APOPTOSIS_CDKN2A_DN,0.99999
REACTOME_GOLGI_TO_ER_RETROGR...,SET,129,-0.10713,-0.0089488,0.069662,0.93795,REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,0.99999
WP_TYPE_II_INTERFERON_SIGNAL...,SET,35,-0.2307,-0.010064,0.15,0.93797,WP_TYPE_II_INTERFERON_SIGNALING,0.99999
TRAVAGLINI_LUNG_MUCOUS_CELL,SET,116,-0.13667,-0.01083,0.08885,0.93799,TRAVAGLINI_LUNG_MUCOUS_CELL,0.99999
WP_NONCLASSICAL_ROLE_OF_VITA...,SET,6,-0.6028,-0.010896,0.39181,0.93803,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...5,SET,240,-0.082336,-0.0093525,0.053516,0.93803,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.99999
GOCC_NUCLEAR_EXOSOME_RNASE_C...,SET,14,-0.312,-0.0086127,0.20279,0.93803,GOCC_NUCLEAR_EXOSOME_RNASE_COMPLEX,0.99999
GOMF_1_PHOSPHATIDYLINOSITOL_...1,SET,10,-0.40174,-0.0093738,0.26113,0.93803,GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY,0.99999
GSE3920_UNTREATED_VS_IFNA_TR...1,SET,146,-0.11027,-0.0097944,0.071671,0.93803,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...7,SET,53,-0.19705,-0.010572,0.12807,0.93805,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,0.99999
HP_LONG_EAR,SET,6,-0.52999,-0.0095799,0.34445,0.93805,HP_LONG_EAR,0.99999
BERGER_MBD2_TARGETS,SET,4,-0.78807,-0.011631,0.51203,0.9381,BERGER_MBD2_TARGETS,0.99999
GOBP_POSITIVE_REGULATION_OF_...436,SET,3,-1.0284,-0.013146,0.66815,0.93811,GOBP_POSITIVE_REGULATION_OF_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,0.99999
ZNF711_TARGET_GENES,SET,1382,-0.03626,-0.0095671,0.023557,0.93812,ZNF711_TARGET_GENES,0.99999
ZF5_B,SET,214,-0.092025,-0.0098776,0.059786,0.93812,ZF5_B,0.99999
MIR490_5P,SET,39,-0.20588,-0.0094794,0.13375,0.93813,MIR490_5P,0.99999
BIOCARTA_GHRELIN_PATHWAY,SET,13,-0.44152,-0.011745,0.28676,0.93817,BIOCARTA_GHRELIN_PATHWAY,0.99999
HP_ECTOPIC_ANUS,SET,72,-0.15727,-0.0098299,0.10214,0.93818,HP_ECTOPIC_ANUS,0.99999
ARNT2_TARGET_GENES,SET,552,-0.055627,-0.0094997,0.036113,0.93825,ARNT2_TARGET_GENES,0.99999
GSE26030_TH1_VS_TH17_DAY15_P...2,SET,181,-0.096152,-0.0095002,0.062419,0.93826,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_UP,0.99999
GCM_TPT1,SET,60,-0.16137,-0.0092103,0.10475,0.93828,GCM_TPT1,0.99999
GSE20366_EX_VIVO_VS_DEC205_C...2,SET,182,-0.10045,-0.009952,0.065193,0.93831,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN,0.99999
LIANG_HEMATOPOIESIS_STEM_CEL...4,SET,33,-0.21688,-0.0091868,0.14073,0.93834,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,0.99999
GSE22935_UNSTIM_VS_48H_MBOVI...4,SET,179,-0.096482,-0.0094806,0.062599,0.93837,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.99999
GSE2405_S_AUREUS_VS_UNTREATE...1,SET,180,-0.098843,-0.0097393,0.064108,0.93843,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN,0.99999
HP_HYPERGONADOTROPIC_HYPOGON...,SET,54,-0.16642,-0.0090128,0.10788,0.93854,HP_HYPERGONADOTROPIC_HYPOGONADISM,0.99999
KEGG_FOLATE_BIOSYNTHESIS,SET,10,-0.4175,-0.0097414,0.2706,0.93856,KEGG_FOLATE_BIOSYNTHESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...815,SET,7,-0.50158,-0.0097925,0.3251,0.93856,GOBP_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...13,SET,191,-0.092028,-0.009338,0.059632,0.93861,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_DN,0.99999
MORF_PRKACA,SET,109,-0.12404,-0.0095292,0.080358,0.93864,MORF_PRKACA,0.99999
GOBP_POSITIVE_REGULATION_OF_...655,SET,303,-0.076524,-0.0097498,0.049569,0.93867,GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS,0.99999
GSE8921_UNSTIM_0H_VS_TLR1_2_...3,SET,184,-0.096409,-0.0096034,0.062446,0.93868,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN,0.99999
GOMF_CYSTEINE_TYPE_PEPTIDASE...,SET,145,-0.10492,-0.0092874,0.067956,0.93869,GOMF_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY,0.99999
GOCC_NEURON_PROJECTION,SET,1213,-0.040419,-0.010041,0.026176,0.93871,GOCC_NEURON_PROJECTION,0.99999
MIR940,SET,164,-0.1041,-0.0097953,0.067415,0.93872,MIR940,0.99999
MIR101_3P,SET,418,-0.067869,-0.010124,0.043935,0.93879,MIR101_3P,0.99999
GSE360_L_MAJOR_VS_B_MALAYI_H...1,SET,180,-0.097925,-0.0096489,0.06339,0.93879,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.99999
WP_LIPID_METABOLISM_PATHWAY,SET,28,-0.24118,-0.0094118,0.15612,0.9388,WP_LIPID_METABOLISM_PATHWAY,0.99999
REACTOME_NRIF_SIGNALS_CELL_D...,SET,14,-0.35178,-0.0097109,0.2277,0.93881,REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS,0.99999
HP_PROTUBERANT_ABDOMEN,SET,39,-0.21279,-0.0097976,0.13774,0.93881,HP_PROTUBERANT_ABDOMEN,0.99999
GSE29618_BCELL_VS_MDC_DN,SET,183,-0.10108,-0.010042,0.065422,0.93883,GSE29618_BCELL_VS_MDC_DN,0.99999
MARSHALL_VIRAL_INFECTION_RES...2,SET,9,-0.51508,-0.011402,0.33329,0.93887,MARSHALL_VIRAL_INFECTION_RESPONSE_UP,0.99999
MIR885_3P,SET,26,-0.25503,-0.0095909,0.16502,0.93888,MIR885_3P,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...8,SET,181,-0.094432,-0.0093303,0.061101,0.93888,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP,0.99999
WP_ZINC_HOMEOSTASIS,SET,36,-0.21932,-0.0097028,0.14184,0.93898,WP_ZINC_HOMEOSTASIS,0.99999
YAO_HOXA10_TARGETS_VIA_PROGE...1,SET,18,-0.36837,-0.011529,0.23817,0.93902,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN,0.99999
GOBP_LUNG_GROWTH,SET,5,-0.71186,-0.011747,0.46017,0.93905,GOBP_LUNG_GROWTH,0.99999
GOMF_HORMONE_BINDING,SET,88,-0.15263,-0.010542,0.098664,0.93905,GOMF_HORMONE_BINDING,0.99999
GSE2935_UV_INACTIVATED_VS_LI...2,SET,163,-0.10879,-0.010206,0.070328,0.93905,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP,0.99999
HP_POSTERIOR_PHARYNGEAL_CLEFT,SET,12,-0.43621,-0.011149,0.28197,0.93906,HP_POSTERIOR_PHARYNGEAL_CLEFT,0.99999
GSE29164_UNTREATED_VS_CD8_TC...7,SET,178,-0.099614,-0.0097612,0.064392,0.93906,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN,0.99999
HP_ABNORMAL_CIRCULATING_CHOL...,SET,138,-0.11633,-0.010048,0.075168,0.93913,HP_ABNORMAL_CIRCULATING_CHOLESTEROL_CONCENTRATION,0.99999
HP_BRADYKINESIA,SET,95,-0.1325,-0.0095066,0.085609,0.93914,HP_BRADYKINESIA,0.99999
MODULE_84,SET,488,-0.064281,-0.01034,0.041524,0.93918,MODULE_84,0.99999
GSE26030_UNSTIM_VS_RESTIM_TH...3,SET,174,-0.10427,-0.010103,0.067351,0.9392,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_DN,0.99999
GOERING_BLOOD_HDL_CHOLESTERO...1,SET,8,-0.52865,-0.011033,0.34144,0.93921,GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS,0.99999
HP_ABNORMAL_CIRCULATING_PROT...1,SET,101,-0.12851,-0.0095054,0.082977,0.93926,HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_CONCENTRATION,0.99999
REACTOME_DEFECTIVE_CHSY1_CAU...,SET,7,-0.45307,-0.0088454,0.29249,0.9393,REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS,0.99999
GOBP_REGULATION_OF_INCLUSION...,SET,17,-0.33189,-0.010095,0.21425,0.93931,GOBP_REGULATION_OF_INCLUSION_BODY_ASSEMBLY,0.99999
HP_INCREASED_DENSITY_OF_LONG...,SET,11,-0.44452,-0.010878,0.28695,0.93932,HP_INCREASED_DENSITY_OF_LONG_BONES,0.99999
GSE32164_RESTING_DIFFERENTIA...3,SET,188,-0.096929,-0.0097585,0.062569,0.93932,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN,0.99999
MCBRYAN_PUBERTAL_BREAST_6_7W...2,SET,177,-0.098487,-0.0096238,0.06357,0.93933,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,0.99999
GOBP_N_ACETYLNEURAMINATE_CAT...,SET,6,-0.55352,-0.010005,0.35724,0.93935,GOBP_N_ACETYLNEURAMINATE_CATABOLIC_PROCESS,0.99999
GOMF_PEPTIDE_N_ACETYLTRANSFE...,SET,46,-0.18294,-0.0091462,0.11802,0.93943,GOMF_PEPTIDE_N_ACETYLTRANSFERASE_ACTIVITY,0.99999
GSE5542_IFNA_VS_IFNA_AND_IFN...1,SET,182,-0.094781,-0.0093904,0.06114,0.93945,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.99999
SALVADOR_MARTIN_PEDIATRIC_TB...1,SET,21,-0.29816,-0.010079,0.1923,0.93948,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP,0.99999
chr16q13,SET,25,-0.44041,-0.016241,0.28393,0.93956,chr16q13,0.99999
GOMF_PROTEIN_SERINE_THREONIN...3,SET,10,-0.44468,-0.010376,0.28663,0.93959,GOMF_PROTEIN_SERINE_THREONINE_KINASE_BINDING,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...5,SET,34,-0.23889,-0.010271,0.15396,0.93961,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,0.99999
WP_ANDROGEN_RECEPTOR_SIGNALI...,SET,83,-0.14597,-0.0097927,0.094072,0.93962,WP_ANDROGEN_RECEPTOR_SIGNALING,0.99999
GSE15330_WT_VS_IKAROS_KO_LYM...2,SET,188,-0.094591,-0.0095231,0.060945,0.93967,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_UP,0.99999
GOBP_REGULATION_OF_AMYLOID_P...,SET,41,-0.20946,-0.0098877,0.13494,0.93968,GOBP_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.99999
GNF2_MSH6,SET,29,-0.20932,-0.0083128,0.13484,0.93969,GNF2_MSH6,0.99999
GSE16386_IL4_VS_IL4_AND_ROSI...1,SET,173,-0.10078,-0.0097367,0.064917,0.93971,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN,0.99999
GOBP_ANTEROGRADE_DENDRITIC_T...2,SET,5,-0.69494,-0.011467,0.44757,0.93974,GOBP_ANTEROGRADE_DENDRITIC_TRANSPORT_OF_NEUROTRANSMITTER_RECEPTOR_COMPLEX,0.99999
GOCC_TRANSPORT_VESICLE_MEMBR...,SET,221,-0.090971,-0.0099211,0.058583,0.93976,GOCC_TRANSPORT_VESICLE_MEMBRANE,0.99999
GOBP_MODULATION_BY_HOST_OF_S...,SET,78,-0.14482,-0.0094194,0.093251,0.93977,GOBP_MODULATION_BY_HOST_OF_SYMBIONT_PROCESS,0.99999
GOMF_LOW_DENSITY_LIPOPROTEIN...2,SET,15,-0.36448,-0.010414,0.23468,0.93979,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY,0.99999
SOBOLEV_T_CELL_PANDEMRIX_AGE...1,SET,23,-0.28022,-0.0099124,0.18042,0.9398,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_1DY_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...293,SET,16,-0.33092,-0.0097651,0.21302,0.93983,GOBP_NEGATIVE_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...57,SET,97,-0.1348,-0.0097729,0.08678,0.93983,GOBP_POSITIVE_REGULATION_OF_BINDING,0.99999
XIE_ST_HSC_S1PR3_OE_DN,SET,23,-0.29684,-0.0105,0.19101,0.9399,XIE_ST_HSC_S1PR3_OE_DN,0.99999
GSE19198_CTRL_VS_IL21_TREATE...2,SET,148,-0.10964,-0.0098045,0.070552,0.9399,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_UP,0.99999
JEON_SMAD6_TARGETS_DN,SET,19,-0.30782,-0.0098978,0.19807,0.93991,JEON_SMAD6_TARGETS_DN,0.99999
GOBP_SPERMATID_NUCLEUS_DIFFE...,SET,22,-0.28823,-0.0099719,0.18543,0.93995,GOBP_SPERMATID_NUCLEUS_DIFFERENTIATION,0.99999
GOBP_MEMBRANE_RAFT_ASSEMBLY,SET,11,-0.40177,-0.0098317,0.25845,0.93996,GOBP_MEMBRANE_RAFT_ASSEMBLY,0.99999
GOBP_CARDIAC_LEFT_VENTRICLE_...,SET,16,-0.36344,-0.010725,0.23379,0.93997,GOBP_CARDIAC_LEFT_VENTRICLE_MORPHOGENESIS,0.99999
GOBP_GLUCOSAMINE_CONTAINING_...1,SET,9,-0.49099,-0.010869,0.31584,0.93997,GOBP_GLUCOSAMINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.99999
REACTOME_SEMA3A_PAK_DEPENDEN...,SET,14,-0.3414,-0.0094242,0.21957,0.94,REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION,0.99999
GOMF_PHOSPHATIDYLETHANOLAMIN...2,SET,5,-0.67485,-0.011136,0.43399,0.94002,GOMF_PHOSPHATIDYLETHANOLAMINE_FLIPPASE_ACTIVITY,0.99999
GOBP_SIRNA_PROCESSING,SET,8,-0.47501,-0.0099139,0.30544,0.94004,GOBP_SIRNA_PROCESSING,0.99999
GOBP_SKELETAL_MUSCLE_TISSUE_...1,SET,10,-0.44833,-0.010461,0.28828,0.94004,GOBP_SKELETAL_MUSCLE_TISSUE_GROWTH,0.99999
GOBP_BLASTOCYST_DEVELOPMENT,SET,110,-0.12188,-0.0094059,0.078358,0.94006,GOBP_BLASTOCYST_DEVELOPMENT,0.99999
GOMF_G_PROTEIN_COUPLED_AMINE...,SET,38,-0.24673,-0.011214,0.15862,0.94007,GOMF_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY,0.99999
MIR520D_5P,SET,852,-0.047586,-0.010011,0.030591,0.94008,MIR520D_5P,0.99999
GOBP_RESPONSE_TO_PHORBOL_13_...,SET,8,-0.48123,-0.010044,0.30931,0.94012,GOBP_RESPONSE_TO_PHORBOL_13_ACETATE_12_MYRISTATE,0.99999
GOBP_NUCLEOTIDE_SUGAR_METABO...,SET,34,-0.20692,-0.0088965,0.13298,0.94014,GOBP_NUCLEOTIDE_SUGAR_METABOLIC_PROCESS,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_DEF...1,SET,23,-0.27394,-0.0096901,0.17605,0.94014,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROBLAST,0.99999
GSE11924_TFH_VS_TH1_CD4_TCEL...2,SET,185,-0.095619,-0.0095503,0.061436,0.94018,GSE11924_TFH_VS_TH1_CD4_TCELL_UP,0.99999
GOBP_RNA_SURVEILLANCE,SET,17,-0.29475,-0.0089654,0.18938,0.94019,GOBP_RNA_SURVEILLANCE,0.99999
GSE27291_0H_VS_7D_STIM_GAMMA...1,SET,159,-0.10337,-0.0095784,0.066408,0.94021,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN,0.99999
TRIP13_TARGET_GENES,SET,69,-0.16205,-0.0099164,0.10409,0.94024,TRIP13_TARGET_GENES,0.99999
GOBP_GROWTH,SET,818,-0.049068,-0.010124,0.031514,0.94026,GOBP_GROWTH,0.99999
HP_PERSISTENT_PUPILLARY_MEMB...,SET,9,-0.48833,-0.01081,0.31356,0.9403,HP_PERSISTENT_PUPILLARY_MEMBRANE,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...8,SET,176,-0.10014,-0.0097584,0.064305,0.9403,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_UP,0.99999
HP_BILATERAL_TALIPES_EQUINOV...,SET,43,-0.21521,-0.010404,0.13818,0.94031,HP_BILATERAL_TALIPES_EQUINOVARUS,0.99999
HP_ABNORMAL_THYROID_MORPHOLO...,SET,166,-0.10398,-0.0098431,0.066731,0.9404,HP_ABNORMAL_THYROID_MORPHOLOGY,0.99999
HP_PSYCHOSIS,SET,94,-0.14099,-0.010063,0.090464,0.94044,HP_PSYCHOSIS,0.99999
KEGG_MEDICUS_REFERENCE_26S_P...,SET,37,-0.18589,-0.0083371,0.11926,0.94047,KEGG_MEDICUS_REFERENCE_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...90,SET,37,-0.18589,-0.0083371,0.11926,0.94047,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_UBQLN2_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
GOMF_G_PROTEIN_COUPLED_RECEP...3,SET,4,-0.6133,-0.009052,0.39342,0.94048,GOMF_G_PROTEIN_COUPLED_RECEPTOR_KINASE_ACTIVITY,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...5,SET,176,-0.10119,-0.0098604,0.064907,0.9405,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN,0.99999
REACTOME_SEMA4D_IN_SEMAPHORI...,SET,24,-0.27326,-0.0098737,0.17524,0.94053,REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,0.99999
GOMF_SYNDECAN_BINDING,SET,5,-0.67773,-0.011183,0.43461,0.94054,GOMF_SYNDECAN_BINDING,0.99999
HP_HYPERPARATHYROIDISM,SET,28,-0.26986,-0.010531,0.173,0.94059,HP_HYPERPARATHYROIDISM,0.99999
HP_CHOROID_PLEXUS_CARCINOMA,SET,5,-0.56376,-0.0093027,0.3614,0.9406,HP_CHOROID_PLEXUS_CARCINOMA,0.99999
GOMF_ACYLTRANSFERASE_ACTIVIT...1,SET,5,-0.58288,-0.0096182,0.37365,0.94061,GOMF_ACYLTRANSFERASE_ACTIVITY_ACYL_GROUPS_CONVERTED_INTO_ALKYL_ON_TRANSFER,0.99999
HP_GLOSSITIS,SET,10,-0.47942,-0.011186,0.30729,0.94063,HP_GLOSSITIS,0.99999
MODULE_212,SET,301,-0.079163,-0.010053,0.050737,0.94064,MODULE_212,0.99999
GOMF_APOLIPOPROTEIN_RECEPTOR...,SET,7,-0.49595,-0.0096826,0.31786,0.94064,GOMF_APOLIPOPROTEIN_RECEPTOR_BINDING,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...3,SET,170,-0.10372,-0.0099344,0.066469,0.94066,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN,0.99999
GCAAGGA_MIR502,SET,65,-0.15971,-0.0094863,0.10234,0.94067,GCAAGGA_MIR502,0.99999
KINSEY_TARGETS_OF_EWSR1_FLII...2,SET,1155,-0.039497,-0.0095903,0.025308,0.94069,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP,0.99999
MODULE_335,SET,14,-0.38838,-0.010721,0.24881,0.94073,MODULE_335,0.99999
GOBP_POSITIVE_REGULATION_OF_...664,SET,6,-0.52845,-0.009552,0.33852,0.94074,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS,0.99999
GOBP_INTESTINAL_LIPID_ABSORP...,SET,21,-0.31085,-0.010507,0.19911,0.94075,GOBP_INTESTINAL_LIPID_ABSORPTION,0.99999
HP_EPIPHORA,SET,22,-0.28294,-0.0097888,0.18123,0.94075,HP_EPIPHORA,0.99999
HP_MALIGNANT_NEOPLASM_OF_THE...,SET,95,-0.1351,-0.0096934,0.08653,0.94076,HP_MALIGNANT_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM,0.99999
GOBP_IN_UTERO_EMBRYONIC_DEVE...,SET,378,-0.068424,-0.0097168,0.043824,0.94077,GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT,0.99999
LIU_VAV3_PROSTATE_CARCINOGEN...1,SET,14,-0.38002,-0.010491,0.24329,0.94085,LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,0.99999
HP_MILD_PROTEINURIA,SET,4,-0.6124,-0.0090387,0.39204,0.94086,HP_MILD_PROTEINURIA,0.99999
GSE17721_PAM3CSK4_VS_CPG_24H...2,SET,176,-0.09829,-0.0095777,0.062921,0.94086,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_UP,0.99999
REACTOME_METABOLISM_OF_CARBO...,SET,267,-0.081366,-0.009741,0.052083,0.94087,REACTOME_METABOLISM_OF_CARBOHYDRATES,0.99999
WP_HEREDITARY_LEIOMYOMATOSIS...,SET,18,-0.30607,-0.0095793,0.19593,0.94087,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,0.99999
HP_INCREASED_CIRCULATING_INT...2,SET,5,-0.64209,-0.010595,0.41093,0.94091,HP_INCREASED_CIRCULATING_INTERLEUKIN_18_CONCENTRATION,0.99999
KYNG_DNA_DAMAGE_BY_GAMMA_RAD...,SET,69,-0.16459,-0.010072,0.10531,0.94096,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,0.99999
MIR5008_3P,SET,150,-0.11146,-0.010034,0.071306,0.94097,MIR5008_3P,0.99999
GOBP_ECTOPIC_GERM_CELL_PROGR...,SET,17,-0.32885,-0.010002,0.21037,0.94099,GOBP_ECTOPIC_GERM_CELL_PROGRAMMED_CELL_DEATH,0.99999
GOBP_COP9_SIGNALOSOME_ASSEMB...,SET,5,-0.61826,-0.010202,0.39538,0.94105,GOBP_COP9_SIGNALOSOME_ASSEMBLY,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...15,SET,189,-0.098447,-0.0099374,0.062957,0.94105,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN,0.99999
WP_PROSURVIVAL_SIGNALING_OF_...,SET,15,-0.34806,-0.0099451,0.22255,0.94108,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,0.99999
GOBP_ADENYLATE_CYCLASE_INHIB...5,SET,7,-0.60302,-0.011773,0.38552,0.9411,GOBP_ADENYLATE_CYCLASE_INHIBITING_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_EXECUTION_PHASE_OF_APOP...,SET,77,-0.15465,-0.0099948,0.098859,0.94112,GOBP_EXECUTION_PHASE_OF_APOPTOSIS,0.99999
GOMF_LYSOPHOSPHATIDIC_ACID_R...,SET,4,-0.58932,-0.008698,0.37664,0.94116,GOMF_LYSOPHOSPHATIDIC_ACID_RECEPTOR_ACTIVITY,0.99999
BROWNE_HCMV_INFECTION_10HR_DN,SET,52,-0.19465,-0.010345,0.1244,0.94117,BROWNE_HCMV_INFECTION_10HR_DN,0.99999
PDGF_UP.V1_UP,SET,133,-0.11411,-0.0096773,0.072923,0.94117,PDGF_UP.V1_UP,0.99999
GOBP_PYRIMIDINE_NUCLEOTIDE_B...,SET,28,-0.24622,-0.0096084,0.15734,0.94118,GOBP_PYRIMIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_ZINC_ION_IMPORT_ACROSS_...,SET,10,-0.42612,-0.0099427,0.2723,0.94119,GOBP_ZINC_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
REACTOME_SYNTHESIS_OF_PC,SET,27,-0.252,-0.0096572,0.16098,0.94125,REACTOME_SYNTHESIS_OF_PC,0.99999
REACTOME_KINESINS,SET,57,-0.17361,-0.0096589,0.11086,0.94132,REACTOME_KINESINS,0.99999
DESCARTES_FETAL_STOMACH_ENS_...2,SET,64,-0.1765,-0.010403,0.1127,0.94133,DESCARTES_FETAL_STOMACH_ENS_NEURONS,0.99999
GOBP_CHROMOSOME_SEPARATION,SET,78,-0.1429,-0.0092951,0.091243,0.94134,GOBP_CHROMOSOME_SEPARATION,0.99999
GOBP_REGULATION_OF_RAS_PROTE...,SET,46,-0.20323,-0.01016,0.12974,0.94136,GOBP_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
HP_ABNORMAL_LYMPHOCYTE_MORPH...,SET,221,-0.092204,-0.010055,0.058864,0.94136,HP_ABNORMAL_LYMPHOCYTE_MORPHOLOGY,0.99999
REACTOME_MATURATION_OF_TCA_E...,SET,19,-0.28395,-0.0091303,0.18124,0.9414,REACTOME_MATURATION_OF_TCA_ENZYMES_AND_REGULATION_OF_TCA_CYCLE,0.99999
AMIT_SERUM_RESPONSE_480_MCF1...,SET,32,-0.23239,-0.0096939,0.14829,0.94144,AMIT_SERUM_RESPONSE_480_MCF10A,0.99999
GSE19923_E2A_KO_VS_HEB_AND_E...2,SET,180,-0.10202,-0.010052,0.0651,0.94144,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,0.99999
HP_HYPOPLASTIC_AORTIC_ARCH,SET,11,-0.40587,-0.0099321,0.25896,0.94147,HP_HYPOPLASTIC_AORTIC_ARCH,0.99999
GOBP_NEGATIVE_REGULATION_OF_...276,SET,21,-0.30277,-0.010234,0.19317,0.94148,GOBP_NEGATIVE_REGULATION_OF_HIPPO_SIGNALING,0.99999
GSE360_L_DONOVANI_VS_B_MALAY...3,SET,187,-0.0945,-0.0094889,0.060274,0.94153,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN,0.99999
BURTON_ADIPOGENESIS_PEAK_AT_...4,SET,40,-0.22697,-0.010583,0.14476,0.94154,BURTON_ADIPOGENESIS_PEAK_AT_2HR,0.99999
GOBP_HEMATOPOIETIC_OR_LYMPHO...,SET,96,-0.13852,-0.0099905,0.088347,0.94154,GOBP_HEMATOPOIETIC_OR_LYMPHOID_ORGAN_DEVELOPMENT,0.99999
GSE27670_BLIMP1_VS_LMP1_TRAN...2,SET,177,-0.10184,-0.0099516,0.064953,0.94154,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP,0.99999
ZHONG_PFC_C1_MICROGLIA,SET,233,-0.082138,-0.0091946,0.052388,0.94154,ZHONG_PFC_C1_MICROGLIA,0.99999
GOBP_REGULATION_OF_SUBSTRATE...,SET,58,-0.17898,-0.010044,0.11412,0.94159,GOBP_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.99999
HP_ABNORMAL_FETAL_MORPHOLOGY,SET,265,-0.082301,-0.0098166,0.052477,0.94159,HP_ABNORMAL_FETAL_MORPHOLOGY,0.99999
GOBP_STEM_CELL_DEVELOPMENT,SET,82,-0.15912,-0.010611,0.10135,0.94179,GOBP_STEM_CELL_DEVELOPMENT,0.99999
GSE21033_CTRL_VS_POLYIC_STIM...7,SET,178,-0.095736,-0.0093812,0.060964,0.94183,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN,0.99999
RELA_DN.V1_UP,SET,136,-0.11767,-0.010091,0.074914,0.94187,RELA_DN.V1_UP,0.99999
MIR3622A_3P_MIR3622B_3P,SET,90,-0.15047,-0.01051,0.095791,0.94188,MIR3622A_3P_MIR3622B_3P,0.99999
HP_CHIARI_TYPE_I_MALFORMATION,SET,41,-0.20523,-0.0096881,0.13065,0.94189,HP_CHIARI_TYPE_I_MALFORMATION,0.99999
GOBP_NEURON_INTRINSIC_APOPTO...,SET,18,-0.33778,-0.010572,0.215,0.94191,GOBP_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS,0.99999
HP_SHAGREEN_PATCH,SET,5,-0.65645,-0.010832,0.4178,0.94193,HP_SHAGREEN_PATCH,0.99999
GSE33374_CD8_ALPHAALPHA_VS_A...1,SET,189,-0.095899,-0.0096802,0.061028,0.94194,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,0.99999
HP_ABSENT_BRAINSTEM_AUDITORY...,SET,9,-0.45058,-0.0099741,0.28673,0.94195,HP_ABSENT_BRAINSTEM_AUDITORY_RESPONSES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...45,SET,97,-0.13419,-0.0097286,0.085389,0.94196,GOBP_NEGATIVE_REGULATION_OF_BINDING,0.99999
HP_POLYDACTYLY,SET,228,-0.088666,-0.0098197,0.05642,0.94196,HP_POLYDACTYLY,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...5,SET,21,-0.32057,-0.010836,0.20398,0.94197,GOBP_PROTEIN_LOCALIZATION_TO_CELL_CELL_JUNCTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...465,SET,52,-0.19516,-0.010372,0.12417,0.94198,GOBP_POSITIVE_REGULATION_OF_MIRNA_TRANSCRIPTION,0.99999
GOBP_PHOSPHATIDYLINOSITOL_3_...2,SET,21,-0.26372,-0.0089142,0.16777,0.942,GOBP_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOCC_BBSOME,SET,8,-0.47743,-0.0099643,0.3037,0.94202,GOCC_BBSOME,0.99999
GOBP_POSITIVE_REGULATION_OF_...651,SET,236,-0.086452,-0.0097389,0.054955,0.94215,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TRANSPORT,0.99999
HP_CONGENITAL_BILATERAL_HIP_...,SET,6,-0.54018,-0.0097641,0.34337,0.94215,HP_CONGENITAL_BILATERAL_HIP_DISLOCATION,0.99999
GSE21546_WT_VS_SAP1A_KO_ANTI...2,SET,183,-0.099476,-0.0098823,0.06323,0.94216,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.99999
DING_LUNG_CANCER_MUTATED_SIG...,SET,25,-0.26218,-0.0096686,0.16664,0.94217,DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY,0.99999
MODY_HIPPOCAMPUS_PRENATAL,SET,42,-0.19871,-0.0094935,0.12622,0.94228,MODY_HIPPOCAMPUS_PRENATAL,0.99999
REACTOME_CALNEXIN_CALRETICUL...,SET,24,-0.26253,-0.0094859,0.16666,0.94239,REACTOME_CALNEXIN_CALRETICULIN_CYCLE,0.99999
GSE27786_CD8_TCELL_VS_NEUTRO...1,SET,179,-0.09733,-0.0095639,0.06177,0.94244,GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN,0.99999
GOBP_MANGANESE_ION_TRANSPORT,SET,11,-0.40188,-0.0098344,0.25496,0.94251,GOBP_MANGANESE_ION_TRANSPORT,0.99999
KEGG_RIBOSOME,SET,79,-0.14747,-0.009653,0.09355,0.94252,KEGG_RIBOSOME,0.99999
GOBP_REGULATION_OF_LYMPHOCYT...4,SET,205,-0.097275,-0.010222,0.061708,0.94252,GOBP_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,0.99999
HP_FOCAL_WHITE_MATTER_LESIONS,SET,13,-0.35762,-0.0095133,0.22687,0.94252,HP_FOCAL_WHITE_MATTER_LESIONS,0.99999
GOBP_REGULATION_OF_CD4_POSIT...1,SET,71,-0.17242,-0.010702,0.10936,0.94255,GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
GOCC_CYTOSOLIC_RIBOSOME,SET,102,-0.12686,-0.0094297,0.080463,0.94255,GOCC_CYTOSOLIC_RIBOSOME,0.99999
GOMF_ESTRADIOL_17_BETA_DEHYD...,SET,18,-0.32863,-0.010285,0.20842,0.94256,GOMF_ESTRADIOL_17_BETA_DEHYDROGENASE_NAD_P_ACTIVITY,0.99999
BIOCARTA_LONGEVITY_PATHWAY,SET,15,-0.36604,-0.010459,0.23214,0.94257,BIOCARTA_LONGEVITY_PATHWAY,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_TH...8,SET,31,-0.25422,-0.010438,0.16122,0.94257,HP_ABNORMAL_MORPHOLOGY_OF_THE_OLFACTORY_BULB,0.99999
MIR491_3P,SET,108,-0.13343,-0.010204,0.08461,0.94259,MIR491_3P,0.99999
GOBP_REGULATION_OF_NEUROTROP...,SET,9,-0.44093,-0.0097605,0.27957,0.94261,GOBP_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,0.99999
WILSON_PROTEASES_AT_TUMOR_BO...1,SET,5,-0.68175,-0.01125,0.43224,0.94262,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN,0.99999
HP_EXERCISE_INDUCED_MUSCLE_S...,SET,7,-0.4258,-0.0083129,0.26992,0.94265,HP_EXERCISE_INDUCED_MUSCLE_STIFFNESS,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_NKT...1,SET,8,-0.51352,-0.010717,0.32554,0.94265,HE_LIM_SUN_FETAL_LUNG_C4_NKT1_CELL,0.99999
GSE17721_0.5H_VS_12H_LPS_BMD...2,SET,174,-0.096784,-0.0093777,0.06133,0.94272,GSE17721_0.5H_VS_12H_LPS_BMDC_UP,0.99999
MIR448,SET,327,-0.077441,-0.010243,0.049061,0.94276,MIR448,0.99999
GOBP_REGULATION_OF_VIRAL_TRA...,SET,18,-0.30909,-0.0096738,0.1958,0.94277,GOBP_REGULATION_OF_VIRAL_TRANSCRIPTION,0.99999
chr5p14,SET,5,-0.88867,-0.014664,0.56293,0.94278,chr5p14,0.99999
BIOCARTA_AMAN_PATHWAY,SET,15,-0.3723,-0.010638,0.23583,0.94278,BIOCARTA_AMAN_PATHWAY,0.99999
HP_RECURRENT_BRONCHITIS,SET,33,-0.24054,-0.010189,0.15235,0.94281,HP_RECURRENT_BRONCHITIS,0.99999
GSE28408_LY6G_POS_VS_NEG_DC_...1,SET,176,-0.09627,-0.0093809,0.060969,0.94282,GSE28408_LY6G_POS_VS_NEG_DC_DN,0.99999
DORSAM_HOXA9_TARGETS_DN,SET,30,-0.25785,-0.010415,0.16329,0.94283,DORSAM_HOXA9_TARGETS_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...728,SET,33,-0.24019,-0.010174,0.15205,0.9429,GOBP_POSITIVE_REGULATION_OF_STEROL_TRANSPORT,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...13,SET,153,-0.1154,-0.010492,0.073039,0.94294,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN,0.99999
HP_ABNORMAL_CORONARY_ARTERY_...1,SET,67,-0.1785,-0.010764,0.11296,0.94296,HP_ABNORMAL_CORONARY_ARTERY_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...327,SET,23,-0.31407,-0.01111,0.19874,0.94297,GOBP_POSITIVE_REGULATION_OF_HEART_RATE,0.99999
TGANTCA_AP1_C,SET,1018,-0.044888,-0.010273,0.028402,0.94299,TGANTCA_AP1_C,0.99999
PASINI_SUZ12_TARGETS_UP,SET,93,-0.14852,-0.010544,0.093966,0.94301,PASINI_SUZ12_TARGETS_UP,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...28,SET,23,-0.30852,-0.010913,0.19516,0.94304,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN,0.99999
HP_ABDOMINAL_DISTENTION,SET,139,-0.11673,-0.010119,0.073841,0.94304,HP_ABDOMINAL_DISTENTION,0.99999
MITSIADES_RESPONSE_TO_APLIDI...2,SET,385,-0.068893,-0.0098717,0.043576,0.94305,MITSIADES_RESPONSE_TO_APLIDIN_UP,0.99999
SILIGAN_BOUND_BY_EWS_FLT1_FU...,SET,43,-0.22154,-0.010709,0.14011,0.94307,SILIGAN_BOUND_BY_EWS_FLT1_FUSION,0.99999
REACTOME_AZATHIOPRINE_ADME,SET,21,-0.31401,-0.010614,0.1986,0.94307,REACTOME_AZATHIOPRINE_ADME,0.99999
HP_SHORT_TOE,SET,89,-0.14473,-0.010053,0.091534,0.94307,HP_SHORT_TOE,0.99999
NFKB_Q6,SET,236,-0.089939,-0.010132,0.056861,0.94314,NFKB_Q6,0.99999
HP_DIMINISHED_MOVEMENT,SET,72,-0.15235,-0.0095223,0.09631,0.94315,HP_DIMINISHED_MOVEMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...702,SET,14,-0.36797,-0.010158,0.23261,0.94316,GOBP_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION,0.99999
GSE17721_LPS_VS_PAM3CSK4_12H...1,SET,179,-0.098238,-0.0096531,0.0621,0.94316,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_DN,0.99999
HP_NEOPLASM_OF_THE_HEART,SET,15,-0.32153,-0.0091869,0.20323,0.94318,HP_NEOPLASM_OF_THE_HEART,0.99999
HP_ABNORMAL_CIRCULATING_CARB...2,SET,305,-0.07722,-0.0098703,0.0488,0.94321,HP_ABNORMAL_CIRCULATING_CARBOXYLIC_ACID_CONCENTRATION,0.99999
MIR518A_3P_MIR518B_MIR518C_3...,SET,8,-0.52196,-0.010894,0.32983,0.94322,MIR518A_3P_MIR518B_MIR518C_3P_MIR518D_3P_MIR518F_3P_MIR526A_3P,0.99999
MIR6857_5P,SET,72,-0.15236,-0.009523,0.096275,0.94323,MIR6857_5P,0.99999
GOBP_ANDROGEN_CATABOLIC_PROC...,SET,5,-0.62498,-0.010313,0.39491,0.94323,GOBP_ANDROGEN_CATABOLIC_PROCESS,0.99999
GSE1432_1H_VS_6H_IFNG_MICROG...2,SET,185,-0.10002,-0.0099901,0.0632,0.94324,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.99999
GOBP_COLLAGEN_FIBRIL_ORGANIZ...,SET,63,-0.1797,-0.010509,0.11353,0.94326,GOBP_COLLAGEN_FIBRIL_ORGANIZATION,0.99999
GOCC_MATRIX_SIDE_OF_MITOCHON...,SET,5,-0.60835,-0.010038,0.38423,0.94331,GOCC_MATRIX_SIDE_OF_MITOCHONDRIAL_INNER_MEMBRANE,0.99999
REACTOME_REGULATION_OF_ENDOG...1,SET,80,-0.14763,-0.0097245,0.09324,0.94332,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS,0.99999
HP_NEOPLASM_OF_THE_THYMUS,SET,7,-0.50382,-0.0098363,0.31817,0.94334,HP_NEOPLASM_OF_THE_THYMUS,0.99999
GOBP_REGULATION_OF_DNA_METHY...,SET,14,-0.38139,-0.010528,0.24082,0.94336,GOBP_REGULATION_OF_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,0.99999
HP_IMPAIRED_ANTIGEN_SPECIFIC...,SET,47,-0.20842,-0.010532,0.1316,0.94337,HP_IMPAIRED_ANTIGEN_SPECIFIC_RESPONSE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...18,SET,22,-0.2703,-0.0093514,0.17064,0.94339,GOBP_NEGATIVE_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.99999
MIR589_5P,SET,77,-0.15486,-0.010008,0.097759,0.9434,MIR589_5P,0.99999
MIR3925_3P,SET,161,-0.10876,-0.01014,0.068652,0.94341,MIR3925_3P,0.99999
SCHLESINGER_H3K27ME3_IN_NORM...,SET,26,-0.32598,-0.012259,0.20575,0.94343,SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER,0.99999
GOMF_PLUS_END_DIRECTED_MICRO...,SET,17,-0.32444,-0.0098683,0.20477,0.94344,GOMF_PLUS_END_DIRECTED_MICROTUBULE_MOTOR_ACTIVITY,0.99999
ZSCAN31_TARGET_GENES,SET,746,-0.051015,-0.010073,0.032194,0.94346,ZSCAN31_TARGET_GENES,0.99999
GOBP_OTIC_VESICLE_DEVELOPMENT,SET,14,-0.36243,-0.010005,0.22871,0.94347,GOBP_OTIC_VESICLE_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_MICROVILL...3,SET,13,-0.36148,-0.0096158,0.22809,0.94349,GOBP_REGULATION_OF_MICROVILLUS_ORGANIZATION,0.99999
KEGG_MEDICUS_REFERENCE_MGLUR...1,SET,13,-0.37716,-0.010033,0.23797,0.9435,KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY,0.99999
HP_MOLLUSCOID_PSEUDOTUMORS,SET,6,-0.61997,-0.011206,0.39117,0.9435,HP_MOLLUSCOID_PSEUDOTUMORS,0.99999
GSE1432_1H_VS_24H_IFNG_MICRO...1,SET,181,-0.10148,-0.010027,0.064021,0.94352,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...483,SET,39,-0.2149,-0.0098943,0.13556,0.94354,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...4,SET,23,-0.30136,-0.01066,0.19007,0.94356,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,0.99999
MIR6766_5P,SET,225,-0.091316,-0.010047,0.057591,0.94358,MIR6766_5P,0.99999
MODULE_102,SET,16,-0.32373,-0.0095531,0.20416,0.94359,MODULE_102,0.99999
HOEK_T_CELL_2011_2012_TIV_AD...4,SET,9,-0.46801,-0.01036,0.29506,0.94364,HOEK_T_CELL_2011_2012_TIV_ADULT_3DY_UP,0.99999
HP_INFANTILE_AXIAL_HYPOTONIA,SET,42,-0.21992,-0.010507,0.13864,0.94365,HP_INFANTILE_AXIAL_HYPOTONIA,0.99999
KEGG_TIGHT_JUNCTION,SET,125,-0.1267,-0.010419,0.079869,0.94366,KEGG_TIGHT_JUNCTION,0.99999
GSE15324_NAIVE_VS_ACTIVATED_...1,SET,183,-0.097551,-0.009691,0.061494,0.94366,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,0.99999
HP_MEGALENCEPHALY,SET,40,-0.22386,-0.010438,0.1411,0.94369,HP_MEGALENCEPHALY,0.99999
GOBP_TRNA_AMINOACYLATION_FOR...,SET,7,-0.438,-0.0085513,0.27605,0.9437,GOBP_TRNA_AMINOACYLATION_FOR_MITOCHONDRIAL_PROTEIN_TRANSLATION,0.99999
GSE29617_DAY3_VS_DAY7_TIV_FL...2,SET,168,-0.10935,-0.010412,0.068896,0.94375,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,0.99999
GSE37416_12H_VS_24H_F_TULARE...1,SET,166,-0.10491,-0.0099306,0.066091,0.94377,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
GSE15930_STIM_VS_STIM_AND_TR...5,SET,181,-0.10287,-0.010164,0.064785,0.94383,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN,0.99999
WEBER_METHYLATED_ICP_IN_SPER...2,SET,8,-0.52536,-0.010965,0.33082,0.94385,WEBER_METHYLATED_ICP_IN_SPERM_UP,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...12,SET,152,-0.10949,-0.0099215,0.068942,0.94386,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP,0.99999
GOBP_REGULATION_OF_GLYCOGEN_...2,SET,6,-0.55835,-0.010092,0.35153,0.94389,GOBP_REGULATION_OF_GLYCOGEN_CATABOLIC_PROCESS,0.99999
STAMBOLSKY_BOUND_BY_MUTATED_...,SET,13,-0.38489,-0.010239,0.24231,0.9439,STAMBOLSKY_BOUND_BY_MUTATED_TP53,0.99999
GOBP_POSITIVE_REGULATION_OF_...644,SET,5,-0.59909,-0.0098856,0.37715,0.9439,GOBP_POSITIVE_REGULATION_OF_PROTEIN_NEDDYLATION,0.99999
CAGNYGKNAAA_UNKNOWN,SET,70,-0.16789,-0.010348,0.10567,0.94395,CAGNYGKNAAA_UNKNOWN,0.99999
GAO_LARGE_INTESTINE_ADULT_CI...,SET,307,-0.081817,-0.010491,0.051489,0.94396,GAO_LARGE_INTESTINE_ADULT_CI_MESENCHYMAL_CELLS,0.99999
HP_COLON_CANCER,SET,40,-0.20775,-0.0096869,0.13073,0.94398,HP_COLON_CANCER,0.99999
GSE17974_0.5H_VS_72H_UNTREAT...2,SET,160,-0.10734,-0.0099768,0.067527,0.94402,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.99999
GOBP_PROTEIN_CONTAINING_COMP...4,SET,34,-0.24714,-0.010626,0.15546,0.94404,GOBP_PROTEIN_CONTAINING_COMPLEX_REMODELING,0.99999
GOBP_CYTOSOLIC_RIBOSOME_ASSE...,SET,7,-0.45934,-0.0089679,0.28893,0.94405,GOBP_CYTOSOLIC_RIBOSOME_ASSEMBLY,0.99999
GOBP_BONE_MATURATION,SET,24,-0.28419,-0.010269,0.17875,0.94407,GOBP_BONE_MATURATION,0.99999
REACTOME_HCMV_EARLY_EVENTS,SET,68,-0.16538,-0.010047,0.10399,0.94412,REACTOME_HCMV_EARLY_EVENTS,0.99999
WANG_METASTASIS_OF_BREAST_CA...2,SET,29,-0.26031,-0.010338,0.16366,0.94414,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...16,SET,58,-0.17467,-0.0098026,0.10981,0.94415,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,0.99999
GSE17721_12H_VS_24H_POLYIC_B...1,SET,180,-0.098655,-0.0097208,0.062019,0.94415,GSE17721_12H_VS_24H_POLYIC_BMDC_DN,0.99999
GOBP_MITOCHONDRIAL_TRANSCRIP...,SET,19,-0.28444,-0.0091459,0.17876,0.9442,GOBP_MITOCHONDRIAL_TRANSCRIPTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...684,SET,33,-0.24961,-0.010573,0.15686,0.94422,GOBP_POSITIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
MIR199B_5P,SET,164,-0.10415,-0.0097994,0.065444,0.94423,MIR199B_5P,0.99999
WHITEHURST_PACLITAXEL_SENSIT...,SET,31,-0.22214,-0.0091205,0.13958,0.94424,WHITEHURST_PACLITAXEL_SENSITIVITY,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MES...3,SET,156,-0.11919,-0.010941,0.074894,0.94424,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL,0.99999
HP_LEUKONYCHIA,SET,14,-0.37387,-0.010321,0.23489,0.94426,HP_LEUKONYCHIA,0.99999
GOBP_SENSORY_ORGAN_MORPHOGEN...,SET,261,-0.090909,-0.010762,0.057108,0.94428,GOBP_SENSORY_ORGAN_MORPHOGENESIS,0.99999
HP_VITREORETINOPATHY,SET,21,-0.2897,-0.0097927,0.18199,0.94428,HP_VITREORETINOPATHY,0.99999
GOBP_MESENCHYMAL_CELL_MIGRAT...,SET,57,-0.1942,-0.010805,0.12199,0.9443,GOBP_MESENCHYMAL_CELL_MIGRATION,0.99999
HP_IMPAIRED_SMOOTH_PURSUIT,SET,38,-0.21103,-0.0095913,0.13255,0.94431,HP_IMPAIRED_SMOOTH_PURSUIT,0.99999
MIR5590_3P,SET,318,-0.076868,-0.010029,0.048271,0.94435,MIR5590_3P,0.99999
GOBP_HEPARIN_METABOLIC_PROCE...,SET,17,-0.35202,-0.010707,0.22105,0.94435,GOBP_HEPARIN_METABOLIC_PROCESS,0.99999
HP_VEGETATIVE_STATE,SET,9,-0.42936,-0.0095044,0.26958,0.94438,HP_VEGETATIVE_STATE,0.99999
GOLDRATH_NAIVE_VS_EFF_CD8_TC...1,SET,180,-0.10162,-0.010013,0.063803,0.94438,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN,0.99999
GSE11924_TH1_VS_TH2_CD4_TCEL...2,SET,192,-0.09376,-0.0095383,0.058865,0.94439,GSE11924_TH1_VS_TH2_CD4_TCELL_UP,0.99999
GSE40666_STAT1_KO_VS_STAT4_K...3,SET,145,-0.12069,-0.010684,0.075764,0.94441,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.99999
GOMF_OXYGEN_BINDING,SET,28,-0.2947,-0.0115,0.18498,0.94442,GOMF_OXYGEN_BINDING,0.99999
MURARO_PANCREAS_DUCTAL_CELL,SET,1166,-0.04333,-0.010568,0.0272,0.94442,MURARO_PANCREAS_DUCTAL_CELL,0.99999
HP_BASILAR_IMPRESSION,SET,5,-0.66265,-0.010934,0.4159,0.94444,HP_BASILAR_IMPRESSION,0.99999
REACTOME_RNA_POLYMERASE_III_...4,SET,26,-0.23011,-0.0086535,0.14441,0.94446,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER,0.99999
MUELLER_COMMON_TARGETS_OF_AM...2,SET,12,-0.40874,-0.010447,0.2565,0.94447,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP,0.99999
FOSTER_KDM1A_TARGETS_DN,SET,185,-0.094927,-0.0094812,0.059556,0.94451,FOSTER_KDM1A_TARGETS_DN,0.99999
MIR4251,SET,353,-0.07574,-0.010401,0.047515,0.94452,MIR4251,0.99999
REACTOME_SERINE_BIOSYNTHESIS,SET,9,-0.42265,-0.0093559,0.26512,0.94454,REACTOME_SERINE_BIOSYNTHESIS,0.99999
HP_DECREASED_SPECIFIC_ANTIBO...1,SET,12,-0.38921,-0.0099476,0.24415,0.94454,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_POLYSACCHARIDE_VACCINE,0.99999
GSE21360_NAIVE_VS_QUATERNARY...1,SET,181,-0.099339,-0.0098151,0.062316,0.94454,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.99999
GOBP_EMBRYO_DEVELOPMENT,SET,1049,-0.044222,-0.010264,0.027739,0.94455,GOBP_EMBRYO_DEVELOPMENT,0.99999
GOBP_FUCOSE_METABOLIC_PROCESS,SET,15,-0.34849,-0.0099574,0.21854,0.94459,GOBP_FUCOSE_METABOLIC_PROCESS,0.99999
HP_INCREASED_CONNECTIVE_TISS...,SET,24,-0.27231,-0.0098394,0.17071,0.94465,HP_INCREASED_CONNECTIVE_TISSUE,0.99999
MIR7153_3P,SET,43,-0.20296,-0.0098112,0.12722,0.94467,MIR7153_3P,0.99999
LEE_LIVER_CANCER_MYC_DN,SET,56,-0.20955,-0.011556,0.13135,0.94468,LEE_LIVER_CANCER_MYC_DN,0.99999
HP_ADDICTIVE_BEHAVIOR,SET,29,-0.26294,-0.010442,0.16477,0.94472,HP_ADDICTIVE_BEHAVIOR,0.99999
GOBP_5S_CLASS_RRNA_TRANSCRIP...,SET,6,-0.44818,-0.0081011,0.28083,0.94473,GOBP_5S_CLASS_RRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.99999
GOCC_TRANSCRIPTION_FACTOR_TF...4,SET,6,-0.44818,-0.0081011,0.28083,0.94473,GOCC_TRANSCRIPTION_FACTOR_TFIIIC_COMPLEX,0.99999
GSE11961_MEMORY_BCELL_DAY7_V...4,SET,179,-0.10178,-0.010001,0.063771,0.94474,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_UP,0.99999
HP_ABNORMALITY_OF_URINARY_UR...,SET,11,-0.41653,-0.010193,0.26096,0.94476,HP_ABNORMALITY_OF_URINARY_URIC_ACID_LEVEL,0.99999
REACTOME_TRANSPORT_OF_CONNEX...,SET,18,-0.35734,-0.011184,0.22387,0.94477,REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE,0.99999
HP_ACHOLIC_STOOLS,SET,8,-0.52579,-0.010974,0.32939,0.94477,HP_ACHOLIC_STOOLS,0.99999
LIN_NPAS4_TARGETS_DN,SET,65,-0.17972,-0.010675,0.11256,0.94482,LIN_NPAS4_TARGETS_DN,0.99999
GSE40274_CTRL_VS_IRF4_TRANSD...1,SET,151,-0.11078,-0.010005,0.069381,0.94482,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
GOBP_CENTROSOME_SEPARATION,SET,16,-0.31717,-0.0093593,0.19863,0.94483,GOBP_CENTROSOME_SEPARATION,0.99999
KEGG_MEDICUS_REFERENCE_MICRO...3,SET,26,-0.29543,-0.01111,0.18499,0.94486,KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION,0.99999
SHIN_B_CELL_LYMPHOMA_CLUSTER...6,SET,27,-0.24098,-0.009235,0.15087,0.94489,SHIN_B_CELL_LYMPHOMA_CLUSTER_7,0.99999
MIR103A_1_5P,SET,136,-0.11972,-0.010266,0.074944,0.94491,MIR103A_1_5P,0.99999
GOBP_INTESTINAL_CHOLESTEROL_...,SET,17,-0.37425,-0.011383,0.23427,0.94491,GOBP_INTESTINAL_CHOLESTEROL_ABSORPTION,0.99999
GSE25147_UNSTIM_VS_HELIOBACT...2,SET,151,-0.10806,-0.0097601,0.067643,0.94492,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...454,SET,35,-0.23316,-0.010171,0.14593,0.94494,GOBP_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,0.99999
GSE10325_CD4_TCELL_VS_MYELOI...1,SET,179,-0.107,-0.010514,0.066971,0.94495,GSE10325_CD4_TCELL_VS_MYELOID_DN,0.99999
GSE17721_CTRL_VS_PAM3CSK4_6H...1,SET,181,-0.10004,-0.0098841,0.062609,0.94495,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN,0.99999
MIKKELSEN_MCV6_ICP_WITH_H3K4...,SET,30,-0.26875,-0.010855,0.16817,0.94497,MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,0.99999
GOBP_REGULATION_OF_AMIDE_MET...,SET,63,-0.17018,-0.009952,0.10644,0.94505,GOBP_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.99999
GOBP_TRANSFERRIN_TRANSPORT,SET,10,-0.42843,-0.0099965,0.26798,0.94505,GOBP_TRANSFERRIN_TRANSPORT,0.99999
GSE19888_ADENOSINE_A3R_ACT_V...2,SET,166,-0.09859,-0.0093325,0.061666,0.94506,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...420,SET,9,-0.46085,-0.010202,0.28819,0.94509,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT,0.99999
MAYBURD_RESPONSE_TO_L663536_...2,SET,22,-0.27416,-0.0094851,0.17143,0.94511,MAYBURD_RESPONSE_TO_L663536_UP,0.99999
GOBP_GLIAL_CELL_APOPTOTIC_PR...,SET,17,-0.31923,-0.0097099,0.19959,0.94513,GOBP_GLIAL_CELL_APOPTOTIC_PROCESS,0.99999
HP_DECREASED_THYROID_STIMULA...,SET,11,-0.4211,-0.010305,0.26328,0.94513,HP_DECREASED_THYROID_STIMULATING_HORMONE_LEVEL,0.99999
HP_ABNORMAL_CIRCULATING_ACYL...,SET,21,-0.28923,-0.0097766,0.18078,0.94518,HP_ABNORMAL_CIRCULATING_ACYLCARNITINE_CONCENTRATION,0.99999
GOBP_REGULATION_OF_CELL_CYCL...2,SET,172,-0.10473,-0.01009,0.065443,0.94523,GOBP_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,0.99999
GSE24142_EARLY_THYMIC_PROGEN...9,SET,186,-0.10042,-0.010057,0.062738,0.94526,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN,0.99999
GOMF_ADENYL_NUCLEOTIDE_EXCHA...,SET,15,-0.29713,-0.00849,0.18559,0.9453,GOMF_ADENYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,0.99999
BIOCARTA_MCALPAIN_PATHWAY,SET,18,-0.35337,-0.01106,0.2207,0.94532,BIOCARTA_MCALPAIN_PATHWAY,0.99999
PID_PLK1_PATHWAY,SET,42,-0.19684,-0.0094043,0.12293,0.94533,PID_PLK1_PATHWAY,0.99999
MIR4468,SET,107,-0.13377,-0.010183,0.083537,0.94533,MIR4468,0.99999
GOMF_ACETYLATION_DEPENDENT_P...,SET,25,-0.27487,-0.010136,0.17166,0.94533,GOMF_ACETYLATION_DEPENDENT_PROTEIN_BINDING,0.99999
HP_SMALL_INTESTINAL_DYSMOTIL...,SET,6,-0.47451,-0.0085771,0.29634,0.94533,HP_SMALL_INTESTINAL_DYSMOTILITY,0.99999
SENESE_HDAC1_TARGETS_DN,SET,220,-0.096743,-0.010527,0.060369,0.94547,SENESE_HDAC1_TARGETS_DN,0.99999
REACTOME_ACTIVATED_PKN1_STIM...,SET,6,-0.59493,-0.010754,0.37126,0.94547,REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3,0.99999
GOMF_PROTEIN_ANTIGEN_BINDING,SET,7,-0.55877,-0.010909,0.34869,0.94547,GOMF_PROTEIN_ANTIGEN_BINDING,0.99999
CSR_EARLY_UP.V1_UP,SET,143,-0.11427,-0.010046,0.071285,0.94552,CSR_EARLY_UP.V1_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...414,SET,81,-0.15706,-0.010409,0.097952,0.94557,GOBP_POSITIVE_REGULATION_OF_LIPID_TRANSPORT,0.99999
ZHU_CMV_24_HR_UP,SET,79,-0.14767,-0.0096661,0.092092,0.94558,ZHU_CMV_24_HR_UP,0.99999
GOBP_REGULATION_OF_PROTEIN_S...3,SET,285,-0.078597,-0.0097167,0.049004,0.94562,GOBP_REGULATION_OF_PROTEIN_STABILITY,0.99999
GSE17186_BLOOD_VS_CORD_BLOOD...3,SET,182,-0.10136,-0.010042,0.063197,0.94562,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN,0.99999
REACTOME_REGULATION_OF_LIPID...,SET,114,-0.12261,-0.0096322,0.076439,0.94564,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,0.99999
WP_PERTURBATIONS_TO_HOSTCELL...,SET,42,-0.20688,-0.009884,0.12897,0.94564,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,0.99999
CEBALLOS_TARGETS_OF_TP53_AND...1,SET,29,-0.25492,-0.010124,0.15891,0.94566,CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,0.99999
ZHENG_FOXP3_TARGETS_IN_T_LYM...2,SET,12,-0.3896,-0.0099576,0.24281,0.94569,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP,0.99999
GOBP_SENSORY_PERCEPTION_OF_L...,SET,201,-0.10384,-0.010806,0.064717,0.94569,GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS,0.99999
GSE3982_DC_VS_MAC_LPS_STIM_UP,SET,173,-0.10144,-0.0098005,0.063218,0.94569,GSE3982_DC_VS_MAC_LPS_STIM_UP,0.99999
AMIT_EGF_RESPONSE_120_MCF10A,SET,38,-0.24091,-0.010949,0.1501,0.94574,AMIT_EGF_RESPONSE_120_MCF10A,0.99999
WOO_LIVER_CANCER_RECURRENCE_...2,SET,97,-0.14425,-0.010458,0.089874,0.94575,WOO_LIVER_CANCER_RECURRENCE_UP,0.99999
HP_FIBER_TYPE_GROUPING,SET,10,-0.37134,-0.0086643,0.23136,0.94575,HP_FIBER_TYPE_GROUPING,0.99999
MARSON_FOXP3_TARGETS_DN,SET,48,-0.21408,-0.010932,0.13337,0.94576,MARSON_FOXP3_TARGETS_DN,0.99999
KEGG_MEDICUS_REFERENCE_VGCC_...,SET,20,-0.31392,-0.010356,0.19557,0.94576,KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY,0.99999
GSE7548_DAY7_VS_DAY28_PCC_IM...1,SET,173,-0.1026,-0.0099131,0.063919,0.94577,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,0.99999
DESCARTES_MAIN_FETAL_GRANULE...,SET,14,-0.39649,-0.010945,0.24697,0.94579,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,0.99999
GOBP_MUCUS_SECRETION,SET,19,-0.3527,-0.011341,0.21968,0.9458,GOBP_MUCUS_SECRETION,0.99999
HP_HYPEROSTOSIS,SET,47,-0.19001,-0.0096016,0.1183,0.94586,HP_HYPEROSTOSIS,0.99999
GOBP_ATP_METABOLIC_PROCESS,SET,176,-0.097366,-0.0094876,0.060622,0.94587,GOBP_ATP_METABOLIC_PROCESS,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_EAR...1,SET,32,-0.28491,-0.011885,0.17734,0.94591,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_AIRWAY_PROGENITOR_CELL,0.99999
GOBP_GLUCOSAMINE_CONTAINING_...2,SET,21,-0.31234,-0.010558,0.19438,0.94594,GOBP_GLUCOSAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
REACTOME_GLYCEROPHOSPHOLIPID...2,SET,7,-0.54393,-0.010619,0.33846,0.94597,REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM,0.99999
GSE10239_NAIVE_VS_DAY4.5_EFF...1,SET,186,-0.099848,-0.0099993,0.06212,0.946,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN,0.99999
REACTOME_RUNX3_REGULATES_IMM...,SET,6,-0.59637,-0.01078,0.37102,0.94601,REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION,0.99999
MIR6808_5P,SET,164,-0.10803,-0.010165,0.067206,0.94601,MIR6808_5P,0.99999
MIR1197,SET,84,-0.14354,-0.009687,0.089274,0.94605,MIR1197,0.99999
HP_ABNORMAL_SPINAL_MENINGEAL...,SET,22,-0.32064,-0.011093,0.19941,0.94606,HP_ABNORMAL_SPINAL_MENINGEAL_MORPHOLOGY,0.99999
chr2p14,SET,17,-0.44076,-0.013406,0.27408,0.94609,chr2p14,0.99999
HEDENFALK_BREAST_CANCER_BRAC...2,SET,15,-0.35698,-0.0102,0.22196,0.94611,HEDENFALK_BREAST_CANCER_BRACX_UP,0.99999
MIR548U,SET,142,-0.12086,-0.010589,0.075149,0.94611,MIR548U,0.99999
PYEON_HPV_POSITIVE_TUMORS_DN,SET,8,-0.55248,-0.011531,0.34349,0.94612,PYEON_HPV_POSITIVE_TUMORS_DN,0.99999
HP_ABNORMAL_RELATIONSHIP,SET,11,-0.44855,-0.010976,0.27885,0.94613,HP_ABNORMAL_RELATIONSHIP,0.99999
PLASARI_TGFB1_SIGNALING_VIA_...3,SET,99,-0.14394,-0.010541,0.08948,0.94614,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,0.99999
OUILLETTE_CLL_13Q14_DELETION...1,SET,47,-0.20562,-0.010391,0.12779,0.94618,OUILLETTE_CLL_13Q14_DELETION_DN,0.99999
STEARMAN_TUMOR_FIELD_EFFECT_...,SET,34,-0.23862,-0.01026,0.14831,0.94618,STEARMAN_TUMOR_FIELD_EFFECT_UP,0.99999
GOBP_3_PHOSPHOADENOSINE_5_PH...,SET,15,-0.39643,-0.011327,0.24633,0.94622,GOBP_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_METABOLIC_PROCESS,0.99999
GSE31082_CD4_VS_CD8_SP_THYMO...1,SET,179,-0.10142,-0.0099657,0.063003,0.94627,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN,0.99999
LASTOWSKA_NEUROBLASTOMA_COPY...2,SET,169,-0.11139,-0.010638,0.069189,0.94628,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,0.99999
MODULE_453,SET,40,-0.20852,-0.0097227,0.1295,0.94631,MODULE_453,0.99999
SNRNP70_TARGET_GENES,SET,684,-0.051972,-0.0098433,0.03227,0.94635,SNRNP70_TARGET_GENES,0.99999
WP_METABOLIC_REPROGRAMMING_I...1,SET,39,-0.20492,-0.0094348,0.12719,0.94642,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,0.99999
GOBP_BLASTOCYST_FORMATION,SET,45,-0.20577,-0.010175,0.12771,0.94643,GOBP_BLASTOCYST_FORMATION,0.99999
HP_SINGLE_VENTRICLE,SET,8,-0.48052,-0.010029,0.2982,0.94644,HP_SINGLE_VENTRICLE,0.99999
MIR127_5P,SET,80,-0.16034,-0.010562,0.099503,0.94645,MIR127_5P,0.99999
GSE360_HIGH_DOSE_B_MALAYI_VS...3,SET,178,-0.10931,-0.010711,0.067804,0.94652,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...18,SET,168,-0.10195,-0.0097078,0.063203,0.94662,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_UP,0.99999
MIR4465,SET,395,-0.070833,-0.010278,0.043911,0.94663,MIR4465,0.99999
GSE16385_UNTREATED_VS_12H_IL...2,SET,179,-0.10533,-0.01035,0.065287,0.94666,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_UP,0.99999
GOBP_EMBRYONIC_PLACENTA_DEVE...,SET,83,-0.15863,-0.010642,0.098315,0.94667,GOBP_EMBRYONIC_PLACENTA_DEVELOPMENT,0.99999
GOBP_GENERAL_ADAPTATION_SYND...2,SET,5,-0.66037,-0.010897,0.40927,0.94668,GOBP_GENERAL_ADAPTATION_SYNDROME_BEHAVIORAL_PROCESS,0.99999
WP_EXTRACELLULAR_VESICLEMEDI...,SET,29,-0.26402,-0.010485,0.16362,0.94669,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,0.99999
MIR199A_5P,SET,165,-0.10539,-0.0099461,0.065303,0.94671,MIR199A_5P,0.99999
GOBP_DNA_TEMPLATED_TRANSCRIP...3,SET,20,-0.3272,-0.010794,0.20271,0.94675,GOBP_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION,0.99999
GSE8685_IL2_ACT_IL2_STARVED_...3,SET,127,-0.12356,-0.010242,0.0765,0.94686,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...22,SET,65,-0.16392,-0.0097366,0.10148,0.94687,GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,0.99999
HP_ABNORMALITY_OF_THE_PYLORUS,SET,92,-0.15166,-0.010709,0.093885,0.94687,HP_ABNORMALITY_OF_THE_PYLORUS,0.99999
DESCARTES_FETAL_MUSCLE_STROM...,SET,65,-0.19375,-0.011508,0.11993,0.94689,DESCARTES_FETAL_MUSCLE_STROMAL_CELLS,0.99999
BANDRES_RESPONSE_TO_CARMUSTI...6,SET,12,-0.33406,-0.0085381,0.20668,0.94697,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...6,SET,127,-0.13349,-0.011064,0.082586,0.94699,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS,0.99999
FARMER_BREAST_CANCER_CLUSTER...2,SET,32,-0.25308,-0.010557,0.15656,0.947,FARMER_BREAST_CANCER_CLUSTER_2,0.99999
SASSON_RESPONSE_TO_FORSKOLIN...1,SET,84,-0.15004,-0.010126,0.09282,0.947,SASSON_RESPONSE_TO_FORSKOLIN_DN,0.99999
GSE24210_CTRL_VS_IL35_TREATE...2,SET,187,-0.10171,-0.010213,0.062884,0.94709,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP,0.99999
ZHENG_BOUND_BY_FOXP3,SET,456,-0.069297,-0.010785,0.042834,0.94714,ZHENG_BOUND_BY_FOXP3,0.99999
PUJANA_BREAST_CANCER_WITH_BR...2,SET,52,-0.17662,-0.0093868,0.10917,0.94715,PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP,0.99999
REACTOME_SCF_SKP2_MEDIATED_D...,SET,57,-0.16228,-0.0090284,0.1003,0.94715,REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,0.99999
GSE17721_0.5H_VS_8H_GARDIQUI...2,SET,174,-0.097867,-0.0094827,0.060483,0.94717,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_UP,0.99999
ZMYND11_TARGET_GENES,SET,34,-0.24572,-0.010565,0.1518,0.94723,ZMYND11_TARGET_GENES,0.99999
YIH_RESPONSE_TO_ARSENITE_C3,SET,26,-0.28619,-0.010763,0.17677,0.94727,YIH_RESPONSE_TO_ARSENITE_C3,0.99999
REACTOME_NEGATIVE_REGULATION...13,SET,116,-0.13538,-0.010728,0.083609,0.94729,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,0.99999
GSE27786_NKCELL_VS_MONO_MAC_...1,SET,177,-0.10547,-0.010306,0.06513,0.94731,GSE27786_NKCELL_VS_MONO_MAC_DN,0.99999
GOBP_PHOSPHATIDYLCHOLINE_BIO...,SET,26,-0.26586,-0.0099981,0.16413,0.94735,GOBP_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS,0.99999
GSE36392_TYPE_2_MYELOID_VS_M...1,SET,181,-0.096212,-0.0095061,0.059397,0.94735,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN,0.99999
HP_HYPOPLASIA_OF_THE_EPIGLOT...,SET,9,-0.48078,-0.010643,0.29673,0.9474,HP_HYPOPLASIA_OF_THE_EPIGLOTTIS,0.99999
HP_INTUSSUSCEPTION,SET,10,-0.45917,-0.010714,0.2834,0.9474,HP_INTUSSUSCEPTION,0.99999
GOMF_HISTONE_BINDING,SET,204,-0.093741,-0.0098266,0.057854,0.94741,GOMF_HISTONE_BINDING,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_CYC...,SET,388,-0.068426,-0.009842,0.042229,0.94741,HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...17,SET,62,-0.17622,-0.010223,0.10874,0.94743,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_VERTEBRAL_COLUMN,0.99999
GOBP_ORGANIC_HYDROXY_COMPOUN...4,SET,251,-0.091162,-0.010586,0.056253,0.94744,GOBP_ORGANIC_HYDROXY_COMPOUND_TRANSPORT,0.99999
KOINUMA_TARGETS_OF_SMAD2_OR_...,SET,773,-0.051914,-0.010426,0.032028,0.94747,KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3,0.99999
GOBP_REGULATION_OF_SODIUM_IO...2,SET,42,-0.24319,-0.011619,0.15002,0.94749,GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
SCIAN_CELL_CYCLE_TARGETS_OF_...1,SET,22,-0.29179,-0.010095,0.17998,0.94751,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN,0.99999
MODULE_445,SET,11,-0.42817,-0.010478,0.26404,0.94755,MODULE_445,0.99999
WP_INTERLEUKIN1_INDUCED_ACTI...,SET,9,-0.462,-0.010227,0.28477,0.94763,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,0.99999
GSE14000_UNSTIM_VS_4H_LPS_DC...3,SET,180,-0.10059,-0.0099112,0.062,0.94763,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP,0.99999
HP_EPISODIC_ATAXIA,SET,24,-0.29418,-0.01063,0.18132,0.94764,HP_EPISODIC_ATAXIA,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...1,SET,52,-0.20303,-0.01079,0.12507,0.94773,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...65,SET,28,-0.2559,-0.0099863,0.15762,0.94775,HP_APLASIA_HYPOPLASIA_OF_THE_SCAPULAE,0.99999
GSE36392_TYPE_2_MYELOID_VS_N...1,SET,180,-0.10164,-0.010015,0.062586,0.94781,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,0.99999
VALK_AML_WITH_11Q23_REARRANG...,SET,16,-0.36508,-0.010773,0.22475,0.94784,VALK_AML_WITH_11Q23_REARRANGED,0.99999
REACTOME_EPHRIN_SIGNALING,SET,17,-0.35019,-0.010651,0.21558,0.94785,REACTOME_EPHRIN_SIGNALING,0.99999
GOBP_REGULATION_OF_GROWTH_HO...,SET,6,-0.62967,-0.011382,0.38758,0.94787,GOBP_REGULATION_OF_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_RECEPTOR_CATABOLIC_PROC...,SET,26,-0.27306,-0.010269,0.16806,0.94789,GOBP_RECEPTOR_CATABOLIC_PROCESS,0.99999
MODULE_533,SET,41,-0.23036,-0.010875,0.14175,0.94793,MODULE_533,0.99999
GSE42021_CD24LO_TREG_VS_CD24...1,SET,184,-0.095881,-0.0095509,0.058996,0.94793,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_DN,0.99999
GSE360_T_GONDII_VS_B_MALAYI_...3,SET,180,-0.10192,-0.010043,0.062712,0.94794,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN,0.99999
HP_BOWEL_DIVERTICULOSIS,SET,32,-0.24287,-0.010131,0.14942,0.94795,HP_BOWEL_DIVERTICULOSIS,0.99999
BDP1_TARGET_GENES,SET,1011,-0.043264,-0.0098695,0.026617,0.94796,BDP1_TARGET_GENES,0.99999
chr5q13,SET,51,-0.37457,-0.019715,0.23039,0.948,chr5q13,0.99999
HP_FULL_CHEEKS,SET,132,-0.11586,-0.0097891,0.071258,0.94801,HP_FULL_CHEEKS,0.99999
HP_UVEITIS,SET,47,-0.21998,-0.011116,0.13528,0.94803,HP_UVEITIS,0.99999
GOBP_MESODERM_MORPHOGENESIS,SET,68,-0.17781,-0.010802,0.10934,0.94804,GOBP_MESODERM_MORPHOGENESIS,0.99999
HP_ABNORMAL_CIRCULATING_LIPI...,SET,288,-0.084287,-0.010474,0.051826,0.94805,HP_ABNORMAL_CIRCULATING_LIPID_CONCENTRATION,0.99999
GSE15659_NAIVE_VS_PTPRC_NEG_...1,SET,170,-0.1075,-0.010297,0.066094,0.94807,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN,0.99999
GSE17721_12H_VS_24H_CPG_BMDC...2,SET,186,-0.10203,-0.010218,0.06273,0.94807,GSE17721_12H_VS_24H_CPG_BMDC_UP,0.99999
LI_PBMC_MENACTRA_AGE_18_45YO...8,SET,15,-0.38986,-0.011139,0.23965,0.9481,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_NEGATIVE,0.99999
REACTOME_EGR2_AND_SOX10_MEDI...,SET,27,-0.28367,-0.010871,0.17434,0.94813,REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,0.99999
HOFFMANN_PRE_BI_TO_LARGE_PRE...2,SET,26,-0.27635,-0.010392,0.16983,0.94815,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,0.99999
GTCNYYATGR_UNKNOWN,SET,103,-0.13269,-0.009911,0.081538,0.94815,GTCNYYATGR_UNKNOWN,0.99999
KEGG_UBIQUITIN_MEDIATED_PROT...,SET,119,-0.11799,-0.0094692,0.0725,0.94818,KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,0.99999
WP_METABOLIC_REPROGRAMMING_I...2,SET,41,-0.21624,-0.010208,0.13287,0.94818,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,0.99999
TGCGCANK_UNKNOWN,SET,491,-0.06158,-0.0099353,0.037829,0.94821,TGCGCANK_UNKNOWN,0.99999
WP_OPIOID_RECEPTOR_PATHWAYS,SET,41,-0.22944,-0.010831,0.14093,0.94823,WP_OPIOID_RECEPTOR_PATHWAYS,0.99999
MODULE_147,SET,101,-0.13615,-0.010071,0.083611,0.94827,MODULE_147,0.99999
GOCC_MANNOSYLTRANSFERASE_COM...,SET,4,-0.51856,-0.0076536,0.31833,0.94834,GOCC_MANNOSYLTRANSFERASE_COMPLEX,0.99999
HP_RECURRENT_PANCREATITIS,SET,11,-0.5279,-0.012918,0.32401,0.94836,HP_RECURRENT_PANCREATITIS,0.99999
MIR12120,SET,164,-0.10817,-0.010178,0.066385,0.94838,MIR12120,0.99999
GSE43863_NAIVE_VS_TH1_EFF_CD...1,SET,147,-0.11877,-0.010585,0.072878,0.9484,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_DN,0.99999
VANTVEER_BREAST_CANCER_ESR1_...1,SET,207,-0.10064,-0.010626,0.061734,0.94846,VANTVEER_BREAST_CANCER_ESR1_DN,0.99999
HP_DEPOSITS_IMMUNOREACTIVE_T...,SET,8,-0.52055,-0.010864,0.31931,0.94846,HP_DEPOSITS_IMMUNOREACTIVE_TO_BETA_AMYLOID_PROTEIN,0.99999
GOMF_ARMADILLO_REPEAT_DOMAIN...,SET,8,-0.44219,-0.0092289,0.27124,0.94847,GOMF_ARMADILLO_REPEAT_DOMAIN_BINDING,0.99999
GOCC_MYOSIN_FILAMENT,SET,24,-0.32153,-0.011618,0.19718,0.94851,GOCC_MYOSIN_FILAMENT,0.99999
GOBP_REGULATION_OF_PROTEIN_K...3,SET,18,-0.3449,-0.010795,0.21145,0.94856,GOBP_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING,0.99999
GOBP_AUTOPHAGY_OF_PEROXISOME,SET,13,-0.38084,-0.010131,0.23345,0.94858,GOBP_AUTOPHAGY_OF_PEROXISOME,0.99999
GSE13411_NAIVE_VS_MEMORY_BCE...1,SET,181,-0.10296,-0.010173,0.063113,0.94859,GSE13411_NAIVE_VS_MEMORY_BCELL_DN,0.99999
TBK1.DF_UP,SET,261,-0.087612,-0.010372,0.053702,0.9486,TBK1.DF_UP,0.99999
GOMF_DEATH_RECEPTOR_BINDING,SET,19,-0.30798,-0.009903,0.18874,0.94863,GOMF_DEATH_RECEPTOR_BINDING,0.99999
KRAS.PROSTATE_UP.V1_DN,SET,124,-0.13103,-0.010732,0.080273,0.94868,KRAS.PROSTATE_UP.V1_DN,0.99999
GOBP_ADENYLATE_CYCLASE_INHIB...1,SET,5,-0.71423,-0.011786,0.43749,0.94871,GOBP_ADENYLATE_CYCLASE_INHIBITING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.99999
CHEOK_RESPONSE_TO_MERCAPTOPU...2,SET,4,-0.78544,-0.011593,0.4811,0.94872,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP,0.99999
HP_SOCIAL_AND_OCCUPATIONAL_D...,SET,14,-0.38616,-0.01066,0.23652,0.94872,HP_SOCIAL_AND_OCCUPATIONAL_DETERIORATION,0.99999
MIR548AY_3P,SET,54,-0.18934,-0.010254,0.11593,0.94878,MIR548AY_3P,0.99999
GOBP_REGULATION_OF_CHROMATIN...2,SET,28,-0.26459,-0.010325,0.162,0.94878,GOBP_REGULATION_OF_CHROMATIN_ORGANIZATION,0.99999
PIONTEK_PKD1_TARGETS_UP,SET,39,-0.22133,-0.01019,0.13551,0.94879,PIONTEK_PKD1_TARGETS_UP,0.99999
REACTOME_SEROTONIN_NEUROTRAN...,SET,16,-0.35484,-0.010471,0.21725,0.94879,REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE,0.99999
RICHERT_PBMC_HIV_LIPO_5_AGE_...2,SET,5,-0.63978,-0.010557,0.39167,0.9488,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_INTERFERON_SUBSET_UP,0.99999
HP_MYELOID_LEUKEMIA,SET,30,-0.25904,-0.010463,0.15854,0.94885,HP_MYELOID_LEUKEMIA,0.99999
WP_TRANSCRIPTION_COFACTORS_S...,SET,17,-0.39432,-0.011994,0.24133,0.94886,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...526,SET,11,-0.49281,-0.012059,0.30151,0.94891,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,0.99999
GOCC_MITOTIC_SPINDLE_ASTRAL_...,SET,7,-0.50537,-0.0098665,0.30916,0.94893,GOCC_MITOTIC_SPINDLE_ASTRAL_MICROTUBULE,0.99999
HP_OSTEOPETROSIS,SET,17,-0.36481,-0.011096,0.22317,0.94893,HP_OSTEOPETROSIS,0.99999
HP_ARTERIOVENOUS_FISTULA,SET,10,-0.46103,-0.010757,0.28196,0.94897,HP_ARTERIOVENOUS_FISTULA,0.99999
FAN_EMBRYONIC_CTX_BIG_GROUPS...5,SET,123,-0.13559,-0.011062,0.082922,0.94899,FAN_EMBRYONIC_CTX_BIG_GROUPS_GLIAL,0.99999
HP_ABNORMAL_IRIS_PIGMENTATION,SET,131,-0.13008,-0.010949,0.079525,0.94904,HP_ABNORMAL_IRIS_PIGMENTATION,0.99999
GSE7852_TREG_VS_TCONV_THYMUS...2,SET,181,-0.10702,-0.010574,0.065425,0.94904,GSE7852_TREG_VS_TCONV_THYMUS_UP,0.99999
HP_ABNORMAL_CIRCULATING_LONG...,SET,16,-0.33531,-0.0098947,0.20499,0.94905,HP_ABNORMAL_CIRCULATING_LONG_CHAIN_FATTY_ACID_CONCENTRATION,0.99999
REACTOME_SEPARATION_OF_SISTE...,SET,174,-0.099597,-0.0096503,0.060881,0.94906,REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,0.99999
REACTOME_NERVOUS_SYSTEM_DEVE...,SET,533,-0.061926,-0.010397,0.037849,0.94908,REACTOME_NERVOUS_SYSTEM_DEVELOPMENT,0.99999
MIR519A_2_5P_MIR520B_5P,SET,190,-0.10111,-0.010233,0.061802,0.94908,MIR519A_2_5P_MIR520B_5P,0.99999
MIR6767_3P,SET,24,-0.29304,-0.010589,0.17906,0.94913,MIR6767_3P,0.99999
GOBP_CALCIUM_ION_IMPORT_ACRO...,SET,36,-0.23799,-0.010528,0.14538,0.94917,GOBP_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GOCC_CELL_CORTEX,SET,288,-0.083696,-0.010401,0.051128,0.94918,GOCC_CELL_CORTEX,0.99999
HP_CARPAL_BONE_HYPOPLASIA,SET,11,-0.37865,-0.009266,0.2313,0.94918,HP_CARPAL_BONE_HYPOPLASIA,0.99999
HP_GLUCOSE_INTOLERANCE,SET,420,-0.069487,-0.010389,0.042429,0.94925,HP_GLUCOSE_INTOLERANCE,0.99999
GOBP_REGULATION_OF_MDA_5_SIG...,SET,6,-0.4876,-0.0088136,0.29767,0.94928,GOBP_REGULATION_OF_MDA_5_SIGNALING_PATHWAY,0.99999
GOMF_METAL_DEPENDENT_DEUBIQU...,SET,11,-0.4433,-0.010848,0.2705,0.94936,GOMF_METAL_DEPENDENT_DEUBIQUITINASE_ACTIVITY,0.99999
GSE15659_RESTING_TREG_VS_NON...1,SET,172,-0.10516,-0.010131,0.064172,0.94936,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN,0.99999
GSE360_DC_VS_MAC_B_MALAYI_HI...2,SET,181,-0.10443,-0.010319,0.063725,0.94937,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP,0.99999
GOBP_GROWTH_PLATE_CARTILAGE_...2,SET,9,-0.45226,-0.010011,0.27588,0.94942,GOBP_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DIFFERENTIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...87,SET,30,-0.27577,-0.011139,0.16818,0.94945,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
GOMF_WNT_RECEPTOR_ACTIVITY,SET,16,-0.40957,-0.012086,0.24968,0.94953,GOMF_WNT_RECEPTOR_ACTIVITY,0.99999
HP_LOW_INSERTION_OF_COLUMELLA,SET,7,-0.51353,-0.010026,0.31298,0.94957,HP_LOW_INSERTION_OF_COLUMELLA,0.99999
GOBP_RESPONSE_TO_ETHER,SET,15,-0.38514,-0.011005,0.23472,0.94958,GOBP_RESPONSE_TO_ETHER,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...4,SET,38,-0.22249,-0.010112,0.13557,0.9496,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,0.99999
GOMF_MHC_CLASS_IB_PROTEIN_BI...,SET,6,-0.61689,-0.011151,0.37586,0.94962,GOMF_MHC_CLASS_IB_PROTEIN_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...585,SET,9,-0.44938,-0.0099475,0.27374,0.94966,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.99999
YAMASHITA_LIVER_CANCER_STEM_...2,SET,46,-0.22605,-0.011301,0.13769,0.94967,YAMASHITA_LIVER_CANCER_STEM_CELL_UP,0.99999
PICCALUGA_ANGIOIMMUNOBLASTIC...2,SET,189,-0.11411,-0.011518,0.069501,0.94968,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,0.99999
DUTERTRE_ESTRADIOL_RESPONSE_...4,SET,209,-0.097026,-0.010293,0.059068,0.94976,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,0.99999
GSE21546_UNSTIM_VS_ANTI_CD3_...7,SET,132,-0.12459,-0.010526,0.075826,0.9498,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_DN,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...14,SET,269,-0.082788,-0.0099477,0.050381,0.94982,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLAR_VERMIS,0.99999
MIKI_COEXPRESSED_WITH_CYP19A1,SET,7,-0.5243,-0.010236,0.31901,0.94985,MIKI_COEXPRESSED_WITH_CYP19A1,0.99999
WIZ_TARGET_GENES,SET,14,-0.3468,-0.0095735,0.21091,0.94994,WIZ_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...336,SET,6,-0.65248,-0.011794,0.39664,0.95001,GOBP_NEGATIVE_REGULATION_OF_LENS_FIBER_CELL_DIFFERENTIATION,0.99999
BUSSLINGER_GASTRIC_G_CELLS,SET,88,-0.17017,-0.011754,0.10345,0.95001,BUSSLINGER_GASTRIC_G_CELLS,0.99999
YAO_HOXA10_TARGETS_VIA_PROGE...2,SET,75,-0.17412,-0.011107,0.10582,0.95005,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,0.99999
GOBP_CITRATE_METABOLIC_PROCE...,SET,5,-0.53867,-0.0088886,0.32736,0.95006,GOBP_CITRATE_METABOLIC_PROCESS,0.99999
DARWICHE_SKIN_TUMOR_PROMOTER...2,SET,128,-0.12403,-0.01032,0.075367,0.95007,DARWICHE_SKIN_TUMOR_PROMOTER_UP,0.99999
HP_ABNORMAL_TISSUE_ENZYME_CO...,SET,55,-0.18506,-0.010114,0.1124,0.95016,HP_ABNORMAL_TISSUE_ENZYME_CONCENTRATION_OR_ACTIVITY,0.99999
GOBP_DOPAMINE_RECEPTOR_SIGNA...,SET,37,-0.24615,-0.01104,0.1495,0.95017,GOBP_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.99999
RYCACNNRNNRNCAG_UNKNOWN,SET,63,-0.17906,-0.010471,0.1087,0.95024,RYCACNNRNNRNCAG_UNKNOWN,0.99999
ACOSTA_PROLIFERATION_INDEPEN...2,SET,77,-0.15554,-0.010052,0.094409,0.95026,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,0.99999
GSE43955_1H_VS_42H_ACT_CD4_T...4,SET,180,-0.10427,-0.010274,0.063289,0.95027,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.99999
POOLA_INVASIVE_BREAST_CANCER...1,SET,123,-0.13275,-0.01083,0.080568,0.95028,POOLA_INVASIVE_BREAST_CANCER_DN,0.99999
WONG_ADULT_TISSUE_STEM_MODULE,SET,658,-0.059115,-0.010989,0.035874,0.9503,WONG_ADULT_TISSUE_STEM_MODULE,0.99999
GSE9988_LPS_VS_LOW_LPS_MONOC...1,SET,147,-0.11681,-0.010411,0.070889,0.9503,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN,0.99999
HP_LYMPHOPENIA,SET,163,-0.11369,-0.010666,0.068988,0.95032,HP_LYMPHOPENIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...317,SET,8,-0.49254,-0.01028,0.29885,0.95033,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,0.99999
GOBP_POST_EMBRYONIC_HEMOPOIE...,SET,5,-0.57315,-0.0094576,0.34771,0.95035,GOBP_POST_EMBRYONIC_HEMOPOIESIS,0.99999
GSE22601_DOUBLE_NEGATIVE_VS_...2,SET,182,-0.10496,-0.010398,0.063667,0.95037,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.99999
HP_LIMITED_EXTRAOCULAR_MOVEM...,SET,14,-0.35879,-0.0099044,0.21762,0.95039,HP_LIMITED_EXTRAOCULAR_MOVEMENTS,0.99999
RSRFC4_Q2,SET,195,-0.10378,-0.010639,0.062942,0.9504,RSRFC4_Q2,0.99999
GOBP_GLUCOSE_CATABOLIC_PROCE...,SET,21,-0.282,-0.0095323,0.17102,0.95041,GOBP_GLUCOSE_CATABOLIC_PROCESS,0.99999
REACTOME_CELL_CYCLE,SET,591,-0.055157,-0.0097359,0.033444,0.95044,REACTOME_CELL_CYCLE,0.99999
WP_EFFECTS_OF_NITRIC_OXIDE,SET,6,-0.64786,-0.01171,0.39277,0.95047,WP_EFFECTS_OF_NITRIC_OXIDE,0.99999
GOBP_SPERM_DNA_CONDENSATION,SET,14,-0.3729,-0.010294,0.22602,0.9505,GOBP_SPERM_DNA_CONDENSATION,0.99999
HP_NORMOCYTIC_ANEMIA,SET,15,-0.33768,-0.0096485,0.20467,0.95051,HP_NORMOCYTIC_ANEMIA,0.99999
GOMF_CYCLIN_DEPENDENT_PROTEI...3,SET,12,-0.42965,-0.010981,0.2604,0.95052,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY,0.99999
WP_LEPTIN_SIGNALING,SET,74,-0.16573,-0.010501,0.10044,0.95053,WP_LEPTIN_SIGNALING,0.99999
BIOCARTA_GSK3_PATHWAY,SET,19,-0.33281,-0.010701,0.20168,0.95054,BIOCARTA_GSK3_PATHWAY,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...15,SET,36,-0.22113,-0.0097827,0.13399,0.95056,GAVISH_3CA_MALIGNANT_METAPROGRAM_24_CILIA,0.99999
GOMF_ATP_DEPENDENT_CHROMATIN...,SET,33,-0.22792,-0.0096547,0.1381,0.95056,GOMF_ATP_DEPENDENT_CHROMATIN_REMODELER_ACTIVITY,0.99999
REACTOME_SIGNALING_BY_ERBB2_...1,SET,15,-0.32837,-0.0093825,0.19892,0.95059,REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS,0.99999
HEBERT_MATRISOME_TNBC_BONE_B...1,SET,13,-0.42825,-0.011392,0.25942,0.9506,HEBERT_MATRISOME_TNBC_BONE_BRAIN_LIVER_LUNG_METASTASTASES,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...34,SET,11,-0.36701,-0.0089811,0.22226,0.95064,GOBP_PROTEIN_LOCALIZATION_TO_NON_MOTILE_CILIUM,0.99999
REACTOME_RHO_GTPASES_ACTIVAT...5,SET,21,-0.32819,-0.011094,0.19874,0.95066,REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES,0.99999
GOMF_NUCLEASE_ACTIVITY,SET,197,-0.095248,-0.0098137,0.057667,0.95069,GOMF_NUCLEASE_ACTIVITY,0.99999
REACTOME_DISEASES_OF_PROGRAM...,SET,42,-0.22149,-0.010582,0.13409,0.9507,REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,0.99999
HP_INFANTILE_ENCEPHALOPATHY,SET,8,-0.51568,-0.010763,0.3122,0.9507,HP_INFANTILE_ENCEPHALOPATHY,0.99999
GOBP_RESPONSE_TO_BILE_ACID,SET,7,-0.57565,-0.011239,0.34845,0.95073,GOBP_RESPONSE_TO_BILE_ACID,0.99999
GOBP_REGULATION_OF_MITOTIC_S...1,SET,53,-0.18605,-0.0099821,0.11261,0.95074,GOBP_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION,0.99999
GSE22025_UNTREATED_VS_PROGES...2,SET,181,-0.10677,-0.01055,0.064593,0.95083,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...411,SET,102,-0.14674,-0.010908,0.088769,0.95084,GOBP_POSITIVE_REGULATION_OF_LIPID_LOCALIZATION,0.99999
GSE2128_C57BL6_VS_NOD_THYMOC...4,SET,179,-0.10154,-0.0099774,0.061414,0.95086,GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP,0.99999
SOTIRIOU_BREAST_CANCER_GRADE...2,SET,137,-0.11492,-0.0098906,0.069498,0.95089,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP,0.99999
GSE35685_CD34POS_CD10NEG_CD6...2,SET,183,-0.10241,-0.010174,0.06192,0.95092,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP,0.99999
APPIERTO_RESPONSE_TO_FENRETI...2,SET,37,-0.21618,-0.0096955,0.13067,0.95097,APPIERTO_RESPONSE_TO_FENRETINIDE_UP,0.99999
GSE15659_NAIVE_CD4_TCELL_VS_...3,SET,175,-0.10747,-0.010442,0.064951,0.95098,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,0.99999
DESCARTES_FETAL_CEREBELLUM_I...,SET,24,-0.33509,-0.012108,0.20253,0.95098,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,0.99999
GOCC_PHOSPHATASE_COMPLEX,SET,49,-0.18775,-0.0096868,0.11345,0.95101,GOCC_PHOSPHATASE_COMPLEX,0.99999
HP_INTESTINAL_HYPOPLASIA,SET,19,-0.31471,-0.010119,0.19016,0.95103,HP_INTESTINAL_HYPOPLASIA,0.99999
PRC2_SUZ12_UP.V1_DN,SET,168,-0.1125,-0.010712,0.067947,0.9511,PRC2_SUZ12_UP.V1_DN,0.99999
HP_CAUDATE_ATROPHY,SET,11,-0.44741,-0.010949,0.27018,0.95113,HP_CAUDATE_ATROPHY,0.99999
GSE1460_DP_THYMOCYTE_VS_NAIV...1,SET,175,-0.1078,-0.010474,0.065081,0.95117,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,0.99999
REACTOME_SIGNALING_BY_HIPPO,SET,19,-0.36751,-0.011817,0.22186,0.95118,REACTOME_SIGNALING_BY_HIPPO,0.99999
MIR2277_3P,SET,15,-0.36641,-0.010469,0.22116,0.9512,MIR2277_3P,0.99999
HP_ABNORMALITY_OF_THE_INTRIN...,SET,35,-0.21826,-0.0095209,0.1317,0.95126,HP_ABNORMALITY_OF_THE_INTRINSIC_PATHWAY,0.99999
HP_HIGH_NARROW_PALATE,SET,128,-0.12171,-0.010127,0.073433,0.95127,HP_HIGH_NARROW_PALATE,0.99999
GSE30962_ACUTE_VS_CHRONIC_LC...3,SET,185,-0.1071,-0.010697,0.064582,0.95137,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN,0.99999
MIR376A_2_5P,SET,59,-0.18998,-0.010753,0.11453,0.9514,MIR376A_2_5P,0.99999
GOBP_COCHLEA_MORPHOGENESIS,SET,22,-0.32391,-0.011206,0.19528,0.9514,GOBP_COCHLEA_MORPHOGENESIS,0.99999
MIR6729_5P,SET,8,-0.44984,-0.0093886,0.27116,0.95143,MIR6729_5P,0.99999
MIR6771_3P,SET,89,-0.15131,-0.01051,0.091206,0.95143,MIR6771_3P,0.99999
GSE2770_TGFB_AND_IL4_VS_IL12...6,SET,184,-0.10303,-0.010263,0.062108,0.95143,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.99999
GSE6269_HEALTHY_VS_E_COLI_IN...1,SET,145,-0.12185,-0.010787,0.073449,0.95143,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN,0.99999
GSE22025_PROGESTERONE_VS_TGF...1,SET,181,-0.1101,-0.010878,0.06636,0.95144,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,0.99999
GSE17580_UNINFECTED_VS_S_MAN...3,SET,175,-0.10842,-0.010535,0.065345,0.95145,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN,0.99999
chr7q32,SET,43,-0.42337,-0.020466,0.25512,0.95149,chr7q32,0.99999
KEGG_MEDICUS_REFERENCE_CA2_P...1,SET,6,-0.60897,-0.011007,0.36678,0.95157,KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_PATHOGEN_HTLV_1...5,SET,9,-0.41585,-0.0092053,0.25044,0.95158,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00497,0.99999
BIOCARTA_BCELLSURVIVAL_PATHW...,SET,14,-0.41527,-0.011464,0.25007,0.9516,BIOCARTA_BCELLSURVIVAL_PATHWAY,0.99999
GSE24210_TCONV_VS_TREG_DN,SET,176,-0.10371,-0.010106,0.062444,0.95162,GSE24210_TCONV_VS_TREG_DN,0.99999
REACTOME_SIGNALING_BY_EGFR_I...,SET,24,-0.28715,-0.010376,0.17287,0.95164,REACTOME_SIGNALING_BY_EGFR_IN_CANCER,0.99999
GOMF_PEPTIDE_RECEPTOR_ACTIVI...,SET,119,-0.14591,-0.011709,0.087798,0.95172,GOMF_PEPTIDE_RECEPTOR_ACTIVITY,0.99999
CHIARADONNA_NEOPLASTIC_TRANS...2,SET,102,-0.14836,-0.011028,0.089264,0.95174,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,0.99999
GOBP_XENOBIOTIC_TRANSMEMBRAN...,SET,17,-0.36507,-0.011104,0.21964,0.95175,GOBP_XENOBIOTIC_TRANSMEMBRANE_TRANSPORT,0.99999
HALLMARK_IL6_JAK_STAT3_SIGNA...,SET,80,-0.1713,-0.011283,0.10304,0.95179,HALLMARK_IL6_JAK_STAT3_SIGNALING,0.99999
REACTOME_INTEGRIN_SIGNALING,SET,27,-0.27975,-0.010721,0.16821,0.95185,REACTOME_INTEGRIN_SIGNALING,0.99999
GSE23925_DARK_ZONE_VS_NAIVE_...2,SET,182,-0.10263,-0.010168,0.061709,0.95185,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_UP,0.99999
GSE24574_NAIVE_VS_TCONV_CD4_...1,SET,185,-0.099987,-0.0099866,0.06011,0.95187,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN,0.99999
PID_RETINOIC_ACID_PATHWAY,SET,30,-0.25757,-0.010404,0.15482,0.9519,PID_RETINOIC_ACID_PATHWAY,0.99999
HP_DILATATION_OF_THE_CEREBRA...,SET,49,-0.20761,-0.010712,0.12476,0.95195,HP_DILATATION_OF_THE_CEREBRAL_ARTERY,0.99999
MULLIGAN_NTF3_SIGNALING_VIA_...2,SET,20,-0.29306,-0.0096677,0.17605,0.952,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,0.99999
GOMF_INTERLEUKIN_1_BINDING,SET,8,-0.53847,-0.011238,0.32347,0.952,GOMF_INTERLEUKIN_1_BINDING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...169,SET,4,-0.64784,-0.0095618,0.38915,0.95201,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,0.99999
CHESLER_BRAIN_HIGHEST_EXPRES...,SET,34,-0.24626,-0.010588,0.14792,0.95202,CHESLER_BRAIN_HIGHEST_EXPRESSION,0.99999
GOBP_MITOTIC_INTRA_S_DNA_DAM...,SET,16,-0.30576,-0.0090228,0.18365,0.95203,GOBP_MITOTIC_INTRA_S_DNA_DAMAGE_CHECKPOINT_SIGNALING,0.99999
GSE6259_BCELL_VS_CD8_TCELL_UP,SET,174,-0.11654,-0.011292,0.069983,0.95207,GSE6259_BCELL_VS_CD8_TCELL_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...19,SET,11,-0.42108,-0.010304,0.25283,0.95208,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,0.99999
MIR4802_3P,SET,153,-0.1298,-0.011801,0.077934,0.95209,MIR4802_3P,0.99999
HP_ABNORMAL_URINE_CARBOXYLIC...,SET,117,-0.13346,-0.01062,0.080126,0.95209,HP_ABNORMAL_URINE_CARBOXYLIC_ACID_LEVEL,0.99999
REACTOME_MITF_M_REGULATED_ME...,SET,124,-0.12853,-0.010527,0.077153,0.95212,REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,0.99999
MIR1258,SET,57,-0.19283,-0.010728,0.11573,0.95215,MIR1258,0.99999
COWLING_MYCN_TARGETS,SET,38,-0.24798,-0.011271,0.14881,0.95218,COWLING_MYCN_TARGETS,0.99999
MAHADEVAN_IMATINIB_RESISTANC...1,SET,19,-0.38677,-0.012436,0.23209,0.95218,MAHADEVAN_IMATINIB_RESISTANCE_DN,0.99999
RICKMAN_HEAD_AND_NECK_CANCER...2,SET,33,-0.27085,-0.011473,0.16253,0.95218,RICKMAN_HEAD_AND_NECK_CANCER_B,0.99999
HP_CONTRACTURE_OF_THE_DISTAL...,SET,6,-0.66097,-0.011947,0.39647,0.95225,HP_CONTRACTURE_OF_THE_DISTAL_INTERPHALANGEAL_JOINT_OF_THE_FINGERS,0.99999
GSE24210_RESTING_TREG_VS_TCO...1,SET,178,-0.10145,-0.0099407,0.060845,0.95226,GSE24210_RESTING_TREG_VS_TCONV_DN,0.99999
GOBP_MODULATION_BY_HOST_OF_V...2,SET,42,-0.22043,-0.010531,0.1322,0.95227,GOBP_MODULATION_BY_HOST_OF_VIRAL_PROCESS,0.99999
GOMF_SOMATOSTATIN_RECEPTOR_A...,SET,5,-0.60912,-0.010051,0.36531,0.95227,GOMF_SOMATOSTATIN_RECEPTOR_ACTIVITY,0.99999
chr11q24,SET,81,-0.29066,-0.019265,0.17431,0.95228,chr11q24,0.99999
BOQUEST_STEM_CELL_DN,SET,205,-0.11146,-0.011712,0.066832,0.9523,BOQUEST_STEM_CELL_DN,0.99999
HALLMARK_PEROXISOME,SET,98,-0.14445,-0.010526,0.086606,0.95232,HALLMARK_PEROXISOME,0.99999
GSE18203_CTRL_VS_INTRATUMORA...2,SET,187,-0.10014,-0.010055,0.060039,0.95233,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP,0.99999
CAIRO_HEPATOBLASTOMA_CLASSES...1,SET,194,-0.10649,-0.010889,0.063841,0.95234,CAIRO_HEPATOBLASTOMA_CLASSES_DN,0.99999
MIR4540,SET,47,-0.20322,-0.010269,0.12181,0.95236,MIR4540,0.99999
GOBP_REGULATION_OF_RESPIRATO...3,SET,22,-0.31941,-0.011051,0.19145,0.95237,GOBP_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE,0.99999
HP_SEVERE_MUSCULAR_HYPOTONIA,SET,58,-0.17139,-0.0096185,0.10271,0.95241,HP_SEVERE_MUSCULAR_HYPOTONIA,0.99999
HP_ABNORMAL_SPINAL_CORD_MORP...,SET,274,-0.087557,-0.010617,0.05246,0.95244,HP_ABNORMAL_SPINAL_CORD_MORPHOLOGY,0.99999
GOBP_ENDOPLASMIC_RETICULUM_T...2,SET,126,-0.11954,-0.0098693,0.071615,0.95245,GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...23,SET,10,-0.40802,-0.0095203,0.24445,0.95245,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.99999
MATSUDA_NATURAL_KILLER_DIFFE...,SET,437,-0.069738,-0.010631,0.041751,0.95256,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...49,SET,147,-0.11734,-0.010458,0.070237,0.9526,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY,0.99999
MIR6792_3P,SET,117,-0.1318,-0.010489,0.078869,0.95265,MIR6792_3P,0.99999
GOBP_ENERGY_HOMEOSTASIS,SET,75,-0.17276,-0.01102,0.10336,0.95267,GOBP_ENERGY_HOMEOSTASIS,0.99999
GOMF_CYSTEINE_TYPE_ENDOPEPTI...1,SET,5,-0.66466,-0.010968,0.39765,0.95268,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...8,SET,13,-0.411,-0.010933,0.24587,0.95269,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY,0.99999
GOMF_PROTEOGLYCAN_BINDING,SET,34,-0.27547,-0.011844,0.16479,0.9527,GOMF_PROTEOGLYCAN_BINDING,0.99999
GOBP_LIPID_DROPLET_DISASSEMB...,SET,6,-0.54998,-0.0099412,0.32897,0.95271,GOBP_LIPID_DROPLET_DISASSEMBLY,0.99999
MIR12115,SET,63,-0.17504,-0.010237,0.10469,0.95272,MIR12115,0.99999
REACTOME_REGULATION_OF_RAS_B...,SET,64,-0.16202,-0.0095498,0.096904,0.95273,REACTOME_REGULATION_OF_RAS_BY_GAPS,0.99999
GSE20500_RETINOIC_ACID_VS_RA...2,SET,182,-0.10748,-0.010648,0.064268,0.95276,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,0.99999
HP_LACRIMAL_DUCT_STENOSIS,SET,13,-0.40509,-0.010776,0.2422,0.95278,HP_LACRIMAL_DUCT_STENOSIS,0.99999
WP_PHOTODYNAMIC_THERAPYINDUC...1,SET,48,-0.21217,-0.010835,0.1268,0.95285,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,0.99999
GSE27092_WT_VS_HDAC7_PHOSPHO...1,SET,186,-0.10103,-0.010118,0.060359,0.95291,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_DN,0.99999
REACTOME_CELL_CYCLE_MITOTIC,SET,469,-0.062807,-0.0099098,0.037517,0.95293,REACTOME_CELL_CYCLE_MITOTIC,0.99999
DESCARTES_FETAL_CEREBRUM_AST...,SET,141,-0.12588,-0.010989,0.075187,0.95294,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.99999
IRX2_TARGET_GENES,SET,187,-0.10065,-0.010106,0.060111,0.95297,IRX2_TARGET_GENES,0.99999
HP_PSEUDOEPIPHYSES_OF_THE_ME...,SET,8,-0.46592,-0.0097241,0.27822,0.95299,HP_PSEUDOEPIPHYSES_OF_THE_METACARPALS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...82,SET,4,-0.63478,-0.009369,0.37901,0.95301,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY,0.99999
GSE5142_CTRL_VS_HTERT_TRANSD...2,SET,188,-0.1023,-0.010299,0.061074,0.95303,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP,0.99999
BIOCARTA_PCAF_PATHWAY,SET,13,-0.36967,-0.0098338,0.22067,0.95304,BIOCARTA_PCAF_PATHWAY,0.99999
HP_RHINITIS,SET,97,-0.1434,-0.010396,0.085594,0.95306,HP_RHINITIS,0.99999
HP_SHOULDER_CONTRACTURE,SET,8,-0.5226,-0.010907,0.31182,0.95312,HP_SHOULDER_CONTRACTURE,0.99999
MIR100_3P,SET,67,-0.17379,-0.01048,0.10368,0.95314,MIR100_3P,0.99999
SUH_COEXPRESSED_WITH_ID1_AND...,SET,18,-0.35721,-0.01118,0.2131,0.95315,SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,0.99999
HP_TENDON_RUPTURE,SET,5,-0.6594,-0.010881,0.39334,0.95316,HP_TENDON_RUPTURE,0.99999
GSE36527_CD62L_HIGH_CD69_NEG...1,SET,178,-0.11058,-0.010836,0.065958,0.95317,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_DN,0.99999
BIOCARTA_DNAFRAGMENT_PATHWAY,SET,10,-0.53152,-0.012402,0.31703,0.95318,BIOCARTA_DNAFRAGMENT_PATHWAY,0.99999
REACTOME_MAP3K8_TPL2_DEPENDE...,SET,14,-0.37293,-0.010295,0.22236,0.95323,REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION,0.99999
GOBP_REGULATION_OF_CELLULAR_...19,SET,24,-0.31344,-0.011326,0.18687,0.95325,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.99999
REACTOME_EGFR_TRANSACTIVATIO...,SET,9,-0.48315,-0.010695,0.28801,0.95328,REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN,0.99999
MIR365A_5P,SET,30,-0.28099,-0.01135,0.16747,0.9533,MIR365A_5P,0.99999
REACTOME_DAP12_SIGNALING,SET,27,-0.26753,-0.010252,0.1594,0.95335,REACTOME_DAP12_SIGNALING,0.99999
GOBP_OLIGOSACCHARIDE_CATABOL...,SET,16,-0.37307,-0.011009,0.22226,0.95337,GOBP_OLIGOSACCHARIDE_CATABOLIC_PROCESS,0.99999
REACTOME_NPAS4_REGULATES_EXP...,SET,20,-0.354,-0.011678,0.21084,0.95341,REACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES,0.99999
GSE13229_MATURE_VS_INTMATURE...1,SET,176,-0.10484,-0.010216,0.062417,0.95349,GSE13229_MATURE_VS_INTMATURE_NKCELL_DN,0.99999
HP_SACROCOCCYGEAL_TERATOMA,SET,5,-0.60632,-0.010005,0.36089,0.95352,HP_SACROCOCCYGEAL_TERATOMA,0.99999
GOBP_SERINE_FAMILY_AMINO_ACI...2,SET,11,-0.39186,-0.0095892,0.23322,0.95353,GOBP_SERINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,0.99999
HP_GLIOMA,SET,48,-0.19596,-0.010007,0.1166,0.95358,HP_GLIOMA,0.99999
BROWNE_INTERFERON_RESPONSIVE...,SET,65,-0.18976,-0.011272,0.11288,0.95362,BROWNE_INTERFERON_RESPONSIVE_GENES,0.99999
GSE11864_CSF1_PAM3CYS_VS_CSF...2,SET,166,-0.11136,-0.010541,0.066221,0.95367,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.99999
GOCC_RIBOSOME,SET,210,-0.092851,-0.0098739,0.055191,0.95374,GOCC_RIBOSOME,0.99999
GSE13306_RA_VS_UNTREATED_MEM...1,SET,170,-0.11348,-0.01087,0.067443,0.95377,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN,0.99999
GOBP_RESPONSE_TO_INTERLEUKIN...1,SET,100,-0.14967,-0.011017,0.088935,0.9538,GOBP_RESPONSE_TO_INTERLEUKIN_1,0.99999
GOBP_COBALAMIN_TRANSPORT,SET,8,-0.50414,-0.010522,0.29951,0.95382,GOBP_COBALAMIN_TRANSPORT,0.99999
GOBP_MITOTIC_SISTER_CHROMATI...4,SET,60,-0.17463,-0.009967,0.10375,0.95382,GOBP_MITOTIC_SISTER_CHROMATID_SEPARATION,0.99999
GSE7218_UNSTIM_VS_ANTIGEN_ST...1,SET,156,-0.12236,-0.011232,0.0727,0.95382,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_DN,0.99999
TOMIDA_METASTASIS_UP,SET,23,-0.30236,-0.010696,0.17961,0.95385,TOMIDA_METASTASIS_UP,0.99999
HP_ABNORMAL_PELVIS_BONE_MORP...,SET,18,-0.32398,-0.01014,0.19245,0.95385,HP_ABNORMAL_PELVIS_BONE_MORPHOLOGY,0.99999
XU_AKT1_TARGETS_6HR,SET,25,-0.25978,-0.0095801,0.15426,0.9539,XU_AKT1_TARGETS_6HR,0.99999
GSE20715_0H_VS_48H_OZONE_TLR...1,SET,190,-0.10261,-0.010385,0.060933,0.9539,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN,0.99999
GOBP_EXTRACELLULAR_MATRIX_CE...,SET,4,-0.82987,-0.012248,0.49276,0.95391,GOBP_EXTRACELLULAR_MATRIX_CELL_SIGNALING,0.99999
GSE6674_CPG_VS_CPG_AND_ANTI_...1,SET,172,-0.11412,-0.010995,0.06776,0.95392,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_DN,0.99999
ZNF146_TARGET_GENES,SET,888,-0.049247,-0.010566,0.029239,0.95393,ZNF146_TARGET_GENES,0.99999
GOMF_HISTONE_H3K9_DEMETHYLAS...,SET,12,-0.35672,-0.0091174,0.21171,0.95399,GOMF_HISTONE_H3K9_DEMETHYLASE_ACTIVITY,0.99999
ZHONG_PFC_C4_UNKNOWN_INP,SET,81,-0.16193,-0.010732,0.096103,0.95399,ZHONG_PFC_C4_UNKNOWN_INP,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...1,SET,176,-0.10375,-0.01011,0.061573,0.954,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_DN,0.99999
GOMF_PHOSPHODIESTERASE_I_ACT...,SET,5,-0.62413,-0.010299,0.37029,0.95404,GOMF_PHOSPHODIESTERASE_I_ACTIVITY,0.99999
chr4q23,SET,18,-0.56482,-0.017678,0.3351,0.95405,chr4q23,0.99999
MIR5586_3P,SET,48,-0.21522,-0.01099,0.12765,0.9541,MIR5586_3P,0.99999
HP_URINARY_RETENTION,SET,24,-0.31031,-0.011213,0.18401,0.95413,HP_URINARY_RETENTION,0.99999
YORDY_RECIPROCAL_REGULATION_...2,SET,20,-0.32883,-0.010848,0.19498,0.95414,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP,0.99999
REACTOME_SYNTHESIS_OF_PG,SET,8,-0.50746,-0.010591,0.30082,0.95418,REACTOME_SYNTHESIS_OF_PG,0.99999
GOBP_MONOCYTE_ACTIVATION,SET,12,-0.44831,-0.011458,0.26575,0.95419,GOBP_MONOCYTE_ACTIVATION,0.99999
GOBP_PHOSPHATIDYLINOSITOL_ME...1,SET,23,-0.30434,-0.010766,0.18039,0.9542,GOBP_PHOSPHATIDYLINOSITOL_MEDIATED_SIGNALING,0.99999
GOMF_INTEGRIN_BINDING_INVOLV...,SET,5,-0.69741,-0.011508,0.41334,0.95422,GOMF_INTEGRIN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION,0.99999
BUSSLINGER_DUODENAL_EC_CELLS,SET,27,-0.31641,-0.012126,0.18749,0.95425,BUSSLINGER_DUODENAL_EC_CELLS,0.99999
MODULE_3,SET,361,-0.075319,-0.010458,0.044624,0.95427,MODULE_3,0.99999
SIX1_TARGET_GENES,SET,292,-0.085972,-0.010756,0.050928,0.9543,SIX1_TARGET_GENES,0.99999
GOBP_CAMP_METABOLIC_PROCESS,SET,23,-0.32315,-0.011431,0.19141,0.95431,GOBP_CAMP_METABOLIC_PROCESS,0.99999
GSE5503_PLN_DC_VS_SPLEEN_DC_...2,SET,186,-0.10295,-0.01031,0.060978,0.95432,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.99999
GSE28726_NAIVE_VS_ACTIVATED_...6,SET,180,-0.10232,-0.010082,0.060594,0.95434,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP,0.99999
TRAVAGLINI_LUNG_CD8_NAIVE_T_...,SET,131,-0.13471,-0.011338,0.079775,0.95434,TRAVAGLINI_LUNG_CD8_NAIVE_T_CELL,0.99999
DESCARTES_FETAL_PLACENTA_SMO...,SET,74,-0.18503,-0.011724,0.10957,0.95435,DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS,0.99999
GOMF_CAMP_DEPENDENT_PROTEIN_...2,SET,10,-0.47785,-0.01115,0.28297,0.95436,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_INHIBITOR_ACTIVITY,0.99999
HP_VERTICAL_SUPRANUCLEAR_GAZ...,SET,26,-0.28195,-0.010603,0.16695,0.95436,HP_VERTICAL_SUPRANUCLEAR_GAZE_PALSY,0.99999
WP_HEPATITIS_C_AND_HEPATOCEL...,SET,49,-0.21393,-0.011038,0.12667,0.95437,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,0.99999
HP_FEW_CAFE_AU_LAIT_SPOTS,SET,6,-0.60011,-0.010847,0.3553,0.95438,HP_FEW_CAFE_AU_LAIT_SPOTS,0.99999
SOGA_COLORECTAL_CANCER_MYC_UP,SET,76,-0.15855,-0.01018,0.093841,0.95444,SOGA_COLORECTAL_CANCER_MYC_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...570,SET,34,-0.25119,-0.0108,0.14866,0.95444,GOBP_POSITIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_GLYCO...4,SET,21,-0.28024,-0.0094727,0.16584,0.95446,KEGG_MEDICUS_REFERENCE_GLYCOLYSIS,0.99999
HP_INTERSTITIAL_CARDIAC_FIBR...,SET,9,-0.52173,-0.011549,0.30863,0.95452,HP_INTERSTITIAL_CARDIAC_FIBROSIS,0.99999
RUBENSTEIN_SKELETAL_MUSCLE_B...,SET,154,-0.11733,-0.010702,0.06941,0.95452,RUBENSTEIN_SKELETAL_MUSCLE_B_CELLS,0.99999
MYCMAX_01,SET,235,-0.097229,-0.01093,0.057488,0.9546,MYCMAX_01,0.99999
MIR346,SET,61,-0.18548,-0.010674,0.10966,0.95461,MIR346,0.99999
MIR4424,SET,109,-0.13788,-0.010593,0.081497,0.95465,MIR4424,0.99999
GOBP_NEGATIVE_REGULATION_OF_...618,SET,13,-0.43121,-0.011471,0.25487,0.95465,GOBP_NEGATIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.99999
HP_CRUMPLED_LONG_BONES,SET,6,-0.55914,-0.010107,0.3305,0.95465,HP_CRUMPLED_LONG_BONES,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...17,SET,175,-0.11418,-0.011095,0.067478,0.95468,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN,0.99999
GOBP_OTIC_VESICLE_FORMATION,SET,8,-0.49228,-0.010274,0.2909,0.95469,GOBP_OTIC_VESICLE_FORMATION,0.99999
GOBP_REGULATION_OF_METALLOPE...,SET,9,-0.55658,-0.012321,0.32888,0.9547,GOBP_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.99999
GOBP_DNA_REPLICATION_DEPENDE...,SET,6,-0.45883,-0.0082937,0.27105,0.95474,GOBP_DNA_REPLICATION_DEPENDENT_CHROMATIN_ASSEMBLY,0.99999
MODULE_387,SET,48,-0.21299,-0.010877,0.12581,0.95475,MODULE_387,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...7,SET,6,-0.67994,-0.01229,0.40164,0.95476,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CLUSTERING,0.99999
TURASHVILI_BREAST_LOBULAR_CA...4,SET,90,-0.15777,-0.01102,0.093188,0.95477,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,0.99999
BENPORATH_ES_1,SET,337,-0.077739,-0.010436,0.045904,0.95481,BENPORATH_ES_1,0.99999
GOMF_DNA_BINDING_BENDING,SET,17,-0.38245,-0.011633,0.22581,0.95483,GOMF_DNA_BINDING_BENDING,0.99999
WP_WNTBETACATENIN_SIGNALING_...2,SET,25,-0.31396,-0.011578,0.18536,0.95484,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,0.99999
HP_AMYLOIDOSIS,SET,34,-0.26494,-0.011391,0.1564,0.95486,HP_AMYLOIDOSIS,0.99999
GOCC_PHOSPHOLIPID_TRANSLOCAT...,SET,13,-0.41898,-0.011145,0.24728,0.95489,GOCC_PHOSPHOLIPID_TRANSLOCATING_ATPASE_COMPLEX,0.99999
GSE16450_CTRL_VS_IFNA_12H_ST...3,SET,188,-0.10261,-0.01033,0.060545,0.95493,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.99999
GOBP_ADENYLATE_CYCLASE_MODUL...,SET,249,-0.10057,-0.011634,0.05933,0.95497,GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
CLIMENT_BREAST_CANCER_COPY_N...1,SET,8,-0.54193,-0.01131,0.31967,0.95498,CLIMENT_BREAST_CANCER_COPY_NUMBER_DN,0.99999
GOBP_REGULATION_OF_CORTICOST...,SET,16,-0.37845,-0.011168,0.22316,0.95503,GOBP_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION,0.99999
GSE27786_BCELL_VS_NKCELL_UP,SET,180,-0.10097,-0.009949,0.059532,0.95505,GSE27786_BCELL_VS_NKCELL_UP,0.99999
REACTOME_GLUCONEOGENESIS,SET,21,-0.29053,-0.0098205,0.17129,0.95506,REACTOME_GLUCONEOGENESIS,0.99999
HP_INCREASED_MUSCLE_GLYCOGEN...,SET,8,-0.47252,-0.0098618,0.27852,0.9551,HP_INCREASED_MUSCLE_GLYCOGEN_CONTENT,0.99999
DESCARTES_FETAL_LUNG_STROMAL...,SET,37,-0.25873,-0.011603,0.1525,0.9551,DESCARTES_FETAL_LUNG_STROMAL_CELLS,0.99999
GOBP_VESICLE_TARGETING_ROUGH...,SET,24,-0.28241,-0.010204,0.16645,0.95511,GOBP_VESICLE_TARGETING_ROUGH_ER_TO_CIS_GOLGI,0.99999
BIOCARTA_EGFR_SMRTE_PATHWAY,SET,11,-0.47196,-0.011549,0.27811,0.95514,BIOCARTA_EGFR_SMRTE_PATHWAY,0.99999
HP_FACIAL_HEMANGIOMA,SET,19,-0.35339,-0.011363,0.20824,0.95514,HP_FACIAL_HEMANGIOMA,0.99999
GSE3982_MEMORY_CD4_TCELL_VS_...5,SET,186,-0.10423,-0.010438,0.061418,0.95515,GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN,0.99999
GSE46606_DAY1_VS_DAY3_CD40L_...4,SET,186,-0.10068,-0.010083,0.059313,0.95519,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...383,SET,6,-0.62396,-0.011278,0.3674,0.95527,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_DEPOLARIZATION,0.99999
WP_IDO_METABOLIC_PATHWAY,SET,9,-0.54204,-0.011999,0.31912,0.95529,WP_IDO_METABOLIC_PATHWAY,0.99999
GOBP_REGULATION_OF_GLUCOCORT...4,SET,10,-0.45382,-0.010589,0.26719,0.95529,GOBP_REGULATION_OF_GLUCOCORTICOID_SECRETION,0.99999
HP_EXERCISE_INDUCED_MUSCLE_C...,SET,14,-0.34291,-0.0094659,0.20186,0.9553,HP_EXERCISE_INDUCED_MUSCLE_CRAMPS,0.99999
GOBP_MUSCLE_CELL_APOPTOTIC_P...,SET,76,-0.16726,-0.01074,0.098433,0.95536,GOBP_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
HP_INCREASED_SERUM_PYRUVATE,SET,41,-0.2022,-0.0095448,0.11894,0.95542,HP_INCREASED_SERUM_PYRUVATE,0.99999
HP_PARESTHESIA,SET,119,-0.13208,-0.010599,0.077682,0.95544,HP_PARESTHESIA,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...60,SET,39,-0.19919,-0.0091713,0.11715,0.95546,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_DEF...3,SET,102,-0.14454,-0.010744,0.085004,0.95546,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_RETICULOCYTE,0.99999
GOBP_REGULATION_OF_RESPONSE_...8,SET,16,-0.37946,-0.011197,0.22313,0.95548,GOBP_REGULATION_OF_RESPONSE_TO_OSMOTIC_STRESS,0.99999
HP_HYPOPLASTIC_PELVIS,SET,14,-0.40116,-0.011074,0.23588,0.95549,HP_HYPOPLASTIC_PELVIS,0.99999
MORF_NME2,SET,137,-0.11725,-0.010091,0.068906,0.95558,MORF_NME2,0.99999
REACTOME_GABA_SYNTHESIS_RELE...,SET,19,-0.36769,-0.011823,0.21606,0.95559,REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION,0.99999
GOBP_GLYCOSYLCERAMIDE_METABO...,SET,16,-0.37604,-0.011097,0.22098,0.95559,GOBP_GLYCOSYLCERAMIDE_METABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...161,SET,8,-0.54101,-0.011291,0.31786,0.95562,GOBP_POSITIVE_REGULATION_OF_CHONDROCYTE_PROLIFERATION,0.99999
HP_PRIMITIVE_NEUROECTODERMAL...,SET,68,-0.17622,-0.010705,0.10352,0.95563,HP_PRIMITIVE_NEUROECTODERMAL_TUMOR,0.99999
HAEGERSTRAND_RESPONSE_TO_IMA...,SET,9,-0.59165,-0.013097,0.34757,0.95564,HAEGERSTRAND_RESPONSE_TO_IMATINIB,0.99999
BLANCO_MELO_COVID19_SARS_COV...4,SET,425,-0.072495,-0.010902,0.042572,0.9557,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,0.99999
GSE30962_ACUTE_VS_CHRONIC_LC...1,SET,185,-0.10953,-0.01094,0.064319,0.9557,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...250,SET,10,-0.47609,-0.011109,0.27952,0.95573,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS,0.99999
HP_DICARBOXYLIC_ACIDURIA,SET,64,-0.17485,-0.010306,0.10265,0.95574,HP_DICARBOXYLIC_ACIDURIA,0.99999
GOBP_ALDITOL_CATABOLIC_PROCE...,SET,5,-0.72299,-0.01193,0.4244,0.95576,GOBP_ALDITOL_CATABOLIC_PROCESS,0.99999
HP_ABNORMALITY_OF_CIRCULATIN...1,SET,41,-0.24905,-0.011756,0.14618,0.95577,HP_ABNORMALITY_OF_CIRCULATING_FIBRINOGEN,0.99999
GSE29618_BCELL_VS_PDC_UP,SET,169,-0.12137,-0.011591,0.071237,0.95577,GSE29618_BCELL_VS_PDC_UP,0.99999
MIR103A_2_5P,SET,140,-0.12591,-0.010953,0.073898,0.95578,MIR103A_2_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...117,SET,9,-0.47204,-0.010449,0.27705,0.95578,GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,0.99999
MIR3661,SET,62,-0.18855,-0.010939,0.11065,0.9558,MIR3661,0.99999
GSE4142_PLASMA_CELL_VS_MEMOR...2,SET,176,-0.11561,-0.011265,0.067828,0.95584,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP,0.99999
GOBP_METHYLATION,SET,180,-0.10012,-0.0098652,0.058734,0.95586,GOBP_METHYLATION,0.99999
GSE3039_NKT_CELL_VS_B1_BCELL...2,SET,176,-0.10561,-0.010291,0.061955,0.95586,GSE3039_NKT_CELL_VS_B1_BCELL_UP,0.99999
GOMF_NITRITE_REDUCTASE_ACTIV...,SET,5,-0.71058,-0.011725,0.41669,0.95592,GOMF_NITRITE_REDUCTASE_ACTIVITY,0.99999
GOBP_PEROXISOME_FISSION,SET,8,-0.51472,-0.010743,0.30156,0.95607,GOBP_PEROXISOME_FISSION,0.99999
HP_ABNORMAL_CORPUS_STRIATUM_...,SET,35,-0.23101,-0.010077,0.13534,0.95607,HP_ABNORMAL_CORPUS_STRIATUM_MORPHOLOGY,0.99999
GOMF_NEUROPEPTIDE_RECEPTOR_B...,SET,29,-0.27843,-0.011058,0.16311,0.95608,GOMF_NEUROPEPTIDE_RECEPTOR_BINDING,0.99999
REACTOME_CELL_CYCLE_CHECKPOI...,SET,241,-0.086984,-0.0099006,0.050954,0.95609,REACTOME_CELL_CYCLE_CHECKPOINTS,0.99999
HP_CONE_CONE_ROD_DYSTROPHY,SET,52,-0.20104,-0.010684,0.11774,0.95612,HP_CONE_CONE_ROD_DYSTROPHY,0.99999
GOMF_PROTEIN_PHOSPHATASE_2A_...,SET,26,-0.30785,-0.011577,0.18028,0.95614,GOMF_PROTEIN_PHOSPHATASE_2A_BINDING,0.99999
BASSO_HAIRY_CELL_LEUKEMIA_UP,SET,74,-0.17708,-0.01122,0.10366,0.95621,BASSO_HAIRY_CELL_LEUKEMIA_UP,0.99999
HP_NUMEROUS_NEVI,SET,11,-0.45095,-0.011035,0.26394,0.95622,HP_NUMEROUS_NEVI,0.99999
GOBP_SPINDLE_ORGANIZATION,SET,184,-0.10237,-0.010197,0.059914,0.95623,GOBP_SPINDLE_ORGANIZATION,0.99999
GOBP_S_ADENOSYLMETHIONINE_ME...,SET,16,-0.37437,-0.011047,0.21905,0.95628,GOBP_S_ADENOSYLMETHIONINE_METABOLIC_PROCESS,0.99999
LU_AGING_BRAIN_UP,SET,234,-0.10094,-0.011324,0.059055,0.95629,LU_AGING_BRAIN_UP,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...4,SET,125,-0.13209,-0.010862,0.077264,0.95632,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,0.99999
GOBP_HYALURONAN_CATABOLIC_PR...,SET,15,-0.36345,-0.010385,0.21259,0.95632,GOBP_HYALURONAN_CATABOLIC_PROCESS,0.99999
GSE25088_WT_VS_STAT6_KO_MACR...4,SET,168,-0.1147,-0.010922,0.067082,0.95635,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_DN,0.99999
REACTOME_TRANSCRIPTIONAL_REG...12,SET,30,-0.28198,-0.01139,0.16485,0.9564,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,0.99999
HP_ABNORMALLY_FOLDED_HELIX,SET,71,-0.18014,-0.011181,0.10531,0.95641,HP_ABNORMALLY_FOLDED_HELIX,0.99999
TGFB_UP.V1_DN,SET,172,-0.11481,-0.01106,0.067112,0.95642,TGFB_UP.V1_DN,0.99999
WP_WNT_SIGNALING_WP363,SET,51,-0.20656,-0.010872,0.12073,0.95645,WP_WNT_SIGNALING_WP363,0.99999
GSE17721_LPS_VS_POLYIC_6H_BM...2,SET,182,-0.11071,-0.010969,0.064708,0.95645,GSE17721_LPS_VS_POLYIC_6H_BMDC_UP,0.99999
GSE12484_HEALTHY_VS_PERIDONT...1,SET,138,-0.12352,-0.010669,0.072184,0.95647,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN,0.99999
REACTOME_REGULATION_OF_EXPRE...,SET,154,-0.11098,-0.010122,0.064852,0.95648,REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,0.99999
HP_DESCENDING_AORTIC_DISSECT...,SET,20,-0.35675,-0.011769,0.20846,0.95648,HP_DESCENDING_AORTIC_DISSECTION,0.99999
GOBP_ALPHA_AMINO_ACID_METABO...,SET,194,-0.10486,-0.010722,0.06127,0.95649,GOBP_ALPHA_AMINO_ACID_METABOLIC_PROCESS,0.99999
GSE37532_VISCERAL_ADIPOSE_TI...5,SET,85,-0.16784,-0.011394,0.09807,0.95649,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN,0.99999
BHAT_ESR1_TARGETS_VIA_AKT1_UP,SET,263,-0.096544,-0.011473,0.056399,0.95652,BHAT_ESR1_TARGETS_VIA_AKT1_UP,0.99999
GSE29164_CD8_TCELL_VS_CD8_TC...1,SET,184,-0.11031,-0.010988,0.064445,0.95652,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,0.99999
GSE20727_CTRL_VS_ROS_INHIBIT...1,SET,180,-0.10691,-0.010534,0.062449,0.95654,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_DN,0.99999
GRAESSMANN_APOPTOSIS_BY_SERU...2,SET,509,-0.06491,-0.010657,0.03791,0.95656,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP,0.99999
REACTOME_COMPLEX_IV_ASSEMBLY,SET,41,-0.19243,-0.0090836,0.11239,0.95656,REACTOME_COMPLEX_IV_ASSEMBLY,0.99999
GOBP_T_CELL_ANTIGEN_PROCESSI...,SET,4,-0.80561,-0.01189,0.47043,0.95659,GOBP_T_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,0.99999
GOCC_INTERPHOTORECEPTOR_MATR...,SET,5,-0.58823,-0.0097065,0.34343,0.95662,GOCC_INTERPHOTORECEPTOR_MATRIX,0.99999
GSE20366_CD103_POS_VS_CD103_...2,SET,181,-0.1089,-0.01076,0.063573,0.95663,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP,0.99999
CTACCTC_LET7A_LET7B_LET7C_LE...,SET,352,-0.079286,-0.010873,0.046276,0.95667,CTACCTC_LET7A_LET7B_LET7C_LET7D_LET7E_LET7F_MIR98_LET7G_LET7I,0.99999
GOBP_NEGATIVE_REGULATION_OF_...28,SET,9,-0.51343,-0.011365,0.29952,0.95674,GOBP_NEGATIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,0.99999
ROESSLER_LIVER_CANCER_METAST...1,SET,46,-0.22073,-0.011035,0.12874,0.95677,ROESSLER_LIVER_CANCER_METASTASIS_DN,0.99999
REACTOME_SHC_MEDIATED_CASCAD...3,SET,19,-0.35121,-0.011293,0.20485,0.95677,REACTOME_SHC_MEDIATED_CASCADE_FGFR4,0.99999
MACLACHLAN_BRCA1_TARGETS_UP,SET,19,-0.32832,-0.010557,0.19145,0.95681,MACLACHLAN_BRCA1_TARGETS_UP,0.99999
BIOCARTA_SALMONELLA_PATHWAY,SET,5,-0.55125,-0.0090963,0.3214,0.95684,BIOCARTA_SALMONELLA_PATHWAY,0.99999
GSE36476_CTRL_VS_TSST_ACT_40...2,SET,178,-0.1112,-0.010896,0.064811,0.95688,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP,0.99999
GOBP_RESPONSE_TO_NITRIC_OXIDE,SET,17,-0.35724,-0.010866,0.20814,0.95694,GOBP_RESPONSE_TO_NITRIC_OXIDE,0.99999
GSE27241_CTRL_VS_DIGOXIN_TRE...4,SET,175,-0.1086,-0.010553,0.063275,0.95695,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,0.99999
REACTOME_CONSTITUTIVE_SIGNAL...4,SET,18,-0.32735,-0.010245,0.19068,0.95698,REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS,0.99999
WALLACE_PROSTATE_CANCER_RACE...2,SET,256,-0.10113,-0.011859,0.058898,0.95701,WALLACE_PROSTATE_CANCER_RACE_UP,0.99999
GSE5589_LPS_VS_LPS_AND_IL6_S...6,SET,176,-0.10883,-0.010605,0.063375,0.95702,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.99999
CHESLER_BRAIN_QTL_CIS,SET,68,-0.18171,-0.011039,0.1058,0.95705,CHESLER_BRAIN_QTL_CIS,0.99999
REACTOME_INTRINSIC_PATHWAY_F...,SET,52,-0.20646,-0.010973,0.12016,0.95711,REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS,0.99999
HP_SLENDER_BUILD,SET,23,-0.27673,-0.0097891,0.16105,0.95712,HP_SLENDER_BUILD,0.99999
REACTOME_CARGO_CONCENTRATION...,SET,31,-0.26634,-0.010936,0.15499,0.95713,REACTOME_CARGO_CONCENTRATION_IN_THE_ER,0.99999
GOBP_NEGATIVE_REGULATION_OF_...214,SET,35,-0.253,-0.011036,0.14719,0.95717,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.99999
REACTOME_N_GLYCAN_TRIMMING_I...,SET,33,-0.24796,-0.010503,0.1442,0.95723,REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,0.99999
DESCARTES_MAIN_FETAL_PHOTORE...,SET,67,-0.19184,-0.011568,0.11156,0.95723,DESCARTES_MAIN_FETAL_PHOTORECEPTOR_CELLS,0.99999
GSE29618_BCELL_VS_MONOCYTE_UP,SET,160,-0.1231,-0.011442,0.071577,0.95726,GSE29618_BCELL_VS_MONOCYTE_UP,0.99999
REACTOME_ASSEMBLY_AND_CELL_S...,SET,39,-0.2567,-0.011819,0.14916,0.95736,REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS,0.99999
RIGGINS_TAMOXIFEN_RESISTANCE...2,SET,53,-0.21967,-0.011786,0.12764,0.95737,RIGGINS_TAMOXIFEN_RESISTANCE_UP,0.99999
SCHLOSSER_MYC_TARGETS_AND_SE...2,SET,45,-0.21018,-0.010393,0.12212,0.95737,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,0.99999
GSE360_L_DONOVANI_VS_M_TUBER...2,SET,177,-0.11014,-0.010762,0.063985,0.95739,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP,0.99999
HP_HEPATIC_FIBROSIS,SET,134,-0.12305,-0.010474,0.071476,0.95741,HP_HEPATIC_FIBROSIS,0.99999
HP_ABSENT_INNER_DYNEIN_ARMS,SET,7,-0.50996,-0.0099562,0.29621,0.95742,HP_ABSENT_INNER_DYNEIN_ARMS,0.99999
REACTOME_RAS_SIGNALING_DOWNS...,SET,7,-0.56364,-0.011004,0.32738,0.95743,REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS,0.99999
GOBP_POSITIVE_REGULATION_OF_...708,SET,69,-0.18636,-0.011404,0.10821,0.95748,GOBP_POSITIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,0.99999
MIR147A,SET,57,-0.20206,-0.011242,0.11732,0.95749,MIR147A,0.99999
HP_POLYHYDRAMNIOS,SET,263,-0.090531,-0.010758,0.05256,0.9575,HP_POLYHYDRAMNIOS,0.99999
REACTOME_BETA_CATENIN_INDEPE...,SET,142,-0.11827,-0.010361,0.068633,0.95756,REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,0.99999
PEART_HDAC_PROLIFERATION_CLU...1,SET,68,-0.17259,-0.010485,0.10013,0.95761,PEART_HDAC_PROLIFERATION_CLUSTER_DN,0.99999
KEGG_MEDICUS_PATHOGEN_HIV_GP...3,SET,26,-0.30112,-0.011324,0.17467,0.95763,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,0.99999
REACTOME_FORMATION_OF_TUBULI...,SET,24,-0.28902,-0.010443,0.16764,0.95764,REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...9,SET,42,-0.22947,-0.010963,0.1331,0.95765,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...10,SET,171,-0.10887,-0.010458,0.063136,0.95766,GSE22886_NAIVE_CD4_TCELL_VS_DC_UP,0.99999
GSE1925_CTRL_VS_24H_IFNG_STI...2,SET,184,-0.11277,-0.011233,0.065376,0.95773,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,0.99999
TARTE_PLASMA_CELL_VS_B_LYMPH...2,SET,75,-0.17053,-0.010878,0.098851,0.95774,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,0.99999
WP_MAMMARY_GLAND_DEVELOPMENT...3,SET,32,-0.28153,-0.011744,0.16319,0.95774,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,0.99999
PID_PDGFRA_PATHWAY,SET,21,-0.325,-0.010986,0.18836,0.95776,PID_PDGFRA_PATHWAY,0.99999
REACTOME_SIGNALING_BY_FGFR,SET,86,-0.1608,-0.01098,0.093163,0.95782,REACTOME_SIGNALING_BY_FGFR,0.99999
GSE3337_CTRL_VS_16H_IFNG_IN_...1,SET,179,-0.10794,-0.010606,0.062518,0.95786,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN,0.99999
SHIN_B_CELL_LYMPHOMA_CLUSTER...5,SET,10,-0.54152,-0.012635,0.31354,0.95792,SHIN_B_CELL_LYMPHOMA_CLUSTER_6,0.99999
MIR6088,SET,152,-0.12075,-0.010942,0.069892,0.95797,MIR6088,0.99999
HP_HYPOKINESIA,SET,46,-0.20248,-0.010123,0.1172,0.95797,HP_HYPOKINESIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...519,SET,10,-0.43814,-0.010223,0.25354,0.958,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,0.99999
GOBP_POSITIVE_REGULATION_OF_...104,SET,205,-0.10356,-0.010882,0.059916,0.95803,GOBP_POSITIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.99999
GSE4984_LPS_VS_VEHICLE_CTRL_...1,SET,177,-0.1129,-0.011033,0.065285,0.95812,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN,0.99999
HP_BURKITT_LYMPHOMA,SET,8,-0.58532,-0.012216,0.33844,0.95813,HP_BURKITT_LYMPHOMA,0.99999
HP_NEOPLASM_OF_THE_SKELETAL_...,SET,97,-0.14475,-0.010494,0.083675,0.95817,HP_NEOPLASM_OF_THE_SKELETAL_SYSTEM,0.99999
LUI_THYROID_CANCER_CLUSTER_3,SET,26,-0.2784,-0.01047,0.16088,0.95822,LUI_THYROID_CANCER_CLUSTER_3,0.99999
DESCARTES_FETAL_EYE_HORIZONT...,SET,13,-0.42983,-0.011434,0.24837,0.95823,DESCARTES_FETAL_EYE_HORIZONTAL_CELLS,0.99999
HP_LEUKEMIA,SET,162,-0.11565,-0.010816,0.066815,0.95825,HP_LEUKEMIA,0.99999
ACTGTAG_MIR139,SET,109,-0.14532,-0.011165,0.08394,0.95829,ACTGTAG_MIR139,0.99999
MODULE_117,SET,651,-0.063794,-0.011798,0.03684,0.95832,MODULE_117,0.99999
RPS14_DN.V1_DN,SET,167,-0.11144,-0.010581,0.064358,0.95832,RPS14_DN.V1_DN,0.99999
GSE32423_CTRL_VS_IL7_MEMORY_...2,SET,179,-0.11604,-0.011403,0.067012,0.95833,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP,0.99999
HP_ABNORMAL_INTESTINE_MORPHO...,SET,675,-0.057969,-0.010909,0.033465,0.95837,HP_ABNORMAL_INTESTINE_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...148,SET,19,-0.32871,-0.010569,0.18974,0.95839,GOBP_NEGATIVE_REGULATION_OF_CILIUM_ASSEMBLY,0.99999
HP_ABNORMAL_VISUAL_ELECTROPH...,SET,233,-0.098717,-0.011051,0.056981,0.95839,HP_ABNORMAL_VISUAL_ELECTROPHYSIOLOGY,0.99999
GNF2_RAB3A,SET,34,-0.27383,-0.011774,0.15805,0.9584,GNF2_RAB3A,0.99999
GSE6259_FLT3L_INDUCED_DEC205...6,SET,134,-0.12837,-0.010927,0.074069,0.95845,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_UP,0.99999
GOBP_EYE_PHOTORECEPTOR_CELL_...1,SET,36,-0.26096,-0.011545,0.15057,0.95846,GOBP_EYE_PHOTORECEPTOR_CELL_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_PHOSPHATI...1,SET,5,-0.71083,-0.01173,0.41008,0.95848,GOBP_REGULATION_OF_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS,0.99999
GSE5542_UNTREATED_VS_IFNA_AN...2,SET,179,-0.10699,-0.010514,0.061725,0.95848,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.99999
HP_TRUNCAL_OBESITY,SET,71,-0.17407,-0.010804,0.1004,0.95851,HP_TRUNCAL_OBESITY,0.99999
HP_BONE_PAIN,SET,82,-0.17227,-0.011488,0.099359,0.95852,HP_BONE_PAIN,0.99999
HP_IMPAIRED_RENAL_CONCENTRAT...,SET,6,-0.58864,-0.01064,0.33941,0.95856,HP_IMPAIRED_RENAL_CONCENTRATING_ABILITY,0.99999
WP_KININKALLIKREIN_PATHWAY,SET,7,-0.67448,-0.013168,0.38888,0.95857,WP_KININKALLIKREIN_PATHWAY,0.99999
HP_COLOR_VISION_DEFECT,SET,133,-0.1309,-0.011101,0.075464,0.95859,HP_COLOR_VISION_DEFECT,0.99999
MIR4507,SET,34,-0.23479,-0.010095,0.13531,0.95864,MIR4507,0.99999
GOBP_HIPPO_SIGNALING,SET,53,-0.22237,-0.011931,0.12814,0.95865,GOBP_HIPPO_SIGNALING,0.99999
GOBP_REGULATION_OF_SPROUTING...,SET,40,-0.24555,-0.011449,0.14149,0.95866,GOBP_REGULATION_OF_SPROUTING_ANGIOGENESIS,0.99999
MIR7109_5P,SET,71,-0.16551,-0.010273,0.095349,0.95869,MIR7109_5P,0.99999
HP_LARGE_FORAMEN_MAGNUM,SET,5,-0.64785,-0.01069,0.37322,0.95869,HP_LARGE_FORAMEN_MAGNUM,0.99999
REACTOME_NOREPINEPHRINE_NEUR...,SET,16,-0.40147,-0.011847,0.23127,0.9587,REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE,0.99999
HP_ABNORMAL_CIRCULATING_INTE...2,SET,8,-0.58435,-0.012196,0.33652,0.95875,HP_ABNORMAL_CIRCULATING_INTERLEUKIN_10_CONCENTRATION,0.99999
NABA_MATRISOME_HGSOC_OMENTAL...,SET,57,-0.21088,-0.011732,0.12143,0.95877,NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS,0.99999
GOBP_MEIOTIC_SISTER_CHROMATI...,SET,12,-0.44597,-0.011398,0.25679,0.95878,GOBP_MEIOTIC_SISTER_CHROMATID_COHESION,0.99999
HP_EDEMA_OF_THE_DORSUM_OF_HA...,SET,14,-0.39235,-0.010831,0.22587,0.9588,HP_EDEMA_OF_THE_DORSUM_OF_HANDS,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...9,SET,15,-0.38428,-0.01098,0.22119,0.95883,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY,0.99999
WP_HIPPO_SIGNALING_REGULATION,SET,98,-0.16101,-0.011733,0.092675,0.95883,WP_HIPPO_SIGNALING_REGULATION,0.99999
REACTOME_REGULATION_OF_IFNG_...,SET,13,-0.41441,-0.011024,0.23848,0.95886,REACTOME_REGULATION_OF_IFNG_SIGNALING,0.99999
KLF7_TARGET_GENES,SET,735,-0.055766,-0.010933,0.03209,0.95887,KLF7_TARGET_GENES,0.99999
REACTOME_SELENOAMINO_ACID_ME...,SET,99,-0.14578,-0.010676,0.083879,0.95888,REACTOME_SELENOAMINO_ACID_METABOLISM,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...16,SET,134,-0.12616,-0.010739,0.072583,0.9589,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GSE41867_DAY8_VS_DAY15_LCMV_...3,SET,178,-0.10358,-0.01015,0.059566,0.95897,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...26,SET,9,-0.5695,-0.012606,0.32745,0.95899,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_OXIDATION_OF_A_PAIR_OF_DONORS_RESULTING_IN_THE_REDUCTION_OF_MOLECULAR_OXYGEN_TO_TWO_MOLECULES_OF_WATER,0.99999
BIOCARTA_MELANOCYTE_PATHWAY,SET,7,-0.67125,-0.013105,0.38593,0.959,BIOCARTA_MELANOCYTE_PATHWAY,0.99999
GOBP_ADHERENS_JUNCTION_MAINT...,SET,6,-0.67505,-0.012202,0.38811,0.959,GOBP_ADHERENS_JUNCTION_MAINTENANCE,0.99999
GOMF_NUCLEOBASE_TRANSMEMBRAN...,SET,10,-0.47195,-0.011012,0.27135,0.959,GOMF_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_ABNORMAL_5TH_FINGER_PHALA...,SET,54,-0.20267,-0.010976,0.11653,0.959,HP_ABNORMAL_5TH_FINGER_PHALANX_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...26,SET,19,-0.33876,-0.010893,0.19475,0.95902,GOBP_POSITIVE_REGULATION_OF_AMYLOID_BETA_FORMATION,0.99999
GOBP_REGULATION_OF_RESPONSE_...7,SET,29,-0.28878,-0.011469,0.16598,0.95905,GOBP_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS,0.99999
REACTOME_DEFECTS_IN_VITAMIN_...,SET,20,-0.32058,-0.010576,0.18404,0.95923,REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM,0.99999
HP_CEREBRAL_VISUAL_IMPAIRMENT,SET,140,-0.1213,-0.010552,0.06963,0.95924,HP_CEREBRAL_VISUAL_IMPAIRMENT,0.99999
WP_LNCRNAMEDIATED_MECHANISMS...,SET,6,-0.60214,-0.010884,0.34564,0.95925,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,0.99999
GOCC_MICROFIBRIL,SET,11,-0.4444,-0.010875,0.25505,0.95927,GOCC_MICROFIBRIL,0.99999
GSE37605_FOXP3_FUSION_GFP_VS...1,SET,157,-0.12163,-0.0112,0.069774,0.95934,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN,0.99999
GOBP_MACROPHAGE_ACTIVATION_I...,SET,19,-0.36429,-0.011713,0.20888,0.95941,GOBP_MACROPHAGE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
GAVISH_3CA_METAPROGRAM_CD4_T...8,SET,49,-0.21052,-0.010862,0.12068,0.95945,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_STRESS_HSP,0.99999
GSE41867_DAY8_VS_DAY15_LCMV_...4,SET,182,-0.1087,-0.01077,0.062309,0.95946,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.99999
WP_ETHER_LIPID_BIOSYNTHESIS,SET,19,-0.34014,-0.010937,0.19492,0.9595,WP_ETHER_LIPID_BIOSYNTHESIS,0.99999
GOBP_ESTABLISHMENT_OF_SKIN_B...,SET,33,-0.27864,-0.011803,0.15964,0.95953,GOBP_ESTABLISHMENT_OF_SKIN_BARRIER,0.99999
GOBP_HYDROCARBON_METABOLIC_P...,SET,7,-0.57644,-0.011254,0.33027,0.95953,GOBP_HYDROCARBON_METABOLIC_PROCESS,0.99999
GOBP_NUCLEOSIDE_MONOPHOSPHAT...1,SET,36,-0.24272,-0.010738,0.13898,0.95963,GOBP_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GSE12507_PDC_CELL_LINE_VS_IM...1,SET,119,-0.14178,-0.011378,0.081178,0.95963,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN,0.99999
HP_GENERALIZED_LIMB_MUSCLE_A...,SET,18,-0.3265,-0.010219,0.18693,0.95964,HP_GENERALIZED_LIMB_MUSCLE_ATROPHY,0.99999
LAMB_CCND1_TARGETS,SET,18,-0.37052,-0.011597,0.21206,0.9597,LAMB_CCND1_TARGETS,0.99999
GOBP_PRONEPHROS_DEVELOPMENT,SET,9,-0.50161,-0.011104,0.28707,0.9597,GOBP_PRONEPHROS_DEVELOPMENT,0.99999
HP_ABNORMAL_PROPORTION_OF_DO...,SET,6,-0.67043,-0.012118,0.38334,0.95984,HP_ABNORMAL_PROPORTION_OF_DOUBLE_NEGATIVE_ALPHA_BETA_REGULATORY_T_CELL,0.99999
HP_NEOPLASM_OF_THE_STOMACH,SET,85,-0.15933,-0.010817,0.091102,0.95984,HP_NEOPLASM_OF_THE_STOMACH,0.99999
GOBP_FAS_SIGNALING_PATHWAY,SET,6,-0.57868,-0.01046,0.33083,0.95986,GOBP_FAS_SIGNALING_PATHWAY,0.99999
CAFFAREL_RESPONSE_TO_THC_24H...3,SET,44,-0.21352,-0.010441,0.12204,0.9599,CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,0.99999
GOMF_MICROTUBULE_MINUS_END_B...,SET,12,-0.40344,-0.010311,0.23059,0.9599,GOMF_MICROTUBULE_MINUS_END_BINDING,0.99999
GSE43863_TH1_VS_LY6C_INT_CXC...2,SET,179,-0.10703,-0.010517,0.061176,0.9599,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,0.99999
HP_CONSTIPATION,SET,388,-0.078177,-0.011245,0.04468,0.95991,HP_CONSTIPATION,0.99999
CHEOK_RESPONSE_TO_MERCAPTOPU...4,SET,8,-0.60422,-0.012611,0.34524,0.95994,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP,0.99999
HP_COMPENSATORY_HEAD_POSTURE,SET,21,-0.33573,-0.011348,0.19182,0.95995,HP_COMPENSATORY_HEAD_POSTURE,0.99999
BENPORATH_SOX2_TARGETS,SET,663,-0.059779,-0.011153,0.034151,0.95997,BENPORATH_SOX2_TARGETS,0.99999
KEGG_MEDICUS_REFERENCE_NUCLE...2,SET,11,-0.48238,-0.011804,0.27555,0.95999,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,0.99999
PID_RAC1_REG_PATHWAY,SET,36,-0.25469,-0.011267,0.14548,0.95999,PID_RAC1_REG_PATHWAY,0.99999
REACTOME_GLUCOSE_METABOLISM,SET,77,-0.15767,-0.01019,0.090064,0.95999,REACTOME_GLUCOSE_METABOLISM,0.99999
GSE21670_IL6_VS_TGFB_AND_IL6...2,SET,173,-0.11572,-0.01118,0.066096,0.96,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,0.99999
BURTON_ADIPOGENESIS_3,SET,95,-0.14579,-0.01046,0.083263,0.96001,BURTON_ADIPOGENESIS_3,0.99999
GOBP_REGULATION_OF_PROTEIN_T...4,SET,39,-0.24777,-0.011408,0.14149,0.96003,GOBP_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.99999
GOBP_RESPONSE_TO_DIETARY_EXC...,SET,32,-0.28047,-0.0117,0.16011,0.96008,GOBP_RESPONSE_TO_DIETARY_EXCESS,0.99999
GSE29618_PRE_VS_DAY7_POST_TI...4,SET,179,-0.10981,-0.01079,0.062689,0.96008,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP,0.99999
HP_ABNORMAL_CIRCULATING_PROT...2,SET,58,-0.18739,-0.010516,0.10694,0.96012,HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_DERIVATIVE_CONCENTRATION,0.99999
MIR1266_3P,SET,48,-0.21685,-0.011074,0.12375,0.96013,MIR1266_3P,0.99999
GSE369_IFNG_KO_VS_WT_LIVER_DN,SET,170,-0.10991,-0.010527,0.062718,0.96014,GSE369_IFNG_KO_VS_WT_LIVER_DN,0.99999
HP_LYMPHOPROLIFERATIVE_DISOR...,SET,13,-0.43077,-0.011459,0.24573,0.96019,HP_LYMPHOPROLIFERATIVE_DISORDER,0.99999
MODULE_388,SET,16,-0.31831,-0.0093931,0.18157,0.9602,MODULE_388,0.99999
EGUCHI_CELL_CYCLE_RB1_TARGETS,SET,22,-0.29403,-0.010172,0.1677,0.96022,EGUCHI_CELL_CYCLE_RB1_TARGETS,0.99999
GSE7460_WT_VS_FOXP3_HET_ACT_...3,SET,176,-0.11303,-0.011014,0.064462,0.96022,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN,0.99999
GOBP_RESPONSE_TO_AMPHETAMINE,SET,34,-0.28409,-0.012215,0.16199,0.96025,GOBP_RESPONSE_TO_AMPHETAMINE,0.99999
GOBP_RESPONSE_TO_RAPAMYCIN,SET,4,-0.79564,-0.011743,0.45368,0.96026,GOBP_RESPONSE_TO_RAPAMYCIN,0.99999
REACTOME_COPI_INDEPENDENT_GO...,SET,50,-0.20704,-0.01079,0.11802,0.9603,REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,0.99999
REACTOME_RHO_GTPASES_ACTIVAT...2,SET,129,-0.12844,-0.010729,0.073213,0.9603,REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,0.99999
WP_OREXIN_RECEPTOR_PATHWAY,SET,189,-0.12179,-0.012294,0.06941,0.96033,WP_OREXIN_RECEPTOR_PATHWAY,0.99999
GOMF_BIOTIN_BINDING,SET,5,-0.71494,-0.011797,0.40742,0.96034,GOMF_BIOTIN_BINDING,0.99999
GSE7509_DC_VS_MONOCYTE_WITH_...1,SET,185,-0.11215,-0.011201,0.063879,0.96042,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN,0.99999
GSE36476_CTRL_VS_TSST_ACT_72...2,SET,174,-0.11539,-0.011181,0.065712,0.96045,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP,0.99999
GSE19888_ADENOSINE_A3R_INH_P...2,SET,170,-0.11703,-0.01121,0.066642,0.96046,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP,0.99999
REACTOME_SIGNALING_BY_FGFR4,SET,39,-0.24093,-0.011093,0.13716,0.96049,REACTOME_SIGNALING_BY_FGFR4,0.99999
SUZUKI_CTCFL_TARGETS_UP,SET,11,-0.46188,-0.011303,0.26293,0.96051,SUZUKI_CTCFL_TARGETS_UP,0.99999
WP_BIOSYNTHESIS_AND_REGENERA...,SET,12,-0.4153,-0.010614,0.2364,0.96051,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,0.99999
KEGG_MEDICUS_VARIANT_BCL2_OV...,SET,7,-0.55594,-0.010854,0.31644,0.96052,KEGG_MEDICUS_VARIANT_BCL2_OVEREXPRESSION_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.99999
HP_PONTOCEREBELLAR_ATROPHY,SET,8,-0.4665,-0.0097362,0.26552,0.96052,HP_PONTOCEREBELLAR_ATROPHY,0.99999
chr12q15,SET,23,-0.58467,-0.020682,0.33264,0.96059,chr12q15,0.99999
HP_COMPLETE_OR_NEAR_COMPLETE...2,SET,5,-0.59885,-0.0098816,0.34067,0.96061,HP_COMPLETE_OR_NEAR_COMPLETE_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_UNCONJUGATED_PNEUMOCOCCUS_VACCINE,0.99999
REACTOME_APOPTOTIC_FACTOR_ME...,SET,17,-0.3697,-0.011245,0.21026,0.96064,REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE,0.99999
BUSSLINGER_ESOPHAGEAL_QUIESC...,SET,70,-0.18787,-0.011579,0.10685,0.96064,BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS,0.99999
ABRAHAM_ALPC_VS_MULTIPLE_MYE...2,SET,24,-0.3201,-0.011566,0.18203,0.96066,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,0.99999
GRADE_COLON_VS_RECTAL_CANCER...1,SET,46,-0.21844,-0.010921,0.12418,0.96071,GRADE_COLON_VS_RECTAL_CANCER_DN,0.99999
GSE20715_0H_VS_24H_OZONE_LUN...1,SET,189,-0.11074,-0.011178,0.062952,0.96071,GSE20715_0H_VS_24H_OZONE_LUNG_DN,0.99999
REACTOME_REGULATION_OF_BACH1...,SET,10,-0.49202,-0.01148,0.27965,0.96073,REACTOME_REGULATION_OF_BACH1_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_P300_...,SET,15,-0.34436,-0.0098395,0.1957,0.96076,KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S,0.99999
ROSS_AML_WITH_MLL_FUSIONS,SET,68,-0.18225,-0.011071,0.10355,0.96079,ROSS_AML_WITH_MLL_FUSIONS,0.99999
GOBP_VISUAL_BEHAVIOR,SET,53,-0.21785,-0.011689,0.12375,0.96083,GOBP_VISUAL_BEHAVIOR,0.99999
REACTOME_TRANSCRIPTIONAL_REG...6,SET,91,-0.1477,-0.010373,0.08389,0.96084,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,0.99999
REACTOME_HDL_CLEARANCE,SET,5,-0.71642,-0.011822,0.40672,0.96091,REACTOME_HDL_CLEARANCE,0.99999
REACTOME_REGULATION_OF_RUNX2...,SET,69,-0.16654,-0.010191,0.09455,0.96091,REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,0.99999
GOBP_REGULATION_OF_INWARD_RE...,SET,4,-0.85963,-0.012688,0.48803,0.96091,GOBP_REGULATION_OF_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.99999
HP_ABNORMAL_TRABECULAR_BONE_...,SET,28,-0.28138,-0.010981,0.15974,0.96091,HP_ABNORMAL_TRABECULAR_BONE_MORPHOLOGY,0.99999
SIG_INSULIN_RECEPTOR_PATHWAY...,SET,48,-0.22469,-0.011474,0.12753,0.96095,SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,0.99999
WP_BDNFTRKB_SIGNALING,SET,33,-0.2726,-0.011547,0.15471,0.96096,WP_BDNFTRKB_SIGNALING,0.99999
GSE14308_TH1_VS_NATURAL_TREG...2,SET,176,-0.10975,-0.010695,0.06227,0.961,GSE14308_TH1_VS_NATURAL_TREG_UP,0.99999
GOBP_DEDIFFERENTIATION,SET,8,-0.63641,-0.013282,0.36089,0.96108,GOBP_DEDIFFERENTIATION,0.99999
GSE25087_TREG_VS_TCONV_ADULT...1,SET,164,-0.11802,-0.011105,0.066925,0.96108,GSE25087_TREG_VS_TCONV_ADULT_DN,0.99999
GSE8921_UNSTIM_0H_VS_TLR1_2_...6,SET,174,-0.11098,-0.010753,0.06293,0.96108,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP,0.99999
GSE5542_UNTREATED_VS_IFNA_TR...2,SET,186,-0.11225,-0.011241,0.063636,0.96112,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,0.99999
MIR1247_5P,SET,4,-0.80363,-0.011861,0.45557,0.96113,MIR1247_5P,0.99999
GOMF_EPHRIN_RECEPTOR_BINDING,SET,26,-0.30625,-0.011517,0.17361,0.96113,GOMF_EPHRIN_RECEPTOR_BINDING,0.99999
GOMF_LYSINE_N_METHYLTRANSFER...,SET,49,-0.21334,-0.011007,0.12092,0.96116,GOMF_LYSINE_N_METHYLTRANSFERASE_ACTIVITY,0.99999
HU_ANGIOGENESIS_DN,SET,32,-0.25433,-0.010609,0.14414,0.96117,HU_ANGIOGENESIS_DN,0.99999
MIR8081,SET,50,-0.20805,-0.010843,0.11791,0.96117,MIR8081,0.99999
SATO_SILENCED_BY_DEACETYLATI...,SET,36,-0.27481,-0.012158,0.15572,0.96119,SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,0.99999
JAERVINEN_AMPLIFIED_IN_LARYN...,SET,39,-0.23823,-0.010969,0.13492,0.96127,JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER,0.99999
MODULE_354,SET,17,-0.41476,-0.012615,0.23488,0.96128,MODULE_354,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...6,SET,15,-0.37288,-0.010654,0.21115,0.96129,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_CARPAL_BONES,0.99999
GOBP_REGULATION_OF_COPII_VES...,SET,5,-0.54466,-0.0089875,0.30839,0.96131,GOBP_REGULATION_OF_COPII_VESICLE_COATING,0.99999
REACTOME_RUNX1_REGULATES_EST...,SET,6,-0.6351,-0.01148,0.35956,0.96132,REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION,0.99999
GSE15930_STIM_VS_STIM_AND_IL...1,SET,174,-0.11666,-0.011303,0.066045,0.96132,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_DN,0.99999
HP_ATYPICAL_NEVI_IN_NON_SUN_...,SET,5,-0.63543,-0.010485,0.35973,0.96133,HP_ATYPICAL_NEVI_IN_NON_SUN_EXPOSED_AREAS,0.99999
GSE15659_CD45RA_NEG_CD4_TCEL...5,SET,172,-0.11428,-0.01101,0.064689,0.96134,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN,0.99999
VILIMAS_NOTCH1_TARGETS_DN,SET,24,-0.34564,-0.012489,0.19564,0.96135,VILIMAS_NOTCH1_TARGETS_DN,0.99999
REACTOME_COBALAMIN_CBL_VITAM...,SET,20,-0.34149,-0.011265,0.19321,0.96141,REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM,0.99999
TERAMOTO_OPN_TARGETS_CLUSTER...7,SET,8,-0.5427,-0.011327,0.30702,0.96143,TERAMOTO_OPN_TARGETS_CLUSTER_8,0.99999
LAKE_ADULT_KIDNEY_C7_PROXIMA...,SET,129,-0.13933,-0.011639,0.078806,0.96146,LAKE_ADULT_KIDNEY_C7_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S3,0.99999
REACTOME_E2F_MEDIATED_REGULA...,SET,20,-0.28703,-0.0094687,0.16233,0.96147,REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION,0.99999
GOMF_TRANSITION_METAL_ION_TR...,SET,41,-0.21517,-0.010157,0.1217,0.96147,GOMF_TRANSITION_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
ZHAN_MULTIPLE_MYELOMA_SUBGRO...,SET,30,-0.2391,-0.0096575,0.13521,0.96149,ZHAN_MULTIPLE_MYELOMA_SUBGROUPS,0.99999
KEGG_MEDICUS_REFERENCE_CXCR4...5,SET,26,-0.311,-0.011696,0.17587,0.96149,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,0.99999
MIR139_5P,SET,145,-0.12962,-0.011474,0.0733,0.96149,MIR139_5P,0.99999
FAN_OVARY_CL17_PUTATIVE_APOP...,SET,209,-0.10229,-0.010852,0.057847,0.96149,FAN_OVARY_CL17_PUTATIVE_APOPTOTIC_SMOOTH_MUSCLE_CELL,0.99999
ASTON_MAJOR_DEPRESSIVE_DISOR...2,SET,42,-0.24568,-0.011738,0.13892,0.9615,ASTON_MAJOR_DEPRESSIVE_DISORDER_UP,0.99999
TRAVAGLINI_LUNG_CAPILLARY_IN...2,SET,353,-0.08054,-0.01106,0.045537,0.96152,TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_2_CELL,0.99999
MIR4677_5P,SET,233,-0.1017,-0.011385,0.057496,0.96153,MIR4677_5P,0.99999
BPTF_TARGET_GENES,SET,885,-0.052814,-0.011313,0.029849,0.96157,BPTF_TARGET_GENES,0.99999
PID_NCADHERIN_PATHWAY,SET,33,-0.26848,-0.011373,0.15174,0.96158,PID_NCADHERIN_PATHWAY,0.99999
GOBP_REGULATION_OF_VASOCONST...,SET,63,-0.21256,-0.012431,0.12013,0.96158,GOBP_REGULATION_OF_VASOCONSTRICTION,0.99999
GSE28449_WT_VS_LRF_KO_GERMIN...2,SET,174,-0.11966,-0.011594,0.067608,0.96162,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_UP,0.99999
MIR759,SET,65,-0.20968,-0.012455,0.11846,0.96163,MIR759,0.99999
GOBP_PROTEIN_TARGETING_TO_PE...,SET,9,-0.45887,-0.010158,0.25918,0.96166,GOBP_PROTEIN_TARGETING_TO_PEROXISOME,0.99999
GOBP_SENSORY_PERCEPTION_OF_U...,SET,7,-0.5222,-0.010195,0.29493,0.96167,GOBP_SENSORY_PERCEPTION_OF_UMAMI_TASTE,0.99999
MIR513A_5P,SET,346,-0.084734,-0.011523,0.047845,0.96171,MIR513A_5P,0.99999
GSE360_CTRL_VS_B_MALAYI_HIGH...1,SET,177,-0.11396,-0.011136,0.064349,0.96171,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.99999
MODULE_329,SET,50,-0.2173,-0.011325,0.12269,0.96172,MODULE_329,0.99999
GOBP_PROTEIN_K27_LINKED_UBIQ...,SET,11,-0.44844,-0.010974,0.2532,0.96172,GOBP_PROTEIN_K27_LINKED_UBIQUITINATION,0.99999
HP_ATLANTOAXIAL_ABNORMALITY,SET,12,-0.41569,-0.010624,0.23469,0.96173,HP_ATLANTOAXIAL_ABNORMALITY,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...89,SET,9,-0.43895,-0.0097168,0.24776,0.96177,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_TP53_TO_TRANSCRIPTION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...669,SET,9,-0.43622,-0.0096563,0.24621,0.96177,GOBP_NEGATIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.99999
PALOMERO_GSI_SENSITIVITY_DN,SET,3,-0.93112,-0.011902,0.52541,0.96181,PALOMERO_GSI_SENSITIVITY_DN,0.99999
MIR6893_5P,SET,163,-0.11937,-0.011198,0.067355,0.96182,MIR6893_5P,0.99999
GOBP_UDP_N_ACETYLGLUCOSAMINE...2,SET,14,-0.41296,-0.0114,0.23301,0.96182,GOBP_UDP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS,0.99999
HP_ABNORMALITY_OF_OCULAR_ABD...,SET,11,-0.4678,-0.011448,0.26394,0.96182,HP_ABNORMALITY_OF_OCULAR_ABDUCTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...239,SET,6,-0.62123,-0.011229,0.3505,0.96183,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DEVELOPMENT,0.99999
GOMF_TUMOR_NECROSIS_FACTOR_R...3,SET,46,-0.22644,-0.011321,0.12773,0.96185,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_BINDING,0.99999
GSE24671_CTRL_VS_BAKIMULC_IN...1,SET,151,-0.12975,-0.011719,0.073199,0.96185,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN,0.99999
GSE4984_GALECTIN1_VS_LPS_STI...2,SET,144,-0.11981,-0.010569,0.067585,0.96185,GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP,0.99999
GSE24726_WT_VS_E2_2_KO_PDC_UP,SET,177,-0.11425,-0.011164,0.06444,0.96187,GSE24726_WT_VS_E2_2_KO_PDC_UP,0.99999
GOCC_PLATELET_DENSE_GRANULE_...2,SET,5,-0.75706,-0.012492,0.42697,0.96188,GOCC_PLATELET_DENSE_GRANULE_MEMBRANE,0.99999
GSE30083_SP3_VS_SP4_THYMOCYT...2,SET,179,-0.1189,-0.011683,0.067046,0.96191,GSE30083_SP3_VS_SP4_THYMOCYTE_UP,0.99999
GOBP_NUCLEOSOME_ORGANIZATION,SET,64,-0.17421,-0.010268,0.098214,0.96194,GOBP_NUCLEOSOME_ORGANIZATION,0.99999
GOBP_RESPONSE_TO_GROWTH_HORM...,SET,35,-0.27499,-0.011995,0.15503,0.96194,GOBP_RESPONSE_TO_GROWTH_HORMONE,0.99999
GSE15930_STIM_VS_STIM_AND_IF...4,SET,180,-0.112,-0.011036,0.063139,0.96195,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP,0.99999
GOMF_RNA_EXONUCLEASE_ACTIVITY,SET,43,-0.21234,-0.010264,0.11967,0.96198,GOMF_RNA_EXONUCLEASE_ACTIVITY,0.99999
chr6q27,SET,25,-0.44199,-0.0163,0.24908,0.962,chr6q27,0.99999
GOBP_MAMMARY_GLAND_ALVEOLUS_...,SET,18,-0.38997,-0.012205,0.2197,0.96204,GOBP_MAMMARY_GLAND_ALVEOLUS_DEVELOPMENT,0.99999
HP_ABNORMAL_CERVICAL_SPINE_M...,SET,19,-0.33844,-0.010882,0.19066,0.96205,HP_ABNORMAL_CERVICAL_SPINE_MORPHOLOGY,0.99999
HP_ELEVATED_CIRCULATING_ASPA...,SET,67,-0.18391,-0.01109,0.10358,0.96209,HP_ELEVATED_CIRCULATING_ASPARTATE_AMINOTRANSFERASE_CONCENTRATION,0.99999
MIR6871_3P,SET,116,-0.14708,-0.011654,0.082827,0.9621,MIR6871_3P,0.99999
ZBED4_TARGET_GENES,SET,248,-0.094678,-0.01093,0.053316,0.96211,ZBED4_TARGET_GENES,0.99999
GSE17301_CTRL_VS_48H_IFNA2_S...1,SET,163,-0.11701,-0.010977,0.06589,0.96211,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN,0.99999
MIR5190,SET,121,-0.14557,-0.011779,0.081953,0.96214,MIR5190,0.99999
HP_CENTRAL_HETEROCHROMIA,SET,6,-0.70318,-0.01271,0.39579,0.96218,HP_CENTRAL_HETEROCHROMIA,0.99999
GOBP_COBALAMIN_METABOLIC_PRO...,SET,9,-0.51376,-0.011373,0.2891,0.96221,GOBP_COBALAMIN_METABOLIC_PROCESS,0.99999
PETRETTO_LEFT_VENTRICLE_MASS...2,SET,5,-0.74208,-0.012245,0.41745,0.96226,PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP,0.99999
STAT4_01,SET,250,-0.09871,-0.01144,0.05553,0.96226,STAT4_01,0.99999
GOMF_DNA_TRANSLOCASE_ACTIVITY,SET,2,-0.7391,-0.0077141,0.41578,0.96226,GOMF_DNA_TRANSLOCASE_ACTIVITY,0.99999
WP_ACETAMINOPHEN_IN_ANALGESI...,SET,9,-0.56823,-0.012578,0.31964,0.96227,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...21,SET,34,-0.24709,-0.010624,0.13895,0.96231,GAVISH_3CA_METAPROGRAM_EPITHELIAL_RESPIRATION,0.99999
WP_DUAL_HIJACK_MODEL_OF_VIF_...,SET,5,-0.68702,-0.011337,0.38629,0.96233,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,0.99999
HP_ABSENT_SKIN_PIGMENTATION,SET,5,-0.77506,-0.012789,0.43571,0.96236,HP_ABSENT_SKIN_PIGMENTATION,0.99999
KEGG_MEDICUS_REFERENCE_MDM2_...2,SET,11,-0.42175,-0.010321,0.23706,0.96238,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00536,0.99999
HP_MITOCHONDRIAL_MYOPATHY,SET,37,-0.22786,-0.010219,0.12797,0.9625,HP_MITOCHONDRIAL_MYOPATHY,0.99999
KEGG_MEDICUS_REFERENCE_CROSS...,SET,15,-0.41069,-0.011735,0.2306,0.96253,KEGG_MEDICUS_REFERENCE_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,0.99999
GOBP_CELL_CELL_ADHESION_INVO...,SET,11,-0.46195,-0.011305,0.25939,0.96253,GOBP_CELL_CELL_ADHESION_INVOLVED_IN_GASTRULATION,0.99999
GSE21360_PRIMARY_VS_SECONDAR...1,SET,179,-0.11116,-0.010922,0.062404,0.96255,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_DN,0.99999
GOBP_AMYLOID_BETA_METABOLIC_...,SET,51,-0.21273,-0.011197,0.11942,0.96256,GOBP_AMYLOID_BETA_METABOLIC_PROCESS,0.99999
GOCC_PREFOLDIN_COMPLEX,SET,6,-0.5039,-0.0091082,0.28288,0.96256,GOCC_PREFOLDIN_COMPLEX,0.99999
REACTOME_REGULATION_OF_MITF_...2,SET,17,-0.34838,-0.010597,0.19556,0.96257,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION,0.99999
GSE369_SOCS3_KO_VS_WT_LIVER_...2,SET,182,-0.11587,-0.01148,0.065027,0.9626,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN,0.99999
GSE22886_NAIVE_BCELL_VS_BM_P...2,SET,178,-0.11077,-0.010855,0.062161,0.96262,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP,0.99999
MINGUEZ_LIVER_CANCER_VASCULA...1,SET,21,-0.35454,-0.011984,0.19886,0.96269,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,0.99999
MIR26B_5P,SET,455,-0.073459,-0.011421,0.041192,0.96272,MIR26B_5P,0.99999
WHITFIELD_CELL_CYCLE_G2,SET,152,-0.11861,-0.010748,0.066494,0.96276,WHITFIELD_CELL_CYCLE_G2,0.99999
GNF2_MKI67,SET,27,-0.3027,-0.0116,0.16969,0.96276,GNF2_MKI67,0.99999
WP_VITAMIN_B12_METABOLISM,SET,48,-0.22986,-0.011738,0.12885,0.96278,WP_VITAMIN_B12_METABOLISM,0.99999
HP_INCREASED_SULFUR_AMINO_AC...,SET,15,-0.42686,-0.012197,0.23922,0.96281,HP_INCREASED_SULFUR_AMINO_ACID_LEVEL_IN_URINE,0.99999
REACTOME_EUKARYOTIC_TRANSLAT...2,SET,108,-0.14111,-0.010792,0.07908,0.96282,REACTOME_EUKARYOTIC_TRANSLATION_INITIATION,0.99999
GOMF_SIGNAL_RECOGNITION_PART...,SET,7,-0.48195,-0.0094092,0.26999,0.96286,GOMF_SIGNAL_RECOGNITION_PARTICLE_BINDING,0.99999
KEGG_MEDICUS_REFERENCE_WNT_S...1,SET,18,-0.40252,-0.012598,0.22548,0.96287,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO,0.99999
GOMF_VOLTAGE_GATED_CALCIUM_C...1,SET,41,-0.25822,-0.012189,0.14462,0.9629,GOMF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.99999
chr7q34,SET,50,-0.3576,-0.018637,0.20023,0.96294,chr7q34,0.99999
WP_CELL_CYCLE,SET,116,-0.13415,-0.01063,0.075102,0.96296,WP_CELL_CYCLE,0.99999
HP_FUNCTIONAL_ABNORMALITY_OF...3,SET,919,-0.050974,-0.011116,0.028537,0.96296,HP_FUNCTIONAL_ABNORMALITY_OF_THE_INNER_EAR,0.99999
HP_ACUTE_KIDNEY_INJURY,SET,34,-0.26042,-0.011197,0.14577,0.96298,HP_ACUTE_KIDNEY_INJURY,0.99999
GSE11961_FOLLICULAR_BCELL_VS...3,SET,182,-0.11192,-0.011088,0.062646,0.96298,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...15,SET,10,-0.47979,-0.011195,0.26852,0.96301,GOBP_POSITIVE_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.99999
GOMF_UDP_GALACTOSE_BETA_N_AC...,SET,12,-0.48819,-0.012477,0.2732,0.96301,GOMF_UDP_GALACTOSE_BETA_N_ACETYLGLUCOSAMINE_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY,0.99999
HUMMEL_BURKITTS_LYMPHOMA_UP,SET,38,-0.25862,-0.011754,0.14472,0.96302,HUMMEL_BURKITTS_LYMPHOMA_UP,0.99999
WP_MITOCHONDRIAL_FATTY_ACID_...2,SET,12,-0.47583,-0.012161,0.26628,0.96302,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,0.99999
WP_OXIDATIVE_DAMAGE_RESPONSE,SET,36,-0.25798,-0.011413,0.14436,0.96302,WP_OXIDATIVE_DAMAGE_RESPONSE,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...4,SET,86,-0.15129,-0.010331,0.084649,0.96304,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,0.99999
GOBP_POSITIVE_REGULATION_OF_...626,SET,10,-0.56384,-0.013156,0.31547,0.96304,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...16,SET,69,-0.17833,-0.010912,0.099775,0.96305,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,0.99999
GOBP_NEGATIVE_REGULATION_OF_...467,SET,26,-0.31442,-0.011824,0.1759,0.96306,GOBP_NEGATIVE_REGULATION_OF_ORGAN_GROWTH,0.99999
REACTOME_THYROXINE_BIOSYNTHE...,SET,10,-0.54026,-0.012606,0.30223,0.96307,REACTOME_THYROXINE_BIOSYNTHESIS,0.99999
GOBP_RRNA_3_END_PROCESSING,SET,10,-0.41968,-0.0097923,0.23477,0.96307,GOBP_RRNA_3_END_PROCESSING,0.99999
REACTOME_SPRY_REGULATION_OF_...,SET,15,-0.3923,-0.011209,0.21944,0.96308,REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING,0.99999
GOBP_PHOSPHATIDYLETHANOLAMIN...3,SET,23,-0.32779,-0.011595,0.18336,0.96308,GOBP_PHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS,0.99999
HP_HEMATOLOGICAL_NEOPLASM,SET,277,-0.091334,-0.011134,0.05107,0.96314,HP_HEMATOLOGICAL_NEOPLASM,0.99999
GSE15735_2H_VS_12H_HDAC_INHI...1,SET,189,-0.11433,-0.011541,0.063925,0.96315,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN,0.99999
HP_NAUSEA,SET,91,-0.15968,-0.011214,0.089258,0.96318,HP_NAUSEA,0.99999
FOURATI_BLOOD_TWINRIX_AGE_25...2,SET,407,-0.077716,-0.011443,0.043437,0.9632,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP,0.99999
ATF4_Q2,SET,226,-0.10101,-0.011139,0.056453,0.96321,ATF4_Q2,0.99999
GCM_PFN1,SET,44,-0.21076,-0.010306,0.11774,0.96327,GCM_PFN1,0.99999
REACTOME_SIGNALING_BY_FGFR1,SET,50,-0.2234,-0.011643,0.1247,0.96339,REACTOME_SIGNALING_BY_FGFR1,0.99999
REACTOME_SEMAPHORIN_INTERACT...,SET,61,-0.20086,-0.011559,0.1121,0.9634,REACTOME_SEMAPHORIN_INTERACTIONS,0.99999
WP_INVOLVEMENT_OF_SECRETASE_...,SET,16,-0.40959,-0.012087,0.22858,0.96342,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,0.99999
WP_3Q29_COPY_NUMBER_VARIATIO...,SET,57,-0.22225,-0.012365,0.12401,0.96344,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GOCC_PARANODAL_JUNCTION,SET,8,-0.50515,-0.010543,0.28186,0.96344,GOCC_PARANODAL_JUNCTION,0.99999
GSE2770_IL12_VS_TGFB_AND_IL1...4,SET,179,-0.11806,-0.011601,0.065868,0.96346,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.99999
MODULE_219,SET,21,-0.32613,-0.011024,0.18193,0.96347,MODULE_219,0.99999
HP_HYPOPLASTIC_ISCHIA,SET,16,-0.38504,-0.011362,0.2148,0.96347,HP_HYPOPLASTIC_ISCHIA,0.99999
BOGNI_TREATMENT_RELATED_MYEL...1,SET,31,-0.25812,-0.010598,0.14398,0.96348,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,0.99999
GOMF_RNA_NUCLEASE_ACTIVITY,SET,117,-0.13949,-0.0111,0.077785,0.96352,GOMF_RNA_NUCLEASE_ACTIVITY,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...5,SET,47,-0.24205,-0.012231,0.1349,0.96361,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_2,0.99999
GSE18281_SUBCAPSULAR_CORTICA...4,SET,187,-0.10425,-0.010468,0.058089,0.96364,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,0.99999
HP_ABNORMAL_LUNG_DEVELOPMENT,SET,208,-0.10657,-0.011279,0.059375,0.96365,HP_ABNORMAL_LUNG_DEVELOPMENT,0.99999
MODULE_36,SET,145,-0.12098,-0.01071,0.067398,0.96367,MODULE_36,0.99999
GOBP_HEPARAN_SULFATE_PROTEOG...3,SET,8,-0.57704,-0.012043,0.32141,0.96369,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_POLYSACCHARIDE_CHAIN_BIOSYNTHETIC_PROCESS,0.99999
GOBP_LOCOMOTION_INVOLVED_IN_...,SET,11,-0.46445,-0.011366,0.25869,0.9637,GOBP_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR,0.99999
GOBP_POSITIVE_REGULATION_OF_...60,SET,33,-0.28746,-0.012177,0.16008,0.96372,GOBP_POSITIVE_REGULATION_OF_BLOOD_CIRCULATION,0.99999
GSE18893_TCONV_VS_TREG_2H_TN...1,SET,174,-0.11528,-0.01117,0.064201,0.96372,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN,0.99999
MODULE_83,SET,281,-0.087101,-0.010693,0.048497,0.96374,MODULE_83,0.99999
GSE36095_WT_VS_HDAC9_KO_TREG...1,SET,109,-0.14864,-0.011419,0.082755,0.96375,GSE36095_WT_VS_HDAC9_KO_TREG_DN,0.99999
GOMF_NUCLEOSIDE_KINASE_ACTIV...,SET,9,-0.46561,-0.010307,0.25923,0.96376,GOMF_NUCLEOSIDE_KINASE_ACTIVITY,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...2,SET,42,-0.2521,-0.012045,0.14034,0.96377,GAVISH_3CA_METAPROGRAM_EPITHELIAL_ANDROGEN_PROSTATE,0.99999
GSE11961_PLASMA_CELL_DAY7_VS...4,SET,175,-0.11571,-0.011244,0.064416,0.96377,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.99999
GSE2770_UNTREATED_VS_IL4_TRE...4,SET,188,-0.11075,-0.01115,0.061651,0.96377,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.99999
STREICHER_LSM1_TARGETS_DN,SET,18,-0.36342,-0.011374,0.20228,0.96379,STREICHER_LSM1_TARGETS_DN,0.99999
HOEK_MONOCYTE_2011_2012_TIV_...6,SET,5,-0.6894,-0.011376,0.38339,0.96392,HOEK_MONOCYTE_2011_2012_TIV_ADULT_7DY_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...774,SET,17,-0.3648,-0.011096,0.20282,0.96396,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,0.99999
MIR6131,SET,89,-0.16041,-0.011142,0.089172,0.96397,MIR6131,0.99999
REACTOME_ALPHA_LINOLENIC_OME...,SET,12,-0.45813,-0.011709,0.25464,0.96399,REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM,0.99999
GOBP_HYALURONAN_METABOLIC_PR...,SET,32,-0.27218,-0.011354,0.15126,0.96402,GOBP_HYALURONAN_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_MICROVILL...1,SET,6,-0.71535,-0.01293,0.39751,0.96403,GOBP_REGULATION_OF_MICROVILLUS_ASSEMBLY,0.99999
HP_BLADDER_NEOPLASM,SET,33,-0.26398,-0.011182,0.14667,0.96405,HP_BLADDER_NEOPLASM,0.99999
GOBP_CD4_POSITIVE_ALPHA_BETA...3,SET,88,-0.1788,-0.01235,0.099334,0.96406,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_INTERLEUK...1,SET,9,-0.48682,-0.010776,0.27039,0.96409,GOBP_REGULATION_OF_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...510,SET,14,-0.42146,-0.011634,0.23393,0.96419,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_FUSION,0.99999
HP_BONE_MARROW_HYPERCELLULAR...,SET,28,-0.31968,-0.012475,0.17744,0.96419,HP_BONE_MARROW_HYPERCELLULARITY,0.99999
MIR331_3P,SET,59,-0.21263,-0.012035,0.11798,0.96424,MIR331_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...574,SET,7,-0.50188,-0.0097985,0.27848,0.96424,GOBP_NEGATIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_GLIAL_CEL...1,SET,12,-0.46447,-0.011871,0.25764,0.96428,GOBP_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS,0.99999
HP_LEFT_SUPERIOR_VENA_CAVA_D...,SET,3,-0.9403,-0.012019,0.52154,0.96429,HP_LEFT_SUPERIOR_VENA_CAVA_DRAINING_TO_CORONARY_SINUS,0.99999
ATATGCA_MIR448,SET,191,-0.12435,-0.012618,0.068954,0.96433,ATATGCA_MIR448,0.99999
GOBP_NEGATIVE_REGULATION_OF_...410,SET,11,-0.44449,-0.010877,0.24646,0.96434,GOBP_NEGATIVE_REGULATION_OF_MOTOR_NEURON_APOPTOTIC_PROCESS,0.99999
chr5q34,SET,12,-0.66804,-0.017074,0.37013,0.96444,chr5q34,0.99999
SPIRA_SMOKERS_LUNG_CANCER_DN,SET,14,-0.40649,-0.011221,0.22521,0.96445,SPIRA_SMOKERS_LUNG_CANCER_DN,0.99999
GOBP_OTIC_VESICLE_MORPHOGENE...,SET,10,-0.47625,-0.011112,0.26386,0.96445,GOBP_OTIC_VESICLE_MORPHOGENESIS,0.99999
HP_ANNULAR_PANCREAS,SET,25,-0.32387,-0.011944,0.17944,0.96445,HP_ANNULAR_PANCREAS,0.99999
REACTOME_METABOLISM_OF_AMINO...,SET,330,-0.082806,-0.011002,0.045866,0.96448,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,0.99999
GSE36009_WT_VS_NLRP10_KO_DC_...2,SET,180,-0.10898,-0.010738,0.06036,0.96449,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN,0.99999
AAAGGAT_MIR501,SET,111,-0.15007,-0.011634,0.083109,0.9645,AAAGGAT_MIR501,0.99999
MIR6503_3P,SET,28,-0.27612,-0.010776,0.1529,0.96453,MIR6503_3P,0.99999
ZHONG_PFC_C6_PLXNA4_POS_EXCI...,SET,6,-0.68501,-0.012382,0.3793,0.96453,ZHONG_PFC_C6_PLXNA4_POS_EXCITATORY_NEURON,0.99999
GSE40277_EOS_AND_LEF1_TRANSD...4,SET,179,-0.11485,-0.011286,0.063589,0.96455,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP,0.99999
HP_ADENOCARCINOMA_OF_THE_SMA...,SET,9,-0.50916,-0.011271,0.28186,0.96456,HP_ADENOCARCINOMA_OF_THE_SMALL_INTESTINE,0.99999
FREAC7_01,SET,173,-0.12423,-0.012003,0.06876,0.96459,FREAC7_01,0.99999
GCM_ATM,SET,23,-0.29994,-0.01061,0.16601,0.96459,GCM_ATM,0.99999
SIMBULAN_UV_RESPONSE_IMMORTA...,SET,31,-0.28581,-0.011735,0.15814,0.96464,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,0.99999
HP_ANTERIORLY_PLACED_ANUS,SET,56,-0.21102,-0.011637,0.11669,0.96471,HP_ANTERIORLY_PLACED_ANUS,0.99999
BLANCO_MELO_BRONCHIAL_EPITHE...4,SET,124,-0.14199,-0.01163,0.078512,0.96473,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...3,SET,43,-0.26194,-0.012663,0.14482,0.96474,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CYTOTOXIC,0.99999
GOBP_NEGATIVE_REGULATION_OF_...243,SET,8,-0.54611,-0.011398,0.30193,0.96474,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_MIGRATION,0.99999
MIR1306_5P,SET,45,-0.22389,-0.011071,0.12378,0.96475,MIR1306_5P,0.99999
GOBP_TERMINATION_OF_RNA_POLY...,SET,10,-0.51648,-0.012051,0.28541,0.96481,GOBP_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION,0.99999
GOBP_FRUCTOSE_1_6_BISPHOSPHA...,SET,9,-0.44725,-0.0099003,0.24709,0.96485,GOBP_FRUCTOSE_1_6_BISPHOSPHATE_METABOLIC_PROCESS,0.99999
GOBP_TRANSLATIONAL_TERMINATI...,SET,13,-0.43508,-0.011574,0.24035,0.96486,GOBP_TRANSLATIONAL_TERMINATION,0.99999
GSE32423_IL7_VS_IL7_IL4_MEMO...2,SET,188,-0.10979,-0.011053,0.060629,0.96491,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,0.99999
HP_ABSENT_OR_MINIMALLY_OSSIF...,SET,11,-0.43164,-0.010563,0.23817,0.96502,HP_ABSENT_OR_MINIMALLY_OSSIFIED_VERTEBRAL_BODIES,0.99999
GOCC_PROTON_TRANSPORTING_V_T...3,SET,12,-0.52853,-0.013508,0.29154,0.96507,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_V1_DOMAIN,0.99999
GOBP_REGULATION_OF_PHOSPHATI...2,SET,9,-0.57031,-0.012625,0.31456,0.96508,GOBP_REGULATION_OF_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS,0.99999
HP_ABNORMALITY_OF_VISUAL_EVO...,SET,63,-0.19567,-0.011443,0.10792,0.96508,HP_ABNORMALITY_OF_VISUAL_EVOKED_POTENTIALS,0.99999
SOBOLEV_PBMC_PANDEMRIX_AGE_1...8,SET,32,-0.30891,-0.012886,0.17037,0.96508,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_1DY_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...267,SET,55,-0.21562,-0.011784,0.11887,0.96514,GOBP_NEGATIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
ALONSO_METASTASIS_EMT_DN,SET,5,-0.85036,-0.014032,0.46867,0.96518,ALONSO_METASTASIS_EMT_DN,0.99999
GOBP_INTESTINAL_EPITHELIAL_C...2,SET,26,-0.31929,-0.012007,0.17597,0.96519,GOBP_INTESTINAL_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
DESCARTES_FETAL_PANCREAS_MES...,SET,63,-0.20544,-0.012014,0.11322,0.96519,DESCARTES_FETAL_PANCREAS_MESOTHELIAL_CELLS,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...3,SET,178,-0.11066,-0.010843,0.060974,0.96521,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN,0.99999
MIR1343_5P,SET,114,-0.14317,-0.011247,0.078867,0.96525,MIR1343_5P,0.99999
GOBP_LYMPH_NODE_DEVELOPMENT,SET,19,-0.34712,-0.011161,0.19115,0.9653,GOBP_LYMPH_NODE_DEVELOPMENT,0.99999
REACTOME_AGGREPHAGY,SET,38,-0.25368,-0.01153,0.13964,0.96535,REACTOME_AGGREPHAGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...449,SET,3,-0.98903,-0.012642,0.54443,0.96535,GOBP_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,0.99999
MIR939_5P,SET,114,-0.14397,-0.01131,0.079218,0.96542,MIR939_5P,0.99999
GOBP_REGULATION_OF_TUBE_SIZE,SET,139,-0.14375,-0.012461,0.079089,0.96543,GOBP_REGULATION_OF_TUBE_SIZE,0.99999
LI_WILMS_TUMOR_VS_FETAL_KIDN...2,SET,169,-0.12576,-0.01201,0.069183,0.96544,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,0.99999
MORF_MTA1,SET,93,-0.15243,-0.010822,0.083853,0.96544,MORF_MTA1,0.99999
GSE37416_0H_VS_6H_F_TULARENS...1,SET,182,-0.11475,-0.011369,0.06312,0.96546,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
HP_POINTED_CHIN,SET,118,-0.14693,-0.011742,0.080801,0.96549,HP_POINTED_CHIN,0.99999
MIR1910_5P,SET,76,-0.17665,-0.011343,0.097131,0.96551,MIR1910_5P,0.99999
GOBP_ORGAN_GROWTH,SET,151,-0.13486,-0.012181,0.074158,0.96551,GOBP_ORGAN_GROWTH,0.99999
MARTINEZ_RB1_TARGETS_DN,SET,496,-0.071523,-0.011596,0.039324,0.96552,MARTINEZ_RB1_TARGETS_DN,0.99999
GSE46143_CTRL_VS_LMP2A_TRANS...1,SET,181,-0.11482,-0.011345,0.063093,0.9656,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN,0.99999
REACTOME_RESPONSE_OF_EIF2AK4...,SET,91,-0.15932,-0.011189,0.087528,0.96563,REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,0.99999
MIR6831_3P,SET,55,-0.19855,-0.010851,0.10907,0.96564,MIR6831_3P,0.99999
CAIRO_PML_TARGETS_BOUND_BY_M...1,SET,12,-0.4678,-0.011956,0.25692,0.96567,CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,0.99999
HP_SINGLE_TRANSVERSE_PALMAR_...,SET,179,-0.11439,-0.011241,0.062827,0.96567,HP_SINGLE_TRANSVERSE_PALMAR_CREASE,0.99999
ZHENG_CORD_BLOOD_C3_MEGAKARY...,SET,89,-0.1612,-0.011197,0.088521,0.96569,ZHENG_CORD_BLOOD_C3_MEGAKARYOCYTE_ERYTHROID_PROGENITOR,0.99999
WP_SMALL_CELL_LUNG_CANCER,SET,93,-0.15693,-0.011141,0.08617,0.9657,WP_SMALL_CELL_LUNG_CANCER,0.99999
SHETH_LIVER_CANCER_VS_TXNIP_...1,SET,236,-0.10264,-0.011562,0.056355,0.96571,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,0.99999
KEGG_MEDICUS_REFERENCE_RAB7_...,SET,40,-0.24084,-0.01123,0.13224,0.96571,KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...8,SET,181,-0.12034,-0.01189,0.066067,0.96572,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP,0.99999
POS_HISTAMINE_RESPONSE_NETWO...,SET,27,-0.3103,-0.011891,0.17033,0.96575,POS_HISTAMINE_RESPONSE_NETWORK,0.99999
LY_AGING_MIDDLE_UP,SET,14,-0.48842,-0.013483,0.26806,0.96577,LY_AGING_MIDDLE_UP,0.99999
GOBP_REGULATION_OF_ATP_METAB...,SET,63,-0.19438,-0.011368,0.10666,0.96579,GOBP_REGULATION_OF_ATP_METABOLIC_PROCESS,0.99999
IVANOVA_HEMATOPOIESIS_MATURE...,SET,259,-0.097481,-0.011497,0.053479,0.96582,IVANOVA_HEMATOPOIESIS_MATURE_CELL,0.99999
GOBP_REGULATION_OF_GUANYLATE...,SET,6,-0.67825,-0.01226,0.37211,0.96582,GOBP_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY,0.99999
HP_SCHWANNOMA,SET,11,-0.4246,-0.01039,0.23289,0.96585,HP_SCHWANNOMA,0.99999
HP_PARKINSONISM_WITH_FAVORAB...,SET,22,-0.32499,-0.011244,0.17821,0.96589,HP_PARKINSONISM_WITH_FAVORABLE_RESPONSE_TO_DOPAMINERGIC_MEDICATION,0.99999
REACTOME_ACETYLCHOLINE_NEURO...,SET,16,-0.4386,-0.012943,0.24044,0.96593,REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE,0.99999
HP_ELEVATED_CIRCULATING_ACYL...,SET,17,-0.36013,-0.010954,0.19742,0.96593,HP_ELEVATED_CIRCULATING_ACYLCARNITINE_CONCENTRATION,0.99999
GSE3982_NEUTROPHIL_VS_NKCELL...1,SET,176,-0.11151,-0.010866,0.061128,0.96593,GSE3982_NEUTROPHIL_VS_NKCELL_DN,0.99999
GOBP_PROTEIN_TARGETING,SET,295,-0.088007,-0.011066,0.048236,0.96595,GOBP_PROTEIN_TARGETING,0.99999
GOBP_SYNAPTIC_VESICLE_LUMEN_...,SET,15,-0.42968,-0.012277,0.23549,0.96596,GOBP_SYNAPTIC_VESICLE_LUMEN_ACIDIFICATION,0.99999
JI_RESPONSE_TO_FSH_DN,SET,49,-0.21795,-0.011245,0.11944,0.96597,JI_RESPONSE_TO_FSH_DN,0.99999
GSE37532_TREG_VS_TCONV_PPARG...3,SET,172,-0.11541,-0.011119,0.06324,0.96599,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,0.99999
GOBP_GOLGI_LUMEN_ACIDIFICATI...,SET,9,-0.54587,-0.012083,0.29903,0.96602,GOBP_GOLGI_LUMEN_ACIDIFICATION,0.99999
RAMJAUN_APOPTOSIS_BY_TGFB1_V...3,SET,10,-0.49524,-0.011555,0.27127,0.96604,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN,0.99999
KEGG_MEDICUS_REFERENCE_CDC25...,SET,9,-0.42253,-0.0093532,0.23144,0.96604,KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M,0.99999
HOXA10_TARGET_GENES,SET,205,-0.10547,-0.011083,0.057738,0.96612,HOXA10_TARGET_GENES,0.99999
ZWANG_DOWN_BY_2ND_EGF_PULSE,SET,210,-0.10466,-0.01113,0.057283,0.96615,ZWANG_DOWN_BY_2ND_EGF_PULSE,0.99999
WP_CLEAR_CELL_RENAL_CELL_CAR...,SET,80,-0.17145,-0.011293,0.093834,0.96615,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,0.99999
HP_IMPAIRED_OCULAR_ADDUCTION,SET,9,-0.54529,-0.012071,0.29845,0.96615,HP_IMPAIRED_OCULAR_ADDUCTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...640,SET,24,-0.32113,-0.011603,0.17574,0.96616,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MATURATION,0.99999
GOBP_RIBOSOME_ASSEMBLY,SET,51,-0.20686,-0.010888,0.11321,0.96616,GOBP_RIBOSOME_ASSEMBLY,0.99999
RUIZ_TNC_TARGETS_DN,SET,136,-0.13607,-0.011669,0.074462,0.96617,RUIZ_TNC_TARGETS_DN,0.99999
REACTOME_CYTOCHROME_C_MEDIAT...,SET,12,-0.45991,-0.011755,0.25166,0.96618,REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE,0.99999
GSE22025_TGFB1_VS_TGFB1_AND_...1,SET,180,-0.12375,-0.012194,0.067707,0.9662,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,0.99999
GSE17721_CTRL_VS_CPG_8H_BMDC...2,SET,178,-0.11442,-0.011212,0.062596,0.96621,GSE17721_CTRL_VS_CPG_8H_BMDC_UP,0.99999
GOBP_PEPTIDYL_HISTIDINE_MODI...,SET,9,-0.4328,-0.0095806,0.23675,0.96622,GOBP_PEPTIDYL_HISTIDINE_MODIFICATION,0.99999
HP_POSTNATAL_GROWTH_RETARDAT...,SET,219,-0.10607,-0.011515,0.058021,0.96622,HP_POSTNATAL_GROWTH_RETARDATION,0.99999
YAGUE_PRETUMOR_DRUG_RESISTAN...2,SET,7,-0.66217,-0.012928,0.36207,0.96628,YAGUE_PRETUMOR_DRUG_RESISTANCE_UP,0.99999
GSE13762_CTRL_VS_125_VITAMIN...1,SET,120,-0.13738,-0.01107,0.075116,0.96628,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN,0.99999
GOBP_COPII_COATED_VESICLE_BU...,SET,42,-0.22677,-0.010834,0.12399,0.96629,GOBP_COPII_COATED_VESICLE_BUDDING,0.99999
REACTOME_G_PROTEIN_MEDIATED_...,SET,52,-0.23288,-0.012377,0.12732,0.9663,REACTOME_G_PROTEIN_MEDIATED_EVENTS,0.99999
HP_PARIETAL_BOSSING,SET,8,-0.46965,-0.009802,0.25677,0.9663,HP_PARIETAL_BOSSING,0.99999
HP_ABNORMAL_CSF_PROTEIN_CONC...,SET,45,-0.24181,-0.011957,0.13211,0.9664,HP_ABNORMAL_CSF_PROTEIN_CONCENTRATION,0.99999
GOBP_CELL_CYCLE_G1_S_PHASE_T...,SET,222,-0.10648,-0.011638,0.058161,0.96642,GOBP_CELL_CYCLE_G1_S_PHASE_TRANSITION,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...14,SET,183,-0.11367,-0.011293,0.062093,0.96642,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_UP,0.99999
KEGG_APOPTOSIS,SET,81,-0.17402,-0.011534,0.095007,0.96649,KEGG_APOPTOSIS,0.99999
GOBP_POST_GOLGI_VESICLE_MEDI...,SET,103,-0.14299,-0.01068,0.078055,0.96651,GOBP_POST_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.99999
REACTOME_RUNX1_REGULATES_TRA...4,SET,7,-0.56312,-0.010994,0.30727,0.96656,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS,0.99999
GOBP_POSITIVE_REGULATION_OF_...231,SET,17,-0.38872,-0.011824,0.2121,0.96657,GOBP_POSITIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT,0.99999
HP_HYPERPHENYLALANINEMIA,SET,6,-0.67097,-0.012128,0.36608,0.96658,HP_HYPERPHENYLALANINEMIA,0.99999
GSE40274_CTRL_VS_IRF4_TRANSD...2,SET,150,-0.12885,-0.0116,0.0703,0.96658,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GSE13411_SWITCHED_MEMORY_BCE...1,SET,160,-0.12565,-0.011679,0.068533,0.96662,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN,0.99999
GOMF_GAP_JUNCTION_CHANNEL_AC...2,SET,5,-0.79462,-0.013112,0.43339,0.96663,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_CONDUCTION_ELECTRICAL_COUPLING,0.99999
HP_HYPERURICOSURIA,SET,8,-0.53646,-0.011196,0.29256,0.96664,HP_HYPERURICOSURIA,0.99999
WP_MITOCHONDRIAL_COMPLEX_IV_...,SET,28,-0.25219,-0.0098417,0.13753,0.96665,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,0.99999
chr3q12,SET,22,-0.55235,-0.01911,0.30099,0.96675,chr3q12,0.99999
GOCC_MSL_COMPLEX,SET,3,-0.6635,-0.0084812,0.36144,0.96679,GOCC_MSL_COMPLEX,0.99999
HP_DILATATION_OF_THE_BLADDER,SET,11,-0.52647,-0.012883,0.28679,0.96679,HP_DILATATION_OF_THE_BLADDER,0.99999
MCCLUNG_DELTA_FOSB_TARGETS_2...,SET,43,-0.26039,-0.012588,0.14184,0.9668,MCCLUNG_DELTA_FOSB_TARGETS_2WK,0.99999
KRAS.600.LUNG.BREAST_UP.V1_UP,SET,248,-0.10962,-0.012654,0.059709,0.9668,KRAS.600.LUNG.BREAST_UP.V1_UP,0.99999
HP_DESQUAMATION_OF_SKIN_SOON...,SET,11,-0.4613,-0.011288,0.2512,0.96684,HP_DESQUAMATION_OF_SKIN_SOON_AFTER_BIRTH,0.99999
WP_NANOMATERIAL_INDUCED_APOP...,SET,19,-0.36333,-0.011683,0.19784,0.96685,WP_NANOMATERIAL_INDUCED_APOPTOSIS,0.99999
GOMF_CAMP_DEPENDENT_PROTEIN_...3,SET,12,-0.45807,-0.011708,0.24943,0.96685,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_REGULATOR_ACTIVITY,0.99999
MIR6089,SET,16,-0.38139,-0.011254,0.20765,0.96686,MIR6089,0.99999
KEGG_MEDICUS_PATHOGEN_EBV_EB...1,SET,10,-0.43731,-0.010204,0.23801,0.96691,KEGG_MEDICUS_PATHOGEN_EBV_EBNA1_TO_P53_MEDIATED_TRANSCRIPTION,0.99999
HP_CHILDHOOD_ONSET_TRUNCAL_O...,SET,30,-0.28749,-0.011612,0.15646,0.96692,HP_CHILDHOOD_ONSET_TRUNCAL_OBESITY,0.99999
CUI_DEVELOPING_HEART_VALVAR_...,SET,126,-0.15187,-0.012538,0.082646,0.96693,CUI_DEVELOPING_HEART_VALVAR_ENDOTHELIAL_CELL,0.99999
BIOCARTA_BAD_PATHWAY,SET,24,-0.35716,-0.012905,0.19434,0.96694,BIOCARTA_BAD_PATHWAY,0.99999
GOBP_BIOLOGICAL_PROCESS_INVO...4,SET,47,-0.23068,-0.011657,0.12553,0.96694,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTRASPECIES_INTERACTION_BETWEEN_ORGANISMS,0.99999
GOCC_H4_HISTONE_ACETYLTRANSF...,SET,37,-0.24407,-0.010946,0.13279,0.96696,GOCC_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.99999
GOBP_REGULATION_OF_LONG_CHAI...2,SET,7,-0.57297,-0.011186,0.31172,0.96697,GOBP_REGULATION_OF_LONG_CHAIN_FATTY_ACID_IMPORT_INTO_CELL,0.99999
MIKKELSEN_IPS_WITH_HCP_H3K27...,SET,97,-0.18357,-0.013308,0.099834,0.96701,MIKKELSEN_IPS_WITH_HCP_H3K27ME3,0.99999
KEGG_CELL_CYCLE,SET,120,-0.13661,-0.011008,0.074293,0.96702,KEGG_CELL_CYCLE,0.99999
GOBP_MICROTUBULE_CYTOSKELETO...2,SET,157,-0.12126,-0.011165,0.065905,0.9671,GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION_INVOLVED_IN_MITOSIS,0.99999
GOBP_V_D_J_RECOMBINATION,SET,17,-0.32885,-0.010003,0.17871,0.96711,GOBP_V_D_J_RECOMBINATION,0.99999
FLECHNER_BIOPSY_KIDNEY_TRANS...3,SET,504,-0.072081,-0.011778,0.039153,0.96718,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,0.99999
GOMF_METAL_ION_SENSOR_ACTIVI...,SET,8,-0.68019,-0.014196,0.36946,0.96718,GOMF_METAL_ION_SENSOR_ACTIVITY,0.99999
MIR26A_5P,SET,455,-0.075773,-0.01178,0.041155,0.96719,MIR26A_5P,0.99999
GSE25087_FETAL_VS_ADULT_TCON...2,SET,174,-0.1161,-0.011249,0.063053,0.9672,GSE25087_FETAL_VS_ADULT_TCONV_UP,0.99999
REACTOME_RUNX1_REGULATES_EXP...,SET,5,-0.73759,-0.012171,0.40047,0.96724,REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS,0.99999
GSE2770_IL12_AND_TGFB_VS_IL4...6,SET,178,-0.11321,-0.011094,0.061465,0.96725,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.99999
MIR4472,SET,93,-0.16655,-0.011824,0.090406,0.96727,MIR4472,0.99999
GOBP_ARGININE_CATABOLIC_PROC...,SET,9,-0.58518,-0.012954,0.31762,0.96728,GOBP_ARGININE_CATABOLIC_PROCESS,0.99999
GOBP_MAMMARY_GLAND_INVOLUTION,SET,8,-0.6347,-0.013247,0.34447,0.96729,GOBP_MAMMARY_GLAND_INVOLUTION,0.99999
HP_NOCTURIA,SET,14,-0.43705,-0.012065,0.23721,0.96729,HP_NOCTURIA,0.99999
HP_PROGRESSIVE_DISTAL_MUSCLE...,SET,14,-0.40671,-0.011227,0.22068,0.96733,HP_PROGRESSIVE_DISTAL_MUSCLE_WEAKNESS,0.99999
GSE15330_HSC_VS_LYMPHOID_PRI...4,SET,181,-0.11778,-0.011637,0.063904,0.96733,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,0.99999
GSE37416_CTRL_VS_24H_F_TULAR...2,SET,166,-0.12323,-0.011665,0.066861,0.96733,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
HP_ABNORMALITY_OF_THE_POSTER...,SET,99,-0.15365,-0.011253,0.083353,0.96736,HP_ABNORMALITY_OF_THE_POSTERIOR_HAIRLINE,0.99999
GSE3039_ALPHAALPHA_VS_ALPHAB...1,SET,188,-0.1209,-0.012172,0.065588,0.96736,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN,0.99999
GOBP_REGULATION_OF_CYTOSOLIC...,SET,52,-0.23932,-0.012719,0.12979,0.96739,GOBP_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.99999
GOBP_G_PROTEIN_COUPLED_RECEP...1,SET,9,-0.50596,-0.0112,0.27419,0.96749,GOBP_G_PROTEIN_COUPLED_RECEPTOR_INTERNALIZATION,0.99999
GOMF_TRANSFERASE_ACTIVITY_TR...3,SET,178,-0.10989,-0.010768,0.059544,0.96751,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS,0.99999
HP_TERATOMA,SET,12,-0.44024,-0.011252,0.23853,0.96752,HP_TERATOMA,0.99999
HP_THYROID_CARCINOMA,SET,57,-0.21053,-0.011713,0.11407,0.96752,HP_THYROID_CARCINOMA,0.99999
GOBP_NEGATIVE_ADAPTATION_OF_...,SET,12,-0.45199,-0.011552,0.24482,0.96756,GOBP_NEGATIVE_ADAPTATION_OF_SIGNALING_PATHWAY,0.99999
HP_METRORRHAGIA,SET,15,-0.43744,-0.012499,0.23694,0.96756,HP_METRORRHAGIA,0.99999
PLASARI_TGFB1_TARGETS_1HR_UP,SET,33,-0.30958,-0.013114,0.16763,0.9676,PLASARI_TGFB1_TARGETS_1HR_UP,0.99999
PEDERSEN_METASTASIS_BY_ERBB2...2,SET,17,-0.43182,-0.013135,0.23381,0.96761,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,0.99999
REACTOME_CELL_DEATH_SIGNALLI...,SET,67,-0.19799,-0.011939,0.10721,0.96761,REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,0.99999
GOBP_INTRINSIC_APOPTOTIC_SIG...9,SET,54,-0.20738,-0.011231,0.11228,0.96762,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS,0.99999
GSE24142_EARLY_THYMIC_PROGEN...8,SET,186,-0.11809,-0.011826,0.063932,0.96763,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP,0.99999
SIG_PIP3_SIGNALING_IN_B_LYMP...,SET,34,-0.28163,-0.012109,0.15244,0.96765,SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,0.99999
MOOTHA_GLUCONEOGENESIS,SET,27,-0.2839,-0.01088,0.15366,0.96766,MOOTHA_GLUCONEOGENESIS,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...11,SET,6,-0.64398,-0.01164,0.34853,0.96767,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1,0.99999
GOBP_REGULATION_OF_AUTOPHAGO...2,SET,15,-0.38061,-0.010875,0.20599,0.96767,GOBP_REGULATION_OF_AUTOPHAGOSOME_MATURATION,0.99999
GSE40666_STAT1_KO_VS_STAT4_K...1,SET,139,-0.14255,-0.012357,0.077152,0.96767,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_DN,0.99999
MIR6769B_3P,SET,76,-0.17943,-0.011521,0.097082,0.96771,MIR6769B_3P,0.99999
GOBP_ICOSANOID_SECRETION,SET,47,-0.25195,-0.012732,0.1363,0.96772,GOBP_ICOSANOID_SECRETION,0.99999
GOBP_SISTER_CHROMATID_SEGREG...,SET,218,-0.10256,-0.01111,0.055471,0.96776,GOBP_SISTER_CHROMATID_SEGREGATION,0.99999
MIR378J,SET,70,-0.19724,-0.012156,0.10666,0.96777,MIR378J,0.99999
GSE43955_1H_VS_42H_ACT_CD4_T...1,SET,186,-0.11499,-0.011515,0.062182,0.96778,GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN,0.99999
GOBP_BLOOD_VESSEL_MORPHOGENE...,SET,578,-0.070606,-0.01233,0.038177,0.96779,GOBP_BLOOD_VESSEL_MORPHOGENESIS,0.99999
GOBP_PML_BODY_ORGANIZATION,SET,6,-0.63066,-0.0114,0.341,0.96779,GOBP_PML_BODY_ORGANIZATION,0.99999
GSE17186_MEMORY_VS_CD21HIGH_...1,SET,187,-0.12262,-0.012312,0.066291,0.96781,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,0.99999
RICHERT_PBMC_HIV_LIPO_5_AGE_...3,SET,5,-0.72037,-0.011887,0.38943,0.96782,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_SIGNIFICANT_VARIATION_UP,0.99999
HP_ABNORMAL_LEUKOCYTE_ENZYME...,SET,6,-0.63909,-0.011552,0.34546,0.96783,HP_ABNORMAL_LEUKOCYTE_ENZYME_CONCENTRATION_OR_ACTIVITY,0.99999
GSE16450_CTRL_VS_IFNA_6H_STI...2,SET,180,-0.12048,-0.011871,0.065127,0.96783,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.99999
GSE22611_NOD2_TRANSDUCED_VS_...1,SET,173,-0.11299,-0.010916,0.061078,0.96783,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN,0.99999
REACTOME_CYCLIN_A_CDK2_ASSOC...,SET,82,-0.15268,-0.010181,0.082525,0.96784,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,0.99999
HP_ABNORMALITY_OF_THE_PREMAX...,SET,11,-0.48039,-0.011756,0.25965,0.96785,HP_ABNORMALITY_OF_THE_PREMAXILLA,0.99999
ATGCAGT_MIR217,SET,97,-0.16177,-0.011728,0.087415,0.96788,ATGCAGT_MIR217,0.99999
HP_TESTICULAR_ATROPHY,SET,9,-0.48685,-0.010777,0.26306,0.96789,HP_TESTICULAR_ATROPHY,0.99999
XU_HGF_TARGETS_INDUCED_BY_AK...1,SET,21,-0.34184,-0.011555,0.18469,0.9679,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN,0.99999
GOBP_MATURATION_OF_5_8S_RRNA,SET,33,-0.2506,-0.010615,0.13538,0.96791,GOBP_MATURATION_OF_5_8S_RRNA,0.99999
GSE14415_INDUCED_TREG_VS_FOX...1,SET,160,-0.12785,-0.011883,0.06906,0.96792,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_DN,0.99999
GSE6259_33D1_POS_VS_DEC205_P...3,SET,179,-0.12572,-0.012354,0.067915,0.96792,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN,0.99999
REACTOME_SIGNALING_BY_RNF43_...,SET,8,-0.59328,-0.012382,0.32047,0.96793,REACTOME_SIGNALING_BY_RNF43_MUTANTS,0.99999
GOCC_DNA_POLYMERASE_COMPLEX,SET,19,-0.31266,-0.010054,0.16884,0.96797,GOCC_DNA_POLYMERASE_COMPLEX,0.99999
HP_ABNORMAL_PUBIC_BONE_MORPH...,SET,39,-0.25903,-0.011926,0.13985,0.968,HP_ABNORMAL_PUBIC_BONE_MORPHOLOGY,0.99999
GOBP_NUCLEOSIDE_DIPHOSPHATE_...3,SET,119,-0.13918,-0.011169,0.075134,0.96801,GOBP_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.99999
REACTOME_RHO_GTPASES_ACTIVAT...7,SET,33,-0.28646,-0.012135,0.15461,0.96804,REACTOME_RHO_GTPASES_ACTIVATE_PKNS,0.99999
DESCARTES_FETAL_PLACENTA_IGF...,SET,94,-0.17615,-0.012572,0.095066,0.96805,DESCARTES_FETAL_PLACENTA_IGFBP1_DKK1_POSITIVE_CELLS,0.99999
HP_ABNORMAL_PARATHYROID_MORP...,SET,22,-0.36709,-0.0127,0.19806,0.96808,HP_ABNORMAL_PARATHYROID_MORPHOLOGY,0.99999
HP_ACROMESOMELIA,SET,5,-0.61075,-0.010078,0.3295,0.96809,HP_ACROMESOMELIA,0.99999
HP_NEOPLASM_OF_THE_RESPIRATO...,SET,74,-0.18219,-0.011544,0.098286,0.9681,HP_NEOPLASM_OF_THE_RESPIRATORY_SYSTEM,0.99999
HP_NEUROMUSCULAR_DYSPHAGIA,SET,11,-0.47027,-0.011508,0.2537,0.9681,HP_NEUROMUSCULAR_DYSPHAGIA,0.99999
GOMF_METALLOENDOPEPTIDASE_IN...,SET,13,-0.43003,-0.011439,0.23193,0.96813,GOMF_METALLOENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.99999
GOBP_REGULATION_OF_MYOBLAST_...2,SET,19,-0.38488,-0.012376,0.20756,0.96815,GOBP_REGULATION_OF_MYOBLAST_FUSION,0.99999
WP_TRYPTOPHAN_CATABOLISM_LEA...,SET,16,-0.41471,-0.012238,0.22363,0.96816,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,0.99999
HP_ABNORMALITY_OF_FACIAL_ADI...,SET,10,-0.5306,-0.01238,0.28607,0.96818,HP_ABNORMALITY_OF_FACIAL_ADIPOSE_TISSUE,0.99999
GSE17721_LPS_VS_CPG_2H_BMDC_...2,SET,183,-0.1199,-0.011912,0.064636,0.9682,GSE17721_LPS_VS_CPG_2H_BMDC_UP,0.99999
GSE11864_CSF1_VS_CSF1_IFNG_P...2,SET,167,-0.11604,-0.011017,0.062531,0.96824,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.99999
MIR891B,SET,115,-0.14353,-0.011325,0.077338,0.96826,MIR891B,0.99999
DING_LUNG_CANCER_BY_MUTATION...,SET,20,-0.37776,-0.012462,0.2035,0.96829,DING_LUNG_CANCER_BY_MUTATION_RATE,0.99999
HP_ANTIPHOSPHOLIPID_ANTIBODY...,SET,16,-0.39296,-0.011596,0.21169,0.96829,HP_ANTIPHOSPHOLIPID_ANTIBODY_POSITIVITY,0.99999
GSE3920_IFNA_VS_IFNG_TREATED...3,SET,172,-0.12392,-0.011938,0.066755,0.96829,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN,0.99999
HP_FLAT_FACE,SET,94,-0.16082,-0.011479,0.086615,0.96832,HP_FLAT_FACE,0.99999
GOBP_BASE_EXCISION_REPAIR_GA...,SET,13,-0.32592,-0.00867,0.17552,0.96833,GOBP_BASE_EXCISION_REPAIR_GAP_FILLING,0.99999
GOCC_COPII_COATED_ER_TO_GOLG...,SET,84,-0.175,-0.01181,0.094228,0.96835,GOCC_COPII_COATED_ER_TO_GOLGI_TRANSPORT_VESICLE,0.99999
MEINHOLD_OVARIAN_CANCER_LOW_...2,SET,10,-0.55418,-0.012931,0.29835,0.96837,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,0.99999
KEGG_MELANOMA,SET,68,-0.2062,-0.012526,0.11101,0.96837,KEGG_MELANOMA,0.99999
NADLER_HYPERGLYCEMIA_AT_OBES...,SET,53,-0.22914,-0.012294,0.12335,0.96839,NADLER_HYPERGLYCEMIA_AT_OBESITY,0.99999
GSE3982_DC_VS_NKCELL_UP,SET,181,-0.12392,-0.012244,0.066702,0.9684,GSE3982_DC_VS_NKCELL_UP,0.99999
GSE9650_EFFECTOR_VS_MEMORY_C...1,SET,184,-0.1166,-0.011615,0.062746,0.96843,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN,0.99999
GSE12845_PRE_GC_VS_DARKZONE_...1,SET,176,-0.11603,-0.011306,0.062434,0.96844,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.99999
GSE4142_NAIVE_BCELL_VS_PLASM...2,SET,175,-0.11664,-0.011334,0.062761,0.96844,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_UP,0.99999
KEGG_MEDICUS_PATHOGEN_HTLV_1...6,SET,8,-0.48376,-0.010096,0.26024,0.96847,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00498,0.99999
GOBP_ACTIVATION_OF_CYSTEINE_...3,SET,5,-0.62614,-0.010332,0.33681,0.96848,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS_BY_CYTOCHROME_C,0.99999
GOCC_INSULIN_LIKE_GROWTH_FAC...,SET,5,-0.82323,-0.013584,0.44266,0.96853,GOCC_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEIN_COMPLEX,0.99999
MODULE_40,SET,81,-0.17998,-0.011929,0.096771,0.96854,MODULE_40,0.99999
GOMF_LYASE_ACTIVITY,SET,179,-0.12229,-0.012016,0.065703,0.96863,GOMF_LYASE_ACTIVITY,0.99999
ZHAN_MULTIPLE_MYELOMA_SPIKED,SET,20,-0.3822,-0.012608,0.20534,0.96864,ZHAN_MULTIPLE_MYELOMA_SPIKED,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...27,SET,11,-0.48136,-0.011779,0.25861,0.96864,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,0.99999
KRAS.DF.V1_UP,SET,174,-0.12598,-0.012207,0.067688,0.96864,KRAS.DF.V1_UP,0.99999
REACTOME_G_ALPHA_Z_SIGNALLIN...,SET,48,-0.2448,-0.012501,0.13149,0.96867,REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS,0.99999
GSE360_L_DONOVANI_VS_T_GONDI...4,SET,175,-0.11927,-0.011589,0.064049,0.9687,GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP,0.99999
GOBP_SOMATOSTATIN_RECEPTOR_S...,SET,6,-0.64541,-0.011666,0.34646,0.96875,GOBP_SOMATOSTATIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
HINATA_NFKB_TARGETS_FIBROBLA...,SET,79,-0.18424,-0.01206,0.098873,0.96879,HINATA_NFKB_TARGETS_FIBROBLAST_UP,0.99999
FAN_EMBRYONIC_CTX_MICROGLIA_1,SET,137,-0.12977,-0.011169,0.069644,0.96879,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.99999
HP_PHONIC_TICS,SET,5,-0.8302,-0.013699,0.44541,0.96882,HP_PHONIC_TICS,0.99999
GOMF_ADP_BINDING,SET,32,-0.2857,-0.011918,0.15323,0.96887,GOMF_ADP_BINDING,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...13,SET,183,-0.12268,-0.012188,0.0658,0.96887,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_DN,0.99999
LUI_TARGETS_OF_PAX8_PPARG_FU...,SET,32,-0.27263,-0.011373,0.14617,0.96891,LUI_TARGETS_OF_PAX8_PPARG_FUSION,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...9,SET,147,-0.12449,-0.011096,0.066732,0.96894,GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME,0.99999
ULE_SPLICING_VIA_NOVA2,SET,42,-0.25768,-0.012311,0.13811,0.96895,ULE_SPLICING_VIA_NOVA2,0.99999
GOMF_VITAMIN_BINDING,SET,133,-0.14049,-0.011915,0.075301,0.96895,GOMF_VITAMIN_BINDING,0.99999
HP_VISCERAL_ANGIOMATOSIS,SET,15,-0.43732,-0.012495,0.23438,0.96896,HP_VISCERAL_ANGIOMATOSIS,0.99999
TERAMOTO_OPN_TARGETS_CLUSTER...5,SET,25,-0.32595,-0.01202,0.17468,0.96897,TERAMOTO_OPN_TARGETS_CLUSTER_6,0.99999
GOMF_GLYCINE_BINDING,SET,10,-0.56013,-0.013069,0.3001,0.969,GOMF_GLYCINE_BINDING,0.99999
GOMF_STEROID_DEHYDROGENASE_A...2,SET,30,-0.30058,-0.012141,0.16105,0.969,GOMF_STEROID_DEHYDROGENASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,0.99999
PSMB5_TARGET_GENES,SET,196,-0.11704,-0.012029,0.062668,0.96909,PSMB5_TARGET_GENES,0.99999
HP_QUADRICEPS_MUSCLE_WEAKNESS,SET,19,-0.38107,-0.012253,0.204,0.96911,HP_QUADRICEPS_MUSCLE_WEAKNESS,0.99999
GSE37532_TREG_VS_TCONV_CD4_T...3,SET,149,-0.12463,-0.011183,0.066704,0.96914,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,0.99999
MIR133A_5P,SET,122,-0.14101,-0.011457,0.075466,0.96915,MIR133A_5P,0.99999
GOBP_ARTICULAR_CARTILAGE_DEV...,SET,5,-0.57691,-0.0095196,0.30862,0.9692,GOBP_ARTICULAR_CARTILAGE_DEVELOPMENT,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_EAR...2,SET,518,-0.074764,-0.01238,0.039993,0.96921,HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL,0.99999
HASEGAWA_TUMORIGENESIS_BY_RE...,SET,9,-0.50462,-0.01117,0.26986,0.96924,HASEGAWA_TUMORIGENESIS_BY_RET_C634R,0.99999
WP_SMC1SMC3_ROLE_IN_DNA_DAMA...,SET,9,-0.47109,-0.010428,0.25195,0.96924,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,0.99999
MIR6132,SET,119,-0.14789,-0.011869,0.079085,0.96925,MIR6132,0.99999
GOBP_L_AMINO_ACID_CATABOLIC_...,SET,60,-0.20682,-0.011805,0.1105,0.96937,GOBP_L_AMINO_ACID_CATABOLIC_PROCESS,0.99999
DAVICIONI_MOLECULAR_ARMS_VS_...2,SET,301,-0.092899,-0.011798,0.049629,0.96938,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,0.99999
GOMF_DESUMOYLASE_ACTIVITY,SET,7,-0.51565,-0.010067,0.27545,0.96939,GOMF_DESUMOYLASE_ACTIVITY,0.99999
REACTOME_RHO_GTPASES_ACTIVAT...9,SET,19,-0.36754,-0.011818,0.19629,0.96942,REACTOME_RHO_GTPASES_ACTIVATE_ROCKS,0.99999
GSE29618_LAIV_VS_TIV_FLU_VAC...2,SET,166,-0.12269,-0.011614,0.065496,0.96947,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP,0.99999
KAYO_CALORIE_RESTRICTION_MUS...1,SET,77,-0.16976,-0.010971,0.090589,0.96952,KAYO_CALORIE_RESTRICTION_MUSCLE_DN,0.99999
REACTOME_SUMOYLATION_OF_TRAN...1,SET,41,-0.23887,-0.011276,0.12748,0.96952,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,0.99999
GOMF_MHC_CLASS_IB_RECEPTOR_A...,SET,6,-0.81121,-0.014663,0.4329,0.96952,GOMF_MHC_CLASS_IB_RECEPTOR_ACTIVITY,0.99999
HP_ABNORMALITY_OF_THE_PERIPH...,SET,405,-0.079039,-0.01161,0.042169,0.96955,HP_ABNORMALITY_OF_THE_PERIPHERAL_NERVOUS_SYSTEM,0.99999
HP_RETINAL_EXUDATE,SET,8,-0.56108,-0.01171,0.29934,0.96956,HP_RETINAL_EXUDATE,0.99999
GOBP_ESTABLISHMENT_OF_BLOOD_...1,SET,14,-0.46855,-0.012934,0.2499,0.96959,GOBP_ESTABLISHMENT_OF_BLOOD_BRAIN_BARRIER,0.99999
GOBP_REGULATION_OF_BINDING,SET,204,-0.11051,-0.011585,0.058943,0.96959,GOBP_REGULATION_OF_BINDING,0.99999
HP_NARROW_PALATE,SET,164,-0.12248,-0.011524,0.065321,0.96959,HP_NARROW_PALATE,0.99999
GSE43863_NAIVE_VS_TH1_EFF_CD...2,SET,165,-0.12392,-0.011696,0.066091,0.9696,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP,0.99999
GOMF_3_5_DNA_EXONUCLEASE_ACT...,SET,13,-0.35261,-0.00938,0.18801,0.96963,GOMF_3_5_DNA_EXONUCLEASE_ACTIVITY,0.99999
GSE17721_0.5H_VS_8H_LPS_BMDC...2,SET,189,-0.11601,-0.01171,0.061847,0.96965,GSE17721_0.5H_VS_8H_LPS_BMDC_UP,0.99999
GCM_APEX1,SET,102,-0.14383,-0.010691,0.076622,0.96974,GCM_APEX1,0.99999
GOBP_REGULATION_OF_PROTEIN_E...1,SET,24,-0.30433,-0.010997,0.16213,0.96974,GOBP_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,0.99999
KIM_MYCL1_AMPLIFICATION_TARG...1,SET,18,-0.40007,-0.012521,0.2131,0.96976,KIM_MYCL1_AMPLIFICATION_TARGETS_DN,0.99999
REACTOME_TELOMERE_C_STRAND_S...,SET,11,-0.42581,-0.01042,0.22679,0.96977,REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION,0.99999
GSE6269_HEALTHY_VS_FLU_INF_P...2,SET,153,-0.12472,-0.011338,0.066421,0.96978,GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP,0.99999
HALLMARK_TGF_BETA_SIGNALING,SET,52,-0.22779,-0.012106,0.12131,0.96979,HALLMARK_TGF_BETA_SIGNALING,0.99999
GOMF_RNA_POLYMERASE_II_C_TER...,SET,10,-0.4283,-0.0099935,0.22799,0.96984,GOMF_RNA_POLYMERASE_II_C_TERMINAL_DOMAIN_BINDING,0.99999
GSE27670_BLIMP1_VS_LMP1_TRAN...1,SET,184,-0.11623,-0.011578,0.061856,0.96987,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN,0.99999
GOCC_SNO_S_RNA_CONTAINING_RI...,SET,19,-0.3348,-0.010765,0.17814,0.9699,GOCC_SNO_S_RNA_CONTAINING_RIBONUCLEOPROTEIN_COMPLEX,0.99999
MODULE_375,SET,85,-0.18865,-0.012807,0.10035,0.96993,MODULE_375,0.99999
GSE15330_MEGAKARYOCYTE_ERYTH...6,SET,165,-0.12962,-0.012233,0.068925,0.96998,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.99999
KEGG_MEDICUS_PATHOGEN_EBV_EB...7,SET,10,-0.45334,-0.010578,0.24103,0.96999,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P53_MEDIATED_TRANSCRIPTION,0.99999
HP_EEG_WITH_FOCAL_SHARP_WAVES,SET,10,-0.50937,-0.011885,0.27083,0.96999,HP_EEG_WITH_FOCAL_SHARP_WAVES,0.99999
STEARMAN_LUNG_CANCER_EARLY_V...1,SET,55,-0.22315,-0.012196,0.11864,0.97,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,0.99999
GLI1_TARGET_GENES,SET,421,-0.079035,-0.011831,0.042016,0.97001,GLI1_TARGET_GENES,0.99999
BIOCARTA_AGPCR_PATHWAY,SET,11,-0.53885,-0.013186,0.28641,0.97003,BIOCARTA_AGPCR_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...308,SET,29,-0.30366,-0.012059,0.16134,0.97008,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,0.99999
HP_FACIAL_SHAPE_DEFORMATION,SET,14,-0.48386,-0.013357,0.25686,0.97019,HP_FACIAL_SHAPE_DEFORMATION,0.99999
GSE3982_NKCELL_VS_TH1_DN,SET,180,-0.12088,-0.01191,0.064151,0.97023,GSE3982_NKCELL_VS_TH1_DN,0.99999
GSE5589_LPS_VS_LPS_AND_IL6_S...2,SET,180,-0.11921,-0.011746,0.063252,0.97025,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...14,SET,174,-0.12289,-0.011907,0.065192,0.97028,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.99999
HP_ABNORMALITY_OF_THE_MUSCUL...1,SET,111,-0.14637,-0.011347,0.077639,0.97029,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_HAND,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...40,SET,142,-0.13664,-0.011971,0.07246,0.97033,HP_APLASIA_HYPOPLASIA_OF_THE_LUNGS,0.99999
BIOCARTA_CHEMICAL_PATHWAY,SET,18,-0.37265,-0.011663,0.19759,0.97034,BIOCARTA_CHEMICAL_PATHWAY,0.99999
MIR29B_1_5P,SET,155,-0.12774,-0.011688,0.067717,0.97037,MIR29B_1_5P,0.99999
GSE22886_IGM_MEMORY_BCELL_VS...2,SET,175,-0.12278,-0.011931,0.065084,0.97038,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,0.99999
HP_LONG_CLAVICLES,SET,13,-0.45462,-0.012094,0.24094,0.9704,HP_LONG_CLAVICLES,0.99999
GOMF_TUMOR_NECROSIS_FACTOR_B...,SET,6,-0.60405,-0.010918,0.32006,0.97043,GOMF_TUMOR_NECROSIS_FACTOR_BINDING,0.99999
KEGG_MEDICUS_VARIANT_MLL_AF4...,SET,25,-0.34765,-0.01282,0.18414,0.97048,KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.99999
GOBP_PROTEIN_DESUMOYLATION,SET,9,-0.46971,-0.010398,0.24872,0.97051,GOBP_PROTEIN_DESUMOYLATION,0.99999
REACTOME_SYNTHESIS_OF_SUBSTR...,SET,58,-0.20381,-0.011437,0.10779,0.97066,REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,0.99999
REACTOME_CYTOSOLIC_SULFONATI...,SET,21,-0.37592,-0.012707,0.1988,0.97067,REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES,0.99999
MORF_WNT1,SET,93,-0.17321,-0.012297,0.091592,0.97068,MORF_WNT1,0.99999
HP_MEDIAL_FLARING_OF_THE_EYE...,SET,35,-0.26707,-0.01165,0.14123,0.97068,HP_MEDIAL_FLARING_OF_THE_EYEBROW,0.99999
GSE29614_DAY3_VS_DAY7_TIV_FL...1,SET,158,-0.12641,-0.011677,0.066847,0.97068,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,0.99999
BIOCARTA_P53HYPOXIA_PATHWAY,SET,20,-0.34681,-0.011441,0.18336,0.97071,BIOCARTA_P53HYPOXIA_PATHWAY,0.99999
GOBP_APOPTOTIC_CELL_CLEARANCE,SET,46,-0.24211,-0.012104,0.12799,0.97072,GOBP_APOPTOTIC_CELL_CLEARANCE,0.99999
GSE29614_CTRL_VS_DAY7_TIV_FL...1,SET,159,-0.12823,-0.011882,0.067784,0.97073,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,0.99999
PID_ATM_PATHWAY,SET,29,-0.26311,-0.010449,0.13906,0.97075,PID_ATM_PATHWAY,0.99999
MIR3183,SET,75,-0.18461,-0.011776,0.097576,0.97075,MIR3183,0.99999
GOBP_PROTEIN_RETENTION_IN_GO...,SET,5,-0.79843,-0.013175,0.42195,0.97076,GOBP_PROTEIN_RETENTION_IN_GOLGI_APPARATUS,0.99999
REACTOME_ABERRANT_REGULATION...2,SET,17,-0.377,-0.011467,0.19922,0.97077,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,0.99999
PID_ER_NONGENOMIC_PATHWAY,SET,39,-0.25687,-0.011827,0.13571,0.9708,PID_ER_NONGENOMIC_PATHWAY,0.99999
SHEDDEN_LUNG_CANCER_GOOD_SUR...3,SET,64,-0.20261,-0.011942,0.10699,0.97086,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5,0.99999
HP_VASCULAR_NEOPLASM,SET,143,-0.13346,-0.011733,0.070471,0.97087,HP_VASCULAR_NEOPLASM,0.99999
HP_VERTEBRAL_ARCH_ANOMALY,SET,16,-0.3899,-0.011506,0.20588,0.97087,HP_VERTEBRAL_ARCH_ANOMALY,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...9,SET,318,-0.09085,-0.011853,0.047965,0.97089,GOBP_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,0.99999
GOBP_SENSORY_PERCEPTION_OF_T...1,SET,65,-0.23042,-0.013686,0.12164,0.9709,GOBP_SENSORY_PERCEPTION_OF_TASTE,0.99999
GSE45739_UNSTIM_VS_ACD3_ACD2...4,SET,181,-0.12272,-0.012125,0.064739,0.97099,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP,0.99999
HP_BIFID_EPIGLOTTIS,SET,5,-0.59334,-0.0097908,0.31295,0.97101,HP_BIFID_EPIGLOTTIS,0.99999
GOBP_PROXIMAL_TUBULE_DEVELOP...,SET,10,-0.52972,-0.01236,0.27935,0.97103,GOBP_PROXIMAL_TUBULE_DEVELOPMENT,0.99999
HP_ABNORMAL_BRAIN_EVOKED_POT...,SET,91,-0.16992,-0.011934,0.089608,0.97103,HP_ABNORMAL_BRAIN_EVOKED_POTENTIALS,0.99999
GSE14769_UNSTIM_VS_40MIN_LPS...1,SET,189,-0.12291,-0.012406,0.064804,0.97105,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN,0.99999
GSE10325_BCELL_VS_MYELOID_UP,SET,170,-0.12671,-0.012137,0.066805,0.97106,GSE10325_BCELL_VS_MYELOID_UP,0.99999
DESCARTES_MAIN_FETAL_MESOTHE...,SET,22,-0.37324,-0.012913,0.19678,0.97106,DESCARTES_MAIN_FETAL_MESOTHELIAL_CELLS,0.99999
GOCC_FICOLIN_1_RICH_GRANULE_...1,SET,120,-0.14472,-0.011662,0.076271,0.97111,GOCC_FICOLIN_1_RICH_GRANULE_LUMEN,0.99999
GOCC_CELL_BODY_FIBER,SET,8,-0.64121,-0.013383,0.3378,0.97116,GOCC_CELL_BODY_FIBER,0.99999
GSE45365_NK_CELL_VS_CD8A_DC_...1,SET,181,-0.12619,-0.012468,0.066466,0.97118,GSE45365_NK_CELL_VS_CD8A_DC_DN,0.99999
MIR93_3P,SET,106,-0.15482,-0.01173,0.081506,0.97124,MIR93_3P,0.99999
GSE13493_CD4INTCD8POS_VS_CD8...2,SET,168,-0.12177,-0.011596,0.064107,0.97124,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP,0.99999
BIOCARTA_SET_PATHWAY,SET,10,-0.60259,-0.01406,0.31719,0.97126,BIOCARTA_SET_PATHWAY,0.99999
GOBP_REGULATION_OF_SKELETAL_...2,SET,11,-0.48591,-0.011891,0.25573,0.97128,GOBP_REGULATION_OF_SKELETAL_MUSCLE_ADAPTATION,0.99999
GOBP_SMOOTH_MUSCLE_CONTRACTI...,SET,104,-0.16862,-0.012655,0.088729,0.9713,GOBP_SMOOTH_MUSCLE_CONTRACTION,0.99999
WP_BONE_MORPHOGENIC_PROTEIN_...,SET,11,-0.50138,-0.012269,0.26378,0.97132,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,0.99999
MIR4534,SET,146,-0.13372,-0.011877,0.070337,0.97134,MIR4534,0.99999
GSE19888_ADENOSINE_A3R_ACT_V...4,SET,164,-0.12243,-0.01152,0.064378,0.97139,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_UP,0.99999
GOBP_ALCOHOL_CATABOLIC_PROCE...,SET,31,-0.32586,-0.013379,0.17125,0.97146,GOBP_ALCOHOL_CATABOLIC_PROCESS,0.99999
GOBP_ALPHA_LINOLENIC_ACID_ME...,SET,9,-0.54592,-0.012085,0.28685,0.97148,GOBP_ALPHA_LINOLENIC_ACID_METABOLIC_PROCESS,0.99999
GOMF_BILE_ACID_SODIUM_SYMPOR...,SET,5,-0.60949,-0.010057,0.32024,0.97149,GOMF_BILE_ACID_SODIUM_SYMPORTER_ACTIVITY,0.99999
GSE32533_WT_VS_MIR17_OVEREXP...2,SET,170,-0.12517,-0.011989,0.065746,0.97152,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,0.99999
GOBP_MICROTUBULE_ORGANIZING_...2,SET,143,-0.12963,-0.011396,0.068084,0.97153,GOBP_MICROTUBULE_ORGANIZING_CENTER_ORGANIZATION,0.99999
HP_FACIAL_ASYMMETRY,SET,128,-0.1432,-0.011916,0.075196,0.97156,HP_FACIAL_ASYMMETRY,0.99999
MIR6505_3P,SET,87,-0.17167,-0.01179,0.090088,0.97164,MIR6505_3P,0.99999
YYCATTCAWW_UNKNOWN,SET,177,-0.12313,-0.012031,0.064606,0.97165,YYCATTCAWW_UNKNOWN,0.99999
GSE25123_ROSIGLITAZONE_VS_IL...1,SET,105,-0.15766,-0.01189,0.082725,0.97166,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.99999
GUILLAUMOND_KLF10_TARGETS_DN,SET,27,-0.32342,-0.012394,0.16964,0.97171,GUILLAUMOND_KLF10_TARGETS_DN,0.99999
REACTOME_ACTIVATION_OF_RAS_I...,SET,5,-0.72495,-0.011963,0.38021,0.97171,REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS,0.99999
ACEVEDO_LIVER_CANCER_WITH_H3...1,SET,141,-0.14955,-0.013056,0.078433,0.97172,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,0.99999
CACGTG_MYC_Q2,SET,931,-0.055259,-0.012124,0.028977,0.97173,CACGTG_MYC_Q2,0.99999
GOBP_ORGANIC_HYDROXY_COMPOUN...2,SET,50,-0.25112,-0.013087,0.1316,0.9718,GOBP_ORGANIC_HYDROXY_COMPOUND_CATABOLIC_PROCESS,0.99999
FULLER_PBMC_F_TULARENSIS_VAC...4,SET,14,-0.40765,-0.011253,0.21358,0.97184,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_UP,0.99999
GOBP_RESPONSE_TO_VIRUS,SET,368,-0.087349,-0.012243,0.045718,0.97196,GOBP_RESPONSE_TO_VIRUS,0.99999
HP_ABNORMAL_T_CELL_PROLIFERA...,SET,14,-0.40954,-0.011305,0.21431,0.97199,HP_ABNORMAL_T_CELL_PROLIFERATION,0.99999
KANG_CISPLATIN_RESISTANCE_UP,SET,18,-0.3786,-0.011849,0.19809,0.972,KANG_CISPLATIN_RESISTANCE_UP,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...47,SET,11,-0.48555,-0.011882,0.25386,0.9721,GOBP_PROTEIN_LOCALIZATION_TO_PRESYNAPSE,0.99999
HP_MIXED_HEARING_IMPAIRMENT,SET,32,-0.30145,-0.012575,0.1576,0.9721,HP_MIXED_HEARING_IMPAIRMENT,0.99999
MED25_TARGET_GENES,SET,76,-0.1907,-0.012244,0.099691,0.97211,MED25_TARGET_GENES,0.99999
REACTOME_ALK_MUTANTS_BIND_TK...,SET,12,-0.47151,-0.012051,0.24641,0.97215,REACTOME_ALK_MUTANTS_BIND_TKIS,0.99999
HP_CEREBRAL_EDEMA,SET,28,-0.30357,-0.011847,0.15862,0.97217,HP_CEREBRAL_EDEMA,0.99999
GNF2_CCNA1,SET,56,-0.22177,-0.01223,0.11587,0.97218,GNF2_CCNA1,0.99999
MILI_PSEUDOPODIA_HAPTOTAXIS_...1,SET,631,-0.064915,-0.011826,0.033915,0.97219,MILI_PSEUDOPODIA_HAPTOTAXIS_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...603,SET,11,-0.54508,-0.013339,0.28452,0.9723,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,0.99999
GOMF_TUMOR_NECROSIS_FACTOR_R...1,SET,9,-0.61752,-0.013669,0.32232,0.9723,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_ACTIVITY,0.99999
HP_ELEVATED_CIRCULATING_ALDO...,SET,6,-0.59781,-0.010806,0.312,0.97231,HP_ELEVATED_CIRCULATING_ALDOLASE_CONCENTRATION,0.99999
BRACHAT_RESPONSE_TO_METHOTRE...1,SET,23,-0.30919,-0.010937,0.16133,0.97234,BRACHAT_RESPONSE_TO_METHOTREXATE_DN,0.99999
GSE3920_UNTREATED_VS_IFNG_TR...4,SET,156,-0.13199,-0.012115,0.068858,0.97236,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_UP,0.99999
GOBP_GLOMERULUS_MORPHOGENESIS,SET,9,-0.61765,-0.013672,0.32221,0.97237,GOBP_GLOMERULUS_MORPHOGENESIS,0.99999
MIR1827,SET,359,-0.086212,-0.011937,0.044969,0.97238,MIR1827,0.99999
GOBP_MITOCHONDRIAL_GENOME_MA...,SET,29,-0.29026,-0.011528,0.15131,0.97246,GOBP_MITOCHONDRIAL_GENOME_MAINTENANCE,0.99999
PARK_HSC_VS_MULTIPOTENT_PROG...2,SET,16,-0.42807,-0.012632,0.22312,0.97247,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP,0.99999
GOBP_EPITHELIAL_CELL_MORPHOG...,SET,30,-0.32316,-0.013053,0.16839,0.97251,GOBP_EPITHELIAL_CELL_MORPHOGENESIS,0.99999
GOBP_RNA_5_END_PROCESSING,SET,32,-0.24321,-0.010145,0.12671,0.97253,GOBP_RNA_5_END_PROCESSING,0.99999
GOBP_RESPONSE_TO_NITROGEN_CO...,SET,991,-0.054152,-0.012238,0.028209,0.97254,GOBP_RESPONSE_TO_NITROGEN_COMPOUND,0.99999
HSIAO_HOUSEKEEPING_GENES,SET,344,-0.086097,-0.011675,0.044847,0.97255,HSIAO_HOUSEKEEPING_GENES,0.99999
RAMASWAMY_METASTASIS_UP,SET,60,-0.20442,-0.011668,0.10647,0.97257,RAMASWAMY_METASTASIS_UP,0.99999
HP_RETINOPATHY_OF_PREMATURITY,SET,4,-0.76449,-0.011283,0.39808,0.97259,HP_RETINOPATHY_OF_PREMATURITY,0.99999
GSE39110_DAY3_VS_DAY6_POST_I...1,SET,181,-0.12149,-0.012004,0.06324,0.97264,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN,0.99999
HP_GENERALIZED_AMYOTROPHY,SET,78,-0.17173,-0.01117,0.089372,0.97266,HP_GENERALIZED_AMYOTROPHY,0.99999
GSE29614_CTRL_VS_TIV_FLU_VAC...2,SET,148,-0.14281,-0.012771,0.0743,0.9727,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP,0.99999
HP_PATELLAR_SUBLUXATION,SET,5,-0.84829,-0.013998,0.44118,0.97274,HP_PATELLAR_SUBLUXATION,0.99999
KAECH_DAY8_EFF_VS_MEMORY_CD8...2,SET,183,-0.11677,-0.0116,0.060724,0.97275,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP,0.99999
REACTOME_SYNTHESIS_OF_UDP_N_...,SET,7,-0.64914,-0.012673,0.33749,0.97278,REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE,0.99999
GSE360_T_GONDII_VS_B_MALAYI_...7,SET,184,-0.1176,-0.011715,0.061144,0.97278,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.99999
GOBP_SENSORY_PERCEPTION,SET,812,-0.069675,-0.014326,0.036209,0.97283,GOBP_SENSORY_PERCEPTION,0.99999
REACTOME_DAG_AND_IP3_SIGNALI...,SET,39,-0.28264,-0.013013,0.14683,0.97287,REACTOME_DAG_AND_IP3_SIGNALING,0.99999
HP_VERY_LONG_CHAIN_FATTY_ACI...,SET,15,-0.41185,-0.011768,0.21395,0.97287,HP_VERY_LONG_CHAIN_FATTY_ACID_ACCUMULATION,0.99999
HP_DEATH_IN_INFANCY,SET,221,-0.10828,-0.011808,0.056216,0.97294,HP_DEATH_IN_INFANCY,0.99999
PUJANA_CHEK2_PCC_NETWORK,SET,694,-0.059673,-0.011381,0.030972,0.97298,PUJANA_CHEK2_PCC_NETWORK,0.99999
GSE22886_IGG_IGA_MEMORY_BCEL...2,SET,180,-0.12665,-0.012479,0.065731,0.97299,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,0.99999
HP_FIBULAR_BOWING,SET,9,-0.59508,-0.013173,0.30882,0.973,HP_FIBULAR_BOWING,0.99999
GSE29618_PRE_VS_DAY7_FLU_VAC...5,SET,180,-0.11526,-0.011357,0.059814,0.973,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN,0.99999
GOCC_NON_MOTILE_CILIUM,SET,146,-0.13531,-0.012019,0.070209,0.97302,GOCC_NON_MOTILE_CILIUM,0.99999
KEGG_MEDICUS_REFERENCE_RORA_...,SET,5,-0.68969,-0.011381,0.35768,0.97308,KEGG_MEDICUS_REFERENCE_RORA_MEDIATED_TRANSCRIPTION,0.99999
MIR613,SET,289,-0.098088,-0.01221,0.050868,0.97308,MIR613,0.99999
HP_OLIGODACTYLY,SET,24,-0.35726,-0.012909,0.18527,0.97308,HP_OLIGODACTYLY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...309,SET,6,-0.59683,-0.010788,0.30941,0.97312,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,0.99999
MIKKELSEN_PARTIALLY_REPROGRA...,SET,9,-0.56955,-0.012608,0.29522,0.97314,MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,0.99999
GOBP_VITAMIN_E_METABOLIC_PRO...,SET,6,-0.64996,-0.011748,0.33682,0.97317,GOBP_VITAMIN_E_METABOLIC_PROCESS,0.99999
GSE10239_MEMORY_VS_KLRG1INT_...1,SET,184,-0.11927,-0.01188,0.061795,0.97319,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN,0.99999
HP_RETROCOLLIS,SET,8,-0.52536,-0.010965,0.27211,0.97323,HP_RETROCOLLIS,0.99999
REACTOME_SRP_DEPENDENT_COTRA...,SET,102,-0.15962,-0.011865,0.082655,0.97326,REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.99999
REACTOME_TRANSMISSION_ACROSS...,SET,252,-0.11263,-0.013105,0.058323,0.97326,REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,0.99999
GSE17186_BLOOD_VS_CORD_BLOOD...2,SET,187,-0.11845,-0.011893,0.061336,0.97326,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP,0.99999
HP_ABNORMAL_CSF_METABOLITE_C...,SET,128,-0.134,-0.01115,0.069382,0.97327,HP_ABNORMAL_CSF_METABOLITE_CONCENTRATION,0.99999
KASLER_HDAC7_TARGETS_2_DN,SET,31,-0.29469,-0.012099,0.15247,0.97336,KASLER_HDAC7_TARGETS_2_DN,0.99999
HP_ASCITES,SET,125,-0.15389,-0.012655,0.079619,0.97336,HP_ASCITES,0.99999
GSE46468_LUNG_INNATE_LYMPHOI...2,SET,164,-0.12108,-0.011392,0.062639,0.97337,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_UP,0.99999
NCOA2_TARGET_GENES,SET,380,-0.088188,-0.012556,0.045617,0.97339,NCOA2_TARGET_GENES,0.99999
LI_PBMC_MENACTRA_AGE_18_45YO...9,SET,53,-0.25971,-0.013934,0.13434,0.97339,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE,0.99999
HP_POOR_COORDINATION,SET,32,-0.29324,-0.012232,0.15165,0.97341,HP_POOR_COORDINATION,0.99999
LUI_THYROID_CANCER_PAX8_PPAR...1,SET,44,-0.23653,-0.011566,0.12231,0.97343,LUI_THYROID_CANCER_PAX8_PPARG_DN,0.99999
GOBP_ENDOSOMAL_LUMEN_ACIDIFI...,SET,11,-0.5245,-0.012835,0.27119,0.97344,GOBP_ENDOSOMAL_LUMEN_ACIDIFICATION,0.99999
MODULE_52,SET,392,-0.087052,-0.012584,0.044993,0.97348,MODULE_52,0.99999
HP_ELEVATED_URINARY_COLLAGEN...,SET,5,-0.74347,-0.012268,0.38415,0.97352,HP_ELEVATED_URINARY_COLLAGEN_DEGRADATION_PRODUCTS,0.99999
GOMF_PROTEIN_METHYLTRANSFERA...,SET,80,-0.17696,-0.011656,0.091419,0.97354,GOMF_PROTEIN_METHYLTRANSFERASE_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_CA2_E...3,SET,24,-0.37102,-0.013406,0.19166,0.97355,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL,0.99999
HP_PRECOCIOUS_PUBERTY_IN_FEM...,SET,9,-0.56889,-0.012593,0.29387,0.97355,HP_PRECOCIOUS_PUBERTY_IN_FEMALES,0.99999
NFE2L3_TARGET_GENES,SET,10,-0.5067,-0.011823,0.26173,0.97356,NFE2L3_TARGET_GENES,0.99999
GOBP_POSITIVE_REGULATION_OF_...586,SET,11,-0.49601,-0.012138,0.2561,0.9736,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.99999
REACTOME_PROCESSING_OF_INTRO...,SET,19,-0.33689,-0.010832,0.17388,0.97365,REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS,0.99999
GSE17721_CTRL_VS_PAM3CSK4_1H...1,SET,184,-0.12496,-0.012447,0.064491,0.97365,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN,0.99999
WP_GLIOBLASTOMA_SIGNALING,SET,80,-0.18494,-0.012182,0.095444,0.97366,WP_GLIOBLASTOMA_SIGNALING,0.99999
GOCC_ORGANELLE_SUBCOMPARTMENT,SET,1359,-0.046931,-0.012287,0.024186,0.97383,GOCC_ORGANELLE_SUBCOMPARTMENT,0.99999
GOMF_MOLECULAR_SEQUESTERING_...,SET,41,-0.25846,-0.012201,0.13317,0.97386,GOMF_MOLECULAR_SEQUESTERING_ACTIVITY,0.99999
HP_MEGACYSTIS,SET,9,-0.60612,-0.013417,0.31223,0.97388,HP_MEGACYSTIS,0.99999
HP_ABNORMAL_CIRCULATING_ORGA...,SET,655,-0.065498,-0.012149,0.033732,0.97391,HP_ABNORMAL_CIRCULATING_ORGANIC_COMPOUND_CONCENTRATION,0.99999
GOBP_BLOOD_VESSEL_ENDOTHELIA...3,SET,23,-0.38375,-0.013575,0.19761,0.97392,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.99999
GOBP_CALCITONIN_FAMILY_RECEP...,SET,7,-0.66734,-0.013029,0.34366,0.97392,GOBP_CALCITONIN_FAMILY_RECEPTOR_SIGNALING_PATHWAY,0.99999
REACTOME_NEGATIVE_REGULATION...7,SET,40,-0.28209,-0.013153,0.14522,0.97396,REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,0.99999
GOCC_CENTRIOLAR_SATELLITE,SET,112,-0.15132,-0.011783,0.077896,0.97396,GOCC_CENTRIOLAR_SATELLITE,0.99999
BIOCARTA_ERK_PATHWAY,SET,26,-0.34231,-0.012873,0.1762,0.97397,BIOCARTA_ERK_PATHWAY,0.99999
WP_NIPBL_ROLE_IN_DNA_DAMAGE_...,SET,7,-0.52639,-0.010277,0.2709,0.97399,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,0.99999
MIR4691_5P,SET,119,-0.15238,-0.012228,0.078403,0.97402,MIR4691_5P,0.99999
MIR8065,SET,134,-0.13671,-0.011637,0.07033,0.97403,MIR8065,0.99999
HP_ABNORMAL_NEUTROPHIL_MORPH...,SET,18,-0.44022,-0.013778,0.2264,0.97407,HP_ABNORMAL_NEUTROPHIL_MORPHOLOGY,0.99999
REACTOME_MAPK_FAMILY_SIGNALI...,SET,308,-0.095717,-0.012294,0.049209,0.97411,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,0.99999
MIR194_3P,SET,81,-0.19191,-0.01272,0.09862,0.97416,MIR194_3P,0.99999
GSE1448_CTRL_VS_ANTI_VBETA5_...1,SET,185,-0.12058,-0.012043,0.061964,0.97416,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...21,SET,28,-0.31256,-0.012197,0.1606,0.97417,GOBP_POSITIVE_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.99999
GSE3982_MAC_VS_NKCELL_DN,SET,177,-0.12528,-0.012242,0.064377,0.97417,GSE3982_MAC_VS_NKCELL_DN,0.99999
ACEVEDO_NORMAL_TISSUE_ADJACE...2,SET,154,-0.12798,-0.011672,0.065748,0.97419,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,0.99999
HP_THORACOLUMBAR_KYPHOSIS,SET,18,-0.41312,-0.01293,0.21223,0.9742,HP_THORACOLUMBAR_KYPHOSIS,0.99999
GSE40666_WT_VS_STAT1_KO_CD8_...4,SET,178,-0.12549,-0.012297,0.064464,0.97421,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.99999
MIR3144_3P,SET,56,-0.21056,-0.011612,0.10813,0.97425,MIR3144_3P,0.99999
GOBP_REGULATION_OF_MAINTENAN...,SET,4,-1.107,-0.016339,0.56828,0.97429,GOBP_REGULATION_OF_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,0.99999
GOBP_REGULATION_OF_GUANYL_NU...,SET,6,-0.73039,-0.013202,0.37481,0.97433,GOBP_REGULATION_OF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,0.99999
KRAS.50_UP.V1_UP,SET,44,-0.2787,-0.013628,0.14301,0.97433,KRAS.50_UP.V1_UP,0.99999
HP_FOCAL_DYSTONIA,SET,122,-0.14433,-0.011727,0.074055,0.97434,HP_FOCAL_DYSTONIA,0.99999
GOMF_NUCLEOSIDE_TRANSMEMBRAN...,SET,10,-0.5784,-0.013496,0.29671,0.97437,GOMF_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE16385_IFNG_TNF_VS_ROSIGLI...2,SET,160,-0.12984,-0.012068,0.066574,0.97442,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.99999
SMID_BREAST_CANCER_BASAL_DN,SET,631,-0.07106,-0.012946,0.03641,0.9745,SMID_BREAST_CANCER_BASAL_DN,0.99999
GOBP_PRIMARY_ALCOHOL_CATABOL...,SET,13,-0.52502,-0.013966,0.26902,0.9745,GOBP_PRIMARY_ALCOHOL_CATABOLIC_PROCESS,0.99999
KEGG_AMINO_SUGAR_AND_NUCLEOT...,SET,40,-0.24747,-0.011539,0.12677,0.97453,KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,0.99999
GOBP_PRESYNAPTIC_MODULATION_...,SET,33,-0.30572,-0.01295,0.15656,0.97457,GOBP_PRESYNAPTIC_MODULATION_OF_CHEMICAL_SYNAPTIC_TRANSMISSION,0.99999
GOBP_L_AMINO_ACID_METABOLIC_...,SET,161,-0.13006,-0.012127,0.066569,0.97463,GOBP_L_AMINO_ACID_METABOLIC_PROCESS,0.99999
GSE360_L_DONOVANI_VS_M_TUBER...4,SET,184,-0.12468,-0.01242,0.063769,0.97471,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP,0.99999
GOBP_REDUCTION_OF_FOOD_INTAK...,SET,6,-0.70131,-0.012677,0.35866,0.97472,GOBP_REDUCTION_OF_FOOD_INTAKE_IN_RESPONSE_TO_DIETARY_EXCESS,0.99999
HP_DEVIATED_NASAL_SEPTUM,SET,6,-0.72879,-0.013173,0.37271,0.97472,HP_DEVIATED_NASAL_SEPTUM,0.99999
GOBP_POSITIVE_REGULATION_OF_...593,SET,7,-0.66123,-0.012909,0.33808,0.97475,GOBP_POSITIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.99999
MODULE_33,SET,346,-0.094691,-0.012877,0.048409,0.97476,MODULE_33,0.99999
MIR3942_5P,SET,197,-0.126,-0.012982,0.064402,0.97478,MIR3942_5P,0.99999
MIR520F_3P,SET,184,-0.12226,-0.012178,0.062494,0.97478,MIR520F_3P,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...4,SET,35,-0.27159,-0.011847,0.13882,0.97479,GAVISH_3CA_METAPROGRAM_EPITHELIAL_CILIA,0.99999
WP_LINOLEIC_ACID_METABOLISM_...,SET,5,-0.82311,-0.013582,0.42041,0.97487,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,0.99999
LY_AGING_PREMATURE_DN,SET,29,-0.29996,-0.011913,0.15319,0.97488,LY_AGING_PREMATURE_DN,0.99999
GSE43863_NAIVE_VS_LY6C_INT_C...1,SET,146,-0.14264,-0.01267,0.072843,0.97488,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_DN,0.99999
GOBP_NUCLEOSIDE_TRANSPORT,SET,10,-0.55993,-0.013065,0.28592,0.9749,GOBP_NUCLEOSIDE_TRANSPORT,0.99999
HP_ABNORMAL_UPPER_LIMB_EPIPH...,SET,54,-0.23329,-0.012634,0.1191,0.97492,HP_ABNORMAL_UPPER_LIMB_EPIPHYSIS_MORPHOLOGY,0.99999
HP_SLURRED_SPEECH,SET,45,-0.24239,-0.011986,0.12373,0.97494,HP_SLURRED_SPEECH,0.99999
GOBP_N_TERMINAL_PROTEIN_AMIN...1,SET,13,-0.45834,-0.012192,0.23393,0.97495,GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_ACETYLATION,0.99999
GSE26030_UNSTIM_VS_RESTIM_TH...2,SET,163,-0.13788,-0.012934,0.070368,0.97496,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP,0.99999
GSE4748_LPS_VS_LPS_AND_CYANO...2,SET,170,-0.12674,-0.012139,0.064683,0.97496,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.99999
MODULE_512,SET,36,-0.27822,-0.012308,0.14198,0.97497,MODULE_512,0.99999
GSE5542_UNTREATED_VS_IFNA_AN...4,SET,163,-0.12921,-0.012121,0.065896,0.97505,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...8,SET,167,-0.133,-0.012627,0.067816,0.97506,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP,0.99999
GSE18281_CORTICAL_VS_MEDULLA...2,SET,182,-0.12782,-0.012663,0.065178,0.97506,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...637,SET,91,-0.16929,-0.011889,0.086274,0.97512,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.99999
KEGG_TASTE_TRANSDUCTION,SET,48,-0.29058,-0.014839,0.14807,0.97514,KEGG_TASTE_TRANSDUCTION,0.99999
WP_IRON_METABOLISM_DISORDERS,SET,15,-0.46027,-0.013151,0.23451,0.97515,WP_IRON_METABOLISM_DISORDERS,0.99999
GOCC_TRANS_GOLGI_NETWORK_MEM...,SET,95,-0.1729,-0.012406,0.088093,0.97515,GOCC_TRANS_GOLGI_NETWORK_MEMBRANE,0.99999
GOBP_REGULATION_OF_MITOCHOND...14,SET,6,-0.6236,-0.011272,0.31768,0.97517,GOBP_REGULATION_OF_MITOCHONDRIAL_TRANSCRIPTION,0.99999
GOBP_REGULATION_OF_SPERM_CAP...,SET,4,-0.96015,-0.014171,0.48906,0.97518,GOBP_REGULATION_OF_SPERM_CAPACITATION,0.99999
MIR4797_5P,SET,105,-0.15468,-0.011664,0.078763,0.97522,MIR4797_5P,0.99999
GOBP_REGULATION_OF_CHOLESTER...2,SET,35,-0.27742,-0.012102,0.14126,0.97522,GOBP_REGULATION_OF_CHOLESTEROL_EFFLUX,0.99999
GOMF_O_ACETYLTRANSFERASE_ACT...,SET,9,-0.57148,-0.01265,0.29097,0.97523,GOMF_O_ACETYLTRANSFERASE_ACTIVITY,0.99999
GOBP_SENSORY_PERCEPTION_OF_M...,SET,170,-0.13762,-0.013181,0.070049,0.97526,GOBP_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS,0.99999
HP_CEREBRAL_INFARCT,SET,35,-0.29304,-0.012783,0.14913,0.97529,HP_CEREBRAL_INFARCT,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...8,SET,46,-0.2822,-0.014108,0.1436,0.9753,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MONOCYTE_SECRETED,0.99999
HP_CRANIAL_HYPEROSTOSIS,SET,40,-0.24544,-0.011444,0.12486,0.97533,HP_CRANIAL_HYPEROSTOSIS,0.99999
XIE_LT_HSC_S1PR3_OE_UP,SET,26,-0.35352,-0.013295,0.17982,0.97534,XIE_LT_HSC_S1PR3_OE_UP,0.99999
HP_MARCUS_GUNN_JAW_WINKING_S...,SET,10,-0.5801,-0.013535,0.29504,0.97535,HP_MARCUS_GUNN_JAW_WINKING_SYNKINESIS,0.99999
GOBP_GALACTOSYLCERAMIDE_BIOS...,SET,6,-0.74929,-0.013544,0.38098,0.97538,GOBP_GALACTOSYLCERAMIDE_BIOSYNTHETIC_PROCESS,0.99999
HP_HYPOPLASTIC_HELICES,SET,10,-0.59145,-0.0138,0.30074,0.97538,HP_HYPOPLASTIC_HELICES,0.99999
WP_MAPK_SIGNALING,SET,234,-0.11535,-0.01294,0.058617,0.97545,WP_MAPK_SIGNALING,0.99999
GOBP_GOLGI_VESICLE_TRANSPORT,SET,281,-0.09628,-0.01182,0.048925,0.97545,GOBP_GOLGI_VESICLE_TRANSPORT,0.99999
HP_ABSENT_FRONTAL_SINUSES,SET,6,-0.60512,-0.010938,0.30741,0.97548,HP_ABSENT_FRONTAL_SINUSES,0.99999
GSE17580_UNINFECTED_VS_S_MAN...1,SET,175,-0.12497,-0.012143,0.06349,0.97548,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN,0.99999
MIR938,SET,69,-0.191,-0.011688,0.09701,0.97551,MIR938,0.99999
GOBP_POSITIVE_REGULATION_OF_...750,SET,29,-0.29559,-0.011739,0.15005,0.97557,GOBP_POSITIVE_REGULATION_OF_TELOMERASE_ACTIVITY,0.99999
DESCARTES_FETAL_LUNG_NEUROEN...,SET,76,-0.21365,-0.013718,0.10845,0.97558,DESCARTES_FETAL_LUNG_NEUROENDOCRINE_CELLS,0.99999
GOBP_CALCIUM_ION_IMPORT,SET,73,-0.20464,-0.012879,0.10386,0.97559,GOBP_CALCIUM_ION_IMPORT,0.99999
WP_NAD_BIOSYNTHETIC_PATHWAYS,SET,22,-0.37125,-0.012844,0.18834,0.97564,WP_NAD_BIOSYNTHETIC_PATHWAYS,0.99999
MIR365B_5P,SET,31,-0.30956,-0.01271,0.15704,0.97564,MIR365B_5P,0.99999
BIOCARTA_EFP_PATHWAY,SET,16,-0.40504,-0.011952,0.20543,0.97567,BIOCARTA_EFP_PATHWAY,0.99999
GSE13485_DAY1_VS_DAY7_YF17D_...2,SET,140,-0.14751,-0.012833,0.074791,0.97571,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_IN...5,SET,196,-0.11953,-0.012284,0.060583,0.97574,GOBP_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...44,SET,260,-0.10475,-0.012377,0.053093,0.97574,GOBP_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,0.99999
HP_MUSCLE_FIBER_NECROSIS,SET,10,-0.53593,-0.012505,0.27157,0.97577,HP_MUSCLE_FIBER_NECROSIS,0.99999
JI_METASTASIS_REPRESSED_BY_S...,SET,24,-0.39535,-0.014285,0.20029,0.97579,JI_METASTASIS_REPRESSED_BY_STK11,0.99999
MURAKAMI_UV_RESPONSE_1HR_UP,SET,14,-0.44447,-0.01227,0.22519,0.97579,MURAKAMI_UV_RESPONSE_1HR_UP,0.99999
REACTOME_SHC_RELATED_EVENTS_...,SET,9,-0.55174,-0.012213,0.27948,0.97581,REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R,0.99999
ZNF423_TARGET_GENES,SET,844,-0.059428,-0.012446,0.030095,0.97584,ZNF423_TARGET_GENES,0.99999
CHEN_HOXA5_TARGETS_9HR_DN,SET,37,-0.29012,-0.013012,0.14686,0.97589,CHEN_HOXA5_TARGETS_9HR_DN,0.99999
GOBP_NUCLEAR_TRANSCRIBED_MRN...4,SET,35,-0.26764,-0.011675,0.13547,0.97589,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,0.99999
GOMF_ADENINE_TRANSMEMBRANE_T...,SET,4,-0.92823,-0.0137,0.46974,0.97592,GOMF_ADENINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_WIDELY_PATENT_FONTANELLES...,SET,15,-0.4632,-0.013235,0.23431,0.97596,HP_WIDELY_PATENT_FONTANELLES_AND_SUTURES,0.99999
GOBP_TRICARBOXYLIC_ACID_META...,SET,15,-0.41368,-0.01182,0.20922,0.97599,GOBP_TRICARBOXYLIC_ACID_METABOLIC_PROCESS,0.99999
HP_IMPAIRED_DISTAL_TACTILE_S...,SET,18,-0.36112,-0.011302,0.18256,0.97604,HP_IMPAIRED_DISTAL_TACTILE_SENSATION,0.99999
GOBP_MEIOTIC_SPINDLE_ORGANIZ...,SET,16,-0.4364,-0.012878,0.22056,0.97606,GOBP_MEIOTIC_SPINDLE_ORGANIZATION,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...43,SET,6,-0.58498,-0.010574,0.29552,0.97611,GOBP_PROTEIN_LOCALIZATION_TO_PHOTORECEPTOR_OUTER_SEGMENT,0.99999
HP_HYDROMETROCOLPOS,SET,28,-0.31977,-0.012479,0.16154,0.97612,HP_HYDROMETROCOLPOS,0.99999
KENNEDY_PBMC_DRYVAX_AGE_18_5...,SET,11,-0.48919,-0.011971,0.2471,0.97612,KENNEDY_PBMC_DRYVAX_AGE_18_50YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...466,SET,22,-0.38109,-0.013184,0.19249,0.97613,GOBP_NEGATIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,0.99999
GAO_LARGE_INTESTINE_24W_C6_S...,SET,12,-0.48929,-0.012505,0.24711,0.97614,GAO_LARGE_INTESTINE_24W_C6_SECRETORY_PROGENITOR,0.99999
GOBP_POSITIVE_REGULATION_OF_...754,SET,37,-0.25032,-0.011226,0.12641,0.97615,GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.99999
chr1q31,SET,30,-0.47026,-0.018994,0.23741,0.97618,chr1q31,0.99999
GSE39916_B_CELL_SPLEEN_VS_PL...2,SET,180,-0.12952,-0.012762,0.065391,0.97618,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP,0.99999
GOBP_REPLACEMENT_OSSIFICATION,SET,28,-0.34087,-0.013302,0.17208,0.97619,GOBP_REPLACEMENT_OSSIFICATION,0.99999
GOBP_REGULATION_OF_INTRACELL...3,SET,139,-0.1365,-0.011832,0.068904,0.9762,GOBP_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,0.99999
GSE22342_CD11C_HIGH_VS_LOW_D...2,SET,174,-0.12988,-0.012585,0.065528,0.97626,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP,0.99999
GOBP_NEURONAL_ACTION_POTENTI...2,SET,10,-0.54869,-0.012803,0.27677,0.97628,GOBP_NEURONAL_ACTION_POTENTIAL_PROPAGATION,0.99999
WP_PROLINE_AND_HYDROXYPROLIN...,SET,5,-0.90104,-0.014868,0.45446,0.97629,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...20,SET,5,-0.66648,-0.010998,0.33613,0.9763,HP_APLASIA_HYPOPLASIA_OF_THE_DIAPHRAGM,0.99999
HP_CYTOCHROME_C_OXIDASE_NEGA...,SET,26,-0.30499,-0.01147,0.15381,0.9763,HP_CYTOCHROME_C_OXIDASE_NEGATIVE_MUSCLE_FIBERS,0.99999
GSE26559_TCF1_KO_VS_WT_LIN_N...2,SET,182,-0.12852,-0.012733,0.0648,0.97633,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP,0.99999
REACTOME_MASTL_FACILITATES_M...,SET,10,-0.51304,-0.011971,0.25857,0.97637,REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION,0.99999
CRX_DN.V1_DN,SET,121,-0.16323,-0.013208,0.082264,0.97638,CRX_DN.V1_DN,0.99999
BIOCARTA_BTG2_PATHWAY,SET,11,-0.44284,-0.010837,0.22301,0.97646,BIOCARTA_BTG2_PATHWAY,0.99999
HP_PULMONARY_HYPOPLASIA,SET,121,-0.15446,-0.012499,0.077771,0.97648,HP_PULMONARY_HYPOPLASIA,0.99999
HP_NECROTIZING_ENTEROCOLITIS,SET,6,-0.66663,-0.01205,0.33561,0.97649,HP_NECROTIZING_ENTEROCOLITIS,0.99999
GSE22103_LPS_VS_GMCSF_AND_IF...2,SET,173,-0.12056,-0.011648,0.060698,0.97649,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,0.99999
REACTOME_MITOTIC_PROMETAPHASE,SET,185,-0.11847,-0.011832,0.059621,0.97653,REACTOME_MITOTIC_PROMETAPHASE,0.99999
GSE36392_MAC_VS_NEUTROPHIL_I...1,SET,186,-0.13224,-0.013243,0.066553,0.97653,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,0.99999
WP_FACTORS_AND_PATHWAYS_AFFE...,SET,36,-0.2892,-0.012794,0.14553,0.97654,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,0.99999
ZERBINI_RESPONSE_TO_SULINDAC...1,SET,6,-0.57301,-0.010357,0.28828,0.97657,ZERBINI_RESPONSE_TO_SULINDAC_DN,0.99999
QUEREC_PBMC_YF_17D_VACCINE_A...1,SET,42,-0.27878,-0.013319,0.14024,0.97658,QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP,0.99999
QUEREC_PBMC_YF_17D_VACCINE_A...2,SET,42,-0.27878,-0.013319,0.14024,0.97658,QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP,0.99999
GSE3337_4H_VS_16H_IFNG_IN_CD...2,SET,185,-0.12167,-0.012152,0.061196,0.9766,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP,0.99999
GOBP_GLUCOSYLCERAMIDE_METABO...,SET,7,-0.6706,-0.013092,0.33717,0.97664,GOBP_GLUCOSYLCERAMIDE_METABOLIC_PROCESS,0.99999
MIKKELSEN_NPC_LCP_WITH_H3K4M...,SET,55,-0.22305,-0.012191,0.11214,0.97665,MIKKELSEN_NPC_LCP_WITH_H3K4ME3,0.99999
HP_LEUKODYSTROPHY,SET,83,-0.16943,-0.011366,0.085167,0.97666,HP_LEUKODYSTROPHY,0.99999
BILD_MYC_ONCOGENIC_SIGNATURE,SET,181,-0.12051,-0.011907,0.060555,0.9767,BILD_MYC_ONCOGENIC_SIGNATURE,0.99999
GSE17186_MEMORY_VS_CD21HIGH_...2,SET,182,-0.12951,-0.012831,0.065059,0.97673,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,0.99999
GOBP_REGULATION_OF_LIPID_LOC...,SET,150,-0.14508,-0.013061,0.072852,0.97678,GOBP_REGULATION_OF_LIPID_LOCALIZATION,0.99999
GOBP_SEMINIFEROUS_TUBULE_DEV...,SET,13,-0.46837,-0.012459,0.23519,0.97678,GOBP_SEMINIFEROUS_TUBULE_DEVELOPMENT,0.99999
HP_ABNORMAL_MYOCARDIUM_MORPH...,SET,511,-0.074954,-0.01233,0.037612,0.97685,HP_ABNORMAL_MYOCARDIUM_MORPHOLOGY,0.99999
PECE_MAMMARY_STEM_CELL_UP,SET,120,-0.1473,-0.01187,0.073911,0.97686,PECE_MAMMARY_STEM_CELL_UP,0.99999
KRAS.LUNG.BREAST_UP.V1_UP,SET,126,-0.16608,-0.013712,0.083292,0.97692,KRAS.LUNG.BREAST_UP.V1_UP,0.99999
GSE12366_GC_BCELL_VS_PLASMA_...2,SET,171,-0.12547,-0.012053,0.062919,0.97692,GSE12366_GC_BCELL_VS_PLASMA_CELL_UP,0.99999
REACTOME_DEFECTIVE_CHST14_CA...,SET,7,-0.58051,-0.011333,0.29108,0.97693,REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE,0.99999
GOMF_FLIPPASE_ACTIVITY,SET,15,-0.46721,-0.01335,0.23428,0.97693,GOMF_FLIPPASE_ACTIVITY,0.99999
TIEN_INTESTINE_PROBIOTICS_24...1,SET,192,-0.12701,-0.012921,0.063678,0.97695,TIEN_INTESTINE_PROBIOTICS_24HR_DN,0.99999
MCDOWELL_ACUTE_LUNG_INJURY_DN,SET,41,-0.28409,-0.013411,0.1424,0.97697,MCDOWELL_ACUTE_LUNG_INJURY_DN,0.99999
NFKBIA_TARGET_GENES,SET,964,-0.056556,-0.012615,0.028338,0.97701,NFKBIA_TARGET_GENES,0.99999
HP_HEMANGIOMATOSIS,SET,19,-0.40967,-0.013173,0.20527,0.97701,HP_HEMANGIOMATOSIS,0.99999
TRAVAGLINI_LUNG_CD4_MEMORY_E...,SET,63,-0.23368,-0.013666,0.11707,0.97703,TRAVAGLINI_LUNG_CD4_MEMORY_EFFECTOR_T_CELL,0.99999
KEGG_MEDICUS_REFERENCE_MITOC...,SET,52,-0.19743,-0.010493,0.09885,0.9771,KEGG_MEDICUS_REFERENCE_MITOCHONDRIAL_COMPLEX_UCP1_IN_THERMOGENESIS,0.99999
GOBP_REGULATION_OF_STEM_CELL...2,SET,10,-0.57009,-0.013302,0.28542,0.9771,GOBP_REGULATION_OF_STEM_CELL_DIVISION,0.99999
CDP_01,SET,87,-0.20454,-0.014047,0.10239,0.97712,CDP_01,0.99999
TRAVAGLINI_LUNG_GOBLET_CELL,SET,138,-0.15172,-0.013105,0.075937,0.97713,TRAVAGLINI_LUNG_GOBLET_CELL,0.99999
GOCC_CALYX_OF_HELD,SET,17,-0.43613,-0.013266,0.21825,0.97715,GOCC_CALYX_OF_HELD,0.99999
GOBP_POSITIVE_REGULATION_OF_...623,SET,39,-0.27068,-0.012463,0.13543,0.97717,GOBP_POSITIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,0.99999
GSE22443_IL2_VS_IL12_TREATED...1,SET,188,-0.12184,-0.012267,0.060953,0.97719,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN,0.99999
GOMF_DEUBIQUITINASE_ACTIVITY,SET,81,-0.17331,-0.011486,0.086652,0.97724,GOMF_DEUBIQUITINASE_ACTIVITY,0.99999
MIR4786_3P,SET,149,-0.15057,-0.01351,0.075251,0.97729,MIR4786_3P,0.99999
THUM_MIR21_TARGETS_HEART_DIS...1,SET,7,-0.80656,-0.015747,0.403,0.97732,THUM_MIR21_TARGETS_HEART_DISEASE_DN,0.99999
GOBP_REGULATION_OF_RNA_POLYM...1,SET,6,-0.69347,-0.012535,0.34648,0.97732,GOBP_REGULATION_OF_RNA_POLYMERASE_II_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.99999
HP_REDUCED_ANTIGEN_SPECIFIC_...,SET,8,-0.57351,-0.01197,0.28654,0.97732,HP_REDUCED_ANTIGEN_SPECIFIC_T_CELL_PROLIFERATION,0.99999
BIOCARTA_MALATEX_PATHWAY,SET,7,-0.59256,-0.011569,0.29605,0.97733,BIOCARTA_MALATEX_PATHWAY,0.99999
GOBP_DOUBLE_STRAND_BREAK_REP...5,SET,9,-0.53628,-0.011871,0.26793,0.97733,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_CLASSICAL_NONHOMOLOGOUS_END_JOINING,0.99999
GSE2585_THYMIC_MACROPHAGE_VS...1,SET,165,-0.13304,-0.012556,0.066461,0.97733,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_DN,0.99999
HP_ACROPARESTHESIA,SET,9,-0.62548,-0.013846,0.31246,0.97734,HP_ACROPARESTHESIA,0.99999
HP_GENERALIZED_EDEMA,SET,24,-0.32688,-0.011811,0.16323,0.97738,HP_GENERALIZED_EDEMA,0.99999
GSE36009_UNSTIM_VS_LPS_STIM_...4,SET,181,-0.12904,-0.012749,0.064437,0.97738,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP,0.99999
GSE27859_CD11C_INT_F480_HI_M...1,SET,179,-0.12613,-0.012394,0.062973,0.9774,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_DN,0.99999
WP_KETOGENESIS_AND_KETOLYSIS,SET,8,-0.68341,-0.014263,0.34117,0.97741,WP_KETOGENESIS_AND_KETOLYSIS,0.99999
GNF2_FBL,SET,129,-0.14255,-0.011907,0.071152,0.97743,GNF2_FBL,0.99999
GOMF_DNA_TOPOISOMERASE_ACTIV...,SET,7,-0.5746,-0.011218,0.2868,0.97743,GOMF_DNA_TOPOISOMERASE_ACTIVITY,0.99999
HP_ABNORMAL_CIRCULATING_AMIN...,SET,150,-0.13726,-0.012357,0.068495,0.97746,HP_ABNORMAL_CIRCULATING_AMINO_ACID_CONCENTRATION,0.99999
GAO_SMALL_INTESTINE_24W_C9_E...,SET,42,-0.27714,-0.013241,0.13828,0.97746,GAO_SMALL_INTESTINE_24W_C9_ENTEROENDOCRINE_CELL,0.99999
USF_C,SET,262,-0.10735,-0.012733,0.053535,0.97752,USF_C,0.99999
GOBP_REGULATION_OF_GROWTH_RA...,SET,5,-0.79364,-0.013096,0.39578,0.97752,GOBP_REGULATION_OF_GROWTH_RATE,0.99999
NGUYEN_NOTCH1_TARGETS_DN,SET,78,-0.19826,-0.012896,0.098865,0.97753,NGUYEN_NOTCH1_TARGETS_DN,0.99999
SESTO_RESPONSE_TO_UV_C3,SET,19,-0.39602,-0.012734,0.19746,0.97754,SESTO_RESPONSE_TO_UV_C3,0.99999
GSE2770_IL12_ACT_VS_ACT_CD4_...3,SET,178,-0.12281,-0.012034,0.061226,0.97755,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN,0.99999
chr9q22,SET,72,-0.3469,-0.021682,0.1729,0.97758,chr9q22,0.99999
GSE11864_CSF1_VS_CSF1_IFNG_I...2,SET,161,-0.13386,-0.012481,0.066723,0.97758,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP,0.99999
GILDEA_METASTASIS,SET,28,-0.33633,-0.013125,0.16758,0.97762,GILDEA_METASTASIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...269,SET,47,-0.27022,-0.013655,0.13463,0.97762,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GSE5589_LPS_VS_LPS_AND_IL10_...7,SET,185,-0.12803,-0.012788,0.063785,0.97763,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_DN,0.99999
GOMF_HISTONE_KINASE_ACTIVITY,SET,21,-0.36326,-0.012279,0.18092,0.97766,GOMF_HISTONE_KINASE_ACTIVITY,0.99999
GSE22611_NOD2_VS_CTRL_TRANSD...2,SET,174,-0.1252,-0.012131,0.062353,0.97766,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,0.99999
GOBP_NUCLEOSIDE_TRIPHOSPHATE...3,SET,220,-0.11085,-0.012062,0.055205,0.97767,GOBP_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...7,SET,5,-0.77312,-0.012757,0.38499,0.97768,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PACER_RUBCN_PI3KC3_C2,0.99999
HP_NARROW_PELVIS_BONE,SET,7,-0.56686,-0.011067,0.28221,0.9777,HP_NARROW_PELVIS_BONE,0.99999
GSE360_L_DONOVANI_VS_B_MALAY...2,SET,173,-0.13475,-0.01302,0.067079,0.97772,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP,0.99999
GOMF_ATPASE_COUPLED_INTRAMEM...,SET,26,-0.35466,-0.013338,0.17642,0.97779,GOMF_ATPASE_COUPLED_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY,0.99999
HP_ABNORMAL_CIRCULATING_HAPT...,SET,11,-0.47949,-0.011734,0.2385,0.9778,HP_ABNORMAL_CIRCULATING_HAPTOGLOBIN_CONCENTRATION,0.99999
GOMF_PROTEIN_SEQUESTERING_AC...,SET,25,-0.34212,-0.012617,0.17014,0.97782,GOMF_PROTEIN_SEQUESTERING_ACTIVITY,0.99999
GOCC_CLATHRIN_SCULPTED_VESIC...,SET,12,-0.54471,-0.013922,0.27086,0.97783,GOCC_CLATHRIN_SCULPTED_VESICLE,0.99999
GOBP_REGULATION_OF_TELOMERAS...,SET,43,-0.24953,-0.012062,0.12399,0.97791,GOBP_REGULATION_OF_TELOMERASE_ACTIVITY,0.99999
TERF1_TARGET_GENES,SET,214,-0.11702,-0.01256,0.058141,0.97792,TERF1_TARGET_GENES,0.99999
GOBP_CXCL12_ACTIVATED_CXCR4_...,SET,4,-0.9796,-0.014458,0.48654,0.97796,GOBP_CXCL12_ACTIVATED_CXCR4_SIGNALING_PATHWAY,0.99999
GSE20715_WT_VS_TLR4_KO_48H_O...2,SET,178,-0.13015,-0.012754,0.064639,0.97796,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP,0.99999
MIR4500,SET,465,-0.082193,-0.012914,0.040819,0.97797,MIR4500,0.99999
MIR4679,SET,141,-0.14878,-0.012988,0.073883,0.97797,MIR4679,0.99999
GOBP_CELLULAR_RESPONSE_TO_IN...8,SET,78,-0.20096,-0.013071,0.099786,0.97798,GOBP_CELLULAR_RESPONSE_TO_INTERLEUKIN_1,0.99999
GOBP_ZINC_ION_TRANSPORT,SET,29,-0.29833,-0.011848,0.14812,0.97799,GOBP_ZINC_ION_TRANSPORT,0.99999
REACTOME_ACTIVATION_OF_CASPA...,SET,5,-0.72507,-0.011964,0.35991,0.97802,REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE,0.99999
MIR3175,SET,158,-0.13484,-0.012455,0.066924,0.97803,MIR3175,0.99999
GOBP_NEGATIVE_REGULATION_OF_...54,SET,4,-0.93623,-0.013818,0.46467,0.97803,GOBP_NEGATIVE_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,0.99999
BOSCO_TH1_CYTOTOXIC_MODULE,SET,107,-0.18175,-0.013835,0.090198,0.97804,BOSCO_TH1_CYTOTOXIC_MODULE,0.99999
GOBP_CELL_PROLIFERATION_IN_M...,SET,7,-0.66982,-0.013077,0.33238,0.97805,GOBP_CELL_PROLIFERATION_IN_MIDBRAIN,0.99999
GCM_HDAC1,SET,35,-0.27173,-0.011854,0.13483,0.97806,GCM_HDAC1,0.99999
MIR6814_3P_MIR6872_5P,SET,7,-0.65837,-0.012854,0.32647,0.97813,MIR6814_3P_MIR6872_5P,0.99999
VERRECCHIA_EARLY_RESPONSE_TO...,SET,52,-0.25003,-0.013288,0.12389,0.97821,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,0.99999
HP_NASAL_DYSARTHRIA,SET,29,-0.31944,-0.012686,0.15828,0.97821,HP_NASAL_DYSARTHRIA,0.99999
HP_COOMBS_POSITIVE_HEMOLYTIC...,SET,9,-0.60499,-0.013392,0.29968,0.97824,HP_COOMBS_POSITIVE_HEMOLYTIC_ANEMIA,0.99999
GOBP_BILE_ACID_SIGNALING_PAT...,SET,11,-0.55218,-0.013512,0.27349,0.97825,GOBP_BILE_ACID_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...251,SET,9,-0.68109,-0.015077,0.33729,0.97826,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_WOUND_HEALING,0.99999
GOCC_9PLUS0_NON_MOTILE_CILIUM,SET,114,-0.16023,-0.012587,0.079311,0.97832,GOCC_9PLUS0_NON_MOTILE_CILIUM,0.99999
GSE24142_EARLY_THYMIC_PROGEN...7,SET,180,-0.12824,-0.012636,0.063469,0.97833,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_DN,0.99999
KANG_IMMORTALIZED_BY_TERT_UP,SET,82,-0.19952,-0.013305,0.098726,0.97835,KANG_IMMORTALIZED_BY_TERT_UP,0.99999
GOBP_REGULATION_OF_HETEROCHR...,SET,18,-0.40969,-0.012822,0.20271,0.97836,GOBP_REGULATION_OF_HETEROCHROMATIN_FORMATION,0.99999
NAB2_TARGET_GENES,SET,1207,-0.051408,-0.012741,0.025432,0.97837,NAB2_TARGET_GENES,0.99999
ZNF582_TARGET_GENES,SET,51,-0.24075,-0.012671,0.11904,0.97842,ZNF582_TARGET_GENES,0.99999
PID_PI3K_PLC_TRK_PATHWAY,SET,36,-0.30223,-0.01337,0.14944,0.97843,PID_PI3K_PLC_TRK_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...258,SET,307,-0.096493,-0.012373,0.047703,0.97845,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.99999
SANCHEZ_MDM2_TARGETS,SET,9,-0.56332,-0.01247,0.27839,0.97848,SANCHEZ_MDM2_TARGETS,0.99999
GSE36476_CTRL_VS_TSST_ACT_16...4,SET,173,-0.13375,-0.012923,0.06608,0.97851,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP,0.99999
HP_NEOPLASM_OF_THE_LUNG,SET,60,-0.22283,-0.012718,0.11004,0.97856,HP_NEOPLASM_OF_THE_LUNG,0.99999
REACTOME_PLATELET_SENSITIZAT...,SET,16,-0.42607,-0.012573,0.21036,0.97858,REACTOME_PLATELET_SENSITIZATION_BY_LDL,0.99999
HINATA_NFKB_MATRIX,SET,10,-0.5974,-0.013939,0.29488,0.97861,HINATA_NFKB_MATRIX,0.99999
MIR935,SET,106,-0.17703,-0.013413,0.087363,0.97863,MIR935,0.99999
HP_INCOORDINATION,SET,251,-0.10777,-0.012515,0.053159,0.97868,HP_INCOORDINATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...525,SET,29,-0.3054,-0.012129,0.1506,0.9787,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,0.99999
KIM_MYCN_AMPLIFICATION_TARGE...2,SET,79,-0.20049,-0.013124,0.09885,0.97872,KIM_MYCN_AMPLIFICATION_TARGETS_UP,0.99999
AMIT_EGF_RESPONSE_40_MCF10A,SET,15,-0.48346,-0.013814,0.23834,0.97873,AMIT_EGF_RESPONSE_40_MCF10A,0.99999
KEGG_ENDOMETRIAL_CANCER,SET,50,-0.25114,-0.013088,0.12381,0.97873,KEGG_ENDOMETRIAL_CANCER,0.99999
GRAHAM_CML_QUIESCENT_VS_CML_...1,SET,10,-0.63209,-0.014748,0.3116,0.97874,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN,0.99999
GCNP_SHH_UP_EARLY.V1_DN,SET,150,-0.14241,-0.012821,0.070182,0.97877,GCNP_SHH_UP_EARLY.V1_DN,0.99999
SHEDDEN_LUNG_CANCER_GOOD_SUR...1,SET,252,-0.11233,-0.01307,0.055354,0.97878,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,0.99999
HP_ANGULAR_CHEILITIS,SET,11,-0.57879,-0.014164,0.28512,0.97881,HP_ANGULAR_CHEILITIS,0.99999
GSE16385_UNTREATED_VS_12H_IF...2,SET,159,-0.13866,-0.012849,0.068288,0.97884,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,0.99999
GOCC_PERINEURONAL_NET,SET,10,-0.56753,-0.013242,0.27939,0.97888,GOCC_PERINEURONAL_NET,0.99999
GOBP_TUBE_DEVELOPMENT,SET,1009,-0.058363,-0.013301,0.028727,0.9789,GOBP_TUBE_DEVELOPMENT,0.99999
GSE26023_PHD3_KO_VS_WT_NEUTR...1,SET,178,-0.12521,-0.01227,0.061626,0.97891,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_DN,0.99999
PURBEY_TARGETS_OF_CTBP1_AND_...2,SET,65,-0.19844,-0.011787,0.097615,0.97896,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,0.99999
MYBL1_TARGET_GENES,SET,353,-0.089362,-0.012272,0.043953,0.97897,MYBL1_TARGET_GENES,0.99999
GSE2770_IL12_AND_TGFB_ACT_VS...4,SET,178,-0.12667,-0.012413,0.062297,0.97898,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP,0.99999
MIKKELSEN_ES_LCP_WITH_H3K4ME3,SET,132,-0.15154,-0.012804,0.074522,0.97899,MIKKELSEN_ES_LCP_WITH_H3K4ME3,0.99999
GOBP_NEUROBLAST_MIGRATION,SET,6,-0.82798,-0.014966,0.40694,0.97905,GOBP_NEUROBLAST_MIGRATION,0.99999
GSE33162_UNTREATED_VS_4H_LPS...2,SET,183,-0.12829,-0.012744,0.063053,0.97905,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP,0.99999
BROWNE_HCMV_INFECTION_6HR_DN,SET,147,-0.1443,-0.012861,0.070893,0.97909,BROWNE_HCMV_INFECTION_6HR_DN,0.99999
MDM2_TARGET_GENES,SET,9,-0.52445,-0.011609,0.25763,0.9791,MDM2_TARGET_GENES,0.99999
MIKKELSEN_MCV6_LCP_WITH_H3K2...,SET,24,-0.36593,-0.013222,0.17972,0.97912,MIKKELSEN_MCV6_LCP_WITH_H3K27ME3,0.99999
HP_CRANIOFACIAL_OSTEOSCLEROS...,SET,13,-0.47062,-0.012519,0.23112,0.97913,HP_CRANIOFACIAL_OSTEOSCLEROSIS,0.99999
MIR670_5P,SET,230,-0.11627,-0.012932,0.057073,0.97917,MIR670_5P,0.99999
GOBP_REGULATION_OF_IRON_ION_...1,SET,3,-1.1666,-0.014912,0.57235,0.97923,GOBP_REGULATION_OF_IRON_ION_TRANSMEMBRANE_TRANSPORT,0.99999
GSE26928_CENTR_MEMORY_VS_CXC...1,SET,158,-0.13659,-0.012617,0.067012,0.97924,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,0.99999
KRAS.600_UP.V1_UP,SET,249,-0.12251,-0.014171,0.060092,0.97926,KRAS.600_UP.V1_UP,0.99999
AAGCACA_MIR218,SET,373,-0.094725,-0.013364,0.046448,0.97929,AAGCACA_MIR218,0.99999
HP_LYMPHOMA,SET,112,-0.16521,-0.012865,0.080988,0.97931,HP_LYMPHOMA,0.99999
GNF2_BUB1,SET,26,-0.31453,-0.011828,0.15415,0.97934,GNF2_BUB1,0.99999
COLLIS_PRKDC_REGULATORS,SET,13,-0.53026,-0.014106,0.25985,0.97935,COLLIS_PRKDC_REGULATORS,0.99999
GSE23321_CD8_STEM_CELL_MEMOR...3,SET,180,-0.12736,-0.012549,0.062406,0.97936,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,0.99999
BLALOCK_ALZHEIMERS_DISEASE_I...1,SET,149,-0.13663,-0.012259,0.0669,0.97943,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,0.99999
PID_P53_REGULATION_PATHWAY,SET,55,-0.22956,-0.012546,0.11239,0.97944,PID_P53_REGULATION_PATHWAY,0.99999
REACTOME_RNA_POLYMERASE_III_...3,SET,26,-0.28576,-0.010747,0.13992,0.97944,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER,0.99999
GSE9946_LISTERIA_INF_MATURE_...2,SET,122,-0.15104,-0.012272,0.073952,0.97944,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,0.99999
GOBP_CHAPERONE_MEDIATED_PROT...2,SET,72,-0.18983,-0.011865,0.092932,0.97945,GOBP_CHAPERONE_MEDIATED_PROTEIN_FOLDING,0.99999
HP_DYSCHROMATOPSIA,SET,29,-0.33373,-0.013254,0.16322,0.97955,HP_DYSCHROMATOPSIA,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...16,SET,46,-0.28948,-0.014472,0.14146,0.97963,GAVISH_3CA_MALIGNANT_METAPROGRAM_25_ASTROCYTES,0.99999
PID_TGFBR_PATHWAY,SET,52,-0.25153,-0.013368,0.12287,0.97966,PID_TGFBR_PATHWAY,0.99999
REACTOME_ER_QUALITY_CONTROL_...,SET,19,-0.38518,-0.012385,0.18816,0.97967,REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC,0.99999
GOMF_CYTOKINE_BINDING,SET,130,-0.16186,-0.013572,0.079061,0.97968,GOMF_CYTOKINE_BINDING,0.99999
KEGG_MEDICUS_REFERENCE_BLOOD...1,SET,6,-0.78352,-0.014163,0.38267,0.97969,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_1_BIOSYNTHESIS,0.99999
REACTOME_PEPTIDE_HORMONE_MET...,SET,81,-0.20743,-0.013748,0.1013,0.97969,REACTOME_PEPTIDE_HORMONE_METABOLISM,0.99999
MIR1288_5P,SET,46,-0.28361,-0.014179,0.13851,0.97969,MIR1288_5P,0.99999
GOBP_HINDBRAIN_RADIAL_GLIA_G...,SET,8,-0.71093,-0.014838,0.347,0.97975,GOBP_HINDBRAIN_RADIAL_GLIA_GUIDED_CELL_MIGRATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_RES...,SET,98,-0.1962,-0.014296,0.095733,0.97978,HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE,0.99999
GOBP_REGULATION_OF_BILE_ACID...3,SET,5,-0.73947,-0.012202,0.36077,0.97979,GOBP_REGULATION_OF_BILE_ACID_SECRETION,0.99999
WIELAND_UP_BY_HBV_INFECTION,SET,93,-0.18681,-0.013263,0.091128,0.97981,WIELAND_UP_BY_HBV_INFECTION,0.99999
KEGG_PENTOSE_PHOSPHATE_PATHW...,SET,22,-0.35657,-0.012336,0.17384,0.97986,KEGG_PENTOSE_PHOSPHATE_PATHWAY,0.99999
MIR631,SET,48,-0.25797,-0.013174,0.12577,0.97987,MIR631,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...15,SET,172,-0.12848,-0.012378,0.062618,0.9799,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN,0.99999
GOMF_GUANYLYLTRANSFERASE_ACT...,SET,4,-0.81777,-0.01207,0.39841,0.97994,GOMF_GUANYLYLTRANSFERASE_ACTIVITY,0.99999
REACTOME_ER_TO_GOLGI_ANTEROG...,SET,150,-0.13525,-0.012176,0.065884,0.97995,REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,0.99999
HP_CUTANEOUS_AMYLOIDOSIS,SET,5,-0.79198,-0.013069,0.38575,0.97996,HP_CUTANEOUS_AMYLOIDOSIS,0.99999
GSE32986_UNSTIM_VS_CURDLAN_L...2,SET,190,-0.12323,-0.012471,0.060012,0.97997,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP,0.99999
GOBP_ADENYLATE_CYCLASE_ACTIV...2,SET,9,-0.67289,-0.014895,0.32737,0.98007,GOBP_ADENYLATE_CYCLASE_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOMF_UBIQUITIN_LIKE_PROTEIN_...6,SET,93,-0.16521,-0.011729,0.080374,0.98008,GOMF_UBIQUITIN_LIKE_PROTEIN_PEPTIDASE_ACTIVITY,0.99999
HP_HOMOCYSTINURIA,SET,9,-0.57179,-0.012657,0.27818,0.98008,HP_HOMOCYSTINURIA,0.99999
CEBPB_01,SET,240,-0.11652,-0.013235,0.056675,0.98009,CEBPB_01,0.99999
WP_VITAMIN_D_RECEPTOR_PATHWAY,SET,168,-0.14663,-0.013963,0.071314,0.98011,WP_VITAMIN_D_RECEPTOR_PATHWAY,0.99999
NAKAMURA_TUMOR_ZONE_PERIPHER...2,SET,249,-0.10917,-0.012628,0.05306,0.98017,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,0.99999
UNTERMAN_PROGRESSIVE_VS_STAB...1,SET,4,-1.0442,-0.015412,0.50733,0.98021,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_B_CELL_DN,0.99999
GOBP_SPHINGOMYELIN_METABOLIC...,SET,20,-0.38816,-0.012805,0.18855,0.98023,GOBP_SPHINGOMYELIN_METABOLIC_PROCESS,0.99999
GOBP_VESICLE_MEDIATED_TRANSP...4,SET,138,-0.14613,-0.012622,0.070978,0.98023,GOBP_VESICLE_MEDIATED_TRANSPORT_TO_THE_PLASMA_MEMBRANE,0.99999
chr4p11,SET,8,-0.97065,-0.020258,0.47146,0.98024,chr4p11,0.99999
JAZAG_TGFB1_SIGNALING_VIA_SM...2,SET,98,-0.17791,-0.012964,0.086405,0.98025,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,0.99999
VILLANUEVA_LIVER_CANCER_KRT1...2,SET,152,-0.13787,-0.012493,0.066954,0.98025,VILLANUEVA_LIVER_CANCER_KRT19_UP,0.99999
MIR4450,SET,66,-0.20629,-0.012347,0.10017,0.98026,MIR4450,0.99999
WP_MALE_INFERTILITY,SET,132,-0.151,-0.012758,0.073301,0.98029,WP_MALE_INFERTILITY,0.99999
GOBP_GOLGI_TO_PLASMA_MEMBRAN...1,SET,40,-0.26669,-0.012435,0.12947,0.98029,GOBP_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.99999
GOMF_STRUCTURAL_MOLECULE_ACT...1,SET,650,-0.072366,-0.013374,0.035123,0.98031,GOMF_STRUCTURAL_MOLECULE_ACTIVITY,0.99999
HP_ABNORMAL_LACRIMAL_PUNCTUM...,SET,8,-0.618,-0.012898,0.29991,0.98032,HP_ABNORMAL_LACRIMAL_PUNCTUM_MORPHOLOGY,0.99999
GOMF_RIBOSOMAL_PROTEIN_S6_KI...,SET,5,-0.73887,-0.012192,0.35855,0.98033,GOMF_RIBOSOMAL_PROTEIN_S6_KINASE_ACTIVITY,0.99999
REACTOME_NEUROTRANSMITTER_RE...2,SET,47,-0.2864,-0.014473,0.13896,0.98034,REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE,0.99999
HP_EARLY_ONSET_OF_SEXUAL_MAT...,SET,150,-0.14919,-0.01343,0.072358,0.98038,HP_EARLY_ONSET_OF_SEXUAL_MATURATION,0.99999
REACTOME_RHOG_GTPASE_CYCLE,SET,68,-0.2283,-0.013869,0.1107,0.9804,REACTOME_RHOG_GTPASE_CYCLE,0.99999
GOBP_REGULATION_OF_SISTER_CH...2,SET,101,-0.16597,-0.012277,0.080471,0.98041,GOBP_REGULATION_OF_SISTER_CHROMATID_SEGREGATION,0.99999
GOCC_NUCLEOLAR_EXOSOME_RNASE...,SET,9,-0.50397,-0.011156,0.2442,0.98047,GOCC_NUCLEOLAR_EXOSOME_RNASE_COMPLEX,0.99999
GOBP_REGULATION_OF_ESTABLISH...1,SET,13,-0.50968,-0.013558,0.24679,0.98054,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY,0.99999
HOLLEMAN_PREDNISOLONE_RESIST...3,SET,9,-0.59913,-0.013262,0.29006,0.98056,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN,0.99999
WP_HOSTPATHOGEN_INTERACTION_...1,SET,21,-0.4108,-0.013886,0.19878,0.98061,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,0.99999
GSE15750_DAY6_VS_DAY10_TRAF6...2,SET,180,-0.12738,-0.012551,0.061636,0.98061,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP,0.99999
BROWNE_HCMV_INFECTION_24HR_UP,SET,134,-0.15454,-0.013155,0.074767,0.98062,BROWNE_HCMV_INFECTION_24HR_UP,0.99999
FRASOR_TAMOXIFEN_RESPONSE_UP,SET,44,-0.27818,-0.013602,0.13458,0.98063,FRASOR_TAMOXIFEN_RESPONSE_UP,0.99999
GOBP_UDP_N_ACETYLGLUCOSAMINE...1,SET,9,-0.61228,-0.013553,0.2962,0.98063,GOBP_UDP_N_ACETYLGLUCOSAMINE_BIOSYNTHETIC_PROCESS,0.99999
REACTOME_MITOTIC_G2_G2_M_PHA...,SET,187,-0.12022,-0.012071,0.058118,0.9807,REACTOME_MITOTIC_G2_G2_M_PHASES,0.99999
GOBP_REGULATION_OF_CD4_POSIT...2,SET,53,-0.25907,-0.0139,0.1252,0.98073,GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
GSE12198_CTRL_VS_HIGH_IL2_ST...2,SET,180,-0.13071,-0.012879,0.063158,0.98075,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_UP,0.99999
chr20p11,SET,52,-0.44673,-0.023742,0.21581,0.98077,chr20p11,0.99999
MIR5004_5P,SET,114,-0.16425,-0.012903,0.079341,0.98078,MIR5004_5P,0.99999
MIR2392,SET,68,-0.21623,-0.013136,0.10443,0.98079,MIR2392,0.99999
REACTOME_DISEASES_OF_SIGNAL_...,SET,439,-0.08442,-0.012898,0.040771,0.9808,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,0.99999
GCM_PPP1CC,SET,51,-0.21018,-0.011062,0.10149,0.98081,GCM_PPP1CC,0.99999
HP_POLAR_CATARACT,SET,15,-0.48194,-0.013771,0.23272,0.98081,HP_POLAR_CATARACT,0.99999
MIR4710,SET,72,-0.20851,-0.013033,0.10067,0.98082,MIR4710,0.99999
HP_TOTAL_OPHTHALMOPLEGIA,SET,5,-0.75544,-0.012466,0.36475,0.98082,HP_TOTAL_OPHTHALMOPLEGIA,0.99999
GSE10325_LUPUS_BCELL_VS_LUPU...1,SET,188,-0.1356,-0.013652,0.065469,0.98082,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN,0.99999
TRAVAGLINI_LUNG_BASOPHIL_MAS...2,SET,423,-0.089077,-0.013365,0.043,0.98084,TRAVAGLINI_LUNG_BASOPHIL_MAST_2_CELL,0.99999
GSE2585_AIRE_KO_VS_WT_CD80_H...1,SET,181,-0.13093,-0.012937,0.0632,0.98085,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_DN,0.99999
WU_HBX_TARGETS_1_DN,SET,22,-0.40421,-0.013984,0.19509,0.98086,WU_HBX_TARGETS_1_DN,0.99999
GOBP_CO_TRANSCRIPTIONAL_RNA_...,SET,10,-0.48609,-0.011342,0.23449,0.9809,GOBP_CO_TRANSCRIPTIONAL_RNA_3_END_PROCESSING_CLEAVAGE_AND_POLYADENYLATION_PATHWAY,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...8,SET,135,-0.15607,-0.013334,0.075293,0.9809,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP,0.99999
GSE339_CD4POS_VS_CD8POS_DC_I...2,SET,183,-0.12818,-0.012734,0.061834,0.9809,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP,0.99999
REACTOME_RRNA_PROCESSING,SET,177,-0.1251,-0.012224,0.060334,0.98093,REACTOME_RRNA_PROCESSING,0.99999
GOBP_KETONE_BODY_BIOSYNTHETI...,SET,6,-0.72918,-0.01318,0.35142,0.981,GOBP_KETONE_BODY_BIOSYNTHETIC_PROCESS,0.99999
GOBP_RESPONSE_TO_PROSTAGLAND...3,SET,23,-0.42622,-0.015077,0.20541,0.981,GOBP_RESPONSE_TO_PROSTAGLANDIN_E,0.99999
GOBP_REGULATION_OF_CARBOHYDR...2,SET,58,-0.22671,-0.012723,0.10923,0.98102,GOBP_REGULATION_OF_CARBOHYDRATE_CATABOLIC_PROCESS,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_B...,SET,4,-0.79539,-0.011739,0.38313,0.98105,GOBP_PYRIMIDINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MYO...3,SET,22,-0.42924,-0.01485,0.20671,0.98107,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_3_CELL,0.99999
GSE21670_TGFB_VS_IL6_TREATED...1,SET,177,-0.12436,-0.012152,0.059846,0.98114,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_DN,0.99999
WP_BURN_WOUND_HEALING,SET,95,-0.19954,-0.014317,0.096009,0.98115,WP_BURN_WOUND_HEALING,0.99999
GOBP_POSITIVE_REGULATION_OF_...541,SET,13,-0.4827,-0.01284,0.23219,0.98118,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,0.99999
GOMF_HISTONE_METHYLTRANSFERA...1,SET,58,-0.22601,-0.012683,0.10872,0.98118,GOMF_HISTONE_METHYLTRANSFERASE_ACTIVITY,0.99999
HP_INTESTINAL_BLEEDING,SET,6,-0.74669,-0.013497,0.35918,0.98118,HP_INTESTINAL_BLEEDING,0.99999
GOCC_LIPID_DROPLET,SET,91,-0.19079,-0.013399,0.091726,0.98123,GOCC_LIPID_DROPLET,0.99999
GOBP_BONE_MARROW_DEVELOPMENT,SET,9,-0.63105,-0.013969,0.30319,0.98129,GOBP_BONE_MARROW_DEVELOPMENT,0.99999
GOBP_PROTEIN_PALMITOYLATION,SET,28,-0.32443,-0.012661,0.15588,0.98129,GOBP_PROTEIN_PALMITOYLATION,0.99999
REACTOME_PEXOPHAGY,SET,9,-0.59035,-0.013068,0.28361,0.9813,REACTOME_PEXOPHAGY,0.99999
GSE3982_MAST_CELL_VS_EFF_MEM...2,SET,178,-0.13534,-0.013262,0.065024,0.9813,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
KIM_BIPOLAR_DISORDER_OLIGODE...2,SET,597,-0.069816,-0.012384,0.033536,0.98131,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP,0.99999
HP_NEUROINFLAMMATION,SET,18,-0.44037,-0.013783,0.21153,0.98131,HP_NEUROINFLAMMATION,0.99999
GSE7831_UNSTIM_VS_CPG_STIM_P...4,SET,185,-0.13056,-0.01304,0.062717,0.98131,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_UP,0.99999
HP_ABNORMAL_THYROID_STIMULAT...,SET,39,-0.29081,-0.01339,0.13952,0.98143,HP_ABNORMAL_THYROID_STIMULATING_HORMONE_LEVEL,0.99999
REACTOME_TRANSPORT_OF_NUCLEO...1,SET,10,-0.60463,-0.014108,0.29002,0.98145,REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE,0.99999
GSE15330_MEGAKARYOCYTE_ERYTH...2,SET,188,-0.13245,-0.013335,0.06353,0.98145,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_UP,0.99999
MORF_PPP5C,SET,87,-0.17566,-0.012064,0.084248,0.98146,MORF_PPP5C,0.99999
HEBERT_MATRISOME_TNBC_BONE_B...2,SET,7,-0.72595,-0.014173,0.34806,0.98149,HEBERT_MATRISOME_TNBC_BONE_BRAIN_LUNG_LIVER_METASTASTASES_TUMOR_CELL_DERIVED,0.99999
MODULE_93,SET,173,-0.13578,-0.013118,0.065097,0.98149,MODULE_93,0.99999
REACTOME_RECYCLING_PATHWAY_O...,SET,40,-0.29494,-0.013752,0.14137,0.98152,REACTOME_RECYCLING_PATHWAY_OF_L1,0.99999
RUBENSTEIN_SKELETAL_MUSCLE_F...2,SET,256,-0.1157,-0.013567,0.055454,0.98152,RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS,0.99999
ZNF257_TARGET_GENES,SET,445,-0.083625,-0.012861,0.04008,0.98153,ZNF257_TARGET_GENES,0.99999
GSE6674_ANTI_IGM_VS_PL2_3_ST...1,SET,176,-0.13121,-0.012785,0.062874,0.98154,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...584,SET,6,-0.77733,-0.014051,0.37246,0.98155,GOBP_NEGATIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.99999
GOMF_PYRIMIDINE_NUCLEOBASE_T...,SET,7,-0.74195,-0.014485,0.35547,0.98156,GOMF_PYRIMIDINE_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE21678_WT_VS_FOXO1_FOXO3_K...2,SET,161,-0.14304,-0.013337,0.068494,0.98161,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_UP,0.99999
chr3q28,SET,12,-0.6327,-0.016171,0.30287,0.98164,chr3q28,0.99999
BIOCARTA_CBL_PATHWAY,SET,11,-0.5614,-0.013738,0.26871,0.98165,BIOCARTA_CBL_PATHWAY,0.99999
HP_APLASIA_OF_THE_UTERUS,SET,18,-0.44319,-0.013871,0.21213,0.98165,HP_APLASIA_OF_THE_UTERUS,0.99999
GOBP_REGULATION_OF_FILOPODIU...,SET,41,-0.31034,-0.01465,0.14852,0.98166,GOBP_REGULATION_OF_FILOPODIUM_ASSEMBLY,0.99999
HAY_BONE_MARROW_CD34_POS_ERP...,SET,10,-0.51851,-0.012098,0.24813,0.98167,HAY_BONE_MARROW_CD34_POS_ERP_EARLY,0.99999
HP_VITREOUS_FLOATERS,SET,11,-0.56365,-0.013793,0.26968,0.98169,HP_VITREOUS_FLOATERS,0.99999
HP_NEURONAL_LOSS_IN_CENTRAL_...,SET,34,-0.28668,-0.012326,0.13712,0.98171,HP_NEURONAL_LOSS_IN_CENTRAL_NERVOUS_SYSTEM,0.99999
GSE13547_2H_VS_12_H_ANTI_IGM...2,SET,166,-0.14279,-0.013516,0.068206,0.98184,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP,0.99999
GSE42724_NAIVE_VS_B1_BCELL_DN,SET,170,-0.13096,-0.012544,0.062548,0.98185,GSE42724_NAIVE_VS_B1_BCELL_DN,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...4,SET,159,-0.14649,-0.013574,0.069963,0.98186,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP,0.99999
GSE4748_CTRL_VS_LPS_STIM_DC_...1,SET,182,-0.1336,-0.013236,0.063797,0.98187,GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN,0.99999
WP_SPINA_BIFIDA,SET,12,-0.4801,-0.012271,0.22922,0.98188,WP_SPINA_BIFIDA,0.99999
WANG_ADIPOGENIC_GENES_REPRES...,SET,24,-0.36683,-0.013255,0.17514,0.98189,WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1,0.99999
DESCARTES_FETAL_LIVER_MESOTH...,SET,266,-0.11991,-0.014329,0.057218,0.98194,DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS,0.99999
GSE3982_CENT_MEMORY_CD4_TCEL...5,SET,184,-0.123,-0.012252,0.05868,0.98196,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN,0.99999
GCM_PSME1,SET,75,-0.19155,-0.012219,0.091374,0.98197,GCM_PSME1,0.99999
HP_ABNORMAL_METACARPAL_EPIPH...,SET,16,-0.4409,-0.013011,0.2103,0.98198,HP_ABNORMAL_METACARPAL_EPIPHYSIS_MORPHOLOGY,0.99999
GOBP_ISOLEUCINE_METABOLIC_PR...,SET,6,-0.76926,-0.013905,0.36685,0.98199,GOBP_ISOLEUCINE_METABOLIC_PROCESS,0.99999
GOBP_SYNAPTIC_MEMBRANE_ADHES...,SET,26,-0.40101,-0.015081,0.19121,0.982,GOBP_SYNAPTIC_MEMBRANE_ADHESION,0.99999
GYORFFY_DOXORUBICIN_RESISTAN...,SET,34,-0.30108,-0.012945,0.14338,0.98212,GYORFFY_DOXORUBICIN_RESISTANCE,0.99999
GAVISH_3CA_METAPROGRAM_CD4_T...7,SET,38,-0.29602,-0.013454,0.14097,0.98212,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_NAIVE_2,0.99999
KEGG_MAPK_SIGNALING_PATHWAY,SET,255,-0.11765,-0.013769,0.055993,0.98218,KEGG_MAPK_SIGNALING_PATHWAY,0.99999
GSE19772_CTRL_VS_HCMV_INF_MO...3,SET,144,-0.14752,-0.013014,0.070194,0.9822,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN,0.99999
RUBENSTEIN_SKELETAL_MUSCLE_S...2,SET,376,-0.089521,-0.01268,0.042576,0.98224,RUBENSTEIN_SKELETAL_MUSCLE_SMOOTH_MUSCLE_CELLS,0.99999
KEGG_MEDICUS_VARIANT_SCRAPIE...5,SET,5,-0.86987,-0.014354,0.41366,0.98225,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY,0.99999
GSE7852_THYMUS_VS_FAT_TREG_DN,SET,178,-0.13715,-0.013439,0.065202,0.98228,GSE7852_THYMUS_VS_FAT_TREG_DN,0.99999
BIOCARTA_CB1R_PATHWAY,SET,7,-0.67477,-0.013174,0.32074,0.98229,BIOCARTA_CB1R_PATHWAY,0.99999
MODULE_213,SET,74,-0.21885,-0.013867,0.10403,0.98229,MODULE_213,0.99999
PASINI_SUZ12_TARGETS_DN,SET,289,-0.11306,-0.014073,0.053716,0.98233,PASINI_SUZ12_TARGETS_DN,0.99999
GSE24142_DN2_VS_DN3_THYMOCYT...3,SET,185,-0.13551,-0.013535,0.064391,0.98233,GSE24142_DN2_VS_DN3_THYMOCYTE_DN,0.99999
GSE15215_CD2_POS_VS_NEG_PDC_...1,SET,179,-0.12568,-0.01235,0.059699,0.98236,GSE15215_CD2_POS_VS_NEG_PDC_DN,0.99999
GOBP_REGULATION_OF_RESPONSE_...6,SET,15,-0.50756,-0.014502,0.24105,0.98237,GOBP_REGULATION_OF_RESPONSE_TO_FOOD,0.99999
MIR3914,SET,50,-0.2627,-0.013691,0.12476,0.98238,MIR3914,0.99999
GAO_SMALL_INTESTINE_24W_C1_T...,SET,8,-0.58205,-0.012148,0.27641,0.98238,GAO_SMALL_INTESTINE_24W_C1_TUFT_PROGENITOR,0.99999
GCM_HBP1,SET,63,-0.2162,-0.012643,0.10266,0.98239,GCM_HBP1,0.99999
HP_ACRAL_OVERGROWTH,SET,3,-0.90829,-0.01161,0.43128,0.98239,HP_ACRAL_OVERGROWTH,0.99999
GSE411_WT_VS_SOCS3_KO_MACROP...1,SET,185,-0.12859,-0.012844,0.061039,0.98242,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN,0.99999
EGR2_01,SET,179,-0.13475,-0.013241,0.063949,0.98244,EGR2_01,0.99999
SENESE_HDAC1_AND_HDAC2_TARGE...1,SET,203,-0.13218,-0.013823,0.06271,0.98247,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...18,SET,185,-0.13211,-0.013195,0.062639,0.98252,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_UP,0.99999
SA_FAS_SIGNALING,SET,9,-0.58827,-0.013022,0.27889,0.98254,SA_FAS_SIGNALING,0.99999
GOBP_CARBOHYDRATE_CATABOLIC_...,SET,157,-0.13998,-0.01289,0.066364,0.98254,GOBP_CARBOHYDRATE_CATABOLIC_PROCESS,0.99999
HP_STUTTERING,SET,9,-0.57589,-0.012748,0.2729,0.98257,HP_STUTTERING,0.99999
GOBP_CELL_JUNCTION_MAINTENAN...,SET,41,-0.30588,-0.014439,0.14485,0.98264,GOBP_CELL_JUNCTION_MAINTENANCE,0.99999
GOMF_S_ADENOSYLMETHIONINE_DE...,SET,133,-0.1446,-0.012263,0.068447,0.98268,GOMF_S_ADENOSYLMETHIONINE_DEPENDENT_METHYLTRANSFERASE_ACTIVITY,0.99999
GOBP_SENSORY_PERCEPTION_OF_S...2,SET,9,-0.62582,-0.013853,0.29616,0.9827,GOBP_SENSORY_PERCEPTION_OF_SOUR_TASTE,0.99999
SNIP1_TARGET_GENES,SET,593,-0.074914,-0.013245,0.03544,0.98273,SNIP1_TARGET_GENES,0.99999
GOMF_PROTEASE_BINDING,SET,126,-0.16163,-0.013344,0.076464,0.98273,GOMF_PROTEASE_BINDING,0.99999
GOBP_GAP_JUNCTION_ASSEMBLY,SET,16,-0.54275,-0.016016,0.25662,0.98278,GOBP_GAP_JUNCTION_ASSEMBLY,0.99999
MIR6716_5P,SET,118,-0.16482,-0.013171,0.077917,0.98279,MIR6716_5P,0.99999
HP_PERONEAL_MUSCLE_ATROPHY,SET,10,-0.64024,-0.014939,0.30263,0.9828,HP_PERONEAL_MUSCLE_ATROPHY,0.99999
REACTOME_DARPP_32_EVENTS,SET,24,-0.35222,-0.012727,0.16648,0.98281,REACTOME_DARPP_32_EVENTS,0.99999
WP_METHIONINE_METABOLISM_LEA...,SET,10,-0.63845,-0.014897,0.3017,0.98283,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,0.99999
GSE28130_ACTIVATED_VS_INDUCE...1,SET,171,-0.14259,-0.013697,0.067373,0.98284,GSE28130_ACTIVATED_VS_INDUCEED_TREG_DN,0.99999
BIOCARTA_PTEN_PATHWAY,SET,18,-0.43861,-0.013727,0.20718,0.98286,BIOCARTA_PTEN_PATHWAY,0.99999
NEMETH_INFLAMMATORY_RESPONSE...2,SET,76,-0.22405,-0.014386,0.10582,0.98288,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,0.99999
HP_ABNORMAL_PROTEIN_O_LINKED...,SET,5,-0.71323,-0.011769,0.33674,0.98291,HP_ABNORMAL_PROTEIN_O_LINKED_GLYCOSYLATION,0.99999
GOBP_PHOSPHOLIPID_HOMEOSTASIS,SET,17,-0.45034,-0.013698,0.21259,0.98292,GOBP_PHOSPHOLIPID_HOMEOSTASIS,0.99999
HP_INTERMITTENT_DIARRHEA,SET,21,-0.36861,-0.01246,0.17393,0.98296,HP_INTERMITTENT_DIARRHEA,0.99999
HP_ESOPHAGEAL_ATRESIA,SET,25,-0.33036,-0.012183,0.15587,0.98297,HP_ESOPHAGEAL_ATRESIA,0.99999
HP_MYOCARDIAL_FIBROSIS,SET,17,-0.46728,-0.014213,0.22041,0.98299,HP_MYOCARDIAL_FIBROSIS,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...7,SET,47,-0.28715,-0.014511,0.13542,0.983,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_2,0.99999
WP_DISORDERS_IN_KETONE_BODY_...,SET,5,-0.8496,-0.014019,0.40049,0.98305,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,0.99999
MODULE_66,SET,500,-0.086733,-0.014118,0.04087,0.98308,MODULE_66,0.99999
GOBP_MATURATION_OF_5_8S_RRNA...,SET,24,-0.33525,-0.012114,0.15796,0.98309,GOBP_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.99999
DESCARTES_FETAL_MUSCLE_SATEL...,SET,41,-0.29788,-0.014061,0.14031,0.98311,DESCARTES_FETAL_MUSCLE_SATELLITE_CELLS,0.99999
REACTOME_INSULIN_PROCESSING,SET,23,-0.38783,-0.013719,0.18265,0.98313,REACTOME_INSULIN_PROCESSING,0.99999
GOBP_REGULATION_OF_NUCLEOTID...6,SET,80,-0.20304,-0.013374,0.095626,0.98313,GOBP_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,0.99999
GOBP_CYTOCHROME_COMPLEX_ASSE...,SET,32,-0.28167,-0.01175,0.13261,0.98316,GOBP_CYTOCHROME_COMPLEX_ASSEMBLY,0.99999
GOBP_RIBOSOMAL_SMALL_SUBUNIT...1,SET,16,-0.41393,-0.012215,0.19478,0.98321,GOBP_RIBOSOMAL_SMALL_SUBUNIT_ASSEMBLY,0.99999
BUFFA_HYPOXIA_METAGENE,SET,44,-0.27573,-0.013483,0.12966,0.98326,BUFFA_HYPOXIA_METAGENE,0.99999
MIR376B_5P_MIR376C_5P,SET,44,-0.28018,-0.0137,0.13176,0.98326,MIR376B_5P_MIR376C_5P,0.99999
HP_ABDOMINAL_CRAMPS,SET,7,-0.61086,-0.011926,0.28721,0.98328,HP_ABDOMINAL_CRAMPS,0.99999
MIR1251_3P,SET,140,-0.16253,-0.014139,0.076405,0.98329,MIR1251_3P,0.99999
WANG_RESPONSE_TO_GSK3_INHIBI...1,SET,313,-0.099006,-0.012817,0.046538,0.9833,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,0.99999
ZHENG_GLIOBLASTOMA_PLASTICIT...1,SET,57,-0.25931,-0.014427,0.12188,0.9833,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...752,SET,17,-0.43176,-0.013133,0.20293,0.98331,GOBP_POSITIVE_REGULATION_OF_TELOMERE_CAPPING,0.99999
GOBP_RESPIRATORY_CHAIN_COMPL...2,SET,23,-0.32308,-0.011428,0.15185,0.98331,GOBP_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY,0.99999
GSE36476_YOUNG_VS_OLD_DONOR_...4,SET,176,-0.14165,-0.013803,0.066546,0.98335,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP,0.99999
GSE1432_CTRL_VS_IFNG_1H_MICR...1,SET,185,-0.13153,-0.013137,0.061765,0.98339,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...2,SET,93,-0.19796,-0.014054,0.09295,0.9834,GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_CELLS,0.99999
VILLANUEVA_LIVER_CANCER_KRT1...1,SET,55,-0.24285,-0.013273,0.11392,0.98348,VILLANUEVA_LIVER_CANCER_KRT19_DN,0.99999
MIR3691_5P,SET,40,-0.28124,-0.013113,0.13192,0.98348,MIR3691_5P,0.99999
GOBP_EAR_MORPHOGENESIS,SET,117,-0.17974,-0.014303,0.084316,0.98348,GOBP_EAR_MORPHOGENESIS,0.99999
GOBP_GANGLIOSIDE_CATABOLIC_P...,SET,7,-0.73125,-0.014276,0.34301,0.98348,GOBP_GANGLIOSIDE_CATABOLIC_PROCESS,0.99999
GOBP_SMOOTH_MUSCLE_CELL_APOP...,SET,29,-0.33815,-0.013429,0.1586,0.98349,GOBP_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
GSE14415_INDUCED_TREG_VS_TCO...1,SET,146,-0.15318,-0.013606,0.071851,0.98349,GSE14415_INDUCED_TREG_VS_TCONV_DN,0.99999
GSE13887_RESTING_VS_NO_TREAT...1,SET,93,-0.18749,-0.013311,0.087784,0.98364,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_DN,0.99999
SU_LIVER,SET,55,-0.26663,-0.014572,0.12483,0.98365,SU_LIVER,0.99999
GSE19198_CTRL_VS_IL21_TREATE...3,SET,186,-0.13499,-0.013519,0.063194,0.98366,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_DN,0.99999
GOBP_REGULATION_OF_STEROL_TR...,SET,53,-0.25603,-0.013737,0.11979,0.9837,GOBP_REGULATION_OF_STEROL_TRANSPORT,0.99999
PEDERSEN_METASTASIS_BY_ERBB2...5,SET,25,-0.42149,-0.015543,0.19717,0.98372,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,0.99999
GOBP_DEFENSE_RESPONSE_TO_VIR...,SET,280,-0.1129,-0.013836,0.052801,0.98374,GOBP_DEFENSE_RESPONSE_TO_VIRUS,0.99999
GOMF_GLYCEROPHOSPHOLIPID_FLI...,SET,12,-0.58394,-0.014925,0.27305,0.98376,GOMF_GLYCEROPHOSPHOLIPID_FLIPPASE_ACTIVITY,0.99999
HP_ELEVATED_URINARY_CARBOXYL...,SET,94,-0.19053,-0.013599,0.089034,0.98382,HP_ELEVATED_URINARY_CARBOXYLIC_ACID,0.99999
REACTOME_SIGNALING_BY_FGFR3,SET,38,-0.29686,-0.013492,0.13869,0.98383,REACTOME_SIGNALING_BY_FGFR3,0.99999
LEE_METASTASIS_AND_ALTERNATI...2,SET,65,-0.23259,-0.013816,0.10864,0.98385,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,0.99999
GOBP_REGULATION_OF_MESODERM_...,SET,5,-0.86696,-0.014306,0.40469,0.98391,GOBP_REGULATION_OF_MESODERM_DEVELOPMENT,0.99999
GOCC_RNA_POLYMERASE_III_TRAN...,SET,9,-0.50259,-0.011125,0.23459,0.98391,GOCC_RNA_POLYMERASE_III_TRANSCRIPTION_REGULATOR_COMPLEX,0.99999
GARCIA_PINERES_PBMC_HPV_16_L...2,SET,21,-0.40645,-0.013739,0.18969,0.98393,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_POSITIVE,0.99999
GOCC_COATED_VESICLE_MEMBRANE,SET,184,-0.13685,-0.013632,0.063843,0.98396,GOCC_COATED_VESICLE_MEMBRANE,0.99999
HP_ABNORMAL_LYMPHOCYTE_APOPT...,SET,8,-0.66787,-0.013939,0.31153,0.98397,HP_ABNORMAL_LYMPHOCYTE_APOPTOSIS,0.99999
GOBP_RESPONSE_TO_TOPOLOGICAL...,SET,144,-0.14808,-0.013063,0.069058,0.98399,GOBP_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,0.99999
MIR7704,SET,5,-0.86838,-0.014329,0.40493,0.984,MIR7704,0.99999
GSE36476_CTRL_VS_TSST_ACT_40...3,SET,181,-0.12925,-0.01277,0.060177,0.98413,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN,0.99999
KONG_E2F3_TARGETS,SET,90,-0.19109,-0.013347,0.088938,0.98416,KONG_E2F3_TARGETS,0.99999
NRF2_Q4,SET,227,-0.12231,-0.013516,0.056899,0.9842,NRF2_Q4,0.99999
RIGGI_EWING_SARCOMA_PROGENIT...1,SET,172,-0.15331,-0.01477,0.07131,0.98421,RIGGI_EWING_SARCOMA_PROGENITOR_DN,0.99999
GOBP_EXTRINSIC_APOPTOTIC_SIG...2,SET,79,-0.20135,-0.01318,0.093598,0.98426,GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,0.99999
HP_CONGENITAL_FIBROSIS_OF_EX...,SET,6,-0.7435,-0.013439,0.34552,0.98429,HP_CONGENITAL_FIBROSIS_OF_EXTRAOCULAR_MUSCLES,0.99999
HP_ABNORMALITY_OF_VITAMIN_B_...,SET,41,-0.28363,-0.013389,0.13174,0.98434,HP_ABNORMALITY_OF_VITAMIN_B_METABOLISM,0.99999
MEISSNER_BRAIN_HCP_WITH_H3K4...3,SET,1021,-0.065034,-0.014904,0.030194,0.98437,MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.99999
GOBP_AMINO_SUGAR_METABOLIC_P...,SET,38,-0.30812,-0.014004,0.14305,0.98437,GOBP_AMINO_SUGAR_METABOLIC_PROCESS,0.99999
BROWNE_HCMV_INFECTION_12HR_DN,SET,88,-0.20666,-0.014274,0.095923,0.98439,BROWNE_HCMV_INFECTION_12HR_DN,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...9,SET,13,-0.55554,-0.014778,0.2578,0.98441,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR,0.99999
MIR6798_3P,SET,34,-0.31342,-0.013476,0.14544,0.98441,MIR6798_3P,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...26,SET,29,-0.31351,-0.012451,0.14547,0.98442,GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS,0.99999
GSE16385_UNTREATED_VS_12H_RO...1,SET,173,-0.13746,-0.013281,0.063774,0.98443,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,0.99999
WU_HBX_TARGETS_2_UP,SET,21,-0.42163,-0.014252,0.19557,0.98445,WU_HBX_TARGETS_2_UP,0.99999
HERNANDEZ_MITOTIC_ARREST_BY_...3,SET,14,-0.46426,-0.012816,0.21527,0.98448,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN,0.99999
NABA_PROTEOGLYCANS,SET,33,-0.35368,-0.014982,0.16398,0.98448,NABA_PROTEOGLYCANS,0.99999
GSE13485_CTRL_VS_DAY1_YF17D_...1,SET,132,-0.16882,-0.014264,0.078277,0.98448,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN,0.99999
NAKAYA_PBMC_FLUMIST_AGE_18_5...1,SET,614,-0.074505,-0.013396,0.034541,0.98449,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN,0.99999
HP_HAND_MUSCLE_WEAKNESS,SET,43,-0.26672,-0.012893,0.12363,0.9845,HP_HAND_MUSCLE_WEAKNESS,0.99999
SA_G1_AND_S_PHASES,SET,15,-0.46689,-0.013341,0.21638,0.98452,SA_G1_AND_S_PHASES,0.99999
MIR206,SET,340,-0.10152,-0.013687,0.047041,0.98453,MIR206,0.99999
CAGGGTC_MIR504,SET,69,-0.22363,-0.013684,0.10362,0.98453,CAGGGTC_MIR504,0.99999
GSE14350_IL2RB_KO_VS_WT_TEFF...2,SET,181,-0.13608,-0.013445,0.063044,0.98455,GSE14350_IL2RB_KO_VS_WT_TEFF_UP,0.99999
GOBP_MITOCHONDRIAL_RESPIRATO...,SET,82,-0.18168,-0.012115,0.084158,0.98456,GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY,0.99999
GOMF_SEROTONIN_BINDING,SET,10,-0.62141,-0.014499,0.28774,0.98459,GOMF_SEROTONIN_BINDING,0.99999
HP_ABNORMAL_LARGE_INTESTINE_...1,SET,295,-0.10854,-0.013648,0.050244,0.98462,HP_ABNORMAL_LARGE_INTESTINE_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_MIRNA_CAT...,SET,4,-0.75447,-0.011136,0.3491,0.98465,GOBP_REGULATION_OF_MIRNA_CATABOLIC_PROCESS,0.99999
STARK_PREFRONTAL_CORTEX_22Q1...1,SET,448,-0.08279,-0.012774,0.038302,0.98466,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN,0.99999
GSE16522_ANTI_CD3CD28_STIM_V...1,SET,175,-0.13366,-0.012988,0.061821,0.98469,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN,0.99999
MIR4645_3P,SET,102,-0.18268,-0.013579,0.084483,0.9847,MIR4645_3P,0.99999
GOMF_GDP_DISSOCIATION_INHIBI...,SET,15,-0.46364,-0.013248,0.21429,0.98474,GOMF_GDP_DISSOCIATION_INHIBITOR_ACTIVITY,0.99999
FOSTER_TOLERANT_MACROPHAGE_UP,SET,151,-0.16048,-0.014495,0.074119,0.98481,FOSTER_TOLERANT_MACROPHAGE_UP,0.99999
REACTOME_ACROSOME_REACTION_A...,SET,6,-0.86312,-0.015601,0.39826,0.98488,REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING,0.99999
MIR101_5P,SET,37,-0.29454,-0.01321,0.13589,0.98489,MIR101_5P,0.99999
HP_INCREASED_VERTEBRAL_HEIGHT,SET,10,-0.54206,-0.012648,0.25003,0.98491,HP_INCREASED_VERTEBRAL_HEIGHT,0.99999
REACTOME_BBSOME_MEDIATED_CAR...,SET,23,-0.37157,-0.013144,0.17137,0.98492,REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...176,SET,11,-0.61558,-0.015064,0.28393,0.98492,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_NITRIC_OX...3,SET,20,-0.42997,-0.014184,0.19831,0.98492,GOBP_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,0.99999
THUM_MIR21_TARGETS_HEART_DIS...2,SET,16,-0.51584,-0.015222,0.23779,0.98496,THUM_MIR21_TARGETS_HEART_DISEASE_UP,0.99999
REACTOME_DEGRADATION_OF_BETA...,SET,80,-0.19689,-0.012969,0.090765,0.98496,REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,0.99999
REACTOME_SHC_MEDIATED_CASCAD...2,SET,17,-0.46497,-0.014143,0.21431,0.98497,REACTOME_SHC_MEDIATED_CASCADE_FGFR3,0.99999
PID_P38_MKK3_6PATHWAY,SET,26,-0.34474,-0.012965,0.15887,0.98499,PID_P38_MKK3_6PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...463,SET,58,-0.24961,-0.014008,0.11503,0.98499,GOBP_POSITIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS,0.99999
CORRE_MULTIPLE_MYELOMA_UP,SET,64,-0.24787,-0.01461,0.1142,0.98501,CORRE_MULTIPLE_MYELOMA_UP,0.99999
REACTOME_SIGNALING_BY_NOTCH3,SET,46,-0.27597,-0.013797,0.12714,0.98502,REACTOME_SIGNALING_BY_NOTCH3,0.99999
GOBP_RESPONSE_TO_PROSTAGLAND...1,SET,31,-0.38994,-0.01601,0.1795,0.98508,GOBP_RESPONSE_TO_PROSTAGLANDIN,0.99999
DESCARTES_FETAL_STOMACH_NEUR...,SET,40,-0.31523,-0.014698,0.14511,0.98508,DESCARTES_FETAL_STOMACH_NEUROENDOCRINE_CELLS,0.99999
REACTOME_BINDING_AND_UPTAKE_...,SET,38,-0.32146,-0.01461,0.14796,0.98509,REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,0.99999
GOCC_RPAP3_R2TP_PREFOLDIN_LI...,SET,9,-0.5763,-0.012757,0.26523,0.9851,GOCC_RPAP3_R2TP_PREFOLDIN_LIKE_COMPLEX,0.99999
HP_ZOLLINGER_ELLISON_SYNDROME,SET,9,-0.62481,-0.013831,0.28727,0.98518,HP_ZOLLINGER_ELLISON_SYNDROME,0.99999
GSE32423_IL7_VS_IL4_MEMORY_C...1,SET,181,-0.13221,-0.013063,0.060773,0.98519,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN,0.99999
MIR8082,SET,104,-0.18316,-0.013747,0.08419,0.9852,MIR8082,0.99999
GRAESSMANN_RESPONSE_TO_MC_AN...3,SET,76,-0.21301,-0.013677,0.097886,0.98522,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,0.99999
SCHLESINGER_METHYLATED_DE_NO...,SET,80,-0.22843,-0.015047,0.1049,0.98528,SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,0.99999
AGGAAGC_MIR5163P,SET,113,-0.17967,-0.014053,0.082446,0.98534,AGGAAGC_MIR5163P,0.99999
REACTOME_SIGNALING_BY_FGFR2_...1,SET,19,-0.39046,-0.012555,0.17913,0.98536,REACTOME_SIGNALING_BY_FGFR2_IIIA_TM,0.99999
VISALA_RESPONSE_TO_HEAT_SHOC...2,SET,14,-0.46421,-0.012814,0.21292,0.98537,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP,0.99999
GSE18804_SPLEEN_MACROPHAGE_V...6,SET,170,-0.14409,-0.013802,0.066075,0.98539,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP,0.99999
GOBP_DICARBOXYLIC_ACID_BIOSY...,SET,12,-0.58778,-0.015023,0.26952,0.9854,GOBP_DICARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMAL_CIRCULATING_METH...,SET,15,-0.49743,-0.014213,0.22808,0.9854,HP_ABNORMAL_CIRCULATING_METHIONINE_CONCENTRATION,0.99999
HP_HYPERURICEMIA,SET,23,-0.3733,-0.013205,0.17117,0.9854,HP_HYPERURICEMIA,0.99999
HP_HYDROPS_FETALIS,SET,115,-0.17022,-0.01343,0.078038,0.98541,HP_HYDROPS_FETALIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...418,SET,19,-0.47293,-0.015207,0.21679,0.98542,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION,0.99999
GOMF_RACEMASE_AND_EPIMERASE_...2,SET,9,-0.60414,-0.013373,0.27695,0.98542,GOMF_RACEMASE_AND_EPIMERASE_ACTIVITY_ACTING_ON_CARBOHYDRATES_AND_DERIVATIVES,0.99999
ATGCTGC_MIR103_MIR107,SET,197,-0.12913,-0.013304,0.059189,0.98543,ATGCTGC_MIR103_MIR107,0.99999
HP_HYPOMETHIONINEMIA,SET,8,-0.63048,-0.013159,0.28879,0.98548,HP_HYPOMETHIONINEMIA,0.99999
HP_ABNORMAL_SEXUAL_BEHAVIOR,SET,7,-0.68698,-0.013412,0.31461,0.9855,HP_ABNORMAL_SEXUAL_BEHAVIOR,0.99999
GSE22601_DOUBLE_NEGATIVE_VS_...6,SET,167,-0.14458,-0.013727,0.066202,0.98551,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,0.99999
GSE11961_MARGINAL_ZONE_BCELL...1,SET,188,-0.14021,-0.014116,0.064196,0.98552,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.99999
BIOCARTA_SARS_PATHWAY,SET,7,-0.75023,-0.014647,0.34338,0.98554,BIOCARTA_SARS_PATHWAY,0.99999
GOMF_ENZYME_SUBSTRATE_ADAPTO...,SET,65,-0.24033,-0.014275,0.11001,0.98554,GOMF_ENZYME_SUBSTRATE_ADAPTOR_ACTIVITY,0.99999
GSE24142_ADULT_VS_FETAL_DN2_...1,SET,169,-0.14702,-0.014041,0.067275,0.98556,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN,0.99999
BILBAN_B_CLL_LPL_DN,SET,37,-0.32057,-0.014377,0.14668,0.98557,BILBAN_B_CLL_LPL_DN,0.99999
GSE26488_CTRL_VS_PEPTIDE_INJ...3,SET,172,-0.14988,-0.014439,0.068572,0.98557,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN,0.99999
GSE10239_NAIVE_VS_KLRG1HIGH_...1,SET,180,-0.13941,-0.013737,0.063765,0.9856,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.99999
BRCA2_TARGET_GENES,SET,1258,-0.054737,-0.013829,0.025028,0.98562,BRCA2_TARGET_GENES,0.99999
NAKAYA_B_CELL_FLUMIST_AGE_18...2,SET,416,-0.089732,-0.013354,0.041013,0.98565,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP,0.99999
GOMF_TRANSLATION_TERMINATION...,SET,4,-0.87228,-0.012874,0.39856,0.98568,GOMF_TRANSLATION_TERMINATION_FACTOR_ACTIVITY,0.99999
GSE6269_FLU_VS_STAPH_AUREUS_...1,SET,146,-0.15799,-0.014034,0.072177,0.98569,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_DN,0.99999
MODULE_320,SET,19,-0.42683,-0.013725,0.19497,0.9857,MODULE_320,0.99999
REACTOME_GDP_FUCOSE_BIOSYNTH...,SET,4,-0.80615,-0.011898,0.36821,0.98571,REACTOME_GDP_FUCOSE_BIOSYNTHESIS,0.99999
RASHI_RESPONSE_TO_IONIZING_R...5,SET,126,-0.16575,-0.013684,0.075694,0.98572,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,0.99999
MIR4455,SET,100,-0.20111,-0.014802,0.091843,0.98572,MIR4455,0.99999
BUSSLINGER_GASTRIC_D_CELLS,SET,24,-0.42583,-0.015387,0.19437,0.98576,BUSSLINGER_GASTRIC_D_CELLS,0.99999
REACTOME_RUNX3_REGULATES_P14...,SET,10,-0.55984,-0.013063,0.25549,0.98577,REACTOME_RUNX3_REGULATES_P14_ARF,0.99999
REACTOME_RNA_POLYMERASE_III_...2,SET,39,-0.25569,-0.011773,0.11669,0.98578,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION,0.99999
HP_MODERATELY_REDUCED_VISUAL...,SET,7,-0.78265,-0.01528,0.35712,0.98579,HP_MODERATELY_REDUCED_VISUAL_ACUITY,0.99999
MYCMAX_03,SET,230,-0.12182,-0.01355,0.055535,0.98586,MYCMAX_03,0.99999
MODULE_100,SET,492,-0.090623,-0.014636,0.041314,0.98586,MODULE_100,0.99999
MIR758_3P,SET,112,-0.17299,-0.013471,0.078849,0.98588,MIR758_3P,0.99999
PUJANA_BRCA1_PCC_NETWORK,SET,1455,-0.049123,-0.01327,0.022377,0.98592,PUJANA_BRCA1_PCC_NETWORK,0.99999
REACTOME_REGULATION_OF_TP53_...4,SET,17,-0.46546,-0.014158,0.21202,0.98593,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...9,SET,58,-0.23602,-0.013245,0.1075,0.98593,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,0.99999
GOBP_PURINE_NUCLEOSIDE_TRANS...,SET,5,-0.85677,-0.014138,0.39025,0.98593,GOBP_PURINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT,0.99999
GOCC_EXORIBONUCLEASE_COMPLEX,SET,22,-0.35232,-0.012189,0.16045,0.98594,GOCC_EXORIBONUCLEASE_COMPLEX,0.99999
JISON_SICKLE_CELL_DISEASE_DN,SET,167,-0.14445,-0.013715,0.065753,0.98598,JISON_SICKLE_CELL_DISEASE_DN,0.99999
HP_DECREASED_CIRCULATING_REN...,SET,11,-0.56799,-0.013899,0.25853,0.98598,HP_DECREASED_CIRCULATING_RENIN_LEVEL,0.99999
HP_LARYNGEAL_DYSTONIA,SET,13,-0.50362,-0.013397,0.22924,0.98598,HP_LARYNGEAL_DYSTONIA,0.99999
GOBP_NITRIC_OXIDE_CGMP_MEDIA...,SET,6,-0.88511,-0.015999,0.40284,0.98599,GOBP_NITRIC_OXIDE_CGMP_MEDIATED_SIGNALING,0.99999
WP_UDPDERIVED_SUGARS_SYNTHES...,SET,11,-0.57442,-0.014057,0.26134,0.98602,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,0.99999
WP_G13_SIGNALING,SET,35,-0.31146,-0.013587,0.14165,0.98605,WP_G13_SIGNALING,0.99999
REACTOME_COPII_MEDIATED_VESI...,SET,66,-0.22164,-0.013265,0.10071,0.98611,REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,0.99999
GOCC_NUCLEAR_PERIPHERY,SET,139,-0.15619,-0.01354,0.07098,0.98611,GOCC_NUCLEAR_PERIPHERY,0.99999
OVSYANNIKOVA_PBMC_FLUARIX_AG...8,SET,8,-0.61999,-0.01294,0.28175,0.98611,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_UP,0.99999
GOBP_SERINE_FAMILY_AMINO_ACI...3,SET,29,-0.32795,-0.013024,0.14899,0.98613,GOBP_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.99999
GSE20366_TREG_VS_NAIVE_CD4_T...5,SET,178,-0.13865,-0.013586,0.062944,0.98619,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP,0.99999
GOMF_HIGH_VOLTAGE_GATED_CALC...,SET,13,-0.5614,-0.014934,0.25477,0.98621,GOMF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.99999
SRF_01,SET,45,-0.28463,-0.014075,0.12902,0.9863,SRF_01,0.99999
HP_STOMACH_CANCER,SET,33,-0.31925,-0.013524,0.14473,0.9863,HP_STOMACH_CANCER,0.99999
GOBP_REGULATION_OF_TELOMERE_...4,SET,57,-0.23147,-0.012878,0.1049,0.98632,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.99999
GOBP_POSITIVE_REGULATION_OF_...156,SET,8,-0.63288,-0.013209,0.28677,0.98633,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMALITY_OF_THE_RADIAL...,SET,46,-0.27871,-0.013934,0.1263,0.98633,HP_ABNORMALITY_OF_THE_RADIAL_HEAD,0.99999
HP_FETAL_AKINESIA_SEQUENCE,SET,32,-0.32431,-0.013528,0.14695,0.98633,HP_FETAL_AKINESIA_SEQUENCE,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_LAT...2,SET,631,-0.078888,-0.014372,0.03574,0.98635,HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL,0.99999
ABBUD_LIF_SIGNALING_1_UP,SET,38,-0.3274,-0.01488,0.14822,0.9864,ABBUD_LIF_SIGNALING_1_UP,0.99999
LIANG_HEMATOPOIESIS_STEM_CEL...3,SET,15,-0.45566,-0.01302,0.20611,0.98647,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL,0.99999
GSE19888_CTRL_VS_A3R_INHIBIT...2,SET,179,-0.12982,-0.012757,0.058724,0.98647,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_UP,0.99999
ZNF610_TARGET_GENES,SET,708,-0.072146,-0.013892,0.032599,0.98655,ZNF610_TARGET_GENES,0.99999
HP_MUSCLE_STIFFNESS,SET,74,-0.21001,-0.013307,0.094877,0.98656,HP_MUSCLE_STIFFNESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...109,SET,71,-0.22474,-0.013949,0.10151,0.98658,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,0.99999
FURUKAWA_DUSP6_TARGETS_PCI35...2,SET,61,-0.26673,-0.01535,0.12042,0.98662,FURUKAWA_DUSP6_TARGETS_PCI35_UP,0.99999
GOBP_N_TERMINAL_PROTEIN_AMIN...2,SET,24,-0.37495,-0.013548,0.16925,0.98663,GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION,0.99999
GOMF_INOSITOL_1_4_5_TRISPHOS...2,SET,11,-0.61655,-0.015088,0.27827,0.98664,GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_BINDING,0.99999
GOCC_COMMITMENT_COMPLEX,SET,5,-0.62596,-0.010329,0.28235,0.98668,GOCC_COMMITMENT_COMPLEX,0.99999
GOBP_MICROTUBULE_BASED_PROCE...,SET,831,-0.065052,-0.013524,0.029335,0.9867,GOBP_MICROTUBULE_BASED_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...228,SET,28,-0.34171,-0.013335,0.1541,0.9867,GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,0.99999
REACTOME_SEROTONIN_RECEPTORS,SET,11,-0.61959,-0.015162,0.27924,0.98675,REACTOME_SEROTONIN_RECEPTORS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...51,SET,17,-0.45903,-0.013962,0.20686,0.98675,HP_APLASIA_HYPOPLASIA_OF_THE_PALMAR_CREASES,0.99999
HP_DISPROPORTIONATE_TALL_STA...,SET,32,-0.34316,-0.014315,0.15462,0.98676,HP_DISPROPORTIONATE_TALL_STATURE,0.99999
REACTOME_REGULATION_OF_TP53_...6,SET,36,-0.31107,-0.013762,0.14009,0.9868,REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION,0.99999
GSE21670_UNTREATED_VS_IL6_TR...1,SET,183,-0.13819,-0.013728,0.06223,0.9868,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN,0.99999
REACTOME_PRESYNAPTIC_DEPOLAR...,SET,11,-0.61109,-0.014954,0.27513,0.98682,REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING,0.99999
GOMF_SNORNA_BINDING,SET,28,-0.33222,-0.012965,0.14958,0.98682,GOMF_SNORNA_BINDING,0.99999
PID_CMYB_PATHWAY,SET,78,-0.22523,-0.01465,0.10137,0.98685,PID_CMYB_PATHWAY,0.99999
GEISS_RESPONSE_TO_DSRNA_DN,SET,15,-0.47968,-0.013706,0.21586,0.98686,GEISS_RESPONSE_TO_DSRNA_DN,0.99999
HP_ABNORMALITY_OF_THE_HUMERO...,SET,51,-0.26702,-0.014054,0.12016,0.98686,HP_ABNORMALITY_OF_THE_HUMERORADIAL_JOINT,0.99999
GOMF_PYRIMIDINE_NUCLEOSIDE_T...,SET,8,-0.74759,-0.015603,0.33631,0.98688,GOMF_PYRIMIDINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...16,SET,167,-0.15206,-0.014437,0.068376,0.98692,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.99999
KORKOLA_CHORIOCARCINOMA_UP,SET,3,-1.2613,-0.016123,0.56706,0.98693,KORKOLA_CHORIOCARCINOMA_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...381,SET,127,-0.15833,-0.013123,0.071161,0.98695,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,0.99999
GOMF_AMYLOID_BETA_BINDING,SET,80,-0.22998,-0.015149,0.10334,0.98697,GOMF_AMYLOID_BETA_BINDING,0.99999
GOBP_GLYCINE_METABOLIC_PROCE...,SET,12,-0.48758,-0.012462,0.21907,0.98698,GOBP_GLYCINE_METABOLIC_PROCESS,0.99999
GAUCHER_PBMC_YF_VAX_STAMARIL...3,SET,12,-0.5289,-0.013518,0.23744,0.98704,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_DN,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...9,SET,173,-0.13786,-0.01332,0.061836,0.9871,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN,0.99999
MIR708_3P,SET,102,-0.19977,-0.014849,0.089567,0.98713,MIR708_3P,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...1,SET,47,-0.30038,-0.015179,0.13467,0.98714,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1,0.99999
WP_TAR_SYNDROME,SET,49,-0.27701,-0.014292,0.12416,0.98716,WP_TAR_SYNDROME,0.99999
GSE27896_HDAC6_KO_VS_WT_TREG...2,SET,164,-0.14859,-0.013982,0.066578,0.98718,GSE27896_HDAC6_KO_VS_WT_TREG_UP,0.99999
MODULE_12,SET,322,-0.11566,-0.015183,0.05182,0.98719,MODULE_12,0.99999
ZHANG_TARGETS_OF_EWSR1_FLI1_...,SET,83,-0.23167,-0.015542,0.10376,0.98721,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,0.99999
HP_MODERATELY_SHORT_STATURE,SET,4,-0.8639,-0.012751,0.3869,0.98721,HP_MODERATELY_SHORT_STATURE,0.99999
GSE24142_DN2_VS_DN3_THYMOCYT...1,SET,180,-0.14351,-0.01414,0.064274,0.98721,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN,0.99999
MORF_RAGE,SET,136,-0.16549,-0.014191,0.074092,0.98724,MORF_RAGE,0.99999
GOBP_GLUTAMINE_FAMILY_AMINO_...2,SET,24,-0.41997,-0.015175,0.1879,0.98729,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,0.99999
GOBP_RESPONSE_TO_MISFOLDED_P...,SET,17,-0.44887,-0.013653,0.20083,0.98729,GOBP_RESPONSE_TO_MISFOLDED_PROTEIN,0.99999
PID_IGF1_PATHWAY,SET,28,-0.37558,-0.014657,0.1679,0.98735,PID_IGF1_PATHWAY,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...17,SET,38,-0.3611,-0.016412,0.1614,0.98736,GAVISH_3CA_METAPROGRAM_EPITHELIAL_NEUROENDOCRINE,0.99999
GSE8921_3H_VS_24H_TLR1_2_STI...2,SET,175,-0.14674,-0.014258,0.065574,0.98737,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP,0.99999
HP_IRRITABILITY,SET,243,-0.12236,-0.013984,0.054659,0.9874,HP_IRRITABILITY,0.99999
GSE16385_UNTREATED_VS_12H_RO...5,SET,165,-0.14988,-0.014145,0.066902,0.98746,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,0.99999
REACTOME_SIGNALING_BY_WNT,SET,260,-0.11916,-0.01408,0.053156,0.9875,REACTOME_SIGNALING_BY_WNT,0.99999
GOMF_PH_DOMAIN_BINDING,SET,8,-0.67809,-0.014152,0.30233,0.98754,GOMF_PH_DOMAIN_BINDING,0.99999
YAGUE_PRETUMOR_DRUG_RESISTAN...1,SET,12,-0.53069,-0.013564,0.2366,0.98755,YAGUE_PRETUMOR_DRUG_RESISTANCE_DN,0.99999
HP_GAZE_EVOKED_NYSTAGMUS,SET,53,-0.24987,-0.013407,0.1114,0.98755,HP_GAZE_EVOKED_NYSTAGMUS,0.99999
HP_ABNORMALITY_OF_SKELETAL_M...2,SET,106,-0.18282,-0.013852,0.081495,0.98756,HP_ABNORMALITY_OF_SKELETAL_MUSCLE_FIBER_SIZE,0.99999
GSE14769_40MIN_VS_360MIN_LPS...2,SET,179,-0.13735,-0.013496,0.061224,0.98756,GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP,0.99999
HP_DELAYED_ERUPTION_OF_PRIMA...,SET,14,-0.46048,-0.012712,0.20523,0.98757,HP_DELAYED_ERUPTION_OF_PRIMARY_TEETH,0.99999
HP_GENERALIZED_HIRSUTISM,SET,86,-0.21002,-0.014341,0.093594,0.98757,HP_GENERALIZED_HIRSUTISM,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...14,SET,164,-0.1434,-0.013493,0.063908,0.98757,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP,0.99999
GSE22601_IMMATURE_CD4_SINGLE...1,SET,180,-0.13701,-0.0135,0.061059,0.98757,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.99999
GOMF_GLYCOSAMINOGLYCAN_BINDI...,SET,225,-0.14007,-0.015411,0.062394,0.98761,GOMF_GLYCOSAMINOGLYCAN_BINDING,0.99999
GOBP_HISTONE_MRNA_METABOLIC_...,SET,20,-0.35498,-0.01171,0.15806,0.98764,GOBP_HISTONE_MRNA_METABOLIC_PROCESS,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...11,SET,177,-0.13732,-0.013419,0.061066,0.98773,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN,0.99999
FLETCHER_PBMC_BCG_10W_INFANT...1,SET,233,-0.13162,-0.014734,0.058524,0.98774,FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...661,SET,5,-0.86899,-0.014339,0.38625,0.98776,GOBP_NEGATIVE_REGULATION_OF_TUBULIN_DEACETYLATION,0.99999
GOMF_LIPOPROTEIN_PARTICLE_RE...1,SET,18,-0.48364,-0.015137,0.21498,0.98776,GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY,0.99999
ROSS_AML_WITH_PML_RARA_FUSION,SET,69,-0.21728,-0.013296,0.096557,0.98778,ROSS_AML_WITH_PML_RARA_FUSION,0.99999
REACTOME_SHC1_EVENTS_IN_EGFR...,SET,14,-0.52814,-0.014579,0.23468,0.98778,REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING,0.99999
GOBP_ELASTIC_FIBER_ASSEMBLY,SET,8,-0.67239,-0.014033,0.29879,0.98778,GOBP_ELASTIC_FIBER_ASSEMBLY,0.99999
GSE6259_FLT3L_INDUCED_33D1_P...2,SET,177,-0.13963,-0.013644,0.062043,0.98778,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_UP,0.99999
PID_DELTA_NP63_PATHWAY,SET,43,-0.30527,-0.014757,0.13564,0.98779,PID_DELTA_NP63_PATHWAY,0.99999
HP_VIRAL_INFECTION_INDUCED_R...,SET,9,-0.62057,-0.013737,0.27567,0.98781,HP_VIRAL_INFECTION_INDUCED_RHABDOMYOLYSIS,0.99999
GSE14000_TRANSLATED_RNA_VS_M...5,SET,160,-0.14897,-0.013847,0.066151,0.98783,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN,0.99999
MOOTHA_GLYCOLYSIS,SET,17,-0.38994,-0.011861,0.17304,0.98788,MOOTHA_GLYCOLYSIS,0.99999
GNF2_CENPE,SET,38,-0.31506,-0.014319,0.13982,0.98788,GNF2_CENPE,0.99999
HP_ABSENT_PALMAR_CREASE,SET,13,-0.52834,-0.014055,0.23446,0.98788,HP_ABSENT_PALMAR_CREASE,0.99999
MIR629_3P,SET,165,-0.15843,-0.014952,0.070292,0.98789,MIR629_3P,0.99999
GOBP_MULTICELLULAR_ORGANISM_...,SET,136,-0.17094,-0.014659,0.075835,0.9879,GOBP_MULTICELLULAR_ORGANISM_GROWTH,0.99999
HP_VAGINAL_FISTULA,SET,25,-0.3655,-0.013479,0.16215,0.9879,HP_VAGINAL_FISTULA,0.99999
MIR4778_5P,SET,161,-0.15366,-0.014327,0.068153,0.98792,MIR4778_5P,0.99999
HP_HASHIMOTO_THYROIDITIS,SET,15,-0.49182,-0.014053,0.21806,0.98794,HP_HASHIMOTO_THYROIDITIS,0.99999
REACTOME_REGULATION_OF_FZD_B...,SET,20,-0.46683,-0.0154,0.20694,0.98795,REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION,0.99999
CCANNAGRKGGC_UNKNOWN,SET,106,-0.19055,-0.014438,0.08447,0.98795,CCANNAGRKGGC_UNKNOWN,0.99999
MIR4723_3P,SET,76,-0.21905,-0.014065,0.097021,0.98802,MIR4723_3P,0.99999
BOQUEST_STEM_CELL_CULTURED_V...2,SET,383,-0.10914,-0.015599,0.048328,0.98803,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,0.99999
GSE24972_MARGINAL_ZONE_BCELL...3,SET,184,-0.14938,-0.01488,0.066151,0.98803,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP,0.99999
HP_EARLY_SATIETY,SET,6,-0.70736,-0.012786,0.3132,0.98804,HP_EARLY_SATIETY,0.99999
REACTOME_RHOQ_GTPASE_CYCLE,SET,57,-0.26231,-0.014594,0.11609,0.98807,REACTOME_RHOQ_GTPASE_CYCLE,0.99999
HP_CONGENITAL_BLINDNESS,SET,8,-0.69101,-0.014422,0.30581,0.98807,HP_CONGENITAL_BLINDNESS,0.99999
HP_SYNOSTOSIS_OF_METACARPALS...,SET,15,-0.54846,-0.015671,0.24263,0.9881,HP_SYNOSTOSIS_OF_METACARPALS_METATARSALS,0.99999
GSE17721_CTRL_VS_CPG_1H_BMDC...2,SET,185,-0.13724,-0.013707,0.060708,0.9881,GSE17721_CTRL_VS_CPG_1H_BMDC_UP,0.99999
GOMF_UBIQUITIN_LIKE_LIGASE_S...,SET,53,-0.27793,-0.014912,0.12293,0.98811,GOMF_UBIQUITIN_LIKE_LIGASE_SUBSTRATE_ADAPTOR_ACTIVITY,0.99999
GSE13411_NAIVE_BCELL_VS_PLAS...1,SET,166,-0.14966,-0.014166,0.066194,0.98811,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN,0.99999
GOMF_5_3_EXONUCLEASE_ACTIVITY,SET,17,-0.40918,-0.012446,0.18093,0.98813,GOMF_5_3_EXONUCLEASE_ACTIVITY,0.99999
GSE360_T_GONDII_VS_B_MALAYI_...2,SET,175,-0.15434,-0.014997,0.0682,0.98818,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP,0.99999
MIR4704_5P,SET,55,-0.26141,-0.014287,0.11548,0.9882,MIR4704_5P,0.99999
GOBP_REGULATION_OF_LIPID_TRA...1,SET,122,-0.17985,-0.014612,0.079444,0.9882,GOBP_REGULATION_OF_LIPID_TRANSPORT,0.99999
GOBP_MYOBLAST_FUSION,SET,44,-0.30837,-0.015079,0.13621,0.98821,GOBP_MYOBLAST_FUSION,0.99999
KEGG_MEDICUS_REFERENCE_GPCR_...1,SET,31,-0.36345,-0.014923,0.16051,0.98822,KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY,0.99999
REACTOME_SCAVENGING_BY_CLASS...2,SET,6,-0.90802,-0.016413,0.40101,0.98822,REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS,0.99999
GOBP_SNRNA_MODIFICATION,SET,6,-0.67571,-0.012214,0.29835,0.98823,GOBP_SNRNA_MODIFICATION,0.99999
HP_ABNORMAL_EPIGLOTTIS_MORPH...,SET,20,-0.4171,-0.01376,0.18414,0.98824,HP_ABNORMAL_EPIGLOTTIS_MORPHOLOGY,0.99999
HP_FOCAL_T2_HYPERINTENSE_THA...,SET,14,-0.48555,-0.013403,0.21435,0.98824,HP_FOCAL_T2_HYPERINTENSE_THALAMIC_LESION,0.99999
GOCC_COATED_VESICLE,SET,291,-0.11517,-0.014384,0.050815,0.98828,GOCC_COATED_VESICLE,0.99999
OSAWA_TNF_TARGETS,SET,10,-0.60726,-0.014169,0.26786,0.9883,OSAWA_TNF_TARGETS,0.99999
DEMAGALHAES_AGING_DN,SET,13,-0.53689,-0.014282,0.23669,0.98834,DEMAGALHAES_AGING_DN,0.99999
GOMF_RNA_7_METHYLGUANOSINE_C...,SET,11,-0.54263,-0.013279,0.23914,0.98836,GOMF_RNA_7_METHYLGUANOSINE_CAP_BINDING,0.99999
REACTOME_LINOLEIC_ACID_LA_ME...,SET,7,-0.81942,-0.015998,0.36103,0.98838,REACTOME_LINOLEIC_ACID_LA_METABOLISM,0.99999
HP_HYPERTHYROIDISM,SET,30,-0.352,-0.014218,0.15506,0.98839,HP_HYPERTHYROIDISM,0.99999
REACTOME_AMYLOID_FIBER_FORMA...,SET,47,-0.29544,-0.01493,0.13009,0.98842,REACTOME_AMYLOID_FIBER_FORMATION,0.99999
GOMF_INTRACELLULARLY_GATED_C...,SET,18,-0.46013,-0.014401,0.20247,0.98847,GOMF_INTRACELLULARLY_GATED_CALCIUM_CHANNEL_ACTIVITY,0.99999
WP_CELLULAR_PROTEOSTASIS,SET,5,-0.69001,-0.011386,0.30353,0.98849,WP_CELLULAR_PROTEOSTASIS,0.99999
GSE37605_NOD_VS_C57BL6_IRES_...2,SET,140,-0.16808,-0.014622,0.073911,0.98851,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP,0.99999
HP_ABNORMALITY_OF_THE_DISTAL...4,SET,34,-0.33187,-0.014269,0.14591,0.98853,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_5TH_FINGER,0.99999
MURARO_PANCREAS_BETA_CELL,SET,858,-0.06966,-0.014703,0.030623,0.98853,MURARO_PANCREAS_BETA_CELL,0.99999
STANELLE_E2F1_TARGETS,SET,26,-0.38697,-0.014553,0.16997,0.98859,STANELLE_E2F1_TARGETS,0.99999
REACTOME_DERMATAN_SULFATE_BI...,SET,10,-0.56755,-0.013243,0.24928,0.98859,REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS,0.99999
REACTOME_NEUROFASCIN_INTERAC...,SET,6,-0.80424,-0.014537,0.35318,0.98861,REACTOME_NEUROFASCIN_INTERACTIONS,0.99999
REACTOME_ASPARAGINE_N_LINKED...,SET,291,-0.11035,-0.013783,0.048404,0.98868,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,0.99999
GERHOLD_ADIPOGENESIS_DN,SET,58,-0.25848,-0.014506,0.11333,0.98872,GERHOLD_ADIPOGENESIS_DN,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...7,SET,181,-0.13257,-0.013098,0.058119,0.98872,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN,0.99999
REACTOME_SIGNALING_BY_LTK,SET,10,-0.61376,-0.014321,0.26903,0.98873,REACTOME_SIGNALING_BY_LTK,0.99999
HP_PROGRESSIVE_MUSCLE_WEAKNE...,SET,64,-0.2358,-0.013899,0.10333,0.98875,HP_PROGRESSIVE_MUSCLE_WEAKNESS,0.99999
GOMF_REGULATORY_RNA_BINDING,SET,38,-0.2886,-0.013117,0.12644,0.98877,GOMF_REGULATORY_RNA_BINDING,0.99999
GSE27786_BCELL_VS_ERYTHROBLA...1,SET,178,-0.14746,-0.014449,0.064601,0.98877,GSE27786_BCELL_VS_ERYTHROBLAST_DN,0.99999
GOBP_REFLEX,SET,22,-0.4286,-0.014828,0.18756,0.98884,GOBP_REFLEX,0.99999
GSE22935_UNSTIM_VS_12H_MBOVI...4,SET,187,-0.14619,-0.014679,0.063976,0.98884,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.99999
GOBP_MITOCHONDRIAL_RNA_METAB...,SET,50,-0.24537,-0.012788,0.10735,0.98886,GOBP_MITOCHONDRIAL_RNA_METABOLIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_DYNEI...,SET,29,-0.3335,-0.013245,0.14587,0.98888,KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE,0.99999
HP_ABNORMAL_PERIOSTEUM_MORPH...,SET,8,-0.78885,-0.016464,0.34502,0.98888,HP_ABNORMAL_PERIOSTEUM_MORPHOLOGY,0.99999
GOBP_RESPONSE_TO_PHEROMONE,SET,6,-0.77726,-0.014049,0.33988,0.98889,GOBP_RESPONSE_TO_PHEROMONE,0.99999
DIERICK_SEROTONIN_FUNCTION_G...,SET,7,-0.67392,-0.013157,0.29461,0.98891,DIERICK_SEROTONIN_FUNCTION_GENES,0.99999
HP_BILATERAL_COXA_VALGA,SET,13,-0.63102,-0.016786,0.27586,0.98891,HP_BILATERAL_COXA_VALGA,0.99999
HP_IMPAIRMENT_IN_PERSONALITY...,SET,199,-0.13804,-0.014294,0.060305,0.98895,HP_IMPAIRMENT_IN_PERSONALITY_FUNCTIONING,0.99999
HP_SKEWFOOT,SET,6,-0.87796,-0.01587,0.38336,0.98899,HP_SKEWFOOT,0.99999
GSE2770_UNTREATED_VS_IL4_TRE...2,SET,188,-0.1406,-0.014156,0.061384,0.989,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
SCHUHMACHER_MYC_TARGETS_UP,SET,74,-0.22268,-0.014109,0.097193,0.98901,SCHUHMACHER_MYC_TARGETS_UP,0.99999
GSE10325_LUPUS_BCELL_VS_LUPU...2,SET,161,-0.15431,-0.014388,0.067335,0.98903,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP,0.99999
MIR1_3P,SET,337,-0.10801,-0.014499,0.047115,0.98905,MIR1_3P,0.99999
GOBP_AMINO_SUGAR_BIOSYNTHETI...,SET,11,-0.59577,-0.014579,0.25991,0.98905,GOBP_AMINO_SUGAR_BIOSYNTHETIC_PROCESS,0.99999
HP_KNEE_CLONUS,SET,5,-0.89802,-0.014818,0.39176,0.98905,HP_KNEE_CLONUS,0.99999
MIR4744,SET,155,-0.15569,-0.014245,0.067912,0.98906,MIR4744,0.99999
GSE43955_TGFB_IL6_VS_TGFB_IL...4,SET,183,-0.14229,-0.014135,0.062062,0.98906,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_PE...1,SET,13,-0.5911,-0.015724,0.25778,0.98907,GOBP_CELLULAR_RESPONSE_TO_PEPTIDE,0.99999
REACTOME_REGULATION_OF_PTEN_...2,SET,7,-0.88756,-0.017328,0.38679,0.98912,REACTOME_REGULATION_OF_PTEN_LOCALIZATION,0.99999
MIR6836_5P,SET,115,-0.18502,-0.014598,0.080573,0.98916,MIR6836_5P,0.99999
WP_GLYCOLYSIS_IN_SENESCENCE,SET,9,-0.56199,-0.01244,0.24474,0.98917,WP_GLYCOLYSIS_IN_SENESCENCE,0.99999
GOBP_VASCULAR_ASSOCIATED_SMO...1,SET,11,-0.59378,-0.014531,0.25854,0.98917,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
GOMF_BETA_1_3_GALACTOSYLTRAN...,SET,14,-0.58308,-0.016096,0.25381,0.98919,GOMF_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY,0.99999
HP_RETINAL_FOLD,SET,10,-0.64047,-0.014944,0.27859,0.98924,HP_RETINAL_FOLD,0.99999
GOBP_REGULATION_OF_ADENYLATE...1,SET,19,-0.42415,-0.013638,0.18448,0.98925,GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE29949_MICROGLIA_BRAIN_VS_...1,SET,176,-0.15086,-0.0147,0.065601,0.98926,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.99999
ACCGAGC_MIR423,SET,5,-0.99235,-0.016375,0.4314,0.98928,ACCGAGC_MIR423,0.99999
GSE24634_TEFF_VS_TCONV_DAY10...2,SET,183,-0.14288,-0.014195,0.062087,0.98931,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP,0.99999
MIR3065_3P,SET,234,-0.12992,-0.014574,0.056442,0.98932,MIR3065_3P,0.99999
GOBP_CELLULAR_RESPONSE_TO_GA...,SET,23,-0.37746,-0.013352,0.16389,0.98936,GOBP_CELLULAR_RESPONSE_TO_GAMMA_RADIATION,0.99999
GOMF_TRANSFERASE_ACTIVITY_TR...2,SET,25,-0.411,-0.015157,0.17844,0.98936,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS,0.99999
REACTOME_TCF_DEPENDENT_SIGNA...,SET,165,-0.14965,-0.014124,0.06497,0.98937,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,0.99999
DAVICIONI_TARGETS_OF_PAX_FOX...1,SET,62,-0.27405,-0.015899,0.11891,0.9894,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,0.99999
GSE17974_0H_VS_4H_IN_VITRO_A...1,SET,179,-0.13855,-0.013614,0.060119,0.9894,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN,0.99999
WP_CALCIUM_REGULATION_IN_CAR...,SET,149,-0.17298,-0.015521,0.075042,0.98942,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,0.99999
DESCARTES_FETAL_KIDNEY_STROM...,SET,123,-0.19331,-0.01577,0.083856,0.98942,DESCARTES_FETAL_KIDNEY_STROMAL_CELLS,0.99999
GOMF_HISTONE_H4_METHYLTRANSF...,SET,13,-0.5478,-0.014572,0.2375,0.98945,GOMF_HISTONE_H4_METHYLTRANSFERASE_ACTIVITY,0.99999
HP_POSITIVE_BLOOD_INFECTIOUS...,SET,17,-0.45764,-0.01392,0.19836,0.98947,HP_POSITIVE_BLOOD_INFECTIOUS_AGENT_TEST,0.99999
KOMMAGANI_TP63_GAMMA_TARGETS,SET,9,-0.63355,-0.014024,0.27452,0.98949,KOMMAGANI_TP63_GAMMA_TARGETS,0.99999
GSE25677_MPL_VS_MPL_AND_R848...2,SET,141,-0.1642,-0.014335,0.071059,0.98957,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP,0.99999
GSE13229_MATURE_VS_INTMATURE...2,SET,173,-0.15621,-0.015092,0.067581,0.98959,GSE13229_MATURE_VS_INTMATURE_NKCELL_UP,0.99999
GSE29617_CTRL_VS_DAY7_TIV_FL...1,SET,160,-0.15227,-0.014153,0.065866,0.9896,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,0.99999
WP_10Q22Q23_COPY_NUMBER_VARI...,SET,55,-0.29634,-0.016196,0.12814,0.98962,WP_10Q22Q23_COPY_NUMBER_VARIATION,0.99999
HP_RECEPTIVE_LANGUAGE_DELAY,SET,13,-0.57569,-0.015314,0.24893,0.98962,HP_RECEPTIVE_LANGUAGE_DELAY,0.99999
DESCARTES_MAIN_FETAL_ACINAR_...,SET,50,-0.307,-0.016,0.13275,0.98962,DESCARTES_MAIN_FETAL_ACINAR_CELLS,0.99999
ZNF544_TARGET_GENES,SET,3,-0.94638,-0.012097,0.4092,0.98963,ZNF544_TARGET_GENES,0.99999
SHETH_LIVER_CANCER_VS_TXNIP_...4,SET,258,-0.12529,-0.014749,0.054164,0.98964,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,0.99999
HP_REDUCED_ATTENTION_REGULAT...,SET,439,-0.096077,-0.014679,0.041529,0.98965,HP_REDUCED_ATTENTION_REGULATION,0.99999
GSE35435_RESTING_VS_IL4_TREA...1,SET,170,-0.15149,-0.01451,0.065465,0.98966,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN,0.99999
REACTOME_CTLA4_INHIBITORY_SI...,SET,21,-0.42424,-0.01434,0.18331,0.98967,REACTOME_CTLA4_INHIBITORY_SIGNALING,0.99999
MIR4430,SET,128,-0.17148,-0.014268,0.074082,0.98968,MIR4430,0.99999
GOBP_MITOTIC_CELL_CYCLE_PROC...,SET,701,-0.074483,-0.014274,0.03218,0.98968,GOBP_MITOTIC_CELL_CYCLE_PROCESS,0.99999
HP_ABNORMAL_GLIAL_CELL_MORPH...,SET,143,-0.16209,-0.01425,0.070024,0.98968,HP_ABNORMAL_GLIAL_CELL_MORPHOLOGY,0.99999
MODULE_137,SET,492,-0.095689,-0.015454,0.041327,0.9897,MODULE_137,0.99999
GOBP_ACTIVATION_OF_NF_KAPPAB...,SET,10,-0.66841,-0.015596,0.28866,0.9897,GOBP_ACTIVATION_OF_NF_KAPPAB_INDUCING_KINASE_ACTIVITY,0.99999
GOMF_LIGAND_GATED_SODIUM_CHA...,SET,16,-0.50738,-0.014973,0.21909,0.98971,GOMF_LIGAND_GATED_SODIUM_CHANNEL_ACTIVITY,0.99999
GSE8515_CTRL_VS_IL1_4H_STIM_...2,SET,177,-0.14742,-0.014405,0.063635,0.98973,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP,0.99999
GSE2585_CTEC_VS_THYMIC_DC_DN,SET,187,-0.1487,-0.014931,0.064172,0.98975,GSE2585_CTEC_VS_THYMIC_DC_DN,0.99999
REACTOME_MET_INTERACTS_WITH_...,SET,5,-1.0355,-0.017087,0.44682,0.98976,REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS,0.99999
MIR502_5P,SET,68,-0.23631,-0.014356,0.10195,0.98977,MIR502_5P,0.99999
HP_DUMBBELL_SHAPED_LONG_BONE,SET,7,-0.73807,-0.01441,0.3184,0.98977,HP_DUMBBELL_SHAPED_LONG_BONE,0.99999
GSE17301_CTRL_VS_48H_ACD3_AC...1,SET,173,-0.14616,-0.014122,0.062947,0.98988,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN,0.99999
P53_DECAMER_Q2,SET,233,-0.13063,-0.014623,0.056247,0.98989,P53_DECAMER_Q2,0.99999
CUI_TCF21_TARGETS_2_DN,SET,762,-0.077069,-0.015372,0.033173,0.98991,CUI_TCF21_TARGETS_2_DN,0.99999
IRITANI_MAD1_TARGETS_DN,SET,41,-0.30273,-0.014291,0.13031,0.98991,IRITANI_MAD1_TARGETS_DN,0.99999
GSE21546_WT_VS_SAP1A_KO_ANTI...1,SET,183,-0.1435,-0.014256,0.061766,0.98991,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...604,SET,12,-0.67773,-0.017322,0.29151,0.98996,GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,0.99999
PASTURAL_RIZ1_TARGETS_DN,SET,5,-1.0264,-0.016938,0.44126,0.98999,PASTURAL_RIZ1_TARGETS_DN,0.99999
GOBP_PREPULSE_INHIBITION,SET,13,-0.56249,-0.014963,0.24171,0.99002,GOBP_PREPULSE_INHIBITION,0.99999
GSE6092_B_BURGDOFERI_VS_B_BU...1,SET,170,-0.151,-0.014463,0.064868,0.99003,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN,0.99999
GINESTIER_BREAST_CANCER_ZNF2...2,SET,63,-0.24073,-0.014078,0.10335,0.99007,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP,0.99999
MIR4493,SET,88,-0.20803,-0.014368,0.089274,0.9901,MIR4493,0.99999
GOBP_RNA_CAPPING,SET,13,-0.45068,-0.011989,0.19336,0.99011,GOBP_RNA_CAPPING,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...6,SET,166,-0.16097,-0.015238,0.069019,0.99015,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,0.99999
MIR12135,SET,185,-0.14744,-0.014726,0.063206,0.99016,MIR12135,0.99999
HP_NEOPLASM_OF_THE_PARATHYRO...,SET,18,-0.50457,-0.015792,0.21626,0.99017,HP_NEOPLASM_OF_THE_PARATHYROID_GLAND,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...2,SET,173,-0.14785,-0.014285,0.063355,0.99019,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP,0.99999
OSADA_ASCL1_TARGETS_UP,SET,43,-0.32727,-0.01582,0.1402,0.99021,OSADA_ASCL1_TARGETS_UP,0.99999
HP_LIMB_DYSTONIA,SET,74,-0.21867,-0.013855,0.093591,0.99026,HP_LIMB_DYSTONIA,0.99999
FAN_OVARY_CL14_MATURE_SMOOTH...,SET,267,-0.12457,-0.014914,0.053275,0.99031,FAN_OVARY_CL14_MATURE_SMOOTH_MUSCLE_CELL,0.99999
HNF4ALPHA_Q6,SET,236,-0.12873,-0.014501,0.055042,0.99032,HNF4ALPHA_Q6,0.99999
ZHOU_CELL_CYCLE_GENES_IN_IR_...1,SET,116,-0.18046,-0.014299,0.077137,0.99034,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR,0.99999
GSE32986_UNSTIM_VS_GMCSF_AND...1,SET,168,-0.15827,-0.015071,0.067573,0.99041,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.99999
LOPEZ_MBD_TARGETS,SET,861,-0.066656,-0.014093,0.028448,0.99043,LOPEZ_MBD_TARGETS,0.99999
REACTOME_NOTCH3_ACTIVATION_A...,SET,23,-0.42284,-0.014957,0.18018,0.99052,REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_SST...,SET,333,-0.1154,-0.015401,0.049134,0.99058,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.99999
SIMBULAN_PARP1_TARGETS_UP,SET,27,-0.4176,-0.016003,0.17774,0.99059,SIMBULAN_PARP1_TARGETS_UP,0.99999
PROVENZANI_METASTASIS_DN,SET,134,-0.17845,-0.01519,0.075941,0.9906,PROVENZANI_METASTASIS_DN,0.99999
GSE41867_DAY8_VS_DAY15_LCMV_...1,SET,133,-0.1848,-0.015672,0.078633,0.99061,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.99999
HP_HYPOPLASIA_OF_THE_FEMORAL...,SET,5,-0.98482,-0.016251,0.41901,0.99062,HP_HYPOPLASIA_OF_THE_FEMORAL_HEAD,0.99999
GOCC_NSL_COMPLEX,SET,9,-0.58119,-0.012865,0.24713,0.99065,GOCC_NSL_COMPLEX,0.99999
MIR330_5P,SET,169,-0.15816,-0.015105,0.067245,0.99066,MIR330_5P,0.99999
HP_BRONCHITIS,SET,62,-0.25755,-0.014942,0.10942,0.99071,HP_BRONCHITIS,0.99999
HU_FETAL_RETINA_HORIZONTAL,SET,34,-0.36442,-0.015669,0.15476,0.99073,HU_FETAL_RETINA_HORIZONTAL,0.99999
GSE9037_CTRL_VS_LPS_4H_STIM_...3,SET,183,-0.1522,-0.01512,0.06459,0.99077,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN,0.99999
GOBP_TUBE_MORPHOGENESIS,SET,811,-0.075188,-0.01545,0.031904,0.99078,GOBP_TUBE_MORPHOGENESIS,0.99999
GSE46606_IRF4MID_VS_WT_CD40L...1,SET,185,-0.16163,-0.016143,0.068561,0.99079,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.99999
GSE4984_UNTREATED_VS_GALECTI...1,SET,154,-0.16637,-0.015174,0.070565,0.9908,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN,0.99999
GOBP_ESTABLISHMENT_OF_BLOOD_...2,SET,4,-1.0996,-0.016229,0.46598,0.99085,GOBP_ESTABLISHMENT_OF_BLOOD_RETINAL_BARRIER,0.99999
GOCC_CYTOPLASMIC_EXOSOME_RNA...,SET,15,-0.43069,-0.012306,0.18238,0.99089,GOCC_CYTOPLASMIC_EXOSOME_RNASE_COMPLEX,0.99999
HP_ABNORMAL_ENZYME_CONCENTRA...,SET,637,-0.080674,-0.014765,0.034155,0.99091,HP_ABNORMAL_ENZYME_CONCENTRATION_OR_ACTIVITY,0.99999
HP_PERSISTENT_EBV_VIREMIA,SET,12,-0.53611,-0.013702,0.22695,0.99091,HP_PERSISTENT_EBV_VIREMIA,0.99999
HP_ABNORMAL_OLFACTORY_LOBE_M...,SET,6,-0.77278,-0.013968,0.32709,0.99092,HP_ABNORMAL_OLFACTORY_LOBE_MORPHOLOGY,0.99999
WP_NAD_BIOSYNTHESIS_II_FROM_...,SET,8,-0.71672,-0.014958,0.30329,0.99093,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,0.99999
GOMF_PEPTIDE_ALPHA_N_ACETYLT...,SET,6,-0.8337,-0.01507,0.35284,0.99093,GOMF_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE_ACTIVITY,0.99999
GSE27786_BCELL_VS_CD8_TCELL_...1,SET,180,-0.14937,-0.014717,0.063207,0.99093,GSE27786_BCELL_VS_CD8_TCELL_DN,0.99999
HP_CERVICAL_KYPHOSIS,SET,8,-0.63127,-0.013175,0.2671,0.99094,HP_CERVICAL_KYPHOSIS,0.99999
GOMF_DEATH_RECEPTOR_ACTIVITY,SET,12,-0.66646,-0.017034,0.28173,0.99099,GOMF_DEATH_RECEPTOR_ACTIVITY,0.99999
GOBP_BRANCHING_INVOLVED_IN_M...,SET,21,-0.47933,-0.016202,0.20252,0.99102,GOBP_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS,0.99999
HP_ABNORMALITY_OF_THYROID_PH...,SET,346,-0.11131,-0.015137,0.046991,0.99107,HP_ABNORMALITY_OF_THYROID_PHYSIOLOGY,0.99999
GOBP_CYTOSKELETON_ORGANIZATI...,SET,1360,-0.057287,-0.015004,0.02417,0.9911,GOBP_CYTOSKELETON_ORGANIZATION,0.99999
GOCC_CIS_GOLGI_NETWORK_MEMBR...,SET,10,-0.63377,-0.014788,0.26728,0.99113,GOCC_CIS_GOLGI_NETWORK_MEMBRANE,0.99999
GOMF_CALCIUM_ION_TRANSMEMBRA...,SET,135,-0.18386,-0.015709,0.077537,0.99113,GOMF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
WAKABAYASHI_ADIPOGENESIS_PPA...5,SET,132,-0.1727,-0.014592,0.072814,0.99115,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,0.99999
GOBP_PHASIC_SMOOTH_MUSCLE_CO...,SET,24,-0.45511,-0.016445,0.19175,0.99118,GOBP_PHASIC_SMOOTH_MUSCLE_CONTRACTION,0.99999
GOBP_TRANSITION_METAL_ION_TR...,SET,89,-0.20964,-0.014561,0.088322,0.99119,GOBP_TRANSITION_METAL_ION_TRANSPORT,0.99999
HP_ABNORMALITY_OF_VITAMIN_B1...,SET,30,-0.3767,-0.015216,0.1587,0.99119,HP_ABNORMALITY_OF_VITAMIN_B12_METABOLISM,0.99999
REACTOME_SYNTHESIS_OF_DIPHTH...,SET,8,-0.64149,-0.013388,0.27004,0.99123,REACTOME_SYNTHESIS_OF_DIPHTHAMIDE_EEF2,0.99999
PPARA_TARGET_GENES,SET,55,-0.26278,-0.014362,0.1106,0.99124,PPARA_TARGET_GENES,0.99999
GOBP_PHOSPHATIDYLINOSITOL_PH...,SET,59,-0.2555,-0.014461,0.10755,0.99124,GOBP_PHOSPHATIDYLINOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...2,SET,167,-0.16787,-0.015938,0.070655,0.99124,GOCC_EXTRINSIC_COMPONENT_OF_MEMBRANE,0.99999
HP_ASTROCYTOSIS,SET,21,-0.4612,-0.01559,0.19413,0.99124,HP_ASTROCYTOSIS,0.99999
RIZKI_TUMOR_INVASIVENESS_3D_...2,SET,186,-0.14832,-0.014853,0.062399,0.99127,RIZKI_TUMOR_INVASIVENESS_3D_UP,0.99999
GOBP_INNER_DYNEIN_ARM_ASSEMB...,SET,11,-0.54531,-0.013344,0.22934,0.99129,GOBP_INNER_DYNEIN_ARM_ASSEMBLY,0.99999
GOMF_UBIQUITIN_LIKE_PROTEIN_...1,SET,112,-0.18603,-0.014486,0.078126,0.99136,GOMF_UBIQUITIN_LIKE_PROTEIN_BINDING,0.99999
GSE32986_GMCSF_VS_GMCSF_AND_...3,SET,161,-0.16395,-0.015287,0.068774,0.99143,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,0.99999
GOBP_INNER_EAR_MORPHOGENESIS,SET,98,-0.219,-0.015958,0.091808,0.99146,GOBP_INNER_EAR_MORPHOGENESIS,0.99999
HOFFMANN_SMALL_PRE_BII_TO_IM...1,SET,35,-0.34559,-0.015075,0.14481,0.99149,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,0.99999
NAKAMURA_LUNG_CANCER,SET,8,-0.83958,-0.017523,0.35179,0.99149,NAKAMURA_LUNG_CANCER,0.99999
MIR944,SET,381,-0.10845,-0.015461,0.045444,0.99149,MIR944,0.99999
HP_ABNORMAL_EPIDERMAL_MORPHO...,SET,87,-0.21679,-0.014889,0.09079,0.99152,HP_ABNORMAL_EPIDERMAL_MORPHOLOGY,0.99999
HALLMARK_ESTROGEN_RESPONSE_L...,SET,185,-0.1573,-0.015711,0.06588,0.99152,HALLMARK_ESTROGEN_RESPONSE_LATE,0.99999
SMID_BREAST_CANCER_RELAPSE_I...10,SET,6,-0.79472,-0.014365,0.33271,0.99154,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP,0.99999
HP_CALVARIAL_HYPEROSTOSIS,SET,10,-0.58612,-0.013676,0.24527,0.99156,HP_CALVARIAL_HYPEROSTOSIS,0.99999
REACTOME_NONSENSE_MEDIATED_D...,SET,103,-0.19369,-0.014467,0.081041,0.99157,REACTOME_NONSENSE_MEDIATED_DECAY_NMD,0.99999
GENTILE_UV_RESPONSE_CLUSTER_...6,SET,30,-0.37054,-0.014967,0.15497,0.99159,GENTILE_UV_RESPONSE_CLUSTER_D7,0.99999
GOBP_NUCLEOSIDE_TRANSMEMBRAN...,SET,8,-0.77414,-0.016157,0.32349,0.99164,GOBP_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT,0.99999
GOBP_PROTEIN_QUALITY_CONTROL...,SET,23,-0.38764,-0.013712,0.16191,0.99167,GOBP_PROTEIN_QUALITY_CONTROL_FOR_MISFOLDED_OR_INCOMPLETELY_SYNTHESIZED_PROTEINS,0.99999
GOMF_5_3_DNA_EXONUCLEASE_ACT...,SET,9,-0.5818,-0.012879,0.24242,0.9918,GOMF_5_3_DNA_EXONUCLEASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...378,SET,89,-0.20208,-0.014036,0.08408,0.99187,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,0.99999
GSE12845_NAIVE_VS_DARKZONE_G...2,SET,170,-0.16162,-0.015481,0.067213,0.9919,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.99999
KEGG_GLIOMA,SET,64,-0.26359,-0.015536,0.10958,0.99192,KEGG_GLIOMA,0.99999
HP_ETHYLMALONIC_ACIDURIA,SET,9,-0.53343,-0.011808,0.22167,0.99194,HP_ETHYLMALONIC_ACIDURIA,0.99999
GSE22025_UNTREATED_VS_TGFB1_...4,SET,184,-0.15816,-0.015754,0.065723,0.99194,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP,0.99999
WP_LACTO_SERIES_SPHINGOLIPID...,SET,6,-0.90393,-0.016339,0.37542,0.99197,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,0.99999
GSE3982_NEUTROPHIL_VS_TH1_DN,SET,179,-0.14518,-0.014266,0.060287,0.99198,GSE3982_NEUTROPHIL_VS_TH1_DN,0.99999
FRIDMAN_SENESCENCE_UP,SET,75,-0.24947,-0.015913,0.10351,0.99202,FRIDMAN_SENESCENCE_UP,0.99999
FREAC2_01,SET,235,-0.14318,-0.016096,0.059395,0.99203,FREAC2_01,0.99999
REACTOME_YAP1_AND_WWTR1_TAZ_...,SET,14,-0.60656,-0.016744,0.25157,0.99204,REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,0.99999
TIEN_INTESTINE_PROBIOTICS_2H...2,SET,28,-0.39917,-0.015577,0.16552,0.99205,TIEN_INTESTINE_PROBIOTICS_2HR_UP,0.99999
HP_SHORT_FEMUR,SET,25,-0.42564,-0.015697,0.17643,0.99207,HP_SHORT_FEMUR,0.99999
VANDESLUIS_COMMD1_TARGETS_GR...2,SET,32,-0.40673,-0.016966,0.16853,0.99209,VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN,0.99999
GOMF_EXONUCLEASE_ACTIVITY,SET,82,-0.20152,-0.013438,0.083494,0.9921,GOMF_EXONUCLEASE_ACTIVITY,0.99999
HP_MACROORCHIDISM,SET,10,-0.70927,-0.016549,0.29371,0.99212,HP_MACROORCHIDISM,0.99999
GSE1925_CTRL_VS_24H_IFNG_STI...3,SET,174,-0.14953,-0.014489,0.06192,0.99213,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN,0.99999
GSE7568_IL4_TGFB_DEXAMETHASO...2,SET,154,-0.15599,-0.014227,0.064503,0.9922,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_UP,0.99999
HP_INTESTINAL_PERFORATION,SET,5,-0.80492,-0.013282,0.33276,0.99221,HP_INTESTINAL_PERFORATION,0.99999
GSE11973_MIR223_KOVS_WT_BONE...1,SET,154,-0.16408,-0.014965,0.067791,0.99224,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_DN,0.99999
HP_ABNORMAL_CIRCULATING_HOMO...,SET,15,-0.52451,-0.014987,0.21668,0.99225,HP_ABNORMAL_CIRCULATING_HOMOCYSTEINE_CONCENTRATION,0.99999
GOBP_CARTILAGE_DEVELOPMENT_I...,SET,31,-0.37965,-0.015588,0.15675,0.99228,GOBP_CARTILAGE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,0.99999
HP_MUSCLE_FIBRILLATION,SET,58,-0.26986,-0.015144,0.11128,0.99234,HP_MUSCLE_FIBRILLATION,0.99999
REACTOME_RESOLUTION_OF_SISTE...,SET,113,-0.19054,-0.014903,0.078519,0.99238,REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...44,SET,5,-0.98263,-0.016215,0.40474,0.9924,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_EXTRINSIC_APOPTOTIC_PATHWAY,0.99999
GOMF_INTERLEUKIN_1_RECEPTOR_...1,SET,6,-0.98289,-0.017766,0.40474,0.99241,GOMF_INTERLEUKIN_1_RECEPTOR_ACTIVITY,0.99999
HP_LETHAL_SKELETAL_DYSPLASIA,SET,8,-0.63044,-0.013158,0.25949,0.99244,HP_LETHAL_SKELETAL_DYSPLASIA,0.99999
HP_WHITE_FORELOCK,SET,14,-0.61979,-0.017109,0.2551,0.99244,HP_WHITE_FORELOCK,0.99999
GSE22443_NAIVE_VS_ACT_AND_IL...4,SET,188,-0.15984,-0.016092,0.065779,0.99244,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_UP,0.99999
HP_SMALL_FOR_GESTATIONAL_AGE,SET,226,-0.13808,-0.015226,0.056819,0.99245,HP_SMALL_FOR_GESTATIONAL_AGE,0.99999
NEBEN_AML_WITH_FLT3_OR_NRAS_...1,SET,12,-0.60939,-0.015575,0.2504,0.99252,NEBEN_AML_WITH_FLT3_OR_NRAS_DN,0.99999
GSE2585_CD80_HIGH_VS_LOW_AIR...2,SET,176,-0.16234,-0.015819,0.06669,0.99253,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_UP,0.99999
MIR7851_3P,SET,52,-0.27978,-0.014869,0.11491,0.99254,MIR7851_3P,0.99999
HP_HYPOPLASIA_OF_THE_PRIMARY...,SET,7,-0.76862,-0.015006,0.31574,0.99254,HP_HYPOPLASIA_OF_THE_PRIMARY_TEETH,0.99999
GOBP_POSITIVE_REGULATION_OF_...489,SET,23,-0.42661,-0.015091,0.17518,0.99255,GOBP_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY,0.99999
GSE24574_BCL6_HIGH_TFH_VS_TC...1,SET,188,-0.15835,-0.015942,0.065012,0.99256,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN,0.99999
GOBP_REGULATION_OF_OXIDOREDU...,SET,53,-0.286,-0.015345,0.11741,0.99257,GOBP_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,0.99999
REACTOME_METABOLISM_OF_STERO...2,SET,33,-0.3804,-0.016114,0.15603,0.99261,REACTOME_METABOLISM_OF_STEROID_HORMONES,0.99999
HP_STOOPED_POSTURE,SET,8,-0.63269,-0.013205,0.25941,0.99263,HP_STOOPED_POSTURE,0.99999
MIR6751_5P,SET,66,-0.26331,-0.01576,0.10794,0.99264,MIR6751_5P,0.99999
REACTOME_DAP12_INTERACTIONS,SET,36,-0.33887,-0.014992,0.13886,0.99266,REACTOME_DAP12_INTERACTIONS,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...9,SET,179,-0.15438,-0.01517,0.06323,0.99268,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
HP_BILATERAL_SINGLE_TRANSVER...,SET,55,-0.28911,-0.015801,0.11833,0.99272,HP_BILATERAL_SINGLE_TRANSVERSE_PALMAR_CREASES,0.99999
GSE17186_CD21LOW_VS_CD21HIGH...4,SET,183,-0.16194,-0.016088,0.066225,0.99276,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,0.99999
GNF2_SMC2L1,SET,32,-0.35627,-0.014861,0.14567,0.99277,GNF2_SMC2L1,0.99999
MODULE_128,SET,87,-0.23731,-0.016298,0.097023,0.99277,MODULE_128,0.99999
GOBP_CELLULAR_RESPONSE_TO_OX...2,SET,11,-0.65806,-0.016103,0.26904,0.99277,GOBP_CELLULAR_RESPONSE_TO_OXIDISED_LOW_DENSITY_LIPOPROTEIN_PARTICLE_STIMULUS,0.99999
DESCARTES_FETAL_EYE_GANGLION...,SET,33,-0.3937,-0.016677,0.16098,0.99277,DESCARTES_FETAL_EYE_GANGLION_CELLS,0.99999
GOBP_POSITIVE_REGULATION_OF_...158,SET,12,-0.60951,-0.015578,0.24902,0.99281,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.99999
chr15q23,SET,33,-0.56009,-0.023725,0.22875,0.99282,chr15q23,0.99999
GOBP_PURINE_NUCLEOBASE_TRANS...,SET,8,-0.81946,-0.017103,0.33448,0.99285,GOBP_PURINE_NUCLEOBASE_TRANSMEMBRANE_TRANSPORT,0.99999
HP_OROMOTOR_APRAXIA,SET,24,-0.44449,-0.016061,0.18144,0.99285,HP_OROMOTOR_APRAXIA,0.99999
MIR11401,SET,7,-0.85104,-0.016615,0.34684,0.99292,MIR11401,0.99999
GOCC_FAR_SIN_STRIPAK_COMPLEX,SET,16,-0.54053,-0.015951,0.22005,0.99298,GOCC_FAR_SIN_STRIPAK_COMPLEX,0.99999
KOKKINAKIS_METHIONINE_DEPRIV...2,SET,125,-0.19508,-0.016043,0.079356,0.99302,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,0.99999
WP_GLYCOSPHINGOLIPID_METABOL...,SET,19,-0.50957,-0.016385,0.2071,0.99306,WP_GLYCOSPHINGOLIPID_METABOLISM,0.99999
ACTACCT_MIR196A_MIR196B,SET,133,-0.18955,-0.016075,0.077021,0.99307,ACTACCT_MIR196A_MIR196B,0.99999
GOMF_ATP_DEPENDENT_PROTEIN_B...,SET,6,-0.81107,-0.014661,0.32953,0.99307,GOMF_ATP_DEPENDENT_PROTEIN_BINDING,0.99999
REACTOME_ACTIVATED_NTRK2_SIG...5,SET,9,-0.6767,-0.01498,0.27485,0.99309,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS,0.99999
HP_ABSENT_LACRIMAL_PUNCTUM,SET,6,-0.8958,-0.016192,0.36377,0.9931,HP_ABSENT_LACRIMAL_PUNCTUM,0.99999
DESCARTES_FETAL_INTESTINE_EN...2,SET,131,-0.203,-0.017087,0.082423,0.9931,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,0.99999
HP_TRACTIONAL_RETINAL_DETACH...,SET,7,-0.73568,-0.014363,0.2985,0.99314,HP_TRACTIONAL_RETINAL_DETACHMENT,0.99999
REACTOME_RUNX1_REGULATES_TRA...6,SET,5,-0.96587,-0.015938,0.39176,0.99315,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_WNT_SIGNALING,0.99999
PID_IL4_2PATHWAY,SET,55,-0.29654,-0.016207,0.12027,0.99316,PID_IL4_2PATHWAY,0.99999
KEGG_P53_SIGNALING_PATHWAY,SET,66,-0.25228,-0.015099,0.10223,0.9932,KEGG_P53_SIGNALING_PATHWAY,0.99999
MODULE_18,SET,415,-0.10482,-0.015581,0.04247,0.9932,MODULE_18,0.99999
GSE36476_CTRL_VS_TSST_ACT_16...3,SET,185,-0.14988,-0.01497,0.060688,0.99323,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN,0.99999
WP_HEMATOPOIETIC_STEM_CELL_G...,SET,19,-0.49543,-0.01593,0.20045,0.99327,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,0.99999
GOBP_ADENOSINE_TRANSPORT,SET,5,-1.0212,-0.016852,0.41319,0.99327,GOBP_ADENOSINE_TRANSPORT,0.99999
GOMF_EXONUCLEASE_ACTIVITY_AC...,SET,58,-0.24271,-0.013621,0.0981,0.99332,GOMF_EXONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,0.99999
GOBP_PROTEIN_TARGETING_TO_VA...2,SET,5,-0.94032,-0.015516,0.37998,0.99333,GOBP_PROTEIN_TARGETING_TO_VACUOLE_INVOLVED_IN_AUTOPHAGY,0.99999
TERAO_AOX4_TARGETS_HG_DN,SET,6,-0.95688,-0.017296,0.38656,0.99334,TERAO_AOX4_TARGETS_HG_DN,0.99999
GOBP_ENDOCHONDRAL_BONE_MORPH...,SET,56,-0.30225,-0.016668,0.12205,0.99336,GOBP_ENDOCHONDRAL_BONE_MORPHOGENESIS,0.99999
REACTOME_RUNX1_REGULATES_TRA...3,SET,8,-0.71392,-0.0149,0.28818,0.99338,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES,0.99999
TURASHVILI_BREAST_LOBULAR_CA...3,SET,67,-0.2723,-0.01642,0.10987,0.9934,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...639,SET,5,-1.0057,-0.016595,0.40539,0.99344,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE,0.99999
GOBP_LONG_CHAIN_FATTY_ACID_T...,SET,64,-0.27044,-0.01594,0.10887,0.9935,GOBP_LONG_CHAIN_FATTY_ACID_TRANSPORT,0.99999
GOBP_POSITIVE_REGULATION_OF_...498,SET,26,-0.4123,-0.015505,0.16597,0.9935,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
WP_HAIR_FOLLICLE_DEVELOPMENT...2,SET,31,-0.43109,-0.0177,0.17344,0.99353,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,0.99999
COLIN_PILOCYTIC_ASTROCYTOMA_...1,SET,26,-0.43835,-0.016485,0.17623,0.99356,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,0.99999
GOBP_BONE_GROWTH,SET,31,-0.39044,-0.016031,0.15683,0.9936,GOBP_BONE_GROWTH,0.99999
GOBP_POSITIVE_REGULATION_OF_...293,SET,6,-1.0376,-0.018756,0.41674,0.99361,GOBP_POSITIVE_REGULATION_OF_GAP_JUNCTION_ASSEMBLY,0.99999
LINDGREN_BLADDER_CANCER_CLUS...1,SET,348,-0.11425,-0.01558,0.045859,0.99363,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,0.99999
REACTOME_BETA_CATENIN_PHOSPH...,SET,16,-0.54049,-0.015949,0.21685,0.99365,REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE,0.99999
SRF_C,SET,198,-0.15223,-0.015724,0.061059,0.99366,SRF_C,0.99999
GOBP_POSITIVE_REGULATION_OF_...48,SET,7,-0.73014,-0.014255,0.29276,0.99368,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION,0.99999
HP_TRUNCAL_ATAXIA,SET,66,-0.26024,-0.015576,0.10434,0.99368,HP_TRUNCAL_ATAXIA,0.99999
GOBP_HORMONE_BIOSYNTHETIC_PR...,SET,64,-0.27543,-0.016234,0.11039,0.9937,GOBP_HORMONE_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMAL_POSTURING,SET,5,-0.88609,-0.014621,0.35508,0.99371,HP_ABNORMAL_POSTURING,0.99999
GOMF_HYALURONIC_ACID_BINDING,SET,24,-0.43983,-0.015893,0.17615,0.99373,GOMF_HYALURONIC_ACID_BINDING,0.99999
HP_HODGKIN_LYMPHOMA,SET,25,-0.39585,-0.014598,0.15856,0.99373,HP_HODGKIN_LYMPHOMA,0.99999
GOBP_REGULATION_OF_RNA_BINDI...,SET,6,-0.80058,-0.014471,0.32051,0.99375,GOBP_REGULATION_OF_RNA_BINDING,0.99999
GOBP_G_PROTEIN_COUPLED_RECEP...2,SET,1095,-0.077387,-0.018328,0.030971,0.99376,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_RESPIRATORY_FAILURE_REQUI...,SET,29,-0.39027,-0.015499,0.1562,0.99376,HP_RESPIRATORY_FAILURE_REQUIRING_ASSISTED_VENTILATION,0.99999
GOMF_STEROID_DEHYDROGENASE_A...1,SET,36,-0.36768,-0.016266,0.147,0.99381,GOMF_STEROID_DEHYDROGENASE_ACTIVITY,0.99999
HP_NARROW_VERTEBRAL_INTERPED...,SET,13,-0.57525,-0.015303,0.22974,0.99385,HP_NARROW_VERTEBRAL_INTERPEDICULAR_DISTANCE,0.99999
HOEK_NK_CELL_2011_2012_TIV_A...1,SET,7,-0.73339,-0.014318,0.29274,0.99388,HOEK_NK_CELL_2011_2012_TIV_ADULT_1DY_UP,0.99999
HP_DECREASED_MUSCLE_MASS,SET,53,-0.29507,-0.015832,0.11774,0.99389,HP_DECREASED_MUSCLE_MASS,0.99999
GOCC_CLATHRIN_SCULPTED_GAMMA...,SET,8,-0.84087,-0.01755,0.33511,0.99395,GOCC_CLATHRIN_SCULPTED_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT_VESICLE,0.99999
KEGG_MEDICUS_REFERENCE_UCHL1...,SET,4,-1.4168,-0.02091,0.56448,0.99396,KEGG_MEDICUS_REFERENCE_UCHL1_MEDIATED_HYDROLYSIS,0.99999
MIR6822_3P,SET,49,-0.29367,-0.015152,0.11701,0.99396,MIR6822_3P,0.99999
GNF2_MLF1,SET,77,-0.24313,-0.015713,0.096857,0.99396,GNF2_MLF1,0.99999
GOBP_REGULATION_OF_INTRACELL...2,SET,9,-0.70352,-0.015573,0.28028,0.99396,GOBP_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,0.99999
REACTOME_TNFR2_NON_CANONICAL...,SET,94,-0.21405,-0.015277,0.085234,0.99398,REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,0.99999
HP_ABNORMAL_CERVICAL_CURVATU...,SET,11,-0.60437,-0.01479,0.24055,0.994,HP_ABNORMAL_CERVICAL_CURVATURE,0.99999
EMX1_TARGET_GENES,SET,183,-0.1603,-0.015925,0.063715,0.99406,EMX1_TARGET_GENES,0.99999
NMYC_01,SET,257,-0.1344,-0.015791,0.05336,0.99411,NMYC_01,0.99999
MIR1276,SET,163,-0.17,-0.015948,0.067461,0.99413,MIR1276,0.99999
REACTOME_PP2A_MEDIATED_DEPHO...,SET,6,-0.87808,-0.015872,0.34825,0.99415,REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS,0.99999
WP_REGUCALCIN_IN_PROXIMAL_TU...,SET,30,-0.39451,-0.015935,0.15636,0.99418,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,0.99999
GOMF_CORTICOTROPIN_RELEASING...,SET,5,-1.0299,-0.016994,0.40793,0.9942,GOMF_CORTICOTROPIN_RELEASING_HORMONE_RECEPTOR_BINDING,0.99999
GOBP_RESOLUTION_OF_DNA_RECOM...,SET,6,-0.78048,-0.014108,0.30901,0.99422,GOBP_RESOLUTION_OF_DNA_RECOMBINATION_INTERMEDIATES,0.99999
WP_AEROBIC_GLYCOLYSIS,SET,10,-0.53809,-0.012555,0.21302,0.99423,WP_AEROBIC_GLYCOLYSIS,0.99999
GOBP_ARACHIDONIC_ACID_SECRET...,SET,31,-0.4046,-0.016612,0.16017,0.99423,GOBP_ARACHIDONIC_ACID_SECRETION,0.99999
GOBP_POSITIVE_REGULATION_OF_...377,SET,4,-1.0685,-0.01577,0.42294,0.99423,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,0.99999
HP_ABNORMAL_TISSUE_METABOLIT...,SET,237,-0.13716,-0.015484,0.054251,0.99426,HP_ABNORMAL_TISSUE_METABOLITE_CONCENTRATION,0.99999
GAUTAM_EYE_CORNEA_FIBROBLASTS,SET,147,-0.18105,-0.016136,0.071615,0.99426,GAUTAM_EYE_CORNEA_FIBROBLASTS,0.99999
GOMF_PROTEIN_LIPID_COMPLEX_B...,SET,27,-0.44168,-0.016926,0.17462,0.99428,GOMF_PROTEIN_LIPID_COMPLEX_BINDING,0.99999
REACTOME_COOPERATION_OF_PREF...,SET,30,-0.36681,-0.014816,0.14499,0.99429,REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING,0.99999
GOBP_GROWTH_PLATE_CARTILAGE_...3,SET,19,-0.4892,-0.01573,0.1933,0.9943,GOBP_GROWTH_PLATE_CARTILAGE_DEVELOPMENT,0.99999
GOBP_VESICLE_TETHERING_INVOL...,SET,9,-0.68108,-0.015077,0.26916,0.9943,GOBP_VESICLE_TETHERING_INVOLVED_IN_EXOCYTOSIS,0.99999
GSE32255_WT_VS_JMJD2D_KNOCKD...1,SET,129,-0.18705,-0.015625,0.07388,0.99432,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,0.99999
TAVOR_CEBPA_TARGETS_UP,SET,47,-0.34556,-0.017462,0.13641,0.99435,TAVOR_CEBPA_TARGETS_UP,0.99999
HP_DIFFUSE_ALVEOLAR_HEMORRHA...,SET,16,-0.57365,-0.016928,0.22643,0.99435,HP_DIFFUSE_ALVEOLAR_HEMORRHAGE,0.99999
MAHADEVAN_GIST_MORPHOLOGICAL...,SET,14,-0.66683,-0.018408,0.26306,0.99437,MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH,0.99999
PALOMERO_GSI_SENSITIVITY_UP,SET,6,-0.87897,-0.015888,0.34674,0.99437,PALOMERO_GSI_SENSITIVITY_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_PER...,SET,186,-0.17288,-0.017313,0.068129,0.99441,HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE,0.99999
HP_FATIGABLE_WEAKNESS_OF_DIS...,SET,8,-0.72749,-0.015183,0.28651,0.99444,HP_FATIGABLE_WEAKNESS_OF_DISTAL_LIMB_MUSCLES,0.99999
HP_HETEROCHROMIA_IRIDIS,SET,23,-0.4899,-0.017329,0.19283,0.99446,HP_HETEROCHROMIA_IRIDIS,0.99999
GSE9960_HEALTHY_VS_GRAM_NEG_...4,SET,186,-0.15927,-0.01595,0.062689,0.99446,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP,0.99999
HP_INTERCOSTAL_MUSCLE_WEAKNE...,SET,9,-0.79081,-0.017505,0.31087,0.99451,HP_INTERCOSTAL_MUSCLE_WEAKNESS,0.99999
GOBP_CELLULAR_RESPONSE_TO_ET...2,SET,6,-0.84014,-0.015186,0.32984,0.99456,GOBP_CELLULAR_RESPONSE_TO_ETHER,0.99999
WP_15Q112_COPY_NUMBER_VARIAT...,SET,4,-1.0374,-0.015312,0.40713,0.99458,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...15,SET,47,-0.33167,-0.016761,0.13016,0.99458,GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_2,0.99999
GOCC_EQUATORIAL_MICROTUBULE_...,SET,4,-1.0374,-0.015312,0.40713,0.99458,GOCC_EQUATORIAL_MICROTUBULE_ORGANIZING_CENTER,0.99999
MODULE_474,SET,13,-0.70915,-0.018865,0.27821,0.99459,MODULE_474,0.99999
GOBP_OSTEOBLAST_DEVELOPMENT,SET,16,-0.56766,-0.016751,0.22269,0.9946,GOBP_OSTEOBLAST_DEVELOPMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...475,SET,14,-0.64171,-0.017714,0.25162,0.99461,GOBP_NEGATIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,0.99999
GOMF_PRE_MRNA_5_SPLICE_SITE_...,SET,2,-1.1786,-0.012301,0.4617,0.99465,GOMF_PRE_MRNA_5_SPLICE_SITE_BINDING,0.99999
WP_MIR5093P_ALTERATION_OF_YA...,SET,17,-0.61437,-0.018687,0.24062,0.99466,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,0.99999
HP_FIBROADENOMA_OF_THE_BREAST,SET,11,-0.68902,-0.016861,0.26986,0.99466,HP_FIBROADENOMA_OF_THE_BREAST,0.99999
GSE339_CD4POS_VS_CD4CD8DN_DC...3,SET,185,-0.15754,-0.015735,0.061704,0.99466,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,0.99999
HP_ABNORMALITY_OF_THE_THYROI...,SET,461,-0.10452,-0.016353,0.040926,0.99467,HP_ABNORMALITY_OF_THE_THYROID_GLAND,0.99999
GSE36392_TYPE_2_MYELOID_VS_M...2,SET,183,-0.17192,-0.017079,0.067287,0.99469,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP,0.99999
HP_EXTERNAL_OPHTHALMOPLEGIA,SET,51,-0.29665,-0.015614,0.11602,0.99472,HP_EXTERNAL_OPHTHALMOPLEGIA,0.99999
HP_FIFTH_FINGER_DISTAL_PHALA...,SET,27,-0.41669,-0.015968,0.16279,0.99476,HP_FIFTH_FINGER_DISTAL_PHALANX_CLINODACTYLY,0.99999
ZHONG_PFC_C2_SOX5_BCL11B_POS...,SET,24,-0.49687,-0.017953,0.1941,0.99476,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...1,SET,84,-0.24913,-0.016813,0.097296,0.99477,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.99999
DESCARTES_MAIN_FETAL_LENS_FI...,SET,137,-0.19026,-0.016374,0.074301,0.99477,DESCARTES_MAIN_FETAL_LENS_FIBRE_CELLS,0.99999
GOBP_POSITIVE_REGULATION_OF_...111,SET,29,-0.42448,-0.016858,0.16574,0.99478,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,0.99999
GSE13411_NAIVE_VS_IGM_MEMORY...2,SET,171,-0.16951,-0.016284,0.066136,0.99481,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP,0.99999
MIR203A_5P,SET,51,-0.2997,-0.015774,0.11672,0.99488,MIR203A_5P,0.99999
GOBP_STEROL_TRANSPORT,SET,103,-0.22103,-0.01651,0.086067,0.99488,GOBP_STEROL_TRANSPORT,0.99999
HP_LATERAL_VENTRICLE_DILATAT...,SET,75,-0.24853,-0.015853,0.096778,0.99488,HP_LATERAL_VENTRICLE_DILATATION,0.99999
GSE28737_FOLLICULAR_VS_MARGI...1,SET,184,-0.16309,-0.016246,0.063497,0.99489,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_DN,0.99999
TIEN_INTESTINE_PROBIOTICS_6H...2,SET,46,-0.3285,-0.016423,0.12773,0.99494,TIEN_INTESTINE_PROBIOTICS_6HR_UP,0.99999
GSE360_DC_VS_MAC_M_TUBERCULO...1,SET,180,-0.16697,-0.016452,0.064895,0.99495,GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN,0.99999
GOBP_MOTOR_NEURON_APOPTOTIC_...,SET,21,-0.46961,-0.015874,0.1825,0.99496,GOBP_MOTOR_NEURON_APOPTOTIC_PROCESS,0.99999
HP_ENTEROCOLITIS,SET,19,-0.47394,-0.015239,0.18407,0.99498,HP_ENTEROCOLITIS,0.99999
GSE22611_MUTANT_NOD2_TRANSDU...2,SET,170,-0.16388,-0.015697,0.063641,0.99498,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_UP,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...4,SET,4,-1.2549,-0.018521,0.48732,0.99499,GOBP_PROTEIN_LOCALIZATION_TO_BICELLULAR_TIGHT_JUNCTION,0.99999
PEDERSEN_METASTASIS_BY_ERBB2...3,SET,99,-0.23707,-0.017362,0.091976,0.99502,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,0.99999
GOCC_CCAAT_BINDING_FACTOR_CO...,SET,5,-0.90866,-0.014994,0.35231,0.99504,GOCC_CCAAT_BINDING_FACTOR_COMPLEX,0.99999
GOCC_NUCLEAR_OUTER_MEMBRANE_...,SET,1100,-0.069125,-0.016406,0.026807,0.99504,GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK,0.99999
HP_DECREASED_SPECIFIC_ANTIBO...2,SET,3,-1.5425,-0.019717,0.59819,0.99504,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_PROTEIN_CONJUGATED_POLYSACCHARIDE_VACCINE,0.99999
HP_THICKENED_CORTEX_OF_LONG_...,SET,14,-0.61555,-0.016992,0.23867,0.99504,HP_THICKENED_CORTEX_OF_LONG_BONES,0.99999
FURUKAWA_DUSP6_TARGETS_PCI35...1,SET,71,-0.26175,-0.016246,0.10145,0.99506,FURUKAWA_DUSP6_TARGETS_PCI35_DN,0.99999
ZNF202_TARGET_GENES,SET,64,-0.28054,-0.016535,0.10855,0.99512,ZNF202_TARGET_GENES,0.99999
GOBP_NOTOCHORD_DEVELOPMENT,SET,16,-0.58183,-0.017169,0.22506,0.99513,GOBP_NOTOCHORD_DEVELOPMENT,0.99999
HP_ABNORMAL_CIRCULATING_VITA...2,SET,24,-0.4737,-0.017116,0.18319,0.99514,HP_ABNORMAL_CIRCULATING_VITAMIN_B12_CONCENTRATION,0.99999
GAO_STOMACH_24W_C5_PUTATIVE_...,SET,51,-0.30758,-0.016189,0.11881,0.99518,GAO_STOMACH_24W_C5_PUTATIVE_PIT_CELL_PROGENITOR,0.99999
HP_ABNORMAL_CIRCULATING_SULF...,SET,23,-0.47212,-0.016701,0.18232,0.99519,HP_ABNORMAL_CIRCULATING_SULFUR_AMINO_ACID_CONCENTRATION,0.99999
HP_MUSCLE_FIBER_ATROPHY,SET,61,-0.26946,-0.015507,0.10402,0.9952,HP_MUSCLE_FIBER_ATROPHY,0.99999
DELLA_RESPONSE_TO_TSA_AND_BU...,SET,20,-0.48816,-0.016104,0.18839,0.99521,DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,0.99999
GCM_NPM1,SET,104,-0.20125,-0.015105,0.077603,0.99524,GCM_NPM1,0.99999
REACTOME_INHIBITION_OF_REPLI...,SET,11,-0.58971,-0.014431,0.22723,0.99527,REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1,0.99999
MIR3177_5P,SET,146,-0.18121,-0.016095,0.069775,0.99529,MIR3177_5P,0.99999
HP_HIGHLY_ELEVATED_CREATINE_...,SET,6,-0.8626,-0.015592,0.33223,0.99529,HP_HIGHLY_ELEVATED_CREATINE_KINASE,0.99999
GSE17721_PAM3CSK4_VS_CPG_0.5...2,SET,179,-0.16409,-0.016124,0.063125,0.99533,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP,0.99999
FRANCO_BLOOD_SANOFI_PASTEUR_...7,SET,17,-0.56137,-0.017075,0.21596,0.99533,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_3DY_POSITIVE,0.99999
MIR4447,SET,255,-0.13794,-0.016144,0.053045,0.99534,MIR4447,0.99999
GOBP_POSITIVE_REGULATION_OF_...722,SET,22,-0.50234,-0.017379,0.19313,0.99535,GOBP_POSITIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS,0.99999
HP_PROGRESSIVE_ENCEPHALOPATHY,SET,10,-0.64676,-0.015091,0.2486,0.99536,HP_PROGRESSIVE_ENCEPHALOPATHY,0.99999
GOBP_REGULATION_OF_MRNA_3_EN...,SET,9,-0.68623,-0.01519,0.26362,0.99538,GOBP_REGULATION_OF_MRNA_3_END_PROCESSING,0.99999
WP_METABOLISM_OF_ALPHALINOLE...,SET,6,-1.0097,-0.018251,0.38773,0.99539,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,0.99999
HP_CHRONIC_BRONCHITIS,SET,21,-0.45554,-0.015398,0.17492,0.99539,HP_CHRONIC_BRONCHITIS,0.99999
HP_CERVICAL_CORD_COMPRESSION,SET,6,-0.93843,-0.016963,0.36025,0.9954,HP_CERVICAL_CORD_COMPRESSION,0.99999
CREIGHTON_AKT1_SIGNALING_VIA...1,SET,20,-0.45552,-0.015027,0.17482,0.99541,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN,0.99999
MIR2116_5P,SET,133,-0.18916,-0.016042,0.072553,0.99543,MIR2116_5P,0.99999
GOMF_INSULIN_RECEPTOR_SUBSTR...,SET,13,-0.62604,-0.016654,0.24004,0.99544,GOMF_INSULIN_RECEPTOR_SUBSTRATE_BINDING,0.99999
HP_BILE_DUCT_PROLIFERATION,SET,18,-0.49387,-0.015457,0.18937,0.99544,HP_BILE_DUCT_PROLIFERATION,0.99999
HP_GASTROSTOMY_TUBE_FEEDING_...,SET,93,-0.22144,-0.015721,0.084908,0.99544,HP_GASTROSTOMY_TUBE_FEEDING_IN_INFANCY,0.99999
TRAYNOR_RETT_SYNDROM_DN,SET,14,-0.63846,-0.017625,0.24477,0.99545,TRAYNOR_RETT_SYNDROM_DN,0.99999
BIOCARTA_TRKA_PATHWAY,SET,14,-0.55747,-0.015389,0.21369,0.99545,BIOCARTA_TRKA_PATHWAY,0.99999
REACTOME_GLUTAMATE_NEUROTRAN...,SET,23,-0.51802,-0.018324,0.1986,0.99545,REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE,0.99999
YTAATTAA_LHX3_01,SET,179,-0.17998,-0.017685,0.068995,0.99545,YTAATTAA_LHX3_01,0.99999
HP_CHOANAL_STENOSIS,SET,25,-0.45574,-0.016807,0.17465,0.99546,HP_CHOANAL_STENOSIS,0.99999
GOBP_REGULATION_OF_FAS_SIGNA...,SET,4,-1.0574,-0.015606,0.40505,0.99548,GOBP_REGULATION_OF_FAS_SIGNALING_PATHWAY,0.99999
GSE20715_0H_VS_48H_OZONE_LUN...1,SET,189,-0.15572,-0.015719,0.059639,0.99548,GSE20715_0H_VS_48H_OZONE_LUNG_DN,0.99999
GSE5099_UNSTIM_VS_MCSF_TREAT...1,SET,186,-0.1593,-0.015953,0.061019,0.99548,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN,0.99999
chr3q25,SET,61,-0.54011,-0.031082,0.20672,0.99551,chr3q25,0.99999
GSE24634_TREG_VS_TCONV_POST_...4,SET,181,-0.15555,-0.015369,0.059463,0.99555,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP,0.99999
WP_VITAMIN_B12_DISORDERS,SET,11,-0.63537,-0.015548,0.24282,0.99556,WP_VITAMIN_B12_DISORDERS,0.99999
GOBP_REGULATION_OF_CORE_PROM...,SET,5,-0.98823,-0.016307,0.37739,0.99558,GOBP_REGULATION_OF_CORE_PROMOTER_BINDING,0.99999
MODULE_79,SET,89,-0.252,-0.017504,0.096224,0.99559,MODULE_79,0.99999
HP_IRREGULAR_MENSTRUATION,SET,58,-0.29588,-0.016605,0.11296,0.99559,HP_IRREGULAR_MENSTRUATION,0.99999
HP_PERSONALITY_DISORDER,SET,16,-0.5404,-0.015947,0.20629,0.99559,HP_PERSONALITY_DISORDER,0.99999
GSE29949_CD8_NEG_DC_SPLEEN_V...5,SET,176,-0.17263,-0.016822,0.065882,0.9956,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,0.99999
ALONSO_METASTASIS_UP,SET,175,-0.16607,-0.016137,0.063337,0.99563,ALONSO_METASTASIS_UP,0.99999
LI_PBMC_MENOMUNE_A_C_Y_W_135...3,SET,19,-0.5581,-0.017945,0.2126,0.99567,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_NEGATIVE,0.99999
GOBP_PROTEIN_C_LINKED_GLYCOS...,SET,4,-1.2973,-0.019148,0.49242,0.99578,GOBP_PROTEIN_C_LINKED_GLYCOSYLATION,0.99999
MODULE_170,SET,89,-0.25105,-0.017438,0.095158,0.99583,MODULE_170,0.99999
GOBP_GASTRO_INTESTINAL_SYSTE...,SET,12,-0.63047,-0.016114,0.23889,0.99584,GOBP_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION,0.99999
GOBP_ENDOTHELIAL_CELL_MORPHO...,SET,9,-0.87941,-0.019467,0.33313,0.99585,GOBP_ENDOTHELIAL_CELL_MORPHOGENESIS,0.99999
GSE5542_IFNG_VS_IFNA_AND_IFN...2,SET,179,-0.16152,-0.015871,0.061142,0.99587,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.99999
HP_DECREASED_CIRCULATING_MET...,SET,8,-0.84846,-0.017708,0.32111,0.99588,HP_DECREASED_CIRCULATING_METHYLCOBALAMIN_CONCENTRATION,0.99999
GOBP_CELLULAR_RESPONSE_TO_LI...3,SET,32,-0.42197,-0.017602,0.15962,0.99589,GOBP_CELLULAR_RESPONSE_TO_LIPOPROTEIN_PARTICLE_STIMULUS,0.99999
GSE37301_GRANULOCYTE_MONOCYT...2,SET,165,-0.17412,-0.016433,0.065864,0.9959,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,0.99999
HP_MASK_LIKE_FACIES,SET,44,-0.33075,-0.016173,0.12505,0.99591,HP_MASK_LIKE_FACIES,0.99999
HP_NONCOMMUNICATING_HYDROCEP...,SET,6,-0.96765,-0.017491,0.36588,0.99591,HP_NONCOMMUNICATING_HYDROCEPHALUS,0.99999
GSE26928_NAIVE_VS_CXCR5_POS_...1,SET,166,-0.16504,-0.015622,0.062354,0.99593,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN,0.99999
ZNF16_TARGET_GENES,SET,66,-0.29989,-0.017949,0.11324,0.99595,ZNF16_TARGET_GENES,0.99999
GOMF_N_METHYLTRANSFERASE_ACT...,SET,82,-0.2374,-0.015831,0.089577,0.99597,GOMF_N_METHYLTRANSFERASE_ACTIVITY,0.99999
HP_ABNORMAL_ENCHONDRAL_OSSIF...,SET,126,-0.20208,-0.016684,0.076268,0.99597,HP_ABNORMAL_ENCHONDRAL_OSSIFICATION,0.99999
HP_WHITE_EYEBROW,SET,11,-0.74029,-0.018116,0.27903,0.99601,HP_WHITE_EYEBROW,0.99999
GOMF_SINGLE_STRANDED_DNA_3_5...,SET,6,-0.68017,-0.012294,0.25582,0.99608,GOMF_SINGLE_STRANDED_DNA_3_5_DNA_EXONUCLEASE_ACTIVITY,0.99999
TURASHVILI_BREAST_LOBULAR_CA...2,SET,62,-0.30943,-0.017952,0.11633,0.99609,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,0.99999
GOBP_REGULATION_OF_G_PROTEIN...,SET,133,-0.2033,-0.017241,0.076415,0.99609,GOBP_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
SETD7_TARGET_GENES,SET,718,-0.082167,-0.015929,0.030876,0.9961,SETD7_TARGET_GENES,0.99999
HP_ABNORMALITY_OF_RETINAL_PI...,SET,283,-0.13413,-0.016525,0.050335,0.99614,HP_ABNORMALITY_OF_RETINAL_PIGMENTATION,0.99999
HP_METATARSAL_SYNOSTOSIS,SET,7,-0.95196,-0.018585,0.35608,0.99624,HP_METATARSAL_SYNOSTOSIS,0.99999
GOBP_PROTEIN_HISTIDYL_MODIFI...,SET,7,-0.76254,-0.014887,0.28464,0.9963,GOBP_PROTEIN_HISTIDYL_MODIFICATION_TO_DIPHTHAMIDE,0.99999
GOMF_PROTEIN_CYSTEINE_S_STEA...,SET,6,-0.9163,-0.016563,0.34168,0.99633,GOMF_PROTEIN_CYSTEINE_S_STEAROYLTRANSFERASE_ACTIVITY,0.99999
WP_AEROBIC_GLYCOLYSIS_AUGMEN...,SET,11,-0.55196,-0.013507,0.2058,0.99634,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,0.99999
HP_ABNORMAL_LIVER_METABOLITE...,SET,181,-0.16636,-0.016437,0.061971,0.99636,HP_ABNORMAL_LIVER_METABOLITE_CONCENTRATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...628,SET,451,-0.10734,-0.016617,0.039976,0.99637,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION,0.99999
HP_ATLANTOAXIAL_DISLOCATION,SET,6,-0.88457,-0.015989,0.32904,0.99641,HP_ATLANTOAXIAL_DISLOCATION,0.99999
MA_RAT_AGING_DN,SET,143,-0.20454,-0.017982,0.076056,0.99642,MA_RAT_AGING_DN,0.99999
HP_CONTRACTURE_OF_THE_PROXIM...1,SET,6,-0.98637,-0.017829,0.36676,0.99642,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_3RD_FINGER,0.99999
GSE1432_1H_VS_24H_IFNG_MICRO...2,SET,188,-0.17598,-0.017717,0.065434,0.99642,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,0.99999
GSE17721_12H_VS_24H_LPS_BMDC...1,SET,181,-0.15899,-0.015709,0.059093,0.99643,GSE17721_12H_VS_24H_LPS_BMDC_DN,0.99999
GOCC_CALCIUM_AND_CALMODULIN_...,SET,5,-1.1383,-0.018784,0.422,0.9965,GOCC_CALCIUM_AND_CALMODULIN_DEPENDENT_PROTEIN_KINASE_COMPLEX,0.99999
GSE19923_E2A_KO_VS_HEB_AND_E...1,SET,163,-0.19044,-0.017865,0.070607,0.9965,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.99999
GOBP_CAP_DEPENDENT_TRANSLATI...,SET,7,-0.69267,-0.013523,0.25656,0.99653,GOBP_CAP_DEPENDENT_TRANSLATIONAL_INITIATION,0.99999
HP_ELEVATED_CIRCULATING_HEPA...,SET,324,-0.12718,-0.016747,0.047068,0.99655,HP_ELEVATED_CIRCULATING_HEPATIC_TRANSAMINASE_CONCENTRATION,0.99999
GSE37416_0H_VS_12H_F_TULAREN...2,SET,168,-0.17855,-0.017002,0.066003,0.99658,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
BCAT_GDS748_UP,SET,45,-0.36849,-0.018222,0.13618,0.99659,BCAT_GDS748_UP,0.99999
BRUECKNER_TARGETS_OF_MIRLET7...2,SET,104,-0.2388,-0.017923,0.08823,0.9966,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,0.99999
HP_TALL_STATURE,SET,147,-0.19086,-0.017011,0.070472,0.99662,HP_TALL_STATURE,0.99999
MIR6841_3P,SET,49,-0.30984,-0.015986,0.11436,0.99663,MIR6841_3P,0.99999
REACTOME_INTRA_GOLGI_AND_RET...,SET,194,-0.15662,-0.016016,0.057761,0.99665,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,0.99999
ZNF669_TARGET_GENES,SET,95,-0.23387,-0.01678,0.086166,0.99667,ZNF669_TARGET_GENES,0.99999
HP_SUBDURAL_HEMORRHAGE,SET,12,-0.73144,-0.018695,0.26949,0.99668,HP_SUBDURAL_HEMORRHAGE,0.99999
RUBENSTEIN_SKELETAL_MUSCLE_P...2,SET,116,-0.2258,-0.017892,0.083154,0.99669,RUBENSTEIN_SKELETAL_MUSCLE_PERICYTES,0.99999
BIOCARTA_MTA3_PATHWAY,SET,17,-0.55938,-0.017014,0.2058,0.99671,BIOCARTA_MTA3_PATHWAY,0.99999
GSE25088_ROSIGLITAZONE_VS_IL...1,SET,181,-0.16749,-0.016549,0.061631,0.99671,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.99999
SKP2_TARGET_GENES,SET,50,-0.32523,-0.01695,0.11961,0.99672,SKP2_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...233,SET,7,-0.85721,-0.016736,0.31525,0.99672,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_TRANSPORT,0.99999
REACTOME_SMAC_XIAP_REGULATED...,SET,6,-0.8496,-0.015357,0.31239,0.99673,REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE,0.99999
GOMF_PROTEIN_SERINE_THREONIN...4,SET,36,-0.39255,-0.017366,0.14434,0.99673,GOMF_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY,0.99999
GSE43955_TGFB_IL6_VS_TGFB_IL...1,SET,176,-0.1886,-0.018378,0.069324,0.99674,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,0.99999
GOBP_VITAMIN_D_BIOSYNTHETIC_...,SET,10,-0.75965,-0.017725,0.27907,0.99675,GOBP_VITAMIN_D_BIOSYNTHETIC_PROCESS,0.99999
GOBP_CHEMOKINE_C_X_C_MOTIF_L...1,SET,6,-1.0629,-0.019212,0.39041,0.99676,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_12_SIGNALING_PATHWAY,0.99999
GOBP_RESPONSE_TO_GAMMA_RADIA...,SET,47,-0.31834,-0.016087,0.11685,0.99678,GOBP_RESPONSE_TO_GAMMA_RADIATION,0.99999
GSE27786_NKTCELL_VS_MONO_MAC...1,SET,178,-0.1764,-0.017285,0.064727,0.99678,GSE27786_NKTCELL_VS_MONO_MAC_DN,0.99999
GSE339_CD8POS_VS_CD4CD8DN_DC...2,SET,182,-0.16824,-0.016669,0.061741,0.99678,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,0.99999
GSE15930_NAIVE_VS_72H_IN_VIT...8,SET,185,-0.1641,-0.01639,0.060052,0.99685,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP,0.99999
WINTER_HYPOXIA_DN,SET,42,-0.38839,-0.018556,0.14193,0.99689,WINTER_HYPOXIA_DN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...87,SET,5,-1.1874,-0.019594,0.43388,0.99689,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RUNX1_TO_TRANSCRIPTION,0.99999
GSE42021_CD24HI_TREG_VS_CD24...1,SET,186,-0.17872,-0.017898,0.065304,0.99689,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_DN,0.99999
MIR6769A_5P,SET,43,-0.3506,-0.016948,0.12806,0.9969,MIR6769A_5P,0.99999
REACTOME_TNFS_BIND_THEIR_PHY...,SET,27,-0.50736,-0.019443,0.18522,0.99692,REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS,0.99999
GAUCHER_PBMC_YF_VAX_STAMARIL...12,SET,274,-0.14877,-0.018039,0.0543,0.99692,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP,0.99999
GSE36476_CTRL_VS_TSST_ACT_40...1,SET,181,-0.16371,-0.016175,0.059734,0.99693,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN,0.99999
DESCARTES_FETAL_MUSCLE_SMOOT...,SET,67,-0.30207,-0.018215,0.1101,0.99696,DESCARTES_FETAL_MUSCLE_SMOOTH_MUSCLE_CELLS,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...6,SET,43,-0.38808,-0.01876,0.14135,0.99698,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_3,0.99999
GOMF_UBIQUITIN_BINDING,SET,94,-0.23708,-0.016921,0.086274,0.997,GOMF_UBIQUITIN_BINDING,0.99999
GSE13946_CTRL_VS_DSS_COLITIS...1,SET,157,-0.18745,-0.017261,0.068112,0.99704,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN,0.99999
REACTOME_ELECTRIC_TRANSMISSI...,SET,4,-1.2885,-0.019017,0.46778,0.99706,REACTOME_ELECTRIC_TRANSMISSION_ACROSS_GAP_JUNCTIONS,0.99999
HP_JOINT_CONTRACTURE_OF_THE_...1,SET,7,-1.0007,-0.019538,0.3633,0.99706,HP_JOINT_CONTRACTURE_OF_THE_4TH_FINGER,0.99999
chr1p36,SET,326,-0.28228,-0.037281,0.10245,0.99707,chr1p36,0.99999
GSE3982_NEUTROPHIL_VS_BCELL_...1,SET,182,-0.16647,-0.016493,0.060385,0.99708,GSE3982_NEUTROPHIL_VS_BCELL_DN,0.99999
GSE13411_PLASMA_CELL_VS_MEMO...2,SET,161,-0.18617,-0.017358,0.067435,0.99711,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP,0.99999
HP_ABNORMAL_CEREBROSPINAL_FL...,SET,531,-0.10009,-0.016774,0.036239,0.99712,HP_ABNORMAL_CEREBROSPINAL_FLUID_MORPHOLOGY,0.99999
HP_MUSCLE_ABNORMALITY_RELATE...,SET,63,-0.26934,-0.015751,0.09751,0.99713,HP_MUSCLE_ABNORMALITY_RELATED_TO_MITOCHONDRIAL_DYSFUNCTION,0.99999
HP_PROGRESSIVE_EXTERNAL_OPHT...,SET,20,-0.47459,-0.015656,0.17177,0.99713,HP_PROGRESSIVE_EXTERNAL_OPHTHALMOPLEGIA,0.99999
HOEGERKORP_CD44_TARGETS_DIRE...1,SET,10,-0.73673,-0.01719,0.26644,0.99715,HOEGERKORP_CD44_TARGETS_DIRECT_DN,0.99999
GSE38304_MYC_NEG_VS_POS_GC_B...2,SET,184,-0.17841,-0.017771,0.064494,0.99716,GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP,0.99999
GOBP_MITOCHONDRIAL_DNA_METAB...,SET,21,-0.48136,-0.016271,0.17397,0.99717,GOBP_MITOCHONDRIAL_DNA_METABOLIC_PROCESS,0.99999
MIR326,SET,115,-0.22855,-0.018032,0.082533,0.99719,MIR326,0.99999
REACTOME_PROCESSING_OF_CAPPE...1,SET,28,-0.39245,-0.015315,0.14151,0.99722,REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA,0.99999
chr6p23,SET,7,-1.2602,-0.024603,0.45375,0.99726,chr6p23,0.99999
LINDGREN_BLADDER_CANCER_CLUS...7,SET,288,-0.13679,-0.016998,0.049244,0.99726,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,0.99999
REACTOME_RAF_ACTIVATION,SET,32,-0.41838,-0.017452,0.15047,0.99728,REACTOME_RAF_ACTIVATION,0.99999
GOMF_MIRNA_BINDING,SET,28,-0.39933,-0.015584,0.14366,0.99728,GOMF_MIRNA_BINDING,0.99999
GOBP_FAT_SOLUBLE_VITAMIN_BIO...,SET,13,-0.69405,-0.018463,0.24921,0.99732,GOBP_FAT_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS,0.99999
GSE22025_UNTREATED_VS_TGFB1_...1,SET,174,-0.18032,-0.017472,0.06475,0.99732,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,0.99999
GOCC_PROTEIN_PHOSPHATASE_TYP...2,SET,16,-0.59613,-0.017591,0.21377,0.99735,GOCC_PROTEIN_PHOSPHATASE_TYPE_2A_COMPLEX,0.99999
WONG_ENDOMETRIAL_CANCER_LATE,SET,7,-1.0198,-0.01991,0.36551,0.99736,WONG_ENDOMETRIAL_CANCER_LATE,0.99999
GOBP_POSITIVE_REGULATION_BY_...2,SET,19,-0.53083,-0.017069,0.19021,0.99737,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS,0.99999
KAAB_HEART_ATRIUM_VS_VENTRIC...2,SET,233,-0.1617,-0.018101,0.057866,0.9974,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,0.99999
GOBP_RESPONSE_TO_ISOQUINOLIN...,SET,13,-0.69633,-0.018524,0.24879,0.99743,GOBP_RESPONSE_TO_ISOQUINOLINE_ALKALOID,0.99999
GOBP_GOLGI_TO_PLASMA_MEMBRAN...2,SET,61,-0.28823,-0.016587,0.10293,0.99744,GOBP_GOLGI_TO_PLASMA_MEMBRANE_TRANSPORT,0.99999
SARTIPY_BLUNTED_BY_INSULIN_R...2,SET,18,-0.58165,-0.018204,0.20763,0.99745,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,0.99999
MIR3652,SET,135,-0.20008,-0.017094,0.071422,0.99745,MIR3652,0.99999
GSE8678_IL7R_LOW_VS_HIGH_EFF...1,SET,171,-0.18329,-0.017607,0.065427,0.99745,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN,0.99999
DESCARTES_FETAL_THYMUS_STROM...,SET,116,-0.24066,-0.01907,0.085926,0.99745,DESCARTES_FETAL_THYMUS_STROMAL_CELLS,0.99999
GOBP_URIDINE_TRANSMEMBRANE_T...,SET,6,-1.0568,-0.019102,0.37695,0.99747,GOBP_URIDINE_TRANSMEMBRANE_TRANSPORT,0.99999
GOBP_CHOLANGIOCYTE_PROLIFERA...,SET,4,-1.1265,-0.016627,0.40172,0.99748,GOBP_CHOLANGIOCYTE_PROLIFERATION,0.99999
COLLER_MYC_TARGETS_UP,SET,23,-0.47913,-0.016948,0.17078,0.99749,COLLER_MYC_TARGETS_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...64,SET,2,-1.4002,-0.014614,0.49891,0.99749,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_REMODELING,0.99999
GOBP_CELL_CELL_JUNCTION_MAIN...,SET,15,-0.68681,-0.019624,0.24459,0.99751,GOBP_CELL_CELL_JUNCTION_MAINTENANCE,0.99999
GOBP_POSITIVE_REGULATION_OF_...179,SET,13,-0.68109,-0.018118,0.24249,0.99751,GOBP_POSITIVE_REGULATION_OF_CREB_TRANSCRIPTION_FACTOR_ACTIVITY,0.99999
GOCC_DNA_DEPENDENT_PROTEIN_K...1,SET,5,-0.92588,-0.015278,0.32962,0.99751,GOCC_DNA_DEPENDENT_PROTEIN_KINASE_COMPLEX,0.99999
GSE22935_24H_VS_48H_MBOVIS_B...1,SET,181,-0.17135,-0.01693,0.060993,0.99752,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.99999
LIANG_HEMATOPOIESIS_STEM_CEL...2,SET,39,-0.38117,-0.01755,0.13554,0.99754,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP,0.99999
CASORELLI_ACUTE_PROMYELOCYTI...2,SET,143,-0.21069,-0.018522,0.074813,0.99757,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,0.99999
MIR3147,SET,35,-0.45266,-0.019746,0.16064,0.99758,MIR3147,0.99999
GOMF_SINGLE_STRANDED_DNA_5_3...,SET,5,-0.91372,-0.015077,0.32405,0.99759,GOMF_SINGLE_STRANDED_DNA_5_3_DNA_EXONUCLEASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_TRANSCRIP...5,SET,29,-0.44644,-0.01773,0.1582,0.99761,GOBP_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,0.99999
ALONSO_METASTASIS_EMT_UP,SET,32,-0.42865,-0.017881,0.15168,0.99764,ALONSO_METASTASIS_EMT_UP,0.99999
NATSUME_RESPONSE_TO_INTERFER...1,SET,51,-0.34604,-0.018213,0.12222,0.99768,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,0.99999
GOMF_AMINO_ACID_BINDING,SET,43,-0.3823,-0.01848,0.135,0.99768,GOMF_AMINO_ACID_BINDING,0.99999
KEGG_OOCYTE_MEIOSIS,SET,105,-0.23112,-0.017429,0.081604,0.99769,KEGG_OOCYTE_MEIOSIS,0.99999
GOMF_ARYL_SULFOTRANSFERASE_A...,SET,7,-1.1595,-0.022637,0.40882,0.99771,GOMF_ARYL_SULFOTRANSFERASE_ACTIVITY,0.99999
GOBP_BRAIN_MORPHOGENESIS,SET,37,-0.40042,-0.017958,0.14115,0.99772,GOBP_BRAIN_MORPHOGENESIS,0.99999
HP_ABNORMAL_ASTROCYTE_MORPHO...,SET,45,-0.35708,-0.017657,0.12583,0.99773,HP_ABNORMAL_ASTROCYTE_MORPHOLOGY,0.99999
GSE4748_CTRL_VS_CYANOBACTERI...3,SET,178,-0.17328,-0.01698,0.061048,0.99773,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,0.99999
GSE38696_LIGHT_ZONE_VS_DARK_...2,SET,165,-0.18022,-0.017009,0.063375,0.99777,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,0.99999
GOCC_ALPHA_DNA_POLYMERASE_PR...,SET,4,-1.0428,-0.015391,0.36645,0.99778,GOCC_ALPHA_DNA_POLYMERASE_PRIMASE_COMPLEX,0.99999
HP_RED_HAIR,SET,8,-0.93216,-0.019455,0.32754,0.99778,HP_RED_HAIR,0.99999
GSE21670_UNTREATED_VS_IL6_TR...3,SET,180,-0.17767,-0.017507,0.062396,0.99779,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.99999
GOMF_INOSITOL_1_3_4_5_TETRAK...,SET,5,-1.117,-0.018432,0.39194,0.99781,GOMF_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE_BINDING,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...7,SET,175,-0.1943,-0.01888,0.068062,0.99784,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN,0.99999
LEE_LIVER_CANCER_MYC_E2F1_DN,SET,58,-0.34734,-0.019493,0.12163,0.99785,LEE_LIVER_CANCER_MYC_E2F1_DN,0.99999
KEGG_BIOSYNTHESIS_OF_UNSATUR...,SET,22,-0.55615,-0.019241,0.19456,0.99787,KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS,0.99999
GOBP_STARTLE_RESPONSE,SET,25,-0.50317,-0.018556,0.17592,0.99788,GOBP_STARTLE_RESPONSE,0.99999
GOBP_SNRNA_TRANSPORT,SET,5,-0.9781,-0.01614,0.34152,0.99791,GOBP_SNRNA_TRANSPORT,0.99999
HP_LYMPHANGIOMA,SET,11,-0.82115,-0.020095,0.28666,0.99791,HP_LYMPHANGIOMA,0.99999
PUIFFE_INVASION_INHIBITED_BY...1,SET,134,-0.2055,-0.017493,0.071687,0.99792,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,0.99999
REACTOME_OPIOID_SIGNALLING,SET,88,-0.27073,-0.018699,0.09442,0.99793,REACTOME_OPIOID_SIGNALLING,0.99999
PID_ARF6_PATHWAY,SET,35,-0.42215,-0.018415,0.14702,0.99795,PID_ARF6_PATHWAY,0.99999
GSE36476_CTRL_VS_TSST_ACT_16...2,SET,170,-0.19087,-0.018282,0.066483,0.99795,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP,0.99999
GOBP_MRNA_3_END_PROCESSING,SET,36,-0.3683,-0.016293,0.12825,0.99796,GOBP_MRNA_3_END_PROCESSING,0.99999
PID_NOTCH_PATHWAY,SET,56,-0.32192,-0.017753,0.11181,0.998,PID_NOTCH_PATHWAY,0.99999
REACTOME_RHOJ_GTPASE_CYCLE,SET,50,-0.3553,-0.018517,0.12342,0.998,REACTOME_RHOJ_GTPASE_CYCLE,0.99999
GOMF_COBALAMIN_BINDING,SET,8,-0.81873,-0.017087,0.28428,0.99801,GOMF_COBALAMIN_BINDING,0.99999
GOBP_RNA_3_END_PROCESSING,SET,76,-0.25317,-0.016256,0.087818,0.99803,GOBP_RNA_3_END_PROCESSING,0.99999
GOBP_LIPOPROTEIN_LOCALIZATION,SET,19,-0.52315,-0.016822,0.18115,0.99806,GOBP_LIPOPROTEIN_LOCALIZATION,0.99999
GSE42021_CD24HI_TREG_VS_CD24...2,SET,179,-0.17569,-0.017263,0.060719,0.99809,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_UP,0.99999
KEGG_MEDICUS_REFERENCE_COHES...3,SET,14,-0.61961,-0.017104,0.21392,0.99811,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE,0.99999
AAANWWTGC_UNKNOWN,SET,183,-0.19103,-0.018978,0.06588,0.99813,AAANWWTGC_UNKNOWN,0.99999
HP_SPINAL_CANAL_STENOSIS,SET,35,-0.43722,-0.019073,0.15075,0.99813,HP_SPINAL_CANAL_STENOSIS,0.99999
REACTOME_G_ALPHA_Q_SIGNALLIN...,SET,203,-0.18837,-0.019699,0.064905,0.99815,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,0.99999
MIR6804_3P,SET,85,-0.27945,-0.018971,0.096159,0.99817,MIR6804_3P,0.99999
GOBP_REGULATION_OF_BLOOD_PRE...,SET,170,-0.20484,-0.019621,0.070428,0.99818,GOBP_REGULATION_OF_BLOOD_PRESSURE,0.99999
HAMAI_APOPTOSIS_VIA_TRAIL_DN,SET,176,-0.18463,-0.017991,0.063375,0.99821,HAMAI_APOPTOSIS_VIA_TRAIL_DN,0.99999
HP_SPINAL_CORD_COMPRESSION,SET,34,-0.45901,-0.019735,0.15746,0.99822,HP_SPINAL_CORD_COMPRESSION,0.99999
GOBP_POSITIVE_REGULATION_OF_...824,SET,8,-0.84496,-0.017635,0.2897,0.99823,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
GOBP_MITOCHONDRIAL_DNA_REPLI...,SET,13,-0.62484,-0.016622,0.214,0.99825,GOBP_MITOCHONDRIAL_DNA_REPLICATION,0.99999
GSE5542_IFNG_VS_IFNA_TREATED...4,SET,175,-0.17798,-0.017294,0.060904,0.99826,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,0.99999
GOBP_MICROTUBULE_CYTOSKELETO...1,SET,577,-0.10199,-0.017794,0.034846,0.99829,GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION,0.99999
HP_CONGENITAL_HIP_DISLOCATION,SET,68,-0.3068,-0.018638,0.10471,0.9983,HP_CONGENITAL_HIP_DISLOCATION,0.99999
LE_EGR2_TARGETS_DN,SET,103,-0.25197,-0.018821,0.08593,0.99832,LE_EGR2_TARGETS_DN,0.99999
REACTOME_DEFECTS_IN_COBALAMI...,SET,12,-0.68243,-0.017442,0.23261,0.99832,REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM,0.99999
REACTOME_SIGNALING_BY_GPCR,SET,652,-0.10859,-0.020097,0.037,0.99833,REACTOME_SIGNALING_BY_GPCR,0.99999
GOMF_ER_RETENTION_SEQUENCE_B...,SET,5,-1.0631,-0.017543,0.36174,0.99835,GOMF_ER_RETENTION_SEQUENCE_BINDING,0.99999
HP_ABNORMAL_CIRCULATING_GABA...,SET,6,-1.0574,-0.019113,0.35991,0.99835,HP_ABNORMAL_CIRCULATING_GABA_CONCENTRATION,0.99999
GSE1791_CTRL_VS_NEUROMEDINU_...5,SET,168,-0.18352,-0.017475,0.062451,0.99835,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN,0.99999
KUWANO_RNA_STABILIZED_BY_NO,SET,7,-1.1551,-0.022551,0.39261,0.99837,KUWANO_RNA_STABILIZED_BY_NO,0.99999
GOBP_INTESTINE_SMOOTH_MUSCLE...,SET,8,-0.87609,-0.018285,0.2975,0.99838,GOBP_INTESTINE_SMOOTH_MUSCLE_CONTRACTION,0.99999
HP_THYROIDITIS,SET,45,-0.37883,-0.018733,0.12866,0.99838,HP_THYROIDITIS,0.99999
GOUYER_TATI_TARGETS_UP,SET,10,-0.91157,-0.021269,0.30858,0.99843,GOUYER_TATI_TARGETS_UP,0.99999
GSE40274_CTRL_VS_FOXP3_AND_E...2,SET,157,-0.20556,-0.018929,0.069554,0.99844,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GOBP_REGULATION_OF_MONOOXYGE...,SET,32,-0.45482,-0.018972,0.15372,0.99845,GOBP_REGULATION_OF_MONOOXYGENASE_ACTIVITY,0.99999
GSE19772_CTRL_VS_HCMV_INF_MO...4,SET,182,-0.18638,-0.018466,0.062969,0.99846,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP,0.99999
GSE25088_CTRL_VS_IL4_STIM_MA...1,SET,174,-0.19074,-0.018481,0.064305,0.99849,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_DN,0.99999
GOBP_MAMMARY_GLAND_MORPHOGEN...,SET,44,-0.41916,-0.020496,0.14121,0.9985,GOBP_MAMMARY_GLAND_MORPHOGENESIS,0.99999
GSE43955_TH0_VS_TGFB_IL6_IL2...4,SET,184,-0.18882,-0.018809,0.063586,0.99851,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,0.99999
LEE_LIVER_CANCER_ACOX1_DN,SET,61,-0.33551,-0.019308,0.1129,0.99852,LEE_LIVER_CANCER_ACOX1_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...711,SET,15,-0.64282,-0.018367,0.21613,0.99853,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
GOBP_GLYCOSYLCERAMIDE_BIOSYN...,SET,8,-0.92659,-0.019339,0.31133,0.99854,GOBP_GLYCOSYLCERAMIDE_BIOSYNTHETIC_PROCESS,0.99999
GSE7548_NAIVE_VS_DAY28_PCC_I...2,SET,186,-0.17603,-0.017629,0.059097,0.99855,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,0.99999
chr3p22,SET,78,-0.51364,-0.03341,0.17237,0.99856,chr3p22,0.99999
SWEET_LUNG_CANCER_KRAS_UP,SET,426,-0.12571,-0.018927,0.042171,0.99856,SWEET_LUNG_CANCER_KRAS_UP,0.99999
KEGG_MEDICUS_REFERENCE_CD80_...2,SET,21,-0.53829,-0.018195,0.18047,0.99857,KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY,0.99999
REACTOME_RETROGRADE_TRANSPOR...,SET,46,-0.34393,-0.017195,0.11519,0.99858,REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK,0.99999
ZHAN_MULTIPLE_MYELOMA_CD1_DN,SET,40,-0.41287,-0.019251,0.13794,0.99862,ZHAN_MULTIPLE_MYELOMA_CD1_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...408,SET,7,-1.0317,-0.020142,0.34452,0.99862,GOBP_NEGATIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY,0.99999
GSE13485_CTRL_VS_DAY21_YF17D...1,SET,129,-0.22984,-0.019199,0.076739,0.99863,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.99999
ODONNELL_METASTASIS_DN,SET,23,-0.60182,-0.021288,0.20057,0.99865,ODONNELL_METASTASIS_DN,0.99999
MIR5197_3P,SET,178,-0.19597,-0.019203,0.065312,0.99865,MIR5197_3P,0.99999
ZNF136_TARGET_GENES,SET,5,-1.1378,-0.018775,0.37865,0.99867,ZNF136_TARGET_GENES,0.99999
GOBP_MAMMARY_GLAND_DUCT_MORP...,SET,30,-0.51158,-0.020664,0.16989,0.9987,GOBP_MAMMARY_GLAND_DUCT_MORPHOGENESIS,0.99999
GSE17186_NAIVE_VS_CD21HIGH_T...3,SET,179,-0.19267,-0.018932,0.063944,0.99871,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,0.99999
CHEN_HOXA5_TARGETS_6HR_DN,SET,4,-1.2871,-0.018996,0.42643,0.99873,CHEN_HOXA5_TARGETS_6HR_DN,0.99999
GOMF_DNA_EXONUCLEASE_ACTIVITY,SET,23,-0.45117,-0.015959,0.14948,0.99873,GOMF_DNA_EXONUCLEASE_ACTIVITY,0.99999
BYSTRYKH_HEMATOPOIESIS_STEM_...7,SET,719,-0.097208,-0.018857,0.032174,0.99874,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS,0.99999
REACTOME_RECEPTOR_TYPE_TYROS...,SET,16,-0.69373,-0.020472,0.22931,0.99876,REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES,0.99999
WP_ENDOMETRIAL_CANCER,SET,61,-0.33236,-0.019127,0.10983,0.99876,WP_ENDOMETRIAL_CANCER,0.99999
REACTOME_HUR_ELAVL1_BINDS_AN...,SET,8,-1.0388,-0.02168,0.34298,0.99877,REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA,0.99999
GSE8685_IL15_ACT_IL2_STARVED...2,SET,149,-0.21798,-0.019558,0.071942,0.99878,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,0.99999
REACTOME_TGF_BETA_RECEPTOR_S...2,SET,15,-0.73113,-0.020891,0.24099,0.99879,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.99999
GCM_CSNK2B,SET,85,-0.24913,-0.016913,0.082044,0.9988,GCM_CSNK2B,0.99999
GSE39110_DAY3_VS_DAY6_POST_I...4,SET,183,-0.18458,-0.018337,0.060816,0.9988,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP,0.99999
BIOCARTA_TFF_PATHWAY,SET,24,-0.54323,-0.019629,0.17866,0.99882,BIOCARTA_TFF_PATHWAY,0.99999
BREDEMEYER_RAG_SIGNALING_NOT...1,SET,57,-0.34673,-0.019291,0.11391,0.99883,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,0.99999
KLEIN_TARGETS_OF_BCR_ABL1_FU...,SET,40,-0.44626,-0.020808,0.14652,0.99884,KLEIN_TARGETS_OF_BCR_ABL1_FUSION,0.99999
GSE12845_IGD_NEG_BLOOD_VS_PR...1,SET,182,-0.1856,-0.018388,0.060906,0.99884,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,0.99999
HP_HYPERKETONEMIA,SET,4,-1.316,-0.019423,0.43123,0.99886,HP_HYPERKETONEMIA,0.99999
SENESE_HDAC2_TARGETS_DN,SET,110,-0.26846,-0.020719,0.087908,0.99887,SENESE_HDAC2_TARGETS_DN,0.99999
GOCC_PHOSPHATIDYLINOSITOL_3_...1,SET,29,-0.51506,-0.020455,0.16836,0.99889,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX,0.99999
MIR4765,SET,44,-0.40831,-0.019966,0.13309,0.99892,MIR4765,0.99999
GOBP_G_PROTEIN_COUPLED_RECEP...3,SET,54,-0.3924,-0.021251,0.12788,0.99892,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_COUPLED_TO_CYCLIC_NUCLEOTIDE_SECOND_MESSENGER,0.99999
GSE21670_UNTREATED_VS_TGFB_I...1,SET,160,-0.20892,-0.019419,0.068118,0.99892,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_DN,0.99999
HOLLEMAN_PREDNISOLONE_RESIST...2,SET,16,-0.53269,-0.015719,0.17356,0.99893,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...704,SET,7,-1.0809,-0.021103,0.3515,0.99895,GOBP_NEGATIVE_REGULATION_OF_VITAMIN_METABOLIC_PROCESS,0.99999
GOMF_HISTONE_H4K20_METHYLTRA...,SET,6,-1.0653,-0.019255,0.34586,0.99896,GOMF_HISTONE_H4K20_METHYLTRANSFERASE_ACTIVITY,0.99999
CAIRO_HEPATOBLASTOMA_DN,SET,243,-0.17904,-0.020462,0.058093,0.99897,CAIRO_HEPATOBLASTOMA_DN,0.99999
HP_SHORT_GREATER_SCIATIC_NOT...,SET,3,-1.6658,-0.021293,0.54057,0.99897,HP_SHORT_GREATER_SCIATIC_NOTCH,0.99999
GSE29618_LAIV_VS_TIV_FLU_VAC...7,SET,173,-0.204,-0.01971,0.066,0.999,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN,0.99999
GSE12845_NAIVE_VS_PRE_GC_TON...2,SET,180,-0.20093,-0.019799,0.064915,0.99902,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP,0.99999
GSE3720_VD1_VS_VD2_GAMMADELT...5,SET,179,-0.18921,-0.018592,0.061015,0.99903,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_DN,0.99999
GSE13306_TREG_VS_TCONV_UP,SET,187,-0.19393,-0.019473,0.062506,0.99904,GSE13306_TREG_VS_TCONV_UP,0.99999
GSE28783_ANTI_MIR33_VS_UNTRE...1,SET,177,-0.20835,-0.020359,0.067004,0.99906,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,0.99999
GSE9006_TYPE_1_DIABETES_AT_D...1,SET,163,-0.19694,-0.018475,0.063374,0.99906,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN,0.99999
LUI_THYROID_CANCER_CLUSTER_2,SET,43,-0.41676,-0.020147,0.13389,0.99907,LUI_THYROID_CANCER_CLUSTER_2,0.99999
REACTOME_RUNX3_REGULATES_YAP...,SET,7,-1.1334,-0.022127,0.36287,0.9991,REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION,0.99999
GOBP_HETEROCHROMATIN_ORGANIZ...,SET,13,-0.68622,-0.018254,0.21944,0.99912,GOBP_HETEROCHROMATIN_ORGANIZATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...686,SET,4,-1.1456,-0.016908,0.36559,0.99913,GOBP_POSITIVE_REGULATION_OF_RNA_BINDING,0.99999
GSE3982_MAC_VS_BCELL_DN,SET,163,-0.20108,-0.018863,0.064209,0.99913,GSE3982_MAC_VS_BCELL_DN,0.99999
KEGG_MEDICUS_REFERENCE_PP2A_...,SET,18,-0.59969,-0.018769,0.19066,0.99917,KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_DNA_BINDI...1,SET,66,-0.34277,-0.020515,0.10892,0.99917,GOBP_REGULATION_OF_DNA_BINDING,0.99999
HP_URETHRAL_FISTULA,SET,4,-0.95844,-0.014146,0.30466,0.99917,HP_URETHRAL_FISTULA,0.99999
HP_URETHROVAGINAL_FISTULA,SET,4,-0.95844,-0.014146,0.30466,0.99917,HP_URETHROVAGINAL_FISTULA,0.99999
GOBP_VASOCONSTRICTION,SET,83,-0.32081,-0.021523,0.10191,0.99918,GOBP_VASOCONSTRICTION,0.99999
GSE37533_UNTREATED_VS_PIOGLI...3,SET,180,-0.2003,-0.019736,0.063447,0.9992,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.99999
SWEET_KRAS_ONCOGENIC_SIGNATU...,SET,82,-0.29944,-0.019968,0.094048,0.99927,SWEET_KRAS_ONCOGENIC_SIGNATURE,0.99999
HP_ABNORMAL_BOWEL_SOUNDS,SET,8,-0.79783,-0.016651,0.24971,0.9993,HP_ABNORMAL_BOWEL_SOUNDS,0.99999
HP_AUDITORY_HALLUCINATION,SET,16,-0.65326,-0.019277,0.20382,0.99932,HP_AUDITORY_HALLUCINATION,0.99999
REACTOME_DISASSEMBLY_OF_THE_...,SET,29,-0.51491,-0.020449,0.16047,0.99933,REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE,0.99999
REACTOME_SIGNALING_BY_CTNNB1...,SET,14,-0.73435,-0.020272,0.22854,0.99934,REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS,0.99999
HP_SUBSARCOLEMMAL_ACCUMULATI...,SET,5,-0.9854,-0.01626,0.30615,0.99935,HP_SUBSARCOLEMMAL_ACCUMULATIONS_OF_ABNORMALLY_SHAPED_MITOCHONDRIA,0.99999
KEGG_MEDICUS_REFERENCE_CONDE...,SET,19,-0.58134,-0.018693,0.1802,0.99937,KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING,0.99999
MIR3911,SET,81,-0.30508,-0.02022,0.094544,0.99937,MIR3911,0.99999
YANG_BREAST_CANCER_ESR1_BULK...1,SET,22,-0.61485,-0.021272,0.18953,0.99941,YANG_BREAST_CANCER_ESR1_BULK_DN,0.99999
GSE32986_UNSTIM_VS_GMCSF_STI...2,SET,166,-0.21178,-0.020047,0.065115,0.99943,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_UP,0.99999
MIR550B_2_5P,SET,46,-0.40248,-0.020122,0.12359,0.99944,MIR550B_2_5P,0.99999
HP_DECREASED_URINE_OUTPUT,SET,24,-0.61713,-0.022299,0.18936,0.99944,HP_DECREASED_URINE_OUTPUT,0.99999
chr12q13,SET,248,-0.43666,-0.050408,0.13354,0.99946,chr12q13,0.99999
GSE36476_CTRL_VS_TSST_ACT_16...1,SET,181,-0.199,-0.019662,0.060842,0.99946,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN,0.99999
HP_POOR_APPETITE,SET,47,-0.39316,-0.019868,0.11987,0.99948,HP_POOR_APPETITE,0.99999
VALK_AML_CLUSTER_16,SET,21,-0.64304,-0.021736,0.19565,0.99949,VALK_AML_CLUSTER_16,0.99999
REACTOME_MET_ACTIVATES_RAS_S...,SET,10,-0.84958,-0.019823,0.2581,0.9995,REACTOME_MET_ACTIVATES_RAS_SIGNALING,0.99999
FLETCHER_PBMC_BCG_10W_INFANT...3,SET,163,-0.23388,-0.02194,0.07109,0.9995,FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN,0.99999
CUI_DEVELOPING_HEART_C5_VALV...,SET,183,-0.2237,-0.022223,0.068024,0.9995,CUI_DEVELOPING_HEART_C5_VALVAR_CELL,0.99999
HP_MICRONODULAR_CIRRHOSIS,SET,21,-0.60018,-0.020287,0.18192,0.99951,HP_MICRONODULAR_CIRRHOSIS,0.99999
GOMF_KINASE_INHIBITOR_ACTIVI...,SET,73,-0.337,-0.021208,0.10185,0.99953,GOMF_KINASE_INHIBITOR_ACTIVITY,0.99999
MIR92A_2_5P,SET,192,-0.20023,-0.020369,0.060315,0.99955,MIR92A_2_5P,0.99999
GOBP_REGULATION_OF_VITAMIN_M...,SET,12,-0.81339,-0.020789,0.24495,0.99955,GOBP_REGULATION_OF_VITAMIN_METABOLIC_PROCESS,0.99999
HP_ABNORMALITY_OF_THE_EXTRAO...,SET,11,-0.7231,-0.017695,0.21787,0.99955,HP_ABNORMALITY_OF_THE_EXTRAOCULAR_MUSCLES,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MID...3,SET,849,-0.10326,-0.021687,0.031018,0.99956,HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL,0.99999
GSE9960_HEALTHY_VS_SEPSIS_PB...2,SET,166,-0.22139,-0.020957,0.066433,0.99957,GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP,0.99999
FAELT_B_CLL_WITH_VH_REARRANG...2,SET,45,-0.42415,-0.020974,0.1271,0.99958,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...703,SET,5,-1.3724,-0.022646,0.41062,0.99958,GOBP_NEGATIVE_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS,0.99999
GSE3039_NKT_CELL_VS_ALPHABET...2,SET,182,-0.20087,-0.019901,0.06007,0.99959,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_UP,0.99999
MIR340_5P,SET,707,-0.11173,-0.0215,0.033233,0.99961,MIR340_5P,0.99999
GSE2770_IL12_VS_TGFB_AND_IL1...1,SET,145,-0.2453,-0.021714,0.072981,0.99961,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.99999
KIM_WT1_TARGETS_DN,SET,425,-0.13884,-0.02088,0.041254,0.99962,KIM_WT1_TARGETS_DN,0.99999
REACTOME_SYNTHESIS_OF_KETONE...,SET,8,-1.1077,-0.023118,0.32894,0.99962,REACTOME_SYNTHESIS_OF_KETONE_BODIES,0.99999
DESERT_PERIPORTAL_HEPATOCELL...,SET,147,-0.24432,-0.021775,0.07227,0.99964,DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.99999
HP_WEAK_VOICE,SET,24,-0.53705,-0.019406,0.15892,0.99964,HP_WEAK_VOICE,0.99999
GSE16522_ANTI_CD3CD28_STIM_V...3,SET,179,-0.21621,-0.021246,0.063989,0.99964,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN,0.99999
GOBP_KETONE_BODY_METABOLIC_P...,SET,10,-0.97627,-0.022779,0.28786,0.99965,GOBP_KETONE_BODY_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...182,SET,28,-0.57383,-0.022393,0.16927,0.99965,GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING,0.99999
HP_DEPLETION_OF_MITOCHONDRIA...,SET,16,-0.66132,-0.019515,0.19427,0.99967,HP_DEPLETION_OF_MITOCHONDRIAL_DNA_IN_MUSCLE_TISSUE,0.99999
GSE17186_BLOOD_VS_CORD_BLOOD...6,SET,186,-0.21576,-0.021608,0.063412,0.99967,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP,0.99999
GSE20727_CTRL_VS_ROS_INHIBIT...2,SET,176,-0.21432,-0.020884,0.062731,0.99968,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_UP,0.99999
HP_ABNORMAL_ISCHIUM_MORPHOLO...,SET,24,-0.59015,-0.021324,0.17256,0.99969,HP_ABNORMAL_ISCHIUM_MORPHOLOGY,0.99999
GOCC_GOLGI_MEMBRANE,SET,624,-0.1206,-0.021854,0.035093,0.9997,GOCC_GOLGI_MEMBRANE,0.99999
GOMF_LOW_DENSITY_LIPOPROTEIN...1,SET,16,-0.78502,-0.023165,0.22664,0.99973,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_BINDING,0.99999
GSE27786_LIN_NEG_VS_ERYTHROB...1,SET,181,-0.21645,-0.021386,0.062478,0.99973,GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN,0.99999
MODULE_2,SET,347,-0.17377,-0.023663,0.049895,0.99975,MODULE_2,0.99999
GOMF_1_PHOSPHATIDYLINOSITOL_...2,SET,15,-0.87153,-0.024902,0.2506,0.99975,GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY,0.99999
GOBP_7_METHYLGUANOSINE_RNA_C...,SET,5,-1.0638,-0.017553,0.30463,0.99976,GOBP_7_METHYLGUANOSINE_RNA_CAPPING,0.99999
GSE360_CTRL_VS_L_DONOVANI_DC...2,SET,178,-0.2164,-0.021205,0.061968,0.99976,GSE360_CTRL_VS_L_DONOVANI_DC_UP,0.99999
GSE9650_EFFECTOR_VS_MEMORY_C...2,SET,183,-0.21467,-0.021326,0.061465,0.99976,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP,0.99999
HP_ABNORMAL_CIRCULATING_NUCL...,SET,42,-0.45124,-0.021559,0.12836,0.99978,HP_ABNORMAL_CIRCULATING_NUCLEOBASE_CONCENTRATION,0.99999
GSE40274_IRF4_VS_FOXP3_AND_I...1,SET,102,-0.31372,-0.02332,0.089205,0.99978,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
LI_WILMS_TUMOR_VS_FETAL_KIDN...4,SET,25,-0.63634,-0.023467,0.18055,0.99979,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP,0.99999
GSE13485_DAY1_VS_DAY3_YF17D_...2,SET,141,-0.26878,-0.023465,0.076195,0.99979,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP,0.99999
HP_SENSORY_ATAXIA,SET,14,-0.77556,-0.021409,0.21846,0.99981,HP_SENSORY_ATAXIA,0.99999
GSE40068_CXCR5NEG_BCL6NEG_CD...2,SET,184,-0.22427,-0.02234,0.063009,0.99981,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_UP,0.99999
GSE6674_ANTI_IGM_VS_CPG_STIM...1,SET,179,-0.2226,-0.021873,0.062573,0.99981,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_DN,0.99999
HP_MULTIPLE_MITOCHONDRIAL_DN...,SET,9,-0.85986,-0.019034,0.24129,0.99982,HP_MULTIPLE_MITOCHONDRIAL_DNA_DELETIONS,0.99999
LET_7E_3P,SET,4,-1.6636,-0.024553,0.46445,0.99983,LET_7E_3P,0.99999
REACTOME_SIGNALING_BY_WNT_IN...,SET,32,-0.54611,-0.02278,0.15197,0.99984,REACTOME_SIGNALING_BY_WNT_IN_CANCER,0.99999
GOBP_NEGATIVE_REGULATION_OF_...6,SET,13,-0.88747,-0.023608,0.24644,0.99984,GOBP_NEGATIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,0.99999
HP_ABNORMAL_CEREBELLAR_CORTE...,SET,4,-1.222,-0.018036,0.33879,0.99984,HP_ABNORMAL_CEREBELLAR_CORTEX_MORPHOLOGY,0.99999
GSE16385_UNTREATED_VS_12H_IF...1,SET,171,-0.22791,-0.021894,0.063234,0.99984,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,0.99999
NADLER_OBESITY_UP,SET,58,-0.42515,-0.023859,0.11761,0.99985,NADLER_OBESITY_UP,0.99999
GOBP_REGULATION_OF_CALCIDIOL...,SET,7,-1.2162,-0.023744,0.33476,0.99986,GOBP_REGULATION_OF_CALCIDIOL_1_MONOOXYGENASE_ACTIVITY,0.99999
MIR4258,SET,5,-1.4706,-0.024267,0.40202,0.99987,MIR4258,0.99999
GOBP_MOTOR_BEHAVIOR,SET,20,-0.70185,-0.023153,0.18964,0.99989,GOBP_MOTOR_BEHAVIOR,0.99999
HP_HYPERPLASIA_OF_THE_MAXILLA,SET,9,-1.2195,-0.026996,0.32895,0.99989,HP_HYPERPLASIA_OF_THE_MAXILLA,0.99999
GSE5455_HEALTHY_VS_TUMOR_BEA...1,SET,179,-0.2426,-0.023838,0.065765,0.99989,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_DN,0.99999
KOKKINAKIS_METHIONINE_DEPRIV...4,SET,113,-0.31569,-0.024691,0.084798,0.9999,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,0.99999
REACTOME_CYCLIN_D_ASSOCIATED...,SET,45,-0.4619,-0.022841,0.12403,0.9999,REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,0.99999
HP_ANASARCA,SET,9,-0.85755,-0.018983,0.23117,0.9999,HP_ANASARCA,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...6,SET,143,-0.28323,-0.0249,0.076318,0.9999,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP,0.99999
REACTOME_SLBP_DEPENDENT_PROC...,SET,11,-0.79883,-0.019548,0.21162,0.99992,REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS,0.99999
GOBP_REGULATION_OF_VITAMIN_D...1,SET,7,-1.2808,-0.025005,0.3359,0.99993,GOBP_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...23,SET,22,-0.71011,-0.024568,0.18497,0.99994,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,0.99999
KEGG_TGF_BETA_SIGNALING_PATH...,SET,84,-0.36887,-0.024894,0.094557,0.99995,KEGG_TGF_BETA_SIGNALING_PATHWAY,0.99999
REACTOME_KETONE_BODY_METABOL...,SET,10,-1.1663,-0.027212,0.29779,0.99995,REACTOME_KETONE_BODY_METABOLISM,0.99999
HP_ANGLE_CLOSURE_GLAUCOMA,SET,5,-1.6975,-0.02801,0.43816,0.99995,HP_ANGLE_CLOSURE_GLAUCOMA,0.99999
GSE14386_UNTREATED_VS_IFNA_T...1,SET,149,-0.28339,-0.025427,0.072689,0.99995,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN,0.99999
GOMF_5_DEOXYRIBOSE_5_PHOSPHA...,SET,7,-0.95785,-0.0187,0.24139,0.99996,GOMF_5_DEOXYRIBOSE_5_PHOSPHATE_LYASE_ACTIVITY,0.99999
HP_OLIGURIA,SET,13,-0.9874,-0.026266,0.2483,0.99996,HP_OLIGURIA,0.99999
HP_PRIMARY_HYPOTHYROIDISM,SET,6,-1.1486,-0.020762,0.29014,0.99996,HP_PRIMARY_HYPOTHYROIDISM,0.99999
GSE17721_LPS_VS_PAM3CSK4_1H_...1,SET,189,-0.2551,-0.02575,0.064277,0.99996,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN,0.99999
REACTOME_G_ALPHA_I_SIGNALLIN...,SET,296,-0.22348,-0.028148,0.055231,0.99997,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,0.99999
GSE6674_ANTI_IGM_VS_ANTI_IGM...1,SET,177,-0.25267,-0.024691,0.062591,0.99997,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,0.99999
WP_MYOMETRIAL_RELAXATION_AND...,SET,153,-0.29931,-0.027211,0.073069,0.99998,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,0.99999
GSE36009_WT_VS_NLRP10_KO_DC_...3,SET,186,-0.25536,-0.025573,0.061906,0.99998,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP,0.99999
GSE3982_DC_VS_TH1_DN,SET,177,-0.25597,-0.025013,0.061436,0.99998,GSE3982_DC_VS_TH1_DN,0.99999
GOMF_SINGLE_STRANDED_DNA_EXO...,SET,10,-0.88522,-0.020655,0.20995,0.99999,GOMF_SINGLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY,0.99999
HP_NARROW_FORAMEN_OBTURATORI...,SET,4,-1.6463,-0.024299,0.39099,0.99999,HP_NARROW_FORAMEN_OBTURATORIUM,0.99999
